{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": 1,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "c5uXGyOb9d7h",
        "outputId": "168ab739-5232-4be0-8aa8-89b018458de9"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting langchain_community\n",
            "  Downloading langchain_community-0.3.19-py3-none-any.whl.metadata (2.4 kB)\n",
            "Collecting tiktoken\n",
            "  Downloading tiktoken-0.9.0-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (6.7 kB)\n",
            "Collecting langchain-openai\n",
            "  Downloading langchain_openai-0.3.8-py3-none-any.whl.metadata (2.3 kB)\n",
            "Collecting langchainhub\n",
            "  Downloading langchainhub-0.1.21-py3-none-any.whl.metadata (659 bytes)\n",
            "Collecting chromadb\n",
            "  Downloading chromadb-0.6.3-py3-none-any.whl.metadata (6.8 kB)\n",
            "Requirement already satisfied: langchain in /usr/local/lib/python3.11/dist-packages (0.3.19)\n",
            "Collecting langchain-core<1.0.0,>=0.3.41 (from langchain_community)\n",
            "  Downloading langchain_core-0.3.43-py3-none-any.whl.metadata (5.9 kB)\n",
            "Collecting langchain\n",
            "  Downloading langchain-0.3.20-py3-none-any.whl.metadata (7.7 kB)\n",
            "Requirement already satisfied: SQLAlchemy<3,>=1.4 in /usr/local/lib/python3.11/dist-packages (from langchain_community) (2.0.38)\n",
            "Requirement already satisfied: requests<3,>=2 in /usr/local/lib/python3.11/dist-packages (from langchain_community) (2.32.3)\n",
            "Requirement already satisfied: PyYAML>=5.3 in /usr/local/lib/python3.11/dist-packages (from langchain_community) (6.0.2)\n",
            "Requirement already satisfied: aiohttp<4.0.0,>=3.8.3 in /usr/local/lib/python3.11/dist-packages (from langchain_community) (3.11.13)\n",
            "Requirement already satisfied: tenacity!=8.4.0,<10,>=8.1.0 in /usr/local/lib/python3.11/dist-packages (from langchain_community) (9.0.0)\n",
            "Collecting dataclasses-json<0.7,>=0.5.7 (from langchain_community)\n",
            "  Downloading dataclasses_json-0.6.7-py3-none-any.whl.metadata (25 kB)\n",
            "Collecting pydantic-settings<3.0.0,>=2.4.0 (from langchain_community)\n",
            "  Downloading pydantic_settings-2.8.1-py3-none-any.whl.metadata (3.5 kB)\n",
            "Requirement already satisfied: langsmith<0.4,>=0.1.125 in /usr/local/lib/python3.11/dist-packages (from langchain_community) (0.3.11)\n",
            "Collecting httpx-sse<1.0.0,>=0.4.0 (from langchain_community)\n",
            "  Downloading httpx_sse-0.4.0-py3-none-any.whl.metadata (9.0 kB)\n",
            "Requirement already satisfied: numpy<3,>=1.26.2 in /usr/local/lib/python3.11/dist-packages (from langchain_community) (1.26.4)\n",
            "Requirement already satisfied: regex>=2022.1.18 in /usr/local/lib/python3.11/dist-packages (from tiktoken) (2024.11.6)\n",
            "Requirement already satisfied: openai<2.0.0,>=1.58.1 in /usr/local/lib/python3.11/dist-packages (from langchain-openai) (1.61.1)\n",
            "Requirement already satisfied: packaging<25,>=23.2 in /usr/local/lib/python3.11/dist-packages (from langchainhub) (24.2)\n",
            "Collecting types-requests<3.0.0.0,>=2.31.0.2 (from langchainhub)\n",
            "  Downloading types_requests-2.32.0.20250306-py3-none-any.whl.metadata (2.3 kB)\n",
            "Collecting build>=1.0.3 (from chromadb)\n",
            "  Downloading build-1.2.2.post1-py3-none-any.whl.metadata (6.5 kB)\n",
            "Requirement already satisfied: pydantic>=1.9 in /usr/local/lib/python3.11/dist-packages (from chromadb) (2.10.6)\n",
            "Collecting chroma-hnswlib==0.7.6 (from chromadb)\n",
            "  Downloading chroma_hnswlib-0.7.6-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (252 bytes)\n",
            "Collecting fastapi>=0.95.2 (from chromadb)\n",
            "  Downloading fastapi-0.115.11-py3-none-any.whl.metadata (27 kB)\n",
            "Collecting uvicorn>=0.18.3 (from uvicorn[standard]>=0.18.3->chromadb)\n",
            "  Downloading uvicorn-0.34.0-py3-none-any.whl.metadata (6.5 kB)\n",
            "Collecting posthog>=2.4.0 (from chromadb)\n",
            "  Downloading posthog-3.19.0-py2.py3-none-any.whl.metadata (2.9 kB)\n",
            "Requirement already satisfied: typing_extensions>=4.5.0 in /usr/local/lib/python3.11/dist-packages (from chromadb) (4.12.2)\n",
            "Collecting onnxruntime>=1.14.1 (from chromadb)\n",
            "  Downloading onnxruntime-1.21.0-cp311-cp311-manylinux_2_27_x86_64.manylinux_2_28_x86_64.whl.metadata (4.5 kB)\n",
            "Requirement already satisfied: opentelemetry-api>=1.2.0 in /usr/local/lib/python3.11/dist-packages (from chromadb) (1.16.0)\n",
            "Collecting opentelemetry-exporter-otlp-proto-grpc>=1.2.0 (from chromadb)\n",
            "  Downloading opentelemetry_exporter_otlp_proto_grpc-1.30.0-py3-none-any.whl.metadata (2.4 kB)\n",
            "Collecting opentelemetry-instrumentation-fastapi>=0.41b0 (from chromadb)\n",
            "  Downloading opentelemetry_instrumentation_fastapi-0.51b0-py3-none-any.whl.metadata (2.2 kB)\n",
            "Requirement already satisfied: opentelemetry-sdk>=1.2.0 in /usr/local/lib/python3.11/dist-packages (from chromadb) (1.16.0)\n",
            "Requirement already satisfied: tokenizers>=0.13.2 in /usr/local/lib/python3.11/dist-packages (from chromadb) (0.21.0)\n",
            "Collecting pypika>=0.48.9 (from chromadb)\n",
            "  Downloading PyPika-0.48.9.tar.gz (67 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m67.3/67.3 kB\u001b[0m \u001b[31m3.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h  Installing build dependencies ... \u001b[?25l\u001b[?25hdone\n",
            "  Getting requirements to build wheel ... \u001b[?25l\u001b[?25hdone\n",
            "  Preparing metadata (pyproject.toml) ... \u001b[?25l\u001b[?25hdone\n",
            "Requirement already satisfied: tqdm>=4.65.0 in /usr/local/lib/python3.11/dist-packages (from chromadb) (4.67.1)\n",
            "Collecting overrides>=7.3.1 (from chromadb)\n",
            "  Downloading overrides-7.7.0-py3-none-any.whl.metadata (5.8 kB)\n",
            "Requirement already satisfied: importlib-resources in /usr/local/lib/python3.11/dist-packages (from chromadb) (6.5.2)\n",
            "Requirement already satisfied: grpcio>=1.58.0 in /usr/local/lib/python3.11/dist-packages (from chromadb) (1.70.0)\n",
            "Collecting bcrypt>=4.0.1 (from chromadb)\n",
            "  Downloading bcrypt-4.3.0-cp39-abi3-manylinux_2_34_x86_64.whl.metadata (10 kB)\n",
            "Requirement already satisfied: typer>=0.9.0 in /usr/local/lib/python3.11/dist-packages (from chromadb) (0.15.2)\n",
            "Collecting kubernetes>=28.1.0 (from chromadb)\n",
            "  Downloading kubernetes-32.0.1-py2.py3-none-any.whl.metadata (1.7 kB)\n",
            "Collecting mmh3>=4.0.1 (from chromadb)\n",
            "  Downloading mmh3-5.1.0-cp311-cp311-manylinux_2_5_x86_64.manylinux1_x86_64.manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (16 kB)\n",
            "Requirement already satisfied: orjson>=3.9.12 in /usr/local/lib/python3.11/dist-packages (from chromadb) (3.10.15)\n",
            "Requirement already satisfied: httpx>=0.27.0 in /usr/local/lib/python3.11/dist-packages (from chromadb) (0.28.1)\n",
            "Requirement already satisfied: rich>=10.11.0 in /usr/local/lib/python3.11/dist-packages (from chromadb) (13.9.4)\n",
            "Requirement already satisfied: langchain-text-splitters<1.0.0,>=0.3.6 in /usr/local/lib/python3.11/dist-packages (from langchain) (0.3.6)\n",
            "Requirement already satisfied: aiohappyeyeballs>=2.3.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (2.4.6)\n",
            "Requirement already satisfied: aiosignal>=1.1.2 in /usr/local/lib/python3.11/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (1.3.2)\n",
            "Requirement already satisfied: attrs>=17.3.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (25.1.0)\n",
            "Requirement already satisfied: frozenlist>=1.1.1 in /usr/local/lib/python3.11/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (1.5.0)\n",
            "Requirement already satisfied: multidict<7.0,>=4.5 in /usr/local/lib/python3.11/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (6.1.0)\n",
            "Requirement already satisfied: propcache>=0.2.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (0.3.0)\n",
            "Requirement already satisfied: yarl<2.0,>=1.17.0 in /usr/local/lib/python3.11/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (1.18.3)\n",
            "Collecting pyproject_hooks (from build>=1.0.3->chromadb)\n",
            "  Downloading pyproject_hooks-1.2.0-py3-none-any.whl.metadata (1.3 kB)\n",
            "Collecting marshmallow<4.0.0,>=3.18.0 (from dataclasses-json<0.7,>=0.5.7->langchain_community)\n",
            "  Downloading marshmallow-3.26.1-py3-none-any.whl.metadata (7.3 kB)\n",
            "Collecting typing-inspect<1,>=0.4.0 (from dataclasses-json<0.7,>=0.5.7->langchain_community)\n",
            "  Downloading typing_inspect-0.9.0-py3-none-any.whl.metadata (1.5 kB)\n",
            "Collecting starlette<0.47.0,>=0.40.0 (from fastapi>=0.95.2->chromadb)\n",
            "  Downloading starlette-0.46.1-py3-none-any.whl.metadata (6.2 kB)\n",
            "Requirement already satisfied: anyio in /usr/local/lib/python3.11/dist-packages (from httpx>=0.27.0->chromadb) (3.7.1)\n",
            "Requirement already satisfied: certifi in /usr/local/lib/python3.11/dist-packages (from httpx>=0.27.0->chromadb) (2025.1.31)\n",
            "Requirement already satisfied: httpcore==1.* in /usr/local/lib/python3.11/dist-packages (from httpx>=0.27.0->chromadb) (1.0.7)\n",
            "Requirement already satisfied: idna in /usr/local/lib/python3.11/dist-packages (from httpx>=0.27.0->chromadb) (3.10)\n",
            "Requirement already satisfied: h11<0.15,>=0.13 in /usr/local/lib/python3.11/dist-packages (from httpcore==1.*->httpx>=0.27.0->chromadb) (0.14.0)\n",
            "Requirement already satisfied: six>=1.9.0 in /usr/local/lib/python3.11/dist-packages (from kubernetes>=28.1.0->chromadb) (1.17.0)\n",
            "Requirement already satisfied: python-dateutil>=2.5.3 in /usr/local/lib/python3.11/dist-packages (from kubernetes>=28.1.0->chromadb) (2.8.2)\n",
            "Requirement already satisfied: google-auth>=1.0.1 in /usr/local/lib/python3.11/dist-packages (from kubernetes>=28.1.0->chromadb) (2.38.0)\n",
            "Requirement already satisfied: websocket-client!=0.40.0,!=0.41.*,!=0.42.*,>=0.32.0 in /usr/local/lib/python3.11/dist-packages (from kubernetes>=28.1.0->chromadb) (1.8.0)\n",
            "Requirement already satisfied: requests-oauthlib in /usr/local/lib/python3.11/dist-packages (from kubernetes>=28.1.0->chromadb) (2.0.0)\n",
            "Requirement already satisfied: oauthlib>=3.2.2 in /usr/local/lib/python3.11/dist-packages (from kubernetes>=28.1.0->chromadb) (3.2.2)\n",
            "Requirement already satisfied: urllib3>=1.24.2 in /usr/local/lib/python3.11/dist-packages (from kubernetes>=28.1.0->chromadb) (2.3.0)\n",
            "Collecting durationpy>=0.7 (from kubernetes>=28.1.0->chromadb)\n",
            "  Downloading durationpy-0.9-py3-none-any.whl.metadata (338 bytes)\n",
            "Requirement already satisfied: jsonpatch<2.0,>=1.33 in /usr/local/lib/python3.11/dist-packages (from langchain-core<1.0.0,>=0.3.41->langchain_community) (1.33)\n",
            "Requirement already satisfied: requests-toolbelt<2.0.0,>=1.0.0 in /usr/local/lib/python3.11/dist-packages (from langsmith<0.4,>=0.1.125->langchain_community) (1.0.0)\n",
            "Requirement already satisfied: zstandard<0.24.0,>=0.23.0 in /usr/local/lib/python3.11/dist-packages (from langsmith<0.4,>=0.1.125->langchain_community) (0.23.0)\n",
            "Collecting coloredlogs (from onnxruntime>=1.14.1->chromadb)\n",
            "  Downloading coloredlogs-15.0.1-py2.py3-none-any.whl.metadata (12 kB)\n",
            "Requirement already satisfied: flatbuffers in /usr/local/lib/python3.11/dist-packages (from onnxruntime>=1.14.1->chromadb) (25.2.10)\n",
            "Requirement already satisfied: protobuf in /usr/local/lib/python3.11/dist-packages (from onnxruntime>=1.14.1->chromadb) (4.25.6)\n",
            "Requirement already satisfied: sympy in /usr/local/lib/python3.11/dist-packages (from onnxruntime>=1.14.1->chromadb) (1.13.1)\n",
            "Requirement already satisfied: distro<2,>=1.7.0 in /usr/local/lib/python3.11/dist-packages (from openai<2.0.0,>=1.58.1->langchain-openai) (1.9.0)\n",
            "Requirement already satisfied: jiter<1,>=0.4.0 in /usr/local/lib/python3.11/dist-packages (from openai<2.0.0,>=1.58.1->langchain-openai) (0.8.2)\n",
            "Requirement already satisfied: sniffio in /usr/local/lib/python3.11/dist-packages (from openai<2.0.0,>=1.58.1->langchain-openai) (1.3.1)\n",
            "Requirement already satisfied: deprecated>=1.2.6 in /usr/local/lib/python3.11/dist-packages (from opentelemetry-api>=1.2.0->chromadb) (1.2.18)\n",
            "Requirement already satisfied: setuptools>=16.0 in /usr/local/lib/python3.11/dist-packages (from opentelemetry-api>=1.2.0->chromadb) (75.1.0)\n",
            "Requirement already satisfied: googleapis-common-protos~=1.52 in /usr/local/lib/python3.11/dist-packages (from opentelemetry-exporter-otlp-proto-grpc>=1.2.0->chromadb) (1.69.0)\n",
            "Collecting opentelemetry-exporter-otlp-proto-common==1.30.0 (from opentelemetry-exporter-otlp-proto-grpc>=1.2.0->chromadb)\n",
            "  Downloading opentelemetry_exporter_otlp_proto_common-1.30.0-py3-none-any.whl.metadata (1.9 kB)\n",
            "Collecting opentelemetry-proto==1.30.0 (from opentelemetry-exporter-otlp-proto-grpc>=1.2.0->chromadb)\n",
            "  Downloading opentelemetry_proto-1.30.0-py3-none-any.whl.metadata (2.4 kB)\n",
            "Collecting opentelemetry-sdk>=1.2.0 (from chromadb)\n",
            "  Downloading opentelemetry_sdk-1.30.0-py3-none-any.whl.metadata (1.6 kB)\n",
            "Collecting protobuf (from onnxruntime>=1.14.1->chromadb)\n",
            "  Downloading protobuf-5.29.3-cp38-abi3-manylinux2014_x86_64.whl.metadata (592 bytes)\n",
            "Collecting opentelemetry-instrumentation-asgi==0.51b0 (from opentelemetry-instrumentation-fastapi>=0.41b0->chromadb)\n",
            "  Downloading opentelemetry_instrumentation_asgi-0.51b0-py3-none-any.whl.metadata (2.1 kB)\n",
            "Collecting opentelemetry-instrumentation==0.51b0 (from opentelemetry-instrumentation-fastapi>=0.41b0->chromadb)\n",
            "  Downloading opentelemetry_instrumentation-0.51b0-py3-none-any.whl.metadata (6.3 kB)\n",
            "Collecting opentelemetry-semantic-conventions==0.51b0 (from opentelemetry-instrumentation-fastapi>=0.41b0->chromadb)\n",
            "  Downloading opentelemetry_semantic_conventions-0.51b0-py3-none-any.whl.metadata (2.5 kB)\n",
            "Collecting opentelemetry-util-http==0.51b0 (from opentelemetry-instrumentation-fastapi>=0.41b0->chromadb)\n",
            "  Downloading opentelemetry_util_http-0.51b0-py3-none-any.whl.metadata (2.6 kB)\n",
            "Requirement already satisfied: wrapt<2.0.0,>=1.0.0 in /usr/local/lib/python3.11/dist-packages (from opentelemetry-instrumentation==0.51b0->opentelemetry-instrumentation-fastapi>=0.41b0->chromadb) (1.17.2)\n",
            "Collecting asgiref~=3.0 (from opentelemetry-instrumentation-asgi==0.51b0->opentelemetry-instrumentation-fastapi>=0.41b0->chromadb)\n",
            "  Downloading asgiref-3.8.1-py3-none-any.whl.metadata (9.3 kB)\n",
            "Collecting opentelemetry-api>=1.2.0 (from chromadb)\n",
            "  Downloading opentelemetry_api-1.30.0-py3-none-any.whl.metadata (1.6 kB)\n",
            "Collecting importlib-metadata<=8.5.0,>=6.0 (from opentelemetry-api>=1.2.0->chromadb)\n",
            "  Downloading importlib_metadata-8.5.0-py3-none-any.whl.metadata (4.8 kB)\n",
            "Collecting monotonic>=1.5 (from posthog>=2.4.0->chromadb)\n",
            "  Downloading monotonic-1.6-py2.py3-none-any.whl.metadata (1.5 kB)\n",
            "Collecting backoff>=1.10.0 (from posthog>=2.4.0->chromadb)\n",
            "  Downloading backoff-2.2.1-py3-none-any.whl.metadata (14 kB)\n",
            "Requirement already satisfied: annotated-types>=0.6.0 in /usr/local/lib/python3.11/dist-packages (from pydantic>=1.9->chromadb) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.27.2 in /usr/local/lib/python3.11/dist-packages (from pydantic>=1.9->chromadb) (2.27.2)\n",
            "Collecting python-dotenv>=0.21.0 (from pydantic-settings<3.0.0,>=2.4.0->langchain_community)\n",
            "  Downloading python_dotenv-1.0.1-py3-none-any.whl.metadata (23 kB)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.11/dist-packages (from requests<3,>=2->langchain_community) (3.4.1)\n",
            "Requirement already satisfied: markdown-it-py>=2.2.0 in /usr/local/lib/python3.11/dist-packages (from rich>=10.11.0->chromadb) (3.0.0)\n",
            "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in /usr/local/lib/python3.11/dist-packages (from rich>=10.11.0->chromadb) (2.18.0)\n",
            "Requirement already satisfied: greenlet!=0.4.17 in /usr/local/lib/python3.11/dist-packages (from SQLAlchemy<3,>=1.4->langchain_community) (3.1.1)\n",
            "Requirement already satisfied: huggingface-hub<1.0,>=0.16.4 in /usr/local/lib/python3.11/dist-packages (from tokenizers>=0.13.2->chromadb) (0.28.1)\n",
            "Requirement already satisfied: click>=8.0.0 in /usr/local/lib/python3.11/dist-packages (from typer>=0.9.0->chromadb) (8.1.8)\n",
            "Requirement already satisfied: shellingham>=1.3.0 in /usr/local/lib/python3.11/dist-packages (from typer>=0.9.0->chromadb) (1.5.4)\n",
            "Collecting httptools>=0.6.3 (from uvicorn[standard]>=0.18.3->chromadb)\n",
            "  Downloading httptools-0.6.4-cp311-cp311-manylinux_2_5_x86_64.manylinux1_x86_64.manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (3.6 kB)\n",
            "Collecting uvloop!=0.15.0,!=0.15.1,>=0.14.0 (from uvicorn[standard]>=0.18.3->chromadb)\n",
            "  Downloading uvloop-0.21.0-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (4.9 kB)\n",
            "Collecting watchfiles>=0.13 (from uvicorn[standard]>=0.18.3->chromadb)\n",
            "  Downloading watchfiles-1.0.4-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (4.9 kB)\n",
            "Requirement already satisfied: websockets>=10.4 in /usr/local/lib/python3.11/dist-packages (from uvicorn[standard]>=0.18.3->chromadb) (14.2)\n",
            "Requirement already satisfied: cachetools<6.0,>=2.0.0 in /usr/local/lib/python3.11/dist-packages (from google-auth>=1.0.1->kubernetes>=28.1.0->chromadb) (5.5.2)\n",
            "Requirement already satisfied: pyasn1-modules>=0.2.1 in /usr/local/lib/python3.11/dist-packages (from google-auth>=1.0.1->kubernetes>=28.1.0->chromadb) (0.4.1)\n",
            "Requirement already satisfied: rsa<5,>=3.1.4 in /usr/local/lib/python3.11/dist-packages (from google-auth>=1.0.1->kubernetes>=28.1.0->chromadb) (4.9)\n",
            "Requirement already satisfied: filelock in /usr/local/lib/python3.11/dist-packages (from huggingface-hub<1.0,>=0.16.4->tokenizers>=0.13.2->chromadb) (3.17.0)\n",
            "Requirement already satisfied: fsspec>=2023.5.0 in /usr/local/lib/python3.11/dist-packages (from huggingface-hub<1.0,>=0.16.4->tokenizers>=0.13.2->chromadb) (2024.10.0)\n",
            "Requirement already satisfied: zipp>=3.20 in /usr/local/lib/python3.11/dist-packages (from importlib-metadata<=8.5.0,>=6.0->opentelemetry-api>=1.2.0->chromadb) (3.21.0)\n",
            "Requirement already satisfied: jsonpointer>=1.9 in /usr/local/lib/python3.11/dist-packages (from jsonpatch<2.0,>=1.33->langchain-core<1.0.0,>=0.3.41->langchain_community) (3.0.0)\n",
            "Requirement already satisfied: mdurl~=0.1 in /usr/local/lib/python3.11/dist-packages (from markdown-it-py>=2.2.0->rich>=10.11.0->chromadb) (0.1.2)\n",
            "Collecting mypy-extensions>=0.3.0 (from typing-inspect<1,>=0.4.0->dataclasses-json<0.7,>=0.5.7->langchain_community)\n",
            "  Downloading mypy_extensions-1.0.0-py3-none-any.whl.metadata (1.1 kB)\n",
            "Collecting humanfriendly>=9.1 (from coloredlogs->onnxruntime>=1.14.1->chromadb)\n",
            "  Downloading humanfriendly-10.0-py2.py3-none-any.whl.metadata (9.2 kB)\n",
            "Requirement already satisfied: mpmath<1.4,>=1.1.0 in /usr/local/lib/python3.11/dist-packages (from sympy->onnxruntime>=1.14.1->chromadb) (1.3.0)\n",
            "Requirement already satisfied: pyasn1<0.7.0,>=0.4.6 in /usr/local/lib/python3.11/dist-packages (from pyasn1-modules>=0.2.1->google-auth>=1.0.1->kubernetes>=28.1.0->chromadb) (0.6.1)\n",
            "Downloading langchain_community-0.3.19-py3-none-any.whl (2.5 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.5/2.5 MB\u001b[0m \u001b[31m41.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading tiktoken-0.9.0-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (1.2 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.2/1.2 MB\u001b[0m \u001b[31m69.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading langchain_openai-0.3.8-py3-none-any.whl (55 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m55.4/55.4 kB\u001b[0m \u001b[31m5.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading langchainhub-0.1.21-py3-none-any.whl (5.2 kB)\n",
            "Downloading chromadb-0.6.3-py3-none-any.whl (611 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m611.1/611.1 kB\u001b[0m \u001b[31m49.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading chroma_hnswlib-0.7.6-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (2.4 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.4/2.4 MB\u001b[0m \u001b[31m95.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading langchain-0.3.20-py3-none-any.whl (1.0 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.0/1.0 MB\u001b[0m \u001b[31m61.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading bcrypt-4.3.0-cp39-abi3-manylinux_2_34_x86_64.whl (284 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m284.2/284.2 kB\u001b[0m \u001b[31m24.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading build-1.2.2.post1-py3-none-any.whl (22 kB)\n",
            "Downloading dataclasses_json-0.6.7-py3-none-any.whl (28 kB)\n",
            "Downloading fastapi-0.115.11-py3-none-any.whl (94 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m94.9/94.9 kB\u001b[0m \u001b[31m9.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading httpx_sse-0.4.0-py3-none-any.whl (7.8 kB)\n",
            "Downloading kubernetes-32.0.1-py2.py3-none-any.whl (2.0 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.0/2.0 MB\u001b[0m \u001b[31m89.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading langchain_core-0.3.43-py3-none-any.whl (415 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m415.4/415.4 kB\u001b[0m \u001b[31m37.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading mmh3-5.1.0-cp311-cp311-manylinux_2_5_x86_64.manylinux1_x86_64.manylinux_2_17_x86_64.manylinux2014_x86_64.whl (101 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m101.6/101.6 kB\u001b[0m \u001b[31m10.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading onnxruntime-1.21.0-cp311-cp311-manylinux_2_27_x86_64.manylinux_2_28_x86_64.whl (16.0 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m16.0/16.0 MB\u001b[0m \u001b[31m105.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading opentelemetry_exporter_otlp_proto_grpc-1.30.0-py3-none-any.whl (18 kB)\n",
            "Downloading opentelemetry_exporter_otlp_proto_common-1.30.0-py3-none-any.whl (18 kB)\n",
            "Downloading opentelemetry_proto-1.30.0-py3-none-any.whl (55 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m55.9/55.9 kB\u001b[0m \u001b[31m5.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading opentelemetry_instrumentation_fastapi-0.51b0-py3-none-any.whl (12 kB)\n",
            "Downloading opentelemetry_instrumentation-0.51b0-py3-none-any.whl (30 kB)\n",
            "Downloading opentelemetry_instrumentation_asgi-0.51b0-py3-none-any.whl (16 kB)\n",
            "Downloading opentelemetry_semantic_conventions-0.51b0-py3-none-any.whl (177 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m177.4/177.4 kB\u001b[0m \u001b[31m16.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading opentelemetry_api-1.30.0-py3-none-any.whl (64 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m65.0/65.0 kB\u001b[0m \u001b[31m6.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading opentelemetry_util_http-0.51b0-py3-none-any.whl (7.3 kB)\n",
            "Downloading opentelemetry_sdk-1.30.0-py3-none-any.whl (118 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m118.7/118.7 kB\u001b[0m \u001b[31m10.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading overrides-7.7.0-py3-none-any.whl (17 kB)\n",
            "Downloading posthog-3.19.0-py2.py3-none-any.whl (77 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m77.8/77.8 kB\u001b[0m \u001b[31m8.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pydantic_settings-2.8.1-py3-none-any.whl (30 kB)\n",
            "Downloading types_requests-2.32.0.20250306-py3-none-any.whl (20 kB)\n",
            "Downloading uvicorn-0.34.0-py3-none-any.whl (62 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m62.3/62.3 kB\u001b[0m \u001b[31m5.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading backoff-2.2.1-py3-none-any.whl (15 kB)\n",
            "Downloading durationpy-0.9-py3-none-any.whl (3.5 kB)\n",
            "Downloading httptools-0.6.4-cp311-cp311-manylinux_2_5_x86_64.manylinux1_x86_64.manylinux_2_17_x86_64.manylinux2014_x86_64.whl (459 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m459.8/459.8 kB\u001b[0m \u001b[31m40.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading importlib_metadata-8.5.0-py3-none-any.whl (26 kB)\n",
            "Downloading marshmallow-3.26.1-py3-none-any.whl (50 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m50.9/50.9 kB\u001b[0m \u001b[31m4.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading monotonic-1.6-py2.py3-none-any.whl (8.2 kB)\n",
            "Downloading protobuf-5.29.3-cp38-abi3-manylinux2014_x86_64.whl (319 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m319.7/319.7 kB\u001b[0m \u001b[31m30.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading python_dotenv-1.0.1-py3-none-any.whl (19 kB)\n",
            "Downloading starlette-0.46.1-py3-none-any.whl (71 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m72.0/72.0 kB\u001b[0m \u001b[31m7.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading typing_inspect-0.9.0-py3-none-any.whl (8.8 kB)\n",
            "Downloading uvloop-0.21.0-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (4.0 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m4.0/4.0 MB\u001b[0m \u001b[31m103.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading watchfiles-1.0.4-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (452 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m452.6/452.6 kB\u001b[0m \u001b[31m38.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading coloredlogs-15.0.1-py2.py3-none-any.whl (46 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m46.0/46.0 kB\u001b[0m \u001b[31m4.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pyproject_hooks-1.2.0-py3-none-any.whl (10 kB)\n",
            "Downloading asgiref-3.8.1-py3-none-any.whl (23 kB)\n",
            "Downloading humanfriendly-10.0-py2.py3-none-any.whl (86 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m86.8/86.8 kB\u001b[0m \u001b[31m7.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading mypy_extensions-1.0.0-py3-none-any.whl (4.7 kB)\n",
            "Building wheels for collected packages: pypika\n",
            "  Building wheel for pypika (pyproject.toml) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for pypika: filename=pypika-0.48.9-py2.py3-none-any.whl size=53770 sha256=58c00b15966db0f1736ea600d618ce926df284b79ffde2f7a7b68228b1a7114d\n",
            "  Stored in directory: /root/.cache/pip/wheels/a3/01/bd/4c40ceb9d5354160cb186dcc153360f4ab7eb23e2b24daf96d\n",
            "Successfully built pypika\n",
            "Installing collected packages: pypika, monotonic, durationpy, uvloop, uvicorn, types-requests, python-dotenv, pyproject_hooks, protobuf, overrides, opentelemetry-util-http, mypy-extensions, mmh3, marshmallow, importlib-metadata, humanfriendly, httpx-sse, httptools, chroma-hnswlib, bcrypt, backoff, asgiref, watchfiles, typing-inspect, tiktoken, starlette, posthog, opentelemetry-proto, opentelemetry-api, langchainhub, coloredlogs, build, pydantic-settings, opentelemetry-semantic-conventions, opentelemetry-exporter-otlp-proto-common, onnxruntime, kubernetes, fastapi, dataclasses-json, opentelemetry-sdk, opentelemetry-instrumentation, langchain-core, opentelemetry-instrumentation-asgi, opentelemetry-exporter-otlp-proto-grpc, langchain-openai, opentelemetry-instrumentation-fastapi, langchain, langchain_community, chromadb\n",
            "  Attempting uninstall: protobuf\n",
            "    Found existing installation: protobuf 4.25.6\n",
            "    Uninstalling protobuf-4.25.6:\n",
            "      Successfully uninstalled protobuf-4.25.6\n",
            "  Attempting uninstall: importlib-metadata\n",
            "    Found existing installation: importlib_metadata 8.6.1\n",
            "    Uninstalling importlib_metadata-8.6.1:\n",
            "      Successfully uninstalled importlib_metadata-8.6.1\n",
            "  Attempting uninstall: opentelemetry-api\n",
            "    Found existing installation: opentelemetry-api 1.16.0\n",
            "    Uninstalling opentelemetry-api-1.16.0:\n",
            "      Successfully uninstalled opentelemetry-api-1.16.0\n",
            "  Attempting uninstall: opentelemetry-semantic-conventions\n",
            "    Found existing installation: opentelemetry-semantic-conventions 0.37b0\n",
            "    Uninstalling opentelemetry-semantic-conventions-0.37b0:\n",
            "      Successfully uninstalled opentelemetry-semantic-conventions-0.37b0\n",
            "  Attempting uninstall: opentelemetry-sdk\n",
            "    Found existing installation: opentelemetry-sdk 1.16.0\n",
            "    Uninstalling opentelemetry-sdk-1.16.0:\n",
            "      Successfully uninstalled opentelemetry-sdk-1.16.0\n",
            "  Attempting uninstall: langchain-core\n",
            "    Found existing installation: langchain-core 0.3.40\n",
            "    Uninstalling langchain-core-0.3.40:\n",
            "      Successfully uninstalled langchain-core-0.3.40\n",
            "  Attempting uninstall: langchain\n",
            "    Found existing installation: langchain 0.3.19\n",
            "    Uninstalling langchain-0.3.19:\n",
            "      Successfully uninstalled langchain-0.3.19\n",
            "Successfully installed asgiref-3.8.1 backoff-2.2.1 bcrypt-4.3.0 build-1.2.2.post1 chroma-hnswlib-0.7.6 chromadb-0.6.3 coloredlogs-15.0.1 dataclasses-json-0.6.7 durationpy-0.9 fastapi-0.115.11 httptools-0.6.4 httpx-sse-0.4.0 humanfriendly-10.0 importlib-metadata-8.5.0 kubernetes-32.0.1 langchain-0.3.20 langchain-core-0.3.43 langchain-openai-0.3.8 langchain_community-0.3.19 langchainhub-0.1.21 marshmallow-3.26.1 mmh3-5.1.0 monotonic-1.6 mypy-extensions-1.0.0 onnxruntime-1.21.0 opentelemetry-api-1.30.0 opentelemetry-exporter-otlp-proto-common-1.30.0 opentelemetry-exporter-otlp-proto-grpc-1.30.0 opentelemetry-instrumentation-0.51b0 opentelemetry-instrumentation-asgi-0.51b0 opentelemetry-instrumentation-fastapi-0.51b0 opentelemetry-proto-1.30.0 opentelemetry-sdk-1.30.0 opentelemetry-semantic-conventions-0.51b0 opentelemetry-util-http-0.51b0 overrides-7.7.0 posthog-3.19.0 protobuf-5.29.3 pydantic-settings-2.8.1 pypika-0.48.9 pyproject_hooks-1.2.0 python-dotenv-1.0.1 starlette-0.46.1 tiktoken-0.9.0 types-requests-2.32.0.20250306 typing-inspect-0.9.0 uvicorn-0.34.0 uvloop-0.21.0 watchfiles-1.0.4\n"
          ]
        },
        {
          "data": {
            "application/vnd.colab-display-data+json": {
              "id": "97a4d39e1a214aaa912c563737b68fb0",
              "pip_warning": {
                "packages": [
                  "importlib_metadata"
                ]
              }
            }
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "# Tiktoken is an open-source Python library that breaks text into tokens\n",
        "#Langchian_community sued to make returiever\n",
        "#Used chromaDB for database\n",
        "\n",
        "!pip install langchain_community tiktoken langchain-openai langchainhub chromadb langchain"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "w4Bhwzj49php"
      },
      "outputs": [],
      "source": [
        "#create .env and add OPENAI_API_KEY, LANGCHAIN_API_KEY\n",
        "\n",
        "import os\n",
        "os.environ['LANGCHAIN_TRACING_V2'] = 'true'\n",
        "os.environ['LANGCHAIN_ENDPOINT'] = 'https://api.smith.langchain.com'\n",
        "os.environ[\"LANGCHAIN_API_KEY\"] = \"\"\n",
        "os.environ[\"OPENAI_API_KEY\"] = \"\""
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 3,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "KxQR0Q5d9w8G",
        "outputId": "630ceebe-6906-499e-fc16-a2e769d2a69a"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting pdfplumber\n",
            "  Downloading pdfplumber-0.11.5-py3-none-any.whl.metadata (42 kB)\n",
            "\u001b[?25l     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m0.0/42.5 kB\u001b[0m \u001b[31m?\u001b[0m eta \u001b[36m-:--:--\u001b[0m\r\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m42.5/42.5 kB\u001b[0m \u001b[31m2.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting pdfminer.six==20231228 (from pdfplumber)\n",
            "  Downloading pdfminer.six-20231228-py3-none-any.whl.metadata (4.2 kB)\n",
            "Requirement already satisfied: Pillow>=9.1 in /usr/local/lib/python3.11/dist-packages (from pdfplumber) (11.1.0)\n",
            "Collecting pypdfium2>=4.18.0 (from pdfplumber)\n",
            "  Downloading pypdfium2-4.30.1-py3-none-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (48 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m48.2/48.2 kB\u001b[0m \u001b[31m3.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: charset-normalizer>=2.0.0 in /usr/local/lib/python3.11/dist-packages (from pdfminer.six==20231228->pdfplumber) (3.4.1)\n",
            "Requirement already satisfied: cryptography>=36.0.0 in /usr/local/lib/python3.11/dist-packages (from pdfminer.six==20231228->pdfplumber) (43.0.3)\n",
            "Requirement already satisfied: cffi>=1.12 in /usr/local/lib/python3.11/dist-packages (from cryptography>=36.0.0->pdfminer.six==20231228->pdfplumber) (1.17.1)\n",
            "Requirement already satisfied: pycparser in /usr/local/lib/python3.11/dist-packages (from cffi>=1.12->cryptography>=36.0.0->pdfminer.six==20231228->pdfplumber) (2.22)\n",
            "Downloading pdfplumber-0.11.5-py3-none-any.whl (59 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m59.5/59.5 kB\u001b[0m \u001b[31m6.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pdfminer.six-20231228-py3-none-any.whl (5.6 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m5.6/5.6 MB\u001b[0m \u001b[31m77.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pypdfium2-4.30.1-py3-none-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (2.9 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.9/2.9 MB\u001b[0m \u001b[31m79.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: pypdfium2, pdfminer.six, pdfplumber\n",
            "Successfully installed pdfminer.six-20231228 pdfplumber-0.11.5 pypdfium2-4.30.1\n"
          ]
        }
      ],
      "source": [
        "!pip install pdfplumber"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 6,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "3ceSPVAQ-DSh",
        "outputId": "48d2bfd9-3e92-495d-d40a-65778b8030d3"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting faiss-cpu\n",
            "  Downloading faiss_cpu-1.10.0-cp311-cp311-manylinux_2_28_x86_64.whl.metadata (4.4 kB)\n",
            "Requirement already satisfied: numpy<3.0,>=1.25.0 in /usr/local/lib/python3.11/dist-packages (from faiss-cpu) (1.26.4)\n",
            "Requirement already satisfied: packaging in /usr/local/lib/python3.11/dist-packages (from faiss-cpu) (24.2)\n",
            "Downloading faiss_cpu-1.10.0-cp311-cp311-manylinux_2_28_x86_64.whl (30.7 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m30.7/30.7 MB\u001b[0m \u001b[31m47.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: faiss-cpu\n",
            "Successfully installed faiss-cpu-1.10.0\n"
          ]
        }
      ],
      "source": [
        "!pip install faiss-cpu"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 8,
      "metadata": {
        "id": "B9SFr71G9U8p"
      },
      "outputs": [],
      "source": [
        "from langchain.document_loaders import PyMuPDFLoader\n",
        "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
        "from langchain.vectorstores import FAISS\n",
        "from langchain_openai import ChatOpenAI, OpenAIEmbeddings\n",
        "from langchain.chains import RetrievalQA\n",
        "from langchain.chat_models import ChatOpenAI\n",
        "import pdfplumber\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 9,
      "metadata": {
        "id": "U9z6qBUC-SgY"
      },
      "outputs": [],
      "source": [
        "\n",
        "# Step 1: Improved PDF Parsing\n",
        "def extract_text_from_pdf(pdf_path):\n",
        "    with pdfplumber.open(pdf_path) as pdf:\n",
        "        text = \"\\n\".join(page.extract_text() for page in pdf.pages if page.extract_text())\n",
        "    return text\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 10,
      "metadata": {
        "id": "gllXbtAp-Tq9"
      },
      "outputs": [],
      "source": [
        "pdf_text = extract_text_from_pdf( \"/content/137253305_bgaawavakhroaw0xoj05dgcq.pdf\")\n",
        "\n",
        "# Step 2: Chunking for Better Retrieval\n",
        "text_splitter = RecursiveCharacterTextSplitter(chunk_size=1000, chunk_overlap=100, separators=[\"\\n\\n\", \"\\n\", \" \", \"\"])\n",
        "documents = text_splitter.create_documents([pdf_text])\n",
        "\n",
        "# Step 3: Optimized Vector Store (FAISS for faster search)\n",
        "embedding_model = OpenAIEmbeddings(model=\"text-embedding-3-large\")\n",
        "vectorstore = FAISS.from_documents(documents, embedding=embedding_model)\n",
        "\n",
        "# Step 4: Better Retrieval with Filters\n",
        "retriever = vectorstore.as_retriever(search_kwargs={\"k\": 5})\n",
        "\n",
        "# Step 5: Optimized QA Chain with Structured Prompting\n",
        "llm = ChatOpenAI(model_name=\"gpt-4o\", temperature=0)\n",
        "qa = RetrievalQA.from_chain_type(llm=llm, retriever=retriever, chain_type=\"refine\")\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 11,
      "metadata": {
        "id": "rewBWRA7-X_k"
      },
      "outputs": [],
      "source": [
        "# query = \"Extract the name of the patient\"\n",
        "# response = qa.run(query)\n",
        "\n",
        "# print(\"Extracted Patient Name:\", response)\n",
        "\n",
        "# Step 6: Structured Lab Test Extraction\n",
        "query_lab_tests = \"\"\"Identify all lab test names and list them as bullet points. Do not include additional explanations or descriptions or recommended lab tests,\n",
        "only test names which were completed. Here is an example of the expected output:\n",
        "[\"CBC\", \"Blood Glucose\", \"Lipid profile\"]\n",
        "\"\"\"\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 12,
      "metadata": {
        "id": "ObT-__-9-aMS"
      },
      "outputs": [],
      "source": [
        "lab_tests_response = qa.run(query_lab_tests)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 13,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 36
        },
        "id": "h55PwKY4-cyc",
        "outputId": "5b89b329-6ec6-4b11-9b7c-9a7d5c093182"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "'- Cholesterol Total\\n- Triglycerides\\n- HDL Cholesterol\\n- LDL Cholesterol\\n- VLDL Cholesterol\\n- Non-HDL Cholesterol'"
            ]
          },
          "execution_count": 13,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "lab_tests_response"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 14,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "DvSkvbtW-bNI",
        "outputId": "eb9c56b7-2bd0-49d3-a506-14711a3394fb"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Extracted Lab Tests: - Cholesterol Total\n",
            "- Triglycerides\n",
            "- HDL Cholesterol\n",
            "- LDL Cholesterol\n",
            "- VLDL Cholesterol\n",
            "- Non-HDL Cholesterol\n"
          ]
        }
      ],
      "source": [
        "# # Convert response into a structured list\n",
        "extracted_lab_tests = [test.strip() for test in lab_tests_response.split(\"\\n-\") if test.strip()]\n",
        "print(\"Extracted Lab Tests:\", lab_tests_response)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "xfChzmDY9U8s"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "KMqFaaHU9U8t"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": 15,
      "metadata": {
        "id": "AHwZSZGJ9U8t"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "\n",
        "# Load CSV containing lab tests and ICD codes\n",
        "icd_df = pd.read_csv(\"/content/ICD_11_Codes.csv\")  # Replace with actual path"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 16,
      "metadata": {
        "id": "GGiq22Ou9U8t",
        "scrolled": true
      },
      "outputs": [],
      "source": [
        "# Convert to dictionary format\n",
        "lab_test_mapping = {row[\"Title\"]: row[\"Code\"] for _, row in icd_df.iterrows()}"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 17,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "collapsed": true,
        "id": "ucWHrSOJ9U8t",
        "jupyter": {
          "outputs_hidden": true
        },
        "outputId": "d2dfe019-adee-484d-a567-16b8a9c16172"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "{'Cholera': '1A00',\n",
              " 'Intestinal infection due to other Vibrio': '1A01',\n",
              " 'Intestinal infections due to Shigella': '1A02',\n",
              " 'Intestinal infections due to Escherichia coli': '1A03',\n",
              " 'Enteropathogenic Escherichia coli infection': '1A03.0',\n",
              " 'Enterotoxigenic Escherichia coli infection': '1A03.1',\n",
              " 'Enteroinvasive Escherichia coli infection': '1A03.2',\n",
              " 'Enterohaemorrhagic Escherichia coli infection': '1A03.3',\n",
              " 'Intestinal infections due to other specified Escherichia coli': '1A03.Y',\n",
              " 'Intestinal infections due to Escherichia coli unspecified': '1A03.Z',\n",
              " 'Intestinal infections due to Clostridioides difficile': '1A04',\n",
              " 'Intestinal infections due to Yersinia enterocolitica': '1A05',\n",
              " 'Gastroenteritis due to Campylobacter': '1A06',\n",
              " 'Typhoid fever': '1A07',\n",
              " 'Typhoid peritonitis': '1A07.0',\n",
              " 'Other specified typhoid fever': '1A07.Y',\n",
              " 'Typhoid fever unspecified': '1A07.Z',\n",
              " 'Paratyphoid fever': '1A08',\n",
              " 'Infections due to other Salmonella': '1A09',\n",
              " 'Salmonella enteritis': '1A09.0',\n",
              " 'Infections due to other Salmonella in other organs': '1A09.Y',\n",
              " 'Salmonella infection unspecified': '1A09.Z',\n",
              " 'Other specified bacterial intestinal infections': '1A0Y',\n",
              " 'Bacterial intestinal infections unspecified': '1A0Z',\n",
              " 'Foodborne staphylococcal intoxication': '1A10',\n",
              " 'Botulism': '1A11',\n",
              " 'Foodborne intoxication by botulinum toxin': '1A11.0',\n",
              " 'Other forms of botulism': '1A11.1',\n",
              " 'Botulism unspecified': '1A11.Z',\n",
              " 'Foodborne Clostridium perfringens intoxication': '1A12',\n",
              " 'Foodborne Bacillus cereus intoxication': '1A13',\n",
              " 'Other specified bacterial foodborne intoxications': '1A1Y',\n",
              " 'Bacterial foodborne intoxications unspecified': '1A1Z',\n",
              " 'Enteritis due to Adenovirus': '1A20',\n",
              " 'Gastroenteritis due to Astrovirus': '1A21',\n",
              " 'Gastroenteritis due to Rotavirus': '1A22',\n",
              " 'Enteritis due to Norovirus': '1A23',\n",
              " 'Intestinal infections due to Cytomegalovirus': '1A24',\n",
              " 'Other specified viral intestinal infections': '1A2Y',\n",
              " 'Viral intestinal infections unspecified': '1A2Z',\n",
              " 'Infections due to Balantidium coli': '1A30',\n",
              " 'Giardiasis': '1A31',\n",
              " 'Cryptosporidiosis': '1A32',\n",
              " 'Cystoisosporiasis': '1A33',\n",
              " 'Cystoisosporiasis of small intestine': '1A33.0',\n",
              " 'Cystoisosporiasis of colon': '1A33.1',\n",
              " 'Other specified cystoisosporiasis': '1A33.Y',\n",
              " 'Cystoisosporiasis unspecified': '1A33.Z',\n",
              " 'Sarcocystosis': '1A34',\n",
              " 'Blastocystosis': '1A35',\n",
              " 'Amoebiasis': '1A36',\n",
              " 'Intestinal infections due to Entamoeba': '1A36.0',\n",
              " 'Acute amoebiasis': '1A36.00',\n",
              " 'Amoeboma of intestine': '1A36.01',\n",
              " 'Other specified intestinal infections due to Entamoeba': '1A36.0Y',\n",
              " 'Intestinal infections due to Entamoeba unspecified': '1A36.0Z',\n",
              " 'Extraintestinal infections due to Entamoeba': '1A36.1',\n",
              " 'Amoebic liver abscess': '1A36.10',\n",
              " 'Amoebic lung abscess': '1A36.11',\n",
              " 'Cutaneous amoebiasis': '1A36.12',\n",
              " 'Amoebiasis of other specified sites': '1A36.1Y',\n",
              " 'Amoebiasis unspecified': '1A36.Z',\n",
              " 'Other specified protozoal intestinal infections': '1A3Y',\n",
              " 'Protozoal intestinal infections unspecified': '1A3Z',\n",
              " 'Gastroenteritis or colitis without specification of infectious agent': '1A40',\n",
              " 'Gastroenteritis or colitis without specification of origin': '1A40.0',\n",
              " 'Infectious gastroenteritis or colitis without specification of infectious agent': '1A40.Z',\n",
              " 'Congenital syphilis': '1A60',\n",
              " 'Early congenital syphilis symptomatic': '1A60.0',\n",
              " 'Early congenital syphilis latent': '1A60.1',\n",
              " 'Late congenital syphilitic oculopathy': '1A60.2',\n",
              " 'Late congenital neurosyphilis': '1A60.3',\n",
              " 'Other late congenital syphilis symptomatic': '1A60.4',\n",
              " 'Late congenital syphilis latent': '1A60.5',\n",
              " 'Congenital syphilis unspecified': '1A60.Z',\n",
              " 'Early syphilis': '1A61',\n",
              " 'Primary genital syphilis': '1A61.0',\n",
              " 'Primary anal syphilis': '1A61.1',\n",
              " 'Primary syphilis of other sites': '1A61.2',\n",
              " 'Secondary syphilis of skin or mucous membranes': '1A61.3',\n",
              " 'Secondary syphilis of other sites': '1A61.4',\n",
              " 'Latent early syphilis': '1A61.5',\n",
              " 'Other specified early syphilis': '1A61.Y',\n",
              " 'Early syphilis unspecified': '1A61.Z',\n",
              " 'Late syphilis': '1A62',\n",
              " 'Neurosyphilis': '1A62.0',\n",
              " 'Asymptomatic neurosyphilis': '1A62.00',\n",
              " 'Symptomatic late neurosyphilis': '1A62.01',\n",
              " 'Neurosyphilis unspecified': '1A62.0Z',\n",
              " 'Cardiovascular late syphilis': '1A62.1',\n",
              " 'Symptomatic late syphilis of other sites': '1A62.2',\n",
              " 'Ocular late syphilis': '1A62.20',\n",
              " 'Late syphilis involving the musculoskeletal system': '1A62.21',\n",
              " 'Late syphilis of skin or mucous membranes': '1A62.22',\n",
              " 'Symptomatic late syphilis of other specified sites': '1A62.2Y',\n",
              " 'Symptomatic late syphilis of unspecified site': '1A62.2Z',\n",
              " 'Other specified late syphilis': '1A62.Y',\n",
              " 'Late syphilis unspecified': '1A62.Z',\n",
              " 'Latent syphilis unspecified as early or late': '1A63',\n",
              " 'Syphilis unspecified': '1A6Z',\n",
              " 'Gonococcal genitourinary infection': '1A70',\n",
              " 'Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess': '1A70.0',\n",
              " 'Gonorrhoea of penis': '1A70.00',\n",
              " 'Other specified gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess': '1A70.0Y',\n",
              " 'Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess unspecified': '1A70.0Z',\n",
              " 'Gonococcal infection of lower genitourinary tract with periurethral or accessory gland abscess': '1A70.1',\n",
              " 'Gonococcal infection of other specified genitourinary organ': '1A70.Y',\n",
              " 'Gonococcal genitourinary infection unspecified': '1A70.Z',\n",
              " 'Gonococcal pelviperitonitis': '1A71',\n",
              " 'Gonococcal infection of other sites': '1A72',\n",
              " 'Gonococcal infection of musculoskeletal system': '1A72.0',\n",
              " 'Gonococcal infection of rectum': '1A72.1',\n",
              " 'Gonococcal infection of anus': '1A72.2',\n",
              " 'Gonococcal pharyngitis': '1A72.3',\n",
              " 'Gonococcal infection of eye': '1A72.4',\n",
              " 'Gonococcal infection of other specified sites': '1A72.Y',\n",
              " 'Disseminated gonococcal infection': '1A73',\n",
              " 'Gonococcal infection unspecified': '1A7Z',\n",
              " 'Chlamydial lymphogranuloma': '1A80',\n",
              " 'Nonulcerative sexually transmitted chlamydial infection': '1A81',\n",
              " 'Chlamydial infection of lower genitourinary tract': '1A81.0',\n",
              " 'Chlamydial infection of internal reproductive organs': '1A81.1',\n",
              " 'Nonulcerative sexually transmitted chlamydial infection of other specified site': '1A81.Y',\n",
              " 'Nonulcerative sexually transmitted chlamydial infection of unspecified site': '1A81.Z',\n",
              " 'Other specified sexually transmissible infections due to chlamydia': '1A8Y',\n",
              " 'Sexually transmissible infections due to chlamydia unspecified': '1A8Z',\n",
              " 'Chancroid': '1A90',\n",
              " 'Granuloma inguinale': '1A91',\n",
              " 'Trichomoniasis': '1A92',\n",
              " 'Sexually transmissible infestations': '1A93',\n",
              " 'Anogenital herpes simplex infection': '1A94',\n",
              " 'Herpes simplex infection of genitalia or urogenital tract': '1A94.0',\n",
              " 'Herpes simplex infection of perianal skin or rectum': '1A94.1',\n",
              " 'Anogenital herpes simplex infection without further specification': '1A94.Z',\n",
              " 'Anogenital warts': '1A95',\n",
              " 'Anal warts': '1A95.0',\n",
              " 'Genital warts': '1A95.1',\n",
              " 'Extragenital condylomata acuminata': '1A95.2',\n",
              " 'Anogenital warts unspecified': '1A95.Z',\n",
              " 'Other specified predominantly sexually transmitted infections': '1A9Y',\n",
              " 'Predominantly sexually transmitted infections unspecified': '1A9Z',\n",
              " 'Tuberculosis of the respiratory system': '1B10',\n",
              " 'Respiratory tuberculosis confirmed': '1B10.0',\n",
              " 'Respiratory tuberculosis not confirmed': '1B10.1',\n",
              " 'Respiratory tuberculosis without mention of bacteriological or histological confirmation': '1B10.Z',\n",
              " 'Tuberculosis of the nervous system': '1B11',\n",
              " 'Tuberculous meningitis': '1B11.0',\n",
              " 'Tuberculous meningoencephalitis': '1B11.1',\n",
              " 'Meningeal tuberculoma': '1B11.2',\n",
              " 'Tuberculous granuloma of brain': '1B11.3',\n",
              " 'Other tuberculosis of nervous system': '1B11.Y',\n",
              " 'Tuberculosis of the nervous system unspecified': '1B11.Z',\n",
              " 'Tuberculosis of other systems and organs': '1B12',\n",
              " 'Tuberculosis of heart': '1B12.0',\n",
              " 'Tuberculosis of eye': '1B12.1',\n",
              " 'Tuberculosis of ear': '1B12.2',\n",
              " 'Tuberculosis of endocrine glands': '1B12.3',\n",
              " 'Tuberculosis of the musculoskeletal system': '1B12.4',\n",
              " 'Tuberculosis of bones or joints': '1B12.40',\n",
              " 'Tuberculous myositis': '1B12.41',\n",
              " 'Tuberculosis of other specified part of the musculoskeletal system': '1B12.4Y',\n",
              " 'Tuberculosis of the musculoskeletal system unspecified': '1B12.4Z',\n",
              " 'Tuberculosis of the genitourinary system': '1B12.5',\n",
              " 'Tuberculous peripheral lymphadenopathy': '1B12.6',\n",
              " 'Tuberculosis of the digestive system': '1B12.7',\n",
              " 'Cutaneous tuberculosis': '1B12.8',\n",
              " 'Tuberculosis of other specified organ or site': '1B12.Y',\n",
              " 'Miliary tuberculosis': '1B13',\n",
              " 'Acute miliary tuberculosis of a single specified site': '1B13.0',\n",
              " 'Acute miliary tuberculosis of multiple sites': '1B13.1',\n",
              " 'Acute miliary tuberculosis unspecified site': '1B13.2',\n",
              " 'Other specified miliary tuberculosis': '1B13.Y',\n",
              " 'Miliary tuberculosis unspecified': '1B13.Z',\n",
              " 'Latent tuberculosis': '1B14',\n",
              " 'Other specified tuberculosis': '1B1Y',\n",
              " 'Tuberculosis unspecified': '1B1Z',\n",
              " 'Leprosy': '1B20',\n",
              " 'Paucibacillary leprosy': '1B20.0',\n",
              " 'Multibacillary leprosy': '1B20.1',\n",
              " 'Leprosy reactions': '1B20.2',\n",
              " 'Type I leprosy reaction': '1B20.20',\n",
              " 'Type II leprosy reaction': '1B20.21',\n",
              " 'Complications of leprosy': '1B20.3',\n",
              " 'Leprosy unspecified': '1B20.Z',\n",
              " 'Infections due to nontuberculous mycobacteria': '1B21',\n",
              " 'Pulmonary infection due to nontuberculous mycobacterium': '1B21.0',\n",
              " 'Nontuberculous mycobacterial lymphadenitis': '1B21.1',\n",
              " 'Cutaneous nontuberculous mycobacterial infection': '1B21.2',\n",
              " 'Mycobacterium ulcerans infection': '1B21.20',\n",
              " 'Cutaneous infection due to other specified nontuberculous mycobacteria': '1B21.2Y',\n",
              " 'Cutaneous infection due to unspecified nontuberculous mycobacteria': '1B21.2Z',\n",
              " 'Disseminated nontuberculous mycobacterial infection': '1B21.3',\n",
              " 'Gastrointestinal nontuberculous mycobacterial infection': '1B21.4',\n",
              " 'Nontuberculous mycobacterial infection of other specified site': '1B21.Y',\n",
              " 'Nontuberculous mycobacterial infection of unspecified site': '1B21.Z',\n",
              " 'Other specified mycobacterial diseases': '1B2Y',\n",
              " 'Mycobacterial diseases unspecified': '1B2Z',\n",
              " 'Acute rheumatic fever without mention of heart involvement': '1B40',\n",
              " 'Rheumatic arthritis acute or subacute': '1B40.0',\n",
              " 'Other specified acute rheumatic fever without mention of heart involvement': '1B40.Y',\n",
              " 'Acute rheumatic fever without mention of heart involvement unspecified': '1B40.Z',\n",
              " 'Acute rheumatic fever with heart involvement': '1B41',\n",
              " 'Acute rheumatic pericarditis': '1B41.0',\n",
              " 'Acute rheumatic endocarditis': '1B41.1',\n",
              " 'Rheumatic aortitis': '1B41.10',\n",
              " 'Other specified acute rheumatic endocarditis': '1B41.1Y',\n",
              " 'Acute rheumatic endocarditis unspecified': '1B41.1Z',\n",
              " 'Acute rheumatic myocarditis': '1B41.2',\n",
              " 'Other acute rheumatic heart disease': '1B41.Y',\n",
              " 'Acute rheumatic heart disease unspecified': '1B41.Z',\n",
              " 'Rheumatic chorea': '1B42',\n",
              " 'Scarlet fever': '1B50',\n",
              " 'Streptococcal pharyngitis': '1B51',\n",
              " 'Meningitis due to Streptococcus': '1B53',\n",
              " 'Meningitis due to Staphylococcus': '1B54',\n",
              " 'Other specified staphylococcal or streptococcal diseases': '1B5Y',\n",
              " 'Staphylococcal or streptococcal diseases unspecified': '1B5Z',\n",
              " 'Bacterial cellulitis erysipelas or lymphangitis': '1B70',\n",
              " 'Erysipelas': '1B70.0',\n",
              " 'Erysipelas of face': '1B70.00',\n",
              " 'Erysipelas of external ear': '1B70.01',\n",
              " 'Erysipelas of lower limb': '1B70.02',\n",
              " 'Erysipelas of other specified site': '1B70.0Y',\n",
              " 'Erysipelas unspecified': '1B70.0Z',\n",
              " 'Streptococcal cellulitis of skin': '1B70.1',\n",
              " 'Staphylococcal cellulitis of skin': '1B70.2',\n",
              " 'Ascending bacterial lymphangitis': '1B70.3',\n",
              " 'Bacterial cellulitis or lymphangitis due to other specified bacterium': '1B70.Y',\n",
              " 'Bacterial cellulitis or lymphangitis due to unspecified bacterium': '1B70.Z',\n",
              " 'Necrotising fasciitis': '1B71',\n",
              " 'Streptococcal necrotising fasciitis': '1B71.0',\n",
              " 'Polymicrobial necrotising fasciitis': '1B71.1',\n",
              " 'Neonatal necrotising fasciitis': '1B71.2',\n",
              " 'Necrotising fasciitis due to other specified bacterial infection': '1B71.Y',\n",
              " 'Necrotising fasciitis unspecified': '1B71.Z',\n",
              " 'Impetigo': '1B72',\n",
              " 'Bullous impetigo': '1B72.0',\n",
              " 'Nonbullous impetigo': '1B72.1',\n",
              " 'Secondary impetiginisation of the skin': '1B72.2',\n",
              " 'Other specified impetigo': '1B72.Y',\n",
              " 'Impetigo unspecified': '1B72.Z',\n",
              " 'Ecthyma': '1B73',\n",
              " 'Streptococcal ecthyma': '1B73.0',\n",
              " 'Staphylococcal ecthyma': '1B73.1',\n",
              " 'Ecthyma gangrenosum': '1B73.2',\n",
              " 'Other specified ecthyma': '1B73.Y',\n",
              " 'Ecthyma unspecified': '1B73.Z',\n",
              " 'Superficial bacterial folliculitis': '1B74',\n",
              " 'Staphylococcus aureus superficial folliculitis': '1B74.0',\n",
              " 'Superficial bacterial folliculitis due to other specified organism': '1B74.Y',\n",
              " 'Superficial bacterial folliculitis due to unspecified organism': '1B74.Z',\n",
              " 'Deep bacterial folliculitis or pyogenic abscess of the skin': '1B75',\n",
              " 'Furuncle': '1B75.0',\n",
              " 'Carbuncle': '1B75.1',\n",
              " 'Furunculosis': '1B75.2',\n",
              " 'Pyogenic abscess of the skin': '1B75.3',\n",
              " 'Chronic deep bacterial folliculitis': '1B75.4',\n",
              " 'Deep bacterial folliculitis or pyogenic abscess of the skin unspecified': '1B75.Z',\n",
              " 'Other specified pyogenic bacterial infection of skin or subcutaneous tissue': '1B7Y',\n",
              " 'Pyogenic bacterial infection of skin or subcutaneous tissue unspecified': '1B7Z',\n",
              " 'Ratbite fevers': '1B90',\n",
              " 'Spirillosis': '1B90.0',\n",
              " 'Streptobacillosis': '1B90.1',\n",
              " 'Leptospirosis': '1B91',\n",
              " 'Glanders': '1B92',\n",
              " 'Plague': '1B93',\n",
              " 'Bubonic plague': '1B93.0',\n",
              " 'Cellulocutaneous plague': '1B93.1',\n",
              " 'Pneumonic plague': '1B93.2',\n",
              " 'Plague meningitis': '1B93.3',\n",
              " 'Other specified plague': '1B93.Y',\n",
              " 'Plague unspecified': '1B93.Z',\n",
              " 'Tularaemia': '1B94',\n",
              " 'Ulceroglandular tularaemia': '1B94.0',\n",
              " 'Other specified tularaemia': '1B94.Y',\n",
              " 'Tularaemia unspecified': '1B94.Z',\n",
              " 'Brucellosis': '1B95',\n",
              " 'Erysipeloid': '1B96',\n",
              " 'Anthrax': '1B97',\n",
              " 'Catscratch disease': '1B98',\n",
              " 'Pasteurellosis': '1B99',\n",
              " 'Extraintestinal yersiniosis': '1B9A',\n",
              " 'Unspecified zoonotic bacterial disease': '1B9Z',\n",
              " 'Actinomycosis': '1C10',\n",
              " 'Pulmonary actinomycosis': '1C10.0',\n",
              " 'Abdominal actinomycosis': '1C10.1',\n",
              " 'Cervicofacial actinomycosis': '1C10.2',\n",
              " 'Primary cutaneous actinomycosis': '1C10.3',\n",
              " 'Other specified forms of actinomycosis': '1C10.Y',\n",
              " 'Actinomycosis unspecified': '1C10.Z',\n",
              " 'Bartonellosis': '1C11',\n",
              " 'Carrion disease': '1C11.0',\n",
              " 'Oroya fever': '1C11.00',\n",
              " 'Verruga peruana': '1C11.01',\n",
              " 'Trench fever': '1C11.1',\n",
              " 'Other forms of bartonellosis': '1C11.Y',\n",
              " 'Bartonellosis unspecified': '1C11.Z',\n",
              " 'Whooping cough': '1C12',\n",
              " 'Whooping cough due to Bordetella pertussis': '1C12.0',\n",
              " 'Whooping cough due to Bordetella parapertussis': '1C12.1',\n",
              " 'Other specified whooping cough': '1C12.Y',\n",
              " 'Whooping cough unspecified': '1C12.Z',\n",
              " 'Tetanus': '1C13',\n",
              " 'Obstetrical tetanus': '1C14',\n",
              " 'Tetanus neonatorum': '1C15',\n",
              " 'Gas gangrene': '1C16',\n",
              " 'Diphtheria': '1C17',\n",
              " 'Pharyngeal or tonsillar diphtheria': '1C17.0',\n",
              " 'Postdiphtheritic paralysis of uvula': '1C17.00',\n",
              " 'Other specified pharyngeal or tonsillar diphtheria': '1C17.0Y',\n",
              " 'Pharyngeal or tonsillar diphtheria unspecified': '1C17.0Z',\n",
              " 'Nasal diphtheria': '1C17.1',\n",
              " 'Laryngeal diphtheria': '1C17.2',\n",
              " 'Cutaneous diphtheria': '1C17.3',\n",
              " 'Other specified diphtheria': '1C17.Y',\n",
              " 'Diphtheria unspecified': '1C17.Z',\n",
              " 'Brazilian purpuric fever': '1C18',\n",
              " 'Legionellosis': '1C19',\n",
              " 'Nonpneumonic Legionnaires disease': '1C19.0',\n",
              " 'Legionnaires disease': '1C19.1',\n",
              " 'Legionellosis unspecified': '1C19.Z',\n",
              " 'Listeriosis': '1C1A',\n",
              " 'Cutaneous listeriosis': '1C1A.0',\n",
              " 'Listerial meningitis or meningoencephalitis': '1C1A.1',\n",
              " 'Other specified listeriosis': '1C1A.Y',\n",
              " 'Listeriosis unspecified': '1C1A.Z',\n",
              " 'Nocardiosis': '1C1B',\n",
              " 'Pulmonary nocardiosis': '1C1B.0',\n",
              " 'Cutaneous nocardiosis': '1C1B.1',\n",
              " 'Other specified forms of nocardiosis': '1C1B.Y',\n",
              " 'Nocardiosis unspecified': '1C1B.Z',\n",
              " 'Meningococcal disease': '1C1C',\n",
              " 'Meningococcal meningitis': '1C1C.0',\n",
              " 'WaterhouseFriderichsen syndrome': '1C1C.1',\n",
              " 'Meningococcaemia': '1C1C.2',\n",
              " 'Acute meningococcaemia': '1C1C.20',\n",
              " 'Other specified meningococcaemia': '1C1C.2Y',\n",
              " 'Meningococcaemia unspecified': '1C1C.2Z',\n",
              " 'Other specified meningococcal disease': '1C1C.Y',\n",
              " 'Meningococcal disease unspecified': '1C1C.Z',\n",
              " 'Yaws': '1C1D',\n",
              " 'Primary yaws': '1C1D.0',\n",
              " 'Secondary yaws': '1C1D.1',\n",
              " 'Tertiary yaws': '1C1D.2',\n",
              " 'Latent yaws': '1C1D.3',\n",
              " 'Yaws unspecified': '1C1D.Z',\n",
              " 'Pinta': '1C1E',\n",
              " 'Primary lesions of pinta': '1C1E.0',\n",
              " 'Intermediate lesions of pinta': '1C1E.1',\n",
              " 'Late lesions of pinta': '1C1E.2',\n",
              " 'Mixed lesions of pinta': '1C1E.3',\n",
              " 'Pinta unspecified': '1C1E.Z',\n",
              " 'Endemic nonvenereal syphilis': '1C1F',\n",
              " 'Lyme borreliosis': '1C1G',\n",
              " 'Early cutaneous Lyme borreliosis': '1C1G.0',\n",
              " 'Disseminated Lyme borreliosis': '1C1G.1',\n",
              " 'Lyme neuroborreliosis': '1C1G.10',\n",
              " 'Lyme carditis': '1C1G.11',\n",
              " 'Ophthalmic Lyme borreliosis': '1C1G.12',\n",
              " 'Lyme arthritis': '1C1G.13',\n",
              " 'Late cutaneous Lyme borreliosis': '1C1G.14',\n",
              " 'Other specified disseminated Lyme borreliosis': '1C1G.1Y',\n",
              " 'Disseminated Lyme borreliosis unspecified': '1C1G.1Z',\n",
              " 'Other specified Lyme borreliosis': '1C1G.Y',\n",
              " 'Lyme borreliosis unspecified': '1C1G.Z',\n",
              " 'Necrotising ulcerative gingivitis': '1C1H',\n",
              " 'Other Vincent infections': '1C1H.0',\n",
              " 'Other specified necrotising ulcerative gingivitis': '1C1H.Y',\n",
              " 'Necrotising ulcerative gingivitis unspecified': '1C1H.Z',\n",
              " 'Relapsing fever': '1C1J',\n",
              " 'Tickborne relapsing fever': '1C1J.0',\n",
              " 'Louseborne relapsing fever': '1C1J.1',\n",
              " 'Relapsing fever unspecified': '1C1J.Z',\n",
              " 'Chlamydial conjunctivitis': '1C20',\n",
              " 'Chlamydial peritonitis': '1C21',\n",
              " 'Infections due to Chlamydia psittaci': '1C22',\n",
              " 'Trachoma': '1C23',\n",
              " 'Initial stage of trachoma': '1C23.0',\n",
              " 'Active stage of trachoma': '1C23.1',\n",
              " 'Other specified trachoma': '1C23.Y',\n",
              " 'Trachoma unspecified': '1C23.Z',\n",
              " 'Other specified diseases due to chlamydiae': '1C2Y',\n",
              " 'Diseases due to chlamydiae unspecified': '1C2Z',\n",
              " 'Typhus fever': '1C30',\n",
              " 'Epidemic louseborne typhus fever due to Rickettsia prowazekii': '1C30.0',\n",
              " 'Recrudescent typhus': '1C30.1',\n",
              " 'Typhus fever due to Rickettsia typhi': '1C30.2',\n",
              " 'Typhus fever due to Orientia tsutsugamushi': '1C30.3',\n",
              " 'Other specified typhus fever': '1C30.Y',\n",
              " 'Typhus fever unspecified': '1C30.Z',\n",
              " 'Spotted fever': '1C31',\n",
              " 'Spotted fever due to Rickettsia rickettsii': '1C31.0',\n",
              " 'Spotted fever due to Rickettsia conorii': '1C31.1',\n",
              " 'Spotted fever due to Rickettsia sibirica': '1C31.2',\n",
              " 'Spotted fever due to Rickettsia australis': '1C31.3',\n",
              " 'Other specified spotted fever': '1C31.Y',\n",
              " 'Spotted fever unspecified': '1C31.Z',\n",
              " 'Rickettsialpox': '1C32',\n",
              " 'Q fever': '1C33',\n",
              " 'Other specified rickettsioses': '1C3Y',\n",
              " 'Rickettsioses unspecified': '1C3Z',\n",
              " 'Campylobacteriosis': '1C40',\n",
              " 'Bacterial infection of unspecified site': '1C41',\n",
              " 'Melioidosis': '1C42',\n",
              " 'Actinomycetoma': '1C43',\n",
              " 'Nonpyogenic bacterial infections of the skin': '1C44',\n",
              " 'Toxic shock syndrome': '1C45',\n",
              " 'Streptococcal toxic shock syndrome': '1C45.0',\n",
              " 'Staphylococcal toxic shock syndrome': '1C45.1',\n",
              " 'Toxic shock syndrome due to other specified infectious agent': '1C45.Y',\n",
              " 'Toxic shock syndrome without specified infectious agent': '1C45.Z',\n",
              " 'Other specified bacterial diseases': '1C4Y',\n",
              " 'Unspecified bacterial disease': '1C4Z',\n",
              " 'Human immunodeficiency virus disease associated with tuberculosis': '1C60',\n",
              " 'HIV disease clinical stage  associated with tuberculosis': '1C60.3',\n",
              " 'Kaposi sarcoma associated with human immunodeficiency virus disease associated with tuberculosis': '1C60.30',\n",
              " 'Other specified HIV disease clinical stage  associated with tuberculosis': '1C60.3Y',\n",
              " 'HIV disease clinical stage  associated with tuberculosis unspecified': '1C60.3Z',\n",
              " 'Human immunodeficiency virus disease associated with tuberculosis clinical stage unspecified': '1C60.Z',\n",
              " 'Human immunodeficiency virus disease associated with malaria': '1C61',\n",
              " 'HIV disease clinical stage  associated with malaria': '1C61.3',\n",
              " 'Kaposi sarcoma associated with human immunodeficiency virus disease associated with malaria': '1C61.30',\n",
              " 'Other specified HIV disease clinical stage  associated with malaria': '1C61.3Y',\n",
              " 'HIV disease clinical stage  associated with malaria unspecified': '1C61.3Z',\n",
              " 'Human immunodeficiency virus disease associated with malaria clinical stage unspecified': '1C61.Z',\n",
              " 'Human immunodeficiency virus disease without mention of tuberculosis or malaria': '1C62',\n",
              " 'HIV disease clinical stage  without mention of tuberculosis or malaria': '1C62.3',\n",
              " 'Kaposi sarcoma associated with human immunodeficiency virus disease without mention of tuberculosis or malaria': '1C62.30',\n",
              " 'Other specified HIV disease clinical stage  without mention of tuberculosis or malaria': '1C62.3Y',\n",
              " 'HIV disease clinical stage  without mention of tuberculosis or malaria unspecified': '1C62.3Z',\n",
              " 'Human immunodeficiency virus disease without mention of tuberculosis or malaria clinical stage unspecified': '1C62.Z',\n",
              " 'Viral encephalitis not elsewhere classified': '1C80',\n",
              " 'Acute poliomyelitis': '1C81',\n",
              " 'Rabies': '1C82',\n",
              " 'Western equine encephalitis': '1C83',\n",
              " 'Eastern equine encephalitis': '1C84',\n",
              " 'Japanese encephalitis': '1C85',\n",
              " 'St Louis encephalitis': '1C86',\n",
              " 'Rocio viral encephalitis': '1C87',\n",
              " 'Murray Valley encephalitis': '1C88',\n",
              " 'California encephalitis': '1C8B',\n",
              " 'Venezuelan equine encephalitis': '1C8C',\n",
              " 'La Crosse encephalitis': '1C8D',\n",
              " 'Viral meningitis not elsewhere classified': '1C8E',\n",
              " 'Enteroviral meningitis': '1C8E.1',\n",
              " 'Meningitis due to adenovirus': '1C8E.2',\n",
              " 'Other specified viral meningitis not elsewhere classified': '1C8E.Y',\n",
              " 'Viral meningitis unspecified': '1C8E.Z',\n",
              " 'Lymphocytic choriomeningitis': '1C8F',\n",
              " 'Tickborne encephalitis': '1C8G',\n",
              " 'Far Eastern tickborne encephalitis': '1C8G.0',\n",
              " 'Central European tickborne encephalitis': '1C8G.1',\n",
              " 'Siberian tickborne encephalitis': '1C8G.2',\n",
              " 'Tickborne encephalitis unspecified': '1C8G.Z',\n",
              " 'Viral myelitis not elsewhere classified': '1C8H',\n",
              " 'Other specified viral infections of the central nervous system': '1C8Y',\n",
              " 'Viral infections of the central nervous system unspecified': '1C8Z',\n",
              " 'Infectious encephalitis not elsewhere classified': '1D00',\n",
              " 'Bacterial encephalitis': '1D00.0',\n",
              " 'Fungal encephalitis': '1D00.1',\n",
              " 'Parasitic or protozoal encephalitis': '1D00.2',\n",
              " 'Other specified infectious encephalitis not elsewhere classified': '1D00.Y',\n",
              " 'Infectious encephalitis unspecified': '1D00.Z',\n",
              " 'Infectious meningitis not elsewhere classified': '1D01',\n",
              " 'Bacterial meningitis': '1D01.0',\n",
              " 'Meningitis due to Haemophilus influenzae': '1D01.00',\n",
              " 'Other specified bacterial meningitis': '1D01.0Y',\n",
              " 'Bacterial meningitis unspecified': '1D01.0Z',\n",
              " 'Fungal meningitis': '1D01.1',\n",
              " 'Parasitic or protozoal meningitis': '1D01.2',\n",
              " 'Benign recurrent meningitis': '1D01.3',\n",
              " 'Other specified infectious meningitis not elsewhere classified': '1D01.Y',\n",
              " 'Infectious meningitis unspecified': '1D01.Z',\n",
              " 'Infectious myelitis not elsewhere classified': '1D02',\n",
              " 'Bacterial myelitis': '1D02.0',\n",
              " 'Fungal myelitis': '1D02.2',\n",
              " 'Parasitic myelitis': '1D02.3',\n",
              " 'Other specified infectious myelitis not elsewhere classified': '1D02.Y',\n",
              " 'Infectious myelitis unspecified': '1D02.Z',\n",
              " 'Infectious abscess of the central nervous system': '1D03',\n",
              " 'Intraspinal intramedullary abscess': '1D03.0',\n",
              " 'Intraspinal subdural abscess': '1D03.1',\n",
              " 'Intraspinal extradural abscess': '1D03.2',\n",
              " 'Intracranial abscess': '1D03.3',\n",
              " 'Deep cerebral hemispheric abscess': '1D03.30',\n",
              " 'Abscess of the corpus callosum': '1D03.31',\n",
              " 'Pituitary abscess': '1D03.32',\n",
              " 'Multiple or widespread intracranial abscess': '1D03.33',\n",
              " 'Other specified intracranial abscess': '1D03.3Y',\n",
              " 'Intracranial abscess unspecified': '1D03.3Z',\n",
              " 'Intraspinal epidural abscess': '1D03.4',\n",
              " 'Spinal cord abscess': '1D03.5',\n",
              " 'Other specified site of infectious abscess of the central nervous system': '1D03.Y',\n",
              " 'Infectious abscess of the central nervous system site unspecified': '1D03.Z',\n",
              " 'Infectious granulomas of the central nervous system': '1D04',\n",
              " 'Parasitic intracerebral granuloma': '1D04.0',\n",
              " 'Intracranial granuloma': '1D04.1',\n",
              " 'Fungal intracranial granuloma': '1D04.10',\n",
              " 'Other specified intracranial granuloma': '1D04.1Y',\n",
              " 'Intracranial granuloma unspecified': '1D04.1Z',\n",
              " 'Intraspinal intramedullary granuloma': '1D04.2',\n",
              " 'Intraspinal subdural granuloma': '1D04.3',\n",
              " 'Intraspinal extradural granuloma': '1D04.4',\n",
              " 'Intraspinal epidural granuloma': '1D04.5',\n",
              " 'Other specified site of infectious granulomas of the central nervous system': '1D04.Y',\n",
              " 'Infectious granulomas of the central nervous system site unspecified': '1D04.Z',\n",
              " 'Infectious cysts of the central nervous system': '1D05',\n",
              " 'Epidural infectious cyst': '1D05.0',\n",
              " 'Subdural infectious cyst': '1D05.1',\n",
              " 'Other specified infectious cysts of the central nervous system': '1D05.Y',\n",
              " 'Infectious cysts of the central nervous system unspecified': '1D05.Z',\n",
              " 'Other specified nonviral and unspecified infections of the central nervous system': '1D0Y',\n",
              " 'Nonviral and unspecified infections of the central nervous system unspecified': '1D0Z',\n",
              " 'Dengue without warning signs': '1D20',\n",
              " 'Dengue with warning signs': '1D21',\n",
              " 'Severe dengue': '1D22',\n",
              " 'Dengue fever unspecified': '1D2Z',\n",
              " 'Chikungunya virus disease': '1D40',\n",
              " 'Colorado tick fever': '1D41',\n",
              " 'Onyongnyong fever': '1D42',\n",
              " 'Oropouche virus disease': '1D43',\n",
              " 'Rift Valley fever': '1D44',\n",
              " 'Sandfly fever': '1D45',\n",
              " 'West Nile virus infection': '1D46',\n",
              " 'Yellow fever': '1D47',\n",
              " 'Zika virus disease': '1D48',\n",
              " 'CrimeanCongo haemorrhagic fever': '1D49',\n",
              " 'Omsk haemorrhagic fever': '1D4A',\n",
              " 'Kyasanur Forest disease': '1D4B',\n",
              " 'Alkhurma haemorrhagic fever': '1D4C',\n",
              " 'Ross River disease': '1D4D',\n",
              " 'Severe fever with thrombocytopenia syndrome': '1D4E',\n",
              " 'Other specified arthropodborne viral fevers': '1D4Y',\n",
              " 'Arthropodborne viral fever virus unspecified': '1D4Z',\n",
              " 'Filovirus disease': '1D60',\n",
              " 'Ebola disease': '1D60.0',\n",
              " 'Bundibugyo virus disease': '1D60.00',\n",
              " 'Ebola virus disease': '1D60.01',\n",
              " 'Sudan virus disease': '1D60.02',\n",
              " 'Atypical Ebola disease': '1D60.03',\n",
              " 'Other specified Ebola disease': '1D60.0Y',\n",
              " 'Ebola disease virus unspecified': '1D60.0Z',\n",
              " 'Marburg disease': '1D60.1',\n",
              " 'Marburg virus disease': '1D60.10',\n",
              " 'Atypical Marburg disease': '1D60.11',\n",
              " 'Other specified Marburg disease': '1D60.1Y',\n",
              " 'Marburg disease virus unspecified': '1D60.1Z',\n",
              " 'Other specified filovirus disease': '1D60.Y',\n",
              " 'Filovirus disease virus unspecified': '1D60.Z',\n",
              " 'Arenavirus disease': '1D61',\n",
              " 'Argentinian haemorrhagic fever': '1D61.0',\n",
              " 'Bolivian haemorrhagic fever': '1D61.1',\n",
              " 'Lassa fever': '1D61.2',\n",
              " 'Venezuelan haemorrhagic fever': '1D61.3',\n",
              " 'Other specified arenavirus disease': '1D61.Y',\n",
              " 'Arenavirus disease unspecified': '1D61.Z',\n",
              " 'Hantavirus disease': '1D62',\n",
              " 'Haemorrhagic fever with renal syndrome': '1D62.0',\n",
              " 'Hantavirus pulmonary syndrome': '1D62.1',\n",
              " 'Atypical hantavirus disease': '1D62.2',\n",
              " 'Other specified hantavirus disease': '1D62.Y',\n",
              " 'Hantavirus disease unspecified': '1D62.Z',\n",
              " 'Henipavirus encephalitis': '1D63',\n",
              " 'Middle East respiratory syndrome': '1D64',\n",
              " 'Severe acute respiratory syndrome': '1D65',\n",
              " 'Other specified zoonotic viral diseases': '1D6Y',\n",
              " 'Zoonotic viral disease virus unspecified': '1D6Z',\n",
              " 'Mumps': '1D80',\n",
              " 'Mumps without complication': '1D80.0',\n",
              " 'Orchitis due to mumps virus': '1D80.1',\n",
              " 'Meningitis due to mumps virus': '1D80.2',\n",
              " 'Encephalitis due to mumps virus': '1D80.3',\n",
              " 'Pancreatitis due to mumps virus': '1D80.4',\n",
              " 'Other specified mumps': '1D80.Y',\n",
              " 'Infectious mononucleosis': '1D81',\n",
              " 'Mononucleosis due to EpsteinBarr virus': '1D81.0',\n",
              " 'Mononucleosis due to cytomegalovirus': '1D81.1',\n",
              " 'Other specified infectious mononucleosis': '1D81.Y',\n",
              " 'Infectious mononucleosis unspecified': '1D81.Z',\n",
              " 'Cytomegaloviral disease': '1D82',\n",
              " 'Cytomegaloviral hepatitis': '1D82.0',\n",
              " 'Cytomegaloviral pancreatitis': '1D82.1',\n",
              " 'Other specified cytomegaloviral disease': '1D82.Y',\n",
              " 'Cytomegaloviral disease unspecified': '1D82.Z',\n",
              " 'Epidemic myalgia': '1D83',\n",
              " 'Viral conjunctivitis': '1D84',\n",
              " 'Conjunctivitis due to adenovirus': '1D84.0',\n",
              " 'Acute epidemic haemorrhagic conjunctivitis': '1D84.1',\n",
              " 'Other specified viral conjunctivitis': '1D84.Y',\n",
              " 'Viral conjunctivitis unspecified': '1D84.Z',\n",
              " 'Viral carditis': '1D85',\n",
              " 'Dilated cardiomyopathy secondary to viral myocarditis': '1D85.0',\n",
              " 'Acute viral carditis': '1D85.1',\n",
              " 'Chronic viral carditis': '1D85.2',\n",
              " 'Aseptic myocarditis of newborn': '1D85.3',\n",
              " 'Coxsackie carditis': '1D85.4',\n",
              " 'Other specified viral carditis': '1D85.Y',\n",
              " 'Viral carditis unspecified': '1D85.Z',\n",
              " 'Viral haemorrhagic fever not elsewhere classified': '1D86',\n",
              " 'Adenovirus infection of unspecified site': '1D90',\n",
              " 'Enterovirus infection of unspecified site': '1D91',\n",
              " 'Coronavirus infection unspecified site': '1D92',\n",
              " 'Parvovirus infection of unspecified site': '1D93',\n",
              " 'Other viral infections of unspecified site': '1D9Y',\n",
              " 'Unspecified viral infection of unspecified site': '1D9Z',\n",
              " 'Other specified viral diseases': '1E1Y',\n",
              " 'Unspecified viral disease': '1E1Z',\n",
              " 'Influenza due to identified seasonal influenza virus': '1E30',\n",
              " 'Influenza due to identified zoonotic or pandemic influenza virus': '1E31',\n",
              " 'Influenza virus not identified': '1E32',\n",
              " 'Acute viral hepatitis': '1E50',\n",
              " 'Acute hepatitis A': '1E50.0',\n",
              " 'Acute hepatitis B': '1E50.1',\n",
              " 'Acute hepatitis C': '1E50.2',\n",
              " 'Acute hepatitis D': '1E50.3',\n",
              " 'Acute hepatitis E': '1E50.4',\n",
              " 'Other specified acute viral hepatitis': '1E50.Y',\n",
              " 'Acute viral hepatitis unspecified': '1E50.Z',\n",
              " 'Chronic viral hepatitis': '1E51',\n",
              " 'Chronic hepatitis B': '1E51.0',\n",
              " 'Chronic hepatitis B with human immunodeficiency virus coinfection': '1E51.00',\n",
              " 'Other specified chronic hepatitis B': '1E51.0Y',\n",
              " 'Chronic hepatitis B unspecified': '1E51.0Z',\n",
              " 'Chronic hepatitis C': '1E51.1',\n",
              " 'Chronic hepatitis D': '1E51.2',\n",
              " 'Chronic hepatitis E': '1E51.3',\n",
              " 'Other specified chronic viral hepatitis': '1E51.Y',\n",
              " 'Chronic viral hepatitis unspecified': '1E51.Z',\n",
              " 'Viral hepatitis unspecified': '1E5Z',\n",
              " 'Smallpox': '1E70',\n",
              " 'Mpox': '1E71',\n",
              " 'Cowpox': '1E72',\n",
              " 'Vaccinia': '1E73',\n",
              " 'Buffalopox': '1E74',\n",
              " 'Orf': '1E75',\n",
              " 'Molluscum contagiosum': '1E76',\n",
              " 'Other specified infections due to poxvirus': '1E7Y',\n",
              " 'Infections due to poxvirus unspecified': '1E7Z',\n",
              " 'Common warts': '1E80',\n",
              " 'Digital or periungual warts': '1E80.0',\n",
              " 'Plantar warts': '1E80.1',\n",
              " 'Other specified common warts': '1E80.Y',\n",
              " 'Common warts unspecified': '1E80.Z',\n",
              " 'Plane warts': '1E81',\n",
              " 'Warts of lips or oral cavity': '1E82',\n",
              " 'Focal epithelial hyperplasia of oral mucous membranes': '1E82.0',\n",
              " 'Wart virus proliferation in immunedeficient states': '1E83',\n",
              " 'Viral warts not elsewhere classified': '1E8Z',\n",
              " 'Varicella': '1E90',\n",
              " 'Varicella without complication': '1E90.0',\n",
              " 'Varicella meningitis': '1E90.1',\n",
              " 'Varicella encephalitis': '1E90.2',\n",
              " 'Varicella with other specified complication': '1E90.Y',\n",
              " 'Varicella unspecified': '1E90.Z',\n",
              " 'Zoster': '1E91',\n",
              " 'Zoster without complications': '1E91.0',\n",
              " 'Ophthalmic zoster': '1E91.1',\n",
              " 'Disseminated zoster': '1E91.2',\n",
              " 'Zoster with central nervous system involvement': '1E91.3',\n",
              " 'Acute neuropathy of cranial nerve due to zoster': '1E91.4',\n",
              " 'Acute trigeminal zoster neuropathy': '1E91.40',\n",
              " 'Acute herpetic geniculate ganglionitis': '1E91.41',\n",
              " 'Other specified acute neuropathy of cranial nerve due to zoster': '1E91.4Y',\n",
              " 'Acute neuropathy of cranial nerve due to zoster unspecified': '1E91.4Z',\n",
              " 'Postherpetic polyneuropathy': '1E91.5',\n",
              " 'Zoster with other specified complications': '1E91.Y',\n",
              " 'Zoster unspecified': '1E91.Z',\n",
              " 'Herpes simplex infections': '1F00',\n",
              " 'Herpes simplex infection of skin or mucous membrane': '1F00.0',\n",
              " 'Herpes simplex infection of skin': '1F00.00',\n",
              " 'Herpes simplex labialis': '1F00.01',\n",
              " 'Herpes simplex gingivostomatitis': '1F00.02',\n",
              " 'Disseminated cutaneous herpes simplex infection complicating other skin diseases': '1F00.03',\n",
              " 'Other specified herpes simplex infection of skin or mucous membrane': '1F00.0Y',\n",
              " 'Herpes simplex infection of the eye': '1F00.1',\n",
              " 'Herpes simplex keratitis': '1F00.10',\n",
              " 'Herpes simplex infection of eyelid': '1F00.11',\n",
              " 'Other specified herpes simplex infection of the eye': '1F00.1Y',\n",
              " 'Herpes simplex infection of the eye unspecified': '1F00.1Z',\n",
              " 'Herpes simplex infection of central nervous system': '1F00.2',\n",
              " 'Herpes simplex meningitis': '1F00.20',\n",
              " 'Encephalitis due to herpes simplex virus': '1F00.21',\n",
              " 'Other specified herpes simplex infection of central nervous system': '1F00.2Y',\n",
              " 'Disseminated herpes simplex infection': '1F00.3',\n",
              " 'Other specified herpes simplex infections': '1F00.Y',\n",
              " 'Herpes simplex infections unspecified': '1F00.Z',\n",
              " 'Roseola infantum': '1F01',\n",
              " 'Rubella': '1F02',\n",
              " 'Rubella with neurological complications': '1F02.0',\n",
              " 'Rubella arthritis': '1F02.1',\n",
              " 'Rubella without complication': '1F02.2',\n",
              " 'Rubella with other specified complication': '1F02.Y',\n",
              " 'Measles': '1F03',\n",
              " 'Measles without complication': '1F03.0',\n",
              " 'Measles complicated by encephalitis': '1F03.1',\n",
              " 'Measles complicated by meningitis': '1F03.2',\n",
              " 'Measles with other complications': '1F03.Y',\n",
              " 'Erythema infectiosum': '1F04',\n",
              " 'Picornavirus infections presenting in the skin or mucous membranes': '1F05',\n",
              " 'Enteroviral vesicular stomatitis': '1F05.0',\n",
              " 'Enteroviral vesicular pharyngitis': '1F05.1',\n",
              " 'Enteroviral exanthematous fever': '1F05.2',\n",
              " 'Foot and mouth disease': '1F05.3',\n",
              " 'Other specified picornavirus infections presenting in the skin or mucous membranes': '1F05.Y',\n",
              " 'Picornavirus infections presenting in the skin or mucous membranes unspecified': '1F05.Z',\n",
              " 'Other specified viral infections characterised by skin or mucous membrane lesions': '1F0Y',\n",
              " 'Viral infections characterised by skin or mucous membrane lesions unspecified': '1F0Z',\n",
              " 'Aspergillosis': '1F20',\n",
              " 'Invasive aspergillosis': '1F20.0',\n",
              " 'Invasive aspergillosis of the digestive tract': '1F20.00',\n",
              " 'Invasive cerebral aspergillosis': '1F20.01',\n",
              " 'Disseminated aspergillosis': '1F20.02',\n",
              " 'Invasive aspergillosis of other specified site': '1F20.0Y',\n",
              " 'Invasive aspergillosis unspecified': '1F20.0Z',\n",
              " 'Noninvasive aspergillosis': '1F20.1',\n",
              " 'Aspergillus otomycosis': '1F20.10',\n",
              " 'Chronic aspergillosis of the paranasal sinuses': '1F20.11',\n",
              " 'Chronic pulmonary aspergillosis': '1F20.12',\n",
              " 'Tonsillar aspergillosis': '1F20.13',\n",
              " 'Aspergillus bronchitis': '1F20.14',\n",
              " 'Obstructing aspergillus tracheobronchitis': '1F20.15',\n",
              " 'Other specified noninvasive aspergillosis': '1F20.1Y',\n",
              " 'Noninvasive aspergillosis unspecified': '1F20.1Z',\n",
              " 'Aspergillosis unspecified': '1F20.Z',\n",
              " 'Basidiobolomycosis': '1F21',\n",
              " 'Blastomycosis': '1F22',\n",
              " 'Candidosis': '1F23',\n",
              " 'Candidosis of lips or oral mucous membranes': '1F23.0',\n",
              " 'Candidosis of skin or mucous membranes': '1F23.1',\n",
              " 'Vulvovaginal candidosis': '1F23.10',\n",
              " 'Candida balanoposthitis': '1F23.11',\n",
              " 'Flexural or intertriginous candidosis': '1F23.12',\n",
              " 'Candidosis of nail or paronychium': '1F23.13',\n",
              " 'Chronic mucocutaneous candidosis': '1F23.14',\n",
              " 'Disseminated cutaneous candidosis': '1F23.15',\n",
              " 'Candida otomycosis': '1F23.16',\n",
              " 'Candidosis of skin or mucous membrane of other specified site': '1F23.1Y',\n",
              " 'Candidosis of skin or mucous membranes unspecified': '1F23.1Z',\n",
              " 'Candidosis of gastrointestinal tract': '1F23.2',\n",
              " 'Systemic or invasive candidosis': '1F23.3',\n",
              " 'Candida meningitis': '1F23.30',\n",
              " 'Pulmonary candidosis': '1F23.31',\n",
              " 'Other specified systemic or invasive candidosis': '1F23.3Y',\n",
              " 'Systemic or invasive candidosis unspecified': '1F23.3Z',\n",
              " 'Other specified candidosis': '1F23.Y',\n",
              " 'Candidosis unspecified': '1F23.Z',\n",
              " 'Chromoblastomycosis': '1F24',\n",
              " 'Coccidioidomycosis': '1F25',\n",
              " 'Pulmonary coccidioidomycosis': '1F25.0',\n",
              " 'Acute pulmonary coccidioidomycosis': '1F25.00',\n",
              " 'Chronic pulmonary coccidioidomycosis': '1F25.01',\n",
              " 'Extrathoracic coccidioidomycosis': '1F25.1',\n",
              " 'Disseminated coccidioidomycosis': '1F25.10',\n",
              " 'Primary cutaneous coccidioidomycosis': '1F25.11',\n",
              " 'Coccidioides meningitis': '1F25.12',\n",
              " 'Other specified extrathoracic coccidioidomycosis': '1F25.1Y',\n",
              " 'Extrathoracic coccidioidomycosis unspecified': '1F25.1Z',\n",
              " 'Coccidioidomycosis unspecified': '1F25.Z',\n",
              " 'Conidiobolomycosis': '1F26',\n",
              " 'Cryptococcosis': '1F27',\n",
              " 'Pulmonary cryptococcosis': '1F27.0',\n",
              " 'Cerebral cryptococcosis': '1F27.1',\n",
              " 'Meningitis due to Cryptococcus neoformans': '1F27.10',\n",
              " 'Disseminated cryptococcosis': '1F27.2',\n",
              " 'Other specified cryptococcosis': '1F27.Y',\n",
              " 'Cryptococcosis unspecified': '1F27.Z',\n",
              " 'Dermatophytosis': '1F28',\n",
              " 'Dermatophytosis of scalp': '1F28.0',\n",
              " 'Dermatophytosis of nail': '1F28.1',\n",
              " 'Dermatophytosis of foot': '1F28.2',\n",
              " 'Genitocrural dermatophytosis': '1F28.3',\n",
              " 'Kerion': '1F28.4',\n",
              " 'Disseminated dermatophytosis': '1F28.5',\n",
              " 'Other specified dermatophytosis': '1F28.Y',\n",
              " 'Dermatophytosis unspecified': '1F28.Z',\n",
              " 'Eumycetoma': '1F29',\n",
              " 'Histoplasmosis': '1F2A',\n",
              " 'Pulmonary histoplasmosis capsulati': '1F2A.0',\n",
              " 'Histoplasmosis due to Histoplasma duboisii': '1F2A.1',\n",
              " 'Other specified histoplasmosis': '1F2A.Y',\n",
              " 'Histoplasmosis unspecified': '1F2A.Z',\n",
              " 'Lobomycosis': '1F2B',\n",
              " 'Mucormycosis': '1F2C',\n",
              " 'Nondermatophyte superficial dermatomycoses': '1F2D',\n",
              " 'Pityriasis versicolor': '1F2D.0',\n",
              " 'Malassezia folliculitis': '1F2D.1',\n",
              " 'White piedra': '1F2D.2',\n",
              " 'Black piedra': '1F2D.3',\n",
              " 'Tinea nigra': '1F2D.4',\n",
              " 'Onychomycosis due to nondermatophyte mould': '1F2D.5',\n",
              " 'Other specified nondermatophyte superficial dermatomycoses': '1F2D.Y',\n",
              " 'Nondermatophyte superficial dermatomycoses unspecified': '1F2D.Z',\n",
              " 'Paracoccidioidomycosis': '1F2E',\n",
              " 'Pulmonary paracoccidioidomycosis': '1F2E.0',\n",
              " 'Disseminated paracoccidioidomycosis': '1F2E.1',\n",
              " 'Other specified paracoccidioidomycosis': '1F2E.Y',\n",
              " 'Paracoccidioidomycosis unspecified': '1F2E.Z',\n",
              " 'Phaeohyphomycosis': '1F2F',\n",
              " 'Pneumocystosis': '1F2G',\n",
              " 'Pulmonary pneumocystosis': '1F2G.0',\n",
              " 'Pneumocystosis unspecified': '1F2G.Z',\n",
              " 'Scedosporiosis': '1F2H',\n",
              " 'Sporotrichosis': '1F2J',\n",
              " 'Lymphocutaneous sporotrichosis': '1F2J.0',\n",
              " 'Fixed cutaneous sporotrichosis': '1F2J.1',\n",
              " 'Pulmonary sporotrichosis': '1F2J.2',\n",
              " 'Disseminated sporotrichosis': '1F2J.3',\n",
              " 'Other specified sporotrichosis': '1F2J.Y',\n",
              " 'Sporotrichosis unspecified': '1F2J.Z',\n",
              " 'Talaromycosis': '1F2K',\n",
              " 'Emmonsiosis': '1F2L',\n",
              " 'Disseminated adiaspiromycosis': '1F2L.0',\n",
              " 'Pulmonary adiaspiromycosis': '1F2L.1',\n",
              " 'Other specified emmonsiosis': '1F2L.Y',\n",
              " 'Emmonsiosis unspecified': '1F2L.Z',\n",
              " 'Other specified mycoses': '1F2Y',\n",
              " 'Mycoses unspecified': '1F2Z',\n",
              " 'Malaria due to Plasmodium falciparum': '1F40',\n",
              " 'Plasmodium falciparum malaria with cerebral complications': '1F40.0',\n",
              " 'Other severe and complicated Plasmodium falciparum malaria': '1F40.Y',\n",
              " 'Malaria due to Plasmodium falciparum unspecified': '1F40.Z',\n",
              " 'Malaria due to Plasmodium vivax': '1F41',\n",
              " 'Plasmodium vivax malaria with rupture of spleen': '1F41.0',\n",
              " 'Malaria due to Plasmodium vivax with other complications': '1F41.Y',\n",
              " 'Plasmodium vivax malaria without complication': '1F41.Z',\n",
              " 'Malaria due to Plasmodium malariae': '1F42',\n",
              " 'Plasmodium malariae malaria with nephropathy': '1F42.0',\n",
              " 'Malaria due to Plasmodium malariae with other complications': '1F42.Y',\n",
              " 'Plasmodium malariae malaria without complication': '1F42.Z',\n",
              " 'Malaria due to Plasmodium ovale': '1F43',\n",
              " 'Other parasitologically confirmed malaria': '1F44',\n",
              " 'Malaria without parasitological confirmation': '1F45',\n",
              " 'Malaria unspecified': '1F4Z',\n",
              " 'Acanthamoebiasis': '1F50',\n",
              " 'African trypanosomiasis': '1F51',\n",
              " 'Gambiense trypanosomiasis': '1F51.0',\n",
              " 'Meningitis in Gambiense trypanosomiasis': '1F51.00',\n",
              " 'Other specified gambiense trypanosomiasis': '1F51.0Y',\n",
              " 'Gambiense trypanosomiasis unspecified': '1F51.0Z',\n",
              " 'Rhodesiense trypanosomiasis': '1F51.1',\n",
              " 'Meningitis in Rhodesiense trypanosomiasis': '1F51.10',\n",
              " 'Other specified rhodesiense trypanosomiasis': '1F51.1Y',\n",
              " 'Rhodesiense trypanosomiasis unspecified': '1F51.1Z',\n",
              " 'Other specified african trypanosomiasis': '1F51.Y',\n",
              " 'African trypanosomiasis unspecified': '1F51.Z',\n",
              " 'Babesiosis': '1F52',\n",
              " 'Chagas disease': '1F53',\n",
              " 'Acute Chagas disease without heart involvement': '1F53.1',\n",
              " 'Chronic Chagas disease with heart involvement': '1F53.2',\n",
              " 'Chagas disease with digestive system involvement': '1F53.3',\n",
              " 'Meningitis in Chagas disease': '1F53.4',\n",
              " 'Other specified Chagas disease': '1F53.Y',\n",
              " 'Chagas disease unspecified': '1F53.Z',\n",
              " 'Leishmaniasis': '1F54',\n",
              " 'Visceral leishmaniasis': '1F54.0',\n",
              " 'Cutaneous leishmaniasis': '1F54.1',\n",
              " 'Mucocutaneous leishmaniasis': '1F54.2',\n",
              " 'Leishmaniasis unspecified': '1F54.Z',\n",
              " 'Naegleriasis': '1F55',\n",
              " 'Rhinosporidiosis': '1F56',\n",
              " 'Toxoplasmosis': '1F57',\n",
              " 'Hepatitis due to Toxoplasma gondii': '1F57.0',\n",
              " 'Meningoencephalitis due to Toxoplasma gondii': '1F57.1',\n",
              " 'Pulmonary toxoplasmosis due to Toxoplasma gondii': '1F57.2',\n",
              " 'Eye disease due to Toxoplasma gondii': '1F57.3',\n",
              " 'Other specified toxoplasmosis': '1F57.Y',\n",
              " 'Toxoplasmosis unspecified': '1F57.Z',\n",
              " 'Microsporidiosis': '1F58',\n",
              " 'Unspecified protozoal disease': '1F5Z',\n",
              " 'Angiostrongyliasis': '1F60',\n",
              " 'Eosinophilic meningitis due to Angiostrongylus cantonensis': '1F60.0',\n",
              " 'Intestinal angiostrongyliasis': '1F60.1',\n",
              " 'Other specified angiostrongyliasis': '1F60.Y',\n",
              " 'Angiostrongyliasis unspecified': '1F60.Z',\n",
              " 'Anisakiasis': '1F61',\n",
              " 'Ascariasis': '1F62',\n",
              " 'Capillariasis': '1F63',\n",
              " 'Capillariasis of the intestine': '1F63.0',\n",
              " 'Other specified capillariasis': '1F63.Y',\n",
              " 'Capillariasis unspecified': '1F63.Z',\n",
              " 'Dracunculiasis': '1F64',\n",
              " 'Enterobiasis': '1F65',\n",
              " 'Filariasis': '1F66',\n",
              " 'Loiasis': '1F66.0',\n",
              " 'Mansonelliasis': '1F66.1',\n",
              " 'Filariasis due to Brugia species': '1F66.2',\n",
              " 'Lymphatic filariasis': '1F66.3',\n",
              " 'Filariasis due to Wuchereria bancrofti': '1F66.30',\n",
              " 'Filariasis due to Brugia malayi': '1F66.31',\n",
              " 'Filariasis due to Brugia timori': '1F66.32',\n",
              " 'Lymphatic filariasis unspecified': '1F66.3Z',\n",
              " 'Subcutaneous dirofilariasis': '1F66.4',\n",
              " 'Other specified filariasis': '1F66.Y',\n",
              " 'Filariasis unspecified': '1F66.Z',\n",
              " 'Gnathostomiasis': '1F67',\n",
              " 'Hookworm diseases': '1F68',\n",
              " 'Ancylostomiasis': '1F68.0',\n",
              " 'Necatoriasis': '1F68.1',\n",
              " 'Cutaneous larva migrans': '1F68.2',\n",
              " 'Other specified hookworm diseases': '1F68.Y',\n",
              " 'Hookworm diseases unspecified': '1F68.Z',\n",
              " 'Oesophagostomiasis': '1F69',\n",
              " 'Onchocerciasis': '1F6A',\n",
              " 'Onchocerciasis of the eye': '1F6A.0',\n",
              " 'Onchocerciasis of the skin': '1F6A.1',\n",
              " 'Other specified onchocerciasis': '1F6A.Y',\n",
              " 'Onchocerciasis unspecified': '1F6A.Z',\n",
              " 'Strongyloidiasis': '1F6B',\n",
              " 'Syngamosis': '1F6C',\n",
              " 'Toxocariasis': '1F6D',\n",
              " 'Trichinosis': '1F6E',\n",
              " 'Trichostrongyliasis': '1F6F',\n",
              " 'Trichuriasis': '1F6G',\n",
              " 'Uncinariosis': '1F6H',\n",
              " 'Other specified diseases due to nematodes': '1F6Y',\n",
              " 'Diseases due to nematodes unspecified': '1F6Z',\n",
              " 'Cysticercosis': '1F70',\n",
              " 'Cysticercosis of central nervous system': '1F70.0',\n",
              " 'Meningitis due to Cysticercosis': '1F70.00',\n",
              " 'Other specified cysticercosis of central nervous system': '1F70.0Y',\n",
              " 'Cysticercosis of central nervous system unspecified': '1F70.0Z',\n",
              " 'Cysticercosis of eye': '1F70.1',\n",
              " 'Other specified cysticercosis': '1F70.Y',\n",
              " 'Cysticercosis unspecified': '1F70.Z',\n",
              " 'Diphyllobothriasis': '1F71',\n",
              " 'Dipylidiasis': '1F72',\n",
              " 'Echinococcosis': '1F73',\n",
              " 'Echinococcus infection of liver': '1F73.0',\n",
              " 'Echinococcus infection of lung': '1F73.1',\n",
              " 'Echinococcus infection of bone': '1F73.2',\n",
              " 'Echinococcus infection of central nervous system': '1F73.3',\n",
              " 'Other specified echinococcosis': '1F73.Y',\n",
              " 'Echinococcosis unspecified': '1F73.Z',\n",
              " 'Hymenolepiasis': '1F74',\n",
              " 'Sparganosis': '1F75',\n",
              " 'Taeniasis': '1F76',\n",
              " 'Taeniasis due to Taenia solium': '1F76.0',\n",
              " 'Taeniasis due to Taenia saginata': '1F76.1',\n",
              " 'Other specified taeniasis': '1F76.Y',\n",
              " 'Taeniasis unspecified': '1F76.Z',\n",
              " 'Other specified diseases due to cestodes': '1F7Y',\n",
              " 'Diseases due to cestodes unspecified': '1F7Z',\n",
              " 'Clonorchiasis': '1F80',\n",
              " 'Dicrocoeliasis': '1F81',\n",
              " 'Fascioliasis': '1F82',\n",
              " 'Fasciolopsiasis': '1F83',\n",
              " 'Opisthorchiasis': '1F84',\n",
              " 'Paragonimiasis': '1F85',\n",
              " 'Schistosomiasis': '1F86',\n",
              " 'Schistosomiasis due to Schistosoma haematobium': '1F86.0',\n",
              " 'Schistosomiasis due to Schistosoma mansoni': '1F86.1',\n",
              " 'Schistosomiasis due to Schistosoma japonicum': '1F86.2',\n",
              " 'Other schistosomiases': '1F86.3',\n",
              " 'Cercarial dermatitis': '1F86.4',\n",
              " 'Schistosomal pneumonitis': '1F86.5',\n",
              " 'Schistosomiasis due to unspecified or unknown Schistosoma species': '1F86.Z',\n",
              " 'Other specified diseases due to trematodes': '1F8Y',\n",
              " 'Diseases due to trematodes unspecified': '1F8Z',\n",
              " 'Other or unspecified infestation by parasitic worms': '1F90',\n",
              " 'Mixed intestinal helminthiases': '1F90.0',\n",
              " 'Intestinal parasitic infestation not otherwise specified': '1F90.1',\n",
              " 'Intestinal helminthiasis unspecified': '1F90.2',\n",
              " 'Other specified infestation by parasitic worms': '1F90.Y',\n",
              " 'Infestation by parasitic worms unspecified': '1F90.Z',\n",
              " 'Diphyllobothriasis and sparganosis': '1F91',\n",
              " 'Helminthiases unspecified': '1F9Z',\n",
              " 'Pediculosis': '1G00',\n",
              " 'Pediculosis capitis': '1G00.0',\n",
              " 'Pediculosis corporis': '1G00.1',\n",
              " 'Pediculosis of unspecified site or type': '1G00.Z',\n",
              " 'Myiasis': '1G01',\n",
              " 'Ocular myiasis': '1G01.0',\n",
              " 'Nasopharyngeal myiasis': '1G01.1',\n",
              " 'Laryngeal myiasis': '1G01.2',\n",
              " 'Cutaneous myiasis': '1G01.3',\n",
              " 'Other specified myiasis': '1G01.Y',\n",
              " 'Myiasis unspecified': '1G01.Z',\n",
              " 'External hirudiniasis': '1G02',\n",
              " 'Pthiriasis': '1G03',\n",
              " 'Scabies': '1G04',\n",
              " 'Classical scabies': '1G04.0',\n",
              " 'Crusted scabies': '1G04.1',\n",
              " 'Other specified scabies': '1G04.Y',\n",
              " 'Scabies unspecified': '1G04.Z',\n",
              " 'Tungiasis': '1G05',\n",
              " 'Cimicosis': '1G06',\n",
              " 'Infestation by mites': '1G07',\n",
              " 'Infestation by Demodex': '1G07.0',\n",
              " 'Infestation of the skin by other specified parasitic mites': '1G07.Y',\n",
              " 'Infestation of the skin by unspecified parasitic mites': '1G07.Z',\n",
              " 'Infestation by other specified ectoparasite': '1G0Y',\n",
              " 'Infestation by unknown or unspecified ectoparasite': '1G0Z',\n",
              " 'Other specified parasitic diseases': '1G2Y',\n",
              " 'Unspecified parasitic diseases': '1G2Z',\n",
              " 'Sepsis without septic shock': '1G40',\n",
              " 'Sepsis with septic shock': '1G41',\n",
              " 'Certain other disorders of infectious origin': '1G60',\n",
              " 'Mycetoma of unknown or unspecified type': '1G60.0',\n",
              " 'Pythiosis': '1G60.1',\n",
              " 'Protothecosis': '1G60.2',\n",
              " ...}"
            ]
          },
          "execution_count": 17,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "lab_test_mapping"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 18,
      "metadata": {
        "id": "mACTe42I9U8u"
      },
      "outputs": [],
      "source": [
        "from langchain.prompts import PromptTemplate\n",
        "from langchain.chains import LLMChain\n",
        "\n",
        "# Define prompt template\n",
        "prompt_template = \"\"\"\n",
        "You are an expert in medical diagnostics. Below is a list of lab tests with their corresponding ICD codes:\n",
        "\n",
        "{lab_test_mapping}\n",
        "\n",
        "Now, given the following extracted lab test names from a report:\n",
        "{extracted_tests}\n",
        "\n",
        "Please map each extracted test to the closest matching ICD code from the given mapping. If no exact match exists, find the most semantically appropriate match.\n",
        "\n",
        "Provide the output in the format:\n",
        "- Extracted Test: [Name]\n",
        "- Mapped ICD Test: [Closest Lab Test Name]\n",
        "- ICD Code: [Code]\n",
        "\"\"\"\n",
        "\n",
        "# Convert dictionary to string for the prompt\n",
        "lab_test_mapping_str = \"\\n\".join([f\"{k}: {v}\" for k, v in lab_test_mapping.items()])"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 19,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 165
        },
        "id": "3whtn80c9U8u",
        "outputId": "9d8b22f1-5ade-4c8c-df45-d9254d92280a"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "'Cholera: 1A00\\nIntestinal infection due to other Vibrio: 1A01\\nIntestinal infections due to Shigella: 1A02\\nIntestinal infections due to Escherichia coli: 1A03\\nEnteropathogenic Escherichia coli infection: 1A03.0\\nEnterotoxigenic Escherichia coli infection: 1A03.1\\nEnteroinvasive Escherichia coli infection: 1A03.2\\nEnterohaemorrhagic Escherichia coli infection: 1A03.3\\nIntestinal infections due to other specified Escherichia coli: 1A03.Y\\nIntestinal infections due to Escherichia coli unspecified: 1A03.Z\\nIntestinal infections due to Clostridioides difficile: 1A04\\nIntestinal infections due to Yersinia enterocolitica: 1A05\\nGastroenteritis due to Campylobacter: 1A06\\nTyphoid fever: 1A07\\nTyphoid peritonitis: 1A07.0\\nOther specified typhoid fever: 1A07.Y\\nTyphoid fever unspecified: 1A07.Z\\nParatyphoid fever: 1A08\\nInfections due to other Salmonella: 1A09\\nSalmonella enteritis: 1A09.0\\nInfections due to other Salmonella in other organs: 1A09.Y\\nSalmonella infection unspecified: 1A09.Z\\nOther specified bacterial intestinal infections: 1A0Y\\nBacterial intestinal infections unspecified: 1A0Z\\nFoodborne staphylococcal intoxication: 1A10\\nBotulism: 1A11\\nFoodborne intoxication by botulinum toxin: 1A11.0\\nOther forms of botulism: 1A11.1\\nBotulism unspecified: 1A11.Z\\nFoodborne Clostridium perfringens intoxication: 1A12\\nFoodborne Bacillus cereus intoxication: 1A13\\nOther specified bacterial foodborne intoxications: 1A1Y\\nBacterial foodborne intoxications unspecified: 1A1Z\\nEnteritis due to Adenovirus: 1A20\\nGastroenteritis due to Astrovirus: 1A21\\nGastroenteritis due to Rotavirus: 1A22\\nEnteritis due to Norovirus: 1A23\\nIntestinal infections due to Cytomegalovirus: 1A24\\nOther specified viral intestinal infections: 1A2Y\\nViral intestinal infections unspecified: 1A2Z\\nInfections due to Balantidium coli: 1A30\\nGiardiasis: 1A31\\nCryptosporidiosis: 1A32\\nCystoisosporiasis: 1A33\\nCystoisosporiasis of small intestine: 1A33.0\\nCystoisosporiasis of colon: 1A33.1\\nOther specified cystoisosporiasis: 1A33.Y\\nCystoisosporiasis unspecified: 1A33.Z\\nSarcocystosis: 1A34\\nBlastocystosis: 1A35\\nAmoebiasis: 1A36\\nIntestinal infections due to Entamoeba: 1A36.0\\nAcute amoebiasis: 1A36.00\\nAmoeboma of intestine: 1A36.01\\nOther specified intestinal infections due to Entamoeba: 1A36.0Y\\nIntestinal infections due to Entamoeba unspecified: 1A36.0Z\\nExtraintestinal infections due to Entamoeba: 1A36.1\\nAmoebic liver abscess: 1A36.10\\nAmoebic lung abscess: 1A36.11\\nCutaneous amoebiasis: 1A36.12\\nAmoebiasis of other specified sites: 1A36.1Y\\nAmoebiasis unspecified: 1A36.Z\\nOther specified protozoal intestinal infections: 1A3Y\\nProtozoal intestinal infections unspecified: 1A3Z\\nGastroenteritis or colitis without specification of infectious agent: 1A40\\nGastroenteritis or colitis without specification of origin: 1A40.0\\nInfectious gastroenteritis or colitis without specification of infectious agent: 1A40.Z\\nCongenital syphilis: 1A60\\nEarly congenital syphilis symptomatic: 1A60.0\\nEarly congenital syphilis latent: 1A60.1\\nLate congenital syphilitic oculopathy: 1A60.2\\nLate congenital neurosyphilis: 1A60.3\\nOther late congenital syphilis symptomatic: 1A60.4\\nLate congenital syphilis latent: 1A60.5\\nCongenital syphilis unspecified: 1A60.Z\\nEarly syphilis: 1A61\\nPrimary genital syphilis: 1A61.0\\nPrimary anal syphilis: 1A61.1\\nPrimary syphilis of other sites: 1A61.2\\nSecondary syphilis of skin or mucous membranes: 1A61.3\\nSecondary syphilis of other sites: 1A61.4\\nLatent early syphilis: 1A61.5\\nOther specified early syphilis: 1A61.Y\\nEarly syphilis unspecified: 1A61.Z\\nLate syphilis: 1A62\\nNeurosyphilis: 1A62.0\\nAsymptomatic neurosyphilis: 1A62.00\\nSymptomatic late neurosyphilis: 1A62.01\\nNeurosyphilis unspecified: 1A62.0Z\\nCardiovascular late syphilis: 1A62.1\\nSymptomatic late syphilis of other sites: 1A62.2\\nOcular late syphilis: 1A62.20\\nLate syphilis involving the musculoskeletal system: 1A62.21\\nLate syphilis of skin or mucous membranes: 1A62.22\\nSymptomatic late syphilis of other specified sites: 1A62.2Y\\nSymptomatic late syphilis of unspecified site: 1A62.2Z\\nOther specified late syphilis: 1A62.Y\\nLate syphilis unspecified: 1A62.Z\\nLatent syphilis unspecified as early or late: 1A63\\nSyphilis unspecified: 1A6Z\\nGonococcal genitourinary infection: 1A70\\nGonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess: 1A70.0\\nGonorrhoea of penis: 1A70.00\\nOther specified gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess: 1A70.0Y\\nGonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess unspecified: 1A70.0Z\\nGonococcal infection of lower genitourinary tract with periurethral or accessory gland abscess: 1A70.1\\nGonococcal infection of other specified genitourinary organ: 1A70.Y\\nGonococcal genitourinary infection unspecified: 1A70.Z\\nGonococcal pelviperitonitis: 1A71\\nGonococcal infection of other sites: 1A72\\nGonococcal infection of musculoskeletal system: 1A72.0\\nGonococcal infection of rectum: 1A72.1\\nGonococcal infection of anus: 1A72.2\\nGonococcal pharyngitis: 1A72.3\\nGonococcal infection of eye: 1A72.4\\nGonococcal infection of other specified sites: 1A72.Y\\nDisseminated gonococcal infection: 1A73\\nGonococcal infection unspecified: 1A7Z\\nChlamydial lymphogranuloma: 1A80\\nNonulcerative sexually transmitted chlamydial infection: 1A81\\nChlamydial infection of lower genitourinary tract: 1A81.0\\nChlamydial infection of internal reproductive organs: 1A81.1\\nNonulcerative sexually transmitted chlamydial infection of other specified site: 1A81.Y\\nNonulcerative sexually transmitted chlamydial infection of unspecified site: 1A81.Z\\nOther specified sexually transmissible infections due to chlamydia: 1A8Y\\nSexually transmissible infections due to chlamydia unspecified: 1A8Z\\nChancroid: 1A90\\nGranuloma inguinale: 1A91\\nTrichomoniasis: 1A92\\nSexually transmissible infestations: 1A93\\nAnogenital herpes simplex infection: 1A94\\nHerpes simplex infection of genitalia or urogenital tract: 1A94.0\\nHerpes simplex infection of perianal skin or rectum: 1A94.1\\nAnogenital herpes simplex infection without further specification: 1A94.Z\\nAnogenital warts: 1A95\\nAnal warts: 1A95.0\\nGenital warts: 1A95.1\\nExtragenital condylomata acuminata: 1A95.2\\nAnogenital warts unspecified: 1A95.Z\\nOther specified predominantly sexually transmitted infections: 1A9Y\\nPredominantly sexually transmitted infections unspecified: 1A9Z\\nTuberculosis of the respiratory system: 1B10\\nRespiratory tuberculosis confirmed: 1B10.0\\nRespiratory tuberculosis not confirmed: 1B10.1\\nRespiratory tuberculosis without mention of bacteriological or histological confirmation: 1B10.Z\\nTuberculosis of the nervous system: 1B11\\nTuberculous meningitis: 1B11.0\\nTuberculous meningoencephalitis: 1B11.1\\nMeningeal tuberculoma: 1B11.2\\nTuberculous granuloma of brain: 1B11.3\\nOther tuberculosis of nervous system: 1B11.Y\\nTuberculosis of the nervous system unspecified: 1B11.Z\\nTuberculosis of other systems and organs: 1B12\\nTuberculosis of heart: 1B12.0\\nTuberculosis of eye: 1B12.1\\nTuberculosis of ear: 1B12.2\\nTuberculosis of endocrine glands: 1B12.3\\nTuberculosis of the musculoskeletal system: 1B12.4\\nTuberculosis of bones or joints: 1B12.40\\nTuberculous myositis: 1B12.41\\nTuberculosis of other specified part of the musculoskeletal system: 1B12.4Y\\nTuberculosis of the musculoskeletal system unspecified: 1B12.4Z\\nTuberculosis of the genitourinary system: 1B12.5\\nTuberculous peripheral lymphadenopathy: 1B12.6\\nTuberculosis of the digestive system: 1B12.7\\nCutaneous tuberculosis: 1B12.8\\nTuberculosis of other specified organ or site: 1B12.Y\\nMiliary tuberculosis: 1B13\\nAcute miliary tuberculosis of a single specified site: 1B13.0\\nAcute miliary tuberculosis of multiple sites: 1B13.1\\nAcute miliary tuberculosis unspecified site: 1B13.2\\nOther specified miliary tuberculosis: 1B13.Y\\nMiliary tuberculosis unspecified: 1B13.Z\\nLatent tuberculosis: 1B14\\nOther specified tuberculosis: 1B1Y\\nTuberculosis unspecified: 1B1Z\\nLeprosy: 1B20\\nPaucibacillary leprosy: 1B20.0\\nMultibacillary leprosy: 1B20.1\\nLeprosy reactions: 1B20.2\\nType I leprosy reaction: 1B20.20\\nType II leprosy reaction: 1B20.21\\nComplications of leprosy: 1B20.3\\nLeprosy unspecified: 1B20.Z\\nInfections due to nontuberculous mycobacteria: 1B21\\nPulmonary infection due to nontuberculous mycobacterium: 1B21.0\\nNontuberculous mycobacterial lymphadenitis: 1B21.1\\nCutaneous nontuberculous mycobacterial infection: 1B21.2\\nMycobacterium ulcerans infection: 1B21.20\\nCutaneous infection due to other specified nontuberculous mycobacteria: 1B21.2Y\\nCutaneous infection due to unspecified nontuberculous mycobacteria: 1B21.2Z\\nDisseminated nontuberculous mycobacterial infection: 1B21.3\\nGastrointestinal nontuberculous mycobacterial infection: 1B21.4\\nNontuberculous mycobacterial infection of other specified site: 1B21.Y\\nNontuberculous mycobacterial infection of unspecified site: 1B21.Z\\nOther specified mycobacterial diseases: 1B2Y\\nMycobacterial diseases unspecified: 1B2Z\\nAcute rheumatic fever without mention of heart involvement: 1B40\\nRheumatic arthritis acute or subacute: 1B40.0\\nOther specified acute rheumatic fever without mention of heart involvement: 1B40.Y\\nAcute rheumatic fever without mention of heart involvement unspecified: 1B40.Z\\nAcute rheumatic fever with heart involvement: 1B41\\nAcute rheumatic pericarditis: 1B41.0\\nAcute rheumatic endocarditis: 1B41.1\\nRheumatic aortitis: 1B41.10\\nOther specified acute rheumatic endocarditis: 1B41.1Y\\nAcute rheumatic endocarditis unspecified: 1B41.1Z\\nAcute rheumatic myocarditis: 1B41.2\\nOther acute rheumatic heart disease: 1B41.Y\\nAcute rheumatic heart disease unspecified: 1B41.Z\\nRheumatic chorea: 1B42\\nScarlet fever: 1B50\\nStreptococcal pharyngitis: 1B51\\nMeningitis due to Streptococcus: 1B53\\nMeningitis due to Staphylococcus: 1B54\\nOther specified staphylococcal or streptococcal diseases: 1B5Y\\nStaphylococcal or streptococcal diseases unspecified: 1B5Z\\nBacterial cellulitis erysipelas or lymphangitis: 1B70\\nErysipelas: 1B70.0\\nErysipelas of face: 1B70.00\\nErysipelas of external ear: 1B70.01\\nErysipelas of lower limb: 1B70.02\\nErysipelas of other specified site: 1B70.0Y\\nErysipelas unspecified: 1B70.0Z\\nStreptococcal cellulitis of skin: 1B70.1\\nStaphylococcal cellulitis of skin: 1B70.2\\nAscending bacterial lymphangitis: 1B70.3\\nBacterial cellulitis or lymphangitis due to other specified bacterium: 1B70.Y\\nBacterial cellulitis or lymphangitis due to unspecified bacterium: 1B70.Z\\nNecrotising fasciitis: 1B71\\nStreptococcal necrotising fasciitis: 1B71.0\\nPolymicrobial necrotising fasciitis: 1B71.1\\nNeonatal necrotising fasciitis: 1B71.2\\nNecrotising fasciitis due to other specified bacterial infection: 1B71.Y\\nNecrotising fasciitis unspecified: 1B71.Z\\nImpetigo: 1B72\\nBullous impetigo: 1B72.0\\nNonbullous impetigo: 1B72.1\\nSecondary impetiginisation of the skin: 1B72.2\\nOther specified impetigo: 1B72.Y\\nImpetigo unspecified: 1B72.Z\\nEcthyma: 1B73\\nStreptococcal ecthyma: 1B73.0\\nStaphylococcal ecthyma: 1B73.1\\nEcthyma gangrenosum: 1B73.2\\nOther specified ecthyma: 1B73.Y\\nEcthyma unspecified: 1B73.Z\\nSuperficial bacterial folliculitis: 1B74\\nStaphylococcus aureus superficial folliculitis: 1B74.0\\nSuperficial bacterial folliculitis due to other specified organism: 1B74.Y\\nSuperficial bacterial folliculitis due to unspecified organism: 1B74.Z\\nDeep bacterial folliculitis or pyogenic abscess of the skin: 1B75\\nFuruncle: 1B75.0\\nCarbuncle: 1B75.1\\nFurunculosis: 1B75.2\\nPyogenic abscess of the skin: 1B75.3\\nChronic deep bacterial folliculitis: 1B75.4\\nDeep bacterial folliculitis or pyogenic abscess of the skin unspecified: 1B75.Z\\nOther specified pyogenic bacterial infection of skin or subcutaneous tissue: 1B7Y\\nPyogenic bacterial infection of skin or subcutaneous tissue unspecified: 1B7Z\\nRatbite fevers: 1B90\\nSpirillosis: 1B90.0\\nStreptobacillosis: 1B90.1\\nLeptospirosis: 1B91\\nGlanders: 1B92\\nPlague: 1B93\\nBubonic plague: 1B93.0\\nCellulocutaneous plague: 1B93.1\\nPneumonic plague: 1B93.2\\nPlague meningitis: 1B93.3\\nOther specified plague: 1B93.Y\\nPlague unspecified: 1B93.Z\\nTularaemia: 1B94\\nUlceroglandular tularaemia: 1B94.0\\nOther specified tularaemia: 1B94.Y\\nTularaemia unspecified: 1B94.Z\\nBrucellosis: 1B95\\nErysipeloid: 1B96\\nAnthrax: 1B97\\nCatscratch disease: 1B98\\nPasteurellosis: 1B99\\nExtraintestinal yersiniosis: 1B9A\\nUnspecified zoonotic bacterial disease: 1B9Z\\nActinomycosis: 1C10\\nPulmonary actinomycosis: 1C10.0\\nAbdominal actinomycosis: 1C10.1\\nCervicofacial actinomycosis: 1C10.2\\nPrimary cutaneous actinomycosis: 1C10.3\\nOther specified forms of actinomycosis: 1C10.Y\\nActinomycosis unspecified: 1C10.Z\\nBartonellosis: 1C11\\nCarrion disease: 1C11.0\\nOroya fever: 1C11.00\\nVerruga peruana: 1C11.01\\nTrench fever: 1C11.1\\nOther forms of bartonellosis: 1C11.Y\\nBartonellosis unspecified: 1C11.Z\\nWhooping cough: 1C12\\nWhooping cough due to Bordetella pertussis: 1C12.0\\nWhooping cough due to Bordetella parapertussis: 1C12.1\\nOther specified whooping cough: 1C12.Y\\nWhooping cough unspecified: 1C12.Z\\nTetanus: 1C13\\nObstetrical tetanus: 1C14\\nTetanus neonatorum: 1C15\\nGas gangrene: 1C16\\nDiphtheria: 1C17\\nPharyngeal or tonsillar diphtheria: 1C17.0\\nPostdiphtheritic paralysis of uvula: 1C17.00\\nOther specified pharyngeal or tonsillar diphtheria: 1C17.0Y\\nPharyngeal or tonsillar diphtheria unspecified: 1C17.0Z\\nNasal diphtheria: 1C17.1\\nLaryngeal diphtheria: 1C17.2\\nCutaneous diphtheria: 1C17.3\\nOther specified diphtheria: 1C17.Y\\nDiphtheria unspecified: 1C17.Z\\nBrazilian purpuric fever: 1C18\\nLegionellosis: 1C19\\nNonpneumonic Legionnaires disease: 1C19.0\\nLegionnaires disease: 1C19.1\\nLegionellosis unspecified: 1C19.Z\\nListeriosis: 1C1A\\nCutaneous listeriosis: 1C1A.0\\nListerial meningitis or meningoencephalitis: 1C1A.1\\nOther specified listeriosis: 1C1A.Y\\nListeriosis unspecified: 1C1A.Z\\nNocardiosis: 1C1B\\nPulmonary nocardiosis: 1C1B.0\\nCutaneous nocardiosis: 1C1B.1\\nOther specified forms of nocardiosis: 1C1B.Y\\nNocardiosis unspecified: 1C1B.Z\\nMeningococcal disease: 1C1C\\nMeningococcal meningitis: 1C1C.0\\nWaterhouseFriderichsen syndrome: 1C1C.1\\nMeningococcaemia: 1C1C.2\\nAcute meningococcaemia: 1C1C.20\\nOther specified meningococcaemia: 1C1C.2Y\\nMeningococcaemia unspecified: 1C1C.2Z\\nOther specified meningococcal disease: 1C1C.Y\\nMeningococcal disease unspecified: 1C1C.Z\\nYaws: 1C1D\\nPrimary yaws: 1C1D.0\\nSecondary yaws: 1C1D.1\\nTertiary yaws: 1C1D.2\\nLatent yaws: 1C1D.3\\nYaws unspecified: 1C1D.Z\\nPinta: 1C1E\\nPrimary lesions of pinta: 1C1E.0\\nIntermediate lesions of pinta: 1C1E.1\\nLate lesions of pinta: 1C1E.2\\nMixed lesions of pinta: 1C1E.3\\nPinta unspecified: 1C1E.Z\\nEndemic nonvenereal syphilis: 1C1F\\nLyme borreliosis: 1C1G\\nEarly cutaneous Lyme borreliosis: 1C1G.0\\nDisseminated Lyme borreliosis: 1C1G.1\\nLyme neuroborreliosis: 1C1G.10\\nLyme carditis: 1C1G.11\\nOphthalmic Lyme borreliosis: 1C1G.12\\nLyme arthritis: 1C1G.13\\nLate cutaneous Lyme borreliosis: 1C1G.14\\nOther specified disseminated Lyme borreliosis: 1C1G.1Y\\nDisseminated Lyme borreliosis unspecified: 1C1G.1Z\\nOther specified Lyme borreliosis: 1C1G.Y\\nLyme borreliosis unspecified: 1C1G.Z\\nNecrotising ulcerative gingivitis: 1C1H\\nOther Vincent infections: 1C1H.0\\nOther specified necrotising ulcerative gingivitis: 1C1H.Y\\nNecrotising ulcerative gingivitis unspecified: 1C1H.Z\\nRelapsing fever: 1C1J\\nTickborne relapsing fever: 1C1J.0\\nLouseborne relapsing fever: 1C1J.1\\nRelapsing fever unspecified: 1C1J.Z\\nChlamydial conjunctivitis: 1C20\\nChlamydial peritonitis: 1C21\\nInfections due to Chlamydia psittaci: 1C22\\nTrachoma: 1C23\\nInitial stage of trachoma: 1C23.0\\nActive stage of trachoma: 1C23.1\\nOther specified trachoma: 1C23.Y\\nTrachoma unspecified: 1C23.Z\\nOther specified diseases due to chlamydiae: 1C2Y\\nDiseases due to chlamydiae unspecified: 1C2Z\\nTyphus fever: 1C30\\nEpidemic louseborne typhus fever due to Rickettsia prowazekii: 1C30.0\\nRecrudescent typhus: 1C30.1\\nTyphus fever due to Rickettsia typhi: 1C30.2\\nTyphus fever due to Orientia tsutsugamushi: 1C30.3\\nOther specified typhus fever: 1C30.Y\\nTyphus fever unspecified: 1C30.Z\\nSpotted fever: 1C31\\nSpotted fever due to Rickettsia rickettsii: 1C31.0\\nSpotted fever due to Rickettsia conorii: 1C31.1\\nSpotted fever due to Rickettsia sibirica: 1C31.2\\nSpotted fever due to Rickettsia australis: 1C31.3\\nOther specified spotted fever: 1C31.Y\\nSpotted fever unspecified: 1C31.Z\\nRickettsialpox: 1C32\\nQ fever: 1C33\\nOther specified rickettsioses: 1C3Y\\nRickettsioses unspecified: 1C3Z\\nCampylobacteriosis: 1C40\\nBacterial infection of unspecified site: 1C41\\nMelioidosis: 1C42\\nActinomycetoma: 1C43\\nNonpyogenic bacterial infections of the skin: 1C44\\nToxic shock syndrome: 1C45\\nStreptococcal toxic shock syndrome: 1C45.0\\nStaphylococcal toxic shock syndrome: 1C45.1\\nToxic shock syndrome due to other specified infectious agent: 1C45.Y\\nToxic shock syndrome without specified infectious agent: 1C45.Z\\nOther specified bacterial diseases: 1C4Y\\nUnspecified bacterial disease: 1C4Z\\nHuman immunodeficiency virus disease associated with tuberculosis: 1C60\\nHIV disease clinical stage  associated with tuberculosis: 1C60.3\\nKaposi sarcoma associated with human immunodeficiency virus disease associated with tuberculosis: 1C60.30\\nOther specified HIV disease clinical stage  associated with tuberculosis: 1C60.3Y\\nHIV disease clinical stage  associated with tuberculosis unspecified: 1C60.3Z\\nHuman immunodeficiency virus disease associated with tuberculosis clinical stage unspecified: 1C60.Z\\nHuman immunodeficiency virus disease associated with malaria: 1C61\\nHIV disease clinical stage  associated with malaria: 1C61.3\\nKaposi sarcoma associated with human immunodeficiency virus disease associated with malaria: 1C61.30\\nOther specified HIV disease clinical stage  associated with malaria: 1C61.3Y\\nHIV disease clinical stage  associated with malaria unspecified: 1C61.3Z\\nHuman immunodeficiency virus disease associated with malaria clinical stage unspecified: 1C61.Z\\nHuman immunodeficiency virus disease without mention of tuberculosis or malaria: 1C62\\nHIV disease clinical stage  without mention of tuberculosis or malaria: 1C62.3\\nKaposi sarcoma associated with human immunodeficiency virus disease without mention of tuberculosis or malaria: 1C62.30\\nOther specified HIV disease clinical stage  without mention of tuberculosis or malaria: 1C62.3Y\\nHIV disease clinical stage  without mention of tuberculosis or malaria unspecified: 1C62.3Z\\nHuman immunodeficiency virus disease without mention of tuberculosis or malaria clinical stage unspecified: 1C62.Z\\nViral encephalitis not elsewhere classified: 1C80\\nAcute poliomyelitis: 1C81\\nRabies: 1C82\\nWestern equine encephalitis: 1C83\\nEastern equine encephalitis: 1C84\\nJapanese encephalitis: 1C85\\nSt Louis encephalitis: 1C86\\nRocio viral encephalitis: 1C87\\nMurray Valley encephalitis: 1C88\\nCalifornia encephalitis: 1C8B\\nVenezuelan equine encephalitis: 1C8C\\nLa Crosse encephalitis: 1C8D\\nViral meningitis not elsewhere classified: 1C8E\\nEnteroviral meningitis: 1C8E.1\\nMeningitis due to adenovirus: 1C8E.2\\nOther specified viral meningitis not elsewhere classified: 1C8E.Y\\nViral meningitis unspecified: 1C8E.Z\\nLymphocytic choriomeningitis: 1C8F\\nTickborne encephalitis: 1C8G\\nFar Eastern tickborne encephalitis: 1C8G.0\\nCentral European tickborne encephalitis: 1C8G.1\\nSiberian tickborne encephalitis: 1C8G.2\\nTickborne encephalitis unspecified: 1C8G.Z\\nViral myelitis not elsewhere classified: 1C8H\\nOther specified viral infections of the central nervous system: 1C8Y\\nViral infections of the central nervous system unspecified: 1C8Z\\nInfectious encephalitis not elsewhere classified: 1D00\\nBacterial encephalitis: 1D00.0\\nFungal encephalitis: 1D00.1\\nParasitic or protozoal encephalitis: 1D00.2\\nOther specified infectious encephalitis not elsewhere classified: 1D00.Y\\nInfectious encephalitis unspecified: 1D00.Z\\nInfectious meningitis not elsewhere classified: 1D01\\nBacterial meningitis: 1D01.0\\nMeningitis due to Haemophilus influenzae: 1D01.00\\nOther specified bacterial meningitis: 1D01.0Y\\nBacterial meningitis unspecified: 1D01.0Z\\nFungal meningitis: 1D01.1\\nParasitic or protozoal meningitis: 1D01.2\\nBenign recurrent meningitis: 1D01.3\\nOther specified infectious meningitis not elsewhere classified: 1D01.Y\\nInfectious meningitis unspecified: 1D01.Z\\nInfectious myelitis not elsewhere classified: 1D02\\nBacterial myelitis: 1D02.0\\nFungal myelitis: 1D02.2\\nParasitic myelitis: 1D02.3\\nOther specified infectious myelitis not elsewhere classified: 1D02.Y\\nInfectious myelitis unspecified: 1D02.Z\\nInfectious abscess of the central nervous system: 1D03\\nIntraspinal intramedullary abscess: 1D03.0\\nIntraspinal subdural abscess: 1D03.1\\nIntraspinal extradural abscess: 1D03.2\\nIntracranial abscess: 1D03.3\\nDeep cerebral hemispheric abscess: 1D03.30\\nAbscess of the corpus callosum: 1D03.31\\nPituitary abscess: 1D03.32\\nMultiple or widespread intracranial abscess: 1D03.33\\nOther specified intracranial abscess: 1D03.3Y\\nIntracranial abscess unspecified: 1D03.3Z\\nIntraspinal epidural abscess: 1D03.4\\nSpinal cord abscess: 1D03.5\\nOther specified site of infectious abscess of the central nervous system: 1D03.Y\\nInfectious abscess of the central nervous system site unspecified: 1D03.Z\\nInfectious granulomas of the central nervous system: 1D04\\nParasitic intracerebral granuloma: 1D04.0\\nIntracranial granuloma: 1D04.1\\nFungal intracranial granuloma: 1D04.10\\nOther specified intracranial granuloma: 1D04.1Y\\nIntracranial granuloma unspecified: 1D04.1Z\\nIntraspinal intramedullary granuloma: 1D04.2\\nIntraspinal subdural granuloma: 1D04.3\\nIntraspinal extradural granuloma: 1D04.4\\nIntraspinal epidural granuloma: 1D04.5\\nOther specified site of infectious granulomas of the central nervous system: 1D04.Y\\nInfectious granulomas of the central nervous system site unspecified: 1D04.Z\\nInfectious cysts of the central nervous system: 1D05\\nEpidural infectious cyst: 1D05.0\\nSubdural infectious cyst: 1D05.1\\nOther specified infectious cysts of the central nervous system: 1D05.Y\\nInfectious cysts of the central nervous system unspecified: 1D05.Z\\nOther specified nonviral and unspecified infections of the central nervous system: 1D0Y\\nNonviral and unspecified infections of the central nervous system unspecified: 1D0Z\\nDengue without warning signs: 1D20\\nDengue with warning signs: 1D21\\nSevere dengue: 1D22\\nDengue fever unspecified: 1D2Z\\nChikungunya virus disease: 1D40\\nColorado tick fever: 1D41\\nOnyongnyong fever: 1D42\\nOropouche virus disease: 1D43\\nRift Valley fever: 1D44\\nSandfly fever: 1D45\\nWest Nile virus infection: 1D46\\nYellow fever: 1D47\\nZika virus disease: 1D48\\nCrimeanCongo haemorrhagic fever: 1D49\\nOmsk haemorrhagic fever: 1D4A\\nKyasanur Forest disease: 1D4B\\nAlkhurma haemorrhagic fever: 1D4C\\nRoss River disease: 1D4D\\nSevere fever with thrombocytopenia syndrome: 1D4E\\nOther specified arthropodborne viral fevers: 1D4Y\\nArthropodborne viral fever virus unspecified: 1D4Z\\nFilovirus disease: 1D60\\nEbola disease: 1D60.0\\nBundibugyo virus disease: 1D60.00\\nEbola virus disease: 1D60.01\\nSudan virus disease: 1D60.02\\nAtypical Ebola disease: 1D60.03\\nOther specified Ebola disease: 1D60.0Y\\nEbola disease virus unspecified: 1D60.0Z\\nMarburg disease: 1D60.1\\nMarburg virus disease: 1D60.10\\nAtypical Marburg disease: 1D60.11\\nOther specified Marburg disease: 1D60.1Y\\nMarburg disease virus unspecified: 1D60.1Z\\nOther specified filovirus disease: 1D60.Y\\nFilovirus disease virus unspecified: 1D60.Z\\nArenavirus disease: 1D61\\nArgentinian haemorrhagic fever: 1D61.0\\nBolivian haemorrhagic fever: 1D61.1\\nLassa fever: 1D61.2\\nVenezuelan haemorrhagic fever: 1D61.3\\nOther specified arenavirus disease: 1D61.Y\\nArenavirus disease unspecified: 1D61.Z\\nHantavirus disease: 1D62\\nHaemorrhagic fever with renal syndrome: 1D62.0\\nHantavirus pulmonary syndrome: 1D62.1\\nAtypical hantavirus disease: 1D62.2\\nOther specified hantavirus disease: 1D62.Y\\nHantavirus disease unspecified: 1D62.Z\\nHenipavirus encephalitis: 1D63\\nMiddle East respiratory syndrome: 1D64\\nSevere acute respiratory syndrome: 1D65\\nOther specified zoonotic viral diseases: 1D6Y\\nZoonotic viral disease virus unspecified: 1D6Z\\nMumps: 1D80\\nMumps without complication: 1D80.0\\nOrchitis due to mumps virus: 1D80.1\\nMeningitis due to mumps virus: 1D80.2\\nEncephalitis due to mumps virus: 1D80.3\\nPancreatitis due to mumps virus: 1D80.4\\nOther specified mumps: 1D80.Y\\nInfectious mononucleosis: 1D81\\nMononucleosis due to EpsteinBarr virus: 1D81.0\\nMononucleosis due to cytomegalovirus: 1D81.1\\nOther specified infectious mononucleosis: 1D81.Y\\nInfectious mononucleosis unspecified: 1D81.Z\\nCytomegaloviral disease: 1D82\\nCytomegaloviral hepatitis: 1D82.0\\nCytomegaloviral pancreatitis: 1D82.1\\nOther specified cytomegaloviral disease: 1D82.Y\\nCytomegaloviral disease unspecified: 1D82.Z\\nEpidemic myalgia: 1D83\\nViral conjunctivitis: 1D84\\nConjunctivitis due to adenovirus: 1D84.0\\nAcute epidemic haemorrhagic conjunctivitis: 1D84.1\\nOther specified viral conjunctivitis: 1D84.Y\\nViral conjunctivitis unspecified: 1D84.Z\\nViral carditis: 1D85\\nDilated cardiomyopathy secondary to viral myocarditis: 1D85.0\\nAcute viral carditis: 1D85.1\\nChronic viral carditis: 1D85.2\\nAseptic myocarditis of newborn: 1D85.3\\nCoxsackie carditis: 1D85.4\\nOther specified viral carditis: 1D85.Y\\nViral carditis unspecified: 1D85.Z\\nViral haemorrhagic fever not elsewhere classified: 1D86\\nAdenovirus infection of unspecified site: 1D90\\nEnterovirus infection of unspecified site: 1D91\\nCoronavirus infection unspecified site: 1D92\\nParvovirus infection of unspecified site: 1D93\\nOther viral infections of unspecified site: 1D9Y\\nUnspecified viral infection of unspecified site: 1D9Z\\nOther specified viral diseases: 1E1Y\\nUnspecified viral disease: 1E1Z\\nInfluenza due to identified seasonal influenza virus: 1E30\\nInfluenza due to identified zoonotic or pandemic influenza virus: 1E31\\nInfluenza virus not identified: 1E32\\nAcute viral hepatitis: 1E50\\nAcute hepatitis A: 1E50.0\\nAcute hepatitis B: 1E50.1\\nAcute hepatitis C: 1E50.2\\nAcute hepatitis D: 1E50.3\\nAcute hepatitis E: 1E50.4\\nOther specified acute viral hepatitis: 1E50.Y\\nAcute viral hepatitis unspecified: 1E50.Z\\nChronic viral hepatitis: 1E51\\nChronic hepatitis B: 1E51.0\\nChronic hepatitis B with human immunodeficiency virus coinfection: 1E51.00\\nOther specified chronic hepatitis B: 1E51.0Y\\nChronic hepatitis B unspecified: 1E51.0Z\\nChronic hepatitis C: 1E51.1\\nChronic hepatitis D: 1E51.2\\nChronic hepatitis E: 1E51.3\\nOther specified chronic viral hepatitis: 1E51.Y\\nChronic viral hepatitis unspecified: 1E51.Z\\nViral hepatitis unspecified: 1E5Z\\nSmallpox: 1E70\\nMpox: 1E71\\nCowpox: 1E72\\nVaccinia: 1E73\\nBuffalopox: 1E74\\nOrf: 1E75\\nMolluscum contagiosum: 1E76\\nOther specified infections due to poxvirus: 1E7Y\\nInfections due to poxvirus unspecified: 1E7Z\\nCommon warts: 1E80\\nDigital or periungual warts: 1E80.0\\nPlantar warts: 1E80.1\\nOther specified common warts: 1E80.Y\\nCommon warts unspecified: 1E80.Z\\nPlane warts: 1E81\\nWarts of lips or oral cavity: 1E82\\nFocal epithelial hyperplasia of oral mucous membranes: 1E82.0\\nWart virus proliferation in immunedeficient states: 1E83\\nViral warts not elsewhere classified: 1E8Z\\nVaricella: 1E90\\nVaricella without complication: 1E90.0\\nVaricella meningitis: 1E90.1\\nVaricella encephalitis: 1E90.2\\nVaricella with other specified complication: 1E90.Y\\nVaricella unspecified: 1E90.Z\\nZoster: 1E91\\nZoster without complications: 1E91.0\\nOphthalmic zoster: 1E91.1\\nDisseminated zoster: 1E91.2\\nZoster with central nervous system involvement: 1E91.3\\nAcute neuropathy of cranial nerve due to zoster: 1E91.4\\nAcute trigeminal zoster neuropathy: 1E91.40\\nAcute herpetic geniculate ganglionitis: 1E91.41\\nOther specified acute neuropathy of cranial nerve due to zoster: 1E91.4Y\\nAcute neuropathy of cranial nerve due to zoster unspecified: 1E91.4Z\\nPostherpetic polyneuropathy: 1E91.5\\nZoster with other specified complications: 1E91.Y\\nZoster unspecified: 1E91.Z\\nHerpes simplex infections: 1F00\\nHerpes simplex infection of skin or mucous membrane: 1F00.0\\nHerpes simplex infection of skin: 1F00.00\\nHerpes simplex labialis: 1F00.01\\nHerpes simplex gingivostomatitis: 1F00.02\\nDisseminated cutaneous herpes simplex infection complicating other skin diseases: 1F00.03\\nOther specified herpes simplex infection of skin or mucous membrane: 1F00.0Y\\nHerpes simplex infection of the eye: 1F00.1\\nHerpes simplex keratitis: 1F00.10\\nHerpes simplex infection of eyelid: 1F00.11\\nOther specified herpes simplex infection of the eye: 1F00.1Y\\nHerpes simplex infection of the eye unspecified: 1F00.1Z\\nHerpes simplex infection of central nervous system: 1F00.2\\nHerpes simplex meningitis: 1F00.20\\nEncephalitis due to herpes simplex virus: 1F00.21\\nOther specified herpes simplex infection of central nervous system: 1F00.2Y\\nDisseminated herpes simplex infection: 1F00.3\\nOther specified herpes simplex infections: 1F00.Y\\nHerpes simplex infections unspecified: 1F00.Z\\nRoseola infantum: 1F01\\nRubella: 1F02\\nRubella with neurological complications: 1F02.0\\nRubella arthritis: 1F02.1\\nRubella without complication: 1F02.2\\nRubella with other specified complication: 1F02.Y\\nMeasles: 1F03\\nMeasles without complication: 1F03.0\\nMeasles complicated by encephalitis: 1F03.1\\nMeasles complicated by meningitis: 1F03.2\\nMeasles with other complications: 1F03.Y\\nErythema infectiosum: 1F04\\nPicornavirus infections presenting in the skin or mucous membranes: 1F05\\nEnteroviral vesicular stomatitis: 1F05.0\\nEnteroviral vesicular pharyngitis: 1F05.1\\nEnteroviral exanthematous fever: 1F05.2\\nFoot and mouth disease: 1F05.3\\nOther specified picornavirus infections presenting in the skin or mucous membranes: 1F05.Y\\nPicornavirus infections presenting in the skin or mucous membranes unspecified: 1F05.Z\\nOther specified viral infections characterised by skin or mucous membrane lesions: 1F0Y\\nViral infections characterised by skin or mucous membrane lesions unspecified: 1F0Z\\nAspergillosis: 1F20\\nInvasive aspergillosis: 1F20.0\\nInvasive aspergillosis of the digestive tract: 1F20.00\\nInvasive cerebral aspergillosis: 1F20.01\\nDisseminated aspergillosis: 1F20.02\\nInvasive aspergillosis of other specified site: 1F20.0Y\\nInvasive aspergillosis unspecified: 1F20.0Z\\nNoninvasive aspergillosis: 1F20.1\\nAspergillus otomycosis: 1F20.10\\nChronic aspergillosis of the paranasal sinuses: 1F20.11\\nChronic pulmonary aspergillosis: 1F20.12\\nTonsillar aspergillosis: 1F20.13\\nAspergillus bronchitis: 1F20.14\\nObstructing aspergillus tracheobronchitis: 1F20.15\\nOther specified noninvasive aspergillosis: 1F20.1Y\\nNoninvasive aspergillosis unspecified: 1F20.1Z\\nAspergillosis unspecified: 1F20.Z\\nBasidiobolomycosis: 1F21\\nBlastomycosis: 1F22\\nCandidosis: 1F23\\nCandidosis of lips or oral mucous membranes: 1F23.0\\nCandidosis of skin or mucous membranes: 1F23.1\\nVulvovaginal candidosis: 1F23.10\\nCandida balanoposthitis: 1F23.11\\nFlexural or intertriginous candidosis: 1F23.12\\nCandidosis of nail or paronychium: 1F23.13\\nChronic mucocutaneous candidosis: 1F23.14\\nDisseminated cutaneous candidosis: 1F23.15\\nCandida otomycosis: 1F23.16\\nCandidosis of skin or mucous membrane of other specified site: 1F23.1Y\\nCandidosis of skin or mucous membranes unspecified: 1F23.1Z\\nCandidosis of gastrointestinal tract: 1F23.2\\nSystemic or invasive candidosis: 1F23.3\\nCandida meningitis: 1F23.30\\nPulmonary candidosis: 1F23.31\\nOther specified systemic or invasive candidosis: 1F23.3Y\\nSystemic or invasive candidosis unspecified: 1F23.3Z\\nOther specified candidosis: 1F23.Y\\nCandidosis unspecified: 1F23.Z\\nChromoblastomycosis: 1F24\\nCoccidioidomycosis: 1F25\\nPulmonary coccidioidomycosis: 1F25.0\\nAcute pulmonary coccidioidomycosis: 1F25.00\\nChronic pulmonary coccidioidomycosis: 1F25.01\\nExtrathoracic coccidioidomycosis: 1F25.1\\nDisseminated coccidioidomycosis: 1F25.10\\nPrimary cutaneous coccidioidomycosis: 1F25.11\\nCoccidioides meningitis: 1F25.12\\nOther specified extrathoracic coccidioidomycosis: 1F25.1Y\\nExtrathoracic coccidioidomycosis unspecified: 1F25.1Z\\nCoccidioidomycosis unspecified: 1F25.Z\\nConidiobolomycosis: 1F26\\nCryptococcosis: 1F27\\nPulmonary cryptococcosis: 1F27.0\\nCerebral cryptococcosis: 1F27.1\\nMeningitis due to Cryptococcus neoformans: 1F27.10\\nDisseminated cryptococcosis: 1F27.2\\nOther specified cryptococcosis: 1F27.Y\\nCryptococcosis unspecified: 1F27.Z\\nDermatophytosis: 1F28\\nDermatophytosis of scalp: 1F28.0\\nDermatophytosis of nail: 1F28.1\\nDermatophytosis of foot: 1F28.2\\nGenitocrural dermatophytosis: 1F28.3\\nKerion: 1F28.4\\nDisseminated dermatophytosis: 1F28.5\\nOther specified dermatophytosis: 1F28.Y\\nDermatophytosis unspecified: 1F28.Z\\nEumycetoma: 1F29\\nHistoplasmosis: 1F2A\\nPulmonary histoplasmosis capsulati: 1F2A.0\\nHistoplasmosis due to Histoplasma duboisii: 1F2A.1\\nOther specified histoplasmosis: 1F2A.Y\\nHistoplasmosis unspecified: 1F2A.Z\\nLobomycosis: 1F2B\\nMucormycosis: 1F2C\\nNondermatophyte superficial dermatomycoses: 1F2D\\nPityriasis versicolor: 1F2D.0\\nMalassezia folliculitis: 1F2D.1\\nWhite piedra: 1F2D.2\\nBlack piedra: 1F2D.3\\nTinea nigra: 1F2D.4\\nOnychomycosis due to nondermatophyte mould: 1F2D.5\\nOther specified nondermatophyte superficial dermatomycoses: 1F2D.Y\\nNondermatophyte superficial dermatomycoses unspecified: 1F2D.Z\\nParacoccidioidomycosis: 1F2E\\nPulmonary paracoccidioidomycosis: 1F2E.0\\nDisseminated paracoccidioidomycosis: 1F2E.1\\nOther specified paracoccidioidomycosis: 1F2E.Y\\nParacoccidioidomycosis unspecified: 1F2E.Z\\nPhaeohyphomycosis: 1F2F\\nPneumocystosis: 1F2G\\nPulmonary pneumocystosis: 1F2G.0\\nPneumocystosis unspecified: 1F2G.Z\\nScedosporiosis: 1F2H\\nSporotrichosis: 1F2J\\nLymphocutaneous sporotrichosis: 1F2J.0\\nFixed cutaneous sporotrichosis: 1F2J.1\\nPulmonary sporotrichosis: 1F2J.2\\nDisseminated sporotrichosis: 1F2J.3\\nOther specified sporotrichosis: 1F2J.Y\\nSporotrichosis unspecified: 1F2J.Z\\nTalaromycosis: 1F2K\\nEmmonsiosis: 1F2L\\nDisseminated adiaspiromycosis: 1F2L.0\\nPulmonary adiaspiromycosis: 1F2L.1\\nOther specified emmonsiosis: 1F2L.Y\\nEmmonsiosis unspecified: 1F2L.Z\\nOther specified mycoses: 1F2Y\\nMycoses unspecified: 1F2Z\\nMalaria due to Plasmodium falciparum: 1F40\\nPlasmodium falciparum malaria with cerebral complications: 1F40.0\\nOther severe and complicated Plasmodium falciparum malaria: 1F40.Y\\nMalaria due to Plasmodium falciparum unspecified: 1F40.Z\\nMalaria due to Plasmodium vivax: 1F41\\nPlasmodium vivax malaria with rupture of spleen: 1F41.0\\nMalaria due to Plasmodium vivax with other complications: 1F41.Y\\nPlasmodium vivax malaria without complication: 1F41.Z\\nMalaria due to Plasmodium malariae: 1F42\\nPlasmodium malariae malaria with nephropathy: 1F42.0\\nMalaria due to Plasmodium malariae with other complications: 1F42.Y\\nPlasmodium malariae malaria without complication: 1F42.Z\\nMalaria due to Plasmodium ovale: 1F43\\nOther parasitologically confirmed malaria: 1F44\\nMalaria without parasitological confirmation: 1F45\\nMalaria unspecified: 1F4Z\\nAcanthamoebiasis: 1F50\\nAfrican trypanosomiasis: 1F51\\nGambiense trypanosomiasis: 1F51.0\\nMeningitis in Gambiense trypanosomiasis: 1F51.00\\nOther specified gambiense trypanosomiasis: 1F51.0Y\\nGambiense trypanosomiasis unspecified: 1F51.0Z\\nRhodesiense trypanosomiasis: 1F51.1\\nMeningitis in Rhodesiense trypanosomiasis: 1F51.10\\nOther specified rhodesiense trypanosomiasis: 1F51.1Y\\nRhodesiense trypanosomiasis unspecified: 1F51.1Z\\nOther specified african trypanosomiasis: 1F51.Y\\nAfrican trypanosomiasis unspecified: 1F51.Z\\nBabesiosis: 1F52\\nChagas disease: 1F53\\nAcute Chagas disease without heart involvement: 1F53.1\\nChronic Chagas disease with heart involvement: 1F53.2\\nChagas disease with digestive system involvement: 1F53.3\\nMeningitis in Chagas disease: 1F53.4\\nOther specified Chagas disease: 1F53.Y\\nChagas disease unspecified: 1F53.Z\\nLeishmaniasis: 1F54\\nVisceral leishmaniasis: 1F54.0\\nCutaneous leishmaniasis: 1F54.1\\nMucocutaneous leishmaniasis: 1F54.2\\nLeishmaniasis unspecified: 1F54.Z\\nNaegleriasis: 1F55\\nRhinosporidiosis: 1F56\\nToxoplasmosis: 1F57\\nHepatitis due to Toxoplasma gondii: 1F57.0\\nMeningoencephalitis due to Toxoplasma gondii: 1F57.1\\nPulmonary toxoplasmosis due to Toxoplasma gondii: 1F57.2\\nEye disease due to Toxoplasma gondii: 1F57.3\\nOther specified toxoplasmosis: 1F57.Y\\nToxoplasmosis unspecified: 1F57.Z\\nMicrosporidiosis: 1F58\\nUnspecified protozoal disease: 1F5Z\\nAngiostrongyliasis: 1F60\\nEosinophilic meningitis due to Angiostrongylus cantonensis: 1F60.0\\nIntestinal angiostrongyliasis: 1F60.1\\nOther specified angiostrongyliasis: 1F60.Y\\nAngiostrongyliasis unspecified: 1F60.Z\\nAnisakiasis: 1F61\\nAscariasis: 1F62\\nCapillariasis: 1F63\\nCapillariasis of the intestine: 1F63.0\\nOther specified capillariasis: 1F63.Y\\nCapillariasis unspecified: 1F63.Z\\nDracunculiasis: 1F64\\nEnterobiasis: 1F65\\nFilariasis: 1F66\\nLoiasis: 1F66.0\\nMansonelliasis: 1F66.1\\nFilariasis due to Brugia species: 1F66.2\\nLymphatic filariasis: 1F66.3\\nFilariasis due to Wuchereria bancrofti: 1F66.30\\nFilariasis due to Brugia malayi: 1F66.31\\nFilariasis due to Brugia timori: 1F66.32\\nLymphatic filariasis unspecified: 1F66.3Z\\nSubcutaneous dirofilariasis: 1F66.4\\nOther specified filariasis: 1F66.Y\\nFilariasis unspecified: 1F66.Z\\nGnathostomiasis: 1F67\\nHookworm diseases: 1F68\\nAncylostomiasis: 1F68.0\\nNecatoriasis: 1F68.1\\nCutaneous larva migrans: 1F68.2\\nOther specified hookworm diseases: 1F68.Y\\nHookworm diseases unspecified: 1F68.Z\\nOesophagostomiasis: 1F69\\nOnchocerciasis: 1F6A\\nOnchocerciasis of the eye: 1F6A.0\\nOnchocerciasis of the skin: 1F6A.1\\nOther specified onchocerciasis: 1F6A.Y\\nOnchocerciasis unspecified: 1F6A.Z\\nStrongyloidiasis: 1F6B\\nSyngamosis: 1F6C\\nToxocariasis: 1F6D\\nTrichinosis: 1F6E\\nTrichostrongyliasis: 1F6F\\nTrichuriasis: 1F6G\\nUncinariosis: 1F6H\\nOther specified diseases due to nematodes: 1F6Y\\nDiseases due to nematodes unspecified: 1F6Z\\nCysticercosis: 1F70\\nCysticercosis of central nervous system: 1F70.0\\nMeningitis due to Cysticercosis: 1F70.00\\nOther specified cysticercosis of central nervous system: 1F70.0Y\\nCysticercosis of central nervous system unspecified: 1F70.0Z\\nCysticercosis of eye: 1F70.1\\nOther specified cysticercosis: 1F70.Y\\nCysticercosis unspecified: 1F70.Z\\nDiphyllobothriasis: 1F71\\nDipylidiasis: 1F72\\nEchinococcosis: 1F73\\nEchinococcus infection of liver: 1F73.0\\nEchinococcus infection of lung: 1F73.1\\nEchinococcus infection of bone: 1F73.2\\nEchinococcus infection of central nervous system: 1F73.3\\nOther specified echinococcosis: 1F73.Y\\nEchinococcosis unspecified: 1F73.Z\\nHymenolepiasis: 1F74\\nSparganosis: 1F75\\nTaeniasis: 1F76\\nTaeniasis due to Taenia solium: 1F76.0\\nTaeniasis due to Taenia saginata: 1F76.1\\nOther specified taeniasis: 1F76.Y\\nTaeniasis unspecified: 1F76.Z\\nOther specified diseases due to cestodes: 1F7Y\\nDiseases due to cestodes unspecified: 1F7Z\\nClonorchiasis: 1F80\\nDicrocoeliasis: 1F81\\nFascioliasis: 1F82\\nFasciolopsiasis: 1F83\\nOpisthorchiasis: 1F84\\nParagonimiasis: 1F85\\nSchistosomiasis: 1F86\\nSchistosomiasis due to Schistosoma haematobium: 1F86.0\\nSchistosomiasis due to Schistosoma mansoni: 1F86.1\\nSchistosomiasis due to Schistosoma japonicum: 1F86.2\\nOther schistosomiases: 1F86.3\\nCercarial dermatitis: 1F86.4\\nSchistosomal pneumonitis: 1F86.5\\nSchistosomiasis due to unspecified or unknown Schistosoma species: 1F86.Z\\nOther specified diseases due to trematodes: 1F8Y\\nDiseases due to trematodes unspecified: 1F8Z\\nOther or unspecified infestation by parasitic worms: 1F90\\nMixed intestinal helminthiases: 1F90.0\\nIntestinal parasitic infestation not otherwise specified: 1F90.1\\nIntestinal helminthiasis unspecified: 1F90.2\\nOther specified infestation by parasitic worms: 1F90.Y\\nInfestation by parasitic worms unspecified: 1F90.Z\\nDiphyllobothriasis and sparganosis: 1F91\\nHelminthiases unspecified: 1F9Z\\nPediculosis: 1G00\\nPediculosis capitis: 1G00.0\\nPediculosis corporis: 1G00.1\\nPediculosis of unspecified site or type: 1G00.Z\\nMyiasis: 1G01\\nOcular myiasis: 1G01.0\\nNasopharyngeal myiasis: 1G01.1\\nLaryngeal myiasis: 1G01.2\\nCutaneous myiasis: 1G01.3\\nOther specified myiasis: 1G01.Y\\nMyiasis unspecified: 1G01.Z\\nExternal hirudiniasis: 1G02\\nPthiriasis: 1G03\\nScabies: 1G04\\nClassical scabies: 1G04.0\\nCrusted scabies: 1G04.1\\nOther specified scabies: 1G04.Y\\nScabies unspecified: 1G04.Z\\nTungiasis: 1G05\\nCimicosis: 1G06\\nInfestation by mites: 1G07\\nInfestation by Demodex: 1G07.0\\nInfestation of the skin by other specified parasitic mites: 1G07.Y\\nInfestation of the skin by unspecified parasitic mites: 1G07.Z\\nInfestation by other specified ectoparasite: 1G0Y\\nInfestation by unknown or unspecified ectoparasite: 1G0Z\\nOther specified parasitic diseases: 1G2Y\\nUnspecified parasitic diseases: 1G2Z\\nSepsis without septic shock: 1G40\\nSepsis with septic shock: 1G41\\nCertain other disorders of infectious origin: 1G60\\nMycetoma of unknown or unspecified type: 1G60.0\\nPythiosis: 1G60.1\\nProtothecosis: 1G60.2\\nInfection of peripheral nervous system: 1G60.3\\nOther specified disorders of infectious origin not elsewhere classified: 1G60.Y\\nSequelae of tuberculosis: 1G80\\nSequelae of trachoma: 1G81\\nSequelae of leprosy: 1G82\\nSequelae of poliomyelitis: 1G83\\nSequelae of viral encephalitis: 1G84\\nSequelae of diphtheria: 1G85\\nSequelae of other specified infectious diseases: 1G8Y\\nSequelae of unspecified infectious diseases: 1G8Z\\nInfection unspecified: 1H0Z\\nPrimary neoplasms of brain: 2A00\\nGliomas of brain: 2A00.0\\nGlioblastoma of brain: 2A00.00\\nOther specified gliomas of brain: 2A00.0Y\\nGliomas of brain unspecified: 2A00.0Z\\nEmbryonal tumours of brain: 2A00.1\\nMedulloblastoma of brain: 2A00.10\\nCentral primitive neuroectodermal tumour: XH89C3\\nOther specified embryonal tumours of brain: 2A00.1Y\\nEmbryonal tumours of brain unspecified: 2A00.1Z\\nTumours of neuroepithelial tissue of brain: 2A00.2\\nTumours of the pineal gland or pineal region: 2A00.20\\nMixed neuronalglial tumours: 2A00.21\\nChoroid plexus tumours: 2A00.22\\nOther specified tumours of neuroepithelial tissue of brain: 2A00.2Y\\nTumours of neuroepithelial tissue of brain unspecified: 2A00.2Z\\nCentral neurocytoma of brain: 2A00.3\\nAstroblastoma of the brain: 2A00.4\\nPrimary neoplasm of brain of unknown or unspecified type: 2A00.5\\nPrimary neoplasms of meninges: 2A01\\nMeningiomas: 2A01.0\\nPrimary malignant meningioma: 2A01.00\\nOther specified meningiomas: 2A01.0Y\\nMeningiomas unspecified: 2A01.0Z\\nMesenchymal tumours of meninges: 2A01.1\\nPrimary neoplasm of meninges of unknown or unspecified type: 2A01.2\\nPrimary neoplasm of spinal cord cranial nerves paraspinal nerves or remaining parts of central nervous system: 2A02\\nGliomas of spinal cord cranial or paraspinal nerves: 2A02.0\\nGlioblastoma of spinal cord cranial or paraspinal nerves: 2A02.00\\nOther specified gliomas of spinal cord cranial or paraspinal nerves: 2A02.0Y\\nGliomas of spinal cord cranial or paraspinal nerves unspecified: 2A02.0Z\\nTumours of cranial or paraspinal nerves: 2A02.1\\nMalignant peripheral nerve sheath tumour of cranial or paraspinal nerves: 2A02.10\\nParaspinal neuroblastoma: 2A02.11\\nMalignant neoplasm of the optic nerve: 2A02.12\\nOther specified tumours of cranial or paraspinal nerves: 2A02.1Y\\nTumours of cranial or paraspinal nerves unspecified: 2A02.1Z\\nPrimary neoplasm of spinal cord of unknown or unspecified type: 2A02.2\\nBenign neoplasm of cranial nerves: 2A02.3\\nBenign neoplasm of spinal cord: 2A02.4\\nPrimary neoplasm of spinal cord cranial nerves paraspinal nerves or remaining parts of central nervous system unspecified: 2A02.Z\\nOther and unspecified neoplasms of brain or central nervous system: 2A0Z\\nNon mast cell myeloproliferative neoplasms: 2A20\\nChronic myelogenous leukaemia BCRABLpositive: 2A20.0\\nChronic myelogenous leukaemia with blast crisis: 2A20.00\\nChronic myelogenous leukaemia Philadelphia chromosome Ph positive: 2A20.01\\nChronic myelogenous leukaemia tq q: 2A20.02\\nNaegelitype monocytic leukaemia: 2A20.03\\nOther specified chronic myelogenous leukaemia BCRABLpositive: 2A20.0Y\\nChronic myelogenous leukaemia BCRABLpositive unspecified: 2A20.0Z\\nChronic neutrophilic leukaemia: XH5NQ7\\nPrimary myelofibrosis: XH7GG7\\nChronic eosinophilic leukaemia not elsewhere classified: 2A20.3\\nPolycythaemia vera: XH0453\\nNon mast cell myeloproliferative neoplasm unclassifiable: 2A20.5\\nOther specified non mast cell myeloproliferative neoplasms: 2A20.Y\\nNon mast cell myeloproliferative neoplasms unspecified: 2A20.Z\\nMastocytosis: 2A21\\nSystemic mastocytosis: 2A21.0\\nMast cell leukaemia: XH5ER6\\nOther specified systemic mastocytosis: 2A21.0Y\\nSystemic mastocytosis unspecified: 2A21.0Z\\nCutaneous mastocytosis: XH74F2\\nUrticaria pigmentosa: XH8VS0\\nOther specified cutaneous mastocytosis: 2A21.1Y\\nCutaneous mastocytosis unspecified: 2A21.1Z\\nMast cell sarcoma: XH6A72\\nExtracutaneous mastocytoma: 2A21.3\\nOther specified mastocytosis: 2A21.Y\\nMastocytosis unspecified: 2A21.Z\\nOther specified myeloproliferative neoplasm: 2A2Y\\nMyeloproliferative neoplasm unspecified: 2A2Z\\nRefractory anaemia: 2A30\\nRefractory neutropaenia: 2A31\\nRefractory thrombocytopenia: 2A32\\nRefractory anaemia with ring sideroblasts: 2A33\\nRefractory cytopenia with multilineage dysplasia: 2A34\\nRefractory anaemia with excess of blasts: 2A35\\nMyelodysplastic syndrome with isolated delq: 2A36\\nMyelodysplastic syndrome unclassifiable: 2A37\\nRefractory cytopenia of childhood: 2A38\\nOther specified myelodysplastic syndromes: 2A3Y\\nMyelodysplastic syndromes unspecified: 2A3Z\\nChronic myelomonocytic leukaemia: 2A40\\nAtypical chronic myeloid leukaemia BCRABLnegative: 2A41\\nJuvenile myelomonocytic leukaemia: XH4QZ1\\nJuvenile myelomonocytic leukaemia in complete remission: 2A42.0\\nOther specified juvenile myelomonocytic leukaemia: 2A42.Y\\nJuvenile myelomonocytic leukaemia unspecified: 2A42.Z\\nRefractory anaemia with ring sideroblasts associated with marked thrombocytosis: 2A43\\nMyeloproliferative and myelodysplastic disease unclassifiable: 2A44\\nOther specified myelodysplastic and myeloproliferative neoplasms: 2A4Y\\nMyelodysplastic and myeloproliferative neoplasms unspecified: 2A4Z\\nMyeloidlymphoid neoplasm associated with PDGFRA rearrangement: 2A50\\nMyeloid neoplasm associated with PDGFRB rearrangement: 2A51\\nMyeloid or lymphoid neoplasms with FGFR abnormalities: 2A52\\nMyeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA PDGFRB or FGFR unspecified: 2A5Z\\nAcute myeloid leukaemias and related precursor neoplasms: 2A60\\nAcute myeloid leukaemia with recurrent genetic abnormalities: 2A60.0\\nAcute myeloid leukaemia with myelodysplasiarelated changes: XH64R4\\nTherapyrelated myeloid neoplasms: 2A60.2\\nTherapy related acute myeloid leukaemia or myelodysplastic syndrome: 2A60.20\\nOther specified therapyrelated myeloid neoplasms: 2A60.2Y\\nTherapyrelated myeloid neoplasms unspecified: 2A60.2Z\\nAcute myeloid leukaemia not elsewhere classified by criteria of other types: 2A60.3\\nAcute myeloid leukaemia with minimal differentiation: 2A60.30\\nAcute myeloid leukaemia without maturation: XH5AH8\\nAcute myeloid leukaemia with maturation: XH1XJ9\\nAcute myelomonocytic leukaemia: XH78Y4\\nAcute monoblastic or monocytic leukaemia: 2A60.34\\nAcute erythroid leukaemia: 2A60.35\\nAcute megakaryoblastic leukaemia: XH4750\\nAcute basophilic leukaemia: XH7MR1\\nAcute panmyelosis with myelofibrosis: XH1075\\nMyeloid sarcoma: XH3L40\\nOther specified acute myeloid leukaemia not elsewhere classified by criteria of other types: 2A60.3Y\\nAcute myeloid leukaemia unspecified: 2A60.3Z\\nMyeloid proliferation associated with Down syndrome: 2A60.4\\nTransient abnormal myelopoiesis: XH67W4\\nMyeloid leukaemia associated with Down syndrome: 2A60.41\\nOther specified myeloid proliferation associated with Down syndrome: 2A60.4Y\\nMyeloid proliferation associated with Down syndrome unspecified: 2A60.4Z\\nBlastic plasmacytoid dendritic cell neoplasm: XH1DB1\\nOther specified acute myeloid leukaemias and related precursor neoplasms: 2A60.Y\\nAcute myeloid leukaemias and related precursor neoplasms unspecified: 2A60.Z\\nAcute leukaemias of ambiguous lineage: 2A61\\nPrecursor Blymphoblastic neoplasms: 2A70\\nB lymphoblastic leukaemia or lymphoma not elsewhere classified: 2A70.0\\nB lymphoblastic leukaemia or lymphoma with t qq BCRABL: 2A70.1\\nOther Blymphoblastic leukaemialymphoma with recurrent genetic abnormalities: 2A70.Y\\nPrecursor Tlymphoblastic neoplasms: 2A71\\nPrecursor lymphoid neoplasms unspecified: 2A7Z\\nFollicular lymphoma: 2A80\\nFollicular lymphoma grade: XH6RN1\\nPrimary cutaneous follicle centre lymphoma: XH1FZ7\\nPaediatric type follicular lymphoma: 2A80.4\\nFollicular lymphoma in situ: 2A80.5\\nFollicular lymphoma of small intestine: 2A80.6\\nOther specified follicular lymphoma: 2A80.Y\\nFollicular lymphoma unspecified: 2A80.Z\\nDiffuse large Bcell lymphomas: 2A81\\nPrimary mediastinal large Bcell lymphoma: 2A81.0\\nIntravascular large Bcell lymphoma: XH50S7\\nPlasmablastic lymphoma: XH6YR5\\nLymphomatoid granulomatosis: XH4P09\\nTcellhistiocyte rich large Bcell lymphoma: XH0WP6\\nPrimary diffuse large Bcell lymphoma of central nervous system: 2A81.5\\nEpsteinBarr Viruspositive diffuse large Bcell lymphoma of the elderly: 2A81.6\\nDiffuse large Bcell lymphoma associated with chronic inflammation: XH3N15\\nALKpositive large Bcell lymphoma: 2A81.8\\nPrimary effusion lymphoma: XH2LN1\\nPrimary cutaneous diffuse large Bcell lymphoma leg type: 2A81.A\\nOther specified diffuse large Bcell lymphomas: 2A81.Y\\nDiffuse large Bcell lymphoma not otherwise specified: 2A81.Z\\nMature Bcell neoplasm with leukaemic behaviour: 2A82\\nChronic lymphocytic leukaemia or small lymphocytic lymphoma: 2A82.0\\nChronic lymphocytic leukaemia of Bcell type: 2A82.00\\nOther specified chronic lymphocytic leukaemia or small lymphocytic lymphoma: 2A82.0Y\\nChronic lymphocytic leukaemia or small lymphocytic lymphoma unspecified: 2A82.0Z\\nBcell prolymphocytic leukaemia: 2A82.1\\nBcell prolymphocytic leukaemia in complete remission: 2A82.10\\nOther specified bcell prolymphocytic leukaemia: 2A82.1Y\\nBcell prolymphocytic leukaemia unspecified: 2A82.1Z\\nHairycell leukaemia: 2A82.2\\nSplenic Bcell lymphoma or leukaemia unclassifiable: 2A82.3\\nOther specified mature Bcell neoplasm with leukaemic behaviour: 2A82.Y\\nMature Bcell neoplasm with leukaemic behaviour unspecified: 2A82.Z\\nPlasma cell neoplasms: 2A83\\nMonoclonal gammopathy of undetermined significance: XH1NV1\\nPlasma cell myeloma: XH4XA9\\nSolitary plasmacytoma: 2A83.2\\nExtraosseous plasmacytoma: 2A83.3\\nPlasma cell leukaemia: XH7GC9\\nMonoclonal immunoglobulin deposition disease: 2A83.5\\nHeavy chain deposition disease: 2A83.50\\nLight and heavy chain deposition disease: 2A83.51\\nLight chain deposition disease: 2A83.52\\nOther specified plasma cell neoplasms: 2A83.Y\\nPlasma cell neoplasm unspecified: 2A83.Z\\nHeavy chain diseases or malignant immunoproliferative diseases: 2A84\\nAlpha heavy chain disease: XH1Y65\\nGamma heavy chain disease: XH1EA7\\nMu heavy chain disease: XH2JK2\\nOther specified malignant immunoproliferative diseases: 2A84.Y\\nHeavy chain diseases unspecified: 2A84.Z\\nOther specified mature Bcell neoplasms or lymphoma: 2A85\\nNodal marginal zone lymphoma: 2A85.0\\nExtranodal marginal zone Bcell lymphoma of mucosaassociated lymphoid tissue of stomach: 2A85.1\\nExtranodal marginal zone Bcell lymphoma primary site skin: 2A85.2\\nExtranodal marginal zone Bcell lymphoma primary site excluding stomach or skin: 2A85.3\\nLymphoplasmacytic lymphoma: XH0QZ9\\nMantle cell lymphoma: XH1VV1\\nBurkitt lymphoma including Burkitt leukaemia: 2A85.6\\nFurther specified mature Bcell neoplasms or lymphoma: 2A85.Y\\nBcell lymphoma mixed features: 2A86\\nMalignant lymphoma of B cell type not elsewhere classified: 2A86.0\\nBcell lymphoma unclassifiable with features intermediate between Burkitt lymphoma and diffuse large Bcell lymphoma: 2A86.1\\nBcell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large Bcell lymphoma: 2A86.2\\nOther specified Bcell lymphoma mixed features: 2A86.Y\\nBcell lymphoma mixed features unspecified: 2A86.Z\\nMature Bcell neoplasms unspecified: 2A8Z\\nMature Tcell lymphoma specified types nodal or systemic: 2A90\\nTcell prolymphocytic leukaemia: 2A90.0\\nTcell large granular lymphocytic leukaemia: XH6687\\nChronic lymphoproliferative disorders of NKcells: 2A90.2\\nAggressive NK cell leukaemia: 2A90.3\\nSystemic EpsteinBarr Viruspositive Tcell lymphoma of childhood: 2A90.4\\nAdult Tcell lymphoma or leukaemia human Tcell lymphotropic virus type associated: 2A90.5\\nExtranodal NKTcell lymphoma nasal type: 2A90.6\\nEnteropathy associated Tcell lymphoma: 2A90.7\\nHepatosplenic Tcell lymphoma: XH8D49\\nAngioimmunoblastic Tcell lymphoma: XH1J86\\nAnaplastic large cell lymphoma ALKpositive: 2A90.A\\nAnaplastic large cell lymphoma ALKnegative: 2A90.B\\nPeripheral Tcell lymphoma not otherwise specified: 2A90.C\\nSubcutaneous panniculitislike Tcell lymphoma: XH3NV1\\nMycosis fungoides: XH8R56\\nSzary syndrome: 2B02\\nPrimary cutaneous CDpositive Tcell lymphoproliferative disorders: 2B03\\nPrimary cutaneous CDpositive anaplastic large cell lymphoma: 2B03.0\\nLymphomatoid papulosis: 2B03.1\\nOther specified primary cutaneous mature Tcell or NKcell lymphomas and lymphoproliferative disorders: 2B0Y\\nPrimary cutaneous Tcell lymphoma of undetermined or unspecified type: 2B0Z\\nOther specified mature Tcell or NKcell neoplasms: 2B2Y\\nMature Tcell or NKcell neoplasms unspecified: 2B2Z\\nHodgkin lymphoma: 2B30\\nNodular lymphocyte predominant Hodgkin lymphoma: 2B30.0\\nClassical Hodgkin lymphoma: 2B30.1\\nNodular sclerosis classical Hodgkin lymphoma: 2B30.10\\nLymphocyterich classical Hodgkin lymphoma: 2B30.11\\nMixed cellularity classical Hodgkin lymphoma: 2B30.12\\nLymphocyte depleted classical Hodgkin lymphoma: 2B30.13\\nClassical Hodgkin lymphoma unspecified: 2B30.1Z\\nHodgkin lymphoma unspecified: 2B30.Z\\nHistiocytic or dendritic cell neoplasms: 2B31\\nJuvenile xanthogranuloma: 2B31.0\\nHistiocytic sarcoma: XH4JD4\\nLangerhans cell histiocytosis: XH1J18\\nLangerhans cell histiocytosis involving the skin: 2B31.20\\nOther specified Langerhans cell histiocytosis: 2B31.2Y\\nLangerhans cell histiocytosis unspecified: 2B31.2Z\\nLangerhans cell sarcoma: XH8J76\\nInterdigitating dendritic cell sarcoma: XH7UM7\\nFollicular dendritic cell sarcoma: XH1JT6\\nIndeterminate cell histiocytosis: 2B31.6\\nFibroblastic reticular cell tumour: XH0124\\nOther specified histiocytic or dendritic cell neoplasms: 2B31.Y\\nHistiocytic or dendritic cell neoplasms unspecified: 2B31.Z\\nImmunodeficiencyassociated lymphoproliferative disorders: 2B32\\nPosttransplant lymphoproliferative disorder early lesion: 2B32.0\\nReactive plasmacytic hyperplasia: 2B32.1\\nPosttransplant lymphoproliferative disorder Infectious mononucleosislike: 2B32.2\\nPolymorphic posttransplant lymphoproliferative disorder: 2B32.3\\nOther specified immunodeficiencyassociated lymphoproliferative disorders: 2B32.Y\\nImmunodeficiencyassociated lymphoproliferative disorders unspecified: 2B32.Z\\nMalignant haematopoietic neoplasms without further specification: 2B33\\nAcute leukaemia not elsewhere classified: 2B33.0\\nMyeloid leukaemia: 2B33.1\\nChronic myeloid leukaemia not elsewhere classified: 2B33.2\\nLymphoid leukaemia not elsewhere classified: 2B33.3\\nLeukaemia unspecified: 2B33.4\\nMalignant lymphoma not elsewhere classified: 2B33.5\\nOther malignant haematopoietic neoplasms without further specification: 2B33.Y\\nNeoplasms of haematopoietic or lymphoid tissues unspecified: 2B3Z\\nChondrosarcoma primary site: 2B50\\nChondrosarcoma of bone or articular cartilage of limbs: 2B50.0\\nChondrosarcoma of bone or articular cartilage of pelvis: 2B50.1\\nChondrosarcoma of bone or articular cartilage of ribs sternum or clavicle: 2B50.2\\nChondrosarcoma of bone or articular cartilage of other specified sites: 2B50.Y\\nChondrosarcoma of bone or articular cartilage of unspecified sites: 2B50.Z\\nOsteosarcoma primary site: 2B51\\nOsteosarcoma of bone or articular cartilage of jaw: 2B51.0\\nOsteosarcoma of bone or articular cartilage of limbs: 2B51.1\\nOsteosarcoma of bone or articular cartilage of pelvis: 2B51.2\\nOsteosarcoma of bone or articular cartilage of other specified sites: 2B51.Y\\nOsteosarcoma of bone or articular cartilage of unspecified sites: 2B51.Z\\nEwing sarcoma primary site: 2B52\\nEwing sarcoma of bone or articular cartilage of limbs: 2B52.0\\nEwing sarcoma of bone or articular cartilage of pelvis: 2B52.1\\nEwing sarcoma of bone or articular cartilage of ribs: 2B52.2\\nEwing sarcoma of soft tissue: 2B52.3\\nEwing sarcoma of bone or articular cartilage of other specified sites: 2B52.Y\\nEwing sarcoma of bone or articular cartilage of unspecified sites: 2B52.Z\\nFibroblastic or myofibroblastic tumour primary site: 2B53\\nMyxofibrosarcoma primary site: 2B53.0\\nFibroblastic or myofibroblastic tumour of skin: 2B53.1\\nOther specified fibroblastic or myofibroblastic tumour primary site: 2B53.Y\\nFibroblastic or myofibroblastic tumour primary site unspecified: 2B53.Z\\nUndifferentiated pleomorphic sarcoma primary site: 2B54\\nUndifferentiated pleomorphic sarcoma of skin: 2B54.0\\nUndifferentiated pleomorphic sarcoma of retroperitoneum or peritoneum: 2B54.1\\nUndifferentiated pleomorphic sarcoma other specified primary site: 2B54.Y\\nUndifferentiated pleomorphic sarcoma unspecified primary site: 2B54.Z\\nRhabdomyosarcoma primary site: 2B55\\nRhabdomyosarcoma of the oral cavity or pharynx: 2B55.0\\nRhabdomyosarcoma of respiratory or intrathoracic organs: 2B55.1\\nRhabdomyosarcoma of male genital organs: 2B55.2\\nRhabdomyosarcoma other specified primary site: 2B55.Y\\nRhabdomyosarcoma unspecified primary site: 2B55.Z\\nAngiosarcoma primary site: 2B56\\nAngiosarcoma of heart: 2B56.0\\nAngiosarcoma of skin: 2B56.1\\nAngiosarcoma of breast: 2B56.2\\nAngiosarcoma of liver: 2B56.3\\nAngiosarcoma other specified primary site: 2B56.Y\\nAngiosarcoma unspecified primary site: 2B56.Z\\nKaposi sarcoma primary site: 2B57\\nKaposi sarcoma of lung: 2B57.0\\nKaposi sarcoma of skin: 2B57.1\\nKaposi sarcoma of gastrointestinal sites: 2B57.2\\nKaposi sarcoma of other specified primary sites: 2B57.Y\\nKaposi sarcoma of unspecified primary site: 2B57.Z\\nLeiomyosarcoma primary site: 2B58\\nLeiomyosarcoma of retroperitoneum or peritoneum: 2B58.0\\nLeiomyosarcoma of uterus: 2B58.1\\nLeiomyosarcoma of stomach: 2B58.2\\nLeiomyosarcoma other specified primary site: 2B58.Y\\nLeiomyosarcoma unspecified primary site: 2B58.Z\\nLiposarcoma primary site: 2B59\\nLiposarcoma of soft tissue of limb: 2B59.0\\nLiposarcoma of retroperitoneum or peritoneum: 2B59.1\\nLiposarcoma of male genital organs: 2B59.2\\nLiposarcoma other specified primary site: 2B59.Y\\nLiposarcoma unspecified primary site: 2B59.Z\\nSynovial sarcoma primary site: 2B5A\\nSynovial sarcoma of soft tissues of limb: 2B5A.0\\nSynovial sarcoma of respiratory or intrathoracic organs: 2B5A.1\\nSynovial sarcoma other specified primary site: 2B5A.Y\\nSynovial sarcoma unspecified primary site: 2B5A.Z\\nGastrointestinal stromal tumour primary site: 2B5B\\nGastrointestinal stromal tumour of stomach: 2B5B.0\\nGastrointestinal stromal tumour of small intestine: 2B5B.1\\nGastrointestinal stromal tumour of other gastrointestinal sites: 2B5B.Y\\nGastrointestinal stromal tumour of unspecified gastrointestinal sites: 2B5B.Z\\nEndometrial stromal sarcoma primary site: 2B5C\\nMalignant mixed epithelial mesenchymal tumour primary site: 2B5D\\nMalignant mixed epithelial mesenchymal tumour of ovary: 2B5D.0\\nMalignant mixed epithelial and mesenchymal tumour of corpus uteri: 2B5D.1\\nMalignant mixed epithelial mesenchymal tumour other specified primary site: 2B5D.Y\\nMalignant mixed epithelial mesenchymal tumour unspecified primary site: 2B5D.Z\\nMalignant nerve sheath tumour of peripheral nerves or autonomic nervous system primary site: 2B5E\\nSarcoma not elsewhere classified primary site: 2B5F\\nSarcoma not elsewhere classified of uterus: 2B5F.0\\nSarcoma not elsewhere classified of retroperitoneum or peritoneum: 2B5F.1\\nMyosarcomas of omentum: 2B5F.10\\nOther specified sarcoma not elsewhere classified of retroperitoneum or peritoneum: 2B5F.1Y\\nSarcoma not elsewhere classified of retroperitoneum or peritoneum unspecified: 2B5F.1Z\\nSarcoma not elsewhere classified of other specified sites: 2B5F.2\\nSarcoma not elsewhere classified primary site unknown: 2B5F.3\\nMyosarcoma of uterus part not specified: 2B5G\\nWell differentiated lipomatous tumour primary site: 2B5H\\nMalignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites: 2B5J\\nUnspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites: 2B5K\\nOther specified malignant mesenchymal neoplasms: 2B5Y\\nMalignant mesenchymal neoplasm of unspecified type: 2B5Z\\nMalignant neoplasms of lip: 2B60\\nBasal cell carcinoma of lip: 2B60.0\\nSquamous cell carcinoma of lip: 2B60.1\\nOther specified malignant neoplasms of lip: 2B60.Y\\nMalignant neoplasms of lip unspecified: 2B60.Z\\nMalignant neoplasms of base of tongue: 2B61\\nSquamous cell carcinoma of the base of the tongue: 2B61.0\\nOther specified malignant neoplasms of base of tongue: 2B61.Y\\nMalignant neoplasms of base of tongue unspecified: 2B61.Z\\nMalignant neoplasms of other or unspecified parts of tongue: 2B62\\nSquamous cell carcinoma of other or unspecified parts of tongue: 2B62.0\\nMalignant neoplasms of lingual tonsil: 2B62.1\\nSquamous cell carcinoma of lingual tonsil: 2B62.10\\nMalignant neoplasms of lingual tonsil unspecified: 2B62.1Z\\nOther specified malignant neoplasms of other or unspecified parts of tongue: 2B62.Y\\nMalignant neoplasms of other or unspecified parts of tongue unspecified: 2B62.Z\\nMalignant neoplasms of gum: 2B63\\nSquamous cell carcinoma of gum: 2B63.0\\nOther specified malignant neoplasm of gum: 2B63.Y\\nMalignant neoplasms of gum unspecified: 2B63.Z\\nMalignant neoplasms of floor of mouth: 2B64\\nSquamous cell carcinoma of floor of mouth: 2B64.0\\nOther specified malignant neoplasm of floor of mouth: 2B64.Y\\nMalignant neoplasms of floor of mouth unspecified: 2B64.Z\\nMalignant neoplasms of palate: 2B65\\nAdenocarcinoma of palate: 2B65.0\\nSquamous cell carcinoma of palate: 2B65.1\\nOther specified malignant neoplasm of palate: 2B65.Y\\nMalignant neoplasms of palate unspecified: 2B65.Z\\nMalignant neoplasms of other or unspecified parts of mouth: 2B66\\nSquamous cell carcinoma of other or unspecified parts of mouth: 2B66.0\\nOther specified malignant neoplasms of other or unspecified parts of mouth: 2B66.Y\\nMalignant neoplasms of other or unspecified parts of mouth unspecified: 2B66.Z\\nMalignant neoplasms of parotid gland: 2B67\\nAdenocarcinoma of parotid gland: 2B67.0\\nSquamous cell carcinoma of parotid gland: 2B67.1\\nOther specified malignant neoplasms of parotid gland: 2B67.Y\\nMalignant neoplasms of parotid gland unspecified: 2B67.Z\\nMalignant neoplasms of submandibular or sublingual glands: 2B68\\nAdenocarcinoma of submandibular or sublingual glands: 2B68.0\\nSquamous cell carcinoma of submandibular or sublingual glands: 2B68.1\\nOther specified malignant neoplasms of submandibular or sublingual glands: 2B68.2\\nMalignant neoplasms of submandibular or sublingual glands unspecified: 2B68.Z\\nMalignant neoplasms of tonsil: 2B69\\nSquamous cell carcinoma of tonsil: 2B69.0\\nOther specified malignant neoplasms of tonsil: 2B69.1\\nMalignant neoplasms of tonsil unspecified: 2B69.Z\\nMalignant neoplasms of oropharynx: 2B6A\\nSquamous cell carcinoma of oropharynx: 2B6A.0\\nOther specified malignant neoplasms of oropharynx: 2B6A.Y\\nMalignant neoplasms of oropharynx unspecified: 2B6A.Z\\nMalignant neoplasms of nasopharynx: 2B6B\\nSquamous cell carcinoma of nasopharynx: 2B6B.0\\nMalignant epithelial neoplasms of nasopharynx unspecified type: 2B6B.1\\nMalignant neoplasms of pharyngeal tonsil: 2B6B.2\\nSquamous cell carcinoma of pharyngeal tonsil: 2B6B.20\\nOther or unspecified malignant epithelial neoplasm of pharyngeal tonsil: 2B6B.21\\nOther specified malignant neoplasms of pharyngeal tonsil: 2B6B.2Y\\nMalignant neoplasm of pharyngeal tonsil without mention of type: 2B6B.2Z\\nOther specified malignant neoplasms of nasopharynx: 2B6B.Y\\nMalignant neoplasms of nasopharynx unspecified: 2B6B.Z\\nMalignant neoplasms of piriform sinus: 2B6C\\nSquamous cell carcinoma of piriform sinus: 2B6C.0\\nOther specified malignant neoplasms of piriform sinus: 2B6C.Y\\nMalignant neoplasms of piriform sinus unspecified: 2B6C.Z\\nMalignant neoplasms of hypopharynx: 2B6D\\nSquamous cell carcinoma of hypopharynx and variants: 2B6D.0\\nOther specified malignant neoplasms of hypopharynx: 2B6D.Y\\nMalignant neoplasms of hypopharynx unspecified: 2B6D.Z\\nMalignant neoplasms of other or illdefined sites in the lip oral cavity or pharynx: 2B6E\\nSquamous cell carcinoma of other or illdefined sites in the lip oral cavity or pharynx: 2B6E.0\\nOther specified malignant neoplasms of other or illdefined sites in the lip oral cavity or pharynx: 2B6E.Y\\nMalignant neoplasms of other or illdefined sites in the lip oral cavity or pharynx unspecified: 2B6E.Z\\nOther specified malignant neoplasms of lip oral cavity or pharynx: 2B6Y\\nMalignant neoplasms of oesophagus: 2B70\\nAdenocarcinoma of oesophagus: 2B70.0\\nBarrett adenocarcinoma: 2B70.00\\nOther specified adenocarcinoma of oesophagus: 2B70.0Y\\nAdenocarcinoma of oesophagus unspecified: 2B70.0Z\\nSquamous cell carcinoma of oesophagus: 2B70.1\\nOther specified malignant neoplasms of oesophagus: 2B70.Y\\nMalignant neoplasms of oesophagus unspecified: 2B70.Z\\nMalignant neoplasms of oesophagogastric junction: 2B71\\nAdenocarcinoma of oesophagogastric junction: 2B71.0\\nOther specified malignant neoplasm of oesophagogastric junction: 2B71.Y\\nMalignant neoplasms of oesophagogastric junction unspecified: 2B71.Z\\nMalignant neoplasms of stomach: 2B72\\nAdenocarcinoma of stomach: 2B72.0\\nMalignant neuroendocrine neoplasm of stomach: 2B72.1\\nOther specified malignant neoplasms of stomach: 2B72.Y\\nMalignant neoplasms of stomach unspecified: 2B72.Z\\nMalignant neoplasms of small intestine: 2B80\\nMalignant neoplasms of duodenum: 2B80.0\\nAdenocarcinoma of duodenum: 2B80.00\\nNeuroendocrine neoplasm of duodenum: 2B80.01\\nOther specified malignant neoplasms of the duodenum: 2B80.0Y\\nMalignant neoplasms of duodenum unspecified: 2B80.0Z\\nMalignant neoplasms of jejunum or ileum: 2B80.1\\nAdenocarcinoma of jejunum or ileum: 2B80.10\\nNeuroendocrine neoplasms of jejunum or ileum: 2B80.11\\nOther specified malignant neoplasms of jejunum or ileum: 2B80.1Y\\nMalignant neoplasms of jejunum or ileum unspecified: 2B80.1Z\\nMalignant neoplasms of small intestine site unspecified: 2B80.2\\nAdenocarcinoma of small intestine site unspecified: 2B80.20\\nNeuroendocrine neoplasms of small intestine site unspecified: 2B80.21\\nOther specified malignant neoplasms of small intestine site unspecified: 2B80.2Y\\nOther specified malignant neoplasms of small intestine: 2B80.Y\\nMalignant neoplasms of small intestine unspecified: 2B80.Z\\nMalignant neoplasms of appendix: 2B81\\nAdenocarcinoma of appendix: 2B81.0\\nMucinous adenocarcinoma of appendix: 2B81.00\\nNeuroendocrine neoplasms of appendix: 2B81.2\\nOther specified malignant neoplasms of appendix: 2B81.Y\\nMalignant neoplasms of appendix unspecified: 2B81.Z\\nMalignant neoplasms of colon: 2B90\\nMalignant neoplasm of ascending colon and right flexure of colon: 2B90.0\\nAdenocarcinoma of ascending colon or right flexure of colon: 2B90.00\\nOther specified malignant neoplasm of ascending colon and right flexure of colon: 2B90.0Y\\nMalignant neoplasm of ascending colon and right flexure of colon unspecified: 2B90.0Z\\nMalignant neoplasm of descending colon and splenic flexure of colon: 2B90.1\\nAdenocarcinoma of descending colon or splenic flexure of colon: 2B90.10\\nOther specified malignant neoplasm of descending colon and splenic flexure of colon: 2B90.1Y\\nMalignant neoplasm of descending colon and splenic flexure of colon unspecified: 2B90.1Z\\nMalignant neoplasm of transverse colon: 2B90.2\\nAdenocarcinoma of transverse colon: 2B90.20\\nOther specified malignant neoplasm of transverse colon: 2B90.2Y\\nMalignant neoplasm of transverse colon unspecified: 2B90.2Z\\nMalignant neoplasm of sigmoid colon: 2B90.3\\nAdenocarcinoma of sigmoid colon: 2B90.30\\nOther specified malignant neoplasm of sigmoid colon: 2B90.3Y\\nMalignant neoplasm of sigmoid colon unspecified: 2B90.3Z\\nOther specified malignant neoplasms of colon: 2B90.Y\\nMalignant neoplasms of colon unspecified: 2B90.Z\\nMalignant neoplasms of rectosigmoid junction: 2B91\\nAdenocarcinoma of rectosigmoid junction: 2B91.0\\nOther specified malignant neoplasms of rectosigmoid junction: 2B91.Y\\nMalignant neoplasms of rectosigmoid junction unspecified: 2B91.Z\\nMalignant neoplasms of rectum: 2B92\\nAdenocarcinomas of rectum: 2B92.0\\nNeuroendocrine neoplasms of rectum: 2B92.1\\nOther specified malignant neoplasms of rectum: 2B92.Y\\nMalignant neoplasms of rectum unspecified: 2B92.Z\\nMalignant neoplasms of large intestine site unspecified: 2B93\\nAdenocarcinoma of large intestine site unspecified: 2B93.0\\nOther specified malignant neoplasms of large intestine site unspecified: 2B93.Y\\nMalignant neoplasms of large intestine site and type unspecified: 2B93.Z\\nOther specified malignant neoplasms of large intestine: 2B9Y\\nMalignant neoplasms of anus or anal canal: 2C00\\nAdenocarcinoma of anus or anal canal: 2C00.0\\nMelanoma of anus or anal canal: 2C00.1\\nNeuroendocrine neoplasm of anus or anal canal: 2C00.2\\nSquamous cell carcinoma of anus or anal canal: 2C00.3\\nOther specified malignant neoplasms of anus or anal canal: 2C00.Y\\nMalignant neoplasms of anus or anal canal unspecified: 2C00.Z\\nOther specified malignant neoplasms of intestine: 2C0Y\\nMalignant neoplasms of intestine unspecified: 2C0Z\\nMalignant neoplasm of pancreas: 2C10\\nAdenocarcinoma of pancreas: 2C10.0\\nNeuroendocrine neoplasms of pancreas: 2C10.1\\nOther specified malignant neoplasms of pancreas: 2C10.Y\\nMalignant neoplasm of pancreas unspecified: 2C10.Z\\nMalignant neoplasms of other or illdefined digestive organs: 2C11\\nAdenocarcinoma of other or illdefined digestive organs: 2C11.0\\nMucinous carcinoma of other or illdefined digestive organs: 2C11.1\\nOther specified malignant neoplasms of other or illdefined digestive organs: 2C11.2\\nMalignant neoplasms of other or illdefined digestive organs unspecified: 2C11.Z\\nMalignant neoplasms of liver or intrahepatic bile ducts: 2C12\\nMalignant neoplasm of liver: 2C12.0\\nCombined hepatocellularcholangiocarcinoma: 2C12.00\\nHepatoblastoma: XH2WE3\\nHepatocellular carcinoma of liver: 2C12.02\\nMesothelial carcinoma of liver: 2C12.03\\nOther specified malignant neoplasm of liver: 2C12.0Y\\nMalignant neoplasm of liver unspecified: 2C12.0Z\\nMalignant neoplasm of intrahepatic bile ducts: 2C12.1\\nIntrahepatic cholangiocarcinoma: 2C12.10\\nOther specified malignant neoplasms of intrahepatic bile ducts: 2C12.1Y\\nMalignant neoplasm of intrahepatic bile ducts unspecified: 2C12.1Z\\nMalignant neoplasms of gallbladder: 2C13\\nAdenocarcinoma of the gallbladder: 2C13.0\\nOther specified malignant neoplasm of gallbladder: 2C13.Y\\nMalignant neoplasms of gallbladder unspecified: 2C13.Z\\nMalignant neoplasms of proximal biliary tract cystic duct: 2C14\\nAdenocarcinoma of proximal biliary tract cystic duct: 2C14.0\\nMucinous cystic neoplasm with associated invasive carcinoma of cystic duct: 2C14.1\\nNeuroendocrine neoplasms of cystic duct: 2C14.2\\nOther specified malignant neoplasms of biliary tract cystic duct: 2C14.Y\\nMalignant neoplasms of proximal biliary tract cystic duct unspecified: 2C14.Z\\nMalignant neoplasms of biliary tract distal bile duct: 2C15\\nAdenocarcinoma of biliary tract distal bile duct: 2C15.0\\nMucinous cystic neoplasm with associated invasive carcinoma of distal bile duct: 2C15.1\\nNeuroendocrine neoplasms of distal bile duct: 2C15.2\\nOther specified malignant neoplasms of biliary tract distal bile duct: 2C15.Y\\nMalignant neoplasms of biliary tract distal bile duct unspecified: 2C15.Z\\nMalignant neoplasms of ampulla of Vater: 2C16\\nAdenocarcinoma of ampulla of Vater: 2C16.0\\nNeuroendocrine neoplasms of ampulla of Vater: 2C16.1\\nOther specified malignant neoplasms of ampulla of Vater: 2C16.Y\\nMalignant neoplasms of ampulla of Vater unspecified: 2C16.Z\\nMalignant neoplasms of other or unspecified parts of biliary tract: 2C17\\nAdenocarcinoma of other or unspecified parts of biliary tract: 2C17.0\\nMucinous cystic neoplasm with associated invasive carcinoma of other or unspecified parts of biliary tract: 2C17.1\\nNeuroendocrine neoplasms of other or unspecified parts of biliary tract: 2C17.2\\nOther specified malignant neoplasms of overlapping lesion of biliary tract: 2C17.Y\\nMalignant neoplasms of other or unspecified parts of biliary tract unspecified: 2C17.Z\\nMalignant neoplasms of perihilar bile duct: 2C18\\nHilar cholangiocarcinoma: 2C18.0\\nMucinous cystic neoplasm with associated invasive carcinoma of perihilar bile duct: 2C18.1\\nNeuroendocrine neoplasm of perihilar bile duct: 2C18.2\\nOther specified malignant neoplasms of perihilar bile duct: 2C18.Y\\nMalignant neoplasms of perihilar bile duct unspecified: 2C18.Z\\nMalignant neoplasms of digestive organs unspecified: 2C1Z\\nMalignant neoplasms of nasal cavity: 2C20\\nAdenocarcinoma of nasal cavity: 2C20.0\\nMalignant neuroepitheliomatous neoplasm of nasal cavity: 2C20.1\\nMelanoma of nasal cavity: 2C20.2\\nOlfactory neuroblastoma: XH50L1\\nSquamous cell carcinoma of nasal cavity: 2C20.4\\nOther specified malignant neoplasm of nasal cavity: 2C20.Y\\nMalignant neoplasms of nasal cavity unspecified: 2C20.Z\\nMalignant neoplasms of middle ear: 2C21\\nAdenocarcinoma of middle ear: 2C21.0\\nSquamous cell carcinoma of middle ear: 2C21.1\\nUnspecified malignant epithelial neoplasm of middle ear: 2C21.2\\nOther specified malignant neoplasm of middle ear: 2C21.Y\\nMalignant neoplasms of middle ear unspecified: 2C21.Z\\nMalignant neoplasms of accessory sinuses: 2C22\\nAdenocarcinoma of accessory sinuses: 2C22.0\\nSquamous cell carcinoma of accessory sinuses: 2C22.1\\nSquamous cell carcinoma of sphenoidal sinus: 2C22.10\\nSquamous cell carcinoma of other specified accessory sinuses: 2C22.1Y\\nMalignant epithelial neoplasms of accessory sinuses unspecified type: 2C22.2\\nMelanomas of accessory sinuses: 2C22.3\\nOther specified malignant neoplasms of accessory sinuses: 2C22.Y\\nMalignant neoplasms of accessory sinuses unspecified: 2C22.Z\\nMalignant neoplasms of larynx: 2C23\\nMalignant neoplasms of glottis of larynx: 2C23.1\\nSquamous cell carcinoma of larynx glottis: 2C23.10\\nOther specified malignant neoplasms of larynx glottis: 2C23.1Y\\nMalignant neoplasms of supraglottis of larynx: 2C23.2\\nSquamous cell carcinoma of larynx supraglottis: 2C23.20\\nOther specified malignant neoplasms of larynx supraglottis: 2C23.2Y\\nMalignant neoplasms of subglottis of larynx: 2C23.3\\nSquamous cell carcinoma of larynx subglottis: 2C23.30\\nAdenocarcinoma of larynx subglottis: 2C23.31\\nOther specified malignant neoplasms of larynx subglottis: 2C23.3Y\\nMalignant neoplasm of laryngeal cartilage: 2C23.4\\nMalignant neoplasm of overlapping lesion of larynx: 2C23.5\\nMalignant neoplasms of larynx unspecified: 2C23.Z\\nMalignant neoplasms of trachea: 2C24\\nAdenocarcinoma of trachea: 2C24.0\\nSquamous cell carcinoma of trachea: 2C24.1\\nMalignant epithelial neoplasms of trachea unspecified type: 2C24.2\\nOther specified malignant neoplasms of trachea: 2C24.Y\\nMalignant neoplasms of trachea unspecified: 2C24.Z\\nMalignant neoplasms of bronchus or lung: 2C25\\nAdenocarcinoma of bronchus or lung: 2C25.0\\nSmall cell carcinoma of bronchus or lung: 2C25.1\\nSquamous cell carcinoma of bronchus or lung: 2C25.2\\nLarge cell carcinoma of bronchus or lung: 2C25.3\\nCarcinoid or other malignant neuroendocrine neoplasms of bronchus or lung: 2C25.4\\nUnspecified malignant epithelial neoplasm of bronchus or lung: 2C25.5\\nOther specified malignant neoplasms of bronchus or lung: 2C25.Y\\nMalignant neoplasms of bronchus or lung unspecified: 2C25.Z\\nMalignant neoplasms of the pleura: 2C26\\nMesothelioma of pleura: 2C26.0\\nOther specified malignant neoplasms of the pleura: 2C26.Y\\nMalignant neoplasms of the pleura unspecified: 2C26.Z\\nMalignant neoplasms of thymus: 2C27\\nCarcinoma of thymus: 2C27.0\\nCarcinoid tumour or other neuroendocrine neoplasms of thymus: 2C27.1\\nThymoma: 2C27.2\\nOther specified malignant neoplasms of thymus: 2C27.Y\\nMalignant neoplasms of thymus unspecified: 2C27.Z\\nMalignant neoplasms of heart or mediastinum: 2C28\\nMalignant germ cell neoplasms of heart mediastinum or nonmesothelioma of pleura: 2C28.0\\nOther specified malignant neoplasms of heart or mediastinum: 2C28.1\\nMalignant neoplasms of heart or mediastinum unspecified: 2C28.Z\\nMalignant neoplasms of other or illdefined sites in the respiratory system or intrathoracic organs: 2C29\\nSquamous cell carcinomas of other and illdefined sites in the respiratory system or intrathoracic organs: 2C29.0\\nOther specified malignant neoplasms of other or illdefined sites in the respiratory system or intrathoracic organs: 2C29.1\\nMalignant neoplasms of other or illdefined sites in the respiratory system or intrathoracic organs unspecified: 2C29.Z\\nOther specified malignant neoplasms of middle ear respiratory or intrathoracic organs: 2C2Y\\nMalignant neoplasms of middle ear respiratory or intrathoracic organs unspecified: 2C2Z\\nMelanoma of skin: 2C30\\nSuperficial spreading melanoma primary: 2C30.0\\nNodular melanoma primary: 2C30.1\\nLentigo maligna melanoma primary: 2C30.2\\nAcral lentiginous melanoma primary: 2C30.3\\nOther specified melanoma of skin: 2C30.Y\\nMelanoma of skin unspecified: 2C30.Z\\nSquamous cell carcinoma of skin: 2C31\\nVerrucous squamous cell carcinoma of skin: 2C31.0\\nKeratoacanthoma: XH9XR8\\nCutaneous squamous cell carcinoma: 2C31.Z\\nBasal cell carcinoma of skin: 2C32\\nNodular basal cell carcinoma of skin: 2C32.0\\nSclerosing basal cell carcinoma of skin: 2C32.1\\nSuperficial basal cell carcinoma of skin: 2C32.2\\nOther specified basal cell carcinoma of skin: 2C32.Y\\nBasal cell carcinoma of skin unspecified: 2C32.Z\\nAdnexal carcinoma of skin: 2C33\\nCutaneous neuroendocrine carcinoma: 2C34\\nCutaneous sarcoma: 2C35\\nOther specified malignant neoplasms of skin: 2C3Y\\nMalignant neoplasm of skin of unknown or unspecified type: 2C3Z\\nMalignant neuroepitheliomatous neoplasms of peripheral nerves or autonomic nervous system: 2C40\\nMalignant perineurioma: 2C41\\nOther specified malignant neoplasms of peripheral nerves and autonomic nervous system: 2C4Y\\nMalignant neoplasms of peripheral nerves or autonomic nervous system unspecified: 2C4Z\\nMalignant neoplasms of retroperitoneum: 2C50\\nCystic mucinous or serous carcinoma of retroperitoneum: 2C50.0\\nOther specified malignant neoplasms of retroperitoneum: 2C50.Y\\nMalignant neoplasms of retroperitoneum unspecified: 2C50.Z\\nMalignant neoplasms of peritoneum: 2C51\\nAdenocarcinomas of peritoneum: 2C51.0\\nCystic mucinous or serous carcinoma of peritoneum: 2C51.1\\nMesotheliomas of peritoneum: 2C51.2\\nMesothelioma of mesocolon: 2C51.20\\nMesothelioma of mesentery: 2C51.21\\nMesotheliomas of other specified sites of peritoneum: 2C51.2Y\\nMesotheliomas of peritoneum site unspecified: 2C51.2Z\\nOther specified malignant neoplasms of peritoneum: 2C51.Y\\nMalignant neoplasms of peritoneum unspecified: 2C51.Z\\nMalignant neoplasms of omentum: 2C52\\nCystic mucinous or serous carcinoma of omentum: 2C52.0\\nOther specified malignant neoplasms of omentum: 2C52.Y\\nMalignant neoplasms of omentum unspecified: 2C52.Z\\nMalignant neoplasm involving overlapping sites of retroperitoneum peritoneum or omentum: 2C53\\nAdenocarcinoma involving overlapping sites of retroperitoneum peritoneum or omentum: 2C53.0\\nMesothelioma involving overlapping sites of retroperitoneum peritoneum or omentum: 2C53.1\\nOther specified malignant neoplasm involving overlapping sites of retroperitoneum peritoneum or omentum: 2C53.Y\\nMalignant neoplasm involving overlapping sites of retroperitoneum peritoneum or omentum unspecified: 2C53.Z\\nCarcinoma of breast specialised type: 2C60\\nInvasive carcinoma of breast: 2C61\\nInvasive ductal carcinoma of breast: 2C61.0\\nInvasive lobular carcinoma of breast: 2C61.1\\nInvasive pleomorphic lobular carcinoma of breast: 2C61.2\\nInvasive carcinoma of breast with mixed ductal and lobular features: 2C61.3\\nInvasive carcinoma of breast unidentifiable type: 2C61.4\\nInflammatory carcinoma of breast: 2C62\\nMalignant phyllodes tumour of breast: 2C63\\nSolid papillary carcinoma of breast with evidence of invasion: 2C64\\nHereditary breast and ovarian cancer syndrome: 2C65\\nOther specified malignant neoplasms of breast: 2C6Y\\nMalignant neoplasms of breast unspecified: 2C6Z\\nMalignant neoplasms of vulva: 2C70\\nBasal cell carcinoma of vulva: 2C70.0\\nMelanoma of vulva: 2C70.1\\nSquamous cell carcinoma of vulva: 2C70.2\\nOther specified malignant neoplasms of vulva: 2C70.Y\\nMalignant neoplasms of vulva unspecified: 2C70.Z\\nMalignant neoplasms of vagina: 2C71\\nAdenocarcinoma of vagina: 2C71.0\\nMelanoma of vagina: 2C71.1\\nSquamous cell carcinoma of vagina: 2C71.2\\nOther specified malignant neoplasms of vagina: 2C71.Y\\nMalignant neoplasms of vagina unspecified: 2C71.Z\\nMalignant neoplasms of uterine ligament parametrium or uterine adnexa: 2C72\\nAdenocarcinoma of uterine ligament parametrium or uterine adnexa: 2C72.0\\nMucinous or serous carcinoma of uterine ligament parametrium or uterine adnexa: 2C72.1\\nCarcinosarcomas of uterine ligament parametrium or uterine adnexa: 2C72.3\\nOther specified malignant neoplasms of uterine ligament parametrium or uterine adnexa: 2C72.Y\\nMalignant neoplasms of uterine ligament parametrium or uterine adnexa unspecified: 2C72.Z\\nMalignant neoplasms of ovary: 2C73\\nCarcinomas of ovary: 2C73.0\\nClear cell adenocarcinoma of ovary: 2C73.00\\nEndometrioid adenocarcinoma of ovary: 2C73.01\\nLow grade serous adenocarcinoma of ovary: 2C73.02\\nHigh grade serous adenocarcinoma of ovary: 2C73.03\\nMucinous adenocarcinoma of ovary: 2C73.04\\nOther specified carcinomas of ovary: 2C73.0Y\\nCarcinomas of ovary unspecified: 2C73.0Z\\nDysgerminoma of ovary: 2C73.1\\nGranulosa cell malignant tumour of ovary: 2C73.2\\nMalignant teratoma of ovary: 2C73.3\\nSerous cystadenoma borderline malignancy of ovary: 2C73.4\\nEndodermal sinus tumour unspecified site female: 2C73.5\\nOther specified malignant neoplasms of the ovary: 2C73.Y\\nMalignant neoplasms of ovary unspecified: 2C73.Z\\nMalignant neoplasms of fallopian tube: 2C74\\nAdenocarcinoma of fallopian tube: 2C74.0\\nOther specified malignant neoplasms of fallopian tube: 2C74.Y\\nMalignant neoplasms of fallopian tube unspecified: 2C74.Z\\nMalignant neoplasms of placenta: 2C75\\nMalignant trophoblastic neoplasms of placenta: 2C75.0\\nOther specified malignant neoplasms of placenta: 2C75.Y\\nMalignant neoplasms of placenta unspecified: 2C75.Z\\nMalignant neoplasms of corpus uteri: 2C76\\nEndometrial endometrioid adenocarcinoma: 2C76.0\\nEndometrial mucinous adenocarcinoma: 2C76.1\\nEndometrial clear cell adenocarcinoma: 2C76.2\\nEndometrial serous adenocarcinoma: 2C76.3\\nEndometrial mixed adenocarcinoma: 2C76.4\\nEndometrial squamous cell carcinoma: 2C76.40\\nEndometrial small cell carcinoma: 2C76.41\\nEndometrial undifferentiated carcinoma: 2C76.42\\nCarcinosarcoma of uterus: 2C76.43\\nEndometrial mixed adenocarcinoma unspecified: 2C76.4Z\\nOther specified malignant neoplasms of corpus uteri: 2C76.Y\\nMalignant neoplasms of corpus uteri unspecified: 2C76.Z\\nMalignant neoplasms of cervix uteri: 2C77\\nSquamous cell carcinoma of cervix uteri: 2C77.0\\nAdenocarcinoma of cervix uteri: 2C77.1\\nAdenosquamous carcinoma of cervix uteri: 2C77.2\\nNeuroendocrine carcinoma of cervix uteri: 2C77.3\\nOther specified malignant neoplasms of cervix uteri: 2C77.Y\\nMalignant neoplasms of cervix uteri unspecified: 2C77.Z\\nMalignant neoplasms of uterus part not specified: 2C78\\nMalignant neoplasm involving overlapping sites of female genital organs: 2C79\\nOther specified malignant neoplasms of female genital organs: 2C7Y\\nMalignant neoplasms of female genital organs unspecified: 2C7Z\\nMalignant neoplasms of testis: 2C80\\nGerm cell tumour of testis: 2C80.2\\nOther specified malignant neoplasms of testis: 2C80.Y\\nMalignant neoplasms of testis unspecified: 2C80.Z\\nMalignant neoplasms of penis: 2C81\\nSquamous cell carcinoma of penis: 2C81.0\\nMelanoma of penis: 2C81.1\\nOther specified malignant neoplasm of penis: 2C81.Y\\nMalignant neoplasms of penis unspecified: 2C81.Z\\nMalignant neoplasms of prostate: 2C82\\nAdenocarcinoma of prostate: 2C82.0\\nOther specified malignant neoplasms of prostate: 2C82.Y\\nMalignant neoplasms of prostate unspecified: 2C82.Z\\nMalignant neoplasms of scrotum: 2C83\\nSquamous cell carcinoma of scrotum: 2C83.0\\nOther specified malignant neoplasms of scrotum: 2C83.Y\\nMalignant neoplasms of scrotum unspecified: 2C83.Z\\nMalignant neoplasms of other specified male genital organs: 2C84\\nMalignant neoplasms of male genital organs unspecified: 2C8Z\\nMalignant neoplasms of kidney except renal pelvis: 2C90\\nRenal cell carcinoma of kidney except renal pelvis: 2C90.0\\nOther specified malignant neoplasms of kidney except renal pelvis: 2C90.Y\\nMalignant neoplasms of kidney except renal pelvis unspecified: 2C90.Z\\nMalignant neoplasms of renal pelvis: 2C91\\nUrothelial carcinoma of renal pelvis: 2C91.0\\nOther specified malignant neoplasms of renal pelvis: 2C91.Y\\nMalignant neoplasms of renal pelvis unspecified: 2C91.Z\\nMalignant neoplasms of ureter: 2C92\\nUrothelial carcinoma of ureter: 2C92.0\\nOther specified malignant neoplasms of ureter: 2C92.Y\\nMalignant neoplasms of ureter unspecified: 2C92.Z\\nMalignant neoplasms of urethra or paraurethral gland: 2C93\\nAdenocarcinoma of urethra or paraurethral gland: 2C93.0\\nSquamous cell carcinoma of urethra or paraurethral gland: 2C93.1\\nUrothelial carcinoma of urethra or paraurethral gland: 2C93.2\\nOther specified malignant neoplasms of urethra or paraurethral gland: 2C93.Y\\nMalignant neoplasms of urethra or paraurethral gland unspecified: 2C93.Z\\nMalignant neoplasms of bladder: 2C94\\nAdenocarcinoma of urinary bladder: 2C94.0\\nSquamous cell carcinoma of urinary bladder: 2C94.1\\nUrothelial carcinoma of bladder: 2C94.2\\nOther specified malignant neoplasms of bladder: 2C94.Y\\nMalignant neoplasms of bladder unspecified: 2C94.Z\\nMalignant neoplasm involving overlapping sites of urinary organs: 2C95\\nAdenocarcinoma involving overlapping sites of urinary organs: 2C95.0\\nSquamous cell carcinomas involving overlapping sites of urinary organs: 2C95.1\\nUrothelial carcinoma involving overlapping sites of urinary organs: 2C95.2\\nOther specified malignant neoplasms of overlapping lesion of urinary organs: 2C95.Y\\nMalignant neoplasm involving overlapping sites of urinary organs unspecified: 2C95.Z\\nOther specified malignant neoplasms of urinary tract: 2C9Y\\nMalignant neoplasms of urinary tract unspecified: 2C9Z\\nMalignant neoplasm of conjunctiva: 2D00\\nMelanoma of conjunctiva: 2D00.0\\nMalignant neoplasm of caruncle: 2D00.1\\nSquamous cell carcinoma of conjunctiva: 2D00.2\\nOther specified malignant neoplasm of conjunctiva: 2D00.Y\\nMalignant neoplasm of conjunctiva unspecified: 2D00.Z\\nMalignant neoplasm of cornea: 2D01\\nMelanoma of cornea: 2D01.0\\nSquamous cell carcinoma of cornea: 2D01.1\\nOther specified malignant neoplasms of cornea: 2D01.Y\\nMalignant neoplasm of cornea unspecified: 2D01.Z\\nMalignant neoplasm of retina: 2D02\\nAdenocarcinoma of retinal pigment epithelium: 2D02.0\\nMalignant neuroepithelial tumours of retina: 2D02.1\\nRetinoblastoma: 2D02.2\\nOther specified malignant neoplasm of retina: 2D02.Y\\nMalignant neoplasm of retina unspecified: 2D02.Z\\nMalignant neoplasm of lacrimal apparatus: 2D03\\nAdenocarcinoma of the lacrimal apparatus: 2D03.0\\nMucoepidermoid carcinoma of lacrimal apparatus: 2D03.1\\nSquamous cell carcinoma of the lacrimal apparatus: 2D03.2\\nOther specified malignant neoplasm of lacrimal apparatus: 2D03.Y\\nMalignant neoplasm of lacrimal apparatus unspecified: 2D03.Z\\nMalignant neoplasm of orbit: 2D04\\nMalignant neoplasm of choroid: 2D05\\nMelanoma of choroid: 2D05.0\\nOther specified malignant neoplasm of choroid: 2D05.Y\\nMalignant neoplasm of choroid unspecified: 2D05.Z\\nMalignant neoplasm of ciliary body: 2D06\\nAdenocarcinoma of ciliary epithelium: 2D06.0\\nMalignant medulloepithelioma of ciliary body: 2D06.1\\nMalignant neuroepithelial tumours of ciliary body: 2D06.3\\nMelanoma of ciliary body: 2D06.4\\nOther specified malignant neoplasm of ciliary body: 2D06.Y\\nMalignant neoplasm of ciliary body unspecified: 2D06.Z\\nMalignant neoplasm of iris: 2D07\\nAdenocarcinoma of iris epithelium: 2D07.0\\nMalignant neuroepithelial tumours of iris: 2D07.1\\nMelanoma of iris: 2D07.2\\nOther specified malignant neoplasm of iris: 2D07.Y\\nMalignant neoplasm of iris unspecified: 2D07.Z\\nOther specified malignant neoplasms of eye or ocular adnexa: 2D0Y\\nMalignant neoplasms of eye or ocular adnexa unspecified: 2D0Z\\nMalignant neoplasms of thyroid gland: 2D10\\nFollicular carcinoma of thyroid gland: 2D10.0\\nPapillary carcinoma of thyroid gland: 2D10.1\\nPoorly differentiated carcinoma of thyroid gland: 2D10.2\\nUndifferentiated carcinoma of thyroid gland: 2D10.3\\nMedullary carcinoma of thyroid gland: 2D10.4\\nOther specified malignant neoplasms of thyroid gland: 2D10.Y\\nMalignant neoplasms of thyroid gland unspecified: 2D10.Z\\nMalignant neoplasms of adrenal gland: 2D11\\nAdenocarcinoma of adrenal gland: 2D11.0\\nMalignant phaeochromocytoma of adrenal gland: 2D11.1\\nNeuroblastoma of adrenal gland: 2D11.2\\nOther specified malignant neoplasms of adrenal gland: 2D11.Y\\nMalignant neoplasms of adrenal gland unspecified: 2D11.Z\\nMalignant neoplasms of other endocrine glands or related structures: 2D12\\nMalignant epithelial neoplasms of other endocrine glands or related structures unspecified type: 2D12.0\\nAdenocarcinoma of other endocrine glands or related structures: 2D12.1\\nOther specified malignant neoplasms of other endocrine glands or related structures: 2D12.Y\\nMalignant neoplasms of other endocrine glands or related structures unspecified: 2D12.Z\\nMalignant neoplasms of endocrine glands unspecified: 2D1Z\\nOther specified malignant neoplasms stated or presumed to be primary of specified sites except of lymphoid haematopoietic central nervous system or related tissues: 2D3Y\\nMalignant neoplasms stated or presumed to be primary of specified sites except of lymphoid haematopoietic central nervous system or related tissues unspecified: 2D3Z\\nAdenocarcinoma of unspecified site: 2D40\\nUnspecified carcinoma of unspecified site: 2D41\\nMalignant neoplasms of illdefined sites: 2D42\\nMalignant neoplasms of independent multiple primary sites: 2D43\\nMalignant neoplasm primary site unknown so stated: 2D44\\nOther specified malignant neoplasms of unspecified primary sites: 2D4Y\\nUnspecified malignant neoplasms of unspecified sites: 2D4Z\\nMalignant neoplasm metastasis in brain: 2D50\\nMalignant neoplasm metastasis in meninges: 2D51\\nMalignant neoplasm metastasis in spinal cord cranial nerves or paraspinal nerves: 2D52\\nMalignant neoplasm metastasis in lymph node of a single region: 2D60\\nMalignant neoplasm metastasis in lymph nodes of head face or neck: 2D60.0\\nMalignant neoplasm metastasis in intrathoracic lymph nodes: 2D60.1\\nMalignant neoplasm metastasis in intraabdominal lymph nodes: 2D60.2\\nMalignant neoplasm metastasis in axillary lymph nodes: 2D60.3\\nMalignant neoplasm metastasis in inguinal lymph nodes: 2D60.4\\nMalignant neoplasm metastasis in intrapelvic lymph nodes: 2D60.5\\nOther specified malignant neoplasm metastasis in lymph node of a single region: 2D60.Y\\nMalignant neoplasm metastasis in lymph node of a single region unspecified: 2D60.Z\\nMalignant neoplasm metastases in lymph nodes of multiple regions: 2D61\\nMetastatic malignant neoplasm to unspecified lymph node: 2D6Z\\nMalignant neoplasm metastasis in lung: 2D70\\nMalignant neoplasm metastasis in mediastinum: 2D71\\nMalignant neoplasm metastasis in pleura: 2D72\\nMalignant neoplasm metastasis in upper respiratory tract organs: 2D73\\nMalignant neoplasm metastasis in other specified thoracic organs: 2D7Y\\nMalignant neoplasm metastasis in thoracic or respiratory organs unspecified: 2D7Z\\nMalignant neoplasm metastasis in liver or intrahepatic bile duct: 2D80\\nMalignant neoplasm metastasis in liver: 2D80.0\\nMalignant neoplasm metastasis in intrahepatic bile duct: 2D80.1\\nMalignant neoplasm metastasis in pancreas: 2D81\\nMalignant neoplasm metastasis in extrahepatic bile ducts: 2D82\\nMalignant neoplasm metastasis in ampulla of Vater: 2D83\\nMalignant neoplasm metastasis in the small intestine: 2D84\\nMalignant neoplasm metastasis in large intestine: 2D85\\nMalignant neoplasm metastasis in anus: 2D86\\nMalignant neoplasm metastasis in other specified digestive system organ: 2D8Y\\nMalignant neoplasm metastasis in unspecified digestive system organ: 2D8Z\\nMalignant neoplasm metastasis in retroperitoneum: 2D90\\nMalignant neoplasm metastasis in peritoneum: 2D91\\nMalignant neoplasm metastasis in kidney or renal pelvis: 2E00\\nMalignant neoplasm metastasis in bladder: 2E01\\nMalignant neoplasm metastasis in other or unspecified urinary system organs: 2E02\\nMalignant neoplasm metastasis in bone or bone marrow: 2E03\\nMalignant neoplasm metastasis in soft tissue: 2E04\\nMalignant neoplasm metastasis in female reproductive system: 2E05\\nMalignant neoplasm metastasis in ovary: 2E05.0\\nMalignant neoplasm metastasis in other female reproductive system organs: 2E05.Y\\nMalignant neoplasm metastasis in female reproductive system unspecified: 2E05.Z\\nMalignant neoplasm metastasis in male genital organs: 2E06\\nMalignant neoplasm metastasis in adrenal gland: 2E07\\nMetastatic malignant neoplasm involving skin: 2E08\\nMalignant neoplasm metastasis in peripheral nervous system: 2E09\\nMalignant neoplasm metastasis in other specified sites: 2E0Y\\nMalignant neoplasm metastasis unspecified: 2E2Z\\nCarcinoma in situ of oral cavity oesophagus or stomach: 2E60\\nCarcinoma in situ of lip oral cavity or pharynx: 2E60.0\\nCarcinoma in situ of oesophagus: 2E60.1\\nCarcinoma in situ of stomach: 2E60.2\\nCarcinoma in situ of other or unspecified digestive organs: 2E61\\nCarcinoma in situ of colon: 2E61.0\\nCarcinoma in situ of rectum: 2E61.1\\nCarcinoma in situ of anal canal: 2E61.2\\nCarcinoma in situ of gallbladder biliary tract or ampulla of Vater: 2E61.3\\nCarcinoma in situ of other specified digestive organs: 2E61.Y\\nCarcinoma in situ of unspecified digestive organs: 2E61.Z\\nCarcinoma in situ of middle ear or respiratory system: 2E62\\nCarcinoma in situ of larynx: 2E62.0\\nCarcinoma in situ of trachea: 2E62.1\\nCarcinoma in situ of bronchus or lung: 2E62.2\\nCarcinoma in situ of other specified sites of middle ear or respiratory system: 2E62.Y\\nCarcinoma in situ of unspecified sites of middle ear or respiratory system: 2E62.Z\\nMelanoma in situ neoplasms: 2E63\\nMelanoma in situ of skin: 2E63.0\\nLentigo maligna: XH9KY6\\nMelanoma in situ of skin unspecified: 2E63.0Z\\nMelanoma in situ of conjunctiva: 2E63.1\\nMelanoma in situ neoplasms other specified site: 2E63.Y\\nMelanoma in situ neoplasms unspecified site: 2E63.Z\\nCarcinoma in situ of skin: 2E64\\nIntraepidermal squamous cell carcinoma: 2E64.0\\nBowen disease of skin: 2E64.00\\nActinic intraepidermal squamous cell carcinoma: 2E64.01\\nOther specified intraepidermal squamous cell carcinoma: 2E64.0Y\\nIntraepidermal squamous cell carcinoma unspecified: 2E64.0Z\\nExtramammary Paget disease of skin: 2E64.1\\nCarcinoma in situ of anal margin or perianal skin: 2E64.2\\nOther specified carcinoma in situ of skin: 2E64.Y\\nCarcinoma in situ of skin unspecified: 2E64.Z\\nCarcinoma in situ of breast: 2E65\\nLobular carcinoma in situ of breast: 2E65.0\\nLobular carcinoma in situ of breast pleomorphic subtype: 2E65.1\\nDuctal carcinoma in situ of breast: 2E65.2\\nDuctal carcinoma in situ of breast comedo subtype: 2E65.3\\nMixed ductal and lobular carcinoma in situ of breast: 2E65.4\\nPaget disease of nipple: 2E65.5\\nOther specified carcinoma in situ of breast: 2E65.Y\\nCarcinoma in situ of breast unspecified: 2E65.Z\\nCarcinoma in situ of cervix uteri: 2E66\\nHigh grade squamous intraepithelial lesion of cervix uteri: 2E66.2\\nOther specified carcinoma in situ of cervix uteri: 2E66.Y\\nCarcinoma in situ of cervix uteri unspecified: 2E66.Z\\nCarcinoma in situ of other or unspecified genital organs: 2E67\\nCarcinoma in situ of endometrium: 2E67.0\\nCarcinoma in situ of vulva: 2E67.1\\nVulvar Paget disease: 2E67.11\\nVulvar intraepithelial neoplasia HPVindependent: 2E67.12\\nHigh grade squamous intraepithelial lesion of vulva HPVassociated: 2E67.13\\nCarcinoma in situ of vagina: 2E67.2\\nHigh grade squamous intraepithelial lesion of vagina: 2E67.22\\nOther specified carcinoma in situ of vagina: 2E67.2Y\\nCarcinoma in situ of vagina unspecified: 2E67.2Z\\nCarcinoma in situ of other or unspecified female genital organs: 2E67.3\\nCarcinoma in situ of penis: 2E67.4\\nSquamous cell carcinoma in situ of skin of penis: 2E67.40\\nSquamous cell carcinoma in situ of mucocutaneous epithelium of penis: 2E67.41\\nHigh grade intraepithelial lesion of prostate: 2E67.5\\nCarcinoma in situ of other or unspecified male genital organs: 2E67.6\\nCarcinoma in situ of bladder: 2E68\\nCarcinoma in situ of other or unspecified urinary organs: 2E69\\nCarcinoma in situ of the eye or ocular adnexa: 2E6A\\nCarcinoma in situ of the conjunctiva: 2E6A.0\\nCarcinoma in situ of the cornea: 2E6A.1\\nCarcinoma in situ of other and unspecified part of the eye and adnexa: 2E6A.Y\\nCarcinoma in situ of thyroid and other endocrine glands: 2E6B\\nCarcinoma in situ of other specified site: 2E6Y\\nCarcinoma in situ of unspecified site: 2E6Z\\nBenign lipomatous neoplasm: 2E80\\nLipoma: 2E80.0\\nSuperficial subcutaneous lipoma: 2E80.00\\nDeep subfascial lipoma: 2E80.01\\nDeep internal or visceral lipoma: 2E80.02\\nLipoma other specified site: 2E80.0Y\\nLipoma unspecified site: 2E80.0Z\\nLipoblastoma: 2E80.1\\nOther specified benign lipomatous neoplasm: 2E80.Y\\nBenign lipomatous neoplasm unspecified: 2E80.Z\\nBenign vascular neoplasms: 2E81\\nNeoplastic haemangioma: 2E81.0\\nUmbilical cord haemangioma: 2E81.00\\nConjunctival haemangioma or haemolymphangioma: 2E81.01\\nNeoplastic haemangioma of other specified site: 2E81.0Y\\nNeoplastic haemangioma unspecified site: 2E81.0Z\\nBenign lymphatic neoplasms: 2E81.1\\nDisseminated lymphangiomatosis: 2E81.10\\nAcquired progressive lymphangioma: 2E81.11\\nOther specified benign lymphatic neoplasms: 2E81.1Y\\nBenign lymphatic neoplasms unspecified: 2E81.1Z\\nBenign vascular neoplasms of infancy or childhood: 2E81.2\\nFocal infantile haemangioma: 2E81.20\\nMultifocal infantile haemangioma: 2E81.21\\nOther specified benign vascular neoplasms of infancy or childhood: 2E81.2Y\\nBenign vascular neoplasms of infancy or childhood unspecified: 2E81.2Z\\nOther specified benign vascular neoplasms: 2E81.Y\\nBenign vascular neoplasms unspecified: 2E81.Z\\nBenign chondrogenic tumours: 2E82\\nBenign chondrogenic tumours of bone or articular cartilage of limbs: 2E82.0\\nBenign chondrogenic tumours of bone or articular cartilage of other specified sites: 2E82.1\\nBenign chondrogenic tumours site unspecified: 2E82.Z\\nBenign osteogenic tumours: 2E83\\nBenign osteogenic tumours of bone or articular cartilage of skull or face: 2E83.0\\nBenign osteogenic tumours of bone or articular cartilage of lower jaw: 2E83.1\\nBenign osteogenic tumours of bone or articular cartilage of vertebral column: 2E83.2\\nBenign osteogenic tumours of bone or articular cartilage of ribs sternum or clavicle: 2E83.3\\nBenign osteogenic tumours of bone or articular cartilage of pelvic bones sacrum or coccyx: 2E83.4\\nBenign osteogenic tumours of bone or articular cartilage of limbs: 2E83.5\\nBenign osteogenic tumour of other specified site: 2E83.Y\\nBenign osteogenic tumour of unspecified site: 2E83.Z\\nBenign fibrogenic or myofibrogenic tumour: 2E84\\nBenign fibrogenic or myofibrogenic tumour of skin: 2E84.0\\nBenign fibrogenic or myofibrogenic tumour of other specified sites: 2E84.Y\\nBenign fibrogenic or myofibrogenic tumour site unknown: 2E84.Z\\nBenign fibrohistiocytic tumour: 2E85\\nBenign fibrohistiocytic tumour of soft tissues of limbs: 2E85.0\\nBenign fibrohistiocytic tumour of retroperitoneum or peritoneum: 2E85.1\\nBenign fibrohistiocytic tumour of skin: 2E85.2\\nBenign fibrohistiocytic tumour of other specified sites: 2E85.Y\\nBenign fibrohistiocytic tumour site unspecified: 2E85.Z\\nBenign smooth muscle or skeletal muscle tumour: 2E86\\nLeiomyoma of uterus: 2E86.0\\nLeiomyoma of other or unspecified sites: 2E86.1\\nRhabdomyoma: 2E86.2\\nOther specified benign smooth muscle or skeletal muscle tumour: 2E86.Y\\nBenign smooth muscle or skeletal muscle tumour unspecified: 2E86.Z\\nBenign gastrointestinal stromal tumour: 2E87\\nBenign endometrial stromal nodule: 2E88\\nBenign mesenchymal tumours of uncertain differentiation: 2E89\\nBenign tumours of uncertain differentiation bone or cartilage: 2E89.0\\nBenign tumours of uncertain differentiation soft tissue: 2E89.1\\nBenign mesenchymal tumours of uncertain differentiation of other specified site: 2E89.Y\\nBenign mesenchymal tumours of uncertain differentiation of unspecified site: 2E89.Z\\nOther mixed benign mesenchymal tumours: 2E8A\\nOther specified benign mesenchymal neoplasm: 2E8Y\\nBenign mesenchymal neoplasms unspecified: 2E8Z\\nBenign neoplasm of lip oral cavity or pharynx: 2E90\\nBenign neoplasm of lip: 2E90.0\\nBenign neoplasm of tongue: 2E90.1\\nBenign neoplasm of floor of mouth: 2E90.2\\nBenign neoplasm of other or unspecified parts of mouth: 2E90.3\\nBenign neoplasm of tonsil: 2E90.4\\nBenign neoplasm of oropharynx: 2E90.5\\nBenign neoplasm of nasopharynx: 2E90.6\\nBenign neoplasm of hypopharynx: 2E90.7\\nBenign neoplasm of pharynx unspecified: 2E90.8\\nBenign neoplasm of major salivary glands: 2E91\\nBenign neoplasm of parotid gland: 2E91.0\\nBenign neoplasm of other specified major salivary glands: 2E91.1\\nBenign neoplasm of unspecified major salivary glands: 2E91.Z\\nBenign neoplasm of digestive organs: 2E92\\nBenign neoplasm of oesophagus: 2E92.0\\nBenign neoplasm of stomach: 2E92.1\\nBenign neoplasm of duodenum: 2E92.2\\nBenign neoplasm of other or unspecified parts of small intestine: 2E92.3\\nBenign neoplasm of the large intestine: 2E92.4\\nPolyposis syndrome: 2E92.40\\nOther specified benign neoplasm of the large intestine: 2E92.4Y\\nBenign neoplasm of the large intestine unspecified: 2E92.4Z\\nBenign neoplasm of anus or anal canal: 2E92.5\\nBenign neoplasm of gallbladder extrahepatic bile ducts or ampulla of Vater: 2E92.6\\nBenign neoplasm of liver or intrahepatic bile ducts: 2E92.7\\nBenign neoplasm of pancreas: 2E92.8\\nBenign neoplasm of endocrine pancreas: 2E92.9\\nBenign neoplasm of other specified digestive organs: 2E92.Y\\nBenign neoplasm of unspecified digestive organs: 2E92.Z\\nBenign neoplasm of middle ear or respiratory system: 2F00\\nMiddle ear endocrine tumour: 2F00.0\\nRecurrent respiratory papillomatosis: 2F00.1\\nLaryngeal endocrine tumour: 2F00.2\\nOther specified benign neoplasm of middle ear or respiratory system: 2F00.Y\\nBenign neoplasm of middle ear or respiratory system unspecified: 2F00.Z\\nBenign neoplasm of other intrathoracic organs: 2F01\\nBenign neoplasm of mesothelial tissue: 2F10\\nBenign cutaneous melanocytic neoplasms: 2F20\\nCommon acquired melanocytic naevus: 2F20.0\\nMultiple benign melanocytic naevi: 2F20.00\\nOther specified common acquired melanocytic naevus: 2F20.0Y\\nCommon acquired melanocytic naevus unspecified: 2F20.0Z\\nAtypical melanocytic naevus: 2F20.1\\nCongenital melanocytic naevus: 2F20.2\\nGiant congenital melanocytic naevus: 2F20.20\\nOther specified congenital melanocytic naevus: 2F20.2Y\\nCongenital melanocytic naevus unspecified: 2F20.2Z\\nGeneralised eruptive melanocytic naevi: 2F20.3\\nOther specific types of melanocytic naevus: 2F20.Y\\nMelanocytic naevus unspecified: 2F20.Z\\nBenign keratinocytic acanthomas: 2F21\\nSeborrhoeic keratosis: XH0949\\nOther specified benign keratinocytic acanthomas: 2F21.Y\\nBenign neoplasms of epidermal appendages: 2F22\\nBenign dermal fibrous or fibrohistiocytic neoplasms: 2F23\\nDermatofibroma: 2F23.0\\nOther specified benign dermal fibrous or fibrohistiocytic neoplasms: 2F23.Y\\nBenign cutaneous neoplasms of neural or nerve sheath origin: 2F24\\nCherry angioma: 2F25\\nLobular capillary haemangioma: 2F26\\nOther specified benign cutaneous neoplasms: 2F2Y\\nBenign cutaneous neoplasm of unspecified type: 2F2Z\\nBenign neoplasm of breast: 2F30\\nTubular adenoma of breast: 2F30.0\\nLactating adenoma of breast: 2F30.1\\nIntraductal papilloma of breast: 2F30.2\\nBenign phyllodes tumour of breast: 2F30.3\\nFibromatosis of breast: 2F30.4\\nFibroadenoma of breast: 2F30.5\\nExtensive adenomatosis of nipple: 2F30.6\\nBenign neoplasm of the nipple: 2F30.7\\nOther specified benign neoplasm of breast: 2F30.Y\\nBenign neoplasm of breast unspecified: 2F30.Z\\nBenign nonmesenchymal neoplasms of uterus: 2F31\\nBenign nonmesenchymal neoplasm of uterus cervix uteri: 2F31.0\\nBenign nonmesenchymal neoplasm of uterus corpus uteri: 2F31.1\\nBenign nonmesenchymal neoplasms of uterus other parts: 2F31.2\\nBenign neoplasm of ovary: 2F32\\nCystic teratoma: 2F32.0\\nOvarian fibroma: 2F32.1\\nMeigs syndrome: 2F32.2\\nSerous ovarian cystadenoma: 2F32.3\\nOther specified benign neoplasm of ovary: 2F32.Y\\nBenign neoplasm of ovary unspecified: 2F32.Z\\nBenign neoplasm of other or unspecified female genital organs: 2F33\\nBenign neoplasm of male genital organs: 2F34\\nBenign neoplasm of urinary organs: 2F35\\nBenign neoplasm of eye or ocular adnexa: 2F36\\nBenign neoplasm of choroid: 2F36.0\\nBenign neoplasm of iris: 2F36.1\\nBenign neoplasm of ciliary body: 2F36.2\\nTeratoma of orbit: 2F36.3\\nCysts of eyelid: 2F36.4\\nOther specified benign neoplasm of eye or ocular adnexa: 2F36.Y\\nBenign neoplasm of eye or ocular adnexa unspecified: 2F36.Z\\nBenign neoplasm of endocrine glands: 2F37\\nNonsecreting pituitary adenoma: 2F37.0\\nOther specified benign neoplasm of endocrine glands: 2F37.Y\\nBenign neoplasm of endocrine glands unspecified: 2F37.Z\\nBenign neoplasms except of mesenchymal origin of other specified site: 2F3Y\\nBenign neoplasms except of mesenchymal origin of unspecified site: 2F3Z\\nNeoplasms of uncertain behaviour of oral cavity or digestive organs: 2F70\\nNeoplasms of uncertain behaviour of lip oral cavity or pharynx: 2F70.0\\nNeoplasms of uncertain behaviour of stomach: 2F70.1\\nNeoplasms of uncertain behaviour of small intestine: 2F70.2\\nNeoplasms of uncertain behaviour of colon: 2F70.3\\nNeoplasms of uncertain behaviour of rectum: 2F70.4\\nNeoplasms of uncertain behaviour of liver gallbladder or bile ducts: 2F70.5\\nNeoplasms of uncertain behaviour of oral cavity or digestive organs other specified site: 2F70.Y\\nNeoplasms of uncertain behaviour of oral cavity or digestive organs unspecified site: 2F70.Z\\nNeoplasms of uncertain behaviour of middle ear respiratory or intrathoracic organs: 2F71\\nNeoplasms of uncertain behaviour of thymus: 2F71.0\\nNeoplasms of uncertain behaviour of larynx: 2F71.1\\nNeoplasms of uncertain behaviour of pleura: 2F71.2\\nNeoplasms of uncertain behaviour of trachea bronchus or lung: 2F71.3\\nNeoplasms of uncertain behaviour of mediastinum: 2F71.4\\nNeoplasms of uncertain behaviour of middle ear respiratory or intrathoracic organs other specified site: 2F71.Y\\nNeoplasms of uncertain behaviour of middle ear respiratory or intrathoracic organs unspecified site: 2F71.Z\\nNeoplasms of uncertain behaviour of skin: 2F72\\nSpitzoid tumour of uncertain malignant potential: 2F72.1\\nMelanocytic naevus with severe melanocytic dysplasia: 2F72.2\\nOther specified neoplasms of uncertain behaviour of skin: 2F72.Y\\nNeoplasms of uncertain behaviour of retroperitoneum: 2F73\\nNeoplasms of uncertain behaviour of peritoneum: 2F74\\nNeoplasms of uncertain behaviour of breast: 2F75\\nNeoplasms of uncertain behaviour of female genital organs: 2F76\\nNeoplasms of uncertain behaviour of male genital organs: 2F77\\nNeoplasms of uncertain behaviour of urinary organs: 2F78\\nNeoplasms of uncertain behaviour of eye or ocular adnexa: 2F79\\nNeoplasms of uncertain behaviour of endocrine glands: 2F7A\\nMultiple polyglandular tumours: 2F7A.0\\nOther specified neoplasms of uncertain behaviour of endocrine glands: 2F7A.Y\\nNeoplasms of uncertain behaviour of endocrine glands unspecified: 2F7A.Z\\nNeoplasms of uncertain behaviour of bone or articular cartilage: 2F7B\\nNeoplasms of uncertain behaviour of connective or other soft tissue: 2F7C\\nNeoplasms of uncertain behaviour of other specified site: 2F7Y\\nNeoplasms of uncertain behaviour of unspecified site: 2F7Z\\nNeoplasms of unknown behaviour of oral cavity or digestive organs: 2F90\\nNeoplasms of unknown behaviour of colon: 2F90.0\\nNeoplasms of unknown behaviour of rectum: 2F90.1\\nNeoplasms of unknown behaviour of oral cavity or digestive organs other specified site: 2F90.Y\\nNeoplasms of unknown behaviour of oral cavity or digestive organs unspecified site: 2F90.Z\\nNeoplasms of unknown behaviour of middle ear respiratory or intrathoracic organs: 2F91\\nNeoplasms of unknown behaviour of larynx: 2F91.0\\nNeoplasms of unknown behaviour of trachea bronchus or lung: 2F91.1\\nNeoplasms of unknown behaviour of other specified respiratory organ intrathoracic organ or middle ear: 2F91.Y\\nNeoplasms of unknown behaviour of unspecified respiratory organ or intrathoracic organ: 2F91.Z\\nNeoplasms of unknown behaviour of skin: 2F92\\nNeoplasms of unknown behaviour of retroperitoneum: 2F93\\nNeoplasms of unknown behaviour of peritoneum: 2F94\\nNeoplasms of unknown behaviour of breast: 2F95\\nNeoplasms of unknown behaviour of female genital organs: 2F96\\nNeoplasms of unknown behaviour of male genital organs: 2F97\\nNeoplasms of unknown behaviour of urinary organs: 2F98\\nNeoplasms of unknown behaviour of eye or ocular adnexa: 2F99\\nNeoplasms of unknown behaviour of endocrine glands: 2F9A\\nNeoplasms of unknown behaviour of bone or articular cartilage: 2F9B\\nNeoplasms of unknown behaviour of connective or other soft tissue: 2F9C\\nNeoplasms of unknown behaviour of other specified site: 2F9Y\\nNeoplasms of unknown behaviour of unspecified site: 2F9Z\\nIron deficiency anaemia: 3A00\\nAcquired iron deficiency anaemia due to blood loss: 3A00.0\\nChronic posthaemorrhagic anaemia: 3A00.01\\nAcquired iron deficiency anaemia due to blood loss unspecified: 3A00.0Z\\nAcquired iron deficiency anaemia due to low intake: 3A00.1\\nAcquired iron deficiency anaemia due to decreased absorption: 3A00.2\\nAcquired iron deficiency anaemia due to increased requirement: 3A00.3\\nOther specified iron deficiency anaemia: 3A00.Y\\nIron deficiency anaemia unspecified: 3A00.Z\\nMegaloblastic anaemia due to vitamin B deficiency: 3A01\\nHereditary vitamin B deficiency anaemia: 3A01.0\\nNeonatal vitamin B deficiency anaemia: 3A01.1\\nVitamin B deficiency anaemia due to low intake: 3A01.2\\nVitamin B deficiency anaemia due to intrinsic factor deficiency: 3A01.3\\nPernicious anaemia: 3A01.30\\nOther specified vitamin B deficiency anaemia due to intrinsic factor deficiency: 3A01.3Y\\nVitamin B deficiency anaemia due to intrinsic factor deficiency unspecified: 3A01.3Z\\nVitamin B deficiency anaemia due to intestinal disease: 3A01.4\\nDruginduced vitamin B deficiency anaemia: 3A01.5\\nOther specified megaloblastic anaemia due to vitamin B deficiency: 3A01.Y\\nMegaloblastic anaemia due to vitamin B deficiency unspecified: 3A01.Z\\nFolate deficiency anaemia: 3A02\\nHereditary folate deficiency anaemia: 3A02.0\\nFolate deficiency anaemia due to low intake: 3A02.1\\nFolate deficiency anaemia due to increased requirements: 3A02.2\\nFolate deficiency anaemia due to decreased intestinal absorption: 3A02.3\\nDruginduced folate deficiency anaemia: 3A02.4\\nOther specified folate deficiency anaemia: 3A02.Y\\nFolate deficiency anaemia unspecified: 3A02.Z\\nOther nutritional or metabolic anaemias: 3A03\\nHereditary orotic aciduria: 3A03.0\\nProtein deficiency anaemia: 3A03.1\\nScorbutic anaemia: 3A03.2\\nCopper deficiency anaemia: 3A03.3\\nAcquired other vitamin B deficiency anaemia: 3A03.4\\nAcquired pyridoxine deficiency anaemia: 3A03.40\\nAcquired riboflavin deficiency anaemia: 3A03.41\\nAcquired thiamine deficiency anaemia: 3A03.42\\nOther specified acquired other vitamin B deficiency anaemia: 3A03.4Y\\nAcquired vitamin A deficiency anaemia: 3A03.5\\nAcquired vitamin E deficiency anaemia: 3A03.6\\nOther and unspecified nutritional or metabolic anaemia: 3A03.Y\\nHereditary haemolytic anaemia: 3A10\\nHaemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies: 3A10.0\\nHaemolytic anaemia due to glucosephosphate dehydrogenase deficiency: 3A10.00\\nOther specified haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies: 3A10.0Y\\nHaemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies unspecified: 3A10.0Z\\nHaemolytic anaemia due to adenosine deaminase excess: 3A10.1\\nHereditary elliptocytosis: 3A10.2\\nFamilial pseudohyperkalaemia: 3A10.3\\nOther specified hereditary haemolytic anaemia: 3A10.Y\\nHereditary haemolytic anaemia unspecified: 3A10.Z\\nOther specified congenital haemolytic anaemia: 3A1Y\\nAcquired haemolytic anaemia immune: 3A20\\nAutoimmune haemolytic anaemia warm type: 3A20.0\\nAutoimmune haemolytic anaemia cold type: 3A20.1\\nAutoimmune haemolytic anaemia mixed type cold and warm: 3A20.2\\nParoxysmal cold haemoglobinuria: 3A20.3\\nAlloimmune haemolytic anaemia: 3A20.4\\nEvans syndrome: 3A20.5\\nOther specified acquired haemolytic anaemia immune: 3A20.Y\\nAcquired haemolytic anaemia immune unspecified: 3A20.Z\\nAcquired haemolytic anaemia nonimmune: 3A21\\nParoxysmal nocturnal haemoglobinuria: 3A21.0\\nMicroangiopathic haemolytic anaemia: 3A21.1\\nHaemolytic uraemic syndrome: 3A21.2\\nOther specified acquired haemolytic anaemia nonimmune: 3A21.Y\\nAcquired haemolytic anaemia nonimmune unspecified: 3A21.Z\\nAcquired haemolytic anaemia unspecified: 3A2Z\\nHaemolytic anaemias unspecified: 3A4Z\\nThalassaemias: 3A50\\nAlpha thalassaemia: 3A50.0\\nMild alpha thalassaemia diseases: 3A50.00\\nThalassaemic alphachain variants: 3A50.01\\nHaemoglobin H disease    included: 3A50.02\\nHomozygous or compound heterozygous alpha thalassaemia: 3A50.03\\nOther specified alpha thalassaemia: 3A50.0Y\\nAlpha thalassaemia unspecified: 3A50.0Z\\nAlpha thalassaemia related syndromes: 3A50.1\\nBeta thalassaemia: 3A50.2\\nDelta deltabeta or gammadeltabeta thalassaemia: 3A50.3\\nHereditary persistence of fetal haemoglobin: 3A50.4\\nOther specified thalassaemias: 3A50.Y\\nThalassaemias unspecified: 3A50.Z\\nSickle cell disorders or other haemoglobinopathies: 3A51\\nSickle cell trait: 3A51.0\\nSickle cell disease without crisis: 3A51.1\\nSickle cell disease with crisis: 3A51.2\\nCompound heterozygous sickling disorders without crisis: 3A51.3\\nCompound heterozygous sickling disorders with crisis: 3A51.4\\nHaemoglobin C disease: 3A51.5\\nHaemoglobin D disease: 3A51.6\\nHigh affinity haemoglobin: 3A51.7\\nLow affinity haemoglobin: 3A51.8\\nHaemoglobin O disease: 3A51.9\\nHaemoglobin E disease: 3A51.A\\nHaemoglobin Cbeta thalassaemia compound heterozygosity: 3A51.B\\nOther specified sickle cell disorders or other haemoglobinopathies: 3A51.Y\\nSickle cell disorders or other haemoglobinopathies unspecified: 3A51.Z\\nCongenital pure red cell aplasia: 3A60\\nCongenital noninherited pure red cell aplasia: 3A60.0\\nHereditary pure red cell aplasia: 3A60.1\\nCongenital pure red cell aplasia unspecified: 3A60.Z\\nAcquired pure red cell aplasia: 3A61\\nAcute acquired pure red cell aplasia: 3A61.0\\nChronic acquired pure red cell aplasia: 3A61.1\\nOther specified acquired pure red cell aplasia: 3A61.Y\\nAcquired pure red cell aplasia unspecified: 3A61.Z\\nPure red cell aplasia unspecified: 3A6Z\\nAplastic anaemia: 3A70\\nCongenital aplastic anaemia: 3A70.0\\nAcquired aplastic anaemias: 3A70.1\\nDruginduced aplastic anaemia: 3A70.10\\nAplastic anaemia due to other external agents: 3A70.11\\nIdiopathic aplastic anaemia: 3A70.12\\nOther specified acquired aplastic anaemias: 3A70.1Y\\nAcquired aplastic anaemias unspecified: 3A70.1Z\\nAplastic anaemia unspecified: 3A70.Z\\nAnaemia due to chronic disease: 3A71\\nAnaemia in neoplastic disease: 3A71.0\\nAnaemia in chronic infectious diseases: 3A71.1\\nAnaemia in chronic kidney disease: 3A71.2\\nAnaemia due to other specified chronic disease: 3A71.Y\\nAnaemia due to chronic disease unspecified: 3A71.Z\\nSideroblastic anaemia: 3A72\\nCongenital sideroblastic anaemias: 3A72.0\\nHereditary sideroblastic anaemias: 3A72.00\\nHereditary syndromic sideroblastic anaemia: 3A72.01\\nOther specified congenital sideroblastic anaemias: 3A72.0Y\\nCongenital sideroblastic anaemias unspecified: 3A72.0Z\\nAcquired sideroblastic anaemias: 3A72.1\\nSideroblastic anaemia unspecified: 3A72.Z\\nCongenital dyserythropoietic anaemia: 3A73\\nCongenital polycythaemia: 3A80\\nPrimary inherited erythrocytosis: 3A80.0\\nOther specified congenital polycythaemia: 3A80.Y\\nCongenital polycythaemia unspecified: 3A80.Z\\nAcquired polycythaemia: 3A81\\nPolycythaemia due to hypoxia including high altitude: 3A81.0\\nPolycythaemia due to overtransfusion or blood doping: 3A81.1\\nRelative polycythaemia: 3A81.2\\nOther specified acquired polycythaemia: 3A81.Y\\nAcquired polycythaemia unspecified: 3A81.Z\\nPolycythaemia unspecified: 3A8Z\\nAnaemia due to acute disease: 3A90\\nCongenital methaemoglobinaemia: 3A91\\nHereditary methaemoglobinaemia: 3A92\\nAcquired methaemoglobinaemia: 3A93\\nAcute posthaemorrhagic anaemia: 3A94\\nOther specified anaemias or erythrocyte disorders: 3A9Y\\nAnaemias or other erythrocyte disorders unspecified: 3A9Z\\nHereditary factor VIII deficiency: 3B10\\nHaemophilia A: 3B10.0\\nHereditary factor VIII deficiency with antifactor VIII inhibitor: 3B10.1\\nOther specified hereditary factor VIII deficiency: 3B10.Y\\nHereditary factor VIII deficiency unspecified: 3B10.Z\\nHereditary factor IX deficiency: 3B11\\nHaemophilia B: 3B11.0\\nOther specified hereditary factor IX deficiency: 3B11.Y\\nHereditary factor IX deficiency unspecified: 3B11.Z\\nVon Willebrand disease: 3B12\\nHaemophilia C: 3B13\\nOther inherited coagulation factor deficiency with bleeding tendency: 3B14\\nHereditary deficiency of factor I: 3B14.0\\nHereditary factor X deficiency: 3B14.1\\nCombined deficiency of vitamin Kdependent clotting factors: 3B14.2\\nOther inherited coagulation factor deficiency with bleeding tendency unspecified: 3B14.Z\\nInherited coagulation factor deficiency without bleeding tendency: 3B15\\nCongenital or constitutional haemorrhagic condition unspecified: 3B1Z\\nDisseminated intravascular coagulation: 3B20\\nHaemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors: 3B21\\nHaemorrhage due to thrombin inhibitor other than heparin: 3B21.0\\nHaemorrhage due to factor Xa inhibitor: 3B21.1\\nHaemorrhagic disorder due to other specified circulating anticoagulants or coagulation factors: 3B21.Y\\nHaemorrhagic disorder due to unspecified circulating anticoagulants or coagulation factors: 3B21.Z\\nAcquired haemophilia: 3B22\\nOther specified haemorrhagic diseases due to acquired coagulation factor defects: 3B2Y\\nCoagulation defects unspecified: 3B4Z\\nInherited fibrinolytic defects: 3B50\\nCongenital alpha antiplasmin deficiency: 3B50.0\\nCongenital plasminogen activator inhibitor type  deficiency: 3B50.1\\nOther specified inherited fibrinolytic defects: 3B50.Y\\nInherited fibrinolytic defects unspecified: 3B50.Z\\nAcquired fibrinolytic defects: 3B51\\nNonthrombocytopenic purpura: 3B60\\nHereditary vascular purpura: 3B60.0\\nAcquired vascular purpura: 3B60.1\\nThrombophilia: 3B61\\nHereditary thrombophilia: 3B61.0\\nHyperhomocysteinaemia: 3B61.00\\nOther specified hereditary thrombophilia: 3B61.0Y\\nHereditary thrombophilia unspecified: 3B61.0Z\\nAcquired thrombophilia: 3B61.1\\nOther specified thrombophilia: 3B61.Y\\nThrombophilia unspecified: 3B61.Z\\nQualitative platelet defects: 3B62\\nInherited qualitative platelet defects: 3B62.0\\nAlphagranule diseases: 3B62.00\\nInherited giant platelet disorder: 3B62.01\\nOther specified inherited qualitative platelet defects: 3B62.0Y\\nInherited qualitative platelet defects unspecified: 3B62.0Z\\nBleeding diathesis due to thromboxane synthesis deficiency: 3B62.1\\nIsolated thrombocytopenia: 3B62.2\\nDense granule disease: 3B62.3\\nAlphadelta dense granule deficiency: 3B62.4\\nHaemophagocytic syndrome associated with infection: 3B62.5\\nOther specified qualitative platelet defects: 3B62.Y\\nQualitative platelet defects unspecified: 3B62.Z\\nThrombocytosis: 3B63\\nCongenital thrombocytosis: 3B63.0\\nAcquired thrombocytosis: 3B63.1\\nSecondary thrombocytosis: 3B63.10\\nOther specified acquired thrombocytosis: 3B63.1Y\\nAcquired thrombocytosis unspecified: 3B63.1Z\\nOther specified thrombocytosis: 3B63.Y\\nThrombocytosis unspecified: 3B63.Z\\nThrombocytopenia: 3B64\\nCongenital thrombocytopenia: 3B64.0\\nCongenital noninherited thrombocytopenia: 3B64.00\\nHereditary thrombocytopenia: 3B64.01\\nCongenital thrombocytopenia unspecified: 3B64.0Z\\nAcquired thrombocytopenia: 3B64.1\\nImmune thrombocytopenic purpura: 3B64.10\\nSecondary thrombocytopenic purpura: 3B64.11\\nDruginduced thrombocytopenic purpura: 3B64.12\\nAlloimmune thrombocytopenia: 3B64.13\\nThrombotic thrombocytopenic purpura: 3B64.14\\nOther specified acquired thrombocytopenia: 3B64.1Y\\nAcquired thrombocytopenia unspecified: 3B64.1Z\\nThrombocytopenia unspecified: 3B64.Z\\nThrombotic microangiopathy not elsewhere classified: 3B65\\nOther specified coagulation defects purpura or other haemorrhagic or related conditions: 3B6Y\\nCoagulation defects purpura or other haemorrhagic or related conditions unspecified: 3B6Z\\nCongenital disorders of spleen: 3B80\\nSplenomegaly in storage diseases: 3B80.0\\nAcquired disorders of spleen: 3B81\\nTumourlike conditions of spleen: 3B81.0\\nPostsurgical asplenia: 3B81.1\\nAtrophy of spleen: 3B81.2\\nNontraumatic laceration or rupture of spleen: 3B81.3\\nSplenosis: 3B81.4\\nSplenic cyst or pseudocyst: 3B81.5\\nPseudocyst of spleen: 3B81.50\\nEpithelial cyst of spleen: 3B81.51\\nOther specified splenic cyst: 3B81.5Y\\nSplenic cyst unspecified: 3B81.5Z\\nInfarction of spleen: 3B81.6\\nInfection of spleen: 3B81.7\\nAcute septic splenitis: 3B81.70\\nAbscess of spleen: 3B81.71\\nOther specified infection of spleen: 3B81.7Y\\nInfection of spleen unspecified: 3B81.7Z\\nTorsion of spleen: 3B81.8\\nFibrosis of spleen: 3B81.9\\nPerisplenitis: 3B81.A\\nHypersplenism: 3B81.B\\nChronic congestive splenomegaly: 3B81.C\\nOther specified acquired disorders of spleen: 3B81.Y\\nAcquired disorders of spleen unspecified: 3B81.Z\\nDiseases of spleen unspecified: 3B8Z\\nOther specified diseases of the blood or bloodforming organs: 3C0Y\\nDiseases of the blood or bloodforming organs unspecified: 3C0Z\\nPrimary immunodeficiencies due to disorders of innate immunity: 4A00\\nFunctional neutrophil defects: 4A00.0\\nNeutrophil immunodeficiency syndrome: 4A00.00\\nOther specified functional neutrophil defects: 4A00.0Y\\nFunctional neutrophil defects unspecified: 4A00.0Z\\nDefects in the complement system: 4A00.1\\nImmunodeficiency with an early component of complement deficiency: 4A00.10\\nImmunodeficiency with a late component of complement deficiency: 4A00.11\\nImmunodeficiency with factor B deficiency: 4A00.12\\nImmunodeficiency with factor D anomaly: 4A00.13\\nHereditary angioedema: 4A00.14\\nAcquired angioedema: 4A00.15\\nOther specified defects in the complement system: 4A00.1Y\\nDefects in the complement system unspecified: 4A00.1Z\\nGenetic susceptibility to particular pathogens: 4A00.2\\nImmunodeficiency with naturalkiller cell deficiency: 4A00.3\\nOther specified primary immunodeficiencies due to disorders of innate immunity: 4A00.Y\\nPrimary immunodeficiencies due to disorders of innate immunity unspecified: 4A00.Z\\nPrimary immunodeficiencies due to disorders of adaptive immunity: 4A01\\nImmunodeficiencies with predominantly antibody defects: 4A01.0\\nHereditary agammaglobulinaemia with profoundly reduced or absent B cells: 4A01.00\\nImmunodeficiencies with severe reduction in at least two serum immunoglobulin isotypes with normal or low numbers of B cells: 4A01.01\\nSpecific antibody deficiency with normal immunoglobulin concentrations or normal number of B cells: 4A01.02\\nTransient hypogammaglobulinaemia of infancy: 4A01.03\\nImmunodeficiencies with isotype or light chain deficiencies with normal number of B cells: 4A01.04\\nImmunodeficiencies with severe reduction in serum IgG or IgA with normal or elevated IgM and normal numbers of Bcells: 4A01.05\\nOther specified immunodeficiencies with predominantly antibody defects: 4A01.0Y\\nImmunodeficiencies with predominantly antibody defects unspecified: 4A01.0Z\\nCombined immunodeficiencies: 4A01.1\\nSevere combined immunodeficiencies: 4A01.10\\nMajor histocompatibility complex class I deficiency: 4A01.11\\nMajor histocompatibility complex class II deficiency: 4A01.12\\nOther specified combined immunodeficiencies: 4A01.1Y\\nCombined immunodeficiencies unspecified: 4A01.1Z\\nDiseases of immune dysregulation: 4A01.2\\nImmune dysregulation syndromes with hypopigmentation: 4A01.20\\nImmune dysregulation syndromes presenting primarily with autoimmunity: 4A01.21\\nImmune dysregulation syndromes presenting primarily with lymphoproliferation: 4A01.22\\nPrimary haemophagocytic lymphohistiocytosis: 4A01.23\\nOther specified diseases of immune dysregulation: 4A01.2Y\\nDiseases of immune dysregulation unspecified: 4A01.2Z\\nOther welldefined immunodeficiency syndromes due to defects in adaptive immunity: 4A01.3\\nImmunodeficiency due to defects of the thymus: 4A01.30\\nDNA repair defects other than combined Tcell or Bcell immunodeficiencies: 4A01.31\\nImmunoosseous dysplasia: 4A01.32\\nHepatic venoocclusive disease immunodeficiency syndrome: 4A01.33\\nHyperimmunoglobulin E syndromes: 4A01.34\\nPrimary immunodeficiencies due to disorders of adaptive immunity unspecified: 4A01.Z\\nOther specified primary immunodeficiencies: 4A0Y\\nPrimary immunodeficiencies unspecified: 4A0Z\\nAcquired immunodeficiencies: 4A20\\nAdultonset immunodeficiency: 4A20.0\\nAcquired immunodeficiency due to loss of immunoglobulin: 4A20.1\\nOther specified acquired immunodeficiencies: 4A20.Y\\nAcquired immunodeficiencies unspecified: 4A20.Z\\nLupus erythematosus: 4A40\\nSystemic lupus erythematosus: 4A40.0\\nSystemic lupus erythematosus with skin involvement: 4A40.00\\nOther specified systemic lupus erythematosus: 4A40.0Y\\nSystemic lupus erythematosus unspecified: 4A40.0Z\\nDruginduced lupus erythematosus: 4A40.1\\nOther specified lupus erythematosus: 4A40.Y\\nLupus erythematosus unspecified: 4A40.Z\\nIdiopathic inflammatory myopathy: 4A41\\nDermatomyositis: 4A41.0\\nAdult dermatomyositis: 4A41.00\\nJuvenile dermatomyositis: 4A41.01\\nDermatomyositis unspecified: 4A41.0Z\\nPolymyositis: 4A41.1\\nJuvenile polymyositis: 4A41.10\\nParaneoplastic polymyositis: 4A41.11\\nOther specified polymyositis: 4A41.1Y\\nPolymyositis unspecified: 4A41.1Z\\nInclusion body myopathy: 4A41.2\\nInflammatory inclusion body myositis: 4A41.20\\nNoninflammatory inclusion body myopathy: 4A41.21\\nInclusion body myopathy unspecified: 4A41.2Z\\nOther specified idiopathic inflammatory myopathy: 4A41.Y\\nIdiopathic inflammatory myopathy unspecified: 4A41.Z\\nSystemic sclerosis: 4A42\\nPaediatric onset systemic sclerosis: 4A42.0\\nDiffuse systemic sclerosis: 4A42.1\\nLimited systemic sclerosis: 4A42.2\\nSystemic sclerosis unspecified: 4A42.Z\\nOverlap or undifferentiated nonorgan specific systemic autoimmune disease: 4A43\\nIgG related disease: 4A43.0\\nMikulicz disease: 4A43.1\\nSjgren syndrome: 4A43.2\\nPrimary Sjgren syndrome: 4A43.20\\nSecondary Sjgren syndrome: 4A43.21\\nPaediatric onset Sjgren syndrome: 4A43.22\\nOther specified sjgren syndrome: 4A43.2Y\\nSjgren syndrome unspecified: 4A43.2Z\\nMixed connective tissue disease: 4A43.3\\nDiffuse eosinophilic fasciitis: 4A43.4\\nOther specified overlap nonorgan specific systemic autoimmune disease: 4A43.Y\\nUndifferentiated nonorgan specific systemic autoimmune disease: 4A43.Z\\nVasculitis: 4A44\\nRhizomelic pseudopolyarthritis: 4A44.0\\nAortic arch syndrome: 4A44.1\\nGiant cell arteritis: 4A44.2\\nSingle organ vasculitis: 4A44.3\\nPolyarteritis nodosa: 4A44.4\\nMucocutaneous lymph node syndrome: 4A44.5\\nSneddon syndrome: 4A44.6\\nPrimary angiitis of the central nervous system: 4A44.7\\nThromboangiitis obliterans: 4A44.8\\nImmune complex small vessel vasculitis: 4A44.9\\nCryoglobulinaemic vasculitis: 4A44.90\\nHypocomplementaemic urticarial vasculitis: 4A44.91\\nIgA vasculitis: 4A44.92\\nOther specified immune complex small vessel vasculitis: 4A44.9Y\\nImmune complex small vessel vasculitis unspecified: 4A44.9Z\\nAntineutrophil cytoplasmic antibodyassociated vasculitis: 4A44.A\\nMicroscopic polyangiitis: 4A44.A0\\nGranulomatosis with polyangiitis: 4A44.A1\\nEosinophilic granulomatosis with polyangiitis: 4A44.A2\\nOther specified antineutrophil cytoplasmic antibodyassociated vasculitis: 4A44.AY\\nAntineutrophil cytoplasmic antibodyassociated vasculitis unspecified: 4A44.AZ\\nLeukocytoclastic vasculitis: 4A44.B\\nCutaneous leukocytoclastic vasculitis: 4A44.B0\\nOther specified leukocytoclastic vasculitis: 4A44.BY\\nLeukocytoclastic vasculitis unspecified: 4A44.BZ\\nOther specified vasculitis: 4A44.Y\\nVasculitis unspecified: 4A44.Z\\nAntiphospholipid syndrome: 4A45\\nPrimary antiphospholipid syndrome: 4A45.0\\nSecondary antiphospholipid syndrome: 4A45.1\\nAntiphospholipid syndrome in pregnancy: 4A45.2\\nLupus anticoagulanthypoprothrombinaemia syndrome: 4A45.3\\nAntiphospholipid syndrome unspecified: 4A45.Z\\nOther specified nonorgan specific systemic autoimmune disorders: 4A4Y\\nNonorgan specific systemic autoimmune disorders unspecified: 4A4Z\\nMonogenic autoinflammatory syndromes: 4A60\\nFamilial Mediterranean fever: 4A60.0\\nCryopyrinassociated periodic syndromes: 4A60.1\\nTumour necrosis factor receptor  associated periodic syndrome: 4A60.2\\nOther specified monogenic autoinflammatory syndromes: 4A60.Y\\nAutoimflammatory syndrome unspecified: 4A60.Z\\nSAPHO syndrome: 4A61\\nBehet disease: 4A62\\nOther specified autoinflammatory disorders: 4A6Y\\nAutoinflammatory disorders unspecified: 4A6Z\\nAllergic or hypersensitivity disorders involving the respiratory tract: 4A80\\nDruginduced bronchospasm: 4A80.0\\nBronchospasm provoked by allergy to food substance: 4A80.1\\nOther specified allergic or hypersensitivity disorders involving the respiratory tract: 4A80.Y\\nAllergic or hypersensitivity disorders involving the respiratory tract unspecified: 4A80.Z\\nAllergic or hypersensitivity disorders involving the eye: 4A81\\nAllergic or hypersensitivity disorders involving skin or mucous membranes: 4A82\\nAllergic or hypersensitivity disorders involving the gastrointestinal tract: 4A83\\nFoodinduced eosinophilic gastroenteritis: 4A83.0\\nFoodinduced eosinophilic oesophagitis: 4A83.1\\nOther specified allergic or hypersensitivity disorders involving the gastrointestinal tract: 4A83.Y\\nAllergic or hypersensitivity disorders involving the gastrointestinal tract unspecified: 4A83.Z\\nAnaphylaxis: 4A84\\nAnaphylaxis due to allergic reaction to food: 4A84.0\\nDruginduced anaphylaxis: 4A84.1\\nAnaphylaxis due to insect venom: 4A84.2\\nAnaphylaxis provoked by physical factors: 4A84.3\\nExerciseinduced anaphylaxis: 4A84.30\\nColdinduced anaphylaxis: 4A84.31\\nAnaphylaxis provoked by other specified physical factors: 4A84.3Y\\nAnaphylaxis provoked by unspecified physical factors: 4A84.3Z\\nAnaphylaxis due to inhaled allergens: 4A84.4\\nAnaphylaxis due to contact with allergens: 4A84.5\\nAnaphylaxis secondary to mast cell disorder: 4A84.6\\nOther specified anaphylaxis: 4A84.Y\\nAnaphylaxis unspecified: 4A84.Z\\nComplex allergic or hypersensitivity conditions: 4A85\\nDrug or pharmacological agents hypersensitivity: 4A85.0\\nDruginduced liver hypersensitivity disease: 4A85.00\\nDruginduced kidney hypersensitivity: 4A85.01\\nDruginduced cytopenia: 4A85.02\\nDruginduced vasculitis: 4A85.03\\nMultiple drug hypersensitivity syndrome: 4A85.04\\nDrug hypersensitivity of other specified type: 4A85.0Y\\nDrug hypersensitivity of unspecified type: 4A85.0Z\\nHypersensitivity to herbal or alternative medical therapies: 4A85.1\\nFood hypersensitivity: 4A85.2\\nFoodinduced gastrointestinal hypersensitivity: 4A85.20\\nFoodinduced urticaria or angioedema: 4A85.21\\nAllergic contact dermatitis due to food allergen: 4A85.22\\nOther specified food hypersensitivity: 4A85.2Y\\nFood hypersensitivity unspecified: 4A85.2Z\\nAllergic or hypersensitivity reactions to arthropods: 4A85.3\\nSystemic allergic reaction due to Hymenoptera venom: 4A85.30\\nCutaneous allergic or hypersensitivity reactions to Hymenoptera venom: 4A85.31\\nCutaneous allergic or hypersensitivity reactions to arthropods: 4A85.32\\nOther specified complex allergic or hypersensitivity conditions: 4A85.Y\\nComplex allergic or hypersensitivity conditions unspecified: 4A85.Z\\nAllergic or hypersensitivity conditions of other specified type: 4A8Y\\nAllergic or hypersensitivity conditions of unspecified type: 4A8Z\\nDisorders of neutrophil number: 4B00\\nNeutropenia: 4B00.0\\nConstitutional neutropaenia: 4B00.00\\nAcquired neutropaenia: 4B00.01\\nNeutropaenia unspecified: 4B00.0Z\\nNeutrophilia: 4B00.1\\nConstitutional neutrophilia: 4B00.10\\nAcquired neutrophilia: 4B00.11\\nNeutrophilia unspecified: 4B00.1Z\\nOther specified disorders of neutrophil number: 4B00.Y\\nDisorders of neutrophil function: 4B01\\nConstitutional disorders of neutrophil function: 4B01.0\\nDisorders of neutrophil adhesion: 4B01.00\\nDisorders of neutrophil chemotaxis: 4B01.01\\nDisorders of neutrophil granule formation or release: 4B01.02\\nDisorders of neutrophil oxidative metabolism: 4B01.03\\nOther specified constitutional disorders of neutrophil function: 4B01.0Y\\nConstitutional disorders of neutrophil function unspecified: 4B01.0Z\\nAcquired disorders of neutrophil function: 4B01.1\\nDisorders of neutrophil function unspecified: 4B01.Z\\nEosinopenia: 4B02\\nConstitutional decrease in eosinophil number: 4B02.0\\nAcquired decrease in eosinophil number: 4B02.1\\nEosinopenia unspecified: 4B02.Z\\nEosinophilia: 4B03\\nConstitutional eosinophilia: 4B03.0\\nAcquired eosinophilia: 4B03.1\\nEosinophilia unspecified: 4B03.Z\\nDisorders with decreased monocyte counts: 4B04\\nDisorders with increased monocyte counts: 4B05\\nAcquired lymphopenia: 4B06\\nAcquired lymphocytosis: 4B07\\nOther specified immune system disorders involving white cell lineages: 4B0Y\\nImmune system disorders involving white cell lineages unspecified: 4B0Z\\nSarcoidosis: 4B20\\nSarcoidosis of lung: 4B20.0\\nSarcoidosis of lymph nodes: 4B20.1\\nSarcoidosis of the digestive system: 4B20.2\\nNeurosarcoidosis: 4B20.3\\nOcular sarcoidosis: 4B20.4\\nCutaneous sarcoidosis: 4B20.5\\nOther specified sarcoidosis: 4B20.Y\\nSarcoidosis unspecified: 4B20.Z\\nPolyclonal hypergammaglobulinaemia: 4B21\\nCryoglobulinaemia: 4B22\\nImmune reconstitution inflammatory syndrome: 4B23\\nGraftversushost disease: 4B24\\nAcute graftversushost disease: 4B24.0\\nChronic graftversushost disease: 4B24.1\\nOther specified graftversushost disease: 4B24.Y\\nGraftversushost disease unspecified: 4B24.Z\\nOther specified disorders involving the immune system: 4B2Y\\nDiseases of thymus: 4B40\\nPersistent hyperplasia of thymus: 4B40.0\\nAbscess of thymus: 4B40.1\\nGood syndrome: 4B40.2\\nOther specified diseases of thymus: 4B40.Y\\nDiseases of thymus unspecified: 4B40.Z\\nOther specified diseases of the immune system: 4B4Y\\nDiseases of the immune system unspecified: 4B4Z\\nHypothyroidism: 5A00\\nCongenital hypothyroidism: 5A00.0\\nPermanent congenital hypothyroidism with diffuse goitre: 5A00.00\\nPermanent congenital hypothyroidism without goitre: 5A00.01\\nPendred syndrome: 5A00.02\\nTransient congenital hypothyroidism: 5A00.03\\nCongenital hypothyroidism due to iodine deficiency: 5A00.04\\nOther specified congenital hypothyroidism: 5A00.0Y\\nCongenital hypothyroidism unspecified: 5A00.0Z\\nIodinedeficiencyrelated thyroid disorders or allied conditions: 5A00.1\\nIodinedeficiencyrelated diffuse goitre: 5A00.10\\nIodinedeficiencyrelated multinodular goitre: 5A00.11\\nIodinedeficiencyrelated thyroid disorders or allied conditions unspecified: 5A00.1Z\\nAcquired hypothyroidism: 5A00.2\\nHypothyroidism due to medicaments or other exogenous substances: 5A00.20\\nMyxoedema coma: 5A00.21\\nSubclinical iodinedeficiency hypothyroidism: 5A00.22\\nOther specified acquired hypothyroidism: 5A00.2Y\\nAcquired hypothyroidism unspecified: 5A00.2Z\\nHypothyroidism unspecified: 5A00.Z\\nNontoxic goitre: 5A01\\nNontoxic diffuse goitre: 5A01.0\\nNontoxic single thyroid nodule: 5A01.1\\nNontoxic multinodular goitre: 5A01.2\\nNontoxic goitre unspecified: 5A01.Z\\nThyrotoxicosis: 5A02\\nThyrotoxicosis with diffuse goitre: 5A02.0\\nThyrotoxicosis with toxic single thyroid nodule: 5A02.1\\nThyrotoxicosis with toxic multinodular goitre: 5A02.2\\nThyrotoxicosis from ectopic thyroid tissue: 5A02.3\\nThyrotoxicosis factitia: 5A02.4\\nThyroid crisis: 5A02.5\\nSecondary hyperthyroidism: 5A02.6\\nOther specified thyrotoxicosis: 5A02.Y\\nThyrotoxicosis unspecified: 5A02.Z\\nThyroiditis: 5A03\\nAcute thyroiditis: 5A03.0\\nSubacute thyroiditis: 5A03.1\\nAutoimmune thyroiditis: 5A03.2\\nHashimoto thyroiditis: 5A03.20\\nPainless thyroiditis: 5A03.21\\nOther specified autoimmune thyroiditis: 5A03.2Y\\nAutoimmune thyroiditis unspecified: 5A03.2Z\\nOther specified thyroiditis: 5A03.Y\\nThyroiditis unspecified: 5A03.Z\\nHypersecretion of calcitonin: 5A04\\nGeneralised resistance to thyroid hormone: 5A05\\nSickeuthyroid syndrome: 5A06\\nOther specified disorders of the thyroid gland or thyroid hormones system: 5A0Y\\nDisorders of the thyroid gland or thyroid hormones system unspecified: 5A0Z\\nType  diabetes mellitus: 5A11\\nMalnutritionrelated diabetes mellitus: 5A12\\nDiabetes mellitus other specified type: 5A13\\nDiabetes mellitus due to genetic defects of beta cell function: 5A13.0\\nDiabetes mellitus due to genetic defects in insulin action: 5A13.1\\nDiabetes mellitus due to diseases of the exocrine pancreas: 5A13.2\\nDiabetes mellitus due to endocrinopathies: 5A13.3\\nDiabetes mellitus due to drug or chemical: 5A13.4\\nDiabetes mellitus due to uncommon forms of immunemediated diabetes: 5A13.5\\nDiabetes mellitus due to other genetic syndromes: 5A13.6\\nDiabetes mellitus due to clinically defined subtypes or syndromes: 5A13.7\\nDiabetes mellitus due to other specified cause: 5A13.Y\\nDiabetes mellitus type unspecified: 5A14\\nDiabetic hyperosmolar hyperglycaemic state: 5A20\\nHyperosmolar hyperglycaemic state without coma: 5A20.0\\nHyperosmolar hyperglycaemic state with coma: 5A20.1\\nDiabetic hyperosmolar hyperglycaemic state unspecified: 5A20.Z\\nHypoglycaemia in the context of diabetes mellitus: 5A21\\nHypoglycaemia in the context of diabetes mellitus without coma: 5A21.0\\nHypoglycaemia in the context of diabetes mellitus with coma: 5A21.1\\nHypoglycaemia in the context of diabetes unspecified: 5A21.Z\\nDiabetic acidosis: 5A22\\nDiabetic ketoacidosis without coma: 5A22.0\\nDiabetic lactic acidosis: 5A22.1\\nDiabetic metabolic acidosis: 5A22.2\\nDiabetic ketoacidosis with coma: 5A22.3\\nOther specified diabetic acidosis: 5A22.Y\\nDiabetic acidosis unspecified: 5A22.Z\\nDiabetic coma: 5A23\\nUncontrolled or unstable diabetes mellitus: 5A24\\nOther specified acute complications of diabetes mellitus: 5A2Y\\nIntermediate hyperglycaemia: 5A40\\nImpaired fasting glucose: 5A40.0\\nImpaired glucose tolerance: 5A40.1\\nOther specified intermediate hyperglycaemia: 5A40.Y\\nIntermediate hyperglycaemia unspecified: 5A40.Z\\nHypoglycaemia without associated diabetes: 5A41\\nIncreased secretion of glucagon: 5A42\\nAbnormal secretion of gastrin: 5A43\\nDruginduced hypergastrinaemia: 5A43.0\\nZollingerEllison syndrome: 5A43.1\\nOther specified abnormal secretion of gastrin: 5A43.Y\\nAbnormal secretion of gastrin unspecified: 5A43.Z\\nInsulinresistance syndromes: 5A44\\nPersistent hyperinsulinaemic hypoglycaemia of infancy: 5A45\\nOther specified disorders of glucose regulation or pancreatic internal secretion: 5A4Y\\nDisorders of glucose regulation or pancreatic internal secretion unspecified: 5A4Z\\nHypoparathyroidism: 5A50\\nHypoparathyroidism due to impaired parathyroid hormone secretion: 5A50.0\\nIdiopathic hypoparathyroidism: 5A50.00\\nSecondary hypoparathyroidism: 5A50.01\\nHypoparathyroidism due to destruction of the parathyroid glands: 5A50.02\\nAutoimmune hypoparathyroidism: 5A50.03\\nOther specified hypoparathyroidism due to impaired parathyroid hormone secretion: 5A50.0Y\\nHypoparathyroidism due to impaired parathyroid hormone secretion unspecified: 5A50.0Z\\nPseudohypoparathyroidism: 5A50.1\\nOther specified hypoparathyroidism: 5A50.Y\\nHypoparathyroidism unspecified: 5A50.Z\\nHyperparathyroidism: 5A51\\nPrimary hyperparathyroidism: 5A51.0\\nSecondary hyperparathyroidism: 5A51.1\\nFamilial hypocalciuric hypercalcaemia: 5A51.2\\nOther specified hyperparathyroidism: 5A51.Y\\nHyperparathyroidism unspecified: 5A51.Z\\nOther specified disorders of the parathyroids or parathyroid hormone system: 5A5Y\\nDisorders of the parathyroids or parathyroid hormone system unspecified: 5A5Z\\nHyperfunction of pituitary gland: 5A60\\nAcromegaly or pituitary gigantism: 5A60.0\\nHyperprolactinaemia: 5A60.1\\nSyndrome of inappropriate secretion of antidiuretic hormone: 5A60.2\\nNephrogenic syndrome of inappropriate antidiuresis: 5A60.20\\nOther specified syndrome of inappropriate secretion of antidiuretic hormone: 5A60.2Y\\nSyndrome of inappropriate secretion of antidiuretic hormone unspecified: 5A60.2Z\\nCentral precocious puberty: 5A60.3\\nOther specified hyperfunction of pituitary gland: 5A60.Y\\nHyperfunction of pituitary gland unspecified: 5A60.Z\\nHypofunction or certain other specified disorders of pituitary gland: 5A61\\nHypopituitarism: 5A61.0\\nAdrenocorticotropic hormone deficiency: 5A61.1\\nGonadotropin deficiency: 5A61.2\\nGrowth hormone deficiency: 5A61.3\\nThyroid stimulating hormone deficiency: 5A61.4\\nAcquired central hypothyroidism: 5A61.40\\nCongenital central hypothyroidism: 5A61.41\\nOther specified thyroid stimulating hormone deficiency: 5A61.4Y\\nThyroid stimulating hormone deficiency unspecified: 5A61.4Z\\nCentral diabetes insipidus: 5A61.5\\nOxytocin deficiency: 5A61.6\\nOther specified hypofunction or disorders of pituitary gland: 5A61.Y\\nDisorders of the pituitary hormone system unspecified: 5A6Z\\nCushing syndrome: 5A70\\nPituitarydependent Cushing disease: 5A70.0\\nEctopic ACTH syndrome: 5A70.1\\nPseudoCushing syndrome: 5A70.2\\nNelson syndrome: 5A70.3\\nOther specified Cushing syndrome: 5A70.Y\\nCushing syndrome unspecified: 5A70.Z\\nAdrenogenital disorders: 5A71\\nXX disorders of sex development induced by androgens of fetal origin: 5A71.0\\nGlucocorticoid resistance: 5A71.00\\nCongenital adrenal hyperplasia: 5A71.01\\nOther specified XX disorders of sex development induced by androgens of fetal origin: 5A71.0Y\\nXX disorders of sex development induced by androgens of fetal origin unspecified: 5A71.0Z\\nXX disorders of sex development induced by androgens of maternal origin: 5A71.1\\nOther specified adrenogenital disorders: 5A71.Y\\nAdrenogenital disorders unspecified: 5A71.Z\\nHyperaldosteronism: 5A72\\nPrimary hyperaldosteronism: 5A72.0\\nSecondary hyperaldosteronism: 5A72.1\\nHyperaldosteronism unspecified: 5A72.Z\\nHypoaldosteronism: 5A73\\nAdrenocortical insufficiency: 5A74\\nAcquired adrenocortical insufficiency: 5A74.0\\nAdrenal crisis: 5A74.1\\nOther specified adrenocortical insufficiency: 5A74.Y\\nAdrenocortical insufficiency unspecified: 5A74.Z\\nAdrenomedullary hyperfunction: 5A75\\nCertain specified disorders of adrenal gland: 5A76\\nPremature adrenarche: 5A76.0\\nOther specified disorders of adrenal gland: 5A76.Y\\nDisorders of the adrenal glands or adrenal hormone system unspecified: 5A7Z\\nOvarian dysfunction: 5A80\\nClinical hyperandrogenism: 5A80.0\\nPolycystic ovary syndrome: 5A80.1\\nPolycystic ovary: 5A80.2\\nAnovulation: 5A80.3\\nOligoovulation: 5A80.4\\nDiminished ovarian reserve: 5A80.5\\nOther specified ovarian dysfunction: 5A80.Y\\nOvarian dysfunction unspecified: 5A80.Z\\nTesticular dysfunction or testosteronerelated disorders: 5A81\\nTesticular hyperfunction: 5A81.0\\nTesticular hypofunction: 5A81.1\\nOther specified testicular dysfunction or testosteronerelated disorders: 5A81.Y\\nTesticular dysfunction or testosteronerelated disorders unspecified: 5A81.Z\\nDisorders of the gonadal hormone system unspecified: 5A8Z\\nDisorder of puberty due to oestrogen resistance: 5A90\\nDelayed puberty: 5A91\\nPeripheral precocious puberty: 5A92\\nOther disorders of puberty: 5A9Y\\nDisorders of puberty unspecified: 5A9Z\\nAutoimmune polyendocrinopathy: 5B00\\nPolyglandular hyperfunction: 5B01\\nOther specified polyglandular dysfunction: 5B0Y\\nPolyglandular dysfunction unspecified: 5B0Z\\nCarcinoid syndrome: 5B10\\nShort stature not elsewhere classified: 5B11\\nConstitutional tall stature: 5B12\\nOther specified endocrine diseases: 5B3Y\\nEndocrine diseases unspecified: 5B3Z\\nUnderweight in infants children or adolescents: 5B50\\nWasting in infants children or adolescents: 5B51\\nAcute malnutrition in infants children or adolescents: 5B52\\nStunting in infants children or adolescents: 5B53\\nUnderweight in adults: 5B54\\nVitamin A deficiency: 5B55\\nVitamin A deficiency with night blindness: 5B55.0\\nVitamin A deficiency with conjunctival xerosis: 5B55.1\\nVitamin A deficiency with conjunctival xerosis and Bitots spots: 5B55.2\\nVitamin A deficiency with corneal xerosis: 5B55.3\\nVitamin A deficiency with corneal ulceration or keratomalacia: 5B55.4\\nVitamin A deficiency with xerophthalmic scars of cornea or blindness: 5B55.5\\nVitamin A deficiency with other specified manifestations: 5B55.Y\\nVitamin A deficiency unspecified: 5B55.Z\\nVitamin C deficiency: 5B56\\nScurvy: 5B56.0\\nOther specified vitamin C deficiency: 5B56.Y\\nVitamin C deficiency unspecified: 5B56.Z\\nVitamin D deficiency: 5B57\\nVitamin D deficiency rickets: 5B57.0\\nVitamin D deficiency osteomalacia: 5B57.1\\nOther specified vitamin D deficiency: 5B57.Y\\nVitamin D deficiency unspecified: 5B57.Z\\nVitamin E deficiency: 5B58\\nVitamin K deficiency: 5B59\\nVitamin B deficiency: 5B5F\\nBeriberi: 5B5A.0\\nDry beriberi: 5B5A.00\\nWet beriberi: 5B5A.01\\nBeriberi unspecified: 5B5A.0Z\\nWernickeKorsakoff Syndrome: 5B5A.1\\nWernicke encephalopathy: 5B5A.10\\nKorsakoff syndrome: 5B5A.11\\nOther specified WernickeKorsakoff Syndrome: 5B5A.1Y\\nWernickeKorsakoff Syndrome unspecified: 5B5A.1Z\\nOther specified vitamin B deficiency: 5B5C.Y\\nVitamin B deficiency unspecified: 5B5C.Z\\nPellagra: 5B5C.0\\nFolate deficiency: 5B5E\\nBiotin deficiency: 5B5G\\nPantothenic acid deficiency: 5B5H\\nCholine deficiency: 5B5J\\nMineral deficiencies: 5B5K\\nIron deficiency: 5B5K.0\\nCalcium deficiency: 5B5K.1\\nTetany due to acute calcium deficiency: 5B5K.10\\nOther specified calcium deficiency: 5B5K.1Y\\nCalcium deficiency unspecified: 5B5K.1Z\\nZinc deficiency: 5B5K.2\\nIodine deficiency: 5B5K.3\\nFluorine deficiency: 5B5K.4\\nSodium chloride deficiency: 5B5K.5\\nCopper deficiency: 5B5K.6\\nSelenium deficiency: 5B5K.7\\nChromium deficiency: 5B5K.8\\nManganese deficiency: 5B5K.9\\nMolybdenum deficiency: 5B5K.A\\nVanadium deficiency: 5B5K.B\\nOther specified mineral deficiency: 5B5K.Y\\nMineral deficiency unspecified: 5B5K.Z\\nSequelae of proteinenergy malnutrition: 5B60\\nSequelae of vitamin A deficiency: 5B61\\nSequelae of vitamin C deficiency: 5B62\\nSequelae of rickets: 5B63\\nOther specified sequelae of malnutrition or certain specified nutritional deficiencies: 5B6Y\\nSequelae of malnutrition or certain specified nutritional deficiencies unspecified: 5B6Z\\nEssential fatty acid deficiency: 5B70\\nProtein deficiency: 5B71\\nOther specified undernutrition: 5B7Y\\nUnspecified undernutrition: 5B7Z\\nOverweight or localised adiposity: 5B80\\nOverweight: 5B80.0\\nOverweight in infants children or adolescents: 5B80.00\\nOverweight in adults: 5B80.01\\nOverweight unspecified: 5B80.0Z\\nLocalised adiposity: 5B80.1\\nObesity: 5B81\\nObesity due to energy imbalance: 5B81.0\\nObesity in children or adolescents: 5B81.00\\nObesity in adults: 5B81.01\\nDruginduced obesity: 5B81.1\\nOther specified obesity: 5B81.Y\\nObesity unspecified: 5B81.Z\\nVitamin excesses: 5B90\\nHypervitaminosis A: 5B90.0\\nHypercarotenaemia: 5B90.1\\nHypervitaminosis D: 5B90.2\\nMegavitaminB syndrome: 5B90.3\\nOther specified vitamin excess: 5B90.Y\\nUnspecified vitamin excesses: 5B90.Z\\nMineral excesses: 5B91\\nHypercalcaemia: 5B91.0\\nZinc excess: 5B91.1\\nSodium chloride excess: 5B91.2\\nFluorine excess: 5B91.3\\nAluminium excess: 5B91.4\\nManganese excess: 5B91.5\\nOther specified mineral excess: 5B91.Y\\nUnspecified mineral excess: 5B91.Z\\nOther specified nutrient excesses: 5B9Y\\nNutrient excesses unspecified: 5B9Z\\nOther specified overweight obesity or specific nutrient excesses: 5C1Y\\nOverweight obesity or specific nutrient excesses unspecified: 5C1Z\\nOther specified nutritional disorders: 5C3Y\\nNutritional disorders unspecified: 5C3Z\\nInborn errors of amino acid or other organic acid metabolism: 5C50\\nPhenylketonuria: 5C50.0\\nClassical phenylketonuria: 5C50.00\\nNonclassical phenylketonuria: 5C50.01\\nEmbryofetopathy due to maternal phenylketonuria: 5C50.02\\nOther specified phenylketonuria: 5C50.0Y\\nPhenylketonuria unspecified: 5C50.0Z\\nDisorders of tyrosine metabolism: 5C50.1\\nAlkaptonuria: 5C50.10\\nTyrosinaemia type: 5C50.12\\nOther specified disorders of tyrosine metabolism: 5C50.1Y\\nDisorders of tyrosine metabolism unspecified: 5C50.1Z\\nDisorders of histidine metabolism: 5C50.2\\nHistidinaemia: 5C50.20\\nUrocanic aciduria: 5C50.21\\nOther specified disorders of histidine metabolism: 5C50.2Y\\nDisorders of histidine metabolism unspecified: 5C50.2Z\\nDisorders of tryptophan metabolism: 5C50.3\\nDisorders of lysine or hydroxylysine metabolism: 5C50.4\\nDisorders of the gammaglutamyl cycle: 5C50.5\\nDisorders of serine metabolism: 5C50.6\\nDisorders of glycine metabolism: 5C50.7\\nGlycine encephalopathy: 5C50.70\\nSarcosinaemia: 5C50.71\\nOther specified disorders of glycine metabolism: 5C50.7Y\\nDisorders of glycine metabolism unspecified: 5C50.7Z\\nDisorders of proline or hydroxyproline metabolism: 5C50.8\\nDisorders of ornithine metabolism: 5C50.9\\nDisorders of urea cycle metabolism: 5C50.A\\nArgininosuccinic aciduria: 5C50.A0\\nCarbamoylphosphate synthetase deficiency: 5C50.A1\\nArgininaemia: 5C50.A2\\nCitrullinaemia: 5C50.A3\\nOther specified disorders of urea cycle metabolism: 5C50.AY\\nDisorders of urea cycle metabolism unspecified: 5C50.AZ\\nDisorders of methionine cycle or sulphur amino acid metabolism: 5C50.B\\nDisorders of beta or omega amino acid metabolism: 5C50.C\\nDisorders of branchedchain amino acid metabolism: 5C50.D\\nMaplesyrupurine disease: 5C50.D0\\nOther specified disorders of branchedchain amino acid metabolism: 5C50.DY\\nDisorders of branchedchain amino acid metabolism unspecified: 5C50.DZ\\nOrganic aciduria: 5C50.E\\nClassical organic aciduria: 5C50.E0\\nCerebral organic aciduria: 5C50.E1\\nOther specified organic aciduria: 5C50.EY\\nOrganic aciduria unspecified: 5C50.EZ\\nDisorders of peptide metabolism: 5C50.F\\nProlidase deficiency: 5C50.F0\\nCarnosinaemia: 5C50.F1\\nHomocarnosinosis: 5C50.F2\\nOther specified disorders of peptide metabolism: 5C50.FY\\nDisorders of peptide metabolism unspecified: 5C50.FZ\\nTrimethylaminuria: 5C50.G\\nOther specified inborn errors of amino acid or other organic acid metabolism: 5C50.Y\\nInborn errors of amino acid or other organic acid metabolism unspecified: 5C50.Z\\nInborn errors of carbohydrate metabolism: 5C51\\nDisorders of the pentose phosphate pathway: 5C51.0\\nDisorders of glycerol metabolism: 5C51.1\\nDisorders of glyoxylate metabolism: 5C51.2\\nPrimary hyperoxaluria type: 5C51.20\\nOther specified disorders of glyoxylate metabolism: 5C51.2Y\\nDisorders of glyoxylate metabolism unspecified: 5C51.2Z\\nGlycogen storage disease: 5C51.3\\nDisorders of galactose metabolism: 5C51.4\\nGalactosephosphate uridyltransferase deficiency: 5C51.40\\nGalactokinase deficiency: 5C51.41\\nGlucose or galactose intolerance of newborn: 5C51.42\\nOther specified disorders of galactose metabolism: 5C51.4Y\\nDisorders of galactose metabolism unspecified: 5C51.4Z\\nDisorders of fructose metabolism: 5C51.5\\nHereditary fructose intolerance: 5C51.50\\nOther specified disorders of fructose metabolism: 5C51.5Y\\nDisorders of fructose metabolism unspecified: 5C51.5Z\\nOther specified inborn errors of carbohydrate metabolism: 5C51.Y\\nInborn errors of carbohydrate metabolism unspecified: 5C51.Z\\nInborn errors of lipid metabolism: 5C52\\nInborn errors of fatty acid oxidation or ketone body metabolism: 5C52.0\\nDisorders of carnitine transport or the carnitine cycle: 5C52.00\\nDisorders of mitochondrial fatty acid oxidation: 5C52.01\\nDisorders of ketone body metabolism: 5C52.02\\nSjgrenLarsson syndrome: 5C52.03\\nOther specified inborn errors of fatty acid oxidation or ketone body metabolism: 5C52.0Y\\nInborn errors of fatty acid oxidation or ketone body metabolism unspecified: 5C52.0Z\\nInborn errors of sterol metabolism: 5C52.1\\nDisorders of cholesterol synthesis: 5C52.10\\nBile acid synthesis defect with cholestasis: 5C52.11\\nOther specified inborn errors of sterol metabolism: 5C52.1Y\\nInborn errors of sterol metabolism unspecified: 5C52.1Z\\nNeutral lipid storage disease: 5C52.2\\nOther specified inborn errors of lipid metabolism: 5C52.Y\\nInborn errors of lipid metabolism unspecified: 5C52.Z\\nInborn errors of energy metabolism: 5C53\\nDisorders of pyruvate metabolism: 5C53.0\\nPyruvate kinase deficiency: 5C53.00\\nLactate dehydrogenase deficiency: 5C53.01\\nPyruvate dehydrogenase complex deficiency: 5C53.02\\nPyruvate carboxylase deficiency: 5C53.03\\nOther specified disorders of pyruvate metabolism: 5C53.0Y\\nDisorders of pyruvate metabolism unspecified: 5C53.0Z\\nDisorders of the citric acid cycle: 5C53.1\\nDisorders of mitochondrial oxidative phosphorylation: 5C53.2\\nMitochondrial DNA depletion syndromes: 5C53.20\\nMultiple mitochondrial DNA deletion syndromes: 5C53.21\\nCoenzyme Q deficiency: 5C53.22\\nMitochondrial protein translation defects: 5C53.23\\nLeigh syndrome: 5C53.24\\nIsolated ATP synthase deficiency: 5C53.25\\nOther specified disorders of mitochondrial oxidative phosphorylation: 5C53.2Y\\nDisorders of mitochondrial oxidative phosphorylation unspecified: 5C53.2Z\\nDisorders of mitochondrial membrane transport: 5C53.3\\nMitochondrial substrate carrier disorders: 5C53.30\\nMitochondrial protein import disorders: 5C53.31\\nOther specified disorders of mitochondrial membrane transport: 5C53.3Y\\nDisorders of mitochondrial membrane transport unspecified: 5C53.3Z\\nDisorders of creatine metabolism: 5C53.4\\nOther specified inborn errors of energy metabolism: 5C53.Y\\nInborn errors of energy metabolism unspecified: 5C53.Z\\nInborn errors of glycosylation or other specified protein modification: 5C54\\nDisorders of protein Nglycosylation: 5C54.0\\nDisorders of protein Oglycosylation: 5C54.1\\nDisorders of multiple glycosylation or other pathways: 5C54.2\\nOther specified congenital disorders of glycosylation and protein modification: 5C54.Y\\nCongenital disorders of glycosylation and protein modification unspecified: 5C54.Z\\nInborn errors of purine pyrimidine or nucleotide metabolism: 5C55\\nDisorders of purine metabolism: 5C55.0\\nXanthinuria: 5C55.00\\nLeschNyhan syndrome: 5C55.01\\nOther specified disorders of purine metabolism: 5C55.0Y\\nDisorders of purine metabolism unspecified: 5C55.0Z\\nDisorders of pyrimidine metabolism: 5C55.1\\nDisorders of nucleotide metabolism: 5C55.2\\nOther specified inborn errors of purine pyrimidine or nucleotide metabolism: 5C55.Y\\nInborn errors of purine pyrimidine or nucleotide metabolism unspecified: 5C55.Z\\nLysosomal diseases: 5C56\\nSphingolipidosis: 5C56.0\\nGangliosidosis: 5C56.00\\nFabry disease: 5C56.01\\nMetachromatic leukodystrophy: 5C56.02\\nOther specified sphingolipidosis: 5C56.0Y\\nSphingolipidosis unspecified: 5C56.0Z\\nNeuronal ceroid lipofuscinosis: 5C56.1\\nGlycoproteinosis: 5C56.2\\nMucolipidosis: 5C56.20\\nOligosaccharidosis: 5C56.21\\nOther specified glycoproteinosis: 5C56.2Y\\nGlycoproteinosis unspecified: 5C56.2Z\\nMucopolysaccharidosis: 5C56.3\\nMucopolysaccharidosis type: 5C56.33\\nOther specified mucopolysaccharidosis: 5C56.3Y\\nMucopolysaccharidosis unspecified: 5C56.3Z\\nDisorders of sialic acid metabolism: 5C56.4\\nOther specified lysosomal diseases: 5C56.Y\\nLysosomal diseases unspecified: 5C56.Z\\nPeroxisomal diseases: 5C57\\nDisorders of peroxisome biogenesis: 5C57.0\\nDisorders of peroxisomal alpha betaor omegaoxidation: 5C57.1\\nOther specified peroxisomal diseases: 5C57.Y\\nPeroxisomal diseases unspecified: 5C57.Z\\nInborn errors of porphyrin or heme metabolism: 5C58\\nDisorders of bilirubin metabolism or excretion: 5C58.0\\nCriglerNajjar syndrome: 5C58.00\\nGilbert syndrome: 5C58.01\\nDubinJohnson syndrome: 5C58.02\\nProgressive familial intrahepatic cholestasis: 5C58.03\\nBenign recurrent intrahepatic cholestasis: 5C58.04\\nOther specified disorders of bilirubin metabolism or excretion: 5C58.0Y\\nDisorders of bilirubin metabolism or excretion unspecified: 5C58.0Z\\nPorphyrias: 5C58.1\\nPorphyria cutanea tarda: 5C58.10\\nErythropoietic porphyrias: 5C58.12\\nVariegate porphyria: 5C58.13\\nOther specified porphyrias: 5C58.1Y\\nPorphyrias unspecified: 5C58.1Z\\nOther specified inborn errors of porphyrin or heme metabolism: 5C58.Y\\nInborn errors of porphyrin or heme metabolism unspecified: 5C58.Z\\nInborn errors of neurotransmitter metabolism: 5C59\\nDisorders of biogenic amine metabolism: 5C59.0\\nDisorders of catecholamine synthesis: 5C59.00\\nDisorders of pterin metabolism: 5C59.01\\nOther specified disorders of biogenic amine metabolism: 5C59.0Y\\nDisorders of biogenic amine metabolism unspecified: 5C59.0Z\\nDisorders of gamma aminobutyric acid metabolism: 5C59.1\\nDisorders of pyridoxine metabolism: 5C59.2\\nOther specified inborn errors of neurotransmitter metabolism: 5C59.Y\\nInborn errors of neurotransmitter metabolism unspecified: 5C59.Z\\nAlphaantitrypsin deficiency: 5C5A\\nOther specified inborn errors of metabolism: 5C5Y\\nInborn errors of metabolism unspecified: 5C5Z\\nDisorders of amino acid absorption or transport: 5C60\\nOculocerebrorenal syndrome: 5C60.0\\nCystinosis: 5C60.1\\nCystinuria: 5C60.2\\nOther specified disorders of amino acid absorption or transport: 5C60.Y\\nDisorders of amino acid absorption or transport unspecified: 5C60.Z\\nDisorders of carbohydrate absorption or transport: 5C61\\nGlucosegalactose malabsorption: 5C61.0\\nMaltaseglucoamylase deficiency: 5C61.1\\nCongenital sucraseisomaltase deficiency: 5C61.2\\nAlpha alpha trehalase deficiency: 5C61.3\\nAcquired monosaccharide malabsorption: 5C61.4\\nFructose malabsorption: 5C61.40\\nOther specified acquired monosaccharide malabsorption: 5C61.4Y\\nAcquired monosaccharide malabsorption unspecified: 5C61.4Z\\nDisorders of facilitated glucose transport: 5C61.5\\nLactose intolerance: 5C61.6\\nPrimary lactase deficiency: 5C61.60\\nCongenital lactase deficiency: 5C61.61\\nSecondary lactase deficiency: 5C61.62\\nLactose intolerance unspecified: 5C61.6Z\\nOther specified disorders of carbohydrate absorption or transport: 5C61.Y\\nDisorders of carbohydrate absorption or transport unspecified: 5C61.Z\\nDisorders of lipid absorption or transport: 5C62\\nDisorders of vitamin or nonprotein cofactor absorption or transport: 5C63\\nDisorders of cobalamin metabolism or transport: 5C63.0\\nDisorders of folate metabolism or transport: 5C63.1\\nDisorders of vitamin D metabolism or transport: 5C63.2\\nHypocalcaemic vitamin D dependent rickets: 5C63.20\\nHypocalcaemic vitamin D resistant rickets: 5C63.21\\nHypophosphataemic rickets: 5C63.22\\nOther specified disorders of vitamin D metabolism or transport: 5C63.2Y\\nDisorders of vitamin D metabolism or transport unspecified: 5C63.2Z\\nOther specified disorders of vitamin or nonprotein cofactor absorption or transport: 5C63.Y\\nDisorders of vitamin or nonprotein cofactor absorption or transport unspecified: 5C63.Z\\nDisorders of mineral absorption or transport: 5C64\\nDisorders of copper metabolism: 5C64.0\\nWilson disease: 5C64.00\\nOther specified disorders of copper metabolism: 5C64.0Y\\nDisorders of copper metabolism unspecified: 5C64.0Z\\nDisorders of iron metabolism: 5C64.1\\nIron overload diseases: 5C64.10\\nOther specified disorders of iron metabolism: 5C64.1Y\\nDisorders of iron metabolism unspecified: 5C64.1Z\\nDisorders of zinc metabolism: 5C64.2\\nAcrodermatitis enteropathica: 5C64.20\\nZinc deficiency syndromes: 5C64.21\\nOther specified disorders of zinc metabolism: 5C64.2Y\\nDisorders of zinc metabolism unspecified: 5C64.2Z\\nDisorders of phosphorus metabolism or phosphatases: 5C64.3\\nDisorders of magnesium metabolism: 5C64.4\\nHypermagnesaemia: 5C64.40\\nHypomagnesaemia: 5C64.41\\nDisorders of magnesium metabolism unspecified: 5C64.4Z\\nDisorders of calcium metabolism: 5C64.5\\nDisorders of sodium metabolism: 5C64.6\\nDisorders of chloride metabolism: 5C64.7\\nDisorders of other specified mineral absorption or transport: 5C64.Y\\nDisorders of mineral absorption or transport unspecified: 5C64.Z\\nOther specified disorders of metabolite absorption or transport: 5C6Y\\nDisorders of metabolite absorption or transport unspecified: 5C6Z\\nVolume depletion: 5C70\\nDehydration: 5C70.0\\nHypovolaemia: 5C70.1\\nOther specified volume depletion: 5C70.Y\\nVolume depletion unspecified: 5C70.Z\\nHyperosmolality or hypernatraemia: 5C71\\nHypoosmolality or hyponatraemia: 5C72\\nAcidosis: 5C73\\nAcute respiratory acidosis: 5C73.0\\nChronic respiratory acidosis: 5C73.1\\nAnion gap metabolic acidosis: 5C73.2\\nOther specified acidosis: 5C73.Y\\nAcidosis unspecified: 5C73.Z\\nAlkalosis: 5C74\\nMixed disorder of acidbase balance: 5C75\\nHyperkalaemia: 5C76\\nHypokalaemia: 5C77\\nFluid overload: 5C78\\nOther specified disorders of fluid electrolyte or acidbase balance: 5C7Y\\nDisorders of fluid electrolyte or acidbase balance unspecified: 5C7Z\\nHyperlipoproteinaemia: 5C80\\nHypercholesterolaemia: 5C80.0\\nPrimary hypercholesterolaemia: 5C80.00\\nSecondary hypercholesterolaemia: 5C80.01\\nHypercholesterolaemia unspecified: 5C80.0Z\\nHypertriglyceridaemia: 5C80.1\\nMixed hyperlipidaemia: 5C80.2\\nHyperalphalipoproteinaemia: 5C80.3\\nOther specified hyperlipoproteinaemia: 5C80.Y\\nHyperlipoproteinaemia unspecified: 5C80.Z\\nHypolipoproteinaemia: 5C81\\nHypoalphalipoproteinaemia: 5C81.0\\nHypobetalipoproteinaemia: 5C81.1\\nOther specified hypolipoproteinaemia: 5C81.Y\\nHypolipoproteinaemia unspecified: 5C81.Z\\nOther specified disorders of lipoprotein metabolism or lipidaemias: 5C8Y\\nUnspecified disorders of lipoprotein metabolism or lipidaemias: 5C8Z\\nMetabolic or transporter liver disease: 5C90\\nLiver diseases due to urea cycle defects: 5C90.0\\nLiver diseases due to disorders of porphyrin or bilirubin metabolism or transport: 5C90.1\\nLiver diseases due to disorders of amino acid metabolism: 5C90.2\\nLiver disease due to disorders of lysosomal storage: 5C90.3\\nLiver diseases due to mitochondrial disorders: 5C90.4\\nLiver diseases due to disorders of mineral metabolism: 5C90.5\\nOther specified metabolic or transporter liver disease: 5C90.Y\\nMetabolic or transporter liver disease unspecified: 5C90.Z\\nAmyloidosis: 5D00\\nAL amyloidosis: 5D00.0\\nAA amyloidosis: 5D00.1\\nHereditary amyloidosis: 5D00.2\\nHereditary ATTR amyloidosis: 5D00.20\\nNonneuropathic heredofamilial amyloidosis: 5D00.21\\nOther specified hereditary amyloidosis: 5D00.2Y\\nHereditary amyloidosis unspecified: 5D00.2Z\\nDialysisassociated amyloidosis: 5D00.3\\nOther specified amyloidosis: 5D00.Y\\nAmyloidosis unspecified: 5D00.Z\\nTumour lysis syndrome: 5D01\\nOther specified metabolic disorders: 5D0Y\\nMetabolic disorders unspecified: 5D2Z\\nPostprocedural hypothyroidism: 5D40\\nPostirridation hypothyroidism: 5D40.0\\nHypothyroidism postradioactive iodine ablation: 5D40.00\\nOther specified postirridation hypothyroidism: 5D40.0Y\\nPostirridation hypothyroidism unspecified: 5D40.0Z\\nOther specified postprocedural hypothyroidism: 5D40.Y\\nPostprocedural hypothyroidism unspecified: 5D40.Z\\nPostprocedural hypoinsulinaemia: 5D41\\nPostprocedural hypoparathyroidism: 5D42\\nPostprocedural hypopituitarism: 5D43\\nPostprocedural ovarian failure: 5D44\\nPostprocedural testicular hypofunction: 5D45\\nPostprocedural adrenocortical hypofunction: 5D46\\nDisorders of intellectual development: 6A00\\nDisorder of intellectual development mild: 6A00.0\\nDisorder of intellectual development moderate: 6A00.1\\nDisorder of intellectual development severe: 6A00.2\\nDisorder of intellectual development profound: 6A00.3\\nDisorder of intellectual development provisional: 6A00.4\\nDisorders of intellectual development unspecified: 6A00.Z\\nDevelopmental speech or language disorders: 6A01\\nDevelopmental speech sound disorder: 6A01.0\\nDevelopmental speech fluency disorder: 6A01.1\\nDevelopmental language disorder: 6A01.2\\nDevelopmental language disorder with impairment of receptive and expressive language: 6A01.20\\nDevelopmental language disorder with impairment of mainly expressive language: 6A01.21\\nDevelopmental language disorder with impairment of mainly pragmatic language: 6A01.22\\nDevelopmental language disorder with other specified language impairment: 6A01.23\\nOther specified developmental speech or language disorders: 6A01.Y\\nDevelopmental speech or language disorders unspecified: 6A01.Z\\nAutism spectrum disorder: 6A02\\nAutism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional language: 6A02.0\\nAutism spectrum disorder with disorder of intellectual development and with mild or no impairment of functional language: 6A02.1\\nAutism spectrum disorder without disorder of intellectual development and with impaired functional language: 6A02.2\\nAutism spectrum disorder with disorder of intellectual development and with impaired functional language: 6A02.3\\nAutism spectrum disorder with disorder of intellectual development and with absence of functional language: 6A02.5\\nOther specified autism spectrum disorder: 6A02.Y\\nAutism spectrum disorder unspecified: 6A02.Z\\nDevelopmental learning disorder: 6A03\\nDevelopmental learning disorder with impairment in reading: 6A03.0\\nDevelopmental learning disorder with impairment in written expression: 6A03.1\\nDevelopmental learning disorder with impairment in mathematics: 6A03.2\\nDevelopmental learning disorder with other specified impairment of learning: 6A03.3\\nDevelopmental learning disorder unspecified: 6A03.Z\\nDevelopmental motor coordination disorder: 6A04\\nAttention deficit hyperactivity disorder: 6A05\\nAttention deficit hyperactivity disorder predominantly inattentive presentation: 6A05.0\\nAttention deficit hyperactivity disorder predominantly hyperactiveimpulsive presentation: 6A05.1\\nAttention deficit hyperactivity disorder combined presentation: 6A05.2\\nAttention deficit hyperactivity disorder other specified presentation: 6A05.Y\\nAttention deficit hyperactivity disorder presentation unspecified: 6A05.Z\\nStereotyped movement disorder: 6A06\\nStereotyped movement disorder without selfinjury: 6A06.0\\nStereotyped movement disorder with selfinjury: 6A06.1\\nStereotyped movement disorder unspecified: 6A06.Z\\nOther specified neurodevelopmental disorders: 6A0Y\\nNeurodevelopmental disorders unspecified: 6A0Z\\nSchizophrenia: 6A20\\nSchizophrenia first episode: 6A20.0\\nSchizophrenia first episode currently symptomatic: 6A20.00\\nSchizophrenia first episode in partial remission: 6A20.01\\nSchizophrenia first episode in full remission: 6A20.02\\nSchizophrenia first episode unspecified: 6A20.0Z\\nSchizophrenia multiple episodes: 6A20.1\\nSchizophrenia multiple episodes currently symptomatic: 6A20.10\\nSchizophrenia multiple episodes in partial remission: 6A20.11\\nSchizophrenia multiple episodes in full remission: 6A20.12\\nSchizophrenia multiple episodes unspecified: 6A20.1Z\\nSchizophrenia continuous: 6A20.2\\nSchizophrenia continuous currently symptomatic: 6A20.20\\nSchizophrenia continuous in partial remission: 6A20.21\\nSchizophrenia continuous in full remission: 6A20.22\\nSchizophrenia continuous unspecified: 6A20.2Z\\nOther specified episode of schizophrenia: 6A20.Y\\nSchizophrenia episode unspecified: 6A20.Z\\nSchizoaffective disorder: 6A21\\nSchizoaffective disorder first episode: 6A21.0\\nSchizoaffective disorder first episode currently symptomatic: 6A21.00\\nSchizoaffective disorder first episode in partial remission: 6A21.01\\nSchizoaffective disorder first episode in full remission: 6A21.02\\nSchizoaffective disorder first episode unspecified: 6A21.0Z\\nSchizoaffective disorder multiple episodes: 6A21.1\\nSchizoaffective disorder multiple episodes currently symptomatic: 6A21.10\\nSchizoaffective disorder multiple episodes in partial remission: 6A21.11\\nSchizoaffective disorder multiple episodes in full remission: 6A21.12\\nSchizoaffective disorder multiple episodes unspecified: 6A21.1Z\\nSchizoaffective disorder continuous: 6A21.2\\nSchizoaffective disorder continuous currently symptomatic: 6A21.20\\nSchizoaffective disorder continuous in partial remission: 6A21.21\\nSchizoaffective disorder continuous in full remission: 6A21.22\\nSchizoaffective disorder continuous unspecified: 6A21.2Z\\nOther specified schizoaffective disorder: 6A21.Y\\nSchizoaffective disorder unspecified: 6A21.Z\\nSchizotypal disorder: 6A22\\nAcute and transient psychotic disorder: 6A23\\nAcute and transient psychotic disorder first episode: 6A23.0\\nAcute and transient psychotic disorder first episode currently symptomatic: 6A23.00\\nAcute and transient psychotic disorder first episode in partial remission: 6A23.01\\nAcute and transient psychotic disorder first episode in full remission: 6A23.02\\nAcute and transient psychotic disorder first episode unspecified: 6A23.0Z\\nAcute and transient psychotic disorder multiple episodes: 6A23.1\\nAcute and transient psychotic disorder multiple episodes currently symptomatic: 6A23.10\\nAcute and transient psychotic disorder multiple episodes in partial remission: 6A23.11\\nAcute and transient psychotic disorder multiple episodes in full remission: 6A23.12\\nAcute and transient psychotic disorder multiple episodes unspecified: 6A23.1Z\\nOther specified acute and transient psychotic disorder: 6A23.Y\\nAcute and transient psychotic disorder unspecified: 6A23.Z\\nDelusional disorder: 6A24\\nDelusional disorder currently symptomatic: 6A24.0\\nDelusional disorder in partial remission: 6A24.1\\nDelusional disorder in full remission: 6A24.2\\nDelusional disorder unspecified: 6A24.Z\\nSymptomatic manifestations of primary psychotic disorders: 6A25\\nPositive symptoms in primary psychotic disorders: 6A25.0\\nNegative symptoms in primary psychotic disorders: 6A25.1\\nDepressive mood symptoms in primary psychotic disorders: 6A25.2\\nManic mood symptoms in primary psychotic disorders: 6A25.3\\nPsychomotor symptoms in primary psychotic disorders: 6A25.4\\nCognitive symptoms in primary psychotic disorders: 6A25.5\\nOther specified primary psychotic disorder: 6A2Y\\nSchizophrenia or other primary psychotic disorders unspecified: 6A2Z\\nCatatonia associated with another mental disorder: 6A40\\nCatatonia induced by substances or medications: 6A41\\nCatatonia unspecified: 6A4Z\\nBipolar type I disorder: 6A60\\nBipolar type I disorder current episode manic without psychotic symptoms: 6A60.0\\nBipolar type I disorder current episode manic with psychotic symptoms: 6A60.1\\nBipolar type I disorder current episode hypomanic: 6A60.2\\nBipolar type I disorder current episode depressive mild: 6A60.3\\nBipolar type I disorder current episode depressive moderate without psychotic symptoms: 6A60.4\\nBipolar type I disorder current episode depressive moderate with psychotic symptoms: 6A60.5\\nBipolar type I disorder current episode depressive severe without psychotic symptoms: 6A60.6\\nBipolar type I disorder current episode depressive severe with psychotic symptoms: 6A60.7\\nBipolar type I disorder current episode depressive unspecified severity: 6A60.8\\nBipolar type I disorder current episode mixed without psychotic symptoms: 6A60.9\\nBipolar type I disorder current episode mixed with psychotic symptoms: 6A60.A\\nBipolar type I disorder currently in partial remission most recent episode manic or hypomanic: 6A60.B\\nBipolar type I disorder currently in partial remission most recent episode depressive: 6A60.C\\nBipolar type I disorder currently in partial remission most recent episode mixed: 6A60.D\\nBipolar type I disorder currently in partial remission most recent episode unspecified: 6A60.E\\nBipolar type I disorder currently in full remission: 6A60.F\\nOther specified bipolar type I disorder: 6A60.Y\\nBipolar type I disorder unspecified: 6A60.Z\\nBipolar type II disorder: 6A61\\nBipolar type II disorder current episode hypomanic: 6A61.0\\nBipolar type II disorder current episode depressive mild: 6A61.1\\nBipolar type II disorder current episode depressive moderate without psychotic symptoms: 6A61.2\\nBipolar type II disorder current episode depressive moderate with psychotic symptoms: 6A61.3\\nBipolar type II disorder current episode depressive severe without psychotic symptoms: 6A61.4\\nBipolar type II disorder current episode depressive severe with psychotic symptoms: 6A61.5\\nBipolar type II disorder current episode depressive unspecified severity: 6A61.6\\nBipolar type II disorder currently in partial remission most recent episode hypomanic: 6A61.7\\nBipolar type II disorder currently in partial remission most recent episode depressive: 6A61.8\\nBipolar type II disorder currently in partial remission most recent episode unspecified: 6A61.9\\nBipolar type II disorder currently in full remission: 6A61.A\\nOther specified bipolar type II disorder: 6A61.Y\\nBipolar type II disorder unspecified: 6A61.Z\\nCyclothymic disorder: 6A62\\nOther specified bipolar or related disorders: 6A6Y\\nBipolar or related disorders unspecified: 6A6Z\\nSingle episode depressive disorder: 6A70\\nSingle episode depressive disorder mild: 6A70.0\\nSingle episode depressive disorder moderate without psychotic symptoms: 6A70.1\\nSingle episode depressive disorder moderate with psychotic symptoms: 6A70.2\\nSingle episode depressive disorder severe without psychotic symptoms: 6A70.3\\nSingle episode depressive disorder severe with psychotic symptoms: 6A70.4\\nSingle episode depressive disorder unspecified severity: 6A70.5\\nSingle episode depressive disorder currently in partial remission: 6A70.6\\nSingle episode depressive disorder currently in full remission: 6A70.7\\nOther specified single episode depressive disorder: 6A70.Y\\nSingle episode depressive disorder unspecified: 6A70.Z\\nRecurrent depressive disorder: 6A71\\nRecurrent depressive disorder current episode mild: 6A71.0\\nRecurrent depressive disorder current episode moderate without psychotic symptoms: 6A71.1\\nRecurrent depressive disorder current episode moderate with psychotic symptoms: 6A71.2\\nRecurrent depressive disorder current episode severe without psychotic symptoms: 6A71.3\\nRecurrent depressive disorder current episode severe with psychotic symptoms: 6A71.4\\nRecurrent depressive disorder current episode unspecified severity: 6A71.5\\nRecurrent depressive disorder currently in partial remission: 6A71.6\\nRecurrent depressive disorder currently in full remission: 6A71.7\\nOther specified recurrent depressive disorder: 6A71.Y\\nRecurrent depressive disorder unspecified: 6A71.Z\\nDysthymic disorder: 6A72\\nMixed depressive and anxiety disorder: 6A73\\nOther specified depressive disorders: 6A7Y\\nDepressive disorders unspecified: 6A7Z\\nSymptomatic and course presentations for mood episodes in mood disorders: 6A80\\nProminent anxiety symptoms in mood episodes: 6A80.0\\nPanic attacks in mood episodes: 6A80.1\\nCurrent depressive episode persistent: 6A80.2\\nCurrent depressive episode with melancholia: 6A80.3\\nSeasonal pattern of mood episode onset: 6A80.4\\nRapid cycling: 6A80.5\\nOther specified mood disorders: 6A8Y\\nMood disorders unspecified: 6A8Z\\nGeneralised anxiety disorder: 6B00\\nPanic disorder: 6B01\\nAgoraphobia: 6B02\\nSpecific phobia: 6B03\\nSocial anxiety disorder: 6B04\\nSeparation anxiety disorder: 6B05\\nSelective mutism: 6B06\\nOther specified anxiety or fearrelated disorders: 6B0Y\\nAnxiety or fearrelated disorders unspecified: 6B0Z\\nObsessivecompulsive disorder: 6B20\\nObsessivecompulsive disorder with fair to good insight: 6B20.0\\nObsessivecompulsive disorder with poor to absent insight: 6B20.1\\nObsessivecompulsive disorder unspecified: 6B20.Z\\nBody dysmorphic disorder: 6B21\\nBody dysmorphic disorder with fair to good insight: 6B21.0\\nBody dysmorphic disorder with poor to absent insight: 6B21.1\\nBody dysmorphic disorder unspecified: 6B21.Z\\nOlfactory reference disorder: 6B22\\nOlfactory reference disorder with fair to good insight: 6B22.0\\nOlfactory reference disorder with poor to absent insight: 6B22.1\\nOlfactory reference disorder unspecified: 6B22.Z\\nHypochondriasis: 6B23\\nHypochondriasis with fair to good insight: 6B23.0\\nHypochondriasis with poor to absent insight: 6B23.1\\nHypochondriasis unspecified: 6B23.Z\\nHoarding disorder: 6B24\\nHoarding disorder with fair to good insight: 6B24.0\\nHoarding disorder with poor to absent insight: 6B24.1\\nHoarding disorder unspecified: 6B24.Z\\nBodyfocused repetitive behaviour disorders: 6B25\\nTrichotillomania: 6B25.0\\nExcoriation disorder: 6B25.1\\nOther specified bodyfocused repetitive behaviour disorders: 6B25.Y\\nBodyfocused repetitive behaviour disorders unspecified: 6B25.Z\\nOther specified obsessivecompulsive or related disorders: 6B2Y\\nObsessivecompulsive or related disorders unspecified: 6B2Z\\nPost traumatic stress disorder: 6B40\\nComplex post traumatic stress disorder: 6B41\\nProlonged grief disorder: 6B42\\nAdjustment disorder: 6B43\\nReactive attachment disorder: 6B44\\nDisinhibited social engagement disorder: 6B45\\nOther specified disorders specifically associated with stress: 6B4Y\\nDisorders specifically associated with stress unspecified: 6B4Z\\nDissociative neurological symptom disorder: 6B60\\nDissociative neurological symptom disorder with visual disturbance: 6B60.0\\nDissociative neurological symptom disorder with auditory disturbance: 6B60.1\\nDissociative neurological symptom disorder with vertigo or dizziness: 6B60.2\\nDissociative neurological symptom disorder with other sensory disturbance: 6B60.3\\nDissociative neurological symptom disorder with nonepileptic seizures: 6B60.4\\nDissociative neurological symptom disorder with speech disturbance: 6B60.5\\nDissociative neurological symptom disorder with paresis or weakness: 6B60.6\\nDissociative neurological symptom disorder with gait disturbance: 6B60.7\\nDissociative neurological symptom disorder with movement disturbance: 6B60.8\\nDissociative neurological symptom disorder with chorea: 6B60.80\\nDissociative neurological symptom disorder with myoclonus: 6B60.81\\nDissociative neurological symptom disorder with tremor: 6B60.82\\nDissociative neurological symptom disorder with dystonia: 6B60.83\\nDissociative neurological symptom disorder with facial spasm: 6B60.84\\nDissociative neurological symptom disorder with Parkinsonism: 6B60.85\\nDissociative neurological symptom disorder with other specified movement disturbance: 6B60.8Y\\nDissociative neurological symptom disorder with unspecified movement disturbance: 6B60.8Z\\nDissociative neurological symptom disorder with cognitive symptoms: 6B60.9\\nDissociative neurological symptom disorder with other specified symptoms: 6B60.Y\\nDissociative neurological symptom disorder with unspecified symptoms: 6B60.Z\\nDissociative amnesia: 6B61\\nDissociative amnesia with dissociative fugue: 6B61.0\\nDissociative amnesia without dissociative fugue: 6B61.1\\nDissociative amnesia unspecified: 6B61.Z\\nTrance disorder: 6B62\\nPossession trance disorder: 6B63\\nDissociative identity disorder: 6B64\\nPartial dissociative identity disorder: 6B65\\nDepersonalizationderealization disorder: 6B66\\nOther specified dissociative disorders: 6B6Y\\nDissociative disorders unspecified: 6B6Z\\nAnorexia Nervosa: 6B80\\nAnorexia Nervosa with significantly low body weight: 6B80.0\\nAnorexia Nervosa with significantly low body weight restricting pattern: 6B80.00\\nAnorexia Nervosa with significantly low body weight bingepurge pattern: 6B80.01\\nAnorexia Nervosa with significantly low body weight unspecified: 6B80.0Z\\nAnorexia Nervosa with dangerously low body weight: 6B80.1\\nAnorexia Nervosa with dangerously low body weight restricting pattern: 6B80.10\\nAnorexia Nervosa with dangerously low body weight bingepurge pattern: 6B80.11\\nAnorexia Nervosa with dangerously low body weight unspecified: 6B80.1Z\\nAnorexia Nervosa in recovery with normal body weight: 6B80.2\\nOther specified anorexia Nervosa: 6B80.Y\\nAnorexia Nervosa unspecified: 6B80.Z\\nBulimia Nervosa: 6B81\\nBinge eating disorder: 6B82\\nAvoidantrestrictive food intake disorder: 6B83\\nPica: 6B84\\nRuminationregurgitation disorder: 6B85\\nOther specified feeding or eating disorders: 6B8Y\\nFeeding or eating disorders unspecified: 6B8Z\\nEnuresis: 6C00\\nNocturnal enuresis: 6C00.0\\nDiurnal enuresis: 6C00.1\\nNocturnal and diurnal enuresis: 6C00.2\\nEnuresis unspecified: 6C00.Z\\nEncopresis: 6C01\\nEncopresis with constipation or overflow incontinence: 6C01.0\\nEncopresis without constipation or overflow incontinence: 6C01.1\\nEncopresis unspecified: 6C01.Z\\nElimination disorders unspecified: 6C0Z\\nBodily distress disorder: 6C20\\nMild bodily distress disorder: 6C20.0\\nModerate bodily distress disorder: 6C20.1\\nSevere bodily distress disorder: 6C20.2\\nBodily distress disorder unspecified: 6C20.Z\\nBody integrity dysphoria: 6C21\\nOther specified disorders of bodily distress or bodily experience: 6C2Y\\nDisorders of bodily distress or bodily experience unspecified: 6C2Z\\nDisorders due to use of alcohol: 6C40\\nEpisode of harmful use of alcohol: 6C40.0\\nHarmful pattern of use of alcohol: 6C40.1\\nHarmful pattern of use of alcohol episodic: 6C40.10\\nHarmful pattern of use of alcohol continuous: 6C40.11\\nHarmful pattern of use of alcohol unspecified: 6C40.1Z\\nAlcohol dependence: 6C40.2\\nAlcohol dependence current use continuous: 6C40.20\\nAlcohol dependence current use episodic: 6C40.21\\nAlcohol dependence early full remission: 6C40.22\\nAlcohol dependence sustained partial remission: 6C40.23\\nAlcohol dependence sustained full remission: 6C40.24\\nAlcohol dependence unspecified: 6C40.2Z\\nAlcohol intoxication: 6C40.3\\nAlcohol withdrawal: 6C40.4\\nAlcohol withdrawal uncomplicated: 6C40.40\\nAlcohol withdrawal with perceptual disturbances: 6C40.41\\nAlcohol withdrawal with seizures: 6C40.42\\nAlcohol withdrawal with perceptual disturbances and seizures: 6C40.43\\nAlcohol withdrawal unspecified: 6C40.4Z\\nAlcoholinduced delirium: 6C40.5\\nAlcoholinduced psychotic disorder: 6C40.6\\nAlcoholinduced psychotic disorder with hallucinations: 6C40.60\\nAlcoholinduced psychotic disorder with delusions: 6C40.61\\nAlcoholinduced psychotic disorder with mixed psychotic symptoms: 6C40.62\\nAlcoholinduced psychotic disorder unspecified: 6C40.6Z\\nCertain specified alcoholinduced mental or behavioural disorders: 6C40.7\\nAlcoholinduced mood disorder: 6C40.70\\nAlcoholinduced anxiety disorder: 6C40.71\\nOther specified disorders due to use of alcohol: 6C40.Y\\nDisorders due to use of alcohol unspecified: 6C40.Z\\nDisorders due to use of cannabis: 6C41\\nEpisode of harmful use of cannabis: 6C41.0\\nHarmful pattern of use of cannabis: 6C41.1\\nHarmful pattern of use of cannabis episodic: 6C41.10\\nHarmful pattern of use of cannabis continuous: 6C41.11\\nHarmful pattern of use of cannabis unspecified: 6C41.1Z\\nCannabis dependence: 6C41.2\\nCannabis dependence current use: 6C41.20\\nCannabis dependence early full remission: 6C41.21\\nCannabis dependence sustained partial remission: 6C41.22\\nCannabis dependence sustained full remission: 6C41.23\\nCannabis dependence unspecified: 6C41.2Z\\nCannabis intoxication: 6C41.3\\nCannabis withdrawal: 6C41.4\\nCannabisinduced delirium: 6C41.5\\nCannabisinduced psychotic disorder: 6C41.6\\nCertain specified cannabisinduced mental or behavioural disorders: 6C41.7\\nCannabisinduced mood disorder: 6C41.70\\nCannabisinduced anxiety disorder: 6C41.71\\nOther specified disorders due to use of cannabis: 6C41.Y\\nDisorders due to use of cannabis unspecified: 6C41.Z\\nDisorders due to use of synthetic cannabinoids: 6C42\\nEpisode of harmful use of synthetic cannabinoids: 6C42.0\\nHarmful pattern of use of synthetic cannabinoids: 6C42.1\\nHarmful pattern of use of synthetic cannabinoids episodic: 6C42.10\\nHarmful pattern of use of synthetic cannabinoids continuous: 6C42.11\\nOther specified harmful pattern of use of synthetic cannabinoids: 6C42.1Y\\nHarmful pattern of use of synthetic cannabinoids unspecified: 6C42.1Z\\nSynthetic cannabinoid dependence: 6C42.2\\nSynthetic cannabinoid dependence current use: 6C42.20\\nSynthetic cannabinoid dependence early full remission: 6C42.21\\nSynthetic cannabinoid dependence sustained partial remission: 6C42.22\\nSynthetic cannabinoid dependence sustained full remission: 6C42.23\\nOther specified synthetic cannabinoid dependence: 6C42.2Y\\nSynthetic cannabinoid dependence unspecified: 6C42.2Z\\nSynthetic cannabinoid intoxication: 6C42.3\\nSynthetic cannabinoid withdrawal: 6C42.4\\nSynthetic cannabinoidinduced delirium: 6C42.5\\nSynthetic cannabinoidinduced psychotic disorder: 6C42.6\\nCertain specified synthetic cannabinoidsinduced mental or behavioural disorders: 6C42.7\\nSynthetic cannabinoidinduced mood disorder: 6C42.70\\nSynthetic cannabinoidinduced anxiety disorder: 6C42.71\\nOther specified disorders due to use of synthetic cannabinoids: 6C42.Y\\nDisorders due to use of synthetic cannabinoids unspecified: 6C42.Z\\nDisorders due to use of opioids: 6C43\\nEpisode of harmful use of opioids: 6C43.0\\nHarmful pattern of use of opioids: 6C43.1\\nHarmful pattern of use of opioids episodic: 6C43.10\\nHarmful pattern of use of opioids continuous: 6C43.11\\nHarmful pattern of use of opioids unspecified: 6C43.1Z\\nOpioid dependence: 6C43.2\\nOpioid dependence current use: 6C43.20\\nOpioid dependence early full remission: 6C43.21\\nOpioid dependence sustained partial remission: 6C43.22\\nOpioid dependence sustained full remission: 6C43.23\\nOpioid dependence unspecified: 6C43.2Z\\nOpioid intoxication: 6C43.3\\nOpioid withdrawal: 6C43.4\\nOpioidinduced delirium: 6C43.5\\nOpioidinduced psychotic disorder: 6C43.6\\nCertain specified opioidinduced mental or behavioural disorders: 6C43.7\\nOpioidinduced mood disorder: 6C43.70\\nOpioidinduced anxiety disorder: 6C43.71\\nOther specified disorders due to use of opioids: 6C43.Y\\nDisorders due to use of opioids unspecified: 6C43.Z\\nDisorders due to use of sedatives hypnotics or anxiolytics: 6C44\\nEpisode of harmful use of sedatives hypnotics or anxiolytics: 6C44.0\\nHarmful pattern of use of sedatives hypnotics or anxiolytics: 6C44.1\\nHarmful pattern of use of sedatives hypnotics or anxiolytics episodic: 6C44.10\\nHarmful pattern of use of sedatives hypnotics or anxiolytics continuous: 6C44.11\\nHarmful pattern of use of sedatives hypnotics or anxiolytics unspecified: 6C44.1Z\\nSedative hypnotic or anxiolytic dependence: 6C44.2\\nSedative hypnotic or anxiolytic dependence current use: 6C44.20\\nSedative hypnotic or anxiolytic dependence early full remission: 6C44.21\\nSedative hypnotic or anxiolytic dependence sustained partial remission: 6C44.22\\nSedative hypnotic or anxiolytic dependence sustained full remission: 6C44.23\\nSedative hypnotic or anxiolytic dependence unspecified: 6C44.2Z\\nSedative hypnotic or anxiolytic intoxication: 6C44.3\\nSedative hypnotic or anxiolytic withdrawal: 6C44.4\\nSedative hypnotic or anxiolytic withdrawal uncomplicated: 6C44.40\\nSedative hypnotic or anxiolytic withdrawal with perceptual disturbances: 6C44.41\\nSedative hypnotic or anxiolytic withdrawal with seizures: 6C44.42\\nSedative hypnotic or anxiolytic withdrawal with perceptual disturbances and seizures: 6C44.43\\nSedative hypnotic or anxiolytic withdrawal unspecified: 6C44.4Z\\nSedative hypnotic or anxiolyticinduced delirium: 6C44.5\\nSedative hypnotic or anxiolyticinduced psychotic disorder: 6C44.6\\nCertain specified sedatives hypnotics or anxiolyticinduced mental or behavioural disorders: 6C44.7\\nSedative hypnotic or anxiolyticinduced mood disorder: 6C44.70\\nSedative hypnotic or anxiolyticinduced anxiety disorder: 6C44.71\\nOther specified disorders due to use of sedatives hypnotics or anxiolytics: 6C44.Y\\nDisorders due to use of sedatives hypnotics or anxiolytics unspecified: 6C44.Z\\nDisorders due to use of cocaine: 6C45\\nEpisode of harmful use of cocaine: 6C45.0\\nHarmful pattern of use of cocaine: 6C45.1\\nHarmful pattern of use of cocaine episodic: 6C45.10\\nHarmful pattern of use of cocaine continuous: 6C45.11\\nHarmful pattern of use of cocaine unspecified: 6C45.1Z\\nCocaine dependence: 6C45.2\\nCocaine dependence current use: 6C45.20\\nCocaine dependence early full remission: 6C45.21\\nCocaine dependence sustained partial remission: 6C45.22\\nCocaine dependence sustained full remission: 6C45.23\\nCocaine dependence unspecified: 6C45.2Z\\nCocaine intoxication: 6C45.3\\nCocaine withdrawal: 6C45.4\\nCocaineinduced delirium: 6C45.5\\nCocaineinduced psychotic disorder: 6C45.6\\nCocaineinduced psychotic disorder with hallucinations: 6C45.60\\nCocaineinduced psychotic disorder with delusions: 6C45.61\\nCocaineinduced psychotic disorder with mixed psychotic symptoms: 6C45.62\\nCocaineinduced psychotic disorder unspecified: 6C45.6Z\\nCertain specified cocaineinduced mental or behavioural disorders: 6C45.7\\nCocaineinduced mood disorder: 6C45.70\\nCocaineinduced anxiety disorder: 6C45.71\\nCocaineinduced obsessivecompulsive or related disorder: 6C45.72\\nCocaineinduced impulse control disorder: 6C45.73\\nOther specified disorders due to use of cocaine: 6C45.Y\\nDisorders due to use of cocaine unspecified: 6C45.Z\\nDisorders due to use of stimulants including amphetamines methamphetamine or methcathinone: 6C46\\nEpisode of harmful use of stimulants including amphetamines methamphetamine or methcathinone: 6C46.0\\nHarmful pattern of use of stimulants including amphetamines methamphetamine or methcathinone: 6C46.1\\nHarmful pattern of use of stimulants including amphetamines methamphetamine or methcathinone episodic: 6C46.10\\nHarmful pattern of use of stimulants including amphetamines methamphetamine or methcathinone continuous: 6C46.11\\nHarmful pattern of use of stimulants including amphetamines methamphetamine and methcathinone unspecified: 6C46.1Z\\nStimulant dependence including amphetamines methamphetamine or methcathinone: 6C46.2\\nStimulant dependence including amphetamines methamphetamine or methcathinone current use: 6C46.20\\nStimulant dependence including amphetamines methamphetamine or methcathinone early full remission: 6C46.21\\nStimulant dependence including amphetamines methamphetamine or methcathinone sustained partial remission: 6C46.22\\nStimulant dependence including amphetamines methamphetamine or methcathinone sustained full remission: 6C46.23\\nStimulant dependence including amphetamines methamphetamine or methcathinone unspecified: 6C46.2Z\\nStimulant intoxication including amphetamines methamphetamine or methcathinone: 6C46.3\\nStimulant withdrawal including amphetamines methamphetamine or methcathinone: 6C46.4\\nStimulantinduced delirium including amphetamines methamphetamine or methcathinone: 6C46.5\\nStimulantinduced psychotic disorder including amphetamines methamphetamine or methcathinone: 6C46.6\\nStimulantinduced psychotic disorder including amphetamines methamphetamine or methcathinone with hallucinations: 6C46.60\\nStimulantinduced psychotic disorder including amphetamines methamphetamine or methcathinone with delusions: 6C46.61\\nStimulantinduced psychotic disorder including amphetamines but excluding caffeine or cocaine with mixed psychotic symptoms: 6C46.62\\nStimulantinduced psychotic disorder including amphetamines methamphetamine or methcathinone unspecified: 6C46.6Z\\nCertain specified stimulantinduced mental or behavioural disorders including amphetamines methamphetamine or methcathinone: 6C46.7\\nStimulantinduced mood disorder including amphetamines methamphetamine or methcathinone: 6C46.70\\nStimulantinduced anxiety disorder including amphetamines methamphetamine or methcathinone: 6C46.71\\nStimulantinduced obsessivecompulsive or related disorder including amphetamines methamphetamine or methcathinone: 6C46.72\\nStimulantinduced impulse control disorder including amphetamines methamphetamine or methcathinone: 6C46.73\\nOther specified disorders due to use of stimulants including amphetamines methamphetamine or methcathinone: 6C46.Y\\nDisorders due to use of stimulants including amphetamines methamphetamine or methcathinone unspecified: 6C46.Z\\nDisorders due to use of synthetic cathinones: 6C47\\nEpisode of harmful use of synthetic cathinones: 6C47.0\\nHarmful pattern of use of synthetic cathinones: 6C47.1\\nHarmful pattern of use of synthetic cathinones episodic: 6C47.10\\nHarmful use of synthetic cathinones continuous: 6C47.11\\nOther specified harmful pattern of use of synthetic cathinones: 6C47.1Y\\nHarmful pattern of use of synthetic cathinones unspecified: 6C47.1Z\\nSynthetic cathinone dependence: 6C47.2\\nSynthetic cathinone dependence current use: 6C47.20\\nSynthetic cathinone dependence early full remission: 6C47.21\\nSynthetic cathinone dependence sustained partial remission: 6C47.22\\nSynthetic cathinone dependence sustained full remission: 6C47.23\\nOther specified synthetic cathinone dependence: 6C47.2Y\\nSynthetic cathinone dependence unspecified: 6C47.2Z\\nSynthetic cathinone intoxication: 6C47.3\\nSynthetic cathinone withdrawal: 6C47.4\\nSynthetic cathinoneinduced delirium: 6C47.5\\nSynthetic cathinoneinduced psychotic disorder: 6C47.6\\nSynthetic cathinoneinduced psychotic disorder with hallucinations: 6C47.60\\nSynthetic cathinoneinduced psychotic disorder with delusions: 6C47.61\\nSynthetic cathinoneinduced psychotic disorder with mixed psychotic symptoms: 6C47.62\\nSynthetic cathinoneinduced psychotic disorder unspecified: 6C47.6Z\\nCertain specified synthetic cathinoneinduced mental or behavioural disorders: 6C47.7\\nSynthetic cathinoneinduced mood disorder: 6C47.70\\nSynthetic cathinoneinduced anxiety disorder: 6C47.71\\nSynthetic cathinoneinduced obsessivecompulsive or related syndrome: 6C47.72\\nSynthetic cathinoneinduced impulse control disorder: 6C47.73\\nOther specified disorders due to use of synthetic cathinones: 6C47.Y\\nDisorders due to use of synthetic cathinones unspecified: 6C47.Z\\nDisorders due to use of caffeine: 6C48\\nEpisode of harmful use of caffeine: 6C48.0\\nHarmful pattern of use of caffeine: 6C48.1\\nHarmful pattern of use of caffeine episodic: 6C48.10\\nHarmful pattern of use of caffeine continuous: 6C48.11\\nHarmful pattern of use of caffeine unspecified: 6C48.1Z\\nCaffeine intoxication: 6C48.2\\nCaffeine withdrawal: 6C48.3\\nCertain specified caffeineinduced mental or behavioural disorders: 6C48.4\\nCaffeineinduced anxiety disorder: 6C48.40\\nOther specified disorders due to use of caffeine: 6C48.Y\\nDisorders due to use of caffeine unspecified: 6C48.Z\\nDisorders due to use of hallucinogens: 6C49\\nEpisode of harmful use of hallucinogens: 6C49.0\\nHarmful pattern of use of hallucinogens: 6C49.1\\nHarmful pattern of use of hallucinogens episodic: 6C49.10\\nHarmful pattern of use of hallucinogens continuous: 6C49.11\\nHarmful pattern of use of hallucinogens unspecified: 6C49.1Z\\nHallucinogen dependence: 6C49.2\\nHallucinogen dependence current use: 6C49.20\\nHallucinogen dependence early full remission: 6C49.21\\nHallucinogen dependence sustained partial remission: 6C49.22\\nHallucinogen dependence sustained full remission: 6C49.23\\nHallucinogen dependence unspecified: 6C49.2Z\\nHallucinogen intoxication: 6C49.3\\nHallucinogeninduced delirium: 6C49.4\\nHallucinogeninduced psychotic disorder: 6C49.5\\nCertain specified hallucinogeninduced mental or behavioural disorders: 6C49.6\\nHallucinogeninduced mood disorder: 6C49.60\\nHallucinogeninduced anxiety disorder: 6C49.61\\nOther specified disorders due to use of hallucinogens: 6C49.Y\\nDisorders due to use of hallucinogens unspecified: 6C49.Z\\nDisorders due to use of nicotine: 6C4A\\nEpisode of harmful use of nicotine: 6C4A.0\\nHarmful pattern of use of nicotine: 6C4A.1\\nHarmful pattern of use of nicotine episodic: 6C4A.10\\nHarmful pattern of use of nicotine continuous: 6C4A.11\\nHarmful pattern of use of nicotine unspecified: 6C4A.1Z\\nNicotine dependence: 6C4A.2\\nNicotine dependence current use: 6C4A.20\\nNicotine dependence early full remission: 6C4A.21\\nNicotine dependence sustained partial remission: 6C4A.22\\nNicotine dependence sustained full remission: 6C4A.23\\nNicotine dependence unspecified: 6C4A.2Z\\nNicotine intoxication: 6C4A.3\\nNicotine withdrawal: 6C4A.4\\nOther specified disorders due to use of nicotine: 6C4A.Y\\nDisorders due to use of nicotine unspecified: 6C4A.Z\\nDisorders due to use of volatile inhalants: 6C4B\\nEpisode of harmful use of volatile inhalants: 6C4B.0\\nHarmful pattern of use of volatile inhalants: 6C4B.1\\nHarmful pattern of use of volatile inhalants episodic: 6C4B.10\\nHarmful pattern of use of volatile inhalants continuous: 6C4B.11\\nHarmful pattern of use of volatile inhalants unspecified: 6C4B.1Z\\nVolatile inhalant dependence: 6C4B.2\\nVolatile inhalant dependence current use: 6C4B.20\\nVolatile inhalant dependence early full remission: 6C4B.21\\nVolatile inhalant dependence sustained partial remission: 6C4B.22\\nVolatile inhalant dependence sustained full remission: 6C4B.23\\nVolatile inhalant dependence unspecified: 6C4B.2Z\\nVolatile inhalant intoxication: 6C4B.3\\nVolatile inhalant withdrawal: 6C4B.4\\nVolatile inhalantinduced delirium: 6C4B.5\\nVolatile inhalantinduced psychotic disorder: 6C4B.6\\nCertain specified volatile inhalantsinduced mental or behavioural disorders: 6C4B.7\\nVolatile inhalantinduced mood disorder: 6C4B.70\\nVolatile inhalantinduced anxiety disorder: 6C4B.71\\nOther specified disorders due to use of volatile inhalants: 6C4B.Y\\nDisorders due to use of volatile inhalants unspecified: 6C4B.Z\\nDisorders due to use of MDMA or related drugs including MDA: 6C4C\\nEpisode of harmful use of MDMA or related drugs including MDA: 6C4C.0\\nHarmful pattern of use of MDMA or related drugs including MDA: 6C4C.1\\nHarmful use of MDMA or related drugs including MDA episodic: 6C4C.10\\nHarmful use of MDMA or related drugs including MDA continuous: 6C4C.11\\nHarmful pattern of use of MDMA or related drugs including MDA unspecified: 6C4C.1Z\\nMDMA or related drug dependence including MDA: 6C4C.2\\nMDMA or related drug dependence including MDA current use: 6C4C.20\\nMDMA or related drug dependence including MDA early full remission: 6C4C.21\\nMDMA or related drug dependence including MDA sustained partial remission: 6C4C.22\\nMDMA or related drug dependence including MDA sustained full remission: 6C4C.23\\nMDMA or related drug dependence including MDA unspecified: 6C4C.2Z\\nMDMA or related drug intoxication including MDA: 6C4C.3\\nMDMA or related drug withdrawal including MDA: 6C4C.4\\nMDMA or related druginduced delirium including MDA: 6C4C.5\\nMDMA or related druginduced psychotic disorder including MDA: 6C4C.6\\nCertain specified MDMA or related druginduced mental or behavioural disorders including MDA: 6C4C.7\\nMDMA or related druginduced mood disorder including MDA: 6C4C.70\\nMDMA or related druginduced anxiety disorder: 6C4C.71\\nOther specified disorders due to use of MDMA or related drugs including MDA: 6C4C.Y\\nDisorders due to use of MDMA or related drugs including MDA unspecified: 6C4C.Z\\nDisorders due to use of dissociative drugs including ketamine and phencyclidine PCP: 6C4D\\nEpisode of harmful use of dissociative drugs including ketamine or PCP: 6C4D.0\\nHarmful pattern of use of dissociative drugs including ketamine or PCP: 6C4D.1\\nHarmful pattern of use of dissociative drugs including ketamine or PCP episodic: 6C4D.10\\nHarmful pattern of use of dissociative drugs including ketamine or PCP continuous: 6C4D.11\\nHarmful pattern of use of dissociative drugs including ketamine or PCP unspecified: 6C4D.1Z\\nDissociative drug dependence including ketamine or PCP: 6C4D.2\\nDissociative drug dependence including Ketamine or PCP current use: 6C4D.20\\nDissociative drug dependence including ketamine or PCP early full remission: 6C4D.21\\nDissociative drug dependence including Ketamine or PCP sustained partial remission: 6C4D.22\\nDissociative drug dependence including Ketamine or PCP sustained full remission: 6C4D.23\\nDissociative drug dependence including ketamine or PCP unspecified: 6C4D.2Z\\nDissociative drug intoxication including Ketamine or PCP: 6C4D.3\\nDissociative druginduced delirium including ketamine or PCP: 6C4D.4\\nDissociative druginduced psychotic disorder including Ketamine or PCP: 6C4D.5\\nCertain specified dissociative druginduced mental or behavioural disorders including ketamine and phencyclidine PCP: 6C4D.6\\nDissociative druginduced mood disorder including Ketamine or PCP: 6C4D.60\\nDissociative druginduced anxiety disorder including Ketamine or PCP: 6C4D.61\\nOther specified disorders due to use of dissociative drugs including ketamine and phencyclidine PCP: 6C4D.Y\\nDisorders due to use of dissociative drugs including ketamine and phencyclidine PCP unspecified: 6C4D.Z\\nDisorders due to use of other specified psychoactive substances including medications: 6C4E\\nEpisode of harmful use of other specified psychoactive substance: 6C4E.0\\nHarmful pattern of use of other specified psychoactive substance: 6C4E.1\\nHarmful pattern of use of other specified psychoactive substance episodic: 6C4E.10\\nHarmful pattern of use of other specified psychoactive substance continuous: 6C4E.11\\nHarmful pattern of use of other specified psychoactive substance unspecified: 6C4E.1Z\\nOther specified psychoactive substance dependence: 6C4E.2\\nOther specified psychoactive substance dependence current use: 6C4E.20\\nOther specified psychoactive substance dependence early full remission: 6C4E.21\\nOther specified psychoactive substance dependence sustained partial remission: 6C4E.22\\nOther specified psychoactive substance dependence sustained full remission: 6C4E.23\\nOther specified psychoactive substance dependence unspecified: 6C4E.2Z\\nOther specified psychoactive substance intoxication: 6C4E.3\\nOther specified psychoactive substance withdrawal: 6C4E.4\\nOther specified psychoactive substance withdrawal uncomplicated: 6C4E.40\\nOther specified psychoactive substance withdrawal with perceptual disturbances: 6C4E.41\\nOther specified psychoactive substance withdrawal with seizures: 6C4E.42\\nOther specified psychoactive substance withdrawal with perceptual disturbances and seizures: 6C4E.43\\nOther specified psychoactive substance withdrawal unspecified: 6C4E.4Z\\nDelirium induced by other specified psychoactive substance including medications: 6C4E.5\\nPsychotic disorder induced by other specified psychoactive substance: 6C4E.6\\nCertain other specified psychoactive substanceinduced mental or behavioural disorders: 6C4E.7\\nMood disorder induced by other specified psychoactive substance: 6C4E.70\\nAnxiety disorder induced by other specified psychoactive substance: 6C4E.71\\nObsessivecompulsive or related disorder induced by other specified psychoactive substance: 6C4E.72\\nImpulse control disorder induced by other specified psychoactive substance: 6C4E.73\\nOther specified disorders due to use of other specified psychoactive substances including medications: 6C4E.Y\\nDisorders due to use of other specified psychoactive substances including medications unspecified: 6C4E.Z\\nDisorders due to use of multiple specified psychoactive substances including medications: 6C4F\\nEpisode of harmful use of multiple specified psychoactive substances: 6C4F.0\\nHarmful pattern of use of multiple specified psychoactive substances: 6C4F.1\\nHarmful pattern of use of multiple specified psychoactive substances episodic: 6C4F.10\\nHarmful pattern of use of multiple specified psychoactive substances continuous: 6C4F.11\\nHarmful pattern of use of multiple specified psychoactive substances unspecified: 6C4F.1Z\\nMultiple specified psychoactive substances dependence: 6C4F.2\\nMultiple specified psychoactive substances dependence current use: 6C4F.20\\nMultiple specified psychoactive substances dependence early full remission: 6C4F.21\\nMultiple specified psychoactive substances dependence sustained partial remission: 6C4F.22\\nMultiple specified psychoactive substances dependence sustained full remission: 6C4F.23\\nMultiple specified psychoactive substances dependence unspecified: 6C4F.2Z\\nIntoxication due to multiple specified psychoactive substances: 6C4F.3\\nMultiple specified psychoactive substances withdrawal: 6C4F.4\\nMultiple specified psychoactive substances withdrawal uncomplicated: 6C4F.40\\nMultiple specified psychoactive substances withdrawal with perceptual disturbances: 6C4F.41\\nMultiple specified psychoactive substances withdrawal with seizures: 6C4F.42\\nMultiple specified psychoactive substances withdrawal with perceptual disturbances and seizures: 6C4F.43\\nOther specified multiple specified psychoactive substances withdrawal: 6C4F.4Y\\nMultiple specified psychoactive substances withdrawal unspecified: 6C4F.4Z\\nDelirium induced by multiple specified psychoactive substances including medications: 6C4F.5\\nPsychotic disorder induced by multiple specified psychoactive substances: 6C4F.6\\nCertain multiple specified psychoactive substancesinduced mental or behavioural disorders: 6C4F.7\\nMood disorder induced by multiple specified psychoactive substances: 6C4F.70\\nAnxiety disorder induced by multiple specified psychoactive substances: 6C4F.71\\nObsessivecompulsive or related disorder induced by multiple specified psychoactive substances: 6C4F.72\\nImpulse control syndrome induced by multiple specified psychoactive substances: 6C4F.73\\nOther specified disorders due to use of multiple specified psychoactive substances including medications: 6C4F.Y\\nDisorders due to use of multiple specified psychoactive substances including medications unspecified: 6C4F.Z\\nDisorders due to use of unknown or unspecified psychoactive substances: 6C4G\\nEpisode of harmful use of unknown or unspecified psychoactive substances: 6C4G.0\\nHarmful pattern of use of unknown or unspecified psychoactive substance: 6C4G.1\\nHarmful pattern of use of unknown or unspecified psychoactive substance episodic: 6C4G.10\\nHarmful pattern of use of unknown or unspecified psychoactive substance continuous: 6C4G.11\\nHarmful pattern of use of unknown or unspecified psychoactive substance unspecified: 6C4G.1Z\\nUnknown or unspecified psychoactive substance dependence: 6C4G.2\\nUnknown or unspecified psychoactive substance dependence current use: 6C4G.20\\nUnknown or unspecified psychoactive substance dependence early full remission: 6C4G.21\\nUnknown or unspecified psychoactive substance dependence sustained partial remission: 6C4G.22\\nUnknown or unspecified psychoactive substance dependence sustained full remission: 6C4G.23\\nUnknown or unspecified psychoactive substance dependence substance and state of remission unspecified: 6C4G.2Z\\nIntoxication due to unknown or unspecified psychoactive substance: 6C4G.3\\nWithdrawal due to unknown or unspecified psychoactive substance: 6C4G.4\\nWithdrawal due to unknown or unspecified psychoactive substance uncomplicated: 6C4G.40\\nWithdrawal due to unknown or unspecified psychoactive substance with perceptual disturbances: 6C4G.41\\nWithdrawal due to unknown or unspecified psychoactive substance with seizures: 6C4G.42\\nWithdrawal due to unknown or unspecified psychoactive with perceptual disturbances and seizures: 6C4G.43\\nWithdrawal due to unknown or unspecified psychoactive substance unspecified: 6C4G.4Z\\nDelirium induced by unknown or unspecified psychoactive substance: 6C4G.5\\nPsychotic disorder induced by unknown or unspecified psychoactive substance: 6C4G.6\\nCertain unknown or unspecified psychoactive substanceinduced mental or behavioural disorders: 6C4G.7\\nMood disorder induced by unknown or unspecified psychoactive substance: 6C4G.70\\nAnxiety disorder induced by unknown or unspecified psychoactive substance: 6C4G.71\\nObsessivecompulsive or related disorder induced by unknown or unspecified psychoactive substance: 6C4G.72\\nImpulse control disorder induced by unknown or unspecified psychoactive substance: 6C4G.73\\nOther specified disorders due to use of unknown or unspecified psychoactive substances: 6C4G.Y\\nDisorders due to use of unknown or unspecified psychoactive substances unspecified: 6C4G.Z\\nDisorders due to use of nonpsychoactive substances: 6C4H\\nEpisode of harmful use of nonpsychoactive substances: 6C4H.0\\nHarmful pattern of use of nonpsychoactive substances: 6C4H.1\\nHarmful pattern of use of nonpsychoactive substances episodic: 6C4H.10\\nHarmful pattern of use of nonpsychoactive substances continuous: 6C4H.11\\nHarmful pattern of use of nonpsychoactive substances unspecified: 6C4H.1Z\\nOther specified disorders due to use of nonpsychoactive substances: 6C4H.Y\\nDisorders due to use of nonpsychoactive substances unspecified: 6C4H.Z\\nOther specified disorders due to substance use: 6C4Y\\nDisorders due to substance use unspecified: 6C4Z\\nGambling disorder: 6C50\\nGambling disorder predominantly offline: 6C50.0\\nGambling disorder predominantly online: 6C50.1\\nGambling disorder unspecified: 6C50.Z\\nGaming disorder: 6C51\\nGaming disorder predominantly online: 6C51.0\\nGaming disorder predominantly offline: 6C51.1\\nGaming disorder unspecified: 6C51.Z\\nOther specified disorders due to addictive behaviours: 6C5Y\\nDisorders due to addictive behaviours unspecified: 6C5Z\\nPyromania: 6C70\\nKleptomania: 6C71\\nCompulsive sexual behaviour disorder: 6C72\\nIntermittent explosive disorder: 6C73\\nOther specified impulse control disorders: 6C7Y\\nImpulse control disorders unspecified: 6C7Z\\nOppositional defiant disorder: 6C90\\nOppositional defiant disorder with chronic irritabilityanger: 6C90.0\\nOppositional defiant disorder with chronic irritabilityanger with limited prosocial emotions: 6C90.00\\nOppositional defiant disorder with chronic irritabilityanger with typical prosocial emotions: 6C90.01\\nOppositional defiant disorder with chronic irritabilityanger unspecified: 6C90.0Z\\nOppositional defiant disorder without chronic irritabilityanger: 6C90.1\\nOppositional defiant disorder without chronic irritabilityanger with limited prosocial emotions: 6C90.10\\nOppositional defiant disorder without chronic irritabilityanger with typical prosocial emotions: 6C90.11\\nOppositional defiant disorder without chronic irritabilityanger unspecified: 6C90.1Z\\nOppositional defiant disorder unspecified: 6C90.Z\\nConductdissocial disorder: 6C91\\nConductdissocial disorder childhood onset: 6C91.0\\nConductdissocial disorder childhood onset with limited prosocial emotions: 6C91.00\\nConductdissocial disorder childhood onset with typical prosocial emotions: 6C91.01\\nConductdissocial disorder childhood onset unspecified: 6C91.0Z\\nConductdissocial disorder adolescent onset: 6C91.1\\nConductdissocial disorder adolescent onset with limited prosocial emotions: 6C91.10\\nConductdissocial disorder adolescent onset with typical prosocial emotions: 6C91.11\\nOther specified conductdissocial disorder adolescent onset: 6C91.1Y\\nConductdissocial disorder unspecified: 6C91.Z\\nOther specified disruptive behaviour or dissocial disorders: 6C9Y\\nDisruptive behaviour or dissocial disorders unspecified: 6C9Z\\nPersonality disorder: 6D10\\nMild personality disorder: 6D10.0\\nModerate personality disorder: 6D10.1\\nSevere personality disorder: 6D10.2\\nPersonality disorder severity unspecified: 6D10.Z\\nProminent personality traits or patterns: 6D11\\nNegative affectivity in personality disorder or personality difficulty: 6D11.0\\nDetachment in personality disorder or personality difficulty: 6D11.1\\nDissociality in personality disorder or personality difficulty: 6D11.2\\nDisinhibition in personality disorder or personality difficulty: 6D11.3\\nAnankastia in personality disorder or personality difficulty: 6D11.4\\nBorderline pattern: 6D11.5\\nExhibitionistic disorder: 6D30\\nVoyeuristic disorder: 6D31\\nPedophilic disorder: 6D32\\nCoercive sexual sadism disorder: 6D33\\nFrotteuristic disorder: 6D34\\nOther paraphilic disorder involving nonconsenting individuals: 6D35\\nParaphilic disorder involving solitary behaviour or consenting individuals: 6D36\\nParaphilic disorders unspecified: 6D3Z\\nFactitious disorder imposed on self: 6D50\\nFactitious disorder imposed on another: 6D51\\nFactitious disorders unspecified: 6D5Z\\nDelirium: 6D70\\nDelirium due to disease classified elsewhere: 6D70.0\\nDelirium due to psychoactive substances including medications: 6D70.1\\nDelirium due to multiple etiological factors: 6D70.2\\nDelirium other specified cause: 6D70.Y\\nDelirium unspecified or unknown cause: 6D70.Z\\nMild neurocognitive disorder: 6D71\\nAmnestic disorder: 6D72\\nAmnestic disorder due to diseases classified elsewhere: 6D72.0\\nAmnestic disorder due to psychoactive substances including medications: 6D72.1\\nAmnestic disorder due to use of alcohol: 6D72.10\\nAmnestic disorder due to use of sedatives hypnotics or anxiolytics: 6D72.11\\nAmnestic disorder due to other specified psychoactive substance including medications: 6D72.12\\nAmnestic disorder due to use of volatile inhalants: 6D72.13\\nAmnestic disorder other specified cause: 6D72.Y\\nAmnestic disorder unknown or unspecified cause: 6D72.Z\\nDementia due to Alzheimer disease: 6D80\\nDementia due to Alzheimer disease with early onset: 6D80.0\\nDementia due to Alzheimer disease with late onset: 6D80.1\\nAlzheimer disease dementia mixed type with cerebrovascular disease: 6D80.2\\nAlzheimer disease dementia mixed type with other nonvascular aetiologies: 6D80.3\\nDementia due to Alzheimer disease onset unknown or unspecified: 6D80.Z\\nDementia due to cerebrovascular disease: 6D81\\nDementia due to Lewy body disease: 6D82\\nFrontotemporal dementia: 6D83\\nDementia due to psychoactive substances including medications: 6D84\\nDementia due to use of alcohol: 6D84.0\\nDementia due to use of sedatives hypnotics or anxiolytics: 6D84.1\\nDementia due to use of volatile inhalants: 6D84.2\\nDementia due to other specified psychoactive substance: 6D84.Y\\nDementia due to diseases classified elsewhere: 6D85\\nDementia due to Parkinson disease: 6D85.0\\nDementia due to Huntington disease: 6D85.1\\nDementia due to exposure to heavy metals and other toxins: 6D85.2\\nDementia due to human immunodeficiency virus: 6D85.3\\nDementia due to multiple sclerosis: 6D85.4\\nDementia due to prion disease: 6D85.5\\nDementia due to normal pressure hydrocephalus: 6D85.6\\nDementia due to injury to the head: 6D85.7\\nDementia due to pellagra: 6D85.8\\nDementia due to Down syndrome: 6D85.9\\nDementia due to other specified diseases classified elsewhere: 6D85.Y\\nBehavioural or psychological disturbances in dementia: 6D86\\nPsychotic symptoms in dementia: 6D86.0\\nMood symptoms in dementia: 6D86.1\\nAnxiety symptoms in dementia: 6D86.2\\nApathy in dementia: 6D86.3\\nAgitation or aggression in dementia: 6D86.4\\nDisinhibition in dementia: 6D86.5\\nWandering in dementia: 6D86.6\\nOther specified behavioural or psychological disturbances in dementia: 6D86.Y\\nBehavioural or psychological disturbances in dementia unspecified: 6D86.Z\\nDementia other specified cause: 6D8Y\\nDementia unknown or unspecified cause: 6D8Z\\nOther specified neurocognitive disorders: 6E0Y\\nNeurocognitive disorders unspecified: 6E0Z\\nMental or behavioural disorders associated with pregnancy childbirth or the puerperium without psychotic symptoms: 6E20\\nMental or behavioural disorders associated with pregnancy childbirth or the puerperium with psychotic symptoms: 6E21\\nMental or behavioural disorders associated with pregnancy childbirth or the puerperium unspecified: 6E2Z\\nPsychological or behavioural factors affecting disorders or diseases classified elsewhere: 6E40\\nMental disorder affecting disorders or diseases classified elsewhere: 6E40.0\\nPsychological symptoms affecting disorders or diseases classified elsewhere: 6E40.1\\nPersonality traits or coping style affecting disorders or diseases classified elsewhere: 6E40.2\\nMaladaptive health behaviours affecting disorders or diseases classified elsewhere: 6E40.3\\nStressrelated physiological response affecting disorders or diseases classified elsewhere: 6E40.4\\nOther specified psychological or behavioural factors affecting disorders or diseases classified elsewhere: 6E40.Y\\nPsychological or behavioural factors affecting disorders or diseases classified elsewhere unspecified: 6E40.Z\\nSecondary neurodevelopmental syndrome: 6E60\\nSecondary speech or language syndrome: 6E60.0\\nOther specified secondary neurodevelopmental syndrome: 6E60.Y\\nSecondary neurodevelopmental syndrome unspecified: 6E60.Z\\nSecondary psychotic syndrome: 6E61\\nSecondary psychotic syndrome with hallucinations: 6E61.0\\nSecondary psychotic syndrome with delusions: 6E61.1\\nSecondary psychotic syndrome with hallucinations and delusions: 6E61.2\\nSecondary psychotic syndrome with unspecified symptoms: 6E61.3\\nSecondary mood syndrome: 6E62\\nSecondary mood syndrome with depressive symptoms: 6E62.0\\nSecondary mood syndrome with manic symptoms: 6E62.1\\nSecondary mood syndrome with mixed symptoms: 6E62.2\\nSecondary mood syndrome with unspecified symptoms: 6E62.3\\nSecondary anxiety syndrome: 6E63\\nSecondary obsessivecompulsive or related syndrome: 6E64\\nSecondary dissociative syndrome: 6E65\\nSecondary impulse control syndrome: 6E66\\nSecondary neurocognitive syndrome: 6E67\\nSecondary personality change: 6E68\\nSecondary catatonia syndrome: 6E69\\nOther specified secondary mental or behavioural syndrome: 6E6Y\\nSecondary mental or behavioural syndrome unspecified: 6E6Z\\nOther specified mental behavioural or neurodevelopmental disorders: 6E8Y\\nMental behavioural or neurodevelopmental disorders unspecified: 6E8Z\\nChronic insomnia: 7A00\\nShortterm insomnia: 7A01\\nInsomnia disorders unspecified: 7A0Z\\nNarcolepsy: 7A20\\nNarcolepsy Type: 7A20.1\\nNarcolepsy unspecified: 7A20.Z\\nIdiopathic hypersomnia: 7A21\\nKleineLevin syndrome: 7A22\\nHypersomnia due to a medical condition: 7A23\\nHypersomnia due to a medication or substance: 7A24\\nHypersomnia associated with a mental disorder: 7A25\\nInsufficient sleep syndrome: 7A26\\nOther specified hypersomnolence disorders: 7A2Y\\nHypersomnolence disorders unspecified: 7A2Z\\nCentral sleep apnoeas: 7A40\\nPrimary central sleep apnoea: 7A40.0\\nPrimary central sleep apnoea of infancy: 7A40.1\\nPrimary central sleep apnoea of prematurity: 7A40.2\\nCentral sleep apnea with CheyneStokes breathing: 7A40.3\\nCentral sleep apnoea due to a medical condition without CheyneStokes breathing: 7A40.4\\nCentral sleep apnoea due to highaltitude periodic breathing: 7A40.5\\nCentral sleep apnoea due to a medication or substance: 7A40.6\\nTreatmentemergent central sleep apnoea: 7A40.7\\nOther specified central sleep apnoeas: 7A40.Y\\nCentral sleep apnoeas unspecified: 7A40.Z\\nObstructive sleep apnoea: 7A41\\nSleeprelated hypoventilation or hypoxemia disorders: 7A42\\nObesity hypoventilation syndrome: 7A42.0\\nCongenital central alveolar sleeprelated hypoventilation: 7A42.1\\nNoncongenital central hypoventilation with hypothalamic abnormalities: 7A42.2\\nIdiopathic central alveolar hypoventilation: 7A42.3\\nSleeprelated hypoventilation due to a medication or substance: 7A42.4\\nSleeprelated hypoventilation due to medical condition: 7A42.5\\nSleeprelated hypoxemia due to a medical condition: 7A42.6\\nOther specified sleeprelated hypoventilation or hypoxemia disorders: 7A42.Y\\nSleeprelated hypoventilation or hypoxemia disorders unspecified: 7A42.Z\\nOther specified sleeprelated breathing disorders: 7A4Y\\nSleeprelated breathing disorders unspecified: 7A4Z\\nDelayed sleepwake phase disorder: 7A60\\nAdvanced sleepwake phase disorder: 7A61\\nIrregular sleepwake rhythm disorder: 7A62\\nNon hour sleepwake rhythm disorder: 7A63\\nCircadian rhythm sleepwake disorder shift work type: 7A64\\nCircadian rhythm sleepwake disorder jet lag type: 7A65\\nCircadian rhythm sleepwake disorders unspecified: 7A6Z\\nRestless legs syndrome: 7A80\\nPeriodic limb movement disorder: 7A81\\nSleeprelated leg cramps: 7A82\\nSleeprelated bruxism: 7A83\\nSleeprelated rhythmic movement disorder: 7A84\\nBenign sleep myoclonus of infancy: 7A85\\nPropriospinal myoclonus at sleep onset: 7A86\\nSleeprelated movement disorder due to a medical condition: 7A87\\nSleeprelated movement disorder due to a medication or substance: 7A88\\nOther specified sleeprelated movement disorders: 7A8Y\\nSleeprelated movement disorders unspecified: 7A8Z\\nDisorders of arousal from nonREM sleep: 7B00\\nConfusional arousals: 7B00.0\\nSleepwalking disorder: 7B00.1\\nSleep terrors: 7B00.2\\nSleeprelated eating disorder: 7B00.3\\nOther specified disorders of arousal from nonREM sleep: 7B00.Y\\nDisorders of arousal from nonREM sleep unspecified: 7B00.Z\\nParasomnias related to REM sleep: 7B01\\nREM sleep behaviour disorder: 7B01.0\\nRecurrent isolated sleep paralysis: 7B01.1\\nNightmare disorder: 7B01.2\\nOther specified parasomnias related to REM sleep: 7B01.Y\\nParasomnias related to REM sleep unspecified: 7B01.Z\\nOther parasomnias: 7B02\\nHypnagogic exploding head syndrome: 7B02.0\\nSleeprelated hallucinations: 7B02.1\\nParasomnia disorder due to a medical condition: 7B02.2\\nParasomnia disorder due to a medication or substance: 7B02.3\\nOther specified parasomnia disorders: 7B0Y\\nParasomnia disorders unspecified: 7B0Z\\nOther specified sleepwake disorders: 7B2Y\\nSleepwake disorders unspecified: 7B2Z\\nParkinsonism: 8A00\\nParkinson disease: 8A00.0\\nSporadic Parkinson disease: 8A00.00\\nFamilial Parkinson disease: 8A00.01\\nOther specified Parkinson disease: 8A00.0Y\\nParkinson disease unspecified: 8A00.0Z\\nAtypical parkinsonism: 8A00.1\\nProgressive supranuclear palsy: 8A00.10\\nOther specified atypical parkinsonism: 8A00.1Y\\nAtypical parkinsonism unspecified: 8A00.1Z\\nSecondary parkinsonism: 8A00.2\\nParkinsonism due to heredodegenerative disorders: 8A00.20\\nHemiparkinsonism hemiatrophy syndrome: 8A00.21\\nInfectious or postinfectious parkinsonism: 8A00.22\\nVascular parkinsonism: 8A00.23\\nDruginduced parkinsonism: 8A00.24\\nPost traumatic Parkinsonism: 8A00.25\\nParkinsonism due to structural lesions: 8A00.26\\nOther specified secondary parkinsonism: 8A00.2Y\\nSecondary parkinsonism unspecified: 8A00.2Z\\nFunctional parkinsonism: 8A00.3\\nOther specified parkinsonism: 8A00.Y\\nParkinsonism unspecified: 8A00.Z\\nChoreiform disorders: 8A01\\nBenign hereditary chorea: 8A01.0\\nSecondary Chorea: 8A01.1\\nHuntington disease: 8A01.10\\nChorea due to Huntington diseaselike conditions: 8A01.11\\nChorea due to Dentatorubral pallidoluysian atrophy: 8A01.12\\nChorea due to Wilson disease: 8A01.13\\nChorea due to infectious or parainfectious causes: 8A01.14\\nChorea due to systemic lupus erythematosus: 8A01.15\\nDruginduced chorea: 8A01.16\\nOther specified secondary chorea: 8A01.1Y\\nSecondary chorea unspecified: 8A01.1Z\\nHemichorea or hemiballismus: 8A01.2\\nHemichorea: 8A01.20\\nBallism: 8A01.21\\nHemiballism: 8A01.22\\nOther specified choreiform disorders: 8A01.Y\\nChoreiform disorders unspecified: 8A01.Z\\nDystonic disorders: 8A02\\nPrimary dystonia: 8A02.0\\nBenign essential blepharospasm: 8A02.00\\nOther specified primary dystonia: 8A02.0Y\\nPrimary dystonia unspecified: 8A02.0Z\\nSecondary dystonia: 8A02.1\\nDruginduced dystonia: 8A02.10\\nDystoniaplus: 8A02.11\\nDystonia associated with heredodegenerative disorders: 8A02.12\\nOther specified secondary dystonia: 8A02.1Y\\nSecondary dystonia unspecified: 8A02.1Z\\nParoxysmal dystonia: 8A02.2\\nFunctional dystonia or spasms: 8A02.3\\nOther specified dystonic disorders: 8A02.Y\\nDystonic disorders unspecified: 8A02.Z\\nAtaxic disorders: 8A03\\nCongenital ataxia: 8A03.0\\nHereditary ataxia: 8A03.1\\nFriedreich ataxia: 8A03.10\\nAtaxia due to Cerebrotendinous xanthomatosis: 8A03.11\\nAtaxia due to Refsum disease: 8A03.12\\nAtaxia due to abetalipoproteinemia: 8A03.13\\nHereditary episodic ataxia: 8A03.14\\nAtaxia due to mitochondrial mutations: 8A03.15\\nSpinocerebellar ataxia: 8A03.16\\nOther specified hereditary ataxia: 8A03.1Y\\nHereditary ataxia unspecified: 8A03.1Z\\nNonhereditary degenerative ataxia: 8A03.2\\nLate onset cerebellar cortical atrophy: 8A03.20\\nOther specified nonhereditary degenerative ataxia: 8A03.2Y\\nNonhereditary degenerative ataxia unspecified: 8A03.2Z\\nAcquired ataxia: 8A03.3\\nAtaxia due to alcoholic cerebellar degeneration: 8A03.30\\nOther specified acquired ataxia: 8A03.3Y\\nAcquired ataxia unspecified: 8A03.3Z\\nOther specified ataxic disorders: 8A03.Y\\nAtaxic disorders unspecified: 8A03.Z\\nDisorders associated with tremor: 8A04\\nEnhanced physiological tremor: 8A04.0\\nEssential tremor or related tremors: 8A04.1\\nRest tremor: 8A04.2\\nSecondary tremor: 8A04.3\\nTremor due to metabolic disorders: 8A04.30\\nTremor due to chronic or acute substance use: 8A04.31\\nTremor due to drug withdrawal: 8A04.32\\nTremor due to certain specified central nervous system diseases: 8A04.33\\nOther specified secondary tremor: 8A04.3Y\\nSecondary tremor unspecified: 8A04.3Z\\nFunctional tremor: 8A04.4\\nOther specified disorders associated with tremor: 8A04.Y\\nDisorders associated with tremor unspecified: 8A04.Z\\nTic disorders: 8A05\\nPrimary tics or tic disorders: 8A05.0\\nTourette syndrome: 8A05.00\\nChronic motor tic disorder: 8A05.01\\nChronic phonic tic disorder: 8A05.02\\nTransient motor tics: 8A05.03\\nOther specified primary tics or tic disorders: 8A05.0Y\\nPrimary tics or tic disorders unspecified: 8A05.0Z\\nSecondary tics: 8A05.1\\nInfectious or postinfectious tics: 8A05.10\\nTics associated with developmental disorders: 8A05.11\\nOther specified secondary tics: 8A05.1Y\\nSecondary tics unspecified: 8A05.1Z\\nOther specified tic disorders: 8A05.Y\\nTic disorders unspecified: 8A05.Z\\nMyoclonic disorders: 8A06\\nEssential myoclonus: 8A06.0\\nSegmental myoclonus: 8A06.1\\nFocal myoclonus: 8A06.2\\nPalatal myoclonus: 8A06.20\\nChronic hiccups: 8A06.21\\nOther specified focal myoclonus: 8A06.2Y\\nFocal myoclonus unspecified: 8A06.2Z\\nOther specified myoclonic disorders: 8A06.Y\\nMyoclonic disorders unspecified: 8A06.Z\\nCertain specified movement disorder: 8A07\\nStereotypies: 8A07.0\\nPrimary stereotypy: 8A07.00\\nSecondary stereotypy: 8A07.01\\nOther specified stereotypies: 8A07.0Y\\nStereotypies unspecified: 8A07.0Z\\nAkathisia: 8A07.1\\nExcessive startle reflex: 8A07.2\\nOther specified movement disorders: 8A0Y\\nMovement disorders unspecified: 8A0Z\\nAlzheimer disease: 8A20\\nProgressive focal atrophies: 8A21\\nPosterior cortical atrophy: 8A21.0\\nOther specified progressive focal atrophies: 8A21.Y\\nProgressive focal atrophies unspecified: 8A21.Z\\nLewy body disease: 8A22\\nFrontotemporal lobar degeneration: 8A23\\nOther specified disorders with neurocognitive impairment as a major feature: 8A2Y\\nDisorders with neurocognitive impairment as a major feature unspecified: 8A2Z\\nMultiple sclerosis: 8A40\\nRelapsingremitting multiple sclerosis: 8A40.0\\nPrimary progressive multiple sclerosis: 8A40.1\\nSecondary progressive multiple sclerosis: 8A40.2\\nOther specified multiple sclerosis: 8A40.Y\\nMultiple sclerosis unspecified: 8A40.Z\\nIsolated demyelinating syndromes of the central nervous system: 8A41\\nTransverse myelitis: 8A41.0\\nNeuromyelitis optica myelin oligodendrocyte glycoprotein antibodypositive: 8A41.1\\nOther specified isolated demyelinating syndromes of the central nervous system: 8A41.Y\\nIsolated demyelinating syndromes of the central nervous system unspecified: 8A41.Z\\nAcute disseminated encephalomyelitis: 8A42\\nAcute haemorrhagic leukoencephalitis: 8A42.0\\nOther specified acute disseminated encephalomyelitis: 8A42.Y\\nAcute disseminated encephalomyelitis unspecified: 8A42.Z\\nNeuromyelitis optica: 8A43\\nNeuromyelitis optica aquaporin antibody positive: 8A43.0\\nNeuromyelitis optica aquaporin antibody negative: 8A43.1\\nSingle transverse myelitis aquaporin antibody positive: 8A43.2\\nRecurrent transverse myelitis aquaporin antibody positive: 8A43.3\\nSingle optic neuritis aquaporin antibody positive: 8A43.4\\nRecurrent optic neuritis aquaporin antibody positive: 8A43.5\\nOther specified neuromyelitis optica: 8A43.Y\\nNeuromyelitis optica unspecified: 8A43.Z\\nLeukodystrophies: 8A44\\nPelizaeusMerzbacher disease: 8A44.0\\nAdrenoleukodystrophy: 8A44.1\\nAlexander disease: 8A44.2\\nCertain specified leukodystrophies: 8A44.3\\nKrabbe disease: 8A44.4\\nLeukodystrophies unspecified: 8A44.Z\\nSecondary white matter disorders: 8A45\\nWhite matter disorders due to infections: 8A45.0\\nHuman Tcell lymphotropic virusassociated myelopathy: 8A45.00\\nSubacute sclerosing panencephalitis: 8A45.01\\nProgressive multifocal leukoencephalopathy: 8A45.02\\nOther specified white matter disorders due to infections: 8A45.0Y\\nWhite matter disorders due to infections unspecified: 8A45.0Z\\nWhite matter disorders due to toxicity: 8A45.1\\nWhite matter disorders due to vascular abnormality or ischemia: 8A45.2\\nWhite matter disorder due to CADASIL: 8A45.20\\nSubacute necrotising myelitis: 8A45.21\\nOther specified white matter disorders due to vascular abnormality or ischemia: 8A45.2Y\\nWhite matter disorders due to vascular abnormality or ischemia unspecified: 8A45.2Z\\nWhite matter disorders due to nutritional deficiency: 8A45.3\\nWhite matter disorder due to vitamin B deficiency: 8A45.30\\nCentral pontine myelinolysis: 8A45.31\\nOther specified white matter disorders due to nutritional deficiency: 8A45.3Y\\nWhite matter disorders due to nutritional deficiency unspecified: 8A45.3Z\\nWhite matter disorders due to certain specified systemic disease: 8A45.4\\nDemyelination due to sarcoidosis: 8A45.40\\nDemyelination due to systemic lupus erythematosus: 8A45.41\\nDemyelination due to Sjgren disease: 8A45.42\\nDemyelination due to Behcet disease: 8A45.43\\nDemyelination due to systemic vasculitis: 8A45.44\\nDemyelination due to mitochondrial disease: 8A45.45\\nWhite matter disorders due to certain specified systemic disease unspecified: 8A45.4Z\\nOther specified secondary white matter disorders: 8A45.Y\\nSecondary white matter disorders unspecified: 8A45.Z\\nCentral demyelination of corpus callosum: 8A46\\nOther specified multiple sclerosis or other white matter disorders: 8A4Y\\nMultiple sclerosis or other white matter disorders unspecified: 8A4Z\\nEpilepsy due to structural or metabolic conditions or diseases: 8A60\\nEpilepsy due to prenatal or perinatal brain insults: 8A60.0\\nEpilepsy due to prenatal or perinatal vascular insults: 8A60.00\\nEpilepsy due to neonatal hypoxic ischemic encephalopathy: 8A60.01\\nEpilepsy due to other prenatal or perinatal brain insults: 8A60.0Y\\nEpilepsy due to unspecified prenatal or perinatal brain insults: 8A60.0Z\\nEpilepsy due to cerebrovascular disorders: 8A60.1\\nEpilepsy due to degenerative brain disorders: 8A60.2\\nEpilepsy due to dementias: 8A60.3\\nEpilepsy due to central nervous system infections or infestations: 8A60.4\\nEpilepsy due to injuries to the head: 8A60.5\\nEpilepsy due to tumours of the nervous system: 8A60.6\\nEpilepsy with mesial temporal sclerosis: 8A60.7\\nEpilepsy due to immune disorders: 8A60.8\\nEpilepsy due to abnormalities of brain development: 8A60.9\\nEpilepsy due to genetic syndromes with widespread or progressive effects: 8A60.A\\nEpilepsy due to multiple sclerosis or other demyelinating disorders: 8A60.B\\nEpilepsy due to other structural or metabolic condition or disease: 8A60.Y\\nEpilepsy due to unspecified structural or metabolic condition or disease: 8A60.Z\\nGenetic or presumed genetic syndromes primarily expressed as epilepsy: 8A61\\nGenetic epileptic syndromes with neonatal onset: 8A61.0\\nPyridoxal dependent epilepsy: 8A61.00\\nOther specified genetic epileptic syndromes with neonatal onset: 8A61.0Y\\nGenetic epileptic syndromes with neonatal onset unspecified: 8A61.0Z\\nGenetic epileptic syndromes with onset in infancy: 8A61.1\\nBenign familial infantile epilepsy: 8A61.10\\nDravet syndrome: 8A61.11\\nEpilepsy of infancy with migrating focal seizures: 8A61.12\\nOther specified genetic epileptic syndromes with onset in infancy: 8A61.1Y\\nGenetic epileptic syndromes with onset in infancy unspecified: 8A61.1Z\\nGenetic epileptic syndromes with childhood onset: 8A61.2\\nBenign childhood epilepsy with centrotemporal spikes: 8A61.20\\nChildhood absence epilepsy: 8A61.21\\nEpilepsy with myoclonicastatic seizures: 8A61.22\\nMyoclonic absences or absences with myoclonias: 8A61.23\\nOther specified genetic epileptic syndromes with childhood onset: 8A61.2Y\\nGenetic epileptic syndromes with childhood onset unspecified: 8A61.2Z\\nGenetic epileptic syndrome with adolescent or adult onset: 8A61.3\\nJuvenile myoclonic epilepsy: 8A61.30\\nJuvenile absence epilepsy: 8A61.31\\nBenign adult familial myoclonus epilepsy: 8A61.32\\nOther specified genetic epileptic syndrome with adolescent or adult onset: 8A61.3Y\\nGenetic epileptic syndrome with adolescent or adult onset unspecified: 8A61.3Z\\nGenetic epileptic syndromes with variable age of onset: 8A61.4\\nReflex epilepsies: 8A61.40\\nProgressive myoclonic epilepsy: 8A61.41\\nOther specified genetic epileptic syndromes with variable age of onset: 8A61.4Y\\nGenetic epileptic syndromes with variable age of onset unspecified: 8A61.4Z\\nOther specified genetic or presumed genetic syndromes primarily expressed as epilepsy: 8A61.Y\\nGenetic or presumed genetic syndromes primarily expressed as epilepsy unspecified: 8A61.Z\\nEpileptic encephalopathies: 8A62\\nInfantile spasms: 8A62.0\\nLennoxGastaut syndrome: 8A62.1\\nAcquired epileptic aphasia: 8A62.2\\nOther specified epileptic encephalopathies: 8A62.Y\\nEpileptic encephalopathies unspecified: 8A62.Z\\nSeizure due to acute causes: 8A63\\nFebrile seizures: 8A63.0\\nSimple febrile seizures: 8A63.00\\nComplex febrile seizures: 8A63.01\\nOther specified febrile seizures: 8A63.0Y\\nFebrile seizures unspecified: 8A63.0Z\\nSeizure due to other acute cause: 8A63.Y\\nSeizure due to unspecified acute cause: 8A63.Z\\nSingle seizure due to remote causes: 8A64\\nSingle unprovoked seizure: 8A65\\nStatus epilepticus: 8A66\\nConvulsive status epilepticus: 8A66.0\\nNonconvulsive status epilepticus: 8A66.1\\nAbsence status epilepticus: 8A66.10\\nOther specified nonconvulsive status epilepticus: 8A66.1Y\\nNonconvulsive status epilepticus unspecified: 8A66.1Z\\nOther specified status epilepticus: 8A66.Y\\nStatus epilepticus unspecified: 8A66.Z\\nAcute repetitive seizures: 8A67\\nTypes of seizures: 8A68\\nFocal unaware seizure: 8A68.0\\nAbsence seizures atypical: 8A68.1\\nAbsence seizures typical: 8A68.2\\nFocal aware seizure: 8A68.3\\nGeneralised tonicclonic seizure: 8A68.4\\nGeneralised myoclonic seizure: 8A68.5\\nGeneralised tonic seizure: 8A68.6\\nGeneralised atonic seizure: 8A68.7\\nOther specified type of seizure: 8A68.Y\\nType of seizure unspecified: 8A68.Z\\nOther specified epilepsy or seizures: 8A6Y\\nEpilepsy or seizures unspecified: 8A6Z\\nMigraine: 8A80\\nMigraine without aura: 8A80.0\\nMigraine with aura: 8A80.1\\nHemiplegic migraine: 8A80.10\\nOther specified migraine with aura: 8A80.1Y\\nMigraine with aura unspecified: 8A80.1Z\\nChronic migraine: 8A80.2\\nComplications related to migraine: 8A80.3\\nStatus migrainosus: 8A80.30\\nOther specified complications related to migraine: 8A80.3Y\\nComplications related to migraine unspecified: 8A80.3Z\\nCyclic vomiting syndrome: 8A80.4\\nOther specified migraine: 8A80.Y\\nMigraine unspecified: 8A80.Z\\nTensiontype headache: 8A81\\nInfrequent episodic tensiontype headache: 8A81.0\\nFrequent episodic tensiontype headache: 8A81.1\\nChronic tensiontype headache: 8A81.2\\nOther specified tensiontype headache: 8A81.Y\\nTensiontype headache unspecified: 8A81.Z\\nTrigeminal autonomic cephalalgias: 8A82\\nOther primary headache disorder: 8A83\\nSecondary headache: 8A84\\nAcute headache associated with traumatic injury to the head: 8A84.0\\nPersistent headache associated with traumatic injury to the head: 8A84.1\\nOther specified secondary headache: 8A84.Y\\nSecondary headache unspecified: 8A84.Z\\nPainful cranial neuropathies or other facial pains: 8A85\\nOther specified headache disorders: 8A8Y\\nHeadache disorders unspecified: 8A8Z\\nIntracerebral haemorrhage: 8B00\\nDeep hemispheric haemorrhage: 8B00.0\\nLobar haemorrhage: 8B00.1\\nBrainstem haemorrhage: 8B00.2\\nCerebellar haemorrhage: 8B00.3\\nIntraventricular haemorrhage without parenchymal haemorrhage: 8B00.4\\nHaemorrhage of multiple sites: 8B00.5\\nIntracerebral haemorrhage site unspecified: 8B00.Z\\nSubarachnoid haemorrhage: 8B01\\nAneurysmal subarachnoid haemorrhage: 8B01.0\\nNonaneurysmal subarachnoid haemorrhage: 8B01.1\\nSubarachnoid haemorrhage not known if aneurysmal or nonaneurysmal: 8B01.2\\nNontraumatic subdural haemorrhage: 8B02\\nNontraumatic epidural haemorrhage: 8B03\\nIntracranial haemorrhage unspecified: 8B0Z\\nTransient ischaemic attack: 8B10\\nAmaurosis fugax: 8B10.0\\nOther specified transient ischaemic attack: 8B10.Y\\nTransient ischaemic attack unspecified: 8B10.Z\\nCerebral ischaemic stroke: 8B11\\nCerebral ischaemic stroke due to extracranial large artery atherosclerosis: 8B11.0\\nCerebral ischaemic stroke due to intracranial large artery atherosclerosis: 8B11.1\\nCerebral ischaemic stroke due to embolic occlusion: 8B11.2\\nCerebral ischaemic stroke due to cardiac embolism: 8B11.20\\nCerebral ischaemic stroke due to aortic arch embolism: 8B11.21\\nCerebral ischaemic stroke due to paradoxical embolism: 8B11.22\\nCerebral ischaemic stroke due to other specified embolic occlusion: 8B11.2Y\\nCerebral ischaemic stroke due to embolic occlusion unspecified: 8B11.2Z\\nCerebral ischaemic stroke due to small artery occlusion: 8B11.3\\nCerebral ischaemic stroke due to other known cause: 8B11.4\\nCerebral ischaemic stroke due to global hypoperfusion with watershed infarct: 8B11.40\\nCerebral ischaemic stroke due to other nonatherosclerotic arteriopathy: 8B11.41\\nCerebral ischaemic stroke due to hypercoagulable state: 8B11.42\\nCerebral ischaemic stroke in association with subarachnoid haemorrhage: 8B11.43\\nCerebral ischemic stroke from dissection: 8B11.44\\nCerebral ischaemic stroke of unknown cause: 8B11.5\\nCerebral ischaemic stroke due to unspecified occlusion or stenosis of extracranial large artery: 8B11.50\\nCerebral ischaemic stroke due to unspecified occlusion or stenosis of intracranial large artery: 8B11.51\\nCerebral ischaemic stroke unspecified: 8B11.5Z\\nOther specified cerebral ischaemia: 8B1Y\\nCerebral ischaemia unspecified: 8B1Z\\nStroke not known if ischaemic or haemorrhagic: 8B20\\nCerebrovascular disease with no acute cerebral symptom: 8B21\\nSilent cerebral infarct: 8B21.0\\nSilent cerebral microbleed: 8B21.1\\nOther specified cerebrovascular disease with no acute cerebral symptom: 8B21.Y\\nCerebrovascular disease with no acute cerebral symptom unspecified: 8B21.Z\\nCertain specified cerebrovascular diseases: 8B22\\nDissection of cerebral arteries: 8B22.0\\nCerebral venous thrombosis: 8B22.1\\nCerebral vasoconstriction syndromes: 8B22.2\\nIsolated cerebral amyloid angiopathy: 8B22.3\\nIntracranial vascular malformation: 8B22.4\\nArteriovenous malformation of cerebral vessels: 8B22.40\\nCerebral cavernous malformation: 8B22.41\\nDural arteriovenous fistula: 8B22.42\\nCarotid cavernous fistula: 8B22.43\\nOther specified intracranial vascular malformation: 8B22.4Y\\nIntracranial vascular malformation unspecified: 8B22.4Z\\nCerebral aneurysm nonruptured: 8B22.5\\nFamilial cerebral saccular aneurysm: 8B22.6\\nCerebral arteritis not elsewhere classified: 8B22.7\\nPrimary cerebral arteritis: 8B22.70\\nOther specified cerebral arteritis not elsewhere classified: 8B22.7Y\\nCerebral arteritis not elsewhere classified unspecified: 8B22.7Z\\nHypertensive encephalopathy: 8B22.8\\nMigraineinduced stroke: 8B22.9\\nSubclavian steal syndrome: 8B22.A\\nMoyamoya syndrome: 8B22.B\\nHereditary cerebrovascular diseases: 8B22.C\\nCADASIL cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome: 8B22.C0\\nCARASIL cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy syndrome: 8B22.C1\\nOther specified hereditary cerebrovascular diseases: 8B22.CY\\nHereditary cerebrovascular diseases unspecified: 8B22.CZ\\nOther specified cerebrovascular disease: 8B22.Y\\nCerebrovascular abnormalities: 8B23\\nHypoxicischaemic encephalopathy: 8B24\\nAnoxicischaemic encephalopathy: 8B24.0\\nOther specified hypoxicischaemic encephalopathy: 8B24.Y\\nHypoxicischaemic encephalopathy unspecified: 8B24.Z\\nLate effects of cerebrovascular disease: 8B25\\nLate effects of cerebral ischemic stroke: 8B25.0\\nLate effects of intracerebral haemorrhage: 8B25.1\\nLate effects of subarachnoid haemorrhage: 8B25.2\\nLate effects of other nontraumatic intracranial haemorrhage: 8B25.3\\nLate effects of stroke not known if ischaemic or haemorrhagic: 8B25.4\\nLate effects of other specified cerebrovascular disease: 8B25.Y\\nLate effects of cerebrovascular disease unspecified: 8B25.Z\\nVascular syndromes of brain in cerebrovascular diseases: 8B26\\nBrainstem stroke syndrome: 8B26.0\\nCerebellar stroke syndrome: 8B26.1\\nMiddle cerebral artery syndrome: 8B26.2\\nAnterior cerebral artery syndrome: 8B26.3\\nPosterior cerebral artery syndrome: 8B26.4\\nLacunar syndromes: 8B26.5\\nPure motor lacunar syndrome: 8B26.50\\nPure sensory lacunar syndrome: 8B26.51\\nOther specified lacunar syndromes: 8B26.5Y\\nLacunar syndromes unspecified: 8B26.5Z\\nOther specified vascular syndromes of brain in cerebrovascular diseases: 8B26.Y\\nVascular syndromes of brain in cerebrovascular diseases unspecified: 8B26.Z\\nCerebrovascular diseases unspecified: 8B2Z\\nCauda equina syndrome: 8B40\\nMyelitis: 8B41\\nMyelopathy: 8B42\\nNoncompressive vascular myelopathies: 8B43\\nAcute arterial infarction of the spinal cord: 8B43.0\\nAcute venous infarction of the spinal cord: 8B43.1\\nChronic venous infarction of the spinal cord: 8B43.2\\nOther specified noncompressive vascular myelopathies: 8B43.Y\\nNoncompressive vascular myelopathies unspecified: 8B43.Z\\nDegenerative myelopathic disorders: 8B44\\nHereditary spastic paraplegia: 8B44.0\\nAutosomal dominant hereditary spastic paraplegia: 8B44.00\\nAutosomal recessive hereditary spastic paraplegia: 8B44.01\\nXlinked hereditary spastic paraplegia: 8B44.02\\nOther specified hereditary spastic paraplegia: 8B44.0Y\\nHereditary spastic paraplegia unspecified: 8B44.0Z\\nOther specified degenerative myelopathic disorders: 8B44.Y\\nDegenerative myelopathic disorders unspecified: 8B44.Z\\nOther specified spinal cord disorders excluding trauma: 8B4Y\\nSpinal cord disorders excluding trauma unspecified: 8B4Z\\nMotor neuron disease: 8B60\\nAmyotrophic lateral sclerosis: 8B60.0\\nProgressive bulbar palsy: 8B60.1\\nProgressive pseudobulbar palsy: 8B60.2\\nProgressive muscular atrophy: 8B60.3\\nPrimary lateral sclerosis: 8B60.4\\nAmyotrophic lateral sclerosisPlus: 8B60.5\\nMonomelic amyotrophy: 8B60.6\\nMadras type motor neuron disease: 8B60.7\\nOther specified motor neuron disease: 8B60.Y\\nMotor neuron disease unspecified: 8B60.Z\\nSpinal muscular atrophy: 8B61\\nInfantile spinal muscular atrophy Type I: 8B61.0\\nLate infantile spinal muscular atrophy Type II: 8B61.1\\nJuvenile form spinal muscular dystrophy Type III: 8B61.2\\nAdult onset spinal muscular atrophy Type IV: 8B61.3\\nLocalised spinal muscular atrophy: 8B61.4\\nOther specified spinal muscular atrophy: 8B61.Y\\nSpinal muscular atrophy unspecified: 8B61.Z\\nPost polio progressive muscular atrophy: 8B62\\nOther specified motor neuron diseases or related disorders: 8B6Y\\nMotor neuron diseases or related disorders unspecified: 8B6Z\\nDisorders of olfactory nerve: 8B80\\nDisorders of vestibulocochlear nerve: 8B81\\nBrainstem lesion: 8B81.0\\nOther specified disorders of vestibulocochlear nerve: 8B81.Y\\nDisorders of vestibulocochlear nerve unspecified: 8B81.Z\\nDisorders of trigeminal nerve: 8B82\\nTrigeminal neuralgia: 8B82.0\\nDisorders of trigeminal nerve unspecified: 8B82.Z\\nDisorders of spinal accessory nerve: 8B83\\nDisorders of hypoglossal nerve: 8B84\\nDisorders of multiple cranial nerves: 8B85\\nDisorders of vagus nerve: 8B86\\nDisorders of glossopharyngeal nerve: 8B87\\nDisorders of facial nerve: 8B88\\nBell palsy: 8B88.0\\nFacial myokymia: 8B88.1\\nHemifacial spasm: 8B88.2\\nFacial neuritis: 8B88.3\\nOther specified disorders of facial nerve: 8B88.Y\\nDisorders of facial nerve unspecified: 8B88.Z\\nOther specified disorders of cranial nerves: 8B8Y\\nDisorders of cranial nerves unspecified: 8B8Z\\nNerve root or plexus compressions: 8B90\\nBrachial plexus disorders: 8B91\\nNeuralgic shoulder amyotrophy: 8B91.0\\nThoracic outlet syndrome due to cervical rib: 8B91.1\\nOther specified brachial plexus disorders: 8B91.Y\\nBrachial plexus disorders unspecified: 8B91.Z\\nLumbosacral plexus disorders: 8B92\\nPost radiation lumbosacral plexopathy: 8B92.0\\nVasculitic lumbosacral plexopathy: 8B92.1\\nDiabetic lumbosacral plexopathy: 8B92.2\\nLumbosacral radiculoplexopathy: 8B92.3\\nOther specified lumbosacral plexus disorders: 8B92.Y\\nLumbosacral plexus disorders unspecified: 8B92.Z\\nRadiculopathy: 8B93\\nRadiculopathy due to compression: 8B93.0\\nRadiculopathy due to metabolic disorders: 8B93.1\\nRadiculopathy due to electric shock or lightning: 8B93.2\\nRadiculopathy due to radiation injury: 8B93.3\\nRadiculopathy due to nutritional deficiencies: 8B93.4\\nRadiculopathy due to toxicity: 8B93.5\\nRadiculopathy due to intervertebral disc disorders: 8B93.6\\nRadiculopathy due to neoplastic disease: 8B93.7\\nRadiculopathy due to spondylosis: 8B93.8\\nOther specified radiculopathy: 8B93.Y\\nRadiculopathy unspecified: 8B93.Z\\nDiabetic radiculoplexoneuropathy: 8B94\\nSecondary brachial plexus lesion due to certain specified disorders: 8B95\\nOther specified nerve root or plexus disorders: 8B9Y\\nNerve root or plexus disorders unspecified: 8B9Z\\nIdiopathic progressive neuropathy: 8C00\\nInflammatory polyneuropathy: 8C01\\nAcute inflammatory demyelinating polyneuropathy: 8C01.0\\nPost vaccinal neuropathy: 8C01.1\\nSubacute inflammatory demyelinating polyneuropathy: 8C01.2\\nChronic inflammatory demyelinating polyneuropathy: 8C01.3\\nOther specified inflammatory polyneuropathy: 8C01.Y\\nInflammatory polyneuropathy unspecified: 8C01.Z\\nOther secondary polyneuropathy: 8C03\\nDiabetic polyneuropathy: 8C03.0\\nPolyneuropathy due to infectious diseases: 8C03.1\\nPolyneuropathy in neoplastic disease: 8C03.2\\nPolyneuropathy in nutritional deficiency: 8C03.3\\nPolyneuropathy in systemic connective tissue disorders: 8C03.4\\nOther specified secondary polyneuropathy: 8C03.Y\\nOther secondary polyneuropathy unspecified: 8C03.Z\\nOther specified polyneuropathy: 8C0Y\\nPolyneuropathy unspecified: 8C0Z\\nMononeuropathies of upper limb: 8C10\\nCarpal tunnel syndrome: 8C10.0\\nLesion of ulnar nerve: 8C10.1\\nLesion of radial nerve: 8C10.2\\nOther specified mononeuropathies of upper limb: 8C10.Y\\nMononeuropathies of upper limb unspecified: 8C10.Z\\nMononeuropathies of lower limb: 8C11\\nLesion of sciatic nerve: 8C11.0\\nSciatic nerve piriformis syndrome: 8C11.00\\nOther specified lesion of sciatic nerve: 8C11.0Y\\nLesion of sciatic nerve unspecified: 8C11.0Z\\nMeralgia paraesthetica: 8C11.1\\nLesion of femoral nerve: 8C11.2\\nLesion of common peroneal nerve: 8C11.3\\nLesion of tibial nerve: 8C11.4\\nTarsal tunnel syndrome: 8C11.5\\nLesion of plantar nerve: 8C11.6\\nOther specified mononeuropathies of lower limb: 8C11.Y\\nMononeuropathies of lower limb unspecified: 8C11.Z\\nCertain specified mononeuropathies: 8C12\\nIntercostal neuropathy: 8C12.0\\nMononeuritis multiplex: 8C12.1\\nLesion of suprascapular nerve: 8C12.2\\nLesion of axillary nerve: 8C12.3\\nLesion of long thoracic nerve: 8C12.4\\nTraumatic neuroma not otherwise specified: 8C12.5\\nMononeuropathy of other specified nerve: 8C12.Y\\nMononeuropathy of other specified site: 8C1Y\\nMononeuropathy of unspecified site: 8C1Z\\nHereditary motor and sensory neuropathy: 8C20\\nCharcotMarieTooth disease  demyelinating: 8C20.0\\nCharcotMarieTooth disease  axonal: 8C20.1\\nIntermediate CharcotMarieTooth disease: 8C20.2\\nOther specified hereditary motor and sensory neuropathy: 8C20.Y\\nHereditary motor and sensory neuropathy unspecified: 8C20.Z\\nHereditary sensory or autonomic neuropathy: 8C21\\nHereditary sensory and autonomic neuropathy type I: 8C21.0\\nHereditary sensory and autonomic neuropathy type III: 8C21.1\\nHereditary sensory and autonomic neuropathy type IV: 8C21.2\\nHereditary sensory and autonomic neuropathy type V: 8C21.3\\nOther specified hereditary sensory or autonomic neuropathy: 8C21.Y\\nHereditary sensory or autonomic neuropathy unspecified: 8C21.Z\\nOther specified hereditary neuropathy: 8C2Y\\nHereditary neuropathy unspecified: 8C2Z\\nOther specified disorders of nerve root plexus or peripheral nerves: 8C4Y\\nDisorders of nerve root plexus or peripheral nerves unspecified: 8C4Z\\nMyasthenia gravis: 8C60\\nDruginduced myasthenia gravis: 8C60.0\\nOther specified myasthenia gravis: 8C60.Y\\nMyasthenia gravis unspecified: 8C60.Z\\nCongenital myasthenic syndromes: 8C61\\nLambertEaton syndrome: 8C62\\nOther specified myasthenia gravis and neuromuscular junction disorders: 8C6Y\\nUnspecified myasthenia gravis or neuromuscular junction disorders: 8C6Z\\nMuscular dystrophy: 8C70\\nBecker muscular dystrophy: 8C70.0\\nDuchenne muscular dystrophy: 8C70.1\\nEmeryDreifuss muscular dystrophy: 8C70.2\\nFacioscapulohumeral muscular dystrophy: 8C70.3\\nLimbgirdle muscular dystrophy: 8C70.4\\nDominant limbgirdle muscular dystrophy: 8C70.40\\nRecessive limbgirdle muscular dystrophy: 8C70.41\\nOther specified limbgirdle muscular dystrophy: 8C70.4Y\\nLimbgirdle muscular dystrophy unspecified: 8C70.4Z\\nScapuloperoneal muscular dystrophy: 8C70.5\\nCongenital muscular dystrophy: 8C70.6\\nOther specified muscular dystrophy: 8C70.Y\\nMuscular dystrophy unspecified: 8C70.Z\\nMyotonic disorders: 8C71\\nMyotonic dystrophy: 8C71.0\\nChondrodystrophic myotonia: 8C71.1\\nMyotonia congenita: 8C71.2\\nDruginduced myotonia: 8C71.3\\nNeuromyotonia: 8C71.4\\nPseudomyotonia: 8C71.5\\nOther specified myotonic disorders: 8C71.Y\\nMyotonic disorders unspecified: 8C71.Z\\nCongenital myopathies: 8C72\\nCongenital myopathy with structural abnormalities: 8C72.0\\nNemaline myopathy: 8C72.00\\nCentronuclear myopathy: 8C72.01\\nCentral core disease: 8C72.02\\nOther specified congenital myopathy with structural abnormalities: 8C72.0Y\\nCongenital myopathy with structural abnormalities unspecified: 8C72.0Z\\nCongenital myopathy with no structural abnormalities: 8C72.1\\nOther specified congenital myopathies: 8C72.Y\\nCongenital myopathies unspecified: 8C72.Z\\nMitochondrial myopathies: 8C73\\nAutosomal recessive cardiomyopathy or ophthalmoplegia: 8C73.0\\nNeuropathy ataxia and retinitis pigmentosa: 8C73.1\\nOther specified mitochondrial myopathies: 8C73.Y\\nMitochondrial myopathies unspecified: 8C73.Z\\nPeriodic paralyses or disorders of muscle membrane excitability: 8C74\\nParamyotonia congenita: 8C74.0\\nPeriodic paralysis: 8C74.1\\nHypokalaemic periodic paralysis: 8C74.10\\nHyperkalaemic periodic paralysis: 8C74.11\\nOther specified periodic paralysis: 8C74.1Y\\nPeriodic paralysis unspecified: 8C74.1Z\\nOther specified periodic paralyses or disorders of muscle membrane excitability: 8C74.Y\\nPeriodic paralyses or disorders of muscle membrane excitability unspecified: 8C74.Z\\nDistal myopathies: 8C75\\nMyofibrillar myopathy: 8C76\\nOcular myopathy: 8C77\\nMalignant hyperthermia or hyperpyrexia: 8C78\\nOther specified primary disorders of muscles: 8C7Y\\nPrimary disorders of muscles unspecified: 8C7Z\\nDruginduced myopathy: 8C80\\nAutoimmune myopathy: 8C81\\nMyopathy in certain specified infectious or parasitic disease: 8C82\\nMyopathy in certain specified endocrine disease: 8C83\\nSecondary rhabdomyolysis: 8C84\\nOther specified secondary myopathies: 8C8Y\\nSecondary myopathies unspecified: 8C8Z\\nOther specified diseases of neuromuscular junction or muscle: 8D0Y\\nDiseases of neuromuscular junction or muscle unspecified: 8D0Z\\nSpastic cerebral palsy: 8D20\\nSpastic unilateral cerebral palsy: 8D20.0\\nSpastic bilateral cerebral palsy: 8D20.1\\nSpastic quadriplegic cerebral palsy: 8D20.10\\nSpastic diplegic cerebral palsy: 8D20.11\\nSpastic bilateral cerebral palsy unspecified: 8D20.1Z\\nOther specified spastic cerebral palsy: 8D20.Y\\nSpastic cerebral palsy unspecified: 8D20.Z\\nDyskinetic cerebral palsy: 8D21\\nAtaxic cerebral palsy: 8D22\\nWorsterDrought syndrome: 8D23\\nOther specified cerebral palsy: 8D2Y\\nCerebral palsy unspecified: 8D2Z\\nNeurological disorders due to nutrient deficiency: 8D40\\nEncephalopathy due to nutritional deficiency: 8D40.0\\nNeuropathy due to nutritional deficiency: 8D40.1\\nMyopathy due to nutritional deficiency: 8D40.2\\nIntellectual developmental disorder due to nutritional deficiency: 8D40.3\\nOther specified neurological disorders due to nutrient deficiency: 8D40.Y\\nNeurological disorders due to nutrient deficiency unspecified: 8D40.Z\\nNeurological disorders due to an excess of micro or macro nutrients: 8D41\\nPeripheral neuropathy due to vitamin B hyperalimentation: 8D41.0\\nMyopathy due to hypercalcaemia: 8D41.1\\nPseudotumour Cerebri related to Hypervitaminosis A: 8D41.2\\nOther specified neurological disorders due to an excess of micro or macro nutrients: 8D41.Y\\nNeurological disorders due to an excess of micro or macro nutrients unspecified: 8D41.Z\\nNeurological disorders due to overweight or obesity in adults or children: 8D42\\nNeurological disorders due to toxicity: 8D43\\nEncephalopathy due to toxicity: 8D43.0\\nEncephalopathy due to ammonia: 8D43.00\\nOther specified encephalopathy due to toxicity: 8D43.0Y\\nEncephalopathy due to toxicity unspecified: 8D43.0Z\\nCognitive impairment due to toxicity: 8D43.1\\nNeuropathy due to toxicity: 8D43.2\\nDruginduced polyneuropathy: 8D43.20\\nPost radiation polyneuropathy: 8D43.21\\nOther specified neuropathy due to toxicity: 8D43.2Y\\nNeuropathy due to toxicity unspecified: 8D43.2Z\\nMyopathy due to toxicity: 8D43.3\\nMovement disorders due to toxicity: 8D43.4\\nCassava poisoning: 8D43.5\\nOther specified neurological disorders due to toxicity: 8D43.Y\\nNeurological disorders due to toxicity unspecified: 8D43.Z\\nAlcoholrelated neurological disorders: 8D44\\nAlcoholic polyneuropathy: 8D44.0\\nAlcoholic myopathy: 8D44.1\\nOther specified alcoholrelated neurological disorders: 8D44.Y\\nAlcoholrelated neurological disorders unspecified: 8D44.Z\\nOther specified nutritional or toxic disorders of the nervous system: 8D4Y\\nNutritional or toxic disorders of the nervous system unspecified: 8D4Z\\nIncreased intracranial pressure: 8D60\\nBrain herniation syndromes: 8D60.0\\nCerebral oedema: 8D60.1\\nOther specified increased intracranial pressure: 8D60.Y\\nIncreased intracranial pressure unspecified: 8D60.Z\\nIntracranial hypotension: 8D61\\nSpontaneous intracranial hypotension: 8D61.0\\nSecondary intracranial hypotension: 8D61.1\\nOther specified intracranial hypotension: 8D61.Y\\nIntracranial hypotension unspecified: 8D61.Z\\nCerebrospinal fluid rhinorrhoea: 8D62\\nCerebrospinal fluid otorrhoea: 8D63\\nHydrocephalus: 8D64\\nCommunicating hydrocephalus: 8D64.0\\nIncreased cerebrospinal fluid production: 8D64.00\\nCongenital agenesis of arachnoid villi: 8D64.01\\nPost haemorrhagic hydrocephalus: 8D64.02\\nPost traumatic hydrocephalus: 8D64.03\\nNormalpressure hydrocephalus: 8D64.04\\nOther specified communicating hydrocephalus: 8D64.0Y\\nCommunicating hydrocephalus unspecified: 8D64.0Z\\nNoncommunicating hydrocephalus: 8D64.1\\nHydrocephalus due to structural malformations: 8D64.10\\nOther specified noncommunicating hydrocephalus: 8D64.1Y\\nNoncommunicating hydrocephalus unspecified: 8D64.1Z\\nExvacuo hydrocephalus: 8D64.2\\nHydrocephalus unspecified: 8D64.Z\\nCerebrospinal fluid fistula: 8D65\\nSyringomyelia or syringobulbia: 8D66\\nIdiopathic syringomyelia: 8D66.0\\nSyringomyelia due to certain specified cause: 8D66.1\\nSyringobulbia: 8D66.2\\nOther specified syringomyelia or syringobulbia: 8D66.Y\\nSyringomyelia or syringobulbia unspecified: 8D66.Z\\nIntracranial arachnoid cyst: 8D67\\nPorencephalic cyst: 8D68\\nOther specified disorders of cerebrospinal fluid pressure or flow: 8D6Y\\nDisorders of cerebrospinal fluid pressure or flow unspecified: 8D6Z\\nCongenital malformations of the autonomic nervous system: 8D80\\nInherited autonomic nervous system disorders: 8D81\\nAutoimmune disorders involving the autonomic nervous system: 8D82\\nAutonomic nervous system disorder due to infection: 8D83\\nPure autonomic nervous system failure: 8D84\\nAutonomic nervous system disorder due to substances: 8D85\\nAutonomic nervous system hyperactivity: 8D86\\nAutonomic nervous system disorder due to certain specified neurodegenerative disorder: 8D87\\nMultiple system atrophy: 8D87.0\\nMultiple system atrophy Cerebellar type: 8D87.00\\nMultiple system atrophy Parkinsonism: 8D87.01\\nOther specified multiple system atrophy: 8D87.0Y\\nMultiple system atrophy unspecified: 8D87.0Z\\nOther specified autonomic nervous system disorder due to specified neurodegenerative disorder: 8D87.Y\\nAutonomic neuropathies: 8D88\\nAutonomic neuropathy due to sodium channelopathies: 8D88.0\\nAutonomic neuropathy due to diabetes mellitus: 8D88.1\\nImmune mediated autonomic neuropathy: 8D88.2\\nAutonomic disorder due to toxins: 8D88.3\\nAutonomic neuropathy in endocrine and metabolic diseases: 8D88.4\\nOther specified autonomic neuropathies: 8D88.Y\\nAutonomic neuropathies unspecified: 8D88.Z\\nDisorders of orthostatic tolerance: 8D89\\nReflex syncope: 8D89.0\\nSyncope due to autonomic failure: 8D89.1\\nPostural orthostatic tachycardia syndrome: 8D89.2\\nBaroreflex failure: 8D89.3\\nOther specified disorders of orthostatic tolerance: 8D89.Y\\nDisorders of orthostatic tolerance unspecified: 8D89.Z\\nFocal or segmental autonomic disorders: 8D8A\\nHorner syndrome: 8D8A.1\\nEpisodic anisocoria: 8D8A.2\\nOther specified focal or segmental autonomic disorders: 8D8A.Y\\nFocal or segmental autonomic disorders unspecified: 8D8A.Z\\nDisorders affecting autonomic synaptic neurotransmission: 8D8B\\nAutonomic dysreflexia: 8D8C\\nHypoglycaemia unawareness: 8D8D\\nOther specified disorders of autonomic nervous system: 8D8Y\\nDisorders of autonomic nervous system unspecified: 8D8Z\\nSporadic CreutzfeldtJakob Disease: 8E00\\nAcquired prion disease: 8E01\\nIatrogenically acquired CreutzfeldtJakob Disease: 8E01.0\\nKuru: 8E01.1\\nVariant CreutzfeldtJakob Disease: 8E01.2\\nOther acquired CreutzfeldtJakob Disease: 8E01.3\\nAcquired prion disease unspecified: 8E01.Z\\nGenetic prion diseases: 8E02\\nGenetic CreutzfeldtJakob disease: 8E02.0\\nGerstmannStrausslerScheinker syndrome: 8E02.1\\nFatal familial insomnia: 8E02.2\\nOther genetic prion diseases: 8E02.3\\nOther specified CreutzfeldtJakob disease: 8E02.Y\\nCreutzfeldtJakob disease unspecified: 8E02.Z\\nVariably protease sensitive prionopathy: 8E03\\nOther specified human prion diseases: 8E0Y\\nHuman prion diseases unspecified: 8E0Z\\nPersistent vegetative state: 8E20\\nPermanent vegetative state: 8E21\\nMinimally conscious state: 8E22\\nMinimally conscious state plus: 8E22.0\\nMinimally conscious state minus: 8E22.1\\nOther specified minimally conscious state: 8E22.Y\\nMinimally conscious state unspecified: 8E22.Z\\nOther specified disorders of consciousness: 8E2Y\\nDisorders of consciousness unspecified: 8E2Z\\nDisorders of the meninges excluding infection: 8E40\\nNeoplastic meningitis: 8E40.0\\nChemical meningitis: 8E40.1\\nInflammatory meningitis: 8E40.2\\nArachnoiditis: 8E40.3\\nOther specified disorders of the meninges excluding infection: 8E40.Y\\nDisorders of the meninges excluding infection unspecified: 8E40.Z\\nPachymeningitis: 8E41\\nPachymeningitis due to infection: 8E41.0\\nIdiopathic hypertrophic pachymeningitis: 8E41.1\\nOther specified pachymeningitis: 8E41.Y\\nPachymeningitis unspecified: 8E41.Z\\nSuperficial siderosis of the nervous system: 8E42\\nPain disorders: 8E43\\nNeuropathic pain: 8E43.0\\nPhantom limb syndrome: 8E43.00\\nOther specified neuropathic pain: 8E43.0Y\\nNeuropathic pain unspecified: 8E43.0Z\\nOther specified pain disorders: 8E43.Y\\nPain disorders unspecified: 8E43.Z\\nPost anoxic brain damage: 8E44\\nLockedin syndrome: 8E45\\nReye syndrome: 8E46\\nEncephalopathy not elsewhere classified: 8E47\\nEncephalitis not elsewhere classified: 8E48\\nPostviral fatigue syndrome: 8E49\\nParaneoplastic or autoimmune disorders of the nervous system: 8E4A\\nParaneoplastic or autoimmune disorders of the central nervous system brain or spinal cord: 8E4A.0\\nParaneoplastic or autoimmune disorders of the peripheral or autonomic nervous system: 8E4A.1\\nParaneoplastic or autoimmune neuromuscular transmission disorders: 8E4A.2\\nParaneoplastic or autoimmune disorders of the muscle: 8E4A.3\\nOther specified paraneoplastic or autoimmune disorders of the nervous system: 8E4A.Y\\nParaneoplastic or autoimmune disorders of the nervous system unspecified: 8E4A.Z\\nPost ventricular shunting leak: 8E60\\nPost radiation injury of the nervous system: 8E61\\nRadiationinduced brain injury: 8E61.0\\nSpinal cord irradiation: 8E61.1\\nPost radiation injury of the nervous system unspecified: 8E61.Z\\nPostprocedural meningitis: 8E62\\nPost pump encephalopathy: 8E63\\nMultifocal cerebral infarctions: 8E64\\nIntracranial hypotension due to lumbar puncture: 8E66\\nOther specified diseases of the nervous system: 8E7Y\\nDiseases of the nervous system unspecified: 8E7Z\\nCongenital malposition of eyelids: 9A00\\nDystopia canthorum: 9A00.0\\nTelecanthus: 9A00.1\\nOther specified congenital malposition of eyelids: 9A00.Y\\nCongenital malposition of eyelids unspecified: 9A00.Z\\nInfectious disorders of eyelid: 9A01\\nPreseptal cellulitis: 9A01.0\\nAbscess of eyelid: 9A01.1\\nHordeolum: 9A01.2\\nHordeolum externum: 9A01.20\\nHordeolum internum: 9A01.21\\nHordeolum unspecified: 9A01.2Z\\nInfectious blepharitis: 9A01.3\\nInfestation of eyelid: 9A01.4\\nOther specified infectious disorders of eyelid: 9A01.Y\\nUnspecified infectious\\xa0disorders of eyelid: 9A01.Z\\nInflammatory disorders of eyelid: 9A02\\nChalazion: 9A02.0\\nChalazion externum: 9A02.00\\nChalazion internum: 9A02.01\\nChalazion unspecified: 9A02.0Z\\nPosterior blepharitis: 9A02.1\\nLigneous conjunctivitis: 9A02.2\\nMeibomian gland dysfunction: 9A02.4\\nOther specified inflammatory disorders of eyelid: 9A02.Y\\nInflammatory disorders of eyelid unspecified: 9A02.Z\\nAcquired malposition of eyelid: 9A03\\nBlepharoptosis: 9A03.0\\nMarcusGunn syndrome: 9A03.00\\nMechanical ptosis of eyelid: 9A03.01\\nMyogenic ptosis of eyelid: 9A03.02\\nParalytic ptosis of eyelid: 9A03.03\\nOther specified blepharoptosis: 9A03.0Y\\nBlepharoptosis unspecified: 9A03.0Z\\nEntropion of eyelid: 9A03.1\\nCicatricial entropion of eyelid: 9A03.10\\nMechanical entropion of eyelid: 9A03.11\\nSenile entropion of eyelid: 9A03.12\\nSpastic entropion of eyelid: 9A03.13\\nOther specified entropion of eyelid: 9A03.1Y\\nEntropion of eyelid unspecified: 9A03.1Z\\nEctropion of eyelid: 9A03.2\\nCicatricial ectropion of eyelid: 9A03.20\\nMechanical ectropion of eyelid: 9A03.21\\nSenile ectropion of eyelid: 9A03.22\\nSpastic ectropion of eyelid: 9A03.23\\nFloppy eyelid syndrome: 9A03.24\\nOther specified ectropion of eyelid: 9A03.2Y\\nEctropion of eyelid unspecified: 9A03.2Z\\nEyelid retraction: 9A03.3\\nLagophthalmos: 9A03.4\\nCicatricial lagophthalmos: 9A03.40\\nMechanical lagophthalmos: 9A03.41\\nParalytic lagophthalmos: 9A03.42\\nOther specified lagophthalmos: 9A03.4Y\\nLagophthalmos unspecified: 9A03.4Z\\nDermatochalasis of eyelid: 9A03.5\\nOther specified acquired malposition of eyelid: 9A03.Y\\nAcquired malposition of eyelid unspecified: 9A03.Z\\nAcquired disorders of eyelashes: 9A04\\nTrichiasis without entropion: 9A04.0\\nMadarosis of eyelid or periocular area: 9A04.1\\nOther specified acquired disorders of eyelashes: 9A04.Y\\nAcquired disorders of eyelashes unspecified: 9A04.Z\\nMovement disorders of eyelid: 9A05\\nMyokymia of eyelid: 9A05.0\\nEyelid apraxia: 9A05.1\\nOther specified movement disorders of eyelid: 9A05.Y\\nMovement disorders of eyelid unspecified: 9A05.Z\\nCertain specified disorders of eyelid: 9A06\\nInvolvement of eyelid by dermatosis classified elsewhere: 9A06.0\\nVitiligo of eyelid or periocular area: 9A06.1\\nSymblepharon acquired: 9A06.2\\nTraumatic scar of eyelid: 9A06.3\\nXanthelasma of eyelid: 9A06.4\\nTear Trough Deformity: 9A06.5\\nSunken Sulcus Deformity: 9A06.6\\nDermatitis or eczema of eyelids: 9A06.7\\nAtopic eczema of eyelids: 9A06.70\\nSeborrhoeic dermatitis of eyelids: 9A06.71\\nAllergic contact blepharoconjunctivitis: 9A06.72\\nOther specified dermatitis or eczema of eyelids: 9A06.7Y\\nDermatitis or eczema of eyelids type unspecified: 9A06.7Z\\nBlepharochalasis: 9A06.8\\nOther specified disorders of eyelid: 9A06.Y\\nOther specified disorders of eyelid or periocular area: 9A0Y\\nDisorders of eyelid or periocular area unspecified: 9A0Z\\nDisorders of lacrimal gland: 9A10\\nInfections of the lacrimal gland: 9A10.0\\nOrbital inflammatory syndrome: 9A10.1\\nBenign lymphoepithelial lesion of lacrimal gland: 9A10.2\\nHyperlacrimation: 9A10.3\\nUnderproduction of tears: 9A10.4\\nOther specified disorders of lacrimal gland: 9A10.Y\\nDisorders of lacrimal gland unspecified: 9A10.Z\\nDisorders of lacrimal drainage system: 9A11\\nEversion of lacrimal punctum: 9A11.0\\nCanaliculitis: 9A11.1\\nDacryocystitis: 9A11.2\\nConjunctivochalasis: 9A11.3\\nPunctal stenosis: 9A11.4\\nNasolacrimal canalicular stenosis: 9A11.5\\nDacryolith: 9A11.6\\nNasolacrimal sac stenosis: 9A11.7\\nNasolacrimal duct obstruction: 9A11.8\\nOther specified disorders of lacrimal drainage system: 9A11.Y\\nDisorders of lacrimal drainage system unspecified: 9A11.Z\\nOther specified disorders of lacrimal apparatus: 9A1Y\\nDisorders of lacrimal apparatus unspecified: 9A1Z\\nDisplacement of eyeball: 9A20\\nAxial displacement of eyeball: 9A20.0\\nOutward displacement of eyeball: 9A20.00\\nInward displacement of eyeball: 9A20.01\\nOther specified axial displacement of eyeball: 9A20.0Y\\nAxial displacement of eyeball unspecified: 9A20.0Z\\nNonaxial displacement of eyeball: 9A20.1\\nOther specified displacement of eyeball: 9A20.Y\\nDisplacement of eyeball unspecified: 9A20.Z\\nOrbital infection: 9A21\\nOrbital cellulitis: 9A21.0\\nOrbital subperiosteal abscess: 9A21.1\\nOrbital abscess: 9A21.2\\nPeriostitis of orbit: 9A21.3\\nOther specified orbital infection: 9A21.Y\\nOrbital infection unspecified: 9A21.Z\\nOrbital inflammation: 9A22\\nDysthyroid orbitopathy: 9A22.0\\nDiffuse orbital inflammation: 9A22.1\\nGranulomatous orbital inflammation: 9A22.2\\nOther specified orbital inflammation: 9A22.Y\\nOrbital inflammation unspecified: 9A22.Z\\nOrbital cyst: 9A23\\nCongenital orbital cyst: 9A23.0\\nAcquired orbital cyst: 9A23.1\\nOrbital cyst unspecified: 9A23.Z\\nBony deformity of orbit: 9A24\\nContraction of orbit: 9A24.0\\nExpansion of orbit: 9A24.1\\nEnlargement of bony orbit: 9A24.3\\nExostosis of orbit: 9A24.4\\nOther specified bony deformity of orbit: 9A24.Y\\nBony deformity of orbit unspecified: 9A24.Z\\nSoft tissue deformity of orbit: 9A25\\nAnophthalmic socket: 9A25.0\\nMicrophthalmic socket: 9A25.1\\nContracted socket: 9A25.2\\nOedema of orbit: 9A25.3\\nHaemorrhage of orbit: 9A25.4\\nAtrophy of soft tissue of orbit: 9A25.5\\nOther specified soft tissue deformity of orbit: 9A25.Y\\nSoft tissue deformity of orbit unspecified: 9A25.Z\\nCombined bony and soft tissue deformity of orbit: 9A26\\nOther specified disorders of orbit: 9A2Y\\nDisorders of orbit unspecified: 9A2Z\\nOther specified disorders of the ocular adnexa or orbit: 9A4Y\\nDisorders of the ocular adnexa or orbit unspecified: 9A4Z\\nConjunctivitis: 9A60\\nPapillary conjunctivitis: 9A60.0\\nGiant papillary conjunctivitis: 9A60.00\\nAcute atopic conjunctivitis: 9A60.01\\nAllergic conjunctivitis: 9A60.02\\nOther specified papillary conjunctivitis: 9A60.0Y\\nPapillary conjunctivitis unspecified: 9A60.0Z\\nFollicular conjunctivitis: 9A60.1\\nCicatrizing conjunctivitis: 9A60.2\\nMucopurulent conjunctivitis: 9A60.3\\nUlceration of conjunctiva: 9A60.30\\nAbscess of conjunctiva: 9A60.31\\nConjunctivitis due to KochWeeks bacillus: 9A60.32\\nAcute epidemic conjunctivitis: 9A60.33\\nOther specified mucopurulent conjunctivitis: 9A60.3Y\\nMucopurulent conjunctivitis unspecified: 9A60.3Z\\nBlepharoconjunctivitis: 9A60.4\\nVernal keratoconjunctivitis: 9A60.5\\nSerous conjunctivitis except viral: 9A60.6\\nOther specified conjunctivitis: 9A60.Y\\nConjunctivitis unspecified: 9A60.Z\\nCertain specified disorders of conjunctiva: 9A61\\nPingueculae: 9A61.0\\nPterygium: 9A61.1\\nPseudopterygium of conjunctiva: 9A61.2\\nConjunctival scars: 9A61.3\\nConjunctival vascular disorders: 9A61.4\\nVascular abnormalities of conjunctiva: 9A61.40\\nOther specified conjunctival vascular disorders: 9A61.4Y\\nConjunctival vascular disorders unspecified: 9A61.4Z\\nConjunctival or subconjunctival haemorrhage: 9A61.5\\nConjunctival or subconjunctival degenerations or deposits: 9A61.6\\nCertain specified disorders of conjunctiva unspecified: 9A61.Z\\nMucous membrane pemphigoid with ocular involvement: 9A62\\nOther specified disorders of conjunctiva: 9A6Y\\nDisorders of conjunctiva unspecified: 9A6Z\\nHereditary corneal dystrophies: 9A70\\nEndothelial corneal dystrophy: 9A70.0\\nOther specified hereditary corneal dystrophies: 9A70.Y\\nHereditary corneal dystrophies unspecified: 9A70.Z\\nInfectious keratitis: 9A71\\nTraumatic keratitis: 9A72\\nExposure keratitis: 9A73\\nNeurotrophic keratitis: 9A74\\nAutoimmune keratitis: 9A75\\nCorneal ulcer: 9A76\\nCorneal scars or opacities: 9A77\\nContact lensassociated corneal infiltrates: 9A77.0\\nAdherent leukoma: 9A77.1\\nOther specified corneal scars or opacities: 9A77.Y\\nCorneal scars or opacities unspecified: 9A77.Z\\nCertain specified disorders of cornea: 9A78\\nCorneal neovascularization: 9A78.0\\nCorneal pigmentations or deposits: 9A78.1\\nCorneal oedema: 9A78.2\\nBullous keratopathy: 9A78.20\\nSecondary corneal oedema: 9A78.21\\nOther specified corneal oedema: 9A78.2Y\\nCorneal oedema unspecified: 9A78.2Z\\nChanges in corneal membranes: 9A78.3\\nCorneal degeneration: 9A78.4\\nCorneal deformities: 9A78.5\\nKeratoconus: 9A78.50\\nCorneal staphyloma: 9A78.51\\nOther specified corneal deformities: 9A78.5Y\\nCorneal deformities unspecified: 9A78.5Z\\nAnaesthesia of cornea: 9A78.6\\nHypoesthesia of cornea: 9A78.7\\nRecurrent erosion of cornea: 9A78.8\\nKeratoconjunctivitis sicca: 9A79\\nCorneal abscess: 9A7A\\nSclerosing keratitis: 9A7B\\nOther specified disorders of the cornea: 9A7Y\\nDisorders of the cornea unspecified: 9A7Z\\nHyphaema: 9A80\\nParasites in the anterior chamber of the eye: 9A81\\nCyst in the anterior chamber of the eye: 9A82\\nFlat anterior chamber hypotony of eye: 9A83\\nOther specified disorders of the anterior chamber: 9A8Y\\nDisorders of the anterior chamber unspecified: 9A8Z\\nDegeneration of iris or ciliary body: 9A90\\nDisorders of chamber angle: 9A90.0\\nDegeneration of iris: 9A90.1\\nIris atrophy: 9A90.2\\nOther specified degeneration of iris or ciliary body: 9A90.Y\\nDegeneration of iris or ciliary body unspecified: 9A90.Z\\nCyst of iris or ciliary body: 9A91\\nPersistent pupillary membranes: 9A92\\nAdhesions or disruptions of iris or ciliary body: 9A93\\nCertain specified disorders of iris or ciliary body: 9A94\\nRubeosis of iris: 9A94.0\\nFloppy iris syndrome: 9A94.1\\nPlateau iris syndrome: 9A94.2\\nOther disorders of iris and ciliary body: 9A94.Y\\nAnterior uveitis: 9A96\\nAnterior uveitis not associated with systemic conditions: 9A96.0\\nAnterior uveitis associated with systemic conditions: 9A96.1\\nInfectionassociated anterior uveitis: 9A96.2\\nPrimary anterior uveitis: 9A96.3\\nOther specified anterior uveitis: 9A96.Y\\nAnterior uveitis unspecified: 9A96.Z\\nOther specified disorders of the anterior uvea: 9A9Y\\nDisorders of the anterior uvea unspecified: 9A9Z\\nDisorders of the afferent pupillary system: 9B00\\nRelative afferent pupillary defects: 9B00.0\\nAmaurotic pupillary reaction: 9B00.1\\nParadoxical pupillary reaction to light or darkness: 9B00.2\\nWernicke pupils: 9B00.3\\nOther specified disorders of the afferent pupillary system: 9B00.Y\\nDisorders of the afferent pupillary system unspecified: 9B00.Z\\nDisorders of the efferent pupillary system: 9B01\\nPhysiologic anisocoria: 9B01.0\\nParasympathoparetic pupils: 9B01.1\\nPharmacologic inhibition of the parasympathetic pathway: 9B01.2\\nIris sphincter disorders: 9B01.3\\nPharmacologic parasympathicotonic pupils: 9B01.4\\nPharmacologic sympathoparetic pupils: 9B01.5\\nSympathotonic pupils: 9B01.6\\nEpisodic unilateral mydriasis: 9B01.7\\nOther specified disorders of the efferent pupillary system: 9B01.Y\\nDisorders of the efferent pupillary system unspecified: 9B01.Z\\nLightnear dissociations: 9B02\\nArgyll Robertson pupil: 9B02.0\\nPregeniculate lightnear dissociations: 9B02.1\\nMesencephalic lightnear dissociations: 9B02.2\\nOther specified lightnear dissociations: 9B02.Y\\nLightnear dissociations unspecified: 9B02.Z\\nOther specified functional disorders of the pupil: 9B0Y\\nFunctional disorders of the pupil unspecified: 9B0Z\\nCataract: 9B10\\nAgerelated cataract: 9B10.0\\nCoronary agerelated cataract: 9B10.00\\nPunctate agerelated cataract: 9B10.01\\nMature agerelated cataract: 9B10.02\\nOther specified agerelated cataract: 9B10.0Y\\nAgerelated cataract unspecified: 9B10.0Z\\nInfantile or juvenile cataract: 9B10.1\\nCombined forms of infantile and juvenile cataract: 9B10.10\\nOther specified infantile or juvenile cataract: 9B10.1Y\\nInfantile or juvenile cataract unspecified: 9B10.1Z\\nCertain specified cataracts: 9B10.2\\nTraumatic cataract: 9B10.20\\nDiabetic cataract: 9B10.21\\nAftercataract: 9B10.22\\nSubcapsular glaucomatous flecks: 9B10.23\\nOther specified cataracts: 9B10.2Y\\nCataract unspecified: 9B10.Z\\nCertain specified disorders of lens: 9B11\\nAphakia: 9B11.0\\nDislocation of lens: 9B11.1\\nOther disorders of lens: 9B11.Y\\nDisorders of lens unspecified: 9B1Z\\nOther specified disorders of the eyeball anterior segment: 9B3Y\\nDisorders of the eyeball anterior segment unspecified: 9B3Z\\nEpiscleritis: 9B50\\nScleritis: 9B51\\nScleral staphyloma: 9B52\\nOther specified disorders of sclera: 9B5Y\\nDisorders of sclera unspecified: 9B5Z\\nChoroidal degeneration: 9B60\\nChoroidal dystrophy: 9B61\\nChorioretinal scars: 9B62\\nChoroidal haemorrhage or rupture: 9B63\\nChoroidal detachment: 9B64\\nPosterior uveitis: 9B65\\nNoninfectious posterior uveitis: 9B65.0\\nInfectious posterior uveitis: 9B65.1\\nPosterior uveitis unspecified: 9B65.Z\\nIntermediate uveitis: 9B66\\nNoninfectious intermediate uveitis: 9B66.0\\nInfectious intermediate uveitis: 9B66.1\\nIntermediate uveitis unspecified: 9B66.Z\\nOther specified disorders of the choroid: 9B6Y\\nDisorders of the choroid unspecified: 9B6Z\\nInherited retinal dystrophies: 9B70\\nRetinopathy: 9B71\\nDiabetic retinopathy: 9B71.0\\nNonproliferative diabetic retinopathy: 9B71.00\\nProliferative diabetic retinopathy: 9B71.01\\nDiabetic macular oedema: 9B71.02\\nDiabetic retinopathy unspecified: 9B71.0Z\\nHypertensive retinopathy: 9B71.1\\nRadiation retinopathy: 9B71.2\\nRetinopathy of prematurity: 9B71.3\\nParaneoplastic retinopathy: 9B71.4\\nMelanoma associated retinopathy: 9B71.40\\nOther specified paraneoplastic retinopathy: 9B71.4Y\\nParaneoplastic retinopathy unspecified: 9B71.4Z\\nAutoimmune retinopathy: 9B71.5\\nOther specified retinopathy: 9B71.Y\\nRetinopathy unspecified: 9B71.Z\\nInflammatory diseases of the retina: 9B72\\nViral retinitis: 9B72.0\\nCytomegaloviral retinitis: 9B72.00\\nHIV retinitis: 9B72.01\\nOther specified viral retinitis: 9B72.0Y\\nViral retinitis unspecified: 9B72.0Z\\nOther specified inflammatory diseases of the retina: 9B72.Y\\nInflammatory diseases of the retina unspecified: 9B72.Z\\nRetinal detachments or breaks: 9B73\\nRetinal detachment with retinal break: 9B73.0\\nRetinoschisis: 9B73.1\\nAdult retinoschisis: 9B73.10\\nJuvenile retinoschisis: 9B73.11\\nOther specified retinoschisis: 9B73.1Y\\nRetinoschisis unspecified: 9B73.1Z\\nRetinal cysts: 9B73.2\\nSerous retinal detachment: 9B73.3\\nRetinal breaks without detachment: 9B73.4\\nOther specified retinal detachments or breaks: 9B73.Y\\nRetinal detachments or breaks unspecified: 9B73.Z\\nRetinal vascular occlusions: 9B74\\nRetinal artery occlusions: 9B74.0\\nRetinal venous occlusions: 9B74.1\\nCombined retinal arterial and vein occlusion: 9B74.2\\nOther specified retinal vascular occlusions: 9B74.Y\\nRetinal vascular occlusions unspecified: 9B74.Z\\nMacular disorders: 9B75\\nAgerelated macular degeneration: 9B75.0\\nEarly agerelated macular degeneration: 9B75.00\\nIntermediate agerelated macular degeneration: 9B75.01\\nAtrophic latestage agerelated macular degeneration: 9B75.03\\nNeovascular latestage agerelated macular degeneration: 9B75.04\\nOther specified agerelated macular degeneration: 9B75.0Y\\nAgerelated macular degeneration unspecified: 9B75.0Z\\nNontraumatic macular hole: 9B75.1\\nCentral serous chorioretinopathy: 9B75.2\\nMacular telangiectasia: 9B75.3\\nOther specified macular disorders: 9B75.Y\\nMacular disorders unspecified: 9B75.Z\\nDegenerative high myopia: 9B76\\nEales disease: 9B77\\nCertain specified retinal disorders: 9B78\\nRetinal vasculopathy and cerebral leukodystrophy: 9B78.0\\nBackground retinopathy and retinal vascular changes: 9B78.1\\nChanges in retinal vascular appearance: 9B78.10\\nExudative retinopathy: 9B78.11\\nRetinal vasculitis: 9B78.12\\nRetinal telangiectasis: 9B78.13\\nOther specified background retinopathy and retinal vascular changes: 9B78.1Y\\nBackground retinopathy and retinal vascular changes unspecified: 9B78.1Z\\nOther proliferative retinopathy: 9B78.2\\nDegeneration of macula or posterior pole: 9B78.3\\nReticular pseudodrusen: 9B78.30\\nOther specified degeneration of macula or posterior pole: 9B78.3Y\\nDegeneration of macula or posterior pole unspecified: 9B78.3Z\\nPeripheral retinal degeneration: 9B78.4\\nRetinal haemorrhage: 9B78.5\\nSeparation of retinal layers: 9B78.6\\nSerous detachment of retinal pigment epithelium: 9B78.60\\nHaemorrhagic detachment of retinal pigment epithelium: 9B78.61\\nOther specified separation of retinal layers: 9B78.6Y\\nSeparation of retinal layers unspecified: 9B78.6Z\\nRetinal oedema: 9B78.7\\nRetinal ischaemia: 9B78.8\\nRetinal atrophy: 9B78.9\\nOther specified disorders of the retina: 9B7Y\\nDisorders of the retina unspecified: 9B7Z\\nInherited vitreoretinal disorders: 9B80\\nPosterior vitreous detachment: 9B81\\nVitreous prolapse: 9B82\\nVitreous haemorrhage: 9B83\\nVitreous opacities membranes or strands: 9B84\\nOther specified disorders of the vitreous body: 9B8Y\\nDisorders of the vitreous body unspecified: 9B8Z\\nOther specified disorders of the eyeball posterior segment: 9C0Y\\nDisorders of the eyeball posterior segment unspecified: 9C0Z\\nPanuveitis: 9C20\\nNoninfectious panuveitis: 9C20.0\\nInfectious panuveitis: 9C20.1\\nPurulent endophthalmitis: 9C20.2\\nOther specified panuveitis: 9C20.Y\\nPanuveitis unspecified: 9C20.Z\\nEndophthalmitis: 9C21\\nSympathetic uveitis: 9C21.0\\nOther specified endophthalmitis: 9C21.Y\\nEndophthalmitis unspecified: 9C21.Z\\nEyeball deformity: 9C22\\nAtrophia bulbi: 9C22.0\\nPhthisis bulbi: 9C22.1\\nOther specified eyeball deformity: 9C22.Y\\nEyeball deformity unspecified: 9C22.Z\\nOther specified disorders of the eyeball affecting both anterior and posterior segments: 9C2Y\\nDisorders of the eyeball affecting both anterior and posterior segments unspecified: 9C2Z\\nDisorder of the optic nerve: 9C40\\nInfectious optic neuropathy: 9C40.0\\nOptic neuritis: 9C40.1\\nRetrobulbar neuritis: 9C40.10\\nOther specified optic neuritis: 9C40.1Y\\nOptic neuritis unspecified: 9C40.1Z\\nNeuroretinitis: 9C40.2\\nPerineuritis of optic nerve: 9C40.3\\nIschaemic optic neuropathy: 9C40.4\\nAnterior ischemic optic neuropathy: 9C40.40\\nPosterior ischemic optic neuropathy: 9C40.41\\nOther specified ischaemic optic neuropathy: 9C40.4Y\\nIschaemic optic neuropathy unspecified: 9C40.4Z\\nCompressive optic neuropathy: 9C40.5\\nInfiltrative optic neuropathy: 9C40.6\\nTraumatic optic neuropathy: 9C40.7\\nHereditary optic neuropathy: 9C40.8\\nGlaucomatous optic neuropathy: 9C40.9\\nOptic disc swelling: 9C40.A\\nPapilloedema: 9C40.A0\\nOptic disc swelling associated with uveitis: 9C40.A1\\nOther specified optic disc swelling: 9C40.AY\\nOptic disc swelling unspecified: 9C40.AZ\\nOptic atrophy: 9C40.B\\nCongenital optic atrophy: 9C40.B0\\nAcquired optic atrophy: 9C40.B1\\nOptic atrophy unspecified: 9C40.BZ\\nOther specified disorder of the optic nerve: 9C40.Y\\nDisorder of the optic nerve unspecified: 9C40.Z\\nDisorder of optic chiasm: 9C41\\nDisorder of post chiasmal visual pathways: 9C42\\nDisorder of visual cortex: 9C43\\nDisorder of higher visual centres: 9C44\\nOther specified disorders of the visual pathways or centres: 9C4Y\\nDisorders of the visual pathways or centres unspecified: 9C4Z\\nGlaucoma suspect: 9C60\\nGlaucoma: 9C61\\nPrimary openangle glaucoma: 9C61.0\\nNormal tension glaucoma: 9C61.00\\nOcular hypertension: 9C61.01\\nHigh pressure primary openangle glaucoma: 9C61.02\\nOther specified primary openangle glaucoma: 9C61.0Y\\nPrimary openangle glaucoma unspecified: 9C61.0Z\\nPrimary angle closure or angle closure glaucoma: 9C61.1\\nPrimary angle closure suspect or anatomical narrow angle: 9C61.10\\nPrimary angleclosure: 9C61.11\\nPrimary angle closure glaucoma: 9C61.12\\nPrimary angle closure without pupillary block: 9C61.13\\nAcute angle closure with pupillary block: 9C61.14\\nIntermittent angleclosure: 9C61.15\\nChronic angleclosure: 9C61.16\\nCondition after acute angleclosure glaucoma attack: 9C61.17\\nOther specified primary angle closure or angle closure glaucoma: 9C61.1Y\\nPrimary angle closure or angle closure glaucoma unspecified: 9C61.1Z\\nSecondary openangle glaucoma: 9C61.2\\nPseudoexfoliative openangle glaucoma: 9C61.20\\nPigmentary openangle glaucoma: 9C61.21\\nLensinduced secondary openangle glaucoma: 9C61.22\\nGlaucoma associated with intraocular haemorrhage: 9C61.23\\nGlaucoma due to eye inflammation: 9C61.24\\nGlaucomatocyclitic crisis: 9C61.25\\nSecondary openangle glaucoma due to parasitic eye disease: 9C61.26\\nGlaucoma due to intraocular tumours: 9C61.27\\nGlaucoma associated with retinal detachment: 9C61.28\\nGlaucoma due to eye trauma: 9C61.29\\nGlaucoma due to drugs: 9C61.2A\\nGlaucoma caused by increased episcleral venous pressure: 9C61.2B\\nSecondary glaucoma due to extraocular mass: 9C61.2C\\nOther specified secondary openangle glaucoma: 9C61.2Y\\nSecondary openangle glaucoma unspecified: 9C61.2Z\\nSecondary angle closure glaucoma: 9C61.3\\nSecondary angle closure glaucoma with pupillary block: 9C61.30\\nSecondary angle closure glaucoma without pupillary block: 9C61.31\\nNeovascular secondary angle closure glaucoma: 9C61.32\\nSecondary angle closure glaucoma due to endothelial overgrowth: 9C61.33\\nSecondary angle closure glaucoma due to epithelial ingrowth: 9C61.34\\nCiliary block glaucoma: 9C61.35\\nSecondary angle closure glaucoma due to other anterior displacement of the lensiris diaphragm: 9C61.36\\nOther specified secondary angle closure glaucoma: 9C61.3Y\\nSecondary angle closure glaucoma unspecified: 9C61.3Z\\nDevelopmental glaucoma: 9C61.4\\nPrimary congenital glaucoma: 9C61.40\\nPrimary infantile glaucoma: 9C61.41\\nSecondary childhood glaucoma: 9C61.42\\nOther specified developmental glaucoma: 9C61.4Y\\nDevelopmental glaucoma unspecified: 9C61.4Z\\nGlaucoma unspecified: 9C61.Z\\nOther specified glaucoma or glaucoma suspect: 9C6Y\\nGlaucoma or glaucoma suspect unspecified: 9C6Z\\nNon paralytic strabismus: 9C80\\nEsotropia: 9C80.0\\nExotropia: 9C80.1\\nVertical or torsional strabismus: 9C80.2\\nIntermittent strabismus: 9C80.3\\nIntermittent divergent exotropia: 9C80.30\\nIntermittent convergent esotropia: 9C80.31\\nOther specified intermittent strabismus: 9C80.3Y\\nIntermittent strabismus unspecified: 9C80.3Z\\nHeterophoria: 9C80.4\\nMechanical strabismus: 9C80.5\\nOther specified non paralytic strabismus: 9C80.Y\\nNon paralytic strabismus unspecified: 9C80.Z\\nOcular motor nerve palsies: 9C81\\nThird nerve palsy: 9C81.0\\nExternal bilateral paralysis of oculomotor nerve: 9C81.00\\nOther specified third nerve palsy: 9C81.0Y\\nThird nerve palsy unspecified: 9C81.0Z\\nFourth nerve palsy: 9C81.1\\nSixth nerve palsy: 9C81.2\\nTotal external ophthalmoplegia: 9C81.3\\nCavernous sinus syndromes: 9C81.4\\nPalsy of other specified ocular motor nerve: 9C81.Y\\nPalsy of unspecified ocular motor nerve: 9C81.Z\\nDisorders of extraocular muscles: 9C82\\nProgressive external ophthalmoplegia: 9C82.0\\nMuscular dystrophy affecting extraocular muscle: 9C82.1\\nCongenital cranial dysinnervation syndrome: 9C82.2\\nRestrictive ophthalmopathy: 9C82.3\\nOculomotor apraxia: 9C82.4\\nOther specified disorders of extraocular muscles: 9C82.Y\\nDisorders of extraocular muscles unspecified: 9C82.Z\\nDisorders of binocular movement: 9C83\\nPalsy of conjugate gaze: 9C83.0\\nHorizontal gaze palsy: 9C83.00\\nVertical gaze palsy: 9C83.01\\nMonocular elevator palsy: 9C83.02\\nOther specified palsy of conjugate gaze: 9C83.0Y\\nPalsy of conjugate gaze unspecified: 9C83.0Z\\nSpasm of conjugate gaze: 9C83.1\\nHorizontal conjugate gaze deviation: 9C83.10\\nUpward gaze deviation: 9C83.11\\nDownward gaze deviation: 9C83.12\\nOculogyric crisis: 9C83.13\\nOther specified spasm of conjugate gaze: 9C83.1Y\\nSpasm of conjugate gaze unspecified: 9C83.1Z\\nConvergence insufficiency: 9C83.2\\nConvergence excess: 9C83.3\\nSpasm of the near reflex: 9C83.4\\nInternuclear ophthalmoplegia: 9C83.5\\nAnomalies of divergence or deviation of eye movement: 9C83.6\\nDivergence insufficiency: 9C83.60\\nDivergence paralysis: 9C83.61\\nDivergence excess: 9C83.62\\nSynergistic divergence: 9C83.63\\nSkew deviation: 9C83.64\\nOcular tilt reaction: 9C83.65\\nAlternating skew deviation: 9C83.66\\nDissociative vertical divergence: 9C83.67\\nOther specified anomalies of divergence or deviation of eye movement: 9C83.6Y\\nAnomalies of divergence or deviation of eye movement unspecified: 9C83.6Z\\nOther specified disorders of binocular movement: 9C83.Y\\nDisorders of binocular movement unspecified: 9C83.Z\\nNystagmus: 9C84\\nPhysiological nystagmus: 9C84.0\\nCongenital forms of nystagmus: 9C84.1\\nVestibular nystagmus: 9C84.2\\nDownbeat nystagmus: 9C84.20\\nUpbeat nystagmus: 9C84.21\\nTorsional nystagmus: 9C84.22\\nPerverted nystagmus: 9C84.23\\nOther specified vestibular nystagmus: 9C84.2Y\\nVestibular nystagmus unspecified: 9C84.2Z\\nSeesaw nystagmus: 9C84.3\\nGazeevoked nystagmus: 9C84.4\\nNystagmus occurring in visual system disorders: 9C84.5\\nVisual deprivation nystagmus: 9C84.50\\nDivergence nystagmus: 9C84.51\\nConvergenceretraction nystagmus: 9C84.52\\nOther specified nystagmus occurring in visual system disorders: 9C84.5Y\\nNystagmus occurring in visual system disorders unspecified: 9C84.5Z\\nEyelid nystagmus: 9C84.6\\nOther specified nystagmus: 9C84.Y\\nNystagmus unspecified: 9C84.Z\\nCertain specified irregular eye movements: 9C85\\nAnomalies of saccadic eye movements: 9C85.0\\nDisorders of the saccadic pulse: 9C85.00\\nDisorders of the saccadic step: 9C85.01\\nInappropriate saccades: 9C85.02\\nOther specified anomalies of saccadic eye movements: 9C85.0Y\\nAnomalies of saccadic eye movements unspecified: 9C85.0Z\\nAnomalies of smooth pursuit movements: 9C85.1\\nNonorganic eye movement disorders: 9C85.2\\nOther specified irregular eye movements: 9C85.Y\\nIrregular eye movements unspecified: 9C85.Z\\nOther specified strabismus or ocular motility disorders: 9C8Y\\nStrabismus or ocular motility disorders unspecified: 9C8Z\\nDisorders of refraction: 9D00\\nMyopia: 9D00.0\\nHypermetropia: 9D00.1\\nAstigmatism: 9D00.2\\nPresbyopia: 9D00.3\\nAnisometropia: 9D00.4\\nAniseikonia: 9D00.5\\nTransient refractive change: 9D00.6\\nOther specified disorders of refraction: 9D00.Y\\nDisorders of refraction unspecified: 9D00.Z\\nDisorders of accommodation: 9D01\\nInternal ophthalmoplegia: 9D01.0\\nParesis of accommodation: 9D01.1\\nSpasm of accommodation: 9D01.2\\nOther specified disorders of accommodation: 9D01.Y\\nDisorders of accommodation unspecified: 9D01.Z\\nOther specified disorders of refraction or accommodation: 9D0Y\\nDisorders of refraction or accommodation unspecified: 9D0Z\\nBullous aphakic keratopathy following cataract surgery: 9D20\\nCataract lens fragments in eye following cataract surgery: 9D21\\nChorioretinal scars after surgery for detachment: 9D22\\nConjunctival blebitis after glaucoma surgery: 9D23\\nComplications with glaucoma drainage devices: 9D24\\nGlaucoma due to ocular surgery or laser: 9D25\\nImpairment of visual field: 9D41\\nPatterns of visual field impairment: 9D42\\nPeripheral field deficit: 9D42.2\\nEnlarged blind spot: 9D42.20\\nArcuate scotoma: 9D42.21\\nNasal step: 9D42.22\\nRing scotoma: 9D42.23\\nIsolated peripheral scotoma: 9D42.24\\nOther specified peripheral field deficit: 9D42.2Y\\nPeripheral field deficit unspecified: 9D42.2Z\\nHemianopic or quadrantic loss: 9D42.3\\nCentral scotoma: 9D42.4\\nParacentral scotoma: 9D42.5\\nHomonymous hemianopia or quadrant anopia: 9D42.6\\nRight hemifield homonymous hemianopia or quadrant anopia: 9D42.60\\nLeft hemifield homonymous hemianopia or quadrant anopia: 9D42.61\\nOther specified homonymous hemianopia or quadrant anopia: 9D42.6Y\\nHomonymous hemianopia or quadrant anopia unspecified: 9D42.6Z\\nHeteronymous hemianopia or quadrant anopia: 9D42.7\\nBinasal defects heteronymous hemianopia or quadrant anopia: 9D42.70\\nBitemporal defects heteronymous hemianopia or quadrant anopia: 9D42.71\\nOther specified heteronymous hemianopia or quadrant anopia: 9D42.7Y\\nHeteronymous hemianopia or quadrant anopia unspecified: 9D42.7Z\\nOther specified patterns of visual field impairment: 9D42.Y\\nPatterns of visual field impairment unspecified: 9D42.Z\\nImpairment of contrast vision: 9D43\\nImpairment of colour vision: 9D44\\nImpairment of light sensitivity: 9D45\\nImpairment of binocular functions: 9D46\\nVisual discomfort: 9D50\\nTransient visual loss: 9D51\\nHemifield losses: 9D52\\nEntoptic phenomena: 9D53\\nVisual illusions: 9D54\\nNonorganic visual loss: 9D55\\nVisual release hallucinations: 9D56\\nOther specified subjective visual experiences: 9D5Y\\nSubjective visual experiences unspecified: 9D5Z\\nOther specified impairment of visual functions: 9D7Y\\nImpairment of visual functions unspecified: 9D7Z\\nVision impairment including blindness: 9D90\\nMild vision impairment: 9D90.1\\nModerate vision impairment: 9D90.2\\nSevere vision impairment: 9D90.3\\nBlindness: 9D90.6\\nNear vision impairment: 9D90.7\\nSpecific vision dysfunctions: 9D92\\nComplex visionrelated dysfunctions: 9D93\\nImpairment of presenting visual acuity: 9D94\\nImpairment of best corrected visual acuity: 9D95\\nImpairment of uncorrected visual acuity: 9D96\\nOther specified vision impairment: 9D9Y\\nVision impairment unspecified: 9D9Z\\nOther specified diseases of the visual system: 9E1Y\\nDiseases of the visual system unspecified: 9E1Z\\nAbscess of external ear: AA00\\nCellulitis of external ear: AA01\\nMalignant otitis externa: AA02\\nOtomycosis: AA03\\nPerichondritis of external ear: AA04\\nOther specified infectious diseases of external ear: AA0Y\\nInfectious diseases of external ear unspecified: AA0Z\\nSeborrhoeic otitis externa: AA10\\nAcute noninfectious otitis externa: AA11\\nChondrodermatitis nodularis: AA12\\nChronic otitis externa: AA13\\nOther specified noninfectious inflammation of external ear: AA1Y\\nNoninfectious inflammation of external ear unspecified: AA1Z\\nOther specified otitis externa: AA3Y\\nOtitis externa unspecified: AA3Z\\nAcquired deformity of external auditory canal: AA40\\nExostosis of external auditory canal: AA40.0\\nAcquired stenosis of external auditory canal: AA40.1\\nCholesteatoma of external auditory canal: AA40.2\\nOther specified acquired deformity of external auditory canal: AA40.Y\\nAcquired deformity of external auditory canal unspecified: AA40.Z\\nAcquired deformity of pinna: AA41\\nCauliflower ear: AA41.0\\nOther specified acquired deformity of pinna: AA41.Y\\nAcquired deformity of pinna unspecified: AA41.Z\\nImpacted cerumen: AA42\\nOther specified noninflammatory disorders of the external ear: AA4Y\\nNoninflammatory disorders of the external ear unspecified: AA4Z\\nDiseases of external ear unspecified: AA6Z\\nAcute serous or mucoid otitis media: AA80\\nAcute nonserous nonsuppurative otitis media: AA81\\nChronic serous or mucoid otitis media: AA82\\nNoninfected otitis media with effusion: AA83\\nNonsuppurative otitis media unspecified: AA8Z\\nAcute suppurative otitis media: AA90\\nChronic suppurative otitis media: AA91\\nChronic tubotympanic suppurative otitis media: AA91.0\\nChronic atticoantral suppurative otitis media: AA91.1\\nOther chronic suppurative otitis media: AA91.2\\nChronic suppurative otitis media unspecified: AA91.Z\\nSuppurative otitis media unspecified whether acute or chronic: AA9Z\\nAcute otitis media: AB00\\nChronic otitis media: AB01\\nOther specified otitis media: AB0Y\\nOtitis media unspecified: AB0Z\\nDisorders of Eustachian tube: AB10\\nDiverticulum of Eustachian tube: AB10.0\\nPatulous Eustachian tube: AB10.1\\nEustachian salpingitis: AB10.2\\nObstruction of Eustachian tube: AB10.3\\nOther specified disorders of Eustachian tube: AB10.Y\\nDisorders of Eustachian tube unspecified: AB10.Z\\nMastoiditis or related conditions: AB11\\nAcute mastoiditis: AB11.0\\nChronic mastoiditis: AB11.1\\nPetrositis: AB11.2\\nMastoiditis unspecified as acute or chronic: AB11.3\\nOther specified mastoiditis related conditions: AB11.Y\\nCholesteatoma of middle ear: AB12\\nPerforation of tympanic membrane: AB13\\nCentral perforation of tympanic membrane: AB13.0\\nAttic perforation of tympanic membrane: AB13.1\\nOther marginal perforations of tympanic membrane: AB13.2\\nOther specified perforation of tympanic membrane: AB13.Y\\nPerforation of tympanic membrane unspecified: AB13.Z\\nAcute myringitis: AB14\\nChronic myringitis: AB15\\nTympanosclerosis: AB16\\nAdhesive middle ear disease: AB17\\nDiscontinuity or dislocation of ear ossicles: AB18\\nAcquired abnormalities of ear ossicles not related to discontinuity or dislocation: AB19\\nPolyp of middle ear: AB1A\\nAural polyp: AB1A.0\\nOther specified polyp of middle ear: AB1A.Y\\nPolyp of middle ear unspecified: AB1A.Z\\nMiddle ear cicatrix: AB1B\\nOther specified diseases of middle ear or mastoid: AB1Y\\nDiseases of middle ear or mastoid unspecified: AB1Z\\nAcute vestibular syndrome: AB30\\nVestibular neuritis: AB30.0\\nLabyrinthitis: AB30.1\\nOther specified acute vestibular syndrome: AB30.Y\\nAcute vestibular syndrome unspecified: AB30.Z\\nEpisodic vestibular syndrome: AB31\\nMeniere disease: AB31.0\\nVestibular migraine: AB31.1\\nBenign positional paroxysmal vertigo: AB31.2\\nSuperior canal dehiscence syndrome: AB31.3\\nDisembarkment syndrome: AB31.4\\nAutoimmune inner ear disease: AB31.5\\nVestibular paroxysmia: AB31.6\\nVertiginous syndromes: AB31.7\\nOther specified episodic vestibular syndrome: AB31.Y\\nEpisodic vestibular syndrome unspecified: AB31.Z\\nChronic vestibular syndrome: AB32\\nPersistent PosturalPerceptual Dizziness: AB32.0\\nChronic unilateral idiopathic vestibulopathy: AB32.1\\nPersistent unilateral vestibulopathy after vestibular neuronitis: AB32.2\\nUnilateral vestibulopathy due to schwannoma: AB32.3\\nUnilateral vestibulopathy after medical intervention: AB32.4\\nChronic bilateral vestibulopathy: AB32.5\\nOther specified chronic vestibular syndrome: AB32.Y\\nChronic vestibular syndrome unspecified: AB32.Z\\nOtosclerosis: AB33\\nDisorders of vestibular function: AB34\\nIdiopathic bilateral vestibulopathy: AB34.0\\nOther peripheral vertigo: AB34.1\\nOther specified disorders of vestibular function: AB34.Y\\nDisorders of vestibular function unspecified: AB34.Z\\nLabyrinthine fistula: AB35\\nLabyrinthine dysfunction: AB36\\nNoise effects on inner ear: AB37\\nOther specified diseases of inner ear: AB3Y\\nDiseases of inner ear unspecified: AB3Z\\nCongenital hearing impairment: AB50\\nCongenital conductive hearing loss: AB50.0\\nCongenital sensorineural hearing loss: AB50.1\\nCongenital mixed conductive and sensorineural hearing loss: AB50.2\\nOther specified congenital hearing impairment: AB50.Y\\nCongenital hearing impairment unspecified: AB50.Z\\nAcquired hearing impairment: AB51\\nAcquired conductive hearing loss: AB51.0\\nAcquired sensorineural hearing loss: AB51.1\\nAcquired mixed conductive and sensorineural hearing loss: AB51.2\\nOther specified acquired hearing impairment: AB51.Y\\nAcquired hearing impairment unspecified: AB51.Z\\nDeafness not otherwise specified: AB52\\nOtotoxic hearing loss: AB53\\nPresbycusis: AB54\\nSudden idiopathic hearing loss: AB55\\nHereditary hearing loss: AB56\\nAuditory synaptopathy or neuropathy: AB57\\nOther specified disorders with hearing impairment: AB5Y\\nDisorders with hearing impairment unspecified: AB5Z\\nOtalgia or effusion of ear: AB70\\nOtorrhoea: AB70.0\\nOtorrhagia: AB70.1\\nOtalgia: AB70.2\\nDegenerative or vascular disorders of ear: AB71\\nDisorders of acoustic nerve: AB72\\nAcoustic neuritis: AB72.0\\nOther specified disorders of acoustic nerve: AB72.Y\\nDisorders of acoustic nerve unspecified: AB72.Z\\nAtrophy ear: AB73\\nOther specified disorders of ear not elsewhere classified: AB7Y\\nRecurrent cholesteatoma of postmastoidectomy cavity: AB90\\nMucosal cyst of postmastoidectomy cavity: AB91\\nGranulation of postmastoidectomy cavity: AB92\\nChronic inflammation of postmastoidectomy cavity: AB93\\nOther specified diseases of the ear or mastoid process: AC0Y\\nDiseases of the ear or mastoid process unspecified: AC0Z\\nEssential hypertension: BA00\\nCombined diastolic and systolic hypertension: BA00.0\\nIsolated diastolic hypertension: BA00.1\\nIsolated systolic hypertension: BA00.2\\nOther specified essential hypertension: BA00.Y\\nEssential hypertension unspecified: BA00.Z\\nHypertensive heart disease: BA01\\nHypertensive renal disease: BA02\\nHypertensive crisis: BA03\\nSecondary hypertension: BA04\\nCombined diastolic and systolic secondary hypertension: BA04.0\\nIsolated diastolic secondary hypertension: BA04.1\\nIsolated systolic secondary hypertension: BA04.2\\nOther specified secondary hypertension: BA04.Y\\nSecondary hypertension unspecified: BA04.Z\\nIdiopathic hypotension: BA20\\nOrthostatic hypotension: BA21\\nOther specified hypotension: BA2Y\\nHypotension unspecified: BA2Z\\nAngina pectoris: BA40\\nUnstable angina: BA40.0\\nStable angina: BA40.1\\nOther specified angina pectoris: BA40.Y\\nAngina pectoris unspecified: BA40.Z\\nAcute myocardial infarction: BA41\\nAcute ST elevation myocardial infarction: BA41.0\\nAcute nonST elevation myocardial infarction: BA41.1\\nAcute myocardial infarction unspecified: BA41.Z\\nSubsequent myocardial infarction: BA42\\nSubsequent myocardial infarction ST elevation myocardial infarction: BA42.0\\nSubsequent myocardial infarction nonST elevation myocardial infarction: BA42.1\\nSubsequent myocardial infarction unspecified: BA42.Z\\nCoronary thrombosis not resulting in myocardial infarction: BA43\\nAcute ischaemic heart disease unspecified: BA4Z\\nOld myocardial infarction: BA50\\nIschaemic cardiomyopathy: BA51\\nDilated cardiomyopathy due to congenital anomaly of coronary artery: BA51.0\\nOther specified ischaemic cardiomyopathy: BA51.Y\\nIschaemic cardiomyopathy unspecified: BA51.Z\\nCoronary atherosclerosis: BA52\\nCoronary atherosclerosis of native coronary artery: BA52.0\\nCoronary atherosclerosis of autologous bypass graft: BA52.1\\nCoronary atherosclerosis of arterial autologous bypass graft: BA52.10\\nCoronary atherosclerosis of venous autologous bypass graft: BA52.11\\nCoronary atherosclerosis of unspecified autologous bypass graft: BA52.1Z\\nCoronary atherosclerosis of nonautologous bypass graft: BA52.2\\nCoronary atherosclerosis unspecified site: BA52.Z\\nOther specified chronic ischaemic heart disease: BA5Y\\nChronic ischaemic heart disease unspecified: BA5Z\\nCertain current complications following acute myocardial infarction: BA60\\nDressler syndrome: BA60.0\\nOther pericarditis as current complication following acute myocardial infarction: BA60.1\\nVentricular aneurysm as current complication following acute myocardial infarction: BA60.2\\nVentricular septal defect as current complication following acute myocardial infarction: BA60.3\\nCardiac rupture as current complication following acute myocardial infarction: BA60.4\\nPulmonary embolism as current complication following acute myocardial infarction: BA60.5\\nRupture of papillary muscle or chordae tendineae as current complication following acute myocardial infarction: BA60.6\\nMural thrombus as current complication following acute myocardial infarction: BA60.7\\nArrhythmia as current complication following acute myocardial infarction: BA60.8\\nCardiogenic shock unrelated to mechanical complications as current complication following acute myocardial infarction: BA60.9\\nOther specified current complications following acute myocardial infarction: BA60.Y\\nCertain current complications following acute myocardial infarction unspecified: BA60.Z\\nIschaemic heart diseases unspecified: BA6Z\\nCoronary artery aneurysm: BA81\\nCoronary artery aneurysm with perforation: BA81.0\\nCoronary artery aneurysm with rupture: BA81.1\\nCoronary artery aneurysm without mention of perforation or rupture: BA81.2\\nCoronary artery dissection: BA82\\nCoronary artery fistula acquired: BA83\\nChronic total occlusion of coronary artery: BA84\\nCoronary vasospastic disease: BA85\\nSilent coronary vasospastic disease: BA85.0\\nOther specified coronary vasospastic disease: BA85.Y\\nCoronary vasospastic disease unspecified: BA85.Z\\nCoronary microvascular disease: BA86\\nOther specified diseases of coronary artery: BA8Y\\nDiseases of coronary artery unspecified: BA8Z\\nPulmonary thromboembolism: BB00\\nAcute pulmonary thromboembolism: BB00.0\\nChronic pulmonary thromboembolism: BB00.1\\nPulmonary thromboembolism unspecified: BB00.Z\\nPulmonary hypertension: BB01\\nPulmonary arterial hypertension: BB01.0\\nPulmonary hypertension due to left heart disease: BB01.1\\nPulmonary hypertension due to lung disease or hypoxia: BB01.2\\nChronic thromboembolic pulmonary hypertension: BB01.3\\nPulmonary hypertension with multifactorial mechanism: BB01.4\\nCor pulmonale: BB01.5\\nPulmonary hypertension unspecified: BB01.Z\\nCertain specified diseases of pulmonary vessels: BB02\\nArteriovenous fistula of pulmonary vessels: BB02.0\\nAneurysm of pulmonary artery: BB02.1\\nAneurysm of pulmonary artery with perforation: BB02.10\\nAneurysm of pulmonary artery with rupture: BB02.11\\nAneurysm of pulmonary artery without mention of perforation or rupture: BB02.12\\nOther specified aneurysm of pulmonary artery: BB02.1Y\\nAneurysm of pulmonary artery unspecified: BB02.1Z\\nRupture of pulmonary vessels: BB02.2\\nAcquired pulmonary arterial tree abnormality: BB02.3\\nAcquired pulmonary venous abnormality: BB03\\nAcquired pulmonary venous obstruction: BB03.0\\nOther specified acquired pulmonary venous abnormality: BB03.Y\\nAcquired pulmonary venous abnormality unspecified: BB03.Z\\nOther specified pulmonary heart disease or diseases of pulmonary circulation: BB0Y\\nPulmonary heart disease or diseases of pulmonary circulation unspecified: BB0Z\\nAcute pericarditis: BB20\\nInfectious pericarditis: BB20.0\\nNeoplastic pericarditis: BB20.1\\nMyopericarditis: BB20.2\\nOther specified acute pericarditis: BB20.Y\\nAcute pericarditis unspecified: BB20.Z\\nChronic rheumatic pericarditis: BB21\\nConstrictive pericarditis: BB22\\nCardiac tamponade: BB23\\nHaemopericardium: BB24\\nPericardial effusion: BB25\\nOther specified pericarditis: BB2Y\\nPericarditis unspecified: BB2Z\\nAcute or subacute infectious endocarditis: BB40\\nMyoendocarditis: BB41\\nPeriendocarditis: BB42\\nOther specified acute or subacute endocarditis: BB4Y\\nAcute or subacute endocarditis unspecified: BB4Z\\nMitral valve stenosis: BB60\\nRheumatic mitral valve stenosis: BB60.0\\nNonrheumatic mitral valve stenosis: BB60.1\\nMitral valve stenosis unspecified: BB60.Z\\nMitral valve insufficiency: BB61\\nRheumatic mitral valve insufficiency: BB61.0\\nOther specified mitral valve insufficiency: BB61.Y\\nMitral valve insufficiency unspecified: BB61.Z\\nMitral valve prolapse: BB62\\nRheumatic mitral valve prolapse: BB62.0\\nDegenerative mitral valve prolapse: BB62.1\\nOther specified nonrheumatic mitral valve prolapse: BB62.Y\\nMitral valve prolapse unspecified: BB62.Z\\nMitral valve stenosis with insufficiency: BB63\\nRheumatic mitral stenosis with insufficiency: BB63.0\\nNonrheumatic mitral stenosis with insufficiency: BB63.1\\nMitral valve stenosis with insufficiency unspecified: BB63.Z\\nMitral valvar abscess: BB64\\nMitral valve rupture: BB65\\nOther specified mitral valve disease: BB6Y\\nMitral valve disease unspecified: BB6Z\\nAortic valve stenosis: BB70\\nRheumatic aortic valve stenosis: BB70.0\\nNonrheumatic aortic valve stenosis: BB70.1\\nOther specified aortic valve stenosis: BB70.Y\\nAortic valve stenosis unspecified: BB70.Z\\nAortic valve insufficiency: BB71\\nRheumatic aortic valve insufficiency: BB71.0\\nOther specified nonrheumatic aortic valve insufficiency: BB71.Y\\nAortic valve insufficiency unspecified: BB71.Z\\nAortic valve stenosis with insufficiency: BB72\\nRheumatic aortic stenosis with insufficiency: BB72.0\\nNonrheumatic aortic valve stenosis with insufficiency: BB72.1\\nAortic valve stenosis with insufficiency unspecified: BB72.Z\\nAortic valvar abscess: BB73\\nAortic valvar prolapse: BB74\\nOther specified aortic valve disease: BB7Y\\nAortic valve disease unspecified: BB7Z\\nTricuspid valve stenosis: BB80\\nRheumatic tricuspid valve stenosis: BB80.0\\nOther specified nonrheumatic tricuspid valve stenosis: BB80.Y\\nTricuspid valve stenosis unspecified: BB80.Z\\nTricuspid valve insufficiency: BB81\\nRheumatic tricuspid valve insufficiency: BB81.0\\nOther specified nonrheumatic tricuspid valve insufficiency: BB81.Y\\nTricuspid valve insufficiency unspecified: BB81.Z\\nTricuspid valve stenosis with insufficiency: BB82\\nRheumatic tricuspid valve stenosis with insufficiency: BB82.0\\nOther specified nonrheumatic tricuspid valve stenosis with insufficiency: BB82.Y\\nTricuspid valve stenosis with insufficiency unspecified: BB82.Z\\nTricuspid valvular abscess: BB83\\nTricuspid valve rupture: BB84\\nOther specified tricuspid valve disease: BB8Y\\nTricuspid valve disease unspecified: BB8Z\\nPulmonary valve stenosis: BB90\\nRheumatic pulmonary valve stenosis: BB90.0\\nOther specified nonrheumatic pulmonary valve stenosis: BB90.Y\\nPulmonary valve stenosis unspecified: BB90.Z\\nPulmonary valve insufficiency: BB91\\nRheumatic pulmonary valve insufficiency: BB91.0\\nOther specified nonrheumatic pulmonary valve insufficiency: BB91.Y\\nPulmonary valve insufficiency unspecified: BB91.Z\\nPulmonary valve stenosis with insufficiency: BB92\\nRheumatic pulmonary valve stenosis with insufficiency: BB92.0\\nNonrheumatic pulmonary valve stenosis with insufficiency: BB92.1\\nPulmonary valve stenosis with insufficiency unspecified: BB92.Z\\nPulmonary valvar abscess: BB93\\nOther specified pulmonary valve disease: BB9Y\\nPulmonary valve disease unspecified: BB9Z\\nMultiple valve disease: BC00\\nProsthetic valve disease: BC01\\nAcquired abnormality of congenitally malformed valve: BC02\\nAcquired common atrioventricular valvar abnormality in biventricular connections: BC02.0\\nAcquired truncal valvar abnormality: BC02.1\\nAcquired common atrioventricular valvar abnormality in double inlet ventricle: BC02.2\\nAcquired abnormality of neoaortic valve of pulmonary origin: BC02.3\\nStenosis of the neoaortic valve of pulmonary origin: BC02.30\\nInsufficiency of the neoaortic valve of pulmonary origin: BC02.31\\nOther specified acquired abnormality of neoaortic valve of pulmonary origin: BC02.3Y\\nAcquired abnormality of neoaortic valve of pulmonary origin unspecified: BC02.3Z\\nAcquired abnormality of the neoaortic valve of truncal origin: BC02.4\\nAcquired stenosis of the neoaortic valve of truncal origin: BC02.40\\nAcquired regurgitation of the neoaortic valve of truncal origin: BC02.41\\nOther specified acquired abnormality of the neoaortic valve of truncal origin: BC02.4Y\\nAcquired abnormality of the neoaortic valve of truncal origin unspecified: BC02.4Z\\nOther specified acquired abnormality of congenitally malformed valve: BC02.Y\\nAcquired abnormality of congenitally malformed valve unspecified: BC02.Z\\nHeart valve diseases unspecified: BC0Z\\nChronic rheumatic heart diseases not elsewhere classified: BC20\\nRheumatic diseases of endocardium valve unspecified: BC20.0\\nOther specified chronic rheumatic heart disease: BC20.Y\\nChronic rheumatic heart disease unspecified: BC20.Z\\nAcquired atrial abnormality: BC40\\nAcquired interatrial communication: BC40.0\\nOther specified acquired atrial abnormality: BC40.Y\\nAcquired atrial abnormality unspecified: BC40.Z\\nAcquired ventricular abnormality: BC41\\nAcquired interventricular communication: BC41.0\\nOther specified acquired ventricular abnormality: BC41.Y\\nAcquired ventricular abnormality unspecified: BC41.Z\\nMyocarditis: BC42\\nGiant cell myocarditis: BC42.0\\nInfectious myocarditis: BC42.1\\nHypersensitivity myocarditis: BC42.2\\nRheumatic myocarditis: BC42.3\\nOther specific myocarditis: BC42.Y\\nMyocarditis unspecified: BC42.Z\\nCardiomyopathy: BC43\\nDilated cardiomyopathy: BC43.0\\nFamilialgenetic dilated cardiomyopathy: BC43.00\\nNonfamilial dilated cardiomyopathy: BC43.01\\nDilated cardiomyopathy unspecified: BC43.0Z\\nHypertrophic cardiomyopathy: BC43.1\\nFamilialgenetic hypertrophic cardiomyopathy: BC43.10\\nNonobstructive hypertrophic cardiomyopathy: BC43.11\\nObstructive hypertrophic cardiomyopathy: BC43.12\\nOther specified hypertrophic cardiomyopathy: BC43.1Y\\nHypertrophic cardiomyopathy unspecified: BC43.1Z\\nRestrictive cardiomyopathy: BC43.2\\nNonfamilial restrictive cardiomyopathy: BC43.20\\nOther specified restrictive cardiomyopathy: BC43.2Y\\nRestrictive cardiomyopathy unspecified: BC43.2Z\\nEndocardial fibroelastosis: BC43.3\\nCardiomyopathy due to drugs or other external agents: BC43.4\\nStressinduced cardiomyopathy: BC43.5\\nArrhythmogenic ventricular cardiomyopathy: BC43.6\\nDiabetic cardiomyopathy: BC43.7\\nOther specified cardiomyopathy: BC43.Y\\nCardiomyopathy unspecified: BC43.Z\\nNoncompaction cardiomyopathy: BC44\\nCardiomegaly: BC45\\nIntracardiac thrombosis: BC46\\nOther specified diseases of the myocardium or cardiac chambers: BC4Y\\nDiseases of the myocardium or cardiac chambers unspecified: BC4Z\\nAtrial premature depolarization: BC60\\nJunctional premature depolarization: BC61\\nAccessory pathway: BC62\\nConduction disorders: BC63\\nAtrioventricular block first degree: BC63.0\\nAtrioventricular block second degree: BC63.1\\nHighgrade second degree atrioventricular block: BC63.10\\nOther specified atrioventricular block second degree: BC63.1Y\\nAtrioventricular block second degree unspecified: BC63.1Z\\nComplete atrioventricular block: BC63.2\\nCongenital complete atrioventricular block: BC63.20\\nAcquired complete atrioventricular block: BC63.21\\nComplete atrioventricular block unspecified: BC63.2Z\\nRight bundle branch block: BC63.3\\nLeft bundle branch block: BC63.4\\nLeft anterior fascicular block: BC63.40\\nLeft posterior fascicular block: BC63.41\\nLeft bundle branch block fascicle unspecified: BC63.4Z\\nNonspecific intraventricular conduction delay: BC63.5\\nOther specified conduction disorders: BC63.Y\\nConduction disorders unspecified: BC63.Z\\nSudden arrhythmic death syndrome: BC64\\nCardiac arrhythmia associated with genetic disorder: BC65\\nLong QT syndrome: BC65.0\\nBrugada syndrome: BC65.1\\nShort QT syndrome: BC65.2\\nEarly repolarisation syndrome: BC65.3\\nIdiopathic ventricular fibrillation: BC65.4\\nCatecholaminergic polymorphic ventricular tachycardia: BC65.5\\nOther specified cardiac arrhythmia associated with genetic disorder: BC65.Y\\nCardiac arrhythmia associated with genetic disorder unspecified: BC65.Z\\nVentricular premature depolarization: BC70\\nVentricular tachyarrhythmia: BC71\\nVentricular tachycardia: BC71.0\\nRight outflow tract ventricular tachycardia: BC71.00\\nPolymorphic ventricular tachycardia: BC71.01\\nSustained ventricular tachycardia: BC71.02\\nNonsustained ventricular tachycardia: BC71.03\\nOther specified ventricular tachycardia: BC71.0Y\\nVentricular tachycardia unspecified: BC71.0Z\\nVentricular fibrillation: BC71.1\\nReentry ventricular arrhythmia: BC71.2\\nOther specified ventricular tachyarrhythmia: BC71.Y\\nVentricular tachyarrhythmia unspecified: BC71.Z\\nOther specified ventricular rhythm disturbance: BC7Y\\nVentricular rhythm disturbance unspecified: BC7Z\\nSupraventricular bradyarrhythmia: BC80\\nSinus pause: BC80.0\\nSinus bradycardia: BC80.1\\nSinus node dysfunction: BC80.2\\nSick sinus syndrome: BC80.20\\nSinoatrial block: BC80.21\\nOther specified sinus node dysfunction: BC80.2Y\\nSinus node dysfunction unspecified: BC80.2Z\\nOther specified supraventricular bradyarrhythmia: BC80.Y\\nSupraventricular bradyarrhythmia unspecified: BC80.Z\\nSupraventricular tachyarrhythmia: BC81\\nEctopic atrial tachycardia: BC81.0\\nJunctional ectopic tachycardia: BC81.1\\nMacro reentrant atrial tachycardia: BC81.2\\nCavotricuspid isthmus dependent macroreentry tachycardia: BC81.20\\nNonscar nonisthmus dependent macro reentrant atrial tachycardia: BC81.21\\nScar mediated macro reentrant atrial tachycardia: BC81.22\\nOther specified macro reentrant atrial tachycardia: BC81.2Y\\nMacro reentrant atrial tachycardia unspecified: BC81.2Z\\nAtrial fibrillation: BC81.3\\nParoxysmal atrial fibrillation: BC81.30\\nPersistent atrial fibrillation: BC81.31\\nPermanent atrial fibrillation: BC81.32\\nPreexcited atrial fibrillation: BC81.33\\nOther specified atrial fibrillation: BC81.3Y\\nAtrial fibrillation unspecified: BC81.3Z\\nWolffParkinsonWhite syndrome: BC81.4\\nSinus node reentrant tachycardia: BC81.5\\nInappropriate sinus tachycardia: BC81.6\\nAtrioventricular reciprocating tachycardia: BC81.7\\nAtrioventricular reciprocating tachycardia orthodromic: BC81.70\\nAtrioventricular reciprocating tachycardia antidromic: BC81.71\\nOther specified atrioventricular reciprocating tachycardia: BC81.7Y\\nAtrioventricular reciprocating tachycardia unspecified: BC81.7Z\\nAtrioventricular nodal reentry tachycardia: BC81.8\\nOther specified supraventricular tachyarrhythmia: BC81.Y\\nSupraventricular tachyarrhythmia unspecified: BC81.Z\\nOther specified supraventricular rhythm disturbance: BC8Y\\nSupraventricular rhythm disturbance unspecified: BC8Z\\nRhythm disturbance at level of atrioventricular junction: BC90\\nPacemaker or implantable cardioverter defibrillator battery at end of battery life: BC91\\nOther specified cardiac arrhythmia: BC9Y\\nCardiac arrhythmia unspecified: BC9Z\\nCongestive heart failure: BD10\\nLeft ventricular failure: BD11\\nLeft ventricular failure with preserved ejection fraction: BD11.0\\nLeft ventricular failure with mid range ejection fraction: BD11.1\\nLeft ventricular failure with reduced ejection fraction: BD11.2\\nLeft ventricular failure unspecified: BD11.Z\\nHigh output syndromes: BD12\\nRight ventricular failure: BD13\\nBiventricular failure: BD14\\nOther specified heart failure: BD1Y\\nHeart failure unspecified: BD1Z\\nAcute arterial occlusion: BD30\\nAcute upper limb arterial occlusion: BD30.0\\nAcute thromboembolic upper limb arterial occlusion: BD30.00\\nAcute thrombotic upper limb arterial occlusion: BD30.01\\nOther specified acute upper limb arterial occlusion: BD30.0Y\\nAcute upper limb arterial occlusion unspecified: BD30.0Z\\nAcute aortoiliac occlusion: BD30.1\\nAcute thromboembolic aortoiliac occlusion: BD30.10\\nAcute thrombotic aortoiliac occlusion: BD30.11\\nOther specified acute aortoiliac occlusion: BD30.1Y\\nAcute aortoiliac occlusion unspecified: BD30.1Z\\nAcute lower limb arterial occlusion: BD30.2\\nAcute thromboembolic lower limb arterial occlusion: BD30.20\\nAcute thrombotic lower limb arterial occlusion: BD30.21\\nOther specified acute lower limb arterial occlusion: BD30.2Y\\nAcute lower limb arterial occlusion unspecified: BD30.2Z\\nOther specified acute arterial occlusion: BD30.Y\\nAcute arterial occlusion unspecified: BD30.Z\\nAtherosclerotic chronic arterial occlusive disease: BD40\\nLower limb atherosclerosis: BD40.0\\nAtherosclerosis of aorta: BD40.1\\nAtherosclerosis of renal artery: BD40.2\\nAortic bifurcation syndrome: BD40.3\\nOther specified atherosclerotic chronic arterial occlusive disease: BD40.Y\\nAtherosclerotic chronic arterial occlusive disease unspecified: BD40.Z\\nNonatherosclerotic chronic arterial occlusive disease: BD41\\nArterial fibromuscular dysplasia: BD41.0\\nOther specified nonatherosclerotic chronic arterial occlusive disease: BD41.Y\\nNonatherosclerotic chronic arterial occlusive disease unspecified: BD41.Z\\nRaynaud phenomenon: BD42\\nPrimary Raynaud disease: BD42.0\\nSecondary Raynaud phenomenon: BD42.1\\nRaynaud phenomenon unspecified: BD42.Z\\nOther specified chronic arterial occlusive disease: BD4Y\\nChronic arterial occlusive disease unspecified: BD4Z\\nAortic aneurysm or dissection: BD50\\nThoracic aortic dissection ascending aorta dissection and propagation beyond arch: BD50.0\\nThoracic aortic dissection ascending aorta dissection and propagation beyond arch with perforation: BD50.00\\nThoracic aortic dissection ascending aorta dissection and propagation beyond arch with rupture: BD50.01\\nThoracic aortic dissection ascending aorta dissection and propagation beyond arch without mention of perforation or rupture: BD50.0Z\\nAscending aorta dissection not beyond arch: BD50.1\\nAscending aorta dissection not beyond arch with perforation: BD50.10\\nAscending aorta dissection not beyond arch with rupture: BD50.11\\nAscending aorta dissection not beyond arch without mention of perforation or rupture: BD50.1Z\\nDescending aorta dissection and distal propagation: BD50.2\\nDescending aorta dissection and distal propagation with perforation: BD50.20\\nDescending aorta dissection and distal propagation with rupture: BD50.21\\nOther specified descending aorta dissection and distal propagation: BD50.2Y\\nDescending aorta dissection and distal propagation unspecified: BD50.2Z\\nThoracic aortic aneurysm: BD50.3\\nThoracic aortic aneurysm with perforation: BD50.30\\nThoracic aortic aneurysm with rupture: BD50.31\\nThoracic aortic aneurysm without mention of perforation or rupture: BD50.3Z\\nAbdominal aortic aneurysm: BD50.4\\nAbdominal aortic aneurysm with perforation: BD50.40\\nAbdominal aortic aneurysm with rupture: BD50.41\\nAbdominal aortic aneurysm without mention of perforation or rupture: BD50.4Z\\nThoracoabdominal aortic aneurysm: BD50.5\\nThoracoabdominal aortic aneurysm with perforation: BD50.50\\nThoracoabdominal aortic aneurysm with rupture: BD50.51\\nThoracoabdominal aortic aneurysm without mention of perforation or rupture: BD50.5Z\\nAortic aneurysm or dissection unspecified: BD50.Z\\nArterial aneurysm or dissection excluding aorta: BD51\\nAneurysm or dissection of carotid artery: BD51.0\\nAneurysm or dissection of vertebral artery: BD51.1\\nAneurysm or dissection of other precerebral arteries: BD51.2\\nAneurysm or dissection of artery of upper extremity: BD51.3\\nAneurysm or dissection of renal artery: BD51.4\\nAneurysm or dissection of iliac artery: BD51.5\\nAneurysm or dissection of artery of lower extremity: BD51.6\\nAneurysm and dissection of other artery excluding aorta: BD51.Y\\nAneurysm and dissection of unspecified artery: BD51.Z\\nCertain specified disorders of arteries or arterioles: BD52\\nSegmental arterial mediolysis: BD52.0\\nArteriovenous fistula acquired: BD52.1\\nStricture of artery: BD52.2\\nRupture of artery: BD52.3\\nNecrosis of artery: BD52.4\\nCoeliac artery compression syndrome: BD52.5\\nCongenital great vessel related acquired abnormality: BD52.6\\nCertain acquired abnormalities of aorta: BD52.7\\nAcquired abnormality of aortic arch branch: BD52.70\\nAcquired ascending aorta or root dilation: BD52.71\\nOther specified certain acquired abnormalities of aorta: BD52.7Y\\nCertain acquired abnormalities of aorta unspecified: BD52.7Z\\nSecondary disorders of arteries and arterioles: BD53\\nArterial cystic medial diseases: BD53.0\\nHypothenar hammer syndrome: BD53.1\\nIliac artery arteriopathy: BD53.2\\nPopliteal entrapment syndrome: BD53.3\\nCholesterol atheroembolism: BD53.4\\nCholesterol atheroembolism to kidneys: BD53.40\\nCholesterol atheroembolism to other specified sites: BD53.4Y\\nCholesterol atheroembolism to unspecified site: BD53.4Z\\nOther specified secondary disorders of arteries and arterioles: BD53.Y\\nSecondary disorders of arteries and arterioles unspecified: BD53.Z\\nDiabetic foot ulcer: BD54\\nAsymptomatic stenosis of intracranial or extracranial artery: BD55\\nAsymptomatic occlusion of intracranial or extracranial artery: BD56\\nOther specified diseases of arteries or arterioles: BD5Y\\nDiseases of arteries or arterioles unspecified: BD5Z\\nSuperficial thrombophlebitis: BD70\\nSuperficial thrombophlebitis of lower limbs: BD70.0\\nSuperficial thrombophlebitis of upper limbs: BD70.1\\nThrombophlebitis migrans: BD70.2\\nMondor disease: BD70.3\\nOther specified superficial thrombophlebitis: BD70.Y\\nSuperficial thrombophlebitis unspecified: BD70.Z\\nDeep vein thrombosis: BD71\\nUpper limb deep vein thrombosis: BD71.0\\nVena caval thrombosis: BD71.1\\nRenal vein thrombosis: BD71.2\\nIliac vein thrombosis: BD71.3\\nLower limb deep vein thrombosis: BD71.4\\nOther specified deep vein thrombosis: BD71.Y\\nVenous thromboembolism: BD72\\nAcquired systemic vein abnormality: BD73\\nAcquired inferior caval vein abnormality: BD73.0\\nAcquired superior caval vein abnormality: BD73.1\\nSystemic vein obstruction: BD73.2\\nObstruction of peripheral vein: BD73.20\\nObstruction of visceral vein: BD73.21\\nOther specified systemic vein obstruction: BD73.2Y\\nSystemic vein obstruction unspecified: BD73.2Z\\nAcquired coronary sinus abnormality: BD73.3\\nOther specified acquired systemic vein abnormality: BD73.Y\\nAcquired systemic vein abnormality unspecified: BD73.Z\\nChronic peripheral venous insufficiency of lower extremities: BD74\\nUncomplicated lower limb venous hypertension: BD74.0\\nLower limb varicose veins: BD74.1\\nVaricose veins with great saphenous reflux: BD74.10\\nVaricose veins with small saphenous reflux: BD74.11\\nVaricose veins with nontruncal reflux: BD74.12\\nLower limb varicose veins not further specified: BD74.1Z\\nLipodermatosclerosis: BD74.2\\nVenous leg ulcer: BD74.3\\nPrimary venous leg ulcer: BD74.30\\nRecurrent venous leg ulcer: BD74.31\\nHealed venous leg ulcer: BD74.32\\nVenous leg ulcer unspecified: BD74.3Z\\nChronic peripheral venous insufficiency of lower extremities unspecified: BD74.Z\\nVenous varicosities of sites other than lower extremity: BD75\\nSublingual varices: BD75.0\\nScrotal varices: BD75.1\\nVulval varices: BD75.2\\nPelvic varices: BD75.3\\nVenous varicosities of other specified sites: BD75.Y\\nVenous varicosities of unspecified site: BD75.Z\\nOther specified diseases of veins: BD7Y\\nDiseases of veins unspecified: BD7Z\\nLymphadenitis: BD90\\nAcute lymphadenitis: BD90.0\\nNonspecific mesenteric lymphadenitis: BD90.1\\nChronic lymphadenitis: BD90.2\\nChronic cervical lymphadenitis: BD90.20\\nChronic axillary lymphadenitis: BD90.21\\nChronic inguinal lymphadenitis: BD90.22\\nOther specified chronic lymphadenitis: BD90.2Y\\nChronic lymphadenitis unspecified: BD90.2Z\\nOther specified lymphadenitis: BD90.Y\\nLymphadenitis unspecified: BD90.Z\\nLymphangitis: BD91\\nLymphangiectasia: BD92\\nIntestinal lymphangiectasia: BD92.0\\nCutaneous lymphangiectasia: BD92.1\\nLymphangiectasia unspecified: BD92.Z\\nLymphoedema: BD93\\nPrimary lymphoedema: BD93.0\\nSecondary lymphoedema: BD93.1\\nLymphoedema due to venous insufficiency: BD93.10\\nLymphoedema due to dependency and immobility: BD93.11\\nLymphoedema due to obesity: BD93.12\\nLymphoedema due to lymphatic filariasis: BD93.13\\nLymphoedema due to podoconiosis: BD93.14\\nLymphoedema due to malignant infiltration: BD93.15\\nLymphoedema secondary to other specified cause: BD93.1Y\\nSecondary lymphoedema unspecified: BD93.1Z\\nOther specified forms of lymphoedema: BD93.Y\\nLymphoedema unspecified: BD93.Z\\nOther specified disorders of lymphatic vessels or lymph nodes: BD9Y\\nDisorders of lymphatic vessels or lymph nodes unspecified: BD9Z\\nPostcardiotomy syndrome: BE10\\nOther functional disturbances following cardiac surgery: BE11\\nPostprocedural valve disorders: BE12\\nPostprocedural mitral valve stenosis: BE12.0\\nPostprocedural mitral valve insufficiency: BE12.1\\nPostprocedural aortic valve stenosis: BE12.2\\nPostprocedural aortic valve insufficiency: BE12.3\\nPostprocedural tricuspid valve stenosis: BE12.4\\nPostprocedural tricuspid valve insufficiency: BE12.5\\nPostprocedural pulmonary valve stenosis: BE12.6\\nPostprocedural pulmonary valve insufficiency: BE12.7\\nPostprocedural true or false aortic aneurysm: BE13\\nPostprocedural disorder of circulatory system following repair of congenital heart or great vessel anomaly: BE14\\nAcquired abnormality of the neopulmonary valve: BE14.4\\nNeopulmonary valve stenosis: BE14.40\\nNeopulmonary valve regurgitation: BE14.41\\nPostprocedural rightsided atrioventricular valvar abnormality in doubleinlet ventricle: BE14.5\\nPostprocedural leftsided atrioventricular valvar abnormality in doubleinlet ventricle: BE14.6\\nPostprocedural common atrioventricular valvar abnormality in doubleinlet ventricle: BE14.7\\nPostprocedural ventricular septal defect disorder: BE14.8\\nPostprocedural aortic disorder related to congenital heart anomaly: BE14.9\\nPostprocedural arterial duct disorder: BE14.A\\nPostprocedural disorder following cardiovascular conduit or shunt procedure: BE14.B\\nPostprocedural pulmonary arterial tree disorder: BE15\\nPostprocedural pulmonary trunk stenosis: BE15.0\\nPostprocedural right pulmonary artery stenosis: BE15.1\\nPostprocedural pulmonary venous disorder: BE16\\nPostprocedural residual or recurrent interatrial communication: BE17\\nPostprocedural ventricular abnormality: BE19\\nCardiac transplant associated coronary allograft vasculopathy: BE1A\\nLymphoedema due to surgery or radiotherapy: BE1B\\nPostmastectomy lymphoedema syndrome: BE1B.0\\nLymphoedema due to other medical or surgical procedures: BE1B.1\\nInferior caval vein obstruction due to foreign body: BE1C\\nSuperior caval vein obstruction due to foreign body: BE1D\\nPostprocedural right atrial complication: BE1E\\nPostprocedural right atrial perforation: BE1E.0\\nRight atrial erosion due to implanted device: BE1E.1\\nPostprocedural left atrial complication: BE1F\\nPostprocedural left atrial perforation: BE1F.0\\nLeft atrial erosion due to implanted device: BE1F.1\\nOther specified diseases of the circulatory system: BE2Y\\nDiseases of the circulatory system unspecified: BE2Z\\nAcute nasopharyngitis: CA00\\nAcute sinusitis: CA01\\nAcute pharyngitis: CA02\\nAcute bacterial pharyngitis: CA02.0\\nAcute viral pharyngitis: CA02.1\\nPharyngitis due to Adenovirus: CA02.10\\nOther specified acute viral pharyngitis: CA02.1Y\\nAcute viral pharyngitis unspecified: CA02.1Z\\nOther specified acute pharyngitis: CA02.Y\\nAcute pharyngitis unspecified: CA02.Z\\nAcute tonsillitis: CA03\\nStreptococcal tonsillitis: CA03.0\\nOther specified acute tonsillitis: CA03.Y\\nAcute tonsillitis unspecified: CA03.Z\\nAcute laryngopharyngitis: CA04\\nAcute laryngitis or tracheitis: CA05\\nAcute laryngitis: CA05.0\\nAcute tracheitis: CA05.1\\nAcute laryngotracheitis: CA05.2\\nAcute obstructive laryngitis or epiglottitis: CA06\\nAcute obstructive laryngitis: CA06.0\\nAcute epiglottitis: CA06.1\\nAcute obstructive laryngitis or epiglottitis unspecified: CA06.Z\\nAcute upper respiratory infections of multiple and unspecified sites: CA07\\nAcute upper respiratory infection site unspecified: CA07.0\\nAcute upper respiratory infections of multiple sites: CA07.1\\nVasomotor or allergic rhinitis: CA08\\nAllergic rhinitis: CA08.0\\nAllergic rhinitis due to pollen: CA08.00\\nAllergic rhinitis due to other seasonal allergens: CA08.01\\nAllergic rhinitis due to house dust mite: CA08.02\\nOther allergic rhinitis: CA08.03\\nAllergic rhinitis unspecified: CA08.0Z\\nNonallergic rhinitis: CA08.1\\nNonallergic rhinitis with eosinophils: CA08.10\\nOther specified nonallergic rhinitis: CA08.1Y\\nNonallergic rhinitis unspecified: CA08.1Z\\nMixed rhinitis: CA08.2\\nVasomotor rhinitis: CA08.3\\nChronic rhinitis nasopharyngitis or pharyngitis: CA09\\nChronic rhinitis: CA09.0\\nChronic nasopharyngitis: CA09.1\\nChronic pharyngitis: CA09.2\\nChronic rhinosinusitis: CA0A\\nSamter syndrome: CA0A.0\\nOther specified chronic rhinosinusitis: CA0A.Y\\nChronic rhinosinusitis unspecified: CA0A.Z\\nSilent sinus syndrome: CA0B\\nCyst or mucocele of nose or nasal sinus: CA0C\\nDeviated nasal septum: CA0D\\nHypertrophy of nasal turbinates: CA0E\\nChronic diseases of tonsils or adenoids: CA0F\\nHypertrophy of tonsils: CA0F.0\\nHypertrophy of adenoids: CA0F.1\\nHypertrophy of tonsils with hypertrophy of adenoids: CA0F.3\\nOther specified chronic diseases of tonsils or adenoids: CA0F.Y\\nChronic diseases of tonsils or adenoids unspecified: CA0F.Z\\nChronic laryngitis or laryngotracheitis: CA0G\\nDiseases of vocal cords or larynx not elsewhere classified: CA0H\\nParalysis of vocal cords or larynx: CA0H.0\\nPolyp of vocal cord or larynx: CA0H.1\\nNodules of vocal cords: CA0H.2\\nOedema of larynx: CA0H.3\\nLaryngeal spasm: CA0H.4\\nStenosis of larynx: CA0H.5\\nOther specified diseases of vocal cords or larynx not elsewhere classified: CA0H.Y\\nDiseases of vocal cords or larynx not elsewhere classified unspecified: CA0H.Z\\nNasal polyp: CA0J\\nPolypoid sinus degeneration: CA0J.0\\nOther specified nasal polyp: CA0J.Y\\nNasal polyp unspecified: CA0J.Z\\nAbscess of upper respiratory tract: CA0K\\nRetropharyngeal or parapharyngeal abscess: CA0K.0\\nPeritonsillar abscess: CA0K.1\\nOther specified abscess of upper respiratory tract: CA0K.Y\\nAbscess of upper respiratory tract unspecified: CA0K.Z\\nOther specified upper respiratory tract disorders: CA0Y\\nUpper respiratory tract disorders unspecified: CA0Z\\nBronchitis: CA20\\nAcute noninfectious bronchitis: CA20.0\\nChronic bronchitis: CA20.1\\nSimple chronic bronchitis: CA20.10\\nMucopurulent chronic bronchitis: CA20.11\\nMixed simple and mucopurulent chronic bronchitis: CA20.12\\nProtracted bacterial bronchitis: CA20.13\\nOther specified chronic bronchitis: CA20.1Y\\nChronic bronchitis unspecified: CA20.1Z\\nOther specified bronchitis: CA20.Y\\nBronchitis unspecified: CA20.Z\\nEmphysema: CA21\\nMacLeod syndrome: CA21.0\\nPanlobular emphysema: CA21.1\\nCentrilobular emphysema: CA21.2\\nOther specified emphysema: CA21.Y\\nEmphysema unspecified: CA21.Z\\nChronic obstructive pulmonary disease: CA22\\nChronic obstructive pulmonary disease with acute exacerbation unspecified: CA22.0\\nCertain specified chronic obstructive pulmonary disease: CA22.1\\nChronic obstructive pulmonary disease unspecified: CA22.Z\\nAsthma: CA23\\nAllergic asthma: CA23.0\\nAllergic asthma with exacerbation: CA23.00\\nAllergic asthma with status asthmaticus: CA23.01\\nAllergic asthma uncomplicated: CA23.02\\nNonallergic asthma: CA23.1\\nNonallergic asthma with exacerbation: CA23.10\\nNonallergic asthma with status asthmaticus: CA23.11\\nNonallergic asthma uncomplicated: CA23.12\\nOther specified forms of asthma or bronchospasm: CA23.2\\nAspirininduced asthma: CA23.20\\nExerciseinduced bronchospasm: CA23.21\\nCough variant asthma: CA23.22\\nUnspecified asthma: CA23.3\\nUnspecified asthma with exacerbation: CA23.30\\nUnspecified asthma with status asthmaticus: CA23.31\\nUnspecified asthma uncomplicated: CA23.32\\nBronchiectasis: CA24\\nCystic fibrosis: CA25\\nClassical cystic fibrosis: CA25.0\\nAtypical cystic fibrosis: CA25.1\\nSubclinical cystic fibrosis: CA25.2\\nCystic fibrosis unspecified: CA25.Z\\nChronic bronchiolitis: CA26\\nChronic obliterative bronchiolitis: CA26.0\\nDiffuse panbronchiolitis: CA26.1\\nOther specified chronic bronchiolitis: CA26.Y\\nChronic bronchiolitis unspecified: CA26.Z\\nTracheobronchitis: CA27\\nTracheobronchopathia osteochondroplastica: CA27.0\\nTracheobronchomegaly: CA27.1\\nOther specified tracheobronchitis: CA27.Y\\nTracheobronchitis unspecified: CA27.Z\\nOther specified lower respiratory tract disease: CA2Y\\nLower respiratory tract disease unspecified: CA2Z\\nPneumonia: CA40\\nBacterial pneumonia: CA40.0\\nPneumonia due to Chlamydophila pneumoniae: CA40.00\\nPneumonia due to Escherichia coli: CA40.01\\nPneumonia due to Haemophilus influenzae: CA40.02\\nPneumonia due to Klebsiella pneumoniae: CA40.03\\nPneumonia due to Mycoplasma pneumoniae: CA40.04\\nPneumonia due to Pseudomonas aeruginosa: CA40.05\\nPneumonia due to Staphylococcus: CA40.06\\nPneumonia due to Streptococcus pneumoniae: CA40.07\\nPneumonia due to betahaemolytic streptococcus: CA40.08\\nPneumonia due to other specified bacteria: CA40.0Y\\nBacterial pneumonia unspecified: CA40.0Z\\nViral pneumonia: CA40.1\\nPneumonia due to Adenovirus: CA40.10\\nPneumonia due to Respiratory syncytial virus: CA40.11\\nPneumonia due to parainfluenza virus: CA40.12\\nPneumonia due to Human metapneumovirus: CA40.13\\nPneumonia due to other specified virus: CA40.1Y\\nViral pneumonia unspecified: CA40.1Z\\nFungal pneumonia: CA40.2\\nPneumonia due to pneumocystis: CA40.20\\nOther specified fungal pneumonia: CA40.2Y\\nFungal pneumonia unspecified: CA40.2Z\\nOther specified pneumonia: CA40.Y\\nPneumonia organism unspecified: CA40.Z\\nAcute bronchiolitis: CA41\\nAcute bronchiolitis due to respiratory syncytial virus: CA41.0\\nOther specified acute bronchiolitis: CA41.Y\\nAcute bronchiolitis unspecified: CA41.Z\\nAcute bronchitis: CA42\\nAcute bronchitis due to Streptococcus: CA42.0\\nAcute bronchitis due to Rhinovirus: CA42.1\\nAcute bronchitis due to Respiratory syncytial virus: CA42.2\\nAcute bronchitis due to Parainfluenza virus: CA42.3\\nAcute bronchitis due to Haemophilus influenzae: CA42.4\\nAcute bronchitis due to Coxsackievirus: CA42.5\\nOther specified acute bronchitis: CA42.Y\\nAcute bronchitis unspecified: CA42.Z\\nAbscess of lung or mediastinum: CA43\\nGangrene or necrosis of lung: CA43.0\\nAbscess of lung with pneumonia: CA43.1\\nAbscess of lung without pneumonia: CA43.2\\nAbscess of mediastinum: CA43.3\\nOther specified abscess of lung or mediastinum: CA43.Y\\nAbscess of lung or mediastinum unspecified: CA43.Z\\nPyothorax: CA44\\nRespiratory infections not elsewhere classified: CA45\\nOther specified lung infections: CA4Y\\nLung infections unspecified: CA4Z\\nPneumoconiosis: CA60\\nPneumoconiosis due to dust containing silica: CA60.0\\nPneumoconiosis due to talc dust: CA60.00\\nOther specified pneumoconiosis due to dust containing silica: CA60.0Y\\nPneumoconiosis due to dust containing silica unspecified: CA60.0Z\\nCoal worker pneumoconiosis: CA60.1\\nPneumoconiosis due to mineral fibres including asbestos: CA60.2\\nPneumoconiosis associated with tuberculosis: CA60.3\\nAluminosis of lung: CA60.4\\nBauxite fibrosis of lung: CA60.5\\nBerylliosis: CA60.6\\nGraphite fibrosis of lung: CA60.7\\nSiderosis: CA60.8\\nStannosis: CA60.9\\nOther specified pneumoconiosis: CA60.Y\\nPneumoconiosis unspecified: CA60.Z\\nHypersensitivity pneumonitis due to organic dust: CA70\\nFarmer lung: CA70.0\\nBagassosis: CA70.1\\nBird fancier lung: CA70.2\\nSuberosis: CA70.3\\nMalt worker lung: CA70.4\\nMushroom worker lung: CA70.5\\nMaple bark stripper lung: CA70.6\\nAir conditioner or humidifier lung: CA70.7\\nOther specified hypersensitivity pneumonitis due to organic dust: CA70.Y\\nHypersensitivity pneumonitis due to organic dust unspecified: CA70.Z\\nPneumonitis due to solids or liquids: CA71\\nPneumonitis due to inhalation of food or vomit: CA71.0\\nPneumonitis due to oils or essences: CA71.1\\nPneumonitis due to aspiration of blood: CA71.2\\nLipoid pneumonitis: CA71.3\\nOther specified pneumonitis due to solids or liquids: CA71.Y\\nPneumonitis due to solids or liquids unspecified: CA71.Z\\nMendelson syndrome: CA72\\nOther specified pneumonitis: CA7Y\\nPneumonitis unspecified: CA7Z\\nAirway disease due to specific organic dust: CA80\\nByssinosis due to exposure to cotton: CA80.0\\nByssinosis due to exposure to flax: CA80.1\\nByssinosis due to exposure to cannabis: CA80.2\\nOther specified airway disease due to specific organic dust: CA80.Y\\nAirway disease due to specific organic dust unspecified: CA80.Z\\nRespiratory conditions due to inhalation of chemicals gases fumes or vapours: CA81\\nBronchitis or pneumonitis due to chemicals gases fumes or vapours: CA81.0\\nPulmonary oedema due to chemicals gases fumes or vapours: CA81.1\\nUpper respiratory inflammation due to chemicals gases fumes or vapours not elsewhere classified: CA81.2\\nOther specified respiratory conditions due to inhalation of chemicals gases fumes or vapours: CA81.Y\\nRespiratory conditions due to inhalation of chemicals gases fumes or vapours unspecified: CA81.Z\\nRespiratory conditions due to other external agents: CA82\\nAcute pulmonary manifestations due to radiation: CA82.0\\nChronic or other pulmonary manifestations due to radiation: CA82.1\\nAcute druginduced interstitial lung disorders: CA82.2\\nChronic druginduced interstitial lung disorders: CA82.3\\nAspergillusinduced allergic or hypersensitivity conditions: CA82.4\\nOther specified respiratory conditions due to other external agents: CA82.Y\\nRespiratory conditions due to other external agents unspecified: CA82.Z\\nOther specified lung diseases due to external agents: CA8Y\\nLung diseases due to external agents unspecified: CA8Z\\nAcute respiratory distress syndrome: CB00\\nPulmonary oedema: CB01\\nPulmonary eosinophilia: CB02\\nAsthmatic pulmonary eosinophilia: CB02.0\\nIdiopathic eosinophilic pneumonitis: CB02.1\\nIdiopathic acute eosinophilic pneumonitis: CB02.10\\nIdiopathic chronic eosinophilic pneumonitis: CB02.11\\nOther specified idiopathic eosinophilic pneumonitis: CB02.1Y\\nIdiopathic eosinophilic pneumonitis unspecified: CB02.1Z\\nTropical pulmonary eosinophilia: CB02.2\\nOther specified pulmonary eosinophilia: CB02.Y\\nPulmonary eosinophilia unspecified: CB02.Z\\nIdiopathic interstitial pneumonitis: CB03\\nAcute interstitial pneumonitis: CB03.0\\nCombined pulmonary fibrosis and emphysema syndrome: CB03.1\\nCryptogenic organizing pneumonitis: CB03.2\\nDesquamative interstitial pneumonitis: CB03.3\\nIdiopathic pulmonary fibrosis: CB03.4\\nLymphoid interstitial pneumonia: CB03.5\\nRespiratory bronchiolitis interstitial lung disease: CB03.6\\nOther specified idiopathic interstitial pneumonitis: CB03.Y\\nIdiopathic interstitial pneumonitis unspecified: CB03.Z\\nPrimary interstitial lung diseases specific to infancy or childhood: CB04\\nDiffuse pulmonary developmental disorders: CB04.0\\nPulmonary lymphatic dysplasia syndromes: CB04.1\\nDisorders of surfactant metabolism: CB04.2\\nAlveolar or perialveolar conditions: CB04.3\\nIdiopathic pulmonary haemosiderosis: CB04.30\\nPulmonary alveolar proteinosis: CB04.31\\nOther specified alveolar or perialveolar conditions: CB04.3Y\\nAlveolar or perialveolar conditions unspecified: CB04.3Z\\nPulmonary capillaritis: CB04.4\\nBrainlungthyroid syndrome: CB04.5\\nChronic pneumonitis of infancy: CB04.6\\nNeuroendocrine cell hyperplasia of infancy: CB04.7\\nOther specified primary interstitial lung diseases specific to infancy or childhood: CB04.Y\\nPrimary interstitial lung diseases specific to infancy or childhood unspecified: CB04.Z\\nInterstitial lung diseases associated with systemic diseases: CB05\\nDiffuse alveolar damage: CB05.0\\nInterstitial lung diseases associated with connective tissue diseases: CB05.1\\nInterstitial lung diseases associated with granulomatous diseases: CB05.2\\nInterstitial lung diseases associated with metabolic diseases: CB05.3\\nInterstitial lung diseases associated with systemic vasculitides: CB05.4\\nRespiratory disorders in ChurgStrauss syndrome: CB05.40\\nRespiratory disorders in microscopic polyangiitis: CB05.41\\nOther specified interstitial lung diseases associated with systemic vasculitides: CB05.4Y\\nInterstitial lung diseases associated with systemic vasculitides unspecified: CB05.4Z\\nSecondary pulmonary haemosiderosis: CB05.5\\nOther specified interstitial lung diseases associated with systemic diseases: CB05.Y\\nInterstitial lung diseases associated with systemic diseases unspecified: CB05.Z\\nPulmonary alveolar microlithiasis: CB06\\nLymphangioleiomyomatosis: CB07\\nLymphangioleiomyomatosis associated with tuberous sclerosis complex: CB07.0\\nSporadic lymphangioleiomyomatosis: CB07.1\\nOther specified lymphangioleiomyomatosis: CB07.Y\\nLymphangioleiomyomatosis unspecified: CB07.Z\\nOther specified respiratory diseases principally affecting the lung interstitium: CB0Y\\nRespiratory diseases principally affecting the lung interstitium unspecified: CB0Z\\nPleural plaque: CB20\\nPneumothorax: CB21\\nSpontaneous tension pneumothorax: CB21.0\\nOther spontaneous pneumothorax: CB21.1\\nOther specified pneumothorax: CB21.Y\\nPneumothorax unspecified: CB21.Z\\nDiseases of mediastinum not elsewhere classified: CB22\\nFibrosing mediastinitis: CB22.0\\nOther specified diseases of mediastinum not elsewhere classified: CB22.Y\\nDisease of mediastinum unspecified: CB22.Z\\nDisorders of diaphragm: CB23\\nChylous effusion: CB24\\nFibrothorax: CB25\\nHaemothorax: CB26\\nPleural effusion: CB27\\nOther specified pleural diaphragm or mediastinal disorders: CB2Y\\nPleural diaphragm or mediastinal disorders unspecified: CB2Z\\nCertain diseases of the respiratory system: CB40\\nCiliary dyskinesia: CB40.0\\nYoung syndrome: CB40.1\\nPulmonary collapse: CB40.2\\nInterstitial emphysema: CB40.3\\nCompensatory emphysema: CB40.4\\nOther specified diseases of the respiratory system: CB40.Y\\nRespiratory failure: CB41\\nAcute respiratory failure: CB41.0\\nAcute respiratory failure Type I: CB41.00\\nAcute respiratory failure Type II: CB41.01\\nAcute respiratory failure unspecified: CB41.0Z\\nChronic respiratory failure: CB41.1\\nChronic respiratory failure Type I: CB41.10\\nChronic respiratory failure Type II: CB41.11\\nChronic respiratory failure unspecified: CB41.1Z\\nRespiratory failure unspecified as acute or chronic: CB41.2\\nRespiratory failure unspecified Type I: CB41.20\\nRespiratory failure unspecified Type II: CB41.21\\nRespiratory failure unspecified: CB41.2Z\\nTracheostomy malfunction: CB60\\nChronic pulmonary insufficiency following surgery: CB61\\nPostprocedural subglottic stenosis: CB62\\nPostprocedural stenosis of the trachea: CB63\\nTransfusion related acute lung injury: CB64\\nDiseases of the respiratory system unspecified: CB7Z\\nDisorders of lips: DA00\\nCheilitis: DA00.0\\nSelfinduced lip trauma: DA00.1\\nPigmentary abnormalities of lips: DA00.2\\nLip fissure: DA00.3\\nOther specified disorders of lips: DA00.Y\\nDisorder of lips unspecified: DA00.Z\\nDisorders of oral mucosa: DA01\\nDisturbances of oral epithelium: DA01.0\\nOral leukoplakia: DA01.00\\nHairy leukoplakia: DA01.01\\nWandering rash of the mouth: DA01.02\\nOther specified disturbances of oral epithelium: DA01.0Y\\nDisturbances of oral epithelium unspecified: DA01.0Z\\nNoninfectious erosive or ulcerative disorders of oral mucosa: DA01.1\\nOral aphthae or aphthalike ulceration: DA01.10\\nOral mucositis: DA01.11\\nChronic ulcerative stomatitis: DA01.12\\nErythema multiforme with oral ulceration: DA01.13\\nDruginduced oral ulcer: DA01.14\\nMouth ulcers: DA01.15\\nOther specified noninfectious erosive or ulcerative disorders of oral mucosa: DA01.1Y\\nNoninfectious erosive or ulcerative disorders of oral mucosa unspecified: DA01.1Z\\nGranuloma or granulomalike lesions of oral mucosa: DA01.2\\nGiant cell granuloma central: DA01.20\\nOrofacial granulomatosis: DA01.21\\nOther specified granuloma or granulomalike lesions of oral mucosa: DA01.2Y\\nGranuloma or granulomalike lesions of oral mucosa unspecified: DA01.2Z\\nInfections of lips or oral mucosa: DA01.3\\nCellulitis or abscess of soft tissues of the mouth: DA01.30\\nOther specified infections of lips or oral mucosa: DA01.3Y\\nInfections of lips or oral mucosa unspecified: DA01.3Z\\nIrritative hyperplasia of oral mucosa: DA01.4\\nPapillary hyperplasia of oral mucosa: DA01.40\\nDenture hyperplasia: DA01.41\\nOral fibroepithelial polyp: DA01.42\\nIrritative hyperplasia of oral mucosa unspecified: DA01.4Z\\nOther specified disorders of oral mucosa: DA01.Y\\nDisorder of oral mucosa unspecified: DA01.Z\\nMiscellaneous specified disorders of lips or oral mucosa: DA02\\nGenetic or developmental disorders involving lips or oral mucosa: DA02.0\\nXerostomia: DA02.1\\nOral submucous fibrosis: DA02.2\\nContact gingivostomatitis: DA02.3\\nAllergic contact gingivostomatitis: DA02.30\\nIrritant contact gingivostomatitis: DA02.31\\nDiseases of tongue: DA03\\nGlossitis: DA03.0\\nGeographic tongue: DA03.1\\nAtrophy of tongue papillae: DA03.2\\nMedian rhomboid glossitis: DA03.3\\nHypertrophy of tongue papillae: DA03.4\\nMacroglossia: DA03.5\\nOther specified diseases of tongue: DA03.Y\\nDiseases of tongue unspecified: DA03.Z\\nDiseases of salivary glands: DA04\\nAtrophy of salivary gland: DA04.0\\nHypertrophy of salivary gland: DA04.1\\nSialoadenitis: DA04.2\\nAbscess of salivary gland: DA04.3\\nSialolithiasis: DA04.4\\nMucocele of salivary gland: DA04.5\\nDisturbances of salivary secretion: DA04.6\\nSialophagia: DA04.7\\nSialoschesis: DA04.8\\nOther specified diseases of salivary glands: DA04.Y\\nDiseases of salivary glands unspecified: DA04.Z\\nCysts of oral or facialneck region: DA05\\nDevelopmental odontogenic cysts: DA05.0\\nDevelopmental nonodontogenic cysts of oral region: DA05.1\\nOther specified cysts of oral or facialneck region: DA05.Y\\nCysts of oral or facialneck region unspecified: DA05.Z\\nDiseases of jaws: DA06\\nInflammatory conditions of jaws: DA06.0\\nAlveolitis of jaw: DA06.1\\nExostosis of jaw: DA06.2\\nStafne mandibular bone cavity: DA06.3\\nOther specified diseases of jaws: DA06.Y\\nDiseases of jaws unspecified: DA06.Z\\nDisorders of tooth development or eruption: DA07\\nFluoride related opacities or lesions: DA07.0\\nNonfluoride enamel opacities: DA07.1\\nDisturbances in tooth formation: DA07.3\\nRoot anomaly: DA07.4\\nCementum dysplasia: DA07.5\\nDisturbances in tooth eruption: DA07.6\\nTeething syndrome: DA07.60\\nAnkylosis of teeth: DA07.61\\nOther specified disturbances in tooth eruption: DA07.6Y\\nDisturbances in tooth eruption unspecified: DA07.6Z\\nEmbedded teeth: DA07.7\\nImpacted teeth: DA07.8\\nOther specified disorders of tooth development or eruption: DA07.Y\\nDisorders of tooth development or eruption unspecified: DA07.Z\\nDiseases of hard tissues of teeth: DA08\\nDental caries: DA08.0\\nCertain specified diseases of hard tissues of teeth: DA08.1\\nExcessive attrition of teeth: DA08.10\\nAbrasion of teeth: DA08.11\\nErosion of teeth: DA08.12\\nAbfraction: DA08.13\\nPathological resorption of teeth: DA08.14\\nPosteruptive colour changes of dental hard tissues: DA08.15\\nChronic dental injuries: DA08.2\\nNontraumatic fracture of tooth: DA08.3\\nDeposits on teeth: DA08.4\\nOther specified diseases of hard tissues of teeth: DA08.Y\\nDiseases of hard tissues of teeth unspecified: DA08.Z\\nDiseases of pulp or periapical tissues: DA09\\nPulpitis: DA09.0\\nNecrosis of pulp: DA09.1\\nPulp abscess: DA09.2\\nPhoenix abscess: DA09.3\\nPulp degeneration: DA09.4\\nAbnormal hard tissue formation in pulp: DA09.5\\nPeriapical abscess: DA09.6\\nPeriapical abscess with facial involvement: DA09.60\\nPeriapical abscess with sinus: DA09.61\\nPeriapical abscess without sinus: DA09.62\\nOther specified periapical abscess: DA09.6Y\\nPeriapical abscess unspecified: DA09.6Z\\nPeriapical periodontitis: DA09.7\\nAcute apical periodontitis of pulpal origin: DA09.70\\nChronic apical periodontitis: DA09.71\\nOther specified periapical periodontitis: DA09.7Y\\nPeriapical periodontitis unspecified: DA09.7Z\\nRadicular cyst: DA09.8\\nOther specified diseases of pulp or periapical tissues: DA09.Y\\nDiseases of pulp or periapical tissues unspecified: DA09.Z\\nCertain specified disorders of teeth or supporting structures: DA0A\\nExfoliation of teeth due to systemic causes: DA0A.0\\nLoss of teeth due to accident extraction or local periodontal disease: DA0A.1\\nAtrophy of edentulous alveolar ridge: DA0A.2\\nRetained dental root: DA0A.3\\nOther specified disorders of teeth and supporting structures: DA0A.Y\\nUnspecified disorders of teeth and supporting structures: DA0A.Z\\nGingival diseases: DA0B\\nAllergic gingivitis: DA0B.0\\nCatarrhal gingivitis: DA0B.1\\nEruptive gingivitis: DA0B.2\\nAtrophic senile gingivitis: DA0B.3\\nAcute multiple gingival abscesses: DA0B.4\\nDevelopmental or acquired deformities or conditions of gingiva: DA0B.5\\nPericoronitis: DA0B.6\\nOther specified gingival diseases: DA0B.Y\\nGingival diseases unspecified: DA0B.Z\\nPeriodontal disease: DA0C\\nAcute periodontitis: DA0C.0\\nAggressive periodontitis: DA0C.1\\nPeriodontosis: DA0C.2\\nNecrotising periodontal diseases: DA0C.3\\nNecrotising ulcerative periodontitis: DA0C.30\\nNoma: DA0C.31\\nOther specified necrotising periodontal diseases: DA0C.3Y\\nNecrotising periodontal diseases unspecified: DA0C.3Z\\nAbscess of periodontium: DA0C.4\\nLinear gingival erythema: DA0C.5\\nOther specified periodontal disease: DA0C.Y\\nPeriodontal disease unspecified: DA0C.Z\\nCertain specified disorders of gingiva or edentulous alveolar ridge: DA0D\\nGingival recession: DA0D.0\\nGingival enlargement: DA0D.1\\nGingival or edentulous alveolar ridge lesions associated with trauma: DA0D.2\\nHypoplasminogenaemia: DA0D.3\\nCottonroll gingivitis: DA0D.4\\nGingival ulceration: DA0D.5\\nOther specified disorders of gingival or edentulous alveolar ridge: DA0D.Y\\nDentofacial anomalies: DA0E\\nMajor anomalies of jaw size: DA0E.0\\nMicrognathia: DA0E.00\\nOther specified major anomalies of jaw size: DA0E.0Y\\nMajor anomalies of jaw size unspecified: DA0E.0Z\\nAnomalies of jawcranial base relationship: DA0E.1\\nAnomalies of dental arch relationship: DA0E.2\\nAnomalies of tooth position: DA0E.3\\nFood impaction: DA0E.4\\nMalocclusion: DA0E.5\\nClass II division  malocclusion: DA0E.50\\nAngle class I malocclusion: DA0E.51\\nOther specified malocclusion: DA0E.5Y\\nMalocclusion unspecified: DA0E.5Z\\nDentofacial functional abnormalities: DA0E.6\\nDentofacial parafunctional disorders: DA0E.7\\nTemporomandibular joint disorders: DA0E.8\\nOther specified dentofacial anomalies: DA0E.Y\\nDentofacial anomalies unspecified: DA0E.Z\\nSensory disturbances affecting orofacial complex: DA0F\\nBurning mouth syndrome: DA0F.0\\nOther specified sensory disturbances affecting orofacial complex: DA0F.Y\\nSensory disturbances affecting orofacial complex unspecified: DA0F.Z\\nOther specified diseases or disorders of orofacial complex: DA0Y\\nDiseases or disorders of orofacial complex unspecified: DA0Z\\nAcquired anatomical alterations of the oesophagus: DA20\\nOesophageal obstruction: DA20.0\\nDiverticulum of oesophagus acquired: DA20.1\\nOesophageal web: DA20.2\\nPerforation of oesophagus: DA20.3\\nSpontaneous rupture of oesophagus: DA20.30\\nOther specified perforation of oesophagus: DA20.3Y\\nPerforation of oesophagus unspecified: DA20.3Z\\nOther specified acquired anatomical alterations of the oesophagus: DA20.Y\\nAcquired anatomical alterations of the oesophagus unspecified: DA20.Z\\nMotility disorders of oesophagus: DA21\\nAchalasia: DA21.0\\nMotility disorder of cervical or upper oesophagus: DA21.1\\nDisorder of oesophageal peristalsis: DA21.2\\nHypertensive peristalsis: DA21.20\\nHypotensive peristalsis: DA21.21\\nSpastic peristalsis: DA21.22\\nOther specified disorder of oesophageal peristalsis: DA21.2Y\\nDisorder of oesophageal peristalsis unspecified: DA21.2Z\\nDisorder of lower oesophageal sphincter function: DA21.3\\nOther specified motility disorders of oesophagus: DA21.Y\\nMotility disorders of oesophagus unspecified: DA21.Z\\nGastrooesophageal reflux disease: DA22\\nNonerosive gastrooesophageal reflux disease: DA22.0\\nErosive gastrooesophageal reflux disease: DA22.1\\nGastrooesophageal reflux disease unspecified: DA22.Z\\nColumnar metaplastic epithelium of the oesophagus: DA23\\nBarrett epithelium: DA23.0\\nDysplasia of Barrett epithelium: DA23.1\\nBarrett ulcer: DA23.2\\nOther specified columnar metaplastic epithelium of the oesophagus: DA23.Y\\nColumnar metaplastic epithelium of the oesophagus unspecified: DA23.Z\\nOesophagitis: DA24\\nInfectious oesophagitis: DA24.0\\nOesophageal phlegmon: DA24.00\\nOther specified infectious oesophagitis: DA24.0Y\\nInfectious oesophagitis unspecified: DA24.0Z\\nEosinophilic oesophagitis: DA24.1\\nOesophagitis due to external causes: DA24.2\\nChemical oesophagitis: DA24.20\\nDruginduced oesophagitis: DA24.21\\nRadiation oesophagitis: DA24.22\\nOesophagitis due to external causes unspecified: DA24.2Z\\nOther specified oesophagitis: DA24.Y\\nOesophagitis unspecified: DA24.Z\\nOesophageal ulcer: DA25\\nOesophageal erosion: DA25.0\\nInfectious oesophageal ulcer: DA25.1\\nBacterial oesophageal ulcer: DA25.10\\nFungal oesophageal ulcer: DA25.11\\nParasitic oesophageal ulcer: DA25.12\\nViral oesophageal ulcer: DA25.13\\nOther specified infectious oesophageal ulcer: DA25.1Y\\nInfectious oesophageal ulcer unspecified: DA25.1Z\\nOesophageal ulcer due to allergic or immunologic disorder: DA25.2\\nOesophageal ulcer due to external causes: DA25.3\\nChemical oesophageal ulcer: DA25.30\\nDruginduced oesophageal ulcer: DA25.31\\nRadiation oesophageal ulcer: DA25.32\\nOesophageal ulcer due to other specified external causes: DA25.3Y\\nOesophageal ulcer due to external causes unspecified: DA25.3Z\\nOther specified oesophageal ulcer: DA25.Y\\nOesophageal ulcer unspecified: DA25.Z\\nVascular disorders of the oesophagus: DA26\\nOesophageal varices: DA26.0\\nOesophageal varices with bleeding: DA26.00\\nOesophageal varices without bleeding: DA26.01\\nOesophageal varices unspecified: DA26.0Z\\nAngiodysplasia or arteriovenous malformation of oesophagus: DA26.1\\nIntramural haemorrhage of oesophagus: DA26.2\\nGastrooesophageal lacerationhaemorrhage syndrome: DA26.3\\nOther specified vascular disorders of the oesophagus: DA26.Y\\nVascular disorders of the oesophagus unspecified: DA26.Z\\nOther specified diseases of oesophagus: DA2Y\\nDiseases of oesophagus unspecified: DA2Z\\nAcquired anatomical alterations of the stomach: DA40\\nGastric outlet obstruction: DA40.0\\nGastric fistula acquired: DA40.1\\nGastric volvulus: DA40.2\\nGastric diverticulum: DA40.3\\nHourglass stricture and stenosis of stomach: DA40.4\\nGastroptosis: DA40.5\\nOther specified acquired anatomical alterations of the stomach: DA40.Y\\nAcquired anatomical alterations of the stomach unspecified: DA40.Z\\nGastroduodenal motor or secretory disorders: DA41\\nAbnormal gastric motility: DA41.0\\nGastroparesis: DA41.00\\nOther specified abnormal gastric motility: DA41.0Y\\nAbnormal gastric motility unspecified: DA41.0Z\\nAcute dilatation of stomach: DA41.1\\nAcid hypersecretion: DA41.2\\nAchlorhydria: DA41.3\\nOther specified gastroduodenal motor or secretory disorders: DA41.Y\\nGastroduodenal motor or secretory disorders unspecified: DA41.Z\\nGastritis: DA42\\nAutoimmune gastritis: DA42.0\\nHelicobacter pylori induced gastritis: DA42.1\\nEosinophilic gastritis: DA42.2\\nLymphocytic gastritis: DA42.3\\nAllergic gastritis: DA42.4\\nAllergic gastritis due to IgEmediated hypersensitivity: DA42.40\\nAllergic gastritis due to nonIgEmediated hypersensitivity: DA42.41\\nOther specified allergic gastritis: DA42.4Y\\nAllergic gastritis unspecified: DA42.4Z\\nGastritis due to duodenogastric reflux: DA42.5\\nMenetrier disease: DA42.6\\nGastritis of unknown aetiology with specific endoscopic or pathological features: DA42.7\\nAcute superficial gastritis of unknown aetiology: DA42.70\\nChronic superficial gastritis of unknown aetiology: DA42.71\\nAcute haemorrhagic gastritis of unknown aetiology: DA42.72\\nChronic atrophic gastritis of unknown aetiology: DA42.73\\nMetaplastic gastritis of unknown aetiology: DA42.74\\nGranulomatous gastritis of unknown aetiology: DA42.75\\nHypertrophic gastritis of unknown aetiology: DA42.76\\nOther specified gastritis of unknown aetiology with specific endoscopic or pathological features: DA42.7Y\\nGastritis due to external causes: DA42.8\\nAlcoholic gastritis: DA42.80\\nRadiation gastritis: DA42.81\\nChemical gastritis: DA42.82\\nDruginduced gastritis: DA42.83\\nGastritis due to external causes unspecified: DA42.8Z\\nGastric phlegmon: DA42.9\\nOther specified gastritis: DA42.Y\\nGastritis unspecified: DA42.Z\\nVascular disorders of the stomach: DA43\\nGastric varices: DA43.0\\nAngiodysplasia of stomach: DA43.1\\nArteriovenous malformation of stomach: DA43.2\\nPortal hypertensive gastropathy: DA43.3\\nDiffuse vascular ectasia of stomach: DA43.4\\nOther specified vascular disorders of the stomach: DA43.Y\\nVascular disorders of the stomach unspecified: DA43.Z\\nGastric polyp: DA44\\nHyperplastic polyp of stomach: DA44.0\\nFundic gland polyp of stomach: DA44.1\\nHamartomatous polyp of stomach: DA44.2\\nOther specified gastric polyp: DA44.Y\\nGastric polyp unspecified: DA44.Z\\nOther specified diseases of stomach: DA4Y\\nDiseases of stomach unspecified: DA4Z\\nAcquired anatomical alterations of the duodenum: DA50\\nObstruction of duodenum: DA50.0\\nDiverticulum of duodenum: DA50.1\\nFistula of duodenum: DA50.2\\nDeformity of duodenum acquired: DA50.3\\nOther specified acquired anatomical alterations of the duodenum: DA50.Y\\nAcquired anatomical alterations of the duodenum unspecified: DA50.Z\\nDuodenitis: DA51\\nHelicobacterpylori associated duodenitis: DA51.0\\nEosinophilic duodenitis: DA51.1\\nLymphocytic duodenitis: DA51.2\\nAllergic duodenitis: DA51.3\\nDuodenitis of unknown aetiology with specific endoscopic or pathologic features: DA51.4\\nAcute haemorrhagic duodenitis of unknown aetiology: DA51.40\\nGranulomatous duodenitis of unknown aetiology: DA51.41\\nDuodenitis of unknown aetiology with specific endoscopic or pathologic features unspecified: DA51.4Z\\nDuodenitis due to external causes: DA51.5\\nAlcoholic duodenitis: DA51.50\\nDruginduced duodenitis: DA51.51\\nChemical duodenitis: DA51.52\\nRadiation duodenitis: DA51.53\\nDuodenitis due to other specified external causes: DA51.5Y\\nDuodenitis due to external causes unspecified: DA51.5Z\\nInfectious duodenitis: DA51.6\\nDuodenal phlegmon: DA51.60\\nOther specified infectious duodenitis: DA51.6Y\\nInfectious duodenitis unspecified: DA51.6Z\\nOther specified duodenitis: DA51.Y\\nDuodenitis unspecified: DA51.Z\\nVascular disorders of the duodenum: DA52\\nDuodenal varices: DA52.0\\nAngiodysplasia of duodenum: DA52.1\\nArteriovenous malformation of duodenum: DA52.2\\nOther specified vascular disorders of the duodenum: DA52.Y\\nVascular disorders of the duodenum unspecified: DA52.Z\\nDuodenal polyp: DA53\\nHyperplastic duodenal polyp: DA53.0\\nOther specified duodenal polyp: DA53.Y\\nDuodenal polyp unspecified: DA53.Z\\nOther specified diseases of duodenum: DA5Y\\nDiseases of duodenum unspecified: DA5Z\\nGastric ulcer: DA60\\nGastric erosion: DA60.0\\nHelicobacter pylori associated gastric ulcer: DA60.1\\nHelicobacter pylori associated and druginduced gastric ulcer: DA60.2\\nStress ulcer of stomach: DA60.3\\nEosinophilic gastric ulcer: DA60.4\\nLymphocytic gastric ulcer: DA60.5\\nGastric ulcer due to external causes: DA60.6\\nAlcoholinduced gastric ulcer: DA60.60\\nChemical gastric ulcer: DA60.61\\nDruginduced gastric ulcer: DA60.62\\nRadiation gastric ulcer: DA60.63\\nOther specified gastric ulcer due to external causes: DA60.6Y\\nGastric ulcer due to external causes unspecified: DA60.6Z\\nInfectious secondary gastric ulcer: DA60.7\\nOther specified gastric ulcer: DA60.Y\\nGastric ulcer unspecified: DA60.Z\\nPeptic ulcer site unspecified: DA61\\nAnastomotic ulcer: DA62\\nAnastomotic erosion: DA62.0\\nHelicobacter pylori associated anastomotic ulcer: DA62.1\\nDruginduced anastomotic ulcer: DA62.2\\nPeptic anastomotic ulcer: DA62.3\\nOther specified anastomotic ulcer: DA62.Y\\nAnastomotic ulcer unspecified: DA62.Z\\nDuodenal ulcer: DA63\\nDuodenal erosion: DA63.0\\nHelicobacterpylori associated duodenal ulcer: DA63.1\\nHelicobacterpylori associated and druginduced duodenal ulcer: DA63.2\\nStress ulcer of duodenum: DA63.3\\nEosinophilic duodenal ulcer: DA63.4\\nDuodenal ulcer due to external causes: DA63.5\\nDruginduced duodenal ulcer: DA63.50\\nRadiation duodenal ulcer: DA63.51\\nChemical duodenal ulcer: DA63.52\\nDuodenal ulcer due to other specified external causes: DA63.5Y\\nDuodenal ulcer due to external causes unspecified: DA63.5Z\\nInfectious duodenal ulcer: DA63.6\\nBacterial duodenal ulcer: DA63.60\\nViral duodenal ulcer: DA63.61\\nFungal duodenal ulcer: DA63.62\\nParasitic duodenal ulcer: DA63.63\\nInfectious duodenal ulcer unspecified: DA63.6Z\\nOther specified duodenal ulcer: DA63.Y\\nDuodenal ulcer unspecified: DA63.Z\\nDiseases of the stomach or the duodenum unspecified: DA7Z\\nNonstructural developmental anomalies of small intestine: DA90\\nSyndromic diarrhoea: DA90.0\\nCongenital intestinal transport defect: DA90.1\\nCongenital intestinal motility disorders: DA90.2\\nOther specified nonstructural developmental anomalies of small intestine: DA90.Y\\nNonstructural developmental anomalies of small intestine unspecified: DA90.Z\\nObstruction of small intestine: DA91\\nIntussusception of small intestine: DA91.0\\nVolvulus of small intestine: DA91.1\\nIntestinal adhesions or bands of small intestine with obstruction: DA91.2\\nObstructive ileus of small intestine due to impaction: DA91.3\\nGallstone ileus of small intestine: DA91.30\\nEnterolith of small intestine: DA91.31\\nOther specified obstructive ileus of small intestine due to impaction: DA91.3Y\\nObstructive ileus of small intestine due to impaction unspecified: DA91.3Z\\nOther specified obstruction of small intestine: DA91.Y\\nObstruction of small intestine unspecified: DA91.Z\\nOther acquired anatomical alterations of small intestine: DA92\\nFistula of small intestine: DA92.0\\nPneumatosis intestinalis of small intestine: DA92.1\\nOther specified acquired anatomical alterations of small intestine: DA92.Y\\nAcquired anatomical alterations of small intestine unspecified: DA92.Z\\nMotility disorders of small intestine: DA93\\nParalytic ileus: DA93.0\\nOther specified motility disorders of small intestine: DA93.Y\\nMotility disorders of small intestine unspecified: DA93.Z\\nNoninfectious enteritis or ulcer of small intestine: DA94\\nPrimary ulcer of small intestine: DA94.0\\nPrimary nonspecific ulceration of small intestine: DA94.00\\nChronic nonspecific multiple ulcers of small intestine: DA94.01\\nCryptogenic multifocal ulcerous stenosing enteritis: DA94.02\\nOther specified primary ulcer of small intestine: DA94.0Y\\nPrimary ulcer of small intestine unspecified: DA94.0Z\\nDruginduced or toxic enteritis of small intestine: DA94.1\\nAllergic or dietetic enteritis of small intestine: DA94.2\\nIgE mediated allergic enteritis of small intestine: DA94.20\\nEosinophilic enteritis: DA94.21\\nFood proteininduced enterocolitis syndrome: DA94.22\\nOther specified allergic or dietetic enteritis of small intestine: DA94.2Y\\nAllergic or dietetic enteritis of small intestine unspecified: DA94.2Z\\nEnteritis or ulcer of small intestine due to other external causes: DA94.3\\nEnteritis or ulcer of small intestine due to foreign body: DA94.30\\nEnteritis or ulcer of small intestine due to radiation: DA94.31\\nEnteritis or ulcer of small intestine due to trauma: DA94.32\\nEnteritis or ulcer of small intestine due to other external causes unspecified: DA94.3Z\\nOther specified noninfectious enteritis or ulcer of small intestine: DA94.Y\\nNoninfectious enteritis or ulcer of small intestine unspecified: DA94.Z\\nCoeliac disease: DA95\\nIntestinal malabsorption or proteinlosing enteropathy: DA96\\nIntestinal malabsorption: DA96.0\\nBacterial overgrowth syndrome: DA96.00\\nTropical sprue: DA96.01\\nMalabsorption or intolerance of specific nutrients: DA96.02\\nShort bowel syndrome: DA96.04\\nIntestinal failure: DA96.05\\nOther specified intestinal malabsorption: DA96.0Y\\nIntestinal malabsorption unspecified: DA96.0Z\\nProteinlosing enteropathy: DA96.1\\nOther specified intestinal malabsorption or proteinlosing enteropathy: DA96.Y\\nIntestinal malabsorption or proteinlosing enteropathy unspecified: DA96.Z\\nCertain vascular disorders of small intestine: DA97\\nAngiodysplasia of small intestine: DA97.0\\nArteriovenous malformation of small intestine: DA97.1\\nVasculitis of mesenteric arteries: DA97.2\\nVarices of small intestine: DA97.3\\nCertain vascular disorders of small intestine unspecified: DA97.Z\\nPolyps of small intestine: DA98\\nHamartoma of small intestine: DA98.0\\nHyperplastic polyp of small intestine: DA98.1\\nInflammatory fibroid polyp of small intestine: DA98.2\\nLymphoid hyperplasia of small intestine: DA98.3\\nOther specified polyps of small intestine: DA98.Y\\nPolyps of small intestine unspecified: DA98.Z\\nOther specified diseases of small intestine: DA9Y\\nDiseases of small intestine unspecified: DA9Z\\nAppendicitis: DB10\\nAcute appendicitis: DB10.0\\nAcute appendicitis with generalised peritonitis: DB10.00\\nAcute appendicitis with localised peritonitis: DB10.01\\nAcute appendicitis without localised or generalised peritonitis: DB10.02\\nChronic appendicitis: DB10.1\\nOther specified appendicitis: DB10.Y\\nAppendicitis unspecified: DB10.Z\\nCertain specified diseases of appendix: DB11\\nMegaloappendix: DB11.0\\nHyperplasia of appendix: DB11.1\\nAppendicular concretions: DB11.2\\nDiverticulum of appendix acquired: DB11.3\\nFistula of appendix: DB11.4\\nIntussusception of appendix: DB11.5\\nMucocele of appendix: DB11.6\\nOther specified diseases of appendix: DB1Y\\nDiseases of appendix unspecified: DB1Z\\nObstruction of large intestine: DB30\\nIntussusception of the large intestine: DB30.0\\nVolvulus of large intestine: DB30.1\\nAdhesions of large intestine with obstruction: DB30.2\\nImpaction of large intestine: DB30.3\\nStenosis of the rectum: DB30.4\\nOther specified obstruction of large intestine: DB30.Y\\nObstruction of large intestine unspecified: DB30.Z\\nOther acquired anatomical alterations of large intestine: DB31\\nFistula of large intestine: DB31.0\\nPneumatosis intestinalis of large intestine: DB31.1\\nRectal prolapse: DB31.2\\nOther specified acquired anatomical alterations of large intestine: DB31.Y\\nAcquired anatomical alterations of large intestine unspecified: DB31.Z\\nMotility disorders of large intestine: DB32\\nPseudoobstruction of colon: DB32.0\\nSlow transit constipation: DB32.1\\nMegacolon: DB32.2\\nToxic megacolon: DB32.20\\nOther specified megacolon: DB32.2Y\\nMegacolon unspecified: DB32.2Z\\nAcquired hypoganglionosis of large intestine: DB32.3\\nOther specified motility disorders of large intestine: DB32.Y\\nMotility disorders of large intestine unspecified: DB32.Z\\nCertain noninfectious colitis or proctitis: DB33\\nPrimary ulcer of colon: DB33.0\\nMicroscopic colitis: DB33.1\\nCollagenous colitis: DB33.10\\nLymphocytic colitis: DB33.11\\nOther specified microscopic colitis: DB33.1Y\\nMicroscopic colitis unspecified: DB33.1Z\\nAllergic or dietetic colitis: DB33.2\\nFood proteininduced proctitis or colitis of infants: DB33.20\\nOther specified allergic or dietetic colitis: DB33.2Y\\nAllergic or dietetic colitis unspecified: DB33.2Z\\nDiversion colitis: DB33.3\\nColitis or proctitis due to external causes: DB33.4\\nChemical colitis or proctitis: DB33.40\\nRadiationinduced colitis: DB33.41\\nRadiation proctitis: DB33.42\\nDruginduced colitis: DB33.43\\nOther specified colitis or proctitis due to external causes: DB33.4Y\\nColitis or proctitis due to external causes unspecified: DB33.4Z\\nOther specified noninfectious colitis or proctitis: DB33.Y\\nNoninfectious colitis or proctitis unspecified: DB33.Z\\nCertain vascular disorders of large intestine: DB34\\nAngiodysplasia of colon: DB34.0\\nArteriovenous malformation of large intestine: DB34.1\\nVasculitis of large intestine: DB34.2\\nVarices of large intestine: DB34.3\\nAcute haemorrhagic rectal ulcer: DB34.4\\nOther specified vascular disorders of large intestine: DB34.Y\\nVascular disorders of large intestine unspecified: DB34.Z\\nPolyp of large intestine: DB35\\nHyperplastic polyp of large intestine: DB35.0\\nInflammatory polyp of large intestine: DB35.1\\nBenign lymphoid polyp of large intestine: DB35.2\\nHamartomatous polyp of large intestine: DB35.3\\nInflammatory fibroid polyp of large intestine: DB35.4\\nOther specified polyp of large intestine: DB35.Y\\nPolyp of large intestine unspecified: DB35.Z\\nCertain infections of the large intestine: DB36\\nColonic abscess: DB36.0\\nRectal abscess: DB36.1\\nPerirectal abscess: DB36.10\\nIschiorectal abscess: DB36.11\\nRectal cellulitis: DB36.12\\nOther specified infections of the large intestine: DB36.Y\\nInfections of the large intestine unspecified: DB36.Z\\nOther specified diseases of large intestine: DB3Y\\nDiseases of large intestine unspecified: DB3Z\\nFissure or fistula of anal regions: DB50\\nAnal fissure: DB50.0\\nAnal fistula: DB50.1\\nAnorectal fistula: DB50.2\\nOther specified fissure or fistula of anal regions: DB50.Y\\nFissure or fistula of anal regions unspecified: DB50.Z\\nStenosis of anal canal: DB51\\nUlcer of anus: DB52\\nAnal prolapse: DB53\\nOther specified acquired anatomical alterations of the anal canal: DB5Y\\nAcquired anatomical alterations of the anal canal unspecified: DB5Z\\nHaemorrhoids: DB60\\nFirst degree haemorrhoids: DB60.0\\nSecond degree haemorrhoids: DB60.1\\nThird degree haemorrhoids: DB60.2\\nFourth degree haemorrhoids: DB60.3\\nHaemorrhoids unspecified: DB60.Z\\nPerianal venous thrombosis: DB61\\nResidual haemorrhoidal skin tags: DB62\\nOther specified haemorrhoids or perianal venous conditions: DB6Y\\nHaemorrhoids or perianal venous conditions unspecified: DB6Z\\nInfections of the anal region: DB70\\nAbscess of anal region: DB70.0\\nAnal abscess: DB70.00\\nAnorectal abscess: DB70.01\\nIntrasphincteric abscess: DB70.02\\nOther specified abscess of anal region: DB70.0Y\\nAbscess of anal region unspecified: DB70.0Z\\nOther specified infections of the anal region: DB70.Y\\nInfections of the anal region unspecified: DB70.Z\\nAnal polyp: DB71\\nInflammatory anal polyp: DB71.0\\nLymphoid polyp: DB71.1\\nHypertrophied anal papillae: DB71.2\\nOther specified anal polyp: DB71.Y\\nAnal polyp unspecified: DB71.Z\\nCertain specified diseases of anal canal: DB72\\nAnal spasm: DB72.0\\nOther specified diseases of anal canal: DB7Y\\nDiseases of anal canal unspecified: DB7Z\\nInfectious liver disease: DB90\\nAbscess of liver: DB90.0\\nOther specified infectious liver disease: DB90.Y\\nInfectious liver disease unspecified: DB90.Z\\nAcute or subacute hepatic failure: DB91\\nAcute or subacute hepatic failure due to hepatitis virus: DB91.0\\nOther acute or subacute hepatic failure: DB91.1\\nAcute or subacute hepatic failure unspecified: DB91.Z\\nNonalcoholic fatty liver disease: DB92\\nNonalcoholic fatty liver disease without nonalcoholic steatohepatitis: DB92.0\\nNonalcoholic steatohepatitis: DB92.1\\nOther specified nonalcoholic fatty liver disease: DB92.Y\\nNonalcoholic fatty liver disease unspecified: DB92.Z\\nHepatic fibrosis or cirrhosis: DB93\\nHepatic fibrosis: DB93.0\\nHepatic cirrhosis: DB93.1\\nCertain specified fibrosis or cirrhosis of liver: DB93.2\\nHereditary North American Indian childhood cirrhosis: DB93.20\\nIdiopathic copperassociated cirrhosis: DB93.21\\nOther specified hepatic fibrosis or cirrhosis: DB93.Y\\nAlcoholic liver disease: DB94\\nAlcoholic fatty liver: DB94.0\\nAlcoholic hepatitis: DB94.1\\nAlcoholic hepatitis with cirrhosis: DB94.10\\nOther specified alcoholic hepatitis: DB94.1Y\\nAlcoholic hepatitis unspecified: DB94.1Z\\nAlcoholic liver fibrosis: DB94.2\\nAlcoholic cirrhosis of liver without hepatitis: DB94.3\\nOther specified alcoholic liver disease: DB94.Y\\nAlcoholic liver disease unspecified: DB94.Z\\nDruginduced or toxic liver disease: DB95\\nDruginduced or toxic liver disease with acute hepatic necrosis or acute hepatitis: DB95.0\\nDruginduced or toxic liver disease with chronic hepatitis: DB95.1\\nDruginduced or toxic liver disease with chronic hepatitis with cirrhosis: DB95.10\\nDruginduced or toxic liver disease with chronic hepatitis without cirrhosis: DB95.11\\nDruginduced or toxic liver disease with chronic hepatitis unspecified: DB95.1Z\\nDruginduced or toxic liver disease with cholestasis: DB95.2\\nChronic druginduced or toxic liver disease with cholestasis: DB95.20\\nOther specified druginduced or toxic liver disease with cholestasis: DB95.2Y\\nDruginduced or toxic liver disease with cholestasis unspecified: DB95.2Z\\nDruginduced or toxic liver disease with fatty liver: DB95.3\\nDruginduced or toxic liver disease with chronic fatty liver disease: DB95.30\\nOther specified druginduced or toxic liver disease with fatty liver: DB95.3Y\\nDruginduced or toxic liver disease with fatty liver unspecified: DB95.3Z\\nDruginduced or toxic liver disease with granulomatous hepatitis: DB95.4\\nDruginduced or toxic liver disease with fibrosis or cirrhosis of liver: DB95.5\\nDruginduced or toxic liver disease with vascular disorders of the liver: DB95.6\\nDruginduced or toxic liver disease with liver tumours: DB95.7\\nOther specified druginduced or toxic liver disease: DB95.Y\\nDruginduced or toxic liver disease unspecified: DB95.Z\\nAutoimmune liver disease: DB96\\nAutoimmune hepatitis: DB96.0\\nPrimary biliary cholangitis: DB96.1\\nPrimary biliary cholangitis with overlap syndrome: DB96.10\\nOther specified primary biliary cholangitis: DB96.1Y\\nPrimary biliary cholangitis unspecified: DB96.1Z\\nPrimary sclerosing cholangitis: DB96.2\\nPrimary sclerosing cholangitis with cirrhosis: DB96.20\\nOther specified primary sclerosing cholangitis: DB96.2Y\\nPrimary sclerosing cholangitis unspecified: DB96.2Z\\nOther specified autoimmune liver disease: DB96.Y\\nAutoimmune liver disease unspecified: DB96.Z\\nCertain specified inflammatory liver diseases: DB97\\nIdiopathic granulomatous hepatitis: DB97.0\\nHepatic berylliosis: DB97.1\\nChronic hepatitis not elsewhere classified: DB97.2\\nOther specified inflammatory liver disease: DB97.Y\\nInflammatory liver disease unspecified: DB97.Z\\nVascular disorders of the liver: DB98\\nInfarction of liver: DB98.0\\nPeliosis hepatis: DB98.1\\nNodular regenerative hyperplasia of liver: DB98.2\\nPortal vein thrombosis: DB98.3\\nSplenic vein thrombosis: DB98.4\\nBuddChiari syndrome: DB98.5\\nHepatic venoocclusive disease: DB98.6\\nPortal hypertension: DB98.7\\nIdiopathic portal hypertension: DB98.70\\nNoncirrhotic portal fibrosis: DB98.71\\nPartial nodular transformation of liver: DB98.72\\nSplanchnic arteriovenous fistula: DB98.73\\nSecondary portal hypertension: DB98.74\\nOther specified portal hypertension: DB98.7Y\\nPortal hypertension unspecified: DB98.7Z\\nPassive congestion of liver: DB98.8\\nHepatic artery aneurysm: DB98.9\\nHepatic haemorrhage: DB98.A\\nIschaemia reperfusion injury of liver: DB98.B\\nOther specified vascular disorders of the liver: DB98.Y\\nVascular disorders of the liver unspecified: DB98.Z\\nCertain specified diseases of liver: DB99\\nChronic liver disease: DB99.0\\nHepatic cyst: DB99.1\\nPolycystic liver disease: DB99.10\\nOther specified hepatic cyst: DB99.1Y\\nHepatic cyst unspecified: DB99.1Z\\nHepatorenal syndrome: DB99.2\\nPortopulmonary hypertension: DB99.3\\nHepatopulmonary syndrome: DB99.4\\nHepatic encephalopathy: DB99.5\\nIntrahepatic cholestasis not elsewhere classified: DB99.6\\nCholestasis of parenteral nutrition: DB99.60\\nOther specified intrahepatic cholestasis: DB99.6Y\\nIntrahepatic cholestasis unspecified: DB99.6Z\\nHepatic failure without mention whether acute or chronic: DB99.7\\nChronic hepatic failure: DB99.8\\nOther specified diseases of liver: DB99.Y\\nDiseases of liver unspecified: DB9Z\\nAcquired anatomical alterations of gallbladder or bile ducts: DC10\\nObstruction of gallbladder or bile ducts: DC10.0\\nObstruction of cystic duct: DC10.00\\nObstruction of gall bladder: DC10.01\\nObstruction of bile duct: DC10.02\\nOther specified obstruction of gallbladder or bile ducts: DC10.0Y\\nObstruction of gallbladder or bile ducts unspecified: DC10.0Z\\nHydrops of gallbladder: DC10.1\\nFistula of gallbladder or bile duct: DC10.2\\nPolyp of gallbladder: DC10.3\\nCholesterolosis of gallbladder: DC10.4\\nOther specified acquired anatomical alterations of gallbladder or bile ducts: DC10.Y\\nAcquired anatomical alterations of gallbladder or bile ducts unspecified: DC10.Z\\nCholelithiasis: DC11\\nCalculus of gallbladder or cystic duct with acute cholecystitis: DC11.0\\nCalculus of gallbladder or cystic duct with other cholecystitis: DC11.1\\nCalculus of gallbladder or cystic duct with cholangitis: DC11.2\\nCalculus of gallbladder or cystic duct without cholecystitis or cholangitis: DC11.3\\nCalculus of bile duct with cholangitis: DC11.4\\nCalculus of bile duct with cholecystitis: DC11.5\\nCalculus of bile duct without cholangitis or cholecystitis: DC11.6\\nIntrahepatic cholelithiasis: DC11.7\\nOther specified cholelithiasis: DC11.Y\\nCholelithiasis unspecified: DC11.Z\\nCholecystitis: DC12\\nAcute cholecystitis: DC12.0\\nAcute on chronic cholecystitis: DC12.00\\nOther specified acute cholecystitis: DC12.0Y\\nAcute cholecystitis unspecified: DC12.0Z\\nChronic cholecystitis: DC12.1\\nOther specified cholecystitis: DC12.Y\\nCholecystitis unspecified: DC12.Z\\nCholangitis: DC13\\nCertain specified biliary diseases: DC14\\nHaemorrhage of bile duct: DC14.0\\nPostcholecystectomy syndrome: DC14.1\\nDyskinesia of sphincter of Oddi: DC14.2\\nAdenomyomatosis of gallbladder: DC14.3\\nOther specified diseases of gallbladder or biliary tract: DC1Y\\nDiseases of gallbladder or biliary tract unspecified: DC1Z\\nCystic diseases of the pancreas: DC30\\nCyst of pancreas: DC30.0\\nPseudocyst of pancreas: DC30.1\\nOther specified cystic diseases of the pancreas: DC30.Y\\nCystic diseases of the pancreas unspecified: DC30.Z\\nAcute pancreatitis: DC31\\nAcute idiopathic pancreatitis: DC31.0\\nAcute alcoholinduced pancreatitis: DC31.1\\nAcute biliary pancreatitis: DC31.2\\nAcute druginduced pancreatitis: DC31.3\\nHereditary acute pancreatitis: DC31.4\\nAcute exacerbation of chronic pancreatitis: DC31.5\\nOther specified acute pancreatitis: DC31.Y\\nAcute pancreatitis unspecified: DC31.Z\\nChronic pancreatitis: DC32\\nCalcific pancreatitis: DC32.0\\nGroove pancreatitis: DC32.1\\nHereditary chronic pancreatitis: DC32.2\\nChronic alcoholinduced pancreatitis: DC32.3\\nChronic idiopathic pancreatitis: DC32.4\\nTropical pancreatitis: DC32.5\\nOther specified chronic pancreatitis: DC32.Y\\nChronic pancreatitis unspecified: DC32.Z\\nAutoimmune pancreatitis: DC33\\nObstructive pancreatitis: DC34\\nCertain specified diseases of pancreas: DC35\\nAtrophy of pancreas: DC35.0\\nSecondary pancreatic insufficiency: DC35.1\\nPancreatic steatorrhoea: DC35.2\\nOther specified diseases of pancreas: DC3Y\\nDiseases of pancreas unspecified: DC3Z\\nPeritonitis: DC50\\nPrimary peritonitis: DC50.0\\nSpontaneous bacterial peritonitis: DC50.00\\nOther specified primary peritonitis: DC50.01\\nSecondary peritonitis: DC50.1\\nEosinophilic peritonitis: DC50.10\\nMesenteric peritonitis: DC50.11\\nChronic proliferative peritonitis: DC50.12\\nPeritonitis due to Streptococcus pneumoniae: DC50.13\\nOther specified secondary peritonitis: DC50.1Y\\nSecondary peritonitis unspecified: DC50.1Z\\nPeritoneal abscess: DC50.2\\nPeritonitis unspecified: DC50.Z\\nCertain specified disorders of peritoneum or retroperitoneum: DC51\\nChylous ascites: DC51.0\\nPeritoneal adhesions: DC51.1\\nHaemoperitoneum: DC51.2\\nOther specified disorders of peritoneum or retroperitoneum: DC51.Y\\nDiseases of peritoneum unspecified: DC5Z\\nDiverticulitis of small intestine: DC70\\nDiverticulitis of small intestine with complication: DC70.0\\nDiverticulitis of small intestine with perforation or abscess: DC70.00\\nDiverticulitis of small intestine with other specified complication: DC70.0Y\\nDiverticulitis of small intestine with unspecified complication: DC70.0Z\\nDiverticulitis of small intestine without complication: DC70.1\\nDiverticulitis of small intestine without specification of presence of complications: DC70.Z\\nDiverticulosis of small intestine: DC71\\nDiverticulosis of small intestine with haemorrhage: DC71.0\\nDiverticulosis of small intestine without haemorrhage: DC71.1\\nDiverticulosis of small intestine unspecified: DC71.Z\\nDiverticulum of small intestine: DC72\\nDiverticulum of small intestine with haemorrhage: DC72.0\\nDiverticulum of small intestine without haemorrhage: DC72.1\\nDiverticulum of small intestine no specification about presence or absence of haemorrhage: DC72.Z\\nDiverticulitis of large intestine: DC80\\nDiverticulitis of large intestine with complication: DC80.0\\nDiverticulitis of large intestine with perforation or abscess: DC80.00\\nDiverticulitis of large intestine with other specified complication: DC80.0Y\\nDiverticulitis of large intestine with unspecified complication: DC80.0Z\\nDiverticulitis of large intestine without complication: DC80.1\\nDiverticulitis of large intestine without specification of presence of complications: DC80.Z\\nDiverticulosis of large intestine: DC81\\nDiverticulosis of large intestine with haemorrhage: DC81.0\\nDiverticulosis of large intestine without haemorrhage: DC81.1\\nDiverticulosis of large intestine unspecified: DC81.Z\\nDiverticulum of large intestine: DC82\\nDiverticulum of large intestine with haemorrhage: DC82.0\\nDiverticulum of large intestine without haemorrhage: DC82.1\\nDiverticulum of large intestine unspecified: DC82.Z\\nDiverticular disease of small and large intestine: DC90\\nDiverticulitis of unspecified part of intestine: DD00\\nDiverticulitis of unspecified part of intestine with complication: DD00.0\\nDiverticulitis of unspecified part of intestine with perforation or abscess: DD00.00\\nDiverticulitis of unspecified part of intestine with other specified complication: DD00.0Y\\nDiverticulitis of unspecified part of intestine with unspecified complication: DD00.0Z\\nDiverticulitis of unspecified part of intestine without complication: DD00.1\\nDiverticulitis of unspecified part of intestine without specification of presence or absence of complications: DD00.Z\\nDiverticulosis of unspecified part of intestine: DD01\\nDiverticulosis of unspecified part of intestine with haemorrhage: DD01.0\\nDiverticulosis of unspecified part of intestine without haemorrhage: DD01.1\\nDiverticulosis of unspecified part of intestine unspecified: DD01.Z\\nDiverticulum of unspecified part of intestine: DD02\\nDiverticular disease of unspecified part of intestine with haemorrhage: DD02.0\\nDiverticulum of unspecified part of intestine without complication: DD02.1\\nDiverticulum of unspecified part of intestine unspecified: DD02.Z\\nDiverticular disease of intestine unspecified: DD1Z\\nAcute vascular disorders of intestine: DD30\\nAcute mesenteric arterial infarction: DD30.0\\nAcute mesenteric arterial ischaemia: DD30.1\\nAcute mesenteric venous occlusion: DD30.2\\nOther specified acute vascular disorders of intestine: DD30.Y\\nAcute vascular disorders of intestine unspecified: DD30.Z\\nChronic vascular disorders of intestine: DD31\\nNonocclusive mesenteric ischaemia: DD31.0\\nIschaemic colitis: DD31.00\\nOther specified nonocclusive mesenteric ischaemia: DD31.0Y\\nNonocclusive mesenteric ischaemia unspecified: DD31.0Z\\nOther specified chronic vascular disorders of intestine: DD31.Y\\nChronic vascular disorders of intestine unspecified: DD31.Z\\nOther specified ischaemic vascular disorders of intestine: DD3Y\\nIschaemic vascular disorders of intestine unspecified: DD3Z\\nNonabdominal wall hernia: DD50\\nDiaphragmatic hernia: DD50.0\\nPelvic hernia: DD50.1\\nIntraabdominal hernia: DD50.2\\nPrimary intraabdominal hernia: DD50.20\\nSecondary intraabdominal hernia: DD50.21\\nOther specified intraabdominal hernia: DD50.2Y\\nIntraabdominal hernia unspecified: DD50.2Z\\nOther specified nonabdominal wall hernia: DD50.Y\\nNonabdominal wall hernia unspecified: DD50.Z\\nInguinal hernia: DD51\\nFemoral hernia: DD52\\nUmbilical hernia: DD53\\nParaumbilical hernia: DD54\\nEpigastric hernia: DD55\\nIncisional hernia: DD56\\nParastomal hernia: DD57\\nOther specified hernias: DD5Y\\nHernias unspecified: DD5Z\\nCrohn disease: DD70\\nCrohn disease of upper gastrointestinal tract: DD70.0\\nCrohn disease of small intestine: DD70.1\\nCrohn disease of appendix: DD70.2\\nCrohn disease of large intestine: DD70.3\\nCrohn disease of anal region: DD70.4\\nCrohn disease of both small and large intestine: DD70.5\\nCrohn disease of anastomotic sites: DD70.6\\nCrohn disease of other specified site: DD70.Y\\nCrohn disease unspecified site: DD70.Z\\nUlcerative colitis: DD71\\nUlcerative pancolitis: DD71.0\\nLeft sided ulcerative colitis: DD71.1\\nUlcerative rectosigmoiditis: DD71.2\\nUlcerative proctitis: DD71.3\\nOther specified ulcerative colitis: DD71.Y\\nUlcerative colitis unspecified: DD71.Z\\nIndeterminate colitis: DD72\\nOther specified inflammatory bowel diseases: DD7Y\\nInflammatory bowel diseases unspecified: DD7Z\\nFunctional oesophageal or gastroduodenal disorders: DD90\\nGlobus: DD90.0\\nFunctional swallowing disorder: DD90.1\\nFunctional heartburn: DD90.2\\nFunctional dyspepsia: DD90.3\\nFunctional nausea or vomiting: DD90.4\\nFunctional belching disorders: DD90.5\\nAdult rumination syndrome: DD90.6\\nOther specified functional oesophageal or gastroduodenal disorders: DD90.Y\\nFunctional oesophageal or gastroduodenal disorders unspecified: DD90.Z\\nIrritable bowel syndrome or certain specified functional bowel disorders: DD91\\nIrritable bowel syndrome: DD91.0\\nIrritable bowel syndrome constipation predominant: DD91.00\\nIrritable bowel syndrome diarrhoea predominant: DD91.01\\nIrritable bowel syndrome mixed type: DD91.02\\nIrritable bowel syndrome unsubtyped: DD91.03\\nIrritable bowel syndrome type unspecified: DD91.0Z\\nFunctional constipation: DD91.1\\nFunctional diarrhoea: DD91.2\\nFunctional bloating: DD91.3\\nFunctional abdominal pain syndrome: DD91.4\\nOther specified irritable bowel syndrome or functional bowel disorders: DD91.Y\\nIrritable bowel syndrome or functional bowel disorders unspecified: DD91.Z\\nFunctional anorectal disorders: DD92\\nFunctional faecal incontinence: DD92.0\\nFunctional anorectal pain: DD92.1\\nFunctional defaecation disorders: DD92.2\\nOther specified functional anorectal disorders: DD92.Y\\nFunctional anorectal disorders unspecified: DD92.Z\\nFunctional digestive disorders of infants toddlers or children: DD93\\nInfant regurgitation: DD93.0\\nInfantile colic: DD93.1\\nInfant dyschezia: DD93.2\\nOther functional digestive disorders of infants neonates or toddlers: DD93.Y\\nFunctional digestive disorders of infants toddlers or children unspecified: DD93.Z\\nFunctional gallbladder disorder: DD94\\nFunctional sphincter of Oddi disorder: DD95\\nOther specified functional gastrointestinal disorders: DD9Y\\nFunctional gastrointestinal disorders unspecified: DD9Z\\nVomiting following gastrointestinal surgery: DE10\\nDumping syndrome: DE11\\nMalfunction or complication of external stoma of digestive organs: DE12\\nColostomy or enterostomy malfunction or complication: DE12.0\\nGastrostomy malfunction: DE12.1\\nPostsurgical malabsorption not elsewhere classified: DE13\\nOther specified diseases of the digestive system: DE2Y\\nDiseases of the digestive system unspecified: DE2Z\\nViral exanthem due to unknown or unspecified agent: EA00\\nViral exanthem due to other specified virus: EA0Y\\nPityriasis rosea: EA10\\nPapular purpuric gloves and socks syndrome: EA11\\nInfantile papular acrodermatitis: EA12\\nNecrolytic acral erythema: EA20\\nUnspecified skin disorder attributable to viral infection: EA3Z\\nTropical phagedaenic ulcer: EA40\\nToxinmediated cutaneous reactions to distant or systemic bacterial infection: EA50\\nErythema marginatum rheumaticum: EA50.0\\nStreptococcal toxinmediated perineal erythema: EA50.1\\nStaphylococcal scalded skin syndrome: EA50.2\\nStaphylococcal scarlatina: EA50.3\\nOther specified toxinmediated cutaneous reactions to distant or systemic bacterial infection: EA50.Y\\nToxinmediated cutaneous reactions to distant or systemic bacterial infection unspecified: EA50.Z\\nSkin complications of BCG immunisation: EA51\\nCutaneous involvement by other specified bacterial infection: EA5Y\\nCutaneous involvement by unspecified bacterial infection: EA5Z\\nCertain skin disorders attributable to fungal infection: EA60\\nSubcutaneous mycoses: EA60.0\\nSystemic mycoses affecting skin: EA60.1\\nSkin involvement in other specified fungal infection: EA60.Y\\nFungal infection of the skin unspecified: EA60.Z\\nCutaneous involvement by other specified infection or infestation: EA6Y\\nAtopic eczema: EA80\\nInfantile atopic eczema: EA80.0\\nChildhood atopic eczema: EA80.1\\nAdult atopic eczema: EA80.2\\nOther specified forms of atopic eczema: EA80.Y\\nAtopic eczema unspecified: EA80.Z\\nSeborrhoeic dermatitis and related conditions: EA81\\nSeborrhoeic dermatitis of face: EA81.0\\nSeborrhoeic dermatitis of the scalp: EA81.1\\nSeborrhoeic dermatosis of other specified type or distribution: EA81.Y\\nSeborrhoeic dermatitis unspecified: EA81.Z\\nNummular dermatitis: EA82\\nLichen simplex or lichenification: EA83\\nLichen simplex: EA83.0\\nLichen simplex of vulva: EA83.00\\nLichen simplex of male genitalia: EA83.01\\nPerianal lichen simplex: EA83.02\\nLichen simplex of other specified site: EA83.0Y\\nLichen simplex of unspecified site: EA83.0Z\\nSecondary lichenification: EA83.1\\nAsteatotic eczema: EA84\\nDermatitis or eczema of hands or feet: EA85\\nVesicular dermatitis of hands or feet: EA85.0\\nHyperkeratotic dermatitis of hands or feet: EA85.1\\nDermatitis of hands: EA85.2\\nAtopic eczema of hands: EA85.20\\nOther specified dermatitis of hands: EA85.2Y\\nDermatitis of hands unspecified: EA85.2Z\\nDermatitis of feet: EA85.3\\nDermatitis or eczema of lower legs: EA86\\nStasis dermatitis of lower legs: EA86.0\\nDermatitis or eczema of lower legs unspecified: EA86.Z\\nDermatitis or eczema of anogenital region: EA87\\nDermatitis or eczema of male genitalia: EA87.0\\nDermatitis or eczema of female genitalia: EA87.1\\nDermatitis or eczema of perianal area: EA87.2\\nDermatitis or eczema of anogenital region unspecified: EA87.Z\\nMiscellaneous specified eczematous dermatoses: EA88\\nInfectious dermatitis: EA88.0\\nHuman Tcell lymphotropic virus type  associated infective dermatitis of childhood: EA88.00\\nOther specified infectious dermatitis: EA88.0Y\\nInfectious dermatitis unspecified: EA88.0Z\\nPost traumatic eczema: EA88.1\\nDisseminated secondary eczema: EA88.2\\nSecondary eczema: EA88.3\\nPityriasis alba: EA88.4\\nGeneralised eczematous dermatitis of unspecified type: EA89\\nOther specified eczematous dermatosis: EA8Y\\nDermatitis or eczema unspecified: EA8Z\\nPsoriasis: EA90\\nPlaque psoriasis: EA90.0\\nGuttate psoriasis: EA90.1\\nUnstable psoriasis: EA90.2\\nErythrodermic psoriasis: EA90.3\\nPustular psoriasis: EA90.4\\nGeneralised pustular psoriasis: EA90.40\\nAcropustulosis of Hallopeau: EA90.41\\nPalmoplantar pustulosis: EA90.42\\nOther specified pustular psoriasis: EA90.4Y\\nPustular psoriasis unspecified: EA90.4Z\\nPsoriasis of specified site or distribution: EA90.5\\nScalp psoriasis: EA90.50\\nNail psoriasis: EA90.51\\nFlexural and intertriginous psoriasis: EA90.52\\nAnogenital psoriasis: EA90.53\\nPsoriasis of other specified site or distribution: EA90.5Y\\nOther specified forms of psoriasis: EA90.Y\\nPsoriasis of unspecified type: EA90.Z\\nLichen planus: EA91\\nAcute eruptive lichen planus: EA91.0\\nHypertrophic lichen planus: EA91.1\\nFollicular lichen planus: EA91.2\\nLichen planus of genital skin and mucous membranes: EA91.3\\nLichen planus and lichenoid reactions of oral mucosa: EA91.4\\nNonerosive lichen planus of oral mucosa: EA91.40\\nErosive oral lichen planus: EA91.41\\nOral lichen planus unspecified: EA91.42\\nLichenoid mucositis: EA91.43\\nOther specified lichenoid reactions of oral mucosa: EA91.4Y\\nLichen planus of the nails: EA91.5\\nSubacute lichen planus: EA91.6\\nOther specified lichen planus: EA91.Y\\nLichen planus of unspecified type: EA91.Z\\nLichenoid dermatoses: EA92\\nPityriasis lichenoides: EA93\\nPityriasis rubra pilaris: EA94\\nSmall plaque parapsoriasis: EA95\\nSpontaneous urticaria: EB00\\nAcute urticaria: EB00.0\\nChronic urticaria: EB00.1\\nSpontaneous urticaria unspecified: EB00.Z\\nInducible urticaria or angioedema: EB01\\nDermographism: EB01.0\\nCold urticaria: EB01.1\\nDelayed pressure urticaria: EB01.2\\nContact urticaria: EB01.3\\nOther specified forms of inducible urticaria or angioedema: EB01.Y\\nInducible urticaria or angioedema unspecified: EB01.Z\\nCholinergic urticaria or related conditions: EB02\\nCholinergic urticaria: EB02.0\\nOther conditions mediated by cholinergic activation: EB02.Y\\nSyndromes with urticarial reactions or angioedema: EB03\\nIdiopathic angioedema: EB04\\nUrticaria of unspecified type: EB05\\nOther specified urticarial disorders: EB0Y\\nDiffuse inflammatory erythemas: EB10\\nAnnular erythema: EB11\\nErythema multiforme: EB12\\nCutaneous erythema multiforme: EB12.0\\nMucocutaneous erythema multiforme: EB12.1\\nOther specified erythema multiforme: EB12.Y\\nErythema multiforme unspecified: EB12.Z\\nStevensJohnson syndrome or toxic epidermal necrolysis: EB13\\nStevensJohnson syndrome: EB13.0\\nToxic epidermal necrolysis: EB13.1\\nStevensJohnson and toxic epidermal necrolysis overlap syndrome: EB13.2\\nAcute febrile neutrophilic dermatosis: EB20\\nPyoderma gangrenosum: EB21\\nOther specified neutrophilic dermatoses: EB2Y\\nEosinophilic cellulitis: EB30\\nErythema nodosum: EB31\\nPemphigus: EB40\\nPemphigus vulgaris: EB40.0\\nOral pemphigus: EB40.00\\nOther specified pemphigus vulgaris: EB40.0Y\\nPemphigus vulgaris unspecified: EB40.0Z\\nPemphigus foliaceus: EB40.1\\nParaneoplastic pemphigus: EB40.2\\nOther specified pemphigus: EB40.Y\\nPemphigus unspecified: EB40.Z\\nPemphigoid: EB41\\nBullous pemphigoid: EB41.0\\nMucous membrane pemphigoid: EB41.1\\nOther specified pemphigoid: EB41.Y\\nPemphigoid unspecified: EB41.Z\\nLinear IgA bullous dermatosis: EB42\\nEpidermolysis bullosa acquisita: EB43\\nDermatitis herpetiformis: EB44\\nOther specified immunobullous disorder: EB4Y\\nSubacute cutaneous lupus erythematosus: EB50\\nChronic cutaneous lupus erythematosus: EB51\\nDiscoid lupus erythematosus: EB51.0\\nOther specified chronic cutaneous lupus erythematosus: EB51.Y\\nChronic cutaneous lupus erythematosus unspecified: EB51.Z\\nCutaneous lupus erythematosus of unspecified type: EB5Z\\nLichen sclerosus: EB60\\nLichen sclerosus of vulva: EB60.0\\nLichen sclerosus of penis: EB60.1\\nLichen sclerosus of other specified sites: EB60.Y\\nLichen sclerosus unspecified: EB60.Z\\nMorphoea: EB61\\nPlaque morphoea: EB61.0\\nLinear morphoea: EB61.1\\nOther specified forms of morphoea: EB61.Y\\nMorphoea unspecified: EB61.Z\\nOther specified inflammatory dermatoses: EB7Y\\nDermatoses resulting from disturbed metabolic processes: EB90\\nDiabetic skin lesions: EB90.0\\nCutaneous mucinosis: EB90.1\\nPretibial myxoedema: EB90.10\\nLichen myxoedematosus: EB90.11\\nReticular erythematous mucinosis: EB90.12\\nOther specified forms of cutaneous mucinosis: EB90.1Y\\nCutaneous or subcutaneous xanthomata: EB90.2\\nPlane xanthoma: EB90.20\\nTuberous xanthoma: EB90.21\\nEruptive xanthoma: EB90.22\\nTendinous xanthoma: EB90.23\\nCutaneous or subcutaneous xanthomata of unspecified type: EB90.2Z\\nPorphyria or pseudoporphyria affecting the skin: EB90.3\\nPseudoporphyria: EB90.30\\nOther specified porphyria or pseudoporphyria affecting the skin: EB90.3Y\\nCalcification of skin or subcutaneous tissue: EB90.4\\nDystrophic calcification of the skin of uncertain or unspecified aetiology: EB90.40\\nCalcific panniculitis: EB90.41\\nCalcific arteriolopathy: EB90.42\\nOther specified calcification of skin or subcutaneous tissue: EB90.4Y\\nOther specified metabolic or nutritional disorders affecting the skin: EB9Y\\nGenetic syndromes with poikiloderma: EC10\\nOther specified genetic syndromes affecting the skin: EC1Y\\nGenetic disorders of keratinisation: EC20\\nNonsyndromic ichthyosis: EC20.0\\nIchthyosis vulgaris: EC20.00\\nXlinked ichthyosis: EC20.01\\nAutosomal recessive congenital ichthyosis: EC20.02\\nKeratinopathic ichthyoses: EC20.03\\nOther specified or unclassifiable nonsyndromic ichthyosis: EC20.0Y\\nHereditary skin peeling: EC20.1\\nHereditary acantholytic dermatoses: EC20.2\\nHereditary palmoplantar keratodermas: EC20.3\\nDiffuse palmoplantar keratodermas: EC20.30\\nFocal palmoplantar keratodermas: EC20.31\\nPapular palmoplantar keratodermas: EC20.32\\nHereditary palmoplantar keratoderma of unspecified type: EC20.3Z\\nOther specified genetic disorders of keratinisation: EC20.Y\\nGenetic defects of hair or hair growth: EC21\\nGenetic defects of the hair shaft: EC21.0\\nGenetic syndromes with abnormalities of the hair shaft: EC21.1\\nHereditary alopecia or hypotrichosis: EC21.2\\nGenetic syndromes with alopecia or hypotrichosis: EC21.3\\nGeneticallydetermined hypertrichosis: EC21.4\\nOther specified genetic defects of hair or hair growth: EC21.Y\\nGenetic defects of hair or hair growth unspecified: EC21.Z\\nGenetic defects of nails or nail growth: EC22\\nInherited deformities of nails: EC22.0\\nGenetic disorders of skin pigmentation: EC23\\nNonsyndromic geneticallydetermined hypermelanosis or lentiginosis: EC23.0\\nSyndromic geneticallydetermined hypermelanosis or lentiginosis: EC23.1\\nAlbinism or other specified geneticallydetermined hypomelanotic disorders: EC23.2\\nOculocutaneous albinism: EC23.20\\nOther specified geneticallydetermined hypomelanotic disorders: EC23.2Y\\nOther specified genetic disorders of skin pigmentation: EC23.Y\\nGenetic disorders of skin pigmentation unspecified: EC23.Z\\nEpidermolysis bullosa simplex: EC30\\nJunctional epidermolysis bullosa: EC31\\nDystrophic epidermolysis bullosa: EC32\\nSyndromic epidermolysis bullosa: EC33\\nEpidermolysis bullosa: EC3Z\\nPseudoxanthoma elasticum: EC40\\nOther specified genetic disorders affecting dermal matrix proteins: EC4Y\\nDevelopmental anomalies of the umbilicus: EC50\\nOther specified developmental anomalies affecting the skin: EC5Y\\nOther specified genetic or developmental disorders affecting the skin: EC7Y\\nPruritus: EC90\\nPruritus due to skin disorder: EC90.0\\nPruritus due to systemic disorder: EC90.1\\nUraemic pruritus: EC90.10\\nCholestatic pruritus: EC90.11\\nHaemodialysisassociated pruritus: EC90.12\\nPruritus due to other specified systemic disorder: EC90.1Y\\nDruginduced pruritus: EC90.2\\nPruritus due to neurological disorder: EC90.3\\nPsychogenic pruritus: EC90.4\\nAnogenital pruritus: EC90.5\\nPruritus of unknown cause: EC90.6\\nPruritus of other specified type or aetiology: EC90.Y\\nPruritus unspecified: EC90.Z\\nPrurigo: EC91\\nNodular prurigo: EC91.0\\nAtopic prurigo: EC91.1\\nPrurigo unspecified: EC91.Z\\nMucocutaneous or cutaneous pain syndromes: EC92\\nPenoscrotodynia: EC92.0\\nScalp dysaesthesia: EC92.1\\nOther specified disturbances of cutaneous sensation: EC9Y\\nArtefactual skin disorder: ED00\\nSimulated skin disease: ED01\\nPainful bruising syndrome: ED02\\nOther specified selfinflicted skin disorders: ED0Y\\nOther specified mental conditions affecting the skin: ED2Y\\nNeuropathic skin damage: ED30\\nNeuropathic skin ulceration: ED30.0\\nOther specified neuropathic skin damage: ED30.Y\\nBurning feet syndrome: ED31\\nCutaneous involvement in other specified neurological condition: ED3Y\\nIchthyoses: ED50\\nAcquired ichthyosis: ED50.0\\nIchthyosis of unspecified type: ED50.Z\\nDiffuse epidermal hyperkeratosis or acanthosis: ED51\\nAcanthosis nigricans: ED51.0\\nBenign acanthosis nigricans: ED51.00\\nOther specified acanthosis nigricans: ED51.0Y\\nAcanthosis nigricans unspecified: ED51.0Z\\nOther specified hyperkeratotic or acanthotic dermatoses: ED51.Y\\nDiffuse epidermal hyperkeratosis or acanthosis unspecified: ED51.Z\\nPorokeratoses: ED52\\nSkin peeling: ED53\\nXerosis cutis or asteatosis: ED54\\nPalmoplantar keratodermas: ED55\\nAcquired palmoplantar keratodermas: ED55.0\\nPalmoplantar keratoderma unspecified: ED55.Z\\nKeratosis pilaris: ED56\\nOther specified disorders of epidermal keratinisation: ED5Y\\nAcquired hypermelanosis: ED60\\nPhysiological hypermelanosis: ED60.0\\nSuntan: ED60.00\\nTanning due to exposure to artificial sources of ultraviolet radiation: ED60.01\\nMelasma: ED60.1\\nPostinflammatory hypermelanosis: ED60.2\\nHypermelanosis of other specified aetiology: ED60.Y\\nHypermelanosis of unspecified aetiology: ED60.Z\\nAcquired melanotic macules or lentigines: ED61\\nFreckles: ED61.0\\nMucosal melanosis: ED61.1\\nPenile melanotic macule: ED61.10\\nVulval melanotic macule: ED61.11\\nOther specified mucosal melanosis: ED61.1Y\\nOther specified acquired melanotic macules or lentigines: ED61.Y\\nEndogenous nonmelanin pigmentation: ED62\\nHaemosiderin pigmentation of skin: ED62.0\\nOther specified endogenous nonmelanin pigmentation: ED62.Y\\nAcquired hypomelanotic disorders: ED63\\nVitiligo: ED63.0\\nHypomelanosis due to exposure to chemicals: ED63.1\\nPostinflammatory hypomelanosis: ED63.2\\nVogtKoyanagiHarada syndrome: ED63.3\\nAcquired hypomelanosis due to other specified disorder: ED63.Y\\nAcquired hypomelanosis of unknown or unspecified aetiology: ED63.Z\\nAbnormal skin pigmentation: ED64\\nOther specified disorders of skin pigmentation: ED6Y\\nAlopecia or hair loss: ED70\\nMale pattern hair loss: ED70.0\\nFemale pattern hair loss: ED70.1\\nAlopecia areata: ED70.2\\nPatchy alopecia areata of scalp: ED70.20\\nAlopecia totalis: ED70.21\\nOther specified forms of alopecia areata: ED70.2Y\\nAlopecia areata unspecified: ED70.2Z\\nTelogen effluvium: ED70.3\\nAcute telogen effluvium: ED70.30\\nPostpartum telogen effluvium: ED70.31\\nTelogen hair shedding due to other specified cause: ED70.3Y\\nTelogen effluvium unspecified: ED70.3Z\\nAnagen effluvium: ED70.4\\nScarring alopecia: ED70.5\\nFolliculitis decalvans: ED70.50\\nDissecting cellulitis: ED70.51\\nScarring alopecia due to other specified cause: ED70.5Y\\nScarring alopecia of unknown or unspecified aetiology: ED70.5Z\\nOther specified alopecia or hair loss: ED70.Y\\nAlopecia unspecified: ED70.Z\\nHypertrichosis: ED71\\nHirsutism or syndromes with hirsutism: ED72\\nConstitutional hirsutism: ED72.0\\nHirsutism associated with hyperandrogenaemia: ED72.1\\nHirsutism unspecified: ED72.Z\\nAcquired disorders of the hair shaft: ED73\\nWeathered hair: ED73.0\\nAcquired changes in hair colour: ED73.1\\nPremature canities: ED73.10\\nAcquired poliosis: ED73.11\\nOther specified acquired disorders of the hair shaft: ED73.Y\\nOther specified disorders of hair: ED7Y\\nAcne: ED80\\nComedonal acne: ED80.0\\nSuperficial mixed comedonal and papulopustular acne: ED80.1\\nPapulopustular acne: ED80.2\\nNodular acne: ED80.3\\nSevere inflammatory acne: ED80.4\\nAcne fulminans: ED80.40\\nAcne conglobata: ED80.41\\nOther specified severe inflammatory acne: ED80.4Y\\nSevere inflammatory acne unspecified: ED80.4Z\\nAcne scarring: ED80.5\\nInfantile acne: ED80.6\\nOther specified acne: ED80.Y\\nAcne unspecified: ED80.Z\\nAcneiform inflammatory disorders: ED81\\nFolliculitis cruris pustulosa atrophicans: ED81.0\\nAcneiform reactions to halogenated aromatic hydrocarbons: ED81.1\\nOther specified acneiform inflammatory disorders: ED81.Y\\nAcneiform inflammatory disorders unspecified: ED81.Z\\nRosacea and related disorders: ED90\\nRosacea: ED90.0\\nErythematotelangiectatic rosacea: ED90.00\\nPapulopustular rosacea: ED90.01\\nPhymatous rosacea: ED90.02\\nOther specified rosacea: ED90.0Y\\nRosacea unspecified: ED90.0Z\\nPeriorificial dermatitis: ED90.1\\nOther specified rosacealike disorders: ED90.Y\\nRosacealike disorders unspecified: ED90.Z\\nDisorders of the sebaceous gland: ED91\\nHeterotopic sebaceous glands: ED91.0\\nSebaceous gland hyperplasia: ED91.1\\nSeborrhoea: ED91.2\\nOther specified disorders of the sebaceous gland: ED91.Y\\nDisorders of the sebaceous gland unspecified: ED91.Z\\nDisorders involving the apocrine follicular unit: ED92\\nHidradenitis suppurativa: ED92.0\\nApocrine sweat disorders: ED92.1\\nOther specified disorders involving the apocrine follicular unit: ED92.Y\\nDisorders involving the apocrine follicular unit unspecified: ED92.Z\\nOther specified disorders involving the hair follicle: ED9Y\\nHyperhidrosis: EE00\\nLocalised hyperhidrosis: EE00.0\\nPalmoplantar hyperhidrosis: EE00.00\\nAxillary hyperhidrosis: EE00.01\\nCraniofacial hyperhidrosis: EE00.02\\nOther specified localised hyperhidrosis: EE00.0Y\\nLocalised hyperhidrosis unspecified: EE00.0Z\\nPrimary generalised hyperhidrosis: EE00.1\\nHyperhidrosis unspecified: EE00.Z\\nHypohidrosis: EE01\\nHypohidrosis attributable to defective sudomotor innervation or function: EE01.0\\nHypohidrosis due to genetic abnormalities of eccrine gland structure or function: EE01.1\\nHypohidrosis of undetermined aetiology: EE01.2\\nOther specified forms of hypohidrosis: EE01.Y\\nHypohidrosis unspecified: EE01.Z\\nMiliaria: EE02\\nNeonatal miliaria: EE02.0\\nOther specified forms of miliaria: EE02.Y\\nMiliaria unspecified: EE02.Z\\nOther specified disorders of eccrine sweat glands or sweating: EE0Y\\nAcquired deformities of the nail plate: EE10\\nAbnormality of nail shape: EE10.0\\nAbnormality of nail surface: EE10.1\\nNail pitting: EE10.10\\nOther specified abnormality of nail surface: EE10.1Y\\nAbnormality of nail surface unspecified: EE10.1Z\\nOnycholysis: EE10.2\\nNail hypertrophy: EE10.3\\nNail atrophy: EE10.4\\nNail dystrophy not otherwise specified: EE10.5\\nOther specified acquired deformities of the nail plate: EE10.Y\\nAcquired deformities of the nail plate unspecified: EE10.Z\\nAcquired abnormalities of nail colour: EE11\\nMelanonychia: EE11.0\\nYellow nail syndrome: EE11.1\\nOther abnormalities of nail colour: EE11.Y\\nAcquired abnormalities of nail colour unspecified: EE11.Z\\nInfections of the nail or perionychium: EE12\\nAcute bacterial paronychia: EE12.0\\nOnychomycosis: EE12.1\\nOther specified infections of the nail or perionychium: EE12.Y\\nInfections of the nail or perionychium unspecified: EE12.Z\\nCertain disorders affecting the nails or perionychium: EE13\\nNail fragility: EE13.0\\nIngrowing nail: EE13.1\\nIngrowing toenail: EE13.10\\nInfected ingrowing toenail: EE13.11\\nOther specified ingrowing nail: EE13.1Y\\nIngrowing nail unspecified: EE13.1Z\\nChronic paronychia: EE13.2\\nNail disorder associated with specified dermatosis: EE13.3\\nNail disorder associated with specified systemic disease: EE13.4\\nEczematous nail dystrophy: EE13.5\\nOther specified nail disorder: EE13.Y\\nOther specified disorders of the nail or perionychium: EE1Y\\nDisorders of the nail or perionychium unspecified: EE1Z\\nAcute cutaneous distension syndrome: EE20\\nEpidermal fragility: EE21\\nAtrophy or degeneration of dermal or subcutaneous connective tissue: EE40\\nCorticosteroidinduced skin atrophy: EE40.0\\nStretch marks: EE40.1\\nStretch marks of pregnancy: EE40.10\\nStretch marks of other specified aetiology: EE40.1Y\\nStretch marks unspecified: EE40.1Z\\nAtrophic scarring of the skin: EE40.2\\nSkin fragility: EE40.3\\nGeneticallydetermined skin fragility: EE40.30\\nAgerelated skin fragility: EE40.31\\nPurpura or bruising due to vascular fragility: EE40.32\\nOther specified atrophy or degeneration of dermal or subcutaneous connective tissue: EE40.Y\\nAtrophy or degeneration of dermal or subcutaneous connective tissue unspecified type: EE40.Z\\nAbnormalities of dermal elastin: EE41\\nCutis laxa: EE41.0\\nAnetoderma: EE41.1\\nOther specified dermatoses characterised by abnormal dermal elastin: EE41.Y\\nAbnormalities of dermal elastin unspecified: EE41.Z\\nAcquired poikiloderma: EE50\\nKeloid or hypertrophic scars: EE60\\nKeloid: EE60.0\\nEarlobe keloid: EE60.00\\nOther specified keloid: EE60.0Y\\nKeloid unspecified: EE60.0Z\\nHypertrophic scar: EE60.1\\nOther specified keloidal disorders: EE60.Y\\nSuperficial fibromatoses: EE61\\nOther specified fibromatous disorders of skin or soft tissue: EE6Y\\nFibromatosis of skin or soft tissue unspecified: EE6Z\\nPerforating dermatoses: EE70\\nAcquired perforating dermatosis: EE70.0\\nOther specified perforating dermatoses: EE70.Y\\nPerforating dermatoses unspecified: EE70.Z\\nOther specified disorders of cutaneous connective tissue: EE7Y\\nNecrobiotic granulomatous skin disorders: EE80\\nGranuloma annulare: EE80.0\\nNecrobiosis lipoidica: EE80.1\\nNecrobiotic granulomatous skin disorders unspecified: EE80.Z\\nDermal dendrocyte Class IIa histiocytoses: EE81\\nOther specified histiocyticgranulomatous disorders of the skin: EE8Y\\nHistiocyticgranulomatous disorders of the skin unspecified: EE8Z\\nBenign lymphocytic infiltration of the skin: EE90\\nLymphocytoma cutis: EE91\\nPanniculitis: EF00\\nPancreatic enzyme panniculitis: EF00.0\\nPanniculitis of other specified aetiology: EF00.Y\\nPanniculitis of undetermined or unspecified etiology: EF00.Z\\nLipoatrophy or lipodystrophy: EF01\\nAcquired partial lipodystrophy: EF01.0\\nLocalised lipoatrophy or lipodystrophy: EF01.1\\nOther specified forms of lipodystrophy and lipoatrophy: EF01.Y\\nLipodystrophy or lipoatrophy unspecified: EF01.Z\\nCertain noninflammatory disorders of subcutaneous fat: EF02\\nFat hypertrophy: EF02.0\\nSubcutaneous lipomatosis: EF02.1\\nLipoedema: EF02.2\\nCellulite: EF02.3\\nOther specified noninflammatory disorders of subcutaneous fat: EF02.Y\\nNoninflammatory disorders of subcutaneous fat unspecified: EF02.Z\\nOther specified disorders of subcutaneous fat: EF0Y\\nAcquired malformations of cutaneous blood vessels: EF20\\nVenous lake: EF20.0\\nAngiokeratoma: XH4KP7\\nLower limb venous telangiectases: EF20.2\\nSpider telangiectasis: EF20.3\\nGeneralised essential telangiectasia: EF20.4\\nOther specified acquired malformations of cutaneous blood vessels: EF20.Y\\nAcquired malformations of cutaneous blood vessels unspecified: EF20.Z\\nCutaneous vascular malformation unspecified: EF2Z\\nPurpura or bruising due to disorders of coagulation: EF30\\nTraumatic purpura: EF31\\nOther specified purpura: EF3Y\\nPurpura of unspecified aetiology: EF3Z\\nVasculitis or capillaritis involving the skin: EF40\\nCapillaritis: EF40.0\\nVasculitis affecting small cutaneous blood vessels: EF40.1\\nUrticarial vasculitis: EF40.10\\nOther specified vasculitis affecting small cutaneous blood vessels: EF40.1Y\\nLocalised cutaneous vasculitis: EF40.2\\nGranuloma faciale: EF40.20\\nOther specified localised cutaneous vasculitis: EF40.2Y\\nCutaneous vasculitis unspecified: EF40.Z\\nLivedoid vasculopathy: EF50\\nOther specified dermatoses attributable to hyperviscosity or microvascular occlusion: EF5Y\\nIschaemic ulceration of skin: EF60\\nLower limb venous eczema: EF70\\nOther specified dermatoses due to venous disease: EF7Y\\nDermatoses due to venous disease unspecified: EF7Z\\nOther specified dermatoses resulting from vascular insufficiency: EF9Y\\nVasodilatation of extremities: EG00\\nVasoconstriction of extremities: EG01\\nFlushing disorders: EG02\\nSkin disorders localised to the scalp: EG30\\nScalp folliculitis: EG30.0\\nErosive pustular dermatosis of scalp: EG30.1\\nPityriasis amiantacea: EG30.2\\nOther specified scalp disorders not elsewhere classifiable: EG30.Y\\nSkin disorders localised to the scalp unspecified: EG30.Z\\nContact dermatitis of external ear: EG40\\nAllergic contact dermatitis of external ear: EG40.0\\nOther specified inflammatory disorder of external ear: EG4Y\\nInflammatory disorder of external ear unspecified: EG4Z\\nAnal pruritus: EG60\\nInfections of the anus or perianal skin: EG61\\nInflammatory dermatoses of the perianal area: EG62\\nSacrococcygeal pilonidal disease: EG63\\nSacrococcygeal pilonidal sinus: EG63.0\\nSacrococcygeal pilonidal cyst: EG63.1\\nSacrococcygeal pilonidal abscess: EG63.2\\nSacrococcygeal pilonidal disease unspecified: EG63.Z\\nOther specified skin disorders involving the genital and perianal regions: EG7Y\\nSkin disorders involving other specific body regions: EG9Y\\nSkin disorders involving certain specific body regions unspecified: EG9Z\\nNeonatal viral infections involving the skin: EH10\\nNeonatal pyogenic skin infections: EH11\\nNeonatal fungal infections involving the skin: EH12\\nNeonatal skin infection unspecified: EH1Z\\nOther specified skin disorders specific to the perinatal or neonatal period: EH3Y\\nDermatoses of infancy: EH40\\nInfantile seborrhoeic dermatitis: EH40.0\\nCradle cap: EH40.00\\nDisseminated infantile seborrhoeic dermatitis: EH40.01\\nPsoriasiform napkin dermatitis: EH40.02\\nInfantile seborrhoeic dermatitis unspecified: EH40.0Z\\nInfantile napkin dermatoses: EH40.1\\nPrimary irritant napkin dermatitis: EH40.10\\nOther specified infantile napkin dermatoses: EH40.1Y\\nInfantile napkin dermatoses unspecified: EH40.1Z\\nErythrodermas of infancy: EH40.2\\nAcute haemorrhagic oedema of infancy: EH40.3\\nOther specified dermatoses of infancy: EH40.Y\\nDermatoses of infancy unspecified: EH40.Z\\nExanthematic drug eruption: EH60\\nDruginduced urticaria angioedema or anaphylaxis: EH61\\nDruginduced urticaria: EH61.0\\nDruginduced angioedema: EH61.1\\nLichenoid drug eruption: EH62\\nStevensJohnson syndrome and toxic epidermal necrolysis due to drug: EH63\\nDruginduced StevensJohnson syndrome: EH63.0\\nDruginduced toxic epidermal necrolysis: EH63.1\\nDruginduced StevensJohnson and toxic epidermal necrolysis overlap syndrome: EH63.2\\nDruginduced erythroderma: EH64\\nDRESS syndrome: EH65\\nFixed drug eruption: EH66\\nAcne or acneiform reactions attributable to drugs: EH67\\nDruginduced acute generalised exanthematous pustulosis: EH67.0\\nOther specified acne or acneiform reactions attributable to drugs: EH67.Y\\nAcne or acneiform reactions attributable to drugs unspecified: EH67.Z\\nDrug eruption of other specified type: EH6Y\\nDrug eruption of unspecified type: EH6Z\\nPigmentary abnormalities of skin due to drug: EH70\\nDermatoses precipitated by drug therapy: EH71\\nDruginduced hair abnormalities: EH72\\nDruginduced alopecia: EH72.0\\nDruginduced telogen hair loss: EH72.00\\nDruginduced anagen effluvium: EH72.01\\nOther specified druginduced hair abnormalities: EH72.Y\\nDruginduced hair abnormalities unspecified: EH72.Z\\nDruginduced nail abnormalities: EH73\\nDruginduced oral conditions: EH74\\nPhotosensitivity due to drug: EH75\\nDermatoses associated with specific classes of medication: EH76\\nDermatoses resulting from cytotoxic or cancer chemotherapy: EH76.0\\nDermatoses resulting from immunosuppressive therapy: EH76.1\\nDermatoses attributable to corticosteroid therapy: EH76.2\\nDermatoses resulting from anticoagulant therapy: EH76.3\\nDermatosis associated with other specific classes of medication: EH76.Y\\nLocalised adverse cutaneous reactions to administration of drug: EH77\\nAdverse cutaneous reactions to herbal homoeopathic or other alternative therapies: EH78\\nOther specified adverse cutaneous reactions to medication: EH7Y\\nUnspecified adverse cutaneous reactions to medication: EH7Z\\nPressure ulceration: EH90\\nPressure ulceration grade: EH90.3\\nSuspected deep pressureinduced tissue damage depth unknown: EH90.4\\nPressure ulceration ungradable: EH90.5\\nPressure ulcer of unspecified grade: EH90.Z\\nDermatoses provoked by friction or mechanical stress: EH92\\nCorns or callosities: EH92.0\\nHard corn: EH92.00\\nSoft corn: EH92.01\\nCallosity unspecified: EH92.0Z\\nFriction blister: EH92.1\\nOther specified skin damage due to repetitive friction or mechanical trauma: EH92.Y\\nDermatoses due to foreign bodies: EH93\\nTattoos or tattoo reactions: EH93.0\\nForeign body reaction to inorganic matter in the skin: EH93.1\\nForeign body reaction to organic matter in the skin: EH93.2\\nForeign body granuloma of skin: EH93.3\\nOther specified reaction to foreign body in the skin: EH93.Y\\nDermatoses due to foreign bodies unspecified: EH93.Z\\nScar of skin not elsewhere classified: EH94\\nOther specified dermatoses provoked or exacerbated by exposure to cold: EJ0Y\\nErythema ab igne: EJ10\\nOther specified dermatoses provoked by heat or electricity: EJ1Y\\nPhotoaging of the skin: EJ20\\nActinic elastosis: EJ20.0\\nActinic lentigo: EJ20.1\\nActinic lentiginosis: EJ20.2\\nActinic telangiectasia: EJ20.3\\nPhotoaging of the skin unspecified: EJ20.Z\\nOther specified chronic effects of ultraviolet radiation on the skin: EJ2Y\\nAutoimmune or other photodermatoses: EJ30\\nPolymorphic light eruption: EJ30.0\\nChronic actinic dermatitis: EJ30.1\\nOther specified photodermatoses: EJ30.Y\\nPhotodermatoses unspecified: EJ30.Z\\nSunburn: EJ40\\nSunburn erythema: EJ40.0\\nSunburn with blisters or exudation: EJ40.1\\nSunburn unspecified: EJ40.Z\\nBurn from exposure to artificial source of ultraviolet radiation: EJ41\\nBurn from exposure to therapeutic ultraviolet radiation: EJ41.0\\nOther specified burn from exposure to artificial source of ultraviolet radiation: EJ41.Y\\nBurn from exposure to artificial source of ultraviolet radiation unspecified: EJ41.Z\\nAcute effects of ultraviolet radiation on normal skin unspecified: EJ4Z\\nOther specified dermatoses provoked by light or UV radiation: EJ6Y\\nChronic effects of ionizing radiation on the skin: EJ71\\nDermatoses due to ionizing radiation unspecified: EJ7Z\\nAllergic contact dermatitis: EK00\\nAllergic contact dermatitis due to clothing or footwear: EK00.0\\nAllergic contact dermatitis due to cosmetics or fragrances: EK00.1\\nAllergic contact dermatitis due to dental materials: EK00.2\\nAllergic contact dermatitis due to food flavours or additives: EK00.3\\nAllergic contact dermatitis due to hairdressing products: EK00.4\\nAllergic contact dermatitis due to industrial biocides cutting oils or disinfectants: EK00.5\\nAllergic contact dermatitis due to metals or metal salts: EK00.6\\nAllergic contact dermatitis due to allergenic haptens derived from plants or organic matter: EK00.7\\nAllergic contact dermatitis due to plastics glues or resin systems: EK00.8\\nAllergic contact dermatitis due to preservatives or biocides: EK00.9\\nAllergic contact dermatitis due to rubber chemicals: EK00.A\\nAllergic contact dermatitis due to systemic medicaments: EK00.B\\nAllergic contact dermatitis due to topical medicaments: EK00.C\\nOther specified allergic contact dermatitis: EK00.Y\\nAllergic contact dermatitis unspecified: EK00.Z\\nPhotoallergic contact dermatitis: EK01\\nIrritant contact dermatitis: EK02\\nIrritant contact dermatitis from specified external agents: EK02.0\\nIrritant contact dermatitis due to wet work: EK02.00\\nIrritant contact dermatitis due to solvents: EK02.01\\nIrritant contact dermatitis due to exposure to acids alkalis or other specified chemical irritants: EK02.02\\nIrritant contact dermatitis due to cosmetics or emollients: EK02.03\\nIrritant contact dermatitis due to topical medicaments or antimicrobials: EK02.04\\nIrritant contact dermatitis due to plants or other vegetable matter: EK02.05\\nIrritant contact dermatitis due to foods: EK02.06\\nIrritant contact dermatitis due to friction sweating or contact with body fluids: EK02.2\\nIntertriginous dermatitis due to friction sweating or contact with body fluids: EK02.20\\nIrritant contact dermatitis due to saliva: EK02.21\\nIrritant contact dermatitis due to incontinence: EK02.22\\nIrritant contact dermatitis related to stoma or fistula: EK02.23\\nIrritant contact dermatitis related to skin contact with prostheses or surgical appliances: EK02.24\\nIrritant contact dermatitis due to other specified cause: EK02.Y\\nIrritant contact dermatitis unspecified: EK02.Z\\nAllergic contact urticaria: EK10\\nOral allergy syndrome: EK10.0\\nContact urticaria due to food allergen: EK10.1\\nOther specified allergic contact urticaria: EK10.Y\\nAllergic contact urticaria unspecified: EK10.Z\\nProtein contact dermatitis: EK11\\nAllergic contact sensitisation: EK12\\nPhototoxic reaction to fragrance or cosmetics: EK20\\nPhototoxic reaction to skin contact with other specified photoactive agent: EK2Y\\nPhototoxic dermatitis unspecified: EK2Z\\nCutaneous reactions to venomous or noxious animals: EK50\\nCutaneous insect bite reactions: EK50.0\\nPapular urticaria: EK50.00\\nBullous insect bite reaction: EK50.01\\nPersistent insect bite reaction: EK50.02\\nOther specified cutaneous insect bite reactions: EK50.0Y\\nCutaneous insect bite reactions unspecified: EK50.0Z\\nOther specified skin disorders provoked by external factors: EK5Y\\nCutaneous cysts: EK70\\nEpidermoid cyst: EK70.0\\nInfected epidermoid cyst: EK70.00\\nEpidermoid cyst unspecified: EK70.0Z\\nTrichilemmal cyst: EK70.1\\nDigital myxoid pseudocyst: EK70.2\\nHidrocystoma: XH7NR3\\nOther specified cutaneous cysts: EK70.Y\\nCutaneous cysts unspecified: EK70.Z\\nSkin tags or polyps: EK71\\nFibroepithelial polyp of skin: EK71.0\\nMultiple skin tags: EK71.1\\nPolyp of skin not elsewhere classified: EK71.Z\\nActinic keratosis and other discrete epidermal dysplasias: EK90\\nActinic keratosis: XH36H6\\nDiffuse actinic keratinocyte dysplasia: EK90.1\\nOther discrete epidermal dysplasias: EK90.Y\\nDermatoses which may presage cutaneous lymphoma: EK91\\nLarge plaque parapsoriasis: EK91.0\\nPoikiloderma vasculare atrophicans: EK91.1\\nPrimary cutaneous plasmacytosis: EK91.2\\nHistiocytoses of uncertain malignant potential: EK92\\nParaneoplastic syndromes involving skin: EL10\\nOther specified cutaneous markers of internal malignancy: EL1Y\\nOther specified cutaneous markers of internal disorders: EL3Y\\nUnsatisfactory surgical scar of skin: EL50\\nKeloidal surgical scar: EL50.0\\nHypertrophic surgical scar: EL50.1\\nAtrophic surgical scar: EL50.2\\nExpanded surgical scar: EL50.3\\nUnsatisfactory surgical scar of skin unspecified: EL50.Z\\nCutaneous flap necrosis: EL51\\nMyocutaneous flap necrosis: EL52\\nSkin graft failure: EL53\\nComposite graft failure: EL54\\nAcute radiodermatitis following radiotherapy: EL60\\nChronic radiodermatitis following radiotherapy: EL61\\nRadionecrosis of skin due to therapeutic ionizing irradiation: EL63\\nUnsatisfactory outcome from cutaneous cosmetic surgical procedure: EL73\\nAdverse reaction to dermal or deep fillers: EL73.0\\nAdverse reaction to chemical peel: EL73.1\\nAdverse reaction to injection of neurotoxin: EL73.2\\nUnsatisfactory outcome from cosmetic laser surgery: EL73.3\\nHypomelanosis resulting from cosmetic procedure: EL73.4\\nDyspigmentation resulting from cosmetic procedure: EL73.5\\nFibrosis or scarring following cosmetic procedure: EL73.6\\nAdverse cutaneous effects of diagnostic procedures: EL80\\nOther specified diseases of the skin: EM0Y\\nSkin disease of unspecified nature: EM0Z\\nOsteoarthritis of hip: FA00\\nPrimary osteoarthritis of hip: FA00.0\\nPost traumatic osteoarthritis of hip: FA00.1\\nOther secondary osteoarthritis of hip: FA00.2\\nOsteoarthritis of hip unspecified: FA00.Z\\nOsteoarthritis of knee: FA01\\nPrimary osteoarthritis of knee: FA01.0\\nPost traumatic osteoarthritis of knee: FA01.1\\nOther secondary osteoarthritis of knee: FA01.2\\nOsteoarthritis of knee unspecified: FA01.Z\\nOsteoarthritis of wrist or hand: FA02\\nPrimary osteoarthritis of wrist or hand: FA02.0\\nPost traumatic osteoarthritis of wrist or hand: FA02.1\\nOther secondary osteoarthritis of wrist or hand: FA02.2\\nOsteoarthritis of wrist or hand unspecified: FA02.Z\\nOsteoarthritis of other specified joint: FA03\\nPrimary osteoarthritis of other specified joint: FA03.0\\nPost traumatic osteoarthritis of other specified joint: FA03.1\\nOther secondary osteoarthritis of other specified joint: FA03.2\\nOsteoarthritis of other specified joint unspecified: FA03.Z\\nOligoosteoarthritis: FA04\\nPolyosteoarthritis: FA05\\nOsteoarthritis unspecified: FA0Z\\nDirect infections of joint: FA10\\nBacterial infection of joint: FA10.0\\nViral infection of joint: FA10.1\\nFungal infection of joint: FA10.2\\nDirect infections of joint unspecified: FA10.Z\\nReactive arthropathies: FA11\\nArthropathy following intestinal bypass: FA11.0\\nArthropathy following vaccination: FA11.1\\nArthropathy following genitourinary infection: FA11.2\\nOther specified reactive arthropathies: FA11.Y\\nReactive arthropathies unspecified: FA11.Z\\nPostinfectious arthropathies: FA12\\nBacterial postinfectious arthropathy: FA12.0\\nViral postinfectious arthropathies: FA12.1\\nFungal postinfectious arthropathies: FA12.2\\nParasitic postinfectious arthropathies: FA12.3\\nOther specified postinfectious arthropathies: FA12.Y\\nPostinfectious arthropathies unspecified: FA12.Z\\nInfectious spondyloarthritis: FA13\\nOther specified infection related arthropathies: FA1Y\\nInfection related arthropathies unspecified: FA1Z\\nRheumatoid arthritis: FA20\\nSeropositive rheumatoid arthritis: FA20.0\\nSeronegative rheumatoid arthritis: FA20.1\\nRheumatoid arthritis serology unspecified: FA20.Z\\nPsoriatic arthritis: FA21\\nPsoriatic spondyloarthritis: FA21.0\\nOther specified psoriatic arthritis: FA21.Y\\nPsoriatic arthritis unspecified: FA21.Z\\nPolymyalgia rheumatica: FA22\\nAdultonset Still disease: FA23\\nJuvenile idiopathic arthritis: FA24\\nJuvenile idiopathic oligoarthritis: FA24.0\\nJuvenile idiopathic oligoarthritis onset persistent: FA24.00\\nJuvenile idiopathic oligoarthritis onset extended: FA24.01\\nJuvenile idiopathic oligoarthritis onset unspecified: FA24.0Z\\nJuvenile idiopathic polyarthritis: FA24.1\\nJuvenile psoriatic arthritis: FA24.2\\nJuvenile enthesitis related arthritis: FA24.3\\nJuvenile systemic arthritis: FA24.4\\nOther specified juvenile idiopathic arthritis: FA24.Y\\nJuvenile idiopathic arthritis unspecified: FA24.Z\\nGout: FA25\\nPrimary gout: FA25.0\\nSecondary gout: FA25.1\\nLeadinduced gout: FA25.10\\nDruginduced gout: FA25.11\\nGouty arthropathy due to enzyme defects or other inherited disorders: FA25.12\\nOther specified secondary gout: FA25.1Y\\nSecondary gout unspecified: FA25.1Z\\nGout without specification whether primary or secondary: FA25.2\\nTophaceous gout: FA25.20\\nOther specified gout without specification whether primary or secondary: FA25.2Y\\nGout unspecified: FA25.2Z\\nCertain specified crystal arthropathies: FA26\\nCalcium pyrophosphate dehydrate deposition disease: FA26.0\\nHydroxyapatite deposition disease: FA26.1\\nChondrocalcinosis: FA26.2\\nOther specified crystal arthropathies: FA26.Y\\nCrystal arthropathies unspecified: FA26.Z\\nCertain specified inflammatory arthropathies: FA27\\nKashinBeck disease: FA27.0\\nPigmented villonodular synovitis: FA27.1\\nPalindromic rheumatism: FA27.2\\nTransient synovitis: FA27.3\\nIntermittent hydrarthrosis: FA27.4\\nOther specified inflammatory arthropathies: FA27.Y\\nInflammatory arthropathies unspecified: FA2Z\\nAcquired deformities of fingers or toes: FA30\\nAcquired hallux valgus: FA30.0\\nHallux rigidus: FA30.1\\nAcquired hammer toe: FA30.2\\nOther specified acquired deformities of fingers or toes: FA30.Y\\nAcquired deformities of fingers or toes unspecified: FA30.Z\\nOther acquired deformities of limbs: FA31\\nValgus deformity not elsewhere classified: FA31.0\\nVarus deformity not elsewhere classified: FA31.1\\nFlexion deformity: FA31.2\\nAcquired wrist drop: FA31.3\\nAcquired foot drop: FA31.4\\nAcquired pes planus: FA31.5\\nAcquired clawhand or clubhand: FA31.6\\nAcquired clawfoot or clubfoot: FA31.7\\nAcquired unequal limb length: FA31.8\\nOther specified acquired deformities of limbs: FA31.Y\\nAcquired deformities of limbs unspecified: FA31.Z\\nDisorders of patella: FA32\\nRecurrent instability of patella: FA32.0\\nPatellofemoral disorders: FA32.1\\nOther specified disorders of patella: FA32.Y\\nDisorders of patella unspecified: FA32.Z\\nInternal derangement of knee: FA33\\nCystic meniscus: FA33.0\\nDiscoid meniscus: FA33.1\\nDerangement of meniscus due to old tear or injury: FA33.2\\nLoose body in knee: FA33.3\\nChronic instability of knee: FA33.4\\nChronic instability of knee medial collateral ligament or other or unspecified part of medial meniscus: FA33.40\\nOther specified chronic instability of knee: FA33.4Y\\nChronic instability of knee unspecified: FA33.4Z\\nOther specified internal derangement of knee: FA33.Y\\nInternal derangement of knee unspecified: FA33.Z\\nCertain specified joint derangements: FA34\\nLoose body in joint: FA34.0\\nDisorder of ligament: FA34.1\\nRecurrent instability of joint: FA34.2\\nContracture of joint: FA34.3\\nAnkylosis of joint: FA34.4\\nImpingement syndrome of hip: FA34.5\\nOther joint derangements: FA34.Y\\nWear of articular bearing surface of joint prosthesis: FA35\\nWear of articular bearing surface of joint prosthesis of hip: FA35.0\\nWear of articular bearing surface of joint prosthesis of knee: FA35.1\\nWear of articular bearing surface of joint prosthesis of other joint: FA35.2\\nWear of articular bearing surface of joint prosthesis of unspecified joint: FA35.Z\\nEffusion of joint: FA36\\nEffusion of joint containing blood: FA36.0\\nOther specified effusion of joint: FA36.Y\\nEffusion of joint unspecified: FA36.Z\\nCertain joint disorders not elsewhere classified: FA37\\nOsteophyte: FA37.0\\nOther specified certain joint disorders not elsewhere classified: FA37.Y\\nCertain joint disorders not elsewhere classified unspecified: FA37.Z\\nArthropathy in diseases classified elsewhere: FA38\\nDiabetic arthropathy: FA38.0\\nNeuropathic arthropathy: FA38.1\\nDiabetic Charcot arthropathy: FA38.10\\nOther specified neuropathic arthropathy: FA38.1Y\\nNeuropathic arthropathy unspecified: FA38.1Z\\nArthropathy in hypersensitivity reactions classified elsewhere: FA38.2\\nHaemophilic arthropathy: FA38.3\\nArthropathy in other specified diseases classified elsewhere: FA38.Y\\nUnspecified joint disorders and deformities of limbs: FA3Z\\nOther specified arthropathies: FA5Y\\nArthropathies unspecified: FA5Z\\nSpinal deformities: FA70\\nKyphosis: FA70.0\\nScoliosis: FA70.1\\nLordosis: FA70.2\\nSpinal deformities unspecified: FA70.Z\\nTorticollis: FA71\\nDisorders of vertebra: FA72\\nAnkylosing hyperostosis: FA72.0\\nKissing spine: FA72.1\\nTraumatic spondylopathy: FA72.2\\nFatigue fracture of vertebra: FA72.3\\nCollapsed vertebra not elsewhere classified: FA72.4\\nOther specified disorders of vertebra: FA72.Y\\nDisorders of vertebra unspecified: FA72.Z\\nOther specified structural disorders of spine: FA7Y\\nStructural disorders of spine unspecified: FA7Z\\nIntervertebral disc degeneration: FA80\\nIntervertebral disc degeneration of cervical spine without prolapsed disc: FA80.0\\nIntervertebral disc degeneration of cervical spine with prolapsed disc: FA80.1\\nIntervertebral disc degeneration of cervical spine with bony spur at the vertebra: FA80.2\\nIntervertebral disc degeneration of cervical spine with nervous system involvement: FA80.3\\nIntervertebral disc degeneration of thoracic spine without prolapsed disc: FA80.4\\nIntervertebral disc degeneration of thoracic spine with prolapsed disc: FA80.5\\nIntervertebral disc degeneration of thoracic spine with bony spur at the vertebra: FA80.6\\nIntervertebral disc degeneration of thoracic spine with nervous system involvement: FA80.7\\nIntervertebral disc degeneration of lumbar spine without prolapsed disc: FA80.8\\nIntervertebral disc degeneration of lumbar spine with prolapsed disc: FA80.9\\nIntervertebral disc degeneration of lumbar spine with bony spur at the vertebra: FA80.A\\nIntervertebral disc degeneration of lumbar spine with nervous system involvement: FA80.B\\nOther specified intervertebral disc degeneration: FA80.Y\\nIntervertebral disc degeneration unspecified: FA80.Z\\nSpondylolysis: FA81\\nSpondylolysis with slippage: FA81.0\\nSpondylolysis without slippage: FA81.1\\nSpondylolysis unspecified: FA81.Z\\nSpinal stenosis: FA82\\nOssification of spinal ligaments: FA83\\nSpondylolisthesis: FA84\\nSpondylolisthesis with pars defect: FA84.0\\nSpondylolisthesis without pars defect: FA84.1\\nSpondylolisthesis unspecified: FA84.Z\\nSpinal endplate defects: FA85\\nSpinal epiphysiopathy with no determinant: FA85.0\\nSpinal epiphysiopathy with determinants: FA85.1\\nLocalised central endplate defect: FA85.10\\nMultiple anterior endplate defect: FA85.11\\nSeparation of ring apophysis: FA85.12\\nOther specified spinal epiphysiopathy with determinants: FA85.1Y\\nSpinal epiphysiopathy with determinants unspecified: FA85.1Z\\nOther specified spinal endplate defects: FA85.Y\\nSpinal endplate defects unspecified: FA85.Z\\nOther specified degenerative condition of spine: FA8Y\\nDegenerative condition of spine unspecified: FA8Z\\nInfection of vertebra: FA90\\nInfection of vertebra with no determinant: FA90.0\\nInfection of vertebra with determinants: FA90.1\\nOther specified infection of vertebra: FA90.Y\\nInfection of vertebra unspecified: FA90.Z\\nInfection of intervertebral disc: FA91\\nInflammatory spondyloarthritis: FA92\\nAxial spondyloarthritis: FA92.0\\nSpinal enthesitis: FA92.00\\nSacroiliitis not elsewhere classified: FA92.01\\nOther specified axial spondyloarthritis: FA92.0Y\\nAxial spondyloarthritis unspecified: FA92.0Z\\nPeripheral spondyloarthritis: FA92.1\\nOther specified inflammatory spondyloarthritis: FA92.Y\\nInflammatory spondyloarthritis unspecified: FA92.Z\\nOther specified inflammation of spine: FA9Y\\nInflammation of spine unspecified: FA9Z\\nAnkylosis of spinal joint: FB00\\nOther specified spondylopathies: FB0Y\\nSpondylopathies unspecified: FB0Z\\nSpinal instabilities: FB10\\nOther specified conditions associated with the spine: FB1Y\\nConditions associated with the spine unspecified: FB1Z\\nInfectious myositis: FB30\\nCalcification or ossification of muscle: FB31\\nProgressive osseous heteroplasia: FB31.0\\nFibrodysplasia ossificans progressiva: FB31.1\\nOther specified calcification or ossification of muscle: FB31.Y\\nCalcification or ossification of muscle unspecified: FB31.Z\\nCertain specified disorders of muscle: FB32\\nDiastasis of muscle: FB32.0\\nSpontaneous rupture of muscle: FB32.1\\nIschaemic infarction of muscle: FB32.2\\nIdiopathic rhabdomyolysis: FB32.20\\nOther specified ischaemic infarction of muscle: FB32.2Y\\nIschaemic infarction of muscle unspecified: FB32.2Z\\nImmobility syndrome: FB32.3\\nContracture of muscle: FB32.4\\nMuscle strain or sprain: FB32.5\\nOther specified disorders of muscles: FB32.Y\\nSecondary disorders of muscle: FB33\\nDisorders of muscles unspecified: FB3Z\\nTenosynovitis: FB40\\nInfectious tenosynovitis: FB40.0\\nPlantar fasciitis: FB40.1\\nPosterior tibial tendonitis: FB40.2\\nCalcific tendinitis: FB40.3\\nTrigger finger: FB40.4\\nRadial styloid tenosynovitis: FB40.5\\nOther specified tenosynovitis: FB40.Y\\nTenosynovitis unspecified: FB40.Z\\nSpontaneous rupture of synovium or tendon: FB41\\nSpontaneous rupture of popliteal cyst: FB41.0\\nSpontaneous rupture of synovium: FB41.1\\nSpontaneous rupture of tendon: FB41.2\\nOther specified spontaneous rupture of synovium or tendon: FB41.Y\\nSpontaneous rupture of synovium or tendon unspecified: FB41.Z\\nCertain specified disorders of synovium or tendon: FB42\\nAcquired short Achilles tendon: FB42.0\\nContracture of tendon sheath: FB42.1\\nGanglion: FB42.2\\nSynovial hypertrophy not elsewhere classified: FB42.3\\nSecondary disorders of synovium or tendon: FB43\\nOther specified disorders of synovium or tendon: FB4Y\\nDisorders of synovium or tendon unspecified: FB4Z\\nBursitis: FB50\\nInfectious bursitis: FB50.0\\nBursitis related to use overuse or pressure: FB50.1\\nSynovial cyst of popliteal space: FB50.2\\nCalcium deposit in bursa: FB50.3\\nOther specified bursitis: FB50.Y\\nBursitis unspecified: FB50.Z\\nFibroblastic disorders: FB51\\nPalmar fascial fibromatosis: FB51.0\\nKnuckle pads: FB51.1\\nFasciitis and fibromatosis: FB51.2\\nFibroblastic rheumatism: FB51.3\\nRetroperitoneal fibrosis: FB51.4\\nPrimary retroperitoneal fibrosis: FB51.40\\nOther specified retroperitoneal fibrosis: FB51.4Y\\nRetroperitoneal fibrosis unspecified: FB51.4Z\\nOther specified fibroblastic disorders: FB51.Y\\nFibroblastic disorders unspecified: FB51.Z\\nSoft tissue disorders in diseases classified elsewhere: FB52\\nShoulder lesions: FB53\\nAdhesive capsulitis of shoulder: FB53.0\\nRotator cuff syndrome: FB53.1\\nImpingement syndrome of shoulder: FB53.2\\nOther specified shoulder lesions: FB53.Y\\nShoulder lesions unspecified: FB53.Z\\nEnthesopathies of lower limb: FB54\\nIliac crest spur: FB54.0\\nIliotibial band syndrome: FB54.1\\nTibial collateral bursitis: FB54.2\\nCalcaneal spur: FB54.3\\nMetatarsalgia: FB54.4\\nOther specified enthesopathies of lower limb: FB54.Y\\nEnthesopathies of lower limb unspecified: FB54.Z\\nCertain specified enthesopathies: FB55\\nMedial epicondylitis of elbow: FB55.0\\nLateral epicondylitis of elbow: FB55.1\\nPeriarthritis of wrist: FB55.2\\nEnthesopathies unspecified: FB55.Z\\nSpecified soft tissue disorders not elsewhere classified: FB56\\nForeign body granuloma of soft tissue not elsewhere classified: FB56.0\\nResidual foreign body in soft tissue: FB56.1\\nMyalgia: FB56.2\\nHypertrophy of infrapatellar fat pad: FB56.3\\nPain in limb: FB56.4\\nOther specified soft tissue disorders: FB56.6\\nSoft tissue disorders unspecified: FB6Z\\nCertain specified disorders of bone density or structure: FB80\\nFibrous dysplasia of bone: FB80.0\\nSkeletal fluorosis: FB80.1\\nOsteitis condensans: FB80.2\\nHyperostosis of skull: FB80.3\\nOsteosclerosis: FB80.4\\nSolitary bone cyst: FB80.5\\nAneurysmal bone cyst: XH23E0\\nMalunion of fracture: FB80.7\\nNonunion of fracture: FB80.8\\nDelayed union of fracture: FB80.9\\nStress fracture not elsewhere classified: FB80.A\\nPathological fracture: FB80.B\\nOther specified disorders of bone density or structure: FB80.Y\\nDisorder of bone density or structure unspecified: FB80.Z\\nOsteonecrosis: FB81\\nIdiopathic aseptic osteonecrosis: FB81.0\\nOsteonecrosis due to dialysis: FB81.1\\nDruginduced osteonecrosis: FB81.2\\nOsteonecrosis due to trauma: FB81.3\\nOsteonecrosis due to haemoglobinopathy: FB81.4\\nOsteonecrosis due to ionizing radiation: FB81.5\\nAlcohol induced osteonecrosis: FB81.6\\nOther specified osteonecrosis: FB81.Y\\nOsteonecrosis unspecified: FB81.Z\\nChondropathies: FB82\\nChondromalacia: FB82.0\\nChondromalacia patellae: FB82.00\\nOther specified chondromalacia: FB82.0Y\\nChondromalacia unspecified: FB82.0Z\\nOsteochondrosis or osteochondritis dissecans: FB82.1\\nSlipped upper femoral epiphysis: FB82.2\\nRelapsing polychondritis: FB82.3\\nOther specified chondropathies: FB82.Y\\nChondropathies unspecified: FB82.Z\\nLow bone mass disorders: FB83\\nOsteopenia: FB83.0\\nPremenopausal idiopathic osteopenia: FB83.00\\nPostmenopausal osteopenia: FB83.01\\nSenile osteopenia: FB83.02\\nOsteopenia of disuse: FB83.03\\nDruginduced osteopenia: FB83.04\\nOther specified osteopenia: FB83.0Y\\nOsteopenia unspecified: FB83.0Z\\nOsteoporosis: FB83.1\\nPremenopausal idiopathic osteoporosis: FB83.10\\nPostmenopausal osteoporosis: FB83.11\\nOsteoporosis of disuse: FB83.12\\nDruginduced osteoporosis: FB83.13\\nOsteoporosis due to malabsorption: FB83.14\\nOther specified osteoporosis: FB83.1Y\\nOsteoporosis unspecified: FB83.1Z\\nAdult osteomalacia: FB83.2\\nAluminium bone disease: FB83.20\\nAdult osteomalacia due to malnutrition: FB83.21\\nDruginduced adult osteomalacia: FB83.22\\nOther specified adult osteomalacia: FB83.2Y\\nAdult osteomalacia unspecified: FB83.2Z\\nOsteomyelitis or osteitis: FB84\\nAcute haematogenous osteomyelitis: FB84.0\\nOther acute osteomyelitis: FB84.1\\nSubacute osteomyelitis: FB84.2\\nChronic multifocal osteomyelitis: FB84.3\\nChronic osteomyelitis with draining sinus: FB84.4\\nOther chronic haematogenous osteomyelitis: FB84.5\\nOther specified osteomyelitis or osteitis: FB84.Y\\nOsteomyelitis or osteitis unspecified: FB84.Z\\nPaget disease of bone: FB85\\nJuvenile Paget disease: FB85.0\\nPaget disease of bone in neoplastic disease: FB85.1\\nOther specified Paget disease of bone: FB85.Y\\nPaget disease of bone unspecified: FB85.Z\\nDisorders associated with bone growth: FB86\\nEpiphyseal arrest: FB86.0\\nBone hyperplasias: FB86.1\\nHypertrophic osteoarthropathy: FB86.10\\nHypertrophy of bone: FB86.11\\nOther specified bone hyperplasias: FB86.1Y\\nBone hyperplasias unspecified: FB86.1Z\\nOsteolysis: FB86.2\\nOther specified disorders associated with bone growth: FB86.Y\\nDisorders associated with bone growth unspecified: FB86.Z\\nOther specified osteopathies or chondropathies: FB8Y\\nOsteopathies or chondropathies unspecified: FB8Z\\nCertain specified acquired deformities of musculoskeletal system or connective tissue not elsewhere classified: FC00\\nAcquired deformity of nose: FC00.0\\nAcquired deformity of neck: FC00.1\\nAcquired deformity of chest or rib: FC00.2\\nAcquired deformity of pelvis: FC00.3\\nAcquired deformity of trunk: FC00.4\\nAcquired deformities of musculoskeletal system and connective tissue not classified elsewhere other specified sites: FC00.Y\\nPostprocedural disorders of the musculoskeletal system: FC01\\nPseudarthrosis after fusion or arthrodesis: FC01.0\\nPostlaminectomy syndrome not elsewhere classified: FC01.1\\nPost radiation kyphosis: FC01.2\\nPostlaminectomy kyphosis: FC01.3\\nPostsurgical lordosis: FC01.4\\nPost radiation scoliosis: FC01.5\\nFracture of bone following insertion of orthopaedic implant joint prosthesis or bone plate: FC01.6\\nNonunion after arthrodesis: FC01.7\\nNonunion after spinal arthrodesis: FC01.70\\nNonunion after arthrodesis of other sites: FC01.7Y\\nPostsurgical osteolysis: FC01.8\\nPostoophorectomy osteoporosis: FC01.9\\nPostsurgical malabsorption osteoporosis: FC01.A\\nOther specified diseases of the musculoskeletal system or connective tissue: FC0Y\\nDiseases of the musculoskeletal system or connective tissue unspecified: FC0Z\\nVulvitis: GA00\\nAcute vulvitis: GA00.0\\nSubacute chronic or recurrent vulvitis: GA00.1\\nAbscess of vulva: GA00.2\\nGenital ulcer of vulva: GA00.3\\nVulvovaginal ulceration or inflammation: GA00.4\\nVulvovaginal ulceration: GA00.40\\nVulvovaginal inflammation: GA00.41\\nVulvitis unspecified: GA00.Z\\nInflammatory disorders of the uterus except cervix: GA01\\nAcute inflammatory disease of uterus: GA01.0\\nAcute endometritis: GA01.00\\nAcute inflammatory disease of uterus with pyometra: GA01.01\\nAcute inflammatory disease of uterus unspecified: GA01.0Z\\nChronic inflammatory disease of uterus: GA01.1\\nChronic endometritis: GA01.10\\nChronic inflammatory disease of uterus with pyometra: GA01.11\\nChronic inflammatory disease of uterus unspecified: GA01.1Z\\nOther specified inflammatory disorders of the uterus except cervix: GA01.Y\\nInflammatory disorders of the uterus except cervix unspecified: GA01.Z\\nVaginitis: GA02\\nAcute vaginitis: GA02.0\\nInflammatory vaginitis: GA02.1\\nSubacute or chronic vaginitis: GA02.2\\nGenital ulcer disease of vagina: GA02.3\\nVaginitis unspecified: GA02.Z\\nDiseases of Bartholin gland: GA03\\nAbscess of Bartholin gland: GA03.0\\nCyst of Bartholin gland: GA03.1\\nOther specified diseases of Bartholin gland: GA03.Y\\nDiseases of Bartholin gland unspecified: GA03.Z\\nCervicitis: GA04\\nFemale pelvic inflammatory diseases: GA05\\nAcute female pelvic inflammatory disease: GA05.0\\nChronic pelvic inflammatory disease: GA05.1\\nFemale pelvic peritonitis unspecified: GA05.2\\nTuboovarian abscess: GA05.3\\nOther specified female pelvic inflammatory diseases: GA05.Y\\nFemale pelvic inflammatory diseases unspecified: GA05.Z\\nPelvic peritoneal adhesions of unknown or combined origin: GA06\\nSalpingitis or oophoritis: GA07\\nAcute salpingitis or oophoritis: GA07.0\\nChronic salpingitis or oophoritis: GA07.1\\nSalpingitis or oophoritis unspecified: GA07.Z\\nInflammatory disorders of the female genital tract unspecified: GA0Z\\nEndometriosis: GA10\\nEndometriosis of the reproductive system: GA10.B\\nEndometriosis of the uterosacral ligaments: GA10.B0\\nEndometriosis of the pelvic side wall: GA10.B1\\nEndometriosis of rectovaginal septum or vagina: GA10.B2\\nEndometriosis of fallopian tube: GA10.B3\\nSuperficial ovarian endometriosis: GA10.B4\\nDeep ovarian endometriosis: GA10.B5\\nEndometriosis of other sites of the reproductive system: GA10.BY\\nEndometriosis of unspecified site of reproductive system: GA10.BZ\\nEndometriosis of the digestive system: GA10.C\\nEndometriosis of the gallbladder: GA10.C0\\nEndometriosis of intestine: GA10.C1\\nEndometriosis of pelvic peritoneum: GA10.C2\\nPeritoneal pockets due to endometriosis: GA10.C3\\nEndometriosis of other sites within the digestive system: GA10.CY\\nEndometriosis of unspecified site within the digestive system: GA10.CZ\\nEndometriosis of urinary system: GA10.D\\nEndometriosis of the bladder: GA10.D0\\nEndometriosis of other sites in the urinary system: GA10.DY\\nEndometriosis of unspecified site in the urinary system: GA10.DZ\\nEndometriosis of the circulatory system: GA10.E\\nEndometriosis of the nervous system: GA10.F\\nThoracic endometriosis: GA10.G\\nEndometriosis in cutaneous scar: GA10.H\\nEndometriosisrelated adhesions: GA10.J\\nEndometriosis of other specified sites: GA10.Y\\nEndometriosis of unspecified site: GA10.Z\\nAdenomyosis: GA11\\nDyspareunia: GA12\\nAcquired abnormalities of vulva or perineum: GA13\\nPolyp of vulva: GA13.0\\nLow grade squamous intraepithelial lesion of vulva: GA13.1\\nHypertrophy of vulva: GA13.2\\nVulvar cyst: GA13.3\\nLabial agglutination: GA13.4\\nSkene duct cyst: GA13.5\\nVulvar laceration: GA13.6\\nVulvar haematoma: GA13.7\\nOther specified acquired abnormalities of vulva or perineum: GA13.Y\\nAcquired abnormalities of vulva or perineum unspecified: GA13.Z\\nAcquired abnormalities of vagina: GA14\\nPolyp of vagina: GA14.0\\nHaematocolpos: GA14.1\\nVaginal foreign body: GA14.2\\nVaginal haematoma: GA14.3\\nLeukoplakia of vagina: GA14.5\\nLow grade squamous intraepithelial lesion of vagina: GA14.6\\nOther specified acquired abnormalities of vagina: GA14.Y\\nAcquired abnormalities of vagina unspecified: GA14.Z\\nAcquired abnormalities of cervix uteri: GA15\\nPolyp of cervix uteri: GA15.0\\nErosion or ectropion of cervix uteri: GA15.1\\nNabothian cyst: GA15.2\\nOld laceration of cervix uteri: GA15.3\\nStricture or stenosis of cervix uteri: GA15.4\\nHypertrophic elongation of cervix uteri: GA15.5\\nIncompetence of cervix uteri: GA15.6\\nLow grade squamous intraepithelial lesion of cervix uteri: GA15.7\\nOther specified acquired abnormalities of cervix uteri: GA15.Y\\nAcquired abnormalities of cervix uteri unspecified: GA15.Z\\nAcquired abnormalities of uterus except cervix: GA16\\nEndometrial glandular hyperplasia: GA16.0\\nMalposition of uterus: GA16.1\\nIntrauterine synechiae: GA16.2\\nHaematometra: GA16.3\\nOther specified acquired abnormalities of uterus except cervix: GA16.Y\\nAcquired abnormalities of uterus except cervix unspecified: GA16.Z\\nAcquired abnormalities of fallopian tube: GA17\\nAcquired parafimbrial cyst of the fallopian tube: GA17.0\\nFimbrial agglutination: GA17.1\\nHydrosalpinx: GA17.2\\nHaematosalpinx: GA17.3\\nSalpingitis isthmica nodosa: GA17.4\\nOther specified acquired abnormalities of fallopian tube: GA17.Y\\nAcquired abnormalities of fallopian tube unspecified: GA17.Z\\nAcquired abnormalities of ovary: GA18\\nFollicular cyst of ovary: GA18.0\\nCorpus luteum cyst: GA18.1\\nTheca lutein cyst: GA18.2\\nPara ovarian cyst: GA18.4\\nTorsion of ovary ovarian pedicle or fallopian tube: GA18.5\\nOther or unspecified ovarian cysts: GA18.6\\nAcquired atrophy of ovary or fallopian tube: GA18.7\\nOther specified acquired abnormalities of ovary: GA18.Y\\nAcquired abnormalities of ovary unspecified: GA18.Z\\nAcquired abnormalities of broad ligament: GA19\\nHaematoma of broad ligament: GA19.0\\nOther specified acquired abnormalities of broad ligament: GA19.Y\\nAcquired abnormalities of broad ligament unspecified: GA19.Z\\nOther specified noninflammatory disorders of female genital tract: GA1Y\\nNoninflammatory disorders of female genital tract unspecified: GA1Z\\nMenstrual cycle bleeding disorders: GA20\\nAmenorrhoea: GA20.0\\nPrimary amenorrhoea: GA20.00\\nSecondary amenorrhoea: GA20.01\\nLactational amenorrhoea: GA20.02\\nOther specified amenorrhoea: GA20.0Y\\nAmenorrhoea unspecified: GA20.0Z\\nAbnormal frequency of uterine bleeding: GA20.1\\nFrequent menstrual bleeding: GA20.10\\nInfrequent menstrual bleeding: GA20.11\\nAbnormal frequency of uterine bleeding unspecified: GA20.1Z\\nOvulation bleeding: GA20.2\\nIntermenstrual bleeding: GA20.20\\nOther specified ovulation bleeding: GA20.2Y\\nOvulation bleeding unspecified: GA20.2Z\\nAbnormal regularity of uterine bleeding: GA20.3\\nAbnormal duration of uterine bleeding: GA20.4\\nAbnormal volume of uterine bleeding: GA20.5\\nHeavy menstrual bleeding: GA20.50\\nLight menstrual bleeding: GA20.51\\nAbnormal volume of uterine bleeding unspecified: GA20.5Z\\nOther specified menstrual cycle bleeding disorders: GA20.Y\\nMenstrual cycle bleeding disorders unspecified: GA20.Z\\nNonmenstrual bleeding disorders: GA21\\nPostcoital or contact bleeding: GA21.0\\nOther specified nonmenstrual bleeding disorders: GA21.Y\\nNonmenstrual bleeding disorders unspecified: GA21.Z\\nExcessive menstruation with irregular cycle: GA22\\nAnovulatory bleeding: GA23\\nOther specified abnormal uterine or vaginal bleeding: GA2Y\\nAbnormal uterine or vaginal bleeding unspecified: GA2Z\\nMenopausal or perimenopausal disorders: GA30\\nMenopause: GA30.0\\nMenopausal or female climacteric states: GA30.00\\nMenopausal transition: GA30.01\\nExcessive bleeding in the premenopausal period: GA30.02\\nOther specified menopause: GA30.0Y\\nMenopause unspecified: GA30.0Z\\nPostmenopausal uterine bleeding: GA30.1\\nPostmenopausal atrophic vaginitis: GA30.2\\nStates associated with artificial menopause: GA30.3\\nMenopausal hot flush: GA30.4\\nMenopausal osteoporosis: GA30.5\\nPremature ovarian failure: GA30.6\\nOther specified menopausal or perimenopausal disorders: GA30.Y\\nMenopausal or perimenopausal disorders unspecified: GA30.Z\\nFemale infertility: GA31\\nPrimary female infertility: GA31.0\\nPrimary female infertility of uterine origin: GA31.00\\nPrimary female infertility of tubal origin: GA31.01\\nPrimary female infertility of other specified origin: GA31.0Y\\nPrimary female infertility of unspecified origin: GA31.0Z\\nSecondary female infertility: GA31.1\\nSecondary female infertility of uterine origin: GA31.10\\nSecondary female infertility of tubal origin: GA31.11\\nSecondary female infertility of other specified origin: GA31.1Y\\nSecondary female infertility of unspecified origin: GA31.1Z\\nFemale infertility without specification whether primary or secondary: GA31.Z\\nComplications associated with medically assisted reproduction: GA32\\nOvarian hyperstimulation syndrome: GA32.0\\nBleeding after egg retrieval: GA32.1\\nInfection associated with medically assisted reproduction: GA32.2\\nComplications of attempted embryo transfer or medically assisted insemination: GA32.3\\nOther specified complications associated with medically assisted reproduction: GA32.Y\\nComplications associated with medically assisted reproduction unspecified: GA32.Z\\nRecurrent pregnancy loss: GA33\\nFemale pelvic pain associated with genital organs or menstrual cycle: GA34\\nPain related to vulva vagina or pelvic floor: GA34.0\\nVulval pain: GA34.00\\nPerineal pain: GA34.01\\nVulvodynia: GA34.02\\nOther specified pain related to vulva vagina or pelvic floor: GA34.0Y\\nPain related to vulva vagina or pelvic floor unspecified: GA34.0Z\\nVaginal laxity: GA34.1\\nFemale pelvic pain: GA34.2\\nCyclic pelvic pain: GA34.20\\nNoncyclic pelvic pain: GA34.21\\nFemale pelvic pain unspecified: GA34.2Z\\nDysmenorrhoea: GA34.3\\nPremenstrual disturbances: GA34.4\\nPremenstrual tension syndrome: GA34.40\\nPremenstrual dysphoric disorder: GA34.41\\nOther specified premenstrual disturbances: GA34.4Y\\nPremenstrual disturbances unspecified: GA34.4Z\\nOvarian remnant syndrome: GA34.5\\nFemale genital pain: GA34.6\\nOther specified female pelvic pain associated with genital organs or menstrual cycle: GA34.Y\\nFemale pelvic pain associated with genital organs or menstrual cycle unspecified: GA34.Z\\nInflammatory dermatoses of the vulva: GA40\\nUlcerative or erosive disorders of the vulva: GA41\\nVulval aphthosis: GA41.0\\nOther specified ulcerative or erosive disorders of the vulva: GA41.Y\\nSensory disturbance of the vulva: GA42\\nVulval pruritus: GA42.0\\nOther specified dermatoses of female genitalia: GA4Y\\nOther specified diseases of the female genital system: GA6Y\\nDiseases of the female genital system unspecified: GA6Z\\nUlcerative disorders of the penis or scrotum: GA80\\nAphthosis of penis or scrotum: GA80.0\\nUlcer of penis of uncertain nature: GA80.1\\nOther specified ulcerative disorders of penis or scrotum: GA80.Y\\nMiscellaneous dermatoses of male genitalia: GA81\\nPenoscrotal pruritus: GA81.0\\nOther specified dermatoses of male genitalia: GA81.Y\\nHyperplasia of prostate: GA90\\nInflammatory or other diseases of prostate: GA91\\nChronic prostatitis: GA91.0\\nAbscess of prostate: GA91.1\\nProstatocystitis: GA91.2\\nCalculus of prostate: GA91.3\\nHaemorrhage of the prostate: GA91.4\\nAtrophy of prostate: GA91.5\\nLow grade intraepithelial lesion of prostate: GA91.6\\nOther specified inflammatory or other diseases of prostate: GA91.Y\\nInflammatory or other diseases of prostate unspecified: GA91.Z\\nHydrocele or spermatocele: GB00\\nEncysted hydrocele: GB00.0\\nInfected hydrocele: GB00.1\\nSpermatocele: GB00.2\\nOther specified hydrocele or spermatocele: GB00.Y\\nHydrocele or spermatocele unspecified: GB00.Z\\nTorsion of testis epididymis or appendices: GB01\\nTorsion of testis: GB01.0\\nTorsion of epididymis: GB01.1\\nTorsion of hydatids: GB01.2\\nTorsion of testis epididymis or appendices unspecified: GB01.Z\\nOrchitis or epididymitis: GB02\\nOrchitis epididymitis or epididymoorchitis with abscess: GB02.0\\nOrchitis epididymitis or epididymoorchitis without abscess: GB02.1\\nOrchitis or epididymitis unspecified: GB02.Z\\nAtrophy of testis: GB03\\nMale infertility: GB04\\nAzoospermia: GB04.0\\nOther specified male infertility: GB04.Y\\nMale infertility unspecified: GB04.Z\\nRedundant prepuce phimosis or paraphimosis: GB05\\nRedundant prepuce: GB05.0\\nFrenulum breve: GB05.1\\nPhimosis: GB05.2\\nParaphimosis: GB05.3\\nAdherent prepuce: GB05.4\\nRedundant prepuce phimosis or paraphimosis unspecified: GB05.Z\\nCertain specified disorders of penis: GB06\\nBalanitis or balanoposthitis: GB06.0\\nIrritant balanoposthitis: GB06.01\\nBalanoposthitis due to infection: GB06.02\\nOther specified forms of balanitis or balanoposthitis: GB06.0Y\\nBalanitis or balanoposthitis unspecified: GB06.0Z\\nPriapism: GB06.1\\nPenile fibromatosis: GB06.2\\nMondor disease of the penis: GB06.3\\nChronic penile oedema: GB06.4\\nSclerosing lymphangitis of penis: GB06.5\\nOther specified disorders of penis: GB06.Y\\nDisorders of penis unspecified: GB06.Z\\nInflammatory disorders of male genital organs not elsewhere classified: GB07\\nInflammatory disorders of seminal vesicle: GB07.0\\nInflammatory disorders of spermatic cord tunica vaginalis or vas deferens: GB07.1\\nInflammatory disorders of scrotum: GB07.2\\nOther specified inflammatory disorders of male genital organs not elsewhere classified: GB07.Y\\nVascular disorders of male genital organs: GB08\\nOther specified diseases of the male genital system: GB0Y\\nDiseases of the male genital system unspecified: GB0Z\\nBenign breast disease: GB20\\nFibrocystic change of breast: GB20.0\\nFibroadenosis of breast: GB20.1\\nOther specified benign breast disease: GB20.Y\\nBenign breast disease unspecified: GB20.Z\\nInflammatory disorders of breast: GB21\\nBreast abscess: GB21.0\\nOther specified inflammatory disorders of breast: GB21.Y\\nInflammatory disorders of breast unspecified: GB21.Z\\nHypertrophy of breast: GB22\\nCertain specified disorders of breast: GB23\\nMammary duct ectasia: GB23.0\\nFissure or fistula of nipple: GB23.1\\nFat necrosis of breast: GB23.2\\nAtrophy of breast: GB23.3\\nGalactorrhoea not associated with childbirth: GB23.4\\nMastodynia: GB23.5\\nOther specified disorders of breast: GB2Y\\nNephritic syndrome: GB40\\nNephrotic syndrome: GB41\\nPersistent proteinuria or albuminuria: GB42\\nAlbuminuria Grade A: GB42.1\\nOther specified persistent proteinuria or albuminuria: GB42.Y\\nPersistent proteinuria or albuminuria unspecified: GB42.Z\\nOther specified glomerular diseases: GB4Y\\nGlomerular diseases unspecified: GB4Z\\nAcute tubulointerstitial nephritis: GB50\\nAcute pyelonephritis: GB51\\nAcute tubular necrosis: GB52\\nAcute renal papillary necrosis: GB53\\nTubulointerstitial nephritis not specified as acute or chronic: GB54\\nChronic tubulointerstitial nephritis: GB55\\nBalkan nephropathy: GB55.0\\nNephropathy induced by heavy metals: GB55.1\\nChronic urate nephropathy: GB55.2\\nOther specified chronic tubulointerstitial nephritis: GB55.Y\\nChronic tubulointerstitial nephritis unspecified: GB55.Z\\nObstructive or reflux nephropathy: GB56\\nHydronephrosis with ureteropelvic junction obstruction: GB56.0\\nHydronephrosis with ureteral obstruction: GB56.1\\nHydronephrosis with ureteral orifice obstruction: GB56.2\\nHydronephrosis due to bladder obstruction: GB56.3\\nOther or unspecified hydronephrosis: GB56.4\\nHydronephrosis and reflux nephropathy with vesicoureteral or vesicoureterorenal reflux: GB56.5\\nOther specified obstructive or reflux nephropathy: GB56.Y\\nObstructive or reflux nephropathy unspecified: GB56.Z\\nNephrocalcinosis: GB57\\nPyonephrosis: GB58\\nRenal or perinephric abscess: GB59\\nOther specified renal tubulointerstitial diseases: GB5Y\\nRenal tubulointerstitial diseases unspecified: GB5Z\\nAcute kidney failure: GB60\\nAcute kidney failure stage: GB60.2\\nOther specified acute kidney failure: GB60.Y\\nAcute kidney failure stage unspecified: GB60.Z\\nChronic kidney disease: GB61\\nChronic kidney disease stage: GB61.5\\nChronic kidney disease stage a: GB61.2\\nChronic kidney disease stage b: GB61.3\\nChronic kidney disease stage unspecified: GB61.Z\\nKidney failure unspecified: GB6Z\\nCalculus of upper urinary tract: GB70\\nCalculus of kidney: GB70.0\\nStaghorn calculus: GB70.00\\nOther specified calculus of kidney: GB70.0Y\\nCalculus of kidney unspecified: GB70.0Z\\nCalculus of ureter: GB70.1\\nCalculus of upper urinary tract unspecified: GB70.Z\\nCalculus of lower urinary tract: GB71\\nCalculus in bladder: GB71.0\\nCalculus in urethra: GB71.1\\nCalculus of bowel segments for urinary diversion: GB71.2\\nCalculus of lower urinary tract unspecified: GB71.Z\\nUrolithiasis unspecified: GB7Z\\nNonfamilial nongenetic cystic kidney disease: GB80\\nSimple renal cyst: GB80.0\\nComplex renal cyst: GB80.1\\nSubscapular or perirenal urinoma: GB80.2\\nOther specified nonfamilial nongenetic cystic kidney disease: GB80.Y\\nNonfamilial nongenetic cystic kidney disease unspecified: GB80.Z\\nAutosomal dominant polycystic kidney disease: GB81\\nAutosomal dominant tubulointerstitial disease: GB82\\nNephronophthisis: GB83\\nOther specified cystic or dysplastic kidney disease: GB8Y\\nCystic or dysplastic kidney disease unspecified: GB8Z\\nCertain specified disorders of kidney or ureter: GB90\\nNephroptosis: GB90.0\\nHydroureter: GB90.1\\nUreteral kinking or deviation without obstruction: GB90.2\\nIschaemia or infarction of kidney: GB90.3\\nRenal tubular function disorders: GB90.4\\nHypotoniacystinuria type: GB90.40\\nPseudohypoaldosteronism type: GB90.41\\nFanconi syndrome: GB90.42\\nBartter syndrome: GB90.43\\nRenal tubular acidosis: GB90.44\\nRenal glycosuria: GB90.45\\nTubular disorders of sodium or potassium transport: GB90.46\\nAminoaciduria: GB90.47\\nDisorders of calcium or phosphate excretion: GB90.48\\nRenal hypocalciuria: GB90.49\\nNephrogenic diabetes insipidus: GB90.4A\\nOther specified renal tubular function disorders: GB90.4Y\\nRenal tubular function disorders unspecified: GB90.4Z\\nOther specified disorders of kidney or ureter: GB90.Y\\nCystitis: GC00\\nTrigonitis: GC00.0\\nInfectious cystitis: GC00.1\\nContracted urinary bladder: GC00.2\\nInterstitial cystitis: GC00.3\\nOther specified cystitis: GC00.Y\\nCystitis unspecified: GC00.Z\\nOther disorders of bladder: GC01\\nBladder neck obstruction: GC01.0\\nVesical fistula not elsewhere classified: GC01.1\\nDiverticulum of bladder: GC01.2\\nRupture of bladder nontraumatic: GC01.3\\nNeuromuscular dysfunction of bladder not elsewhere classified: GC01.4\\nOther specified disorders of bladder: GC01.Y\\nDisorder of bladder unspecified: GC01.Z\\nUrethritis and urethral syndrome: GC02\\nUrethral abscess: GC02.0\\nNonspecific urethritis: GC02.1\\nOther specified urethritis and urethral syndrome: GC02.Y\\nUrethritis and urethral syndrome unspecified: GC02.Z\\nUrethral stricture: GC03\\nFistula of the genitourinary tract: GC04\\nUrethral fistula: GC04.0\\nFistulae involving female genital tract: GC04.1\\nVesicovaginal fistula: GC04.10\\nFistula of small intestine to vagina: GC04.11\\nFistula of large intestine to vagina: GC04.12\\nFemale genital tractskin fistulae: GC04.13\\nUrethrovaginal fistula: GC04.14\\nCombined urethrovesicovaginal fistula: GC04.15\\nRectovaginal fistula: GC04.16\\nVesicouterine fistula with severe scar or extensive tissue loss: GC04.17\\nOther combined urinary fistula with severe scar or extensive tissue loss: GC04.18\\nCombined urinary and rectal fistula including cloaca with severe scar or extensive tissue loss: GC04.19\\nVaginal stenosis or gynatresia related to obstetric fistula: GC04.1A\\nOther specified fistulae involving female genital tract: GC04.1Y\\nFistulae involving female genital tract unspecified: GC04.1Z\\nUreteral fistula: GC04.2\\nOther specified fistula of the genitourinary tract: GC04.Y\\nFistula of the genitourinary tract unspecified: GC04.Z\\nProlapsed urethral mucosa: GC05\\nUrethral diverticulum: GC06\\nUrethral caruncle: GC07\\nUrinary tract infection site not specified: GC08\\nUrinary tract infection site not specified due to Escherichia coli: GC08.0\\nUrinary tract infection site not specified due to Klebsiella pneumoniae: GC08.1\\nUrinary tract infection site not specified due to Proteus: GC08.2\\nUrinary tract infection site not specified due to other agent: GC08.Y\\nUrinary tract infection site and agent not specified: GC08.Z\\nOther diseases of urinary system: GC0Y\\nDiseases of the urinary system unspecified: GC2Z\\nPelvic organ prolapse: GC40\\nProlapse of anterior vaginal wall: GC40.0\\nIncomplete anterior vaginal wall prolapse: GC40.00\\nComplete anterior vaginal wall prolapse: GC40.01\\nProlapse of anterior vaginal wall unspecified: GC40.0Z\\nProlapse of posterior vaginal wall: GC40.1\\nIncomplete posterior vaginal wall prolapse: GC40.10\\nComplete posterior vaginal wall prolapse: GC40.11\\nProlapse of posterior vaginal wall unspecified: GC40.1Z\\nProlapse of the vaginal apex: GC40.2\\nIncomplete apical vaginal wall prolapse: GC40.20\\nComplete apical vaginal wall prolapse: GC40.21\\nProlapse of the vaginal apex unspecified: GC40.2Z\\nUterovaginal prolapse: GC40.3\\nIncomplete uterovaginal prolapse: GC40.30\\nIncomplete uterine prolapse with anterior vaginal wall prolapse: GC40.31\\nIncomplete uterine prolapse with posterior vaginal wall prolapse: GC40.32\\nIncomplete uterine prolapse with anterior and posterior vaginal wall prolapse: GC40.33\\nComplete uterovaginal prolapse: GC40.34\\nComplete uterine prolapse with anterior vaginal wall prolapse: GC40.35\\nComplete uterine prolapse with posterior vaginal wall prolapse: GC40.36\\nComplete uterine prolapse with anterior and posterior vaginal wall prolapse: GC40.37\\nUterovaginal prolapse unspecified: GC40.3Z\\nPelvic floor muscle disruption: GC40.4\\nLevator avulsion from symphysis pubis: GC40.40\\nOther specified pelvic floor muscle disruption: GC40.4Y\\nPelvic floor muscle disruption unspecified: GC40.4Z\\nUrinary incontinence associated with pelvic organ prolapse: GC40.5\\nStress incontinence associated with pelvic organ prolapse: GC40.50\\nUrge incontinence associated with pelvic organ prolapse: GC40.51\\nMixed urinary incontinence associated with pelvic organ prolapse: GC40.52\\nOverflow incontinence associated with pelvic organ prolapse: GC40.53\\nUrinary incontinence not otherwise specified with pelvic organ prolapse: GC40.54\\nFunctional bladder disorders associated with pelvic organ prolapse: GC40.6\\nOveractive bladder associated with pelvic organ prolapse: GC40.60\\nOther specified functional bladder disorders associated with pelvic organ prolapse: GC40.6Y\\nFunctional bladder disorders associated with pelvic organ prolapse unspecified: GC40.6Z\\nPelvic organ prolapse unspecified: GC40.Z\\nAnorectal dysfunction associated with pelvic organ prolapse: GC41\\nSexual dysfunction associated with pelvic organ prolapse: GC42\\nDiminished sensation due to vaginal or introital laxity: GC42.0\\nObstructed intercourse: GC42.1\\nFemale pelvic floor dysfunction unspecified: GC4Z\\nFunctional bladder disorders not otherwise specified: GC50\\nOveractive bladder: GC50.0\\nAbsent or diminished bladder sensation: GC50.1\\nAbsent or diminished bladder sensation associated with pelvic organ prolapse: GC50.10\\nOther specified absent or diminished bladder sensation: GC50.1Y\\nAbsent or diminished bladder sensation unspecified: GC50.1Z\\nOther specified functional bladder disorders not otherwise specified: GC50.Y\\nFunctional bladder disorders not otherwise specified unspecified: GC50.Z\\nFemale Genital Mutilation: GC51\\nFemale Genital Mutilation Type: GC51.3\\nFemale Genital Mutilation Type a: GC51.20\\nFemale Genital Mutilation Type b: GC51.21\\nFemale Genital Mutilation Type  unspecified: GC51.2Z\\nFemale Genital Mutilation Type c: GC51.12\\nFemale Genital Mutilation unspecified: GC51.Z\\nPostoperative adhesions of vagina: GC70\\nProlapse of vaginal vault after hysterectomy: GC71\\nPostprocedural urethral stricture: GC72\\nPostprocedural pelvic peritoneal adhesions: GC73\\nMalfunction or complication of external stoma of urinary tract: GC74\\nMalfunction of the afferent segment of a continent urinary pouch: GC75\\nMalfunction of the efferent segment of a continent urinary pouch: GC76\\nPostprocedural nonmenstrual uterine bleeding: GC77\\nPostprocedural acute female pelvic inflammatory disease: GC78\\nDisorders of breast reduction: GC79\\nDisorders of breast augmentation: GC7A\\nPostinterventional ischemia or infarction of kidney: GC7B\\nCaesarean scar defect of uterus: GC7C\\nOther specified diseases of the genitourinary system: GC8Y\\nDiseases of the genitourinary system unspecified: GC8Z\\nHypoactive sexual desire dysfunction: HA00\\nHypoactive sexual desire dysfunction lifelong generalised: HA00.0\\nHypoactive sexual desire dysfunction lifelong situational: HA00.1\\nHypoactive sexual desire dysfunction acquired generalised: HA00.2\\nHypoactive sexual desire dysfunction acquired situational: HA00.3\\nHypoactive sexual desire dysfunction unspecified: HA00.Z\\nSexual arousal dysfunctions: HA01\\nFemale sexual arousal dysfunction: HA01.0\\nFemale sexual arousal dysfunction lifelong generalised: HA01.00\\nFemale sexual arousal dysfunction lifelong situational: HA01.01\\nFemale sexual arousal dysfunction acquired generalised: HA01.02\\nFemale sexual arousal dysfunction acquired situational: HA01.03\\nFemale sexual arousal dysfunction unspecified: HA01.0Z\\nMale erectile dysfunction: HA01.1\\nMale erectile dysfunction lifelong generalised: HA01.10\\nMale erectile dysfunction lifelong situational: HA01.11\\nMale erectile dysfunction acquired generalised: HA01.12\\nMale erectile dysfunction acquired situational: HA01.13\\nMale erectile dysfunction unspecified: HA01.1Z\\nOther specified sexual arousal dysfunctions: HA01.Y\\nSexual arousal dysfunctions unspecified: HA01.Z\\nOrgasmic dysfunctions: HA02\\nAnorgasmia: HA02.0\\nAnorgasmia lifelong generalised: HA02.00\\nAnorgasmia lifelong situational: HA02.01\\nAnorgasmia acquired generalised: HA02.02\\nAnorgasmia acquired situational: HA02.03\\nAnorgasmia unspecified: HA02.0Z\\nOther specified orgasmic dysfunctions: HA02.Y\\nOrgasmic dysfunctions unspecified: HA02.Z\\nEjaculatory dysfunctions: HA03\\nMale early ejaculation: HA03.0\\nMale early ejaculation lifelong generalised: HA03.00\\nMale early ejaculation lifelong situational: HA03.01\\nMale early ejaculation acquired generalised: HA03.02\\nMale early ejaculation acquired situational: HA03.03\\nMale early ejaculation unspecified: HA03.0Z\\nMale delayed ejaculation: HA03.1\\nMale delayed ejaculation lifelong generalised: HA03.10\\nMale delayed ejaculation lifelong situational: HA03.11\\nMale delayed ejaculation acquired generalised: HA03.12\\nMale delayed ejaculation acquired situational: HA03.13\\nMale delayed ejaculation unspecified: HA03.1Z\\nOther specified ejaculatory dysfunctions: HA03.Y\\nEjaculatory dysfunctions unspecified: HA03.Z\\nOther specified sexual dysfunctions: HA0Y\\nSexual dysfunctions unspecified: HA0Z\\nSexual painpenetration disorder: HA20\\nSexual painpenetration disorder lifelong generalised: HA20.0\\nSexual painpenetration disorder lifelong situational: HA20.1\\nSexual painpenetration disorder acquired generalised: HA20.2\\nSexual painpenetration disorder acquired situational: HA20.3\\nSexual painpenetration disorder unspecified: HA20.Z\\nOther specified sexual pain disorders: HA2Y\\nSexual pain disorders unspecified: HA2Z\\nAetiological considerations in sexual dysfunctions and sexual pain disorders: HA40\\nAetiological considerations associated with a medical condition injury or the effects of surgery or radiation treatment: HA40.0\\nAetiological considerations associated with psychological or behavioural factors including mental disorders: HA40.1\\nAetiological considerations associated with use of psychoactive substance or medication: HA40.2\\nAetiological considerations associated with lack of knowledge or experience: HA40.3\\nAetiological considerations associated with relationship factors: HA40.4\\nAetiological considerations associated with cultural factors: HA40.5\\nOther specified aetiological considerations in sexual dysfunctions and sexual pain disorders: HA40.Y\\nGender incongruence of adolescence or adulthood: HA60\\nGender incongruence of childhood: HA61\\nGender incongruence unspecified: HA6Z\\nOther specified conditions related to sexual health: HA8Y\\nConditions related to sexual health unspecified: HA8Z\\nAbortion: JA00\\nSpontaneous abortion: JA00.0\\nSpontaneous abortion incomplete complicated by genital tract or pelvic infection: JA00.00\\nSpontaneous abortion incomplete complicated by delayed or excessive haemorrhage: JA00.01\\nSpontaneous abortion incomplete complicated by embolism: JA00.02\\nSpontaneous abortion incomplete with other or unspecified complications: JA00.03\\nSpontaneous abortion incomplete without complication: JA00.04\\nSpontaneous abortion complete or unspecified complicated by genital tract or pelvic infection: JA00.05\\nSpontaneous abortion complete or unspecified complicated by delayed or excessive haemorrhage: JA00.06\\nSpontaneous abortion complete or unspecified complicated by embolism: JA00.07\\nSpontaneous abortion complete or unspecified with other or unspecified complications: JA00.08\\nSpontaneous abortion complete or unspecified without complication: JA00.09\\nInduced abortion: JA00.1\\nInduced abortion incomplete complicated by genital tract or pelvic infection: JA00.10\\nInduced abortion incomplete complicated by delayed or excessive haemorrhage: JA00.11\\nInduced abortion incomplete complicated by embolism: JA00.12\\nInduced abortion incomplete with other or unspecified complications: JA00.13\\nInduced abortion incomplete without complication: JA00.14\\nInduced abortion complete or unspecified complicated by genital tract or pelvic infection: JA00.15\\nInduced abortion complete or unspecified complicated by delayed or excessive haemorrhage: JA00.16\\nInduced abortion complete or unspecified complicated by embolism: JA00.17\\nInduced abortion complete or unspecified with other complication: JA00.18\\nInduced abortion complete or unspecified without complication: JA00.19\\nUnspecified abortion: JA00.2\\nUnspecified abortion incomplete complicated by genital tract or pelvic infection: JA00.20\\nUnspecified abortion incomplete complicated by delayed or excessive haemorrhage: JA00.21\\nUnspecified abortion incomplete complicated by embolism: JA00.22\\nUnspecified abortion incomplete with other or unspecified complications: JA00.23\\nUnspecified abortion incomplete without complication: JA00.24\\nUnspecified abortion complete or unspecified complicated by genital tract or pelvic infection: JA00.25\\nUnspecified abortion complete or unspecified complicated by delayed or excessive haemorrhage: JA00.26\\nUnspecified abortion complete or unspecified complicated by embolism: JA00.27\\nUnspecified abortion complete or unspecified with other or unspecified complications: JA00.28\\nUnspecified abortion complete or unspecified without complication: JA00.29\\nFailed attempted abortion: JA00.3\\nFailed medical abortion complicated by genital tract or pelvic infection: JA00.30\\nFailed medical abortion complicated by delayed or excessive haemorrhage: JA00.31\\nFailed medical abortion complicated by embolism: JA00.32\\nFailed medical abortion with other or unspecified complications: JA00.33\\nFailed medical abortion without complication: JA00.34\\nOther or unspecified failed attempted abortion complicated by genital tract or pelvic infection: JA00.35\\nOther or unspecified failed attempted abortion complicated by delayed or excessive haemorrhage: JA00.36\\nOther or unspecified failed attempted abortion complicated by embolism: JA00.37\\nOther or unspecified failed attempted abortion with other or unspecified complications: JA00.38\\nOther or unspecified failed attempted abortion without complication: JA00.39\\nEctopic pregnancy: JA01\\nAbdominal pregnancy: JA01.0\\nTubal pregnancy: JA01.1\\nOvarian pregnancy: JA01.2\\nOther specified ectopic pregnancy: JA01.Y\\nEctopic pregnancy unspecified: JA01.Z\\nMolar pregnancy: JA02\\nComplete hydatidiform mole: JA02.0\\nIncomplete or partial hydatidiform mole: JA02.1\\nOther specified molar pregnancy: JA02.Y\\nMolar pregnancy unspecified: JA02.Z\\nMissed abortion: JA03\\nBlighted ovum or nonhydatidiform mole: JA04\\nComplications following abortion ectopic or molar pregnancy: JA05\\nGenital tract or pelvic infection following abortion ectopic or molar pregnancy: JA05.0\\nDelayed or excessive haemorrhage following abortion ectopic or molar pregnancy: JA05.1\\nEmbolism following abortion ectopic or molar pregnancy: JA05.2\\nShock following abortion ectopic or molar pregnancy: JA05.3\\nRenal failure following abortion ectopic or molar pregnancy: JA05.4\\nMetabolic disorders following abortion ectopic or molar pregnancy: JA05.5\\nDamage to pelvic organs and tissues following abortion ectopic or molar pregnancy: JA05.6\\nOther venous complications following abortion ectopic or molar pregnancy: JA05.7\\nOther specified complications following abortion ectopic or molar pregnancy: JA05.Y\\nComplications following abortion ectopic or molar pregnancy unspecified: JA05.Z\\nAbortive outcome of pregnancy unspecified: JA0Z\\nPreexisting hypertension complicating pregnancy childbirth or the puerperium: JA20\\nPreexisting essential hypertension complicating pregnancy childbirth or the puerperium: JA20.0\\nPreexisting hypertensive heart disease complicating pregnancy childbirth or the puerperium: JA20.1\\nPreexisting hypertensive renal disease complicating pregnancy childbirth or the puerperium: JA20.2\\nPreexisting hypertensive heart and renal disease complicating pregnancy childbirth or the puerperium: JA20.3\\nPreexisting secondary hypertension complicating pregnancy childbirth or the puerperium: JA20.4\\nOther specified preexisting hypertension complicating pregnancy childbirth or the puerperium: JA20.Y\\nPreexisting hypertension complicating pregnancy childbirth or the puerperium unspecified: JA20.Z\\nPreeclampsia superimposed on chronic hypertension: JA21\\nGestational oedema or proteinuria without hypertension: JA22\\nGestational proteinuria without hypertension: JA22.0\\nGestational oedema without hypertension: JA22.1\\nGestational oedema with proteinuria without hypertension: JA22.2\\nGestational hypertension: JA23\\nPreeclampsia: JA24\\nMild to moderate preeclampsia: JA24.0\\nSevere preeclampsia: JA24.1\\nHELLP syndrome: JA24.2\\nPreeclampsia unspecified: JA24.Z\\nEclampsia: JA25\\nEclampsia in pregnancy: JA25.0\\nEclampsia in labour: JA25.1\\nEclampsia in the puerperium: JA25.2\\nEclampsia time period unspecified: JA25.3\\nOedema proteinuria or hypertensive disorders in pregnancy childbirth or the puerperium unspecified: JA2Z\\nHaemorrhage in early pregnancy: JA40\\nThreatened abortion: JA40.0\\nOther specified haemorrhage in early pregnancy: JA40.Y\\nHaemorrhage in early pregnancy unspecified: JA40.Z\\nAntepartum haemorrhage: JA41\\nAntepartum haemorrhage with coagulation defect: JA41.0\\nOther specified antepartum haemorrhage: JA41.Y\\nAntepartum haemorrhage unspecified: JA41.Z\\nIntrapartum haemorrhage: JA42\\nIntrapartum haemorrhage with coagulation defect: JA42.0\\nIntrapartum haemorrhage resulting from obstructed labour with uterine rupture: JA42.1\\nIntrapartum haemorrhage resulting from obstructed labour without mention of uterine rupture: JA42.2\\nOther specified intrapartum haemorrhage: JA42.Y\\nIntrapartum haemorrhage unspecified: JA42.Z\\nPostpartum haemorrhage: JA43\\nThirdstage haemorrhage: JA43.0\\nOther immediate postpartum haemorrhage: JA43.1\\nDelayed or secondary postpartum haemorrhage: JA43.2\\nPostpartum coagulation defects: JA43.3\\nPostpartum haemorrhage following obstructed labour with uterine rupture: JA43.4\\nPostpartum haemorrhage following obstructed labour without mention of uterine rupture: JA43.5\\nOther specified postpartum haemorrhage: JA43.Y\\nPostpartum haemorrhage unspecified: JA43.Z\\nObstetric haemorrhage unspecified: JA4Z\\nExcessive vomiting in pregnancy: JA60\\nMild hyperemesis gravidarum: JA60.0\\nHyperemesis gravidarum with metabolic disturbance: JA60.1\\nLate vomiting of pregnancy: JA60.2\\nOther specified excessive vomiting in pregnancy: JA60.Y\\nExcessive vomiting in pregnancy unspecified: JA60.Z\\nVenous complications in pregnancy: JA61\\nVaricose veins of lower extremity in pregnancy: JA61.0\\nGenital varices in pregnancy: JA61.1\\nSuperficial thrombophlebitis in pregnancy: JA61.2\\nDeep phlebothrombosis in pregnancy: JA61.3\\nHaemorrhoids in pregnancy: JA61.4\\nCerebral venous thrombosis in pregnancy: JA61.5\\nOther specified venous complications in pregnancy: JA61.Y\\nVenous complications in pregnancy unspecified: JA61.Z\\nInfections of genitourinary tract in pregnancy: JA62\\nInfections of kidney in pregnancy: JA62.0\\nInfections of bladder in pregnancy: JA62.1\\nInfections of urethra in pregnancy: JA62.2\\nInfections of other parts of urinary tract in pregnancy: JA62.3\\nInfections of the genital tract in pregnancy: JA62.4\\nInfections of genitourinary tract in pregnancy other specified site: JA62.Y\\nInfection of genitourinary tract in pregnancy site unspecified: JA62.Z\\nDiabetes mellitus in pregnancy: JA63\\nPreexisting type  diabetes mellitus in pregnancy: JA63.1\\nDiabetes mellitus arising in pregnancy: JA63.2\\nOther specified diabetes mellitus in pregnancy: JA63.Y\\nDiabetes mellitus in pregnancy unspecified: JA63.Z\\nMalnutrition in pregnancy: JA64\\nMaternal care for other conditions predominantly related to pregnancy: JA65\\nLiver disorders in pregnancy childbirth or the puerperium: JA65.0\\nPregnancy dermatoses: JA65.1\\nGestational pemphigoid: JA65.10\\nPruritus of pregnancy: JA65.11\\nPolymorphic eruption of pregnancy: JA65.12\\nOther specified pregnancy dermatoses: JA65.1Y\\nPregnancy dermatoses unspecified: JA65.1Z\\nExcessive weight gain in pregnancy: JA65.2\\nLow weight gain in pregnancy: JA65.3\\nPregnancy care of habitual aborter: JA65.4\\nRetained intrauterine contraceptive device in pregnancy: JA65.5\\nMaternal hypotension syndrome: JA65.6\\nSubluxation of symphysis pubis in pregnancy childbirth or the puerperium: JA65.7\\nMaternal care for other specified conditions predominantly related to pregnancy: JA65.Y\\nMaternal care for unspecified conditions predominantly related to pregnancy: JA65.Z\\nClinical findings on antenatal screening of mother: JA66\\nAbnormal haematological finding on antenatal screening of mother: JA66.0\\nAbnormal biochemical finding on antenatal screening of mother: JA66.1\\nAbnormal cytological finding on antenatal screening of mother: JA66.2\\nAbnormal ultrasonic finding on antenatal screening of mother: JA66.3\\nAbnormal radiological finding on antenatal screening of mother: JA66.4\\nAbnormal chromosomal or genetic finding on antenatal screening of mother: JA66.5\\nOther specified clinical findings on antenatal screening of mother: JA66.Y\\nClinical findings on antenatal screening of mother unspecified: JA66.Z\\nComplications of anaesthesia during pregnancy: JA67\\nPulmonary complications of anaesthesia during pregnancy: JA67.0\\nCardiac complications of anaesthesia during pregnancy: JA67.1\\nCentral nervous system complications of anaesthesia during pregnancy: JA67.2\\nToxic reaction to local anaesthesia during pregnancy: JA67.3\\nSpinal or epidural anaesthesiainduced headache during pregnancy: JA67.4\\nFailed or difficult intubation during pregnancy: JA67.5\\nFailed intubation during pregnancy: JA67.50\\nDifficult intubation during pregnancy: JA67.51\\nOther specified failed or difficult intubation during pregnancy: JA67.5Y\\nFailed or difficult intubation during pregnancy unspecified: JA67.5Z\\nAwareness under general anaesthesia during pregnancy: JA67.6\\nOther specified complications of anaesthesia during pregnancy: JA67.Y\\nComplications of anaesthesia during pregnancy unspecified: JA67.Z\\nMaternal disorders predominantly related to pregnancy unspecified: JA6Z\\nMaternal care related to multiple gestation: JA80\\nTwin pregnancy: JA80.0\\nTriplet pregnancy: JA80.1\\nQuadruplet pregnancy: JA80.2\\nMaternal care related to other specified multiple gestation: JA80.Y\\nMaternal care related to unspecified multiple gestation: JA80.Z\\nMaternal care related to complications specific to multiple gestation: JA81\\nPapyraceous fetus: JA81.0\\nContinuing pregnancy after abortion of one fetus or more: JA81.1\\nContinuing pregnancy after intrauterine death of one fetus or more: JA81.2\\nLoss of pregnancy after abortion or intrauterine death of one fetus or more: JA81.3\\nOther specified maternal care related to complications specific to multiple gestation: JA81.Y\\nMaternal care related to complications specific to multiple gestation unspecified: JA81.Z\\nMaternal care for malpresentation of fetus: JA82\\nMaternal care for unstable lie: JA82.0\\nMaternal care for breech presentation: JA82.1\\nMaternal care for transverse or oblique lie: JA82.2\\nMaternal care for face brow or chin presentation: JA82.3\\nMaternal care for high head at term: JA82.4\\nMaternal care for multiple gestation with malpresentation of one fetus or more: JA82.5\\nMaternal care for compound presentation: JA82.6\\nMaternal care for other specified malpresentation of fetus: JA82.Y\\nMaternal care for malpresentation of fetus unspecified: JA82.Z\\nMaternal care for disproportion: JA83\\nMaternal care for disproportion due to deformity of maternal pelvic bones: JA83.0\\nMaternal care for disproportion due to generally contracted pelvis: JA83.1\\nMaternal care for disproportion due to inlet contraction of pelvis: JA83.2\\nMaternal care for disproportion due to outlet contraction of pelvis: JA83.3\\nMaternal care for disproportion of mixed maternal and fetal origin: JA83.4\\nMaternal care for disproportion due to unusually large fetus: JA83.5\\nMaternal care for disproportion due to hydrocephalic fetus: JA83.6\\nMaternal care for other specified disproportion: JA83.Y\\nMaternal care for disproportion unspecified: JA83.Z\\nMaternal care for abnormality of pelvic organs: JA84\\nMaternal care for congenital malformation of uterus: JA84.0\\nMaternal care for tumour of corpus uteri: JA84.1\\nMaternal care due to uterine scar from previous surgery: JA84.2\\nMaternal care for cervical incompetence: JA84.3\\nMaternal care for abnormality of vagina: JA84.4\\nMaternal care for abnormality of vulva or perineum: JA84.5\\nMaternal care for other specified abnormality of pelvic organs: JA84.Y\\nMaternal care for abnormality of pelvic organs unspecified: JA84.Z\\nMaternal care for fetal abnormality or damage: JA85\\nMaternal care for central nervous system malformation in fetus: JA85.0\\nMaternal care for chromosomal abnormality in fetus: JA85.1\\nMaternal care for hereditary disease in fetus: JA85.2\\nMaternal care for damage to fetus from viral disease in mother: JA85.3\\nMaternal care for other specified fetal abnormality or damage: JA85.Y\\nMaternal care for fetal abnormality or damage unspecified: JA85.Z\\nMaternal care for other fetal problems: JA86\\nMaternal care for red cell antibodies: JA86.0\\nMaternal care for hydrops fetalis: JA86.1\\nMaternal care for signs of fetal hypoxia: JA86.2\\nMaternal care for intrauterine death: JA86.3\\nMaternal care for fetal growth restriction: JA86.4\\nMaternal care for suspected macrosomia: JA86.5\\nMaternal care for viable fetus in abdominal pregnancy: JA86.6\\nMaternal care for other specified fetal problems: JA86.Y\\nMaternal care for other fetal problems unspecified: JA86.Z\\nMaternal care related to polyhydramnios: JA87\\nMaternal care related to certain specified disorders of amniotic fluid or membranes: JA88\\nOligohydramnios: JA88.0\\nInfection of amniotic sac or membranes: JA88.1\\nOther specified disorders of amniotic fluid and membranes: JA88.Y\\nDisorders of amniotic fluid and membranes unspecified: JA88.Z\\nMaternal care related to premature rupture of membranes: JA89\\nPremature rupture of membranes onset of labour within  hours: JA89.0\\nPremature rupture of membranes onset of labour after  hours: JA89.1\\nPremature rupture of membranes labour delayed by therapy: JA89.2\\nPreterm premature rupture of membranes: JA89.3\\nOther specified maternal care related to premature rupture of membranes: JA89.Y\\nMaternal care related to premature rupture of membranes unspecified: JA89.Z\\nMaternal care related to placental disorders: JA8A\\nPlacental transfusion syndromes: JA8A.0\\nMalformation of placenta: JA8A.1\\nMorbidly adherent placenta: JA8A.2\\nOther specified maternal care related to placental disorders: JA8A.Y\\nMaternal care related to placental disorders unspecified: JA8A.Z\\nMaternal care related to placenta praevia or low lying placenta: JA8B\\nPlacenta praevia specified as without haemorrhage: JA8B.0\\nPlacenta praevia with haemorrhage: JA8B.1\\nMaternal care related to placenta praevia or low lying placenta unspecified: JA8B.Z\\nMaternal care related to premature separation of placenta: JA8C\\nPremature separation of placenta with coagulation defect: JA8C.0\\nOther specified maternal care related to premature separation of placenta: JA8C.Y\\nMaternal care related to premature separation of placenta unspecified: JA8C.Z\\nMaternal care related to false labour: JA8D\\nFalse labour before  completed weeks of gestation: JA8D.0\\nFalse labour at or after  completed weeks of gestation: JA8D.1\\nMaternal care related to false labour unspecified: JA8D.Z\\nMaternal care related to prolonged pregnancy: JA8E\\nMaternal care related to other specified fetus amniotic cavity or possible delivery problems: JA8Y\\nMaternal care related to unspecified fetus amniotic cavity or possible delivery problems: JA8Z\\nPreterm labour or delivery: JB00\\nPreterm labour without delivery: JB00.0\\nPreterm spontaneous labour with preterm delivery: JB00.1\\nPreterm labour with term delivery: JB00.2\\nPreterm delivery following iatrogenic induction of labour or caesarean section: JB00.3\\nOther specified preterm labour or delivery: JB00.Y\\nPreterm labour or delivery unspecified: JB00.Z\\nFailed induction of labour: JB01\\nFailed medical induction of labour: JB01.0\\nFailed instrumental induction of labour: JB01.1\\nFailed induction of labour unspecified: JB01.Z\\nAbnormalities of forces of labour: JB02\\nPrimary uterine inertia: JB02.0\\nSecondary uterine inertia: JB02.1\\nOther uterine inertia: JB02.2\\nPrecipitate labour: JB02.3\\nHypertonic incoordinate or prolonged uterine contractions: JB02.4\\nOther specified abnormalities of forces of labour: JB02.Y\\nAbnormalities of forces of labour unspecified: JB02.Z\\nLong labour: JB03\\nProlonged first stage of labour: JB03.0\\nProlonged second stage of labour: JB03.1\\nDelayed delivery of successive neonates: JB03.2\\nLong labour unspecified: JB03.Z\\nObstructed labour due to malposition or malpresentation of fetus: JB04\\nObstructed labour due to incomplete rotation of fetal head: JB04.0\\nObstructed labour due to breech presentation: JB04.1\\nObstructed labour due to face presentation: JB04.2\\nObstructed labour due to brow presentation: JB04.3\\nObstructed labour due to shoulder presentation: JB04.4\\nObstructed labour due to compound presentation: JB04.5\\nObstructed labour due to other malposition and malpresentation of fetus: JB04.Y\\nObstructed labour due to malposition or malpresentation of fetus unspecified: JB04.Z\\nObstructed labour due to maternal pelvic abnormality: JB05\\nObstructed labour due to deformed pelvis: JB05.0\\nObstructed labour due to generally contracted pelvis: JB05.1\\nObstructed labour due to pelvic inlet contraction: JB05.2\\nObstructed labour due to pelvic outlet or midcavity contraction: JB05.3\\nObstructed labour due to foetopelvic disproportion unspecified: JB05.4\\nObstructed labour due to abnormality of maternal pelvic organs: JB05.5\\nObstructed labour due to other maternal pelvic abnormalities: JB05.Y\\nObstructed labour due to maternal pelvic abnormality unspecified: JB05.Z\\nObstructed labour due to other causes: JB06\\nObstructed labour due to shoulder dystocia: JB06.0\\nObstructed labour due to locked twins: JB06.1\\nObstructed labour due to unusually large fetus: JB06.2\\nObstructed labour due to other abnormalities of fetus: JB06.3\\nObstructed labour due to other specified causes: JB06.Y\\nObstructed labour due to unspecified causes: JB06.Z\\nLabour or delivery complicated by fetal distress: JB07\\nLabour or delivery complicated by fetal heart rate anomaly: JB07.0\\nLabour or delivery complicated by meconium in amniotic fluid: JB07.1\\nLabour or delivery complicated by biochemical evidence of fetal stress: JB07.2\\nOther specified labour or delivery complicated by fetal distress: JB07.Y\\nLabour or delivery complicated by fetal distress unspecified: JB07.Z\\nLabour or delivery complicated by umbilical cord complications: JB08\\nLabour or delivery complicated by prolapse of cord: JB08.0\\nLabour or delivery complicated by cord around neck with compression: JB08.1\\nLabour or delivery complicated by short cord: JB08.2\\nLabour or delivery complicated by vasa praevia: JB08.3\\nLabour or delivery complicated by vascular lesion of cord: JB08.4\\nLabour or delivery complicated by other cord entanglement with compression: JB08.5\\nLabour and delivery complicated by other specified umbilical cord complications: JB08.Y\\nLabour or delivery complicated by umbilical cord complications unspecified: JB08.Z\\nPerineal laceration during delivery: JB09\\nFirst degree perineal laceration during delivery: JB09.0\\nSecond degree perineal laceration during delivery: JB09.1\\nThird degree perineal laceration during delivery: JB09.2\\nFourth degree perineal laceration during delivery: JB09.3\\nPerineal laceration during delivery unspecified: JB09.Z\\nCertain specified obstetric trauma: JB0A\\nRupture of uterus before onset of labour: JB0A.0\\nRupture of uterus during labour: JB0A.1\\nPostpartum inversion of uterus: JB0A.2\\nObstetric laceration of cervix: JB0A.3\\nObstetric high vaginal laceration: JB0A.4\\nObstetric uterine laceration or tear: JB0A.5\\nOther obstetric injury to pelvic organs: JB0A.6\\nObstetric damage to pelvic joints or ligaments: JB0A.7\\nObstetric haematoma of pelvis: JB0A.8\\nOther specified obstetric trauma: JB0A.Y\\nObstetric trauma unspecified: JB0A.Z\\nRetained placenta or membranes without haemorrhage: JB0B\\nRetained placenta without haemorrhage: JB0B.0\\nRetained portions of placenta or membranes without haemorrhage: JB0B.1\\nComplications of anaesthesia during labour or delivery: JB0C\\nAspiration pneumonitis due to anaesthesia during labour or delivery: JB0C.0\\nOther pulmonary complications of anaesthesia during labour or delivery: JB0C.1\\nCardiac complications of anaesthesia during labour or delivery: JB0C.2\\nCentral nervous system complications of anaesthesia during labour or delivery: JB0C.3\\nToxic reaction to local anaesthesia during labour or delivery: JB0C.4\\nSpinal or epidural anaesthesiainduced headache during labour or delivery: JB0C.5\\nOther complications of spinal or epidural anaesthesia during labour or delivery: JB0C.6\\nFailed or difficult intubation during labour or delivery: JB0C.7\\nFailed intubation during labour or delivery: JB0C.70\\nDifficult intubation during labour or delivery: JB0C.71\\nOther specified failed or difficult intubation during labour or delivery: JB0C.7Y\\nFailed or difficult intubation during labour or delivery unspecified: JB0C.7Z\\nAwareness under general anaesthesia during labour or delivery: JB0C.8\\nOther specified complications of anaesthesia during labour or delivery: JB0C.Y\\nComplications of anaesthesia during labour or delivery unspecified: JB0C.Z\\nCertain specified complications of labour or delivery not elsewhere classified: JB0D\\nMaternal distress during labour or delivery: JB0D.0\\nShock during or following labour or delivery: JB0D.1\\nPyrexia during labour not elsewhere classified: JB0D.2\\nOther complications of obstetric surgery or procedures: JB0D.3\\nDelayed delivery after artificial rupture of membranes: JB0D.4\\nDelayed delivery after spontaneous or unspecified rupture of membranes: JB0D.5\\nVaginal delivery following previous caesarean section: JB0D.6\\nFailed application of vacuum extractor or forceps unspecified: JB0D.7\\nFailed trial of labour unspecified: JB0D.8\\nOther specified complications of labour or delivery not elsewhere classified: JB0D.Y\\nOther specified complications of labour or delivery: JB0Y\\nComplications of labour or delivery unspecified: JB0Z\\nSingle spontaneous delivery: JB20\\nSpontaneous vertex delivery: JB20.0\\nSpontaneous breech delivery: JB20.1\\nSingle spontaneous delivery with other specified presentation: JB20.Y\\nSingle spontaneous delivery unspecified: JB20.Z\\nSingle delivery by forceps or vacuum extractor: JB21\\nSingle delivery by caesarean section: JB22\\nDelivery by elective caesarean section: JB22.0\\nDelivery by emergency caesarean section: JB22.1\\nSingle delivery by caesarean hysterectomy: JB22.2\\nSingle delivery by caesarean section unspecified: JB22.Z\\nOther assisted single delivery: JB23\\nBreech extraction: JB23.0\\nOther assisted breech delivery: JB23.1\\nOther manipulationassisted delivery: JB23.2\\nDelivery of viable fetus in abdominal pregnancy: JB23.3\\nDestructive operation for delivery: JB23.4\\nOther assisted single delivery unspecified: JB23.Z\\nMultiple delivery: JB24\\nMultiple delivery all spontaneous: JB24.0\\nMultiple delivery all by forceps or vacuum extractor: JB24.1\\nMultiple delivery all by caesarean section: JB24.2\\nMultiple delivery by combination of methods with caesarean: JB24.3\\nOther specified multiple delivery: JB24.Y\\nMultiple delivery unspecified: JB24.Z\\nDelivery unspecified: JB2Z\\nInfections in the puerperium: JB40\\nPuerperal sepsis: JB40.0\\nInfection of obstetric surgical wound: JB40.1\\nOther infection of genital tract following delivery: JB40.2\\nUrinary tract infection following delivery: JB40.3\\nPyrexia of unknown origin following delivery: JB40.4\\nOther specified infections in the puerperium: JB40.Y\\nInfections in the puerperium unspecified: JB40.Z\\nVenous complications in the puerperium: JB41\\nSuperficial thrombophlebitis in the puerperium: JB41.0\\nDeep phlebothrombosis in the puerperium: JB41.1\\nHaemorrhoids in the puerperium: JB41.2\\nCerebral venous thrombosis in the puerperium: JB41.3\\nOther specified venous complications in the puerperium: JB41.Y\\nVenous complications in the puerperium unspecified: JB41.Z\\nObstetric embolism: JB42\\nObstetric air embolism: JB42.0\\nAmniotic fluid embolism: JB42.1\\nObstetric bloodclot embolism: JB42.2\\nObstetric pyaemic or septic embolism: JB42.3\\nOther specified obstetric embolism: JB42.Y\\nObstetric embolism unspecified: JB42.Z\\nComplications of anaesthesia during the puerperium: JB43\\nPulmonary complications of anaesthesia during the puerperium: JB43.0\\nCardiac complications of anaesthesia during the puerperium: JB43.1\\nCentral nervous system complications of anaesthesia during the puerperium: JB43.2\\nSpinal or epidural anaesthesiainduced headache during the puerperium: JB43.3\\nOther complications of spinal or epidural anaesthesia during the puerperium: JB43.4\\nFailed or difficult intubation during the puerperium: JB43.5\\nFailed intubation during the puerperium: JB43.50\\nDifficult intubation during the puerperium: JB43.51\\nOther specified failed or difficult intubation during the puerperium: JB43.5Y\\nFailed or difficult intubation during the puerperium unspecified: JB43.5Z\\nAwareness under general anaesthesia during the puerperium: JB43.6\\nOther specified complications of anaesthesia during the puerperium: JB43.Y\\nComplications of anaesthesia during the puerperium unspecified: JB43.Z\\nCertain specified complications of the puerperium: JB44\\nDisruption of caesarean section wound: JB44.0\\nDisruption of perineal obstetric wound: JB44.1\\nHaematoma of obstetric wound: JB44.2\\nCardiomyopathy in the puerperium: JB44.3\\nPostpartum acute renal failure: JB44.4\\nPostpartum thyroiditis: JB44.5\\nPuerperal osteomalacia: JB44.6\\nOther specified complications of the puerperium: JB44.Y\\nComplications of the puerperium unspecified: JB44.Z\\nInfections of breast associated with childbirth: JB45\\nAbscess of breast associated with childbirth: JB45.0\\nNonpurulent mastitis associated with childbirth: JB45.1\\nOther specified infections of breast associated with childbirth: JB45.Y\\nInfections of breast associated with childbirth unspecified: JB45.Z\\nCertain specified disorders of breast or lactation associated with childbirth: JB46\\nRetracted nipple associated with childbirth: JB46.0\\nCracked nipple associated with childbirth: JB46.1\\nOther or unspecified disorders of breast associated with childbirth: JB46.2\\nAgalactia: JB46.3\\nHypogalactia: JB46.4\\nSuppressed lactation: JB46.5\\nGalactorrhoea: JB46.6\\nOther or unspecified disorders of lactation: JB46.7\\nComplications predominantly related to the puerperium unspecified: JB4Z\\nObstetric death of unspecified cause: JB60\\nDeath from any obstetric cause occurring more than  days but less than one year after delivery: JB61\\nDeath from direct obstetric cause occurring more than  days but less than one year after delivery: JB61.0\\nDeath from indirect obstetric cause occurring more than  days but less than one year after delivery: JB61.1\\nDeath from obstetric cause occurring more than  days but less than one year after delivery unspecified whether direct or indirect: JB61.Z\\nDeath from sequelae of obstetric causes: JB62\\nDeath from sequelae of direct obstetric cause: JB62.0\\nDeath from sequelae of indirect obstetric cause: JB62.1\\nDeath from sequelae of obstetric causes unspecified: JB62.Z\\nMaternal infectious diseases classifiable elsewhere but complicating pregnancy childbirth or the puerperium: JB63\\nTuberculosis complicating pregnancy childbirth or the puerperium: JB63.0\\nTuberculous placenta: JB63.00\\nOther specified tuberculosis complicating pregnancy childbirth or the puerperium: JB63.0Y\\nTuberculosis complicating pregnancy childbirth or the puerperium unspecified: JB63.0Z\\nSyphilis complicating pregnancy childbirth or the puerperium: JB63.1\\nGonorrhoea complicating pregnancy childbirth or the puerperium: JB63.2\\nOther infections with a predominantly sexual mode of transmission complicating pregnancy childbirth or the puerperium: JB63.3\\nViral hepatitis complicating pregnancy childbirth or the puerperium: JB63.4\\nOther viral diseases complicating pregnancy childbirth or the puerperium: JB63.5\\nProtozoal diseases complicating pregnancy childbirth or the puerperium: JB63.6\\nMalaria complicating pregnancy childbirth or the puerperium: JB63.60\\nOther specified protozoal diseases complicating pregnancy childbirth or the puerperium: JB63.6Y\\nProtozoal diseases complicating pregnancy childbirth or the puerperium unspecified: JB63.6Z\\nHuman immunodeficiency disease complicating pregnancy childbirth or the puerperium: JB63.7\\nOther specified maternal infectious diseases classifiable elsewhere but complicating pregnancy childbirth or the puerperium: JB63.Y\\nMaternal infectious diseases classifiable elsewhere but complicating pregnancy childbirth or the puerperium unspecified: JB63.Z\\nCertain maternal diseases classifiable elsewhere but complicating pregnancy childbirth or the puerperium: JB64\\nAnaemia complicating pregnancy childbirth or the puerperium: JB64.0\\nOther diseases of the blood or bloodforming organs or certain disorders involving the immune mechanism complicating pregnancy childbirth or the puerperium: JB64.1\\nEndocrine nutritional or metabolic diseases complicating pregnancy childbirth or the puerperium: JB64.2\\nDiseases of the nervous system complicating pregnancy childbirth or the puerperium: JB64.3\\nDiseases of the circulatory system complicating pregnancy childbirth or the puerperium: JB64.4\\nDiseases of the respiratory system complicating pregnancy childbirth or the puerperium: JB64.5\\nDiseases of the digestive system complicating pregnancy childbirth or the puerperium: JB64.6\\nDiseases of the skin complicating pregnancy childbirth or the puerperium: JB64.7\\nCongenital anomaly complicating pregnancy: JB64.8\\nOther specified maternal diseases classifiable elsewhere but complicating pregnancy childbirth or the puerperium: JB64.Y\\nSequelae of complication of pregnancy childbirth or the puerperium: JB65\\nOther specified obstetric conditions not elsewhere classified: JB6Y\\nUnspecified obstetric condition: JB6Z\\nFetus or newborn affected by maternal conditions that may be unrelated to present pregnancy: KA00\\nFetus or newborn affected by maternal hypertensive disorders: KA00.0\\nFetus or newborn affected by gestational oedema or proteinuria without hypertension: KA00.1\\nFetus or newborn affected by maternal renal or urinary tract diseases: KA00.2\\nFetus or newborn affected by maternal infectious diseases: KA00.3\\nFetus or newborn affected by periodontal disease in mother: KA00.4\\nFetus or newborn affected by maternal respiratory diseases: KA00.5\\nFetus or newborn affected by maternal nutritional disorders: KA00.6\\nFetus or newborn affected by maternal malnutrition: KA00.60\\nFetus or newborn affected by maternal overweight or obesity: KA00.61\\nOther specified fetus or newborn affected by maternal nutritional disorders: KA00.6Y\\nFetus or newborn affected by maternal nutritional disorders unspecified: KA00.6Z\\nFetus or newborn affected by abnormal maternal chemistry: KA00.7\\nFetus or newborn affected by maternal injury: KA00.8\\nFetus or newborn affected by maternal chemotherapy: KA00.9\\nFetus or newborn affected by surgical procedure on mother: KA00.A\\nFetus or newborn affected by maternal anaemia: KA00.B\\nFetus or newborn affected by other specified maternal condition that may be unrelated to present pregnancy: KA00.Y\\nFetus or newborn affected by unspecified maternal condition that may be unrelated to present pregnancy: KA00.Z\\nFetus or newborn affected by maternal complications of pregnancy: KA01\\nFetus or newborn affected by incompetence of cervix uteri: KA01.0\\nFetus or newborn affected by premature rupture of membranes: KA01.1\\nFetus or newborn affected by oligohydramnios: KA01.2\\nFetus or newborn affected by polyhydramnios: KA01.3\\nFetus or newborn affected by ectopic pregnancy: KA01.4\\nFetus or newborn affected by multiple pregnancy: KA01.5\\nFetus or newborn affected by maternal death: KA01.6\\nFetus or newborn affected by malpresentation before labour: KA01.7\\nFetus or newborn affected by maternal blood loss: KA01.8\\nFetus or newborn affected by other specified maternal complication of pregnancy: KA01.Y\\nFetus or newborn affected by unspecified maternal complication of pregnancy: KA01.Z\\nFetus or newborn affected by complications of placenta: KA02\\nFetus or newborn affected by placenta praevia: KA02.0\\nFetus or newborn affected by placental oedema or large placenta: KA02.1\\nFetus or newborn affected by placental infarction: KA02.2\\nFetus or newborn affected by placental insufficiency or small placenta: KA02.3\\nFetus or newborn affected by placental transfusion syndromes: KA02.4\\nFetus or newborn affected by other specified complication of placenta: KA02.Y\\nFetus or newborn affected by unspecified complication of placenta: KA02.Z\\nFetus or newborn affected by complications of umbilical cord: KA03\\nFetus or newborn affected by prolapsed cord: KA03.0\\nFetus or newborn affected by other compression of umbilical cord: KA03.1\\nFetus or newborn affected by abnormalities of umbilical cord length: KA03.2\\nFetus or newborn affected by short umbilical cord: KA03.20\\nFetus or newborn affected by long umbilical cord: KA03.21\\nOther specified fetus or newborn affected by abnormalities of umbilical cord length: KA03.2Y\\nFetus or newborn affected by abnormalities of umbilical cord length unspecified: KA03.2Z\\nFetus or newborn affected by vasa praevia: KA03.3\\nFetus or newborn affected by traumatic injury of the umbilical cord: KA03.4\\nFetus or newborn affected by other specified complication of umbilical cord: KA03.Y\\nFetus or newborn affected by unspecified complication of umbilical cord: KA03.Z\\nFetus or newborn affected by other abnormalities of membranes: KA04\\nFetus or newborn affected by chorioamnionitis: KA04.0\\nFetus or newborn affected by amniotic band syndrome: KA04.1\\nFetus or newborn affected by other specified abnormality of membranes: KA04.Y\\nFetus or newborn affected by unspecified abnormality of membranes: KA04.Z\\nFetus or newborn affected by certain complications of labour or delivery: KA05\\nFetus or newborn affected by breech delivery or extraction: KA05.0\\nFetus or newborn affected by other malpresentation malposition or disproportion during labour or delivery: KA05.1\\nFetus or newborn affected by forceps delivery: KA05.2\\nFetus or newborn affected by delivery by vacuum extractor: KA05.3\\nFetus or newborn affected by caesarean delivery: KA05.4\\nFetus or newborn affected by precipitate delivery: KA05.5\\nFetus or newborn affected by abnormal uterine contractions: KA05.6\\nFetus or newborn affected by abnormality in fetal intrauterine heart rate or rhythm: KA05.7\\nFetus and newborn affected by abnormality in fetal intrauterine heart rate or rhythm before onset of labour: KA05.70\\nFetus and newborn affected by abnormality in fetal intrauterine heart rate or rhythm during labour: KA05.71\\nFetus or newborn affected by abnormality in fetal intrauterine heart rate or rhythm unspecified: KA05.7Z\\nMeconium passage during delivery: KA05.8\\nFetus or newborn affected or suspected to be affected by other specified complications of labour or delivery: KA05.Y\\nFetus or newborn affected or suspected to be affected by unspecified complications of labour or delivery: KA05.Z\\nFetus or newborn affected by noxious influences transmitted via placenta or breast milk: KA06\\nFetus or newborn affected by maternal anaesthesia or analgesia in pregnancy labour or delivery: KA06.0\\nFetus or newborn affected by maternal use of tobacco: KA06.1\\nFetus or newborn affected by maternal use of alcohol: KA06.2\\nFetus or newborn affected by maternal use of drugs of addiction: KA06.3\\nFetus or newborn affected by maternal use of nutritional chemical substances: KA06.4\\nFetus or newborn affected by maternal exposure to environmental chemical substances: KA06.5\\nFetus or newborn affected by other specified noxious influence transmitted via placenta or breast milk: KA06.Y\\nFetus or newborn affected by unspecified noxious influence transmitted via placenta or breast milk: KA06.Z\\nNeonatal dermatoses due to maternal antibodies: KA07\\nNeonatal lupus erythematosus: KA07.0\\nNeonatal pemphigus: KA07.1\\nOther specified neonatal dermatoses due to maternal antibodies: KA07.Y\\nFetus or newborn affected by unspecified maternal factors or by complications of pregnancy labour or delivery: KA0Z\\nDisorders of newborn related to slow fetal growth or fetal malnutrition: KA20\\nSmall for gestational age: KA20.0\\nSmall for gestational age symmetrical: KA20.00\\nSmall for gestational age asymmetrical: KA20.01\\nSmall for gestational age unspecified: KA20.0Z\\nIntrauterine growth restriction: KA20.1\\nAsymmetrical intrauterine growth restriction: KA20.10\\nSymmetrical intrauterine growth restriction: KA20.11\\nIntrauterine growth restriction associated with small for gestational age: KA20.12\\nOther specified intrauterine growth restriction: KA20.1Y\\nIntrauterine growth restriction unspecified: KA20.1Z\\nFetal intrauterine malnutrition without mention of small for gestational age: KA20.2\\nOther specified disorders of newborn related to slow fetal growth or fetal malnutrition: KA20.Y\\nDisorders of newborn related to slow fetal growth or fetal malnutrition unspecified: KA20.Z\\nDisorders of newborn related to short gestation or low birth weight not elsewhere classified: KA21\\nExtremely low birth weight of newborn: KA21.0\\nExtremely low birth weight of newborn g or less: KA21.00\\nExtremely low birth weight of newborn g: KA21.02\\nExtremely low birth weight of newborn unspecified: KA21.0Z\\nVery low birth weight of newborn: KA21.1\\nVery low birth weight of newborn g: KA21.11\\nVery low birth weight of newborn unspecified: KA21.1Z\\nLow birth weight of newborn: KA21.2\\nLow birth weight of newborn g: KA21.21\\nLow birth weight of newborn unspecified: KA21.2Z\\nExtreme prematurity of newborn: KA21.3\\nExtreme prematurity of newborn gestational age less than  completed weeks: KA21.30\\nExtreme prematurity of newborn gestational age  completed weeks: KA21.36\\nExtreme prematurity of newborn unspecified: KA21.3Z\\nPreterm newborn: KA21.4\\nPreterm newborn gestational age  completed weeks: KA21.48\\nPreterm newborn unspecified: KA21.4Z\\nDisorders of newborn related to long gestation or high birth weight: KA22\\nExceptionally large newborn: KA22.0\\nLarge newborn for gestational age: KA22.1\\nPostterm newborn: KA22.2\\nPostmaturity syndrome: KA22.3\\nOther specified disorders of newborn related to length of gestation or fetal growth: KA2Y\\nDisorders of newborn related to length of gestation or fetal growth unspecified: KA2Z\\nBirth injury to central nervous system: KA40\\nIntracranial laceration or haemorrhage due to birth injury: KA40.0\\nSubdural haemorrhage due to birth injury: KA40.00\\nCerebral haemorrhage due to birth injury: KA40.01\\nCerebellar haemorrhage due to birth injury: KA40.02\\nIntraventricular haemorrhage due to birth injury: KA40.03\\nSubarachnoid haemorrhage due to birth injury: KA40.04\\nTentorial tear due to birth injury: KA40.05\\nCerebellar contusion due to birth injury: KA40.06\\nCerebral contusion due to birth injury: KA40.07\\nExtradural or epidural haemorrhage due to birth injury: KA40.08\\nOther specified intracranial laceration or haemorrhage due to birth injury: KA40.0Y\\nIntracranial laceration or haemorrhage due to birth injury unspecified: KA40.0Z\\nCerebral oedema due to birth injury: KA40.1\\nBirth injury to spine or spinal cord: KA40.2\\nBirth injury to brainstem: KA40.3\\nOther specified birth injury to central nervous system: KA40.Y\\nBirth injury to central nervous system unspecified: KA40.Z\\nBirth injury to eye: KA41\\nBirth injury to scalp: KA42\\nBruising of scalp due to birth injury: KA42.0\\nCephalohaematoma due to birth injury: KA42.1\\nChignon due to birth injury: KA42.2\\nMonitoring injury of scalp of newborn: KA42.3\\nSubgaleal epicranial subaponeurotic haemorrhage due to birth injury: KA42.4\\nOther specified birth injury to scalp: KA42.Y\\nBirth injury to scalp unspecified: KA42.Z\\nBirth injury to skin or soft tissues: KA43\\nBirth injury to sternocleidomastoid: KA43.0\\nBirth injury to external genitalia: KA43.1\\nSubcutaneous fat necrosis due to birth injury: KA43.2\\nBirth injury to face: KA43.3\\nOther specified birth injury to skin or soft tissues: KA43.Y\\nBirth injury to skin or soft tissues unspecified: KA43.Z\\nBirth injury to peripheral nervous system: KA44\\nBirth injury to cranial nerves: KA44.0\\nBirth injury to facial nerve: KA44.00\\nBirth injury to other specified cranial nerve: KA44.0Y\\nBirth injury to unspecified cranial nerve: KA44.0Z\\nBrachial plexus palsy in newborn: KA44.1\\nErb paralysis: KA44.10\\nKlumpke paralysis: KA44.11\\nBrachial plexus palsy in newborn unspecified: KA44.1Z\\nPhrenic nerve paralysis due to birth injury: KA44.2\\nBirth injury to other specified peripheral nerve: KA44.Y\\nBirth injury to unspecified peripheral nerve: KA44.Z\\nBirth injury to skeleton: KA45\\nFracture of skull due to birth injury: KA45.0\\nLinear skull fracture due to birth injury: KA45.00\\nDepressed skull fracture due to birth injury: KA45.01\\nOther specified fracture of skull due to birth injury: KA45.0Y\\nFracture of skull due to birth injury unspecified: KA45.0Z\\nOccipital osteodiastasis due to birth injury: KA45.1\\nBirth injury to facial bones: KA45.2\\nMandibular bone fracture due to birth injury: KA45.20\\nNasal bone fracture due to birth injury: KA45.21\\nBirth injury to other specified facial bones: KA45.2Y\\nBirth injury to facial bones unspecified: KA45.2Z\\nBirth injury of thorax: KA45.3\\nFracture dislocation or subluxation of spine due to birth injury: KA45.4\\nFracture of clavicle due to birth injury: KA45.5\\nBirth injury to long bones: KA45.6\\nOther specified birth injury to skeleton: KA45.Y\\nBirth injury to skeleton unspecified: KA45.Z\\nBirth injury to other organs: KA46\\nBirth injury to liver: KA46.0\\nBirth injury to spleen: KA46.1\\nAdrenal haemorrhage due to birth injury: KA46.2\\nBirth injury to other specified organ: KA46.Y\\nBirth injury unspecified: KA4Z\\nSepsis of fetus or newborn: KA60\\nOther bacterial infections of the fetus or newborn: KA61\\nCongenital tuberculosis: KA61.0\\nNeonatal listeriosis: KA61.1\\nBacterial infection of the fetus or newborn unspecified: KA61.Z\\nViral infection in the fetus or newborn: KA62\\nCongenital Zika virus infection: KA62.0\\nCongenital EpsteinBarr virus infection: KA62.1\\nCongenital Varicella Zoster virus infection: KA62.2\\nCongenital cytomegalovirus infection: KA62.3\\nCongenital echovirus infection: KA62.4\\nCongenital enterovirus infection: KA62.5\\nCongenital human immunodeficiency virus infection: KA62.6\\nCongenital parvovirus syndrome: KA62.7\\nCongenital rubella syndrome: KA62.8\\nCongenital viral hepatitis: KA62.9\\nPerinatal Herpes simplex infection: KA62.A\\nOther specified viral infection in the fetus or newborn: KA62.Y\\nViral infection in the fetus or newborn unspecified: KA62.Z\\nFungal infection of fetus or newborn: KA63\\nMalassezia infection in newborn: KA63.0\\nNeonatal aspergillosis: KA63.1\\nNeonatal candidosis: KA63.2\\nOther specified fungal infection of fetus or newborn: KA63.Y\\nFungal infection of fetus or newborn unspecified: KA63.Z\\nParasitic diseases in the fetus or newborn: KA64\\nCongenital toxoplasmosis: KA64.0\\nCongenital falciparum malaria: KA64.1\\nOther specified parasitic diseases in the fetus or newborn: KA64.Y\\nParasitic diseases in the fetus or newborn unspecified: KA64.Z\\nNeonatal infections of certain specified sites: KA65\\nNeonatal conjunctivitis or dacryocystitis: KA65.0\\nOmphalitis of newborn: KA65.1\\nNeonatal urinary tract infection: KA65.2\\nNeonatal infectious mastitis: KA65.3\\nNeonatal meningitis: KA65.4\\nNeonatal infections of other specified sites: KA65.Y\\nOther specified infections of the fetus or newborn: KA6Y\\nInfections of the fetus or newborn unspecified: KA6Z\\nFetal blood loss: KA80\\nFetal blood loss from vasa praevia: KA80.0\\nFetal blood loss from ruptured cord: KA80.1\\nFetal blood loss from placenta: KA80.2\\nHaemorrhage into cotwin: KA80.3\\nHaemorrhage into maternal circulation: KA80.4\\nFetal blood loss from cut end of cotwin cord: KA80.5\\nOther specified fetal blood loss: KA80.Y\\nFetal blood loss unspecified: KA80.Z\\nUmbilical haemorrhage of newborn: KA81\\nIntracranial nontraumatic haemorrhage of fetus or newborn: KA82\\nIntraventricular nontraumatic haemorrhage grade  of fetus or newborn: KA82.3\\nIntracerebral nontraumatic haemorrhage of fetus or newborn: KA82.4\\nSubarachnoid nontraumatic haemorrhage of fetus or newborn: KA82.5\\nCerebellar nontraumatic hemispheres or vermis or posterior fossa haemorrhage of fetus or newborn: KA82.6\\nSubdural nontraumatic haemorrhage of fetus or newborn: KA82.7\\nIntracranial nontraumatic haemorrhage of fetus or newborn unspecified: KA82.Z\\nCertain specified neonatal haemorrhages: KA83\\nNeonatal bleeding originating in the mouth nose or pharynx: KA83.0\\nNeonatal epistaxis: KA83.00\\nOther specified neonatal bleeding in the mouth nose or pharynx: KA83.0Y\\nNeonatal bleeding originating in the mouth nose or pharynx unspecified: KA83.0Z\\nNeonatal bleeding originating in the oesophagus stomach small or large intestine: KA83.1\\nNeonatal rectal haemorrhage: KA83.2\\nNeonatal hepatic haemorrhage: KA83.3\\nNeonatal haemorrhage originating in adrenal gland: KA83.4\\nNeonatal haemorrhage originating in spleen: KA83.5\\nNeonatal haemorrhage originating in kidney or bladder: KA83.6\\nNeonatal haemorrhage originating in trachea or pulmonary parenchyma: KA83.7\\nNeonatal cutaneous haemorrhage: KA83.8\\nNeonatal vaginal or uterine haemorrhage: KA83.9\\nHaemolytic disease of fetus or newborn: KA84\\nRh isoimmunization of fetus or newborn: KA84.0\\nIsoimmunization due to other red cell factors: KA84.1\\nABO isoimmunization of fetus or newborn: KA84.2\\nHaemolytic anaemia due to other unclassified antibodies of fetus or newborn: KA84.3\\nHaemolytic disease due to disease of other neonatal organs: KA84.4\\nNeonatal haemolysis due to systemic bacterial infection with or without concomitant diffuse intravascular coagulation: KA84.5\\nHaemolytic disease of fetus or newborn unspecified: KA84.Z\\nHydrops fetalis due to haemolytic disease: KA85\\nHydrops fetalis due to isoimmunization: KA85.0\\nOther specified hydrops fetalis due to haemolytic disease: KA85.Y\\nHydrops fetalis due to haemolytic disease unspecified: KA85.Z\\nNeonatal kernicterus: KA86\\nNeonatal hyperbilirubinaemia: KA87\\nNeonatal hyperbilirubinaemia due to swallowed maternal blood: KA87.0\\nNeonatal hyperbilirubinaemia due to enzymatic defect in bilirubin degradation: KA87.1\\nNeonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation: KA87.2\\nNeonatal hyperbilirubinaemia due to total parenteral nutrition: KA87.3\\nNeonatal hyperbilirubinaemia due to drugs or toxins transmitted from mother: KA87.4\\nNeonatal hyperbilirubinaemia due to drugs or toxins given to newborn: KA87.5\\nNeonatal hyperbilirubinaemia from other or unspecified hepatocellular damage: KA87.6\\nOther specified neonatal hyperbilirubinaemia: KA87.Y\\nNeonatal hyperbilirubinaemia unspecified: KA87.Z\\nDisseminated intravascular coagulation of fetus or newborn: KA88\\nTransient neonatal thrombocytopaenia: KA89\\nThrombocytopaenia following systemic infection including diffuse intravascular coagulation: KA89.0\\nOther specified transient neonatal thrombocytopaenia: KA89.Y\\nTransient neonatal thrombocytopaenia unspecified: KA89.Z\\nPolycythaemia neonatorum: KA8A\\nPolycythaemia neonatorum due to placental insufficiency or fetal intrauterine growth restriction: KA8A.0\\nPolycythaemia neonatorum due to twin to twin transfusion: KA8A.1\\nPolycythaemia neonatorum due to inherited disorder of erythropoietin production: KA8A.2\\nPolycythaemia neonatorum following umbilical cord transfusion or stripping at delivery: KA8A.3\\nPolycythaemia neonatorum following blood transfusion: KA8A.4\\nOther specified polycythaemia neonatorum: KA8A.Y\\nPolycythaemia neonatorum unspecified: KA8A.Z\\nAnaemia of prematurity: KA8B\\nCongenital hypoplastic anaemia: KA8C\\nTransient neonatal neutropaenia: KA8D\\nAlloimmune neonatal neutropaenia: KA8E\\nNeonatal vitamin K deficiency: KA8F\\nDiffuse bleeding diathesis due to vitamin K deficient haemorrhagic disease of fetus or newborn: KA8F.0\\nOther specified neonatal vitamin K deficiency: KA8F.Y\\nNeonatal vitamin K deficiency unspecified: KA8F.Z\\nOther specified haemorrhagic or haematological disorders of fetus or newborn: KA8Y\\nHaemorrhagic or haematological disorders of fetus or newborn unspecified: KA8Z\\nNeonatal cerebral ischaemia: KB00\\nPerinatal arterial stroke: KB00.0\\nNeonatal cerebral sinovenous thrombosis: KB00.1\\nOther specified neonatal cerebral ischaemia: KB00.Y\\nNeonatal cerebral ischaemia unspecified: KB00.Z\\nPeriventricular cysts of newborn: KB01\\nNeonatal cerebral leukomalacia: KB02\\nNeonatal encephalopathy: KB03\\nHypoxic ischaemic encephalopathy of newborn: KB04\\nNeonatal hydrocephalus: KB05\\nNeonatal obstructive hydrocephalus: KB05.0\\nOther specified neonatal hydrocephalus: KB05.Y\\nNeonatal hydrocephalus unspecified: KB05.Z\\nNeonatal seizures: KB06\\nCompression of brain in neonate: KB07\\nDisorders of muscle tone of newborn: KB08\\nTransient neonatal myasthenia gravis: KB08.0\\nCongenital hypertonia: KB08.1\\nCongenital hypotonia: KB08.2\\nOther specified disorders of muscle tone of newborn: KB08.Y\\nDisorders of muscle tone of newborn unspecified: KB08.Z\\nOther specified neurological disorders specific to the perinatal or neonatal period: KB0Y\\nNeurological disorders specific to the perinatal or neonatal period unspecified: KB0Z\\nIntrauterine hypoxia: KB20\\nIntrauterine hypoxia first noted before onset of labour: KB20.0\\nIntrauterine hypoxia first noted during labour or delivery: KB20.1\\nIntrauterine hypoxia unspecified: KB20.Z\\nBirth asphyxia: KB21\\nSevere birth asphyxia: KB21.0\\nMild and moderate birth asphyxia: KB21.1\\nBirth asphyxia unspecified: KB21.Z\\nMetabolic acidaemia in newborn: KB22\\nRespiratory distress of newborn: KB23\\nRespiratory distress syndrome of newborn: KB23.0\\nRespiratory distress syndrome of the newborn altered by maternal corticosteroid therapy: KB23.00\\nRespiratory distress syndrome of the newborn altered by pulmonary surfactant replacement therapy: KB23.01\\nRespiratory distress syndrome of the newborn altered by maternal corticosteroid therapy or pulmonary surfactant replacement therapy: KB23.02\\nOther specified respiratory distress syndrome of newborn: KB23.0Y\\nRespiratory distress syndrome of newborn unspecified: KB23.0Z\\nTransient tachypnoea of newborn: KB23.1\\nRespiratory instability of prematurity: KB23.2\\nOther specified respiratory distress of newborn: KB23.Y\\nRespiratory distress of newborn unspecified: KB23.Z\\nCongenital pneumonia: KB24\\nNeonatal tracheitis: KB25\\nNeonatal aspiration syndromes: KB26\\nNeonatal aspiration of meconium: KB26.0\\nNeonatal aspiration of amniotic fluid or mucus: KB26.1\\nNeonatal aspiration of blood: KB26.2\\nNeonatal aspiration of milk or regurgitated food: KB26.3\\nOther specified neonatal aspiration syndromes: KB26.Y\\nNeonatal aspiration syndromes unspecified: KB26.Z\\nPulmonary air leak or related conditions originating in the perinatal period: KB27\\nInterstitial emphysema originating in the perinatal period: KB27.0\\nPneumothorax originating in the perinatal period: KB27.1\\nPneumomediastinum originating in the perinatal period: KB27.2\\nPneumopericardium originating in the perinatal period: KB27.3\\nPneumoperitoneum originating in the perinatal period due to primary pulmonary air leak syndromes: KB27.4\\nOther specified pulmonary air leak or related conditions originating in the perinatal period: KB27.Y\\nPulmonary air leak or related conditions originating in the perinatal period unspecified: KB27.Z\\nPulmonary haemorrhage originating in the perinatal period: KB28\\nTracheobronchial haemorrhage originating in the perinatal period: KB28.0\\nTraumatic pulmonary haemorrhage originating in the perinatal period: KB28.1\\nOther specified pulmonary haemorrhage originating in the perinatal period: KB28.Y\\nPulmonary haemorrhage originating in the perinatal period unspecified: KB28.Z\\nChronic respiratory disease originating in the perinatal period: KB29\\nBronchopulmonary dysplasia originating in the perinatal period: KB29.0\\nOther specified chronic respiratory disease originating in the perinatal period: KB29.Y\\nChronic respiratory disease originating in the perinatal period unspecified: KB29.Z\\nApnoea of newborn: KB2A\\nCentral neonatal apnoea: KB2A.0\\nObstructive neonatal apnoea: KB2A.1\\nMixed neonatal apnoea: KB2A.2\\nApnoea of newborn due to neurologic injury: KB2A.3\\nOther specified apnoea of newborn: KB2A.Y\\nApnoea of newborn unspecified: KB2A.Z\\nPrimary atelectasis of newborn: KB2B\\nCyanotic attacks of newborn: KB2C\\nRespiratory failure of newborn: KB2D\\nRespiratory arrest of newborn: KB2E\\nCongenital lung or lobar atelectasis: KB2F\\nTracheal haemorrhage of newborn due to airway trauma: KB2G\\nAcquired vocal cord paralysis in newborn: KB2H\\nAirway obstruction in the neonate due to airway abnormality: KB2J\\nHypotonia of hypopharynx in neonate: KB2J.0\\nHypopharyngeal mass in neonate: KB2J.1\\nTracheobronchial malacia in neonate: KB2J.2\\nOther specified airway obstruction in the neonate due to airway abnormality: KB2J.Y\\nAirway obstruction in the neonate due to airway abnormality unspecified: KB2J.Z\\nPulmonary cysts in newborn: KB2K\\nAcquired pulmonary cysts in newborn: KB2K.0\\nPulmonary cysts in newborn unspecified: KB2K.Z\\nOther specified respiratory disorders specific to the perinatal or neonatal period: KB2Y\\nRespiratory disorders specific to the perinatal or neonatal period unspecified: KB2Z\\nNeonatal cardiac failure: KB40\\nNeonatal cardiac failure due to pulmonary overperfusion: KB40.0\\nNeonatal cardiac failure due to decreased left ventricular output: KB40.1\\nOther specified neonatal cardiac failure: KB40.Y\\nNeonatal cardiac failure unspecified: KB40.Z\\nCardiac arrhythmias in the neonate: KB41\\nPersistent pulmonary hypertension of the newborn: KB42\\nTransient myocardial ischaemia of newborn: KB44\\nNeonatal hypertension: KB45\\nNeonatal hypotension: KB46\\nBenign or innocent cardiac murmurs in newborn: KB47\\nPatent arterial duct of prematurity: KB48\\nOther specified cardiovascular disorders present in the perinatal or neonatal period: KB4Y\\nCardiovascular disorders present in the perinatal or neonatal period unspecified: KB4Z\\nTransitory disorders of carbohydrate metabolism specific to fetus or newborn: KB60\\nSyndrome of infant of mother with gestational diabetes: KB60.0\\nSyndrome of infant of a diabetic mother type  or  nongestational insulin dependent: KB60.1\\nNeonatal diabetes mellitus: KB60.2\\nTransient neonatal diabetes mellitus: KB60.20\\nOther specified neonatal diabetes mellitus: KB60.2Y\\nNeonatal diabetes mellitus unspecified: KB60.2Z\\nNeonatal hyperglycaemia: KB60.3\\nNeonatal hyperglycaemia due to insulin deficiency: KB60.30\\nNeonatal hyperglycaemia due to iatrogenic intravenous therapy: KB60.31\\nOther specified neonatal hyperglycaemia: KB60.3Y\\nNeonatal hyperglycaemia unspecified: KB60.3Z\\nNeonatal hypoglycaemia: KB60.4\\nTransient hyperinsulinaemic neonatal hypoglycaemia: KB60.40\\nTransitory iatrogenic neonatal hypoglycaemia: KB60.41\\nOther transitory neonatal hypoglycaemia: KB60.42\\nOther specified neonatal hypoglycaemia: KB60.4Y\\nNeonatal hypoglycaemia unspecified: KB60.4Z\\nOther specified transitory disorders of carbohydrate metabolism specific to fetus or newborn: KB60.Y\\nTransitory disorders of carbohydrate metabolism specific to fetus or newborn unspecified: KB60.Z\\nTransitory neonatal disorders of calcium or magnesium metabolism: KB61\\nNeonatal hypomagnesaemia: KB61.0\\nNeonatal tetany without calcium or magnesium deficiency: KB61.1\\nNeonatal hypocalcaemia: KB61.2\\nNeonatal osteopenia: KB61.3\\nOther specified transitory neonatal disorders of calcium or magnesium metabolism: KB61.Y\\nTransitory neonatal disorders of calcium or magnesium metabolism unspecified: KB61.Z\\nTransitory neonatal disorders of thyroid function: KB62\\nTransitory neonatal hyperthyroidism: KB62.0\\nOther transitory neonatal disorders of thyroid function not elsewhere classified: KB62.1\\nTransient hyperthyrotropinaemia: KB62.2\\nTransient hypothyroxinaemia: KB62.3\\nOther specified transitory neonatal disorders of thyroid function: KB62.Y\\nTransitory neonatal disorders of thyroid function unspecified: KB62.Z\\nCertain specified transitory neonatal electrolyte or metabolic disturbances: KB63\\nLate metabolic acidosis of newborn: KB63.0\\nDehydration of newborn: KB63.1\\nDisturbances of sodium balance of newborn: KB63.2\\nHyponatremia of newborn: KB63.20\\nHypernatremia of newborn: KB63.21\\nOther specified disturbances of sodium balance of newborn: KB63.2Y\\nDisturbances of sodium balance of newborn unspecified: KB63.2Z\\nDisturbances of potassium balance of newborn: KB63.3\\nHypokalaemia of newborn: KB63.30\\nHyperkalaemia of newborn: KB63.31\\nOther specified disturbances of potassium balance of newborn: KB63.3Y\\nDisturbances of potassium balance of newborn unspecified: KB63.3Z\\nTransitory tyrosinaemia of newborn: KB63.4\\nMetabolic bone disease of prematurity: KB63.5\\nTransitory neonatal hypoparathyroidism: KB64\\nTransitory endocrine or metabolic disorders specific to fetus or newborn unspecified: KB6Z\\nGastrooesophageal reflux disease in newborn: KB80\\nOesophagitis in newborn: KB81\\nNeonatal eosinophilic oesophagitis: KB81.0\\nOther specified oesophagitis in newborn: KB81.Y\\nOesophagitis in newborn unspecified: KB81.Z\\nPrenatal gastric perforation: KB82\\nPostnatal gastric perforation: KB83\\nPostnatal isolated ileal perforation: KB84\\nPrenatal intrauterine intestinal perforation: KB85\\nPrenatal intrauterine intestinal perforation due to in utero volvulus: KB85.0\\nPrenatal intrauterine intestinal perforation due to intestinal atresia or stenosis: KB85.1\\nPrenatal intrauterine intestinal perforation due to intraluminal obstruction: KB85.2\\nOther specified prenatal intrauterine intestinal perforation: KB85.Y\\nPrenatal intrauterine intestinal perforation unspecified: KB85.Z\\nPostnatal intestinal perforation: KB86\\nPostnatal intestinal perforation due to drugs: KB86.0\\nPostnatal intestinal perforation due to in utero volvulus: KB86.1\\nPostnatal intestinal perforation due to intestinal atresia or stenosis: KB86.2\\nPostnatal intestinal perforation due to intraluminal obstruction: KB86.3\\nOther specified postnatal intestinal perforation: KB86.Y\\nPostnatal intestinal perforation unspecified: KB86.Z\\nIntestinal obstruction of newborn: KB87\\nIntestinal obstruction due to inspissated milk: KB87.0\\nMeconium plug without ileus: KB87.1\\nMeconium ileus without perforation: KB87.2\\nTransitory ileus of newborn: KB87.3\\nMeconium ileus with perforation: KB87.4\\nOther specified intestinal obstruction of newborn: KB87.Y\\nIntestinal obstruction of newborn unspecified: KB87.Z\\nNecrotising enterocolitis of newborn: KB88\\nNecrotising enterocolitis of newborn Stage A  B: KB88.1\\nNecrotising enterocolitis of newborn Stage A: KB88.2\\nNecrotising enterocolitis of newborn Stage B: KB88.3\\nOther specified necrotising enterocolitis of newborn: KB88.Y\\nNecrotising enterocolitis of newborn unspecified: KB88.Z\\nNeonatal malabsorption syndromes: KB89\\nNeonatal malabsorption due to endocrine secreting tumour: KB89.0\\nShort bowel syndrome in neonate: KB89.1\\nOther specified neonatal malabsorption syndromes: KB89.Y\\nNeonatal malabsorption syndromes unspecified: KB89.Z\\nNeonatal haematemesis or melaena due to swallowed maternal blood: KB8A\\nNeonatal peritonitis: KB8B\\nNoninfectious neonatal diarrhoea: KB8C\\nOther specified digestive system disorders of fetus or newborn: KB8Y\\nDigestive system disorders of fetus or newborn unspecified: KB8Z\\nCongenital hydrocele: KC00\\nCongenital renal failure: KC01\\nOther specified genitourinary system disorders specific to the perinatal or neonatal period: KC0Y\\nGenitourinary system disorders specific to the perinatal or neonatal period unspecified: KC0Z\\nConditions involving the umbilical cord: KC20\\nDelayed separation of umbilical cord: KC20.0\\nUmbilical cutis or polyp of newborn: KC20.1\\nUmbilical granuloma of newborn: KC20.2\\nOther specified conditions involving the umbilical cord: KC20.Y\\nConditions involving the umbilical cord unspecified: KC20.Z\\nInflammatory dermatoses of the newborn: KC21\\nNeonatal acne: KC21.0\\nNeonatal toxic erythema: KC21.1\\nPerianal dermatitis of the newborn: KC21.2\\nOther specified inflammatory dermatoses of the newborn: KC21.Y\\nInflammatory dermatoses of the newborn unspecified: KC21.Z\\nNeonatal disorders of subcutaneous fat: KC22\\nSubcutaneous fat necrosis of the newborn: KC22.0\\nCold panniculitis of the newborn: KC22.1\\nSclerema neonatorum: KC22.2\\nOther specified neonatal disorders of subcutaneous fat: KC22.Y\\nNeonatal disorders of subcutaneous fat unspecified: KC22.Z\\nNeonatal disorders of the oral mucosa: KC23\\nNeonatal nutritional disorders affecting the skin: KC24\\nSkin fragility of prematurity: KC30\\nCongenital erosive or vesicular dermatosis healing with reticulated supple scarring: KC31\\nOther specified skin disorders associated with prematurity: KC3Y\\nMiscellaneous skin disorders in the neonate: KC40\\nCongenital sucking blisters: KC40.0\\nNeonatal milia: KC40.1\\nOther specified skin disorders in the neonate: KC40.Y\\nMiscellaneous specified conditions of integument specific to fetus or newborn: KC41\\nBreast engorgement of newborn: KC41.0\\nHydrops fetalis not due to haemolytic disease: KC41.1\\nOther specified conditions of integument specific to fetus and newborn: KC41.Y\\nNeonatal phototherapy burn: KC50\\nOther specified postnatal iatrogenic skin injury: KC5Y\\nPostnatal iatrogenic skin injury unspecified: KC5Z\\nOther specified iatrogenic injuries involving the skin of the neonate: KC7Y\\nDisorders involving the integument of fetus or newborn unspecified: KC9Z\\nEnvironmental hyperthermia of newborn: KD10\\nFever of newborn: KD11\\nHypothermia of newborn: KD12\\nNeonatal cold injury syndrome: KD12.0\\nOther specified hypothermia of newborn: KD12.Y\\nHypothermia of newborn unspecified: KD12.Z\\nOther specified disturbances of temperature regulation of newborn: KD1Y\\nDisturbances of temperature regulation of newborn unspecified: KD1Z\\nBirth depression: KD30\\nBirth depression with  minute Apgar score: KD30.1\\nBirth depression with associated metabolic acidaemia of cord blood: KD30.2\\nBirth depression unspecified: KD30.Z\\nWide cranial sutures of newborn: KD31\\nFeeding problems of newborn: KD32\\nSlow feeding of newborn: KD32.0\\nUnderfeeding of newborn: KD32.1\\nOverfeeding of newborn: KD32.2\\nNeonatal difficulty in feeding at breast: KD32.3\\nFailure to thrive in newborn: KD32.4\\nOther specified feeding problems of newborn: KD32.Y\\nFeeding problems of newborn unspecified: KD32.Z\\nJittery baby not elsewhere classified: KD33\\nReactions or intoxications due to drugs administered to fetus or newborn: KD34\\nNeonatal withdrawal syndrome from maternal use of drugs of addiction: KD35\\nWithdrawal symptoms from therapeutic use of drugs in newborn: KD36\\nExposure to tobacco smoke in the perinatal period: KD37\\nMeconium staining: KD38\\nComplications of intrauterine procedures not elsewhere classified: KD39\\nFetus or newborn affected by amniocentesis: KD39.0\\nFetus or newborn affected by chorionic villous sampling: KD39.1\\nFetus or newborn affected by fetal blood sampling: KD39.2\\nFetus or newborn affected by complications of fetal surgery: KD39.3\\nFetus or newborn affected by complications of intrauterine fetal surgery: KD39.4\\nOther specified complications of intrauterine procedures not elsewhere classified: KD39.Y\\nComplications of intrauterine procedures not elsewhere classified unspecified: KD39.Z\\nTermination of pregnancy affecting surviving fetus or newborn: KD3A\\nFetal death cause not specified: KD3B\\nAntepartum fetal death: KD3B.0\\nIntrapartum fetal death: KD3B.1\\nUnspecified time of fetal death cause not specified: KD3B.Z\\nVomiting in newborn: KD3C\\nBilious vomiting of newborn: KD3C.0\\nOther specified vomiting in newborn: KD3C.Y\\nVomiting in newborn unspecified: KD3C.Z\\nOther specified disorders originating in the perinatal period: KD3Y\\nConditions originating in the perinatal or neonatal period unspecified: KD5Z\\nAnencephaly or similar anomalies: LA00\\nAnencephaly: LA00.0\\nCraniorachischisis: LA00.00\\nOther specified anencephaly: LA00.0Y\\nAnencephaly unspecified: LA00.0Z\\nIniencephaly: LA00.1\\nAcephaly: LA00.2\\nAmyelencephaly: LA00.3\\nOther specified anencephaly or similar anomalies: LA00.Y\\nAnencephaly or similar anomalies unspecified: LA00.Z\\nCephalocele: LA01\\nSpina bifida: LA02\\nSpina bifida cystica: LA02.0\\nMyelomeningocele with hydrocephalus: LA02.00\\nMyelomeningocele without hydrocephalus: LA02.01\\nMyelocystocele: LA02.02\\nOther specified spina bifida cystica: LA02.0Y\\nSpina bifida cystica unspecified: LA02.0Z\\nSpina bifida aperta: LA02.1\\nOther specified spina bifida: LA02.Y\\nSpina bifida unspecified: LA02.Z\\nArnoldChiari malformation type II: LA03\\nCongenital hydrocephalus: LA04\\nHydrocephalus with stenosis of the aqueduct of Sylvius: LA04.0\\nOther specified congenital hydrocephalus: LA04.Y\\nCongenital hydrocephalus unspecified: LA04.Z\\nCerebral structural developmental anomalies: LA05\\nMicrocephaly: LA05.0\\nMegalencephaly: LA05.1\\nHoloprosencephaly: LA05.2\\nCorpus callosum agenesis: LA05.3\\nArrhinencephaly: LA05.4\\nAbnormal neuronal migration: LA05.5\\nPolymicrogyria: LA05.50\\nCortical dysplasia: LA05.51\\nOther specified abnormal neuronal migration: LA05.5Y\\nAbnormal neuronal migration unspecified: LA05.5Z\\nEncephaloclastic disorders: LA05.6\\nPorencephaly: LA05.60\\nSchizencephaly: LA05.61\\nHydranencephaly: LA05.62\\nOther specified encephaloclastic disorders: LA05.6Y\\nEncephaloclastic disorders unspecified: LA05.6Z\\nBrain cystic malformations: LA05.7\\nColpocephaly: LA05.8\\nOther specified cerebral structural developmental anomalies: LA05.Y\\nCerebral structural developmental anomalies unspecified: LA05.Z\\nCerebellar structural developmental anomalies: LA06\\nDandyWalker malformation: LA06.0\\nHypoplasia or agenesis of cerebellar hemispheres: LA06.1\\nFocal cerebellar dysplasia: LA06.2\\nOther specified cerebellar structural developmental anomalies: LA06.Y\\nCerebellar structural developmental anomalies unspecified: LA06.Z\\nStructural developmental anomalies of the neurenteric canal spinal cord or vertebral column: LA07\\nPrimary tethered cord syndrome: LA07.0\\nDiastematomyelia: LA07.1\\nAmyelia: LA07.2\\nPrimary syringomyelia or hydromyelia: LA07.3\\nArnoldChiari malformation type I: LA07.4\\nOther specified structural developmental anomalies of the neurenteric canal spinal cord or vertebral column: LA07.Y\\nStructural developmental anomalies of the neurenteric canal spinal cord or vertebral column unspecified: LA07.Z\\nOther specified structural developmental anomalies of the nervous system: LA0Y\\nStructural developmental anomalies of the nervous system unspecified: LA0Z\\nStructural developmental anomalies of ocular globes: LA10\\nMicrophthalmos: LA10.0\\nClinical anophthalmos: LA10.1\\nBuphthalmos: LA10.2\\nCongenital macrophthalmos: LA10.3\\nOther specified structural developmental anomalies of ocular globes: LA10.Y\\nStructural developmental anomalies of ocular globes unspecified: LA10.Z\\nStructural developmental anomalies of the anterior segment of eye: LA11\\nBlue sclera: LA11.0\\nStructural developmental anomalies of cornea: LA11.1\\nAnterior segment dysgenesis: LA11.2\\nAniridia: LA11.3\\nColoboma of iris: LA11.4\\nCongenital corneal opacity: LA11.5\\nStructural disorders of the pupil: LA11.6\\nIrregular pupil of the eye: LA11.60\\nIridoschisis: LA11.61\\nAnomalies of pupillary function: LA11.62\\nOther specified structural disorders of the pupil: LA11.6Y\\nStructural disorders of the pupil unspecified: LA11.6Z\\nOther specified structural developmental anomalies of the anterior segment of eye: LA11.Y\\nStructural developmental anomalies of the anterior segment of eye unspecified: LA11.Z\\nStructural developmental anomalies of lens or zonula: LA12\\nColoboma of lens: LA12.0\\nCongenital cataract: LA12.1\\nCongenital aphakia: LA12.2\\nSpherophakia: LA12.3\\nOther specified structural developmental anomalies of lens or zonula: LA12.Y\\nStructural developmental anomalies of lens or zonula unspecified: LA12.Z\\nStructural developmental anomalies of the posterior segment of eye: LA13\\nCongenital anomalies of the vitreous: LA13.0\\nColoboma of choroid or retina: LA13.1\\nColoboma of macula: LA13.2\\nCongenital vitreoretinal dysplasia: LA13.3\\nCongenital retinal aneurysm: LA13.5\\nCongenital malformations of choroid: LA13.6\\nCongenital malformation of optic disc: LA13.7\\nIsolated optic nerve hypoplasia: LA13.70\\nOptic nerve aplasia: LA13.71\\nCongenitally elevated optic disc: LA13.72\\nOptic disc dysplasia: LA13.73\\nMegalopapilla: LA13.74\\nColoboma of optic disc: LA13.76\\nOther specified congenital malformation of optic disc: LA13.7Y\\nCongenital malformation of optic disc unspecified: LA13.7Z\\nCertain congenital malformations of posterior segment of eye: LA13.8\\nAnastomosis of retinal or choroidal vessels: LA13.80\\nOther specified structural developmental anomalies of the posterior segment of eye: LA13.Y\\nStructural developmental anomalies of the posterior segment of eye unspecified: LA13.Z\\nStructural developmental anomalies of eyelid lacrimal apparatus or orbit: LA14\\nStructural developmental anomalies of eyelids: LA14.0\\nPalpebral cleft or coloboma: LA14.00\\nCryptophthalmia: LA14.01\\nCongenital entropion: LA14.02\\nCongenital ectropion: LA14.03\\nCongenital ptosis: LA14.04\\nCongenital eyelid retraction: LA14.05\\nEpibulbar choristoma: LA14.06\\nAnkyloblepharon filiforme adnatum: LA14.07\\nOther specified structural developmental anomalies of eyelids: LA14.0Y\\nStructural developmental anomalies of eyelids unspecified: LA14.0Z\\nStructural developmental anomalies of lacrimal apparatus: LA14.1\\nAplasia of lacrimal or salivary glands: LA14.10\\nAgenesis of lacrimal ducts: LA14.11\\nCongenital dacryocele: LA14.12\\nCongenital agenesis of lacrimal punctum: LA14.13\\nCongenital stenosis or stricture of lacrimal duct: LA14.14\\nOther specified structural developmental anomalies of lacrimal apparatus: LA14.1Y\\nStructural developmental anomalies of lacrimal apparatus unspecified: LA14.1Z\\nStructural developmental anomalies of orbit: LA14.2\\nOther specified structural developmental anomalies of eyelid lacrimal apparatus or orbit: LA14.Y\\nStructural developmental anomalies of eyelid lacrimal apparatus or orbit unspecified: LA14.Z\\nOther specified structural developmental anomalies of the eye eyelid or lacrimal apparatus: LA1Y\\nStructural developmental anomalies of the eye eyelid or lacrimal apparatus unspecified: LA1Z\\nStructural anomaly of eustachian apparatus: LA20\\nMinor anomalies of pinnae: LA21\\nMacrotia: LA21.0\\nProtruding ear: LA21.1\\nLowset ear: LA21.2\\nMisshapen ear: LA21.3\\nOther specified minor anomalies of pinnae: LA21.Y\\nMinor anomalies of pinnae unspecified: LA21.Z\\nStructural developmental anomalies of ear causing hearing impairment: LA22\\nMicrotia: LA22.0\\nAnotia: LA22.1\\nAplasia or hypoplasia of external auditory canal: LA22.2\\nStructural developmental anomalies of ear ossicles: LA22.3\\nStructural developmental anomalies of inner ear: LA22.4\\nOther specified structural developmental anomalies of ear causing hearing impairment: LA22.Y\\nStructural developmental anomalies of ear causing hearing impairment unspecified: LA22.Z\\nOtocephaly: LA23\\nAccessory auricle: LA24\\nOther specified structural developmental anomalies of the ear: LA2Y\\nStructural developmental anomalies of the ear unspecified: LA2Z\\nStructural developmental anomalies of teeth and periodontal tissues: LA30\\nAnodontia: LA30.0\\nHypodontia: LA30.1\\nOligodontia: LA30.2\\nHyperdontia: LA30.3\\nAbnormalities of size or form of teeth: LA30.4\\nAnomalies in tooth resorption or loss: LA30.5\\nEarly exfoliation of teeth: LA30.50\\nLate exfoliation of teeth: LA30.51\\nOther specified anomalies in tooth resorption or loss: LA30.5Y\\nAnomalies in tooth resorption or loss unspecified: LA30.5Z\\nAmelogenesis imperfecta: LA30.6\\nDentine dysplasia: LA30.7\\nDentinogenesis imperfecta: LA30.8\\nOdontogenesis imperfecta: LA30.9\\nOther specified structural developmental anomalies of teeth and periodontal tissues: LA30.Y\\nStructural developmental anomalies of teeth and periodontal tissues unspecified: LA30.Z\\nStructural developmental anomalies of mouth or tongue: LA31\\nCongenital macroglossia: LA31.0\\nHypoglossia or aglossia: LA31.1\\nAnkyloglossia: LA31.2\\nMacrostomia: LA31.3\\nMicrostomia: LA31.4\\nOther specified structural developmental anomalies of mouth or tongue: LA31.Y\\nStructural developmental anomalies of mouth or tongue unspecified: LA31.Z\\nCleft lip: LA40\\nCleft lip unilateral: LA40.0\\nCleft lip bilateral: LA40.1\\nCleft lip median: LA40.2\\nCleft lip unspecified: LA40.Z\\nCleft lip and alveolus: LA41\\nCleft lip and alveolus unilateral: LA41.0\\nCleft lip and alveolus bilateral: LA41.1\\nCleft lip and alveolus unspecified: LA41.Z\\nCleft palate: LA42\\nCleft hard palate: LA42.0\\nCleft soft palate: LA42.1\\nCleft uvula: LA42.2\\nCleft palate unspecified: LA42.Z\\nOther specified clefts of lip alveolus or palate: LA4Y\\nClefts of lip alveolus or palate unspecified: LA4Z\\nCongenital velopharyngeal incompetence: LA50\\nFacial clefts: LA51\\nFacial asymmetry: LA52\\nMacrocheilia: LA53\\nMicrocheilia: LA54\\nCompression facies: LA55\\nPierre Robin syndrome: LA56\\nOther specified structural developmental anomalies of the face: LA5Y\\nStructural developmental anomalies of the face unspecified: LA5Z\\nWebbed neck: LA60\\nCongenital sternomastoid tumour: LA61\\nCongenital torticollis: LA62\\nOther specified structural developmental anomalies of the neck: LA6Y\\nStructural developmental anomalies of the neck unspecified: LA6Z\\nStructural developmental anomalies of the nose or cavum: LA70\\nArrhinia: LA70.0\\nBifid nose: LA70.1\\nChoanal atresia: LA70.2\\nCongenital perforated nasal septum: LA70.3\\nOther specified structural developmental anomalies of the nose or cavum: LA70.Y\\nStructural developmental anomalies of the nose or cavum unspecified: LA70.Z\\nStructural developmental anomalies of larynx: LA71\\nCongenital laryngomalacia: LA71.0\\nLaryngocele: LA71.1\\nLaryngeal hypoplasia: LA71.2\\nCongenital subglottic stenosis: LA71.3\\nOther specified structural developmental anomalies of larynx: LA71.Y\\nStructural developmental anomalies of larynx unspecified: LA71.Z\\nLaryngotracheooesophageal cleft: LA72\\nStructural developmental anomalies of trachea: LA73\\nCongenital stenosis of trachea: LA73.0\\nCongenital tracheomalacia: LA73.1\\nOther specified structural developmental anomalies of trachea: LA73.Y\\nStructural developmental anomalies of trachea unspecified: LA73.Z\\nStructural developmental anomalies of bronchi: LA74\\nCongenital stenosis or atresia of bronchus: LA74.0\\nCongenital bronchomalacia: LA74.1\\nOther specified structural developmental anomalies of bronchi: LA74.Y\\nStructural developmental anomalies of bronchi unspecified: LA74.Z\\nStructural developmental anomalies of lungs: LA75\\nAccessory lobe of lung: LA75.0\\nAgenesis of lung: LA75.1\\nCongenital hypoplasia of lung: LA75.2\\nCongenital hyperplasia of lung: LA75.3\\nCongenital pulmonary airway malformations: LA75.4\\nCongenital lobar emphysema: LA75.5\\nCongenital sequestration of lung: LA75.6\\nOther specified structural developmental anomalies of lungs: LA75.Y\\nStructural developmental anomalies of lungs unspecified: LA75.Z\\nStructural developmental anomalies of pleura: LA76\\nCongenital cyst of mediastinum: LA77\\nOther specified structural developmental anomalies of the respiratory system: LA7Y\\nStructural developmental anomalies of the respiratory system unspecified: LA7Z\\nAnomalous positionorientation of heart: LA80\\nLaevocardia: LA80.0\\nDextrocardia: LA80.1\\nMesocardia: LA80.2\\nExtrathoracic heart: LA80.3\\nOther specified anomalous positionorientation of heart: LA80.Y\\nAnomalous positionorientation of heart unspecified: LA80.Z\\nAbnormal ventricular relationships: LA81\\nTotal mirror imagery: LA82\\nRight isomerism: LA83\\nLeft isomerism: LA84\\nCongenital anomaly of an atrioventricular or ventriculoarterial connection: LA85\\nDiscordant atrioventricular connections: LA85.0\\nCongenitally corrected transposition of great arteries: LA85.00\\nOther specified discordant atrioventricular connections: LA85.0Y\\nDiscordant atrioventricular connections unspecified: LA85.0Z\\nTransposition of the great arteries: LA85.1\\nDouble outlet right ventricle: LA85.2\\nDouble outlet right ventricle with subpulmonary ventricular septal defect transposition type: LA85.20\\nDouble outlet right ventricle with noncommitted ventricular septal defect: LA85.21\\nDouble outlet right ventricle with subaortic or doubly committed ventricular septal defect without pulmonary stenosis ventricular septal defect type: LA85.22\\nDouble outlet right ventricle with subaortic or doubly committed ventricular septal defect and pulmonary stenosis Fallot type: LA85.23\\nOther specified double outlet right ventricle: LA85.2Y\\nDouble outlet right ventricle unspecified: LA85.2Z\\nDouble outlet left ventricle: LA85.3\\nCommon arterial trunk: LA85.4\\nCommon arterial trunk with aortic dominance: LA85.40\\nCommon arterial trunk with pulmonary dominance and interrupted aortic arch: LA85.41\\nOther specified common arterial trunk: LA85.4Y\\nCommon arterial trunk unspecified: LA85.4Z\\nOther specified congenital anomaly of an atrioventricular or ventriculoarterial connection: LA85.Y\\nCongenital anomaly of an atrioventricular or ventriculoarterial connection unspecified: LA85.Z\\nCongenital anomaly of mediastinal vein: LA86\\nLeft superior caval vein: LA86.0\\nUnroofed coronary sinus: LA86.1\\nAnomalous pulmonary venous connection: LA86.2\\nTotal anomalous pulmonary venous connection: LA86.20\\nPartial anomalous pulmonary venous connection: LA86.21\\nScimitar syndrome: LA86.22\\nOther specified anomalous pulmonary venous connection: LA86.2Y\\nAnomalous pulmonary venous connection unspecified: LA86.2Z\\nCongenital pulmonary venous stenosis or hypoplasia: LA86.3\\nOther specified congenital anomaly of mediastinal vein: LA86.Y\\nCongenital anomaly of mediastinal vein unspecified: LA86.Z\\nCongenital anomaly of an atrioventricular valve or atrioventricular septum: LA87\\nCongenital anomaly of tricuspid valve: LA87.0\\nCongenital tricuspid regurgitation: LA87.00\\nCongenital tricuspid valvar stenosis: LA87.01\\nDysplasia of tricuspid valve: LA87.02\\nEbstein malformation of tricuspid valve: LA87.03\\nOther specified congenital anomaly of tricuspid valve: LA87.0Y\\nCongenital anomaly of tricuspid valve unspecified: LA87.0Z\\nCongenital anomaly of mitral valve: LA87.1\\nCongenital mitral regurgitation: LA87.10\\nCongenital mitral valvar stenosis: LA87.11\\nDysplasia of mitral valve: LA87.12\\nCongenital anomaly of mitral subvalvar apparatus: LA87.13\\nOther specified congenital anomaly of mitral valve: LA87.1Y\\nCongenital anomaly of mitral valve unspecified: LA87.1Z\\nCommon atrioventricular junction without an atrioventricular septal defect: LA87.3\\nCommon atrioventricular junction with atrioventricular septal defect: LA87.4\\nAtrioventricular septal defect with communication at the atrial level only: LA87.40\\nAtrioventricular septal defect with communication at the ventricular level only: LA87.41\\nAtrioventricular septal defect with communication at atrial level and restrictive communication at ventricular level: LA87.42\\nAtrioventricular septal defect with communication at atrial level and unrestrictive communication at ventricular level: LA87.43\\nAtrioventricular septal defect with ventricular imbalance: LA87.44\\nAtrioventricular septal defect and tetralogy of Fallot: LA87.45\\nOther specified common atrioventricular junction with atrioventricular septal defect: LA87.4Y\\nCommon atrioventricular junction with atrioventricular septal defect unspecified: LA87.4Z\\nOther specified congenital anomaly of an atrioventricular valve or atrioventricular septum: LA87.Y\\nCongenital anomaly of an atrioventricular valve or atrioventricular septum unspecified: LA87.Z\\nCongenital anomaly of a ventricle or the ventricular septum: LA88\\nCongenital right ventricular outflow tract obstruction: LA88.0\\nDouble chambered right ventricle: LA88.1\\nTetralogy of Fallot: LA88.2\\nTetralogy of Fallot with absent pulmonary valve syndrome: LA88.20\\nTetralogy of Fallot with pulmonary atresia: LA88.21\\nTetralogy of Fallot with pulmonary atresia and systemictopulmonary collateral artery: LA88.22\\nOther specified tetralogy of Fallot: LA88.2Y\\nTetralogy of Fallot unspecified: LA88.2Z\\nCongenital left ventricular outflow tract obstruction: LA88.3\\nVentricular septal defect: LA88.4\\nTrabecular muscular ventricular septal defect: LA88.40\\nPerimembranous central ventricular septal defect: LA88.41\\nVentricular septal defect haemodynamically insignificant: LA88.42\\nOther specified ventricular septal defect: LA88.4Y\\nVentricular septal defect unspecified: LA88.4Z\\nOther specified congenital anomaly of a ventricle or the ventricular septum: LA88.Y\\nCongenital anomaly of a ventricle or the ventricular septum unspecified: LA88.Z\\nFunctionally univentricular heart: LA89\\nDouble inlet atrioventricular connection: LA89.0\\nTricuspid atresia: LA89.1\\nMitral atresia: LA89.2\\nHypoplastic left heart syndrome: LA89.3\\nOther specified functionally univentricular heart: LA89.Y\\nFunctionally univentricular heart unspecified: LA89.Z\\nCongenital anomaly of a ventriculoarterial valve or adjacent regions: LA8A\\nCongenital anomaly of pulmonary valve: LA8A.0\\nCongenital pulmonary valvar stenosis: LA8A.00\\nCongenital pulmonary regurgitation: LA8A.01\\nOther specified congenital anomaly of pulmonary valve: LA8A.0Y\\nCongenital anomaly of pulmonary valve unspecified: LA8A.0Z\\nCongenital pulmonary atresia: LA8A.1\\nPulmonary atresia with intact ventricular septum: LA8A.10\\nOther specified congenital pulmonary atresia: LA8A.1Y\\nCongenital pulmonary atresia unspecified: LA8A.1Z\\nCongenital anomaly of aortic valve: LA8A.2\\nCongenital aortic valvar stenosis: LA8A.20\\nCongenital aortic regurgitation: LA8A.21\\nBicuspid aortic valve: LA8A.22\\nAortic valvar atresia: LA8A.23\\nUnicuspid aortic valve: LA8A.24\\nOther specified congenital anomaly of aortic valve: LA8A.2Y\\nCongenital anomaly of aortic valve unspecified: LA8A.2Z\\nCongenital supravalvar aortic stenosis: LA8A.3\\nAneurysm of aortic sinus of Valsalva: LA8A.4\\nCongenital subaortic stenosis: LA8A.5\\nCongenital subpulmonary stenosis: LA8A.6\\nOther specified congenital anomaly of a ventriculoarterial valve or adjacent regions: LA8A.Y\\nCongenital anomaly of a ventriculoarterial valve or adjacent regions unspecified: LA8A.Z\\nCongenital anomaly of great arteries including arterial duct: LA8B\\nCongenital aortopulmonary window: LA8B.0\\nCongenital anomaly of pulmonary arterial tree: LA8B.1\\nCongenital anomaly of aorta or its branches: LA8B.2\\nCoarctation of aorta: LA8B.21\\nInterrupted aortic arch: LA8B.22\\nCongenital anomaly of descending thoracic or abdominal aorta: LA8B.23\\nCongenital anomaly of aortic arch branch: LA8B.24\\nOther specified congenital anomaly of aorta or its branches: LA8B.2Y\\nCongenital anomaly of aorta or its branches unspecified: LA8B.2Z\\nTracheooesophageal compressive syndrome: LA8B.3\\nPatent arterial duct: LA8B.4\\nOther specified congenital anomaly of great arteries including arterial duct: LA8B.Y\\nCongenital anomaly of great arteries including arterial duct unspecified: LA8B.Z\\nCongenital anomaly of coronary artery: LA8C\\nAnomalous origin of coronary artery from pulmonary arterial tree: LA8C.0\\nAnomalous aortic origin or course of coronary artery: LA8C.1\\nCongenital coronary arterial fistula: LA8C.2\\nOther specified congenital anomaly of coronary artery: LA8C.Y\\nCongenital anomaly of coronary artery unspecified: LA8C.Z\\nCongenital pericardial anomaly: LA8D\\nCongenital anomaly of atrial septum: LA8E\\nPatent oval foramen: LA8E.0\\nAtrial septal defect within oval fossa: LA8E.1\\nSinus venosus defect: LA8E.2\\nInteratrial communication through coronary sinus orifice: LA8E.3\\nOther specified congenital anomaly of atrial septum: LA8E.Y\\nCongenital anomaly of atrial septum unspecified: LA8E.Z\\nCongenital anomaly of right atrium: LA8F\\nCongenital anomaly of left atrium: LA8G\\nDivided left atrium: LA8G.0\\nOther specified congenital anomaly of left atrium: LA8G.Y\\nCongenital anomaly of left atrium unspecified: LA8G.Z\\nOther specified structural developmental anomaly of heart or great vessels: LA8Y\\nStructural developmental anomaly of heart or great vessels unspecified: LA8Z\\nStructural developmental anomalies of the peripheral vascular system: LA90\\nCapillary malformations: LA90.0\\nHereditary haemorrhagic telangiectasia: LA90.00\\nOther specified capillary malformations: LA90.0Y\\nCapillary malformations unspecified: LA90.0Z\\nLymphatic malformations: LA90.1\\nMacrocystic lymphatic malformation: LA90.10\\nMicrocystic lymphatic malformation: LA90.11\\nLymphatic malformations of certain specified sites: LA90.12\\nCystic hygroma in fetus: LA90.13\\nOther specified lymphatic malformations: LA90.1Y\\nLymphatic malformations unspecified: LA90.1Z\\nPeripheral venous malformations: LA90.2\\nVein of Galen aneurysm: LA90.20\\nCongenital portosystemic shunt: LA90.21\\nOther specified peripheral venous malformations: LA90.2Y\\nPeripheral venous malformations unspecified: LA90.2Z\\nPeripheral arteriovenous malformations: LA90.3\\nPortal veinhepatic artery fistula: LA90.30\\nArteriovenous malformation of precerebral vessels: LA90.31\\nUterine arteriovenous malformations: LA90.32\\nOther specified peripheral arteriovenous malformations: LA90.3Y\\nPeripheral arteriovenous malformations unspecified: LA90.3Z\\nPeripheral arterial malformations: LA90.4\\nCongenital renal artery stenosis: LA90.40\\nCongenital precerebral nonruptured aneurysm: LA90.41\\nCongenital cerebral nonruptured aneurysm: LA90.42\\nOther specified peripheral arterial malformations: LA90.4Y\\nPeripheral arterial malformations unspecified: LA90.4Z\\nPulmonary arteriovenous fistula: LA90.5\\nOther specified structural developmental anomalies of the peripheral vascular system: LA90.Y\\nStructural developmental anomalies of the peripheral vascular system unspecified: LA90.Z\\nOther specified structural developmental anomalies of the circulatory system: LA9Y\\nStructural developmental anomalies of the circulatory system unspecified: LA9Z\\nStructural developmental anomalies of diaphragm: LB00\\nCongenital diaphragmatic hernia: LB00.0\\nAbsence of diaphragm: LB00.1\\nOther specified structural developmental anomalies of diaphragm: LB00.Y\\nStructural developmental anomalies of diaphragm unspecified: LB00.Z\\nOmphalocele: LB01\\nGastroschisis: LB02\\nStructural developmental anomalies of umbilical cord: LB03\\nAllantoic duct remnants or cysts: LB03.0\\nSingle umbilical cord artery: LB03.1\\nOther specified structural developmental anomalies of umbilical cord: LB03.Y\\nStructural developmental anomalies of umbilical cord unspecified: LB03.Z\\nOther specified structural developmental anomalies of the diaphragm abdominal wall or umbilical cord: LB0Y\\nStructural developmental anomalies of the diaphragm abdominal wall or umbilical cord unspecified: LB0Z\\nStructural developmental anomalies of salivary glands or ducts: LB10\\nCongenital diverticulum of pharynx: LB11\\nStructural developmental anomalies of oesophagus: LB12\\nCongenital oesophageal web or ring: LB12.0\\nAtresia of oesophagus: LB12.1\\nAtresia of oesophagus with oesophagobronchial fistula: LB12.10\\nOther specified atresia of oesophagus: LB12.1Y\\nAtresia of oesophagus unspecified: LB12.1Z\\nOesophageal fistula without atresia: LB12.2\\nCongenital stenosis or stricture of oesophagus: LB12.3\\nCongenital diverticulum of oesophagus: LB12.4\\nCongenital dilatation of oesophagus: LB12.5\\nOther specified structural developmental anomalies of oesophagus: LB12.Y\\nStructural developmental anomalies of oesophagus unspecified: LB12.Z\\nStructural developmental anomalies of stomach: LB13\\nCongenital hypertrophic pyloric stenosis: LB13.0\\nCongenital hiatus hernia: LB13.1\\nCongenital antral web: LB13.2\\nOther specified structural developmental anomalies of stomach: LB13.Y\\nStructural developmental anomalies of stomach unspecified: LB13.Z\\nStructural developmental anomalies of duodenum: LB14\\nStructural developmental anomalies of small intestine: LB15\\nMeckel diverticulum: LB15.0\\nAtresia of small intestine: LB15.1\\nCongenital short bowel: LB15.2\\nCongenital diverticulitis of small intestine: LB15.3\\nCongenital diverticulosis of small intestine: LB15.4\\nCongenital diverticulum of small intestine: LB15.5\\nOther specified structural developmental anomalies of small intestine: LB15.Y\\nStructural developmental anomalies of small intestine unspecified: LB15.Z\\nStructural developmental anomalies of large intestine: LB16\\nCongenital absence atresia or stenosis of large intestine: LB16.0\\nHirschsprung disease: LB16.1\\nImmature ganglionosis of large intestine: LB16.2\\nCongenital hypoganglionosis of large intestine: LB16.3\\nOther specified structural developmental anomalies of large intestine: LB16.Y\\nStructural developmental anomalies of large intestine unspecified: LB16.Z\\nStructural developmental anomalies of anal canal: LB17\\nAnorectal malformations: LB17.0\\nEctopic anus: LB17.1\\nPersistent cloaca: LB17.2\\nCloacal exstrophy: LB17.3\\nPerineal groove: LB17.4\\nOther specified structural developmental anomalies of anal canal: LB17.Y\\nStructural developmental anomalies of anal canal unspecified: LB17.Z\\nCongenital anomalies of intestinal fixation: LB18\\nOther specified structural developmental anomalies of the digestive tract: LB1Y\\nStructural developmental anomalies of the digestive tract unspecified: LB1Z\\nStructural developmental anomalies of gallbladder bile ducts or liver: LB20\\nStructural developmental anomalies of liver: LB20.0\\nFibropolycystic liver disease: LB20.00\\nOther specified structural developmental anomalies of liver: LB20.0Y\\nStructural developmental anomalies of liver unspecified: LB20.0Z\\nStructural developmental anomalies of gallbladder: LB20.1\\nAgenesis aplasia or hypoplasia of gallbladder: LB20.10\\nOther specified structural developmental anomalies of gallbladder: LB20.1Y\\nStructural developmental anomalies of gallbladder unspecified: LB20.1Z\\nStructural developmental anomalies of bile ducts: LB20.2\\nCholedochal cyst: LB20.20\\nBiliary atresia: LB20.21\\nCongenital stenosis or stricture of bile ducts: LB20.22\\nStructural developmental anomalies of cystic duct: LB20.23\\nAccessory bile duct: LB20.24\\nOther specified structural developmental anomalies of bile ducts: LB20.2Y\\nStructural developmental anomalies of bile ducts unspecified: LB20.2Z\\nOther specified structural developmental anomalies of gallbladder bile ducts or liver: LB20.Y\\nStructural developmental anomalies of gallbladder bile ducts or liver unspecified: LB20.Z\\nStructural developmental anomalies of pancreas: LB21\\nAnnular pancreas: LB21.0\\nPancreas divisum: LB21.1\\nAccessory pancreas: LB21.2\\nAgenesisaplasia of pancreas: LB21.3\\nPartial agenesis of pancreas: LB21.4\\nHypoplasia of pancreas: LB21.5\\nOther specified structural developmental anomalies of pancreas: LB21.Y\\nStructural developmental anomalies of pancreas unspecified: LB21.Z\\nStructural developmental anomalies of spleen: LB22\\nCongenital asplenia: LB22.0\\nPolysplenia: LB22.1\\nEctopic spleen: LB22.2\\nOther specified structural developmental anomalies of spleen: LB22.Y\\nStructural developmental anomalies of spleen unspecified: LB22.Z\\nOther specified structural developmental anomalies of the liver biliary tract pancreas or spleen: LB2Y\\nStructural developmental anomalies of the liver biliary tract pancreas or spleen unspecified: LB2Z\\nStructural developmental anomalies of kidneys: LB30\\nRenal agenesis or other reduction defects of kidney: LB30.0\\nRenal agenesis: LB30.00\\nOther specified renal agenesis or other reduction defects of kidney: LB30.0Y\\nRenal agenesis or other reduction defects of kidney unspecified: LB30.0Z\\nRenal dysplasia: LB30.1\\nCongenital single renal cyst: LB30.2\\nRenal tubular dysgenesis: LB30.3\\nOligomeganephronia: LB30.4\\nAccessory kidney: LB30.5\\nFusion anomaly of kidneys: LB30.6\\nLobulated kidney: LB30.60\\nFused pelvic kidney: LB30.61\\nHorseshoe kidney: LB30.62\\nOther specified fusion anomaly of kidneys: LB30.6Y\\nFusion anomaly of kidneys unspecified: LB30.6Z\\nEctopic or pelvic kidney: LB30.7\\nMedullary sponge kidney: LB30.8\\nMulticystic renal dysplasia: LB30.9\\nOther specified structural developmental anomalies of kidneys: LB30.Y\\nStructural developmental anomalies of kidneys unspecified: LB30.Z\\nStructural developmental anomalies of urinary tract: LB31\\nCongenital hydronephrosis: LB31.0\\nCongenital primary megaureter: LB31.1\\nFetal lower urinary tract obstruction: LB31.2\\nExstrophy of urinary bladder: LB31.3\\nCongenital diverticulum of urinary bladder: LB31.4\\nDuplication of urethra: LB31.5\\nCongenital megalourethra: LB31.6\\nMegacystismegaureter: LB31.7\\nAtresia or stenosis of ureter: LB31.8\\nAgenesis of ureter: LB31.9\\nDuplication of ureter: LB31.A\\nMalposition of ureter: LB31.B\\nCongenital absence of bladder or urethra: LB31.C\\nCongenital vesicoureterorenal reflux: LB31.D\\nOther specified structural developmental anomalies of urinary tract: LB31.Y\\nStructural developmental anomalies of urinary tract unspecified: LB31.Z\\nOther specified structural developmental anomalies of the urinary system: LB3Y\\nStructural developmental anomalies of the urinary system unspecified: LB3Z\\nStructural developmental anomalies of vulva: LB40\\nAbsence of vulva: LB40.0\\nEmbryonic cyst of vulva: LB40.1\\nFusion of labia: LB40.2\\nOther specified structural developmental anomalies of vulva: LB40.Y\\nStructural developmental anomalies of vulva unspecified: LB40.Z\\nStructural developmental anomalies of clitoris: LB41\\nAgenesis of clitoris: LB41.0\\nDuplication of clitoris: LB41.1\\nClitoromegaly: LB41.2\\nOther specified structural developmental anomalies of clitoris: LB41.Y\\nStructural developmental anomalies of clitoris unspecified: LB41.Z\\nStructural developmental anomalies of vagina: LB42\\nAbsence of vagina: LB42.0\\nSeptate vagina: LB42.1\\nCongenital rectovaginal fistula: LB42.2\\nTight hymenal ring: LB42.3\\nImperforate hymen: LB42.4\\nStricture or atresia of vagina: LB42.5\\nOther specified structural developmental anomalies of vagina: LB42.Y\\nStructural developmental anomalies of vagina unspecified: LB42.Z\\nStructural developmental anomalies of cervix uteri: LB43\\nEmbryonic cyst of cervix: LB43.0\\nAgenesis or aplasia of cervix: LB43.1\\nOther specified structural developmental anomalies of cervix uteri: LB43.Y\\nStructural developmental anomalies of cervix uteri unspecified: LB43.Z\\nStructural developmental anomalies of uterus except cervix: LB44\\nAgenesis or aplasia of uterine body: LB44.0\\nHypoplasia of uterus: LB44.1\\nUnicornuate uterus: LB44.2\\nBicornuate uterus: LB44.3\\nSeptate uterus: LB44.4\\nCongenital fistulae between uterus and digestive and urinary tracts: LB44.5\\nUterovaginal malformation due to diethylstilbestrol syndrome: LB44.6\\nOther specified structural developmental anomalies of uterus except cervix: LB44.Y\\nStructural developmental anomalies of uterus except cervix unspecified: LB44.Z\\nStructural developmental anomalies of ovaries fallopian tubes or broad ligaments: LB45\\nCongenital absence of ovary: LB45.0\\nXX gonadal dysgenesis: LB45.1\\nDevelopmental ovarian cyst: LB45.2\\nCongenital torsion of ovary: LB45.3\\nAccessory ovary: LB45.4\\nCongenital absence of fallopian tube: LB45.5\\nAtresia of fallopian tube: LB45.6\\nAccessory fallopian tube: LB45.7\\nEmbryonic cyst of fallopian tube: LB45.8\\nEmbryonic cyst of broad ligament: LB45.9\\nOther specified structural developmental anomalies of ovaries fallopian tubes or broad ligaments: LB45.Y\\nStructural developmental anomalies of ovaries fallopian tubes or broad ligaments unspecified: LB45.Z\\nOther specified structural developmental anomalies of the female genital system: LB4Y\\nStructural developmental anomalies of the female genital system unspecified: LB4Z\\nMicropenis or penis agenesis: LB50\\nAnorchia or microorchidia: LB51\\nCryptorchidism: LB52\\nEctopic testis: LB52.0\\nUndescended testicle unilateral: LB52.1\\nUndescended testicle bilateral: LB52.2\\nOther specified cryptorchidism: LB52.Y\\nCryptorchidism unspecified: LB52.Z\\nHypospadias: LB53\\nHypospadias balanic: LB53.0\\nHypospadias coronal: LB53.00\\nHypospadias glandular: LB53.01\\nOther specified hypospadias balanic: LB53.0Y\\nHypospadias balanic unspecified: LB53.0Z\\nHypospadias penile: LB53.1\\nHypospadias penoscrotal: LB53.2\\nHypospadias scrotal: LB53.3\\nHypospadias perineal: LB53.4\\nOther specified hypospadias: LB53.Y\\nHypospadias unspecified: LB53.Z\\nCongenital chordee: LB54\\nEpispadias: LB55\\nBifid scrotum: LB56\\nAgenesis of vas deferens: LB57\\nPolyorchidism: LB58\\nHypoplasia of testis or scrotum: LB59\\nOther specified structural developmental anomalies of the male genital system: LB5Y\\nStructural developmental anomalies of the male genital system unspecified: LB5Z\\nBreast aplasia: LB60\\nAbsent nipple: LB61\\nSupernumerary breasts: LB62\\nAccessory nipple: LB63\\nOther specified structural developmental anomalies of the breast: LB6Y\\nStructural developmental anomalies of the breast unspecified: LB6Z\\nStructural developmental anomalies of cranium: LB70\\nCraniosynostosis: LB70.0\\nPlagiocephaly: LB70.00\\nOther specified craniosynostosis: LB70.0Y\\nCraniosynostosis unspecified: LB70.0Z\\nWormian bones: LB70.1\\nJshaped sella turcica: LB70.2\\nMacrocephaly: LB70.3\\nOther specified structural developmental anomalies of cranium: LB70.Y\\nStructural developmental anomalies of cranium unspecified: LB70.Z\\nStructural developmental anomalies of facial bones: LB71\\nHypotelorism: LB71.0\\nHypertelorism: LB71.1\\nOther specified structural developmental anomalies of facial bones: LB71.Y\\nStructural developmental anomalies of facial bones unspecified: LB71.Z\\nStructural developmental anomalies of shoulder girdle: LB72\\nCervical rib: LB72.0\\nSprengel deformity: LB72.1\\nDeformation of scapula: LB72.2\\nOther specified structural developmental anomalies of shoulder girdle: LB72.Y\\nStructural developmental anomalies of shoulder girdle unspecified: LB72.Z\\nStructural developmental anomalies of spine or bony thorax: LB73\\nOccult spinal dysraphism: LB73.0\\nStructural developmental anomalies of chest wall: LB73.1\\nPoland syndrome: LB73.10\\nBifid rib: LB73.11\\nAccessory rib: LB73.12\\nStructural developmental anomalies of sternum: LB73.13\\nOther specified structural developmental anomalies of chest wall: LB73.1Y\\nStructural developmental anomalies of chest wall unspecified: LB73.1Z\\nStructural developmental anomalies of spine: LB73.2\\nKlippelFeil anomaly: LB73.20\\nOccipitalisation of atlas: LB73.21\\nAtlantoaxial instability or subluxation: LB73.22\\nAplasia or hypoplasia of the odontoid process of axis: LB73.23\\nSegmentation anomalies of vertebrae: LB73.24\\nCongenital scoliosis due to congenital bony malformation: LB73.25\\nSacralisation of the last lumbar vertebra: LB73.26\\nLumbarisation of the first sacral vertebra: LB73.27\\nSacrum agenesis or hypoplasia: LB73.28\\nCaudal appendage: LB73.29\\nCongenital spondylolisthesis: LB73.2A\\nOther specified structural developmental anomalies of spine: LB73.2Y\\nStructural developmental anomalies of spine unspecified: LB73.2Z\\nOther specified structural developmental anomalies of spine or bony thorax: LB73.Y\\nStructural developmental anomalies of spine or bony thorax unspecified: LB73.Z\\nStructural developmental anomalies of pelvic girdle: LB74\\nDevelopmental dysplasia of hip: LB74.0\\nCongenital subluxation of hip: LB74.1\\nUnstable hip: LB74.2\\nCongenital coxa vara: LB74.3\\nCongenital coxa valga: LB74.4\\nWide symphysis pubis: LB74.5\\nOther specified structural developmental anomalies of pelvic girdle: LB74.Y\\nStructural developmental anomalies of pelvic girdle unspecified: LB74.Z\\nBrachydactyly: LB75\\nBrachydactyly of fingers: LB75.0\\nBrachydactyly of toes: LB75.1\\nSymbrachydactyly of hands or feet: LB75.2\\nOther specified brachydactyly: LB75.Y\\nBrachydactyly unspecified: LB75.Z\\nTriphalangeal thumb: LB76\\nHyperphalangy: LB77\\nPolydactyly: LB78\\nPolydactyly of the thumb: LB78.0\\nPolysyndactyly: LB78.1\\nPostaxial polydactyly of fingers: LB78.2\\nPolydactyly of toes: LB78.3\\nOther specified polydactyly: LB78.Y\\nPolydactyly unspecified: LB78.Z\\nSyndactyly: LB79\\nFused fingers: LB79.0\\nWebbed fingers: LB79.1\\nFused toes: LB79.2\\nWebbed toes: LB79.3\\nOther specified syndactyly: LB79.Y\\nSyndactyly unspecified: LB79.Z\\nCongenital deformities of fingers: LB80\\nClinodactyly of fingers: LB80.0\\nRadial deviation of fingers: LB80.2\\nOther specified congenital deformities of fingers: LB80.Y\\nCongenital deformities of fingers unspecified: LB80.Z\\nCongenital deformities of toes: LB81\\nClinodactyly of toes: LB81.0\\nOther specified congenital deformities of toes: LB81.Y\\nCongenital deformities of toes unspecified: LB81.Z\\nJoint formation defects: LB90\\nHumeroradioulnar synostosis: LB90.0\\nHumeroradial synostosis: LB90.1\\nHumeroulnar synostosis: LB90.2\\nRadioulnar synostosis: LB90.3\\nMadelung deformity: LB90.4\\nCongenital digital clubbing: LB90.5\\nTibiofibular synostosis: LB90.6\\nCubitus valgus: LB90.7\\nCubitus varus: LB90.8\\nOther specified joint formation defects: LB90.Y\\nJoint formation defects unspecified: LB90.Z\\nCongenital shoulder dislocation: LB91\\nCongenital elbow dislocation: LB92\\nCongenital knee dislocation: LB93\\nCongenital genu recurvatum: LB93.0\\nCongenital genu flexum: LB93.1\\nOther specified congenital knee dislocation: LB93.Y\\nCongenital knee dislocation unspecified: LB93.Z\\nCongenital patella dislocation: LB94\\nPatella aplasia or hypoplasia: LB95\\nCongenital bowing of long bones: LB96\\nCongenital bowing of femur: LB96.0\\nCongenital bowing of tibia: LB96.1\\nOther specified congenital bowing of long bones: LB96.Y\\nCongenital bowing of long bones unspecified: LB96.Z\\nLimb overgrowth: LB97\\nMacrodactyly of fingers: LB97.0\\nMacrodactyly of toes: LB97.1\\nUpper limb hypertrophy: LB97.2\\nLower limb hypertrophy: LB97.3\\nOther specified limb overgrowth: LB97.Y\\nLimb overgrowth unspecified: LB97.Z\\nCongenital deformities of feet: LB98\\nCongenital varus deformities of feet: LB98.0\\nTalipes equinovarus: LB98.00\\nTalipes calcaneovarus: LB98.01\\nMetatarsus varus: LB98.02\\nOther specified congenital varus deformities of feet: LB98.0Y\\nCongenital varus deformities of feet unspecified: LB98.0Z\\nCongenital pes planus: LB98.1\\nCongenital valgus deformities of feet: LB98.2\\nCongenital hallux valgus: LB98.20\\nMetatarsus valgus: LB98.21\\nTalipes calcaneovalgus: LB98.22\\nOther specified congenital valgus deformities of feet: LB98.2Y\\nCongenital valgus deformities of feet unspecified: LB98.2Z\\nCongenital pes cavus: LB98.3\\nCongenital vertical talus: LB98.4\\nCongenital hammer toe: LB98.5\\nOther specified congenital deformities of feet: LB98.Y\\nCongenital deformities of feet unspecified: LB98.Z\\nReduction defects of upper limb: LB99\\nAmelia of upper limb: LB99.0\\nHumeral agenesis or hypoplasia: LB99.1\\nRadial hemimelia: LB99.2\\nUlnar hemimelia: LB99.3\\nCongenital absence of upper arm or forearm with hand present: LB99.4\\nCongenital absence of both forearm and hand: LB99.5\\nAcheiria: LB99.6\\nAdactyly of hands: LB99.7\\nSplit hand: LB99.8\\nOther specified reduction defects of upper limb: LB99.Y\\nReduction defects of upper limb unspecified: LB99.Z\\nReduction defects of lower limb: LB9A\\nAmelia of lower limb: LB9A.0\\nTibial hemimelia: LB9A.1\\nFibular hemimelia: LB9A.2\\nCongenital absence of thigh or lower leg with foot present: LB9A.3\\nApodia: LB9A.4\\nAdactyly of feet: LB9A.5\\nSplit foot: LB9A.6\\nCongenital absence of both lower leg and foot: LB9A.7\\nFemoral agenesis or hypoplasia: LB9A.8\\nOther specified reduction defects of lower limb: LB9A.Y\\nReduction defects of lower limb unspecified: LB9A.Z\\nReduction defects of upper and lower limbs: LB9B\\nOther specified structural developmental anomalies of the skeleton: LB9Y\\nStructural developmental anomalies of the skeleton unspecified: LB9Z\\nKeratinocytic epidermal hamartoma: LC00\\nEpidermal naevus: LC00.0\\nOther specified keratinocytic epidermal hamartoma: LC00.Y\\nKeratinocytic epidermal hamartoma unspecified: LC00.Z\\nPilosebaceous hamartoma: LC01\\nComplex epidermal hamartoma: LC02\\nOther specified developmental hamartomata of the epidermis and epidermal appendages: LC0Y\\nDermal melanocytosis: LC10\\nOther specified developmental anomalies of skin pigmentation: LC1Y\\nConnective tissue hamartoma: LC20\\nOther specified hamartomata derived from dermal connective tissue: LC2Y\\nDevelopmental defects of hair or hair growth: LC30\\nDevelopmental defects of the nail apparatus: LC31\\nDermoid cyst: LC40\\nDevelopmental capillary vascular malformations of the skin: LC50\\nSalmon patch: LC50.0\\nPortwine stain: LC50.1\\nOther specified developmental capillary vascular malformations of the skin: LC50.Y\\nDevelopmental venous malformations involving the skin: LC51\\nComplex or combined developmental vascular malformations involving the skin: LC52\\nOther specified developmental anomalies of cutaneous vasculature: LC5Y\\nDevelopmental anomalies of cutaneous vasculature unspecified: LC5Z\\nAplasia cutis congenita: LC60\\nOther specified structural developmental anomalies of the skin: LC7Y\\nStructural developmental anomalies of the skin unspecified: LC7Z\\nCongenital adrenal hypoplasia: LC80\\nOther specified structural developmental anomalies of the adrenal glands: LC8Y\\nStructural developmental anomalies of the adrenal glands unspecified: LC8Z\\nOther specified structural developmental anomalies primarily affecting one body system: LD0Y\\nStructural developmental anomalies primarily affecting one body system unspecified: LD0Z\\nSyndromes with central nervous system anomalies as a major feature: LD20\\nSyndromes with cerebellar anomalies as a major feature: LD20.0\\nJoubert syndrome: LD20.00\\nPontocerebellar hypoplasia: LD20.01\\nOther specified syndromes with cerebellar anomalies as a major feature: LD20.0Y\\nSyndromes with cerebellar anomalies as a major feature unspecified: LD20.0Z\\nSyndromes with lissencephaly as a major feature: LD20.1\\nSyndromes with microcephaly as a major feature: LD20.2\\nSyndromes with holoprosencephaly as a major feature: LD20.3\\nSyndromes with brain calcifications as a major feature: LD20.4\\nOther specified syndromes with central nervous system anomalies as a major feature: LD20.Y\\nSyndromes with central nervous system anomalies as a major feature unspecified: LD20.Z\\nSyndromes with eye anomalies as a major feature: LD21\\nSyndromes with microphthalmia as a major feature: LD21.0\\nOther specified syndromes with eye anomalies as a major feature: LD21.Y\\nSyndromes with eye anomalies as a major feature unspecified: LD21.Z\\nSyndromes with dental anomalies as a major feature: LD22\\nSyndromes with vascular anomalies as a major feature: LD23\\nSyndromes with skeletal anomalies as a major feature: LD24\\nSyndromes with micromelia: LD24.0\\nAchondroplasia: LD24.00\\nHypochondroplasia: LD24.01\\nThanatophoric dysplasia: LD24.02\\nDiastrophic dysplasia: LD24.03\\nChondrodysplasia punctata: LD24.04\\nOther specified syndromes with micromelia: LD24.0Y\\nSyndromes with micromelia unspecified: LD24.0Z\\nBone diseases with increased bone density: LD24.1\\nOsteopetrosis: LD24.10\\nOsteopoikilosis: LD24.11\\nOther specified bone diseases with increased bone density: LD24.1Y\\nBone diseases with increased bone density unspecified: LD24.1Z\\nBone diseases with disorganised development of skeletal components: LD24.2\\nMultiple osteochondromas: LD24.20\\nExostoses with anetodermia and brachydactyly type E: LD24.21\\nCherubism: LD24.22\\nYunisVaron disease: LD24.23\\nOther specified bone diseases with disorganised development of skeletal components: LD24.2Y\\nBone diseases with disorganised development of skeletal components unspecified: LD24.2Z\\nSpondyloepiphyseal or spondyloepimetaphyseal dysplasias: LD24.3\\nSpondylometaphyseal dysplasias: LD24.4\\nSpondylodysplastic dysplasias: LD24.5\\nAchondrogenesis: LD24.50\\nHypochondrogenesis: LD24.51\\nOther specified spondylodysplastic dysplasias: LD24.5Y\\nSpondylodysplastic dysplasias unspecified: LD24.5Z\\nMultiple epiphyseal dysplasia or pseudoachondroplasia: LD24.6\\nPseudoachondroplasia: LD24.60\\nMultiple epiphyseal dysplasias: LD24.61\\nOther specified multiple epiphyseal dysplasia or pseudoachondroplasia: LD24.6Y\\nMultiple metaphyseal dysplasias: LD24.7\\nAcromelic dysplasias: LD24.8\\nLangerGiedion syndrome: LD24.80\\nOther specified acromelic dysplasias: LD24.8Y\\nAcromelic dysplasias unspecified: LD24.8Z\\nAcromesomelic dysplasias: LD24.9\\nMesomelic or rhizomesomelic dysplasias: LD24.A\\nShort rib syndromes: LD24.B\\nShort ribpolydactyly syndrome: LD24.B0\\nAsphyxiating thoracic dystrophy: LD24.B1\\nOther specified short rib syndromes: LD24.BY\\nShort rib syndromes unspecified: LD24.BZ\\nBent bone dysplasias: LD24.C\\nSlender bone dysplasias: LD24.D\\nBone dysplasias with multiple joint dislocations: LD24.E\\nProgressive ossification of skin skeletal muscle fascia tendons or ligaments: LD24.F\\nSyndromic craniosynostoses: LD24.G\\nPfeiffer syndrome: LD24.G0\\nCrouzon disease: LD24.G1\\nApert syndrome: LD24.G2\\nOther specified syndromic craniosynostoses: LD24.GY\\nSyndromic craniosynostoses unspecified: LD24.GZ\\nDysostoses with predominant vertebral and costal involvement: LD24.H\\nPatellar dysostoses: LD24.J\\nNailpatella syndrome: LD24.J0\\nOther specified patellar dysostoses: LD24.JY\\nPatellar dysostoses unspecified: LD24.JZ\\nGenetic bone diseases with decreased bone density: LD24.K\\nOsteogenesis imperfecta: LD24.K0\\nOther specified genetic bone diseases with decreased bone density: LD24.KY\\nGenetic bone diseases with decreased bone density unspecified: LD24.KZ\\nOther specified syndromes with skeletal anomalies as a major feature: LD24.Y\\nSyndromes with skeletal anomalies as a major feature unspecified: LD24.Z\\nSyndromes with face or limb anomalies as a major feature: LD25\\nOromandibularlimb anomaly syndrome: LD25.0\\nOralfacialdigital syndrome: LD25.00\\nOther specified oromandibularlimb anomaly syndrome: LD25.0Y\\nOromandibularlimb anomaly syndrome unspecified: LD25.0Z\\nFrontootopalatodigital syndromes: LD25.1\\nAcrofacial dysostoses: LD25.2\\nCraniofacial dysostoses: LD25.3\\nOther specified syndromes with face or limb anomalies as a major feature: LD25.Y\\nSyndromes with face or limb anomalies as a major feature unspecified: LD25.Z\\nSyndromes with limb anomalies as a major feature: LD26\\nCombined reduction defects of upper and lower limbs: LD26.0\\nComplex brachydactylies: LD26.1\\nSyndromes with limb duplication polydactyly syndactyly or triphalangism: LD26.2\\nSyndromes with synostoses of limbs: LD26.3\\nArthrogryposis syndromes: LD26.4\\nMultiple pterygium syndrome: LD26.40\\nArthrogryposis multiplex congenita: LD26.41\\nOther specified arthrogryposis syndromes: LD26.4Y\\nArthrogryposis syndromes unspecified: LD26.4Z\\nConstriction rings: LD26.5\\nCongenital vascular bone syndromes: LD26.6\\nAngioosteohypertrophic syndrome: LD26.60\\nOther specified congenital vascular bone syndromes: LD26.6Y\\nCongenital vascular bone syndromes unspecified: LD26.6Z\\nOther specified syndromes with limb anomalies as a major feature: LD26.Y\\nSyndromes with limb anomalies as a major feature unspecified: LD26.Z\\nSyndromes with skin or mucosal anomalies as a major feature: LD27\\nEctodermal dysplasia syndromes: LD27.0\\nIncontinentia pigmenti: LD27.00\\nCronkhiteCanada syndrome: LD27.01\\nHypohidrotic ectodermal dysplasia: LD27.02\\nHidrotic ectodermal dysplasia Clouston type: LD27.03\\nOther specified ectodermal dysplasia syndromes: LD27.0Y\\nEctodermal dysplasia syndrome unspecified: LD27.0Z\\nXeroderma pigmentosum: LD27.1\\nSyndromic ichthyosis: LD27.2\\nGenetic syndromes with hypertrichosis: LD27.3\\nGenetic syndromes affecting nails: LD27.4\\nGenetic hamartoneoplastic syndromes affecting the skin: LD27.5\\nGenetic lipodystrophy: LD27.6\\nCongenital generalised lipodystrophy: LD27.60\\nGenetic lipodystrophy unspecified: LD27.6Z\\nOther specified syndromes with skin or mucosal anomalies as a major feature: LD27.Y\\nSyndromes with skin or mucosal anomalies as a major feature unspecified: LD27.Z\\nSyndromes with connective tissue involvement as a major feature: LD28\\nMarfan syndrome or Marfanrelated disorders: LD28.0\\nCongenital contractural arachnodactyly: LD28.00\\nMarfan syndrome: LD28.01\\nOther specified Marfan syndrome or Marfanrelated disorders: LD28.0Y\\nMarfan syndrome or Marfanrelated disorders unspecified: LD28.0Z\\nEhlersDanlos syndrome: LD28.1\\nEhlersDanlos syndrome classical type: LD28.10\\nOther specified types of EhlersDanlos syndrome: LD28.1Y\\nEhlersDanlos syndrome unspecified: LD28.1Z\\nGeneticallydetermined cutis laxa: LD28.2\\nOther specified syndromes with connective tissue involvement as a major feature: LD28.Y\\nSyndromes with connective tissue involvement as a major feature unspecified: LD28.Z\\nSyndromes with obesity as a major feature: LD29\\nMalformative disorders of sex development: LD2A\\nOvotesticular disorder of sex development: LD2A.0\\nXY gonadal dysgenesis: LD2A.1\\nTesticular agenesis: LD2A.2\\nXY disorder of sex development due to a defect in testosterone metabolism: LD2A.3\\nXY disorder of sex development due to androgen resistance: LD2A.4\\nOther specified malformative disorders of sex development: LD2A.Y\\nMalformative disorders of sex development unspecified: LD2A.Z\\nSyndromes with premature ageing appearance as a major feature: LD2B\\nOvergrowth syndromes: LD2C\\nPhakomatoses or hamartoneoplastic syndromes: LD2D\\nPeutzJeghers syndrome: LD2D.0\\nNeurofibromatoses: LD2D.1\\nNeurofibromatosis type: LD2D.12\\nOther specified neurofibromatoses: LD2D.1Y\\nNeurofibromatosis unspecified: LD2D.1Z\\nTuberous sclerosis: LD2D.2\\nGardner syndrome: LD2D.3\\nGorlin syndrome: LD2D.4\\nOther specified phakomatoses or hamartoneoplastic syndromes: LD2D.Y\\nPhakomatoses or hamartoneoplastic syndromes unspecified: LD2D.Z\\nSyndromes with structural anomalies due to inborn errors of metabolism: LD2E\\nSyndromes with multiple structural anomalies without predominant body system involvement: LD2F\\nToxic or drugrelated embryofetopathies: LD2F.0\\nFetal alcohol syndrome: LD2F.00\\nFetal hydantoin syndrome: LD2F.01\\nEmbryofetopathy due to oral anticoagulant therapy: LD2F.02\\nFetal Valproate Spectrum Disorder: LD2F.03\\nOther specified toxic or drugrelated embryofetopathies: LD2F.0Y\\nToxic or drugrelated embryofetopathies unspecified: LD2F.0Z\\nSyndromes with multiple structural anomalies not of environmental origin: LD2F.1\\nPrune belly syndrome: LD2F.10\\nVATER association: LD2F.11\\nSirenomelia: LD2F.12\\nMeckelGruber syndrome: LD2F.13\\nMURCS association: LD2F.14\\nNoonan syndrome: LD2F.15\\nOtomandibular dysplasia: LD2F.16\\nOther specified syndromes with multiple structural anomalies not of environmental origin: LD2F.1Y\\nSyndromes with multiple structural anomalies not of environmental origin unspecified: LD2F.1Z\\nOther specified syndromes with multiple structural anomalies without predominant body system involvement: LD2F.Y\\nSyndromes with multiple structural anomalies without predominant body system involvement unspecified: LD2F.Z\\nConjoined twins: LD2G\\nSyndromic genetic deafness: LD2H\\nFraser syndrome: LD2H.0\\nNeuropathy with hearing impairment: LD2H.1\\nProgressive deafness with stapes fixation: LD2H.2\\nWaardenburgShah syndrome: LD2H.3\\nUsher syndrome: LD2H.4\\nOther specified syndromic genetic deafness: LD2H.Y\\nSyndromic genetic deafness unspecified: LD2H.Z\\nOther specified multiple developmental anomalies or syndromes: LD2Y\\nMultiple developmental anomalies or syndromes unspecified: LD2Z\\nComplete trisomies of the autosomes: LD40\\nComplete trisomy: LD40.2\\nOther specified complete trisomies of the autosomes: LD40.Y\\nComplete trisomies of the autosomes unspecified: LD40.Z\\nDuplications of the autosomes: LD41\\nDuplications of chromosome: LD41.M\\nDuplications of the long arm of chromosome: LD41.K0\\nDuplications of the short arm of chromosome: LD41.K1\\nOther specified duplications of chromosome: LD41.KY\\nDuplications of chromosome  unspecified: LD41.KZ\\nExtra ring or dicentric chromosomes: LD41.N\\nDuplications with other complex rearrangements: LD41.P\\nExtra marker chromosomes: LD41.Q\\nOther specified duplications of the autosomes: LD41.Y\\nDuplications of the autosomes unspecified: LD41.Z\\nPolyploidies: LD42\\nTriploidy: LD42.0\\nTetraploidy: LD42.1\\nOther specified polyploidies: LD42.Y\\nPolyploidies unspecified: LD42.Z\\nComplete monosomies of the autosomes: LD43\\nComplete monosomy of autosome: LD43.0\\nMosaic monosomy of autosome: LD43.1\\nOther specified complete monosomies of the autosomes: LD43.Y\\nComplete monosomies of the autosomes unspecified: LD43.Z\\nDeletions of the autosomes: LD44\\nDeletions of chromosome: LD44.N\\nDeletions of the long arm of chromosome: LD44.L0\\nDeletions of the short arm of chromosome: LD44.L1\\nOther specified deletions of chromosome: LD44.NY\\nDeletions of chromosome  unspecified: LD44.NZ\\nCATCH  phenotype: LD44.N0\\nDeletions with other complex rearrangements: LD44.P\\nOther specified deletions of the autosomes: LD44.Y\\nDeletions of the autosomes unspecified: LD44.Z\\nUniparental disomies: LD45\\nUniparental disomies of maternal origin: LD45.0\\nUniparental disomies of paternal origin: LD45.1\\nOther specified uniparental disomies: LD45.Y\\nUniparental disomies unspecified: LD45.Z\\nImprinting errors: LD46\\nMaternal imprinting error: LD46.0\\nPaternal imprinting error: LD46.1\\nOther specified imprinting errors: LD46.Y\\nImprinting errors unspecified: LD46.Z\\nBalanced rearrangements or structural rearrangements: LD47\\nBalanced translocation and insertion in normal individual: LD47.0\\nChromosome inversion in normal individual: LD47.1\\nBalanced autosomal rearrangement in abnormal individual: LD47.2\\nBalanced sex or autosomal rearrangement in abnormal individual: LD47.3\\nAutosomal fragile site: LD47.4\\nOther specified balanced rearrangements or structural rearrangements: LD47.Y\\nBalanced rearrangements or structural rearrangements unspecified: LD47.Z\\nNumber anomalies of chromosome X: LD50\\nTurner syndrome: LD50.0\\nKaryotype  X: LD50.00\\nKaryotype  X iso Xq: LD50.01\\nKaryotype  X with abnormal sex chromosome except iso Xq: LD50.02\\nMosaicism  X  XX or XY: LD50.03\\nMosaicism  X or other cell line with abnormal sex chromosome: LD50.04\\nKaryotype XXX: LD50.1\\nMosaicism lines with various numbers of X chromosomes: LD50.2\\nKlinefelter syndrome: LD50.3\\nKlinefelter syndrome with karyotype XXY regular: LD50.30\\nKlinefelter syndrome male with more than two X chromosomes: LD50.31\\nOther specified Klinefelter syndrome: LD50.3Y\\nKlinefelter syndrome unspecified: LD50.3Z\\nOther specified number anomalies of chromosome X: LD50.Y\\nNumber anomalies of chromosome X unspecified: LD50.Z\\nStructural anomalies of chromosome X excluding Turner syndrome: LD51\\nNumber anomalies of chromosome Y: LD52\\nMale with XX karyotype: LD52.0\\nMale with double or multiple Y: LD52.1\\nOther specified number anomalies of chromosome Y: LD52.Y\\nNumber anomalies of chromosome Y unspecified: LD52.Z\\nStructural anomalies of chromosome Y: LD53\\nMale with sex chromosome mosaicism: LD54\\nFragile X chromosome: LD55\\nChimaera  XX  XY: LD56\\nAndrogenetic chimaera: LD56.0\\nGynogenetic chimaera: LD56.1\\nOther specified chimaera  XX  XY: LD56.Y\\nChimaera  XX  XY unspecified: LD56.Z\\nOther specified sex chromosome anomalies: LD5Y\\nSex chromosome anomalies unspecified: LD5Z\\nOther specified chromosomal anomalies excluding gene mutations: LD7Y\\nChromosomal anomalies excluding gene mutations unspecified: LD7Z\\nConditions with disorders of intellectual development as a relevant clinical feature: LD90\\nAngelman syndrome: LD90.0\\nEarlyonset parkinsonism intellectual deficit: LD90.1\\nPelizaeusMerzbacherlike disease: LD90.2\\nPraderWilli syndrome: LD90.3\\nRett syndrome: LD90.4\\nOther specified conditions with disorders of intellectual development as a relevant clinical feature: LD90.Y\\nConditions with disorders of intellectual development as a relevant clinical feature unspecified: LD90.Z\\nOther specified developmental anomalies: LD9Y\\nDevelopmental anomalies unspecified: LD9Z\\nSymptom or complaint of the blood: MA00\\nEnlarged lymph nodes: MA01\\nLocalised lymph node enlargement: MA01.0\\nGeneralised lymph node enlargement: MA01.1\\nEnlarged lymph nodes unspecified: MA01.Z\\nOther specified symptoms or signs of blood bloodforming organs or the immune system: MA0Y\\nAbnormal serum enzyme levels: MA10\\nElevation of levels of transaminase or lactic acid dehydrogenase: MA10.0\\nAbnormal levels of other specified serum enzymes: MA10.1\\nAbnormal level of unspecified serum enzyme: MA10.2\\nClinical findings of hormones in blood bloodforming organs or the immune system: MA11\\nClinical findings of drugs medicaments and biological substances in blood bloodforming organs or the immune system: MA12\\nFinding of opiate drug in blood: MA12.0\\nFinding of cocaine in blood: MA12.1\\nFinding of hallucinogen in blood: MA12.2\\nFinding of psychotropic drug in blood: MA12.3\\nFinding of steroid agent in blood: MA12.4\\nOther specified clinical findings of drugs medicaments and biological substances in blood bloodforming organs or the immune system: MA12.Y\\nClinical findings of substances chiefly nonmedicinal as to source in blood bloodforming organs or the immune system: MA13\\nFinding of abnormal level of heavy metals in blood: MA13.0\\nAbnormal level of lead in blood: MA13.00\\nFinding of abnormal level of other specified heavy metals in blood: MA13.0Y\\nFinding of alcohol in blood: MA13.1\\nAbnormal level of other specified substances chiefly nonmedicinal as to source in blood bloodforming organs and the immune system: MA13.Y\\nImmunological findings in blood bloodforming organs or the immune system: MA14\\nLaboratory evidence of human immunodeficiency virus: MA14.0\\nCertain specified immunological findings: MA14.1\\nAbnormal reaction to tuberculin test: MA14.10\\nAnticitrullinated protein antibody negative: MA14.11\\nAnticitrullinated protein antibody positive: MA14.12\\nAntinuclear antibody negative: MA14.13\\nAntinuclear antibody positive: MA14.14\\nElevated Creactive protein: MA14.15\\nFalsepositive serological test for syphilis: MA14.16\\nHuman leukocyte antigen negative: MA14.17\\nHuman leukocyte antigen positive: MA14.18\\nNeural autoantibody negative: MA14.19\\nNeural autoantibody positive: MA14.1A\\nProstate specific antigen positive: MA14.1B\\nRaised antibody titre: MA14.1C\\nRheumatoid factor negative: MA14.1D\\nRheumatoid factor positive: MA14.1E\\nOther specified immunological findings in blood bloodforming organs or the immune system: MA14.Y\\nMicrobiological findings in blood bloodforming organs or the immune system: MA15\\nBacteraemia: MA15.0\\nFungaemia: MA15.1\\nOther specified microbiological findings in blood bloodforming organs or the immune system: MA15.Y\\nCytological findings in blood bloodforming organs or the immune system: MA16\\nAbnormality of red blood cells: MA16.0\\nHaemolysis not elsewhere classified: MA16.00\\nOther specified abnormality of red blood cells: MA16.0Y\\nAbnormality of red blood cells unspecified: MA16.0Z\\nAbnormality of white blood cells: MA16.1\\nDecreased white blood cell count: MA16.10\\nElevated white blood cell count: MA16.11\\nAbnormality of white blood cells unspecified: MA16.1Z\\nOther specified cytological findings in blood bloodforming organs or the immune system: MA16.Y\\nCytological findings in blood bloodforming organs or the immune system unspecified: MA16.Z\\nHistological findings in blood bloodforming organs or the immune system: MA17\\nCertain clinical findings of blood chemistry: MA18\\nElevated blood glucose level: MA18.0\\nAbnormal glucose tolerance test: MA18.00\\nOther specified elevated blood glucose level: MA18.0Y\\nElevated blood glucose level unspecified: MA18.0Z\\nAbnormal level of blood mineral: MA18.1\\nAbnormal arterial bloodgas level: MA18.2\\nAbnormal coagulation profile: MA18.3\\nLow haemoglobin: MA18.4\\nOther specified abnormal findings of blood chemistry: MA18.Y\\nAbnormal findings of blood chemistry unspecified: MA18.Z\\nCertain abnormalities of plasma proteins: MA19\\nAbnormality of albumin: MA19.0\\nAbnormality of alphafetoprotein: MA19.1\\nAbnormality of globulin: MA19.2\\nAbnormalities of other specified plasma proteins: MA19.Y\\nAbnormalities of unspecified plasma proteins: MA19.Z\\nElevated erythrocyte sedimentation rate or abnormality of plasma viscosity: MA1A\\nElevated erythrocyte sedimentation rate: MA1A.0\\nAbnormal plasma viscosity: MA1A.1\\nOther specified clinical findings in blood bloodforming organs or the immune system: MA1Y\\nAbnormal results of thyroid function studies: MA50\\nAbnormal results of other endocrine function studies: MA51\\nOther specified symptoms signs or clinical findings of endocrine nutritional or metabolic diseases: MA6Y\\nSpeech or language disturbances: MA80\\nAphasia: MA80.0\\nDysphasia: MA80.1\\nDysarthria: MA80.2\\nAnarthria: MA80.20\\nOther specified dysarthria: MA80.2Y\\nDysarthria unspecified: MA80.2Z\\nOther specified speech or language disturbances: MA80.Y\\nSpeech or language disturbances unspecified: MA80.Z\\nSpeech dysfluency: MA81\\nVoice disturbances: MA82\\nAphonia: MA82.0\\nDysphonia: MA82.1\\nHoarseness: MA82.10\\nOther specified dysphonia: MA82.1Y\\nDysphonia unspecified: MA82.1Z\\nNasality: MA82.2\\nOther specified voice disturbances: MA82.Y\\nVoice disturbances unspecified: MA82.Z\\nOther specified symptoms or signs involving speech language or voice: MA8Y\\nOther specified symptoms signs or clinical findings of speech language or voice: MB0Y\\nSymptoms signs or clinical findings involving consciousness: MB20\\nStupor: MB20.0\\nComa: MB20.1\\nClouding of consciousness: MB20.2\\nOther specified symptoms signs or clinical findings involving consciousness: MB20.Y\\nSymptoms signs or clinical findings involving cognition: MB21\\nAgeassociated cognitive decline: MB21.0\\nAmnesia: MB21.1\\nAnterograde amnesia: MB21.10\\nRetrograde amnesia: MB21.11\\nTransient global amnesia: MB21.12\\nOther specified amnesia: MB21.1Y\\nAmnesia unspecified: MB21.1Z\\nAnosognosia: MB21.2\\nConfabulation: MB21.3\\nDisorientation: MB21.4\\nDistractibility: MB21.5\\nImpaired abstract thinking: MB21.6\\nImpaired executive functioning: MB21.7\\nImpaired judgment: MB21.8\\nPerseveration: MB21.9\\nPoor concentration: MB21.A\\nRacing thoughts: MB21.B\\nOther specified symptoms signs or clinical findings involving cognition: MB21.Y\\nSymptoms signs or clinical findings involving cognition unspecified: MB21.Z\\nSymptoms or signs involving motivation or energy: MB22\\nAvolition: MB22.0\\nDecreased libido: MB22.1\\nDemoralization: MB22.2\\nHopelessness: MB22.3\\nIncreased energy: MB22.4\\nIncreased goaldirected activity: MB22.5\\nIncreased libido: MB22.6\\nTiredness: MB22.7\\nOther specified symptoms or signs involving motivation or energy: MB22.Y\\nSymptoms or signs involving motivation or energy unspecified: MB22.Z\\nSymptoms or signs involving appearance or behaviour: MB23\\nAggressive behaviour: MB23.0\\nAntisocial behaviour: MB23.1\\nAvoidance behaviour: MB23.2\\nBradyphrenia: MB23.3\\nCompulsions: MB23.4\\nCoprolalia: MB23.5\\nDisorganised behaviour: MB23.6\\nDisheveled appearance: MB23.7\\nDisruptive behaviour: MB23.8\\nEcholalia: MB23.9\\nExcessive crying of child adolescent or adult: MB23.A\\nIncreased sociability: MB23.C\\nMutism: MB23.D\\nNonsuicidal selfinjury: MB23.E\\nOdd or peculiar appearance: MB23.F\\nOdd or peculiar behaviour: MB23.G\\nPanic attack: MB23.H\\nPoor personal hygiene: MB23.J\\nPoverty of speech: MB23.K\\nPressured speech: MB23.L\\nPsychomotor agitation: MB23.M\\nPsychomotor retardation: MB23.N\\nSocial withdrawal: MB23.Q\\nSuicide attempt: MB23.R\\nSuicidal behaviour: MB23.S\\nOther specified symptoms and signs involving appearance and behaviour: MB23.Y\\nSymptoms and signs involving appearance and behaviour unspecified: MB23.Z\\nSymptoms or signs involving mood or affect: MB24\\nAmbivalence: MB24.0\\nAnger: MB24.1\\nAnhedonia: MB24.2\\nAnxiety: MB24.3\\nApathy: MB24.4\\nDepressed mood: MB24.5\\nDisturbance of affect: MB24.6\\nConstricted affect: MB24.60\\nBlunted affect: MB24.61\\nFlat affect: MB24.62\\nLabile affect: MB24.63\\nInappropriate affect: MB24.64\\nOther specified disturbance of affect: MB24.6Y\\nDisturbance of affect unspecified: MB24.6Z\\nDysphoria: MB24.7\\nElevated mood: MB24.8\\nEuphoria: MB24.9\\nFear: MB24.A\\nFeelings of guilt: MB24.B\\nIrritability: MB24.C\\nLeaden paralysis: MB24.D\\nMental rumination: MB24.E\\nRestlessness: MB24.F\\nTantrum: MB24.G\\nWorry: MB24.H\\nOther specified symptoms and signs involving mood or affect: MB24.Y\\nSymptoms and signs involving mood or affect unspecified: MB24.Z\\nSymptoms or signs involving form of thought: MB25\\nSymptoms or signs of thought disorder: MB25.0\\nCircumstantiality: MB25.00\\nTangentiality: MB25.01\\nDisorganised thinking: MB25.02\\nIncoherence: MB25.03\\nOther specified symptoms or signs of thought disorder: MB25.0Y\\nSymptoms or signs of thought disorder unspecified: MB25.0Z\\nFlight of ideas: MB25.1\\nNeologisms: MB25.2\\nThought blocking: MB25.3\\nOther specified symptoms or signs of form of thought: MB25.Y\\nSymptoms or signs of form of thought unspecified: MB25.Z\\nSymptoms or signs involving content of thought: MB26\\nDelusion: MB26.0\\nBizarre delusion: MB26.00\\nDelusion of being controlled: MB26.01\\nDelusion of guilt: MB26.02\\nDelusion of reference: MB26.03\\nErotomanic delusion: MB26.04\\nGrandiose delusion: MB26.05\\nJealous delusion: MB26.06\\nPersecutory delusion: MB26.07\\nReligious delusion: MB26.08\\nSomatic delusion: MB26.09\\nNihilistic delusion: MB26.0A\\nMisidentification delusion: MB26.0B\\nDelusion of impoverishment: MB26.0C\\nOther specified delusion: MB26.0Y\\nDelusion unspecified: MB26.0Z\\nExperiences of influence passivity and control: MB26.1\\nThought broadcasting: MB26.10\\nThought insertion: MB26.11\\nThought withdrawal: MB26.12\\nOther specified experiences of influence passivity and control: MB26.1Y\\nExperiences of influence passivity and control unspecified: MB26.1Z\\nGrandiosity: MB26.2\\nHomicidal ideation: MB26.3\\nIdentity disturbance: MB26.4\\nObsessions: MB26.5\\nOvervalued ideas: MB26.6\\nParanoid ideation: MB26.7\\nReferential thinking: MB26.8\\nSuspiciousness: MB26.9\\nSuicidal ideation: MB26.A\\nOther specified symptoms or signs involving content of thought: MB26.Y\\nSymptoms or signs involving content of thought unspecified: MB26.Z\\nSymptoms or signs involving perceptual disturbance: MB27\\nDepersonalisation: MB27.0\\nDerealisation: MB27.1\\nHallucinations: MB27.2\\nAuditory hallucinations: MB27.20\\nGustatory hallucinations: MB27.21\\nHypnopompic hallucinations: MB27.22\\nHypnagogic hallucinations: MB27.23\\nOlfactory hallucinations: MB27.24\\nSomatic hallucinations: MB27.25\\nTactile hallucinations: MB27.26\\nVisual hallucinations: MB27.27\\nOther specified hallucinations: MB27.2Y\\nHallucinations unspecified: MB27.2Z\\nDisturbance of body image: MB27.3\\nIllusions: MB27.4\\nOther specified symptoms or signs of perceptual disturbance: MB27.Y\\nSymptoms or signs of perceptual disturbance unspecified: MB27.Z\\nSymptoms or signs related to personality features: MB28\\nAttention seeking: MB28.0\\nCallousness: MB28.1\\nEccentricity: MB28.2\\nEntitlement: MB28.3\\nHostility: MB28.4\\nImpulsivity: MB28.5\\nIndecisiveness: MB28.6\\nIrresponsibility: MB28.7\\nLow frustration tolerance: MB28.8\\nLow selfesteem: MB28.9\\nNegative affectivity: MB28.A\\nNegativism: MB28.B\\nPerfectionism: MB28.C\\nPessimism: MB28.D\\nRecklessness: MB28.E\\nSensation seeking: MB28.F\\nStubbornness: MB28.G\\nSubmissiveness: MB28.H\\nOther specified symptoms and signs related to personality features: MB28.Y\\nSymptoms and signs related to personality features unspecified: MB28.Z\\nSymptoms or signs involving eating and related behaviour: MB29\\nAvoidant or restrictive eating: MB29.0\\nBinge eating: MB29.1\\nEating of nonnutritive substances: MB29.2\\nPurging behaviour: MB29.3\\nRuminationregurgitation: MB29.4\\nOther specified symptoms and signs involving eating and related behaviour: MB29.Y\\nSymptoms and signs involving eating and related behaviour unspecified: MB29.Z\\nSymptoms or signs involving elimination: MB2A\\nSoiling: MB2A.0\\nWetting: MB2A.1\\nOther specified symptoms and signs involving elimination: MB2A.Y\\nSymptoms and signs involving elimination unspecified: MB2A.Z\\nOther specified mental or behavioural symptoms signs or clinical findings: MB2Y\\nSensation disturbance: MB40\\nAsomatognosia: MB40.0\\nAllodynia: MB40.1\\nAnacusis: MB40.2\\nAnaesthesia of skin: MB40.3\\nTingling fingers or feet or toes: MB40.4\\nHyperaesthesia: MB40.5\\nDysesthesia: MB40.6\\nAcroparaesthesia: MB40.7\\nAnalgesia: MB40.8\\nNeurological neglect syndrome: MB40.9\\nOther specified sensation disturbance: MB40.Y\\nSensation disturbance unspecified: MB40.Z\\nDisturbances of smell or taste: MB41\\nAnosmia: MB41.0\\nParosmia: MB41.1\\nDysgeusia: MB41.2\\nHyposmia: MB41.3\\nOther specified disturbances of smell or taste: MB41.Y\\nDisturbances of smell or taste unspecified: MB41.Z\\nPhonophobia: MB42\\nDyssomnia: MB43\\nAbnormalities of gait or mobility: MB44\\nAtaxic gait: MB44.0\\nParalytic gait: MB44.1\\nDifficulty in walking: MB44.2\\nImmobility: MB44.3\\nOther specified abnormalities of gait or mobility: MB44.Y\\nAbnormalities of gait or mobility unspecified: MB44.Z\\nLack of coordination: MB45\\nAtaxia unspecified: MB45.0\\nAutomatism: MB45.1\\nAtonia: MB45.2\\nHead drop: MB45.3\\nIntention tremor: MB45.4\\nOther specified lack of coordination: MB45.Y\\nLack of coordination unspecified: MB45.Z\\nAbnormal involuntary movements: MB46\\nAsterixis: MB46.0\\nAbnormal head movements: MB46.1\\nAthetosis: MB46.2\\nDrop attack: MB46.3\\nTitubation: MB46.4\\nShuddering: MB46.5\\nOther specified abnormal involuntary movements: MB46.Y\\nAbnormal involuntary movements unspecified: MB46.Z\\nAbnormality of tonus or reflex: MB47\\nAbnormal reflex: MB47.0\\nAbnormal posture: MB47.1\\nClonus: MB47.2\\nCramp or spasm: MB47.3\\nDystonia: MB47.4\\nFasciculation: MB47.5\\nMeningismus: MB47.6\\nMuscle fibrillation: MB47.7\\nMuscular hypertonia: MB47.8\\nMyotonia: MB47.9\\nOphthalmoparesis: MB47.A\\nOpisthotonos: MB47.B\\nTendency to fall: MB47.C\\nTetany: MB47.D\\nOther specified abnormality of tonus or reflex: MB47.Y\\nAbnormality of tonus or reflex unspecified: MB47.Z\\nDizziness or giddiness: MB48\\nVertigo: MB48.0\\nVertigo of central origin: MB48.00\\nOther specified vertigo: MB48.0Y\\nVertigo unspecified: MB48.0Z\\nDisorder of equilibrium: MB48.1\\nExertional dizziness: MB48.2\\nLightheadedness: MB48.3\\nPresyncope: MB48.4\\nOther specified dizziness or giddiness: MB48.Y\\nDizziness or giddiness unspecified: MB48.Z\\nAura: MB49\\nApraxia: MB4A\\nSymbolic dysfunctions: MB4B\\nDyslexia and alexia: MB4B.0\\nAgnosia: MB4B.1\\nAcalculia: MB4B.2\\nAgraphia: MB4B.3\\nAnomia: MB4B.4\\nDyscalculia: MB4B.5\\nOther specified symbolic dysfunctions: MB4B.Y\\nSymbolic dysfunctions unspecified: MB4B.Z\\nGerstmann syndrome: MB4C\\nHeadache not elsewhere classified: MB4D\\nTetraplegia: MB50\\nFlaccid tetraplegia: MB50.0\\nSpastic tetraplegia: MB50.1\\nTetraplegia unspecified: MB50.Z\\nDiplegia of upper extremities: MB51\\nFlaccid diplegia of upper extremities: MB51.0\\nSpastic diplegia of upper extremities: MB51.1\\nDiplegia of upper extremities unspecified: MB51.Z\\nDiplegia of lower extremities: MB52\\nHemiplegia: MB53\\nAlternating hemiplegia: MB53.0\\nFlaccid hemiplegia: MB53.1\\nSpastic hemiplegia: MB53.2\\nHemiplegia unspecified: MB53.Z\\nMonoplegia of upper extremity: MB54\\nFlaccid monoplegia of upper extremity: MB54.0\\nSpastic monoplegia of upper extremity: MB54.1\\nMonoplegia of upper extremity unspecified: MB54.Z\\nMonoplegia of lower extremity: MB55\\nFlaccid monoplegia of lower extremity: MB55.0\\nSpastic monoplegia of lower extremity: MB55.1\\nMonoplegia of lower extremity unspecified: MB55.Z\\nParaplegia: MB56\\nFunctional level of injury of spinal cord: MB57\\nFunctional level of injury of cervical spinal cord: MB57.0\\nFunctional level of injury of thoracic spinal cord: MB57.1\\nFunctional level of injury of lumbar spinal cord: MB57.2\\nFunctional level of injury of spinal cord sacrum: MB57.3\\nOther specified functional level of injury of spinal cord: MB57.Y\\nFunctional level of injury of spinal cord unspecified: MB57.Z\\nOther specified paralytic symptoms: MB5Y\\nParalytic symptoms unspecified: MB5Z\\nSleeptalking: MB60\\nOther specified symptoms or signs involving the nervous system: MB6Y\\nClinical findings in cerebrospinal fluid: MB70\\nAbnormal level of enzymes in cerebrospinal fluid: MB70.0\\nAbnormal level of hormones in cerebrospinal fluid: MB70.1\\nAbnormal level of drugs medicaments and biological substances in cerebrospinal fluid: MB70.2\\nAbnormal level of substances chiefly nonmedicinal as to source in cerebrospinal fluid: MB70.3\\nAbnormal immunological findings in cerebrospinal fluid: MB70.4\\nAbnormal microbiological findings in cerebrospinal fluid: MB70.5\\nAbnormal cytological findings in cerebrospinal fluid: MB70.6\\nAbnormal histological findings in cerebrospinal fluid: MB70.7\\nOther abnormal findings in cerebrospinal fluid: MB70.8\\nOther specified clinical findings in cerebrospinal fluid: MB70.Y\\nClinical findings in cerebrospinal fluid unspecified: MB70.Z\\nClinical findings on diagnostic imaging of central nervous system: MB71\\nIntracranial spaceoccupying lesion: MB71.0\\nOther specified clinical findings on diagnostic imaging of central nervous system: MB71.Y\\nClinical findings on diagnostic imaging of central nervous system unspecified: MB71.Z\\nResults of function studies of the nervous system: MB72\\nOther specified clinical findings in the nervous system: MB7Y\\nOther specified symptoms signs or clinical findings of the nervous system: MB9Y\\nEye appearance abnormal: MC10\\nEye sensation abnormal: MC11\\nChronic enlargement of lacrimal gland: MC12\\nEpiphora: MC13\\nEye discharge: MC14\\nRed eye: MC15\\nPallor conjunctiva: MC16\\nIcteric sclera: MC17\\nOcular pain: MC18\\nQuadrantanopia: MC19\\nVisual floaters: MC1A\\nSymptom or complaint of the eyelid: MC1B\\nSymptom or complaint of glasses: MC1C\\nSymptom or complaint of contact lens: MC1D\\nOther specified symptoms or signs involving the visual system: MC1Y\\nClinical findings of the visual system: MC20\\nStaphyloma: MC20.0\\nSmall drusen of the macula: MC20.1\\nHypopyon: MC20.2\\nOther specified clinical findings of the visual system: MC20.Y\\nImpairment of electrophysiological functions: MC21\\nProfound impairment of electrooculogram: MC21.0\\nNormal electroretinogram: MC21.1\\nOther specified impairment of electrophysiological functions: MC21.Y\\nImpairment of electrophysiological functions unspecified: MC21.Z\\nOther specified symptoms signs or clinical findings of the visual system: MC2Y\\nPlugged feeling ear: MC40\\nTinnitus: MC41\\nOther specified symptoms or signs involving the ear or mastoid process: MC4Y\\nOther specified symptoms signs or clinical findings of ear or mastoid process: MC6Y\\nAbnormal bloodpressure reading without diagnosis: MC80\\nElevated bloodpressure reading without diagnosis of hypertension: MC80.0\\nWhite coat hypertension: MC80.00\\nCombined diastolic and systolic elevated blood pressure reading without diagnosis of hypertension: MC80.01\\nDiastolic elevated blood pressure reading without diagnosis of hypertension: MC80.02\\nSystolic elevated blood pressure reading without diagnosis of hypertension: MC80.03\\nOther specified elevated bloodpressure reading without diagnosis of hypertension: MC80.0Y\\nElevated bloodpressure reading without diagnosis of hypertension unspecified: MC80.0Z\\nNonspecific low bloodpressure reading: MC80.1\\nOther specified abnormal bloodpressure reading without diagnosis: MC80.Y\\nAbnormal bloodpressure reading without diagnosis unspecified: MC80.Z\\nAbnormalities of heart beat: MC81\\nTachycardia unspecified: MC81.0\\nBradycardia unspecified: MC81.1\\nPalpitations: MC81.2\\nParoxysmal tachycardia: MC81.3\\nPulseless electrical activity not elsewhere classified: MC81.4\\nOther specified abnormalities of heart beat: MC81.Y\\nAbnormalities of heart beat unspecified: MC81.Z\\nCardiac arrest: MC82\\nVentricular tachycardia and fibrillation cardiac arrest: MC82.0\\nBradycardic cardiac arrest: MC82.1\\nAsystolic cardiac arrest: MC82.2\\nCardiac arrest with pulseless electrical activity: MC82.3\\nCardiopulmonary arrest: MC82.4\\nCardiac arrest unspecified: MC82.Z\\nCardiac murmurs or other cardiac sounds: MC83\\nBenign or innocent cardiac murmurs: MC83.0\\nOther cardiac sounds: MC83.1\\nCardiac murmurs or sounds unspecified: MC83.Z\\nCardiovascular pain: MC84\\nGangrene: MC85\\nPrecordial pain: MC86\\nPressure or tightness of heart: MC87\\nProminent veins: MC88\\nOther specified symptoms or signs involving the circulatory system: MC8Y\\nClinical findings on diagnostic imaging of heart or coronary circulation: MC90\\nResults of function studies of the circulatory system: MC91\\nOther specified symptoms signs or clinical findings of the circulatory system: MC9Y\\nAbnormal sputum: MD10\\nAbnormalities of breathing: MD11\\nApnoea: MD11.0\\nAsphyxia: MD11.1\\nAtaxic breathing: MD11.2\\nBreath holding: MD11.3\\nSleep related CheyneStokes respiration: MD11.4\\nDyspnoea: MD11.5\\nHiccough: MD11.6\\nHyperventilation: MD11.7\\nMouth breathing: MD11.8\\nStertor: MD11.80\\nOther specified mouth breathing: MD11.8Y\\nMouth breathing unspecified: MD11.8Z\\nNasal congestion: MD11.9\\nSneezing: MD11.A\\nStridor: MD11.B\\nWheezing: MD11.C\\nYawning: MD11.D\\nOther specified abnormalities of breathing: MD11.Y\\nAbnormalities of breathing unspecified: MD11.Z\\nCough: MD12\\nEpistaxis: MD20\\nHaemorrhage from throat: MD21\\nHaemoptysis: MD22\\nHaemorrhage from other sites in respiratory passages: MD23\\nAcute idiopathic pulmonary haemorrhage in infants over  days of age: MD24\\nHaemorrhage from respiratory passages unspecified: MD2Z\\nPain in throat or chest: MD30\\nChest pain on breathing: MD30.0\\nOther chest pain: MD30.1\\nChest pain unspecified: MD30.Z\\nPleurisy: MD31\\nRales: MD32\\nRespiratory arrest: MD33\\nSymptom or complaint of the nose: MD34\\nSymptom or complaint of the sinus: MD35\\nSymptom or complaint of the throat: MD36\\nPain in throat: MD36.0\\nOther specified symptom or complaint of the throat: MD36.Y\\nSymptom or complaint of the throat unspecified: MD36.Z\\nOther specified symptoms or signs involving the respiratory system: MD3Y\\nClinical findings in specimens from respiratory organs and thorax: MD40\\nAbnormal level of enzymes in specimens from respiratory organs and thorax: MD40.0\\nAbnormal level of hormones in specimens from respiratory organs and thorax: MD40.1\\nAbnormal level of drugs medicaments and biological substances in specimens from respiratory organs and thorax: MD40.2\\nAbnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax: MD40.3\\nAbnormal immunological findings in specimens from respiratory organs and thorax: MD40.4\\nAbnormal microbiological findings in specimens from respiratory organs and thorax: MD40.5\\nPositive culture from nose: MD40.50\\nPositive sputum culture: MD40.51\\nPositive throat culture: MD40.52\\nOther specified abnormal microbiological findings in specimens from respiratory organs and thorax: MD40.5Y\\nAbnormal microbiological findings in specimens from respiratory organs and thorax unspecified: MD40.5Z\\nAbnormal cytological findings in specimens from respiratory organs and thorax: MD40.6\\nAbnormal histological findings in specimens from respiratory organs and thorax: MD40.7\\nOther specified clinical findings in specimens from respiratory organs and thorax: MD40.Y\\nClinical findings on diagnostic imaging of lung: MD41\\nResults of function studies of the respiratory system: MD42\\nOther specified clinical findings in the respiratory system: MD4Y\\nOther specified symptoms signs or clinical findings of the respiratory system: MD6Y\\nSymptoms or signs of the orofacial complex: MD80\\nSymptom or complaint of the teeth or gum: MD80.0\\nSymptom or complaint of the mouth tongue or lip: MD80.1\\nOther specified symptoms or signs of the orofacial complex: MD80.Y\\nAbdominal or pelvic pain: MD81\\nAbdominal tenderness: MD81.0\\nLocalised abdominal pain: MD81.1\\nPain localised to upper abdomen: MD81.10\\nPelvic or perineal pain: MD81.11\\nPain localised to other parts of lower abdomen: MD81.12\\nLocalised abdominal pain unspecified: MD81.1Z\\nGeneralised abdominal pain: MD81.2\\nAcute abdomen: MD81.3\\nOther and unspecified abdominal pain: MD81.4\\nIntraabdominal or pelvic swelling mass or lump: MD82\\nNausea or vomiting: MD90\\nNausea: MD90.0\\nVomiting: MD90.1\\nBelching: MD91\\nDyspepsia: MD92\\nDysphagia: MD93\\nHalitosis: MD94\\nHeartburn: MD95\\nOther specified symptoms related to the upper gastrointestinal tract: MD9Y\\nAbdominal compartment syndrome: ME00\\nAbdominal distension: ME01\\nAbdominal rigidity: ME02\\nAbnormal bowel sounds: ME03\\nHyperactive bowel sounds: ME03.0\\nAbsent bowel sounds: ME03.1\\nAbnormal bowel sounds unspecified: ME03.Z\\nAscites: ME04\\nFluid in peritoneal cavity: ME04.0\\nOther specified ascites: ME04.Y\\nAscites unspecified: ME04.Z\\nChange in bowel habit: ME05\\nConstipation: ME05.0\\nDiarrhoea: ME05.1\\nOther specified change in bowel habit: ME05.Y\\nChange in bowel habit unspecified: ME05.Z\\nChronic enteritis of uncertain aetiology: ME06\\nFaecal incontinence: ME07\\nFaecal smearing: ME07.0\\nIncomplete defaecation: ME07.1\\nFaecal urgency: ME07.2\\nOther specified faecal incontinence: ME07.Y\\nFaecal incontinence unspecified: ME07.Z\\nFlatulence and related conditions: ME08\\nRectal tenesmus: ME09\\nVisible peristalsis: ME0A\\nProblems with defaecation not otherwise specified: ME0B\\nOther specified symptoms related to the lower gastrointestinal tract or abdomen: ME0Y\\nAbnormalities related to hepatobiliary system: ME10\\nHepatomegaly or splenomegaly: ME10.0\\nHepatomegaly not elsewhere classified: ME10.00\\nSplenomegaly not elsewhere classified: ME10.01\\nHepatomegaly with splenomegaly: ME10.02\\nUnspecified jaundice: ME10.1\\nOther specified symptoms or signs involving the digestive system or abdomen: ME1Y\\nClinical findings in specimens from digestive organs or abdominal cavity: ME20\\nAbnormal level of enzymes in specimens from digestive organs or abdominal cavity: ME20.0\\nAbnormal level of hormones in specimens from digestive organs or abdominal cavity: ME20.1\\nAbnormal level of drugs medicaments or biological substances in specimens from digestive organs of abdominal cavity: ME20.2\\nAbnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity: ME20.3\\nAbnormal immunological findings in specimens from digestive organs and abdominal cavity: ME20.4\\nAbnormal microbiological findings in specimens from digestive organs and abdominal cavity: ME20.5\\nAbnormal cytological findings in specimens from digestive organs and abdominal cavity: ME20.6\\nAbnormal histological findings in specimens from digestive organs and abdominal cavity: ME20.7\\nOther specified clinical findings in specimens from digestive organs or abdominal cavity: ME20.Y\\nClinical findings in specimens from digestive organs or abdominal cavity unspecified: ME20.Z\\nClinical findings on diagnostic imaging of liver or biliary tract: ME21\\nClinical findings on diagnostic imaging of digestive tract: ME22\\nResults of function studies of the digestive system: ME23\\nClinical manifestations of the digestive system: ME24\\nDigestive system abscess: ME24.0\\nDigestive system fistula: ME24.1\\nDigestive system obstruction: ME24.2\\nDigestive system perforation: ME24.3\\nPerforation of small intestine: ME24.30\\nPerforation of large intestine: ME24.31\\nPerforation of gallbladder or bile ducts: ME24.35\\nDigestive system perforation of other specified site: ME24.3Y\\nDigestive system perforation of unspecified site: ME24.3Z\\nDigestive system stenosis: ME24.4\\nDigestive system ulcer: ME24.5\\nDigestive system dilatation: ME24.6\\nDigestive system incarceration: ME24.7\\nDigestive system strangulation or gangrene: ME24.8\\nGastrointestinal bleeding: ME24.9\\nAcute gastrointestinal bleeding not elsewhere classified: ME24.90\\nChronic gastrointestinal bleeding not elsewhere classified: ME24.91\\nGastrointestinal bleeding unspecified: ME24.9Z\\nOther digestive system haemorrhage not elsewhere classified: ME24.A\\nObscure gastrointestinal bleeding: ME24.A0\\nHaemorrhage of anus and rectum: ME24.A1\\nOesophageal haemorrhage: ME24.A2\\nHaematochezia: ME24.A3\\nMelaena: ME24.A4\\nHaematemesis: ME24.A5\\nPositive occult blood in stool: ME24.A6\\nOther specified clinical manifestations of the digestive system: ME24.Y\\nOther specified clinical findings in the digestive system: ME2Y\\nOther specified symptoms signs or clinical findings of the digestive system or abdomen: ME4Y\\nSkin lesion of uncertain or unspecified nature: ME60\\nSkin lesion of uncertain nature: ME60.0\\nPigmented skin lesion of uncertain nature: ME60.1\\nUlcer of skin of uncertain nature: ME60.2\\nKeratosis of skin of uncertain or unspecified nature: ME60.3\\nSkin lesion of unspecified nature: ME60.Z\\nSubcutaneous swelling mass or lump of uncertain or unspecified nature: ME61\\nAcute skin eruption of uncertain or unspecified nature: ME62\\nAcute erythematous skin eruption: ME62.0\\nAcute purpuric skin eruption: ME62.1\\nAcute urticarial skin eruption: ME62.2\\nAcute maculopapular skin eruption: ME62.3\\nAcute papular skin eruption: ME62.4\\nAcute exudative skin eruption: ME62.5\\nAcute blistering skin eruption: ME62.6\\nAcute desquamating skin eruption: ME62.7\\nAcute discoid or annular skin eruption: ME62.8\\nAcute excoriation of skin: ME62.9\\nOther specified acute skin eruption of uncertain or unspecified nature: ME62.Y\\nChronic skin disorder of uncertain or unspecified nature: ME63\\nChronic erythematous skin disorder: ME63.0\\nChronic urticarial skin disorder: ME63.1\\nChronic papular skin disorder: ME63.2\\nChronic blistering skin disorder: ME63.3\\nChronic scaling or hyperkeratotic skin disorder: ME63.4\\nChronic lichenified skin disorder: ME63.5\\nChronic discoid or annular skin disorder: ME63.6\\nChronic excoriation of skin: ME63.7\\nNonspecific cutaneous vascular signs: ME64\\nErythema: ME64.0\\nCyanosis: ME64.1\\nPallor: ME64.2\\nPetechiae: ME64.3\\nFlushing: ME64.4\\nDisturbances of skin sensation of unspecified aetiology: ME65\\nBurning of skin: ME65.0\\nItching of skin: ME65.1\\nPain or tenderness of skin: ME65.2\\nStinging of skin: ME65.3\\nTingling of skin: ME65.4\\nOther specified disturbance of skin sensation: ME65.Y\\nMiscellaneous nonspecific skinrelated symptoms and signs: ME66\\nAbnormal sensitivity to light or UV radiation of uncertain or unspecified nature: ME66.0\\nChanges in skin texture: ME66.1\\nExcess and redundant skin: ME66.2\\nSymptom or complaint relating to hair or scalp: ME66.3\\nSymptom or complaint relating to nails: ME66.4\\nComplaint of abnormal sweating: ME66.5\\nRash: ME66.6\\nRash localised: ME66.60\\nRash generalised: ME66.61\\nOther specified rash: ME66.6Y\\nRash unspecified: ME66.6Z\\nOther specified skin changes: ME66.Y\\nSkin disorder of uncertain or unspecified nature: ME67\\nOther specified symptoms or signs involving the skin: ME6Y\\nClicking hip: ME80\\nMusculoskeletal chest pain: ME81\\nIntercostal pain: ME81.0\\nOther specified musculoskeletal chest pain: ME81.Y\\nMusculoskeletal chest pain unspecified: ME81.Z\\nPain in joint: ME82\\nRheumatism unspecified: ME83\\nSpinal pain: ME84\\nCervical spine pain: ME84.0\\nThoracic spine pain: ME84.1\\nLow back pain: ME84.2\\nLumbago with sciatica: ME84.20\\nOther specified low back pain: ME84.2Y\\nLow back pain unspecified: ME84.2Z\\nSciatica: ME84.3\\nSpinal pain unspecified: ME84.Z\\nStiffness of joint: ME85\\nSymptom or complaint of a body part: ME86\\nSymptom or complaint of the ankle: ME86.0\\nSymptom or complaint of the arm: ME86.1\\nSymptom or complaint of the back: ME86.2\\nBack syndrome without radiating pain: ME86.20\\nBack syndrome with radiating pain: ME86.21\\nSymptom or complaint of the low back: ME86.22\\nOther specified symptom or complaint of the back: ME86.2Y\\nSymptom or complaint of the back unspecified: ME86.2Z\\nSymptom or complaint of the chest: ME86.3\\nSymptom or complaint of the elbow: ME86.4\\nSymptom or complaint of the flank or axilla: ME86.5\\nSymptom or complaint of the foot or toe: ME86.6\\nSymptom or complaint of the hand or finger: ME86.7\\nSymptom or complaint of the hip: ME86.8\\nSymptom or complaint of the jaw: ME86.9\\nSymptom or complaint of the knee: ME86.A\\nSymptom or complaint of the leg or thigh: ME86.B\\nSymptom or complaint of the neck: ME86.C\\nSymptom or complaint of the shoulder: ME86.D\\nShoulder syndrome: ME86.D0\\nOther specified symptom or complaint of the shoulder: ME86.DY\\nSymptom or complaint of the shoulder unspecified: ME86.DZ\\nSymptom or complaint of the wrist: ME86.E\\nSymptom or complaint of joint not otherwise specified: ME86.F\\nSymptom or complaint of muscle not otherwise specified: ME86.G\\nProblem of other specified body part: ME86.Y\\nProblem of unspecified body part: ME86.Z\\nOther specified symptoms or signs of the musculoskeletal system: ME8Y\\nClinical findings on diagnostic imaging of skull and head: ME90\\nClinical findings on diagnostic imaging of limbs: ME91\\nClinical findings on diagnostic imaging of other parts of musculoskeletal system: ME92\\nWedging of vertebra: ME92.0\\nBony erosion: ME92.1\\nOther specified clinical findings on diagnostic imaging of other parts of musculoskeletal system: ME92.Y\\nClinical findings on diagnostic imaging of other parts of musculoskeletal system unspecified: ME92.Z\\nBiomechanical lesions not elsewhere classified: ME93\\nSegmental and somatic dysfunction: ME93.0\\nSubluxation stenosis of neural canal: ME93.1\\nOsseous stenosis of neural canal: ME93.2\\nConnective tissue stenosis of neural canal: ME93.3\\nIntervertebral disc stenosis of neural canal: ME93.4\\nIntervertebral disc stenosis of neural canal head region: ME93.40\\nIntervertebral disc stenosis of neural canal cervical region: ME93.41\\nIntervertebral disc stenosis of neural canal thoracic region: ME93.42\\nIntervertebral disc stenosis of neural canal lumbar region: ME93.43\\nIntervertebral disc stenosis of neural canal sacral region: ME93.44\\nOther specified intervertebral disc stenosis of neural canal: ME93.4Y\\nIntervertebral disc stenosis of neural canal unspecified: ME93.4Z\\nOsseous and subluxation stenosis of intervertebral foramina: ME93.5\\nConnective tissue and disc stenosis of intervertebral foramina: ME93.6\\nOther specified biomechanical lesions not elsewhere classified: ME93.Y\\nBiomechanical lesions unspecified: ME93.Z\\nOther specified clinical findings in the musculoskeletal system: ME9Y\\nOther specified symptoms signs or clinical findings of the musculoskeletal system: MF1Y\\nBreast lump or mass female: MF30\\nBreast or lactation symptom or complaint: MF31\\nMenopausal symptom or complaint: MF32\\nPremenstrual symptom or complaint: MF33\\nPregnancy symptom or complaint: MF34\\nPostpartum symptom or complaint: MF35\\nOther symptom or complaint of vagina: MF36\\nSymptom or complaint of female nipple: MF37\\nSymptom or complaint of female pelvis: MF38\\nSymptom or complaint of the vulva: MF39\\nVaginal discharge: MF3A\\nOther specified symptoms signs or clinical findings involving the female genital system: MF3Y\\nProblems of male genital organs: MF40\\nSymptom or complaint of the penis: MF40.0\\nPain in penis: MF40.00\\nOther specified symptom or complaint of the penis: MF40.0Y\\nSymptom or complaint of the penis unspecified: MF40.0Z\\nProblems of the prostate: MF40.1\\nSymptom or complaint of the scrotum or testis: MF40.2\\nAcute scrotal pain: MF40.20\\nTesticular pain: MF40.21\\nOther specified symptom or complaint of the scrotum or testis: MF40.2Y\\nSymptom or complaint of the scrotum or testis unspecified: MF40.2Z\\nRetrograde ejaculation: MF40.3\\nOther specified problems of male genital organs: MF40.Y\\nProblems of male genital organs unspecified: MF40.Z\\nSymptom or complaint of male sexual function: MF41\\nRetractile testis migrans: MF42\\nOther specified symptoms signs or clinical findings involving the male genital system: MF4Y\\nAbnormal micturition: MF50\\nFrequent micturition: MF50.0\\nPollakiuria: MF50.1\\nUrinary incontinence: MF50.2\\nStress incontinence: MF50.20\\nUrge Incontinence: MF50.21\\nMixed incontinence: MF50.22\\nFunctional urinary incontinence: MF50.23\\nReflex incontinence: MF50.24\\nOther specified urinary incontinence: MF50.2Y\\nUrinary incontinence unspecified: MF50.2Z\\nRetention of urine: MF50.3\\nHaematuria: MF50.4\\nMacroscopic haematuria: MF50.40\\nMicroscopic haematuria: MF50.41\\nHaematuria unspecified: MF50.4Z\\nExtravasation of urine: MF50.5\\nOther difficulties with micturition: MF50.6\\nHesitancy of micturition: MF50.60\\nPoor urinary stream: MF50.61\\nSplitting of urinary stream: MF50.62\\nUrgency of urination: MF50.63\\nFeeling of incomplete bladder emptying: MF50.64\\nStraining to void: MF50.65\\nOther specified difficulties with micturition: MF50.6Y\\nDifficulties with micturition unspecified: MF50.6Z\\nDysuria: MF50.7\\nVesical tenesmus: MF50.8\\nOther specified abnormal micturition: MF50.Y\\nAbnormal micturition unspecified: MF50.Z\\nAnuria or oliguria: MF51\\nBladder pain: MF52\\nExtrarenal uraemia: MF53\\nMacroscopic changes of size of the kidney: MF54\\nSmooth contracted kidney: MF54.0\\nIrregularly contracted kidney: MF54.1\\nSmall kidney: MF54.2\\nOther specified macroscopic changes of size of the kidney: MF54.Y\\nMacroscopic changes of size of the kidney unspecified: MF54.Z\\nPolyuria: MF55\\nRenal colic: MF56\\nSymptom or complaint of bladder: MF57\\nUrethral discharge: MF58\\nUrinary symptom or complaint: MF59\\nOther specified symptoms signs or clinical findings involving the urinary system: MF5Y\\nAbnormal level of enzymes in specimens from female genital organs: MF60\\nAbnormal level of hormones in specimens from female genital organs: MF61\\nAbnormal level of drugs medicaments and biological substances in specimens from female genital organs: MF62\\nAbnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs: MF63\\nAbnormal immunological findings in specimens from female genital organs: MF64\\nAbnormal microbiological findings in specimens from female genital organs: MF65\\nAbnormal cytological findings in specimens from female genital organs: MF66\\nAbnormal cervix smear: MF66.0\\nOther specified abnormal cytological findings in specimens from female genital organs: MF66.Y\\nAbnormal cytological findings in specimens from female genital organs unspecified: MF66.Z\\nAbnormal histological findings in specimens from female genital organs: MF67\\nAbnormal chromosomal findings in specimens from female genital organs: MF68\\nOther specified clinical findings in specimens from female genital organs: MF6Y\\nClinical findings in specimens from female genital organs unspecified: MF6Z\\nAbnormal level of enzymes in specimens from male genital organs: MF70\\nAbnormal level of hormones in specimens from male genital organs: MF71\\nAbnormal level of drugs medicaments and biological substances in specimens from male genital organs: MF72\\nAbnormal level of substances chiefly nonmedicinal as to source in specimens from male genital organs: MF73\\nAbnormal immunological findings in specimens from male genital organs: MF74\\nAbnormal microbiological findings in specimens from male genital organs: MF75\\nAbnormal cytological findings in specimens from male genital organs: MF76\\nAbnormal histological findings in specimens from male genital organs: MF77\\nAbnormal chromosomal findings in specimens from male genital organs: MF78\\nOther specified clinical findings in specimens from male genital organs: MF7Y\\nClinical findings in specimens from male genital organs unspecified: MF7Z\\nDiffuse mesangial sclerosis: MF80\\nFibronectin glomerulopathy: MF81\\nLipoprotein glomerulopathy: MF82\\nDiabetic glomerular changes: MF83\\nPauciimmune proliferative glomerulonephritis: MF84\\nAntiglomerular basement membrane antibody mediated disease: MF85\\nOther specified clinical findings in specimens from the urinary system: MF8Y\\nClinical findings in specimens from the urinary system unspecified: MF8Z\\nAcetonuria: MF90\\nBilirubinuria: MF91\\nChyluria: MF92\\nGlycosuria: MF93\\nHaemoglobinuria: MF94\\nMyoglobinuria: MF95\\nProteinuria: MF96\\nOrthostatic proteinuria: MF96.0\\nBence Jones proteinuria: MF96.1\\nOther specified proteinuria: MF96.Y\\nProteinuria unspecified: MF96.Z\\nPyuria: MF97\\nAbnormal levels of serum electrolytes in the urine: MF98\\nHypercalciuria: MF98.0\\nHyperkaluria: MF98.1\\nHypermagnesuria: MF98.2\\nHypocalciuria: MF98.3\\nHypokaluria: MF98.4\\nHypomagnesuria: MF98.5\\nHypophosphaturia: MF98.6\\nOther specified abnormal levels of serum electrolytes in the urine: MF98.Y\\nAbnormal levels of serum electrolytes in the urine unspecified: MF98.Z\\nElevated urine levels of drugs medicaments and biological substances: MF99\\nAbnormal urine levels of substances chiefly nonmedicinal as to source: MF9A\\nAbnormal findings on microbiological examination of urine: MF9B\\nAbnormal findings on cytological and histological examination of urine: MF9C\\nOther specified clinical findings on examination of urine without diagnosis: MF9Y\\nClinical findings on diagnostic imaging of breast: MG00\\nClinical findings on diagnostic imaging of urinary organs: MG01\\nResults of kidney function studies: MG02\\nOther specified symptoms signs or clinical findings of the genitourinary system: MG0Y\\nCachexia: MG20\\nMalignant cachexia: MG20.0\\nCachexia unspecified: MG20.Z\\nChills: MG21\\nFatigue: MG22\\nFear of death or dying: MG23\\nFear of disease: MG24\\nFear of cancer: MG24.0\\nFear of cancer of digestive system: MG24.00\\nFear of breast cancer female: MG24.01\\nFear of genital cancer male: MG24.02\\nOther specified fear of cancer: MG24.0Y\\nFear of cancer unspecified: MG24.0Z\\nFear of human immunodeficiency virus: MG24.1\\nFear of haematological disease: MG24.2\\nFear of digestive disease: MG24.3\\nFear of eye disease: MG24.4\\nFear of heart disease: MG24.5\\nFear of hypertension: MG24.6\\nFear of cardiovascular disease: MG24.7\\nFear of musculoskeletal disease: MG24.8\\nFear of neurological disease: MG24.9\\nFear of respiratory disease: MG24.A\\nFear of endocrine metabolic or nutritional disease: MG24.B\\nFear of urinary disease: MG24.C\\nFear of complications of pregnancy: MG24.D\\nFear of sexually transmitted disease female: MG24.E\\nFear of female genital or breast disease: MG24.F\\nFear of sexually transmitted disease male: MG24.G\\nFear of genital disease male: MG24.H\\nFear of mental disorder: MG24.J\\nFear of other specified disease: MG24.Y\\nFear of disease unspecified: MG24.Z\\nFeeling ill: MG25\\nFever of other or unknown origin: MG26\\nHaemorrhage not elsewhere classified: MG27\\nHypothermia not associated with low environmental temperature: MG28\\nOedema: MG29\\nLocalised oedema: MG29.0\\nAnkle oedema: MG29.00\\nOedema of legs: MG29.01\\nPitting of lip: MG29.02\\nOther specified localised oedema: MG29.0Y\\nGeneralised oedema: MG29.1\\nOedema due to increased capillary pressure: MG29.10\\nOther specified generalised oedema: MG29.1Y\\nInfectious oedema: MG29.2\\nPitting oedema: MG29.3\\nOedema unspecified: MG29.Z\\nAgeing associated decline in intrinsic capacity: MG2A\\nChronic pain: MG30\\nChronic primary pain: MG30.0\\nChronic primary visceral pain: MG30.00\\nChronic widespread pain: MG30.01\\nChronic primary musculoskeletal pain: MG30.02\\nChronic primary headache or orofacial pain: MG30.03\\nComplex regional pain syndrome: MG30.04\\nOther specified chronic primary pain: MG30.0Y\\nChronic primary pain unspecified: MG30.0Z\\nChronic cancer related pain: MG30.1\\nChronic cancer pain: MG30.10\\nChronic post cancer treatment pain: MG30.11\\nOther specified chronic cancer related pain: MG30.1Y\\nChronic cancer related pain unspecified: MG30.1Z\\nChronic postsurgical or post traumatic pain: MG30.2\\nChronic post traumatic pain: MG30.20\\nChronic postsurgical pain: MG30.21\\nOther specified chronic postsurgical or post traumatic pain: MG30.2Y\\nChronic postsurgical or post traumatic pain unspecified: MG30.2Z\\nChronic secondary musculoskeletal pain: MG30.3\\nChronic secondary musculoskeletal pain from persistent inflammation: MG30.30\\nChronic secondary musculoskeletal pain associated with structural changes: MG30.31\\nChronic secondary musculoskeletal pain due to disease of the nervous system: MG30.32\\nOther specified chronic secondary musculoskeletal pain: MG30.3Y\\nChronic secondary musculoskeletal pain unspecified: MG30.3Z\\nChronic secondary visceral pain: MG30.4\\nChronic visceral pain from mechanical factors: MG30.40\\nChronic visceral pain from vascular mechanisms: MG30.41\\nChronic visceral pain from persistent inflammation: MG30.42\\nOther specified chronic secondary visceral pain: MG30.4Y\\nChronic secondary visceral pain unspecified: MG30.4Z\\nChronic neuropathic pain: MG30.5\\nChronic central neuropathic pain: MG30.50\\nChronic peripheral neuropathic pain: MG30.51\\nOther specified chronic neuropathic pain: MG30.5Y\\nChronic neuropathic pain unspecified: MG30.5Z\\nChronic secondary headache or orofacial pain: MG30.6\\nChronic dental pain: MG30.61\\nChronic neuropathic orofacial pain: MG30.62\\nHeadache or orofacial pain associated with chronic secondary temporomandibular disorders: MG30.63\\nChronic headache or orofacial pain associated with disorders of homoeostasis or their nonpharmacological treatment: MG30.64\\nChronic headache or orofacial pain associated with cranial or cervical vascular disorder: MG30.65\\nChronic headache or orofacial pain associated with nonvascular intracranial disorder: MG30.66\\nChronic headache associated with a substance or its withdrawal: MG30.67\\nOther specified chronic secondary headache or orofacial pain: MG30.6Y\\nChronic secondary headache or orofacial pain unspecified: MG30.6Z\\nOther specified chronic pain: MG30.Y\\nChronic pain unspecified: MG30.Z\\nAcute pain: MG31\\nAcute pain in the face not elsewhere classified: MG31.0\\nAcute headache not elsewhere classified: MG31.1\\nAcute postoperative pain not elsewhere classified: MG31.2\\nOther specified acute pain: MG31.Y\\nAcute pain unspecified: MG31.Z\\nPain unspecified: MG3Z\\nShock: MG40\\nCardiogenic shock: MG40.0\\nHypovolaemic shock: MG40.1\\nOther specified shock: MG40.Y\\nShock unspecified: MG40.Z\\nSleep disturbance not elsewhere classified: MG41\\nSomnolence not elsewhere classified: MG42\\nSymptoms or signs concerning food or fluid intake: MG43\\nPolydipsia: MG43.0\\nOvereating: MG43.1\\nAbulia: MG43.2\\nFeeding difficulties: MG43.3\\nFeeding problem of infant: MG43.30\\nFeeding problem of child: MG43.31\\nFeeding problem of adult: MG43.32\\nFeeding difficulties unspecified: MG43.3Z\\nInsufficient intake of food or water due to self neglect: MG43.4\\nRefusal of food not elsewhere classified: MG43.40\\nRefusal of fluid not elsewhere classified: MG43.41\\nOther specified insufficient intake of food or water due to self neglect: MG43.4Y\\nInsufficient intake of food or water due to self neglect unspecified: MG43.4Z\\nExcessive weight loss: MG43.5\\nExcessive weight gain: MG43.6\\nAnorexia: MG43.7\\nDecreased appetite: MG43.8\\nIncreased appetite: MG43.9\\nOther specified symptoms or signs concerning food or fluid intake: MG43.Y\\nSymptoms peculiar to infancy: MG44\\nExcessive crying of infant: MG44.0\\nLack of expected normal physiological development: MG44.1\\nDelayed milestone: MG44.10\\nFailure to thrive in infant or child: MG44.11\\nShort stature of child: MG44.12\\nConstitutional delay of growth and puberty: MG44.13\\nFamilial short stature: MG44.14\\nOther specified lack of expected normal physiological development: MG44.1Y\\nLack of expected normal physiological development unspecified: MG44.1Z\\nOther specified symptoms peculiar to infancy: MG44.Y\\nSymptoms peculiar to infancy unspecified: MG44.Z\\nSyncope or collapse: MG45\\nCardiac syncope: MG45.0\\nOther specified syncope or collapse: MG45.Y\\nSyncope or collapse unspecified: MG45.Z\\nSystemic inflammatory response syndrome of noninfectious origin: MG46\\nToxicosis not further specified: MG47\\nUnknown or unspecified causes of morbidity: MG48\\nHangover: MG49\\nMulti organ failure: MG4A\\nOther specified general symptoms: MG4Y\\nFinding of gram negative bacteria resistant to antimicrobial drugs: MG50\\nAntibiotic resistant Acinetobacter baumannii: MG50.0\\nTetracycline resistant Acinetobacter baumannii: MG50.00\\nAminoglycoside resistant Acinetobacter baumannii: MG50.01\\nCarbapenem resistant Acinetobacter baumannii: MG50.02\\nPolymyxin resistant Acinetobacter baumannii: MG50.03\\nAcinetobacter resistant to other antibiotic: MG50.0Y\\nAcinetobacter resistant to unspecified antibiotic: MG50.0Z\\nAntibiotic resistant Campylobacter: MG50.1\\nFluoroquinolone resistant Campylobacter: MG50.10\\nOther specified antibiotic resistant Campylobacter: MG50.1Y\\nCampylobacter resistant to unspecified antibiotic: MG50.1Z\\nAntibiotic resistant Escherichia coli: MG50.2\\nSulfonamide or trimethoprim resistant Escherichia coli: MG50.20\\nFluoroquinolone resistant Escherichia coli: MG50.21\\nThird generation cephalosporin resistant Escherichia coli: MG50.22\\nFourthgeneration cephalosporins resistant Escherichia coli: MG50.23\\nCarbapenem resistant Escherichia coli: MG50.24\\nPolymyxin resistant Escherichia coli: MG50.25\\nPenicillin resistant Escherichia coli: MG50.26\\nExtended spectrum betalactamase producing Escherichia coli: MG50.27\\nEscherichia coli resistant to other antibiotic: MG50.2Y\\nEscherichia coli resistant to unspecified antibiotic: MG50.2Z\\nAntibiotic resistant Haemophilus influenzae: MG50.3\\nAmpicillin resistant Haemophilus influenzae: MG50.30\\nOther specified antibiotic resistant Haemophilus influenzae: MG50.3Y\\nAntibiotic resistant Haemophilus influenzae unspecified: MG50.3Z\\nAntibiotic resistant Helicobacter pylori: MG50.4\\nClarithromycin resistant Helicobacter pylori: MG50.40\\nOther specified antibiotic resistant Helicobacter pylori: MG50.4Y\\nAntibiotic resistant Helicobacter pylori unspecified: MG50.4Z\\nAntibiotic resistant Klebsiella pneumoniae: MG50.5\\nSulfonamide or trimethoprim resistant Klebsiella pneumoniae: MG50.50\\nFluoroquinolone resistant Klebsiella pneumoniae: MG50.51\\nThirdgeneration cephalosporin resistant Klebsiella pneumoniae: MG50.52\\nFourthgeneration cephalosporin resistant Klebsiella pneumoniae: MG50.53\\nCarbapenem resistant Klebsiella pneumoniae: MG50.54\\nPolymyxin resistant Klebsiella pneumoniae: MG50.55\\nExtendedspectrum betalactamase producing Klebsiella pneumoniae: MG50.56\\nKlebsiella pneumoniae resistant to other antibiotic: MG50.5Y\\nKlebsiella pneumoniae resistant to unspecified antibiotic: MG50.5Z\\nAntibiotic resistant Neisseria gonorrhoeae: MG50.6\\nThird generation cephalosporin resistant Neisseria gonorrhoeae: MG50.60\\nMacrolide resistant Neisseria gonorrhoeae: MG50.61\\nAminocyclitol resistant Neisseria gonorrhoeae: MG50.62\\nFluoroquinolone resistant Neisseria gonorrhoeae: MG50.63\\nAminoglycoside resistant Neisseria gonorrhoeae: MG50.64\\nNeisseria gonorrhoeae resistant to other antibiotic: MG50.6Y\\nNeisseria gonorrhoeae resistant to unspecified antibiotic: MG50.6Z\\nAntibiotic resistant Neisseria meningitidis: MG50.7\\nPenicillin resistant Neisseria meningitidis: MG50.70\\nOther specified antibiotic resistant Neisseria meningitidis: MG50.7Y\\nAntibiotic resistant Neisseria meningitidis unspecified: MG50.7Z\\nAntibiotic resistant Pseudomonas aeruginosa: MG50.8\\nCarbapenemresistant Pseudomonas aeruginosa: MG50.80\\nPolymyxinresistant Pseudomonas aeruginosa: MG50.81\\nPseudomonas aeruginosa resistant to other antibiotic: MG50.8Y\\nPseudomonas aeruginosa resistant to unspecified antibiotic: MG50.8Z\\nAntibiotic resistant Salmonella: MG50.9\\nFluoroquinolone resistant Salmonella: MG50.90\\nThird generation cephalosporin resistant Salmonella: MG50.91\\nCarbapenem resistant Salmonella: MG50.92\\nSalmonella resistant to other antibiotic: MG50.9Y\\nSalmonella resistant to unspecified antibiotic: MG50.9Z\\nAntibiotic resistant Shigella: MG50.A\\nCarbapenem resistant Shigella: MG50.A0\\nFluoroquinolone resistant Shigella: MG50.A1\\nThirdgeneration cephalosporins resistant Shigella: MG50.A2\\nMacrolides resistant Shigella: MG50.A3\\nShigella resistant to other antibiotic: MG50.AY\\nShigella resistant to unspecified antibiotic: MG50.AZ\\nAntibiotic resistant Vibrio: MG50.B\\nFluoroquinolone resistant Vibrio: MG50.B0\\nVibrio resistant to other antibiotic: MG50.BY\\nVibrio resistant to unspecified antibiotic: MG50.BZ\\nOther antibiotic resistant Enterobacterales: MG50.C\\nOther carbapenem resistant Enterobacterales: MG50.C0\\nOther thirdgeneration cephalosporin resistant Enterobacterales: MG50.C1\\nOther specified other antibiotic resistant Enterobacterales: MG50.CY\\nOther antibiotic resistant Enterobacterales unspecified: MG50.CZ\\nOther specified finding of gram negative bacteria resistant to antimicrobial drugs: MG50.Y\\nFinding of gram negative bacteria resistant to antimicrobial drugs unspecified: MG50.Z\\nFinding of gram positive bacteria resistant to antimicrobial drugs: MG51\\nAntibiotic resistant Staphylococcus aureus: MG51.0\\nMethicillin resistant Staphylococcus aureus: MG51.00\\nVancomycin resistant Staphylococcus aureus: MG51.01\\nPenicillinasestable beta lactams resistant Staphylococcus aureus: MG51.02\\nOther specified antibiotic resistant Staphylococcus aureus: MG51.0Y\\nAntibiotic resistant Staphylococcus aureus unspecified: MG51.0Z\\nAntibiotic resistant Streptococcus pneumoniae: MG51.1\\nPenicillin resistant Streptococcus pneumoniae: MG51.10\\nSulfonamide and trimethoprim resistant Streptococcus pneumoniae: MG51.11\\nThirdgeneration cephalosporins resistant Streptococcus pneumoniae: MG51.12\\nStreptococcus pneumoniae resistant to other antibiotic: MG51.1Y\\nStreptococcus pneumoniae resistant to unspecified antibiotic: MG51.1Z\\nAntibiotic resistant Enterococcus: MG51.2\\nVancomycin resistant Enterococcus: MG51.20\\nEnterococcus resistant to other antibiotic: MG51.2Y\\nEnteroccus resistant to unspecified antibiotic: MG51.2Z\\nOther specified finding of gram positive bacteria resistant to antimicrobial drugs: MG51.Y\\nFinding of gram positive bacteria resistant to antimicrobial drugs unspecified: MG51.Z\\nFinding of bacteria neither gram negative nor positive resistant to antimicrobial drugs: MG52\\nAntibiotic resistant Mycobacterium: MG52.0\\nMultidrug resistant Mycobacterium tuberculosis: MG52.00\\nAntibiotic resistant nontuberculous Mycobacterium: MG52.01\\nExtensively drugresistant mycobacterium tuberculosis: MG52.02\\nOther specified antibiotic resistant Mycobacterium: MG52.0Y\\nAntibiotic resistant Mycobacterium unspecified: MG52.0Z\\nOther specified finding of bacteria neither gram negative nor positive resistant to antimicrobial drugs: MG52.Y\\nFinding of bacteria neither gram negative nor positive resistant to antimicrobial drugs unspecified: MG52.Z\\nFinding of virus resistant to antimicrobial drugs: MG53\\nAntiretroviral therapy resistant Human immunodeficiency virus: MG53.0\\nOther specified finding of virus resistant to antimicrobial drugs: MG53.Y\\nFinding of virus resistant to antimicrobial drugs unspecified: MG53.Z\\nFinding of fungus resistant to antimicrobial drugs: MG54\\nFinding of parasite resistant to antimicrobial drugs: MG55\\nArtemisinin resistant Plasmodium falciparum: MG55.0\\nOther specified finding of parasite resistant to antimicrobial drugs: MG55.Y\\nFinding of parasite resistant to antimicrobial drugs unspecified: MG55.Z\\nFinding of microorganism resistant to other multiple antimicrobial drugs: MG56\\nFinding of other microorganism resistant to antimicrobial drugs: MG5Y\\nFinding of microorganism resistant to antimicrobial drugs unspecified: MG5Z\\nAbnormal level of enzymes in specimens from other organs systems and tissues: MG60\\nAbnormal level of hormones in specimens from other organs systems and tissues: MG61\\nAbnormal level of drugs medicaments and biological substances in specimens from other organs systems and tissues: MG62\\nAbnormal level of substances chiefly nonmedicinal as to source in specimens from other organs systems and tissues: MG63\\nAbnormal immunological findings in specimens from other organs systems and tissues: MG64\\nAbnormal microbiological findings in specimens from other organs systems and tissues: MG65\\nAbnormal cytological findings in specimens from other organs systems and tissues: MG66\\nAbnormal histological findings in specimens from other organs systems and tissues: MG67\\nOther specified clinical findings in specimens from other specified organs systems and tissues: MG6Y\\nAbnormal diagnostic imaging results not elsewhere classified: MG70\\nAbnormal laboratory results not elsewhere classified: MG71\\nAbnormal findings on neonatal screening: MG71.0\\nOther specified abnormal laboratory results not elsewhere classified: MG71.Y\\nAbnormal laboratory results not elsewhere classified unspecified: MG71.Z\\nAbnormal results of function studies of other organs and systems: MG72\\nOther specified abnormal results not elsewhere classified: MG7Y\\nAbnormal results not elsewhere classified unspecified: MG7Z\\nBrain death: MH10\\nSudden infant death syndrome: MH11\\nSudden infant death syndrome with mention of autopsy: MH11.0\\nSudden infant death syndrome without autopsy: MH11.1\\nSudden infant death syndrome unspecified: MH11.Z\\nOther sudden death cause unknown: MH12\\nInstantaneous death: MH12.0\\nDeath occurring less than  hours from onset of symptoms not otherwise explained: MH12.1\\nOther specified sudden death cause unknown: MH12.Y\\nUnattended death: MH13\\nOther illdefined or unspecified causes of mortality: MH14\\nSudden unexpected death in epilepsy: MH15\\nOther specified symptoms signs or clinical findings not elsewhere classified: MH2Y\\nSuperficial injury of head: NA00\\nSuperficial injury of scalp: NA00.0\\nAbrasion of scalp: NA00.00\\nContusion of scalp: NA00.01\\nSuperficial foreign body in scalp: NA00.02\\nOther specified superficial injury of scalp: NA00.0Y\\nSuperficial injury of scalp type unspecified: NA00.0Z\\nSuperficial injury of eyelid or periocular area: NA00.1\\nAbrasion of eyelid or periocular area: NA00.10\\nContusion of eyelid or periocular area: NA00.11\\nOther specified superficial injury of eyelid or periocular area: NA00.1Y\\nSuperficial injury of eyelid or periocular area unspecified: NA00.1Z\\nSuperficial injury of ear: NA00.2\\nSuperficial injury of nose: NA00.3\\nSuperficial injury of lip or oral cavity: NA00.4\\nMultiple superficial injuries of head: NA00.5\\nAbrasion of other or unspecified sites of head: NA00.6\\nContusion of other or unspecified sites of head: NA00.7\\nSuperficial injury of other specified part of head: NA00.Y\\nSuperficial injury of unspecified part of head: NA00.Z\\nOpen wound of head: NA01\\nLaceration without foreign body of head: NA01.2\\nLaceration with foreign body of head: NA01.3\\nPuncture wound without foreign body of head: NA01.4\\nPuncture wound with foreign body of head: NA01.5\\nOpen bite of head: NA01.6\\nMultiple open wounds of head: NA01.7\\nOther specified open wound of head: NA01.Y\\nOpen wound of head unspecified: NA01.Z\\nFracture of skull or facial bones: NA02\\nFracture of vault of skull: NA02.0\\nFracture of squama of frontal bone of skull: NA02.00\\nFracture of parietal bone of skull: NA02.01\\nFracture of squama of temporal bone of skull: NA02.02\\nFracture of squama of occipital bone of skull: NA02.03\\nFracture of vault of skull unspecified: NA02.0Z\\nFracture of base of skull: NA02.1\\nFracture of anterior fossa of base of skull: NA02.10\\nFracture of middle fossa of base of skull: NA02.11\\nFracture of posterior fossa of base of skull: NA02.12\\nFracture of sinus of ethmoid bone of skull: NA02.13\\nFracture of frontal sinus of skull: NA02.14\\nFracture of sphenoid bone of skull: NA02.15\\nFracture of occipital condyle of skull type I: NA02.16\\nFracture of occipital condyle of skull type II: NA02.17\\nFracture of occipital condyle of skull type III: NA02.18\\nFracture of other part of occipital bone of skull: NA02.19\\nOther fractures of base of skull: NA02.1A\\nFracture of base of skull unspecified: NA02.1Z\\nOrbital fracture: NA02.2\\nFracture of orbital roof: NA02.20\\nFracture of orbital floor: NA02.21\\nOther specified orbital fracture: NA02.2Y\\nOrbital fracture unspecified: NA02.2Z\\nFracture of nasal bones: NA02.3\\nFracture of maxilla: NA02.4\\nLe Fort fracture type I: NA02.40\\nLe Fort fracture type II: NA02.41\\nLe Fort fracture type III: NA02.42\\nOther specified fracture of maxilla: NA02.4Y\\nFracture of maxilla unspecified: NA02.4Z\\nFracture of zygoma: NA02.5\\nFracture of mandible: NA02.7\\nFracture of condylar process of mandible: NA02.70\\nFracture of subcondylar process of mandible: NA02.71\\nFracture of coronoid process of mandible: NA02.72\\nFracture of ramus of mandible: NA02.73\\nFracture of angle of mandible: NA02.74\\nFracture of alveolar margin of mandible: NA02.75\\nFracture of symphysis of mandible: NA02.76\\nOther specified fracture of mandible: NA02.7Y\\nFracture of mandible unspecified: NA02.7Z\\nMultiple fractures involving skull or facial bones: NA02.8\\nFracture of other specified skull or facial bones: NA02.Y\\nFracture of skull or facial bones part unspecified: NA02.Z\\nDislocation or strain or sprain of joints or ligaments of head: NA03\\nDislocation of jaw: NA03.0\\nDislocation of septal cartilage of nose: NA03.1\\nStrain or sprain of jaw: NA03.3\\nDislocation or sprain of other specified joints or ligaments of head: NA03.Y\\nDislocation or strain or sprain of joints or ligaments of head unspecified: NA03.Z\\nInjury of cranial nerves: NA04\\nInjury of olfactory nerve: NA04.0\\nInjury of optic nerve or pathways: NA04.1\\nInjury of optic nerve unilateral: NA04.10\\nInjury of optic nerve bilateral: NA04.11\\nInjury of optic chiasm: NA04.12\\nInjury of optic tract or pathways unilateral: NA04.13\\nInjury of optic tract or pathways bilateral: NA04.14\\nInjury of visual cortex unilateral: NA04.15\\nInjury of visual cortex bilateral: NA04.16\\nOther specified injury of optic nerve or pathways: NA04.1Y\\nInjury of optic nerve or pathways unspecified: NA04.1Z\\nInjury of oculomotor nerve: NA04.2\\nInjury of trochlear nerve: NA04.3\\nInjury of trigeminal nerve: NA04.4\\nInjury of abducent nerve: NA04.5\\nInjury of facial nerve: NA04.6\\nInjury of acoustic nerve: NA04.7\\nInjury of glossopharyngeal nerve: NA04.8\\nInjury of vagus nerve: NA04.9\\nInjury of accessory nerve: NA04.A\\nInjury of hypoglossal nerve: NA04.B\\nInjury of cranial nerves unspecified: NA04.Z\\nInjury of blood vessels of head: NA05\\nInjury of intracranial vessels of head: NA05.0\\nInjury of extracranial vessels of head: NA05.1\\nInjury of blood vessels of head unspecified: NA05.Z\\nInjury of eye or orbit: NA06\\nEyelid trauma: NA06.0\\nEyelid avulsion: NA06.00\\nHaematoma of eyelid: NA06.01\\nOedema of eyelid: NA06.02\\nRetained foreign body in eyelid: NA06.03\\nOpen wound of eyelid or periocular area: NA06.04\\nOther specified eyelid trauma: NA06.0Y\\nEyelid trauma unspecified: NA06.0Z\\nPenetrating wound of orbit with or without foreign body: NA06.1\\nRetained foreign body following penetrating wound of orbit: NA06.2\\nTraumatic orbital haemorrhage: NA06.3\\nInjury of conjunctiva or corneal abrasion without mention of foreign body: NA06.4\\nTrauma to the iris sphincter: NA06.5\\nTraumatic injuries of the retina: NA06.6\\nTraumatic macular hole: NA06.60\\nChoroidal rupture: NA06.61\\nCommotio retinae: NA06.62\\nOptic nerve avulsion: NA06.63\\nOther specified traumatic injuries of the retina: NA06.6Y\\nTraumatic injuries of the retina unspecified: NA06.6Z\\nTraumatic retinal haemorrhage: NA06.7\\nTraumatic injury to eyeball: NA06.8\\nRetained intraocular magnetic foreign body unilateral: NA06.80\\nRetained intraocular nonmagnetic foreign body unilateral: NA06.81\\nClosed eyeball trauma unilateral: NA06.82\\nClosed eyeball trauma bilateral: NA06.83\\nPenetrating wound of eyeball without foreign body unilateral: NA06.84\\nAvulsion of eye unilateral: NA06.85\\nAvulsion of eye bilateral: NA06.86\\nOcular laceration or rupture with prolapse or loss of intraocular tissue unilateral: NA06.87\\nOcular laceration or rupture with prolapse or loss of intraocular tissue bilateral: NA06.88\\nPenetrating injury of eyeball bilateral: NA06.89\\nPerforating injury of eyeball bilateral: NA06.8A\\nRetained intraocular magnetic foreign body bilateral: NA06.8B\\nRetained intraocular nonmagnetic foreign body bilateral: NA06.8C\\nOcular laceration without prolapse or loss of intraocular tissue unilateral: NA06.8D\\nOcular laceration without prolapse or loss of intraocular tissue bilateral: NA06.8E\\nOther specified traumatic injury to eyeball: NA06.8Y\\nTraumatic injury to eyeball unspecified: NA06.8Z\\nContusion of eyeball or orbital tissues: NA06.9\\nInjury of lens: NA06.A\\nOther specified injury of eye or orbit: NA06.Y\\nInjury of eye or orbit unspecified: NA06.Z\\nIntracranial injury: NA07\\nConcussion: NA07.0\\nConcussion with incomplete loss of consciousness with amnesia: NA07.00\\nConcussion with incomplete loss of consciousness without amnesia: NA07.01\\nConcussion with loss of consciousness short duration of less than  minutes: NA07.02\\nConcussion with loss of consciousness short duration of  minutes to less than one hour: NA07.03\\nConcussion with loss of consciousness short duration of one hour to less than  hours: NA07.04\\nConcussion with loss of consciousness intermediate duration of  hours to less than  hours: NA07.05\\nConcussion with loss of consciousness persisting longer than  hours or until discharge or latest assessment: NA07.06\\nConcussion with loss of consciousness persisting until death: NA07.07\\nConcussion with loss of consciousness duration unspecified or unknown due to effects of therapy: NA07.08\\nConcussion with loss of consciousness duration unspecified or unknown due to lack of information: NA07.09\\nOther specified concussion: NA07.0Y\\nConcussion unspecified: NA07.0Z\\nTraumatic intracerebral haemorrhage: NA07.1\\nTraumatic cerebral oedema: NA07.2\\nDiffuse traumatic cerebral oedema: NA07.20\\nFocal traumatic cerebral oedema: NA07.21\\nOther specified traumatic cerebral oedema: NA07.2Y\\nTraumatic cerebral oedema unspecified: NA07.2Z\\nDiffuse brain injury: NA07.3\\nDiffuse injury of cerebrum: NA07.30\\nDiffuse injury of cerebellum: NA07.31\\nDiffuse injury of brainstem: NA07.32\\nDiffuse injury of multiple parts of brain: NA07.33\\nOther specified diffuse brain injury: NA07.3Y\\nUnspecified diffuse traumatic brain injury: NA07.3Z\\nFocal brain injury: NA07.4\\nFocal nonhaemorrhagic contusion of cerebrum: NA07.40\\nFocal haemorrhagic contusion of cerebrum: NA07.41\\nFocal laceration of cerebrum: NA07.42\\nMultiple focal injuries of cerebrum: NA07.43\\nFocal nonhaemorrhagic contusion of cerebellum: NA07.44\\nFocal haematoma or haemorrhage of cerebellum: NA07.45\\nFocal laceration of cerebellum: NA07.46\\nMultiple focal injuries of cerebellum: NA07.47\\nFocal nonhaemorrhagic contusion of brainstem: NA07.48\\nFocal haematoma or haemorrhage of brainstem: NA07.49\\nContusion of temporal lobe: NA07.4A\\nFocal laceration of brainstem: NA07.4B\\nFocal brain contusion: NA07.4C\\nFocal brain laceration: NA07.4D\\nContusion of parietal lobe: NA07.4E\\nContusion of occipital lobe: NA07.4F\\nUnspecified focal traumatic brain injury: NA07.4Z\\nTraumatic epidural haemorrhage: NA07.5\\nTraumatic subdural haemorrhage: NA07.6\\nAcute traumatic subdural haemorrhage: NA07.60\\nChronic traumatic subdural haemorrhage: NA07.61\\nTraumatic subdural haemorrhage unspecified whether acute or chronic: NA07.6Z\\nTraumatic subarachnoid haemorrhage: NA07.7\\nTraumatic haemorrhage in brain tissue: NA07.8\\nTraumatic haemorrhage in cerebrum white matter: NA07.80\\nTraumatic haemorrhage in thalamus or basal ganglia: NA07.81\\nTraumatic haemorrhage in cerebellum: NA07.82\\nTraumatic haemorrhage in brainstem without specification whether primary or secondary: NA07.83\\nTraumatic haemorrhage in brainstem primary: NA07.84\\nTraumatic haemorrhage in brainstem secondary: NA07.85\\nMultiple traumatic haemorrhages: NA07.86\\nOther specified traumatic haemorrhage in brain tissue: NA07.8Y\\nTraumatic haemorrhage in brain tissue unspecified: NA07.8Z\\nOther specified intracranial injury: NA07.Y\\nIntracranial injury unspecified: NA07.Z\\nCrushing injury of head: NA08\\nCrushing injury of brain: NA08.0\\nCrushing injury of face: NA08.1\\nCrushing injury of skull: NA08.2\\nCrushed scalp: NA08.3\\nOther specified crushing injury of head: NA08.Y\\nCrushing injury of head unspecified: NA08.Z\\nTraumatic amputation of part of head: NA09\\nAvulsion of scalp: NA09.0\\nTraumatic amputation of ear: NA09.1\\nTraumatic amputation of ear complete: NA09.10\\nTraumatic amputation of ear partial: NA09.11\\nTraumatic amputation of ear unspecified: NA09.1Z\\nTraumatic amputation of nose: NA09.2\\nTraumatic amputation of nose complete: NA09.20\\nTraumatic amputation of nose partial: NA09.21\\nTraumatic amputation of nose unspecified: NA09.2Z\\nTraumatic amputation of lip: NA09.3\\nOther specified traumatic amputation of part of head: NA09.Y\\nTraumatic amputation of part of head unspecified: NA09.Z\\nCertain specified injuries of head: NA0A\\nComplex wounds to the head: NA0A.0\\nComplex wounds to the head with retained external material: NA0A.00\\nComplex wounds to the head with intracranial haemorrhage: NA0A.01\\nComplex wounds to the head with through and through perforation: NA0A.02\\nComplex wounds to the head with avulsive loss of part of skull and cranial contents: NA0A.03\\nOther specified complex wounds to the head: NA0A.0Y\\nComplex wounds to the head unspecified: NA0A.0Z\\nInjury of muscle fascia or tendon of head: NA0A.1\\nStrain or sprain of muscle fascia or tendon of head: NA0A.10\\nLaceration of muscle fascia or tendon of head: NA0A.11\\nOther specified injury of muscle fascia or tendon of head: NA0A.1Y\\nInjury of muscle fascia or tendon of head unspecified: NA0A.1Z\\nTraumatic rupture of ear drum: NA0A.2\\nMultiple injuries of head: NA0A.3\\nOther specified injuries of head: NA0A.Y\\nInjury of the auricle: NA0B\\nInjury of middle or inner ear: NA0C\\nInjury of teeth or supporting structures: NA0D\\nInjury of hard dental tissues and pulp: NA0D.0\\nEnamel infraction: NA0D.00\\nEnamel fracture: NA0D.01\\nEnameldentin fracture: NA0D.02\\nComplicated crown fracture: NA0D.03\\nUncomplicated crownroot fracture: NA0D.04\\nComplicated crownroot fracture: NA0D.05\\nRoot fracture: NA0D.06\\nOther specified injury of hard dental tissues and pulp: NA0D.0Y\\nInjury of hard dental tissues and pulp unspecified: NA0D.0Z\\nInjury of periodontal tissues: NA0D.1\\nConcussion of periodontal tissue: NA0D.10\\nSubluxation of tooth: NA0D.11\\nExtrusive luxation of tooth: NA0D.12\\nLateral luxation of tooth: NA0D.13\\nIntrusive luxation of tooth: NA0D.14\\nAvulsion of tooth: NA0D.15\\nOther specified injury of periodontal tissues: NA0D.1Y\\nInjury of periodontal tissues unspecified: NA0D.1Z\\nOther specified injury of teeth or supporting structures: NA0D.Y\\nInjury of teeth or supporting structures unspecified: NA0D.Z\\nInjuries to the head unspecified: NA0Z\\nSuperficial injury of neck: NA20\\nAbrasion of throat: NA20.0\\nContusion of throat: NA20.1\\nOther or unspecified superficial injuries of throat: NA20.2\\nMultiple superficial injuries of neck: NA20.3\\nOther specified superficial injury of neck: NA20.Y\\nSuperficial injury of neck unspecified: NA20.Z\\nOpen wound of neck: NA21\\nLaceration without foreign body of neck: NA21.0\\nLaceration with foreign body of neck: NA21.1\\nPuncture wound without foreign body of neck: NA21.2\\nPuncture wound with foreign body of neck: NA21.3\\nOpen bite of neck: NA21.4\\nMultiple open wounds of neck: NA21.5\\nOther specified open wound of neck: NA21.Y\\nOpen wound of neck unspecified: NA21.Z\\nFracture of neck: NA22\\nFracture of first cervical vertebra: NA22.0\\nFracture of first cervical vertebra burst fracture: NA22.00\\nFracture of posterior arch of first cervical vertebra: NA22.01\\nFracture of lateral mass of first cervical vertebra: NA22.02\\nOther fracture of first cervical vertebra: NA22.03\\nFracture of first cervical vertebra unspecified: NA22.0Z\\nFracture of second cervical vertebra: NA22.1\\nTraumatic spondylolisthesis of second cervical vertebra type III: NA22.10\\nOther traumatic spondylolisthesis of second cervical vertebra: NA22.11\\nFracture of odontoid process: NA22.12\\nOther fracture of second cervical vertebra: NA22.13\\nFracture of second cervical vertebra unspecified: NA22.1Z\\nFracture of other specified cervical vertebra: NA22.2\\nMultiple fractures of cervical spine: NA22.3\\nFracture of neck unspecified: NA22.Z\\nDislocation or strain or sprain of joints or ligaments at neck level: NA23\\nTraumatic rupture of cervical intervertebral disc: NA23.0\\nDislocation of cervical vertebra: NA23.1\\nCraniocervical dissociation: NA23.10\\nAtlantoaxial dislocation: NA23.11\\nDislocation of other specified cervical vertebra: NA23.12\\nDislocation of cervical vertebra unspecified: NA23.1Z\\nDislocation of other or unspecified parts of neck: NA23.2\\nMultiple dislocations of neck: NA23.3\\nStrain or sprain of cervical spine: NA23.4\\nAcute whiplash associated disorder with complaint of neck pain stiffness or tenderness only: NA23.40\\nAcute whiplash associated disorder with complaint of neck pain with musculoskeletal signs: NA23.41\\nAcute whiplash associated disorder with complaint of neck pain with neurological signs: NA23.42\\nOther specified strain or sprain of cervical spine: NA23.4Y\\nStrain or sprain of cervical spine unspecified: NA23.4Z\\nStrain or sprain of thyroid region: NA23.5\\nOther specified dislocation or strain or sprain of joints or ligaments at neck level: NA23.Y\\nDislocation or strain or sprain of joints or ligaments at neck level unspecified: NA23.Z\\nConcussion or oedema of cervical spinal cord: NA30\\nCertain specified injuries of cervical spinal cord: NA31\\nComplete lesion of cervical spinal cord: NA31.0\\nCentral cord syndrome of cervical spinal cord: NA31.1\\nAnterior cord syndrome of cervical spinal cord: NA31.2\\nPosterior cord syndrome of cervical spinal cord: NA31.3\\nBrownSequard syndrome of cervical spinal cord: NA31.4\\nOther incomplete cord syndrome of cervical spinal cord: NA31.5\\nInjury of cervical spinal cord unspecified: NA3Z\\nInjury of nerve root of cervical spine: NA40\\nInjury of brachial plexus: NA41\\nInjury of brachial plexus cord: NA41.0\\nInjury of brachial plexus division: NA41.1\\nInjury of brachial plexus trunk: NA41.2\\nOther specified injury of brachial plexus: NA41.Y\\nInjury of brachial plexus unspecified: NA41.Z\\nInjury of peripheral nerves of neck: NA42\\nInjury of supraclavicular nerve: NA42.0\\nInjury to anterior cutaneous nerve of neck: NA42.1\\nInjury of other specified peripheral nerves of neck: NA42.Y\\nInjury of peripheral nerves of neck unspecified: NA42.Z\\nInjury of cervical sympathetic nerves: NA43\\nInjury of phrenic nerve: NA44\\nInjury of other specified nerves at neck level: NA4Y\\nInjury of nerves at neck level unspecified: NA4Z\\nInjury of blood vessels at neck level: NA60\\nInjury of carotid artery: NA60.0\\nLaceration of carotid artery minor: NA60.00\\nLaceration of carotid artery major: NA60.01\\nOther specified injury of carotid artery: NA60.0Y\\nInjury of carotid artery unspecified: NA60.0Z\\nInjury of vertebral artery: NA60.1\\nLaceration of vertebral artery minor: NA60.10\\nLaceration of vertebral artery major: NA60.11\\nOther specified injury of vertebral artery: NA60.1Y\\nInjury of vertebral artery unspecified: NA60.1Z\\nInjury of external jugular vein: NA60.2\\nLaceration of external jugular vein minor: NA60.20\\nLaceration of external jugular vein major: NA60.21\\nOther specified injury of external jugular vein: NA60.2Y\\nInjury of external jugular vein unspecified: NA60.2Z\\nInjury of internal jugular vein: NA60.3\\nLaceration of internal jugular vein minor: NA60.30\\nLaceration of internal jugular vein major: NA60.31\\nOther specified injury of internal jugular vein: NA60.3Y\\nInjury of internal jugular vein unspecified: NA60.3Z\\nInjury of multiple blood vessels at neck level: NA60.4\\nInjury of other specified blood vessels at neck level: NA60.Y\\nInjury of blood vessels at neck level unspecified: NA60.Z\\nInjury of muscle fascia or tendon at neck level: NA61\\nStrain or sprain of muscle fascia or tendon at neck level: NA61.0\\nLaceration of muscle fascia or tendon at neck level: NA61.1\\nOther specified injury of muscle fascia or tendon at neck level: NA61.Y\\nInjury of muscle fascia or tendon at neck level unspecified: NA61.Z\\nCrushing injury of neck: NA62\\nCrushing injury of larynx or trachea: NA62.0\\nCrushing injury of other specified site of neck: NA62.Y\\nCrushing injury of neck unspecified: NA62.Z\\nTraumatic amputation at neck level: NA63\\nMultiple injuries of neck: NA64\\nOther specified injuries to the neck: NA6Y\\nInjuries to the neck unspecified: NA6Z\\nSuperficial injury of thorax: NA80\\nAbrasion of breast: NA80.0\\nContusion of breast: NA80.1\\nOther or unspecified superficial injuries of breast: NA80.2\\nOther superficial injuries of front wall of thorax: NA80.3\\nOther superficial injuries of back wall of thorax: NA80.4\\nAbrasion of thorax: NA80.5\\nContusion of thorax: NA80.6\\nMultiple superficial injuries of thorax: NA80.7\\nOther specified superficial injury of thorax: NA80.Y\\nSuperficial injury of thorax unspecified: NA80.Z\\nOpen wound of thorax: NA81\\nLaceration without foreign body of thorax: NA81.0\\nLaceration with foreign body of thorax: NA81.1\\nPuncture wound without foreign body of thorax: NA81.2\\nPuncture wound with foreign body of thorax: NA81.3\\nOpen bite of thorax: NA81.4\\nMultiple open wounds of thoracic wall: NA81.5\\nOther specified open wound of thorax: NA81.Y\\nOpen wound of thorax unspecified: NA81.Z\\nFracture of rib sternum or thoracic spine: NA82\\nFracture of thoracic vertebra: NA82.0\\nMultiple fractures of thoracic spine: NA82.1\\nFracture of sternum: NA82.2\\nFracture of rib: NA82.3\\nFracture of rib posterior or posterior and lateral: NA82.30\\nOther specified fracture of rib: NA82.3Y\\nFracture of rib unspecified: NA82.3Z\\nMultiple fractures of ribs: NA82.4\\nFlail chest: NA82.5\\nOther specified fracture of rib sternum or thoracic spine: NA82.Y\\nFracture of rib sternum or thoracic spine unspecified: NA82.Z\\nDislocation or strain or sprain of joints or ligaments of thorax: NA83\\nTraumatic rupture of thoracic intervertebral disc: NA83.0\\nDislocation of thoracic vertebra: NA83.1\\nDislocation of other or unspecified parts of thorax: NA83.2\\nStrain or sprain of ligaments of thoracic spine: NA83.3\\nStrain or sprain of ribs or sternum: NA83.4\\nStrain or sprain of sternum: NA83.40\\nStrain or sprain of sternoclavicular joint or ligament: NA83.41\\nStrain or sprain of chondrosternal joint: NA83.42\\nStrain or sprain of rib: NA83.43\\nOther specified dislocation or strain or sprain of joints or ligaments of thorax: NA83.Y\\nDislocation or strain or sprain of joints or ligaments of thorax unspecified: NA83.Z\\nConcussion or oedema of thoracic spinal cord: NA90\\nCertain specified injuries of thoracic spinal cord: NA91\\nComplete lesion of thoracic spinal cord: NA91.0\\nCentral cord syndrome of thoracic spinal cord: NA91.1\\nAnterior cord syndrome of thoracic spinal cord: NA91.2\\nPosterior cord syndrome of thoracic spinal cord: NA91.3\\nBrownSequard syndrome of thoracic spinal cord: NA91.4\\nOther incomplete cord syndrome of thoracic spinal cord: NA91.5\\nInjury of thoracic spinal cord unspecified: NA9Z\\nInjury of nerve root of thoracic spine: NB00\\nInjury of peripheral nerves of thorax: NB01\\nInjury of thoracic sympathetic nerves: NB02\\nInjury of other specified nerves at thorax level: NB0Y\\nOther specified injury of nerves or spinal cord at thorax level: NB2Y\\nInjury of nerves or spinal cord at thorax level unspecified: NB2Z\\nInjury of blood vessels of thorax: NB30\\nInjury of thoracic aorta: NB30.0\\nMinor laceration of thoracic aorta: NB30.00\\nMajor laceration of thoracic aorta: NB30.01\\nOther specified injury of thoracic aorta: NB30.0Y\\nInjury of thoracic aorta unspecified: NB30.0Z\\nInjury of innominate or subclavian artery: NB30.1\\nMinor laceration of innominate or subclavian artery: NB30.10\\nMajor laceration of innominate or subclavian artery: NB30.11\\nOther specified injury of innominate or subclavian artery: NB30.1Y\\nInjury of innominate or subclavian artery unspecified: NB30.1Z\\nInjury of superior vena cava: NB30.2\\nMinor laceration of superior vena cava: NB30.20\\nMajor laceration of superior vena cava: NB30.21\\nOther specified injury of superior vena cava: NB30.2Y\\nInjury of superior vena cava unspecified: NB30.2Z\\nInjury of innominate or subclavian vein: NB30.3\\nMinor laceration of innominate or subclavian vein: NB30.30\\nMajor laceration of innominate or subclavian vein: NB30.31\\nOther specified injury of innominate or subclavian vein: NB30.3Y\\nInjury of innominate or subclavian vein unspecified: NB30.3Z\\nInjury of pulmonary blood vessels: NB30.4\\nMinor laceration of pulmonary blood vessels: NB30.40\\nMajor laceration of pulmonary blood vessels: NB30.41\\nOther specified injury of pulmonary blood vessels: NB30.4Y\\nInjury of pulmonary blood vessels unspecified: NB30.4Z\\nInjury of intercostal blood vessels: NB30.5\\nLaceration of intercostal blood vessels: NB30.50\\nOther specified injury of intercostal blood vessels: NB30.5Y\\nInjury of intercostal blood vessels unspecified: NB30.5Z\\nInjury of multiple blood vessels of thorax: NB30.6\\nInjury of other specified blood vessels of thorax: NB30.Y\\nInjury of unspecified blood vessels of thorax: NB30.Z\\nInjury of heart: NB31\\nInjury of heart with haemopericardium: NB31.0\\nContusion of heart with haemopericardium: NB31.00\\nMinor laceration of heart with haemopericardium: NB31.01\\nModerate laceration of heart with haemopericardium: NB31.02\\nMajor laceration of heart with haemopericardium: NB31.03\\nOther specified injury of heart with haemopericardium: NB31.0Y\\nInjury of heart with haemopericardium unspecified: NB31.0Z\\nInjury of heart without haemopericardium: NB31.1\\nContusion of heart without haemopericardium: NB31.10\\nLaceration of heart without haemopericardium: NB31.11\\nOther specified injury of heart without haemopericardium: NB31.1Y\\nInjury of heart without haemopericardium unspecified: NB31.1Z\\nInjury of heart unspecified without open wound into thoracic cavity: NB31.2\\nInjury of heart unspecified with open wound into thoracic cavity: NB31.3\\nInjury of heart valve: NB31.4\\nInjury to mitral valve: NB31.40\\nInjury of other specified heart valve: NB31.4Y\\nInjury of heart valve unspecified: NB31.4Z\\nOther specified injury of heart: NB31.Y\\nInjury of heart unspecified: NB31.Z\\nInjury of other or unspecified intrathoracic organs: NB32\\nTraumatic pneumothorax: NB32.0\\nTraumatic haemothorax: NB32.1\\nTraumatic haemopneumothorax: NB32.2\\nCertain injuries of lung: NB32.3\\nContusion of lung: NB32.30\\nLaceration of lung: NB32.31\\nInhalation injury of lung: NB32.32\\nPrimary blast injury of lung: NB32.33\\nOther injury of lung: NB32.3Y\\nInjury of lung unspecified: NB32.3Z\\nInjury of bronchus: NB32.4\\nContusion of bronchus: NB32.40\\nMinor laceration of bronchus: NB32.41\\nModerate laceration of bronchus: NB32.42\\nMajor laceration of bronchus: NB32.43\\nOther specified injury of bronchus: NB32.4Y\\nInjury of bronchus unspecified: NB32.4Z\\nInjury of thoracic trachea: NB32.5\\nContusion of thoracic trachea: NB32.50\\nMinor laceration of thoracic trachea: NB32.51\\nModerate laceration of thoracic trachea: NB32.52\\nMajor laceration of thoracic trachea: NB32.53\\nOther specified injury of thoracic trachea: NB32.5Y\\nInjury of thoracic trachea unspecified: NB32.5Z\\nInjury of pleura: NB32.6\\nLaceration of pleura: NB32.60\\nOther specified injury of pleura: NB32.6Y\\nInjury of pleura unspecified: NB32.6Z\\nMultiple injuries of intrathoracic organs: NB32.7\\nOther specified injury of other or unspecified intrathoracic organs: NB32.Y\\nUnspecified injury of unspecified intrathoracic organs: NB32.Z\\nCrushing injury of thorax or traumatic amputation of part of thorax: NB33\\nCrushed chest: NB33.0\\nTraumatic amputation of breast: NB33.1\\nTraumatic amputation of part of breast: NB33.10\\nTraumatic amputation of entire breast: NB33.11\\nTraumatic amputation of breast unspecified: NB33.1Z\\nTraumatic amputation of other or unspecified part of thorax: NB33.2\\nInjury of muscle fascia or tendon at thorax level: NB34\\nStrain or sprain of muscle fascia or tendon at thorax level: NB34.0\\nLaceration of muscle fascia or tendon at thorax level: NB34.1\\nOther specified injury of muscle fascia or tendon at thorax level: NB34.Y\\nInjury of muscle fascia or tendon at thorax level unspecified: NB34.Z\\nMultiple injuries of thorax: NB35\\nOther specified injuries to the thorax: NB3Y\\nInjuries to the thorax unspecified: NB3Z\\nSuperficial injury of abdomen lower back or pelvis: NB50\\nAbrasion of lower back or pelvis: NB50.0\\nContusion of lower back or pelvis: NB50.1\\nAbrasion of abdominal wall: NB50.2\\nContusion of abdominal wall: NB50.3\\nAbrasion of external genital organs: NB50.4\\nContusion of external genital organs: NB50.5\\nMultiple superficial injuries of abdomen lower back or pelvis: NB50.6\\nOther specified superficial injury of abdomen lower back or pelvis: NB50.Y\\nSuperficial injury of abdomen lower back or pelvis unspecified: NB50.Z\\nOpen wound of abdomen lower back or pelvis: NB51\\nLaceration without foreign body of abdomen lower back or pelvis: NB51.0\\nLaceration with foreign body of abdomen lower back or pelvis: NB51.1\\nPuncture wound without foreign body of abdomen lower back or pelvis: NB51.2\\nPuncture wound with foreign body of abdomen lower back or pelvis: NB51.3\\nOpen bite of abdomen lower back or pelvis: NB51.4\\nMultiple open wounds of abdomen lower back or pelvis: NB51.5\\nOther specified open wound of abdomen lower back or pelvis: NB51.Y\\nOpen wound of abdomen lower back or pelvis unspecified: NB51.Z\\nFracture of lumbar spine or pelvis: NB52\\nFracture of lumbar vertebra: NB52.0\\nFracture of pelvic bone without disruption of posterior arch of pelvic ring: NB52.1\\nFracture of sacrum without disruption of pelvic ring: NB52.10\\nFracture of coccyx: NB52.11\\nFracture of ilium without disruption of pelvic ring: NB52.12\\nFracture of acetabulum without disruption of pelvic ring: NB52.13\\nFracture of pubis without disruption of pelvic ring: NB52.14\\nFracture of ischium without disruption of pelvic ring: NB52.15\\nFracture of other specified pelvic bone without disruption of posterior arch of pelvic ring: NB52.1Y\\nFracture of unspecified pelvic bone without disruption of posterior arch of pelvic ring: NB52.1Z\\nFracture of the pelvic ring with incomplete disruption of posterior arch: NB52.2\\nFracture of pelvic ring with complete disruption of posterior arch: NB52.3\\nMultiple fractures of lumbar spine or pelvis: NB52.4\\nOther specified fracture of lumbar spine or pelvis: NB52.Y\\nFracture of lumbar spine or pelvis unspecified: NB52.Z\\nDislocation or strain or sprain of joints or ligaments of lumbar spine or pelvis: NB53\\nTraumatic rupture of lumbar intervertebral disc: NB53.0\\nDislocation of lumbar vertebra: NB53.1\\nDislocation of sacroiliac or sacrococcygeal joint without disruption of pelvic ring: NB53.2\\nDislocation of other or unspecified parts of lumbar spine or pelvis without disruption of pelvic ring: NB53.3\\nTraumatic rupture of symphysis pubis without disruption of pelvic ring: NB53.4\\nStrain or sprain of lumbar spine: NB53.5\\nStrain or sprain of sacroiliac joint: NB53.6\\nOther specified dislocation or strain or sprain of joints or ligaments of lumbar spine or pelvis: NB53.Y\\nDislocation or strain or sprain of joints or ligaments of lumbar spine or pelvis unspecified: NB53.Z\\nConcussion or oedema of lumbar spinal cord: NB60\\nConcussion or oedema of sacral spinal cord: NB61\\nCertain specified injuries of lumbar spinal cord: NB62\\nComplete lesion of lumbar spinal cord: NB62.0\\nCentral cord syndrome of lumbar spinal cord: NB62.1\\nAnterior cord syndrome of lumbar spinal cord: NB62.2\\nPosterior cord syndrome of lumbar spinal cord: NB62.3\\nBrownSequard syndrome of lumbar spinal cord: NB62.4\\nOther incomplete cord syndrome of lumbar spinal cord: NB62.5\\nPuncture wound or laceration of dura mater of lumbar spinal cord: NB62.6\\nCertain specified injuries of sacral spinal cord: NB63\\nComplete injury of sacral spinal cord: NB63.0\\nIncomplete injury of sacral spinal cord: NB63.1\\nInjury of sacral spinal cord unspecified: NB63.Z\\nInjury of spinal cord at abdomen lower back or pelvis level unspecified: NB6Z\\nInjury of nerve root of lumbar spine: NB70\\nInjury of nerve root of sacral spine: NB71\\nInjury of cauda equina: NB72\\nInjury of lumbosacral plexus: NB73\\nInjury of lumbar sacral or pelvic sympathetic nerves: NB74\\nInjury of peripheral nerve of abdomen lower back or pelvis: NB75\\nOther specified injury of nerves at abdomen lower back or pelvis level: NB7Y\\nInjury of nerves at abdomen lower back or pelvis level unspecified: NB7Z\\nInjury of blood vessels at abdomen lower back or pelvis level: NB90\\nInjury of abdominal aorta: NB90.0\\nMinor laceration of abdominal aorta: NB90.00\\nMajor laceration of abdominal aorta: NB90.01\\nOther specified injury of abdominal aorta: NB90.0Y\\nInjury of abdominal aorta unspecified: NB90.0Z\\nInjury of inferior vena cava: NB90.1\\nMinor laceration of inferior vena cava: NB90.10\\nMajor laceration of inferior vena cava: NB90.11\\nOther specified injury of inferior vena cava: NB90.1Y\\nInjury of inferior vena cava unspecified: NB90.1Z\\nInjury of coeliac artery: NB90.2\\nMinor laceration of coeliac artery: NB90.20\\nMajor laceration of coeliac artery: NB90.21\\nOther specified injury of coeliac artery: NB90.2Y\\nInjury of coeliac artery unspecified: NB90.2Z\\nInjury of mesenteric artery: NB90.3\\nMinor laceration mesenteric artery: NB90.30\\nMajor laceration of mesenteric artery: NB90.31\\nOther specified injury of mesenteric artery: NB90.3Y\\nInjury of mesenteric artery unspecified: NB90.3Z\\nInjury of portal or splenic vein: NB90.4\\nMinor laceration of portal or splenic vein: NB90.40\\nMajor laceration of portal or splenic vein: NB90.41\\nOther specified injury of portal or splenic vein: NB90.4Y\\nInjury of portal or splenic vein unspecified: NB90.4Z\\nInjury of renal blood vessels: NB90.5\\nMinor laceration of renal blood vessels: NB90.50\\nMajor laceration of renal blood vessels: NB90.51\\nOther specified injury of renal blood vessels: NB90.5Y\\nInjury of renal blood vessels unspecified: NB90.5Z\\nInjury of iliac blood vessels: NB90.6\\nMinor laceration of iliac blood vessels: NB90.60\\nMajor laceration of iliac blood vessels: NB90.61\\nOther specified injury of iliac blood vessels: NB90.6Y\\nInjury of iliac blood vessels unspecified: NB90.6Z\\nInjury of multiple blood vessels at abdomen lower back or pelvis level: NB90.7\\nInjury of other specified blood vessels at abdomen lower back or pelvis level: NB90.Y\\nInjury of unspecified blood vessel at abdomen lower back or pelvis level: NB90.Z\\nInjury of intraabdominal organs: NB91\\nInjury of spleen: NB91.0\\nContusion of spleen minor: NB91.00\\nContusion of spleen major: NB91.01\\nLaceration of spleen minor: NB91.02\\nLaceration of spleen moderate: NB91.03\\nLaceration of spleen major: NB91.04\\nAvulsion of spleen: NB91.05\\nOther specified injury of spleen: NB91.0Y\\nInjury of spleen unspecified: NB91.0Z\\nInjury of liver: NB91.1\\nContusion of liver: NB91.10\\nLaceration of liver minor: NB91.11\\nLaceration of liver moderate: NB91.12\\nLaceration of liver major: NB91.13\\nInjury of hepatic duct: NB91.14\\nOther specified injury of liver: NB91.1Y\\nInjury of liver unspecified: NB91.1Z\\nInjury of gallbladder: NB91.2\\nInjury of bile duct: NB91.3\\nInjury of pancreas: NB91.4\\nContusion of pancreas: NB91.40\\nLaceration of pancreas minor: NB91.41\\nLaceration of pancreas moderate: NB91.42\\nLaceration of pancreas major: NB91.43\\nOther specified injury of pancreas: NB91.4Y\\nInjury of pancreas unspecified: NB91.4Z\\nInjury of stomach: NB91.5\\nContusion of stomach: NB91.50\\nLaceration of stomach without perforation: NB91.51\\nLaceration of stomach with perforation avulsion or massive damage: NB91.52\\nIngestion injury of stomach without perforation: NB91.53\\nIngestion injury of stomach with perforation: NB91.54\\nOther specified injury of stomach: NB91.5Y\\nInjury of stomach unspecified: NB91.5Z\\nInjury of duodenum: NB91.6\\nContusion of duodenum: NB91.60\\nLaceration of duodenum: NB91.61\\nPrimary blast injury of duodenum: NB91.62\\nPerforation of duodenum: NB91.63\\nOther specified injury of duodenum: NB91.6Y\\nInjury of duodenum unspecified: NB91.6Z\\nInjury of small intestine: NB91.7\\nContusion of small intestine: NB91.70\\nLaceration of small intestine: NB91.71\\nPrimary blast injury of small intestine: NB91.72\\nOther specified injury of small intestine: NB91.7Y\\nInjury of small intestine unspecified: NB91.7Z\\nInjury of colon: NB91.8\\nContusion of colon: NB91.80\\nLaceration of colon: NB91.81\\nPrimary blast injury of colon: NB91.82\\nOther specified injury of colon: NB91.8Y\\nInjury of colon unspecified: NB91.8Z\\nInjury of rectum: NB91.9\\nContusion of rectum: NB91.90\\nLaceration of rectum: NB91.91\\nPrimary blast injury of rectum: NB91.92\\nOther specified injury of rectum: NB91.9Y\\nInjury of rectum unspecified: NB91.9Z\\nInjury of mesentery: NB91.A\\nInjury of multiple intraabdominal organs: NB91.B\\nInjury of other specified intraabdominal organs: NB91.Y\\nInjury of intraabdominal organs unspecified: NB91.Z\\nInjury of urinary or pelvic organs: NB92\\nInjury of kidney: NB92.0\\nContusion of kidney minor: NB92.00\\nContusion of kidney major: NB92.01\\nLaceration of kidney minor: NB92.02\\nLaceration of kidney moderate: NB92.03\\nLaceration of kidney major: NB92.04\\nOther specified injury of kidney: NB92.0Y\\nInjury of kidney unspecified: NB92.0Z\\nInjury of ureter: NB92.1\\nContusion of ureter: NB92.10\\nLaceration of ureter: NB92.11\\nOther specified injury of ureter: NB92.1Y\\nInjury of ureter unspecified: NB92.1Z\\nInjury of bladder: NB92.2\\nContusion of bladder: NB92.20\\nLaceration of bladder: NB92.21\\nOther specified injury of bladder: NB92.2Y\\nInjury of bladder unspecified: NB92.2Z\\nInjury of urethra: NB92.3\\nContusion of urethra: NB92.30\\nLaceration of urethra: NB92.31\\nOther specified injury of urethra: NB92.3Y\\nInjury of urethra unspecified: NB92.3Z\\nInjury of ovary: NB92.4\\nContusion of ovary: NB92.40\\nLaceration of ovary: NB92.41\\nOther specified injury of ovary: NB92.4Y\\nInjury of ovary unspecified: NB92.4Z\\nInjury of fallopian tube: NB92.5\\nInjury of uterus: NB92.6\\nInjury of urinary tract: NB92.7\\nInjury of multiple pelvic organs: NB92.8\\nInjury of other specified pelvic organs: NB92.Y\\nInjury of urinary or pelvic organs unspecified: NB92.Z\\nCrushing injury or traumatic amputation of part of abdomen lower back or pelvis: NB93\\nCrushing injury of external genital organs: NB93.0\\nCrushing injury of penis: NB93.00\\nCrushing injury of testes or scrotum: NB93.01\\nCrushing injury of vulva: NB93.02\\nCrushing injury of external genital organs unspecified: NB93.0Z\\nCrushing injury of other or unspecified parts of abdomen lower back or pelvis: NB93.1\\nTraumatic amputation of external genital organs: NB93.2\\nTraumatic amputation of entire penis: NB93.20\\nTraumatic amputation of part of penis: NB93.21\\nTraumatic amputation of entire testis or scrotum: NB93.22\\nTraumatic amputation of part of testis or scrotum: NB93.23\\nTraumatic amputation of entire vulva: NB93.24\\nTraumatic amputation of part of vulva: NB93.25\\nTraumatic amputation of external genital organs unspecified: NB93.2Z\\nTraumatic amputation of other or unspecified parts of abdomen lower back or pelvis: NB93.3\\nInjury of muscle fascia or tendon of abdomen lower back or pelvis: NB94\\nStrain or sprain of muscle fascia or tendon of abdomen: NB94.0\\nStrain or sprain of muscle fascia or tendon of lower back: NB94.1\\nStrain or sprain of muscle fascia or tendon of pelvis: NB94.2\\nLaceration of muscle fascia or tendon of abdomen: NB94.3\\nLaceration of muscle fascia or tendon of lower back: NB94.4\\nLaceration of muscle fascia or tendon of pelvis: NB94.5\\nOther specified injury of muscle fascia or tendon of abdomen lower back or pelvis: NB94.Y\\nInjury of muscle fascia or tendon of abdomen lower back or pelvis unspecified: NB94.Z\\nInjury of intraabdominal organ with pelvic organ: NB95\\nOther multiple injuries of abdomen lower back or pelvis: NB96\\nCertain specified injuries of abdomen lower back or pelvis: NB97\\nRetroperitoneal haemorrhage or haematoma: NB97.0\\nFractured penis: NB97.1\\nInjury to female genital organ without specification of injury type: NB98\\nInjury to male genital organ without specification of injury type: NB99\\nOther specified injuries to the abdomen lower back lumbar spine or pelvis: NB9Y\\nInjuries to the abdomen lower back lumbar spine or pelvis unspecified: NB9Z\\nSuperficial injury of shoulder or upper arm: NC10\\nAbrasion of shoulder or upper arm: NC10.0\\nContusion of shoulder or upper arm: NC10.1\\nMultiple superficial injuries of shoulder or upper arm: NC10.2\\nOther specified superficial injury of shoulder or upper arm: NC10.Y\\nSuperficial injury of shoulder or upper arm unspecified: NC10.Z\\nOpen wound of shoulder or upper arm: NC11\\nLaceration without foreign body of shoulder or upper arm: NC11.0\\nLaceration with foreign body of shoulder or upper arm: NC11.1\\nPuncture wound without foreign body of shoulder or upper arm: NC11.2\\nPuncture wound with foreign body of shoulder or upper arm: NC11.3\\nOpen bite of shoulder or upper arm: NC11.4\\nMultiple open wounds of shoulder or upper arm: NC11.5\\nOther specified open wound of shoulder or upper arm: NC11.Y\\nOpen wound of shoulder or upper arm unspecified: NC11.Z\\nFracture of shoulder or upper arm: NC12\\nFracture of clavicle: NC12.0\\nFracture of sternal end of clavicle: NC12.00\\nFracture of shaft of clavicle: NC12.01\\nFracture of acromial end of clavicle: NC12.02\\nMultiple fractures of clavicle alone: NC12.03\\nOther specified fracture of clavicle: NC12.0Y\\nFracture of clavicle unspecified: NC12.0Z\\nFracture of scapula: NC12.1\\nMultiple fractures of scapula: NC12.10\\nOther specified fracture of scapula: NC12.1Y\\nFracture of scapula unspecified: NC12.1Z\\nFracture of upper end of humerus: NC12.2\\nFracture of upper end of humerus head: NC12.20\\nFracture of surgical neck of humerus: NC12.21\\nFracture of anatomical neck of humerus: NC12.22\\nFracture of greater tuberosity of humerus: NC12.23\\nFracture of lesser tuberosity of humerus: NC12.24\\nFracture of upper end of humerus unspecified site: NC12.2Z\\nFracture of shaft of humerus: NC12.3\\nFracture of lower end of humerus: NC12.4\\nSupracondylar fracture of humerus: NC12.40\\nFracture of lateral epicondyle of humerus: NC12.41\\nFracture of medial epicondyle of humerus: NC12.42\\nFracture of lateral condyle of humerus: NC12.43\\nFracture of medial condyle of humerus: NC12.44\\nOther specified fracture of lower end of humerus: NC12.4Y\\nFracture of lower end of humerus unspecified: NC12.4Z\\nMultiple fractures of clavicle scapula or humerus: NC12.5\\nOther specified fracture of shoulder or upper arm: NC12.Y\\nFracture of shoulder or upper arm unspecified: NC12.Z\\nDislocation or strain or sprain of joints or ligaments of shoulder girdle: NC13\\nDislocation of shoulder joint: NC13.0\\nDislocation of acromioclavicular joint: NC13.1\\nDislocation of sternoclavicular joint: NC13.2\\nDislocation of scapula: NC13.3\\nDislocation of other or unspecified parts of shoulder girdle: NC13.4\\nStrain or sprain of shoulder joint: NC13.5\\nStrain or sprain of acromioclavicular joint: NC13.6\\nStrain or sprain of sternoclavicular joint: NC13.7\\nStrain or sprain of other or unspecified parts of shoulder girdle: NC13.8\\nDislocation or sprain of other specified joints or ligaments of shoulder girdle: NC13.Y\\nDislocation or strain or sprain of joints or ligaments of shoulder girdle unspecified: NC13.Z\\nInjury of nerves at shoulder or upper arm level: NC14\\nInjury of ulnar nerve at upper arm level: NC14.0\\nInjury of median nerve at upper arm level: NC14.1\\nInjury of radial nerve at upper arm level: NC14.2\\nInjury of axillary nerve: NC14.3\\nInjury of musculocutaneous nerve: NC14.4\\nInjury of cutaneous sensory nerve at shoulder or upper arm level: NC14.5\\nInjury of multiple nerves at shoulder or upper arm level: NC14.6\\nInjury of other specified nerves at shoulder or upper arm level: NC14.Y\\nInjury of unspecified nerve at shoulder or upper arm level: NC14.Z\\nInjury of blood vessels at shoulder or upper arm level: NC15\\nInjury of axillary artery: NC15.0\\nLaceration of axillary artery: NC15.00\\nOther specified injury of axillary artery: NC15.0Y\\nInjury of axillary artery unspecified: NC15.0Z\\nInjury of brachial artery: NC15.1\\nLaceration of brachial artery: NC15.10\\nOther specified injury of brachial artery: NC15.1Y\\nInjury of brachial artery unspecified: NC15.1Z\\nInjury of axillary or brachial vein: NC15.2\\nLaceration of axillary or brachial vein: NC15.20\\nOther specified injury of axillary or brachial vein: NC15.2Y\\nInjury of axillary or brachial vein unspecified: NC15.2Z\\nInjury of superficial vein at shoulder or upper arm level: NC15.3\\nLaceration of superficial vein at shoulder or upper arm level: NC15.30\\nOther specified injury of superficial vein at shoulder or upper arm level: NC15.3Y\\nInjury of superficial vein at shoulder or upper arm level unspecified: NC15.3Z\\nInjury of multiple blood vessels at shoulder or upper arm level: NC15.4\\nInjury of other specified blood vessels at shoulder or upper arm level: NC15.Y\\nInjury of unspecified blood vessel at shoulder or upper arm level: NC15.Z\\nInjury of muscle fascia tendon or bursa at shoulder or upper arm level: NC16\\nInjury of muscle or tendon of the rotator cuff of shoulder: NC16.0\\nStrain or sprain of muscle or tendon of the rotator cuff of shoulder: NC16.00\\nLaceration of muscle or tendon of the rotator cuff of shoulder: NC16.01\\nOther specified injury of muscle or tendon of the rotator cuff of shoulder: NC16.0Y\\nInjury of muscle or tendon of the rotator cuff of shoulder unspecified: NC16.0Z\\nInjury of muscle fascia or tendon of long head of biceps: NC16.1\\nStrain or sprain of muscle fascia or tendon of long head of biceps: NC16.10\\nLaceration of muscle fascia or tendon of long head of biceps: NC16.11\\nOther specified injury of muscle fascia or tendon of long head of biceps: NC16.1Y\\nInjury of muscle fascia or tendon of long head of biceps unspecified: NC16.1Z\\nInjury of muscle fascia or tendon of other parts of biceps: NC16.2\\nStrain or sprain of muscle fascia or tendon of other parts of biceps: NC16.20\\nLaceration of muscle fascia or tendon of other parts of biceps: NC16.21\\nOther specified injury of muscle fascia or tendon of other parts of biceps: NC16.2Y\\nInjury of muscle fascia or tendon of other parts of biceps unspecified: NC16.2Z\\nInjury of muscle fascia or tendon of triceps: NC16.3\\nStrain or sprain of muscle fascia or tendon of triceps: NC16.30\\nLaceration of muscle fascia or tendon of triceps: NC16.31\\nOther specified injury of muscle fascia or tendon of triceps: NC16.3Y\\nInjury of muscle fascia or tendon of triceps unspecified: NC16.3Z\\nInjury of multiple muscles or tendons at shoulder or upper arm level: NC16.4\\nStrain or sprain of multiple muscles or tendons at shoulder or upper arm level: NC16.40\\nLaceration of multiple muscles or tendons at shoulder or upper arm level: NC16.41\\nOther specified injury of multiple muscles or tendons at shoulder or upper arm level: NC16.4Y\\nInjury of multiple muscles or tendons at shoulder or upper arm level unspecified: NC16.4Z\\nInjury of bursa of shoulder: NC16.5\\nInjury of other specified muscle fascia tendon or bursa at shoulder or upper arm level: NC16.Y\\nInjury of unspecified muscle fascia or tendon at shoulder or upper arm level: NC16.Z\\nCrushing injury of shoulder or upper arm: NC17\\nTraumatic amputation of shoulder or upper arm: NC18\\nTraumatic amputation at right shoulder joint: NC18.0\\nTraumatic amputation at left shoulder joint: NC18.1\\nTraumatic amputation at shoulder joint bilateral: NC18.2\\nTraumatic amputation at level between right shoulder and elbow: NC18.3\\nTraumatic amputation at level between left shoulder and elbow: NC18.4\\nTraumatic amputation at level between shoulder and elbow bilateral: NC18.5\\nTraumatic amputation of shoulder or upper arm unspecified: NC18.Z\\nMultiple injuries of shoulder or upper arm: NC19\\nOther specified injuries to the shoulder or upper arm: NC1Y\\nInjuries to the shoulder or upper arm unspecified: NC1Z\\nSuperficial injury of forearm: NC30\\nAbrasion of elbow: NC30.0\\nContusion of elbow: NC30.1\\nAbrasion of other or unspecified parts of forearm: NC30.2\\nContusion of other or unspecified parts of forearm: NC30.3\\nMultiple superficial injuries of forearm: NC30.4\\nOther specified superficial injury of forearm: NC30.Y\\nSuperficial injury of forearm unspecified: NC30.Z\\nOpen wound of forearm: NC31\\nLaceration without foreign body of forearm: NC31.0\\nLaceration with foreign body of forearm: NC31.1\\nPuncture wound without foreign body of forearm: NC31.2\\nPuncture wound with foreign body of forearm: NC31.3\\nOpen bite of forearm: NC31.4\\nMultiple open wounds of forearm: NC31.5\\nOther specified open wound of forearm: NC31.Y\\nOpen wound of forearm unspecified: NC31.Z\\nFracture of forearm: NC32\\nFracture of upper end of ulna: NC32.0\\nFracture of upper end of radius: NC32.1\\nFracture of shaft of ulna: NC32.2\\nFracture of shaft of radius: NC32.3\\nFracture of shafts of both ulna and radius: NC32.4\\nFracture of lower end of radius: NC32.5\\nFracture of lower end of radius dorsal tilt: NC32.50\\nFracture of lower end of radius volar tilt: NC32.51\\nOther specified fracture of lower end of radius: NC32.5Y\\nFracture of lower end of radius unspecified: NC32.5Z\\nFracture of lower end of both ulna and radius: NC32.6\\nMultiple fractures of forearm: NC32.7\\nFracture of other specified parts of forearm: NC32.Y\\nFracture of forearm unspecified: NC32.Z\\nDislocation or strain or sprain of joints or ligaments of elbow: NC33\\nDislocation of radial head: NC33.0\\nDislocation of elbow: NC33.1\\nTraumatic rupture of radial collateral ligament: NC33.2\\nTraumatic rupture of ulnar collateral ligament: NC33.3\\nStrain or sprain of elbow: NC33.4\\nDislocation or sprain of other specified joints or ligaments of elbow: NC33.Y\\nDislocation or strain or sprain of joints or ligaments of elbow unspecified: NC33.Z\\nInjury of nerves at forearm level: NC34\\nInjury of ulnar nerve at forearm level: NC34.0\\nInjury of median nerve at forearm level: NC34.1\\nInjury of radial nerve at forearm level: NC34.2\\nInjury of cutaneous sensory nerve at forearm level: NC34.3\\nInjury of multiple nerves at forearm level: NC34.4\\nInjury of other specified nerves at forearm level: NC34.Y\\nInjury of unspecified nerve at forearm level: NC34.Z\\nInjury of blood vessels at forearm level: NC35\\nInjury of ulnar artery at forearm level: NC35.0\\nLaceration of ulnar artery at forearm level: NC35.00\\nOther specified injury of ulnar artery at forearm level: NC35.0Y\\nInjury of ulnar artery at forearm level unspecified: NC35.0Z\\nInjury of radial artery at forearm level: NC35.1\\nLaceration of radial artery at forearm level: NC35.10\\nOther specified injury of radial artery at forearm level: NC35.1Y\\nInjury of radial artery at forearm level unspecified: NC35.1Z\\nInjury of vein at forearm level: NC35.2\\nLaceration of vein at forearm level: NC35.20\\nOther specified injury of vein at forearm level: NC35.2Y\\nInjury of vein at forearm level unspecified: NC35.2Z\\nInjury of multiple blood vessels at forearm level: NC35.3\\nInjury of other specified blood vessels at forearm level: NC35.Y\\nInjury of unspecified blood vessel at forearm level: NC35.Z\\nInjury of muscle fascia tendon or bursa at forearm level: NC36\\nInjury of flexor muscle fascia or tendon of thumb at forearm level: NC36.0\\nStrain or sprain of flexor muscle fascia or tendon of thumb at forearm level: NC36.00\\nLaceration of flexor muscle fascia or tendon of thumb at forearm level: NC36.01\\nOther specified injury of flexor muscle fascia or tendon of thumb at forearm level: NC36.0Y\\nInjury of flexor muscle fascia or tendon of thumb at forearm level unspecified: NC36.0Z\\nInjury of long flexor muscle fascia or tendon of other finger at forearm level: NC36.1\\nStrain or sprain of long flexor muscle fascia or tendon of other finger at forearm level: NC36.10\\nLaceration of long flexor muscle fascia or tendon of other finger at forearm level: NC36.11\\nOther specified injury of long flexor muscle fascia or tendon of other finger at forearm level: NC36.1Y\\nInjury of long flexor muscle fascia or tendon of other finger at forearm level unspecified: NC36.1Z\\nInjury of other flexor muscle fascia or tendon at forearm level: NC36.2\\nStrain or sprain of other flexor muscle fascia or tendon at forearm level: NC36.20\\nLaceration of other flexor muscle fascia or tendon at forearm level: NC36.21\\nOther specified injury of other flexor muscle fascia or tendon at forearm level: NC36.2Y\\nInjury of other flexor muscle fascia or tendon at forearm level unspecified: NC36.2Z\\nInjury of extensor or abductor muscles or tendons of thumb at forearm level: NC36.3\\nStrain or sprain of extensor or abductor muscles or tendons of thumb at forearm level: NC36.30\\nLaceration of extensor or abductor muscles or tendons of thumb at forearm level: NC36.31\\nOther specified injury of extensor or abductor muscles or tendons of thumb at forearm level: NC36.3Y\\nInjury of extensor or abductor muscles or tendons of thumb at forearm level unspecified: NC36.3Z\\nInjury of extensor muscle fascia or tendon of other finger at forearm level: NC36.4\\nStrain or sprain of extensor muscle fascia or tendon of other finger at forearm level: NC36.40\\nLaceration of extensor muscle fascia or tendon of other finger at forearm level: NC36.41\\nOther specified injury of extensor muscle fascia or tendon of other finger at forearm level: NC36.4Y\\nInjury of extensor muscle fascia or tendon of other finger at forearm level unspecified: NC36.4Z\\nInjury of other extensor muscle fascia or tendon at forearm level: NC36.5\\nStrain or sprain of other extensor muscle fascia or tendon at forearm level: NC36.50\\nLaceration of other extensor muscle fascia or tendon at forearm level: NC36.51\\nOther specified injury of other extensor muscle fascia or tendon at forearm level: NC36.5Y\\nInjury of other extensor muscle fascia or tendon at forearm level unspecified: NC36.5Z\\nInjury of multiple muscles or tendons at forearm level: NC36.6\\nInjury of bursa of elbow: NC36.7\\nInjury of other specified muscle fascia tendon or bursa at forearm level: NC36.Y\\nInjury of unspecified muscle fascia tendon or bursa at forearm level: NC36.Z\\nCrushing injury of forearm: NC37\\nCrushing injury of elbow: NC37.0\\nCrushing injury of other specified part of forearm: NC37.Y\\nCrushing injury of forearm unspecified: NC37.Z\\nTraumatic amputation of forearm: NC38\\nTraumatic amputation at right elbow level: NC38.0\\nTraumatic amputation at left elbow level: NC38.1\\nTraumatic amputation at elbow level bilateral: NC38.2\\nTraumatic amputation at level between right elbow and wrist: NC38.3\\nTraumatic amputation at level between left elbow and wrist: NC38.4\\nTraumatic amputation between elbow and wrist bilateral: NC38.5\\nTraumatic amputation of forearm unspecified: NC38.Z\\nMultiple injuries of forearm: NC39\\nOther specified injuries to the elbow or forearm: NC3Y\\nInjuries to the elbow or forearm unspecified: NC3Z\\nInjury to fingernail: NC50\\nSuperficial injury of wrist or hand: NC51\\nSuperficial injury of finger or thumb: NC51.0\\nAbrasion of finger or thumb: NC51.00\\nContusion of finger or thumb: NC51.01\\nOther specified superficial injury of finger or thumb: NC51.0Y\\nSuperficial injury of finger or thumb unspecified: NC51.0Z\\nSuperficial injury of other parts of wrist or hand: NC51.1\\nContusion of other parts of wrist or hand: NC51.10\\nNonvenomous insect bite of other parts of wrist or hand: NC51.11\\nOther specified superficial injury of other parts of wrist or hand: NC51.1Y\\nSuperficial injury of other parts of wrist or hand unspecified: NC51.1Z\\nMultiple superficial injuries of wrist or hand: NC51.2\\nOpen wound of wrist or hand: NC52\\nOpen wound of finger or thumb: NC52.0\\nLaceration without foreign body of finger or thumb: NC52.00\\nLaceration with foreign body of finger or thumb: NC52.01\\nPuncture wound without foreign body of finger or thumb: NC52.02\\nPuncture wound with foreign body of finger or thumb: NC52.03\\nOpen bite of finger or thumb: NC52.04\\nOther specified open wound of finger or thumb: NC52.0Y\\nOpen wound of finger or thumb unspecified: NC52.0Z\\nOpen wound of other parts of wrist or hand: NC52.1\\nLaceration without foreign body of other parts of wrist or hand: NC52.10\\nLaceration with foreign body of other parts of wrist or hand: NC52.11\\nPuncture wound with foreign body of other parts of wrist or hand: NC52.12\\nPuncture wound without foreign body of other parts of wrist or hand: NC52.13\\nOpen bite of other parts of wrist or hand: NC52.14\\nOther specified open wound of other parts of wrist or hand: NC52.1Y\\nOpen wound of other parts of wrist or hand unspecified: NC52.1Z\\nMultiple open wounds of wrist or hand: NC52.2\\nFracture at wrist or hand level: NC53\\nFracture of scaphoid bone of hand: NC53.0\\nFracture of other carpal bone: NC53.1\\nFracture of first metacarpal bone: NC53.2\\nFracture of other metacarpal bone: NC53.3\\nFracture of shaft of other metacarpal bone: NC53.30\\nFracture of neck of other metacarpal bone: NC53.31\\nFracture of other specified part of other metacarpal bone: NC53.3Y\\nFracture of other metacarpal bone unspecified: NC53.3Z\\nMultiple fractures of metacarpal bones: NC53.4\\nFracture of thumb bone: NC53.5\\nFracture of other finger bone: NC53.6\\nFracture of index finger: NC53.60\\nFracture of middle finger: NC53.61\\nFracture of ring finger: NC53.62\\nFracture of little finger: NC53.63\\nOther specified fracture of other finger bone: NC53.6Y\\nFracture of other finger bone unspecified: NC53.6Z\\nMultiple fractures of fingers: NC53.7\\nFracture at other specified part of wrist or hand level: NC53.Y\\nFracture at wrist or hand level unspecified: NC53.Z\\nDislocation or strain or sprain of joints or ligaments at wrist or hand level: NC54\\nDislocation of wrist: NC54.0\\nDislocation of distal radioulnar joint: NC54.00\\nDislocation of radiocarpal joint: NC54.01\\nDislocation of midcarpal joint: NC54.02\\nDislocation of carpometacarpal joint of thumb: NC54.03\\nDislocation of other carpometacarpal joint: NC54.04\\nDislocation of metacarpal bone proximal end: NC54.05\\nDislocation of other specified part of wrist: NC54.0Y\\nDislocation of wrist unspecified: NC54.0Z\\nDislocation of thumb: NC54.1\\nDislocation of metacarpophalangeal joint of thumb: NC54.10\\nDislocation of interphalangeal joint of thumb: NC54.11\\nDislocation of other specified part of thumb: NC54.1Y\\nDislocation of thumb unspecified: NC54.1Z\\nDislocation of finger: NC54.2\\nDislocation of metacarpophalangeal joint of finger: NC54.20\\nDislocation of interphalangeal joint of finger: NC54.21\\nDislocation of other specified part of finger: NC54.2Y\\nDislocation of finger unspecified: NC54.2Z\\nMultiple dislocations of fingers: NC54.3\\nTraumatic rupture of ligament of wrist or carpus: NC54.4\\nTraumatic rupture of scapholunate ligament: NC54.40\\nTraumatic rupture of radiocarpal ligament: NC54.41\\nTraumatic rupture of ulnocarpal ligament: NC54.42\\nTraumatic rupture of lunotriquetral ligament: NC54.43\\nTraumatic rupture of other specified ligament of wrist or carpus: NC54.4Y\\nTraumatic rupture of ligament of wrist or carpus unspecified: NC54.4Z\\nTraumatic rupture of ligament of finger at metacarpophalangeal or interphalangeal joint: NC54.5\\nTraumatic rupture of collateral ligament of finger at metacarpophalangeal or interphalangeal joint: NC54.50\\nTraumatic rupture of palmar ligament of finger at metacarpophalangeal or interphalangeal joint: NC54.51\\nTraumatic rupture of volar plate of finger at metacarpophalangeal or interphalangeal joint: NC54.52\\nTraumatic rupture of other ligament of finger at metacarpophalangeal or interphalangeal joint: NC54.53\\nTraumatic rupture of ligament of finger at metacarpophalangeal or interphalangeal joint unspecified: NC54.5Z\\nStrain or sprain of wrist: NC54.6\\nStrain or sprain of carpal joint: NC54.60\\nStrain or sprain of radiocarpal joint: NC54.61\\nStrain or sprain of carpometacarpal joint: NC54.62\\nSprain of other specified part of wrist: NC54.6Y\\nStrain or sprain of wrist unspecified: NC54.6Z\\nStrain or sprain of thumb: NC54.7\\nStrain or sprain of metacarpophalangeal joint of thumb: NC54.70\\nStrain or sprain of interphalangeal joint of thumb: NC54.71\\nSprain or strain of other specified part of thumb: NC54.7Y\\nStrain or sprain of thumb unspecified: NC54.7Z\\nStrain or sprain of finger: NC54.8\\nStrain or sprain of metacarpophalangeal joint of finger: NC54.80\\nStrain or sprain of interphalangeal joint of finger: NC54.81\\nSprain of other specified part of finger: NC54.8Y\\nStrain or sprain of finger unspecified: NC54.8Z\\nDislocation or sprain of other specified joints or ligaments at wrist or hand level: NC54.Y\\nDislocation or strain or sprain of joints or ligaments at wrist or hand level unspecified: NC54.Z\\nInjury of nerves at wrist or hand level: NC55\\nInjury of ulnar nerve at wrist or hand level: NC55.0\\nInjury of median nerve at wrist or hand level: NC55.1\\nInjury of radial nerve at wrist or hand level: NC55.2\\nInjury of multiple nerves at wrist or hand level: NC55.3\\nInjury of other specified nerves at wrist or hand level: NC55.Y\\nInjury of unspecified nerve at wrist or hand level: NC55.Z\\nInjury of blood vessels at wrist or hand level: NC56\\nInjury of ulnar artery at wrist or hand level: NC56.0\\nLaceration of ulnar artery at wrist or hand level: NC56.00\\nContusion of ulnar artery at wrist or hand level: NC56.01\\nOther specified injury of ulnar artery at wrist or hand level: NC56.0Y\\nInjury of ulnar artery at wrist or hand level unspecified: NC56.0Z\\nInjury of radial artery at wrist or hand level: NC56.1\\nLaceration of radial artery at wrist or hand level: NC56.10\\nContusion of radial artery at wrist or hand level: NC56.11\\nOther specified injury of radial artery at wrist or hand level: NC56.1Y\\nInjury of radial artery at wrist or hand level unspecified: NC56.1Z\\nInjury of superficial palmar arch: NC56.2\\nLaceration of superficial palmar arch: NC56.20\\nContusion of superficial palmar arch: NC56.21\\nOther specified injury of superficial palmar arch: NC56.2Y\\nInjury of superficial palmar arch unspecified: NC56.2Z\\nInjury of deep palmar arch: NC56.3\\nLaceration of deep palmar arch: NC56.30\\nContusion of deep palmar arch: NC56.31\\nOther specified injury of deep palmar arch: NC56.3Y\\nInjury of deep palmar arch unspecified: NC56.3Z\\nInjury of blood vessel of thumb: NC56.4\\nLaceration of blood vessel of thumb: NC56.40\\nContusion of blood vessel of thumb: NC56.41\\nOther specified injury of blood vessel of thumb: NC56.4Y\\nInjury of blood vessel of thumb unspecified: NC56.4Z\\nInjury of blood vessel of other finger: NC56.5\\nLaceration of blood vessel of other finger: NC56.50\\nContusion of blood vessel of other finger: NC56.51\\nOther specified injury of blood vessel of other finger: NC56.5Y\\nInjury of blood vessel of other finger unspecified: NC56.5Z\\nInjury of multiple blood vessels at wrist or hand level: NC56.6\\nLaceration of multiple blood vessels at wrist or hand level: NC56.60\\nContusion of multiple blood vessels at wrist or hand level: NC56.61\\nOther specified injury of multiple blood vessels at wrist or hand level: NC56.6Y\\nInjury of multiple blood vessels at wrist or hand level unspecified: NC56.6Z\\nInjury of other specified blood vessels at wrist or hand level: NC56.Y\\nInjury of unspecified blood vessel at wrist or hand level: NC56.Z\\nInjury of muscle fascia or tendon at wrist or hand level: NC57\\nInjury of long flexor muscle fascia or tendon of thumb at wrist or hand level: NC57.0\\nStrain or sprain of long flexor muscle fascia or tendon of thumb at wrist or hand level: NC57.00\\nLaceration of long flexor muscle fascia or tendon of thumb at wrist or hand level: NC57.01\\nOther specified injury of long flexor muscle fascia or tendon of thumb at wrist or hand level: NC57.0Y\\nInjury of long flexor muscle fascia or tendon of thumb at wrist or hand level unspecified: NC57.0Z\\nInjury of flexor muscle fascia or tendon of other finger at wrist or hand level: NC57.1\\nStrain or sprain of flexor muscle fascia or tendon of other finger at wrist or hand level: NC57.10\\nLaceration of flexor muscle fascia or tendon of other finger at wrist or hand level: NC57.11\\nOther specified injury of flexor muscle fascia or tendon of other finger at wrist or hand level: NC57.1Y\\nInjury of flexor muscle fascia or tendon of other finger at wrist or hand level unspecified: NC57.1Z\\nInjury of extensor muscle fascia or tendon of thumb at wrist or hand level: NC57.2\\nStrain or sprain of extensor muscle fascia or tendon of thumb at wrist or hand level: NC57.20\\nLaceration of extensor muscle fascia or tendon of thumb at wrist or hand level: NC57.21\\nOther specified injury of extensor muscle fascia or tendon of thumb at wrist or hand level: NC57.2Y\\nInjury of extensor muscle fascia or tendon of thumb at wrist or hand level unspecified: NC57.2Z\\nInjury of extensor muscle fascia or tendon of other finger at wrist or hand level: NC57.3\\nStrain or sprain of extensor muscle fascia or tendon of other finger at wrist or hand level: NC57.30\\nLaceration of extensor muscle fascia or tendon of other finger at wrist or hand level: NC57.31\\nOther specified injury of extensor muscle fascia or tendon of other finger at wrist or hand level: NC57.3Y\\nInjury of extensor muscle fascia or tendon of other finger at wrist or hand level unspecified: NC57.3Z\\nInjury of intrinsic muscle fascia or tendon of thumb at wrist or hand level: NC57.4\\nStrain or sprain of intrinsic muscle fascia or tendon of thumb at wrist or hand level: NC57.40\\nLaceration of intrinsic muscle fascia or tendon of thumb at wrist or hand level: NC57.41\\nOther specified injury of intrinsic muscle fascia or tendon of thumb at wrist or hand level: NC57.4Y\\nInjury of intrinsic muscle fascia or tendon of thumb at wrist or hand level unspecified: NC57.4Z\\nInjury of intrinsic muscle fascia or tendon of other finger at wrist or hand level: NC57.5\\nStrain or sprain of intrinsic muscle fascia or tendon of other finger at wrist or hand level: NC57.50\\nLaceration of intrinsic muscle fascia or tendon of other finger at wrist or hand level: NC57.51\\nOther specified injury of intrinsic muscle fascia or tendon of other finger at wrist or hand level: NC57.5Y\\nInjury of intrinsic muscle fascia or tendon of other finger at wrist or hand level unspecified: NC57.5Z\\nInjury of multiple flexor muscles or tendons at wrist or hand level: NC57.6\\nInjury of multiple extensor muscles or tendons at wrist or hand level: NC57.7\\nInjury of other specified muscle fascia or tendon at wrist or hand level: NC57.Y\\nInjury of unspecified muscle fascia or tendon at wrist or hand level: NC57.Z\\nCrushing injury of wrist or hand: NC58\\nCrushing injury of thumb: NC58.0\\nCrushing injury of other finger: NC58.1\\nCrushing injury of hand: NC58.2\\nCrushing injury of wrist: NC58.3\\nCrushing injury of other specified part of wrist or hand: NC58.Y\\nCrushing injury of wrist or hand unspecified: NC58.Z\\nTraumatic amputation of wrist or hand: NC59\\nTraumatic amputation of thumb: NC59.0\\nTraumatic amputation at or near base of right thumb: NC59.00\\nTraumatic amputation at or near base of left thumb: NC59.01\\nTraumatic amputation at or near base of thumb bilateral: NC59.02\\nOther specified traumatic amputation of thumb: NC59.0Y\\nTraumatic amputation of thumb unspecified: NC59.0Z\\nTraumatic amputation of other single finger: NC59.1\\nTraumatic amputation of two or more fingers alone: NC59.2\\nTraumatic amputation of two or more fingers at or near base right hand: NC59.20\\nTraumatic amputation of two or more fingers at or near base left hand: NC59.21\\nTraumatic amputation of two or more fingers alone at or near base bilateral: NC59.22\\nOther specified traumatic amputation of two or more fingers alone: NC59.2Y\\nTraumatic amputation of two or more fingers alone unspecified: NC59.2Z\\nCombined traumatic amputation of finger with other parts of wrist or hand: NC59.3\\nTraumatic amputation of hand at metacarpal level: NC59.4\\nTraumatic amputation of wrist or hand unspecified: NC59.Z\\nMultiple injuries of wrist or hand: NC5A\\nInjury of multiple sites of hand: NC5A.0\\nInjury of multiple sites of wrist: NC5A.1\\nOther specified multiple injuries of wrist or hand: NC5A.Y\\nMultiple injuries of wrist or hand unspecified: NC5A.Z\\nOther specified injuries to the wrist or hand: NC5Y\\nInjuries to the wrist or hand unspecified: NC5Z\\nSuperficial injury of hip or thigh: NC70\\nAbrasion of hip: NC70.0\\nContusion of hip: NC70.1\\nAbrasion of thigh: NC70.2\\nContusion of thigh: NC70.3\\nMultiple superficial injuries of hip or thigh: NC70.4\\nOther specified superficial injury of hip or thigh: NC70.Y\\nSuperficial injury of hip or thigh unspecified: NC70.Z\\nOpen wound of hip or thigh: NC71\\nLaceration without foreign body of hip or thigh: NC71.0\\nLaceration with foreign body of hip or thigh: NC71.1\\nPuncture wound without foreign body of hip or thigh: NC71.2\\nPuncture wound with foreign body of hip or thigh: NC71.3\\nOpen bite of hip or thigh: NC71.4\\nMultiple open wounds of hip or thigh: NC71.5\\nOther specified open wound of hip or thigh: NC71.Y\\nOpen wound of hip or thigh unspecified: NC71.Z\\nFracture of femur: NC72\\nFracture of head of femur: NC72.0\\nFracture of upper epiphysis of femur: NC72.1\\nFracture of neck of femur: NC72.2\\nFracture of neck of femur subcapital: NC72.20\\nFracture of neck of femur midcervical: NC72.21\\nFracture of base of neck of femur: NC72.22\\nIntracapsular fracture of femur: NC72.23\\nOther specified fracture of neck of femur: NC72.2Y\\nFracture of neck of femur unspecified: NC72.2Z\\nFracture of trochanteric section of femur: NC72.3\\nIntertrochanteric fracture of femur: NC72.30\\nPertrochanteric fracture of femur: NC72.31\\nFracture of other specified trochanteric section of femur: NC72.3Y\\nFracture of unspecified trochanteric section of femur: NC72.3Z\\nSubtrochanteric fracture of femur: NC72.4\\nFracture of shaft of femur: NC72.5\\nFracture of lower end of femur: NC72.6\\nFracture of lower end of femur not extending into joint simple: NC72.60\\nFracture of lower end of femur not extending into joint wedge: NC72.61\\nFracture of lower end of femur not extending into joint complex: NC72.62\\nFracture of lower end of femur extending into joint lateral condyle: NC72.63\\nFracture of lower end of femur extending into joint medial condyle: NC72.64\\nFracture of lower end of femur extending into joint frontal: NC72.65\\nFracture of lower end of femur extending into joint complete articular: NC72.66\\nOther specified fracture of lower end of femur: NC72.6Y\\nFracture of lower end of femur unspecified: NC72.6Z\\nMultiple fractures of femur: NC72.7\\nFractures of other parts of femur: NC72.8\\nOther specified fracture of femur: NC72.Y\\nFracture of femur unspecified: NC72.Z\\nDislocation or strain or sprain of joint or ligaments of hip: NC73\\nDislocation of hip: NC73.0\\nPosterior dislocation of hip: NC73.00\\nObturator dislocation of hip: NC73.01\\nOther anterior dislocation of hip: NC73.02\\nCentral dislocation of hip: NC73.03\\nOther specified dislocation of hip: NC73.0Y\\nDislocation of hip unspecified: NC73.0Z\\nStrain or sprain of hip: NC73.1\\nIliofemoral ligament strain or sprain of hip: NC73.10\\nIschiocapsular ligament strain or sprain of hip: NC73.11\\nOther specified strain or sprain of hip: NC73.1Y\\nStrain or sprain of hip unspecified: NC73.1Z\\nInjury of nerves at hip or thigh level: NC74\\nInjury of sciatic nerve at hip or thigh level: NC74.0\\nInjury of femoral nerve at hip or thigh level: NC74.1\\nInjury of cutaneous sensory nerve at hip or thigh level: NC74.2\\nInjury of multiple nerves at hip or thigh level: NC74.3\\nInjury of other specified nerves at hip or thigh level: NC74.Y\\nInjury of unspecified nerve at hip or thigh level: NC74.Z\\nInjury of blood vessels at hip or thigh level: NC75\\nInjury of femoral artery: NC75.0\\nLaceration of femoral artery minor: NC75.00\\nLaceration of femoral artery major: NC75.01\\nOther specified injury of femoral artery: NC75.0Y\\nInjury of femoral artery unspecified: NC75.0Z\\nInjury of femoral vein at hip or thigh level: NC75.1\\nLaceration of femoral vein at hip or thigh level minor: NC75.10\\nLaceration of femoral vein at hip or thigh level major: NC75.11\\nOther specified injury of femoral vein at hip or thigh level: NC75.1Y\\nInjury of femoral vein at hip or thigh level unspecified: NC75.1Z\\nInjury of greater saphenous vein at hip or thigh level: NC75.2\\nLaceration of greater saphenous vein at hip or thigh level minor: NC75.20\\nLaceration of greater saphenous vein at hip or thigh level major: NC75.21\\nOther specified injury of greater saphenous vein at hip or thigh level: NC75.2Y\\nInjury of greater saphenous vein at hip or thigh level unspecified: NC75.2Z\\nInjury of multiple blood vessels at hip or thigh level: NC75.3\\nInjury of other specified blood vessels at hip or thigh level: NC75.Y\\nInjury of unspecified blood vessel at hip or thigh level: NC75.Z\\nInjury of muscle fascia tendon or bursa at hip or thigh level: NC76\\nInjury of muscle fascia or tendon of hip: NC76.0\\nStrain or sprain of muscle fascia or tendon of hip: NC76.00\\nLaceration of muscle fascia or tendon of hip: NC76.01\\nOther specified injury of muscle fascia or tendon of hip: NC76.0Y\\nInjury of muscle fascia or tendon of hip unspecified: NC76.0Z\\nInjury of quadriceps muscle or tendon: NC76.1\\nStrain or sprain of quadriceps muscle or tendon: NC76.10\\nLaceration of quadriceps muscle or tendon: NC76.11\\nOther specified injury of quadriceps muscle or tendon: NC76.1Y\\nInjury of quadriceps muscle or tendon unspecified: NC76.1Z\\nInjury of adductor muscle fascia or tendon of thigh: NC76.2\\nStrain or sprain of adductor muscle fascia or tendon of thigh: NC76.20\\nLaceration of adductor muscle fascia or tendon of thigh: NC76.21\\nOther specified injury of adductor muscle fascia or tendon of thigh: NC76.2Y\\nInjury of adductor muscle fascia or tendon of thigh unspecified: NC76.2Z\\nInjury of muscle fascia or tendon of the posterior muscle group at thigh level: NC76.3\\nStrain or sprain of muscle fascia or tendon of the posterior muscle group at thigh level: NC76.30\\nLaceration of muscle fascia or tendon of the posterior muscle group at thigh level: NC76.31\\nOther specified injury of muscle fascia or tendon of the posterior muscle group at thigh level: NC76.3Y\\nInjury of muscle fascia or tendon of the posterior muscle group at thigh level unspecified: NC76.3Z\\nInjury of multiple muscles or tendons at hip or thigh level: NC76.4\\nInjury of bursa of hip: NC76.40\\nOther specified injury of multiple muscles or tendons at hip or thigh level: NC76.4Y\\nInjury of multiple muscles or tendons at hip or thigh level unspecified: NC76.4Z\\nInjury of other specified muscle fascia tendon or bursa at hip or thigh level: NC76.Y\\nInjury of unspecified muscle fascia tendon or bursa at hip or thigh level: NC76.Z\\nCrushing injury of hip or thigh: NC77\\nCrushing injury of hip: NC77.0\\nCrushing injury of thigh: NC77.1\\nCrushing injury of hip with thigh: NC77.2\\nCrushing injury of hip or thigh unspecified: NC77.Z\\nTraumatic amputation of hip or thigh: NC78\\nTraumatic amputation at right hip joint: NC78.0\\nTraumatic amputation at left hip joint: NC78.1\\nTraumatic amputation at hip joint bilateral: NC78.2\\nTraumatic amputation at level between right hip and knee: NC78.3\\nTraumatic amputation at level between left hip and knee: NC78.4\\nTraumatic amputation at level between hip and knee bilateral: NC78.5\\nTraumatic amputation of hip or thigh unspecified: NC78.Z\\nMultiple injuries of hip or thigh: NC79\\nOther specified injuries to the hip or thigh: NC7Y\\nInjuries to the hip or thigh unspecified: NC7Z\\nSuperficial injury of knee or lower leg: NC90\\nAbrasion of knee: NC90.0\\nContusion of knee: NC90.1\\nAbrasion of other or unspecified parts of lower leg: NC90.2\\nContusion of other or unspecified parts of lower leg: NC90.3\\nMultiple superficial injuries of lower leg: NC90.4\\nOther specified superficial injury of knee or lower leg: NC90.Y\\nSuperficial injury of knee or lower leg unspecified: NC90.Z\\nOpen wound of knee or lower leg: NC91\\nLaceration without foreign body of lower leg: NC91.0\\nLaceration with foreign body of lower leg: NC91.1\\nPuncture wound without foreign body of lower leg: NC91.2\\nPuncture wound with foreign body of lower leg: NC91.3\\nOpen bite of lower leg: NC91.4\\nMultiple open wounds of lower leg: NC91.5\\nOther specified open wound of knee or lower leg: NC91.Y\\nOpen wound of knee or lower leg unspecified: NC91.Z\\nFracture of lower leg including ankle: NC92\\nFracture of patella: NC92.0\\nFracture of upper end of tibia: NC92.1\\nAvulsion of cruciate ligament insertion: NC92.10\\nAvulsion of tibial tuberosity: NC92.11\\nMetaphyseal fracture of upper end of tibia: NC92.12\\nFracture of upper end of tibia lateral condyle: NC92.13\\nFracture of upper end of tibia medial condyle: NC92.14\\nOther specified fracture of upper end of tibia: NC92.1Y\\nFracture of upper end of tibia unspecified: NC92.1Z\\nFracture of shaft of tibia: NC92.2\\nFracture of lower end of tibia: NC92.3\\nFracture of fibula: NC92.4\\nAvulsion of fibular head: NC92.40\\nOther specified fracture of fibula: NC92.4Y\\nFracture of fibula unspecified: NC92.4Z\\nFracture of medial malleolus: NC92.5\\nFracture of lateral malleolus: NC92.6\\nComplex fractures of ankle: NC92.7\\nFracture avulsion or collateral ligament rupture of lateral malleolus below syndesmosis with fracture avulsion or collateral ligament rupture of medial malleolus: NC92.70\\nFracture avulsion or collateral ligament rupture of lateral malleolus below syndesmosis with fracture avulsion or collateral ligament rupture of medial malleolus and fracture of posterior margin of distal tibia: NC92.71\\nFracture of lateral malleolus at syndesmosis with fracture avulsion or collateral ligament rupture of medial malleolus: NC92.72\\nFracture of lateral malleolus at syndesmosis with fracture avulsion or collateral ligament rupture of medial malleolus and fracture of posterior margin of distal tibia: NC92.73\\nFracture avulsion or collateral ligament rupture of medial malleolus with fracture of fibula above syndesmosis: NC92.74\\nFracture avulsion or collateral ligament rupture of medial malleolus with fracture of fibula above syndesmosis and fracture of posterior margin of distal tibia: NC92.75\\nBimalleolar fracture of ankle not otherwise specified: NC92.76\\nTrimalleolar fracture of ankle not otherwise specified: NC92.77\\nOther specified complex fractures of ankle: NC92.7Y\\nComplex fractures of ankle unspecified: NC92.7Z\\nMultiple fractures of lower leg: NC92.8\\nFracture of other specified part of lower leg including ankle: NC92.Y\\nFracture of lower leg including ankle unspecified: NC92.Z\\nDislocation or strain or sprain of joints or ligaments of knee: NC93\\nAcute internal damage of knee: NC93.0\\nDislocation of patella: NC93.1\\nLateral dislocation of patella: NC93.10\\nOther specified dislocation of patella: NC93.1Y\\nDislocation of patella unspecified: NC93.1Z\\nDislocation of knee: NC93.2\\nAnterior dislocation of proximal end of tibia: NC93.20\\nPosterior dislocation of proximal end of tibia: NC93.21\\nMedial dislocation of proximal end of tibia: NC93.22\\nLateral dislocation of proximal end of tibia: NC93.23\\nOther specified dislocation of knee: NC93.2Y\\nDislocation of knee unspecified: NC93.2Z\\nTear of meniscus current: NC93.3\\nTear of medial meniscus: NC93.30\\nTear of lateral meniscus: NC93.31\\nOther specified tear of meniscus current: NC93.3Y\\nTear of meniscus current unspecified: NC93.3Z\\nTear of articular cartilage of knee: NC93.4\\nStrain or sprain involving fibular or tibial collateral ligament of knee: NC93.5\\nStrain or sprain of medial collateral ligament of knee excluding rupture: NC93.50\\nStrain or sprain of lateral collateral ligament of knee excluding rupture: NC93.51\\nRupture of medial collateral ligament of knee: NC93.52\\nRupture of lateral collateral ligament of knee: NC93.53\\nOther specified strain or sprain involving fibular or tibial collateral ligament of knee: NC93.5Y\\nStrain or sprain involving fibular or tibial collateral ligament of knee unspecified: NC93.5Z\\nStrain or sprain involving anterior or posterior cruciate ligament of knee: NC93.6\\nStrain or sprain of anterior cruciate ligament of knee excluding rupture: NC93.60\\nStrain or sprain of posterior cruciate ligament of knee excluding rupture: NC93.61\\nRupture of anterior cruciate ligament: NC93.62\\nRupture of posterior cruciate ligament: NC93.63\\nOther specified strain or sprain involving anterior or posterior cruciate ligament of knee: NC93.6Y\\nStrain or sprain involving anterior or posterior cruciate ligament of knee unspecified: NC93.6Z\\nStrain or sprain of other or unspecified parts of knee: NC93.7\\nInjury to multiple structures of knee: NC93.8\\nOther specified dislocation or strain or sprain of joints or ligaments of knee: NC93.Y\\nDislocation or strain or sprain of joints or ligaments of knee unspecified: NC93.Z\\nInjury of nerves at lower leg level: NC94\\nInjury of tibial nerve at lower leg level: NC94.0\\nInjury of peroneal nerve at lower leg level: NC94.1\\nInjury of cutaneous sensory nerve at lower leg level: NC94.2\\nInjury of multiple nerves at lower leg level: NC94.3\\nInjury of other specified nerves at lower leg level: NC94.Y\\nInjury of unspecified nerve at lower leg level: NC94.Z\\nInjury of blood vessels at lower leg level: NC95\\nInjury of popliteal artery: NC95.0\\nLaceration of popliteal artery: NC95.00\\nOther specified injury of popliteal artery: NC95.0Y\\nInjury of popliteal artery unspecified: NC95.0Z\\nInjury of anterior tibial artery: NC95.1\\nLaceration of anterior tibial artery: NC95.10\\nOther specified injury of anterior tibial artery: NC95.1Y\\nInjury of anterior tibial artery unspecified: NC95.1Z\\nInjury of posterior tibial artery: NC95.2\\nLaceration of posterior tibial artery: NC95.20\\nOther specified injury of posterior tibial artery: NC95.2Y\\nInjury of posterior tibial artery unspecified: NC95.2Z\\nInjury of peroneal artery: NC95.3\\nLaceration of peroneal artery: NC95.30\\nOther specified injury of peroneal artery: NC95.3Y\\nInjury of peroneal artery unspecified: NC95.3Z\\nInjury of greater saphenous vein at lower leg level: NC95.4\\nLaceration of greater saphenous vein at lower leg level: NC95.40\\nOther specified injury of greater saphenous vein at lower leg level: NC95.4Y\\nInjury of greater saphenous vein at lower leg level unspecified: NC95.4Z\\nInjury of lesser saphenous vein at lower leg level: NC95.5\\nLaceration of lesser saphenous vein at lower leg level: NC95.50\\nOther specified injury of lesser saphenous vein at lower leg level: NC95.5Y\\nInjury of lesser saphenous vein at lower leg level unspecified: NC95.5Z\\nInjury of popliteal vein: NC95.6\\nLaceration of popliteal vein: NC95.60\\nOther specified injury of popliteal vein: NC95.6Y\\nInjury of popliteal vein unspecified: NC95.6Z\\nInjury of multiple blood vessels at lower leg level: NC95.7\\nInjury of other specified blood vessels at lower leg level: NC95.Y\\nInjury of unspecified blood vessel at lower leg level: NC95.Z\\nInjury of muscle fascia tendon or bursa at lower leg level: NC96\\nInjury of Achilles tendon: NC96.0\\nStrain or sprain of Achilles tendon: NC96.00\\nLaceration of Achilles tendon: NC96.01\\nRupture of Achilles tendon: NC96.02\\nOther specified injury of Achilles tendon: NC96.0Y\\nInjury of Achilles tendon unspecified: NC96.0Z\\nInjury of other muscle fascia or tendon of posterior muscle group at lower leg level: NC96.1\\nStrain or sprain of other muscle fascia or tendon of posterior muscle group at lower leg level: NC96.10\\nLaceration of other muscle fascia or tendon of posterior muscle group at lower leg level: NC96.11\\nOther specified injury of other muscle fascia or tendon of posterior muscle group at lower leg level: NC96.1Y\\nInjury of other muscle fascia or tendon of posterior muscle group at lower leg level unspecified: NC96.1Z\\nInjury of muscle fascia or tendon of anterior muscle group at lower leg level: NC96.2\\nStrain or sprain of muscle fascia or tendon of anterior muscle group at lower leg level: NC96.20\\nLaceration of muscle fascia or tendon of anterior muscle group at lower leg level: NC96.21\\nOther specified injury of muscle fascia or tendon of anterior muscle group at lower leg level: NC96.2Y\\nInjury of muscle fascia or tendon of anterior muscle group at lower leg level unspecified: NC96.2Z\\nInjury of muscle fascia or tendon of peroneal muscle group at lower leg level: NC96.3\\nStrain or sprain of muscle fascia or tendon of peroneal muscle group at lower leg level: NC96.30\\nLaceration of muscle fascia or tendon of peroneal muscle group at lower leg level: NC96.31\\nOther specified injury of muscle fascia or tendon of peroneal muscle group at lower leg level: NC96.3Y\\nInjury of muscle fascia or tendon of peroneal muscle group at lower leg level unspecified: NC96.3Z\\nInjury of multiple muscles fasciae or tendons at lower leg level: NC96.4\\nInjury of bursa of knee: NC96.5\\nInjury of other specified muscle fascia tendon or bursa at lower leg level: NC96.Y\\nInjury of unspecified muscle fascia tendon or bursa at lower leg level: NC96.Z\\nCrushing injury of lower leg: NC97\\nCrushing injury of knee: NC97.0\\nCrushing injury of other specified part of lower leg: NC97.Y\\nCrushing injury of lower leg unspecified: NC97.Z\\nTraumatic amputation of lower leg: NC98\\nTraumatic amputation of right lower leg at knee level: NC98.0\\nTraumatic amputation of left lower leg at knee level: NC98.1\\nTraumatic amputation at knee level bilateral: NC98.2\\nTraumatic amputation at level between right knee and ankle: NC98.3\\nTraumatic amputation at level between left knee and ankle: NC98.4\\nTraumatic amputation at level between knee and ankle bilateral: NC98.5\\nOther specified traumatic amputation of lower leg: NC98.Y\\nTraumatic amputation of lower leg unspecified: NC98.Z\\nMultiple injuries of lower leg: NC99\\nOther specified injuries to the knee or lower leg: NC9Y\\nInjuries to the knee or lower leg unspecified: NC9Z\\nInjury to toenail: ND10\\nSuperficial injury of ankle or foot: ND11\\nAbrasion of ankle: ND11.0\\nContusion of ankle: ND11.1\\nNonthermal blister of ankle: ND11.2\\nNonvenomous insect bite of ankle: ND11.3\\nSuperficial foreign body in ankle: ND11.4\\nSplinter in ankle: ND11.40\\nOther specified superficial foreign body in ankle: ND11.4Y\\nSuperficial foreign body in ankle unspecified: ND11.4Z\\nAbrasion of toe: ND11.5\\nContusion of toe: ND11.6\\nAbrasion of other or unspecified parts of foot: ND11.7\\nContusion of other or unspecified parts of foot: ND11.8\\nNonthermal blister of other or unspecified parts of foot: ND11.9\\nNonvenomous insect bite of other or unspecified parts of foot: ND11.A\\nSuperficial foreign body in other or unspecified parts of foot: ND11.B\\nSplinter in other or unspecified parts of foot: ND11.B0\\nOther specified superficial foreign body in other or unspecified parts of foot: ND11.BY\\nSuperficial foreign body in other or unspecified parts of foot unspecified: ND11.BZ\\nMultiple superficial injuries of ankle or foot: ND11.C\\nOther specified superficial injury of ankle or foot: ND11.Y\\nSuperficial injury of ankle or foot unspecified: ND11.Z\\nOpen wound of ankle or foot: ND12\\nLaceration without foreign body of ankle or foot: ND12.0\\nLaceration with foreign body of ankle or foot: ND12.1\\nPuncture wound with foreign body of ankle or foot: ND12.2\\nPuncture wound without foreign body of ankle or foot: ND12.3\\nOpen bite of ankle or foot: ND12.4\\nMultiple open wounds of ankle or foot: ND12.5\\nOpen wound of toe: ND12.6\\nLaceration without foreign body of toe: ND12.60\\nLaceration with foreign body of toe: ND12.61\\nPuncture wound without foreign body of toe: ND12.62\\nPuncture wound with foreign body of toe: ND12.63\\nOpen bite of toe: ND12.64\\nOther specified open wound of toe: ND12.6Y\\nOpen wound of toe unspecified: ND12.6Z\\nOther specified open wound of ankle or foot: ND12.Y\\nOpen wound of ankle or foot unspecified: ND12.Z\\nFracture of foot except ankle: ND13\\nFracture of calcaneus: ND13.0\\nFracture of talus: ND13.1\\nFracture of unspecified tarsal bone: ND13.2\\nFracture of metatarsal bone: ND13.3\\nFracture of great toe: ND13.4\\nFracture of other toe: ND13.5\\nMultiple fractures of foot: ND13.6\\nFracture of cuboid bone: ND13.7\\nFracture of lateral cuneiform: ND13.8\\nFracture of intermediate cuneiform: ND13.9\\nFracture of medial cuneiform: ND13.A\\nFracture of navicular of foot: ND13.B\\nFracture of other specified part of foot except ankle: ND13.Y\\nFracture of foot except ankle unspecified: ND13.Z\\nDislocation or strain or sprain of joints or ligaments at ankle or foot level: ND14\\nDislocation of ankle joint: ND14.0\\nDislocation of great toe: ND14.1\\nDislocation of metatarsophalangeal joint of great toe: ND14.10\\nDislocation of interphalangeal joint of great toe: ND14.11\\nDislocation of great toe unspecified: ND14.1Z\\nDislocation of other toe: ND14.2\\nDislocation of metatarsophalangeal joint of lesser toe: ND14.20\\nDislocation of interphalangeal joints of lesser toe: ND14.21\\nDislocation of other specified toe: ND14.2Y\\nDislocation of other toe unspecified: ND14.2Z\\nDislocation of tarsal joint: ND14.3\\nDislocation of tarsometatarsal joint: ND14.4\\nRupture of ligaments at ankle or foot level: ND14.5\\nDislocation of other or unspecified parts of foot: ND14.6\\nStrain or sprain of ankle: ND14.7\\nStrain or sprain of calcaneofibular ligament: ND14.70\\nStrain or sprain of deltoid ligament: ND14.71\\nStrain or sprain of tibiofibular ligament: ND14.72\\nStrain or sprain of other ligament of ankle: ND14.73\\nStrain or sprain of ankle unspecified: ND14.7Z\\nStrain or sprain of other toe: ND14.8\\nStrain or sprain of metatarsophalangeal joint of lesser toe: ND14.80\\nStrain or sprain of interphalangeal joints of lesser toe: ND14.81\\nStrain or sprain of other specified toe: ND14.8Y\\nStrain or sprain of other toe unspecified: ND14.8Z\\nStrain or sprain of great toe: ND14.9\\nStrain or sprain of metatarsophalangeal joint of great toe: ND14.90\\nStrain or sprain of interphalangeal joint of great toe: ND14.91\\nStrain or sprain of great toe unspecified: ND14.9Z\\nStrain or sprain of other or unspecified parts of foot: ND14.A\\nOther specified dislocation or strain or sprain of joints or ligaments at ankle or foot level: ND14.Y\\nDislocation or strain or sprain of joints or ligaments at ankle or foot level unspecified: ND14.Z\\nInjury of nerves at ankle or foot level: ND15\\nInjury of lateral plantar nerve: ND15.0\\nInjury of medial plantar nerve: ND15.1\\nInjury of deep peroneal nerve at ankle or foot level: ND15.2\\nInjury of cutaneous sensory nerve at ankle or foot level: ND15.3\\nInjury of multiple nerves at ankle or foot level: ND15.4\\nInjury of other specified nerves at ankle or foot level: ND15.Y\\nInjury of unspecified nerve at ankle or foot level: ND15.Z\\nInjury of blood vessels at ankle or foot level: ND16\\nInjury of dorsal artery of foot: ND16.0\\nLaceration of dorsal artery of foot: ND16.00\\nOther specified injury of dorsal artery of foot: ND16.0Y\\nInjury of dorsal artery of foot unspecified: ND16.0Z\\nInjury of plantar artery of foot: ND16.1\\nLaceration of plantar artery of foot: ND16.10\\nOther specified injury of plantar artery of foot: ND16.1Y\\nInjury of plantar artery of foot unspecified: ND16.1Z\\nInjury of dorsal vein of foot: ND16.2\\nLaceration of dorsal vein of foot: ND16.20\\nOther specified injury of dorsal vein of foot: ND16.2Y\\nInjury of dorsal vein of foot unspecified: ND16.2Z\\nInjury of multiple blood vessels at ankle or foot level: ND16.3\\nInjury of other specified blood vessels at ankle or foot level: ND16.Y\\nInjury of unspecified blood vessel at ankle or foot level: ND16.Z\\nInjury of muscle fascia or tendon at ankle or foot level: ND17\\nInjury of muscle fascia or tendon of long flexor muscle of toe at ankle or foot level: ND17.0\\nStrain or sprain of muscle fascia or tendon of long flexor muscle of toe at ankle or foot level: ND17.00\\nLaceration of muscle fascia or tendon of long flexor muscle of toe at ankle or foot level: ND17.01\\nOther specified injury of muscle fascia or tendon of long flexor muscle of toe at ankle or foot level: ND17.0Y\\nInjury of muscle fascia or tendon of long flexor muscle of toe at ankle or foot level unspecified: ND17.0Z\\nInjury of muscle fascia or tendon of long extensor muscle of toe at ankle or foot level: ND17.1\\nStrain or sprain of muscle fascia or tendon of long extensor muscle of toe at ankle or foot level: ND17.10\\nLaceration of muscle fascia or tendon of long extensor muscle of toe at ankle or foot level: ND17.11\\nOther specified injury of muscle fascia or tendon of long extensor muscle of toe at ankle or foot level: ND17.1Y\\nInjury of muscle fascia or tendon of long extensor muscle of toe at ankle or foot level unspecified: ND17.1Z\\nInjury of intrinsic muscle fascia or tendon at ankle or foot level: ND17.2\\nStrain or sprain of intrinsic muscle fascia or tendon at ankle or foot level: ND17.20\\nLaceration of intrinsic muscle fascia or tendon at ankle or foot level: ND17.21\\nOther specified injury of intrinsic muscle fascia or tendon at ankle or foot level: ND17.2Y\\nInjury of intrinsic muscle fascia or tendon at ankle or foot level unspecified: ND17.2Z\\nInjury of multiple muscles or tendons at ankle or foot level: ND17.3\\nInjury of other specified muscle fascia or tendon at ankle or foot level: ND17.Y\\nInjury of unspecified muscle fascia or tendon at ankle or foot level: ND17.Z\\nCrushing injury of ankle or foot: ND18\\nCrushing injury of ankle: ND18.0\\nCrushing injury of toe: ND18.1\\nCrushing injury of other parts of ankle or foot: ND18.2\\nCrushing injury of ankle or foot unspecified: ND18.Z\\nTraumatic amputation of ankle or foot: ND19\\nTraumatic amputation of right foot at ankle level: ND19.0\\nTraumatic amputation of left foot at ankle level: ND19.1\\nTraumatic amputation of foot at ankle level bilateral: ND19.2\\nTraumatic amputation of right foot at metatarsal level: ND19.3\\nTraumatic amputation of left foot at metatarsal level: ND19.4\\nTraumatic amputation of foot at metatarsal level bilateral: ND19.5\\nTraumatic amputation of one toe: ND19.6\\nTraumatic amputation of two or more toes: ND19.7\\nTraumatic amputation of other parts of foot: ND19.8\\nTraumatic amputation of ankle or foot unspecified: ND19.Z\\nMultiple injuries of ankle or foot: ND1A\\nOther specified injuries to the ankle or foot: ND1Y\\nInjuries to the ankle or foot unspecified: ND1Z\\nSuperficial injuries involving multiple body regions: ND30\\nOpen wounds involving multiple body regions: ND31\\nFractures involving multiple body regions: ND32\\nDislocations strains or sprains involving multiple body regions: ND33\\nCrushing injuries involving multiple body regions: ND34\\nTraumatic amputations involving multiple body regions: ND35\\nOther injuries involving multiple body regions not elsewhere classified: ND36\\nUnspecified multiple injuries: ND37\\nFracture of spine level unspecified: ND50\\nOther injuries of spine or trunk level unspecified: ND51\\nDislocation or strain or sprain of unspecified joint or ligament of trunk: ND51.0\\nInjury of unspecified nerve spinal nerve root or plexus of trunk: ND51.1\\nInjury of spinal cord level unspecified: ND51.2\\nInjury of unspecified muscle fascia or tendon of trunk: ND51.3\\nCrushing injury of spine or trunk level unspecified: ND51.4\\nOther specified injuries of spine or trunk level unspecified: ND51.Y\\nUnspecified injuries of spine or trunk level unspecified: ND51.Z\\nFracture of arm level unspecified: ND52\\nOther injuries of arm level unspecified: ND53\\nCrushing injury of arm level unspecified: ND53.0\\nOther specified injuries of arm level unspecified: ND53.Y\\nFracture of leg level unspecified: ND54\\nOther injuries of leg level unspecified: ND55\\nInjury of unspecified body region: ND56\\nSuperficial injury of unspecified body region: ND56.0\\nOpen wound of unspecified body region: ND56.1\\nFracture of unspecified body region: ND56.2\\nDislocation or strain or sprain of unspecified body region: ND56.3\\nInjury of nerve of unspecified body region: ND56.4\\nInjury of blood vessel of unspecified body region: ND56.5\\nInjury of muscles or tendons of unspecified body region: ND56.6\\nCrushing injury of unspecified body region: ND56.7\\nTraumatic amputation of unspecified body region: ND56.8\\nInjury complicating pregnancy: ND56.9\\nOther specified injury of unspecified body region: ND56.Y\\nUnspecified injury to unspecified part of trunk limb or body region: ND56.Z\\nSecondary effect of trauma: ND57\\nOther specified injuries to unspecified part of trunk limb or body region: ND5Y\\nInjuries to unspecified part of trunk limb or body region unspecified: ND5Z\\nForeign body on external eye: ND70\\nForeign body in cornea: ND70.0\\nForeign body in conjunctival sac: ND70.1\\nForeign body in multiple parts of external eye: ND70.2\\nForeign body in other specified part of external eye: ND70.Y\\nForeign body on external eye unspecified: ND70.Z\\nForeign body in ear: ND71\\nForeign body in respiratory tract: ND72\\nForeign body in nasal sinus: ND72.0\\nForeign body in nostril: ND72.1\\nForeign body in pharynx: ND72.2\\nAsphyxia on mucus in nasopharynx: ND72.20\\nOther specified foreign body in pharynx: ND72.2Y\\nForeign body in pharynx unspecified: ND72.2Z\\nForeign body in larynx: ND72.3\\nForeign body in trachea: ND72.4\\nForeign body in bronchus: ND72.5\\nForeign body in multiple parts of respiratory tract: ND72.6\\nForeign body in other parts of respiratory tract: ND72.Y\\nForeign body in unspecified part of respiratory tract: ND72.Z\\nForeign body in alimentary tract: ND73\\nForeign body in mouth: ND73.0\\nForeign body in oesophagus: ND73.1\\nForeign body in stomach: ND73.2\\nTrichobezoar: ND73.20\\nOther specified foreign body in stomach: ND73.2Y\\nForeign body in stomach unspecified: ND73.2Z\\nForeign body in small intestine: ND73.3\\nForeign body in colon: ND73.4\\nForeign body in anus or rectum: ND73.5\\nForeign body in other specified part of alimentary tract: ND73.Y\\nForeign body in alimentary tract unspecified: ND73.Z\\nForeign body in genitourinary tract: ND74\\nForeign body in urethra: ND74.0\\nForeign body in bladder: ND74.1\\nForeign body in vulva or vagina: ND74.2\\nForeign body in uterus any part: ND74.3\\nForeign body in other specified part of genitourinary tract: ND74.Y\\nForeign body in genitourinary tract unspecified: ND74.Z\\nEffects of foreign body entering through natural orifice unspecified: ND7Z\\nBurn of head or neck except face: ND90\\nBurn of head or neck except face epidermal burn: ND90.0\\nBurn of head or neck except face superficial partial thickness burn: ND90.1\\nBurn of head or neck except face deep partial thickness burn: ND90.2\\nBurn of head or neck except face full thickness burn: ND90.3\\nBurn of head or neck except face deep full thickness or complex burn: ND90.4\\nBurn of head or neck except face depth of burn unspecified: ND90.Z\\nBurn of face except eye or ocular adnexa: ND91\\nBurn of face except eye or ocular adnexa epidermal burn: ND91.0\\nBurn of face except eye or ocular adnexa superficial partial thickness burn: ND91.1\\nBurn of face except eye or ocular adnexa deep partial thickness burn: ND91.2\\nBurn of face except eye or ocular adnexa full thickness burn: ND91.3\\nBurn of face except eye or ocular adnexa deep full thickness or complex burn: ND91.4\\nBurn of face except eye depth of burn unspecified: ND91.Z\\nBurn of trunk except perineum or genitalia: ND92\\nBurn of trunk except perineum or genitalia epidermal burn: ND92.0\\nBurn of breast epidermal burn: ND92.00\\nBurn of chest wall epidermal burn: ND92.01\\nBurn of abdominal wall epidermal burn: ND92.02\\nBurn of back any part epidermal burn: ND92.03\\nOther specified burn of trunk except perineum or genitalia epidermal burn: ND92.0Y\\nBurn of trunk except perineum or genitalia epidermal burn unspecified: ND92.0Z\\nBurn of trunk except perineum or genitalia superficial partial thickness burn: ND92.1\\nBurn of trunk except perineum or genitalia deep partial thickness burn: ND92.2\\nBurn of trunk except perineum or genitalia full thickness burn: ND92.3\\nBurn of trunk except perineum or genitalia deep full thickness or complex burn: ND92.4\\nBurn of trunk except perineum or genitalia depth of burn unspecified: ND92.Z\\nBurn of perineum or genitalia: ND93\\nBurn of perineum or genitalia epidermal burn: ND93.0\\nBurn of perineum or genitalia superficial partial thickness burn: ND93.1\\nBurn of perineum or genitalia deep partial thickness burn: ND93.2\\nBurn of perineum or genitalia full thickness burn: ND93.3\\nBurn of perineum or genitalia deep full thickness or complex burn: ND93.4\\nBurn of perineum or genitalia depth of burn unspecified: ND93.Z\\nBurn of shoulder or arm except wrist or hand: ND94\\nBurn of shoulder or arm except wrist or hand epidermal burn: ND94.0\\nBurn of shoulder or arm except wrist or hand superficial partial thickness burn: ND94.1\\nBurn of forearm or elbow superficial partial thickness burn: ND94.10\\nOther specified burn of shoulder or arm except wrist or hand superficial partial thickness burn: ND94.1Y\\nBurn of shoulder or arm except wrist or hand superficial partial thickness burn unspecified: ND94.1Z\\nBurn of shoulder or arm except wrist or hand deep partial thickness burn: ND94.2\\nBurn of forearm or elbow deep partial thickness burn: ND94.20\\nOther specified burn of shoulder or arm except wrist or hand deep partial thickness burn: ND94.2Y\\nBurn of shoulder or arm except wrist or hand deep partial thickness burn unspecified: ND94.2Z\\nBurn of shoulder or arm except wrist or hand full thickness burn: ND94.3\\nBurn of shoulder or arm except wrist or hand deep full thickness or complex burn: ND94.4\\nBurn of shoulder or arm except wrist or hand depth of burn unspecified: ND94.Z\\nBurn of wrist or hand: ND95\\nBurn of wrist or hand epidermal burn: ND95.0\\nBurn of wrist or hand superficial partial thickness burn: ND95.1\\nBurn of wrist or hand deep partial thickness burn: ND95.2\\nBurn of wrist or hand full thickness burn: ND95.3\\nBurn of wrist or hand deep full thickness or complex burn: ND95.4\\nBurn of wrist or hand depth of burn unspecified: ND95.Z\\nBurn of hip or leg except ankle or foot: ND96\\nBurn of hip or leg except ankle or foot epidermal burn: ND96.0\\nBurn of hip or leg except ankle or foot superficial partial thickness burn: ND96.1\\nBurn of hip or leg except ankle or foot deep partial thickness burn: ND96.2\\nBurn of hip or leg except ankle or foot full thickness burn: ND96.3\\nBurn of hip or leg except ankle or foot deep full thickness or complex burn: ND96.4\\nBurn of hip or leg except ankle or foot depth of burn unspecified: ND96.Z\\nBurn of ankle or foot: ND97\\nBurn of ankle or foot epidermal burn: ND97.0\\nBurn of ankle or foot superficial partial thickness burn: ND97.1\\nBurn of ankle or foot deep partial thickness burn: ND97.2\\nBurn of ankle or foot full thickness burn: ND97.3\\nBurn of ankle or foot deep full thickness or complex burn: ND97.4\\nBurn of ankle or foot depth of burn unspecified: ND97.Z\\nAcute skin injury due to skin contact with corrosive substance: ND99\\nChemical burn due to skin contact with corrosive substance: ND99.1\\nBurns of external body surface other specified site: ND9Y\\nBurns of external body surface unspecified site: ND9Z\\nBurn of eye or ocular adnexa: NE00\\nBurn of respiratory tract: NE01\\nBurn of other internal organs: NE02\\nBurns of unspecified internal organ: NE0Z\\nBurns of multiple body regions: NE10\\nBurn of unspecified body region: NE11\\nBurns unspecified: NE2Z\\nSuperficial frostbite: NE40\\nFrostbite with tissue necrosis: NE41\\nFrostbite involving multiple body regions: NE42\\nFrostbite unspecified: NE4Z\\nHarmful effects of drugs medicaments or biological substances not elsewhere classified: NE60\\nHarmful effects of or exposure to noxious substances chiefly nonmedicinal as to source not elsewhere classified: NE61\\nHarmful effects of unspecified substance: NE6Z\\nInjury or harm arising following infusion transfusion or therapeutic injection not elsewhere classified: NE80\\nAir embolism following infusion transfusion or therapeutic injection: NE80.0\\nABO incompatibility reaction: NE80.1\\nRh incompatibility reaction: NE80.2\\nOther serum reactions: NE80.3\\nOther specified injury or harm arising following infusion transfusion or therapeutic injection not elsewhere classified: NE80.Y\\nInjury or harm arising following infusion transfusion or therapeutic injection not elsewhere classified unspecified: NE80.Z\\nInjury or harm arising from a procedure not elsewhere classified: NE81\\nHaemorrhage or haematoma complicating a procedure not elsewhere classified: NE81.0\\nHaematoma of surgical wound of skin: NE81.00\\nHaemorrhage and haematoma of eye or ocular adnexa complicating a procedure: NE81.01\\nHaemorrhage or haematoma of other or unspecified site complicating a procedure not elsewhere classified: NE81.0Z\\nDisruption of operation wound not elsewhere classified: NE81.1\\nSurgical site infection: NE81.2\\nSuperficial incisional site infection: NE81.20\\nDeep incisional site infection: NE81.21\\nOrgan or organ space surgical site infection: NE81.22\\nOther specified surgical site infection: NE81.2Y\\nSurgical site infection unspecified: NE81.2Z\\nPostsurgical leak: NE81.3\\nOther specified injury or harm arising from a procedure not elsewhere classified: NE81.Y\\nInjury or harm arising from a procedure not elsewhere classified unspecified: NE81.Z\\nDysfunction or complication of pacemaker pacemaker lead or implantable cardioverter defibrillator not elsewhere classified: NE82\\nPacemaker or implantable cardioverter defibrillator complication: NE82.0\\nPacemaker or implantable cardioverter defibrillator pocket erosion: NE82.00\\nPacemaker or implantable cardioverter defibrillator pocket muscle stimulation: NE82.01\\nPacemaker or implantable cardioverter defibrillator phrenic nerve stimulation: NE82.02\\nPacinginduced cardiomyopathy: NE82.03\\nOther specified pacemaker or implantable cardioverter defibrillator complication: NE82.0Y\\nPacemaker or implantable cardioverter defibrillator complication unspecified: NE82.0Z\\nPacemaker or implantable cardioverter defibrillator dysfunction: NE82.1\\nInappropriate implantable cardioverter defibrillator shock: NE82.10\\nPacemaker syndrome: NE82.11\\nPacemaker generator dysfunction: NE82.12\\nOther specified pacemaker or implantable cardioverter defibrillator dysfunction: NE82.1Y\\nPacemaker or implantable cardioverter defibrillator dysfunction unspecified: NE82.1Z\\nPacemaker or implantable cardioverter defibrillator lead complication: NE82.2\\nPacemaker or implantable cardioverter defibrillator lead fracture: NE82.20\\nPacemaker or implantable cardioverter defibrillator lead dislodgement: NE82.21\\nPacemaker or implantable cardioverter defibrillator lead insulation break: NE82.22\\nOther specified pacemaker or implantable cardioverter defibrillator lead complication: NE82.2Y\\nPacemaker or implantable cardioverter defibrillator lead complication unspecified: NE82.2Z\\nPacemaker or implantable cardioverter defibrillator lead dysfunction: NE82.3\\nOther specified dysfunction or complication of pacemaker pacemaker lead or implantable cardioverter defibrillator not elsewhere classified: NE82.Y\\nDysfunction or complication of pacemaker pacemaker lead or implantable cardioverter defibrillator not elsewhere classified unspecified: NE82.Z\\nInjury or harm arising from other device implant or graft not elsewhere classified: NE83\\nDestruction or cartilage wear of joint with hemiarthroplasty: NE83.0\\nInfection arising from device implant or graft not elsewhere classified: NE83.1\\nOther specified injury or harm arising from other device implant or graft not elsewhere classified: NE83.Y\\nFailure or rejection of transplanted organs or tissues: NE84\\nComplications peculiar to reattachment or amputation: NE85\\nComplications of reattached upper extremity: NE85.0\\nComplications of reattached lower extremity: NE85.1\\nComplications of other reattached body part: NE85.2\\nNeuroma of amputation stump: NE85.3\\nInfection of amputation stump: NE85.4\\nNecrosis of amputation stump: NE85.5\\nOther or unspecified complications of amputation stump: NE85.6\\nMalignant hyperthermia due to anaesthesia: NE86\\nFailed or difficult intubation: NE87\\nDrug toxicity associated with harm in surgical or medical care not elsewhere classified: NE88\\nAwareness under general anaesthesia: NE89\\nOther specified injury or harm arising from surgical or medical care not elsewhere classified: NE8Y\\nInjury or harm arising from surgical or medical care not elsewhere classified unspecified: NE8Z\\nEffects of radiation not elsewhere classified: NF00\\nEffects of heat: NF01\\nHeat stroke: NF01.0\\nHeat syncope: NF01.1\\nHeat exhaustion due to fluid depletion: NF01.2\\nHeat fatigue transient: NF01.3\\nOther specified effects of heat: NF01.Y\\nEffects of heat unspecified: NF01.Z\\nHypothermia: NF02\\nOther effects of reduced temperature: NF03\\nChilblains: NF03.0\\nImmersion hand or foot: NF03.1\\nOther specified effects of reduced temperature: NF03.Y\\nUnspecified effects of reduced temperature: NF03.Z\\nEffects of air pressure or water pressure: NF04\\nOtitic barotrauma: NF04.0\\nSinus barotrauma: NF04.1\\nCaisson disease: NF04.2\\nEffects of highpressure fluids: NF04.3\\nOther specified effects of air pressure or water pressure: NF04.Y\\nEffects of air pressure or water pressure unspecified: NF04.Z\\nAsphyxiation: NF05\\nEffects of strenuous physical exercise: NF06\\nExertional heat stroke: NF06.0\\nPost exercise postural hypotension: NF06.1\\nPost exertional dehydration: NF06.2\\nExercise muscle cramp: NF06.3\\nOther specified effects of strenuous physical exercise: NF06.Y\\nEffects of strenuous physical exercise unspecified: NF06.Z\\nEffects of other deprivation: NF07\\nEffects of hunger: NF07.0\\nEffects of thirst: NF07.1\\nExhaustion due to exposure: NF07.2\\nOther specified effects of deprivation: NF07.Y\\nEffects of other deprivation unspecified: NF07.Z\\nEffects of certain specified external causes: NF08\\nEffects of lightning: NF08.0\\nDrowning or nonfatal submersion: NF08.1\\nEffects of vibration: NF08.2\\nHand and arm vibration syndrome: NF08.20\\nOther specified effects of vibration: NF08.2Y\\nEffects of vibration unspecified: NF08.2Z\\nMotion sickness: NF08.3\\nEffects of electric current: NF08.4\\nAdverse effects not elsewhere classified: NF09\\nCertain early complications of trauma not elsewhere classified: NF0A\\nAir embolism traumatic not elsewhere classified: NF0A.0\\nFat embolism traumatic not elsewhere classified: NF0A.1\\nTraumatic secondary or recurrent haemorrhage not elsewhere classified: NF0A.2\\nPost traumatic wound infection not elsewhere classified: NF0A.3\\nTraumatic shock not elsewhere classified: NF0A.4\\nTraumatic anuria not elsewhere classified: NF0A.5\\nTraumatic ischaemia of muscle not elsewhere classified: NF0A.6\\nTraumatic subcutaneous emphysema not elsewhere classified: NF0A.7\\nOther early complication of trauma not elsewhere classified: NF0A.Y\\nEarly complications of trauma not elsewhere classified: NF0A.Z\\nOther specified effects of external causes: NF0Y\\nUnspecified effects of external causes: NF0Z\\nOther specified injury poisoning or certain other consequences of external causes: NF2Y\\nUnspecified injury poisoning or certain other consequences of external causes: NF2Z\\nUnintentional land transport traffic event injuring a pedestrian: PA00\\nUnintentional land transport traffic event injuring the user of a pedestrian conveyance: PA01\\nUnintentional land transport traffic event injuring a pedal cyclist: PA02\\nUnintentional land transport traffic event injuring a motor cyclist: PA03\\nUnintentional land transport traffic event injuring a car occupant: PA04\\nUnintentional land transport traffic event injuring an occupant of a bus or coach: PA05\\nUnintentional land transport traffic event injuring an occupant of a light goods vehicle: PA06\\nUnintentional land transport traffic event injuring an occupant of a heavy goods vehicle: PA07\\nUnintentional land transport traffic event injuring an occupant of a streetcar or tram: PA08\\nUnintentional land transport traffic event injuring an occupant of a low powered passenger vehicle: PA09\\nUnintentional land transport traffic event injuring a user of a special vehicle mainly used in agriculture: PA0A\\nUnintentional land transport traffic event injuring a user of a special vehicle mainly used on industrial premises: PA0B\\nUnintentional land transport traffic event injuring a user of a special construction vehicle: PA0C\\nUnintentional land transport traffic event injuring a user of an allterrain vehicle: PA0D\\nUnintentional land transport traffic event injuring a rider of an animal: PA0E\\nUnintentional land transport traffic event injuring an occupant of an animaldrawn vehicle: PA0F\\nUnintentional land transport traffic event injuring a user of other specified land transport: PA0Y\\nUnintentional land transport traffic event injuring a user of unspecified land transport: PA0Z\\nUnintentional land transport nontraffic event injuring a pedestrian: PA10\\nUnintentional land transport nontraffic event injuring the user of a pedestrian conveyance: PA11\\nUnintentional land transport nontraffic event injuring a pedal cyclist: PA12\\nUnintentional land transport nontraffic event injuring a motor cyclist: PA13\\nUnintentional land transport nontraffic event injuring a car occupant: PA14\\nUnintentional land transport nontraffic event injuring an occupant of a bus or coach: PA15\\nUnintentional land transport nontraffic event injuring an occupant of a light goods vehicle: PA16\\nUnintentional land transport nontraffic event injuring an occupant of a heavy goods vehicle: PA17\\nUnintentional land transport nontraffic event injuring an occupant of a streetcar or tram: PA18\\nUnintentional land transport nontraffic event injuring an occupant of a low powered passenger vehicle: PA19\\nUnintentional land transport nontraffic event injuring a user of a special vehicle mainly used in agriculture: PA1A\\nUnintentional land transport nontraffic event injuring a user of a special vehicle mainly used on industrial premises: PA1B\\nUnintentional land transport nontraffic event injuring a user of a special construction vehicle: PA1C\\nUnintentional land transport nontraffic event injuring a user of an allterrain vehicle: PA1D\\nUnintentional land transport nontraffic event injuring a rider of an animal: PA1E\\nUnintentional land transport nontraffic event injuring an occupant of an animaldrawn vehicle: PA1F\\nUnintentional land transport nontraffic event injuring a user of other specified land transport: PA1Y\\nUnintentional land transport nontraffic event injuring a user of unknown or unspecified land transport: PA1Z\\nUnintentional land transport event unknown whether traffic or nontraffic injuring a pedestrian: PA20\\nUnintentional land transport event unknown whether traffic or nontraffic injuring the user of a pedestrian conveyance: PA21\\nUnintentional land transport event unknown whether traffic or nontraffic injuring a pedal cyclist: PA22\\nUnintentional land transport event unknown whether traffic or nontraffic injuring a motor cyclist: PA23\\nUnintentional land transport event unknown whether traffic or nontraffic injuring a car occupant: PA24\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a bus or coach: PA25\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a light goods vehicle: PA26\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a heavy goods vehicle: PA27\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a streetcar or tram: PA28\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a low powered passenger vehicle: PA29\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a special vehicle mainly used in agriculture: PA2A\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a special vehicle mainly used on industrial premises: PA2B\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a special construction vehicle: PA2C\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of an allterrain vehicle: PA2D\\nUnintentional land transport event unknown whether traffic or nontraffic injuring a rider of an animal: PA2E\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of an animaldrawn vehicle: PA2F\\nUnintentional land transport injury event unknown whether traffic or nontraffic injuring a user of other specified transport: PA2Y\\nUnintentional land transport injury event unknown whether traffic or nontraffic injuring a user of unspecified transport: PA2Z\\nUnintentional railway transport injury event with collision or derailment: PA30\\nUnintentional railway transport injury event without collision or derailment: PA31\\nUnintentional railway transport injury event of unspecified type: PA3Z\\nUnintentional water transport injury event with water vessel not damaged disabled or destroyed: PA40\\nUnintentional water transport injury event with water vessel not damaged disabled or destroyed causing submersion or drowning: PA40.0\\nUnintentional water transport injury event with water vessel not damaged disabled or destroyed causing other injury: PA40.1\\nUnintentional water transport injury event with water vessel not damaged disabled or destroyed causing unspecified injury: PA40.Z\\nUnintentional water transport injury event with water vessel damaged disabled or destroyed: PA41\\nUnintentional water transport injury event with water vessel damaged disabled or destroyed causing submersion or drowning: PA41.0\\nUnintentional water transport injury event with water vessel damaged disabled or destroyed causing unspecified injury: PA41.Z\\nUnintentional water transport injury event with damage to water vessel unspecified: PA4Z\\nUnintentional air or space transport injury event: PA50\\nUnintentional air or space transport injury event with aircraft or spacecraft not damaged disabled or destroyed: PA50.0\\nUnintentional air or space transport injury event with aircraft or spacecraft damaged disabled or destroyed: PA50.1\\nUnintentional air or space transport injury event unspecified: PA50.Z\\nOther specified unintentional transport injury event: PA5Y\\nUnintentional transport injury event unspecified: PA5Z\\nUnintentional fall on the same level or from less than  metre: PA60\\nUnintentional fall from a height of  metre or more: PA61\\nUnintentional fall from unspecified height: PA6Z\\nUnintentionally struck kicked or bumped by person: PA70\\nUnintentionally struck kicked or bumped by animal: PA71\\nUnintentionally stepped on or crushed by person: PA72\\nUnintentionally stepped on or crushed by animal: PA73\\nUnintentionally bitten by person: PA74\\nUnintentionally bitten by animal: PA75\\nUnintentionally scratched or clawed by person: PA76\\nUnintentionally scratched or clawed by animal: PA77\\nUnintentionally stung or envenomated by animal: PA78\\nUnintentionally injured by contact with plant: PA79\\nOther specified type of unintentional contact with person animal or plant: PA7Y\\nUnintentional contact with person animal or plant type unspecified: PA7Z\\nUnintentionally struck by projectile from firearm: PA80\\nUnintentionally struck by projectile from handgun: PA80.0\\nUnintentionally struck by projectile from rifle shotgun or larger firearm: PA80.1\\nUnintentionally struck by projectile from other specified firearm: PA80.Y\\nUnintentionally struck by projectile from unspecified firearm: PA80.Z\\nUnintentionally struck by moving object: PA81\\nUnintentional striking against stationary object: PA82\\nUnintentionally cut or pierced by sharp object: PA83\\nUnintentionally cut or pierced by knife sword or dagger: PA83.0\\nUnintentionally cut or pierced by sharp glass: PA83.1\\nUnintentionally cut or pierced by other or unspecified sharp object: PA83.2\\nUnintentionally struck by blunt object: PA84\\nUnintentionally caught crushed jammed or pinched between objects: PA85\\nUnintentional exposure to other specified object not elsewhere classified: PA8Y\\nUnintentional exposure to object unspecified: PA8Z\\nUnintentional drowning or submersion while in body of water: PA90\\nUnintentional drowning or submersion following fall into body of water: PA91\\nUnintentional injury other than drowning following fall into body of water: PA92\\nUnintentional immersion submersion or falling into water unspecified: PA9Z\\nUnintentional threat to breathing by suffocation from object covering mouth or nose: PB00\\nUnintentional threat to breathing by hanging: PB01\\nUnintentional threat to breathing by strangulation: PB02\\nUnintentional threat to breathing by external compression of airways or chest: PB03\\nUnintentional threat to breathing by inhalation or ingestion of gastric contents: PB04\\nUnintentional threat to breathing by inhalation or ingestion of liquids: PB05\\nUnintentional threat to breathing by inhalation or ingestion of food: PB06\\nUnintentional threat to breathing by inhalation or ingestion of other objects or materials: PB07\\nUnintentional threat to breathing from low oxygen environment: PB08\\nUnintentional threat to breathing by other specified means: PB0Y\\nUnintentional threat to breathing by unspecified means: PB0Z\\nUnintentional exposure to uncontrolled fire: PB10\\nUnintentional exposure to controlled fire: PB11\\nUnintentional exposure to ignition or melting of material: PB12\\nUnintentional contact with hot object or liquid: PB13\\nUnintentional exposure to steam hot vapour air or gases: PB14\\nUnintentional exposure to excessive heat: PB15\\nUnintentional exposure to excessive cold: PB16\\nUnintentional exposure to other specified thermal mechanism: PB1Y\\nUnintentional exposure to unspecified thermal mechanism: PB1Z\\nUnintentional exposure to or harmful effects of opioids or related analgesics: PB20\\nUnintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants: PB21\\nUnintentional exposure to or harmful effects of psychostimulants: PB22\\nUnintentional exposure to or harmful effects of cannabinoids or hallucinogens: PB23\\nUnintentional exposure to or harmful effects of analgesics antipyretics or nonsteroidal antiinflammatory drugs: PB24\\nUnintentional exposure to or harmful effects of antidepressants: PB25\\nUnintentional exposure to or harmful effects of antipsychotics: PB26\\nUnintentional exposure to or harmful effects of antiepileptics or antiparkinsonism drugs: PB27\\nUnintentional exposure to or harmful effects of other or unspecified drug medicament or biological substance: PB28\\nUnintentional exposure to or harmful effects of multiple drugs medicaments or biological substances: PB29\\nUnintentional exposure to or harmful effects of alcohols: PB30\\nUnintentional exposure to or harmful effects of organic solvents: PB31\\nUnintentional exposure to or harmful effects of carbon monoxide: PB32\\nUnintentional exposure to or harmful effects of pesticides: PB33\\nUnintentional exposure to or harmful effects of corrosive substances: PB34\\nUnintentional exposure to or harmful effects of halogen derivatives of aliphatic or aromatic hydrocarbons: PB35\\nUnintentional exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source: PB36\\nUnintentional exposure to foreign body in orifice: PB50\\nUnintentional exposure to electric current: PB51\\nUnintentional exposure to sunlight: PB52\\nUnintentional exposure to radiation: PB53\\nUnintentional exposure to high or low air pressure or changes in air pressure: PB54\\nUnintentional exposure to explosion: PB55\\nUnintentional exposure to chemical explosion: PB55.0\\nUnintentional exposure to explosion or rupture of pressurised materials or object: PB55.1\\nOther specified unintentional exposure to explosion: PB55.Y\\nUnintentional exposure to explosion unspecified: PB55.Z\\nUnintentional exposure to physical overexertion: PB56\\nUnintentional lack of food: PB57\\nUnintentional lack of water: PB58\\nUnintentional other specified privation: PB59\\nUnintentional abandonment: PB5A\\nUnintentional neglect: PB5B\\nOther unintentional cause of morbidity or mortality: PB6Y\\nUnspecified unintentional cause of morbidity or mortality: PB6Z\\nIntentional selfharm by land transport road traffic injury event: PB80\\nIntentional selfharm by land transport offroad nontraffic injury event: PB81\\nIntentional selfharm by land transport injury event unknown whether traffic or nontraffic: PB82\\nIntentional selfharm by railway transport injury event: PB83\\nIntentional selfharm by water transport injury event with water vessel damaged disabled or destroyed: PB90\\nIntentional selfharm by water transport injury event with water vessel not damaged disabled or destroyed: PB91\\nIntentional selfharm by water transport injury event with water vessel not damaged disabled or destroyed causing submersion or drowning: PB91.0\\nIntentional selfharm by water transport injury event with water vessel not damaged disabled or destroyed causing other injury: PB91.1\\nIntentional selfharm by water transport injury event with water vessel not damaged disabled or destroyed unspecified: PB91.Z\\nIntentional selfharm by water transport injury event with damage to water vessel unspecified: PB9Z\\nIntentional selfharm by air or space transport injury event with aircraft or spacecraft damaged disabled or destroyed: PC00\\nIntentional selfharm by air or space transport injury event with aircraft or spacecraft not damaged disabled or destroyed: PC01\\nIntentional selfharm by air or space transport injury event with damage to aircraft or spacecraft unspecified: PC0Z\\nIntentional selfharm by other specified transport injury event: PC2Y\\nIntentional selfharm by transport injury event unspecified: PC2Z\\nIntentional selfharm by fall or jump on same level or from less than  metre: PC30\\nIntentional selfharm by fall or jump from a height of  metre or more: PC31\\nOther specified intentional selfharm by fall or jump: PC3Y\\nIntentional selfharm by fall or jump unspecified: PC3Z\\nIntentional selfharm by being struck kicked or bumped by person: PC40\\nIntentional selfharm by being struck kicked or bumped by animal: PC41\\nIntentional selfharm by being stepped on or crushed by person: PC42\\nIntentional selfharm by being stepped on or crushed by animal: PC43\\nIntentional selfharm by being bitten by animal: PC44\\nIntentional selfharm by being scratched or clawed by person: PC45\\nIntentional selfharm by being scratched or clawed by animal: PC46\\nIntentional selfharm by being stung or envenomated by animal: PC47\\nIntentional selfharm by contact with plant: PC48\\nOther specified type of intentional selfharm by contact with person animal or plant: PC4Y\\nIntentional selfharm by contact with person animal or plant type unspecified: PC4Z\\nIntentional selfharm by being struck by projectile from firearm: PC50\\nIntentional selfharm by projectile from handgun: PC50.0\\nIntentional selfharm by projectile from rifle shotgun or larger firearm: PC50.1\\nOther specified intentional selfharm by being struck by projectile from firearm: PC50.Y\\nIntentional selfharm by being struck by projectile from firearm unspecified: PC50.Z\\nIntentional selfharm by being struck by moving object not elsewhere classified: PC51\\nIntentional selfharm by striking against stationary object: PC52\\nIntentional selfharm by being cut or pierced by sharp object: PC53\\nIntentional selfharm by being cut or pierced by knife sword or dagger: PC53.0\\nIntentional selfharm by being cut or pierced by sharp glass: PC53.1\\nOther specified intentional selfharm by being cut or pierced by sharp object: PC53.Y\\nIntentional selfharm by being cut or pierced by sharp object unspecified: PC53.Z\\nIntentional selfharm by being struck by blunt object: PC54\\nIntentional selfharm by being caught crushed jammed or pinched between objects: PC55\\nIntentional self harm by contact with other specified type of weapon: PC5Y\\nIntentional self harm by contact with weapon type unspecified: PC5Z\\nIntentional selfharm by drowning or submersion while in body of water: PC60\\nIntentional selfharm by drowning or submersion following fall into body of water: PC61\\nIntentional selfharm by injury other than drowning while in body of water: PC62\\nIntentional selfharm by injury other than drowning following fall into body of water: PC63\\nIntentional selfharm by immersion submersion or falling into water unspecified: PC6Z\\nIntentional selfharm by threat to breathing by suffocation from object covering mouth or nose: PC70\\nIntentional selfharm by threat to breathing by hanging: PC71\\nIntentional selfharm by threat to breathing by strangulation: PC72\\nIntentional selfharm by threat to breathing by external compression of airways or chest: PC73\\nIntentional selfharm by inhalation or ingestion of gastric contents: PC74\\nIntentional selfharm by threat to breathing by inhalation or ingestion of liquids: PC75\\nIntentional selfharm by threat to breathing by inhalation or ingestion of food: PC76\\nIntentional selfharm by threat to breathing by inhalation or ingestion of other objects or materials: PC77\\nIntentional selfharm by threat to breathing from low oxygen environment: PC78\\nOther specified intentional selfharm by threat to breathing: PC7Y\\nIntentional selfharm by threat to breathing unspecified: PC7Z\\nIntentional selfharm by exposure to controlled fire: PC80\\nIntentional selfharm by exposure to uncontrolled fire: PC81\\nIntentional selfharm by exposure to ignition or melting of material: PC82\\nIntentional selfharm by contact with hot object or liquid: PC83\\nIntentional selfharm by exposure to steam hot vapour air or gases: PC84\\nIntentional selfharm by exposure to excessive heat: PC85\\nIntentional selfharm by exposure to excessive cold: PC86\\nIntentional selfharm by exposure to other specified thermal mechanism: PC8Y\\nIntentional selfharm by exposure to unspecified thermal mechanism: PC8Z\\nIntentional selfharm by exposure to or harmful effects of opioids or related analgesics: PC90\\nIntentional selfharm by exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants: PC91\\nIntentional selfharm by exposure to or harmful effects of psychostimulants: PC92\\nIntentional selfharm by exposure to or harmful effects of cannabinoids or hallucinogens: PC93\\nIntentional selfharm by exposure to or harmful effects of analgesics antipyretics or nonsteroidal antiinflammatory drugs: PC94\\nIntentional selfharm by exposure to or harmful effects of antidepressants: PC95\\nIntentional selfharm by exposure to or harmful effects of antipsychotics: PC96\\nIntentional selfharm by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs: PC97\\nIntentional selfharm by exposure to other or unspecified drug medicament or biological substance: PC98\\nIntentional selfharm by exposure to or harmful effects of multiple drugs medicaments or biological substances: PC99\\nIntentional selfharm by exposure to or harmful effects of alcohols: PD00\\nIntentional selfharm by exposure to or harmful effects of organic solvents: PD01\\nIntentional selfharm by exposure to or harmful effects of carbon monoxide: PD02\\nIntentional selfharm by exposure to or harmful effects of pesticides: PD03\\nIntentional selfharm by exposure to or harmful effects of corrosive substances: PD04\\nIntentional selfharm by exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source: PD05\\nIntentional selfharm by foreign body in orifice: PD20\\nIntentional selfharm by exposure to electric current: PD21\\nIntentional selfharm by exposure to sunlight: PD22\\nIntentional selfharm by exposure to radiation: PD23\\nIntentional selfharm by exposure to high or low air pressure or changes in air pressure: PD24\\nIntentional selfharm by explosion or rupture of pressurised materials or object: PD25\\nIntentional selfharm by physical overexertion: PD26\\nIntentional selfharm by lack of food: PD27\\nIntentional selfharm by lack of water: PD28\\nIntentional selfharm by other specified privation: PD29\\nOther specified intentional selfharm: PD3Y\\nIntentional selfharm unspecified: PD3Z\\nAssault by land transport road traffic injury event: PD50\\nAssault by land transport offroad nontraffic injury event: PD51\\nAssault by land transport injury event unknown whether road traffic or offroad nontraffic: PD52\\nAssault by railway transport injury event: PD53\\nAssault by water transport injury event with water vessel damaged disabled or destroyed: PD60\\nAssault by water transport injury event with water vessel damaged disabled or destroyed causing submersion or drowning: PD60.0\\nAssault by water transport injury event with water vessel damaged disabled or destroyed causing other injury: PD60.1\\nAssault by water transport injury event with water vessel damaged disabled or destroyed causing unspecified injury: PD60.Z\\nAssault by water transport injury event with water vessel not damaged disabled or destroyed: PD61\\nAssault by water transport injury event with water vessel not damaged disabled or destroyed causing submersion or drowning: PD61.0\\nAssault by water transport injury event with water vessel not damaged disabled or destroyed causing other injury: PD61.1\\nAssault by water transport injury event with water vessel not damaged disabled or destroyed causing unspecified injury: PD61.Y\\nAssault by water transport injury event with water vessel not damaged disabled or destroyed unspecified: PD61.Z\\nAssault by water transport injury event with damage to water vessel unspecified: PD6Z\\nAssault by air or space transport injury event with aircraft or spacecraft damaged disabled or destroyed: PD70\\nAssault by air or space transport injury event with aircraft or spacecraft not damaged disabled or destroyed: PD71\\nAssault by air or space transport injury event with damage to aircraft or spacecraft unspecified: PD7Z\\nOther specified assault by transport injury event: PD9Y\\nAssault by transport injury event unspecified: PD9Z\\nAssault by causing a fall or jump on same level or from less than  metre: PE00\\nAssault by causing a fall or jump from a height of  metre or more: PE01\\nAssault by causing a fall or jump from unspecified height: PE0Z\\nAssault by being struck kicked or bumped by person: PE10\\nAssault by being struck kicked or bumped by animal: PE11\\nAssault by being crushed or stepped on by person: PE12\\nAssault by being crushed or stepped on by animal: PE13\\nAssault by being bitten by person: PE14\\nAssault by being bitten by animal: PE15\\nAssault by being scratched or clawed by person: PE16\\nAssault by being scratched or clawed by animal: PE17\\nAssault by being stung or envenomated by animal: PE18\\nAssault by contact with plant: PE19\\nOther specified type of assault by contact with person animal or plant: PE1Y\\nAssault by contact with person animal or plant type unspecified: PE1Z\\nAssault by projectile from firearm: PE20\\nAssault by projectile from handgun: PE20.0\\nAssault by projectile from rifle shotgun or larger firearm: PE20.1\\nAssault by being struck by projectile from other specified firearm: PE20.Y\\nAssault by being struck by projectile from unspecified firearm: PE20.Z\\nAssault by being struck by moving object not elsewhere classified: PE21\\nAssault by striking against stationary object: PE22\\nAssault by being cut or pierced by knife sword or dagger: PE30\\nAssault by being cut or pierced by sharp glass: PE31\\nAssault by being cut or pierced by other or unspecified sharp object: PE3Z\\nAssault by being struck by blunt object: PE40\\nAssault by being caught crushed jammed or pinched between objects: PE41\\nAssault by contact with other specified object not elsewhere classified: PE4Y\\nAssault by exposure to unspecified object not elsewhere classified: PE4Z\\nAssault by drowning or submersion while in body of water: PE50\\nAssault by drowning or submersion following fall into body of water: PE51\\nAssault by injury other than drowning while in body of water: PE52\\nAssault by injury other than drowning following fall into body of water: PE53\\nOther specified assault by immersion submersion or falling into water: PE5Y\\nAssault by immersion submersion or falling into water unspecified: PE5Z\\nAssault by threat to breathing suffocation from object covering mouth or nose: PE60\\nAssault by threat to breathing by hanging: PE61\\nAssault by threat to breathing by strangulation: PE62\\nAssault by threat to breathing by external compression of airways or chest: PE63\\nAssault by threat to breathing by inhalation or ingestion of liquids: PE64\\nAssault by threat to breathing by inhalation or ingestion of food: PE65\\nAssault by threat to breathing by inhalation or ingestion of other objects or materials: PE66\\nAssault by threat to breathing by low oxygen environment: PE67\\nOther specified assault by threat to breathing: PE6Y\\nAssault by threat to breathing unspecified: PE6Z\\nAssault by exposure to uncontrolled fire: PE70\\nAssault by exposure to controlled fire: PE71\\nAssault by exposure to ignition or melting of materials: PE72\\nAssault by contact with hot object or liquid: PE73\\nAssault by contact with steam hot vapour air or gases: PE74\\nAssault by exposure to excessive heat: PE75\\nAssault by exposure to excessive cold: PE76\\nAssault by exposure to other specified thermal mechanism: PE7Y\\nAssault by exposure to unspecified thermal mechanism: PE7Z\\nAssault by exposure to or harmful effects of opioids or related analgesics: PE80\\nAssault by exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants: PE81\\nAssault by exposure to or harmful effects of psychostimulants: PE82\\nAssault by exposure to or harmful effects of cannabinoids or hallucinogens: PE83\\nAssault by exposure to or harmful effects of analgesics antipyretics or nonsteroidal antiinflammatory drugs: PE84\\nAssault by exposure to or harmful effects of antidepressants: PE85\\nAssault by exposure to or harmful effects of antipsychotics: PE86\\nAssault by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs: PE87\\nAssault by exposure to or harmful effects of other or unspecified drug medicament or biological substance: PE88\\nAssault by exposure to or harmful effects of multiple drugs medicaments or biological substances: PE89\\nOther specified assault by exposure to or harmful effects of drugs medicaments or biological substances: PE8Y\\nAssault by exposure to or harmful effects of drugs medicaments or biological substances unspecified: PE8Z\\nAssault by exposure to or harmful effects of alcohols: PE90\\nAssault by exposure to or harmful effects of organic solvents: PE91\\nAssault by exposure to or harmful effects of carbon monoxide: PE92\\nAssault by exposure to or harmful effects of pesticides: PE93\\nAssault by exposure to or harmful effects of corrosive substances: PE94\\nAssault by exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source: PE95\\nAssault by foreign body in orifice or eye: PF10\\nAssault by exposure to electric current: PF11\\nAssault by exposure to sunlight: PF12\\nAssault by exposure to radiation: PF13\\nAssault by exposure to high or low air pressure or changes in air pressure: PF14\\nAssault by exposure to explosion: PF15\\nAssault by exposure to chemical explosion: PF15.0\\nAssault by explosion or rupture of materials or object: PF15.1\\nOther specified assault by exposure to explosion: PF15.Y\\nAssault by exposure to explosion unspecified: PF15.Z\\nAssault by physical overexertion: PF16\\nAssault by lack of food: PF17\\nAssault by lack of water: PF18\\nAssault by other specified privation: PF19\\nAssault by abandonment: PF1A\\nAssault by neglect: PF1B\\nOther specified assault: PF2Y\\nAssault unspecified: PF2Z\\nLand transport traffic injury event of undetermined intent injuring a pedestrian: PF40\\nLand transport traffic injury event of undetermined intent injuring the user of a pedestrian conveyance: PF41\\nLand transport traffic injury event of undetermined intent injuring a pedal cyclist: PF42\\nLand transport traffic injury event of undetermined intent injuring a motor cyclist: PF43\\nLand transport traffic injury event of undetermined intent injuring a car occupant: PF44\\nLand transport traffic injury event of undetermined intent injuring a bus or coach occupant: PF45\\nLand transport traffic injury event of undetermined intent injuring an occupant of light goods vehicle: PF46\\nLand transport traffic injury event of undetermined intent injuring an occupant of heavy goods vehicle: PF47\\nLand transport traffic injury event of undetermined intent injuring an occupant of a streetcar or tram: PF48\\nLand transport traffic injury event of undetermined intent injuring an occupant of a low powered passenger vehicle: PF49\\nLand transport traffic injury event of undetermined intent injuring a user of a special vehicle mainly used in agriculture: PF4A\\nLand transport traffic injury event of undetermined intent injuring a user of a special vehicle mainly used on industrial premises: PF4B\\nLand transport traffic injury event of undetermined intent injuring a user of a special construction vehicle: PF4C\\nLand transport traffic injury event of undetermined intent injuring a user of an allterrain vehicle: PF4D\\nLand transport traffic injury event of undetermined intent injuring a rider of an animal: PF4E\\nLand transport traffic injury event of undetermined intent injuring an occupant of an animaldrawn vehicle: PF4F\\nLand transport traffic injury event of undetermined intent injuring a user of other specified land transport: PF4Y\\nLand transport traffic injury event of undetermined intent injuring a user of unknown or unspecified land transport: PF4Z\\nLand transport nontraffic injury event of undetermined intent injuring a pedestrian: PF50\\nLand transport nontraffic injury event of undetermined intent injuring the user of a pedestrian conveyance: PF51\\nLand transport nontraffic injury event of undetermined intent injuring a pedal cyclist: PF52\\nLand transport nontraffic injury event of undetermined intent injuring a motor cyclist: PF53\\nLand transport nontraffic injury event of undetermined intent injuring a car occupant: PF54\\nLand transport nontraffic injury event of undetermined intent injuring a bus or coach occupant: PF55\\nLand transport nontraffic injury event of undetermined intent injuring an occupant of light goods vehicle: PF56\\nLand transport nontraffic injury event of undetermined intent injuring an occupant of heavy goods vehicle: PF57\\nLand transport nontraffic injury event of undetermined intent injuring an occupant of a streetcar or tram: PF58\\nLand transport nontraffic injury event of undetermined intent injuring an occupant of a low powered passenger vehicle: PF59\\nLand transport nontraffic injury event of undetermined intent injuring a user of a special vehicle mainly used in agriculture: PF5A\\nLand transport nontraffic injury event of undetermined intent injuring a user of a special vehicle mainly used on industrial premises: PF5B\\nLand transport nontraffic injury event of undetermined intent injuring a user of a special construction vehicle: PF5C\\nLand transport nontraffic injury event of undetermined intent injuring a user of an allterrain vehicle: PF5D\\nLand transport nontraffic injury event of undetermined intent injuring a rider of an animal: PF5E\\nLand transport nontraffic injury event of undetermined intent injuring an occupant of an animaldrawn vehicle: PF5F\\nLand transport nontraffic injury event of undetermined intent injuring a user of other specified land transport: PF5Y\\nLand transport nontraffic injury event of undetermined intent injuring a user of unknown or unspecified land transport: PF5Z\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a pedestrian: PF60\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring the user of a pedestrian conveyance: PF61\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a pedal cyclist: PF62\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a motor cyclist: PF63\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a car occupant: PF64\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a bus or coach occupant: PF65\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring an occupant of light goods vehicle: PF66\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring an occupant of heavy goods vehicle: PF67\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring an occupant of a streetcar or tram: PF68\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring an occupant of a low powered passenger vehicle: PF69\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a user of a special vehicle mainly used in agriculture: PF6A\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a user of a special vehicle mainly used on industrial premises: PF6B\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a user of a special construction vehicle: PF6C\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a user of an allterrain vehicle: PF6D\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a rider of an animal: PF6E\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring an occupant of an animaldrawn vehicle: PF6F\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a user of an other specified vehicle: PF6Y\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a user of an unknown or unspecified vehicle: PF6Z\\nRailway transport injury event of undetermined intent with collision or derailment: PF70\\nRailway transport injury event of undetermined intent without collision or derailment: PF71\\nRailway transport injury event of undetermined intent of unspecified type: PF7Z\\nWater transport injury event of undetermined intent with water vessel damaged disabled or destroyed causing submersion or drowning: PF80\\nWater transport injury event of undetermined intent with water vessel damaged disabled or destroyed causing other injury: PF8Y\\nWater transport injury event of undetermined intent with water vessel damaged disabled or destroyed causing unspecified injury: PF8Z\\nWater transport injury event of undetermined intent with water vessel not damaged disabled or destroyed causing submersion or drowning: PF90\\nWater transport injury event of undetermined intent with water vessel not damaged disabled or destroyed causing other injury: PF9Y\\nWater transport injury event of undetermined intent with water vessel not damaged disabled or destroyed causing unspecified injury: PF9Z\\nWater transport injury event of undetermined intent damage to water vessel unspecified: PG1Z\\nAir or space transport injury event of undetermined intent with aircraft or spacecraft damaged disabled or destroyed: PG20\\nAir or space transport injury event of undetermined intent with aircraft or spacecraft not damaged disabled or destroyed: PG21\\nAir or space transport event injury of undetermined intent damage to aircraft or spacecraft unspecified: PG2Z\\nOther specified transport injury event of undetermined intent: PG4Y\\nUnspecified transport injury event of undetermined intent: PG4Z\\nFall or jump of undetermined intent on the same level or from less than  metre: PG50\\nFall or jump of undetermined intent from a height of  metre or more: PG51\\nFall or jump of undetermined intent height unspecified: PG5Z\\nStruck kicked or bumped with undetermined intent by person: PG60\\nStruck kicked or bumped with undetermined intent by animal: PG61\\nStepped on or crushed with undetermined intent by person: PG62\\nStepped on or crushed with undetermined intent by animal: PG63\\nBitten with undetermined intent by person: PG64\\nBitten with undetermined intent by animal: PG65\\nScratched or clawed with undetermined intent by person: PG66\\nScratched or clawed with undetermined intent by animal: PG67\\nStung or envenomated with undetermined intent by animal: PG68\\nContact with plant of undetermined intent: PG69\\nOther specified type of contact with person animal or plant of undetermined intent: PG6Y\\nUnspecified type of contact with person animal or plant of undetermined intent: PG6Z\\nStruck by projectile from handgun of undetermined intent: PG70\\nStruck by projectile from rifle shotgun or larger firearm of undetermined intent: PG71\\nStruck by projectile from other specified firearm with undetermined intent: PG7Y\\nStruck by projectile from unspecified firearm with undetermined intent: PG7Z\\nStruck by moving object not elsewhere classified of undetermined intent: PG80\\nStriking against stationary object of undetermined intent: PG81\\nCut or pierced by knife sword or dagger of undetermined intent: PG90\\nCut or pierced by sharp glass of undetermined intent: PG91\\nCut or pierced by other or unspecified sharp object undetermined intent: PG9Z\\nStruck by blunt object with undetermined intent: PH00\\nCaught crushed jammed or pinched between objects with undetermined intent: PH01\\nContact with other specified object not elsewhere classified with undetermined intent: PH0Y\\nExposure to unspecified object not elsewhere classified undetermined intent: PH0Z\\nDrowning or submersion while in body of water with undetermined intent: PH10\\nDrowning or submersion following fall into body of water with undetermined intent: PH11\\nInjury other than drowning while in body of water with undetermined intent: PH12\\nInjury other than drowning following fall into body of water with undetermined intent: PH13\\nImmersion submersion or falling into water with undetermined intent unspecified: PH1Z\\nThreat to breathing by suffocation from object covering mouth or nose with undetermined intent: PH20\\nThreat to breathing by hanging with undetermined intent: PH21\\nThreat to breathing by strangulation with undetermined intent: PH22\\nThreat to breathing by external compression of airways or chest with undetermined intent: PH23\\nThreat to breathing by inhalation or ingestion of liquids with undetermined intent: PH24\\nThreat to breathing by inhalation or ingestion of food with undetermined intent: PH25\\nThreat to breathing by inhalation or ingestion of other objects or materials with undetermined intent: PH26\\nThreat to breathing by low oxygen environment with undetermined intent: PH27\\nOther specified threat to breathing with undetermined intent: PH2Y\\nThreat to breathing with undetermined intent unspecified: PH2Z\\nExposure to uncontrolled fire with undetermined intent: PH30\\nExposure to controlled fire with undetermined intent: PH31\\nExposure to ignition or melting of materials with undetermined intent: PH32\\nContact with hot object or liquid with undetermined intent: PH33\\nContact with steam hot vapour air or gases with undetermined intent: PH34\\nExposure to excessive heat with undetermined intent: PH35\\nExposure to excessive cold with undetermined intent: PH36\\nExposure to other specified thermal mechanism with undetermined intent: PH3Y\\nExposure to unspecified thermal mechanism with undetermined intent: PH3Z\\nExposure to or harmful effects of undetermined intent of opioids or related analgesics: PH40\\nExposure to or harmful effects of undetermined intent of sedative hypnotic drugs or other CNS depressants: PH41\\nExposure to or harmful effects of undetermined intent of psychostimulants: PH42\\nExposure to or harmful effects of undetermined intent of cannabinoids or hallucinogens: PH43\\nExposure to or harmful effects of undetermined intent of analgesics antipyretics or nonsteroidal antiinflammatory drugs: PH44\\nExposure to or harmful effects of undetermined intent of antidepressants: PH45\\nExposure to or harmful effects of undetermined intent of antipsychotics: PH46\\nExposure to or harmful effects of undetermined intent of antiepileptics or antiparkinsonism drugs: PH47\\nHarmful effects of or exposure to mixed antiepileptics not elsewhere classified undetermined intent: PH47.0\\nUndetermined intent Harmful effects of and exposure to noxious substances Drugs medicaments or biological substances Unspecified antiepileptics or antiparkinsonism drugs: PH47.Z\\nExposure to or harmful effects of undetermined intent of other or unspecified drugs medicaments or biological substances: PH48\\nExposure to or harmful effects of undetermined intent of multiple drugs medicaments or biological substances: PH49\\nExposure to or harmful effects of undetermined intent of alcohols: PH50\\nExposure to or harmful effects of undetermined intent of organic solvents: PH51\\nExposure to or harmful effects of undetermined intent of carbon monoxide: PH52\\nExposure to or harmful effects of undetermined intent of pesticides: PH53\\nExposure to or harmful effects of undetermined intent of corrosive substances: PH54\\nExposure to or harmful effects of undetermined intent of halogen derivatives of aliphatic or aromatic hydrocarbons: PH55\\nExposure to or harmful effects of undetermined intent of other or unspecified substances chiefly nonmedicinal as to source: PH56\\nExposure to foreign body in orifice or eye with undetermined intent: PH70\\nExposure to electric current with undetermined intent: PH71\\nExposure to sunlight with undetermined intent: PH72\\nExposure to radiation with undetermined intent: PH73\\nExposure to high or low air pressure or changes in air pressure with undetermined intent: PH74\\nExposure to explosion with undetermined intent: PH75\\nExposure to chemical explosion with undetermined intent: PH75.0\\nExposure to explosion or rupture of pressurised materials or object with undetermined intent: PH75.1\\nOther specified exposure to explosion with undetermined intent: PH75.Y\\nExposure to explosion with undetermined intent unspecified: PH75.Z\\nPhysical overexertion with undetermined intent: PH76\\nLack of food with undetermined intent: PH77\\nLack of water with undetermined intent: PH78\\nOther specified privation with undetermined intent: PH79\\nAbandonment with undetermined intent: PH7A\\nNeglect with undetermined intent: PH7B\\nOther specified injury event of undetermined intent: PH8Y\\nUnspecified injury event of undetermined intent: PH8Z\\nVictim of lightning: PJ00\\nVictim of earthquake: PJ01\\nVictim of cataclysmic earth movements caused by earthquake: PJ02\\nVictim of tsunami: PJ03\\nVictim of volcanic eruption: PJ04\\nVictim of avalanche landslide or other earth movements: PJ05\\nVictim of cataclysmic storm: PJ06\\nVictim of flood: PJ07\\nExposure to other specified forces of nature: PJ0Y\\nExposure to unspecified forces of nature: PJ0Z\\nPhysical maltreatment: PJ20\\nSexual maltreatment: PJ21\\nPsychological maltreatment: PJ22\\nOther specified maltreatment: PJ2Y\\nMaltreatment unspecified: PJ2Z\\nLegal intervention involving projectile from firearm: PJ40\\nLegal intervention involving other projectile: PJ41\\nLegal intervention involving blunt object: PJ42\\nLegal intervention involving sharp object: PJ43\\nLegal intervention involving electric weapon: PJ44\\nLegal intervention involving explosive: PJ45\\nLegal intervention involving gas: PJ46\\nLegal intervention involving application of physical force: PJ47\\nLegal intervention involving other means: PJ4Y\\nLegal intervention involving unspecified means: PJ4Z\\nExplosion of depthcharge or marine mine during armed conflict: PJ60\\nExplosion of torpedo during armed conflict: PJ61\\nExplosion of seabased artillery shell during armed conflict: PJ62\\nExplosion of other marine weapons during armed conflict: PJ6Y\\nExplosion of unspecified marine weapon: PJ6Z\\nAttack on or destruction of aircraft during armed conflict due to enemy fire or explosives: PJ70\\nAttack on or destruction of aircraft during armed conflict due to collision with other aircraft: PJ71\\nOther destruction of aircraft during armed conflict: PJ7Y\\nUnspecified destruction of aircraft during armed conflict: PJ7Z\\nExplosion of missile during armed conflict: PJ80\\nExplosion of aerial bomb during armed conflict: PJ81\\nExplosion of munitions or weapons during armed conflict: PJ82\\nExplosion of improvised explosive device during armed conflict: PJ83\\nOther explosion or fragments during armed conflict: PJ8Y\\nUnspecified explosion or fragments during armed conflict: PJ8Z\\nUse of gasoline bomb during armed conflict: PJ90\\nUse of flamethrower during armed conflict: PJ91\\nUse of incendiary bullets during armed conflict: PJ92\\nOther specified fires conflagrations or hot substances during armed conflict: PJ9Y\\nUnspecified fire conflagration or hot substance during armed conflict: PJ9Z\\nUse of rubber bullets during armed conflict: PK00\\nUse of firearm pellets during armed conflict: PK01\\nOther firearms discharge during armed conflict: PK02\\nOther weapons use during armed conflict: PK03\\nUnarmed combat during armed conflict: PK04\\nOther specified forms of conventional weapons use during armed conflict: PK0Y\\nUnspecified forms of conventional weapons use during armed conflict: PK0Z\\nThermal or blast effects of nuclear weapon during armed conflict: PK10\\nNuclear radiation effects of nuclear weapon during armed conflict: PK11\\nOther specified effect of nuclear weapon during armed conflict: PK1Y\\nUnspecified effect of nuclear weapon during armed conflict: PK1Z\\nUse of weaponised microorganisms during armed conflict: PK20\\nUse of other specified biological weapons during armed conflict: PK2Y\\nUse of unspecified biological weapons during armed conflict: PK2Z\\nUse of chemical weapons during armed conflict: PK30\\nUse of lasers or other energetic beams or fields during armed conflict: PK31\\nUse of electric weapons during armed conflict: PK32\\nUse of autonomous or semiautonomous machines as weapons during armed conflict: PK33\\nOther specified forms of unconventional warfare during armed conflict: PK3Y\\nUnspecified forms of unconventional warfare during armed conflict: PK3Z\\nExplosion of mine after cessation of armed conflict: PK40\\nExplosion of bomb after cessation of armed conflict: PK41\\nUnspecified harmful event occurring after cessation of armed conflict: PK4Z\\nOther specified armed conflict: PK6Y\\nUnspecified armed conflict: PK6Z\\nMedical or surgical procedure associated with injury or harm in therapeutic use: PK80\\nNeurological procedure associated with injury or harm in therapeutic use: PK80.0\\nNeurological procedure associated with injury or harm open approach: PK80.00\\nNeurological procedure associated with injury or harm percutaneous approach: PK80.01\\nNeurological procedure associated with injury or harm endoscopic approach: PK80.02\\nNeurological procedure associated with injury or harm other specified approach: PK80.0Y\\nNeurological procedure associated with injury or harm unspecified approach: PK80.0Z\\nCardiac procedure associated with injury or harm in therapeutic use: PK80.1\\nCardiac procedure for repair of congenital anomaly associated with injury or harm open approach: PK80.10\\nCardiac procedure for repair of congenital anomaly associated with injury or harm percutaneous approach: PK80.11\\nCardiac procedure for repair of congenital anomaly associated with injury or harm endoscopic approach: PK80.12\\nCardiac procedure for repair of congenital anomaly associated with injury or harm unspecified approach: PK80.13\\nOther cardiac procedure associated with injury or harm open approach: PK80.14\\nOther cardiac procedure associated with injury or harm percutaneous approach: PK80.15\\nOther cardiac procedure associated with injury or harm endoscopic approach: PK80.16\\nOther cardiac procedure associated with injury or harm unspecified approach: PK80.17\\nUnspecified type of cardiac procedure associated with injury or harm in therapeutic use other specified approach: PK80.1Y\\nUnspecified type of cardiac procedure associated with injury or harm in therapeutic use unspecified approach: PK80.1Z\\nThoracic procedure associated with injury or harm in therapeutic use: PK80.2\\nThoracic procedure associated with injury or harm open approach: PK80.20\\nThoracic procedure associated with injury or harm percutaneous approach: PK80.21\\nThoracic procedure associated with injury or harm endoscopic approach: PK80.22\\nThoracic procedure associated with injury or harm other specified approach: PK80.2Y\\nThoracic procedure associated with injury or harm unspecified approach: PK80.2Z\\nGastrointestinal abdominal or abdominal wall procedure associated with injury or harm in therapeutic use: PK80.3\\nGastrointestinal abdominal or abdominal wall procedure associated with injury or harm open approach: PK80.30\\nGastrointestinal abdominal or abdominal wall procedure associated with injury or harm percutaneous approach: PK80.31\\nGastrointestinal abdominal or abdominal wall procedure associated with injury or harm endoscopic approach: PK80.32\\nGastrointestinal abdominal or abdominal wall procedure associated with injury or harm in therapeutic use other specified approach: PK80.3Y\\nGastrointestinal abdominal or abdominal wall procedure associated with injury or harm in therapeutic use unspecified approach: PK80.3Z\\nEndocrine procedure associated with injury or harm in therapeutic use: PK80.4\\nEndocrine procedure associated with injury or harm open approach: PK80.40\\nEndocrine procedure associated with injury or harm percutaneous approach: PK80.41\\nEndocrine procedure associated with injury or harm endoscopic approach: PK80.42\\nEndocrine procedure associated with injury or harm in therapeutic use other specified approach: PK80.4Y\\nEndocrine procedure associated with injury or harm in therapeutic use unspecified approach: PK80.4Z\\nGynaecological or breast procedure associated with injury or harm in therapeutic use: PK80.5\\nGynaecological or breast procedure associated with injury or harm open approach: PK80.50\\nGynaecological or breast procedure associated with injury or harm percutaneous approach: PK80.51\\nGynaecological or breast procedure associated with injury or harm endoscopic approach: PK80.52\\nGynaecological or breast procedure associated with injury or harm in therapeutic use per orifice approach: PK80.53\\nGynaecological or breast procedure associated with injury or harm in therapeutic use other specified approach: PK80.5Y\\nGynaecological or breast procedure associated with injury or harm in therapeutic use unspecified approach: PK80.5Z\\nUrological procedure associated with injury or harm in therapeutic use: PK80.6\\nUrological procedure associated with injury or harm open approach: PK80.60\\nUrological procedure associated with injury or harm percutaneous approach: PK80.61\\nUrological procedure associated with injury or harm endoscopic approach: PK80.62\\nUrological procedure associated with injury or harm other specified approach: PK80.6Y\\nUrological procedure associated with injury or harm unspecified approach: PK80.6Z\\nObstetric procedure associated with injury or harm in therapeutic use: PK80.7\\nCaesarean section or other obstetric procedure associated with injury or harm open approach: PK80.70\\nObstetric procedure associated with injury or harm percutaneous approach: PK80.71\\nObstetric procedure associated with injury or harm endoscopic approach: PK80.72\\nObstetric procedure associated with injury or harm in therapeutic use per orifice approach: PK80.73\\nCaesarean section or other obstetric procedure associated with injury or harm other specified approach: PK80.7Y\\nCaesarean section or other obstetric procedure associated with injury or harm unspecified approach: PK80.7Z\\nMusculoskeletal procedure associated with injury or harm in therapeutic use: PK80.8\\nMusculoskeletal procedure associated with injury or harm open approach: PK80.80\\nMusculoskeletal procedure associated with injury or harm percutaneous approach: PK80.81\\nMusculoskeletal procedure associated with injury or harm endoscopic approach: PK80.82\\nMusculoskeletal procedure associated with injury or harm in therapeutic use other specified approach: PK80.8Y\\nMusculoskeletal procedure associated with injury or harm in therapeutic use unspecified approach: PK80.8Z\\nVascular procedure associated with injury or harm in therapeutic use: PK80.9\\nVascular procedure associated with injury or harm open approach: PK80.90\\nVascular procedure associated with injury or harm percutaneous approach: PK80.91\\nVascular procedure associated with injury or harm endoscopic approach: PK80.92\\nVascular procedure associated with injury or harm other specified approach: PK80.9Y\\nVascular procedure associated with injury or harm unspecified approach: PK80.9Z\\nEar nose oral or throat procedure associated with injury or harm in therapeutic use: PK80.A\\nEar nose oral or throat procedure associated with injury or harm open approach: PK80.A0\\nEar nose oral or throat procedure associated with injury or harm percutaneous approach: PK80.A1\\nEar nose oral or throat procedure associated with injury or harm endoscopic approach: PK80.A2\\nEar nose oral or throat procedure associated with injury or harm in therapeutic use other specified approach: PK80.AY\\nEar nose oral or throat procedure associated with injury or harm in therapeutic use unspecified approach: PK80.AZ\\nDental procedure associated with injury or harm in therapeutic use: PK80.B\\nDental procedure associated with injury or harm open approach: PK80.B0\\nDental procedure associated with injury or harm percutaneous approach: PK80.B1\\nDental procedure associated with injury or harm endoscopic approach: PK80.B2\\nDental procedure associated with injury or harm other specified approach: PK80.BY\\nDental procedure associated with injury or harm unspecified approach: PK80.BZ\\nSkin or integument procedure associated with injury or harm in therapeutic use: PK80.C\\nSkin or integument procedure associated with injury or harm open approach: PK80.C0\\nSkin or integument procedure associated with injury or harm percutaneous approach: PK80.C1\\nSkin or integument procedure associated with injury or harm endoscopic approach: PK80.C2\\nSkin or integument procedure associated with injury or harm in therapeutic use other specified approach: PK80.CY\\nSkin or integument procedure associated with injury or harm in therapeutic use unspecified approach: PK80.CZ\\nOphthalmic procedure associated with injury or harm in therapeutic use: PK80.D\\nCertain medical procedures associated with injury or harm in therapeutic use: PK81\\nVentilation associated with injury or harm in therapeutic use: PK81.0\\nExtracorporeal life support procedure associated with injury or harm in therapeutic use: PK81.1\\nAspiration or drainage of body cavity or fluid collection associated with injury or harm in therapeutic use: PK81.2\\nAcupuncture or related therapies associated with injury or harm in therapeutic use: PK81.3\\nAcupuncture cupping associated with injury or harm in therapeutic use: PK81.30\\nOther specified acupuncture or related therapies associated with injury or harm in therapeutic use: PK81.3Y\\nAcupuncture or related therapies associated with injury or harm in therapeutic use unspecified: PK81.3Z\\nBone marrow aspiration or biopsy associated with injury or harm in therapeutic use: PK81.4\\nBiopsy procedure not elsewhere classified associated with injury or harm in therapeutic use: PK81.5\\nDialysis associated with injury or harm in therapeutic use: PK81.6\\nInjection or infusion for therapeutic or diagnostic purposes associated with injury or harm in therapeutic use: PK81.7\\nInsertion of tube associated with injury or harm in therapeutic use: PK81.8\\nJoint aspiration associated with injury or harm in therapeutic use: PK81.9\\nLumbar puncture associated with injury or harm in therapeutic use: PK81.A\\nManipulative therapies associated with injury or harm in therapeutic use: PK81.B\\nRadiation therapy associated with injury or harm in therapeutic use: PK81.C\\nOther specified medical procedure associated with injury or harm in therapeutic use: PK81.D\\nCardiopulmonary resuscitation associated with injury or harm in therapeutic use: PK81.E\\nNeedle stick associated with injury or harm in therapeutic use: PK81.F\\nOther specified surgical or other medical procedures associated with injury or harm in diagnostic or therapeutic use: PK8Y\\nSurgical or other medical procedures associated with injury or harm in diagnostic or therapeutic use unspecified: PK8Z\\nAnaesthesiology devices associated with injury or harm: PK90\\nAnaesthesiology devices associated with injury or harm diagnostic or monitoring devices: PK90.0\\nAnaesthesiology devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK90.1\\nAnaesthesiology devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK90.2\\nAnaesthesiology devices associated with injury or harm surgical instruments materials or devices: PK90.3\\nAnaesthesiology devices associated with injury or harm miscellaneous devices not elsewhere classified: PK90.4\\nOther specified anaesthesiology devices associated with injury or harm: PK90.Y\\nAnaesthesiology devices associated with injury or harm unspecified: PK90.Z\\nCardiovascular devices implants or grafts associated with injury or harm: PK91\\nCardiovascular devices associated with injury or harm diagnostic or monitoring devices: PK91.0\\nCardiovascular devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK91.1\\nCardiovascular devices associated with injury or harm pacemaker: PK91.10\\nCardiovascular devices associated with injury or harm implantable defibrillator: PK91.11\\nCardiovascular devices associated with injury or harm left ventricular assist devices: PK91.12\\nCardiovascular devices associated with injury or harm intraaortic balloon pump: PK91.13\\nCardiovascular devices associated with injury or harm IVC filter: PK91.14\\nCardiovascular devices associated with injury or harm central venous catheter: PK91.15\\nCardiovascular devices associated with injury or harm peripheral venous catheter: PK91.16\\nOther specified cardiovascular devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK91.1Y\\nCardiovascular devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices unspecified: PK91.1Z\\nCardiovascular devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK91.2\\nCardiovascular devices associated with injury or harm grafts: PK91.20\\nCardiovascular devices associated with injury or harm stents: PK91.21\\nCardiovascular devices associated with injury or harm mechanical or bioprosthetic valves: PK91.22\\nOther specified cardiovascular devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK91.2Y\\nCardiovascular devices associated with injury or harm prosthetic or other implants materials or accessory devices unspecified: PK91.2Z\\nCardiovascular devices associated with injury or harm surgical instruments materials or devices: PK91.3\\nCardiovascular devices associated with injury or harm miscellaneous devices not elsewhere classified: PK91.4\\nOther specified cardiovascular devices implants or grafts associated with injury or harm: PK91.Y\\nCardiovascular devices implants or grafts associated with injury or harm unspecified: PK91.Z\\nOtorhinolaryngological devices implants or grafts associated with injury or harm: PK92\\nOtorhinolaryngological devices associated with injury or harm diagnostic or monitoring devices: PK92.0\\nOtorhinolaryngological devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK92.1\\nOtorhinolaryngological devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK92.2\\nOtorhinolaryngological devices associated with injury or harm surgical instruments materials or devices: PK92.3\\nOtorhinolaryngological devices associated with injury or harm miscellaneous devices not elsewhere classified: PK92.4\\nOther specified otorhinolaryngological devices implants or grafts associated with injury or harm: PK92.Y\\nOtorhinolaryngological devices implants or grafts associated with injury or harm unspecified: PK92.Z\\nGastroenterology or urology devices implants or grafts associated with injury or harm: PK93\\nGastroenterology or urology devices associated with injury or harm diagnostic or monitoring devices: PK93.0\\nGastroenterology or urology devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK93.1\\nGastroenterology or urology devices associated with injury or harm urinary catheter: PK93.10\\nOther specified gastroenterology or urology devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK93.1Y\\nGastroenterology or urology devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices unspecified: PK93.1Z\\nGastroenterology or urology devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK93.2\\nGastroenterology or urology devices associated with injury or harm surgical instruments materials or devices: PK93.3\\nGastroenterology or urology devices associated with injury or harm miscellaneous devices not elsewhere classified: PK93.4\\nOther specified gastroenterology or urology devices implants or grafts associated with injury or harm: PK93.Y\\nGastroenterology or urology devices implants or grafts associated with injury or harm unspecified: PK93.Z\\nGeneral hospital or personal use devices associated with injury or harm: PK94\\nGeneral hospital or personal use devices associated with injury or harm diagnostic or monitoring devices: PK94.0\\nGeneral hospital or personal use devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK94.1\\nGeneral hospital or personal use devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK94.2\\nGeneral hospital or personal use devices associated with injury or harm surgical instruments materials or devices: PK94.3\\nGeneral hospital or personal use devices associated with injury or harm miscellaneous devices not elsewhere classified: PK94.4\\nOther specified general hospital or personal use devices associated with injury or harm: PK94.Y\\nGeneral hospital or personal use devices associated with injury or harm unspecified: PK94.Z\\nNeurological devices implants or grafts associated with injury or harm: PK95\\nNeurological devices associated with injury or harm diagnostic or monitoring devices: PK95.0\\nNeurological devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK95.1\\nNeurological devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK95.2\\nNeurological devices associated with injury or harm ventricular shunt: PK95.20\\nOther specified neurological devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK95.2Y\\nNeurological devices associated with injury or harm prosthetic or other implants materials or accessory devices unspecified: PK95.2Z\\nNeurological devices associated with injury or harm surgical instruments materials or devices: PK95.3\\nNeurological devices associated with injury or harm miscellaneous devices not elsewhere classified: PK95.4\\nOther specified neurological devices implants or grafts associated with injury or harm: PK95.Y\\nNeurological devices implants or grafts associated with injury or harm unspecified: PK95.Z\\nObstetric or gynaecological devices implants or grafts associated with injury or harm: PK96\\nObstetric or gynaecological devices associated with injury or harm diagnostic or monitoring devices: PK96.0\\nObstetric or gynaecological devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK96.1\\nObstetric or gynaecological devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK96.2\\nObstetric or gynaecological devices associated with injury or harm surgical instruments materials or devices: PK96.3\\nObstetric or gynaecological devices associated with injury or harm miscellaneous devices not elsewhere classified: PK96.4\\nOther specified obstetric or gynaecological devices implants or grafts associated with injury or harm: PK96.Y\\nObstetric or gynaecological devices implants or grafts associated with injury or harm unspecified: PK96.Z\\nOphthalmic devices implants or grafts associated with injury or harm: PK97\\nOphthalmic devices associated with injury or harm diagnostic or monitoring devices: PK97.0\\nOphthalmic devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK97.1\\nOphthalmic devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK97.2\\nOphthalmic devices associated with injury or harm surgical instruments materials or devices: PK97.3\\nOphthalmic devices associated with injury or harm miscellaneous devices not elsewhere classified: PK97.4\\nOther specified ophthalmic devices implants or grafts associated with injury or harm: PK97.Y\\nOphthalmic devices implants or grafts associated with injury or harm unspecified: PK97.Z\\nRadiological devices associated with injury or harm: PK98\\nRadiological devices associated with injury or harm diagnostic or monitoring devices: PK98.0\\nRadiological devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK98.1\\nRadiological devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK98.2\\nRadiological devices associated with injury or harm surgical instruments materials or devices: PK98.3\\nRadiological devices associated with injury or harm miscellaneous devices not elsewhere classified: PK98.4\\nOther specified radiological devices associated with injury or harm: PK98.Y\\nRadiological devices associated with injury or harm unspecified: PK98.Z\\nOrthopaedic devices implants or grafts associated with injury or harm: PK99\\nOrthopaedic devices associated with injury or harm diagnostic or monitoring devices: PK99.0\\nOrthopaedic devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK99.1\\nOrthopaedic devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK99.2\\nOrthopaedic devices associated with injury or harm surgical instruments materials or devices: PK99.3\\nOrthopaedic devices associated with injury or harm miscellaneous devices not elsewhere classified: PK99.4\\nOther specified orthopaedic devices implants or grafts associated with injury or harm: PK99.Y\\nOrthopaedic devices implants or grafts associated with injury or harm unspecified: PK99.Z\\nPhysical medicine devices associated with injury or harm: PK9A\\nPhysical medicine devices associated with injury or harm diagnostic or monitoring devices: PK9A.0\\nPhysical medicine devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK9A.1\\nPhysical medicine devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK9A.2\\nCommunication system devices associated with adverse incidents: PK9A.20\\nCommunication system devices associated with adverse incidents in a physical medicine care environment: PK9A.21\\nEnvironmental control system devices associated with adverse incidents: PK9A.22\\nMobility aids associated with adverse incidents: PK9A.23\\nOrthotic devices associated with adverse incidents: PK9A.24\\nOther specified physical medicine devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK9A.2Y\\nPhysical medicine devices associated with injury or harm prosthetic or other implants materials or accessory devices unspecified: PK9A.2Z\\nPhysical medicine devices associated with injury or harm surgical instruments materials or devices: PK9A.3\\nPhysical medicine devices associated with injury or harm miscellaneous devices not elsewhere classified: PK9A.4\\nOther specified physical medicine devices associated with injury or harm: PK9A.Y\\nPhysical medicine devices associated with injury or harm unspecified: PK9A.Z\\nGeneral or plastic surgery devices implants or grafts associated with injury or harm: PK9B\\nGeneral or plastic surgery devices associated with injury or harm diagnostic or monitoring devices: PK9B.0\\nGeneral or plastic surgery devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK9B.1\\nGeneral or plastic surgery devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK9B.2\\nGeneral or plastic surgery devices associated with injury or harm surgical instruments materials or devices: PK9B.3\\nGeneral or plastic surgery devices associated with injury or harm miscellaneous devices not elsewhere classified: PK9B.4\\nOther specified general or plastic surgery devices implants or grafts associated with injury or harm: PK9B.Y\\nGeneral or plastic surgery devices implants or grafts associated with injury or harm unspecified: PK9B.Z\\nOther or unspecified medical devices implants or grafts associated with injury or harm: PK9C\\nOther or unspecified medical devices associated with injury or harm diagnostic or monitoring devices: PK9C.0\\nOther or unspecified medical devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK9C.1\\nOther or unspecified medical devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK9C.2\\nOther or unspecified medical devices associated with injury or harm surgical instruments materials or devices: PK9C.3\\nMechanical complication of nonabsorbable surgical material not otherwise specified: PK9C.30\\nMechanical complication of permanent sutures: PK9C.31\\nOther specified other or unspecified medical devices associated with injury or harm surgical instruments materials or devices: PK9C.3Y\\nOther or unspecified medical devices associated with injury or harm surgical instruments materials or devices unspecified: PK9C.3Z\\nOther or unspecified medical devices associated with injury or harm miscellaneous devices not elsewhere classified: PK9C.4\\nDrugs medicaments or biological substances associated with injury or harm in therapeutic use: PL00\\nComplementary or traditional medicines associated with injury or harm in therapeutic use: PL01\\nComplementary or traditional medicines associated with injury or harm in therapeutic use Herbal Preparations or Formulas: PL01.0\\nComplementary or traditional medicines associated with injury or harm in therapeutic use Dietary Supplements Vitamins or Minerals: PL01.1\\nComplementary or traditional medicines associated with injury or harm in therapeutic use Complementary or Traditional Medicines not elsewhere classified: PL01.2\\nOther specified complementary or traditional medicines associated with injury or harm in therapeutic use: PL01.Y\\nComplementary or traditional medicines associated with injury or harm in therapeutic use unspecified: PL01.Z\\nSubstances associated with injury or harm in therapeutic use unspecified: PL0Z\\nOther health care related causes of injury or harm: PL10\\nMode of injury or harm associated with a surgical or other medical procedure: PL11\\nCut puncture or tear as mode of injury or harm: PL11.0\\nBurn arising during procedure as mode of injury or harm: PL11.1\\nEmbolisation as mode of injury or harm: PL11.2\\nAir embolism as mode of injury: PL11.20\\nOther specified embolisation as mode of injury or harm: PL11.2Y\\nEmbolisation as mode of injury or harm unspecified: PL11.2Z\\nForeign body accidentally left in body as mode of injury or harm: PL11.3\\nFailure of sterile precautions as mode of injury or harm: PL11.4\\nProcedure undertaken at wrong site or wrong side as mode of injury or harm: PL11.5\\nPressure as mode of injury or harm: PL11.6\\nOther specified mode of injury or harm associated with a surgical or other medical procedure: PL11.Y\\nUnspecified mode of injury or harm associated with a surgical or other medical procedure: PL11.Z\\nMode of injury or harm associated with a surgical or other medical device implant or graft: PL12\\nStructural device failure as mode of injury or harm: PL12.0\\nFunctional device failure as mode of injury or harm: PL12.1\\nPerforation or protrusion by device as mode of injury or harm: PL12.2\\nObstruction of device as mode of injury or harm: PL12.3\\nDislodgement misconnection or deattachment as mode of injury or harm: PL12.4\\nOperator error as mode of injury or harm: PL12.5\\nCombination or interaction of operator error and device failure as mode of injury or harm: PL12.6\\nOther specified mode of injury or harm associated with a surgical or other medical device implant or graft: PL12.Y\\nMode of injury or harm associated with a surgical or other medical device implant or graft unspecified: PL12.Z\\nMode of injury or harm associated with exposure to a drug medicament or biological substance: PL13\\nOverdose of substance as mode of injury or harm: PL13.0\\nUnderdosing as mode of injury or harm: PL13.1\\nDrugrelated injury or harm in the context of correct administration or dosage as mode of injury or harm: PL13.2\\nIncorrect substance as mode of injury or harm: PL13.3\\nIncorrect administration of drug or medicament as mode of injury: PL13.5\\nIncorrect route of drug or medicament as mode of injury: PL13.50\\nIncorrect rate of drug or medicament as mode of injury: PL13.51\\nIncorrect timing of drug or medicament as mode of injury: PL13.52\\nIncorrect duration of drug or medicament as mode of injury: PL13.53\\nOther specified incorrect administration of drug or medicament as mode of injury: PL13.5Y\\nIncorrect administration of drug or medicament as mode of injury unspecified: PL13.5Z\\nMedication or substance that is known to be an allergen as mode of injury or harm: PL13.6\\nMedication or substance that is known to be contraindicated for the patient as mode of injury or harm: PL13.7\\nExpired or deteriorated medication or substance as mode of injury or harm: PL13.8\\nDrug or substance interactions as mode of injury or harm: PL13.9\\nInappropriate stoppage or discontinuation of drug as mode of injury or harm: PL13.A\\nOther specified mode of injury or harm associated with exposure to a drug medicament or biological substance: PL13.Y\\nMode of injury or harm associated with exposure to a drug medicament or biological substance unspecified: PL13.Z\\nMode of injury or harm associated with other health care related causes: PL14\\nNonadministration of necessary drug: PL14.0\\nNon provision of necessary procedure: PL14.1\\nProblem associated with physical transfer of patient: PL14.2\\nMismatched blood used in transfusion: PL14.3\\nOther problem associated with transfusion: PL14.4\\nProblem associated with physical restraints: PL14.5\\nProblem associated with isolation protocol: PL14.6\\nProblem associated with clinical documentation: PL14.7\\nProblem associated with clinical software: PL14.8\\nIncorrect diagnosis: PL14.9\\nDelayed diagnosis: PL14.A\\nDelayed treatment: PL14.B\\nPatient received diagnostic test or treatment intended for another patient: PL14.C\\nProblem associated with transitions of care hand offs or handovers: PL14.D\\nFall in health care: PL14.E\\nOther specified aspects of care associated with injury or harm: PL14.Y\\nMode of injury or harm associated with other health care related causes unspecified: PL14.Z\\nOther specified external causes of morbidity or mortality: PL2Y\\nExternal causes of morbidity or mortality unspecified: PL2Z\\nGeneral examination or investigation of persons without complaint or reported diagnosis: QA00\\nGeneral adult medical examination: QA00.0\\nRoutine child health examination: QA00.1\\nRoutine newborn health examination: QA00.2\\nGeneral mental examination: QA00.3\\nExamination of potential donor of organ or tissue: QA00.4\\nExamination for normal comparison or control in clinical research programme: QA00.5\\nExamination of eyes or vision: QA00.6\\nNormal Visual Field: QA00.61\\nNo vision impairment: QA00.62\\nOther specified examination of eyes or vision: QA00.6Y\\nExamination of eyes or vision unspecified: QA00.6Z\\nExamination of ears and hearing: QA00.7\\nDental examination: QA00.8\\nGynaecological examination: QA00.9\\nSkin or other sensitisation tests: QA00.A\\nRadiological examination: QA00.B\\nLaboratory examination: QA00.C\\nEncounter for blood typing: QA00.D\\nEncounter for antibody response examination: QA00.E\\nOther specified general examination or investigation of persons without complaint or reported diagnosis: QA00.Y\\nGeneral examination or investigation of persons without complaint or reported diagnosis unspecified: QA00.Z\\nExamination or encounter for administrative purposes: QA01\\nExamination for admission to educational institution: QA01.0\\nPreemployment examination: QA01.1\\nExamination for admission to residential institutions: QA01.2\\nExamination for recruitment to armed forces: QA01.3\\nExamination for driving license: QA01.4\\nExamination for participation in sport: QA01.5\\nExamination for insurance purposes: QA01.6\\nIssue of medical certificate: QA01.7\\nEncounter for adoption services: QA01.8\\nOther specified examination or encounter for administrative purposes: QA01.Y\\nExamination or encounter for administrative purposes unspecified: QA01.Z\\nMedical observation or evaluation for suspected diseases or conditions ruled out: QA02\\nObservation for suspected tuberculosis ruled out: QA02.0\\nObservation for suspected Dengue ruled out: QA02.1\\nObservation for suspected malignant neoplasm ruled out: QA02.2\\nObservation for suspected mental or behavioural disorders ruled out: QA02.3\\nObservation for suspected nervous system disorder ruled out: QA02.4\\nObservation for suspected toxic effect from ingested substance ruled out: QA02.5\\nObservation and evaluation of newborn for suspected condition ruled out: QA02.6\\nObservation for suspected suicide ideation or attempt ruled out: QA02.7\\nObservation for suspected allergy or hypersensitivity ruled out: QA02.8\\nMedical observation or evaluation for other suspected diseases or conditions ruled out: QA02.Y\\nRoutine general health checkup of defined subpopulation: QA03\\nOccupational health examination: QA03.0\\nRoutine general health checkup of inhabitants of institutions: QA03.1\\nRoutine general health checkup of armed forces: QA03.2\\nRoutine general health checkup of sports teams: QA03.3\\nOther specified routine general health checkup of defined subpopulation: QA03.Y\\nRoutine general health checkup of defined subpopulation unspecified: QA03.Z\\nExamination or observation for reasons other than suspected diseases or conditions or administrative purposes: QA04\\nBloodalcohol or blooddrug test: QA04.0\\nAlcohol and drug testing other than by blood: QA04.1\\nExamination or observation following transport accident: QA04.2\\nExamination or observation following work accident: QA04.3\\nExamination or observation following accident other than work or transport: QA04.4\\nExamination or observation for suspected maltreatment: QA04.5\\nExamination or observation for suspected physical maltreatment: QA04.50\\nExamination or observation for suspected sexual maltreatment: QA04.51\\nExamination or observation for suspected psychological maltreatment: QA04.52\\nExamination or observation for suspected neglect or abandonment: QA04.53\\nOther specified examination or observation for suspected maltreatment: QA04.5Y\\nExamination or observation for suspected maltreatment unspecified: QA04.5Z\\nGeneral mental examination requested by authority: QA04.6\\nExamination for medicolegal reasons: QA04.7\\nOther specified examination or observation for reasons other than suspected diseases or conditions or administrative purposes: QA04.Y\\nExamination or observation for reasons other than suspected diseases or conditions or administrative purposes unspecified: QA04.Z\\nPerson consulting for explanation of investigation findings: QA05\\nFollowup examination after treatment for malignant neoplasms: QA06\\nFollowup examination after treatment for conditions other than malignant neoplasms: QA07\\nFollowup examination after organ transplant: QA07.0\\nOther specified followup examination after treatment for conditions other than malignant neoplasms: QA07.Y\\nFollowup examination after treatment for conditions other than malignant neoplasms unspecified: QA07.Z\\nSpecial screening examination for infectious diseases: QA08\\nSpecial screening examination for intestinal infectious diseases: QA08.0\\nSpecial screening examination for respiratory tuberculosis: QA08.1\\nSpecial screening examination for other bacterial diseases: QA08.2\\nSpecial screening examination for infections with a predominantly sexual mode of transmission: QA08.3\\nSpecial screening examination for human immunodeficiency virus: QA08.4\\nSpecial screening examination for other viral diseases: QA08.5\\nSpecial screening examination for other protozoal diseases or helminthiases: QA08.6\\nSpecial screening examination for other specified infectious diseases: QA08.Y\\nSpecial screening examination for unspecified infectious diseases: QA08.Z\\nSpecial screening examination for neoplasms: QA09\\nSpecial screening examination for neoplasm of stomach: QA09.0\\nSpecial screening examination for neoplasm of intestinal tract: QA09.1\\nSpecial screening examination for neoplasm of respiratory organs: QA09.2\\nSpecial screening examination for neoplasm of breast: QA09.3\\nSpecial screening examination for neoplasm of cervix: QA09.4\\nSpecial screening examination for neoplasm of prostate: QA09.5\\nSpecial screening examination for neoplasm of bladder: QA09.6\\nSpecial screening examination for neoplasm of skin: QA09.7\\nOther specified special screening examination for neoplasms: QA09.Y\\nSpecial screening for neoplasm of unspecified site: QA09.Z\\nSpecial screening examination for other diseases or disorders: QA0A\\nSpecial screening examination for diseases of the blood or bloodforming organs or certain disorders involving the immune mechanism: QA0A.0\\nSpecial screening examination for endocrine and metabolic disorder: QA0A.1\\nSpecial screening examination for diabetes mellitus: QA0A.10\\nOther specified special screening examination for endocrine and metabolic disorder: QA0A.1Y\\nSpecial screening examination for endocrine and metabolic disorder unspecified: QA0A.1Z\\nSpecial screening examination for nutritional disorders: QA0A.2\\nSpecial screening examination for mental or behavioural disorders: QA0A.3\\nSpecial screening examination for certain developmental disorders in childhood: QA0A.4\\nSpecial screening examination for eye or ear disorders: QA0A.5\\nSpecial screening examination for cardiovascular disorders: QA0A.6\\nSpecial screening examination for allergic and hypersensitivity conditions: QA0A.7\\nSpecial screening for diseases or disorders not elsewhere classified: QA0A.Y\\nSpecial screening examination for other diseases or disorders unspecified: QA0A.Z\\nPreprocedural examination: QA0B\\nOther examination or investigation: QA0Y\\nExamination or investigation unspecified: QA0Z\\nContact with health services for dietary counselling or surveillance: QA10\\nContact with health services for alcohol use counselling or surveillance: QA11\\nContact with health services for drug use counselling or surveillance: QA12\\nContact with health services for tobacco use counselling: QA13\\nContact with health services for human immunodeficiency virus counselling: QA14\\nCounselling related to sexuality: QA15\\nCounselling related to sexual attitudes: QA15.0\\nCounselling related to sexual behaviour and orientation or sexual relationships of the person: QA15.1\\nCounselling related to sexual behaviour and orientation or sexual relationships of third party: QA15.2\\nCounselling related to combined sexual attitudes sexual behaviour and sexual relationships: QA15.3\\nOther specified counselling related to sexuality: QA15.Y\\nCounselling related to sexuality unspecified: QA15.Z\\nIndividual psychological or behavioural counselling: QA16\\nMarital or couples counselling: QA17\\nFamily counselling: QA18\\nGroup counselling: QA19\\nDiscussion of issues surrounding impending death: QA1A\\nConcern about or fear of medical treatment: QA1B\\nPerson with feared complaint in whom no diagnosis is made: QA1C\\nContact with health services for other specified counselling: QA1Y\\nContact with health services for unspecified counselling: QA1Z\\nContact with health services for concerns about pregnancy: QA20\\nContact with health services for contraceptive management: QA21\\nContact with health services for postcoital contraception: QA21.0\\nContact with health services for general counselling or advice on contraception: QA21.1\\nContact with health services for insertion of contraceptive device: QA21.2\\nContact with health services for sterilisation: QA21.3\\nContact with health services for menstrual extraction: QA21.4\\nSurveillance of contraceptive drugs: QA21.5\\nSurveillance of contraceptive device: QA21.6\\nRetained intrauterine device without injury or harm in nonpregnant uterus: QA21.60\\nOther specified surveillance of contraceptive device: QA21.6Y\\nSurveillance of contraceptive device unspecified: QA21.6Z\\nOther specified contact with health services for contraceptive management: QA21.Y\\nContact with health services for contraceptive management unspecified: QA21.Z\\nContact with health services for medically assisted reproduction: QA30\\nContact with health services for assisted insemination: QA30.0\\nContact with health services for gamete intrafallopian transfer: QA30.00\\nContact with health services for procreative management by artificial insemination: QA30.01\\nContact with health services for medically assisted sperm insemination: QA30.02\\nContact with health services for other specified assisted insemination: QA30.0Y\\nContact with health services for unspecified assisted insemination: QA30.0Z\\nContact with health services for assisted reproductive technology: QA30.1\\nContact with health services for in vitro fertilisation: QA30.10\\nContact with health services for egg retrieval: QA30.11\\nContact with health services for embryo transfer: QA30.12\\nContact with health services for ovum implantation: QA30.13\\nContact with health services for harvesting ovum for in vitro fertilisation: QA30.14\\nContact with health services for harvesting or implantation of ova: QA30.15\\nContact with health services for other specified assisted reproductive technology: QA30.1Y\\nContact with health services for unspecified assisted reproductive technology: QA30.1Z\\nContact with health services for other assisted fertilisation methods: QA30.2\\nContact with health services for controlled ovarian stimulation for assisted reproductive technology: QA30.20\\nContact with health services for controlled ovarian stimulation for nonassisted reproductive technology cycles: QA30.21\\nContact with health services for ovulation induction: QA30.22\\nContact with health services for other specified assisted fertilisation methods: QA30.2Y\\nContact with health services for unspecified assisted fertilisation methods: QA30.2Z\\nOther specified contact with health services for medically assisted reproduction: QA30.Y\\nContact with health services for medically assisted reproduction unspecified: QA30.Z\\nContact with health services for genetic counselling: QA31\\nContact with health services for tuboplasty or vasoplasty after previous sterilisation: QA32\\nContact with health services for preconception counselling: QA33\\nContact with health services for fertility preservation counselling: QA34\\nContact with health services by gestational carrier: QA35\\nContact with health services for other specified procreative management: QA3Y\\nContact with health services for procreative management unspecified: QA3Z\\nPregnancy examination or test: QA40\\nPregnant state: QA41\\nSupervision of normal pregnancy: QA42\\nSupervision of normal first pregnancy: QA42.0\\nSupervision of other specified normal pregnancy: QA42.Y\\nSupervision of normal pregnancy unspecified: QA42.Z\\nSupervision of highrisk pregnancy: QA43\\nSupervision of pregnancy with history of infertility: QA43.0\\nSupervision of pregnancy with history of abortive outcome: QA43.1\\nSupervision of pregnancy with other poor reproductive or obstetric history: QA43.2\\nSupervision of pregnancy with history of insufficient antenatal care: QA43.3\\nConcealed pregnancy: QA43.30\\nOther specified supervision of pregnancy with history of insufficient antenatal care: QA43.3Y\\nSupervision of pregnancy with history of insufficient antenatal care unspecified: QA43.3Z\\nSupervision of elderly primigravida: QA43.4\\nSupervision of very young primigravida: QA43.5\\nSupervision of highrisk pregnancy due to social problems: QA43.6\\nOther specified supervision of highrisk pregnancy: QA43.Y\\nSupervision of highrisk pregnancy unspecified: QA43.Z\\nExpectant parent prebirth visit: QA44\\nAntenatal screening: QA45\\nAntenatal screening for chromosomal anomalies: QA45.0\\nAntenatal screening due to raised alphafetoprotein level: QA45.1\\nOther specified antenatal screening: QA45.Y\\nAntenatal screening unspecified: QA45.Z\\nOutcome of delivery: QA46\\nSingle live birth: QA46.0\\nSingle stillbirth: QA46.1\\nTwins both liveborn: QA46.2\\nTwins one liveborn and one stillborn: QA46.3\\nTwins both stillborn: QA46.4\\nTriplets all liveborn: QA46.5\\nTriplets some liveborn: QA46.6\\nTriplets all stillborn: QA46.7\\nQuadruplets all liveborn: QA46.8\\nQuadruplets some liveborn: QA46.9\\nQuadruplets all stillborn: QA46.A\\nQuintuplets all liveborn: QA46.B\\nQuintuplets some liveborn: QA46.C\\nQuintuplets all stillborn: QA46.D\\nSextuplets all liveborn: QA46.E\\nSextuplets some liveborn: QA46.F\\nSextuplets all stillborn: QA46.G\\nOther multiple births all liveborn: QA46.H\\nOther multiple births some liveborn: QA46.J\\nOther multiple births all stillborn: QA46.K\\nOutcome of delivery unspecified: QA46.Z\\nLiveborn infants according to place of birth: QA47\\nSingleton born in hospital: QA47.0\\nSingle liveborn infant delivered vaginally: QA47.00\\nSingle liveborn infant delivered by caesarean: QA47.01\\nOther specified singleton born in hospital: QA47.0Y\\nSingleton born in hospital unspecified: QA47.0Z\\nSingleton born outside hospital: QA47.1\\nSingleton unspecified as to place of birth: QA47.2\\nTwin born in hospital: QA47.3\\nTwin liveborn infant delivered vaginally: QA47.30\\nTwin liveborn infant delivered by caesarean: QA47.31\\nOther specified twin born in hospital: QA47.3Y\\nTwin born in hospital unspecified: QA47.3Z\\nTwin born outside hospital: QA47.4\\nTwin unspecified as to place of birth: QA47.5\\nMultiple other than twins born in hospital: QA47.6\\nMultiple other than twins delivered vaginally: QA47.60\\nMultiple other than twins delivered by caesarean section: QA47.61\\nOther specified multiple other than twins born in hospital: QA47.6Y\\nMultiple other than twins born in hospital unspecified: QA47.6Z\\nMultiple other than twins born outside hospital: QA47.7\\nOther multiple unspecified as to place of birth: QA47.8\\nLiveborn infants according to place of birth unspecified: QA47.Z\\nPostpartum care or examination: QA48\\nCare or examination immediately after delivery: QA48.0\\nCare or examination of lactating mother: QA48.1\\nRoutine postpartum followup: QA48.2\\nOther specified postpartum care or examination: QA48.Y\\nPostpartum care or examination unspecified: QA48.Z\\nProblems related to unwanted pregnancy: QA49\\nProblems related to multiparity: QA4A\\nContact with health services for menopausal counselling: QA4B\\nOther specified contact with health services for reasons associated with reproduction: QA4Y\\nContact with health services for reasons associated with reproduction unspecified: QA4Z\\nEmbolisation without injury or harm: QA50\\nForeign body accidentally left in body without injury or harm: QA51\\nFailure of sterile precautions without injury or harm: QA52\\nPressure as potential mode of injury without injury or harm: QA53\\nOther specified circumstances associated with a surgical or other medical procedure influencing the episode of care without injury or harm: QA5Y\\nCircumstances associated with a surgical or other medical procedure influencing the episode of care without injury or harm unspecified: QA5Z\\nStructural device failure without injury or harm: QA60\\nFunctional device failure without injury or harm: QA61\\nDislodgement misconnection or deattachment of a surgical or medical device without injury or harm: QA62\\nObstruction of device without injury or harm: QA63\\nOperator error without injury or harm: QA64\\nCombination or interaction of operator error and device failure without injury or harm: QA65\\nOther specified circumstances associated with a surgical or other medical device influencing the episode of care without injury or harm: QA6Y\\nCircumstances associated with a surgical or other medical device influencing the episode of care without injury or harm unspecified: QA6Z\\nOverdose of substance without injury or harm: QA70\\nUnderdosing without injury or harm: QA71\\nIncorrect substance without injury or harm: QA72\\nIncorrect route of administration without injury or harm: QA73\\nUnspecified appropriateness of dosing or administration without injury or harm: QA74\\nIncorrect duration of administration or course of therapy without injury or harm: QA75\\nMedication or substance that is known to be an allergen without injury or harm: QA76\\nMedication or substance that is known to be contraindicated for the patient without injury or harm: QA77\\nExpired or deteriorated medication or substance without injury or harm: QA78\\nDrug or substance interactions without injury or harm: QA79\\nInappropriate stoppage or discontinuation of drug without injury or harm: QA7A\\nOther specified circumstances associated with exposure to a drug medicament or biological substance influencing the episode of care without injury or harm: QA7Y\\nCircumstances associated with exposure to a drug medicament or biological substance influencing the episode of care without injury or harm unspecified: QA7Z\\nNonadministration of necessary drug without injury or harm: QA80\\nNonprovision of necessary procedure without injury or harm: QA81\\nProblem associated with physical transfer of patient without injury or harm: QA82\\nMismatched blood used in transfusion without injury or harm: QA83\\nOther problem with transfusion without injury or harm: QA84\\nProblem with physical restraints without injury or harm: QA85\\nProblem with isolation protocol without injury or harm: QA86\\nProblem with clinical documentation without injury or harm: QA87\\nProblem with clinical software without injury or harm: QA88\\nIncorrect diagnosis without injury or harm: QA89\\nDelayed diagnosis without injury or harm: QA8A\\nDelayed treatment without injury or harm: QA8B\\nProblem with transitions of care hand offs or handovers without injury or harm: QA8C\\nPatient received diagnostic test or treatment intended for another patient without injury or harm: QA8D\\nFall in health care without injury or harm: QA8E\\nNeedle stick without injury or harm: QA8F\\nOther specified circumstances associated with other aspects of care influencing the episode of care without injury or harm: QA8Y\\nCircumstances associated with other aspects of care influencing the episode of care without injury or harm unspecified: QA8Z\\nOther specified health care related circumstances influencing the episode of care without injury or harm: QB0Y\\nHealth care related circumstances influencing the episode of care without injury or harm unspecified: QB0Z\\nMedical services not available in home: QB10\\nPerson awaiting admission to adequate facility elsewhere: QB11\\nWaiting period for investigation or treatment other than awaiting admission to adequate facility elsewhere: QB12\\nOrgan transplant candidate: QB12.0\\nOther specified waiting period for investigation or treatment other than awaiting admission to adequate facility elsewhere: QB12.Y\\nWaiting period for investigation or treatment other than awaiting admission to adequate facility elsewhere unspecified: QB12.Z\\nUnavailability or inaccessibility of helping agencies other than health care facilities: QB13\\nUnavailability or inaccessibility of health care facilities: QB14\\nMedical services not available in current medical facility: QB15\\nRespite care: QB16\\nOther specified factors related to medical facilities or other health care: QB1Y\\nFactors related to medical facilities or other health care unspecified: QB1Z\\nBlood donor: QB20\\nBone marrow donor: QB21\\nKidney donor: QB22\\nCornea donor: QB23\\nLiver donor: QB24\\nHeart donor: QB25\\nDonors of other specified organs or tissues: QB2Y\\nDonors of organs or tissues unspecified: QB2Z\\nAdjustment or management of implanted devices: QB30\\nAdjustment or management of implanted hearing device: QB30.0\\nAdjustment or management of bone conduction device: QB30.00\\nAdjustment or management of cochlear device: QB30.01\\nAdjustment or management of other implanted hearing device: QB30.0Y\\nAdjustment or management of implanted hearing device unspecified: QB30.0Z\\nAdjustment or management of infusion pump: QB30.1\\nAdjustment or management of cardiac devices: QB30.2\\nAdjustment or management of cardiac pacemaker: QB30.20\\nAdjustment or management of cardiac resynchronization therapy defibrillator: QB30.21\\nAdjustment or management of cardiac resynchronization therapy pacemaker: QB30.22\\nAdjustment or management of cardioverterdefibrillator: QB30.23\\nOther specified adjustment or management of cardiac devices: QB30.2Y\\nAdjustment or management of cardiac devices unspecified: QB30.2Z\\nAdjustment or management of vascular access device: QB30.3\\nAdjustment or management of implanted gastric device: QB30.4\\nFitting or adjustment of urinary device: QB30.5\\nAdjustment or management of breast implant: QB30.6\\nAdjustment or removal of myringotomy stent or tube: QB30.7\\nAdjustment and management of a neurostimulator: QB30.8\\nFitting or adjustment of cerebrospinal fluid drainage device: QB30.9\\nFitting or adjustment of neuropacemaker: QB30.A\\nFitting adjustment or management of other specified implanted devices: QB30.Y\\nAdjustment or management of implanted devices unspecified: QB30.Z\\nFitting adjustment or management of external devices: QB31\\nFitting or adjustment of external prosthetic device: QB31.0\\nFitting or adjustment of artificial arm: QB31.00\\nFitting or adjustment of artificial leg: QB31.01\\nFitting or adjustment of artificial eye: QB31.02\\nFitting or adjustment of external breast prosthesis: QB31.03\\nOther specified fitting or adjustment of external prosthetic device: QB31.0Y\\nFitting or adjustment of external prosthetic device unspecified: QB31.0Z\\nFitting or adjustment of orthopaedic device: QB31.1\\nFitting or adjustment of orthodontic device: QB31.2\\nFitting or adjustment of dental prosthetic device: QB31.3\\nFitting or adjustment of hearing aid: QB31.4\\nFitting or adjustment of spectacles or contact lenses: QB31.5\\nFitting adjustment or management of other specified external devices: QB31.Y\\nFitting adjustment or management of external devices unspecified: QB31.Z\\nFitting adjustment or management of devices unspecified: QB3Z\\nDependence on aspirator: QB40\\nDependence on respirator: QB41\\nDependence on renal dialysis: QB42\\nDependence on artificial heart: QB43\\nDependence on wheelchair: QB44\\nDependence on other specified machine or device: QB4Y\\nDependence on unspecified machine or device: QB4Z\\nPresence of cardiac or vascular implants or grafts: QB50\\nPresence of electronic cardiac devices: QB50.0\\nPresence of cardiac pacemaker: QB50.00\\nPresence of cardiac resynchronization therapy defibrillator: QB50.01\\nPresence of cardiac resynchronization therapy pacemaker: QB50.02\\nPresence of cardioverterdefibrillator: QB50.03\\nOther specified presence of electronic cardiac devices: QB50.0Y\\nPresence of electronic cardiac devices unspecified: QB50.0Z\\nPresence of aortocoronary bypass graft: QB50.1\\nPresence of prosthetic heart valve: QB50.2\\nPresence of mechanical heart valve: QB50.21\\nPresence of bioprosthetic heart valve: QB50.24\\nPresence of prosthetic heart valve other specified type: QB50.2Y\\nPresence of prosthetic heart valve unspecified: QB50.2Z\\nPresence of coronary angioplasty implant or graft: QB50.4\\nPresence of other specified cardiac or vascular implants or grafts: QB50.Y\\nPresence of unspecified cardiac or vascular implants or grafts: QB50.Z\\nPresence of devices other than cardiac or vascular implants: QB51\\nPresence of a neurostimulator: QB51.0\\nPresence of urogenital implants: QB51.1\\nPresence of intraocular lens: QB51.2\\nPresence of otological or audiological implants: QB51.3\\nPresence of artificial larynx: QB51.4\\nPresence of endocrine implants: QB51.5\\nPresence of toothroot or mandibular implants: QB51.6\\nPresence of orthopaedic joint implants: QB51.7\\nPresence of artificial eye: QB51.8\\nPresence of artificial limb: QB51.9\\nPresence of dental prosthetic device: QB51.A\\nPresence of external hearingaid: QB51.B\\nPresence of contraceptive device: QB51.C\\nPresence of cerebrospinal fluid drainage device: QB51.D\\nPresence of other specified devices other than cardiac or vascular implants: QB51.Y\\nPresence of unspecified device: QB5Z\\nPresence of arthrodesis: QB60\\nPresence of artificial opening: QB61\\nPresence of tracheostomy: QB61.0\\nPresence of thoracostomy: QB61.1\\nPresence of gastrostomy: QB61.2\\nPresence of enterostomy: QB61.3\\nPresence of ileostomy: QB61.30\\nOther specified presence of enterostomy: QB61.3Y\\nPresence of enterostomy unspecified: QB61.3Z\\nPresence of colostomy: QB61.4\\nPresence of cystostomy: QB61.5\\nPresence of nephrostomy: QB61.6\\nPresence of ureterostomy: QB61.7\\nPresence of urethrostomy: QB61.8\\nPresence of other artificial opening: QB61.Y\\nPresence of artificial opening unspecified: QB61.Z\\nAttention to artificial openings: QB62\\nAttention to tracheostomy: QB62.0\\nAttention to gastrostomy: QB62.1\\nAttention to ileostomy: QB62.2\\nAttention to colostomy: QB62.3\\nAttention to cystostomy: QB62.4\\nAttention to artificial vagina: QB62.5\\nAttention to nephrostomy: QB62.6\\nAttention to ureterostomy: QB62.7\\nAttention to urethrostomy: QB62.8\\nAttention to other artificial openings: QB62.Y\\nAttention to artificial openings unspecified: QB62.Z\\nPresence of transplanted organ or tissue: QB63\\nPresence of transplanted kidney: QB63.0\\nPresence of transplanted heart: QB63.1\\nPresence of transplanted lung: QB63.2\\nPresence of transplanted liver: QB63.3\\nPresence of transplanted skin: QB63.4\\nPresence of transplanted bone: QB63.5\\nPresence of transplanted bone marrow: QB63.6\\nPresence of transfused blood: QB63.7\\nPresence of transplanted stem cell: QB63.8\\nPresence of transplanted cornea: QB63.9\\nPresence of other transplanted organ or tissue: QB63.Y\\nPresence of transplanted organ or tissue unspecified: QB63.Z\\nOther specified surgical or postsurgical states: QB6Y\\nSurgical or postsurgical states unspecified: QB6Z\\nConvalescence following chemotherapy: QB70\\nConvalescence following psychotherapy: QB71\\nConvalescence following treatment of fracture: QB72\\nConvalescence following combined treatment: QB73\\nOther specified convalescence: QB7Y\\nConvalescence unspecified: QB7Z\\nContact with health services for prophylactic surgery: QB80\\nContact with health services for prophylactic surgery for riskfactors related to malignant neoplasms: QB80.0\\nOther specified contact with health services for prophylactic surgery: QB80.Y\\nContact with health services for prophylactic surgery unspecified: QB80.Z\\nContact with health services for plastic surgery for unacceptable cosmetic appearance other than hair transplant: QB81\\nContact with health services for routine or ritual circumcision: QB82\\nFollowup care involving plastic surgery: QB83\\nFollowup care involving removal of fracture plate or other internal fixation device: QB84\\nAttention to surgical dressings drains or sutures: QB85\\nContact with health services for hair transplant: QB86\\nContact with health services for other specified surgical interventions: QB8Y\\nContact with health services for specific surgical interventions unspecified: QB8Z\\nContact with health services for ear piercing: QB90\\nContact with health services for piercing of body site other than ear: QB91\\nContact with health services for issue of repeat prescription: QB92\\nContact with health services for orthodontic care: QB93\\nCare involving dialysis: QB94\\nPreparatory care for dialysis: QB94.0\\nCare involving extracorporeal dialysis: QB94.1\\nCare involving peritoneal dialysis: QB94.2\\nCare involving other specified dialysis: QB94.Y\\nCare involving dialysis unspecified: QB94.Z\\nCare involving use of rehabilitation procedures: QB95\\nCardiac rehabilitation: QB95.0\\nPhysical rehabilitation: QB95.1\\nAlcohol rehabilitation: QB95.2\\nDrug rehabilitation: QB95.3\\nPsychotherapy: QB95.4\\nSpeech therapy: QB95.5\\nOrthoptic training: QB95.6\\nOccupational therapy or vocational rehabilitation: QB95.7\\nTobacco rehabilitation: QB95.8\\nCare involving use of other specified rehabilitation procedures: QB95.Y\\nCare involving use of rehabilitation procedures unspecified: QB95.Z\\nContact with health services for radiotherapy session: QB96\\nContact with health services for chemotherapy session for neoplasm: QB97\\nBlood transfusion without reported diagnosis: QB98\\nApheresis: QB99\\nPreparatory care for subsequent treatment: QB9A\\nPalliative care: QB9B\\nAllergen immunotherapy: QB9C\\nOther specified contact with health services for nonsurgical interventions not involving devices: QB9Y\\nContact with health services for nonsurgical interventions not involving devices unspecified: QB9Z\\nNeed for immunization against single bacterial diseases: QC00\\nNeed for immunization against cholera alone: QC00.0\\nNeed for immunization against typhoidparatyphoid alone: QC00.1\\nNeed for immunization against tuberculosis: QC00.2\\nNeed for immunization against plague: QC00.3\\nNeed for immunization against tularaemia: QC00.4\\nNeed for immunization against tetanus alone: QC00.5\\nNeed for immunization against diphtheria alone: QC00.6\\nNeed for immunization against pertussis alone: QC00.7\\nOther specified need for immunization against single bacterial diseases: QC00.Y\\nNeed for immunization against single bacterial diseases unspecified: QC00.Z\\nNeed for immunization against certain single viral diseases: QC01\\nNeed for immunization against poliomyelitis: QC01.0\\nNeed for immunization against arthropodborne viral encephalitis: QC01.1\\nNeed for immunization against rabies: QC01.2\\nNeed for immunization against yellow fever: QC01.3\\nNeed for immunization against measles alone: QC01.4\\nNeed for immunization against rubella alone: QC01.5\\nNeed for immunization against viral hepatitis: QC01.6\\nNeed for immunization against mumps alone: QC01.7\\nNeed for immunization against influenza: QC01.8\\nNeed for immunization against COVID: QC01.9\\nOther specified need for immunization against certain single viral diseases: QC01.Y\\nNeed for immunization against certain single viral diseases unspecified: QC01.Z\\nNeed for immunization against certain specified single infectious diseases: QC02\\nNeed for immunization against leishmaniasis: QC02.0\\nOther specified need for immunization against certain specified single infectious diseases: QC02.Y\\nNeed for immunization against certain specified single infectious diseases unspecified: QC02.Z\\nNeed for immunization against combinations of infectious diseases: QC03\\nNeed for immunization against cholera with typhoidparatyphoid: QC03.0\\nNeed for immunization against diphtheriatetanuspertussis combined: QC03.1\\nNeed for immunization against diphtheriatetanuspertussis with typhoidparatyphoid: QC03.2\\nNeed for immunization against diphtheriatetanuspertussis with poliomyelitis: QC03.3\\nNeed for immunization against measlesmumpsrubella: QC03.4\\nOther specified need for immunization against combinations of infectious diseases: QC03.Y\\nNeed for immunization against combinations of infectious diseases unspecified: QC03.Z\\nImmunization not carried out: QC04\\nImmunization not carried out due to patient having had the disease: QC04.0\\nImmunization not carried out because of acute illness: QC04.1\\nImmunization not carried out because of chronic illness or condition of patient: QC04.2\\nImmunization not carried out because of immunecompromised state of patient: QC04.3\\nImmunization not carried out because of patient allergy to vaccine or component: QC04.4\\nImmunization not carried out because of patient refusal: QC04.5\\nImmunization not carried out because of caregiver refusal: QC04.6\\nImmunization not carried out due to lack of availability: QC04.7\\nImmunization not carried out for other reasons: QC04.Y\\nImmunization not carried out for unspecified reason: QC04.Z\\nNeed for certain specified other prophylactic measures: QC05\\nIsolation: QC05.0\\nProphylactic immunotherapy: QC05.1\\nOther specified prophylactic measures: QC05.Y\\nProphylactic measures unspecified: QC05.Z\\nUnderimmunization status: QC06\\nOther specified contact with health services related to immunizations or certain other prophylactic measures: QC0Y\\nContact with health services related to immunizations or certain other prophylactic measures unspecified: QC0Z\\nProcedure not carried out because of contraindication: QC10\\nProcedure not carried out because of patients decision for reasons of belief or group pressure: QC11\\nProcedure not carried out because of patients decision for reasons other than belief or group pressure: QC12\\nIntervention not carried out for other reasons: QC1Y\\nIntervention not carried out unspecified reason: QC1Z\\nPerson consulting on behalf of another person: QC20\\nPartner illness problem: QC20.0\\nIllness problem with child: QC20.1\\nOther specified person consulting on behalf of another person: QC20.Y\\nPerson consulting on behalf of another person unspecified: QC20.Z\\nHealthy person accompanying sick person: QC21\\nHealth supervision or care of abandoned infant: QC22\\nOther specified contact with health services associated with the health of others: QC2Y\\nContact with health services associated with the health of others unspecified: QC2Z\\nMalingering: QC30\\nPersonal history of malignant neoplasm: QC40\\nPersonal history of malignant neoplasm of digestive organs: QC40.0\\nPersonal history of malignant neoplasm of trachea bronchus or lung: QC40.1\\nPersonal history of malignant neoplasm of respiratory or intrathoracic organs other than the digestive organs trachea bronchus or lung: QC40.2\\nPersonal history of malignant neoplasm of breast: QC40.3\\nPersonal history of malignant neoplasm of genital organs: QC40.4\\nPersonal history of malignant neoplasm of urinary tract: QC40.5\\nPersonal history of leukaemia: QC40.6\\nPersonal history of other malignant neoplasms of lymphoid haematopoietic or related tissues: QC40.7\\nPersonal history of malignant neoplasm of other specified site: QC40.Y\\nPersonal history of malignant neoplasm of unspecified site: QC40.Z\\nPersonal history of nonmalignant neoplasms: QC41\\nPersonal history of infectious or parasitic diseases: QC42\\nPersonal history of COVID: QC42.0\\nOther specified personal history of infectious or parasitic diseases: QC42.Y\\nPersonal history of infectious or parasitic diseases unspecified: QC42.Z\\nPersonal history of diseases of the blood or bloodforming organs: QC43\\nPersonal history of diseases of the immune system: QC44\\nPersonal history of anaphylaxis: QC44.0\\nPersonal history of foodinduced allergy or hypersensitivity: QC44.1\\nPersonal history of allergy to drugs medicaments or biological substances: QC44.2\\nPersonal history of allergy other than to drugs or biological substances: QC44.3\\nOther specified personal history of diseases of the immune system: QC44.Y\\nPersonal history of diseases of the immune system unspecified: QC44.Z\\nPersonal history of endocrine nutritional or metabolic diseases: QC45\\nPersonal history of mental or behavioural disorder: QC46\\nPersonal history of diseases of the nervous system or sense organs: QC47\\nPersonal history of medical treatment: QC48\\nPersonal history of longterm use of anticoagulants: QC48.0\\nOther specified personal history of medical treatment: QC48.Y\\nPersonal history of medical treatment unspecified: QC48.Z\\nPersonal history of noncompliance with medical treatment or regimen: QC49\\nPersonal history of poor personal hygiene: QC4A\\nPersonal history of selfharm: QC4B\\nPersonal history of other specified health problems: QC4Y\\nPersonal history of health problems unspecified: QC4Z\\nLate effect of prior health problem not elsewhere classified: QC50\\nFamily history of infectious diseases: QC60\\nFamily history of malignant neoplasm: QC61\\nFamily history of malignant neoplasm of digestive organs: QC61.0\\nFamily history of malignant neoplasm of trachea bronchus or lung: QC61.1\\nFamily history of malignant neoplasm of respiratory or intrathoracic organs other than digestive organs trachea bronchus or lung: QC61.2\\nFamily history of malignant neoplasm of breast: QC61.3\\nFamily history of malignant neoplasm of genital organs: QC61.4\\nFamily history of malignant neoplasm of urinary tract: QC61.5\\nFamily history of leukaemia: QC61.6\\nFamily history of malignant neoplasms of lymphoid haematopoietic or related tissues: QC61.7\\nOther specified family history of malignant neoplasm: QC61.Y\\nFamily history of malignant neoplasm unspecified: QC61.Z\\nFamily history of diseases of the blood or bloodforming organs: QC62\\nFamily history of disorders involving the immune mechanism: QC63\\nFamily history of endocrine nutritional or metabolic diseases: QC64\\nFamily history of diabetes mellitus: QC64.0\\nOther specified family history of endocrine nutritional or metabolic diseases: QC64.Y\\nFamily history of endocrine nutritional or metabolic diseases unspecified: QC64.Z\\nFamily history of mental or behavioural disorder: QC65\\nFamily history of eye or ear disorders: QC66\\nFamily history of ischaemic heart disease or other diseases of the circulatory system: QC67\\nFamily history of consanguinity: QC68\\nFamily history of stroke: QC69\\nFamily history of other specified health problems: QC6Y\\nFamily history of health problems unspecified: QC6Z\\nOther specified personal or family history or late effect of prior health problems: QC8Y\\nPersonal or family history or late effect of prior health problems unspecified: QC8Z\\nContact with or exposure to communicable diseases: QC90\\nContact with or exposure to intestinal infectious diseases: QC90.0\\nExposure to cholera: QC90.00\\nOther specified contact with or exposure to intestinal infectious diseases: QC90.0Y\\nContact with or exposure to intestinal infectious diseases unspecified: QC90.0Z\\nContact with or exposure to tuberculosis: QC90.1\\nContact with or exposure to infections with a predominantly sexual mode of transmission: QC90.2\\nContact with or exposure to rabies: QC90.3\\nContact with or exposure to rubella: QC90.4\\nContact with or exposure to viral hepatitis: QC90.5\\nContact with or exposure to human immunodeficiency virus: QC90.6\\nContact with or exposure to pediculosis acariasis or other infestations: QC90.7\\nContact with or exposure to other specified communicable diseases: QC90.Y\\nContact with or exposure to communicable diseases unspecified: QC90.Z\\nCarrier of salmonella typhi: QD00\\nCarrier of intestinal infectious agents: QD01\\nAsymptomatic enteric carriage of Entamoeba: QD01.0\\nOther specified carrier of intestinal infectious agents: QD01.Y\\nCarrier of intestinal infectious agents unspecified: QD01.Z\\nCarrier of corynebacterium diphtheriae: QD02\\nCarrier of infectious agents with a predominantly sexual mode of transmission: QD03\\nAsymptomatic colonization of the skin by virulent or therapy resistant bacteria: QD04\\nCarrier of other specified infectious disease agent: QD0Y\\nCarrier of infectious disease agent unspecified: QD0Z\\nOther specified health status associated with infectious or certain specified conditions: QD2Y\\nUnspecified health status associated with infectious or certain specified conditions: QD2Z\\nConcern about breast appearance: QD30\\nContact with health services for concerns about body image related to pregnancy: QD31\\nOther specified concern about body appearance: QD3Y\\nConcern about body appearance unspecified: QD3Z\\nPoverty: QD50\\nLow income: QD51\\nOther specified problems associated with finances: QD5Y\\nProblems associated with finances unspecified: QD5Z\\nProblems associated with inadequate drinkingwater: QD60\\nInadequate food: QD61\\nProblems associated with drinking water or nutrition unspecified: QD6Z\\nProblems associated with the natural environment or humanmade changes to the environment: QD70\\nProblems associated with exposure to noise: QD70.0\\nProblems associated with exposure to air pollution: QD70.1\\nProblems associated with exposure to water pollution: QD70.2\\nProblems associated with exposure to soil pollution: QD70.3\\nProblems associated with exposure to radiation: QD70.4\\nProblems associated with exposure to tobacco smoke: QD70.5\\nProblems associated with inadequate access to electricity: QD70.6\\nProblems associated with the natural environment or humanmade changes to the environment unspecified: QD70.Z\\nProblems associated with housing: QD71\\nHomelessness: QD71.0\\nInadequate housing: QD71.1\\nProblems related to living in residential institution: QD71.2\\nProblems associated with housing unspecified: QD71.Z\\nOther specified problems associated with the environment: QD7Y\\nProblems associated with the environment unspecified: QD7Z\\nProblem associated with unemployment: QD80\\nProblem associated with change of job: QD81\\nProblem associated with threat of job loss: QD82\\nProblem with employment conditions: QD83\\nProblem associated with uncongenial work: QD83.0\\nProblem associated with stressful work schedule: QD83.1\\nOther specified problem with employment conditions: QD83.Y\\nProblem with employment conditions unspecified: QD83.Z\\nOccupational exposure to riskfactors: QD84\\nOccupational exposure to dust: QD84.0\\nOccupational exposure to toxic agents in agriculture: QD84.1\\nOccupational exposure to toxic agents in industries other than agriculture: QD84.2\\nOccupational exposure to vibration: QD84.3\\nOccupational exposure to ergonomic risk: QD84.4\\nOther specified occupational exposure to riskfactors: QD84.Y\\nOccupational exposure to riskfactors unspecified: QD84.Z\\nBurnout: QD85\\nOther specified problems associated with employment or unemployment: QD8Y\\nProblems associated with employment or unemployment unspecified: QD8Z\\nProblem associated with illiteracy or lowlevel literacy: QD90\\nProblem associated with education unavailable or unattainable: QD91\\nProblem with educational progress: QD92\\nOther specified problems associated with education: QD9Y\\nProblems associated with education unspecified: QD9Z\\nAcculturation difficulty: QE00\\nStress not elsewhere classified: QE01\\nSocial role conflict: QE02\\nSocial exclusion or rejection: QE03\\nTarget of perceived adverse discrimination or persecution: QE04\\nOther specified problems associated with social or cultural environment: QE0Y\\nProblems associated with social or cultural environment unspecified: QE0Z\\nHazardous alcohol use: QE10\\nHazardous drug use: QE11\\nHazardous use of opioids: QE11.0\\nHazardous use of cannabis: QE11.1\\nHazardous use of sedatives hypnotics or anxiolytics: QE11.2\\nHazardous use of cocaine: QE11.3\\nHazardous use of stimulants including amphetamines or methamphetamine: QE11.4\\nHazardous use of caffeine: QE11.5\\nHazardous use of MDMA or related drugs: QE11.6\\nHazardous use of dissociative drugs including ketamine or PCP: QE11.7\\nHazardous use of other specified psychoactive substances: QE11.8\\nHazardous use of unknown or unspecified psychoactive substances: QE11.9\\nOther specified hazardous drug use: QE11.Y\\nHazardous drug use unspecified: QE11.Z\\nHazardous nicotine use: QE12\\nTobacco use: QE13\\nOther specified hazardous substance use: QE1Y\\nHazardous substance use unspecified: QE1Z\\nLack of physical exercise: QE20\\nHazardous gambling or betting: QE21\\nHazardous gaming: QE22\\nProblems with inappropriate diet or eating habits: QE23\\nProblems with hygiene behaviours: QE24\\nProblems with oral health behaviours: QE25\\nProblem with sun exposure behaviour: QE26\\nProblem with behaviours related to psychological health or wellbeing: QE27\\nProblem with health literacy: QE28\\nProblems with other specified healthrelated behaviours: QE2Y\\nProblem with healthrelated behaviours unspecified: QE2Z\\nInsufficient social insurance support: QE30\\nInsufficient social insurance support aged: QE30.0\\nInsufficient social insurance support disability: QE30.1\\nInsufficient social insurance support unemployment: QE30.2\\nInsufficient social insurance support family support: QE30.3\\nInsufficient social insurance support unspecified: QE30.Z\\nInsufficient social welfare support: QE31\\nInsufficient social welfare support child protection: QE31.0\\nInsufficient social welfare support protection against domestic violence: QE31.1\\nInsufficient social welfare support protection against homelessness: QE31.2\\nInsufficient social welfare support post prison services: QE31.3\\nInsufficient social welfare support unspecified: QE31.Z\\nOther specified problems associated with social insurance or welfare: QE3Y\\nProblems associated with social insurance or welfare unspecified: QE3Z\\nProblem associated with conviction in civil or criminal proceedings without imprisonment: QE40\\nProblem associated with imprisonment and other incarceration: QE41\\nProblem associated with release from prison: QE42\\nOther specified problems associated with the justice system: QE4Y\\nProblems associated with the justice system unspecified: QE4Z\\nProblem associated with interpersonal interactions: QE50\\nProblem associated with relationship with friend: QE50.0\\nRelationships with teachers or classmates: QE50.1\\nDissatisfaction with school environment: QE50.10\\nOther specified relationships with teachers or classmates: QE50.1Y\\nRelationships with teachers or classmates unspecified: QE50.1Z\\nProblem associated with relationships with people at work: QE50.2\\nRelationships with neighbours tenant or landlord: QE50.3\\nRelationship with parents inlaws or other family members: QE50.4\\nDiscord with counsellors: QE50.5\\nInadequate social skills: QE50.6\\nPersonality difficulty: QE50.7\\nOther specified problem associated with interpersonal interactions: QE50.Y\\nProblem associated with interactions with spouse or partner: QE51\\nRelationship distress with spouse or partner: QE51.0\\nHistory of spouse or partner violence: QE51.1\\nOther specified problem associated with interactions with spouse or partner: QE51.Y\\nProblem associated with interactions with spouse or partner unspecified: QE51.Z\\nProblem associated with interpersonal interactions in childhood: QE52\\nCaregiverchild relationship problem: QE52.0\\nLoss of love relationship in childhood: QE52.1\\nOther specified problem associated with interpersonal interactions in childhood: QE52.Y\\nProblem associated with interpersonal interactions in childhood unspecified: QE52.Z\\nOther specified problems associated with relationships: QE5Y\\nProblems associated with relationships unspecified: QE5Z\\nAbsence of family member: QE60\\nDisappearance or death of family member: QE61\\nLoss or death of child: QE61.0\\nDisappearance or death of other family member: QE61.Y\\nUncomplicated bereavement: QE62\\nOther specified problems associated with absence loss or death of others: QE6Y\\nProblems associated with absence loss or death of others unspecified: QE6Z\\nProblems related to primary support group including family circumstances: QE70\\nInadequate family support: QE70.0\\nDisruption of family by separation or divorce: QE70.1\\nDependent relative needing care at home: QE70.2\\nProblems related to primary support group including family circumstances unspecified: QE70.Z\\nVictim of crime or terrorism: QE80\\nExposure to disaster war or other hostilities: QE81\\nPersonal history of maltreatment: QE82\\nPersonal history of physical abuse: QE82.0\\nPersonal history of sexual abuse: QE82.1\\nPersonal history of psychological abuse: QE82.2\\nPersonal history of neglect: QE82.3\\nOther specified personal history of maltreatment: QE82.Y\\nPersonal history of maltreatment unspecified: QE82.Z\\nPersonal frightening experience in childhood: QE83\\nAcute stress reaction: QE84\\nOther specified problems associated with harmful or traumatic events: QE8Y\\nProblems associated with harmful or traumatic events unspecified: QE8Z\\nInadequate parental supervision or control: QE90\\nParental overprotection: QE91\\nAltered pattern of family relationships in childhood: QE92\\nRemoval from home in childhood: QE93\\nInstitutional upbringing: QE94\\nInappropriate parental pressure or other abnormal qualities of upbringing: QE95\\nEvents resulting in loss of selfesteem in childhood: QE96\\nOther specified problems associated with upbringing: QE9Y\\nProblems associated with upbringing unspecified: QE9Z\\nAcquired absence of limb: QF00\\nAcquired absence of organs: QF01\\nAcquired absence of breast: QF01.0\\nAcquired absence of genital organs: QF01.1\\nAcquired absence of female genital organs: QF01.10\\nAcquired absence of male genital organs: QF01.11\\nOther specified acquired absence of organs: QF01.Y\\nAcquired absence of organs unspecified: QF01.Z\\nOther specified acquired absence of body structure: QF0Y\\nAcquired absence of body structure unspecified: QF0Z\\nLimited function or disability of body organ or system: QF10\\nDifficulty or need for assistance with learning: QF20\\nDifficulty or need for assistance with general life tasks or life management: QF21\\nDifficulty or need for assistance with communication: QF22\\nDifficulty or need for assistance with mobility: QF23\\nDifficulty or need for assistance with selfcare: QF24\\nDifficulty or need for assistance with relationships: QF25\\nDifficulty or need for assistance with household tasks: QF26\\nDifficulty or need for assistance at home and no other household member able to render care: QF27\\nDifficulty or need for assistance with work activities: QF28\\nDifficulty or need for assistance with major areas of life: QF29\\nDifficulty or need for assistance with community participation: QF2A\\nNeed for continuous supervision: QF2B\\nDifficulty or need for assistance with other specified activity: QF2Y\\nDifficulty or need for assistance with unspecified activity: QF2Z\\nOther specified factors influencing health status or contact with health services: QF4Y\\nFactors influencing health status or contact with health services unspecified: QF4Z\\nConditions of uncertain aetiology and emergency use: RA00\\nVaping related disorder: RA00.0\\nCOVID: RA01\\nCOVID virus identified: RA01.0\\nCOVID virus not identified: RA01.1\\nPost COVID condition: RA02\\nMultisystem inflammatory syndrome associated with COVID: RA03\\nInternational emergency code: RA09\\nNational emergency code: RA26\\nHypochondrium pain disorder TM: SA00\\nJaundice disorder TM: SM41\\nLiver distension disorder TM: SA02\\nTympanites disorder TM: SA03\\nLiver abscess disorder TM: SM40\\nGallbladder distension disorder TM: SA05\\nOther specified liver system disorders TM: SA0Y\\nLiver system disorders TM unspecified: SA0Z\\nInducible palpitation disorder TM: SA10\\nSpontaneous palpitation disorder TM: SA11\\nOther specified palpitation disorders TM: SA1Y\\nPalpitation disorders TM unspecified: SA1Z\\nTrue heart pain disorder TM: SA20\\nOther specified chest impediment disorders TM: SA2Y\\nChest impediment disorders TM unspecified: SA2Z\\nOther specified heart system disorders TM: SA4Y\\nHeart system disorders TM unspecified: SA4Z\\nDysphagia disorder TM: SA50\\nStomach ache disorder TM: SA51\\nEpigastric distension disorder TM: SA52\\nEpigastric upset disorder TM: SA53\\nFood retention disorder TM: SA54\\nDiarrhea disorder TM: SA55\\nDysentery disorder TM: SM38\\nConstipation disorder TM: SM34\\nAbdominal pain disorder TM: SM33\\nIntestinal abscess disorder TM: SA59\\nOther specified spleen system disorders TM: SA5Y\\nSpleen system disorders TM unspecified: SA5Z\\nCommon cold disorder TM: SA60\\nCough with dyspnea disorder TM: SA70\\nOther specified cough disorders TM: SA7Y\\nCough disorders TM unspecified: SA7Z\\nDyspnea disorder TM: SA80\\nWheezing disorder TM: SA81\\nLung distension disorder TM: SA82\\nPleural fluid retention disorder TM: SA83\\nLung heat disorder TM: SA84\\nLung withering disorder TM: SA85\\nChest bind disorder TM: SA86\\nOther specified lung system disorders TM: SA8Y\\nLung system disorders TM unspecified: SA8Z\\nStony stranguria disorder TM: SA90\\nHeat stranguria disorder TM: SA91\\nOther specified strangury disorders TM: SA9Y\\nStrangury disorders TM unspecified: SA9Z\\nKidney stagnation disorder TM: SB00\\nFlooding urine disorder TM: SB01\\nEnuresis disorder TM: SB02\\nTurbid urine disorder TM: SB03\\nDribbling urinary block disorder TM: SB04\\nBlock and repulsion disorder TM: SB05\\nEdema disorders TM: SB06\\nKidney edema disorder TM: SB06.0\\nWind edema disorder TM: SB06.1\\nOther specified edema disorders TM: SB06.Y\\nEdema disorders TM unspecified: SB06.Z\\nLower abdominal colic disorder TM: SB07\\nPremature ejaculation disorder TM: SB08\\nInvoluntary ejaculation disorder TM: SB09\\nPersistent erection disorder TM: SB0A\\nImpotence disorder TM: SB0B\\nMale infertility disorder TM: SB0C\\nOther specified kidney system disorders TM: SB0Y\\nKidney system disorders TM unspecified: SB0Z\\nOther specified organ system disorders TM: SB2Y\\nOrgan system disorders TM unspecified: SB2Z\\nDampness sore disorder TM: SB30\\nImpetigo disorder TM: SB31\\nSepticemic furunculosis disorder TM: SB40\\nOther specified furuncle disorders TM: SB4Y\\nFuruncle disorders TM unspecified: SB4Z\\nBed sore disorder TM: SB50\\nDeep multiple abscess disorder TM: SB60\\nAnal abscess disorder TM: SM56\\nOther specified abscess disorders TM: SB6Y\\nAbscess disorders TM unspecified: SB6Z\\nHeaded carbuncle disorder TM: SB70\\nFoot dampness itch disorder TM: SB71\\nTinea circinate disorder TM: SB72\\nDry skin disorder TM: SB73\\nGangrene disorder TM: SB74\\nWart disorder TM: SB75\\nHand dampness itch disorder TM: SB76\\nErysipelas disorder TM: SB77\\nCellulitis disorder TM: SB78\\nThrush disorder TM: SB79\\nHerpes zoster disorder TM: SB7A\\nInterior haemorrhoid disorder TM: SB7B\\nFissured anus disorder TM: SB7C\\nOther specified skin and mucosa system disorders TM: SB7Y\\nSkin and mucosa system disorders TM unspecified: SB7Z\\nAdvanced menstruation disorder TM: SB80\\nDelayed menstruation disorder TM: SB81\\nIrregular menstruation disorders TM: SB82\\nOther specified menstruation cycle disorders TM: SB8Y\\nMenstruation cycle disorders TM unspecified: SB8Z\\nMenorrhagia disorder TM: SB90\\nDecreased menstruation disorder TM: SB91\\nProlonged menstruation disorder TM: SB92\\nMetrorrhagia disorder TM: SB93\\nAmenorrhea disorder TM: SB94\\nMenopausal disorder TM: SB95\\nDysmenorrhea disorder TM: SB96\\nOther specified menstruation associated disorders TM: SB9Y\\nMenstruation associated disorders TM unspecified: SB9Z\\nMorning sickness disorder TM: SC00\\nUnstable fetus disorder TM: SC01\\nBladder pressure disorder TM: SC02\\nEclampsia disorder TM: SC03\\nFloating sensation pregnancy disorder TM: SC04\\nOther specified pregnancy associated disorders TM: SC0Y\\nPregnancy associated disorders TM unspecified: SC0Z\\nPuerperal abdominal pain disorder TM: SC10\\nPuerperal wind disorder TM: SC11\\nHypogalactia disorder TM: SC12\\nPostpartum lochiorrhea disorder TM: SC13\\nOther specified puerperium associated disorders TM: SC1Y\\nPuerperium associated disorders TM unspecified: SC1Z\\nLeukorrhea disorder TM: SC20\\nVaginal flatus disorder TM: SC21\\nInfertility disorder TM: SC22\\nUterine mass disorder TM: SC23\\nBreast lump disorder TM: SC24\\nOther specified other female reproductive system associated disorders TM: SC2Y\\nOther female reproductive system associated disorders TM unspecified: SC2Z\\nOther specified female reproductive system disorders TM including childbirth: SC4Y\\nFemale reproductive system disorders TM including childbirth unspecified: SC4Z\\nCold impediment disorder TM: SC50\\nWind impediment disorder TM: SC51\\nDampness impediment disorder TM: SC52\\nOther specified joint impediment disorders TM: SC5Y\\nJoint impediment disorders TM unspecified: SC5Z\\nMuscle spasm disorder TM: SC60\\nLumbago disorder TM: SC61\\nNumbness disorder TM: SK54\\nWilting disorder TM: SC63\\nOther specified bone joint and muscle system disorders TM: SC6Y\\nBone joint and muscle system disorders TM unspecified: SC6Z\\nNight blindness disorder TM: SK64\\nWind glaucoma disorder TM: SC71\\nInflammatory eyelid disorder TM: SC72\\nNoninflammatory eyelid disorder TM: SC73\\nCorneal opacity disorder TM: SK6V\\nTinnitus disorder TM: SK86\\nSudden deafness disorder TM: SC80\\nGradual deafness disorder TM: SC81\\nOther specified deafness disorders TM: SC8Y\\nDeafness disorders TM unspecified: SC8Z\\nAllergic rhinitis disorder TM: SC90\\nNasal sinusitis disorder TM: SC91\\nHoarseness disorder TM: SC92\\nTonsillitis disorder TM: SL06\\nOther specified eye ear nose and throat system disorders TM: SC9Y\\nEye ear nose and throat system disorders TM unspecified: SC9Z\\nFacial paralysis disorder TM: SD00\\nMigraine disorder TM: SK01\\nHead wind disorder TM: SD11\\nOther specified headache disorders TM: SK0Y\\nHeadache disorders TM unspecified: SK0Z\\nConvulsion disorder TM: SD20\\nCerebral tinnitus disorder TM: SD21\\nVertigo disorder TM: SD22\\nForgetfulness disorder TM: SD23\\nFrequent protrusion of tongue disorder TM: SD24\\nProdrome of wind stroke disorder TM: SD30\\nSequela of wind stroke disorder TM: SD31\\nOther specified wind stroke disorders TM: SD3Y\\nWind stroke disorders TM unspecified: SD3Z\\nSyncope disorder TM: SP98\\nOther specified brain system disorders TM: SD4Y\\nBrain system disorders TM unspecified: SD4Z\\nOther specified other body system disorders TM: SD6Y\\nOther body system disorders TM unspecified: SD6Z\\nQi goiter disorder TM: SD70\\nWasting thirst disorder TM: SD71\\nConsumptive disorder TM: SP5B\\nOther specified qi blood and fluid disorders TM: SD7Y\\nQi blood and fluid disorders TM unspecified: SD7Z\\nLily disorder TM: SD80\\nManic disorder TM: SD81\\nDepression disorder TM: SD82\\nUneasiness disorder TM: SD83\\nInsomnia disorder TM: SQ24\\nSomnolence disorder TM: SD85\\nDementia disorder TM: SD86\\nRepressed fire disorder TM: SD87\\nOther specified mental and emotional disorders TM: SD8Y\\nMental and emotional disorders TM unspecified: SD8Z\\nSeasonal cold disorder TM: SD90\\nFatigue consumption disorder TM: SD91\\nSevere vomiting and diarrhoea disorder TM: SM76\\nAlternating fever and chills disorder TM: SD93\\nParasitic disorder TM: SD94\\nFlowing phlegm disorder TM: SD95\\nSummerheat disorder TM: SE00\\nSpring warmth disorder TM: SE01\\nDampness and warmth disorder TM: SE02\\nOther specified warmth disorders TM: SE0Y\\nWarmth disorders TM unspecified: SE0Z\\nOther specified external contraction disorders TM: SE2Y\\nExternal contraction disorders TM unspecified: SE2Z\\nDevelopmental delay disorder TM: SE30\\nGrowth fever disorder TM: SE31\\nGrowth pain disorder TM: SE32\\nAcute convulsion disorder TM: SE33\\nRecurrent convulsion disorder TM: SE34\\nFright seizure disorder TM: SE35\\nNight crying disorder TM: SE36\\nInfantile malnutrition disorder TM: SE37\\nDribbling disorder TM: SE38\\nDiaper dermatitis disorder TM: SE39\\nInfant stiffness disorder TM: SE3A\\nInfant limpness disorder TM: SE3B\\nOther specified childhood and adolescence associated disorders TM: SE3Y\\nChildhood and adolescence associated disorders TM unspecified: SE3Z\\nOther specified traditional medicine disorders TM: SE5Y\\nTraditional medicine disorders TM unspecified: SE5Z\\nYang pattern TM: SE70\\nYin pattern TM: SE71\\nHeat pattern TM: SE72\\nCold pattern TM: SE73\\nExcess pattern TM: SE74\\nDeficiency pattern TM: SE75\\nExterior pattern TM: SE76\\nInterior pattern TM: SE77\\nModerate HeatCold pattern TM: SE78\\nMedium ExcessDeficiency pattern TM: SE79\\nTangled cold and heat pattern TM: SE7A\\nOther specified principlebased patterns TM: SE7Y\\nPrinciplebased patterns TM unspecified: SE7Z\\nWind factor pattern TM: SE80\\nCold factor pattern TM: SE81\\nDampness factor pattern TM: SE82\\nDryness factor pattern TM: SE83\\nFireheat factor pattern TM: SE84\\nSummerheat factor pattern TM: SE85\\nPestilent factor pattern TM: SE86\\nOther specified environmental factor patterns TM: SE8Y\\nEnvironmental factor patterns TM unspecified: SE8Z\\nQi deficiency pattern TM: SE90\\nQi stagnation pattern TM: SE91\\nQi uprising pattern TM: SE92\\nQi sinking pattern TM: SE93\\nQi collapse pattern TM: SE94\\nOther specified qi patterns TM: SE9Y\\nQi patterns TM unspecified: SE9Z\\nBlood deficiency pattern TM: SR1T\\nBlood stasis pattern TM: SF01\\nBlood heat pattern TM: SF02\\nBlood cold pattern TM: SF03\\nBlood dryness pattern TM: SF04\\nOther specified blood patterns TM: SF0Y\\nBlood patterns TM unspecified: SF0Z\\nFluid deficiency pattern TM: SF10\\nFluid disturbance pattern TM: SF11\\nDryphlegm pattern TM: SF12\\nDamp phlegm pattern TM: SF13\\nPhlegmfire harassing the heart system pattern TM: SF14\\nWindphlegm pattern TM: SF15\\nOther specified fluid patterns TM: SF1Y\\nFluid patterns TM unspecified: SF1Z\\nEssence deficiency pattern TM: SF20\\nOther specified essence patterns TM: SF2Y\\nEssence patterns TM unspecified: SF2Z\\nOther specified body constituents patterns TM: SF4Y\\nBody constituents patterns TM unspecified: SF4Z\\nLiver yin deficiency pattern TM: SF50\\nLiver yang deficiency pattern TM: SF51\\nLiver yang ascendant hyperactivity pattern TM: SF52\\nLiver qi deficiency pattern TM: SF53\\nLiver blood deficiency pattern TM: SF54\\nLiver depression and blood stasis pattern TM: SF55\\nLiver wind stirring the interior pattern TM: SF56\\nLiver qi stagnation pattern TM: SF57\\nLiver fire flaming upward pattern TM: SF58\\nLiver heat stirring wind pattern TM: SF59\\nLivergallbladder dampnessheat pattern TM: SF5A\\nLiver meridian dampnessheat pattern TM: SF5B\\nLiver meridian cold stagnation pattern TM: SF5C\\nGallbladder qi deficiency pattern TM: SF5D\\nGallbladder depression with phlegm harassment pattern TM: SF5E\\nGallbladder heat pattern TM: SF5F\\nGallbladder cold pattern TM: SF5G\\nLiver and kidney yin deficiency pattern TM: SF5H\\nDisharmony of liver and spleen systems pattern TM: SF5J\\nDisharmony of liver and stomach systems pattern TM: SF5K\\nLiver fire invading the stomach system pattern TM: SF5L\\nLiver fire invading the lung system pattern TM: SF5M\\nOther specified liver system patterns TM: SF5Y\\nLiver system patterns TM unspecified: SF5Z\\nHeart qi deficiency pattern TM: SF60\\nHeart blood deficiency pattern TM: SF61\\nDual deficiency of heart qi and blood pattern TM: SF62\\nHeart meridian obstruction pattern TM: SF63\\nHeart yin deficiency pattern TM: SF64\\nDeficiency of heart qi and yin pattern TM: SF65\\nHeart yang deficiency pattern TM: SF66\\nHeart yang collapse pattern TM: SF67\\nHeart fire flaming upward pattern TM: SF68\\nFire harassing heart spirit pattern TM: SF69\\nWater qi intimidating the heart system pattern TM: SF6A\\nHeart spirit restlessness pattern TM: SF6B\\nAnxiety damaging the spirit pattern TM: SF6C\\nSmall intestine qi stagnation pattern TM: SF6D\\nSmall intestine excess heat pattern TM: SF6E\\nSmall intestine deficiency cold pattern TM: SF6F\\nHeart and liver blood deficiency pattern TM: SF6G\\nHeart and gallbladder qi deficiency pattern TM: SF6H\\nHeart and spleen systems deficiency pattern TM: SF6J\\nHeart and lung qi deficiency pattern TM: SF6K\\nHeart and kidney systems disharmony pattern TM: SF6L\\nHeart and kidney yang deficiency pattern TM: SF6M\\nOther specified heart system patterns TM: SF6Y\\nHeart system patterns TM unspecified: SF6Z\\nSpleen qi deficiency pattern TM: SF70\\nSpleen qi sinking pattern TM: SF71\\nSpleen deficiency with qi stagnation pattern TM: SF72\\nSpleen deficiency with food retention pattern TM: SF73\\nSpleen failing to control the blood pattern TM: SF74\\nSpleen deficiency and blood depletion pattern TM: SF75\\nSpleen yin deficiency pattern TM: SF76\\nSpleen yang deficiency pattern TM: SF77\\nDampnessheat encumbering the spleen system pattern TM: SF78\\nSpleen deficiency with dampness accumulation pattern TM: SF79\\nSpleen deficiency with water flooding pattern TM: SF7A\\nColddampness encumbering the spleen system pattern TM: SF7B\\nStomach qi deficiency pattern TM: SF7C\\nStomach qi uprising pattern TM: SF7D\\nStomach yin deficiency pattern TM: SF7E\\nStomach heat pattern TM: SF7F\\nDampness in the intestines pattern TM: SF7G\\nCold invading the stomach system pattern TM: SF7H\\nIntestine cold stagnation pattern TM: SF7J\\nAnxiety damaging the spleen system pattern TM: SF7K\\nLung and spleen deficiency pattern TM: SF7L\\nSpleen and kidney yang deficiency pattern TM: SF7M\\nOther specified spleen system patterns TM: SF7Y\\nSpleen system patterns TM unspecified: SF7Z\\nLung qi deficiency pattern TM: SF80\\nLung yin deficiency pattern TM: SF81\\nLung and kidney yin deficiency pattern TM: SF82\\nLung qi and yin deficiency pattern TM: SF83\\nLung yang deficiency pattern TM: SF84\\nCold phlegm obstructing the lung pattern TM: SF85\\nTurbid phlegm accumulation in the lung pattern TM: SF86\\nExterior cold with lung heat pattern TM: SF87\\nIntense congestion of lung heat pattern TM: SF88\\nPhlegm heat obstructing the lung pattern TM: SF89\\nWindheat invading the lung pattern TM: SF8A\\nLung heat transmitting into the intestine pattern TM: SF8B\\nWindcold fettering the lung pattern TM: SF8C\\nDryness invading the lung pattern TM: SF8D\\nLung dryness with intestinal obstruction pattern TM: SF8E\\nLarge intestine excess heat pattern TM: SF8F\\nLarge intestine dampness heat pattern TM: SF8G\\nLarge intestine fluid deficiency pattern TM: SF8H\\nLarge intestine deficiency cold pattern TM: SF8J\\nOther specified lung system patterns TM: SF8Y\\nLung system patterns TM unspecified: SF8Z\\nKidney qi deficiency pattern TM: SF90\\nKidney failing to receive qi pattern TM: SF91\\nKidney qi deficiency with water retention pattern TM: SF92\\nKidney yin deficiency pattern TM: SF93\\nKidney yin and yang deficiency pattern TM: SF94\\nKidney deficiency with marrow depletion pattern TM: SF95\\nKidney essence deficiency pattern TM: SF96\\nKidney yang deficiency pattern TM: SF97\\nFear damaging the kidney system pattern TM: SF98\\nBlood and heat accumulation in the uterus pattern TM: SF99\\nPhlegm obstructing the uterus pattern TM: SF9A\\nDampnessheat in the uterus pattern TM: SF9B\\nCold stagnation in the uterus pattern TM: SF9C\\nUterine deficiency cold pattern TM: SF9D\\nBlood accumulation in the bladder pattern TM: SF9E\\nBladder heat accumulation pattern TM: SF9F\\nBladder dampnessheat pattern TM: SF9G\\nBladder water accumulation pattern TM: SF9H\\nBladder deficiency cold pattern TM: SF9J\\nOther specified kidney system patterns TM: SF9Y\\nKidney system patterns TM unspecified: SF9Z\\nOther specified organ system patterns TM: SG1Y\\nOrgan system patterns TM unspecified: SG1Z\\nLung meridian pattern TM: SG20\\nLarge intestine meridian pattern TM: SG21\\nStomach meridian pattern TM: SG22\\nSpleen meridian pattern TM: SG23\\nHeart meridian pattern TM: SG24\\nSmall intestine meridian pattern TM: SG25\\nBladder meridian pattern TM: SG26\\nKidney meridian pattern TM: SG27\\nPericardium meridian pattern TM: SG28\\nTriple energizer meridian pattern TM: SG29\\nGallbladder meridian pattern TM: SG2A\\nLiver meridian pattern TM: SG2B\\nOther specified main Meridian Patterns TM: SG2Y\\nMain Meridian Patterns TM unspecified: SG2Z\\nGovernor vessel pattern TM: SG30\\nConception vessel pattern TM: SG31\\nYin heel vessel pattern TM: SG32\\nYang heel vessel pattern TM: SG33\\nYin link vessel pattern TM: SG34\\nYang link vessel pattern TM: SG35\\nThoroughfare vessel pattern TM: SG36\\nBelt vessel pattern TM: SG37\\nOther specified extra Meridian Patterns TM: SG3Y\\nExtra Meridian Patterns TM unspecified: SG3Z\\nOther specified meridian and collateral patterns TM: SG5Y\\nMeridian and collateral patterns TM unspecified: SG5Z\\nEarly yang stage pattern TM: SG60\\nMiddle yang stage pattern TM: SG61\\nLate yang stage pattern TM: SG62\\nEarly yin stage pattern TM: SG63\\nMiddle yin stage pattern TM: SG64\\nLate yin stage pattern TM: SG65\\nOther specified six stage patterns TM: SG6Y\\nSix stage patterns TM unspecified: SG6Z\\nUpper energizer stage patterns TM: SG70\\nMiddle energizer stage patterns TM: SG71\\nLower energizer stage patterns TM: SG72\\nOther specified triple energizer stage patterns TM: SG7Y\\nTriple energizer stage patterns TM unspecified: SG7Z\\nDampness obstructing the defense yang pattern TM: SG80\\nHeat attacking the lung defense pattern TM: SG81\\nOther specified defense phase patterns TM: SG8Y\\nDefense phase patterns TM unspecified: SG8Z\\nHeat entering the qi phase pattern TM: SG90\\nQi phase dampness and heat pattern TM: SG91\\nDampness obstructing the qi phase pattern TM: SG92\\nOther specified qi phase patterns TM: SG9Y\\nQi phase patterns TM unspecified: SG9Z\\nNutrient qi and defense qi disharmony pattern TM: SH00\\nHeat in the nutrient phase patternTM: SH01\\nHeat entering the nutrient and blood phase pattern TM: SH02\\nOther specified nutrient phase patterns TM: SH0Y\\nNutrient phase patterns TM unspecified: SH0Z\\nBlood phase pattern TM: SH10\\nHeat entering the blood phase patternTM: SH11\\nOther specified blood phase patterns TM: SH1Y\\nBlood phase patterns TM unspecified: SH1Z\\nOther specified four phase patterns TM: SH3Y\\nFour phase patterns TM unspecified: SH3Z\\nLarge yang type exterior origin lower back pattern TM: SH40\\nLarge yang type interior origin small intestine pattern TM: SH41\\nLarge yang type exterior interior combined pattern TM: SH42\\nOther specified large yang type patterns TM: SH4Y\\nLarge yang type patterns TM unspecified: SH4Z\\nSmall yang type lesser yang wind damage pattern TM: SH50\\nSmall yang type yin depletion pattern TM: SH51\\nSmall yang type chest heat congested pattern TM: SH52\\nSmall yang type yin deficit pattern TM: SH53\\nSmall yang type exterior interior combined pattern TM: SH54\\nOther specified small yang type patterns TM: SH5Y\\nSmall yang type patterns TM unspecified: SH5Z\\nLarge yin type supraspinal exterior pattern TM: SH60\\nLarge yin type esophagus cold pattern TM: SH61\\nLarge yin type liver heat pattern TM: SH62\\nLarge yin type dryness heat pattern TM: SH63\\nLarge yin type exterior Interior combined pattern TM: SH64\\nOther specified large yin type patterns TM: SH6Y\\nLarge yin type patterns TM unspecified: SH6Z\\nSmall yin type congestive hyperpsychotic pattern TM: SH70\\nSmall yin type yang depletion pattern TM: SH71\\nSmall yin type greater yin pattern TM: SH72\\nSmall yin type lesser yin pattern TM: SH73\\nSmall yin type exterior interior combined pattern TM: SH74\\nOther specified small yin type patternsTM: SH7Y\\nSmall yin type patternsTM unspecified: SH7Z\\nOther specified four constitution medicine patterns TM: SH9Y\\nFour constitution medicine patterns TM unspecified: SH9Z\\nOther specified traditional medicine patterns TM: SJ1Y\\nTraditional medicine patterns TM unspecified: SJ1Z\\nCephalalgia disorder TM: SK00\\nVertigo and giddiness disorder TM: SK10\\nOther specified nervous system disorders TM: SK1Y\\nNervous system disorders TM unspecified: SK1Z\\nFacial palsy disorder TM: SK20\\nParaplegia disorder TM: SK21\\nHemiplegia disorder TM: SK22\\nOther specified paralysis disorders TM: SK2Y\\nParalysis disorders TM unspecified: SK2Z\\nSeizure disorder TM: SK30\\nEpilepsy disorder TM: SK31\\nOther specified paroxysmal disorders TM: SK3Y\\nParoxysmal disorders TM unspecified: SK3Z\\nScalp affliction disorder TM: SK50\\nCervicobrachial pain disorder TM: SK51\\nTremor disorder TM: SK52\\nStammering disorder TM: SK53\\nWeakness of thighs due to vata disorder TM: SK55\\nOther specified head brain nerve and movement disorders TM: SK5Y\\nHead brain nerve and movement disorders TM unspecified: SK5Z\\nOcular hyperemia disorder TM: SK60\\nProlapse iris disorder TM: SK61\\nBlepharitis disorder TM: SK62\\nDay blindness disorder TM: SK63\\nCataract disorder TM: SK65\\nConjunctivitis disorder TM: SK66\\nCorneal disorder TM: SK67\\nTear sac swelling disorder TM: SK68\\nEyelid cyst disorder TM: SK69\\nDry eye disorder TM: SK6A\\nEctropion disorder TM: SK6B\\nPterygium disorder TM: SK6C\\nLacrimation disorder TM: SK6D\\nTrichiasis disorder TM: SK6E\\nEyelid tumour disorder TM: SK6F\\nHard swelling of eyelid disorder TM: SK6G\\nEyelid wart disorder TM: SK6H\\nExcessive blinking disorder TM: SK6J\\nEyelid haematoma disorder TM: SK6K\\nPtosis disorder TM: SK6L\\nSticky eyelids disorder TM: SK6M\\nChalazion disorder TM: SK6N\\nStye disorder TM: SK6P\\nPtilosis disorder TM: SK6Q\\nNoninflammatory swelling of eye disorder TM: SK6R\\nPeriorbital polyp disorder TM: SK6S\\nPhlyctenular nodule disorder TM: SK6T\\nTrachoma disorder TM: SK6U\\nPanopthalmitis disorder TM: SK6W\\nPhthisis bulbi disorder TM: SK6X\\nOther specified eye disorders TM: SK7Y\\nEye disorders TM unspecified: SK7Z\\nEar abscess disorder TM: SK80\\nDeafness disorder TM: SK81\\nOtorrhoea disorder TM: SK82\\nPruritus of ear disorder TM: SK83\\nDysacousia disorder TM: SK84\\nImpacted cerumen disorder TM: SK85\\nOtalgia disorder TM: SK87\\nOtitis disorder TM: SK88\\nPustules of pinna disorder TM: SK89\\nOther specified ear disorders TM: SK8Y\\nEar disorders TM unspecified: SK8Z\\nEpistaxis disorder TM: SK90\\nAnosmia disorder TM: SK91\\nDry nose disorder TM: SK92\\nAtrophic rhinitis disorder TM: SK93\\nNasal polyp disorder TM: SK94\\nRhinitis disorder TM: SK95\\nCoryza and catarrh disorder TM: SK96\\nNasal obstruction disorder TM: SK97\\nOzaena disorder TM: SK98\\nSinusitis disorder TM: SK99\\nAdenoiditis disorder TM: SK9A\\nOther specified nose disorders TM: SK9Y\\nNose disorders TM unspecified: SK9Z\\nThroat tumour disorder TM: SL00\\nRetropharyngeal abscess disorder TM: SL01\\nHoarseness of voice disorder TM: SL02\\nIndistinctabnormal voice disorder TM: SL03\\nSevere throat inflammation disorder TM: SL04\\nPharyngitis disorder TM: SL05\\nSpeech disorder TM: SL07\\nLymphadenopathy in throat region disorder TM: SL08\\nLaryngitis disorder TM: SL09\\nOther specified neck and throat disorders TM: SL0Y\\nNeck and throat disorders TM unspecified: SL0Z\\nExcessive sneezing disorder TM: SL20\\nHypernasal speech disorder TM: SL21\\nOther specified eye ear nose throat and neck disorders TM: SL2Y\\nEye ear nose throat and neck disorders TM unspecified: SL2Z\\nBronchial asthma disorder TM: SL40\\nCough disorder TM: SL41\\nDyspnoea disorder TM: SL42\\nOther specified respiratory system disorders TM: SL4Y\\nRespiratory system disorders TM unspecified: SL4Z\\nSlow heart disorder TM: SL60\\nHeart pain disorder TM: SL61\\nPalpitation disorder TM: SL62\\nOther specified heart disorders TM: SL6Y\\nHeart disorders TM unspecified: SL6Z\\nVaricose veins disorder TM: SL70\\nVaricose ulcer disorder TM: SL71\\nThickened arteries disorder TM: SL72\\nOther specified circulatory disorders TM: SL7Y\\nCirculatory disorders TM unspecified: SL7Z\\nAnaemia disorder TM: SL80\\nBleeding disorder disorder TM: SL81\\nOther specified blood related disorders TM: SL8Y\\nBlood related disorders TM unspecified: SL8Z\\nLymphadenopathy disorder TM: SM00\\nElephantiasis disorder TM: SM01\\nOther specified heart blood and circulatory disorders TM: SM0Y\\nHeart blood and circulatory disorders TM unspecified: SM0Z\\nStomatitis disorder TM: SM10\\nDental abscess disorder TM: SM11\\nBruxism disorder TM: SM12\\nPyorrhoea disorder TM: SM13\\nGingivitis disorder TM: SM14\\nHalitosis disorder TM: SM15\\nSialorrhoea disorder TM: SM16\\nPalatitis disorder TM: SM17\\nUvulitis disorder TM: SM18\\nLudwigs angina disorder TM: SM19\\nOdontalgia disorder TM: SM1A\\nBleeding gum disorder TM: SM1B\\nRanula disorder TM: SM1C\\nParotitis disorder TM: SM1D\\nDental caries disorder TM: SM1E\\nDental plaque disorder TM: SM1F\\nDiscolouration of teeth disorder TM: SM1G\\nOdontoseisis disorder TM: SM1H\\nSensitive teeth disorder TM: SM1J\\nLip chapping and bleeding disorder TM: SM1K\\nItchy swollen lip diorder TM: SM1L\\nDry chapped lip disorder TM: SM1M\\nXerostomia disorder TM: SM1N\\nAgeusia disorder TM: SM1P\\nOther specified oral cavity disorders TM: SM1Y\\nOral cavity disorders TM unspecified: SM1Z\\nHaematemesis disorder TM: SM30\\nAbdominal distension disorder TM: SM31\\nAscites disorder TM: SM32\\nVolvulus disorder TM: SM35\\nMalabsorption disorder TM: SM36\\nDiarrhoea disorder TM: SM37\\nDyspepsia disorder TM: SM39\\nHyperacidity disorder TM: SM3A\\nIndigestion disorder TM: SM3B\\nFood stasis indigestion disorder TM: SM3C\\nDuodenal ulcer disorder TM: SM3D\\nGastric ulcer disorder TM: SM3E\\nGastritis disorder TM: SM3F\\nHernia disorder TM: SM3G\\nNausea disorder TM: SM3H\\nRetching disorder TM: SM3J\\nAbdominal lumps disorder TM: SM3K\\nVomiting disorder TM: SM3L\\nOther specified abdominal cavity disorders TM: SM3Y\\nAbdominal cavity disorders TM unspecified: SM3Z\\nHepatomegaly disorder TM: SM42\\nHepatitis disorder TM: SM43\\nSplenomegaly disorder TM: SM44\\nOther specified liver and Spleen disorders TM: SM4Y\\nLiver and Spleen disorders TM unspecified: SM4Z\\nProctalgia disorder TM: SM50\\nAnal fissure disorder TM: SM51\\nFistula in ano disorder TM: SM52\\nHaemorrhoids disorder TM: SM53\\nProctitis disorder TM: SM54\\nRectal prolapse disorder TM: SM55\\nOther specified anorectal disorders TM: SM5Y\\nAnorectal disorders TM unspecified: SM5Z\\nFlank pain disorder TM: SM70\\nAnorexia disorder TM: SM71\\nBowel inflammation disorder TM: SM72\\nInfantile tenesmus disorder TM: SM73\\nHiccough disorder TM: SM74\\nDynamic intestinal obstruction disorder TM: SM75\\nOther specified gastrointestinal disorders TM: SM7Y\\nGastrointestinal disorders TM unspecified: SM7Z\\nRenal abscess disorder TM: SM80\\nRetention of urine disorder TM: SM81\\nInsufficiency of the urinary bladder disorder TM: SM82\\nRenal colic disorder TM: SM83\\nNephritis disorder TM: SM84\\nCystitis disorder TM: SM85\\nWound of the urinary bladder disorder TM: SM86\\nDysuria disorder TM: SM87\\nDribbling of urine disorder TM: SM88\\nThick urine disorder TM: SM89\\nHaematuria disorder TM: SM8A\\nUrinary incontinence disorder TM: SM8B\\nUrinary stone disorder TM: SM8C\\nPolyuria disorder TM: SM8D\\nOliguria disorder TM: SM8E\\nOther specified urinary system disorders TM: SM8Y\\nUrinary system disorders TM unspecified: SM8Z\\nAmenorrhoea disorder TM: SM90\\nEndocervicitis disorder TM: SM91\\nBartholins cyst disorder TM: SM92\\nLeucorrhoea disorder TM: SM93\\nFemale infertility disorder TM: SM94\\nVaginitis disorder TM: SM95\\nDysmenorrhoea disorder TM: SM96\\nHypomenorrhoea disorder TM: SM97\\nDysfunctional uterine bleeding disorder TM: SM98\\nUterine polyps disorder TM: SM99\\nUterine prolapse disorder TM: SM9A\\nVaginismus disorder TM: SM9B\\nMetritis disorder TM: SM9C\\nOther specified female Reproductive System disorders TM: SM9Y\\nFemale Reproductive System disorders TM unspecified: SM9Z\\nBalanitis disorder TM: SN00\\nHydrocele disorder TM: SN01\\nErectile dysfunction disorder TM: SN02\\nOligospermia disorder TM: SN03\\nMustardsize boils on penis disorder TM: SN04\\nOrchitis disorder TM: SN05\\nPenile growth disorder TM: SN06\\nPriapism disorder TM: SN07\\nProstatic enlargement disorder TM: SN08\\nSpermatorrhoea disorder TM: SN09\\nPhimosis disorder TM: SN0A\\nOther specified male Reproductive System disorders TM: SN0Y\\nMale Reproductive System disorders TM unspecified: SN0Z\\nDecreased breastmilk disorder TM: SN10\\nVitiated breast milk disorder TM: SN11\\nRecurrent pregnancy loss disorder TM: SN12\\nOther specified pregnancy and childbirth related disorders TM: SN1Y\\nPregnancy and childbirth related disorders TM unspecified: SN1Z\\nGonorrhoea disorder TM: SN30\\nSyphillis disorder TM: SN31\\nOther specified urinary and reproductive system disorders TM: SN3Y\\nUrinary and reproductive system disorders TM unspecified: SN3Z\\nDermatitis disorder TM: SN40\\nDiscoloration of body disorder TM: SN41\\nDryness of skin disorder TM: SN42\\nEczema disorder TM: SN43\\nFoul body smelling disorder TM: SN44\\nExcess of sweat disorder TM: SN45\\nScabies disorder TM: SN46\\nDracunculosis disorder TM: SN47\\nIntertrigo disorder TM: SN48\\nIntegumentary disorder TM: SN49\\nPsoriasis disorder TM: SN4A\\nIchthyosis disorder TM: SN4B\\nScaling of scalp and forehead skin disorder TM: SN4C\\nVitiligo disorder TM: SN4D\\nLentigo disorder TM: SN4E\\nBirth mark blackish red disorder TM: SN4F\\nMelasma disorder TM: SN4G\\nMole disorder TM: SN4H\\nBlack red skin lesion disorder TM: SN4J\\nUrticaria disorder TM: SN4K\\nWheal disorder TM: SN4L\\nBoil disorder TM: SN4M\\nPrickly heat disorder TM: SN4N\\nPemphigus vulgaris disorder TM: SN4P\\nScar marks disorder TM: SN4Q\\nRoughness of skin disorder TM: SN4R\\nVerruca disorder TM: SN4S\\nHerpes disorder TM: SN4T\\nRing worm infection disorder TM: SN4U\\nAcne disorder TM: SN4V\\nUlcer disorder TM: SN4W\\nOther specified skin disorders TM: SN5Y\\nSkin disorders TM unspecified: SN5Z\\nBrittle nails disorder TM: SN60\\nOther specified nail disorders TM: SN6Y\\nNail disorders TM unspecified: SN6Z\\nFurunculosis of scalp disorder TM: SN70\\nBaldness disorder TM: SN71\\nFolliculitis disorder TM: SN72\\nPremature greying of hair disorder TM: SN73\\nOther specified hair disorders TM: SN7Y\\nHair disorders TM unspecified: SN7Z\\nPatchy alopecia disorder TM: SN90\\nDandruff disorder TM: SN91\\nCarbuncle disorder TM: SN92\\nOther specified skin nail and hair disorders TM: SN9Y\\nSkin nail and hair disorders TM unspecified: SN9Z\\nOsteoporosis disorder TM: SP00\\nOther specified bone disorders TM: SP0Y\\nBone disorders TM unspecified: SP0Z\\nPolyarthritis disorder TM: SP10\\nRheumatism disorder TM: SP11\\nOsteoarthritis disorder TM: SP12\\nHip joint pain disorder TM: SP13\\nGout disorder TM: SP14\\nFrozen shoulder disorder TM: SP15\\nOther specified joint disorders TM: SP1Y\\nJoint disorders TM unspecified: SP1Z\\nMuscle pain twisting disorder TM: SP20\\nAtony disorder TM: SP21\\nOther specified muscle disorders TM: SP2Y\\nMuscle disorders TM unspecified: SP2Z\\nAchillodynia disorder TM: SP40\\nSciatica disorder TM: SP41\\nLumbar spondylosis disorder TM: SP42\\nLumbosacroiliac disorder TM: SP43\\nTorticollis disorder TM: SP44\\nCervical spondylosis disorder TM: SP45\\nOther specified bone joint and muscle disorders TM: SP4Y\\nBone joint and muscle disorders TM unspecified: SP4Z\\nEnteric fever disorder TM: SP50\\nFever disorder TM: SP51\\nFever disorder with excessive salivation TM: SP52\\nHigh fever disorder with yellow discouloration TM: SP53\\nFever with body pain disorder TM: SP54\\nFever with chills disorder TM: SP55\\nHigh grade fever disorder TM: SP56\\nIntermittent fever disorder TM: SP57\\nContinuous fever disorder TM: SP58\\nFever disorder due to external factor TM: SP59\\nInflammation with morbid matter disorder TM: SP5A\\nOther specified febricity disorders TM: SP5Y\\nFebricity disorders TM unspecified: SP5Z\\nDiabetes mellitus disorder TM: SP60\\nEmaciation disorder TM: SP61\\nHigh fat disorder TM: SP62\\nPolydipsia disorder TM: SP63\\nObesity disorder TM: SP64\\nOther specified metabolic disorders TM: SP6Y\\nMetabolic disorders TM unspecified: SP6Z\\nLipoma disorder TM: SP70\\nBenign tumour disorder TM: SP71\\nDeep rooted spreading tumour disorder TM: SP72\\nOther specified tumours disorders TM: SP7Y\\nTumours disorders TM unspecified: SP7Z\\nAbscess disorder TM: SP90\\nGeneralised oedema disorder TM: SP91\\nOedema disorder TM: SP92\\nImpaired immunity disorder TM: SP93\\nInflammation disorder TM: SP94\\nExcessive yawning disorder TM: SP95\\nLaziness disorder TM: SP96\\nSevere fatigue disorder TM: SP97\\nPruritus disorder TM: SP99\\nGeneral debility disorder TM: SP9A\\nOther specified disorders affecting the whole body TM: SP9Y\\nDisorders affecting the whole body TM unspecified: SP9Z\\nDelirium disorder TM: SQ00\\nHallucination disorder TM: SQ01\\nHysteria disorder TM: SQ02\\nInsanity disorder TM: SQ03\\nDepressive disorder TM: SQ04\\nLack of concentration confusion disorder TM: SQ05\\nOther specified mental disorders TM: SQ0Y\\nMental disorders TM unspecified: SQ0Z\\nAnxiety ephemeral fever disorder TM: SQ10\\nOther specified emotional disorders TM: SQ1Y\\nEmotional disorders TM unspecified: SQ1Z\\nAlcoholism disorder TM: SQ20\\nEgomania disorder TM: SQ21\\nNon alcoholic intoxication disorder TM: SQ22\\nPanic attack disorder TM: SQ23\\nOther specified behavioural disorders TM: SQ2Y\\nBehavioural disorders TM unspecified: SQ2Z\\nHypersomnia disorder TM: SQ40\\nLycanthropy disorder TM: SQ41\\nOther specified mental emotional and behavioural disorders TM: SQ4Y\\nMental emotional and behavioural disorders TM unspecified: SQ4Z\\nWorm infestation disorder TM: SQ50\\nOther specified infestation disorders TM: SQ5Y\\nInfestation disorders TM unspecified: SQ5Z\\nPseudo poisoning disorder TM: SQ60\\nArtificial poison disorder TM: SQ61\\nOther specified poisoning disorders TM: SQ6Y\\nPoisoning disorders TM unspecified: SQ6Z\\nInadequate diet disorders TM: SQ80\\nOther specified external factors disorders TM: SQ8Y\\nExternal factors disorders TM unspecified: SQ8Z\\nMarasmus disorder TM: SR00\\nBed wetting disorder TM: SR01\\nInfantile dysentry disorder TM: SR02\\nInfantile epilepsy disorder TM: SR03\\nOphthalmia neonatarum disorder TM: SR04\\nChildhood malnutrition disorder TM: SR05\\nOral thrush in babies disorder TM: SR06\\nOther specified childhood disorders TM: SR0Y\\nChildhood disorders TM unspecified: SR0Z\\nVitiation of vta pattern TM: SR10\\nAccumulation of Vata pattern TM: SR11\\nAggravation of vata pattern TM: SR12\\nSpreading of vata pattern TM: SR13\\nDepletion of vata pattern TM: SR14\\nVitiation of pitta pattern TM: SR15\\nAccumulation of pitta pattern TM: SR16\\nAggravation of pitta pattern TM: SR17\\nSpreading of pitta pattern TM: SR18\\nDepletion of pitta pattern TM: SR19\\nVitiation of kapha pattern TM: SR1A\\nAccumulation of kapha pattern TM: SR1B\\nAggravation of kapha pattern TM: SR1C\\nSpreading of kapha pattern TM: SR1D\\nDepletion of kapha pattern TM: SR1E\\nIncrease of Vai pattern TM: SR1F\\nIncrease of Aal pattern TM: SR1G\\nIncrease of Aiyam pattern TM: SR1H\\nDecrease of Vai pattern TM: SR1J\\nDecrease of Aal pattern TM: SR1K\\nDecrease of Aiyam pattern TM: SR1L\\nPredominance of Dam pattern TM: SR1M\\nPredominance of afr pattern TM: SR1N\\nPredominance of Balgham pattern TM: SR1P\\nPredominance of Sawd pattern TM: SR1Q\\nBlood thickening pattern TM: SR1R\\nBlood thinning pattern TM: SR1S\\nBlood hyperviscosity pattern TM: SR1U\\nSpoilage of humors pattern TM: SR1V\\nBurning of humors pattern TM: SR1W\\nThickening of humors pattern TM: SR1X\\nPattern of occlusion TM: SR20\\nOther specified functional elements and humoral derangement patterns TM: SR2Y\\nFunctional elements and humoral derangement patterns TM unspecified: SR2Z\\nVitiation of primary structural components of the body pattern TM: SR40\\nAggravation of primary circulating nutrient fluid pattern TM: SR41\\nDepletion of primary circulating nutrient fluid pattern TM: SR42\\nMorbid increase of blood pattern TM: SR43\\nDepletion of blood pattern TM: SR44\\nExcessive increase of muscular tissues pattern TM: SR45\\nDepletion of muscular tissues pattern TM: SR46\\nIncrease of adipose tissues pattern TM: SR47\\nDepletion of adipose tissues pattern TM: SR48\\nIncrease of bone tissues pattern TM: SR49\\nDepletion of bone tissues pattern TM: SR4A\\nIncrease of bone marrow pattern TM: SR4B\\nDepletion of bone marrow pattern TM: SR4C\\nIncrease of reproductive tissues and semen pattern TM: SR4D\\nDepletion of reproductive tissues and semen pattern TM: SR4E\\nDiminution of Ojas pattern TM: SR4F\\nDerangement of Ojas pattern TM: SR4G\\nDislodgement of Ojas pattern TM: SR4H\\nIncreased menstrual flow pattern TM: SR4J\\nDiminution of menstrual flow pattern TM: SR4K\\nIncreased secretion of breast milk pattern TM: SR4L\\nDecreased secretion of breast milk pattern TM: SR4M\\nDerangement of channels carrying essense of digested food pattern TM: SR50\\nDerangement of channels enriching blood pattern TM: SR51\\nDerangement of channels enriching muscle tissue pattern TM: SR52\\nDerangement of channels carrying fat pattern TM: SR53\\nDerangement of channels enriching bone pattern TM: SR54\\nDerangement of channels enriching bone marrow pattern TM: SR55\\nDerangement of channels enriching seminal fluid pattern TM: SR56\\nDerangement of channels enriching vital life force pattern TM: SR57\\nDerangement of channels for fluid circulation pattern TM: SR58\\nDerangement of digestive tract pattern TM: SR59\\nDerangement of channels of faeces pattern TM: SR5A\\nDerangement of urinary tract pattern TM: SR5B\\nDerangement of channels producing sweat pattern TM: SR5C\\nDerangement of channels enriching breast milk pattern TM: SR5D\\nDerangement of mind related channels pattern TM: SR5E\\nOther specified derangement of channels pattern TM: SR5Y\\nDerangement of channels pattern TM unspecified: SR5Z\\nIncrease of female reproductive tissue pattern TM: SR60\\nDecrease of female reproductive tissue pattern TM: SR61\\nPattern resulting in abnormal number of organs and appendages TM: SR62\\nPattern of abnormal positioning of organs and appendages TM: SR63\\nPattern of abnormal relative position of organs TM: SR64\\nLoss of continuity pattern TM: SR65\\nR pattern TM: SR66\\nBukhrt pattern TM: SR67\\nCompound pattern TM: SR68\\nPattern of quantity TM: SR69\\nOther specified physical constituent derangement patterns TM: SR6Y\\nPhysical constituent derangement patterns TM unspecified: SR6Z\\nMorbid increase of feces pattern TM: SR80\\nDepletion of faeces pattern TM: SR81\\nExcessive urine pattern TM: SR82\\nReduced urine pattern TM: SR83\\nHyperhidrosis pattern TM: SR84\\nAnhidrosis pattern TM: SR85\\nFaeces with undigested food residues pattern TM: SR86\\nUrine of over heat pattern TM: SR87\\nUrine colour of excessive cold pattern TM: SR88\\nUrine colour of excessive depravement of Vai Aal and Aiyam pattern TM: SR89\\nUrine like colour of rawmeat washings pattern TM: SR8A\\nDelayed passing of stool pattern TM: SR8B\\nDry stool pattern TM: SR8C\\nLarger quantity of stool pattern TM: SR8D\\nSharp smelling sweat pattern TM: SR8E\\nSour smelling sweat pattern TM: SR8F\\nSweat of thick consistency pattern TM: SR8G\\nSweat of thin consistency pattern TM: SR8H\\nLack of sweat pattern TM: SR8J\\nExcess of sputum pattern TM: SR8K\\nLack of sputum pattern TM: SR8L\\nModerate quantity of sputum during convalescence pattern TM: SR8M\\nExcess of sweat pattern due to decreased vitality TM: SR8N\\nOther specified excretory products derangement patterns TM: SR8Y\\nExcretory products derangement patterns TM unspecified: SR8Z\\nDerangement of digestive power pattern TM: SS10\\nIrregular digestive power pattern TM: SS11\\nElevated digestive power pattern TM: SS12\\nSubdued digestive power pattern TM: SS13\\nHighly elevated digestive power pattern TM: SS14\\nState of incomplete digestion transformation or metabolism pattern TM: SS15\\nNatural digestive fire pattern TM: SS16\\nStrong digestive fire pattern TM: SS17\\nToxic digestive fire pattern TM: SS18\\nWeak digestive fire pattern TM: SS19\\nOther specified digestive fire based patterns TM: SS1Y\\nDigestive fire based patterns TM unspecified: SS1Z\\nSuppression of breath pattern TM: SS20\\nSuppression of yawning pattern TM: SS21\\nSuppression of hunger and thirst together pattern TM: SS22\\nSuppression of semen pattern TM: SS23\\nSuppression of cough pattern TM: SS24\\nSuppression of micturition pattern TM: SS25\\nSuppression of sleep pattern TM: SS26\\nSuppression of sneeze pattern TM: SS27\\nSuppression of tears pattern TM: SS28\\nSuppression of vomiting pattern TM: SS29\\nSuppression of stool pattern TM: SS2A\\nSupression of exertional hyperpnea pattern TM: SS2B\\nSuppression of hunger pattern TM: SS2C\\nSuppression of thirst pattern TM: SS2D\\nSuppression of flatus pattern TM: SS2E\\nPattern of humour accumulated with air TM: SS2F\\nPattern of humour accumulated with excess cold TM: SS2G\\nPattern of humour accumulated with excess heat TM: SS2H\\nOther specified chronic accumulation patterns TM: SS2Y\\nChronic accumulation patterns TM unspecified: SS2Z\\nPhysical faculties derangement pattern TM: SS30\\nNutritive faculty derangement pattern TM: SS31\\nCollecting faculty derangement pattern TM: SS32\\nAdhesive faculty derangement pattern TM: SS33\\nAssimilation faculty derangement pattern TM: SS34\\nAbsorptive faculty derangement pattern TM: SS35\\nRetentive faculty derangement pattern TM: SS36\\nDigestive faculty derangement pattern TM: SS37\\nExpulsive faculty derangement pattern TM: SS38\\nGrowth faculty derangement pattern TM: SS39\\nReproductive faculties derangement pattern TM: SS3A\\nVital faculty derangement pattern TM: SS3B\\nPsychic faculties derangement pattern TM: SS3C\\nDebility of organs pattern TM: SS3D\\nInnate heat weakness pattern TM: SS3E\\nDisruption of innate heat pattern TM: SS3F\\nWeakness of psychic spirit pattern TM: SS3G\\nWeakness of natural spirit pattern TM: SS3H\\nWeakness of vital spirit pattern TM: SS3J\\nOther specified power derangement patterns TM: SS3Y\\nPower derangement patterns TM unspecified: SS3Z\\nOther specified power derangement and chronic accumulation patterns TM: SS4Y\\nPower derangement and chronic accumulation patterns TM unspecified: SS4Z\\nVata constitution pattern TM: SS50\\nPitta constitution pattern TM: SS51\\nKapha constitution pattern TM: SS52\\nVataPitta constitution pattern TM: SS53\\nPittaKapha constitution pattern TM: SS54\\nKaphaVata constitution pattern TM: SS55\\nBody constitution with a predominance of all three dosha pattern TM: SS56\\nVai body constitution pattern TM: SS57\\nAal body constitution pattern TM: SS58\\nAiyam body constitution pattern TM: SS59\\nVaipredominant Aal body constitution pattern TM: SS5A\\nVaipredominant Aiyam body constitution pattern TM: SS5B\\nAalpredominant Vai body constitution pattern TM: SS5C\\nAalpredominant Aiyam body constitution pattern TM: SS5D\\nAiyapredominant Aal body constitution pattern TM: SS5E\\nAiyapredominant Vai body constitution pattern TM: SS5F\\nOther specified constitution patterns TM: SS5Y\\nConstitution patterns TM unspecified: SS5Z\\nPersonality with a calm composed mindset TM: SS60\\nPersonality with an agitated reactive mindset TM: SS61\\nPersonality with a confused negative mindset TM: SS62\\nOther specified personality patterns TM: SS6Y\\nPersonality patterns TM unspecified: SS6Z\\nHuman temperament pattern TM: SS70\\nTemperament according to age pattern TM: SS71\\nDam predominant temperament pattern TM: SS72\\nafr predominant temperament pattern TM: SS73\\nBalgham predominant temperament pattern TM: SS74\\nSawd predominant temperament pattern TM: SS75\\nOther specified temperament based patterns TM: SS7Y\\nTemperament based patterns TM unspecified: SS7Z\\nKapha predominant age pattern TM: SS80\\nPitta predominant age pattern TM: SS81\\nVata predominant age pattern TM: SS82\\nChildhood age pattern TM: SS83\\nAdult age pattern TM: SS84\\nOld age pattern TM: SS85\\nHot and moist predominant temperament age pattern TM: SS86\\nHot predominant temperament with lesser degree of moistness age pattern TM: SS87\\nCold and dry predominant temperament age pattern TM: SS88\\nCold predominant temperament with greater degree of dryness age pattern TM: SS89\\nOther specified age dependent patterns TM: SS8Y\\nAge dependent patterns TM unspecified: SS8Z\\nAbnormal temperament pattern TM: ST00\\nSimple morbid temperament pattern TM: ST01\\nSimple abnormal temperament without substance pattern TM: ST02\\nAbnormal hot temperament pattern TM: ST03\\nAbnormal cold temperament pattern TM: ST04\\nAbnormal moist temperament pattern TM: ST05\\nAbnormal dry temperament pattern TM: ST06\\nAbnormal temperament associated with substance pattern TM: ST07\\nAbnormal hot temperament with substance pattern TM: ST08\\nAbnormal cold temperament with substance pattern TM: ST09\\nAbnormal moist temperament with substance pattern TM: ST0A\\nAbnormal dry temperament with substance pattern TM: ST0B\\nCompound morbid temperament pattern TM: ST0C\\nSimple compound abnormal temperament pattern TM: ST0D\\nSimple hot and moist abnormal temperament pattern TM: ST0E\\nSimple hot and dry abnormal temperament pattern TM: ST0F\\nSimple cold and moist abnormal temperament pattern TM: ST0G\\nSimple cold and dry abnormal temperament pattern TM: ST0H\\nCompound abnormal temperament associated with substance pattern TM: ST0J\\nAbnormal hot and moist temperament associated with substance pattern TM: ST0K\\nAbnormal hot and dry temperament associated with substance pattern TM: ST0L\\nAbnormal cold and moist temperament associated with substance pattern TM: ST0M\\nAbnormal cold and dry temperament associated with substance pattern TM: ST0N\\nStable abnormal temperament pattern TM: ST0P\\nUnstable abnormal temperament pattern TM: ST0Q\\nThickening of moisture pattern TM: ST0R\\nPresence of foreign moisture pattern TM: ST0S\\nThinning of moistures pattern TM: ST0T\\nInfection of moistures pattern TM: ST0U\\nChange of temperament of psychic R pattern TM: ST0V\\nPredominance of hotness pattern TM: ST0W\\nPredominance of coldness pattern TM: ST0X\\nPredominance of moistness pattern TM: ST10\\nPredominance of dryness pattern TM: ST11\\nOther specified body constitution and temperament patterns TM: ST1Y\\nBody constitution and temperament patterns TM unspecified: ST1Z\\nInjury pattern in the varmam or marmam TM: ST20\\nOther specified varmam and Marmam patterns TM: ST2Y\\nVarmam and Marmam patterns TM unspecified: ST2Z\\nAttention functions WHODAS: VD00\\nMemory functions WHODAS: VD01\\nSolving problems WHODAS: VD02\\nBasic learning WHODAS: VD03\\nCommunicating with receiving spoken messages WHODAS: VD04\\nConversation WHODAS: VD05\\nMaintaining a standing position WHODAS: VD10\\nChanging body position standing WHODAS: VD11\\nMoving around within the home WHODAS: VD12\\nMoving around outside the home and other buildings WHODAS: VD13\\nWalking WHODAS: VD14\\nWashing oneself WHODAS: VD20\\nDressing WHODAS: VD21\\nEating WHODAS: VD22\\nCarrying out daily routine WHODAS: VD23\\nRelating with strangers WHODAS: VD30\\nInformal relationship with friends maintaining WHODAS: VD31\\nFamily relationships WHODAS: VD32\\nInformal relationship with friends making new friends WHODAS: VD33\\nIntimate relationships WHODAS: VD34\\nTaking care of household responsibilities WHODAS: VD40\\nDoing most important household tasks WHODAS: VD41\\nDoing housework WHODAS: VD42\\nGetting all needed housework done WHODAS: VD42.0\\nGetting household work done quickly WHODAS: VD42.1\\nOther specified doing housework WHODAS: VD42.Y\\nDoing housework WHODAS unspecified: VD42.Z\\nRemunerative employment WHODAS: VD43\\nDifficulties in daily work or school WHODAS: VD43.0\\nDoing most important work or school task WHODAS: VD43.1\\nGetting all needed work or school work done WHODAS: VD43.2\\nGetting remunerative work or school work done quickly WHODAS: VD43.3\\nOther specified remunerative employment WHODAS: VD43.Y\\nRemunerative employment WHODAS unspecified: VD43.Z\\nRecreation and leisure WHODAS: VD50\\nProblems by barriers WHODAS: VD51\\nHuman rights WHODAS: VD52\\nTime spent on health condition WHODAS: VD53\\nEmotional effect of health condition WHODAS: VD54\\nHealth drain on financial resources WHODAS: VD55\\nHealth problems causing family problems WHODAS: VD56\\nProblems in relaxation or pleasure WHODAS: VD57\\nSeeing and related functions BMDS: VE00\\nHearing and vestibular functions BMDS: VE01\\nEnergy and drive functions BMDS: VE10\\nSleep functions BMDS: VE11\\nEmotional functions BMDS: VE12\\nAttention functions BMDS: VE13\\nMemory functions BMDS: VE14\\nSensation of pain BMDS: VE20\\nEnergy and drive functions: VV00\\nSleep functions: VV01\\nAttention functions: VV02\\nMemory functions: VV03\\nEmotional functions: VV04\\nOther specified mental functions: VV0Y\\nMental functions unspecified: VV0Z\\nSeeing and related functions: VV10\\nHearing and vestibular functions: VV11\\nSensation of pain: VV12\\nOther specified sensory functions and pain: VV1Y\\nSensory functions and pain unspecified: VV1Z\\nVoice functions: VV20\\nOther specified voice and speech functions: VV2Y\\nVoice and speech functions unspecified: VV2Z\\nExercise tolerance functions: VV30\\nOther specified functions of the cardiovascular haematological immunological and respiratory systems: VV3Y\\nFunctions of the cardiovascular haematological immunological and respiratory systems unspecified: VV3Z\\nFunctions related to the digestive system: VV40\\nOther specified functions of the digestive metabolic and endocrine systems: VV4Y\\nFunctions of the digestive metabolic and endocrine systems unspecified: VV4Z\\nUrination functions: VV50\\nSexual functions: VV51\\nOther specified genitourinary and reproductive functions: VV5Y\\nGenitourinary and reproductive functions unspecified: VV5Z\\nMobility of joint functions: VV60\\nMuscle power functions: VV61\\nOther specified neuromusculoskeletal and movementrelated functions: VV6Y\\nNeuromusculoskeletal and movementrelated functions unspecified: VV6Z\\nFunctions of the skin: VV70\\nOther specified functions of the skin and related structures: VV7Y\\nFunctions of the skin and related structures unspecified: VV7Z\\nBasic learning: VV80\\nSolving problems: VV81\\nOther specified learning and applying knowledge: VV8Y\\nLearning and applying knowledge unspecified: VV8Z\\nCarrying out daily routine: VV90\\nHandling stress and other psychological demands: VV91\\nOther specified general tasks and demands: VV9Y\\nGeneral tasks and demands unspecified: VV9Z\\nCommunicating with receiving spoken messages: VW00\\nConversation: VW01\\nOther specified communication: VW0Y\\nCommunication unspecified: VW0Z\\nMaintaining a standing position: VW10\\nTransferring oneself: VW11\\nCarrying moving and handling objects: VW12\\nWalking: VW13\\nMoving around within the home: VW14\\nMoving around using equipment: VW15\\nUsing transportation: VW16\\nOther specified mobility: VW1Y\\nMobility unspecified: VW1Z\\nWashing oneself: VW20\\nCaring for body parts: VW21\\nToileting: VW22\\nDressing: VW23\\nEating: VW24\\nLooking after ones health: VW25\\nOther specified selfcare: VW2Y\\nSelfcare unspecified: VW2Z\\nPreparing meals: VW30\\nDoing housework: VW31\\nAssisting others: VW32\\nOther specified domestic life: VW3Y\\nDomestic life unspecified: VW3Z\\nBasic interpersonal interactions: VW40\\nRelating with strangers: VW41\\nIntimate relationships: VW42\\nOther specified interpersonal interactions and relationships: VW4Y\\nInterpersonal interactions and relationships unspecified: VW4Z\\nRemunerative employment: VW50\\nOther specified major life areas: VW5Y\\nMajor life areas unspecified: VW5Z\\nRecreation and leisure: VW60\\nHuman rights: VW61\\nOther specified community social and civic life: VW6Y\\nCommunity social and civic life unspecified: VW6Z\\nOther specified generic functioning domains: VW8Y\\nGeneric functioning domains unspecified: VW8Z\\nnan: XS8H\\nMild: XS5W\\nModerate: XS0T\\nSevere: XS25\\nProfound: XS2R\\nStage: XS76\\nStage a: XS3T\\nStage b: XS90\\nGrade: XS57\\nPhase: XS47\\nNo problem: XS5C\\nMild problem: XS6Y\\nModerate problem: XS8T\\nSevere problem: XS9D\\nComplete problem: XS91\\nNot applicable: XS5P\\nA Remission  Free of disease: XS0J\\nB Local Disease: XS05\\nLocal limited: XS0E\\nLocally advanced: XS67\\nC Regional disease: XS9S\\nD Distant disease: XS4Z\\nStage I: XS1G\\nStage II: XS4P\\nStage III: XS6H\\nStage IV: XS9R\\nGrade I: XS56\\nGrade II: XS58\\nGrade III: XS7Z\\nGrade IV: XS7M\\nUndetermined grade: XS7H\\nNYHA Class I No limitation of physical activity: XS3A\\nNYHA Class II Slight limitation of physical activity: XS6B\\nNYHA Class III Marked limitation of physical activity: XS9T\\nNYHA Class IV Unable to carry on any physical activity without discomfort: XS9F\\nGOLD  mild FEV  predicted: XS80\\nGOLD  moderate  FEV  predicted: XS7U\\nGOLD  severe  FEV  predicted: XS8K\\nGOLD  very severe FEV  predicted: XS50\\nStage I Asymptomatic incomplete blood vessel obstruction: XS1Y\\nStage II Mild claudication pain in limb: XS5L\\nStage IIA Claudication at a distance   metres: XS5V\\nStage IIB Claudication at a distance   metres: XS6C\\nStage III Rest pain mostly in the feet: XS9L\\nStage IV Necrosis andor gangrene of the limb: XS2J\\nNo endometriosis: XS3V\\nFilmy endometriosis: XS5N\\nDense endometriosis: XS55\\nIncomplete vocal cord paralysis: XS1H\\nPartial vocal cord paralysis: XS66\\nComplete vocal cord paralysis: XS7K\\nMild sepsis: XS5E\\nSevere sepsis: XS65\\nSeptic shock: XS26\\nGrade  Category  Asymptomatic no hemodynamically significant occlusive disease: XS1T\\nGrade  Category  Mild claudication: XS0Q\\nGrade I Category  Moderate claudication: XS2W\\nGrade I Category  Severe claudication: XS51\\nGrade II Category  Ischaemic rest pain: XS8M\\nGrade III Category  Minor tissue loss nonhealing ulcer focal gangrene with diffuse pedal ischaemia: XS6U\\nGrade III Category  Major tissue loss extending above transmetatarsal TM level functional foot no longer salvageable: XS0U\\nNo pain: XS5B\\nMild pain: XS5D\\nModerate pain: XS9Q\\nSevere pain: XS2E\\nNo distress: XS1J\\nMild distress: XS3R\\nModerate distress: XS7C\\nSevere distress: XS7N\\nNo painrelated interference: XS71\\nMild painrelated interference: XS5R\\nModerate painrelated interference: XS2L\\nSevere painrelated interference: XS2U\\nPsychosocial factors present: XS7G\\nNo psychosocial factors present: XS8B\\nUnderweight BMI Below  kgm: XS11\\nNormal weight BMI  kgm: XS43\\nPreobesity BMI  kgm: XS7R\\nObesity class I BMI  kgm: XS3Y\\nObesity class II BMI  kgm: XS6N\\nObesity class III BMI greater than or equal to  kgm: XS2B\\nSingle vessel disease: XS2V\\nMultiple vessel disease: XS8U\\nAnaphylaxis grade: XS85\\nIntermittent: XT5G\\nPersistent: XT6Z\\nPersistent with overlaid attacks: XT5T\\nAsymptomatic: XT3B\\nSubclinical: XT1T\\nActive: XT98\\nEpisodic: XT7X\\nProdromal: XT4M\\nRecurrent: XT44\\nRelapse: XT4D\\nCause of late effect: XT9C\\nAcute: XT5R\\nSubacute: XT1L\\nChronic: XT8W\\nEarly onset: XT2Q\\nImmediate onset: XT46\\nLate onset: XT3R\\nDelayed onset: XT64\\nRapid onset: XT3Z\\nGradual onset: XT42\\nPregnancy: XT0S\\nPostpartum: XT4Z\\nPuerperium: XT1G\\nAntenatal WHO Standard: XT77\\nAntenatal Aus Standard: XT5L\\nAntenatal Can Standard: XT5P\\nAntenatal Ger Standard: XT04\\nAntenatal US Standard: XT9S\\nNeonatal: XT16\\nEarly Neonatal: XT6P\\nLate Neonatal: XT30\\nPerinatal: XT3N\\nInfancy: XT2C\\nChild under: XT4X\\nChild over: XT50\\nMiddle Childhood: XT9V\\nEarly Adolescence: XT7Q\\nAdolescent: XT7M\\nMiddle Adolescence: XT4T\\nLate Adolescence: XT9X\\nYoung Adult: XT15\\nAdult: XT6S\\nEarly Geriatric: XT19\\nLate Geriatric: XT13\\nDuration of pregnancy less than  completed weeks: XT3X\\nDuration of pregnancy  completed weeks: XT84\\nDuration of pregnancy more than  completed weeks: XT6G\\nUnspecified duration of pregnancy: XT6K\\nCongenital: XB8M\\nIatrogenic: XB8D\\nIdiopathic: XB5F\\nFamilial: XB1Y\\nNosocomial: XB25\\nEnvironmental: XB4Q\\nOccupation as primary factor: XB17\\nOccupation as cofactor: XB5G\\nNot occupationrelated: XB80\\nLifestyle: XB5W\\nCommunity acquired: XB22\\nAgeingrelated: XT9T\\nPost traumatic: XB2G\\nGenetic: XB4S\\nHereditary: XB7K\\nNonhereditary: XB7S\\nBacteria: XN74M\\nGram Negative Bacteria: XN5PZ\\nAcinetobacter: XN25B\\nAcinetobacter baumannii: XN8LS\\nAcinetobacter junii: XN5YN\\nAcinetobacter nosocomialis: XN0DS\\nAcinetobacter pittii: XN2QH\\nAnaplasma: XN048\\nAnaplasma phagocytophilum: XN1MH\\nBartonella: XN3NJ\\nBartonella bacilliformis: XN0W4\\nBartonella clarridgeiae: XN3F6\\nBartonella elizabethae: XN5J5\\nBartonella grahamii: XN5SH\\nBartonella henselae: XN862\\nBartonella koehlerae: XN302\\nBartonella quintana: XN14D\\nBartonella rochalimae: XN43H\\nBartonella vinsonii: XN6KD\\nBartonella washoensis: XN94Y\\nBordetella: XN9W3\\nBordetella bronchiseptica: XN173\\nBordetella pertussis: XN23B\\nBordetella parapertussis: XN7LQ\\nBrucella: XN22N\\nBrucella abortus: XN7A8\\nBrucella canis: XN84J\\nBrucella melitensis: XN7ZW\\nBrucella suis: XN3UP\\nBurkholderia: XN01M\\nBurkholderia gladioli: XN351\\nBurkholderia mallei: XN6Y3\\nBurkholderia pseudomallei: XN3LD\\nBurkholderia cepacia complex: XN335\\nBurkholderia stabilis: XN06D\\nBurkholderia anthina: XN0ZW\\nBurkholderia contaminans: XN15B\\nCampylobacter: XN7US\\nCampylobacter coli: XN0BA\\nCampylobacter fetus: XN3EN\\nCampylobacter jejuni: XN4Q5\\nChlamydia: XN27H\\nChlamydia pneumoniae: XN9EE\\nChlamydia psittaci: XN4S7\\nChlamydia trachomatis: XN4Q4\\nCitrobacter: XN0FZ\\nCitrobacter freundii: XN0M3\\nCoxiella: XN5H6\\nCoxiella burnetii: XN0QS\\nEhrlichia: XN9M7\\nEhrlichia canis: XN293\\nEhrlichia chaffeensis: XN4GW\\nEhrlichia ewingii: XN2YH\\nEikenella: XN1VF\\nEnterobacter: XN9W5\\nEnterobacter cloacae: XN3YM\\nEscherichia: XN4WC\\nEscherichia coli: XN6P4\\nEnteroinvasive Escherichia coli: XN88S\\nEnteropathogenic Escherichia coli: XN2U0\\nEnterotoxigenic Escherichia coli: XN81Z\\nShiga toxinproducing Escherichia coli: XN108\\nEnterohaemorrhagic Escherichia coli: XN5NF\\nEnteroaggregative Escherichia coli: XN55V\\nEscherichia hermannii: XN6MP\\nPseudescherichia vulneris: XN2S7\\nFrancisella: XN94G\\nFrancisella philomiragia: XN6HJ\\nFrancisella tularensis: XN0BX\\nFrancisella novicida: XN4ZY\\nFusobacterium: XN4LF\\nFusobacterium necrophorum: XN7B1\\nFusobacterium novum: XN5MA\\nFusobacterium nucleatum: XN4P8\\nFusobacterium polymorphum: XN911\\nHaemophilus: XN2HK\\nHaemophilus ducreyi: XN6MB\\nHaemophilus influenzae: XN1P6\\nHaemophilus influenzae aegyptius: XN1BX\\nHaemophilus influenzae type B: XN0FG\\nHelicobacter: XN6XR\\nHelicobacter bilis: XN0YS\\nHelicobacter bizzozeronii: XN0TD\\nHelicobacter canis: XN42L\\nHelicobacter cinaedi: XN354\\nHelicobacter felis: XN6JN\\nHelicobacter ganmani: XN9X3\\nHelicobacter hepaticus: XN8PN\\nHelicobacter pylori: XN3DY\\nHelicobacter salomonis: XN9D7\\nHelicobacter suis: XN079\\nKlebsiella: XN620\\nKlebsiella granulomatis: XN027\\nKlebsiella oxytoca: XN7WL\\nKlebsiella pneumoniae: XN741\\nKingella kingae: XN7EJ\\nLegionella: XN3SZ\\nLegionella longbeachae: XN14Z\\nLegionella pneumophila: XN9YS\\nLeptospira: XN9RA\\nLeptospira alexanderi: XN1R8\\nLeptospira borgpetersenii: XN7D2\\nLeptospira broomii: XN9K9\\nLeptospira fainei: XN5HC\\nLeptospira inadai: XN20F\\nLeptospira interrogans: XN78P\\nLeptospira kirschneri: XN110\\nLeptospira kmetyi: XN481\\nLeptospira licerasiae: XN6NU\\nLeptospira noguchii: XN4KP\\nLeptospira santarosai: XN01X\\nLeptospira species: XN4FL\\nLeptospira weilii: XN4E7\\nLeptospira wolffii: XN77E\\nLeptospira\\xa0genomospecies  alstonii: XN5UB\\nLeptotrichia: XN2JD\\nLeptotrichia buccalis: XN734\\nLeptotrichia goodfellowii: XN4GY\\nLeptotrichia hofstadii: XN0SF\\nLeptotrichia hongkongensis: XN4SA\\nLeptotrichia shahii: XN7NF\\nLeptotrichia trevisanii: XN6QY\\nLeptotrichia wadei: XN5SN\\nMoraxella: XN90V\\nMorganella: XN8G6\\nMycoplasma: XN1W2\\nMycoplasma fermentans: XN3NR\\nMycoplasma genitalium: XN9UG\\nMycoplasma hyorhinis: XN674\\nMycoplasma penetrans: XN3AD\\nMycoplasma pneumoniae: XN4NV\\nNeisseria: XN69X\\nNeisseria gonorrhoeae: XN59Y\\nNeisseria meningitidis: XN1DV\\nNeisseria meningitidis serogroup A: XN3CR\\nNeisseria meningitidis serogroup B: XN8FU\\nNeisseria meningitidis serogroup C: XN7EM\\nNeisseria meningitidis serogroup W: XN03X\\nNeisseria meningitidis serogroup X: XN0C2\\nNeisseria meningitidis serogroup Y: XN5H0\\nNeorickettsia: XN8ST\\nNeorickettsia sennetsu: XN7C8\\nPasteurella: XN3U2\\nPasteurella multocida: XN30D\\nPleisiomonas: XN1ZM\\nProteus: XN3BS\\nProteus mirabilis: XN9ZF\\nProteus morganii: XN9DS\\nProteus penneri: XN7PE\\nProteus vulgaris: XN118\\nProvidencia: XN7R2\\nProvidencia rettgeri: XN2PG\\nPseudomonas: XN022\\nPseudomonas aeruginosa: XN5L6\\nPseudomonas oryzihabitans: XN3JP\\nPseudomonas mallei: XN52E\\nPseudomonas plecoglossicida: XN8J7\\nPseudomonas pseudomallei: XN8AA\\nRickettsia: XN4YH\\nRickettsia africae: XN9YP\\nRickettsia akari: XN7WV\\nRickettsia australis: XN23V\\nRickettsia conorii: XN8U4\\nRickettsia felis: XN6W8\\nRickettsia helvetica: XN9NE\\nRickettsia hoogstraalii: XN5NY\\nRickettsia japonica: XN3XV\\nRickettsia prowazekii: XN8SY\\nRickettsia rickettsii: XN33Q\\nRickettsia sibirica: XN1N6\\nRickettsia typhi: XN2AR\\nSalmonellae: XN0QE\\nSalmonella enterica spp: XN5VC\\nSalmonella Paratyphi: XN0UV\\nSalmonella paratyphi A: XN1K5\\nSalmonella paratyphi B: XN322\\nSalmonella paratyphi C: XN5TR\\nSalmonella Typhi: XN4AM\\nSalmonella Panama: XN7U5\\nSalmonella Weltevreden: XN97K\\nSalmonella Wandsworth: XN13V\\nSalmonella Virchow: XN3DF\\nSalmonella Give: XN4QY\\nSalmonella Gaminara: XN3AE\\nSalmonella Agona: XN0N5\\nSalmonella Kiambu: XN5SM\\nSalmonella Thompson: XN3TU\\nSalmonella Typhimurium: XN15L\\nSalmonella Saintpaul: XN8SF\\nSalmonella Stanley: XN2MU\\nSalmonella Strathcona: XN0LX\\nSalmonella Senftenberg: XN5WE\\nSalmonella Tennessee: XN291\\nSalmonella Newport: XN87G\\nSalmonella Hartford: XN5TM\\nSalmonella Oranienburg: XN1QX\\nSalmonella Poona: XN2SZ\\nSalmonella Kedougou: XN36N\\nSalmonella Litchfield: XN5LV\\nSalmonella Mbandaka: XN4LH\\nSalmonella Montevideo: XN1FK\\nSalmonella Mikawasima: XN3UH\\nSalmonella Concord: XN7QM\\nSalmonella Cubana: XN8RF\\nSalmonella Infantis: XN39C\\nSalmonella Havana: XN6JL\\nSalmonella Enteritidis: XN1W7\\nSalmonella Bareilly: XN0Q7\\nSalmonella Braenderup: XN4MS\\nSalmonella Brandenburg: XN3KA\\nSalmonella Choleraesuis: XN0NU\\nSalmonella Bredeney: XN910\\nSalmonella Nchanga: XN52S\\nSalmonella Lille: XN8F6\\nSalmonella Sandiego: XN7EC\\nSalmonella enterica subspecies enterica serovar i: XN7PN\\nSalmonella bongori spp: XN2DW\\nSerratia spp: XN71D\\nSerratia marcescens: XN2V6\\nShigella spp: XN7HG\\nShigella flexneri: XN7Y2\\nShigella boydii: XN8RN\\nShigella dysenteriae: XN285\\nShigella sonnei: XN9M9\\nSpirillum: XN23Z\\nSpirillum minus: XN0J7\\nSpirillum pulli: XN78V\\nSpirillum volutans: XN17K\\nSpirillum winogradskyi: XN96A\\nStreptobacillus: XN708\\nStreptobacillus moniliformis: XN91U\\nStenotrophomonas: XN1L0\\nStenotrophomonas maltophilia: XN0AD\\nTreponema: XN36C\\nTreponema carateum: XN76V\\nTreponema pallidum: XN711\\nTreponema pallidum carateum: XN6AL\\nTreponema pallidum endemicum: XN35Z\\nTreponema pallidum pallidum: XN030\\nTreponema pallidum pertenue: XN46P\\nUreaplasma: XN1R2\\nVibrio: XN8RL\\nVibrio cholerae: XN7N1\\nVibrio cholerae O biovar cholerae: XN8P1\\nVibrio cholerae O biovar eltor: XN62R\\nVibrio cholerae O: XN8KD\\nVibrio parahaemolyticus: XN1AA\\nVibrio vulnificus: XN44G\\nYersinia: XN4QG\\nYersinia enterocolitica: XN91V\\nYersinia pestis: XN6QS\\nYersinia pseudotuberculosis: XN6K8\\nBacteroides: XN65H\\nBacteroides fragilis: XN2R7\\nCronobacter: XN9EB\\nCronobacter sakazakii: XN2YF\\nBrevundimonas: XN9AS\\nBrevundimonas diminuta: XN8W4\\nBrevundimonas vesicularis: XN2F0\\nAeromonas: XN1J7\\nAeromonas hydrophila: XN40Z\\nAeromonas caviae: XN0XY\\nHerbaspirillum: XN4X0\\nHerbaspirillum huttiense: XN7QA\\nElizabethkingia: XN706\\nElizabethkingia anophelis: XN6BA\\nElizabethkingia meningoseptica: XN6C4\\nRalstonia: XN15X\\nRalstonia picketti: XN6AH\\nRalstonia mannitolilytica: XN694\\nRalstonia insidiosa: XN9VM\\nRaoultella: XN3NY\\nRaoultella ornithinolytica: XN0MD\\nOrientia: XN6PA\\nOrientia tsutsugamushi: XN675\\nGram Positive Bacteria: XN2QM\\nActinomyces: XN3G0\\nActinomyces gerencseriae: XN0GV\\nActinomyces israelii: XN15T\\nActinomyces species: XN8HN\\nActinomycetales: XN8EK\\nActinomadura: XN8P7\\nBacillus: XN9ZE\\nBacillus anthracis: XN94F\\nBacillus cereus: XN8PY\\nBifidobacterium: XN33F\\nBifidobacterium dentium: XN0PT\\nClostridium: XN198\\nClostridium botulinum: XN2JN\\nClostridium perfringens: XN7J5\\nClostridium sordellii: XN4LP\\nClostridium tetani: XN5NQ\\nCorynebacterium: XN3NT\\nCorynebacterium diphtheriae: XN9N1\\nCorynebacterium minutissimum: XN78S\\nCorynebacterium striatum: XN752\\nCorynebacterium tenuis: XN3MP\\nEnterococcus: XN1F7\\nEnterococcus faecalis: XN2H4\\nEnterococcus faecium: XN51E\\nEnterococcus avium: XN0DT\\nEnterococcus casseliflavus: XN3XY\\nEnterococcus durans: XN724\\nEnterococcus gallinarum: XN8BQ\\nEnterococcus mundtii: XN4ZZ\\nEnterococcus raffinosus: XN3QK\\nErysipelothrix: XN494\\nErysipelothrix rhusiopathiae: XN4FJ\\nListeria: XN4D1\\nListeria ivanovii: XN39H\\nListeria monocytogenes: XN602\\nNocardia: XN20K\\nNocardia asteroides: XN2BK\\nNocardia brasiliensis: XN1LG\\nPropionibacterium: XN5M7\\nPropionibacterium propionicus: XN27L\\nStaphylococcus: XN9ZG\\nStaphylococcus aureus: XN6BM\\nPantonValentine Leukocidinproducing Staphylococcus aureus: XN4B5\\nCoagulasenegative Staphylococci: XN9LM\\nStaphylococcus auricularis: XN0PR\\nStaphylococcus capitis: XN0H1\\nStaphylococcus caprae: XN99G\\nStaphylococcus cohnii: XN95B\\nStaphylococcus epidermidis: XN8KJ\\nStaphylococcus haemolyticus: XN2GD\\nStaphylococcus leei: XN09P\\nStaphylococcus lugdunensis: XN4N7\\nStaphylococcus pasteuri: XN8WC\\nStaphylococcus pettenkoferi: XN6FH\\nStaphylococcus schleiferi: XN9X8\\nStaphylococcus sciuri: XN2HN\\nStaphylococcus simulans: XN7RE\\nStaphylococcus warneri: XN4C9\\nStaphylococcus xylosus: XN7TQ\\nStaphylococcus hominis: XN567\\nStreptococcus: XN3NM\\nAlphahemolytic Streptococcus: XN1V3\\nStreptococcus pneumoniae: XN3PW\\nStreptococcus viridans: XN9LA\\nBetahaemolytic Streptococcus: XN1AF\\nGammahaemolytic Streptococcus: XN2NS\\nStreptococcus group A: XN6LP\\nStreptococcus pyogenes: XN7YG\\nStreptococcus group B: XN2M1\\nStreptococcus agalactiae: XN0KC\\nGroup C Streptococcus: XN518\\nStreptococcus zooepidemicus: XN0TY\\nStreptococcus group D: XN5KC\\nStreptococcus bovis: XN6KJ\\nStreptococcus equinus: XN625\\nGroup E Streptococcus: XN8BJ\\nGroup F Streptococcus: XN6BB\\nGroup G Streptococcus: XN84N\\nStreptococcus dysgalactiae: XN8UN\\nGroup H Streptococcus: XN40Y\\nStreptococcus anginosus: XN39R\\nStreptococcus canis: XN3L7\\nStreptococcus constellatus: XN0FR\\nStreptococcus iniae: XN4PA\\nStreptococcus intermedius: XN67P\\nStreptococcus mitis: XN5BP\\nStreptococcus mutans: XN2RH\\nStreptococcus oralis: XN4B2\\nStreptococcus parasanguinis: XN18T\\nStreptococcus peroris: XN58W\\nStreptococcus pseudopneumoniae: XN6KE\\nStreptococcus ratti: XN5DB\\nStreptococcus salivarius: XN3BQ\\nStreptococcus sanguinis: XN9FP\\nStreptococcus sobrinus: XN0XM\\nStreptococcus suis: XN5SE\\nStreptococcus thermophilus: XN4LM\\nStreptococcus uberis: XN1TV\\nStreptococcus vestibularis: XN0Z2\\nTropheryma: XN7PP\\nTropheryma whipplei: XN5P4\\nClostridioides difficile: XN0SE\\nBacteria neither Gram Negative nor Gram Positive: XN87X\\nBorrelia: XN2DX\\nBorrelia afzelii: XN7GL\\nBorrelia burgdorferi: XN13C\\nBorrelia garinii: XN4VZ\\nBorrelia hermsii: XN3PD\\nBorrelia miyamotoi: XN2P3\\nBorrelia parkeri: XN6VH\\nBorrelia recurrentis: XN5R4\\nBorrelia vincentii: XN140\\nMycobacterium: XN2NR\\nMycobacterium africanum: XN6YB\\nMycobacterium bovis: XN8AB\\nMycobacterium canettii: XN8N3\\nMycobacterium caprae: XN4MR\\nMycobacterium colombiense: XN9H9\\nMycobacterium indicus pranii: XN8FC\\nMycobacterium leprae: XN5TS\\nMycobacterium microti: XN3T2\\nMycobacterium pinnipedii: XN7H2\\nMycobacterium tuberculosis: XN1N2\\nNontuberculous mycobacterium: XN96Q\\nMycobacterium kansasii: XN3L9\\nMycobacterium malmoense: XN5C1\\nMycobacterium xenopi: XN53D\\nMycobacterium asiaticum: XN6PL\\nMycobacterium simiae: XN4MW\\nMycobacterium szulgai: XN975\\nMycobacterium scrofulaceum: XN74T\\nMycobacterium haemophilum: XN7YR\\nMycobacterium fortuitum: XN8ZX\\nMycobacterium marinum: XN8RB\\nMycobacterium ulcerans: XN9M0\\nMycobacterium chelonei: XN3D3\\nMycobacterium avium complex: XN97H\\nMycobacterium avium: XN5LZ\\nMycobacterium avium hominissuis: XN8FF\\nMycobacterium avium paratuberculosis: XN5NW\\nMycobacterium avium silvaticum: XN145\\nMycobacterium intracellulare: XN3ZQ\\nMycobacterium chimaera: XN077\\nMycobacterium abscessus complex: XN4TQ\\nMycobacterium abscessus subsp abscessus: XN7V4\\nMycobacterium abscessus subsp massiliense: XN5SW\\nMycobacterium abscessus subsp bolletii: XN017\\nMycobacterium chelonae: XN44M\\nVirus: XN3BH\\nAdenovirus: XN000\\nAtadenovirus: XN0R0\\nAviadenovirus: XN05K\\nIchtadenovirus: XN728\\nMastadenovirus: XN93P\\nSiadenovirus: XN13L\\nAlphavirus: XN6ME\\nAura virus: XN0SK\\nBabanki virus: XN434\\nBarmah Forest virus: XN5KQ\\nBebaru virus: XN6XS\\nCabassou virus: XN0UF\\nChikungunya virus: XN4ZB\\nEastern equine encephalitis virus: XN78T\\nEverglades virus: XN26A\\nKyzylagach virus: XN87D\\nMayaro virus: XN5ZC\\nMiddelburg virus: XN1VS\\nMosso das Pedras virus: XN34P\\nMucambo virus: XN7PD\\nNdumu virus: XN0H9\\nOckelbo virus: XN9WS\\nonyong nyong virus: XN6AD\\nParamana virus: XN240\\nPixuna virus: XN3YZ\\nRo Negro virus: XN79Q\\nRoss River virus: XN49A\\nSalmon pancreatic disease virus: XN4D3\\nSemliki Forest virus: XN3D4\\nSindbis virus: XN0D6\\nSleeping Disease virus: XN132\\nSouthern elephant seal virus: XN5MK\\nTonate virus: XN4ER\\nTrocara virus: XN2B3\\nVenezuelan equine encephalitis virus: XN445\\nWhataroa virus: XN8PC\\nWestern equine encephalitis virus: XN2CK\\nArbovirus: XN1BE\\nLa Crosse virus: XN5VQ\\nArenavirus: XN8AC\\nChapare virus: XN2WG\\nGuanarito virus: XN56K\\nJunn virus: XN2ZL\\nLassa virus: XN0CU\\nLujo virus: XN77P\\nLymphocytic choriomeningitis virus: XN4ZL\\nMachupo virus: XN45B\\nSabi virus: XN55S\\nBornavirus: XN5VM\\nBorna disease virus: XN395\\nvariegated squirrel bornavirus: XN125\\nBunyavirus: XN7S5\\nAmur virus: XN9UC\\nCrimeanCongo haemorrhagic fever virus: XN17V\\nDobrava virus: XN16H\\ngu virus: XN2QZ\\nHantaan virus: XN3GW\\nKurkino virus: XN8UR\\nMuju virus: XN8AF\\nOrthobunyavirus: XN4S8\\nCristoli virus: XN09U\\nOropouche orthobunyavirus: XN4U2\\nPuumala virus: XN28L\\nSaaremaa virus: XN9PD\\nSeoul virus: XN3PV\\nSochi virus: XN95V\\nSoochong virus: XN0E0\\nTula virus: XN9G5\\nAnajatuba virus: XN2VY\\nAndes virus: XN4AP\\nAraucria virus: XN2C8\\nbayou virus: XN2WJ\\nBermejo virus: XN0A0\\nBlack Creek Canal virus: XN66E\\nBlue River virus: XN8LW\\nCastelo dos Sonhos virus: XN18Y\\nEl Moro Canyon virus: XN6XF\\nJuquitiba virus: XN8G9\\nLaguna Negra virus: XN6P0\\nLechiguanas virus: XN2CJ\\nMaciel virus: XN2BW\\nMonongahela virus: XN3WK\\nMuleshoe virus: XN5SF\\nNew York virus: XN9VX\\nOrn virus: XN9BY\\nParano virus: XN5JV\\nPergamino virus: XN65X\\nRo Mamor virus: XN2VC\\nsin nombre virus: XN7R1\\nTunari virus: XN057\\nAraraquara virus: XN8AQ\\nPhlebovirus: XN5VU\\nPunta Toro virus: XN2YW\\nRift Valley fever phlebovirus: XN7AS\\nSicilian phlebovirus: XN72W\\nNaples phlebovirus: XN7FG\\nToscana phlebovirus: XN3V9\\nDabie bandavirus: XN3BT\\nCalicivirus: XN9RK\\nLagovirus: XN4EB\\nNebovirus: XN8L1\\nNorovirus: XN3Y2\\nSapovirus: XN9EH\\nVesivirus: XN0R6\\nCoronavirus: XN83D\\nHuman coronavirus E: XN0UA\\nHuman coronavirus HKU: XN9KN\\nHuman coronavirus OC: XN7CX\\nMiddle East respiratory syndrome coronavirus: XN3BD\\nPipistrellus bat coronavirus HKU: XN5V7\\nRousettus bat coronavirus HKU: XN1N9\\nSevere Acute Respiratory Syndrome coronavirus: XN1V8\\nTylonycteris bat coronavirus HKU: XN1GJ\\nSARSCoV: XN109\\nSARSCoV Alpha: XN0HL\\nSARSCoV Beta: XN4Q7\\nSARSCoV Gamma: XN5BQ\\nSARSCoV Delta: XN8V6\\nSARSCoV Epsilon: XN1GK\\nSARSCoV Zeta: XN3ZE\\nSARSCoV Eta: XN2V4\\nSARSCoV Theta: XN4Q1\\nSARSCoV Iota: XN3UD\\nSARSCoV Kappa: XN9LB\\nSARSCoV Lambda: XN6AM\\nSARSCoV Mu: XN39J\\nSARSCoV Omicron: XN161\\nBA: XN53K\\nBQ: XN4UD\\nXBB: XN201\\nEG: XN8RW\\nEnterovirus: XN2P0\\nCoxsackievirus: XN3MC\\nEchovirus: XN2TU\\nPoliovirus: XN3M0\\nWild poliovirus type: XN97R\\nCirculating vaccinederived poliovirus type: XN7UU\\nRhinovirus: XN19Z\\nFilovirus: XN6R5\\nGenus Orthoebolavirus: XN2LW\\nEbola virus: XN1EN\\nBundibugyo virus: XN8JT\\nReston virus: XN9QG\\nSudan virus: XN13U\\nTa Forest virus: XN8TT\\nBombali virus: XN12Y\\nGenus Orthomarburgvirus: XN4XZ\\nMarburg virus: XN3F2\\nRavn virus: XN5M2\\nFlavivirus: XN0AC\\nDengue virus: XN2EQ\\nJapanese encephalitis virus: XN9ZK\\nSaint Louis encephalitis virus: XN5QW\\nTickborne encephalitis virus: XN0L1\\nTickborne encephalitis virusEuropean subtype: XN1MT\\nTickborne encephalitis virusFar Eastern subtype: XN8WB\\nTickborne encephalitis virusSiberian subtype: XN4LG\\nWest Nile virus: XN4E1\\nYellow fever virus: XN9S3\\nZika virus: XN1H2\\nRocio virus: XN7C2\\nAlkhurma hemorrhagic fever virus: XN7W2\\nKyasanur Forest disease virus: XN2JR\\nHepatitis virus: XN41M\\nGB virus C: XN5XD\\nHepatitis A virus: XN40D\\nHepatitis B virus: XN0GA\\nHepatitis C virus: XN1EZ\\nHepatitis D virus: XN99N\\nHepatitis E virus: XN7TG\\nHepatitis F virus: XN6BW\\nHuman herpesvirus: XN7V1\\nIctalurvirus: XN6DH\\nPityriasis Rosea virus: XN9QL\\nAlphaherpesvirinae: XN465\\nMardivirus: XN42C\\nHerpes simplex virus: XN5V1\\nVaricella zoster virus: XN0TA\\nIltovirus: XN4P4\\nBetaherpesvirinae: XN8TA\\nCytomegalovirus: XN3SQ\\nMuromegalovirus: XN5FN\\nRoseolavirus: XN1GF\\nRoseolavirus A: XN9NM\\nRoseolavirus B: XN8AM\\nGammaherpesvirinae: XN2VN\\nEpsteinBarr virus: XN0R2\\nRhadinovirus: XN7NE\\nHuman immunodeficiency virus: XN487\\nHuman immunodeficiency virus type: XN71W\\nHuman papillomavirus: XN3HA\\nHuman Tcell lymphotropic virus: XN1WJ\\nInfluenza virus: XN5SG\\nInfluenza A virus: XN8WJ\\nInfluenza A HN virus: XN0MW\\nInfluenza A H virus: XN71C\\nInfluenza A HNv virus: XN9FE\\nInfluenza A HN pdm virus: XN9SG\\nInfluenza A HpdmN  reassortant influenza virus: XN3UJ\\nSwine influenza A HN virus: XN476\\nInfluenza A HN variant: XN2SA\\nInfluenza A HN Panama virus: XN3UU\\nInfluenza A HN Moscow virus: XN9HE\\nEquine influenza A HN virus: XN81W\\nInfluenza B virus: XN8SG\\nInfluenza C virus: XN8U3\\nInfluenza D virus: XN67Q\\nLyssavirus: XN33B\\nRabies virus: XN796\\nOrthopolyomavirus: XN8R7\\nJohn Cunningham virus: XN7UP\\nParamyxovirus: XN82V\\nHenipavirus: XN98T\\nCedar Virus: XN5PM\\nHendra virus: XN53N\\nNipah virus: XN931\\nHuman metapneumovirus: XN513\\nMeasles virus: XN186\\nMumps virus: XN22H\\nParainfluenza virus: XN6CR\\nRubulavirus: XN4QJ\\nParvovirus: XN7X8\\nErythrovirus: XN8PS\\nBocaparvovirus: XN447\\nPneumovirus: XN8W9\\nHuman respiratory syncytial virus: XN275\\nPolyomavirus: XN9WH\\nBK polyoma virus: XN0TQ\\nPoxvirus: XN7UC\\nOrthopoxvirus: XN32K\\nBuffalopox virus: XN3Y3\\nCowpox virus: XN0AU\\nMonkeypox virus: XN2GM\\nMonkeypox virus Clade I: XN4L3\\nMonkeypox virus Clade Ia: XN9XX\\nMonkeypox virus Clade Ib: XN8ZK\\nMonkeypox virus Clade II: XN1BH\\nMonkeypox virus Clade IIa: XN00B\\nMonkeypox virus Clade IIb: XN7VR\\nVariola virus: XN4Q0\\nVaccinia virus: XN06N\\nParapox virus: XN1M0\\nbovine papular stomatitis virus: XN7JF\\nOrf virus: XN8E5\\npseudocowpox virus: XN8JR\\nYatapox virus: XN0CV\\ntanapox virus: XN0K5\\nyaba monkey tumour virus: XN81C\\nMolluscipoxvirus: XN5G8\\nMolluscum contagiosum virus: XN7YE\\nReovirus: XN22T\\nRetrovirus: XN6FR\\nAlpharetrovirus: XN2R0\\nBetaretrovirus: XN0TH\\nDeltaretrovirus: XN787\\nEpsilonretrovirus: XN6HX\\nGammaretrovirus: XN4K8\\nLentivirus: XN5R7\\nOncovirus: XN6JB\\nRotavirus: XN6N7\\nRotavirus A: XN6TN\\nRotavirus B: XN55H\\nRotavirus C: XN0F5\\nRotavirus D: XN29P\\nRotavirus E: XN71N\\nRubivirus: XN2F7\\nRubella virus: XN2WE\\nAstrovirus: XN7R4\\nVesiculovirus: XN6T9\\nChandipura virus: XN2BR\\nVesicular stomatitis virus: XN9XS\\nFungi: XN8AY\\nAspergillus: XN0WC\\nAspergillus clavatus: XN6Q9\\nAspergillus flavus: XN6B8\\nAspergillus fumigatus: XN5Z7\\nAspergillus terreus: XN25K\\nAspergillus niger: XN7Q2\\nBasidiobolus: XN4XX\\nBasidiobolus ranarum: XN4RM\\nBlastomyces: XN08A\\nBlastomyces dermatitidis: XN14F\\nCandida: XN3CL\\nCandida albicans: XN31P\\nCandida auris: XN72N\\nCandida haemulonii: XN0RY\\nChromomycosis: XN066\\nChrysosporium: XN106\\nChrysosporium parvum: XN8W1\\nCoccidioides: XN7Q9\\nCoccidioides immitis: XN53F\\nCoccidioides posadasii: XN5TT\\nConidiobolus: XN62A\\nConidiobolus coronatus: XN3KM\\nConidiobolus incongruus: XN4AQ\\nCryptococcus: XN69C\\nCryptococcus gattii: XN0LE\\nCryptococcus neoformans: XN3EH\\nDermatophyte fungi: XN7WW\\nAnthropophilic dermatophytes: XN655\\nEpidermophyton floccosum: XN2T0\\nMicrosporum audouinii: XN3YF\\nMicrosporum ferrugineum: XN2R2\\nTrichophyton concentricum: XN8M6\\nTrichophyton gourvilii: XN628\\nTrichophyton interdigitale: XN8BW\\nTrichophyton megninii: XN96H\\nTrichophyton rubrum: XN2JF\\nTrichophyton schoenleinii: XN53A\\nTrichophyton soudanense: XN135\\nTrichophyton tonsurans: XN1K6\\nTrichophyton violaceum: XN31R\\nTrichophyton yaoundei: XN8BF\\nZoophilic dermatophytes: XN2SY\\nMicrosporum canis: XN5ER\\nMicrosporum equinum: XN6NM\\nMicrosporum gallinae: XN5GR\\nMicrosporum nanum: XN3WX\\nMicrosporum persicolor: XN7JK\\nTrichophyton equinum: XN3YG\\nTrichophyton mentagrophytes: XN4DQ\\nTrichophyton simii: XN4H4\\nTrichophyton verrucosum: XN69S\\nGeophilic dermatophytes: XN1Z2\\nMicrosporum gypseum: XN2VZ\\nMicrosporum praecox: XN7TP\\nGeotrichum: XN3AG\\nGeotrichum candidum: XN0ES\\nHistoplasma: XN9LU\\nHistoplasma capsulatum: XN8VH\\nHistoplasma duboisii: XN7YN\\nHortaea: XN119\\nHortaea werneckii: XN0EF\\nLacazia: XN3CM\\nLacazia loboi: XN3NU\\nLoboa: XN9ZX\\nMalassezia: XN43L\\nMalassezia furfur: XN25C\\nMalassezia globosa fungus: XN0TE\\nMicrosporidia: XN9ZV\\nMucor: XN1NU\\nRhizopus: XN6QM\\nRhizopus arrhizus: XN9KP\\nParacoccidioides: XN7RH\\nParacoccidioides brasiliensis: XN5UX\\nTalaromyces: XN79A\\nPenicillium: XN1ZF\\nPenicillium notatum: XN7JJ\\nTalaromyces marneffei: XN0LD\\nPiedraia: XN4YW\\nPiedraia hortae: XN6H7\\nPneumocystidomycetes: XN5XK\\nPseudallescheria: XN3NS\\nPseudallescheria boydii: XN6BV\\nRhinosporidium: XN720\\nRhinosporidium seeberi: XN18W\\nSporothrix: XN200\\nSporothrix schenckii: XN6GM\\nTrichosporon: XN766\\nFusarium: XN0X5\\nFusarium sporotrichioides: XN55Z\\nFusarium incaratumequiseti: XN7KH\\nFusarium chlamydosporum: XN1FQ\\nFusarium dimerum: XN5KR\\nFusarium fujikuroi: XN6XG\\nFusarium oxysporum: XN3HT\\nFusarium solani: XN0E6\\nAlternaria alternata: XN16V\\nCladosporium herbarum: XN8XY\\nEpicoccum purpurascens: XN7TH\\nMucor racemosus: XN79P\\nPhoma: XN6EG\\nStemphylium botryosum: XN4FM\\nCurvularia lunata: XN93N\\nExserohilum: XN0W9\\nExserohilum rostratum: XN26M\\nExserohilum longirostratum: XN9SM\\nExserohilum mcginnisii: XN9LC\\nSarocladium: XN4XH\\nSarocladium kiliense: XN8VN\\nSarocladium strictum: XN7ZD\\nParasites: XN9S1\\nAncylostoma: XN9CG\\nAncylostoma duodenal: XN5V8\\nAngiostrongylus: XN7A5\\nAngiostrongylus cantonensis: XN2UG\\nAngiostrongylus costaricensis: XN23C\\nAnisakis: XN574\\nAnisakis marina: XN9HA\\nAscaris: XN9PQ\\nAscaris lumbricoides: XN97M\\nBrugia: XN0JL\\nBrugia malayi: XN5RM\\nBrugia timori: XN80F\\nCapillaria: XN8T0\\nCapillaria philippinensis: XN9DT\\nClonorchis: XN9GC\\nClonorchis sinensis: XN5SV\\nDicrocoelium: XN3QD\\nDiphyllobothrium: XN6EF\\nDiphyllobothrium latum: XN67S\\nDiphyllobothrium species: XN7UT\\nDipylidium: XN570\\nDipylidium caninum: XN20Y\\nDirofilaria: XN15W\\nDirofilaria immitis: XN3BX\\nDirofilaria repens: XN7JS\\nDracunculus: XN7A6\\nDracunculus medinensis: XN9Q5\\nEchinococcus: XN84K\\nEchinococcus granulosus: XN1H0\\nEchinococcus multilocularis: XN0K1\\nEchinococcus oligarthrus: XN6TQ\\nEchinococcus vogeli: XN9LQ\\nEchinostoma: XN801\\nEnterobius: XN1DG\\nEnterobius vermicularis: XN4AR\\nFasciola: XN1H3\\nFasciola gigantica: XN90A\\nFasciola hepatica: XN7X9\\nFasciolopsis: XN35Y\\nFasciolopsis buski: XN024\\nGnathostoma: XN0H2\\nGnathostoma hispidum: XN8DD\\nGnathostoma spinigerum: XN8GS\\nHeterophyes: XN23M\\nHookworm: XN69Y\\nHymenolepis: XN629\\nHymenolepis nana: XN9S5\\nLoa: XN8ZQ\\nLoa loa: XN1QQ\\nMansonella: XN5Z0\\nMansonella ozzardi: XN6PZ\\nMansonella perstans: XN8AX\\nMansonella streptocerca: XN0JQ\\nMetagonimus: XN123\\nNanophyetus: XN3E8\\nNecator: XN9T3\\nNecator americanus: XN8K8\\nOesophagostomum: XN7L5\\nOesophagostomum bifurcum: XN0NZ\\nOnchocerca: XN9R1\\nOnchocerca volvulus: XN8T4\\nOpisthorchis: XN91W\\nParagonimus: XN27A\\nParagonimus westermani: XN0A6\\nPhylum Nemata: XN9NR\\nSchistosoma: XN78L\\nSchistosoma haematobium: XN86N\\nSchistosoma matthei: XN90N\\nSchistosoma intercalatum: XN9FK\\nSchistosoma japonicum: XN1ZJ\\nSchistosoma mansoni: XN8HD\\nSchistosoma mekongi: XN9T7\\nSparganum: XN5B9\\nSpirometra: XN89M\\nStrongyloides: XN07X\\nStrongyloides stercoralis: XN1KQ\\nSyngamus: XN5RB\\nSyngamus trachea: XN04L\\nTaenia: XN0D8\\nTaenia saginata: XN871\\nTaenia solium: XN8XE\\nTernidens: XN8DL\\nToxocara: XN2L3\\nToxocara canis: XN7MR\\nToxocara cati: XN54C\\nTrichinella: XN597\\nTrichinella spiralis: XN34A\\nTrichostrongylus: XN025\\nTrichostrongylus colubriformis: XN4K7\\nTrichuris: XN4MM\\nTrichuris trichiura: XN6UA\\nWuchereria: XN0H3\\nWuchereria bancrofti: XN3V2\\nHalicephalobus: XN2DD\\nHalicephalobus gingivalis: XN10L\\nAcanthamoeba: XN0HM\\nAmoeba: XN7S2\\nBabesia: XN9YX\\nBalantidium: XN7ZS\\nBalantidium coli: XN3H4\\nBlastocystis: XN6UY\\nBlastocystis hominis: XN1M7\\nCoccidia: XN1XA\\nCryptosporidium: XN8LE\\nCryptosporidium canis: XN0NC\\nCryptosporidium felis: XN5SZ\\nCryptosporidium hominis: XN4ZT\\nCryptosporidium meleagridis: XN4VU\\nCryptosporidium muris: XN4MN\\nCryptosporidium parvum: XN9BP\\nCyclospora: XN7VL\\nCyclospora cayetanensis: XN4BR\\nEntamoeba: XN3S1\\nEntamoeba histolytica: XN82F\\nGiardia: XN6H5\\nGiardia lamblia: XN94Z\\nIsospora: XN4Y2\\nIsospora belli: XN9ZT\\nLeishmania: XN8JE\\nLeishmania aethiopica: XN87Z\\nLeishmania brasiliensis: XN6DJ\\nLeishmania donovani infantum: XN1M5\\nLeishmania chagasii: XN3HN\\nLeishmania major: XN7EU\\nLeishmania mexicana: XN1EE\\nLeishmania tropica: XN95N\\nNaegleria: XN1M1\\nNaegleria fowleri: XN6EV\\nPlasmodium: XN5FW\\nPlasmodium falciparum: XN69B\\nPlasmodium malariae: XN7K1\\nPlasmodium ovale: XN5WD\\nPlasmodium vivax: XN217\\nPlasmodium knowlesi: XN93K\\nPlasmodium cynomolgi: XN12A\\nSarcocystis: XN92F\\nToxoplasma: XN7HC\\nToxoplasma gondii: XN896\\nTrichomonas: XN316\\nTrichomonas vaginalis: XN7YM\\nTrypanosoma: XN9H4\\nTrypanosoma brucei: XN0C1\\nTrypanosoma brucei gambiense: XN7TC\\nTrypanosoma brucei rhodesiense: XN5C7\\nTrypanosoma cruzi: XN56V\\nDientamoeba: XN7XH\\nDientamoeba fragilis: XN86U\\nRetortamonas: XN30L\\nRetortamonas intestinalis: XN9K3\\nChilomastix: XN4BE\\nChilomastix mesnili: XN0UD\\nDemodex: XN4RB\\nDermanyssus: XN9EL\\nVandellia cirrhosa: XN59U\\nInfestation by beetle: XN857\\nInsect larva: XN00Z\\nLeech: XN2K0\\nLinguatula serrata: XN9MA\\nLiponyssoides: XN0ZB\\nPediculus: XN0D5\\nPhthirus: XN84U\\nSarcoptes: XN3E3\\nSarcoptes scabiei var hominis: XN5YU\\nTrombicula: XN7Z8\\nTunga: XN6VS\\nPorocephalidae: XN2GY\\nScrewworm: XN8CT\\nNew World screwworm: XN4JW\\nOld World screwworm: XN8TR\\nPrion: XN7AM\\nPrototheca: XN42T\\nPythium: XN47C\\nAnterior: XK7V\\nPosterior: XK8L\\nMedial: XK9H\\nLateral: XK09\\nSuperior: XK5N\\nInferior: XK4H\\nVentral: XK4M\\nDorsal: XK87\\nProximal: XK6J\\nDistal: XK6C\\nIpsilateral: XK3Z\\nContralateral: XK3Y\\nExternal: XK2H\\nInternal: XK49\\nSuperficial: XK7F\\nDeep: XK16\\nComplete distribution: XK2J\\nConsolidated distribution: XK6P\\nDiffuse distribution: XK31\\nDisseminated distribution: XK5A\\nFocal distribution: XK37\\nGeneralised distribution: XK63\\nIncomplete distribution: XK06\\nIntertriginous distribution: XK0V\\nLinear distribution: XK5F\\nLocalised distribution: XK9A\\nSegmental distribution: XK36\\nSystematised distribution: XK7Z\\nBilateral: XK9J\\nLeft: XK8G\\nRight: XK9K\\nUnilateral unspecified: XK70\\nBrachial: XK62\\nCaudal: XK07\\nCranial: XK2K\\nInfratentorial: XK0P\\nSupratentorial: XK18\\nBlood: XA8EC5\\nBlood cells: XA8UK8\\nErythrocytes: XM8QV9\\nLeucocytes: XA32R4\\nGranulocytes: XA2WC0\\nNeutrophils: XA8C44\\nBasophils: XA5G96\\nEosinophils: XA0V82\\nMonocytes: XA46Q2\\nMacrophages: XA9DP6\\nLymphocytes: XA8YQ2\\nPlatelets: XA10B5\\nPlasma: XA7UR0\\nPlateletrich plasma: XA3JX0\\nBone marrow: XA9XK1\\nHaematopoietic stem cells: XA5869\\nCommon myeloid progenitor: XA3K78\\nErythroblast: XA8LY0\\nMyeloblast: XA6385\\nMegakaryoblast: XA3EA5\\nLymphoblast: XA0TJ1\\nThymus: XA8373\\nConnective and other soft tissues of thymus: XA2PK9\\nSpleen: XA7FU9\\nLingual tonsil: XA1EM4\\nWaldeyer ring: XA8US7\\nPalatine tonsil: XA3V90\\nLymph nodes: XA33X2\\nLymph nodes of head face and neck: XA9U65\\nOccipital lymph node: XA6H69\\nAuricular lymph node: XA7YF1\\nPosterior auricular lymph node: XA91C5\\nPreauricular lymph node: XA56J5\\nParotid lymph node: XA0W17\\nSubparotid lymph node: XA1Q47\\nSuperficial parotid lymph node: XA85E1\\nDeep parotid lymph node: XA07P4\\nFacial lymph node: XA2U89\\nBuccinator lymph node: XA1SG7\\nMandibular lymph node: XA8DW7\\nDeep facial lymph node: XA2S79\\nLingual lymph node: XA1DV2\\nSublingual lymph node: XA8027\\nSubmental lymph node: XA42P9\\nSubmandibular lymph node: XA9E80\\nAnterior cervical lymph node: XA4759\\nDeep cervical lymph node: XA9PW0\\nPrelaryngeal lymph node: XA2RE9\\nPretracheal lymph node: XA4LC1\\nParatracheal lymph node: XA7W32\\nRetropharyngeal lymph node: XA08L8\\nJugular lymph node: XA60D1\\nAnterior jugular node: XA6YX2\\nJugulodigastric lymph node: XA6HG6\\nJuguloomohyoid lymph node: XA5A75\\nCervical lymph node: XA5XT7\\nInferior cervical lymph node: XA4R20\\nLateral cervical lymph node: XA1W79\\nSuperior deep cervical lymph node: XA6AC0\\nInferior deep cervical lymph node: XA3S48\\nSuperficial cervical lymph node: XA7N00\\nSupraclavicular lymph node: XA00M7\\nIntrathoracic lymph nodes: XA9WH0\\nTracheobronchial lymph node: XA41B8\\nBronchopulmonary lymph node: XA96Z0\\nHilar lymph node: XA5MW1\\nPulmonary lymph node: XA9QW9\\nTracheal lymph node: XA3194\\nSuperior tracheobronchial lymph node: XA2JX0\\nInferior tracheobronchial lymph node: XA1PA1\\nMediastinal lymph node: XA61B8\\nAnterior mediastinal visceral lymph node: XA5HA3\\nPosterior mediastinal visceral lymph node: XA7571\\nOesophageal lymph node: XA8VY5\\nIntercostal lymph node: XA8E34\\nParasternal lymph node: XA2CH0\\nSuperior diaphragmatic lymph node: XA1478\\nInnominate lymph node: XA4P97\\nIntraabdominal lymph nodes: XA05C1\\nLumbar lymph node: XA59Q1\\nAortic lymph node: XA25W0\\nPreaortic lymph node: XA4WV3\\nCoeliac lymph node: XA38T7\\nGastric lymph node: XA1HL1\\nInferior gastric lymph node: XA1FW5\\nUpper superior gastric lymph node: XA1T01\\nSuperior gastric lymph node: XA3F65\\nLower superior gastric lymph node: XA3ET7\\nParacardial superior gastric lymph node: XA4WL5\\nPyloric lymph node: XA2AX1\\nSubpyloric lymph node: XA1RP0\\nHepatic lymph node: XA11U1\\nCommon duct lymph node: XA35G1\\nCystic lymph node: XA71D7\\nPancreaticosplenic lymph node: XA7ZP7\\nPancreaticoduodenal lymph node: XA6W89\\nSplenic lymph node: XA9PJ7\\nSplenic hilar lymph node: XA8X72\\nPancreatic lymph node: XA7T42\\nPeripancreatic lymph node: XA2P83\\nInferior mesenteric lymph node: XA8Y29\\nPararectal inferior mesenteric lymph node: XA6ZA5\\nSuperior mesenteric lymph node: XA37Y9\\nMesenteric lymph node: XA26J2\\nIleocolic lymph node: XA69J6\\nIleal ileocolic lymph node: XA66B8\\nAnterior ileocolic lymph node: XA8W06\\nPosterior ileocolic lymph node: XA7JE2\\nRight colic ileocolic lymph node: XA73R0\\nColic lymph node: XA09W7\\nMidcolic lymph node: XA4F32\\nEpicolic lymph node: XA8JH9\\nParacolic lymph node: XA9JM2\\nIntermediate colic lymph node: XA7PM1\\nPreterminal colic lymph node: XA3TX6\\nLateral aortic lymph node: XA6KK3\\nEpigastric lymph node: XA9T50\\nIliac circumflex lymph node: XA53K4\\nRetroaortic lymph node: XA0TK3\\nIntestinal lymph node: XA3TG4\\nRetroperitoneal lymph node: XA0KH9\\nSuprarenal lymph node: XA7DX9\\nPorta hepatis lymph node: XA2YR9\\nPelvic lymph nodes: XA5HU6\\nIliac lymph node: XA50T5\\nCommon iliac lymph node: XA1MS6\\nInternal iliac lymph node: XA0TJ6\\nExternal iliac lymph node: XA8M66\\nObturator lymph node: XA9Z71\\nSuprainguinal lymph node: XA4J45\\nSacral lymph node: XA24Q3\\nLateral sacral lymph node: XA1EN9\\nMedian sacral lymph node: XA86R4\\nPresymphysial lymph node: XA32C4\\nInferior epigastric lymph node: XA5VA3\\nFemale genital lymph node: XA9TN5\\nParametrial lymph node: XA3QA5\\nUterine paracervical lymph node: XA5M72\\nLymph nodes of upper extremity: XA7TQ3\\nAxillary lymph node: XA90B2\\nPectoral lymph node: XA63L4\\nLateral axillary lymph node: XA6NK2\\nSubscapular lymph node: XA9R12\\nCentral axillary lymph node: XA8HY4\\nSubclavicular axillary lymph node: XA1N88\\nSubclavian lymphatic trunk: XA9CD6\\nIntermediate lymph node: XA2UJ4\\nCubital lymph node: XA3H20\\nEpitrochlear lymph node: XA5183\\nInfraclavicular lymph node: XA0MR2\\nLymph nodes of lower extremity: XA86X1\\nInguinal lymph node: XA7N26\\nSuperficial inguinal lymph node: XA1114\\nSubinguinal lymph node: XA4RT0\\nSuperficial subinguinal lymph node: XA30V5\\nDeep subinguinal lymph nodes: XA6EE2\\nFemoral lymph node: XA5130\\nLymph node of Cloquet: XA4AU1\\nPopliteal lymph node: XA4W98\\nTibial lymph node: XA2PP2\\nAnterior tibial lymph node: XA3X71\\nLymph nodes of multiple regions: XA4T07\\nMononuclear phagocyte system: XA0GJ0\\nHypothalamus: XA1CN1\\nPineal\\xa0gland: XA1EU3\\nPituitary\\xa0gland: XA8J35\\nRathke pouch: XA9787\\nCraniopharyngeal duct: XA5309\\nThyroid\\xa0gland: XA8RK3\\nLeft lobe of thyroid gland: XA8LV3\\nRight lobe of thyroid gland: XA9L72\\nIsthmus of thyroid gland: XA4NE5\\nPyramidal lobe of thyroid gland: XA5109\\nParathyroid\\xa0gland: XA1342\\nPancreatic islets: XA45E6\\nAdrenal gland: XA0NE9\\nAdrenal\\xa0cortex: XA8956\\nAdrenal\\xa0medulla: XA6SS0\\nCentral nervous system: XA3JU6\\nMeninges: XA0AK4\\nCerebral meninges: XA6HA2\\nCranial dura mater: XA9M51\\nCranial arachnoid: XA6WL2\\nCranial pia mater: XA2T81\\nTentorium cerebelli: XA7N98\\nFalx without further specification: XA09H1\\nFalx cerebri: XA1FV7\\nFalx cerebelli: XA33G9\\nSpinal meninges: XA5AH0\\nSpinal dura mater: XA8R98\\nSpinal arachnoid: XA0382\\nSpinal pia mater: XA8SH5\\nDura mater: XA04B5\\nArachnoid mater: XA3D30\\nPia mater: XA6AF5\\nBrain: XA9738\\nCerebrum: XA1M33\\nCerebral hemisphere: XA8GR3\\nFrontal Lobe: XA2NT0\\nFrontal pole: XA3RD9\\nTemporal lobe: XA97T4\\nHippocampus: XA7BD1\\nUncus: XA7J78\\nAmygdala: XA1XY9\\nParietal Lobe: XA92Y6\\nOccipital lobe: XA89Y2\\nBrodmann area: XA5TY2\\nOccipital pole: XA0B59\\nCerebral cortex: XA64R0\\nThalamus: XA7L93\\nBasal ganglia: XA4T82\\nCorpus striatum: XA64F9\\nLentiform nucleus: XA8W72\\nGlobus pallidus: XA80J3\\nPutamen: XA8KA5\\nCaudate nucleus: XA7TX5\\nClaustrum: XA00D6\\nOptic chiasm: XA5TX3\\nOptic tract: XA63Y1\\nVisual cortex: XA5CF8\\nCerebral white matter: XA1ZN9\\nInsula: XA0XP7\\nInternal capsule: XA5JN6\\nOperculum: XA84G1\\nPallium: XA4F88\\nRhinencephalon: XA0Z39\\nCerebral lobe: XA5N14\\nSupratentorial region of brain: XA73A8\\nCerebellum: XA1CW2\\nCerebellar hemisphere: XA4SL2\\nCerebellar tonsil: XA7E38\\nCerebellar vermis: XA8E64\\nSuperior vermis: XA5694\\nInferior vermis: XA70Y8\\nLimbic system: XA8733\\nCerebral ventricle: XA26E8\\nLateral ventricle of the brain: XA45Y8\\nChoroid plexus of lateral ventricle: XA1XM1\\nThird ventricle of the brain: XA1H64\\nChoroid plexus of third ventricle: XA53A3\\nCerebral aqueduct: XA83T2\\nFourth ventricle of the brain: XA1804\\nChoroid plexus of fourth ventricle: XA1B86\\nChoroid plexus: XA9KX2\\nEpendyma: XA6J38\\nBrainstem: XA8AT9\\nMedulla oblongata: XA17J6\\nMidbrain: XA5KS6\\nCerebral peduncle: XA1AA8\\nPons: XA9CM4\\nReticular formation: XA34M4\\nOlives: XA5KN2\\nPyramid: XA5097\\nInfratentorial region of brain: XA1GA1\\nIntracranial site not elsewhere classified: XA08F7\\nSpinal cord: XA0V83\\nCervical spinal cord: XA1SP1\\nC level: XA8965\\nThoracic spinal cord: XA6Z51\\nT level: XA6FB9\\nLumbar spinal cord: XA8PP5\\nL level: XA86M5\\nSacral spinal cord: XA85J0\\nS level: XA4L09\\nMedullary cavity: XA5QM0\\nConus medullaris: XA2FQ1\\nCranial Nerve: XA8EK9\\nOlfactory nerve: XA5QD6\\nOptic nerve: XA1E00\\nOculomotor nerve: XA7488\\nTrochlear nerve: XA0GK2\\nTrigeminal nerve: XA72G0\\nTrigeminal nerve ophthalmic branch: XA95Y8\\nEthmoidal nerve: XA5BP8\\nExternal nasal nerve: XA8482\\nFrontal nerve: XA7F46\\nSupraorbital nerve: XA31J6\\nSupratrochlear nerve: XA95V8\\nLacrimal nerve: XA16M4\\nNasociliary nerve: XA5WM9\\nTrigeminal nerve maxillary branch: XA8KJ5\\nInferior palpebral nerve: XA4E11\\nInfraorbital nerve: XA3G43\\nMiddle meningeal nerve: XA9G70\\nNasopalatine nerve: XA0S35\\nNerve of pterygoid canal: XA9LR9\\nPalatine nerve: XA7P00\\nPharyngeal nerve: XA5Q86\\nSphenopalatine nerves: XA3W58\\nSuperior labial nerve: XA6AE9\\nZygomatic nerve: XA4DJ9\\nZygomaticofacial nerve: XA62X3\\nZygomaticotemporal nerve: XA9MM8\\nTrigeminal nerve mandibular branch: XA1F17\\nAuriculotemporal nerve: XA5DA8\\nBuccal nerve: XA7UK9\\nDeep temporal nerve: XA52H1\\nInferior alveolar nerve: XA3VT0\\nMylohyoid nerve: XA9FV5\\nLateral pterygoid nerve: XA3114\\nLingual nerve: XA5CT7\\nMasseteric nerve: XA5NQ5\\nMedial pterygoid nerve: XA1RH8\\nMental nerve: XA6ZD8\\nAbducens nerve: XA4GX3\\nFacial nerve: XA64Y7\\nPosterior auricular nerve: XA7F87\\nTemporal branch of the facial nerve: XA1VA9\\nZygomatic branch of the facial nerve: XA7JD7\\nBuccal branch of the facial nerve: XA3A57\\nMarginal mandibular branch of the facial nerve: XA1TY5\\nCervical branch of the facial nerve: XA5241\\nDigastric branch of the facial nerve: XA1ZH3\\nStylohyoid branch of the facial nerve: XA36Y9\\nChorda tympani: XA2BL2\\nNerve to the stapedius: XA69Y7\\nVestibulocochlear nerve: XA6LY7\\nCochlear nerve: XA1QU6\\nVestibular nerve: XA1AL7\\nGlossopharyngeal nerve: XA8RW1\\nPharyngeal branches of glossopharyngeal nerve: XA5QA5\\nVagus nerve: XA6VN1\\nAuricular branch of vagus nerve: XA0P44\\nPharyngeal plexus: XA9LV7\\nPharyngeal branch of vagus nerve: XA8F53\\nSuperior laryngeal nerve: XA2HA5\\nExternal laryngeal nerve: XA9LP4\\nInternal laryngeal nerve: XA6UK8\\nLeft recurrent laryngeal nerve: XA3524\\nPulmonary branches of vagus nerve: XA2KY5\\nAccessory nerve: XA2M45\\nHypoglossal nerve: XA3YX3\\nPetrous ganglion: XA48Z8\\nTympanic nerve: XA4Q30\\nDeep petrosal nerve: XA9CT5\\nGreater petrosal nerve: XA4W18\\nCiliary ganglion: XA1SG6\\nLong ciliary nerves: XA3VY1\\nOtic ganglion: XA2260\\nPterygopalatine ganglion: XA0ER1\\nSubmandibular ganglion: XA74N6\\nPeripheral nervous system: XA1630\\nSpinal nerve: XA65L3\\nCervical spinal nerve: XA1YC9\\nFirst cervical spinal nerve: XA9DY6\\nSecond cervical spinal nerve: XA1LR0\\nThird cervical spinal nerve: XA7LF0\\nFourth cervical spinal nerve: XA1QX0\\nFifth cervical spinal nerve: XA06Q1\\nSixth cervical spinal nerve: XA26W5\\nSeventh cervical spinal nerve: XA4WT3\\nEighth cervical spinal nerve: XA3XK7\\nThoracic spinal nerve: XA6KS1\\nFirst thoracic spinal nerve: XA2QF3\\nSecond thoracic spinal nerve: XA1K85\\nThird thoracic spinal nerve: XA0DY5\\nFourth thoracic spinal nerve: XA7BM1\\nFifth thoracic spinal nerve: XA48M5\\nSixth thoracic spinal nerve: XA4GT3\\nSeventh thoracic spinal nerve: XA0RA9\\nEighth thoracic spinal nerve: XA2VJ9\\nNinth thoracic spinal nerve: XA64N5\\nTenth thoracic spinal nerve: XA5AZ7\\nEleventh thoracic spinal nerve: XA6369\\nTwelfth thoracic spinal nerve: XA7QX3\\nLumbar spinal nerve: XA44R0\\nFirst lumbar spinal nerve: XA1471\\nSecond lumbar spinal nerve: XA0VF5\\nThird lumbar spinal nerve: XA9178\\nFourth lumbar spinal nerve: XA6N66\\nFifth lumbar spinal nerve: XA7VL6\\nSacral spinal nerve: XA17Y2\\nFirst sacral spinal nerve: XA2E82\\nSecond sacral spinal nerve: XA9V46\\nThird sacral spinal nerve: XA74E6\\nFourth sacral spinal nerve: XA25F0\\nFifth sacral spinal nerve: XA73B4\\nDorsal spinal nerve: XA4CU7\\nVentral spinal nerve: XA7TS7\\nSpinal nerve root: XA6EC2\\nCervical nerve root: XA3UZ3\\nFirst cervical nerve root: XA53S6\\nSecond cervical nerve root: XA15A2\\nThird cervical nerve root: XA2MT0\\nFourth cervical nerve root: XA36V3\\nFifth cervical nerve root: XA87U1\\nSixth cervical nerve root: XA8YT7\\nSeventh cervical nerve root: XA5BL9\\nEighth cervical nerve root: XA0245\\nThoracic nerve root: XA5SU4\\nFirst thoracic nerve root: XA22C5\\nSecond thoracic nerve root: XA8933\\nThird thoracic nerve root: XA2EK5\\nFourth thoracic nerve root: XA6NV1\\nFifth thoracic nerve root: XA8DN4\\nSixth thoracic nerve root: XA1AB6\\nSeventh thoracic nerve root: XA1VM6\\nEighth thoracic nerve root: XA2UY4\\nNinth thoracic nerve root: XA8QS1\\nTenth thoracic nerve root: XA2VK2\\nEleventh thoracic nerve root: XA61G0\\nTwelfth thoracic nerve root: XA76V2\\nLumbar nerve root: XA4T95\\nFirst lumbar nerve root: XA8VX2\\nSecond lumbar nerve root: XA9BK9\\nThird lumbar nerve root: XA4N03\\nFourth lumbar nerve root: XA2ZQ7\\nFifth lumbar nerve root: XA5W91\\nSacral nerve root: XA9F62\\nFirst sacral nerve root: XA4HY7\\nSecond sacral nerve root: XA4PP9\\nThird sacral nerve root: XA32J7\\nFourth sacral nerve root: XA0WH3\\nFifth sacral nerve root: XA7BN5\\nDorsal nerve root ganglion: XA9J98\\nDorsal nerve root: XA1TP8\\nVentral nerve root ganglion: XA8G34\\nVentral nerve root: XA1V70\\nSpinal nerve plexus: XA64F0\\nCervical plexus: XA6LU7\\nBrachial plexus: XA22K9\\nPosterior cord of brachial plexus: XA1UT5\\nLateral cord of brachial plexus: XA9PG2\\nMedial cord of brachial plexus: XA7UA9\\nLumbosacral plexus: XA8YS2\\nLumbar plexus: XA1E79\\nPresacral plexus: XA1JE5\\nSacral plexus: XA0929\\nPatellar plexus: XA5186\\nSplanchnic plexus: XA3SK8\\nUterovaginal plexus: XA2G95\\nVesical nervous plexus: XA1KP5\\nPeripheral nerve: XA06U6\\nInferior cervical ganglion: XA20S2\\nSuboccipital nerve: XA0Z50\\nGreater auricular nerve: XA4WK4\\nGreater occipital nerve: XA6BB0\\nLesser occipital nerve: XA3ND8\\nThird occipital nerve: XA18D0\\nIliohypogastric nerve: XA8T30\\nIlioinguinal nerve: XA5Q50\\nInferior anal nerves: XA8CZ0\\nLumbar splanchnic nerve: XA8U35\\nMiddle cardiac nerve: XA8ML2\\nPosterior branch of spinal nerve: XA11K1\\nPosterior superior alveolar nerve: XA9AN9\\nProper palmar digital nerves of median nerve: XA7ZD7\\nSacral splanchnic nerves: XA0SA1\\nSemilunar ganglion: XA1SM8\\nShort ciliary nerves: XA07F8\\nSuperior cardiac nerve: XA1AC5\\nSuperior cervical ganglion: XA6BG1\\nSuperior ganglion: XA6YL5\\nTransverse cervical nerve: XA25F4\\nPhrenic nerve: XA9ZM0\\nSympathetic trunk: XA6W14\\nCommon fibular nerve: XA7HH4\\nDeep fibular nerve: XA3QB5\\nFemoral nerve: XA11D4\\nGenitofemoral nerve: XA9JZ4\\nGluteal nerve: XA60R4\\nInferior gluteal nerve: XA1GU3\\nLateral femoral cutaneous nerve: XA4834\\nLateral plantar nerve: XA9958\\nLumbar nerve: XA5UE9\\nLumboinguinal nerve: XA8307\\nLumbosacral trunk: XA76D3\\nMedial plantar nerve: XA9AF5\\nNerve to quadratus femoris: XA7S27\\nPlantar nerve: XA3906\\nPosterior cutaneous nerve of thigh: XA83P9\\nSaphenous nerve: XA9EW1\\nSciatic nerve: XA9KK8\\nSuperficial fibular nerve: XA2125\\nSuperior gluteal nerve: XA9AC5\\nSural nerve: XA4HR8\\nTibial nerve: XA7534\\nAnococcygeal nerve: XA9JU0\\nCauda equina: XA84W1\\nCoccygeal nerve: XA5C62\\nDorsal nerve of clitoris: XA76C3\\nDorsal nerve of the penis: XA8CC3\\nGenital branch of genitofemoral nerve: XA99Q6\\nPerineal nerve: XA0W10\\nPosterior scrotal nerve: XA7NU3\\nPudendal nerve: XA6WU3\\nAccessory obturator nerve: XA55J8\\nDorsal scapular nerve: XA9RP3\\nInferior cardiac nerve: XA9TB4\\nIntercostal nerve: XA5HJ3\\nIntercostobrachial nerve: XA2F71\\nLateral pectoral nerve: XA5A06\\nLong thoracic nerve: XA0A05\\nLower subscapular nerve: XA9XA5\\nMedial pectoral nerve: XA49V5\\nRight recurrent laryngeal nerve: XA1BR5\\nSubcostal nerve: XA3RU6\\nSupraclavicular nerves: XA5318\\nSuprascapular nerve: XA8QY6\\nThoracic splanchnic nerve: XA2R06\\nThoracoabdominal nerve: XA0462\\nThoracodorsal nerve: XA2542\\nUpper subscapular nerve: XA5KR0\\nAxillary nerve: XA1ZC4\\nCommon palmar digital nerves of median nerve: XA1LW6\\nDeep branch of the radial nerve: XA5179\\nDigital nerve: XA37M8\\nDorsal branch of ulnar nerve: XA1TY7\\nLateral cutaneous nerve of forearm: XA6166\\nMedial cutaneous nerve: XA9HJ5\\nMedial cutaneous nerve of arm: XA7K97\\nMedial cutaneous nerve of forearm: XA26F7\\nMuscular branches of the radial nerve: XA3P46\\nPalmar branch of the median nerve: XA89K2\\nPalmar branch of ulnar nerve: XA7FU0\\nPosterior cutaneous nerve of forearm: XA0KL7\\nPosterior cutaneous nerve of arm: XA2XU7\\nSuperficial branch of the radial nerve: XA2E94\\nSuperior lateral cutaneous nerve of arm: XA6B07\\nAnsa cervicalis: XA2M04\\nAnterior interosseous nerve: XA6RQ4\\nAnterior superior alveolar nerve: XA6PJ8\\nBulbar nuclei: XA54B9\\nCeliac ganglion: XA89R1\\nDiagonal band of Broca: XA8QL3\\nGeniculate ganglion: XA66H0\\nIntermediate cutaneous nerve: XA6B81\\nJugular ganglion: XA8AU6\\nLong root of the ciliary ganglion: XA1Z01\\nMiddle cervical ganglion: XA9RD0\\nMusculocutaneous nerve: XA5QF4\\nNerve of the cervical region: XA96Q6\\nNerve to obturator internus: XA1HC7\\nNerve to the piriformis: XA8PE3\\nNerve to the subclavius: XA4XD7\\nNervus intermedius: XA0869\\nNervus spinosus: XA2KG8\\nNodose ganglion: XA5NY4\\nObturator nerve: XA4548\\nParaganglion: XA9519\\nAortic body: XA0VA6\\nCoccygeal glomus: XA6Y08\\nGlomus jugulare: XA17K2\\nParaaortic body: XA8S02\\nPelvic splanchnic nerve: XA1GM8\\nPerforating cutaneous nerve: XA6GZ8\\nPerineal branches of posterior femoral cutaneous nerve: XA4A74\\nAutonomic nervous system: XA7718\\nNerves of the autonomic nervous system: XA2BH4\\nAortic plexus: XA3XN8\\nAuerbach plexus: XA2G56\\nCardiac plexus: XA9QM5\\nCavernous plexus: XA3FS7\\nCoeliac plexus: XA4U92\\nGastric plexus: XA2Y82\\nHepatic plexus: XA4YZ0\\nInferior hypogastric plexus: XA05T1\\nInferior mesenteric plexus: XA8QG3\\nInternal carotid plexus: XA5JN1\\nMeissner plexus: XA8Z10\\nOesophageal plexus: XA7K49\\nOvarian plexus: XA9PB2\\nPancreatic plexus: XA0C44\\nPhrenic plexus: XA9ME3\\nProstatic plexus: XA16Y3\\nPudendal plexus: XA9411\\nRenal plexus: XA82M9\\nSplenic plexus: XA4V38\\nSuperior hypogastric plexus: XA33C1\\nSuperior mesenteric plexus: XA3DJ3\\nSuperior rectal plexus: XA4G22\\nSuprarenal plexus: XA6MY2\\nParasympathetic nervous system: XA7EA2\\nSympathetic nervous system: XA93B4\\nNerve ganglia: XA3PR2\\nInfraorbital plexus: XA2B55\\nMedian nerve: XA0GB0\\nNerve of the Thorax: XA3M58\\nMultiple Nerves: XA2330\\nSingle Nerve: XA7MX8\\nRadial nerve: XA8BJ3\\nUlnar nerve: XA2AS2\\nVentral ramus: XA4M27\\nEye: XA7D89\\nEyelid and ocular surface: XA17K1\\nEyelids: XA3RB1\\nUpper eyelid: XA9K79\\nUpper eyelid margin: XA53T1\\nSuperior palpebral sulcus: XA4649\\nLower eyelid: XA0JV9\\nLower eyelid margin: XA4AX5\\nLateral canthus: XA0403\\nMedial canthus: XA2GQ3\\nConjunctiva: XA8PS3\\nPalpebral conjunctiva: XA3X70\\nConjunctival fornices: XA6EZ4\\nSuperior conjunctival fornix: XA4H06\\nInferior conjunctival fornix: XA3KE6\\nBulbar conjunctiva: XA6V06\\nEyeball: XA0M40\\nSclera: XA2AF4\\nCornea: XA4C02\\nLimbus of cornea: XA1DA5\\nUvea: XA4MT3\\nCiliary body: XA03X9\\nCiliary muscle: XA9SH1\\nCiliary processes: XA1S43\\nChoroid: XA96A7\\nIris: XA3GW7\\nPupil: XA0B15\\nPupillary membrane: XA0571\\nCrystalline lens: XA13U9\\nSuspensory ligament of lens: XA6U53\\nRetina: XA8WV8\\nMacula lutea: XA9V06\\nFovea: XA2U02\\nOptic disc: XA4A75\\nPeripheral retina: XA4YS8\\nChamber of eye: XA0BB2\\nPosterior chamber of the eye: XA0N58\\nVitreous humor: XA4HU2\\nAnterior chamber of the eye: XA4MZ4\\nAqueous humour: XA3518\\nEye fluid: XA1TF9\\nLacrimal apparatus: XA0096\\nLacrimal gland: XA75Y9\\nLacrimal gland ducts: XA2PA4\\nMeibomian gland: XA9D80\\nLacrimal puncta: XA8EM9\\nSuperior lacrimal punctum: XA2VR4\\nInferior lacrimal punctum: XA99D0\\nLacrimal canaliculi: XA6C35\\nNasolacrimal duct: XA5SW9\\nOrbit: XA2WJ9\\nConnective and other soft tissue of orbit: XA9WT4\\nNasofrontal vein: XA8GT2\\nSupraorbital vein: XA7LQ0\\nEar: XA01U5\\nInner Ear: XA57R3\\nSemicircular canals: XA3MS6\\nCochlea: XA0JV0\\nInternal Acoustic Meatus: XA6ZY7\\nLabyrinth: XA0L54\\nAuditory vestibule: XA44P4\\nMiddle Ear: XA0G74\\nEustachian tube: XA7XY6\\nOval window: XA16S6\\nMastoid antrum: XA9RH9\\nTympanic cavity: XA3KB2\\nConnective and other soft tissues of middle ear: XA3UT7\\nTympanic membrane: XA08X4\\nExternal Ear: XA6ZY6\\nPinna: XA4E71\\nHelix of pinna: XA6B58\\nCrus of helix: XA9A86\\nApex of helix: XA9M10\\nSpine of helix: XA7AB8\\nTail of helix: XA1BZ8\\nAntihelix: XA7V14\\nCrura of antihelix: XA96Q7\\nScaphoid fossa of pinna: XA5LW2\\nConcha of pinna: XA8W55\\nCymba conchae: XA5KM5\\nConchal bowl of pinna: XA8D58\\nTriangular fossa of pinna: XA3RC6\\nTragus of pinna: XA2N71\\nIntertragic notch of pinna: XA5VK5\\nEarlobe: XA0TW7\\nAntitragus of pinna: XA7RR9\\nPosterior surface of pinna: XA3S47\\nAntihelical fossa: XA6NU1\\nEminence of concha: XA6KW8\\nEminence of scapha: XA0H47\\nEminence of triangular fossa: XA8VK6\\nRetroauricular sulcus: XA4DV9\\nExternal auditory canal: XA3UC1\\nExternal auditory meatus: XA5GS5\\nCeruminal gland: XA5K66\\nSkin of auricle: XA9E26\\nCardiovascular system: XA4PM9\\nArteries: XA5999\\nArtery of head face and neck: XA4TS7\\nAnterior communicating artery: XA2B10\\nAnterior ethmoidal artery: XA2QF4\\nNasal branches of the anterior ethmoidal artery: XA53D3\\nAnterior meningeal artery: XA00K1\\nAnterior superior alveolar artery: XA1GU9\\nArtery of pterygoid canal: XA2505\\nCarotid artery: XA9AD7\\nCarotid body: XA0F61\\nCommon carotid artery: XA1V84\\nInternal carotid artery: XA78C0\\nOphthalmic artery: XA1CW5\\nExternal carotid artery: XA9EK2\\nCerebellar artery: XA5SN3\\nCerebral artery: XA13S2\\nAnterior cerebral artery: XA1VB0\\nBasilar artery: XA2K99\\nPontine branches of the basilar artery: XA3185\\nMiddle cerebral artery: XA2JH8\\nAnterolateral central artery: XA4WT4\\nPosterior cerebral artery: XA7C50\\nCostocervical trunk: XA2UK9\\nDeep auricular artery: XA7SK1\\nDeep cervical artery: XA1NY7\\nDorsal nasal artery: XA18D8\\nDorsal nasal artery to the root of nose: XA56R8\\nDorsal nasal artery to the dorsum of the nose: XA0PF0\\nExternal striate of the anterolateral central artery: XA4QF0\\nFacial artery: XA3FL3\\nAscending palatine artery: XA7YP8\\nSuperior labial artery: XA4UT8\\nInferior labial artery: XA2ZM0\\nAngular artery: XA36S6\\nCervical artery: XA9QG7\\nDeep branch of the submental artery: XA85T4\\nGlandular branches of the cervical artery: XA83M8\\nGreater palatine artery: XA2626\\nHyoid artery: XA4H29\\nInferior palpebral arch artery: XA4VH9\\nInternal striate of the anterolateral central artery: XA5VX8\\nIntracranial artery: XA85W7\\nLateral branch of the posterior inferior cerebellar artery: XA16L7\\nLateral nasal branch of the facial artery: XA3N26\\nLesser palatine artery: XA5Z38\\nLingual branch of the inferior alveolar artery: XA5TR9\\nMaxillary artery: XA18M5\\nFirst portion of the maxillary artery: XA49F5\\nDeep temporal artery\\xa0anterior and posterior: XA0BD0\\nInferior alveolar artery: XA7SV5\\nIncisor branch of the Inferior alveolar artery: XA3W87\\nMental branch of the Inferior alveolar artery: XA7AG7\\nMasseteric artery: XA49F4\\nDescending palatine artery: XA55G2\\nPharyngeal artery: XA9XM3\\nPosterior superior alveolar artery: XA3WA5\\nBuccal artery: XA0LK0\\nAnterior tympanic artery: XA9MM1\\nAccessory meningeal artery: XA8YX3\\nMiddle meningeal artery: XA5RM1\\nLingual artery: XA2WS5\\nOccipital artery: XA9EU7\\nPosterior auricular artery: XA13U3\\nSuperficial temporal artery: XA0SB1\\nFrontal branch of the superficial temporal artery: XA7WG0\\nSuperior thyroid artery: XA7K29\\nCricothyroid artery: XA0FT7\\nInferior thyroid artery: XA2V10\\nSternocleidomastoid artery: XA77C5\\nAscending pharyngeal artery: XA00E5\\nRight common carotid artery: XA53A8\\nMiddle temporal artery: XA6X36\\nMylohyoid branch of the inferior alveolar artery: XA3TE9\\nParietal branch of the superficial temporal artery: XA6XV2\\nPosterior communicating artery: XA7U73\\nPosterior ethmoidal artery: XA5881\\nNasal branches of the posterior ethmoidal artery: XA7561\\nMeningeal branch of the posterior ethmoidal artery: XA7945\\nPosterior inferior cerebellar artery: XA8RM9\\nPosterior lateral nasal branches of the sphenopalatine artery: XA9VV0\\nPosterior meningeal artery: XA8FA1\\nPosterior septal branches of the sphenopalatine artery: XA4Q78\\nPterygoid branches: XA1K74\\nSphenopalatine artery terminal branch: XA1BZ0\\nSubmental artery of the cervical artery: XA90T0\\nSuperficial branch of the submental artery: XA6FR0\\nSuperficial branch of the transverse cervical artery: XA0898\\nSuperficial petrosal branch of the anterior and posterior meningeal artery: XA82P9\\nSuperior cerebellar artery: XA7423\\nSuperior laryngeal artery: XA9GU1\\nSuperior tympanic artery: XA50Q9\\nSupratrochlear artery: XA6W31\\nTemporal branches of the anterior and posterior meningeal artery: XA65G3\\nThyrocervical trunk: XA9XH0\\nTonsillar branch of the cervical artery: XA2E78\\nTransverse cervical artery: XA6142\\nTransverse facial artery: XA9M59\\nTwig to the upper part of\\xa0lacrimal sac of the dorsal nasal artery: XA5D86\\nVertebral artery: XA1XP6\\nMeningeal branches of vertebral artery: XA3NW4\\nAscending branch of the vertebral artery: XA6TE8\\nDescending branch of the vertebral artery: XA3R20\\nSupraorbital artery: XA1C15\\nSuperficial branch of the supraorbital artery: XA6503\\nDeep branch of the supraorbital artery: XA8BL5\\nOrbital branches of the anterior and posterior meningeal artery: XA34H5\\nInfraorbital artery: XA5C33\\nOrbital branches of the infraorbital artery: XA05E9\\nLong posterior ciliary artery: XA9RA2\\nShort posterior ciliary artery: XA04E2\\nAnterior ciliary artery: XA94Y6\\nCentral retinal artery: XA5RB0\\nCirculus arteriosus major artery: XA22D8\\nCirculus arteriosus minor artery: XA8T70\\nLacrimal artery: XA5P69\\nLateral palpebral artery: XA00Q9\\nMedial palpebral artery: XA8VA1\\nSuperior palpebral arch artery: XA35L5\\nZygomatic branches of the lacrimal artery: XA1Q49\\nBranches to\\xa0gingiva: XA4KE1\\nArtery of thorax: XA9UT1\\nBranches to\\xa0diaphragm of the musculophrenic artery: XA4TH8\\nBranches to lower part of the\\xa0pericardium of the musculophrenic artery: XA1PX4\\nBrachiocephalic trunk: XA2KA0\\nDeep branch of dorsal scapular artery: XA3M86\\nIntercostal artery: XA7KK5\\nIntercostal branches of the musculophrenic artery: XA0T62\\nInternal thoracic artery: XA9S49\\nMediastinal artery: XA4XE2\\nLateral thoracic artery: XA3DE1\\nPulmonary artery: XA09J9\\nLower rd to th\\xa0posterior intercostal artery: XA1EE3\\nLower branches of the space anastomoses of the six\\xa0anterior intercostal branches of the internal thoracic artery: XA0QG6\\nMusculophrenic artery: XA7EC2\\nPerforating branches of the internal thoracic artery: XA1190\\nPosterior intercostal artery: XA0WT1\\nSix\\xa0anterior intercostal branches of the internal thoracic artery: XA14K0\\nSternal\\xa0branches of the internal thoracic artery: XA6UQ6\\nSubcostal artery: XA3311\\nSuperior phrenic artery: XA9J15\\nSuperior thoracic artery: XA8M67\\nSupreme intercostal artery: XA7TT5\\nThoracoacromial artery: XA79X5\\nUpper branches of the six\\xa0anterior intercostal branches of the internal thoracic artery: XA99C2\\nOesophageal artery: XA8ES3\\nAorta of thorax: XA8K52\\nArch of the aorta: XA75Z8\\nAscending aorta: XA01A6\\nDescending aorta: XA5H34\\nBronchial artery: XA6E07\\nSubclavian artery: XA5D68\\nArtery of abdomen: XA9JK8\\nAnterior suprarenal artery: XA7TZ1\\nAscending branch of the left colic artery: XA82R7\\nBranches to\\xa0abdominal muscles of the musculophrenic artery: XA8BY2\\nCoeliac artery: XA8577\\nCommon hepatic artery: XA26R6\\nCystic artery: XA0JE4\\nDescending branch of the left colic artery: XA6NY6\\nDescending\\xa0vasa recta: XA1VJ7\\nDorsal pancreatic artery: XA1QB0\\nGastroduodenal artery: XA0NN4\\nHepatic artery: XA5AP2\\nHepatic branch of the left gastric artery: XA2LQ8\\nIleocolic artery: XA2Z43\\nInferior epigastric artery: XA3F13\\nInferior mesenteric artery: XA2N15\\nInferior pancreaticoduodenal artery: XA6358\\nInferior phrenic artery: XA2LL9\\nIntestinal artery: XA68L7\\nLeft colic artery: XA6WR7\\nLeft gastric artery: XA0LL0\\nLeft gastroomental artery: XA9AQ6\\nLumbar artery: XA4UK9\\nMesenteric artery: XA6CA5\\nMiddle colic artery: XA1Z62\\nMiddle suprarenal artery: XA1GQ7\\nPosterior suprarenal artery: XA00T1\\nProper hepatic artery: XA8C72\\nRenal artery: XA69V9\\nRight colic artery: XA6GC2\\nRight gastric artery: XA9HE0\\nRight gastroomental artery: XA8V02\\nSigmoid artery: XA02A2\\nSplenic artery: XA0R02\\nSuperior pancreaticoduodenal artery: XA2870\\nTerminal branches of the proper hepatic artery: XA51U4\\nUmbilical artery: XA0VZ0\\nSuperior mesenteric artery: XA3VR0\\nArtery of pelvis: XA4GP1\\nArtery of bulb of penis: XA5PV1\\nArtery of bulb of vestibule: XA30X9\\nDeep artery of clitoris: XA4XP0\\nDeep artery of penis: XA7AM0\\nDeep branch of the superior gluteal artery: XA14N2\\nDeep external pudendal artery: XA4AP3\\nDeferential artery: XA27B8\\nDorsal artery of clitoris: XA4FK8\\nDorsal artery of penis: XA4X54\\nIliac branch of the iliolumbar artery: XA5GV0\\nIliolumbar artery: XA7D46\\nInferior branch of the lateral sacral artery: XA3XS2\\nInferior gluteal artery: XA0G82\\nInferior vesical artery: XA2QX3\\nInternal pudendal artery: XA7FK7\\nLateral sacral artery: XA5Y50\\nMedian sacral artery: XA82V4\\nMiddle rectal artery: XA8X93\\nObturator artery: XA69V8\\nOvarian artery\\xa0in females: XA1MF5\\nPerineal artery: XA5MN1\\nPosterior labial branches\\xa0\\xa0of the internal pudendal artery: XA34Z7\\nPosterior scrotal branches\\xa0of the internal pudendal artery: XA2025\\nSuperficial branch of the superior gluteal artery: XA2TT0\\nSuperior branch of the lateral sacral artery: XA0AZ8\\nSuperior gluteal artery: XA26E6\\nSuperior vesical artery: XA1426\\nTesticular artery\\xa0in males: XA0UK9\\nUrethral artery: XA85K8\\nUterine artery: XA0610\\nVaginal artery: XA47A2\\nIliac artery: XA83D6\\nCommon iliac artery: XA6PZ8\\nDeep circumflex iliac artery: XA9MJ1\\nInternal iliac artery: XA4HL2\\nExternal iliac artery: XA53T4\\nInferior adrenal artery: XA9QC3\\nArtery of upper extremity: XA81N7\\nAnterior humeral circumflex artery: XA0H14\\nAnterior ulnar recurrent artery: XA7U09\\nAnterior interosseous artery: XA2PP8\\nAscending branches of the Inferior ulnar collateral artery: XA8ZA6\\nAxillary artery: XA38W3\\nBrachial artery: XA1138\\nBranch to\\xa0volar carpal network of the anterior interosseous artery: XA5RC6\\nBranches to the\\xa0deltoid muscle of the Profunda brachii artery: XA91T8\\nCommon interosseous artery: XA4RU3\\nDeep palmar arch: XA3M37\\nDescending branches of the Inferior ulnar collateral artery: XA1ES5\\nFirst dorsal metacarpal artery: XA2UT9\\nInferior ulnar collateral artery: XA9F90\\nInterosseous recurrent artery: XA9179\\nMedial collateral artery: XA2722\\nMuscular branches of the anterior interosseous artery: XA8LL2\\nPalmar carpal arch: XA0GZ0\\nPalmar carpal branch of radial artery: XA2F13\\nPosterior interosseous artery: XA51P8\\nPosterior ulnar recurrent artery: XA8JY7\\nPrinceps pollicis artery: XA05L5\\nProfunda brachii artery: XA2PP0\\nRadial artery: XA8RG5\\nRadial branches at the\\xa0wrist of the radial artery: XA9W25\\nRadial branches in the hand of the radial artery: XA91J7\\nRadial branches in the\\xa0forearm of the radial artery: XA3SL1\\nRadial collateral artery: XA3PZ4\\nRadial recurrent artery: XA3H61\\nRadialis indicis of the radial artery: XA62C1\\nSuperficial palmar arch: XA5AG1\\nSuperficial palmar branch of the radial artery: XA5BG5\\nSuperior ulnar collateral artery: XA0JA6\\nUlnar artery: XA23B7\\nVolar carpal network: XA90B4\\nDeep volar branch of ulnar artery: XA1VB5\\nDorsal carpal arch: XA9ZJ6\\nDorsal carpal branch of radial artery: XA44C1\\nDorsal carpal network: XA7M90\\nSubscapular artery: XA2YJ5\\nPosterior humeral circumflex artery: XA0882\\nArtery of lower extremity: XA8DW5\\nAcetabular branch: XA61E8\\nAnterior lateral malleolar artery: XA91J1\\nAnterior medial malleolar artery: XA4K68\\nAnterior tibial artery: XA6CN3\\nAnterior tibial recurrent artery: XA7BL5\\nAscending branch of the lateral femoral circumflex artery: XA5BU3\\nAscending branch of the medial femoral circumflex artery: XA0DB6\\nBranch of the medial inferior genicular artery to\\xa0popliteus: XA42R8\\nBranch of the medial superior genicular artery to\\xa0vastus medialis: XA7WF1\\nBranch of the medial superior genicular artery to surface of the femur and the kneejoint: XA2DD1\\nCommunicating branch of the fibular artery to the\\xa0anterior tibial artery: XA4VS8\\nDeep branch of the descending branch of the Medial femoral circumflex artery: XA7DF6\\nDeep branch of the lateral superior genicular artery: XA19F5\\nDeep femoral artery: XA3KL5\\nDescending branch of the lateral femoral circumflex artery: XA3SV6\\nDescending branch of the Medial femoral circumflex artery: XA15J8\\nDescending genicular artery: XA3CV5\\nDorsalis pedis artery: XA41L4\\nFemoral artery: XA2JF3\\nFibular artery: XA9GM6\\nFirst perforating artery: XA2GU0\\nLateral femoral circumflex artery: XA9EP9\\nLateral inferior genicular artery: XA4B67\\nMedial femoral circumflex artery: XA6920\\nMedial inferior genicular artery: XA1QB3\\nMedial plantar artery: XA7PN1\\nMiddle genicular artery: XA5LB1\\nMuscular branches of the anterior tibial artery: XA0PT7\\nMusculoarticular branch of the Descending genicular artery: XA9TP5\\nPerforating artery: XA0GA4\\nPerforating branch of the fibular artery to the\\xa0posterior tibial artery: XA1YF2\\nPopliteal artery: XA44K1\\nPosterior tibial artery: XA6LK2\\nPosterior tibial recurrent artery: XA33D9\\nSaphenous branch of the Descending genicular artery: XA09P5\\nSecond perforating artery: XA2Z59\\nSuperficial branch of the descending branch of the Medial femoral circumflex artery: XA7W56\\nSuperficial branch of the lateral superior genicular artery: XA5687\\nSural artery: XA08Q7\\nThird or fourth perforating artery: XA8J55\\nTransverse branch of the lateral femoral circumflex artery: XA4XR2\\nLateral plantar artery: XA6QR6\\nCommon femoral artery: XA8YC8\\nSuperficial femoral artery: XA5PP5\\nAfferent arteriole of the interlobular artery: XA9PU5\\nAorta: XA6Y34\\nThoracoabdominal aorta: XA9NQ2\\nAbdominal aorta: XA5Z66\\nSuprarenal abdominal aorta: XA5EX6\\nInfrarenal abdominal aorta: XA2LN9\\nVeins: XA5J49\\nVein of head face and neck: XA59M2\\nCortical vein: XA9TJ8\\nBasal vein: XA8ZU5\\nAlveolar vein: XA37J7\\nAngular vein: XA8ZS9\\nTemporal vein: XA6HG4\\nDeep anterior temporal vein: XA1GE4\\nMiddle temporal vein: XA8SD6\\nDeep posterior temporal vein: XA30B2\\nSuperficial temporal vein: XA2NX9\\nBasilar plexus: XA6SL1\\nBuccinator vein: XA5SG1\\nCerebellar vein: XA91N0\\nInferior cerebellar vein: XA93W0\\nSuperior cerebellar vein: XA2Z35\\nCerebral vein: XA2LX2\\nInternal cerebral vein: XA6DC3\\nDeep middle cerebral vein: XA1MX7\\nInferior cerebral vein: XA0U80\\nMiddle cerebral vein: XA43H1\\nSuperficial middle cerebral vein: XA4WV6\\nSuperior cerebral vein: XA0E47\\nSmall anterior cerebral vein: XA7VW1\\nGreat cerebral vein: XA18W3\\nChoroid vein: XA49Y4\\nCricothyroid vein: XA7C08\\nDeep cervical vein: XA9U81\\nDiploic vein: XA2QB0\\nFrontal diploic vein: XA6VQ5\\nAnterior temporal diploic vein: XA6694\\nPosterior temporal diploic vein: XA5AY0\\nOccipital diploic vein: XA2HM1\\nEmissary vein of the foramen of Vesalius: XA12G2\\nEmissary vein: XA14M4\\nCondyloid emissary vein: XA6BA1\\nOccipital emissary vein: XA4K04\\nMastoid emissary vein: XA8C81\\nParietal emissary vein: XA0T02\\nFrontal vein: XA74U9\\nFrontal venous lacunae: XA0CA3\\nGreat anastomotic vein of Trolard: XA3DS7\\nInferior striate vein: XA9GT2\\nMaxillary vein: XA4ZZ3\\nLaryngeal vein: XA23C4\\nInferior laryngeal vein: XA2JH6\\nSuperior laryngeal vein: XA3XZ1\\nMasseteric vein: XA8Z61\\nLingual vein: XA8NY9\\nMeningeal vein: XA4105\\nAnterior meningeal vein: XA8D07\\nMiddle meningeal vein: XA5600\\nPosterior meningeal vein: XA73V2\\nOccipital vein: XA01E7\\nOccipital venous lacunae: XA7AS3\\nOphthalmic vein: XA0X91\\nSuperior ophthalmic vein: XA6C95\\nInferior ophthalmic vein: XA8M04\\nPalatine vein: XA1SM5\\nParietal venous lacunae: XA4HX4\\nParotid vein: XA91G2\\nPharyngeal vein: XA98C1\\nPosterior anastomotic vein of Labb: XA2NF3\\nPterygoid venous plexus: XA0QP2\\nSphenopalatine vein: XA0M51\\nStylomastoid vein: XA4XY4\\nSublingual vein: XA7K99\\nSubmaxillary vein: XA7ZY4\\nSubmental vein: XA1LD6\\nTerminal vein: XA8680\\nTracheal vein: XA7F45\\nTransverse cervical vein: XA6945\\nVein from the tympanic cavity: XA22T9\\nVein of the ala nasi: XA21F0\\nVein of the pterygoid canal: XA9914\\nVena comitans of the hypoglossal nerve: XA1RH4\\nVenous jugular arch: XA1K34\\nVenous Sinuses: XA1VJ8\\nCavernous sinus: XA5WN3\\nConfluence of the sinuses: XA4NJ4\\nInferior petrosal sinus: XA6ZV2\\nInferior sagittal sinus: XA9ED6\\nOccipital sinus: XA2SC7\\nSigmoid sinus: XA4041\\nStraight sinus: XA03D2\\nSuperior sagittal sinus: XA81R3\\nSuperior petrosal sinus: XA1YP1\\nTransverse sinus: XA4289\\nSphenoparietal sinus: XA5255\\nIntercavernous sinus: XA3U52\\nAnterior intercavernous sinus: XA8P44\\nPosterior intercavernous sinus: XA7QE4\\nCircular sinus: XA9JS4\\nPetrosquamous sinus: XA6UW5\\nSinus of the dura mater: XA6HK7\\nCranial venous sinus: XA5UX2\\nThyroid vein: XA9VA8\\nInferior thyroid vein: XA2KJ8\\nMiddle thyroid vein: XA2DN0\\nSuperior thyroid vein: XA9BZ3\\nPalpebral vein: XA9SD5\\nInferior palpebral vein: XA9K84\\nSuperior palpebral vein: XA9T11\\nLateral palpebral vein: XA0Z20\\nLabial vein: XA52V8\\nInferior labial vein: XA5DP6\\nSuperior labial vein: XA4AG1\\nAuricular vein: XA97T8\\nAnterior auricular vein: XA46F3\\nPosterior auricular vein: XA67N9\\nFacial vein: XA0BP3\\nAnterior facial vein: XA7WC0\\nDeep facial vein: XA2681\\nCommon facial vein: XA3LQ0\\nPosterior facial vein: XA4NP1\\nTransverse facial vein: XA5GY9\\nJugular vein: XA4582\\nAnterior jugular vein: XA9U48\\nInternal jugular vein: XA46B9\\nExternal jugular vein: XA99S7\\nPosterior external jugular vein: XA31W7\\nOrbital vein: XA9XW7\\nVein of the pericranium: XA73J2\\nAnterior vertebral vein: XA0ET2\\nDeep temporal vein: XA1LU7\\nExtraspinal vein: XA2L55\\nInternal auditory vein: XA5YM5\\nPterygoid plexus: XA5TG4\\nPterygoid vein: XA1VP6\\nSuperior sagittal vein: XA1RV1\\nVertebral vein: XA7QR6\\nAnterior vertebral venous plexus: XA0BP6\\nVein of thorax: XA8CT1\\nAccessory hemiazygos vein: XA6DM9\\nAzygos vein: XA7AN5\\nBrachiocephalic vein: XA57F8\\nBronchial vein: XA1GY9\\nDiaphragmatic vein: XA9NE2\\nOesophageal vein: XA3VU3\\nHemiazygos vein: XA4GF1\\nInnominate vein: XA27D1\\nIntercostal vein: XA9HG3\\nMediastinal vein: XA6JE5\\nSubclavian vein: XA6YT2\\nSubcostal vein: XA3568\\nSuperior epigastric vein: XA4VD1\\nSuperior vena cava: XA5WA4\\nSuperior intercostal vein: XA4DR2\\nInternal mammary vein: XA3V69\\nTransverse scapular vein: XA2DL5\\nSubscapular vein: XA8WJ4\\nThymic vein: XA2YF2\\nVein of abdomen: XA0RA8\\nAscending lumbar vein: XA4DQ4\\nCaput medusae vein: XA9PF5\\nCystic Vein: XA1MQ4\\nIleocolic vein: XA95M2\\nInferior vena cava: XA7UV5\\nHepatic Vein: XA2UD7\\nLumbar vein: XA52L9\\nPancreatic vein: XA3X37\\nPancreaticoduodenal vein: XA4XM0\\nParaumbilical Vein: XA0N54\\nPortal Vein: XA1E17\\nRectal venous plexus: XA5JV6\\nSplenic vein: XA0J33\\nThoracoepigastric vein: XA46Q0\\nColic vein: XA2DK6\\nRight colic vein: XA2UN4\\nMiddle colic vein: XA49E0\\nLeft colic vein: XA2WF1\\nRectal vein: XA5T10\\nMiddle rectal vein: XA6NJ4\\nInferior rectal vein: XA80L8\\nSuperior hemorrhoidal vein: XA30C9\\nPerineal hemorrhoidal vein: XA34F0\\nPhrenic vein: XA1EK8\\nSuperior phrenic vein: XA27Y3\\nInferior phrenic vein: XA0EZ6\\nMesenteric vein: XA5KA1\\nSuperior mesenteric vein: XA4DA7\\nInferior mesenteric vein: XA4EK2\\nEpigastric vein: XA04Q7\\nSuperficial epigastric vein: XA8WC0\\nInferior epigastric vein: XA30F2\\nVeins of stomach: XA1C53\\nGastric vein: XA7CB3\\nLeft gastric vein: XA73S8\\nRight gastric vein: XA23Q4\\nShort gastric vein: XA5QC9\\nGastroepiploic vein: XA2R35\\nIntestinal vein: XA55H2\\nVein of pelvis: XA26H2\\nRenal vein: XA3200\\nCorpus cavernosum penis: XA6YL8\\nDeep dorsal vein of the penis: XA03F7\\nIliolumbar vein: XA9X28\\nDeep vein of the penis: XA7U63\\nObturator vein: XA5AH6\\nOvarian Vein: XA4PC3\\nPampiniform plexus: XA05M3\\nPerineal vein: XA1W18\\nProstatic vein: XA8WY0\\nPubic vein: XA0GG0\\nSigmoid vein: XA8HY5\\nSuperficial dorsal vein of the penis: XA4TQ4\\nSuprarenal vein: XA2WW4\\nUterine plexus: XA7AB3\\nUterine vein: XA8M77\\nVaginal vein: XA1MK5\\nVesical plexus: XA0DB7\\nVesical vein: XA7GN4\\nVulval vein: XA9GG9\\nGluteal vein: XA8GA3\\nInferior gluteal vein: XA3HW8\\nSuperior gluteal vein: XA47S7\\nIliac vein: XA03Q4\\nInternal iliac vein: XA3EG0\\nExternal iliac vein: XA49T5\\nCommon iliac vein: XA7W40\\nDeep iliac circumflex vein: XA3H93\\nSacral vein: XA71Q4\\nLateral sacral vein: XA4PJ8\\nMiddle sacral vein: XA9Z04\\nSpermatic Vein: XA5KK7\\nPudendal vein: XA3F81\\nInternal pudendal vein: XA7XD2\\nSuperficial external pudendal vein: XA6NF9\\nDeep external pudendal vein: XA1ET7\\nAdrenal vein: XA6TQ3\\nVein of upper extremity: XA9WN7\\nAccessory cephalic vein: XA0QT1\\nAxillary vein: XA3EY8\\nBasilic vein: XA6JD7\\nBrachial vein: XA43Q5\\nCephalic vein: XA4YQ8\\nCommon volar digital vein: XA7FD2\\nDeep volar venous arch: XA7902\\nDorsal interosseous vein: XA6NS3\\nDorsal metacarpal vein: XA9886\\nLateral thoracic vein: XA4A41\\nMedian antebrachial vein: XA3TW9\\nMedian basilic vein: XA1YZ7\\nProper volar digital vein: XA3GZ6\\nRadial vein: XA32L8\\nSuperficial volar venous arch: XA7HM9\\nUlnar vein: XA8CK3\\nVolar digital vein: XA2Y72\\nVolar interosseous vein: XA2C08\\nVolar metacarpal vein: XA13N1\\nVein of lower extremity: XA76A3\\nAccessory saphenous vein: XA8WJ3\\nAnterior tibial vein: XA4CQ8\\nCommon digital vein: XA23R2\\nDeep Femoral Vein: XA3E41\\nDeep plantar venous arch: XA8RN9\\nFemoral vein: XA3QX9\\nGreat saphenous vein: XA59H1\\nLateral femoral circumflex vein: XA74K2\\nLateral marginal vein: XA4L08\\nLateral plantar vein: XA0L88\\nMedial femoral circumflex vein: XA8PZ9\\nMedial marginal vein: XA1XM3\\nMedial plantar vein: XA85B7\\nMetatarsal vein: XA7ND7\\nPlantar cutaneous venous arch: XA4EV7\\nPlantar digital vein: XA8657\\nPopliteal vein: XA08Q1\\nPosterior tibial vein: XA5D60\\nSmall saphenous vein: XA2073\\nSuperficial iliac circumflex vein: XA8HR9\\nPeroneal vein: XA4930\\nAnterior femoral cutaneous vein: XA8LE8\\nVena cava: XA60H0\\nBlood Vessels: XA21T7\\nBlood vessel of the finger: XA6943\\nBlood vessel of the thumb: XA7SM4\\nBlood vessels at wrist or hand level: XA6Y60\\nBlood vessel of the kidney: XA08R7\\nBlood vessel of the lung: XA5K61\\nBlood vessel of the neck: XA9AN5\\nBlood vessel of the thorax: XA8N71\\nBlood vessel of hip: XA7P54\\nBlood vessels at lower leg level: XA9M17\\nCapillary not elsewhere classified: XA2769\\nCerebral vasculature: XA5TF7\\nIntracranial blood vessels not elsewhere classified: XA4H19\\nExtracranial blood vessels not elsewhere classified: XA1SX5\\nHeart: XA6H07\\nLeft atrium: XA6548\\nMitral valve: XA7V72\\nCusps of mitral valve: XA3GE9\\nChordae tendineae of mitral valve: XA69W6\\nInteratrial septum: XA78X5\\nRight atrium: XA6T92\\nTricuspid valve: XA6FF2\\nCusps of tricuspid valve: XA19H9\\nChordae tendineae of tricuspid valve: XA4LY3\\nLeft ventricle: XA8FJ7\\nAortic valve: XA19J4\\nCusps of aortic valve: XA2QK7\\nLeft ventricular papillary muscles: XA7S34\\nInterventricular septum: XA5651\\nRight ventricle: XA9HH8\\nRight ventricular papillary muscles: XA5Y16\\nPulmonary valve: XA6WC4\\nCusps of pulmonary valve: XA1403\\nCoronary arteries: XA3B03\\nLeft main coronary artery: XA0F62\\nLeft circumflex artery: XA9FX9\\nLeft anterior descending coronary artery: XA7NQ7\\nDiagonal branches of left anterior descending coronary artery: XA2N78\\nD first diagonal branch: XA20E5\\nD second diagonal branch: XA86J1\\nD third diagonal branch: XA5SR3\\nLeft obtuse marginal artery: XA1SH6\\nRamus intermedius artery: XA3QP2\\nSeptal artery: XA5LW8\\nRight coronary artery: XA2QX7\\nRight acute marginal artery: XA1LL7\\nPosterior interventricular artery: XA81T7\\nPosterolateral artery: XA8PS0\\nSinoatrial nodal artery: XA7TB5\\nCardiac veins: XA9FK9\\nOblique vein of the left atrium: XA6YW4\\nLeft marginal vein of heart: XA0HP7\\nGreat cardiac vein: XA38Z5\\nPosterior vein of the left ventricle: XA8HT6\\nMiddle cardiac vein: XA3UN3\\nSmall cardiac vein: XA6QD7\\nCoronary sinus: XA16E4\\nAnterior cardiac veins: XA4TZ2\\nSmallest cardiac vein: XA9498\\nRight marginal vein of heart: XA2KE8\\nPericardial vein: XA4366\\nChamber of the heart: XA10E0\\nCardiac atrium: XA91S4\\nCardiac ventricle: XA7XU8\\nConnective and other soft tissue of heart: XA3113\\nArteries of heart: XA42G7\\nPericardiophrenic artery: XA9X98\\nPericardium: XA2XU0\\nParietal pericardium: XA8RK9\\nPericardial cavity: XA48H9\\nEpicardium: XA37Q8\\nEndocardium: XA3227\\nCardiac septum: XA81Z5\\nPapillary muscle: XA2DC8\\nHeart wall: XA6CK2\\nAnterior wall of heart: XA7RE3\\nAnterolateral wall of heart: XA5W05\\nAnteroseptal wall of heart: XA2RT9\\nAnteroapical wall of heart: XA4U99\\nInferior wall of heart: XA3RM8\\nInferolateral wall of heart: XA61Y9\\nInferoposterior wall of heart: XA2H88\\nApicallateral wall of heart: XA8ZQ8\\nBasallateral wall of heart: XA6GR4\\nHigh lateral wall of heart: XA1HH6\\nLateral wall of heart: XA3XS7\\nTrue posterior wall of heart: XA01U7\\nPosterobasal wall of heart: XA7D76\\nPosterolateral wall of heart: XA4RC1\\nPosteroseptal wall of heart: XA60V2\\nSeptal wall of heart: XA83Q5\\nCardiac electrical conducting system: XA79Z5\\nSinoatrial node: XA1UE3\\nAtrioventricular node: XA4359\\nBundle of His: XA7J11\\nHeart valve: XA0QB6\\nMyocardium: XA8SK6\\nLymphatic system of the head and neck: XA10P2\\nJugular lymphatic trunk: XA0LH6\\nLymphatic vessel of the pinna: XA6TY4\\nLymphatic vessel of the external acoustic meatus: XA02Y8\\nLymphatic vessel of the face: XA1EC8\\nLymphatic vessel of the palatine tonsil: XA0167\\nLymphatic vessel of the scalp: XA4QZ6\\nLymphatic vessel of the tongue: XA9FT5\\nLymphatic vessels of the skin and muscles of the neck: XA1G40\\nLymphatic system of the upper extremity: XA23Z9\\nDeep lymphatic vessel: XA05S0\\nDorsal interosseous lymphatic vessel: XA6D43\\nMedian lymphatic vessel: XA7FS7\\nRadial lymphatic vessel: XA3HQ3\\nSuperficial lymphatic vessel: XA12G8\\nUlnar lymphatic vessel: XA4UB1\\nVolar lymphatic vessel: XA5SZ5\\nLymphatic system of the thorax: XA52C3\\nBronchomediastinal trunk: XA94Z9\\nCisterna chyli lymph sac: XA7474\\nDeep lymphatic vessel of the thoracic wall: XA1VK9\\nIntestinal lymphatic trunk: XA9D98\\nJugular lymph sac: XA8JF4\\nLymph Sac: XA1SQ2\\nLymphatic vessel of the diaphragm: XA8YM1\\nLymphatic vessel of the breast: XA4RC7\\nLymphatic vessel of the thoracic viscera: XA3SY2\\nLymphatic vessel of the heart: XA55B8\\nLymphatic vessel of the lungs: XA3EB8\\nLymphatic vessel of the oesophagus: XA8QZ0\\nLymphatic vessel of the pericardium: XA6J62\\nLymphatic vessel of the pleura: XA4QL2\\nLymphatic vessel of the thymus: XA3JF4\\nPosterior lymph sac: XA4J10\\nRetroperitoneal lymph sac: XA8MX8\\nRight lymphatic duct: XA3ER1\\nSuperficial lymphatic vessel of the thoracic wall: XA3TX9\\nThoracic duct: XA8A74\\nLymphatic system of the abdomen: XA81G2\\nIntestinal lumbar trunk: XA07V7\\nLumbar lymphatic trunk: XA6R71\\nLymphatic vessel of the caecum: XA9XL5\\nLymphatic vessel of the colon: XA1BU5\\nLymphatic vessel of the duodenum: XA92E5\\nLymphatic vessel of the gallbladder: XA6VD0\\nLymphatic vessel of the ileum: XA55Y5\\nLymphatic vessel of the jejunum: XA4CQ1\\nLymphatic vessel of the kidney: XA3610\\nLymphatic vessel of the liver: XA0WY9\\nLymphatic vessel of the pancreas: XA9YZ4\\nLymphatic vessel of the spleen: XA5LE6\\nLymphatic vessel of the stomach: XA1599\\nLymphatic vessel of the subdiaphragmatic portion of the digestive tube: XA3RD0\\nLymphatic vessel of the suprarenal lymph node: XA21T8\\nLymphatic vessel of the vermiform process: XA29U5\\nLymphatic system of the pelvis and perineum: XA6709\\nAnterior vesical lymphatic vessel of the bladder: XA9H16\\nLateral vesical lymphatic vessel of the bladder: XA28F6\\nLymphatic vessel of the anal canal: XA4LM3\\nLymphatic vessel of the anus: XA5C29\\nLymphatic vessel of the bladder: XA1UK6\\nLymphatic vessel of the ductus deferens: XA16J8\\nLymphatic vessel of the ovary: XA4229\\nLymphatic vessel of the prostate: XA1SS8\\nLymphatic vessel of the rectum: XA6DH7\\nLymphatic vessel of the reproductive organs: XA2XZ6\\nLymphatic vessel of the testes: XA1UA0\\nLymphatic vessel of the ureter: XA6324\\nLymphatic vessel of the urethra: XA6HM6\\nLymphatic vessel of the urinary organ: XA7JY4\\nLymphatic vessel of the uterine tube: XA5755\\nLymphatic vessel of the uterus: XA9PA3\\nLymphatic vessel of the vagina: XA1ZK1\\nLymphatic vessel of the seminal vesicles: XA0GB7\\nLymphatic system of the lower extremity: XA0Z86\\nAnterior tibial lymphatic trunk: XA6UC7\\nUpper respiratory tract: XA8Z63\\nNasal cavity: XA43C9\\nNasal vestibule: XA53X2\\nNasal septum: XA8D47\\nNasal turbinate: XA8817\\nNasal cartilage: XA7WQ4\\nNasal mucosa: XA4CN5\\nConnective subcutaneous and other soft tissues of nasal cavity: XA6YH7\\nnasal arch vein: XA3HQ4\\nAccessory sinuses: XA3523\\nMaxillary sinus: XA1R64\\nEthmoid sinus: XA58F6\\nFrontal sinus: XA91G8\\nSphenoid sinus: XA4U67\\nNasopharynx: XA9AZ1\\nSuperior wall of nasopharynx: XA0659\\nAnterior wall of nasopharynx: XA21P9\\nPosterior wall of nasopharynx: XA4BR4\\nAdenoid: XA5AS8\\nLateral wall of nasopharynx: XA7PX5\\nPharyngeal recess: XA7W35\\nRetropharyngeal recess: XA9P89\\nParapharyngeal recess: XA6QY3\\nLarynx: XA2RH5\\nSupraglottic larynx: XA1PB3\\nEpiglottis: XA9ZY9\\nAnterior surface of epiglottis: XA4DV7\\nPosterior surface of epiglottis: XA8U54\\nAryepiglottic fold: XA9907\\nLaryngeal aspect of aryepiglottic fold: XA8N50\\nGlottis: XA7AE7\\nVocal cord: XA3299\\nSubglottic larynx: XA25B1\\nLaryngeal cartilage: XA0NK8\\nArytenoid cartilage: XA0AF3\\nCricoid cartilage: XA7S05\\nCricoarytenoid articulation: XA2383\\nCricothyroid articulation: XA73G2\\nCuneiform cartilage: XA7SZ3\\nThyroid cartilage: XA2716\\nLower respiratory tract: XA07R2\\nTrachea: XA26H1\\nCervical trachea: XA7SG3\\nThoracic trachea: XA4RN3\\nLung: XA57M6\\nMain bronchus: XA9TC5\\nRight main bronchus: XA3L52\\nLeft main bronchus: XA5FV2\\nCarina: XA4JA0\\nRight lung: XA7EZ3\\nHilum of right lung: XA29Y4\\nRight upper lobe bronchus: XA8Z30\\nRight lower lobe bronchus: XA41Z3\\nRight middle lobe bronchus: XA1QM3\\nLeft lung: XA2UD3\\nHilum of left lung: XA6VA2\\nLeft upper lobe bronchus: XA6F58\\nLingula of lung: XA4565\\nLeft lower lobe bronchus: XA2XH5\\nLobe of lung: XA90M2\\nUpper lobe of lung: XA9HN5\\nMiddle lobe of lung: XA1N36\\nLower lobe of lung: XA7L34\\nUpper lobe bronchus: XA37W0\\nMiddle lobe bronchus: XA1K94\\nLower lobe bronchus: XA8JM5\\nConnective and other soft tissues of lung: XA2PV7\\nBronchus: XA61M6\\nLung parenchyma: XA8Z62\\nAlveoli: XA5772\\nPulmonary vasculature: XA4646\\nPulmonary vein: XA8FY4\\nLeft pulmonary vein: XA1WN5\\nLeft superior pulmonary vein: XA9941\\nLeft inferior pulmonary vein: XA8TW3\\nRight pulmonary vein: XA86L0\\nRight superior pulmonary vein: XA05T2\\nRight inferior pulmonary vein: XA41F3\\nAccesory right pulmonary vein: XA4530\\nCommon left sided trunk of pulmonary veins: XA1SF4\\nPulmonary capillaries: XA0F36\\nPleura: XA5TT2\\nVisceral pleura: XA1B59\\nParietal pleura: XA7RC6\\nArtery of lung: XA4U64\\nEfferent arteriole of the interlobular artery: XA2AT1\\nInterlobar artery: XA6WT9\\nInterlobular artery: XA2S57\\nPulmonary trunk: XA3713\\nBronchioles: XA5437\\nMouth: XA8182\\nVestibule of mouth: XA5TW5\\nLabial mucosa of upper lip: XA9072\\nLabial mucosa of lower lip: XA72W2\\nBuccal mucosa: XA8WB3\\nRetromolar region: XA0S17\\nLabial sulcus: XA44M8\\nSuperior labial sulcus: XA2151\\nInferior labial sulcus: XA52Q7\\nBuccal sulcus: XA6A73\\nSuperolateral buccal sulcus: XA6WJ3\\nInferolateral buccal sulcus: XA5MG3\\nGingivae: XA54T3\\nUpper gingiva: XA6743\\nUpper alveolar mucosa: XA2C94\\nUpper alveolar ridge mucosa: XA7DA0\\nLower gingiva: XA9303\\nLower alveolar mucosa: XA96F2\\nLower alveolar ridge mucosa: XA8C21\\nAlveolar mucosa: XA3SP9\\nTeeth: XA6CZ2\\nPermanent dentition: XA4GG3\\nUpper right rd molar: XA5306\\nUpper right nd molar: XA0BR9\\nUpper right st molar: XA0TL3\\nUpper right nd bicuspid: XA45K9\\nUpper right st bicuspid: XA64J5\\nUpper right canine: XA0LE1\\nUpper right \\xa0lateral incisor: XA3QH3\\nUpper right central incisor: XA43X2\\nUpper left rd molar: XA8328\\nUpper left nd molar: XA1YK1\\nUpper left st molar: XA2GW7\\nUpper left nd bicuspid: XA5Z15\\nUpper left st bicuspid: XA3EF6\\nUpper left canine: XA2LF2\\nUpper left \\xa0lateral incisor: XA0MG2\\nUpper left central incisor: XA9P69\\nLower right rd molar: XA8YF6\\nLower right nd molar: XA5CA4\\nLower right st molar: XA5M57\\nLower right nd bicuspid: XA26X2\\nLower right st bicuspid: XA47C4\\nLower right canine: XA95A1\\nLower right \\xa0lateral incisor: XA8660\\nLower right central incisor: XA5NT8\\nLower left rd molar: XA0XB1\\nLower left nd molar: XA8YV5\\nLower left st molar: XA6R23\\nLower left nd bicuspid: XA80S2\\nLower left st bicuspid: XA1SQ7\\nLower left canine: XA8P88\\nLower left \\xa0lateral incisor: XA4B13\\nLower left central incisor: XA7B54\\nDeciduous dentition: XA7675\\nUpper right nd molar deciduous: XA2GE5\\nUpper right st molar deciduous: XA7ZT9\\nUpper right canine deciduous: XA06P0\\nUpper right \\xa0lateral incisor deciduous: XA2XZ5\\nUpper right central incisor deciduous: XA3BG3\\nUpper left nd molar deciduous: XA2BD4\\nUpper left st molar deciduous: XA85K7\\nUpper left canine deciduous: XA98V8\\nUpper left lateral incisor deciduous: XA9QP7\\nUpper left central incisor deciduous: XA4ZQ5\\nLower right nd molar deciduous: XA6F50\\nLower right st molar deciduous: XA36B2\\nLower right canine deciduous: XA8KQ7\\nLower right \\xa0lateral incisor deciduous: XA1W31\\nLower right central incisor deciduous: XA6TB6\\nLower left nd molar deciduous: XA8NE2\\nLower left st molar deciduous: XA55D8\\nLower left canine deciduous: XA8QV7\\nLower left \\xa0lateral incisor deciduous: XA8MH6\\nLower left central incisor deciduous: XA2RW5\\nParts of tooth: XA1PT3\\nPulp: XA5B71\\nDentin: XA6FX3\\nEnamel: XA5R09\\nCementum: XA4KC7\\nPeriapical tissue: XA2CA1\\nSurfaces of the teeth: XA2US1\\nDistal surface of tooth: XA5ML5\\nLabial surface of tooth: XA4UP2\\nBuccal surface of tooth: XA6DE2\\nIncisal surface of tooth: XA3W20\\nLingual surface of tooth: XA8M68\\nMesial surface of tooth: XA5Z48\\nOcclusal surface of tooth: XA5DM8\\nProximal surface of tooth: XA3HD5\\nOral cavity: XA1WN1\\nPalate: XA7ZA6\\nHard palate: XA4527\\nSoft palate: XA8HL5\\nUvula: XA2993\\nPalatal mucosa: XA00H5\\nTongue: XA1T19\\nBody of tongue: XA8Q87\\nMidline of tongue: XA65E9\\nJunctional zone of tongue: XA8SX3\\nBase of tongue: XA25G3\\nPosterior of tongue: XA2B11\\nDorsal surface of tongue: XA1V27\\nDorsal surface of body of tongue: XA8YB9\\nDorsal surface of base of tongue: XA0HQ3\\nOther and unspecified parts of tongue: XA9RP1\\nVentral surface of tongue: XA8FK4\\nLingual frenulum: XA9YA2\\nBorder of tongue: XA4DB6\\nLateral margin of tongue: XA49C6\\nTip of tongue: XA1WZ8\\nFloor of mouth: XA8EY7\\nAlveololingual sulcus: XA69M6\\nMucosa of floor of mouth: XA8CF9\\nTonsillar region: XA29D3\\nGlossopalatine arch: XA9A13\\nAnterior tonsillar pillar: XA2JB0\\nTonsillar fossa: XA46Z4\\nPharyngopalatine arch: XA3021\\nPosterior tonsillar pillar: XA0X58\\nPalatine arch: XA15G1\\nOral mucosa: XA6NQ7\\nOther and unspecified parts of mouth: XA2KN0\\nSalivary gland apparatus: XA5T23\\nParotid gland: XA07S5\\nSubmandibular gland: XA9Q61\\nLeft submandibular gland: XA0CS1\\nRight submandibular gland: XA8GQ5\\nSubmandibular gland duct: XA7GY0\\nSublingual gland: XA51Q9\\nMinor salivary gland: XA30Q1\\nSalivary duct: XA5CM1\\nParotid gland duct: XA44X8\\nSublingual gland duct: XA1J93\\nPharynx: XA93V5\\nOropharynx: XA4J67\\nLateral wall of oropharynx: XA8RX5\\nPosterior wall of oropharynx: XA8659\\nVallecula: XA88V4\\nBranchial cleft: XA60Q5\\nHypopharynx: XA2J67\\nPiriform recess: XA3MZ0\\nPostcricoid region: XA4NZ9\\nHypopharyngeal wall: XA0XK1\\nGastrointestinal tract: XA9607\\nOesophagus: XA0828\\nUpper third of oesophagus: XA1180\\nMiddle third of oesophagus: XA2BY3\\nLower third of oesophagus: XA9CB6\\nCervical oesophagus: XA0N03\\nThoracic oesophagus: XA8JT3\\nAbdominal oesophagus: XA0TN5\\nOverlapping sites of oesophagus: XA4YW8\\nCardioesophageal junction: XA7SR6\\nStomach: XA7MC7\\nGastric cardia: XA2828\\nGastric corpus: XA7UE1\\nGastric fundus: XA56K7\\nGastric pylorus: XA6P89\\nPyloric antrum: XA4EC5\\nGreater curvature of stomach: XA7WQ5\\nLesser curvature of stomach: XA4ML9\\nSmall intestine: XA6452\\nDuodenum: XA9780\\nJejunum: XA8UM1\\nIleum: XA0QT6\\nLarge intestine: XA1B13\\nCaecum: XA6J68\\nColon: XA03U9\\nAscending colon: XA3AL5\\nHepatic flexure of colon: XA95L3\\nTransverse colon: XA49U1\\nSplenic flexure of colon: XA1PY9\\nDescending colon: XA2G13\\nSigmoid colon: XA8YJ9\\nRectosigmoid junction: XA33J5\\nDescending colon and splenic flexure of colon: XA7177\\nAscending colon and right flexure of colon: XA25P9\\nRectum: XA4KU2\\nAnus: XA0D34\\nAnal Canal: XA39S6\\nCloacogenic zone: XA8QB7\\nUpper gastrointestinal tract not elsewhere classified: XA28R6\\nAppendix: XA8PW4\\nHepatobiliary system: XA0W19\\nLiver: XA5DY0\\nLeft lobe of liver: XA5766\\nRight lobe of liver: XA2KG6\\nCaudate lobe of liver: XA3278\\nQuadrate lobe of liver: XA13D3\\nBiliary tract: XA0KT3\\nHepatic bile ducts: XA4415\\nLeft hepatic duct: XA89K4\\nRight hepatic duct: XA6M95\\nCommon hepatic duct: XA96K1\\nCystic duct: XA0077\\nGallbladder: XA8KL9\\nCommon bile duct: XA6R80\\nSphincter of Oddi: XA6WA8\\nAmpulla of Vater: XA7QA8\\nExtrahepatic bile duct: XA9HM5\\nPancreas: XA3QC5\\nHead of pancreas: XA1412\\nNeck of pancreas: XA8LA4\\nBody of pancreas: XA6ZE4\\nTail of pancreas: XA0CX6\\nPancreatic duct: XA1XL7\\nDuct of Santorini: XA8WC8\\nDuct of Wirsung: XA3789\\nPeritoneum: XA0KZ0\\nRetroperitoneum: XA6S21\\nMesentery: XA43V8\\nOmentum: XA6DF7\\nMesoappendix: XA46W1\\nMesocolon: XA4QM7\\nPelvic peritoneum: XA5PF4\\nSkin: XA0364\\nEpidermis: XA3JN1\\nStratum corneum: XA5P21\\nStratum lucidum: XA3G02\\nStratum granulosum: XA4W90\\nStratum spinosum: XA8AM6\\nStratum basale: XA9QS1\\nEpidermal basement membrane: XA8JE9\\nEpidermal appendages: XA8113\\nHair follicle: XA0XC8\\nHair bulb: XA2MW3\\nSebaceous gland: XA6666\\nApocrine sweat gland: XA7487\\nHair shaft: XA6DT2\\nHair: XA8T72\\nScalp hair: XA5Y68\\nEyebrow hairs: XA78D2\\nEyelashes: XA1RK2\\nBeard hair: XA9N28\\nBody hair: XA1WH2\\nPubic hair: XA12U4\\nNail apparatus: XA4S72\\nNail matrix: XA4KT3\\nGerminal matrix: XA5LM0\\nSterile matrix: XA0060\\nNail: XA6Q52\\nPerionychium: XA5US0\\nEponychium: XA1ES4\\nHyponychium: XA0NS1\\nEccrine gland: XA63U7\\nAcrosyringium: XA6PJ1\\nEccrine sweat duct: XA7P52\\nEccrine sweat coil: XA5VA9\\nDermis: XA1QT7\\nPapillary dermis: XA4LG9\\nReticular dermis: XA2Q30\\nHypodermis: XA2013\\nSubcutaneous fat: XA5CS6\\nAxial skeleton: XA4S38\\nBones of the head: XA4RY5\\nCranial Bones: XA1RZ4\\nBase of the skull: XA0E94\\nCalvarium: XA2BH0\\nCranial fossa: XA0KU6\\nAnterior fossa: XA7B66\\nMiddle fossa: XA8Y22\\nPosterior fossa: XA5U78\\nEthmoid bone: XA2SR4\\nFrontal bone: XA6ZM9\\nOccipital bone: XA5JA2\\nOccipital condyle: XA4RS9\\nOcciput: XA33W1\\nParietal bone: XA2J87\\nSphenoid bone: XA63R0\\nPituitary fossa: XA9N34\\nTemporal bone: XA2P19\\nPetrous bone: XA1E15\\nMastoid: XA68N3\\nOrbital bone: XA8E69\\nOrbital roof: XA9XW3\\nOrbital floor: XA7MW9\\nFacial bones: XA3Y16\\nHyoid bone: XA5CQ0\\nInferior nasal conchae: XA6UV6\\nLacrimal bone: XA9GZ6\\nPalatine bone: XA4319\\nVomer bone: XA14T2\\nZygomatic bone: XA8N32\\nMandible: XA51B7\\nAlveolar border of body of mandible: XA3B77\\nAngle of mandible: XA0M61\\nCondylar process of the mandible: XA98M7\\nSubcondylar process of mandible: XA7919\\nCoronoid process of the mandible: XA24B3\\nRamus of mandible: XA5969\\nSymphysis of mandible: XA8JR9\\nInferior maxilla: XA0NC8\\nMaxilla: XA7VK5\\nNasal bone: XA8E16\\nJaw unspecified: XA88P5\\nBones of middle ear: XA6EQ1\\nIncus: XA4D04\\nMalleus: XA5DS8\\nStapes: XA3WA4\\nVertebral column: XA5J55\\nVertebra: XA7MS2\\nCervical vertebra: XA9ZW8\\nAtlas: XA2XE8\\nPosterior arch of first cervical vertebra: XA0KQ4\\nLateral mass of first cervical vertebra: XA1304\\nAxis: XA17N0\\nOdontoid process: XA5W02\\nThird cervical vertebra: XA2W05\\nArch of third cervical vertebra: XA51V4\\nBody of third cervical vertebra: XA4UV1\\nProcesses of third cervical vertebra: XA8CG0\\nFourth cervical vertebra: XA3RE9\\nArch of fourth cervical vertebra: XA24X7\\nBody of fourth cervical vertebra: XA3GT0\\nProcesses of fourth cervical vertebra: XA75V3\\nFifth cervical vertebra: XA9C12\\nArch of fifth cervical vertebra: XA1PJ5\\nBody of fifth cervical vertebra: XA1BS2\\nProcesses of fifth cervical vertebra: XA2FY7\\nSixth cervical vertebra: XA5S79\\nArch of sixth cervical vertebra: XA8W16\\nBody of sixth cervical vertebra: XA9Q12\\nProcesses of sixth cervical vertebra: XA60Z0\\nSeventh cervical vertebra: XA34U8\\nArch of seventh cervical vertebra: XA05M5\\nBody of seventh cervical vertebra: XA1JS3\\nProcesses of seventh cervical vertebra: XA91D7\\nThoracic vertebra: XA6E88\\nFirst thoracic vertebra: XA3F93\\nArch of first thoracic vertebra: XA7UP5\\nBody of first thoracic vertebra: XA8PH0\\nProcesses of first thoracic vertebra: XA1AX4\\nSecond thoracic vertebra: XA8QS0\\nArch of second thoracic vertebra: XA2VV9\\nBody of second thoracic vertebra: XA3Z42\\nProcesses of second thoracic vertebra: XA6T61\\nThird thoracic vertebra: XA1Z15\\nArch of third thoracic vertebra: XA2SM3\\nBody of third thoracic vertebra: XA35A0\\nProcesses of third thoracic vertebra: XA41U9\\nFourth thoracic vertebra: XA0C31\\nArch of fourth thoracic vertebra: XA22W3\\nBody of fourth thoracic vertebra: XA3J42\\nProcesses of fourth thoracic vertebra: XA1WL4\\nFifth thoracic vertebra: XA3PH5\\nArch of fifth thoracic vertebra: XA28A7\\nBody of fifth thoracic vertebra: XA8W59\\nProcesses of fifth thoracic vertebra: XA0449\\nSixth thoracic vertebra: XA45S2\\nArch of sixth thoracic vertebra: XA29X2\\nBody of sixth thoracic vertebra: XA0YY2\\nProcesses of sixth thoracic vertebra: XA1R53\\nSeventh thoracic vertebra: XA59Y3\\nArch of seventh thoracic vertebra: XA54G1\\nBody of seventh thoracic vertebra: XA62Y3\\nProcesses of seventh thoracic vertebra: XA1CQ7\\nEighth thoracic vertebra: XA8NQ5\\nArch of eighth thoracic vertebra: XA3PL7\\nBody of eighth thoracic vertebra: XA5JX9\\nProcesses of eighth thoracic vertebra: XA1SD8\\nNinth thoracic vertebra: XA3E70\\nArch of ninth thoracic vertebra: XA9N69\\nBody of ninth thoracic vertebra: XA2X21\\nProcesses of ninth thoracic vertebra: XA5SW1\\nTenth thoracic vertebra: XA0AV7\\nArch of tenth thoracic vertebra: XA7LF7\\nBody of tenth thoracic vertebra: XA6VP6\\nProcesses of tenth thoracic vertebra: XA7122\\nEleventh thoracic vertebra: XA7T69\\nArch of eleventh thoracic vertebra: XA98R9\\nBody of eleventh thoracic vertebra: XA91J0\\nProcesses of eleventh thoracic vertebra: XA92Q6\\nTwelfth thoracic vertebra: XA69W5\\nArch of twelfth thoracic vertebra: XA15N3\\nBody of twelfth thoracic vertebra: XA1401\\nProcesses of twelfth thoracic vertebra: XA2D62\\nLumbar vertebra: XA0D60\\nFirst lumbar vertebra: XA3291\\nArch of first lumbar vertebra: XA8AX7\\nBody of first lumbar vertebra: XA9E61\\nProcesses of first lumbar vertebra: XA4U01\\nSecond lumbar vertebra: XA2GH9\\nArch of second lumbar vertebra: XA24M1\\nBody of second lumbar vertebra: XA5079\\nProcesses of second lumbar vertebra: XA52T1\\nThird lumbar vertebra: XA3N97\\nArch of third lumbar vertebra: XA3G24\\nBody of third lumbar vertebra: XA0TL0\\nProcesses of third lumbar vertebra: XA80X7\\nFourth lumbar vertebra: XA9A53\\nArch of fourth lumbar vertebra: XA7CH7\\nBody of fourth lumbar vertebra: XA4145\\nProcesses of fourth lumbar vertebra: XA38A4\\nFifth lumbar vertebra: XA9641\\nArch of fifth lumbar vertebra: XA2JV2\\nBody of fifth lumbar vertebra: XA5886\\nProcesses of fifth lumbar vertebra: XA4PS3\\nSacrum: XA14W3\\nCoccyx: XA4V28\\nIntervertebral disc or space: XA02R1\\nCervical discs or space: XA8D30\\nCervical intervertebral disc or space CC: XA16L1\\nCervicothoracic disc or space CT: XA2SG0\\nThoracic discs or space: XA1N54\\nThoracic intervertebral disc or space TT: XA5LG2\\nThoracolumbar intervertebral disc or space TL: XA97A4\\nLumbar discs or space: XA54S5\\nLumbar intervertebral disc or space LL: XA2N96\\nLumbosacral intervertebral disc or space LS: XA54R2\\nIntervertebral disc: XA2Y58\\nNucleus pulposus: XA8WM9\\nAnnulus fibrosus: XA10M1\\nBones of the thorax: XA5VB6\\nRib: XA5TK7\\nFirst rib: XA98Q1\\nSecond rib: XA7XY2\\nThird rib: XA2U21\\nFourth rib: XA4SQ6\\nFifth rib: XA31L8\\nSixth rib: XA63Z2\\nSeventh rib: XA2WC3\\nEighth rib: XA9WQ3\\nNinth rib: XA31V8\\nTenth rib: XA54R4\\nEleventh rib: XA3VH4\\nTwelfth rib: XA6W52\\nSternum: XA6NB3\\nBody of sternum: XA3M45\\nManubrium: XA0K13\\nXiphoid: XA2RB7\\nBones of the pelvis: XA4N47\\nPelvis: XA8Y23\\nIlium: XA5FT5\\nIliac crest: XA4743\\nIschium: XA5L47\\nPubis: XA82W3\\nSuperior pubic ramus: XA1XZ3\\nInferior pubic ramus: XA4VB9\\nAcetabulum: XA6Z32\\nPeripheral skeleton: XA4TM1\\nBones of the upper extremity: XA7R53\\nBones of the shoulder girdle: XA2AL0\\nClavicle: XA6384\\nSternal end of clavicle: XA76N8\\nShaft of the clavicle: XA4PT6\\nAcromial end of clavicle: XA09P2\\nScapula: XA53X6\\nNeck of the scapula: XA2HS8\\nGlenoid cavity of the scapula: XA1216\\nCoracoid process of the scapula: XA2Y48\\nAcromion: XA3664\\nHumerus: XA2XL4\\nHead of the humerus: XA4VY5\\nAnatomical neck of the humerus: XA0XN0\\nSurgical neck of the humerus: XA6FR2\\nGreater tuberosity of the humerus: XA7144\\nLesser tuberosity of the humerus: XA72X2\\nShaft of the humerus: XA4RN8\\nCondyle of the humerus: XA3RE0\\nCapitulum of humerus: XA11M8\\nTrochlea of humerus: XA9LK4\\nLateral epicondyle of the humerus: XA6EF8\\nMedial epicondyle of the humerus: XA4097\\nRadius: XA3WG1\\nRadial head: XA2N25\\nRadial neck: XA0ZF7\\nShaft of radius: XA35U4\\nRadial groove: XA6YE5\\nStyloid process of radius: XA3MH2\\nLower end of radius not otherwise specified: XA4X32\\nUpper end of radius not otherwise specified: XA76U7\\nUlna: XA5007\\nCoronoid process of the ulna: XA0NS5\\nLower end of ulna not otherwise specified: XA0725\\nOlecranon process of the ulna: XA5VA1\\nShaft of the ulna: XA8U33\\nStyloid process of the ulna: XA05C5\\nUpper end of ulna not otherwise specified: XA6SV9\\nCarpal\\xa0bones: XA09H2\\nScaphoid bone: XA7480\\nDistal pole of scaphoid: XA8E71\\nDistal third of the scaphoid bone: XA1GV4\\nMiddle third of the scaphoid bone: XA3ZG5\\nProximal third of the scaphoid bone: XA5ZE5\\nLunate bone: XA30C8\\nTriquetrum bone: XA4A64\\nPisiform bone: XA8SZ6\\nTrapezium bone: XA7XM2\\nTrapezoid bone: XA9DH2\\nCapitate bone: XA06T2\\nHamate bone: XA8488\\nHook of hamate: XA97A0\\nCarpal tunnel: XA0GJ4\\nBase of other carpal bone: XA22M5\\nNeck of other carpal bone: XA9640\\nShaft of other carpal bone: XA5TX9\\nMetacarpal bone: XA3YX4\\nFirst metacarpal: XA58X4\\nHead of the first metacarpal bone: XA12D2\\nNeck of the first metacarpal bone: XA8J87\\nShaft of the first metacarpal bone: XA5N95\\nBase of the first metacarpal bone: XA2P67\\nSecond metacarpal: XA5HE0\\nHead of the second metacarpal bone: XA93C5\\nNeck of the second metacarpal bone: XA8KU0\\nShaft of the second metacarpal bone: XA4RC8\\nBase of the second metacarpal bone: XA37V2\\nThird metacarpal: XA7J93\\nHead of the third metacarpal bone: XA6442\\nNeck of the third metacarpal bone: XA50H4\\nShaft of the third metacarpal bone: XA8BP2\\nBase of the third metacarpal bone: XA8NK6\\nFourth metacarpal: XA9KB7\\nHead of the fourth metacarpal bone: XA8X42\\nNeck of the fourth metacarpal bone: XA9NT7\\nShaft of the fourth metacarpal bone: XA4CP7\\nBase of the fourth metacarpal bone: XA3ZF8\\nFifth metacarpal: XA88S1\\nHead of the fifth metacarpal bone: XA3Z46\\nNeck of the fifth metacarpal bone: XA16Y6\\nShaft of the fifth metacarpal bone: XA92G8\\nBase of the fifth metacarpal bone: XA65Y7\\nPhalanx of the hand: XA3PA7\\nProximal phalanx of the hand: XA0HH1\\nProximal phalanx of index finger: XA25U2\\nProximal phalanx of middle finger: XA6ET0\\nProximal phalanx of ring finger: XA9MR0\\nProximal phalanx of little finger: XA73Q6\\nProximal phalanx of thumb: XA0903\\nMiddle phalanx of hand: XA89G7\\nMiddle phalanx of index finger: XA3JL6\\nMiddle phalanx of middle finger: XA5910\\nMiddle phalanx of ring finger: XA8N14\\nMiddle phalanx of little finger: XA6HX0\\nDistal phalanx of the hand: XA7LS3\\nDistal phalanx of index finger: XA54X0\\nDistal phalanx of middle finger: XA8NR0\\nDistal phalanx of ring finger: XA51S6\\nDistal phalanx of little finger: XA32G6\\nDistal phalanx of thumb: XA70H5\\nBone of finger not elsewhere classified: XA5D87\\nBone of thumb not elsewhere classified: XA95Q5\\nBones of the lower extremity: XA2T04\\nFemur: XA6BA0\\nFemoral head: XA96S5\\nFemoral neck: XA1673\\nTrochanter: XA32G0\\nGreater trochanter of femur: XA1VJ3\\nLesser trochanter of femur: XA9TD9\\nIntertrochanteric crest of femur: XA9JB2\\nFemoral shaft: XA4AF2\\nFemoral condyle: XA6UG0\\nFemoral epiphysis: XA2BJ0\\nPertrochanter: XA00N4\\nSubtrochanteric line of femur: XA5EL8\\nPatella: XA4T36\\nTibia: XA44U1\\nTibial condyle: XA5RE8\\nLateral condyle of tibia: XA87A0\\nMedial condyle of tibia: XA7Y69\\nTibial tuberosity: XA3DL5\\nTibial shaft: XA66B3\\nTibial spine: XA2EN5\\nMedial malleolus: XA1HS9\\nPosterior malleolus: XA3450\\nFibula: XA3KT5\\nFibular head: XA0K77\\nFibular shaft: XA5G97\\nLateral malleolus: XA4UL1\\nTarsal\\xa0bone: XA7NN4\\nCalcaneus: XA5LU2\\nAnterior process of calcaneus: XA57V1\\nTuberosity of calcaneus: XA62P4\\nTalus: XA1LF4\\nDome of the talus: XA1N98\\nNeck of the talus: XA6L02\\nPosterior process of the talus: XA3MT9\\nNavicular bone: XA84E6\\nMedial cuneiform bone: XA4J74\\nIntermediate cuneiform bone: XA4046\\nLateral cuneiform bone: XA8462\\nCuboid bone: XA0LW4\\nBone of ankle: XA43L9\\nTarsal canal: XA6UL8\\nMetatarsal\\xa0bone: XA6VH2\\nPhalanx of the foot: XA39M2\\nProximal phalanx\\xa0of the toe: XA6U96\\nProximal phalanx of great toe: XA8KC3\\nProximal phalanx of second toe: XA0AQ0\\nProximal phalanx of third toe: XA11P1\\nProximal phalanx of fourth toe: XA8CX6\\nProximal phalanx of fifth toe: XA8PK1\\nMiddle phalanx of toe: XA8539\\nMiddle phalanx of second toe: XA1UN2\\nMiddle phalanx of third toe: XA9YP5\\nMiddle phalanx of fourth toe: XA2SX4\\nMiddle phalanx of fifth toe: XA90F0\\nDistal phalanx\\xa0of the toe: XA4352\\nDistal phalanx of great toe: XA2AC2\\nDistal phalanx of second toe: XA3QM7\\nDistal phalanx of third toe: XA38Q1\\nDistal phalanx of fourth toe: XA8XV0\\nDistal phalanx of fifth toe: XA6ED4\\nJoints and ligaments of the head and neck: XA7948\\nJoints of the head: XA6UT2\\nAtlantooccipital joint: XA65F2\\nAtlantoaxial joint: XA7EM1\\nTemporomandibular joint: XA2SM2\\nLigaments of the head and neck: XA1LE7\\nAnterior atlantoaxial ligament: XA68Z9\\nAnterior atlantooccipital ligament: XA4XK9\\nAnterior longitudinal ligament: XA9F16\\nApical odontoid ligament: XA3K95\\nArticular capsules: XA3XV5\\nInterarticular ligament: XA3ZW3\\nInterspinal ligament: XA9M15\\nIntertransverse ligament: XA9NZ1\\nIntervertebral fibrocartilage ligament: XA5180\\nLateral atlantooccipital ligament: XA97L7\\nLigamenta flava: XA72L3\\nLigamentum nuchae: XA6RG7\\nOccipitoaxial ligament: XA3J99\\nPosterior atlantoaxial ligament: XA1CC5\\nPosterior atlantooccipital ligament: XA80K5\\nPosterior longitudinal ligament: XA8E20\\nSphenomandibular ligament: XA4FR7\\nStylomandibular ligament: XA4WM3\\nSupraspinal ligament: XA7WU3\\nTemporomandibular ligament: XA4WJ7\\nTransverse ligament of the atlas: XA8389\\nThyrohyoid ligament: XA33F9\\nCricoarytenoid ligament: XA9XG3\\nCricopharyngeal ligament: XA6B16\\nCricotracheal ligament: XA3BV9\\nHyoepiglottic ligament: XA3JR5\\nCricothyroid ligament: XA4051\\nThyroepiglottic ligament: XA56S4\\nVestibular ligament: XA4KB2\\nVocal ligament: XA6928\\nJoints and ligaments of the thorax: XA2EL4\\nJoints of the thorax: XA2NG8\\nSternocostal joint: XA83N6\\nCostochondral joint: XA30Q4\\nCostovertebral joint: XA0892\\nCostotransverse joint: XA7AR2\\nFacet joint: XA0ZE4\\nLigaments of the thorax: XA2UN9\\nAnterior costotransverse ligament: XA70E9\\nAnterior intersternal ligament: XA0QM2\\nAnterior ligament of the spine: XA8V32\\nCostotransverse ligament: XA5G44\\nCostoxiphoid ligament: XA2S05\\nIliolumbar ligament: XA4356\\nInterarticular sternocostal ligament: XA70A1\\nInterchondral ligament: XA8D15\\nLigament of the neck of the rib: XA6ZD7\\nLigament of the tubercle of the rib: XA81P3\\nPosterior costotransverse ligament: XA4A37\\nLumbocostal ligament: XA8B33\\nPosterior intersternal ligament: XA26A7\\nRadiate ligament: XA8RC0\\nRadiate sternocostal ligament: XA43Z7\\nJoints and ligaments of the pelvis and perineum: XA6KC7\\nJoints of the pelvis: XA1TL5\\nLumbosacral joint: XA5A04\\nSacrococcygeal joint: XA70B6\\nSacroiliac joint: XA3T32\\nLigaments of the pelvis and perineum: XA9TF3\\nAnterior pubic ligament: XA5S21\\nAnterior sacroiliac ligament: XA10C4\\nArcuate pubic ligament: XA9621\\nBroad ligament of the uterus: XA0EJ9\\nMesovarium: XA6VF6\\nParovarian region: XA9TX2\\nMesosalpinx: XA6CV1\\nMesometrium: XA3AN2\\nInterarticular ligament of the pelvis: XA46Z2\\nInterosseous sacroiliac ligament: XA02T6\\nLigamentum teres of the Liver: XA1NT7\\nPosterior pubic ligament: XA92G5\\nPosterior sacroiliac ligament: XA6RS4\\nLong posterior sacroiliac ligament: XA69U0\\nShort posterior sacroiliac ligament: XA9HV6\\nPubic symphysis: XA1UP6\\nRound ligament of uterus: XA23X3\\nSacrococcygeal ligament: XA8GZ2\\nAnterior sacrococcygeal ligament: XA2MA4\\nLateral sacrococcygeal ligament: XA4B16\\nPosterior sacrococcygeal ligament: XA2U92\\nSacrospinous ligament: XA8J68\\nSacrotuberous ligament: XA6396\\nSuperior pubic ligament: XA68K7\\nUterine ligament: XA4T57\\nUterosacral ligament: XA2NB2\\nJoints and ligaments of the upper extremity: XA4XC0\\nJoints of the upper extremity: XA4U90\\nShoulder joint: XA05J7\\nGlenohumeral joint: XA49P8\\nAcromioclavicular joint: XA69U6\\nSternoclavicular joint: XA0CH1\\nElbow joint: XA69H4\\nProximal radioulnar joint: XA3G42\\nHumeroulnar joint: XA46J3\\nHumeroradial joint: XA53P1\\nWrist joint: XA64C3\\nDistal radioulnar joint: XA78S6\\nRadiocarpal joint: XA0P38\\nJoints of the hand: XA62V5\\nCarpal joint: XA3MB4\\nIntercarpal joint: XA0E90\\nMidcarpal joint: XA4AS7\\nCarpometacarpal joint: XA0JX0\\nIntermetacarpal joint: XA9DN6\\nMetacarpophalangeal joint: XA86T5\\nFirst metacarpophalangeal joint: XA3M83\\nSecond metacarpophalangeal joint: XA9YH1\\nThird metacarpophalangeal joint: XA6HB0\\nFourth metacarpophalangeal joint: XA7XA8\\nFifth metacarpophalangeal joint: XA7KA0\\nInterphalangeal joint of the hand: XA9291\\nInterphalangeal joint of the thumb: XA6L43\\nProximal interphalangeal joint of finger: XA1307\\nProximal interphalangeal joint of index finger: XA1DN6\\nProximal interphalangeal joint of middle finger: XA3NW6\\nProximal interphalangeal joint of ring finger: XA0BF5\\nProximal interphalangeal joint of little finger: XA4175\\nDistal interphalangeal joint of finger: XA4U75\\nDistal interphalangeal joint of index finger: XA6KB0\\nDistal interphalangeal joint of middle finger: XA15C8\\nDistal interphalangeal joint of ring finger: XA0LT5\\nDistal interphalangeal joint of little finger: XA1928\\nLigaments of the upper extremity: XA4BC2\\nLigament of the shoulder: XA93X9\\nAcromioclavicular ligament: XA2H23\\nInferior acromioclavicular ligament: XA49Z7\\nSuperior acromioclavicular ligament: XA8RC9\\nAnterior ligament of the shoulder: XA01C8\\nAnterior sternoclavicular ligament: XA2JQ3\\nCoracoacromial ligament: XA8MA3\\nCoracoclavicular ligament: XA9WP5\\nConoid ligament: XA4PU7\\nTrapezoid ligament: XA5SJ7\\nCoracohumeral ligament: XA5EW9\\nCostoclavicular ligament: XA1PK9\\nGlenohumeral ligament: XA8H81\\nGlenoidal labrum ligament: XA5Z24\\nInterclavicular ligament: XA84L3\\nPosterior sternoclavicular ligament: XA3PT9\\nRotator cuff capsule: XA6EG3\\nSpinoglenoid ligament: XA6EE7\\nSuprascapular ligament: XA5MU7\\nTransverse humeral ligament: XA9C92\\nLigament of the elbow: XA5Y12\\nAnnular ligament: XA0JJ8\\nLigament of Struthers: XA4S76\\nPosterior ligament of elbow: XA16Y4\\nQuadrate ligament: XA8B40\\nRadial collateral ligament: XA9WJ8\\nUlnar collateral ligament: XA9220\\nInterosseous membrane of forearm: XA6SA0\\nLigament of the wrist and hand: XA9Y28\\nCollateral carpal ligament: XA9MY7\\nCollateral metacarpophalangeal ligament: XA0K88\\nDorsal carpometacarpal ligament: XA20K5\\nDorsal intercarpal ligament: XA0PE4\\nDorsal intermetacarpal ligament: XA0WZ1\\nDorsal metacarpophalangeal ligament: XA2PN5\\nDorsal radiocarpal ligament: XA7Q52\\nInterosseous ligament: XA52E8\\nPalmar aponeurosis: XA10U4\\nPisohamate ligament: XA1Z72\\nPisometacarpal ligament: XA3VJ3\\nRadioulnar ligament: XA0PY0\\nDorsal radioulnar ligament: XA4396\\nVolar radioulnar ligament: XA2940\\nTransverse metacarpal ligament: XA3SZ9\\nUlnocarpal ligament: XA3K32\\nVolar carpometacarpal ligament: XA1PU7\\nVolar intercarpal ligaments: XA47N4\\nVolar intermetacarpal ligament: XA1LF5\\nVolar metacarpophalangeal ligament: XA3VN5\\nVolar radiocarpal ligament: XA0492\\nJoints and ligaments of the lower extremity: XA5ST4\\nJoints of lower extremity: XA7L41\\nHip joint: XA4XS4\\nKnee joint: XA8RL1\\nTibiofemoral joint: XA0LC4\\nPatellofemoral joint: XA0VJ4\\nProximal tibiofibular joint: XA0LG3\\nSemilunar cartilage: XA8VV2\\nAnkle joint: XA27P3\\nTalocrural joint: XA8MM7\\nDistal tibiofibular joint: XA2K81\\nSubtalar joint: XA7SZ8\\nJoint of the foot: XA22T0\\nIntertarsal joint: XA2YS1\\nCalcaneocuboid joint: XA4JJ1\\nTalocalcaneonavicular joint: XA0WY5\\nCuneonavicular joint: XA6NT7\\nCuboideonavicular joint: XA1N77\\nIntercuneiform joint: XA9SD1\\nCuneocuboid joint: XA2FA3\\nTarsometatarsal joint: XA2MY1\\nIntermetatarsal joint: XA6FF3\\nMetatarsophalangeal joint: XA8XU1\\nFirst metatarsophalangeal joint: XA7NJ7\\nSecond metatarsophalangeal joint: XA58K5\\nThird metatarsophalangeal joint: XA2792\\nFourth metatarsophalangeal joint: XA7QC6\\nFifth metatarsophalangeal joint: XA5A23\\nInterphalangeal joint of the foot: XA04T7\\nInterphalangeal joint of great toe: XA87P9\\nProximal interphalangeal joint of the foot: XA5573\\nProximal interphalangeal joint of second toe: XA56K9\\nProximal interphalangeal joint of third toe: XA2QY2\\nProximal interphalangeal joint of fourth toe: XA2R87\\nProximal interphalangeal joint of fifth toe: XA1LM0\\nDistal interphalangeal joint of the foot: XA0RK3\\nDistal interphalangeal joint of second toe: XA8UM5\\nDistal interphalangeal joint of third toe: XA43F0\\nDistal interphalangeal joint of fourth toe: XA8NU9\\nDistal interphalangeal joint of fifth toe: XA39U1\\nTransverse tarsal joint: XA9Z55\\nLigaments of the lower extremity: XA7U26\\nLigament of the hip: XA1A66\\nIliofemoral ligament: XA1F23\\nIliotibial ligament: XA6KC6\\nIliotrochanteric ligament: XA6TZ6\\nIschiocapsular ligament: XA5HX9\\nLigamentum teres femoris: XA13S4\\nPubofemoral ligament: XA3GE8\\nTransverse acetabular ligament: XA9J44\\nLigament of the knee: XA8P38\\nAnterior cruciate ligament: XA0ZC8\\nCoronary ligament: XA04S7\\nFibular collateral ligament: XA4YJ0\\nLateral meniscus of knee joint: XA6HQ4\\nOblique popliteal ligament: XA87R6\\nPatellar ligament: XA3772\\nPosterior cruciate ligament: XA4635\\nTibial collateral ligament: XA7LD2\\nTransverse ligament of the knee: XA71L7\\nMedial meniscus of knee joint: XA7LB6\\nLigament of the ankle or foot: XA2F70\\nAnterior inferior ligament: XA93X1\\nAnterior talofibular ligament: XA84J2\\nAnterior tibiofibular ligament: XA1259\\nBifurcated ligament: XA5EY2\\nCalcaneofibular ligament: XA3154\\nCollateral ligament of the foot: XA59Z4\\nCuneometatarsal ligament: XA2314\\nDeltoid ligament: XA9YS6\\nDorsal calcaneocuboid ligament: XA42X4\\nDorsal cuboideonavicular ligament: XA6Q67\\nDorsal intermetatarsal ligament: XA3TS2\\nDorsal naviculocuneiform ligament: XA8NU3\\nDorsal talonavicular ligament: XA86X4\\nDorsal tarsometatarsal ligament: XA9E13\\nInferior transverse ligament of ankle: XA2FV7\\nIntercuneiform ligament: XA16V1\\nDorsal intercuneiform ligament: XA7075\\nPlantar intercuneiform ligament: XA5HQ7\\nInterosseous talocalcaneal ligament: XA4XJ2\\nLong plantar ligament: XA6NS2\\nPlantar accessory ligament: XA59U6\\nPlantar aponeurosis: XA87B0\\nPlantar calcaneocuboid ligament: XA4N86\\nPlantar calcaneonavicular ligament: XA5KN3\\nPlantar cuboideonavicular ligament: XA2NX5\\nPlantar intermetatarsal ligament: XA18T4\\nPlantar naviculocuneiform ligament: XA1747\\nPlantar tarsometatarsal ligament: XA71L9\\nPosterior inferior ligament: XA2D55\\nPosterior talofibular ligament: XA93E6\\nPosterior tibiofibular ligament: XA6RA3\\nTalocalcaneal ligament: XA6546\\nAnterior talocalcaneal ligament: XA93N5\\nLateral talocalcaneal ligament: XA4VX8\\nMedial talocalcaneal ligament: XA09E2\\nPosterior talocalcaneal ligament: XA60T4\\nTransverse metatarsal ligament: XA5BX0\\nLigaments and joints of multiple sites: XA2P74\\nMultiple Joints: XA4EJ6\\nOligoarticular: XA1CK9\\nPolyarticular: XA3FU7\\nMultiple large joints only: XA02P3\\nMultiple small joints only: XA2SK7\\nBoth large and small joints: XA3BZ3\\nLarge joints only with cervical spine or temporomandibular involvement: XA5X22\\nMonoarticular: XA4BF0\\nMultiple ligaments: XA5XD5\\nSingle ligament: XA5NN2\\nElastic cartilage: XA8YS7\\nFibrous cartilage: XA8VH7\\nHyaline cartilage: XA2686\\nArticular cartilage: XA3NV3\\nCostal cartilage: XA6958\\nMuscles of the head and neck: XA2JQ8\\nAlaeque nasi muscle: XA2SJ6\\nAnterior auricularis muscle: XA2QF2\\nAryepiglotticus muscle: XA3SS4\\nBuccinator muscle: XA8GG0\\nConstrictor of pharynx inferior muscle: XA0UH6\\nConstrictor of pharynx middle muscle: XA3S80\\nConstrictor of pharynx superior muscle: XA9568\\nCorrugator supercilii muscle: XA01U4\\nCricothyroid muscle: XA7W64\\nDepressor anguli oris muscle: XA04G0\\nDepressor labii inferioris muscle: XA60C8\\nDigastric muscle: XA2967\\nFrontalis muscle: XA09D1\\nGenioglossus muscle: XA50R5\\nGeniohyoid muscle: XA5YU7\\nHyoglossus muscle: XA5DX5\\nHyoid muscle: XA3PY5\\nInferior oblique muscle: XA4N79\\nInferior rectus muscle: XA1X67\\nIntrinsic muscles of tongue: XA31C3\\nLateral cricoarytenoid muscle: XA5WQ9\\nLateral pterygoid muscle: XA8ZB7\\nLateral rectus muscle: XA3282\\nLevator anguli oris muscle: XA75X0\\nLevator labii superioris muscle: XA1490\\nLevator palpebrae superioris muscle: XA2R46\\nLevator veli palatini muscle: XA5LP4\\nLongus capitis muscle: XA6YE6\\nLongus colli muscle: XA8EM8\\nMasseter muscle: XA2VD8\\nMedial pterygoid muscle: XA2DX4\\nMedial rectus muscle: XA95N1\\nMentalis muscle: XA0U25\\nMusculus uvulae muscle: XA8AR7\\nMylohyoid muscle: XA83A9\\nNasalis muscle: XA0Y41\\nOblique arytenoid muscle: XA59J0\\nOblique auricularis muscle: XA8L72\\nObliquus capitis inferior muscle: XA6LS5\\nObliquus capitis superior muscle: XA0X13\\nOmohyoid muscle: XA4RN7\\nOrbicularis oculi muscle: XA0ZM1\\nOrbicularis oris muscle: XA55R2\\nPalatoglossus muscle: XA2U72\\nPalatopharyngeus muscle: XA1PG4\\nPlatysma muscle: XA17T6\\nPosterior auricularis muscle: XA8C48\\nPosterior cricoarytenoid muscle: XA9RS8\\nProcerus muscle: XA6648\\nRectus capitis anterior muscle: XA16A4\\nRectus capitis lateralis muscle: XA0JK2\\nRectus capitis posterior major muscle: XA20Q8\\nRectus capitis posterior minor muscle: XA80F2\\nRisorius muscle: XA49A7\\nSalpingopharyngeus muscle: XA81P5\\nScalenus anterior muscle: XA0JF1\\nScalenus medius muscle: XA6S71\\nScalenus minimus muscle: XA3TF5\\nScalenus posterior muscle: XA35K5\\nSplenius capitis muscle: XA58T9\\nSplenius cervicis muscle: XA6095\\nStapedius muscle: XA8D61\\nSternocleidomastoid muscle: XA2H61\\nSternohyoid muscle: XA5QR5\\nSternothyroid muscle: XA9H91\\nStyloglossus muscle: XA5L15\\nStylohyoid muscle: XA1TY3\\nStylopharyngeus muscle: XA9AM5\\nSuperior auricularis muscle: XA8SW4\\nSuperior oblique muscle: XA2X27\\nSuperior rectus muscle: XA51R1\\nTemporalis muscle: XA01H9\\nTemporoparietalis muscle: XA1CQ1\\nTensor tympani muscle: XA42R7\\nTensor veli palatini muscle: XA7LF2\\nThyroarytenoid muscle: XA8352\\nThyroepiglotticus muscle: XA2ZL4\\nThyrohyoid muscle: XA87S0\\nTransverse arytenoid muscle: XA3856\\nTransverse auricularis muscle: XA9AU8\\nVocalis muscle: XA0M12\\nZygomaticus major muscle: XA37U4\\nZygomaticus minor muscle: XA2AP2\\nMuscle of the thorax: XA19W0\\nDiaphragm: XA2JL0\\nExternal intercostal muscle: XA6RW0\\nInnermost intercostal muscle: XA3P12\\nInternal intercostal muscle: XA1256\\nLevator costarum muscle: XA7NL0\\nPectoralis major muscle: XA1QH6\\nPectoralis minor muscle: XA0SB2\\nSerratus anterior muscle: XA7QL8\\nSubcostalis muscle: XA44Y8\\nTransversus thoracis muscle: XA3G64\\nMuscle of the abdomen: XA8PG5\\nExternal oblique abdominis muscle: XA3TW8\\nInternal oblique abdominis muscle: XA9B36\\nPsoas major muscle: XA43E9\\nPsoas minor muscle: XA7DA1\\nPyramidalis muscle: XA6AY9\\nQuadratus lumborum muscle: XA1GP3\\nRectus abdominis muscle: XA1N65\\nTransversus abdominis muscle: XA9FR3\\nMuscle of the back: XA8Z76\\nIliocostalis muscle: XA19S9\\nInterspinales muscle: XA8YU1\\nIntertransversarii muscle: XA02Z7\\nLatissimus dorsi muscle: XA9AG9\\nLevator scapulae muscle: XA00C1\\nLongissimus muscle: XA6MB7\\nMultifidus muscle: XA8512\\nRhomboid major muscle: XA25S1\\nRhomboid minor muscle: XA5GH5\\nRotatores muscle: XA76Q0\\nSemispinalis muscle: XA60Q0\\nSerratus posterior inferior muscle: XA4A47\\nSerratus posterior superior muscle: XA15B6\\nSpinalis muscle: XA0U57\\nTeres major muscle: XA7RM2\\nTrapezius muscle: XA86Q8\\nMuscles of the pelvis and perineum: XA2J71\\nBulbospongiosus muscle: XA2E07\\nCremaster muscle: XA5FZ1\\nDartos muscle: XA8HG2\\nDeep transverse perinei muscle: XA2LG6\\nIliococcygeus muscle: XA3YC6\\nIschiocavernosus muscle: XA73H8\\nLevator anicoccygeus muscle: XA9T66\\nPubococcygeus muscle: XA3HP4\\nPuborectalis muscle: XA7MM8\\nPubovaginalis muscle: XA4RK4\\nSphincter ani muscle: XA3ML6\\nSphincter urethrae muscle: XA8FT0\\nSuperficial transverse perinei muscle: XA56U7\\nMuscles of the upper extremity: XA4Z20\\nAbductor digiti minimi muscle hand: XA90T3\\nAbductor pollicis brevis muscle: XA0Z05\\nAbductor pollicis longus muscle: XA7PS1\\nAdductor pollicis muscle: XA54Z7\\nAnconeus muscle: XA2583\\nArticularis cubiti muscle: XA0GV5\\nBiceps brachii muscle: XA1KL5\\nLong head of the biceps brachii muscle: XA0481\\nShort head of the biceps brachii muscle: XA3J17\\nBrachialis muscle: XA6CR7\\nBrachioradialis muscle: XA2ZN1\\nCoracobrachialis muscle: XA0TQ5\\nDeltoid muscle: XA3VN0\\nExtensor carpi radialis brevis: XA4U40\\nExtensor carpi radialis longus muscle: XA8824\\nExtensor carpi ulnaris muscle: XA9304\\nExtensor digiti minimi muscle hand: XA0T60\\nExtensor digitorum muscle hand: XA7QU8\\nExtensor indicis muscle: XA1AV6\\nExtensor pollicis brevis muscle: XA4V20\\nExtensor pollicis longus muscle: XA0CS4\\nFlexor carpi radialis muscle: XA0S07\\nFlexor carpi ulnaris muscle: XA4HV9\\nFlexor digiti minimi brevis muscle hand: XA3UK3\\nFlexor digitorum profundus muscle: XA4Z43\\nFlexor digitorum superficialis muscle: XA1NW3\\nFlexor pollicis brevis muscle: XA5QD0\\nFlexor pollicis longus muscle: XA3GQ7\\nInterossei of the hand muscle: XA6463\\nDorsal interossei of the hand muscle: XA2QW3\\nPalmar interossei of the hand muscle: XA5055\\nLumbricals of hand muscle: XA9B77\\nOpponens digiti minimi muscle hand: XA4RW9\\nOpponens pollicis muscle: XA0Q73\\nPalmaris brevis muscle: XA9KL5\\nPalmaris longus muscle: XA6P76\\nPronator quadratus muscle: XA91W0\\nPronator teres muscle: XA58Z6\\nRotator cuff muscle: XA3DL4\\nInfraspinatus muscle: XA7E49\\nSubscapularis muscle: XA1QF1\\nSupraspinatus muscle: XA74P3\\nTeres minor muscle: XA3CP1\\nSupinator muscle: XA90Z6\\nTriceps brachii muscle: XA2EB2\\nMuscles of the lower extremity: XA47J0\\nAbductor digiti minimi muscle foot: XA0W07\\nAbductor hallucis muscle: XA7119\\nAdductor brevis muscle: XA8GU7\\nAdductor hallucis muscle: XA0FW7\\nAdductor longus muscle: XA01U3\\nAdductor magnus muscle: XA8HR3\\nArticularis genu muscle: XA0DE1\\nBiceps femoris muscle: XA3CB9\\nExtensor digitorum brevis muscle foot: XA7FZ1\\nExtensor digitorum longus muscle foot: XA24U7\\nExtensor hallucis brevis muscle: XA3T27\\nExtensor hallucis longus muscle: XA7R67\\nFlexor digiti minimi brevis muscle foot: XA20W3\\nFlexor digitorum brevis muscle: XA97C3\\nFlexor digitorum longus muscle foot: XA23Q3\\nFlexor hallucis brevis muscle: XA3MB7\\nFlexor hallucis longus muscle: XA7E33\\nGastrocnemius muscle: XA1PK6\\nGemellus inferior muscle: XA7PN8\\nGemellus superior muscle: XA0472\\nGracilis muscle: XA1HH2\\nIliacus muscle: XA0200\\nInterossei dorsal of foot muscle: XA15P6\\nInterossei plantar of foot muscle: XA8TS8\\nLumbricals of foot muscle: XA7PN0\\nObturator externus muscle: XA7Y24\\nObturator internus muscle: XA11E8\\nPectineus muscle: XA9E00\\nPeroneus brevis muscle: XA26M7\\nPeroneus longus muscle: XA3P60\\nPeroneus tertius muscle: XA9D52\\nPiriformis muscle: XA7XS8\\nPlantaris muscle: XA7W96\\nPopliteus muscle: XA8CL8\\nQuadratus plantae muscle: XA41G3\\nQuadriceps femoris muscle: XA1BT5\\nRectus femoris muscle: XA5447\\nSartorius muscle: XA5CE3\\nSemimembranosus muscle: XA5AM5\\nSemitendinosus muscle: XA2EK1\\nSoleus muscle: XA5B83\\nTibialis anterior muscle: XA02U9\\nTibialis posterior muscle: XA3VR3\\nVastus intermedius muscle: XA33F6\\nVastus lateralis muscle: XA00Z6\\nVastus medialis muscle: XA9RD2\\nGluteus maximus muscle: XA48F2\\nGluteus medius muscle: XA5VJ8\\nGluteus minimus muscle: XA7BY4\\nTensor fasciae lata muscle: XA11U3\\nTendons of the head and neck: XA3PP9\\nAlaeque nasi tendon: XA46A9\\nAryepiglotticus tendon: XA6J99\\nAuricularis tendon: XA8XC7\\nBuccinator tendon: XA3163\\nCorrugator supercilii tendon: XA6L11\\nCricothyroid tendon: XA01X1\\nDepressor anguli oris tendon: XA28X5\\nDepressor labii inferioris tendon: XA6WZ3\\nDigastric tendon: XA5S69\\nFrontalis tendon: XA5CP4\\nGenioglossus tendon: XA6BT8\\nGeniohyoid tendon: XA9L90\\nHyoglossus tendon: XA8N10\\nHyoid tendon: XA7EE6\\nInferior oblique tendon: XA3ZA2\\nInferior rectus tendon: XA7HT8\\nLateral cricoarytenoid tendon: XA1394\\nLateral pterygoid tendon: XA6PK4\\nLateral rectus tendon: XA3LT8\\nLevator anguli oris tendon: XA7653\\nLevator labii superioris tendon: XA0YK7\\nLevator palpebrae superioris tendon: XA61C9\\nLevator veli palatini tendon: XA7VD7\\nLongus capitis tendon: XA1FR7\\nLongus colli tendon: XA0UD3\\nMasseter tendon: XA1FB3\\nMedial pterygoid tendon: XA8F95\\nMedial rectus tendon: XA6SG3\\nMentalis tendon: XA7JW2\\nMylohyoid tendon: XA7ZZ8\\nNasalis tendon: XA7NU6\\nOblique arytenoid tendon: XA5Q22\\nObliquus capitis inferior tendon: XA8AT8\\nObliquus capitis superior tendon: XA39M0\\nOmohyoid tendon: XA2JY6\\nOrbicularis oculi tendon: XA65X4\\nOrbicularis oris tendon: XA0W74\\nPalatoglossus tendon: XA6SX4\\nPalatopharyngeus tendon: XA6LA2\\nPlatysma tendon: XA4758\\nPosterior cricoarytenoid ligament: XA0AE2\\nProcerus tendon: XA5HD8\\nRectus capitis anterior tendon: XA8CQ6\\nRectus capitis lateralis tendon: XA4RG2\\nRectus capitis posterior major tendon: XA6WL6\\nRectus capitis posterior minor tendon: XA1XH8\\nRisorius tendon: XA9450\\nSalpingopharyngeus tendon: XA0SH8\\nScalene tendon: XA3XC1\\nscalenus anterior tendon: XA45L1\\nscalenus medius tendon: XA7XV7\\nscalenus minimus tendon: XA7NL5\\nscalenus posterior tendon: XA9HH7\\nSplenius capitis tendon: XA39C9\\nSplenius cervicis tendon: XA2HL1\\nStapedius tendon: XA8W69\\nSternocleidomastoid tendon: XA70V9\\nSternohyoid tendon: XA6S11\\nSternothyroid tendon: XA4VX2\\nStyloglossus tendon: XA90J0\\nStylohyoid tendon: XA20E0\\nStylopharyngeus tendon: XA7GV2\\nSuperior oblique tendon: XA5ES8\\nSuperior rectus tendon: XA3ZN4\\nTemporalis tendon: XA7D16\\nTemporoparietalis tendon: XA8BT2\\nTensor tympani tendon: XA5956\\nTensor veli palatini tendon: XA2W44\\nThyroarytenoid tendon: XA4ME3\\nThyroepiglotticus tendon: XA0CT5\\nTransverse arytenoid tendon: XA9YC3\\nVocalis tendon: XA4CN7\\nZygomaticus major tendon: XA0XQ7\\nZygomaticus minor tendon: XA0SZ1\\nTendons of the thorax: XA3SA1\\nChordae tendineae: XA01T0\\nDiaphragm tendon: XA9N29\\nIntercostals external tendon: XA5WL5\\nIntercostals innermost tendon: XA8FV0\\nIntercostals internal tendon: XA92E2\\nLevatores costarum tendon: XA5R18\\nPectoralis major tendon: XA3C70\\nPectoralis minor tendon: XA40K0\\nSerratus anterior tendon: XA91D0\\nSerratus posterior inferior tendon: XA7J14\\nSerratus posterior superior tendon: XA0MH0\\nSubcostalis tendon: XA8WS6\\nTendon of Todaro: XA3XC9\\nTransversus thoracis tendon: XA1HX3\\nTendons of the abdomen: XA4797\\nExternal oblique abdominis tendon: XA0101\\nInternal oblique abdominis tendon: XA45G1\\nPsoas major tendon: XA3045\\nPsoas minor tendon: XA7V41\\nPyramidalis tendon: XA49W5\\nQuadratus lumborum tendon: XA34K5\\nRectus abdominis tendon: XA1HT1\\nTransversus abdominis tendon: XA0V25\\nTendons of the back: XA9Z26\\nIliocostalis tendon: XA48X7\\nInfraspinatus tendon: XA2MX3\\nInterspinales tendon: XA2E69\\nIntertransversarii tendon: XA8UU5\\nLatissimus dorsi tendon: XA8467\\nLongissimus tendon: XA3TD7\\nMultifidus tendon: XA33T4\\nRhomboid major tendon: XA3P63\\nRhomboid minor tendon: XA8918\\nRotatores tendon: XA16J2\\nSemispinalis tendon: XA3D42\\nSpinalis tendon: XA28J9\\nTeres major tendon: XA09K4\\nTeres minor tendon: XA42P8\\nTrapezius tendon: XA9PV0\\nTendons of the pelvis and perineum: XA1SN1\\nBulbospongiosus tendon: XA15H4\\nCoccygeus tendon: XA45X9\\nCremaster tendon: XA4755\\nDartos tendon: XA2BV5\\nDeep transverse perinei tendon: XA2TD5\\nIliococcygeus tendon: XA6QW7\\nIschiocavernosus tendon: XA7YP5\\nPubococcygeus tendon: XA5JV1\\nPuborectalis tendon: XA66F5\\nPubovaginalis tendon: XA32R3\\nTendons of the upper extremity: XA0WU6\\nAbductor digiti minimi tendon: XA5AY5\\nAbductor pollicis brevis tendon: XA7YE1\\nAbductor pollicis longus tendon: XA0UY5\\nAdductor pollicis tendon: XA9749\\nAnconeus tendon: XA4HK3\\nBiceps brachii tendon: XA8AM4\\nLong head of biceps brachii tendon: XA2UD9\\nShort head of biceps brachii tendon: XA0FB1\\nBrachialis tendon: XA9G06\\nBrachioradialis tendon: XA3YY6\\nCoracobrachialis tendon: XA83R8\\nDeltoid tendon: XA0942\\nDorsal Interosseous tendon: XA24P4\\nExtensor carpi radialis brevis tendon: XA18F0\\nExtensor carpi radialis longus tendon: XA1T90\\nExtensor carpi ulnaris tendon: XA4PY2\\nExtensor digiti minimi tendon: XA4WU2\\nExtensor digitorum tendon: XA5H06\\nExtensor indicis tendon: XA4EE2\\nExtensor pollicis brevis tendon: XA5KN6\\nExtensor pollicis longus tendon: XA4CG6\\nExtensor tendon: XA8U10\\nFlexor carpi radialis tendon: XA8H50\\nFlexor carpi ulnaris tendon: XA5CE2\\nFlexor digiti minimi tendon: XA23D8\\nFlexor digitorum profundus tendon: XA0GQ6\\nFlexor digitorum superficialis tendon: XA9526\\nFlexor digitorum tendon: XA9Q34\\nFlexor pollicis brevis tendon: XA1Q82\\nFlexor pollicis longus tendon: XA92F7\\nFlexor tendon: XA5YQ2\\nInterossei tendon: XA4M25\\nLevator scapulae tendon: XA1X89\\nLumbrical tendon: XA8TQ1\\nOpponens digiti minimi tendon: XA9KM7\\nOpponens pollicis tendon: XA3W45\\nPalmar interosseous tendon: XA82E6\\nPalmaris brevis tendon: XA7B73\\nPalmaris longus tendon: XA41L1\\nPronator quadratus tendon: XA41Z5\\nPronator teres tendon: XA7EK5\\nSubclavius tendon: XA7V30\\nSubscapularis tendon: XA54N6\\nSupinator tendon: XA5EJ6\\nSupraspinatus tendon: XA5VZ4\\nTriceps brachii tendon: XA5RS6\\nTendons of the lower extremity: XA5L93\\nAbductor digiti minimi foot tendon: XA5ZK0\\nAbductor hallucis tendon: XA14Z8\\nAchilles tendon: XA8BK1\\nAdductor brevis tendon: XA4HF0\\nAdductor hallucis tendon: XA8B14\\nAdductor longus tendon: XA1TK8\\nAdductor magnus tendon: XA8746\\nAnterior ligament of the lower extremity: XA9381\\nArticularis genu tendon: XA7MT0\\nBiceps femoris tendon: XA1MF8\\nDorsal interossei of foot tendon: XA86H9\\nExtensor digitorum brevis foot tendon: XA6230\\nExtensor digitorum longus foot tendon: XA1ZF4\\nExtensor hallucis brevis tendon: XA4NZ0\\nExtensor hallucis longus tendon: XA5L26\\nFlexor digiti minimi brevis foot tendon: XA8X38\\nFlexor digitorum brevis tendon: XA8GD0\\nFlexor digitorum longus foot tendon: XA3MK8\\nFlexor hallucis brevis tendon: XA00Z8\\nFlexor hallucis longus tendon: XA1MF0\\nGastrocnemius tendon: XA5LZ0\\nGemellus inferior tendon: XA2HX4\\nGemellus superior tendon: XA5M18\\nGluteus maximus tendon: XA1JL3\\nGluteus medius tendon: XA1387\\nGluteus minimus tendon: XA4HK9\\nGracilis tendon: XA12U3\\nIliacus tendon: XA8FT1\\nLumbrical of foot tendon: XA5DE3\\nObturator externus tendon: XA3EE9\\nObturator internus tendon: XA2469\\nPectineus tendon: XA07E4\\nPeroneus brevis tendon: XA3AN0\\nPeroneus longus tendon: XA7VY0\\nPeroneus tertius tendon: XA3D16\\nPiriformis tendon: XA3EU4\\nPlantar interossei of foot tendon: XA7L19\\nPlantaris tendon: XA6BZ6\\nPopliteus tendon: XA4V24\\nQuadratus plantae tendon: XA1L44\\nQuadriceps femoris tendon: XA9420\\nRectus femoris tendon: XA4ZG0\\nSartorius tendon: XA0981\\nSemimembranosus tendon: XA4AL5\\nSemitendinosus tendon: XA7DY9\\nSoleus tendon: XA7E05\\nTensor fasciae lata tendon: XA33Q1\\nTibialis anterior tendon: XA8SN1\\nTibialis posterior tendon: XA7FR7\\nVastus intermedius tendon: XA8ST5\\nVastus lateralis tendon: XA8CQ5\\nVastus medialis tendon: XA6RK3\\nEnthesis: XA2C51\\nBursa: XA16K5\\nBursa olecrani: XA12U7\\nBursa praepatellaris: XA7P88\\nKidney: XA6KU8\\nRenal capsule: XA5EP6\\nRenal cortex: XA35W4\\nRenal medulla: XA91E4\\nRenal pyramid: XA9Q52\\nRenal pelvis: XA21J4\\nRenal calyces: XA0AC1\\nMajor calyx: XA6N83\\nMinor calyx: XA8XL0\\nUreteropelvic junction: XA7NQ9\\nRenal hilum: XA4UD2\\nGlomerulus: XA40R2\\nNephron: XA8AN8\\nRenal tubule: XA2364\\nUreter: XA7156\\nUreterovesical orifice: XA9L57\\nUrinary bladder: XA77K2\\nDome of bladder: XA2PT2\\nBladder wall: XA0R03\\nLateral wall of bladder: XA3JA5\\nAnterior wall of bladder: XA4UM5\\nPosterior wall of bladder: XA2562\\nSuperior wall of bladder: XA6SR9\\nTrigone of bladder: XA6KF2\\nUreteric orifice: XA4P63\\nInternal urethral orifice: XA8KN5\\nBladder neck: XA0VZ5\\nUrethra: XA5TA5\\nInternal urethral sphincter: XA33M0\\nMembranous urethra: XA75T3\\nProstatic urethra: XA7869\\nExternal urethral sphincter: XA4DF2\\nPenile urethra: XA8EW9\\nExternal urethral meatus: XA4NU9\\nUrinary tract not elsewhere classified: XA4V93\\nLower urinary tract: XA34X0\\nUpper urinary tract: XA6RS6\\nMale genital organs: XA75A2\\nPenis: XA7QV2\\nRoot of penis: XA0970\\nBody of penis: XA9A26\\nDorsal surface of penis: XA03Y8\\nVentral surface of penis: XA3D56\\nGlans penis: XA0MH6\\nPenile urethral meatus: XA3Q76\\nParaurethral gland: XA3KB3\\nPrepuce: XA71S4\\nOuter surface of prepuce: XA2BL8\\nMucosal surface of prepuce: XA1CP6\\nCoronal sulcus of penis: XA54U4\\nFrenulum of penis: XA7V24\\nTestis: XA4947\\nTunica vaginalis: XA1FS5\\nTunica albuginea: XA07W9\\nSeminiferous tubules: XA9636\\nDescended testis: XA13Z7\\nTesticular appendage: XA14M8\\nEpididymis: XA4D25\\nSpermatic cord: XA9235\\nVas deferens: XA8PQ1\\nSeminal vesicle: XA0MJ1\\nProstate gland: XA63E5\\nFemale genital organs: XA2GU7\\nVulva: XA78U5\\nLabia of vulva: XA11L9\\nLabium majus: XA59G9\\nLabium minus: XA0MU9\\nClitoris: XA4851\\nClitoral hood: XA3C45\\nVulval vestibule: XA1A52\\nBartholin gland: XA27K9\\nPosterior fourchette of vulva: XA0565\\nVagina: XA1LK7\\nVaginal introitus: XA4AH3\\nHymen: XA3A69\\nGartner duct: XA9BM1\\nVaginal vault: XA46V2\\nUterus: XA99N3\\nFundus of uterus: XA3V49\\nCorpus uteri: XA5229\\nEndometrium: XA8QA8\\nEndometrial gland: XA9DM0\\nEndometrial stroma: XA3FR4\\nMyometrium: XA2LU5\\nParametrium: XA9HG1\\nUterine cavity: XA3QZ2\\nIsthmus uteri: XA7F09\\nCervix uteri: XA5WW1\\nInternal os: XA3Z33\\nCervical canal: XA7Z73\\nConnective and other soft tissues of uterus: XA0KR7\\nOvary: XA1QK0\\nCortex of ovary: XA6FA5\\nMedulla of ovary: XA44X6\\nUterine adnexa: XA7E69\\nFallopian tube: XA3EF0\\nEmbryological structures: XA1MQ5\\nDevelopmental tissue: XA7A99\\nEctoderm: XA7TJ5\\nEndoderm: XA3HM5\\nMesoderm: XA3D33\\nEmbryo: XA3NA0\\nFetus: XA23B0\\nFetal membranes: XA85H6\\nAmniotic sac: XA7MU1\\nAmnion: XA8XR0\\nChorion: XA66R5\\nAmniotic fluid: XA33K4\\nAllantois: XA9YJ5\\nThyroglossal duct: XA0SH3\\nUrachus: XA1NC2\\nUmbilical cord: XA3L42\\nPlacenta: XA90F8\\nHead and neck: XA1RS6\\nHead: XA20Q1\\nScalp: XA6CW5\\nFrontal scalp: XA0WK0\\nFrontal scalp margin: XA0WG9\\nTemporal scalp: XA9DZ0\\nTemporal scalp margin: XA26C1\\nParietal scalp: XA4W34\\nOccipital scalp: XA7JE5\\nOccipital scalp margin: XA3EK3\\nVertex of scalp: XA5BY6\\nScalp margin: XA6AL1\\nParietal scalp margin: XA93S9\\nFace: XA86S4\\nForehead: XA6TR8\\nCentral forehead: XA9SG2\\nParamedian forehead: XA1UW4\\nLateral forehead: XA1Z38\\nGlabella: XA90D8\\nTemple: XA9T94\\nOrbital region: XA29E7\\nPeriorbital region: XA0SB3\\nSupraorbital region: XA5WP1\\nEyebrow: XA1LZ5\\nInfraorbital region: XA6TV2\\nCheek: XA7MK8\\nUpper cheek: XA5KE9\\nMalar region: XA0M67\\nMalar eminence: XA57N0\\nCentral cheek: XA6C41\\nParanasal region: XA3ZL3\\nLower cheek: XA7207\\nPreauricular region: XA0SU2\\nMandibular region: XA8KA2\\nNose: XA3H13\\nRoot of nose: XA0LR7\\nDorsum of nose: XA5YP3\\nSupratip of nose: XA3057\\nLateral side wall of nose: XA9JN5\\nTip of nose: XA56T3\\nInfratip lobule of nose: XA3ZG3\\nAla nasi: XA32Q9\\nAlar groove: XA5ED7\\nAlar rim: XA7LG9\\nSide wall of ala nasi: XA2TK5\\nNostril: XA1B05\\nColumella: XA4S17\\nSill of nostril: XA9YZ7\\nOral region: XA5A87\\nPerioral region: XA1A48\\nLip: XA8JD4\\nUpper lip: XA7VQ4\\nExternal upper lip: XA0K68\\nPhiltrum: XA5LY8\\nNasolabial fold: XA5163\\nVermilion border of upper lip: XA8RK1\\nVermilion of upper lip: XA75S0\\nLabial commissure: XA1EF8\\nLower lip: XA15W6\\nExternal lower lip: XA5VD0\\nVermilion border of lower lip: XA9TK2\\nVermilion of lower lip: XA7H02\\nInner aspect of lip: XA1BP2\\nFrenulum of lip: XA3141\\nExternal lip: XA3K27\\nChin: XA2C62\\nSkin of nose: XA04T9\\nNeck: XA7AA6\\nFront of neck: XA4QS6\\nAnterior triangle of neck: XA1NS6\\nSubmental region: XA5TZ1\\nSubmandibular region: XA0MP5\\nSuprasternal notch: XA8RA2\\nSupraclavicular region: XA9DQ5\\nSide of neck: XA2ZF0\\nPosterior triangle of neck: XA45K8\\nNape of neck: XA1M78\\nTrunk: XA3FR3\\nUpper trunk: XA4QH7\\nThorax: XA5D93\\nChest wall: XA55T2\\nAnterior thoracic region: XA00R3\\nUpper anterior thoracic region: XA8ML7\\nClavicular region: XA4MN6\\nInfraclavicular region: XA6M63\\nPresternal region: XA5MS8\\nLower anterior thoracic region: XA7GU3\\nLateral thoracic region: XA7884\\nUpper lateral thoracic region: XA9RL9\\nAnterolateral upper thoracic region: XA0XL3\\nPosterolateral upper thoracic region: XA5C28\\nLower lateral thoracic region: XA9MN4\\nAnterolateral lower thoracic region: XA3266\\nPosterolateral lower thoracic region: XA7MS4\\nUpper back: XA10L7\\nSuprascapular region: XA3PG8\\nScapular region: XA3WD7\\nInterscapular region: XA9LN5\\nInfrascapular region: XA8NK1\\nLower thoracic paraspinal region: XA6RF2\\nSkin of thorax: XA8EK1\\nBreast: XA12C1\\nUpper half of breast: XA1NS5\\nUpper inner quadrant of breast: XA3LS6\\nUpper outer quadrant of breast: XA2Q54\\nAxillary tail of breast: XA3PG5\\nCentral portion of breast: XA0US1\\nAreola: XA2JK3\\nLactiferous ducts: XA85A1\\nNipple: XA5MC5\\nLower half of breast: XA3UY3\\nLower inner quadrant of breast: XA0VX8\\nLower outer quadrant of breast: XA94U2\\nLateral half of breast: XA9CM2\\nMedial half of breast: XA3JH6\\nInframammary flexure: XA0T50\\nLower trunk: XA6CY1\\nAbdomen: XA6GV0\\nUpper abdomen: XA0U66\\nEpigastrium: XA8ZL8\\nHypochondrium: XA3TD4\\nPeriumbilical region: XA1LM1\\nUmbilicus: XA3MT8\\nLateral lumbar region: XA1DN2\\nLower abdomen: XA4TC0\\nHypogastrium: XA6N20\\nIliac region: XA0NH8\\nAbdominal wall: XA3KX0\\nAnterior abdominal wall: XA4SN6\\nLumbosacral region: XA25R8\\nMid back: XA6ZR2\\nLumbar paraspinal region: XA7ZW8\\nPosterior lumbar region: XA8FK6\\nLower back: XA9ET2\\nCoccygeal area: XA6DS1\\nSacral region: XA2UC8\\nSacrococcygeal region: XA4L23\\nBack: XA2P90\\nAnogenital region: XA8HA7\\nGenital region: XA5FG3\\nFemale external genitalia: XA9PG6\\nMale external genitalia: XA1AK8\\nScrotum: XA8MT4\\nPerigenital region: XA9PX3\\nSuprapubic area: XA0LF4\\nMons pubis: XA10Z0\\nInguinocrural fold: XA2XG2\\nInguinal canal: XA00B4\\nPerianal region: XA4B34\\nPerineum: XA53N9\\nIntergluteal cleft: XA2F27\\nExtremities: XA6AS2\\nUpper extremity: XA4BA8\\nShoulder: XA2ND5\\nAnterior surface of shoulder: XA3PZ3\\nApex of shoulder: XA5BU5\\nPosterior surface of shoulder: XA34G7\\nAxilla: XA17J1\\nAnterior axillary fold: XA41A1\\nApex of axilla: XA86E8\\nPosterior axillary fold: XA2RY5\\nUpper arm: XA6809\\nAnterior surface of upper arm: XA22Q1\\nLateral surface of upper arm: XA2W33\\nPosterior surface of upper arm: XA5TK8\\nMedial surface of upper arm: XA3J41\\nElbow: XA9FF8\\nAntecubital fossa: XA9NE6\\nLateral condylar surface of elbow: XA6599\\nElbow tip: XA3RT8\\nMedial condylar surface of elbow: XA4983\\nForearm: XA7WB0\\nVolar surface of forearm: XA8ZL6\\nLateral surface of forearm: XA1VA2\\nDorsal surface of forearm: XA8WH0\\nMedial surface of forearm: XA2Q46\\nWrist: XA2J63\\nVolar surface of wrist: XA6AR5\\nRadial border of wrist: XA3LK1\\nDorsal surface of wrist: XA0SH5\\nUlnar border of wrist: XA0J47\\nHand: XA5R12\\nDorsum of hand: XA30Z6\\nKnuckles: XA3T43\\nInterdigital web space of hand: XA65Z3\\nFirst interdigital web space of hand: XA1BR6\\nSecond interdigital web space of hand: XA5PY9\\nThird interdigital web space of hand: XA4012\\nFourth interdigital web space of hand: XA3WG2\\nPalm of hand: XA3NY8\\nProximal palm: XA3FJ0\\nThenar eminence: XA2JN4\\nHypothenar eminence: XA5TQ4\\nCentral palm: XA50E4\\nDistal palm: XA00D7\\nFingers and thumb: XA2593\\nThumb: XA8DJ6\\nPerionychium of thumb: XA0RL8\\nProximal nailfold of thumb: XA13E9\\nEponychium of thumb: XA20L7\\nLateral nailfold of thumb: XA4GD7\\nHyponychium of thumb: XA63L0\\nThumbnail: XA5PD5\\nLunula of thumb: XA6DM1\\nNail bed of thumb: XA9N39\\nNail plate of thumb: XA5V24\\nPad of thumb: XA5ZV0\\nDorsum of thumb: XA76N2\\nIndex finger: XA6NZ0\\nPerionychium of index finger: XA6YH1\\nEponychium of index finger: XA90K8\\nHyponychium of index finger: XA2UG0\\nIndex fingernail: XA40D9\\nLunula of index finger: XA1GS3\\nNail bed of index finger: XA1SB3\\nNail plate of index finger: XA2XE0\\nPad of index finger: XA6TA9\\nMiddle finger: XA0Y38\\nPerionychium of middle finger: XA1FY2\\nProximal nail fold of middle finger: XA8YE5\\nEponychium of middle finger: XA13L6\\nLateral nail fold of middle finger: XA2N38\\nHyponychium of middle finger: XA8KX8\\nMiddle fingernail: XA9YZ9\\nLunula of middle finger: XA8VS0\\nNail bed of middle finger: XA2A53\\nNail plate of middle finger: XA10T8\\nPad of middle finger: XA79X0\\nRing finger: XA06X8\\nPerionychium of ring finger: XA7K11\\nProximal nail fold of ring finger: XA1F61\\nEponychium of ring finger: XA8L06\\nLateral nail fold of ring finger: XA3HG9\\nHyponychium of ring finger: XA1W89\\nRing fingernail: XA6Y59\\nLunula of ring finger: XA4P58\\nNail bed of ring finger: XA3MW5\\nNail plate of ring finger: XA3PS0\\nPad of ring finger: XA6C72\\nLittle finger: XA5EN3\\nPerionychium of little finger: XA89P0\\nProximal nail fold of little finger: XA4KU5\\nEponychium of little finger: XA2AV8\\nLateral nail fold of little finger: XA3LC5\\nHyponychium of little finger: XA1C10\\nPad of little finger: XA4WN3\\nLittle fingernail: XA29K9\\nLunula of little finger: XA3R66\\nNail bed of little finger: XA6HB9\\nNail plate of little finger: XA4A79\\nSide of finger: XA4HZ3\\nTips of fingers: XA7GT9\\nTip of index finger: XA41X5\\nTip of middle finger: XA9Y99\\nTip of ring finger: XA91S7\\nTip of little finger: XA8QW7\\nFingernails: XA0EH9\\nSkin of elbow: XA66R9\\nLower extremity: XA45A6\\nButtock: XA3VA7\\nGluteal fold: XA5UE3\\nThigh: XA5S78\\nAnterior surface of thigh: XA98B3\\nLateral surface of thigh: XA8RH9\\nTrochanteric region: XA4TQ2\\nPosterior surface of thigh: XA0183\\nMedial surface of thigh: XA1YQ6\\nUpper medial surface of thigh: XA9ZB4\\nKnee: XA8KL5\\nPatellar region: XA9L17\\nLateral surface of knee: XA77E9\\nMedial surface of knee: XA9S09\\nPopliteal fossa: XA4DM3\\nLower leg: XA3YG1\\nAnterior surface of lower leg: XA33X4\\nCalf: XA4K86\\nLateral surface of lower leg: XA4RR4\\nPosterior surface of lower leg: XA0LQ2\\nMedial surface of lower leg: XA15P0\\nDistal lower leg: XA5U49\\nProximal lower leg: XA90X0\\nAnkle: XA67V4\\nAnterior surface of ankle: XA2V14\\nLateral surface of ankle: XA7AM4\\nLateral supramalleolar region: XA1D83\\nLateral retromalleolar region: XA41K4\\nMedial surface of ankle: XA7P78\\nMedial supramalleolar region: XA87M9\\nMedial retromalleolar region: XA1SM7\\nPosterior surface of ankle: XA6AP4\\nFoot: XA47V8\\nHindfoot: XA99M7\\nHeel: XA5HK0\\nPosterior surface of heel: XA5ZE2\\nMedial surface of heel: XA1QH8\\nLateral surface of heel: XA3R99\\nPlantar surface of heel: XA2N02\\nMidfoot: XA5151\\nDorsal surface of midfoot: XA02P2\\nForefoot: XA5YL1\\nDorsal surface of forefoot: XA81Z3\\nInterdigital web space of foot: XA1FL5\\nFirst interdigital web space of foot: XA81N1\\nSecond interdigital web space of foot: XA8HC5\\nThird interdigital web space of foot: XA9LB9\\nFourth interdigital web space of foot: XA2A07\\nPlantar surface of forefoot: XA6KE9\\nFirst metatarsal head region: XA6V29\\nSecond metatarsal head region: XA2P22\\nThird metatarsal head region: XA0HX4\\nFourth metatarsal head region: XA86J0\\nFifth metatarsal head region: XA05N7\\nDorsum of foot: XA8BE2\\nSole of foot: XA1XM4\\nLateral border of foot: XA9Y82\\nMedial border of foot: XA3WM8\\nArch of foot: XA3T29\\nToes: XA4LC9\\nGreat toe: XA2RP7\\nPerionychium of great toe: XA4774\\nProximal nail fold of great toe: XA8L19\\nEponychium of great toe: XA7WP9\\nLateral nail fold of great toe: XA7GD8\\nHyponychium of great toe: XA2F64\\nGreat toenail: XA1RE3\\nLunula of great toe: XA64R9\\nNail bed of great toe: XA0HX8\\nNail plate of great toe: XA47T1\\nPad of great toe: XA6VJ2\\nSecond toe: XA8ZZ3\\nPerionychium of second toe: XA5446\\nProximal nail fold of second toe: XA1ED1\\nEponychium of second toe: XA0SL7\\nLateral nail fold of second toe: XA7003\\nHyponychium of second toe: XA2ZJ7\\nSecond toenail: XA7GG3\\nLunula of second toe: XA9439\\nNail bed of second toe: XA7B22\\nNail plate of second toe: XA1WQ6\\nPad of second toe: XA3626\\nThird toe: XA0SP3\\nPerionychium of third toe: XA3UC8\\nProximal nail fold of third toe: XA2484\\nEponychium of third toe: XA8DQ2\\nLateral nail fold of third toe: XA1MM3\\nHyponychium of third toe: XA2H72\\nPad of third toe: XA5JP9\\nThird toenail: XA3D73\\nLunula of third toe: XA9UL1\\nNail bed of third toe: XA6189\\nNail plate of third toe: XA3LW9\\nFourth toe: XA4KK7\\nPerionychium of fourth toe: XA40R3\\nProximal nail fold of fourth toe: XA2Y79\\nEponychium of fourth toe: XA0XZ8\\nLateral nail fold of fourth toe: XA0PV4\\nHyponychium of fourth toe: XA4ZB3\\nPad of fourth toe: XA9316\\nFourth toenail: XA6TS5\\nLunula of fourth toe: XA2PD3\\nNail bed of fourth toe: XA65U3\\nNail plate of fourth toe: XA8F87\\nFifth toe: XA42W4\\nPerionychium of fifth toe: XA1AV3\\nProximal nail fold of fifth toe: XA43K6\\nEponychium of fifth toe: XA2W24\\nLateral nail fold of fifth toe: XA38J0\\nHyponychium of fifth toe: XA0DD8\\nPad of fifth toe: XA3C43\\nFifth toenail: XA3VM6\\nLunula of fifth toe: XA1PK7\\nNail bed of fifth toe: XA9L52\\nNail plate of fifth toe: XA4U10\\nPlantar surface of toe: XA9LJ5\\nDorsal surface of toe: XA7J49\\nSide of toe: XA14Y9\\nToenail: XA9E36\\nAlveolar wall: XA4UM2\\nCell wall: XA5UL3\\nIntestinal Wall: XA3JR1\\nOral floor: XA37C7\\nParietal wall: XA9KX3\\nPelvic floor: XA5CW9\\nPelvic wall: XA29C1\\nRectovaginal septum: XA60B5\\nRectovesical septum: XA37K5\\nUterine wall: XA1DP8\\nVaginal wall: XA57Q2\\nBody fluid: XA06R8\\nCerebrospinal fluid: XA1N55\\nInterstitial fluid: XA08M4\\nSerous fluid: XA2L90\\nSynovial fluid: XA0518\\nBone tissue: XA0UK0\\nCollagen fibres: XA7YJ2\\nConnective tissue: XA5A05\\nAdipose tissue: XA6R65\\nFascia: XA0FR0\\nLoose connective tissue: XA51U1\\nPerichondrium: XA53R0\\nPeriodontium: XA7YP0\\nPeriosteum: XA6FQ2\\nSynovium: XA3G85\\nLymphatic tissue: XA8SZ4\\nSoft tissue not elsewhere classified: XA97C4\\nSoft tissue of limb not elsewhere classified: XA5P05\\nEpithelium: XA56S9\\nMucosa: XA0PT3\\nMesothelium: XA0182\\nGamete: XA1922\\nFemale gamete: XA95A3\\nMale gamete: XA2470\\nMuscle tissue: XA39T1\\nCardiac muscle: XA6283\\nSkeletal muscle: XA0DD5\\nSmooth muscle: XA0JY3\\nNervous Tissue: XA5B23\\nNeuroglia: XA1J91\\nNeuron: XA1413\\nInterneuron: XA5BW5\\nMotor Neuron: XA5DJ5\\nSensory Neuron: XA2LT7\\nCranial cavity: XA1ZV6\\nSubarachnoid space: XA1XM6\\nSubdural space: XA1FQ8\\nDorsal body cavity: XA9QA7\\nPerineural space: XA1GB6\\nVentral body cavity: XA2N82\\nAbdominopelvic cavity: XA34B0\\nAbdominal cavity: XA9M74\\nPelvic cavity: XA25Q2\\nIschiorectal fossa: XA9CK0\\nPresacral region: XA53A7\\nPerirectal region: XA2EG4\\nInguinal region: XA0GN7\\nMediastinum: XA7WA2\\nAnterior mediastinum: XA5UF8\\nMiddle mediastinum: XA99Z0\\nPosterior mediastinum: XA1FD0\\nConnective and other soft tissues of mediastinum: XA8607\\nVertebral cavity: XA8YW7\\nEpidural space: XA8SS8\\nIntramedullary space: XA4LQ4\\nThoracic cavity: XA1XJ5\\nPleural cavity: XA3LX5\\nPrecordium: XA2RT1\\nAcinar cell adenoma: XH96Q1\\nAcinar cell carcinoma: XH3PG9\\nAcinar cell cystadenocarcinoma: XH99S4\\nMixed acinarductal carcinoma: XH9B93\\nAcinar adenocarcinoma of the lung: XH0F68\\nAcinar cell tumour: XH2SK9\\nAcidophil adenoma: XH9574\\nAdenoma NOS: XH3DV3\\nAdenomatous polyposis coli: XH1CV4\\nAdrenal cortical adenoma clear cell: XH1YP0\\nAdrenal cortical adenoma compact cell: XH2CT2\\nAdrenal cortical adenoma glomerulosa cell: XH60N5\\nAdrenal cortical adenoma mixed cell: XH2VZ8\\nAdrenal cortical adenoma pigmented: XH2FJ6\\nAlveolar adenoma: XH9356\\nBasal cell adenoma: XH60D1\\nBasophil adenoma: XH3AH8\\nBile duct adenoma: XH6KR6\\nBile duct cystadenoma: XH0778\\nBiliary intraepithelial neoplasia low grade: XH7BS0\\nBiliary papillomatosis: XH5YG5\\nCanalicular adenoma: XH1TD7\\nChief cell adenoma: XH6WK1\\nChromophobe adenoma: XH7475\\nClear cell adenofibroma: XH9JJ4\\nClear cell adenoma: XH8R87\\nCylindroma of skin: XH6J91\\nEccrine dermal cylindroma: XH5GN1\\nEmbryonal adenoma: XH6685\\nOesophageal glandular dysplasia intraepithelial neoplasia low grade: XH3K13\\nFlat adenoma: XH83X4\\nFollicular adenoma: XH0LM0\\nFollicular adenoma oxyphilic cell: XH5SM2\\nGlandular intraepithelial neoplasia low grade: XH6AF9\\nGlandular papilloma: XH3BK2\\nHurthle cell adenoma: XH6PG8\\nHurthle cell tumour: XH5X53\\nJuxtaglomerular tumour: XH6M13\\nLactating adenoma: XH0W31\\nLipoadenoma: XH8P28\\nLiver cell adenoma: XH68V1\\nMacrofollicular adenoma: XH19E3\\nMetanephric adenoma: XH0JC7\\nMicrocystic adenoma: XH3DH3\\nMixed acidophilbasophil adenoma: XH5LD9\\nMixed adenomatous and hyperplastic polyp: XH0WV8\\nMixed cell adenoma: XH1XU4\\nMonomorphic adenoma: XH2CQ8\\nMultiple adenomatous polyps: XH6CZ4\\nOxyphilic adenoma: XH9Z86\\nPancreatobiliary neoplasm noninvasive: XH0BF2\\nPancreatic microadenoma: XH6GG6\\nPapillomatosis glandular: XH1BH4\\nPapillotubular adenoma: XH6EJ4\\nLactotroph adenoma: XH1QS0\\nSerrated adenoma: XH5903\\nTrabecular adenoma: XH9G87\\nTurban tumour: XH8T50\\nVillous papilloma: XH0731\\nWaterclear cell adenoma: XH8UC1\\nCylindroma of breast: XH28X1\\nAdenomatous polyp NOS: XH8MU5\\nTubular adenoma NOS: XH7SY6\\nSessile serrated adenoma: XH2F06\\nSessile serrated polyp: XH63V9\\nTraditional sessile serrated adenoma: XH9PD9\\nAtypical adenomatous hyperplasia: XH5QL3\\nPapillary adenoma NOS: XH09B0\\nVillous adenoma NOS: XH90D6\\nTubulovillous adenoma NOS: XH10B0\\nPituitary adenoma NOS: XH94U0\\nSpindle cell oncocytoma: XH26P7\\nAdrenal cortical adenoma NOS: XH52F6\\nEndometrioid adenoma NOS: XH6ZD0\\nEndometrioid adenofibroma NOS: XH1CX5\\nMicrofollicular adenoma NOS: XH2H83\\nAdenoma intestinal type: XH7DU3\\nPancreatic neuroendocrine microadenoma: XH1Q16\\nOncocytic papillary cystadenoma: XH8NK5\\nNull cell adenoma: XH8Y40\\nPlurihormonal adenoma: XH1JL3\\nGonadotroph adenoma: XH50K4\\nSomatotroph adenoma: XH4HE3\\nThyrotroph adenoma: XH0MY4\\nPituitary adenoma ectopic: XH5RH2\\nCorticotroph adenoma: XH1C58\\nBronchiolar adenoma  Ciliated muconodular papillary tumour: XH7743\\nAdenocarcinoma in situ NOS: XH2L30\\nAdenocarcinoma in situ in adenomatous polyp: XH4J07\\nAdenocarcinoma in situ in tubulovillous adenoma: XH3770\\nAdenocarcinoma in situ in villous adenoma: XH8TV2\\nBiliary intraepithelial neoplasia high grade: XH5U91\\nCribriform carcinoma in situ: XH7Y32\\nDuctal carcinoma in situ solid type: XH0557\\nOesophageal glandular dysplasia intraepithelial neoplasia high grade: XH36M5\\nFlat intraepithelial glandular neoplasia high grade: XH5161\\nGlandular intraepithelial neoplasia high grade: XH28N7\\nPapillary neoplasm pancreatobiliarytype with high grade intraepithelial neoplasia: XH26M2\\nProstatic intraepithelial neoplasia grade III: XH5C49\\nAdenocarcinoma in situ of lung nonmucinous: XH1FR9\\nAdenocarcinoma in situ of lung mucinous: XH6BU6\\nEndometrioid intraepithelial neoplasia: XH4Z68\\nAcidophil carcinoma: XH2QZ6\\nAdenocarcinoid tumour: XH5LA4\\nAdenocarcinoma NOS: XH74S1\\nAdenocarcinoma in adenomatous polyp: XH7QZ0\\nAdenocarcinoma in adenomatous polyposis coli: XH2ZH8\\nAdenocarcinoma in multiple adenomatous polyps: XH9YR3\\nAdenocarcinoma in tubulovillous adenoma: XH7QB1\\nAdenocarcinoma in villous adenoma: XH6DA5\\nAdenocarcinoma of anal glands: XH5RE1\\nAdenocarcinoma with mixed subtypes: XH2ZQ0\\nAdenocarcinoma intestinal type: XH0349\\nSolid carcinoma NOS: XH8B45\\nNeuroendocrine tumour NOS: XH8DS0\\nNeuroendocrine carcinoma low grade: XH8LX8\\nNeuroendocrine carcinoma welldifferentiated: XH55D7\\nNeuroendocrine tumor grade: XH9LV8\\nEnterochromaffin cell carcinoid: XH7NM1\\nNeuroendocrine carcinoma NOS: XH0U20\\nNeuroendocrine carcinoma moderately differentiated: XH7F73\\nLepidic adenocarcinoma: XH24W2\\nMinimally invasive adenocarcinoma Nonmucinous: XH3QM0\\nAdenoid cystic carcinoma: XH4302\\nMinimally invasive adenocarcinoma Mucinous: XH2098\\nPapillary adenocarcinoma NOS: XH6LV9\\nVilloglandular carcinoma: XH95U1\\nMicropapillary carcinoma NOS: XH6QG3\\nMicropapillary adenocarcinoma: XH4MW7\\nPituitary carcinoma NOS: XH7KL6\\nClear cell adenocarcinoma NOS: XH6L02\\nHereditary leiomyomatosis and renal cell carcinoma HLRCC syndromeassociated renal cell carcinoma: XH5085\\nMiT Family translocation carcinomas: XH1442\\nSuccinate dehydrogenase deficient renal cell carcinoma: XH8EN1\\nAlveolar adenocarcinoma: XH07X3\\nRenal cell carcinoma NOS: XH05V6\\nRenal cell carcinoma unclassified: XH3Z08\\nAcquired cystic disease associated renal cell carcinoma: XH0RU3\\nTubulocystic renal cell carcinoma: XH7K79\\nHybrid oncocytic chromophobe tumour: XH1VB1\\nFollicular carcinoma NOS: XH3Z50\\nEndometrioid adenocarcinoma ciliated cell variant: XH9508\\nEndometrioid adenocarcinoma secretory variant: XH0718\\nAdrenal cortical carcinoma: XH4KH2\\nEndometrioid adenocarcinoma NOS: XH0SD2\\nNeuroendocrine tumour grade: XH5QW8\\nEndometrioid cystadenocarcinoma: XH09B7\\nEndometrioid adenofibroma malignant: XH6KR7\\nAdenocarcinoma endocervical type: XH0GS9\\nIslet cell adenomatosis: XH8SF8\\nPerihilar cholangiocarcinoma: XH43E4\\nIslet cell adenoma: XH4BY1\\nVilloglandular variant of endometrioid adenocarcinoma: XH3CU4\\nPituitary blastoma: XH5QV8\\nFollicular carcinoma encapsulated angioinvasive: XH0Y80\\nClear cell renal cell carcinoma NOS: XH46F1\\nBasal cell adenocarcinoma: XH9SA7\\nEndolymphatic sac tumor: XH85C2\\nAcinar adenocarcinoma of prostate: XH4PB1\\nMixed neuroendocrine nonneuroendocrine neoplasm MiNEN: XH8E54\\nNesidioblastoma: XH1NL5\\nIslet cell carcinoma: XH5XB7\\nIslet cell tumor NOS: XH2ST7\\nInsulinoma NOS: XH4SH8\\nGastrinoma: XH93H8\\nParathyroid carcinoma: XH7JQ0\\nBasophil carcinoma: XH9LV7\\nGlucagonlike peptideproducing tumour: XH7152\\nLcell tumour: XH7LW9\\nPancreatic peptide and pancreatic peptidelike peptide within terminal tyrosine amide producing tumour: XH9ZS8\\nGlucagonoma: XH4NQ8\\nEnteroglucagonoma: XH2PF0\\nVipoma: XH72E5\\nSomatostatinoma: XH5VH0\\nEndocrine tumour functioning NOS: XH41P2\\nACTHproducing tumour: XH7AG8\\nMedullary thyroid carcinoma: XH60V1\\nBile duct cystadenocarcinoma: XH3BU6\\nMedullary carcinoma with amyloid stroma: XH2MW1\\nPoorly differentiated thyroid carcinoma: XH8VU6\\nPituitary neuroendocrine tumour: XH4NH4\\nBronchial adenoma carcinoid: XH2ZA2\\nAdenocarcinoma of lung mixed mucinous and nonmucinous: XH5TR7\\nAdenocarcinoma of lung mucinous: XH7GY6\\nBronchioloalveolar carcinoma nonmucinous: XH2035\\nCarcinoma simplex: XH6LF9\\nCarcinoma diffuse type: XH0XL5\\nCholangiocarcinoma: XH7M15\\nChromophobe carcinoma: XH7SS7\\nClear cell adenocarcinofibroma: XH2Q13\\nClear cell adenocarcinoma mesonephroid: XH6YS0\\nCollecting duct carcinoma: XH4SQ4\\nCombined hepatocellular carcinoma and cholangiocarcinoma: XH7QJ6\\nCystassociated renal cell carcinoma: XH4KK0\\nEnterochromaffinlike cell tumour: XH0LH8\\nFetal adenocarcinoma: XH5P16\\nFollicular adenocarcinoma moderately differentiated: XH7TE3\\nFollicular adenocarcinoma trabecular: XH0VD1\\nFollicular adenocarcinoma well differentiated: XH8FK7\\nFollicular carcinoma minimally invasive: XH3DN7\\nFollicular carcinoma oxyphilic cell: XH90N9\\nGlycogenrich carcinoma: XH3XT5\\nGoblet cell carcinoid: XH4262\\nGranular cell carcinoma: XH2EH4\\nHepatocellular carcinoma clear cell type: XH4T58\\nHepatocellular carcinoma fibrolamellar: XH9Q35\\nHepatocellular carcinoma pleomorphic type: XH0G90\\nHepatocellular carcinoma scirrhous: XH5761\\nHepatocellular carcinoma spindle cell variant: XH3T17\\nHurthle cell adenocarcinoma: XH6YH5\\nHurthle cell carcinoma: XH8MQ3\\nLinitis plastica: XH8WM4\\nLipidrich carcinoma: XH6TK0\\nMerkel cell carcinoma: XH81N8\\nMixed acidophilbasophil carcinoma: XH7019\\nMixed acinarendocrine carcinoma: XH8EZ3\\nMixed acinarendocrineductal carcinoma: XH74Y9\\nMixed adenoneuroendocrine carcinoma: XH6H10\\nMixed cell adenocarcinoma: XH2AM6\\nMixed ductalendocrine carcinoma: XH7CY5\\nMixed endocrine and exocrine adenocarcinoma: XH6UP4\\nMixed medullaryfollicular carcinoma: XH7DG7\\nMixed medullarypapillary carcinoma: XH3340\\nMixed pancreatic endocrine and exocrine tumour malignant: XH9LZ7\\nNonencapsulated sclerosing carcinoma: XH1108\\nOxyphilic adenocarcinoma: XH09D6\\nIslet cell adenocarcinoma: XH3614\\nPancreatic neuroendocrine tumor nonfunctioning: XH3709\\nPancreatobiliarytype carcinoma: XH6XY9\\nPapillary carcinoma of thyroid: XH1ND9\\nPapillary carcinoma columnar cell: XH85E5\\nPapillary carcinoma diffuse sclerosing: XH0426\\nPapillary carcinoma encapsulated of thyroid: XH0Q59\\nPapillary carcinoma follicular variant: XH29M4\\nPapillary carcinoma oncocytic variant: XH5YT2\\nPapillary microcarcinoma: XH2AW7\\nPapillary renal cell carcinoma: XH1D07\\nPapillotubular adenocarcinoma: XH4Q20\\nParietal cell carcinoma: XH1JZ0\\nRenal cell carcinoma chromophobe type: XH6153\\nRenal cell carcinoma sarcomatoid: XH9DH7\\nScirrhous adenocarcinoma: XH4FS4\\nSolid carcinoma with mucin formation: XH34G3\\nSuperficial spreading adenocarcinoma: XH0JE3\\nTrabecular adenocarcinoma: XH7EX3\\nTubular adenocarcinoma: XH4TA4\\nTypical carcinoid: XH1Z69\\nCarcinoma of Skene Cowper and Littre Glands: XH22Z8\\nVillous adenocarcinoma: XH0X20\\nWaterclear cell adenocarcinoma: XH0A57\\nAdenocarcinoma metastatic NOS: XH8UE4\\nBasal cell carcinoma of the prostate: XH4ZC3\\nHepatocellular carcinoma NOS: XH4W48\\nBronchial adenoma cylindroid: XH81Q9\\nThymic carcinoma with adenoid cystic carcinomalike features: XH92Y9\\nCribriform carcinoma NOS: XH1YZ3\\nCribriform comedotype carcinoma: XH4YG1\\nSerrated adenocarcinoma: XH74B2\\nApudoma: XH6770\\nAtypical adenoma: XH6VL9\\nAtypical follicular adenoma: XH3T38\\nClear cell adenofibroma of borderline malignancy: XH0S86\\nEndometrioid adenoma borderline malignancy: XH5DQ2\\nMultiple endocrine adenomas: XH76W6\\nPulmonary adenomatosis: XH8468\\nHypernephroid tumour: XH54H3\\nMultilocular cystic renal neoplasm of low malignant potential: XH7PR9\\nEndometrioid adenofibroma borderline malignancy: XH9DS4\\nTubular carcinoid: XH4JG0\\nAggressive papillary tumour: XH4XL2\\nWell differentiated tumor of uncertain malignant potential: XH9PN4\\nNoninvasive follicular thyroid neoplasm with papillarylike nuclear features NIFTP: XH6SY0\\nHyalinizing trabecular tumour: XH1Y66\\nFollicular tumor of uncertain malignant potential: XH27W5\\nClear cell papillary renal cell carcinoma: XH9T60\\nClear cell borderline tumour: XH6CZ3\\nApocrine adenoma: XH6YZ9\\nClear cell hidradenoma: XH0AQ8\\nEccrine acrospiroma: XH46Z2\\nEccrine papillary adenoma: XH42Z3\\nEccrine poroma: XH25Z9\\nSpiradenoma NOS: XH3AM1\\nFollicular fibroma: XH4YU8\\nHidradenoma NOS: XH4MV7\\nPapillary hidradenoma: XH4DX4\\nSyringocystadenoma papilliferum: XH1PY0\\nSkin appendage adenoma: XH96Q5\\nSweat gland adenoma: XH3U61\\nSyringofibroadenoma: XH06Y5\\nSyringoma NOS: XH6325\\nSyringomatous tumour of nipple: XH9GB7\\nSebaceous adenoma: XH1NC5\\nSebaceous epithelioma: XH0SH5\\nCeruminous adenoma: XH7AL8\\nSpindle cell predominant trichodiscoma: XH8R55\\nApocrine poroma: XH1A80\\nPoroma NOS: XH8N28\\nSebaceoma: XH0QL4\\nPorocarcinoma in situ: XH7WE6\\nApocrine adenocarcinoma: XH9L77\\nDigital papillary adenocarcinoma: XH6FB5\\nPorocarcinoma NOS: XH7VK4\\nMalignant eccrine spiradenoma: XH58E1\\nHidradenocarcinoma: XH7NK9\\nMicrocystic adnexal carcinoma: XH17P2\\nAdnexal adenocarcinoma NOS: XH89V4\\nSweat gland adenocarcinoma: XH5LY3\\nSebaceous carcinoma: XH4VR2\\nEccrine adenocarcinoma: XH8NE4\\nCeruminous adenocarcinoma: XH6Z69\\nMalignant neoplasm arising from preexisting spiradenoma: XH9C82\\nMalignant neoplasm arising from preexisting cylindroma: XH2ZK9\\nMalignant neoplasm arising from preexisting spiradenocylindroma: XH9NW9\\nSialadenoma papilliferum: XH65F9\\nSyringocystadenocarcinoma papilliferum: XH0BE5\\nSweat gland tumour NOS: XH8BW1\\nIntraepidermal epithelioma of Jadassohn: XH1PG0\\nTrichilemmoma: XH5AU2\\nTrichoepithelioma: XH6QT9\\nTrichofolliculoma: XH0U05\\nPilar tumour: XH5L76\\nPilomatricoma NOS: XH9E37\\nTrichogerminoma: XH05Z3\\nMelanocytic matricoma: XH7CM2\\nPilar sheath acanthoma: XH3EY8\\nTumor of follicular infundibulum: XH0489\\nTrichoblastoma: XH2K97\\nAdenoid basal carcinoma: XH70J2\\nBasal cell carcinoma fibroepithelial: XH45F3\\nBasal cell carcinoma micronodular: XH4GJ2\\nBasal cell carcinoma nodular: XH2CR0\\nBasal cell carcinoma NOS: XH2615\\nBasosquamous carcinoma: XH4C18\\nInfiltrating basal cell carcinoma NOS: XH5VK4\\nInfiltrating basal cell carcinoma nonsclerosing: XH0T12\\nInfiltrating basal cell carcinoma sclerosing: XH67Y4\\nMetatypical carcinoma: XH9E93\\nSuperficial basal cell carcinoma: XH5NL6\\nPigmented basal cell carcinoma: XH2HE7\\nTrichilemmocarcinoma: XH9K96\\nPilomatrical carcinoma: XH9G49\\nBasal cell carcinoma with adnexal differentiation: XH6S67\\nTrichoblastic carcinoma: XH3DL9\\nTrichoblastic carcinosarcoma: XH8324\\nBasal cell carcinoma sarcomatoid: XH1JH6\\nBasal cell tumour: XH8189\\nProliferating trichilemmal cyst: XH7WJ7\\nCapillary haemangioma: XH3U29\\nCavernous haemangioma: XH1GU2\\nEpithelioid haemangioma: XH10T4\\nHaemangioendothelioma benign: XH0LN3\\nIntramuscular haemangioma: XH0553\\nRacemose haemangioma: XH2HR3\\nVenous haemangioma: XH4NS3\\nHaemangioma NOS: XH5AW4\\nMyointimoma: XH37N4\\nAngiofibroma NOS: XH1JJ2\\nVerrucous keratotic haemangioma: XH23S6\\nCellular angiofibroma: XH4E06\\nGiant cell angiofibroma: XH73S9\\nAcquired tufted haemangioma: XH2EX4\\nCutaneous epithelioid angiomatoid nodule: XH8SM9\\nAtypical vascular lesion: XH8KN7\\nCherry hemangioma: XH9Q71\\nSinusoidal hemangioma: XH88L5\\nMicrovenular hemangioma: XH9UU3\\nGlomeruloid hemangioma: XH9NB0\\nSpindle cell hemangioma: XH6RP8\\nCongenital hemangioma NOS: XH27G6\\nCongenital hemangioma rapidly involuting: XH6RC4\\nCongenital hemangioma noninvoluting: XH5427\\nHobnail hemangioma: XH8PD3\\nLobular capillary hemangioma: XH4LY5\\nHaemangioendothelioma malignant: XH4E71\\nHemangiosarcoma: XH6264\\nKaposi sarcoma: XH36A5\\nKupffer cell sarcoma: XH6FJ5\\nIntravascular bronchial alveolar tumour: XH3C78\\nIntimal sarcoma: XH36H7\\nEpithelioid haemangioendothelioma NOS: XH9GF8\\nPapillary intralymphatic angioendothelioma: XH4SY7\\nKaposiform haemangioendothelioma: XH6PA4\\nSpindle cell haemangioendothelioma: XH2PS0\\nPseudomyogenic epithelioid sarcomalike haemangioendothelioma: XH26F6\\nRetiform haemangioendothelioma: XH64U8\\nComposite haemangioendothelioma: XH8D24\\nHaemangioendothelioma NOS: XH2L98\\nHaemangioblastoma: XH6810\\nAdenolymphoma: XH9ZB2\\nMixed squamous cell and glandular papilloma: XH1TX5\\nLymphadenoma: XH7J33\\nAdenocarcinoma with squamous metaplasia: XH2PY4\\nAdenosquamous carcinoma: XH7873\\nEpithelialmyoepithelial carcinoma: XH9JP2\\nAdenocarcinoma with cartilaginous and osseous metaplasia: XH7247\\nAdenocarcinoma with spindle cell metaplasia: XH2QL8\\nFibromatosislike metaplastic carcinoma: XH6G98\\nAdenocarcinoma with apocrine metaplasia: XH4GA3\\nAdenocarcinoma with neuroendocrine differentiation: XH4T39\\nMetaplastic carcinoma NOS: XH0RD4\\nHepatoid adenocarcinoma: XH7MV6\\nSquamoid eccrine ductal carcinoma: XH95Y6\\nEndometrioid carcinoma with squamous differentiation: XH8XD1\\nAdenomyoma: XH4ZH4\\nAtypical polypoid adenomyoma: XH7ZB1\\nBenign cystic nephroma: XH6YS4\\nChondroid syringoma: XH70N8\\nEndometrial stromal nodule: XH8C13\\nOssifying renal tumour: XH3SR2\\nPleomorphic adenoma: XH2KC1\\nRenomedullary interstitial cell tumour: XH3470\\nStromal tumour benign: XH2E97\\nMixed epithelial and stromal tumour: XH0533\\nPaediatric cystic nephroma: XH7TJ0\\nAdenomyoepithelioma NOS: XH5QU1\\nAdenomyoepithelioma benign: XH2V57\\nPhosphaturic mesenchymal tumour benign: XH9T96\\nPulmonary hamartoma: XH3UD9\\nMyoepithelioma: XH3CQ8\\nMesenchymoma benign: XH7AA3\\nAdult cystic nephroma: XH1SP3\\nMesenchymal hamartoma: XH2P15\\nEctomesenchymal chondromyxoid tumour: XH1WZ6\\nAdenosarcoma: XH5544\\nCarcinofibroma: XH1YV7\\nCarcinoma ex pleomorphic adenoma: XH42V2\\nCarcinosarcoma embryonal: XH2RK1\\nEndometrial stromal sarcoma high grade: XH2CV3\\nEndometrial stromal sarcoma low grade: XH1S94\\nGastrointestinal stromal tumour: XH9HQ1\\nClear cell sarcoma of kidney: XH0765\\nMalignant chondroid syringoma: XH64D5\\nMalignant cystic nephroma: XH9M31\\nRhabdoid tumor NOS: XH3RF3\\nMesodermal mixed tumour: XH0Y65\\nMullerian mixed tumour: XH7ZJ9\\nPancreatoblastoma: XH27L5\\nPleuropulmonary blastoma: XH2FY9\\nPulmonary blastoma: XH5VH1\\nEndometrial stromal sarcoma NOS: XH1TK5\\nStromal sarcoma NOS: XH49Y5\\nMixed tumour malignant NOS: XH0V86\\nNephroblastoma NOS: XH5QN3\\nHepatoblastoma epithelioid: XH0H07\\nHepatoblastoma mixed epithelialmesenchymal: XH33R5\\nCarcinosarcoma NOS: XH2W45\\nAdenomyoepithelioma with carcinoma: XH7TL5\\nPhosphaturic mesenchymal tumour malignant: XH3B27\\nMyoepithelial carcinoma: XH43E6\\nMesenchymoma malignant: XH9N95\\nEmbryonal sarcoma: XH42Q2\\nGastroblastoma: XH4VQ1\\nGastrointestinal autonomic nerve tumour: XH5CT2\\nGastrointestinal pacemaker cell tumour: XH0712\\nCystic partially differentiated nephroblastoma: XH1JB4\\nMesoblastic nephroma: XH10F1\\nSialoblastoma: XH0G00\\nStromal tumour NOS: XH6R49\\nMetanephric stromal tumour: XH4N88\\nStromal tumour of uncertain malignant potential: XH8747\\nCalcifying nested stromalepithelial tumor: XH8X78\\nMesenchymoma NOS: XH2AD1\\nPrimitive nonneural granular cell tumor: XH5LL8\\nClear cell cystadenoma: XH6ZU1\\nCystic tumour of atrioventricular node: XH55F1\\nIntraductal papillarymucinous adenoma: XH5232\\nIntraductal papillarymucinous tumour with intermediate dysplasia: XH4070\\nIntraductal papillarymucinous tumour with low grade dysplasia: XH8MD2\\nIntraductal papillarymucinous tumour with moderate dysplasia: XH8ML6\\nSerous microcystic adenoma: XH0556\\nSerous surface papilloma: XH38C4\\nCystadenoma NOS: XH5RJ2\\nSerous cystadenoma NOS: XH8TJ0\\nPapillary cystadenoma NOS: XH0FM6\\nMucinous cystadenoma NOS: XH6H73\\nMucinous cystic neoplasm with intermediategrade dysplasia: XH8XL1\\nMucinous cystic neoplasm with lowgrade intraepithelial neoplasia: XH6NK7\\nMucinous cystic tumour with intermediate dysplasia: XH7K36\\nMucinous cystic tumour with moderate dysplasia: XH7834\\nMucinous cystic neoplasm with lowgrade dysplasia: XH0EK3\\nMucinous cystic neoplasm with intermediategrade intraepithelial neoplasia: XH8EW6\\nSeromucinous cystadenoma: XH9BE7\\nMucinous adenoma: XH2M29\\nMucous gland adenoma: XH5RX2\\nPapillary cystadenofibroma: XH9MS1\\nIntraductal papillarymucinous carcinoma noninvasive: XH5E08\\nIntraductal papillary mucinous neoplasm with high grade dysplasia: XH3MB3\\nMucinous cystadenocarcinoma noninvasive: XH06M2\\nMucinous cystic neoplasm with highgrade dysplasia: XH81P3\\nSerous intraepithelial carcinoma: XH8PZ6\\nSerous borderline tumour micropapillary variant: XH9DM1\\nSerous tubal intraepithelial carcinoma STIC: XH8NV8\\nSerous endometrial intraepithelial carcinoma: XH1YW4\\nIntraductal papillarymucinous carcinoma invasive: XH5WU3\\nIntraductal papillary mucinous neoplasm with an associated invasive carcinoma: XH2SE1\\nMicropapillary serous carcinoma: XH0572\\nSolid pseudopapillary carcinoma: XH5P21\\nCystadenocarcinoma NOS: XH0219\\nSerous carcinoma NOS: XH7A08\\nPapillary cystadenocarcinoma NOS: XH6JU6\\nLow grade serous carcinoma: XH12V5\\nHigh grade serous carcinoma: XH24N6\\nMucinous cystadenocarcinoma NOS: XH1390\\nMucinous cystic tumour with an associated invasive carcinoma: XH1K19\\nSeromucinous carcinoma: XH4186\\nMucinous adenocarcinoma: XH1S75\\nPseudomyxoma peritonei with unknown primary site: XH4U83\\nMucinous tubular and spindle cell carcinoma: XH5EQ2\\nPseudomyxoma peritonei: XH83J5\\nMucinous carcinoma gastric type: XH4KC5\\nMetastatic signet ring cell carcinoma: XH56K0\\nMucinproducing adenocarcinoma: XH5AF5\\nSignet ring cell carcinoma: XH4546\\nPoorly cohesive carcinoma: XH2KK0\\nKrukenberg tumour: XH3RD4\\nSignet ring cellhistiocytoid carcinoma: XH0XE5\\nSolid pseudopapillary neoplasm of pancreas: XH3AE9\\nMucinous cystic tumour of borderline malignancy: XH2FF0\\nPapillary cystadenoma borderline malignancy: XH1P30\\nSeromucinous borderline tumour: XH0RB9\\nSerous borderline tumour NOS: XH3ZK9\\nSolid pseudopapillary tumor of ovary: XH3FD4\\nLow grade appendiceal mucinous neoplasm: XH7BB4\\nIntracystic papillary neoplasm with low grade intraepithelial neoplasia: XH6RX1\\nIntraductal papillary neoplasm with low grade intraepithelial neoplasia: XH5ZH7\\nIntraductal papilloma: XH4LZ4\\nIntraductal tubularpapillary neoplasm low grade: XH7QS7\\nIntraductal papillary neoplasm NOS: XH6HK2\\nIntraductal papilloma with atypical ductal hyperplasia: XH60S7\\nAdenoma of nipple: XH7GN3\\nIntracystic papillary adenoma: XH9F80\\nIntraductal papillomatosis NOS: XH4JD3\\nComedocarcinoma noninfiltrating: XH8P86\\nIntraductal papillary neoplasm with high grade intraepithelial neoplasia: XH6AH7\\nNoninfiltrating intraductal papillary adenocarcinoma: XH9VG0\\nIntraductal carcinoma noninfiltrating NOS: XH1H31\\nDuctal carcinoma in situ NOS: XH4V32\\nIntraductal papilloma with DCIS: XH11S9\\nIntraductal tubularpapillary neoplasm high grade: XH64S7\\nNoninfiltrating intracystic carcinoma: XH9XV2\\nSolid papillary carcinoma in situ: XH0134\\nIntraductal carcinoma clinging high grade: XH39X8\\nCystic hypersecretory carcinoma intraductal: XH9SL6\\nIntraductal micropapillary carcinoma: XH0GQ3\\nLobular carcinoma in situ pleomorphic: XH2HB2\\nLobular carcinoma in situ NOS: XH6EH0\\nIntraductal carcinoma and lobular carcinoma in situ: XH7XE0\\nIntraductal tubulopapillary neoplasm: XH3PE9\\nEndocrine mucinproducing sweat gland carcinoma in situ: XH8010\\nIntraductal papilloma with lobular carcinoma in situ: XH4US4\\nSecretory carcinoma: XH44J4\\nInfiltrating duct carcinoma NOS: XH7KH3\\nAdenocarcinoma of mammary gland type: XH9FX2\\nComedocarcinoma NOS: XH1N58\\nIntraductal papillary adenocarcinoma with invasion: XH8MA7\\nPapillary carcinoma of the breast: XH8KR8\\nIntraductal papillary neoplasm with associated invasive carcinoma: XH90W1\\nEncapsulated papillary carcinoma with invasion: XH0GT6\\nInvasive micropapillary carcinoma of breast: XH9C56\\nSolid papillary carcinoma with invasion: XH1XB5\\nMedullary carcinoma NOS: XH2YP5\\nMedullarylike carcinoma: XH9B99\\nLobular carcinoma NOS: XH2XR3\\nMedullary adenocarcinoma: XH9620\\nAtypical medullary carcinoma: XH6KZ1\\nDuct carcinoma desmoplastic type: XH6PY4\\nMedullary carcinoma with lymphoid stroma: XH55H7\\nTubulolobular carcinoma: XH3RK9\\nInfiltrating ductular carcinoma: XH0408\\nInfiltrating duct and lobular carcinoma: XH8RN5\\nIntraductal and lobular carcinoma: XH9Z29\\nInfiltrating duct and lobular carcinoma in situ: XH6MH3\\nInfiltrating lobular carcinoma and ductal carcinoma in situ: XH9551\\nInfiltrating duct mixed with other types of carcinoma: XH8CS0\\nInfiltrating duct and colloid carcinoma: XH9GX4\\nInfiltrating duct and cribriform carcinoma: XH2ST9\\nInfiltrating duct and mucinous carcinoma: XH3969\\nInfiltrating duct and tubular carcinoma: XH1ND7\\nInfiltrating lobular mixed with other types of carcinoma: XH3CB4\\nPolymorphous adenocarcinoma: XH5SD5\\nInflammatory carcinoma: XH9G73\\nPaget disease mammary: XH3E21\\nPaget disease and infiltrating duct carcinoma of breast: XH47A6\\nPaget disease extramammary: XH70F8\\nPaget disease and intraductal carcinoma of breast: XH0C76\\nBasallike carcinoma of breast: XH32K6\\nAdenocarcinoma of anogenital mammarylike glands: XH4ZU9\\nCarcinoma of male breast: XH5KW8\\nEndocrine mucinproducing sweat gland carcinoma: XH4EK4\\nLobular carcinoma pleomorphic: XH9HB7\\nJuvenile carcinoma of breast: XH1146\\nCystic hypersecretory carcinoma: XH8TH6\\nEpithelial tumour benign: XH9HV0\\nTumourlet benign: XH1TD2\\nEpithelioma benign: XH65S3\\nFocal nodular hyperplasia: XH0M86\\nCarcinoma in situ NOS: XH5NV6\\nCarcinoma with osteoclastlike giant cells: XH56X7\\nCarcinoma NOS: XH63D2\\nGiant cell and spindle cell carcinoma: XH3XZ6\\nGiant cell carcinoma: XH1JZ2\\nGlassy cell carcinoma: XH00N7\\nLarge cell carcinoma with rhabdoid phenotype: XH4QU2\\nLarge cell neuroendocrine carcinoma: XH0NL5\\nPleomorphic carcinoma: XH35G0\\nPolygonal cell carcinoma: XH92T7\\nPseudosarcomatous carcinoma: XH35M3\\nCarcinoma metastatic NOS: XH1YN3\\nCarcinomatosis: XH8D74\\nEpithelioma malignant: XH4P61\\nLarge cell carcinoma NOS: XH45J4\\nCarcinoma undifferentiated NOS: XH1YY4\\nCarcinoma anaplastic NOS: XH57U9\\nNuclear protein in testis NUT associated carcinoma: XH2855\\nSpindle cell carcinoma NOS: XH3RZ4\\nSmall cell carcinoma NOS: XH0YB0\\nSmall cell neuroendocrine carcinoma: XH9SY0\\nOat cell carcinoma: XH28J9\\nSmall cell carcinoma fusiform cell: XH3T00\\nSmall cell carcinoma intermediate cell: XH6GK0\\nSmall cell carcinoma hypercalcaemic type: XH8ZR8\\nCombined small cell carcinoma: XH7YE3\\nCombined small celladenocarcinoma: XH0793\\nCombined small celllarge cell carcinoma: XH6FK9\\nCombined small cellsquamous cell carcinoma: XH9ZD2\\nNonsmall cell carcinoma: XH1DU4\\nHeterotopiaassociated carcinoma: XH26N1\\nCombined large cell neuroendocrine carcinoma: XH90B3\\nAnaplastic undifferentiated carcinoma: XH98Z7\\nDedifferentiated carcinoma: XH5R16\\nSquamous carcinoma with osteoclastlike giant cells: XH2BS4\\nUndifferentiated carcinoma with osteoclastlike giant cells: XH2224\\nTumourlet NOS: XH1N44\\nBrenner tumour NOS: XH5DX3\\nIntracanalicular fibroadenoma: XH4MA6\\nPapillary adenofibroma: XH7JU0\\nPericanalicular fibroadenoma: XH0N11\\nFibroadenoma NOS: XH9HE2\\nAdenofibroma NOS: XH91Y8\\nCystadenofibroma NOS: XH5S99\\nSerous adenofibroma NOS: XH5ZB5\\nSerous cystadenofibroma NOS: XH6RL8\\nSeromucinous adenofibroma: XH1VJ0\\nMucinous adenofibroma NOS: XH59X8\\nMucinous cystadenofibroma NOS: XH9SM7\\nPhyllodes tumour benign: XH50P7\\nGiant fibroadenoma: XH4RU1\\nJuvenile fibroadenoma: XH70H4\\nLipofibroadenoma: XH5853\\nMetanephric adenofibroma: XH7ZU2\\nBrenner tumour malignant: XH6NJ7\\nMucinous adenocarcinofibroma: XH7284\\nPeriductal stromal tumour low grade: XH75P5\\nSerous adenocarcinofibroma: XH9JC2\\nSerous cystadenocarcinofibroma: XH6PQ0\\nMucinous cystadenocarcinofibroma: XH0WW5\\nPhyllodes tumour malignant: XH8HJ7\\nBrenner tumour borderline malignancy: XH2CH8\\nMucinous adenofibroma of borderline malignancy: XH7AR7\\nMucinous cystadenofibroma of borderline malignancy: XH2YZ1\\nPhyllodes tumour borderline: XH5NK4\\nSerous adenofibroma of borderline malignancy: XH07C7\\nSerous cystadenofibroma of borderline malignancy: XH2M30\\nAngiomyofibroblastoma: XH8A47\\nBenign fibrous histiocytoma: XH06N0\\nElastofibroma: XH3BQ8\\nFascial fibroma: XH2MW3\\nFibromyxoma: XH5XQ3\\nMyofibroblastoma: XH3NQ0\\nMyofibroma: XH0953\\nPeriosteal fibroma: XH7FV0\\nFibroma NOS: XH8E66\\nDesmoplastic fibroblastoma: XH2ZF3\\nGardner fibroma: XH7GT0\\nNuchal fibroma: XH0XH6\\nPlexiform fibromyxoma: XH2WT6\\nFibroma of tendon sheath: XH0WB3\\nSolitary fibrous tumourHaemangiopericytoma grade: XH1EH1\\nCalcifying fibrous tumour: XH7TH6\\nNodular fasciitis: XH5LM1\\nHistiocytoma NOS: XH1UJ5\\nDermatofibroma NOS: XH8B90\\nSclerosing pneumocytoma: XH7436\\nDeep histiocytoma: XH5DP4\\nJuvenile histiocytoma: XH9VG1\\nReticulohistiocytoma: XH33Q1\\nCalcifying aponeurotic fibroma: XH8ZE3\\nCollagenous fibroma: XH2874\\nPlaquelike CD positive dermal fibroma: XH3665\\nAcral fibromyxoma: XH8173\\nSclerotic fibroma: XH5JG7\\nProliferative fasciitis: XH6JX7\\nProliferative myositis: XH87F9\\nEpithelioid fibrous histiocytoma: XH15M9\\nPleomorphic fibroma: XH1BV2\\nDermatomyofibroma: XH18K3\\nMyopericytoma: XH2HE9\\nFibrous dysplasia: XH5FY2\\nFascial fibrosarcoma: XH8EV4\\nFibromyxosarcoma: XH6LT0\\nInfantile fibrosarcoma: XH7BC6\\nPeriosteal fibrosarcoma: XH3406\\nPeriosteal sarcoma NOS: XH56W2\\nSolitary fibrous tumour malignant: XH1HP3\\nFibrosarcoma NOS: XH4EP1\\nMyofibroblastic sarcoma: XH2668\\nMalignant fibrous histiocytoma: XH0947\\nMyxofibrosarcoma: XH8WH0\\nDermatofibrosarcoma protuberans fibrosarcomatous: XH9V92\\nAbdominal fibromatosis: XH6116\\nAggressive fibromatosis: XH13Z3\\nAtypical fibrous histiocytoma: XH1RM7\\nCellular fibroma: XH9HH5\\nCongenital generalised fibromatosis: XH5MH2\\nMyofibroblastic tumour peribronchial: XH85R1\\nMyofibromatosis: XH1N00\\nMyxoinflammatory fibroblastic sarcoma: XH2D15\\nAtypical myxoinflammatory fibroblastic tumour: XH0TA8\\nHaemosiderotic fibrolipomatous tumour: XH9526\\nPalmarplantar type fibromatosis: XH75J5\\nSolitary fibrous tumour NOS: XH7E62\\nMyofibroblastic tumour NOS: XH66Z0\\nDesmoplastic fibroma: XH6YK5\\nDermatofibrosarcoma protuberans NOS: XH4QZ8\\nPigmented dermatofibrosarcoma protuberans: XH5CT4\\nGiant cell fibroblastoma: XH9AV8\\nPlexiform fibrohistiocytic tumour: XH4GL1\\nAngiomatoid fibrous histiocytoma: XH9362\\nHaemangiopericytic meningioma: XH7050\\nTeratoma benign: XH3GV5\\nDermoid cyst NOS: XH9F67\\nTeratoma prepubertal type: XH52Q4\\nStruma ovarii NOS: XH22M4\\nIntratubular malignant germ cells: XH8AD3\\nDysgerminoma: XH24E0\\nGerm cell tumour nonseminomatous: XH0A34\\nGerminoma: XH1E13\\nHepatoid yolk sac tumour: XH7SG5\\nImmature teratoma malignant: XH0N49\\nMalignant teratoma undifferentiated: XH2PP9\\nPolyembryoma: XH9Z28\\nSeminoma anaplastic: XH6YQ4\\nSpermatocytic seminoma: XH80D1\\nTeratocarcinoma: XH56W1\\nYolk sac tumour: XH09W7\\nSeminoma NOS: XH9FM4\\nEmbryonal carcinoma NOS: XH8MB9\\nYolk sac tumour post pubertal type: XH15X1\\nTeratoma malignant NOS: XH7YZ9\\nMalignant teratoma intermediate: XH43T4\\nTeratoma with malignant transformation: XH33E8\\nMixed germ cell tumour: XH2PS1\\nGerm cell tumour with associated haematological malignancy: XH9QP9\\nMixed teratoma and seminoma: XH5U02\\nStruma ovarii malignant: XH5PU7\\nTeratocarcinosarcoma: XH1P78\\nGonadoblastoma: XH0K61\\nTeratoma NOS: XH83G5\\nGerm cell tumour regressed: XH4NU1\\nImmature teratoma of the lung: XH5MG2\\nImmature teratoma of the thymus: XH2KP9\\nStrumal carcinoid: XH2XW3\\nImmature teratoma of thyroid: XH5PC3\\nTenosynovial giant cell tumour localised: XH6911\\nTenosynovial giant cell tumour NOS: XH0HZ1\\nGiant cell tumour of bone malignant: XH0492\\nMalignant giant cell tumour of soft parts: XH84X1\\nGiant cell tumour of bone NOS: XH4TC2\\nGiant cell tumour of soft parts NOS: XH81M1\\nTenosynovial giant cell tumour diffuse: XH52J9\\nMalignant tenosynovial giant cell tumour: XH5AQ9\\nChoroid plexus papilloma NOS: XH0RF9\\nDysembryoplastic neuroepithelial tumour: XH0H76\\nSellar ependymoma: XH1Q28\\nAstroblastoma: XH1DC5\\nAstrocytoma anaplastic: XH96C7\\nAstrocytoma low grade: XH1S63\\nCellular ependymoma: XH54D9\\nChoroid plexus carcinoma: XH3M77\\nClear cell ependymoma: XH6E51\\nDiffuse astrocytoma: XH8W32\\nDiffuse astrocytoma low grade: XH6UY7\\nEpendymoma anaplastic: XH6922\\nFibrillary astrocytoma: XH6C35\\nGemistocytic astrocytoma: XH5Y81\\nGlioma malignant: XH4RQ3\\nGliomatosis cerebri: XH6ZH4\\nGliosarcoma: XH9RC8\\nOligoastrocytoma NOS: XH6F49\\nPapillary ependymoma: XH9J28\\nPleomorphic xanthoastrocytoma: XH99U2\\nProtoplasmic astrocytoma: XH6UV4\\nTanycytic ependymoma: XH4BJ4\\nDiffuse midline glioma H KMmutant: XH7692\\nDiffuse intrinsic pontine glioma H KMmutant: XH9YU2\\nEpendymoma NOS: XH1511\\nEpendymoma RELA fusionpositive: XH2AY7\\nAstrocytoma NOS: XH6PH6\\nCystic astrocytoma: XH36Y8\\nDiffuse astrocytoma IDHmutant: XH2HK4\\nAstrocytoma anaplastic IDHmutant: XH7HQ6\\nPolar spongioblastoma: XH83Y5\\nAnaplastic pleomorphic xanthoastrocytoma: XH8BK8\\nGlioblastoma NOS: XH7F82\\nGlioblastoma IDHwild type: XH5571\\nGlioblastoma primary NOS: XH0MB1\\nDiffuse midline glioma NOS: XH3N49\\nDiffuse intrinsic pontine glioma: XH61Y5\\nGlioblastoma IDH mutant: XH4FN3\\nGlioblastoma secondary NOS: XH17J4\\nOligodendroglioma NOS: XH7W59\\nOligodendroglioma IDHmutant and pq co deleted: XH7K31\\nOligodendroglioma anaplastic IDH mutant and pq co deleted: XH9QF3\\nOligodendroblastoma: XH7CX7\\nMedulloblastoma NOS: XH8P29\\nMedulloblastoma SHHactivated and TPwild type: XH9M38\\nOligodendroglioma anaplastic: XH8844\\nMelanotic medulloblastoma: XH4B47\\nMedulloblastoma with extensive nodularity: XH6JN6\\nMedulloblastoma SHH activated NOS: XH85M7\\nCNS embryonal tumour NOS: XH8SH6\\nMedulloblastoma WNTactivated classic: XH3EX1\\nMedulloblastoma WNTactivated Large cell type: XH5163\\nMedulloblastoma WNTactivated Anaplastic type: XH2FW8\\nMedulloblastoma SHHactivated and TPmutant: XH1SH4\\nMedulloblastoma nonWNTnonSHH: XH87Q5\\nEmbryonal tumours with multilayered rosettes with CMC alteration: XH51C5\\nEmbryonal tumour with multilayered rosettes NOS: XH0KZ2\\nCerebellar sarcoma NOS: XH5538\\nMedullomyoblastoma: XH8R14\\nSupratentorial PNET: XH7Y86\\nLarge cell medulloblastoma: XH5PR7\\nAnaplastic medulloblastoma: XH0H95\\nGiant cell glioblastoma: XH8UC5\\nClassic medulloblastoma: XH0RY1\\nDesmoplastic nodular medulloblastoma: XH7PN5\\nPapillary tumour of the pineal region: XH3904\\nDiffuse astrocytoma IDHwildtype: XH2C49\\nEpithelioid glioblastoma: XH2BA5\\nMedulloblastoma WNTactivated NOS: XH0ZP6\\nMedulloblastoma group: XH25R4\\nAstrocytoma anaplastic IDHwildtype: XH39Z7\\nDiffuse lowgrade glioma MAPK pathwayaltered: XH17F8\\nDiffuse hemispheric glioma H Gmutant: XH2SS9\\nDiffuse paediatrictype highgrade glioma Hwildtype and IDHwildtype: XH4Q01\\nInfanttype hemispheric glioma: XH4ZM8\\nPilocytic astrocytoma: XH12D2\\nPilomyxoid astrocytoma: XH29Q5\\nAngiocentric glioma: XH41C5\\nAtypical choroid plexus papilloma: XH3Y57\\nDesmoplastic infantile astrocytoma: XH7M44\\nDesmoplastic infantile ganglioglioma: XH6TQ7\\nGliofibroma: XH0B58\\nMixed subependymomaependymoma: XH6738\\nMyxopapillary ependymoma: XH15U1\\nSubependymal giant cell astrocytoma: XH1L48\\nSubependymoma: XH8FZ9\\nPituicytoma: XH59V4\\nChordoid glioma: XH9HV1\\nChordoid glioma of third ventricle: XH4101\\nGranular cell tumour NOS: XH09A9\\nGranular cell tumour of the sellar region: XH2XW8\\nAlveolar soft part sarcoma: XH8V95\\nGranular cell tumour malignant: XH90D3\\nFibrolipoma: XH2SJ1\\nFibromyxolipoma: XH0PH8\\nInfiltrating angiolipoma: XH7TB0\\nInfiltrating lipoma: XH5GN5\\nIntramuscular lipoma: XH3TE0\\nPleomorphic lipoma: XH30M7\\nSpindle cell lipoma: XH4E98\\nLipoma NOS: XH1PL8\\nThymolipoma: XH4G31\\nAngiolipoma NOS: XH3C77\\nAngiomyolipoma: XH4VB4\\nChondroid lipoma: XH7WX8\\nMyelolipoma: XH17C5\\nHibernoma: XH1054\\nLipoblastomatosis: XH8L55\\nDedifferentiated liposarcoma: XH1C03\\nFibroblastic liposarcoma: XH6R46\\nInflammatory liposarcoma: XH7PE7\\nLiposarcoma well differentiated: XH7Y61\\nMixed liposarcoma: XH8VG3\\nMyxoid liposarcoma: XH3EL0\\nPleomorphic liposarcoma: XH25R1\\nSclerosing liposarcoma: XH8D43\\nLiposarcoma NOS: XH2J05\\nAtypical lipomatous tumour: XH0RW4\\nLipofibromatosis: XH4QB6\\nAngiomyolipoma Epithelioid: XH0QR3\\nLymphangioma NOS: XH9MR8\\nCapillary lymphangioma: XH6LF7\\nCavernous lymphangioma: XH2EU7\\nCystic lymphangioma: XH8G00\\nLymphangiomyoma: XH2DS9\\nHaemolymphangioma: XH62A3\\nLymphangiosarcoma: XH10U6\\nLymphangiomyomatosis: XH10K6\\nFibrous meningioma: XH5ZC7\\nLymphoplasmacyterich meningioma: XH0R11\\nMeningioma NOS: XH11P5\\nMeningothelial meningioma: XH40T5\\nMetaplastic meningioma: XH7N06\\nMicrocystic meningioma: XH1F70\\nSecretory meningioma: XH6Z51\\nHaemangioblastic meningioma: XH3L73\\nPsammomatous meningioma: XH4ZM7\\nAngiomatous meningioma: XH6L68\\nTransitional meningioma: XH4EX5\\nMeningioma malignant: XH0324\\nPapillary meningioma: XH2NY9\\nRhabdoid meningioma: XH6QS9\\nMeningeal sarcomatosis: XH5976\\nClear cell meningioma: XH71V9\\nChordoid meningioma: XH2LS4\\nAtypical meningioma: XH1PF6\\nAdenoma of rete ovarii: XH3SX7\\nMesonephroma benign: XH5AH3\\nAdenocarcinoma of rete ovarii: XH71B5\\nMesonephroma malignant: XH5WG5\\nWolffian tumour: XH2WJ5\\nFibrous mesothelioma benign: XH2VV6\\nMesothelioma benign: XH1SS1\\nEpithelioid mesothelioma benign: XH0KC4\\nWell differentiated papillary mesothelioma: XH67N8\\nPeritoneal inclusion cysts: XH8U12\\nAdenomatoid tumour NOS: XH6BY3\\nFibrous mesothelioma malignant: XH54S8\\nMesothelioma malignant: XH0XV0\\nMesothelioma biphasic malignant: XH1DX8\\nEpithelioid mesothelioma malignant: XH0VP5\\nWell differentiated papillary mesothelioma of the pleura: XH85T6\\nOssifying fibroma: XH6M86\\nAdamantinoma of long bones: XH8F52\\nMelanotic neuroectodermal tumour: XH6C72\\nBenign notochordal cell tumour: XH7MT7\\nParachordoma: XH0S20\\nMixed pineal tumour: XH2S71\\nPineal parenchymal tumour of intermediate differentiation: XH1S48\\nPineoblastoma: XH1ZH1\\nTransitional pineal tumour: XH3D20\\nNeuroectodermal tumour NOS: XH7K24\\nPeripheral primitive neuroectodermal tumour: XH6P76\\nChordoma NOS: XH9GH0\\nEwing sarcoma: XH8KJ8\\nAskin tumour: XH0FH0\\nChondroid chordoma: XH17D8\\nDedifferentiated chordoma: XH7303\\nCraniopharyngioma: XH1AZ2\\nCraniopharyngioma adamantinomatous: XH15X9\\nCraniopharyngioma papillary: XH2BF0\\nPinealoma: XH8QA9\\nPineocytoma: XH1K94\\nMucoepidermoid carcinoma: XH1J36\\nMucoepidermoid tumour: XH80V3\\nAngiomyoma: XH7CL0\\nBizarre leiomyoma: XH9824\\nCellular leiomyoma: XH9662\\nEpithelioid leiomyoma: XH8S79\\nFetal rhabdomyoma: XH4729\\nLipoleiomyoma: XH4FS5\\nMyoma: XH1CZ1\\nPlexiform leiomyoma: XH4EP9\\nLeiomyoma NOS: XH4CY6\\nMyxoid leiomyoma: XH9CC7\\nRhabdomyoma NOS: XH8WG9\\nAdult cellular rhabdomyoma: XH4BG5\\nGlycogenic rhabdomyoma: XH2736\\nGenital rhabdomyoma: XH5AF2\\nLeiomyoma apoplectic: XH8B88\\nLeiomyoma hydropic: XH5Z76\\nCotyledonoid leiomyoma: XH5G84\\nMyolipoma: XH6GV7\\nAngiomyosarcoma: XH27W3\\nEpithelioid leiomyosarcoma: XH13Z5\\nLeiomyosarcoma NOS: XH7ED4\\nMixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma: XH08B3\\nMixed type rhabdomyosarcoma: XH6YL0\\nMyosarcoma: XH8H07\\nMyxoid leiomyosarcoma: XH3122\\nPleomorphic rhabdomyosarcoma NOS: XH5SX9\\nPleomorphic rhabdomyosarcoma adult type: XH4VB5\\nRhabdomyosarcoma NOS: XH0GA1\\nEmbryonal rhabdomyosarcoma NOS: XH83G1\\nEmbryonal rhabdomyosarcoma pleomorphic: XH4749\\nSarcoma botryoides: XH7V57\\nSpindle cell rhabdomyosarcoma: XH7NM2\\nAlveolar rhabdomyosarcoma: XH7099\\nEctomesenchymoma: XH0S12\\nIntravascular leiomyomatosis: XH60C2\\nLeiomyomatosis NOS: XH2L80\\nMetastasizing leiomyoma: XH1EX8\\nSmooth muscle tumour of uncertain malignant potential: XH1EN1\\nSmooth muscle tumour NOS: XH00B4\\nLeiomyomatosis peritonealis disseminata: XH8MR2\\nLeiomyosarcoma cutaneous: XH22N2\\nMyxoma NOS: XH6Q84\\nAngiomyxoma: XH9HK9\\nOssifying fibromyxoid tumour: XH1DA7\\nDeep angiomyxoma: XH4V74\\nSuperficial angiomyxoma: XH58A9\\nLow grade fibromyxoid sarcoma: XH4V76\\nSclerosing epithelioid fibrosarcoma: XH4BT2\\nOssifying fibromyxoid tumour malignant: XH3TB0\\nPulmonary myxoid sarcoma with EWSRCREB translocation: XH51Y9\\nMyxosarcoma: XH5WF6\\nAcoustic neuroma: XH5T39\\nAncient schwannoma: XH0U07\\nCellular schwannoma: XH8WW8\\nDegenerated schwannoma: XH75P8\\nMelanotic neurofibroma: XH2GD5\\nNeurofibroma NOS: XH87J5\\nPlexiform neurofibroma: XH2MJ4\\nPlexiform schwannoma: XH9XT2\\nPsammomatous schwannoma: XH9MN2\\nSchwannoma NOS: XH98Z3\\nNerve sheath tumour NOS: XH27Y1\\nHybrid nerve sheath tumour: XH01G0\\nNeuroma NOS: XH4UE6\\nSolitary circumscribed neuroma: XH90Y8\\nPerineurioma NOS: XH0XF7\\nNerve sheath myxoma: XH3L35\\nSoft tissue perineurioma: XH9QH2\\nIntraneural perineurioma: XH4BQ8\\nCellular neurothekeoma: XH1UZ6\\nBenign Triton tumour: XH9J01\\nMalignant peripheral nerve sheath tumour: XH2XP8\\nMelanotic MPNST: XH5C30\\nMelanotic psammomatous MPNST: XH3NT0\\nMPNST with glandular differentiation: XH8HF5\\nMPNST with mesenchymal differentiation: XH7HR8\\nMPNST with perineurial differentiation: XH3W53\\nMalignant peripheral nerve sheath tumour epithelioid: XH4V81\\nNeurilemoma malignant: XH88C2\\nMalignant peripheral nerve sheath tumour with rhabdomyoblastic differentiation: XH2VV8\\nPerineurioma malignant: XH31C8\\nMelanotic schwannoma: XH2637\\nDysplastic gangliocytoma of cerebellum LhermitteDuclos: XH6K00\\nGangliocytoma: XH6KA6\\nGanglioneuroma: XH03L9\\nGanglioneuromatosis: XH6LR5\\nMedulloepithelioma benign: XH28W9\\nPacinian tumour: XH8NQ6\\nRetinocytoma: XH5AV1\\nTeratoid medulloepithelioma benign: XH5NR7\\nAtypical teratoidrhabdoid tumour: XH7ZQ4\\nGanglioglioma anaplastic: XH2GG3\\nGanglioneuroblastoma: XH77W7\\nGanglioneuroblastoma intermixed: XH0RB7\\nRetinoblastoma differentiated: XH6JM6\\nSpongioneuroblastoma: XH49K9\\nTeratoid medulloepithelioma: XH0AM8\\nCNS ganglioneuroblastoma: XH70S0\\nNeuroblastoma NOS: XH85Z0\\nMedulloepithelioma NOS: XH2WK5\\nNeuroepithelioma NOS: XH9FP2\\nRetinoblastoma NOS: XH8WC7\\nRetinoblastoma undifferentiated: XH7KP6\\nRetinoblastoma diffuse: XH1YZ7\\nOlfactory neurogenic tumour: XH09A4\\nOlfactory neurocytoma: XH7QE0\\nOlfactory neuroepithelioma: XH2Y49\\nCNS embryonal tumor with rhabdoid features: XH3AV2\\nCentral neurocytoma: XH0C11\\nCerebellar liponeurocytoma: XH2GB0\\nGanglioglioma NOS: XH5FJ3\\nExtraventricular neurocytoma: XH2HS1\\nPapillary glioneuronal tumour: XH3XU4\\nRosetteforming glioneuronal tumour: XH2JU8\\nRetinoblastoma spontaneously regressed: XH2F27\\nBalloon cell naevus: XH8RN4\\nCompound naevus: XH27A6\\nInflamed juvenile conjunctival naevus: XH8WP0\\nDiffuse melanocytosis: XH6DN3\\nDysplastic naevus: XH9035\\nEpithelioid and spindle cell naevus: XH2HG8\\nHairy naevus: XH8ZB4\\nHalo naevus: XH5971\\nDermal naevus: XH2MQ5\\nMagnocellular naevus: XH1BE4\\nNeuronevus: XH8CU4\\nNonpigmented naevus: XH0XH2\\nPigmented naevus NOS: XH4L78\\nMelanocytoma NOS: XH02Z5\\nMeningeal melanocytosis: XH8974\\nJunctional naevus NOS: XH1M79\\nSpindle cell naevus NOS: XH9QV1\\nBlue nevus NOS: XH7QJ7\\nPigmented spindle cell naevus of Reed: XH2P88\\nEpithelioid cell naevus: XH79G6\\nCellular blue naevus: XH3X84\\nNaevus spilus: XH40S8\\nDeep penetrating naevus: XH81Y1\\nCombined naevus: XH0DU8\\nGenital naevus: XH5EL4\\nConjunctival naevus: XH8FS8\\nLentiginous melanocytic naevus: XH9QC8\\nSimple lentigo: XH88L0\\nAcral naevus: XH9DB2\\nMeyerson naevus: XH8NP4\\nCongenital melanocytic naevus NOS: XH5YN0\\nSpitz naevus atypical: XH9WF4\\nMelanoma in situ: XH3XX3\\nPrecancerous melanosis NOS: XH41F9\\nAcral melanoma: XH9L11\\nAmelanotic melanoma: XH3TK1\\nBalloon cell melanoma: XH8TE3\\nDesmoplastic melanoma amelanotic: XH1P36\\nDesmoplastic melanoma NOS: XH1Z15\\nLentigo maligna melanoma: XH9NL4\\nMalignant melanoma arising in giant congenital naevus: XH5L25\\nMalignant melanoma in junctional naevus: XH23B1\\nMalignant melanoma in precancerous melanosis: XH7L76\\nMalignant melanoma regressing: XH6XP3\\nMeningeal melanomatosis: XH1BP7\\nMucosal lentiginous melanoma: XH5QP3\\nNeurotropic melanoma malignant: XH5F94\\nNodular melanoma: XH4QG5\\nSuperficial spreading melanoma: XH08X7\\nMalignant melanoma NOS: XH4846\\nSpindle cell melanoma NOS: XH25M1\\nMixed epithelioid and spindle cell melanoma: XH8HA2\\nEpithelioid cell melanoma: XH0QL5\\nSpindle cell melanoma type A: XH5KW3\\nSpindle cell melanoma type B: XH5YE7\\nBlue naevus malignant: XH1G74\\nLow cumulative sun damage melanoma: XH7JW1\\nMalignant Spitz tumour: XH8DS3\\nMelanoma meningeal: XH3DN1\\nNevoid melanoma: XH8681\\nGiant pigmented naevus NOS: XH2C28\\nIntermediate and giant congenital naevus: XH1XJ3\\nMeningeal melanocytoma: XH2RY7\\nProliferative dermal lesion in congenital naevus: XH6AH3\\nPigmented epithelioid melanocytoma: XH4VD0\\nAdenomatoid odontogenic tumour: XH2SD0\\nAmeloblastic fibroodontoma: XH44W7\\nAmeloblastic fibrodentinoma: XH0964\\nCalcifying odontogenic cyst: XH3R33\\nCementifying fibroma: XH5Y46\\nCementoossifying fibroma: XH52T0\\nCementoblastoma benign: XH4VL1\\nOdontogenic fibroma NOS: XH1MT3\\nComplex odontoma: XH7H47\\nCompound odontoma: XH57B1\\nGigantiform cementoma: XH6W94\\nOdontoameloblastoma: XH06N8\\nDentinogenic ghost cell tumour: XH12N4\\nOdontogenic myxoma: XH48L4\\nOdontogenic tumour benign: XH43L1\\nSquamous odontogenic tumour: XH4PV9\\nCementoma NOS: XH8FX0\\nOdontoma NOS: XH4QJ8\\nAmeloblastoma NOS: XH1SV4\\nPeripheral odontogenic fibroma: XH2M31\\nAmeloblastic fibroma: XH06Y3\\nCalcifying epithelial odontogenic tumour: XH4PT4\\nSinonasal ameloblastoma: XH39C5\\nAmeloblastoma unicystic type: XH5ZZ6\\nAmeloblastoma extraosseousperipheral type: XH4KQ4\\nAmeloblastic odontosarcoma: XH1MW0\\nAmeloblastoma metastasizing: XH96J9\\nOdontogenic tumour malignant: XH4M89\\nAmeloblastic fibrosarcoma: XH0XD5\\nOdontogenic carcinosarcoma: XH4LP1\\nGhost cell odontogenic carcinoma: XH2BX2\\nClear cell odontogenic carcinoma: XH5DZ4\\nOdontogenic tumour NOS: XH1P03\\nEnchondroma: XH9SY5\\nOsteochondroma: XH5Y87\\nOsteoma NOS: XH4818\\nOsteoid osteoma NOS: XH61J9\\nOsteoblastoma NOS: XH4316\\nOsteochondromyxoma: XH6KR3\\nBizarre parosteal osteochondromatous proliferation: XH23J5\\nChondroma NOS: XH0NS4\\nJuxtacortical chondroma: XH49G1\\nPeriosteal chondroma: XH3BC3\\nChondromyxoid fibroma: XH89S0\\nSubungual exostosis: XH1XL9\\nCentral osteosarcoma: XH1Y90\\nChondroblastic osteosarcoma: XH3T03\\nFibroblastic osteosarcoma: XH23T4\\nFibrochondrosarcoma: XH29N8\\nHigh grade surface osteosarcoma: XH6TL0\\nIntracortical osteosarcoma: XH9LS2\\nIntraosseous well differentiated osteosarcoma: XH9119\\nOsteosarcoma in Paget disease of bone: XH06W9\\nParosteal osteosarcoma: XH8HG5\\nPeriosteal osteosarcoma: XH48A9\\nSmall cell osteosarcoma: XH4EZ4\\nTelangiectatic osteosarcoma: XH5CL5\\nOsteosarcoma NOS: XH1XF3\\nOsteosarcoma extraskeletal: XH2CD6\\nLow grade central osteosarcoma: XH7N84\\nChondrosarcoma NOS: XH8J23\\nChondrosarcoma grade: XH0Y34\\nJuxtacortical chondrosarcoma: XH5FH4\\nPeriosteal chondrosarcoma: XH1S32\\nChondroblastoma malignant: XH6W00\\nMyxoid chondrosarcoma: XH9344\\nMesenchymal chondrosarcoma: XH8X47\\nClear cell chondrosarcoma: XH7XB9\\nDedifferentiated chondrosarcoma: XH6E77\\nAggressive osteoblastoma: XH2RD1\\nOsteochondromatosis NOS: XH70W8\\nChondromatosis NOS: XH5BT0\\nAtypical cartilaginous tumour: XH0FY0\\nChondroblastoma NOS: XH4NK2\\nGangliocytic paraganglioma: XH2012\\nGlomus tumour NOS: XH47J2\\nPerivascular epithelioid tumour benign: XH4CC6\\nGlomangioma: XH3RX1\\nGlomangiomyoma: XH2702\\nPerivascular epithelioid tumour malignant: XH9WD1\\nExtraadrenal paraganglioma: XH1UN6\\nNonchromaffin paraganglioma: XH8GG7\\nGlomangiosarcoma: XH05Y1\\nGlomus tumour malignant: XH21E6\\nMiddle ear paraganglioma: XH9YX6\\nLaryngeal paraganglioma: XH5521\\nVagal paraganglioma: XH1493\\nComposite paraganglioma: XH3JF3\\nComposite pheochromocytoma: XH9K97\\nParaganglioma NOS: XH0EW6\\nSympathetic paraganglioma: XH4G21\\nParasympathetic paraganglioma: XH5LK3\\nAortic body tumour: XH7YU4\\nCarotid body paraganglioma: XH3FS7\\nChemodectoma: XH20B4\\nPheochromocytoma NOS: XH3854\\nGlomangiomatosis: XH7CP7\\nGlomus tumor of uncertain malignant potential: XH5D10\\nSoft tissue tumour benign: XH67T7\\nSarcoma NOS: XH4UM7\\nSarcomatosis NOS: XH7Y17\\nSpindle cell sarcoma: XH7AN8\\nGiant cell sarcoma: XH73J4\\nSmall cell sarcoma: XH85G7\\nEpithelioid sarcoma: XH4F96\\nUndifferentiated sarcoma: XH6HY6\\nDesmoplastic small round cell tumour: XH5SN6\\nPleomorphic dermal sarcoma: XH7XH3\\nEpithelioid sarcoma undifferentiated: XH92Y0\\nPleomorphic hyalinizing angiectatic tumour: XH2193\\nGLIaltered epithelioid soft tissue tumor: XH52J1\\nAndroblastoma benign: XH7H87\\nSclerosing stromal tumour: XH6NZ8\\nSertoli cell tumour with lipid storage: XH0BG7\\nSertoliLeydig cell tumour well differentiated: XH7E53\\nThecoma luteinized: XH0Z30\\nSex cordstromal tumour benign: XH3C14\\nSignetring stromal tumour: XH69N5\\nMicrocystic stromal tumour: XH35B3\\nThecoma NOS: XH34A0\\nLuteoma NOS: XH40J2\\nGranulosa cell tumour of the testis juvenile: XH2U25\\nLeydig cell tumour of the ovary NOS: XH5XQ2\\nHilus cell tumour: XH9LH4\\nLipid cell tumour of ovary: XH9XY1\\nMasculinovoblastoma: XH1PE9\\nAdrenal rest tumour: XH9RV1\\nAndroblastoma malignant: XH44E8\\nGranulosa cell carcinoma: XH1QG7\\nGranulosa cell tumour sarcomatoid: XH97Z8\\nSertoliLeydig cell tumour poorly differentiated: XH29E0\\nSertoliLeydig cell tumour poorly differentiated with heterologous elements: XH3BT2\\nSertoliLeydig cell tumour sarcomatoid: XH4KB9\\nThecoma malignant: XH1JS6\\nAdult granulosa cell tumor of ovary: XH0GA5\\nGranulosa cell tumour adult type: XH7DV5\\nLeydig cell tumour malignant: XH9G68\\nSteroid cell tumour malignant: XH4L39\\nSertoli cell carcinoma: XH7051\\nGranulosa cell tumour juvenile: XH2KH2\\nGranulosa celltheca cell tumour: XH37K7\\nGynandroblastoma: XH0Q64\\nLarge cell calcifying Sertoli cell tumour: XH9E02\\nSertoliLeydig cell tumour of intermediate differentiation: XH0UP7\\nSertoliLeydig cell tumour NOS: XH6FQ9\\nSertoliLeydig cell tumour intermediate differentiation with heterologous elements: XH8U56\\nSertoliLeydig cell tumour retiform: XH6XB6\\nSertoliLeydig cell tumour retiform with heterologous elements: XH3PN1\\nSex cord tumour with annular tubules: XH5BV8\\nSex cordgonadal stromal tumour incompletely differentiated: XH5PC7\\nSex cordgonadal stromal tumour mixed forms: XH19F9\\nSex cordgonadal stromal tumour NOS: XH9G57\\nStromal tumour with minor sex cord elements: XH8033\\nUterine tumour resembling ovarian sex cord tumour: XH8CW8\\nSex cordstromal tumour unclassified: XH0667\\nMixed germ cellsex cordstromal tumour NOS: XH0U48\\nMixed germ cellsex cordstromal tumour unclassified: XH27A8\\nAdult granulosa cell tumour of testis: XH5BN5\\nAndroblastoma NOS: XH0GT2\\nSertoli cell tumour NOS: XH4H24\\nIntratubular large cell hyalinizing Sertoli cell neoplasia: XH7RD2\\nLeydig cell tumour of the testis NOS: XH51L7\\nPapilloma NOS: XH17Q9\\nSquamous cell papilloma inverted: XH7YQ5\\nSquamous cell papilloma NOS: XH50T2\\nSquamous intraepithelial neoplasia low grade: XH4611\\nSquamous papillomatosis: XH50N3\\nVerrucous papilloma: XH2Y10\\nAnal intraepithelial neoplasia low grade: XH9S34\\nCervical intraepithelial neoplasia low grade: XH1W63\\nOesophageal squamous intraepithelial neoplasia dysplasia low grade: XH3Y37\\nBenign keratosis NOS: XH0S03\\nLichen planuslike keratosis: XH63L8\\nLarge cell acanthoma: XH7AQ2\\nPUVA keratosis: XH8MN8\\nArsenical keratosis: XH5NG4\\nClear cell acanthoma: XH13L5\\nWarty dyskeratoma: XH65S7\\nSolar lentigo: XH7B58\\nBowen disease: XH2NM8\\nDifferentiated VIN: XH9CL8\\nDifferentiated PeIN: XH6824\\nPapillary carcinoma in situ: XH4JA4\\nPapillary squamous cell carcinoma noninvasive: XH8YK9\\nSquamous cell carcinoma in situ with questionable stromal invasion: XH1U36\\nSquamous cell carcinoma in situ NOS: XH7WM7\\nSquamous intraepithelial neoplasia high grade: XH3EA2\\nAnal intraepithelial neoplasia grade III: XH7SX5\\nCervical intraepithelial neoplasia grade III: XH62N8\\nOesophageal squamous intraepithelial neoplasia dysplasia high grade: XH9ND8\\nVaginal intraepithelial neoplasia grade III: XH6F63\\nVulvar intraepithelial neoplasia grade III: XH5FT2\\nQueyrat erythroplasia: XH2H04\\nDifferentiated intraepithelial neoplasia: XH6RW7\\nBasaloid squamous cell carcinoma: XH3GS1\\nPapillary carcinoma NOS: XH0UU4\\nPapillary squamous cell carcinoma: XH6S97\\nSquamous cell carcinoma adenoid: XH7LH0\\nSquamous cell carcinoma clear cell type: XH9DC1\\nSquamous cell carcinoma keratinizing NOS: XH4CR9\\nSquamous cell carcinoma metastatic NOS: XH84Q4\\nSquamous cell carcinoma microinvasive: XH90Y3\\nSquamous cell carcinoma NOS: XH0945\\nSquamous cell carcinoma small cell nonkeratinizing: XH2435\\nSquamous cell carcinoma spindle cell: XH6D80\\nVerrucous carcinoma NOS: XH5PM0\\nWarty carcinoma: XH7UR7\\nSquamous cell carcinoma large cell nonkeratinizing NOS: XH6705\\nSquamous cell carcinoma with horn formation: XH2JN3\\nLymphoepithelial carcinoma: XH1E40\\nSchmincke tumour: XH4GV2\\nPseudovascular squamous cell carcinoma: XH0Z16\\nPapillarybasaloid carcinoma: XH24M0\\nSquamous cell carcinoma HPV positive: XH0EJ7\\nSquamous cell carcinoma HPV negative: XH2137\\nWartybasaloid carcinoma: XH6FU0\\nSynovioma benign: XH2AW8\\nSynovial sarcoma NOS: XH9B22\\nClear cell sarcoma NOS: XH77N6\\nSynovial sarcoma spindle cell: XH9346\\nSynovial sarcoma epithelioid cell: XH06L8\\nSynovial sarcoma biphasic: XH1J28\\nBiphenotypic sinonasal sarcoma: XH3797\\nMalignant melanoma of soft parts: XH5854\\nMicroscopic thymoma: XH9QW0\\nThymoma benign: XH4341\\nEctopic hamartomatous thymoma: XH0707\\nThymoma type A: XH6WN9\\nThymoma type AB: XH0JH0\\nThymoma type B: XH4EW9\\nThymoma NOS: XH3734\\nIntrapulmonary thymoma: XH1GA4\\nSclerosing thymoma: XH6QN6\\nMetaplastic thymoma: XH3DX0\\nThymic carcinoma NOS: XH6AK2\\nSpindle epithelial tumour with thymuslike element: XH6ZG8\\nIntrathyroid thymic carcinoma: XH33N4\\nMicronodular thymoma with lymphoid stroma: XH56K5\\nSinonasal papilloma exophytic: XH0TP8\\nTransitional papilloma inverted NOS: XH3HQ8\\nUrothelial papilloma inverted: XH5A08\\nUrothelial papilloma NOS: XH5M82\\nPapillary urothelial carcinoma noninvasive: XH12F0\\nUrothelial carcinoma in situ: XH5GH8\\nCylindrical cell carcinoma: XH4UA2\\nSchneiderian carcinoma: XH35M0\\nTransitional cell carcinoma NOS: XH8EH1\\nTransitional carcinoma: XH7TL4\\nUrothelial carcinoma sarcomatoid: XH5P27\\nPapillary urothelial carcinoma: XH0NZ4\\nTransitional cell carcinoma micropapillary: XH08S6\\nCloacogenic carcinoma: XH3UJ1\\nBasaloid carcinoma: XH2V80\\nUrothelial carcinoma micropapillary: XH4W76\\nCylindrical cell papilloma: XH7R01\\nSchneiderian papilloma inverted: XH4PB5\\nPapillary urothelial neoplasm of low malignant potential: XH5UU5\\nSinonasal papilloma inverted: XH8FH7\\nSinonasal papilloma oncocytic: XH8CD4\\nHydatidiform mole NOS: XH8CX2\\nPartial hydatidiform mole: XH5325\\nChoriocarcinoma combined with other germ cell elements: XH3WM1\\nMalignant teratoma trophoblastic: XH0774\\nChoriocarcinoma NOS: XH8PK7\\nTrophoblastic tumour epithelioid: XH8FW3\\nInvasive hydatidiform mole: XH46G2\\nPlacental site trophoblastic tumour: XH1RM5\\nMyelodysplastic syndrome with single lineage dysplasia: XH2N45\\nMyelodysplastic syndrome with ring sideroblasts and single lineage dysplasia: XH5B21\\nMyelodysplastic syndrome with excess blasts: XH79X8\\nRefractory anaemia with excess blasts in transformation: XH1D20\\nMyelodysplastic syndrome with multilineage dysplasia: XH5DA2\\nMyelodysplastic syndrome with isolated del q: XH3T02\\nTherapyrelated myelodysplastic syndrome NOS: XH0L58\\nMyelodysplastic syndrome NOS: XH7PK9\\nMyelodysplastic syndrome with ring sideroblasts and multilineage dysplasia: XH8BA8\\nMyeloproliferative neoplasm unclassifiable: XH3EJ1\\nMyelodysplasticmyeloproliferative neoplasm unclassifiable: XH28M3\\nLymphoproliferative disorder NOS: XH2LK2\\nPost transplant lymphoproliferative disorder NOS: XH2R75\\nPolymorphic post transplant lymphoproliferative disorder: XH74K1\\nMyeloproliferative neoplasm NOS: XH5HH7\\nEssential thrombocythemia: XH4ZM5\\nChronic eosinophilic leukaemia: XH51D2\\nMyeloid and lymphoid neoplasms with PDGFRA rearrangement: XH07H5\\nMyeloid neoplasms with PDGFRB rearrangement: XH6QD4\\nMyeloid and lymphoid neoplasms with FGFR abnormalities: XH1WR8\\nMyeloid or lymphoid neoplasm with PCMJAK: XH2WB4\\nLeukaemia NOS: XH4S92\\nAleukemic leukaemia NOS: XH29P0\\nChronic leukaemia NOS: XH80C3\\nSubacute leukaemia NOS: XH6QV5\\nAcute leukaemia NOS: XH1B20\\nAcute biphenotypic leukaemia: XH37U0\\nAcute bilineal leukaemia: XH2H98\\nAcute mixed lineage leukaemia: XH3VV7\\nMixed phenotype acute leukaemia with tqq BCRABL: XH97B7\\nMixed phenotype acute leukaemia with tvq MLL rearranged: XH2S51\\nMixed phenotype acute leukaemia Bmyeloid NOS: XH1928\\nMixed phenotype acute leukaemia Tmyeloid NOS: XH4YB5\\nB lymphoblastic leukaemialymphoma NOS: XH81V3\\nB lymphoblastic leukaemialymphoma with tqq BCRABL: XH73L9\\nB lymphoblastic leukaemialymphoma with tvq MLL rearranged: XH8GG0\\nB lymphoblastic leukaemialymphoma with tpq TELAML ETVRUNX: XH4KA2\\nB lymphoblastic leukaemialymphoma with hyperdiploidy: XH24C7\\nB lymphoblastic leukaemialymphoma with hypodiploidy Hypodiploid ALL: XH2MD9\\nB lymphoblastic leukaemialymphoma with tqq ILIGH: XH4ZL2\\nB lymphoblastic leukaemialymphoma with tqp EAPBX TCFPBX: XH3GU8\\nLymphoid leukaemia NOS: XH7Q12\\nLymphatic leukaemia NOS: XH1GQ1\\nLymphocytic leukaemia NOS: XH7PW5\\nAleukemic lymphoid leukaemia: XH4KS4\\nLymphosarcoma cell leukaemia: XH5BA6\\nSubacute lymphoid leukaemia: XH8GQ0\\nBcell chronic lymphocytic leukaemiasmall lymphocytic lymphoma: XH15T2\\nAdult Tcell leukaemialymphoma HTLV positive: XH6TE2\\nChronic lymphoproliferative disorder of NK cells: XH5EN4\\nProlymphocytic leukaemia NOS: XH8TD6\\nProlymphocytic leukaemia Bcell type: XH95H2\\nProlymphocytic leukaemia Tcell type: XH0DU4\\nPrecursor cell lymphoblastic leukaemia NOS: XH5J37\\nPrecursor Tcell lymphoblastic leukaemia: XH7T28\\nT lymphoblastic leukaemialymphoma: XH50W7\\nB lymphoblastic leukemialymphoma BCRABLlike: XH1D04\\nB lymphoblastic leukemialymphoma with iAMP: XH0KD4\\nEarly Tcell precursor acute lymphoblastic leukemia: XH8F29\\nAcute erythroid leukemia: XH43N4\\nMyeloid leukaemia NOS: XH7S21\\nAleukemic myeloid leukaemia: XH7LG8\\nAleukemic monocytic leukaemia: XH5DV4\\nChronic monocytic leukaemia: XH0E35\\nEosinophilic leukaemia: XH6JX2\\nMonocytic leukaemia NOS: XH5JT8\\nSubacute monocytic leukaemia: XH1S60\\nSubacute myeloid leukaemia: XH7DF6\\nAcute myeloid leukaemia NOS: XH8AA5\\nAcute myeloid leukemia with biallelic mutation of CEBPA: XH4M02\\nAcute myeloid leukaemia with mutated NPM: XH74W8\\nChronic myeloid leukaemia NOS: XH4XG8\\nAcute myeloid leukaemia with tpq DEKNUP: XH9Y46\\nAcute promyelocytic leukaemia tqq: XH1A50\\nAcute myeloid leukaemia with invqq or tqq RPNEVI: XH2KE3\\nAcute myeloid leukaemia with abnormal marrow eosinophils: XH3PA4\\nAcute myeloid leukaemia minimal differentiation: XH90G0\\nChronic myelogenous leukaemia BCRABL positive: XH2AB7\\nAtypical chronic myeloid leukaemia BCRABL negative: XH21X5\\nAtypical chronic myeloid leukaemia Philadelphia chromosome Ph negative: XH26U9\\nAcute monocytic leukaemia: XH9NE2\\nAcute monoblastic and monocytic leukaemia: XH1K97\\nAcute myeloid leukaemia tqq: XH3CX5\\nAcute myeloid leukaemia q abnormalities: XH1E41\\nMyeloid leukaemia associated with Down Syndrome: XH6AQ7\\nAcute myeloid leukaemia megakaryoblastic with tpq RBMMKL: XH16K4\\nTherapy related myeloid neoplasm: XH7045\\nTherapyrelated acute myeloid leukaemia alkylating agent related: XH6Z50\\nTherapyrelated acute myeloid leukaemia epipodophyllotoxinrelated: XH4EJ0\\nAcute myeloid leukemia with BCRABL: XH6FZ7\\nAcute myeloid leukemia with mutated RUNX: XH1EK4\\nChronic myelomonocytic leukaemia NOS: XH86N4\\nChronic myelomonocytic leukaemia Type I: XH0FC4\\nChronic myelomonocytic leukaemia Type II: XH7HJ7\\nAggressive NKcell leukaemia: XH9MA0\\nHairy cell leukaemia: XH5J10\\nMalignant lymphoma NOS: XH5FJ5\\nMalignant lymphoma nonHodgkin NOS: XH50P3\\nB cell lymphoma NOS: XH5RG7\\nLymphosarcoma NOS: XH9MU1\\nMalignant lymphoma diffuse NOS: XH8226\\nMalignant lymphoma noncleaved cell NOS: XH5WX8\\nReticulum cell sarcoma NOS: XH51A9\\nHairy cell leukaemia variant: XH9E18\\nMalignant lymphoma lymphocytic intermediate differentiation nodular: XH1SK1\\nMalignant lymphoma lymphocytic poorly differentiated diffuse: XH06Q4\\nMalignant lymphoma small cell noncleaved diffuse: XH9PT6\\nMalignant lymphoma small cleaved cell diffuse: XH2TN1\\nSplenic Bcell lymphomaleukaemia unclassifiable: XH75T5\\nSplenic diffuse red pulp small Bcell lymphoma: XH99V9\\nComposite Hodgkin and nonHodgkin lymphoma: XH3BP6\\nBcell lymphoma unclassifiable with features intermediate between diffuse large Bcell lymphoma and classical Hodgkin lymphoma: XH04Y1\\nMonoclonal Bcell lymphocytosis NOS: XH73D5\\nMonoclonal Bcell lymphocytosis nonCLL type: XH5M35\\nHodgkin lymphoma NOS: XH94F7\\nClassical Hodgkin lymphoma posttransplant lymphoproliferative disease: XH22K3\\nHodgkin lymphoma lymphocyterich: XH8CB2\\nHodgkin disease lymphocyte predominance NOS: XH7KX4\\nHodgkin lymphoma mixed cellularity NOS: XH9NJ5\\nHodgkin lymphoma lymphocyte depletion NOS: XH7RN9\\nHodgkin lymphoma lymphocyte depletion diffuse fibrosis: XH7299\\nHodgkin lymphoma lymphocyte depletion reticular: XH4E19\\nHodgkin lymphoma nodular lymphocyte predominant: XH2FG7\\nHodgkin granuloma: XH13B0\\nHodgkin sarcoma: XH11Y2\\nHodgkin lymphoma nodular sclerosis NOS: XH6SC5\\nHodgkin lymphoma nodular sclerosis cellular phase: XH51K7\\nHodgkin lymphoma nodular sclerosis grade: XH8K28\\nMature Bcell lymphomas: XH3FE9\\nImmunocytoma: XH43K4\\nMalignant lymphoma plasmacytoid: XH9TT4\\nPlasmacytic lymphoma: XH3KQ3\\nMalignant lymphoma mixed small and large cell diffuse: XH1J80\\nMediastinal large Bcell lymphoma: XH8U09\\nDiffuse large Bcell lymphoma NOS: XH9B17\\nFibrinassociated EBV diffuse large Bcell lymphoma: XH0RM6\\nMalignant lymphoma centroblastic NOS: XH1VQ1\\nMalignant lymphoma centroblastic diffuse: XH9JY8\\nAnaplastic large Bcell lymphoma: XH78W3\\nBcell lymphoma unclassifiable with features intermediate between diffuse large Bcell lymphoma and Burkitt lymphoma: XH9L43\\nEBV positive diffuse large Bcell lymphoma: XH1QK0\\nPrimary cutaneous DLBCL leg type: XH8657\\nPrimary diffuse large Bcell lymphoma of CNS: XH2MP0\\nHigh grade Bcell lymphoma NOS: XH2WM7\\nHigh grade Bcell lymphoma with MYC and BCL andor BCL rearrangements: XH23Z3\\nVitreoretinal lymphoma: XH86B5\\nMalignant lymphoma large Bcell diffuse immunoblastic NOS: XH7Z25\\nBurkitt lymphoma NOS: XH4KA9\\nBurkittlike lymphoma: XH0H23\\nBurkittlike lymphoma with q aberration: XH8NN2\\nBurkitt cell leukaemia: XH6B12\\nSplenic marginal zone Bcell lymphoma: XH0MV1\\nFollicular lymphoma NOS: XH0LK1\\nFollicular lymphoma pediatric type: XH9RH9\\nFollicular lymphoma duodenal type: XH9L76\\nLarge Bcell lymphoma with IRF rearrangement: XH6SU8\\nMarginal zone Bcell lymphoma NOS: XH1X21\\nExtranodal marginal zone lymphoma of mucosaassociated lymphoid tissue: XH1V99\\nPrimary choroidal lymphoma: XH6JB5\\nIn situ mantle cell neoplasia: XH8EM2\\nEBV positive mucocutaneous ulcer: XH3SG2\\nIn situ follicular neoplasia: XH4L38\\nMature Tand NKcell lymphomas: XH3400\\nGranulomatous slack skin: XH0EH1\\nSezary syndrome: XH8HN3\\nMature Tcell lymphoma NOS: XH3HJ2\\nLymphoepithelioid lymphoma: XH92G2\\nFollicular Tcell lymphoma: XH14S3\\nNodal peripheral Tcell lymphoma with T follicular helper phenotype: XH6SR1\\nCutaneous Tcell lymphoma NOS: XH1951\\nPrimary cutaneous CDpositive aggressive epidermotropic cytotoxic Tcell lymphoma: XH2513\\nPrimary cutaneous acral CD positive Tcell lymphoma: XH7S84\\nAnaplastic large cell lymphoma T cell and Null cell type: XH7EZ9\\nAnaplastic large cell lymphoma NOS: XH1LC0\\nAnaplastic large cell lymphoma ALK positive: XH9484\\nIntestinal Tcell lymphoma: XH9FT0\\nMonomorphic epitheliotropic intestinal Tcell lymphoma: XH1AG7\\nPrimary cutaneous anaplastic large cell lymphoma: XH5SC3\\nPrimary mucosal CD Tcell lymphoproliferative disorder: XH0353\\nNKTcell lymphoma nasal and nasaltype: XH5LU6\\nIndolent Tcell lymphoproliferative disorder of gastrointestinal tract: XH0B02\\nPrimary cutaneous CD positive smallmedium Tcell lymphoproliferative disorder: XH3QE7\\nPrimary cutaneous CDpositive smallmedium Tcell lymphoma: XH7EL2\\nAnaplastic large cell lymphoma ALK negative: XH9T74\\nBreast implantassociated anaplastic large cell lymphoma: XH05D8\\nPrimary cutaneous CD Tcell lymphoproliferative disorder: XH40C0\\nPrecursor cell lymphoblastic lymphoma: XH2216\\nSystemic EBV positive Tcell lymphoproliferative disease of childhood: XH6TZ4\\nPrimary cutaneous gammadelta Tcell lymphoma: XH84A5\\nPrecursor cell lymphoblastic lymphoma NOS: XH14N1\\nBlastic NKcell lymphoma: XH42X4\\nHydroa vacciniformelike lymphoproliferative disorder: XH0AK5\\nImmunoproliferative disease NOS: XH4KF3\\nWaldenstrom macroglobulinemia: XH8GW4\\nHeavy chain disease NOS: XH7RJ1\\nImmunoproliferative small intestinal disease: XH3SS7\\nLymphomatoid granulomatosis grade: XH7BG6\\nAngiocentric immunoproliferative lesion: XH3U73\\nAngioimmunoblastic lymphadenopathy AIL: XH2A53\\nTgamma lymphoproliferative disease: XH0HS7\\nImmunoglobulin deposition disease: XH2WA6\\nIgM monoclonal gammopathy of undetermined significance: XH16T1\\nPlasmacytoma NOS: XH4BL1\\nPlasmacytoma extramedullary: XH0N40\\nALK positive large Bcell lymphoma: XH1EB9\\nLarge Bcell lymphoma arising in HHVassociated multicentric Castleman disease: XH5HJ5\\nMalignant mastocytosis: XH2992\\nAggressive systemic mastocytosis: XH10N1\\nSystemic mastocytosis with AHNMD: XH1H01\\nSystemic mastocytosis with associated haematological clonal nonmast cell disorder: XH5191\\nErdheimChester disease: XH1VJ3\\nMastocytoma NOS: XH1J17\\nDiffuse cutaneous mastocytosis: XH2RG8\\nIndolent systemic mastocytosis: XH2Y59\\nSolitary mastocytoma of skin: XH2RL8\\nMalignant histiocytosis: XH2WJ3\\nHistiocytic medullary reticulosis: XH7PV7\\nAcute progressive histiocytosis X: XH4XT4\\nHistiocytosis X NOS: XH8VV4\\nHandSchullerChristian disease: XH86U0\\nLettererSiwe disease: XH60Q1\\nNonlipid reticuloendotheliosis: XH0YE1\\nLangerhans cell histiocytosis disseminated: XH40U7\\nTrue histiocytic lymphoma: XH46Q0\\nDendritic cell sarcoma NOS: XH8Q19\\nIndeterminate dendritic cell tumour: XH3ZM0\\nFollicular dendritic cell tumour: XH6ZR5\\nEosinophilic granuloma: XH75E6\\nLangerhans cell histiocytosis monostotic: XH0RF4\\nLangerhans cell histiocytosis polyostotic: XH2PY9\\nBurns involving less than  of body surface: XJ4NH\\nBurns involving  of body surface: XJ1HD\\nBurns involving  or more of body surface: XJ9JX\\nFull thickness or deep full thickness burn involving less than  of body surface: XJ243\\nFull thickness or deep full thickness burn involving  of body surface: XJ9UE\\nFull thickness or deep full thickness burn involving  or more of body surface: XJ3MB\\nDeep full thickness or complex burn with no loss of limb: XJ71T\\nDeep full thickness or complex burn with loss of digit: XJ6NX\\nDeep full thickness or complex burn with loss of limb: XJ36Y\\nFracture extends into joint: XJ5GS\\nFracture extends into joint and a portion of the articular part remains attached to the main part of the bone: XJ5L7\\nFracture extends into joint and the entire articular part is detached from the main part of the bone: XJ92H\\nFracture does not extend into joint: XJ5VJ\\nClosed fracture: XJ44E\\nOpen fracture: XJ7YM\\nAvulsion fracture: XJ36W\\nBucket handle or corner fracture: XJ2EL\\nBuckle fracture: XJ76E\\nBurst fracture: XJ7ZH\\nComminuted fracture: XJ1Z6\\nCompound fracture: XJ1PP\\nCompression fracture: XJ778\\nDepressed fracture: XJ9UB\\nDislocated fracture: XJ69V\\nDisplaced fracture: XJ8PQ\\nElevated fracture: XJ0QE\\nFissured fracture: XJ5N9\\nGreenstick fracture: XJ45W\\nImpacted fracture: XJ7AT\\nInfected fracture: XJ4PE\\nLinear fracture: XJ392\\nLongitudinal fracture: XJ6RL\\nMissile fracture: XJ4CX\\nOsteochondral fracture: XJ4FU\\nPhyseal fracture: XJ3HH\\nPuncture fracture: XJ64N\\nSimple fracture: XJ909\\nSlipped epiphysis fracture: XJ9XQ\\nSpiral fracture: XJ967\\nTransverse fracture: XJ5V7\\nWedge fracture: XJ6NA\\nFracture with foreign body: XJ8QL\\nAbrasion: XJ652\\nBlister nonthermal: XJ8JK\\nContusion: XJ9NV\\nExternal constriction: XJ4D1\\nInsect bite nonvenomous: XJ69A\\nSuperficial foreign body: XJ06K\\nSuperficial splinter: XJ3U1\\nSuperficial haematoma: XJ1C6\\nExposure to injurious transport event: XE72E\\nExposure to land transport injury event: XE9S7\\nExposure to land transport onroad injury event: XE9EE\\nExposure to land transport offroad injury event: XE8TM\\nExposure to railway transport injury event: XE3S3\\nExposure to water transport injury event: XE85L\\nExposure to air or space transport injury event: XE5XH\\nExposure to fall: XE3Y8\\nExposure to fall on the same level or from less than  metre: XE8J4\\nExposure to fall from a height of  metre or more: XE3QG\\nExposure to person animal or plant: XE4U1\\nExposure to being struck kicked or bumped: XE1TU\\nExposure to being stepped on or crushed: XE0VW\\nExposure to being bitten: XE359\\nExposure to being scratched or clawed: XE9PG\\nExposure to being stung or envenomated: XE972\\nExposure to object not elsewhere classified: XE214\\nExposure to being struck by projectile from firearm: XE2YW\\nExposure to being struck by moving object: XE4UV\\nExposure to being struck against stationary object: XE6LQ\\nExposure to being cut or pierced by sharp object: XE20S\\nExposure to being struck by blunt object: XE59C\\nExposure to being caught crushed jammed or pinched between objects: XE4FE\\nExposure to immersion submersion or falling into water: XE64Q\\nExposure to drowning or submersion while in body of water: XE72F\\nExposure to drowning or submersion following fall into body of water: XE1AF\\nExposure to threat to breathing: XE8NX\\nExposure to threat to breathing by suffocation from object covering mouth or nose: XE9N2\\nExposure to threat to breathing by hanging: XE9LA\\nExposure to threat to breathing by strangulation: XE17S\\nExposure to threat to breathing by external compression of airways or chest: XE2NR\\nExposure to threat to breathing by inhalation or ingestion of gastric contents: XE33X\\nExposure to threat to breathing by inhalation or ingestion of liquids: XE2PV\\nExposure to threat to breathing by inhalation or ingestion of food: XE5QH\\nExposure to threat to breathing by inhalation or ingestion of other objects or materials: XE9RJ\\nExposure to threat to breathing from low oxygen environment: XE2DJ\\nExposure to thermal mechanism: XE6JM\\nExposure to uncontrolled fire: XE0S0\\nExposure to controlled fire: XE5WP\\nExposure to ignition or melting of material: XE9T8\\nExposure to hot object or liquid: XE494\\nExposure to steam hot vapour air or gases: XE515\\nExposure to excessive heat: XE00Z\\nExposure to excessive cold: XE4AY\\nExposure to or harmful effects of substances: XE3SH\\nPoisoning or toxic effect of exposure to substance: XE13E\\nCorrosion due to exposure to substance: XE1SS\\nForeign body in orifice: XE202\\nExposure to electric current: XE8A0\\nExposure to sunlight: XE8DS\\nExposure to radiation: XE60C\\nExposure to welding light: XE82Y\\nExposure to other visible and ultraviolet light of manmade sources: XE436\\nExposure to ultraviolet radiation: XE500\\nExposure to other nonionizing radiation: XE6JQ\\nExposure to microwave radiation: XE6VK\\nExposure to infrared radiation: XE9G0\\nExposure to ionizing radiation: XE5PJ\\nExposure to high or low air pressure or changes in air pressure: XE5DF\\nExposure to changes in air pressure: XE4ZB\\nExposure to high air pressure: XE07M\\nExposure to low air pressure: XE67J\\nExposure to explosion: XE9Y8\\nExposure to chemical explosion: XE22U\\nExposure to explosion or rupture of pressurised materials or object: XE27P\\nExposure to noise: XE7Y1\\nExposure to vibration: XE3RX\\nExposure to suction: XE7BT\\nLack of food: XE7SS\\nLack of water: XE3WS\\nExposure to physical overexertion: XE4TW\\nExposure to other specified privation: XE67Q\\nAbandonment: XE42R\\nNeglect: XE00G\\nPaid work: XE545\\nTravelling to or from paid work: XE7NW\\nTravelling in the course of paid work: XE9Q2\\nRepetitive forceful work: XE2QJ\\nExtended periods of work in a kneeling position: XE88E\\nExtended periods of work in a squatting position: XE714\\nUnpaid work: XE8VF\\nTravelling to or from unpaid work: XE1C6\\nTravelling in the course of unpaid work: XE3RL\\nUnpaid cleaning cooking or maintenance at own place of residence: XE9ME\\nEducational activity: XE729\\nPhysical education class school sports: XE3HD\\nTravelling to or from educational activity: XE4SM\\nOrganised sports and exercise during leisure time: XE5UF\\nLeisure or play: XE617\\nOther specified sports and exercise during leisure time: XE5C9\\nBeing taken care of by health care professional: XE245\\nBeing taken care of by non health care person: XE2EZ\\nBeing taken care of by a person not specified as a health care professional or non health care person: XE643\\nHome: XE266\\nDetached house: XE9XY\\nTerrace house or row house: XE9P0\\nApartment or flat: XE7DU\\nFarmhouse: XE7F8\\nResidential caravan mobile home houseboat or motor home: XE1LE\\nHut: XE3ZC\\nBoarding house or hotel: XE6X4\\nResidential institution: XE9DC\\nHome for the elderly: XE8PL\\nNursing home: XE498\\nPrison: XE30E\\nShelter for battered women and their children: XE8BC\\nMilitary institution: XE138\\nMedical service area: XE9VC\\nHospital: XE28K\\nOutpatient clinic or health centre: XE8DZ\\nHealth professionals office: XE86F\\nHospice: XE9ZD\\nSchool or educational area: XE6TU\\nChild centre or day care centre: XE3JM\\nPreschool or kindergarten: XE9LH\\nPrimary school: XE1ZF\\nSecondary school: XE3CZ\\nCollege or university: XE9BK\\nAdult education institution: XE1JM\\nSports and athletics area: XE7K0\\nOutdoor sporting grounds: XE9WC\\nIndoor sporting hall: XE1CY\\nPublic swimming centre: XE3YG\\nRacetrack or racecourse: XE8BN\\nEquestrian facility: XE2LU\\nSkating rink or ice palace: XE7QG\\nSkiing or snowboarding area: XE7WU\\nPublic highway street or road: XE5NE\\nRoadway: XE6NQ\\nSidewalk: XE53A\\nCycleway: XE4U4\\nTransport area other than highway street or road: XE5KY\\nParking area: XE3NV\\nPublic transport area or facility: XE4N9\\nIndustrial or construction area: XE7T4\\nBuilding under construction: XE11T\\nDemolition site: XE0Z7\\nFactory or plant: XE3U5\\nMine or quarry: XE0Y1\\nOil or gas extraction facility: XE7GD\\nShipyard: XE7MT\\nPower station: XE8Q1\\nFarm or other place of primary production: XE9CS\\nArea for growing crops market gardening horticulture: XE1ES\\nArea for raising or care of animals: XE54N\\nAnimal stables: XE9WB\\nArea for growing crops combined with raising and care of animals: XE9C6\\nPlace for socialising and consumption of alcoholic drinks: XE1WL\\nBar pub saloon or other commercial place primarily for provision of alcoholic drinks: XE03P\\nNightclub restaurant or other commercial place for socialising and recreation: XE7Y2\\nRecreational area cultural area or public building: XE7GY\\nPublic playground: XE0AJ\\nAmusement park or theme park: XE35Q\\nPublic park: XE5C2\\nNoncultural public building: XE774\\nHoliday park or campground: XE4TG\\nPublic religious place: XE0ES\\nCommercial area nonrecreational: XE48U\\nShop or store: XE319\\nCaf or fast food outlet: XE058\\nCommercial garage: XE543\\nOffice building: XE58T\\nCountryside: XE5JL\\nArea of still water: XE0ZP\\nStream of water: XE17F\\nLarge area of water: XE93X\\nMarsh or swamp: XE5TX\\nBeach shore or bank of a body of water: XE010\\nForest: XE6AV\\nDesert: XE601\\nOutofhospital: XE2BE\\nInhospital: XE36S\\nPart of building or grounds bathroom toilet: XE2XM\\nPart of building or grounds kitchen: XE4XM\\nPart of building or grounds living room: XE1M5\\nPart of building or grounds bedroom: XE8RZ\\nPart of building or grounds playroom or family room: XE45Z\\nPart of building or grounds office or home office: XE051\\nPart of building or grounds classroom: XE115\\nPart of building or grounds canteen or cafeteria: XE70Z\\nPart of building or grounds balcony: XE4U5\\nPart of building or grounds stairs: XE2NQ\\nPart of building or grounds elevator: XE9L8\\nPart of building or grounds corridor: XE6ZJ\\nPart of building or grounds lobby: XE3R6\\nPart of building or grounds garden or yard: XE3DE\\nPart of building or grounds garage: XE2Q4\\nPart of building or grounds driveway: XE65J\\nPart of building or grounds swimming pool: XE4PW\\nPart of building or grounds tennis court: XE7DE\\nPart of building or grounds other specified sporting facility: XE9DN\\nPart of building or grounds playground: XE8SG\\nPart of building or grounds private road: XE5RE\\nPart of building or grounds private parking area: XE5MW\\nPart of building or grounds other specified indoor part of building or grounds: XE6ZY\\nPart of building or grounds other specified outdoor part of building or grounds: XE06N\\nPersonpowered means of transport: XE81T\\nTransport vehicle drawn or pushed by person: XE38Y\\nPedal cycle: XE94Q\\nAnimalpowered means of transport: XE1MP\\nAnimal being ridden: XE0ZZ\\nAnimaldrawn vehicle: XE1CF\\nMotorised twoor threewheeled vehicle: XE3ZP\\nMotorcycle: XE0TY\\nMoped scooter: XE9N6\\nThreewheeled motor vehicle or scooter: XE9AX\\nLight transport vehicle with four or more wheels: XE3GH\\nPassenger car: XE50Z\\nLight truck Sports Utility Vehicle SUV utility van x vehicle jeep pickup truck: XE4BF\\nMinibus: XE6DC\\nHeavy transport vehicle with four or more wheels: XE4NR\\nBus coach: XE60G\\nTractortrailer articulated lorry wheeler rig: XE8XB\\nHeavy truck not elsewhere classified: XE5A8\\nTrailer or horsefloat: XE5KW\\nRail vehicle: XE0ZK\\nStreetcar tram electric car car trolley: XE40X\\nTrain: XE9Q3\\nFunicular monorail or other similar rail vehicle: XE3P6\\nParts or components of land vehicle or means of land transport: XE0YD\\nVehicle doors not elsewhere classified: XE954\\nVehicle seat belts deploying air bags: XE226\\nTyre tire or battery attached or unattached: XE8UK\\nVehicle window or windshield: XE8CT\\nInterior of vehicle: XE1LF\\nEngine of vehicle: XE5D5\\nCertain specified land vehicle or means of land transport: XE3C0\\nCable car ski chair lift ski lift with gondola: XE8KJ\\nMotorized wheelchair: XE8C8\\nSmallsized motorized vehicles for children: XE4D7\\nMotor home: XE3FP\\nMobile machinery or special purpose vehicle mainly used in agriculture: XE7X0\\nRideon lawn mower: XE9HQ\\nTractor: XE0S2\\nHarvesting machine: XE0YP\\nAuger post hole digger: XE7SF\\nEquipment towed or powered by tractors not elsewhere classified: XE0LF\\nMobile machinery or special purpose vehicle mainly used in industry: XE0M8\\nForklift or lift truck: XE21P\\nMobile crane: XE8TB\\nBatterypowered airport passenger vehicle: XE6VY\\nLogging car: XE13Q\\nCoalcar in mine: XE6B4\\nTram truck or tub in mine or quarry: XE1BG\\nMobile machinery or special purpose vehicle mainly used in construction: XE1GE\\nGrader: XE4MS\\nFrontend loader bulldozer: XE69J\\nExcavator digger mechanical shovel: XE6XP\\nRoad roller: XE3GR\\nCertain specified mobile machinery or special purpose vehicle: XE381\\nAmbulance: XE80A\\nFire truck fire engine: XE5BQ\\nRace car: XE387\\nSnowmobile skiscooter: XE2LT\\nSpecial allterrain vehicle or offroad vehicle: XE6R9\\nPowered watercraft or means of water transport: XE70T\\nMerchant ship cargo ship oil tanker: XE7NQ\\nPassenger ship passenger liner ocean liner: XE3HS\\nFishing boat trawler: XE801\\nFerry used for short trips across closed waters: XE69F\\nMotorised yacht motorboat powered boat personal powered watercraft: XE3WZ\\nHouseboat: XE304\\nHovercraft: XE5ZR\\nAirboat: XE3PW\\nSubmarine or related craft: XE4UQ\\nUnpowered watercraft or means of water transport: XE29V\\nSailboat unpowered yacht: XE9SF\\nCanoe kayak row boat pirogue piragua: XE8BZ\\nWave board surfboard paddle ski: XE3CC\\nWindsurfer: XE3LU\\nPart or component of powered or unpowered watercraft: XE5G3\\nPowered aircraft or means of air transport: XE9LQ\\nHelicopter: XE4LN\\nAirship blimp: XE8RL\\nUltralight powered aircraft: XE0WR\\nPrivate fixedwing powered aircraft: XE7MP\\nCommercial fixedwing powered aircraft: XE7FK\\nMilitary fixedwing powered aircraft: XE6FD\\nSpacecraft: XE346\\nUnpowered aircraft or means of air transport: XE4QU\\nPassenger balloon unpowered: XE96T\\nParachute: XE627\\nHangglider: XE3VU\\nGlider: XE2KU\\nPart or component of powered or unpowered aircraft: XE79E\\nFurniture or furnishing: XE5HA\\nBed bedding or bedding accessories: XE8PK\\nBunk bed: XE86G\\nSpecial bed orthopaedic bed or stretcher: XE7QQ\\nHammock: XE27V\\nMattress sleeping mat: XE0TM\\nOther specified bed: XE2DR\\nPillow cushion: XE6R1\\nBed rails: XE38G\\nChair or sofa: XE769\\nUpholstered chair or sofa: XE33K\\nHard chair or bench: XE853\\nRocking or gliding chair: XE5NL\\nFolding chair: XE1NC\\nRevolving chair: XE7FS\\nStool: XE484\\nCommode chair: XE61B\\nTable stand cupboard shelf or partition: XE2F3\\nRack bookshelf: XE002\\nCabinet cupboard side board chest of drawers tall boy dresser: XE3BY\\nDining room or kitchen table: XE1DK\\nCoffee table: XE6E5\\nNight table end table: XE2C9\\nDesk workbench: XE2AM\\nTelevision table stand cupboard: XE3TY\\nFolding table: XE6EN\\nRoom divider or partition: XE4B1\\nDecoration decorating item: XE7MK\\nRug mat loose carpet: XE3WK\\nDraperies curtains: XE003\\nRoller or venetian blind or indoor shutter: XE92A\\nWindow covering hardware: XE3EA\\nMirror or mirror glass: XE962\\nPortrait picture picture frame or other wall hanging or similar decoration: XE05Q\\nChristmas tree: XE1FR\\nHoliday decorations: XE4CE\\nInfant or child product: XE8RW\\nBaby or child article: XE1AW\\nBaby pram buggy pusher stroller carriage: XE0CS\\nBaby walker: XE4JE\\nBaby exerciser jumper or portable swing for home use: XE8U9\\nHigh chair booster seat: XE39K\\nBaby or child car seat: XE52H\\nPotty chair training seat: XE9MB\\nCot crib baby bed: XE8RG\\nPlaypen travel yard: XE5QK\\nBaby gate or barrier: XE12N\\nBaby carrier back pack type: XE34A\\nPedal cycle baby carrier: XE8HU\\nBaby baths or bathinettes: XE8VC\\nBaby or child changing table: XE49V\\nBaby or child pacifier dummy: XE9R1\\nBaby bottle or nipple: XE1JQ\\nDiaper nappy: XE7HA\\nDiaper fastener: XE5E9\\nToy: XE3Y2\\nChilds tricycle or other rideon toy: XE0GX\\nToy vehicle: XE959\\nToy gun or related accessory: XE93L\\nOther toy weapon or projectile toy: XE8ZY\\nToy art craft or kit: XE1DG\\nBoard game or accessory or piece: XE9DY\\nToy sports equipment: XE887\\nBall general other than sport specific: XE1HM\\nInfant or child product flying toy: XE5FF\\nInfant or child product doll doll accessory or part stuffed toy: XE30M\\nInfant or child product toy balloon: XE5E1\\nInfant or child product inflatable toy: XE4HX\\nInfant or child product marble bead: XE2KV\\nInfant or child product play tent tunnel or other enclosure: XE1X0\\nInfant or child product toy box or chest: XE7UT\\nPlayground equipment: XE6JS\\nTree house play house: XE7YQ\\nPlayground equipment flying fox: XE8H2\\nPlayground equipment monkey bar: XE27W\\nOther playground climbing apparatus: XE8K7\\nPlayground equipment slide sliding board: XE0R1\\nPlayground equipment swing swing set: XE5W3\\nPlayground equipment seesaw teeter totter: XE9AU\\nPowered amusement rides: XE59P\\nAppliance mainly used in household: XE14C\\nCooking or kitchen appliance: XE68B\\nElectric kettle: XE3WY\\nElectric frying pan deep fryer: XE3FW\\nElectric bread making machine: XE03R\\nFood processor blender juicer: XE6DV\\nPowered knife: XE02T\\nElectric toaster toaster oven: XE5LB\\nMicrowave oven: XE7D9\\nStove oven cooktop: XE6PT\\nPressurised kerosene or paraffin cooking stove: XE464\\nCoal pot: XE0U0\\nChulo stove: XE5YC\\nBarbeque outdoor cookers or griller outdoor clay oven: XE6A4\\nDishwasher: XE0U1\\nRefrigerator freezer appliance: XE3JZ\\nCleaning or laundering appliance or tool: XE87D\\nWashing machine: XE4FB\\nClothes dryer: XE0Y0\\nClothes iron press: XE2VW\\nClothesline clothes drying rack clotheshorse: XE06L\\nUnpowered cleaning tool: XE9H2\\nVacuum cleaner: XE5PE\\nPowered cleaning tool not elsewhere classified: XE7Z3\\nLighting appliance: XE4KD\\nFreestanding gas oil or kerosene lamp: XE3QJ\\nElectric lamp: XE926\\nOther specified lamp or lamp component: XE5GA\\nBatteryoperated torch: XE1D7\\nCandle candlestick: XE01B\\nHeating or cooling appliance: XE84K\\nFan: XE5VR\\nElectric or gas radiator heater: XE1ZZ\\nKerosene heater: XE0KQ\\nSewing appliance or equipment: XE9WK\\nSewing machine: XE0PW\\nScissors: XE204\\nPin needle: XE8D1\\nEntertainment appliance: XE80T\\nTelevision: XE6SR\\nVideo recorder decoder player: XE1PK\\nVideo camera camera digital camera or accessory: XE5Y8\\nSound equipment: XE59W\\nCord of household appliance extension cord: XE2MS\\nCooking or food processing utensil: XE4G0\\nNonelectric kettle: XE7VX\\nKnife not elsewhere classified: XE8WH\\nCooking pot pan: XE9LY\\nPressure cooker: XE50Y\\nCutlery food preparation utensil: XE5CG\\nCrockery kitchen container: XE9W8\\nDrinking glass cup made from glass or china: XE532\\nPlate bowl dish made from glass or china: XE9Q8\\nGlass bottle or jar: XE6LK\\nContainer made from plastic wood or clay: XE5G7\\nCleaning utensil or container: XE8EL\\nBucket pail: XE383\\nFood storage or related utensil or container: XE4WL\\nTinned container tin can: XE1GJ\\nBox or carton containing food or drink: XE5N6\\nGrocery or shopping trolley or cart: XE8JZ\\nCertain specified utensil or container: XE31H\\nRubbish bin trash can dumpster: XE3SR\\nHeavy container box package not elsewhere classified: XE0GP\\nBag sack not elsewhere classified: XE80G\\nClothes foot wear or related products: XE12D\\nBelt braces suspenders sash: XE42F\\nButton: XE06P\\nOther specified clothes fastener: XE8H8\\nShoe sandal slipper boot: XE1KG\\nShoelace shoe buckle: XE0MQ\\nShirt blouse tshirt trousers slacks jacket coat outerwear: XE6A6\\nNightclothes pyjamas nightwear underwear undergarment lingerie: XE4AP\\nClothing accessory or personal decoration item: XE91F\\nWristwatch jewellery: XE79Y\\nPersonal grooming utensil: XE9WV\\nHair dryer curling iron curler: XE7FF\\nComb hairbrush: XE2CA\\nRazor razor blade: XE22C\\nElectric shaver: XE39S\\nElectric toothbrush: XE1RS\\nOther toothbrush: XE88G\\nToiletries cosmetics or related product: XE45T\\nCleaning agent for contact lenses: XE5U0\\nDental care products: XE5CY\\nCotton swab cotton bud Qtip: XE94F\\nSoap: XE1H5\\nDeodorants: XE1B1\\nPerfume cologne: XE5DV\\nHair colouring preparation: XE8PE\\nHair removal preparation depilatory: XE1T3\\nOther hair care product: XE8EH\\nNail polish: XE3EV\\nBody or facial cream or lotion: XE7DF\\nBody powder talc: XE8W8\\nCosmetics not elsewhere classified: XE79N\\nSuntan or sunscreen products selftan products: XE8NY\\nEssential oils oils used in aromatherapy: XE4KX\\nCommunication or related utensil or accessory: XE3AM\\nTelephone mobile phone cellular phone: XE2A3\\nPersonal computer or related accessory: XE9K5\\nFax machine and other related equipment: XE38S\\nTypewriter correction fluid: XE5V8\\nPen pencil: XE38A\\nOther stationery item: XE1RG\\nArts and crafts supplies: XE58R\\nArtist paint: XE0NW\\nChalk crayon: XE2EN\\nGlazes: XE6E6\\nCanvas: XE8ZP\\nPersonal aid: XE0X7\\nEyewear: XE5EM\\nWheelchair: XE293\\nCane walker walking stick walking frame: XE90Y\\nProsthesis: XE5W4\\nRubber bathtub mat: XE6ZS\\nTobacco or related product: XE7P9\\nCigarette cigar pipe: XE01N\\nLighter match: XE4U8\\nAids to quit smoking: XE0Q7\\nCertain specified personal use item: XE2H2\\nVaporizer humidifier: XE1NP\\nOil burner: XE1PV\\nCondom or other contraceptive device: XE7S6\\nSex aids: XE9GS\\nAlarm clock clock: XE030\\nUmbrella: XE9R0\\nCoins: XE3T5\\nHandheld fan: XE6N6\\nBall used in sport: XE5BJ\\nSoft ball: XE9X9\\nPuck hard ball: XE7M5\\nHandheld sports equipment: XE68L\\nSpear javelin not elsewhere classified: XE3H8\\nBow arrow crossbow bolt crossbow not elsewhere classified: XE9CT\\nOther specified sports projectile: XE557\\nBat hockey stick: XE23P\\nRacquet: XE9MP\\nIce pick: XE1HX\\nEquipment or structure for playing sports or exercise: XE0AQ\\nNet for sports or exercise: XE2EM\\nRugby pole net pole goal post: XE9R3\\nTrampoline for playing sports or exercise: XE6HE\\nGymnastic equipment: XE8C0\\nSports mat for playing sports or exercise: XE76Q\\nDiving board platform: XE9TW\\nExercise fitness equipment movable: XE1EH\\nExercise fitness equipment fixed: XE6G9\\nEquipment with wheels or designed for movement mainly for use in sports or recreational activity: XE70Q\\nRoller skates rollerski inline skates roller blades: XE38Q\\nSkateboard: XE7TJ\\nFolding scooter: XE06X\\nWaterski: XE9XZ\\nSnow ski: XE5W5\\nSnow board: XE6DZ\\nIce skate: XE2AY\\nSled toboggan sleigh snow disk snow tube: XE0AR\\nUnderwater diving equipment: XE9TA\\nAqualung: XE1WX\\nDiving belt weight: XE85D\\nWetsuit: XE8X8\\nGoggle or mask flipper or fin snorkel: XE3NW\\nCertain specified equipment for sports or recreational activity: XE8FX\\nPersonal protective equipment PPE designed for use in sports: XE92X\\nTool machine apparatus mainly used for workrelated activity: XE0P3\\nMachinery or fixed plant: XE6TZ\\nCutting or slicing machinery or fixed plant: XE43P\\nCrushing or pressing machinery or fixed plant: XE0VT\\nHeating or cooking machinery or fixed plant: XE1WC\\nRefrigeration machinery or fixed plant: XE76C\\nLifting machinery: XE14G\\nHoist machinery: XE77A\\nCrane machinery or fixed plant: XE3BT\\nElevated work platform: XE9U1\\nConveyors: XE6T6\\nMains gas water sewerage steam hot water electricity: XE99N\\nShearing plant: XE8FD\\nDairy or milking plant: XE6VH\\nPress: XE6AF\\nGarbage compactor: XE0JX\\nThreshing machine: XE02Q\\nChaffcutter foddercutter: XE8KN\\nPowered hand tool or equipment: XE5WX\\nDrill: XE88U\\nChainsaw: XE8MJ\\nOther power saw: XE66P\\nWelder welding equipment: XE0TD\\nNail gun stud driver: XE3E3\\nGrinder buffer polisher sander: XE3UP\\nPowered garden tool: XE8T6\\nPowered push lawn mower: XE89A\\nIndustrial vacuum cleaner: XE0N1\\nUnpowered hand tool or equipment: XE16F\\nUnpowered push lawnmower: XE8P1\\nHammer mallet: XE0VV\\nChopping tool: XE56E\\nCutting tool: XE9CU\\nDigging or tilling tool: XE9GT\\nLifting tool: XE3KL\\nNail screw tack: XE7VR\\nFishhook used for workrelated activity: XE3W7\\nRat or mouse trap used for workrelated activity: XE8KL\\nPressurebased equipment: XE9N7\\nGas cylinder: XE5VQ\\nPressurised hose pipe: XE974\\nCertain unpowered equipment: XE3RZ\\nLadder movable step: XE9P7\\nScaffolding: XE7RK\\nHelmet: XE5F6\\nEarplugs: XE67K\\nWelding mask: XE2PS\\nPersonal protective equipment not elsewhere classified: XE7RJ\\nFire extinguisher: XE7HB\\nMechanical power transmission device: XE505\\nSharp object: XE4BU\\nSpear javelin designed as weapon: XE3KV\\nArrow or bolt designed as weapon: XE9PM\\nKnife designed as weapon: XE174\\nSword dagger bayonet machete panga cutlass: XE598\\nFirearm or related item: XE04A\\nBullet pellet: XE4KC\\nHand gun: XE72J\\nRifle: XE0Q9\\nShotgun: XE32H\\nAir gun: XE6YZ\\nCertain specified weapon: XE1XM\\nClub cudgel rod knobkierie: XE61H\\nElectrical prod stun gun: XE9F9\\nCapsicum spray mace pepper spray: XE203\\nPlant: XE3C1\\nTree plant: XE9CV\\nLeaves flowers: XE2ZX\\nMushroom toadstool fungus: XE4DN\\nPlant seed: XE8XA\\nFruit from plant: XE4KB\\nPlant thorn: XE8SV\\nBranch or stick separate from branch or tree: XE50M\\nVenomous or toxic plant not elsewhere classified: XE2PR\\nBird: XE6L5\\nOstrich emu: XE99A\\nParrot parakeet cockatoo: XE69N\\nRaven crow magpie: XE1Q3\\nInsect invertebrate: XE6UV\\nBee: XE4D9\\nWasp: XE6LT\\nHornet: XE322\\nYellow hornet: XE7WQ\\nWhitefaced hornet: XE7TV\\nAnt: XE4YS\\nSpider: XE75L\\nScorpion: XE2EP\\nTick: XE779\\nCentipede millipede: XE11M\\nCochineal: XM6QA5\\nLand mammal: XE813\\nDog: XE33Q\\nDog dander: XE0W5\\nDog epithelium: XE3GM\\nCat: XE4V0\\nCat dander: XE896\\nRat guinea pig mouse: XE8X3\\nPig wild boar: XE3UD\\nSheep goat: XE25P\\nCow bull bovine animals: XE257\\nBeef: XE1LR\\nCow dander: XE5NG\\nHorse pony donkey mule ass: XE5VC\\nBaboon monkey chimpanzee gorilla: XE7NS\\nMarsupials: XE4TZ\\nDeer moose antelope zebra wildebeest: XE1MH\\nHippopotamus: XE37L\\nLion puma panther cougar mountain lion tiger: XE82S\\nBear grizzly bear polar bear: XE7UA\\nElephant: XE2Q6\\nBuffalo bison African buffalo: XE96F\\nHamster epithelium: XE08V\\nHorse dander: XE09T\\nMouse epithelium: XE7CQ\\nMouse urine proteins: XE43Q\\nRabbit epithelium: XE7TQ\\nPork: XE9BL\\nBlue mussel: XE6T4\\nScallop: XE6WA\\nGuinea pig epithelium: XE5ZB\\nMarine animal: XE2AH\\nShark: XE765\\nOther fishes: XE71F\\nSea snake: XE48L\\nMarine mammal: XE3UQ\\nJellyfish: XE8BW\\nNematocysts: XE40R\\nCoral: XE75E\\nSea urchin: XE6ZA\\nSea anemone: XE45C\\nSea cucumber: XE43L\\nReptile or amphibian: XE1PT\\nNonvenomous snake: XE44L\\nVenomous snake: XE9H6\\nCobra: XE9X2\\nFer de lance: XE5N3\\nRattlesnake: XE2RM\\nViper: XE8LD\\nKrait: XE2UZ\\nSnake unspecified whether venomous or not: XE11V\\nLizard gecko goanna: XE6A7\\nGila monster: XE65X\\nFrog toad: XE4YK\\nCrocodile alligator: XE4FD\\nPerson: XE653\\nPerson self: XE70B\\nCrowd of people: XE0TZ\\nBuilding fitting: XE1P6\\nFlush toilet: XE766\\nPit latrine: XE429\\nBathtub spabath shower cubicle: XE2C6\\nBathtub: XE78X\\nspabath: XE5T1\\nshower cubicle: XE5RW\\nShower: XE31Q\\nFitted counter countertop kitchen top: XE8P0\\nDoor window or related fitting or feature: XE2AC\\nDoor door sill: XE68A\\nGlass door: XE4YT\\nSecurity door or gate fly gate: XE4NX\\nBars on windows: XE6FE\\nWindow: XE4BD\\nExterior window shutters: XE5B1\\nFloor or related fitting or feature: XE7SG\\nFloor carpeted: XE0SK\\nFloor tile brick concrete: XE19Z\\nFloor wood: XE6M6\\nFloor mud clay animal dung: XE6ZE\\nWall or related fitting or feature: XE4ZE\\nFireplace: XE19W\\nBuiltin barbecue: XE1B2\\nWall brick concrete tile: XE0WS\\nWall wood: XE7CH\\nWall mud clay animal dung: XE3GJ\\nCertain specified building building component or fitting: XE3PF\\nInground swimming pool: XE39L\\nAboveground swimming pool external spa or hot tub: XE4PB\\nAboveground swimming pool: XE5PL\\nexternal spa: XE3PX\\nexternal hot tub: XE8AX\\nFence gate: XE7FP\\nFence: XE3BP\\nGate: XE3GT\\nMoving ramp escalator: XE9QW\\nMoving ramp: XE0KF\\nEscalator: XE73T\\nLift elevator: XE8PC\\nStairs steps: XE3HC\\nHandrail railing banister: XE2VG\\nElectrical transmission line in or around building: XE6T1\\nFittings or pipes for gas steam or hot water: XE7UU\\nFittings or pipes for gas: XE171\\nFittings or pipes for steam: XE2BH\\nFittings or pipes for hot water: XE48P\\nElectrical fixture: XE871\\nDucted airconditioning unit or related fitting: XE9HH\\nGround surface: XE58F\\nCliff: XE1AK\\nSlope ramp: XE94G\\nTrench ditch pit: XE3EC\\nSewer grate: XE5Y0\\nOpen drain channel: XE2G4\\nBody of water: XE7K9\\nBody of water manmade well dug well for underground water: XE9TJ\\nBody of water water reservoir: XE40U\\nBody of water puddle: XE64D\\nBody of water dam lake: XE285\\nBody of water river stream: XE1CZ\\nBody of water swamp marsh estuary: XE57J\\nBody of water beach seashore: XE636\\nBody of water open sea: XE5N4\\nBody of water flood water: XE0CX\\nBody of water canal or irrigation channel: XE2QX\\nCertain specified surface conformation: XE7CY\\nSloping surface not elsewhere classified: XE45P\\nEven surface not elsewhere classified: XE9CC\\nUneven surface not elsewhere classified: XE1DA\\nNatural material: XE4BY\\nSnow ice: XE3LV\\nNatural grass: XE233\\nRock stone not elsewhere classified: XE83R\\nWood timber board splinter not elsewhere classified: XE2JN\\nGravel soil sand not elsewhere classified: XE9D4\\nHay straw: XE36E\\nGrain in bulk: XE410\\nManufactured or industrial material: XE4Y6\\nArtificial grass: XE59G\\nBrick concrete concrete block: XE6MG\\nMolten metal: XE983\\nMetal sheet part piece etc: XE1FP\\nChina ceramics sheet part piece: XE1LM\\nMolten glass: XE57U\\nGlass sheet piece shard: XE4KU\\nPlastic: XE7K4\\nPaper cardboard: XE63Q\\nBitumen: XE7CA\\nMaterial not mentioned elsewhere: XE16B\\nTextiles: XE5XN\\nFire flame or smoke causing injury: XE3NR\\nFire flame causing injury: XE9DT\\nBurning oil: XE7PM\\nOther burning liquid: XE73M\\nBurning gas not elsewhere classified: XE3K6\\nControlled fire flame in building or structure: XE27S\\nControlled fire flame not in building or structure: XE7W8\\nUncontrolled fire flame in building or structure: XE87S\\nUncontrolled fire flame not in building or structure: XE7V9\\nSmoke causing injury: XE4F3\\nHot object or substance not elsewhere classified: XE63H\\nHot liquid: XE4VA\\nHot tap water: XE396\\nBoiling water other than tap water: XE4WG\\nHot air or gas: XE3BS\\nSteam hot vapour: XE77R\\nFood drink or related product: XE3FD\\nHot cooking oil or fat: XE5VU\\nHot solid food: XE3KH\\nHot drink: XE36T\\nCold solid food: XE3VM\\nCold drink nonalcoholic: XE6SF\\nLaw enforcement equipment: XE4QT\\nHandcuffs: XE8YS\\nPublic use item: XE5TH\\nFire hydrant: XE6KX\\nTelephone pole Stobie pole: XE0MT\\nHightension overhead power line: XE35R\\nCamping equipment: XE63M\\nTent: XE14D\\nFastening binding or securing item not elsewhere classified: XE11D\\nRope string or twine: XE4H9\\nBarbed wire: XE3U7\\nOther wire: XE1PL\\nChain: XE18Y\\nExplosive material or flammable object not elsewhere classified: XE3WL\\nFireworks: XE6KQ\\nExplosive: XE59Q\\nCertain other specified object or living thing involved in causing injury: XE908\\nHighpressure jet: XE2JA\\nLaser light and equipment: XE5DQ\\nLaser pointer: XE9AP\\nSharp object not elsewhere classified: XE6UH\\nBlunt object not elsewhere classified: XE9GE\\nMotor engine not elsewhere classified: XE98K\\nDry cell battery: XE8AE\\nDisc battery: XE8H0\\nBattery not elsewhere classified: XE72W\\nAnimal cage: XE146\\nGastric content: XE12Z\\nExcrement human or animal: XE8FT\\nBlood carcass body bone not elsewhere classified human or animal: XE08P\\nPlastic bag: XE2DW\\nGarbage litter trash: XE2AU\\nEnvironmental pollution not elsewhere classified: XE2VX\\nMedical or surgical device not in therapeutic use: XE6QS\\nAlcohol use no information available: XE47R\\nAlcohol use no suspicion or evidence of alcohol use by any person involved in the injury event: XE08X\\nAlcohol use suspicion or evidence of alcohol use by the injured person: XE1G3\\nAlcohol use suspicion or evidence of alcohol use by other persons involved in the injury event: XE15H\\nAlcohol use suspicion or evidence of alcohol use by both the injured person and other persons involved in the injury event: XE3JF\\nPsychoactive drug use no information available: XE43G\\nPsychoactive drug use no suspicion or evidence of psychoactive drug use by any person involved in the injury event: XE5TU\\nPsychoactive drug use suspicion or evidence of psychoactive drug use by the injured person: XE5VY\\nPsychoactive drug use suspicion or evidence of psychoactive drug use by other persons involved in the injury event: XE8GW\\nPsychoactive drug use suspicion or evidence of psychoactive drug use by both the injured person and other persons involved in the injury event: XE28E\\nPedestrian as mode of transport of person injured in transport event: XE88K\\nPerson on foot injured in transport related event: XE645\\nPerson on foot standing walking or running at the time of the crash: XE0HE\\nPedestrian conveyance as mode of transport of person injured in transport event: XE7ZY\\nMobility scooter as mode of transport of person injured in transport related event: XE0TE\\nMotorised wheelchair as mode of transport of person injured in transport related event: XE80N\\nIce skates as mode of transport of person injured in transport related event: XE08H\\nSkis as mode of transport of person injured in transport related event: XE0FX\\nSnowboard as mode of transport of person injured in transport related event: XE3JS\\nSled as mode of transport of person injured in transport related event: XE036\\nSkateboard as mode of transport of person injured in transport related event: XE96G\\nRoller skates as mode of transport of person injured in transport related event: XE2PW\\nScooter as mode of transport of person injured in transport related event: XE4HS\\nBaby carriage as mode of transport of person injured in transport related event: XE7RL\\nPerambulator as mode of transport of person injured in transport related event: XE1BH\\nPush chair as mode of transport of person injured in transport related event: XE9SV\\nStroller as mode of transport of person injured in transport related event: XE7KT\\nPedal cycle as mode of transport of person injured in transport related event: XE71D\\nTrailer or sidecar attached to a pedal cycle as mode of transport of person injured in transport related event: XE2BW\\nCycle rickshaw or trishaw as mode of transport of person injured in transport related event: XE6R4\\nMotorcycle as mode of transport of person injured in transport related event: XE7NK\\nMoped as mode of transport of person injured in transport related event: XE2J1\\nUnderbone motorcycle as mode of transport of person injured in transport related event: XE39A\\nMotor scooter as mode of transport of person injured in transport related event: XE9BU\\nMotorised bicycle as mode of transport of injured person in transport related event: XE9RC\\nAg bike as mode of transport of person injured in transport related event: XE1ZG\\nCar as mode of transport of person injured in transport related event: XE2W4\\nx vehicle as mode of transport of person injured in transport related event: XE0V3\\nLight transport vehicle with four or more wheels used in sport and leisure activities as mode of transport of person injured in transport related event: XE2TP\\nMicrocar as mode of transport of person injured in transport related event: XE9K7\\nMotor car as mode of transport of person injured in transport related event: XE62M\\nStation wagon as mode of transport of person injured in transport related event: XE85J\\nMinivan as mode of transport of person injured in transport related event: XE7LL\\nJeep as mode of transport of person injured in transport related event: XE1CK\\nSport utility vehicle as mode of transport of person injured in transport related event: XE5X0\\nBus or coach as mode of transport of person injured in transport related event: XE2RA\\nLight goods vehicle as mode of transport of person injured in transport related event: XE9JB\\nMinibus or passenger van as mode of transport of person injured in transport related event: XE6PF\\nPickup truck goods or work van ambulance motor home as mode of transport of person injured in transport related event: XE165\\nHeavy goods vehicle as mode of transport of person injured in transport related event: XE1PH\\nTrucks lorries and other heavy goods vehicle as mode of transport of person injured in transport related event: XE10A\\nFire brigade pump vehicle as mode of transport of person injured in transport related event: XE1VN\\nRoad tractor with or without semitrailer as mode of transport of person injured in transport related event: XE7XM\\nTruck with trailer as mode of transport of person injured in transport related event: XE5ET\\nStreetcar or tram as mode of transport of person injured in transport related event: XE41E\\nLowpowered passenger vehicle as mode of transport of person injured in transport event: XE5WB\\nTuktuk as mode of transport of person injured in transport related event: XE8DK\\nMototaxi as mode of transport of person injured in transport related event: XE1DF\\nAuto rickshaw threewheeler as mode of transport of person injured in transport related event: XE4SA\\nSpecial vehicle mainly used in agriculture as mode of transport of person injured in transport related event: XE35C\\nSelfpropelled agricultural machine as mode of transport of person injured in transport related event: XE3WV\\nHarvester as mode of transport of person injured in transport related event: XE3QK\\nAgricultural tractor as mode of transport of person injured in transport related event: XE872\\nSpecial vehicle mainly used on industrial premises as mode of transport of person injured in transport related event: XE885\\nFork lift truck as mode of transport of person injured in transport related event: XE31K\\nSpecial construction vehicle as mode of transport of person injured in transport related event: XE312\\nSpecial allterrain vehicle as mode of transport of person injured in transport related event: XE5RK\\nSnowmobile as mode of transport of person injured in transport related event: XE63N\\nHovercraft operating on land or swamp as mode of transport of person injured in transport related event: XE5U7\\nAmphibious vehicle on land as mode of transport of person injured in transport related event: XE4MT\\nQuad bike as mode of transport of person injured in transport related event: XE3SA\\nAnimal being ridden as mode of transport of person injured in transport related event: XE940\\nHorse as mode of transport of person injured in transport related event: XE1ZJ\\nAnimal drawn vehicle as mode of transport of person injured in transport related event: XE4ZZ\\nRailway vehicle as mode of transport of person injured in transport related event: XE8YD\\nRailway train as mode of transport of person injured in transport related event: XE1KN\\nFunicular or monorail as mode of transport of person injured in transport related event: XE3NY\\nWatercraft as mode of transport of person injured in transport related event: XE27K\\nSubmarine as mode of transport of person injured in transport related event: XE4FF\\nMerchant ship as mode of transport of person injured in transport related event: XE3QY\\nPassenger ship as mode of transport of person injured in transport related event: XE9YQ\\nFishing boat or trawler as mode of transport of person injured in transport related event: XE9PA\\nSailboat or unpowered yacht as mode of transport of person injured in transport related event: XE0L4\\nHovercraft and amphibious vehicles when in or above a body of water as mode of transport of person injured in transport related event: XE4AK\\nOther specified powered or motorised watercraft as mode of transport of person injured in transport related event: XE5WL\\nOther specified unpowered watercraft as mode of transport of person injured in transport related event: XE36L\\nAircraft as mode of transport of person injured in transport related event: XE1JR\\nBalloons and other lighter than air devices as mode of transport of person injured in transport related event: XE3J3\\nPowered aircraft as mode of transport of person injured in transport related event: XE2UU\\nUnpowered aircraft as mode of transport of person injured in transport related event: XE6SQ\\nParachute used in descent from damaged aircraft as mode of transport of person injured in transport related event: XE4VS\\nParachute used in descent from undamaged aircraft as mode of transport of person injured in transport related event: XE08L\\nGlider as mode of transport of person injured in transport related event: XE33H\\nHelicopter as mode of transport of person injured in transport related event: XE48X\\nSpacecraft as mode of transport of person injured in transport related event: XE0VS\\nDevices or parts of devices designed for ascent from and landing on earth or the surface of other bodies as mode of transport of person injured in transport related event: XE82G\\nVehicle driver injured in transport related event: XE42A\\nPerson driving a motor vehicle injured in transport related event: XE8ZW\\nPerson riding operating or controlling a motorcycle or pedal cycle injured in transport related event: XE65U\\nPerson responsible to resume manual control of a vehicle under autonomous or partly autonomous control injured in transport related event: XE3WH\\nPerson with control of steering and braking in the case of a tandem bicycle or similar vehicle injured in transport related event: XE8SZ\\nPerson directing or attempting to direct an animal injured in transport related event: XE302\\nVehicle passenger injured in transport related event: XE1LZ\\nVehicle occupant not otherwise specified: XE5X3\\nOccupant of position provided for patient in an ambulance: XE3FA\\nOccupants of wheelchair or mobility scooter located in a position in a motor vehicle provided for carrying such devices: XE9FE\\nOccupants of area in a bus provided for standing: XE9CP\\nPerson boarding or alighting a vehicle injured in transport related event: XE9Y1\\nPerson getting into or out of a vehicle injured in transport related event: XE76V\\nPerson boarding or alighting from a bus tram streetcar or railway vehicle injured in transport related event: XE6LC\\nPerson on outside of vehicle or in load space injured in transport related event: XE166\\nPerson being transported by a vehicle and occupying space intended for the transport of goods or cargo injured in transport related event: XE7FA\\nPerson being transported by a vehicle and occupying space on the roof injured in transport related event: XE4CZ\\nPerson being transported by a vehicle and occupying space on a running board injured in transport related event: XE9X1\\nPerson being transported by a vehicle and occupying space outside the cabin holding onto the vehicle injured in transport related event: XE7PL\\nRider of an animal injured in transport event: XE6R5\\nPedestrian as counterpart in land transport crash: XE6K0\\nPerson on foot as counterpart in land transport crash: XE57K\\nPerson using a pedestrian conveyance as counterpart in land transport crash: XE2ZK\\nPedestrian conveyance as counterpart in land transport crash: XE3NU\\nMobility scooter as counterpart in land transport crash: XE93R\\nWheelchair as counterpart in land transport crash: XE3XF\\nIce skates as counterpart in land transport crash: XE1TJ\\nSkis as counterpart in land transport crash: XE5XW\\nSnowboard as counterpart in land transport crash: XE4NZ\\nSled as counterpart in land transport crash: XE5D9\\nSkateboard as counterpart in land transport crash: XE5H4\\nRoller skates as counterpart in land transport crash: XE9J0\\nScooter as counterpart in land transport crash: XE28X\\nBaby carriage as counterpart in land transport crash: XE5SX\\nPerambulator as counterpart in land transport crash: XE1ZX\\nPush chair as counterpart in land transport crash: XE168\\nStroller as counterpart in land transport crash: XE2JL\\nPedal cycle as counterpart in land transport crash: XE7ZZ\\nTrailer or sidecar attached to a pedal cycle as counterpart in land transport crash: XE5GG\\nCycle rickshaw or trishaw as counterpart in land transport crash: XE2PY\\nMotorcycle as counterpart in land transport crash: XE8XQ\\nMotorised bicycle as counterpart in land transport crash: XE1SA\\nMoped as counterpart in land transport crash: XE0V4\\nUnderbone motorcycle as counterpart in land transport crash: XE4C1\\nMotor scooter as counterpart in land transport crash: XE9FR\\nAgbike as counterpart in land transport crash: XE59J\\nCar as counterpart in land transport crash: XE0JH\\nMotorcar as counterpart in land transport crash: XE0LP\\nStation wagon as counterpart in land transport crash: XE0HH\\nMinivan as counterpart in land transport crash: XE0T7\\nx as counterpart in land transport crash: XE38X\\nSport utility vehicle as counterpart in land transport crash: XE6G7\\nJeep as counterpart in land transport crash: XE3BW\\nMicrocar as counterpart in land transport crash: XE0ZR\\nBus or coach as counterpart in land transport crash: XE5LJ\\nLight goods vehicle as counterpart in land transport crash: XE6UN\\nMinibus or passenger van as counterpart in land transport crash: XE0ZL\\nPickup truck goods or work van ambulance or motor home as counterpart in land transport crash: XE4DB\\nLight transport vehicle with four or more wheels used in sport and leisure activities as counterpart in land transport crash: XE0MB\\nHeavy goods vehicle as counterpart in land transport crash: XE854\\nTrucks lorries and other heavy goods vehicles as counterpart in land transport crash: XE590\\nTruck with trailer as counterpart in land transport crash: XE4Q6\\nRoad tractor with or without semitrailer as counterpart in land transport crash: XE45E\\nFire brigade pump vehicle as counterpart in land transport crash: XE3M3\\nStreetcar or tram as counterpart in land transport crash: XE8UX\\nLow powered passenger vehicle as counterpart in land transport crash: XE90S\\nTuktuk as counterpart in land transport crash: XE9VV\\nMototaxi as counterpart in land transport crash: XE9ML\\nAuto rickshaw threewheeler as counterpart in land transport crash: XE73V\\nSpecial vehicle mainly used in agriculture as counterpart in land transport crash: XE9HB\\nSelfpropelled agricultural machine as counterpart in land transport crash: XE9HZ\\nHarvester as counterpart in land transport crash: XE6W7\\nAgricultural tractor as counterpart in land transport crash: XE9GD\\nSpecial vehicle mainly used on industrial premises as counterpart in land transport crash: XE9DQ\\nFork lift truck as counterpart in land transport crash: XE1U3\\nSpecial construction vehicle as counterpart in land transport crash: XE1YW\\nSpecial allterrain vehicle as counterpart in land transport crash: XE23Q\\nSnowmobile as counterpart in land transport crash: XE60L\\nHovercraft operating on land or swamp as counterpart in land transport crash: XE28S\\nAmphibious vehicle on land as counterpart in land transport crash: XE8AH\\nQuad bike as counterpart in land transport crash: XE9KN\\nAnimal as counterpart in land transport crash: XE6QK\\nUnattended animal as counterpart in land transport crash: XE7A0\\nAnimal being herded as counterpart in land transport crash: XE22V\\nAnimal being ridden as counterpart in land transport crash: XE756\\nAnimal drawn vehicle as counterpart in land transport crash: XE6X8\\nRailway vehicle as counterpart in land transport crash: XE6DQ\\nRailway train as counterpart in land transport crash: XE320\\nFunicular or monorail as counterpart in land transport crash: XE1W8\\nFixed or stationary object as counterpart in land transport crash: XE98X\\nVehicle parked at the side of a road or in a parking lot as counterpart in land transport crash: XE3KY\\nSmall loose object as counterpart in land transport crash: XE1RC\\nSmall or light fixed object as counterpart in land transport crash: XE9KG\\nLarge or heavy fixed object as counterpart in land transport crash: XE43C\\nFall in mode of transport without counterpart: XE0JJ\\nFall from mode of transport without counterpart: XE3M5\\nFall from horse without counterpart: XE64P\\nFall from motor vehicle without counterpart: XE20L\\nFall from motorcycle without counterpart: XE7JA\\nFall from pedal cycle without counterpart: XE2K7\\nFall from pedestrian conveyance without counterpart: XE929\\nOther specified mechanism with no counterpart: XE5XB\\nSudden movement of vehicle without collision resulting in injury: XE5FP\\nVehicle overturned without counterpart: XE9K8\\nVehicle out of control without mention of collision with another vehicle or fixed object: XE5YL\\nTeam ball sports: XE3GK\\nType of sport or exercise activity basketball: XE9UG\\nType of sport or exercise activity football American tackle: XE3T2\\nType of sport or exercise activity football American touch or flag: XE31W\\nType of sport or exercise activity football Australian rules: XE72L\\nType of sport or exercise activity football not otherwise specified: XE3BA\\nType of sport or exercise activity handball team: XE7D6\\nType of sport or exercise activity netball: XE510\\nType of sport or exercise activity rugby union: XE9RW\\nType of sport or exercise activity rugby league: XE5XZ\\nType of sport or exercise activity rugby not otherwise specified: XE1XR\\nType of sport or exercise activity soccer outdoor: XE5EU\\nType of sport or exercise activity soccer indoor: XE0TN\\nType of sport or exercise activity soccer not otherwise specified: XE8WP\\nType of sport or exercise activity volleyball: XE79M\\nType of sport or exercise activity wallyball: XE0JP\\nTeam bat or stick sports: XE2BF\\nType of sport or exercise activity baseball: XE84M\\nType of sport or exercise activity cricket: XE5M7\\nType of sport or exercise activity ice hockey: XE2UD\\nType of sport or exercise activity hockey street or ball: XE6B7\\nType of sport or exercise activity field hockey: XE8HB\\nType of sport or exercise activity floor hockey: XE9N5\\nType of sport or exercise activity hockey not otherwise specified: XE02P\\nType of sport or exercise activity ringette: XE8M1\\nType of sport or exercise activity softball: XE63E\\nType of sport or exercise activity tball: XE5WM\\nTeam water sports: XE2BG\\nType of sport or exercise activity rescue and resuscitation: XE8KM\\nType of sport or exercise activity synchronized swimming: XE6Y2\\nType of sport or exercise activity underwater hockey: XE323\\nType of sport or exercise activity water polo: XE2YS\\nBoating sports: XE85T\\nType of sport or exercise activity canoeing: XE1LG\\nType of sport or exercise activity jet skiing: XE7BZ\\nType of sport or exercise activity kayaking or whitewater rafting: XE99V\\nType of sport or exercise activity power boat racing: XE4LT\\nType of sport or exercise activity rowing or sculling: XE4XV\\nType of sport or exercise activity surf boating: XE0XD\\nType of sport or exercise activity yachting or sailing: XE0G3\\nIndividual water sports: XE6W9\\nType of sport or exercise activity platform diving: XE3R2\\nType of sport or exercise activity springboard diving: XE7S0\\ntype of sportexercise activity diving unspecified: XE5UC\\nType of sport or exercise activity fishing: XE5FN\\nType of sport or exercise activity scuba diving: XE1TE\\nType of sport or exercise activity snorkelling: XE1ZK\\nType of sport or exercise activity surfing or boogie boarding: XE48G\\nType of sport or exercise activity surf life saving: XE84Q\\nType of sport or exercise activity competitive swimming: XE1FN\\nType of sport or exercise activity water skiing: XE167\\nType of sport or exercise activity water tubing: XE92F\\nType of sport or exercise activity wind surfing: XE7PV\\nType of sport or exercise activity cliff diving: XE5RZ\\nType of sport or exercise activity recreational swimming: XE6P1\\nIce or snow sports: XE9DF\\nType of sport or exercise activity bobsledding: XE225\\nType of sport or exercise activity curling: XE7J1\\nType of sport or exercise activity ice skating or ice dancing: XE1SZ\\nType of sport or exercise activity luge: XE9KF\\nType of sport or exercise activity ski patrolling: XE7E1\\nType of sport or exercise activity skiing alpine or downhill: XE9X7\\nType of sport or exercise activity skiing Nordic cross country: XE8CR\\nType of sport or exercise activity freestyle skiing: XE8UF\\nType of sport or exercise activity snow ski jumping: XE471\\nType of sport or exercise activity snowmobiling: XE240\\nType of sport or exercise activity snow boarding: XE7J0\\nType of sport or exercise activity speed skating: XE6RE\\nType of sport or exercise activity tobogganing: XE8G0\\nIndividual athletic activities: XE3L1\\nType of sport or exercise activity aerobic or callisthenics: XE286\\nType of sport or exercise activity jogging or running: XE5KC\\nType of sport or exercise activity tai chi: XE05C\\nType of sport or exercise activity track and field racing over obstacles or hurdles: XE1SW\\nType of sport or exercise activity track and field sprinting  metres: XE02A\\nType of sport or exercise activity track and field running middle distances  metres: XE2RC\\nType of sport or exercise activity track and field running long distances greater than  metres: XE4Y7\\nType of sport or exercise activity track and field high jump: XE1X1\\nType of sport or exercise activity track and field long jump: XE10W\\nType of sport or exercise activity track and field pole vault: XE8YM\\nType of sport or exercise activity track and field triple jump: XE5X4\\nType of sport or exercise activity track and field discus: XE4C5\\nType of sport or exercise activity track and field javelin: XE037\\nType of sport or exercise activity track and field hammer throw: XE1FT\\nType of sport or exercise activity track and field shot putt: XE3M7\\nType of sport or exercise activity walking: XE2TV\\nType of sport or exercise activity yoga or Pilates: XE7F9\\nType of sport or exercise activity stationary aerobic exercise with equipment: XE9V7\\nAcrobatic sports: XE4HZ\\nType of sport or exercise activity cheerleading: XE2T9\\nType of sport or exercise activity gymnastics balance beam: XE65D\\nType of sport or exercise activity gymnastics floor exercise or tumbling: XE5WY\\nType of sport or exercise activity gymnastics high bar: XE69D\\nType of sport or exercise activity gymnastics parallel bars: XE6R6\\nType of sport or exercise activity gymnastics rhythmic with or without props: XE4YF\\nType of sport or exercise activity gymnastics rings: XE8WK\\nType of sport or exercise activity gymnastics side horse or pommel horse: XE802\\nType of sport or exercise activity gymnastics trampoline or minitrampoline: XE8V7\\nType of sport or exercise activity gymnastics uneven parallel bars: XE5KU\\nType of sport or exercise activity gymnastics vault: XE7PU\\nAesthetic activities: XE9SK\\nType of sport or exercise activity dancing: XE6H2\\nType of sport or exercise activity marching: XE0R2\\nRacquet sports: XE0KE\\nType of sport or exercise activity badminton: XE3SV\\nType of sport or exercise activity racquetball: XE5Z7\\nType of sport or exercise activity squash: XE629\\nType of sport or exercise activity table tennis or pingpong: XE5JM\\nType of sport or exercise activity tennis: XE97B\\nTarget or precision sports: XE2NY\\nType of sport or exercise activity archery: XE0KA\\nType of sport or exercise activity bocce boules or petanque: XE760\\nType of sport or exercise activity billiards pool or snooker: XE5XX\\nType of sport or exercise activity lawn bowling: XE5VJ\\nType of sport or exercise activity croquet: XE8AU\\nType of sport or exercise activity darts: XE7NG\\nType of sport or exercise activity golf: XE416\\nType of sport or exercise activity tenpin bowling: XE6YY\\nType of sport or exercise activity firearm shooting: XE08Q\\nType of sport or exercise activity bb or pellet gun shooting: XE0HX\\nType of sport or exercise activity paintball gun shooting: XE1N9\\nCombative sports: XE3E4\\nType of sport or exercise activity aikido: XE7K5\\nType of sport or exercise activity boxing: XE8AB\\nType of sport or exercise activity fencing: XE4E3\\nType of sport or exercise activity judo: XE6B1\\nType of sport or exercise activity jujitsu: XE0U2\\nType of sport or exercise activity karate: XE567\\nType of sport or exercise activity kendo: XE8WT\\nType of sport or exercise activity kickboxing: XE0Y9\\nType of sport or exercise activity kung fu: XE5QV\\nType of sport or exercise activity tae kwon do: XE7RA\\nType of sport or exercise activity freestyle wrestling: XE0CG\\nType of sport or exercise activity GrecoRoman wrestling: XE8M6\\nType of sport or exercise activity professional wrestling entertainment style: XE4QQ\\nType of sport or exercise activity self defence training: XE75J\\nPower sports: XE1EU\\nType of sport or exercise activity power lifting: XE7QE\\nType of sport or exercise activity Olympic weightlifting: XE6RQ\\nType of sport or exercise activity strength training or body building: XE0N6\\nType of sport or exercise activity timberrelated sports: XE3PG\\nEquestrian activities: XE42Q\\nType of sport or exercise activity equestrian dressage: XE6DF\\nType of sport or exercise activity endurance riding: XE75K\\nType of sport or exercise activity equestrian eventing: XE8JM\\nType of sport or exercise activity mustering or stock work: XE0BK\\nType of sport or exercise activity equestrian polo or polocrosse: XE6PK\\nType of sport or exercise activity pony club: XE4GZ\\nType of sport or exercise activity horse racing: XE0P4\\nType of sport or exercise activity rodeo: XE56X\\nType of sport or exercise activity show jumping: XE7X5\\nType of sport or exercise activity equestrian steeplechase: XE7MC\\nType of sport or exercise activity trail or general horseback riding: XE1LH\\nType of sport or exercise activity equestrian trotting or harness: XE2LJ\\nAdventure sports: XE3T3\\nType of sport or exercise activity abseiling or rappelling: XE08U\\nType of sport or exercise activity hiking: XE5BS\\nType of sport or exercise activity mountaineering: XE79W\\nType of sport or exercise activity orienteering or rogaining: XE8WG\\nType of sport or exercise activity river rafting: XE2J8\\nType of sport or exercise activity rock climbing: XE6Z2\\nType of sport or exercise activity bungee jumping: XE74G\\nWheeled motor sports: XE85A\\nType of sport or exercise activity riding an allterrain vehicle ATV: XE7HV\\nType of sport or exercise activity motorcycling: XE1R5\\nType of sport or exercise activity motor car racing: XE26F\\nType of sport or exercise activity gocarting or carting: XE46F\\nType of sport or exercise activity motorised scootering: XE1MM\\nWheeled nonmotored sports: XE4DA\\nType of sport or exercise activity BMX cycling: XE5UJ\\nType of sport or exercise activity mountain cycling: XE4SS\\nType of sport or exercise activity road cycling: XE87G\\nType of sport or exercise activity track or velodrome cycling: XE8U6\\nType of sport or exercise activity cycling not otherwise specified: XE7MG\\ntype of sportexercise activity inline skatingrollerblading: XE5V9\\nType of sport or exercise activity roller skating: XE2DY\\nType of sport or exercise activity skate boarding: XE1AS\\nType of sport or exercise activity scootering: XE6X9\\nType of sport or exercise activity spinning or stationary bike riding: XE72X\\nType of sport or exercise activity street luge: XE78K\\nMultidiscipline sports: XE7BS\\nType of sport or exercise activity biathlon crosscountry skiing event: XE3BK\\nType of sport or exercise activity biathlon shooting event: XE05T\\nType of sport or exercise activity biathlon unspecified event: XE7ZX\\nType of sport or exercise activity decathlon  metre event: XE9AM\\nType of sport or exercise activity decathlon  metre hurdles event: XE5C1\\nType of sport or exercise activity decathlon long jump event: XE6CK\\nType of sport or exercise activity decathlon high jump event: XE331\\nType of sport or exercise activity decathlon shot put event: XE6GN\\nType of sport or exercise activity decathlon discus event: XE11Q\\nType of sport or exercise activity decathlon javelin event: XE37C\\nType of sport or exercise activity decathlon pole vault event: XE7LJ\\nType of sport or exercise activity decathlon unspecified event: XE48E\\nType of sport or exercise activity heptathlon  metre event: XE4CW\\nType of sport or exercise activity heptathlon  metre hurdles event: XE9EF\\nType of sport or exercise activity heptathlon high jump event: XE90J\\nType of sport or exercise activity heptathlon long jump event: XE8WE\\nType of sport or exercise activity heptathlon javelin event: XE7TG\\nType of sport or exercise activity heptathlon shot putt event: XE294\\nType of sport or exercise activity heptathlon unspecified event: XE1JE\\nType of sport or exercise activity modern pentathlon shooting event: XE3GA\\nType of sport or exercise activity modern pentathlon fencing event: XE758\\nType of sport or exercise activity modern pentathlon swimming event: XE7GA\\nType of sport or exercise activity modern pentathlon equestrian event: XE8KQ\\nType of sport or exercise activity modern pentathlon running event: XE84E\\nType of sport or exercise activity modern pentathlon unspecified event: XE2B4\\nType of sport or exercise activity triathlon cycling event: XE2XU\\nType of sport or exercise activity triathlon running event: XE0J9\\nType of sport or exercise activity triathlon swimming event: XE8ZK\\nType of sport or exercise activity triathlon unspecified event: XE01T\\nAero nonmotored sports: XE03W\\nType of sport or exercise activity aerobatics: XE34L\\nType of sport or exercise activity gliding: XE88Y\\nType of sport or exercise activity hang gliding: XE3VS\\ntype of sportexercise activity parachutingsky diving: XE0JU\\nType of sport or exercise activity paragliding or parasailing: XE06C\\nType of sport or exercise activity hot air ballooning: XE99S\\nOther schoolrelated recreational activities: XE68C\\nType of sport or exercise activity school physical education class: XE49T\\nType of sport or exercise activity school free play: XE67P\\nPhase of sport or exercise activity Training or practice: XE9ET\\nPhase of activity sportspecific or skillspecific practice: XE1U5\\nPhase of activity scrimmaging: XE07B\\nPhase of activity strength and conditioning or weight training: XE0BT\\nPhase of activity cardiovascular training: XE945\\nPhase of activity not otherwise specified training or practice: XE583\\nPhase of activity preevent: XE8MZ\\nPhase of activity warmup: XE2D1\\nPhase of sport or exercise activity Competition or participation: XE5TJ\\nPhase of activity competition or participation first  of expected event duration: XE66C\\nPhase of activity competition or participation middle  of expected event duration: XE0QY\\nPhase of activity competition or participation last  of expected event duration: XE2CG\\nPhase of activity competition or participation events whose time course can not be anticipated: XE20Y\\nPhase of activity competition or participation unspecified stage of the event: XE4ZN\\nPhase of activity cool down: XE1P9\\nPhase of activity postevent: XE2BD\\nPhase of activity recreational participation: XE49R\\nPhase of activity other specified phase of activity: XE0QV\\nUnspecified phase of activity: XE8ZT\\nPersonal countermeasures no protective devices used: XE4K4\\nPersonal countermeasures braces guards or orthoses: XE8Z8\\nPersonal countermeasures rigid taping of joint: XE75U\\nPersonal countermeasures padding of joint bony prominence or muscle: XE9TY\\nPersonal countermeasures thermal devices: XE10N\\nPersonal countermeasures splints: XE0LS\\nPersonal countermeasures jock strap or protective cup: XE16J\\nPersonal countermeasures gloves: XE4RU\\nPersonal countermeasures mouth guard: XE49L\\nPersonal countermeasures eye goggles or protective glasses: XE338\\nPersonal countermeasures helmet: XE2ZG\\nPersonal countermeasures face mask or shield: XE3RM\\nPersonal countermeasures foot wear: XE7K8\\nPersonal countermeasures personal flotation device: XE26E\\nEnvironmental countermeasures no protective devices used: XE3U8\\nEnvironmental countermeasures protective padding on competition surface: XE0DA\\nEnvironmental countermeasures padded goal posts or corner markers: XE0W0\\nEnvironmental countermeasures barrier between area of activity and spectators or surrounds: XE8UC\\nEnvironmental countermeasures safety restraints or vehicle restraints: XE0LL\\nEconomic activity agriculture hunting or forestry: XE7J2\\nEconomic activity fishing: XE227\\nEconomic activity mining quarrying or extraction: XE45Q\\nEconomic activity manufacturing: XE13G\\nEconomic activity electricity gas or water supply: XE6WE\\nEconomic activity construction: XE0SE\\nEconomic activity wholesale or retail trade: XE139\\nEconomic activity repair of motor vehicles motorcycles or personal and household goods: XE6J4\\nEconomic activity hotels or restaurants: XE4JS\\nEconomic activity transport storage or communications: XE5JN\\nEconomic activity financial intermediation: XE8A7\\nEconomic activity real estate renting or business activities: XE3YF\\nEconomic activity public administration defence or compulsory social security: XE3K1\\nEconomic activity providing education: XE54F\\nEconomic activity health or social work: XE0G4\\nEconomic activity other community social or personal service activities: XE7X1\\nEconomic activity private households with employed persons: XE2PM\\nEconomic activity extraterritorial organisations or bodies: XE6N7\\nOccupation legislators senior officials managers: XE3TU\\nOccupation professionals: XE59Y\\nOccupation technicians or associate professionals: XE558\\nOccupation clerks secretaries: XE17U\\nOccupation service workers shop and market sales workers: XE1CA\\nOccupation skilled agriculture or fishery workers: XE6TG\\nOccupation craft or related trades workers: XE0VC\\nOccupation plantmachine operators or assemblers: XE37Y\\nOccupation elementary occupations: XE4EE\\nOccupation armed forces: XE5G8\\nSpouse or partner: XE454\\nPerpetratorvictim relationship legal spouse: XE041\\nPerpetratorvictim relationship cohabiting partner: XE8JN\\nPerpetratorvictim relationship noncohabiting partner: XE8GZ\\nPerpetratorvictim relationship Exspouse: XE6Q9\\nPerpetratorvictim relationship Expartner: XE8TC\\nParent: XE8AA\\nPerpetratorvictim relationship father or mother: XE8QX\\nPerpetratorvictim relationship stepparent: XE9FD\\nOther relative: XE5WN\\nPerpetratorvictim relationship full sibling: XE9JY\\nperpetratorvictim relationship partial or half sibling: XE9RK\\nPerpetratorvictim relationship stepsibling: XE4KJ\\nPerpetratorvictim relationship grandparent: XE9S0\\nPerpetratorvictim relationship offspring: XE10C\\nPerpetratorvictim relationship other blood relative: XE8EU\\nPerpetratorvictim relationship inlaws: XE8FS\\nUnrelated care giver: XE4BG\\nPerpetratorvictim relationship foster parent: XE4BZ\\nPerpetratorvictim relationship care giver in institution: XE670\\nPerpetratorvictim relationship health care provider: XE02B\\nAcquaintance or friend: XE270\\nPerpetratorvictim relationship parents partner: XE1X5\\nPerpetratorvictim relationship date: XE7GT\\nPerpetratorvictim relationship roommate: XE6WK\\nPerpetratorvictim relationship business relation: XE6P9\\nPerpetratorvictim relationship neighbour: XE32X\\nPerpetratorvictim relationship institutional comember: XE80F\\nPerpetratorvictim relationship friend not otherwise specified: XE5MH\\nPerpetratorvictim relationship acquaintance not otherwise specified: XE39B\\nOfficial or legal authority: XE2HC\\nPerpetratorvictim relationship official or legal authority military: XE6AM\\nPerpetratorvictim relationship official or legal authority police: XE2Z7\\nPerpetratorvictim relationship national or official authority not otherwise specified: XE5ZT\\nPerpetratorvictim relationship security group not otherwise specified: XE8PB\\nPerpetratorvictim relationship official or legal authority civilian authority: XE59K\\nStranger: XE4WS\\nPerpetratorvictim relationship stranger in vigilante group: XE0CA\\nPerpetratorvictim relationship stranger in mob: XE7XG\\nPerpetratorvictim relationship stranger not otherwise specified: XE2XY\\nPerpetratorvictim relationship prisoner or detainee: XE0H2\\nPerpetratorvictim relationship person executing a felony or crime: XE3FJ\\nPerpetratorvictim relationship person interceding in a crime: XE388\\nGender of perpetrator male: XE5YG\\nGender of perpetrator female: XE56C\\nGender of perpetrator unknown: XE9SL\\nGender of perpetrator other: XE6W8\\nAltercation: XE0UM\\nAbout family issues: XE591\\nContext of assault altercation about family issues children: XE2RR\\nContext of assault altercation about family issues inlaws: XE37R\\nContext of assault altercation about family issues dowry issues: XE1B3\\nContext of assault altercation about family issues family honour: XE1F9\\nAbout personal issues: XE9SP\\nContext of assault altercation about current love relationship: XE1XB\\nContext of assault altercation about terminating a love relationship: XE3YH\\nContext of assault altercation about sex: XE6DB\\nAbout personallyheld views: XE4H5\\nContext of assault altercation about personallyheld views regarding politics: XE03X\\nContext of assault altercation about personallyheld views regarding religious or spiritual matters: XE860\\nContext of assault altercation about personallyheld views regarding cultural issues: XE1RW\\nContext of assault altercation about personallyheld views regarding racial or ethnic issues: XE6YL\\nContext of assault altercation about personallyheld views regarding issues of gender or sexual orientation: XE1Q8\\nAbout business or financial issues: XE0Z5\\nContext of assault altercation about loss of employment: XE4ML\\nContext of assault altercation about other financial losses related to employment or business: XE00W\\nContext of assault other employment disputes: XE05L\\nContext of assault altercation about money or property: XE62S\\nAbout sports and other leisure: XE6VD\\nContext of assault altercation about gambling: XE81U\\nContext of assault altercation about sports: XE47F\\nContext of assault altercation about traffic: XE8NL\\nContext of assault malicious misconduct: XE4XA\\nContext of assault bullying intimidation: XE4P2\\nContext of assault altercation about past altercation: XE3KE\\nIllegal acquisition or attempted illegal acquisition of money or property: XE91G\\nContext of assault burglary: XE0LR\\nRobbery: XE6PL\\nContext of assault unarmed robbery: XE6YM\\nContext of assault armed robbery: XE989\\nDrugrelated incident: XE933\\nContext of assault selling drugs or drug business: XE5AY\\nContext of assault argument over possession use or cost of drugs: XE0Z6\\nContext of assault failure to pay a drug debt: XE1GC\\nContext of assault probable drug involvement but no positive evidence: XE1LL\\nContext of assault sexual assault: XE213\\nContext of assault rape or attempted rape: XE6U2\\nContext of assault sodomy or attempted sodomy: XE85Q\\nContext of assault touching or fondling of genitals: XE29Q\\nContext of assault oral sex: XE18N\\nGangrelated incident: XE8DB\\nContext of assault gang initiation: XE3QM\\nContext of assault gang rivalry: XE2A5\\nOther criminal activity: XE3V7\\nContext of assault blackmail: XE2QF\\nContext of assault kidnapping: XE1N7\\nContext of assault contract injuring or killing: XE0NB\\nContext of assault driveby shooting: XE5A7\\nOther specified context of assault: XE5QX\\nContext of assault retaliation or revenge: XE6FN\\nContext of assault mercy killing or euthanasia: XE3G0\\nContext of assault neglect: XE90G\\nContext of assault torture: XE580\\nContext of assault additional context mistaken identity: XE92U\\nConflict in relationship with family member partner or friend: XE17Z\\nProximal risk factors for intentional selfharm Conflict in relationship with spouse partner boygirlfriend: XE9SZ\\nProximal risk factors for intentional selfharm Conflict in relationship with parent: XE6QA\\nProximal risk factors for intentional selfharm Conflict in relationship with offspring: XE1A1\\nDeath of a relative partner or friend: XE3GP\\nProximal risk factors for intentional selfharm Suicide of a relative partner or friend: XE19R\\nProximal risk factors for intentional selfharm Other manner of death of a relative partner or friend: XE8T3\\nProximal risk factors for intentional selfharm Unspecified manner of death of a relative partner or friend: XE2FT\\nPhysical problem: XE97R\\nProximal risk factors for intentional selfharm HIV or AIDS: XE5CU\\nProximal risk factors for intentional selfharm Unwanted pregnancy: XE3AG\\nMental condition: XE6XD\\nProximal risk factors for intentional selfharm Substance abuse: XE2Q7\\nProximal risk factors for intentional selfharm Postpartum depression: XE79G\\nIncomerelated or financial problem: XE3U9\\nProximal risk factors for intentional selfharm Workrelated: XE70C\\nProximal risk factors for intentional selfharm Dowry: XE4UX\\nAbuse: XE5J3\\nProximal risk factors for intentional selfharm Sexual abuse: XE8HX\\nProximal risk factors for intentional selfharm Physical abuse: XE8ND\\nProximal risk factors for intentional selfharm Neglect: XE2RX\\nProximal risk factors for intentional selfharm Legal system encounters: XE31V\\nProximal risk factors for intentional selfharm Schoolrelated problem: XE8MK\\nProximal risk factors for intentional selfharm Religious belief or affiliation: XE98Q\\nProximal risk factors for intentional selfharm Cultural issue: XE6TW\\nPrevious suicide attempt No: XE76W\\nPrevious suicide attempt Yes: XE3YR\\nIntentional selfharm person intended to die: XE97V\\nIntentional selfharm person did not intend to die: XE5D6\\nIntentional selfharm not known or not determined if person intended to die: XE2SF\\nType of conflict civil war or guerrilla operation: XE2RB\\nType of conflict war: XE324\\nType of conflict declared terrorism: XE4RJ\\nType of conflict civil insurrection: XE0EG\\nType of conflict postconflict incident: XE7HW\\nMilitary personnel: XE42H\\nCivilian: XE2WZ\\nRole of injured person in armed conflict unknown: XE3P0\\nPotential arrest situation: XE52B\\nType of legal intervention potential arrest related traffic pursuit: XE9JF\\nType of legal intervention potential arrest related investigation of a suspicious person or incident: XE25D\\nType of legal intervention potential arrest related execution of an arrest: XE3XD\\nResponse to a disturbance call: XE8Z9\\nType of legal intervention response to a disturbance call because of a family dispute: XE84H\\nType of legal intervention response to a disturbance call because of a person behaving aberrantly: XE8WD\\nType of legal intervention response to other specified disturbance call: XE3FV\\nType of legal intervention response to unspecified disturbance call: XE439\\nType of legal intervention ambush situation: XE8M2\\nType of legal intervention civil disorder: XE1DD\\nType of legal intervention handling transporting or custody of prisoner: XE0RZ\\nType of legal intervention execution of a legal sentence: XE7AT\\nPatient device interaction problem: XE4HK\\nPatientdevice incompatibility: XE6GS\\nBiocompatibility: XE7ZE\\nDevice appears to trigger rejection: XE2CL\\nInadequacy of device shape or size: XE584\\nOsseointegration problem: XE7JV\\nFailure to osseointegrate: XE94Z\\nLoss of osseointegration: XE0Z9\\nLoosening of implant not related to boneingrowth: XE2K9\\nMigration or expulsion of device: XE0VD\\nMigration of device: XE763\\nExpulsion of device: XE1FH\\nManufacturing packaging or shipping problem: XE7Q8\\nProduct quality problem: XE5Y1\\nDull or blunt: XE4UR\\nNonstandard device: XE46G\\nDefective component: XE1K1\\nDefective device: XE9CD\\nDevice damaged prior to use: XE12L\\nPackaging problem: XE8RY\\nDifficult to open or remove packaging material: XE01Z\\nIncomplete or missing packaging: XE5YH\\nUnsealed device packaging: XE4VM\\nTear rip or hole in device packaging: XE2AN\\nDevice misassembled during manufacturing or shipping: XE151\\nComponent misassembled: XE9R8\\nComponent missing: XE89V\\nShipping damage or problem: XE8ZA\\nDelivered as unsterile product: XE78P\\nChemical problem: XE52X\\nDevice emits odour: XE9AC\\nDevice ingredient or reagent problem: XE3E0\\nClumping in device or device ingredient: XE4BC\\nCoagulation in device or device ingredient: XE49W\\nPrecipitate in device or device ingredient: XE4VP\\nCross reactivity: XE8Z6\\nParticulates: XE0VB\\nHigh pH: XE0K7\\nLow pH: XE657\\nImproper chemical reaction: XE6E7\\nMaterial integrity problem: XE4LP\\nBreak: XE8D2\\nFracture of device: XE1M6\\nLoss of or failure to bond: XE9DU\\nMaterial fragmentation: XE2ET\\nSolder joint fracture: XE82N\\nBurst container or vessel: XE638\\nExplosion: XE5EZ\\nCrack: XE38M\\nDegraded: XE0HB\\nCalcified: XE8J3\\nCorroded: XE228\\nMaterial erosion: XE1WE\\nPitted: XE9F6\\nFlaked: XE0YK\\nPeeled or delaminated: XE3VG\\nNaturally worn: XE975\\nUnraveled material: XE9JW\\nMaterial deformation: XE1LJ\\nDeformation due to compressive stress: XE0JB\\nDent in material: XE5NT\\nFailure to fold: XE0ZV\\nFailure to unfold or unwrap: XE06Q\\nMaterial frayed: XE37M\\nMaterial invagination: XE8PS\\nMaterial too rigid or stiff: XE4Z7\\nMaterial too soft or flexible: XE9WH\\nMaterial twisted or bent: XE47S\\nMelted: XE8ZQ\\nStretched: XE5D0\\nMaterial discoloured: XE2G9\\nMaterial disintegration: XE0RF\\nMaterial opacification: XE585\\nMaterial perforation: XE9AR\\nMaterial puncture or hole: XE0X4\\nMaterial protrusion or extrusion: XE72S\\nMaterial rupture: XE6G0\\nMaterial separation: XE6K7\\nMaterial split cut or torn: XE4FP\\nScratched material: XE609\\nMechanical problem: XE2GF\\nDetachment of device or device component: XE2CM\\nDevice damaged by another device: XE634\\nEjection problem: XE7NX\\nFailure to eject: XE0VZ\\nUnintended ejection: XE1PM\\nLeak or splash: XE944\\nFluid leak: XE2ZY\\nGas leak: XE0RV\\nGel leak: XE53W\\nRadiation leak: XE0B1\\nPerivalvular leak: XE2JE\\nFiring problem: XE1RJ\\nFailure to fire: XE666\\nMisfire: XE5P4\\nMechanical jam: XE88N\\nMechanics altered: XE279\\nFailure to align: XE7KY\\nFailure to cut: XE0XR\\nFailure to cycle: XE23L\\nFailure to form staple: XE289\\nNoise audible: XE4F9\\nPhysical resistance or sticking: XE635\\nRetraction problem: XE306\\nStructural problem: XE79Q\\nStructural collapse: XE8H1\\nSharp edges: XE3VF\\nDifficult to fold or unfold: XE8ZX\\nDifficult to open or close: XE2EV\\nIncomplete coaptation: XE3UJ\\nUnintended movement: XE8ZZ\\nDevice dislodged or dislocated: XE6KT\\nDevice tipped over: XE78C\\nDevice fell: XE5JJ\\nDevice slipped: XE1Q1\\nUnintended collision of device: XE0QZ\\nUnintended system motion: XE1Y1\\nUnstable device: XE5CH\\nVibration of device: XE76A\\nOptical problem: XE941\\nMisfocusing: XE5CX\\nOptical decentration: XE4W1\\nOptical discolouration: XE1VT\\nOptical distortion: XE4BE\\nOptical obstruction: XE93N\\nOutput problem: XE28Y\\nAudible prompt or feedback: XE8NW\\nInappropriate audible prompt or feedback: XE0WU\\nInaudible or unclear audible prompt or feedback: XE487\\nNo audible prompt or feedback: XE8MP\\nDisplay or visual feedback problem: XE2S2\\nDevice displays incorrect message: XE4TX\\nDisplay difficult to read: XE2NW\\nErratic or intermittent display: XE2ES\\nImage display error or artifact: XE7T8\\nImage orientation incorrect: XE2V3\\nNo display or image: XE5Q5\\nNo visual prompts or feedback: XE4FQ\\nPoor quality image: XE5XP\\nVisual prompts will not clear: XE1C5\\nTactile prompts or feedback: XE7Z4\\nInappropriate tactile prompt or feedback: XE6CE\\nNo tactile prompts or feedback: XE963\\nEnergy output problem: XE0KH\\nEnergy spectrum incorrect: XE7ST\\nFailure to deliver energy: XE5PU\\nIntermittent energy output: XE538\\nOutput above specifications: XE81P\\nOutput below specifications: XE8XC\\nTherapeutic or diagnostic output failure: XE2MC\\nTherapy delivered to incorrect body area: XE1US\\nRadiation output problem: XE1ED\\nRadiation output failure: XE5F0\\nRadiation overexposure: XE0JA\\nRadiation underexposure: XE74E\\nUnexpected or unintended radiation output: XE6UD\\nGas output problem: XE68Z\\nNo device output: XE7E5\\nIncorrect inadequate or imprecise result or readings: XE4BB\\nSignal artifact: XE7TS\\nFailure to obtain sample: XE3MS\\nFalse negative result: XE2E8\\nFalse positive result: XE9K2\\nIncorrect measurement: XE3XG\\nNonreproducible results: XE5E8\\nHigh readings: XE9D6\\nLow readings: XE5KE\\nHigh test results: XE485\\nLow test results: XE8EM\\nUnable to obtain readings: XE8YH\\nMissing test results: XE56S\\nUnexpected therapeutic results: XE3YZ\\nElectrical or electronic property problem: XE16C\\nCapturing problem: XE57L\\nFailure to capture: XE0UH\\nHigh capture threshold: XE18Z\\nIntermittent capture: XE1T0\\nUnstable capture threshold: XE350\\nContinuous firing: XE4QC\\nArcing: XE4HP\\nArcing at paddles: XE4X8\\nArcing of electrodes: XE7KZ\\nSparking: XE2SR\\nBattery problem: XE16Z\\nBattery problem with high impedance: XE2MD\\nBattery problem with low impedance: XE41Q\\nFailure to run on battery: XE548\\nPremature discharge of battery: XE5U8\\nCharging problem: XE5ER\\nAborted charge: XE6QY\\nDelayed charge time: XE67U\\nFailure to charge: XE5PM\\nFailure to discharge: XE8DT\\nPower problem: XE2B3\\nComplete loss of power: XE1DB\\nIntermittent loss of power: XE2A6\\nFailure to power up: XE38R\\nUnintended power up: XE7Z7\\nDevice sensing problem: XE0Q2\\nDecreased sensitivity: XE6SM\\nIncreased sensitivity: XE7QR\\nFailure to analyze signal: XE8H3\\nFailure to select signal: XE0K3\\nHigh sensing threshold: XE6H7\\nLow sensing threshold: XE2P7\\nLoss of threshold: XE9TK\\nFailure to sense: XE210\\nOversensing: XE02C\\nUndersensing: XE73Q\\nSensing intermittently: XE69X\\nIncorrect interpretation of signal: XE28F\\nFailure to conduct: XE22D\\nInterrogation problem: XE8S0\\nDifficult to interrogate: XE9HR\\nFailure to interrogate: XE3PE\\nPacing problem: XE8HJ\\nFailure to convert rhythm: XE19S\\nInaccurate synchronization: XE47M\\nInappropriate waveform: XE2LL\\nNo pacing: XE9A9\\nPacemaker found in backup mode: XE281\\nPacing asynchronously: XE13R\\nPacing inadequately: XE10M\\nPacing intermittently: XE1SU\\nPocket stimulation: XE99K\\nDefibrillation problem: XE440\\nFailure to deliver shock: XE12S\\nInappropriate shock: XE6T0\\nIntermittent shock: XE8BU\\nUnintended electrical shock: XE739\\nGrounding malfunction: XE9QT\\nElectrical overstress: XE3S7\\nElectrostatic discharge: XE268\\nFailure to shut off: XE20P\\nUnexpected shutdown: XE7JN\\nElectromagnetic compatibility problem: XE4PR\\nCircuit failure: XE5FA\\nImpedance problem: XE6ZB\\nCalibration problem: XE55U\\nFailure to calibrate: XE6GR\\nFailure to recalibrate: XE8MT\\nImprecision: XE7H5\\nOvercorrection: XE1WU\\nTemperature problem: XE586\\nExcessive cooling: XE9C7\\nExcessive heating: XE77H\\nInsufficient cooling: XE200\\nInsufficient heating: XE2A4\\nOverheating of device: XE14Q\\nThermal decomposition of device: XE6DP\\nFire: XE5T3\\nFlare or flash: XE03F\\nSmoke: XE5H5\\nComputer software problem: XE85E\\nApplication network problem: XE6PS\\nApplication program problem: XE8HP\\nApplication program freezes or becomes nonfunctional: XE5YA\\nApplication program problem dose calculation error: XE46R\\nApplication program problem medication error: XE09U\\nApplication program problem parameter calculation error: XE2BJ\\nApplication program problem power calculation error: XE6SW\\nApplication program version or upgrade problem: XE2CW\\nProblem with software installation: XE5CT\\nUnintended application program shutdown: XE842\\nProgram or algorithm execution problem: XE1HG\\nDelayed program or algorithm execution: XE87N\\nIntermittent program or algorithm execution: XE1WW\\nProgram or algorithm execution failure: XE0UN\\nComputer operating system problem: XE4Z0\\nOperating system becomes nonfunctional: XE5F1\\nOperating system version or upgrade problem: XE6VL\\nComputer system security problem: XE5EP\\nApplication security problem: XE9XK\\nUnauthorized access to computer system: XE15X\\nData backup problem: XE2ZM\\nFailure to back up: XE72G\\nFailure to convert to backup: XE8PZ\\nData problem: XE99Y\\nLoss of data: XE992\\nPatient data problem: XE7BE\\nDate or time related software problem: XE048\\nConnection problem: XE3UR\\nBlocked connection: XE9D0\\nDecoupling: XE74X\\nDisconnection: XE5WZ\\nFailure to disconnect: XE9HJ\\nLoose or intermittent connection: XE3G6\\nMisconnection: XE0WB\\nIncomplete or inadequate connection: XE4C0\\nFitting problem: XE0P9\\nCommunication or transmission problem: XE0JD\\nFailure to read input signal: XE3EG\\nFailure to transmit record: XE0V5\\nIntermittent communication failure: XE4JX\\nTelemetry discrepancy: XE5H8\\nWireless communication problem: XE4YY\\nInfusion or flow problem: XE7NV\\nDeflation problem: XE4VT\\nExcess flow or overinfusion: XE6YH\\nFilling problem: XE49K\\nInability to autofill: XE3T4\\nOverfill: XE97E\\nShort fill: XE8RE\\nVolume accuracy problem: XE1QQ\\nFiltration problem: XE2YK\\nInadequate filtration process: XE3VH\\nInadequate ultra filtration: XE4UN\\nImproper flow or infusion: XE1H4\\nBackflow: XE9RA\\nFree or unrestricted flow: XE447\\nGradient increase: XE628\\nInaccurate delivery: XE667\\nInaccurate flow rate: XE44F\\nIntermittent infusion: XE2DM\\nReflux with device: XE09Q\\nRestricted flow rate: XE8AY\\nTidal volume fluctuations: XE1V7\\nInflation problem: XE5GY\\nInsufficient flow or under infusion: XE1S7\\nNo flow: XE1Y3\\nFailure to deliver flow: XE94H\\nFailure to infuse: XE1JK\\nInability to irrigate: XE8L2\\nObstruction of flow: XE3GX\\nComplete blockage: XE3QL\\nPartial blockage: XE2JF\\nDifficult to flush: XE6BM\\nPressure problem: XE8Z5\\nDecrease in pressure: XE3XR\\nIncrease in pressure of device: XE6S6\\nNo pressure: XE94J\\nPumping problem: XE6Z5\\nDecreased pump speed: XE64X\\nIncreased pump speed: XE7BN\\nFailure to pump: XE5R0\\nPumping stopped: XE0TF\\nSuction problem: XE69E\\nDecrease in suction: XE3Y3\\nIncrease in suction: XE35T\\nSuction failure: XE5FE\\nPriming problem: XE0B4\\nFailure to prime: XE3KR\\nIncomplete or inadequate priming: XE63F\\nActivation positioning or separation problem: XE4GH\\nActivation problem: XE76U\\nActivation failure or expansion failures: XE48N\\nDifficult or delayed activation: XE9Y0\\nPremature activation: XE6E9\\nSelfactivation or keying: XE5VT\\nPositioning problem: XE2J9\\nPositioning failure: XE41N\\nMalposition of device: XE8P2\\nDifficult or delayed positioning: XE74U\\nFailure to advance: XE4CG\\nDifficult to advance: XE9NU\\nDifficult to insert: XE2JZ\\nDifficult to remove: XE0HC\\nEntrapment of device: XE9MQ\\nSeparation problem: XE1KB\\nSeparation failure: XE9BM\\nDifficult or delayed separation: XE6U9\\nPremature separation of device: XE1TT\\nProtective measures problem: XE1XC\\nDevice alarm system: XE98H\\nAlarm not visible: XE5JP\\nNo audible alarm: XE6DH\\nLow audible alarm: XE2RK\\nDelayed alarm: XE3QU\\nFalse alarm: XE2K0\\nDefective alarm: XE3UE\\nFailsafe problem: XE78D\\nFailsafe did not activate: XE659\\nNo failsafe mechanism: XE6VE\\nFailure of device to selftest: XE3V3\\nFailure to auto stop: XE16Y\\nReset problem: XE4KE\\nFailure to reset: XE59S\\nFailure to zero: XE0HZ\\nInappropriate or unexpected reset: XE2T4\\nPremature indicator activation: XE1H0\\nPremature elective replacement indicator: XE6KH\\nPremature endoflife indicator: XE6ND\\nShielding failure: XE4PS\\nCompatibility problem: XE452\\nComponent or accessory incompatibility: XE02E\\nAccessory incompatible: XE7N5\\nComponent incompatible: XE1UE\\nDevicedevice incompatibility: XE8KS\\nMeasurement system incompatibility: XE0HJ\\nUnintended compatibility: XE4UP\\nContamination or decontamination problem: XE4XW\\nContamination during use: XE9L2\\nBiofilm coating in device: XE9H4\\nContamination of device ingredient or reagent: XE2AR\\nDevice contamination with body fluid: XE4VF\\nDevice contamination with chemical or other material: XE9AH\\nMicrobial contamination of device: XE97G\\nDevice contaminated during manufacture or shipping: XE450\\nDevice reprocessing problem: XE5LK\\nFailure to clean adequately: XE3MN\\nFailure to disinfect: XE4A4\\nFlushing problem: XE0VE\\nProblem with sterilisation: XE2LR\\nResidue after decontamination: XE0HG\\nEnvironmental compatibility problem: XE6K5\\nAmbient noise problem: XE027\\nAmbient temperature problem: XE5R1\\nFumes or vapours as environmental compatibility problem: XE50X\\nFungus in device environment: XE011\\nMoisture or humidity problem: XE8HD\\nVentilation problem in device environment: XE7KA\\nDevice unsafe to use in environment: XE5NF\\nEnvironmental particulates: XE55E\\nMedical gas supply problem: XE6V9\\nElectrical power problem: XE5ZE\\nInstallation related problem: XE2H3\\nMisassembled during installation: XE36N\\nLabelling instructions for use or training problem: XE3J4\\nDevice markings or labelling problem: XE23E\\nLack of maintenance documentation or guidelines: XE25T\\nInadequate instructions for healthcare professional: XE13S\\nInadequate instructions for nonhealthcare professional: XE17P\\nInadequate or insufficient training: XE22G\\nHumandevice interface problem: XE5DG\\nDevice difficult to set up or prepare: XE1C2\\nDevice difficult to program or calibrate: XE3B8\\nDevice difficult to maintain: XE2N3\\nInadequate user interface: XE35S\\nUse of device problem: XE0AG\\nDevice handling problem: XE6PE\\nUse of incorrect control settings: XE7S3\\nImproper or incorrect procedure or method: XE2XZ\\nOfflabel use: XE7VD\\nMisassembled: XE61V\\nAdverse event without identified device or use problem: XE3GL\\nNo apparent adverse event: XE3DN\\nAppropriate term or code not available for aspects of incidents related to devices: XE1W0\\nCause traced to device design: XE1UR\\nCause traced to component failure: XE7NC\\nCause traced to manufacturing: XE2TX\\nCause traced to transport or storage: XE18E\\nCause traced to infrastructure: XE7NN\\nCause traced to environment: XE1WV\\nCause traced to maintenance: XE5AS\\nCause traced to training: XE5UX\\nCause traced to labeling: XE674\\nCause cannot be traced to device: XE5BM\\nCause traced to user: XE6LX\\nKnown inherent risk of device: XE0QB\\nFalsified device: XE8UG\\nNo problem with device detected: XE51D\\nCause of problem with device not established: XE2SY\\nConclusion not yet available regarding problem with device: XE0T3\\nBiological problem with device identified: XE0WX\\nBiocompatibility problem with device identified: XE5T0\\nBiological contamination of device: XE4YZ\\nMaterial or material leachate pyrogenic problem with device identified: XE7B7\\nCytotoxicity problem with device identified: XE2RY\\nGenotoxicity problem with device identified: XE2PA\\nHematological problem with device identified: XE7AM\\nUnintended presence of allergens in device identified: XE1Y9\\nReproductive toxicity problem with device identified: XE2XW\\nElectrical problem with device identified: XE4CB\\nElectrical or electronic component problem with device identified: XE1YA\\nHardware timing problem with device identified: XE53K\\nImpedance problem with device identified: XE546\\nInsulation problem with device identified: XE1TX\\nOpen circuit in device: XE4PP\\nCurrent leakage problem of device identified: XE2V6\\nPower source problem identified in device: XE0KB\\nEnergy storage system problem in device: XE4ZM\\nLoss of power to device: XE2WJ\\nPower fluctuation in device: XE7RB\\nShort circuit of device: XE7AB\\nSignal loss of device: XE8KR\\nElectromagnetic compatibility problem with device identified: XE6AQ\\nConducted interference with device: XE6BD\\nElectrostatic discharge of device: XE8P9\\nInadequate immunity of device: XE2ME\\nUnintended emission of device: XE8TZ\\nRadiofrequency interference with device identified: XE1LT\\nInteroperability problem with device identified: XE02N\\nCommunications problem with device identified: XE6C8\\nWired communication problem with device identified: XE22K\\nWireless communication problem with device identified: XE1PD\\nNetwork communication problem with device identified: XE5NA\\nIncompatible component or accessory of device identified: XE1SP\\nLabeling and instructions for use or maintenance of device problem identified: XE1YT\\nInadequate labelling or instructions for use of device identified: XE3PV\\nIncorrect labelling or instructions for use of device identified: XE4MR\\nInadequate or incorrect instructions for maintenance of device identified: XE7Y7\\nMaterial or chemical problem with device identified: XE3RW\\nDegradation problem identified with device: XE2H0\\nInappropriate material identified in device: XE2WT\\nInadequate physicochemical properties identified in device: XE60T\\nIncompatible material identified in device: XE4EB\\nReactivity problem identified with device: XE25Z\\nTolerance stackup identified in device: XE6U0\\nMechanical problem with device identified: XE640\\nDevice migration identified: XE8RU\\nFriction problem identified with device: XE3HZ\\nLeakage or seal problem identified with device: XE1P8\\nLubrication problem identified with device: XE6UT\\nStiffness problem identified with device: XE69Q\\nStress problem with device identified: XE8V5\\nDeformation problem with device identified: XE0WG\\nFatigue problem with device identified: XE3Y4\\nFracture problem with device identified: XE1ZP\\nMechanical shock problem with device identified: XE1UJ\\nVibration problem with device identified: XE1H3\\nWear problem with device identified: XE1ZQ\\nIncorrect dimension of device identified: XE1EJ\\nOptical problem with device identified: XE4KN\\nOptical transmission problem identified with device: XE42B\\nLight source problem identified with device: XE8XT\\nClinical imaging problem with device identified: XE05W\\nGradient induced field problem with device identified: XE15N\\nImage artifact identified in device: XE1HK\\nMagneticallyinduced movement of device identified: XE6YW\\nRadiofrequency induced overheating of device identified: XE9Y9\\nSoftware problem with device identified: XE6TE\\nConfiguration issue of device identified: XE77W\\nDesign error of device identified: XE6DT\\nData compression error in device identified: XE006\\nIncorrect algorithm in device identified: XE62E\\nIncorrect data definition in device identified: XE1X4\\nInterface design error of device identified: XE2FL\\nNonfunctional defect in device identified: XE85U\\nSoftware timing problem in device identified: XE3RD\\nSoftware maintenance problem identified with device: XE9JR\\nSoftware installation problem identified with device: XE688\\nSoftware requirement error with device identified: XE4SV\\nSoftware runtime error in device identified: XE51Q\\nSoftware security vulnerability of device identified: XE9W2\\nErroneous data transfer in device identified: XE1KR\\nData storage or loss of data problem in device identified: XE2A7\\nThermal problem with device identified: XE8XM\\nOverheating of device problem identified: XE62G\\nExcessive heating of device problem identified: XE9HT\\nInadequate cooling of device problem identified: XE7A1\\nProtective system problem with device identified: XE5HU\\nFailsafe problem with device identified: XE0WJ\\nAlarm system problem with device identified: XE4JQ\\nProblem of device to selftest identified: XE7ZT\\nProblem of device to auto stop identified: XE1JG\\nReset problem with device identified: XE9AV\\nPremature indicator activation problem identified: XE2FY\\nShielding problem with device identified: XE3BG\\nMissing or inadequate safety measures of device identified: XE0M6\\nOperational problem with device identified: XE82X\\nDevice incorrectly reprocessed: XE5RS\\nDevice incorrectly cleaned during reprocessing identified: XE2RQ\\nDevice incorrectly disinfected or sterilised during reprocessing identified: XE63T\\nDevice incorrectly assembled during reprocessing identified: XE0TU\\nFailure to calibrate problem identified: XE15Q\\nDevice difficult to operate problem identified: XE3W1\\nIncorrect interpretation of results or data problem identified: XE2QD\\nPatient sample problem with device identified: XE2YD\\nNew or unknown interferent problem with device identified: XE8DL\\nKnown interferent problem with device identified: XE9C0\\nPreanalytical handling problem with device identified: XE83B\\nEnvironment problem with device identified: XE3AL\\nEnvironmental temperature problem with device identified: XE5K2\\nDust or dirt problem with device identified: XE9HK\\nContamination of environment by device identified: XE2VF\\nEnvironmental pressure problem with device identified: XE6QW\\nAmbient light problem with device identified: XE5SF\\nEnvironmental humidity problem with device identified: XE4V1\\nManufacturing process problem with device identified: XE205\\nAssembly problem with device identified: XE3NF\\nSterilization problem with device identified: XE00F\\nInstallation problem with device identified: XE1PG\\nMaintenance of manufacturing machinery problem with device identified: XE843\\nPackaging problem with device identified: XE278\\nPackaging of device compromised problem identified: XE9F7\\nPackaging materials of device problem identified: XE0KG\\nPackaging of device contains unintended material problem identified: XE8S1\\nPackaging contains incorrect device problem identified: XE8TA\\nMaintenance problem with device identified: XE6LZ\\nTransport or storage problem with device identified: XE9VK\\nStorage of device problem identified: XE32G\\nNo device problem found: XE41R\\nNo findings available: XE587\\nResults pending completion of investigation: XE3PA\\nAppropriate term or code for investigation of device not available: XE3WR\\nTesting of actual or suspected device: XE9HD\\nTesting of device from same lot or batch retained by manufacturer: XE7XH\\nTesting of device from same lot batch returned from user: XE4S0\\nTesting of device from other lot batch retained by manufacturer: XE2ZR\\nTesting of device from other lot or batch returned from user: XE4X1\\nTesting of model variant: XE1XT\\nTesting of raw or starting materials: XE8XV\\nTesting of patient sample or reference material using manufacturers device: XE6FS\\nTesting of patient sample or reference material using reference method: XE9MY\\nTesting of patient sample or reference material using competitors device: XE89L\\nHistorical data analysis: XE8UH\\nTrend analysis: XE8BM\\nCommunication or interviews: XE7GK\\nAnalysis of production records: XE4KV\\nAnalysis of data provided by user or third party: XE59M\\nDevice not manufactured by reporting manufacturer: XE8FB\\nDevice not returned: XE970\\nDevice discarded: XE18W\\nIncomplete device returned: XE5AN\\nDevice not accessible for testing: XE53L\\nType of investigation not yet determined: XE6Q2\\nInsufficient information available: XE3TW\\nAbsorber component of medical device: XE8XD\\nCautery tip component of medical device: XE6Z7\\nDevice ingredient or reagent component of medical device: XE7JR\\nGas scavenging component of medical device: XE8HT\\nMonomer liquid component of medical device: XE4VK\\nTest strip component of medical device: XE68H\\nPolymer powder component of medical device: XE7WP\\nAntenna component of medical device: XE321\\nBattery component of medical device: XE3WM\\nBattery charger component of medical device: XE80Z\\nCable electrical component of medical device: XE7JQ\\nCable grip component of medical device: XE77B\\nCable sleeve component of medical device: XE2BS\\nCircuit board component of medical device: XE2WY\\nCircuit breaker component of medical device: XE5BT\\nComputer hardware component of medical device: XE2ZE\\nComputer processor component of medical device: XE3Q8\\nMemory or storage component of medical device: XE1JS\\nNetwork interface component of medical device: XE2YC\\nComputer software component of medical device: XE8UU\\nComputer software driver component of medical device: XE59Z\\nSoftware interface component of medical device: XE2JQ\\nUser interface component of medical device: XE8V6\\nCooling module component of medical device: XE7P0\\nDevice programmer component of medical device: XE8UV\\nDevice reader component of medical device: XE033\\nDiscrete electrical component of medical device: XE6UE\\nElectrical capacitor component of medical device: XE845\\nElectrical fuse component of medical device: XE38E\\nElectrical inductor component of medical device: XE1UQ\\nElectrical resistor component of medical device: XE2AJ\\nElectrical solenoid component of medical device: XE4VJ\\nElectrical transducer component of medical device: XE018\\nElectrical semiconductor component of medical device: XE27R\\nIntegrated circuit chip component of medical device: XE9ZW\\nDisplay component of medical device: XE8GY\\nDisplay indicator component of medical device: XE4YD\\nDisplay screen component of medical device: XE2JV\\nElectrical lead or wire component of medical device: XE59E\\nElectrode component of medical device: XE5U9\\nGround strap or wire component of medical device: XE561\\nWiring harness component of medical device: XE753\\nElectrical mixer component of medical device: XE6S4\\nElectrical port component of medical device: XE0Y5\\nEmitter component of medical device: XE2PX\\nHeadphone or headset component of medical device: XE5GC\\nHeater component of medical device: XE9TB\\nHub component of medical device: XE713\\nInverter component of medical device: XE8JV\\nMagnet component of medical device: XE4BN\\nOscillator component of medical device: XE7YS\\nPatient lead component of medical device: XE525\\nLead conductor component of medical device: XE7F1\\nPatient electrode component of medical device: XE25C\\nPower cord component of medical device: XE4XJ\\nPower supply component of medical device: XE4Q4\\nPressure transducer probe component of medical device: XE7EJ\\nPrinter component of medical device: XE062\\nReceiver component of medical device: XE2KA\\nReceiver stimulator unit component of medical device: XE6SG\\nScanner component of medical device: XE4TH\\nSpeaker or sounder component of medical device: XE0ST\\nSwitch or relay component of medical device: XE5R5\\nPower switch component of medical device: XE1EF\\nRelay component of medical device: XE4QR\\nTelemetry component of medical device: XE884\\nTemperature compensator component of medical device: XE30P\\nThermostat component of medical device: XE56F\\nTransformer component of medical device: XE256\\nTransmitter component of medical device: XE579\\nUser input device component of medical device: XE5A0\\nJoystick component of medical device: XE9TZ\\nKeyboard or keypad component of medical device: XE6CN\\nMicrophone component of medical device: XE9FY\\nTouchscreen component of medical device: XE9ZJ\\nAnalyzer component of medical device: XE37A\\nOxygen analyzer component of medical device: XE0A7\\nAperture component of medical device: XE6E8\\nCalibrator component of medical device: XE34X\\nClock component of medical device: XE06B\\nCounter component of medical device: XE9NB\\nCurvette component of medical device: XE20X\\nGauges or meters component of medical device: XE00B\\nFlowmeter component of medical device: XE1WJ\\nManometer component of medical device: XE6V2\\nThermometer component of medical device: XE019\\nMarker component of medical device: XE8RD\\nPipette component of medical device: XE7MS\\nPointer component of medical device: XE5UB\\nScale component of medical device: XE2MH\\nSensor component of medical device: XE8GP\\nBubble sensor component of medical device: XE5Q2\\nOxygen sensor component of medical device: XE5ZD\\nPhotodetector component of medical device: XE9G5\\nPressure sensor component of medical device: XE5WR\\nSensor probe component of medical device: XE7Q4\\nTemperature sensor component of medical device: XE3W9\\nTimer component of medical device: XE3R3\\nAccess port component of medical device: XE3UX\\nActuator component of medical device: XE0WZ\\nAdaptor component of medical device: XE0SV\\nAir eliminator component of medical device: XE6D6\\nAnchor component of medical device: XE4F2\\nApplicator component of medical device: XE94Y\\nAutomatic injection system component of medical device: XE968\\nBag component of medical device: XE7E4\\nBall component of medical device: XE0HN\\nBalloon component of medical device: XE5AV\\nBearings component of medical device: XE1G8\\nPotting component of medical device: XE0Y2\\nProbe component of medical device: XE46S\\nProcessor component of medical device: XE23M\\nPulley component of medical device: XE9DJ\\nPump component of medical device: XE0K1\\nPusher component of medical device: XE8RF\\nRachet component of medical device: XE76K\\nRail component of medical device: XE4JZ\\nSide rail component of medical device: XE0KN\\nRegulator component of medical device: XE6YN\\nReservoir component of medical device: XE65T\\nBellows component of medical device: XE1XK\\nRing component of medical device: XE7DG\\nRod or shaft component of medical device: XE017\\nSeal component of medical device: XE4BJ\\nShock absorber component of medical device: XE7N2\\nSleeve component of medical device: XE7ZG\\nSlide component of medical device: XE6VJ\\nSocket component of medical device: XE740\\nSpacer component of medical device: XE4DU\\nSpring component of medical device: XE7QZ\\nStand component of medical device: XE4K0\\nBelt component of medical device: XE9CF\\nSteering wire component of medical device: XE82E\\nStent component of medical device: XE7UE\\nStopcock component of medical device: XE8M4\\nStopper component of medical device: XE00C\\nStrain relief component of medical device: XE4E4\\nStylet component of medical device: XE3GN\\nSyringe component of medical device: XE05P\\nTable component of medical device: XE3ED\\nTip component of medical device: XE06W\\nTool component of medical device: XE6GE\\nBottle component of medical device: XE7G4\\nTranslational motion component of medical device: XE0UG\\nTrap component of medical device: XE2FM\\nTrocar component of medical device: XE4M3\\nTube component of medical device: XE8TY\\nCapillary tube component of medical device: XE2PZ\\nValve component of medical device: XE01P\\nControl valve component of medical device: XE3YJ\\nLuer valve component of medical device: XE229\\nOneway valve component of medical device: XE2LS\\nVaporiser component of medical device: XE6MT\\nVibrator component of medical device: XE0FP\\nWasher component of medical device: XE83A\\nWeld component of medical device: XE1PW\\nWheel component of medical device: XE6HA\\nBreathing circuit component of medical device: XE0C3\\nWindow component of medical device: XE99Z\\nShutter component of medical device: XE2Q3\\nBrush component of medical device: XE5YT\\nBrushing component of medical device: XE0AX\\nCable mechanical structural component of medical device: XE4NU\\nCannula component of medical device: XE2UB\\nCannula hub component of medical device: XE9FK\\nCap component of medical device: XE44H\\nCarrier component of medical device: XE00E\\nCaster component of medical device: XE3K0\\nCatheter component of medical device: XE088\\nCatheter hub component of medical device: XE8NS\\nCell component of medical device: XE1TF\\nChain component of medical device: XE65A\\nChamber component of medical device: XE6N0\\nChassis or frame component of medical device: XE4BK\\nClutch component of medical device: XE5CL\\nCoating material component of medical device: XE3C8\\nCoil component of medical device: XE1S0\\nHelifix coil component of medical device: XE8AQ\\nCollimator component of medical device: XE0YX\\nConcentrator component of medical device: XE7YF\\nCone component of medical device: XE5TK\\nConnector or coupler component of medical device: XE7EE\\nConnector pin component of medical device: XE4T6\\nController component of medical device: XE83L\\nCompressor component of medical device: XE46J\\nCover component of medical device: XE1S2\\nCuff component of medical device: XE8LZ\\nCup component of medical device: XE8YR\\nCusp and leaflet component of medical device: XE8T8\\nCutter or blade component of medical device: XE3LB\\nCylinder component of medical device: XE9WL\\nDevice collapser component of medical device: XE3CX\\nDevice deployer component of medical device: XE8J5\\nDiaphragm component of medical device: XE1KD\\nDome component of medical device: XE85G\\nEjector component of medical device: XE5K4\\nEquipment pole component of medical device: XE1VC\\nExtender component of medical device: XE8ZU\\nFabric component of medical device: XE026\\nFan or blower component of medical device: XE8VD\\nFastner component of medical device: XE5DL\\nAdhesive fastner component of medical device: XE1A5\\nBolt fastner component of medical device: XE4V8\\nClamp fastner component of medical device: XE4PG\\nClip fastner component of medical device: XE3VN\\nFixation wire fastner component of medical device: XE9KR\\nLatch fastner component of medical device: XE6R2\\nNail fastner component of medical device: XE7GP\\nNut fastner component of medical device: XE0F0\\nPin fastner component of medical device: XE6A2\\nProng fastner component of medical device: XE059\\nRetainer fastner component of medical device: XE33C\\nRivet fastner component of medical device: XE9MM\\nScrew fastner component of medical device: XE3NX\\nStaple fastner component of medical device: XE2HY\\nSuture thread fastner component of medical device: XE0NL\\nTape for fixation component of medical device: XE8MX\\nFiber component of medical device: XE15J\\nFilter component of medical device: XE65M\\nFlange component of medical device: XE10F\\nFoil component of medical device: XE4PC\\nGas exchanger component of medical device: XE3HQ\\nGasket component of medical device: XE3QZ\\nGears component of medical device: XE5M6\\nGenerator component of medical device: XE0RK\\nGuide component of medical device: XE1ND\\nGuidewire component of medical device: XE64H\\nHandpiece component of medical device: XE11W\\nHeader component of medical device: XE37B\\nSewing ring component of medical device: XE2AL\\nHeat exchanger component of medical device: XE12Q\\nHinge component of medical device: XE5ZS\\nHolder component of medical device: XE4FZ\\nHose component of medical device: XE3A4\\nHousing component of medical device: XE5S9\\nHumidifier component of medical device: XE0YE\\nHydraulic system component of medical device: XE1TK\\nImpeller component of medical device: XE4NN\\nInserter component of medical device: XE3WA\\nInsulation component of medical device: XE1Y2\\nIsolator component of medical device: XE7JF\\nJaw component of medical device: XE7N3\\nJoint component of medical device: XE7GQ\\nKnob component of medical device: XE3AW\\nLabel component of medical device: XE6R7\\nLeaflet component of medical device: XE1VQ\\nLever component of medical device: XE5XR\\nFoot pedal component of medical device: XE08E\\nLiner component of medical device: XE80W\\nMagazine or cassette component of medical device: XE17E\\nManifold component of medical device: XE87E\\nMask component of medical device: XE26U\\nMechanical mixer component of medical device: XE74K\\nMembrane component of medical device: XE9VQ\\nMesh component of medical device: XE8R6\\nMotor component of medical device: XE0R5\\nMount component of medical device: XE8X1\\nNeedle component of medical device: XE4BH\\nNozzle component of medical device: XE78G\\nPackaging component of medical device: XE7C4\\nPad component of medical device: XE5AR\\nPanel component of medical device: XE080\\nPlate component of medical device: XE965\\nPlug component of medical device: XE09R\\nPlunger component of medical device: XE9R2\\nPost component of medical device: XE25A\\nCamera component of medical device: XE120\\nFilm component of medical device: XE5CR\\nImager component of medical device: XE7NH\\nLaser component of medical device: XE6GJ\\nLight emitting diode component of medical device: XE6QH\\nLenses component of medical device: XE616\\nLight source component of medical device: XE5LN\\nBulb component of medical device: XE5G9\\nMirror component of medical device: XE9EM\\nOptical fiber component of medical device: XE7A6\\nAlarm component of medical device: XE28G\\nAlarm component of medical device audible: XE5DW\\nAlarm component of medical device visual: XE3WT\\nEmergency button or switch component of medical device: XE2N6\\nFailsafe system component of medical device: XE37H\\nLocking mechanism component of medical device: XE51V\\nProtector or shield component of medical device: XE8RN\\nSafety interlock component of medical device: XE0ZU\\nNeedle stick prevention mechanism: XE4HV\\nSafety valve component of medical device: XE58K\\nPart component or subassembly term not applicable: XE27U\\nAppropriate term or code not available for medical device component: XE8NG\\nOne or both eyes are opening spontaneously: XC3W\\nOne or both eyes opening to verbal stimulation: XC5L\\nOne or both eyes opening to pressure stimulation: XC3H\\nNo eye opening even with pressure stimulation: XC87\\nEyes opening non testable: XC2N\\nObeys commands: XC4L\\nLocalising response to pressure stimulation: XC6J\\nNormal flexion response to pressure stimulation: XC8Q\\nAbnormal flexion response to pressure stimulation: XC8W\\nExtension response to pressure stimulation: XC8H\\nNo motion even with pressure stimulation: XC34\\nMotor score non testable: XC3S\\nOriented normal speech: XC2X\\nConfused disoriented speech: XC4Y\\nIntelligible single words: XC4A\\nIncomprehensible sounds to pressure stimulation: XC7U\\nNo verbal output even with pressure stimulation: XC8U\\nVerbal score non testable: XC03\\nNeither pupil reacts: XC5Y\\nOne pupil reacts: XC16\\nBoth pupils react: XC5K\\nData not available: XC85\\nAntacids: XM1349\\nMagnesium compounds: XM7GM7\\nMagnesium hydroxide: XM39M3\\nAluminium aluminium magnesium silicate: XM35X7\\nAluminium compounds: XM3JP8\\nAlgeldrate: XM9N47\\nAluminium aluminium phosphate: XM2VU8\\nAloglutamol: XM4NY5\\nAluminium aluminium glycinate: XM7DC3\\nDihydroxyaluminum sodium carbonate: XM9PG0\\nAluminum hydroxide gel: XM38T8\\nCalcium compounds: XM0SA0\\nCalcium carbonate: XM9003\\nCalcium silicate: XM8EF6\\nCombinations and complexes of aluminium calcium and magnesium compounds: XM0D52\\nMagaldrate: XM5R16\\nAlmagate: XM8J56\\nHydrotalcite: XM3EB6\\nAlmasilate: XM9Y49\\nCimetidine: XM9YL4\\nFamotidine: XM6441\\nNizatidine: XM9ZP3\\nRanitidine: XM6WY8\\nRoxatidine: XM0SH0\\nNiperotidine: XM08A8\\nRanitidine bismuth citrate: XM1ZT1\\nLafutidine: XM0Q37\\nProton pump inhibitors: XM2WX5\\nOmeprazole: XM8X45\\nPantoprazole: XM86M3\\nLansoprazole: XM39X4\\nRabeprazole: XM3M01\\nEsomeprazole: XM8YE1\\nDexlansoprazole: XM5RA0\\nDexrabeprazole: XM1J18\\nTegoprazan: XM3MK2\\nProstaglandins: XM4ML1\\nMisoprostol: XM28N9\\nEnprostil: XM4GD1\\nAlprostadil: XM1CF2\\nDinoprost: XM3Q43\\nDinoprostone: XM5VF9\\nGemeprost: XM2L11\\nCarboprost: XM8XM0\\nSulprostone: XM9BJ7\\nCarbenoxolone: XM2H82\\nSucralfate: XM0044\\nPirenzepine: XM6690\\nProglumide: XM6WX3\\nGefarnate: XM0HB8\\nSulglicotide: XM2689\\nAlginic acid: XM4H50\\nRebamipide: XM2891\\nMethiosulfonium chloride: XM1F15\\nBismuth subcitrate: XM1BG6\\nAcetoxolone: XM1LT9\\nZolimidine: XM9SW3\\nTroxipide: XM1Y11\\nBismuthyl subnitrate: XM84X1\\nFixed Combinations for Helicobacter pylori eradication: XM1364\\nSerotonin receptor antagonists: XM4S40\\nOndansetron: XM7423\\nGranisetron: XM8123\\nCilansetron: XM3X37\\nDiisopromine: XM2493\\nChlorbenzoxamine: XM30Q8\\nPinaverium: XM2GC8\\nFenoverine: XM3CZ9\\nAlverine: XM5RS2\\nIsometheptene: XM27M9\\nMigalstat: XM6UH6\\nFenpiprane: XM49K4\\nIdanpramine: XM7F16\\nProxazole: XM8N97\\nTrepibutone: XM2SK3\\nCaroverine: XM3R36\\nPhloroglucinol: XM66E5\\nTrimethyldiphenylpropylamine: XM7ZC5\\nValethamate bromide: XM9K48\\nAluminium aluminium tannate: XM6Q06\\nAmylopectin: XM62S7\\nAntidiarrhoeal drug absorbent: XM8A95\\nAttapulgite: XM6V74\\nBacillus subtilis: XM4SG9\\nBismuth salts subcarbonate: XM98L3\\nBismuth salts: XM5U61\\nCarbo medicinalis: XM3962\\nCharcoal: XM0S42\\nCharcoal activated: XM46T5\\nCharcoal medicinal activated: XM2269\\nCharcoal medicinal antidiarrhoeal: XM8D61\\nDifenoxin: XM8ET0\\nFetoxilate: XM15K3\\nIntestinal motility control drug: XM3ZU0\\nKaolin: XM7CN8\\nKaolin light: XM2GB1\\nLactobacillus acidophilus compound: XM1N12\\nLactobacillus acidophilus: XM0EB5\\nLactobacillus bifidus lyophilized: XM0QG1\\nLactobacillus bulgaricus: XM1TF2\\nLactobacillus sporogenes: XM4KH7\\nLignin hemicellulose: XM48X2\\nLomotil: XM8683\\nMiyari bacteria: XM2UP7\\nPectin: XM2HR7\\nSaccharomyces boulardii: XM4X08\\nAnise oil: XM2663\\nAntiflatulent: XM8A26\\nBetaine: XM0090\\nBile salts: XM0TD5\\nCarminative: XM5TC9\\nCholagogues: XM5QD3\\nCholeretic: XM6RN6\\nCytochrome C: XM5CH0\\nDehydrocholic acid: XM00U8\\nDill: XM0365\\nElastase: XM4RK4\\nEnzyme intestinal: XM5H83\\nFlorantyrone: XM2Q01\\nGastric enzymes: XM5BH7\\nGentian: XM63F8\\nGinger: XM1TN8\\nGlutamic acid: XM0994\\nHydrochloric acid medicinal digestant: XM15D5\\nOx bile extract: XM2702\\nPancreatin: XM6HM1\\nPancrelipase: XM9Z07\\nPapain: XM6DW4\\nPapain digestant: XM72V4\\nPeppermint oil: XM1XP0\\nPepsin digestant: XM17U7\\nPhenylpropanol: XM7L34\\nTilactase: XM4U70\\nCerium oxalate: XM4H25\\nCopper emetic: XM3ME7\\nCopper sulfate medicinal emetic: XM9FG8\\nMustard black: XM2WE8\\nChlorobutanol: XM5SW7\\nTrimethobenzamide: XM8SN3\\nMetopimazine: XM46N1\\nAprepitant: XM1DC1\\nCasopitant: XM2633\\nRolapitant: XM41Y6\\nPipamazine: XM2170\\nPyrathiazine: XM9FU8\\nAmmonium sulfonate resin: XM3KJ5\\nBacillus lactobacillus: XM4KK2\\nCarrageenan: XM4663\\nCharcoal medicinal poison control: XM8NM7\\nCharcoal medicinal specified use other than for diarrhoea: XM4GA5\\nDimethyl polysiloxane: XM7ER1\\nGastrointestinal drug biological: XM30A7\\nGastrointestinal drug specified: XM0KJ8\\nGlucurolactone: XM7L13\\nHepatic secretion stimulant: XM9Q94\\nIntestinal motility control drug biological: XM7EV4\\nIon exchange resin anion: XM9S11\\nIon exchange resin intestinal: XM1AX0\\nLiquorice extract: XM0UP4\\nMesalazine: XM8UW6\\nOlsalazine: XM0TN5\\nPancreatic digestive secretion stimulant: XM73P5\\nPolysilane: XM0EK0\\nSodium alginate: XM2K96\\nSodium amylosulfate: XM7M46\\nSulfated amylopectin: XM7AL9\\nAlexitol sodium: XM6347\\nAluminium aluminium carbonate gel basic: XM8YP0\\nAluminium aluminium chlorhydroxidecomplex: XM3Q55\\nAluminium aluminium hydroxidemagnesium carb gel: XM9DS4\\nAluminium aluminium silicate: XM8FL6\\nAluminium aluminium sodium silicate: XM0BM4\\nAntacid: XM37S3\\nAntigastricsecretion drug: XM5XT4\\nBenexate: XM9KD3\\nBismuth salts aluminate: XM1F19\\nBurimamide: XM5R07\\nCetraxate: XM7Y04\\nChalk precipitated: XM1WQ5\\nDihydroxyaluminum aminoacetate: XM1622\\nDimethicone: XM9BS9\\nMagnesia magma: XM6YR9\\nMagnesium carbonate: XM7V20\\nMagnesium trisilicate: XM8L43\\nMethylpolysiloxane: XM1EN3\\nMetiamide: XM9414\\nMilk of magnesia: XM7SH2\\nOrnoprostil: XM01K0\\nPepstatin: XM7K87\\nPotassium glucaldrate: XM7W08\\nRolaids: XM7Z18\\nRosaprostol: XM87Z0\\nSimaldrate: XM64X9\\nSimethicone: XM38C5\\nSoda bicarb: XM0QL9\\nSodium glucaldrate: XM43U8\\nSodium polyhydroxyaluminium monocarbonate: XM7M59\\nTriple carbonate: XM38H3\\nVitamin ulceroprotectant: XM5QM5\\nAgar: XM8K92\\nArachis oil cathartic: XM5FL6\\nAtonia drug intestinal: XM5993\\nBran wheat: XM9281\\nBulk filler cathartic: XM21B3\\nCalcium dioctyl sulfosuccinate: XM0ML8\\nCarboxymethylcellulose: XM0HS3\\nCarmellose: XM3EV1\\nCathartic bulk: XM99E9\\nCathartic emollient: XM4DA2\\nCathartic mucilage: XM2Y48\\nCellulose cathartic: XM3000\\nCellulose hydroxyethyl: XM22V5\\nDioctyl sulfosuccinate calcium sodium: XM6ZN5\\nEthylhydroxycellulose: XM2UB3\\nFecal softener: XM6CL0\\nFiber dietary: XM1RJ7\\nIspagula husk: XM4A22\\nKaraya gum: XM1J98\\nKonsyl: XM5CR2\\nMetamucil: XM2J55\\nMethylcellulose laxative: XM0X73\\nMucilage plant: XM5VW0\\nOlive oil medicinal: XM1VV2\\nPeach kernel oil emulsion: XM3CM0\\nPeanut oil emulsion: XM85Z3\\nPhosphate laxative: XM4PD5\\nPoloxamer: XM95P7\\nPolycarbophil: XM9PF1\\nPsyllium hydrophilic mucilloid: XM4YU2\\nSoap enema: XM0ZU4\\nSodium dioctyl sulfosuccinate: XM6J59\\nTartrate laxative: XM3DH4\\nCathartic saline: XM69K0\\nEpsom salt: XM40M7\\nLaxative osmotic: XM4WX6\\nLaxative saline: XM5NK8\\nPotassium bisulfate: XM06D3\\nAloes: XM9P20\\nAloin: XM6UQ2\\nBryonia: XM9N98\\nCarters Little Pills: XM9YN3\\nCathartic anthacene derivative: XM2632\\nCathartic contact: XM3W96\\nCathartic irritant: XM53Q7\\nCathartic vegetable: XM6LH5\\nColocynth: XM0JN3\\nCroton oil: XM4217\\nDianthone: XM4C29\\nDihydroxyanthraquinone: XM8PF5\\nDulcolax: XM77A6\\nElaterium: XM9KZ8\\nExLax phenolphthalein: XM6CR4\\nFrangula: XM7XD6\\nFrangula extract: XM6L10\\nGamboge: XM1L58\\nHinkles pills: XM1RP5\\nJalap: XM6XG3\\nMineral oil emulsion: XM9DZ3\\nPhenisatin: XM4CS7\\nPotassium sulfate: XM5042\\nRhubarb dry extract: XM14Q1\\nRhubarb tincture compound: XM40D1\\nScammony: XM38T6\\nSennoside AB: XM91P4\\nSodium phosphate dibasic: XM9ML9\\nSodium phosphate monobasic: XM38A9\\nSquirting cucumber cathartic: XM7XV5\\nSulisatin: XM8WQ0\\nYellow phenolphthalein: XM69R3\\nSofteners or emollients: XM1NY1\\nLiquid paraffin: XM8UE2\\nDocusate sodium: XM59Z2\\nContact laxatives: XM5CM0\\nOxyphenisatine: XM5E72\\nBisacodyl: XM14G1\\nDantron: XM86Q2\\nPhenolphthalein: XM30Q0\\nCastor oil: XM7G77\\nSenna glycosides: XM9LC4\\nSodium picosulfate: XM8YN7\\nBisoxatin: XM00W5\\nCascara: XM8N88\\nBulkforming laxatives: XM42M0\\nSterculia: XM9JR8\\nLinseed: XM3VP9\\nMethylcellulose: XM5DN2\\nIspaghula: XM3JB5\\nEthulose: XM0LV6\\nTriticum wheat fibre: XM4SJ2\\nPolycarbophil calcium: XM5BR4\\nOsmotically acting laxatives: XM2806\\nMagnesium oxide: XM7G33\\nMagnesium sulfate: XM6EC7\\nMagnesium peroxide: XM3CD3\\nLactulose: XM7W31\\nSodium sulfate: XM6AX9\\nMacrogol: XM6FQ8\\nSorbitol: XM9YJ1\\nLactitol: XM4RE1\\nPentaerithrityl: XM7RN6\\nGlycerol: XM5348\\nCarbon dioxide producing drugs: XM7DT2\\nLubiprostone: XM4U05\\nLinaclotide: XM3086\\nPrucalopride: XM2396\\nTegaserod: XM2SC1\\nPlecanatide: XM78V7\\nOil: XM6DL1\\nMetoclopramide: XM3XX3\\nCisapride: XM3346\\nDomperidone: XM3GF5\\nBromopride: XM2Q19\\nAlizapride: XM6AH6\\nClebopride: XM4GL7\\nItopride: XM2KJ6\\nCinitapride: XM1W04\\nMosapride: XM6ZM7\\nEluxadoline: XM8136\\nAlkylating agents: XM09D9\\nNitrogen mustard analogues: XM06G0\\nCyclophosphamide: XM7SY9\\nChlorambucil: XM5TX7\\nMelphalan: XM2VC7\\nChlormethine: XM9W18\\nIfosfamide: XM7FY4\\nTrofosfamide: XM4EP0\\nPrednimustine: XM4NR8\\nBendamustine: XM45K9\\nMelphalan flufenamide: XM0DA1\\nAlkyl sulfonates: XM3WS2\\nBusulfan: XM7WX6\\nTreosulfan: XM9CR4\\nMannosulfan: XM4TU0\\nEthylene imines: XM66A3\\nThiotepa: XM8QS9\\nTriaziquone: XM2RU1\\nCarboquone: XM8A50\\nNitrosoureas: XM9708\\nCarmustine: XM82H4\\nLomustine: XM2G49\\nSemustine: XM0VS7\\nStreptozocin: XM5GB0\\nNimustine: XM1KF0\\nUramustine: XM9KU3\\nFotemustine: XM5RH5\\nRanimustine: XM64P5\\nEtoglucid: XM4KL3\\nMitobronitol: XM31W0\\nPipobroman: XM0MB5\\nTemozolomide: XM3VF4\\nDacarbazine: XM32Y8\\nBischloromethyl ether: XM7Y28\\nFolic acid analogues: XM4DQ8\\nMethotrexate: XM7KT0\\nMercaptopurine: XM1SK9\\nTioguanine: XM3FP5\\nRaltitrexed: XM5NF9\\nPemetrexed: XM16W8\\nPralatrexate: XM06R0\\nPurine analogues: XM71S1\\nCytarabine: XM3ZN1\\nFluorouracil: XM55V5\\nTegafur: XM10L4\\nCarmofur: XM6CQ5\\nAzacitidine: XM92X1\\nCladribine: XM1055\\nFludarabine: XM9RH9\\nClofarabine: XM2YA3\\nNelarabine: XM6079\\nPyrimidine analogues: XM9584\\nTrifluridine combinations: XM0YN9\\nGemcitabine: XM8GX9\\nCapecitabine: XM40Y4\\nDecitabine: XM1458\\nAminopterin sodium: XM7GE5\\nAntibiotic anticancer: XM3264\\nAntimetabolite: XM8T13\\nAntineoplastic antibiotics: XM9D05\\nAzaribine: XM4TR6\\nBroxuridine: XM3HR8\\nChloropurine: XM3A97\\nDoxifluridine: XM1BL2\\nEnocitabine: XM5ZK1\\nFolic acid antagonist: XM2SL0\\nMopidamol: XM0KZ3\\nPyrimidine antagonist: XM2FK2\\nVinca alkaloids and analogues: XM6137\\nVinblastine: XM0BG8\\nVincristine: XM82R6\\nVindesine: XM59U2\\nVinorelbine: XM1Y07\\nVinflunine: XM9QY3\\nVintafolide: XM9DS3\\nPodophyllotoxin derivatives: XM3SH7\\nEtoposide: XM9VL7\\nTeniposide: XM4565\\nTaxanes: XM05L1\\nPaclitaxel: XM5TC8\\nDocetaxel: XM5U86\\nPaclitaxel poliglumex: XM9NR6\\nCabazitaxel: XM50E3\\nActinomycin C: XM6F82\\nDemecolcine: XM7K70\\nTrabectedin: XM3F90\\nCytotoxic antibiotics and related substances: XM4DQ7\\nAnthracyclines and related substances: XM5GC9\\nDoxorubicin: XM7JU8\\nDaunorubicin: XM0031\\nEpirubicin: XM6LT8\\nAclarubicin: XM1VB7\\nZorubicin: XM9R95\\nIdarubicin: XM3PF9\\nMitoxantrone: XM26H0\\nPirarubicin: XM4AY9\\nValrubicin: XM9CA4\\nAmrubicin: XM3J03\\nPixantrone: XM8ZP9\\nBleomycin: XM0VU1\\nPlicamycin: XM3JL4\\nMitomycin: XM21Z8\\nIxabepilone: XM65P2\\nFibroblast growth factor receptor tyrosine kinase inhibitors: XM4RQ4\\nEdrecolomab: XM52L2\\nRituximab: XM3AY3\\nTrastuzumab: XM2FU8\\nGemtuzumab ozogamicin: XM1WL2\\nCetuximab: XM3VL3\\nBevacizumab: XM5ST9\\nPanitumumab: XM1GA2\\nCatumaxomab: XM9P40\\nOfatumumab: XM2KB4\\nIpilimumab: XM5JH7\\nBrentuximab vedotin: XM5VT7\\nPertuzumab: XM6618\\nTrastuzumab emtansine: XM6H29\\nObinutuzumab: XM6ES5\\nDinutuximab: XM74W8\\nNivolumab: XM6M26\\nPembrolizumab: XM8UG5\\nBlinatumomab: XM9BU9\\nRamucirumab: XM6Y05\\nNecitumumab: XM5WX4\\nElotuzumab: XM10Z6\\nDaratumumab: XM4ES5\\nMogamulizumab: XM3JP4\\nInotuzumab ozogamicin: XM8648\\nOlaratumab: XM3DU2\\nDurvalumab: XM7NY5\\nErmekumab: XM6PT2\\nAvelumab: XM2065\\nAtezolizumab: XM8SU2\\nCemiplimab: XM9Z80\\nAlemtuzumab: XM5WX2\\nErenumab: XM8LF5\\nGalcanezumab: XM4XM4\\nFremanezumab: XM47L7\\nUbrogepant: XM46X2\\nEptinezumab: XM1D23\\nRimegepant: XM8C95\\nAtogepant: XM4W34\\nSensitizers used in photodynamic or radiation therapy: XM3T47\\nPorfimer sodium: XM8EW4\\nMethyl aminolevulinate: XM5GF8\\nAminolevulinic acid: XM40J3\\nTemoporfin: XM04X3\\nEfaproxiral: XM2BE2\\nPadeliporfin: XM1ER6\\nPlatinum compounds: XM40B7\\nCisplatin: XM05M0\\nCarboplatin: XM6Z30\\nOxaliplatin: XM2LX1\\nSatraplatin: XM86Z5\\nPolyplatillen: XM0FB2\\nProcarbazine: XM1MP7\\nAmsacrine: XM8307\\nAsparaginase: XM4LJ7\\nAltretamine: XM9YD3\\nHydroxycarbamide: XM7SD2\\nLonidamine: XM3R45\\nEstramustine: XM9JX7\\nTretinoin: XM9DB5\\nPentostatin: XM9T72\\nMitoguazone: XM2Q11\\nVenetoclax: XM7PT2\\nVosaroxin: XM1NF7\\nNiraparib: XM1DL2\\nRucaparib: XM2G84\\nEtirinotecan pegol: XM0569\\nPlitidepsin: XM8UF4\\nEpacadostat: XM8QL8\\nEnasidenib: XM8NP2\\nTalazoparib: XM5QR0\\nCopanlisib: XM44N1\\nMitotane: XM10P3\\nIvosidenib: XM56L5\\nGlasdegib: XM6038\\nEntinostat: XM7FX3\\nAlpelisib: XM3BC1\\nSelinexor: XM1840\\nTagraxofusp: XM4MB0\\nBelotecan: XM7RN1\\nHolmium: XM5A01\\nArsenic trioxide: XM2HS5\\nAlkylating drug antimyeloproliferative: XM3ST0\\nAlkylating drug lymphatic: XM9DP5\\nAlkylating drug: XM6AB6\\nHexalen: XM0JA8\\nAntramycin: XM07W3\\nAnticancer agents: XM9F82\\nAntimitotic agent: XM3MH4\\nAntineoplastic without further specification: XM6Q44\\nAntineoplastic alkaloidal: XM0V25\\nAntineoplastic combination: XM4DV2\\nAzaserine: XM1Q78\\nAzatepa: XM0TE5\\nBenzcarbimine: XM7WD3\\nCactinomycin: XM3WB5\\nCancer chemotherapy drug regimen: XM7RS5\\nChlorhexamide: XM6Z55\\nChromic phosphate P: XM3ZJ5\\nChromomycin A: XM5VY1\\nCorynebacterium parvum: XM6ZM0\\nCycloleucin: XM8C02\\nDactinomycin: XM7L47\\nElliptinium acetate: XM0HK3\\nFAC fluorouracil  doxorubicin  cyclophosphamide: XM32L4\\nFloxuridine: XM8NR1\\nHormone cancer therapy: XM9FT7\\nImidazolecarboxamide: XM5UH8\\nInproquone: XM2D46\\nIproplatin: XM5DL7\\nMvac: XM8C52\\nMannomustine: XM8XQ7\\nMatulane: XM33V8\\nMetoprine: XM1NW0\\nMitolactol: XM6VK8\\nMitopodozide: XM3A89\\nMOPP mechlorethamine  vincristine  prednisone  procarbazine: XM3L39\\nMustard emetic: XM4582\\nMyelobromal: XM6MP1\\nMyleran: XM5C25\\nOlivomycin: XM5MX5\\nOncovin: XM9TL3\\nParoxypropione: XM7TK6\\nPeplomycin: XM7040\\nPhenyl hydrazine antineoplastic: XM7NL0\\nPhenylalanine mustard: XM03S1\\nPorfiromycin: XM7S82\\nPteroyltriglutamate: XM6QJ7\\nRazoxane: XM2CG3\\nRufocromomycin: XM9TR7\\nSarcolysin: XM4ZA6\\nSarkomycin: XM1TG4\\nTauromustine: XM5FB8\\nTEPA: XM0L32\\nTrichlormethine: XM3SV7\\nTrichlorotriethylamine: XM5FH3\\nTriethanomelamine: XM7TR9\\nTriethylenemelamine: XM9T22\\nTriethylenephosphoramide: XM6NM1\\nTriethylenethiophosphoramide: XM5GV6\\nTrimustine: XM4J62\\nUracil mustard: XM6A19\\nUrethane: XM9AV3\\nZinostatin: XM1DU5\\nMasoprocol: XM4KU8\\nTopotecan: XM7ST9\\nTiazofurine: XM3ZR1\\nIrinotecan: XM0992\\nAlitretinoin: XM8200\\nPegaspargase: XM6AL6\\nBexarotene: XM3NJ7\\nDenileukin diftitox: XM6027\\nBortezomib: XM5Z86\\nAnagrelide: XM2PZ5\\nOblimersen: XM1NQ8\\nSitimagene ceradenovec: XM3VC2\\nVorinostat: XM7R04\\nRomidepsin: XM91S2\\nOmacetaxine mepesuccinate: XM3RX2\\nEribulin: XM3BC3\\nPanobinostat: XM96L9\\nVismodegib: XM0N96\\nAflibercept: XM4XD1\\nCarfilzomib: XM0A07\\nOlaparib: XM7202\\nIdelalisib: XM8F40\\nSonidegib: XM9E27\\nBelinostat: XM0Y26\\nIxazomib: XM3753\\nTalimogene laherparepvec: XM1BM0\\nProtein kinase inhibitors: XM1CT6\\nImatinib: XM5W30\\nGefitinib: XM3A37\\nErlotinib: XM3420\\nSunitinib: XM1982\\nSorafenib: XM4A57\\nDasatinib: XM50U1\\nLapatinib: XM1FM4\\nNilotinib: XM6BP0\\nTemsirolimus: XM93U4\\nEverolimus: XM69S5\\nPazopanib: XM4FT3\\nVandetanib: XM3W52\\nAfatinib: XM7917\\nBosutinib: XM60L5\\nVemurafenib: XM55B8\\nCrizotinib: XM2U80\\nAxitinib: XM6JL9\\nRuxolitinib: XM0853\\nRidaforolimus: XM0SL6\\nRegorafenib: XM0601\\nMasitinib: XM0JZ7\\nDabrafenib: XM1HB8\\nPonatinib: XM70G2\\nTrametinib: XM7VJ9\\nCabozantinib: XM4TL0\\nIbrutinib: XM0C70\\nCeritinib: XM14D3\\nLenvatinib: XM7ZH9\\nNintedanib: XM4EA3\\nCediranib: XM2QS0\\nPalbociclib: XM4K70\\nTivozanib: XM8B31\\nOsimertinib: XM8YD2\\nAlectinib: XM4JL2\\nRociletinib: XM21J7\\nCobimetinib: XM6K99\\nMidostaurin: XM5Y46\\nOlmutinib: XM0J75\\nBinimetinib: XM3YP5\\nRibociclib: XM2RL4\\nBrigatinib: XM2DD8\\nLorlatinib: XM59V9\\nNeratinib: XM5MT6\\nEncorafenib: XM5RQ2\\nDacomitinib: XM15D6\\nIcotinib: XM9L11\\nAbemaciclib: XM8E34\\nAcalabrutinib: XM09W7\\nQuizartinib: XM1L31\\nLarotrectinib: XM2LF4\\nGilteritinib: XM4BT2\\nEntrectinib: XM16Z9\\nFedratinib: XM28Z0\\nAsciminib: XM7168\\nPacritinib: XM7380\\nInfigratinib: XM9U75\\nFutibatinib: XM9XE8\\nSelpercatinib: XM74A3\\nPralsetinib: XM1UG8\\nMonoclonal antibodies and antibody drug conjugates: XM1JG6\\nClusters of differentiation  inhibitors: XM4F67\\nHuman epidermal growth factor receptor  inhibitors: XM6DT1\\nEpidermal growth factor receptor inhibitors: XM3ZP2\\nTrastuzumab duocarmazine: XM9KZ5\\nProgrammed cell death protein death ligand  inhibitors: XM9ND9\\nTislelizumab: XM3Q80\\nRetifanlimab: XM2KA7\\nOportuzumab monatox: XM0AN7\\nSacituzumab govitecan: XM5Q93\\nAmivantamab: XM0550\\nVascular endothelial growth factor inhibitors: XM1GS6\\nOther monoclonal antibodies and antibody drug conjugates: XM4ZA4\\nPamiparib: XM0PX7\\nTazemetostat: XM4WB3\\nSotorasib: XM78S9\\nBelzutifan: XM7SW9\\nColony stimulating factors: XM9VN3\\nFilgrastim: XM93Q2\\nMolgramostim: XM2M96\\nSargramostim: XM38N5\\nLenograstim: XM7UB4\\nAncestim: XM17W1\\nPegfilgrastim: XM4TX7\\nLipegfilgrastim: XM1G49\\nBalugrastim: XM7670\\nEmpegfilgrastim: XM9RV6\\nPegteograstim: XM8VY9\\nInterferon alfaa: XM1KX1\\nInterferons: XM58E0\\nInterferon alfa: XM1GZ3\\nInterferon beta: XM3CU5\\nInterferon gamma: XM3KQ4\\nInterferon alfab: XM6QT3\\nInterferon betaa: XM6D22\\nInterferon betab: XM0CS1\\nInterferon alfacon: XM0C05\\nPeginterferon alfacon: XM5L32\\nPeginterferon alfab: XM70P0\\nPeginterferon alfaa: XM1RW9\\nAlbinterferon alfab: XM1HG5\\nPeginterferon betaa: XM3XV8\\nCepeginterferon alfab: XM41L0\\nRopeginterferon alfab: XM24N9\\nInterleukins: XM2Q27\\nInterferon alfan: XM4MJ0\\nAldesleukin: XM0RF4\\nOprelvekin: XM4PY0\\nNetakimab: XM3SM5\\nBimekizumab: XM8615\\nSpesolimab: XM4YW3\\nThymopentin: XM7N26\\nLentinan: XM6GW5\\nRoquinimex: XM48E5\\nPegademase: XM9D28\\nPidotimod: XM30D0\\nPoly IC: XM1R32\\nPoly ICLC: XM4J95\\nImmunocyanin: XM9D43\\nTasonermin: XM94J4\\nMelanoma vaccine: XM99P5\\nGlatiramer acetate: XM4PM9\\nHistamine dihydrochloride: XM5KS2\\nMifamurtide: XM97M6\\nPlerixafor: XM19S3\\nSipuleucelT: XM2ZJ6\\nCridanimod: XM4ZS8\\nDasiprotimutT: XM9BT1\\nElapegademase: XM3R87\\nSelective immunosuppressants: XM5140\\nMuromonabCD: XM9RY3\\nAntilymphocyte immunoglobulin horse: XM3TG8\\nAntithymocyte immunoglobulin rabbit: XM2Q51\\nMycophenolic acid: XM57B1\\nSirolimus: XM76R4\\nLeflunomide: XM5M04\\nAlefacept: XM1PY3\\nGusperimus: XM75G0\\nEfalizumab: XM8CX4\\nAbetimus: XM4RN7\\nNatalizumab: XM9YN4\\nAbatacept: XM45M8\\nEculizumab: XM3KK5\\nBelimumab: XM9M75\\nFingolimod: XM9K56\\nBelatacept: XM4FP8\\nTofacitinib: XM7U27\\nTeriflunomide: XM1835\\nApremilast: XM9UD1\\nVedolizumab: XM5MC2\\nBegelomab: XM7BS8\\nOcrelizumab: XM2B74\\nBaricitinib: XM1SM6\\nOzanimod: XM0700\\nEmapalumab: XM3F23\\nImlifidase: XM09N4\\nSiponimod: XM6N55\\nRavulizumab: XM31G3\\nUpadacitinib: XM0V48\\nBelumosudil: XM6QJ6\\nPeficitinib: XM3RJ6\\nPonesimod: XM69Y4\\nAnifrolumab: XM1PC0\\nTeprotumumab: XM8AR9\\nPegcetacoplan: XM8913\\nSutimlimab: XM6PD2\\nDeucravacitinib: XM93Q8\\nTumour necrosis factor alpha inhibitors: XM9PG4\\nEtanercept: XM0FU1\\nInfliximab: XM3MX3\\nAfelimomab: XM31F7\\nAdalimumab: XM9DS9\\nCertolizumab pegol: XM9QW1\\nGolimumab: XM97H7\\nOpinercept: XM0PE5\\nInterleukin inhibitors: XM5ZL1\\nDaclizumab: XM3CD8\\nBasiliximab: XM6FT1\\nAnakinra: XM3CP6\\nRilonacept: XM4YD0\\nUstekinumab: XM1BA7\\nTocilizumab: XM2FV1\\nCanakinumab: XM67R0\\nBriakinumab: XM5JM2\\nSecukinumab: XM0NF8\\nSiltuximab: XM9D29\\nBrodalumab: XM6601\\nIxekizumab: XM7AB4\\nSarilumab: XM45G5\\nSirukumab: XM7N41\\nGuselkumab: XM2L20\\nTildrakizumab: XM9VJ6\\nRisankizumab: XM70N9\\nCalcineurin inhibitors: XM3CM4\\nCiclosporin: XM28J8\\nTacrolimus: XM1661\\nVoclosporin: XM0Z09\\nImmunosuppressive drug: XM1079\\nAzathioprine: XM99R8\\nThalidomide: XM6B78\\nLenalidomide: XM5Q10\\nPirfenidone: XM7952\\nPomalidomide: XM6S50\\nDimethyl fumarate: XM2EM8\\nDarvadstrocel: XM0LG0\\nMepolizumab: XM8X05\\nDiroximel fumarate: XM9UK4\\nVitamin K antagonists: XM7S34\\nDicoumarol: XM8RN0\\nPhenindione: XM79U8\\nWarfarin: XM86W0\\nPhenprocoumon: XM4E47\\nAcenocoumarol: XM6QR1\\nEthyl biscoumacetate: XM5XY7\\nDiphenadione: XM2567\\nTioclomarol: XM6550\\nFluindione: XM4GN9\\nClorindione: XM3508\\nHeparin and heparin derivatives: XM2YP8\\nHeparin: XM1MN3\\nAntithrombin III: XM12N6\\nDalteparin: XM3DU0\\nEnoxaparin: XM8ZP5\\nNadroparin: XM5727\\nParnaparin: XM9V60\\nReviparin: XM9JC4\\nDanaparoid: XM2YJ7\\nTinzaparin: XM3SS4\\nSulodexide: XM3E38\\nBemiparin: XM7QG7\\nDipyridamole: XM9J84\\nEpoprostenol: XM51R2\\nIndobufen: XM5G01\\nTiclopidine: XM5A15\\nIloprost: XM00R9\\nTriflusal: XM5PR9\\nDitazole: XM5K56\\nCloricromen: XM8NM5\\nPicotamide: XM09W2\\nClopidogrel: XM7CM7\\nAbciximab: XM39C9\\nEptifibatide: XM2924\\nTirofiban: XM0DS1\\nBeraprost: XM8Y64\\nTreprostinil: XM5057\\nPrasugrel: XM8LN2\\nCilostazol: XM92L1\\nTicagrelor: XM1HH4\\nCangrelor: XM3126\\nVorapaxar: XM3835\\nSelexipag: XM5MZ5\\nAnticoagulant and antithrombotic enzymes: XM17B1\\nStreptokinase: XM1AV3\\nAlteplase: XM9A41\\nAnistreplase: XM1P81\\nUrokinase: XM1QH1\\nBrinase: XM77L2\\nAncrod: XM3YU3\\nDirect thrombin inhibitors: XM5PV9\\nDesirudin: XM84G2\\nLepirudin: XM2HU1\\nArgatroban: XM7Y21\\nMelagatran: XM1D58\\nXimelagatran: XM2QF7\\nBivalirudin: XM1WF7\\nDabigatran etexilate: XM16E4\\nDirect factor Xa inhibitors: XM4SD9\\nRivaroxaban: XM48G2\\nApixaban: XM3Y33\\nEdoxaban: XM2SN5\\nOther antithrombotic agents: XM1AM0\\nDefibrotide: XM2JQ1\\nDermatan sulfate: XM2XP4\\nFondaparinux: XM31P2\\nAnticoagulants: XM3W80\\nAnisindione: XM02P8\\nBromindione: XM54A7\\nCoumarin: XM9E78\\nCoumetarol: XM0SY0\\nDrotrecogin alfa: XM0PM7\\nEnoxaparin sodium: XM9313\\nEthylidene dicoumarol: XM7AL6\\nHeparin sodium: XM4S57\\nHeparinfraction: XM5YT5\\nHeparinoid systemic: XM5LC3\\nIndandione derivatives: XM38V8\\nIndendione derivatives: XM4Z97\\nPanwarfin: XM5796\\nProthrombin synthesis inhibitor: XM04M3\\nXigris: XM8J87\\nZovant: XM7EQ6\\nAmino acids: XM4Z15\\nArginine hydrochloride: XM0ES3\\nAlanyl glutamine: XM2NR2\\nLysine: XM44Y2\\nTyrosine: XM8KJ7\\nPhenylalanine: XM4PP7\\nLeucine: XM4H38\\nCysteine: XM2K61\\nAlanine: XM6VX4\\nAminocaproic acid: XM4BG8\\nTranexamic acid: XM8GE2\\nAminomethylbenzoic acid: XM41G3\\nFibrinolysis inhibitor: XM3QV9\\nAprotinin: XM6Y53\\nAntifibrinolytic drug: XM0UH4\\nEpsilon aminocaproic acid: XM7XD3\\nHemostatic drug systemic: XM8X82\\nAlfa antitrypsin: XM9PF3\\nCamostat: XM9QH4\\nVitamin K: XM1YD0\\nMenadione: XM1KN2\\nEtamsylate: XM1VC9\\nAcetomenaphthone: XM0M37\\nAnticoagulant Antagonist: XM5LG4\\nAntihemophilic globulin concentrate: XM0D26\\nAntihemophilic plasma dried: XM2KH0\\nAntiheparin drug: XM0RA5\\nCoagulant: XM4Z99\\nCotarnine: XM3RB9\\nCytozyme: XM8MM4\\nGelfoam: XM5WF6\\nHeparin action reverser: XM35E4\\nHexadimethrine bromide: XM9CA7\\nMenadiol: XM3AJ3\\nMenadiol sodium sulfate: XM2JG9\\nMenadione sodium bisulfite: XM7MA9\\nMenaquinone: XM8912\\nMenatetrenone: XM55W0\\nProtamine sulfate: XM4U16\\nProthrombin activator: XM0SY7\\nRussels viper venin: XM8RT8\\nSnake venom or bite hemocoagulase: XM6QQ2\\nThromboplastin: XM0HF1\\nCarbazochrome: XM5UU0\\nCarbazochrome sodium sulfonate: XM6RT1\\nBatroxobin: XM7KW2\\nRomiplostim: XM96S9\\nEltrombopag: XM95R8\\nCoagulation factor VIII: XM9766\\nThrombin: XM3GR1\\nBlood plasma: XM04N3\\nAlbumin bovine: XM5WD4\\nAlbumin human serum saltpoor: XM1YW8\\nAlbumin human serum: XM7150\\nBlood derivatives natural plasma whole: XM2NV9\\nBlood dried: XM1GJ9\\nBlood fraction: XM5GG5\\nEPO: XM9TT2\\nEpoetin alpha: XM6BM2\\nErythropoietin human: XM79U3\\nFactor I fibrinogen: XM3TM8\\nFactor III thromboplastin: XM3ZZ2\\nCoagulation factor IX: XM44Z6\\nFibrin: XM9JK6\\nHuman albumin: XM6HF0\\nNatural blood product: XM0XT3\\nNormal serum albumin saltpoor human: XM3YQ9\\nWhole blood human: XM8TU6\\nBlood substitutes and plasma protein fractions: XM1596\\nOther plasma protein fractions: XM84Y1\\nGelatin agents: XM0CQ3\\nGelatin intravenous: XM4NU0\\nPolygeline: XM99H6\\nHemoglobin crosfumaril: XM8BW6\\nHemoglobin raffimer: XM4MK5\\nHemoglobin glutamer: XM6W72\\nDextran: XM3CZ0\\nPlasma protein fraction human: XM1H99\\nAlbumin: XM6KC5\\nHydroxyethylstarch: XM8H48\\nOxypolygelatin: XM6YJ2\\nPolyvinylpyrrolidone: XM8UH8\\nHematin: XM8K98\\nFactor VIII inhibitor bypassing activity: XM3P96\\nCoagulation factor VII: XM58W5\\nCoagulation factor XIII: XM1UV6\\nCoagulation factor VIIa: XM0A85\\nVon Willebrand factor: XM25U1\\nCatridecacog: XM4S88\\nCoagulation factor X: XM2RZ4\\nSusoctocog alfa: XM6B13\\nThrombocytes: XM7KC2\\nStem cells from umbilical cord blood: XM6GB5\\nSerum complement inhibitor: XM7JU3\\nSerum hemolytic complement: XM08V1\\nEpoetin beta: XM8VX7\\nRed blood cells packed: XM26D5\\nCalcium ferrous citrate: XM8ZX9\\nDextriferron: XM6S51\\nFerric chloride: XM5DJ4\\nFerric hydroxide colloidal: XM60G9\\nFerric hydroxide polymaltose: XM9W49\\nFerric pyrophosphate: XM2C90\\nFerritin: XM55G4\\nFerrocholinate: XM8GJ1\\nFerrodextrane: XM3SU9\\nFerropolimaler: XM1018\\nFerrous fumerate gluconate lactate salt sulfate medicinal: XM7EW8\\nFerrous phosphate: XM2LA7\\nFerrous salt: XM8L47\\nIron compounds medicinal: XM8Z42\\nIron ammonium: XM6FS8\\nIron dextran injection: XM7PP8\\nIron salts: XM54R9\\nIron sorbitol citric acid complex: XM3EH2\\nIsomaltose ferric complex: XM8KK0\\nJectofer: XM77C5\\nPolyferose: XM1Y67\\nSodium iron edetate: XM5SE8\\nSaccharated iron oxide: XM85E8\\nSodium feredetate: XM5HE0\\nFerrous glycine sulfate: XM7E86\\nFerrous fumarate: XM04C6\\nFerrous gluconate: XM3N76\\nFerrous carbonate: XM2865\\nFerrous chloride: XM6UB4\\nFerrous succinate: XM8SK2\\nFerrous sulfate: XM3SQ1\\nFerrous tartrate: XM0FD3\\nFerrous aspartate: XM8638\\nFerrous ascorbate: XM0S20\\nFerrous iodine: XM1BG1\\nFerric sodium citrate: XM7FV2\\nFerric hydroxide: XM4HF0\\nFerric oxide polymaltose complexes: XM5AW9\\nChondroitin sulfateiron complex: XM6CK7\\nFerric acetyl transferrin: XM5L86\\nFerric proteinsuccinylate: XM8NX7\\nFerric maltol: XM4J31\\nFerrous amino acid complex: XM0216\\nSodium dipantoyl ferrate: XM6435\\nHydroxocobalamin: XM7CP9\\nFolic acid: XM7R82\\nMecobalamin: XM2AT9\\nCobalamine: XM2RU3\\nCyanocobalamin: XM9KD4\\nHematinic preparation: XM20E6\\nLeucovorin factor: XM16W1\\nErythropoietin: XM9130\\nCyanocobalamin tannin complex: XM09N3\\nCobamamide: XM2NR4\\nDarbepoetin alfa: XM7M42\\nMethoxy polyethylene glycolepoetin beta: XM66M0\\nPeginesatide: XM9D96\\nDaprodustat: XM27M4\\nVadadustat: XM59J5\\nAlidase: XM6Y81\\nAlpha amylase: XM0KX8\\nChymotrypsin: XM7NZ6\\nCocarboxylase: XM8P48\\nDeoxyribonuclease: XM1819\\nDiffusin: XM3HF5\\nEnzyme fibrolytic: XM3TF2\\nEnzyme thrombolytic: XM5GS9\\nHyaluronidase: XM0543\\nPancreatic dornase: XM2P48\\nPenicillinase: XM9J86\\nPronase: XM52N4\\nSerrapeptase: XM94J1\\nStreptodornase: XM93U7\\nSutilains: XM8183\\nTrypsin: XM40V6\\nReteplase: XM6RN7\\nSaruplase: XM04S7\\nDrotrecogin alfa activated: XM8K47\\nTenecteplase: XM5ZA2\\nProtein C: XM35D2\\nFibrinolysin and desoxyribonuclease: XM32Y3\\nFibrinolysin: XM4XM2\\nTissue plasminogen activator: XM9PZ9\\nCinhibitor plasma derived: XM9AX4\\nIcatibant: XM7TQ2\\nEcallantide: XM9192\\nConestat alfa: XM7M63\\nBerotralstat: XM2UN9\\nAbsorbable gelatin sponge: XM3RF2\\nOxidized cellulose: XM6EK6\\nTetragalacturonic acid hydroxymethylester: XM1MS7\\nAdrenalone: XM6BS8\\nCalcium alginate: XM1JS6\\nVoxelotor: XM8F45\\nAtosiban: XM8R05\\nFlibanserin: XM5EY9\\nAgni casti fructus: XM19G4\\nCimicifugae rhizoma: XM6DH4\\nPlastic intrauterine contraceptive device: XM92Y5\\nPlastic intrauterine contraceptive device with copper: XM0B44\\nPlastic intrauterine contraceptive device with progestogen: XM7P32\\nVaginal ring with progestogen and estrogen: XM2AH3\\nProgestogens and estrogens fixed combinations: XM9N33\\nLevonorgestrel with ethinylestradiol: XM65V3\\nGestodene and ethinylestradiol: XM4BC7\\nNorgestimate and ethinylestradiol: XM5PH2\\nNorelgestromin and ethinylestradiol: XM01B4\\nNomegestrol and estradiol: XM0QV1\\nChlormadinone and ethinylestradiol: XM3727\\nQuingestanol and ethinylestradiol: XM4AD5\\nLynestrenol and ethinylestradiol: XM9ZQ5\\nMegestrol and ethinylestradiol: XM3344\\nNorethisterone with ethinylestradiol: XM7D82\\nMedroxyprogesterone and ethinyloestradiol: XM6EU8\\nDesogestrel and ethinylestradiol: XM6Y16\\nDrospirenone and ethinylestradiol: XM3L86\\nDienogest and ethinylestradiol: XM5KE9\\nEthinylestradiol ethinyloestradiol with levonorgestrel: XM3WW4\\nEthinylestradiol ethinyloestradiol with norethisterone: XM7M76\\nEthynodiol with mestranol diacetate: XM8HJ8\\nProgestogens and estrogens sequential preparations: XM0ZZ0\\nEstrogens: XM70N0\\nDiethylstilbestrol: XM51S9\\nEpimestrol: XM7YR1\\nEstriol: XM4EH0\\nChlorotrianisene: XM1058\\nEstrone: XM8YK8\\nEstrogen conjugated: XM56M0\\nDienoestrol: XM6UC0\\nMethallenestril: XM4T41\\nPolyestradiol phosphate: XM3YX8\\nFosfestrol: XM03K8\\nPromestriene: XM7FC3\\nMoxestrol: XM7ST1\\nTibolone: XM70N6\\nEthinyloestradiol: XM1SV5\\nEstrogen: XM7CP4\\nProgestogens: XM9HA7\\nMedroxyprogesterone acetate depot: XM2HB5\\nGestonorone caproate: XM1KX5\\nLevonorgestrel: XM6U53\\nQuingestanol: XM1DX1\\nLynestrenol: XM8Y77\\nMegestrol: XM7KS3\\nNorethisterone: XM7LY6\\nDesogestrel: XM7ZG5\\nDrospirenone: XM7XY6\\nHydroxyprogesterone: XM0R79\\nProgesterone: XM3799\\nDydrogesterone: XM71X5\\nMedrogestone: XM4HQ9\\nNomegestrol: XM2LR3\\nDemegestone: XM6SD5\\nChlormadinone: XM5FK8\\nPromegestone: XM71B5\\nDienogest: XM0U58\\nAllylestrenol: XM77R9\\nEthisterone: XM0TH1\\nEthynodiol: XM6TX3\\nMethylestrenolone: XM37T7\\nEtonogestrel: XM94C4\\nNorgestrienone: XM31C0\\nAnhydrohydroxyprogesterone: XM6CL2\\nAntineoplastic combination estrogen: XM0W29\\nConjugated estrogenic substances: XM76F9\\nDelalutin: XM4DR7\\nDimestrol: XM49U4\\nDimethisterone: XM5RK3\\nEpiestriol: XM1P34\\nEstradiol benzoate: XM39W0\\nEstrogen with progesterone: XM2GR3\\nEstropipate: XM6133\\nGonadal tissue extract female: XM7JV9\\nHexestrol: XM8WE5\\nHydroxyestrone: XM4NZ9\\nHydroxyprogesterone caproate: XM5A00\\nMestranol: XM3AK8\\nNoretynodrel: XM1SH1\\nNormethandrone: XM1B43\\nOvarian hormone: XM3MJ7\\nOvarian stimulant: XM26R0\\nOxendolone: XM8AV0\\nPregnandiol: XM1K26\\nProgestogen: XM8FT3\\nQuinestradol: XM9HS1\\nQuinestrol: XM3HH8\\nSteroid antineoplastic hormone estrogen: XM0SU9\\nClomiphene: XM74M2\\nOrmeloxifene: XM1ZT8\\nCyclofenil: XM7P20\\nRaloxifene: XM2CF9\\nBazedoxifene: XM8818\\nLasofoxifene: XM4JW0\\nOspemifene: XM8HF1\\nMifepristone: XM4RW1\\nUlipristal: XM04R5\\nStanozolol: XM8VE0\\nMethandrostenolone: XM24D1\\nMestanolone: XM0E55\\nOxymesterone: XM1E21\\nOxymetholone: XM7WQ1\\nQuinbolone: XM8788\\nPrasterone: XM5Q72\\nOxandrolone: XM6327\\nNorethandrolone: XM5115\\nFluoxymesterone: XM29P0\\nMethyltestosterone: XM4TC8\\nTestosterone: XM3HM6\\nMesterolone: XM3QK3\\nAndrostalone: XM3478\\nAnabolic steroid: XM3BT9\\nAndrogen: XM65R6\\nAndrogenestrogen mixture: XM5CT6\\nAndrosterone: XM89R1\\nAntineoplastic steroid: XM7LM1\\nCalusterone: XM0T50\\nCongener anabolic: XM1SV6\\nDromostanolone: XM1RM3\\nDurabolin: XM81H5\\nEpitiostanol: XM76Q0\\nEstradiol with testosterone: XM3UJ6\\nGonadal tissue extract male: XM7X01\\nMacrolide anabolic drug: XM6R95\\nMepitiostane: XM21D8\\nMetenolone: XM2GQ1\\nMethandriol: XM6966\\nMethyl androstanolone: XM8HC6\\nNandrolone: XM8NZ0\\nSteroid androgenic: XM3KV3\\nSteroid antineoplastic hormone: XM1KA5\\nTestolactone: XM5T49\\nZeranol: XM50S2\\nEthylestrenol: XM54A1\\nOxabolone cipionate: XM6RN8\\nDrugs for urinary frequency and incontinence: XM11B1\\nPhenyl salicylate: XM1TG5\\nAcetohydroxamic acid: XM5549\\nPhenazopyridine: XM2VJ5\\nDimethyl sulfoxide: XM1JS5\\nPentosan polysulfate sodium: XM8GM2\\nTiopronin: XM2D76\\nSuccinimide: XM6VX1\\nDapoxetine: XM8BX6\\nPrunus africanae cortex: XM3WK8\\nSabalis serrulatae fructus: XM5B91\\nFexapotide: XM2Y08\\nAdrenocorticotrophic hormone: XM5Y80\\nCorticotropin: XM7XJ1\\nTetracosactide: XM4B77\\nAnterior pituitary hormone: XM7309\\nCosyntropin: XM1EM4\\nFolliclestimulating hormone human: XM4MB2\\nFSH: XM1027\\nHuman growth hormone HGH: XM1NX7\\nLuteinizing hormone: XM86N5\\nMenotropins: XM92R5\\nPergonal: XM4QA7\\nPituitary extracts anterior: XM0Y82\\nProlactin: XM77Q1\\nSeractide: XM9NW5\\nSomatotropin: XM3LZ6\\nTetracosactrin: XM52T6\\nThyrotrophin: XM4WS0\\nThyrotropic hormone: XM7J71\\nUrofollitropin: XM8HC4\\nSomatropin and somatropin agonists: XM03E8\\nSomatrem: XM96L8\\nSermorelin: XM30J6\\nMecasermin: XM3038\\nPegvisomant: XM5CS4\\nMecasermin rinfabate: XM9BW0\\nTesamorelin: XM9109\\nSomatrogon: XM9WW0\\nChorionic gonadotrophin: XM49L1\\nHuman menopausal gonadotrophin: XM2J59\\nSerum gonadotrophin: XM5ZL8\\nFollitropin alfa: XM4K30\\nFollitropin beta: XM6EZ5\\nLutropin alfa: XM8TP5\\nChoriogonadotropin alfa: XM6HX4\\nCorifollitropin alfa: XM5M71\\nFollitropin delta: XM0RZ5\\nThyrotropin alfa: XM26R5\\nEnterogastrone: XM9EQ9\\nFelypressin: XM3MT8\\nGonadal tissue extract: XM6X07\\nGonadotropin: XM10K7\\nLeuprolide: XM3GP5\\nMelanocytestimulating hormone: XM7399\\nPituitary extracts posterior: XM00P3\\nPlacental hormone: XM0J12\\nPosterior pituitary hormone: XM5714\\nThymus extract: XM7LM2\\nVasopressor drugs: XM1Y33\\nVasopressin and analogues: XM25M7\\nVasopressin: XM6A76\\nDesmopressin: XM77T2\\nLypressin: XM3GU1\\nTerlipressin: XM4E12\\nOrnipressin: XM3LP5\\nOxytocin and analogues: XM1DB3\\nOxytocin: XM9SN0\\nDemoxytocin: XM41G8\\nCarbetocin: XM4ZX0\\nBuserelin: XM32E8\\nGoserelin: XM8CG4\\nGonadorelin: XM2TU9\\nNafarelin: XM4VT6\\nHistrelin: XM78X7\\nLeuprorelin: XM3S25\\nSomatostatin and analogues: XM9XC3\\nSomatostatin: XM5L29\\nOctreotide: XM01Z4\\nLanreotide: XM7GZ3\\nVapreotide: XM28Z2\\nPasireotide: XM3AN9\\nCabergoline: XM4S44\\nMetergoline: XM7828\\nQuinagolide: XM96P1\\nTerguride: XM3MG0\\nAdrenal extract cortex or medulla glucocorticoids hormones mineralocorticoids: XM51K6\\nBetamethasone: XM6SU0\\nClocortolone: XM0XB5\\nCloprednol: XM4AF4\\nCompound E cortisone: XM3R56\\nCompound F hydrocortisone: XM4HH6\\nCortate: XM6FJ6\\nCorticosteroid: XM6TY3\\nCortisone: XM5AE3\\nCortivazol: XM17S1\\nCortone: XM25L1\\nDeflazacort: XM5CF7\\nDexamethasone: XM72R5\\nFluorinated corticosteroids: XM48E4\\nFluprednisolone: XM2GK4\\nGlucocorticoids: XM4Z52\\nHormone adrenal cortical steroids: XM0XY8\\nKenacort: XM2UL5\\nMeprednisone: XM5V41\\nParamethasone: XM4RH1\\nPercorten: XM5AM2\\nPrednisolone: XM6JJ4\\nPrednisone: XM39W4\\nPrednylidene: XM3YJ1\\nSteroid: XM8JY6\\nFluocortolone: XM5FR6\\nTriamcinolone: XM4J30\\nHydrocortisone: XM21H0\\nBudesonide: XM3UP9\\nFlunisolide: XM9VX0\\nMometasone: XM8PN0\\nFluticasone: XM5PW9\\nMethylprednisolone: XM3FX7\\nRimexolone: XM3SM4\\nBeclometasone: XM3293\\nCiclesonide: XM4TY1\\nFluticasone furoate: XM1XF3\\nTrilostane: XM7DQ5\\nOsilodrostat: XM8676\\nGonadotrophinreleasing hormone antagonists: XM6W81\\nGanirelix: XM5JS1\\nCetrorelix: XM8Z22\\nElagolix: XM5064\\nAbarelix: XM5ZS9\\nDegarelix: XM8292\\nLinzagolix: XM3NR0\\nAntiestrogen: XM10A6\\nTamoxifen: XM2UX2\\nToremifene: XM1312\\nFulvestrant: XM2ZV3\\nAntiandrogen: XM7JF4\\nFlutamide: XM3G31\\nNilutamide: XM9AL0\\nBicalutamide: XM5FE9\\nEnzalutamide: XM7BF6\\nApalutamide: XM6Q81\\nDarolutamide: XM3FZ0\\nAromatase inhibitors: XM9X91\\nAminoglutethimide: XM7D25\\nFormestane: XM14P8\\nAnastrozole: XM4Z64\\nLetrozole: XM2J37\\nVorozole: XM6976\\nExemestane: XM2VT0\\nAntigonadotrophin: XM8MB2\\nCyproterone: XM3C58\\nDanazol: XM0FW7\\nNafoxidine: XM9QT3\\nTaleranol: XM0P47\\nMepartricin: XM40Q3\\nTestosteronealpha reductase inhibitors: XM3028\\nFinasteride: XM8P68\\nDutasteride: XM01Y3\\nGestrinone: XM7E94\\nAbiraterone: XM1517\\nRelugolix: XM5XB7\\nDetrothyronine: XM68B8\\nDextrothyroxine: XM2YU4\\nDextrothyroxine sodium: XM27J7\\nEuthroid: XM5M40\\nHormone thyroid: XM93X7\\nLevoid: XM10Z7\\nLevothyroxine: XM5G81\\nLevothyroxine sodium: XM2WC1\\nLiothyronine: XM2XB6\\nLiotrix: XM0P56\\nProloid: XM9RU3\\nSodium Ltriiodothyronine: XM65J7\\nThyroglobulin: XM66B8\\nThyroxine: XM5685\\nTiratricol: XM4H64\\nTitroid: XM5590\\nLiothyronine sodium: XM47Z3\\nThyroid gland preparations: XM8CX3\\nBenzylthiouracil: XM1H03\\nCarbimazole: XM35K1\\nDiiodotyrosine: XM6Y24\\nIodine  therapeutic: XM8492\\nIodine for thyroid conditions antithyroid: XM6VL9\\nIothiouracil: XM7TM9\\nMethimazole: XM38T7\\nMethylthiouracil: XM54P6\\nPotassium perchlorate antithyroid: XM6V39\\nPotassium perchlorate medicinal: XM9LL4\\nPropylthiouracil: XM5DE7\\nThiouracil benzyl methyl propyl: XM8X98\\nThiourea: XM3G29\\nDibromotyrosine: XM2MJ8\\nSodium iodide: XM8AS5\\nGlucagon: XM9N95\\nParathyroid gland extract: XM7GD6\\nTeriparatide: XM59Z3\\nParathyroid hormone: XM4RN4\\nCalcitonin preparations: XM0S16\\nCalcitonin salmon synthetic: XM74V3\\nCalcitonin pork natural: XM28Z6\\nCalcitonin human synthetic: XM32U7\\nElcatonin: XM6US3\\nCinacalcet: XM40P9\\nParicalcitol: XM9LS5\\nDoxercalciferol: XM48A9\\nEtelcalcetide: XM0NY4\\nInsulin human: XM21C9\\nAntidiabetic: XM8S35\\nAntidiabetic biguanide and sulfonyl combined: XM9AX5\\nBiguanides: XM5DC4\\nPhenformin: XM4K79\\nMetformin: XM0JN5\\nBuformin: XM6EJ2\\nProguanil: XM0S91\\nCycloguanil embonate: XM0EG5\\nAntidiabetic combined: XM5SK7\\nSulfonylureas: XM11C9\\nChlorpropamide: XM8S18\\nTolbutamide: XM1RV6\\nGlibornuride: XM8E97\\nTolazamide: XM8YD0\\nCarbutamide: XM8ZU0\\nGlipizide: XM3TQ4\\nGliquidone: XM8597\\nGliclazide: XM2G21\\nGlisoxepide: XM65J8\\nAcetohexamide: XM60R0\\nMetahexamide: XM5N48\\nGlimepiride: XM5N74\\nBiguanide derivatives oral: XM6932\\nGlimidine: XM06A4\\nGlisolamide: XM2584\\nGlobin zinc insulin: XM4SE3\\nGlyburide: XM6JN8\\nGlyclopyramide: XM0K09\\nGlycyclamide: XM6861\\nGlymidine sodium: XM88E8\\nHormone antidiabetic agents: XM4M26\\nIletin: XM5MV9\\nInsular tissue extract: XM4C63\\nInsulin amorphous globin isophane Lente NPH Semilente Ultralente: XM2JC7\\nInsulin defalan: XM3RW5\\nBiphasic insulin injection: XM16M5\\nInsulin injection soluble: XM1DZ9\\nInsulin intermediate acting: XM9728\\nInsulin protamine zinc: XM54Q2\\nInsulin slow acting: XM0KT2\\nProtamine zinc insulin injection: XM7VD3\\nInsulin zinc suspension amorphous crystalline: XM0US2\\nIsophane insulin: XM73L8\\nLente iletin insulin: XM9AZ3\\nNeutral insulin injection: XM8502\\nNPH iletin insulin: XM8VX4\\nProtamine sulfate zinc insulin: XM3J06\\nPZI: XM8QQ1\\nSulfonylurea derivatives oral: XM73P6\\nInsulins and analogues: XM99F8\\nAlpha glucosidase inhibitors: XM2WY1\\nAcarbose: XM9JV9\\nMiglitol: XM9EX0\\nVoglibose: XM4QD6\\nAcedapsone: XM19U1\\nAcesulfamethoxypyridazine: XM91Z9\\nAcetylsulfamethoxypyridazine: XM1RU4\\nDiaphenylsulfone: XM7WC8\\nDisulfanilamide: XM96M6\\nNeoprontosil: XM3GA0\\nPhthalylsulfathiazole: XM1RY1\\nProntosil: XM55D8\\nSuccinylsulfathiazole: XM85A7\\nSulfachlorpyridazine: XM69G3\\nSulfacitine: XM5C46\\nSulfadoxine: XM57L7\\nSulfaethidole: XM03X3\\nSulfaguanidine: XM0F36\\nSulfaloxate: XM6N26\\nSulfaloxic acid: XM57M8\\nSulfameter: XM8UP5\\nSulfamethylthiazole: XM5X85\\nSulfamonomethoxine: XM6D90\\nSulfaphenylthiazole: XM2187\\nSulfaproxyline: XM8QW8\\nSulfasalazine: XM2XQ2\\nSulfasuxidine: XM9MJ3\\nSulfasymazine: XM2Y59\\nSulfisomidine: XM6BM7\\nTrisulfapyrimidines: XM7Z85\\nGlymidine: XM5EH1\\nThiazolidinediones: XM4UA3\\nTroglitazone: XM0NQ7\\nRosiglitazone: XM27D8\\nPioglitazone: XM0TX6\\nDipeptidyl peptidase  inhibitors: XM9SM6\\nSitagliptin: XM4M71\\nVildagliptin: XM9867\\nSaxagliptin: XM5QH2\\nAlogliptin: XM1044\\nLinagliptin: XM9X94\\nGemigliptin: XM5T11\\nEvogliptin: XM5SF9\\nGlucagonlike peptide analogues: XM4MK4\\nExenatide: XM06C6\\nLiraglutide: XM0EQ7\\nLixisenatide: XM3U71\\nAlbiglutide: XM2516\\nDulaglutide: XM1FT0\\nSemaglutide: XM9KJ3\\nMeglitinide: XM0FD1\\nRepaglinide: XM9V31\\nNateglinide: XM5Z74\\nMitiglinide: XM7967\\nOther blood glucose lowering drugs: XM9EK1\\nPramlintide: XM62R6\\nTeduglutide: XM7VJ0\\nSodiumglucose cotransporter  inhibitors: XM0615\\nDapagliflozin: XM97T4\\nCanagliflozin: XM1NP2\\nEmpagliflozin: XM9RW3\\nErtugliflozin: XM66V1\\nIpragliflozin: XM8Y84\\nSotagliflozin: XM7947\\nInsulin beef: XM29C4\\nInsulin pork: XM8YE2\\nInsulin lispro: XM6NY5\\nInsulin aspart: XM0HQ0\\nInsulin glulisine: XM7WH3\\nInsulin detemir: XM96W1\\nInsulin degludec: XM6R62\\nTolrestat: XM65E7\\nImeglimin: XM93G5\\nCholecystokinin: XM5374\\nClodronic acid: XM7171\\nEtidronic acid: XM6UW3\\nPamidronic acid: XM55G3\\nAlendronic acid: XM94M8\\nTiludronic acid: XM2M01\\nIbandronic acid: XM93D5\\nRisedronic acid: XM5CM8\\nZoledronic acid: XM5908\\nDibotermin alfa: XM5GF1\\nEptotermin alfa: XM8NB9\\nCollagen: XM94X8\\nChymopapain: XM2UE2\\nBromelains: XM6F64\\nCollagenase clostridium histolyticum: XM0NQ8\\nIpriflavone: XM4GT8\\nAluminium chlorohydrate: XM5AP2\\nStrontium ranelate: XM6U91\\nDenosumab: XM2P79\\nBurosumab: XM4MQ4\\nRomosozumab: XM7AJ2\\nHyaluronic acid: XM6EQ0\\nChondrocytes autologous: XM2SL6\\nVosoritide: XM99J5\\nPreparations inhibiting uric acid production: XM2ZB4\\nAllopurinol: XM9589\\nTisopurine: XM47Z2\\nFebuxostat: XM0K04\\nPreparations increasing uric acid excretion: XM7F05\\nProbenecid: XM0WT0\\nSulfinpyrazone: XM7K05\\nBenzbromarone: XM9DK8\\nIsobromindione: XM3WF1\\nLesinurad: XM95H8\\nAtophan: XM2D08\\nCinchophen: XM3WA0\\nEthebenecid: XM0M93\\nNeocinchophen: XM5VG7\\nOxipurinol: XM6FA5\\nPhenoquin: XM3JP7\\nSpindle inactivator: XM9DH5\\nUrate oxidase: XM56G7\\nUric acid metabolism drug: XM95S3\\nUricosuric agent: XM6953\\nPegloticase: XM9TL4\\nCalcium: XM8KC2\\nCalcium phosphate: XM1AY1\\nCalcium glubionate: XM7ND2\\nCalcium gluconate: XM3EU2\\nCalcium lactate: XM46G3\\nCalcium acetate: XM0VY0\\nCalcium lactate gluconate: XM4N33\\nCalcium glycerylphosphate: XM9WA2\\nCalcium citrate lysine complex: XM4X88\\nCalcium glucoheptonate: XM08S9\\nCalcium pangamate: XM7G46\\nCalcium acetate anhydrous: XM5TW4\\nCalcium citrate: XM4S97\\nCalcium laevulate: XM6AK3\\nCalcium bromolactobionate: XM8AM9\\nCalcium salts: XM9566\\nPotassium: XM8278\\nPotassium citrate: XM7D96\\nPotassium bitartrate: XM46S4\\nPotassium bicarbonate: XM56J9\\nPotassium gluconate: XM2P49\\nPotassium salts: XM0H50\\nSodium: XM1ZS4\\nSodium acid phosphate: XM0VG1\\nSodium biphosphate: XM6R29\\nSodium cyclamate: XM8ZD6\\nSodium hydrogen carbonate: XM9KZ3\\nSodium magnesium citrate: XM7L15\\nSodium salt: XM3H90\\nZinc: XM1U95\\nZinc chloride nonmedicinal: XM3E63\\nZinc chromate: XM52P2\\nZinc oxide nonmedicinal: XM93K2\\nZinc phosphide: XM6D77\\nZinc sulfate nonmedicinal: XM82L3\\nZinc pesticide not elsewhere classified: XM27E8\\nZinc sulfate: XM68Z2\\nZinc gluconate: XM5WL8\\nZinc protein complex: XM0418\\nZinc acetate: XM3R55\\nMagnesium: XM5TD2\\nMagnesium citrate: XM7KF0\\nMagnesium gluconate: XM1AU1\\nMagnesium aspartate: XM2U66\\nMagnesium lactate: XM3U21\\nMagnesium levulinate: XM8W21\\nMagnesium pidolate: XM9GU6\\nMagnesium orotate: XM8P82\\nMagnesium silicofluoride: XM5VT1\\nFluoride: XM1VS5\\nSodium fluoride: XM1F39\\nSodium monofluorophosphate: XM82S0\\nSelenium: XM47M7\\nSelenium fumes: XM4HH9\\nSodium selenate: XM5RR4\\nSodium selenite: XM7809\\nAcetic acid irrigating solution: XM6777\\nAminoacetic acid derivatives: XM7KG7\\nCarbacrylamine resin: XM6DF0\\nDialysis solution intraperitoneal: XM1619\\nElectrolytic agent: XM6YF0\\nGlucose with sodium chloride: XM6598\\nGlycerol intravenous: XM02Y3\\nGlycine: XM7NQ3\\nLactated potassic saline: XM8UU5\\nMineral salt: XM5FN3\\nPolyaminostyrene resins: XM6P40\\nPotassic saline injection lactated: XM3UT8\\nRinger solution lactate: XM11X8\\nSodium free salt: XM6XG7\\nTravert: XM7JQ2\\nWater balance drug: XM1DP8\\nWater distilled: XM5N49\\nWater purified: XM9V59\\nCobalt medicinal trace chloride: XM8323\\nCopper medicinal trace: XM5DN1\\nDietary supplements rich in vitamins and antioxidants: XM3046\\nLiver extract: XM7113\\nLiver fraction: XM9GC7\\nLiver hydrolysate: XM25P4\\nCodliver oil: XM09R3\\nYeast: XM9FC4\\nYeast dried: XM2W18\\nReadytouse therapeutic food: XM40J4\\nSolutions producing osmotic diuresis: XM0N15\\nMannitol: XM5BJ8\\nCarbamide: XM4HL5\\nAntikaluretic: XM62S0\\nCaloric agent: XM51Y8\\nDextrose: XM7BR0\\nElectrolyte balance drug: XM7UQ5\\nElectrolyte solutions: XM9SL7\\nPotassium chloride: XM0U09\\nSodium bicarbonate: XM4XZ4\\nSodium chloride: XM0X22\\nCalcium chloride: XM9VN8\\nAmmonium chloride: XM1W37\\nSodium phosphate: XM76C9\\nSodium acetate: XM7F36\\nMagnesium phosphate: XM6NV5\\nMagnesium chloride: XM03Q8\\nZinc chloride: XM40H8\\nSodium glycerophosphate: XM83Z9\\nPotassium lactate: XM3T43\\nCardioplegia solutions: XM99L3\\nPotassium acetate: XM45S7\\nCompound solution of sodium lactate: XM3US9\\nGluconic acid: XM7E16\\nGlycerophosphate: XM2S34\\nSodium citrate: XM61E9\\nHartmanns solution: XM5Y58\\nInvert sugar: XM0KH7\\nLevulose: XM9XU2\\nOral rehydration salts: XM39B5\\nPeritoneal dialysis solution: XM39C1\\nPotassiumremoving resin: XM03B7\\nPotassiumretaining drug: XM5KE7\\nReplacement solution: XM3UA2\\nSodium removing resins: XM4EK0\\nSucrose: XM9Y86\\nCarnitine: XM6JX1\\nElectrolytes: XM5S14\\nTrometamol: XM9QW3\\nAdemethionine: XM7345\\nGlutamine: XM1P36\\nMercaptamine: XM85F8\\nCarglumic acid: XM0977\\nFat emulsions: XM9GM1\\nCarbohydrates: XM4YU3\\nProtein hydrolysates: XM55C2\\nAminometradine: XM5W29\\nAmisometradine: XM2E81\\nAnhydron: XM8U06\\nBenzothiadiazides: XM8TM1\\nBenzylhydrochlorothiazide: XM0JW3\\nCarbonic acid gas anhydrase inhibitor: XM3ER5\\nChlorazanil: XM80T6\\nChlormerodrin: XM6946\\nDiupres: XM4JM8\\nDiuretic: XM4D06\\nDiuretic benzothiadiazine: XM68T7\\nDiuretic carbonic acid anhydrase inhibitors: XM8B36\\nDiuretic furfuryl: XM1N83\\nDiuretic mercurial: XM6VW0\\nDiuretic saluretic: XM43Q2\\nDiuretic sulfonamide: XM3558\\nDiuretic thiazide: XM58W3\\nDiurgin: XM04R3\\nFlumethiazide: XM5L31\\nHydromox: XM8T28\\nMeralluride: XM8HM6\\nMerbaphen: XM5R34\\nMercaptomerin: XM1SB8\\nMercumatilin: XM3PF7\\nMercurophylline: XM3L13\\nOsmotic diuretics: XM4B84\\nPurine diuretics: XM6BR0\\nRegroton: XM7660\\nSalicylate theobromine calcium: XM01E9\\nSaluretic: XM9409\\nSodium mersalate: XM7J43\\nThiomercaptomerin: XM9VJ2\\nThiomerin: XM1177\\nTiamizide: XM0YS2\\nTripamide: XM3YV1\\nXanthine diuretics: XM93H5\\nLowceiling diuretics: XM3K70\\nAltizide: XM5FV5\\nBendroflumethiazide: XM64R7\\nBenzthiazide: XM7Q17\\nButizide: XM83Q3\\nChlorothiazide: XM3PJ4\\nCyclopenthiazide: XM4SP9\\nCyclothiazide: XM1PM4\\nDisulfamide: XM71N6\\nEpitizide: XM8532\\nHydrochlorothiazide: XM6910\\nHydroflumethiazide: XM2671\\nMebutizide: XM3EW9\\nMethyclothiazide: XM9T97\\nPenflutizide: XM1DC4\\nPolythiazide: XM7NZ7\\nTeclothiazide: XM26G2\\nTrichlormethiazide: XM1L59\\nMersalyl: XM4AF6\\nCicletanine: XM0G11\\nLowceiling diuretic sulfonamides: XM6U69\\nQuinethazone: XM3WN8\\nClopamide: XM7A66\\nChlortalidone: XM51L8\\nMefruside: XM1DG9\\nClofenamide: XM0EZ6\\nMetolazone: XM7G39\\nMeticrane: XM3GK5\\nXipamide: XM4U11\\nIndapamide: XM49L3\\nClorexolone: XM8GT1\\nFenquizone: XM6CD1\\nAldosterone antagonists and other potassiumsparing agents: XM3L93\\nAldosterone: XM94A6\\nCanrenoic acid: XM6QK1\\nCanrenone: XM1ML2\\nEplerenone: XM0TH6\\nPotassium canrenoate: XM0ET8\\nSpironolactone: XM1JS8\\nFinerenone: XM8ZW7\\nAmiloride: XM1SM2\\nTriamterene: XM5SJ5\\nDiuretic loop highceiling: XM8CG7\\nEthacrynate sodium: XM79L6\\nEtacrynic acid: XM2LW1\\nEtozolin: XM1H00\\nLasix: XM06E2\\nLyovac Sodium Edecrin: XM2C78\\nTienilic acid: XM9KF7\\nMuzolimine: XM6M47\\nLoop highceiling diuretic sulfonamides: XM2W24\\nFurosemide: XM8UE3\\nBumetanide: XM6MV2\\nPiretanide: XM9ML2\\nTorasemide: XM4DR4\\nVasopressin antagonists: XM7VU2\\nTolvaptan: XM9LF5\\nConivaptan: XM25L2\\nAntagonist Aldosterone: XM44R0\\nCorticosteroid mineral: XM8CC8\\nSaltretaining mineralocorticoid: XM4HZ4\\nDeoxycortone: XM9SX2\\nDesoxycorticosteroid: XM6PJ9\\nDesoxycortone: XM9HZ6\\nFludrocortisone: XM6JQ6\\nMineralocorticosteroid: XM9X54\\nVitamin D: XM5G71\\nErgocalciferol: XM75Z5\\nDihydrotachysterol: XM37C2\\nAlfacalcidol: XM3NT7\\nCalcitriol: XM85V3\\nCholecalciferol: XM11C6\\nCalcifediol: XM8SM6\\nB complex vitamins and derivates: XM4H09\\nBenfotiamine: XM5HF5\\nNicotinamide: XM4PS9\\nRiboflavin: XM8V93\\nBiotin: XM9RX3\\nPyridoxal phosphate: XM4GD2\\nDexpanthenol: XM41P5\\nCalcium pantothenate: XM7398\\nThiamine: XM50T4\\nsulbutiamine: XM42G9\\nVitamin Bcomplex plain: XM2SV4\\nPotassium aminobenzoate: XM0Y25\\nAcetiamine: XM3UQ2\\nBisbentiamine: XM3HE8\\nBisbutiamine: XM5LG0\\nCetotiamine: XM8SY7\\nFursultiamine: XM20C9\\nOctotiamine: XM9609\\nPanthenol: XM72U8\\nProsultiamine: XM7D01\\nPyridoxine: XM5MM0\\nAscorbic acid: XM7XY8\\nTocopherol: XM1PU6\\nVitamin E: XM5TU4\\nThioctic acid: XM9CG5\\nOctyl gallate: XM1SD9\\nSodium metabisulfite: XM88X6\\nChlorophyll: XM4BD4\\nThioctamide: XM31S0\\nPangamic acid: XM2EM5\\nBetacarotene: XM7E89\\nRetinol: XM4BT6\\nChenodeoxycholic acid: XM7KX6\\nUrsodeoxycholic acid: XM8MG9\\nCholic acid: XM37T5\\nDiastase: XM1F53\\nMultienzymes: XM5888\\nProtease: XM2VN0\\nPepsin: XM3UE5\\nHydrochloric acid: XM6F61\\nHydrochloric acid vapor: XM6QZ3\\nCitric acid: XM3RH9\\nAlglucerase: XM96V4\\nObeticholic acid: XM51F9\\nGlutamic acid hydrochloride: XM3UT3\\nBetaine hydrochloride: XM7Y97\\nImiglucerase: XM7EN2\\nAgalsidase alfa: XM3EW0\\nAgalsidase beta: XM1CJ9\\nLaronidase: XM4PC4\\nSacrosidase: XM69V4\\nAlglucosidase alfa: XM3EE9\\nGalsulfase: XM11U1\\nIdursulfase: XM3Z98\\nVelaglucerase alfa: XM8J61\\nTaliglucerase alfa: XM8HN5\\nElosulfase alfa: XM7QH6\\nAsfotase alfa: XM5U98\\nSebelipase alfa: XM6UN5\\nVelmanase alfa: XM5U91\\nIdursulfase beta: XM98F5\\nCerliponase alfa: XM9L40\\nVestronidase alfa: XM3FP4\\nPegvaliase: XM8F43\\nPegunigalsidase alfa: XM30U5\\nAtidarsagene autotemcel: XM56M4\\nAvalglucosidase alfa: XM9F01\\nArginine glutamate: XM4HD8\\nSilymarin: XM5RS5\\nEpomediol: XM6T01\\nOrnithine: XM1GT0\\nNicotinyl methylamide: XM1R31\\nPiprozolin: XM03F0\\nHymecromone: XM0HT0\\nCyclobutyrol: XM2EM9\\nCitiolone: XM0413\\nTidiacic arginine: XM0F81\\nAnethole trithione: XM7600\\nSodium dehydrocholate: XM8B34\\nMonooctanoin: XM56J1\\nOrazamide: XM44G8\\nTidiacic: XM3E24\\nMaralixibat chloride: XM3VV1\\nOdevixibat: XM30B2\\nBenfluorex: XM9UB7\\nCentrally acting antiobesity products: XM2AF4\\nPhentermine: XM5VK3\\nFenfluramine: XM5TZ8\\nAmfepramone: XM84W9\\nDexfenfluramine: XM5WS4\\nMazindol: XM25W6\\nCathine: XM8K95\\nClobenzorex: XM2NX7\\nMefenorex: XM3DL8\\nEtilamfetamine: XM7830\\nSibutramine: XM13P5\\nLorcaserin: XM4NN9\\nAminorex: XM54E8\\nBenzphetamine: XM4DD3\\nChlorphentermine: XM16Q1\\nCloforex: XM3AJ4\\nClortermine: XM8H60\\nDiethylpropion: XM5FP0\\nFenproporex: XM1145\\nPhenbutrazate: XM4PR1\\nPhendimetrazine: XM6AJ3\\nPhenmetrazine: XM73T8\\nSetmelanotide: XM5DN4\\nOrlistat: XM0NL0\\nRimonabant: XM7GX4\\nAmfetamine and amfetamine derivatives: XM2520\\nAmfetamine: XM48Z9\\nFencamfamin: XM2154\\nFenetylline: XM8N26\\nLisdexamfetamine: XM4SD7\\nSolriamfetol: XM0462\\nSodium phenylbutyrate: XM5SC6\\nNitisinone: XM1843\\nMiglustat: XM19C6\\nSapropterin: XM6ZV0\\nGlycerol phenylbutyrate: XM4F44\\nEliglustat: XM0K95\\nSodium benzoate: XM2QP5\\nMigalastat: XM6QN8\\nCholine chloride: XM53N4\\nCholine dihydrogen citrate: XM3KK0\\nInositol: XM7291\\nAdenine: XM9J35\\nFlavine adenine dinucleotide: XM3CJ7\\nFosdenopterin: XM7ZH6\\nLonafarnib: XM4L78\\nImidapril: XM4MG6\\nAngiotensinconvertingenzyme inhibitors: XM72L5\\nRenininhibitors: XM3FH7\\nZofenopril: XM9N15\\nSpirapril: XM8091\\nRamipril: XM2A48\\nQuinapril: XM3DU1\\nPerindopril: XM58G7\\nLisinopril: XM7TF8\\nFosinopril: XM4Z53\\nEnalaprilat: XM5609\\nEnalapril: XM6X56\\nCilazapril: XM1AZ4\\nCaptopril: XM6P97\\nBenazepril: XM0HG1\\nAngiotensin II antagonists: XM7169\\nLosartan: XM7DY0\\nEprosartan: XM2F90\\nValsartan: XM29M2\\nIrbesartan: XM1935\\nTasosartan: XM0T42\\nCandesartan: XM4168\\nTelmisartan: XM2P63\\nOlmesartan medoxomil: XM1B39\\nAzilsartan: XM5GC5\\nFimasartan: XM2T51\\nAlacepril: XM3YY8\\nTrandolapril: XM3F15\\nDelapril: XM3DT0\\nMoexipril: XM6DX1\\nTemocapril: XM25N5\\nHMG CoA reductase inhibitors: XM5SK2\\nSimvastatin: XM7AU9\\nPravastatin: XM7SM7\\nLovastatin: XM72M6\\nFluvastatin: XM5UF1\\nAtorvastatin: XM2WF6\\nCerivastatin: XM0M94\\nRosuvastatin: XM6NK5\\nPitavastatin: XM8420\\nFibrates: XM1KP1\\nClofibrate: XM19J9\\nBezafibrate: XM3F75\\nAluminium clofibrate: XM7929\\nGemfibrozil: XM01S9\\nFenofibrate: XM73E0\\nSimfibrate: XM6MW5\\nRonifibrate: XM39Z8\\nCiprofibrate: XM9HU7\\nEtofibrate: XM4390\\nClofibride: XM93U8\\nCholine fenofibrate: XM9554\\nBile acid sequestrants: XM1W44\\nColestyramine: XM0HQ4\\nColestipol: XM0KK8\\nColextran: XM5RQ3\\nColesevelam: XM6MC3\\nNicotinic acid and derivatives: XM0563\\nInositol nicotinate: XM5QD1\\nCiclonicate: XM48Y3\\nAcipimox: XM6QT0\\nOxiniacic acid: XM2KX4\\nAntiarteriosclerotic drug: XM3N68\\nAnticholesterolemic drug: XM2EA3\\nAntihyperlipidemic drug: XM3108\\nAntilipemic drug: XM4FN5\\nbbenzalbutyramide: XM2GM2\\nbsitosterol s: XM4KW6\\nBenzalbutyramide: XM6BA8\\nBenzyl nicotinate: XM4WS4\\nBinifibrate: XM43X4\\nCholesterollowering agents: XM35X4\\nCholestyramine resin: XM8FB5\\nClinofibrate: XM2LR7\\nClofibric acid: XM6DX0\\nCyamopsis tetragonoloba: XM2R17\\nDetaxtran: XM8K49\\nEthylparachlorophenoxyisobutyrate: XM8FC2\\nEtiroxate: XM0TN1\\nEtofylline clofibrate: XM6B07\\nGuar gum medicinal: XM6DW9\\nHalofenate: XM4E46\\nIon exchange resin cholestyramine: XM2WA3\\nLinoleic acid: XM0H99\\nLinolenic acid: XM5VN6\\nMesoglycan: XM0KD7\\nOleic acid: XM45F6\\nPirozadil: XM68L2\\nPolidexide sulfate: XM1Q10\\nProbucol: XM4UK3\\nSafflower oil: XM2YX6\\nSitosterols: XM5F26\\nSoysterol: XM2LX5\\nSunflower seed oil: XM3C43\\nTriparanol: XM95B1\\nUnsaturated fatty acid: XM3PL9\\nOmegatriglycerides: XM2KC4\\nTiadenol: XM2AL6\\nMeglutol: XM44B6\\nMagnesium pyridoxal phosphate glutamate: XM10P8\\nPolicosanol: XM9HP8\\nEzetimibe: XM5BK7\\nAlipogene tiparvovec: XM52K4\\nMipomersen: XM7049\\nLomitapide: XM3RL5\\nEvolocumab: XM9F64\\nAlirocumab: XM1LB0\\nEvinacumab: XM2KT4\\nVolanesorsen: XM4RG7\\nSelective calciumchannel blockers: XM8BT9\\nDihydropyridine derivatives: XM3D74\\nFelodipine: XM1BZ0\\nIsradipine: XM1SC0\\nNicardipine: XM3L32\\nNifedipine: XM3N90\\nNimodipine: XM5TX8\\nNisoldipine: XM5W45\\nNitrendipine: XM17Z8\\nLacidipine: XM2QH8\\nAmlodipine: XM68M5\\nNilvadipine: XM6PC3\\nManidipine: XM3GA2\\nBarnidipine: XM84M5\\nLercanidipine: XM3MV9\\nCilnidipine: XM3TF3\\nBenidipine: XM8EW6\\nClevidipine: XM5GS7\\nLevamlodipine: XM91L4\\nPhenylalkylamine derivatives selective: XM2XU6\\nVerapamil: XM5GX3\\nGallopamil: XM2WH6\\nMibefradil: XM6GX5\\nDiltiazem: XM5K59\\nTiapamil: XM1EL1\\nOxodipine: XM3BC0\\nNonselective calciumchannel blockers: XM2JS2\\nPhenylalkylamine derivatives nonselective: XM6T88\\nBepridil: XM1LR8\\nFendiline: XM5BR3\\nLidoflazine: XM3NU8\\nMoxonidine hydrochloride: XM0T83\\nCardiac glycosides: XM5JS3\\nDigitalis glycosides: XM2EL5\\nAcetyldigitoxin: XM0QK0\\nAcetyldigoxin: XM1640\\nDigitalis leaves: XM2GT4\\nDigoxin: XM8VJ6\\nDigitoxin: XM13W9\\nLanatoside C: XM8036\\nDeslanoside: XM8XH2\\nMetildigoxin: XM37V6\\nGitoformate: XM2505\\nScilla glycosides: XM71V6\\nProscillaridin: XM1EG1\\nStrophanthus glycosides: XM6GX1\\nCymarin: XM30Z9\\ngStrophanthin: XM9YU9\\nPeruvoside: XM3WU3\\nPhosphodiesterase inhibitors: XM2PQ4\\nAmrinone: XM0QD0\\nMilrinone: XM6JT4\\nEnoximone: XM2H68\\nBucladesine: XM4BC1\\nPredominantly alphaadrenoreceptor and dopamine receptor agonists: XM1K71\\nDopamine: XM9NM4\\nNorfenefrine: XM2A75\\nOxedrine: XM5HS9\\nMetaraminol: XM6L38\\nMethoxamine: XM2CG2\\nGepefrine: XM4B54\\nIbopamine: XM1641\\nDimetofrine: XM6LP2\\nDopexamine: XM4ZY2\\nMidodrine: XM79K5\\nFenoldopam: XM91X4\\nCafedrine: XM2BX9\\nTheodrenaline: XM1CS6\\nDexmedetomidine: XM9QY5\\nAmidefrine mesilate: XM38P3\\nFenoxazoline: XM7AV8\\nIndanazoline: XM0H59\\nMetizoline: XM5J98\\nNaphazoline: XM3Q12\\nOxymetazoline: XM4KH5\\nPropylhexedrine: XM4435\\nTramazoline: XM1RJ9\\nTuaminoheptane: XM8706\\nTymazoline: XM0240\\nXylometazoline: XM8US0\\nAgonist predominantly betaadrenoreceptor: XM96M5\\nAngiotensin: XM10L5\\nBeclomethasone: XM3D85\\nDobutamine: XM4E14\\nPrenalterol: XM18Q9\\nRacepinephrine: XM5HL3\\nRitodrine: XM1CS3\\nSelective betaadrenoceptor agonists: XM1X48\\nSalbutamol: XM8MA0\\nTerbutaline: XM6NE3\\nFenoterol: XM2HS2\\nClenbuterol: XM3NS3\\nReproterol: XM7MM4\\nProcaterol: XM2YD0\\nBitolterol: XM15R7\\nBambuterol: XM2U16\\nIndacaterol: XM51C1\\nOlodaterol: XM1QR3\\nBroxaterol: XM05Y4\\nCarbuterol: XM4ZB3\\nRimiterol: XM22C3\\nHexoprenaline: XM1GA5\\nIsoetarine: XM8ZC3\\nPirbuterol: XM1QR7\\nTretoquinol: XM3GQ2\\nTulobuterol: XM2YE0\\nSalmeterol: XM6B34\\nClorprenaline: XM27W7\\nEtafedrine: XM4YX5\\nIbuterol: XM55D7\\nLevalbuterol: XM6EU7\\nFormoterol: XM0QJ7\\nIsoprenaline: XM6KG3\\nOrciprenaline: XM6AG0\\nMethoxyphenamine: XM78W6\\nOctopamine: XM9TS0\\nArbutamine: XM17S3\\nProtokylol: XM0FE9\\nAlpha acetyldigoxin: XM7YK1\\nbacetyldigoxin: XM0SY1\\nCardiotonic glycoside: XM91S1\\nCerberin: XM1W74\\nChan su: XM5NG4\\nConvallaria glycosides: XM11U7\\nCrataegus extract: XM4Q19\\nDigitalin e: XM7RY5\\nDigitalis lanata: XM2SP4\\nDigitalis purpurea: XM3Y64\\nDigitoxose: XM0V98\\nGitalin: XM0DG3\\nGitaloxin: XM8K74\\nLanatosides: XM7KP5\\nMeproscillarin: XM2X57\\nOleandrin: XM6AA6\\nOuabain e: XM0N63\\nPengitoxin: XM02F5\\nSquill: XM77L9\\nStrophanthin: XM2AW9\\nAngiotensinamide: XM0EP6\\nXamoterol: XM45U9\\nLevosimendan: XM88B5\\nAngiotensin II: XM11H1\\nAntiarrhythmics class Ia: XM2FU1\\nQuinidine: XM8AL5\\nProcainamide: XM4MK3\\nDisopyramide: XM8B35\\nSparteine: XM9ZC0\\nAjmaline: XM5CS7\\nLorajmine: XM18V8\\nHydroquinidine: XM0D87\\nPrajmaline: XM6FW1\\nAntiarrhythmics class Ib: XM7844\\nLidocaine: XM2BR1\\nLidocaine regional: XM93V0\\nLidocaine spinal: XM4RU4\\nMexiletine: XM3XK1\\nTocainide: XM1V81\\nAprindine: XM37J0\\nAntiarrhythmics class Ic: XM0NC9\\nPropafenone: XM9R82\\nFlecainide: XM1E38\\nLorcainide: XM04P2\\nEncainide: XM6TZ8\\nEthacizine: XM23Q8\\nAntiarrhythmics class III: XM1AP6\\nAmiodarone: XM3ZJ7\\nBretylium tosilate: XM3ZG2\\nBunaftine: XM56N7\\nDofetilide: XM1143\\nIbutilide: XM8AA1\\nTedisamil: XM8QN8\\nDronedarone: XM8K75\\nOther antiarrhythmics class I and III: XM5JW0\\nCibenzoline: XM1SV2\\nMoracizine: XM6KX7\\nVernakalant: XM6602\\nAntidysrhythmic: XM0KK7\\nCardiac depressants: XM9ZL3\\nCardiac rhythm regulator specified: XM2W76\\nCardiac rhythm regulator: XM88L7\\nPilsicainide: XM0Y13\\nPrajmalium bitartrate: XM64X0\\nQuinaglute: XM1NG6\\nTiracizine: XM7MH8\\nCentrally acting antiadrenergic agents: XM4X84\\nRauwolfia alkaloids: XM67X4\\nRescinnamine: XM9SB3\\nDeserpidine: XM7424\\nMethoserpidine: XM0ND0\\nReserpine: XM2764\\nRauwolfia alkaloids whole root: XM39Z4\\nBietaserpine: XM64M5\\nMethyldopa: XM9G49\\nMethyldopa levorotatory: XM54Y3\\nMethyldopa racemic: XM9ZV9\\nImidazoline receptor agonists: XM2298\\nClonidine: XM6GV8\\nGuanfacine: XM5KP4\\nTolonidine: XM9SU8\\nMoxonidine: XM4NH5\\nRilmenidine: XM6AB8\\nGanglionblocking antiadrenergic agents: XM7NT3\\nPeripherally acting antiadrenergic agents: XM8SX7\\nGuanidine derivatives: XM3EN5\\nBetanidine: XM8LD0\\nGuanethidine: XM3QD6\\nGuanoxan: XM3952\\nDebrisoquine: XM4L51\\nGuanoclor: XM4189\\nGuanoxabenz: XM4L63\\nGuanazodine: XM6N54\\nRipasudil: XM9M92\\nAgents affecting arteriolar smooth muscle: XM1AF9\\nThiazide derivatives: XM7XR3\\nDiazoxide: XM8YG1\\nHydrazinophthalazine derivatives: XM9021\\nDihydralazine: XM2FP9\\nHydralazine: XM8D89\\nEndralazine: XM1KN9\\nCadralazine: XM33U1\\nAntihypertensives for pulmonary arterial hypertension: XM8V56\\nBosentan: XM4KA3\\nAmbrisentan: XM8HR5\\nSitaxentan: XM7WR2\\nMacitentan: XM21T1\\nRiociguat: XM8BU0\\nAlkavervir: XM4NN7\\nAlseroxylon: XM28Y3\\nAmiquinsin: XM6T97\\nAntagonist serotonin: XM3WP0\\nAntihypertensive drug: XM2PT6\\nApresoline: XM0CY8\\nBenazepril hydrochloride: XM4FW8\\nBudralazine: XM5E71\\nCryptenamine tannates: XM9W04\\nDHE: XM8DJ7\\nDihydrazine: XM24X9\\nGuanabenz: XM7NV2\\nGuanacline: XM5ET8\\nGuanadrel: XM5JL6\\nGuanoctine: XM7TE8\\nHarmonyl: XM1LN2\\nHypotensive drug: XM4EP4\\nMethyldopate: XM7W35\\nMetirosine: XM1F18\\nModeril: XM7HA8\\nPargyline: XM1U35\\nProtoveratrine s A B: XM1GS9\\nRaudixin: XM01D4\\nRautina: XM74W2\\nRautotal: XM5FH0\\nRauwoldin: XM5PW7\\nSaralasin: XM00F2\\nSerpasil: XM6E07\\nSodium nitroprusside: XM2W66\\nSyrosingopine: XM8AK5\\nTeprotide: XM3HS0\\nTodralazine: XM5T36\\nVeratrine: XM48R9\\nVeratrum: XM8BQ9\\nKetanserin: XM0YY0\\nOrganic nitrates: XM2856\\nGlyceryl trinitrate: XM8LK8\\nPentaerythrityl tetranitrate: XM7KD0\\nPropatylnitrate: XM0DY4\\nIsosorbide dinitrate: XM3077\\nTrolnitrate: XM55H8\\nEritrityl tetranitrate: XM8SP5\\nTenitramine: XM5KH9\\nMethylpropylpropanediol dinitrate: XM9UE1\\nIsosorbide: XM01Q8\\nAmikhelline: XM6801\\nBendazol: XM5QW3\\nBenziodarone: XM3K91\\nCarbocromen: XM38C7\\nCoronary vasodilator: XM38U6\\nCromonar: XM0SG8\\nDiisopropylamine: XM0MW9\\nDilazep: XM1E15\\nDimoxyline: XM8Q26\\nEfloxate: XM5M47\\nEtafenone: XM3ZB0\\nFenalcomine: XM3E93\\nFluorosol: XM6QE9\\nHeptaminol: XM8Y13\\nHexadiline: XM4A49\\nHexobendine: XM5MP5\\nIsoamyl nitrite: XM5B68\\nItramin tosilate: XM5BS6\\nKhellin: XM9PV4\\nKhelloside: XM39T6\\nMannitol hexanitrate: XM30P9\\nMolsidomine: XM5720\\nNicorandil: XM7HW6\\nNitrite amyl medicinal vapor: XM5YX5\\nNitrous ether spirit: XM4J35\\nOctyl nitrite: XM1VC4\\nOrganonitrate: XM0A82\\nOxyfedrine: XM5YA6\\nPentaerythritol: XM2N57\\nPentrinat: XM3VX9\\nPerhexiline: XM7F31\\nPiridoxilate: XM7FE6\\nPrenylamine: XM4K89\\nSweet niter spirit: XM2BJ0\\nTrapidil: XM24R2\\nTriethanolamine trinitrate biphosphate: XM5770\\nTrinitrine: XM8YZ8\\nFlosequinan: XM23M8\\nImolamine: XM6V17\\nCinepazet: XM0UA6\\nCloridarol: XM30L8\\nLinsidomine: XM5AY1\\nNesiritide: XM2460\\nSerelaxin: XM1M18\\nRegadenoson: XM2VG8\\nMeldonium: XM1HP8\\nTadalafil: XM6G82\\nVardenafil: XM9AZ1\\nSildenafil: XM65A3\\nAluminium nicotinate: XM7DC4\\nAzapetine: XM1269\\nBencyclane: XM3GB4\\nBrovincamine: XM3FH5\\nBuflomedil: XM3B71\\nButalamine: XM6XW8\\nCetiedil: XM1UQ0\\nCinepazide: XM7LH3\\nCyclandelate: XM16K3\\nDihydroergocornine: XM9Q04\\nDihydroergokryptine: XM7K86\\nDihydroergotoxine: XM3WW1\\nEtofylline: XM9CH9\\nHepronicate: XM8317\\nHydromethylpyridine: XM2LT4\\nIfenprodil: XM86J1\\nKallidinogenase: XM8MZ0\\nKallikrein: XM5TC7\\nLipoalprostadil: XM6F75\\nMinoxidil: XM46T4\\nMoxisylyte: XM8YE5\\nNaftidrofuryl: XM3J93\\nNiacin: XM3PK2\\nNicametate: XM2GA2\\nNicofuranose: XM5TA2\\nNicotinyl alcohol: XM0274\\nNylidrin: XM6B85\\nPhenoxybenzamine: XM12T2\\nProstaglandin E: XM67M9\\nRaubasine: XM1B47\\nSuloctidil: XM9761\\nTetranicotinoyl fructose: XM07V4\\nThurfyl nicotinate: XM4074\\nThymoxamine: XM79S2\\nVasodilan: XM1UM9\\nVinburnine: XM3LG1\\nViquidil: XM51E4\\nXanthinol nicotinate: XM0122\\naminophenylethanol derivatives: XM0BT5\\nIsoxsuprine: XM5RH0\\nBamethan: XM0HU4\\nImidazoline derivatives: XM0B82\\nPhentolamine: XM5NP2\\nTolazoline: XM3BY1\\nPurine derivatives: XM5NF4\\nPentifylline: XM5RL7\\nXantinol nicotinate: XM91G7\\nPentoxifylline: XM8BD1\\nEtofylline nicotinate: XM0JV4\\nPinacidil: XM9PA9\\nVincamine: XM3VH9\\nVisnadine: XM68C7\\nErgot alkaloids: XM0XY6\\nErgoloid mesylates: XM0U65\\nNicergoline: XM5TD8\\nDihydroergocristine mesilate: XM0TP6\\nMethylergometrine: XM93Q7\\nErgometrine: XM3LX6\\nErgotamine: XM5P25\\nMethysergide: XM4G36\\nLisuride: XM4E49\\nfasudil: XM4CT2\\nYohimbine: XM5021\\nAvanafil: XM1WB2\\nUdenafil: XM4914\\nAdrenochrome semicarbazone mono: XM20Z9\\nAdrenochrome derivative: XM7NH6\\nAurantiin: XM8ZY5\\nBenzopyrone: XM6YS0\\nCalcium dobesilate: XM3LU4\\nChlorisondamine chloride: XM53V8\\nEscin: XM1H36\\nEthoxazorutoside: XM8AB2\\nFlavodic acid: XM6BM1\\nHesperidin: XM0WZ5\\nLeucocianidol: XM63M1\\nMetescufylline: XM4U20\\nPhenopyrazone: XM6102\\nPholedrine: XM6EY7\\nAdenosine: XM62Q1\\nTrimetazidine: XM3PB7\\nCamphora: XM5FW1\\nCrataegus glycosides: XM7F77\\nCreatinolfosfate: XM6619\\nFosfocreatine: XM8R77\\nFructose diphosphate: XM2PV3\\nUbidecarenone: XM4MP2\\nAcadesine: XM2UJ1\\nIvabradine: XM09Q3\\nRanolazine: XM9DF5\\nTiazotic acid: XM2DH5\\nCapillary stabilising agents: XM50P4\\nBioflavonoids: XM41G5\\nRutoside: XM5734\\nDiosmin: XM6UE1\\nTroxerutin: XM71U2\\nmonoxerutin: XM7EF1\\nhidrosmin: XM2SA0\\nTribenoside: XM6N03\\nNaftazone: XM1PT0\\nHippocastani semen: XM0MJ2\\nEsculin: XM93T6\\nAntivaricose drug: XM0NL5\\nDextrose concentrated solution intravenous: XM57B0\\nEthanolamine oleate: XM1ME2\\nPhenol in oil injection: XM6C05\\nSclerosing agent: XM9854\\nSodium morrhuate: XM3846\\nSodium psylliate: XM52L8\\nSodium tetradecyl sulfate: XM2N32\\nVaricose reduction drug: XM1LV9\\nVenous sclerosing drug: XM3FL1\\nZinc antivaricose: XM4J29\\nMonoethanolamine: XM3WS8\\nPolidocanol: XM4DD8\\nSotradecol: XM81W1\\nAlphaand betaadrenoreceptor agonists: XM36U7\\nEtilefrine: XM9187\\nMephentermine: XM6RQ3\\nEpinephrine: XM3273\\nAmezinium metilsulfate: XM10F0\\nEphedrine: XM5H72\\nDroxidopa: XM7B75\\nEthylnorepinephrine: XM9K94\\nCinnamedrine: XM1H52\\nPredominantly alphaadrenoreceptor agonists: XM3LR7\\nThenyldiamine: XM39Y4\\nPhenyltoloxamine: XM2V55\\nParedrine: XM7D21\\nNorepinephrine: XM81D8\\nMoxastine: XM7RF2\\nMethaphenilene: XM8TK4\\nLevocabastine hydrochloride: XM4TB9\\nHomochlorcyclizine: XM2305\\nEmbramine: XM59T1\\nDimenhydrinate: XM8ZH9\\nDifenidol: XM29D4\\nDibenzheptropine: XM62B0\\nCyclopentamine: XM8Y26\\nClemizole: XM0Y33\\nChlorothen: XM4PH8\\nChlorTrimeton: XM66X7\\nCetoxime: XM0AN5\\nBisulepin hydrochloride: XM88Z7\\nBenzquinamide: XM35M7\\nApraclonidine hydrochloride: XM25T0\\nAntistine: XM0W81\\nPhenylpropanolamine: XM6XN3\\nPhenylephrine: XM6ZQ3\\nPseudoephedrine: XM0CL2\\nPrazosin: XM45W7\\nIndoramin: XM3L37\\nDoxazosin: XM58X5\\nUrapidil: XM30L7\\nAlpha adrenergic blocking drug: XM2L44\\nBunazosin: XM6MJ9\\nDibenamine: XM4UW6\\nDibenzyline: XM70W7\\nHydergine: XM3Y81\\nPriscol Priscoline: XM81R1\\nTamsulosin: XM3F82\\nTerazosin: XM9LH2\\nAlfuzosin: XM1C94\\nTrimazosin: XM7D19\\nSilodosin: XM1FQ5\\nBetaadrenoreceptor antagonists non selective: XM7R98\\nAlprenolol: XM2YK6\\nOxprenolol: XM0M15\\nPindolol: XM2SH3\\nPropranolol: XM3HA9\\nTimolol: XM1KQ9\\nSotalol: XM5BT4\\nNadolol: XM69F3\\nMepindolol: XM89L8\\nCarteolol: XM1AJ9\\nTertatolol: XM6489\\nBopindolol: XM79L8\\nBupranolol: XM9RX1\\nPenbutolol: XM17Y6\\nCloranolol: XM2M62\\nBetaadrenoreceptor antagonists selective: XM9MF0\\nPractolol: XM9VG1\\nMetoprolol: XM8L21\\nAtenolol: XM0M62\\nAcebutolol: XM0V36\\nBetaxolol: XM7U87\\nBevantolol: XM0HY3\\nBisoprolol: XM8QC9\\nCeliprolol: XM54E1\\nEsmolol: XM4AB1\\nEpanolol: XM1T80\\nSatenolol: XM7115\\nNebivolol: XM0995\\nTalinolol: XM3156\\nLandiolol: XM44F9\\nBeta adrenergic blocking agent heart: XM5S93\\nBunitrolol: XM8026\\nCarazolol: XM3N87\\nIndenolol: XM7V19\\nPronetalol: XM91L7\\nTolamolol: XM77W2\\nAlpha and beta blocking agents antagonists: XM77E7\\nLabetalol: XM8ER3\\nCarvedilol: XM80G6\\nMedroxalol: XM0TY3\\nAgents predominantly used for gastrointestinal disorders: XM9FY5\\nSynthetic anticholinergics esters with tertiary amino group: XM8921\\nOxyphencyclimine: XM5D56\\nCamylofin: XM5RM7\\nMebeverine: XM90R8\\nTrimebutine: XM0EL4\\nRociverine: XM7GS6\\nDicycloverine: XM0CE0\\nPiperidolate: XM24K8\\nOxyphenonium: XM1LM4\\nPropantheline: XM05C6\\nOtilonium bromide: XM8YF7\\nMethantheline: XM5WL4\\nIsopropamide: XM6XN4\\nHexocyclium: XM1WN2\\nPoldine: XM7EV5\\nMepenzolate: XM7W33\\nPipenzolate: XM6FV2\\nBevonium: XM63B0\\nDihexyverine: XM4SN3\\nDifemerine: XM2043\\nSynthetic anticholinergics quaternary ammonium compounds: XM26J4\\nbenzhydryloxyethyldiethylmethylammonium iodide: XM2WF7\\nTiemonium iodide: XM2LU4\\nPrifinium bromide: XM6X69\\nTimepidium bromide: XM51J2\\nBenzilone: XM7XV6\\nTridihexethyl: XM4LY7\\nFenpiverinium: XM0D83\\nSynthetic antispasmodics amides with tertiary amines: XM7W64\\nDimethylaminopropionylphenothiazine: XM4VE1\\nNicofetamide: XM5LN3\\nTiropramide: XM36J3\\nPapaverine and derivatives: XM7FH3\\nPapaverine: XM8X70\\nDrotaverine: XM13K8\\nMoxaverine: XM1V30\\nBelladonna alkaloids and derivatives: XM6089\\nAtropine: XM7Y01\\nHyoscyamine: XM11J9\\nMethylatropine: XM4P67\\nCimetropium bromide: XM0PN2\\nHomatropine methylbromide: XM1642\\nScopolamine: XM1MW1\\nButylscopolamine: XM0QS6\\nMethylscopolamine: XM3068\\nFentonium: XM08K5\\nAgents predominantly used for urinary frequency and incontinence: XM1JA8\\nAnticholinergics predominantly used for Parkinson disease: XM6WD2\\nTertiary amines: XM8U00\\nMetixene: XM4RV4\\nTrihexyphenidyl: XM9W98\\nBiperiden: XM65C9\\nProcyclidine: XM9AG2\\nProfenamine: XM8VR6\\nDexetimide: XM1H88\\nPhenglutarimide: XM64K1\\nBornaprine: XM8T72\\nTropatepine: XM4YL9\\nMazaticol: XM3FW6\\nDiethazine: XM0HT8\\nEthers chemically close to antihistamines: XM3B14\\nOrphenadrine: XM7U62\\nEtanautine: XM8UB6\\nEthers of tropine or tropine derivatives: XM72C6\\nBenzatropine: XM8ZR2\\nEtybenzatropine: XM2789\\nEmepronium bromide: XM0CR7\\nAdiphenine: XM1Q67\\nAmbutonium bromide: XM0DF0\\nAminopentamide: XM0TL7\\nAmprotropine: XM1Q22\\nAniscoropine: XM3HR2\\nAnticholinergic: XM0B31\\nAntimuscarinic: XM5BE4\\nArtane: XM66R0\\nAtropine derivative: XM7LZ6\\nBelladonna alkaloids: XM5098\\nBelladonna extract: XM6RQ9\\nBelladonna herb: XM2YW9\\nBenactyzine: XM29D7\\nBenaprizine: XM3NJ0\\nBenzilonium bromide: XM54W7\\nBenztropine anticholinergic: XM8NZ1\\nButropium bromide: XM5ML2\\nButyl scopolamine bromide: XM1T59\\nCaramiphen: XM9633\\nCarpronium chloride: XM8JS6\\nClidinium bromide: XM2619\\nClorotepine: XM8KY2\\nCogentin: XM2HD0\\nCyclodrine: XM0VC2\\nCyclopentolate: XM7VB2\\nCycrimine: XM93T2\\nDibutoline sulfate: XM4CZ8\\nDiphemanil: XM89R5\\nDuboisine: XM1M52\\nDyphylline: XM3A08\\nEthaverine: XM17M9\\nEtomidoline: XM62B7\\nEuphthalmine: XM1VS4\\nExtrapyramidal antagonist: XM6L51\\nFlopropione: XM3L41\\nHexasonium iodide: XM8WX2\\nHomatropine: XM7832\\nHyoscyamus: XM1EF8\\nHyoscyamus dry extract: XM4FB2\\nIsopropamide iodide: XM4QH8\\nLevsin: XM5ED5\\nMepenzolate bromide: XM0WK8\\nMepiperphenidol: XM1FH6\\nMethanthelinium bromide: XM39X0\\nMethscopolamine bromide: XM0E13\\nMethylatropine nitrate: XM3KR9\\nMethylbenactyzium bromide: XM14X3\\nMilverine: XM5F96\\nMuscle affecting agents relaxants smooth: XM3YV6\\nOctatropine methylbromide: XM4U03\\nOxapium iodide: XM5YT3\\nParasympatholytic: XM3A77\\nPenthienate: XM8U27\\nPipethanate: XM6MG0\\nPramiverine: XM7711\\nProfenil: XM3CK8\\nPropantheline bromide: XM7VK4\\nQuaternary ammonium parasympatholytic: XM1JN1\\nScopolia extract: XM3UE6\\nSmooth muscle relaxant: XM31L2\\nSpacoline: XM7PY1\\nSpasmolytic anticholinergics: XM14Z1\\nSpasmolytic autonomic: XM6RA6\\nSpasmolytic quaternary ammonium: XM9NH9\\nThiphenamil: XM0GS2\\nTiemonium: XM9WW9\\nTigloidine: XM8346\\nTiquizium bromide: XM2595\\nToquizine: XM8YD7\\nTriampyzine: XM64P0\\nTricyclamol chloride: XM2TJ3\\nTridihexethyl iodide: XM17K9\\nTrimeprazine tartrate: XM5S52\\nTriperiden: XM2M46\\nTritiozine: XM4YB7\\nTropacine: XM2973\\nTropicamide: XM4466\\nTrospium chloride: XM8F25\\nAnticholinergics predominantly used for obstructive airway diseases: XM1CE8\\nIpratropium bromide: XM54K2\\nOxitropium bromide: XM55K5\\nGlycopyrronium bromide: XM42V2\\nStramonium: XM6LS6\\nTiotropium bromide: XM9HA8\\nAclidinium bromide: XM2PE9\\nUmeclidinium bromide: XM3MF8\\nRevefenacin: XM8BL4\\nFlutropium bromide: XM4DL3\\nPropiverine: XM9FU4\\nTolterodine: XM82U8\\nSolifenacin: XM2Z66\\nTrospium: XM7V08\\nDarifenacin: XM1N89\\nFesoterodine: XM4265\\nMirabegron: XM5L72\\nDesfesoterodine: XM5QR7\\nEmepronium: XM6190\\nFlavoxate: XM0CH2\\nMeladrazine: XM0M49\\nOxybutynin: XM0LB8\\nTerodiline: XM4DW3\\nAceclidine: XM4AJ3\\nAcetylcholine chloride: XM1EC3\\nAcetylcholine derivative: XM3GM3\\nAmbenonium: XM4PZ3\\nAnticholinesterase: XM8KF3\\nAnticholinesterase organophosphorus: XM87V2\\nAnticholinesterase reversible: XM9D92\\nCholinergic organophosphorus: XM4VC4\\nDFP: XM1L81\\nDiflos: XM1389\\nDifluorophate: XM86K6\\nDiisopropylfluorophosphonate: XM0UQ3\\nDistigmine bromide: XM5YK5\\nEdrophonium chloride: XM6565\\nGalantamine: XM99M6\\nIsoflurophate: XM1NE7\\nNeomycin with neostigmine: XM40R6\\nNeostigmine bromide: XM3671\\nProstigmin: XM3YR0\\nPyridostigmine bromide: XM41N9\\nTacrine: XM4LN1\\nDonepezil: XM62U1\\nRivastigmine: XM0NP3\\nIpidacrine: XM3B88\\nNeostigmine: XM8C30\\nPyridostigmine: XM4NE1\\nArecoline: XM7494\\nBenzpyrinium bromide: XM0000\\nBethanechol chloride: XM0MZ4\\nCholinergic drug: XM4LE7\\nCholinergic muscle tone enhancer: XM4ZZ7\\nCholinergic trimethyl ammonium propanediol: XM6VJ2\\nParasympathomimetic drug: XM8JX6\\nPilocarpine: XM0RX5\\nPilocarpus extract jaborandi: XM5EY0\\nCholine esters: XM9223\\nCarbachol: XM4AT9\\nBethanechol: XM9XA2\\nCholine alfoscerate: XM63Q0\\nCevimeline: XM31K4\\nVarenicline: XM6PN9\\nCytisinicline: XM7HS1\\nAmifampridine: XM4C58\\nHexamethonium bromide: XM90S5\\nMecamylamine: XM13Z0\\nPempidine: XM8JB8\\nPentamethonium bromide: XM68K9\\nPentolonium tartrate: XM2A33\\nQuaternary ammonium ganglion blocking: XM3YS6\\nTetraethylammonium chloride: XM6JW6\\nTetrylammonium chloride: XM9MS2\\nTrimetaphan camsilate: XM3YZ9\\nTrimethaphan: XM4BZ9\\nTrimethidinium: XM9BT3\\nDisulfiram: XM51D2\\nCalcium carbimide: XM2FC3\\nNicotine: XM6BN2\\nAcamprosate: XM9T01\\nBetahistine: XM14C0\\nCinnarizine: XM7CE7\\nFlunarizine: XM52G4\\nAcetylleucine: XM2U21\\nErgot derivative: XM0Q45\\nErgot prepared: XM77J5\\nErgotocine: XM5NB5\\nHormone oxytocic: XM4534\\nMuscle affecting agents oxytocic: XM8BU6\\nProstaglandin F alpha: XM5606\\nTocosamine: XM7F20\\nVetrabutine: XM6MR2\\nMuscle relaxants peripherally acting: XM8SY4\\nAlcuronium: XM23H5\\nTubocurarine: XM7139\\nDimethyltubocurarine: XM2RT6\\nHexafluronium: XM0L61\\nFazadinium bromide: XM87E3\\nMivacurium chloride: XM2SB5\\nAtracurium: XM0FZ0\\nPipecuronium bromide: XM0Q59\\nDoxacurium chloride: XM2811\\nRocuronium bromide: XM4R62\\nCisatracurium: XM0SQ7\\nBotulinum toxin: XM9M51\\nMuscle relaxants centrally acting: XM9YY8\\nCarbamic acid esters: XM5AB5\\nPhenprobamate: XM8DV7\\nCarisoprodol: XM2DC7\\nMethocarbamol: XM7AC3\\nStyramate: XM3KM3\\nFebarbamate: XM2339\\nOxazol thiazine and triazine derivatives: XM09D8\\nChlormezanone: XM8MD5\\nChlorzoxazone: XM7Q44\\nZoxazolamine: XM7ZQ9\\nMetaxalone: XM5PZ1\\nSuxamethonium: XM09Y8\\nPancuronium: XM5CB4\\nGallamine: XM9416\\nVecuronium: XM7S28\\nOrphenadrine citrate: XM6X03\\nBaclofen: XM5US2\\nTizanidine: XM1BK1\\nPridinol: XM26R3\\nTolperisone: XM4MA5\\nMephenesin: XM1HD7\\nTetrazepam: XM2RH8\\nCyclobenzaprine: XM7LP5\\nThiocolchicoside: XM52Y2\\nEperisone: XM9UU4\\nFenyramidol: XM7995\\nAfloqualone: XM0W80\\nAclatonium napadisilate: XM3V06\\nAnesthesia muscle relaxation: XM9RW1\\nAtracurium besilate: XM5GC4\\nCarbolonium bromide: XM8PU1\\nDecamethonium bromide: XM7DG2\\nDimethyltubocurarinium chloride: XM6XS1\\nFlaxedil: XM8A87\\nHexafluorenium bromide: XM9QC2\\nHexanuorenium: XM9WH2\\nHexcarbacholine bromide: XM82Z5\\nLaudexium: XM3676\\nMethocarbamol skeletal muscle relaxant: XM3RJ7\\nMuscle affecting agents relaxants skeletal: XM4W78\\nMyoneural blocking agents: XM3SC6\\nNeuromuscular blocking drug: XM2UG5\\nSkeletal muscle relaxants: XM8QC2\\nSpasmolytic skeletal muscle: XM91M0\\nSuxethonium chloride: XM7142\\nWoorali: XM9502\\nDantrolene: XM5ZN8\\nBruceine: XM0WW2\\nHydrastine: XM7E87\\nLututrin: XM7C89\\nStrychnine medicinal: XM20G5\\nDuchenne muscular dystrophy therapy: XM8NV1\\nAtaluren: XM1CL7\\nDrisapersen: XM7H79\\nEteplirsen: XM0BM1\\nHydroquinine: XM6TG6\\nAceneuramic acid: XM0TQ8\\nNusinersen: XM90G7\\nViltolarsen: XM0U21\\nCasimersen: XM4VE2\\nRimabotulinumtoxinB: XM2501\\nAbobotulinumtoxinA: XM0BF0\\nIncobotulinumtoxinA: XM21V3\\nDaxibotulinumtoxinA: XM5JZ1\\nLetibotulinumtoxinA: XM2L71\\nDrugs for obstructive airway diseases: XM9P78\\nCromoglicic acid: XM3R34\\nNedocromil: XM4TP3\\nAntileukotrienes: XM0B09\\nZafirlukast: XM9BZ0\\nPranlukast: XM1C43\\nMontelukast: XM10P5\\nIbudilast: XM12R0\\nMonoclonal antibodies used in airway diseases: XM4U85\\nOmalizumab: XM4LH9\\nReslizumab: XM6VB5\\nBenralizumab: XM0KT0\\nAmlexanox: XM82N7\\nAcefylline piperazine: XM5SD1\\nAcepifylline: XM1719\\nAmbuphylline: XM6493\\nAminophylline: XM5XJ1\\nBamifylline: XM5Y44\\nBufylline: XM1QL3\\nEnprofylline: XM31P6\\nEtamiphylline: XM1W21\\nLevoproxyphylline: XM3ZP6\\nOxtriphylline: XM81W0\\nProxyphylline: XM5YJ3\\nTheobromine: XM4L37\\nTheophylline: XM1FP4\\nTheophylline aminobenzoic acid: XM07L0\\nTheophylline piperazine paminobenzoate: XM07F4\\nDoxofylline: XM9608\\nMepyramine theophyllinacetate: XM7X44\\nFenspiride: XM42T9\\nEprozinol: XM40T5\\nSeratrodast: XM8DS8\\nRoflumilast: XM53U2\\nTranilast: XM5Y33\\nBufrolin: XM2351\\nTezepelumab: XM9Y50\\nAmbroxol: XM6JV7\\nAmmonium chloride expectorant: XM4A47\\nBromhexine: XM8CT0\\nCalcium iodide: XM9FP2\\nCarbocisteine: XM3XU8\\nCough mixture syrup: XM2NU9\\nCough mixture expectorants: XM1MJ1\\nCreosote: XM81Q9\\nCreosote syrup: XM4C87\\nDeglycyrrhizinized extract of liquorice: XM68U4\\nDomiodol: XM1KM0\\nDornase: XM28N4\\nEprazinone: XM71N5\\nGlyceryl guaiacolate: XM7QX2\\nGlycyrrhiza extract: XM86G0\\nGlycyrrhizic acid: XM3CL2\\nGlycyrrhizinate potassium: XM8EW0\\nGuaiacol derivatives: XM0G60\\nGuaimesal: XM48K1\\nGuaiphenesin: XM8GY5\\nHydriodic acid: XM31Y1\\nIodide potassium expectorant: XM3E62\\nIodinated glycerol: XM60L0\\nIpecacuanha: XM8BL3\\nLetosteine: XM2K57\\nLiquorice: XM9Q09\\nMecysteine: XM6MB5\\nMucolytic drug: XM4DQ1\\nOrganidin: XM4KG8\\nQuillaja extract: XM8A78\\nRespiratory drug expectorant: XM44A1\\nSCarboxymethylcysteine: XM4Y94\\nSenega: XM1Y62\\nSobrerol: XM92P8\\nSodium dibunate: XM06E7\\nSputum viscositylowering drug: XM2BM5\\nStepronin: XM7BF1\\nSulfogaiacol: XM1PU5\\nSuperinone: XM6JE5\\nTenoglicin: XM1CP3\\nTerpin hydrate cis: XM0ES0\\nTyloxapol: XM1F74\\nAntimony pentasulfide: XM1KG9\\nDornase alfa: XM61F4\\nAlthaeae radix: XM48C4\\nGuaiacolsulfonate: XM8983\\nLevoverbenone: XM5QU8\\nHederae helicis folium: XM48W4\\nCineole: XM7Q79\\nNeltenexine: XM66E3\\nErdosteine: XM7Y66\\nBenproperine: XM6NJ7\\nBenzonatate: XM8G23\\nBibenzonium bromide: XM1U36\\nButamirate: XM8WM3\\nClobutinol: XM4D27\\nChlophedianol: XM9DL9\\nCloperastine: XM80M9\\nDimethoxanate: XM9KL2\\nDropropizine: XM6995\\nEthyl dibunate: XM61F3\\nFedrilate: XM0SA9\\nFominoben: XM5BB1\\nIsoaminile: XM8300\\nLevodropropizine: XM97D0\\nMethorate: XM3WX2\\nOxeladin: XM2ET3\\nOxolamine: XM9FU3\\nPentoxyverine: XM4331\\nPicoperine: XM7G25\\nPipazetate: XM84C4\\nPiperidione: XM0HR9\\nPrenoxdiazine: XM8JR1\\nZipeprol: XM9KN8\\nDibunate: XM6SJ0\\nMeprotixol: XM1G75\\nMorclofone: XM2W89\\nNepinalone: XM7UA5\\nButetamate: XM06F9\\nGefapixant: XM4SL3\\nAntihistamines: XM4J58\\nFirstgeneration antihistamine: XM2JE5\\nAminoalkyl ethers: XM8MV2\\nBromazine: XM1TL5\\nDiphenhydramine: XM6KY0\\nClemastine: XM3DL4\\nChlorphenoxamine: XM4QD7\\nDiphenylpyraline: XM7GV4\\nCarbinoxamine: XM9KZ9\\nDoxylamine: XM77K6\\nPiprinhydrinate: XM7180\\nRotoxamine: XM3FN3\\nSubstituted alkylamines: XM5YE8\\nBrompheniramine: XM5PK9\\nDexchlorpheniramine: XM6CF9\\nDimetindene: XM74S1\\nChlorpheniramine: XM9VG3\\nPheniramine: XM4UU4\\nDexbrompheniramine: XM1107\\nTalastine: XM4AA0\\nSubstituted ethylene diamines: XM9MB0\\nPyrilamine: XM54R1\\nChloropyramine: XM9CM1\\nTripelennamine: XM0N55\\nMethapyrilene: XM7TD1\\nThonzylamine: XM6NM2\\nHistapyrrodine: XM4NS9\\nPhenothiazine derivatives: XM52P9\\nAlimemazine: XM1N75\\nPromethazine: XM0605\\nThiethylperazine: XM9QY1\\nMethdilazine: XM5E89\\nMequitazine: XM5EB9\\nOxomemazine: XM5DB5\\nIsothipendyl: XM4Z91\\nHydroxyethylpromethazine: XM5QG6\\nThiazinam: XM29Q8\\nPiperazine derivatives of firstgeneration antihistaminic agents: XM9NA0\\nBuclizine: XM8GH2\\nCyclizine: XM0S26\\nChlorcyclizine: XM9SK3\\nMeclozine: XM1A78\\nOxatomide: XM6AV1\\nCetirizine: XM0QD9\\nPiperazine: XM07V7\\nDiethylcarbamazine: XM1VF1\\nLevocetirizine: XM5AC9\\nBamipine: XM4GX4\\nCyproheptadine: XM11C5\\nPhenindamine: XM9BD4\\nAntazolin: XM5Q41\\nTriprolidine: XM8RT2\\nAzatadine: XM6Z93\\nMebhydrolin: XM4280\\nThenalidine: XM7ZS2\\nPipoxizine: XM0404\\nSetastine: XM5463\\nSecondgeneration antihistamine: XM3B95\\nPiperazine derivatives of secondgeneration antihistaminic agents: XM6G21\\nAstemizole: XM7S59\\nTerfenadine: XM2S36\\nLoratadine: XM4PE5\\nKetotifen: XM4F63\\nAcrivastine: XM4GA2\\nAzelastine: XM9VB8\\nEbastine: XM9EU0\\nMizolastine: XM7J45\\nFexofenadine: XM1586\\nDesloratadine: XM2656\\nRupatadine: XM3E25\\nBilastine: XM1WZ8\\nQuifenadine: XM3YG8\\nPyrrobutamine: XM57C9\\nDeptropine: XM8ZS4\\nTritoqualine: XM0J21\\nPimethixene: XM70F3\\nEpinastine: XM5BJ5\\nSequifenadine: XM40P7\\nDoxantrazole: XM9L77\\nAlmitrine: XM0AP5\\nAmiphenazole: XM9QA2\\nBemegride: XM0WB3\\nBicuculline: XM5T65\\nCentral nervous system stimulants analeptics: XM7BN2\\nCentral nervous system stimulants opiate antagonists: XM6938\\nCrotethamide with cropropamide: XM3465\\nDimefline: XM0A24\\nDimorpholamine: XM2ZT4\\nDoxapram: XM3FP9\\nEtamivan: XM6D72\\nLeptazol: XM6YR1\\nLobeline: XM4CU0\\nNikethamide: XM0001\\nPentetrazol: XM0Q86\\nPimeclone: XM5VY2\\nPrethcamide: XM4901\\nMepixanox: XM1D17\\nOther respiratory system products: XM04S2\\nNitric oxide: XM4HQ2\\nIvacaftor: XM3CW0\\nIvacaftor and lumacaftor: XM15G5\\nIvacaftor and tezacaftor: XM2QZ5\\nAmphenicols: XM0MG9\\nChloramphenicol: XM2TE7\\nThiamphenicol: XM40F4\\nAdicillin: XM1JY8\\nAncillin: XM1LV7\\nApalcillin: XM0JT4\\nBacampicillin: XM46K9\\nBenethamine penicillin: XM94E1\\nCarfecillin: XM2SP1\\nCephalosporins N adicillin: XM9MK4\\nClemizole penicillin: XM4YY1\\nCiclacillin: XM2361\\nHydrabamine penicillin: XM9VG2\\nImipenem: XM7LA4\\nIsoxazolyl penicillin: XM0V84\\nMethoxybenzyl penicillin: XM00H2\\nPenethamate: XM9XB6\\nPenicillin any: XM7Q57\\nPhenbenicillin: XM71L1\\nXantocillin: XM3UP8\\nPenicillins with extended spectrum: XM3173\\nAmpicillin: XM5MY7\\nPivampicillin: XM7CR7\\nCarbenicillin: XM3D58\\nAmoxicillin: XM7CM1\\nCarindacillin: XM7J83\\nEpicillin: XM31J4\\nPivmecillinam: XM9LR3\\nAzlocillin: XM8820\\nMezlocillin: XM1Z93\\nMecillinam: XM5562\\nPiperacillin: XM3MP9\\nTicarcillin: XM4D90\\nMetampicillin: XM1HX8\\nTalampicillin: XM3Z13\\nSulbenicillin: XM3S35\\nTemocillin: XM1QC3\\nHetacillin: XM9HP3\\nAspoxicillin: XM70P4\\nBetalactamase sensitive penicillins: XM9FQ5\\nBenzylpenicillin: XM83S8\\nPhenoxymethylpenicillin: XM9B11\\nPropicillin: XM5MN2\\nAzidocillin: XM4EZ4\\nPheneticillin: XM9NF6\\nPenamecillin: XM16L6\\nClometocillin: XM5N44\\nBenzathine benzylpenicillin: XM4E82\\nProcaine benzylpenicillin: XM4HD6\\nBenzathine phenoxymethylpenicillin: XM6MK0\\nBetalactamase resistant penicillins: XM9QY0\\nDicloxacillin: XM5SF7\\nCloxacillin: XM6L30\\nMethicillin: XM0PP7\\nOxacillin: XM2UY3\\nFlucloxacillin: XM6AV2\\nNafcillin: XM8HL9\\nCombinations of penicillins: XM6QQ6\\nSultamicillin: XM0RU1\\nAmpicillin and betalactamase inhibitor: XM3DN8\\nAmoxicillin and betalactamase inhibitor: XM7UP4\\nTicarcillin and betalactamase inhibitor: XM1FZ0\\nPiperacillin and betalactamase inhibitor: XM0LH3\\nBetalactamase inhibitors: XM9XT2\\nSulbactam: XM3Y87\\nTazobactam: XM2D37\\nAntibiotic blactam: XM3WK4\\nAntibiotic cephalosporin group: XM7TD6\\nCefaloglycin: XM5J74\\nCefamycin antibiotic: XM8J52\\nCefpimizole: XM01V2\\nCefteram: XM45T3\\nCefuzonam: XM0C25\\nCephalosporins: XM4HC8\\nCephalothin: XM67G9\\nClavulanic acid: XM2K88\\nFirstgeneration cephalosporins: XM9BE0\\nCefalexin: XM9Z22\\nCefaloridine: XM7GR3\\nCefazolin: XM0BY6\\nCefadroxil: XM11S1\\nCefazedone: XM1EQ8\\nCefatrizine: XM8UF3\\nCefapirin: XM6DE1\\nCefradine: XM8X72\\nCefacetrile: XM7DR9\\nCefroxadine: XM75P2\\nCeftezole: XM2L78\\nSecondgeneration cephalosporins: XM4DG8\\nCefoxitin: XM26N9\\nCefuroxime: XM7VY3\\nCefamandole: XM8839\\nCefaclor: XM1ZJ9\\nCefotetan: XM5QJ0\\nCefonicid: XM3M14\\nCefotiam: XM3V37\\nCefmetazole: XM8S59\\nCeforanide: XM3QK7\\nCefminox: XM27Z3\\nCefbuperazone: XM14Q0\\nFlomoxef: XM83K2\\nLoracarbef: XM6KH0\\nCefprozil: XM4CP3\\nThirdgeneration cephalosporins: XM3FN8\\nCefotaxime: XM7CZ4\\nCeftazidime: XM94G4\\nCefsulodin: XM9732\\nCeftriaxone: XM3P83\\nCefmenoxime: XM6FL0\\nLatamoxef: XM0B94\\nCeftizoxime: XM1064\\nCefixime: XM4Q77\\nCefetamet: XM8YC6\\nCefpiramide: XM9YD6\\nCefoperazone: XM5425\\nCefodizime: XM12J5\\nCefpodoxime: XM85Q0\\nCeftibuten: XM2D98\\nCefdinir: XM2141\\nCefditoren: XM2SP6\\nCefcapene: XM0H82\\nCefotaxime and betalactamase inhibitor: XM9RH3\\nCeftazidime and betalactamase inhibitor: XM8EN5\\nCefoperazone and betalactamase inhibitor: XM4UZ8\\nCeftriaxone and betalactamase inhibitor: XM19K3\\nFourthgeneration cephalosporins: XM60V7\\nCefepime: XM1HW5\\nCefpirome: XM0MR4\\nCefozopran: XM1BL5\\nMonobactams: XM3XC6\\nAztreonam: XM3DB8\\nCarumonam: XM9FE9\\nCarbapenems: XM1JU9\\nMeropenem: XM82S6\\nErtapenem: XM50J4\\nDoripenem: XM27D0\\nBiapenem: XM1Q21\\nImipenem and cilastatin: XM12K6\\nPanipenem: XM02N8\\nFaropenem: XM1N97\\nBetamipron: XM5261\\nCeftobiprole medocaril: XM3QS2\\nCeftaroline fosamil: XM2LW5\\nCeftolozane and betalactamase inhibitor: XM7RT0\\nSulfonamides and trimethoprim derivatives: XM8SY8\\nTrimethoprim derivatives: XM3MG7\\nTrimethoprim: XM7NY9\\nShortacting sulfonamides: XM8162\\nSulfamethizole: XM0XY9\\nSulfapyridine: XM72R1\\nSulfathiazole: XM3G53\\nSulfanilamide: XM72K1\\nSulfisoxazole: XM9TQ5\\nIntermediateacting sulfonamides: XM06K1\\nSulphamethoxazole: XM1AM5\\nSulfadiazine: XM12D1\\nSulfamoxole: XM43U3\\nLongacting sulfonamides: XM4J39\\nSulfadimethoxine: XM3ER6\\nSulfalene: XM8LL9\\nSulfamethoxypyridazine: XM7XJ2\\nSulfaperin: XM92E0\\nSulfamerazine: XM7R74\\nSulfaphenazole: XM1G41\\nSulfamazone: XM0ZN8\\nSulfametomidine: XM95D0\\nSulfonamides and trimethoprim derivatives fixed combinations: XM3EU7\\nTrimethoprim with sulfamethoxazole: XM22Y8\\nSulfadiazine and trimethoprim: XM18A9\\nSulfametrole and trimethoprim: XM87N2\\nSulfamoxole and trimethoprim: XM4008\\nSulfadimidine and trimethoprim: XM4WW1\\nSulfadiazine and tetroxoprim: XM1UR3\\nSulfamerazine and trimethoprim: XM3Y04\\nBrodimoprim: XM4YB5\\nIclaprim: XM98X3\\nSulfathiourea: XM4L44\\nAzithromycin: XM1329\\nErythromycin: XM36F7\\nJosamycin: XM2YT6\\nKitasamycin: XM06K0\\nMidecamycin: XM80A1\\nMiocamycin: XM3CC3\\nOleandomycin: XM8HR9\\nRokitamycin: XM8UC1\\nRoxithromycin: XM98M0\\nSpiramycin: XM1K16\\nTroleandomycin: XM2WF8\\nClarithromycin: XM1VG4\\nDirithromycin: XM0EH3\\nFlurithromycin: XM2J45\\nTelithromycin: XM5TV4\\nSolithromycin: XM2LU0\\nAnsamycin: XM4094\\nLincosamides: XM7E36\\nClindamycin: XM8158\\nLincomycin: XM53Q9\\nStreptogramins: XM69N7\\nPristinamycin: XM48W5\\nQuinupristin: XM4NJ6\\nDalfopristin: XM2YS9\\nAmikacin: XM3X89\\nAntibiotic aminoglycoside: XM4LV0\\nAntitubercular antibiotics: XM7WC2\\nAstromicin: XM4BG6\\nBekanamycin: XM4PT0\\nDibekacin: XM45U4\\nDihydrostreptomycin: XM8KT1\\nFramycetin: XM0PH0\\nGentamicin: XM3YS5\\nIsepamicin: XM6YS3\\nKanamycin: XM0C03\\nMicronomicin: XM9VS3\\nNeomycin derivatives: XM2YC8\\nNetilmicin: XM1W69\\nNovobiocin: XM1QQ2\\nParomomycin: XM1696\\nRibostamycin: XM58T2\\nSisomicin: XM4GS3\\nStreptomycin: XM6T34\\nStreptomycin derivative: XM32G0\\nStreptoduocin: XM7N64\\nStreptonivicin: XM4YK6\\nStreptovarycin: XM40X6\\nTobramycin: XM6G20\\nArbekacin: XM79T7\\nPlazomicin: XM1KN3\\nQuinolones and derivatives: XM7YK9\\nFluoroquinolones: XM3HL2\\nOfloxacin: XM8072\\nCiprofloxacin: XM77G2\\nPefloxacin: XM1Z91\\nEnoxacin: XM7SH9\\nNorfloxacin: XM85E7\\nFleroxacin: XM2GR2\\nTemafloxacin: XM98Z1\\nLomefloxacin: XM3JX8\\nSparfloxacin: XM6MR3\\nRufloxacin: XM7BN7\\nGrepafloxacin: XM6RS6\\nLevofloxacin: XM7KX7\\nTrovafloxacin: XM6YH9\\nMoxifloxacin: XM8147\\nGemifloxacin: XM5HN4\\nGatifloxacin: XM17A4\\nPrulifloxacin: XM3NU2\\nPazufloxacin: XM3Z59\\nGarenoxacin: XM1QZ5\\nSitafloxacin: XM5MK4\\nTosufloxacin: XM3S71\\nDelafloxacin: XM9CC7\\nRosoxacin: XM8SV4\\nNalidixic acid: XM82P4\\nPiromidic acid: XM1298\\nPipemidic acid: XM61M8\\nCombinations of antibacterials: XM3GX9\\nSulfonamides combinations with other antibacterials: XM5CX9\\nPenicillins combinations with other antibacterials: XM39C8\\nCefuroxime and metronidazole: XM9162\\nSpiramycin and metronidazole: XM3E19\\nLevofloxacin and ornidazole: XM8TH8\\nCefepime and amikacin: XM3DB6\\nAzithromycin fluconazole and secnidazole: XM5QC3\\nTetracycline and oleandomycin: XM1CM9\\nOfloxacin and ornidazole: XM2CJ8\\nCiprofloxacin and metronidazole: XM9T47\\nCiprofloxacin and tinidazole: XM36B5\\nCiprofloxacin and ornidazole: XM51W6\\nNorfloxacin and tinidazole: XM31E8\\nGlycopeptides: XM8S33\\nVancomycin: XM9YD1\\nTeicoplanin: XM2004\\nTelavancin: XM8WT1\\nDalbavancin: XM4F99\\nOritavancin: XM9LJ3\\nNitrofuran derivatives: XM2CE2\\nNitrofurantoin: XM09K7\\nNifurtoinol: XM1QV5\\nNifurtimox: XM9F49\\nFurazidin: XM8FX2\\nFurazolidone: XM08Z2\\nPolymyxins: XM3DZ3\\nColistin: XM6510\\nPolymyxin B: XM0NQ2\\nPolymyxin: XM8MH4\\nAerosporin: XM5183\\nAlbamycin: XM5PV6\\nAmphomycin: XM4E54\\nAntiinfective antibiotics specified: XM2H40\\nAntibiotic intestinal: XM41T2\\nAntibiotic polypeptide: XM0MJ1\\nAntibiotic specified: XM7SQ4\\nBetamicin: XM2EH2\\nCarbomycin: XM0D75\\nEnviomycin: XM74K5\\nFosfomycin: XM0HU8\\nFusafungine: XM5UL0\\nFusidic acid: XM6AH3\\nNeosporin: XM14K4\\nRistocetin: XM19A7\\nSodium fusidate: XM0BX1\\nSulfomyxin: XM4F54\\nViomycin: XM6HE3\\nVirginiamycin: XM2A60\\nXibornol: XM71G5\\nSpectinomycin: XM2TG1\\nMethenamine mandelate: XM02L5\\nMandelic acid: XM3HJ6\\nNitroxoline: XM33S9\\nClofoctol: XM11V4\\nLinezolid: XM9WV9\\nDaptomycin: XM2NL4\\nBacitracin: XM20R8\\nTedizolid: XM9GT9\\nLefamulin: XM9QK9\\nAntibiotic tetracycline group: XM8124\\nChlormethylenecycline: XM7FD5\\nChlortetracycline: XM1JT2\\nClomocycline: XM0WY0\\nDemeclocycline: XM9219\\nDemethylchlortetracycline: XM17F8\\nDemethyltetracycline: XM7KG3\\nDoxycycline: XM7J58\\nGuamecycline: XM4492\\nLymecycline: XM47D7\\nMeclocycline: XM9KD5\\nMetacycline: XM4CA1\\nMinocycline: XM5TY0\\nOxytetracycline: XM8DQ8\\nPenimepicycline: XM3D34\\nRolitetracycline: XM45X2\\nTetracycline: XM0BP1\\nTigecycline: XM74B7\\nAminosalicylic acid and derivatives: XM8781\\nAminosalicylic acid: XM1X82\\nSodium aminosalicylate: XM6TY4\\nCalcium aminosalicylate: XM7FE7\\nThiocarbamide derivatives: XM3BE3\\nProtionamide: XM1GT1\\nEthionamide: XM86N7\\nDrugs for treatment of lepra: XM8Q31\\nClofazimine: XM3122\\nDapsone: XM73W4\\nClascoterone: XM34C6\\nAminosalylum: XM6QT5\\nAntiinfective antimycobacterial: XM4TV0\\nAntimycobacterial drug combination: XM5K63\\nAntituberculars: XM6DX3\\nBenzoylpas calcium: XM18Y4\\nBromosalicylhydroxamic acid: XM3307\\nCalcium benzamidosalicylate: XM2754\\nChaulmosulfone: XM7TM4\\nCyanacetyl hydrazide: XM95S8\\nEthambutol: XM4N96\\nEthyl chaulmoograte: XM64N2\\nFenamisal: XM23G7\\nGlucosulfone sodium: XM4RF4\\nGlyconiazide: XM7945\\nIsoniazid: XM5FH2\\nIsonicotinic acid hydrazide: XM2ZK2\\nMethaniazide: XM3XE5\\nMorinamide: XM8UX1\\nMorphazinamide: XM6LM1\\nPasiniazid: XM2QH1\\nPentylsalicylamide: XM4Q32\\nPotassium aminosalicylate: XM3UQ6\\nPromacetin: XM8DJ8\\nPromin: XM8CP2\\nPyrazinamide: XM4611\\nRimifon: XM4GU0\\nSalinazid: XM7SC9\\nAcetosulfone sodium: XM3070\\nSolasulfone: XM06Z9\\nSulfonazide: XM3SD9\\nSulfones: XM3SN8\\nAldesulfone sodium: XM72Q4\\nTerizidone: XM9TD0\\nThiambutosine: XM99P0\\nThioacetazone: XM0AR8\\nThioacetazone with isoniazid: XM5MQ5\\nTiocarlide: XM62H2\\nBedaquiline: XM60U0\\nDelamanid: XM1FD5\\nAntimycobacterial antibiotic: XM7AQ6\\nCycloserine: XM63V4\\nRifampicin: XM0R30\\nRifamycin: XM7HL1\\nRifabutin: XM5QH8\\nRifapentine: XM8MQ4\\nCapreomycin: XM0892\\nRifaximin: XM2LE1\\nRifamide: XM38J6\\nImidazole derivatives: XM2SD6\\nMiconazole: XM9UH0\\nKetoconazole: XM9795\\nTriazole and tetrazole derivatives: XM4GT1\\nFluconazole: XM97S6\\nItraconazole: XM5XD2\\nVoriconazole: XM70R4\\nPosaconazole: XM1VE3\\nOteseconazole: XM69J7\\nGriseofulvin: XM8YE6\\nNystatin: XM32L5\\nFlucytosine: XM3BU7\\nTerbinafine: XM7HQ1\\nCaspofungin: XM0K47\\nMicafungin: XM1F82\\nAnidulafungin: XM0HG4\\nAntifungal antibiotics: XM7S10\\nAmphotericin B: XM5TR4\\nHachimycin: XM9CM4\\nNucleosides and nucleotides: XM56B8\\nAciclovir: XM3MC4\\nVidarabine: XM30N1\\nGanciclovir: XM1M61\\nIdoxuridine: XM2GP5\\nFamciclovir: XM3RL1\\nValaciclovir: XM4GK4\\nCidofovir: XM6HE0\\nPenciclovir: XM3AF7\\nValganciclovir: XM2RU2\\nBrivudine: XM5L76\\nRemdesivir: XM1ES0\\nBrincidofovir: XM4CD1\\nCyclic amines: XM7QR0\\nRimantadine: XM2TS5\\nTromantadine: XM7GR8\\nPhosphonic acid derivatives: XM90G3\\nFoscarnet: XM5XQ9\\nFosfonet: XM8Z26\\nProtease inhibitors: XM8GK2\\nSaquinavir: XM7YP4\\nIndinavir: XM1VT6\\nRitonavir: XM56L1\\nNelfinavir: XM6175\\nAmprenavir: XM6WJ3\\nFosamprenavir: XM2AR2\\nAtazanavir: XM2U50\\nTipranavir: XM8QH1\\nDarunavir: XM63Q8\\nNucleoside and nucleotide reverse transcriptase inhibitors: XM3EZ0\\nZidovudine: XM9C07\\nZalcitabine: XM7XQ2\\nDidanosine: XM8Z78\\nStavudine: XM7RM1\\nLamivudine: XM5471\\nAbacavir: XM35P4\\nTenofovir disoproxil: XM67N3\\nAdefovir: XM96H1\\nEmtricitabine: XM2L06\\nEntecavir: XM0Z52\\nTelbivudine: XM2P85\\nClevudine: XM9K66\\nTenofovir alafenamide: XM06Z6\\nNonnucleoside reverse transcriptase inhibitors: XM5PT4\\nNevirapine: XM10T5\\nDelavirdine: XM0LC3\\nEfavirenz: XM1DX2\\nEtravirine: XM7N44\\nRilpivirine: XM1KD4\\nNeuraminidase inhibitors: XM6DT0\\nZanamivir: XM0JN4\\nOseltamivir: XM6823\\nPeramivir: XM0AQ6\\nLaninamivir: XM6M67\\nAntivirals for treatment of hepatitis C infections: XM9DH8\\nRibavirin: XM8YT1\\nTelaprevir: XM2WF9\\nBoceprevir: XM07W4\\nFaldaprevir: XM1QK4\\nSimeprevir: XM9FF9\\nAsunaprevir: XM6LF8\\nDaclatasvir: XM41F6\\nSofosbuvir: XM0ZZ5\\nDasabuvir: XM34X5\\nElbasvir: XM5HK2\\nGrazoprevir: XM9WK5\\nCoblopasvir: XM6ZX2\\nAntivirals for treatment of hepatitis C infections combinations: XM3SJ3\\nSofosbuvir and Ledipasvir: XM5CA7\\nDasabuvir Ombitasvir Paritaprevir and Ritonavir: XM4R75\\nOmbitasvir Paritaprevir and Ritonavir: XM70P2\\nElbasvir and Grazoprevir: XM7VS7\\nSofosbuvir and Velpatasvir: XM3K33\\nSofosbuvir Velpatasvir and Voxilaprevir: XM14S9\\nGlecaprevir and Pibrentasvir: XM1NF4\\nDaclatasvir Asunaprevir and Beclabuvir: XM10G0\\nAntivirals for treatment of human immunodeficiency virus infections combinations: XM3U67\\nZidovudine and Lamivudine: XM5UM7\\nLamivudine and Abacavir: XM41D4\\nTenofovir disoproxil and Emtricitabine: XM75H2\\nZidovudine Lamivudine and Abacavir: XM2F89\\nZidovudine Lamivudine and Nevirapine: XM0SL5\\nEmtricitabine Tenofovir disoproxil and Efavirenz: XM7RZ6\\nStavudine Lamivudine and Nevirapine: XM99U8\\nEmtricitabine Tenofovir disoproxil and Rilpivirine: XM1KH0\\nEmtricitabine Tenofovir disoproxil Elvitegravir and Cobicistat: XM99Q5\\nLopinavir: XM3EH7\\nLamivudine Tenofovir disoproxil and Efavirenz: XM9NL2\\nLamivudine and Tenofovir disoproxil: XM50Z0\\nLamivudine Abacavir and Dolutegravir: XM2UU9\\nDarunavir and Cobicistat: XM1FA4\\nAtazanavir and Cobicistat: XM4KM0\\nLamivudine and Raltegravir: XM0229\\nEmtricitabine and Tenofovir alafenamide: XM8RF0\\nEmtricitabine Tenofovir alafenamide Elvitegravir and Cobicistat: XM4JT2\\nEmtricitabine Tenofovir alafenamide and Rilpivirine: XM08B7\\nEmtricitabine Tenofovir alafenamide and Bictegravir: XM0UN9\\nDolutegravir and Rilpivirine: XM4C60\\nEmtricitabine Tenofovir alafenamide Darunavir and Cobicistat: XM7T33\\nAtazanavir and Ritonavir: XM4TF3\\nLamivudine Tenofovir disoproxil and Doravirine: XM5FB9\\nLamivudine and Dolutegravir: XM9CE4\\nDarunavir and Ritonavir: XM8ZN1\\nLamivudine Tenofovir disoproxil and Dolutegravir: XM8QY9\\nAntiinfective antiviral: XM63K0\\nDideoxyinosine: XM7SG2\\nFoscarnet sodium: XM9VL0\\nFosfonet sodium: XM6CJ2\\nIbacitabine: XM1R42\\nMetisazone: XM6SP8\\nMoroxydine: XM5GV1\\nTrifluridine: XM6WB2\\nLysozyme: XM60K5\\nInosine pranobex: XM8AQ1\\nPleconaril: XM23V6\\nEnfuvirtide: XM1EQ6\\nRaltegravir: XM82D3\\nMaraviroc: XM3FG0\\nMaribavir: XM7HJ6\\nElvitegravir: XM7WY9\\nDolutegravir: XM6K45\\nUmifenovir: XM3S98\\nEnisamium iodide: XM8CN1\\nLetermovir: XM01X3\\nTilorone: XM1UC2\\nPentanedioic acid imidazolyl ethanamide: XM90X2\\nIbalizumab: XM2KW1\\nTecovirimat: XM7FP8\\nBaloxavir marboxil: XM9A16\\nAmenamevir: XM1QY5\\nFavipiravir: XM2L29\\nCobicistat: XM1KL9\\nLenacapavir: XM85A9\\nAHLG: XM6MB2\\nAntihuman lymphocytic globulin: XM9CH0\\nAntidiphtheria serum: XM9L34\\nAntiscorpion sera: XM9D37\\nAntitoxin: XM5CP2\\nAntitoxin gas gangrene: XM81Z0\\nAntivenin antivenom sera: XM5TW5\\nAntivenin antivenom crotaline: XM2T48\\nAntivenin antivenom spider bite: XM6D91\\nBlack widow spider antivenin: XM4XP6\\nGamimune: XM7VG2\\nGamma globulin: XM6Z81\\nGamulin: XM7MC6\\nGlandular extract medicinal: XM1AG2\\nGlobulin antilymphocytic: XM8MQ7\\nGlobulin antirhesus: XM6UW5\\nGlobulin antivenin: XM3LT2\\nGlobulin antiviral: XM9XP6\\nHomotet: XM5443\\nHorse antihuman lymphocytic serum: XM3KZ0\\nHuman immune serum: XM7BR5\\nHypertussis: XM42S1\\nPegademase bovine: XM5DZ4\\nRhoGAM: XM67L1\\nSerum antiRh: XM77D4\\nSerum antibotulinus: XM3HE6\\nSerum anticytotoxic: XM9V23\\nSerum antimeningococcus: XM7HP0\\nSerum antitetanic: XM5F14\\nSerum antitoxic: XM8MX1\\nSerum convalescent: XM9QJ7\\nSerum protective: XM0SJ2\\nSpider antivenin: XM5CC6\\nTetanus toxoid or vaccine antitoxin: XM2042\\nTetanus toxoid or vaccine immune globulin human: XM2GK5\\nVaccine antineoplastic: XM8Y67\\nImmune sera: XM6VF9\\nDiphtheria antitoxin: XM2MN8\\nTetanus antitoxin: XM18X1\\nAntirabies hyperimmune serum: XM5083\\nSnake venom antiserum: XM18Y9\\nBotulinum antitoxin: XM0AD6\\nGasgangrene sera: XM1FR6\\nImmunoglobulins: XM1RS8\\nImmunoglobulins normal human: XM0AQ7\\nImmunoglobulins normal human intravenous: XM26U5\\nImmunoglobulins normal human extravascular: XM3H32\\nSpecific immunoglobulins: XM5YM7\\nAntiD rh immunoglobulin: XM4361\\nTetanus immunoglobulin: XM8824\\nHepatitis B immunoglobulin: XM6JK2\\nRabies immunoglobulin: XM5R25\\nVaccinia immunoglobulin: XM8Q08\\nPertussis immunoglobulin: XM3FU2\\nMumps immunoglobulin: XM8Z30\\nVaricella zoster immunoglobulin: XM7X82\\nRubella immunoglobulin: XM3ZS8\\nStaphylococcus immunoglobulin: XM1V63\\nCytomegalovirus immunoglobulin: XM7NM9\\nDiphtheria immunoglobulin: XM4YT6\\nHepatitis A immunoglobulin: XM7LD1\\nEncephalitis tick borne immunoglobulin: XM5NX5\\nMeasles immunoglobulin: XM1GU6\\nPalivizumab: XM45N8\\nMotavizumab: XM0QB1\\nRaxibacumab: XM0U74\\nAnthrax immunoglobulin: XM8Y60\\nBezlotoxumab: XM6GD5\\nObiltoxaximab: XM54X9\\nImmunoglobulin not elsewhere classified: XM1BS2\\nAntiviral monoclonal antibodies: XM3NK9\\nTixagevimab: XM78P5\\nCilgavimab: XM1CT9\\nBacterial vaccines: XM3KV2\\nCholera vaccines: XM29K4\\nCholera inactivated whole cell vaccines: XM3Z26\\nCholera live attenuated vaccines: XM72A0\\nCholera combinations with typhoid vaccine inactivated whole cell vaccines: XM1FT6\\nHaemophilus influenzae B vaccines: XM11V3\\nHib purified antigen conjugated vaccines: XM6RG9\\nHib combinations with toxoids vaccines: XM7F70\\nHib combinations with pertussis and toxoids vaccines: XM81F7\\nHib combinations with meningococcus C conjugated vaccines: XM0X86\\nMeningococcal vaccines: XM2WV4\\nMeningococcal monovalent purified polysaccharides antigen vaccines: XM92B2\\nMeningococcal polyvalent purified polysaccharides antigen vaccines: XM5LC2\\nMeningococcus A C bivalent purified polysaccharides antigen vaccines: XM3T39\\nMeningococcus A C Y W tetravalent purified polysaccharides antigen vaccines: XM2AR0\\nMeningococcus A C Y W tetravalent purified polysaccharides antigen conjugated vaccines: XM2EH7\\nMeningococcus C purified polysaccharides antigen conjugated vaccines: XM18Y8\\nMeningococcus A purified polysaccharides antigen conjugated vaccines: XM2280\\nMeningococcus B outer membrane vesicle vaccines: XM9GJ1\\nMeningococcus B multicomponent vaccines: XM1X81\\nMeningococcus A purified polysaccharides antigen vaccines: XM37L5\\nPertussis vaccines: XM43M9\\nPertussis inactivated whole cell vaccines: XM45L8\\nPertussis purified antigen vaccines: XM62J1\\nPertussis inactivated whole cell combinations with toxoids vaccines: XM2TK2\\nPertussis purified antigen combinations with toxoids vaccines: XM4082\\nVaccines pertussis with diphtheria: XM2CV8\\nPneumococcal vaccines: XM9EM7\\nPneumococcal conjugate valent vaccines: XM9G97\\nPneumococcal polysaccharide valent vaccines: XM2249\\nPneumococcus purified polysaccharides antigen vaccines: XM91D7\\nPneumococcus purified polysaccharides antigen conjugated vaccines: XM96S7\\nPneumococcus purified polysaccharides antigen and Haemophilus influenzae conjugated vaccines: XM4R39\\nTetanus vaccines: XM5L44\\nTetanus toxoid vaccines: XM29H5\\nTetanus toxoid combinations with diphtheria toxoid vaccines: XM1G86\\nTetanus toxoid combinations with tetanus immunoglobulin vaccines: XM9AK2\\nTetanus diphtheria acellular pertussis vaccines: XM31Q8\\nTriple vaccines DPT: XM1PB8\\nPertussis vaccines with diphtheria toxoid with tetanus toxoid: XM9ZL9\\nDiphtheria toxoid with tetanus toxoid with pertussis component vaccines: XM9YH9\\nTetanus and diphtheria vaccines: XM32Q5\\nVaccines diphtheria with tetanus: XM4039\\nTetanus toxoid or vaccines toxoid with diphtheria toxoid: XM8XH5\\nTyphoid vaccines: XM8BU8\\nTyphoid oral live attenuated vaccines: XM33K4\\nTyphoid inactivated whole cell vaccines: XM89G3\\nTyphoid purified polysaccharide antigen vaccines: XM3SF6\\nTyphoidparatyphoid vaccines: XM9UB1\\nVaccines TAB: XM3VD2\\nParatyphoid vaccines: XM95H3\\nPlague vaccines: XM8ZX8\\nPlague inactivated whole cell vaccines: XM3796\\nVaccines bacterial with other bacterial component: XM9SW5\\nVaccines rickettsial: XM91J8\\nTyphus exanthematicus vaccines: XM3JJ2\\nTyphus exanthematicus inactivated whole cell vaccines: XM2NU8\\nVaccines rickettsial with bacterial component: XM4F19\\nRocky Mountain spotted fever vaccines: XM0E84\\nVaccines bacterial mixed not elsewhere classified: XM5926\\nAnthrax vaccines: XM8NU9\\nAnthrax antigen vaccines: XM2C05\\nBrucellosis vaccines: XM7PB3\\nBrucella antigen vaccines: XM7RX8\\nDiphtheria vaccines: XM8AW3\\nDiphtheria toxoid vaccines: XM86V7\\nDiphtheria vaccines combination including pertussis: XM46V1\\nDiphtheria vaccines combination without pertussis: XM39K8\\nDiphtheria vaccines combination: XM8YP9\\nTuberculosis vaccines: XM4639\\nTuberculosis live attenuated vaccines: XM8142\\nViral vaccines: XM61M7\\nCOVID vaccines: XM68M6\\nCOVID vaccines inactivated virus: XM1NL1\\nCoronaVac: XM7HT3\\nCovilo: XM8866\\nKCONVAC: XM9TQ1\\nCovaxin: XM1G90\\nCoviVac: XM85P5\\nHayatVax: XM9FQ7\\nQazVac: XM97N6\\nCOVIran Barekat: XM2YG8\\nCovidful: XM0K39\\nFAKHRAVAC MIVAC: XM0J98\\nInactivated SARSCoV vaccine: XM1FB4\\nTurkovac: XM86F7\\nVLA: XM42N8\\nInavac: XM7KM9\\nCOVID vaccines live attenuated virus: XM5DF6\\nCOVID vaccines nonreplicating viral vector: XM9QW8\\nCOVID Vaccine AstraZeneca Vaxzevria: XM4YL8\\nCovishield: XM97T2\\nCOVID Vaccine Janssen: XM6QV1\\nConvidecia: XM1AG7\\nSputnikLight: XM5QM6\\nConvidecia Air: XM4T09\\nConvidecia Air XBB: XM2LP0\\nGamCOVIDVac intranasal: XM6Z24\\nGamCOVIDVacM: XM4PM4\\niNCOVACC: XM5309\\nSputnikV: XM37C0\\nCOVID vaccines replicating viral vector: XM0CX4\\nDelNSnCoVRBDOPT: XM5BL0\\nPatria: XM3UC0\\nCOVID vaccines virus protein subunit: XM5JC5\\nZifivax: XM3CT4\\nAbdala: XM8T18\\nSoberana: XM3PG0\\nMVC COVID: XM4EC8\\nEpiVacCorona: XM6SZ8\\nSoberana Plus: XM0RV9\\nAuroraCoV: XM3SK8\\nSpikoGen: XM9P21\\nNUVAXOVID: XM9T65\\nRazi COV PARS: XM9N08\\nBimervax: XM6790\\nBivalent Omicron: XM8R60\\nCorbevax: XM63N7\\nCoviccine: XM2NP9\\nCoviccine Trivalent XBBBADelta: XM0E93\\nCovovax: XM85Q5\\nEuCorVac: XM85Q8\\nIndovac: XM7E37\\nNoora: XM7P85\\nNUVAXOVID XBB: XM2FM2\\nPastoCovac: XM97Q5\\nPastoCovac Plus: XM8BU1\\nRecombinant SARSCoV Vaccine CHO Cell: XM9P29\\nSARSCOV Bivalent: XM5YS2\\nSCB: XM8ME2\\nSCTVC: XM71X6\\nSKYCovione: XM62V8\\nTetravalent SCTVE: XM8267\\nV: XM6WB0\\nVidprevtyn Beta: XM9ZB6\\nNUVAXOVID JN: XM6YA9\\nConvacell: XM5TF6\\nARVACCG Gamma  Omicron: XM4AC5\\nCOVID RECOMBINANT: XM7Y13\\nCOVID vaccines virus like particle: XM1J92\\nCovifenz: XM0BS6\\nCOVID vaccines DNA based: XM6AT1\\nZyCovD: XM52P3\\nCOVID vaccines RNA based: XM0GQ8\\nComirnaty: XM8NQ0\\nCOVID Vaccine Moderna Spikevax: XM3DT5\\nAWcorna: XM5E97\\nComirnaty Bivalent OriginalOmicron BA: XM1CQ8\\nComirnaty Bivalent OriginalOmicron BABA: XM5U85\\nComirnaty XBB: XM7U45\\nDaichirona: XM6HM3\\nDuentai: XM15E9\\nDuentai Bivalent XBBBQ: XM2708\\nGemcovac: XM3X29\\nGemcovacOM: XM8FH6\\nKOSTAIVE: XM6FF0\\nCOVID Vaccine Moderna Spikevax Bivalent OriginalOmicron BA: XM0QH5\\nCOVID Vaccine Moderna Spikevax Bivalent OriginalOmicron BABA: XM3984\\nCOVID Vaccine Moderna Spikevax XBB: XM21B8\\nComirnaty KP: XM52Y9\\nSpikevax KP: XM15B2\\nDengue vaccines: XM38G7\\nEbola vaccines: XM7P50\\nrVSVGZEBOVGP vaccine: XM4P37\\nAdZEBOV and MVABNFilo vaccine: XM4TZ2\\nEncephalitis vaccines: XM0RC1\\nEncephalitis tick borne inactivated whole virus: XM8MP6\\nEncephalitis Japanese inactivated whole virus: XM0LB5\\nEncephalitis Japanese live attenuated: XM47S0\\nInfluenza vaccines: XM1LR5\\nInfluenza vaccines inactivated whole virus: XM8857\\nInfluenza vaccines live attenuated: XM5V64\\nInfluenza vaccines inactivated split virus or surface antigen: XM8MP2\\nInfluenza vaccines virus like particle: XM9E16\\nInfluenza purified antigen: XM33X8\\nHepatitis vaccines: XM6LL6\\nHepatitis B purified antigen: XM9V38\\nHepatitis A inactivated whole virus: XM2A12\\nCombinations hepatitis vaccines: XM03Y7\\nMeasles vaccines: XM28X5\\nMeasles live attenuated: XM8L15\\nMeasles combinations with mumps live attenuated: XM9439\\nMeasles combinations with mumps and rubella live attenuated: XM8TF3\\nMeasles combinations with rubella live attenuated: XM21H2\\nMeasles combinations with mumps rubella and varicella live attenuated: XM4AJ8\\nMumps vaccines: XM1131\\nMumps live attenuated: XM2340\\nPoliomyelitis vaccines: XM0N50\\nOrimune: XM4KG4\\nVaccine sabin oral: XM1Y59\\nDiplovax: XM2KH7\\nPoliomyelitis oral monovalent live attenuated: XM0VX8\\nPoliomyelitis oral trivalent live attenuated: XM0KZ1\\nPoliomyelitis oral bivalent live attenuated: XM79H3\\nPoliomyelitis trivalent inactivated whole virus: XM5V19\\nRotavirus diarrhoea vaccines: XM1CE0\\nRota virus live attenuated: XM4GV0\\nRota virus pentavalent live reassorted: XM4VG1\\nRubella vaccines: XM7PP1\\nRubella live attenuated: XM9PS9\\nRubella combinations with mumps live attenuated: XM3B09\\nVaricella zoster vaccines: XM8DG3\\nVaricella live attenuated: XM0NS8\\nZoster live attenuated: XM1SS1\\nPapillomavirus vaccines: XM9QP0\\nPapillomavirus human types: XM5CE9\\nSmallpox vaccine: XM95R0\\nRabies vaccines: XM6T09\\nRabies inactivated whole virus: XM7BE8\\nRespiratory syncytial virus vaccines: XM02Y0\\nSynagis: XM69P6\\nYellow fever vaccines: XM0N24\\nYellow fever live attenuated: XM3418\\nMpox vaccines: XM7ZF1\\nLCm vaccine: XM3ZY6\\nBacterial and viral vaccines combined: XM7C66\\nDiphtheria poliomyelitis tetanus vaccines: XM8AW1\\nDiphtheria pertussis poliomyelitis tetanus vaccines: XM09Q7\\nDiphtheria rubella tetanus vaccines: XM9744\\nDiphtheria hepatitis B pertussis tetanus vaccines: XM41N3\\nDiphtheria hemophilus influenzae B pertussis poliomyelitis tetanus vaccines: XM1LX9\\nDiphtheria hepatitis B tetanus vaccines: XM3G68\\nHemophilus influenzae B and hepatitis B vaccines: XM32L7\\nTyphoid hepatitis A vaccines: XM3JA6\\nDiphtheria hemophilus influenzae B pertussis tetanus hepatitis B vaccines: XM7JP3\\nDiphtheria pertussis poliomyelitis tetanus hepatitis B vaccines: XM0LT9\\nDiphtheria hemophilus influenzae B pertussis tetanushepatitis B meningococcus A  C vaccines: XM5XP9\\nDiphtheria tetanus acellular pertussis inactivated polio virus haemophilus Influenzae type B vaccines: XM21E6\\nDiphtheria hepatitis B tetanus acellular pertussis inactivated polio virus haemophilus Influenzae type B vaccines: XM84S1\\nDiphtheria tetanus acellular pertussis inactivated polio virus vaccines: XM9JP8\\nHemophilus influenzae B and poliomyelitis vaccines: XM01H1\\nMetronidazole: XM5YM6\\nTinidazole: XM7Z72\\nTrimetrexate: XM6BF7\\nAcetarsol: XM3Y85\\nPentamidine: XM0067\\nSuramin sodium: XM11F5\\nAtovaquone: XM9CB1\\nMiltefosine: XM71Y7\\nHydroxyquinoline derivatives: XM21E9\\nBroxyquinoline: XM5MW6\\nClioquinol: XM1V59\\nChlorquinaldol: XM56H5\\nTilbroquinol: XM1KS8\\nTiliquinol: XM0V89\\nAminoquinoline drugs: XM6M61\\nAmopyroquin: XM0NC8\\nAntiinfective antimalarial: XM37R2\\nAntiinfective antiprotozoal blood: XM0VE8\\nAntimalarial: XM1914\\nAntimalarial prophylactic: XM5WN6\\nAntimalarial pyrimidine derivative: XM5Q32\\nAntiprotozoal drug blood: XM7LP3\\nChlorproguanil: XM0KE4\\nCinchona: XM38E0\\nCinchonine alkaloids: XM9V39\\nDaraprim: XM9511\\nGuanatol: XM23A5\\nHalofantrine: XM3T26\\nIsopentaquine: XM17W0\\nMefloquine: XM50J2\\nPamaquine naphthoate: XM08Q1\\nPentaquine: XM0346\\nPyrimethamine: XM0XQ2\\nPyrimethamine with sulfadoxine: XM90Z4\\nQuinacrine: XM10R3\\nQuinine: XM8RC3\\nQuinocide: XM0RU7\\nSchizontocide blood tissue: XM9Z81\\nAminoquinolines: XM50C8\\nChloroquine: XM6ZE6\\nHydroxychloroquine: XM9YB2\\nPrimaquine: XM9F55\\nAmodiaquine: XM3GB3\\nTafenoquine: XM5EL4\\nArtemisinin and derivatives plain: XM5SP0\\nArtemisinin: XM1ED1\\nArtemether: XM7D52\\nArtesunate: XM7Q22\\nArtemotil: XM37K1\\nArtenimol: XM9ND1\\nArterolane and Piperaquine: XM3B54\\nNaphthoquine: XM8H63\\nArtemether and Lumefantrine: XM6TH1\\nActerol: XM8MB3\\nAminitrozole: XM0FS7\\nAntiinfective antiprotozoal: XM4GE4\\nAntimony dimercaptosuccinate: XM4W96\\nAntimony sodium dimercaptosuccinate: XM9GG8\\nAntiprotozoal drug: XM4393\\nAntitrichomonal drug: XM2HL1\\nBialamicol: XM83L5\\nCarbarsone: XM8E05\\nGlaucarubin: XM1RE2\\nHydroxystilbamidine: XM1LB9\\nMelarsonyl potassium: XM5NQ7\\nMelarsoprol: XM4UC9\\nMisonidazole: XM1HA1\\nOrnidazole: XM3WL0\\nOxophenarsine: XM3E43\\nStibogluconate: XM45H6\\nStilbamidine isetionate: XM0CL7\\nTeclozan: XM05U5\\nTrichomonacides: XM6XS3\\nTryparsamide: XM5R30\\nNitroimidazole derivatives: XM7BM9\\nAzanidazole: XM4HZ1\\nNimorazole: XM5LH9\\nSecnidazole: XM98K0\\nBenznidazole: XM0JG6\\nPropenidazole: XM61Z9\\nFexinidazole: XM5VX1\\nDichloroacetamide derivatives: XM4RW6\\nDiloxanide: XM7AM3\\nClefamide: XM9H76\\nEtofamide: XM3PL8\\nArsenic compounds: XM4787\\nArsthinol: XM09B5\\nDifetarsone: XM0A09\\nGlycobiarsol: XM6V40\\nAntimony compounds: XM64G7\\nMeglumine antimonate: XM2TP0\\nSodium stibogluconate: XM2284\\nAkritoin: XM3E78\\nAntiinfective arsenical: XM8LB8\\nAntiinfective heavy metals: XM44A9\\nAntimony antiinfectives: XM8CX5\\nAntimony potassium tartrate sodium: XM69W3\\nAntimony tartrated: XM2AH2\\nAntiparasitic drug specified: XM1Z32\\nArsphenamine silver: XM0L93\\nBismuth salts antiinfectives: XM12U8\\nBismuth salts subsalicylate: XM7A39\\nBithionol: XM8SJ3\\nChiniofon: XM7PV2\\nCinoxacin: XM6DH1\\nCroconazole: XM0402\\nDichlorhydroxyquinoline: XM1YN6\\nDisinfectant intestinal: XM59A1\\nFlumequine: XM4923\\nFlunidazole: XM7BY8\\nFluorocytosine: XM4XE9\\nHexetidine: XM6UT2\\nIodobismitol: XM74Y8\\nIodoquinol: XM80M5\\nLead antiinfectives: XM7T64\\nMapharsen: XM0FS9\\nMercury mercurial mercuric mercurous antiinfective systemic: XM0RW4\\nNeoarsphenamine: XM08P3\\nNeosilversalvarsan: XM0M05\\nNifuratel: XM39N3\\nOxolinic acid: XM70Q8\\nPotassium antimony tartrate: XM10R8\\nQuiniobine: XM8WV6\\nQuinoline derivatives: XM8U22\\nSalvarsan  neosilver silver: XM3VB9\\nSilver salvarsan: XM6260\\nSodium cacodylate antiinfective: XM3DB2\\nStovarsal: XM9L57\\nSulfarsphenamine: XM80F6\\nTartar emetic: XM96Q1\\nTartrated antimony antiinfective: XM6A32\\nThiobismol: XM9KU4\\nThiocarbarsone: XM9UP9\\nTin antiinfectives: XM5VM3\\nUrinary antiinfective: XM2SB0\\nEmetine: XM2HD6\\nPhanquinone: XM5GF4\\nMepacrine: XM9VB9\\nTenonitrozole: XM5RX3\\nDehydroemetine: XM28N6\\nFumagillin: XM5WJ8\\nNitazoxanide: XM84S6\\nEflornithine: XM9JL2\\nAlantolactone: XM2NT3\\nAmphotalide: XM1PP4\\nAnthiolimine: XM8LU8\\nAntiinfective anthelmintic: XM95R7\\nAntifilarial drug: XM43K9\\nAntihelmintics: XM4EC0\\nAntihookworm drug: XM9637\\nAntinematode drug: XM16G5\\nAntiplatyhelmintic drug: XM2078\\nAntischistosomal drug: XM60W7\\nAntitapeworm drug: XM6500\\nAntiwhipworm drug: XM5273\\nAscaridole: XM7QL4\\nAspidium oleoresin: XM9GK4\\nBenzimidazole derivatives: XM3JR4\\nMebendazole: XM3GX0\\nTiabendazole: XM0CU8\\nAlbendazole: XM79J1\\nFlubendazole: XM8RG6\\nFenbendazole: XM5XC2\\nCiclobendazole: XM7982\\nBephenium: XM3667\\nBithionol anthelminthic: XM6FY4\\nBitoscanate: XM5L27\\nChenopodium: XM4WY5\\nDichlorophen: XM0ZD3\\nDithiazanine iodide: XM8C12\\nFilix mas: XM2RX7\\nIvermectin: XM05F2\\nLevamisole: XM5W42\\nLucanthone: XM9Z70\\nMale fern extract: XM4SZ4\\nNiclosamide: XM2034\\nNiridazole: XM2WY0\\nNitrothiazol: XM7NR1\\nOxamniquine: XM5JZ6\\nPelletierine tannate: XM9FH0\\nPerchloroethylene medicinal: XM5ZH0\\nPinkroot: XM3T27\\nPraziquantel: XM8205\\nPumpkin seed extract: XM7SZ5\\nPyrvinium: XM5PX0\\nSantonin: XM9KL1\\nSpigelia root: XM3FE9\\nStibophen: XM5VV1\\nTeroxalene: XM4GA8\\nTetrachloroethylene medicinal: XM7PN4\\nTetramisole: XM93X2\\nUrea stibamine: XM2621\\nVeroxil: XM5C18\\nViprynium: XM3AT4\\nWormseed American: XM4555\\nTetrahydropyrimidine derivatives: XM6U56\\nPyrantel: XM90N4\\nOxantel: XM05V2\\nMetrifonate: XM9H59\\nTriclabendazole: XM7VW8\\nMoxidectin: XM7F99\\nDesaspidin: XM0399\\nTetrabenazine: XM9DZ4\\nMemantine: XM3BR4\\nGinkgo folium: XM1CG4\\nTirilazad: XM9VG8\\nRiluzole: XM9Z74\\nXaliproden: XM4ER7\\nFampridine: XM5PS1\\nTafamidis: XM2AL2\\nLaquinimod: XM1LU9\\nPitolisant: XM3QR7\\nPatisiran: XM3FT2\\nEdaravone: XM1KZ8\\nInotersen: XM7DT3\\nValbenazine: XM8MX8\\nAducanumab: XM87M0\\nDeutetrabenazine: XM5UK9\\nArimoclomol: XM4F26\\nNonsteroidal antiinflammatory and antirheumatic agents: XM4KS4\\nButylpyrazolidines: XM7W23\\nPhenylbutazone: XM8HN0\\nMofebutazone: XM8P27\\nOxyphenbutazone: XM12M5\\nClofezone: XM8X86\\nKebuzone: XM4H41\\nAcetic acid derivatives and related substances: XM74U4\\nIndometacin: XM7497\\nSulindac: XM24W2\\nTolmetin: XM97N5\\nZomepirac: XM92G8\\nDiclofenac: XM2AU1\\nEtodolac: XM2186\\nKetorolac: XM8M52\\nBumadizone: XM6KJ8\\nLonazolac: XM12Q6\\nFentiazac: XM2AX1\\nAcemetacin: XM3458\\nDifenpiramide: XM7K80\\nOxametacin: XM7CA3\\nProglumetacin: XM2P51\\nAceclofenac: XM5W40\\nBufexamac: XM7AB1\\nAlclofenac: XM9S89\\nIbufenac: XM8G95\\nOxicams: XM0UL8\\nPiroxicam: XM9MD6\\nDroxicam: XM7WP9\\nLornoxicam: XM3X14\\nMeloxicam: XM1XY0\\nIsoxicam: XM83U4\\nTenoxicam: XM1867\\nPropionic acid derivatives: XM2S54\\nIbuprofen: XM2RR6\\nNaproxen: XM1KL8\\nKetoprofen: XM63J5\\nFenoprofen: XM7BS7\\nSuprofen: XM2N63\\nFlurbiprofen: XM8VP8\\nTiaprofenic acid: XM0WQ1\\nOxaprozin: XM9694\\nIbuproxam: XM1918\\nFenbufen: XM4W51\\nBenoxaprofen: XM7F06\\nPirprofen: XM4KX7\\nIndoprofen: XM3G14\\nDexibuprofen: XM32V2\\nFlunoxaprofen: XM4FK3\\nAlminoprofen: XM1W06\\nDexketoprofen: XM1ZF2\\nNaproxcinod: XM9ES5\\nCarprofen: XM8GM3\\nFenamates: XM9DC7\\nMefenamic acid: XM6Q83\\nFlufenamic acid: XM31G8\\nMeclofenamic acid: XM3W40\\nTolfenamic acid: XM9WQ9\\nCoxibs: XM16D6\\nCelecoxib: XM63D2\\nRofecoxib: XM70K9\\nValdecoxib: XM4SK9\\nParecoxib: XM96Q4\\nEtoricoxib: XM2W58\\nLumiracoxib: XM0BC7\\nPolmacoxib: XM1N20\\nGlafenine: XM7AM9\\nFloctafenine: XM3WB0\\nNabumetone: XM8WS4\\nAzapropazone: XM6SW5\\nGlucosamine: XM6SR1\\nBenzydamine: XM73Q0\\nProquazone: XM8GX7\\nNimesulide: XM5C49\\nFeprazone: XM37T1\\nNiflumic acid: XM4KV5\\nGlucosaminoglycan polysulfate: XM5Z51\\nOrgotein: XM9Z19\\nDiacerein: XM51H0\\nMorniflumate: XM1019\\nTenidap: XM7Z95\\nOxaceprol: XM4L54\\nChondroitin sulfate: XM9352\\nAvocado and soyabean oil unsaponifiables: XM0H27\\nEthoxazene: XM9C36\\nFenflumizol: XM85Z4\\nAnalgesic antirheumatic: XM46B3\\nAntiphlogistic: XM8DE1\\nAntirheumatic: XM95N2\\nAurothioglycanide: XM8526\\nFarnesil: XM4XH9\\nSodium aurothiosulfate: XM4DJ6\\nGold preparations: XM3LE3\\nSodium aurothiomalate: XM9ZC2\\nAuranofin: XM5HT1\\nAurothioglucose: XM1MX1\\nAurotioprol: XM28Y9\\nSodium aurotiosulfate: XM8CF5\\nBucillamine: XM0VQ7\\nOxycinchophen: XM5L52\\nPenicillamine: XM1QA0\\nAcetylsalicylic acid: XM4G06\\nCarbaspirin: XM0XT0\\nCholine salicylate: XM0GX7\\nFiorinal: XM72N6\\nSodium salicylate: XM6PW4\\nSalicylamide: XM4WV7\\nSalsalate: XM68K3\\nDiflunisal: XM5UX6\\nAloxiprin: XM2JA1\\nEthenzamide: XM3ZP5\\nMorpholine salicylate: XM49Y6\\nDipyrocetyl: XM9TC0\\nBenorilate: XM1UA7\\nPotassium salicylate: XM2CV1\\nGuacetisal: XM1DD2\\nCarbasalate calcium: XM4TV1\\nImidazole salicylate: XM5UF9\\nCalcium salicylate: XM8F16\\nCarbethyl salicylate: XM5X48\\nMagnesium salicylate: XM6M40\\nSodium thiosalicylate: XM8FA6\\nAminophenazone: XM7045\\nAnalgesic pyrazole: XM7840\\nAntipyrine: XM22E9\\nCoal tar medicinal analgesics: XM60M2\\nDipyrone: XM4T98\\nIsopropylaminophenazone: XM2FJ5\\nMyochrysin e: XM8762\\nNifenazone: XM4YB4\\nNoramidopyrine: XM53Q3\\nPropyphenazone: XM6GV7\\nPyrazole derivatives: XM5H28\\nPyrazolone analgesic: XM5L33\\nRamifenazone: XM0K68\\nSulfamidopyrine: XM1SG0\\nSuxibuzone: XM9CV5\\nAcetaminophen: XM5DJ7\\nParaaminophenol derivatives: XM75Y5\\nPhenacetin: XM43A6\\nBucetin: XM7HP8\\nPropacetamol: XM8QF6\\nAcetaminosalol: XM24R8\\nAcetanilide: XM45S5\\nBromoseltzer: XM4T97\\nAcetylphenylhydrazine: XM2XD8\\nClonixin: XM3J63\\nCropropamide: XM1LX8\\nCrotethamide: XM0LT4\\nCyclopyrabital: XM0M53\\nDarvon: XM3YJ4\\nDiclonixin: XM7K04\\nDoloxene: XM2PY3\\nEmorfazone: XM7SA1\\nEtomide: XM9455\\nFluradoline: XM5YR6\\nJamaica dogwood bark: XM7983\\nLefetamine: XM6233\\nMethopholine: XM03M0\\nNefopam: XM4WT5\\nPerisoxal: XM8QV3\\nPhenicarbazide: XM0D38\\nPhenyramidol: XM2DH4\\nPiroxicam betacyclodextrin complex: XM0X95\\nPiscidia bark erythrina: XM63V3\\nPyrabital: XM49C9\\nPyridium: XM3WM4\\nRimazolium metilsulfate: XM4PW4\\nTiaramide: XM3375\\nTinoridine: XM9YA8\\nZactane: XM0794\\nMethoxyflurane: XM3P63\\nRimazolium: XM6Z00\\nFlupirtine: XM5WQ7\\nZiconotide: XM5XN0\\nTanezumab: XM70Q6\\nAntimigraine drugs: XM6HK1\\nTriptans: XM6FB9\\nSumatriptan: XM9AV2\\nNaratriptan: XM8BC6\\nZolmitriptan: XM06P8\\nRizatriptan: XM6W13\\nAlmotriptan: XM92S7\\nEletriptan: XM7YU2\\nFrovatriptan: XM4WN0\\nLasmiditan: XM7P17\\nDimetotiazine: XM81Q8\\nOxetorone: XM7N03\\nPizotifen: XM4WH4\\nIprazochrome: XM2G27\\nAntiepileptics: XM63D6\\nAlbutoin: XM52B4\\nAminodiphenylhydantoin valeric acid: XM9QF8\\nAnticonvulsant hydantoin: XM55H4\\nDilantin: XM08H9\\nEpanutin: XM45R0\\nEthotoin: XM8MV0\\nMephenytoin: XM4A36\\nMetetoin: XM02E9\\nPhenytoin: XM0RY4\\nOxazolidine derivatives: XM4DR6\\nParamethadione: XM7N89\\nTrimethadione: XM31H5\\nEthadione: XM9993\\nAloxidone: XM1535\\nFatty acid derivatives: XM4521\\nValproic acid: XM29Q3\\nValpromide: XM71X1\\nVigabatrin: XM5G31\\nProgabide: XM2HC7\\nAminobutyric acid: XM2XY6\\nTiagabine: XM8HQ0\\nSuccinimide derivatives: XM3C23\\nEthosuximide: XM1K85\\nPhensuximide: XM9E68\\nMesuximide: XM2KZ3\\nMorsuximide: XM6421\\nOther antiepileptics: XM9GA9\\nSultiame: XM1RS9\\nPhenacemide: XM7BQ9\\nPheneturide: XM4RJ7\\nBeclamide: XM6KR2\\nLamotrigine: XM6FN4\\nFelbamate: XM15W2\\nTopiramate: XM2103\\nGabapentin: XM0J96\\nLevetiracetam: XM9326\\nZonisamide: XM0SP9\\nPregabalin: XM0AK1\\nStiripentol: XM34S0\\nLacosamide: XM30R8\\nCarisbamate: XM7PP9\\nRetigabine: XM1P90\\nPerampanel: XM46J5\\nBrivaracetam: XM78C3\\nGanaxolone: XM7QW2\\nCarboxamide derivatives: XM70W8\\nCarbamazepine: XM3D95\\nOxcarbazepine: XM69D6\\nRufinamide: XM6BU4\\nEslicarbazepine: XM5HL7\\nClonazepam: XM2909\\nAntiparkinson drugs: XM9G63\\nDopaminergic agents: XM5Y20\\nCarbidopa: XM1Z60\\nDopa and dopa derivatives: XM7SN1\\nLevodopa: XM2WU7\\nDifluoromethyldopa: XM7RF5\\nLevodopa with carbidopa: XM3MW1\\nLevodopa and decarboxylase inhibitor: XM7ZB9\\nLevodopa Decarboxylase inhibitor and COMT inhibitor: XM3PK3\\nMelevodopa: XM1JZ7\\nMelevodopa and Decarboxylase inhibitor: XM0D22\\nEtilevodopa and Decarboxylase inhibitor: XM6R13\\nBromocriptine: XM5QR9\\nPergolide: XM1GL7\\nApomorphine: XM5PE4\\nPiribedil: XM2QX7\\nDihydroergocryptine mesylate: XM5DT8\\nRopinirole: XM9D35\\nPramipexole: XM5YJ4\\nRotigotine: XM7B98\\nMesulergine: XM50V4\\nMonoamine oxidase B inhibitors: XM9GG4\\nSelegiline: XM8FH5\\nRasagiline: XM6XW7\\nSafinamide: XM8H59\\nAmantadine: XM2H09\\nTolcapone: XM0BA4\\nEntacapone: XM07G6\\nBudipine: XM0K96\\nOpicapone: XM6TZ5\\nCarphenazine: XM7KE0\\nCompazine: XM83L8\\nDioxopromethazine: XM7WF8\\nEthyl aminophenothiazine: XM5EP8\\nIsopromethazine: XM9C32\\nMellaril: XM2WD3\\nMepazine: XM2VU6\\nMethoxypromazine: XM8ZW1\\nMetofenazate: XM4TX5\\nPhenothiazine psychotropic: XM52V9\\nPiperacetazine: XM0F82\\nPropylaminophenothiazine: XM6GY2\\nSparine: XM2XX6\\nStelazine: XM5JH1\\nStemetil: XM9Q32\\nSulforidazine: XM5Z28\\nThiazinamium metilsulfate: XM6YW4\\nTindal: XM87F3\\nTranquilizer dimethylamine: XM0EE9\\nTranquilizer ethylamine: XM9B27\\nTranquilizer phenothiazine: XM1QV8\\nTranquilizer piperazine: XM7057\\nTranquilizer piperidine: XM5KD3\\nTranquilizer propylamine: XM3Z20\\nPhenothiazines with aliphatic sidechain: XM4SG0\\nChlorpromazine: XM4U75\\nLevomepromazine: XM61Z1\\nPromazine: XM3CL7\\nAcepromazine: XM8LW2\\nTriflupromazine: XM1TZ3\\nCyamemazine: XM3AU5\\nChlorproethazine: XM6WY7\\nPhenothiazines with piperazine structure: XM1YC7\\nDixyrazine: XM75P4\\nFluphenazine: XM6Z10\\nPerphenazine: XM5Z27\\nProchlorperazine: XM84U4\\nThiopropazate: XM0PU2\\nTrifluoperazine: XM18F5\\nAcetophenazine: XM3EY1\\nThioproperazine: XM1V98\\nButaperazine: XM5JD6\\nPerazine: XM0TU3\\nPhenothiazines with piperidine structure: XM9HH5\\nPericiazine: XM5664\\nThioridazine: XM4DG6\\nMesoridazine: XM6447\\nPipotiazine: XM0168\\nBenperidol: XM12B1\\nBromperidol: XM4QG3\\nButyrophenonebased tranquilizers: XM2HT3\\nDroperidol: XM6FV0\\nFluanisone: XM0FM0\\nHaloperidol: XM9580\\nLenperone: XM6E81\\nMelperone: XM26W9\\nMoperone: XM7DW6\\nPipamperone: XM5AB4\\nSpiperone: XM1UG0\\nTimiperone: XM7RP6\\nTranquilizer butyrophenone: XM5NL7\\nTrifluperidol: XM4U52\\nLumateperone: XM9NX2\\nIndole derivatives: XM1QY7\\nOxypertine: XM84W2\\nMolindone: XM61G1\\nSertindole: XM69Z2\\nZiprasidone: XM8YM0\\nLurasidone: XM9EW5\\nThioxanthene derivatives: XM8X87\\nFlupentixol: XM4EY8\\nClopenthixol: XM87S1\\nChlorprothixene: XM2H35\\nTiotixene: XM6B79\\nZuclopenthixol: XM3MW6\\nDiphenylbutylpiperidine derivatives: XM2NF9\\nFluspirilene: XM0Q81\\nPimozide: XM1FB1\\nPenfluridol: XM5SZ6\\nDiazepines oxazepines thiazepines and oxepines: XM12F2\\nLoxapine: XM8FG8\\nClozapine: XM8UG6\\nOlanzapine: XM6GK7\\nQuetiapine: XM4G70\\nAsenapine: XM90C7\\nClotiapine: XM9DC4\\nVeralipride: XM9Q20\\nLevosulpiride: XM0624\\nBenzamides: XM1W79\\nSulpiride: XM7Z05\\nSultopride: XM9G21\\nTiapride: XM8KD4\\nRemoxipride: XM3WA3\\nAmisulpride: XM1DG3\\nLithium gluconate: XM0W09\\nLithium salts carbonate: XM5C35\\nAmperozide: XM4GQ2\\nAmphenidone: XM3JM5\\nAntipsychotic drug specified: XM7AA5\\nAzacyclonol: XM23M7\\nBenzperidine: XM56Y5\\nBenzperidol: XM9VY2\\nEnpiprazole: XM3KB9\\nHydroxyphenamate: XM9097\\nMebutamate: XM7EB1\\nMosapramine: XM88L2\\nNemonapride: XM7B44\\nOxanamide: XM5F36\\nPhenaglycodol: XM9799\\nProthipendyl: XM3BH3\\nRaclopride: XM7L04\\nSetoperone: XM7KX5\\nSpirilene: XM6YS4\\nTranquilizer carbamate: XM0ES8\\nTranquilizer hydroxyzine: XM7Z64\\nTranquilizer specified: XM3ES1\\nTranquilizer thioxanthene: XM0GN3\\nTybamate: XM06W2\\nZotepine: XM4EU4\\nRisperidone: XM1Z15\\nAripiprazole: XM67P4\\nPaliperidone: XM7H28\\nIloperidone: XM0FR9\\nCariprazine: XM1SS2\\nBrexpiprazole: XM8504\\nPimavanserin: XM0715\\nAmiflamine: XM3533\\nAntidepressant monoamine oxidase inhibitor: XM8CW9\\nClorgiline: XM9VZ7\\nIproclozide: XM2WY9\\nIproniazid: XM6DW5\\nIsocarboxazid: XM4T23\\nMebanazine: XM2K50\\nMonoamine oxidase inhibitor hydrazine: XM2GX9\\nMonoamine oxidase inhibitor: XM6944\\nNialamide: XM0158\\nParnate: XM3KZ3\\nPhenelzine: XM4S21\\nPheniprazine: XM4A50\\nSafrazine: XM96M0\\nTranylcypromine: XM1023\\nAntidepressant selective serotonin reuptake inhibitor: XM2NP3\\nCitalopram: XM6WT9\\nFemoxetine: XM24M0\\nFluoxetine: XM7LE6\\nFluvoxamine: XM64L1\\nIndalpine: XM5R26\\nParoxetine: XM3PJ6\\nZimeldine: XM6WB9\\nSertraline: XM5TZ9\\nAlaproclate: XM7ZN2\\nEtoperidone: XM4MF4\\nEscitalopram: XM7PX8\\nCianopramine: XM0HR7\\nAntidepressant selective serotonin norepinephrine reuptake inhibitor: XM0PE4\\nAntidepressant triazolopyridine: XM8D31\\nDuloxetine: XM10Q5\\nDesvenlafaxine: XM3KS5\\nMilnacipran: XM6J21\\nLevomilnacipran: XM17Z4\\nVenlafaxine: XM36V6\\nBifemelane: XM03J9\\nBupropion: XM03E6\\nDiclofensine: XM7U12\\nOther specified antidepressant: XM78C1\\nMianserin: XM0T46\\nMinaprine: XM5QV7\\nNomifensine: XM6X89\\nOxitriptan: XM6AP8\\nPrazitone: XM4WM9\\nThiazesim: XM0ST5\\nTianeptine: XM5DV5\\nViloxazine: XM5L45\\nTrazodone: XM62E7\\nMirtazapine: XM0B23\\nTryptophan: XM54Q7\\nNefazodone: XM85H1\\nOxaflozane: XM4ML8\\nMedifoxamine: XM80H8\\nPivagabine: XM4ZF1\\nReboxetine: XM70H2\\nGepirone: XM5KP8\\nAgomelatine: XM5F11\\nVilazodone: XM7T91\\nHyperici herba: XM4230\\nVortioxetine: XM0EP0\\nSerotonin: XM8FB6\\nMetapramine: XM0227\\nNonselective monoamine reuptake inhibitors: XM9KG1\\nDesipramine: XM6FC9\\nImipramine: XM6PZ9\\nClomipramine: XM76Z6\\nOpipramol: XM37K4\\nTrimipramine: XM9WZ5\\nLofepramine: XM7T42\\nDibenzepin: XM6H22\\nAmitriptyline: XM7BL0\\nNortriptyline: XM79G5\\nProtriptyline: XM2WA4\\nDoxepin: XM1LC7\\nIprindole: XM24M7\\nMelitracen: XM1575\\nButriptyline: XM8QA6\\nDosulepin: XM2T20\\nAmoxapine: XM8TQ9\\nAmineptine: XM1190\\nMaprotiline: XM41L8\\nQuinupramine: XM34S5\\nImipramine oxide: XM4SZ9\\nDimetacrine: XM3MV6\\nOxaprotiline: XM5RG3\\nNoxiptiline: XM7GY1\\nMonoamine oxidase A inhibitors: XM1UL5\\nMoclobemide: XM14X9\\nToloxatone: XM1TG1\\nCannabinoids: XM2PL7\\nNabilone: XM3UF9\\nTetrahydrocannabinol: XM4HM2\\nCannabidiol: XM5B55\\nDronabinol: XM1W83\\nHallucinogens: XM4SV9\\nPsilocin: XM5JH5\\nPsilocybin: XM7642\\nMescaline: XM0T53\\nAeruginascin: XM78V1\\nBufotenine: XM9WX3\\nNNDimethyltryptamine: XM9T61\\nLysergic acid amide: XM9CL3\\nPhencyclidine: XM5M84\\nMuscimol: XM50E4\\nIbotenic acid: XM1PJ8\\nSalvinorin A: XM5SB5\\nAmfetaminil: XM3C53\\nBenzedrine amphetamine: XM3E65\\nCentral nervous system stimulants amphetamines: XM1NA8\\nDexedrine: XM1WW4\\nDextroamphetamine: XM6LD5\\nEcstasy: XM07Y4\\nMethamphetamine: XM5B49\\nMethedrine: XM3WD9\\nMethylamphetamine: XM3Q37\\nPsychostimulant caffeine: XM9932\\nPsychostimulant amphetamine: XM6RB6\\nTenamfetamine: XM6V10\\nPsychostimulants ADHD and nootropic agents: XM12M9\\nCentrally acting sympathomimetics: XM7LR7\\nMethylphenidate: XM1NX2\\nPemoline: XM52S5\\nModafinil: XM75Z6\\nFenozolone: XM5921\\nAtomoxetine: XM9DQ5\\nDexmethylphenidate: XM5288\\nArmodafinil: XM3ZW9\\nEtryptamine: XM9FY1\\nLevopropylhexedrine: XM3K58\\nXanthine derivatives: XM2XU4\\nCaffeine: XM0NG8\\nPropentofylline: XM3Y68\\nMeclofenoxate: XM1SE2\\nNizofenone: XM8QG2\\nProlintane: XM84X9\\nPipradrol: XM8EX0\\nVinpocetine: XM8029\\nTipepidine: XM37E2\\nPyritinol: XM1LB1\\nPiracetam: XM5207\\nDeanol: XM3HZ4\\nFipexide: XM2AB6\\nCiticoline: XM5TT1\\nOxiracetam: XM5N75\\nPirisudanol: XM6EM2\\nLinopirdine: XM1MZ1\\nAniracetam: XM0Z60\\nAcetylcarnitine: XM77H2\\nIdebenone: XM5CY6\\nPramiracetam: XM59Z4\\nAdrafinil: XM3WZ9\\nMebicar: XM94C0\\nPhenibut: XM3J14\\nDeanol aceglumate: XM45U3\\nDiethyltryptamine DET: XM9DQ3\\nDimethyl tryptamine: XM6LV4\\nHawaiian Woodrose seeds: XM9438\\nHeavenly Blue morning glory: XM52J2\\nMagic mushroom: XM79N5\\nMescal buttons: XM0169\\nMorning glory seeds: XM32H5\\nPearly Gates morning glory seeds: XM4B51\\nPeyote: XM0QA2\\nYohimbic acid: XM0075\\nCannabinol: XM8E16\\nCentral nervous system depressants hallucinogenics: XM0XQ5\\nPsychodysleptic drug: XM31A7\\nPsychotomimetic agents: XM3Z58\\nHallucinogen: XM8X97\\nMegahallucinogen: XM7DW4\\nDiamorphine: XM05B3\\nMorphine morphine derivatives and metabolites: XM69R4\\nhydroxydihydromorphinone: XM39E2\\nAcemorphan: XM5CY8\\nBenzomorphan: XM0E25\\nBenzyl morphine: XM8YM7\\nBlue velvet: XM0BB1\\nDesomorphine: XM45R8\\nDihydromorphine: XM4T95\\nHydromorphinol: XM3473\\nHydromorphone: XM8SD7\\nMetopon: XM78E0\\nMorpholinylethylmorphine: XM7VL7\\nNicomorphine: XM7W06\\nNormorphine: XM9BE3\\nOxymorphone: XM64M0\\nMorphine: XM1KZ5\\nBenzylmorphine: XM0P98\\nMyrophine: XM7ZJ1\\nOpium: XM4ES0\\nOpium alkaloids total: XM2T93\\nOpium alkaloids standardized powdered: XM69X3\\nOpium alkaloids tincture camphorated: XM91H1\\nLaudanum: XM1EE2\\nPapaveretum: XM1YK2\\nParegoric: XM1LB8\\nOxycodone: XM4SL9\\nAcetyldihydrocodeinone: XM79K2\\nEucodal: XM7HX3\\nNalfurafine: XM9UH3\\nCodeine codeine derivatives and other opioids used in cough suppression: XM4587\\nAcetyldihydrocodeine: XM3DS6\\nAntitussive codeine mixture: XM05R0\\nCliradon: XM3YP8\\nDesocodeine: XM4046\\nDihydrocodeine: XM06K5\\nDihydroisocodeine: XM77C9\\nHycodan: XM9UN6\\nHydroxydihydrocodeinone: XM0YG5\\nPercodan: XM07U7\\nPiminodine: XM5NP7\\nEthylmorphine: XM3WN9\\nHydrocodone: XM8E09\\nNoscapine: XM6RX7\\nPholcodine: XM4QV7\\nDextromethorphan: XM9UV0\\nThebacon: XM2358\\nDimemorfan: XM7V96\\nNormethadone: XM5PZ4\\nMethadone methadone derivatives and other drugs used to treat opioid addictive disorders: XM1ZY9\\nMethadone: XM7XP1\\nLevoisomethadone: XM9RG7\\nOpioid anaesthetics: XM4MV8\\nAlfentanil: XM4G88\\nSufentanil: XM1EF3\\nAnileridine: XM7YQ6\\nRemifentanil: XM0YQ0\\nAntagonist narcotic analgesic: XM7TT0\\nCyclazocine: XM0850\\nLevallorphan: XM65J2\\nMorphine antagonist: XM4HP3\\nNaloxone: XM14T9\\nNaltrexone: XM2M16\\nNarcotic antagonist: XM9BM4\\nOpiate antagonists: XM5DJ2\\nMethylnaltrexone bromide: XM3TK0\\nAlvimopan: XM4GP3\\nNaloxegol: XM93Z3\\nOpioid antagonist: XM6KY8\\nOther opioid analgesics natural synthetic and semisynthetic: XM4S22\\nProdine: XM30T6\\nAntitussive opiate: XM9907\\nCough mixture containing opiates: XM6C31\\nDextrorphan: XM8ZF5\\nDifencloxazine: XM1K75\\nDipipanone: XM9SW6\\nDromoran: XM81P5\\nEptazocine: XM4EW3\\nEthoheptazine: XM6CK0\\nHeptalgin: XM35C1\\nLevodromoran: XM5F21\\nLevopropoxyphene: XM4P40\\nLevorphanol: XM1R71\\nMeperidine: XM0GS3\\nNarcotic synthetic: XM8PP7\\nNisentil: XM8MP5\\nOpioid: XM7S23\\nPhenadoxone: XM04Z5\\nPhenazocine: XM2542\\nPhenomorphan: XM9B34\\nPipadone: XM72D5\\nProfadol: XM39L3\\nPromedol: XM9AZ5\\nPropoxyphene: XM3E08\\nRacemoramide: XM6625\\nThebaine: XM8804\\nTilidine: XM09H6\\nTramadol: XM7KC0\\nViminol: XM5UK3\\nDiphenoxylate: XM9Y28\\nLoperamide: XM86N4\\nPhenylpiperidine derivatives: XM9NL3\\nKetobemidone: XM9HP7\\nFentanyl: XM76M8\\nDiphenylpropylamine derivatives: XM8286\\nDextromoramide: XM3246\\nPiritramide: XM55Z5\\nDextropropoxyphene: XM8GB8\\nBezitramide: XM5GN5\\nBenzomorphan derivatives: XM1QE0\\nPentazocine: XM9K14\\nMorphinan derivatives: XM09R6\\nButorphanol: XM1682\\nNalbuphine: XM4P05\\nBuprenorphine: XM9Z94\\nEtorphine: XM02X7\\nAcetorphine: XM3PK7\\nPhenoperidine: XM0K66\\nMeptazinol: XM40T9\\nDrotebanol: XM0GU8\\nLoperamide oxide: XM7VK6\\nDezocine: XM13Q9\\nTapentadol: XM25Z3\\nOliceridine: XM1G85\\nNalmefene: XM4PD9\\nDifelikefalin: XM4M74\\nCatha edulis tea: XM0VG7\\nKhat: XM0238\\nCentral nervous system stimulants not elsewhere classified: XM3GQ0\\nCerebral stimulants psychotherapeutic: XM0854\\nCerebral stimulants: XM93X4\\nStimulant central nervous system psychotherapeutic: XM7125\\nInhaled anaesthetics: XM8T75\\nEthers: XM4VX3\\nDiethyl ether: XM3J00\\nVinyl ether: XM7UB3\\nHalogenated hydrocarbons: XM0TE1\\nHalothane: XM2FH0\\nChloroform: XM7MX5\\nChloroform vapor: XM1GP5\\nEnflurane: XM35M6\\nTrichloroethylene anaesthetic gas: XM1E91\\nIsoflurane: XM9HY9\\nAnaesthesia endotracheal: XM0ZA2\\nAnaesthetic gaseous: XM05Z8\\nAnaesthetic halogenated hydrocarbon derivatives: XM8V73\\nCentral nervous system depressants anaesthetic gases: XM5UK1\\nChloroform anaesthetic: XM42D4\\nChloroform water concentrated: XM2DK4\\nDivinyl ether: XM9TE3\\nEthyl bromide anaesthetic: XM3EA4\\nEthyl chloride anaesthetic: XM2D90\\nEthylene anaesthetic: XM6WF0\\nFluroxene: XM9K99\\nNitrous oxide: XM73B5\\nTrifluoroethyl vinyl ether: XM9NP2\\nVinesthene: XM7Q24\\nDesflurane: XM1C44\\nSevoflurane: XM07G7\\nXenon: XM8X62\\nIntravenous anaesthetics: XM7D47\\nAlphadolone: XM14F2\\nAlfaxalone: XM4PF7\\nBarbiturate anaesthetic intravenous: XM59B1\\nBrevital sodium: XM9CB4\\nButhalitone sodium: XM6LE6\\nButyl thiobarbital sodium: XM5K69\\nCentral nervous system depressants anaesthetic intravenous: XM9SR9\\nEtomidate: XM5MB2\\nEvipal sodium: XM93E9\\nSernyl: XM5ZF4\\nThialbarbital: XM4XN0\\nThiamylal: XM66H8\\nThiamylal sodium: XM8UK0\\nThiobarbital sodium: XM4NL3\\nThiobarbiturate anaesthetic: XM1QW9\\nThiobutabarbital sodium: XM72F2\\nMethohexital: XM7JR4\\nHexobarbital: XM08U4\\nThiopental sodium: XM0EL8\\nKetamine: XM7C11\\nPropanidid: XM4BS0\\nPropofol: XM1903\\nEsketamine: XM2W08\\nCyclopropane: XM7T11\\nGammahydroxybutyrate: XM9MS5\\nHexobarbital rectal: XM5C03\\nMinaxolone: XM20X3\\nTiletamine: XM2MR8\\nTribromoethanol rectal: XM8DR0\\nLocal anaesthetics: XM7Y85\\nAmylocaine regional: XM1FJ6\\nAmylocaine regional infiltration: XM1H49\\nAmylocaine regional nerve block: XM7CH6\\nAmylocaine regional spinal: XM37J6\\nAmylocaine regional topical: XM5JY6\\nAnaesthesia caudal: XM5R82\\nAnaesthesia epidural: XM8MY3\\nAnaesthesia mucosal: XM25C7\\nAnesthesia rectal local: XM0D14\\nAnesthesia regional: XM0FJ3\\nAnaesthetic infiltration: XM0LM0\\nAnaesthetic spinal: XM7EC3\\nAnesthetic topical: XM8E23\\nAnaesthetic with local muscle relaxant: XM3S41\\nAptocaine: XM5ZK7\\nArticaine: XM52S4\\nBenzamine: XM4YN0\\nBenzocaine: XM8KD9\\nBetoxycaine: XM1604\\nBupivacaine: XM5YL1\\nBupivacaine infiltration: XM7WQ7\\nBupivacaine nerve block: XM4216\\nBupivacaine spinal: XM46M2\\nButacaine: XM3781\\nButamben: XM7MD5\\nButanilicaine: XM9VA7\\nButyl aminobenzoate: XM0HA0\\nButyn: XM5NW5\\nCarbocaine infiltration: XM2YU2\\nCarbocaine nerve block: XM8C65\\nCarbocaine topical: XM2DT1\\nChloroprocaine: XM6HZ0\\nChloroprocaine infiltration: XM8XD3\\nChloroprocaine nerve block: XM0GC2\\nChloroprocaine spinal: XM94U2\\nCinchocaine: XM0L28\\nCinchocaine topical: XM5Y10\\nCyclaine: XM7FD6\\nCyclomethycaine: XM41W7\\nDimethocaine: XM3BB4\\nDiperodon: XM8UZ3\\nDorsacaine: XM23R3\\nDyclone: XM5601\\nDyclonine: XM3QB4\\nEndocaine: XM20M0\\nEPAB: XM0P92\\nEthocaine infiltration: XM2H77\\nEthocaine nerve block: XM6585\\nEthocaine spinal: XM7217\\nEthyl aminobenzoate: XM1WJ3\\nEthyl chloride local anaesthetic: XM87H9\\nEtidocaine: XM8X57\\nEtidocaine infiltration: XM8013\\nEtidocaine nerve block: XM8RU6\\nEucaine: XM2F20\\nHexylcaine: XM76M6\\nLeucinocaine: XM5863\\nMepivacaine: XM1MK4\\nMepivacaine epidural: XM0EH7\\nMeprylcaine: XM9DE9\\nMetabutethamine: XM7CG8\\nNesacaine: XM68T6\\nNesacaine infiltration: XM6AA0\\nNesacaine nerve block: XM4148\\nNovocain infiltration: XM38C9\\nNovocain topical: XM6R58\\nNupercaine spinal: XM6NN7\\nNupercaine topical: XM8739\\nOrthocaine: XM0QU2\\nOxetacaine: XM5HP0\\nOxethazine: XM6V01\\nOxybuprocaine: XM6RN9\\nPercaine spinal: XM7H65\\nPercaine topical: XM7EK6\\nPhenacaine: XM6Z26\\nPiperocaine: XM2ZH3\\nPiperocaine infiltration: XM7UW6\\nPiperocaine nerve block: XM8J09\\nPiperocaine topical: XM40M8\\nPitkins solution: XM8AE6\\nPrilocaine: XM2X66\\nPrilocaine infiltration: XM9NH0\\nPrilocaine nerve block: XM85Q7\\nPrilocaine regional: XM4EE1\\nProcaine: XM5L66\\nProcaine nerve block: XM05Z5\\nProcaine regional: XM1CG3\\nProcaine spinal: XM8KS3\\nProparacaine: XM97J9\\nPropoxycaine: XM72A2\\nPropoxycaine infiltration: XM9BY7\\nPropoxycaine nerve block: XM2DT4\\nPropoxycaine topical: XM0BG4\\nQuotane: XM87E0\\nStovaine: XM2MX6\\nStovaine infiltration: XM79W4\\nStovaine nerve block: XM08B5\\nStovaine spinal: XM9657\\nStovaine topical: XM3MW8\\nSurfacaine: XM6392\\nTetracaine: XM1HW1\\nTetracaine nerve block: XM32E4\\nTetracaine regional: XM9H96\\nTetracaine spinal: XM9CQ9\\nTrimecaine: XM3QD1\\nTronothane: XM2FR2\\nXylocaine infiltration: XM7771\\nXylocaine nerve block: XM18M2\\nXylocaine spinal: XM5K48\\nXylocaine topical: XM5G11\\nAlprazolam: XM1030\\nBentazepam: XM4R58\\nBenzodiapin: XM2GL0\\nBromazepam: XM9JC7\\nBrotizolam: XM2S43\\nCamazepam: XM5133\\nCarpipramine: XM9S41\\nCentral nervous system depressants benzodiazepines: XM1J81\\nChlordiazepoxide: XM5JC4\\nClobazam: XM43U0\\nDipotassium clorazepate: XM3C29\\nClotiazepam: XM0A75\\nCloxazolam: XM5M11\\nDelorazepam: XM0GD3\\nDiazepam: XM8P99\\nEstazolam: XM9YX9\\nEthyl loflazepate: XM54N1\\nEtizolam: XM9DN9\\nFludiazepam: XM8NC2\\nFlunitrazepam: XM9W71\\nFlurazepam: XM73H1\\nFlutazolam: XM68Z6\\nFlutoprazepam: XM81V7\\nHalazepam: XM3FR2\\nHaloxazolam: XM86G3\\nKetazolam: XM5WE7\\nLoprazolam: XM6KW2\\nLorazepam: XM85H7\\nLormetazepam: XM1EE3\\nMedazepam: XM9KN4\\nMexazolam: XM7QC1\\nMidazolam: XM9PG6\\nNimetazepam: XM8TH1\\nNitrazepam: XM4TR7\\nNordazepam: XM4FQ9\\nOxazepam: XM1A29\\nOxazolam: XM62U2\\nPerlapine: XM3LR9\\nPinazepam: XM0GW7\\nPrazepam: XM4M86\\nQuazepam: XM42F4\\nTemazepam: XM3215\\nTofisopam: XM79N8\\nTranquilizer benzodiazepine: XM9X46\\nTriazolam: XM1VC3\\nPotassium clorazepate: XM36R8\\nAdinazolam: XM94Z2\\nDoxefazepam: XM66N4\\nCinolazepam: XM4BU2\\nDiphenylmethane derivatives: XM8CM3\\nHydroxyzine: XM8CV8\\nCaptodiame: XM70L1\\nCarbamates: XM96H3\\nMeprobamate: XM3MX1\\nEmylcamate: XM8G67\\nAldehydes and derivatives: XM3XU7\\nChloral hydrate: XM8AH5\\nChloralodol: XM8D85\\nParacetaldehyde: XM0ZC2\\nAcetylglycinamide chloral hydrate: XM46J8\\nDichloralphenazone: XM9V32\\nCinnamaldehyde: XM0V58\\nHexyl cinnamal: XM37U9\\nAmyl cinnamal: XM5TZ2\\nButylchloral hydrate: XM9J50\\nPiperidinedione derivatives: XM6R00\\nGlutethimide: XM5S80\\nMethyprylon: XM2MN1\\nPyrithyldione: XM2MC9\\nBarbiturates and derivatives: XM4YG0\\nNarcobarbital: XM3Z73\\nPentobarbital: XM01Z3\\nAmobarbital: XM01F5\\nButobarbital: XM8TB8\\nBarbital: XM2B90\\nSecobarbital: XM6QG0\\nTalbutal: XM28V1\\nVinylbital: XM6NX3\\nVinbarbital: XM9VX7\\nCyclobarbital: XM89L9\\nHeptabarbital: XM7ZK9\\nAllobarbital: XM8FN0\\nProxibarbal: XM8C15\\nMethylphenobarbital: XM60H4\\nPhenobarbital: XM2605\\nPrimidone: XM5J41\\nBarbexaclone: XM45T7\\nMetharbital: XM64T5\\nReposal: XM1ZM1\\nEtallobarbital: XM1WN6\\nAprobarbital: XM8YV1\\nBrallobarbital: XM50Q3\\nButalbital: XM3UQ5\\nButallylonal: XM6XH1\\nDifebarbamate: XM4C65\\nMethobarbital methobarbitone: XM8DQ9\\nNealbarbital: XM3YG4\\nProbarbital: XM6F85\\nPropallylonal: XM37N4\\nSecbutabarbital: XM81J9\\nZdrugs: XM4843\\nZopiclone: XM8LM1\\nZolpidem: XM8188\\nzaleplon: XM0UU3\\nEszopiclone: XM4DP1\\nMelatonin receptor agonists: XM0GA0\\nMelatonin: XM7R38\\nRamelteon: XM4Y11\\nTasimelteon: XM0DX1\\nBromide salts: XM93J2\\nAcecarbromal: XM5V35\\nBromisoval: XM3260\\nBromoform: XM7XH5\\nCarbromal: XM68H5\\nAcetylpheneturide: XM4JD8\\nAllylisopropylacetylurea: XM0Y74\\nAllyltribromide: XM2MT0\\nAmmonium bromide: XM0FX2\\nAnticonvulsant hypnotic: XM2P06\\nAnticonvulsant pyrimidinedione: XM4LR0\\nAnticonvulsant specified: XM80V1\\nApronal: XM2851\\nAvomine: XM8WF0\\nBetaChlor: XM34M8\\nBromal hydrate: XM2S35\\nBromine compounds medicinal: XM16D8\\nBromine sedative: XM0JD2\\nBromisovalum: XM14P7\\nBromural: XM0L99\\nCalcium bromide: XM7Q19\\nBromides: XM44G1\\nCentral nervous system depressants chloral hydrate: XM6Z70\\nCentral nervous system depressants hypnotics specified: XM4A26\\nCentral nervous system depressants paraldehyde: XM0MP0\\nChloral derivative: XM2PX1\\nChloralamide: XM5HQ1\\nChloretone: XM1XU2\\nChlorhexadol: XM7N56\\nClomethiazole: XM7GE6\\nCroton chloral: XM58S5\\nDiethylsulfonediethylmethane: XM1L51\\nDivalproex: XM5P16\\nDoriden: XM2ML0\\nDormison: XM0YS0\\nEctylurea: XM76A5\\nEthchlorvynol: XM4SW2\\nEthinamate: XM8HM5\\nEtifoxine: XM0959\\nHexapropymate: XM5084\\nHypnotic drug specified: XM3GR8\\nLactuca virosa extract: XM1H40\\nLactucarium: XM7EA2\\nLettuce opium: XM2447\\nLevanil: XM1SJ9\\nLevoprome: XM9S20\\nMethaqualone: XM3C52\\nMethyl sulfonal: XM8UW8\\nMethylpentynol: XM79Y3\\nNiaprazine: XM9L86\\nNoludar: XM67F2\\nPericlor: XM41Z4\\nPetrichloral: XM7865\\nPhenergan: XM8U36\\nPotassium bromide: XM3YQ0\\nPropionaldehyde medicinal: XM23J2\\nQuaalude: XM5KU5\\nSedative mixed: XM5YQ4\\nSedormid: XM53R6\\nSerenesil: XM5BF2\\nSodium bromide: XM8SU3\\nSodium valproate: XM9F88\\nSomnos: XM4ZG6\\nSopor: XM1BT3\\nSoporific drug specified type: XM2N03\\nSulfonal: XM81Z5\\nSulfonethylmethane: XM9QV2\\nSulfonmethane: XM4YF8\\nTetronal: XM8296\\nTranquilizer with hypnotic or sedative: XM6WP4\\nTribromacetaldehyde: XM9XF5\\nTrichloroethanol: XM1DU6\\nTrichloroethyl phosphate: XM4236\\nTriclofos: XM68E8\\nTrional: XM2334\\nTriple bromides: XM16S3\\nValerian root: XM3PP3\\nValerian tincture: XM0MV0\\nValmid: XM1WZ4\\nValnoctamide: XM2TP4\\nWelldorm: XM2AQ9\\nBuspirone: XM1ZF1\\nMephenoxalone: XM01J5\\nPropiomazine: XM9TL2\\nSodium oxybate: XM15N4\\nBenzoctamine: XM3EH5\\nGedocarnil: XM9727\\nFabomotizole: XM5928\\nLavandulae aetheroleum: XM4DF5\\nValerianae radix: XM8488\\nSuvorexant: XM2HN6\\nDipiperonylaminoethanol: XM2AY7\\nLemborexant: XM9235\\nHexethal sodium: XM1VL2\\nMephebarbital: XM7MG1\\nMethitural: XM0217\\nAlcohol deterrent: XM3XY4\\nAntabuse: XM2XV6\\nAntidote: XM1S43\\nChelating agent: XM65Y8\\nCholinesterase reactivator: XM68U2\\nCysteamine: XM81B1\\nDetoxifying agent: XM9M46\\nDisodium edetate: XM0ZM0\\nEDTA: XM1V56\\nPhytic acid nonasodium: XM0FL5\\nGlutathione: XM7SW5\\nMethylthioninium chloride: XM1YY3\\nNitrefazole: XM7Z31\\nObidoxime chloride: XM7HV6\\nPralidoxime: XM2ZD4\\nPotassium ferric hexacyanoferrate medicinal: XM6TE9\\nPralidoxime iodide: XM7K47\\nPralidoxime chloride: XM6BZ5\\nPrussian blue therapeutic: XM8P25\\nPyridine aldoxime methiodide: XM6DU2\\nPyridine aldoxime methyl chloride: XM6043\\nSodium nitrite: XM3810\\nSodium phytate: XM7LV6\\nThiosulfate: XM6NW5\\nSodium versenate: XM2KC9\\nTetraethylthiuram disulfide: XM99S5\\nTrientine: XM6GP9\\nTrisodium hydrogen edetate: XM2U68\\nVersenate: XM7KV3\\nNalorphine: XM4UW9\\nDimercaprol: XM89R9\\nPotassium iodide: XM1260\\nAcetylcysteine: XM7372\\nMethionine: XM5MC0\\nUridine triacetate: XM28B1\\nEdetates: XM0588\\nPrednisolone and Promethazine: XM5VJ5\\nObidoxime: XM8ET8\\nProtamine: XM2GR4\\nCopper sulfate: XM4JM7\\nDigitalis antitoxin: XM9AD6\\nFlumazenil: XM2UQ5\\ndimethylaminophenol: XM2H17\\nCholinesterase: XM8ZA0\\nPrussian blue: XM62Q3\\nFomepizole: XM7LQ9\\nSugammadex: XM9NQ8\\nIdarucizumab: XM0666\\nAndexanet alfa: XM01C9\\nDeferoxamine: XM5A41\\nDeferiprone: XM03A5\\nDeferasirox: XM12X8\\nPolystyrene sulfonate: XM3B07\\nFerric citrate: XM8NS1\\nSodium phosphate cellulose: XM1AY3\\nSevelamer: XM6Q80\\nLanthanum carbonate: XM22K8\\nCalcium acetate and Magnesium carbonate: XM4MP9\\nSucroferric oxyhydroxide: XM9188\\nColestilan: XM4C26\\nMesna: XM1JB5\\nCalcium folinate: XM7BJ9\\nDexrazoxane: XM45R5\\nCalcium levofolinate: XM2852\\nAmifostine: XM5GF2\\nSodium folinate: XM61A6\\nRasburicase: XM4NB1\\nPalifermin: XM8J47\\nGlucarpidase: XM8L87\\nSodium levofolinate: XM1EU2\\nArginine and Lysine: XM0MC0\\nTrilaciclib: XM7PK0\\nAfamelanotide: XM0LA6\\nCanthaxanthin: XM8337\\nRetinoids: XM3GF4\\nEtretinate: XM0Z07\\nAcitretin: XM2M63\\nTrioxysalen: XM4RP3\\nMethoxsalen: XM47G3\\nBergapten: XM1G69\\nFumaric acid: XM7WA3\\nIsotretinoin: XM98J9\\nIchtasol: XM9FP6\\nCoccidioidin: XM4CF3\\nCongo red: XM1V31\\nEvans blue: XM34X2\\nFluorescein: XM5618\\nHistoplasmin: XM3Y60\\nIndocyanine green: XM2818\\nLymphogranuloma venereum antigen: XM3WZ1\\nMumps skin test antigen: XM1VN8\\nPenicilloyl polylysine: XM3Q40\\nSodium metrizoate: XM36R6\\nSulfonphthalein sulfonphthol: XM1QL6\\nSulkowitchs reagent: XM8478\\nToxin diphtheria Schick Test: XM4DA3\\nTuberculin purified protein derivative PPD: XM0EK6\\nGlucose: XM6XX8\\nSincalide: XM53M3\\nCeruletide: XM0D92\\nMetyrapone: XM5GR6\\nSomatorelin: XM7E13\\nCorticorelin: XM1UJ0\\nMacimorelin: XM5AM6\\nTests for liver functional capacity: XM60V4\\nGalactose: XM9ZW8\\nSulfobromophthalein: XM1XE0\\nMethacetin C: XM0N95\\nIprofenin: XM90L9\\nLidofenin: XM3114\\nRose bengal sodium i: XM2PX0\\nTests for gastric secretion: XM9H30\\nCation exchange resin: XM44K8\\nBetazole: XM1MP2\\nHistamine phosphate: XM1286\\nPentagastrin: XM9AU1\\nCaffeine and Sodium benzoate: XM1Q27\\nAzuresin: XM1F97\\nTests for renal function and ureteral injuries: XM4E68\\nIndigo carmine: XM9RK1\\nAlsactide: XM3G67\\nAminohippuric acid: XM27H8\\nSodium paraaminohippurate: XM87Y9\\nInulin and other polyfructosans: XM2JZ2\\nPhenolsulfonphthalein: XM7M20\\nTests for thyroid function: XM0N07\\nProtirelin: XM7R30\\nTests for pancreatic function: XM76Z9\\nSecretin: XM3L99\\nBentiromide: XM7A79\\nPancreozymincholecystokinin: XM6014\\nSelenomethionine Se: XM24K5\\nEdrophonium: XM8B05\\nMethacholine: XM3YJ9\\nFructose: XM5K20\\nVitamin A concentrates: XM9258\\nTuberculin: XM7PF6\\nCurea: XM9QZ5\\nHexaminolevulinate: XM0UW4\\nPatent blue: XM02S2\\nBromophenol blue reagent: XM9Y95\\nDiacetyl monoxime: XM5PT0\\nGuaiac reagent: XM8M78\\nOxalic acid ammonium salt: XM3385\\nPhenaphthazine reagent: XM74W0\\nOxygen: XM4SZ3\\nCarbon dioxide medicinal: XM6NZ1\\nNitrogen: XM3K31\\nMedical air: XM7EZ9\\nXray contrast media iodinated: XM2S71\\nWatersoluble nephrotropic high osmolar Xray contrast media: XM7YS2\\nMetrizoic acid: XM7PH4\\nIodamide: XM6583\\nIotalamic acid: XM8XV8\\nIoxitalamic acid: XM34M9\\nAcetrizoic acid: XM50Y6\\nIocarmic acid: XM7ZV2\\nDiodone: XM2DC4\\nDiatrizoic acid: XM8KK9\\nIoglicic acid: XM50U3\\nMethiodal: XM9C52\\nWatersoluble nephrotropic low osmolar Xray contrast media: XM4AG5\\nMetrizamide: XM3WB6\\nIohexol: XM3R65\\nIoxaglic acid: XM5EP5\\nIopamidol: XM8C50\\nIopromide: XM4UK7\\nIotrolan: XM8VT7\\nIotroxic acid: XM5LW4\\nIopentol: XM6227\\nIodixanol: XM8NA7\\nIomeprol: XM75B4\\nIobitridol: XM79B6\\nIoxilan: XM6VV1\\nWatersoluble hepatotropic Xray contrast media: XM0KA6\\nIodoxamic acid: XM2VE6\\nIoglycamic acid: XM8411\\nAdipiodone: XM7QU5\\nIobenzamic acid: XM1QH8\\nIopanoic acid: XM2NU7\\nIocetamic acid: XM8PW2\\nSodium iopodate: XM4ZU7\\nTyropanoic acid: XM8WD0\\nCalcium iopodate: XM6TF5\\nNonwatersoluble Xray contrast media: XM0LK3\\nIopydol: XM1AX3\\nPropyliodone: XM1YV8\\nIofendylate: XM1R87\\nEthyl esters of iodised fatty acids: XM6SE3\\nDiatrizoate: XM6XU2\\nIodophthalein sodium: XM8QZ2\\nAmidotrizoate: XM0L44\\nBunamiodyl: XM80W7\\nIodipamide: XM5NA9\\nIodohippuric acid: XM4E01\\nIophenoic acid: XM9402\\nIopodic acid: XM7S30\\nIotroxate: XM4R74\\nIoxaglate: XM44B9\\nMethiodal sodium: XM5N73\\nPhenobutiodil: XM96Q8\\nThorium dioxide suspension: XM3E15\\nTyropanoate: XM90A9\\nBarium sulfate with suspending agents: XM2MR0\\nBarium sulfate without suspending agents: XM1FW7\\nMagnetic resonance imaging contrast media: XM05Z9\\nParamagnetic contrast media: XM2LS2\\nGadopentetic acid: XM7CY5\\nGadoteric acid: XM4UX1\\nGadodiamide: XM1564\\nGadoteridol: XM0FN2\\nMangafodipir: XM73Z5\\nGadoversetamide: XM3BF7\\nFerric ammonium citrate: XM29E1\\nGadobenic acid: XM0XE4\\nGadobutrol: XM3VG2\\nGadoxetic acid: XM7W85\\nGadofosveset: XM6GF6\\nSuperparamagnetic contrast media: XM8966\\nferumoxsil: XM33C2\\nferristene: XM84N5\\niron oxide nanoparticles: XM2945\\nPerflubron: XM2666\\nUltrasound contrast media: XM5TN4\\nMicrospheres of human albumin: XM40N1\\nMicroparticles of galactose: XM3PF3\\nPerflenapent: XM7S16\\nMicrospheres of phospholipids: XM4VR4\\nSulfur hexafluoride: XM8169\\nPerflubutane polymer microspheres: XM8G80\\nDiagnostic radiopharmaceuticals: XM9320\\nTechnetium mTc compounds: XM8ZM1\\nSodium pertechnetate Tcm: XM5VK7\\nIodine I compounds: XM9YB1\\nsodium iodide i: XM2R88\\nRubidium chloride Rb: XM6941\\nGallium citrate: XM3GL6\\nGallium Ga citrate: XM8SB4\\nFludeoxyglucose F: XM3WK3\\nIodocholesterol I: XM4ML0\\nXenon Xe gas: XM6Z69\\nXenon xe: XM6EQ3\\nSodium iodide I: XM1899\\nMaternal antibodies: XM9F18\\nferric Fe citrate: XM3HU5\\nSodium iodohippurate I: XM0RB0\\nIobenguane I: XM1QL4\\nFluoroethylLtyrosine F: XM6UT0\\nFluoroestradiol F: XM80F7\\nFluciclovine F: XM5G08\\nFluorodopa F: XM3LK2\\nFluoromethylcholine F: XM1N90\\nFluoroethylcholine F: XM5XR7\\nGallium Ga edotreotide: XM5EC5\\nCobalt Co cyanocobalamine: XM8YZ3\\nTauroselcholic acid: XM5FA9\\nSelenium Se norcholesterol: XM42A5\\nIodinated i human serum albumin: XM2MJ2\\nIodine: XM8YZ7\\nSodium iothalamate I: XM15W7\\nAmmonia N: XM5674\\nGallium Ga gozetotide: XM05N6\\nTherapeutic radiopharmaceuticals: XM45C8\\nSodium iodide I therapeutic: XM6RC9\\nIsoaminile citrate: XM01S1\\nAntimonic sulfide: XM9XW5\\nYttrium Y ferrihydroxide colloid: XM8Z31\\nSamarium Sm hydroxyapatite colloid: XM0JJ4\\nDysprosium Dy colloid: XM56F9\\nYttrium Y citrate colloid: XM10B1\\nErbium Er citrate colloid: XM3MD6\\nAmylene dichloride: XM5ZE8\\nEthiodized oil  i: XM1WG6\\nIodine I omburtamab: XM7MV3\\nbeucaine: XM32B6\\nBenzamine lactate: XM79Q0\\nCoal tar: XM8MM9\\nEthersoluble tar distillate: XM96H7\\nJuniper tar: XM6PP6\\nPhenol medicinal: XM8YS8\\nPhenolic preparation: XM96T6\\nPramoxine: XM8485\\nQuinisocaine: XM6A20\\nTar distillate: XM8W74\\nTar ointment: XM8WM2\\nTolpropamine: XM4543\\nMepyramine topical: XM2833\\nDiphenhydramine methylbromide: XM29P8\\nThonzylamine topical: XM9UN5\\nThenalidine topical: XM7JY5\\nPromethazine topical: XM6WM2\\nAcetic acid with sodium acetate ointment: XM4B01\\nAcrylic resin: XM7MV6\\nAllylthiourea: XM8U60\\nAluminium aluminum ointment surgical topical: XM06X6\\nAminobenzoic acid p: XM1S82\\nArachis oil: XM3VB3\\nBarrier cream: XM8SU9\\nBentonite: XM5L08\\nBenzophenones: XM7D95\\nBenzophenone: XM4DT5\\nBetula oil: XM08U7\\nCalamine lotion: XM7K00\\nCellulose nitrates topical: XM2EP3\\nChlordiethyl benzamide: XM9ZA9\\nCold cream: XM88R8\\nCorn starch: XM7033\\nCornhuskers lotion: XM38M3\\nCottonseed oil: XM8P34\\nDemulcent external: XM5PK1\\nDiethyl toluamide medicinal: XM0XB3\\nDimethyl phthalate: XM9U76\\nFlaxseed medicinal: XM8KY4\\nHomosalate: XM6694\\nHydrophilic lotion: XM8M74\\nLanolin: XM8WH4\\nLanolin alcohol: XM4HE0\\nMecrilate: XM7TK2\\nMelanizing agents: XM7VP7\\nMexenone: XM8EY7\\nMineral oil topical: XM9TZ7\\nOctafonium chloride: XM3214\\nOil wintergreen bitter: XM66S8\\nMethoxsalen topical: XM9CQ4\\nPadimate: XM0VT0\\nParaaminobenzoic acid: XM9AG3\\nPeanut oil topical: XM1U48\\nPetrolatum: XM8PB6\\nPlaster dressing: XM8J96\\nPlastic dressing: XM9V04\\nPolyethylene adhesive: XM2BL7\\nProtectant skin: XM6J14\\nPyroxylin: XM9VE3\\nRose water ointment: XM8293\\nSilicone medicinal: XM06Y2\\nTopical sunscreen: XM9410\\nSulisobenzone: XM4YA6\\nSweet oil birch: XM7YQ8\\nTalcum: XM3599\\nThiosinamine: XM3MF9\\nTitanium dioxide: XM7Q94\\nTitanium oxide: XM6WX7\\nUltraviolet light protectants: XM5E39\\nDiethylaminohydroxybenzoylbenzoic acid hexylester: XM4D35\\nMethylenebisbenzotriazolyltetramethylbutylphenol: XM8A13\\nPhenylbenzimidazolsulfonic acid: XM6UT3\\nTrianilinopcarboethylhexyloxitriazine: XM65Q8\\nUnnas boot: XM5PP3\\nZinc gelatin: XM8H46\\nZinc oxide: XM7RG9\\nZinc stearate: XM4NT3\\nColophonium: XM8YJ6\\nSorbitan sesquioleate: XM1LY7\\nOctinoxate: XM2M34\\nHyaluronic acid topical: XM2F87\\nCetomacrogol: XM90Q0\\nEtofenamate: XM8N69\\nFluoride medicinal dental use: XM85Z1\\nStannous fluoride: XM9RB7\\nBismuth salts formic iodide: XM60N7\\nCadexomer: XM0DJ3\\nDiiodohydroxypropane: XM12P7\\nDiiodohydroxyquin topical: XM8UZ7\\nIodide: XM0809\\nIodide mercury ointment: XM8C24\\nIodide methylate: XM3Q63\\nIodochlorhydroxyquin topical: XM6TG8\\nIodoform: XM3X72\\nPotassium iodate: XM58X1\\nPovidone iodine: XM24J7\\nAllantoin: XM9ZS1\\nAlum medicinal: XM7H25\\nAmmonium ichthyosulfonate: XM2GV6\\nAmmonium persulfate: XM8RR9\\nAnthralin: XM8HL4\\nAntiseborrheics: XM8SX1\\nButantrone: XM8GU1\\nCade oil: XM4FV2\\nCadmium sulfide medicinal: XM2ST0\\nCapsicum: XM9TT3\\nCarbon dioxide snow: XM4AW0\\nChlorothymol: XM01Q7\\nChloroxine: XM92H5\\nChrysarobin: XM7HY4\\nCoal tar medicinal ointment: XM3P37\\nCollagenase topical: XM3LD7\\nCorn cures: XM7PM1\\nDepilatory: XM5W78\\nDiachylon plaster: XM95C8\\nDimethyl sulfoxide medicinal: XM64V2\\nDimethylamine sulfate: XM26P0\\nDithranol: XM8RS8\\nEnzyme proteolytic: XM17Y7\\nEthyl chloride local: XM3JC8\\nEthyl fumarate: XM4P92\\nEuresol: XM7WC9\\nHair dye: XM7VL9\\nHemostyptic: XM8GV4\\nIsopropyl alcohol medicinal: XM7KM8\\nKeratolytic drug anthracene: XM6ES1\\nKeratolytic drug: XM23V5\\nKeratoplastic: XM4KL1\\nLassars paste: XM76E0\\nMethyl nicotinate: XM1VX5\\nMonobenzone: XM8N27\\nPyrithione zinc: XM6YQ8\\nResorcin resorcinol medicinal: XM4549\\nRubefacient: XM5DQ2\\nSalicylic acid: XM68B5\\nSavin oil: XM02N6\\nSelenium sulfide: XM43T8\\nSelsun: XM1UK4\\nSilver nitrate toughened keratolytic: XM3E07\\nSulfur compounds not elsewhere classified medicinal: XM1FW6\\nSulfur keratolytic ointment: XM6ZA6\\nThioglycolate: XM1W96\\nTioxolone: XM7GY2\\nTriacetoxyanthracene: XM4ZP4\\nTrichloroacetic acid medicinal: XM6U21\\nVleminckxs solution: XM2V83\\nWhite lotion keratolytic: XM6T99\\nXenysalate: XM25J6\\nGlyceryl monothioglycolate: XM7AM5\\npToluenediamine: XM5L79\\nAdrenal ophthalmic preparation: XM75W8\\nAmmonium acid tartrate: XM6H73\\nAntiinfective ophthalmic preparation: XM6G79\\nAnticholinesterase reversible ophthalmological: XM5568\\nBefunolol: XM5T83\\nBibrocathol: XM6NB7\\nChymotrypsin ophthalmic preparation: XM32H1\\nColistin sulfate eye preparation: XM6E41\\nContact lens solution: XM1WZ1\\nCopper sulfate cupric medicinal eye: XM3X79\\nCycloplegic drug: XM3918\\nDemecarium bromide: XM8S71\\nDendrid: XM1X30\\nDipivefrine: XM0L12\\nEchothiophate: XM17P1\\nEcothiopate iodide: XM7K14\\nEdoxudine: XM09W6\\nEucatropine: XM8PJ6\\nFluorphenylalanine: XM45L3\\nHerplex: XM1783\\nHydroxyamphetamine: XM9EN3\\nHypromellose: XM9E72\\nLachesine: XM0PE3\\nLevobunolol: XM8098\\nMethylparaben ophthalmic: XM4QZ9\\nMetipranolol: XM0YH4\\nMiotic drug: XM2JE0\\nMycitracin ophthalmic preparation: XM4DY8\\nMydriatic drug: XM5PU9\\nNeosporin ophthalmic preparation: XM28C3\\nPhospholine: XM4PY4\\nPhysostigmine: XM4605\\nPolymyxin E sulfate eye preparation: XM9N59\\nPropylparaben ophthalmic: XM2WK3\\nSilver protein: XM56H1\\nSodium borate cleanser eye: XM7AV0\\nStoxil: XM6Q18\\nSulfisoxazole ophthalmic preparation: XM8A14\\nSulfonamide eye: XM9PG5\\nTear solution: XM61C9\\nTetrahydrozoline: XM5RC2\\nVisine: XM31C8\\nAcetazolamide: XM9X81\\nDichlorphenamide: XM4LU1\\nEthoxzolamide: XM4DH5\\nMethazolamide: XM8P33\\nPemirolast: XM3ZJ4\\nPicloxydine: XM2JR8\\nFluostigmine: XM6JB1\\nDorzolamide: XM3BT0\\nBrinzolamide: XM9GB8\\nLatanoprost: XM5130\\nUnoprostone: XM5ZG4\\nBimatoprost: XM6E95\\nTravoprost: XM9BS0\\nTafluprost: XM3UC8\\nDapiprazole: XM6PD6\\nNetarsudil: XM8469\\nPegaptanib: XM0GK6\\nRanibizumab: XM95Y7\\nIodoheparinate: XM42E0\\nLifitegrast: XM67C4\\nCenegermin: XM57P1\\nOcriplasmin: XM2RM5\\nAutologous limbal stem cells: XM0YQ8\\nArtificial tears and other indifferent preparations: XM2GK8\\nAnecortave: XM3PF8\\nGuaiazulen: XM7CE4\\nOlopatadine: XM0ST2\\nAzidamfenicol: XM49V8\\nSulfadicramide: XM3G39\\nSulfafenazol: XM13T1\\nInterferon ophthalmic preparation: XM4F24\\nFomivirsen: XM0C71\\nBesifloxacin: XM1A96\\nMercury compounds: XM7415\\nLoteprednol: XM9KL6\\nFormocortal: XM6GF5\\nPranoprofen: XM9166\\nNepafenac: XM4GZ0\\nBromfenac: XM0QS2\\nBrimonidine ophthalmic preparation: XM14H0\\nAcetylcholine ophthalmic preparation: XM9KS5\\nLevocabastine: XM32J7\\nLodoxamide: XM9L65\\nEmedastine: XM1CM1\\nAlcaftadine: XM4JE3\\nSodium chloride hypertonic ophthalmic: XM7SY2\\nSodium edetate ophthalmic preparation: XM2LQ4\\nCiclosporin ophthalmic preparation: XM3ZG3\\nNandrolone ophthalmic preparation: XM7UH0\\nApraclonidine: XM3XE4\\nVerteporfin: XM2Y24\\nSpaglumic acid: XM63C9\\nDentifrice: XM3YZ7\\nDressing live pulp: XM1JW3\\nEucalyptus oil: XM0PR1\\nOil cloves: XM3XP7\\nPulp devitalizing paste: XM8PE1\\nAcetylsalicylic acid topical: XM9023\\nOlaflur: XM7K59\\nSodium monofluorophosphate topical: XM5GY2\\nTetracycline topical: XM53X2\\nAcriflavinium chloride: XM2FL0\\nAcrinol: XM8K50\\nAcrisorcin: XM5PD0\\nAdrenal topical: XM7696\\nAerosporin topical: XM9B70\\nAlclometasone: XM2ET5\\nAlkonium bromide: XM3NX2\\nAllethrin: XM7TF6\\nAluminium acetate solution: XM0CC9\\nAluminium sulfate: XM6JG7\\nGlutaraldehyde medicinal: XM18N0\\nGlyceryl triacetate topical: XM7XA4\\nGramicidin: XM7Y78\\nHalcinolone: XM5UQ0\\nHalethazole: XM9Q64\\nHaloprogin: XM0C80\\nHalquinols: XM3KW0\\nHCH medicinal: XM6XH7\\nHedaquinium: XM8UW4\\nHexachlorophene: XM95K6\\nAminoacridine: XM6RK6\\nHexamidine: XM7RK5\\nHydrargaphen: XM19W1\\nHydrargyri aminochloridum: XM0JC1\\nHydrogen peroxide: XM4AG2\\nHydroxytoluene medicinal: XM6E35\\nHypochlorite: XM02H1\\nIchthammol: XM3PT9\\nIsoconazole: XM6BF8\\nKwell antiinfective topical: XM07S0\\nLaurolinium: XM3U48\\nAmphotericin B topical: XM7CU1\\nLidex: XM8C45\\nLindane medicinal: XM8E58\\nLocorten: XM7CM3\\nMafenide: XM5MZ8\\nMalathion medicinal: XM6QD7\\nMedrysone: XM6L15\\nMelaleuca alternifolia oil: XM53R5\\nMerbromin: XM35K3\\nMercaptobenzothiazole salts: XM7FY5\\nMercurochrome: XM1B13\\nAntiinfective bismuth local: XM8GN4\\nMercury ammoniated: XM2J64\\nMercury antiinfective topical: XM9Z76\\nMercury chloride ammoniated: XM10V3\\nMercury oxide yellow: XM6Q50\\nMerthiolate: XM9613\\nMesulfen: XM2JH4\\nMetactesylacetate: XM2M00\\nMethyl paraben: XM0XV0\\nMethyl prednisolone topical: XM1910\\nMethylbenzethonium chloride: XM5HR1\\nAntifungal disinfectant local: XM1JC6\\nMethylrosaniline: XM7C91\\nMethylrosanilinium chloride: XM2793\\nMicatin: XM0ZY9\\nMonistat: XM9A06\\nMupirocin: XM23B6\\nMycifradin topical: XM43U9\\nMyralact: XM14D6\\nNaftifine: XM1HX1\\nNatamycin: XM2BK7\\nNeomycin topical: XM7D13\\nArgyrol: XM44R8\\nNeomycin with bacitracin: XM51P6\\nNeosporin topical: XM6YS1\\nNilstat topical: XM5BH2\\nNitrofurazone: XM71W2\\nNitromersol: XM4T72\\nNitrozone: XM2HP9\\nNoxytiolin: XM1102\\nOrthoboric acid: XM70Z6\\nOxiconazole: XM63S9\\nOxychlorosene: XM8610\\nAsiaticoside: XM7VP9\\nOxylone: XM7N08\\nParachlorophenol camphorated: XM9LG4\\nParamethasone acetate: XM12F4\\nPeruvian balsam: XM0MS1\\nPhenoctide: XM70C4\\nPhenol: XM6L76\\nPhenothrin: XM4H85\\nPhenoxyethanol: XM9D74\\nPhenylmercuric acetate: XM3R68\\nPhenylmercuric borate: XM89P9\\nChlortetracycline topical: XM0295\\nPhenylmercuric nitrate: XM0K18\\nPiketoprofen: XM3DV8\\nPolymyxin B topical: XM7B69\\nPolynoxylin: XM0J95\\nPolyoxymethyleneurea: XM2G74\\nPotassium Permanganate medicinal: XM0XP0\\nProflavine: XM6YA5\\nPropamidine: XM35Q1\\nPropiolactone: XM4TA7\\nPropion gel: XM3DH9\\nAzelaic acid: XM6SG3\\nPropionate calcium sodium: XM77H8\\nPyrethrum extract: XM03K3\\nPyrogallic acid: XM2A13\\nPyrogallol: XM8BE0\\nQuaternary ammonium antiinfective: XM97F8\\nRetinoic acid: XM2SR9\\nSalicylhydroxamic acid: XM9773\\nSodium hypochlorite medicinal antiinfective external: XM5GX7\\nSodium hyposulfite: XM5372\\nSodium perborate medicinal: XM7Z80\\nBacimycin: XM4PL5\\nSodium propionate: XM7EV2\\nSporostacin: XM1VV3\\nStaphisagria or stavesacre pediculicide: XM38S1\\nSteroid topical: XM8HC5\\nSulbentine: XM2237\\nSulfacetamide: XM2CH0\\nSulfiram: XM06Y3\\nSulfur ointment: XM4XY4\\nSynalar: XM9ST9\\nTerconazole: XM33Y9\\nBacitracin zinc: XM00V5\\nTetramethylthiuram medicinal: XM2GG6\\nThimerosal: XM9ZY9\\nThymol: XM7W47\\nTiclatone: XM3C36\\nTioconazole: XM9HG1\\nTolciclate: XM9SF6\\nTolnaftate: XM23C3\\nTriacetin: XM6848\\nTriamcinolone hexacetonide: XM4873\\nTriclobisonium chloride: XM5KU0\\nBacitracin zinc with neomycin: XM6Y48\\nTriclocarban: XM74T6\\nTriclosan: XM5WW5\\nTridesilon: XM93J3\\nUndecenoic acid: XM84C7\\nUndecoylium: XM5GQ1\\nUndecylenic acid derivatives: XM1TP6\\nUrea peroxide: XM81Z1\\nValisone: XM2VU7\\nVioform topical: XM0GR5\\nZinc antiinfectives: XM2B18\\nBasic fuchsin: XM7E88\\nZinc peroxide: XM6KL1\\nZinc sulfate topical: XM8SM1\\nZinc undecylenate: XM5L28\\nCloponone: XM71H0\\nAcriflavine: XM0BF3\\nNifuraldezone: XM1KZ4\\nTibezonium iodide: XM4DT4\\nEosin: XM5U34\\nPropanol: XM24W5\\nIsopropanol: XM5DR7\\nBenisone: XM2ZR2\\nPecilocin: XM2Q40\\nPyrrolnitrin: XM6UW2\\nPolihexanide: XM8S89\\nPolicresulen: XM0SV3\\nBiphenylol: XM80T0\\nDidecyldimethylammonium chloride: XM68P2\\nMercury metallic: XM5LX3\\nDecamethoxine: XM53J8\\nEuflavine: XM2UH3\\nSodium chlorite: XM7KH0\\nBenzalkonium chloride: XM2VS1\\nNadifloxacin: XM7022\\nClindamycin topical: XM8BY6\\nChlormidazole: XM6AC5\\nSulconazole: XM2NB3\\nBifonazole: XM8B91\\nFenticonazole: XM4J78\\nOmoconazole: XM0072\\nSertaconazole: XM9U15\\nFlutrimazole: XM49Z6\\nEberconazole: XM5XM5\\nBenzethonium chloride: XM1QH3\\nLuliconazole: XM6H72\\nBromochlorosalicylanilide: XM7CT0\\nTribromometacresol: XM89W5\\nchlorphenoxyethanol: XM8JJ2\\nEthyl hydroxybenzoate: XM67B0\\nAmorolfine: XM6474\\nButenafine: XM2L70\\nTavaborole: XM3PR6\\nEfinaconazole: XM20T9\\nImiquimod: XM0CH6\\nBenzoic acid with salicylic acid: XM7SQ2\\nInosine: XM8BH0\\nDocosanol: XM4BA3\\nSinecatechins: XM2CA6\\nMercuric iodide: XM0N01\\nBenzododecinium: XM4796\\nAluminium acetotartrate: XM2PS8\\nBendazac: XM0P54\\nBioallethrin: XM3J77\\nCopper oleinate: XM7MQ0\\nDecamethrin: XM73B3\\nBenzoic acid: XM9JZ6\\nDibutylsuccinate: XM4KG9\\nDibutylphthalate: XM84S5\\nDimethylcarbate: XM1BB3\\nDimethylphthalate: XM74X3\\nEthacridine lactate: XM4UE1\\nEtohexadiol: XM2Y03\\nFelbinac: XM8XZ0\\nOxyquinoline: XM6XJ9\\nPotassium polysulfide: XM4PX0\\nQuassia: XM9R96\\nBenzoxonium chloride: XM63Y9\\nTyrothricin: XM0GR6\\nFidaxomicin: XM0FD5\\nNifuroxazide: XM1071\\nNifurzide: XM5BH0\\nBalsalazide: XM7MF9\\nDimeticone topical: XM0JJ7\\nStreptomycin topical: XM6XD8\\nAcetic acid medicinal: XM4KV4\\nTerbinafine topical: XM7014\\nIdoxuridine topical: XM0K16\\nBenzoyl peroxide: XM43M3\\nPenciclovir topical: XM9X60\\nFamciclovir topical: XM3SK7\\nGanciclovir topical: XM7A63\\nLomefloxacin topical: XM1P27\\nLevofloxacin topical: XM3CL3\\nGatifloxacin topical: XM92Q3\\nMoxifloxacin topical: XM6VX8\\nLoxoprofen: XM1HU5\\nAbametapir: XM8TB9\\nBenzyl benzoate: XM7QG0\\nBenzyl Benzoic acid: XM0GX2\\nBHC medicinal: XM9208\\nBismuth salts glycolylarsenate: XM7S48\\nBoric acid: XM5RT8\\nBromosalicylchloranitide: XM84D8\\nBuclosamide: XM0YT9\\nButoconazole nitrate: XM6862\\nCalomel: XM7VA5\\nCandicidin: XM2AV1\\nCarbamide peroxide: XM2V43\\nCarbol fuchsin: XM2ZX1\\nCarfusin: XM6C04\\nCastellanis paint: XM9H69\\nCeepryn: XM5ZY9\\nCetalkonium chloride: XM9432\\nCethexonium chloride: XM1BP8\\nCetrimide: XM62D0\\nCetrimonium bromide: XM6ZW9\\nCetylpyridinium chloride: XM94W4\\nChamomile: XM7CX5\\nChloramine T: XM8HU1\\nChloramphenicol topical: XM72P5\\nChlorhexidine: XM7DZ3\\nChlorhydroxyquinolin: XM2ZT2\\nChlorinated lime and boric acid solution: XM5D99\\nChlorinated soda solution: XM0HL8\\nChlorocresol: XM8FE7\\nChloroxylenol: XM3XC5\\nChlorphenesin topical antifungal: XM93C6\\nChlorquinol: XM2CN0\\nCiclopirox olamine: XM0852\\nClobetasone: XM6MJ1\\nClodantoin: XM2WP5\\nClofenotane: XM8TG2\\nClotrimazole: XM8W85\\nCloxiquine: XM6BT6\\nCopper gluconate: XM4M83\\nCreosol compound: XM42L5\\nCreosote coal tar beechwood: XM35M5\\nCresol s: XM7ZK1\\nCresol and soap solution: XM0WM0\\nCresyl acetate: XM4YB3\\nCresylic acid: XM0348\\nCrotamiton: XM3726\\nDakins solution: XM7YY8\\nDequalinium chloride: XM8CF0\\nDesonide: XM6LZ1\\nDettol: XM0PQ7\\nDibromopropamidine isethionate: XM1RR7\\nDibrompropamidine: XM0UE0\\nDicophane: XM06U7\\nDiethyltoluamide: XM2355\\nDimazole: XM4A13\\nDixanthogen: XM42D3\\nDodicin: XM3JL3\\nDofamium chloride: XM7YF5\\nDomiphen bromide: XM3TY6\\nEconazole: XM5XH3\\nErythromycin topical: XM8E88\\nEthacridine: XM5QE6\\nEthylene oxide medicinal: XM09B1\\nEurax: XM91H3\\nExalamide: XM2258\\nFenticlor: XM9K22\\nFluocinonide: XM2E99\\nFlurobate: XM67C1\\nFurazolium chloride: XM6AZ9\\nGammabenzene hexachloride medicinal: XM5JA4\\nGentamicin topical: XM0XR4\\nAluminium acetate: XM3P38\\nAluminium chloride: XM7FE1\\nAluminium diacetate: XM2D21\\nAluminium subacetate: XM2399\\nAntihemorrhoidal preparation: XM38V9\\nDetergent external medication: XM1KT1\\nDial soap: XM16X4\\nDuponol C EP: XM2KD7\\nGreen soap: XM3Y82\\nLauryl sulfoacetate: XM2273\\nLead acetate: XM8P35\\nPolyethanolamine alkyl sulfate: XM3E94\\nSoap medicinal soft: XM2P20\\nSoap superfatted: XM6EW6\\nSodium lauryl sulfate: XM1X23\\nTannic acid medicinal astringent: XM1484\\nThiram medicinal: XM7KD1\\nVegetable extract astringent: XM19Y0\\nWitch hazel: XM4S15\\nAntiperspirant: XM4KJ0\\nHamamelis: XM20Y8\\nIproheptine: XM1DT0\\nLowila: XM9RY1\\nSeptisol: XM1AY0\\nSulfatostearate: XM3DK8\\nBenoquin: XM9R98\\nCantharides: XM4597\\nCell stimulants and proliferants: XM8JB2\\nCharcoal medicinal topical: XM4JD6\\nChloresium: XM6GG8\\nDextromoramide topical: XM9YX8\\nElase: XM1KB4\\nEnzyme depolymerizing: XM0M69\\nGelfilm: XM5VL6\\nHeet: XM1FF8\\nLactic acid: XM6P44\\nLytta vittatta: XM2D09\\nNonoxinol: XM54L7\\nNonylphenoxy polyethoxyethanol: XM4M68\\nOctoxinol: XM2TV0\\nPanthenol topical: XM7DL5\\nPodophyllotoxin: XM8865\\nPreparation H: XM3403\\nSantyl: XM0VK2\\nScarlet red: XM4AZ3\\nSodium borate therapeutic: XM6Z04\\nSpermicide: XM8EC8\\nTosylchloramide sodium: XM0M54\\nUrea topical: XM8WU4\\nBecaplermin: XM0M02\\nGamolenic acid: XM4QZ6\\nCapsaicin: XM14C4\\nZucapsaicin: XM5DL8\\nOrganoheparinoid: XM7ZQ6\\nSodium apolate: XM1485\\nTacalcitol: XM3711\\nTazarotene: XM6BQ3\\nDextranomer: XM3GL1\\nCrilanomer: XM7618\\nEnoxolone: XM1JG0\\nTrolamine: XM0W31\\nBetulae cortex: XM1W34\\nIngenol mebutate: XM1NP5\\nSelenium compounds: XM60N1\\nMetandienone topical: XM4HG0\\nPimecrolimus: XM5DF2\\nDupilumab: XM1015\\nBrimonidine: XM1A95\\nDeoxycholic acid: XM8HP9\\nCalcipotriol: XM2TT0\\nAluminium oxide: XM41S0\\nCadmium compounds medicinal: XM8ZR0\\nLithium succinate: XM9MC0\\nMequinol: XM0RJ6\\nAlbumin tannate: XM7XL9\\nDiosmectite: XM87L7\\nCeratonia: XM0XA0\\nCrospovidone: XM3AJ8\\nRacecadotril: XM86M9\\nTrafermin: XM33M4\\nAbrocitinib: XM0A16\\nAlkaline antiseptic solution aromatic: XM7BG3\\nAmbazone: XM7CJ4\\nAmylmetacresol: XM9SX0\\nBiclotymol: XM59F4\\nBisdequalinium salts diacetate: XM51P8\\nChloromycetin otic solution: XM0LW6\\nCopper sulfate cupric medicinal ear: XM2954\\nCorbadrine: XM6270\\nDichlorobenzyl alcohol: XM96Z5\\nGlycerol borax: XM37H6\\nLevonordefrin: XM4UQ0\\nNeosporin ENT agent: XM9EQ5\\nNose preparations: XM4RA5\\nThenoic acid: XM8YH0\\nZinc chloride mouthwash: XM9VY0\\nAcetic acid ENT agent: XM83Z7\\nRitiometan: XM0G17\\nMyristylbenzalkonium: XM3RP3\\nAntazoline topical: XM8XE9\\nCalcium hexamine thiocyanate: XM9FX7\\nOctenidine: XM3NR8\\nPhenazone topical: XM0M82\\nPodophyllin: XM5HX7\\nPodophyllum resin: XM4L14\\nAmcinonide: XM35S7\\nTriamcinolone topical: XM8WS1\\nBetamethasone topical: XM46G7\\nClobetasol: XM4FN3\\nCorticosteroid topical: XM57Z7\\nDesoximetasone: XM5PM3\\nDexamethasone topical: XM6TE1\\nDiflorasone: XM8V58\\nDiflucortolone: XM4XD6\\nFluclorolone acetonide: XM4TV8\\nFludrocortisone topical: XM0WP2\\nFludroxycortide: XM84F4\\nFlumethasone: XM6LQ2\\nFluocortin butyl: XM3EM1\\nFluorometholone: XM7MM0\\nFluprednidene: XM52K8\\nFlurandrenolide: XM5086\\nHalcinonide: XM0ZX1\\nHalometasone: XM8TL4\\nHydrocortisone aceponate: XM8KB5\\nHydrocortisone topical: XM6JE7\\nPrednicarbate: XM0ME0\\nPrednisolone steaglate: XM1B59\\nPrednisolone topical: XM09Z4\\nHydrocortisone butyrate: XM4Y24\\nFlumetasone: XM55S3\\nFluperolone: XM41T8\\nButeprate: XM5ZS6\\nUlobetasol: XM64R0\\nDifluprednate: XM6DT9\\nMethylprednisolone aceponate: XM5EY3\\nFluocinolone acetonide: XM4HA4\\nFluclorolone: XM1068\\nCiclesonide topical: XM9DE4\\nTixocortol pivalate: XM8963\\nUfenamate: XM5PA8\\nChlorphenesin: XM3VA9\\nIdrocilamide: XM2NU3\\nMethyl salicylate: XM6H69\\nAdapalene: XM10R5\\nMotretinide: XM6KD7\\nTretinoin topical: XM7C94\\nRetinol topical: XM6PV8\\nIsotretinoin topical: XM2PQ2\\nSilver: XM01G3\\nSilver antiinfectives: XM0CN1\\nSilver colloidal: XM3QX7\\nSilver nitrate ophthalmic preparation: XM2U36\\nSilver sulfadiazine: XM9R64\\nSilver nitrate: XM6RF0\\nAcrylamide: XM5LS4\\nAgrochemical: XM1SE1\\nFertilizer: XM10X3\\nAmmonium nitrate: XM4NU1\\nGuano: XM0AR7\\nMagnesium thiosulfate: XM7046\\nPesticide: XM7D46\\nDibromochloropropane: XM6PM8\\nDichloropropene: XM61U9\\nEthylene oxide: XM4G15\\nFungicide: XM83G4\\nAuramine: XM0MT5\\nBenzimidazole: XM44B4\\nCarbendazim: XM9F10\\nBenomyl: XM2WG5\\nFuberidazole: XM0ZM1\\nThiabendazole nonmedicinal: XM7ZN0\\nThiophanatemethyl: XM7E92\\nBlasticidinS: XM9051\\nBordeaux mixture: XM6TA8\\nCaptafol: XM3F05\\nCaptan: XM9BL0\\nChlorothalonil: XM75T2\\nCycloheximide: XM21E5\\nDichlone: XM8E94\\nDifenoconazole: XM3365\\nDithiocarbamate: XM5KQ8\\nEdifenphos: XM3TR4\\nFolpet: XM04K8\\nGlutaral nonmedicinal: XM40T8\\nHexachlorobenzene: XM4AW6\\nTetramethylthiuram disulfide: XM0HQ1\\nZineb: XM3JA8\\nOctylisothiazolinone: XM0P16\\nHerbicide: XM6J29\\nAmmonium sulfamate: XM3FE7\\nBromoxynil: XM2RT5\\nChloroacetic acid: XM62D4\\nDalapon: XM3KU8\\nDicamba: XM3MM5\\nDichlobenil: XM5DH1\\nDichlorophenoxyacetic acid: XM9CD8\\nDinoseb: XM23C2\\nDinoseb acetate: XM60K0\\nDinoterb: XM62Q7\\nDiquat: XM1M07\\nDiuron: XM5TV1\\nEndothall: XM6KX6\\nGlyphosate: XM50V7\\nMCPA: XM88B4\\nMCPAthioethyl: XM6T93\\nMecoprop: XM0CJ6\\nMecopropP: XM0QY2\\nMonuron: XM0TQ1\\nParaquat: XM4SL8\\nPropachlor: XM8J05\\nPropanil: XM66Q3\\nSimazine: XM48M2\\nSodium cacodylate herbicide: XM7KH8\\nTriazine derivative herbicide not elsewhere classified: XM0MH9\\nTriazole: XM7ML8\\nTrichlorophenoxyacetic acid: XM9MT5\\nCarbamate herbicide not elsewhere classified: XM4PA4\\nInsecticide: XM3K66\\nCarbamate insecticide: XM0231\\nAldicarb: XM0HS9\\nButocarboxim: XM0ZT6\\nButoxycarboxim: XM4DS5\\nCarbaryl: XM9G20\\nNaphthol: XM1KX0\\nCarbofuran: XM7A68\\nEthiofencarb: XM8FU1\\nFurathiocarb: XM9HR4\\nMethiocarb: XM9Y05\\nMethomyl: XM2CU6\\nOxamyl: XM0DL6\\nPropoxur: XM79F9\\nThiofanox: XM3358\\nCryolite: XM7LT1\\nDEET: XM12C2\\nDiflubenzuron: XM4NG6\\nNaphthalene: XM5S01\\nNicotine insecticide: XM3AD4\\nOrganochlorine insecticide: XM41B3\\nAldrin: XM5Y08\\nChlordane: XM12L2\\nChlorobenzilate: XM7JD5\\nDDT: XM9EL1\\nDDE dichlorodiphenyldichloroethylene: XM1UT2\\nParadichlorobenzene: XM3XK2\\nDicofol: XM2CK5\\nDieldrin: XM5U23\\nEndosulfan: XM5C19\\nEndrin: XM6ZU9\\nHeptachlor: XM2JS5\\nIsobenzan: XM5642\\nKelevan: XM4H89\\nLindane: XM16G7\\nLindane vapor: XM07J5\\nMirex: XM5NU4\\nPentachlorophenol: XM32P2\\nStrobane: XM4FV5\\nToxaphene: XM91D0\\nOrganophosphate insecticide: XM7154\\nAzinphosethyl: XM7RX0\\nAzinphosmethyl: XM7H46\\nCadusafos: XM2JZ1\\nCarbophenothion: XM8AZ4\\nChlorethoxyfos: XM3DK0\\nChlorfenvinphos: XM20D7\\nChlormephos: XM4RG9\\nChlorpyrifos: XM3QX6\\nChlorthion: XM5566\\nChlorthiophos: XM2MP2\\nCoumaphos: XM8WL8\\nDemephion: XM6L87\\nDemephionO: XM4WK8\\nDemephionS: XM8KA9\\nDemeton: XM5F29\\nDemetonO: XM4724\\nDemetonOmethyl: XM8LS8\\nDemetonS: XM6UD3\\nDemetonSmethyl: XM8ZM3\\nDiazinon: XM6AY4\\nDicapthon: XM26D3\\nDichlorvos: XM03V8\\nDicrotophos: XM5UL4\\nDimefox: XM5Q52\\nDimethoate: XM58G9\\nDimetilan: XM56E1\\nDioxathion: XM3494\\nDisulfoton: XM9SP5\\nEPN: XM5BC5\\nEthion: XM7X81\\nEthoprophos: XM9F71\\nFamphur: XM7818\\nFenthion: XM7SU5\\nFluorophosphate insecticide: XM5KA2\\nHeptenophos: XM7TZ6\\nHexaethyl tetraphosphate: XM5G36\\nIsoxathion: XM5JS5\\nLeptophos: XM6A89\\nMalathion insecticide: XM0G23\\nMecarbam: XM5406\\nMephosfolan: XM9R34\\nMethamidophos: XM56W1\\nMethidathion: XM83J2\\nMevinphos: XM8ZT2\\nMipafox: XM4197\\nMonocrotophos: XM27J3\\nNaled: XM0US9\\nOmethoate: XM2D86\\nOxydemetonmethyl: XM48D2\\nParaoxon: XM7LW0\\nParathion: XM14N6\\nParathionmethyl: XM1YY0\\nPhorate: XM20V2\\nPhosfolan: XM2324\\nPhosphamidon: XM3QY4\\nPropetamphos: XM6YG2\\nProthoate: XM7GK7\\nQuinalphos: XM7UW2\\nSchradan: XM0TB4\\nSulfotep: XM1E56\\nTebupirimfos: XM7LH6\\nTEPP: XM6P90\\nTerbufos: XM2QB5\\nThiometon: XM72Q5\\nThionazin: XM4T49\\nTriazophos: XM2AH6\\nTrichloronate: XM13H5\\nVamidothion: XM9FN4\\nPhenothiazine insecticide: XM5EB8\\nPyrethroid insecticide: XM4AP8\\nAllethrin insecticide: XM27C9\\nBifenthrin: XM79U4\\nCyfluthrin: XM7YT2\\nCyhalothrin: XM8HR7\\nCypermethrin: XM1MQ5\\nCyphenothrin: XM3Y88\\nDeltamethrin: XM3BQ7\\nEsfenvalerate: XM76R8\\nFenpropathrin: XM1Z58\\nFenvalerate: XM9JZ0\\nFlucythrinate: XM6H26\\nPermethrin: XM7461\\nPrallethrin: XM4AC0\\nTefluthrin: XM5QE0\\nTetramethrin: XM1MW0\\nTralomethrin: XM2H33\\nRotenone: XM1S21\\nMetaldehyde: XM95F1\\nMethyl bromide: XM0NK1\\nPiperonyl butoxide: XM6FE7\\nRodenticide: XM2KK3\\nAlpha chlorhydrin: XM8UV3\\nAlpha naphthylthiourea: XM4X40\\nBrodifacoum: XM7138\\nBromadiolone: XM7RU0\\nBromethalin: XM3QV7\\nChloralose: XM1GN8\\nChlorophacinone: XM1FD8\\nCoumatetralyl: XM0DK0\\nCrimidine: XM3KE1\\nDifenacoum: XM9VL9\\nDifethialone: XM6DL4\\nDiphacinone: XM4J38\\nFlocoumafen: XM7HA0\\nFluoroacetamide: XM7P90\\nNorbormide: XM2WD6\\nPindone: XM4116\\nPyriminil: XM8QH8\\nSodium fluoroacetate: XM9LE1\\nWarfarin rodenticide: XM8LJ0\\nTetradifon: XM6BS1\\nAcaricide not elsewhere classified: XM6372\\nFumigant not elsewhere classified: XM8V89\\nMolluscicide not elsewhere classified: XM0ZQ8\\nOrganochlorine pesticide not elsewhere classified: XM5E09\\nSeed disinfectant not elsewhere classified: XM8HA3\\nSulfur pesticide not elsewhere classified: XM86Y5\\nThiocarbamate pesticides not elsewhere classified: XM0J68\\nWood preservative not elsewhere classified: XM86L9\\nCopper oleate: XM55D5\\nAlcohol: XM6U34\\nAlcohol vapor: XM9BA5\\nAllyl Alcohol: XM51N7\\nBay rum: XM6K71\\nBenzyl alcohol nonmedicinal: XM0AD5\\nCinnamyl alcohol: XM7VB3\\nCyclohexanol: XM3XS0\\nEthanol: XM8ZW3\\nAlcohol beverage: XM1A61\\nAbsolute alcohol: XM8HG4\\nDenatured alcohol: XM3094\\nEthanol disinfectant: XM6DN6\\nEthanol motor fuel: XM8RP6\\nEthyl methylcarbinol: XM2VC0\\nFusel alcohol: XM48D0\\nAmyl alcohol: XM88C8\\nAmylene hydrate: XM5JW4\\nButyl alcohol: XM49S0\\nDiethyl carbinol: XM6HQ5\\nIsoamyl alcohol: XM5SH0\\nPropyl alcohol: XM5RS7\\nTrimethylcarbinol: XM5M32\\nHexahydrocresol: XM6C11\\nHydroabietyl alcohol: XM4BN8\\nIsopropyl alcohol: XM5531\\nIsopropyl rubbing alcohol: XM8YA1\\nJamaica ginger: XM80Q0\\nMethanol: XM7KD9\\nMethanol motor fuel: XM0ZA4\\nAntifreeze not elsewhere classified: XM6VD7\\nCanned heat not elsewhere classified: XM7XX5\\nGeraniol: XM4S45\\nHydroxycitronellal: XM7UN9\\nAlgal toxin: XM9TZ4\\nCyanotoxin: XM6F50\\nMicrocystin: XM38M2\\nAmyl propionate: XM9RM0\\nAmphibian toxin: XM26J2\\nFrog toxin: XM0KH6\\nBrunos casque headed frog venom: XM0CW7\\nGreenings frog venom: XM8QW3\\nPoison dart frog poison: XM7JP5\\nGolden poison frog poison: XM4BD8\\nAnthonys poison arrow frog poison: XM6K27\\nStrawberry poison dart frog poison: XM7JV0\\nKokoe poison frog poison: XM9TX1\\nBlack legged poison frog poison: XM2698\\nSalamander toxin: XM7P83\\nNewt toxin: XM93N2\\nToad toxin: XM7YQ1\\nColorado River toad toxin: XM8YT6\\nMarine toad toxin: XM54D9\\nArthropod venom: XM7930\\nArachnid venom: XM12G1\\nScorpion venom: XM9DM8\\nAsian black scorpion venom: XM0HC0\\nBlack emperor scorpion venom: XM8F59\\nGiant forest scorpion venom: XM52D7\\nAustralian forest scorpion venom: XM72V7\\nAustralian urodacus scorpion venom: XM10T2\\nAustralian black rock scorpion venom: XM48S4\\nAustralian desert scorpion venom: XM10R0\\nAustralian marbled scorpion venom: XM0YV3\\nBark scorpion venom: XM3HL0\\nBrazilian yellow scorpion venom: XM2HW7\\nChinese scorpion venom: XM12P5\\nCommon yellow scorpion venom: XM5QE7\\nDeath stalker scorpion venom: XM0E23\\nFattail scorpion venom: XM95A6\\nFlat rock scorpion venom: XM91Z5\\nIndian red scorpion venom: XM67X5\\nLesser Asian scorpion venom: XM11L8\\nTransvaal thick tailed scorpion venom: XM1WF9\\nYellow creeping leg scorpion venom: XM8XC7\\nSpider venom: XM6NN5\\nBrown recluse spider venom: XM2RM6\\nFalse widow spider venom: XM6SD4\\nFunnel web spider venom: XM3KD6\\nHobo spider venom: XM57S7\\nJumping spider venom: XM0C68\\nMouse spider venom: XM1LF5\\nSix eyed sand spider venom: XM6QH2\\nTarantula spider venom: XM8095\\nWandering spider venom: XM8FT7\\nWidow spider venom: XM7JS2\\nBlack widow spider venom: XM7M21\\nBrown widow spider venom: XM9Z42\\nRedback spider venom: XM1TF6\\nRed widow spider venom: XM2JA0\\nWolf spider venom: XM2WM2\\nYellow sac spider venom: XM3UW9\\nTick venom: XM94S4\\nAmerican dog tick venom: XM7WR0\\nAustralian paralysis tick venom: XM51Y1\\nBrown dog tick venom: XM3J29\\nDeer tick venom: XM77E1\\nLone star tick venom: XM5RS1\\nSpinose ear tick venom: XM8YN1\\nCentipede venom: XM6TD6\\nAmazonian giant centipede venom: XM5LB1\\nAustralian giant centipede venom: XM52L4\\nTexas redheaded centipede venom: XM9FP1\\nVietnamese centipede venom: XM2WU4\\nInsect venom: XM50Y9\\nAnt venom: XM3Y95\\nBull ant venom: XM4CP1\\nBullet ant venom: XM02L8\\nFire ant venom: XM3UK8\\nHarvester ant venom: XM1547\\nJack jumper ant venom: XM5ZS2\\nBee venom: XM13H7\\nAfricanized honey bee venom: XM1GA3\\nBumblebee venom: XM0NK4\\nHoney bee venom: XM42T0\\nCaterpillar venom: XM1142\\nCup moth caterpillar venom: XM2T44\\nPuss caterpillar venom: XM57P9\\nHorsefly venom: XM7D92\\nWasp venom: XM2YA4\\nYellow jacket venom: XM6D92\\nPaper wasp venom: XM1PF5\\nHornet venom: XM31U2\\nAsian giant hornet venom: XM7CC3\\nMillipede toxin: XM4C00\\nBird toxin: XM0HS8\\nIfrita bird toxin: XM5V29\\nPitohui bird toxin: XM5Y38\\nMammal toxin: XM35H6\\nPlatypus venom: XM27R8\\nShrew venom: XM8EC2\\nSlow loris venom: XM9R52\\nSolenodon venom: XM67Y0\\nVampire bat venom: XM6NB8\\nMarine and freshwater animal toxins: XM2P96\\nMarine and freshwater animal venom: XM99J1\\nBlue ringed octopus venom: XM2GR5\\nBrittle star venom: XM56D3\\nCoral venom: XM0CW4\\nFire coral venom: XM65N5\\nSoft coral venom: XM0R26\\nFish venom: XM05Z4\\nCobbler fish venom: XM0UJ4\\nDogfish shark venom: XM6643\\nGhost shark venom: XM3DB5\\nGoblinfish venom: XM5FP5\\nLionfish venom: XM4CL4\\nRabbitfish venom: XM17D1\\nScorpionfish venom: XM5V26\\nStargazer fish venom: XM73V9\\nStingray venom: XM7P10\\nStonefish venom: XM8P00\\nStriped blenny fish venom: XM83T2\\nStriped eel catfish venom: XM0784\\nToadfish venom: XM33N5\\nWaspfish venom: XM0U57\\nWeeverfish venom: XM1VW1\\nJellyfish venom: XM9YA3\\nBox jellyfish venom: XM4057\\nIrukandji jellyfish venom: XM0ZB2\\nSea wasp venom: XM87R6\\nLions mane jellyfish venom: XM6PY9\\nSea nettle venom: XM8EA9\\nPortuguese man o war venom: XM6S92\\nSea anemone venom: XM41L4\\nSea cucumber venom: XM2HU5\\nSea urchin venom: XM2M75\\nSnail venom: XM48L3\\nStarfish venom: XM7A02\\nCrown of thorns starfish venom: XM3X53\\nSeafood poison: XM3BZ7\\nCrab seafood poison: XM1KF5\\nFish seafood poison: XM7V29\\nCiguatera fish seafood poison: XM1DD9\\nGreenland shark seafood poison: XM7N43\\nPuffer fish seafood poison: XM33K2\\nScombroid fish seafood poison: XM74Y6\\nToadfish seafood poison: XM40D3\\nSea cucumber seafood poison: XM5QW5\\nSea snail seafood poison: XM51R6\\nShellfish seafood poison: XM7VB5\\nOyster seafood poison: XM3XQ0\\nClam seafood poison: XM3S96\\nScallop seafood poison: XM3KC2\\nMussel seafood poison: XM41B9\\nTurtle seafood poison: XM7DB8\\nBox turtle seafood poison: XM2YA1\\nGreen sea turtle seafood poison: XM1C12\\nHawksbill sea turtle seafood poison: XM0RH0\\nReptile venom: XM2X61\\nLizard venom: XM4RP9\\nBeaded lizard venom: XM5HY6\\nGila monster lizard venom: XM7HD4\\nSnake venom: XM4KN1\\nSea snake venom: XM6UB3\\nTerrestrial snake venom: XM8DS9\\nAdder snake venom: XM9034\\nPuff adder snake venom: XM4R63\\nDeath adder snake venom: XM8DE0\\nEuropean adder snake venom: XM2J41\\nAmerican copperhead snake venom: XM6CL7\\nAsp viper snake venom: XM5UK6\\nAustralasian black snake venom: XM3DZ2\\nMulga snake venom: XM9E44\\nAustralian brown snake venom: XM5MD7\\nCommon brown snake venom: XM2UN5\\nAustralian copperhead snake venom: XM1FY9\\nBoomslang snake venom: XM0RN4\\nBush viper snake venom: XM26Z0\\nBushmaster snake venom: XM2650\\nCarpet viper snake venom: XM6HP1\\nCobra snake venom: XM1R49\\nChinese cobra snake venom: XM45D4\\nEgyptian cobra snake venom: XM4760\\nIndian cobra snake venom: XM6052\\nKing cobra snake venom: XM0W24\\nNorthern Philippine cobra snake venom: XM1UH2\\nSpitting cobra snake venom: XM5F28\\nBlack necked spitting cobra snake venom: XM7LZ0\\nJavan spitting cobra snake venom: XM69M0\\nMozambique spitting cobra venom: XM6U92\\nRed spitting cobra snake venom: XM2B16\\nWest African brown spitting cobra venom: XM7BF9\\nTree cobra snake venom: XM7P11\\nCoral snake venom: XM4WV8\\nHarlequin coralsnake venom: XM2PM7\\nTexas coralsnake venom: XM0EN5\\nDesert viper snake venom: XM5A72\\nGaboon viper snake venom: XM2RJ2\\nHorned viper snake venom: XM6LU5\\nHump nosed pit viper snake venom: XM7WL0\\nKrait snake venom: XM7TD0\\nBanded krait snake venom: XM2RD0\\nIndian krait snake venom: XM5J22\\nMalayan krait snake venom: XM78S0\\nLancehead snake venom: XM7JF1\\nCommon lancehead snake venom: XM2267\\nFer de lance snake venom: XM9Y58\\nLevant viper snake venom: XM40A2\\nMamba snake venom: XM9JL4\\nBlack mamba snake venom: XM2SH0\\nEastern green mamba snake venom: XM1RM0\\nJamesons mamba snake venom: XM8E53\\nWestern green mamba snake venom: XM1GY6\\nMole viper snake venom: XM81Z8\\nMoorish viper snake venom: XM3G20\\nOttoman viper snake venom: XM2A66\\nPalestine viper snake venom: XM88F6\\nRattlesnake venom: XM1504\\nEastern diamondback rattlesnake venom: XM3RE1\\nMojave rattlesnake venom: XM1RY2\\nPrairie rattlesnake venom: XM8MU5\\nTimber rattlesnake venom: XM2P01\\nWestern diamondback rattlesnake venom: XM5JD1\\nRussell viper snake venom: XM8JD0\\nTaipan snake venom: XM4SM0\\nCoastal taipan snake venom: XM5T51\\nInland taipan snake venom: XM7NG4\\nWestern ranges taipan snake venom: XM7XU4\\nTiger snake venom: XM23U8\\nWater mocassin snake venom: XM59V3\\nTetrodotoxin: XM7FH1\\nCarbon disulfide: XM7S46\\nAcetic anhydride: XM34D2\\nAcrolein: XM4HP5\\nAcrolein gas: XM2MJ1\\nAziridine: XM3GN3\\nBenzidine: XM9WX0\\nCorrosive acid: XM6PB5\\nFormic acid: XM6HP3\\nFormic acid vapor: XM6SY2\\nHydrazoic acid: XM3C02\\nHydrogen fluoride: XM0VA0\\nHydrogen fluoride vapor: XM34T7\\nNitric acid: XM5NZ1\\nNitric acid vapor: XM5CC8\\nNitrohydrochloric acid: XM5WU5\\nNitrous acid: XM2WH3\\nNitrous acid fumes: XM6QY4\\nOrthotolidine: XM5JW8\\nOsmic acid: XM22A0\\nOsmic acid fumes: XM07R4\\nOxalic acid: XM4AK6\\nPotassium oxalate: XM03N8\\nSodium oxalate: XM6CB1\\nPhosphoric acid: XM0270\\nPicric acid: XM0KV1\\nSulfuric acid: XM8724\\nTrichloroacetic acid: XM9SC9\\nCorrosive alkali: XM2R89\\nAmmonia: XM4TP4\\nAmmonia liquid: XM2KS4\\nAmmonium carbonate: XM51W3\\nBorate nonmedicinal: XM8X28\\nSodium borate cleanser: XM4Q76\\nSodium perborate nonmedicinal: XM25T4\\nCalcium hydroxide: XM4AF1\\nCalcium hypochlorite: XM50U9\\nCalcium oxide: XM87X9\\nCaustic hydroxide: XM8586\\nPotassium hydroxide: XM5N47\\nSodium hydroxide: XM4SW1\\nPotassium carbonate: XM8WC7\\nSodium carbonate: XM9370\\nSodium hypochlorite: XM0KW1\\nSodium hypochlorite vapor: XM6KZ0\\nTriethanolamine: XM8F93\\nAlkaline disinfectant not elsewhere classified: XM9JC6\\nDimethyl sulfate: XM71L2\\nDimethyl sulfate fumes: XM8TX4\\nFluoride nonmedicinal: XM10Z2\\nSulfuryl fluoride: XM48A5\\nHydrazine: XM8LE5\\nMethyl hydrazine: XM0WH6\\nMethyl iodide: XM7BT1\\nPhenol nonmedicinal: XM92T1\\nAminophenol: XM3FK8\\nMethyl aminophenol: XM9JR4\\nButylated hydroxytoluene: XM2PP7\\nNitrophenol: XM7645\\nPhenol disinfectant not elsewhere classified: XM0HB7\\nPhenol pesticide not elsewhere classified: XM5YF7\\nLiquor cresolis compositus: XM9814\\nPhthalic anhydride: XM5380\\nSilver nitrate nonmedicinal: XM49E4\\nSodium bisulfate: XM9GW2\\nSodium chlorate: XM0345\\nSodium oxide: XM5M78\\nSodium peroxide: XM4XF6\\nSodium silicate: XM8FM5\\nThioglycolic acid: XM6826\\nCorrosive aromatics not elsewhere classified: XM85F7\\nCorrosive cleaning product not elsewhere classified: XM1ZR1\\nBleach not elsewhere classified: XM2A78\\nDrain cleaner not elsewhere classified: XM6AU8\\nCorrosive cleaning product fumes not elsewhere classified: XM57L3\\nOxidizing agent not elsewhere classified: XM05Q8\\nCyanide: XM3HX8\\nAcrylonitrile: XM23N0\\nAliphatic thiocyanates: XM9R22\\nCalcium cyanide: XM42L1\\nCyanogen: XM1ZE4\\nCyanogen chloride: XM1293\\nHydrogen cyanide: XM8WA4\\nIsocyanate: XM0YF6\\nMethyl isothiocyanate: XM4QN2\\nPotassium cyanide: XM1VD7\\nPotassium ferric hexacyanoferrate nonmedicinal: XM2Q39\\nSodium cyanide: XM1AZ9\\nToluene diisocyanate: XM36N4\\nCyanide pesticide not elsewhere classified: XM77X3\\nDichloroformoxine: XM4VA2\\nEthylidene diacetate: XM14Q4\\nCordite: XM5NJ3\\nCordite vapor: XM1926\\nNitrocellulose: XM4PQ8\\nNitroglycerin nonmedicinal: XM8T02\\nNitroglycerin nonmedicinal fumes: XM5VU2\\nDynamite: XM9YX2\\nDynamite fumes: XM7Q61\\nNitronaphthalene: XM7GP0\\nPotassium chlorate: XM7EN6\\nFiberglass: XM8SN2\\nBromine vapor: XM3GS6\\nCarbon dioxide: XM8XZ6\\nCarbon monoxide: XM1X11\\nBlast furnace gas: XM8MR4\\nCarbon monoxide from engine exhaust gas: XM7SP6\\nCarbon monoxide from engine driven electrical generator: XM7R97\\nCarbon monoxide from motor vehicle exhaust: XM2LM9\\nCarbon monoxide from incomplete combustion of\\xa0charcoal: XM4QD5\\nCarbon monoxide from incomplete combustion of\\xa0coal: XM2EK4\\nCarbon monoxide from incomplete combustion of\\xa0coke: XM7NG7\\nCarbon monoxide from incomplete combustion of fuel gas: XM9675\\nCarbon monoxide from incomplete combustion of\\xa0acetylene: XM1MB6\\nCarbon monoxide from incomplete combustion of\\xa0coal gas: XM5TT8\\nCarbon monoxide from incomplete combustion of producer gas: XM1JF3\\nCarbon monoxide from incomplete combustion of\\xa0utility gas: XM3ES0\\nCarbon monoxide from incomplete combustion of\\xa0liquefied petroleum gas: XM5XY1\\nCarbon monoxide from incomplete combustion of\\xa0butane: XM45F2\\nCarbon monoxide from incomplete combustion of propane: XM3UB7\\nCarbon monoxide from incomplete combustion of utility natural gas: XM6708\\nCarbon monoxide from incomplete combustion of\\xa0water gas: XM9ZV7\\nCarbon monoxide from incomplete combustion of\\xa0wood: XM8WR8\\nChlorine: XM0GT6\\nCyanic acid: XM3KE4\\nDiazomethane: XM8Z33\\nDiborane: XM70H1\\nDichloroethyl sulfide: XM6UG7\\nEthidium chloride: XM0YQ4\\nEthylene: XM1947\\nFerrovanadium: XM5EU1\\nFluorine: XM9SB2\\nFormaldehyde: XM0TV9\\nHelium: XM0JJ6\\nHydrocarbon gas: XM5LN6\\nAcetylene: XM3FZ1\\nCoal gas: XM8GS7\\nLiquefied petroleum gas: XM53K7\\nPropane: XM76Q9\\nButane: XM4653\\nNatural gas: XM6BD0\\nMethane: XM56Q2\\nProducer gas: XM6993\\nWater gas: XM4X82\\nHydrogen: XM8ZY7\\nHydrogen sulfide: XM7FL0\\nIodine vapor: XM74J0\\nLacrimogenic gas: XM2JX3\\nBromobenzylcyanide: XM9FN5\\nChloroacetone: XM2N89\\nChloroacetophenone: XM7J14\\nEthyl iodoacetate: XM41V6\\nMace lacrimogenic gas: XM3RL0\\nMethyl chloroformate: XM6RK9\\nMethyl chloride: XM29D2\\nMethyl mercaptan: XM4FU5\\nMustard gas: XM16X6\\nNitrogen oxide: XM69M3\\nNitrogen dioxide: XM05F4\\nNonchlorofluorocarbon refrigerant gas: XM1418\\nOzone: XM54H2\\nPhosgene: XM91W5\\nPolyester fumes: XM3D40\\nPolytetrafluoroethylene: XM1663\\nPropylene: XM8242\\nSulfur oxides: XM2598\\nSulfur dioxide: XM0Z74\\nAerosol spray not elsewhere classified: XM3NH9\\nFiredamp not elsewhere classified: XM1D37\\nNerve gas not elsewhere classified: XM61G0\\nOil fumes not elsewhere classified: XM60X6\\nSewer gas not elsewhere classified: XM1EM9\\nSmog not elsewhere classified: XM6QK6\\nSmoke not elsewhere classified: XM9N00\\nSternutator gas not elsewhere classified: XM0G86\\nAcetyl bromide: XM2X70\\nAcetyl chloride: XM7594\\nAcetylene tetrachloride: XM2W36\\nAcetylene tetrachloride vapor: XM4YD3\\nAmyl chloride: XM45Q9\\nCarbon tetrachloride: XM3CP7\\nCarbon tetrachloride vapor: XM0386\\nChlorex: XM77V1\\nChlorinated camphene: XM1363\\nChlorinated hydrocarbons not elsewhere classified: XM4XU4\\nChlorinated naphthalene: XM1YR6\\nChlorinated naphthalene vapor: XM9P39\\nChloroaniline: XM0WL1\\nChlorobenzene: XM6LC4\\nChlorobromomethane: XM0KE3\\nChlorodinitrobenzene: XM6QB9\\nChlorodinitrobenzene vapor: XM5VH9\\nChlorodiphenyl: XM8D04\\nChloroethylene: XM6YR0\\nChlorofluorocarbons: XM2HX1\\nFreon: XM9813\\nDichlorodifluoromethane: XM3QE2\\nTrichlorofluoromethane: XM7FF5\\nChloronitrobenzene: XM8G05\\nChloronitrobenzene vapor: XM5S30\\nChlorophenol: XM84K8\\nChloropicrin: XM3U53\\nDibromoethane: XM9GK3\\nDichlorobenzene: XM55X0\\nDichloroethane: XM1AF0\\nDichloroethylene: XM8G49\\nAcetylene dichloride: XM7JZ1\\nVinylidene chloride: XM3DX7\\nDichloromethane: XM73T7\\nDichloromethane vapor: XM7EF6\\nDioxin: XM9Y80\\nEthyl chloride: XM45K4\\nEthylene chlorohydrin: XM9B31\\nEthylene chlorohydrin vapor: XM5HK4\\nEthylene dichloride: XM4Z80\\nEthylene dichloride vapor: XM8QX0\\nHexachlorocyclohexane: XM8PE4\\nMethoxychlor: XM0MD1\\nOrthodichlorobenzene: XM42E8\\nPentachloroethane: XM5JU8\\nPolybrominated biphenyl: XM59S9\\nPolychlorinated biphenyl: XM77J7\\nTetrachloroethane: XM4D89\\nTetrachloroethane vapor: XM4N54\\nTetrachloroethylene: XM3DA8\\nTetrachloroethylene vapor: XM86D7\\nTrichloroethane: XM9R55\\ntrichloroethane: XM1992\\nTrichloroethylene: XM3NB3\\nTrichloroethylene vapor: XM7YS9\\nTrichloropropane: XM58Q9\\nArsenic: XM2KQ2\\nArsine: XM00Z1\\nCacodyl: XM0DR1\\nCacodylic acid: XM6C50\\nChlorovinyldichloroarsine: XM1BL4\\nCopper\\xa0arsenic complex: XM8SC0\\nDiphenylchlorarsine: XM9YA9\\nEthyl dichloroarsine: XM1AE2\\nLead arsenate: XM8LC6\\nLead arsenite: XM3M96\\nPotassium arsenite: XM4TW8\\nRealgar: XM32L9\\nSodium arsenate: XM7H00\\nSodium arsenite: XM7Y18\\nArsenic pesticide not elsewhere classified: XM4GU5\\nAsbestos: XM53B3\\nBarium nonmedicinal: XM8SU1\\nBarium carbonate: XM3709\\nBarium chloride: XM5DL6\\nBarium sulfite: XM38G1\\nBorane complex: XM8QL6\\nBoron: XM2BF4\\nBoron hydride: XM3FZ9\\nBoron trifluoride: XM5AP1\\nCalcium dichromate: XM0XT5\\nChloramine: XM4QG2\\nDecaborane: XM5JW5\\nDecaborane fumes: XM74T0\\nHydrogen chloride: XM97M0\\nManganese: XM3FY4\\nManganese dioxide: XM9ZR0\\nPermanganate: XM1FQ3\\nPotassium permanganate nonmedicinal: XM3VC7\\nPhosphorus: XM2AZ6\\nPhosphine: XM3G46\\nYellow phosphorus: XM0LP4\\nPotassium perchlorate nonmedicinal: XM95X4\\nPotassium Fluoride: XM2SG3\\nPotassium nitrate: XM2G85\\nSodium bichromate: XM5XL5\\nSodium chromate: XM9EQ8\\nSodium nitrate: XM7FZ2\\nErionite: XM3M65\\nAlum nonmedicinal: XM68C9\\nAlum ammonium: XM9CV4\\nAlum potassium: XM5GN1\\nAluminium nonmedicinal: XM7JJ2\\nAluminium phosphide: XM3TB8\\nAntimony: XM5HW4\\nAntimony hydride: XM2AE9\\nAntimony pesticide not elsewhere classified: XM81B2\\nBeryllium: XM4QG7\\nBismuth nonmedicinal: XM0TX8\\nBrass: XM4DZ8\\nCadmium: XM0V73\\nCadmium carbonate: XM3S39\\nCadmium chloride: XM3YF2\\nCadmium selenide: XM4YU7\\nCadmium succinate: XM9217\\nCadmium sulfate: XM0TH7\\nCadmium sulfide nonmedicinal: XM5YV2\\nCadmium pesticide not elsewhere classified: XM1TW0\\nChromium: XM9YJ8\\nChromic acid: XM95L9\\nChromyl chloride: XM79V9\\nPotassium dichromate: XM0QY9\\nChromium VI compounds: XM34P0\\nCobalt: XM1NV2\\nCopper: XM5KH2\\nCopper acetate: XM5U84\\nCopper hydroxide: XM0EX6\\nCopper oxide: XM0Y98\\nCopper oxychloride: XM48K0\\nCopper sulfate nonmedicinal: XM6859\\nOxinecopper: XM98Z3\\nVerdigris: XM30V1\\nCopper pesticide not elsewhere classified: XM3757\\nIron nonmedicinal: XM8U54\\nLead: XM0ZH6\\nLead acetate nonmedicinal: XM5071\\nLead alkyl: XM17Q5\\nLead antimonate: XM2PV9\\nLead azide: XM9WK6\\nLead carbonate: XM3Y96\\nLead chromate: XM91V9\\nLead dioxide: XM59W8\\nLead iodide: XM4EW1\\nLead monoxide: XM7LD9\\nLead oxide: XM2R16\\nLead sulfide: XM3ZU1\\nLead paint not elsewhere classified: XM0891\\nLithium nonmedicinal: XM4AM4\\nMercury: XM1FG4\\nEthyl mercuric chloride: XM8JX9\\nMethoxyethyl mercuric chloride: XM90P2\\nMercuric chloride nonmedicinal: XM9524\\nMercuric cyanide nonmedicinal: XM39J4\\nMercuric\\xa0oxide nonmedicinal: XM5X38\\nMercuric sulfate nonmedicinal: XM8HV3\\nMercury fulminate: XM4WJ1\\nMercury thiocyanate: XM3W50\\nMethyl mercury: XM5DJ5\\nPhenylmercury acetate: XM2Z22\\nMercury pesticide not elsewhere classified: XM7UW8\\nNickel: XM4E11\\nNickel carbonyl: XM9P91\\nNickel sulphate: XM7K88\\nNickelocene: XM5F09\\nSilver nonmedicinal: XM9359\\nTellurium: XM0XQ4\\nThallium: XM63C5\\nThallium sulfate: XM9YD2\\nTin: XM1NS5\\nTin chloride: XM9KC4\\nTin oxide: XM0K92\\nTitanium: XM7B62\\nTitanium tetrachloride: XM4WJ2\\nTitanocene: XM89Q2\\nVanadium: XM0907\\nAmalgam: XM7UJ7\\nPalladium chloride: XM0FY1\\nMetal not elsewhere classified: XM6NP0\\nHard metal dust: XM3AW0\\nOsmium: XM1UC6\\nTungsten: XM0JD9\\nMethyl acrylate: XM5H13\\nMonosodium glutamate: XM34R5\\nMycotoxin: XM5490\\nAflatoxin: XM7U84\\nCitreoviridin: XM0232\\nCitrinin: XM4UE5\\nCyclopiazonic acid: XM3NK1\\nFusarium toxin: XM3G74\\nErgot alkaloid mycotoxin: XM2BE5\\nFumonisin: XM9C09\\nMoniliformin: XM9GV7\\nTrichothecenes: XM6X33\\nZearalenone: XM4E53\\nNitropropionic acid: XM9F85\\nOchratoxin: XM5WG7\\nPatulin: XM9C47\\nPenitrem: XM28H1\\nSatratoxin: XM77Q2\\nSterigmatocystin: XM6VH6\\nTenuazonic acid: XM1PM8\\nNaphthylamine: XM6PE4\\nAcetal: XM50A4\\nAcetaldehyde: XM4LM8\\nAcetaldehyde vapor: XM5Q94\\nAcetic acid ester: XM6QH4\\nAmyl acetate: XM2KF5\\nAmyl acetate vapor: XM1JM2\\nBenzyl acetate: XM5AK0\\nButyl acetate: XM3RG6\\nCyclohexyl acetate: XM3AP0\\nEthyl acetate: XM00H9\\nIsobutyl acetate: XM3MD8\\nIsopropyl acetate: XM1EQ5\\nMethyl cyclohexyl acetate: XM27U4\\nAcetonitrile: XM6XW9\\nAmyl formate: XM5HX1\\nBenzene: XM0QY7\\nBenzene homologue: XM2738\\nButyltoluene: XM4214\\nHexylresorcinol: XM01R0\\nHydroquinone: XM50B6\\nHydroquinone vapor: XM1N69\\nToluene: XM00E9\\nXylene: XM0D44\\nBenzene\\xa0vapor: XM3TU9\\nDiphenylmethane: XM9UH2\\nNitroderivative or aminoderivative of benzene or benzene homologue: XM83H3\\nAniline: XM76E2\\nAniline vapor: XM0061\\nAnisidine: XM3R71\\nAzobenzene: XM1UP9\\nDinitroorthocresol: XM1ZR2\\nDichlorobenzidine: XM76A0\\nDinitrobenzene: XM11G0\\nDinitrobenzene vapor: XM54Q3\\nDinitrocyclohexylphenol: XM95M5\\nDinitrophenol: XM73Y7\\nDiphenylamine: XM2732\\nNitroaniline: XM0179\\nNitroaniline vapor: XM8M07\\nNitrobenzene: XM2W93\\nNitrobenzene vapor: XM2VA4\\nNitrobiphenyl: XM6GM2\\nNitrosodimethylamine: XM1MY0\\nNitrotoluene: XM6EB1\\nNitrotoluene vapor: XM5F24\\nPhenylenediamine: XM1E24\\nNisopropylNphenylpparaphenylenediamine: XM54V0\\npPhenylenediamine: XM0AK0\\nPhenylhydrazine: XM9BN0\\nTetryl: XM9ZV3\\nTNT: XM1X35\\nToluylenediamine: XM67F1\\nTrinitrobenzol: XM4B36\\nResorcin nonmedicinal: XM6ZJ9\\nStyrene: XM5V50\\nButyl butyrate: XM0M80\\nButyl formate: XM3XT7\\nButyl lactate: XM59Y7\\nButyl propionate: XM3NC8\\nDecahydronaphthalene: XM4DT3\\nDialkyl carbonate: XM8R64\\nEthyl carbonate: XM77E6\\nMethyl carbonate: XM7CR8\\nDichlorhydrin: XM38Z7\\nDimethylformamide: XM7MB5\\nDioxane: XM2XU7\\nDipentene: XM1LN6\\nEpichlorhydrin: XM5L21\\nEthyl benzoate: XM29X5\\nEthyl ether\\xa0nonmedicinal: XM0N40\\nPhenylglycidylether: XM5YV7\\nEthyl formate: XM6FX9\\nEthyl hydroxyisobutyrate: XM7TN8\\nEthyl lactate: XM3NZ9\\nEthyl oxybutyrate: XM6FQ2\\nFurfural: XM7QX9\\nHexahydrobenzene: XM4QR6\\nIsophorone: XM2D79\\nIsophoronediisocyanate: XM4XC6\\nIsophoronediamine: XM58V1\\nIsopropyl ether: XM38W0\\nKetones: XM9UX0\\nAcetone: XM7U59\\nNail polish remover: XM0ES5\\nAcetophenone: XM0AM0\\nCyclohexanone: XM1L02\\nDiacetone alcohol: XM9F73\\nHexanone: XM7KB7\\nHydroxymethylpentanone: XM5E65\\nMethyl acetate: XM12H2\\nMethyl acetone: XM9LD3\\nMethyl isobutyl ketone: XM5H65\\nNHexane and Methyl nbutyl ketone solvent: XM5LH2\\nBenzoquinone: XM4GN3\\nMethyl benzoate: XM6UK4\\nMethyl cyclohexane: XM4513\\nMethyl cyclohexanone: XM91A0\\nMethyl sulfate: XM5BM9\\nMethyl sulfate fumes: XM5Y11\\nNitropropane: XM5CA9\\nPetroleum: XM0TB3\\nPetroleum product: XM7MJ9\\nAutomobile fuel: XM27Z5\\nAutomobile fuel vapor: XM7CM2\\nGas oil: XM4RN1\\nDiesel fuel: XM9A95\\nGasoline: XM8WE9\\nGasohol: XM52C5\\nGasoline vapor: XM0FK9\\nCoal tar fumes: XM81T5\\nCoal tar naphtha: XM6U93\\nCoal tar nonmedicinal: XM2CE3\\nPitch: XM16M2\\nAnthracene: XM7WM1\\nKerosene: XM2Q78\\nKerosine vapor: XM3QU8\\nMineral oil nonmedicinal: XM3SU8\\nLubricating oil: XM4NT9\\nMineral spirits: XM7CX7\\nMineral spirits fumes: XM2E62\\nParaffin wax: XM8PX9\\nPetrolatum nonmedicinal: XM3ZG5\\nSolid petroleum: XM9WJ0\\nTar: XM4C94\\nTar fumes: XM5LE8\\nPetroleum pesticide not elsewhere classified: XM8AA6\\nPetroleum vapor: XM0B41\\nPhosphate solvent: XM02T2\\nTricresyl phosphate: XM5FS3\\nPyridine: XM2NF0\\nPyridine vapor: XM7TE7\\nTetrahydrofuran: XM5XP8\\nTetralin: XM2GY2\\nOrganic solvents not elsewhere classified: XM0W28\\nGlue: XM3U55\\nLighter fluid: XM0R56\\nPaint stripper: XM9B14\\nPolishing compound: XM0KG9\\nCar polish: XM39J1\\nFloor polish: XM1545\\nFurniture polish: XM2BC0\\nMetal polish: XM1J33\\nSilver polish: XM5J78\\nPorcelain\\xa0polish: XM1P52\\nPolyester resin hardener: XM3JF2\\nPolyester resin hardener fumes: XM3EF0\\nEthylene glycol: XM1762\\nEthylene glycol dinitrate: XM0WA9\\nEthylene glycol monobutyl ether: XM8BF5\\nEthylene\\xa0glycol\\xa0monoethyl\\xa0ether: XM4E62\\nEthylene\\xa0glycol\\xa0monomethyl\\xa0ether: XM0C04\\nDiethylene glycol: XM55M8\\nDiethylene glycol monoacetate: XM3834\\nDiethylene glycol monobutyl ether: XM1A56\\nDiethylene glycol monoethyl ether: XM8XU3\\nBrake fluid not elsewhere classified: XM99B7\\nBrake fluid vapor: XM8TE5\\nAcridine: XM9UE9\\nAcridine vapor: XM2QW2\\nDisperse dye: XM4UG8\\nLacquer: XM5C83\\nNitrocellulose lacquer: XM8B47\\nPrussian blue nonmedicinal: XM2FV2\\nWhitewash: XM9WW6\\nInk not elsewhere classified: XM6HZ8\\nPaint fumes not elsewhere classified: XM1XL9\\nDye not elsewhere classified: XM8H37\\nCochineal extract: XM3K54\\nParatertiary butylphenol formaldehyde resin: XM7U05\\nPhthalate: XM5B21\\nDiethylhexyl phthalate: XM75C9\\nDimethyl phthalate nonmedicinal: XM34N7\\nDinbutyl phthalate: XM9HC2\\nPoisonous mushroom: XM74S8\\nAgaricus xanthodermus mushroom: XM0366\\nAmanita mushroom: XM7P94\\nAmanita bisporigera mushroom: XM82H0\\nAmanita hygroscopica mushroom: XM5911\\nAmanita muscaria mushroom: XM91N3\\nAmanita ocreata mushroom: XM8MF4\\nAmanita phalloides mushroom: XM6HP7\\nAmanita pantherina mushroom: XM4NS6\\nAmanita pseudoporphyria hongo mushroom: XM23X2\\nAmanita suballiacea mushroom: XM2HH5\\nAmanita smithiana mushroom: XM3VN8\\nAmanita tenuifolia mushroom: XM5039\\nAmanita verna mushroom: XM0G40\\nAmanita virosa mushroom: XM1DV5\\nClitocybe mushroom: XM2FU2\\nClitocybe rivulosa mushroom: XM2BD5\\nConocybe filaris mushroom: XM9BX0\\nCortinarius mushroom: XM4CB0\\nCortinarius rubellus mushroom: XM85A8\\nCortinarius orellanus mushroom: XM9TZ1\\nCortinarius speciosissimus mushroom: XM2BB9\\nGalerina mushroom: XM1LD8\\nGalerina fasciculata mushroom: XM6W91\\nGalerina marginata mushroom: XM7NR0\\nGalerina sulcipes mushroom: XM24L3\\nGalerina venenata mushroom: XM78T5\\nGyromitra mushroom: XM0M17\\nGyromitra ambigua mushroom: XM0BM0\\nGyromitra esculenta mushroom: XM76X5\\nGyromitra infula mushroom: XM3LC5\\nHapalopilus rutilans\\xa0mushroom: XM1PK2\\nHebeloma crustuliniforme mushroom: XM87D0\\nInocybe mushroom: XM9B73\\nLepiota mushroom: XM2BC2\\nLepiota brunneoincarnata mushroom: XM7K06\\nLepiota brunneolilacea mushroom: XM4L76\\nLepiota chlorophyllum mushroom: XM0FJ0\\nLepiota fulvella mushroom: XM6882\\nLepiota helveola mushroom: XM1UJ5\\nLepiota josserandii mushroom: XM8R10\\nOmphalotus mushroom: XM95E9\\nOmphalotus nidiformis mushroom: XM8VV0\\nOmphalotus illudens mushroom: XM7RG5\\nPanaeolus mushroom: XM1M89\\nPanaeolus papilionaceus mushroom: XM3NJ2\\nPanaeolus sphinctrinus mushroom: XM0B62\\nPanaeolus subbalteatus mushroom: XM27Y3\\nPleurocybella porrigens mushroom: XM44P3\\nPodostroma cornudamae mushroom: XM3CK7\\nPsilocybe semilanceata mushroom: XM4321\\nRussula subnigricans mushroom: XM36C7\\nTricholoma equestre mushroom: XM0QR2\\nSilicone: XM9KE6\\nSilicon dioxide: XM3DP9\\nAbrus precatorius plant: XM98Y1\\nAconitum plant: XM99Y1\\nAconitine: XM2WR7\\nAconitum ferox plant: XM3VB6\\nActaea plant: XM7BA0\\nActaea spicata: XM3QE1\\nAethusa cynapium plant: XM55K4\\nAnamirta cocculus plant: XM3AF3\\nPicrotoxin: XM6KR6\\nAntiaris toxicaria plant: XM8SE2\\nArum maculatum plant: XM2X16\\nAtropa belladonna plant: XM1EY0\\nAzadirachta plant: XM17F2\\nBergamot oil: XM5W16\\nBitter almond: XM1GJ1\\nDiallyl disulfide: XM4XS8\\nSesquiterpene lactones: XM6A31\\nCitronellol: XM4W45\\nCitral: XM9CQ1\\nEugenol: XM6CP3\\nEvernia prunastri extract: XM9CZ8\\nIsoeugenol: XM5AM5\\nAbietic acid: XM88U7\\nTurpentine oil: XM9L39\\nAtranorin: XM3B42\\nBlighia sapida plant: XM4BW2\\nEvernic acid: XM6635\\nUsnic acid: XM26G6\\nGrains and flours: XM3XH8\\nPlant or herbal extracted compounds: XM21W4\\nFolium stramoniae: XM7CA8\\nEphedra: XM1D48\\nBenzoin tincture: XM82G2\\nMenthol: XM9GX9\\nCianidanol: XM8UA9\\nGelsemine: XM4Y73\\nPalm kernel oil: XM2YX0\\nTragacanth: XM1PQ5\\nDatura stramonium plant: XM8VJ2\\nRubber: XM8MB5\\nCotton plant: XM0XN7\\nSisal: XM1KF1\\nBrucea javanica plant: XM2BX6\\nCaladium plant: XM9B82\\nCaladium bicolor: XM1021\\nCaladium seguinum: XM0BS2\\nCannabis natural phytocannabinoids: XM9S25\\nAfghanistan black: XM08L6\\nIndian hemp: XM5WR8\\nLebanese red: XM3R78\\nMarijuana: XM8PV1\\nCelastrus scandens plant: XM0WA6\\nCerbera plant: XM5L03\\nCerbera odollam plant: XM2KR7\\nCerbera manghas plant: XM1FN8\\nCerbera venenifera plant: XM8AZ9\\nChelidonium majus plant: XM9DJ3\\nChrysanthemum cinerariifolium plant: XM49V0\\nPyrethrin nonmedicinal: XM5HR7\\nCicuta maculata plant: XM6709\\nCicutoxin: XM1S86\\nCinnamomum camphora plant: XM6YA3\\nClematis plant: XM5804\\nClematis vitalba plant: XM5D25\\nCoffee: XM9KW2\\nColchicum plant: XM7TP8\\nColchicine: XM3Q99\\nConium maculatum plant: XM9Z51\\nConiine: XM3FY5\\nConvallaria majalis plant: XM9T69\\nCyclamen plant: XM72P9\\nCyclamen europaeum plant: XM56R9\\nCyclamen persicum plant: XM5174\\nCytisus laburnum plant: XM5ZF9\\nCytisus scoparius plant: XM2YN7\\nDaphne plant: XM4TF9\\nDelphinium plant: XM8YH8\\nDerris elliptica plant: XM3KT4\\nDigitalis purpurea plant: XM46Y1\\nErythroxylum coca lam plant: XM1LE7\\nCocaine: XM7UN8\\nCocaine topical anesthetic: XM0BC6\\nEquisetum plant: XM0XS0\\nEquisetum diuretic: XM0EC2\\nEuphorbia plant: XM4TJ7\\nGaultheria procumbens plant: XM91T0\\nGaultheria procumbens plant oil: XM5P41\\nGelsemium sempervirens plant: XM1VX3\\nGloriosa superba plant: XM66Z7\\nGratiola officinalis plant: XM5EL7\\nHelleborus niger plant: XM3QP5\\nHelleborus viridis plant: XM0SF4\\nHyoscyamus niger plant: XM4UC8\\nIlex plant: XM3EA9\\nJatropha plant: XM7ED8\\nJatropha curcas plant: XM8QC3\\nJatropha gossypiifolia plant: XM7CZ8\\nJatropha hastata plant: XM2C70\\nJatropha macrorhiza plant: XM4R06\\nJatropha multifida plant: XM84E3\\nJatropha podagrica plant: XM04B0\\nLatex: XM7762\\nLathyrus sativus plant: XM5EH9\\nLigustrum plant: XM5F38\\nLigustrum lucidum plant: XM1WT1\\nLigustrum sinense plant: XM4CK0\\nLigustrum vulgare plant: XM23X8\\nLobelia plant: XM2BQ5\\nLolium temulentum plant: XM76G6\\nManihot esculenta plant: XM6LL4\\nMelia azedarach plant: XM1TB2\\nMyristica fragrans plant: XM3M91\\nNutmeg oil: XM6FE5\\nMyristicin: XM31J1\\nMyrsine africana plant: XM14Y1\\nNerium oleander plant: XM3XT1\\nNicotiana plant: XM2VY1\\nTobacco: XM88J8\\nNux vomica plant: XM33X3\\nBrucine: XM7134\\nStrychnine: XM5421\\nStrychnine rodenticide: XM9JS2\\nPhysostigma venenosum plant: XM7JG0\\nPhytolacca decandra plant: XM61M4\\nPine oil: XM19G9\\nPiper cubeba plant: XM1XZ4\\nPoison oak plant: XM21J6\\nPoison sumak plant: XM4882\\nPrimula plant: XM95D5\\nPrimula obconica plant: XM9HN7\\nPrimin: XM07P7\\nPrimula officinalis plant: XM4TX6\\nPrimula veris plant: XM19S7\\nPrunus plant: XM3QL7\\nAmygdalin: XM01R5\\nApricot kernel: XM0PX4\\nCherry kernel: XM5MK6\\nPeach kernel: XM7B39\\nPlum kernel: XM52C3\\nPsoralea corylifolia plant: XM6Z57\\nPsoralen nonmedicinal: XM1MV4\\nPulsatilla plant: XM03C0\\nPyrrolizidine alkaloids: XM3PV6\\nRanunculus plant: XM0NB5\\nRicinus communis plant: XM0PR3\\nRicin: XM2VG9\\nRuta graveolens plant: XM4AC2\\nSambucus plant: XM7BE0\\nSanguinaria canadensis plant: XM9W70\\nSchoenocaulon officinale plant: XM0EH6\\nSabadilla insecticide: XM4BY7\\nSenecio vulgaris plant: XM8YX9\\nSolanum plant: XM4TE3\\nSolanum dulcamara plant: XM56G1\\nSolanum nigrum plant: XM1AE1\\nSolanum pseudocapsicum plant: XM0QV6\\nSolanine: XM9588\\nSpartium junceum plant: XM4UE4\\nStrophanthus gratus plant: XM9834\\nStrophanthink: XM9QZ9\\nTanacetum plant: XM58G8\\nTartaric acid: XM7EL5\\nTaxus plant: XM5YT6\\nThevetia peruviana plant: XM6WF4\\nToxicodendron radicans plant: XM40N4\\nUrginea maritima plant: XM46N0\\nScilliroside: XM0SG7\\nUrtica plant: XM84R4\\nVeratrum plant: XM5KR7\\nVeratrum album plant: XM86L8\\nVeratrum viride plant: XM9Z08\\nWisteria plant: XM43H5\\nWisteria floribunda plant: XM29R2\\nWisteria sinensis plant: XM8ZH3\\nZygadenus plant: XM6076\\nPlant derived pesticide not elsewhere classified: XM8PU3\\nPoisonous plant berries not elsewhere classified: XM98M9\\nPoisonous plant flowers not elsewhere classified: XM7MT6\\nPoisonous plant fruits not elsewhere classified: XM6LL5\\nPoisonous plant leaves not elsewhere classified: XM2BH3\\nPoisonous plant roots not elsewhere classified: XM0GB3\\nPoisonous plant sap not elsewhere classified: XM2CE0\\nPoisonous plant seeds not elsewhere classified: XM7JK8\\nPoisonous plant stem not elsewhere classified: XM7KY1\\nPoisonous plant thorns not elsewhere classified: XM56V2\\nSubstance of marine plant origin not elsewhere classified: XM5NH2\\nPlant protein: XM8A62\\nAmerican beech wood dust: XM7A46\\nOak wood dust: XM4M03\\nEuropean ash wood dust: XM6VG6\\nApple: XM1K52\\nBanana: XM07U6\\nGrape: XM77D3\\nKiwifruit: XM4TY6\\nMango: XM6AW1\\nMelon: XM0DF7\\nOlive: XM2Q13\\nOrange: XM2XN1\\nPaprika: XM9UT8\\nCabbage: XM7S13\\nGrapefruit: XM5J64\\nBlack pepper: XM5733\\nGreen bean: XM9BG0\\nSpinach: XM25M2\\nMexican firebush: XM3EW6\\nRice: XM3XQ1\\nPecan or hickory nut: XM9135\\nPeach: XM5S85\\nPear: XM4GG6\\nStrawberry: XM5ZK9\\nPineapple: XM6E89\\nBarley: XM9MB5\\nBahia grass: XM47Z9\\nBermuda grass: XM5ZN2\\nBuckwheat: XM13D1\\nCorn: XM3GC8\\nGluten: XM56U7\\nJapanese hop: XM9898\\nJohnson grass: XM39Y3\\nKentucky blue grass: XM0D79\\nOat: XM8X04\\nRye: XM6JA2\\nPerennial rye grass: XM01D6\\nCultivated rye: XM8M82\\nSalt grass: XM4BW3\\nSweet vernal grass: XM13U2\\nTimothy: XM94M9\\nAvocado: XM63G5\\nBaker yeast: XM1E00\\nCarrot: XM9S46\\nCelery: XM1PN2\\nCocksfoot: XM5TW0\\nCocoa: XM9SJ1\\nCommon pigweed: XM9DZ5\\nCommon ragweed: XM5V61\\nEnglish plantain: XM3KE2\\nGarlic: XM40Y5\\nGoosefoot: XM4GX7\\nGiant ragweed: XM1X29\\nLentils: XM45L6\\nLettuce: XM6798\\nMugwort: XM0L96\\nMustard: XM7GY3\\nNettle: XM8F26\\nOnion: XM9KB5\\nPea: XM56E2\\nPotato: XM9J59\\nRough pigweed: XM3VS0\\nSheep sorrel: XM72E8\\nSoybean: XM3TW1\\nTomato: XM72C5\\nWall pellitory: XM3LL8\\nWestern ragweed: XM42C5\\nWhite bean: XM0GA2\\nWormwood: XM9S45\\nAlmond: XM60Q8\\nAmerican beech: XM1304\\nArizona cypress: XM5TH6\\nBrazil nut: XM3ES3\\nCedar elm: XM9GG3\\nCoastal maple: XM36B2\\nCoconut: XM6MF9\\nCottonwood: XM9JG2\\nEnglish walnut pollen: XM2044\\nCashew nut: XM2EQ3\\nGrey alder: XM7QD6\\nHazelnut: XM7L19\\nItalian cypress: XM4WW3\\nJapanese cedar: XM3940\\nJapanese cypress: XM8QG1\\nMacadamia: XM9AZ7\\nMesquite: XM0QL5\\nMountain juniper: XM7G21\\nPaper mulberry: XM8K37\\nPeanut: XM6Q82\\nPecan or hickory tree: XM1QN3\\nPine nut: XM7833\\nPistachio: XM2B46\\nRed maple: XM34T8\\nRed mulberry: XM03B3\\nSesame seed: XM1L09\\nSilver birch: XM30J5\\nWalnut: XM3DB3\\nWattle: XM5VB3\\nWestern white pine: XM3ZG1\\nWhite ash: XM3DL1\\nWhite birch: XM3VX2\\nWhite hickory: XM6V15\\nWhite mulberry: XM5AD4\\nWillow: XM4YR5\\nRed top grass: XM8SV5\\nPacific squid: XM6SX5\\nLemon: XM7AS2\\nSunflower seed: XM2YD2\\nChick pea: XM2XV2\\nSweet gum: XM1FG7\\nGumtree: XM1A07\\nCherry: XM0885\\nHuman seminal plasma: XM0RZ0\\nToluidine: XM7FG4\\nToluidine vapor: XM7S87\\nTriorthocresyl phosphate: XM5NA2\\nTriphenyl phosphate: XM90U0\\nVinyl acetate: XM3FJ3\\nVinyl bromide: XM6A87\\nEpoxy resin not elsewhere classified: XM23X0\\nButylglycidylether: XM9MV5\\nChromium sesquioxide: XM87D3\\nBorate buffer: XM83G3\\nCyclamate: XM1FY5\\nSaccharin: XM7CN5\\nSodium propyl hydroxybenzoate: XM5567\\nSodium barbiturate: XM16M4\\nIminostilbene: XM6DJ2\\nNCyclohexylbenzothiazyl sulphenamide: XM45E1\\nDibenzothiazyl disulphide: XM90X8\\nDipentamethylenethiuram disulphide: XM2RH1\\nTetramethylthiuram monosulphide: XM3BY9\\nMorpholinylmercaptobenzothiazole: XM1A88\\nDetergent nonmedicinal not elsewhere classified: XM0XA8\\nDisinfectant not elsewhere classified: XM7DD6\\nScouring powder not elsewhere classified: XM5151\\nShampoo not elsewhere classified: XM8VR0\\nSoap not elsewhere classified: XM8B44\\nWindow cleaning fluid not elsewhere classified: XM5FV8\\nParatertiary butylphenol: XM6PY1\\nMethylcoumarin: XM6000\\nDiaminodiphenyl methane: XM2EK8\\nHydroxyisohexyl cyclohexene carboxaldehyde: XM7N15\\nFarnesol: XM2TV3\\nBisphenol Aglycidyl methacrylate: XM3MM6\\nHydroxyethylmethacrylate: XM0BY4\\nDiurethane dimethacrylate: XM90H5\\nMethyl methacrylate: XM49C3\\nDiethanolamine: XM58E5\\nDiethylenetriamine: XM0L39\\nHexamethylenetetramine: XM2TA7\\nTriethylenetetramine: XM7QN7\\nBisphenol A: XM1GH9\\nCresylglycidylether: XM7AX9\\nBromonitropropanediol: XM1AH4\\nMercaptobenzothiazole: XM3TN8\\nEthylhexyl methoxycinnamate: XM2ZT3\\nOctocrylene: XM63U8\\nOctyltriazone: XM3YZ8\\nAminoethylisothiourium: XM8VV3\\nSodium cacodylate nonmedicinal: XM7W63\\nButylated hydroxyanisole: XM6GU7\\nCoenzyme A: XM2YA2\\nCogalactoisomerase: XM4S70\\nLactose as excipient: XM1X04\\nMethylethyl cellulose: XM82Y6\\nPentane: XM39E8\\nBenzisothiazolinone: XM2RB2\\nMethylenebismethyloxazolidine: XM6XV7\\nDMDM hydantoin: XM88M1\\nMethylchloroisothiazolinone and methylisothiazolinone: XM8DV5\\nMethylisothiazolinone: XM87J0\\nMethyldibromo glutaronitrile and phenoxyethanol: XM9NB7\\nMethyl parahydroxybenzoate: XM04A1\\nEthyl parahydroxybenzoate: XM1CG8\\nPropyl parahydroxybenzoate: XM0XV1\\nButyl parahydroxybenzoate: XM38K5\\nDiazolidinyl urea: XM51H6\\nImidazolidinyl urea: XM5TQ9\\nFentichlor: XM0562\\nSoldering fluid not elsewhere classified: XM6F66\\nBone meal: XM44A4\\nFungus eaten in food not elsewhere classified: XM77G6\\nClaviceps purpurea: XM00E5\\nNoxious meat non bacterial not elsewhere classified: XM4L77\\nAnimal protein: XM3825\\nChicken: XM9Y41\\nChicken feather: XM4500\\nCockatiel droppings: XM66A9\\nCockatiel feather: XM9LW5\\nCockatiel serum: XM9JZ2\\nEgg white: XM6AD6\\nWhole egg: XM2E06\\nEgg yolk: XM9CD1\\nGoose feather: XM2PB2\\nDuck feather: XM3LH5\\nFish: XM95M8\\nCodfish: XM6BL6\\nSalmon: XM8Q65\\nTuna: XM3QU9\\nHalibut: XM31E6\\nSardine: XM8Y82\\nTrout: XM64N8\\nCrab: XM5MB3\\nLobster: XM9JT3\\nShrimp: XM7E84\\nOyster: XM55Z4\\nOctopus: XM66P3\\nBlomia tropicalis: XM6ZC1\\nAmerican house dust mite: XM5AK3\\nDermatophagoides pteronyssinus: XM8BV4\\nMite dust: XM99T8\\nMosquito: XM0B91\\nAedes: XM95T4\\nAnopheles: XM7VF0\\nCulex: XM0ZZ8\\nMoth: XM3WD1\\nCockroach: XM0K01\\nAmerican cockroach: XM27E1\\nMilk: XM8RU4\\nCow milk: XM6RB2\\nGoat milk: XM4Y68\\nCheese: XM4JV9\\nCheese cheddar type: XM5GA5\\nCheese mold type: XM3FK1\\nEthylenediamine dihydrochloride: XM5T39\\nVarnish not elsewhere classified: XM15W5\\nSoot not elsewhere classified: XM6MC4\\nAromatic amine: XM4VX8\\nAntiseptic not elsewhere classified: XM6ZV1\\nBetanaphthylamine: XM60L2\\nHouse dust: XM76S9\\nWheat dust: XM7XM0\\nMain condition: XY0Y\\nMain resource condition: XY7B\\nInitial reason for encounter or admission: XY6E\\nPresent on admission: XY6M\\nDeveloped after admission: XY69\\nUncertain timing of onset relative to admission: XY85\\nPreoperative: XY9U\\nIntraoperative: XY9N\\nPostoperative: XY7V\\nDiagnosis confirmed by laboratory examination: XY3B\\nDiagnosis confirmed by serology: XY0E\\nDiagnosis confirmed by histology: XY9Q\\nDiagnosis confirmed by genetics: XY8K\\nDiagnosis confirmed by imaging: XY9R\\nDiagnosis confirmed by microscopy: XY19\\nDiagnosis confirmed by culture: XY0K\\nProvisional diagnosis: XY7Z\\nDifferential diagnosis: XY75\\nDelivered with or without mention of antepartum condition: XY3K\\nDelivered with mention of postpartum condition: XY8Q\\nAntepartum condition or complication: XY8U\\nPostpartum condition or complication: XY9P\\nUnspecified as to episode of care or not applicable: XY9S\\nInitial encounter: XY18\\nSubsequent encounter: XY8S\\nCondition of the fetus and newborn reported in the context of the mother: XX2QG9\\nFemale: XX2V25\\nMale: XX2UQ8\\nIntersex: XX45B7\\nBiological sex not specified: XX2PX3\\nCentral venous catheters: XD7FF9\\nStethoscopes: XD4ZY0\\nStethoscopes Binaural: XD8DB0\\nStethoscopes MRI: XD04L8\\nDialysis filters: XD8V84\\nHaemodialysis hemofiltration haemodiafiltration filters: XD8DD4\\nDialyzers UHF   mlhmmHg: XD1904\\nDialyzers UHF   mlhmmHg cellulose membranes: XD2T66\\nDialyzers UHF   mlhmmHg substituted cellulose membranes: XD4S95\\nDialyzers UHF   mlhmmHg synthetic membranes: XD4379\\nDialyzers UHF   mlhmmHg others: XD8UZ1\\nDialyzers UHF    mlhmmHg: XD4WX5\\nDialyzers UHF    mlhmmHg cellulose membranes: XD9RP1\\nDialyzers UHF    mlhmmHg substituted cellulose membranes: XD0XB0\\nDialyzers UHF    mlhmmHg synthetic membranes: XD2KD5\\nDialyzers UHF    mlhmmHg others: XD7ZP1\\nDialyzers for special hemodiafiltration and other therapies: XD8VS0\\nHemoperfusion filters: XD1V74\\nHemoperfusion carbon filters: XD27T5\\nHemoperfusion resin filters: XD2RV2\\nHemoperfusion filters others: XD9GN2\\nAbsorption filters and columns: XD5TA3\\nImmunoabsorption filters and columns: XD8NE7\\nImmunoabsorption filters: XD0TG6\\nImmunoabsorption columns: XD6RX5\\nEndotoxin removal filters and columns: XD3RD1\\nEndotoxin removal filters: XD5SV0\\nEndotoxin removal columns: XD6KC0\\nHaemodialysis filters others: XD5DX9\\nDialysis lines: XD6F86\\nDialysis lines haemodialysishaemofiltrationhaemodiafiltration: XD12J0\\nArterovenous dialysis lines one needle: XD5BR1\\nArterovenous dialysis lines two needles: XD0B51\\nReinfusion dialysis lines: XD5ED6\\nArterovenous dialysis lines accessories: XD8QE4\\nArterovenous dialysis lines others: XD0270\\nPeritoneal dialysis lines: XD65W3\\nPermanent peritoneal dialysis lines: XD51F1\\nPermanent peritoneal dialysis lines one bag CAPD: XD65K8\\nPermanent peritoneal dialysis lines two bags CAPD: XD6QD1\\nPermanent peritoneal dialysis lines others: XD0DE3\\nTemporary peritoneal dialysis lines: XD8H28\\nTemporary peritoneal dialysis lines gravimetric APD: XD6606\\nTemporary peritoneal dialysis lines with pump APD: XD89M1\\nTemporary peritoneal dialysis lines others: XD2M70\\nPeritoneal dialysis lines accessories: XD4SJ0\\nPeritoneal dialysis lines others: XD2WX9\\nDialysis lines others: XD0ZQ3\\nDialysis sets: XD83M2\\nHaemofiltrationhaemodiafiltration sets: XD0KV9\\nBiofiltration sets: XD0R67\\nHaemodialysis sets: XD6TC6\\nDialysis washingfilling sets: XD80S8\\nHemoperfusion sets: XD2QE7\\nContinuous dialysis sets: XD7QD7\\nUltrafiltration sets: XD5KR3\\nDialysis sets others: XD9Z50\\nDialysates: XD5C20\\nDialysates acid solutions: XD62N1\\nDialysates acid solutions nonsterile: XD3V66\\nDialysates acid solutions sterile: XD1KF2\\nDialysates basic solutions: XD0UL9\\nDialysates basic solutions powder: XD2JY9\\nDialysates basic solutions liquid: XD5240\\nDialysates without acetate buffer: XD6LX2\\nDialysates without acetate buffer AFB: XD9594\\nDialysates without acetate buffer other treatments: XD6W13\\nDialysis procedures salts: XD7157\\nDialysates others: XD67E6\\nDialysis devices various: XD8VC9\\nPeritoneal dialysis devices not in other groups: XD18U5\\nPeritoneal dialysis catheters: XD7RE0\\nPeritoneal dialysis others: XD47T0\\nVascular access devices only for haemodialysis: XD8689\\nTemporary haemodialysis catheters: XD9YY6\\nPermanent haemodialysis catheters: XD3AU4\\nVascular access devices only for haemodialysis others: XD3297\\nDialysis adaptors: XD2EM7\\nHaemodialysis adaptors: XD8Q72\\nPeritoneal dialysis adaptors: XD39M3\\nDialysate tanks collection and reinfusion: XD25C5\\nDialysate tanks collection: XD6LH4\\nHaemodialysate tanks collection: XD6MC0\\nPeritoneal dialysate tanks collection: XD22A9\\nDialysate tanks reinfusion: XD1ZR7\\nExtracorporeal dialysis devices: XD8A37\\nDialysis devices other accessories: XD9KW0\\nDialysis devices others: XD46Z0\\nNasogastric tube: XD53A5\\nNasopharyngeal tubes: XD9246\\nAirway guedel tubes: XD2M69\\nLaryngeal masks: XD78N3\\nEndotracheal tubes without cuff: XD0T92\\nEndotracheal tubes with cuff: XD37X2\\nEndotracheal tubes accessories: XD3UM6\\nTracheolaryngostomy cannulas and kits with cuff: XD2MG6\\nBipapCPAP circuits: XD7EB1\\nRespiratory masks and balloons singleuse and reusable: XD5GF6\\nAiroxygen masks and nasal cannulas: XD3W67\\nAiroxygen masks: XD0VQ3\\nVenturi masks: XD5RM4\\nAiroxygen nasal cannulas: XD61Z5\\nOxygen administration tubings: XD5AL4\\nHandoperated ventilation balloons: XD51T0\\nVentilation filters antibacterial and antiviral moisturizer: XD9AF0\\nRespiratory suction probes and systems: XD35D5\\nHumidifying systems oxygen administration: XD76M0\\nExamination  treatment gloves nitrile: XD3ZH8\\nSurgical drapes: XD3LV8\\nSurgical gowns standard: XD4E80\\nStandard surgical face masks: XD9LJ2\\nUrological catheters selfretained: XD1ZP3\\nElectronic thermometers and end caps: XD2AJ4\\nClinical trays and bowls: XD97L1\\nCREACTIVE PROTEIN: XD5GV0\\nTransport media: XD9YL7\\nCoronavirusNA Reagents: XD9S44\\nCoronavirus diagnostic: XD9N16\\nOther Virology RT  POC: XD7M68\\nReagents for DNA andor RNA extraction and preparation  bacteria andor virus: XD1C76\\nBlood gas portable analysers: XD6EG0\\nSamples transport containers other: XD80L4\\nUltrasound Scanners: XD6EX8\\nUltrasound Scanners Mobile: XD89G9\\nUltrasound Scanners Portable: XD7FU9\\nUltrasound Scanners Handheld: XD4T57\\nBulk steam sterilizing units: XD8DR8\\nLaryngoscopes: XD0U91\\nVideolaryngoscopes: XD3JX1\\nContinuous positive airway pressure units CPAP: XD7EC8\\nTransportable ventilators: XD60Z6\\nIntensive care ventilators: XD3SM4\\nPortable multiparameter patient monitors: XD4KU3\\nPulse Oximeters: XD66D8\\nPulse Oximeters Tabletop: XD8QN4\\nPulse Oximeters Handheld: XD4U89\\nPulse Oximeters Spotcheck: XD5QV8\\nInfusion Pumps: XD8QY1\\nInfusion Pumps Volumetric: XD4CT3\\nInfusion Pumps Volumetric Nuclear Magnetic Resonance: XD52M6\\nInfusion Pumps Enteral nutrition: XD8DH3\\nInfusion Pumps Syringe: XD36Q1\\nInfusion Pumps Syringe Nuclear Magnetic Resonance: XD1N14\\nMedicalmedicinal gas systems and relative accessories: XD80Z7\\nGeneral purpose electrocardiographs: XD4U38\\nOxygen Concentrators: XD6UU3'"
            ]
          },
          "execution_count": 19,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "lab_test_mapping_str"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 20,
      "metadata": {
        "id": "I8WdBeX29U8u"
      },
      "outputs": [],
      "source": [
        "\n",
        "\n",
        "# Format the prompt\n",
        "prompt = prompt_template.format(\n",
        "    lab_test_mapping=lab_test_mapping_str,\n",
        "    extracted_tests=\"\\n\".join(extracted_lab_tests))\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 21,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 165
        },
        "id": "IT2c_TvD9U8v",
        "outputId": "6f753ec4-f292-49c7-c802-6ab0e89ee0b8"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "'\\nYou are an expert in medical diagnostics. Below is a list of lab tests with their corresponding ICD codes:\\n\\nCholera: 1A00\\nIntestinal infection due to other Vibrio: 1A01\\nIntestinal infections due to Shigella: 1A02\\nIntestinal infections due to Escherichia coli: 1A03\\nEnteropathogenic Escherichia coli infection: 1A03.0\\nEnterotoxigenic Escherichia coli infection: 1A03.1\\nEnteroinvasive Escherichia coli infection: 1A03.2\\nEnterohaemorrhagic Escherichia coli infection: 1A03.3\\nIntestinal infections due to other specified Escherichia coli: 1A03.Y\\nIntestinal infections due to Escherichia coli unspecified: 1A03.Z\\nIntestinal infections due to Clostridioides difficile: 1A04\\nIntestinal infections due to Yersinia enterocolitica: 1A05\\nGastroenteritis due to Campylobacter: 1A06\\nTyphoid fever: 1A07\\nTyphoid peritonitis: 1A07.0\\nOther specified typhoid fever: 1A07.Y\\nTyphoid fever unspecified: 1A07.Z\\nParatyphoid fever: 1A08\\nInfections due to other Salmonella: 1A09\\nSalmonella enteritis: 1A09.0\\nInfections due to other Salmonella in other organs: 1A09.Y\\nSalmonella infection unspecified: 1A09.Z\\nOther specified bacterial intestinal infections: 1A0Y\\nBacterial intestinal infections unspecified: 1A0Z\\nFoodborne staphylococcal intoxication: 1A10\\nBotulism: 1A11\\nFoodborne intoxication by botulinum toxin: 1A11.0\\nOther forms of botulism: 1A11.1\\nBotulism unspecified: 1A11.Z\\nFoodborne Clostridium perfringens intoxication: 1A12\\nFoodborne Bacillus cereus intoxication: 1A13\\nOther specified bacterial foodborne intoxications: 1A1Y\\nBacterial foodborne intoxications unspecified: 1A1Z\\nEnteritis due to Adenovirus: 1A20\\nGastroenteritis due to Astrovirus: 1A21\\nGastroenteritis due to Rotavirus: 1A22\\nEnteritis due to Norovirus: 1A23\\nIntestinal infections due to Cytomegalovirus: 1A24\\nOther specified viral intestinal infections: 1A2Y\\nViral intestinal infections unspecified: 1A2Z\\nInfections due to Balantidium coli: 1A30\\nGiardiasis: 1A31\\nCryptosporidiosis: 1A32\\nCystoisosporiasis: 1A33\\nCystoisosporiasis of small intestine: 1A33.0\\nCystoisosporiasis of colon: 1A33.1\\nOther specified cystoisosporiasis: 1A33.Y\\nCystoisosporiasis unspecified: 1A33.Z\\nSarcocystosis: 1A34\\nBlastocystosis: 1A35\\nAmoebiasis: 1A36\\nIntestinal infections due to Entamoeba: 1A36.0\\nAcute amoebiasis: 1A36.00\\nAmoeboma of intestine: 1A36.01\\nOther specified intestinal infections due to Entamoeba: 1A36.0Y\\nIntestinal infections due to Entamoeba unspecified: 1A36.0Z\\nExtraintestinal infections due to Entamoeba: 1A36.1\\nAmoebic liver abscess: 1A36.10\\nAmoebic lung abscess: 1A36.11\\nCutaneous amoebiasis: 1A36.12\\nAmoebiasis of other specified sites: 1A36.1Y\\nAmoebiasis unspecified: 1A36.Z\\nOther specified protozoal intestinal infections: 1A3Y\\nProtozoal intestinal infections unspecified: 1A3Z\\nGastroenteritis or colitis without specification of infectious agent: 1A40\\nGastroenteritis or colitis without specification of origin: 1A40.0\\nInfectious gastroenteritis or colitis without specification of infectious agent: 1A40.Z\\nCongenital syphilis: 1A60\\nEarly congenital syphilis symptomatic: 1A60.0\\nEarly congenital syphilis latent: 1A60.1\\nLate congenital syphilitic oculopathy: 1A60.2\\nLate congenital neurosyphilis: 1A60.3\\nOther late congenital syphilis symptomatic: 1A60.4\\nLate congenital syphilis latent: 1A60.5\\nCongenital syphilis unspecified: 1A60.Z\\nEarly syphilis: 1A61\\nPrimary genital syphilis: 1A61.0\\nPrimary anal syphilis: 1A61.1\\nPrimary syphilis of other sites: 1A61.2\\nSecondary syphilis of skin or mucous membranes: 1A61.3\\nSecondary syphilis of other sites: 1A61.4\\nLatent early syphilis: 1A61.5\\nOther specified early syphilis: 1A61.Y\\nEarly syphilis unspecified: 1A61.Z\\nLate syphilis: 1A62\\nNeurosyphilis: 1A62.0\\nAsymptomatic neurosyphilis: 1A62.00\\nSymptomatic late neurosyphilis: 1A62.01\\nNeurosyphilis unspecified: 1A62.0Z\\nCardiovascular late syphilis: 1A62.1\\nSymptomatic late syphilis of other sites: 1A62.2\\nOcular late syphilis: 1A62.20\\nLate syphilis involving the musculoskeletal system: 1A62.21\\nLate syphilis of skin or mucous membranes: 1A62.22\\nSymptomatic late syphilis of other specified sites: 1A62.2Y\\nSymptomatic late syphilis of unspecified site: 1A62.2Z\\nOther specified late syphilis: 1A62.Y\\nLate syphilis unspecified: 1A62.Z\\nLatent syphilis unspecified as early or late: 1A63\\nSyphilis unspecified: 1A6Z\\nGonococcal genitourinary infection: 1A70\\nGonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess: 1A70.0\\nGonorrhoea of penis: 1A70.00\\nOther specified gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess: 1A70.0Y\\nGonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess unspecified: 1A70.0Z\\nGonococcal infection of lower genitourinary tract with periurethral or accessory gland abscess: 1A70.1\\nGonococcal infection of other specified genitourinary organ: 1A70.Y\\nGonococcal genitourinary infection unspecified: 1A70.Z\\nGonococcal pelviperitonitis: 1A71\\nGonococcal infection of other sites: 1A72\\nGonococcal infection of musculoskeletal system: 1A72.0\\nGonococcal infection of rectum: 1A72.1\\nGonococcal infection of anus: 1A72.2\\nGonococcal pharyngitis: 1A72.3\\nGonococcal infection of eye: 1A72.4\\nGonococcal infection of other specified sites: 1A72.Y\\nDisseminated gonococcal infection: 1A73\\nGonococcal infection unspecified: 1A7Z\\nChlamydial lymphogranuloma: 1A80\\nNonulcerative sexually transmitted chlamydial infection: 1A81\\nChlamydial infection of lower genitourinary tract: 1A81.0\\nChlamydial infection of internal reproductive organs: 1A81.1\\nNonulcerative sexually transmitted chlamydial infection of other specified site: 1A81.Y\\nNonulcerative sexually transmitted chlamydial infection of unspecified site: 1A81.Z\\nOther specified sexually transmissible infections due to chlamydia: 1A8Y\\nSexually transmissible infections due to chlamydia unspecified: 1A8Z\\nChancroid: 1A90\\nGranuloma inguinale: 1A91\\nTrichomoniasis: 1A92\\nSexually transmissible infestations: 1A93\\nAnogenital herpes simplex infection: 1A94\\nHerpes simplex infection of genitalia or urogenital tract: 1A94.0\\nHerpes simplex infection of perianal skin or rectum: 1A94.1\\nAnogenital herpes simplex infection without further specification: 1A94.Z\\nAnogenital warts: 1A95\\nAnal warts: 1A95.0\\nGenital warts: 1A95.1\\nExtragenital condylomata acuminata: 1A95.2\\nAnogenital warts unspecified: 1A95.Z\\nOther specified predominantly sexually transmitted infections: 1A9Y\\nPredominantly sexually transmitted infections unspecified: 1A9Z\\nTuberculosis of the respiratory system: 1B10\\nRespiratory tuberculosis confirmed: 1B10.0\\nRespiratory tuberculosis not confirmed: 1B10.1\\nRespiratory tuberculosis without mention of bacteriological or histological confirmation: 1B10.Z\\nTuberculosis of the nervous system: 1B11\\nTuberculous meningitis: 1B11.0\\nTuberculous meningoencephalitis: 1B11.1\\nMeningeal tuberculoma: 1B11.2\\nTuberculous granuloma of brain: 1B11.3\\nOther tuberculosis of nervous system: 1B11.Y\\nTuberculosis of the nervous system unspecified: 1B11.Z\\nTuberculosis of other systems and organs: 1B12\\nTuberculosis of heart: 1B12.0\\nTuberculosis of eye: 1B12.1\\nTuberculosis of ear: 1B12.2\\nTuberculosis of endocrine glands: 1B12.3\\nTuberculosis of the musculoskeletal system: 1B12.4\\nTuberculosis of bones or joints: 1B12.40\\nTuberculous myositis: 1B12.41\\nTuberculosis of other specified part of the musculoskeletal system: 1B12.4Y\\nTuberculosis of the musculoskeletal system unspecified: 1B12.4Z\\nTuberculosis of the genitourinary system: 1B12.5\\nTuberculous peripheral lymphadenopathy: 1B12.6\\nTuberculosis of the digestive system: 1B12.7\\nCutaneous tuberculosis: 1B12.8\\nTuberculosis of other specified organ or site: 1B12.Y\\nMiliary tuberculosis: 1B13\\nAcute miliary tuberculosis of a single specified site: 1B13.0\\nAcute miliary tuberculosis of multiple sites: 1B13.1\\nAcute miliary tuberculosis unspecified site: 1B13.2\\nOther specified miliary tuberculosis: 1B13.Y\\nMiliary tuberculosis unspecified: 1B13.Z\\nLatent tuberculosis: 1B14\\nOther specified tuberculosis: 1B1Y\\nTuberculosis unspecified: 1B1Z\\nLeprosy: 1B20\\nPaucibacillary leprosy: 1B20.0\\nMultibacillary leprosy: 1B20.1\\nLeprosy reactions: 1B20.2\\nType I leprosy reaction: 1B20.20\\nType II leprosy reaction: 1B20.21\\nComplications of leprosy: 1B20.3\\nLeprosy unspecified: 1B20.Z\\nInfections due to nontuberculous mycobacteria: 1B21\\nPulmonary infection due to nontuberculous mycobacterium: 1B21.0\\nNontuberculous mycobacterial lymphadenitis: 1B21.1\\nCutaneous nontuberculous mycobacterial infection: 1B21.2\\nMycobacterium ulcerans infection: 1B21.20\\nCutaneous infection due to other specified nontuberculous mycobacteria: 1B21.2Y\\nCutaneous infection due to unspecified nontuberculous mycobacteria: 1B21.2Z\\nDisseminated nontuberculous mycobacterial infection: 1B21.3\\nGastrointestinal nontuberculous mycobacterial infection: 1B21.4\\nNontuberculous mycobacterial infection of other specified site: 1B21.Y\\nNontuberculous mycobacterial infection of unspecified site: 1B21.Z\\nOther specified mycobacterial diseases: 1B2Y\\nMycobacterial diseases unspecified: 1B2Z\\nAcute rheumatic fever without mention of heart involvement: 1B40\\nRheumatic arthritis acute or subacute: 1B40.0\\nOther specified acute rheumatic fever without mention of heart involvement: 1B40.Y\\nAcute rheumatic fever without mention of heart involvement unspecified: 1B40.Z\\nAcute rheumatic fever with heart involvement: 1B41\\nAcute rheumatic pericarditis: 1B41.0\\nAcute rheumatic endocarditis: 1B41.1\\nRheumatic aortitis: 1B41.10\\nOther specified acute rheumatic endocarditis: 1B41.1Y\\nAcute rheumatic endocarditis unspecified: 1B41.1Z\\nAcute rheumatic myocarditis: 1B41.2\\nOther acute rheumatic heart disease: 1B41.Y\\nAcute rheumatic heart disease unspecified: 1B41.Z\\nRheumatic chorea: 1B42\\nScarlet fever: 1B50\\nStreptococcal pharyngitis: 1B51\\nMeningitis due to Streptococcus: 1B53\\nMeningitis due to Staphylococcus: 1B54\\nOther specified staphylococcal or streptococcal diseases: 1B5Y\\nStaphylococcal or streptococcal diseases unspecified: 1B5Z\\nBacterial cellulitis erysipelas or lymphangitis: 1B70\\nErysipelas: 1B70.0\\nErysipelas of face: 1B70.00\\nErysipelas of external ear: 1B70.01\\nErysipelas of lower limb: 1B70.02\\nErysipelas of other specified site: 1B70.0Y\\nErysipelas unspecified: 1B70.0Z\\nStreptococcal cellulitis of skin: 1B70.1\\nStaphylococcal cellulitis of skin: 1B70.2\\nAscending bacterial lymphangitis: 1B70.3\\nBacterial cellulitis or lymphangitis due to other specified bacterium: 1B70.Y\\nBacterial cellulitis or lymphangitis due to unspecified bacterium: 1B70.Z\\nNecrotising fasciitis: 1B71\\nStreptococcal necrotising fasciitis: 1B71.0\\nPolymicrobial necrotising fasciitis: 1B71.1\\nNeonatal necrotising fasciitis: 1B71.2\\nNecrotising fasciitis due to other specified bacterial infection: 1B71.Y\\nNecrotising fasciitis unspecified: 1B71.Z\\nImpetigo: 1B72\\nBullous impetigo: 1B72.0\\nNonbullous impetigo: 1B72.1\\nSecondary impetiginisation of the skin: 1B72.2\\nOther specified impetigo: 1B72.Y\\nImpetigo unspecified: 1B72.Z\\nEcthyma: 1B73\\nStreptococcal ecthyma: 1B73.0\\nStaphylococcal ecthyma: 1B73.1\\nEcthyma gangrenosum: 1B73.2\\nOther specified ecthyma: 1B73.Y\\nEcthyma unspecified: 1B73.Z\\nSuperficial bacterial folliculitis: 1B74\\nStaphylococcus aureus superficial folliculitis: 1B74.0\\nSuperficial bacterial folliculitis due to other specified organism: 1B74.Y\\nSuperficial bacterial folliculitis due to unspecified organism: 1B74.Z\\nDeep bacterial folliculitis or pyogenic abscess of the skin: 1B75\\nFuruncle: 1B75.0\\nCarbuncle: 1B75.1\\nFurunculosis: 1B75.2\\nPyogenic abscess of the skin: 1B75.3\\nChronic deep bacterial folliculitis: 1B75.4\\nDeep bacterial folliculitis or pyogenic abscess of the skin unspecified: 1B75.Z\\nOther specified pyogenic bacterial infection of skin or subcutaneous tissue: 1B7Y\\nPyogenic bacterial infection of skin or subcutaneous tissue unspecified: 1B7Z\\nRatbite fevers: 1B90\\nSpirillosis: 1B90.0\\nStreptobacillosis: 1B90.1\\nLeptospirosis: 1B91\\nGlanders: 1B92\\nPlague: 1B93\\nBubonic plague: 1B93.0\\nCellulocutaneous plague: 1B93.1\\nPneumonic plague: 1B93.2\\nPlague meningitis: 1B93.3\\nOther specified plague: 1B93.Y\\nPlague unspecified: 1B93.Z\\nTularaemia: 1B94\\nUlceroglandular tularaemia: 1B94.0\\nOther specified tularaemia: 1B94.Y\\nTularaemia unspecified: 1B94.Z\\nBrucellosis: 1B95\\nErysipeloid: 1B96\\nAnthrax: 1B97\\nCatscratch disease: 1B98\\nPasteurellosis: 1B99\\nExtraintestinal yersiniosis: 1B9A\\nUnspecified zoonotic bacterial disease: 1B9Z\\nActinomycosis: 1C10\\nPulmonary actinomycosis: 1C10.0\\nAbdominal actinomycosis: 1C10.1\\nCervicofacial actinomycosis: 1C10.2\\nPrimary cutaneous actinomycosis: 1C10.3\\nOther specified forms of actinomycosis: 1C10.Y\\nActinomycosis unspecified: 1C10.Z\\nBartonellosis: 1C11\\nCarrion disease: 1C11.0\\nOroya fever: 1C11.00\\nVerruga peruana: 1C11.01\\nTrench fever: 1C11.1\\nOther forms of bartonellosis: 1C11.Y\\nBartonellosis unspecified: 1C11.Z\\nWhooping cough: 1C12\\nWhooping cough due to Bordetella pertussis: 1C12.0\\nWhooping cough due to Bordetella parapertussis: 1C12.1\\nOther specified whooping cough: 1C12.Y\\nWhooping cough unspecified: 1C12.Z\\nTetanus: 1C13\\nObstetrical tetanus: 1C14\\nTetanus neonatorum: 1C15\\nGas gangrene: 1C16\\nDiphtheria: 1C17\\nPharyngeal or tonsillar diphtheria: 1C17.0\\nPostdiphtheritic paralysis of uvula: 1C17.00\\nOther specified pharyngeal or tonsillar diphtheria: 1C17.0Y\\nPharyngeal or tonsillar diphtheria unspecified: 1C17.0Z\\nNasal diphtheria: 1C17.1\\nLaryngeal diphtheria: 1C17.2\\nCutaneous diphtheria: 1C17.3\\nOther specified diphtheria: 1C17.Y\\nDiphtheria unspecified: 1C17.Z\\nBrazilian purpuric fever: 1C18\\nLegionellosis: 1C19\\nNonpneumonic Legionnaires disease: 1C19.0\\nLegionnaires disease: 1C19.1\\nLegionellosis unspecified: 1C19.Z\\nListeriosis: 1C1A\\nCutaneous listeriosis: 1C1A.0\\nListerial meningitis or meningoencephalitis: 1C1A.1\\nOther specified listeriosis: 1C1A.Y\\nListeriosis unspecified: 1C1A.Z\\nNocardiosis: 1C1B\\nPulmonary nocardiosis: 1C1B.0\\nCutaneous nocardiosis: 1C1B.1\\nOther specified forms of nocardiosis: 1C1B.Y\\nNocardiosis unspecified: 1C1B.Z\\nMeningococcal disease: 1C1C\\nMeningococcal meningitis: 1C1C.0\\nWaterhouseFriderichsen syndrome: 1C1C.1\\nMeningococcaemia: 1C1C.2\\nAcute meningococcaemia: 1C1C.20\\nOther specified meningococcaemia: 1C1C.2Y\\nMeningococcaemia unspecified: 1C1C.2Z\\nOther specified meningococcal disease: 1C1C.Y\\nMeningococcal disease unspecified: 1C1C.Z\\nYaws: 1C1D\\nPrimary yaws: 1C1D.0\\nSecondary yaws: 1C1D.1\\nTertiary yaws: 1C1D.2\\nLatent yaws: 1C1D.3\\nYaws unspecified: 1C1D.Z\\nPinta: 1C1E\\nPrimary lesions of pinta: 1C1E.0\\nIntermediate lesions of pinta: 1C1E.1\\nLate lesions of pinta: 1C1E.2\\nMixed lesions of pinta: 1C1E.3\\nPinta unspecified: 1C1E.Z\\nEndemic nonvenereal syphilis: 1C1F\\nLyme borreliosis: 1C1G\\nEarly cutaneous Lyme borreliosis: 1C1G.0\\nDisseminated Lyme borreliosis: 1C1G.1\\nLyme neuroborreliosis: 1C1G.10\\nLyme carditis: 1C1G.11\\nOphthalmic Lyme borreliosis: 1C1G.12\\nLyme arthritis: 1C1G.13\\nLate cutaneous Lyme borreliosis: 1C1G.14\\nOther specified disseminated Lyme borreliosis: 1C1G.1Y\\nDisseminated Lyme borreliosis unspecified: 1C1G.1Z\\nOther specified Lyme borreliosis: 1C1G.Y\\nLyme borreliosis unspecified: 1C1G.Z\\nNecrotising ulcerative gingivitis: 1C1H\\nOther Vincent infections: 1C1H.0\\nOther specified necrotising ulcerative gingivitis: 1C1H.Y\\nNecrotising ulcerative gingivitis unspecified: 1C1H.Z\\nRelapsing fever: 1C1J\\nTickborne relapsing fever: 1C1J.0\\nLouseborne relapsing fever: 1C1J.1\\nRelapsing fever unspecified: 1C1J.Z\\nChlamydial conjunctivitis: 1C20\\nChlamydial peritonitis: 1C21\\nInfections due to Chlamydia psittaci: 1C22\\nTrachoma: 1C23\\nInitial stage of trachoma: 1C23.0\\nActive stage of trachoma: 1C23.1\\nOther specified trachoma: 1C23.Y\\nTrachoma unspecified: 1C23.Z\\nOther specified diseases due to chlamydiae: 1C2Y\\nDiseases due to chlamydiae unspecified: 1C2Z\\nTyphus fever: 1C30\\nEpidemic louseborne typhus fever due to Rickettsia prowazekii: 1C30.0\\nRecrudescent typhus: 1C30.1\\nTyphus fever due to Rickettsia typhi: 1C30.2\\nTyphus fever due to Orientia tsutsugamushi: 1C30.3\\nOther specified typhus fever: 1C30.Y\\nTyphus fever unspecified: 1C30.Z\\nSpotted fever: 1C31\\nSpotted fever due to Rickettsia rickettsii: 1C31.0\\nSpotted fever due to Rickettsia conorii: 1C31.1\\nSpotted fever due to Rickettsia sibirica: 1C31.2\\nSpotted fever due to Rickettsia australis: 1C31.3\\nOther specified spotted fever: 1C31.Y\\nSpotted fever unspecified: 1C31.Z\\nRickettsialpox: 1C32\\nQ fever: 1C33\\nOther specified rickettsioses: 1C3Y\\nRickettsioses unspecified: 1C3Z\\nCampylobacteriosis: 1C40\\nBacterial infection of unspecified site: 1C41\\nMelioidosis: 1C42\\nActinomycetoma: 1C43\\nNonpyogenic bacterial infections of the skin: 1C44\\nToxic shock syndrome: 1C45\\nStreptococcal toxic shock syndrome: 1C45.0\\nStaphylococcal toxic shock syndrome: 1C45.1\\nToxic shock syndrome due to other specified infectious agent: 1C45.Y\\nToxic shock syndrome without specified infectious agent: 1C45.Z\\nOther specified bacterial diseases: 1C4Y\\nUnspecified bacterial disease: 1C4Z\\nHuman immunodeficiency virus disease associated with tuberculosis: 1C60\\nHIV disease clinical stage  associated with tuberculosis: 1C60.3\\nKaposi sarcoma associated with human immunodeficiency virus disease associated with tuberculosis: 1C60.30\\nOther specified HIV disease clinical stage  associated with tuberculosis: 1C60.3Y\\nHIV disease clinical stage  associated with tuberculosis unspecified: 1C60.3Z\\nHuman immunodeficiency virus disease associated with tuberculosis clinical stage unspecified: 1C60.Z\\nHuman immunodeficiency virus disease associated with malaria: 1C61\\nHIV disease clinical stage  associated with malaria: 1C61.3\\nKaposi sarcoma associated with human immunodeficiency virus disease associated with malaria: 1C61.30\\nOther specified HIV disease clinical stage  associated with malaria: 1C61.3Y\\nHIV disease clinical stage  associated with malaria unspecified: 1C61.3Z\\nHuman immunodeficiency virus disease associated with malaria clinical stage unspecified: 1C61.Z\\nHuman immunodeficiency virus disease without mention of tuberculosis or malaria: 1C62\\nHIV disease clinical stage  without mention of tuberculosis or malaria: 1C62.3\\nKaposi sarcoma associated with human immunodeficiency virus disease without mention of tuberculosis or malaria: 1C62.30\\nOther specified HIV disease clinical stage  without mention of tuberculosis or malaria: 1C62.3Y\\nHIV disease clinical stage  without mention of tuberculosis or malaria unspecified: 1C62.3Z\\nHuman immunodeficiency virus disease without mention of tuberculosis or malaria clinical stage unspecified: 1C62.Z\\nViral encephalitis not elsewhere classified: 1C80\\nAcute poliomyelitis: 1C81\\nRabies: 1C82\\nWestern equine encephalitis: 1C83\\nEastern equine encephalitis: 1C84\\nJapanese encephalitis: 1C85\\nSt Louis encephalitis: 1C86\\nRocio viral encephalitis: 1C87\\nMurray Valley encephalitis: 1C88\\nCalifornia encephalitis: 1C8B\\nVenezuelan equine encephalitis: 1C8C\\nLa Crosse encephalitis: 1C8D\\nViral meningitis not elsewhere classified: 1C8E\\nEnteroviral meningitis: 1C8E.1\\nMeningitis due to adenovirus: 1C8E.2\\nOther specified viral meningitis not elsewhere classified: 1C8E.Y\\nViral meningitis unspecified: 1C8E.Z\\nLymphocytic choriomeningitis: 1C8F\\nTickborne encephalitis: 1C8G\\nFar Eastern tickborne encephalitis: 1C8G.0\\nCentral European tickborne encephalitis: 1C8G.1\\nSiberian tickborne encephalitis: 1C8G.2\\nTickborne encephalitis unspecified: 1C8G.Z\\nViral myelitis not elsewhere classified: 1C8H\\nOther specified viral infections of the central nervous system: 1C8Y\\nViral infections of the central nervous system unspecified: 1C8Z\\nInfectious encephalitis not elsewhere classified: 1D00\\nBacterial encephalitis: 1D00.0\\nFungal encephalitis: 1D00.1\\nParasitic or protozoal encephalitis: 1D00.2\\nOther specified infectious encephalitis not elsewhere classified: 1D00.Y\\nInfectious encephalitis unspecified: 1D00.Z\\nInfectious meningitis not elsewhere classified: 1D01\\nBacterial meningitis: 1D01.0\\nMeningitis due to Haemophilus influenzae: 1D01.00\\nOther specified bacterial meningitis: 1D01.0Y\\nBacterial meningitis unspecified: 1D01.0Z\\nFungal meningitis: 1D01.1\\nParasitic or protozoal meningitis: 1D01.2\\nBenign recurrent meningitis: 1D01.3\\nOther specified infectious meningitis not elsewhere classified: 1D01.Y\\nInfectious meningitis unspecified: 1D01.Z\\nInfectious myelitis not elsewhere classified: 1D02\\nBacterial myelitis: 1D02.0\\nFungal myelitis: 1D02.2\\nParasitic myelitis: 1D02.3\\nOther specified infectious myelitis not elsewhere classified: 1D02.Y\\nInfectious myelitis unspecified: 1D02.Z\\nInfectious abscess of the central nervous system: 1D03\\nIntraspinal intramedullary abscess: 1D03.0\\nIntraspinal subdural abscess: 1D03.1\\nIntraspinal extradural abscess: 1D03.2\\nIntracranial abscess: 1D03.3\\nDeep cerebral hemispheric abscess: 1D03.30\\nAbscess of the corpus callosum: 1D03.31\\nPituitary abscess: 1D03.32\\nMultiple or widespread intracranial abscess: 1D03.33\\nOther specified intracranial abscess: 1D03.3Y\\nIntracranial abscess unspecified: 1D03.3Z\\nIntraspinal epidural abscess: 1D03.4\\nSpinal cord abscess: 1D03.5\\nOther specified site of infectious abscess of the central nervous system: 1D03.Y\\nInfectious abscess of the central nervous system site unspecified: 1D03.Z\\nInfectious granulomas of the central nervous system: 1D04\\nParasitic intracerebral granuloma: 1D04.0\\nIntracranial granuloma: 1D04.1\\nFungal intracranial granuloma: 1D04.10\\nOther specified intracranial granuloma: 1D04.1Y\\nIntracranial granuloma unspecified: 1D04.1Z\\nIntraspinal intramedullary granuloma: 1D04.2\\nIntraspinal subdural granuloma: 1D04.3\\nIntraspinal extradural granuloma: 1D04.4\\nIntraspinal epidural granuloma: 1D04.5\\nOther specified site of infectious granulomas of the central nervous system: 1D04.Y\\nInfectious granulomas of the central nervous system site unspecified: 1D04.Z\\nInfectious cysts of the central nervous system: 1D05\\nEpidural infectious cyst: 1D05.0\\nSubdural infectious cyst: 1D05.1\\nOther specified infectious cysts of the central nervous system: 1D05.Y\\nInfectious cysts of the central nervous system unspecified: 1D05.Z\\nOther specified nonviral and unspecified infections of the central nervous system: 1D0Y\\nNonviral and unspecified infections of the central nervous system unspecified: 1D0Z\\nDengue without warning signs: 1D20\\nDengue with warning signs: 1D21\\nSevere dengue: 1D22\\nDengue fever unspecified: 1D2Z\\nChikungunya virus disease: 1D40\\nColorado tick fever: 1D41\\nOnyongnyong fever: 1D42\\nOropouche virus disease: 1D43\\nRift Valley fever: 1D44\\nSandfly fever: 1D45\\nWest Nile virus infection: 1D46\\nYellow fever: 1D47\\nZika virus disease: 1D48\\nCrimeanCongo haemorrhagic fever: 1D49\\nOmsk haemorrhagic fever: 1D4A\\nKyasanur Forest disease: 1D4B\\nAlkhurma haemorrhagic fever: 1D4C\\nRoss River disease: 1D4D\\nSevere fever with thrombocytopenia syndrome: 1D4E\\nOther specified arthropodborne viral fevers: 1D4Y\\nArthropodborne viral fever virus unspecified: 1D4Z\\nFilovirus disease: 1D60\\nEbola disease: 1D60.0\\nBundibugyo virus disease: 1D60.00\\nEbola virus disease: 1D60.01\\nSudan virus disease: 1D60.02\\nAtypical Ebola disease: 1D60.03\\nOther specified Ebola disease: 1D60.0Y\\nEbola disease virus unspecified: 1D60.0Z\\nMarburg disease: 1D60.1\\nMarburg virus disease: 1D60.10\\nAtypical Marburg disease: 1D60.11\\nOther specified Marburg disease: 1D60.1Y\\nMarburg disease virus unspecified: 1D60.1Z\\nOther specified filovirus disease: 1D60.Y\\nFilovirus disease virus unspecified: 1D60.Z\\nArenavirus disease: 1D61\\nArgentinian haemorrhagic fever: 1D61.0\\nBolivian haemorrhagic fever: 1D61.1\\nLassa fever: 1D61.2\\nVenezuelan haemorrhagic fever: 1D61.3\\nOther specified arenavirus disease: 1D61.Y\\nArenavirus disease unspecified: 1D61.Z\\nHantavirus disease: 1D62\\nHaemorrhagic fever with renal syndrome: 1D62.0\\nHantavirus pulmonary syndrome: 1D62.1\\nAtypical hantavirus disease: 1D62.2\\nOther specified hantavirus disease: 1D62.Y\\nHantavirus disease unspecified: 1D62.Z\\nHenipavirus encephalitis: 1D63\\nMiddle East respiratory syndrome: 1D64\\nSevere acute respiratory syndrome: 1D65\\nOther specified zoonotic viral diseases: 1D6Y\\nZoonotic viral disease virus unspecified: 1D6Z\\nMumps: 1D80\\nMumps without complication: 1D80.0\\nOrchitis due to mumps virus: 1D80.1\\nMeningitis due to mumps virus: 1D80.2\\nEncephalitis due to mumps virus: 1D80.3\\nPancreatitis due to mumps virus: 1D80.4\\nOther specified mumps: 1D80.Y\\nInfectious mononucleosis: 1D81\\nMononucleosis due to EpsteinBarr virus: 1D81.0\\nMononucleosis due to cytomegalovirus: 1D81.1\\nOther specified infectious mononucleosis: 1D81.Y\\nInfectious mononucleosis unspecified: 1D81.Z\\nCytomegaloviral disease: 1D82\\nCytomegaloviral hepatitis: 1D82.0\\nCytomegaloviral pancreatitis: 1D82.1\\nOther specified cytomegaloviral disease: 1D82.Y\\nCytomegaloviral disease unspecified: 1D82.Z\\nEpidemic myalgia: 1D83\\nViral conjunctivitis: 1D84\\nConjunctivitis due to adenovirus: 1D84.0\\nAcute epidemic haemorrhagic conjunctivitis: 1D84.1\\nOther specified viral conjunctivitis: 1D84.Y\\nViral conjunctivitis unspecified: 1D84.Z\\nViral carditis: 1D85\\nDilated cardiomyopathy secondary to viral myocarditis: 1D85.0\\nAcute viral carditis: 1D85.1\\nChronic viral carditis: 1D85.2\\nAseptic myocarditis of newborn: 1D85.3\\nCoxsackie carditis: 1D85.4\\nOther specified viral carditis: 1D85.Y\\nViral carditis unspecified: 1D85.Z\\nViral haemorrhagic fever not elsewhere classified: 1D86\\nAdenovirus infection of unspecified site: 1D90\\nEnterovirus infection of unspecified site: 1D91\\nCoronavirus infection unspecified site: 1D92\\nParvovirus infection of unspecified site: 1D93\\nOther viral infections of unspecified site: 1D9Y\\nUnspecified viral infection of unspecified site: 1D9Z\\nOther specified viral diseases: 1E1Y\\nUnspecified viral disease: 1E1Z\\nInfluenza due to identified seasonal influenza virus: 1E30\\nInfluenza due to identified zoonotic or pandemic influenza virus: 1E31\\nInfluenza virus not identified: 1E32\\nAcute viral hepatitis: 1E50\\nAcute hepatitis A: 1E50.0\\nAcute hepatitis B: 1E50.1\\nAcute hepatitis C: 1E50.2\\nAcute hepatitis D: 1E50.3\\nAcute hepatitis E: 1E50.4\\nOther specified acute viral hepatitis: 1E50.Y\\nAcute viral hepatitis unspecified: 1E50.Z\\nChronic viral hepatitis: 1E51\\nChronic hepatitis B: 1E51.0\\nChronic hepatitis B with human immunodeficiency virus coinfection: 1E51.00\\nOther specified chronic hepatitis B: 1E51.0Y\\nChronic hepatitis B unspecified: 1E51.0Z\\nChronic hepatitis C: 1E51.1\\nChronic hepatitis D: 1E51.2\\nChronic hepatitis E: 1E51.3\\nOther specified chronic viral hepatitis: 1E51.Y\\nChronic viral hepatitis unspecified: 1E51.Z\\nViral hepatitis unspecified: 1E5Z\\nSmallpox: 1E70\\nMpox: 1E71\\nCowpox: 1E72\\nVaccinia: 1E73\\nBuffalopox: 1E74\\nOrf: 1E75\\nMolluscum contagiosum: 1E76\\nOther specified infections due to poxvirus: 1E7Y\\nInfections due to poxvirus unspecified: 1E7Z\\nCommon warts: 1E80\\nDigital or periungual warts: 1E80.0\\nPlantar warts: 1E80.1\\nOther specified common warts: 1E80.Y\\nCommon warts unspecified: 1E80.Z\\nPlane warts: 1E81\\nWarts of lips or oral cavity: 1E82\\nFocal epithelial hyperplasia of oral mucous membranes: 1E82.0\\nWart virus proliferation in immunedeficient states: 1E83\\nViral warts not elsewhere classified: 1E8Z\\nVaricella: 1E90\\nVaricella without complication: 1E90.0\\nVaricella meningitis: 1E90.1\\nVaricella encephalitis: 1E90.2\\nVaricella with other specified complication: 1E90.Y\\nVaricella unspecified: 1E90.Z\\nZoster: 1E91\\nZoster without complications: 1E91.0\\nOphthalmic zoster: 1E91.1\\nDisseminated zoster: 1E91.2\\nZoster with central nervous system involvement: 1E91.3\\nAcute neuropathy of cranial nerve due to zoster: 1E91.4\\nAcute trigeminal zoster neuropathy: 1E91.40\\nAcute herpetic geniculate ganglionitis: 1E91.41\\nOther specified acute neuropathy of cranial nerve due to zoster: 1E91.4Y\\nAcute neuropathy of cranial nerve due to zoster unspecified: 1E91.4Z\\nPostherpetic polyneuropathy: 1E91.5\\nZoster with other specified complications: 1E91.Y\\nZoster unspecified: 1E91.Z\\nHerpes simplex infections: 1F00\\nHerpes simplex infection of skin or mucous membrane: 1F00.0\\nHerpes simplex infection of skin: 1F00.00\\nHerpes simplex labialis: 1F00.01\\nHerpes simplex gingivostomatitis: 1F00.02\\nDisseminated cutaneous herpes simplex infection complicating other skin diseases: 1F00.03\\nOther specified herpes simplex infection of skin or mucous membrane: 1F00.0Y\\nHerpes simplex infection of the eye: 1F00.1\\nHerpes simplex keratitis: 1F00.10\\nHerpes simplex infection of eyelid: 1F00.11\\nOther specified herpes simplex infection of the eye: 1F00.1Y\\nHerpes simplex infection of the eye unspecified: 1F00.1Z\\nHerpes simplex infection of central nervous system: 1F00.2\\nHerpes simplex meningitis: 1F00.20\\nEncephalitis due to herpes simplex virus: 1F00.21\\nOther specified herpes simplex infection of central nervous system: 1F00.2Y\\nDisseminated herpes simplex infection: 1F00.3\\nOther specified herpes simplex infections: 1F00.Y\\nHerpes simplex infections unspecified: 1F00.Z\\nRoseola infantum: 1F01\\nRubella: 1F02\\nRubella with neurological complications: 1F02.0\\nRubella arthritis: 1F02.1\\nRubella without complication: 1F02.2\\nRubella with other specified complication: 1F02.Y\\nMeasles: 1F03\\nMeasles without complication: 1F03.0\\nMeasles complicated by encephalitis: 1F03.1\\nMeasles complicated by meningitis: 1F03.2\\nMeasles with other complications: 1F03.Y\\nErythema infectiosum: 1F04\\nPicornavirus infections presenting in the skin or mucous membranes: 1F05\\nEnteroviral vesicular stomatitis: 1F05.0\\nEnteroviral vesicular pharyngitis: 1F05.1\\nEnteroviral exanthematous fever: 1F05.2\\nFoot and mouth disease: 1F05.3\\nOther specified picornavirus infections presenting in the skin or mucous membranes: 1F05.Y\\nPicornavirus infections presenting in the skin or mucous membranes unspecified: 1F05.Z\\nOther specified viral infections characterised by skin or mucous membrane lesions: 1F0Y\\nViral infections characterised by skin or mucous membrane lesions unspecified: 1F0Z\\nAspergillosis: 1F20\\nInvasive aspergillosis: 1F20.0\\nInvasive aspergillosis of the digestive tract: 1F20.00\\nInvasive cerebral aspergillosis: 1F20.01\\nDisseminated aspergillosis: 1F20.02\\nInvasive aspergillosis of other specified site: 1F20.0Y\\nInvasive aspergillosis unspecified: 1F20.0Z\\nNoninvasive aspergillosis: 1F20.1\\nAspergillus otomycosis: 1F20.10\\nChronic aspergillosis of the paranasal sinuses: 1F20.11\\nChronic pulmonary aspergillosis: 1F20.12\\nTonsillar aspergillosis: 1F20.13\\nAspergillus bronchitis: 1F20.14\\nObstructing aspergillus tracheobronchitis: 1F20.15\\nOther specified noninvasive aspergillosis: 1F20.1Y\\nNoninvasive aspergillosis unspecified: 1F20.1Z\\nAspergillosis unspecified: 1F20.Z\\nBasidiobolomycosis: 1F21\\nBlastomycosis: 1F22\\nCandidosis: 1F23\\nCandidosis of lips or oral mucous membranes: 1F23.0\\nCandidosis of skin or mucous membranes: 1F23.1\\nVulvovaginal candidosis: 1F23.10\\nCandida balanoposthitis: 1F23.11\\nFlexural or intertriginous candidosis: 1F23.12\\nCandidosis of nail or paronychium: 1F23.13\\nChronic mucocutaneous candidosis: 1F23.14\\nDisseminated cutaneous candidosis: 1F23.15\\nCandida otomycosis: 1F23.16\\nCandidosis of skin or mucous membrane of other specified site: 1F23.1Y\\nCandidosis of skin or mucous membranes unspecified: 1F23.1Z\\nCandidosis of gastrointestinal tract: 1F23.2\\nSystemic or invasive candidosis: 1F23.3\\nCandida meningitis: 1F23.30\\nPulmonary candidosis: 1F23.31\\nOther specified systemic or invasive candidosis: 1F23.3Y\\nSystemic or invasive candidosis unspecified: 1F23.3Z\\nOther specified candidosis: 1F23.Y\\nCandidosis unspecified: 1F23.Z\\nChromoblastomycosis: 1F24\\nCoccidioidomycosis: 1F25\\nPulmonary coccidioidomycosis: 1F25.0\\nAcute pulmonary coccidioidomycosis: 1F25.00\\nChronic pulmonary coccidioidomycosis: 1F25.01\\nExtrathoracic coccidioidomycosis: 1F25.1\\nDisseminated coccidioidomycosis: 1F25.10\\nPrimary cutaneous coccidioidomycosis: 1F25.11\\nCoccidioides meningitis: 1F25.12\\nOther specified extrathoracic coccidioidomycosis: 1F25.1Y\\nExtrathoracic coccidioidomycosis unspecified: 1F25.1Z\\nCoccidioidomycosis unspecified: 1F25.Z\\nConidiobolomycosis: 1F26\\nCryptococcosis: 1F27\\nPulmonary cryptococcosis: 1F27.0\\nCerebral cryptococcosis: 1F27.1\\nMeningitis due to Cryptococcus neoformans: 1F27.10\\nDisseminated cryptococcosis: 1F27.2\\nOther specified cryptococcosis: 1F27.Y\\nCryptococcosis unspecified: 1F27.Z\\nDermatophytosis: 1F28\\nDermatophytosis of scalp: 1F28.0\\nDermatophytosis of nail: 1F28.1\\nDermatophytosis of foot: 1F28.2\\nGenitocrural dermatophytosis: 1F28.3\\nKerion: 1F28.4\\nDisseminated dermatophytosis: 1F28.5\\nOther specified dermatophytosis: 1F28.Y\\nDermatophytosis unspecified: 1F28.Z\\nEumycetoma: 1F29\\nHistoplasmosis: 1F2A\\nPulmonary histoplasmosis capsulati: 1F2A.0\\nHistoplasmosis due to Histoplasma duboisii: 1F2A.1\\nOther specified histoplasmosis: 1F2A.Y\\nHistoplasmosis unspecified: 1F2A.Z\\nLobomycosis: 1F2B\\nMucormycosis: 1F2C\\nNondermatophyte superficial dermatomycoses: 1F2D\\nPityriasis versicolor: 1F2D.0\\nMalassezia folliculitis: 1F2D.1\\nWhite piedra: 1F2D.2\\nBlack piedra: 1F2D.3\\nTinea nigra: 1F2D.4\\nOnychomycosis due to nondermatophyte mould: 1F2D.5\\nOther specified nondermatophyte superficial dermatomycoses: 1F2D.Y\\nNondermatophyte superficial dermatomycoses unspecified: 1F2D.Z\\nParacoccidioidomycosis: 1F2E\\nPulmonary paracoccidioidomycosis: 1F2E.0\\nDisseminated paracoccidioidomycosis: 1F2E.1\\nOther specified paracoccidioidomycosis: 1F2E.Y\\nParacoccidioidomycosis unspecified: 1F2E.Z\\nPhaeohyphomycosis: 1F2F\\nPneumocystosis: 1F2G\\nPulmonary pneumocystosis: 1F2G.0\\nPneumocystosis unspecified: 1F2G.Z\\nScedosporiosis: 1F2H\\nSporotrichosis: 1F2J\\nLymphocutaneous sporotrichosis: 1F2J.0\\nFixed cutaneous sporotrichosis: 1F2J.1\\nPulmonary sporotrichosis: 1F2J.2\\nDisseminated sporotrichosis: 1F2J.3\\nOther specified sporotrichosis: 1F2J.Y\\nSporotrichosis unspecified: 1F2J.Z\\nTalaromycosis: 1F2K\\nEmmonsiosis: 1F2L\\nDisseminated adiaspiromycosis: 1F2L.0\\nPulmonary adiaspiromycosis: 1F2L.1\\nOther specified emmonsiosis: 1F2L.Y\\nEmmonsiosis unspecified: 1F2L.Z\\nOther specified mycoses: 1F2Y\\nMycoses unspecified: 1F2Z\\nMalaria due to Plasmodium falciparum: 1F40\\nPlasmodium falciparum malaria with cerebral complications: 1F40.0\\nOther severe and complicated Plasmodium falciparum malaria: 1F40.Y\\nMalaria due to Plasmodium falciparum unspecified: 1F40.Z\\nMalaria due to Plasmodium vivax: 1F41\\nPlasmodium vivax malaria with rupture of spleen: 1F41.0\\nMalaria due to Plasmodium vivax with other complications: 1F41.Y\\nPlasmodium vivax malaria without complication: 1F41.Z\\nMalaria due to Plasmodium malariae: 1F42\\nPlasmodium malariae malaria with nephropathy: 1F42.0\\nMalaria due to Plasmodium malariae with other complications: 1F42.Y\\nPlasmodium malariae malaria without complication: 1F42.Z\\nMalaria due to Plasmodium ovale: 1F43\\nOther parasitologically confirmed malaria: 1F44\\nMalaria without parasitological confirmation: 1F45\\nMalaria unspecified: 1F4Z\\nAcanthamoebiasis: 1F50\\nAfrican trypanosomiasis: 1F51\\nGambiense trypanosomiasis: 1F51.0\\nMeningitis in Gambiense trypanosomiasis: 1F51.00\\nOther specified gambiense trypanosomiasis: 1F51.0Y\\nGambiense trypanosomiasis unspecified: 1F51.0Z\\nRhodesiense trypanosomiasis: 1F51.1\\nMeningitis in Rhodesiense trypanosomiasis: 1F51.10\\nOther specified rhodesiense trypanosomiasis: 1F51.1Y\\nRhodesiense trypanosomiasis unspecified: 1F51.1Z\\nOther specified african trypanosomiasis: 1F51.Y\\nAfrican trypanosomiasis unspecified: 1F51.Z\\nBabesiosis: 1F52\\nChagas disease: 1F53\\nAcute Chagas disease without heart involvement: 1F53.1\\nChronic Chagas disease with heart involvement: 1F53.2\\nChagas disease with digestive system involvement: 1F53.3\\nMeningitis in Chagas disease: 1F53.4\\nOther specified Chagas disease: 1F53.Y\\nChagas disease unspecified: 1F53.Z\\nLeishmaniasis: 1F54\\nVisceral leishmaniasis: 1F54.0\\nCutaneous leishmaniasis: 1F54.1\\nMucocutaneous leishmaniasis: 1F54.2\\nLeishmaniasis unspecified: 1F54.Z\\nNaegleriasis: 1F55\\nRhinosporidiosis: 1F56\\nToxoplasmosis: 1F57\\nHepatitis due to Toxoplasma gondii: 1F57.0\\nMeningoencephalitis due to Toxoplasma gondii: 1F57.1\\nPulmonary toxoplasmosis due to Toxoplasma gondii: 1F57.2\\nEye disease due to Toxoplasma gondii: 1F57.3\\nOther specified toxoplasmosis: 1F57.Y\\nToxoplasmosis unspecified: 1F57.Z\\nMicrosporidiosis: 1F58\\nUnspecified protozoal disease: 1F5Z\\nAngiostrongyliasis: 1F60\\nEosinophilic meningitis due to Angiostrongylus cantonensis: 1F60.0\\nIntestinal angiostrongyliasis: 1F60.1\\nOther specified angiostrongyliasis: 1F60.Y\\nAngiostrongyliasis unspecified: 1F60.Z\\nAnisakiasis: 1F61\\nAscariasis: 1F62\\nCapillariasis: 1F63\\nCapillariasis of the intestine: 1F63.0\\nOther specified capillariasis: 1F63.Y\\nCapillariasis unspecified: 1F63.Z\\nDracunculiasis: 1F64\\nEnterobiasis: 1F65\\nFilariasis: 1F66\\nLoiasis: 1F66.0\\nMansonelliasis: 1F66.1\\nFilariasis due to Brugia species: 1F66.2\\nLymphatic filariasis: 1F66.3\\nFilariasis due to Wuchereria bancrofti: 1F66.30\\nFilariasis due to Brugia malayi: 1F66.31\\nFilariasis due to Brugia timori: 1F66.32\\nLymphatic filariasis unspecified: 1F66.3Z\\nSubcutaneous dirofilariasis: 1F66.4\\nOther specified filariasis: 1F66.Y\\nFilariasis unspecified: 1F66.Z\\nGnathostomiasis: 1F67\\nHookworm diseases: 1F68\\nAncylostomiasis: 1F68.0\\nNecatoriasis: 1F68.1\\nCutaneous larva migrans: 1F68.2\\nOther specified hookworm diseases: 1F68.Y\\nHookworm diseases unspecified: 1F68.Z\\nOesophagostomiasis: 1F69\\nOnchocerciasis: 1F6A\\nOnchocerciasis of the eye: 1F6A.0\\nOnchocerciasis of the skin: 1F6A.1\\nOther specified onchocerciasis: 1F6A.Y\\nOnchocerciasis unspecified: 1F6A.Z\\nStrongyloidiasis: 1F6B\\nSyngamosis: 1F6C\\nToxocariasis: 1F6D\\nTrichinosis: 1F6E\\nTrichostrongyliasis: 1F6F\\nTrichuriasis: 1F6G\\nUncinariosis: 1F6H\\nOther specified diseases due to nematodes: 1F6Y\\nDiseases due to nematodes unspecified: 1F6Z\\nCysticercosis: 1F70\\nCysticercosis of central nervous system: 1F70.0\\nMeningitis due to Cysticercosis: 1F70.00\\nOther specified cysticercosis of central nervous system: 1F70.0Y\\nCysticercosis of central nervous system unspecified: 1F70.0Z\\nCysticercosis of eye: 1F70.1\\nOther specified cysticercosis: 1F70.Y\\nCysticercosis unspecified: 1F70.Z\\nDiphyllobothriasis: 1F71\\nDipylidiasis: 1F72\\nEchinococcosis: 1F73\\nEchinococcus infection of liver: 1F73.0\\nEchinococcus infection of lung: 1F73.1\\nEchinococcus infection of bone: 1F73.2\\nEchinococcus infection of central nervous system: 1F73.3\\nOther specified echinococcosis: 1F73.Y\\nEchinococcosis unspecified: 1F73.Z\\nHymenolepiasis: 1F74\\nSparganosis: 1F75\\nTaeniasis: 1F76\\nTaeniasis due to Taenia solium: 1F76.0\\nTaeniasis due to Taenia saginata: 1F76.1\\nOther specified taeniasis: 1F76.Y\\nTaeniasis unspecified: 1F76.Z\\nOther specified diseases due to cestodes: 1F7Y\\nDiseases due to cestodes unspecified: 1F7Z\\nClonorchiasis: 1F80\\nDicrocoeliasis: 1F81\\nFascioliasis: 1F82\\nFasciolopsiasis: 1F83\\nOpisthorchiasis: 1F84\\nParagonimiasis: 1F85\\nSchistosomiasis: 1F86\\nSchistosomiasis due to Schistosoma haematobium: 1F86.0\\nSchistosomiasis due to Schistosoma mansoni: 1F86.1\\nSchistosomiasis due to Schistosoma japonicum: 1F86.2\\nOther schistosomiases: 1F86.3\\nCercarial dermatitis: 1F86.4\\nSchistosomal pneumonitis: 1F86.5\\nSchistosomiasis due to unspecified or unknown Schistosoma species: 1F86.Z\\nOther specified diseases due to trematodes: 1F8Y\\nDiseases due to trematodes unspecified: 1F8Z\\nOther or unspecified infestation by parasitic worms: 1F90\\nMixed intestinal helminthiases: 1F90.0\\nIntestinal parasitic infestation not otherwise specified: 1F90.1\\nIntestinal helminthiasis unspecified: 1F90.2\\nOther specified infestation by parasitic worms: 1F90.Y\\nInfestation by parasitic worms unspecified: 1F90.Z\\nDiphyllobothriasis and sparganosis: 1F91\\nHelminthiases unspecified: 1F9Z\\nPediculosis: 1G00\\nPediculosis capitis: 1G00.0\\nPediculosis corporis: 1G00.1\\nPediculosis of unspecified site or type: 1G00.Z\\nMyiasis: 1G01\\nOcular myiasis: 1G01.0\\nNasopharyngeal myiasis: 1G01.1\\nLaryngeal myiasis: 1G01.2\\nCutaneous myiasis: 1G01.3\\nOther specified myiasis: 1G01.Y\\nMyiasis unspecified: 1G01.Z\\nExternal hirudiniasis: 1G02\\nPthiriasis: 1G03\\nScabies: 1G04\\nClassical scabies: 1G04.0\\nCrusted scabies: 1G04.1\\nOther specified scabies: 1G04.Y\\nScabies unspecified: 1G04.Z\\nTungiasis: 1G05\\nCimicosis: 1G06\\nInfestation by mites: 1G07\\nInfestation by Demodex: 1G07.0\\nInfestation of the skin by other specified parasitic mites: 1G07.Y\\nInfestation of the skin by unspecified parasitic mites: 1G07.Z\\nInfestation by other specified ectoparasite: 1G0Y\\nInfestation by unknown or unspecified ectoparasite: 1G0Z\\nOther specified parasitic diseases: 1G2Y\\nUnspecified parasitic diseases: 1G2Z\\nSepsis without septic shock: 1G40\\nSepsis with septic shock: 1G41\\nCertain other disorders of infectious origin: 1G60\\nMycetoma of unknown or unspecified type: 1G60.0\\nPythiosis: 1G60.1\\nProtothecosis: 1G60.2\\nInfection of peripheral nervous system: 1G60.3\\nOther specified disorders of infectious origin not elsewhere classified: 1G60.Y\\nSequelae of tuberculosis: 1G80\\nSequelae of trachoma: 1G81\\nSequelae of leprosy: 1G82\\nSequelae of poliomyelitis: 1G83\\nSequelae of viral encephalitis: 1G84\\nSequelae of diphtheria: 1G85\\nSequelae of other specified infectious diseases: 1G8Y\\nSequelae of unspecified infectious diseases: 1G8Z\\nInfection unspecified: 1H0Z\\nPrimary neoplasms of brain: 2A00\\nGliomas of brain: 2A00.0\\nGlioblastoma of brain: 2A00.00\\nOther specified gliomas of brain: 2A00.0Y\\nGliomas of brain unspecified: 2A00.0Z\\nEmbryonal tumours of brain: 2A00.1\\nMedulloblastoma of brain: 2A00.10\\nCentral primitive neuroectodermal tumour: XH89C3\\nOther specified embryonal tumours of brain: 2A00.1Y\\nEmbryonal tumours of brain unspecified: 2A00.1Z\\nTumours of neuroepithelial tissue of brain: 2A00.2\\nTumours of the pineal gland or pineal region: 2A00.20\\nMixed neuronalglial tumours: 2A00.21\\nChoroid plexus tumours: 2A00.22\\nOther specified tumours of neuroepithelial tissue of brain: 2A00.2Y\\nTumours of neuroepithelial tissue of brain unspecified: 2A00.2Z\\nCentral neurocytoma of brain: 2A00.3\\nAstroblastoma of the brain: 2A00.4\\nPrimary neoplasm of brain of unknown or unspecified type: 2A00.5\\nPrimary neoplasms of meninges: 2A01\\nMeningiomas: 2A01.0\\nPrimary malignant meningioma: 2A01.00\\nOther specified meningiomas: 2A01.0Y\\nMeningiomas unspecified: 2A01.0Z\\nMesenchymal tumours of meninges: 2A01.1\\nPrimary neoplasm of meninges of unknown or unspecified type: 2A01.2\\nPrimary neoplasm of spinal cord cranial nerves paraspinal nerves or remaining parts of central nervous system: 2A02\\nGliomas of spinal cord cranial or paraspinal nerves: 2A02.0\\nGlioblastoma of spinal cord cranial or paraspinal nerves: 2A02.00\\nOther specified gliomas of spinal cord cranial or paraspinal nerves: 2A02.0Y\\nGliomas of spinal cord cranial or paraspinal nerves unspecified: 2A02.0Z\\nTumours of cranial or paraspinal nerves: 2A02.1\\nMalignant peripheral nerve sheath tumour of cranial or paraspinal nerves: 2A02.10\\nParaspinal neuroblastoma: 2A02.11\\nMalignant neoplasm of the optic nerve: 2A02.12\\nOther specified tumours of cranial or paraspinal nerves: 2A02.1Y\\nTumours of cranial or paraspinal nerves unspecified: 2A02.1Z\\nPrimary neoplasm of spinal cord of unknown or unspecified type: 2A02.2\\nBenign neoplasm of cranial nerves: 2A02.3\\nBenign neoplasm of spinal cord: 2A02.4\\nPrimary neoplasm of spinal cord cranial nerves paraspinal nerves or remaining parts of central nervous system unspecified: 2A02.Z\\nOther and unspecified neoplasms of brain or central nervous system: 2A0Z\\nNon mast cell myeloproliferative neoplasms: 2A20\\nChronic myelogenous leukaemia BCRABLpositive: 2A20.0\\nChronic myelogenous leukaemia with blast crisis: 2A20.00\\nChronic myelogenous leukaemia Philadelphia chromosome Ph positive: 2A20.01\\nChronic myelogenous leukaemia tq q: 2A20.02\\nNaegelitype monocytic leukaemia: 2A20.03\\nOther specified chronic myelogenous leukaemia BCRABLpositive: 2A20.0Y\\nChronic myelogenous leukaemia BCRABLpositive unspecified: 2A20.0Z\\nChronic neutrophilic leukaemia: XH5NQ7\\nPrimary myelofibrosis: XH7GG7\\nChronic eosinophilic leukaemia not elsewhere classified: 2A20.3\\nPolycythaemia vera: XH0453\\nNon mast cell myeloproliferative neoplasm unclassifiable: 2A20.5\\nOther specified non mast cell myeloproliferative neoplasms: 2A20.Y\\nNon mast cell myeloproliferative neoplasms unspecified: 2A20.Z\\nMastocytosis: 2A21\\nSystemic mastocytosis: 2A21.0\\nMast cell leukaemia: XH5ER6\\nOther specified systemic mastocytosis: 2A21.0Y\\nSystemic mastocytosis unspecified: 2A21.0Z\\nCutaneous mastocytosis: XH74F2\\nUrticaria pigmentosa: XH8VS0\\nOther specified cutaneous mastocytosis: 2A21.1Y\\nCutaneous mastocytosis unspecified: 2A21.1Z\\nMast cell sarcoma: XH6A72\\nExtracutaneous mastocytoma: 2A21.3\\nOther specified mastocytosis: 2A21.Y\\nMastocytosis unspecified: 2A21.Z\\nOther specified myeloproliferative neoplasm: 2A2Y\\nMyeloproliferative neoplasm unspecified: 2A2Z\\nRefractory anaemia: 2A30\\nRefractory neutropaenia: 2A31\\nRefractory thrombocytopenia: 2A32\\nRefractory anaemia with ring sideroblasts: 2A33\\nRefractory cytopenia with multilineage dysplasia: 2A34\\nRefractory anaemia with excess of blasts: 2A35\\nMyelodysplastic syndrome with isolated delq: 2A36\\nMyelodysplastic syndrome unclassifiable: 2A37\\nRefractory cytopenia of childhood: 2A38\\nOther specified myelodysplastic syndromes: 2A3Y\\nMyelodysplastic syndromes unspecified: 2A3Z\\nChronic myelomonocytic leukaemia: 2A40\\nAtypical chronic myeloid leukaemia BCRABLnegative: 2A41\\nJuvenile myelomonocytic leukaemia: XH4QZ1\\nJuvenile myelomonocytic leukaemia in complete remission: 2A42.0\\nOther specified juvenile myelomonocytic leukaemia: 2A42.Y\\nJuvenile myelomonocytic leukaemia unspecified: 2A42.Z\\nRefractory anaemia with ring sideroblasts associated with marked thrombocytosis: 2A43\\nMyeloproliferative and myelodysplastic disease unclassifiable: 2A44\\nOther specified myelodysplastic and myeloproliferative neoplasms: 2A4Y\\nMyelodysplastic and myeloproliferative neoplasms unspecified: 2A4Z\\nMyeloidlymphoid neoplasm associated with PDGFRA rearrangement: 2A50\\nMyeloid neoplasm associated with PDGFRB rearrangement: 2A51\\nMyeloid or lymphoid neoplasms with FGFR abnormalities: 2A52\\nMyeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA PDGFRB or FGFR unspecified: 2A5Z\\nAcute myeloid leukaemias and related precursor neoplasms: 2A60\\nAcute myeloid leukaemia with recurrent genetic abnormalities: 2A60.0\\nAcute myeloid leukaemia with myelodysplasiarelated changes: XH64R4\\nTherapyrelated myeloid neoplasms: 2A60.2\\nTherapy related acute myeloid leukaemia or myelodysplastic syndrome: 2A60.20\\nOther specified therapyrelated myeloid neoplasms: 2A60.2Y\\nTherapyrelated myeloid neoplasms unspecified: 2A60.2Z\\nAcute myeloid leukaemia not elsewhere classified by criteria of other types: 2A60.3\\nAcute myeloid leukaemia with minimal differentiation: 2A60.30\\nAcute myeloid leukaemia without maturation: XH5AH8\\nAcute myeloid leukaemia with maturation: XH1XJ9\\nAcute myelomonocytic leukaemia: XH78Y4\\nAcute monoblastic or monocytic leukaemia: 2A60.34\\nAcute erythroid leukaemia: 2A60.35\\nAcute megakaryoblastic leukaemia: XH4750\\nAcute basophilic leukaemia: XH7MR1\\nAcute panmyelosis with myelofibrosis: XH1075\\nMyeloid sarcoma: XH3L40\\nOther specified acute myeloid leukaemia not elsewhere classified by criteria of other types: 2A60.3Y\\nAcute myeloid leukaemia unspecified: 2A60.3Z\\nMyeloid proliferation associated with Down syndrome: 2A60.4\\nTransient abnormal myelopoiesis: XH67W4\\nMyeloid leukaemia associated with Down syndrome: 2A60.41\\nOther specified myeloid proliferation associated with Down syndrome: 2A60.4Y\\nMyeloid proliferation associated with Down syndrome unspecified: 2A60.4Z\\nBlastic plasmacytoid dendritic cell neoplasm: XH1DB1\\nOther specified acute myeloid leukaemias and related precursor neoplasms: 2A60.Y\\nAcute myeloid leukaemias and related precursor neoplasms unspecified: 2A60.Z\\nAcute leukaemias of ambiguous lineage: 2A61\\nPrecursor Blymphoblastic neoplasms: 2A70\\nB lymphoblastic leukaemia or lymphoma not elsewhere classified: 2A70.0\\nB lymphoblastic leukaemia or lymphoma with t qq BCRABL: 2A70.1\\nOther Blymphoblastic leukaemialymphoma with recurrent genetic abnormalities: 2A70.Y\\nPrecursor Tlymphoblastic neoplasms: 2A71\\nPrecursor lymphoid neoplasms unspecified: 2A7Z\\nFollicular lymphoma: 2A80\\nFollicular lymphoma grade: XH6RN1\\nPrimary cutaneous follicle centre lymphoma: XH1FZ7\\nPaediatric type follicular lymphoma: 2A80.4\\nFollicular lymphoma in situ: 2A80.5\\nFollicular lymphoma of small intestine: 2A80.6\\nOther specified follicular lymphoma: 2A80.Y\\nFollicular lymphoma unspecified: 2A80.Z\\nDiffuse large Bcell lymphomas: 2A81\\nPrimary mediastinal large Bcell lymphoma: 2A81.0\\nIntravascular large Bcell lymphoma: XH50S7\\nPlasmablastic lymphoma: XH6YR5\\nLymphomatoid granulomatosis: XH4P09\\nTcellhistiocyte rich large Bcell lymphoma: XH0WP6\\nPrimary diffuse large Bcell lymphoma of central nervous system: 2A81.5\\nEpsteinBarr Viruspositive diffuse large Bcell lymphoma of the elderly: 2A81.6\\nDiffuse large Bcell lymphoma associated with chronic inflammation: XH3N15\\nALKpositive large Bcell lymphoma: 2A81.8\\nPrimary effusion lymphoma: XH2LN1\\nPrimary cutaneous diffuse large Bcell lymphoma leg type: 2A81.A\\nOther specified diffuse large Bcell lymphomas: 2A81.Y\\nDiffuse large Bcell lymphoma not otherwise specified: 2A81.Z\\nMature Bcell neoplasm with leukaemic behaviour: 2A82\\nChronic lymphocytic leukaemia or small lymphocytic lymphoma: 2A82.0\\nChronic lymphocytic leukaemia of Bcell type: 2A82.00\\nOther specified chronic lymphocytic leukaemia or small lymphocytic lymphoma: 2A82.0Y\\nChronic lymphocytic leukaemia or small lymphocytic lymphoma unspecified: 2A82.0Z\\nBcell prolymphocytic leukaemia: 2A82.1\\nBcell prolymphocytic leukaemia in complete remission: 2A82.10\\nOther specified bcell prolymphocytic leukaemia: 2A82.1Y\\nBcell prolymphocytic leukaemia unspecified: 2A82.1Z\\nHairycell leukaemia: 2A82.2\\nSplenic Bcell lymphoma or leukaemia unclassifiable: 2A82.3\\nOther specified mature Bcell neoplasm with leukaemic behaviour: 2A82.Y\\nMature Bcell neoplasm with leukaemic behaviour unspecified: 2A82.Z\\nPlasma cell neoplasms: 2A83\\nMonoclonal gammopathy of undetermined significance: XH1NV1\\nPlasma cell myeloma: XH4XA9\\nSolitary plasmacytoma: 2A83.2\\nExtraosseous plasmacytoma: 2A83.3\\nPlasma cell leukaemia: XH7GC9\\nMonoclonal immunoglobulin deposition disease: 2A83.5\\nHeavy chain deposition disease: 2A83.50\\nLight and heavy chain deposition disease: 2A83.51\\nLight chain deposition disease: 2A83.52\\nOther specified plasma cell neoplasms: 2A83.Y\\nPlasma cell neoplasm unspecified: 2A83.Z\\nHeavy chain diseases or malignant immunoproliferative diseases: 2A84\\nAlpha heavy chain disease: XH1Y65\\nGamma heavy chain disease: XH1EA7\\nMu heavy chain disease: XH2JK2\\nOther specified malignant immunoproliferative diseases: 2A84.Y\\nHeavy chain diseases unspecified: 2A84.Z\\nOther specified mature Bcell neoplasms or lymphoma: 2A85\\nNodal marginal zone lymphoma: 2A85.0\\nExtranodal marginal zone Bcell lymphoma of mucosaassociated lymphoid tissue of stomach: 2A85.1\\nExtranodal marginal zone Bcell lymphoma primary site skin: 2A85.2\\nExtranodal marginal zone Bcell lymphoma primary site excluding stomach or skin: 2A85.3\\nLymphoplasmacytic lymphoma: XH0QZ9\\nMantle cell lymphoma: XH1VV1\\nBurkitt lymphoma including Burkitt leukaemia: 2A85.6\\nFurther specified mature Bcell neoplasms or lymphoma: 2A85.Y\\nBcell lymphoma mixed features: 2A86\\nMalignant lymphoma of B cell type not elsewhere classified: 2A86.0\\nBcell lymphoma unclassifiable with features intermediate between Burkitt lymphoma and diffuse large Bcell lymphoma: 2A86.1\\nBcell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large Bcell lymphoma: 2A86.2\\nOther specified Bcell lymphoma mixed features: 2A86.Y\\nBcell lymphoma mixed features unspecified: 2A86.Z\\nMature Bcell neoplasms unspecified: 2A8Z\\nMature Tcell lymphoma specified types nodal or systemic: 2A90\\nTcell prolymphocytic leukaemia: 2A90.0\\nTcell large granular lymphocytic leukaemia: XH6687\\nChronic lymphoproliferative disorders of NKcells: 2A90.2\\nAggressive NK cell leukaemia: 2A90.3\\nSystemic EpsteinBarr Viruspositive Tcell lymphoma of childhood: 2A90.4\\nAdult Tcell lymphoma or leukaemia human Tcell lymphotropic virus type associated: 2A90.5\\nExtranodal NKTcell lymphoma nasal type: 2A90.6\\nEnteropathy associated Tcell lymphoma: 2A90.7\\nHepatosplenic Tcell lymphoma: XH8D49\\nAngioimmunoblastic Tcell lymphoma: XH1J86\\nAnaplastic large cell lymphoma ALKpositive: 2A90.A\\nAnaplastic large cell lymphoma ALKnegative: 2A90.B\\nPeripheral Tcell lymphoma not otherwise specified: 2A90.C\\nSubcutaneous panniculitislike Tcell lymphoma: XH3NV1\\nMycosis fungoides: XH8R56\\nSzary syndrome: 2B02\\nPrimary cutaneous CDpositive Tcell lymphoproliferative disorders: 2B03\\nPrimary cutaneous CDpositive anaplastic large cell lymphoma: 2B03.0\\nLymphomatoid papulosis: 2B03.1\\nOther specified primary cutaneous mature Tcell or NKcell lymphomas and lymphoproliferative disorders: 2B0Y\\nPrimary cutaneous Tcell lymphoma of undetermined or unspecified type: 2B0Z\\nOther specified mature Tcell or NKcell neoplasms: 2B2Y\\nMature Tcell or NKcell neoplasms unspecified: 2B2Z\\nHodgkin lymphoma: 2B30\\nNodular lymphocyte predominant Hodgkin lymphoma: 2B30.0\\nClassical Hodgkin lymphoma: 2B30.1\\nNodular sclerosis classical Hodgkin lymphoma: 2B30.10\\nLymphocyterich classical Hodgkin lymphoma: 2B30.11\\nMixed cellularity classical Hodgkin lymphoma: 2B30.12\\nLymphocyte depleted classical Hodgkin lymphoma: 2B30.13\\nClassical Hodgkin lymphoma unspecified: 2B30.1Z\\nHodgkin lymphoma unspecified: 2B30.Z\\nHistiocytic or dendritic cell neoplasms: 2B31\\nJuvenile xanthogranuloma: 2B31.0\\nHistiocytic sarcoma: XH4JD4\\nLangerhans cell histiocytosis: XH1J18\\nLangerhans cell histiocytosis involving the skin: 2B31.20\\nOther specified Langerhans cell histiocytosis: 2B31.2Y\\nLangerhans cell histiocytosis unspecified: 2B31.2Z\\nLangerhans cell sarcoma: XH8J76\\nInterdigitating dendritic cell sarcoma: XH7UM7\\nFollicular dendritic cell sarcoma: XH1JT6\\nIndeterminate cell histiocytosis: 2B31.6\\nFibroblastic reticular cell tumour: XH0124\\nOther specified histiocytic or dendritic cell neoplasms: 2B31.Y\\nHistiocytic or dendritic cell neoplasms unspecified: 2B31.Z\\nImmunodeficiencyassociated lymphoproliferative disorders: 2B32\\nPosttransplant lymphoproliferative disorder early lesion: 2B32.0\\nReactive plasmacytic hyperplasia: 2B32.1\\nPosttransplant lymphoproliferative disorder Infectious mononucleosislike: 2B32.2\\nPolymorphic posttransplant lymphoproliferative disorder: 2B32.3\\nOther specified immunodeficiencyassociated lymphoproliferative disorders: 2B32.Y\\nImmunodeficiencyassociated lymphoproliferative disorders unspecified: 2B32.Z\\nMalignant haematopoietic neoplasms without further specification: 2B33\\nAcute leukaemia not elsewhere classified: 2B33.0\\nMyeloid leukaemia: 2B33.1\\nChronic myeloid leukaemia not elsewhere classified: 2B33.2\\nLymphoid leukaemia not elsewhere classified: 2B33.3\\nLeukaemia unspecified: 2B33.4\\nMalignant lymphoma not elsewhere classified: 2B33.5\\nOther malignant haematopoietic neoplasms without further specification: 2B33.Y\\nNeoplasms of haematopoietic or lymphoid tissues unspecified: 2B3Z\\nChondrosarcoma primary site: 2B50\\nChondrosarcoma of bone or articular cartilage of limbs: 2B50.0\\nChondrosarcoma of bone or articular cartilage of pelvis: 2B50.1\\nChondrosarcoma of bone or articular cartilage of ribs sternum or clavicle: 2B50.2\\nChondrosarcoma of bone or articular cartilage of other specified sites: 2B50.Y\\nChondrosarcoma of bone or articular cartilage of unspecified sites: 2B50.Z\\nOsteosarcoma primary site: 2B51\\nOsteosarcoma of bone or articular cartilage of jaw: 2B51.0\\nOsteosarcoma of bone or articular cartilage of limbs: 2B51.1\\nOsteosarcoma of bone or articular cartilage of pelvis: 2B51.2\\nOsteosarcoma of bone or articular cartilage of other specified sites: 2B51.Y\\nOsteosarcoma of bone or articular cartilage of unspecified sites: 2B51.Z\\nEwing sarcoma primary site: 2B52\\nEwing sarcoma of bone or articular cartilage of limbs: 2B52.0\\nEwing sarcoma of bone or articular cartilage of pelvis: 2B52.1\\nEwing sarcoma of bone or articular cartilage of ribs: 2B52.2\\nEwing sarcoma of soft tissue: 2B52.3\\nEwing sarcoma of bone or articular cartilage of other specified sites: 2B52.Y\\nEwing sarcoma of bone or articular cartilage of unspecified sites: 2B52.Z\\nFibroblastic or myofibroblastic tumour primary site: 2B53\\nMyxofibrosarcoma primary site: 2B53.0\\nFibroblastic or myofibroblastic tumour of skin: 2B53.1\\nOther specified fibroblastic or myofibroblastic tumour primary site: 2B53.Y\\nFibroblastic or myofibroblastic tumour primary site unspecified: 2B53.Z\\nUndifferentiated pleomorphic sarcoma primary site: 2B54\\nUndifferentiated pleomorphic sarcoma of skin: 2B54.0\\nUndifferentiated pleomorphic sarcoma of retroperitoneum or peritoneum: 2B54.1\\nUndifferentiated pleomorphic sarcoma other specified primary site: 2B54.Y\\nUndifferentiated pleomorphic sarcoma unspecified primary site: 2B54.Z\\nRhabdomyosarcoma primary site: 2B55\\nRhabdomyosarcoma of the oral cavity or pharynx: 2B55.0\\nRhabdomyosarcoma of respiratory or intrathoracic organs: 2B55.1\\nRhabdomyosarcoma of male genital organs: 2B55.2\\nRhabdomyosarcoma other specified primary site: 2B55.Y\\nRhabdomyosarcoma unspecified primary site: 2B55.Z\\nAngiosarcoma primary site: 2B56\\nAngiosarcoma of heart: 2B56.0\\nAngiosarcoma of skin: 2B56.1\\nAngiosarcoma of breast: 2B56.2\\nAngiosarcoma of liver: 2B56.3\\nAngiosarcoma other specified primary site: 2B56.Y\\nAngiosarcoma unspecified primary site: 2B56.Z\\nKaposi sarcoma primary site: 2B57\\nKaposi sarcoma of lung: 2B57.0\\nKaposi sarcoma of skin: 2B57.1\\nKaposi sarcoma of gastrointestinal sites: 2B57.2\\nKaposi sarcoma of other specified primary sites: 2B57.Y\\nKaposi sarcoma of unspecified primary site: 2B57.Z\\nLeiomyosarcoma primary site: 2B58\\nLeiomyosarcoma of retroperitoneum or peritoneum: 2B58.0\\nLeiomyosarcoma of uterus: 2B58.1\\nLeiomyosarcoma of stomach: 2B58.2\\nLeiomyosarcoma other specified primary site: 2B58.Y\\nLeiomyosarcoma unspecified primary site: 2B58.Z\\nLiposarcoma primary site: 2B59\\nLiposarcoma of soft tissue of limb: 2B59.0\\nLiposarcoma of retroperitoneum or peritoneum: 2B59.1\\nLiposarcoma of male genital organs: 2B59.2\\nLiposarcoma other specified primary site: 2B59.Y\\nLiposarcoma unspecified primary site: 2B59.Z\\nSynovial sarcoma primary site: 2B5A\\nSynovial sarcoma of soft tissues of limb: 2B5A.0\\nSynovial sarcoma of respiratory or intrathoracic organs: 2B5A.1\\nSynovial sarcoma other specified primary site: 2B5A.Y\\nSynovial sarcoma unspecified primary site: 2B5A.Z\\nGastrointestinal stromal tumour primary site: 2B5B\\nGastrointestinal stromal tumour of stomach: 2B5B.0\\nGastrointestinal stromal tumour of small intestine: 2B5B.1\\nGastrointestinal stromal tumour of other gastrointestinal sites: 2B5B.Y\\nGastrointestinal stromal tumour of unspecified gastrointestinal sites: 2B5B.Z\\nEndometrial stromal sarcoma primary site: 2B5C\\nMalignant mixed epithelial mesenchymal tumour primary site: 2B5D\\nMalignant mixed epithelial mesenchymal tumour of ovary: 2B5D.0\\nMalignant mixed epithelial and mesenchymal tumour of corpus uteri: 2B5D.1\\nMalignant mixed epithelial mesenchymal tumour other specified primary site: 2B5D.Y\\nMalignant mixed epithelial mesenchymal tumour unspecified primary site: 2B5D.Z\\nMalignant nerve sheath tumour of peripheral nerves or autonomic nervous system primary site: 2B5E\\nSarcoma not elsewhere classified primary site: 2B5F\\nSarcoma not elsewhere classified of uterus: 2B5F.0\\nSarcoma not elsewhere classified of retroperitoneum or peritoneum: 2B5F.1\\nMyosarcomas of omentum: 2B5F.10\\nOther specified sarcoma not elsewhere classified of retroperitoneum or peritoneum: 2B5F.1Y\\nSarcoma not elsewhere classified of retroperitoneum or peritoneum unspecified: 2B5F.1Z\\nSarcoma not elsewhere classified of other specified sites: 2B5F.2\\nSarcoma not elsewhere classified primary site unknown: 2B5F.3\\nMyosarcoma of uterus part not specified: 2B5G\\nWell differentiated lipomatous tumour primary site: 2B5H\\nMalignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites: 2B5J\\nUnspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites: 2B5K\\nOther specified malignant mesenchymal neoplasms: 2B5Y\\nMalignant mesenchymal neoplasm of unspecified type: 2B5Z\\nMalignant neoplasms of lip: 2B60\\nBasal cell carcinoma of lip: 2B60.0\\nSquamous cell carcinoma of lip: 2B60.1\\nOther specified malignant neoplasms of lip: 2B60.Y\\nMalignant neoplasms of lip unspecified: 2B60.Z\\nMalignant neoplasms of base of tongue: 2B61\\nSquamous cell carcinoma of the base of the tongue: 2B61.0\\nOther specified malignant neoplasms of base of tongue: 2B61.Y\\nMalignant neoplasms of base of tongue unspecified: 2B61.Z\\nMalignant neoplasms of other or unspecified parts of tongue: 2B62\\nSquamous cell carcinoma of other or unspecified parts of tongue: 2B62.0\\nMalignant neoplasms of lingual tonsil: 2B62.1\\nSquamous cell carcinoma of lingual tonsil: 2B62.10\\nMalignant neoplasms of lingual tonsil unspecified: 2B62.1Z\\nOther specified malignant neoplasms of other or unspecified parts of tongue: 2B62.Y\\nMalignant neoplasms of other or unspecified parts of tongue unspecified: 2B62.Z\\nMalignant neoplasms of gum: 2B63\\nSquamous cell carcinoma of gum: 2B63.0\\nOther specified malignant neoplasm of gum: 2B63.Y\\nMalignant neoplasms of gum unspecified: 2B63.Z\\nMalignant neoplasms of floor of mouth: 2B64\\nSquamous cell carcinoma of floor of mouth: 2B64.0\\nOther specified malignant neoplasm of floor of mouth: 2B64.Y\\nMalignant neoplasms of floor of mouth unspecified: 2B64.Z\\nMalignant neoplasms of palate: 2B65\\nAdenocarcinoma of palate: 2B65.0\\nSquamous cell carcinoma of palate: 2B65.1\\nOther specified malignant neoplasm of palate: 2B65.Y\\nMalignant neoplasms of palate unspecified: 2B65.Z\\nMalignant neoplasms of other or unspecified parts of mouth: 2B66\\nSquamous cell carcinoma of other or unspecified parts of mouth: 2B66.0\\nOther specified malignant neoplasms of other or unspecified parts of mouth: 2B66.Y\\nMalignant neoplasms of other or unspecified parts of mouth unspecified: 2B66.Z\\nMalignant neoplasms of parotid gland: 2B67\\nAdenocarcinoma of parotid gland: 2B67.0\\nSquamous cell carcinoma of parotid gland: 2B67.1\\nOther specified malignant neoplasms of parotid gland: 2B67.Y\\nMalignant neoplasms of parotid gland unspecified: 2B67.Z\\nMalignant neoplasms of submandibular or sublingual glands: 2B68\\nAdenocarcinoma of submandibular or sublingual glands: 2B68.0\\nSquamous cell carcinoma of submandibular or sublingual glands: 2B68.1\\nOther specified malignant neoplasms of submandibular or sublingual glands: 2B68.2\\nMalignant neoplasms of submandibular or sublingual glands unspecified: 2B68.Z\\nMalignant neoplasms of tonsil: 2B69\\nSquamous cell carcinoma of tonsil: 2B69.0\\nOther specified malignant neoplasms of tonsil: 2B69.1\\nMalignant neoplasms of tonsil unspecified: 2B69.Z\\nMalignant neoplasms of oropharynx: 2B6A\\nSquamous cell carcinoma of oropharynx: 2B6A.0\\nOther specified malignant neoplasms of oropharynx: 2B6A.Y\\nMalignant neoplasms of oropharynx unspecified: 2B6A.Z\\nMalignant neoplasms of nasopharynx: 2B6B\\nSquamous cell carcinoma of nasopharynx: 2B6B.0\\nMalignant epithelial neoplasms of nasopharynx unspecified type: 2B6B.1\\nMalignant neoplasms of pharyngeal tonsil: 2B6B.2\\nSquamous cell carcinoma of pharyngeal tonsil: 2B6B.20\\nOther or unspecified malignant epithelial neoplasm of pharyngeal tonsil: 2B6B.21\\nOther specified malignant neoplasms of pharyngeal tonsil: 2B6B.2Y\\nMalignant neoplasm of pharyngeal tonsil without mention of type: 2B6B.2Z\\nOther specified malignant neoplasms of nasopharynx: 2B6B.Y\\nMalignant neoplasms of nasopharynx unspecified: 2B6B.Z\\nMalignant neoplasms of piriform sinus: 2B6C\\nSquamous cell carcinoma of piriform sinus: 2B6C.0\\nOther specified malignant neoplasms of piriform sinus: 2B6C.Y\\nMalignant neoplasms of piriform sinus unspecified: 2B6C.Z\\nMalignant neoplasms of hypopharynx: 2B6D\\nSquamous cell carcinoma of hypopharynx and variants: 2B6D.0\\nOther specified malignant neoplasms of hypopharynx: 2B6D.Y\\nMalignant neoplasms of hypopharynx unspecified: 2B6D.Z\\nMalignant neoplasms of other or illdefined sites in the lip oral cavity or pharynx: 2B6E\\nSquamous cell carcinoma of other or illdefined sites in the lip oral cavity or pharynx: 2B6E.0\\nOther specified malignant neoplasms of other or illdefined sites in the lip oral cavity or pharynx: 2B6E.Y\\nMalignant neoplasms of other or illdefined sites in the lip oral cavity or pharynx unspecified: 2B6E.Z\\nOther specified malignant neoplasms of lip oral cavity or pharynx: 2B6Y\\nMalignant neoplasms of oesophagus: 2B70\\nAdenocarcinoma of oesophagus: 2B70.0\\nBarrett adenocarcinoma: 2B70.00\\nOther specified adenocarcinoma of oesophagus: 2B70.0Y\\nAdenocarcinoma of oesophagus unspecified: 2B70.0Z\\nSquamous cell carcinoma of oesophagus: 2B70.1\\nOther specified malignant neoplasms of oesophagus: 2B70.Y\\nMalignant neoplasms of oesophagus unspecified: 2B70.Z\\nMalignant neoplasms of oesophagogastric junction: 2B71\\nAdenocarcinoma of oesophagogastric junction: 2B71.0\\nOther specified malignant neoplasm of oesophagogastric junction: 2B71.Y\\nMalignant neoplasms of oesophagogastric junction unspecified: 2B71.Z\\nMalignant neoplasms of stomach: 2B72\\nAdenocarcinoma of stomach: 2B72.0\\nMalignant neuroendocrine neoplasm of stomach: 2B72.1\\nOther specified malignant neoplasms of stomach: 2B72.Y\\nMalignant neoplasms of stomach unspecified: 2B72.Z\\nMalignant neoplasms of small intestine: 2B80\\nMalignant neoplasms of duodenum: 2B80.0\\nAdenocarcinoma of duodenum: 2B80.00\\nNeuroendocrine neoplasm of duodenum: 2B80.01\\nOther specified malignant neoplasms of the duodenum: 2B80.0Y\\nMalignant neoplasms of duodenum unspecified: 2B80.0Z\\nMalignant neoplasms of jejunum or ileum: 2B80.1\\nAdenocarcinoma of jejunum or ileum: 2B80.10\\nNeuroendocrine neoplasms of jejunum or ileum: 2B80.11\\nOther specified malignant neoplasms of jejunum or ileum: 2B80.1Y\\nMalignant neoplasms of jejunum or ileum unspecified: 2B80.1Z\\nMalignant neoplasms of small intestine site unspecified: 2B80.2\\nAdenocarcinoma of small intestine site unspecified: 2B80.20\\nNeuroendocrine neoplasms of small intestine site unspecified: 2B80.21\\nOther specified malignant neoplasms of small intestine site unspecified: 2B80.2Y\\nOther specified malignant neoplasms of small intestine: 2B80.Y\\nMalignant neoplasms of small intestine unspecified: 2B80.Z\\nMalignant neoplasms of appendix: 2B81\\nAdenocarcinoma of appendix: 2B81.0\\nMucinous adenocarcinoma of appendix: 2B81.00\\nNeuroendocrine neoplasms of appendix: 2B81.2\\nOther specified malignant neoplasms of appendix: 2B81.Y\\nMalignant neoplasms of appendix unspecified: 2B81.Z\\nMalignant neoplasms of colon: 2B90\\nMalignant neoplasm of ascending colon and right flexure of colon: 2B90.0\\nAdenocarcinoma of ascending colon or right flexure of colon: 2B90.00\\nOther specified malignant neoplasm of ascending colon and right flexure of colon: 2B90.0Y\\nMalignant neoplasm of ascending colon and right flexure of colon unspecified: 2B90.0Z\\nMalignant neoplasm of descending colon and splenic flexure of colon: 2B90.1\\nAdenocarcinoma of descending colon or splenic flexure of colon: 2B90.10\\nOther specified malignant neoplasm of descending colon and splenic flexure of colon: 2B90.1Y\\nMalignant neoplasm of descending colon and splenic flexure of colon unspecified: 2B90.1Z\\nMalignant neoplasm of transverse colon: 2B90.2\\nAdenocarcinoma of transverse colon: 2B90.20\\nOther specified malignant neoplasm of transverse colon: 2B90.2Y\\nMalignant neoplasm of transverse colon unspecified: 2B90.2Z\\nMalignant neoplasm of sigmoid colon: 2B90.3\\nAdenocarcinoma of sigmoid colon: 2B90.30\\nOther specified malignant neoplasm of sigmoid colon: 2B90.3Y\\nMalignant neoplasm of sigmoid colon unspecified: 2B90.3Z\\nOther specified malignant neoplasms of colon: 2B90.Y\\nMalignant neoplasms of colon unspecified: 2B90.Z\\nMalignant neoplasms of rectosigmoid junction: 2B91\\nAdenocarcinoma of rectosigmoid junction: 2B91.0\\nOther specified malignant neoplasms of rectosigmoid junction: 2B91.Y\\nMalignant neoplasms of rectosigmoid junction unspecified: 2B91.Z\\nMalignant neoplasms of rectum: 2B92\\nAdenocarcinomas of rectum: 2B92.0\\nNeuroendocrine neoplasms of rectum: 2B92.1\\nOther specified malignant neoplasms of rectum: 2B92.Y\\nMalignant neoplasms of rectum unspecified: 2B92.Z\\nMalignant neoplasms of large intestine site unspecified: 2B93\\nAdenocarcinoma of large intestine site unspecified: 2B93.0\\nOther specified malignant neoplasms of large intestine site unspecified: 2B93.Y\\nMalignant neoplasms of large intestine site and type unspecified: 2B93.Z\\nOther specified malignant neoplasms of large intestine: 2B9Y\\nMalignant neoplasms of anus or anal canal: 2C00\\nAdenocarcinoma of anus or anal canal: 2C00.0\\nMelanoma of anus or anal canal: 2C00.1\\nNeuroendocrine neoplasm of anus or anal canal: 2C00.2\\nSquamous cell carcinoma of anus or anal canal: 2C00.3\\nOther specified malignant neoplasms of anus or anal canal: 2C00.Y\\nMalignant neoplasms of anus or anal canal unspecified: 2C00.Z\\nOther specified malignant neoplasms of intestine: 2C0Y\\nMalignant neoplasms of intestine unspecified: 2C0Z\\nMalignant neoplasm of pancreas: 2C10\\nAdenocarcinoma of pancreas: 2C10.0\\nNeuroendocrine neoplasms of pancreas: 2C10.1\\nOther specified malignant neoplasms of pancreas: 2C10.Y\\nMalignant neoplasm of pancreas unspecified: 2C10.Z\\nMalignant neoplasms of other or illdefined digestive organs: 2C11\\nAdenocarcinoma of other or illdefined digestive organs: 2C11.0\\nMucinous carcinoma of other or illdefined digestive organs: 2C11.1\\nOther specified malignant neoplasms of other or illdefined digestive organs: 2C11.2\\nMalignant neoplasms of other or illdefined digestive organs unspecified: 2C11.Z\\nMalignant neoplasms of liver or intrahepatic bile ducts: 2C12\\nMalignant neoplasm of liver: 2C12.0\\nCombined hepatocellularcholangiocarcinoma: 2C12.00\\nHepatoblastoma: XH2WE3\\nHepatocellular carcinoma of liver: 2C12.02\\nMesothelial carcinoma of liver: 2C12.03\\nOther specified malignant neoplasm of liver: 2C12.0Y\\nMalignant neoplasm of liver unspecified: 2C12.0Z\\nMalignant neoplasm of intrahepatic bile ducts: 2C12.1\\nIntrahepatic cholangiocarcinoma: 2C12.10\\nOther specified malignant neoplasms of intrahepatic bile ducts: 2C12.1Y\\nMalignant neoplasm of intrahepatic bile ducts unspecified: 2C12.1Z\\nMalignant neoplasms of gallbladder: 2C13\\nAdenocarcinoma of the gallbladder: 2C13.0\\nOther specified malignant neoplasm of gallbladder: 2C13.Y\\nMalignant neoplasms of gallbladder unspecified: 2C13.Z\\nMalignant neoplasms of proximal biliary tract cystic duct: 2C14\\nAdenocarcinoma of proximal biliary tract cystic duct: 2C14.0\\nMucinous cystic neoplasm with associated invasive carcinoma of cystic duct: 2C14.1\\nNeuroendocrine neoplasms of cystic duct: 2C14.2\\nOther specified malignant neoplasms of biliary tract cystic duct: 2C14.Y\\nMalignant neoplasms of proximal biliary tract cystic duct unspecified: 2C14.Z\\nMalignant neoplasms of biliary tract distal bile duct: 2C15\\nAdenocarcinoma of biliary tract distal bile duct: 2C15.0\\nMucinous cystic neoplasm with associated invasive carcinoma of distal bile duct: 2C15.1\\nNeuroendocrine neoplasms of distal bile duct: 2C15.2\\nOther specified malignant neoplasms of biliary tract distal bile duct: 2C15.Y\\nMalignant neoplasms of biliary tract distal bile duct unspecified: 2C15.Z\\nMalignant neoplasms of ampulla of Vater: 2C16\\nAdenocarcinoma of ampulla of Vater: 2C16.0\\nNeuroendocrine neoplasms of ampulla of Vater: 2C16.1\\nOther specified malignant neoplasms of ampulla of Vater: 2C16.Y\\nMalignant neoplasms of ampulla of Vater unspecified: 2C16.Z\\nMalignant neoplasms of other or unspecified parts of biliary tract: 2C17\\nAdenocarcinoma of other or unspecified parts of biliary tract: 2C17.0\\nMucinous cystic neoplasm with associated invasive carcinoma of other or unspecified parts of biliary tract: 2C17.1\\nNeuroendocrine neoplasms of other or unspecified parts of biliary tract: 2C17.2\\nOther specified malignant neoplasms of overlapping lesion of biliary tract: 2C17.Y\\nMalignant neoplasms of other or unspecified parts of biliary tract unspecified: 2C17.Z\\nMalignant neoplasms of perihilar bile duct: 2C18\\nHilar cholangiocarcinoma: 2C18.0\\nMucinous cystic neoplasm with associated invasive carcinoma of perihilar bile duct: 2C18.1\\nNeuroendocrine neoplasm of perihilar bile duct: 2C18.2\\nOther specified malignant neoplasms of perihilar bile duct: 2C18.Y\\nMalignant neoplasms of perihilar bile duct unspecified: 2C18.Z\\nMalignant neoplasms of digestive organs unspecified: 2C1Z\\nMalignant neoplasms of nasal cavity: 2C20\\nAdenocarcinoma of nasal cavity: 2C20.0\\nMalignant neuroepitheliomatous neoplasm of nasal cavity: 2C20.1\\nMelanoma of nasal cavity: 2C20.2\\nOlfactory neuroblastoma: XH50L1\\nSquamous cell carcinoma of nasal cavity: 2C20.4\\nOther specified malignant neoplasm of nasal cavity: 2C20.Y\\nMalignant neoplasms of nasal cavity unspecified: 2C20.Z\\nMalignant neoplasms of middle ear: 2C21\\nAdenocarcinoma of middle ear: 2C21.0\\nSquamous cell carcinoma of middle ear: 2C21.1\\nUnspecified malignant epithelial neoplasm of middle ear: 2C21.2\\nOther specified malignant neoplasm of middle ear: 2C21.Y\\nMalignant neoplasms of middle ear unspecified: 2C21.Z\\nMalignant neoplasms of accessory sinuses: 2C22\\nAdenocarcinoma of accessory sinuses: 2C22.0\\nSquamous cell carcinoma of accessory sinuses: 2C22.1\\nSquamous cell carcinoma of sphenoidal sinus: 2C22.10\\nSquamous cell carcinoma of other specified accessory sinuses: 2C22.1Y\\nMalignant epithelial neoplasms of accessory sinuses unspecified type: 2C22.2\\nMelanomas of accessory sinuses: 2C22.3\\nOther specified malignant neoplasms of accessory sinuses: 2C22.Y\\nMalignant neoplasms of accessory sinuses unspecified: 2C22.Z\\nMalignant neoplasms of larynx: 2C23\\nMalignant neoplasms of glottis of larynx: 2C23.1\\nSquamous cell carcinoma of larynx glottis: 2C23.10\\nOther specified malignant neoplasms of larynx glottis: 2C23.1Y\\nMalignant neoplasms of supraglottis of larynx: 2C23.2\\nSquamous cell carcinoma of larynx supraglottis: 2C23.20\\nOther specified malignant neoplasms of larynx supraglottis: 2C23.2Y\\nMalignant neoplasms of subglottis of larynx: 2C23.3\\nSquamous cell carcinoma of larynx subglottis: 2C23.30\\nAdenocarcinoma of larynx subglottis: 2C23.31\\nOther specified malignant neoplasms of larynx subglottis: 2C23.3Y\\nMalignant neoplasm of laryngeal cartilage: 2C23.4\\nMalignant neoplasm of overlapping lesion of larynx: 2C23.5\\nMalignant neoplasms of larynx unspecified: 2C23.Z\\nMalignant neoplasms of trachea: 2C24\\nAdenocarcinoma of trachea: 2C24.0\\nSquamous cell carcinoma of trachea: 2C24.1\\nMalignant epithelial neoplasms of trachea unspecified type: 2C24.2\\nOther specified malignant neoplasms of trachea: 2C24.Y\\nMalignant neoplasms of trachea unspecified: 2C24.Z\\nMalignant neoplasms of bronchus or lung: 2C25\\nAdenocarcinoma of bronchus or lung: 2C25.0\\nSmall cell carcinoma of bronchus or lung: 2C25.1\\nSquamous cell carcinoma of bronchus or lung: 2C25.2\\nLarge cell carcinoma of bronchus or lung: 2C25.3\\nCarcinoid or other malignant neuroendocrine neoplasms of bronchus or lung: 2C25.4\\nUnspecified malignant epithelial neoplasm of bronchus or lung: 2C25.5\\nOther specified malignant neoplasms of bronchus or lung: 2C25.Y\\nMalignant neoplasms of bronchus or lung unspecified: 2C25.Z\\nMalignant neoplasms of the pleura: 2C26\\nMesothelioma of pleura: 2C26.0\\nOther specified malignant neoplasms of the pleura: 2C26.Y\\nMalignant neoplasms of the pleura unspecified: 2C26.Z\\nMalignant neoplasms of thymus: 2C27\\nCarcinoma of thymus: 2C27.0\\nCarcinoid tumour or other neuroendocrine neoplasms of thymus: 2C27.1\\nThymoma: 2C27.2\\nOther specified malignant neoplasms of thymus: 2C27.Y\\nMalignant neoplasms of thymus unspecified: 2C27.Z\\nMalignant neoplasms of heart or mediastinum: 2C28\\nMalignant germ cell neoplasms of heart mediastinum or nonmesothelioma of pleura: 2C28.0\\nOther specified malignant neoplasms of heart or mediastinum: 2C28.1\\nMalignant neoplasms of heart or mediastinum unspecified: 2C28.Z\\nMalignant neoplasms of other or illdefined sites in the respiratory system or intrathoracic organs: 2C29\\nSquamous cell carcinomas of other and illdefined sites in the respiratory system or intrathoracic organs: 2C29.0\\nOther specified malignant neoplasms of other or illdefined sites in the respiratory system or intrathoracic organs: 2C29.1\\nMalignant neoplasms of other or illdefined sites in the respiratory system or intrathoracic organs unspecified: 2C29.Z\\nOther specified malignant neoplasms of middle ear respiratory or intrathoracic organs: 2C2Y\\nMalignant neoplasms of middle ear respiratory or intrathoracic organs unspecified: 2C2Z\\nMelanoma of skin: 2C30\\nSuperficial spreading melanoma primary: 2C30.0\\nNodular melanoma primary: 2C30.1\\nLentigo maligna melanoma primary: 2C30.2\\nAcral lentiginous melanoma primary: 2C30.3\\nOther specified melanoma of skin: 2C30.Y\\nMelanoma of skin unspecified: 2C30.Z\\nSquamous cell carcinoma of skin: 2C31\\nVerrucous squamous cell carcinoma of skin: 2C31.0\\nKeratoacanthoma: XH9XR8\\nCutaneous squamous cell carcinoma: 2C31.Z\\nBasal cell carcinoma of skin: 2C32\\nNodular basal cell carcinoma of skin: 2C32.0\\nSclerosing basal cell carcinoma of skin: 2C32.1\\nSuperficial basal cell carcinoma of skin: 2C32.2\\nOther specified basal cell carcinoma of skin: 2C32.Y\\nBasal cell carcinoma of skin unspecified: 2C32.Z\\nAdnexal carcinoma of skin: 2C33\\nCutaneous neuroendocrine carcinoma: 2C34\\nCutaneous sarcoma: 2C35\\nOther specified malignant neoplasms of skin: 2C3Y\\nMalignant neoplasm of skin of unknown or unspecified type: 2C3Z\\nMalignant neuroepitheliomatous neoplasms of peripheral nerves or autonomic nervous system: 2C40\\nMalignant perineurioma: 2C41\\nOther specified malignant neoplasms of peripheral nerves and autonomic nervous system: 2C4Y\\nMalignant neoplasms of peripheral nerves or autonomic nervous system unspecified: 2C4Z\\nMalignant neoplasms of retroperitoneum: 2C50\\nCystic mucinous or serous carcinoma of retroperitoneum: 2C50.0\\nOther specified malignant neoplasms of retroperitoneum: 2C50.Y\\nMalignant neoplasms of retroperitoneum unspecified: 2C50.Z\\nMalignant neoplasms of peritoneum: 2C51\\nAdenocarcinomas of peritoneum: 2C51.0\\nCystic mucinous or serous carcinoma of peritoneum: 2C51.1\\nMesotheliomas of peritoneum: 2C51.2\\nMesothelioma of mesocolon: 2C51.20\\nMesothelioma of mesentery: 2C51.21\\nMesotheliomas of other specified sites of peritoneum: 2C51.2Y\\nMesotheliomas of peritoneum site unspecified: 2C51.2Z\\nOther specified malignant neoplasms of peritoneum: 2C51.Y\\nMalignant neoplasms of peritoneum unspecified: 2C51.Z\\nMalignant neoplasms of omentum: 2C52\\nCystic mucinous or serous carcinoma of omentum: 2C52.0\\nOther specified malignant neoplasms of omentum: 2C52.Y\\nMalignant neoplasms of omentum unspecified: 2C52.Z\\nMalignant neoplasm involving overlapping sites of retroperitoneum peritoneum or omentum: 2C53\\nAdenocarcinoma involving overlapping sites of retroperitoneum peritoneum or omentum: 2C53.0\\nMesothelioma involving overlapping sites of retroperitoneum peritoneum or omentum: 2C53.1\\nOther specified malignant neoplasm involving overlapping sites of retroperitoneum peritoneum or omentum: 2C53.Y\\nMalignant neoplasm involving overlapping sites of retroperitoneum peritoneum or omentum unspecified: 2C53.Z\\nCarcinoma of breast specialised type: 2C60\\nInvasive carcinoma of breast: 2C61\\nInvasive ductal carcinoma of breast: 2C61.0\\nInvasive lobular carcinoma of breast: 2C61.1\\nInvasive pleomorphic lobular carcinoma of breast: 2C61.2\\nInvasive carcinoma of breast with mixed ductal and lobular features: 2C61.3\\nInvasive carcinoma of breast unidentifiable type: 2C61.4\\nInflammatory carcinoma of breast: 2C62\\nMalignant phyllodes tumour of breast: 2C63\\nSolid papillary carcinoma of breast with evidence of invasion: 2C64\\nHereditary breast and ovarian cancer syndrome: 2C65\\nOther specified malignant neoplasms of breast: 2C6Y\\nMalignant neoplasms of breast unspecified: 2C6Z\\nMalignant neoplasms of vulva: 2C70\\nBasal cell carcinoma of vulva: 2C70.0\\nMelanoma of vulva: 2C70.1\\nSquamous cell carcinoma of vulva: 2C70.2\\nOther specified malignant neoplasms of vulva: 2C70.Y\\nMalignant neoplasms of vulva unspecified: 2C70.Z\\nMalignant neoplasms of vagina: 2C71\\nAdenocarcinoma of vagina: 2C71.0\\nMelanoma of vagina: 2C71.1\\nSquamous cell carcinoma of vagina: 2C71.2\\nOther specified malignant neoplasms of vagina: 2C71.Y\\nMalignant neoplasms of vagina unspecified: 2C71.Z\\nMalignant neoplasms of uterine ligament parametrium or uterine adnexa: 2C72\\nAdenocarcinoma of uterine ligament parametrium or uterine adnexa: 2C72.0\\nMucinous or serous carcinoma of uterine ligament parametrium or uterine adnexa: 2C72.1\\nCarcinosarcomas of uterine ligament parametrium or uterine adnexa: 2C72.3\\nOther specified malignant neoplasms of uterine ligament parametrium or uterine adnexa: 2C72.Y\\nMalignant neoplasms of uterine ligament parametrium or uterine adnexa unspecified: 2C72.Z\\nMalignant neoplasms of ovary: 2C73\\nCarcinomas of ovary: 2C73.0\\nClear cell adenocarcinoma of ovary: 2C73.00\\nEndometrioid adenocarcinoma of ovary: 2C73.01\\nLow grade serous adenocarcinoma of ovary: 2C73.02\\nHigh grade serous adenocarcinoma of ovary: 2C73.03\\nMucinous adenocarcinoma of ovary: 2C73.04\\nOther specified carcinomas of ovary: 2C73.0Y\\nCarcinomas of ovary unspecified: 2C73.0Z\\nDysgerminoma of ovary: 2C73.1\\nGranulosa cell malignant tumour of ovary: 2C73.2\\nMalignant teratoma of ovary: 2C73.3\\nSerous cystadenoma borderline malignancy of ovary: 2C73.4\\nEndodermal sinus tumour unspecified site female: 2C73.5\\nOther specified malignant neoplasms of the ovary: 2C73.Y\\nMalignant neoplasms of ovary unspecified: 2C73.Z\\nMalignant neoplasms of fallopian tube: 2C74\\nAdenocarcinoma of fallopian tube: 2C74.0\\nOther specified malignant neoplasms of fallopian tube: 2C74.Y\\nMalignant neoplasms of fallopian tube unspecified: 2C74.Z\\nMalignant neoplasms of placenta: 2C75\\nMalignant trophoblastic neoplasms of placenta: 2C75.0\\nOther specified malignant neoplasms of placenta: 2C75.Y\\nMalignant neoplasms of placenta unspecified: 2C75.Z\\nMalignant neoplasms of corpus uteri: 2C76\\nEndometrial endometrioid adenocarcinoma: 2C76.0\\nEndometrial mucinous adenocarcinoma: 2C76.1\\nEndometrial clear cell adenocarcinoma: 2C76.2\\nEndometrial serous adenocarcinoma: 2C76.3\\nEndometrial mixed adenocarcinoma: 2C76.4\\nEndometrial squamous cell carcinoma: 2C76.40\\nEndometrial small cell carcinoma: 2C76.41\\nEndometrial undifferentiated carcinoma: 2C76.42\\nCarcinosarcoma of uterus: 2C76.43\\nEndometrial mixed adenocarcinoma unspecified: 2C76.4Z\\nOther specified malignant neoplasms of corpus uteri: 2C76.Y\\nMalignant neoplasms of corpus uteri unspecified: 2C76.Z\\nMalignant neoplasms of cervix uteri: 2C77\\nSquamous cell carcinoma of cervix uteri: 2C77.0\\nAdenocarcinoma of cervix uteri: 2C77.1\\nAdenosquamous carcinoma of cervix uteri: 2C77.2\\nNeuroendocrine carcinoma of cervix uteri: 2C77.3\\nOther specified malignant neoplasms of cervix uteri: 2C77.Y\\nMalignant neoplasms of cervix uteri unspecified: 2C77.Z\\nMalignant neoplasms of uterus part not specified: 2C78\\nMalignant neoplasm involving overlapping sites of female genital organs: 2C79\\nOther specified malignant neoplasms of female genital organs: 2C7Y\\nMalignant neoplasms of female genital organs unspecified: 2C7Z\\nMalignant neoplasms of testis: 2C80\\nGerm cell tumour of testis: 2C80.2\\nOther specified malignant neoplasms of testis: 2C80.Y\\nMalignant neoplasms of testis unspecified: 2C80.Z\\nMalignant neoplasms of penis: 2C81\\nSquamous cell carcinoma of penis: 2C81.0\\nMelanoma of penis: 2C81.1\\nOther specified malignant neoplasm of penis: 2C81.Y\\nMalignant neoplasms of penis unspecified: 2C81.Z\\nMalignant neoplasms of prostate: 2C82\\nAdenocarcinoma of prostate: 2C82.0\\nOther specified malignant neoplasms of prostate: 2C82.Y\\nMalignant neoplasms of prostate unspecified: 2C82.Z\\nMalignant neoplasms of scrotum: 2C83\\nSquamous cell carcinoma of scrotum: 2C83.0\\nOther specified malignant neoplasms of scrotum: 2C83.Y\\nMalignant neoplasms of scrotum unspecified: 2C83.Z\\nMalignant neoplasms of other specified male genital organs: 2C84\\nMalignant neoplasms of male genital organs unspecified: 2C8Z\\nMalignant neoplasms of kidney except renal pelvis: 2C90\\nRenal cell carcinoma of kidney except renal pelvis: 2C90.0\\nOther specified malignant neoplasms of kidney except renal pelvis: 2C90.Y\\nMalignant neoplasms of kidney except renal pelvis unspecified: 2C90.Z\\nMalignant neoplasms of renal pelvis: 2C91\\nUrothelial carcinoma of renal pelvis: 2C91.0\\nOther specified malignant neoplasms of renal pelvis: 2C91.Y\\nMalignant neoplasms of renal pelvis unspecified: 2C91.Z\\nMalignant neoplasms of ureter: 2C92\\nUrothelial carcinoma of ureter: 2C92.0\\nOther specified malignant neoplasms of ureter: 2C92.Y\\nMalignant neoplasms of ureter unspecified: 2C92.Z\\nMalignant neoplasms of urethra or paraurethral gland: 2C93\\nAdenocarcinoma of urethra or paraurethral gland: 2C93.0\\nSquamous cell carcinoma of urethra or paraurethral gland: 2C93.1\\nUrothelial carcinoma of urethra or paraurethral gland: 2C93.2\\nOther specified malignant neoplasms of urethra or paraurethral gland: 2C93.Y\\nMalignant neoplasms of urethra or paraurethral gland unspecified: 2C93.Z\\nMalignant neoplasms of bladder: 2C94\\nAdenocarcinoma of urinary bladder: 2C94.0\\nSquamous cell carcinoma of urinary bladder: 2C94.1\\nUrothelial carcinoma of bladder: 2C94.2\\nOther specified malignant neoplasms of bladder: 2C94.Y\\nMalignant neoplasms of bladder unspecified: 2C94.Z\\nMalignant neoplasm involving overlapping sites of urinary organs: 2C95\\nAdenocarcinoma involving overlapping sites of urinary organs: 2C95.0\\nSquamous cell carcinomas involving overlapping sites of urinary organs: 2C95.1\\nUrothelial carcinoma involving overlapping sites of urinary organs: 2C95.2\\nOther specified malignant neoplasms of overlapping lesion of urinary organs: 2C95.Y\\nMalignant neoplasm involving overlapping sites of urinary organs unspecified: 2C95.Z\\nOther specified malignant neoplasms of urinary tract: 2C9Y\\nMalignant neoplasms of urinary tract unspecified: 2C9Z\\nMalignant neoplasm of conjunctiva: 2D00\\nMelanoma of conjunctiva: 2D00.0\\nMalignant neoplasm of caruncle: 2D00.1\\nSquamous cell carcinoma of conjunctiva: 2D00.2\\nOther specified malignant neoplasm of conjunctiva: 2D00.Y\\nMalignant neoplasm of conjunctiva unspecified: 2D00.Z\\nMalignant neoplasm of cornea: 2D01\\nMelanoma of cornea: 2D01.0\\nSquamous cell carcinoma of cornea: 2D01.1\\nOther specified malignant neoplasms of cornea: 2D01.Y\\nMalignant neoplasm of cornea unspecified: 2D01.Z\\nMalignant neoplasm of retina: 2D02\\nAdenocarcinoma of retinal pigment epithelium: 2D02.0\\nMalignant neuroepithelial tumours of retina: 2D02.1\\nRetinoblastoma: 2D02.2\\nOther specified malignant neoplasm of retina: 2D02.Y\\nMalignant neoplasm of retina unspecified: 2D02.Z\\nMalignant neoplasm of lacrimal apparatus: 2D03\\nAdenocarcinoma of the lacrimal apparatus: 2D03.0\\nMucoepidermoid carcinoma of lacrimal apparatus: 2D03.1\\nSquamous cell carcinoma of the lacrimal apparatus: 2D03.2\\nOther specified malignant neoplasm of lacrimal apparatus: 2D03.Y\\nMalignant neoplasm of lacrimal apparatus unspecified: 2D03.Z\\nMalignant neoplasm of orbit: 2D04\\nMalignant neoplasm of choroid: 2D05\\nMelanoma of choroid: 2D05.0\\nOther specified malignant neoplasm of choroid: 2D05.Y\\nMalignant neoplasm of choroid unspecified: 2D05.Z\\nMalignant neoplasm of ciliary body: 2D06\\nAdenocarcinoma of ciliary epithelium: 2D06.0\\nMalignant medulloepithelioma of ciliary body: 2D06.1\\nMalignant neuroepithelial tumours of ciliary body: 2D06.3\\nMelanoma of ciliary body: 2D06.4\\nOther specified malignant neoplasm of ciliary body: 2D06.Y\\nMalignant neoplasm of ciliary body unspecified: 2D06.Z\\nMalignant neoplasm of iris: 2D07\\nAdenocarcinoma of iris epithelium: 2D07.0\\nMalignant neuroepithelial tumours of iris: 2D07.1\\nMelanoma of iris: 2D07.2\\nOther specified malignant neoplasm of iris: 2D07.Y\\nMalignant neoplasm of iris unspecified: 2D07.Z\\nOther specified malignant neoplasms of eye or ocular adnexa: 2D0Y\\nMalignant neoplasms of eye or ocular adnexa unspecified: 2D0Z\\nMalignant neoplasms of thyroid gland: 2D10\\nFollicular carcinoma of thyroid gland: 2D10.0\\nPapillary carcinoma of thyroid gland: 2D10.1\\nPoorly differentiated carcinoma of thyroid gland: 2D10.2\\nUndifferentiated carcinoma of thyroid gland: 2D10.3\\nMedullary carcinoma of thyroid gland: 2D10.4\\nOther specified malignant neoplasms of thyroid gland: 2D10.Y\\nMalignant neoplasms of thyroid gland unspecified: 2D10.Z\\nMalignant neoplasms of adrenal gland: 2D11\\nAdenocarcinoma of adrenal gland: 2D11.0\\nMalignant phaeochromocytoma of adrenal gland: 2D11.1\\nNeuroblastoma of adrenal gland: 2D11.2\\nOther specified malignant neoplasms of adrenal gland: 2D11.Y\\nMalignant neoplasms of adrenal gland unspecified: 2D11.Z\\nMalignant neoplasms of other endocrine glands or related structures: 2D12\\nMalignant epithelial neoplasms of other endocrine glands or related structures unspecified type: 2D12.0\\nAdenocarcinoma of other endocrine glands or related structures: 2D12.1\\nOther specified malignant neoplasms of other endocrine glands or related structures: 2D12.Y\\nMalignant neoplasms of other endocrine glands or related structures unspecified: 2D12.Z\\nMalignant neoplasms of endocrine glands unspecified: 2D1Z\\nOther specified malignant neoplasms stated or presumed to be primary of specified sites except of lymphoid haematopoietic central nervous system or related tissues: 2D3Y\\nMalignant neoplasms stated or presumed to be primary of specified sites except of lymphoid haematopoietic central nervous system or related tissues unspecified: 2D3Z\\nAdenocarcinoma of unspecified site: 2D40\\nUnspecified carcinoma of unspecified site: 2D41\\nMalignant neoplasms of illdefined sites: 2D42\\nMalignant neoplasms of independent multiple primary sites: 2D43\\nMalignant neoplasm primary site unknown so stated: 2D44\\nOther specified malignant neoplasms of unspecified primary sites: 2D4Y\\nUnspecified malignant neoplasms of unspecified sites: 2D4Z\\nMalignant neoplasm metastasis in brain: 2D50\\nMalignant neoplasm metastasis in meninges: 2D51\\nMalignant neoplasm metastasis in spinal cord cranial nerves or paraspinal nerves: 2D52\\nMalignant neoplasm metastasis in lymph node of a single region: 2D60\\nMalignant neoplasm metastasis in lymph nodes of head face or neck: 2D60.0\\nMalignant neoplasm metastasis in intrathoracic lymph nodes: 2D60.1\\nMalignant neoplasm metastasis in intraabdominal lymph nodes: 2D60.2\\nMalignant neoplasm metastasis in axillary lymph nodes: 2D60.3\\nMalignant neoplasm metastasis in inguinal lymph nodes: 2D60.4\\nMalignant neoplasm metastasis in intrapelvic lymph nodes: 2D60.5\\nOther specified malignant neoplasm metastasis in lymph node of a single region: 2D60.Y\\nMalignant neoplasm metastasis in lymph node of a single region unspecified: 2D60.Z\\nMalignant neoplasm metastases in lymph nodes of multiple regions: 2D61\\nMetastatic malignant neoplasm to unspecified lymph node: 2D6Z\\nMalignant neoplasm metastasis in lung: 2D70\\nMalignant neoplasm metastasis in mediastinum: 2D71\\nMalignant neoplasm metastasis in pleura: 2D72\\nMalignant neoplasm metastasis in upper respiratory tract organs: 2D73\\nMalignant neoplasm metastasis in other specified thoracic organs: 2D7Y\\nMalignant neoplasm metastasis in thoracic or respiratory organs unspecified: 2D7Z\\nMalignant neoplasm metastasis in liver or intrahepatic bile duct: 2D80\\nMalignant neoplasm metastasis in liver: 2D80.0\\nMalignant neoplasm metastasis in intrahepatic bile duct: 2D80.1\\nMalignant neoplasm metastasis in pancreas: 2D81\\nMalignant neoplasm metastasis in extrahepatic bile ducts: 2D82\\nMalignant neoplasm metastasis in ampulla of Vater: 2D83\\nMalignant neoplasm metastasis in the small intestine: 2D84\\nMalignant neoplasm metastasis in large intestine: 2D85\\nMalignant neoplasm metastasis in anus: 2D86\\nMalignant neoplasm metastasis in other specified digestive system organ: 2D8Y\\nMalignant neoplasm metastasis in unspecified digestive system organ: 2D8Z\\nMalignant neoplasm metastasis in retroperitoneum: 2D90\\nMalignant neoplasm metastasis in peritoneum: 2D91\\nMalignant neoplasm metastasis in kidney or renal pelvis: 2E00\\nMalignant neoplasm metastasis in bladder: 2E01\\nMalignant neoplasm metastasis in other or unspecified urinary system organs: 2E02\\nMalignant neoplasm metastasis in bone or bone marrow: 2E03\\nMalignant neoplasm metastasis in soft tissue: 2E04\\nMalignant neoplasm metastasis in female reproductive system: 2E05\\nMalignant neoplasm metastasis in ovary: 2E05.0\\nMalignant neoplasm metastasis in other female reproductive system organs: 2E05.Y\\nMalignant neoplasm metastasis in female reproductive system unspecified: 2E05.Z\\nMalignant neoplasm metastasis in male genital organs: 2E06\\nMalignant neoplasm metastasis in adrenal gland: 2E07\\nMetastatic malignant neoplasm involving skin: 2E08\\nMalignant neoplasm metastasis in peripheral nervous system: 2E09\\nMalignant neoplasm metastasis in other specified sites: 2E0Y\\nMalignant neoplasm metastasis unspecified: 2E2Z\\nCarcinoma in situ of oral cavity oesophagus or stomach: 2E60\\nCarcinoma in situ of lip oral cavity or pharynx: 2E60.0\\nCarcinoma in situ of oesophagus: 2E60.1\\nCarcinoma in situ of stomach: 2E60.2\\nCarcinoma in situ of other or unspecified digestive organs: 2E61\\nCarcinoma in situ of colon: 2E61.0\\nCarcinoma in situ of rectum: 2E61.1\\nCarcinoma in situ of anal canal: 2E61.2\\nCarcinoma in situ of gallbladder biliary tract or ampulla of Vater: 2E61.3\\nCarcinoma in situ of other specified digestive organs: 2E61.Y\\nCarcinoma in situ of unspecified digestive organs: 2E61.Z\\nCarcinoma in situ of middle ear or respiratory system: 2E62\\nCarcinoma in situ of larynx: 2E62.0\\nCarcinoma in situ of trachea: 2E62.1\\nCarcinoma in situ of bronchus or lung: 2E62.2\\nCarcinoma in situ of other specified sites of middle ear or respiratory system: 2E62.Y\\nCarcinoma in situ of unspecified sites of middle ear or respiratory system: 2E62.Z\\nMelanoma in situ neoplasms: 2E63\\nMelanoma in situ of skin: 2E63.0\\nLentigo maligna: XH9KY6\\nMelanoma in situ of skin unspecified: 2E63.0Z\\nMelanoma in situ of conjunctiva: 2E63.1\\nMelanoma in situ neoplasms other specified site: 2E63.Y\\nMelanoma in situ neoplasms unspecified site: 2E63.Z\\nCarcinoma in situ of skin: 2E64\\nIntraepidermal squamous cell carcinoma: 2E64.0\\nBowen disease of skin: 2E64.00\\nActinic intraepidermal squamous cell carcinoma: 2E64.01\\nOther specified intraepidermal squamous cell carcinoma: 2E64.0Y\\nIntraepidermal squamous cell carcinoma unspecified: 2E64.0Z\\nExtramammary Paget disease of skin: 2E64.1\\nCarcinoma in situ of anal margin or perianal skin: 2E64.2\\nOther specified carcinoma in situ of skin: 2E64.Y\\nCarcinoma in situ of skin unspecified: 2E64.Z\\nCarcinoma in situ of breast: 2E65\\nLobular carcinoma in situ of breast: 2E65.0\\nLobular carcinoma in situ of breast pleomorphic subtype: 2E65.1\\nDuctal carcinoma in situ of breast: 2E65.2\\nDuctal carcinoma in situ of breast comedo subtype: 2E65.3\\nMixed ductal and lobular carcinoma in situ of breast: 2E65.4\\nPaget disease of nipple: 2E65.5\\nOther specified carcinoma in situ of breast: 2E65.Y\\nCarcinoma in situ of breast unspecified: 2E65.Z\\nCarcinoma in situ of cervix uteri: 2E66\\nHigh grade squamous intraepithelial lesion of cervix uteri: 2E66.2\\nOther specified carcinoma in situ of cervix uteri: 2E66.Y\\nCarcinoma in situ of cervix uteri unspecified: 2E66.Z\\nCarcinoma in situ of other or unspecified genital organs: 2E67\\nCarcinoma in situ of endometrium: 2E67.0\\nCarcinoma in situ of vulva: 2E67.1\\nVulvar Paget disease: 2E67.11\\nVulvar intraepithelial neoplasia HPVindependent: 2E67.12\\nHigh grade squamous intraepithelial lesion of vulva HPVassociated: 2E67.13\\nCarcinoma in situ of vagina: 2E67.2\\nHigh grade squamous intraepithelial lesion of vagina: 2E67.22\\nOther specified carcinoma in situ of vagina: 2E67.2Y\\nCarcinoma in situ of vagina unspecified: 2E67.2Z\\nCarcinoma in situ of other or unspecified female genital organs: 2E67.3\\nCarcinoma in situ of penis: 2E67.4\\nSquamous cell carcinoma in situ of skin of penis: 2E67.40\\nSquamous cell carcinoma in situ of mucocutaneous epithelium of penis: 2E67.41\\nHigh grade intraepithelial lesion of prostate: 2E67.5\\nCarcinoma in situ of other or unspecified male genital organs: 2E67.6\\nCarcinoma in situ of bladder: 2E68\\nCarcinoma in situ of other or unspecified urinary organs: 2E69\\nCarcinoma in situ of the eye or ocular adnexa: 2E6A\\nCarcinoma in situ of the conjunctiva: 2E6A.0\\nCarcinoma in situ of the cornea: 2E6A.1\\nCarcinoma in situ of other and unspecified part of the eye and adnexa: 2E6A.Y\\nCarcinoma in situ of thyroid and other endocrine glands: 2E6B\\nCarcinoma in situ of other specified site: 2E6Y\\nCarcinoma in situ of unspecified site: 2E6Z\\nBenign lipomatous neoplasm: 2E80\\nLipoma: 2E80.0\\nSuperficial subcutaneous lipoma: 2E80.00\\nDeep subfascial lipoma: 2E80.01\\nDeep internal or visceral lipoma: 2E80.02\\nLipoma other specified site: 2E80.0Y\\nLipoma unspecified site: 2E80.0Z\\nLipoblastoma: 2E80.1\\nOther specified benign lipomatous neoplasm: 2E80.Y\\nBenign lipomatous neoplasm unspecified: 2E80.Z\\nBenign vascular neoplasms: 2E81\\nNeoplastic haemangioma: 2E81.0\\nUmbilical cord haemangioma: 2E81.00\\nConjunctival haemangioma or haemolymphangioma: 2E81.01\\nNeoplastic haemangioma of other specified site: 2E81.0Y\\nNeoplastic haemangioma unspecified site: 2E81.0Z\\nBenign lymphatic neoplasms: 2E81.1\\nDisseminated lymphangiomatosis: 2E81.10\\nAcquired progressive lymphangioma: 2E81.11\\nOther specified benign lymphatic neoplasms: 2E81.1Y\\nBenign lymphatic neoplasms unspecified: 2E81.1Z\\nBenign vascular neoplasms of infancy or childhood: 2E81.2\\nFocal infantile haemangioma: 2E81.20\\nMultifocal infantile haemangioma: 2E81.21\\nOther specified benign vascular neoplasms of infancy or childhood: 2E81.2Y\\nBenign vascular neoplasms of infancy or childhood unspecified: 2E81.2Z\\nOther specified benign vascular neoplasms: 2E81.Y\\nBenign vascular neoplasms unspecified: 2E81.Z\\nBenign chondrogenic tumours: 2E82\\nBenign chondrogenic tumours of bone or articular cartilage of limbs: 2E82.0\\nBenign chondrogenic tumours of bone or articular cartilage of other specified sites: 2E82.1\\nBenign chondrogenic tumours site unspecified: 2E82.Z\\nBenign osteogenic tumours: 2E83\\nBenign osteogenic tumours of bone or articular cartilage of skull or face: 2E83.0\\nBenign osteogenic tumours of bone or articular cartilage of lower jaw: 2E83.1\\nBenign osteogenic tumours of bone or articular cartilage of vertebral column: 2E83.2\\nBenign osteogenic tumours of bone or articular cartilage of ribs sternum or clavicle: 2E83.3\\nBenign osteogenic tumours of bone or articular cartilage of pelvic bones sacrum or coccyx: 2E83.4\\nBenign osteogenic tumours of bone or articular cartilage of limbs: 2E83.5\\nBenign osteogenic tumour of other specified site: 2E83.Y\\nBenign osteogenic tumour of unspecified site: 2E83.Z\\nBenign fibrogenic or myofibrogenic tumour: 2E84\\nBenign fibrogenic or myofibrogenic tumour of skin: 2E84.0\\nBenign fibrogenic or myofibrogenic tumour of other specified sites: 2E84.Y\\nBenign fibrogenic or myofibrogenic tumour site unknown: 2E84.Z\\nBenign fibrohistiocytic tumour: 2E85\\nBenign fibrohistiocytic tumour of soft tissues of limbs: 2E85.0\\nBenign fibrohistiocytic tumour of retroperitoneum or peritoneum: 2E85.1\\nBenign fibrohistiocytic tumour of skin: 2E85.2\\nBenign fibrohistiocytic tumour of other specified sites: 2E85.Y\\nBenign fibrohistiocytic tumour site unspecified: 2E85.Z\\nBenign smooth muscle or skeletal muscle tumour: 2E86\\nLeiomyoma of uterus: 2E86.0\\nLeiomyoma of other or unspecified sites: 2E86.1\\nRhabdomyoma: 2E86.2\\nOther specified benign smooth muscle or skeletal muscle tumour: 2E86.Y\\nBenign smooth muscle or skeletal muscle tumour unspecified: 2E86.Z\\nBenign gastrointestinal stromal tumour: 2E87\\nBenign endometrial stromal nodule: 2E88\\nBenign mesenchymal tumours of uncertain differentiation: 2E89\\nBenign tumours of uncertain differentiation bone or cartilage: 2E89.0\\nBenign tumours of uncertain differentiation soft tissue: 2E89.1\\nBenign mesenchymal tumours of uncertain differentiation of other specified site: 2E89.Y\\nBenign mesenchymal tumours of uncertain differentiation of unspecified site: 2E89.Z\\nOther mixed benign mesenchymal tumours: 2E8A\\nOther specified benign mesenchymal neoplasm: 2E8Y\\nBenign mesenchymal neoplasms unspecified: 2E8Z\\nBenign neoplasm of lip oral cavity or pharynx: 2E90\\nBenign neoplasm of lip: 2E90.0\\nBenign neoplasm of tongue: 2E90.1\\nBenign neoplasm of floor of mouth: 2E90.2\\nBenign neoplasm of other or unspecified parts of mouth: 2E90.3\\nBenign neoplasm of tonsil: 2E90.4\\nBenign neoplasm of oropharynx: 2E90.5\\nBenign neoplasm of nasopharynx: 2E90.6\\nBenign neoplasm of hypopharynx: 2E90.7\\nBenign neoplasm of pharynx unspecified: 2E90.8\\nBenign neoplasm of major salivary glands: 2E91\\nBenign neoplasm of parotid gland: 2E91.0\\nBenign neoplasm of other specified major salivary glands: 2E91.1\\nBenign neoplasm of unspecified major salivary glands: 2E91.Z\\nBenign neoplasm of digestive organs: 2E92\\nBenign neoplasm of oesophagus: 2E92.0\\nBenign neoplasm of stomach: 2E92.1\\nBenign neoplasm of duodenum: 2E92.2\\nBenign neoplasm of other or unspecified parts of small intestine: 2E92.3\\nBenign neoplasm of the large intestine: 2E92.4\\nPolyposis syndrome: 2E92.40\\nOther specified benign neoplasm of the large intestine: 2E92.4Y\\nBenign neoplasm of the large intestine unspecified: 2E92.4Z\\nBenign neoplasm of anus or anal canal: 2E92.5\\nBenign neoplasm of gallbladder extrahepatic bile ducts or ampulla of Vater: 2E92.6\\nBenign neoplasm of liver or intrahepatic bile ducts: 2E92.7\\nBenign neoplasm of pancreas: 2E92.8\\nBenign neoplasm of endocrine pancreas: 2E92.9\\nBenign neoplasm of other specified digestive organs: 2E92.Y\\nBenign neoplasm of unspecified digestive organs: 2E92.Z\\nBenign neoplasm of middle ear or respiratory system: 2F00\\nMiddle ear endocrine tumour: 2F00.0\\nRecurrent respiratory papillomatosis: 2F00.1\\nLaryngeal endocrine tumour: 2F00.2\\nOther specified benign neoplasm of middle ear or respiratory system: 2F00.Y\\nBenign neoplasm of middle ear or respiratory system unspecified: 2F00.Z\\nBenign neoplasm of other intrathoracic organs: 2F01\\nBenign neoplasm of mesothelial tissue: 2F10\\nBenign cutaneous melanocytic neoplasms: 2F20\\nCommon acquired melanocytic naevus: 2F20.0\\nMultiple benign melanocytic naevi: 2F20.00\\nOther specified common acquired melanocytic naevus: 2F20.0Y\\nCommon acquired melanocytic naevus unspecified: 2F20.0Z\\nAtypical melanocytic naevus: 2F20.1\\nCongenital melanocytic naevus: 2F20.2\\nGiant congenital melanocytic naevus: 2F20.20\\nOther specified congenital melanocytic naevus: 2F20.2Y\\nCongenital melanocytic naevus unspecified: 2F20.2Z\\nGeneralised eruptive melanocytic naevi: 2F20.3\\nOther specific types of melanocytic naevus: 2F20.Y\\nMelanocytic naevus unspecified: 2F20.Z\\nBenign keratinocytic acanthomas: 2F21\\nSeborrhoeic keratosis: XH0949\\nOther specified benign keratinocytic acanthomas: 2F21.Y\\nBenign neoplasms of epidermal appendages: 2F22\\nBenign dermal fibrous or fibrohistiocytic neoplasms: 2F23\\nDermatofibroma: 2F23.0\\nOther specified benign dermal fibrous or fibrohistiocytic neoplasms: 2F23.Y\\nBenign cutaneous neoplasms of neural or nerve sheath origin: 2F24\\nCherry angioma: 2F25\\nLobular capillary haemangioma: 2F26\\nOther specified benign cutaneous neoplasms: 2F2Y\\nBenign cutaneous neoplasm of unspecified type: 2F2Z\\nBenign neoplasm of breast: 2F30\\nTubular adenoma of breast: 2F30.0\\nLactating adenoma of breast: 2F30.1\\nIntraductal papilloma of breast: 2F30.2\\nBenign phyllodes tumour of breast: 2F30.3\\nFibromatosis of breast: 2F30.4\\nFibroadenoma of breast: 2F30.5\\nExtensive adenomatosis of nipple: 2F30.6\\nBenign neoplasm of the nipple: 2F30.7\\nOther specified benign neoplasm of breast: 2F30.Y\\nBenign neoplasm of breast unspecified: 2F30.Z\\nBenign nonmesenchymal neoplasms of uterus: 2F31\\nBenign nonmesenchymal neoplasm of uterus cervix uteri: 2F31.0\\nBenign nonmesenchymal neoplasm of uterus corpus uteri: 2F31.1\\nBenign nonmesenchymal neoplasms of uterus other parts: 2F31.2\\nBenign neoplasm of ovary: 2F32\\nCystic teratoma: 2F32.0\\nOvarian fibroma: 2F32.1\\nMeigs syndrome: 2F32.2\\nSerous ovarian cystadenoma: 2F32.3\\nOther specified benign neoplasm of ovary: 2F32.Y\\nBenign neoplasm of ovary unspecified: 2F32.Z\\nBenign neoplasm of other or unspecified female genital organs: 2F33\\nBenign neoplasm of male genital organs: 2F34\\nBenign neoplasm of urinary organs: 2F35\\nBenign neoplasm of eye or ocular adnexa: 2F36\\nBenign neoplasm of choroid: 2F36.0\\nBenign neoplasm of iris: 2F36.1\\nBenign neoplasm of ciliary body: 2F36.2\\nTeratoma of orbit: 2F36.3\\nCysts of eyelid: 2F36.4\\nOther specified benign neoplasm of eye or ocular adnexa: 2F36.Y\\nBenign neoplasm of eye or ocular adnexa unspecified: 2F36.Z\\nBenign neoplasm of endocrine glands: 2F37\\nNonsecreting pituitary adenoma: 2F37.0\\nOther specified benign neoplasm of endocrine glands: 2F37.Y\\nBenign neoplasm of endocrine glands unspecified: 2F37.Z\\nBenign neoplasms except of mesenchymal origin of other specified site: 2F3Y\\nBenign neoplasms except of mesenchymal origin of unspecified site: 2F3Z\\nNeoplasms of uncertain behaviour of oral cavity or digestive organs: 2F70\\nNeoplasms of uncertain behaviour of lip oral cavity or pharynx: 2F70.0\\nNeoplasms of uncertain behaviour of stomach: 2F70.1\\nNeoplasms of uncertain behaviour of small intestine: 2F70.2\\nNeoplasms of uncertain behaviour of colon: 2F70.3\\nNeoplasms of uncertain behaviour of rectum: 2F70.4\\nNeoplasms of uncertain behaviour of liver gallbladder or bile ducts: 2F70.5\\nNeoplasms of uncertain behaviour of oral cavity or digestive organs other specified site: 2F70.Y\\nNeoplasms of uncertain behaviour of oral cavity or digestive organs unspecified site: 2F70.Z\\nNeoplasms of uncertain behaviour of middle ear respiratory or intrathoracic organs: 2F71\\nNeoplasms of uncertain behaviour of thymus: 2F71.0\\nNeoplasms of uncertain behaviour of larynx: 2F71.1\\nNeoplasms of uncertain behaviour of pleura: 2F71.2\\nNeoplasms of uncertain behaviour of trachea bronchus or lung: 2F71.3\\nNeoplasms of uncertain behaviour of mediastinum: 2F71.4\\nNeoplasms of uncertain behaviour of middle ear respiratory or intrathoracic organs other specified site: 2F71.Y\\nNeoplasms of uncertain behaviour of middle ear respiratory or intrathoracic organs unspecified site: 2F71.Z\\nNeoplasms of uncertain behaviour of skin: 2F72\\nSpitzoid tumour of uncertain malignant potential: 2F72.1\\nMelanocytic naevus with severe melanocytic dysplasia: 2F72.2\\nOther specified neoplasms of uncertain behaviour of skin: 2F72.Y\\nNeoplasms of uncertain behaviour of retroperitoneum: 2F73\\nNeoplasms of uncertain behaviour of peritoneum: 2F74\\nNeoplasms of uncertain behaviour of breast: 2F75\\nNeoplasms of uncertain behaviour of female genital organs: 2F76\\nNeoplasms of uncertain behaviour of male genital organs: 2F77\\nNeoplasms of uncertain behaviour of urinary organs: 2F78\\nNeoplasms of uncertain behaviour of eye or ocular adnexa: 2F79\\nNeoplasms of uncertain behaviour of endocrine glands: 2F7A\\nMultiple polyglandular tumours: 2F7A.0\\nOther specified neoplasms of uncertain behaviour of endocrine glands: 2F7A.Y\\nNeoplasms of uncertain behaviour of endocrine glands unspecified: 2F7A.Z\\nNeoplasms of uncertain behaviour of bone or articular cartilage: 2F7B\\nNeoplasms of uncertain behaviour of connective or other soft tissue: 2F7C\\nNeoplasms of uncertain behaviour of other specified site: 2F7Y\\nNeoplasms of uncertain behaviour of unspecified site: 2F7Z\\nNeoplasms of unknown behaviour of oral cavity or digestive organs: 2F90\\nNeoplasms of unknown behaviour of colon: 2F90.0\\nNeoplasms of unknown behaviour of rectum: 2F90.1\\nNeoplasms of unknown behaviour of oral cavity or digestive organs other specified site: 2F90.Y\\nNeoplasms of unknown behaviour of oral cavity or digestive organs unspecified site: 2F90.Z\\nNeoplasms of unknown behaviour of middle ear respiratory or intrathoracic organs: 2F91\\nNeoplasms of unknown behaviour of larynx: 2F91.0\\nNeoplasms of unknown behaviour of trachea bronchus or lung: 2F91.1\\nNeoplasms of unknown behaviour of other specified respiratory organ intrathoracic organ or middle ear: 2F91.Y\\nNeoplasms of unknown behaviour of unspecified respiratory organ or intrathoracic organ: 2F91.Z\\nNeoplasms of unknown behaviour of skin: 2F92\\nNeoplasms of unknown behaviour of retroperitoneum: 2F93\\nNeoplasms of unknown behaviour of peritoneum: 2F94\\nNeoplasms of unknown behaviour of breast: 2F95\\nNeoplasms of unknown behaviour of female genital organs: 2F96\\nNeoplasms of unknown behaviour of male genital organs: 2F97\\nNeoplasms of unknown behaviour of urinary organs: 2F98\\nNeoplasms of unknown behaviour of eye or ocular adnexa: 2F99\\nNeoplasms of unknown behaviour of endocrine glands: 2F9A\\nNeoplasms of unknown behaviour of bone or articular cartilage: 2F9B\\nNeoplasms of unknown behaviour of connective or other soft tissue: 2F9C\\nNeoplasms of unknown behaviour of other specified site: 2F9Y\\nNeoplasms of unknown behaviour of unspecified site: 2F9Z\\nIron deficiency anaemia: 3A00\\nAcquired iron deficiency anaemia due to blood loss: 3A00.0\\nChronic posthaemorrhagic anaemia: 3A00.01\\nAcquired iron deficiency anaemia due to blood loss unspecified: 3A00.0Z\\nAcquired iron deficiency anaemia due to low intake: 3A00.1\\nAcquired iron deficiency anaemia due to decreased absorption: 3A00.2\\nAcquired iron deficiency anaemia due to increased requirement: 3A00.3\\nOther specified iron deficiency anaemia: 3A00.Y\\nIron deficiency anaemia unspecified: 3A00.Z\\nMegaloblastic anaemia due to vitamin B deficiency: 3A01\\nHereditary vitamin B deficiency anaemia: 3A01.0\\nNeonatal vitamin B deficiency anaemia: 3A01.1\\nVitamin B deficiency anaemia due to low intake: 3A01.2\\nVitamin B deficiency anaemia due to intrinsic factor deficiency: 3A01.3\\nPernicious anaemia: 3A01.30\\nOther specified vitamin B deficiency anaemia due to intrinsic factor deficiency: 3A01.3Y\\nVitamin B deficiency anaemia due to intrinsic factor deficiency unspecified: 3A01.3Z\\nVitamin B deficiency anaemia due to intestinal disease: 3A01.4\\nDruginduced vitamin B deficiency anaemia: 3A01.5\\nOther specified megaloblastic anaemia due to vitamin B deficiency: 3A01.Y\\nMegaloblastic anaemia due to vitamin B deficiency unspecified: 3A01.Z\\nFolate deficiency anaemia: 3A02\\nHereditary folate deficiency anaemia: 3A02.0\\nFolate deficiency anaemia due to low intake: 3A02.1\\nFolate deficiency anaemia due to increased requirements: 3A02.2\\nFolate deficiency anaemia due to decreased intestinal absorption: 3A02.3\\nDruginduced folate deficiency anaemia: 3A02.4\\nOther specified folate deficiency anaemia: 3A02.Y\\nFolate deficiency anaemia unspecified: 3A02.Z\\nOther nutritional or metabolic anaemias: 3A03\\nHereditary orotic aciduria: 3A03.0\\nProtein deficiency anaemia: 3A03.1\\nScorbutic anaemia: 3A03.2\\nCopper deficiency anaemia: 3A03.3\\nAcquired other vitamin B deficiency anaemia: 3A03.4\\nAcquired pyridoxine deficiency anaemia: 3A03.40\\nAcquired riboflavin deficiency anaemia: 3A03.41\\nAcquired thiamine deficiency anaemia: 3A03.42\\nOther specified acquired other vitamin B deficiency anaemia: 3A03.4Y\\nAcquired vitamin A deficiency anaemia: 3A03.5\\nAcquired vitamin E deficiency anaemia: 3A03.6\\nOther and unspecified nutritional or metabolic anaemia: 3A03.Y\\nHereditary haemolytic anaemia: 3A10\\nHaemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies: 3A10.0\\nHaemolytic anaemia due to glucosephosphate dehydrogenase deficiency: 3A10.00\\nOther specified haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies: 3A10.0Y\\nHaemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies unspecified: 3A10.0Z\\nHaemolytic anaemia due to adenosine deaminase excess: 3A10.1\\nHereditary elliptocytosis: 3A10.2\\nFamilial pseudohyperkalaemia: 3A10.3\\nOther specified hereditary haemolytic anaemia: 3A10.Y\\nHereditary haemolytic anaemia unspecified: 3A10.Z\\nOther specified congenital haemolytic anaemia: 3A1Y\\nAcquired haemolytic anaemia immune: 3A20\\nAutoimmune haemolytic anaemia warm type: 3A20.0\\nAutoimmune haemolytic anaemia cold type: 3A20.1\\nAutoimmune haemolytic anaemia mixed type cold and warm: 3A20.2\\nParoxysmal cold haemoglobinuria: 3A20.3\\nAlloimmune haemolytic anaemia: 3A20.4\\nEvans syndrome: 3A20.5\\nOther specified acquired haemolytic anaemia immune: 3A20.Y\\nAcquired haemolytic anaemia immune unspecified: 3A20.Z\\nAcquired haemolytic anaemia nonimmune: 3A21\\nParoxysmal nocturnal haemoglobinuria: 3A21.0\\nMicroangiopathic haemolytic anaemia: 3A21.1\\nHaemolytic uraemic syndrome: 3A21.2\\nOther specified acquired haemolytic anaemia nonimmune: 3A21.Y\\nAcquired haemolytic anaemia nonimmune unspecified: 3A21.Z\\nAcquired haemolytic anaemia unspecified: 3A2Z\\nHaemolytic anaemias unspecified: 3A4Z\\nThalassaemias: 3A50\\nAlpha thalassaemia: 3A50.0\\nMild alpha thalassaemia diseases: 3A50.00\\nThalassaemic alphachain variants: 3A50.01\\nHaemoglobin H disease    included: 3A50.02\\nHomozygous or compound heterozygous alpha thalassaemia: 3A50.03\\nOther specified alpha thalassaemia: 3A50.0Y\\nAlpha thalassaemia unspecified: 3A50.0Z\\nAlpha thalassaemia related syndromes: 3A50.1\\nBeta thalassaemia: 3A50.2\\nDelta deltabeta or gammadeltabeta thalassaemia: 3A50.3\\nHereditary persistence of fetal haemoglobin: 3A50.4\\nOther specified thalassaemias: 3A50.Y\\nThalassaemias unspecified: 3A50.Z\\nSickle cell disorders or other haemoglobinopathies: 3A51\\nSickle cell trait: 3A51.0\\nSickle cell disease without crisis: 3A51.1\\nSickle cell disease with crisis: 3A51.2\\nCompound heterozygous sickling disorders without crisis: 3A51.3\\nCompound heterozygous sickling disorders with crisis: 3A51.4\\nHaemoglobin C disease: 3A51.5\\nHaemoglobin D disease: 3A51.6\\nHigh affinity haemoglobin: 3A51.7\\nLow affinity haemoglobin: 3A51.8\\nHaemoglobin O disease: 3A51.9\\nHaemoglobin E disease: 3A51.A\\nHaemoglobin Cbeta thalassaemia compound heterozygosity: 3A51.B\\nOther specified sickle cell disorders or other haemoglobinopathies: 3A51.Y\\nSickle cell disorders or other haemoglobinopathies unspecified: 3A51.Z\\nCongenital pure red cell aplasia: 3A60\\nCongenital noninherited pure red cell aplasia: 3A60.0\\nHereditary pure red cell aplasia: 3A60.1\\nCongenital pure red cell aplasia unspecified: 3A60.Z\\nAcquired pure red cell aplasia: 3A61\\nAcute acquired pure red cell aplasia: 3A61.0\\nChronic acquired pure red cell aplasia: 3A61.1\\nOther specified acquired pure red cell aplasia: 3A61.Y\\nAcquired pure red cell aplasia unspecified: 3A61.Z\\nPure red cell aplasia unspecified: 3A6Z\\nAplastic anaemia: 3A70\\nCongenital aplastic anaemia: 3A70.0\\nAcquired aplastic anaemias: 3A70.1\\nDruginduced aplastic anaemia: 3A70.10\\nAplastic anaemia due to other external agents: 3A70.11\\nIdiopathic aplastic anaemia: 3A70.12\\nOther specified acquired aplastic anaemias: 3A70.1Y\\nAcquired aplastic anaemias unspecified: 3A70.1Z\\nAplastic anaemia unspecified: 3A70.Z\\nAnaemia due to chronic disease: 3A71\\nAnaemia in neoplastic disease: 3A71.0\\nAnaemia in chronic infectious diseases: 3A71.1\\nAnaemia in chronic kidney disease: 3A71.2\\nAnaemia due to other specified chronic disease: 3A71.Y\\nAnaemia due to chronic disease unspecified: 3A71.Z\\nSideroblastic anaemia: 3A72\\nCongenital sideroblastic anaemias: 3A72.0\\nHereditary sideroblastic anaemias: 3A72.00\\nHereditary syndromic sideroblastic anaemia: 3A72.01\\nOther specified congenital sideroblastic anaemias: 3A72.0Y\\nCongenital sideroblastic anaemias unspecified: 3A72.0Z\\nAcquired sideroblastic anaemias: 3A72.1\\nSideroblastic anaemia unspecified: 3A72.Z\\nCongenital dyserythropoietic anaemia: 3A73\\nCongenital polycythaemia: 3A80\\nPrimary inherited erythrocytosis: 3A80.0\\nOther specified congenital polycythaemia: 3A80.Y\\nCongenital polycythaemia unspecified: 3A80.Z\\nAcquired polycythaemia: 3A81\\nPolycythaemia due to hypoxia including high altitude: 3A81.0\\nPolycythaemia due to overtransfusion or blood doping: 3A81.1\\nRelative polycythaemia: 3A81.2\\nOther specified acquired polycythaemia: 3A81.Y\\nAcquired polycythaemia unspecified: 3A81.Z\\nPolycythaemia unspecified: 3A8Z\\nAnaemia due to acute disease: 3A90\\nCongenital methaemoglobinaemia: 3A91\\nHereditary methaemoglobinaemia: 3A92\\nAcquired methaemoglobinaemia: 3A93\\nAcute posthaemorrhagic anaemia: 3A94\\nOther specified anaemias or erythrocyte disorders: 3A9Y\\nAnaemias or other erythrocyte disorders unspecified: 3A9Z\\nHereditary factor VIII deficiency: 3B10\\nHaemophilia A: 3B10.0\\nHereditary factor VIII deficiency with antifactor VIII inhibitor: 3B10.1\\nOther specified hereditary factor VIII deficiency: 3B10.Y\\nHereditary factor VIII deficiency unspecified: 3B10.Z\\nHereditary factor IX deficiency: 3B11\\nHaemophilia B: 3B11.0\\nOther specified hereditary factor IX deficiency: 3B11.Y\\nHereditary factor IX deficiency unspecified: 3B11.Z\\nVon Willebrand disease: 3B12\\nHaemophilia C: 3B13\\nOther inherited coagulation factor deficiency with bleeding tendency: 3B14\\nHereditary deficiency of factor I: 3B14.0\\nHereditary factor X deficiency: 3B14.1\\nCombined deficiency of vitamin Kdependent clotting factors: 3B14.2\\nOther inherited coagulation factor deficiency with bleeding tendency unspecified: 3B14.Z\\nInherited coagulation factor deficiency without bleeding tendency: 3B15\\nCongenital or constitutional haemorrhagic condition unspecified: 3B1Z\\nDisseminated intravascular coagulation: 3B20\\nHaemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors: 3B21\\nHaemorrhage due to thrombin inhibitor other than heparin: 3B21.0\\nHaemorrhage due to factor Xa inhibitor: 3B21.1\\nHaemorrhagic disorder due to other specified circulating anticoagulants or coagulation factors: 3B21.Y\\nHaemorrhagic disorder due to unspecified circulating anticoagulants or coagulation factors: 3B21.Z\\nAcquired haemophilia: 3B22\\nOther specified haemorrhagic diseases due to acquired coagulation factor defects: 3B2Y\\nCoagulation defects unspecified: 3B4Z\\nInherited fibrinolytic defects: 3B50\\nCongenital alpha antiplasmin deficiency: 3B50.0\\nCongenital plasminogen activator inhibitor type  deficiency: 3B50.1\\nOther specified inherited fibrinolytic defects: 3B50.Y\\nInherited fibrinolytic defects unspecified: 3B50.Z\\nAcquired fibrinolytic defects: 3B51\\nNonthrombocytopenic purpura: 3B60\\nHereditary vascular purpura: 3B60.0\\nAcquired vascular purpura: 3B60.1\\nThrombophilia: 3B61\\nHereditary thrombophilia: 3B61.0\\nHyperhomocysteinaemia: 3B61.00\\nOther specified hereditary thrombophilia: 3B61.0Y\\nHereditary thrombophilia unspecified: 3B61.0Z\\nAcquired thrombophilia: 3B61.1\\nOther specified thrombophilia: 3B61.Y\\nThrombophilia unspecified: 3B61.Z\\nQualitative platelet defects: 3B62\\nInherited qualitative platelet defects: 3B62.0\\nAlphagranule diseases: 3B62.00\\nInherited giant platelet disorder: 3B62.01\\nOther specified inherited qualitative platelet defects: 3B62.0Y\\nInherited qualitative platelet defects unspecified: 3B62.0Z\\nBleeding diathesis due to thromboxane synthesis deficiency: 3B62.1\\nIsolated thrombocytopenia: 3B62.2\\nDense granule disease: 3B62.3\\nAlphadelta dense granule deficiency: 3B62.4\\nHaemophagocytic syndrome associated with infection: 3B62.5\\nOther specified qualitative platelet defects: 3B62.Y\\nQualitative platelet defects unspecified: 3B62.Z\\nThrombocytosis: 3B63\\nCongenital thrombocytosis: 3B63.0\\nAcquired thrombocytosis: 3B63.1\\nSecondary thrombocytosis: 3B63.10\\nOther specified acquired thrombocytosis: 3B63.1Y\\nAcquired thrombocytosis unspecified: 3B63.1Z\\nOther specified thrombocytosis: 3B63.Y\\nThrombocytosis unspecified: 3B63.Z\\nThrombocytopenia: 3B64\\nCongenital thrombocytopenia: 3B64.0\\nCongenital noninherited thrombocytopenia: 3B64.00\\nHereditary thrombocytopenia: 3B64.01\\nCongenital thrombocytopenia unspecified: 3B64.0Z\\nAcquired thrombocytopenia: 3B64.1\\nImmune thrombocytopenic purpura: 3B64.10\\nSecondary thrombocytopenic purpura: 3B64.11\\nDruginduced thrombocytopenic purpura: 3B64.12\\nAlloimmune thrombocytopenia: 3B64.13\\nThrombotic thrombocytopenic purpura: 3B64.14\\nOther specified acquired thrombocytopenia: 3B64.1Y\\nAcquired thrombocytopenia unspecified: 3B64.1Z\\nThrombocytopenia unspecified: 3B64.Z\\nThrombotic microangiopathy not elsewhere classified: 3B65\\nOther specified coagulation defects purpura or other haemorrhagic or related conditions: 3B6Y\\nCoagulation defects purpura or other haemorrhagic or related conditions unspecified: 3B6Z\\nCongenital disorders of spleen: 3B80\\nSplenomegaly in storage diseases: 3B80.0\\nAcquired disorders of spleen: 3B81\\nTumourlike conditions of spleen: 3B81.0\\nPostsurgical asplenia: 3B81.1\\nAtrophy of spleen: 3B81.2\\nNontraumatic laceration or rupture of spleen: 3B81.3\\nSplenosis: 3B81.4\\nSplenic cyst or pseudocyst: 3B81.5\\nPseudocyst of spleen: 3B81.50\\nEpithelial cyst of spleen: 3B81.51\\nOther specified splenic cyst: 3B81.5Y\\nSplenic cyst unspecified: 3B81.5Z\\nInfarction of spleen: 3B81.6\\nInfection of spleen: 3B81.7\\nAcute septic splenitis: 3B81.70\\nAbscess of spleen: 3B81.71\\nOther specified infection of spleen: 3B81.7Y\\nInfection of spleen unspecified: 3B81.7Z\\nTorsion of spleen: 3B81.8\\nFibrosis of spleen: 3B81.9\\nPerisplenitis: 3B81.A\\nHypersplenism: 3B81.B\\nChronic congestive splenomegaly: 3B81.C\\nOther specified acquired disorders of spleen: 3B81.Y\\nAcquired disorders of spleen unspecified: 3B81.Z\\nDiseases of spleen unspecified: 3B8Z\\nOther specified diseases of the blood or bloodforming organs: 3C0Y\\nDiseases of the blood or bloodforming organs unspecified: 3C0Z\\nPrimary immunodeficiencies due to disorders of innate immunity: 4A00\\nFunctional neutrophil defects: 4A00.0\\nNeutrophil immunodeficiency syndrome: 4A00.00\\nOther specified functional neutrophil defects: 4A00.0Y\\nFunctional neutrophil defects unspecified: 4A00.0Z\\nDefects in the complement system: 4A00.1\\nImmunodeficiency with an early component of complement deficiency: 4A00.10\\nImmunodeficiency with a late component of complement deficiency: 4A00.11\\nImmunodeficiency with factor B deficiency: 4A00.12\\nImmunodeficiency with factor D anomaly: 4A00.13\\nHereditary angioedema: 4A00.14\\nAcquired angioedema: 4A00.15\\nOther specified defects in the complement system: 4A00.1Y\\nDefects in the complement system unspecified: 4A00.1Z\\nGenetic susceptibility to particular pathogens: 4A00.2\\nImmunodeficiency with naturalkiller cell deficiency: 4A00.3\\nOther specified primary immunodeficiencies due to disorders of innate immunity: 4A00.Y\\nPrimary immunodeficiencies due to disorders of innate immunity unspecified: 4A00.Z\\nPrimary immunodeficiencies due to disorders of adaptive immunity: 4A01\\nImmunodeficiencies with predominantly antibody defects: 4A01.0\\nHereditary agammaglobulinaemia with profoundly reduced or absent B cells: 4A01.00\\nImmunodeficiencies with severe reduction in at least two serum immunoglobulin isotypes with normal or low numbers of B cells: 4A01.01\\nSpecific antibody deficiency with normal immunoglobulin concentrations or normal number of B cells: 4A01.02\\nTransient hypogammaglobulinaemia of infancy: 4A01.03\\nImmunodeficiencies with isotype or light chain deficiencies with normal number of B cells: 4A01.04\\nImmunodeficiencies with severe reduction in serum IgG or IgA with normal or elevated IgM and normal numbers of Bcells: 4A01.05\\nOther specified immunodeficiencies with predominantly antibody defects: 4A01.0Y\\nImmunodeficiencies with predominantly antibody defects unspecified: 4A01.0Z\\nCombined immunodeficiencies: 4A01.1\\nSevere combined immunodeficiencies: 4A01.10\\nMajor histocompatibility complex class I deficiency: 4A01.11\\nMajor histocompatibility complex class II deficiency: 4A01.12\\nOther specified combined immunodeficiencies: 4A01.1Y\\nCombined immunodeficiencies unspecified: 4A01.1Z\\nDiseases of immune dysregulation: 4A01.2\\nImmune dysregulation syndromes with hypopigmentation: 4A01.20\\nImmune dysregulation syndromes presenting primarily with autoimmunity: 4A01.21\\nImmune dysregulation syndromes presenting primarily with lymphoproliferation: 4A01.22\\nPrimary haemophagocytic lymphohistiocytosis: 4A01.23\\nOther specified diseases of immune dysregulation: 4A01.2Y\\nDiseases of immune dysregulation unspecified: 4A01.2Z\\nOther welldefined immunodeficiency syndromes due to defects in adaptive immunity: 4A01.3\\nImmunodeficiency due to defects of the thymus: 4A01.30\\nDNA repair defects other than combined Tcell or Bcell immunodeficiencies: 4A01.31\\nImmunoosseous dysplasia: 4A01.32\\nHepatic venoocclusive disease immunodeficiency syndrome: 4A01.33\\nHyperimmunoglobulin E syndromes: 4A01.34\\nPrimary immunodeficiencies due to disorders of adaptive immunity unspecified: 4A01.Z\\nOther specified primary immunodeficiencies: 4A0Y\\nPrimary immunodeficiencies unspecified: 4A0Z\\nAcquired immunodeficiencies: 4A20\\nAdultonset immunodeficiency: 4A20.0\\nAcquired immunodeficiency due to loss of immunoglobulin: 4A20.1\\nOther specified acquired immunodeficiencies: 4A20.Y\\nAcquired immunodeficiencies unspecified: 4A20.Z\\nLupus erythematosus: 4A40\\nSystemic lupus erythematosus: 4A40.0\\nSystemic lupus erythematosus with skin involvement: 4A40.00\\nOther specified systemic lupus erythematosus: 4A40.0Y\\nSystemic lupus erythematosus unspecified: 4A40.0Z\\nDruginduced lupus erythematosus: 4A40.1\\nOther specified lupus erythematosus: 4A40.Y\\nLupus erythematosus unspecified: 4A40.Z\\nIdiopathic inflammatory myopathy: 4A41\\nDermatomyositis: 4A41.0\\nAdult dermatomyositis: 4A41.00\\nJuvenile dermatomyositis: 4A41.01\\nDermatomyositis unspecified: 4A41.0Z\\nPolymyositis: 4A41.1\\nJuvenile polymyositis: 4A41.10\\nParaneoplastic polymyositis: 4A41.11\\nOther specified polymyositis: 4A41.1Y\\nPolymyositis unspecified: 4A41.1Z\\nInclusion body myopathy: 4A41.2\\nInflammatory inclusion body myositis: 4A41.20\\nNoninflammatory inclusion body myopathy: 4A41.21\\nInclusion body myopathy unspecified: 4A41.2Z\\nOther specified idiopathic inflammatory myopathy: 4A41.Y\\nIdiopathic inflammatory myopathy unspecified: 4A41.Z\\nSystemic sclerosis: 4A42\\nPaediatric onset systemic sclerosis: 4A42.0\\nDiffuse systemic sclerosis: 4A42.1\\nLimited systemic sclerosis: 4A42.2\\nSystemic sclerosis unspecified: 4A42.Z\\nOverlap or undifferentiated nonorgan specific systemic autoimmune disease: 4A43\\nIgG related disease: 4A43.0\\nMikulicz disease: 4A43.1\\nSjgren syndrome: 4A43.2\\nPrimary Sjgren syndrome: 4A43.20\\nSecondary Sjgren syndrome: 4A43.21\\nPaediatric onset Sjgren syndrome: 4A43.22\\nOther specified sjgren syndrome: 4A43.2Y\\nSjgren syndrome unspecified: 4A43.2Z\\nMixed connective tissue disease: 4A43.3\\nDiffuse eosinophilic fasciitis: 4A43.4\\nOther specified overlap nonorgan specific systemic autoimmune disease: 4A43.Y\\nUndifferentiated nonorgan specific systemic autoimmune disease: 4A43.Z\\nVasculitis: 4A44\\nRhizomelic pseudopolyarthritis: 4A44.0\\nAortic arch syndrome: 4A44.1\\nGiant cell arteritis: 4A44.2\\nSingle organ vasculitis: 4A44.3\\nPolyarteritis nodosa: 4A44.4\\nMucocutaneous lymph node syndrome: 4A44.5\\nSneddon syndrome: 4A44.6\\nPrimary angiitis of the central nervous system: 4A44.7\\nThromboangiitis obliterans: 4A44.8\\nImmune complex small vessel vasculitis: 4A44.9\\nCryoglobulinaemic vasculitis: 4A44.90\\nHypocomplementaemic urticarial vasculitis: 4A44.91\\nIgA vasculitis: 4A44.92\\nOther specified immune complex small vessel vasculitis: 4A44.9Y\\nImmune complex small vessel vasculitis unspecified: 4A44.9Z\\nAntineutrophil cytoplasmic antibodyassociated vasculitis: 4A44.A\\nMicroscopic polyangiitis: 4A44.A0\\nGranulomatosis with polyangiitis: 4A44.A1\\nEosinophilic granulomatosis with polyangiitis: 4A44.A2\\nOther specified antineutrophil cytoplasmic antibodyassociated vasculitis: 4A44.AY\\nAntineutrophil cytoplasmic antibodyassociated vasculitis unspecified: 4A44.AZ\\nLeukocytoclastic vasculitis: 4A44.B\\nCutaneous leukocytoclastic vasculitis: 4A44.B0\\nOther specified leukocytoclastic vasculitis: 4A44.BY\\nLeukocytoclastic vasculitis unspecified: 4A44.BZ\\nOther specified vasculitis: 4A44.Y\\nVasculitis unspecified: 4A44.Z\\nAntiphospholipid syndrome: 4A45\\nPrimary antiphospholipid syndrome: 4A45.0\\nSecondary antiphospholipid syndrome: 4A45.1\\nAntiphospholipid syndrome in pregnancy: 4A45.2\\nLupus anticoagulanthypoprothrombinaemia syndrome: 4A45.3\\nAntiphospholipid syndrome unspecified: 4A45.Z\\nOther specified nonorgan specific systemic autoimmune disorders: 4A4Y\\nNonorgan specific systemic autoimmune disorders unspecified: 4A4Z\\nMonogenic autoinflammatory syndromes: 4A60\\nFamilial Mediterranean fever: 4A60.0\\nCryopyrinassociated periodic syndromes: 4A60.1\\nTumour necrosis factor receptor  associated periodic syndrome: 4A60.2\\nOther specified monogenic autoinflammatory syndromes: 4A60.Y\\nAutoimflammatory syndrome unspecified: 4A60.Z\\nSAPHO syndrome: 4A61\\nBehet disease: 4A62\\nOther specified autoinflammatory disorders: 4A6Y\\nAutoinflammatory disorders unspecified: 4A6Z\\nAllergic or hypersensitivity disorders involving the respiratory tract: 4A80\\nDruginduced bronchospasm: 4A80.0\\nBronchospasm provoked by allergy to food substance: 4A80.1\\nOther specified allergic or hypersensitivity disorders involving the respiratory tract: 4A80.Y\\nAllergic or hypersensitivity disorders involving the respiratory tract unspecified: 4A80.Z\\nAllergic or hypersensitivity disorders involving the eye: 4A81\\nAllergic or hypersensitivity disorders involving skin or mucous membranes: 4A82\\nAllergic or hypersensitivity disorders involving the gastrointestinal tract: 4A83\\nFoodinduced eosinophilic gastroenteritis: 4A83.0\\nFoodinduced eosinophilic oesophagitis: 4A83.1\\nOther specified allergic or hypersensitivity disorders involving the gastrointestinal tract: 4A83.Y\\nAllergic or hypersensitivity disorders involving the gastrointestinal tract unspecified: 4A83.Z\\nAnaphylaxis: 4A84\\nAnaphylaxis due to allergic reaction to food: 4A84.0\\nDruginduced anaphylaxis: 4A84.1\\nAnaphylaxis due to insect venom: 4A84.2\\nAnaphylaxis provoked by physical factors: 4A84.3\\nExerciseinduced anaphylaxis: 4A84.30\\nColdinduced anaphylaxis: 4A84.31\\nAnaphylaxis provoked by other specified physical factors: 4A84.3Y\\nAnaphylaxis provoked by unspecified physical factors: 4A84.3Z\\nAnaphylaxis due to inhaled allergens: 4A84.4\\nAnaphylaxis due to contact with allergens: 4A84.5\\nAnaphylaxis secondary to mast cell disorder: 4A84.6\\nOther specified anaphylaxis: 4A84.Y\\nAnaphylaxis unspecified: 4A84.Z\\nComplex allergic or hypersensitivity conditions: 4A85\\nDrug or pharmacological agents hypersensitivity: 4A85.0\\nDruginduced liver hypersensitivity disease: 4A85.00\\nDruginduced kidney hypersensitivity: 4A85.01\\nDruginduced cytopenia: 4A85.02\\nDruginduced vasculitis: 4A85.03\\nMultiple drug hypersensitivity syndrome: 4A85.04\\nDrug hypersensitivity of other specified type: 4A85.0Y\\nDrug hypersensitivity of unspecified type: 4A85.0Z\\nHypersensitivity to herbal or alternative medical therapies: 4A85.1\\nFood hypersensitivity: 4A85.2\\nFoodinduced gastrointestinal hypersensitivity: 4A85.20\\nFoodinduced urticaria or angioedema: 4A85.21\\nAllergic contact dermatitis due to food allergen: 4A85.22\\nOther specified food hypersensitivity: 4A85.2Y\\nFood hypersensitivity unspecified: 4A85.2Z\\nAllergic or hypersensitivity reactions to arthropods: 4A85.3\\nSystemic allergic reaction due to Hymenoptera venom: 4A85.30\\nCutaneous allergic or hypersensitivity reactions to Hymenoptera venom: 4A85.31\\nCutaneous allergic or hypersensitivity reactions to arthropods: 4A85.32\\nOther specified complex allergic or hypersensitivity conditions: 4A85.Y\\nComplex allergic or hypersensitivity conditions unspecified: 4A85.Z\\nAllergic or hypersensitivity conditions of other specified type: 4A8Y\\nAllergic or hypersensitivity conditions of unspecified type: 4A8Z\\nDisorders of neutrophil number: 4B00\\nNeutropenia: 4B00.0\\nConstitutional neutropaenia: 4B00.00\\nAcquired neutropaenia: 4B00.01\\nNeutropaenia unspecified: 4B00.0Z\\nNeutrophilia: 4B00.1\\nConstitutional neutrophilia: 4B00.10\\nAcquired neutrophilia: 4B00.11\\nNeutrophilia unspecified: 4B00.1Z\\nOther specified disorders of neutrophil number: 4B00.Y\\nDisorders of neutrophil function: 4B01\\nConstitutional disorders of neutrophil function: 4B01.0\\nDisorders of neutrophil adhesion: 4B01.00\\nDisorders of neutrophil chemotaxis: 4B01.01\\nDisorders of neutrophil granule formation or release: 4B01.02\\nDisorders of neutrophil oxidative metabolism: 4B01.03\\nOther specified constitutional disorders of neutrophil function: 4B01.0Y\\nConstitutional disorders of neutrophil function unspecified: 4B01.0Z\\nAcquired disorders of neutrophil function: 4B01.1\\nDisorders of neutrophil function unspecified: 4B01.Z\\nEosinopenia: 4B02\\nConstitutional decrease in eosinophil number: 4B02.0\\nAcquired decrease in eosinophil number: 4B02.1\\nEosinopenia unspecified: 4B02.Z\\nEosinophilia: 4B03\\nConstitutional eosinophilia: 4B03.0\\nAcquired eosinophilia: 4B03.1\\nEosinophilia unspecified: 4B03.Z\\nDisorders with decreased monocyte counts: 4B04\\nDisorders with increased monocyte counts: 4B05\\nAcquired lymphopenia: 4B06\\nAcquired lymphocytosis: 4B07\\nOther specified immune system disorders involving white cell lineages: 4B0Y\\nImmune system disorders involving white cell lineages unspecified: 4B0Z\\nSarcoidosis: 4B20\\nSarcoidosis of lung: 4B20.0\\nSarcoidosis of lymph nodes: 4B20.1\\nSarcoidosis of the digestive system: 4B20.2\\nNeurosarcoidosis: 4B20.3\\nOcular sarcoidosis: 4B20.4\\nCutaneous sarcoidosis: 4B20.5\\nOther specified sarcoidosis: 4B20.Y\\nSarcoidosis unspecified: 4B20.Z\\nPolyclonal hypergammaglobulinaemia: 4B21\\nCryoglobulinaemia: 4B22\\nImmune reconstitution inflammatory syndrome: 4B23\\nGraftversushost disease: 4B24\\nAcute graftversushost disease: 4B24.0\\nChronic graftversushost disease: 4B24.1\\nOther specified graftversushost disease: 4B24.Y\\nGraftversushost disease unspecified: 4B24.Z\\nOther specified disorders involving the immune system: 4B2Y\\nDiseases of thymus: 4B40\\nPersistent hyperplasia of thymus: 4B40.0\\nAbscess of thymus: 4B40.1\\nGood syndrome: 4B40.2\\nOther specified diseases of thymus: 4B40.Y\\nDiseases of thymus unspecified: 4B40.Z\\nOther specified diseases of the immune system: 4B4Y\\nDiseases of the immune system unspecified: 4B4Z\\nHypothyroidism: 5A00\\nCongenital hypothyroidism: 5A00.0\\nPermanent congenital hypothyroidism with diffuse goitre: 5A00.00\\nPermanent congenital hypothyroidism without goitre: 5A00.01\\nPendred syndrome: 5A00.02\\nTransient congenital hypothyroidism: 5A00.03\\nCongenital hypothyroidism due to iodine deficiency: 5A00.04\\nOther specified congenital hypothyroidism: 5A00.0Y\\nCongenital hypothyroidism unspecified: 5A00.0Z\\nIodinedeficiencyrelated thyroid disorders or allied conditions: 5A00.1\\nIodinedeficiencyrelated diffuse goitre: 5A00.10\\nIodinedeficiencyrelated multinodular goitre: 5A00.11\\nIodinedeficiencyrelated thyroid disorders or allied conditions unspecified: 5A00.1Z\\nAcquired hypothyroidism: 5A00.2\\nHypothyroidism due to medicaments or other exogenous substances: 5A00.20\\nMyxoedema coma: 5A00.21\\nSubclinical iodinedeficiency hypothyroidism: 5A00.22\\nOther specified acquired hypothyroidism: 5A00.2Y\\nAcquired hypothyroidism unspecified: 5A00.2Z\\nHypothyroidism unspecified: 5A00.Z\\nNontoxic goitre: 5A01\\nNontoxic diffuse goitre: 5A01.0\\nNontoxic single thyroid nodule: 5A01.1\\nNontoxic multinodular goitre: 5A01.2\\nNontoxic goitre unspecified: 5A01.Z\\nThyrotoxicosis: 5A02\\nThyrotoxicosis with diffuse goitre: 5A02.0\\nThyrotoxicosis with toxic single thyroid nodule: 5A02.1\\nThyrotoxicosis with toxic multinodular goitre: 5A02.2\\nThyrotoxicosis from ectopic thyroid tissue: 5A02.3\\nThyrotoxicosis factitia: 5A02.4\\nThyroid crisis: 5A02.5\\nSecondary hyperthyroidism: 5A02.6\\nOther specified thyrotoxicosis: 5A02.Y\\nThyrotoxicosis unspecified: 5A02.Z\\nThyroiditis: 5A03\\nAcute thyroiditis: 5A03.0\\nSubacute thyroiditis: 5A03.1\\nAutoimmune thyroiditis: 5A03.2\\nHashimoto thyroiditis: 5A03.20\\nPainless thyroiditis: 5A03.21\\nOther specified autoimmune thyroiditis: 5A03.2Y\\nAutoimmune thyroiditis unspecified: 5A03.2Z\\nOther specified thyroiditis: 5A03.Y\\nThyroiditis unspecified: 5A03.Z\\nHypersecretion of calcitonin: 5A04\\nGeneralised resistance to thyroid hormone: 5A05\\nSickeuthyroid syndrome: 5A06\\nOther specified disorders of the thyroid gland or thyroid hormones system: 5A0Y\\nDisorders of the thyroid gland or thyroid hormones system unspecified: 5A0Z\\nType  diabetes mellitus: 5A11\\nMalnutritionrelated diabetes mellitus: 5A12\\nDiabetes mellitus other specified type: 5A13\\nDiabetes mellitus due to genetic defects of beta cell function: 5A13.0\\nDiabetes mellitus due to genetic defects in insulin action: 5A13.1\\nDiabetes mellitus due to diseases of the exocrine pancreas: 5A13.2\\nDiabetes mellitus due to endocrinopathies: 5A13.3\\nDiabetes mellitus due to drug or chemical: 5A13.4\\nDiabetes mellitus due to uncommon forms of immunemediated diabetes: 5A13.5\\nDiabetes mellitus due to other genetic syndromes: 5A13.6\\nDiabetes mellitus due to clinically defined subtypes or syndromes: 5A13.7\\nDiabetes mellitus due to other specified cause: 5A13.Y\\nDiabetes mellitus type unspecified: 5A14\\nDiabetic hyperosmolar hyperglycaemic state: 5A20\\nHyperosmolar hyperglycaemic state without coma: 5A20.0\\nHyperosmolar hyperglycaemic state with coma: 5A20.1\\nDiabetic hyperosmolar hyperglycaemic state unspecified: 5A20.Z\\nHypoglycaemia in the context of diabetes mellitus: 5A21\\nHypoglycaemia in the context of diabetes mellitus without coma: 5A21.0\\nHypoglycaemia in the context of diabetes mellitus with coma: 5A21.1\\nHypoglycaemia in the context of diabetes unspecified: 5A21.Z\\nDiabetic acidosis: 5A22\\nDiabetic ketoacidosis without coma: 5A22.0\\nDiabetic lactic acidosis: 5A22.1\\nDiabetic metabolic acidosis: 5A22.2\\nDiabetic ketoacidosis with coma: 5A22.3\\nOther specified diabetic acidosis: 5A22.Y\\nDiabetic acidosis unspecified: 5A22.Z\\nDiabetic coma: 5A23\\nUncontrolled or unstable diabetes mellitus: 5A24\\nOther specified acute complications of diabetes mellitus: 5A2Y\\nIntermediate hyperglycaemia: 5A40\\nImpaired fasting glucose: 5A40.0\\nImpaired glucose tolerance: 5A40.1\\nOther specified intermediate hyperglycaemia: 5A40.Y\\nIntermediate hyperglycaemia unspecified: 5A40.Z\\nHypoglycaemia without associated diabetes: 5A41\\nIncreased secretion of glucagon: 5A42\\nAbnormal secretion of gastrin: 5A43\\nDruginduced hypergastrinaemia: 5A43.0\\nZollingerEllison syndrome: 5A43.1\\nOther specified abnormal secretion of gastrin: 5A43.Y\\nAbnormal secretion of gastrin unspecified: 5A43.Z\\nInsulinresistance syndromes: 5A44\\nPersistent hyperinsulinaemic hypoglycaemia of infancy: 5A45\\nOther specified disorders of glucose regulation or pancreatic internal secretion: 5A4Y\\nDisorders of glucose regulation or pancreatic internal secretion unspecified: 5A4Z\\nHypoparathyroidism: 5A50\\nHypoparathyroidism due to impaired parathyroid hormone secretion: 5A50.0\\nIdiopathic hypoparathyroidism: 5A50.00\\nSecondary hypoparathyroidism: 5A50.01\\nHypoparathyroidism due to destruction of the parathyroid glands: 5A50.02\\nAutoimmune hypoparathyroidism: 5A50.03\\nOther specified hypoparathyroidism due to impaired parathyroid hormone secretion: 5A50.0Y\\nHypoparathyroidism due to impaired parathyroid hormone secretion unspecified: 5A50.0Z\\nPseudohypoparathyroidism: 5A50.1\\nOther specified hypoparathyroidism: 5A50.Y\\nHypoparathyroidism unspecified: 5A50.Z\\nHyperparathyroidism: 5A51\\nPrimary hyperparathyroidism: 5A51.0\\nSecondary hyperparathyroidism: 5A51.1\\nFamilial hypocalciuric hypercalcaemia: 5A51.2\\nOther specified hyperparathyroidism: 5A51.Y\\nHyperparathyroidism unspecified: 5A51.Z\\nOther specified disorders of the parathyroids or parathyroid hormone system: 5A5Y\\nDisorders of the parathyroids or parathyroid hormone system unspecified: 5A5Z\\nHyperfunction of pituitary gland: 5A60\\nAcromegaly or pituitary gigantism: 5A60.0\\nHyperprolactinaemia: 5A60.1\\nSyndrome of inappropriate secretion of antidiuretic hormone: 5A60.2\\nNephrogenic syndrome of inappropriate antidiuresis: 5A60.20\\nOther specified syndrome of inappropriate secretion of antidiuretic hormone: 5A60.2Y\\nSyndrome of inappropriate secretion of antidiuretic hormone unspecified: 5A60.2Z\\nCentral precocious puberty: 5A60.3\\nOther specified hyperfunction of pituitary gland: 5A60.Y\\nHyperfunction of pituitary gland unspecified: 5A60.Z\\nHypofunction or certain other specified disorders of pituitary gland: 5A61\\nHypopituitarism: 5A61.0\\nAdrenocorticotropic hormone deficiency: 5A61.1\\nGonadotropin deficiency: 5A61.2\\nGrowth hormone deficiency: 5A61.3\\nThyroid stimulating hormone deficiency: 5A61.4\\nAcquired central hypothyroidism: 5A61.40\\nCongenital central hypothyroidism: 5A61.41\\nOther specified thyroid stimulating hormone deficiency: 5A61.4Y\\nThyroid stimulating hormone deficiency unspecified: 5A61.4Z\\nCentral diabetes insipidus: 5A61.5\\nOxytocin deficiency: 5A61.6\\nOther specified hypofunction or disorders of pituitary gland: 5A61.Y\\nDisorders of the pituitary hormone system unspecified: 5A6Z\\nCushing syndrome: 5A70\\nPituitarydependent Cushing disease: 5A70.0\\nEctopic ACTH syndrome: 5A70.1\\nPseudoCushing syndrome: 5A70.2\\nNelson syndrome: 5A70.3\\nOther specified Cushing syndrome: 5A70.Y\\nCushing syndrome unspecified: 5A70.Z\\nAdrenogenital disorders: 5A71\\nXX disorders of sex development induced by androgens of fetal origin: 5A71.0\\nGlucocorticoid resistance: 5A71.00\\nCongenital adrenal hyperplasia: 5A71.01\\nOther specified XX disorders of sex development induced by androgens of fetal origin: 5A71.0Y\\nXX disorders of sex development induced by androgens of fetal origin unspecified: 5A71.0Z\\nXX disorders of sex development induced by androgens of maternal origin: 5A71.1\\nOther specified adrenogenital disorders: 5A71.Y\\nAdrenogenital disorders unspecified: 5A71.Z\\nHyperaldosteronism: 5A72\\nPrimary hyperaldosteronism: 5A72.0\\nSecondary hyperaldosteronism: 5A72.1\\nHyperaldosteronism unspecified: 5A72.Z\\nHypoaldosteronism: 5A73\\nAdrenocortical insufficiency: 5A74\\nAcquired adrenocortical insufficiency: 5A74.0\\nAdrenal crisis: 5A74.1\\nOther specified adrenocortical insufficiency: 5A74.Y\\nAdrenocortical insufficiency unspecified: 5A74.Z\\nAdrenomedullary hyperfunction: 5A75\\nCertain specified disorders of adrenal gland: 5A76\\nPremature adrenarche: 5A76.0\\nOther specified disorders of adrenal gland: 5A76.Y\\nDisorders of the adrenal glands or adrenal hormone system unspecified: 5A7Z\\nOvarian dysfunction: 5A80\\nClinical hyperandrogenism: 5A80.0\\nPolycystic ovary syndrome: 5A80.1\\nPolycystic ovary: 5A80.2\\nAnovulation: 5A80.3\\nOligoovulation: 5A80.4\\nDiminished ovarian reserve: 5A80.5\\nOther specified ovarian dysfunction: 5A80.Y\\nOvarian dysfunction unspecified: 5A80.Z\\nTesticular dysfunction or testosteronerelated disorders: 5A81\\nTesticular hyperfunction: 5A81.0\\nTesticular hypofunction: 5A81.1\\nOther specified testicular dysfunction or testosteronerelated disorders: 5A81.Y\\nTesticular dysfunction or testosteronerelated disorders unspecified: 5A81.Z\\nDisorders of the gonadal hormone system unspecified: 5A8Z\\nDisorder of puberty due to oestrogen resistance: 5A90\\nDelayed puberty: 5A91\\nPeripheral precocious puberty: 5A92\\nOther disorders of puberty: 5A9Y\\nDisorders of puberty unspecified: 5A9Z\\nAutoimmune polyendocrinopathy: 5B00\\nPolyglandular hyperfunction: 5B01\\nOther specified polyglandular dysfunction: 5B0Y\\nPolyglandular dysfunction unspecified: 5B0Z\\nCarcinoid syndrome: 5B10\\nShort stature not elsewhere classified: 5B11\\nConstitutional tall stature: 5B12\\nOther specified endocrine diseases: 5B3Y\\nEndocrine diseases unspecified: 5B3Z\\nUnderweight in infants children or adolescents: 5B50\\nWasting in infants children or adolescents: 5B51\\nAcute malnutrition in infants children or adolescents: 5B52\\nStunting in infants children or adolescents: 5B53\\nUnderweight in adults: 5B54\\nVitamin A deficiency: 5B55\\nVitamin A deficiency with night blindness: 5B55.0\\nVitamin A deficiency with conjunctival xerosis: 5B55.1\\nVitamin A deficiency with conjunctival xerosis and Bitots spots: 5B55.2\\nVitamin A deficiency with corneal xerosis: 5B55.3\\nVitamin A deficiency with corneal ulceration or keratomalacia: 5B55.4\\nVitamin A deficiency with xerophthalmic scars of cornea or blindness: 5B55.5\\nVitamin A deficiency with other specified manifestations: 5B55.Y\\nVitamin A deficiency unspecified: 5B55.Z\\nVitamin C deficiency: 5B56\\nScurvy: 5B56.0\\nOther specified vitamin C deficiency: 5B56.Y\\nVitamin C deficiency unspecified: 5B56.Z\\nVitamin D deficiency: 5B57\\nVitamin D deficiency rickets: 5B57.0\\nVitamin D deficiency osteomalacia: 5B57.1\\nOther specified vitamin D deficiency: 5B57.Y\\nVitamin D deficiency unspecified: 5B57.Z\\nVitamin E deficiency: 5B58\\nVitamin K deficiency: 5B59\\nVitamin B deficiency: 5B5F\\nBeriberi: 5B5A.0\\nDry beriberi: 5B5A.00\\nWet beriberi: 5B5A.01\\nBeriberi unspecified: 5B5A.0Z\\nWernickeKorsakoff Syndrome: 5B5A.1\\nWernicke encephalopathy: 5B5A.10\\nKorsakoff syndrome: 5B5A.11\\nOther specified WernickeKorsakoff Syndrome: 5B5A.1Y\\nWernickeKorsakoff Syndrome unspecified: 5B5A.1Z\\nOther specified vitamin B deficiency: 5B5C.Y\\nVitamin B deficiency unspecified: 5B5C.Z\\nPellagra: 5B5C.0\\nFolate deficiency: 5B5E\\nBiotin deficiency: 5B5G\\nPantothenic acid deficiency: 5B5H\\nCholine deficiency: 5B5J\\nMineral deficiencies: 5B5K\\nIron deficiency: 5B5K.0\\nCalcium deficiency: 5B5K.1\\nTetany due to acute calcium deficiency: 5B5K.10\\nOther specified calcium deficiency: 5B5K.1Y\\nCalcium deficiency unspecified: 5B5K.1Z\\nZinc deficiency: 5B5K.2\\nIodine deficiency: 5B5K.3\\nFluorine deficiency: 5B5K.4\\nSodium chloride deficiency: 5B5K.5\\nCopper deficiency: 5B5K.6\\nSelenium deficiency: 5B5K.7\\nChromium deficiency: 5B5K.8\\nManganese deficiency: 5B5K.9\\nMolybdenum deficiency: 5B5K.A\\nVanadium deficiency: 5B5K.B\\nOther specified mineral deficiency: 5B5K.Y\\nMineral deficiency unspecified: 5B5K.Z\\nSequelae of proteinenergy malnutrition: 5B60\\nSequelae of vitamin A deficiency: 5B61\\nSequelae of vitamin C deficiency: 5B62\\nSequelae of rickets: 5B63\\nOther specified sequelae of malnutrition or certain specified nutritional deficiencies: 5B6Y\\nSequelae of malnutrition or certain specified nutritional deficiencies unspecified: 5B6Z\\nEssential fatty acid deficiency: 5B70\\nProtein deficiency: 5B71\\nOther specified undernutrition: 5B7Y\\nUnspecified undernutrition: 5B7Z\\nOverweight or localised adiposity: 5B80\\nOverweight: 5B80.0\\nOverweight in infants children or adolescents: 5B80.00\\nOverweight in adults: 5B80.01\\nOverweight unspecified: 5B80.0Z\\nLocalised adiposity: 5B80.1\\nObesity: 5B81\\nObesity due to energy imbalance: 5B81.0\\nObesity in children or adolescents: 5B81.00\\nObesity in adults: 5B81.01\\nDruginduced obesity: 5B81.1\\nOther specified obesity: 5B81.Y\\nObesity unspecified: 5B81.Z\\nVitamin excesses: 5B90\\nHypervitaminosis A: 5B90.0\\nHypercarotenaemia: 5B90.1\\nHypervitaminosis D: 5B90.2\\nMegavitaminB syndrome: 5B90.3\\nOther specified vitamin excess: 5B90.Y\\nUnspecified vitamin excesses: 5B90.Z\\nMineral excesses: 5B91\\nHypercalcaemia: 5B91.0\\nZinc excess: 5B91.1\\nSodium chloride excess: 5B91.2\\nFluorine excess: 5B91.3\\nAluminium excess: 5B91.4\\nManganese excess: 5B91.5\\nOther specified mineral excess: 5B91.Y\\nUnspecified mineral excess: 5B91.Z\\nOther specified nutrient excesses: 5B9Y\\nNutrient excesses unspecified: 5B9Z\\nOther specified overweight obesity or specific nutrient excesses: 5C1Y\\nOverweight obesity or specific nutrient excesses unspecified: 5C1Z\\nOther specified nutritional disorders: 5C3Y\\nNutritional disorders unspecified: 5C3Z\\nInborn errors of amino acid or other organic acid metabolism: 5C50\\nPhenylketonuria: 5C50.0\\nClassical phenylketonuria: 5C50.00\\nNonclassical phenylketonuria: 5C50.01\\nEmbryofetopathy due to maternal phenylketonuria: 5C50.02\\nOther specified phenylketonuria: 5C50.0Y\\nPhenylketonuria unspecified: 5C50.0Z\\nDisorders of tyrosine metabolism: 5C50.1\\nAlkaptonuria: 5C50.10\\nTyrosinaemia type: 5C50.12\\nOther specified disorders of tyrosine metabolism: 5C50.1Y\\nDisorders of tyrosine metabolism unspecified: 5C50.1Z\\nDisorders of histidine metabolism: 5C50.2\\nHistidinaemia: 5C50.20\\nUrocanic aciduria: 5C50.21\\nOther specified disorders of histidine metabolism: 5C50.2Y\\nDisorders of histidine metabolism unspecified: 5C50.2Z\\nDisorders of tryptophan metabolism: 5C50.3\\nDisorders of lysine or hydroxylysine metabolism: 5C50.4\\nDisorders of the gammaglutamyl cycle: 5C50.5\\nDisorders of serine metabolism: 5C50.6\\nDisorders of glycine metabolism: 5C50.7\\nGlycine encephalopathy: 5C50.70\\nSarcosinaemia: 5C50.71\\nOther specified disorders of glycine metabolism: 5C50.7Y\\nDisorders of glycine metabolism unspecified: 5C50.7Z\\nDisorders of proline or hydroxyproline metabolism: 5C50.8\\nDisorders of ornithine metabolism: 5C50.9\\nDisorders of urea cycle metabolism: 5C50.A\\nArgininosuccinic aciduria: 5C50.A0\\nCarbamoylphosphate synthetase deficiency: 5C50.A1\\nArgininaemia: 5C50.A2\\nCitrullinaemia: 5C50.A3\\nOther specified disorders of urea cycle metabolism: 5C50.AY\\nDisorders of urea cycle metabolism unspecified: 5C50.AZ\\nDisorders of methionine cycle or sulphur amino acid metabolism: 5C50.B\\nDisorders of beta or omega amino acid metabolism: 5C50.C\\nDisorders of branchedchain amino acid metabolism: 5C50.D\\nMaplesyrupurine disease: 5C50.D0\\nOther specified disorders of branchedchain amino acid metabolism: 5C50.DY\\nDisorders of branchedchain amino acid metabolism unspecified: 5C50.DZ\\nOrganic aciduria: 5C50.E\\nClassical organic aciduria: 5C50.E0\\nCerebral organic aciduria: 5C50.E1\\nOther specified organic aciduria: 5C50.EY\\nOrganic aciduria unspecified: 5C50.EZ\\nDisorders of peptide metabolism: 5C50.F\\nProlidase deficiency: 5C50.F0\\nCarnosinaemia: 5C50.F1\\nHomocarnosinosis: 5C50.F2\\nOther specified disorders of peptide metabolism: 5C50.FY\\nDisorders of peptide metabolism unspecified: 5C50.FZ\\nTrimethylaminuria: 5C50.G\\nOther specified inborn errors of amino acid or other organic acid metabolism: 5C50.Y\\nInborn errors of amino acid or other organic acid metabolism unspecified: 5C50.Z\\nInborn errors of carbohydrate metabolism: 5C51\\nDisorders of the pentose phosphate pathway: 5C51.0\\nDisorders of glycerol metabolism: 5C51.1\\nDisorders of glyoxylate metabolism: 5C51.2\\nPrimary hyperoxaluria type: 5C51.20\\nOther specified disorders of glyoxylate metabolism: 5C51.2Y\\nDisorders of glyoxylate metabolism unspecified: 5C51.2Z\\nGlycogen storage disease: 5C51.3\\nDisorders of galactose metabolism: 5C51.4\\nGalactosephosphate uridyltransferase deficiency: 5C51.40\\nGalactokinase deficiency: 5C51.41\\nGlucose or galactose intolerance of newborn: 5C51.42\\nOther specified disorders of galactose metabolism: 5C51.4Y\\nDisorders of galactose metabolism unspecified: 5C51.4Z\\nDisorders of fructose metabolism: 5C51.5\\nHereditary fructose intolerance: 5C51.50\\nOther specified disorders of fructose metabolism: 5C51.5Y\\nDisorders of fructose metabolism unspecified: 5C51.5Z\\nOther specified inborn errors of carbohydrate metabolism: 5C51.Y\\nInborn errors of carbohydrate metabolism unspecified: 5C51.Z\\nInborn errors of lipid metabolism: 5C52\\nInborn errors of fatty acid oxidation or ketone body metabolism: 5C52.0\\nDisorders of carnitine transport or the carnitine cycle: 5C52.00\\nDisorders of mitochondrial fatty acid oxidation: 5C52.01\\nDisorders of ketone body metabolism: 5C52.02\\nSjgrenLarsson syndrome: 5C52.03\\nOther specified inborn errors of fatty acid oxidation or ketone body metabolism: 5C52.0Y\\nInborn errors of fatty acid oxidation or ketone body metabolism unspecified: 5C52.0Z\\nInborn errors of sterol metabolism: 5C52.1\\nDisorders of cholesterol synthesis: 5C52.10\\nBile acid synthesis defect with cholestasis: 5C52.11\\nOther specified inborn errors of sterol metabolism: 5C52.1Y\\nInborn errors of sterol metabolism unspecified: 5C52.1Z\\nNeutral lipid storage disease: 5C52.2\\nOther specified inborn errors of lipid metabolism: 5C52.Y\\nInborn errors of lipid metabolism unspecified: 5C52.Z\\nInborn errors of energy metabolism: 5C53\\nDisorders of pyruvate metabolism: 5C53.0\\nPyruvate kinase deficiency: 5C53.00\\nLactate dehydrogenase deficiency: 5C53.01\\nPyruvate dehydrogenase complex deficiency: 5C53.02\\nPyruvate carboxylase deficiency: 5C53.03\\nOther specified disorders of pyruvate metabolism: 5C53.0Y\\nDisorders of pyruvate metabolism unspecified: 5C53.0Z\\nDisorders of the citric acid cycle: 5C53.1\\nDisorders of mitochondrial oxidative phosphorylation: 5C53.2\\nMitochondrial DNA depletion syndromes: 5C53.20\\nMultiple mitochondrial DNA deletion syndromes: 5C53.21\\nCoenzyme Q deficiency: 5C53.22\\nMitochondrial protein translation defects: 5C53.23\\nLeigh syndrome: 5C53.24\\nIsolated ATP synthase deficiency: 5C53.25\\nOther specified disorders of mitochondrial oxidative phosphorylation: 5C53.2Y\\nDisorders of mitochondrial oxidative phosphorylation unspecified: 5C53.2Z\\nDisorders of mitochondrial membrane transport: 5C53.3\\nMitochondrial substrate carrier disorders: 5C53.30\\nMitochondrial protein import disorders: 5C53.31\\nOther specified disorders of mitochondrial membrane transport: 5C53.3Y\\nDisorders of mitochondrial membrane transport unspecified: 5C53.3Z\\nDisorders of creatine metabolism: 5C53.4\\nOther specified inborn errors of energy metabolism: 5C53.Y\\nInborn errors of energy metabolism unspecified: 5C53.Z\\nInborn errors of glycosylation or other specified protein modification: 5C54\\nDisorders of protein Nglycosylation: 5C54.0\\nDisorders of protein Oglycosylation: 5C54.1\\nDisorders of multiple glycosylation or other pathways: 5C54.2\\nOther specified congenital disorders of glycosylation and protein modification: 5C54.Y\\nCongenital disorders of glycosylation and protein modification unspecified: 5C54.Z\\nInborn errors of purine pyrimidine or nucleotide metabolism: 5C55\\nDisorders of purine metabolism: 5C55.0\\nXanthinuria: 5C55.00\\nLeschNyhan syndrome: 5C55.01\\nOther specified disorders of purine metabolism: 5C55.0Y\\nDisorders of purine metabolism unspecified: 5C55.0Z\\nDisorders of pyrimidine metabolism: 5C55.1\\nDisorders of nucleotide metabolism: 5C55.2\\nOther specified inborn errors of purine pyrimidine or nucleotide metabolism: 5C55.Y\\nInborn errors of purine pyrimidine or nucleotide metabolism unspecified: 5C55.Z\\nLysosomal diseases: 5C56\\nSphingolipidosis: 5C56.0\\nGangliosidosis: 5C56.00\\nFabry disease: 5C56.01\\nMetachromatic leukodystrophy: 5C56.02\\nOther specified sphingolipidosis: 5C56.0Y\\nSphingolipidosis unspecified: 5C56.0Z\\nNeuronal ceroid lipofuscinosis: 5C56.1\\nGlycoproteinosis: 5C56.2\\nMucolipidosis: 5C56.20\\nOligosaccharidosis: 5C56.21\\nOther specified glycoproteinosis: 5C56.2Y\\nGlycoproteinosis unspecified: 5C56.2Z\\nMucopolysaccharidosis: 5C56.3\\nMucopolysaccharidosis type: 5C56.33\\nOther specified mucopolysaccharidosis: 5C56.3Y\\nMucopolysaccharidosis unspecified: 5C56.3Z\\nDisorders of sialic acid metabolism: 5C56.4\\nOther specified lysosomal diseases: 5C56.Y\\nLysosomal diseases unspecified: 5C56.Z\\nPeroxisomal diseases: 5C57\\nDisorders of peroxisome biogenesis: 5C57.0\\nDisorders of peroxisomal alpha betaor omegaoxidation: 5C57.1\\nOther specified peroxisomal diseases: 5C57.Y\\nPeroxisomal diseases unspecified: 5C57.Z\\nInborn errors of porphyrin or heme metabolism: 5C58\\nDisorders of bilirubin metabolism or excretion: 5C58.0\\nCriglerNajjar syndrome: 5C58.00\\nGilbert syndrome: 5C58.01\\nDubinJohnson syndrome: 5C58.02\\nProgressive familial intrahepatic cholestasis: 5C58.03\\nBenign recurrent intrahepatic cholestasis: 5C58.04\\nOther specified disorders of bilirubin metabolism or excretion: 5C58.0Y\\nDisorders of bilirubin metabolism or excretion unspecified: 5C58.0Z\\nPorphyrias: 5C58.1\\nPorphyria cutanea tarda: 5C58.10\\nErythropoietic porphyrias: 5C58.12\\nVariegate porphyria: 5C58.13\\nOther specified porphyrias: 5C58.1Y\\nPorphyrias unspecified: 5C58.1Z\\nOther specified inborn errors of porphyrin or heme metabolism: 5C58.Y\\nInborn errors of porphyrin or heme metabolism unspecified: 5C58.Z\\nInborn errors of neurotransmitter metabolism: 5C59\\nDisorders of biogenic amine metabolism: 5C59.0\\nDisorders of catecholamine synthesis: 5C59.00\\nDisorders of pterin metabolism: 5C59.01\\nOther specified disorders of biogenic amine metabolism: 5C59.0Y\\nDisorders of biogenic amine metabolism unspecified: 5C59.0Z\\nDisorders of gamma aminobutyric acid metabolism: 5C59.1\\nDisorders of pyridoxine metabolism: 5C59.2\\nOther specified inborn errors of neurotransmitter metabolism: 5C59.Y\\nInborn errors of neurotransmitter metabolism unspecified: 5C59.Z\\nAlphaantitrypsin deficiency: 5C5A\\nOther specified inborn errors of metabolism: 5C5Y\\nInborn errors of metabolism unspecified: 5C5Z\\nDisorders of amino acid absorption or transport: 5C60\\nOculocerebrorenal syndrome: 5C60.0\\nCystinosis: 5C60.1\\nCystinuria: 5C60.2\\nOther specified disorders of amino acid absorption or transport: 5C60.Y\\nDisorders of amino acid absorption or transport unspecified: 5C60.Z\\nDisorders of carbohydrate absorption or transport: 5C61\\nGlucosegalactose malabsorption: 5C61.0\\nMaltaseglucoamylase deficiency: 5C61.1\\nCongenital sucraseisomaltase deficiency: 5C61.2\\nAlpha alpha trehalase deficiency: 5C61.3\\nAcquired monosaccharide malabsorption: 5C61.4\\nFructose malabsorption: 5C61.40\\nOther specified acquired monosaccharide malabsorption: 5C61.4Y\\nAcquired monosaccharide malabsorption unspecified: 5C61.4Z\\nDisorders of facilitated glucose transport: 5C61.5\\nLactose intolerance: 5C61.6\\nPrimary lactase deficiency: 5C61.60\\nCongenital lactase deficiency: 5C61.61\\nSecondary lactase deficiency: 5C61.62\\nLactose intolerance unspecified: 5C61.6Z\\nOther specified disorders of carbohydrate absorption or transport: 5C61.Y\\nDisorders of carbohydrate absorption or transport unspecified: 5C61.Z\\nDisorders of lipid absorption or transport: 5C62\\nDisorders of vitamin or nonprotein cofactor absorption or transport: 5C63\\nDisorders of cobalamin metabolism or transport: 5C63.0\\nDisorders of folate metabolism or transport: 5C63.1\\nDisorders of vitamin D metabolism or transport: 5C63.2\\nHypocalcaemic vitamin D dependent rickets: 5C63.20\\nHypocalcaemic vitamin D resistant rickets: 5C63.21\\nHypophosphataemic rickets: 5C63.22\\nOther specified disorders of vitamin D metabolism or transport: 5C63.2Y\\nDisorders of vitamin D metabolism or transport unspecified: 5C63.2Z\\nOther specified disorders of vitamin or nonprotein cofactor absorption or transport: 5C63.Y\\nDisorders of vitamin or nonprotein cofactor absorption or transport unspecified: 5C63.Z\\nDisorders of mineral absorption or transport: 5C64\\nDisorders of copper metabolism: 5C64.0\\nWilson disease: 5C64.00\\nOther specified disorders of copper metabolism: 5C64.0Y\\nDisorders of copper metabolism unspecified: 5C64.0Z\\nDisorders of iron metabolism: 5C64.1\\nIron overload diseases: 5C64.10\\nOther specified disorders of iron metabolism: 5C64.1Y\\nDisorders of iron metabolism unspecified: 5C64.1Z\\nDisorders of zinc metabolism: 5C64.2\\nAcrodermatitis enteropathica: 5C64.20\\nZinc deficiency syndromes: 5C64.21\\nOther specified disorders of zinc metabolism: 5C64.2Y\\nDisorders of zinc metabolism unspecified: 5C64.2Z\\nDisorders of phosphorus metabolism or phosphatases: 5C64.3\\nDisorders of magnesium metabolism: 5C64.4\\nHypermagnesaemia: 5C64.40\\nHypomagnesaemia: 5C64.41\\nDisorders of magnesium metabolism unspecified: 5C64.4Z\\nDisorders of calcium metabolism: 5C64.5\\nDisorders of sodium metabolism: 5C64.6\\nDisorders of chloride metabolism: 5C64.7\\nDisorders of other specified mineral absorption or transport: 5C64.Y\\nDisorders of mineral absorption or transport unspecified: 5C64.Z\\nOther specified disorders of metabolite absorption or transport: 5C6Y\\nDisorders of metabolite absorption or transport unspecified: 5C6Z\\nVolume depletion: 5C70\\nDehydration: 5C70.0\\nHypovolaemia: 5C70.1\\nOther specified volume depletion: 5C70.Y\\nVolume depletion unspecified: 5C70.Z\\nHyperosmolality or hypernatraemia: 5C71\\nHypoosmolality or hyponatraemia: 5C72\\nAcidosis: 5C73\\nAcute respiratory acidosis: 5C73.0\\nChronic respiratory acidosis: 5C73.1\\nAnion gap metabolic acidosis: 5C73.2\\nOther specified acidosis: 5C73.Y\\nAcidosis unspecified: 5C73.Z\\nAlkalosis: 5C74\\nMixed disorder of acidbase balance: 5C75\\nHyperkalaemia: 5C76\\nHypokalaemia: 5C77\\nFluid overload: 5C78\\nOther specified disorders of fluid electrolyte or acidbase balance: 5C7Y\\nDisorders of fluid electrolyte or acidbase balance unspecified: 5C7Z\\nHyperlipoproteinaemia: 5C80\\nHypercholesterolaemia: 5C80.0\\nPrimary hypercholesterolaemia: 5C80.00\\nSecondary hypercholesterolaemia: 5C80.01\\nHypercholesterolaemia unspecified: 5C80.0Z\\nHypertriglyceridaemia: 5C80.1\\nMixed hyperlipidaemia: 5C80.2\\nHyperalphalipoproteinaemia: 5C80.3\\nOther specified hyperlipoproteinaemia: 5C80.Y\\nHyperlipoproteinaemia unspecified: 5C80.Z\\nHypolipoproteinaemia: 5C81\\nHypoalphalipoproteinaemia: 5C81.0\\nHypobetalipoproteinaemia: 5C81.1\\nOther specified hypolipoproteinaemia: 5C81.Y\\nHypolipoproteinaemia unspecified: 5C81.Z\\nOther specified disorders of lipoprotein metabolism or lipidaemias: 5C8Y\\nUnspecified disorders of lipoprotein metabolism or lipidaemias: 5C8Z\\nMetabolic or transporter liver disease: 5C90\\nLiver diseases due to urea cycle defects: 5C90.0\\nLiver diseases due to disorders of porphyrin or bilirubin metabolism or transport: 5C90.1\\nLiver diseases due to disorders of amino acid metabolism: 5C90.2\\nLiver disease due to disorders of lysosomal storage: 5C90.3\\nLiver diseases due to mitochondrial disorders: 5C90.4\\nLiver diseases due to disorders of mineral metabolism: 5C90.5\\nOther specified metabolic or transporter liver disease: 5C90.Y\\nMetabolic or transporter liver disease unspecified: 5C90.Z\\nAmyloidosis: 5D00\\nAL amyloidosis: 5D00.0\\nAA amyloidosis: 5D00.1\\nHereditary amyloidosis: 5D00.2\\nHereditary ATTR amyloidosis: 5D00.20\\nNonneuropathic heredofamilial amyloidosis: 5D00.21\\nOther specified hereditary amyloidosis: 5D00.2Y\\nHereditary amyloidosis unspecified: 5D00.2Z\\nDialysisassociated amyloidosis: 5D00.3\\nOther specified amyloidosis: 5D00.Y\\nAmyloidosis unspecified: 5D00.Z\\nTumour lysis syndrome: 5D01\\nOther specified metabolic disorders: 5D0Y\\nMetabolic disorders unspecified: 5D2Z\\nPostprocedural hypothyroidism: 5D40\\nPostirridation hypothyroidism: 5D40.0\\nHypothyroidism postradioactive iodine ablation: 5D40.00\\nOther specified postirridation hypothyroidism: 5D40.0Y\\nPostirridation hypothyroidism unspecified: 5D40.0Z\\nOther specified postprocedural hypothyroidism: 5D40.Y\\nPostprocedural hypothyroidism unspecified: 5D40.Z\\nPostprocedural hypoinsulinaemia: 5D41\\nPostprocedural hypoparathyroidism: 5D42\\nPostprocedural hypopituitarism: 5D43\\nPostprocedural ovarian failure: 5D44\\nPostprocedural testicular hypofunction: 5D45\\nPostprocedural adrenocortical hypofunction: 5D46\\nDisorders of intellectual development: 6A00\\nDisorder of intellectual development mild: 6A00.0\\nDisorder of intellectual development moderate: 6A00.1\\nDisorder of intellectual development severe: 6A00.2\\nDisorder of intellectual development profound: 6A00.3\\nDisorder of intellectual development provisional: 6A00.4\\nDisorders of intellectual development unspecified: 6A00.Z\\nDevelopmental speech or language disorders: 6A01\\nDevelopmental speech sound disorder: 6A01.0\\nDevelopmental speech fluency disorder: 6A01.1\\nDevelopmental language disorder: 6A01.2\\nDevelopmental language disorder with impairment of receptive and expressive language: 6A01.20\\nDevelopmental language disorder with impairment of mainly expressive language: 6A01.21\\nDevelopmental language disorder with impairment of mainly pragmatic language: 6A01.22\\nDevelopmental language disorder with other specified language impairment: 6A01.23\\nOther specified developmental speech or language disorders: 6A01.Y\\nDevelopmental speech or language disorders unspecified: 6A01.Z\\nAutism spectrum disorder: 6A02\\nAutism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional language: 6A02.0\\nAutism spectrum disorder with disorder of intellectual development and with mild or no impairment of functional language: 6A02.1\\nAutism spectrum disorder without disorder of intellectual development and with impaired functional language: 6A02.2\\nAutism spectrum disorder with disorder of intellectual development and with impaired functional language: 6A02.3\\nAutism spectrum disorder with disorder of intellectual development and with absence of functional language: 6A02.5\\nOther specified autism spectrum disorder: 6A02.Y\\nAutism spectrum disorder unspecified: 6A02.Z\\nDevelopmental learning disorder: 6A03\\nDevelopmental learning disorder with impairment in reading: 6A03.0\\nDevelopmental learning disorder with impairment in written expression: 6A03.1\\nDevelopmental learning disorder with impairment in mathematics: 6A03.2\\nDevelopmental learning disorder with other specified impairment of learning: 6A03.3\\nDevelopmental learning disorder unspecified: 6A03.Z\\nDevelopmental motor coordination disorder: 6A04\\nAttention deficit hyperactivity disorder: 6A05\\nAttention deficit hyperactivity disorder predominantly inattentive presentation: 6A05.0\\nAttention deficit hyperactivity disorder predominantly hyperactiveimpulsive presentation: 6A05.1\\nAttention deficit hyperactivity disorder combined presentation: 6A05.2\\nAttention deficit hyperactivity disorder other specified presentation: 6A05.Y\\nAttention deficit hyperactivity disorder presentation unspecified: 6A05.Z\\nStereotyped movement disorder: 6A06\\nStereotyped movement disorder without selfinjury: 6A06.0\\nStereotyped movement disorder with selfinjury: 6A06.1\\nStereotyped movement disorder unspecified: 6A06.Z\\nOther specified neurodevelopmental disorders: 6A0Y\\nNeurodevelopmental disorders unspecified: 6A0Z\\nSchizophrenia: 6A20\\nSchizophrenia first episode: 6A20.0\\nSchizophrenia first episode currently symptomatic: 6A20.00\\nSchizophrenia first episode in partial remission: 6A20.01\\nSchizophrenia first episode in full remission: 6A20.02\\nSchizophrenia first episode unspecified: 6A20.0Z\\nSchizophrenia multiple episodes: 6A20.1\\nSchizophrenia multiple episodes currently symptomatic: 6A20.10\\nSchizophrenia multiple episodes in partial remission: 6A20.11\\nSchizophrenia multiple episodes in full remission: 6A20.12\\nSchizophrenia multiple episodes unspecified: 6A20.1Z\\nSchizophrenia continuous: 6A20.2\\nSchizophrenia continuous currently symptomatic: 6A20.20\\nSchizophrenia continuous in partial remission: 6A20.21\\nSchizophrenia continuous in full remission: 6A20.22\\nSchizophrenia continuous unspecified: 6A20.2Z\\nOther specified episode of schizophrenia: 6A20.Y\\nSchizophrenia episode unspecified: 6A20.Z\\nSchizoaffective disorder: 6A21\\nSchizoaffective disorder first episode: 6A21.0\\nSchizoaffective disorder first episode currently symptomatic: 6A21.00\\nSchizoaffective disorder first episode in partial remission: 6A21.01\\nSchizoaffective disorder first episode in full remission: 6A21.02\\nSchizoaffective disorder first episode unspecified: 6A21.0Z\\nSchizoaffective disorder multiple episodes: 6A21.1\\nSchizoaffective disorder multiple episodes currently symptomatic: 6A21.10\\nSchizoaffective disorder multiple episodes in partial remission: 6A21.11\\nSchizoaffective disorder multiple episodes in full remission: 6A21.12\\nSchizoaffective disorder multiple episodes unspecified: 6A21.1Z\\nSchizoaffective disorder continuous: 6A21.2\\nSchizoaffective disorder continuous currently symptomatic: 6A21.20\\nSchizoaffective disorder continuous in partial remission: 6A21.21\\nSchizoaffective disorder continuous in full remission: 6A21.22\\nSchizoaffective disorder continuous unspecified: 6A21.2Z\\nOther specified schizoaffective disorder: 6A21.Y\\nSchizoaffective disorder unspecified: 6A21.Z\\nSchizotypal disorder: 6A22\\nAcute and transient psychotic disorder: 6A23\\nAcute and transient psychotic disorder first episode: 6A23.0\\nAcute and transient psychotic disorder first episode currently symptomatic: 6A23.00\\nAcute and transient psychotic disorder first episode in partial remission: 6A23.01\\nAcute and transient psychotic disorder first episode in full remission: 6A23.02\\nAcute and transient psychotic disorder first episode unspecified: 6A23.0Z\\nAcute and transient psychotic disorder multiple episodes: 6A23.1\\nAcute and transient psychotic disorder multiple episodes currently symptomatic: 6A23.10\\nAcute and transient psychotic disorder multiple episodes in partial remission: 6A23.11\\nAcute and transient psychotic disorder multiple episodes in full remission: 6A23.12\\nAcute and transient psychotic disorder multiple episodes unspecified: 6A23.1Z\\nOther specified acute and transient psychotic disorder: 6A23.Y\\nAcute and transient psychotic disorder unspecified: 6A23.Z\\nDelusional disorder: 6A24\\nDelusional disorder currently symptomatic: 6A24.0\\nDelusional disorder in partial remission: 6A24.1\\nDelusional disorder in full remission: 6A24.2\\nDelusional disorder unspecified: 6A24.Z\\nSymptomatic manifestations of primary psychotic disorders: 6A25\\nPositive symptoms in primary psychotic disorders: 6A25.0\\nNegative symptoms in primary psychotic disorders: 6A25.1\\nDepressive mood symptoms in primary psychotic disorders: 6A25.2\\nManic mood symptoms in primary psychotic disorders: 6A25.3\\nPsychomotor symptoms in primary psychotic disorders: 6A25.4\\nCognitive symptoms in primary psychotic disorders: 6A25.5\\nOther specified primary psychotic disorder: 6A2Y\\nSchizophrenia or other primary psychotic disorders unspecified: 6A2Z\\nCatatonia associated with another mental disorder: 6A40\\nCatatonia induced by substances or medications: 6A41\\nCatatonia unspecified: 6A4Z\\nBipolar type I disorder: 6A60\\nBipolar type I disorder current episode manic without psychotic symptoms: 6A60.0\\nBipolar type I disorder current episode manic with psychotic symptoms: 6A60.1\\nBipolar type I disorder current episode hypomanic: 6A60.2\\nBipolar type I disorder current episode depressive mild: 6A60.3\\nBipolar type I disorder current episode depressive moderate without psychotic symptoms: 6A60.4\\nBipolar type I disorder current episode depressive moderate with psychotic symptoms: 6A60.5\\nBipolar type I disorder current episode depressive severe without psychotic symptoms: 6A60.6\\nBipolar type I disorder current episode depressive severe with psychotic symptoms: 6A60.7\\nBipolar type I disorder current episode depressive unspecified severity: 6A60.8\\nBipolar type I disorder current episode mixed without psychotic symptoms: 6A60.9\\nBipolar type I disorder current episode mixed with psychotic symptoms: 6A60.A\\nBipolar type I disorder currently in partial remission most recent episode manic or hypomanic: 6A60.B\\nBipolar type I disorder currently in partial remission most recent episode depressive: 6A60.C\\nBipolar type I disorder currently in partial remission most recent episode mixed: 6A60.D\\nBipolar type I disorder currently in partial remission most recent episode unspecified: 6A60.E\\nBipolar type I disorder currently in full remission: 6A60.F\\nOther specified bipolar type I disorder: 6A60.Y\\nBipolar type I disorder unspecified: 6A60.Z\\nBipolar type II disorder: 6A61\\nBipolar type II disorder current episode hypomanic: 6A61.0\\nBipolar type II disorder current episode depressive mild: 6A61.1\\nBipolar type II disorder current episode depressive moderate without psychotic symptoms: 6A61.2\\nBipolar type II disorder current episode depressive moderate with psychotic symptoms: 6A61.3\\nBipolar type II disorder current episode depressive severe without psychotic symptoms: 6A61.4\\nBipolar type II disorder current episode depressive severe with psychotic symptoms: 6A61.5\\nBipolar type II disorder current episode depressive unspecified severity: 6A61.6\\nBipolar type II disorder currently in partial remission most recent episode hypomanic: 6A61.7\\nBipolar type II disorder currently in partial remission most recent episode depressive: 6A61.8\\nBipolar type II disorder currently in partial remission most recent episode unspecified: 6A61.9\\nBipolar type II disorder currently in full remission: 6A61.A\\nOther specified bipolar type II disorder: 6A61.Y\\nBipolar type II disorder unspecified: 6A61.Z\\nCyclothymic disorder: 6A62\\nOther specified bipolar or related disorders: 6A6Y\\nBipolar or related disorders unspecified: 6A6Z\\nSingle episode depressive disorder: 6A70\\nSingle episode depressive disorder mild: 6A70.0\\nSingle episode depressive disorder moderate without psychotic symptoms: 6A70.1\\nSingle episode depressive disorder moderate with psychotic symptoms: 6A70.2\\nSingle episode depressive disorder severe without psychotic symptoms: 6A70.3\\nSingle episode depressive disorder severe with psychotic symptoms: 6A70.4\\nSingle episode depressive disorder unspecified severity: 6A70.5\\nSingle episode depressive disorder currently in partial remission: 6A70.6\\nSingle episode depressive disorder currently in full remission: 6A70.7\\nOther specified single episode depressive disorder: 6A70.Y\\nSingle episode depressive disorder unspecified: 6A70.Z\\nRecurrent depressive disorder: 6A71\\nRecurrent depressive disorder current episode mild: 6A71.0\\nRecurrent depressive disorder current episode moderate without psychotic symptoms: 6A71.1\\nRecurrent depressive disorder current episode moderate with psychotic symptoms: 6A71.2\\nRecurrent depressive disorder current episode severe without psychotic symptoms: 6A71.3\\nRecurrent depressive disorder current episode severe with psychotic symptoms: 6A71.4\\nRecurrent depressive disorder current episode unspecified severity: 6A71.5\\nRecurrent depressive disorder currently in partial remission: 6A71.6\\nRecurrent depressive disorder currently in full remission: 6A71.7\\nOther specified recurrent depressive disorder: 6A71.Y\\nRecurrent depressive disorder unspecified: 6A71.Z\\nDysthymic disorder: 6A72\\nMixed depressive and anxiety disorder: 6A73\\nOther specified depressive disorders: 6A7Y\\nDepressive disorders unspecified: 6A7Z\\nSymptomatic and course presentations for mood episodes in mood disorders: 6A80\\nProminent anxiety symptoms in mood episodes: 6A80.0\\nPanic attacks in mood episodes: 6A80.1\\nCurrent depressive episode persistent: 6A80.2\\nCurrent depressive episode with melancholia: 6A80.3\\nSeasonal pattern of mood episode onset: 6A80.4\\nRapid cycling: 6A80.5\\nOther specified mood disorders: 6A8Y\\nMood disorders unspecified: 6A8Z\\nGeneralised anxiety disorder: 6B00\\nPanic disorder: 6B01\\nAgoraphobia: 6B02\\nSpecific phobia: 6B03\\nSocial anxiety disorder: 6B04\\nSeparation anxiety disorder: 6B05\\nSelective mutism: 6B06\\nOther specified anxiety or fearrelated disorders: 6B0Y\\nAnxiety or fearrelated disorders unspecified: 6B0Z\\nObsessivecompulsive disorder: 6B20\\nObsessivecompulsive disorder with fair to good insight: 6B20.0\\nObsessivecompulsive disorder with poor to absent insight: 6B20.1\\nObsessivecompulsive disorder unspecified: 6B20.Z\\nBody dysmorphic disorder: 6B21\\nBody dysmorphic disorder with fair to good insight: 6B21.0\\nBody dysmorphic disorder with poor to absent insight: 6B21.1\\nBody dysmorphic disorder unspecified: 6B21.Z\\nOlfactory reference disorder: 6B22\\nOlfactory reference disorder with fair to good insight: 6B22.0\\nOlfactory reference disorder with poor to absent insight: 6B22.1\\nOlfactory reference disorder unspecified: 6B22.Z\\nHypochondriasis: 6B23\\nHypochondriasis with fair to good insight: 6B23.0\\nHypochondriasis with poor to absent insight: 6B23.1\\nHypochondriasis unspecified: 6B23.Z\\nHoarding disorder: 6B24\\nHoarding disorder with fair to good insight: 6B24.0\\nHoarding disorder with poor to absent insight: 6B24.1\\nHoarding disorder unspecified: 6B24.Z\\nBodyfocused repetitive behaviour disorders: 6B25\\nTrichotillomania: 6B25.0\\nExcoriation disorder: 6B25.1\\nOther specified bodyfocused repetitive behaviour disorders: 6B25.Y\\nBodyfocused repetitive behaviour disorders unspecified: 6B25.Z\\nOther specified obsessivecompulsive or related disorders: 6B2Y\\nObsessivecompulsive or related disorders unspecified: 6B2Z\\nPost traumatic stress disorder: 6B40\\nComplex post traumatic stress disorder: 6B41\\nProlonged grief disorder: 6B42\\nAdjustment disorder: 6B43\\nReactive attachment disorder: 6B44\\nDisinhibited social engagement disorder: 6B45\\nOther specified disorders specifically associated with stress: 6B4Y\\nDisorders specifically associated with stress unspecified: 6B4Z\\nDissociative neurological symptom disorder: 6B60\\nDissociative neurological symptom disorder with visual disturbance: 6B60.0\\nDissociative neurological symptom disorder with auditory disturbance: 6B60.1\\nDissociative neurological symptom disorder with vertigo or dizziness: 6B60.2\\nDissociative neurological symptom disorder with other sensory disturbance: 6B60.3\\nDissociative neurological symptom disorder with nonepileptic seizures: 6B60.4\\nDissociative neurological symptom disorder with speech disturbance: 6B60.5\\nDissociative neurological symptom disorder with paresis or weakness: 6B60.6\\nDissociative neurological symptom disorder with gait disturbance: 6B60.7\\nDissociative neurological symptom disorder with movement disturbance: 6B60.8\\nDissociative neurological symptom disorder with chorea: 6B60.80\\nDissociative neurological symptom disorder with myoclonus: 6B60.81\\nDissociative neurological symptom disorder with tremor: 6B60.82\\nDissociative neurological symptom disorder with dystonia: 6B60.83\\nDissociative neurological symptom disorder with facial spasm: 6B60.84\\nDissociative neurological symptom disorder with Parkinsonism: 6B60.85\\nDissociative neurological symptom disorder with other specified movement disturbance: 6B60.8Y\\nDissociative neurological symptom disorder with unspecified movement disturbance: 6B60.8Z\\nDissociative neurological symptom disorder with cognitive symptoms: 6B60.9\\nDissociative neurological symptom disorder with other specified symptoms: 6B60.Y\\nDissociative neurological symptom disorder with unspecified symptoms: 6B60.Z\\nDissociative amnesia: 6B61\\nDissociative amnesia with dissociative fugue: 6B61.0\\nDissociative amnesia without dissociative fugue: 6B61.1\\nDissociative amnesia unspecified: 6B61.Z\\nTrance disorder: 6B62\\nPossession trance disorder: 6B63\\nDissociative identity disorder: 6B64\\nPartial dissociative identity disorder: 6B65\\nDepersonalizationderealization disorder: 6B66\\nOther specified dissociative disorders: 6B6Y\\nDissociative disorders unspecified: 6B6Z\\nAnorexia Nervosa: 6B80\\nAnorexia Nervosa with significantly low body weight: 6B80.0\\nAnorexia Nervosa with significantly low body weight restricting pattern: 6B80.00\\nAnorexia Nervosa with significantly low body weight bingepurge pattern: 6B80.01\\nAnorexia Nervosa with significantly low body weight unspecified: 6B80.0Z\\nAnorexia Nervosa with dangerously low body weight: 6B80.1\\nAnorexia Nervosa with dangerously low body weight restricting pattern: 6B80.10\\nAnorexia Nervosa with dangerously low body weight bingepurge pattern: 6B80.11\\nAnorexia Nervosa with dangerously low body weight unspecified: 6B80.1Z\\nAnorexia Nervosa in recovery with normal body weight: 6B80.2\\nOther specified anorexia Nervosa: 6B80.Y\\nAnorexia Nervosa unspecified: 6B80.Z\\nBulimia Nervosa: 6B81\\nBinge eating disorder: 6B82\\nAvoidantrestrictive food intake disorder: 6B83\\nPica: 6B84\\nRuminationregurgitation disorder: 6B85\\nOther specified feeding or eating disorders: 6B8Y\\nFeeding or eating disorders unspecified: 6B8Z\\nEnuresis: 6C00\\nNocturnal enuresis: 6C00.0\\nDiurnal enuresis: 6C00.1\\nNocturnal and diurnal enuresis: 6C00.2\\nEnuresis unspecified: 6C00.Z\\nEncopresis: 6C01\\nEncopresis with constipation or overflow incontinence: 6C01.0\\nEncopresis without constipation or overflow incontinence: 6C01.1\\nEncopresis unspecified: 6C01.Z\\nElimination disorders unspecified: 6C0Z\\nBodily distress disorder: 6C20\\nMild bodily distress disorder: 6C20.0\\nModerate bodily distress disorder: 6C20.1\\nSevere bodily distress disorder: 6C20.2\\nBodily distress disorder unspecified: 6C20.Z\\nBody integrity dysphoria: 6C21\\nOther specified disorders of bodily distress or bodily experience: 6C2Y\\nDisorders of bodily distress or bodily experience unspecified: 6C2Z\\nDisorders due to use of alcohol: 6C40\\nEpisode of harmful use of alcohol: 6C40.0\\nHarmful pattern of use of alcohol: 6C40.1\\nHarmful pattern of use of alcohol episodic: 6C40.10\\nHarmful pattern of use of alcohol continuous: 6C40.11\\nHarmful pattern of use of alcohol unspecified: 6C40.1Z\\nAlcohol dependence: 6C40.2\\nAlcohol dependence current use continuous: 6C40.20\\nAlcohol dependence current use episodic: 6C40.21\\nAlcohol dependence early full remission: 6C40.22\\nAlcohol dependence sustained partial remission: 6C40.23\\nAlcohol dependence sustained full remission: 6C40.24\\nAlcohol dependence unspecified: 6C40.2Z\\nAlcohol intoxication: 6C40.3\\nAlcohol withdrawal: 6C40.4\\nAlcohol withdrawal uncomplicated: 6C40.40\\nAlcohol withdrawal with perceptual disturbances: 6C40.41\\nAlcohol withdrawal with seizures: 6C40.42\\nAlcohol withdrawal with perceptual disturbances and seizures: 6C40.43\\nAlcohol withdrawal unspecified: 6C40.4Z\\nAlcoholinduced delirium: 6C40.5\\nAlcoholinduced psychotic disorder: 6C40.6\\nAlcoholinduced psychotic disorder with hallucinations: 6C40.60\\nAlcoholinduced psychotic disorder with delusions: 6C40.61\\nAlcoholinduced psychotic disorder with mixed psychotic symptoms: 6C40.62\\nAlcoholinduced psychotic disorder unspecified: 6C40.6Z\\nCertain specified alcoholinduced mental or behavioural disorders: 6C40.7\\nAlcoholinduced mood disorder: 6C40.70\\nAlcoholinduced anxiety disorder: 6C40.71\\nOther specified disorders due to use of alcohol: 6C40.Y\\nDisorders due to use of alcohol unspecified: 6C40.Z\\nDisorders due to use of cannabis: 6C41\\nEpisode of harmful use of cannabis: 6C41.0\\nHarmful pattern of use of cannabis: 6C41.1\\nHarmful pattern of use of cannabis episodic: 6C41.10\\nHarmful pattern of use of cannabis continuous: 6C41.11\\nHarmful pattern of use of cannabis unspecified: 6C41.1Z\\nCannabis dependence: 6C41.2\\nCannabis dependence current use: 6C41.20\\nCannabis dependence early full remission: 6C41.21\\nCannabis dependence sustained partial remission: 6C41.22\\nCannabis dependence sustained full remission: 6C41.23\\nCannabis dependence unspecified: 6C41.2Z\\nCannabis intoxication: 6C41.3\\nCannabis withdrawal: 6C41.4\\nCannabisinduced delirium: 6C41.5\\nCannabisinduced psychotic disorder: 6C41.6\\nCertain specified cannabisinduced mental or behavioural disorders: 6C41.7\\nCannabisinduced mood disorder: 6C41.70\\nCannabisinduced anxiety disorder: 6C41.71\\nOther specified disorders due to use of cannabis: 6C41.Y\\nDisorders due to use of cannabis unspecified: 6C41.Z\\nDisorders due to use of synthetic cannabinoids: 6C42\\nEpisode of harmful use of synthetic cannabinoids: 6C42.0\\nHarmful pattern of use of synthetic cannabinoids: 6C42.1\\nHarmful pattern of use of synthetic cannabinoids episodic: 6C42.10\\nHarmful pattern of use of synthetic cannabinoids continuous: 6C42.11\\nOther specified harmful pattern of use of synthetic cannabinoids: 6C42.1Y\\nHarmful pattern of use of synthetic cannabinoids unspecified: 6C42.1Z\\nSynthetic cannabinoid dependence: 6C42.2\\nSynthetic cannabinoid dependence current use: 6C42.20\\nSynthetic cannabinoid dependence early full remission: 6C42.21\\nSynthetic cannabinoid dependence sustained partial remission: 6C42.22\\nSynthetic cannabinoid dependence sustained full remission: 6C42.23\\nOther specified synthetic cannabinoid dependence: 6C42.2Y\\nSynthetic cannabinoid dependence unspecified: 6C42.2Z\\nSynthetic cannabinoid intoxication: 6C42.3\\nSynthetic cannabinoid withdrawal: 6C42.4\\nSynthetic cannabinoidinduced delirium: 6C42.5\\nSynthetic cannabinoidinduced psychotic disorder: 6C42.6\\nCertain specified synthetic cannabinoidsinduced mental or behavioural disorders: 6C42.7\\nSynthetic cannabinoidinduced mood disorder: 6C42.70\\nSynthetic cannabinoidinduced anxiety disorder: 6C42.71\\nOther specified disorders due to use of synthetic cannabinoids: 6C42.Y\\nDisorders due to use of synthetic cannabinoids unspecified: 6C42.Z\\nDisorders due to use of opioids: 6C43\\nEpisode of harmful use of opioids: 6C43.0\\nHarmful pattern of use of opioids: 6C43.1\\nHarmful pattern of use of opioids episodic: 6C43.10\\nHarmful pattern of use of opioids continuous: 6C43.11\\nHarmful pattern of use of opioids unspecified: 6C43.1Z\\nOpioid dependence: 6C43.2\\nOpioid dependence current use: 6C43.20\\nOpioid dependence early full remission: 6C43.21\\nOpioid dependence sustained partial remission: 6C43.22\\nOpioid dependence sustained full remission: 6C43.23\\nOpioid dependence unspecified: 6C43.2Z\\nOpioid intoxication: 6C43.3\\nOpioid withdrawal: 6C43.4\\nOpioidinduced delirium: 6C43.5\\nOpioidinduced psychotic disorder: 6C43.6\\nCertain specified opioidinduced mental or behavioural disorders: 6C43.7\\nOpioidinduced mood disorder: 6C43.70\\nOpioidinduced anxiety disorder: 6C43.71\\nOther specified disorders due to use of opioids: 6C43.Y\\nDisorders due to use of opioids unspecified: 6C43.Z\\nDisorders due to use of sedatives hypnotics or anxiolytics: 6C44\\nEpisode of harmful use of sedatives hypnotics or anxiolytics: 6C44.0\\nHarmful pattern of use of sedatives hypnotics or anxiolytics: 6C44.1\\nHarmful pattern of use of sedatives hypnotics or anxiolytics episodic: 6C44.10\\nHarmful pattern of use of sedatives hypnotics or anxiolytics continuous: 6C44.11\\nHarmful pattern of use of sedatives hypnotics or anxiolytics unspecified: 6C44.1Z\\nSedative hypnotic or anxiolytic dependence: 6C44.2\\nSedative hypnotic or anxiolytic dependence current use: 6C44.20\\nSedative hypnotic or anxiolytic dependence early full remission: 6C44.21\\nSedative hypnotic or anxiolytic dependence sustained partial remission: 6C44.22\\nSedative hypnotic or anxiolytic dependence sustained full remission: 6C44.23\\nSedative hypnotic or anxiolytic dependence unspecified: 6C44.2Z\\nSedative hypnotic or anxiolytic intoxication: 6C44.3\\nSedative hypnotic or anxiolytic withdrawal: 6C44.4\\nSedative hypnotic or anxiolytic withdrawal uncomplicated: 6C44.40\\nSedative hypnotic or anxiolytic withdrawal with perceptual disturbances: 6C44.41\\nSedative hypnotic or anxiolytic withdrawal with seizures: 6C44.42\\nSedative hypnotic or anxiolytic withdrawal with perceptual disturbances and seizures: 6C44.43\\nSedative hypnotic or anxiolytic withdrawal unspecified: 6C44.4Z\\nSedative hypnotic or anxiolyticinduced delirium: 6C44.5\\nSedative hypnotic or anxiolyticinduced psychotic disorder: 6C44.6\\nCertain specified sedatives hypnotics or anxiolyticinduced mental or behavioural disorders: 6C44.7\\nSedative hypnotic or anxiolyticinduced mood disorder: 6C44.70\\nSedative hypnotic or anxiolyticinduced anxiety disorder: 6C44.71\\nOther specified disorders due to use of sedatives hypnotics or anxiolytics: 6C44.Y\\nDisorders due to use of sedatives hypnotics or anxiolytics unspecified: 6C44.Z\\nDisorders due to use of cocaine: 6C45\\nEpisode of harmful use of cocaine: 6C45.0\\nHarmful pattern of use of cocaine: 6C45.1\\nHarmful pattern of use of cocaine episodic: 6C45.10\\nHarmful pattern of use of cocaine continuous: 6C45.11\\nHarmful pattern of use of cocaine unspecified: 6C45.1Z\\nCocaine dependence: 6C45.2\\nCocaine dependence current use: 6C45.20\\nCocaine dependence early full remission: 6C45.21\\nCocaine dependence sustained partial remission: 6C45.22\\nCocaine dependence sustained full remission: 6C45.23\\nCocaine dependence unspecified: 6C45.2Z\\nCocaine intoxication: 6C45.3\\nCocaine withdrawal: 6C45.4\\nCocaineinduced delirium: 6C45.5\\nCocaineinduced psychotic disorder: 6C45.6\\nCocaineinduced psychotic disorder with hallucinations: 6C45.60\\nCocaineinduced psychotic disorder with delusions: 6C45.61\\nCocaineinduced psychotic disorder with mixed psychotic symptoms: 6C45.62\\nCocaineinduced psychotic disorder unspecified: 6C45.6Z\\nCertain specified cocaineinduced mental or behavioural disorders: 6C45.7\\nCocaineinduced mood disorder: 6C45.70\\nCocaineinduced anxiety disorder: 6C45.71\\nCocaineinduced obsessivecompulsive or related disorder: 6C45.72\\nCocaineinduced impulse control disorder: 6C45.73\\nOther specified disorders due to use of cocaine: 6C45.Y\\nDisorders due to use of cocaine unspecified: 6C45.Z\\nDisorders due to use of stimulants including amphetamines methamphetamine or methcathinone: 6C46\\nEpisode of harmful use of stimulants including amphetamines methamphetamine or methcathinone: 6C46.0\\nHarmful pattern of use of stimulants including amphetamines methamphetamine or methcathinone: 6C46.1\\nHarmful pattern of use of stimulants including amphetamines methamphetamine or methcathinone episodic: 6C46.10\\nHarmful pattern of use of stimulants including amphetamines methamphetamine or methcathinone continuous: 6C46.11\\nHarmful pattern of use of stimulants including amphetamines methamphetamine and methcathinone unspecified: 6C46.1Z\\nStimulant dependence including amphetamines methamphetamine or methcathinone: 6C46.2\\nStimulant dependence including amphetamines methamphetamine or methcathinone current use: 6C46.20\\nStimulant dependence including amphetamines methamphetamine or methcathinone early full remission: 6C46.21\\nStimulant dependence including amphetamines methamphetamine or methcathinone sustained partial remission: 6C46.22\\nStimulant dependence including amphetamines methamphetamine or methcathinone sustained full remission: 6C46.23\\nStimulant dependence including amphetamines methamphetamine or methcathinone unspecified: 6C46.2Z\\nStimulant intoxication including amphetamines methamphetamine or methcathinone: 6C46.3\\nStimulant withdrawal including amphetamines methamphetamine or methcathinone: 6C46.4\\nStimulantinduced delirium including amphetamines methamphetamine or methcathinone: 6C46.5\\nStimulantinduced psychotic disorder including amphetamines methamphetamine or methcathinone: 6C46.6\\nStimulantinduced psychotic disorder including amphetamines methamphetamine or methcathinone with hallucinations: 6C46.60\\nStimulantinduced psychotic disorder including amphetamines methamphetamine or methcathinone with delusions: 6C46.61\\nStimulantinduced psychotic disorder including amphetamines but excluding caffeine or cocaine with mixed psychotic symptoms: 6C46.62\\nStimulantinduced psychotic disorder including amphetamines methamphetamine or methcathinone unspecified: 6C46.6Z\\nCertain specified stimulantinduced mental or behavioural disorders including amphetamines methamphetamine or methcathinone: 6C46.7\\nStimulantinduced mood disorder including amphetamines methamphetamine or methcathinone: 6C46.70\\nStimulantinduced anxiety disorder including amphetamines methamphetamine or methcathinone: 6C46.71\\nStimulantinduced obsessivecompulsive or related disorder including amphetamines methamphetamine or methcathinone: 6C46.72\\nStimulantinduced impulse control disorder including amphetamines methamphetamine or methcathinone: 6C46.73\\nOther specified disorders due to use of stimulants including amphetamines methamphetamine or methcathinone: 6C46.Y\\nDisorders due to use of stimulants including amphetamines methamphetamine or methcathinone unspecified: 6C46.Z\\nDisorders due to use of synthetic cathinones: 6C47\\nEpisode of harmful use of synthetic cathinones: 6C47.0\\nHarmful pattern of use of synthetic cathinones: 6C47.1\\nHarmful pattern of use of synthetic cathinones episodic: 6C47.10\\nHarmful use of synthetic cathinones continuous: 6C47.11\\nOther specified harmful pattern of use of synthetic cathinones: 6C47.1Y\\nHarmful pattern of use of synthetic cathinones unspecified: 6C47.1Z\\nSynthetic cathinone dependence: 6C47.2\\nSynthetic cathinone dependence current use: 6C47.20\\nSynthetic cathinone dependence early full remission: 6C47.21\\nSynthetic cathinone dependence sustained partial remission: 6C47.22\\nSynthetic cathinone dependence sustained full remission: 6C47.23\\nOther specified synthetic cathinone dependence: 6C47.2Y\\nSynthetic cathinone dependence unspecified: 6C47.2Z\\nSynthetic cathinone intoxication: 6C47.3\\nSynthetic cathinone withdrawal: 6C47.4\\nSynthetic cathinoneinduced delirium: 6C47.5\\nSynthetic cathinoneinduced psychotic disorder: 6C47.6\\nSynthetic cathinoneinduced psychotic disorder with hallucinations: 6C47.60\\nSynthetic cathinoneinduced psychotic disorder with delusions: 6C47.61\\nSynthetic cathinoneinduced psychotic disorder with mixed psychotic symptoms: 6C47.62\\nSynthetic cathinoneinduced psychotic disorder unspecified: 6C47.6Z\\nCertain specified synthetic cathinoneinduced mental or behavioural disorders: 6C47.7\\nSynthetic cathinoneinduced mood disorder: 6C47.70\\nSynthetic cathinoneinduced anxiety disorder: 6C47.71\\nSynthetic cathinoneinduced obsessivecompulsive or related syndrome: 6C47.72\\nSynthetic cathinoneinduced impulse control disorder: 6C47.73\\nOther specified disorders due to use of synthetic cathinones: 6C47.Y\\nDisorders due to use of synthetic cathinones unspecified: 6C47.Z\\nDisorders due to use of caffeine: 6C48\\nEpisode of harmful use of caffeine: 6C48.0\\nHarmful pattern of use of caffeine: 6C48.1\\nHarmful pattern of use of caffeine episodic: 6C48.10\\nHarmful pattern of use of caffeine continuous: 6C48.11\\nHarmful pattern of use of caffeine unspecified: 6C48.1Z\\nCaffeine intoxication: 6C48.2\\nCaffeine withdrawal: 6C48.3\\nCertain specified caffeineinduced mental or behavioural disorders: 6C48.4\\nCaffeineinduced anxiety disorder: 6C48.40\\nOther specified disorders due to use of caffeine: 6C48.Y\\nDisorders due to use of caffeine unspecified: 6C48.Z\\nDisorders due to use of hallucinogens: 6C49\\nEpisode of harmful use of hallucinogens: 6C49.0\\nHarmful pattern of use of hallucinogens: 6C49.1\\nHarmful pattern of use of hallucinogens episodic: 6C49.10\\nHarmful pattern of use of hallucinogens continuous: 6C49.11\\nHarmful pattern of use of hallucinogens unspecified: 6C49.1Z\\nHallucinogen dependence: 6C49.2\\nHallucinogen dependence current use: 6C49.20\\nHallucinogen dependence early full remission: 6C49.21\\nHallucinogen dependence sustained partial remission: 6C49.22\\nHallucinogen dependence sustained full remission: 6C49.23\\nHallucinogen dependence unspecified: 6C49.2Z\\nHallucinogen intoxication: 6C49.3\\nHallucinogeninduced delirium: 6C49.4\\nHallucinogeninduced psychotic disorder: 6C49.5\\nCertain specified hallucinogeninduced mental or behavioural disorders: 6C49.6\\nHallucinogeninduced mood disorder: 6C49.60\\nHallucinogeninduced anxiety disorder: 6C49.61\\nOther specified disorders due to use of hallucinogens: 6C49.Y\\nDisorders due to use of hallucinogens unspecified: 6C49.Z\\nDisorders due to use of nicotine: 6C4A\\nEpisode of harmful use of nicotine: 6C4A.0\\nHarmful pattern of use of nicotine: 6C4A.1\\nHarmful pattern of use of nicotine episodic: 6C4A.10\\nHarmful pattern of use of nicotine continuous: 6C4A.11\\nHarmful pattern of use of nicotine unspecified: 6C4A.1Z\\nNicotine dependence: 6C4A.2\\nNicotine dependence current use: 6C4A.20\\nNicotine dependence early full remission: 6C4A.21\\nNicotine dependence sustained partial remission: 6C4A.22\\nNicotine dependence sustained full remission: 6C4A.23\\nNicotine dependence unspecified: 6C4A.2Z\\nNicotine intoxication: 6C4A.3\\nNicotine withdrawal: 6C4A.4\\nOther specified disorders due to use of nicotine: 6C4A.Y\\nDisorders due to use of nicotine unspecified: 6C4A.Z\\nDisorders due to use of volatile inhalants: 6C4B\\nEpisode of harmful use of volatile inhalants: 6C4B.0\\nHarmful pattern of use of volatile inhalants: 6C4B.1\\nHarmful pattern of use of volatile inhalants episodic: 6C4B.10\\nHarmful pattern of use of volatile inhalants continuous: 6C4B.11\\nHarmful pattern of use of volatile inhalants unspecified: 6C4B.1Z\\nVolatile inhalant dependence: 6C4B.2\\nVolatile inhalant dependence current use: 6C4B.20\\nVolatile inhalant dependence early full remission: 6C4B.21\\nVolatile inhalant dependence sustained partial remission: 6C4B.22\\nVolatile inhalant dependence sustained full remission: 6C4B.23\\nVolatile inhalant dependence unspecified: 6C4B.2Z\\nVolatile inhalant intoxication: 6C4B.3\\nVolatile inhalant withdrawal: 6C4B.4\\nVolatile inhalantinduced delirium: 6C4B.5\\nVolatile inhalantinduced psychotic disorder: 6C4B.6\\nCertain specified volatile inhalantsinduced mental or behavioural disorders: 6C4B.7\\nVolatile inhalantinduced mood disorder: 6C4B.70\\nVolatile inhalantinduced anxiety disorder: 6C4B.71\\nOther specified disorders due to use of volatile inhalants: 6C4B.Y\\nDisorders due to use of volatile inhalants unspecified: 6C4B.Z\\nDisorders due to use of MDMA or related drugs including MDA: 6C4C\\nEpisode of harmful use of MDMA or related drugs including MDA: 6C4C.0\\nHarmful pattern of use of MDMA or related drugs including MDA: 6C4C.1\\nHarmful use of MDMA or related drugs including MDA episodic: 6C4C.10\\nHarmful use of MDMA or related drugs including MDA continuous: 6C4C.11\\nHarmful pattern of use of MDMA or related drugs including MDA unspecified: 6C4C.1Z\\nMDMA or related drug dependence including MDA: 6C4C.2\\nMDMA or related drug dependence including MDA current use: 6C4C.20\\nMDMA or related drug dependence including MDA early full remission: 6C4C.21\\nMDMA or related drug dependence including MDA sustained partial remission: 6C4C.22\\nMDMA or related drug dependence including MDA sustained full remission: 6C4C.23\\nMDMA or related drug dependence including MDA unspecified: 6C4C.2Z\\nMDMA or related drug intoxication including MDA: 6C4C.3\\nMDMA or related drug withdrawal including MDA: 6C4C.4\\nMDMA or related druginduced delirium including MDA: 6C4C.5\\nMDMA or related druginduced psychotic disorder including MDA: 6C4C.6\\nCertain specified MDMA or related druginduced mental or behavioural disorders including MDA: 6C4C.7\\nMDMA or related druginduced mood disorder including MDA: 6C4C.70\\nMDMA or related druginduced anxiety disorder: 6C4C.71\\nOther specified disorders due to use of MDMA or related drugs including MDA: 6C4C.Y\\nDisorders due to use of MDMA or related drugs including MDA unspecified: 6C4C.Z\\nDisorders due to use of dissociative drugs including ketamine and phencyclidine PCP: 6C4D\\nEpisode of harmful use of dissociative drugs including ketamine or PCP: 6C4D.0\\nHarmful pattern of use of dissociative drugs including ketamine or PCP: 6C4D.1\\nHarmful pattern of use of dissociative drugs including ketamine or PCP episodic: 6C4D.10\\nHarmful pattern of use of dissociative drugs including ketamine or PCP continuous: 6C4D.11\\nHarmful pattern of use of dissociative drugs including ketamine or PCP unspecified: 6C4D.1Z\\nDissociative drug dependence including ketamine or PCP: 6C4D.2\\nDissociative drug dependence including Ketamine or PCP current use: 6C4D.20\\nDissociative drug dependence including ketamine or PCP early full remission: 6C4D.21\\nDissociative drug dependence including Ketamine or PCP sustained partial remission: 6C4D.22\\nDissociative drug dependence including Ketamine or PCP sustained full remission: 6C4D.23\\nDissociative drug dependence including ketamine or PCP unspecified: 6C4D.2Z\\nDissociative drug intoxication including Ketamine or PCP: 6C4D.3\\nDissociative druginduced delirium including ketamine or PCP: 6C4D.4\\nDissociative druginduced psychotic disorder including Ketamine or PCP: 6C4D.5\\nCertain specified dissociative druginduced mental or behavioural disorders including ketamine and phencyclidine PCP: 6C4D.6\\nDissociative druginduced mood disorder including Ketamine or PCP: 6C4D.60\\nDissociative druginduced anxiety disorder including Ketamine or PCP: 6C4D.61\\nOther specified disorders due to use of dissociative drugs including ketamine and phencyclidine PCP: 6C4D.Y\\nDisorders due to use of dissociative drugs including ketamine and phencyclidine PCP unspecified: 6C4D.Z\\nDisorders due to use of other specified psychoactive substances including medications: 6C4E\\nEpisode of harmful use of other specified psychoactive substance: 6C4E.0\\nHarmful pattern of use of other specified psychoactive substance: 6C4E.1\\nHarmful pattern of use of other specified psychoactive substance episodic: 6C4E.10\\nHarmful pattern of use of other specified psychoactive substance continuous: 6C4E.11\\nHarmful pattern of use of other specified psychoactive substance unspecified: 6C4E.1Z\\nOther specified psychoactive substance dependence: 6C4E.2\\nOther specified psychoactive substance dependence current use: 6C4E.20\\nOther specified psychoactive substance dependence early full remission: 6C4E.21\\nOther specified psychoactive substance dependence sustained partial remission: 6C4E.22\\nOther specified psychoactive substance dependence sustained full remission: 6C4E.23\\nOther specified psychoactive substance dependence unspecified: 6C4E.2Z\\nOther specified psychoactive substance intoxication: 6C4E.3\\nOther specified psychoactive substance withdrawal: 6C4E.4\\nOther specified psychoactive substance withdrawal uncomplicated: 6C4E.40\\nOther specified psychoactive substance withdrawal with perceptual disturbances: 6C4E.41\\nOther specified psychoactive substance withdrawal with seizures: 6C4E.42\\nOther specified psychoactive substance withdrawal with perceptual disturbances and seizures: 6C4E.43\\nOther specified psychoactive substance withdrawal unspecified: 6C4E.4Z\\nDelirium induced by other specified psychoactive substance including medications: 6C4E.5\\nPsychotic disorder induced by other specified psychoactive substance: 6C4E.6\\nCertain other specified psychoactive substanceinduced mental or behavioural disorders: 6C4E.7\\nMood disorder induced by other specified psychoactive substance: 6C4E.70\\nAnxiety disorder induced by other specified psychoactive substance: 6C4E.71\\nObsessivecompulsive or related disorder induced by other specified psychoactive substance: 6C4E.72\\nImpulse control disorder induced by other specified psychoactive substance: 6C4E.73\\nOther specified disorders due to use of other specified psychoactive substances including medications: 6C4E.Y\\nDisorders due to use of other specified psychoactive substances including medications unspecified: 6C4E.Z\\nDisorders due to use of multiple specified psychoactive substances including medications: 6C4F\\nEpisode of harmful use of multiple specified psychoactive substances: 6C4F.0\\nHarmful pattern of use of multiple specified psychoactive substances: 6C4F.1\\nHarmful pattern of use of multiple specified psychoactive substances episodic: 6C4F.10\\nHarmful pattern of use of multiple specified psychoactive substances continuous: 6C4F.11\\nHarmful pattern of use of multiple specified psychoactive substances unspecified: 6C4F.1Z\\nMultiple specified psychoactive substances dependence: 6C4F.2\\nMultiple specified psychoactive substances dependence current use: 6C4F.20\\nMultiple specified psychoactive substances dependence early full remission: 6C4F.21\\nMultiple specified psychoactive substances dependence sustained partial remission: 6C4F.22\\nMultiple specified psychoactive substances dependence sustained full remission: 6C4F.23\\nMultiple specified psychoactive substances dependence unspecified: 6C4F.2Z\\nIntoxication due to multiple specified psychoactive substances: 6C4F.3\\nMultiple specified psychoactive substances withdrawal: 6C4F.4\\nMultiple specified psychoactive substances withdrawal uncomplicated: 6C4F.40\\nMultiple specified psychoactive substances withdrawal with perceptual disturbances: 6C4F.41\\nMultiple specified psychoactive substances withdrawal with seizures: 6C4F.42\\nMultiple specified psychoactive substances withdrawal with perceptual disturbances and seizures: 6C4F.43\\nOther specified multiple specified psychoactive substances withdrawal: 6C4F.4Y\\nMultiple specified psychoactive substances withdrawal unspecified: 6C4F.4Z\\nDelirium induced by multiple specified psychoactive substances including medications: 6C4F.5\\nPsychotic disorder induced by multiple specified psychoactive substances: 6C4F.6\\nCertain multiple specified psychoactive substancesinduced mental or behavioural disorders: 6C4F.7\\nMood disorder induced by multiple specified psychoactive substances: 6C4F.70\\nAnxiety disorder induced by multiple specified psychoactive substances: 6C4F.71\\nObsessivecompulsive or related disorder induced by multiple specified psychoactive substances: 6C4F.72\\nImpulse control syndrome induced by multiple specified psychoactive substances: 6C4F.73\\nOther specified disorders due to use of multiple specified psychoactive substances including medications: 6C4F.Y\\nDisorders due to use of multiple specified psychoactive substances including medications unspecified: 6C4F.Z\\nDisorders due to use of unknown or unspecified psychoactive substances: 6C4G\\nEpisode of harmful use of unknown or unspecified psychoactive substances: 6C4G.0\\nHarmful pattern of use of unknown or unspecified psychoactive substance: 6C4G.1\\nHarmful pattern of use of unknown or unspecified psychoactive substance episodic: 6C4G.10\\nHarmful pattern of use of unknown or unspecified psychoactive substance continuous: 6C4G.11\\nHarmful pattern of use of unknown or unspecified psychoactive substance unspecified: 6C4G.1Z\\nUnknown or unspecified psychoactive substance dependence: 6C4G.2\\nUnknown or unspecified psychoactive substance dependence current use: 6C4G.20\\nUnknown or unspecified psychoactive substance dependence early full remission: 6C4G.21\\nUnknown or unspecified psychoactive substance dependence sustained partial remission: 6C4G.22\\nUnknown or unspecified psychoactive substance dependence sustained full remission: 6C4G.23\\nUnknown or unspecified psychoactive substance dependence substance and state of remission unspecified: 6C4G.2Z\\nIntoxication due to unknown or unspecified psychoactive substance: 6C4G.3\\nWithdrawal due to unknown or unspecified psychoactive substance: 6C4G.4\\nWithdrawal due to unknown or unspecified psychoactive substance uncomplicated: 6C4G.40\\nWithdrawal due to unknown or unspecified psychoactive substance with perceptual disturbances: 6C4G.41\\nWithdrawal due to unknown or unspecified psychoactive substance with seizures: 6C4G.42\\nWithdrawal due to unknown or unspecified psychoactive with perceptual disturbances and seizures: 6C4G.43\\nWithdrawal due to unknown or unspecified psychoactive substance unspecified: 6C4G.4Z\\nDelirium induced by unknown or unspecified psychoactive substance: 6C4G.5\\nPsychotic disorder induced by unknown or unspecified psychoactive substance: 6C4G.6\\nCertain unknown or unspecified psychoactive substanceinduced mental or behavioural disorders: 6C4G.7\\nMood disorder induced by unknown or unspecified psychoactive substance: 6C4G.70\\nAnxiety disorder induced by unknown or unspecified psychoactive substance: 6C4G.71\\nObsessivecompulsive or related disorder induced by unknown or unspecified psychoactive substance: 6C4G.72\\nImpulse control disorder induced by unknown or unspecified psychoactive substance: 6C4G.73\\nOther specified disorders due to use of unknown or unspecified psychoactive substances: 6C4G.Y\\nDisorders due to use of unknown or unspecified psychoactive substances unspecified: 6C4G.Z\\nDisorders due to use of nonpsychoactive substances: 6C4H\\nEpisode of harmful use of nonpsychoactive substances: 6C4H.0\\nHarmful pattern of use of nonpsychoactive substances: 6C4H.1\\nHarmful pattern of use of nonpsychoactive substances episodic: 6C4H.10\\nHarmful pattern of use of nonpsychoactive substances continuous: 6C4H.11\\nHarmful pattern of use of nonpsychoactive substances unspecified: 6C4H.1Z\\nOther specified disorders due to use of nonpsychoactive substances: 6C4H.Y\\nDisorders due to use of nonpsychoactive substances unspecified: 6C4H.Z\\nOther specified disorders due to substance use: 6C4Y\\nDisorders due to substance use unspecified: 6C4Z\\nGambling disorder: 6C50\\nGambling disorder predominantly offline: 6C50.0\\nGambling disorder predominantly online: 6C50.1\\nGambling disorder unspecified: 6C50.Z\\nGaming disorder: 6C51\\nGaming disorder predominantly online: 6C51.0\\nGaming disorder predominantly offline: 6C51.1\\nGaming disorder unspecified: 6C51.Z\\nOther specified disorders due to addictive behaviours: 6C5Y\\nDisorders due to addictive behaviours unspecified: 6C5Z\\nPyromania: 6C70\\nKleptomania: 6C71\\nCompulsive sexual behaviour disorder: 6C72\\nIntermittent explosive disorder: 6C73\\nOther specified impulse control disorders: 6C7Y\\nImpulse control disorders unspecified: 6C7Z\\nOppositional defiant disorder: 6C90\\nOppositional defiant disorder with chronic irritabilityanger: 6C90.0\\nOppositional defiant disorder with chronic irritabilityanger with limited prosocial emotions: 6C90.00\\nOppositional defiant disorder with chronic irritabilityanger with typical prosocial emotions: 6C90.01\\nOppositional defiant disorder with chronic irritabilityanger unspecified: 6C90.0Z\\nOppositional defiant disorder without chronic irritabilityanger: 6C90.1\\nOppositional defiant disorder without chronic irritabilityanger with limited prosocial emotions: 6C90.10\\nOppositional defiant disorder without chronic irritabilityanger with typical prosocial emotions: 6C90.11\\nOppositional defiant disorder without chronic irritabilityanger unspecified: 6C90.1Z\\nOppositional defiant disorder unspecified: 6C90.Z\\nConductdissocial disorder: 6C91\\nConductdissocial disorder childhood onset: 6C91.0\\nConductdissocial disorder childhood onset with limited prosocial emotions: 6C91.00\\nConductdissocial disorder childhood onset with typical prosocial emotions: 6C91.01\\nConductdissocial disorder childhood onset unspecified: 6C91.0Z\\nConductdissocial disorder adolescent onset: 6C91.1\\nConductdissocial disorder adolescent onset with limited prosocial emotions: 6C91.10\\nConductdissocial disorder adolescent onset with typical prosocial emotions: 6C91.11\\nOther specified conductdissocial disorder adolescent onset: 6C91.1Y\\nConductdissocial disorder unspecified: 6C91.Z\\nOther specified disruptive behaviour or dissocial disorders: 6C9Y\\nDisruptive behaviour or dissocial disorders unspecified: 6C9Z\\nPersonality disorder: 6D10\\nMild personality disorder: 6D10.0\\nModerate personality disorder: 6D10.1\\nSevere personality disorder: 6D10.2\\nPersonality disorder severity unspecified: 6D10.Z\\nProminent personality traits or patterns: 6D11\\nNegative affectivity in personality disorder or personality difficulty: 6D11.0\\nDetachment in personality disorder or personality difficulty: 6D11.1\\nDissociality in personality disorder or personality difficulty: 6D11.2\\nDisinhibition in personality disorder or personality difficulty: 6D11.3\\nAnankastia in personality disorder or personality difficulty: 6D11.4\\nBorderline pattern: 6D11.5\\nExhibitionistic disorder: 6D30\\nVoyeuristic disorder: 6D31\\nPedophilic disorder: 6D32\\nCoercive sexual sadism disorder: 6D33\\nFrotteuristic disorder: 6D34\\nOther paraphilic disorder involving nonconsenting individuals: 6D35\\nParaphilic disorder involving solitary behaviour or consenting individuals: 6D36\\nParaphilic disorders unspecified: 6D3Z\\nFactitious disorder imposed on self: 6D50\\nFactitious disorder imposed on another: 6D51\\nFactitious disorders unspecified: 6D5Z\\nDelirium: 6D70\\nDelirium due to disease classified elsewhere: 6D70.0\\nDelirium due to psychoactive substances including medications: 6D70.1\\nDelirium due to multiple etiological factors: 6D70.2\\nDelirium other specified cause: 6D70.Y\\nDelirium unspecified or unknown cause: 6D70.Z\\nMild neurocognitive disorder: 6D71\\nAmnestic disorder: 6D72\\nAmnestic disorder due to diseases classified elsewhere: 6D72.0\\nAmnestic disorder due to psychoactive substances including medications: 6D72.1\\nAmnestic disorder due to use of alcohol: 6D72.10\\nAmnestic disorder due to use of sedatives hypnotics or anxiolytics: 6D72.11\\nAmnestic disorder due to other specified psychoactive substance including medications: 6D72.12\\nAmnestic disorder due to use of volatile inhalants: 6D72.13\\nAmnestic disorder other specified cause: 6D72.Y\\nAmnestic disorder unknown or unspecified cause: 6D72.Z\\nDementia due to Alzheimer disease: 6D80\\nDementia due to Alzheimer disease with early onset: 6D80.0\\nDementia due to Alzheimer disease with late onset: 6D80.1\\nAlzheimer disease dementia mixed type with cerebrovascular disease: 6D80.2\\nAlzheimer disease dementia mixed type with other nonvascular aetiologies: 6D80.3\\nDementia due to Alzheimer disease onset unknown or unspecified: 6D80.Z\\nDementia due to cerebrovascular disease: 6D81\\nDementia due to Lewy body disease: 6D82\\nFrontotemporal dementia: 6D83\\nDementia due to psychoactive substances including medications: 6D84\\nDementia due to use of alcohol: 6D84.0\\nDementia due to use of sedatives hypnotics or anxiolytics: 6D84.1\\nDementia due to use of volatile inhalants: 6D84.2\\nDementia due to other specified psychoactive substance: 6D84.Y\\nDementia due to diseases classified elsewhere: 6D85\\nDementia due to Parkinson disease: 6D85.0\\nDementia due to Huntington disease: 6D85.1\\nDementia due to exposure to heavy metals and other toxins: 6D85.2\\nDementia due to human immunodeficiency virus: 6D85.3\\nDementia due to multiple sclerosis: 6D85.4\\nDementia due to prion disease: 6D85.5\\nDementia due to normal pressure hydrocephalus: 6D85.6\\nDementia due to injury to the head: 6D85.7\\nDementia due to pellagra: 6D85.8\\nDementia due to Down syndrome: 6D85.9\\nDementia due to other specified diseases classified elsewhere: 6D85.Y\\nBehavioural or psychological disturbances in dementia: 6D86\\nPsychotic symptoms in dementia: 6D86.0\\nMood symptoms in dementia: 6D86.1\\nAnxiety symptoms in dementia: 6D86.2\\nApathy in dementia: 6D86.3\\nAgitation or aggression in dementia: 6D86.4\\nDisinhibition in dementia: 6D86.5\\nWandering in dementia: 6D86.6\\nOther specified behavioural or psychological disturbances in dementia: 6D86.Y\\nBehavioural or psychological disturbances in dementia unspecified: 6D86.Z\\nDementia other specified cause: 6D8Y\\nDementia unknown or unspecified cause: 6D8Z\\nOther specified neurocognitive disorders: 6E0Y\\nNeurocognitive disorders unspecified: 6E0Z\\nMental or behavioural disorders associated with pregnancy childbirth or the puerperium without psychotic symptoms: 6E20\\nMental or behavioural disorders associated with pregnancy childbirth or the puerperium with psychotic symptoms: 6E21\\nMental or behavioural disorders associated with pregnancy childbirth or the puerperium unspecified: 6E2Z\\nPsychological or behavioural factors affecting disorders or diseases classified elsewhere: 6E40\\nMental disorder affecting disorders or diseases classified elsewhere: 6E40.0\\nPsychological symptoms affecting disorders or diseases classified elsewhere: 6E40.1\\nPersonality traits or coping style affecting disorders or diseases classified elsewhere: 6E40.2\\nMaladaptive health behaviours affecting disorders or diseases classified elsewhere: 6E40.3\\nStressrelated physiological response affecting disorders or diseases classified elsewhere: 6E40.4\\nOther specified psychological or behavioural factors affecting disorders or diseases classified elsewhere: 6E40.Y\\nPsychological or behavioural factors affecting disorders or diseases classified elsewhere unspecified: 6E40.Z\\nSecondary neurodevelopmental syndrome: 6E60\\nSecondary speech or language syndrome: 6E60.0\\nOther specified secondary neurodevelopmental syndrome: 6E60.Y\\nSecondary neurodevelopmental syndrome unspecified: 6E60.Z\\nSecondary psychotic syndrome: 6E61\\nSecondary psychotic syndrome with hallucinations: 6E61.0\\nSecondary psychotic syndrome with delusions: 6E61.1\\nSecondary psychotic syndrome with hallucinations and delusions: 6E61.2\\nSecondary psychotic syndrome with unspecified symptoms: 6E61.3\\nSecondary mood syndrome: 6E62\\nSecondary mood syndrome with depressive symptoms: 6E62.0\\nSecondary mood syndrome with manic symptoms: 6E62.1\\nSecondary mood syndrome with mixed symptoms: 6E62.2\\nSecondary mood syndrome with unspecified symptoms: 6E62.3\\nSecondary anxiety syndrome: 6E63\\nSecondary obsessivecompulsive or related syndrome: 6E64\\nSecondary dissociative syndrome: 6E65\\nSecondary impulse control syndrome: 6E66\\nSecondary neurocognitive syndrome: 6E67\\nSecondary personality change: 6E68\\nSecondary catatonia syndrome: 6E69\\nOther specified secondary mental or behavioural syndrome: 6E6Y\\nSecondary mental or behavioural syndrome unspecified: 6E6Z\\nOther specified mental behavioural or neurodevelopmental disorders: 6E8Y\\nMental behavioural or neurodevelopmental disorders unspecified: 6E8Z\\nChronic insomnia: 7A00\\nShortterm insomnia: 7A01\\nInsomnia disorders unspecified: 7A0Z\\nNarcolepsy: 7A20\\nNarcolepsy Type: 7A20.1\\nNarcolepsy unspecified: 7A20.Z\\nIdiopathic hypersomnia: 7A21\\nKleineLevin syndrome: 7A22\\nHypersomnia due to a medical condition: 7A23\\nHypersomnia due to a medication or substance: 7A24\\nHypersomnia associated with a mental disorder: 7A25\\nInsufficient sleep syndrome: 7A26\\nOther specified hypersomnolence disorders: 7A2Y\\nHypersomnolence disorders unspecified: 7A2Z\\nCentral sleep apnoeas: 7A40\\nPrimary central sleep apnoea: 7A40.0\\nPrimary central sleep apnoea of infancy: 7A40.1\\nPrimary central sleep apnoea of prematurity: 7A40.2\\nCentral sleep apnea with CheyneStokes breathing: 7A40.3\\nCentral sleep apnoea due to a medical condition without CheyneStokes breathing: 7A40.4\\nCentral sleep apnoea due to highaltitude periodic breathing: 7A40.5\\nCentral sleep apnoea due to a medication or substance: 7A40.6\\nTreatmentemergent central sleep apnoea: 7A40.7\\nOther specified central sleep apnoeas: 7A40.Y\\nCentral sleep apnoeas unspecified: 7A40.Z\\nObstructive sleep apnoea: 7A41\\nSleeprelated hypoventilation or hypoxemia disorders: 7A42\\nObesity hypoventilation syndrome: 7A42.0\\nCongenital central alveolar sleeprelated hypoventilation: 7A42.1\\nNoncongenital central hypoventilation with hypothalamic abnormalities: 7A42.2\\nIdiopathic central alveolar hypoventilation: 7A42.3\\nSleeprelated hypoventilation due to a medication or substance: 7A42.4\\nSleeprelated hypoventilation due to medical condition: 7A42.5\\nSleeprelated hypoxemia due to a medical condition: 7A42.6\\nOther specified sleeprelated hypoventilation or hypoxemia disorders: 7A42.Y\\nSleeprelated hypoventilation or hypoxemia disorders unspecified: 7A42.Z\\nOther specified sleeprelated breathing disorders: 7A4Y\\nSleeprelated breathing disorders unspecified: 7A4Z\\nDelayed sleepwake phase disorder: 7A60\\nAdvanced sleepwake phase disorder: 7A61\\nIrregular sleepwake rhythm disorder: 7A62\\nNon hour sleepwake rhythm disorder: 7A63\\nCircadian rhythm sleepwake disorder shift work type: 7A64\\nCircadian rhythm sleepwake disorder jet lag type: 7A65\\nCircadian rhythm sleepwake disorders unspecified: 7A6Z\\nRestless legs syndrome: 7A80\\nPeriodic limb movement disorder: 7A81\\nSleeprelated leg cramps: 7A82\\nSleeprelated bruxism: 7A83\\nSleeprelated rhythmic movement disorder: 7A84\\nBenign sleep myoclonus of infancy: 7A85\\nPropriospinal myoclonus at sleep onset: 7A86\\nSleeprelated movement disorder due to a medical condition: 7A87\\nSleeprelated movement disorder due to a medication or substance: 7A88\\nOther specified sleeprelated movement disorders: 7A8Y\\nSleeprelated movement disorders unspecified: 7A8Z\\nDisorders of arousal from nonREM sleep: 7B00\\nConfusional arousals: 7B00.0\\nSleepwalking disorder: 7B00.1\\nSleep terrors: 7B00.2\\nSleeprelated eating disorder: 7B00.3\\nOther specified disorders of arousal from nonREM sleep: 7B00.Y\\nDisorders of arousal from nonREM sleep unspecified: 7B00.Z\\nParasomnias related to REM sleep: 7B01\\nREM sleep behaviour disorder: 7B01.0\\nRecurrent isolated sleep paralysis: 7B01.1\\nNightmare disorder: 7B01.2\\nOther specified parasomnias related to REM sleep: 7B01.Y\\nParasomnias related to REM sleep unspecified: 7B01.Z\\nOther parasomnias: 7B02\\nHypnagogic exploding head syndrome: 7B02.0\\nSleeprelated hallucinations: 7B02.1\\nParasomnia disorder due to a medical condition: 7B02.2\\nParasomnia disorder due to a medication or substance: 7B02.3\\nOther specified parasomnia disorders: 7B0Y\\nParasomnia disorders unspecified: 7B0Z\\nOther specified sleepwake disorders: 7B2Y\\nSleepwake disorders unspecified: 7B2Z\\nParkinsonism: 8A00\\nParkinson disease: 8A00.0\\nSporadic Parkinson disease: 8A00.00\\nFamilial Parkinson disease: 8A00.01\\nOther specified Parkinson disease: 8A00.0Y\\nParkinson disease unspecified: 8A00.0Z\\nAtypical parkinsonism: 8A00.1\\nProgressive supranuclear palsy: 8A00.10\\nOther specified atypical parkinsonism: 8A00.1Y\\nAtypical parkinsonism unspecified: 8A00.1Z\\nSecondary parkinsonism: 8A00.2\\nParkinsonism due to heredodegenerative disorders: 8A00.20\\nHemiparkinsonism hemiatrophy syndrome: 8A00.21\\nInfectious or postinfectious parkinsonism: 8A00.22\\nVascular parkinsonism: 8A00.23\\nDruginduced parkinsonism: 8A00.24\\nPost traumatic Parkinsonism: 8A00.25\\nParkinsonism due to structural lesions: 8A00.26\\nOther specified secondary parkinsonism: 8A00.2Y\\nSecondary parkinsonism unspecified: 8A00.2Z\\nFunctional parkinsonism: 8A00.3\\nOther specified parkinsonism: 8A00.Y\\nParkinsonism unspecified: 8A00.Z\\nChoreiform disorders: 8A01\\nBenign hereditary chorea: 8A01.0\\nSecondary Chorea: 8A01.1\\nHuntington disease: 8A01.10\\nChorea due to Huntington diseaselike conditions: 8A01.11\\nChorea due to Dentatorubral pallidoluysian atrophy: 8A01.12\\nChorea due to Wilson disease: 8A01.13\\nChorea due to infectious or parainfectious causes: 8A01.14\\nChorea due to systemic lupus erythematosus: 8A01.15\\nDruginduced chorea: 8A01.16\\nOther specified secondary chorea: 8A01.1Y\\nSecondary chorea unspecified: 8A01.1Z\\nHemichorea or hemiballismus: 8A01.2\\nHemichorea: 8A01.20\\nBallism: 8A01.21\\nHemiballism: 8A01.22\\nOther specified choreiform disorders: 8A01.Y\\nChoreiform disorders unspecified: 8A01.Z\\nDystonic disorders: 8A02\\nPrimary dystonia: 8A02.0\\nBenign essential blepharospasm: 8A02.00\\nOther specified primary dystonia: 8A02.0Y\\nPrimary dystonia unspecified: 8A02.0Z\\nSecondary dystonia: 8A02.1\\nDruginduced dystonia: 8A02.10\\nDystoniaplus: 8A02.11\\nDystonia associated with heredodegenerative disorders: 8A02.12\\nOther specified secondary dystonia: 8A02.1Y\\nSecondary dystonia unspecified: 8A02.1Z\\nParoxysmal dystonia: 8A02.2\\nFunctional dystonia or spasms: 8A02.3\\nOther specified dystonic disorders: 8A02.Y\\nDystonic disorders unspecified: 8A02.Z\\nAtaxic disorders: 8A03\\nCongenital ataxia: 8A03.0\\nHereditary ataxia: 8A03.1\\nFriedreich ataxia: 8A03.10\\nAtaxia due to Cerebrotendinous xanthomatosis: 8A03.11\\nAtaxia due to Refsum disease: 8A03.12\\nAtaxia due to abetalipoproteinemia: 8A03.13\\nHereditary episodic ataxia: 8A03.14\\nAtaxia due to mitochondrial mutations: 8A03.15\\nSpinocerebellar ataxia: 8A03.16\\nOther specified hereditary ataxia: 8A03.1Y\\nHereditary ataxia unspecified: 8A03.1Z\\nNonhereditary degenerative ataxia: 8A03.2\\nLate onset cerebellar cortical atrophy: 8A03.20\\nOther specified nonhereditary degenerative ataxia: 8A03.2Y\\nNonhereditary degenerative ataxia unspecified: 8A03.2Z\\nAcquired ataxia: 8A03.3\\nAtaxia due to alcoholic cerebellar degeneration: 8A03.30\\nOther specified acquired ataxia: 8A03.3Y\\nAcquired ataxia unspecified: 8A03.3Z\\nOther specified ataxic disorders: 8A03.Y\\nAtaxic disorders unspecified: 8A03.Z\\nDisorders associated with tremor: 8A04\\nEnhanced physiological tremor: 8A04.0\\nEssential tremor or related tremors: 8A04.1\\nRest tremor: 8A04.2\\nSecondary tremor: 8A04.3\\nTremor due to metabolic disorders: 8A04.30\\nTremor due to chronic or acute substance use: 8A04.31\\nTremor due to drug withdrawal: 8A04.32\\nTremor due to certain specified central nervous system diseases: 8A04.33\\nOther specified secondary tremor: 8A04.3Y\\nSecondary tremor unspecified: 8A04.3Z\\nFunctional tremor: 8A04.4\\nOther specified disorders associated with tremor: 8A04.Y\\nDisorders associated with tremor unspecified: 8A04.Z\\nTic disorders: 8A05\\nPrimary tics or tic disorders: 8A05.0\\nTourette syndrome: 8A05.00\\nChronic motor tic disorder: 8A05.01\\nChronic phonic tic disorder: 8A05.02\\nTransient motor tics: 8A05.03\\nOther specified primary tics or tic disorders: 8A05.0Y\\nPrimary tics or tic disorders unspecified: 8A05.0Z\\nSecondary tics: 8A05.1\\nInfectious or postinfectious tics: 8A05.10\\nTics associated with developmental disorders: 8A05.11\\nOther specified secondary tics: 8A05.1Y\\nSecondary tics unspecified: 8A05.1Z\\nOther specified tic disorders: 8A05.Y\\nTic disorders unspecified: 8A05.Z\\nMyoclonic disorders: 8A06\\nEssential myoclonus: 8A06.0\\nSegmental myoclonus: 8A06.1\\nFocal myoclonus: 8A06.2\\nPalatal myoclonus: 8A06.20\\nChronic hiccups: 8A06.21\\nOther specified focal myoclonus: 8A06.2Y\\nFocal myoclonus unspecified: 8A06.2Z\\nOther specified myoclonic disorders: 8A06.Y\\nMyoclonic disorders unspecified: 8A06.Z\\nCertain specified movement disorder: 8A07\\nStereotypies: 8A07.0\\nPrimary stereotypy: 8A07.00\\nSecondary stereotypy: 8A07.01\\nOther specified stereotypies: 8A07.0Y\\nStereotypies unspecified: 8A07.0Z\\nAkathisia: 8A07.1\\nExcessive startle reflex: 8A07.2\\nOther specified movement disorders: 8A0Y\\nMovement disorders unspecified: 8A0Z\\nAlzheimer disease: 8A20\\nProgressive focal atrophies: 8A21\\nPosterior cortical atrophy: 8A21.0\\nOther specified progressive focal atrophies: 8A21.Y\\nProgressive focal atrophies unspecified: 8A21.Z\\nLewy body disease: 8A22\\nFrontotemporal lobar degeneration: 8A23\\nOther specified disorders with neurocognitive impairment as a major feature: 8A2Y\\nDisorders with neurocognitive impairment as a major feature unspecified: 8A2Z\\nMultiple sclerosis: 8A40\\nRelapsingremitting multiple sclerosis: 8A40.0\\nPrimary progressive multiple sclerosis: 8A40.1\\nSecondary progressive multiple sclerosis: 8A40.2\\nOther specified multiple sclerosis: 8A40.Y\\nMultiple sclerosis unspecified: 8A40.Z\\nIsolated demyelinating syndromes of the central nervous system: 8A41\\nTransverse myelitis: 8A41.0\\nNeuromyelitis optica myelin oligodendrocyte glycoprotein antibodypositive: 8A41.1\\nOther specified isolated demyelinating syndromes of the central nervous system: 8A41.Y\\nIsolated demyelinating syndromes of the central nervous system unspecified: 8A41.Z\\nAcute disseminated encephalomyelitis: 8A42\\nAcute haemorrhagic leukoencephalitis: 8A42.0\\nOther specified acute disseminated encephalomyelitis: 8A42.Y\\nAcute disseminated encephalomyelitis unspecified: 8A42.Z\\nNeuromyelitis optica: 8A43\\nNeuromyelitis optica aquaporin antibody positive: 8A43.0\\nNeuromyelitis optica aquaporin antibody negative: 8A43.1\\nSingle transverse myelitis aquaporin antibody positive: 8A43.2\\nRecurrent transverse myelitis aquaporin antibody positive: 8A43.3\\nSingle optic neuritis aquaporin antibody positive: 8A43.4\\nRecurrent optic neuritis aquaporin antibody positive: 8A43.5\\nOther specified neuromyelitis optica: 8A43.Y\\nNeuromyelitis optica unspecified: 8A43.Z\\nLeukodystrophies: 8A44\\nPelizaeusMerzbacher disease: 8A44.0\\nAdrenoleukodystrophy: 8A44.1\\nAlexander disease: 8A44.2\\nCertain specified leukodystrophies: 8A44.3\\nKrabbe disease: 8A44.4\\nLeukodystrophies unspecified: 8A44.Z\\nSecondary white matter disorders: 8A45\\nWhite matter disorders due to infections: 8A45.0\\nHuman Tcell lymphotropic virusassociated myelopathy: 8A45.00\\nSubacute sclerosing panencephalitis: 8A45.01\\nProgressive multifocal leukoencephalopathy: 8A45.02\\nOther specified white matter disorders due to infections: 8A45.0Y\\nWhite matter disorders due to infections unspecified: 8A45.0Z\\nWhite matter disorders due to toxicity: 8A45.1\\nWhite matter disorders due to vascular abnormality or ischemia: 8A45.2\\nWhite matter disorder due to CADASIL: 8A45.20\\nSubacute necrotising myelitis: 8A45.21\\nOther specified white matter disorders due to vascular abnormality or ischemia: 8A45.2Y\\nWhite matter disorders due to vascular abnormality or ischemia unspecified: 8A45.2Z\\nWhite matter disorders due to nutritional deficiency: 8A45.3\\nWhite matter disorder due to vitamin B deficiency: 8A45.30\\nCentral pontine myelinolysis: 8A45.31\\nOther specified white matter disorders due to nutritional deficiency: 8A45.3Y\\nWhite matter disorders due to nutritional deficiency unspecified: 8A45.3Z\\nWhite matter disorders due to certain specified systemic disease: 8A45.4\\nDemyelination due to sarcoidosis: 8A45.40\\nDemyelination due to systemic lupus erythematosus: 8A45.41\\nDemyelination due to Sjgren disease: 8A45.42\\nDemyelination due to Behcet disease: 8A45.43\\nDemyelination due to systemic vasculitis: 8A45.44\\nDemyelination due to mitochondrial disease: 8A45.45\\nWhite matter disorders due to certain specified systemic disease unspecified: 8A45.4Z\\nOther specified secondary white matter disorders: 8A45.Y\\nSecondary white matter disorders unspecified: 8A45.Z\\nCentral demyelination of corpus callosum: 8A46\\nOther specified multiple sclerosis or other white matter disorders: 8A4Y\\nMultiple sclerosis or other white matter disorders unspecified: 8A4Z\\nEpilepsy due to structural or metabolic conditions or diseases: 8A60\\nEpilepsy due to prenatal or perinatal brain insults: 8A60.0\\nEpilepsy due to prenatal or perinatal vascular insults: 8A60.00\\nEpilepsy due to neonatal hypoxic ischemic encephalopathy: 8A60.01\\nEpilepsy due to other prenatal or perinatal brain insults: 8A60.0Y\\nEpilepsy due to unspecified prenatal or perinatal brain insults: 8A60.0Z\\nEpilepsy due to cerebrovascular disorders: 8A60.1\\nEpilepsy due to degenerative brain disorders: 8A60.2\\nEpilepsy due to dementias: 8A60.3\\nEpilepsy due to central nervous system infections or infestations: 8A60.4\\nEpilepsy due to injuries to the head: 8A60.5\\nEpilepsy due to tumours of the nervous system: 8A60.6\\nEpilepsy with mesial temporal sclerosis: 8A60.7\\nEpilepsy due to immune disorders: 8A60.8\\nEpilepsy due to abnormalities of brain development: 8A60.9\\nEpilepsy due to genetic syndromes with widespread or progressive effects: 8A60.A\\nEpilepsy due to multiple sclerosis or other demyelinating disorders: 8A60.B\\nEpilepsy due to other structural or metabolic condition or disease: 8A60.Y\\nEpilepsy due to unspecified structural or metabolic condition or disease: 8A60.Z\\nGenetic or presumed genetic syndromes primarily expressed as epilepsy: 8A61\\nGenetic epileptic syndromes with neonatal onset: 8A61.0\\nPyridoxal dependent epilepsy: 8A61.00\\nOther specified genetic epileptic syndromes with neonatal onset: 8A61.0Y\\nGenetic epileptic syndromes with neonatal onset unspecified: 8A61.0Z\\nGenetic epileptic syndromes with onset in infancy: 8A61.1\\nBenign familial infantile epilepsy: 8A61.10\\nDravet syndrome: 8A61.11\\nEpilepsy of infancy with migrating focal seizures: 8A61.12\\nOther specified genetic epileptic syndromes with onset in infancy: 8A61.1Y\\nGenetic epileptic syndromes with onset in infancy unspecified: 8A61.1Z\\nGenetic epileptic syndromes with childhood onset: 8A61.2\\nBenign childhood epilepsy with centrotemporal spikes: 8A61.20\\nChildhood absence epilepsy: 8A61.21\\nEpilepsy with myoclonicastatic seizures: 8A61.22\\nMyoclonic absences or absences with myoclonias: 8A61.23\\nOther specified genetic epileptic syndromes with childhood onset: 8A61.2Y\\nGenetic epileptic syndromes with childhood onset unspecified: 8A61.2Z\\nGenetic epileptic syndrome with adolescent or adult onset: 8A61.3\\nJuvenile myoclonic epilepsy: 8A61.30\\nJuvenile absence epilepsy: 8A61.31\\nBenign adult familial myoclonus epilepsy: 8A61.32\\nOther specified genetic epileptic syndrome with adolescent or adult onset: 8A61.3Y\\nGenetic epileptic syndrome with adolescent or adult onset unspecified: 8A61.3Z\\nGenetic epileptic syndromes with variable age of onset: 8A61.4\\nReflex epilepsies: 8A61.40\\nProgressive myoclonic epilepsy: 8A61.41\\nOther specified genetic epileptic syndromes with variable age of onset: 8A61.4Y\\nGenetic epileptic syndromes with variable age of onset unspecified: 8A61.4Z\\nOther specified genetic or presumed genetic syndromes primarily expressed as epilepsy: 8A61.Y\\nGenetic or presumed genetic syndromes primarily expressed as epilepsy unspecified: 8A61.Z\\nEpileptic encephalopathies: 8A62\\nInfantile spasms: 8A62.0\\nLennoxGastaut syndrome: 8A62.1\\nAcquired epileptic aphasia: 8A62.2\\nOther specified epileptic encephalopathies: 8A62.Y\\nEpileptic encephalopathies unspecified: 8A62.Z\\nSeizure due to acute causes: 8A63\\nFebrile seizures: 8A63.0\\nSimple febrile seizures: 8A63.00\\nComplex febrile seizures: 8A63.01\\nOther specified febrile seizures: 8A63.0Y\\nFebrile seizures unspecified: 8A63.0Z\\nSeizure due to other acute cause: 8A63.Y\\nSeizure due to unspecified acute cause: 8A63.Z\\nSingle seizure due to remote causes: 8A64\\nSingle unprovoked seizure: 8A65\\nStatus epilepticus: 8A66\\nConvulsive status epilepticus: 8A66.0\\nNonconvulsive status epilepticus: 8A66.1\\nAbsence status epilepticus: 8A66.10\\nOther specified nonconvulsive status epilepticus: 8A66.1Y\\nNonconvulsive status epilepticus unspecified: 8A66.1Z\\nOther specified status epilepticus: 8A66.Y\\nStatus epilepticus unspecified: 8A66.Z\\nAcute repetitive seizures: 8A67\\nTypes of seizures: 8A68\\nFocal unaware seizure: 8A68.0\\nAbsence seizures atypical: 8A68.1\\nAbsence seizures typical: 8A68.2\\nFocal aware seizure: 8A68.3\\nGeneralised tonicclonic seizure: 8A68.4\\nGeneralised myoclonic seizure: 8A68.5\\nGeneralised tonic seizure: 8A68.6\\nGeneralised atonic seizure: 8A68.7\\nOther specified type of seizure: 8A68.Y\\nType of seizure unspecified: 8A68.Z\\nOther specified epilepsy or seizures: 8A6Y\\nEpilepsy or seizures unspecified: 8A6Z\\nMigraine: 8A80\\nMigraine without aura: 8A80.0\\nMigraine with aura: 8A80.1\\nHemiplegic migraine: 8A80.10\\nOther specified migraine with aura: 8A80.1Y\\nMigraine with aura unspecified: 8A80.1Z\\nChronic migraine: 8A80.2\\nComplications related to migraine: 8A80.3\\nStatus migrainosus: 8A80.30\\nOther specified complications related to migraine: 8A80.3Y\\nComplications related to migraine unspecified: 8A80.3Z\\nCyclic vomiting syndrome: 8A80.4\\nOther specified migraine: 8A80.Y\\nMigraine unspecified: 8A80.Z\\nTensiontype headache: 8A81\\nInfrequent episodic tensiontype headache: 8A81.0\\nFrequent episodic tensiontype headache: 8A81.1\\nChronic tensiontype headache: 8A81.2\\nOther specified tensiontype headache: 8A81.Y\\nTensiontype headache unspecified: 8A81.Z\\nTrigeminal autonomic cephalalgias: 8A82\\nOther primary headache disorder: 8A83\\nSecondary headache: 8A84\\nAcute headache associated with traumatic injury to the head: 8A84.0\\nPersistent headache associated with traumatic injury to the head: 8A84.1\\nOther specified secondary headache: 8A84.Y\\nSecondary headache unspecified: 8A84.Z\\nPainful cranial neuropathies or other facial pains: 8A85\\nOther specified headache disorders: 8A8Y\\nHeadache disorders unspecified: 8A8Z\\nIntracerebral haemorrhage: 8B00\\nDeep hemispheric haemorrhage: 8B00.0\\nLobar haemorrhage: 8B00.1\\nBrainstem haemorrhage: 8B00.2\\nCerebellar haemorrhage: 8B00.3\\nIntraventricular haemorrhage without parenchymal haemorrhage: 8B00.4\\nHaemorrhage of multiple sites: 8B00.5\\nIntracerebral haemorrhage site unspecified: 8B00.Z\\nSubarachnoid haemorrhage: 8B01\\nAneurysmal subarachnoid haemorrhage: 8B01.0\\nNonaneurysmal subarachnoid haemorrhage: 8B01.1\\nSubarachnoid haemorrhage not known if aneurysmal or nonaneurysmal: 8B01.2\\nNontraumatic subdural haemorrhage: 8B02\\nNontraumatic epidural haemorrhage: 8B03\\nIntracranial haemorrhage unspecified: 8B0Z\\nTransient ischaemic attack: 8B10\\nAmaurosis fugax: 8B10.0\\nOther specified transient ischaemic attack: 8B10.Y\\nTransient ischaemic attack unspecified: 8B10.Z\\nCerebral ischaemic stroke: 8B11\\nCerebral ischaemic stroke due to extracranial large artery atherosclerosis: 8B11.0\\nCerebral ischaemic stroke due to intracranial large artery atherosclerosis: 8B11.1\\nCerebral ischaemic stroke due to embolic occlusion: 8B11.2\\nCerebral ischaemic stroke due to cardiac embolism: 8B11.20\\nCerebral ischaemic stroke due to aortic arch embolism: 8B11.21\\nCerebral ischaemic stroke due to paradoxical embolism: 8B11.22\\nCerebral ischaemic stroke due to other specified embolic occlusion: 8B11.2Y\\nCerebral ischaemic stroke due to embolic occlusion unspecified: 8B11.2Z\\nCerebral ischaemic stroke due to small artery occlusion: 8B11.3\\nCerebral ischaemic stroke due to other known cause: 8B11.4\\nCerebral ischaemic stroke due to global hypoperfusion with watershed infarct: 8B11.40\\nCerebral ischaemic stroke due to other nonatherosclerotic arteriopathy: 8B11.41\\nCerebral ischaemic stroke due to hypercoagulable state: 8B11.42\\nCerebral ischaemic stroke in association with subarachnoid haemorrhage: 8B11.43\\nCerebral ischemic stroke from dissection: 8B11.44\\nCerebral ischaemic stroke of unknown cause: 8B11.5\\nCerebral ischaemic stroke due to unspecified occlusion or stenosis of extracranial large artery: 8B11.50\\nCerebral ischaemic stroke due to unspecified occlusion or stenosis of intracranial large artery: 8B11.51\\nCerebral ischaemic stroke unspecified: 8B11.5Z\\nOther specified cerebral ischaemia: 8B1Y\\nCerebral ischaemia unspecified: 8B1Z\\nStroke not known if ischaemic or haemorrhagic: 8B20\\nCerebrovascular disease with no acute cerebral symptom: 8B21\\nSilent cerebral infarct: 8B21.0\\nSilent cerebral microbleed: 8B21.1\\nOther specified cerebrovascular disease with no acute cerebral symptom: 8B21.Y\\nCerebrovascular disease with no acute cerebral symptom unspecified: 8B21.Z\\nCertain specified cerebrovascular diseases: 8B22\\nDissection of cerebral arteries: 8B22.0\\nCerebral venous thrombosis: 8B22.1\\nCerebral vasoconstriction syndromes: 8B22.2\\nIsolated cerebral amyloid angiopathy: 8B22.3\\nIntracranial vascular malformation: 8B22.4\\nArteriovenous malformation of cerebral vessels: 8B22.40\\nCerebral cavernous malformation: 8B22.41\\nDural arteriovenous fistula: 8B22.42\\nCarotid cavernous fistula: 8B22.43\\nOther specified intracranial vascular malformation: 8B22.4Y\\nIntracranial vascular malformation unspecified: 8B22.4Z\\nCerebral aneurysm nonruptured: 8B22.5\\nFamilial cerebral saccular aneurysm: 8B22.6\\nCerebral arteritis not elsewhere classified: 8B22.7\\nPrimary cerebral arteritis: 8B22.70\\nOther specified cerebral arteritis not elsewhere classified: 8B22.7Y\\nCerebral arteritis not elsewhere classified unspecified: 8B22.7Z\\nHypertensive encephalopathy: 8B22.8\\nMigraineinduced stroke: 8B22.9\\nSubclavian steal syndrome: 8B22.A\\nMoyamoya syndrome: 8B22.B\\nHereditary cerebrovascular diseases: 8B22.C\\nCADASIL cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome: 8B22.C0\\nCARASIL cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy syndrome: 8B22.C1\\nOther specified hereditary cerebrovascular diseases: 8B22.CY\\nHereditary cerebrovascular diseases unspecified: 8B22.CZ\\nOther specified cerebrovascular disease: 8B22.Y\\nCerebrovascular abnormalities: 8B23\\nHypoxicischaemic encephalopathy: 8B24\\nAnoxicischaemic encephalopathy: 8B24.0\\nOther specified hypoxicischaemic encephalopathy: 8B24.Y\\nHypoxicischaemic encephalopathy unspecified: 8B24.Z\\nLate effects of cerebrovascular disease: 8B25\\nLate effects of cerebral ischemic stroke: 8B25.0\\nLate effects of intracerebral haemorrhage: 8B25.1\\nLate effects of subarachnoid haemorrhage: 8B25.2\\nLate effects of other nontraumatic intracranial haemorrhage: 8B25.3\\nLate effects of stroke not known if ischaemic or haemorrhagic: 8B25.4\\nLate effects of other specified cerebrovascular disease: 8B25.Y\\nLate effects of cerebrovascular disease unspecified: 8B25.Z\\nVascular syndromes of brain in cerebrovascular diseases: 8B26\\nBrainstem stroke syndrome: 8B26.0\\nCerebellar stroke syndrome: 8B26.1\\nMiddle cerebral artery syndrome: 8B26.2\\nAnterior cerebral artery syndrome: 8B26.3\\nPosterior cerebral artery syndrome: 8B26.4\\nLacunar syndromes: 8B26.5\\nPure motor lacunar syndrome: 8B26.50\\nPure sensory lacunar syndrome: 8B26.51\\nOther specified lacunar syndromes: 8B26.5Y\\nLacunar syndromes unspecified: 8B26.5Z\\nOther specified vascular syndromes of brain in cerebrovascular diseases: 8B26.Y\\nVascular syndromes of brain in cerebrovascular diseases unspecified: 8B26.Z\\nCerebrovascular diseases unspecified: 8B2Z\\nCauda equina syndrome: 8B40\\nMyelitis: 8B41\\nMyelopathy: 8B42\\nNoncompressive vascular myelopathies: 8B43\\nAcute arterial infarction of the spinal cord: 8B43.0\\nAcute venous infarction of the spinal cord: 8B43.1\\nChronic venous infarction of the spinal cord: 8B43.2\\nOther specified noncompressive vascular myelopathies: 8B43.Y\\nNoncompressive vascular myelopathies unspecified: 8B43.Z\\nDegenerative myelopathic disorders: 8B44\\nHereditary spastic paraplegia: 8B44.0\\nAutosomal dominant hereditary spastic paraplegia: 8B44.00\\nAutosomal recessive hereditary spastic paraplegia: 8B44.01\\nXlinked hereditary spastic paraplegia: 8B44.02\\nOther specified hereditary spastic paraplegia: 8B44.0Y\\nHereditary spastic paraplegia unspecified: 8B44.0Z\\nOther specified degenerative myelopathic disorders: 8B44.Y\\nDegenerative myelopathic disorders unspecified: 8B44.Z\\nOther specified spinal cord disorders excluding trauma: 8B4Y\\nSpinal cord disorders excluding trauma unspecified: 8B4Z\\nMotor neuron disease: 8B60\\nAmyotrophic lateral sclerosis: 8B60.0\\nProgressive bulbar palsy: 8B60.1\\nProgressive pseudobulbar palsy: 8B60.2\\nProgressive muscular atrophy: 8B60.3\\nPrimary lateral sclerosis: 8B60.4\\nAmyotrophic lateral sclerosisPlus: 8B60.5\\nMonomelic amyotrophy: 8B60.6\\nMadras type motor neuron disease: 8B60.7\\nOther specified motor neuron disease: 8B60.Y\\nMotor neuron disease unspecified: 8B60.Z\\nSpinal muscular atrophy: 8B61\\nInfantile spinal muscular atrophy Type I: 8B61.0\\nLate infantile spinal muscular atrophy Type II: 8B61.1\\nJuvenile form spinal muscular dystrophy Type III: 8B61.2\\nAdult onset spinal muscular atrophy Type IV: 8B61.3\\nLocalised spinal muscular atrophy: 8B61.4\\nOther specified spinal muscular atrophy: 8B61.Y\\nSpinal muscular atrophy unspecified: 8B61.Z\\nPost polio progressive muscular atrophy: 8B62\\nOther specified motor neuron diseases or related disorders: 8B6Y\\nMotor neuron diseases or related disorders unspecified: 8B6Z\\nDisorders of olfactory nerve: 8B80\\nDisorders of vestibulocochlear nerve: 8B81\\nBrainstem lesion: 8B81.0\\nOther specified disorders of vestibulocochlear nerve: 8B81.Y\\nDisorders of vestibulocochlear nerve unspecified: 8B81.Z\\nDisorders of trigeminal nerve: 8B82\\nTrigeminal neuralgia: 8B82.0\\nDisorders of trigeminal nerve unspecified: 8B82.Z\\nDisorders of spinal accessory nerve: 8B83\\nDisorders of hypoglossal nerve: 8B84\\nDisorders of multiple cranial nerves: 8B85\\nDisorders of vagus nerve: 8B86\\nDisorders of glossopharyngeal nerve: 8B87\\nDisorders of facial nerve: 8B88\\nBell palsy: 8B88.0\\nFacial myokymia: 8B88.1\\nHemifacial spasm: 8B88.2\\nFacial neuritis: 8B88.3\\nOther specified disorders of facial nerve: 8B88.Y\\nDisorders of facial nerve unspecified: 8B88.Z\\nOther specified disorders of cranial nerves: 8B8Y\\nDisorders of cranial nerves unspecified: 8B8Z\\nNerve root or plexus compressions: 8B90\\nBrachial plexus disorders: 8B91\\nNeuralgic shoulder amyotrophy: 8B91.0\\nThoracic outlet syndrome due to cervical rib: 8B91.1\\nOther specified brachial plexus disorders: 8B91.Y\\nBrachial plexus disorders unspecified: 8B91.Z\\nLumbosacral plexus disorders: 8B92\\nPost radiation lumbosacral plexopathy: 8B92.0\\nVasculitic lumbosacral plexopathy: 8B92.1\\nDiabetic lumbosacral plexopathy: 8B92.2\\nLumbosacral radiculoplexopathy: 8B92.3\\nOther specified lumbosacral plexus disorders: 8B92.Y\\nLumbosacral plexus disorders unspecified: 8B92.Z\\nRadiculopathy: 8B93\\nRadiculopathy due to compression: 8B93.0\\nRadiculopathy due to metabolic disorders: 8B93.1\\nRadiculopathy due to electric shock or lightning: 8B93.2\\nRadiculopathy due to radiation injury: 8B93.3\\nRadiculopathy due to nutritional deficiencies: 8B93.4\\nRadiculopathy due to toxicity: 8B93.5\\nRadiculopathy due to intervertebral disc disorders: 8B93.6\\nRadiculopathy due to neoplastic disease: 8B93.7\\nRadiculopathy due to spondylosis: 8B93.8\\nOther specified radiculopathy: 8B93.Y\\nRadiculopathy unspecified: 8B93.Z\\nDiabetic radiculoplexoneuropathy: 8B94\\nSecondary brachial plexus lesion due to certain specified disorders: 8B95\\nOther specified nerve root or plexus disorders: 8B9Y\\nNerve root or plexus disorders unspecified: 8B9Z\\nIdiopathic progressive neuropathy: 8C00\\nInflammatory polyneuropathy: 8C01\\nAcute inflammatory demyelinating polyneuropathy: 8C01.0\\nPost vaccinal neuropathy: 8C01.1\\nSubacute inflammatory demyelinating polyneuropathy: 8C01.2\\nChronic inflammatory demyelinating polyneuropathy: 8C01.3\\nOther specified inflammatory polyneuropathy: 8C01.Y\\nInflammatory polyneuropathy unspecified: 8C01.Z\\nOther secondary polyneuropathy: 8C03\\nDiabetic polyneuropathy: 8C03.0\\nPolyneuropathy due to infectious diseases: 8C03.1\\nPolyneuropathy in neoplastic disease: 8C03.2\\nPolyneuropathy in nutritional deficiency: 8C03.3\\nPolyneuropathy in systemic connective tissue disorders: 8C03.4\\nOther specified secondary polyneuropathy: 8C03.Y\\nOther secondary polyneuropathy unspecified: 8C03.Z\\nOther specified polyneuropathy: 8C0Y\\nPolyneuropathy unspecified: 8C0Z\\nMononeuropathies of upper limb: 8C10\\nCarpal tunnel syndrome: 8C10.0\\nLesion of ulnar nerve: 8C10.1\\nLesion of radial nerve: 8C10.2\\nOther specified mononeuropathies of upper limb: 8C10.Y\\nMononeuropathies of upper limb unspecified: 8C10.Z\\nMononeuropathies of lower limb: 8C11\\nLesion of sciatic nerve: 8C11.0\\nSciatic nerve piriformis syndrome: 8C11.00\\nOther specified lesion of sciatic nerve: 8C11.0Y\\nLesion of sciatic nerve unspecified: 8C11.0Z\\nMeralgia paraesthetica: 8C11.1\\nLesion of femoral nerve: 8C11.2\\nLesion of common peroneal nerve: 8C11.3\\nLesion of tibial nerve: 8C11.4\\nTarsal tunnel syndrome: 8C11.5\\nLesion of plantar nerve: 8C11.6\\nOther specified mononeuropathies of lower limb: 8C11.Y\\nMononeuropathies of lower limb unspecified: 8C11.Z\\nCertain specified mononeuropathies: 8C12\\nIntercostal neuropathy: 8C12.0\\nMononeuritis multiplex: 8C12.1\\nLesion of suprascapular nerve: 8C12.2\\nLesion of axillary nerve: 8C12.3\\nLesion of long thoracic nerve: 8C12.4\\nTraumatic neuroma not otherwise specified: 8C12.5\\nMononeuropathy of other specified nerve: 8C12.Y\\nMononeuropathy of other specified site: 8C1Y\\nMononeuropathy of unspecified site: 8C1Z\\nHereditary motor and sensory neuropathy: 8C20\\nCharcotMarieTooth disease  demyelinating: 8C20.0\\nCharcotMarieTooth disease  axonal: 8C20.1\\nIntermediate CharcotMarieTooth disease: 8C20.2\\nOther specified hereditary motor and sensory neuropathy: 8C20.Y\\nHereditary motor and sensory neuropathy unspecified: 8C20.Z\\nHereditary sensory or autonomic neuropathy: 8C21\\nHereditary sensory and autonomic neuropathy type I: 8C21.0\\nHereditary sensory and autonomic neuropathy type III: 8C21.1\\nHereditary sensory and autonomic neuropathy type IV: 8C21.2\\nHereditary sensory and autonomic neuropathy type V: 8C21.3\\nOther specified hereditary sensory or autonomic neuropathy: 8C21.Y\\nHereditary sensory or autonomic neuropathy unspecified: 8C21.Z\\nOther specified hereditary neuropathy: 8C2Y\\nHereditary neuropathy unspecified: 8C2Z\\nOther specified disorders of nerve root plexus or peripheral nerves: 8C4Y\\nDisorders of nerve root plexus or peripheral nerves unspecified: 8C4Z\\nMyasthenia gravis: 8C60\\nDruginduced myasthenia gravis: 8C60.0\\nOther specified myasthenia gravis: 8C60.Y\\nMyasthenia gravis unspecified: 8C60.Z\\nCongenital myasthenic syndromes: 8C61\\nLambertEaton syndrome: 8C62\\nOther specified myasthenia gravis and neuromuscular junction disorders: 8C6Y\\nUnspecified myasthenia gravis or neuromuscular junction disorders: 8C6Z\\nMuscular dystrophy: 8C70\\nBecker muscular dystrophy: 8C70.0\\nDuchenne muscular dystrophy: 8C70.1\\nEmeryDreifuss muscular dystrophy: 8C70.2\\nFacioscapulohumeral muscular dystrophy: 8C70.3\\nLimbgirdle muscular dystrophy: 8C70.4\\nDominant limbgirdle muscular dystrophy: 8C70.40\\nRecessive limbgirdle muscular dystrophy: 8C70.41\\nOther specified limbgirdle muscular dystrophy: 8C70.4Y\\nLimbgirdle muscular dystrophy unspecified: 8C70.4Z\\nScapuloperoneal muscular dystrophy: 8C70.5\\nCongenital muscular dystrophy: 8C70.6\\nOther specified muscular dystrophy: 8C70.Y\\nMuscular dystrophy unspecified: 8C70.Z\\nMyotonic disorders: 8C71\\nMyotonic dystrophy: 8C71.0\\nChondrodystrophic myotonia: 8C71.1\\nMyotonia congenita: 8C71.2\\nDruginduced myotonia: 8C71.3\\nNeuromyotonia: 8C71.4\\nPseudomyotonia: 8C71.5\\nOther specified myotonic disorders: 8C71.Y\\nMyotonic disorders unspecified: 8C71.Z\\nCongenital myopathies: 8C72\\nCongenital myopathy with structural abnormalities: 8C72.0\\nNemaline myopathy: 8C72.00\\nCentronuclear myopathy: 8C72.01\\nCentral core disease: 8C72.02\\nOther specified congenital myopathy with structural abnormalities: 8C72.0Y\\nCongenital myopathy with structural abnormalities unspecified: 8C72.0Z\\nCongenital myopathy with no structural abnormalities: 8C72.1\\nOther specified congenital myopathies: 8C72.Y\\nCongenital myopathies unspecified: 8C72.Z\\nMitochondrial myopathies: 8C73\\nAutosomal recessive cardiomyopathy or ophthalmoplegia: 8C73.0\\nNeuropathy ataxia and retinitis pigmentosa: 8C73.1\\nOther specified mitochondrial myopathies: 8C73.Y\\nMitochondrial myopathies unspecified: 8C73.Z\\nPeriodic paralyses or disorders of muscle membrane excitability: 8C74\\nParamyotonia congenita: 8C74.0\\nPeriodic paralysis: 8C74.1\\nHypokalaemic periodic paralysis: 8C74.10\\nHyperkalaemic periodic paralysis: 8C74.11\\nOther specified periodic paralysis: 8C74.1Y\\nPeriodic paralysis unspecified: 8C74.1Z\\nOther specified periodic paralyses or disorders of muscle membrane excitability: 8C74.Y\\nPeriodic paralyses or disorders of muscle membrane excitability unspecified: 8C74.Z\\nDistal myopathies: 8C75\\nMyofibrillar myopathy: 8C76\\nOcular myopathy: 8C77\\nMalignant hyperthermia or hyperpyrexia: 8C78\\nOther specified primary disorders of muscles: 8C7Y\\nPrimary disorders of muscles unspecified: 8C7Z\\nDruginduced myopathy: 8C80\\nAutoimmune myopathy: 8C81\\nMyopathy in certain specified infectious or parasitic disease: 8C82\\nMyopathy in certain specified endocrine disease: 8C83\\nSecondary rhabdomyolysis: 8C84\\nOther specified secondary myopathies: 8C8Y\\nSecondary myopathies unspecified: 8C8Z\\nOther specified diseases of neuromuscular junction or muscle: 8D0Y\\nDiseases of neuromuscular junction or muscle unspecified: 8D0Z\\nSpastic cerebral palsy: 8D20\\nSpastic unilateral cerebral palsy: 8D20.0\\nSpastic bilateral cerebral palsy: 8D20.1\\nSpastic quadriplegic cerebral palsy: 8D20.10\\nSpastic diplegic cerebral palsy: 8D20.11\\nSpastic bilateral cerebral palsy unspecified: 8D20.1Z\\nOther specified spastic cerebral palsy: 8D20.Y\\nSpastic cerebral palsy unspecified: 8D20.Z\\nDyskinetic cerebral palsy: 8D21\\nAtaxic cerebral palsy: 8D22\\nWorsterDrought syndrome: 8D23\\nOther specified cerebral palsy: 8D2Y\\nCerebral palsy unspecified: 8D2Z\\nNeurological disorders due to nutrient deficiency: 8D40\\nEncephalopathy due to nutritional deficiency: 8D40.0\\nNeuropathy due to nutritional deficiency: 8D40.1\\nMyopathy due to nutritional deficiency: 8D40.2\\nIntellectual developmental disorder due to nutritional deficiency: 8D40.3\\nOther specified neurological disorders due to nutrient deficiency: 8D40.Y\\nNeurological disorders due to nutrient deficiency unspecified: 8D40.Z\\nNeurological disorders due to an excess of micro or macro nutrients: 8D41\\nPeripheral neuropathy due to vitamin B hyperalimentation: 8D41.0\\nMyopathy due to hypercalcaemia: 8D41.1\\nPseudotumour Cerebri related to Hypervitaminosis A: 8D41.2\\nOther specified neurological disorders due to an excess of micro or macro nutrients: 8D41.Y\\nNeurological disorders due to an excess of micro or macro nutrients unspecified: 8D41.Z\\nNeurological disorders due to overweight or obesity in adults or children: 8D42\\nNeurological disorders due to toxicity: 8D43\\nEncephalopathy due to toxicity: 8D43.0\\nEncephalopathy due to ammonia: 8D43.00\\nOther specified encephalopathy due to toxicity: 8D43.0Y\\nEncephalopathy due to toxicity unspecified: 8D43.0Z\\nCognitive impairment due to toxicity: 8D43.1\\nNeuropathy due to toxicity: 8D43.2\\nDruginduced polyneuropathy: 8D43.20\\nPost radiation polyneuropathy: 8D43.21\\nOther specified neuropathy due to toxicity: 8D43.2Y\\nNeuropathy due to toxicity unspecified: 8D43.2Z\\nMyopathy due to toxicity: 8D43.3\\nMovement disorders due to toxicity: 8D43.4\\nCassava poisoning: 8D43.5\\nOther specified neurological disorders due to toxicity: 8D43.Y\\nNeurological disorders due to toxicity unspecified: 8D43.Z\\nAlcoholrelated neurological disorders: 8D44\\nAlcoholic polyneuropathy: 8D44.0\\nAlcoholic myopathy: 8D44.1\\nOther specified alcoholrelated neurological disorders: 8D44.Y\\nAlcoholrelated neurological disorders unspecified: 8D44.Z\\nOther specified nutritional or toxic disorders of the nervous system: 8D4Y\\nNutritional or toxic disorders of the nervous system unspecified: 8D4Z\\nIncreased intracranial pressure: 8D60\\nBrain herniation syndromes: 8D60.0\\nCerebral oedema: 8D60.1\\nOther specified increased intracranial pressure: 8D60.Y\\nIncreased intracranial pressure unspecified: 8D60.Z\\nIntracranial hypotension: 8D61\\nSpontaneous intracranial hypotension: 8D61.0\\nSecondary intracranial hypotension: 8D61.1\\nOther specified intracranial hypotension: 8D61.Y\\nIntracranial hypotension unspecified: 8D61.Z\\nCerebrospinal fluid rhinorrhoea: 8D62\\nCerebrospinal fluid otorrhoea: 8D63\\nHydrocephalus: 8D64\\nCommunicating hydrocephalus: 8D64.0\\nIncreased cerebrospinal fluid production: 8D64.00\\nCongenital agenesis of arachnoid villi: 8D64.01\\nPost haemorrhagic hydrocephalus: 8D64.02\\nPost traumatic hydrocephalus: 8D64.03\\nNormalpressure hydrocephalus: 8D64.04\\nOther specified communicating hydrocephalus: 8D64.0Y\\nCommunicating hydrocephalus unspecified: 8D64.0Z\\nNoncommunicating hydrocephalus: 8D64.1\\nHydrocephalus due to structural malformations: 8D64.10\\nOther specified noncommunicating hydrocephalus: 8D64.1Y\\nNoncommunicating hydrocephalus unspecified: 8D64.1Z\\nExvacuo hydrocephalus: 8D64.2\\nHydrocephalus unspecified: 8D64.Z\\nCerebrospinal fluid fistula: 8D65\\nSyringomyelia or syringobulbia: 8D66\\nIdiopathic syringomyelia: 8D66.0\\nSyringomyelia due to certain specified cause: 8D66.1\\nSyringobulbia: 8D66.2\\nOther specified syringomyelia or syringobulbia: 8D66.Y\\nSyringomyelia or syringobulbia unspecified: 8D66.Z\\nIntracranial arachnoid cyst: 8D67\\nPorencephalic cyst: 8D68\\nOther specified disorders of cerebrospinal fluid pressure or flow: 8D6Y\\nDisorders of cerebrospinal fluid pressure or flow unspecified: 8D6Z\\nCongenital malformations of the autonomic nervous system: 8D80\\nInherited autonomic nervous system disorders: 8D81\\nAutoimmune disorders involving the autonomic nervous system: 8D82\\nAutonomic nervous system disorder due to infection: 8D83\\nPure autonomic nervous system failure: 8D84\\nAutonomic nervous system disorder due to substances: 8D85\\nAutonomic nervous system hyperactivity: 8D86\\nAutonomic nervous system disorder due to certain specified neurodegenerative disorder: 8D87\\nMultiple system atrophy: 8D87.0\\nMultiple system atrophy Cerebellar type: 8D87.00\\nMultiple system atrophy Parkinsonism: 8D87.01\\nOther specified multiple system atrophy: 8D87.0Y\\nMultiple system atrophy unspecified: 8D87.0Z\\nOther specified autonomic nervous system disorder due to specified neurodegenerative disorder: 8D87.Y\\nAutonomic neuropathies: 8D88\\nAutonomic neuropathy due to sodium channelopathies: 8D88.0\\nAutonomic neuropathy due to diabetes mellitus: 8D88.1\\nImmune mediated autonomic neuropathy: 8D88.2\\nAutonomic disorder due to toxins: 8D88.3\\nAutonomic neuropathy in endocrine and metabolic diseases: 8D88.4\\nOther specified autonomic neuropathies: 8D88.Y\\nAutonomic neuropathies unspecified: 8D88.Z\\nDisorders of orthostatic tolerance: 8D89\\nReflex syncope: 8D89.0\\nSyncope due to autonomic failure: 8D89.1\\nPostural orthostatic tachycardia syndrome: 8D89.2\\nBaroreflex failure: 8D89.3\\nOther specified disorders of orthostatic tolerance: 8D89.Y\\nDisorders of orthostatic tolerance unspecified: 8D89.Z\\nFocal or segmental autonomic disorders: 8D8A\\nHorner syndrome: 8D8A.1\\nEpisodic anisocoria: 8D8A.2\\nOther specified focal or segmental autonomic disorders: 8D8A.Y\\nFocal or segmental autonomic disorders unspecified: 8D8A.Z\\nDisorders affecting autonomic synaptic neurotransmission: 8D8B\\nAutonomic dysreflexia: 8D8C\\nHypoglycaemia unawareness: 8D8D\\nOther specified disorders of autonomic nervous system: 8D8Y\\nDisorders of autonomic nervous system unspecified: 8D8Z\\nSporadic CreutzfeldtJakob Disease: 8E00\\nAcquired prion disease: 8E01\\nIatrogenically acquired CreutzfeldtJakob Disease: 8E01.0\\nKuru: 8E01.1\\nVariant CreutzfeldtJakob Disease: 8E01.2\\nOther acquired CreutzfeldtJakob Disease: 8E01.3\\nAcquired prion disease unspecified: 8E01.Z\\nGenetic prion diseases: 8E02\\nGenetic CreutzfeldtJakob disease: 8E02.0\\nGerstmannStrausslerScheinker syndrome: 8E02.1\\nFatal familial insomnia: 8E02.2\\nOther genetic prion diseases: 8E02.3\\nOther specified CreutzfeldtJakob disease: 8E02.Y\\nCreutzfeldtJakob disease unspecified: 8E02.Z\\nVariably protease sensitive prionopathy: 8E03\\nOther specified human prion diseases: 8E0Y\\nHuman prion diseases unspecified: 8E0Z\\nPersistent vegetative state: 8E20\\nPermanent vegetative state: 8E21\\nMinimally conscious state: 8E22\\nMinimally conscious state plus: 8E22.0\\nMinimally conscious state minus: 8E22.1\\nOther specified minimally conscious state: 8E22.Y\\nMinimally conscious state unspecified: 8E22.Z\\nOther specified disorders of consciousness: 8E2Y\\nDisorders of consciousness unspecified: 8E2Z\\nDisorders of the meninges excluding infection: 8E40\\nNeoplastic meningitis: 8E40.0\\nChemical meningitis: 8E40.1\\nInflammatory meningitis: 8E40.2\\nArachnoiditis: 8E40.3\\nOther specified disorders of the meninges excluding infection: 8E40.Y\\nDisorders of the meninges excluding infection unspecified: 8E40.Z\\nPachymeningitis: 8E41\\nPachymeningitis due to infection: 8E41.0\\nIdiopathic hypertrophic pachymeningitis: 8E41.1\\nOther specified pachymeningitis: 8E41.Y\\nPachymeningitis unspecified: 8E41.Z\\nSuperficial siderosis of the nervous system: 8E42\\nPain disorders: 8E43\\nNeuropathic pain: 8E43.0\\nPhantom limb syndrome: 8E43.00\\nOther specified neuropathic pain: 8E43.0Y\\nNeuropathic pain unspecified: 8E43.0Z\\nOther specified pain disorders: 8E43.Y\\nPain disorders unspecified: 8E43.Z\\nPost anoxic brain damage: 8E44\\nLockedin syndrome: 8E45\\nReye syndrome: 8E46\\nEncephalopathy not elsewhere classified: 8E47\\nEncephalitis not elsewhere classified: 8E48\\nPostviral fatigue syndrome: 8E49\\nParaneoplastic or autoimmune disorders of the nervous system: 8E4A\\nParaneoplastic or autoimmune disorders of the central nervous system brain or spinal cord: 8E4A.0\\nParaneoplastic or autoimmune disorders of the peripheral or autonomic nervous system: 8E4A.1\\nParaneoplastic or autoimmune neuromuscular transmission disorders: 8E4A.2\\nParaneoplastic or autoimmune disorders of the muscle: 8E4A.3\\nOther specified paraneoplastic or autoimmune disorders of the nervous system: 8E4A.Y\\nParaneoplastic or autoimmune disorders of the nervous system unspecified: 8E4A.Z\\nPost ventricular shunting leak: 8E60\\nPost radiation injury of the nervous system: 8E61\\nRadiationinduced brain injury: 8E61.0\\nSpinal cord irradiation: 8E61.1\\nPost radiation injury of the nervous system unspecified: 8E61.Z\\nPostprocedural meningitis: 8E62\\nPost pump encephalopathy: 8E63\\nMultifocal cerebral infarctions: 8E64\\nIntracranial hypotension due to lumbar puncture: 8E66\\nOther specified diseases of the nervous system: 8E7Y\\nDiseases of the nervous system unspecified: 8E7Z\\nCongenital malposition of eyelids: 9A00\\nDystopia canthorum: 9A00.0\\nTelecanthus: 9A00.1\\nOther specified congenital malposition of eyelids: 9A00.Y\\nCongenital malposition of eyelids unspecified: 9A00.Z\\nInfectious disorders of eyelid: 9A01\\nPreseptal cellulitis: 9A01.0\\nAbscess of eyelid: 9A01.1\\nHordeolum: 9A01.2\\nHordeolum externum: 9A01.20\\nHordeolum internum: 9A01.21\\nHordeolum unspecified: 9A01.2Z\\nInfectious blepharitis: 9A01.3\\nInfestation of eyelid: 9A01.4\\nOther specified infectious disorders of eyelid: 9A01.Y\\nUnspecified infectious\\xa0disorders of eyelid: 9A01.Z\\nInflammatory disorders of eyelid: 9A02\\nChalazion: 9A02.0\\nChalazion externum: 9A02.00\\nChalazion internum: 9A02.01\\nChalazion unspecified: 9A02.0Z\\nPosterior blepharitis: 9A02.1\\nLigneous conjunctivitis: 9A02.2\\nMeibomian gland dysfunction: 9A02.4\\nOther specified inflammatory disorders of eyelid: 9A02.Y\\nInflammatory disorders of eyelid unspecified: 9A02.Z\\nAcquired malposition of eyelid: 9A03\\nBlepharoptosis: 9A03.0\\nMarcusGunn syndrome: 9A03.00\\nMechanical ptosis of eyelid: 9A03.01\\nMyogenic ptosis of eyelid: 9A03.02\\nParalytic ptosis of eyelid: 9A03.03\\nOther specified blepharoptosis: 9A03.0Y\\nBlepharoptosis unspecified: 9A03.0Z\\nEntropion of eyelid: 9A03.1\\nCicatricial entropion of eyelid: 9A03.10\\nMechanical entropion of eyelid: 9A03.11\\nSenile entropion of eyelid: 9A03.12\\nSpastic entropion of eyelid: 9A03.13\\nOther specified entropion of eyelid: 9A03.1Y\\nEntropion of eyelid unspecified: 9A03.1Z\\nEctropion of eyelid: 9A03.2\\nCicatricial ectropion of eyelid: 9A03.20\\nMechanical ectropion of eyelid: 9A03.21\\nSenile ectropion of eyelid: 9A03.22\\nSpastic ectropion of eyelid: 9A03.23\\nFloppy eyelid syndrome: 9A03.24\\nOther specified ectropion of eyelid: 9A03.2Y\\nEctropion of eyelid unspecified: 9A03.2Z\\nEyelid retraction: 9A03.3\\nLagophthalmos: 9A03.4\\nCicatricial lagophthalmos: 9A03.40\\nMechanical lagophthalmos: 9A03.41\\nParalytic lagophthalmos: 9A03.42\\nOther specified lagophthalmos: 9A03.4Y\\nLagophthalmos unspecified: 9A03.4Z\\nDermatochalasis of eyelid: 9A03.5\\nOther specified acquired malposition of eyelid: 9A03.Y\\nAcquired malposition of eyelid unspecified: 9A03.Z\\nAcquired disorders of eyelashes: 9A04\\nTrichiasis without entropion: 9A04.0\\nMadarosis of eyelid or periocular area: 9A04.1\\nOther specified acquired disorders of eyelashes: 9A04.Y\\nAcquired disorders of eyelashes unspecified: 9A04.Z\\nMovement disorders of eyelid: 9A05\\nMyokymia of eyelid: 9A05.0\\nEyelid apraxia: 9A05.1\\nOther specified movement disorders of eyelid: 9A05.Y\\nMovement disorders of eyelid unspecified: 9A05.Z\\nCertain specified disorders of eyelid: 9A06\\nInvolvement of eyelid by dermatosis classified elsewhere: 9A06.0\\nVitiligo of eyelid or periocular area: 9A06.1\\nSymblepharon acquired: 9A06.2\\nTraumatic scar of eyelid: 9A06.3\\nXanthelasma of eyelid: 9A06.4\\nTear Trough Deformity: 9A06.5\\nSunken Sulcus Deformity: 9A06.6\\nDermatitis or eczema of eyelids: 9A06.7\\nAtopic eczema of eyelids: 9A06.70\\nSeborrhoeic dermatitis of eyelids: 9A06.71\\nAllergic contact blepharoconjunctivitis: 9A06.72\\nOther specified dermatitis or eczema of eyelids: 9A06.7Y\\nDermatitis or eczema of eyelids type unspecified: 9A06.7Z\\nBlepharochalasis: 9A06.8\\nOther specified disorders of eyelid: 9A06.Y\\nOther specified disorders of eyelid or periocular area: 9A0Y\\nDisorders of eyelid or periocular area unspecified: 9A0Z\\nDisorders of lacrimal gland: 9A10\\nInfections of the lacrimal gland: 9A10.0\\nOrbital inflammatory syndrome: 9A10.1\\nBenign lymphoepithelial lesion of lacrimal gland: 9A10.2\\nHyperlacrimation: 9A10.3\\nUnderproduction of tears: 9A10.4\\nOther specified disorders of lacrimal gland: 9A10.Y\\nDisorders of lacrimal gland unspecified: 9A10.Z\\nDisorders of lacrimal drainage system: 9A11\\nEversion of lacrimal punctum: 9A11.0\\nCanaliculitis: 9A11.1\\nDacryocystitis: 9A11.2\\nConjunctivochalasis: 9A11.3\\nPunctal stenosis: 9A11.4\\nNasolacrimal canalicular stenosis: 9A11.5\\nDacryolith: 9A11.6\\nNasolacrimal sac stenosis: 9A11.7\\nNasolacrimal duct obstruction: 9A11.8\\nOther specified disorders of lacrimal drainage system: 9A11.Y\\nDisorders of lacrimal drainage system unspecified: 9A11.Z\\nOther specified disorders of lacrimal apparatus: 9A1Y\\nDisorders of lacrimal apparatus unspecified: 9A1Z\\nDisplacement of eyeball: 9A20\\nAxial displacement of eyeball: 9A20.0\\nOutward displacement of eyeball: 9A20.00\\nInward displacement of eyeball: 9A20.01\\nOther specified axial displacement of eyeball: 9A20.0Y\\nAxial displacement of eyeball unspecified: 9A20.0Z\\nNonaxial displacement of eyeball: 9A20.1\\nOther specified displacement of eyeball: 9A20.Y\\nDisplacement of eyeball unspecified: 9A20.Z\\nOrbital infection: 9A21\\nOrbital cellulitis: 9A21.0\\nOrbital subperiosteal abscess: 9A21.1\\nOrbital abscess: 9A21.2\\nPeriostitis of orbit: 9A21.3\\nOther specified orbital infection: 9A21.Y\\nOrbital infection unspecified: 9A21.Z\\nOrbital inflammation: 9A22\\nDysthyroid orbitopathy: 9A22.0\\nDiffuse orbital inflammation: 9A22.1\\nGranulomatous orbital inflammation: 9A22.2\\nOther specified orbital inflammation: 9A22.Y\\nOrbital inflammation unspecified: 9A22.Z\\nOrbital cyst: 9A23\\nCongenital orbital cyst: 9A23.0\\nAcquired orbital cyst: 9A23.1\\nOrbital cyst unspecified: 9A23.Z\\nBony deformity of orbit: 9A24\\nContraction of orbit: 9A24.0\\nExpansion of orbit: 9A24.1\\nEnlargement of bony orbit: 9A24.3\\nExostosis of orbit: 9A24.4\\nOther specified bony deformity of orbit: 9A24.Y\\nBony deformity of orbit unspecified: 9A24.Z\\nSoft tissue deformity of orbit: 9A25\\nAnophthalmic socket: 9A25.0\\nMicrophthalmic socket: 9A25.1\\nContracted socket: 9A25.2\\nOedema of orbit: 9A25.3\\nHaemorrhage of orbit: 9A25.4\\nAtrophy of soft tissue of orbit: 9A25.5\\nOther specified soft tissue deformity of orbit: 9A25.Y\\nSoft tissue deformity of orbit unspecified: 9A25.Z\\nCombined bony and soft tissue deformity of orbit: 9A26\\nOther specified disorders of orbit: 9A2Y\\nDisorders of orbit unspecified: 9A2Z\\nOther specified disorders of the ocular adnexa or orbit: 9A4Y\\nDisorders of the ocular adnexa or orbit unspecified: 9A4Z\\nConjunctivitis: 9A60\\nPapillary conjunctivitis: 9A60.0\\nGiant papillary conjunctivitis: 9A60.00\\nAcute atopic conjunctivitis: 9A60.01\\nAllergic conjunctivitis: 9A60.02\\nOther specified papillary conjunctivitis: 9A60.0Y\\nPapillary conjunctivitis unspecified: 9A60.0Z\\nFollicular conjunctivitis: 9A60.1\\nCicatrizing conjunctivitis: 9A60.2\\nMucopurulent conjunctivitis: 9A60.3\\nUlceration of conjunctiva: 9A60.30\\nAbscess of conjunctiva: 9A60.31\\nConjunctivitis due to KochWeeks bacillus: 9A60.32\\nAcute epidemic conjunctivitis: 9A60.33\\nOther specified mucopurulent conjunctivitis: 9A60.3Y\\nMucopurulent conjunctivitis unspecified: 9A60.3Z\\nBlepharoconjunctivitis: 9A60.4\\nVernal keratoconjunctivitis: 9A60.5\\nSerous conjunctivitis except viral: 9A60.6\\nOther specified conjunctivitis: 9A60.Y\\nConjunctivitis unspecified: 9A60.Z\\nCertain specified disorders of conjunctiva: 9A61\\nPingueculae: 9A61.0\\nPterygium: 9A61.1\\nPseudopterygium of conjunctiva: 9A61.2\\nConjunctival scars: 9A61.3\\nConjunctival vascular disorders: 9A61.4\\nVascular abnormalities of conjunctiva: 9A61.40\\nOther specified conjunctival vascular disorders: 9A61.4Y\\nConjunctival vascular disorders unspecified: 9A61.4Z\\nConjunctival or subconjunctival haemorrhage: 9A61.5\\nConjunctival or subconjunctival degenerations or deposits: 9A61.6\\nCertain specified disorders of conjunctiva unspecified: 9A61.Z\\nMucous membrane pemphigoid with ocular involvement: 9A62\\nOther specified disorders of conjunctiva: 9A6Y\\nDisorders of conjunctiva unspecified: 9A6Z\\nHereditary corneal dystrophies: 9A70\\nEndothelial corneal dystrophy: 9A70.0\\nOther specified hereditary corneal dystrophies: 9A70.Y\\nHereditary corneal dystrophies unspecified: 9A70.Z\\nInfectious keratitis: 9A71\\nTraumatic keratitis: 9A72\\nExposure keratitis: 9A73\\nNeurotrophic keratitis: 9A74\\nAutoimmune keratitis: 9A75\\nCorneal ulcer: 9A76\\nCorneal scars or opacities: 9A77\\nContact lensassociated corneal infiltrates: 9A77.0\\nAdherent leukoma: 9A77.1\\nOther specified corneal scars or opacities: 9A77.Y\\nCorneal scars or opacities unspecified: 9A77.Z\\nCertain specified disorders of cornea: 9A78\\nCorneal neovascularization: 9A78.0\\nCorneal pigmentations or deposits: 9A78.1\\nCorneal oedema: 9A78.2\\nBullous keratopathy: 9A78.20\\nSecondary corneal oedema: 9A78.21\\nOther specified corneal oedema: 9A78.2Y\\nCorneal oedema unspecified: 9A78.2Z\\nChanges in corneal membranes: 9A78.3\\nCorneal degeneration: 9A78.4\\nCorneal deformities: 9A78.5\\nKeratoconus: 9A78.50\\nCorneal staphyloma: 9A78.51\\nOther specified corneal deformities: 9A78.5Y\\nCorneal deformities unspecified: 9A78.5Z\\nAnaesthesia of cornea: 9A78.6\\nHypoesthesia of cornea: 9A78.7\\nRecurrent erosion of cornea: 9A78.8\\nKeratoconjunctivitis sicca: 9A79\\nCorneal abscess: 9A7A\\nSclerosing keratitis: 9A7B\\nOther specified disorders of the cornea: 9A7Y\\nDisorders of the cornea unspecified: 9A7Z\\nHyphaema: 9A80\\nParasites in the anterior chamber of the eye: 9A81\\nCyst in the anterior chamber of the eye: 9A82\\nFlat anterior chamber hypotony of eye: 9A83\\nOther specified disorders of the anterior chamber: 9A8Y\\nDisorders of the anterior chamber unspecified: 9A8Z\\nDegeneration of iris or ciliary body: 9A90\\nDisorders of chamber angle: 9A90.0\\nDegeneration of iris: 9A90.1\\nIris atrophy: 9A90.2\\nOther specified degeneration of iris or ciliary body: 9A90.Y\\nDegeneration of iris or ciliary body unspecified: 9A90.Z\\nCyst of iris or ciliary body: 9A91\\nPersistent pupillary membranes: 9A92\\nAdhesions or disruptions of iris or ciliary body: 9A93\\nCertain specified disorders of iris or ciliary body: 9A94\\nRubeosis of iris: 9A94.0\\nFloppy iris syndrome: 9A94.1\\nPlateau iris syndrome: 9A94.2\\nOther disorders of iris and ciliary body: 9A94.Y\\nAnterior uveitis: 9A96\\nAnterior uveitis not associated with systemic conditions: 9A96.0\\nAnterior uveitis associated with systemic conditions: 9A96.1\\nInfectionassociated anterior uveitis: 9A96.2\\nPrimary anterior uveitis: 9A96.3\\nOther specified anterior uveitis: 9A96.Y\\nAnterior uveitis unspecified: 9A96.Z\\nOther specified disorders of the anterior uvea: 9A9Y\\nDisorders of the anterior uvea unspecified: 9A9Z\\nDisorders of the afferent pupillary system: 9B00\\nRelative afferent pupillary defects: 9B00.0\\nAmaurotic pupillary reaction: 9B00.1\\nParadoxical pupillary reaction to light or darkness: 9B00.2\\nWernicke pupils: 9B00.3\\nOther specified disorders of the afferent pupillary system: 9B00.Y\\nDisorders of the afferent pupillary system unspecified: 9B00.Z\\nDisorders of the efferent pupillary system: 9B01\\nPhysiologic anisocoria: 9B01.0\\nParasympathoparetic pupils: 9B01.1\\nPharmacologic inhibition of the parasympathetic pathway: 9B01.2\\nIris sphincter disorders: 9B01.3\\nPharmacologic parasympathicotonic pupils: 9B01.4\\nPharmacologic sympathoparetic pupils: 9B01.5\\nSympathotonic pupils: 9B01.6\\nEpisodic unilateral mydriasis: 9B01.7\\nOther specified disorders of the efferent pupillary system: 9B01.Y\\nDisorders of the efferent pupillary system unspecified: 9B01.Z\\nLightnear dissociations: 9B02\\nArgyll Robertson pupil: 9B02.0\\nPregeniculate lightnear dissociations: 9B02.1\\nMesencephalic lightnear dissociations: 9B02.2\\nOther specified lightnear dissociations: 9B02.Y\\nLightnear dissociations unspecified: 9B02.Z\\nOther specified functional disorders of the pupil: 9B0Y\\nFunctional disorders of the pupil unspecified: 9B0Z\\nCataract: 9B10\\nAgerelated cataract: 9B10.0\\nCoronary agerelated cataract: 9B10.00\\nPunctate agerelated cataract: 9B10.01\\nMature agerelated cataract: 9B10.02\\nOther specified agerelated cataract: 9B10.0Y\\nAgerelated cataract unspecified: 9B10.0Z\\nInfantile or juvenile cataract: 9B10.1\\nCombined forms of infantile and juvenile cataract: 9B10.10\\nOther specified infantile or juvenile cataract: 9B10.1Y\\nInfantile or juvenile cataract unspecified: 9B10.1Z\\nCertain specified cataracts: 9B10.2\\nTraumatic cataract: 9B10.20\\nDiabetic cataract: 9B10.21\\nAftercataract: 9B10.22\\nSubcapsular glaucomatous flecks: 9B10.23\\nOther specified cataracts: 9B10.2Y\\nCataract unspecified: 9B10.Z\\nCertain specified disorders of lens: 9B11\\nAphakia: 9B11.0\\nDislocation of lens: 9B11.1\\nOther disorders of lens: 9B11.Y\\nDisorders of lens unspecified: 9B1Z\\nOther specified disorders of the eyeball anterior segment: 9B3Y\\nDisorders of the eyeball anterior segment unspecified: 9B3Z\\nEpiscleritis: 9B50\\nScleritis: 9B51\\nScleral staphyloma: 9B52\\nOther specified disorders of sclera: 9B5Y\\nDisorders of sclera unspecified: 9B5Z\\nChoroidal degeneration: 9B60\\nChoroidal dystrophy: 9B61\\nChorioretinal scars: 9B62\\nChoroidal haemorrhage or rupture: 9B63\\nChoroidal detachment: 9B64\\nPosterior uveitis: 9B65\\nNoninfectious posterior uveitis: 9B65.0\\nInfectious posterior uveitis: 9B65.1\\nPosterior uveitis unspecified: 9B65.Z\\nIntermediate uveitis: 9B66\\nNoninfectious intermediate uveitis: 9B66.0\\nInfectious intermediate uveitis: 9B66.1\\nIntermediate uveitis unspecified: 9B66.Z\\nOther specified disorders of the choroid: 9B6Y\\nDisorders of the choroid unspecified: 9B6Z\\nInherited retinal dystrophies: 9B70\\nRetinopathy: 9B71\\nDiabetic retinopathy: 9B71.0\\nNonproliferative diabetic retinopathy: 9B71.00\\nProliferative diabetic retinopathy: 9B71.01\\nDiabetic macular oedema: 9B71.02\\nDiabetic retinopathy unspecified: 9B71.0Z\\nHypertensive retinopathy: 9B71.1\\nRadiation retinopathy: 9B71.2\\nRetinopathy of prematurity: 9B71.3\\nParaneoplastic retinopathy: 9B71.4\\nMelanoma associated retinopathy: 9B71.40\\nOther specified paraneoplastic retinopathy: 9B71.4Y\\nParaneoplastic retinopathy unspecified: 9B71.4Z\\nAutoimmune retinopathy: 9B71.5\\nOther specified retinopathy: 9B71.Y\\nRetinopathy unspecified: 9B71.Z\\nInflammatory diseases of the retina: 9B72\\nViral retinitis: 9B72.0\\nCytomegaloviral retinitis: 9B72.00\\nHIV retinitis: 9B72.01\\nOther specified viral retinitis: 9B72.0Y\\nViral retinitis unspecified: 9B72.0Z\\nOther specified inflammatory diseases of the retina: 9B72.Y\\nInflammatory diseases of the retina unspecified: 9B72.Z\\nRetinal detachments or breaks: 9B73\\nRetinal detachment with retinal break: 9B73.0\\nRetinoschisis: 9B73.1\\nAdult retinoschisis: 9B73.10\\nJuvenile retinoschisis: 9B73.11\\nOther specified retinoschisis: 9B73.1Y\\nRetinoschisis unspecified: 9B73.1Z\\nRetinal cysts: 9B73.2\\nSerous retinal detachment: 9B73.3\\nRetinal breaks without detachment: 9B73.4\\nOther specified retinal detachments or breaks: 9B73.Y\\nRetinal detachments or breaks unspecified: 9B73.Z\\nRetinal vascular occlusions: 9B74\\nRetinal artery occlusions: 9B74.0\\nRetinal venous occlusions: 9B74.1\\nCombined retinal arterial and vein occlusion: 9B74.2\\nOther specified retinal vascular occlusions: 9B74.Y\\nRetinal vascular occlusions unspecified: 9B74.Z\\nMacular disorders: 9B75\\nAgerelated macular degeneration: 9B75.0\\nEarly agerelated macular degeneration: 9B75.00\\nIntermediate agerelated macular degeneration: 9B75.01\\nAtrophic latestage agerelated macular degeneration: 9B75.03\\nNeovascular latestage agerelated macular degeneration: 9B75.04\\nOther specified agerelated macular degeneration: 9B75.0Y\\nAgerelated macular degeneration unspecified: 9B75.0Z\\nNontraumatic macular hole: 9B75.1\\nCentral serous chorioretinopathy: 9B75.2\\nMacular telangiectasia: 9B75.3\\nOther specified macular disorders: 9B75.Y\\nMacular disorders unspecified: 9B75.Z\\nDegenerative high myopia: 9B76\\nEales disease: 9B77\\nCertain specified retinal disorders: 9B78\\nRetinal vasculopathy and cerebral leukodystrophy: 9B78.0\\nBackground retinopathy and retinal vascular changes: 9B78.1\\nChanges in retinal vascular appearance: 9B78.10\\nExudative retinopathy: 9B78.11\\nRetinal vasculitis: 9B78.12\\nRetinal telangiectasis: 9B78.13\\nOther specified background retinopathy and retinal vascular changes: 9B78.1Y\\nBackground retinopathy and retinal vascular changes unspecified: 9B78.1Z\\nOther proliferative retinopathy: 9B78.2\\nDegeneration of macula or posterior pole: 9B78.3\\nReticular pseudodrusen: 9B78.30\\nOther specified degeneration of macula or posterior pole: 9B78.3Y\\nDegeneration of macula or posterior pole unspecified: 9B78.3Z\\nPeripheral retinal degeneration: 9B78.4\\nRetinal haemorrhage: 9B78.5\\nSeparation of retinal layers: 9B78.6\\nSerous detachment of retinal pigment epithelium: 9B78.60\\nHaemorrhagic detachment of retinal pigment epithelium: 9B78.61\\nOther specified separation of retinal layers: 9B78.6Y\\nSeparation of retinal layers unspecified: 9B78.6Z\\nRetinal oedema: 9B78.7\\nRetinal ischaemia: 9B78.8\\nRetinal atrophy: 9B78.9\\nOther specified disorders of the retina: 9B7Y\\nDisorders of the retina unspecified: 9B7Z\\nInherited vitreoretinal disorders: 9B80\\nPosterior vitreous detachment: 9B81\\nVitreous prolapse: 9B82\\nVitreous haemorrhage: 9B83\\nVitreous opacities membranes or strands: 9B84\\nOther specified disorders of the vitreous body: 9B8Y\\nDisorders of the vitreous body unspecified: 9B8Z\\nOther specified disorders of the eyeball posterior segment: 9C0Y\\nDisorders of the eyeball posterior segment unspecified: 9C0Z\\nPanuveitis: 9C20\\nNoninfectious panuveitis: 9C20.0\\nInfectious panuveitis: 9C20.1\\nPurulent endophthalmitis: 9C20.2\\nOther specified panuveitis: 9C20.Y\\nPanuveitis unspecified: 9C20.Z\\nEndophthalmitis: 9C21\\nSympathetic uveitis: 9C21.0\\nOther specified endophthalmitis: 9C21.Y\\nEndophthalmitis unspecified: 9C21.Z\\nEyeball deformity: 9C22\\nAtrophia bulbi: 9C22.0\\nPhthisis bulbi: 9C22.1\\nOther specified eyeball deformity: 9C22.Y\\nEyeball deformity unspecified: 9C22.Z\\nOther specified disorders of the eyeball affecting both anterior and posterior segments: 9C2Y\\nDisorders of the eyeball affecting both anterior and posterior segments unspecified: 9C2Z\\nDisorder of the optic nerve: 9C40\\nInfectious optic neuropathy: 9C40.0\\nOptic neuritis: 9C40.1\\nRetrobulbar neuritis: 9C40.10\\nOther specified optic neuritis: 9C40.1Y\\nOptic neuritis unspecified: 9C40.1Z\\nNeuroretinitis: 9C40.2\\nPerineuritis of optic nerve: 9C40.3\\nIschaemic optic neuropathy: 9C40.4\\nAnterior ischemic optic neuropathy: 9C40.40\\nPosterior ischemic optic neuropathy: 9C40.41\\nOther specified ischaemic optic neuropathy: 9C40.4Y\\nIschaemic optic neuropathy unspecified: 9C40.4Z\\nCompressive optic neuropathy: 9C40.5\\nInfiltrative optic neuropathy: 9C40.6\\nTraumatic optic neuropathy: 9C40.7\\nHereditary optic neuropathy: 9C40.8\\nGlaucomatous optic neuropathy: 9C40.9\\nOptic disc swelling: 9C40.A\\nPapilloedema: 9C40.A0\\nOptic disc swelling associated with uveitis: 9C40.A1\\nOther specified optic disc swelling: 9C40.AY\\nOptic disc swelling unspecified: 9C40.AZ\\nOptic atrophy: 9C40.B\\nCongenital optic atrophy: 9C40.B0\\nAcquired optic atrophy: 9C40.B1\\nOptic atrophy unspecified: 9C40.BZ\\nOther specified disorder of the optic nerve: 9C40.Y\\nDisorder of the optic nerve unspecified: 9C40.Z\\nDisorder of optic chiasm: 9C41\\nDisorder of post chiasmal visual pathways: 9C42\\nDisorder of visual cortex: 9C43\\nDisorder of higher visual centres: 9C44\\nOther specified disorders of the visual pathways or centres: 9C4Y\\nDisorders of the visual pathways or centres unspecified: 9C4Z\\nGlaucoma suspect: 9C60\\nGlaucoma: 9C61\\nPrimary openangle glaucoma: 9C61.0\\nNormal tension glaucoma: 9C61.00\\nOcular hypertension: 9C61.01\\nHigh pressure primary openangle glaucoma: 9C61.02\\nOther specified primary openangle glaucoma: 9C61.0Y\\nPrimary openangle glaucoma unspecified: 9C61.0Z\\nPrimary angle closure or angle closure glaucoma: 9C61.1\\nPrimary angle closure suspect or anatomical narrow angle: 9C61.10\\nPrimary angleclosure: 9C61.11\\nPrimary angle closure glaucoma: 9C61.12\\nPrimary angle closure without pupillary block: 9C61.13\\nAcute angle closure with pupillary block: 9C61.14\\nIntermittent angleclosure: 9C61.15\\nChronic angleclosure: 9C61.16\\nCondition after acute angleclosure glaucoma attack: 9C61.17\\nOther specified primary angle closure or angle closure glaucoma: 9C61.1Y\\nPrimary angle closure or angle closure glaucoma unspecified: 9C61.1Z\\nSecondary openangle glaucoma: 9C61.2\\nPseudoexfoliative openangle glaucoma: 9C61.20\\nPigmentary openangle glaucoma: 9C61.21\\nLensinduced secondary openangle glaucoma: 9C61.22\\nGlaucoma associated with intraocular haemorrhage: 9C61.23\\nGlaucoma due to eye inflammation: 9C61.24\\nGlaucomatocyclitic crisis: 9C61.25\\nSecondary openangle glaucoma due to parasitic eye disease: 9C61.26\\nGlaucoma due to intraocular tumours: 9C61.27\\nGlaucoma associated with retinal detachment: 9C61.28\\nGlaucoma due to eye trauma: 9C61.29\\nGlaucoma due to drugs: 9C61.2A\\nGlaucoma caused by increased episcleral venous pressure: 9C61.2B\\nSecondary glaucoma due to extraocular mass: 9C61.2C\\nOther specified secondary openangle glaucoma: 9C61.2Y\\nSecondary openangle glaucoma unspecified: 9C61.2Z\\nSecondary angle closure glaucoma: 9C61.3\\nSecondary angle closure glaucoma with pupillary block: 9C61.30\\nSecondary angle closure glaucoma without pupillary block: 9C61.31\\nNeovascular secondary angle closure glaucoma: 9C61.32\\nSecondary angle closure glaucoma due to endothelial overgrowth: 9C61.33\\nSecondary angle closure glaucoma due to epithelial ingrowth: 9C61.34\\nCiliary block glaucoma: 9C61.35\\nSecondary angle closure glaucoma due to other anterior displacement of the lensiris diaphragm: 9C61.36\\nOther specified secondary angle closure glaucoma: 9C61.3Y\\nSecondary angle closure glaucoma unspecified: 9C61.3Z\\nDevelopmental glaucoma: 9C61.4\\nPrimary congenital glaucoma: 9C61.40\\nPrimary infantile glaucoma: 9C61.41\\nSecondary childhood glaucoma: 9C61.42\\nOther specified developmental glaucoma: 9C61.4Y\\nDevelopmental glaucoma unspecified: 9C61.4Z\\nGlaucoma unspecified: 9C61.Z\\nOther specified glaucoma or glaucoma suspect: 9C6Y\\nGlaucoma or glaucoma suspect unspecified: 9C6Z\\nNon paralytic strabismus: 9C80\\nEsotropia: 9C80.0\\nExotropia: 9C80.1\\nVertical or torsional strabismus: 9C80.2\\nIntermittent strabismus: 9C80.3\\nIntermittent divergent exotropia: 9C80.30\\nIntermittent convergent esotropia: 9C80.31\\nOther specified intermittent strabismus: 9C80.3Y\\nIntermittent strabismus unspecified: 9C80.3Z\\nHeterophoria: 9C80.4\\nMechanical strabismus: 9C80.5\\nOther specified non paralytic strabismus: 9C80.Y\\nNon paralytic strabismus unspecified: 9C80.Z\\nOcular motor nerve palsies: 9C81\\nThird nerve palsy: 9C81.0\\nExternal bilateral paralysis of oculomotor nerve: 9C81.00\\nOther specified third nerve palsy: 9C81.0Y\\nThird nerve palsy unspecified: 9C81.0Z\\nFourth nerve palsy: 9C81.1\\nSixth nerve palsy: 9C81.2\\nTotal external ophthalmoplegia: 9C81.3\\nCavernous sinus syndromes: 9C81.4\\nPalsy of other specified ocular motor nerve: 9C81.Y\\nPalsy of unspecified ocular motor nerve: 9C81.Z\\nDisorders of extraocular muscles: 9C82\\nProgressive external ophthalmoplegia: 9C82.0\\nMuscular dystrophy affecting extraocular muscle: 9C82.1\\nCongenital cranial dysinnervation syndrome: 9C82.2\\nRestrictive ophthalmopathy: 9C82.3\\nOculomotor apraxia: 9C82.4\\nOther specified disorders of extraocular muscles: 9C82.Y\\nDisorders of extraocular muscles unspecified: 9C82.Z\\nDisorders of binocular movement: 9C83\\nPalsy of conjugate gaze: 9C83.0\\nHorizontal gaze palsy: 9C83.00\\nVertical gaze palsy: 9C83.01\\nMonocular elevator palsy: 9C83.02\\nOther specified palsy of conjugate gaze: 9C83.0Y\\nPalsy of conjugate gaze unspecified: 9C83.0Z\\nSpasm of conjugate gaze: 9C83.1\\nHorizontal conjugate gaze deviation: 9C83.10\\nUpward gaze deviation: 9C83.11\\nDownward gaze deviation: 9C83.12\\nOculogyric crisis: 9C83.13\\nOther specified spasm of conjugate gaze: 9C83.1Y\\nSpasm of conjugate gaze unspecified: 9C83.1Z\\nConvergence insufficiency: 9C83.2\\nConvergence excess: 9C83.3\\nSpasm of the near reflex: 9C83.4\\nInternuclear ophthalmoplegia: 9C83.5\\nAnomalies of divergence or deviation of eye movement: 9C83.6\\nDivergence insufficiency: 9C83.60\\nDivergence paralysis: 9C83.61\\nDivergence excess: 9C83.62\\nSynergistic divergence: 9C83.63\\nSkew deviation: 9C83.64\\nOcular tilt reaction: 9C83.65\\nAlternating skew deviation: 9C83.66\\nDissociative vertical divergence: 9C83.67\\nOther specified anomalies of divergence or deviation of eye movement: 9C83.6Y\\nAnomalies of divergence or deviation of eye movement unspecified: 9C83.6Z\\nOther specified disorders of binocular movement: 9C83.Y\\nDisorders of binocular movement unspecified: 9C83.Z\\nNystagmus: 9C84\\nPhysiological nystagmus: 9C84.0\\nCongenital forms of nystagmus: 9C84.1\\nVestibular nystagmus: 9C84.2\\nDownbeat nystagmus: 9C84.20\\nUpbeat nystagmus: 9C84.21\\nTorsional nystagmus: 9C84.22\\nPerverted nystagmus: 9C84.23\\nOther specified vestibular nystagmus: 9C84.2Y\\nVestibular nystagmus unspecified: 9C84.2Z\\nSeesaw nystagmus: 9C84.3\\nGazeevoked nystagmus: 9C84.4\\nNystagmus occurring in visual system disorders: 9C84.5\\nVisual deprivation nystagmus: 9C84.50\\nDivergence nystagmus: 9C84.51\\nConvergenceretraction nystagmus: 9C84.52\\nOther specified nystagmus occurring in visual system disorders: 9C84.5Y\\nNystagmus occurring in visual system disorders unspecified: 9C84.5Z\\nEyelid nystagmus: 9C84.6\\nOther specified nystagmus: 9C84.Y\\nNystagmus unspecified: 9C84.Z\\nCertain specified irregular eye movements: 9C85\\nAnomalies of saccadic eye movements: 9C85.0\\nDisorders of the saccadic pulse: 9C85.00\\nDisorders of the saccadic step: 9C85.01\\nInappropriate saccades: 9C85.02\\nOther specified anomalies of saccadic eye movements: 9C85.0Y\\nAnomalies of saccadic eye movements unspecified: 9C85.0Z\\nAnomalies of smooth pursuit movements: 9C85.1\\nNonorganic eye movement disorders: 9C85.2\\nOther specified irregular eye movements: 9C85.Y\\nIrregular eye movements unspecified: 9C85.Z\\nOther specified strabismus or ocular motility disorders: 9C8Y\\nStrabismus or ocular motility disorders unspecified: 9C8Z\\nDisorders of refraction: 9D00\\nMyopia: 9D00.0\\nHypermetropia: 9D00.1\\nAstigmatism: 9D00.2\\nPresbyopia: 9D00.3\\nAnisometropia: 9D00.4\\nAniseikonia: 9D00.5\\nTransient refractive change: 9D00.6\\nOther specified disorders of refraction: 9D00.Y\\nDisorders of refraction unspecified: 9D00.Z\\nDisorders of accommodation: 9D01\\nInternal ophthalmoplegia: 9D01.0\\nParesis of accommodation: 9D01.1\\nSpasm of accommodation: 9D01.2\\nOther specified disorders of accommodation: 9D01.Y\\nDisorders of accommodation unspecified: 9D01.Z\\nOther specified disorders of refraction or accommodation: 9D0Y\\nDisorders of refraction or accommodation unspecified: 9D0Z\\nBullous aphakic keratopathy following cataract surgery: 9D20\\nCataract lens fragments in eye following cataract surgery: 9D21\\nChorioretinal scars after surgery for detachment: 9D22\\nConjunctival blebitis after glaucoma surgery: 9D23\\nComplications with glaucoma drainage devices: 9D24\\nGlaucoma due to ocular surgery or laser: 9D25\\nImpairment of visual field: 9D41\\nPatterns of visual field impairment: 9D42\\nPeripheral field deficit: 9D42.2\\nEnlarged blind spot: 9D42.20\\nArcuate scotoma: 9D42.21\\nNasal step: 9D42.22\\nRing scotoma: 9D42.23\\nIsolated peripheral scotoma: 9D42.24\\nOther specified peripheral field deficit: 9D42.2Y\\nPeripheral field deficit unspecified: 9D42.2Z\\nHemianopic or quadrantic loss: 9D42.3\\nCentral scotoma: 9D42.4\\nParacentral scotoma: 9D42.5\\nHomonymous hemianopia or quadrant anopia: 9D42.6\\nRight hemifield homonymous hemianopia or quadrant anopia: 9D42.60\\nLeft hemifield homonymous hemianopia or quadrant anopia: 9D42.61\\nOther specified homonymous hemianopia or quadrant anopia: 9D42.6Y\\nHomonymous hemianopia or quadrant anopia unspecified: 9D42.6Z\\nHeteronymous hemianopia or quadrant anopia: 9D42.7\\nBinasal defects heteronymous hemianopia or quadrant anopia: 9D42.70\\nBitemporal defects heteronymous hemianopia or quadrant anopia: 9D42.71\\nOther specified heteronymous hemianopia or quadrant anopia: 9D42.7Y\\nHeteronymous hemianopia or quadrant anopia unspecified: 9D42.7Z\\nOther specified patterns of visual field impairment: 9D42.Y\\nPatterns of visual field impairment unspecified: 9D42.Z\\nImpairment of contrast vision: 9D43\\nImpairment of colour vision: 9D44\\nImpairment of light sensitivity: 9D45\\nImpairment of binocular functions: 9D46\\nVisual discomfort: 9D50\\nTransient visual loss: 9D51\\nHemifield losses: 9D52\\nEntoptic phenomena: 9D53\\nVisual illusions: 9D54\\nNonorganic visual loss: 9D55\\nVisual release hallucinations: 9D56\\nOther specified subjective visual experiences: 9D5Y\\nSubjective visual experiences unspecified: 9D5Z\\nOther specified impairment of visual functions: 9D7Y\\nImpairment of visual functions unspecified: 9D7Z\\nVision impairment including blindness: 9D90\\nMild vision impairment: 9D90.1\\nModerate vision impairment: 9D90.2\\nSevere vision impairment: 9D90.3\\nBlindness: 9D90.6\\nNear vision impairment: 9D90.7\\nSpecific vision dysfunctions: 9D92\\nComplex visionrelated dysfunctions: 9D93\\nImpairment of presenting visual acuity: 9D94\\nImpairment of best corrected visual acuity: 9D95\\nImpairment of uncorrected visual acuity: 9D96\\nOther specified vision impairment: 9D9Y\\nVision impairment unspecified: 9D9Z\\nOther specified diseases of the visual system: 9E1Y\\nDiseases of the visual system unspecified: 9E1Z\\nAbscess of external ear: AA00\\nCellulitis of external ear: AA01\\nMalignant otitis externa: AA02\\nOtomycosis: AA03\\nPerichondritis of external ear: AA04\\nOther specified infectious diseases of external ear: AA0Y\\nInfectious diseases of external ear unspecified: AA0Z\\nSeborrhoeic otitis externa: AA10\\nAcute noninfectious otitis externa: AA11\\nChondrodermatitis nodularis: AA12\\nChronic otitis externa: AA13\\nOther specified noninfectious inflammation of external ear: AA1Y\\nNoninfectious inflammation of external ear unspecified: AA1Z\\nOther specified otitis externa: AA3Y\\nOtitis externa unspecified: AA3Z\\nAcquired deformity of external auditory canal: AA40\\nExostosis of external auditory canal: AA40.0\\nAcquired stenosis of external auditory canal: AA40.1\\nCholesteatoma of external auditory canal: AA40.2\\nOther specified acquired deformity of external auditory canal: AA40.Y\\nAcquired deformity of external auditory canal unspecified: AA40.Z\\nAcquired deformity of pinna: AA41\\nCauliflower ear: AA41.0\\nOther specified acquired deformity of pinna: AA41.Y\\nAcquired deformity of pinna unspecified: AA41.Z\\nImpacted cerumen: AA42\\nOther specified noninflammatory disorders of the external ear: AA4Y\\nNoninflammatory disorders of the external ear unspecified: AA4Z\\nDiseases of external ear unspecified: AA6Z\\nAcute serous or mucoid otitis media: AA80\\nAcute nonserous nonsuppurative otitis media: AA81\\nChronic serous or mucoid otitis media: AA82\\nNoninfected otitis media with effusion: AA83\\nNonsuppurative otitis media unspecified: AA8Z\\nAcute suppurative otitis media: AA90\\nChronic suppurative otitis media: AA91\\nChronic tubotympanic suppurative otitis media: AA91.0\\nChronic atticoantral suppurative otitis media: AA91.1\\nOther chronic suppurative otitis media: AA91.2\\nChronic suppurative otitis media unspecified: AA91.Z\\nSuppurative otitis media unspecified whether acute or chronic: AA9Z\\nAcute otitis media: AB00\\nChronic otitis media: AB01\\nOther specified otitis media: AB0Y\\nOtitis media unspecified: AB0Z\\nDisorders of Eustachian tube: AB10\\nDiverticulum of Eustachian tube: AB10.0\\nPatulous Eustachian tube: AB10.1\\nEustachian salpingitis: AB10.2\\nObstruction of Eustachian tube: AB10.3\\nOther specified disorders of Eustachian tube: AB10.Y\\nDisorders of Eustachian tube unspecified: AB10.Z\\nMastoiditis or related conditions: AB11\\nAcute mastoiditis: AB11.0\\nChronic mastoiditis: AB11.1\\nPetrositis: AB11.2\\nMastoiditis unspecified as acute or chronic: AB11.3\\nOther specified mastoiditis related conditions: AB11.Y\\nCholesteatoma of middle ear: AB12\\nPerforation of tympanic membrane: AB13\\nCentral perforation of tympanic membrane: AB13.0\\nAttic perforation of tympanic membrane: AB13.1\\nOther marginal perforations of tympanic membrane: AB13.2\\nOther specified perforation of tympanic membrane: AB13.Y\\nPerforation of tympanic membrane unspecified: AB13.Z\\nAcute myringitis: AB14\\nChronic myringitis: AB15\\nTympanosclerosis: AB16\\nAdhesive middle ear disease: AB17\\nDiscontinuity or dislocation of ear ossicles: AB18\\nAcquired abnormalities of ear ossicles not related to discontinuity or dislocation: AB19\\nPolyp of middle ear: AB1A\\nAural polyp: AB1A.0\\nOther specified polyp of middle ear: AB1A.Y\\nPolyp of middle ear unspecified: AB1A.Z\\nMiddle ear cicatrix: AB1B\\nOther specified diseases of middle ear or mastoid: AB1Y\\nDiseases of middle ear or mastoid unspecified: AB1Z\\nAcute vestibular syndrome: AB30\\nVestibular neuritis: AB30.0\\nLabyrinthitis: AB30.1\\nOther specified acute vestibular syndrome: AB30.Y\\nAcute vestibular syndrome unspecified: AB30.Z\\nEpisodic vestibular syndrome: AB31\\nMeniere disease: AB31.0\\nVestibular migraine: AB31.1\\nBenign positional paroxysmal vertigo: AB31.2\\nSuperior canal dehiscence syndrome: AB31.3\\nDisembarkment syndrome: AB31.4\\nAutoimmune inner ear disease: AB31.5\\nVestibular paroxysmia: AB31.6\\nVertiginous syndromes: AB31.7\\nOther specified episodic vestibular syndrome: AB31.Y\\nEpisodic vestibular syndrome unspecified: AB31.Z\\nChronic vestibular syndrome: AB32\\nPersistent PosturalPerceptual Dizziness: AB32.0\\nChronic unilateral idiopathic vestibulopathy: AB32.1\\nPersistent unilateral vestibulopathy after vestibular neuronitis: AB32.2\\nUnilateral vestibulopathy due to schwannoma: AB32.3\\nUnilateral vestibulopathy after medical intervention: AB32.4\\nChronic bilateral vestibulopathy: AB32.5\\nOther specified chronic vestibular syndrome: AB32.Y\\nChronic vestibular syndrome unspecified: AB32.Z\\nOtosclerosis: AB33\\nDisorders of vestibular function: AB34\\nIdiopathic bilateral vestibulopathy: AB34.0\\nOther peripheral vertigo: AB34.1\\nOther specified disorders of vestibular function: AB34.Y\\nDisorders of vestibular function unspecified: AB34.Z\\nLabyrinthine fistula: AB35\\nLabyrinthine dysfunction: AB36\\nNoise effects on inner ear: AB37\\nOther specified diseases of inner ear: AB3Y\\nDiseases of inner ear unspecified: AB3Z\\nCongenital hearing impairment: AB50\\nCongenital conductive hearing loss: AB50.0\\nCongenital sensorineural hearing loss: AB50.1\\nCongenital mixed conductive and sensorineural hearing loss: AB50.2\\nOther specified congenital hearing impairment: AB50.Y\\nCongenital hearing impairment unspecified: AB50.Z\\nAcquired hearing impairment: AB51\\nAcquired conductive hearing loss: AB51.0\\nAcquired sensorineural hearing loss: AB51.1\\nAcquired mixed conductive and sensorineural hearing loss: AB51.2\\nOther specified acquired hearing impairment: AB51.Y\\nAcquired hearing impairment unspecified: AB51.Z\\nDeafness not otherwise specified: AB52\\nOtotoxic hearing loss: AB53\\nPresbycusis: AB54\\nSudden idiopathic hearing loss: AB55\\nHereditary hearing loss: AB56\\nAuditory synaptopathy or neuropathy: AB57\\nOther specified disorders with hearing impairment: AB5Y\\nDisorders with hearing impairment unspecified: AB5Z\\nOtalgia or effusion of ear: AB70\\nOtorrhoea: AB70.0\\nOtorrhagia: AB70.1\\nOtalgia: AB70.2\\nDegenerative or vascular disorders of ear: AB71\\nDisorders of acoustic nerve: AB72\\nAcoustic neuritis: AB72.0\\nOther specified disorders of acoustic nerve: AB72.Y\\nDisorders of acoustic nerve unspecified: AB72.Z\\nAtrophy ear: AB73\\nOther specified disorders of ear not elsewhere classified: AB7Y\\nRecurrent cholesteatoma of postmastoidectomy cavity: AB90\\nMucosal cyst of postmastoidectomy cavity: AB91\\nGranulation of postmastoidectomy cavity: AB92\\nChronic inflammation of postmastoidectomy cavity: AB93\\nOther specified diseases of the ear or mastoid process: AC0Y\\nDiseases of the ear or mastoid process unspecified: AC0Z\\nEssential hypertension: BA00\\nCombined diastolic and systolic hypertension: BA00.0\\nIsolated diastolic hypertension: BA00.1\\nIsolated systolic hypertension: BA00.2\\nOther specified essential hypertension: BA00.Y\\nEssential hypertension unspecified: BA00.Z\\nHypertensive heart disease: BA01\\nHypertensive renal disease: BA02\\nHypertensive crisis: BA03\\nSecondary hypertension: BA04\\nCombined diastolic and systolic secondary hypertension: BA04.0\\nIsolated diastolic secondary hypertension: BA04.1\\nIsolated systolic secondary hypertension: BA04.2\\nOther specified secondary hypertension: BA04.Y\\nSecondary hypertension unspecified: BA04.Z\\nIdiopathic hypotension: BA20\\nOrthostatic hypotension: BA21\\nOther specified hypotension: BA2Y\\nHypotension unspecified: BA2Z\\nAngina pectoris: BA40\\nUnstable angina: BA40.0\\nStable angina: BA40.1\\nOther specified angina pectoris: BA40.Y\\nAngina pectoris unspecified: BA40.Z\\nAcute myocardial infarction: BA41\\nAcute ST elevation myocardial infarction: BA41.0\\nAcute nonST elevation myocardial infarction: BA41.1\\nAcute myocardial infarction unspecified: BA41.Z\\nSubsequent myocardial infarction: BA42\\nSubsequent myocardial infarction ST elevation myocardial infarction: BA42.0\\nSubsequent myocardial infarction nonST elevation myocardial infarction: BA42.1\\nSubsequent myocardial infarction unspecified: BA42.Z\\nCoronary thrombosis not resulting in myocardial infarction: BA43\\nAcute ischaemic heart disease unspecified: BA4Z\\nOld myocardial infarction: BA50\\nIschaemic cardiomyopathy: BA51\\nDilated cardiomyopathy due to congenital anomaly of coronary artery: BA51.0\\nOther specified ischaemic cardiomyopathy: BA51.Y\\nIschaemic cardiomyopathy unspecified: BA51.Z\\nCoronary atherosclerosis: BA52\\nCoronary atherosclerosis of native coronary artery: BA52.0\\nCoronary atherosclerosis of autologous bypass graft: BA52.1\\nCoronary atherosclerosis of arterial autologous bypass graft: BA52.10\\nCoronary atherosclerosis of venous autologous bypass graft: BA52.11\\nCoronary atherosclerosis of unspecified autologous bypass graft: BA52.1Z\\nCoronary atherosclerosis of nonautologous bypass graft: BA52.2\\nCoronary atherosclerosis unspecified site: BA52.Z\\nOther specified chronic ischaemic heart disease: BA5Y\\nChronic ischaemic heart disease unspecified: BA5Z\\nCertain current complications following acute myocardial infarction: BA60\\nDressler syndrome: BA60.0\\nOther pericarditis as current complication following acute myocardial infarction: BA60.1\\nVentricular aneurysm as current complication following acute myocardial infarction: BA60.2\\nVentricular septal defect as current complication following acute myocardial infarction: BA60.3\\nCardiac rupture as current complication following acute myocardial infarction: BA60.4\\nPulmonary embolism as current complication following acute myocardial infarction: BA60.5\\nRupture of papillary muscle or chordae tendineae as current complication following acute myocardial infarction: BA60.6\\nMural thrombus as current complication following acute myocardial infarction: BA60.7\\nArrhythmia as current complication following acute myocardial infarction: BA60.8\\nCardiogenic shock unrelated to mechanical complications as current complication following acute myocardial infarction: BA60.9\\nOther specified current complications following acute myocardial infarction: BA60.Y\\nCertain current complications following acute myocardial infarction unspecified: BA60.Z\\nIschaemic heart diseases unspecified: BA6Z\\nCoronary artery aneurysm: BA81\\nCoronary artery aneurysm with perforation: BA81.0\\nCoronary artery aneurysm with rupture: BA81.1\\nCoronary artery aneurysm without mention of perforation or rupture: BA81.2\\nCoronary artery dissection: BA82\\nCoronary artery fistula acquired: BA83\\nChronic total occlusion of coronary artery: BA84\\nCoronary vasospastic disease: BA85\\nSilent coronary vasospastic disease: BA85.0\\nOther specified coronary vasospastic disease: BA85.Y\\nCoronary vasospastic disease unspecified: BA85.Z\\nCoronary microvascular disease: BA86\\nOther specified diseases of coronary artery: BA8Y\\nDiseases of coronary artery unspecified: BA8Z\\nPulmonary thromboembolism: BB00\\nAcute pulmonary thromboembolism: BB00.0\\nChronic pulmonary thromboembolism: BB00.1\\nPulmonary thromboembolism unspecified: BB00.Z\\nPulmonary hypertension: BB01\\nPulmonary arterial hypertension: BB01.0\\nPulmonary hypertension due to left heart disease: BB01.1\\nPulmonary hypertension due to lung disease or hypoxia: BB01.2\\nChronic thromboembolic pulmonary hypertension: BB01.3\\nPulmonary hypertension with multifactorial mechanism: BB01.4\\nCor pulmonale: BB01.5\\nPulmonary hypertension unspecified: BB01.Z\\nCertain specified diseases of pulmonary vessels: BB02\\nArteriovenous fistula of pulmonary vessels: BB02.0\\nAneurysm of pulmonary artery: BB02.1\\nAneurysm of pulmonary artery with perforation: BB02.10\\nAneurysm of pulmonary artery with rupture: BB02.11\\nAneurysm of pulmonary artery without mention of perforation or rupture: BB02.12\\nOther specified aneurysm of pulmonary artery: BB02.1Y\\nAneurysm of pulmonary artery unspecified: BB02.1Z\\nRupture of pulmonary vessels: BB02.2\\nAcquired pulmonary arterial tree abnormality: BB02.3\\nAcquired pulmonary venous abnormality: BB03\\nAcquired pulmonary venous obstruction: BB03.0\\nOther specified acquired pulmonary venous abnormality: BB03.Y\\nAcquired pulmonary venous abnormality unspecified: BB03.Z\\nOther specified pulmonary heart disease or diseases of pulmonary circulation: BB0Y\\nPulmonary heart disease or diseases of pulmonary circulation unspecified: BB0Z\\nAcute pericarditis: BB20\\nInfectious pericarditis: BB20.0\\nNeoplastic pericarditis: BB20.1\\nMyopericarditis: BB20.2\\nOther specified acute pericarditis: BB20.Y\\nAcute pericarditis unspecified: BB20.Z\\nChronic rheumatic pericarditis: BB21\\nConstrictive pericarditis: BB22\\nCardiac tamponade: BB23\\nHaemopericardium: BB24\\nPericardial effusion: BB25\\nOther specified pericarditis: BB2Y\\nPericarditis unspecified: BB2Z\\nAcute or subacute infectious endocarditis: BB40\\nMyoendocarditis: BB41\\nPeriendocarditis: BB42\\nOther specified acute or subacute endocarditis: BB4Y\\nAcute or subacute endocarditis unspecified: BB4Z\\nMitral valve stenosis: BB60\\nRheumatic mitral valve stenosis: BB60.0\\nNonrheumatic mitral valve stenosis: BB60.1\\nMitral valve stenosis unspecified: BB60.Z\\nMitral valve insufficiency: BB61\\nRheumatic mitral valve insufficiency: BB61.0\\nOther specified mitral valve insufficiency: BB61.Y\\nMitral valve insufficiency unspecified: BB61.Z\\nMitral valve prolapse: BB62\\nRheumatic mitral valve prolapse: BB62.0\\nDegenerative mitral valve prolapse: BB62.1\\nOther specified nonrheumatic mitral valve prolapse: BB62.Y\\nMitral valve prolapse unspecified: BB62.Z\\nMitral valve stenosis with insufficiency: BB63\\nRheumatic mitral stenosis with insufficiency: BB63.0\\nNonrheumatic mitral stenosis with insufficiency: BB63.1\\nMitral valve stenosis with insufficiency unspecified: BB63.Z\\nMitral valvar abscess: BB64\\nMitral valve rupture: BB65\\nOther specified mitral valve disease: BB6Y\\nMitral valve disease unspecified: BB6Z\\nAortic valve stenosis: BB70\\nRheumatic aortic valve stenosis: BB70.0\\nNonrheumatic aortic valve stenosis: BB70.1\\nOther specified aortic valve stenosis: BB70.Y\\nAortic valve stenosis unspecified: BB70.Z\\nAortic valve insufficiency: BB71\\nRheumatic aortic valve insufficiency: BB71.0\\nOther specified nonrheumatic aortic valve insufficiency: BB71.Y\\nAortic valve insufficiency unspecified: BB71.Z\\nAortic valve stenosis with insufficiency: BB72\\nRheumatic aortic stenosis with insufficiency: BB72.0\\nNonrheumatic aortic valve stenosis with insufficiency: BB72.1\\nAortic valve stenosis with insufficiency unspecified: BB72.Z\\nAortic valvar abscess: BB73\\nAortic valvar prolapse: BB74\\nOther specified aortic valve disease: BB7Y\\nAortic valve disease unspecified: BB7Z\\nTricuspid valve stenosis: BB80\\nRheumatic tricuspid valve stenosis: BB80.0\\nOther specified nonrheumatic tricuspid valve stenosis: BB80.Y\\nTricuspid valve stenosis unspecified: BB80.Z\\nTricuspid valve insufficiency: BB81\\nRheumatic tricuspid valve insufficiency: BB81.0\\nOther specified nonrheumatic tricuspid valve insufficiency: BB81.Y\\nTricuspid valve insufficiency unspecified: BB81.Z\\nTricuspid valve stenosis with insufficiency: BB82\\nRheumatic tricuspid valve stenosis with insufficiency: BB82.0\\nOther specified nonrheumatic tricuspid valve stenosis with insufficiency: BB82.Y\\nTricuspid valve stenosis with insufficiency unspecified: BB82.Z\\nTricuspid valvular abscess: BB83\\nTricuspid valve rupture: BB84\\nOther specified tricuspid valve disease: BB8Y\\nTricuspid valve disease unspecified: BB8Z\\nPulmonary valve stenosis: BB90\\nRheumatic pulmonary valve stenosis: BB90.0\\nOther specified nonrheumatic pulmonary valve stenosis: BB90.Y\\nPulmonary valve stenosis unspecified: BB90.Z\\nPulmonary valve insufficiency: BB91\\nRheumatic pulmonary valve insufficiency: BB91.0\\nOther specified nonrheumatic pulmonary valve insufficiency: BB91.Y\\nPulmonary valve insufficiency unspecified: BB91.Z\\nPulmonary valve stenosis with insufficiency: BB92\\nRheumatic pulmonary valve stenosis with insufficiency: BB92.0\\nNonrheumatic pulmonary valve stenosis with insufficiency: BB92.1\\nPulmonary valve stenosis with insufficiency unspecified: BB92.Z\\nPulmonary valvar abscess: BB93\\nOther specified pulmonary valve disease: BB9Y\\nPulmonary valve disease unspecified: BB9Z\\nMultiple valve disease: BC00\\nProsthetic valve disease: BC01\\nAcquired abnormality of congenitally malformed valve: BC02\\nAcquired common atrioventricular valvar abnormality in biventricular connections: BC02.0\\nAcquired truncal valvar abnormality: BC02.1\\nAcquired common atrioventricular valvar abnormality in double inlet ventricle: BC02.2\\nAcquired abnormality of neoaortic valve of pulmonary origin: BC02.3\\nStenosis of the neoaortic valve of pulmonary origin: BC02.30\\nInsufficiency of the neoaortic valve of pulmonary origin: BC02.31\\nOther specified acquired abnormality of neoaortic valve of pulmonary origin: BC02.3Y\\nAcquired abnormality of neoaortic valve of pulmonary origin unspecified: BC02.3Z\\nAcquired abnormality of the neoaortic valve of truncal origin: BC02.4\\nAcquired stenosis of the neoaortic valve of truncal origin: BC02.40\\nAcquired regurgitation of the neoaortic valve of truncal origin: BC02.41\\nOther specified acquired abnormality of the neoaortic valve of truncal origin: BC02.4Y\\nAcquired abnormality of the neoaortic valve of truncal origin unspecified: BC02.4Z\\nOther specified acquired abnormality of congenitally malformed valve: BC02.Y\\nAcquired abnormality of congenitally malformed valve unspecified: BC02.Z\\nHeart valve diseases unspecified: BC0Z\\nChronic rheumatic heart diseases not elsewhere classified: BC20\\nRheumatic diseases of endocardium valve unspecified: BC20.0\\nOther specified chronic rheumatic heart disease: BC20.Y\\nChronic rheumatic heart disease unspecified: BC20.Z\\nAcquired atrial abnormality: BC40\\nAcquired interatrial communication: BC40.0\\nOther specified acquired atrial abnormality: BC40.Y\\nAcquired atrial abnormality unspecified: BC40.Z\\nAcquired ventricular abnormality: BC41\\nAcquired interventricular communication: BC41.0\\nOther specified acquired ventricular abnormality: BC41.Y\\nAcquired ventricular abnormality unspecified: BC41.Z\\nMyocarditis: BC42\\nGiant cell myocarditis: BC42.0\\nInfectious myocarditis: BC42.1\\nHypersensitivity myocarditis: BC42.2\\nRheumatic myocarditis: BC42.3\\nOther specific myocarditis: BC42.Y\\nMyocarditis unspecified: BC42.Z\\nCardiomyopathy: BC43\\nDilated cardiomyopathy: BC43.0\\nFamilialgenetic dilated cardiomyopathy: BC43.00\\nNonfamilial dilated cardiomyopathy: BC43.01\\nDilated cardiomyopathy unspecified: BC43.0Z\\nHypertrophic cardiomyopathy: BC43.1\\nFamilialgenetic hypertrophic cardiomyopathy: BC43.10\\nNonobstructive hypertrophic cardiomyopathy: BC43.11\\nObstructive hypertrophic cardiomyopathy: BC43.12\\nOther specified hypertrophic cardiomyopathy: BC43.1Y\\nHypertrophic cardiomyopathy unspecified: BC43.1Z\\nRestrictive cardiomyopathy: BC43.2\\nNonfamilial restrictive cardiomyopathy: BC43.20\\nOther specified restrictive cardiomyopathy: BC43.2Y\\nRestrictive cardiomyopathy unspecified: BC43.2Z\\nEndocardial fibroelastosis: BC43.3\\nCardiomyopathy due to drugs or other external agents: BC43.4\\nStressinduced cardiomyopathy: BC43.5\\nArrhythmogenic ventricular cardiomyopathy: BC43.6\\nDiabetic cardiomyopathy: BC43.7\\nOther specified cardiomyopathy: BC43.Y\\nCardiomyopathy unspecified: BC43.Z\\nNoncompaction cardiomyopathy: BC44\\nCardiomegaly: BC45\\nIntracardiac thrombosis: BC46\\nOther specified diseases of the myocardium or cardiac chambers: BC4Y\\nDiseases of the myocardium or cardiac chambers unspecified: BC4Z\\nAtrial premature depolarization: BC60\\nJunctional premature depolarization: BC61\\nAccessory pathway: BC62\\nConduction disorders: BC63\\nAtrioventricular block first degree: BC63.0\\nAtrioventricular block second degree: BC63.1\\nHighgrade second degree atrioventricular block: BC63.10\\nOther specified atrioventricular block second degree: BC63.1Y\\nAtrioventricular block second degree unspecified: BC63.1Z\\nComplete atrioventricular block: BC63.2\\nCongenital complete atrioventricular block: BC63.20\\nAcquired complete atrioventricular block: BC63.21\\nComplete atrioventricular block unspecified: BC63.2Z\\nRight bundle branch block: BC63.3\\nLeft bundle branch block: BC63.4\\nLeft anterior fascicular block: BC63.40\\nLeft posterior fascicular block: BC63.41\\nLeft bundle branch block fascicle unspecified: BC63.4Z\\nNonspecific intraventricular conduction delay: BC63.5\\nOther specified conduction disorders: BC63.Y\\nConduction disorders unspecified: BC63.Z\\nSudden arrhythmic death syndrome: BC64\\nCardiac arrhythmia associated with genetic disorder: BC65\\nLong QT syndrome: BC65.0\\nBrugada syndrome: BC65.1\\nShort QT syndrome: BC65.2\\nEarly repolarisation syndrome: BC65.3\\nIdiopathic ventricular fibrillation: BC65.4\\nCatecholaminergic polymorphic ventricular tachycardia: BC65.5\\nOther specified cardiac arrhythmia associated with genetic disorder: BC65.Y\\nCardiac arrhythmia associated with genetic disorder unspecified: BC65.Z\\nVentricular premature depolarization: BC70\\nVentricular tachyarrhythmia: BC71\\nVentricular tachycardia: BC71.0\\nRight outflow tract ventricular tachycardia: BC71.00\\nPolymorphic ventricular tachycardia: BC71.01\\nSustained ventricular tachycardia: BC71.02\\nNonsustained ventricular tachycardia: BC71.03\\nOther specified ventricular tachycardia: BC71.0Y\\nVentricular tachycardia unspecified: BC71.0Z\\nVentricular fibrillation: BC71.1\\nReentry ventricular arrhythmia: BC71.2\\nOther specified ventricular tachyarrhythmia: BC71.Y\\nVentricular tachyarrhythmia unspecified: BC71.Z\\nOther specified ventricular rhythm disturbance: BC7Y\\nVentricular rhythm disturbance unspecified: BC7Z\\nSupraventricular bradyarrhythmia: BC80\\nSinus pause: BC80.0\\nSinus bradycardia: BC80.1\\nSinus node dysfunction: BC80.2\\nSick sinus syndrome: BC80.20\\nSinoatrial block: BC80.21\\nOther specified sinus node dysfunction: BC80.2Y\\nSinus node dysfunction unspecified: BC80.2Z\\nOther specified supraventricular bradyarrhythmia: BC80.Y\\nSupraventricular bradyarrhythmia unspecified: BC80.Z\\nSupraventricular tachyarrhythmia: BC81\\nEctopic atrial tachycardia: BC81.0\\nJunctional ectopic tachycardia: BC81.1\\nMacro reentrant atrial tachycardia: BC81.2\\nCavotricuspid isthmus dependent macroreentry tachycardia: BC81.20\\nNonscar nonisthmus dependent macro reentrant atrial tachycardia: BC81.21\\nScar mediated macro reentrant atrial tachycardia: BC81.22\\nOther specified macro reentrant atrial tachycardia: BC81.2Y\\nMacro reentrant atrial tachycardia unspecified: BC81.2Z\\nAtrial fibrillation: BC81.3\\nParoxysmal atrial fibrillation: BC81.30\\nPersistent atrial fibrillation: BC81.31\\nPermanent atrial fibrillation: BC81.32\\nPreexcited atrial fibrillation: BC81.33\\nOther specified atrial fibrillation: BC81.3Y\\nAtrial fibrillation unspecified: BC81.3Z\\nWolffParkinsonWhite syndrome: BC81.4\\nSinus node reentrant tachycardia: BC81.5\\nInappropriate sinus tachycardia: BC81.6\\nAtrioventricular reciprocating tachycardia: BC81.7\\nAtrioventricular reciprocating tachycardia orthodromic: BC81.70\\nAtrioventricular reciprocating tachycardia antidromic: BC81.71\\nOther specified atrioventricular reciprocating tachycardia: BC81.7Y\\nAtrioventricular reciprocating tachycardia unspecified: BC81.7Z\\nAtrioventricular nodal reentry tachycardia: BC81.8\\nOther specified supraventricular tachyarrhythmia: BC81.Y\\nSupraventricular tachyarrhythmia unspecified: BC81.Z\\nOther specified supraventricular rhythm disturbance: BC8Y\\nSupraventricular rhythm disturbance unspecified: BC8Z\\nRhythm disturbance at level of atrioventricular junction: BC90\\nPacemaker or implantable cardioverter defibrillator battery at end of battery life: BC91\\nOther specified cardiac arrhythmia: BC9Y\\nCardiac arrhythmia unspecified: BC9Z\\nCongestive heart failure: BD10\\nLeft ventricular failure: BD11\\nLeft ventricular failure with preserved ejection fraction: BD11.0\\nLeft ventricular failure with mid range ejection fraction: BD11.1\\nLeft ventricular failure with reduced ejection fraction: BD11.2\\nLeft ventricular failure unspecified: BD11.Z\\nHigh output syndromes: BD12\\nRight ventricular failure: BD13\\nBiventricular failure: BD14\\nOther specified heart failure: BD1Y\\nHeart failure unspecified: BD1Z\\nAcute arterial occlusion: BD30\\nAcute upper limb arterial occlusion: BD30.0\\nAcute thromboembolic upper limb arterial occlusion: BD30.00\\nAcute thrombotic upper limb arterial occlusion: BD30.01\\nOther specified acute upper limb arterial occlusion: BD30.0Y\\nAcute upper limb arterial occlusion unspecified: BD30.0Z\\nAcute aortoiliac occlusion: BD30.1\\nAcute thromboembolic aortoiliac occlusion: BD30.10\\nAcute thrombotic aortoiliac occlusion: BD30.11\\nOther specified acute aortoiliac occlusion: BD30.1Y\\nAcute aortoiliac occlusion unspecified: BD30.1Z\\nAcute lower limb arterial occlusion: BD30.2\\nAcute thromboembolic lower limb arterial occlusion: BD30.20\\nAcute thrombotic lower limb arterial occlusion: BD30.21\\nOther specified acute lower limb arterial occlusion: BD30.2Y\\nAcute lower limb arterial occlusion unspecified: BD30.2Z\\nOther specified acute arterial occlusion: BD30.Y\\nAcute arterial occlusion unspecified: BD30.Z\\nAtherosclerotic chronic arterial occlusive disease: BD40\\nLower limb atherosclerosis: BD40.0\\nAtherosclerosis of aorta: BD40.1\\nAtherosclerosis of renal artery: BD40.2\\nAortic bifurcation syndrome: BD40.3\\nOther specified atherosclerotic chronic arterial occlusive disease: BD40.Y\\nAtherosclerotic chronic arterial occlusive disease unspecified: BD40.Z\\nNonatherosclerotic chronic arterial occlusive disease: BD41\\nArterial fibromuscular dysplasia: BD41.0\\nOther specified nonatherosclerotic chronic arterial occlusive disease: BD41.Y\\nNonatherosclerotic chronic arterial occlusive disease unspecified: BD41.Z\\nRaynaud phenomenon: BD42\\nPrimary Raynaud disease: BD42.0\\nSecondary Raynaud phenomenon: BD42.1\\nRaynaud phenomenon unspecified: BD42.Z\\nOther specified chronic arterial occlusive disease: BD4Y\\nChronic arterial occlusive disease unspecified: BD4Z\\nAortic aneurysm or dissection: BD50\\nThoracic aortic dissection ascending aorta dissection and propagation beyond arch: BD50.0\\nThoracic aortic dissection ascending aorta dissection and propagation beyond arch with perforation: BD50.00\\nThoracic aortic dissection ascending aorta dissection and propagation beyond arch with rupture: BD50.01\\nThoracic aortic dissection ascending aorta dissection and propagation beyond arch without mention of perforation or rupture: BD50.0Z\\nAscending aorta dissection not beyond arch: BD50.1\\nAscending aorta dissection not beyond arch with perforation: BD50.10\\nAscending aorta dissection not beyond arch with rupture: BD50.11\\nAscending aorta dissection not beyond arch without mention of perforation or rupture: BD50.1Z\\nDescending aorta dissection and distal propagation: BD50.2\\nDescending aorta dissection and distal propagation with perforation: BD50.20\\nDescending aorta dissection and distal propagation with rupture: BD50.21\\nOther specified descending aorta dissection and distal propagation: BD50.2Y\\nDescending aorta dissection and distal propagation unspecified: BD50.2Z\\nThoracic aortic aneurysm: BD50.3\\nThoracic aortic aneurysm with perforation: BD50.30\\nThoracic aortic aneurysm with rupture: BD50.31\\nThoracic aortic aneurysm without mention of perforation or rupture: BD50.3Z\\nAbdominal aortic aneurysm: BD50.4\\nAbdominal aortic aneurysm with perforation: BD50.40\\nAbdominal aortic aneurysm with rupture: BD50.41\\nAbdominal aortic aneurysm without mention of perforation or rupture: BD50.4Z\\nThoracoabdominal aortic aneurysm: BD50.5\\nThoracoabdominal aortic aneurysm with perforation: BD50.50\\nThoracoabdominal aortic aneurysm with rupture: BD50.51\\nThoracoabdominal aortic aneurysm without mention of perforation or rupture: BD50.5Z\\nAortic aneurysm or dissection unspecified: BD50.Z\\nArterial aneurysm or dissection excluding aorta: BD51\\nAneurysm or dissection of carotid artery: BD51.0\\nAneurysm or dissection of vertebral artery: BD51.1\\nAneurysm or dissection of other precerebral arteries: BD51.2\\nAneurysm or dissection of artery of upper extremity: BD51.3\\nAneurysm or dissection of renal artery: BD51.4\\nAneurysm or dissection of iliac artery: BD51.5\\nAneurysm or dissection of artery of lower extremity: BD51.6\\nAneurysm and dissection of other artery excluding aorta: BD51.Y\\nAneurysm and dissection of unspecified artery: BD51.Z\\nCertain specified disorders of arteries or arterioles: BD52\\nSegmental arterial mediolysis: BD52.0\\nArteriovenous fistula acquired: BD52.1\\nStricture of artery: BD52.2\\nRupture of artery: BD52.3\\nNecrosis of artery: BD52.4\\nCoeliac artery compression syndrome: BD52.5\\nCongenital great vessel related acquired abnormality: BD52.6\\nCertain acquired abnormalities of aorta: BD52.7\\nAcquired abnormality of aortic arch branch: BD52.70\\nAcquired ascending aorta or root dilation: BD52.71\\nOther specified certain acquired abnormalities of aorta: BD52.7Y\\nCertain acquired abnormalities of aorta unspecified: BD52.7Z\\nSecondary disorders of arteries and arterioles: BD53\\nArterial cystic medial diseases: BD53.0\\nHypothenar hammer syndrome: BD53.1\\nIliac artery arteriopathy: BD53.2\\nPopliteal entrapment syndrome: BD53.3\\nCholesterol atheroembolism: BD53.4\\nCholesterol atheroembolism to kidneys: BD53.40\\nCholesterol atheroembolism to other specified sites: BD53.4Y\\nCholesterol atheroembolism to unspecified site: BD53.4Z\\nOther specified secondary disorders of arteries and arterioles: BD53.Y\\nSecondary disorders of arteries and arterioles unspecified: BD53.Z\\nDiabetic foot ulcer: BD54\\nAsymptomatic stenosis of intracranial or extracranial artery: BD55\\nAsymptomatic occlusion of intracranial or extracranial artery: BD56\\nOther specified diseases of arteries or arterioles: BD5Y\\nDiseases of arteries or arterioles unspecified: BD5Z\\nSuperficial thrombophlebitis: BD70\\nSuperficial thrombophlebitis of lower limbs: BD70.0\\nSuperficial thrombophlebitis of upper limbs: BD70.1\\nThrombophlebitis migrans: BD70.2\\nMondor disease: BD70.3\\nOther specified superficial thrombophlebitis: BD70.Y\\nSuperficial thrombophlebitis unspecified: BD70.Z\\nDeep vein thrombosis: BD71\\nUpper limb deep vein thrombosis: BD71.0\\nVena caval thrombosis: BD71.1\\nRenal vein thrombosis: BD71.2\\nIliac vein thrombosis: BD71.3\\nLower limb deep vein thrombosis: BD71.4\\nOther specified deep vein thrombosis: BD71.Y\\nVenous thromboembolism: BD72\\nAcquired systemic vein abnormality: BD73\\nAcquired inferior caval vein abnormality: BD73.0\\nAcquired superior caval vein abnormality: BD73.1\\nSystemic vein obstruction: BD73.2\\nObstruction of peripheral vein: BD73.20\\nObstruction of visceral vein: BD73.21\\nOther specified systemic vein obstruction: BD73.2Y\\nSystemic vein obstruction unspecified: BD73.2Z\\nAcquired coronary sinus abnormality: BD73.3\\nOther specified acquired systemic vein abnormality: BD73.Y\\nAcquired systemic vein abnormality unspecified: BD73.Z\\nChronic peripheral venous insufficiency of lower extremities: BD74\\nUncomplicated lower limb venous hypertension: BD74.0\\nLower limb varicose veins: BD74.1\\nVaricose veins with great saphenous reflux: BD74.10\\nVaricose veins with small saphenous reflux: BD74.11\\nVaricose veins with nontruncal reflux: BD74.12\\nLower limb varicose veins not further specified: BD74.1Z\\nLipodermatosclerosis: BD74.2\\nVenous leg ulcer: BD74.3\\nPrimary venous leg ulcer: BD74.30\\nRecurrent venous leg ulcer: BD74.31\\nHealed venous leg ulcer: BD74.32\\nVenous leg ulcer unspecified: BD74.3Z\\nChronic peripheral venous insufficiency of lower extremities unspecified: BD74.Z\\nVenous varicosities of sites other than lower extremity: BD75\\nSublingual varices: BD75.0\\nScrotal varices: BD75.1\\nVulval varices: BD75.2\\nPelvic varices: BD75.3\\nVenous varicosities of other specified sites: BD75.Y\\nVenous varicosities of unspecified site: BD75.Z\\nOther specified diseases of veins: BD7Y\\nDiseases of veins unspecified: BD7Z\\nLymphadenitis: BD90\\nAcute lymphadenitis: BD90.0\\nNonspecific mesenteric lymphadenitis: BD90.1\\nChronic lymphadenitis: BD90.2\\nChronic cervical lymphadenitis: BD90.20\\nChronic axillary lymphadenitis: BD90.21\\nChronic inguinal lymphadenitis: BD90.22\\nOther specified chronic lymphadenitis: BD90.2Y\\nChronic lymphadenitis unspecified: BD90.2Z\\nOther specified lymphadenitis: BD90.Y\\nLymphadenitis unspecified: BD90.Z\\nLymphangitis: BD91\\nLymphangiectasia: BD92\\nIntestinal lymphangiectasia: BD92.0\\nCutaneous lymphangiectasia: BD92.1\\nLymphangiectasia unspecified: BD92.Z\\nLymphoedema: BD93\\nPrimary lymphoedema: BD93.0\\nSecondary lymphoedema: BD93.1\\nLymphoedema due to venous insufficiency: BD93.10\\nLymphoedema due to dependency and immobility: BD93.11\\nLymphoedema due to obesity: BD93.12\\nLymphoedema due to lymphatic filariasis: BD93.13\\nLymphoedema due to podoconiosis: BD93.14\\nLymphoedema due to malignant infiltration: BD93.15\\nLymphoedema secondary to other specified cause: BD93.1Y\\nSecondary lymphoedema unspecified: BD93.1Z\\nOther specified forms of lymphoedema: BD93.Y\\nLymphoedema unspecified: BD93.Z\\nOther specified disorders of lymphatic vessels or lymph nodes: BD9Y\\nDisorders of lymphatic vessels or lymph nodes unspecified: BD9Z\\nPostcardiotomy syndrome: BE10\\nOther functional disturbances following cardiac surgery: BE11\\nPostprocedural valve disorders: BE12\\nPostprocedural mitral valve stenosis: BE12.0\\nPostprocedural mitral valve insufficiency: BE12.1\\nPostprocedural aortic valve stenosis: BE12.2\\nPostprocedural aortic valve insufficiency: BE12.3\\nPostprocedural tricuspid valve stenosis: BE12.4\\nPostprocedural tricuspid valve insufficiency: BE12.5\\nPostprocedural pulmonary valve stenosis: BE12.6\\nPostprocedural pulmonary valve insufficiency: BE12.7\\nPostprocedural true or false aortic aneurysm: BE13\\nPostprocedural disorder of circulatory system following repair of congenital heart or great vessel anomaly: BE14\\nAcquired abnormality of the neopulmonary valve: BE14.4\\nNeopulmonary valve stenosis: BE14.40\\nNeopulmonary valve regurgitation: BE14.41\\nPostprocedural rightsided atrioventricular valvar abnormality in doubleinlet ventricle: BE14.5\\nPostprocedural leftsided atrioventricular valvar abnormality in doubleinlet ventricle: BE14.6\\nPostprocedural common atrioventricular valvar abnormality in doubleinlet ventricle: BE14.7\\nPostprocedural ventricular septal defect disorder: BE14.8\\nPostprocedural aortic disorder related to congenital heart anomaly: BE14.9\\nPostprocedural arterial duct disorder: BE14.A\\nPostprocedural disorder following cardiovascular conduit or shunt procedure: BE14.B\\nPostprocedural pulmonary arterial tree disorder: BE15\\nPostprocedural pulmonary trunk stenosis: BE15.0\\nPostprocedural right pulmonary artery stenosis: BE15.1\\nPostprocedural pulmonary venous disorder: BE16\\nPostprocedural residual or recurrent interatrial communication: BE17\\nPostprocedural ventricular abnormality: BE19\\nCardiac transplant associated coronary allograft vasculopathy: BE1A\\nLymphoedema due to surgery or radiotherapy: BE1B\\nPostmastectomy lymphoedema syndrome: BE1B.0\\nLymphoedema due to other medical or surgical procedures: BE1B.1\\nInferior caval vein obstruction due to foreign body: BE1C\\nSuperior caval vein obstruction due to foreign body: BE1D\\nPostprocedural right atrial complication: BE1E\\nPostprocedural right atrial perforation: BE1E.0\\nRight atrial erosion due to implanted device: BE1E.1\\nPostprocedural left atrial complication: BE1F\\nPostprocedural left atrial perforation: BE1F.0\\nLeft atrial erosion due to implanted device: BE1F.1\\nOther specified diseases of the circulatory system: BE2Y\\nDiseases of the circulatory system unspecified: BE2Z\\nAcute nasopharyngitis: CA00\\nAcute sinusitis: CA01\\nAcute pharyngitis: CA02\\nAcute bacterial pharyngitis: CA02.0\\nAcute viral pharyngitis: CA02.1\\nPharyngitis due to Adenovirus: CA02.10\\nOther specified acute viral pharyngitis: CA02.1Y\\nAcute viral pharyngitis unspecified: CA02.1Z\\nOther specified acute pharyngitis: CA02.Y\\nAcute pharyngitis unspecified: CA02.Z\\nAcute tonsillitis: CA03\\nStreptococcal tonsillitis: CA03.0\\nOther specified acute tonsillitis: CA03.Y\\nAcute tonsillitis unspecified: CA03.Z\\nAcute laryngopharyngitis: CA04\\nAcute laryngitis or tracheitis: CA05\\nAcute laryngitis: CA05.0\\nAcute tracheitis: CA05.1\\nAcute laryngotracheitis: CA05.2\\nAcute obstructive laryngitis or epiglottitis: CA06\\nAcute obstructive laryngitis: CA06.0\\nAcute epiglottitis: CA06.1\\nAcute obstructive laryngitis or epiglottitis unspecified: CA06.Z\\nAcute upper respiratory infections of multiple and unspecified sites: CA07\\nAcute upper respiratory infection site unspecified: CA07.0\\nAcute upper respiratory infections of multiple sites: CA07.1\\nVasomotor or allergic rhinitis: CA08\\nAllergic rhinitis: CA08.0\\nAllergic rhinitis due to pollen: CA08.00\\nAllergic rhinitis due to other seasonal allergens: CA08.01\\nAllergic rhinitis due to house dust mite: CA08.02\\nOther allergic rhinitis: CA08.03\\nAllergic rhinitis unspecified: CA08.0Z\\nNonallergic rhinitis: CA08.1\\nNonallergic rhinitis with eosinophils: CA08.10\\nOther specified nonallergic rhinitis: CA08.1Y\\nNonallergic rhinitis unspecified: CA08.1Z\\nMixed rhinitis: CA08.2\\nVasomotor rhinitis: CA08.3\\nChronic rhinitis nasopharyngitis or pharyngitis: CA09\\nChronic rhinitis: CA09.0\\nChronic nasopharyngitis: CA09.1\\nChronic pharyngitis: CA09.2\\nChronic rhinosinusitis: CA0A\\nSamter syndrome: CA0A.0\\nOther specified chronic rhinosinusitis: CA0A.Y\\nChronic rhinosinusitis unspecified: CA0A.Z\\nSilent sinus syndrome: CA0B\\nCyst or mucocele of nose or nasal sinus: CA0C\\nDeviated nasal septum: CA0D\\nHypertrophy of nasal turbinates: CA0E\\nChronic diseases of tonsils or adenoids: CA0F\\nHypertrophy of tonsils: CA0F.0\\nHypertrophy of adenoids: CA0F.1\\nHypertrophy of tonsils with hypertrophy of adenoids: CA0F.3\\nOther specified chronic diseases of tonsils or adenoids: CA0F.Y\\nChronic diseases of tonsils or adenoids unspecified: CA0F.Z\\nChronic laryngitis or laryngotracheitis: CA0G\\nDiseases of vocal cords or larynx not elsewhere classified: CA0H\\nParalysis of vocal cords or larynx: CA0H.0\\nPolyp of vocal cord or larynx: CA0H.1\\nNodules of vocal cords: CA0H.2\\nOedema of larynx: CA0H.3\\nLaryngeal spasm: CA0H.4\\nStenosis of larynx: CA0H.5\\nOther specified diseases of vocal cords or larynx not elsewhere classified: CA0H.Y\\nDiseases of vocal cords or larynx not elsewhere classified unspecified: CA0H.Z\\nNasal polyp: CA0J\\nPolypoid sinus degeneration: CA0J.0\\nOther specified nasal polyp: CA0J.Y\\nNasal polyp unspecified: CA0J.Z\\nAbscess of upper respiratory tract: CA0K\\nRetropharyngeal or parapharyngeal abscess: CA0K.0\\nPeritonsillar abscess: CA0K.1\\nOther specified abscess of upper respiratory tract: CA0K.Y\\nAbscess of upper respiratory tract unspecified: CA0K.Z\\nOther specified upper respiratory tract disorders: CA0Y\\nUpper respiratory tract disorders unspecified: CA0Z\\nBronchitis: CA20\\nAcute noninfectious bronchitis: CA20.0\\nChronic bronchitis: CA20.1\\nSimple chronic bronchitis: CA20.10\\nMucopurulent chronic bronchitis: CA20.11\\nMixed simple and mucopurulent chronic bronchitis: CA20.12\\nProtracted bacterial bronchitis: CA20.13\\nOther specified chronic bronchitis: CA20.1Y\\nChronic bronchitis unspecified: CA20.1Z\\nOther specified bronchitis: CA20.Y\\nBronchitis unspecified: CA20.Z\\nEmphysema: CA21\\nMacLeod syndrome: CA21.0\\nPanlobular emphysema: CA21.1\\nCentrilobular emphysema: CA21.2\\nOther specified emphysema: CA21.Y\\nEmphysema unspecified: CA21.Z\\nChronic obstructive pulmonary disease: CA22\\nChronic obstructive pulmonary disease with acute exacerbation unspecified: CA22.0\\nCertain specified chronic obstructive pulmonary disease: CA22.1\\nChronic obstructive pulmonary disease unspecified: CA22.Z\\nAsthma: CA23\\nAllergic asthma: CA23.0\\nAllergic asthma with exacerbation: CA23.00\\nAllergic asthma with status asthmaticus: CA23.01\\nAllergic asthma uncomplicated: CA23.02\\nNonallergic asthma: CA23.1\\nNonallergic asthma with exacerbation: CA23.10\\nNonallergic asthma with status asthmaticus: CA23.11\\nNonallergic asthma uncomplicated: CA23.12\\nOther specified forms of asthma or bronchospasm: CA23.2\\nAspirininduced asthma: CA23.20\\nExerciseinduced bronchospasm: CA23.21\\nCough variant asthma: CA23.22\\nUnspecified asthma: CA23.3\\nUnspecified asthma with exacerbation: CA23.30\\nUnspecified asthma with status asthmaticus: CA23.31\\nUnspecified asthma uncomplicated: CA23.32\\nBronchiectasis: CA24\\nCystic fibrosis: CA25\\nClassical cystic fibrosis: CA25.0\\nAtypical cystic fibrosis: CA25.1\\nSubclinical cystic fibrosis: CA25.2\\nCystic fibrosis unspecified: CA25.Z\\nChronic bronchiolitis: CA26\\nChronic obliterative bronchiolitis: CA26.0\\nDiffuse panbronchiolitis: CA26.1\\nOther specified chronic bronchiolitis: CA26.Y\\nChronic bronchiolitis unspecified: CA26.Z\\nTracheobronchitis: CA27\\nTracheobronchopathia osteochondroplastica: CA27.0\\nTracheobronchomegaly: CA27.1\\nOther specified tracheobronchitis: CA27.Y\\nTracheobronchitis unspecified: CA27.Z\\nOther specified lower respiratory tract disease: CA2Y\\nLower respiratory tract disease unspecified: CA2Z\\nPneumonia: CA40\\nBacterial pneumonia: CA40.0\\nPneumonia due to Chlamydophila pneumoniae: CA40.00\\nPneumonia due to Escherichia coli: CA40.01\\nPneumonia due to Haemophilus influenzae: CA40.02\\nPneumonia due to Klebsiella pneumoniae: CA40.03\\nPneumonia due to Mycoplasma pneumoniae: CA40.04\\nPneumonia due to Pseudomonas aeruginosa: CA40.05\\nPneumonia due to Staphylococcus: CA40.06\\nPneumonia due to Streptococcus pneumoniae: CA40.07\\nPneumonia due to betahaemolytic streptococcus: CA40.08\\nPneumonia due to other specified bacteria: CA40.0Y\\nBacterial pneumonia unspecified: CA40.0Z\\nViral pneumonia: CA40.1\\nPneumonia due to Adenovirus: CA40.10\\nPneumonia due to Respiratory syncytial virus: CA40.11\\nPneumonia due to parainfluenza virus: CA40.12\\nPneumonia due to Human metapneumovirus: CA40.13\\nPneumonia due to other specified virus: CA40.1Y\\nViral pneumonia unspecified: CA40.1Z\\nFungal pneumonia: CA40.2\\nPneumonia due to pneumocystis: CA40.20\\nOther specified fungal pneumonia: CA40.2Y\\nFungal pneumonia unspecified: CA40.2Z\\nOther specified pneumonia: CA40.Y\\nPneumonia organism unspecified: CA40.Z\\nAcute bronchiolitis: CA41\\nAcute bronchiolitis due to respiratory syncytial virus: CA41.0\\nOther specified acute bronchiolitis: CA41.Y\\nAcute bronchiolitis unspecified: CA41.Z\\nAcute bronchitis: CA42\\nAcute bronchitis due to Streptococcus: CA42.0\\nAcute bronchitis due to Rhinovirus: CA42.1\\nAcute bronchitis due to Respiratory syncytial virus: CA42.2\\nAcute bronchitis due to Parainfluenza virus: CA42.3\\nAcute bronchitis due to Haemophilus influenzae: CA42.4\\nAcute bronchitis due to Coxsackievirus: CA42.5\\nOther specified acute bronchitis: CA42.Y\\nAcute bronchitis unspecified: CA42.Z\\nAbscess of lung or mediastinum: CA43\\nGangrene or necrosis of lung: CA43.0\\nAbscess of lung with pneumonia: CA43.1\\nAbscess of lung without pneumonia: CA43.2\\nAbscess of mediastinum: CA43.3\\nOther specified abscess of lung or mediastinum: CA43.Y\\nAbscess of lung or mediastinum unspecified: CA43.Z\\nPyothorax: CA44\\nRespiratory infections not elsewhere classified: CA45\\nOther specified lung infections: CA4Y\\nLung infections unspecified: CA4Z\\nPneumoconiosis: CA60\\nPneumoconiosis due to dust containing silica: CA60.0\\nPneumoconiosis due to talc dust: CA60.00\\nOther specified pneumoconiosis due to dust containing silica: CA60.0Y\\nPneumoconiosis due to dust containing silica unspecified: CA60.0Z\\nCoal worker pneumoconiosis: CA60.1\\nPneumoconiosis due to mineral fibres including asbestos: CA60.2\\nPneumoconiosis associated with tuberculosis: CA60.3\\nAluminosis of lung: CA60.4\\nBauxite fibrosis of lung: CA60.5\\nBerylliosis: CA60.6\\nGraphite fibrosis of lung: CA60.7\\nSiderosis: CA60.8\\nStannosis: CA60.9\\nOther specified pneumoconiosis: CA60.Y\\nPneumoconiosis unspecified: CA60.Z\\nHypersensitivity pneumonitis due to organic dust: CA70\\nFarmer lung: CA70.0\\nBagassosis: CA70.1\\nBird fancier lung: CA70.2\\nSuberosis: CA70.3\\nMalt worker lung: CA70.4\\nMushroom worker lung: CA70.5\\nMaple bark stripper lung: CA70.6\\nAir conditioner or humidifier lung: CA70.7\\nOther specified hypersensitivity pneumonitis due to organic dust: CA70.Y\\nHypersensitivity pneumonitis due to organic dust unspecified: CA70.Z\\nPneumonitis due to solids or liquids: CA71\\nPneumonitis due to inhalation of food or vomit: CA71.0\\nPneumonitis due to oils or essences: CA71.1\\nPneumonitis due to aspiration of blood: CA71.2\\nLipoid pneumonitis: CA71.3\\nOther specified pneumonitis due to solids or liquids: CA71.Y\\nPneumonitis due to solids or liquids unspecified: CA71.Z\\nMendelson syndrome: CA72\\nOther specified pneumonitis: CA7Y\\nPneumonitis unspecified: CA7Z\\nAirway disease due to specific organic dust: CA80\\nByssinosis due to exposure to cotton: CA80.0\\nByssinosis due to exposure to flax: CA80.1\\nByssinosis due to exposure to cannabis: CA80.2\\nOther specified airway disease due to specific organic dust: CA80.Y\\nAirway disease due to specific organic dust unspecified: CA80.Z\\nRespiratory conditions due to inhalation of chemicals gases fumes or vapours: CA81\\nBronchitis or pneumonitis due to chemicals gases fumes or vapours: CA81.0\\nPulmonary oedema due to chemicals gases fumes or vapours: CA81.1\\nUpper respiratory inflammation due to chemicals gases fumes or vapours not elsewhere classified: CA81.2\\nOther specified respiratory conditions due to inhalation of chemicals gases fumes or vapours: CA81.Y\\nRespiratory conditions due to inhalation of chemicals gases fumes or vapours unspecified: CA81.Z\\nRespiratory conditions due to other external agents: CA82\\nAcute pulmonary manifestations due to radiation: CA82.0\\nChronic or other pulmonary manifestations due to radiation: CA82.1\\nAcute druginduced interstitial lung disorders: CA82.2\\nChronic druginduced interstitial lung disorders: CA82.3\\nAspergillusinduced allergic or hypersensitivity conditions: CA82.4\\nOther specified respiratory conditions due to other external agents: CA82.Y\\nRespiratory conditions due to other external agents unspecified: CA82.Z\\nOther specified lung diseases due to external agents: CA8Y\\nLung diseases due to external agents unspecified: CA8Z\\nAcute respiratory distress syndrome: CB00\\nPulmonary oedema: CB01\\nPulmonary eosinophilia: CB02\\nAsthmatic pulmonary eosinophilia: CB02.0\\nIdiopathic eosinophilic pneumonitis: CB02.1\\nIdiopathic acute eosinophilic pneumonitis: CB02.10\\nIdiopathic chronic eosinophilic pneumonitis: CB02.11\\nOther specified idiopathic eosinophilic pneumonitis: CB02.1Y\\nIdiopathic eosinophilic pneumonitis unspecified: CB02.1Z\\nTropical pulmonary eosinophilia: CB02.2\\nOther specified pulmonary eosinophilia: CB02.Y\\nPulmonary eosinophilia unspecified: CB02.Z\\nIdiopathic interstitial pneumonitis: CB03\\nAcute interstitial pneumonitis: CB03.0\\nCombined pulmonary fibrosis and emphysema syndrome: CB03.1\\nCryptogenic organizing pneumonitis: CB03.2\\nDesquamative interstitial pneumonitis: CB03.3\\nIdiopathic pulmonary fibrosis: CB03.4\\nLymphoid interstitial pneumonia: CB03.5\\nRespiratory bronchiolitis interstitial lung disease: CB03.6\\nOther specified idiopathic interstitial pneumonitis: CB03.Y\\nIdiopathic interstitial pneumonitis unspecified: CB03.Z\\nPrimary interstitial lung diseases specific to infancy or childhood: CB04\\nDiffuse pulmonary developmental disorders: CB04.0\\nPulmonary lymphatic dysplasia syndromes: CB04.1\\nDisorders of surfactant metabolism: CB04.2\\nAlveolar or perialveolar conditions: CB04.3\\nIdiopathic pulmonary haemosiderosis: CB04.30\\nPulmonary alveolar proteinosis: CB04.31\\nOther specified alveolar or perialveolar conditions: CB04.3Y\\nAlveolar or perialveolar conditions unspecified: CB04.3Z\\nPulmonary capillaritis: CB04.4\\nBrainlungthyroid syndrome: CB04.5\\nChronic pneumonitis of infancy: CB04.6\\nNeuroendocrine cell hyperplasia of infancy: CB04.7\\nOther specified primary interstitial lung diseases specific to infancy or childhood: CB04.Y\\nPrimary interstitial lung diseases specific to infancy or childhood unspecified: CB04.Z\\nInterstitial lung diseases associated with systemic diseases: CB05\\nDiffuse alveolar damage: CB05.0\\nInterstitial lung diseases associated with connective tissue diseases: CB05.1\\nInterstitial lung diseases associated with granulomatous diseases: CB05.2\\nInterstitial lung diseases associated with metabolic diseases: CB05.3\\nInterstitial lung diseases associated with systemic vasculitides: CB05.4\\nRespiratory disorders in ChurgStrauss syndrome: CB05.40\\nRespiratory disorders in microscopic polyangiitis: CB05.41\\nOther specified interstitial lung diseases associated with systemic vasculitides: CB05.4Y\\nInterstitial lung diseases associated with systemic vasculitides unspecified: CB05.4Z\\nSecondary pulmonary haemosiderosis: CB05.5\\nOther specified interstitial lung diseases associated with systemic diseases: CB05.Y\\nInterstitial lung diseases associated with systemic diseases unspecified: CB05.Z\\nPulmonary alveolar microlithiasis: CB06\\nLymphangioleiomyomatosis: CB07\\nLymphangioleiomyomatosis associated with tuberous sclerosis complex: CB07.0\\nSporadic lymphangioleiomyomatosis: CB07.1\\nOther specified lymphangioleiomyomatosis: CB07.Y\\nLymphangioleiomyomatosis unspecified: CB07.Z\\nOther specified respiratory diseases principally affecting the lung interstitium: CB0Y\\nRespiratory diseases principally affecting the lung interstitium unspecified: CB0Z\\nPleural plaque: CB20\\nPneumothorax: CB21\\nSpontaneous tension pneumothorax: CB21.0\\nOther spontaneous pneumothorax: CB21.1\\nOther specified pneumothorax: CB21.Y\\nPneumothorax unspecified: CB21.Z\\nDiseases of mediastinum not elsewhere classified: CB22\\nFibrosing mediastinitis: CB22.0\\nOther specified diseases of mediastinum not elsewhere classified: CB22.Y\\nDisease of mediastinum unspecified: CB22.Z\\nDisorders of diaphragm: CB23\\nChylous effusion: CB24\\nFibrothorax: CB25\\nHaemothorax: CB26\\nPleural effusion: CB27\\nOther specified pleural diaphragm or mediastinal disorders: CB2Y\\nPleural diaphragm or mediastinal disorders unspecified: CB2Z\\nCertain diseases of the respiratory system: CB40\\nCiliary dyskinesia: CB40.0\\nYoung syndrome: CB40.1\\nPulmonary collapse: CB40.2\\nInterstitial emphysema: CB40.3\\nCompensatory emphysema: CB40.4\\nOther specified diseases of the respiratory system: CB40.Y\\nRespiratory failure: CB41\\nAcute respiratory failure: CB41.0\\nAcute respiratory failure Type I: CB41.00\\nAcute respiratory failure Type II: CB41.01\\nAcute respiratory failure unspecified: CB41.0Z\\nChronic respiratory failure: CB41.1\\nChronic respiratory failure Type I: CB41.10\\nChronic respiratory failure Type II: CB41.11\\nChronic respiratory failure unspecified: CB41.1Z\\nRespiratory failure unspecified as acute or chronic: CB41.2\\nRespiratory failure unspecified Type I: CB41.20\\nRespiratory failure unspecified Type II: CB41.21\\nRespiratory failure unspecified: CB41.2Z\\nTracheostomy malfunction: CB60\\nChronic pulmonary insufficiency following surgery: CB61\\nPostprocedural subglottic stenosis: CB62\\nPostprocedural stenosis of the trachea: CB63\\nTransfusion related acute lung injury: CB64\\nDiseases of the respiratory system unspecified: CB7Z\\nDisorders of lips: DA00\\nCheilitis: DA00.0\\nSelfinduced lip trauma: DA00.1\\nPigmentary abnormalities of lips: DA00.2\\nLip fissure: DA00.3\\nOther specified disorders of lips: DA00.Y\\nDisorder of lips unspecified: DA00.Z\\nDisorders of oral mucosa: DA01\\nDisturbances of oral epithelium: DA01.0\\nOral leukoplakia: DA01.00\\nHairy leukoplakia: DA01.01\\nWandering rash of the mouth: DA01.02\\nOther specified disturbances of oral epithelium: DA01.0Y\\nDisturbances of oral epithelium unspecified: DA01.0Z\\nNoninfectious erosive or ulcerative disorders of oral mucosa: DA01.1\\nOral aphthae or aphthalike ulceration: DA01.10\\nOral mucositis: DA01.11\\nChronic ulcerative stomatitis: DA01.12\\nErythema multiforme with oral ulceration: DA01.13\\nDruginduced oral ulcer: DA01.14\\nMouth ulcers: DA01.15\\nOther specified noninfectious erosive or ulcerative disorders of oral mucosa: DA01.1Y\\nNoninfectious erosive or ulcerative disorders of oral mucosa unspecified: DA01.1Z\\nGranuloma or granulomalike lesions of oral mucosa: DA01.2\\nGiant cell granuloma central: DA01.20\\nOrofacial granulomatosis: DA01.21\\nOther specified granuloma or granulomalike lesions of oral mucosa: DA01.2Y\\nGranuloma or granulomalike lesions of oral mucosa unspecified: DA01.2Z\\nInfections of lips or oral mucosa: DA01.3\\nCellulitis or abscess of soft tissues of the mouth: DA01.30\\nOther specified infections of lips or oral mucosa: DA01.3Y\\nInfections of lips or oral mucosa unspecified: DA01.3Z\\nIrritative hyperplasia of oral mucosa: DA01.4\\nPapillary hyperplasia of oral mucosa: DA01.40\\nDenture hyperplasia: DA01.41\\nOral fibroepithelial polyp: DA01.42\\nIrritative hyperplasia of oral mucosa unspecified: DA01.4Z\\nOther specified disorders of oral mucosa: DA01.Y\\nDisorder of oral mucosa unspecified: DA01.Z\\nMiscellaneous specified disorders of lips or oral mucosa: DA02\\nGenetic or developmental disorders involving lips or oral mucosa: DA02.0\\nXerostomia: DA02.1\\nOral submucous fibrosis: DA02.2\\nContact gingivostomatitis: DA02.3\\nAllergic contact gingivostomatitis: DA02.30\\nIrritant contact gingivostomatitis: DA02.31\\nDiseases of tongue: DA03\\nGlossitis: DA03.0\\nGeographic tongue: DA03.1\\nAtrophy of tongue papillae: DA03.2\\nMedian rhomboid glossitis: DA03.3\\nHypertrophy of tongue papillae: DA03.4\\nMacroglossia: DA03.5\\nOther specified diseases of tongue: DA03.Y\\nDiseases of tongue unspecified: DA03.Z\\nDiseases of salivary glands: DA04\\nAtrophy of salivary gland: DA04.0\\nHypertrophy of salivary gland: DA04.1\\nSialoadenitis: DA04.2\\nAbscess of salivary gland: DA04.3\\nSialolithiasis: DA04.4\\nMucocele of salivary gland: DA04.5\\nDisturbances of salivary secretion: DA04.6\\nSialophagia: DA04.7\\nSialoschesis: DA04.8\\nOther specified diseases of salivary glands: DA04.Y\\nDiseases of salivary glands unspecified: DA04.Z\\nCysts of oral or facialneck region: DA05\\nDevelopmental odontogenic cysts: DA05.0\\nDevelopmental nonodontogenic cysts of oral region: DA05.1\\nOther specified cysts of oral or facialneck region: DA05.Y\\nCysts of oral or facialneck region unspecified: DA05.Z\\nDiseases of jaws: DA06\\nInflammatory conditions of jaws: DA06.0\\nAlveolitis of jaw: DA06.1\\nExostosis of jaw: DA06.2\\nStafne mandibular bone cavity: DA06.3\\nOther specified diseases of jaws: DA06.Y\\nDiseases of jaws unspecified: DA06.Z\\nDisorders of tooth development or eruption: DA07\\nFluoride related opacities or lesions: DA07.0\\nNonfluoride enamel opacities: DA07.1\\nDisturbances in tooth formation: DA07.3\\nRoot anomaly: DA07.4\\nCementum dysplasia: DA07.5\\nDisturbances in tooth eruption: DA07.6\\nTeething syndrome: DA07.60\\nAnkylosis of teeth: DA07.61\\nOther specified disturbances in tooth eruption: DA07.6Y\\nDisturbances in tooth eruption unspecified: DA07.6Z\\nEmbedded teeth: DA07.7\\nImpacted teeth: DA07.8\\nOther specified disorders of tooth development or eruption: DA07.Y\\nDisorders of tooth development or eruption unspecified: DA07.Z\\nDiseases of hard tissues of teeth: DA08\\nDental caries: DA08.0\\nCertain specified diseases of hard tissues of teeth: DA08.1\\nExcessive attrition of teeth: DA08.10\\nAbrasion of teeth: DA08.11\\nErosion of teeth: DA08.12\\nAbfraction: DA08.13\\nPathological resorption of teeth: DA08.14\\nPosteruptive colour changes of dental hard tissues: DA08.15\\nChronic dental injuries: DA08.2\\nNontraumatic fracture of tooth: DA08.3\\nDeposits on teeth: DA08.4\\nOther specified diseases of hard tissues of teeth: DA08.Y\\nDiseases of hard tissues of teeth unspecified: DA08.Z\\nDiseases of pulp or periapical tissues: DA09\\nPulpitis: DA09.0\\nNecrosis of pulp: DA09.1\\nPulp abscess: DA09.2\\nPhoenix abscess: DA09.3\\nPulp degeneration: DA09.4\\nAbnormal hard tissue formation in pulp: DA09.5\\nPeriapical abscess: DA09.6\\nPeriapical abscess with facial involvement: DA09.60\\nPeriapical abscess with sinus: DA09.61\\nPeriapical abscess without sinus: DA09.62\\nOther specified periapical abscess: DA09.6Y\\nPeriapical abscess unspecified: DA09.6Z\\nPeriapical periodontitis: DA09.7\\nAcute apical periodontitis of pulpal origin: DA09.70\\nChronic apical periodontitis: DA09.71\\nOther specified periapical periodontitis: DA09.7Y\\nPeriapical periodontitis unspecified: DA09.7Z\\nRadicular cyst: DA09.8\\nOther specified diseases of pulp or periapical tissues: DA09.Y\\nDiseases of pulp or periapical tissues unspecified: DA09.Z\\nCertain specified disorders of teeth or supporting structures: DA0A\\nExfoliation of teeth due to systemic causes: DA0A.0\\nLoss of teeth due to accident extraction or local periodontal disease: DA0A.1\\nAtrophy of edentulous alveolar ridge: DA0A.2\\nRetained dental root: DA0A.3\\nOther specified disorders of teeth and supporting structures: DA0A.Y\\nUnspecified disorders of teeth and supporting structures: DA0A.Z\\nGingival diseases: DA0B\\nAllergic gingivitis: DA0B.0\\nCatarrhal gingivitis: DA0B.1\\nEruptive gingivitis: DA0B.2\\nAtrophic senile gingivitis: DA0B.3\\nAcute multiple gingival abscesses: DA0B.4\\nDevelopmental or acquired deformities or conditions of gingiva: DA0B.5\\nPericoronitis: DA0B.6\\nOther specified gingival diseases: DA0B.Y\\nGingival diseases unspecified: DA0B.Z\\nPeriodontal disease: DA0C\\nAcute periodontitis: DA0C.0\\nAggressive periodontitis: DA0C.1\\nPeriodontosis: DA0C.2\\nNecrotising periodontal diseases: DA0C.3\\nNecrotising ulcerative periodontitis: DA0C.30\\nNoma: DA0C.31\\nOther specified necrotising periodontal diseases: DA0C.3Y\\nNecrotising periodontal diseases unspecified: DA0C.3Z\\nAbscess of periodontium: DA0C.4\\nLinear gingival erythema: DA0C.5\\nOther specified periodontal disease: DA0C.Y\\nPeriodontal disease unspecified: DA0C.Z\\nCertain specified disorders of gingiva or edentulous alveolar ridge: DA0D\\nGingival recession: DA0D.0\\nGingival enlargement: DA0D.1\\nGingival or edentulous alveolar ridge lesions associated with trauma: DA0D.2\\nHypoplasminogenaemia: DA0D.3\\nCottonroll gingivitis: DA0D.4\\nGingival ulceration: DA0D.5\\nOther specified disorders of gingival or edentulous alveolar ridge: DA0D.Y\\nDentofacial anomalies: DA0E\\nMajor anomalies of jaw size: DA0E.0\\nMicrognathia: DA0E.00\\nOther specified major anomalies of jaw size: DA0E.0Y\\nMajor anomalies of jaw size unspecified: DA0E.0Z\\nAnomalies of jawcranial base relationship: DA0E.1\\nAnomalies of dental arch relationship: DA0E.2\\nAnomalies of tooth position: DA0E.3\\nFood impaction: DA0E.4\\nMalocclusion: DA0E.5\\nClass II division  malocclusion: DA0E.50\\nAngle class I malocclusion: DA0E.51\\nOther specified malocclusion: DA0E.5Y\\nMalocclusion unspecified: DA0E.5Z\\nDentofacial functional abnormalities: DA0E.6\\nDentofacial parafunctional disorders: DA0E.7\\nTemporomandibular joint disorders: DA0E.8\\nOther specified dentofacial anomalies: DA0E.Y\\nDentofacial anomalies unspecified: DA0E.Z\\nSensory disturbances affecting orofacial complex: DA0F\\nBurning mouth syndrome: DA0F.0\\nOther specified sensory disturbances affecting orofacial complex: DA0F.Y\\nSensory disturbances affecting orofacial complex unspecified: DA0F.Z\\nOther specified diseases or disorders of orofacial complex: DA0Y\\nDiseases or disorders of orofacial complex unspecified: DA0Z\\nAcquired anatomical alterations of the oesophagus: DA20\\nOesophageal obstruction: DA20.0\\nDiverticulum of oesophagus acquired: DA20.1\\nOesophageal web: DA20.2\\nPerforation of oesophagus: DA20.3\\nSpontaneous rupture of oesophagus: DA20.30\\nOther specified perforation of oesophagus: DA20.3Y\\nPerforation of oesophagus unspecified: DA20.3Z\\nOther specified acquired anatomical alterations of the oesophagus: DA20.Y\\nAcquired anatomical alterations of the oesophagus unspecified: DA20.Z\\nMotility disorders of oesophagus: DA21\\nAchalasia: DA21.0\\nMotility disorder of cervical or upper oesophagus: DA21.1\\nDisorder of oesophageal peristalsis: DA21.2\\nHypertensive peristalsis: DA21.20\\nHypotensive peristalsis: DA21.21\\nSpastic peristalsis: DA21.22\\nOther specified disorder of oesophageal peristalsis: DA21.2Y\\nDisorder of oesophageal peristalsis unspecified: DA21.2Z\\nDisorder of lower oesophageal sphincter function: DA21.3\\nOther specified motility disorders of oesophagus: DA21.Y\\nMotility disorders of oesophagus unspecified: DA21.Z\\nGastrooesophageal reflux disease: DA22\\nNonerosive gastrooesophageal reflux disease: DA22.0\\nErosive gastrooesophageal reflux disease: DA22.1\\nGastrooesophageal reflux disease unspecified: DA22.Z\\nColumnar metaplastic epithelium of the oesophagus: DA23\\nBarrett epithelium: DA23.0\\nDysplasia of Barrett epithelium: DA23.1\\nBarrett ulcer: DA23.2\\nOther specified columnar metaplastic epithelium of the oesophagus: DA23.Y\\nColumnar metaplastic epithelium of the oesophagus unspecified: DA23.Z\\nOesophagitis: DA24\\nInfectious oesophagitis: DA24.0\\nOesophageal phlegmon: DA24.00\\nOther specified infectious oesophagitis: DA24.0Y\\nInfectious oesophagitis unspecified: DA24.0Z\\nEosinophilic oesophagitis: DA24.1\\nOesophagitis due to external causes: DA24.2\\nChemical oesophagitis: DA24.20\\nDruginduced oesophagitis: DA24.21\\nRadiation oesophagitis: DA24.22\\nOesophagitis due to external causes unspecified: DA24.2Z\\nOther specified oesophagitis: DA24.Y\\nOesophagitis unspecified: DA24.Z\\nOesophageal ulcer: DA25\\nOesophageal erosion: DA25.0\\nInfectious oesophageal ulcer: DA25.1\\nBacterial oesophageal ulcer: DA25.10\\nFungal oesophageal ulcer: DA25.11\\nParasitic oesophageal ulcer: DA25.12\\nViral oesophageal ulcer: DA25.13\\nOther specified infectious oesophageal ulcer: DA25.1Y\\nInfectious oesophageal ulcer unspecified: DA25.1Z\\nOesophageal ulcer due to allergic or immunologic disorder: DA25.2\\nOesophageal ulcer due to external causes: DA25.3\\nChemical oesophageal ulcer: DA25.30\\nDruginduced oesophageal ulcer: DA25.31\\nRadiation oesophageal ulcer: DA25.32\\nOesophageal ulcer due to other specified external causes: DA25.3Y\\nOesophageal ulcer due to external causes unspecified: DA25.3Z\\nOther specified oesophageal ulcer: DA25.Y\\nOesophageal ulcer unspecified: DA25.Z\\nVascular disorders of the oesophagus: DA26\\nOesophageal varices: DA26.0\\nOesophageal varices with bleeding: DA26.00\\nOesophageal varices without bleeding: DA26.01\\nOesophageal varices unspecified: DA26.0Z\\nAngiodysplasia or arteriovenous malformation of oesophagus: DA26.1\\nIntramural haemorrhage of oesophagus: DA26.2\\nGastrooesophageal lacerationhaemorrhage syndrome: DA26.3\\nOther specified vascular disorders of the oesophagus: DA26.Y\\nVascular disorders of the oesophagus unspecified: DA26.Z\\nOther specified diseases of oesophagus: DA2Y\\nDiseases of oesophagus unspecified: DA2Z\\nAcquired anatomical alterations of the stomach: DA40\\nGastric outlet obstruction: DA40.0\\nGastric fistula acquired: DA40.1\\nGastric volvulus: DA40.2\\nGastric diverticulum: DA40.3\\nHourglass stricture and stenosis of stomach: DA40.4\\nGastroptosis: DA40.5\\nOther specified acquired anatomical alterations of the stomach: DA40.Y\\nAcquired anatomical alterations of the stomach unspecified: DA40.Z\\nGastroduodenal motor or secretory disorders: DA41\\nAbnormal gastric motility: DA41.0\\nGastroparesis: DA41.00\\nOther specified abnormal gastric motility: DA41.0Y\\nAbnormal gastric motility unspecified: DA41.0Z\\nAcute dilatation of stomach: DA41.1\\nAcid hypersecretion: DA41.2\\nAchlorhydria: DA41.3\\nOther specified gastroduodenal motor or secretory disorders: DA41.Y\\nGastroduodenal motor or secretory disorders unspecified: DA41.Z\\nGastritis: DA42\\nAutoimmune gastritis: DA42.0\\nHelicobacter pylori induced gastritis: DA42.1\\nEosinophilic gastritis: DA42.2\\nLymphocytic gastritis: DA42.3\\nAllergic gastritis: DA42.4\\nAllergic gastritis due to IgEmediated hypersensitivity: DA42.40\\nAllergic gastritis due to nonIgEmediated hypersensitivity: DA42.41\\nOther specified allergic gastritis: DA42.4Y\\nAllergic gastritis unspecified: DA42.4Z\\nGastritis due to duodenogastric reflux: DA42.5\\nMenetrier disease: DA42.6\\nGastritis of unknown aetiology with specific endoscopic or pathological features: DA42.7\\nAcute superficial gastritis of unknown aetiology: DA42.70\\nChronic superficial gastritis of unknown aetiology: DA42.71\\nAcute haemorrhagic gastritis of unknown aetiology: DA42.72\\nChronic atrophic gastritis of unknown aetiology: DA42.73\\nMetaplastic gastritis of unknown aetiology: DA42.74\\nGranulomatous gastritis of unknown aetiology: DA42.75\\nHypertrophic gastritis of unknown aetiology: DA42.76\\nOther specified gastritis of unknown aetiology with specific endoscopic or pathological features: DA42.7Y\\nGastritis due to external causes: DA42.8\\nAlcoholic gastritis: DA42.80\\nRadiation gastritis: DA42.81\\nChemical gastritis: DA42.82\\nDruginduced gastritis: DA42.83\\nGastritis due to external causes unspecified: DA42.8Z\\nGastric phlegmon: DA42.9\\nOther specified gastritis: DA42.Y\\nGastritis unspecified: DA42.Z\\nVascular disorders of the stomach: DA43\\nGastric varices: DA43.0\\nAngiodysplasia of stomach: DA43.1\\nArteriovenous malformation of stomach: DA43.2\\nPortal hypertensive gastropathy: DA43.3\\nDiffuse vascular ectasia of stomach: DA43.4\\nOther specified vascular disorders of the stomach: DA43.Y\\nVascular disorders of the stomach unspecified: DA43.Z\\nGastric polyp: DA44\\nHyperplastic polyp of stomach: DA44.0\\nFundic gland polyp of stomach: DA44.1\\nHamartomatous polyp of stomach: DA44.2\\nOther specified gastric polyp: DA44.Y\\nGastric polyp unspecified: DA44.Z\\nOther specified diseases of stomach: DA4Y\\nDiseases of stomach unspecified: DA4Z\\nAcquired anatomical alterations of the duodenum: DA50\\nObstruction of duodenum: DA50.0\\nDiverticulum of duodenum: DA50.1\\nFistula of duodenum: DA50.2\\nDeformity of duodenum acquired: DA50.3\\nOther specified acquired anatomical alterations of the duodenum: DA50.Y\\nAcquired anatomical alterations of the duodenum unspecified: DA50.Z\\nDuodenitis: DA51\\nHelicobacterpylori associated duodenitis: DA51.0\\nEosinophilic duodenitis: DA51.1\\nLymphocytic duodenitis: DA51.2\\nAllergic duodenitis: DA51.3\\nDuodenitis of unknown aetiology with specific endoscopic or pathologic features: DA51.4\\nAcute haemorrhagic duodenitis of unknown aetiology: DA51.40\\nGranulomatous duodenitis of unknown aetiology: DA51.41\\nDuodenitis of unknown aetiology with specific endoscopic or pathologic features unspecified: DA51.4Z\\nDuodenitis due to external causes: DA51.5\\nAlcoholic duodenitis: DA51.50\\nDruginduced duodenitis: DA51.51\\nChemical duodenitis: DA51.52\\nRadiation duodenitis: DA51.53\\nDuodenitis due to other specified external causes: DA51.5Y\\nDuodenitis due to external causes unspecified: DA51.5Z\\nInfectious duodenitis: DA51.6\\nDuodenal phlegmon: DA51.60\\nOther specified infectious duodenitis: DA51.6Y\\nInfectious duodenitis unspecified: DA51.6Z\\nOther specified duodenitis: DA51.Y\\nDuodenitis unspecified: DA51.Z\\nVascular disorders of the duodenum: DA52\\nDuodenal varices: DA52.0\\nAngiodysplasia of duodenum: DA52.1\\nArteriovenous malformation of duodenum: DA52.2\\nOther specified vascular disorders of the duodenum: DA52.Y\\nVascular disorders of the duodenum unspecified: DA52.Z\\nDuodenal polyp: DA53\\nHyperplastic duodenal polyp: DA53.0\\nOther specified duodenal polyp: DA53.Y\\nDuodenal polyp unspecified: DA53.Z\\nOther specified diseases of duodenum: DA5Y\\nDiseases of duodenum unspecified: DA5Z\\nGastric ulcer: DA60\\nGastric erosion: DA60.0\\nHelicobacter pylori associated gastric ulcer: DA60.1\\nHelicobacter pylori associated and druginduced gastric ulcer: DA60.2\\nStress ulcer of stomach: DA60.3\\nEosinophilic gastric ulcer: DA60.4\\nLymphocytic gastric ulcer: DA60.5\\nGastric ulcer due to external causes: DA60.6\\nAlcoholinduced gastric ulcer: DA60.60\\nChemical gastric ulcer: DA60.61\\nDruginduced gastric ulcer: DA60.62\\nRadiation gastric ulcer: DA60.63\\nOther specified gastric ulcer due to external causes: DA60.6Y\\nGastric ulcer due to external causes unspecified: DA60.6Z\\nInfectious secondary gastric ulcer: DA60.7\\nOther specified gastric ulcer: DA60.Y\\nGastric ulcer unspecified: DA60.Z\\nPeptic ulcer site unspecified: DA61\\nAnastomotic ulcer: DA62\\nAnastomotic erosion: DA62.0\\nHelicobacter pylori associated anastomotic ulcer: DA62.1\\nDruginduced anastomotic ulcer: DA62.2\\nPeptic anastomotic ulcer: DA62.3\\nOther specified anastomotic ulcer: DA62.Y\\nAnastomotic ulcer unspecified: DA62.Z\\nDuodenal ulcer: DA63\\nDuodenal erosion: DA63.0\\nHelicobacterpylori associated duodenal ulcer: DA63.1\\nHelicobacterpylori associated and druginduced duodenal ulcer: DA63.2\\nStress ulcer of duodenum: DA63.3\\nEosinophilic duodenal ulcer: DA63.4\\nDuodenal ulcer due to external causes: DA63.5\\nDruginduced duodenal ulcer: DA63.50\\nRadiation duodenal ulcer: DA63.51\\nChemical duodenal ulcer: DA63.52\\nDuodenal ulcer due to other specified external causes: DA63.5Y\\nDuodenal ulcer due to external causes unspecified: DA63.5Z\\nInfectious duodenal ulcer: DA63.6\\nBacterial duodenal ulcer: DA63.60\\nViral duodenal ulcer: DA63.61\\nFungal duodenal ulcer: DA63.62\\nParasitic duodenal ulcer: DA63.63\\nInfectious duodenal ulcer unspecified: DA63.6Z\\nOther specified duodenal ulcer: DA63.Y\\nDuodenal ulcer unspecified: DA63.Z\\nDiseases of the stomach or the duodenum unspecified: DA7Z\\nNonstructural developmental anomalies of small intestine: DA90\\nSyndromic diarrhoea: DA90.0\\nCongenital intestinal transport defect: DA90.1\\nCongenital intestinal motility disorders: DA90.2\\nOther specified nonstructural developmental anomalies of small intestine: DA90.Y\\nNonstructural developmental anomalies of small intestine unspecified: DA90.Z\\nObstruction of small intestine: DA91\\nIntussusception of small intestine: DA91.0\\nVolvulus of small intestine: DA91.1\\nIntestinal adhesions or bands of small intestine with obstruction: DA91.2\\nObstructive ileus of small intestine due to impaction: DA91.3\\nGallstone ileus of small intestine: DA91.30\\nEnterolith of small intestine: DA91.31\\nOther specified obstructive ileus of small intestine due to impaction: DA91.3Y\\nObstructive ileus of small intestine due to impaction unspecified: DA91.3Z\\nOther specified obstruction of small intestine: DA91.Y\\nObstruction of small intestine unspecified: DA91.Z\\nOther acquired anatomical alterations of small intestine: DA92\\nFistula of small intestine: DA92.0\\nPneumatosis intestinalis of small intestine: DA92.1\\nOther specified acquired anatomical alterations of small intestine: DA92.Y\\nAcquired anatomical alterations of small intestine unspecified: DA92.Z\\nMotility disorders of small intestine: DA93\\nParalytic ileus: DA93.0\\nOther specified motility disorders of small intestine: DA93.Y\\nMotility disorders of small intestine unspecified: DA93.Z\\nNoninfectious enteritis or ulcer of small intestine: DA94\\nPrimary ulcer of small intestine: DA94.0\\nPrimary nonspecific ulceration of small intestine: DA94.00\\nChronic nonspecific multiple ulcers of small intestine: DA94.01\\nCryptogenic multifocal ulcerous stenosing enteritis: DA94.02\\nOther specified primary ulcer of small intestine: DA94.0Y\\nPrimary ulcer of small intestine unspecified: DA94.0Z\\nDruginduced or toxic enteritis of small intestine: DA94.1\\nAllergic or dietetic enteritis of small intestine: DA94.2\\nIgE mediated allergic enteritis of small intestine: DA94.20\\nEosinophilic enteritis: DA94.21\\nFood proteininduced enterocolitis syndrome: DA94.22\\nOther specified allergic or dietetic enteritis of small intestine: DA94.2Y\\nAllergic or dietetic enteritis of small intestine unspecified: DA94.2Z\\nEnteritis or ulcer of small intestine due to other external causes: DA94.3\\nEnteritis or ulcer of small intestine due to foreign body: DA94.30\\nEnteritis or ulcer of small intestine due to radiation: DA94.31\\nEnteritis or ulcer of small intestine due to trauma: DA94.32\\nEnteritis or ulcer of small intestine due to other external causes unspecified: DA94.3Z\\nOther specified noninfectious enteritis or ulcer of small intestine: DA94.Y\\nNoninfectious enteritis or ulcer of small intestine unspecified: DA94.Z\\nCoeliac disease: DA95\\nIntestinal malabsorption or proteinlosing enteropathy: DA96\\nIntestinal malabsorption: DA96.0\\nBacterial overgrowth syndrome: DA96.00\\nTropical sprue: DA96.01\\nMalabsorption or intolerance of specific nutrients: DA96.02\\nShort bowel syndrome: DA96.04\\nIntestinal failure: DA96.05\\nOther specified intestinal malabsorption: DA96.0Y\\nIntestinal malabsorption unspecified: DA96.0Z\\nProteinlosing enteropathy: DA96.1\\nOther specified intestinal malabsorption or proteinlosing enteropathy: DA96.Y\\nIntestinal malabsorption or proteinlosing enteropathy unspecified: DA96.Z\\nCertain vascular disorders of small intestine: DA97\\nAngiodysplasia of small intestine: DA97.0\\nArteriovenous malformation of small intestine: DA97.1\\nVasculitis of mesenteric arteries: DA97.2\\nVarices of small intestine: DA97.3\\nCertain vascular disorders of small intestine unspecified: DA97.Z\\nPolyps of small intestine: DA98\\nHamartoma of small intestine: DA98.0\\nHyperplastic polyp of small intestine: DA98.1\\nInflammatory fibroid polyp of small intestine: DA98.2\\nLymphoid hyperplasia of small intestine: DA98.3\\nOther specified polyps of small intestine: DA98.Y\\nPolyps of small intestine unspecified: DA98.Z\\nOther specified diseases of small intestine: DA9Y\\nDiseases of small intestine unspecified: DA9Z\\nAppendicitis: DB10\\nAcute appendicitis: DB10.0\\nAcute appendicitis with generalised peritonitis: DB10.00\\nAcute appendicitis with localised peritonitis: DB10.01\\nAcute appendicitis without localised or generalised peritonitis: DB10.02\\nChronic appendicitis: DB10.1\\nOther specified appendicitis: DB10.Y\\nAppendicitis unspecified: DB10.Z\\nCertain specified diseases of appendix: DB11\\nMegaloappendix: DB11.0\\nHyperplasia of appendix: DB11.1\\nAppendicular concretions: DB11.2\\nDiverticulum of appendix acquired: DB11.3\\nFistula of appendix: DB11.4\\nIntussusception of appendix: DB11.5\\nMucocele of appendix: DB11.6\\nOther specified diseases of appendix: DB1Y\\nDiseases of appendix unspecified: DB1Z\\nObstruction of large intestine: DB30\\nIntussusception of the large intestine: DB30.0\\nVolvulus of large intestine: DB30.1\\nAdhesions of large intestine with obstruction: DB30.2\\nImpaction of large intestine: DB30.3\\nStenosis of the rectum: DB30.4\\nOther specified obstruction of large intestine: DB30.Y\\nObstruction of large intestine unspecified: DB30.Z\\nOther acquired anatomical alterations of large intestine: DB31\\nFistula of large intestine: DB31.0\\nPneumatosis intestinalis of large intestine: DB31.1\\nRectal prolapse: DB31.2\\nOther specified acquired anatomical alterations of large intestine: DB31.Y\\nAcquired anatomical alterations of large intestine unspecified: DB31.Z\\nMotility disorders of large intestine: DB32\\nPseudoobstruction of colon: DB32.0\\nSlow transit constipation: DB32.1\\nMegacolon: DB32.2\\nToxic megacolon: DB32.20\\nOther specified megacolon: DB32.2Y\\nMegacolon unspecified: DB32.2Z\\nAcquired hypoganglionosis of large intestine: DB32.3\\nOther specified motility disorders of large intestine: DB32.Y\\nMotility disorders of large intestine unspecified: DB32.Z\\nCertain noninfectious colitis or proctitis: DB33\\nPrimary ulcer of colon: DB33.0\\nMicroscopic colitis: DB33.1\\nCollagenous colitis: DB33.10\\nLymphocytic colitis: DB33.11\\nOther specified microscopic colitis: DB33.1Y\\nMicroscopic colitis unspecified: DB33.1Z\\nAllergic or dietetic colitis: DB33.2\\nFood proteininduced proctitis or colitis of infants: DB33.20\\nOther specified allergic or dietetic colitis: DB33.2Y\\nAllergic or dietetic colitis unspecified: DB33.2Z\\nDiversion colitis: DB33.3\\nColitis or proctitis due to external causes: DB33.4\\nChemical colitis or proctitis: DB33.40\\nRadiationinduced colitis: DB33.41\\nRadiation proctitis: DB33.42\\nDruginduced colitis: DB33.43\\nOther specified colitis or proctitis due to external causes: DB33.4Y\\nColitis or proctitis due to external causes unspecified: DB33.4Z\\nOther specified noninfectious colitis or proctitis: DB33.Y\\nNoninfectious colitis or proctitis unspecified: DB33.Z\\nCertain vascular disorders of large intestine: DB34\\nAngiodysplasia of colon: DB34.0\\nArteriovenous malformation of large intestine: DB34.1\\nVasculitis of large intestine: DB34.2\\nVarices of large intestine: DB34.3\\nAcute haemorrhagic rectal ulcer: DB34.4\\nOther specified vascular disorders of large intestine: DB34.Y\\nVascular disorders of large intestine unspecified: DB34.Z\\nPolyp of large intestine: DB35\\nHyperplastic polyp of large intestine: DB35.0\\nInflammatory polyp of large intestine: DB35.1\\nBenign lymphoid polyp of large intestine: DB35.2\\nHamartomatous polyp of large intestine: DB35.3\\nInflammatory fibroid polyp of large intestine: DB35.4\\nOther specified polyp of large intestine: DB35.Y\\nPolyp of large intestine unspecified: DB35.Z\\nCertain infections of the large intestine: DB36\\nColonic abscess: DB36.0\\nRectal abscess: DB36.1\\nPerirectal abscess: DB36.10\\nIschiorectal abscess: DB36.11\\nRectal cellulitis: DB36.12\\nOther specified infections of the large intestine: DB36.Y\\nInfections of the large intestine unspecified: DB36.Z\\nOther specified diseases of large intestine: DB3Y\\nDiseases of large intestine unspecified: DB3Z\\nFissure or fistula of anal regions: DB50\\nAnal fissure: DB50.0\\nAnal fistula: DB50.1\\nAnorectal fistula: DB50.2\\nOther specified fissure or fistula of anal regions: DB50.Y\\nFissure or fistula of anal regions unspecified: DB50.Z\\nStenosis of anal canal: DB51\\nUlcer of anus: DB52\\nAnal prolapse: DB53\\nOther specified acquired anatomical alterations of the anal canal: DB5Y\\nAcquired anatomical alterations of the anal canal unspecified: DB5Z\\nHaemorrhoids: DB60\\nFirst degree haemorrhoids: DB60.0\\nSecond degree haemorrhoids: DB60.1\\nThird degree haemorrhoids: DB60.2\\nFourth degree haemorrhoids: DB60.3\\nHaemorrhoids unspecified: DB60.Z\\nPerianal venous thrombosis: DB61\\nResidual haemorrhoidal skin tags: DB62\\nOther specified haemorrhoids or perianal venous conditions: DB6Y\\nHaemorrhoids or perianal venous conditions unspecified: DB6Z\\nInfections of the anal region: DB70\\nAbscess of anal region: DB70.0\\nAnal abscess: DB70.00\\nAnorectal abscess: DB70.01\\nIntrasphincteric abscess: DB70.02\\nOther specified abscess of anal region: DB70.0Y\\nAbscess of anal region unspecified: DB70.0Z\\nOther specified infections of the anal region: DB70.Y\\nInfections of the anal region unspecified: DB70.Z\\nAnal polyp: DB71\\nInflammatory anal polyp: DB71.0\\nLymphoid polyp: DB71.1\\nHypertrophied anal papillae: DB71.2\\nOther specified anal polyp: DB71.Y\\nAnal polyp unspecified: DB71.Z\\nCertain specified diseases of anal canal: DB72\\nAnal spasm: DB72.0\\nOther specified diseases of anal canal: DB7Y\\nDiseases of anal canal unspecified: DB7Z\\nInfectious liver disease: DB90\\nAbscess of liver: DB90.0\\nOther specified infectious liver disease: DB90.Y\\nInfectious liver disease unspecified: DB90.Z\\nAcute or subacute hepatic failure: DB91\\nAcute or subacute hepatic failure due to hepatitis virus: DB91.0\\nOther acute or subacute hepatic failure: DB91.1\\nAcute or subacute hepatic failure unspecified: DB91.Z\\nNonalcoholic fatty liver disease: DB92\\nNonalcoholic fatty liver disease without nonalcoholic steatohepatitis: DB92.0\\nNonalcoholic steatohepatitis: DB92.1\\nOther specified nonalcoholic fatty liver disease: DB92.Y\\nNonalcoholic fatty liver disease unspecified: DB92.Z\\nHepatic fibrosis or cirrhosis: DB93\\nHepatic fibrosis: DB93.0\\nHepatic cirrhosis: DB93.1\\nCertain specified fibrosis or cirrhosis of liver: DB93.2\\nHereditary North American Indian childhood cirrhosis: DB93.20\\nIdiopathic copperassociated cirrhosis: DB93.21\\nOther specified hepatic fibrosis or cirrhosis: DB93.Y\\nAlcoholic liver disease: DB94\\nAlcoholic fatty liver: DB94.0\\nAlcoholic hepatitis: DB94.1\\nAlcoholic hepatitis with cirrhosis: DB94.10\\nOther specified alcoholic hepatitis: DB94.1Y\\nAlcoholic hepatitis unspecified: DB94.1Z\\nAlcoholic liver fibrosis: DB94.2\\nAlcoholic cirrhosis of liver without hepatitis: DB94.3\\nOther specified alcoholic liver disease: DB94.Y\\nAlcoholic liver disease unspecified: DB94.Z\\nDruginduced or toxic liver disease: DB95\\nDruginduced or toxic liver disease with acute hepatic necrosis or acute hepatitis: DB95.0\\nDruginduced or toxic liver disease with chronic hepatitis: DB95.1\\nDruginduced or toxic liver disease with chronic hepatitis with cirrhosis: DB95.10\\nDruginduced or toxic liver disease with chronic hepatitis without cirrhosis: DB95.11\\nDruginduced or toxic liver disease with chronic hepatitis unspecified: DB95.1Z\\nDruginduced or toxic liver disease with cholestasis: DB95.2\\nChronic druginduced or toxic liver disease with cholestasis: DB95.20\\nOther specified druginduced or toxic liver disease with cholestasis: DB95.2Y\\nDruginduced or toxic liver disease with cholestasis unspecified: DB95.2Z\\nDruginduced or toxic liver disease with fatty liver: DB95.3\\nDruginduced or toxic liver disease with chronic fatty liver disease: DB95.30\\nOther specified druginduced or toxic liver disease with fatty liver: DB95.3Y\\nDruginduced or toxic liver disease with fatty liver unspecified: DB95.3Z\\nDruginduced or toxic liver disease with granulomatous hepatitis: DB95.4\\nDruginduced or toxic liver disease with fibrosis or cirrhosis of liver: DB95.5\\nDruginduced or toxic liver disease with vascular disorders of the liver: DB95.6\\nDruginduced or toxic liver disease with liver tumours: DB95.7\\nOther specified druginduced or toxic liver disease: DB95.Y\\nDruginduced or toxic liver disease unspecified: DB95.Z\\nAutoimmune liver disease: DB96\\nAutoimmune hepatitis: DB96.0\\nPrimary biliary cholangitis: DB96.1\\nPrimary biliary cholangitis with overlap syndrome: DB96.10\\nOther specified primary biliary cholangitis: DB96.1Y\\nPrimary biliary cholangitis unspecified: DB96.1Z\\nPrimary sclerosing cholangitis: DB96.2\\nPrimary sclerosing cholangitis with cirrhosis: DB96.20\\nOther specified primary sclerosing cholangitis: DB96.2Y\\nPrimary sclerosing cholangitis unspecified: DB96.2Z\\nOther specified autoimmune liver disease: DB96.Y\\nAutoimmune liver disease unspecified: DB96.Z\\nCertain specified inflammatory liver diseases: DB97\\nIdiopathic granulomatous hepatitis: DB97.0\\nHepatic berylliosis: DB97.1\\nChronic hepatitis not elsewhere classified: DB97.2\\nOther specified inflammatory liver disease: DB97.Y\\nInflammatory liver disease unspecified: DB97.Z\\nVascular disorders of the liver: DB98\\nInfarction of liver: DB98.0\\nPeliosis hepatis: DB98.1\\nNodular regenerative hyperplasia of liver: DB98.2\\nPortal vein thrombosis: DB98.3\\nSplenic vein thrombosis: DB98.4\\nBuddChiari syndrome: DB98.5\\nHepatic venoocclusive disease: DB98.6\\nPortal hypertension: DB98.7\\nIdiopathic portal hypertension: DB98.70\\nNoncirrhotic portal fibrosis: DB98.71\\nPartial nodular transformation of liver: DB98.72\\nSplanchnic arteriovenous fistula: DB98.73\\nSecondary portal hypertension: DB98.74\\nOther specified portal hypertension: DB98.7Y\\nPortal hypertension unspecified: DB98.7Z\\nPassive congestion of liver: DB98.8\\nHepatic artery aneurysm: DB98.9\\nHepatic haemorrhage: DB98.A\\nIschaemia reperfusion injury of liver: DB98.B\\nOther specified vascular disorders of the liver: DB98.Y\\nVascular disorders of the liver unspecified: DB98.Z\\nCertain specified diseases of liver: DB99\\nChronic liver disease: DB99.0\\nHepatic cyst: DB99.1\\nPolycystic liver disease: DB99.10\\nOther specified hepatic cyst: DB99.1Y\\nHepatic cyst unspecified: DB99.1Z\\nHepatorenal syndrome: DB99.2\\nPortopulmonary hypertension: DB99.3\\nHepatopulmonary syndrome: DB99.4\\nHepatic encephalopathy: DB99.5\\nIntrahepatic cholestasis not elsewhere classified: DB99.6\\nCholestasis of parenteral nutrition: DB99.60\\nOther specified intrahepatic cholestasis: DB99.6Y\\nIntrahepatic cholestasis unspecified: DB99.6Z\\nHepatic failure without mention whether acute or chronic: DB99.7\\nChronic hepatic failure: DB99.8\\nOther specified diseases of liver: DB99.Y\\nDiseases of liver unspecified: DB9Z\\nAcquired anatomical alterations of gallbladder or bile ducts: DC10\\nObstruction of gallbladder or bile ducts: DC10.0\\nObstruction of cystic duct: DC10.00\\nObstruction of gall bladder: DC10.01\\nObstruction of bile duct: DC10.02\\nOther specified obstruction of gallbladder or bile ducts: DC10.0Y\\nObstruction of gallbladder or bile ducts unspecified: DC10.0Z\\nHydrops of gallbladder: DC10.1\\nFistula of gallbladder or bile duct: DC10.2\\nPolyp of gallbladder: DC10.3\\nCholesterolosis of gallbladder: DC10.4\\nOther specified acquired anatomical alterations of gallbladder or bile ducts: DC10.Y\\nAcquired anatomical alterations of gallbladder or bile ducts unspecified: DC10.Z\\nCholelithiasis: DC11\\nCalculus of gallbladder or cystic duct with acute cholecystitis: DC11.0\\nCalculus of gallbladder or cystic duct with other cholecystitis: DC11.1\\nCalculus of gallbladder or cystic duct with cholangitis: DC11.2\\nCalculus of gallbladder or cystic duct without cholecystitis or cholangitis: DC11.3\\nCalculus of bile duct with cholangitis: DC11.4\\nCalculus of bile duct with cholecystitis: DC11.5\\nCalculus of bile duct without cholangitis or cholecystitis: DC11.6\\nIntrahepatic cholelithiasis: DC11.7\\nOther specified cholelithiasis: DC11.Y\\nCholelithiasis unspecified: DC11.Z\\nCholecystitis: DC12\\nAcute cholecystitis: DC12.0\\nAcute on chronic cholecystitis: DC12.00\\nOther specified acute cholecystitis: DC12.0Y\\nAcute cholecystitis unspecified: DC12.0Z\\nChronic cholecystitis: DC12.1\\nOther specified cholecystitis: DC12.Y\\nCholecystitis unspecified: DC12.Z\\nCholangitis: DC13\\nCertain specified biliary diseases: DC14\\nHaemorrhage of bile duct: DC14.0\\nPostcholecystectomy syndrome: DC14.1\\nDyskinesia of sphincter of Oddi: DC14.2\\nAdenomyomatosis of gallbladder: DC14.3\\nOther specified diseases of gallbladder or biliary tract: DC1Y\\nDiseases of gallbladder or biliary tract unspecified: DC1Z\\nCystic diseases of the pancreas: DC30\\nCyst of pancreas: DC30.0\\nPseudocyst of pancreas: DC30.1\\nOther specified cystic diseases of the pancreas: DC30.Y\\nCystic diseases of the pancreas unspecified: DC30.Z\\nAcute pancreatitis: DC31\\nAcute idiopathic pancreatitis: DC31.0\\nAcute alcoholinduced pancreatitis: DC31.1\\nAcute biliary pancreatitis: DC31.2\\nAcute druginduced pancreatitis: DC31.3\\nHereditary acute pancreatitis: DC31.4\\nAcute exacerbation of chronic pancreatitis: DC31.5\\nOther specified acute pancreatitis: DC31.Y\\nAcute pancreatitis unspecified: DC31.Z\\nChronic pancreatitis: DC32\\nCalcific pancreatitis: DC32.0\\nGroove pancreatitis: DC32.1\\nHereditary chronic pancreatitis: DC32.2\\nChronic alcoholinduced pancreatitis: DC32.3\\nChronic idiopathic pancreatitis: DC32.4\\nTropical pancreatitis: DC32.5\\nOther specified chronic pancreatitis: DC32.Y\\nChronic pancreatitis unspecified: DC32.Z\\nAutoimmune pancreatitis: DC33\\nObstructive pancreatitis: DC34\\nCertain specified diseases of pancreas: DC35\\nAtrophy of pancreas: DC35.0\\nSecondary pancreatic insufficiency: DC35.1\\nPancreatic steatorrhoea: DC35.2\\nOther specified diseases of pancreas: DC3Y\\nDiseases of pancreas unspecified: DC3Z\\nPeritonitis: DC50\\nPrimary peritonitis: DC50.0\\nSpontaneous bacterial peritonitis: DC50.00\\nOther specified primary peritonitis: DC50.01\\nSecondary peritonitis: DC50.1\\nEosinophilic peritonitis: DC50.10\\nMesenteric peritonitis: DC50.11\\nChronic proliferative peritonitis: DC50.12\\nPeritonitis due to Streptococcus pneumoniae: DC50.13\\nOther specified secondary peritonitis: DC50.1Y\\nSecondary peritonitis unspecified: DC50.1Z\\nPeritoneal abscess: DC50.2\\nPeritonitis unspecified: DC50.Z\\nCertain specified disorders of peritoneum or retroperitoneum: DC51\\nChylous ascites: DC51.0\\nPeritoneal adhesions: DC51.1\\nHaemoperitoneum: DC51.2\\nOther specified disorders of peritoneum or retroperitoneum: DC51.Y\\nDiseases of peritoneum unspecified: DC5Z\\nDiverticulitis of small intestine: DC70\\nDiverticulitis of small intestine with complication: DC70.0\\nDiverticulitis of small intestine with perforation or abscess: DC70.00\\nDiverticulitis of small intestine with other specified complication: DC70.0Y\\nDiverticulitis of small intestine with unspecified complication: DC70.0Z\\nDiverticulitis of small intestine without complication: DC70.1\\nDiverticulitis of small intestine without specification of presence of complications: DC70.Z\\nDiverticulosis of small intestine: DC71\\nDiverticulosis of small intestine with haemorrhage: DC71.0\\nDiverticulosis of small intestine without haemorrhage: DC71.1\\nDiverticulosis of small intestine unspecified: DC71.Z\\nDiverticulum of small intestine: DC72\\nDiverticulum of small intestine with haemorrhage: DC72.0\\nDiverticulum of small intestine without haemorrhage: DC72.1\\nDiverticulum of small intestine no specification about presence or absence of haemorrhage: DC72.Z\\nDiverticulitis of large intestine: DC80\\nDiverticulitis of large intestine with complication: DC80.0\\nDiverticulitis of large intestine with perforation or abscess: DC80.00\\nDiverticulitis of large intestine with other specified complication: DC80.0Y\\nDiverticulitis of large intestine with unspecified complication: DC80.0Z\\nDiverticulitis of large intestine without complication: DC80.1\\nDiverticulitis of large intestine without specification of presence of complications: DC80.Z\\nDiverticulosis of large intestine: DC81\\nDiverticulosis of large intestine with haemorrhage: DC81.0\\nDiverticulosis of large intestine without haemorrhage: DC81.1\\nDiverticulosis of large intestine unspecified: DC81.Z\\nDiverticulum of large intestine: DC82\\nDiverticulum of large intestine with haemorrhage: DC82.0\\nDiverticulum of large intestine without haemorrhage: DC82.1\\nDiverticulum of large intestine unspecified: DC82.Z\\nDiverticular disease of small and large intestine: DC90\\nDiverticulitis of unspecified part of intestine: DD00\\nDiverticulitis of unspecified part of intestine with complication: DD00.0\\nDiverticulitis of unspecified part of intestine with perforation or abscess: DD00.00\\nDiverticulitis of unspecified part of intestine with other specified complication: DD00.0Y\\nDiverticulitis of unspecified part of intestine with unspecified complication: DD00.0Z\\nDiverticulitis of unspecified part of intestine without complication: DD00.1\\nDiverticulitis of unspecified part of intestine without specification of presence or absence of complications: DD00.Z\\nDiverticulosis of unspecified part of intestine: DD01\\nDiverticulosis of unspecified part of intestine with haemorrhage: DD01.0\\nDiverticulosis of unspecified part of intestine without haemorrhage: DD01.1\\nDiverticulosis of unspecified part of intestine unspecified: DD01.Z\\nDiverticulum of unspecified part of intestine: DD02\\nDiverticular disease of unspecified part of intestine with haemorrhage: DD02.0\\nDiverticulum of unspecified part of intestine without complication: DD02.1\\nDiverticulum of unspecified part of intestine unspecified: DD02.Z\\nDiverticular disease of intestine unspecified: DD1Z\\nAcute vascular disorders of intestine: DD30\\nAcute mesenteric arterial infarction: DD30.0\\nAcute mesenteric arterial ischaemia: DD30.1\\nAcute mesenteric venous occlusion: DD30.2\\nOther specified acute vascular disorders of intestine: DD30.Y\\nAcute vascular disorders of intestine unspecified: DD30.Z\\nChronic vascular disorders of intestine: DD31\\nNonocclusive mesenteric ischaemia: DD31.0\\nIschaemic colitis: DD31.00\\nOther specified nonocclusive mesenteric ischaemia: DD31.0Y\\nNonocclusive mesenteric ischaemia unspecified: DD31.0Z\\nOther specified chronic vascular disorders of intestine: DD31.Y\\nChronic vascular disorders of intestine unspecified: DD31.Z\\nOther specified ischaemic vascular disorders of intestine: DD3Y\\nIschaemic vascular disorders of intestine unspecified: DD3Z\\nNonabdominal wall hernia: DD50\\nDiaphragmatic hernia: DD50.0\\nPelvic hernia: DD50.1\\nIntraabdominal hernia: DD50.2\\nPrimary intraabdominal hernia: DD50.20\\nSecondary intraabdominal hernia: DD50.21\\nOther specified intraabdominal hernia: DD50.2Y\\nIntraabdominal hernia unspecified: DD50.2Z\\nOther specified nonabdominal wall hernia: DD50.Y\\nNonabdominal wall hernia unspecified: DD50.Z\\nInguinal hernia: DD51\\nFemoral hernia: DD52\\nUmbilical hernia: DD53\\nParaumbilical hernia: DD54\\nEpigastric hernia: DD55\\nIncisional hernia: DD56\\nParastomal hernia: DD57\\nOther specified hernias: DD5Y\\nHernias unspecified: DD5Z\\nCrohn disease: DD70\\nCrohn disease of upper gastrointestinal tract: DD70.0\\nCrohn disease of small intestine: DD70.1\\nCrohn disease of appendix: DD70.2\\nCrohn disease of large intestine: DD70.3\\nCrohn disease of anal region: DD70.4\\nCrohn disease of both small and large intestine: DD70.5\\nCrohn disease of anastomotic sites: DD70.6\\nCrohn disease of other specified site: DD70.Y\\nCrohn disease unspecified site: DD70.Z\\nUlcerative colitis: DD71\\nUlcerative pancolitis: DD71.0\\nLeft sided ulcerative colitis: DD71.1\\nUlcerative rectosigmoiditis: DD71.2\\nUlcerative proctitis: DD71.3\\nOther specified ulcerative colitis: DD71.Y\\nUlcerative colitis unspecified: DD71.Z\\nIndeterminate colitis: DD72\\nOther specified inflammatory bowel diseases: DD7Y\\nInflammatory bowel diseases unspecified: DD7Z\\nFunctional oesophageal or gastroduodenal disorders: DD90\\nGlobus: DD90.0\\nFunctional swallowing disorder: DD90.1\\nFunctional heartburn: DD90.2\\nFunctional dyspepsia: DD90.3\\nFunctional nausea or vomiting: DD90.4\\nFunctional belching disorders: DD90.5\\nAdult rumination syndrome: DD90.6\\nOther specified functional oesophageal or gastroduodenal disorders: DD90.Y\\nFunctional oesophageal or gastroduodenal disorders unspecified: DD90.Z\\nIrritable bowel syndrome or certain specified functional bowel disorders: DD91\\nIrritable bowel syndrome: DD91.0\\nIrritable bowel syndrome constipation predominant: DD91.00\\nIrritable bowel syndrome diarrhoea predominant: DD91.01\\nIrritable bowel syndrome mixed type: DD91.02\\nIrritable bowel syndrome unsubtyped: DD91.03\\nIrritable bowel syndrome type unspecified: DD91.0Z\\nFunctional constipation: DD91.1\\nFunctional diarrhoea: DD91.2\\nFunctional bloating: DD91.3\\nFunctional abdominal pain syndrome: DD91.4\\nOther specified irritable bowel syndrome or functional bowel disorders: DD91.Y\\nIrritable bowel syndrome or functional bowel disorders unspecified: DD91.Z\\nFunctional anorectal disorders: DD92\\nFunctional faecal incontinence: DD92.0\\nFunctional anorectal pain: DD92.1\\nFunctional defaecation disorders: DD92.2\\nOther specified functional anorectal disorders: DD92.Y\\nFunctional anorectal disorders unspecified: DD92.Z\\nFunctional digestive disorders of infants toddlers or children: DD93\\nInfant regurgitation: DD93.0\\nInfantile colic: DD93.1\\nInfant dyschezia: DD93.2\\nOther functional digestive disorders of infants neonates or toddlers: DD93.Y\\nFunctional digestive disorders of infants toddlers or children unspecified: DD93.Z\\nFunctional gallbladder disorder: DD94\\nFunctional sphincter of Oddi disorder: DD95\\nOther specified functional gastrointestinal disorders: DD9Y\\nFunctional gastrointestinal disorders unspecified: DD9Z\\nVomiting following gastrointestinal surgery: DE10\\nDumping syndrome: DE11\\nMalfunction or complication of external stoma of digestive organs: DE12\\nColostomy or enterostomy malfunction or complication: DE12.0\\nGastrostomy malfunction: DE12.1\\nPostsurgical malabsorption not elsewhere classified: DE13\\nOther specified diseases of the digestive system: DE2Y\\nDiseases of the digestive system unspecified: DE2Z\\nViral exanthem due to unknown or unspecified agent: EA00\\nViral exanthem due to other specified virus: EA0Y\\nPityriasis rosea: EA10\\nPapular purpuric gloves and socks syndrome: EA11\\nInfantile papular acrodermatitis: EA12\\nNecrolytic acral erythema: EA20\\nUnspecified skin disorder attributable to viral infection: EA3Z\\nTropical phagedaenic ulcer: EA40\\nToxinmediated cutaneous reactions to distant or systemic bacterial infection: EA50\\nErythema marginatum rheumaticum: EA50.0\\nStreptococcal toxinmediated perineal erythema: EA50.1\\nStaphylococcal scalded skin syndrome: EA50.2\\nStaphylococcal scarlatina: EA50.3\\nOther specified toxinmediated cutaneous reactions to distant or systemic bacterial infection: EA50.Y\\nToxinmediated cutaneous reactions to distant or systemic bacterial infection unspecified: EA50.Z\\nSkin complications of BCG immunisation: EA51\\nCutaneous involvement by other specified bacterial infection: EA5Y\\nCutaneous involvement by unspecified bacterial infection: EA5Z\\nCertain skin disorders attributable to fungal infection: EA60\\nSubcutaneous mycoses: EA60.0\\nSystemic mycoses affecting skin: EA60.1\\nSkin involvement in other specified fungal infection: EA60.Y\\nFungal infection of the skin unspecified: EA60.Z\\nCutaneous involvement by other specified infection or infestation: EA6Y\\nAtopic eczema: EA80\\nInfantile atopic eczema: EA80.0\\nChildhood atopic eczema: EA80.1\\nAdult atopic eczema: EA80.2\\nOther specified forms of atopic eczema: EA80.Y\\nAtopic eczema unspecified: EA80.Z\\nSeborrhoeic dermatitis and related conditions: EA81\\nSeborrhoeic dermatitis of face: EA81.0\\nSeborrhoeic dermatitis of the scalp: EA81.1\\nSeborrhoeic dermatosis of other specified type or distribution: EA81.Y\\nSeborrhoeic dermatitis unspecified: EA81.Z\\nNummular dermatitis: EA82\\nLichen simplex or lichenification: EA83\\nLichen simplex: EA83.0\\nLichen simplex of vulva: EA83.00\\nLichen simplex of male genitalia: EA83.01\\nPerianal lichen simplex: EA83.02\\nLichen simplex of other specified site: EA83.0Y\\nLichen simplex of unspecified site: EA83.0Z\\nSecondary lichenification: EA83.1\\nAsteatotic eczema: EA84\\nDermatitis or eczema of hands or feet: EA85\\nVesicular dermatitis of hands or feet: EA85.0\\nHyperkeratotic dermatitis of hands or feet: EA85.1\\nDermatitis of hands: EA85.2\\nAtopic eczema of hands: EA85.20\\nOther specified dermatitis of hands: EA85.2Y\\nDermatitis of hands unspecified: EA85.2Z\\nDermatitis of feet: EA85.3\\nDermatitis or eczema of lower legs: EA86\\nStasis dermatitis of lower legs: EA86.0\\nDermatitis or eczema of lower legs unspecified: EA86.Z\\nDermatitis or eczema of anogenital region: EA87\\nDermatitis or eczema of male genitalia: EA87.0\\nDermatitis or eczema of female genitalia: EA87.1\\nDermatitis or eczema of perianal area: EA87.2\\nDermatitis or eczema of anogenital region unspecified: EA87.Z\\nMiscellaneous specified eczematous dermatoses: EA88\\nInfectious dermatitis: EA88.0\\nHuman Tcell lymphotropic virus type  associated infective dermatitis of childhood: EA88.00\\nOther specified infectious dermatitis: EA88.0Y\\nInfectious dermatitis unspecified: EA88.0Z\\nPost traumatic eczema: EA88.1\\nDisseminated secondary eczema: EA88.2\\nSecondary eczema: EA88.3\\nPityriasis alba: EA88.4\\nGeneralised eczematous dermatitis of unspecified type: EA89\\nOther specified eczematous dermatosis: EA8Y\\nDermatitis or eczema unspecified: EA8Z\\nPsoriasis: EA90\\nPlaque psoriasis: EA90.0\\nGuttate psoriasis: EA90.1\\nUnstable psoriasis: EA90.2\\nErythrodermic psoriasis: EA90.3\\nPustular psoriasis: EA90.4\\nGeneralised pustular psoriasis: EA90.40\\nAcropustulosis of Hallopeau: EA90.41\\nPalmoplantar pustulosis: EA90.42\\nOther specified pustular psoriasis: EA90.4Y\\nPustular psoriasis unspecified: EA90.4Z\\nPsoriasis of specified site or distribution: EA90.5\\nScalp psoriasis: EA90.50\\nNail psoriasis: EA90.51\\nFlexural and intertriginous psoriasis: EA90.52\\nAnogenital psoriasis: EA90.53\\nPsoriasis of other specified site or distribution: EA90.5Y\\nOther specified forms of psoriasis: EA90.Y\\nPsoriasis of unspecified type: EA90.Z\\nLichen planus: EA91\\nAcute eruptive lichen planus: EA91.0\\nHypertrophic lichen planus: EA91.1\\nFollicular lichen planus: EA91.2\\nLichen planus of genital skin and mucous membranes: EA91.3\\nLichen planus and lichenoid reactions of oral mucosa: EA91.4\\nNonerosive lichen planus of oral mucosa: EA91.40\\nErosive oral lichen planus: EA91.41\\nOral lichen planus unspecified: EA91.42\\nLichenoid mucositis: EA91.43\\nOther specified lichenoid reactions of oral mucosa: EA91.4Y\\nLichen planus of the nails: EA91.5\\nSubacute lichen planus: EA91.6\\nOther specified lichen planus: EA91.Y\\nLichen planus of unspecified type: EA91.Z\\nLichenoid dermatoses: EA92\\nPityriasis lichenoides: EA93\\nPityriasis rubra pilaris: EA94\\nSmall plaque parapsoriasis: EA95\\nSpontaneous urticaria: EB00\\nAcute urticaria: EB00.0\\nChronic urticaria: EB00.1\\nSpontaneous urticaria unspecified: EB00.Z\\nInducible urticaria or angioedema: EB01\\nDermographism: EB01.0\\nCold urticaria: EB01.1\\nDelayed pressure urticaria: EB01.2\\nContact urticaria: EB01.3\\nOther specified forms of inducible urticaria or angioedema: EB01.Y\\nInducible urticaria or angioedema unspecified: EB01.Z\\nCholinergic urticaria or related conditions: EB02\\nCholinergic urticaria: EB02.0\\nOther conditions mediated by cholinergic activation: EB02.Y\\nSyndromes with urticarial reactions or angioedema: EB03\\nIdiopathic angioedema: EB04\\nUrticaria of unspecified type: EB05\\nOther specified urticarial disorders: EB0Y\\nDiffuse inflammatory erythemas: EB10\\nAnnular erythema: EB11\\nErythema multiforme: EB12\\nCutaneous erythema multiforme: EB12.0\\nMucocutaneous erythema multiforme: EB12.1\\nOther specified erythema multiforme: EB12.Y\\nErythema multiforme unspecified: EB12.Z\\nStevensJohnson syndrome or toxic epidermal necrolysis: EB13\\nStevensJohnson syndrome: EB13.0\\nToxic epidermal necrolysis: EB13.1\\nStevensJohnson and toxic epidermal necrolysis overlap syndrome: EB13.2\\nAcute febrile neutrophilic dermatosis: EB20\\nPyoderma gangrenosum: EB21\\nOther specified neutrophilic dermatoses: EB2Y\\nEosinophilic cellulitis: EB30\\nErythema nodosum: EB31\\nPemphigus: EB40\\nPemphigus vulgaris: EB40.0\\nOral pemphigus: EB40.00\\nOther specified pemphigus vulgaris: EB40.0Y\\nPemphigus vulgaris unspecified: EB40.0Z\\nPemphigus foliaceus: EB40.1\\nParaneoplastic pemphigus: EB40.2\\nOther specified pemphigus: EB40.Y\\nPemphigus unspecified: EB40.Z\\nPemphigoid: EB41\\nBullous pemphigoid: EB41.0\\nMucous membrane pemphigoid: EB41.1\\nOther specified pemphigoid: EB41.Y\\nPemphigoid unspecified: EB41.Z\\nLinear IgA bullous dermatosis: EB42\\nEpidermolysis bullosa acquisita: EB43\\nDermatitis herpetiformis: EB44\\nOther specified immunobullous disorder: EB4Y\\nSubacute cutaneous lupus erythematosus: EB50\\nChronic cutaneous lupus erythematosus: EB51\\nDiscoid lupus erythematosus: EB51.0\\nOther specified chronic cutaneous lupus erythematosus: EB51.Y\\nChronic cutaneous lupus erythematosus unspecified: EB51.Z\\nCutaneous lupus erythematosus of unspecified type: EB5Z\\nLichen sclerosus: EB60\\nLichen sclerosus of vulva: EB60.0\\nLichen sclerosus of penis: EB60.1\\nLichen sclerosus of other specified sites: EB60.Y\\nLichen sclerosus unspecified: EB60.Z\\nMorphoea: EB61\\nPlaque morphoea: EB61.0\\nLinear morphoea: EB61.1\\nOther specified forms of morphoea: EB61.Y\\nMorphoea unspecified: EB61.Z\\nOther specified inflammatory dermatoses: EB7Y\\nDermatoses resulting from disturbed metabolic processes: EB90\\nDiabetic skin lesions: EB90.0\\nCutaneous mucinosis: EB90.1\\nPretibial myxoedema: EB90.10\\nLichen myxoedematosus: EB90.11\\nReticular erythematous mucinosis: EB90.12\\nOther specified forms of cutaneous mucinosis: EB90.1Y\\nCutaneous or subcutaneous xanthomata: EB90.2\\nPlane xanthoma: EB90.20\\nTuberous xanthoma: EB90.21\\nEruptive xanthoma: EB90.22\\nTendinous xanthoma: EB90.23\\nCutaneous or subcutaneous xanthomata of unspecified type: EB90.2Z\\nPorphyria or pseudoporphyria affecting the skin: EB90.3\\nPseudoporphyria: EB90.30\\nOther specified porphyria or pseudoporphyria affecting the skin: EB90.3Y\\nCalcification of skin or subcutaneous tissue: EB90.4\\nDystrophic calcification of the skin of uncertain or unspecified aetiology: EB90.40\\nCalcific panniculitis: EB90.41\\nCalcific arteriolopathy: EB90.42\\nOther specified calcification of skin or subcutaneous tissue: EB90.4Y\\nOther specified metabolic or nutritional disorders affecting the skin: EB9Y\\nGenetic syndromes with poikiloderma: EC10\\nOther specified genetic syndromes affecting the skin: EC1Y\\nGenetic disorders of keratinisation: EC20\\nNonsyndromic ichthyosis: EC20.0\\nIchthyosis vulgaris: EC20.00\\nXlinked ichthyosis: EC20.01\\nAutosomal recessive congenital ichthyosis: EC20.02\\nKeratinopathic ichthyoses: EC20.03\\nOther specified or unclassifiable nonsyndromic ichthyosis: EC20.0Y\\nHereditary skin peeling: EC20.1\\nHereditary acantholytic dermatoses: EC20.2\\nHereditary palmoplantar keratodermas: EC20.3\\nDiffuse palmoplantar keratodermas: EC20.30\\nFocal palmoplantar keratodermas: EC20.31\\nPapular palmoplantar keratodermas: EC20.32\\nHereditary palmoplantar keratoderma of unspecified type: EC20.3Z\\nOther specified genetic disorders of keratinisation: EC20.Y\\nGenetic defects of hair or hair growth: EC21\\nGenetic defects of the hair shaft: EC21.0\\nGenetic syndromes with abnormalities of the hair shaft: EC21.1\\nHereditary alopecia or hypotrichosis: EC21.2\\nGenetic syndromes with alopecia or hypotrichosis: EC21.3\\nGeneticallydetermined hypertrichosis: EC21.4\\nOther specified genetic defects of hair or hair growth: EC21.Y\\nGenetic defects of hair or hair growth unspecified: EC21.Z\\nGenetic defects of nails or nail growth: EC22\\nInherited deformities of nails: EC22.0\\nGenetic disorders of skin pigmentation: EC23\\nNonsyndromic geneticallydetermined hypermelanosis or lentiginosis: EC23.0\\nSyndromic geneticallydetermined hypermelanosis or lentiginosis: EC23.1\\nAlbinism or other specified geneticallydetermined hypomelanotic disorders: EC23.2\\nOculocutaneous albinism: EC23.20\\nOther specified geneticallydetermined hypomelanotic disorders: EC23.2Y\\nOther specified genetic disorders of skin pigmentation: EC23.Y\\nGenetic disorders of skin pigmentation unspecified: EC23.Z\\nEpidermolysis bullosa simplex: EC30\\nJunctional epidermolysis bullosa: EC31\\nDystrophic epidermolysis bullosa: EC32\\nSyndromic epidermolysis bullosa: EC33\\nEpidermolysis bullosa: EC3Z\\nPseudoxanthoma elasticum: EC40\\nOther specified genetic disorders affecting dermal matrix proteins: EC4Y\\nDevelopmental anomalies of the umbilicus: EC50\\nOther specified developmental anomalies affecting the skin: EC5Y\\nOther specified genetic or developmental disorders affecting the skin: EC7Y\\nPruritus: EC90\\nPruritus due to skin disorder: EC90.0\\nPruritus due to systemic disorder: EC90.1\\nUraemic pruritus: EC90.10\\nCholestatic pruritus: EC90.11\\nHaemodialysisassociated pruritus: EC90.12\\nPruritus due to other specified systemic disorder: EC90.1Y\\nDruginduced pruritus: EC90.2\\nPruritus due to neurological disorder: EC90.3\\nPsychogenic pruritus: EC90.4\\nAnogenital pruritus: EC90.5\\nPruritus of unknown cause: EC90.6\\nPruritus of other specified type or aetiology: EC90.Y\\nPruritus unspecified: EC90.Z\\nPrurigo: EC91\\nNodular prurigo: EC91.0\\nAtopic prurigo: EC91.1\\nPrurigo unspecified: EC91.Z\\nMucocutaneous or cutaneous pain syndromes: EC92\\nPenoscrotodynia: EC92.0\\nScalp dysaesthesia: EC92.1\\nOther specified disturbances of cutaneous sensation: EC9Y\\nArtefactual skin disorder: ED00\\nSimulated skin disease: ED01\\nPainful bruising syndrome: ED02\\nOther specified selfinflicted skin disorders: ED0Y\\nOther specified mental conditions affecting the skin: ED2Y\\nNeuropathic skin damage: ED30\\nNeuropathic skin ulceration: ED30.0\\nOther specified neuropathic skin damage: ED30.Y\\nBurning feet syndrome: ED31\\nCutaneous involvement in other specified neurological condition: ED3Y\\nIchthyoses: ED50\\nAcquired ichthyosis: ED50.0\\nIchthyosis of unspecified type: ED50.Z\\nDiffuse epidermal hyperkeratosis or acanthosis: ED51\\nAcanthosis nigricans: ED51.0\\nBenign acanthosis nigricans: ED51.00\\nOther specified acanthosis nigricans: ED51.0Y\\nAcanthosis nigricans unspecified: ED51.0Z\\nOther specified hyperkeratotic or acanthotic dermatoses: ED51.Y\\nDiffuse epidermal hyperkeratosis or acanthosis unspecified: ED51.Z\\nPorokeratoses: ED52\\nSkin peeling: ED53\\nXerosis cutis or asteatosis: ED54\\nPalmoplantar keratodermas: ED55\\nAcquired palmoplantar keratodermas: ED55.0\\nPalmoplantar keratoderma unspecified: ED55.Z\\nKeratosis pilaris: ED56\\nOther specified disorders of epidermal keratinisation: ED5Y\\nAcquired hypermelanosis: ED60\\nPhysiological hypermelanosis: ED60.0\\nSuntan: ED60.00\\nTanning due to exposure to artificial sources of ultraviolet radiation: ED60.01\\nMelasma: ED60.1\\nPostinflammatory hypermelanosis: ED60.2\\nHypermelanosis of other specified aetiology: ED60.Y\\nHypermelanosis of unspecified aetiology: ED60.Z\\nAcquired melanotic macules or lentigines: ED61\\nFreckles: ED61.0\\nMucosal melanosis: ED61.1\\nPenile melanotic macule: ED61.10\\nVulval melanotic macule: ED61.11\\nOther specified mucosal melanosis: ED61.1Y\\nOther specified acquired melanotic macules or lentigines: ED61.Y\\nEndogenous nonmelanin pigmentation: ED62\\nHaemosiderin pigmentation of skin: ED62.0\\nOther specified endogenous nonmelanin pigmentation: ED62.Y\\nAcquired hypomelanotic disorders: ED63\\nVitiligo: ED63.0\\nHypomelanosis due to exposure to chemicals: ED63.1\\nPostinflammatory hypomelanosis: ED63.2\\nVogtKoyanagiHarada syndrome: ED63.3\\nAcquired hypomelanosis due to other specified disorder: ED63.Y\\nAcquired hypomelanosis of unknown or unspecified aetiology: ED63.Z\\nAbnormal skin pigmentation: ED64\\nOther specified disorders of skin pigmentation: ED6Y\\nAlopecia or hair loss: ED70\\nMale pattern hair loss: ED70.0\\nFemale pattern hair loss: ED70.1\\nAlopecia areata: ED70.2\\nPatchy alopecia areata of scalp: ED70.20\\nAlopecia totalis: ED70.21\\nOther specified forms of alopecia areata: ED70.2Y\\nAlopecia areata unspecified: ED70.2Z\\nTelogen effluvium: ED70.3\\nAcute telogen effluvium: ED70.30\\nPostpartum telogen effluvium: ED70.31\\nTelogen hair shedding due to other specified cause: ED70.3Y\\nTelogen effluvium unspecified: ED70.3Z\\nAnagen effluvium: ED70.4\\nScarring alopecia: ED70.5\\nFolliculitis decalvans: ED70.50\\nDissecting cellulitis: ED70.51\\nScarring alopecia due to other specified cause: ED70.5Y\\nScarring alopecia of unknown or unspecified aetiology: ED70.5Z\\nOther specified alopecia or hair loss: ED70.Y\\nAlopecia unspecified: ED70.Z\\nHypertrichosis: ED71\\nHirsutism or syndromes with hirsutism: ED72\\nConstitutional hirsutism: ED72.0\\nHirsutism associated with hyperandrogenaemia: ED72.1\\nHirsutism unspecified: ED72.Z\\nAcquired disorders of the hair shaft: ED73\\nWeathered hair: ED73.0\\nAcquired changes in hair colour: ED73.1\\nPremature canities: ED73.10\\nAcquired poliosis: ED73.11\\nOther specified acquired disorders of the hair shaft: ED73.Y\\nOther specified disorders of hair: ED7Y\\nAcne: ED80\\nComedonal acne: ED80.0\\nSuperficial mixed comedonal and papulopustular acne: ED80.1\\nPapulopustular acne: ED80.2\\nNodular acne: ED80.3\\nSevere inflammatory acne: ED80.4\\nAcne fulminans: ED80.40\\nAcne conglobata: ED80.41\\nOther specified severe inflammatory acne: ED80.4Y\\nSevere inflammatory acne unspecified: ED80.4Z\\nAcne scarring: ED80.5\\nInfantile acne: ED80.6\\nOther specified acne: ED80.Y\\nAcne unspecified: ED80.Z\\nAcneiform inflammatory disorders: ED81\\nFolliculitis cruris pustulosa atrophicans: ED81.0\\nAcneiform reactions to halogenated aromatic hydrocarbons: ED81.1\\nOther specified acneiform inflammatory disorders: ED81.Y\\nAcneiform inflammatory disorders unspecified: ED81.Z\\nRosacea and related disorders: ED90\\nRosacea: ED90.0\\nErythematotelangiectatic rosacea: ED90.00\\nPapulopustular rosacea: ED90.01\\nPhymatous rosacea: ED90.02\\nOther specified rosacea: ED90.0Y\\nRosacea unspecified: ED90.0Z\\nPeriorificial dermatitis: ED90.1\\nOther specified rosacealike disorders: ED90.Y\\nRosacealike disorders unspecified: ED90.Z\\nDisorders of the sebaceous gland: ED91\\nHeterotopic sebaceous glands: ED91.0\\nSebaceous gland hyperplasia: ED91.1\\nSeborrhoea: ED91.2\\nOther specified disorders of the sebaceous gland: ED91.Y\\nDisorders of the sebaceous gland unspecified: ED91.Z\\nDisorders involving the apocrine follicular unit: ED92\\nHidradenitis suppurativa: ED92.0\\nApocrine sweat disorders: ED92.1\\nOther specified disorders involving the apocrine follicular unit: ED92.Y\\nDisorders involving the apocrine follicular unit unspecified: ED92.Z\\nOther specified disorders involving the hair follicle: ED9Y\\nHyperhidrosis: EE00\\nLocalised hyperhidrosis: EE00.0\\nPalmoplantar hyperhidrosis: EE00.00\\nAxillary hyperhidrosis: EE00.01\\nCraniofacial hyperhidrosis: EE00.02\\nOther specified localised hyperhidrosis: EE00.0Y\\nLocalised hyperhidrosis unspecified: EE00.0Z\\nPrimary generalised hyperhidrosis: EE00.1\\nHyperhidrosis unspecified: EE00.Z\\nHypohidrosis: EE01\\nHypohidrosis attributable to defective sudomotor innervation or function: EE01.0\\nHypohidrosis due to genetic abnormalities of eccrine gland structure or function: EE01.1\\nHypohidrosis of undetermined aetiology: EE01.2\\nOther specified forms of hypohidrosis: EE01.Y\\nHypohidrosis unspecified: EE01.Z\\nMiliaria: EE02\\nNeonatal miliaria: EE02.0\\nOther specified forms of miliaria: EE02.Y\\nMiliaria unspecified: EE02.Z\\nOther specified disorders of eccrine sweat glands or sweating: EE0Y\\nAcquired deformities of the nail plate: EE10\\nAbnormality of nail shape: EE10.0\\nAbnormality of nail surface: EE10.1\\nNail pitting: EE10.10\\nOther specified abnormality of nail surface: EE10.1Y\\nAbnormality of nail surface unspecified: EE10.1Z\\nOnycholysis: EE10.2\\nNail hypertrophy: EE10.3\\nNail atrophy: EE10.4\\nNail dystrophy not otherwise specified: EE10.5\\nOther specified acquired deformities of the nail plate: EE10.Y\\nAcquired deformities of the nail plate unspecified: EE10.Z\\nAcquired abnormalities of nail colour: EE11\\nMelanonychia: EE11.0\\nYellow nail syndrome: EE11.1\\nOther abnormalities of nail colour: EE11.Y\\nAcquired abnormalities of nail colour unspecified: EE11.Z\\nInfections of the nail or perionychium: EE12\\nAcute bacterial paronychia: EE12.0\\nOnychomycosis: EE12.1\\nOther specified infections of the nail or perionychium: EE12.Y\\nInfections of the nail or perionychium unspecified: EE12.Z\\nCertain disorders affecting the nails or perionychium: EE13\\nNail fragility: EE13.0\\nIngrowing nail: EE13.1\\nIngrowing toenail: EE13.10\\nInfected ingrowing toenail: EE13.11\\nOther specified ingrowing nail: EE13.1Y\\nIngrowing nail unspecified: EE13.1Z\\nChronic paronychia: EE13.2\\nNail disorder associated with specified dermatosis: EE13.3\\nNail disorder associated with specified systemic disease: EE13.4\\nEczematous nail dystrophy: EE13.5\\nOther specified nail disorder: EE13.Y\\nOther specified disorders of the nail or perionychium: EE1Y\\nDisorders of the nail or perionychium unspecified: EE1Z\\nAcute cutaneous distension syndrome: EE20\\nEpidermal fragility: EE21\\nAtrophy or degeneration of dermal or subcutaneous connective tissue: EE40\\nCorticosteroidinduced skin atrophy: EE40.0\\nStretch marks: EE40.1\\nStretch marks of pregnancy: EE40.10\\nStretch marks of other specified aetiology: EE40.1Y\\nStretch marks unspecified: EE40.1Z\\nAtrophic scarring of the skin: EE40.2\\nSkin fragility: EE40.3\\nGeneticallydetermined skin fragility: EE40.30\\nAgerelated skin fragility: EE40.31\\nPurpura or bruising due to vascular fragility: EE40.32\\nOther specified atrophy or degeneration of dermal or subcutaneous connective tissue: EE40.Y\\nAtrophy or degeneration of dermal or subcutaneous connective tissue unspecified type: EE40.Z\\nAbnormalities of dermal elastin: EE41\\nCutis laxa: EE41.0\\nAnetoderma: EE41.1\\nOther specified dermatoses characterised by abnormal dermal elastin: EE41.Y\\nAbnormalities of dermal elastin unspecified: EE41.Z\\nAcquired poikiloderma: EE50\\nKeloid or hypertrophic scars: EE60\\nKeloid: EE60.0\\nEarlobe keloid: EE60.00\\nOther specified keloid: EE60.0Y\\nKeloid unspecified: EE60.0Z\\nHypertrophic scar: EE60.1\\nOther specified keloidal disorders: EE60.Y\\nSuperficial fibromatoses: EE61\\nOther specified fibromatous disorders of skin or soft tissue: EE6Y\\nFibromatosis of skin or soft tissue unspecified: EE6Z\\nPerforating dermatoses: EE70\\nAcquired perforating dermatosis: EE70.0\\nOther specified perforating dermatoses: EE70.Y\\nPerforating dermatoses unspecified: EE70.Z\\nOther specified disorders of cutaneous connective tissue: EE7Y\\nNecrobiotic granulomatous skin disorders: EE80\\nGranuloma annulare: EE80.0\\nNecrobiosis lipoidica: EE80.1\\nNecrobiotic granulomatous skin disorders unspecified: EE80.Z\\nDermal dendrocyte Class IIa histiocytoses: EE81\\nOther specified histiocyticgranulomatous disorders of the skin: EE8Y\\nHistiocyticgranulomatous disorders of the skin unspecified: EE8Z\\nBenign lymphocytic infiltration of the skin: EE90\\nLymphocytoma cutis: EE91\\nPanniculitis: EF00\\nPancreatic enzyme panniculitis: EF00.0\\nPanniculitis of other specified aetiology: EF00.Y\\nPanniculitis of undetermined or unspecified etiology: EF00.Z\\nLipoatrophy or lipodystrophy: EF01\\nAcquired partial lipodystrophy: EF01.0\\nLocalised lipoatrophy or lipodystrophy: EF01.1\\nOther specified forms of lipodystrophy and lipoatrophy: EF01.Y\\nLipodystrophy or lipoatrophy unspecified: EF01.Z\\nCertain noninflammatory disorders of subcutaneous fat: EF02\\nFat hypertrophy: EF02.0\\nSubcutaneous lipomatosis: EF02.1\\nLipoedema: EF02.2\\nCellulite: EF02.3\\nOther specified noninflammatory disorders of subcutaneous fat: EF02.Y\\nNoninflammatory disorders of subcutaneous fat unspecified: EF02.Z\\nOther specified disorders of subcutaneous fat: EF0Y\\nAcquired malformations of cutaneous blood vessels: EF20\\nVenous lake: EF20.0\\nAngiokeratoma: XH4KP7\\nLower limb venous telangiectases: EF20.2\\nSpider telangiectasis: EF20.3\\nGeneralised essential telangiectasia: EF20.4\\nOther specified acquired malformations of cutaneous blood vessels: EF20.Y\\nAcquired malformations of cutaneous blood vessels unspecified: EF20.Z\\nCutaneous vascular malformation unspecified: EF2Z\\nPurpura or bruising due to disorders of coagulation: EF30\\nTraumatic purpura: EF31\\nOther specified purpura: EF3Y\\nPurpura of unspecified aetiology: EF3Z\\nVasculitis or capillaritis involving the skin: EF40\\nCapillaritis: EF40.0\\nVasculitis affecting small cutaneous blood vessels: EF40.1\\nUrticarial vasculitis: EF40.10\\nOther specified vasculitis affecting small cutaneous blood vessels: EF40.1Y\\nLocalised cutaneous vasculitis: EF40.2\\nGranuloma faciale: EF40.20\\nOther specified localised cutaneous vasculitis: EF40.2Y\\nCutaneous vasculitis unspecified: EF40.Z\\nLivedoid vasculopathy: EF50\\nOther specified dermatoses attributable to hyperviscosity or microvascular occlusion: EF5Y\\nIschaemic ulceration of skin: EF60\\nLower limb venous eczema: EF70\\nOther specified dermatoses due to venous disease: EF7Y\\nDermatoses due to venous disease unspecified: EF7Z\\nOther specified dermatoses resulting from vascular insufficiency: EF9Y\\nVasodilatation of extremities: EG00\\nVasoconstriction of extremities: EG01\\nFlushing disorders: EG02\\nSkin disorders localised to the scalp: EG30\\nScalp folliculitis: EG30.0\\nErosive pustular dermatosis of scalp: EG30.1\\nPityriasis amiantacea: EG30.2\\nOther specified scalp disorders not elsewhere classifiable: EG30.Y\\nSkin disorders localised to the scalp unspecified: EG30.Z\\nContact dermatitis of external ear: EG40\\nAllergic contact dermatitis of external ear: EG40.0\\nOther specified inflammatory disorder of external ear: EG4Y\\nInflammatory disorder of external ear unspecified: EG4Z\\nAnal pruritus: EG60\\nInfections of the anus or perianal skin: EG61\\nInflammatory dermatoses of the perianal area: EG62\\nSacrococcygeal pilonidal disease: EG63\\nSacrococcygeal pilonidal sinus: EG63.0\\nSacrococcygeal pilonidal cyst: EG63.1\\nSacrococcygeal pilonidal abscess: EG63.2\\nSacrococcygeal pilonidal disease unspecified: EG63.Z\\nOther specified skin disorders involving the genital and perianal regions: EG7Y\\nSkin disorders involving other specific body regions: EG9Y\\nSkin disorders involving certain specific body regions unspecified: EG9Z\\nNeonatal viral infections involving the skin: EH10\\nNeonatal pyogenic skin infections: EH11\\nNeonatal fungal infections involving the skin: EH12\\nNeonatal skin infection unspecified: EH1Z\\nOther specified skin disorders specific to the perinatal or neonatal period: EH3Y\\nDermatoses of infancy: EH40\\nInfantile seborrhoeic dermatitis: EH40.0\\nCradle cap: EH40.00\\nDisseminated infantile seborrhoeic dermatitis: EH40.01\\nPsoriasiform napkin dermatitis: EH40.02\\nInfantile seborrhoeic dermatitis unspecified: EH40.0Z\\nInfantile napkin dermatoses: EH40.1\\nPrimary irritant napkin dermatitis: EH40.10\\nOther specified infantile napkin dermatoses: EH40.1Y\\nInfantile napkin dermatoses unspecified: EH40.1Z\\nErythrodermas of infancy: EH40.2\\nAcute haemorrhagic oedema of infancy: EH40.3\\nOther specified dermatoses of infancy: EH40.Y\\nDermatoses of infancy unspecified: EH40.Z\\nExanthematic drug eruption: EH60\\nDruginduced urticaria angioedema or anaphylaxis: EH61\\nDruginduced urticaria: EH61.0\\nDruginduced angioedema: EH61.1\\nLichenoid drug eruption: EH62\\nStevensJohnson syndrome and toxic epidermal necrolysis due to drug: EH63\\nDruginduced StevensJohnson syndrome: EH63.0\\nDruginduced toxic epidermal necrolysis: EH63.1\\nDruginduced StevensJohnson and toxic epidermal necrolysis overlap syndrome: EH63.2\\nDruginduced erythroderma: EH64\\nDRESS syndrome: EH65\\nFixed drug eruption: EH66\\nAcne or acneiform reactions attributable to drugs: EH67\\nDruginduced acute generalised exanthematous pustulosis: EH67.0\\nOther specified acne or acneiform reactions attributable to drugs: EH67.Y\\nAcne or acneiform reactions attributable to drugs unspecified: EH67.Z\\nDrug eruption of other specified type: EH6Y\\nDrug eruption of unspecified type: EH6Z\\nPigmentary abnormalities of skin due to drug: EH70\\nDermatoses precipitated by drug therapy: EH71\\nDruginduced hair abnormalities: EH72\\nDruginduced alopecia: EH72.0\\nDruginduced telogen hair loss: EH72.00\\nDruginduced anagen effluvium: EH72.01\\nOther specified druginduced hair abnormalities: EH72.Y\\nDruginduced hair abnormalities unspecified: EH72.Z\\nDruginduced nail abnormalities: EH73\\nDruginduced oral conditions: EH74\\nPhotosensitivity due to drug: EH75\\nDermatoses associated with specific classes of medication: EH76\\nDermatoses resulting from cytotoxic or cancer chemotherapy: EH76.0\\nDermatoses resulting from immunosuppressive therapy: EH76.1\\nDermatoses attributable to corticosteroid therapy: EH76.2\\nDermatoses resulting from anticoagulant therapy: EH76.3\\nDermatosis associated with other specific classes of medication: EH76.Y\\nLocalised adverse cutaneous reactions to administration of drug: EH77\\nAdverse cutaneous reactions to herbal homoeopathic or other alternative therapies: EH78\\nOther specified adverse cutaneous reactions to medication: EH7Y\\nUnspecified adverse cutaneous reactions to medication: EH7Z\\nPressure ulceration: EH90\\nPressure ulceration grade: EH90.3\\nSuspected deep pressureinduced tissue damage depth unknown: EH90.4\\nPressure ulceration ungradable: EH90.5\\nPressure ulcer of unspecified grade: EH90.Z\\nDermatoses provoked by friction or mechanical stress: EH92\\nCorns or callosities: EH92.0\\nHard corn: EH92.00\\nSoft corn: EH92.01\\nCallosity unspecified: EH92.0Z\\nFriction blister: EH92.1\\nOther specified skin damage due to repetitive friction or mechanical trauma: EH92.Y\\nDermatoses due to foreign bodies: EH93\\nTattoos or tattoo reactions: EH93.0\\nForeign body reaction to inorganic matter in the skin: EH93.1\\nForeign body reaction to organic matter in the skin: EH93.2\\nForeign body granuloma of skin: EH93.3\\nOther specified reaction to foreign body in the skin: EH93.Y\\nDermatoses due to foreign bodies unspecified: EH93.Z\\nScar of skin not elsewhere classified: EH94\\nOther specified dermatoses provoked or exacerbated by exposure to cold: EJ0Y\\nErythema ab igne: EJ10\\nOther specified dermatoses provoked by heat or electricity: EJ1Y\\nPhotoaging of the skin: EJ20\\nActinic elastosis: EJ20.0\\nActinic lentigo: EJ20.1\\nActinic lentiginosis: EJ20.2\\nActinic telangiectasia: EJ20.3\\nPhotoaging of the skin unspecified: EJ20.Z\\nOther specified chronic effects of ultraviolet radiation on the skin: EJ2Y\\nAutoimmune or other photodermatoses: EJ30\\nPolymorphic light eruption: EJ30.0\\nChronic actinic dermatitis: EJ30.1\\nOther specified photodermatoses: EJ30.Y\\nPhotodermatoses unspecified: EJ30.Z\\nSunburn: EJ40\\nSunburn erythema: EJ40.0\\nSunburn with blisters or exudation: EJ40.1\\nSunburn unspecified: EJ40.Z\\nBurn from exposure to artificial source of ultraviolet radiation: EJ41\\nBurn from exposure to therapeutic ultraviolet radiation: EJ41.0\\nOther specified burn from exposure to artificial source of ultraviolet radiation: EJ41.Y\\nBurn from exposure to artificial source of ultraviolet radiation unspecified: EJ41.Z\\nAcute effects of ultraviolet radiation on normal skin unspecified: EJ4Z\\nOther specified dermatoses provoked by light or UV radiation: EJ6Y\\nChronic effects of ionizing radiation on the skin: EJ71\\nDermatoses due to ionizing radiation unspecified: EJ7Z\\nAllergic contact dermatitis: EK00\\nAllergic contact dermatitis due to clothing or footwear: EK00.0\\nAllergic contact dermatitis due to cosmetics or fragrances: EK00.1\\nAllergic contact dermatitis due to dental materials: EK00.2\\nAllergic contact dermatitis due to food flavours or additives: EK00.3\\nAllergic contact dermatitis due to hairdressing products: EK00.4\\nAllergic contact dermatitis due to industrial biocides cutting oils or disinfectants: EK00.5\\nAllergic contact dermatitis due to metals or metal salts: EK00.6\\nAllergic contact dermatitis due to allergenic haptens derived from plants or organic matter: EK00.7\\nAllergic contact dermatitis due to plastics glues or resin systems: EK00.8\\nAllergic contact dermatitis due to preservatives or biocides: EK00.9\\nAllergic contact dermatitis due to rubber chemicals: EK00.A\\nAllergic contact dermatitis due to systemic medicaments: EK00.B\\nAllergic contact dermatitis due to topical medicaments: EK00.C\\nOther specified allergic contact dermatitis: EK00.Y\\nAllergic contact dermatitis unspecified: EK00.Z\\nPhotoallergic contact dermatitis: EK01\\nIrritant contact dermatitis: EK02\\nIrritant contact dermatitis from specified external agents: EK02.0\\nIrritant contact dermatitis due to wet work: EK02.00\\nIrritant contact dermatitis due to solvents: EK02.01\\nIrritant contact dermatitis due to exposure to acids alkalis or other specified chemical irritants: EK02.02\\nIrritant contact dermatitis due to cosmetics or emollients: EK02.03\\nIrritant contact dermatitis due to topical medicaments or antimicrobials: EK02.04\\nIrritant contact dermatitis due to plants or other vegetable matter: EK02.05\\nIrritant contact dermatitis due to foods: EK02.06\\nIrritant contact dermatitis due to friction sweating or contact with body fluids: EK02.2\\nIntertriginous dermatitis due to friction sweating or contact with body fluids: EK02.20\\nIrritant contact dermatitis due to saliva: EK02.21\\nIrritant contact dermatitis due to incontinence: EK02.22\\nIrritant contact dermatitis related to stoma or fistula: EK02.23\\nIrritant contact dermatitis related to skin contact with prostheses or surgical appliances: EK02.24\\nIrritant contact dermatitis due to other specified cause: EK02.Y\\nIrritant contact dermatitis unspecified: EK02.Z\\nAllergic contact urticaria: EK10\\nOral allergy syndrome: EK10.0\\nContact urticaria due to food allergen: EK10.1\\nOther specified allergic contact urticaria: EK10.Y\\nAllergic contact urticaria unspecified: EK10.Z\\nProtein contact dermatitis: EK11\\nAllergic contact sensitisation: EK12\\nPhototoxic reaction to fragrance or cosmetics: EK20\\nPhototoxic reaction to skin contact with other specified photoactive agent: EK2Y\\nPhototoxic dermatitis unspecified: EK2Z\\nCutaneous reactions to venomous or noxious animals: EK50\\nCutaneous insect bite reactions: EK50.0\\nPapular urticaria: EK50.00\\nBullous insect bite reaction: EK50.01\\nPersistent insect bite reaction: EK50.02\\nOther specified cutaneous insect bite reactions: EK50.0Y\\nCutaneous insect bite reactions unspecified: EK50.0Z\\nOther specified skin disorders provoked by external factors: EK5Y\\nCutaneous cysts: EK70\\nEpidermoid cyst: EK70.0\\nInfected epidermoid cyst: EK70.00\\nEpidermoid cyst unspecified: EK70.0Z\\nTrichilemmal cyst: EK70.1\\nDigital myxoid pseudocyst: EK70.2\\nHidrocystoma: XH7NR3\\nOther specified cutaneous cysts: EK70.Y\\nCutaneous cysts unspecified: EK70.Z\\nSkin tags or polyps: EK71\\nFibroepithelial polyp of skin: EK71.0\\nMultiple skin tags: EK71.1\\nPolyp of skin not elsewhere classified: EK71.Z\\nActinic keratosis and other discrete epidermal dysplasias: EK90\\nActinic keratosis: XH36H6\\nDiffuse actinic keratinocyte dysplasia: EK90.1\\nOther discrete epidermal dysplasias: EK90.Y\\nDermatoses which may presage cutaneous lymphoma: EK91\\nLarge plaque parapsoriasis: EK91.0\\nPoikiloderma vasculare atrophicans: EK91.1\\nPrimary cutaneous plasmacytosis: EK91.2\\nHistiocytoses of uncertain malignant potential: EK92\\nParaneoplastic syndromes involving skin: EL10\\nOther specified cutaneous markers of internal malignancy: EL1Y\\nOther specified cutaneous markers of internal disorders: EL3Y\\nUnsatisfactory surgical scar of skin: EL50\\nKeloidal surgical scar: EL50.0\\nHypertrophic surgical scar: EL50.1\\nAtrophic surgical scar: EL50.2\\nExpanded surgical scar: EL50.3\\nUnsatisfactory surgical scar of skin unspecified: EL50.Z\\nCutaneous flap necrosis: EL51\\nMyocutaneous flap necrosis: EL52\\nSkin graft failure: EL53\\nComposite graft failure: EL54\\nAcute radiodermatitis following radiotherapy: EL60\\nChronic radiodermatitis following radiotherapy: EL61\\nRadionecrosis of skin due to therapeutic ionizing irradiation: EL63\\nUnsatisfactory outcome from cutaneous cosmetic surgical procedure: EL73\\nAdverse reaction to dermal or deep fillers: EL73.0\\nAdverse reaction to chemical peel: EL73.1\\nAdverse reaction to injection of neurotoxin: EL73.2\\nUnsatisfactory outcome from cosmetic laser surgery: EL73.3\\nHypomelanosis resulting from cosmetic procedure: EL73.4\\nDyspigmentation resulting from cosmetic procedure: EL73.5\\nFibrosis or scarring following cosmetic procedure: EL73.6\\nAdverse cutaneous effects of diagnostic procedures: EL80\\nOther specified diseases of the skin: EM0Y\\nSkin disease of unspecified nature: EM0Z\\nOsteoarthritis of hip: FA00\\nPrimary osteoarthritis of hip: FA00.0\\nPost traumatic osteoarthritis of hip: FA00.1\\nOther secondary osteoarthritis of hip: FA00.2\\nOsteoarthritis of hip unspecified: FA00.Z\\nOsteoarthritis of knee: FA01\\nPrimary osteoarthritis of knee: FA01.0\\nPost traumatic osteoarthritis of knee: FA01.1\\nOther secondary osteoarthritis of knee: FA01.2\\nOsteoarthritis of knee unspecified: FA01.Z\\nOsteoarthritis of wrist or hand: FA02\\nPrimary osteoarthritis of wrist or hand: FA02.0\\nPost traumatic osteoarthritis of wrist or hand: FA02.1\\nOther secondary osteoarthritis of wrist or hand: FA02.2\\nOsteoarthritis of wrist or hand unspecified: FA02.Z\\nOsteoarthritis of other specified joint: FA03\\nPrimary osteoarthritis of other specified joint: FA03.0\\nPost traumatic osteoarthritis of other specified joint: FA03.1\\nOther secondary osteoarthritis of other specified joint: FA03.2\\nOsteoarthritis of other specified joint unspecified: FA03.Z\\nOligoosteoarthritis: FA04\\nPolyosteoarthritis: FA05\\nOsteoarthritis unspecified: FA0Z\\nDirect infections of joint: FA10\\nBacterial infection of joint: FA10.0\\nViral infection of joint: FA10.1\\nFungal infection of joint: FA10.2\\nDirect infections of joint unspecified: FA10.Z\\nReactive arthropathies: FA11\\nArthropathy following intestinal bypass: FA11.0\\nArthropathy following vaccination: FA11.1\\nArthropathy following genitourinary infection: FA11.2\\nOther specified reactive arthropathies: FA11.Y\\nReactive arthropathies unspecified: FA11.Z\\nPostinfectious arthropathies: FA12\\nBacterial postinfectious arthropathy: FA12.0\\nViral postinfectious arthropathies: FA12.1\\nFungal postinfectious arthropathies: FA12.2\\nParasitic postinfectious arthropathies: FA12.3\\nOther specified postinfectious arthropathies: FA12.Y\\nPostinfectious arthropathies unspecified: FA12.Z\\nInfectious spondyloarthritis: FA13\\nOther specified infection related arthropathies: FA1Y\\nInfection related arthropathies unspecified: FA1Z\\nRheumatoid arthritis: FA20\\nSeropositive rheumatoid arthritis: FA20.0\\nSeronegative rheumatoid arthritis: FA20.1\\nRheumatoid arthritis serology unspecified: FA20.Z\\nPsoriatic arthritis: FA21\\nPsoriatic spondyloarthritis: FA21.0\\nOther specified psoriatic arthritis: FA21.Y\\nPsoriatic arthritis unspecified: FA21.Z\\nPolymyalgia rheumatica: FA22\\nAdultonset Still disease: FA23\\nJuvenile idiopathic arthritis: FA24\\nJuvenile idiopathic oligoarthritis: FA24.0\\nJuvenile idiopathic oligoarthritis onset persistent: FA24.00\\nJuvenile idiopathic oligoarthritis onset extended: FA24.01\\nJuvenile idiopathic oligoarthritis onset unspecified: FA24.0Z\\nJuvenile idiopathic polyarthritis: FA24.1\\nJuvenile psoriatic arthritis: FA24.2\\nJuvenile enthesitis related arthritis: FA24.3\\nJuvenile systemic arthritis: FA24.4\\nOther specified juvenile idiopathic arthritis: FA24.Y\\nJuvenile idiopathic arthritis unspecified: FA24.Z\\nGout: FA25\\nPrimary gout: FA25.0\\nSecondary gout: FA25.1\\nLeadinduced gout: FA25.10\\nDruginduced gout: FA25.11\\nGouty arthropathy due to enzyme defects or other inherited disorders: FA25.12\\nOther specified secondary gout: FA25.1Y\\nSecondary gout unspecified: FA25.1Z\\nGout without specification whether primary or secondary: FA25.2\\nTophaceous gout: FA25.20\\nOther specified gout without specification whether primary or secondary: FA25.2Y\\nGout unspecified: FA25.2Z\\nCertain specified crystal arthropathies: FA26\\nCalcium pyrophosphate dehydrate deposition disease: FA26.0\\nHydroxyapatite deposition disease: FA26.1\\nChondrocalcinosis: FA26.2\\nOther specified crystal arthropathies: FA26.Y\\nCrystal arthropathies unspecified: FA26.Z\\nCertain specified inflammatory arthropathies: FA27\\nKashinBeck disease: FA27.0\\nPigmented villonodular synovitis: FA27.1\\nPalindromic rheumatism: FA27.2\\nTransient synovitis: FA27.3\\nIntermittent hydrarthrosis: FA27.4\\nOther specified inflammatory arthropathies: FA27.Y\\nInflammatory arthropathies unspecified: FA2Z\\nAcquired deformities of fingers or toes: FA30\\nAcquired hallux valgus: FA30.0\\nHallux rigidus: FA30.1\\nAcquired hammer toe: FA30.2\\nOther specified acquired deformities of fingers or toes: FA30.Y\\nAcquired deformities of fingers or toes unspecified: FA30.Z\\nOther acquired deformities of limbs: FA31\\nValgus deformity not elsewhere classified: FA31.0\\nVarus deformity not elsewhere classified: FA31.1\\nFlexion deformity: FA31.2\\nAcquired wrist drop: FA31.3\\nAcquired foot drop: FA31.4\\nAcquired pes planus: FA31.5\\nAcquired clawhand or clubhand: FA31.6\\nAcquired clawfoot or clubfoot: FA31.7\\nAcquired unequal limb length: FA31.8\\nOther specified acquired deformities of limbs: FA31.Y\\nAcquired deformities of limbs unspecified: FA31.Z\\nDisorders of patella: FA32\\nRecurrent instability of patella: FA32.0\\nPatellofemoral disorders: FA32.1\\nOther specified disorders of patella: FA32.Y\\nDisorders of patella unspecified: FA32.Z\\nInternal derangement of knee: FA33\\nCystic meniscus: FA33.0\\nDiscoid meniscus: FA33.1\\nDerangement of meniscus due to old tear or injury: FA33.2\\nLoose body in knee: FA33.3\\nChronic instability of knee: FA33.4\\nChronic instability of knee medial collateral ligament or other or unspecified part of medial meniscus: FA33.40\\nOther specified chronic instability of knee: FA33.4Y\\nChronic instability of knee unspecified: FA33.4Z\\nOther specified internal derangement of knee: FA33.Y\\nInternal derangement of knee unspecified: FA33.Z\\nCertain specified joint derangements: FA34\\nLoose body in joint: FA34.0\\nDisorder of ligament: FA34.1\\nRecurrent instability of joint: FA34.2\\nContracture of joint: FA34.3\\nAnkylosis of joint: FA34.4\\nImpingement syndrome of hip: FA34.5\\nOther joint derangements: FA34.Y\\nWear of articular bearing surface of joint prosthesis: FA35\\nWear of articular bearing surface of joint prosthesis of hip: FA35.0\\nWear of articular bearing surface of joint prosthesis of knee: FA35.1\\nWear of articular bearing surface of joint prosthesis of other joint: FA35.2\\nWear of articular bearing surface of joint prosthesis of unspecified joint: FA35.Z\\nEffusion of joint: FA36\\nEffusion of joint containing blood: FA36.0\\nOther specified effusion of joint: FA36.Y\\nEffusion of joint unspecified: FA36.Z\\nCertain joint disorders not elsewhere classified: FA37\\nOsteophyte: FA37.0\\nOther specified certain joint disorders not elsewhere classified: FA37.Y\\nCertain joint disorders not elsewhere classified unspecified: FA37.Z\\nArthropathy in diseases classified elsewhere: FA38\\nDiabetic arthropathy: FA38.0\\nNeuropathic arthropathy: FA38.1\\nDiabetic Charcot arthropathy: FA38.10\\nOther specified neuropathic arthropathy: FA38.1Y\\nNeuropathic arthropathy unspecified: FA38.1Z\\nArthropathy in hypersensitivity reactions classified elsewhere: FA38.2\\nHaemophilic arthropathy: FA38.3\\nArthropathy in other specified diseases classified elsewhere: FA38.Y\\nUnspecified joint disorders and deformities of limbs: FA3Z\\nOther specified arthropathies: FA5Y\\nArthropathies unspecified: FA5Z\\nSpinal deformities: FA70\\nKyphosis: FA70.0\\nScoliosis: FA70.1\\nLordosis: FA70.2\\nSpinal deformities unspecified: FA70.Z\\nTorticollis: FA71\\nDisorders of vertebra: FA72\\nAnkylosing hyperostosis: FA72.0\\nKissing spine: FA72.1\\nTraumatic spondylopathy: FA72.2\\nFatigue fracture of vertebra: FA72.3\\nCollapsed vertebra not elsewhere classified: FA72.4\\nOther specified disorders of vertebra: FA72.Y\\nDisorders of vertebra unspecified: FA72.Z\\nOther specified structural disorders of spine: FA7Y\\nStructural disorders of spine unspecified: FA7Z\\nIntervertebral disc degeneration: FA80\\nIntervertebral disc degeneration of cervical spine without prolapsed disc: FA80.0\\nIntervertebral disc degeneration of cervical spine with prolapsed disc: FA80.1\\nIntervertebral disc degeneration of cervical spine with bony spur at the vertebra: FA80.2\\nIntervertebral disc degeneration of cervical spine with nervous system involvement: FA80.3\\nIntervertebral disc degeneration of thoracic spine without prolapsed disc: FA80.4\\nIntervertebral disc degeneration of thoracic spine with prolapsed disc: FA80.5\\nIntervertebral disc degeneration of thoracic spine with bony spur at the vertebra: FA80.6\\nIntervertebral disc degeneration of thoracic spine with nervous system involvement: FA80.7\\nIntervertebral disc degeneration of lumbar spine without prolapsed disc: FA80.8\\nIntervertebral disc degeneration of lumbar spine with prolapsed disc: FA80.9\\nIntervertebral disc degeneration of lumbar spine with bony spur at the vertebra: FA80.A\\nIntervertebral disc degeneration of lumbar spine with nervous system involvement: FA80.B\\nOther specified intervertebral disc degeneration: FA80.Y\\nIntervertebral disc degeneration unspecified: FA80.Z\\nSpondylolysis: FA81\\nSpondylolysis with slippage: FA81.0\\nSpondylolysis without slippage: FA81.1\\nSpondylolysis unspecified: FA81.Z\\nSpinal stenosis: FA82\\nOssification of spinal ligaments: FA83\\nSpondylolisthesis: FA84\\nSpondylolisthesis with pars defect: FA84.0\\nSpondylolisthesis without pars defect: FA84.1\\nSpondylolisthesis unspecified: FA84.Z\\nSpinal endplate defects: FA85\\nSpinal epiphysiopathy with no determinant: FA85.0\\nSpinal epiphysiopathy with determinants: FA85.1\\nLocalised central endplate defect: FA85.10\\nMultiple anterior endplate defect: FA85.11\\nSeparation of ring apophysis: FA85.12\\nOther specified spinal epiphysiopathy with determinants: FA85.1Y\\nSpinal epiphysiopathy with determinants unspecified: FA85.1Z\\nOther specified spinal endplate defects: FA85.Y\\nSpinal endplate defects unspecified: FA85.Z\\nOther specified degenerative condition of spine: FA8Y\\nDegenerative condition of spine unspecified: FA8Z\\nInfection of vertebra: FA90\\nInfection of vertebra with no determinant: FA90.0\\nInfection of vertebra with determinants: FA90.1\\nOther specified infection of vertebra: FA90.Y\\nInfection of vertebra unspecified: FA90.Z\\nInfection of intervertebral disc: FA91\\nInflammatory spondyloarthritis: FA92\\nAxial spondyloarthritis: FA92.0\\nSpinal enthesitis: FA92.00\\nSacroiliitis not elsewhere classified: FA92.01\\nOther specified axial spondyloarthritis: FA92.0Y\\nAxial spondyloarthritis unspecified: FA92.0Z\\nPeripheral spondyloarthritis: FA92.1\\nOther specified inflammatory spondyloarthritis: FA92.Y\\nInflammatory spondyloarthritis unspecified: FA92.Z\\nOther specified inflammation of spine: FA9Y\\nInflammation of spine unspecified: FA9Z\\nAnkylosis of spinal joint: FB00\\nOther specified spondylopathies: FB0Y\\nSpondylopathies unspecified: FB0Z\\nSpinal instabilities: FB10\\nOther specified conditions associated with the spine: FB1Y\\nConditions associated with the spine unspecified: FB1Z\\nInfectious myositis: FB30\\nCalcification or ossification of muscle: FB31\\nProgressive osseous heteroplasia: FB31.0\\nFibrodysplasia ossificans progressiva: FB31.1\\nOther specified calcification or ossification of muscle: FB31.Y\\nCalcification or ossification of muscle unspecified: FB31.Z\\nCertain specified disorders of muscle: FB32\\nDiastasis of muscle: FB32.0\\nSpontaneous rupture of muscle: FB32.1\\nIschaemic infarction of muscle: FB32.2\\nIdiopathic rhabdomyolysis: FB32.20\\nOther specified ischaemic infarction of muscle: FB32.2Y\\nIschaemic infarction of muscle unspecified: FB32.2Z\\nImmobility syndrome: FB32.3\\nContracture of muscle: FB32.4\\nMuscle strain or sprain: FB32.5\\nOther specified disorders of muscles: FB32.Y\\nSecondary disorders of muscle: FB33\\nDisorders of muscles unspecified: FB3Z\\nTenosynovitis: FB40\\nInfectious tenosynovitis: FB40.0\\nPlantar fasciitis: FB40.1\\nPosterior tibial tendonitis: FB40.2\\nCalcific tendinitis: FB40.3\\nTrigger finger: FB40.4\\nRadial styloid tenosynovitis: FB40.5\\nOther specified tenosynovitis: FB40.Y\\nTenosynovitis unspecified: FB40.Z\\nSpontaneous rupture of synovium or tendon: FB41\\nSpontaneous rupture of popliteal cyst: FB41.0\\nSpontaneous rupture of synovium: FB41.1\\nSpontaneous rupture of tendon: FB41.2\\nOther specified spontaneous rupture of synovium or tendon: FB41.Y\\nSpontaneous rupture of synovium or tendon unspecified: FB41.Z\\nCertain specified disorders of synovium or tendon: FB42\\nAcquired short Achilles tendon: FB42.0\\nContracture of tendon sheath: FB42.1\\nGanglion: FB42.2\\nSynovial hypertrophy not elsewhere classified: FB42.3\\nSecondary disorders of synovium or tendon: FB43\\nOther specified disorders of synovium or tendon: FB4Y\\nDisorders of synovium or tendon unspecified: FB4Z\\nBursitis: FB50\\nInfectious bursitis: FB50.0\\nBursitis related to use overuse or pressure: FB50.1\\nSynovial cyst of popliteal space: FB50.2\\nCalcium deposit in bursa: FB50.3\\nOther specified bursitis: FB50.Y\\nBursitis unspecified: FB50.Z\\nFibroblastic disorders: FB51\\nPalmar fascial fibromatosis: FB51.0\\nKnuckle pads: FB51.1\\nFasciitis and fibromatosis: FB51.2\\nFibroblastic rheumatism: FB51.3\\nRetroperitoneal fibrosis: FB51.4\\nPrimary retroperitoneal fibrosis: FB51.40\\nOther specified retroperitoneal fibrosis: FB51.4Y\\nRetroperitoneal fibrosis unspecified: FB51.4Z\\nOther specified fibroblastic disorders: FB51.Y\\nFibroblastic disorders unspecified: FB51.Z\\nSoft tissue disorders in diseases classified elsewhere: FB52\\nShoulder lesions: FB53\\nAdhesive capsulitis of shoulder: FB53.0\\nRotator cuff syndrome: FB53.1\\nImpingement syndrome of shoulder: FB53.2\\nOther specified shoulder lesions: FB53.Y\\nShoulder lesions unspecified: FB53.Z\\nEnthesopathies of lower limb: FB54\\nIliac crest spur: FB54.0\\nIliotibial band syndrome: FB54.1\\nTibial collateral bursitis: FB54.2\\nCalcaneal spur: FB54.3\\nMetatarsalgia: FB54.4\\nOther specified enthesopathies of lower limb: FB54.Y\\nEnthesopathies of lower limb unspecified: FB54.Z\\nCertain specified enthesopathies: FB55\\nMedial epicondylitis of elbow: FB55.0\\nLateral epicondylitis of elbow: FB55.1\\nPeriarthritis of wrist: FB55.2\\nEnthesopathies unspecified: FB55.Z\\nSpecified soft tissue disorders not elsewhere classified: FB56\\nForeign body granuloma of soft tissue not elsewhere classified: FB56.0\\nResidual foreign body in soft tissue: FB56.1\\nMyalgia: FB56.2\\nHypertrophy of infrapatellar fat pad: FB56.3\\nPain in limb: FB56.4\\nOther specified soft tissue disorders: FB56.6\\nSoft tissue disorders unspecified: FB6Z\\nCertain specified disorders of bone density or structure: FB80\\nFibrous dysplasia of bone: FB80.0\\nSkeletal fluorosis: FB80.1\\nOsteitis condensans: FB80.2\\nHyperostosis of skull: FB80.3\\nOsteosclerosis: FB80.4\\nSolitary bone cyst: FB80.5\\nAneurysmal bone cyst: XH23E0\\nMalunion of fracture: FB80.7\\nNonunion of fracture: FB80.8\\nDelayed union of fracture: FB80.9\\nStress fracture not elsewhere classified: FB80.A\\nPathological fracture: FB80.B\\nOther specified disorders of bone density or structure: FB80.Y\\nDisorder of bone density or structure unspecified: FB80.Z\\nOsteonecrosis: FB81\\nIdiopathic aseptic osteonecrosis: FB81.0\\nOsteonecrosis due to dialysis: FB81.1\\nDruginduced osteonecrosis: FB81.2\\nOsteonecrosis due to trauma: FB81.3\\nOsteonecrosis due to haemoglobinopathy: FB81.4\\nOsteonecrosis due to ionizing radiation: FB81.5\\nAlcohol induced osteonecrosis: FB81.6\\nOther specified osteonecrosis: FB81.Y\\nOsteonecrosis unspecified: FB81.Z\\nChondropathies: FB82\\nChondromalacia: FB82.0\\nChondromalacia patellae: FB82.00\\nOther specified chondromalacia: FB82.0Y\\nChondromalacia unspecified: FB82.0Z\\nOsteochondrosis or osteochondritis dissecans: FB82.1\\nSlipped upper femoral epiphysis: FB82.2\\nRelapsing polychondritis: FB82.3\\nOther specified chondropathies: FB82.Y\\nChondropathies unspecified: FB82.Z\\nLow bone mass disorders: FB83\\nOsteopenia: FB83.0\\nPremenopausal idiopathic osteopenia: FB83.00\\nPostmenopausal osteopenia: FB83.01\\nSenile osteopenia: FB83.02\\nOsteopenia of disuse: FB83.03\\nDruginduced osteopenia: FB83.04\\nOther specified osteopenia: FB83.0Y\\nOsteopenia unspecified: FB83.0Z\\nOsteoporosis: FB83.1\\nPremenopausal idiopathic osteoporosis: FB83.10\\nPostmenopausal osteoporosis: FB83.11\\nOsteoporosis of disuse: FB83.12\\nDruginduced osteoporosis: FB83.13\\nOsteoporosis due to malabsorption: FB83.14\\nOther specified osteoporosis: FB83.1Y\\nOsteoporosis unspecified: FB83.1Z\\nAdult osteomalacia: FB83.2\\nAluminium bone disease: FB83.20\\nAdult osteomalacia due to malnutrition: FB83.21\\nDruginduced adult osteomalacia: FB83.22\\nOther specified adult osteomalacia: FB83.2Y\\nAdult osteomalacia unspecified: FB83.2Z\\nOsteomyelitis or osteitis: FB84\\nAcute haematogenous osteomyelitis: FB84.0\\nOther acute osteomyelitis: FB84.1\\nSubacute osteomyelitis: FB84.2\\nChronic multifocal osteomyelitis: FB84.3\\nChronic osteomyelitis with draining sinus: FB84.4\\nOther chronic haematogenous osteomyelitis: FB84.5\\nOther specified osteomyelitis or osteitis: FB84.Y\\nOsteomyelitis or osteitis unspecified: FB84.Z\\nPaget disease of bone: FB85\\nJuvenile Paget disease: FB85.0\\nPaget disease of bone in neoplastic disease: FB85.1\\nOther specified Paget disease of bone: FB85.Y\\nPaget disease of bone unspecified: FB85.Z\\nDisorders associated with bone growth: FB86\\nEpiphyseal arrest: FB86.0\\nBone hyperplasias: FB86.1\\nHypertrophic osteoarthropathy: FB86.10\\nHypertrophy of bone: FB86.11\\nOther specified bone hyperplasias: FB86.1Y\\nBone hyperplasias unspecified: FB86.1Z\\nOsteolysis: FB86.2\\nOther specified disorders associated with bone growth: FB86.Y\\nDisorders associated with bone growth unspecified: FB86.Z\\nOther specified osteopathies or chondropathies: FB8Y\\nOsteopathies or chondropathies unspecified: FB8Z\\nCertain specified acquired deformities of musculoskeletal system or connective tissue not elsewhere classified: FC00\\nAcquired deformity of nose: FC00.0\\nAcquired deformity of neck: FC00.1\\nAcquired deformity of chest or rib: FC00.2\\nAcquired deformity of pelvis: FC00.3\\nAcquired deformity of trunk: FC00.4\\nAcquired deformities of musculoskeletal system and connective tissue not classified elsewhere other specified sites: FC00.Y\\nPostprocedural disorders of the musculoskeletal system: FC01\\nPseudarthrosis after fusion or arthrodesis: FC01.0\\nPostlaminectomy syndrome not elsewhere classified: FC01.1\\nPost radiation kyphosis: FC01.2\\nPostlaminectomy kyphosis: FC01.3\\nPostsurgical lordosis: FC01.4\\nPost radiation scoliosis: FC01.5\\nFracture of bone following insertion of orthopaedic implant joint prosthesis or bone plate: FC01.6\\nNonunion after arthrodesis: FC01.7\\nNonunion after spinal arthrodesis: FC01.70\\nNonunion after arthrodesis of other sites: FC01.7Y\\nPostsurgical osteolysis: FC01.8\\nPostoophorectomy osteoporosis: FC01.9\\nPostsurgical malabsorption osteoporosis: FC01.A\\nOther specified diseases of the musculoskeletal system or connective tissue: FC0Y\\nDiseases of the musculoskeletal system or connective tissue unspecified: FC0Z\\nVulvitis: GA00\\nAcute vulvitis: GA00.0\\nSubacute chronic or recurrent vulvitis: GA00.1\\nAbscess of vulva: GA00.2\\nGenital ulcer of vulva: GA00.3\\nVulvovaginal ulceration or inflammation: GA00.4\\nVulvovaginal ulceration: GA00.40\\nVulvovaginal inflammation: GA00.41\\nVulvitis unspecified: GA00.Z\\nInflammatory disorders of the uterus except cervix: GA01\\nAcute inflammatory disease of uterus: GA01.0\\nAcute endometritis: GA01.00\\nAcute inflammatory disease of uterus with pyometra: GA01.01\\nAcute inflammatory disease of uterus unspecified: GA01.0Z\\nChronic inflammatory disease of uterus: GA01.1\\nChronic endometritis: GA01.10\\nChronic inflammatory disease of uterus with pyometra: GA01.11\\nChronic inflammatory disease of uterus unspecified: GA01.1Z\\nOther specified inflammatory disorders of the uterus except cervix: GA01.Y\\nInflammatory disorders of the uterus except cervix unspecified: GA01.Z\\nVaginitis: GA02\\nAcute vaginitis: GA02.0\\nInflammatory vaginitis: GA02.1\\nSubacute or chronic vaginitis: GA02.2\\nGenital ulcer disease of vagina: GA02.3\\nVaginitis unspecified: GA02.Z\\nDiseases of Bartholin gland: GA03\\nAbscess of Bartholin gland: GA03.0\\nCyst of Bartholin gland: GA03.1\\nOther specified diseases of Bartholin gland: GA03.Y\\nDiseases of Bartholin gland unspecified: GA03.Z\\nCervicitis: GA04\\nFemale pelvic inflammatory diseases: GA05\\nAcute female pelvic inflammatory disease: GA05.0\\nChronic pelvic inflammatory disease: GA05.1\\nFemale pelvic peritonitis unspecified: GA05.2\\nTuboovarian abscess: GA05.3\\nOther specified female pelvic inflammatory diseases: GA05.Y\\nFemale pelvic inflammatory diseases unspecified: GA05.Z\\nPelvic peritoneal adhesions of unknown or combined origin: GA06\\nSalpingitis or oophoritis: GA07\\nAcute salpingitis or oophoritis: GA07.0\\nChronic salpingitis or oophoritis: GA07.1\\nSalpingitis or oophoritis unspecified: GA07.Z\\nInflammatory disorders of the female genital tract unspecified: GA0Z\\nEndometriosis: GA10\\nEndometriosis of the reproductive system: GA10.B\\nEndometriosis of the uterosacral ligaments: GA10.B0\\nEndometriosis of the pelvic side wall: GA10.B1\\nEndometriosis of rectovaginal septum or vagina: GA10.B2\\nEndometriosis of fallopian tube: GA10.B3\\nSuperficial ovarian endometriosis: GA10.B4\\nDeep ovarian endometriosis: GA10.B5\\nEndometriosis of other sites of the reproductive system: GA10.BY\\nEndometriosis of unspecified site of reproductive system: GA10.BZ\\nEndometriosis of the digestive system: GA10.C\\nEndometriosis of the gallbladder: GA10.C0\\nEndometriosis of intestine: GA10.C1\\nEndometriosis of pelvic peritoneum: GA10.C2\\nPeritoneal pockets due to endometriosis: GA10.C3\\nEndometriosis of other sites within the digestive system: GA10.CY\\nEndometriosis of unspecified site within the digestive system: GA10.CZ\\nEndometriosis of urinary system: GA10.D\\nEndometriosis of the bladder: GA10.D0\\nEndometriosis of other sites in the urinary system: GA10.DY\\nEndometriosis of unspecified site in the urinary system: GA10.DZ\\nEndometriosis of the circulatory system: GA10.E\\nEndometriosis of the nervous system: GA10.F\\nThoracic endometriosis: GA10.G\\nEndometriosis in cutaneous scar: GA10.H\\nEndometriosisrelated adhesions: GA10.J\\nEndometriosis of other specified sites: GA10.Y\\nEndometriosis of unspecified site: GA10.Z\\nAdenomyosis: GA11\\nDyspareunia: GA12\\nAcquired abnormalities of vulva or perineum: GA13\\nPolyp of vulva: GA13.0\\nLow grade squamous intraepithelial lesion of vulva: GA13.1\\nHypertrophy of vulva: GA13.2\\nVulvar cyst: GA13.3\\nLabial agglutination: GA13.4\\nSkene duct cyst: GA13.5\\nVulvar laceration: GA13.6\\nVulvar haematoma: GA13.7\\nOther specified acquired abnormalities of vulva or perineum: GA13.Y\\nAcquired abnormalities of vulva or perineum unspecified: GA13.Z\\nAcquired abnormalities of vagina: GA14\\nPolyp of vagina: GA14.0\\nHaematocolpos: GA14.1\\nVaginal foreign body: GA14.2\\nVaginal haematoma: GA14.3\\nLeukoplakia of vagina: GA14.5\\nLow grade squamous intraepithelial lesion of vagina: GA14.6\\nOther specified acquired abnormalities of vagina: GA14.Y\\nAcquired abnormalities of vagina unspecified: GA14.Z\\nAcquired abnormalities of cervix uteri: GA15\\nPolyp of cervix uteri: GA15.0\\nErosion or ectropion of cervix uteri: GA15.1\\nNabothian cyst: GA15.2\\nOld laceration of cervix uteri: GA15.3\\nStricture or stenosis of cervix uteri: GA15.4\\nHypertrophic elongation of cervix uteri: GA15.5\\nIncompetence of cervix uteri: GA15.6\\nLow grade squamous intraepithelial lesion of cervix uteri: GA15.7\\nOther specified acquired abnormalities of cervix uteri: GA15.Y\\nAcquired abnormalities of cervix uteri unspecified: GA15.Z\\nAcquired abnormalities of uterus except cervix: GA16\\nEndometrial glandular hyperplasia: GA16.0\\nMalposition of uterus: GA16.1\\nIntrauterine synechiae: GA16.2\\nHaematometra: GA16.3\\nOther specified acquired abnormalities of uterus except cervix: GA16.Y\\nAcquired abnormalities of uterus except cervix unspecified: GA16.Z\\nAcquired abnormalities of fallopian tube: GA17\\nAcquired parafimbrial cyst of the fallopian tube: GA17.0\\nFimbrial agglutination: GA17.1\\nHydrosalpinx: GA17.2\\nHaematosalpinx: GA17.3\\nSalpingitis isthmica nodosa: GA17.4\\nOther specified acquired abnormalities of fallopian tube: GA17.Y\\nAcquired abnormalities of fallopian tube unspecified: GA17.Z\\nAcquired abnormalities of ovary: GA18\\nFollicular cyst of ovary: GA18.0\\nCorpus luteum cyst: GA18.1\\nTheca lutein cyst: GA18.2\\nPara ovarian cyst: GA18.4\\nTorsion of ovary ovarian pedicle or fallopian tube: GA18.5\\nOther or unspecified ovarian cysts: GA18.6\\nAcquired atrophy of ovary or fallopian tube: GA18.7\\nOther specified acquired abnormalities of ovary: GA18.Y\\nAcquired abnormalities of ovary unspecified: GA18.Z\\nAcquired abnormalities of broad ligament: GA19\\nHaematoma of broad ligament: GA19.0\\nOther specified acquired abnormalities of broad ligament: GA19.Y\\nAcquired abnormalities of broad ligament unspecified: GA19.Z\\nOther specified noninflammatory disorders of female genital tract: GA1Y\\nNoninflammatory disorders of female genital tract unspecified: GA1Z\\nMenstrual cycle bleeding disorders: GA20\\nAmenorrhoea: GA20.0\\nPrimary amenorrhoea: GA20.00\\nSecondary amenorrhoea: GA20.01\\nLactational amenorrhoea: GA20.02\\nOther specified amenorrhoea: GA20.0Y\\nAmenorrhoea unspecified: GA20.0Z\\nAbnormal frequency of uterine bleeding: GA20.1\\nFrequent menstrual bleeding: GA20.10\\nInfrequent menstrual bleeding: GA20.11\\nAbnormal frequency of uterine bleeding unspecified: GA20.1Z\\nOvulation bleeding: GA20.2\\nIntermenstrual bleeding: GA20.20\\nOther specified ovulation bleeding: GA20.2Y\\nOvulation bleeding unspecified: GA20.2Z\\nAbnormal regularity of uterine bleeding: GA20.3\\nAbnormal duration of uterine bleeding: GA20.4\\nAbnormal volume of uterine bleeding: GA20.5\\nHeavy menstrual bleeding: GA20.50\\nLight menstrual bleeding: GA20.51\\nAbnormal volume of uterine bleeding unspecified: GA20.5Z\\nOther specified menstrual cycle bleeding disorders: GA20.Y\\nMenstrual cycle bleeding disorders unspecified: GA20.Z\\nNonmenstrual bleeding disorders: GA21\\nPostcoital or contact bleeding: GA21.0\\nOther specified nonmenstrual bleeding disorders: GA21.Y\\nNonmenstrual bleeding disorders unspecified: GA21.Z\\nExcessive menstruation with irregular cycle: GA22\\nAnovulatory bleeding: GA23\\nOther specified abnormal uterine or vaginal bleeding: GA2Y\\nAbnormal uterine or vaginal bleeding unspecified: GA2Z\\nMenopausal or perimenopausal disorders: GA30\\nMenopause: GA30.0\\nMenopausal or female climacteric states: GA30.00\\nMenopausal transition: GA30.01\\nExcessive bleeding in the premenopausal period: GA30.02\\nOther specified menopause: GA30.0Y\\nMenopause unspecified: GA30.0Z\\nPostmenopausal uterine bleeding: GA30.1\\nPostmenopausal atrophic vaginitis: GA30.2\\nStates associated with artificial menopause: GA30.3\\nMenopausal hot flush: GA30.4\\nMenopausal osteoporosis: GA30.5\\nPremature ovarian failure: GA30.6\\nOther specified menopausal or perimenopausal disorders: GA30.Y\\nMenopausal or perimenopausal disorders unspecified: GA30.Z\\nFemale infertility: GA31\\nPrimary female infertility: GA31.0\\nPrimary female infertility of uterine origin: GA31.00\\nPrimary female infertility of tubal origin: GA31.01\\nPrimary female infertility of other specified origin: GA31.0Y\\nPrimary female infertility of unspecified origin: GA31.0Z\\nSecondary female infertility: GA31.1\\nSecondary female infertility of uterine origin: GA31.10\\nSecondary female infertility of tubal origin: GA31.11\\nSecondary female infertility of other specified origin: GA31.1Y\\nSecondary female infertility of unspecified origin: GA31.1Z\\nFemale infertility without specification whether primary or secondary: GA31.Z\\nComplications associated with medically assisted reproduction: GA32\\nOvarian hyperstimulation syndrome: GA32.0\\nBleeding after egg retrieval: GA32.1\\nInfection associated with medically assisted reproduction: GA32.2\\nComplications of attempted embryo transfer or medically assisted insemination: GA32.3\\nOther specified complications associated with medically assisted reproduction: GA32.Y\\nComplications associated with medically assisted reproduction unspecified: GA32.Z\\nRecurrent pregnancy loss: GA33\\nFemale pelvic pain associated with genital organs or menstrual cycle: GA34\\nPain related to vulva vagina or pelvic floor: GA34.0\\nVulval pain: GA34.00\\nPerineal pain: GA34.01\\nVulvodynia: GA34.02\\nOther specified pain related to vulva vagina or pelvic floor: GA34.0Y\\nPain related to vulva vagina or pelvic floor unspecified: GA34.0Z\\nVaginal laxity: GA34.1\\nFemale pelvic pain: GA34.2\\nCyclic pelvic pain: GA34.20\\nNoncyclic pelvic pain: GA34.21\\nFemale pelvic pain unspecified: GA34.2Z\\nDysmenorrhoea: GA34.3\\nPremenstrual disturbances: GA34.4\\nPremenstrual tension syndrome: GA34.40\\nPremenstrual dysphoric disorder: GA34.41\\nOther specified premenstrual disturbances: GA34.4Y\\nPremenstrual disturbances unspecified: GA34.4Z\\nOvarian remnant syndrome: GA34.5\\nFemale genital pain: GA34.6\\nOther specified female pelvic pain associated with genital organs or menstrual cycle: GA34.Y\\nFemale pelvic pain associated with genital organs or menstrual cycle unspecified: GA34.Z\\nInflammatory dermatoses of the vulva: GA40\\nUlcerative or erosive disorders of the vulva: GA41\\nVulval aphthosis: GA41.0\\nOther specified ulcerative or erosive disorders of the vulva: GA41.Y\\nSensory disturbance of the vulva: GA42\\nVulval pruritus: GA42.0\\nOther specified dermatoses of female genitalia: GA4Y\\nOther specified diseases of the female genital system: GA6Y\\nDiseases of the female genital system unspecified: GA6Z\\nUlcerative disorders of the penis or scrotum: GA80\\nAphthosis of penis or scrotum: GA80.0\\nUlcer of penis of uncertain nature: GA80.1\\nOther specified ulcerative disorders of penis or scrotum: GA80.Y\\nMiscellaneous dermatoses of male genitalia: GA81\\nPenoscrotal pruritus: GA81.0\\nOther specified dermatoses of male genitalia: GA81.Y\\nHyperplasia of prostate: GA90\\nInflammatory or other diseases of prostate: GA91\\nChronic prostatitis: GA91.0\\nAbscess of prostate: GA91.1\\nProstatocystitis: GA91.2\\nCalculus of prostate: GA91.3\\nHaemorrhage of the prostate: GA91.4\\nAtrophy of prostate: GA91.5\\nLow grade intraepithelial lesion of prostate: GA91.6\\nOther specified inflammatory or other diseases of prostate: GA91.Y\\nInflammatory or other diseases of prostate unspecified: GA91.Z\\nHydrocele or spermatocele: GB00\\nEncysted hydrocele: GB00.0\\nInfected hydrocele: GB00.1\\nSpermatocele: GB00.2\\nOther specified hydrocele or spermatocele: GB00.Y\\nHydrocele or spermatocele unspecified: GB00.Z\\nTorsion of testis epididymis or appendices: GB01\\nTorsion of testis: GB01.0\\nTorsion of epididymis: GB01.1\\nTorsion of hydatids: GB01.2\\nTorsion of testis epididymis or appendices unspecified: GB01.Z\\nOrchitis or epididymitis: GB02\\nOrchitis epididymitis or epididymoorchitis with abscess: GB02.0\\nOrchitis epididymitis or epididymoorchitis without abscess: GB02.1\\nOrchitis or epididymitis unspecified: GB02.Z\\nAtrophy of testis: GB03\\nMale infertility: GB04\\nAzoospermia: GB04.0\\nOther specified male infertility: GB04.Y\\nMale infertility unspecified: GB04.Z\\nRedundant prepuce phimosis or paraphimosis: GB05\\nRedundant prepuce: GB05.0\\nFrenulum breve: GB05.1\\nPhimosis: GB05.2\\nParaphimosis: GB05.3\\nAdherent prepuce: GB05.4\\nRedundant prepuce phimosis or paraphimosis unspecified: GB05.Z\\nCertain specified disorders of penis: GB06\\nBalanitis or balanoposthitis: GB06.0\\nIrritant balanoposthitis: GB06.01\\nBalanoposthitis due to infection: GB06.02\\nOther specified forms of balanitis or balanoposthitis: GB06.0Y\\nBalanitis or balanoposthitis unspecified: GB06.0Z\\nPriapism: GB06.1\\nPenile fibromatosis: GB06.2\\nMondor disease of the penis: GB06.3\\nChronic penile oedema: GB06.4\\nSclerosing lymphangitis of penis: GB06.5\\nOther specified disorders of penis: GB06.Y\\nDisorders of penis unspecified: GB06.Z\\nInflammatory disorders of male genital organs not elsewhere classified: GB07\\nInflammatory disorders of seminal vesicle: GB07.0\\nInflammatory disorders of spermatic cord tunica vaginalis or vas deferens: GB07.1\\nInflammatory disorders of scrotum: GB07.2\\nOther specified inflammatory disorders of male genital organs not elsewhere classified: GB07.Y\\nVascular disorders of male genital organs: GB08\\nOther specified diseases of the male genital system: GB0Y\\nDiseases of the male genital system unspecified: GB0Z\\nBenign breast disease: GB20\\nFibrocystic change of breast: GB20.0\\nFibroadenosis of breast: GB20.1\\nOther specified benign breast disease: GB20.Y\\nBenign breast disease unspecified: GB20.Z\\nInflammatory disorders of breast: GB21\\nBreast abscess: GB21.0\\nOther specified inflammatory disorders of breast: GB21.Y\\nInflammatory disorders of breast unspecified: GB21.Z\\nHypertrophy of breast: GB22\\nCertain specified disorders of breast: GB23\\nMammary duct ectasia: GB23.0\\nFissure or fistula of nipple: GB23.1\\nFat necrosis of breast: GB23.2\\nAtrophy of breast: GB23.3\\nGalactorrhoea not associated with childbirth: GB23.4\\nMastodynia: GB23.5\\nOther specified disorders of breast: GB2Y\\nNephritic syndrome: GB40\\nNephrotic syndrome: GB41\\nPersistent proteinuria or albuminuria: GB42\\nAlbuminuria Grade A: GB42.1\\nOther specified persistent proteinuria or albuminuria: GB42.Y\\nPersistent proteinuria or albuminuria unspecified: GB42.Z\\nOther specified glomerular diseases: GB4Y\\nGlomerular diseases unspecified: GB4Z\\nAcute tubulointerstitial nephritis: GB50\\nAcute pyelonephritis: GB51\\nAcute tubular necrosis: GB52\\nAcute renal papillary necrosis: GB53\\nTubulointerstitial nephritis not specified as acute or chronic: GB54\\nChronic tubulointerstitial nephritis: GB55\\nBalkan nephropathy: GB55.0\\nNephropathy induced by heavy metals: GB55.1\\nChronic urate nephropathy: GB55.2\\nOther specified chronic tubulointerstitial nephritis: GB55.Y\\nChronic tubulointerstitial nephritis unspecified: GB55.Z\\nObstructive or reflux nephropathy: GB56\\nHydronephrosis with ureteropelvic junction obstruction: GB56.0\\nHydronephrosis with ureteral obstruction: GB56.1\\nHydronephrosis with ureteral orifice obstruction: GB56.2\\nHydronephrosis due to bladder obstruction: GB56.3\\nOther or unspecified hydronephrosis: GB56.4\\nHydronephrosis and reflux nephropathy with vesicoureteral or vesicoureterorenal reflux: GB56.5\\nOther specified obstructive or reflux nephropathy: GB56.Y\\nObstructive or reflux nephropathy unspecified: GB56.Z\\nNephrocalcinosis: GB57\\nPyonephrosis: GB58\\nRenal or perinephric abscess: GB59\\nOther specified renal tubulointerstitial diseases: GB5Y\\nRenal tubulointerstitial diseases unspecified: GB5Z\\nAcute kidney failure: GB60\\nAcute kidney failure stage: GB60.2\\nOther specified acute kidney failure: GB60.Y\\nAcute kidney failure stage unspecified: GB60.Z\\nChronic kidney disease: GB61\\nChronic kidney disease stage: GB61.5\\nChronic kidney disease stage a: GB61.2\\nChronic kidney disease stage b: GB61.3\\nChronic kidney disease stage unspecified: GB61.Z\\nKidney failure unspecified: GB6Z\\nCalculus of upper urinary tract: GB70\\nCalculus of kidney: GB70.0\\nStaghorn calculus: GB70.00\\nOther specified calculus of kidney: GB70.0Y\\nCalculus of kidney unspecified: GB70.0Z\\nCalculus of ureter: GB70.1\\nCalculus of upper urinary tract unspecified: GB70.Z\\nCalculus of lower urinary tract: GB71\\nCalculus in bladder: GB71.0\\nCalculus in urethra: GB71.1\\nCalculus of bowel segments for urinary diversion: GB71.2\\nCalculus of lower urinary tract unspecified: GB71.Z\\nUrolithiasis unspecified: GB7Z\\nNonfamilial nongenetic cystic kidney disease: GB80\\nSimple renal cyst: GB80.0\\nComplex renal cyst: GB80.1\\nSubscapular or perirenal urinoma: GB80.2\\nOther specified nonfamilial nongenetic cystic kidney disease: GB80.Y\\nNonfamilial nongenetic cystic kidney disease unspecified: GB80.Z\\nAutosomal dominant polycystic kidney disease: GB81\\nAutosomal dominant tubulointerstitial disease: GB82\\nNephronophthisis: GB83\\nOther specified cystic or dysplastic kidney disease: GB8Y\\nCystic or dysplastic kidney disease unspecified: GB8Z\\nCertain specified disorders of kidney or ureter: GB90\\nNephroptosis: GB90.0\\nHydroureter: GB90.1\\nUreteral kinking or deviation without obstruction: GB90.2\\nIschaemia or infarction of kidney: GB90.3\\nRenal tubular function disorders: GB90.4\\nHypotoniacystinuria type: GB90.40\\nPseudohypoaldosteronism type: GB90.41\\nFanconi syndrome: GB90.42\\nBartter syndrome: GB90.43\\nRenal tubular acidosis: GB90.44\\nRenal glycosuria: GB90.45\\nTubular disorders of sodium or potassium transport: GB90.46\\nAminoaciduria: GB90.47\\nDisorders of calcium or phosphate excretion: GB90.48\\nRenal hypocalciuria: GB90.49\\nNephrogenic diabetes insipidus: GB90.4A\\nOther specified renal tubular function disorders: GB90.4Y\\nRenal tubular function disorders unspecified: GB90.4Z\\nOther specified disorders of kidney or ureter: GB90.Y\\nCystitis: GC00\\nTrigonitis: GC00.0\\nInfectious cystitis: GC00.1\\nContracted urinary bladder: GC00.2\\nInterstitial cystitis: GC00.3\\nOther specified cystitis: GC00.Y\\nCystitis unspecified: GC00.Z\\nOther disorders of bladder: GC01\\nBladder neck obstruction: GC01.0\\nVesical fistula not elsewhere classified: GC01.1\\nDiverticulum of bladder: GC01.2\\nRupture of bladder nontraumatic: GC01.3\\nNeuromuscular dysfunction of bladder not elsewhere classified: GC01.4\\nOther specified disorders of bladder: GC01.Y\\nDisorder of bladder unspecified: GC01.Z\\nUrethritis and urethral syndrome: GC02\\nUrethral abscess: GC02.0\\nNonspecific urethritis: GC02.1\\nOther specified urethritis and urethral syndrome: GC02.Y\\nUrethritis and urethral syndrome unspecified: GC02.Z\\nUrethral stricture: GC03\\nFistula of the genitourinary tract: GC04\\nUrethral fistula: GC04.0\\nFistulae involving female genital tract: GC04.1\\nVesicovaginal fistula: GC04.10\\nFistula of small intestine to vagina: GC04.11\\nFistula of large intestine to vagina: GC04.12\\nFemale genital tractskin fistulae: GC04.13\\nUrethrovaginal fistula: GC04.14\\nCombined urethrovesicovaginal fistula: GC04.15\\nRectovaginal fistula: GC04.16\\nVesicouterine fistula with severe scar or extensive tissue loss: GC04.17\\nOther combined urinary fistula with severe scar or extensive tissue loss: GC04.18\\nCombined urinary and rectal fistula including cloaca with severe scar or extensive tissue loss: GC04.19\\nVaginal stenosis or gynatresia related to obstetric fistula: GC04.1A\\nOther specified fistulae involving female genital tract: GC04.1Y\\nFistulae involving female genital tract unspecified: GC04.1Z\\nUreteral fistula: GC04.2\\nOther specified fistula of the genitourinary tract: GC04.Y\\nFistula of the genitourinary tract unspecified: GC04.Z\\nProlapsed urethral mucosa: GC05\\nUrethral diverticulum: GC06\\nUrethral caruncle: GC07\\nUrinary tract infection site not specified: GC08\\nUrinary tract infection site not specified due to Escherichia coli: GC08.0\\nUrinary tract infection site not specified due to Klebsiella pneumoniae: GC08.1\\nUrinary tract infection site not specified due to Proteus: GC08.2\\nUrinary tract infection site not specified due to other agent: GC08.Y\\nUrinary tract infection site and agent not specified: GC08.Z\\nOther diseases of urinary system: GC0Y\\nDiseases of the urinary system unspecified: GC2Z\\nPelvic organ prolapse: GC40\\nProlapse of anterior vaginal wall: GC40.0\\nIncomplete anterior vaginal wall prolapse: GC40.00\\nComplete anterior vaginal wall prolapse: GC40.01\\nProlapse of anterior vaginal wall unspecified: GC40.0Z\\nProlapse of posterior vaginal wall: GC40.1\\nIncomplete posterior vaginal wall prolapse: GC40.10\\nComplete posterior vaginal wall prolapse: GC40.11\\nProlapse of posterior vaginal wall unspecified: GC40.1Z\\nProlapse of the vaginal apex: GC40.2\\nIncomplete apical vaginal wall prolapse: GC40.20\\nComplete apical vaginal wall prolapse: GC40.21\\nProlapse of the vaginal apex unspecified: GC40.2Z\\nUterovaginal prolapse: GC40.3\\nIncomplete uterovaginal prolapse: GC40.30\\nIncomplete uterine prolapse with anterior vaginal wall prolapse: GC40.31\\nIncomplete uterine prolapse with posterior vaginal wall prolapse: GC40.32\\nIncomplete uterine prolapse with anterior and posterior vaginal wall prolapse: GC40.33\\nComplete uterovaginal prolapse: GC40.34\\nComplete uterine prolapse with anterior vaginal wall prolapse: GC40.35\\nComplete uterine prolapse with posterior vaginal wall prolapse: GC40.36\\nComplete uterine prolapse with anterior and posterior vaginal wall prolapse: GC40.37\\nUterovaginal prolapse unspecified: GC40.3Z\\nPelvic floor muscle disruption: GC40.4\\nLevator avulsion from symphysis pubis: GC40.40\\nOther specified pelvic floor muscle disruption: GC40.4Y\\nPelvic floor muscle disruption unspecified: GC40.4Z\\nUrinary incontinence associated with pelvic organ prolapse: GC40.5\\nStress incontinence associated with pelvic organ prolapse: GC40.50\\nUrge incontinence associated with pelvic organ prolapse: GC40.51\\nMixed urinary incontinence associated with pelvic organ prolapse: GC40.52\\nOverflow incontinence associated with pelvic organ prolapse: GC40.53\\nUrinary incontinence not otherwise specified with pelvic organ prolapse: GC40.54\\nFunctional bladder disorders associated with pelvic organ prolapse: GC40.6\\nOveractive bladder associated with pelvic organ prolapse: GC40.60\\nOther specified functional bladder disorders associated with pelvic organ prolapse: GC40.6Y\\nFunctional bladder disorders associated with pelvic organ prolapse unspecified: GC40.6Z\\nPelvic organ prolapse unspecified: GC40.Z\\nAnorectal dysfunction associated with pelvic organ prolapse: GC41\\nSexual dysfunction associated with pelvic organ prolapse: GC42\\nDiminished sensation due to vaginal or introital laxity: GC42.0\\nObstructed intercourse: GC42.1\\nFemale pelvic floor dysfunction unspecified: GC4Z\\nFunctional bladder disorders not otherwise specified: GC50\\nOveractive bladder: GC50.0\\nAbsent or diminished bladder sensation: GC50.1\\nAbsent or diminished bladder sensation associated with pelvic organ prolapse: GC50.10\\nOther specified absent or diminished bladder sensation: GC50.1Y\\nAbsent or diminished bladder sensation unspecified: GC50.1Z\\nOther specified functional bladder disorders not otherwise specified: GC50.Y\\nFunctional bladder disorders not otherwise specified unspecified: GC50.Z\\nFemale Genital Mutilation: GC51\\nFemale Genital Mutilation Type: GC51.3\\nFemale Genital Mutilation Type a: GC51.20\\nFemale Genital Mutilation Type b: GC51.21\\nFemale Genital Mutilation Type  unspecified: GC51.2Z\\nFemale Genital Mutilation Type c: GC51.12\\nFemale Genital Mutilation unspecified: GC51.Z\\nPostoperative adhesions of vagina: GC70\\nProlapse of vaginal vault after hysterectomy: GC71\\nPostprocedural urethral stricture: GC72\\nPostprocedural pelvic peritoneal adhesions: GC73\\nMalfunction or complication of external stoma of urinary tract: GC74\\nMalfunction of the afferent segment of a continent urinary pouch: GC75\\nMalfunction of the efferent segment of a continent urinary pouch: GC76\\nPostprocedural nonmenstrual uterine bleeding: GC77\\nPostprocedural acute female pelvic inflammatory disease: GC78\\nDisorders of breast reduction: GC79\\nDisorders of breast augmentation: GC7A\\nPostinterventional ischemia or infarction of kidney: GC7B\\nCaesarean scar defect of uterus: GC7C\\nOther specified diseases of the genitourinary system: GC8Y\\nDiseases of the genitourinary system unspecified: GC8Z\\nHypoactive sexual desire dysfunction: HA00\\nHypoactive sexual desire dysfunction lifelong generalised: HA00.0\\nHypoactive sexual desire dysfunction lifelong situational: HA00.1\\nHypoactive sexual desire dysfunction acquired generalised: HA00.2\\nHypoactive sexual desire dysfunction acquired situational: HA00.3\\nHypoactive sexual desire dysfunction unspecified: HA00.Z\\nSexual arousal dysfunctions: HA01\\nFemale sexual arousal dysfunction: HA01.0\\nFemale sexual arousal dysfunction lifelong generalised: HA01.00\\nFemale sexual arousal dysfunction lifelong situational: HA01.01\\nFemale sexual arousal dysfunction acquired generalised: HA01.02\\nFemale sexual arousal dysfunction acquired situational: HA01.03\\nFemale sexual arousal dysfunction unspecified: HA01.0Z\\nMale erectile dysfunction: HA01.1\\nMale erectile dysfunction lifelong generalised: HA01.10\\nMale erectile dysfunction lifelong situational: HA01.11\\nMale erectile dysfunction acquired generalised: HA01.12\\nMale erectile dysfunction acquired situational: HA01.13\\nMale erectile dysfunction unspecified: HA01.1Z\\nOther specified sexual arousal dysfunctions: HA01.Y\\nSexual arousal dysfunctions unspecified: HA01.Z\\nOrgasmic dysfunctions: HA02\\nAnorgasmia: HA02.0\\nAnorgasmia lifelong generalised: HA02.00\\nAnorgasmia lifelong situational: HA02.01\\nAnorgasmia acquired generalised: HA02.02\\nAnorgasmia acquired situational: HA02.03\\nAnorgasmia unspecified: HA02.0Z\\nOther specified orgasmic dysfunctions: HA02.Y\\nOrgasmic dysfunctions unspecified: HA02.Z\\nEjaculatory dysfunctions: HA03\\nMale early ejaculation: HA03.0\\nMale early ejaculation lifelong generalised: HA03.00\\nMale early ejaculation lifelong situational: HA03.01\\nMale early ejaculation acquired generalised: HA03.02\\nMale early ejaculation acquired situational: HA03.03\\nMale early ejaculation unspecified: HA03.0Z\\nMale delayed ejaculation: HA03.1\\nMale delayed ejaculation lifelong generalised: HA03.10\\nMale delayed ejaculation lifelong situational: HA03.11\\nMale delayed ejaculation acquired generalised: HA03.12\\nMale delayed ejaculation acquired situational: HA03.13\\nMale delayed ejaculation unspecified: HA03.1Z\\nOther specified ejaculatory dysfunctions: HA03.Y\\nEjaculatory dysfunctions unspecified: HA03.Z\\nOther specified sexual dysfunctions: HA0Y\\nSexual dysfunctions unspecified: HA0Z\\nSexual painpenetration disorder: HA20\\nSexual painpenetration disorder lifelong generalised: HA20.0\\nSexual painpenetration disorder lifelong situational: HA20.1\\nSexual painpenetration disorder acquired generalised: HA20.2\\nSexual painpenetration disorder acquired situational: HA20.3\\nSexual painpenetration disorder unspecified: HA20.Z\\nOther specified sexual pain disorders: HA2Y\\nSexual pain disorders unspecified: HA2Z\\nAetiological considerations in sexual dysfunctions and sexual pain disorders: HA40\\nAetiological considerations associated with a medical condition injury or the effects of surgery or radiation treatment: HA40.0\\nAetiological considerations associated with psychological or behavioural factors including mental disorders: HA40.1\\nAetiological considerations associated with use of psychoactive substance or medication: HA40.2\\nAetiological considerations associated with lack of knowledge or experience: HA40.3\\nAetiological considerations associated with relationship factors: HA40.4\\nAetiological considerations associated with cultural factors: HA40.5\\nOther specified aetiological considerations in sexual dysfunctions and sexual pain disorders: HA40.Y\\nGender incongruence of adolescence or adulthood: HA60\\nGender incongruence of childhood: HA61\\nGender incongruence unspecified: HA6Z\\nOther specified conditions related to sexual health: HA8Y\\nConditions related to sexual health unspecified: HA8Z\\nAbortion: JA00\\nSpontaneous abortion: JA00.0\\nSpontaneous abortion incomplete complicated by genital tract or pelvic infection: JA00.00\\nSpontaneous abortion incomplete complicated by delayed or excessive haemorrhage: JA00.01\\nSpontaneous abortion incomplete complicated by embolism: JA00.02\\nSpontaneous abortion incomplete with other or unspecified complications: JA00.03\\nSpontaneous abortion incomplete without complication: JA00.04\\nSpontaneous abortion complete or unspecified complicated by genital tract or pelvic infection: JA00.05\\nSpontaneous abortion complete or unspecified complicated by delayed or excessive haemorrhage: JA00.06\\nSpontaneous abortion complete or unspecified complicated by embolism: JA00.07\\nSpontaneous abortion complete or unspecified with other or unspecified complications: JA00.08\\nSpontaneous abortion complete or unspecified without complication: JA00.09\\nInduced abortion: JA00.1\\nInduced abortion incomplete complicated by genital tract or pelvic infection: JA00.10\\nInduced abortion incomplete complicated by delayed or excessive haemorrhage: JA00.11\\nInduced abortion incomplete complicated by embolism: JA00.12\\nInduced abortion incomplete with other or unspecified complications: JA00.13\\nInduced abortion incomplete without complication: JA00.14\\nInduced abortion complete or unspecified complicated by genital tract or pelvic infection: JA00.15\\nInduced abortion complete or unspecified complicated by delayed or excessive haemorrhage: JA00.16\\nInduced abortion complete or unspecified complicated by embolism: JA00.17\\nInduced abortion complete or unspecified with other complication: JA00.18\\nInduced abortion complete or unspecified without complication: JA00.19\\nUnspecified abortion: JA00.2\\nUnspecified abortion incomplete complicated by genital tract or pelvic infection: JA00.20\\nUnspecified abortion incomplete complicated by delayed or excessive haemorrhage: JA00.21\\nUnspecified abortion incomplete complicated by embolism: JA00.22\\nUnspecified abortion incomplete with other or unspecified complications: JA00.23\\nUnspecified abortion incomplete without complication: JA00.24\\nUnspecified abortion complete or unspecified complicated by genital tract or pelvic infection: JA00.25\\nUnspecified abortion complete or unspecified complicated by delayed or excessive haemorrhage: JA00.26\\nUnspecified abortion complete or unspecified complicated by embolism: JA00.27\\nUnspecified abortion complete or unspecified with other or unspecified complications: JA00.28\\nUnspecified abortion complete or unspecified without complication: JA00.29\\nFailed attempted abortion: JA00.3\\nFailed medical abortion complicated by genital tract or pelvic infection: JA00.30\\nFailed medical abortion complicated by delayed or excessive haemorrhage: JA00.31\\nFailed medical abortion complicated by embolism: JA00.32\\nFailed medical abortion with other or unspecified complications: JA00.33\\nFailed medical abortion without complication: JA00.34\\nOther or unspecified failed attempted abortion complicated by genital tract or pelvic infection: JA00.35\\nOther or unspecified failed attempted abortion complicated by delayed or excessive haemorrhage: JA00.36\\nOther or unspecified failed attempted abortion complicated by embolism: JA00.37\\nOther or unspecified failed attempted abortion with other or unspecified complications: JA00.38\\nOther or unspecified failed attempted abortion without complication: JA00.39\\nEctopic pregnancy: JA01\\nAbdominal pregnancy: JA01.0\\nTubal pregnancy: JA01.1\\nOvarian pregnancy: JA01.2\\nOther specified ectopic pregnancy: JA01.Y\\nEctopic pregnancy unspecified: JA01.Z\\nMolar pregnancy: JA02\\nComplete hydatidiform mole: JA02.0\\nIncomplete or partial hydatidiform mole: JA02.1\\nOther specified molar pregnancy: JA02.Y\\nMolar pregnancy unspecified: JA02.Z\\nMissed abortion: JA03\\nBlighted ovum or nonhydatidiform mole: JA04\\nComplications following abortion ectopic or molar pregnancy: JA05\\nGenital tract or pelvic infection following abortion ectopic or molar pregnancy: JA05.0\\nDelayed or excessive haemorrhage following abortion ectopic or molar pregnancy: JA05.1\\nEmbolism following abortion ectopic or molar pregnancy: JA05.2\\nShock following abortion ectopic or molar pregnancy: JA05.3\\nRenal failure following abortion ectopic or molar pregnancy: JA05.4\\nMetabolic disorders following abortion ectopic or molar pregnancy: JA05.5\\nDamage to pelvic organs and tissues following abortion ectopic or molar pregnancy: JA05.6\\nOther venous complications following abortion ectopic or molar pregnancy: JA05.7\\nOther specified complications following abortion ectopic or molar pregnancy: JA05.Y\\nComplications following abortion ectopic or molar pregnancy unspecified: JA05.Z\\nAbortive outcome of pregnancy unspecified: JA0Z\\nPreexisting hypertension complicating pregnancy childbirth or the puerperium: JA20\\nPreexisting essential hypertension complicating pregnancy childbirth or the puerperium: JA20.0\\nPreexisting hypertensive heart disease complicating pregnancy childbirth or the puerperium: JA20.1\\nPreexisting hypertensive renal disease complicating pregnancy childbirth or the puerperium: JA20.2\\nPreexisting hypertensive heart and renal disease complicating pregnancy childbirth or the puerperium: JA20.3\\nPreexisting secondary hypertension complicating pregnancy childbirth or the puerperium: JA20.4\\nOther specified preexisting hypertension complicating pregnancy childbirth or the puerperium: JA20.Y\\nPreexisting hypertension complicating pregnancy childbirth or the puerperium unspecified: JA20.Z\\nPreeclampsia superimposed on chronic hypertension: JA21\\nGestational oedema or proteinuria without hypertension: JA22\\nGestational proteinuria without hypertension: JA22.0\\nGestational oedema without hypertension: JA22.1\\nGestational oedema with proteinuria without hypertension: JA22.2\\nGestational hypertension: JA23\\nPreeclampsia: JA24\\nMild to moderate preeclampsia: JA24.0\\nSevere preeclampsia: JA24.1\\nHELLP syndrome: JA24.2\\nPreeclampsia unspecified: JA24.Z\\nEclampsia: JA25\\nEclampsia in pregnancy: JA25.0\\nEclampsia in labour: JA25.1\\nEclampsia in the puerperium: JA25.2\\nEclampsia time period unspecified: JA25.3\\nOedema proteinuria or hypertensive disorders in pregnancy childbirth or the puerperium unspecified: JA2Z\\nHaemorrhage in early pregnancy: JA40\\nThreatened abortion: JA40.0\\nOther specified haemorrhage in early pregnancy: JA40.Y\\nHaemorrhage in early pregnancy unspecified: JA40.Z\\nAntepartum haemorrhage: JA41\\nAntepartum haemorrhage with coagulation defect: JA41.0\\nOther specified antepartum haemorrhage: JA41.Y\\nAntepartum haemorrhage unspecified: JA41.Z\\nIntrapartum haemorrhage: JA42\\nIntrapartum haemorrhage with coagulation defect: JA42.0\\nIntrapartum haemorrhage resulting from obstructed labour with uterine rupture: JA42.1\\nIntrapartum haemorrhage resulting from obstructed labour without mention of uterine rupture: JA42.2\\nOther specified intrapartum haemorrhage: JA42.Y\\nIntrapartum haemorrhage unspecified: JA42.Z\\nPostpartum haemorrhage: JA43\\nThirdstage haemorrhage: JA43.0\\nOther immediate postpartum haemorrhage: JA43.1\\nDelayed or secondary postpartum haemorrhage: JA43.2\\nPostpartum coagulation defects: JA43.3\\nPostpartum haemorrhage following obstructed labour with uterine rupture: JA43.4\\nPostpartum haemorrhage following obstructed labour without mention of uterine rupture: JA43.5\\nOther specified postpartum haemorrhage: JA43.Y\\nPostpartum haemorrhage unspecified: JA43.Z\\nObstetric haemorrhage unspecified: JA4Z\\nExcessive vomiting in pregnancy: JA60\\nMild hyperemesis gravidarum: JA60.0\\nHyperemesis gravidarum with metabolic disturbance: JA60.1\\nLate vomiting of pregnancy: JA60.2\\nOther specified excessive vomiting in pregnancy: JA60.Y\\nExcessive vomiting in pregnancy unspecified: JA60.Z\\nVenous complications in pregnancy: JA61\\nVaricose veins of lower extremity in pregnancy: JA61.0\\nGenital varices in pregnancy: JA61.1\\nSuperficial thrombophlebitis in pregnancy: JA61.2\\nDeep phlebothrombosis in pregnancy: JA61.3\\nHaemorrhoids in pregnancy: JA61.4\\nCerebral venous thrombosis in pregnancy: JA61.5\\nOther specified venous complications in pregnancy: JA61.Y\\nVenous complications in pregnancy unspecified: JA61.Z\\nInfections of genitourinary tract in pregnancy: JA62\\nInfections of kidney in pregnancy: JA62.0\\nInfections of bladder in pregnancy: JA62.1\\nInfections of urethra in pregnancy: JA62.2\\nInfections of other parts of urinary tract in pregnancy: JA62.3\\nInfections of the genital tract in pregnancy: JA62.4\\nInfections of genitourinary tract in pregnancy other specified site: JA62.Y\\nInfection of genitourinary tract in pregnancy site unspecified: JA62.Z\\nDiabetes mellitus in pregnancy: JA63\\nPreexisting type  diabetes mellitus in pregnancy: JA63.1\\nDiabetes mellitus arising in pregnancy: JA63.2\\nOther specified diabetes mellitus in pregnancy: JA63.Y\\nDiabetes mellitus in pregnancy unspecified: JA63.Z\\nMalnutrition in pregnancy: JA64\\nMaternal care for other conditions predominantly related to pregnancy: JA65\\nLiver disorders in pregnancy childbirth or the puerperium: JA65.0\\nPregnancy dermatoses: JA65.1\\nGestational pemphigoid: JA65.10\\nPruritus of pregnancy: JA65.11\\nPolymorphic eruption of pregnancy: JA65.12\\nOther specified pregnancy dermatoses: JA65.1Y\\nPregnancy dermatoses unspecified: JA65.1Z\\nExcessive weight gain in pregnancy: JA65.2\\nLow weight gain in pregnancy: JA65.3\\nPregnancy care of habitual aborter: JA65.4\\nRetained intrauterine contraceptive device in pregnancy: JA65.5\\nMaternal hypotension syndrome: JA65.6\\nSubluxation of symphysis pubis in pregnancy childbirth or the puerperium: JA65.7\\nMaternal care for other specified conditions predominantly related to pregnancy: JA65.Y\\nMaternal care for unspecified conditions predominantly related to pregnancy: JA65.Z\\nClinical findings on antenatal screening of mother: JA66\\nAbnormal haematological finding on antenatal screening of mother: JA66.0\\nAbnormal biochemical finding on antenatal screening of mother: JA66.1\\nAbnormal cytological finding on antenatal screening of mother: JA66.2\\nAbnormal ultrasonic finding on antenatal screening of mother: JA66.3\\nAbnormal radiological finding on antenatal screening of mother: JA66.4\\nAbnormal chromosomal or genetic finding on antenatal screening of mother: JA66.5\\nOther specified clinical findings on antenatal screening of mother: JA66.Y\\nClinical findings on antenatal screening of mother unspecified: JA66.Z\\nComplications of anaesthesia during pregnancy: JA67\\nPulmonary complications of anaesthesia during pregnancy: JA67.0\\nCardiac complications of anaesthesia during pregnancy: JA67.1\\nCentral nervous system complications of anaesthesia during pregnancy: JA67.2\\nToxic reaction to local anaesthesia during pregnancy: JA67.3\\nSpinal or epidural anaesthesiainduced headache during pregnancy: JA67.4\\nFailed or difficult intubation during pregnancy: JA67.5\\nFailed intubation during pregnancy: JA67.50\\nDifficult intubation during pregnancy: JA67.51\\nOther specified failed or difficult intubation during pregnancy: JA67.5Y\\nFailed or difficult intubation during pregnancy unspecified: JA67.5Z\\nAwareness under general anaesthesia during pregnancy: JA67.6\\nOther specified complications of anaesthesia during pregnancy: JA67.Y\\nComplications of anaesthesia during pregnancy unspecified: JA67.Z\\nMaternal disorders predominantly related to pregnancy unspecified: JA6Z\\nMaternal care related to multiple gestation: JA80\\nTwin pregnancy: JA80.0\\nTriplet pregnancy: JA80.1\\nQuadruplet pregnancy: JA80.2\\nMaternal care related to other specified multiple gestation: JA80.Y\\nMaternal care related to unspecified multiple gestation: JA80.Z\\nMaternal care related to complications specific to multiple gestation: JA81\\nPapyraceous fetus: JA81.0\\nContinuing pregnancy after abortion of one fetus or more: JA81.1\\nContinuing pregnancy after intrauterine death of one fetus or more: JA81.2\\nLoss of pregnancy after abortion or intrauterine death of one fetus or more: JA81.3\\nOther specified maternal care related to complications specific to multiple gestation: JA81.Y\\nMaternal care related to complications specific to multiple gestation unspecified: JA81.Z\\nMaternal care for malpresentation of fetus: JA82\\nMaternal care for unstable lie: JA82.0\\nMaternal care for breech presentation: JA82.1\\nMaternal care for transverse or oblique lie: JA82.2\\nMaternal care for face brow or chin presentation: JA82.3\\nMaternal care for high head at term: JA82.4\\nMaternal care for multiple gestation with malpresentation of one fetus or more: JA82.5\\nMaternal care for compound presentation: JA82.6\\nMaternal care for other specified malpresentation of fetus: JA82.Y\\nMaternal care for malpresentation of fetus unspecified: JA82.Z\\nMaternal care for disproportion: JA83\\nMaternal care for disproportion due to deformity of maternal pelvic bones: JA83.0\\nMaternal care for disproportion due to generally contracted pelvis: JA83.1\\nMaternal care for disproportion due to inlet contraction of pelvis: JA83.2\\nMaternal care for disproportion due to outlet contraction of pelvis: JA83.3\\nMaternal care for disproportion of mixed maternal and fetal origin: JA83.4\\nMaternal care for disproportion due to unusually large fetus: JA83.5\\nMaternal care for disproportion due to hydrocephalic fetus: JA83.6\\nMaternal care for other specified disproportion: JA83.Y\\nMaternal care for disproportion unspecified: JA83.Z\\nMaternal care for abnormality of pelvic organs: JA84\\nMaternal care for congenital malformation of uterus: JA84.0\\nMaternal care for tumour of corpus uteri: JA84.1\\nMaternal care due to uterine scar from previous surgery: JA84.2\\nMaternal care for cervical incompetence: JA84.3\\nMaternal care for abnormality of vagina: JA84.4\\nMaternal care for abnormality of vulva or perineum: JA84.5\\nMaternal care for other specified abnormality of pelvic organs: JA84.Y\\nMaternal care for abnormality of pelvic organs unspecified: JA84.Z\\nMaternal care for fetal abnormality or damage: JA85\\nMaternal care for central nervous system malformation in fetus: JA85.0\\nMaternal care for chromosomal abnormality in fetus: JA85.1\\nMaternal care for hereditary disease in fetus: JA85.2\\nMaternal care for damage to fetus from viral disease in mother: JA85.3\\nMaternal care for other specified fetal abnormality or damage: JA85.Y\\nMaternal care for fetal abnormality or damage unspecified: JA85.Z\\nMaternal care for other fetal problems: JA86\\nMaternal care for red cell antibodies: JA86.0\\nMaternal care for hydrops fetalis: JA86.1\\nMaternal care for signs of fetal hypoxia: JA86.2\\nMaternal care for intrauterine death: JA86.3\\nMaternal care for fetal growth restriction: JA86.4\\nMaternal care for suspected macrosomia: JA86.5\\nMaternal care for viable fetus in abdominal pregnancy: JA86.6\\nMaternal care for other specified fetal problems: JA86.Y\\nMaternal care for other fetal problems unspecified: JA86.Z\\nMaternal care related to polyhydramnios: JA87\\nMaternal care related to certain specified disorders of amniotic fluid or membranes: JA88\\nOligohydramnios: JA88.0\\nInfection of amniotic sac or membranes: JA88.1\\nOther specified disorders of amniotic fluid and membranes: JA88.Y\\nDisorders of amniotic fluid and membranes unspecified: JA88.Z\\nMaternal care related to premature rupture of membranes: JA89\\nPremature rupture of membranes onset of labour within  hours: JA89.0\\nPremature rupture of membranes onset of labour after  hours: JA89.1\\nPremature rupture of membranes labour delayed by therapy: JA89.2\\nPreterm premature rupture of membranes: JA89.3\\nOther specified maternal care related to premature rupture of membranes: JA89.Y\\nMaternal care related to premature rupture of membranes unspecified: JA89.Z\\nMaternal care related to placental disorders: JA8A\\nPlacental transfusion syndromes: JA8A.0\\nMalformation of placenta: JA8A.1\\nMorbidly adherent placenta: JA8A.2\\nOther specified maternal care related to placental disorders: JA8A.Y\\nMaternal care related to placental disorders unspecified: JA8A.Z\\nMaternal care related to placenta praevia or low lying placenta: JA8B\\nPlacenta praevia specified as without haemorrhage: JA8B.0\\nPlacenta praevia with haemorrhage: JA8B.1\\nMaternal care related to placenta praevia or low lying placenta unspecified: JA8B.Z\\nMaternal care related to premature separation of placenta: JA8C\\nPremature separation of placenta with coagulation defect: JA8C.0\\nOther specified maternal care related to premature separation of placenta: JA8C.Y\\nMaternal care related to premature separation of placenta unspecified: JA8C.Z\\nMaternal care related to false labour: JA8D\\nFalse labour before  completed weeks of gestation: JA8D.0\\nFalse labour at or after  completed weeks of gestation: JA8D.1\\nMaternal care related to false labour unspecified: JA8D.Z\\nMaternal care related to prolonged pregnancy: JA8E\\nMaternal care related to other specified fetus amniotic cavity or possible delivery problems: JA8Y\\nMaternal care related to unspecified fetus amniotic cavity or possible delivery problems: JA8Z\\nPreterm labour or delivery: JB00\\nPreterm labour without delivery: JB00.0\\nPreterm spontaneous labour with preterm delivery: JB00.1\\nPreterm labour with term delivery: JB00.2\\nPreterm delivery following iatrogenic induction of labour or caesarean section: JB00.3\\nOther specified preterm labour or delivery: JB00.Y\\nPreterm labour or delivery unspecified: JB00.Z\\nFailed induction of labour: JB01\\nFailed medical induction of labour: JB01.0\\nFailed instrumental induction of labour: JB01.1\\nFailed induction of labour unspecified: JB01.Z\\nAbnormalities of forces of labour: JB02\\nPrimary uterine inertia: JB02.0\\nSecondary uterine inertia: JB02.1\\nOther uterine inertia: JB02.2\\nPrecipitate labour: JB02.3\\nHypertonic incoordinate or prolonged uterine contractions: JB02.4\\nOther specified abnormalities of forces of labour: JB02.Y\\nAbnormalities of forces of labour unspecified: JB02.Z\\nLong labour: JB03\\nProlonged first stage of labour: JB03.0\\nProlonged second stage of labour: JB03.1\\nDelayed delivery of successive neonates: JB03.2\\nLong labour unspecified: JB03.Z\\nObstructed labour due to malposition or malpresentation of fetus: JB04\\nObstructed labour due to incomplete rotation of fetal head: JB04.0\\nObstructed labour due to breech presentation: JB04.1\\nObstructed labour due to face presentation: JB04.2\\nObstructed labour due to brow presentation: JB04.3\\nObstructed labour due to shoulder presentation: JB04.4\\nObstructed labour due to compound presentation: JB04.5\\nObstructed labour due to other malposition and malpresentation of fetus: JB04.Y\\nObstructed labour due to malposition or malpresentation of fetus unspecified: JB04.Z\\nObstructed labour due to maternal pelvic abnormality: JB05\\nObstructed labour due to deformed pelvis: JB05.0\\nObstructed labour due to generally contracted pelvis: JB05.1\\nObstructed labour due to pelvic inlet contraction: JB05.2\\nObstructed labour due to pelvic outlet or midcavity contraction: JB05.3\\nObstructed labour due to foetopelvic disproportion unspecified: JB05.4\\nObstructed labour due to abnormality of maternal pelvic organs: JB05.5\\nObstructed labour due to other maternal pelvic abnormalities: JB05.Y\\nObstructed labour due to maternal pelvic abnormality unspecified: JB05.Z\\nObstructed labour due to other causes: JB06\\nObstructed labour due to shoulder dystocia: JB06.0\\nObstructed labour due to locked twins: JB06.1\\nObstructed labour due to unusually large fetus: JB06.2\\nObstructed labour due to other abnormalities of fetus: JB06.3\\nObstructed labour due to other specified causes: JB06.Y\\nObstructed labour due to unspecified causes: JB06.Z\\nLabour or delivery complicated by fetal distress: JB07\\nLabour or delivery complicated by fetal heart rate anomaly: JB07.0\\nLabour or delivery complicated by meconium in amniotic fluid: JB07.1\\nLabour or delivery complicated by biochemical evidence of fetal stress: JB07.2\\nOther specified labour or delivery complicated by fetal distress: JB07.Y\\nLabour or delivery complicated by fetal distress unspecified: JB07.Z\\nLabour or delivery complicated by umbilical cord complications: JB08\\nLabour or delivery complicated by prolapse of cord: JB08.0\\nLabour or delivery complicated by cord around neck with compression: JB08.1\\nLabour or delivery complicated by short cord: JB08.2\\nLabour or delivery complicated by vasa praevia: JB08.3\\nLabour or delivery complicated by vascular lesion of cord: JB08.4\\nLabour or delivery complicated by other cord entanglement with compression: JB08.5\\nLabour and delivery complicated by other specified umbilical cord complications: JB08.Y\\nLabour or delivery complicated by umbilical cord complications unspecified: JB08.Z\\nPerineal laceration during delivery: JB09\\nFirst degree perineal laceration during delivery: JB09.0\\nSecond degree perineal laceration during delivery: JB09.1\\nThird degree perineal laceration during delivery: JB09.2\\nFourth degree perineal laceration during delivery: JB09.3\\nPerineal laceration during delivery unspecified: JB09.Z\\nCertain specified obstetric trauma: JB0A\\nRupture of uterus before onset of labour: JB0A.0\\nRupture of uterus during labour: JB0A.1\\nPostpartum inversion of uterus: JB0A.2\\nObstetric laceration of cervix: JB0A.3\\nObstetric high vaginal laceration: JB0A.4\\nObstetric uterine laceration or tear: JB0A.5\\nOther obstetric injury to pelvic organs: JB0A.6\\nObstetric damage to pelvic joints or ligaments: JB0A.7\\nObstetric haematoma of pelvis: JB0A.8\\nOther specified obstetric trauma: JB0A.Y\\nObstetric trauma unspecified: JB0A.Z\\nRetained placenta or membranes without haemorrhage: JB0B\\nRetained placenta without haemorrhage: JB0B.0\\nRetained portions of placenta or membranes without haemorrhage: JB0B.1\\nComplications of anaesthesia during labour or delivery: JB0C\\nAspiration pneumonitis due to anaesthesia during labour or delivery: JB0C.0\\nOther pulmonary complications of anaesthesia during labour or delivery: JB0C.1\\nCardiac complications of anaesthesia during labour or delivery: JB0C.2\\nCentral nervous system complications of anaesthesia during labour or delivery: JB0C.3\\nToxic reaction to local anaesthesia during labour or delivery: JB0C.4\\nSpinal or epidural anaesthesiainduced headache during labour or delivery: JB0C.5\\nOther complications of spinal or epidural anaesthesia during labour or delivery: JB0C.6\\nFailed or difficult intubation during labour or delivery: JB0C.7\\nFailed intubation during labour or delivery: JB0C.70\\nDifficult intubation during labour or delivery: JB0C.71\\nOther specified failed or difficult intubation during labour or delivery: JB0C.7Y\\nFailed or difficult intubation during labour or delivery unspecified: JB0C.7Z\\nAwareness under general anaesthesia during labour or delivery: JB0C.8\\nOther specified complications of anaesthesia during labour or delivery: JB0C.Y\\nComplications of anaesthesia during labour or delivery unspecified: JB0C.Z\\nCertain specified complications of labour or delivery not elsewhere classified: JB0D\\nMaternal distress during labour or delivery: JB0D.0\\nShock during or following labour or delivery: JB0D.1\\nPyrexia during labour not elsewhere classified: JB0D.2\\nOther complications of obstetric surgery or procedures: JB0D.3\\nDelayed delivery after artificial rupture of membranes: JB0D.4\\nDelayed delivery after spontaneous or unspecified rupture of membranes: JB0D.5\\nVaginal delivery following previous caesarean section: JB0D.6\\nFailed application of vacuum extractor or forceps unspecified: JB0D.7\\nFailed trial of labour unspecified: JB0D.8\\nOther specified complications of labour or delivery not elsewhere classified: JB0D.Y\\nOther specified complications of labour or delivery: JB0Y\\nComplications of labour or delivery unspecified: JB0Z\\nSingle spontaneous delivery: JB20\\nSpontaneous vertex delivery: JB20.0\\nSpontaneous breech delivery: JB20.1\\nSingle spontaneous delivery with other specified presentation: JB20.Y\\nSingle spontaneous delivery unspecified: JB20.Z\\nSingle delivery by forceps or vacuum extractor: JB21\\nSingle delivery by caesarean section: JB22\\nDelivery by elective caesarean section: JB22.0\\nDelivery by emergency caesarean section: JB22.1\\nSingle delivery by caesarean hysterectomy: JB22.2\\nSingle delivery by caesarean section unspecified: JB22.Z\\nOther assisted single delivery: JB23\\nBreech extraction: JB23.0\\nOther assisted breech delivery: JB23.1\\nOther manipulationassisted delivery: JB23.2\\nDelivery of viable fetus in abdominal pregnancy: JB23.3\\nDestructive operation for delivery: JB23.4\\nOther assisted single delivery unspecified: JB23.Z\\nMultiple delivery: JB24\\nMultiple delivery all spontaneous: JB24.0\\nMultiple delivery all by forceps or vacuum extractor: JB24.1\\nMultiple delivery all by caesarean section: JB24.2\\nMultiple delivery by combination of methods with caesarean: JB24.3\\nOther specified multiple delivery: JB24.Y\\nMultiple delivery unspecified: JB24.Z\\nDelivery unspecified: JB2Z\\nInfections in the puerperium: JB40\\nPuerperal sepsis: JB40.0\\nInfection of obstetric surgical wound: JB40.1\\nOther infection of genital tract following delivery: JB40.2\\nUrinary tract infection following delivery: JB40.3\\nPyrexia of unknown origin following delivery: JB40.4\\nOther specified infections in the puerperium: JB40.Y\\nInfections in the puerperium unspecified: JB40.Z\\nVenous complications in the puerperium: JB41\\nSuperficial thrombophlebitis in the puerperium: JB41.0\\nDeep phlebothrombosis in the puerperium: JB41.1\\nHaemorrhoids in the puerperium: JB41.2\\nCerebral venous thrombosis in the puerperium: JB41.3\\nOther specified venous complications in the puerperium: JB41.Y\\nVenous complications in the puerperium unspecified: JB41.Z\\nObstetric embolism: JB42\\nObstetric air embolism: JB42.0\\nAmniotic fluid embolism: JB42.1\\nObstetric bloodclot embolism: JB42.2\\nObstetric pyaemic or septic embolism: JB42.3\\nOther specified obstetric embolism: JB42.Y\\nObstetric embolism unspecified: JB42.Z\\nComplications of anaesthesia during the puerperium: JB43\\nPulmonary complications of anaesthesia during the puerperium: JB43.0\\nCardiac complications of anaesthesia during the puerperium: JB43.1\\nCentral nervous system complications of anaesthesia during the puerperium: JB43.2\\nSpinal or epidural anaesthesiainduced headache during the puerperium: JB43.3\\nOther complications of spinal or epidural anaesthesia during the puerperium: JB43.4\\nFailed or difficult intubation during the puerperium: JB43.5\\nFailed intubation during the puerperium: JB43.50\\nDifficult intubation during the puerperium: JB43.51\\nOther specified failed or difficult intubation during the puerperium: JB43.5Y\\nFailed or difficult intubation during the puerperium unspecified: JB43.5Z\\nAwareness under general anaesthesia during the puerperium: JB43.6\\nOther specified complications of anaesthesia during the puerperium: JB43.Y\\nComplications of anaesthesia during the puerperium unspecified: JB43.Z\\nCertain specified complications of the puerperium: JB44\\nDisruption of caesarean section wound: JB44.0\\nDisruption of perineal obstetric wound: JB44.1\\nHaematoma of obstetric wound: JB44.2\\nCardiomyopathy in the puerperium: JB44.3\\nPostpartum acute renal failure: JB44.4\\nPostpartum thyroiditis: JB44.5\\nPuerperal osteomalacia: JB44.6\\nOther specified complications of the puerperium: JB44.Y\\nComplications of the puerperium unspecified: JB44.Z\\nInfections of breast associated with childbirth: JB45\\nAbscess of breast associated with childbirth: JB45.0\\nNonpurulent mastitis associated with childbirth: JB45.1\\nOther specified infections of breast associated with childbirth: JB45.Y\\nInfections of breast associated with childbirth unspecified: JB45.Z\\nCertain specified disorders of breast or lactation associated with childbirth: JB46\\nRetracted nipple associated with childbirth: JB46.0\\nCracked nipple associated with childbirth: JB46.1\\nOther or unspecified disorders of breast associated with childbirth: JB46.2\\nAgalactia: JB46.3\\nHypogalactia: JB46.4\\nSuppressed lactation: JB46.5\\nGalactorrhoea: JB46.6\\nOther or unspecified disorders of lactation: JB46.7\\nComplications predominantly related to the puerperium unspecified: JB4Z\\nObstetric death of unspecified cause: JB60\\nDeath from any obstetric cause occurring more than  days but less than one year after delivery: JB61\\nDeath from direct obstetric cause occurring more than  days but less than one year after delivery: JB61.0\\nDeath from indirect obstetric cause occurring more than  days but less than one year after delivery: JB61.1\\nDeath from obstetric cause occurring more than  days but less than one year after delivery unspecified whether direct or indirect: JB61.Z\\nDeath from sequelae of obstetric causes: JB62\\nDeath from sequelae of direct obstetric cause: JB62.0\\nDeath from sequelae of indirect obstetric cause: JB62.1\\nDeath from sequelae of obstetric causes unspecified: JB62.Z\\nMaternal infectious diseases classifiable elsewhere but complicating pregnancy childbirth or the puerperium: JB63\\nTuberculosis complicating pregnancy childbirth or the puerperium: JB63.0\\nTuberculous placenta: JB63.00\\nOther specified tuberculosis complicating pregnancy childbirth or the puerperium: JB63.0Y\\nTuberculosis complicating pregnancy childbirth or the puerperium unspecified: JB63.0Z\\nSyphilis complicating pregnancy childbirth or the puerperium: JB63.1\\nGonorrhoea complicating pregnancy childbirth or the puerperium: JB63.2\\nOther infections with a predominantly sexual mode of transmission complicating pregnancy childbirth or the puerperium: JB63.3\\nViral hepatitis complicating pregnancy childbirth or the puerperium: JB63.4\\nOther viral diseases complicating pregnancy childbirth or the puerperium: JB63.5\\nProtozoal diseases complicating pregnancy childbirth or the puerperium: JB63.6\\nMalaria complicating pregnancy childbirth or the puerperium: JB63.60\\nOther specified protozoal diseases complicating pregnancy childbirth or the puerperium: JB63.6Y\\nProtozoal diseases complicating pregnancy childbirth or the puerperium unspecified: JB63.6Z\\nHuman immunodeficiency disease complicating pregnancy childbirth or the puerperium: JB63.7\\nOther specified maternal infectious diseases classifiable elsewhere but complicating pregnancy childbirth or the puerperium: JB63.Y\\nMaternal infectious diseases classifiable elsewhere but complicating pregnancy childbirth or the puerperium unspecified: JB63.Z\\nCertain maternal diseases classifiable elsewhere but complicating pregnancy childbirth or the puerperium: JB64\\nAnaemia complicating pregnancy childbirth or the puerperium: JB64.0\\nOther diseases of the blood or bloodforming organs or certain disorders involving the immune mechanism complicating pregnancy childbirth or the puerperium: JB64.1\\nEndocrine nutritional or metabolic diseases complicating pregnancy childbirth or the puerperium: JB64.2\\nDiseases of the nervous system complicating pregnancy childbirth or the puerperium: JB64.3\\nDiseases of the circulatory system complicating pregnancy childbirth or the puerperium: JB64.4\\nDiseases of the respiratory system complicating pregnancy childbirth or the puerperium: JB64.5\\nDiseases of the digestive system complicating pregnancy childbirth or the puerperium: JB64.6\\nDiseases of the skin complicating pregnancy childbirth or the puerperium: JB64.7\\nCongenital anomaly complicating pregnancy: JB64.8\\nOther specified maternal diseases classifiable elsewhere but complicating pregnancy childbirth or the puerperium: JB64.Y\\nSequelae of complication of pregnancy childbirth or the puerperium: JB65\\nOther specified obstetric conditions not elsewhere classified: JB6Y\\nUnspecified obstetric condition: JB6Z\\nFetus or newborn affected by maternal conditions that may be unrelated to present pregnancy: KA00\\nFetus or newborn affected by maternal hypertensive disorders: KA00.0\\nFetus or newborn affected by gestational oedema or proteinuria without hypertension: KA00.1\\nFetus or newborn affected by maternal renal or urinary tract diseases: KA00.2\\nFetus or newborn affected by maternal infectious diseases: KA00.3\\nFetus or newborn affected by periodontal disease in mother: KA00.4\\nFetus or newborn affected by maternal respiratory diseases: KA00.5\\nFetus or newborn affected by maternal nutritional disorders: KA00.6\\nFetus or newborn affected by maternal malnutrition: KA00.60\\nFetus or newborn affected by maternal overweight or obesity: KA00.61\\nOther specified fetus or newborn affected by maternal nutritional disorders: KA00.6Y\\nFetus or newborn affected by maternal nutritional disorders unspecified: KA00.6Z\\nFetus or newborn affected by abnormal maternal chemistry: KA00.7\\nFetus or newborn affected by maternal injury: KA00.8\\nFetus or newborn affected by maternal chemotherapy: KA00.9\\nFetus or newborn affected by surgical procedure on mother: KA00.A\\nFetus or newborn affected by maternal anaemia: KA00.B\\nFetus or newborn affected by other specified maternal condition that may be unrelated to present pregnancy: KA00.Y\\nFetus or newborn affected by unspecified maternal condition that may be unrelated to present pregnancy: KA00.Z\\nFetus or newborn affected by maternal complications of pregnancy: KA01\\nFetus or newborn affected by incompetence of cervix uteri: KA01.0\\nFetus or newborn affected by premature rupture of membranes: KA01.1\\nFetus or newborn affected by oligohydramnios: KA01.2\\nFetus or newborn affected by polyhydramnios: KA01.3\\nFetus or newborn affected by ectopic pregnancy: KA01.4\\nFetus or newborn affected by multiple pregnancy: KA01.5\\nFetus or newborn affected by maternal death: KA01.6\\nFetus or newborn affected by malpresentation before labour: KA01.7\\nFetus or newborn affected by maternal blood loss: KA01.8\\nFetus or newborn affected by other specified maternal complication of pregnancy: KA01.Y\\nFetus or newborn affected by unspecified maternal complication of pregnancy: KA01.Z\\nFetus or newborn affected by complications of placenta: KA02\\nFetus or newborn affected by placenta praevia: KA02.0\\nFetus or newborn affected by placental oedema or large placenta: KA02.1\\nFetus or newborn affected by placental infarction: KA02.2\\nFetus or newborn affected by placental insufficiency or small placenta: KA02.3\\nFetus or newborn affected by placental transfusion syndromes: KA02.4\\nFetus or newborn affected by other specified complication of placenta: KA02.Y\\nFetus or newborn affected by unspecified complication of placenta: KA02.Z\\nFetus or newborn affected by complications of umbilical cord: KA03\\nFetus or newborn affected by prolapsed cord: KA03.0\\nFetus or newborn affected by other compression of umbilical cord: KA03.1\\nFetus or newborn affected by abnormalities of umbilical cord length: KA03.2\\nFetus or newborn affected by short umbilical cord: KA03.20\\nFetus or newborn affected by long umbilical cord: KA03.21\\nOther specified fetus or newborn affected by abnormalities of umbilical cord length: KA03.2Y\\nFetus or newborn affected by abnormalities of umbilical cord length unspecified: KA03.2Z\\nFetus or newborn affected by vasa praevia: KA03.3\\nFetus or newborn affected by traumatic injury of the umbilical cord: KA03.4\\nFetus or newborn affected by other specified complication of umbilical cord: KA03.Y\\nFetus or newborn affected by unspecified complication of umbilical cord: KA03.Z\\nFetus or newborn affected by other abnormalities of membranes: KA04\\nFetus or newborn affected by chorioamnionitis: KA04.0\\nFetus or newborn affected by amniotic band syndrome: KA04.1\\nFetus or newborn affected by other specified abnormality of membranes: KA04.Y\\nFetus or newborn affected by unspecified abnormality of membranes: KA04.Z\\nFetus or newborn affected by certain complications of labour or delivery: KA05\\nFetus or newborn affected by breech delivery or extraction: KA05.0\\nFetus or newborn affected by other malpresentation malposition or disproportion during labour or delivery: KA05.1\\nFetus or newborn affected by forceps delivery: KA05.2\\nFetus or newborn affected by delivery by vacuum extractor: KA05.3\\nFetus or newborn affected by caesarean delivery: KA05.4\\nFetus or newborn affected by precipitate delivery: KA05.5\\nFetus or newborn affected by abnormal uterine contractions: KA05.6\\nFetus or newborn affected by abnormality in fetal intrauterine heart rate or rhythm: KA05.7\\nFetus and newborn affected by abnormality in fetal intrauterine heart rate or rhythm before onset of labour: KA05.70\\nFetus and newborn affected by abnormality in fetal intrauterine heart rate or rhythm during labour: KA05.71\\nFetus or newborn affected by abnormality in fetal intrauterine heart rate or rhythm unspecified: KA05.7Z\\nMeconium passage during delivery: KA05.8\\nFetus or newborn affected or suspected to be affected by other specified complications of labour or delivery: KA05.Y\\nFetus or newborn affected or suspected to be affected by unspecified complications of labour or delivery: KA05.Z\\nFetus or newborn affected by noxious influences transmitted via placenta or breast milk: KA06\\nFetus or newborn affected by maternal anaesthesia or analgesia in pregnancy labour or delivery: KA06.0\\nFetus or newborn affected by maternal use of tobacco: KA06.1\\nFetus or newborn affected by maternal use of alcohol: KA06.2\\nFetus or newborn affected by maternal use of drugs of addiction: KA06.3\\nFetus or newborn affected by maternal use of nutritional chemical substances: KA06.4\\nFetus or newborn affected by maternal exposure to environmental chemical substances: KA06.5\\nFetus or newborn affected by other specified noxious influence transmitted via placenta or breast milk: KA06.Y\\nFetus or newborn affected by unspecified noxious influence transmitted via placenta or breast milk: KA06.Z\\nNeonatal dermatoses due to maternal antibodies: KA07\\nNeonatal lupus erythematosus: KA07.0\\nNeonatal pemphigus: KA07.1\\nOther specified neonatal dermatoses due to maternal antibodies: KA07.Y\\nFetus or newborn affected by unspecified maternal factors or by complications of pregnancy labour or delivery: KA0Z\\nDisorders of newborn related to slow fetal growth or fetal malnutrition: KA20\\nSmall for gestational age: KA20.0\\nSmall for gestational age symmetrical: KA20.00\\nSmall for gestational age asymmetrical: KA20.01\\nSmall for gestational age unspecified: KA20.0Z\\nIntrauterine growth restriction: KA20.1\\nAsymmetrical intrauterine growth restriction: KA20.10\\nSymmetrical intrauterine growth restriction: KA20.11\\nIntrauterine growth restriction associated with small for gestational age: KA20.12\\nOther specified intrauterine growth restriction: KA20.1Y\\nIntrauterine growth restriction unspecified: KA20.1Z\\nFetal intrauterine malnutrition without mention of small for gestational age: KA20.2\\nOther specified disorders of newborn related to slow fetal growth or fetal malnutrition: KA20.Y\\nDisorders of newborn related to slow fetal growth or fetal malnutrition unspecified: KA20.Z\\nDisorders of newborn related to short gestation or low birth weight not elsewhere classified: KA21\\nExtremely low birth weight of newborn: KA21.0\\nExtremely low birth weight of newborn g or less: KA21.00\\nExtremely low birth weight of newborn g: KA21.02\\nExtremely low birth weight of newborn unspecified: KA21.0Z\\nVery low birth weight of newborn: KA21.1\\nVery low birth weight of newborn g: KA21.11\\nVery low birth weight of newborn unspecified: KA21.1Z\\nLow birth weight of newborn: KA21.2\\nLow birth weight of newborn g: KA21.21\\nLow birth weight of newborn unspecified: KA21.2Z\\nExtreme prematurity of newborn: KA21.3\\nExtreme prematurity of newborn gestational age less than  completed weeks: KA21.30\\nExtreme prematurity of newborn gestational age  completed weeks: KA21.36\\nExtreme prematurity of newborn unspecified: KA21.3Z\\nPreterm newborn: KA21.4\\nPreterm newborn gestational age  completed weeks: KA21.48\\nPreterm newborn unspecified: KA21.4Z\\nDisorders of newborn related to long gestation or high birth weight: KA22\\nExceptionally large newborn: KA22.0\\nLarge newborn for gestational age: KA22.1\\nPostterm newborn: KA22.2\\nPostmaturity syndrome: KA22.3\\nOther specified disorders of newborn related to length of gestation or fetal growth: KA2Y\\nDisorders of newborn related to length of gestation or fetal growth unspecified: KA2Z\\nBirth injury to central nervous system: KA40\\nIntracranial laceration or haemorrhage due to birth injury: KA40.0\\nSubdural haemorrhage due to birth injury: KA40.00\\nCerebral haemorrhage due to birth injury: KA40.01\\nCerebellar haemorrhage due to birth injury: KA40.02\\nIntraventricular haemorrhage due to birth injury: KA40.03\\nSubarachnoid haemorrhage due to birth injury: KA40.04\\nTentorial tear due to birth injury: KA40.05\\nCerebellar contusion due to birth injury: KA40.06\\nCerebral contusion due to birth injury: KA40.07\\nExtradural or epidural haemorrhage due to birth injury: KA40.08\\nOther specified intracranial laceration or haemorrhage due to birth injury: KA40.0Y\\nIntracranial laceration or haemorrhage due to birth injury unspecified: KA40.0Z\\nCerebral oedema due to birth injury: KA40.1\\nBirth injury to spine or spinal cord: KA40.2\\nBirth injury to brainstem: KA40.3\\nOther specified birth injury to central nervous system: KA40.Y\\nBirth injury to central nervous system unspecified: KA40.Z\\nBirth injury to eye: KA41\\nBirth injury to scalp: KA42\\nBruising of scalp due to birth injury: KA42.0\\nCephalohaematoma due to birth injury: KA42.1\\nChignon due to birth injury: KA42.2\\nMonitoring injury of scalp of newborn: KA42.3\\nSubgaleal epicranial subaponeurotic haemorrhage due to birth injury: KA42.4\\nOther specified birth injury to scalp: KA42.Y\\nBirth injury to scalp unspecified: KA42.Z\\nBirth injury to skin or soft tissues: KA43\\nBirth injury to sternocleidomastoid: KA43.0\\nBirth injury to external genitalia: KA43.1\\nSubcutaneous fat necrosis due to birth injury: KA43.2\\nBirth injury to face: KA43.3\\nOther specified birth injury to skin or soft tissues: KA43.Y\\nBirth injury to skin or soft tissues unspecified: KA43.Z\\nBirth injury to peripheral nervous system: KA44\\nBirth injury to cranial nerves: KA44.0\\nBirth injury to facial nerve: KA44.00\\nBirth injury to other specified cranial nerve: KA44.0Y\\nBirth injury to unspecified cranial nerve: KA44.0Z\\nBrachial plexus palsy in newborn: KA44.1\\nErb paralysis: KA44.10\\nKlumpke paralysis: KA44.11\\nBrachial plexus palsy in newborn unspecified: KA44.1Z\\nPhrenic nerve paralysis due to birth injury: KA44.2\\nBirth injury to other specified peripheral nerve: KA44.Y\\nBirth injury to unspecified peripheral nerve: KA44.Z\\nBirth injury to skeleton: KA45\\nFracture of skull due to birth injury: KA45.0\\nLinear skull fracture due to birth injury: KA45.00\\nDepressed skull fracture due to birth injury: KA45.01\\nOther specified fracture of skull due to birth injury: KA45.0Y\\nFracture of skull due to birth injury unspecified: KA45.0Z\\nOccipital osteodiastasis due to birth injury: KA45.1\\nBirth injury to facial bones: KA45.2\\nMandibular bone fracture due to birth injury: KA45.20\\nNasal bone fracture due to birth injury: KA45.21\\nBirth injury to other specified facial bones: KA45.2Y\\nBirth injury to facial bones unspecified: KA45.2Z\\nBirth injury of thorax: KA45.3\\nFracture dislocation or subluxation of spine due to birth injury: KA45.4\\nFracture of clavicle due to birth injury: KA45.5\\nBirth injury to long bones: KA45.6\\nOther specified birth injury to skeleton: KA45.Y\\nBirth injury to skeleton unspecified: KA45.Z\\nBirth injury to other organs: KA46\\nBirth injury to liver: KA46.0\\nBirth injury to spleen: KA46.1\\nAdrenal haemorrhage due to birth injury: KA46.2\\nBirth injury to other specified organ: KA46.Y\\nBirth injury unspecified: KA4Z\\nSepsis of fetus or newborn: KA60\\nOther bacterial infections of the fetus or newborn: KA61\\nCongenital tuberculosis: KA61.0\\nNeonatal listeriosis: KA61.1\\nBacterial infection of the fetus or newborn unspecified: KA61.Z\\nViral infection in the fetus or newborn: KA62\\nCongenital Zika virus infection: KA62.0\\nCongenital EpsteinBarr virus infection: KA62.1\\nCongenital Varicella Zoster virus infection: KA62.2\\nCongenital cytomegalovirus infection: KA62.3\\nCongenital echovirus infection: KA62.4\\nCongenital enterovirus infection: KA62.5\\nCongenital human immunodeficiency virus infection: KA62.6\\nCongenital parvovirus syndrome: KA62.7\\nCongenital rubella syndrome: KA62.8\\nCongenital viral hepatitis: KA62.9\\nPerinatal Herpes simplex infection: KA62.A\\nOther specified viral infection in the fetus or newborn: KA62.Y\\nViral infection in the fetus or newborn unspecified: KA62.Z\\nFungal infection of fetus or newborn: KA63\\nMalassezia infection in newborn: KA63.0\\nNeonatal aspergillosis: KA63.1\\nNeonatal candidosis: KA63.2\\nOther specified fungal infection of fetus or newborn: KA63.Y\\nFungal infection of fetus or newborn unspecified: KA63.Z\\nParasitic diseases in the fetus or newborn: KA64\\nCongenital toxoplasmosis: KA64.0\\nCongenital falciparum malaria: KA64.1\\nOther specified parasitic diseases in the fetus or newborn: KA64.Y\\nParasitic diseases in the fetus or newborn unspecified: KA64.Z\\nNeonatal infections of certain specified sites: KA65\\nNeonatal conjunctivitis or dacryocystitis: KA65.0\\nOmphalitis of newborn: KA65.1\\nNeonatal urinary tract infection: KA65.2\\nNeonatal infectious mastitis: KA65.3\\nNeonatal meningitis: KA65.4\\nNeonatal infections of other specified sites: KA65.Y\\nOther specified infections of the fetus or newborn: KA6Y\\nInfections of the fetus or newborn unspecified: KA6Z\\nFetal blood loss: KA80\\nFetal blood loss from vasa praevia: KA80.0\\nFetal blood loss from ruptured cord: KA80.1\\nFetal blood loss from placenta: KA80.2\\nHaemorrhage into cotwin: KA80.3\\nHaemorrhage into maternal circulation: KA80.4\\nFetal blood loss from cut end of cotwin cord: KA80.5\\nOther specified fetal blood loss: KA80.Y\\nFetal blood loss unspecified: KA80.Z\\nUmbilical haemorrhage of newborn: KA81\\nIntracranial nontraumatic haemorrhage of fetus or newborn: KA82\\nIntraventricular nontraumatic haemorrhage grade  of fetus or newborn: KA82.3\\nIntracerebral nontraumatic haemorrhage of fetus or newborn: KA82.4\\nSubarachnoid nontraumatic haemorrhage of fetus or newborn: KA82.5\\nCerebellar nontraumatic hemispheres or vermis or posterior fossa haemorrhage of fetus or newborn: KA82.6\\nSubdural nontraumatic haemorrhage of fetus or newborn: KA82.7\\nIntracranial nontraumatic haemorrhage of fetus or newborn unspecified: KA82.Z\\nCertain specified neonatal haemorrhages: KA83\\nNeonatal bleeding originating in the mouth nose or pharynx: KA83.0\\nNeonatal epistaxis: KA83.00\\nOther specified neonatal bleeding in the mouth nose or pharynx: KA83.0Y\\nNeonatal bleeding originating in the mouth nose or pharynx unspecified: KA83.0Z\\nNeonatal bleeding originating in the oesophagus stomach small or large intestine: KA83.1\\nNeonatal rectal haemorrhage: KA83.2\\nNeonatal hepatic haemorrhage: KA83.3\\nNeonatal haemorrhage originating in adrenal gland: KA83.4\\nNeonatal haemorrhage originating in spleen: KA83.5\\nNeonatal haemorrhage originating in kidney or bladder: KA83.6\\nNeonatal haemorrhage originating in trachea or pulmonary parenchyma: KA83.7\\nNeonatal cutaneous haemorrhage: KA83.8\\nNeonatal vaginal or uterine haemorrhage: KA83.9\\nHaemolytic disease of fetus or newborn: KA84\\nRh isoimmunization of fetus or newborn: KA84.0\\nIsoimmunization due to other red cell factors: KA84.1\\nABO isoimmunization of fetus or newborn: KA84.2\\nHaemolytic anaemia due to other unclassified antibodies of fetus or newborn: KA84.3\\nHaemolytic disease due to disease of other neonatal organs: KA84.4\\nNeonatal haemolysis due to systemic bacterial infection with or without concomitant diffuse intravascular coagulation: KA84.5\\nHaemolytic disease of fetus or newborn unspecified: KA84.Z\\nHydrops fetalis due to haemolytic disease: KA85\\nHydrops fetalis due to isoimmunization: KA85.0\\nOther specified hydrops fetalis due to haemolytic disease: KA85.Y\\nHydrops fetalis due to haemolytic disease unspecified: KA85.Z\\nNeonatal kernicterus: KA86\\nNeonatal hyperbilirubinaemia: KA87\\nNeonatal hyperbilirubinaemia due to swallowed maternal blood: KA87.0\\nNeonatal hyperbilirubinaemia due to enzymatic defect in bilirubin degradation: KA87.1\\nNeonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation: KA87.2\\nNeonatal hyperbilirubinaemia due to total parenteral nutrition: KA87.3\\nNeonatal hyperbilirubinaemia due to drugs or toxins transmitted from mother: KA87.4\\nNeonatal hyperbilirubinaemia due to drugs or toxins given to newborn: KA87.5\\nNeonatal hyperbilirubinaemia from other or unspecified hepatocellular damage: KA87.6\\nOther specified neonatal hyperbilirubinaemia: KA87.Y\\nNeonatal hyperbilirubinaemia unspecified: KA87.Z\\nDisseminated intravascular coagulation of fetus or newborn: KA88\\nTransient neonatal thrombocytopaenia: KA89\\nThrombocytopaenia following systemic infection including diffuse intravascular coagulation: KA89.0\\nOther specified transient neonatal thrombocytopaenia: KA89.Y\\nTransient neonatal thrombocytopaenia unspecified: KA89.Z\\nPolycythaemia neonatorum: KA8A\\nPolycythaemia neonatorum due to placental insufficiency or fetal intrauterine growth restriction: KA8A.0\\nPolycythaemia neonatorum due to twin to twin transfusion: KA8A.1\\nPolycythaemia neonatorum due to inherited disorder of erythropoietin production: KA8A.2\\nPolycythaemia neonatorum following umbilical cord transfusion or stripping at delivery: KA8A.3\\nPolycythaemia neonatorum following blood transfusion: KA8A.4\\nOther specified polycythaemia neonatorum: KA8A.Y\\nPolycythaemia neonatorum unspecified: KA8A.Z\\nAnaemia of prematurity: KA8B\\nCongenital hypoplastic anaemia: KA8C\\nTransient neonatal neutropaenia: KA8D\\nAlloimmune neonatal neutropaenia: KA8E\\nNeonatal vitamin K deficiency: KA8F\\nDiffuse bleeding diathesis due to vitamin K deficient haemorrhagic disease of fetus or newborn: KA8F.0\\nOther specified neonatal vitamin K deficiency: KA8F.Y\\nNeonatal vitamin K deficiency unspecified: KA8F.Z\\nOther specified haemorrhagic or haematological disorders of fetus or newborn: KA8Y\\nHaemorrhagic or haematological disorders of fetus or newborn unspecified: KA8Z\\nNeonatal cerebral ischaemia: KB00\\nPerinatal arterial stroke: KB00.0\\nNeonatal cerebral sinovenous thrombosis: KB00.1\\nOther specified neonatal cerebral ischaemia: KB00.Y\\nNeonatal cerebral ischaemia unspecified: KB00.Z\\nPeriventricular cysts of newborn: KB01\\nNeonatal cerebral leukomalacia: KB02\\nNeonatal encephalopathy: KB03\\nHypoxic ischaemic encephalopathy of newborn: KB04\\nNeonatal hydrocephalus: KB05\\nNeonatal obstructive hydrocephalus: KB05.0\\nOther specified neonatal hydrocephalus: KB05.Y\\nNeonatal hydrocephalus unspecified: KB05.Z\\nNeonatal seizures: KB06\\nCompression of brain in neonate: KB07\\nDisorders of muscle tone of newborn: KB08\\nTransient neonatal myasthenia gravis: KB08.0\\nCongenital hypertonia: KB08.1\\nCongenital hypotonia: KB08.2\\nOther specified disorders of muscle tone of newborn: KB08.Y\\nDisorders of muscle tone of newborn unspecified: KB08.Z\\nOther specified neurological disorders specific to the perinatal or neonatal period: KB0Y\\nNeurological disorders specific to the perinatal or neonatal period unspecified: KB0Z\\nIntrauterine hypoxia: KB20\\nIntrauterine hypoxia first noted before onset of labour: KB20.0\\nIntrauterine hypoxia first noted during labour or delivery: KB20.1\\nIntrauterine hypoxia unspecified: KB20.Z\\nBirth asphyxia: KB21\\nSevere birth asphyxia: KB21.0\\nMild and moderate birth asphyxia: KB21.1\\nBirth asphyxia unspecified: KB21.Z\\nMetabolic acidaemia in newborn: KB22\\nRespiratory distress of newborn: KB23\\nRespiratory distress syndrome of newborn: KB23.0\\nRespiratory distress syndrome of the newborn altered by maternal corticosteroid therapy: KB23.00\\nRespiratory distress syndrome of the newborn altered by pulmonary surfactant replacement therapy: KB23.01\\nRespiratory distress syndrome of the newborn altered by maternal corticosteroid therapy or pulmonary surfactant replacement therapy: KB23.02\\nOther specified respiratory distress syndrome of newborn: KB23.0Y\\nRespiratory distress syndrome of newborn unspecified: KB23.0Z\\nTransient tachypnoea of newborn: KB23.1\\nRespiratory instability of prematurity: KB23.2\\nOther specified respiratory distress of newborn: KB23.Y\\nRespiratory distress of newborn unspecified: KB23.Z\\nCongenital pneumonia: KB24\\nNeonatal tracheitis: KB25\\nNeonatal aspiration syndromes: KB26\\nNeonatal aspiration of meconium: KB26.0\\nNeonatal aspiration of amniotic fluid or mucus: KB26.1\\nNeonatal aspiration of blood: KB26.2\\nNeonatal aspiration of milk or regurgitated food: KB26.3\\nOther specified neonatal aspiration syndromes: KB26.Y\\nNeonatal aspiration syndromes unspecified: KB26.Z\\nPulmonary air leak or related conditions originating in the perinatal period: KB27\\nInterstitial emphysema originating in the perinatal period: KB27.0\\nPneumothorax originating in the perinatal period: KB27.1\\nPneumomediastinum originating in the perinatal period: KB27.2\\nPneumopericardium originating in the perinatal period: KB27.3\\nPneumoperitoneum originating in the perinatal period due to primary pulmonary air leak syndromes: KB27.4\\nOther specified pulmonary air leak or related conditions originating in the perinatal period: KB27.Y\\nPulmonary air leak or related conditions originating in the perinatal period unspecified: KB27.Z\\nPulmonary haemorrhage originating in the perinatal period: KB28\\nTracheobronchial haemorrhage originating in the perinatal period: KB28.0\\nTraumatic pulmonary haemorrhage originating in the perinatal period: KB28.1\\nOther specified pulmonary haemorrhage originating in the perinatal period: KB28.Y\\nPulmonary haemorrhage originating in the perinatal period unspecified: KB28.Z\\nChronic respiratory disease originating in the perinatal period: KB29\\nBronchopulmonary dysplasia originating in the perinatal period: KB29.0\\nOther specified chronic respiratory disease originating in the perinatal period: KB29.Y\\nChronic respiratory disease originating in the perinatal period unspecified: KB29.Z\\nApnoea of newborn: KB2A\\nCentral neonatal apnoea: KB2A.0\\nObstructive neonatal apnoea: KB2A.1\\nMixed neonatal apnoea: KB2A.2\\nApnoea of newborn due to neurologic injury: KB2A.3\\nOther specified apnoea of newborn: KB2A.Y\\nApnoea of newborn unspecified: KB2A.Z\\nPrimary atelectasis of newborn: KB2B\\nCyanotic attacks of newborn: KB2C\\nRespiratory failure of newborn: KB2D\\nRespiratory arrest of newborn: KB2E\\nCongenital lung or lobar atelectasis: KB2F\\nTracheal haemorrhage of newborn due to airway trauma: KB2G\\nAcquired vocal cord paralysis in newborn: KB2H\\nAirway obstruction in the neonate due to airway abnormality: KB2J\\nHypotonia of hypopharynx in neonate: KB2J.0\\nHypopharyngeal mass in neonate: KB2J.1\\nTracheobronchial malacia in neonate: KB2J.2\\nOther specified airway obstruction in the neonate due to airway abnormality: KB2J.Y\\nAirway obstruction in the neonate due to airway abnormality unspecified: KB2J.Z\\nPulmonary cysts in newborn: KB2K\\nAcquired pulmonary cysts in newborn: KB2K.0\\nPulmonary cysts in newborn unspecified: KB2K.Z\\nOther specified respiratory disorders specific to the perinatal or neonatal period: KB2Y\\nRespiratory disorders specific to the perinatal or neonatal period unspecified: KB2Z\\nNeonatal cardiac failure: KB40\\nNeonatal cardiac failure due to pulmonary overperfusion: KB40.0\\nNeonatal cardiac failure due to decreased left ventricular output: KB40.1\\nOther specified neonatal cardiac failure: KB40.Y\\nNeonatal cardiac failure unspecified: KB40.Z\\nCardiac arrhythmias in the neonate: KB41\\nPersistent pulmonary hypertension of the newborn: KB42\\nTransient myocardial ischaemia of newborn: KB44\\nNeonatal hypertension: KB45\\nNeonatal hypotension: KB46\\nBenign or innocent cardiac murmurs in newborn: KB47\\nPatent arterial duct of prematurity: KB48\\nOther specified cardiovascular disorders present in the perinatal or neonatal period: KB4Y\\nCardiovascular disorders present in the perinatal or neonatal period unspecified: KB4Z\\nTransitory disorders of carbohydrate metabolism specific to fetus or newborn: KB60\\nSyndrome of infant of mother with gestational diabetes: KB60.0\\nSyndrome of infant of a diabetic mother type  or  nongestational insulin dependent: KB60.1\\nNeonatal diabetes mellitus: KB60.2\\nTransient neonatal diabetes mellitus: KB60.20\\nOther specified neonatal diabetes mellitus: KB60.2Y\\nNeonatal diabetes mellitus unspecified: KB60.2Z\\nNeonatal hyperglycaemia: KB60.3\\nNeonatal hyperglycaemia due to insulin deficiency: KB60.30\\nNeonatal hyperglycaemia due to iatrogenic intravenous therapy: KB60.31\\nOther specified neonatal hyperglycaemia: KB60.3Y\\nNeonatal hyperglycaemia unspecified: KB60.3Z\\nNeonatal hypoglycaemia: KB60.4\\nTransient hyperinsulinaemic neonatal hypoglycaemia: KB60.40\\nTransitory iatrogenic neonatal hypoglycaemia: KB60.41\\nOther transitory neonatal hypoglycaemia: KB60.42\\nOther specified neonatal hypoglycaemia: KB60.4Y\\nNeonatal hypoglycaemia unspecified: KB60.4Z\\nOther specified transitory disorders of carbohydrate metabolism specific to fetus or newborn: KB60.Y\\nTransitory disorders of carbohydrate metabolism specific to fetus or newborn unspecified: KB60.Z\\nTransitory neonatal disorders of calcium or magnesium metabolism: KB61\\nNeonatal hypomagnesaemia: KB61.0\\nNeonatal tetany without calcium or magnesium deficiency: KB61.1\\nNeonatal hypocalcaemia: KB61.2\\nNeonatal osteopenia: KB61.3\\nOther specified transitory neonatal disorders of calcium or magnesium metabolism: KB61.Y\\nTransitory neonatal disorders of calcium or magnesium metabolism unspecified: KB61.Z\\nTransitory neonatal disorders of thyroid function: KB62\\nTransitory neonatal hyperthyroidism: KB62.0\\nOther transitory neonatal disorders of thyroid function not elsewhere classified: KB62.1\\nTransient hyperthyrotropinaemia: KB62.2\\nTransient hypothyroxinaemia: KB62.3\\nOther specified transitory neonatal disorders of thyroid function: KB62.Y\\nTransitory neonatal disorders of thyroid function unspecified: KB62.Z\\nCertain specified transitory neonatal electrolyte or metabolic disturbances: KB63\\nLate metabolic acidosis of newborn: KB63.0\\nDehydration of newborn: KB63.1\\nDisturbances of sodium balance of newborn: KB63.2\\nHyponatremia of newborn: KB63.20\\nHypernatremia of newborn: KB63.21\\nOther specified disturbances of sodium balance of newborn: KB63.2Y\\nDisturbances of sodium balance of newborn unspecified: KB63.2Z\\nDisturbances of potassium balance of newborn: KB63.3\\nHypokalaemia of newborn: KB63.30\\nHyperkalaemia of newborn: KB63.31\\nOther specified disturbances of potassium balance of newborn: KB63.3Y\\nDisturbances of potassium balance of newborn unspecified: KB63.3Z\\nTransitory tyrosinaemia of newborn: KB63.4\\nMetabolic bone disease of prematurity: KB63.5\\nTransitory neonatal hypoparathyroidism: KB64\\nTransitory endocrine or metabolic disorders specific to fetus or newborn unspecified: KB6Z\\nGastrooesophageal reflux disease in newborn: KB80\\nOesophagitis in newborn: KB81\\nNeonatal eosinophilic oesophagitis: KB81.0\\nOther specified oesophagitis in newborn: KB81.Y\\nOesophagitis in newborn unspecified: KB81.Z\\nPrenatal gastric perforation: KB82\\nPostnatal gastric perforation: KB83\\nPostnatal isolated ileal perforation: KB84\\nPrenatal intrauterine intestinal perforation: KB85\\nPrenatal intrauterine intestinal perforation due to in utero volvulus: KB85.0\\nPrenatal intrauterine intestinal perforation due to intestinal atresia or stenosis: KB85.1\\nPrenatal intrauterine intestinal perforation due to intraluminal obstruction: KB85.2\\nOther specified prenatal intrauterine intestinal perforation: KB85.Y\\nPrenatal intrauterine intestinal perforation unspecified: KB85.Z\\nPostnatal intestinal perforation: KB86\\nPostnatal intestinal perforation due to drugs: KB86.0\\nPostnatal intestinal perforation due to in utero volvulus: KB86.1\\nPostnatal intestinal perforation due to intestinal atresia or stenosis: KB86.2\\nPostnatal intestinal perforation due to intraluminal obstruction: KB86.3\\nOther specified postnatal intestinal perforation: KB86.Y\\nPostnatal intestinal perforation unspecified: KB86.Z\\nIntestinal obstruction of newborn: KB87\\nIntestinal obstruction due to inspissated milk: KB87.0\\nMeconium plug without ileus: KB87.1\\nMeconium ileus without perforation: KB87.2\\nTransitory ileus of newborn: KB87.3\\nMeconium ileus with perforation: KB87.4\\nOther specified intestinal obstruction of newborn: KB87.Y\\nIntestinal obstruction of newborn unspecified: KB87.Z\\nNecrotising enterocolitis of newborn: KB88\\nNecrotising enterocolitis of newborn Stage A  B: KB88.1\\nNecrotising enterocolitis of newborn Stage A: KB88.2\\nNecrotising enterocolitis of newborn Stage B: KB88.3\\nOther specified necrotising enterocolitis of newborn: KB88.Y\\nNecrotising enterocolitis of newborn unspecified: KB88.Z\\nNeonatal malabsorption syndromes: KB89\\nNeonatal malabsorption due to endocrine secreting tumour: KB89.0\\nShort bowel syndrome in neonate: KB89.1\\nOther specified neonatal malabsorption syndromes: KB89.Y\\nNeonatal malabsorption syndromes unspecified: KB89.Z\\nNeonatal haematemesis or melaena due to swallowed maternal blood: KB8A\\nNeonatal peritonitis: KB8B\\nNoninfectious neonatal diarrhoea: KB8C\\nOther specified digestive system disorders of fetus or newborn: KB8Y\\nDigestive system disorders of fetus or newborn unspecified: KB8Z\\nCongenital hydrocele: KC00\\nCongenital renal failure: KC01\\nOther specified genitourinary system disorders specific to the perinatal or neonatal period: KC0Y\\nGenitourinary system disorders specific to the perinatal or neonatal period unspecified: KC0Z\\nConditions involving the umbilical cord: KC20\\nDelayed separation of umbilical cord: KC20.0\\nUmbilical cutis or polyp of newborn: KC20.1\\nUmbilical granuloma of newborn: KC20.2\\nOther specified conditions involving the umbilical cord: KC20.Y\\nConditions involving the umbilical cord unspecified: KC20.Z\\nInflammatory dermatoses of the newborn: KC21\\nNeonatal acne: KC21.0\\nNeonatal toxic erythema: KC21.1\\nPerianal dermatitis of the newborn: KC21.2\\nOther specified inflammatory dermatoses of the newborn: KC21.Y\\nInflammatory dermatoses of the newborn unspecified: KC21.Z\\nNeonatal disorders of subcutaneous fat: KC22\\nSubcutaneous fat necrosis of the newborn: KC22.0\\nCold panniculitis of the newborn: KC22.1\\nSclerema neonatorum: KC22.2\\nOther specified neonatal disorders of subcutaneous fat: KC22.Y\\nNeonatal disorders of subcutaneous fat unspecified: KC22.Z\\nNeonatal disorders of the oral mucosa: KC23\\nNeonatal nutritional disorders affecting the skin: KC24\\nSkin fragility of prematurity: KC30\\nCongenital erosive or vesicular dermatosis healing with reticulated supple scarring: KC31\\nOther specified skin disorders associated with prematurity: KC3Y\\nMiscellaneous skin disorders in the neonate: KC40\\nCongenital sucking blisters: KC40.0\\nNeonatal milia: KC40.1\\nOther specified skin disorders in the neonate: KC40.Y\\nMiscellaneous specified conditions of integument specific to fetus or newborn: KC41\\nBreast engorgement of newborn: KC41.0\\nHydrops fetalis not due to haemolytic disease: KC41.1\\nOther specified conditions of integument specific to fetus and newborn: KC41.Y\\nNeonatal phototherapy burn: KC50\\nOther specified postnatal iatrogenic skin injury: KC5Y\\nPostnatal iatrogenic skin injury unspecified: KC5Z\\nOther specified iatrogenic injuries involving the skin of the neonate: KC7Y\\nDisorders involving the integument of fetus or newborn unspecified: KC9Z\\nEnvironmental hyperthermia of newborn: KD10\\nFever of newborn: KD11\\nHypothermia of newborn: KD12\\nNeonatal cold injury syndrome: KD12.0\\nOther specified hypothermia of newborn: KD12.Y\\nHypothermia of newborn unspecified: KD12.Z\\nOther specified disturbances of temperature regulation of newborn: KD1Y\\nDisturbances of temperature regulation of newborn unspecified: KD1Z\\nBirth depression: KD30\\nBirth depression with  minute Apgar score: KD30.1\\nBirth depression with associated metabolic acidaemia of cord blood: KD30.2\\nBirth depression unspecified: KD30.Z\\nWide cranial sutures of newborn: KD31\\nFeeding problems of newborn: KD32\\nSlow feeding of newborn: KD32.0\\nUnderfeeding of newborn: KD32.1\\nOverfeeding of newborn: KD32.2\\nNeonatal difficulty in feeding at breast: KD32.3\\nFailure to thrive in newborn: KD32.4\\nOther specified feeding problems of newborn: KD32.Y\\nFeeding problems of newborn unspecified: KD32.Z\\nJittery baby not elsewhere classified: KD33\\nReactions or intoxications due to drugs administered to fetus or newborn: KD34\\nNeonatal withdrawal syndrome from maternal use of drugs of addiction: KD35\\nWithdrawal symptoms from therapeutic use of drugs in newborn: KD36\\nExposure to tobacco smoke in the perinatal period: KD37\\nMeconium staining: KD38\\nComplications of intrauterine procedures not elsewhere classified: KD39\\nFetus or newborn affected by amniocentesis: KD39.0\\nFetus or newborn affected by chorionic villous sampling: KD39.1\\nFetus or newborn affected by fetal blood sampling: KD39.2\\nFetus or newborn affected by complications of fetal surgery: KD39.3\\nFetus or newborn affected by complications of intrauterine fetal surgery: KD39.4\\nOther specified complications of intrauterine procedures not elsewhere classified: KD39.Y\\nComplications of intrauterine procedures not elsewhere classified unspecified: KD39.Z\\nTermination of pregnancy affecting surviving fetus or newborn: KD3A\\nFetal death cause not specified: KD3B\\nAntepartum fetal death: KD3B.0\\nIntrapartum fetal death: KD3B.1\\nUnspecified time of fetal death cause not specified: KD3B.Z\\nVomiting in newborn: KD3C\\nBilious vomiting of newborn: KD3C.0\\nOther specified vomiting in newborn: KD3C.Y\\nVomiting in newborn unspecified: KD3C.Z\\nOther specified disorders originating in the perinatal period: KD3Y\\nConditions originating in the perinatal or neonatal period unspecified: KD5Z\\nAnencephaly or similar anomalies: LA00\\nAnencephaly: LA00.0\\nCraniorachischisis: LA00.00\\nOther specified anencephaly: LA00.0Y\\nAnencephaly unspecified: LA00.0Z\\nIniencephaly: LA00.1\\nAcephaly: LA00.2\\nAmyelencephaly: LA00.3\\nOther specified anencephaly or similar anomalies: LA00.Y\\nAnencephaly or similar anomalies unspecified: LA00.Z\\nCephalocele: LA01\\nSpina bifida: LA02\\nSpina bifida cystica: LA02.0\\nMyelomeningocele with hydrocephalus: LA02.00\\nMyelomeningocele without hydrocephalus: LA02.01\\nMyelocystocele: LA02.02\\nOther specified spina bifida cystica: LA02.0Y\\nSpina bifida cystica unspecified: LA02.0Z\\nSpina bifida aperta: LA02.1\\nOther specified spina bifida: LA02.Y\\nSpina bifida unspecified: LA02.Z\\nArnoldChiari malformation type II: LA03\\nCongenital hydrocephalus: LA04\\nHydrocephalus with stenosis of the aqueduct of Sylvius: LA04.0\\nOther specified congenital hydrocephalus: LA04.Y\\nCongenital hydrocephalus unspecified: LA04.Z\\nCerebral structural developmental anomalies: LA05\\nMicrocephaly: LA05.0\\nMegalencephaly: LA05.1\\nHoloprosencephaly: LA05.2\\nCorpus callosum agenesis: LA05.3\\nArrhinencephaly: LA05.4\\nAbnormal neuronal migration: LA05.5\\nPolymicrogyria: LA05.50\\nCortical dysplasia: LA05.51\\nOther specified abnormal neuronal migration: LA05.5Y\\nAbnormal neuronal migration unspecified: LA05.5Z\\nEncephaloclastic disorders: LA05.6\\nPorencephaly: LA05.60\\nSchizencephaly: LA05.61\\nHydranencephaly: LA05.62\\nOther specified encephaloclastic disorders: LA05.6Y\\nEncephaloclastic disorders unspecified: LA05.6Z\\nBrain cystic malformations: LA05.7\\nColpocephaly: LA05.8\\nOther specified cerebral structural developmental anomalies: LA05.Y\\nCerebral structural developmental anomalies unspecified: LA05.Z\\nCerebellar structural developmental anomalies: LA06\\nDandyWalker malformation: LA06.0\\nHypoplasia or agenesis of cerebellar hemispheres: LA06.1\\nFocal cerebellar dysplasia: LA06.2\\nOther specified cerebellar structural developmental anomalies: LA06.Y\\nCerebellar structural developmental anomalies unspecified: LA06.Z\\nStructural developmental anomalies of the neurenteric canal spinal cord or vertebral column: LA07\\nPrimary tethered cord syndrome: LA07.0\\nDiastematomyelia: LA07.1\\nAmyelia: LA07.2\\nPrimary syringomyelia or hydromyelia: LA07.3\\nArnoldChiari malformation type I: LA07.4\\nOther specified structural developmental anomalies of the neurenteric canal spinal cord or vertebral column: LA07.Y\\nStructural developmental anomalies of the neurenteric canal spinal cord or vertebral column unspecified: LA07.Z\\nOther specified structural developmental anomalies of the nervous system: LA0Y\\nStructural developmental anomalies of the nervous system unspecified: LA0Z\\nStructural developmental anomalies of ocular globes: LA10\\nMicrophthalmos: LA10.0\\nClinical anophthalmos: LA10.1\\nBuphthalmos: LA10.2\\nCongenital macrophthalmos: LA10.3\\nOther specified structural developmental anomalies of ocular globes: LA10.Y\\nStructural developmental anomalies of ocular globes unspecified: LA10.Z\\nStructural developmental anomalies of the anterior segment of eye: LA11\\nBlue sclera: LA11.0\\nStructural developmental anomalies of cornea: LA11.1\\nAnterior segment dysgenesis: LA11.2\\nAniridia: LA11.3\\nColoboma of iris: LA11.4\\nCongenital corneal opacity: LA11.5\\nStructural disorders of the pupil: LA11.6\\nIrregular pupil of the eye: LA11.60\\nIridoschisis: LA11.61\\nAnomalies of pupillary function: LA11.62\\nOther specified structural disorders of the pupil: LA11.6Y\\nStructural disorders of the pupil unspecified: LA11.6Z\\nOther specified structural developmental anomalies of the anterior segment of eye: LA11.Y\\nStructural developmental anomalies of the anterior segment of eye unspecified: LA11.Z\\nStructural developmental anomalies of lens or zonula: LA12\\nColoboma of lens: LA12.0\\nCongenital cataract: LA12.1\\nCongenital aphakia: LA12.2\\nSpherophakia: LA12.3\\nOther specified structural developmental anomalies of lens or zonula: LA12.Y\\nStructural developmental anomalies of lens or zonula unspecified: LA12.Z\\nStructural developmental anomalies of the posterior segment of eye: LA13\\nCongenital anomalies of the vitreous: LA13.0\\nColoboma of choroid or retina: LA13.1\\nColoboma of macula: LA13.2\\nCongenital vitreoretinal dysplasia: LA13.3\\nCongenital retinal aneurysm: LA13.5\\nCongenital malformations of choroid: LA13.6\\nCongenital malformation of optic disc: LA13.7\\nIsolated optic nerve hypoplasia: LA13.70\\nOptic nerve aplasia: LA13.71\\nCongenitally elevated optic disc: LA13.72\\nOptic disc dysplasia: LA13.73\\nMegalopapilla: LA13.74\\nColoboma of optic disc: LA13.76\\nOther specified congenital malformation of optic disc: LA13.7Y\\nCongenital malformation of optic disc unspecified: LA13.7Z\\nCertain congenital malformations of posterior segment of eye: LA13.8\\nAnastomosis of retinal or choroidal vessels: LA13.80\\nOther specified structural developmental anomalies of the posterior segment of eye: LA13.Y\\nStructural developmental anomalies of the posterior segment of eye unspecified: LA13.Z\\nStructural developmental anomalies of eyelid lacrimal apparatus or orbit: LA14\\nStructural developmental anomalies of eyelids: LA14.0\\nPalpebral cleft or coloboma: LA14.00\\nCryptophthalmia: LA14.01\\nCongenital entropion: LA14.02\\nCongenital ectropion: LA14.03\\nCongenital ptosis: LA14.04\\nCongenital eyelid retraction: LA14.05\\nEpibulbar choristoma: LA14.06\\nAnkyloblepharon filiforme adnatum: LA14.07\\nOther specified structural developmental anomalies of eyelids: LA14.0Y\\nStructural developmental anomalies of eyelids unspecified: LA14.0Z\\nStructural developmental anomalies of lacrimal apparatus: LA14.1\\nAplasia of lacrimal or salivary glands: LA14.10\\nAgenesis of lacrimal ducts: LA14.11\\nCongenital dacryocele: LA14.12\\nCongenital agenesis of lacrimal punctum: LA14.13\\nCongenital stenosis or stricture of lacrimal duct: LA14.14\\nOther specified structural developmental anomalies of lacrimal apparatus: LA14.1Y\\nStructural developmental anomalies of lacrimal apparatus unspecified: LA14.1Z\\nStructural developmental anomalies of orbit: LA14.2\\nOther specified structural developmental anomalies of eyelid lacrimal apparatus or orbit: LA14.Y\\nStructural developmental anomalies of eyelid lacrimal apparatus or orbit unspecified: LA14.Z\\nOther specified structural developmental anomalies of the eye eyelid or lacrimal apparatus: LA1Y\\nStructural developmental anomalies of the eye eyelid or lacrimal apparatus unspecified: LA1Z\\nStructural anomaly of eustachian apparatus: LA20\\nMinor anomalies of pinnae: LA21\\nMacrotia: LA21.0\\nProtruding ear: LA21.1\\nLowset ear: LA21.2\\nMisshapen ear: LA21.3\\nOther specified minor anomalies of pinnae: LA21.Y\\nMinor anomalies of pinnae unspecified: LA21.Z\\nStructural developmental anomalies of ear causing hearing impairment: LA22\\nMicrotia: LA22.0\\nAnotia: LA22.1\\nAplasia or hypoplasia of external auditory canal: LA22.2\\nStructural developmental anomalies of ear ossicles: LA22.3\\nStructural developmental anomalies of inner ear: LA22.4\\nOther specified structural developmental anomalies of ear causing hearing impairment: LA22.Y\\nStructural developmental anomalies of ear causing hearing impairment unspecified: LA22.Z\\nOtocephaly: LA23\\nAccessory auricle: LA24\\nOther specified structural developmental anomalies of the ear: LA2Y\\nStructural developmental anomalies of the ear unspecified: LA2Z\\nStructural developmental anomalies of teeth and periodontal tissues: LA30\\nAnodontia: LA30.0\\nHypodontia: LA30.1\\nOligodontia: LA30.2\\nHyperdontia: LA30.3\\nAbnormalities of size or form of teeth: LA30.4\\nAnomalies in tooth resorption or loss: LA30.5\\nEarly exfoliation of teeth: LA30.50\\nLate exfoliation of teeth: LA30.51\\nOther specified anomalies in tooth resorption or loss: LA30.5Y\\nAnomalies in tooth resorption or loss unspecified: LA30.5Z\\nAmelogenesis imperfecta: LA30.6\\nDentine dysplasia: LA30.7\\nDentinogenesis imperfecta: LA30.8\\nOdontogenesis imperfecta: LA30.9\\nOther specified structural developmental anomalies of teeth and periodontal tissues: LA30.Y\\nStructural developmental anomalies of teeth and periodontal tissues unspecified: LA30.Z\\nStructural developmental anomalies of mouth or tongue: LA31\\nCongenital macroglossia: LA31.0\\nHypoglossia or aglossia: LA31.1\\nAnkyloglossia: LA31.2\\nMacrostomia: LA31.3\\nMicrostomia: LA31.4\\nOther specified structural developmental anomalies of mouth or tongue: LA31.Y\\nStructural developmental anomalies of mouth or tongue unspecified: LA31.Z\\nCleft lip: LA40\\nCleft lip unilateral: LA40.0\\nCleft lip bilateral: LA40.1\\nCleft lip median: LA40.2\\nCleft lip unspecified: LA40.Z\\nCleft lip and alveolus: LA41\\nCleft lip and alveolus unilateral: LA41.0\\nCleft lip and alveolus bilateral: LA41.1\\nCleft lip and alveolus unspecified: LA41.Z\\nCleft palate: LA42\\nCleft hard palate: LA42.0\\nCleft soft palate: LA42.1\\nCleft uvula: LA42.2\\nCleft palate unspecified: LA42.Z\\nOther specified clefts of lip alveolus or palate: LA4Y\\nClefts of lip alveolus or palate unspecified: LA4Z\\nCongenital velopharyngeal incompetence: LA50\\nFacial clefts: LA51\\nFacial asymmetry: LA52\\nMacrocheilia: LA53\\nMicrocheilia: LA54\\nCompression facies: LA55\\nPierre Robin syndrome: LA56\\nOther specified structural developmental anomalies of the face: LA5Y\\nStructural developmental anomalies of the face unspecified: LA5Z\\nWebbed neck: LA60\\nCongenital sternomastoid tumour: LA61\\nCongenital torticollis: LA62\\nOther specified structural developmental anomalies of the neck: LA6Y\\nStructural developmental anomalies of the neck unspecified: LA6Z\\nStructural developmental anomalies of the nose or cavum: LA70\\nArrhinia: LA70.0\\nBifid nose: LA70.1\\nChoanal atresia: LA70.2\\nCongenital perforated nasal septum: LA70.3\\nOther specified structural developmental anomalies of the nose or cavum: LA70.Y\\nStructural developmental anomalies of the nose or cavum unspecified: LA70.Z\\nStructural developmental anomalies of larynx: LA71\\nCongenital laryngomalacia: LA71.0\\nLaryngocele: LA71.1\\nLaryngeal hypoplasia: LA71.2\\nCongenital subglottic stenosis: LA71.3\\nOther specified structural developmental anomalies of larynx: LA71.Y\\nStructural developmental anomalies of larynx unspecified: LA71.Z\\nLaryngotracheooesophageal cleft: LA72\\nStructural developmental anomalies of trachea: LA73\\nCongenital stenosis of trachea: LA73.0\\nCongenital tracheomalacia: LA73.1\\nOther specified structural developmental anomalies of trachea: LA73.Y\\nStructural developmental anomalies of trachea unspecified: LA73.Z\\nStructural developmental anomalies of bronchi: LA74\\nCongenital stenosis or atresia of bronchus: LA74.0\\nCongenital bronchomalacia: LA74.1\\nOther specified structural developmental anomalies of bronchi: LA74.Y\\nStructural developmental anomalies of bronchi unspecified: LA74.Z\\nStructural developmental anomalies of lungs: LA75\\nAccessory lobe of lung: LA75.0\\nAgenesis of lung: LA75.1\\nCongenital hypoplasia of lung: LA75.2\\nCongenital hyperplasia of lung: LA75.3\\nCongenital pulmonary airway malformations: LA75.4\\nCongenital lobar emphysema: LA75.5\\nCongenital sequestration of lung: LA75.6\\nOther specified structural developmental anomalies of lungs: LA75.Y\\nStructural developmental anomalies of lungs unspecified: LA75.Z\\nStructural developmental anomalies of pleura: LA76\\nCongenital cyst of mediastinum: LA77\\nOther specified structural developmental anomalies of the respiratory system: LA7Y\\nStructural developmental anomalies of the respiratory system unspecified: LA7Z\\nAnomalous positionorientation of heart: LA80\\nLaevocardia: LA80.0\\nDextrocardia: LA80.1\\nMesocardia: LA80.2\\nExtrathoracic heart: LA80.3\\nOther specified anomalous positionorientation of heart: LA80.Y\\nAnomalous positionorientation of heart unspecified: LA80.Z\\nAbnormal ventricular relationships: LA81\\nTotal mirror imagery: LA82\\nRight isomerism: LA83\\nLeft isomerism: LA84\\nCongenital anomaly of an atrioventricular or ventriculoarterial connection: LA85\\nDiscordant atrioventricular connections: LA85.0\\nCongenitally corrected transposition of great arteries: LA85.00\\nOther specified discordant atrioventricular connections: LA85.0Y\\nDiscordant atrioventricular connections unspecified: LA85.0Z\\nTransposition of the great arteries: LA85.1\\nDouble outlet right ventricle: LA85.2\\nDouble outlet right ventricle with subpulmonary ventricular septal defect transposition type: LA85.20\\nDouble outlet right ventricle with noncommitted ventricular septal defect: LA85.21\\nDouble outlet right ventricle with subaortic or doubly committed ventricular septal defect without pulmonary stenosis ventricular septal defect type: LA85.22\\nDouble outlet right ventricle with subaortic or doubly committed ventricular septal defect and pulmonary stenosis Fallot type: LA85.23\\nOther specified double outlet right ventricle: LA85.2Y\\nDouble outlet right ventricle unspecified: LA85.2Z\\nDouble outlet left ventricle: LA85.3\\nCommon arterial trunk: LA85.4\\nCommon arterial trunk with aortic dominance: LA85.40\\nCommon arterial trunk with pulmonary dominance and interrupted aortic arch: LA85.41\\nOther specified common arterial trunk: LA85.4Y\\nCommon arterial trunk unspecified: LA85.4Z\\nOther specified congenital anomaly of an atrioventricular or ventriculoarterial connection: LA85.Y\\nCongenital anomaly of an atrioventricular or ventriculoarterial connection unspecified: LA85.Z\\nCongenital anomaly of mediastinal vein: LA86\\nLeft superior caval vein: LA86.0\\nUnroofed coronary sinus: LA86.1\\nAnomalous pulmonary venous connection: LA86.2\\nTotal anomalous pulmonary venous connection: LA86.20\\nPartial anomalous pulmonary venous connection: LA86.21\\nScimitar syndrome: LA86.22\\nOther specified anomalous pulmonary venous connection: LA86.2Y\\nAnomalous pulmonary venous connection unspecified: LA86.2Z\\nCongenital pulmonary venous stenosis or hypoplasia: LA86.3\\nOther specified congenital anomaly of mediastinal vein: LA86.Y\\nCongenital anomaly of mediastinal vein unspecified: LA86.Z\\nCongenital anomaly of an atrioventricular valve or atrioventricular septum: LA87\\nCongenital anomaly of tricuspid valve: LA87.0\\nCongenital tricuspid regurgitation: LA87.00\\nCongenital tricuspid valvar stenosis: LA87.01\\nDysplasia of tricuspid valve: LA87.02\\nEbstein malformation of tricuspid valve: LA87.03\\nOther specified congenital anomaly of tricuspid valve: LA87.0Y\\nCongenital anomaly of tricuspid valve unspecified: LA87.0Z\\nCongenital anomaly of mitral valve: LA87.1\\nCongenital mitral regurgitation: LA87.10\\nCongenital mitral valvar stenosis: LA87.11\\nDysplasia of mitral valve: LA87.12\\nCongenital anomaly of mitral subvalvar apparatus: LA87.13\\nOther specified congenital anomaly of mitral valve: LA87.1Y\\nCongenital anomaly of mitral valve unspecified: LA87.1Z\\nCommon atrioventricular junction without an atrioventricular septal defect: LA87.3\\nCommon atrioventricular junction with atrioventricular septal defect: LA87.4\\nAtrioventricular septal defect with communication at the atrial level only: LA87.40\\nAtrioventricular septal defect with communication at the ventricular level only: LA87.41\\nAtrioventricular septal defect with communication at atrial level and restrictive communication at ventricular level: LA87.42\\nAtrioventricular septal defect with communication at atrial level and unrestrictive communication at ventricular level: LA87.43\\nAtrioventricular septal defect with ventricular imbalance: LA87.44\\nAtrioventricular septal defect and tetralogy of Fallot: LA87.45\\nOther specified common atrioventricular junction with atrioventricular septal defect: LA87.4Y\\nCommon atrioventricular junction with atrioventricular septal defect unspecified: LA87.4Z\\nOther specified congenital anomaly of an atrioventricular valve or atrioventricular septum: LA87.Y\\nCongenital anomaly of an atrioventricular valve or atrioventricular septum unspecified: LA87.Z\\nCongenital anomaly of a ventricle or the ventricular septum: LA88\\nCongenital right ventricular outflow tract obstruction: LA88.0\\nDouble chambered right ventricle: LA88.1\\nTetralogy of Fallot: LA88.2\\nTetralogy of Fallot with absent pulmonary valve syndrome: LA88.20\\nTetralogy of Fallot with pulmonary atresia: LA88.21\\nTetralogy of Fallot with pulmonary atresia and systemictopulmonary collateral artery: LA88.22\\nOther specified tetralogy of Fallot: LA88.2Y\\nTetralogy of Fallot unspecified: LA88.2Z\\nCongenital left ventricular outflow tract obstruction: LA88.3\\nVentricular septal defect: LA88.4\\nTrabecular muscular ventricular septal defect: LA88.40\\nPerimembranous central ventricular septal defect: LA88.41\\nVentricular septal defect haemodynamically insignificant: LA88.42\\nOther specified ventricular septal defect: LA88.4Y\\nVentricular septal defect unspecified: LA88.4Z\\nOther specified congenital anomaly of a ventricle or the ventricular septum: LA88.Y\\nCongenital anomaly of a ventricle or the ventricular septum unspecified: LA88.Z\\nFunctionally univentricular heart: LA89\\nDouble inlet atrioventricular connection: LA89.0\\nTricuspid atresia: LA89.1\\nMitral atresia: LA89.2\\nHypoplastic left heart syndrome: LA89.3\\nOther specified functionally univentricular heart: LA89.Y\\nFunctionally univentricular heart unspecified: LA89.Z\\nCongenital anomaly of a ventriculoarterial valve or adjacent regions: LA8A\\nCongenital anomaly of pulmonary valve: LA8A.0\\nCongenital pulmonary valvar stenosis: LA8A.00\\nCongenital pulmonary regurgitation: LA8A.01\\nOther specified congenital anomaly of pulmonary valve: LA8A.0Y\\nCongenital anomaly of pulmonary valve unspecified: LA8A.0Z\\nCongenital pulmonary atresia: LA8A.1\\nPulmonary atresia with intact ventricular septum: LA8A.10\\nOther specified congenital pulmonary atresia: LA8A.1Y\\nCongenital pulmonary atresia unspecified: LA8A.1Z\\nCongenital anomaly of aortic valve: LA8A.2\\nCongenital aortic valvar stenosis: LA8A.20\\nCongenital aortic regurgitation: LA8A.21\\nBicuspid aortic valve: LA8A.22\\nAortic valvar atresia: LA8A.23\\nUnicuspid aortic valve: LA8A.24\\nOther specified congenital anomaly of aortic valve: LA8A.2Y\\nCongenital anomaly of aortic valve unspecified: LA8A.2Z\\nCongenital supravalvar aortic stenosis: LA8A.3\\nAneurysm of aortic sinus of Valsalva: LA8A.4\\nCongenital subaortic stenosis: LA8A.5\\nCongenital subpulmonary stenosis: LA8A.6\\nOther specified congenital anomaly of a ventriculoarterial valve or adjacent regions: LA8A.Y\\nCongenital anomaly of a ventriculoarterial valve or adjacent regions unspecified: LA8A.Z\\nCongenital anomaly of great arteries including arterial duct: LA8B\\nCongenital aortopulmonary window: LA8B.0\\nCongenital anomaly of pulmonary arterial tree: LA8B.1\\nCongenital anomaly of aorta or its branches: LA8B.2\\nCoarctation of aorta: LA8B.21\\nInterrupted aortic arch: LA8B.22\\nCongenital anomaly of descending thoracic or abdominal aorta: LA8B.23\\nCongenital anomaly of aortic arch branch: LA8B.24\\nOther specified congenital anomaly of aorta or its branches: LA8B.2Y\\nCongenital anomaly of aorta or its branches unspecified: LA8B.2Z\\nTracheooesophageal compressive syndrome: LA8B.3\\nPatent arterial duct: LA8B.4\\nOther specified congenital anomaly of great arteries including arterial duct: LA8B.Y\\nCongenital anomaly of great arteries including arterial duct unspecified: LA8B.Z\\nCongenital anomaly of coronary artery: LA8C\\nAnomalous origin of coronary artery from pulmonary arterial tree: LA8C.0\\nAnomalous aortic origin or course of coronary artery: LA8C.1\\nCongenital coronary arterial fistula: LA8C.2\\nOther specified congenital anomaly of coronary artery: LA8C.Y\\nCongenital anomaly of coronary artery unspecified: LA8C.Z\\nCongenital pericardial anomaly: LA8D\\nCongenital anomaly of atrial septum: LA8E\\nPatent oval foramen: LA8E.0\\nAtrial septal defect within oval fossa: LA8E.1\\nSinus venosus defect: LA8E.2\\nInteratrial communication through coronary sinus orifice: LA8E.3\\nOther specified congenital anomaly of atrial septum: LA8E.Y\\nCongenital anomaly of atrial septum unspecified: LA8E.Z\\nCongenital anomaly of right atrium: LA8F\\nCongenital anomaly of left atrium: LA8G\\nDivided left atrium: LA8G.0\\nOther specified congenital anomaly of left atrium: LA8G.Y\\nCongenital anomaly of left atrium unspecified: LA8G.Z\\nOther specified structural developmental anomaly of heart or great vessels: LA8Y\\nStructural developmental anomaly of heart or great vessels unspecified: LA8Z\\nStructural developmental anomalies of the peripheral vascular system: LA90\\nCapillary malformations: LA90.0\\nHereditary haemorrhagic telangiectasia: LA90.00\\nOther specified capillary malformations: LA90.0Y\\nCapillary malformations unspecified: LA90.0Z\\nLymphatic malformations: LA90.1\\nMacrocystic lymphatic malformation: LA90.10\\nMicrocystic lymphatic malformation: LA90.11\\nLymphatic malformations of certain specified sites: LA90.12\\nCystic hygroma in fetus: LA90.13\\nOther specified lymphatic malformations: LA90.1Y\\nLymphatic malformations unspecified: LA90.1Z\\nPeripheral venous malformations: LA90.2\\nVein of Galen aneurysm: LA90.20\\nCongenital portosystemic shunt: LA90.21\\nOther specified peripheral venous malformations: LA90.2Y\\nPeripheral venous malformations unspecified: LA90.2Z\\nPeripheral arteriovenous malformations: LA90.3\\nPortal veinhepatic artery fistula: LA90.30\\nArteriovenous malformation of precerebral vessels: LA90.31\\nUterine arteriovenous malformations: LA90.32\\nOther specified peripheral arteriovenous malformations: LA90.3Y\\nPeripheral arteriovenous malformations unspecified: LA90.3Z\\nPeripheral arterial malformations: LA90.4\\nCongenital renal artery stenosis: LA90.40\\nCongenital precerebral nonruptured aneurysm: LA90.41\\nCongenital cerebral nonruptured aneurysm: LA90.42\\nOther specified peripheral arterial malformations: LA90.4Y\\nPeripheral arterial malformations unspecified: LA90.4Z\\nPulmonary arteriovenous fistula: LA90.5\\nOther specified structural developmental anomalies of the peripheral vascular system: LA90.Y\\nStructural developmental anomalies of the peripheral vascular system unspecified: LA90.Z\\nOther specified structural developmental anomalies of the circulatory system: LA9Y\\nStructural developmental anomalies of the circulatory system unspecified: LA9Z\\nStructural developmental anomalies of diaphragm: LB00\\nCongenital diaphragmatic hernia: LB00.0\\nAbsence of diaphragm: LB00.1\\nOther specified structural developmental anomalies of diaphragm: LB00.Y\\nStructural developmental anomalies of diaphragm unspecified: LB00.Z\\nOmphalocele: LB01\\nGastroschisis: LB02\\nStructural developmental anomalies of umbilical cord: LB03\\nAllantoic duct remnants or cysts: LB03.0\\nSingle umbilical cord artery: LB03.1\\nOther specified structural developmental anomalies of umbilical cord: LB03.Y\\nStructural developmental anomalies of umbilical cord unspecified: LB03.Z\\nOther specified structural developmental anomalies of the diaphragm abdominal wall or umbilical cord: LB0Y\\nStructural developmental anomalies of the diaphragm abdominal wall or umbilical cord unspecified: LB0Z\\nStructural developmental anomalies of salivary glands or ducts: LB10\\nCongenital diverticulum of pharynx: LB11\\nStructural developmental anomalies of oesophagus: LB12\\nCongenital oesophageal web or ring: LB12.0\\nAtresia of oesophagus: LB12.1\\nAtresia of oesophagus with oesophagobronchial fistula: LB12.10\\nOther specified atresia of oesophagus: LB12.1Y\\nAtresia of oesophagus unspecified: LB12.1Z\\nOesophageal fistula without atresia: LB12.2\\nCongenital stenosis or stricture of oesophagus: LB12.3\\nCongenital diverticulum of oesophagus: LB12.4\\nCongenital dilatation of oesophagus: LB12.5\\nOther specified structural developmental anomalies of oesophagus: LB12.Y\\nStructural developmental anomalies of oesophagus unspecified: LB12.Z\\nStructural developmental anomalies of stomach: LB13\\nCongenital hypertrophic pyloric stenosis: LB13.0\\nCongenital hiatus hernia: LB13.1\\nCongenital antral web: LB13.2\\nOther specified structural developmental anomalies of stomach: LB13.Y\\nStructural developmental anomalies of stomach unspecified: LB13.Z\\nStructural developmental anomalies of duodenum: LB14\\nStructural developmental anomalies of small intestine: LB15\\nMeckel diverticulum: LB15.0\\nAtresia of small intestine: LB15.1\\nCongenital short bowel: LB15.2\\nCongenital diverticulitis of small intestine: LB15.3\\nCongenital diverticulosis of small intestine: LB15.4\\nCongenital diverticulum of small intestine: LB15.5\\nOther specified structural developmental anomalies of small intestine: LB15.Y\\nStructural developmental anomalies of small intestine unspecified: LB15.Z\\nStructural developmental anomalies of large intestine: LB16\\nCongenital absence atresia or stenosis of large intestine: LB16.0\\nHirschsprung disease: LB16.1\\nImmature ganglionosis of large intestine: LB16.2\\nCongenital hypoganglionosis of large intestine: LB16.3\\nOther specified structural developmental anomalies of large intestine: LB16.Y\\nStructural developmental anomalies of large intestine unspecified: LB16.Z\\nStructural developmental anomalies of anal canal: LB17\\nAnorectal malformations: LB17.0\\nEctopic anus: LB17.1\\nPersistent cloaca: LB17.2\\nCloacal exstrophy: LB17.3\\nPerineal groove: LB17.4\\nOther specified structural developmental anomalies of anal canal: LB17.Y\\nStructural developmental anomalies of anal canal unspecified: LB17.Z\\nCongenital anomalies of intestinal fixation: LB18\\nOther specified structural developmental anomalies of the digestive tract: LB1Y\\nStructural developmental anomalies of the digestive tract unspecified: LB1Z\\nStructural developmental anomalies of gallbladder bile ducts or liver: LB20\\nStructural developmental anomalies of liver: LB20.0\\nFibropolycystic liver disease: LB20.00\\nOther specified structural developmental anomalies of liver: LB20.0Y\\nStructural developmental anomalies of liver unspecified: LB20.0Z\\nStructural developmental anomalies of gallbladder: LB20.1\\nAgenesis aplasia or hypoplasia of gallbladder: LB20.10\\nOther specified structural developmental anomalies of gallbladder: LB20.1Y\\nStructural developmental anomalies of gallbladder unspecified: LB20.1Z\\nStructural developmental anomalies of bile ducts: LB20.2\\nCholedochal cyst: LB20.20\\nBiliary atresia: LB20.21\\nCongenital stenosis or stricture of bile ducts: LB20.22\\nStructural developmental anomalies of cystic duct: LB20.23\\nAccessory bile duct: LB20.24\\nOther specified structural developmental anomalies of bile ducts: LB20.2Y\\nStructural developmental anomalies of bile ducts unspecified: LB20.2Z\\nOther specified structural developmental anomalies of gallbladder bile ducts or liver: LB20.Y\\nStructural developmental anomalies of gallbladder bile ducts or liver unspecified: LB20.Z\\nStructural developmental anomalies of pancreas: LB21\\nAnnular pancreas: LB21.0\\nPancreas divisum: LB21.1\\nAccessory pancreas: LB21.2\\nAgenesisaplasia of pancreas: LB21.3\\nPartial agenesis of pancreas: LB21.4\\nHypoplasia of pancreas: LB21.5\\nOther specified structural developmental anomalies of pancreas: LB21.Y\\nStructural developmental anomalies of pancreas unspecified: LB21.Z\\nStructural developmental anomalies of spleen: LB22\\nCongenital asplenia: LB22.0\\nPolysplenia: LB22.1\\nEctopic spleen: LB22.2\\nOther specified structural developmental anomalies of spleen: LB22.Y\\nStructural developmental anomalies of spleen unspecified: LB22.Z\\nOther specified structural developmental anomalies of the liver biliary tract pancreas or spleen: LB2Y\\nStructural developmental anomalies of the liver biliary tract pancreas or spleen unspecified: LB2Z\\nStructural developmental anomalies of kidneys: LB30\\nRenal agenesis or other reduction defects of kidney: LB30.0\\nRenal agenesis: LB30.00\\nOther specified renal agenesis or other reduction defects of kidney: LB30.0Y\\nRenal agenesis or other reduction defects of kidney unspecified: LB30.0Z\\nRenal dysplasia: LB30.1\\nCongenital single renal cyst: LB30.2\\nRenal tubular dysgenesis: LB30.3\\nOligomeganephronia: LB30.4\\nAccessory kidney: LB30.5\\nFusion anomaly of kidneys: LB30.6\\nLobulated kidney: LB30.60\\nFused pelvic kidney: LB30.61\\nHorseshoe kidney: LB30.62\\nOther specified fusion anomaly of kidneys: LB30.6Y\\nFusion anomaly of kidneys unspecified: LB30.6Z\\nEctopic or pelvic kidney: LB30.7\\nMedullary sponge kidney: LB30.8\\nMulticystic renal dysplasia: LB30.9\\nOther specified structural developmental anomalies of kidneys: LB30.Y\\nStructural developmental anomalies of kidneys unspecified: LB30.Z\\nStructural developmental anomalies of urinary tract: LB31\\nCongenital hydronephrosis: LB31.0\\nCongenital primary megaureter: LB31.1\\nFetal lower urinary tract obstruction: LB31.2\\nExstrophy of urinary bladder: LB31.3\\nCongenital diverticulum of urinary bladder: LB31.4\\nDuplication of urethra: LB31.5\\nCongenital megalourethra: LB31.6\\nMegacystismegaureter: LB31.7\\nAtresia or stenosis of ureter: LB31.8\\nAgenesis of ureter: LB31.9\\nDuplication of ureter: LB31.A\\nMalposition of ureter: LB31.B\\nCongenital absence of bladder or urethra: LB31.C\\nCongenital vesicoureterorenal reflux: LB31.D\\nOther specified structural developmental anomalies of urinary tract: LB31.Y\\nStructural developmental anomalies of urinary tract unspecified: LB31.Z\\nOther specified structural developmental anomalies of the urinary system: LB3Y\\nStructural developmental anomalies of the urinary system unspecified: LB3Z\\nStructural developmental anomalies of vulva: LB40\\nAbsence of vulva: LB40.0\\nEmbryonic cyst of vulva: LB40.1\\nFusion of labia: LB40.2\\nOther specified structural developmental anomalies of vulva: LB40.Y\\nStructural developmental anomalies of vulva unspecified: LB40.Z\\nStructural developmental anomalies of clitoris: LB41\\nAgenesis of clitoris: LB41.0\\nDuplication of clitoris: LB41.1\\nClitoromegaly: LB41.2\\nOther specified structural developmental anomalies of clitoris: LB41.Y\\nStructural developmental anomalies of clitoris unspecified: LB41.Z\\nStructural developmental anomalies of vagina: LB42\\nAbsence of vagina: LB42.0\\nSeptate vagina: LB42.1\\nCongenital rectovaginal fistula: LB42.2\\nTight hymenal ring: LB42.3\\nImperforate hymen: LB42.4\\nStricture or atresia of vagina: LB42.5\\nOther specified structural developmental anomalies of vagina: LB42.Y\\nStructural developmental anomalies of vagina unspecified: LB42.Z\\nStructural developmental anomalies of cervix uteri: LB43\\nEmbryonic cyst of cervix: LB43.0\\nAgenesis or aplasia of cervix: LB43.1\\nOther specified structural developmental anomalies of cervix uteri: LB43.Y\\nStructural developmental anomalies of cervix uteri unspecified: LB43.Z\\nStructural developmental anomalies of uterus except cervix: LB44\\nAgenesis or aplasia of uterine body: LB44.0\\nHypoplasia of uterus: LB44.1\\nUnicornuate uterus: LB44.2\\nBicornuate uterus: LB44.3\\nSeptate uterus: LB44.4\\nCongenital fistulae between uterus and digestive and urinary tracts: LB44.5\\nUterovaginal malformation due to diethylstilbestrol syndrome: LB44.6\\nOther specified structural developmental anomalies of uterus except cervix: LB44.Y\\nStructural developmental anomalies of uterus except cervix unspecified: LB44.Z\\nStructural developmental anomalies of ovaries fallopian tubes or broad ligaments: LB45\\nCongenital absence of ovary: LB45.0\\nXX gonadal dysgenesis: LB45.1\\nDevelopmental ovarian cyst: LB45.2\\nCongenital torsion of ovary: LB45.3\\nAccessory ovary: LB45.4\\nCongenital absence of fallopian tube: LB45.5\\nAtresia of fallopian tube: LB45.6\\nAccessory fallopian tube: LB45.7\\nEmbryonic cyst of fallopian tube: LB45.8\\nEmbryonic cyst of broad ligament: LB45.9\\nOther specified structural developmental anomalies of ovaries fallopian tubes or broad ligaments: LB45.Y\\nStructural developmental anomalies of ovaries fallopian tubes or broad ligaments unspecified: LB45.Z\\nOther specified structural developmental anomalies of the female genital system: LB4Y\\nStructural developmental anomalies of the female genital system unspecified: LB4Z\\nMicropenis or penis agenesis: LB50\\nAnorchia or microorchidia: LB51\\nCryptorchidism: LB52\\nEctopic testis: LB52.0\\nUndescended testicle unilateral: LB52.1\\nUndescended testicle bilateral: LB52.2\\nOther specified cryptorchidism: LB52.Y\\nCryptorchidism unspecified: LB52.Z\\nHypospadias: LB53\\nHypospadias balanic: LB53.0\\nHypospadias coronal: LB53.00\\nHypospadias glandular: LB53.01\\nOther specified hypospadias balanic: LB53.0Y\\nHypospadias balanic unspecified: LB53.0Z\\nHypospadias penile: LB53.1\\nHypospadias penoscrotal: LB53.2\\nHypospadias scrotal: LB53.3\\nHypospadias perineal: LB53.4\\nOther specified hypospadias: LB53.Y\\nHypospadias unspecified: LB53.Z\\nCongenital chordee: LB54\\nEpispadias: LB55\\nBifid scrotum: LB56\\nAgenesis of vas deferens: LB57\\nPolyorchidism: LB58\\nHypoplasia of testis or scrotum: LB59\\nOther specified structural developmental anomalies of the male genital system: LB5Y\\nStructural developmental anomalies of the male genital system unspecified: LB5Z\\nBreast aplasia: LB60\\nAbsent nipple: LB61\\nSupernumerary breasts: LB62\\nAccessory nipple: LB63\\nOther specified structural developmental anomalies of the breast: LB6Y\\nStructural developmental anomalies of the breast unspecified: LB6Z\\nStructural developmental anomalies of cranium: LB70\\nCraniosynostosis: LB70.0\\nPlagiocephaly: LB70.00\\nOther specified craniosynostosis: LB70.0Y\\nCraniosynostosis unspecified: LB70.0Z\\nWormian bones: LB70.1\\nJshaped sella turcica: LB70.2\\nMacrocephaly: LB70.3\\nOther specified structural developmental anomalies of cranium: LB70.Y\\nStructural developmental anomalies of cranium unspecified: LB70.Z\\nStructural developmental anomalies of facial bones: LB71\\nHypotelorism: LB71.0\\nHypertelorism: LB71.1\\nOther specified structural developmental anomalies of facial bones: LB71.Y\\nStructural developmental anomalies of facial bones unspecified: LB71.Z\\nStructural developmental anomalies of shoulder girdle: LB72\\nCervical rib: LB72.0\\nSprengel deformity: LB72.1\\nDeformation of scapula: LB72.2\\nOther specified structural developmental anomalies of shoulder girdle: LB72.Y\\nStructural developmental anomalies of shoulder girdle unspecified: LB72.Z\\nStructural developmental anomalies of spine or bony thorax: LB73\\nOccult spinal dysraphism: LB73.0\\nStructural developmental anomalies of chest wall: LB73.1\\nPoland syndrome: LB73.10\\nBifid rib: LB73.11\\nAccessory rib: LB73.12\\nStructural developmental anomalies of sternum: LB73.13\\nOther specified structural developmental anomalies of chest wall: LB73.1Y\\nStructural developmental anomalies of chest wall unspecified: LB73.1Z\\nStructural developmental anomalies of spine: LB73.2\\nKlippelFeil anomaly: LB73.20\\nOccipitalisation of atlas: LB73.21\\nAtlantoaxial instability or subluxation: LB73.22\\nAplasia or hypoplasia of the odontoid process of axis: LB73.23\\nSegmentation anomalies of vertebrae: LB73.24\\nCongenital scoliosis due to congenital bony malformation: LB73.25\\nSacralisation of the last lumbar vertebra: LB73.26\\nLumbarisation of the first sacral vertebra: LB73.27\\nSacrum agenesis or hypoplasia: LB73.28\\nCaudal appendage: LB73.29\\nCongenital spondylolisthesis: LB73.2A\\nOther specified structural developmental anomalies of spine: LB73.2Y\\nStructural developmental anomalies of spine unspecified: LB73.2Z\\nOther specified structural developmental anomalies of spine or bony thorax: LB73.Y\\nStructural developmental anomalies of spine or bony thorax unspecified: LB73.Z\\nStructural developmental anomalies of pelvic girdle: LB74\\nDevelopmental dysplasia of hip: LB74.0\\nCongenital subluxation of hip: LB74.1\\nUnstable hip: LB74.2\\nCongenital coxa vara: LB74.3\\nCongenital coxa valga: LB74.4\\nWide symphysis pubis: LB74.5\\nOther specified structural developmental anomalies of pelvic girdle: LB74.Y\\nStructural developmental anomalies of pelvic girdle unspecified: LB74.Z\\nBrachydactyly: LB75\\nBrachydactyly of fingers: LB75.0\\nBrachydactyly of toes: LB75.1\\nSymbrachydactyly of hands or feet: LB75.2\\nOther specified brachydactyly: LB75.Y\\nBrachydactyly unspecified: LB75.Z\\nTriphalangeal thumb: LB76\\nHyperphalangy: LB77\\nPolydactyly: LB78\\nPolydactyly of the thumb: LB78.0\\nPolysyndactyly: LB78.1\\nPostaxial polydactyly of fingers: LB78.2\\nPolydactyly of toes: LB78.3\\nOther specified polydactyly: LB78.Y\\nPolydactyly unspecified: LB78.Z\\nSyndactyly: LB79\\nFused fingers: LB79.0\\nWebbed fingers: LB79.1\\nFused toes: LB79.2\\nWebbed toes: LB79.3\\nOther specified syndactyly: LB79.Y\\nSyndactyly unspecified: LB79.Z\\nCongenital deformities of fingers: LB80\\nClinodactyly of fingers: LB80.0\\nRadial deviation of fingers: LB80.2\\nOther specified congenital deformities of fingers: LB80.Y\\nCongenital deformities of fingers unspecified: LB80.Z\\nCongenital deformities of toes: LB81\\nClinodactyly of toes: LB81.0\\nOther specified congenital deformities of toes: LB81.Y\\nCongenital deformities of toes unspecified: LB81.Z\\nJoint formation defects: LB90\\nHumeroradioulnar synostosis: LB90.0\\nHumeroradial synostosis: LB90.1\\nHumeroulnar synostosis: LB90.2\\nRadioulnar synostosis: LB90.3\\nMadelung deformity: LB90.4\\nCongenital digital clubbing: LB90.5\\nTibiofibular synostosis: LB90.6\\nCubitus valgus: LB90.7\\nCubitus varus: LB90.8\\nOther specified joint formation defects: LB90.Y\\nJoint formation defects unspecified: LB90.Z\\nCongenital shoulder dislocation: LB91\\nCongenital elbow dislocation: LB92\\nCongenital knee dislocation: LB93\\nCongenital genu recurvatum: LB93.0\\nCongenital genu flexum: LB93.1\\nOther specified congenital knee dislocation: LB93.Y\\nCongenital knee dislocation unspecified: LB93.Z\\nCongenital patella dislocation: LB94\\nPatella aplasia or hypoplasia: LB95\\nCongenital bowing of long bones: LB96\\nCongenital bowing of femur: LB96.0\\nCongenital bowing of tibia: LB96.1\\nOther specified congenital bowing of long bones: LB96.Y\\nCongenital bowing of long bones unspecified: LB96.Z\\nLimb overgrowth: LB97\\nMacrodactyly of fingers: LB97.0\\nMacrodactyly of toes: LB97.1\\nUpper limb hypertrophy: LB97.2\\nLower limb hypertrophy: LB97.3\\nOther specified limb overgrowth: LB97.Y\\nLimb overgrowth unspecified: LB97.Z\\nCongenital deformities of feet: LB98\\nCongenital varus deformities of feet: LB98.0\\nTalipes equinovarus: LB98.00\\nTalipes calcaneovarus: LB98.01\\nMetatarsus varus: LB98.02\\nOther specified congenital varus deformities of feet: LB98.0Y\\nCongenital varus deformities of feet unspecified: LB98.0Z\\nCongenital pes planus: LB98.1\\nCongenital valgus deformities of feet: LB98.2\\nCongenital hallux valgus: LB98.20\\nMetatarsus valgus: LB98.21\\nTalipes calcaneovalgus: LB98.22\\nOther specified congenital valgus deformities of feet: LB98.2Y\\nCongenital valgus deformities of feet unspecified: LB98.2Z\\nCongenital pes cavus: LB98.3\\nCongenital vertical talus: LB98.4\\nCongenital hammer toe: LB98.5\\nOther specified congenital deformities of feet: LB98.Y\\nCongenital deformities of feet unspecified: LB98.Z\\nReduction defects of upper limb: LB99\\nAmelia of upper limb: LB99.0\\nHumeral agenesis or hypoplasia: LB99.1\\nRadial hemimelia: LB99.2\\nUlnar hemimelia: LB99.3\\nCongenital absence of upper arm or forearm with hand present: LB99.4\\nCongenital absence of both forearm and hand: LB99.5\\nAcheiria: LB99.6\\nAdactyly of hands: LB99.7\\nSplit hand: LB99.8\\nOther specified reduction defects of upper limb: LB99.Y\\nReduction defects of upper limb unspecified: LB99.Z\\nReduction defects of lower limb: LB9A\\nAmelia of lower limb: LB9A.0\\nTibial hemimelia: LB9A.1\\nFibular hemimelia: LB9A.2\\nCongenital absence of thigh or lower leg with foot present: LB9A.3\\nApodia: LB9A.4\\nAdactyly of feet: LB9A.5\\nSplit foot: LB9A.6\\nCongenital absence of both lower leg and foot: LB9A.7\\nFemoral agenesis or hypoplasia: LB9A.8\\nOther specified reduction defects of lower limb: LB9A.Y\\nReduction defects of lower limb unspecified: LB9A.Z\\nReduction defects of upper and lower limbs: LB9B\\nOther specified structural developmental anomalies of the skeleton: LB9Y\\nStructural developmental anomalies of the skeleton unspecified: LB9Z\\nKeratinocytic epidermal hamartoma: LC00\\nEpidermal naevus: LC00.0\\nOther specified keratinocytic epidermal hamartoma: LC00.Y\\nKeratinocytic epidermal hamartoma unspecified: LC00.Z\\nPilosebaceous hamartoma: LC01\\nComplex epidermal hamartoma: LC02\\nOther specified developmental hamartomata of the epidermis and epidermal appendages: LC0Y\\nDermal melanocytosis: LC10\\nOther specified developmental anomalies of skin pigmentation: LC1Y\\nConnective tissue hamartoma: LC20\\nOther specified hamartomata derived from dermal connective tissue: LC2Y\\nDevelopmental defects of hair or hair growth: LC30\\nDevelopmental defects of the nail apparatus: LC31\\nDermoid cyst: LC40\\nDevelopmental capillary vascular malformations of the skin: LC50\\nSalmon patch: LC50.0\\nPortwine stain: LC50.1\\nOther specified developmental capillary vascular malformations of the skin: LC50.Y\\nDevelopmental venous malformations involving the skin: LC51\\nComplex or combined developmental vascular malformations involving the skin: LC52\\nOther specified developmental anomalies of cutaneous vasculature: LC5Y\\nDevelopmental anomalies of cutaneous vasculature unspecified: LC5Z\\nAplasia cutis congenita: LC60\\nOther specified structural developmental anomalies of the skin: LC7Y\\nStructural developmental anomalies of the skin unspecified: LC7Z\\nCongenital adrenal hypoplasia: LC80\\nOther specified structural developmental anomalies of the adrenal glands: LC8Y\\nStructural developmental anomalies of the adrenal glands unspecified: LC8Z\\nOther specified structural developmental anomalies primarily affecting one body system: LD0Y\\nStructural developmental anomalies primarily affecting one body system unspecified: LD0Z\\nSyndromes with central nervous system anomalies as a major feature: LD20\\nSyndromes with cerebellar anomalies as a major feature: LD20.0\\nJoubert syndrome: LD20.00\\nPontocerebellar hypoplasia: LD20.01\\nOther specified syndromes with cerebellar anomalies as a major feature: LD20.0Y\\nSyndromes with cerebellar anomalies as a major feature unspecified: LD20.0Z\\nSyndromes with lissencephaly as a major feature: LD20.1\\nSyndromes with microcephaly as a major feature: LD20.2\\nSyndromes with holoprosencephaly as a major feature: LD20.3\\nSyndromes with brain calcifications as a major feature: LD20.4\\nOther specified syndromes with central nervous system anomalies as a major feature: LD20.Y\\nSyndromes with central nervous system anomalies as a major feature unspecified: LD20.Z\\nSyndromes with eye anomalies as a major feature: LD21\\nSyndromes with microphthalmia as a major feature: LD21.0\\nOther specified syndromes with eye anomalies as a major feature: LD21.Y\\nSyndromes with eye anomalies as a major feature unspecified: LD21.Z\\nSyndromes with dental anomalies as a major feature: LD22\\nSyndromes with vascular anomalies as a major feature: LD23\\nSyndromes with skeletal anomalies as a major feature: LD24\\nSyndromes with micromelia: LD24.0\\nAchondroplasia: LD24.00\\nHypochondroplasia: LD24.01\\nThanatophoric dysplasia: LD24.02\\nDiastrophic dysplasia: LD24.03\\nChondrodysplasia punctata: LD24.04\\nOther specified syndromes with micromelia: LD24.0Y\\nSyndromes with micromelia unspecified: LD24.0Z\\nBone diseases with increased bone density: LD24.1\\nOsteopetrosis: LD24.10\\nOsteopoikilosis: LD24.11\\nOther specified bone diseases with increased bone density: LD24.1Y\\nBone diseases with increased bone density unspecified: LD24.1Z\\nBone diseases with disorganised development of skeletal components: LD24.2\\nMultiple osteochondromas: LD24.20\\nExostoses with anetodermia and brachydactyly type E: LD24.21\\nCherubism: LD24.22\\nYunisVaron disease: LD24.23\\nOther specified bone diseases with disorganised development of skeletal components: LD24.2Y\\nBone diseases with disorganised development of skeletal components unspecified: LD24.2Z\\nSpondyloepiphyseal or spondyloepimetaphyseal dysplasias: LD24.3\\nSpondylometaphyseal dysplasias: LD24.4\\nSpondylodysplastic dysplasias: LD24.5\\nAchondrogenesis: LD24.50\\nHypochondrogenesis: LD24.51\\nOther specified spondylodysplastic dysplasias: LD24.5Y\\nSpondylodysplastic dysplasias unspecified: LD24.5Z\\nMultiple epiphyseal dysplasia or pseudoachondroplasia: LD24.6\\nPseudoachondroplasia: LD24.60\\nMultiple epiphyseal dysplasias: LD24.61\\nOther specified multiple epiphyseal dysplasia or pseudoachondroplasia: LD24.6Y\\nMultiple metaphyseal dysplasias: LD24.7\\nAcromelic dysplasias: LD24.8\\nLangerGiedion syndrome: LD24.80\\nOther specified acromelic dysplasias: LD24.8Y\\nAcromelic dysplasias unspecified: LD24.8Z\\nAcromesomelic dysplasias: LD24.9\\nMesomelic or rhizomesomelic dysplasias: LD24.A\\nShort rib syndromes: LD24.B\\nShort ribpolydactyly syndrome: LD24.B0\\nAsphyxiating thoracic dystrophy: LD24.B1\\nOther specified short rib syndromes: LD24.BY\\nShort rib syndromes unspecified: LD24.BZ\\nBent bone dysplasias: LD24.C\\nSlender bone dysplasias: LD24.D\\nBone dysplasias with multiple joint dislocations: LD24.E\\nProgressive ossification of skin skeletal muscle fascia tendons or ligaments: LD24.F\\nSyndromic craniosynostoses: LD24.G\\nPfeiffer syndrome: LD24.G0\\nCrouzon disease: LD24.G1\\nApert syndrome: LD24.G2\\nOther specified syndromic craniosynostoses: LD24.GY\\nSyndromic craniosynostoses unspecified: LD24.GZ\\nDysostoses with predominant vertebral and costal involvement: LD24.H\\nPatellar dysostoses: LD24.J\\nNailpatella syndrome: LD24.J0\\nOther specified patellar dysostoses: LD24.JY\\nPatellar dysostoses unspecified: LD24.JZ\\nGenetic bone diseases with decreased bone density: LD24.K\\nOsteogenesis imperfecta: LD24.K0\\nOther specified genetic bone diseases with decreased bone density: LD24.KY\\nGenetic bone diseases with decreased bone density unspecified: LD24.KZ\\nOther specified syndromes with skeletal anomalies as a major feature: LD24.Y\\nSyndromes with skeletal anomalies as a major feature unspecified: LD24.Z\\nSyndromes with face or limb anomalies as a major feature: LD25\\nOromandibularlimb anomaly syndrome: LD25.0\\nOralfacialdigital syndrome: LD25.00\\nOther specified oromandibularlimb anomaly syndrome: LD25.0Y\\nOromandibularlimb anomaly syndrome unspecified: LD25.0Z\\nFrontootopalatodigital syndromes: LD25.1\\nAcrofacial dysostoses: LD25.2\\nCraniofacial dysostoses: LD25.3\\nOther specified syndromes with face or limb anomalies as a major feature: LD25.Y\\nSyndromes with face or limb anomalies as a major feature unspecified: LD25.Z\\nSyndromes with limb anomalies as a major feature: LD26\\nCombined reduction defects of upper and lower limbs: LD26.0\\nComplex brachydactylies: LD26.1\\nSyndromes with limb duplication polydactyly syndactyly or triphalangism: LD26.2\\nSyndromes with synostoses of limbs: LD26.3\\nArthrogryposis syndromes: LD26.4\\nMultiple pterygium syndrome: LD26.40\\nArthrogryposis multiplex congenita: LD26.41\\nOther specified arthrogryposis syndromes: LD26.4Y\\nArthrogryposis syndromes unspecified: LD26.4Z\\nConstriction rings: LD26.5\\nCongenital vascular bone syndromes: LD26.6\\nAngioosteohypertrophic syndrome: LD26.60\\nOther specified congenital vascular bone syndromes: LD26.6Y\\nCongenital vascular bone syndromes unspecified: LD26.6Z\\nOther specified syndromes with limb anomalies as a major feature: LD26.Y\\nSyndromes with limb anomalies as a major feature unspecified: LD26.Z\\nSyndromes with skin or mucosal anomalies as a major feature: LD27\\nEctodermal dysplasia syndromes: LD27.0\\nIncontinentia pigmenti: LD27.00\\nCronkhiteCanada syndrome: LD27.01\\nHypohidrotic ectodermal dysplasia: LD27.02\\nHidrotic ectodermal dysplasia Clouston type: LD27.03\\nOther specified ectodermal dysplasia syndromes: LD27.0Y\\nEctodermal dysplasia syndrome unspecified: LD27.0Z\\nXeroderma pigmentosum: LD27.1\\nSyndromic ichthyosis: LD27.2\\nGenetic syndromes with hypertrichosis: LD27.3\\nGenetic syndromes affecting nails: LD27.4\\nGenetic hamartoneoplastic syndromes affecting the skin: LD27.5\\nGenetic lipodystrophy: LD27.6\\nCongenital generalised lipodystrophy: LD27.60\\nGenetic lipodystrophy unspecified: LD27.6Z\\nOther specified syndromes with skin or mucosal anomalies as a major feature: LD27.Y\\nSyndromes with skin or mucosal anomalies as a major feature unspecified: LD27.Z\\nSyndromes with connective tissue involvement as a major feature: LD28\\nMarfan syndrome or Marfanrelated disorders: LD28.0\\nCongenital contractural arachnodactyly: LD28.00\\nMarfan syndrome: LD28.01\\nOther specified Marfan syndrome or Marfanrelated disorders: LD28.0Y\\nMarfan syndrome or Marfanrelated disorders unspecified: LD28.0Z\\nEhlersDanlos syndrome: LD28.1\\nEhlersDanlos syndrome classical type: LD28.10\\nOther specified types of EhlersDanlos syndrome: LD28.1Y\\nEhlersDanlos syndrome unspecified: LD28.1Z\\nGeneticallydetermined cutis laxa: LD28.2\\nOther specified syndromes with connective tissue involvement as a major feature: LD28.Y\\nSyndromes with connective tissue involvement as a major feature unspecified: LD28.Z\\nSyndromes with obesity as a major feature: LD29\\nMalformative disorders of sex development: LD2A\\nOvotesticular disorder of sex development: LD2A.0\\nXY gonadal dysgenesis: LD2A.1\\nTesticular agenesis: LD2A.2\\nXY disorder of sex development due to a defect in testosterone metabolism: LD2A.3\\nXY disorder of sex development due to androgen resistance: LD2A.4\\nOther specified malformative disorders of sex development: LD2A.Y\\nMalformative disorders of sex development unspecified: LD2A.Z\\nSyndromes with premature ageing appearance as a major feature: LD2B\\nOvergrowth syndromes: LD2C\\nPhakomatoses or hamartoneoplastic syndromes: LD2D\\nPeutzJeghers syndrome: LD2D.0\\nNeurofibromatoses: LD2D.1\\nNeurofibromatosis type: LD2D.12\\nOther specified neurofibromatoses: LD2D.1Y\\nNeurofibromatosis unspecified: LD2D.1Z\\nTuberous sclerosis: LD2D.2\\nGardner syndrome: LD2D.3\\nGorlin syndrome: LD2D.4\\nOther specified phakomatoses or hamartoneoplastic syndromes: LD2D.Y\\nPhakomatoses or hamartoneoplastic syndromes unspecified: LD2D.Z\\nSyndromes with structural anomalies due to inborn errors of metabolism: LD2E\\nSyndromes with multiple structural anomalies without predominant body system involvement: LD2F\\nToxic or drugrelated embryofetopathies: LD2F.0\\nFetal alcohol syndrome: LD2F.00\\nFetal hydantoin syndrome: LD2F.01\\nEmbryofetopathy due to oral anticoagulant therapy: LD2F.02\\nFetal Valproate Spectrum Disorder: LD2F.03\\nOther specified toxic or drugrelated embryofetopathies: LD2F.0Y\\nToxic or drugrelated embryofetopathies unspecified: LD2F.0Z\\nSyndromes with multiple structural anomalies not of environmental origin: LD2F.1\\nPrune belly syndrome: LD2F.10\\nVATER association: LD2F.11\\nSirenomelia: LD2F.12\\nMeckelGruber syndrome: LD2F.13\\nMURCS association: LD2F.14\\nNoonan syndrome: LD2F.15\\nOtomandibular dysplasia: LD2F.16\\nOther specified syndromes with multiple structural anomalies not of environmental origin: LD2F.1Y\\nSyndromes with multiple structural anomalies not of environmental origin unspecified: LD2F.1Z\\nOther specified syndromes with multiple structural anomalies without predominant body system involvement: LD2F.Y\\nSyndromes with multiple structural anomalies without predominant body system involvement unspecified: LD2F.Z\\nConjoined twins: LD2G\\nSyndromic genetic deafness: LD2H\\nFraser syndrome: LD2H.0\\nNeuropathy with hearing impairment: LD2H.1\\nProgressive deafness with stapes fixation: LD2H.2\\nWaardenburgShah syndrome: LD2H.3\\nUsher syndrome: LD2H.4\\nOther specified syndromic genetic deafness: LD2H.Y\\nSyndromic genetic deafness unspecified: LD2H.Z\\nOther specified multiple developmental anomalies or syndromes: LD2Y\\nMultiple developmental anomalies or syndromes unspecified: LD2Z\\nComplete trisomies of the autosomes: LD40\\nComplete trisomy: LD40.2\\nOther specified complete trisomies of the autosomes: LD40.Y\\nComplete trisomies of the autosomes unspecified: LD40.Z\\nDuplications of the autosomes: LD41\\nDuplications of chromosome: LD41.M\\nDuplications of the long arm of chromosome: LD41.K0\\nDuplications of the short arm of chromosome: LD41.K1\\nOther specified duplications of chromosome: LD41.KY\\nDuplications of chromosome  unspecified: LD41.KZ\\nExtra ring or dicentric chromosomes: LD41.N\\nDuplications with other complex rearrangements: LD41.P\\nExtra marker chromosomes: LD41.Q\\nOther specified duplications of the autosomes: LD41.Y\\nDuplications of the autosomes unspecified: LD41.Z\\nPolyploidies: LD42\\nTriploidy: LD42.0\\nTetraploidy: LD42.1\\nOther specified polyploidies: LD42.Y\\nPolyploidies unspecified: LD42.Z\\nComplete monosomies of the autosomes: LD43\\nComplete monosomy of autosome: LD43.0\\nMosaic monosomy of autosome: LD43.1\\nOther specified complete monosomies of the autosomes: LD43.Y\\nComplete monosomies of the autosomes unspecified: LD43.Z\\nDeletions of the autosomes: LD44\\nDeletions of chromosome: LD44.N\\nDeletions of the long arm of chromosome: LD44.L0\\nDeletions of the short arm of chromosome: LD44.L1\\nOther specified deletions of chromosome: LD44.NY\\nDeletions of chromosome  unspecified: LD44.NZ\\nCATCH  phenotype: LD44.N0\\nDeletions with other complex rearrangements: LD44.P\\nOther specified deletions of the autosomes: LD44.Y\\nDeletions of the autosomes unspecified: LD44.Z\\nUniparental disomies: LD45\\nUniparental disomies of maternal origin: LD45.0\\nUniparental disomies of paternal origin: LD45.1\\nOther specified uniparental disomies: LD45.Y\\nUniparental disomies unspecified: LD45.Z\\nImprinting errors: LD46\\nMaternal imprinting error: LD46.0\\nPaternal imprinting error: LD46.1\\nOther specified imprinting errors: LD46.Y\\nImprinting errors unspecified: LD46.Z\\nBalanced rearrangements or structural rearrangements: LD47\\nBalanced translocation and insertion in normal individual: LD47.0\\nChromosome inversion in normal individual: LD47.1\\nBalanced autosomal rearrangement in abnormal individual: LD47.2\\nBalanced sex or autosomal rearrangement in abnormal individual: LD47.3\\nAutosomal fragile site: LD47.4\\nOther specified balanced rearrangements or structural rearrangements: LD47.Y\\nBalanced rearrangements or structural rearrangements unspecified: LD47.Z\\nNumber anomalies of chromosome X: LD50\\nTurner syndrome: LD50.0\\nKaryotype  X: LD50.00\\nKaryotype  X iso Xq: LD50.01\\nKaryotype  X with abnormal sex chromosome except iso Xq: LD50.02\\nMosaicism  X  XX or XY: LD50.03\\nMosaicism  X or other cell line with abnormal sex chromosome: LD50.04\\nKaryotype XXX: LD50.1\\nMosaicism lines with various numbers of X chromosomes: LD50.2\\nKlinefelter syndrome: LD50.3\\nKlinefelter syndrome with karyotype XXY regular: LD50.30\\nKlinefelter syndrome male with more than two X chromosomes: LD50.31\\nOther specified Klinefelter syndrome: LD50.3Y\\nKlinefelter syndrome unspecified: LD50.3Z\\nOther specified number anomalies of chromosome X: LD50.Y\\nNumber anomalies of chromosome X unspecified: LD50.Z\\nStructural anomalies of chromosome X excluding Turner syndrome: LD51\\nNumber anomalies of chromosome Y: LD52\\nMale with XX karyotype: LD52.0\\nMale with double or multiple Y: LD52.1\\nOther specified number anomalies of chromosome Y: LD52.Y\\nNumber anomalies of chromosome Y unspecified: LD52.Z\\nStructural anomalies of chromosome Y: LD53\\nMale with sex chromosome mosaicism: LD54\\nFragile X chromosome: LD55\\nChimaera  XX  XY: LD56\\nAndrogenetic chimaera: LD56.0\\nGynogenetic chimaera: LD56.1\\nOther specified chimaera  XX  XY: LD56.Y\\nChimaera  XX  XY unspecified: LD56.Z\\nOther specified sex chromosome anomalies: LD5Y\\nSex chromosome anomalies unspecified: LD5Z\\nOther specified chromosomal anomalies excluding gene mutations: LD7Y\\nChromosomal anomalies excluding gene mutations unspecified: LD7Z\\nConditions with disorders of intellectual development as a relevant clinical feature: LD90\\nAngelman syndrome: LD90.0\\nEarlyonset parkinsonism intellectual deficit: LD90.1\\nPelizaeusMerzbacherlike disease: LD90.2\\nPraderWilli syndrome: LD90.3\\nRett syndrome: LD90.4\\nOther specified conditions with disorders of intellectual development as a relevant clinical feature: LD90.Y\\nConditions with disorders of intellectual development as a relevant clinical feature unspecified: LD90.Z\\nOther specified developmental anomalies: LD9Y\\nDevelopmental anomalies unspecified: LD9Z\\nSymptom or complaint of the blood: MA00\\nEnlarged lymph nodes: MA01\\nLocalised lymph node enlargement: MA01.0\\nGeneralised lymph node enlargement: MA01.1\\nEnlarged lymph nodes unspecified: MA01.Z\\nOther specified symptoms or signs of blood bloodforming organs or the immune system: MA0Y\\nAbnormal serum enzyme levels: MA10\\nElevation of levels of transaminase or lactic acid dehydrogenase: MA10.0\\nAbnormal levels of other specified serum enzymes: MA10.1\\nAbnormal level of unspecified serum enzyme: MA10.2\\nClinical findings of hormones in blood bloodforming organs or the immune system: MA11\\nClinical findings of drugs medicaments and biological substances in blood bloodforming organs or the immune system: MA12\\nFinding of opiate drug in blood: MA12.0\\nFinding of cocaine in blood: MA12.1\\nFinding of hallucinogen in blood: MA12.2\\nFinding of psychotropic drug in blood: MA12.3\\nFinding of steroid agent in blood: MA12.4\\nOther specified clinical findings of drugs medicaments and biological substances in blood bloodforming organs or the immune system: MA12.Y\\nClinical findings of substances chiefly nonmedicinal as to source in blood bloodforming organs or the immune system: MA13\\nFinding of abnormal level of heavy metals in blood: MA13.0\\nAbnormal level of lead in blood: MA13.00\\nFinding of abnormal level of other specified heavy metals in blood: MA13.0Y\\nFinding of alcohol in blood: MA13.1\\nAbnormal level of other specified substances chiefly nonmedicinal as to source in blood bloodforming organs and the immune system: MA13.Y\\nImmunological findings in blood bloodforming organs or the immune system: MA14\\nLaboratory evidence of human immunodeficiency virus: MA14.0\\nCertain specified immunological findings: MA14.1\\nAbnormal reaction to tuberculin test: MA14.10\\nAnticitrullinated protein antibody negative: MA14.11\\nAnticitrullinated protein antibody positive: MA14.12\\nAntinuclear antibody negative: MA14.13\\nAntinuclear antibody positive: MA14.14\\nElevated Creactive protein: MA14.15\\nFalsepositive serological test for syphilis: MA14.16\\nHuman leukocyte antigen negative: MA14.17\\nHuman leukocyte antigen positive: MA14.18\\nNeural autoantibody negative: MA14.19\\nNeural autoantibody positive: MA14.1A\\nProstate specific antigen positive: MA14.1B\\nRaised antibody titre: MA14.1C\\nRheumatoid factor negative: MA14.1D\\nRheumatoid factor positive: MA14.1E\\nOther specified immunological findings in blood bloodforming organs or the immune system: MA14.Y\\nMicrobiological findings in blood bloodforming organs or the immune system: MA15\\nBacteraemia: MA15.0\\nFungaemia: MA15.1\\nOther specified microbiological findings in blood bloodforming organs or the immune system: MA15.Y\\nCytological findings in blood bloodforming organs or the immune system: MA16\\nAbnormality of red blood cells: MA16.0\\nHaemolysis not elsewhere classified: MA16.00\\nOther specified abnormality of red blood cells: MA16.0Y\\nAbnormality of red blood cells unspecified: MA16.0Z\\nAbnormality of white blood cells: MA16.1\\nDecreased white blood cell count: MA16.10\\nElevated white blood cell count: MA16.11\\nAbnormality of white blood cells unspecified: MA16.1Z\\nOther specified cytological findings in blood bloodforming organs or the immune system: MA16.Y\\nCytological findings in blood bloodforming organs or the immune system unspecified: MA16.Z\\nHistological findings in blood bloodforming organs or the immune system: MA17\\nCertain clinical findings of blood chemistry: MA18\\nElevated blood glucose level: MA18.0\\nAbnormal glucose tolerance test: MA18.00\\nOther specified elevated blood glucose level: MA18.0Y\\nElevated blood glucose level unspecified: MA18.0Z\\nAbnormal level of blood mineral: MA18.1\\nAbnormal arterial bloodgas level: MA18.2\\nAbnormal coagulation profile: MA18.3\\nLow haemoglobin: MA18.4\\nOther specified abnormal findings of blood chemistry: MA18.Y\\nAbnormal findings of blood chemistry unspecified: MA18.Z\\nCertain abnormalities of plasma proteins: MA19\\nAbnormality of albumin: MA19.0\\nAbnormality of alphafetoprotein: MA19.1\\nAbnormality of globulin: MA19.2\\nAbnormalities of other specified plasma proteins: MA19.Y\\nAbnormalities of unspecified plasma proteins: MA19.Z\\nElevated erythrocyte sedimentation rate or abnormality of plasma viscosity: MA1A\\nElevated erythrocyte sedimentation rate: MA1A.0\\nAbnormal plasma viscosity: MA1A.1\\nOther specified clinical findings in blood bloodforming organs or the immune system: MA1Y\\nAbnormal results of thyroid function studies: MA50\\nAbnormal results of other endocrine function studies: MA51\\nOther specified symptoms signs or clinical findings of endocrine nutritional or metabolic diseases: MA6Y\\nSpeech or language disturbances: MA80\\nAphasia: MA80.0\\nDysphasia: MA80.1\\nDysarthria: MA80.2\\nAnarthria: MA80.20\\nOther specified dysarthria: MA80.2Y\\nDysarthria unspecified: MA80.2Z\\nOther specified speech or language disturbances: MA80.Y\\nSpeech or language disturbances unspecified: MA80.Z\\nSpeech dysfluency: MA81\\nVoice disturbances: MA82\\nAphonia: MA82.0\\nDysphonia: MA82.1\\nHoarseness: MA82.10\\nOther specified dysphonia: MA82.1Y\\nDysphonia unspecified: MA82.1Z\\nNasality: MA82.2\\nOther specified voice disturbances: MA82.Y\\nVoice disturbances unspecified: MA82.Z\\nOther specified symptoms or signs involving speech language or voice: MA8Y\\nOther specified symptoms signs or clinical findings of speech language or voice: MB0Y\\nSymptoms signs or clinical findings involving consciousness: MB20\\nStupor: MB20.0\\nComa: MB20.1\\nClouding of consciousness: MB20.2\\nOther specified symptoms signs or clinical findings involving consciousness: MB20.Y\\nSymptoms signs or clinical findings involving cognition: MB21\\nAgeassociated cognitive decline: MB21.0\\nAmnesia: MB21.1\\nAnterograde amnesia: MB21.10\\nRetrograde amnesia: MB21.11\\nTransient global amnesia: MB21.12\\nOther specified amnesia: MB21.1Y\\nAmnesia unspecified: MB21.1Z\\nAnosognosia: MB21.2\\nConfabulation: MB21.3\\nDisorientation: MB21.4\\nDistractibility: MB21.5\\nImpaired abstract thinking: MB21.6\\nImpaired executive functioning: MB21.7\\nImpaired judgment: MB21.8\\nPerseveration: MB21.9\\nPoor concentration: MB21.A\\nRacing thoughts: MB21.B\\nOther specified symptoms signs or clinical findings involving cognition: MB21.Y\\nSymptoms signs or clinical findings involving cognition unspecified: MB21.Z\\nSymptoms or signs involving motivation or energy: MB22\\nAvolition: MB22.0\\nDecreased libido: MB22.1\\nDemoralization: MB22.2\\nHopelessness: MB22.3\\nIncreased energy: MB22.4\\nIncreased goaldirected activity: MB22.5\\nIncreased libido: MB22.6\\nTiredness: MB22.7\\nOther specified symptoms or signs involving motivation or energy: MB22.Y\\nSymptoms or signs involving motivation or energy unspecified: MB22.Z\\nSymptoms or signs involving appearance or behaviour: MB23\\nAggressive behaviour: MB23.0\\nAntisocial behaviour: MB23.1\\nAvoidance behaviour: MB23.2\\nBradyphrenia: MB23.3\\nCompulsions: MB23.4\\nCoprolalia: MB23.5\\nDisorganised behaviour: MB23.6\\nDisheveled appearance: MB23.7\\nDisruptive behaviour: MB23.8\\nEcholalia: MB23.9\\nExcessive crying of child adolescent or adult: MB23.A\\nIncreased sociability: MB23.C\\nMutism: MB23.D\\nNonsuicidal selfinjury: MB23.E\\nOdd or peculiar appearance: MB23.F\\nOdd or peculiar behaviour: MB23.G\\nPanic attack: MB23.H\\nPoor personal hygiene: MB23.J\\nPoverty of speech: MB23.K\\nPressured speech: MB23.L\\nPsychomotor agitation: MB23.M\\nPsychomotor retardation: MB23.N\\nSocial withdrawal: MB23.Q\\nSuicide attempt: MB23.R\\nSuicidal behaviour: MB23.S\\nOther specified symptoms and signs involving appearance and behaviour: MB23.Y\\nSymptoms and signs involving appearance and behaviour unspecified: MB23.Z\\nSymptoms or signs involving mood or affect: MB24\\nAmbivalence: MB24.0\\nAnger: MB24.1\\nAnhedonia: MB24.2\\nAnxiety: MB24.3\\nApathy: MB24.4\\nDepressed mood: MB24.5\\nDisturbance of affect: MB24.6\\nConstricted affect: MB24.60\\nBlunted affect: MB24.61\\nFlat affect: MB24.62\\nLabile affect: MB24.63\\nInappropriate affect: MB24.64\\nOther specified disturbance of affect: MB24.6Y\\nDisturbance of affect unspecified: MB24.6Z\\nDysphoria: MB24.7\\nElevated mood: MB24.8\\nEuphoria: MB24.9\\nFear: MB24.A\\nFeelings of guilt: MB24.B\\nIrritability: MB24.C\\nLeaden paralysis: MB24.D\\nMental rumination: MB24.E\\nRestlessness: MB24.F\\nTantrum: MB24.G\\nWorry: MB24.H\\nOther specified symptoms and signs involving mood or affect: MB24.Y\\nSymptoms and signs involving mood or affect unspecified: MB24.Z\\nSymptoms or signs involving form of thought: MB25\\nSymptoms or signs of thought disorder: MB25.0\\nCircumstantiality: MB25.00\\nTangentiality: MB25.01\\nDisorganised thinking: MB25.02\\nIncoherence: MB25.03\\nOther specified symptoms or signs of thought disorder: MB25.0Y\\nSymptoms or signs of thought disorder unspecified: MB25.0Z\\nFlight of ideas: MB25.1\\nNeologisms: MB25.2\\nThought blocking: MB25.3\\nOther specified symptoms or signs of form of thought: MB25.Y\\nSymptoms or signs of form of thought unspecified: MB25.Z\\nSymptoms or signs involving content of thought: MB26\\nDelusion: MB26.0\\nBizarre delusion: MB26.00\\nDelusion of being controlled: MB26.01\\nDelusion of guilt: MB26.02\\nDelusion of reference: MB26.03\\nErotomanic delusion: MB26.04\\nGrandiose delusion: MB26.05\\nJealous delusion: MB26.06\\nPersecutory delusion: MB26.07\\nReligious delusion: MB26.08\\nSomatic delusion: MB26.09\\nNihilistic delusion: MB26.0A\\nMisidentification delusion: MB26.0B\\nDelusion of impoverishment: MB26.0C\\nOther specified delusion: MB26.0Y\\nDelusion unspecified: MB26.0Z\\nExperiences of influence passivity and control: MB26.1\\nThought broadcasting: MB26.10\\nThought insertion: MB26.11\\nThought withdrawal: MB26.12\\nOther specified experiences of influence passivity and control: MB26.1Y\\nExperiences of influence passivity and control unspecified: MB26.1Z\\nGrandiosity: MB26.2\\nHomicidal ideation: MB26.3\\nIdentity disturbance: MB26.4\\nObsessions: MB26.5\\nOvervalued ideas: MB26.6\\nParanoid ideation: MB26.7\\nReferential thinking: MB26.8\\nSuspiciousness: MB26.9\\nSuicidal ideation: MB26.A\\nOther specified symptoms or signs involving content of thought: MB26.Y\\nSymptoms or signs involving content of thought unspecified: MB26.Z\\nSymptoms or signs involving perceptual disturbance: MB27\\nDepersonalisation: MB27.0\\nDerealisation: MB27.1\\nHallucinations: MB27.2\\nAuditory hallucinations: MB27.20\\nGustatory hallucinations: MB27.21\\nHypnopompic hallucinations: MB27.22\\nHypnagogic hallucinations: MB27.23\\nOlfactory hallucinations: MB27.24\\nSomatic hallucinations: MB27.25\\nTactile hallucinations: MB27.26\\nVisual hallucinations: MB27.27\\nOther specified hallucinations: MB27.2Y\\nHallucinations unspecified: MB27.2Z\\nDisturbance of body image: MB27.3\\nIllusions: MB27.4\\nOther specified symptoms or signs of perceptual disturbance: MB27.Y\\nSymptoms or signs of perceptual disturbance unspecified: MB27.Z\\nSymptoms or signs related to personality features: MB28\\nAttention seeking: MB28.0\\nCallousness: MB28.1\\nEccentricity: MB28.2\\nEntitlement: MB28.3\\nHostility: MB28.4\\nImpulsivity: MB28.5\\nIndecisiveness: MB28.6\\nIrresponsibility: MB28.7\\nLow frustration tolerance: MB28.8\\nLow selfesteem: MB28.9\\nNegative affectivity: MB28.A\\nNegativism: MB28.B\\nPerfectionism: MB28.C\\nPessimism: MB28.D\\nRecklessness: MB28.E\\nSensation seeking: MB28.F\\nStubbornness: MB28.G\\nSubmissiveness: MB28.H\\nOther specified symptoms and signs related to personality features: MB28.Y\\nSymptoms and signs related to personality features unspecified: MB28.Z\\nSymptoms or signs involving eating and related behaviour: MB29\\nAvoidant or restrictive eating: MB29.0\\nBinge eating: MB29.1\\nEating of nonnutritive substances: MB29.2\\nPurging behaviour: MB29.3\\nRuminationregurgitation: MB29.4\\nOther specified symptoms and signs involving eating and related behaviour: MB29.Y\\nSymptoms and signs involving eating and related behaviour unspecified: MB29.Z\\nSymptoms or signs involving elimination: MB2A\\nSoiling: MB2A.0\\nWetting: MB2A.1\\nOther specified symptoms and signs involving elimination: MB2A.Y\\nSymptoms and signs involving elimination unspecified: MB2A.Z\\nOther specified mental or behavioural symptoms signs or clinical findings: MB2Y\\nSensation disturbance: MB40\\nAsomatognosia: MB40.0\\nAllodynia: MB40.1\\nAnacusis: MB40.2\\nAnaesthesia of skin: MB40.3\\nTingling fingers or feet or toes: MB40.4\\nHyperaesthesia: MB40.5\\nDysesthesia: MB40.6\\nAcroparaesthesia: MB40.7\\nAnalgesia: MB40.8\\nNeurological neglect syndrome: MB40.9\\nOther specified sensation disturbance: MB40.Y\\nSensation disturbance unspecified: MB40.Z\\nDisturbances of smell or taste: MB41\\nAnosmia: MB41.0\\nParosmia: MB41.1\\nDysgeusia: MB41.2\\nHyposmia: MB41.3\\nOther specified disturbances of smell or taste: MB41.Y\\nDisturbances of smell or taste unspecified: MB41.Z\\nPhonophobia: MB42\\nDyssomnia: MB43\\nAbnormalities of gait or mobility: MB44\\nAtaxic gait: MB44.0\\nParalytic gait: MB44.1\\nDifficulty in walking: MB44.2\\nImmobility: MB44.3\\nOther specified abnormalities of gait or mobility: MB44.Y\\nAbnormalities of gait or mobility unspecified: MB44.Z\\nLack of coordination: MB45\\nAtaxia unspecified: MB45.0\\nAutomatism: MB45.1\\nAtonia: MB45.2\\nHead drop: MB45.3\\nIntention tremor: MB45.4\\nOther specified lack of coordination: MB45.Y\\nLack of coordination unspecified: MB45.Z\\nAbnormal involuntary movements: MB46\\nAsterixis: MB46.0\\nAbnormal head movements: MB46.1\\nAthetosis: MB46.2\\nDrop attack: MB46.3\\nTitubation: MB46.4\\nShuddering: MB46.5\\nOther specified abnormal involuntary movements: MB46.Y\\nAbnormal involuntary movements unspecified: MB46.Z\\nAbnormality of tonus or reflex: MB47\\nAbnormal reflex: MB47.0\\nAbnormal posture: MB47.1\\nClonus: MB47.2\\nCramp or spasm: MB47.3\\nDystonia: MB47.4\\nFasciculation: MB47.5\\nMeningismus: MB47.6\\nMuscle fibrillation: MB47.7\\nMuscular hypertonia: MB47.8\\nMyotonia: MB47.9\\nOphthalmoparesis: MB47.A\\nOpisthotonos: MB47.B\\nTendency to fall: MB47.C\\nTetany: MB47.D\\nOther specified abnormality of tonus or reflex: MB47.Y\\nAbnormality of tonus or reflex unspecified: MB47.Z\\nDizziness or giddiness: MB48\\nVertigo: MB48.0\\nVertigo of central origin: MB48.00\\nOther specified vertigo: MB48.0Y\\nVertigo unspecified: MB48.0Z\\nDisorder of equilibrium: MB48.1\\nExertional dizziness: MB48.2\\nLightheadedness: MB48.3\\nPresyncope: MB48.4\\nOther specified dizziness or giddiness: MB48.Y\\nDizziness or giddiness unspecified: MB48.Z\\nAura: MB49\\nApraxia: MB4A\\nSymbolic dysfunctions: MB4B\\nDyslexia and alexia: MB4B.0\\nAgnosia: MB4B.1\\nAcalculia: MB4B.2\\nAgraphia: MB4B.3\\nAnomia: MB4B.4\\nDyscalculia: MB4B.5\\nOther specified symbolic dysfunctions: MB4B.Y\\nSymbolic dysfunctions unspecified: MB4B.Z\\nGerstmann syndrome: MB4C\\nHeadache not elsewhere classified: MB4D\\nTetraplegia: MB50\\nFlaccid tetraplegia: MB50.0\\nSpastic tetraplegia: MB50.1\\nTetraplegia unspecified: MB50.Z\\nDiplegia of upper extremities: MB51\\nFlaccid diplegia of upper extremities: MB51.0\\nSpastic diplegia of upper extremities: MB51.1\\nDiplegia of upper extremities unspecified: MB51.Z\\nDiplegia of lower extremities: MB52\\nHemiplegia: MB53\\nAlternating hemiplegia: MB53.0\\nFlaccid hemiplegia: MB53.1\\nSpastic hemiplegia: MB53.2\\nHemiplegia unspecified: MB53.Z\\nMonoplegia of upper extremity: MB54\\nFlaccid monoplegia of upper extremity: MB54.0\\nSpastic monoplegia of upper extremity: MB54.1\\nMonoplegia of upper extremity unspecified: MB54.Z\\nMonoplegia of lower extremity: MB55\\nFlaccid monoplegia of lower extremity: MB55.0\\nSpastic monoplegia of lower extremity: MB55.1\\nMonoplegia of lower extremity unspecified: MB55.Z\\nParaplegia: MB56\\nFunctional level of injury of spinal cord: MB57\\nFunctional level of injury of cervical spinal cord: MB57.0\\nFunctional level of injury of thoracic spinal cord: MB57.1\\nFunctional level of injury of lumbar spinal cord: MB57.2\\nFunctional level of injury of spinal cord sacrum: MB57.3\\nOther specified functional level of injury of spinal cord: MB57.Y\\nFunctional level of injury of spinal cord unspecified: MB57.Z\\nOther specified paralytic symptoms: MB5Y\\nParalytic symptoms unspecified: MB5Z\\nSleeptalking: MB60\\nOther specified symptoms or signs involving the nervous system: MB6Y\\nClinical findings in cerebrospinal fluid: MB70\\nAbnormal level of enzymes in cerebrospinal fluid: MB70.0\\nAbnormal level of hormones in cerebrospinal fluid: MB70.1\\nAbnormal level of drugs medicaments and biological substances in cerebrospinal fluid: MB70.2\\nAbnormal level of substances chiefly nonmedicinal as to source in cerebrospinal fluid: MB70.3\\nAbnormal immunological findings in cerebrospinal fluid: MB70.4\\nAbnormal microbiological findings in cerebrospinal fluid: MB70.5\\nAbnormal cytological findings in cerebrospinal fluid: MB70.6\\nAbnormal histological findings in cerebrospinal fluid: MB70.7\\nOther abnormal findings in cerebrospinal fluid: MB70.8\\nOther specified clinical findings in cerebrospinal fluid: MB70.Y\\nClinical findings in cerebrospinal fluid unspecified: MB70.Z\\nClinical findings on diagnostic imaging of central nervous system: MB71\\nIntracranial spaceoccupying lesion: MB71.0\\nOther specified clinical findings on diagnostic imaging of central nervous system: MB71.Y\\nClinical findings on diagnostic imaging of central nervous system unspecified: MB71.Z\\nResults of function studies of the nervous system: MB72\\nOther specified clinical findings in the nervous system: MB7Y\\nOther specified symptoms signs or clinical findings of the nervous system: MB9Y\\nEye appearance abnormal: MC10\\nEye sensation abnormal: MC11\\nChronic enlargement of lacrimal gland: MC12\\nEpiphora: MC13\\nEye discharge: MC14\\nRed eye: MC15\\nPallor conjunctiva: MC16\\nIcteric sclera: MC17\\nOcular pain: MC18\\nQuadrantanopia: MC19\\nVisual floaters: MC1A\\nSymptom or complaint of the eyelid: MC1B\\nSymptom or complaint of glasses: MC1C\\nSymptom or complaint of contact lens: MC1D\\nOther specified symptoms or signs involving the visual system: MC1Y\\nClinical findings of the visual system: MC20\\nStaphyloma: MC20.0\\nSmall drusen of the macula: MC20.1\\nHypopyon: MC20.2\\nOther specified clinical findings of the visual system: MC20.Y\\nImpairment of electrophysiological functions: MC21\\nProfound impairment of electrooculogram: MC21.0\\nNormal electroretinogram: MC21.1\\nOther specified impairment of electrophysiological functions: MC21.Y\\nImpairment of electrophysiological functions unspecified: MC21.Z\\nOther specified symptoms signs or clinical findings of the visual system: MC2Y\\nPlugged feeling ear: MC40\\nTinnitus: MC41\\nOther specified symptoms or signs involving the ear or mastoid process: MC4Y\\nOther specified symptoms signs or clinical findings of ear or mastoid process: MC6Y\\nAbnormal bloodpressure reading without diagnosis: MC80\\nElevated bloodpressure reading without diagnosis of hypertension: MC80.0\\nWhite coat hypertension: MC80.00\\nCombined diastolic and systolic elevated blood pressure reading without diagnosis of hypertension: MC80.01\\nDiastolic elevated blood pressure reading without diagnosis of hypertension: MC80.02\\nSystolic elevated blood pressure reading without diagnosis of hypertension: MC80.03\\nOther specified elevated bloodpressure reading without diagnosis of hypertension: MC80.0Y\\nElevated bloodpressure reading without diagnosis of hypertension unspecified: MC80.0Z\\nNonspecific low bloodpressure reading: MC80.1\\nOther specified abnormal bloodpressure reading without diagnosis: MC80.Y\\nAbnormal bloodpressure reading without diagnosis unspecified: MC80.Z\\nAbnormalities of heart beat: MC81\\nTachycardia unspecified: MC81.0\\nBradycardia unspecified: MC81.1\\nPalpitations: MC81.2\\nParoxysmal tachycardia: MC81.3\\nPulseless electrical activity not elsewhere classified: MC81.4\\nOther specified abnormalities of heart beat: MC81.Y\\nAbnormalities of heart beat unspecified: MC81.Z\\nCardiac arrest: MC82\\nVentricular tachycardia and fibrillation cardiac arrest: MC82.0\\nBradycardic cardiac arrest: MC82.1\\nAsystolic cardiac arrest: MC82.2\\nCardiac arrest with pulseless electrical activity: MC82.3\\nCardiopulmonary arrest: MC82.4\\nCardiac arrest unspecified: MC82.Z\\nCardiac murmurs or other cardiac sounds: MC83\\nBenign or innocent cardiac murmurs: MC83.0\\nOther cardiac sounds: MC83.1\\nCardiac murmurs or sounds unspecified: MC83.Z\\nCardiovascular pain: MC84\\nGangrene: MC85\\nPrecordial pain: MC86\\nPressure or tightness of heart: MC87\\nProminent veins: MC88\\nOther specified symptoms or signs involving the circulatory system: MC8Y\\nClinical findings on diagnostic imaging of heart or coronary circulation: MC90\\nResults of function studies of the circulatory system: MC91\\nOther specified symptoms signs or clinical findings of the circulatory system: MC9Y\\nAbnormal sputum: MD10\\nAbnormalities of breathing: MD11\\nApnoea: MD11.0\\nAsphyxia: MD11.1\\nAtaxic breathing: MD11.2\\nBreath holding: MD11.3\\nSleep related CheyneStokes respiration: MD11.4\\nDyspnoea: MD11.5\\nHiccough: MD11.6\\nHyperventilation: MD11.7\\nMouth breathing: MD11.8\\nStertor: MD11.80\\nOther specified mouth breathing: MD11.8Y\\nMouth breathing unspecified: MD11.8Z\\nNasal congestion: MD11.9\\nSneezing: MD11.A\\nStridor: MD11.B\\nWheezing: MD11.C\\nYawning: MD11.D\\nOther specified abnormalities of breathing: MD11.Y\\nAbnormalities of breathing unspecified: MD11.Z\\nCough: MD12\\nEpistaxis: MD20\\nHaemorrhage from throat: MD21\\nHaemoptysis: MD22\\nHaemorrhage from other sites in respiratory passages: MD23\\nAcute idiopathic pulmonary haemorrhage in infants over  days of age: MD24\\nHaemorrhage from respiratory passages unspecified: MD2Z\\nPain in throat or chest: MD30\\nChest pain on breathing: MD30.0\\nOther chest pain: MD30.1\\nChest pain unspecified: MD30.Z\\nPleurisy: MD31\\nRales: MD32\\nRespiratory arrest: MD33\\nSymptom or complaint of the nose: MD34\\nSymptom or complaint of the sinus: MD35\\nSymptom or complaint of the throat: MD36\\nPain in throat: MD36.0\\nOther specified symptom or complaint of the throat: MD36.Y\\nSymptom or complaint of the throat unspecified: MD36.Z\\nOther specified symptoms or signs involving the respiratory system: MD3Y\\nClinical findings in specimens from respiratory organs and thorax: MD40\\nAbnormal level of enzymes in specimens from respiratory organs and thorax: MD40.0\\nAbnormal level of hormones in specimens from respiratory organs and thorax: MD40.1\\nAbnormal level of drugs medicaments and biological substances in specimens from respiratory organs and thorax: MD40.2\\nAbnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax: MD40.3\\nAbnormal immunological findings in specimens from respiratory organs and thorax: MD40.4\\nAbnormal microbiological findings in specimens from respiratory organs and thorax: MD40.5\\nPositive culture from nose: MD40.50\\nPositive sputum culture: MD40.51\\nPositive throat culture: MD40.52\\nOther specified abnormal microbiological findings in specimens from respiratory organs and thorax: MD40.5Y\\nAbnormal microbiological findings in specimens from respiratory organs and thorax unspecified: MD40.5Z\\nAbnormal cytological findings in specimens from respiratory organs and thorax: MD40.6\\nAbnormal histological findings in specimens from respiratory organs and thorax: MD40.7\\nOther specified clinical findings in specimens from respiratory organs and thorax: MD40.Y\\nClinical findings on diagnostic imaging of lung: MD41\\nResults of function studies of the respiratory system: MD42\\nOther specified clinical findings in the respiratory system: MD4Y\\nOther specified symptoms signs or clinical findings of the respiratory system: MD6Y\\nSymptoms or signs of the orofacial complex: MD80\\nSymptom or complaint of the teeth or gum: MD80.0\\nSymptom or complaint of the mouth tongue or lip: MD80.1\\nOther specified symptoms or signs of the orofacial complex: MD80.Y\\nAbdominal or pelvic pain: MD81\\nAbdominal tenderness: MD81.0\\nLocalised abdominal pain: MD81.1\\nPain localised to upper abdomen: MD81.10\\nPelvic or perineal pain: MD81.11\\nPain localised to other parts of lower abdomen: MD81.12\\nLocalised abdominal pain unspecified: MD81.1Z\\nGeneralised abdominal pain: MD81.2\\nAcute abdomen: MD81.3\\nOther and unspecified abdominal pain: MD81.4\\nIntraabdominal or pelvic swelling mass or lump: MD82\\nNausea or vomiting: MD90\\nNausea: MD90.0\\nVomiting: MD90.1\\nBelching: MD91\\nDyspepsia: MD92\\nDysphagia: MD93\\nHalitosis: MD94\\nHeartburn: MD95\\nOther specified symptoms related to the upper gastrointestinal tract: MD9Y\\nAbdominal compartment syndrome: ME00\\nAbdominal distension: ME01\\nAbdominal rigidity: ME02\\nAbnormal bowel sounds: ME03\\nHyperactive bowel sounds: ME03.0\\nAbsent bowel sounds: ME03.1\\nAbnormal bowel sounds unspecified: ME03.Z\\nAscites: ME04\\nFluid in peritoneal cavity: ME04.0\\nOther specified ascites: ME04.Y\\nAscites unspecified: ME04.Z\\nChange in bowel habit: ME05\\nConstipation: ME05.0\\nDiarrhoea: ME05.1\\nOther specified change in bowel habit: ME05.Y\\nChange in bowel habit unspecified: ME05.Z\\nChronic enteritis of uncertain aetiology: ME06\\nFaecal incontinence: ME07\\nFaecal smearing: ME07.0\\nIncomplete defaecation: ME07.1\\nFaecal urgency: ME07.2\\nOther specified faecal incontinence: ME07.Y\\nFaecal incontinence unspecified: ME07.Z\\nFlatulence and related conditions: ME08\\nRectal tenesmus: ME09\\nVisible peristalsis: ME0A\\nProblems with defaecation not otherwise specified: ME0B\\nOther specified symptoms related to the lower gastrointestinal tract or abdomen: ME0Y\\nAbnormalities related to hepatobiliary system: ME10\\nHepatomegaly or splenomegaly: ME10.0\\nHepatomegaly not elsewhere classified: ME10.00\\nSplenomegaly not elsewhere classified: ME10.01\\nHepatomegaly with splenomegaly: ME10.02\\nUnspecified jaundice: ME10.1\\nOther specified symptoms or signs involving the digestive system or abdomen: ME1Y\\nClinical findings in specimens from digestive organs or abdominal cavity: ME20\\nAbnormal level of enzymes in specimens from digestive organs or abdominal cavity: ME20.0\\nAbnormal level of hormones in specimens from digestive organs or abdominal cavity: ME20.1\\nAbnormal level of drugs medicaments or biological substances in specimens from digestive organs of abdominal cavity: ME20.2\\nAbnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity: ME20.3\\nAbnormal immunological findings in specimens from digestive organs and abdominal cavity: ME20.4\\nAbnormal microbiological findings in specimens from digestive organs and abdominal cavity: ME20.5\\nAbnormal cytological findings in specimens from digestive organs and abdominal cavity: ME20.6\\nAbnormal histological findings in specimens from digestive organs and abdominal cavity: ME20.7\\nOther specified clinical findings in specimens from digestive organs or abdominal cavity: ME20.Y\\nClinical findings in specimens from digestive organs or abdominal cavity unspecified: ME20.Z\\nClinical findings on diagnostic imaging of liver or biliary tract: ME21\\nClinical findings on diagnostic imaging of digestive tract: ME22\\nResults of function studies of the digestive system: ME23\\nClinical manifestations of the digestive system: ME24\\nDigestive system abscess: ME24.0\\nDigestive system fistula: ME24.1\\nDigestive system obstruction: ME24.2\\nDigestive system perforation: ME24.3\\nPerforation of small intestine: ME24.30\\nPerforation of large intestine: ME24.31\\nPerforation of gallbladder or bile ducts: ME24.35\\nDigestive system perforation of other specified site: ME24.3Y\\nDigestive system perforation of unspecified site: ME24.3Z\\nDigestive system stenosis: ME24.4\\nDigestive system ulcer: ME24.5\\nDigestive system dilatation: ME24.6\\nDigestive system incarceration: ME24.7\\nDigestive system strangulation or gangrene: ME24.8\\nGastrointestinal bleeding: ME24.9\\nAcute gastrointestinal bleeding not elsewhere classified: ME24.90\\nChronic gastrointestinal bleeding not elsewhere classified: ME24.91\\nGastrointestinal bleeding unspecified: ME24.9Z\\nOther digestive system haemorrhage not elsewhere classified: ME24.A\\nObscure gastrointestinal bleeding: ME24.A0\\nHaemorrhage of anus and rectum: ME24.A1\\nOesophageal haemorrhage: ME24.A2\\nHaematochezia: ME24.A3\\nMelaena: ME24.A4\\nHaematemesis: ME24.A5\\nPositive occult blood in stool: ME24.A6\\nOther specified clinical manifestations of the digestive system: ME24.Y\\nOther specified clinical findings in the digestive system: ME2Y\\nOther specified symptoms signs or clinical findings of the digestive system or abdomen: ME4Y\\nSkin lesion of uncertain or unspecified nature: ME60\\nSkin lesion of uncertain nature: ME60.0\\nPigmented skin lesion of uncertain nature: ME60.1\\nUlcer of skin of uncertain nature: ME60.2\\nKeratosis of skin of uncertain or unspecified nature: ME60.3\\nSkin lesion of unspecified nature: ME60.Z\\nSubcutaneous swelling mass or lump of uncertain or unspecified nature: ME61\\nAcute skin eruption of uncertain or unspecified nature: ME62\\nAcute erythematous skin eruption: ME62.0\\nAcute purpuric skin eruption: ME62.1\\nAcute urticarial skin eruption: ME62.2\\nAcute maculopapular skin eruption: ME62.3\\nAcute papular skin eruption: ME62.4\\nAcute exudative skin eruption: ME62.5\\nAcute blistering skin eruption: ME62.6\\nAcute desquamating skin eruption: ME62.7\\nAcute discoid or annular skin eruption: ME62.8\\nAcute excoriation of skin: ME62.9\\nOther specified acute skin eruption of uncertain or unspecified nature: ME62.Y\\nChronic skin disorder of uncertain or unspecified nature: ME63\\nChronic erythematous skin disorder: ME63.0\\nChronic urticarial skin disorder: ME63.1\\nChronic papular skin disorder: ME63.2\\nChronic blistering skin disorder: ME63.3\\nChronic scaling or hyperkeratotic skin disorder: ME63.4\\nChronic lichenified skin disorder: ME63.5\\nChronic discoid or annular skin disorder: ME63.6\\nChronic excoriation of skin: ME63.7\\nNonspecific cutaneous vascular signs: ME64\\nErythema: ME64.0\\nCyanosis: ME64.1\\nPallor: ME64.2\\nPetechiae: ME64.3\\nFlushing: ME64.4\\nDisturbances of skin sensation of unspecified aetiology: ME65\\nBurning of skin: ME65.0\\nItching of skin: ME65.1\\nPain or tenderness of skin: ME65.2\\nStinging of skin: ME65.3\\nTingling of skin: ME65.4\\nOther specified disturbance of skin sensation: ME65.Y\\nMiscellaneous nonspecific skinrelated symptoms and signs: ME66\\nAbnormal sensitivity to light or UV radiation of uncertain or unspecified nature: ME66.0\\nChanges in skin texture: ME66.1\\nExcess and redundant skin: ME66.2\\nSymptom or complaint relating to hair or scalp: ME66.3\\nSymptom or complaint relating to nails: ME66.4\\nComplaint of abnormal sweating: ME66.5\\nRash: ME66.6\\nRash localised: ME66.60\\nRash generalised: ME66.61\\nOther specified rash: ME66.6Y\\nRash unspecified: ME66.6Z\\nOther specified skin changes: ME66.Y\\nSkin disorder of uncertain or unspecified nature: ME67\\nOther specified symptoms or signs involving the skin: ME6Y\\nClicking hip: ME80\\nMusculoskeletal chest pain: ME81\\nIntercostal pain: ME81.0\\nOther specified musculoskeletal chest pain: ME81.Y\\nMusculoskeletal chest pain unspecified: ME81.Z\\nPain in joint: ME82\\nRheumatism unspecified: ME83\\nSpinal pain: ME84\\nCervical spine pain: ME84.0\\nThoracic spine pain: ME84.1\\nLow back pain: ME84.2\\nLumbago with sciatica: ME84.20\\nOther specified low back pain: ME84.2Y\\nLow back pain unspecified: ME84.2Z\\nSciatica: ME84.3\\nSpinal pain unspecified: ME84.Z\\nStiffness of joint: ME85\\nSymptom or complaint of a body part: ME86\\nSymptom or complaint of the ankle: ME86.0\\nSymptom or complaint of the arm: ME86.1\\nSymptom or complaint of the back: ME86.2\\nBack syndrome without radiating pain: ME86.20\\nBack syndrome with radiating pain: ME86.21\\nSymptom or complaint of the low back: ME86.22\\nOther specified symptom or complaint of the back: ME86.2Y\\nSymptom or complaint of the back unspecified: ME86.2Z\\nSymptom or complaint of the chest: ME86.3\\nSymptom or complaint of the elbow: ME86.4\\nSymptom or complaint of the flank or axilla: ME86.5\\nSymptom or complaint of the foot or toe: ME86.6\\nSymptom or complaint of the hand or finger: ME86.7\\nSymptom or complaint of the hip: ME86.8\\nSymptom or complaint of the jaw: ME86.9\\nSymptom or complaint of the knee: ME86.A\\nSymptom or complaint of the leg or thigh: ME86.B\\nSymptom or complaint of the neck: ME86.C\\nSymptom or complaint of the shoulder: ME86.D\\nShoulder syndrome: ME86.D0\\nOther specified symptom or complaint of the shoulder: ME86.DY\\nSymptom or complaint of the shoulder unspecified: ME86.DZ\\nSymptom or complaint of the wrist: ME86.E\\nSymptom or complaint of joint not otherwise specified: ME86.F\\nSymptom or complaint of muscle not otherwise specified: ME86.G\\nProblem of other specified body part: ME86.Y\\nProblem of unspecified body part: ME86.Z\\nOther specified symptoms or signs of the musculoskeletal system: ME8Y\\nClinical findings on diagnostic imaging of skull and head: ME90\\nClinical findings on diagnostic imaging of limbs: ME91\\nClinical findings on diagnostic imaging of other parts of musculoskeletal system: ME92\\nWedging of vertebra: ME92.0\\nBony erosion: ME92.1\\nOther specified clinical findings on diagnostic imaging of other parts of musculoskeletal system: ME92.Y\\nClinical findings on diagnostic imaging of other parts of musculoskeletal system unspecified: ME92.Z\\nBiomechanical lesions not elsewhere classified: ME93\\nSegmental and somatic dysfunction: ME93.0\\nSubluxation stenosis of neural canal: ME93.1\\nOsseous stenosis of neural canal: ME93.2\\nConnective tissue stenosis of neural canal: ME93.3\\nIntervertebral disc stenosis of neural canal: ME93.4\\nIntervertebral disc stenosis of neural canal head region: ME93.40\\nIntervertebral disc stenosis of neural canal cervical region: ME93.41\\nIntervertebral disc stenosis of neural canal thoracic region: ME93.42\\nIntervertebral disc stenosis of neural canal lumbar region: ME93.43\\nIntervertebral disc stenosis of neural canal sacral region: ME93.44\\nOther specified intervertebral disc stenosis of neural canal: ME93.4Y\\nIntervertebral disc stenosis of neural canal unspecified: ME93.4Z\\nOsseous and subluxation stenosis of intervertebral foramina: ME93.5\\nConnective tissue and disc stenosis of intervertebral foramina: ME93.6\\nOther specified biomechanical lesions not elsewhere classified: ME93.Y\\nBiomechanical lesions unspecified: ME93.Z\\nOther specified clinical findings in the musculoskeletal system: ME9Y\\nOther specified symptoms signs or clinical findings of the musculoskeletal system: MF1Y\\nBreast lump or mass female: MF30\\nBreast or lactation symptom or complaint: MF31\\nMenopausal symptom or complaint: MF32\\nPremenstrual symptom or complaint: MF33\\nPregnancy symptom or complaint: MF34\\nPostpartum symptom or complaint: MF35\\nOther symptom or complaint of vagina: MF36\\nSymptom or complaint of female nipple: MF37\\nSymptom or complaint of female pelvis: MF38\\nSymptom or complaint of the vulva: MF39\\nVaginal discharge: MF3A\\nOther specified symptoms signs or clinical findings involving the female genital system: MF3Y\\nProblems of male genital organs: MF40\\nSymptom or complaint of the penis: MF40.0\\nPain in penis: MF40.00\\nOther specified symptom or complaint of the penis: MF40.0Y\\nSymptom or complaint of the penis unspecified: MF40.0Z\\nProblems of the prostate: MF40.1\\nSymptom or complaint of the scrotum or testis: MF40.2\\nAcute scrotal pain: MF40.20\\nTesticular pain: MF40.21\\nOther specified symptom or complaint of the scrotum or testis: MF40.2Y\\nSymptom or complaint of the scrotum or testis unspecified: MF40.2Z\\nRetrograde ejaculation: MF40.3\\nOther specified problems of male genital organs: MF40.Y\\nProblems of male genital organs unspecified: MF40.Z\\nSymptom or complaint of male sexual function: MF41\\nRetractile testis migrans: MF42\\nOther specified symptoms signs or clinical findings involving the male genital system: MF4Y\\nAbnormal micturition: MF50\\nFrequent micturition: MF50.0\\nPollakiuria: MF50.1\\nUrinary incontinence: MF50.2\\nStress incontinence: MF50.20\\nUrge Incontinence: MF50.21\\nMixed incontinence: MF50.22\\nFunctional urinary incontinence: MF50.23\\nReflex incontinence: MF50.24\\nOther specified urinary incontinence: MF50.2Y\\nUrinary incontinence unspecified: MF50.2Z\\nRetention of urine: MF50.3\\nHaematuria: MF50.4\\nMacroscopic haematuria: MF50.40\\nMicroscopic haematuria: MF50.41\\nHaematuria unspecified: MF50.4Z\\nExtravasation of urine: MF50.5\\nOther difficulties with micturition: MF50.6\\nHesitancy of micturition: MF50.60\\nPoor urinary stream: MF50.61\\nSplitting of urinary stream: MF50.62\\nUrgency of urination: MF50.63\\nFeeling of incomplete bladder emptying: MF50.64\\nStraining to void: MF50.65\\nOther specified difficulties with micturition: MF50.6Y\\nDifficulties with micturition unspecified: MF50.6Z\\nDysuria: MF50.7\\nVesical tenesmus: MF50.8\\nOther specified abnormal micturition: MF50.Y\\nAbnormal micturition unspecified: MF50.Z\\nAnuria or oliguria: MF51\\nBladder pain: MF52\\nExtrarenal uraemia: MF53\\nMacroscopic changes of size of the kidney: MF54\\nSmooth contracted kidney: MF54.0\\nIrregularly contracted kidney: MF54.1\\nSmall kidney: MF54.2\\nOther specified macroscopic changes of size of the kidney: MF54.Y\\nMacroscopic changes of size of the kidney unspecified: MF54.Z\\nPolyuria: MF55\\nRenal colic: MF56\\nSymptom or complaint of bladder: MF57\\nUrethral discharge: MF58\\nUrinary symptom or complaint: MF59\\nOther specified symptoms signs or clinical findings involving the urinary system: MF5Y\\nAbnormal level of enzymes in specimens from female genital organs: MF60\\nAbnormal level of hormones in specimens from female genital organs: MF61\\nAbnormal level of drugs medicaments and biological substances in specimens from female genital organs: MF62\\nAbnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs: MF63\\nAbnormal immunological findings in specimens from female genital organs: MF64\\nAbnormal microbiological findings in specimens from female genital organs: MF65\\nAbnormal cytological findings in specimens from female genital organs: MF66\\nAbnormal cervix smear: MF66.0\\nOther specified abnormal cytological findings in specimens from female genital organs: MF66.Y\\nAbnormal cytological findings in specimens from female genital organs unspecified: MF66.Z\\nAbnormal histological findings in specimens from female genital organs: MF67\\nAbnormal chromosomal findings in specimens from female genital organs: MF68\\nOther specified clinical findings in specimens from female genital organs: MF6Y\\nClinical findings in specimens from female genital organs unspecified: MF6Z\\nAbnormal level of enzymes in specimens from male genital organs: MF70\\nAbnormal level of hormones in specimens from male genital organs: MF71\\nAbnormal level of drugs medicaments and biological substances in specimens from male genital organs: MF72\\nAbnormal level of substances chiefly nonmedicinal as to source in specimens from male genital organs: MF73\\nAbnormal immunological findings in specimens from male genital organs: MF74\\nAbnormal microbiological findings in specimens from male genital organs: MF75\\nAbnormal cytological findings in specimens from male genital organs: MF76\\nAbnormal histological findings in specimens from male genital organs: MF77\\nAbnormal chromosomal findings in specimens from male genital organs: MF78\\nOther specified clinical findings in specimens from male genital organs: MF7Y\\nClinical findings in specimens from male genital organs unspecified: MF7Z\\nDiffuse mesangial sclerosis: MF80\\nFibronectin glomerulopathy: MF81\\nLipoprotein glomerulopathy: MF82\\nDiabetic glomerular changes: MF83\\nPauciimmune proliferative glomerulonephritis: MF84\\nAntiglomerular basement membrane antibody mediated disease: MF85\\nOther specified clinical findings in specimens from the urinary system: MF8Y\\nClinical findings in specimens from the urinary system unspecified: MF8Z\\nAcetonuria: MF90\\nBilirubinuria: MF91\\nChyluria: MF92\\nGlycosuria: MF93\\nHaemoglobinuria: MF94\\nMyoglobinuria: MF95\\nProteinuria: MF96\\nOrthostatic proteinuria: MF96.0\\nBence Jones proteinuria: MF96.1\\nOther specified proteinuria: MF96.Y\\nProteinuria unspecified: MF96.Z\\nPyuria: MF97\\nAbnormal levels of serum electrolytes in the urine: MF98\\nHypercalciuria: MF98.0\\nHyperkaluria: MF98.1\\nHypermagnesuria: MF98.2\\nHypocalciuria: MF98.3\\nHypokaluria: MF98.4\\nHypomagnesuria: MF98.5\\nHypophosphaturia: MF98.6\\nOther specified abnormal levels of serum electrolytes in the urine: MF98.Y\\nAbnormal levels of serum electrolytes in the urine unspecified: MF98.Z\\nElevated urine levels of drugs medicaments and biological substances: MF99\\nAbnormal urine levels of substances chiefly nonmedicinal as to source: MF9A\\nAbnormal findings on microbiological examination of urine: MF9B\\nAbnormal findings on cytological and histological examination of urine: MF9C\\nOther specified clinical findings on examination of urine without diagnosis: MF9Y\\nClinical findings on diagnostic imaging of breast: MG00\\nClinical findings on diagnostic imaging of urinary organs: MG01\\nResults of kidney function studies: MG02\\nOther specified symptoms signs or clinical findings of the genitourinary system: MG0Y\\nCachexia: MG20\\nMalignant cachexia: MG20.0\\nCachexia unspecified: MG20.Z\\nChills: MG21\\nFatigue: MG22\\nFear of death or dying: MG23\\nFear of disease: MG24\\nFear of cancer: MG24.0\\nFear of cancer of digestive system: MG24.00\\nFear of breast cancer female: MG24.01\\nFear of genital cancer male: MG24.02\\nOther specified fear of cancer: MG24.0Y\\nFear of cancer unspecified: MG24.0Z\\nFear of human immunodeficiency virus: MG24.1\\nFear of haematological disease: MG24.2\\nFear of digestive disease: MG24.3\\nFear of eye disease: MG24.4\\nFear of heart disease: MG24.5\\nFear of hypertension: MG24.6\\nFear of cardiovascular disease: MG24.7\\nFear of musculoskeletal disease: MG24.8\\nFear of neurological disease: MG24.9\\nFear of respiratory disease: MG24.A\\nFear of endocrine metabolic or nutritional disease: MG24.B\\nFear of urinary disease: MG24.C\\nFear of complications of pregnancy: MG24.D\\nFear of sexually transmitted disease female: MG24.E\\nFear of female genital or breast disease: MG24.F\\nFear of sexually transmitted disease male: MG24.G\\nFear of genital disease male: MG24.H\\nFear of mental disorder: MG24.J\\nFear of other specified disease: MG24.Y\\nFear of disease unspecified: MG24.Z\\nFeeling ill: MG25\\nFever of other or unknown origin: MG26\\nHaemorrhage not elsewhere classified: MG27\\nHypothermia not associated with low environmental temperature: MG28\\nOedema: MG29\\nLocalised oedema: MG29.0\\nAnkle oedema: MG29.00\\nOedema of legs: MG29.01\\nPitting of lip: MG29.02\\nOther specified localised oedema: MG29.0Y\\nGeneralised oedema: MG29.1\\nOedema due to increased capillary pressure: MG29.10\\nOther specified generalised oedema: MG29.1Y\\nInfectious oedema: MG29.2\\nPitting oedema: MG29.3\\nOedema unspecified: MG29.Z\\nAgeing associated decline in intrinsic capacity: MG2A\\nChronic pain: MG30\\nChronic primary pain: MG30.0\\nChronic primary visceral pain: MG30.00\\nChronic widespread pain: MG30.01\\nChronic primary musculoskeletal pain: MG30.02\\nChronic primary headache or orofacial pain: MG30.03\\nComplex regional pain syndrome: MG30.04\\nOther specified chronic primary pain: MG30.0Y\\nChronic primary pain unspecified: MG30.0Z\\nChronic cancer related pain: MG30.1\\nChronic cancer pain: MG30.10\\nChronic post cancer treatment pain: MG30.11\\nOther specified chronic cancer related pain: MG30.1Y\\nChronic cancer related pain unspecified: MG30.1Z\\nChronic postsurgical or post traumatic pain: MG30.2\\nChronic post traumatic pain: MG30.20\\nChronic postsurgical pain: MG30.21\\nOther specified chronic postsurgical or post traumatic pain: MG30.2Y\\nChronic postsurgical or post traumatic pain unspecified: MG30.2Z\\nChronic secondary musculoskeletal pain: MG30.3\\nChronic secondary musculoskeletal pain from persistent inflammation: MG30.30\\nChronic secondary musculoskeletal pain associated with structural changes: MG30.31\\nChronic secondary musculoskeletal pain due to disease of the nervous system: MG30.32\\nOther specified chronic secondary musculoskeletal pain: MG30.3Y\\nChronic secondary musculoskeletal pain unspecified: MG30.3Z\\nChronic secondary visceral pain: MG30.4\\nChronic visceral pain from mechanical factors: MG30.40\\nChronic visceral pain from vascular mechanisms: MG30.41\\nChronic visceral pain from persistent inflammation: MG30.42\\nOther specified chronic secondary visceral pain: MG30.4Y\\nChronic secondary visceral pain unspecified: MG30.4Z\\nChronic neuropathic pain: MG30.5\\nChronic central neuropathic pain: MG30.50\\nChronic peripheral neuropathic pain: MG30.51\\nOther specified chronic neuropathic pain: MG30.5Y\\nChronic neuropathic pain unspecified: MG30.5Z\\nChronic secondary headache or orofacial pain: MG30.6\\nChronic dental pain: MG30.61\\nChronic neuropathic orofacial pain: MG30.62\\nHeadache or orofacial pain associated with chronic secondary temporomandibular disorders: MG30.63\\nChronic headache or orofacial pain associated with disorders of homoeostasis or their nonpharmacological treatment: MG30.64\\nChronic headache or orofacial pain associated with cranial or cervical vascular disorder: MG30.65\\nChronic headache or orofacial pain associated with nonvascular intracranial disorder: MG30.66\\nChronic headache associated with a substance or its withdrawal: MG30.67\\nOther specified chronic secondary headache or orofacial pain: MG30.6Y\\nChronic secondary headache or orofacial pain unspecified: MG30.6Z\\nOther specified chronic pain: MG30.Y\\nChronic pain unspecified: MG30.Z\\nAcute pain: MG31\\nAcute pain in the face not elsewhere classified: MG31.0\\nAcute headache not elsewhere classified: MG31.1\\nAcute postoperative pain not elsewhere classified: MG31.2\\nOther specified acute pain: MG31.Y\\nAcute pain unspecified: MG31.Z\\nPain unspecified: MG3Z\\nShock: MG40\\nCardiogenic shock: MG40.0\\nHypovolaemic shock: MG40.1\\nOther specified shock: MG40.Y\\nShock unspecified: MG40.Z\\nSleep disturbance not elsewhere classified: MG41\\nSomnolence not elsewhere classified: MG42\\nSymptoms or signs concerning food or fluid intake: MG43\\nPolydipsia: MG43.0\\nOvereating: MG43.1\\nAbulia: MG43.2\\nFeeding difficulties: MG43.3\\nFeeding problem of infant: MG43.30\\nFeeding problem of child: MG43.31\\nFeeding problem of adult: MG43.32\\nFeeding difficulties unspecified: MG43.3Z\\nInsufficient intake of food or water due to self neglect: MG43.4\\nRefusal of food not elsewhere classified: MG43.40\\nRefusal of fluid not elsewhere classified: MG43.41\\nOther specified insufficient intake of food or water due to self neglect: MG43.4Y\\nInsufficient intake of food or water due to self neglect unspecified: MG43.4Z\\nExcessive weight loss: MG43.5\\nExcessive weight gain: MG43.6\\nAnorexia: MG43.7\\nDecreased appetite: MG43.8\\nIncreased appetite: MG43.9\\nOther specified symptoms or signs concerning food or fluid intake: MG43.Y\\nSymptoms peculiar to infancy: MG44\\nExcessive crying of infant: MG44.0\\nLack of expected normal physiological development: MG44.1\\nDelayed milestone: MG44.10\\nFailure to thrive in infant or child: MG44.11\\nShort stature of child: MG44.12\\nConstitutional delay of growth and puberty: MG44.13\\nFamilial short stature: MG44.14\\nOther specified lack of expected normal physiological development: MG44.1Y\\nLack of expected normal physiological development unspecified: MG44.1Z\\nOther specified symptoms peculiar to infancy: MG44.Y\\nSymptoms peculiar to infancy unspecified: MG44.Z\\nSyncope or collapse: MG45\\nCardiac syncope: MG45.0\\nOther specified syncope or collapse: MG45.Y\\nSyncope or collapse unspecified: MG45.Z\\nSystemic inflammatory response syndrome of noninfectious origin: MG46\\nToxicosis not further specified: MG47\\nUnknown or unspecified causes of morbidity: MG48\\nHangover: MG49\\nMulti organ failure: MG4A\\nOther specified general symptoms: MG4Y\\nFinding of gram negative bacteria resistant to antimicrobial drugs: MG50\\nAntibiotic resistant Acinetobacter baumannii: MG50.0\\nTetracycline resistant Acinetobacter baumannii: MG50.00\\nAminoglycoside resistant Acinetobacter baumannii: MG50.01\\nCarbapenem resistant Acinetobacter baumannii: MG50.02\\nPolymyxin resistant Acinetobacter baumannii: MG50.03\\nAcinetobacter resistant to other antibiotic: MG50.0Y\\nAcinetobacter resistant to unspecified antibiotic: MG50.0Z\\nAntibiotic resistant Campylobacter: MG50.1\\nFluoroquinolone resistant Campylobacter: MG50.10\\nOther specified antibiotic resistant Campylobacter: MG50.1Y\\nCampylobacter resistant to unspecified antibiotic: MG50.1Z\\nAntibiotic resistant Escherichia coli: MG50.2\\nSulfonamide or trimethoprim resistant Escherichia coli: MG50.20\\nFluoroquinolone resistant Escherichia coli: MG50.21\\nThird generation cephalosporin resistant Escherichia coli: MG50.22\\nFourthgeneration cephalosporins resistant Escherichia coli: MG50.23\\nCarbapenem resistant Escherichia coli: MG50.24\\nPolymyxin resistant Escherichia coli: MG50.25\\nPenicillin resistant Escherichia coli: MG50.26\\nExtended spectrum betalactamase producing Escherichia coli: MG50.27\\nEscherichia coli resistant to other antibiotic: MG50.2Y\\nEscherichia coli resistant to unspecified antibiotic: MG50.2Z\\nAntibiotic resistant Haemophilus influenzae: MG50.3\\nAmpicillin resistant Haemophilus influenzae: MG50.30\\nOther specified antibiotic resistant Haemophilus influenzae: MG50.3Y\\nAntibiotic resistant Haemophilus influenzae unspecified: MG50.3Z\\nAntibiotic resistant Helicobacter pylori: MG50.4\\nClarithromycin resistant Helicobacter pylori: MG50.40\\nOther specified antibiotic resistant Helicobacter pylori: MG50.4Y\\nAntibiotic resistant Helicobacter pylori unspecified: MG50.4Z\\nAntibiotic resistant Klebsiella pneumoniae: MG50.5\\nSulfonamide or trimethoprim resistant Klebsiella pneumoniae: MG50.50\\nFluoroquinolone resistant Klebsiella pneumoniae: MG50.51\\nThirdgeneration cephalosporin resistant Klebsiella pneumoniae: MG50.52\\nFourthgeneration cephalosporin resistant Klebsiella pneumoniae: MG50.53\\nCarbapenem resistant Klebsiella pneumoniae: MG50.54\\nPolymyxin resistant Klebsiella pneumoniae: MG50.55\\nExtendedspectrum betalactamase producing Klebsiella pneumoniae: MG50.56\\nKlebsiella pneumoniae resistant to other antibiotic: MG50.5Y\\nKlebsiella pneumoniae resistant to unspecified antibiotic: MG50.5Z\\nAntibiotic resistant Neisseria gonorrhoeae: MG50.6\\nThird generation cephalosporin resistant Neisseria gonorrhoeae: MG50.60\\nMacrolide resistant Neisseria gonorrhoeae: MG50.61\\nAminocyclitol resistant Neisseria gonorrhoeae: MG50.62\\nFluoroquinolone resistant Neisseria gonorrhoeae: MG50.63\\nAminoglycoside resistant Neisseria gonorrhoeae: MG50.64\\nNeisseria gonorrhoeae resistant to other antibiotic: MG50.6Y\\nNeisseria gonorrhoeae resistant to unspecified antibiotic: MG50.6Z\\nAntibiotic resistant Neisseria meningitidis: MG50.7\\nPenicillin resistant Neisseria meningitidis: MG50.70\\nOther specified antibiotic resistant Neisseria meningitidis: MG50.7Y\\nAntibiotic resistant Neisseria meningitidis unspecified: MG50.7Z\\nAntibiotic resistant Pseudomonas aeruginosa: MG50.8\\nCarbapenemresistant Pseudomonas aeruginosa: MG50.80\\nPolymyxinresistant Pseudomonas aeruginosa: MG50.81\\nPseudomonas aeruginosa resistant to other antibiotic: MG50.8Y\\nPseudomonas aeruginosa resistant to unspecified antibiotic: MG50.8Z\\nAntibiotic resistant Salmonella: MG50.9\\nFluoroquinolone resistant Salmonella: MG50.90\\nThird generation cephalosporin resistant Salmonella: MG50.91\\nCarbapenem resistant Salmonella: MG50.92\\nSalmonella resistant to other antibiotic: MG50.9Y\\nSalmonella resistant to unspecified antibiotic: MG50.9Z\\nAntibiotic resistant Shigella: MG50.A\\nCarbapenem resistant Shigella: MG50.A0\\nFluoroquinolone resistant Shigella: MG50.A1\\nThirdgeneration cephalosporins resistant Shigella: MG50.A2\\nMacrolides resistant Shigella: MG50.A3\\nShigella resistant to other antibiotic: MG50.AY\\nShigella resistant to unspecified antibiotic: MG50.AZ\\nAntibiotic resistant Vibrio: MG50.B\\nFluoroquinolone resistant Vibrio: MG50.B0\\nVibrio resistant to other antibiotic: MG50.BY\\nVibrio resistant to unspecified antibiotic: MG50.BZ\\nOther antibiotic resistant Enterobacterales: MG50.C\\nOther carbapenem resistant Enterobacterales: MG50.C0\\nOther thirdgeneration cephalosporin resistant Enterobacterales: MG50.C1\\nOther specified other antibiotic resistant Enterobacterales: MG50.CY\\nOther antibiotic resistant Enterobacterales unspecified: MG50.CZ\\nOther specified finding of gram negative bacteria resistant to antimicrobial drugs: MG50.Y\\nFinding of gram negative bacteria resistant to antimicrobial drugs unspecified: MG50.Z\\nFinding of gram positive bacteria resistant to antimicrobial drugs: MG51\\nAntibiotic resistant Staphylococcus aureus: MG51.0\\nMethicillin resistant Staphylococcus aureus: MG51.00\\nVancomycin resistant Staphylococcus aureus: MG51.01\\nPenicillinasestable beta lactams resistant Staphylococcus aureus: MG51.02\\nOther specified antibiotic resistant Staphylococcus aureus: MG51.0Y\\nAntibiotic resistant Staphylococcus aureus unspecified: MG51.0Z\\nAntibiotic resistant Streptococcus pneumoniae: MG51.1\\nPenicillin resistant Streptococcus pneumoniae: MG51.10\\nSulfonamide and trimethoprim resistant Streptococcus pneumoniae: MG51.11\\nThirdgeneration cephalosporins resistant Streptococcus pneumoniae: MG51.12\\nStreptococcus pneumoniae resistant to other antibiotic: MG51.1Y\\nStreptococcus pneumoniae resistant to unspecified antibiotic: MG51.1Z\\nAntibiotic resistant Enterococcus: MG51.2\\nVancomycin resistant Enterococcus: MG51.20\\nEnterococcus resistant to other antibiotic: MG51.2Y\\nEnteroccus resistant to unspecified antibiotic: MG51.2Z\\nOther specified finding of gram positive bacteria resistant to antimicrobial drugs: MG51.Y\\nFinding of gram positive bacteria resistant to antimicrobial drugs unspecified: MG51.Z\\nFinding of bacteria neither gram negative nor positive resistant to antimicrobial drugs: MG52\\nAntibiotic resistant Mycobacterium: MG52.0\\nMultidrug resistant Mycobacterium tuberculosis: MG52.00\\nAntibiotic resistant nontuberculous Mycobacterium: MG52.01\\nExtensively drugresistant mycobacterium tuberculosis: MG52.02\\nOther specified antibiotic resistant Mycobacterium: MG52.0Y\\nAntibiotic resistant Mycobacterium unspecified: MG52.0Z\\nOther specified finding of bacteria neither gram negative nor positive resistant to antimicrobial drugs: MG52.Y\\nFinding of bacteria neither gram negative nor positive resistant to antimicrobial drugs unspecified: MG52.Z\\nFinding of virus resistant to antimicrobial drugs: MG53\\nAntiretroviral therapy resistant Human immunodeficiency virus: MG53.0\\nOther specified finding of virus resistant to antimicrobial drugs: MG53.Y\\nFinding of virus resistant to antimicrobial drugs unspecified: MG53.Z\\nFinding of fungus resistant to antimicrobial drugs: MG54\\nFinding of parasite resistant to antimicrobial drugs: MG55\\nArtemisinin resistant Plasmodium falciparum: MG55.0\\nOther specified finding of parasite resistant to antimicrobial drugs: MG55.Y\\nFinding of parasite resistant to antimicrobial drugs unspecified: MG55.Z\\nFinding of microorganism resistant to other multiple antimicrobial drugs: MG56\\nFinding of other microorganism resistant to antimicrobial drugs: MG5Y\\nFinding of microorganism resistant to antimicrobial drugs unspecified: MG5Z\\nAbnormal level of enzymes in specimens from other organs systems and tissues: MG60\\nAbnormal level of hormones in specimens from other organs systems and tissues: MG61\\nAbnormal level of drugs medicaments and biological substances in specimens from other organs systems and tissues: MG62\\nAbnormal level of substances chiefly nonmedicinal as to source in specimens from other organs systems and tissues: MG63\\nAbnormal immunological findings in specimens from other organs systems and tissues: MG64\\nAbnormal microbiological findings in specimens from other organs systems and tissues: MG65\\nAbnormal cytological findings in specimens from other organs systems and tissues: MG66\\nAbnormal histological findings in specimens from other organs systems and tissues: MG67\\nOther specified clinical findings in specimens from other specified organs systems and tissues: MG6Y\\nAbnormal diagnostic imaging results not elsewhere classified: MG70\\nAbnormal laboratory results not elsewhere classified: MG71\\nAbnormal findings on neonatal screening: MG71.0\\nOther specified abnormal laboratory results not elsewhere classified: MG71.Y\\nAbnormal laboratory results not elsewhere classified unspecified: MG71.Z\\nAbnormal results of function studies of other organs and systems: MG72\\nOther specified abnormal results not elsewhere classified: MG7Y\\nAbnormal results not elsewhere classified unspecified: MG7Z\\nBrain death: MH10\\nSudden infant death syndrome: MH11\\nSudden infant death syndrome with mention of autopsy: MH11.0\\nSudden infant death syndrome without autopsy: MH11.1\\nSudden infant death syndrome unspecified: MH11.Z\\nOther sudden death cause unknown: MH12\\nInstantaneous death: MH12.0\\nDeath occurring less than  hours from onset of symptoms not otherwise explained: MH12.1\\nOther specified sudden death cause unknown: MH12.Y\\nUnattended death: MH13\\nOther illdefined or unspecified causes of mortality: MH14\\nSudden unexpected death in epilepsy: MH15\\nOther specified symptoms signs or clinical findings not elsewhere classified: MH2Y\\nSuperficial injury of head: NA00\\nSuperficial injury of scalp: NA00.0\\nAbrasion of scalp: NA00.00\\nContusion of scalp: NA00.01\\nSuperficial foreign body in scalp: NA00.02\\nOther specified superficial injury of scalp: NA00.0Y\\nSuperficial injury of scalp type unspecified: NA00.0Z\\nSuperficial injury of eyelid or periocular area: NA00.1\\nAbrasion of eyelid or periocular area: NA00.10\\nContusion of eyelid or periocular area: NA00.11\\nOther specified superficial injury of eyelid or periocular area: NA00.1Y\\nSuperficial injury of eyelid or periocular area unspecified: NA00.1Z\\nSuperficial injury of ear: NA00.2\\nSuperficial injury of nose: NA00.3\\nSuperficial injury of lip or oral cavity: NA00.4\\nMultiple superficial injuries of head: NA00.5\\nAbrasion of other or unspecified sites of head: NA00.6\\nContusion of other or unspecified sites of head: NA00.7\\nSuperficial injury of other specified part of head: NA00.Y\\nSuperficial injury of unspecified part of head: NA00.Z\\nOpen wound of head: NA01\\nLaceration without foreign body of head: NA01.2\\nLaceration with foreign body of head: NA01.3\\nPuncture wound without foreign body of head: NA01.4\\nPuncture wound with foreign body of head: NA01.5\\nOpen bite of head: NA01.6\\nMultiple open wounds of head: NA01.7\\nOther specified open wound of head: NA01.Y\\nOpen wound of head unspecified: NA01.Z\\nFracture of skull or facial bones: NA02\\nFracture of vault of skull: NA02.0\\nFracture of squama of frontal bone of skull: NA02.00\\nFracture of parietal bone of skull: NA02.01\\nFracture of squama of temporal bone of skull: NA02.02\\nFracture of squama of occipital bone of skull: NA02.03\\nFracture of vault of skull unspecified: NA02.0Z\\nFracture of base of skull: NA02.1\\nFracture of anterior fossa of base of skull: NA02.10\\nFracture of middle fossa of base of skull: NA02.11\\nFracture of posterior fossa of base of skull: NA02.12\\nFracture of sinus of ethmoid bone of skull: NA02.13\\nFracture of frontal sinus of skull: NA02.14\\nFracture of sphenoid bone of skull: NA02.15\\nFracture of occipital condyle of skull type I: NA02.16\\nFracture of occipital condyle of skull type II: NA02.17\\nFracture of occipital condyle of skull type III: NA02.18\\nFracture of other part of occipital bone of skull: NA02.19\\nOther fractures of base of skull: NA02.1A\\nFracture of base of skull unspecified: NA02.1Z\\nOrbital fracture: NA02.2\\nFracture of orbital roof: NA02.20\\nFracture of orbital floor: NA02.21\\nOther specified orbital fracture: NA02.2Y\\nOrbital fracture unspecified: NA02.2Z\\nFracture of nasal bones: NA02.3\\nFracture of maxilla: NA02.4\\nLe Fort fracture type I: NA02.40\\nLe Fort fracture type II: NA02.41\\nLe Fort fracture type III: NA02.42\\nOther specified fracture of maxilla: NA02.4Y\\nFracture of maxilla unspecified: NA02.4Z\\nFracture of zygoma: NA02.5\\nFracture of mandible: NA02.7\\nFracture of condylar process of mandible: NA02.70\\nFracture of subcondylar process of mandible: NA02.71\\nFracture of coronoid process of mandible: NA02.72\\nFracture of ramus of mandible: NA02.73\\nFracture of angle of mandible: NA02.74\\nFracture of alveolar margin of mandible: NA02.75\\nFracture of symphysis of mandible: NA02.76\\nOther specified fracture of mandible: NA02.7Y\\nFracture of mandible unspecified: NA02.7Z\\nMultiple fractures involving skull or facial bones: NA02.8\\nFracture of other specified skull or facial bones: NA02.Y\\nFracture of skull or facial bones part unspecified: NA02.Z\\nDislocation or strain or sprain of joints or ligaments of head: NA03\\nDislocation of jaw: NA03.0\\nDislocation of septal cartilage of nose: NA03.1\\nStrain or sprain of jaw: NA03.3\\nDislocation or sprain of other specified joints or ligaments of head: NA03.Y\\nDislocation or strain or sprain of joints or ligaments of head unspecified: NA03.Z\\nInjury of cranial nerves: NA04\\nInjury of olfactory nerve: NA04.0\\nInjury of optic nerve or pathways: NA04.1\\nInjury of optic nerve unilateral: NA04.10\\nInjury of optic nerve bilateral: NA04.11\\nInjury of optic chiasm: NA04.12\\nInjury of optic tract or pathways unilateral: NA04.13\\nInjury of optic tract or pathways bilateral: NA04.14\\nInjury of visual cortex unilateral: NA04.15\\nInjury of visual cortex bilateral: NA04.16\\nOther specified injury of optic nerve or pathways: NA04.1Y\\nInjury of optic nerve or pathways unspecified: NA04.1Z\\nInjury of oculomotor nerve: NA04.2\\nInjury of trochlear nerve: NA04.3\\nInjury of trigeminal nerve: NA04.4\\nInjury of abducent nerve: NA04.5\\nInjury of facial nerve: NA04.6\\nInjury of acoustic nerve: NA04.7\\nInjury of glossopharyngeal nerve: NA04.8\\nInjury of vagus nerve: NA04.9\\nInjury of accessory nerve: NA04.A\\nInjury of hypoglossal nerve: NA04.B\\nInjury of cranial nerves unspecified: NA04.Z\\nInjury of blood vessels of head: NA05\\nInjury of intracranial vessels of head: NA05.0\\nInjury of extracranial vessels of head: NA05.1\\nInjury of blood vessels of head unspecified: NA05.Z\\nInjury of eye or orbit: NA06\\nEyelid trauma: NA06.0\\nEyelid avulsion: NA06.00\\nHaematoma of eyelid: NA06.01\\nOedema of eyelid: NA06.02\\nRetained foreign body in eyelid: NA06.03\\nOpen wound of eyelid or periocular area: NA06.04\\nOther specified eyelid trauma: NA06.0Y\\nEyelid trauma unspecified: NA06.0Z\\nPenetrating wound of orbit with or without foreign body: NA06.1\\nRetained foreign body following penetrating wound of orbit: NA06.2\\nTraumatic orbital haemorrhage: NA06.3\\nInjury of conjunctiva or corneal abrasion without mention of foreign body: NA06.4\\nTrauma to the iris sphincter: NA06.5\\nTraumatic injuries of the retina: NA06.6\\nTraumatic macular hole: NA06.60\\nChoroidal rupture: NA06.61\\nCommotio retinae: NA06.62\\nOptic nerve avulsion: NA06.63\\nOther specified traumatic injuries of the retina: NA06.6Y\\nTraumatic injuries of the retina unspecified: NA06.6Z\\nTraumatic retinal haemorrhage: NA06.7\\nTraumatic injury to eyeball: NA06.8\\nRetained intraocular magnetic foreign body unilateral: NA06.80\\nRetained intraocular nonmagnetic foreign body unilateral: NA06.81\\nClosed eyeball trauma unilateral: NA06.82\\nClosed eyeball trauma bilateral: NA06.83\\nPenetrating wound of eyeball without foreign body unilateral: NA06.84\\nAvulsion of eye unilateral: NA06.85\\nAvulsion of eye bilateral: NA06.86\\nOcular laceration or rupture with prolapse or loss of intraocular tissue unilateral: NA06.87\\nOcular laceration or rupture with prolapse or loss of intraocular tissue bilateral: NA06.88\\nPenetrating injury of eyeball bilateral: NA06.89\\nPerforating injury of eyeball bilateral: NA06.8A\\nRetained intraocular magnetic foreign body bilateral: NA06.8B\\nRetained intraocular nonmagnetic foreign body bilateral: NA06.8C\\nOcular laceration without prolapse or loss of intraocular tissue unilateral: NA06.8D\\nOcular laceration without prolapse or loss of intraocular tissue bilateral: NA06.8E\\nOther specified traumatic injury to eyeball: NA06.8Y\\nTraumatic injury to eyeball unspecified: NA06.8Z\\nContusion of eyeball or orbital tissues: NA06.9\\nInjury of lens: NA06.A\\nOther specified injury of eye or orbit: NA06.Y\\nInjury of eye or orbit unspecified: NA06.Z\\nIntracranial injury: NA07\\nConcussion: NA07.0\\nConcussion with incomplete loss of consciousness with amnesia: NA07.00\\nConcussion with incomplete loss of consciousness without amnesia: NA07.01\\nConcussion with loss of consciousness short duration of less than  minutes: NA07.02\\nConcussion with loss of consciousness short duration of  minutes to less than one hour: NA07.03\\nConcussion with loss of consciousness short duration of one hour to less than  hours: NA07.04\\nConcussion with loss of consciousness intermediate duration of  hours to less than  hours: NA07.05\\nConcussion with loss of consciousness persisting longer than  hours or until discharge or latest assessment: NA07.06\\nConcussion with loss of consciousness persisting until death: NA07.07\\nConcussion with loss of consciousness duration unspecified or unknown due to effects of therapy: NA07.08\\nConcussion with loss of consciousness duration unspecified or unknown due to lack of information: NA07.09\\nOther specified concussion: NA07.0Y\\nConcussion unspecified: NA07.0Z\\nTraumatic intracerebral haemorrhage: NA07.1\\nTraumatic cerebral oedema: NA07.2\\nDiffuse traumatic cerebral oedema: NA07.20\\nFocal traumatic cerebral oedema: NA07.21\\nOther specified traumatic cerebral oedema: NA07.2Y\\nTraumatic cerebral oedema unspecified: NA07.2Z\\nDiffuse brain injury: NA07.3\\nDiffuse injury of cerebrum: NA07.30\\nDiffuse injury of cerebellum: NA07.31\\nDiffuse injury of brainstem: NA07.32\\nDiffuse injury of multiple parts of brain: NA07.33\\nOther specified diffuse brain injury: NA07.3Y\\nUnspecified diffuse traumatic brain injury: NA07.3Z\\nFocal brain injury: NA07.4\\nFocal nonhaemorrhagic contusion of cerebrum: NA07.40\\nFocal haemorrhagic contusion of cerebrum: NA07.41\\nFocal laceration of cerebrum: NA07.42\\nMultiple focal injuries of cerebrum: NA07.43\\nFocal nonhaemorrhagic contusion of cerebellum: NA07.44\\nFocal haematoma or haemorrhage of cerebellum: NA07.45\\nFocal laceration of cerebellum: NA07.46\\nMultiple focal injuries of cerebellum: NA07.47\\nFocal nonhaemorrhagic contusion of brainstem: NA07.48\\nFocal haematoma or haemorrhage of brainstem: NA07.49\\nContusion of temporal lobe: NA07.4A\\nFocal laceration of brainstem: NA07.4B\\nFocal brain contusion: NA07.4C\\nFocal brain laceration: NA07.4D\\nContusion of parietal lobe: NA07.4E\\nContusion of occipital lobe: NA07.4F\\nUnspecified focal traumatic brain injury: NA07.4Z\\nTraumatic epidural haemorrhage: NA07.5\\nTraumatic subdural haemorrhage: NA07.6\\nAcute traumatic subdural haemorrhage: NA07.60\\nChronic traumatic subdural haemorrhage: NA07.61\\nTraumatic subdural haemorrhage unspecified whether acute or chronic: NA07.6Z\\nTraumatic subarachnoid haemorrhage: NA07.7\\nTraumatic haemorrhage in brain tissue: NA07.8\\nTraumatic haemorrhage in cerebrum white matter: NA07.80\\nTraumatic haemorrhage in thalamus or basal ganglia: NA07.81\\nTraumatic haemorrhage in cerebellum: NA07.82\\nTraumatic haemorrhage in brainstem without specification whether primary or secondary: NA07.83\\nTraumatic haemorrhage in brainstem primary: NA07.84\\nTraumatic haemorrhage in brainstem secondary: NA07.85\\nMultiple traumatic haemorrhages: NA07.86\\nOther specified traumatic haemorrhage in brain tissue: NA07.8Y\\nTraumatic haemorrhage in brain tissue unspecified: NA07.8Z\\nOther specified intracranial injury: NA07.Y\\nIntracranial injury unspecified: NA07.Z\\nCrushing injury of head: NA08\\nCrushing injury of brain: NA08.0\\nCrushing injury of face: NA08.1\\nCrushing injury of skull: NA08.2\\nCrushed scalp: NA08.3\\nOther specified crushing injury of head: NA08.Y\\nCrushing injury of head unspecified: NA08.Z\\nTraumatic amputation of part of head: NA09\\nAvulsion of scalp: NA09.0\\nTraumatic amputation of ear: NA09.1\\nTraumatic amputation of ear complete: NA09.10\\nTraumatic amputation of ear partial: NA09.11\\nTraumatic amputation of ear unspecified: NA09.1Z\\nTraumatic amputation of nose: NA09.2\\nTraumatic amputation of nose complete: NA09.20\\nTraumatic amputation of nose partial: NA09.21\\nTraumatic amputation of nose unspecified: NA09.2Z\\nTraumatic amputation of lip: NA09.3\\nOther specified traumatic amputation of part of head: NA09.Y\\nTraumatic amputation of part of head unspecified: NA09.Z\\nCertain specified injuries of head: NA0A\\nComplex wounds to the head: NA0A.0\\nComplex wounds to the head with retained external material: NA0A.00\\nComplex wounds to the head with intracranial haemorrhage: NA0A.01\\nComplex wounds to the head with through and through perforation: NA0A.02\\nComplex wounds to the head with avulsive loss of part of skull and cranial contents: NA0A.03\\nOther specified complex wounds to the head: NA0A.0Y\\nComplex wounds to the head unspecified: NA0A.0Z\\nInjury of muscle fascia or tendon of head: NA0A.1\\nStrain or sprain of muscle fascia or tendon of head: NA0A.10\\nLaceration of muscle fascia or tendon of head: NA0A.11\\nOther specified injury of muscle fascia or tendon of head: NA0A.1Y\\nInjury of muscle fascia or tendon of head unspecified: NA0A.1Z\\nTraumatic rupture of ear drum: NA0A.2\\nMultiple injuries of head: NA0A.3\\nOther specified injuries of head: NA0A.Y\\nInjury of the auricle: NA0B\\nInjury of middle or inner ear: NA0C\\nInjury of teeth or supporting structures: NA0D\\nInjury of hard dental tissues and pulp: NA0D.0\\nEnamel infraction: NA0D.00\\nEnamel fracture: NA0D.01\\nEnameldentin fracture: NA0D.02\\nComplicated crown fracture: NA0D.03\\nUncomplicated crownroot fracture: NA0D.04\\nComplicated crownroot fracture: NA0D.05\\nRoot fracture: NA0D.06\\nOther specified injury of hard dental tissues and pulp: NA0D.0Y\\nInjury of hard dental tissues and pulp unspecified: NA0D.0Z\\nInjury of periodontal tissues: NA0D.1\\nConcussion of periodontal tissue: NA0D.10\\nSubluxation of tooth: NA0D.11\\nExtrusive luxation of tooth: NA0D.12\\nLateral luxation of tooth: NA0D.13\\nIntrusive luxation of tooth: NA0D.14\\nAvulsion of tooth: NA0D.15\\nOther specified injury of periodontal tissues: NA0D.1Y\\nInjury of periodontal tissues unspecified: NA0D.1Z\\nOther specified injury of teeth or supporting structures: NA0D.Y\\nInjury of teeth or supporting structures unspecified: NA0D.Z\\nInjuries to the head unspecified: NA0Z\\nSuperficial injury of neck: NA20\\nAbrasion of throat: NA20.0\\nContusion of throat: NA20.1\\nOther or unspecified superficial injuries of throat: NA20.2\\nMultiple superficial injuries of neck: NA20.3\\nOther specified superficial injury of neck: NA20.Y\\nSuperficial injury of neck unspecified: NA20.Z\\nOpen wound of neck: NA21\\nLaceration without foreign body of neck: NA21.0\\nLaceration with foreign body of neck: NA21.1\\nPuncture wound without foreign body of neck: NA21.2\\nPuncture wound with foreign body of neck: NA21.3\\nOpen bite of neck: NA21.4\\nMultiple open wounds of neck: NA21.5\\nOther specified open wound of neck: NA21.Y\\nOpen wound of neck unspecified: NA21.Z\\nFracture of neck: NA22\\nFracture of first cervical vertebra: NA22.0\\nFracture of first cervical vertebra burst fracture: NA22.00\\nFracture of posterior arch of first cervical vertebra: NA22.01\\nFracture of lateral mass of first cervical vertebra: NA22.02\\nOther fracture of first cervical vertebra: NA22.03\\nFracture of first cervical vertebra unspecified: NA22.0Z\\nFracture of second cervical vertebra: NA22.1\\nTraumatic spondylolisthesis of second cervical vertebra type III: NA22.10\\nOther traumatic spondylolisthesis of second cervical vertebra: NA22.11\\nFracture of odontoid process: NA22.12\\nOther fracture of second cervical vertebra: NA22.13\\nFracture of second cervical vertebra unspecified: NA22.1Z\\nFracture of other specified cervical vertebra: NA22.2\\nMultiple fractures of cervical spine: NA22.3\\nFracture of neck unspecified: NA22.Z\\nDislocation or strain or sprain of joints or ligaments at neck level: NA23\\nTraumatic rupture of cervical intervertebral disc: NA23.0\\nDislocation of cervical vertebra: NA23.1\\nCraniocervical dissociation: NA23.10\\nAtlantoaxial dislocation: NA23.11\\nDislocation of other specified cervical vertebra: NA23.12\\nDislocation of cervical vertebra unspecified: NA23.1Z\\nDislocation of other or unspecified parts of neck: NA23.2\\nMultiple dislocations of neck: NA23.3\\nStrain or sprain of cervical spine: NA23.4\\nAcute whiplash associated disorder with complaint of neck pain stiffness or tenderness only: NA23.40\\nAcute whiplash associated disorder with complaint of neck pain with musculoskeletal signs: NA23.41\\nAcute whiplash associated disorder with complaint of neck pain with neurological signs: NA23.42\\nOther specified strain or sprain of cervical spine: NA23.4Y\\nStrain or sprain of cervical spine unspecified: NA23.4Z\\nStrain or sprain of thyroid region: NA23.5\\nOther specified dislocation or strain or sprain of joints or ligaments at neck level: NA23.Y\\nDislocation or strain or sprain of joints or ligaments at neck level unspecified: NA23.Z\\nConcussion or oedema of cervical spinal cord: NA30\\nCertain specified injuries of cervical spinal cord: NA31\\nComplete lesion of cervical spinal cord: NA31.0\\nCentral cord syndrome of cervical spinal cord: NA31.1\\nAnterior cord syndrome of cervical spinal cord: NA31.2\\nPosterior cord syndrome of cervical spinal cord: NA31.3\\nBrownSequard syndrome of cervical spinal cord: NA31.4\\nOther incomplete cord syndrome of cervical spinal cord: NA31.5\\nInjury of cervical spinal cord unspecified: NA3Z\\nInjury of nerve root of cervical spine: NA40\\nInjury of brachial plexus: NA41\\nInjury of brachial plexus cord: NA41.0\\nInjury of brachial plexus division: NA41.1\\nInjury of brachial plexus trunk: NA41.2\\nOther specified injury of brachial plexus: NA41.Y\\nInjury of brachial plexus unspecified: NA41.Z\\nInjury of peripheral nerves of neck: NA42\\nInjury of supraclavicular nerve: NA42.0\\nInjury to anterior cutaneous nerve of neck: NA42.1\\nInjury of other specified peripheral nerves of neck: NA42.Y\\nInjury of peripheral nerves of neck unspecified: NA42.Z\\nInjury of cervical sympathetic nerves: NA43\\nInjury of phrenic nerve: NA44\\nInjury of other specified nerves at neck level: NA4Y\\nInjury of nerves at neck level unspecified: NA4Z\\nInjury of blood vessels at neck level: NA60\\nInjury of carotid artery: NA60.0\\nLaceration of carotid artery minor: NA60.00\\nLaceration of carotid artery major: NA60.01\\nOther specified injury of carotid artery: NA60.0Y\\nInjury of carotid artery unspecified: NA60.0Z\\nInjury of vertebral artery: NA60.1\\nLaceration of vertebral artery minor: NA60.10\\nLaceration of vertebral artery major: NA60.11\\nOther specified injury of vertebral artery: NA60.1Y\\nInjury of vertebral artery unspecified: NA60.1Z\\nInjury of external jugular vein: NA60.2\\nLaceration of external jugular vein minor: NA60.20\\nLaceration of external jugular vein major: NA60.21\\nOther specified injury of external jugular vein: NA60.2Y\\nInjury of external jugular vein unspecified: NA60.2Z\\nInjury of internal jugular vein: NA60.3\\nLaceration of internal jugular vein minor: NA60.30\\nLaceration of internal jugular vein major: NA60.31\\nOther specified injury of internal jugular vein: NA60.3Y\\nInjury of internal jugular vein unspecified: NA60.3Z\\nInjury of multiple blood vessels at neck level: NA60.4\\nInjury of other specified blood vessels at neck level: NA60.Y\\nInjury of blood vessels at neck level unspecified: NA60.Z\\nInjury of muscle fascia or tendon at neck level: NA61\\nStrain or sprain of muscle fascia or tendon at neck level: NA61.0\\nLaceration of muscle fascia or tendon at neck level: NA61.1\\nOther specified injury of muscle fascia or tendon at neck level: NA61.Y\\nInjury of muscle fascia or tendon at neck level unspecified: NA61.Z\\nCrushing injury of neck: NA62\\nCrushing injury of larynx or trachea: NA62.0\\nCrushing injury of other specified site of neck: NA62.Y\\nCrushing injury of neck unspecified: NA62.Z\\nTraumatic amputation at neck level: NA63\\nMultiple injuries of neck: NA64\\nOther specified injuries to the neck: NA6Y\\nInjuries to the neck unspecified: NA6Z\\nSuperficial injury of thorax: NA80\\nAbrasion of breast: NA80.0\\nContusion of breast: NA80.1\\nOther or unspecified superficial injuries of breast: NA80.2\\nOther superficial injuries of front wall of thorax: NA80.3\\nOther superficial injuries of back wall of thorax: NA80.4\\nAbrasion of thorax: NA80.5\\nContusion of thorax: NA80.6\\nMultiple superficial injuries of thorax: NA80.7\\nOther specified superficial injury of thorax: NA80.Y\\nSuperficial injury of thorax unspecified: NA80.Z\\nOpen wound of thorax: NA81\\nLaceration without foreign body of thorax: NA81.0\\nLaceration with foreign body of thorax: NA81.1\\nPuncture wound without foreign body of thorax: NA81.2\\nPuncture wound with foreign body of thorax: NA81.3\\nOpen bite of thorax: NA81.4\\nMultiple open wounds of thoracic wall: NA81.5\\nOther specified open wound of thorax: NA81.Y\\nOpen wound of thorax unspecified: NA81.Z\\nFracture of rib sternum or thoracic spine: NA82\\nFracture of thoracic vertebra: NA82.0\\nMultiple fractures of thoracic spine: NA82.1\\nFracture of sternum: NA82.2\\nFracture of rib: NA82.3\\nFracture of rib posterior or posterior and lateral: NA82.30\\nOther specified fracture of rib: NA82.3Y\\nFracture of rib unspecified: NA82.3Z\\nMultiple fractures of ribs: NA82.4\\nFlail chest: NA82.5\\nOther specified fracture of rib sternum or thoracic spine: NA82.Y\\nFracture of rib sternum or thoracic spine unspecified: NA82.Z\\nDislocation or strain or sprain of joints or ligaments of thorax: NA83\\nTraumatic rupture of thoracic intervertebral disc: NA83.0\\nDislocation of thoracic vertebra: NA83.1\\nDislocation of other or unspecified parts of thorax: NA83.2\\nStrain or sprain of ligaments of thoracic spine: NA83.3\\nStrain or sprain of ribs or sternum: NA83.4\\nStrain or sprain of sternum: NA83.40\\nStrain or sprain of sternoclavicular joint or ligament: NA83.41\\nStrain or sprain of chondrosternal joint: NA83.42\\nStrain or sprain of rib: NA83.43\\nOther specified dislocation or strain or sprain of joints or ligaments of thorax: NA83.Y\\nDislocation or strain or sprain of joints or ligaments of thorax unspecified: NA83.Z\\nConcussion or oedema of thoracic spinal cord: NA90\\nCertain specified injuries of thoracic spinal cord: NA91\\nComplete lesion of thoracic spinal cord: NA91.0\\nCentral cord syndrome of thoracic spinal cord: NA91.1\\nAnterior cord syndrome of thoracic spinal cord: NA91.2\\nPosterior cord syndrome of thoracic spinal cord: NA91.3\\nBrownSequard syndrome of thoracic spinal cord: NA91.4\\nOther incomplete cord syndrome of thoracic spinal cord: NA91.5\\nInjury of thoracic spinal cord unspecified: NA9Z\\nInjury of nerve root of thoracic spine: NB00\\nInjury of peripheral nerves of thorax: NB01\\nInjury of thoracic sympathetic nerves: NB02\\nInjury of other specified nerves at thorax level: NB0Y\\nOther specified injury of nerves or spinal cord at thorax level: NB2Y\\nInjury of nerves or spinal cord at thorax level unspecified: NB2Z\\nInjury of blood vessels of thorax: NB30\\nInjury of thoracic aorta: NB30.0\\nMinor laceration of thoracic aorta: NB30.00\\nMajor laceration of thoracic aorta: NB30.01\\nOther specified injury of thoracic aorta: NB30.0Y\\nInjury of thoracic aorta unspecified: NB30.0Z\\nInjury of innominate or subclavian artery: NB30.1\\nMinor laceration of innominate or subclavian artery: NB30.10\\nMajor laceration of innominate or subclavian artery: NB30.11\\nOther specified injury of innominate or subclavian artery: NB30.1Y\\nInjury of innominate or subclavian artery unspecified: NB30.1Z\\nInjury of superior vena cava: NB30.2\\nMinor laceration of superior vena cava: NB30.20\\nMajor laceration of superior vena cava: NB30.21\\nOther specified injury of superior vena cava: NB30.2Y\\nInjury of superior vena cava unspecified: NB30.2Z\\nInjury of innominate or subclavian vein: NB30.3\\nMinor laceration of innominate or subclavian vein: NB30.30\\nMajor laceration of innominate or subclavian vein: NB30.31\\nOther specified injury of innominate or subclavian vein: NB30.3Y\\nInjury of innominate or subclavian vein unspecified: NB30.3Z\\nInjury of pulmonary blood vessels: NB30.4\\nMinor laceration of pulmonary blood vessels: NB30.40\\nMajor laceration of pulmonary blood vessels: NB30.41\\nOther specified injury of pulmonary blood vessels: NB30.4Y\\nInjury of pulmonary blood vessels unspecified: NB30.4Z\\nInjury of intercostal blood vessels: NB30.5\\nLaceration of intercostal blood vessels: NB30.50\\nOther specified injury of intercostal blood vessels: NB30.5Y\\nInjury of intercostal blood vessels unspecified: NB30.5Z\\nInjury of multiple blood vessels of thorax: NB30.6\\nInjury of other specified blood vessels of thorax: NB30.Y\\nInjury of unspecified blood vessels of thorax: NB30.Z\\nInjury of heart: NB31\\nInjury of heart with haemopericardium: NB31.0\\nContusion of heart with haemopericardium: NB31.00\\nMinor laceration of heart with haemopericardium: NB31.01\\nModerate laceration of heart with haemopericardium: NB31.02\\nMajor laceration of heart with haemopericardium: NB31.03\\nOther specified injury of heart with haemopericardium: NB31.0Y\\nInjury of heart with haemopericardium unspecified: NB31.0Z\\nInjury of heart without haemopericardium: NB31.1\\nContusion of heart without haemopericardium: NB31.10\\nLaceration of heart without haemopericardium: NB31.11\\nOther specified injury of heart without haemopericardium: NB31.1Y\\nInjury of heart without haemopericardium unspecified: NB31.1Z\\nInjury of heart unspecified without open wound into thoracic cavity: NB31.2\\nInjury of heart unspecified with open wound into thoracic cavity: NB31.3\\nInjury of heart valve: NB31.4\\nInjury to mitral valve: NB31.40\\nInjury of other specified heart valve: NB31.4Y\\nInjury of heart valve unspecified: NB31.4Z\\nOther specified injury of heart: NB31.Y\\nInjury of heart unspecified: NB31.Z\\nInjury of other or unspecified intrathoracic organs: NB32\\nTraumatic pneumothorax: NB32.0\\nTraumatic haemothorax: NB32.1\\nTraumatic haemopneumothorax: NB32.2\\nCertain injuries of lung: NB32.3\\nContusion of lung: NB32.30\\nLaceration of lung: NB32.31\\nInhalation injury of lung: NB32.32\\nPrimary blast injury of lung: NB32.33\\nOther injury of lung: NB32.3Y\\nInjury of lung unspecified: NB32.3Z\\nInjury of bronchus: NB32.4\\nContusion of bronchus: NB32.40\\nMinor laceration of bronchus: NB32.41\\nModerate laceration of bronchus: NB32.42\\nMajor laceration of bronchus: NB32.43\\nOther specified injury of bronchus: NB32.4Y\\nInjury of bronchus unspecified: NB32.4Z\\nInjury of thoracic trachea: NB32.5\\nContusion of thoracic trachea: NB32.50\\nMinor laceration of thoracic trachea: NB32.51\\nModerate laceration of thoracic trachea: NB32.52\\nMajor laceration of thoracic trachea: NB32.53\\nOther specified injury of thoracic trachea: NB32.5Y\\nInjury of thoracic trachea unspecified: NB32.5Z\\nInjury of pleura: NB32.6\\nLaceration of pleura: NB32.60\\nOther specified injury of pleura: NB32.6Y\\nInjury of pleura unspecified: NB32.6Z\\nMultiple injuries of intrathoracic organs: NB32.7\\nOther specified injury of other or unspecified intrathoracic organs: NB32.Y\\nUnspecified injury of unspecified intrathoracic organs: NB32.Z\\nCrushing injury of thorax or traumatic amputation of part of thorax: NB33\\nCrushed chest: NB33.0\\nTraumatic amputation of breast: NB33.1\\nTraumatic amputation of part of breast: NB33.10\\nTraumatic amputation of entire breast: NB33.11\\nTraumatic amputation of breast unspecified: NB33.1Z\\nTraumatic amputation of other or unspecified part of thorax: NB33.2\\nInjury of muscle fascia or tendon at thorax level: NB34\\nStrain or sprain of muscle fascia or tendon at thorax level: NB34.0\\nLaceration of muscle fascia or tendon at thorax level: NB34.1\\nOther specified injury of muscle fascia or tendon at thorax level: NB34.Y\\nInjury of muscle fascia or tendon at thorax level unspecified: NB34.Z\\nMultiple injuries of thorax: NB35\\nOther specified injuries to the thorax: NB3Y\\nInjuries to the thorax unspecified: NB3Z\\nSuperficial injury of abdomen lower back or pelvis: NB50\\nAbrasion of lower back or pelvis: NB50.0\\nContusion of lower back or pelvis: NB50.1\\nAbrasion of abdominal wall: NB50.2\\nContusion of abdominal wall: NB50.3\\nAbrasion of external genital organs: NB50.4\\nContusion of external genital organs: NB50.5\\nMultiple superficial injuries of abdomen lower back or pelvis: NB50.6\\nOther specified superficial injury of abdomen lower back or pelvis: NB50.Y\\nSuperficial injury of abdomen lower back or pelvis unspecified: NB50.Z\\nOpen wound of abdomen lower back or pelvis: NB51\\nLaceration without foreign body of abdomen lower back or pelvis: NB51.0\\nLaceration with foreign body of abdomen lower back or pelvis: NB51.1\\nPuncture wound without foreign body of abdomen lower back or pelvis: NB51.2\\nPuncture wound with foreign body of abdomen lower back or pelvis: NB51.3\\nOpen bite of abdomen lower back or pelvis: NB51.4\\nMultiple open wounds of abdomen lower back or pelvis: NB51.5\\nOther specified open wound of abdomen lower back or pelvis: NB51.Y\\nOpen wound of abdomen lower back or pelvis unspecified: NB51.Z\\nFracture of lumbar spine or pelvis: NB52\\nFracture of lumbar vertebra: NB52.0\\nFracture of pelvic bone without disruption of posterior arch of pelvic ring: NB52.1\\nFracture of sacrum without disruption of pelvic ring: NB52.10\\nFracture of coccyx: NB52.11\\nFracture of ilium without disruption of pelvic ring: NB52.12\\nFracture of acetabulum without disruption of pelvic ring: NB52.13\\nFracture of pubis without disruption of pelvic ring: NB52.14\\nFracture of ischium without disruption of pelvic ring: NB52.15\\nFracture of other specified pelvic bone without disruption of posterior arch of pelvic ring: NB52.1Y\\nFracture of unspecified pelvic bone without disruption of posterior arch of pelvic ring: NB52.1Z\\nFracture of the pelvic ring with incomplete disruption of posterior arch: NB52.2\\nFracture of pelvic ring with complete disruption of posterior arch: NB52.3\\nMultiple fractures of lumbar spine or pelvis: NB52.4\\nOther specified fracture of lumbar spine or pelvis: NB52.Y\\nFracture of lumbar spine or pelvis unspecified: NB52.Z\\nDislocation or strain or sprain of joints or ligaments of lumbar spine or pelvis: NB53\\nTraumatic rupture of lumbar intervertebral disc: NB53.0\\nDislocation of lumbar vertebra: NB53.1\\nDislocation of sacroiliac or sacrococcygeal joint without disruption of pelvic ring: NB53.2\\nDislocation of other or unspecified parts of lumbar spine or pelvis without disruption of pelvic ring: NB53.3\\nTraumatic rupture of symphysis pubis without disruption of pelvic ring: NB53.4\\nStrain or sprain of lumbar spine: NB53.5\\nStrain or sprain of sacroiliac joint: NB53.6\\nOther specified dislocation or strain or sprain of joints or ligaments of lumbar spine or pelvis: NB53.Y\\nDislocation or strain or sprain of joints or ligaments of lumbar spine or pelvis unspecified: NB53.Z\\nConcussion or oedema of lumbar spinal cord: NB60\\nConcussion or oedema of sacral spinal cord: NB61\\nCertain specified injuries of lumbar spinal cord: NB62\\nComplete lesion of lumbar spinal cord: NB62.0\\nCentral cord syndrome of lumbar spinal cord: NB62.1\\nAnterior cord syndrome of lumbar spinal cord: NB62.2\\nPosterior cord syndrome of lumbar spinal cord: NB62.3\\nBrownSequard syndrome of lumbar spinal cord: NB62.4\\nOther incomplete cord syndrome of lumbar spinal cord: NB62.5\\nPuncture wound or laceration of dura mater of lumbar spinal cord: NB62.6\\nCertain specified injuries of sacral spinal cord: NB63\\nComplete injury of sacral spinal cord: NB63.0\\nIncomplete injury of sacral spinal cord: NB63.1\\nInjury of sacral spinal cord unspecified: NB63.Z\\nInjury of spinal cord at abdomen lower back or pelvis level unspecified: NB6Z\\nInjury of nerve root of lumbar spine: NB70\\nInjury of nerve root of sacral spine: NB71\\nInjury of cauda equina: NB72\\nInjury of lumbosacral plexus: NB73\\nInjury of lumbar sacral or pelvic sympathetic nerves: NB74\\nInjury of peripheral nerve of abdomen lower back or pelvis: NB75\\nOther specified injury of nerves at abdomen lower back or pelvis level: NB7Y\\nInjury of nerves at abdomen lower back or pelvis level unspecified: NB7Z\\nInjury of blood vessels at abdomen lower back or pelvis level: NB90\\nInjury of abdominal aorta: NB90.0\\nMinor laceration of abdominal aorta: NB90.00\\nMajor laceration of abdominal aorta: NB90.01\\nOther specified injury of abdominal aorta: NB90.0Y\\nInjury of abdominal aorta unspecified: NB90.0Z\\nInjury of inferior vena cava: NB90.1\\nMinor laceration of inferior vena cava: NB90.10\\nMajor laceration of inferior vena cava: NB90.11\\nOther specified injury of inferior vena cava: NB90.1Y\\nInjury of inferior vena cava unspecified: NB90.1Z\\nInjury of coeliac artery: NB90.2\\nMinor laceration of coeliac artery: NB90.20\\nMajor laceration of coeliac artery: NB90.21\\nOther specified injury of coeliac artery: NB90.2Y\\nInjury of coeliac artery unspecified: NB90.2Z\\nInjury of mesenteric artery: NB90.3\\nMinor laceration mesenteric artery: NB90.30\\nMajor laceration of mesenteric artery: NB90.31\\nOther specified injury of mesenteric artery: NB90.3Y\\nInjury of mesenteric artery unspecified: NB90.3Z\\nInjury of portal or splenic vein: NB90.4\\nMinor laceration of portal or splenic vein: NB90.40\\nMajor laceration of portal or splenic vein: NB90.41\\nOther specified injury of portal or splenic vein: NB90.4Y\\nInjury of portal or splenic vein unspecified: NB90.4Z\\nInjury of renal blood vessels: NB90.5\\nMinor laceration of renal blood vessels: NB90.50\\nMajor laceration of renal blood vessels: NB90.51\\nOther specified injury of renal blood vessels: NB90.5Y\\nInjury of renal blood vessels unspecified: NB90.5Z\\nInjury of iliac blood vessels: NB90.6\\nMinor laceration of iliac blood vessels: NB90.60\\nMajor laceration of iliac blood vessels: NB90.61\\nOther specified injury of iliac blood vessels: NB90.6Y\\nInjury of iliac blood vessels unspecified: NB90.6Z\\nInjury of multiple blood vessels at abdomen lower back or pelvis level: NB90.7\\nInjury of other specified blood vessels at abdomen lower back or pelvis level: NB90.Y\\nInjury of unspecified blood vessel at abdomen lower back or pelvis level: NB90.Z\\nInjury of intraabdominal organs: NB91\\nInjury of spleen: NB91.0\\nContusion of spleen minor: NB91.00\\nContusion of spleen major: NB91.01\\nLaceration of spleen minor: NB91.02\\nLaceration of spleen moderate: NB91.03\\nLaceration of spleen major: NB91.04\\nAvulsion of spleen: NB91.05\\nOther specified injury of spleen: NB91.0Y\\nInjury of spleen unspecified: NB91.0Z\\nInjury of liver: NB91.1\\nContusion of liver: NB91.10\\nLaceration of liver minor: NB91.11\\nLaceration of liver moderate: NB91.12\\nLaceration of liver major: NB91.13\\nInjury of hepatic duct: NB91.14\\nOther specified injury of liver: NB91.1Y\\nInjury of liver unspecified: NB91.1Z\\nInjury of gallbladder: NB91.2\\nInjury of bile duct: NB91.3\\nInjury of pancreas: NB91.4\\nContusion of pancreas: NB91.40\\nLaceration of pancreas minor: NB91.41\\nLaceration of pancreas moderate: NB91.42\\nLaceration of pancreas major: NB91.43\\nOther specified injury of pancreas: NB91.4Y\\nInjury of pancreas unspecified: NB91.4Z\\nInjury of stomach: NB91.5\\nContusion of stomach: NB91.50\\nLaceration of stomach without perforation: NB91.51\\nLaceration of stomach with perforation avulsion or massive damage: NB91.52\\nIngestion injury of stomach without perforation: NB91.53\\nIngestion injury of stomach with perforation: NB91.54\\nOther specified injury of stomach: NB91.5Y\\nInjury of stomach unspecified: NB91.5Z\\nInjury of duodenum: NB91.6\\nContusion of duodenum: NB91.60\\nLaceration of duodenum: NB91.61\\nPrimary blast injury of duodenum: NB91.62\\nPerforation of duodenum: NB91.63\\nOther specified injury of duodenum: NB91.6Y\\nInjury of duodenum unspecified: NB91.6Z\\nInjury of small intestine: NB91.7\\nContusion of small intestine: NB91.70\\nLaceration of small intestine: NB91.71\\nPrimary blast injury of small intestine: NB91.72\\nOther specified injury of small intestine: NB91.7Y\\nInjury of small intestine unspecified: NB91.7Z\\nInjury of colon: NB91.8\\nContusion of colon: NB91.80\\nLaceration of colon: NB91.81\\nPrimary blast injury of colon: NB91.82\\nOther specified injury of colon: NB91.8Y\\nInjury of colon unspecified: NB91.8Z\\nInjury of rectum: NB91.9\\nContusion of rectum: NB91.90\\nLaceration of rectum: NB91.91\\nPrimary blast injury of rectum: NB91.92\\nOther specified injury of rectum: NB91.9Y\\nInjury of rectum unspecified: NB91.9Z\\nInjury of mesentery: NB91.A\\nInjury of multiple intraabdominal organs: NB91.B\\nInjury of other specified intraabdominal organs: NB91.Y\\nInjury of intraabdominal organs unspecified: NB91.Z\\nInjury of urinary or pelvic organs: NB92\\nInjury of kidney: NB92.0\\nContusion of kidney minor: NB92.00\\nContusion of kidney major: NB92.01\\nLaceration of kidney minor: NB92.02\\nLaceration of kidney moderate: NB92.03\\nLaceration of kidney major: NB92.04\\nOther specified injury of kidney: NB92.0Y\\nInjury of kidney unspecified: NB92.0Z\\nInjury of ureter: NB92.1\\nContusion of ureter: NB92.10\\nLaceration of ureter: NB92.11\\nOther specified injury of ureter: NB92.1Y\\nInjury of ureter unspecified: NB92.1Z\\nInjury of bladder: NB92.2\\nContusion of bladder: NB92.20\\nLaceration of bladder: NB92.21\\nOther specified injury of bladder: NB92.2Y\\nInjury of bladder unspecified: NB92.2Z\\nInjury of urethra: NB92.3\\nContusion of urethra: NB92.30\\nLaceration of urethra: NB92.31\\nOther specified injury of urethra: NB92.3Y\\nInjury of urethra unspecified: NB92.3Z\\nInjury of ovary: NB92.4\\nContusion of ovary: NB92.40\\nLaceration of ovary: NB92.41\\nOther specified injury of ovary: NB92.4Y\\nInjury of ovary unspecified: NB92.4Z\\nInjury of fallopian tube: NB92.5\\nInjury of uterus: NB92.6\\nInjury of urinary tract: NB92.7\\nInjury of multiple pelvic organs: NB92.8\\nInjury of other specified pelvic organs: NB92.Y\\nInjury of urinary or pelvic organs unspecified: NB92.Z\\nCrushing injury or traumatic amputation of part of abdomen lower back or pelvis: NB93\\nCrushing injury of external genital organs: NB93.0\\nCrushing injury of penis: NB93.00\\nCrushing injury of testes or scrotum: NB93.01\\nCrushing injury of vulva: NB93.02\\nCrushing injury of external genital organs unspecified: NB93.0Z\\nCrushing injury of other or unspecified parts of abdomen lower back or pelvis: NB93.1\\nTraumatic amputation of external genital organs: NB93.2\\nTraumatic amputation of entire penis: NB93.20\\nTraumatic amputation of part of penis: NB93.21\\nTraumatic amputation of entire testis or scrotum: NB93.22\\nTraumatic amputation of part of testis or scrotum: NB93.23\\nTraumatic amputation of entire vulva: NB93.24\\nTraumatic amputation of part of vulva: NB93.25\\nTraumatic amputation of external genital organs unspecified: NB93.2Z\\nTraumatic amputation of other or unspecified parts of abdomen lower back or pelvis: NB93.3\\nInjury of muscle fascia or tendon of abdomen lower back or pelvis: NB94\\nStrain or sprain of muscle fascia or tendon of abdomen: NB94.0\\nStrain or sprain of muscle fascia or tendon of lower back: NB94.1\\nStrain or sprain of muscle fascia or tendon of pelvis: NB94.2\\nLaceration of muscle fascia or tendon of abdomen: NB94.3\\nLaceration of muscle fascia or tendon of lower back: NB94.4\\nLaceration of muscle fascia or tendon of pelvis: NB94.5\\nOther specified injury of muscle fascia or tendon of abdomen lower back or pelvis: NB94.Y\\nInjury of muscle fascia or tendon of abdomen lower back or pelvis unspecified: NB94.Z\\nInjury of intraabdominal organ with pelvic organ: NB95\\nOther multiple injuries of abdomen lower back or pelvis: NB96\\nCertain specified injuries of abdomen lower back or pelvis: NB97\\nRetroperitoneal haemorrhage or haematoma: NB97.0\\nFractured penis: NB97.1\\nInjury to female genital organ without specification of injury type: NB98\\nInjury to male genital organ without specification of injury type: NB99\\nOther specified injuries to the abdomen lower back lumbar spine or pelvis: NB9Y\\nInjuries to the abdomen lower back lumbar spine or pelvis unspecified: NB9Z\\nSuperficial injury of shoulder or upper arm: NC10\\nAbrasion of shoulder or upper arm: NC10.0\\nContusion of shoulder or upper arm: NC10.1\\nMultiple superficial injuries of shoulder or upper arm: NC10.2\\nOther specified superficial injury of shoulder or upper arm: NC10.Y\\nSuperficial injury of shoulder or upper arm unspecified: NC10.Z\\nOpen wound of shoulder or upper arm: NC11\\nLaceration without foreign body of shoulder or upper arm: NC11.0\\nLaceration with foreign body of shoulder or upper arm: NC11.1\\nPuncture wound without foreign body of shoulder or upper arm: NC11.2\\nPuncture wound with foreign body of shoulder or upper arm: NC11.3\\nOpen bite of shoulder or upper arm: NC11.4\\nMultiple open wounds of shoulder or upper arm: NC11.5\\nOther specified open wound of shoulder or upper arm: NC11.Y\\nOpen wound of shoulder or upper arm unspecified: NC11.Z\\nFracture of shoulder or upper arm: NC12\\nFracture of clavicle: NC12.0\\nFracture of sternal end of clavicle: NC12.00\\nFracture of shaft of clavicle: NC12.01\\nFracture of acromial end of clavicle: NC12.02\\nMultiple fractures of clavicle alone: NC12.03\\nOther specified fracture of clavicle: NC12.0Y\\nFracture of clavicle unspecified: NC12.0Z\\nFracture of scapula: NC12.1\\nMultiple fractures of scapula: NC12.10\\nOther specified fracture of scapula: NC12.1Y\\nFracture of scapula unspecified: NC12.1Z\\nFracture of upper end of humerus: NC12.2\\nFracture of upper end of humerus head: NC12.20\\nFracture of surgical neck of humerus: NC12.21\\nFracture of anatomical neck of humerus: NC12.22\\nFracture of greater tuberosity of humerus: NC12.23\\nFracture of lesser tuberosity of humerus: NC12.24\\nFracture of upper end of humerus unspecified site: NC12.2Z\\nFracture of shaft of humerus: NC12.3\\nFracture of lower end of humerus: NC12.4\\nSupracondylar fracture of humerus: NC12.40\\nFracture of lateral epicondyle of humerus: NC12.41\\nFracture of medial epicondyle of humerus: NC12.42\\nFracture of lateral condyle of humerus: NC12.43\\nFracture of medial condyle of humerus: NC12.44\\nOther specified fracture of lower end of humerus: NC12.4Y\\nFracture of lower end of humerus unspecified: NC12.4Z\\nMultiple fractures of clavicle scapula or humerus: NC12.5\\nOther specified fracture of shoulder or upper arm: NC12.Y\\nFracture of shoulder or upper arm unspecified: NC12.Z\\nDislocation or strain or sprain of joints or ligaments of shoulder girdle: NC13\\nDislocation of shoulder joint: NC13.0\\nDislocation of acromioclavicular joint: NC13.1\\nDislocation of sternoclavicular joint: NC13.2\\nDislocation of scapula: NC13.3\\nDislocation of other or unspecified parts of shoulder girdle: NC13.4\\nStrain or sprain of shoulder joint: NC13.5\\nStrain or sprain of acromioclavicular joint: NC13.6\\nStrain or sprain of sternoclavicular joint: NC13.7\\nStrain or sprain of other or unspecified parts of shoulder girdle: NC13.8\\nDislocation or sprain of other specified joints or ligaments of shoulder girdle: NC13.Y\\nDislocation or strain or sprain of joints or ligaments of shoulder girdle unspecified: NC13.Z\\nInjury of nerves at shoulder or upper arm level: NC14\\nInjury of ulnar nerve at upper arm level: NC14.0\\nInjury of median nerve at upper arm level: NC14.1\\nInjury of radial nerve at upper arm level: NC14.2\\nInjury of axillary nerve: NC14.3\\nInjury of musculocutaneous nerve: NC14.4\\nInjury of cutaneous sensory nerve at shoulder or upper arm level: NC14.5\\nInjury of multiple nerves at shoulder or upper arm level: NC14.6\\nInjury of other specified nerves at shoulder or upper arm level: NC14.Y\\nInjury of unspecified nerve at shoulder or upper arm level: NC14.Z\\nInjury of blood vessels at shoulder or upper arm level: NC15\\nInjury of axillary artery: NC15.0\\nLaceration of axillary artery: NC15.00\\nOther specified injury of axillary artery: NC15.0Y\\nInjury of axillary artery unspecified: NC15.0Z\\nInjury of brachial artery: NC15.1\\nLaceration of brachial artery: NC15.10\\nOther specified injury of brachial artery: NC15.1Y\\nInjury of brachial artery unspecified: NC15.1Z\\nInjury of axillary or brachial vein: NC15.2\\nLaceration of axillary or brachial vein: NC15.20\\nOther specified injury of axillary or brachial vein: NC15.2Y\\nInjury of axillary or brachial vein unspecified: NC15.2Z\\nInjury of superficial vein at shoulder or upper arm level: NC15.3\\nLaceration of superficial vein at shoulder or upper arm level: NC15.30\\nOther specified injury of superficial vein at shoulder or upper arm level: NC15.3Y\\nInjury of superficial vein at shoulder or upper arm level unspecified: NC15.3Z\\nInjury of multiple blood vessels at shoulder or upper arm level: NC15.4\\nInjury of other specified blood vessels at shoulder or upper arm level: NC15.Y\\nInjury of unspecified blood vessel at shoulder or upper arm level: NC15.Z\\nInjury of muscle fascia tendon or bursa at shoulder or upper arm level: NC16\\nInjury of muscle or tendon of the rotator cuff of shoulder: NC16.0\\nStrain or sprain of muscle or tendon of the rotator cuff of shoulder: NC16.00\\nLaceration of muscle or tendon of the rotator cuff of shoulder: NC16.01\\nOther specified injury of muscle or tendon of the rotator cuff of shoulder: NC16.0Y\\nInjury of muscle or tendon of the rotator cuff of shoulder unspecified: NC16.0Z\\nInjury of muscle fascia or tendon of long head of biceps: NC16.1\\nStrain or sprain of muscle fascia or tendon of long head of biceps: NC16.10\\nLaceration of muscle fascia or tendon of long head of biceps: NC16.11\\nOther specified injury of muscle fascia or tendon of long head of biceps: NC16.1Y\\nInjury of muscle fascia or tendon of long head of biceps unspecified: NC16.1Z\\nInjury of muscle fascia or tendon of other parts of biceps: NC16.2\\nStrain or sprain of muscle fascia or tendon of other parts of biceps: NC16.20\\nLaceration of muscle fascia or tendon of other parts of biceps: NC16.21\\nOther specified injury of muscle fascia or tendon of other parts of biceps: NC16.2Y\\nInjury of muscle fascia or tendon of other parts of biceps unspecified: NC16.2Z\\nInjury of muscle fascia or tendon of triceps: NC16.3\\nStrain or sprain of muscle fascia or tendon of triceps: NC16.30\\nLaceration of muscle fascia or tendon of triceps: NC16.31\\nOther specified injury of muscle fascia or tendon of triceps: NC16.3Y\\nInjury of muscle fascia or tendon of triceps unspecified: NC16.3Z\\nInjury of multiple muscles or tendons at shoulder or upper arm level: NC16.4\\nStrain or sprain of multiple muscles or tendons at shoulder or upper arm level: NC16.40\\nLaceration of multiple muscles or tendons at shoulder or upper arm level: NC16.41\\nOther specified injury of multiple muscles or tendons at shoulder or upper arm level: NC16.4Y\\nInjury of multiple muscles or tendons at shoulder or upper arm level unspecified: NC16.4Z\\nInjury of bursa of shoulder: NC16.5\\nInjury of other specified muscle fascia tendon or bursa at shoulder or upper arm level: NC16.Y\\nInjury of unspecified muscle fascia or tendon at shoulder or upper arm level: NC16.Z\\nCrushing injury of shoulder or upper arm: NC17\\nTraumatic amputation of shoulder or upper arm: NC18\\nTraumatic amputation at right shoulder joint: NC18.0\\nTraumatic amputation at left shoulder joint: NC18.1\\nTraumatic amputation at shoulder joint bilateral: NC18.2\\nTraumatic amputation at level between right shoulder and elbow: NC18.3\\nTraumatic amputation at level between left shoulder and elbow: NC18.4\\nTraumatic amputation at level between shoulder and elbow bilateral: NC18.5\\nTraumatic amputation of shoulder or upper arm unspecified: NC18.Z\\nMultiple injuries of shoulder or upper arm: NC19\\nOther specified injuries to the shoulder or upper arm: NC1Y\\nInjuries to the shoulder or upper arm unspecified: NC1Z\\nSuperficial injury of forearm: NC30\\nAbrasion of elbow: NC30.0\\nContusion of elbow: NC30.1\\nAbrasion of other or unspecified parts of forearm: NC30.2\\nContusion of other or unspecified parts of forearm: NC30.3\\nMultiple superficial injuries of forearm: NC30.4\\nOther specified superficial injury of forearm: NC30.Y\\nSuperficial injury of forearm unspecified: NC30.Z\\nOpen wound of forearm: NC31\\nLaceration without foreign body of forearm: NC31.0\\nLaceration with foreign body of forearm: NC31.1\\nPuncture wound without foreign body of forearm: NC31.2\\nPuncture wound with foreign body of forearm: NC31.3\\nOpen bite of forearm: NC31.4\\nMultiple open wounds of forearm: NC31.5\\nOther specified open wound of forearm: NC31.Y\\nOpen wound of forearm unspecified: NC31.Z\\nFracture of forearm: NC32\\nFracture of upper end of ulna: NC32.0\\nFracture of upper end of radius: NC32.1\\nFracture of shaft of ulna: NC32.2\\nFracture of shaft of radius: NC32.3\\nFracture of shafts of both ulna and radius: NC32.4\\nFracture of lower end of radius: NC32.5\\nFracture of lower end of radius dorsal tilt: NC32.50\\nFracture of lower end of radius volar tilt: NC32.51\\nOther specified fracture of lower end of radius: NC32.5Y\\nFracture of lower end of radius unspecified: NC32.5Z\\nFracture of lower end of both ulna and radius: NC32.6\\nMultiple fractures of forearm: NC32.7\\nFracture of other specified parts of forearm: NC32.Y\\nFracture of forearm unspecified: NC32.Z\\nDislocation or strain or sprain of joints or ligaments of elbow: NC33\\nDislocation of radial head: NC33.0\\nDislocation of elbow: NC33.1\\nTraumatic rupture of radial collateral ligament: NC33.2\\nTraumatic rupture of ulnar collateral ligament: NC33.3\\nStrain or sprain of elbow: NC33.4\\nDislocation or sprain of other specified joints or ligaments of elbow: NC33.Y\\nDislocation or strain or sprain of joints or ligaments of elbow unspecified: NC33.Z\\nInjury of nerves at forearm level: NC34\\nInjury of ulnar nerve at forearm level: NC34.0\\nInjury of median nerve at forearm level: NC34.1\\nInjury of radial nerve at forearm level: NC34.2\\nInjury of cutaneous sensory nerve at forearm level: NC34.3\\nInjury of multiple nerves at forearm level: NC34.4\\nInjury of other specified nerves at forearm level: NC34.Y\\nInjury of unspecified nerve at forearm level: NC34.Z\\nInjury of blood vessels at forearm level: NC35\\nInjury of ulnar artery at forearm level: NC35.0\\nLaceration of ulnar artery at forearm level: NC35.00\\nOther specified injury of ulnar artery at forearm level: NC35.0Y\\nInjury of ulnar artery at forearm level unspecified: NC35.0Z\\nInjury of radial artery at forearm level: NC35.1\\nLaceration of radial artery at forearm level: NC35.10\\nOther specified injury of radial artery at forearm level: NC35.1Y\\nInjury of radial artery at forearm level unspecified: NC35.1Z\\nInjury of vein at forearm level: NC35.2\\nLaceration of vein at forearm level: NC35.20\\nOther specified injury of vein at forearm level: NC35.2Y\\nInjury of vein at forearm level unspecified: NC35.2Z\\nInjury of multiple blood vessels at forearm level: NC35.3\\nInjury of other specified blood vessels at forearm level: NC35.Y\\nInjury of unspecified blood vessel at forearm level: NC35.Z\\nInjury of muscle fascia tendon or bursa at forearm level: NC36\\nInjury of flexor muscle fascia or tendon of thumb at forearm level: NC36.0\\nStrain or sprain of flexor muscle fascia or tendon of thumb at forearm level: NC36.00\\nLaceration of flexor muscle fascia or tendon of thumb at forearm level: NC36.01\\nOther specified injury of flexor muscle fascia or tendon of thumb at forearm level: NC36.0Y\\nInjury of flexor muscle fascia or tendon of thumb at forearm level unspecified: NC36.0Z\\nInjury of long flexor muscle fascia or tendon of other finger at forearm level: NC36.1\\nStrain or sprain of long flexor muscle fascia or tendon of other finger at forearm level: NC36.10\\nLaceration of long flexor muscle fascia or tendon of other finger at forearm level: NC36.11\\nOther specified injury of long flexor muscle fascia or tendon of other finger at forearm level: NC36.1Y\\nInjury of long flexor muscle fascia or tendon of other finger at forearm level unspecified: NC36.1Z\\nInjury of other flexor muscle fascia or tendon at forearm level: NC36.2\\nStrain or sprain of other flexor muscle fascia or tendon at forearm level: NC36.20\\nLaceration of other flexor muscle fascia or tendon at forearm level: NC36.21\\nOther specified injury of other flexor muscle fascia or tendon at forearm level: NC36.2Y\\nInjury of other flexor muscle fascia or tendon at forearm level unspecified: NC36.2Z\\nInjury of extensor or abductor muscles or tendons of thumb at forearm level: NC36.3\\nStrain or sprain of extensor or abductor muscles or tendons of thumb at forearm level: NC36.30\\nLaceration of extensor or abductor muscles or tendons of thumb at forearm level: NC36.31\\nOther specified injury of extensor or abductor muscles or tendons of thumb at forearm level: NC36.3Y\\nInjury of extensor or abductor muscles or tendons of thumb at forearm level unspecified: NC36.3Z\\nInjury of extensor muscle fascia or tendon of other finger at forearm level: NC36.4\\nStrain or sprain of extensor muscle fascia or tendon of other finger at forearm level: NC36.40\\nLaceration of extensor muscle fascia or tendon of other finger at forearm level: NC36.41\\nOther specified injury of extensor muscle fascia or tendon of other finger at forearm level: NC36.4Y\\nInjury of extensor muscle fascia or tendon of other finger at forearm level unspecified: NC36.4Z\\nInjury of other extensor muscle fascia or tendon at forearm level: NC36.5\\nStrain or sprain of other extensor muscle fascia or tendon at forearm level: NC36.50\\nLaceration of other extensor muscle fascia or tendon at forearm level: NC36.51\\nOther specified injury of other extensor muscle fascia or tendon at forearm level: NC36.5Y\\nInjury of other extensor muscle fascia or tendon at forearm level unspecified: NC36.5Z\\nInjury of multiple muscles or tendons at forearm level: NC36.6\\nInjury of bursa of elbow: NC36.7\\nInjury of other specified muscle fascia tendon or bursa at forearm level: NC36.Y\\nInjury of unspecified muscle fascia tendon or bursa at forearm level: NC36.Z\\nCrushing injury of forearm: NC37\\nCrushing injury of elbow: NC37.0\\nCrushing injury of other specified part of forearm: NC37.Y\\nCrushing injury of forearm unspecified: NC37.Z\\nTraumatic amputation of forearm: NC38\\nTraumatic amputation at right elbow level: NC38.0\\nTraumatic amputation at left elbow level: NC38.1\\nTraumatic amputation at elbow level bilateral: NC38.2\\nTraumatic amputation at level between right elbow and wrist: NC38.3\\nTraumatic amputation at level between left elbow and wrist: NC38.4\\nTraumatic amputation between elbow and wrist bilateral: NC38.5\\nTraumatic amputation of forearm unspecified: NC38.Z\\nMultiple injuries of forearm: NC39\\nOther specified injuries to the elbow or forearm: NC3Y\\nInjuries to the elbow or forearm unspecified: NC3Z\\nInjury to fingernail: NC50\\nSuperficial injury of wrist or hand: NC51\\nSuperficial injury of finger or thumb: NC51.0\\nAbrasion of finger or thumb: NC51.00\\nContusion of finger or thumb: NC51.01\\nOther specified superficial injury of finger or thumb: NC51.0Y\\nSuperficial injury of finger or thumb unspecified: NC51.0Z\\nSuperficial injury of other parts of wrist or hand: NC51.1\\nContusion of other parts of wrist or hand: NC51.10\\nNonvenomous insect bite of other parts of wrist or hand: NC51.11\\nOther specified superficial injury of other parts of wrist or hand: NC51.1Y\\nSuperficial injury of other parts of wrist or hand unspecified: NC51.1Z\\nMultiple superficial injuries of wrist or hand: NC51.2\\nOpen wound of wrist or hand: NC52\\nOpen wound of finger or thumb: NC52.0\\nLaceration without foreign body of finger or thumb: NC52.00\\nLaceration with foreign body of finger or thumb: NC52.01\\nPuncture wound without foreign body of finger or thumb: NC52.02\\nPuncture wound with foreign body of finger or thumb: NC52.03\\nOpen bite of finger or thumb: NC52.04\\nOther specified open wound of finger or thumb: NC52.0Y\\nOpen wound of finger or thumb unspecified: NC52.0Z\\nOpen wound of other parts of wrist or hand: NC52.1\\nLaceration without foreign body of other parts of wrist or hand: NC52.10\\nLaceration with foreign body of other parts of wrist or hand: NC52.11\\nPuncture wound with foreign body of other parts of wrist or hand: NC52.12\\nPuncture wound without foreign body of other parts of wrist or hand: NC52.13\\nOpen bite of other parts of wrist or hand: NC52.14\\nOther specified open wound of other parts of wrist or hand: NC52.1Y\\nOpen wound of other parts of wrist or hand unspecified: NC52.1Z\\nMultiple open wounds of wrist or hand: NC52.2\\nFracture at wrist or hand level: NC53\\nFracture of scaphoid bone of hand: NC53.0\\nFracture of other carpal bone: NC53.1\\nFracture of first metacarpal bone: NC53.2\\nFracture of other metacarpal bone: NC53.3\\nFracture of shaft of other metacarpal bone: NC53.30\\nFracture of neck of other metacarpal bone: NC53.31\\nFracture of other specified part of other metacarpal bone: NC53.3Y\\nFracture of other metacarpal bone unspecified: NC53.3Z\\nMultiple fractures of metacarpal bones: NC53.4\\nFracture of thumb bone: NC53.5\\nFracture of other finger bone: NC53.6\\nFracture of index finger: NC53.60\\nFracture of middle finger: NC53.61\\nFracture of ring finger: NC53.62\\nFracture of little finger: NC53.63\\nOther specified fracture of other finger bone: NC53.6Y\\nFracture of other finger bone unspecified: NC53.6Z\\nMultiple fractures of fingers: NC53.7\\nFracture at other specified part of wrist or hand level: NC53.Y\\nFracture at wrist or hand level unspecified: NC53.Z\\nDislocation or strain or sprain of joints or ligaments at wrist or hand level: NC54\\nDislocation of wrist: NC54.0\\nDislocation of distal radioulnar joint: NC54.00\\nDislocation of radiocarpal joint: NC54.01\\nDislocation of midcarpal joint: NC54.02\\nDislocation of carpometacarpal joint of thumb: NC54.03\\nDislocation of other carpometacarpal joint: NC54.04\\nDislocation of metacarpal bone proximal end: NC54.05\\nDislocation of other specified part of wrist: NC54.0Y\\nDislocation of wrist unspecified: NC54.0Z\\nDislocation of thumb: NC54.1\\nDislocation of metacarpophalangeal joint of thumb: NC54.10\\nDislocation of interphalangeal joint of thumb: NC54.11\\nDislocation of other specified part of thumb: NC54.1Y\\nDislocation of thumb unspecified: NC54.1Z\\nDislocation of finger: NC54.2\\nDislocation of metacarpophalangeal joint of finger: NC54.20\\nDislocation of interphalangeal joint of finger: NC54.21\\nDislocation of other specified part of finger: NC54.2Y\\nDislocation of finger unspecified: NC54.2Z\\nMultiple dislocations of fingers: NC54.3\\nTraumatic rupture of ligament of wrist or carpus: NC54.4\\nTraumatic rupture of scapholunate ligament: NC54.40\\nTraumatic rupture of radiocarpal ligament: NC54.41\\nTraumatic rupture of ulnocarpal ligament: NC54.42\\nTraumatic rupture of lunotriquetral ligament: NC54.43\\nTraumatic rupture of other specified ligament of wrist or carpus: NC54.4Y\\nTraumatic rupture of ligament of wrist or carpus unspecified: NC54.4Z\\nTraumatic rupture of ligament of finger at metacarpophalangeal or interphalangeal joint: NC54.5\\nTraumatic rupture of collateral ligament of finger at metacarpophalangeal or interphalangeal joint: NC54.50\\nTraumatic rupture of palmar ligament of finger at metacarpophalangeal or interphalangeal joint: NC54.51\\nTraumatic rupture of volar plate of finger at metacarpophalangeal or interphalangeal joint: NC54.52\\nTraumatic rupture of other ligament of finger at metacarpophalangeal or interphalangeal joint: NC54.53\\nTraumatic rupture of ligament of finger at metacarpophalangeal or interphalangeal joint unspecified: NC54.5Z\\nStrain or sprain of wrist: NC54.6\\nStrain or sprain of carpal joint: NC54.60\\nStrain or sprain of radiocarpal joint: NC54.61\\nStrain or sprain of carpometacarpal joint: NC54.62\\nSprain of other specified part of wrist: NC54.6Y\\nStrain or sprain of wrist unspecified: NC54.6Z\\nStrain or sprain of thumb: NC54.7\\nStrain or sprain of metacarpophalangeal joint of thumb: NC54.70\\nStrain or sprain of interphalangeal joint of thumb: NC54.71\\nSprain or strain of other specified part of thumb: NC54.7Y\\nStrain or sprain of thumb unspecified: NC54.7Z\\nStrain or sprain of finger: NC54.8\\nStrain or sprain of metacarpophalangeal joint of finger: NC54.80\\nStrain or sprain of interphalangeal joint of finger: NC54.81\\nSprain of other specified part of finger: NC54.8Y\\nStrain or sprain of finger unspecified: NC54.8Z\\nDislocation or sprain of other specified joints or ligaments at wrist or hand level: NC54.Y\\nDislocation or strain or sprain of joints or ligaments at wrist or hand level unspecified: NC54.Z\\nInjury of nerves at wrist or hand level: NC55\\nInjury of ulnar nerve at wrist or hand level: NC55.0\\nInjury of median nerve at wrist or hand level: NC55.1\\nInjury of radial nerve at wrist or hand level: NC55.2\\nInjury of multiple nerves at wrist or hand level: NC55.3\\nInjury of other specified nerves at wrist or hand level: NC55.Y\\nInjury of unspecified nerve at wrist or hand level: NC55.Z\\nInjury of blood vessels at wrist or hand level: NC56\\nInjury of ulnar artery at wrist or hand level: NC56.0\\nLaceration of ulnar artery at wrist or hand level: NC56.00\\nContusion of ulnar artery at wrist or hand level: NC56.01\\nOther specified injury of ulnar artery at wrist or hand level: NC56.0Y\\nInjury of ulnar artery at wrist or hand level unspecified: NC56.0Z\\nInjury of radial artery at wrist or hand level: NC56.1\\nLaceration of radial artery at wrist or hand level: NC56.10\\nContusion of radial artery at wrist or hand level: NC56.11\\nOther specified injury of radial artery at wrist or hand level: NC56.1Y\\nInjury of radial artery at wrist or hand level unspecified: NC56.1Z\\nInjury of superficial palmar arch: NC56.2\\nLaceration of superficial palmar arch: NC56.20\\nContusion of superficial palmar arch: NC56.21\\nOther specified injury of superficial palmar arch: NC56.2Y\\nInjury of superficial palmar arch unspecified: NC56.2Z\\nInjury of deep palmar arch: NC56.3\\nLaceration of deep palmar arch: NC56.30\\nContusion of deep palmar arch: NC56.31\\nOther specified injury of deep palmar arch: NC56.3Y\\nInjury of deep palmar arch unspecified: NC56.3Z\\nInjury of blood vessel of thumb: NC56.4\\nLaceration of blood vessel of thumb: NC56.40\\nContusion of blood vessel of thumb: NC56.41\\nOther specified injury of blood vessel of thumb: NC56.4Y\\nInjury of blood vessel of thumb unspecified: NC56.4Z\\nInjury of blood vessel of other finger: NC56.5\\nLaceration of blood vessel of other finger: NC56.50\\nContusion of blood vessel of other finger: NC56.51\\nOther specified injury of blood vessel of other finger: NC56.5Y\\nInjury of blood vessel of other finger unspecified: NC56.5Z\\nInjury of multiple blood vessels at wrist or hand level: NC56.6\\nLaceration of multiple blood vessels at wrist or hand level: NC56.60\\nContusion of multiple blood vessels at wrist or hand level: NC56.61\\nOther specified injury of multiple blood vessels at wrist or hand level: NC56.6Y\\nInjury of multiple blood vessels at wrist or hand level unspecified: NC56.6Z\\nInjury of other specified blood vessels at wrist or hand level: NC56.Y\\nInjury of unspecified blood vessel at wrist or hand level: NC56.Z\\nInjury of muscle fascia or tendon at wrist or hand level: NC57\\nInjury of long flexor muscle fascia or tendon of thumb at wrist or hand level: NC57.0\\nStrain or sprain of long flexor muscle fascia or tendon of thumb at wrist or hand level: NC57.00\\nLaceration of long flexor muscle fascia or tendon of thumb at wrist or hand level: NC57.01\\nOther specified injury of long flexor muscle fascia or tendon of thumb at wrist or hand level: NC57.0Y\\nInjury of long flexor muscle fascia or tendon of thumb at wrist or hand level unspecified: NC57.0Z\\nInjury of flexor muscle fascia or tendon of other finger at wrist or hand level: NC57.1\\nStrain or sprain of flexor muscle fascia or tendon of other finger at wrist or hand level: NC57.10\\nLaceration of flexor muscle fascia or tendon of other finger at wrist or hand level: NC57.11\\nOther specified injury of flexor muscle fascia or tendon of other finger at wrist or hand level: NC57.1Y\\nInjury of flexor muscle fascia or tendon of other finger at wrist or hand level unspecified: NC57.1Z\\nInjury of extensor muscle fascia or tendon of thumb at wrist or hand level: NC57.2\\nStrain or sprain of extensor muscle fascia or tendon of thumb at wrist or hand level: NC57.20\\nLaceration of extensor muscle fascia or tendon of thumb at wrist or hand level: NC57.21\\nOther specified injury of extensor muscle fascia or tendon of thumb at wrist or hand level: NC57.2Y\\nInjury of extensor muscle fascia or tendon of thumb at wrist or hand level unspecified: NC57.2Z\\nInjury of extensor muscle fascia or tendon of other finger at wrist or hand level: NC57.3\\nStrain or sprain of extensor muscle fascia or tendon of other finger at wrist or hand level: NC57.30\\nLaceration of extensor muscle fascia or tendon of other finger at wrist or hand level: NC57.31\\nOther specified injury of extensor muscle fascia or tendon of other finger at wrist or hand level: NC57.3Y\\nInjury of extensor muscle fascia or tendon of other finger at wrist or hand level unspecified: NC57.3Z\\nInjury of intrinsic muscle fascia or tendon of thumb at wrist or hand level: NC57.4\\nStrain or sprain of intrinsic muscle fascia or tendon of thumb at wrist or hand level: NC57.40\\nLaceration of intrinsic muscle fascia or tendon of thumb at wrist or hand level: NC57.41\\nOther specified injury of intrinsic muscle fascia or tendon of thumb at wrist or hand level: NC57.4Y\\nInjury of intrinsic muscle fascia or tendon of thumb at wrist or hand level unspecified: NC57.4Z\\nInjury of intrinsic muscle fascia or tendon of other finger at wrist or hand level: NC57.5\\nStrain or sprain of intrinsic muscle fascia or tendon of other finger at wrist or hand level: NC57.50\\nLaceration of intrinsic muscle fascia or tendon of other finger at wrist or hand level: NC57.51\\nOther specified injury of intrinsic muscle fascia or tendon of other finger at wrist or hand level: NC57.5Y\\nInjury of intrinsic muscle fascia or tendon of other finger at wrist or hand level unspecified: NC57.5Z\\nInjury of multiple flexor muscles or tendons at wrist or hand level: NC57.6\\nInjury of multiple extensor muscles or tendons at wrist or hand level: NC57.7\\nInjury of other specified muscle fascia or tendon at wrist or hand level: NC57.Y\\nInjury of unspecified muscle fascia or tendon at wrist or hand level: NC57.Z\\nCrushing injury of wrist or hand: NC58\\nCrushing injury of thumb: NC58.0\\nCrushing injury of other finger: NC58.1\\nCrushing injury of hand: NC58.2\\nCrushing injury of wrist: NC58.3\\nCrushing injury of other specified part of wrist or hand: NC58.Y\\nCrushing injury of wrist or hand unspecified: NC58.Z\\nTraumatic amputation of wrist or hand: NC59\\nTraumatic amputation of thumb: NC59.0\\nTraumatic amputation at or near base of right thumb: NC59.00\\nTraumatic amputation at or near base of left thumb: NC59.01\\nTraumatic amputation at or near base of thumb bilateral: NC59.02\\nOther specified traumatic amputation of thumb: NC59.0Y\\nTraumatic amputation of thumb unspecified: NC59.0Z\\nTraumatic amputation of other single finger: NC59.1\\nTraumatic amputation of two or more fingers alone: NC59.2\\nTraumatic amputation of two or more fingers at or near base right hand: NC59.20\\nTraumatic amputation of two or more fingers at or near base left hand: NC59.21\\nTraumatic amputation of two or more fingers alone at or near base bilateral: NC59.22\\nOther specified traumatic amputation of two or more fingers alone: NC59.2Y\\nTraumatic amputation of two or more fingers alone unspecified: NC59.2Z\\nCombined traumatic amputation of finger with other parts of wrist or hand: NC59.3\\nTraumatic amputation of hand at metacarpal level: NC59.4\\nTraumatic amputation of wrist or hand unspecified: NC59.Z\\nMultiple injuries of wrist or hand: NC5A\\nInjury of multiple sites of hand: NC5A.0\\nInjury of multiple sites of wrist: NC5A.1\\nOther specified multiple injuries of wrist or hand: NC5A.Y\\nMultiple injuries of wrist or hand unspecified: NC5A.Z\\nOther specified injuries to the wrist or hand: NC5Y\\nInjuries to the wrist or hand unspecified: NC5Z\\nSuperficial injury of hip or thigh: NC70\\nAbrasion of hip: NC70.0\\nContusion of hip: NC70.1\\nAbrasion of thigh: NC70.2\\nContusion of thigh: NC70.3\\nMultiple superficial injuries of hip or thigh: NC70.4\\nOther specified superficial injury of hip or thigh: NC70.Y\\nSuperficial injury of hip or thigh unspecified: NC70.Z\\nOpen wound of hip or thigh: NC71\\nLaceration without foreign body of hip or thigh: NC71.0\\nLaceration with foreign body of hip or thigh: NC71.1\\nPuncture wound without foreign body of hip or thigh: NC71.2\\nPuncture wound with foreign body of hip or thigh: NC71.3\\nOpen bite of hip or thigh: NC71.4\\nMultiple open wounds of hip or thigh: NC71.5\\nOther specified open wound of hip or thigh: NC71.Y\\nOpen wound of hip or thigh unspecified: NC71.Z\\nFracture of femur: NC72\\nFracture of head of femur: NC72.0\\nFracture of upper epiphysis of femur: NC72.1\\nFracture of neck of femur: NC72.2\\nFracture of neck of femur subcapital: NC72.20\\nFracture of neck of femur midcervical: NC72.21\\nFracture of base of neck of femur: NC72.22\\nIntracapsular fracture of femur: NC72.23\\nOther specified fracture of neck of femur: NC72.2Y\\nFracture of neck of femur unspecified: NC72.2Z\\nFracture of trochanteric section of femur: NC72.3\\nIntertrochanteric fracture of femur: NC72.30\\nPertrochanteric fracture of femur: NC72.31\\nFracture of other specified trochanteric section of femur: NC72.3Y\\nFracture of unspecified trochanteric section of femur: NC72.3Z\\nSubtrochanteric fracture of femur: NC72.4\\nFracture of shaft of femur: NC72.5\\nFracture of lower end of femur: NC72.6\\nFracture of lower end of femur not extending into joint simple: NC72.60\\nFracture of lower end of femur not extending into joint wedge: NC72.61\\nFracture of lower end of femur not extending into joint complex: NC72.62\\nFracture of lower end of femur extending into joint lateral condyle: NC72.63\\nFracture of lower end of femur extending into joint medial condyle: NC72.64\\nFracture of lower end of femur extending into joint frontal: NC72.65\\nFracture of lower end of femur extending into joint complete articular: NC72.66\\nOther specified fracture of lower end of femur: NC72.6Y\\nFracture of lower end of femur unspecified: NC72.6Z\\nMultiple fractures of femur: NC72.7\\nFractures of other parts of femur: NC72.8\\nOther specified fracture of femur: NC72.Y\\nFracture of femur unspecified: NC72.Z\\nDislocation or strain or sprain of joint or ligaments of hip: NC73\\nDislocation of hip: NC73.0\\nPosterior dislocation of hip: NC73.00\\nObturator dislocation of hip: NC73.01\\nOther anterior dislocation of hip: NC73.02\\nCentral dislocation of hip: NC73.03\\nOther specified dislocation of hip: NC73.0Y\\nDislocation of hip unspecified: NC73.0Z\\nStrain or sprain of hip: NC73.1\\nIliofemoral ligament strain or sprain of hip: NC73.10\\nIschiocapsular ligament strain or sprain of hip: NC73.11\\nOther specified strain or sprain of hip: NC73.1Y\\nStrain or sprain of hip unspecified: NC73.1Z\\nInjury of nerves at hip or thigh level: NC74\\nInjury of sciatic nerve at hip or thigh level: NC74.0\\nInjury of femoral nerve at hip or thigh level: NC74.1\\nInjury of cutaneous sensory nerve at hip or thigh level: NC74.2\\nInjury of multiple nerves at hip or thigh level: NC74.3\\nInjury of other specified nerves at hip or thigh level: NC74.Y\\nInjury of unspecified nerve at hip or thigh level: NC74.Z\\nInjury of blood vessels at hip or thigh level: NC75\\nInjury of femoral artery: NC75.0\\nLaceration of femoral artery minor: NC75.00\\nLaceration of femoral artery major: NC75.01\\nOther specified injury of femoral artery: NC75.0Y\\nInjury of femoral artery unspecified: NC75.0Z\\nInjury of femoral vein at hip or thigh level: NC75.1\\nLaceration of femoral vein at hip or thigh level minor: NC75.10\\nLaceration of femoral vein at hip or thigh level major: NC75.11\\nOther specified injury of femoral vein at hip or thigh level: NC75.1Y\\nInjury of femoral vein at hip or thigh level unspecified: NC75.1Z\\nInjury of greater saphenous vein at hip or thigh level: NC75.2\\nLaceration of greater saphenous vein at hip or thigh level minor: NC75.20\\nLaceration of greater saphenous vein at hip or thigh level major: NC75.21\\nOther specified injury of greater saphenous vein at hip or thigh level: NC75.2Y\\nInjury of greater saphenous vein at hip or thigh level unspecified: NC75.2Z\\nInjury of multiple blood vessels at hip or thigh level: NC75.3\\nInjury of other specified blood vessels at hip or thigh level: NC75.Y\\nInjury of unspecified blood vessel at hip or thigh level: NC75.Z\\nInjury of muscle fascia tendon or bursa at hip or thigh level: NC76\\nInjury of muscle fascia or tendon of hip: NC76.0\\nStrain or sprain of muscle fascia or tendon of hip: NC76.00\\nLaceration of muscle fascia or tendon of hip: NC76.01\\nOther specified injury of muscle fascia or tendon of hip: NC76.0Y\\nInjury of muscle fascia or tendon of hip unspecified: NC76.0Z\\nInjury of quadriceps muscle or tendon: NC76.1\\nStrain or sprain of quadriceps muscle or tendon: NC76.10\\nLaceration of quadriceps muscle or tendon: NC76.11\\nOther specified injury of quadriceps muscle or tendon: NC76.1Y\\nInjury of quadriceps muscle or tendon unspecified: NC76.1Z\\nInjury of adductor muscle fascia or tendon of thigh: NC76.2\\nStrain or sprain of adductor muscle fascia or tendon of thigh: NC76.20\\nLaceration of adductor muscle fascia or tendon of thigh: NC76.21\\nOther specified injury of adductor muscle fascia or tendon of thigh: NC76.2Y\\nInjury of adductor muscle fascia or tendon of thigh unspecified: NC76.2Z\\nInjury of muscle fascia or tendon of the posterior muscle group at thigh level: NC76.3\\nStrain or sprain of muscle fascia or tendon of the posterior muscle group at thigh level: NC76.30\\nLaceration of muscle fascia or tendon of the posterior muscle group at thigh level: NC76.31\\nOther specified injury of muscle fascia or tendon of the posterior muscle group at thigh level: NC76.3Y\\nInjury of muscle fascia or tendon of the posterior muscle group at thigh level unspecified: NC76.3Z\\nInjury of multiple muscles or tendons at hip or thigh level: NC76.4\\nInjury of bursa of hip: NC76.40\\nOther specified injury of multiple muscles or tendons at hip or thigh level: NC76.4Y\\nInjury of multiple muscles or tendons at hip or thigh level unspecified: NC76.4Z\\nInjury of other specified muscle fascia tendon or bursa at hip or thigh level: NC76.Y\\nInjury of unspecified muscle fascia tendon or bursa at hip or thigh level: NC76.Z\\nCrushing injury of hip or thigh: NC77\\nCrushing injury of hip: NC77.0\\nCrushing injury of thigh: NC77.1\\nCrushing injury of hip with thigh: NC77.2\\nCrushing injury of hip or thigh unspecified: NC77.Z\\nTraumatic amputation of hip or thigh: NC78\\nTraumatic amputation at right hip joint: NC78.0\\nTraumatic amputation at left hip joint: NC78.1\\nTraumatic amputation at hip joint bilateral: NC78.2\\nTraumatic amputation at level between right hip and knee: NC78.3\\nTraumatic amputation at level between left hip and knee: NC78.4\\nTraumatic amputation at level between hip and knee bilateral: NC78.5\\nTraumatic amputation of hip or thigh unspecified: NC78.Z\\nMultiple injuries of hip or thigh: NC79\\nOther specified injuries to the hip or thigh: NC7Y\\nInjuries to the hip or thigh unspecified: NC7Z\\nSuperficial injury of knee or lower leg: NC90\\nAbrasion of knee: NC90.0\\nContusion of knee: NC90.1\\nAbrasion of other or unspecified parts of lower leg: NC90.2\\nContusion of other or unspecified parts of lower leg: NC90.3\\nMultiple superficial injuries of lower leg: NC90.4\\nOther specified superficial injury of knee or lower leg: NC90.Y\\nSuperficial injury of knee or lower leg unspecified: NC90.Z\\nOpen wound of knee or lower leg: NC91\\nLaceration without foreign body of lower leg: NC91.0\\nLaceration with foreign body of lower leg: NC91.1\\nPuncture wound without foreign body of lower leg: NC91.2\\nPuncture wound with foreign body of lower leg: NC91.3\\nOpen bite of lower leg: NC91.4\\nMultiple open wounds of lower leg: NC91.5\\nOther specified open wound of knee or lower leg: NC91.Y\\nOpen wound of knee or lower leg unspecified: NC91.Z\\nFracture of lower leg including ankle: NC92\\nFracture of patella: NC92.0\\nFracture of upper end of tibia: NC92.1\\nAvulsion of cruciate ligament insertion: NC92.10\\nAvulsion of tibial tuberosity: NC92.11\\nMetaphyseal fracture of upper end of tibia: NC92.12\\nFracture of upper end of tibia lateral condyle: NC92.13\\nFracture of upper end of tibia medial condyle: NC92.14\\nOther specified fracture of upper end of tibia: NC92.1Y\\nFracture of upper end of tibia unspecified: NC92.1Z\\nFracture of shaft of tibia: NC92.2\\nFracture of lower end of tibia: NC92.3\\nFracture of fibula: NC92.4\\nAvulsion of fibular head: NC92.40\\nOther specified fracture of fibula: NC92.4Y\\nFracture of fibula unspecified: NC92.4Z\\nFracture of medial malleolus: NC92.5\\nFracture of lateral malleolus: NC92.6\\nComplex fractures of ankle: NC92.7\\nFracture avulsion or collateral ligament rupture of lateral malleolus below syndesmosis with fracture avulsion or collateral ligament rupture of medial malleolus: NC92.70\\nFracture avulsion or collateral ligament rupture of lateral malleolus below syndesmosis with fracture avulsion or collateral ligament rupture of medial malleolus and fracture of posterior margin of distal tibia: NC92.71\\nFracture of lateral malleolus at syndesmosis with fracture avulsion or collateral ligament rupture of medial malleolus: NC92.72\\nFracture of lateral malleolus at syndesmosis with fracture avulsion or collateral ligament rupture of medial malleolus and fracture of posterior margin of distal tibia: NC92.73\\nFracture avulsion or collateral ligament rupture of medial malleolus with fracture of fibula above syndesmosis: NC92.74\\nFracture avulsion or collateral ligament rupture of medial malleolus with fracture of fibula above syndesmosis and fracture of posterior margin of distal tibia: NC92.75\\nBimalleolar fracture of ankle not otherwise specified: NC92.76\\nTrimalleolar fracture of ankle not otherwise specified: NC92.77\\nOther specified complex fractures of ankle: NC92.7Y\\nComplex fractures of ankle unspecified: NC92.7Z\\nMultiple fractures of lower leg: NC92.8\\nFracture of other specified part of lower leg including ankle: NC92.Y\\nFracture of lower leg including ankle unspecified: NC92.Z\\nDislocation or strain or sprain of joints or ligaments of knee: NC93\\nAcute internal damage of knee: NC93.0\\nDislocation of patella: NC93.1\\nLateral dislocation of patella: NC93.10\\nOther specified dislocation of patella: NC93.1Y\\nDislocation of patella unspecified: NC93.1Z\\nDislocation of knee: NC93.2\\nAnterior dislocation of proximal end of tibia: NC93.20\\nPosterior dislocation of proximal end of tibia: NC93.21\\nMedial dislocation of proximal end of tibia: NC93.22\\nLateral dislocation of proximal end of tibia: NC93.23\\nOther specified dislocation of knee: NC93.2Y\\nDislocation of knee unspecified: NC93.2Z\\nTear of meniscus current: NC93.3\\nTear of medial meniscus: NC93.30\\nTear of lateral meniscus: NC93.31\\nOther specified tear of meniscus current: NC93.3Y\\nTear of meniscus current unspecified: NC93.3Z\\nTear of articular cartilage of knee: NC93.4\\nStrain or sprain involving fibular or tibial collateral ligament of knee: NC93.5\\nStrain or sprain of medial collateral ligament of knee excluding rupture: NC93.50\\nStrain or sprain of lateral collateral ligament of knee excluding rupture: NC93.51\\nRupture of medial collateral ligament of knee: NC93.52\\nRupture of lateral collateral ligament of knee: NC93.53\\nOther specified strain or sprain involving fibular or tibial collateral ligament of knee: NC93.5Y\\nStrain or sprain involving fibular or tibial collateral ligament of knee unspecified: NC93.5Z\\nStrain or sprain involving anterior or posterior cruciate ligament of knee: NC93.6\\nStrain or sprain of anterior cruciate ligament of knee excluding rupture: NC93.60\\nStrain or sprain of posterior cruciate ligament of knee excluding rupture: NC93.61\\nRupture of anterior cruciate ligament: NC93.62\\nRupture of posterior cruciate ligament: NC93.63\\nOther specified strain or sprain involving anterior or posterior cruciate ligament of knee: NC93.6Y\\nStrain or sprain involving anterior or posterior cruciate ligament of knee unspecified: NC93.6Z\\nStrain or sprain of other or unspecified parts of knee: NC93.7\\nInjury to multiple structures of knee: NC93.8\\nOther specified dislocation or strain or sprain of joints or ligaments of knee: NC93.Y\\nDislocation or strain or sprain of joints or ligaments of knee unspecified: NC93.Z\\nInjury of nerves at lower leg level: NC94\\nInjury of tibial nerve at lower leg level: NC94.0\\nInjury of peroneal nerve at lower leg level: NC94.1\\nInjury of cutaneous sensory nerve at lower leg level: NC94.2\\nInjury of multiple nerves at lower leg level: NC94.3\\nInjury of other specified nerves at lower leg level: NC94.Y\\nInjury of unspecified nerve at lower leg level: NC94.Z\\nInjury of blood vessels at lower leg level: NC95\\nInjury of popliteal artery: NC95.0\\nLaceration of popliteal artery: NC95.00\\nOther specified injury of popliteal artery: NC95.0Y\\nInjury of popliteal artery unspecified: NC95.0Z\\nInjury of anterior tibial artery: NC95.1\\nLaceration of anterior tibial artery: NC95.10\\nOther specified injury of anterior tibial artery: NC95.1Y\\nInjury of anterior tibial artery unspecified: NC95.1Z\\nInjury of posterior tibial artery: NC95.2\\nLaceration of posterior tibial artery: NC95.20\\nOther specified injury of posterior tibial artery: NC95.2Y\\nInjury of posterior tibial artery unspecified: NC95.2Z\\nInjury of peroneal artery: NC95.3\\nLaceration of peroneal artery: NC95.30\\nOther specified injury of peroneal artery: NC95.3Y\\nInjury of peroneal artery unspecified: NC95.3Z\\nInjury of greater saphenous vein at lower leg level: NC95.4\\nLaceration of greater saphenous vein at lower leg level: NC95.40\\nOther specified injury of greater saphenous vein at lower leg level: NC95.4Y\\nInjury of greater saphenous vein at lower leg level unspecified: NC95.4Z\\nInjury of lesser saphenous vein at lower leg level: NC95.5\\nLaceration of lesser saphenous vein at lower leg level: NC95.50\\nOther specified injury of lesser saphenous vein at lower leg level: NC95.5Y\\nInjury of lesser saphenous vein at lower leg level unspecified: NC95.5Z\\nInjury of popliteal vein: NC95.6\\nLaceration of popliteal vein: NC95.60\\nOther specified injury of popliteal vein: NC95.6Y\\nInjury of popliteal vein unspecified: NC95.6Z\\nInjury of multiple blood vessels at lower leg level: NC95.7\\nInjury of other specified blood vessels at lower leg level: NC95.Y\\nInjury of unspecified blood vessel at lower leg level: NC95.Z\\nInjury of muscle fascia tendon or bursa at lower leg level: NC96\\nInjury of Achilles tendon: NC96.0\\nStrain or sprain of Achilles tendon: NC96.00\\nLaceration of Achilles tendon: NC96.01\\nRupture of Achilles tendon: NC96.02\\nOther specified injury of Achilles tendon: NC96.0Y\\nInjury of Achilles tendon unspecified: NC96.0Z\\nInjury of other muscle fascia or tendon of posterior muscle group at lower leg level: NC96.1\\nStrain or sprain of other muscle fascia or tendon of posterior muscle group at lower leg level: NC96.10\\nLaceration of other muscle fascia or tendon of posterior muscle group at lower leg level: NC96.11\\nOther specified injury of other muscle fascia or tendon of posterior muscle group at lower leg level: NC96.1Y\\nInjury of other muscle fascia or tendon of posterior muscle group at lower leg level unspecified: NC96.1Z\\nInjury of muscle fascia or tendon of anterior muscle group at lower leg level: NC96.2\\nStrain or sprain of muscle fascia or tendon of anterior muscle group at lower leg level: NC96.20\\nLaceration of muscle fascia or tendon of anterior muscle group at lower leg level: NC96.21\\nOther specified injury of muscle fascia or tendon of anterior muscle group at lower leg level: NC96.2Y\\nInjury of muscle fascia or tendon of anterior muscle group at lower leg level unspecified: NC96.2Z\\nInjury of muscle fascia or tendon of peroneal muscle group at lower leg level: NC96.3\\nStrain or sprain of muscle fascia or tendon of peroneal muscle group at lower leg level: NC96.30\\nLaceration of muscle fascia or tendon of peroneal muscle group at lower leg level: NC96.31\\nOther specified injury of muscle fascia or tendon of peroneal muscle group at lower leg level: NC96.3Y\\nInjury of muscle fascia or tendon of peroneal muscle group at lower leg level unspecified: NC96.3Z\\nInjury of multiple muscles fasciae or tendons at lower leg level: NC96.4\\nInjury of bursa of knee: NC96.5\\nInjury of other specified muscle fascia tendon or bursa at lower leg level: NC96.Y\\nInjury of unspecified muscle fascia tendon or bursa at lower leg level: NC96.Z\\nCrushing injury of lower leg: NC97\\nCrushing injury of knee: NC97.0\\nCrushing injury of other specified part of lower leg: NC97.Y\\nCrushing injury of lower leg unspecified: NC97.Z\\nTraumatic amputation of lower leg: NC98\\nTraumatic amputation of right lower leg at knee level: NC98.0\\nTraumatic amputation of left lower leg at knee level: NC98.1\\nTraumatic amputation at knee level bilateral: NC98.2\\nTraumatic amputation at level between right knee and ankle: NC98.3\\nTraumatic amputation at level between left knee and ankle: NC98.4\\nTraumatic amputation at level between knee and ankle bilateral: NC98.5\\nOther specified traumatic amputation of lower leg: NC98.Y\\nTraumatic amputation of lower leg unspecified: NC98.Z\\nMultiple injuries of lower leg: NC99\\nOther specified injuries to the knee or lower leg: NC9Y\\nInjuries to the knee or lower leg unspecified: NC9Z\\nInjury to toenail: ND10\\nSuperficial injury of ankle or foot: ND11\\nAbrasion of ankle: ND11.0\\nContusion of ankle: ND11.1\\nNonthermal blister of ankle: ND11.2\\nNonvenomous insect bite of ankle: ND11.3\\nSuperficial foreign body in ankle: ND11.4\\nSplinter in ankle: ND11.40\\nOther specified superficial foreign body in ankle: ND11.4Y\\nSuperficial foreign body in ankle unspecified: ND11.4Z\\nAbrasion of toe: ND11.5\\nContusion of toe: ND11.6\\nAbrasion of other or unspecified parts of foot: ND11.7\\nContusion of other or unspecified parts of foot: ND11.8\\nNonthermal blister of other or unspecified parts of foot: ND11.9\\nNonvenomous insect bite of other or unspecified parts of foot: ND11.A\\nSuperficial foreign body in other or unspecified parts of foot: ND11.B\\nSplinter in other or unspecified parts of foot: ND11.B0\\nOther specified superficial foreign body in other or unspecified parts of foot: ND11.BY\\nSuperficial foreign body in other or unspecified parts of foot unspecified: ND11.BZ\\nMultiple superficial injuries of ankle or foot: ND11.C\\nOther specified superficial injury of ankle or foot: ND11.Y\\nSuperficial injury of ankle or foot unspecified: ND11.Z\\nOpen wound of ankle or foot: ND12\\nLaceration without foreign body of ankle or foot: ND12.0\\nLaceration with foreign body of ankle or foot: ND12.1\\nPuncture wound with foreign body of ankle or foot: ND12.2\\nPuncture wound without foreign body of ankle or foot: ND12.3\\nOpen bite of ankle or foot: ND12.4\\nMultiple open wounds of ankle or foot: ND12.5\\nOpen wound of toe: ND12.6\\nLaceration without foreign body of toe: ND12.60\\nLaceration with foreign body of toe: ND12.61\\nPuncture wound without foreign body of toe: ND12.62\\nPuncture wound with foreign body of toe: ND12.63\\nOpen bite of toe: ND12.64\\nOther specified open wound of toe: ND12.6Y\\nOpen wound of toe unspecified: ND12.6Z\\nOther specified open wound of ankle or foot: ND12.Y\\nOpen wound of ankle or foot unspecified: ND12.Z\\nFracture of foot except ankle: ND13\\nFracture of calcaneus: ND13.0\\nFracture of talus: ND13.1\\nFracture of unspecified tarsal bone: ND13.2\\nFracture of metatarsal bone: ND13.3\\nFracture of great toe: ND13.4\\nFracture of other toe: ND13.5\\nMultiple fractures of foot: ND13.6\\nFracture of cuboid bone: ND13.7\\nFracture of lateral cuneiform: ND13.8\\nFracture of intermediate cuneiform: ND13.9\\nFracture of medial cuneiform: ND13.A\\nFracture of navicular of foot: ND13.B\\nFracture of other specified part of foot except ankle: ND13.Y\\nFracture of foot except ankle unspecified: ND13.Z\\nDislocation or strain or sprain of joints or ligaments at ankle or foot level: ND14\\nDislocation of ankle joint: ND14.0\\nDislocation of great toe: ND14.1\\nDislocation of metatarsophalangeal joint of great toe: ND14.10\\nDislocation of interphalangeal joint of great toe: ND14.11\\nDislocation of great toe unspecified: ND14.1Z\\nDislocation of other toe: ND14.2\\nDislocation of metatarsophalangeal joint of lesser toe: ND14.20\\nDislocation of interphalangeal joints of lesser toe: ND14.21\\nDislocation of other specified toe: ND14.2Y\\nDislocation of other toe unspecified: ND14.2Z\\nDislocation of tarsal joint: ND14.3\\nDislocation of tarsometatarsal joint: ND14.4\\nRupture of ligaments at ankle or foot level: ND14.5\\nDislocation of other or unspecified parts of foot: ND14.6\\nStrain or sprain of ankle: ND14.7\\nStrain or sprain of calcaneofibular ligament: ND14.70\\nStrain or sprain of deltoid ligament: ND14.71\\nStrain or sprain of tibiofibular ligament: ND14.72\\nStrain or sprain of other ligament of ankle: ND14.73\\nStrain or sprain of ankle unspecified: ND14.7Z\\nStrain or sprain of other toe: ND14.8\\nStrain or sprain of metatarsophalangeal joint of lesser toe: ND14.80\\nStrain or sprain of interphalangeal joints of lesser toe: ND14.81\\nStrain or sprain of other specified toe: ND14.8Y\\nStrain or sprain of other toe unspecified: ND14.8Z\\nStrain or sprain of great toe: ND14.9\\nStrain or sprain of metatarsophalangeal joint of great toe: ND14.90\\nStrain or sprain of interphalangeal joint of great toe: ND14.91\\nStrain or sprain of great toe unspecified: ND14.9Z\\nStrain or sprain of other or unspecified parts of foot: ND14.A\\nOther specified dislocation or strain or sprain of joints or ligaments at ankle or foot level: ND14.Y\\nDislocation or strain or sprain of joints or ligaments at ankle or foot level unspecified: ND14.Z\\nInjury of nerves at ankle or foot level: ND15\\nInjury of lateral plantar nerve: ND15.0\\nInjury of medial plantar nerve: ND15.1\\nInjury of deep peroneal nerve at ankle or foot level: ND15.2\\nInjury of cutaneous sensory nerve at ankle or foot level: ND15.3\\nInjury of multiple nerves at ankle or foot level: ND15.4\\nInjury of other specified nerves at ankle or foot level: ND15.Y\\nInjury of unspecified nerve at ankle or foot level: ND15.Z\\nInjury of blood vessels at ankle or foot level: ND16\\nInjury of dorsal artery of foot: ND16.0\\nLaceration of dorsal artery of foot: ND16.00\\nOther specified injury of dorsal artery of foot: ND16.0Y\\nInjury of dorsal artery of foot unspecified: ND16.0Z\\nInjury of plantar artery of foot: ND16.1\\nLaceration of plantar artery of foot: ND16.10\\nOther specified injury of plantar artery of foot: ND16.1Y\\nInjury of plantar artery of foot unspecified: ND16.1Z\\nInjury of dorsal vein of foot: ND16.2\\nLaceration of dorsal vein of foot: ND16.20\\nOther specified injury of dorsal vein of foot: ND16.2Y\\nInjury of dorsal vein of foot unspecified: ND16.2Z\\nInjury of multiple blood vessels at ankle or foot level: ND16.3\\nInjury of other specified blood vessels at ankle or foot level: ND16.Y\\nInjury of unspecified blood vessel at ankle or foot level: ND16.Z\\nInjury of muscle fascia or tendon at ankle or foot level: ND17\\nInjury of muscle fascia or tendon of long flexor muscle of toe at ankle or foot level: ND17.0\\nStrain or sprain of muscle fascia or tendon of long flexor muscle of toe at ankle or foot level: ND17.00\\nLaceration of muscle fascia or tendon of long flexor muscle of toe at ankle or foot level: ND17.01\\nOther specified injury of muscle fascia or tendon of long flexor muscle of toe at ankle or foot level: ND17.0Y\\nInjury of muscle fascia or tendon of long flexor muscle of toe at ankle or foot level unspecified: ND17.0Z\\nInjury of muscle fascia or tendon of long extensor muscle of toe at ankle or foot level: ND17.1\\nStrain or sprain of muscle fascia or tendon of long extensor muscle of toe at ankle or foot level: ND17.10\\nLaceration of muscle fascia or tendon of long extensor muscle of toe at ankle or foot level: ND17.11\\nOther specified injury of muscle fascia or tendon of long extensor muscle of toe at ankle or foot level: ND17.1Y\\nInjury of muscle fascia or tendon of long extensor muscle of toe at ankle or foot level unspecified: ND17.1Z\\nInjury of intrinsic muscle fascia or tendon at ankle or foot level: ND17.2\\nStrain or sprain of intrinsic muscle fascia or tendon at ankle or foot level: ND17.20\\nLaceration of intrinsic muscle fascia or tendon at ankle or foot level: ND17.21\\nOther specified injury of intrinsic muscle fascia or tendon at ankle or foot level: ND17.2Y\\nInjury of intrinsic muscle fascia or tendon at ankle or foot level unspecified: ND17.2Z\\nInjury of multiple muscles or tendons at ankle or foot level: ND17.3\\nInjury of other specified muscle fascia or tendon at ankle or foot level: ND17.Y\\nInjury of unspecified muscle fascia or tendon at ankle or foot level: ND17.Z\\nCrushing injury of ankle or foot: ND18\\nCrushing injury of ankle: ND18.0\\nCrushing injury of toe: ND18.1\\nCrushing injury of other parts of ankle or foot: ND18.2\\nCrushing injury of ankle or foot unspecified: ND18.Z\\nTraumatic amputation of ankle or foot: ND19\\nTraumatic amputation of right foot at ankle level: ND19.0\\nTraumatic amputation of left foot at ankle level: ND19.1\\nTraumatic amputation of foot at ankle level bilateral: ND19.2\\nTraumatic amputation of right foot at metatarsal level: ND19.3\\nTraumatic amputation of left foot at metatarsal level: ND19.4\\nTraumatic amputation of foot at metatarsal level bilateral: ND19.5\\nTraumatic amputation of one toe: ND19.6\\nTraumatic amputation of two or more toes: ND19.7\\nTraumatic amputation of other parts of foot: ND19.8\\nTraumatic amputation of ankle or foot unspecified: ND19.Z\\nMultiple injuries of ankle or foot: ND1A\\nOther specified injuries to the ankle or foot: ND1Y\\nInjuries to the ankle or foot unspecified: ND1Z\\nSuperficial injuries involving multiple body regions: ND30\\nOpen wounds involving multiple body regions: ND31\\nFractures involving multiple body regions: ND32\\nDislocations strains or sprains involving multiple body regions: ND33\\nCrushing injuries involving multiple body regions: ND34\\nTraumatic amputations involving multiple body regions: ND35\\nOther injuries involving multiple body regions not elsewhere classified: ND36\\nUnspecified multiple injuries: ND37\\nFracture of spine level unspecified: ND50\\nOther injuries of spine or trunk level unspecified: ND51\\nDislocation or strain or sprain of unspecified joint or ligament of trunk: ND51.0\\nInjury of unspecified nerve spinal nerve root or plexus of trunk: ND51.1\\nInjury of spinal cord level unspecified: ND51.2\\nInjury of unspecified muscle fascia or tendon of trunk: ND51.3\\nCrushing injury of spine or trunk level unspecified: ND51.4\\nOther specified injuries of spine or trunk level unspecified: ND51.Y\\nUnspecified injuries of spine or trunk level unspecified: ND51.Z\\nFracture of arm level unspecified: ND52\\nOther injuries of arm level unspecified: ND53\\nCrushing injury of arm level unspecified: ND53.0\\nOther specified injuries of arm level unspecified: ND53.Y\\nFracture of leg level unspecified: ND54\\nOther injuries of leg level unspecified: ND55\\nInjury of unspecified body region: ND56\\nSuperficial injury of unspecified body region: ND56.0\\nOpen wound of unspecified body region: ND56.1\\nFracture of unspecified body region: ND56.2\\nDislocation or strain or sprain of unspecified body region: ND56.3\\nInjury of nerve of unspecified body region: ND56.4\\nInjury of blood vessel of unspecified body region: ND56.5\\nInjury of muscles or tendons of unspecified body region: ND56.6\\nCrushing injury of unspecified body region: ND56.7\\nTraumatic amputation of unspecified body region: ND56.8\\nInjury complicating pregnancy: ND56.9\\nOther specified injury of unspecified body region: ND56.Y\\nUnspecified injury to unspecified part of trunk limb or body region: ND56.Z\\nSecondary effect of trauma: ND57\\nOther specified injuries to unspecified part of trunk limb or body region: ND5Y\\nInjuries to unspecified part of trunk limb or body region unspecified: ND5Z\\nForeign body on external eye: ND70\\nForeign body in cornea: ND70.0\\nForeign body in conjunctival sac: ND70.1\\nForeign body in multiple parts of external eye: ND70.2\\nForeign body in other specified part of external eye: ND70.Y\\nForeign body on external eye unspecified: ND70.Z\\nForeign body in ear: ND71\\nForeign body in respiratory tract: ND72\\nForeign body in nasal sinus: ND72.0\\nForeign body in nostril: ND72.1\\nForeign body in pharynx: ND72.2\\nAsphyxia on mucus in nasopharynx: ND72.20\\nOther specified foreign body in pharynx: ND72.2Y\\nForeign body in pharynx unspecified: ND72.2Z\\nForeign body in larynx: ND72.3\\nForeign body in trachea: ND72.4\\nForeign body in bronchus: ND72.5\\nForeign body in multiple parts of respiratory tract: ND72.6\\nForeign body in other parts of respiratory tract: ND72.Y\\nForeign body in unspecified part of respiratory tract: ND72.Z\\nForeign body in alimentary tract: ND73\\nForeign body in mouth: ND73.0\\nForeign body in oesophagus: ND73.1\\nForeign body in stomach: ND73.2\\nTrichobezoar: ND73.20\\nOther specified foreign body in stomach: ND73.2Y\\nForeign body in stomach unspecified: ND73.2Z\\nForeign body in small intestine: ND73.3\\nForeign body in colon: ND73.4\\nForeign body in anus or rectum: ND73.5\\nForeign body in other specified part of alimentary tract: ND73.Y\\nForeign body in alimentary tract unspecified: ND73.Z\\nForeign body in genitourinary tract: ND74\\nForeign body in urethra: ND74.0\\nForeign body in bladder: ND74.1\\nForeign body in vulva or vagina: ND74.2\\nForeign body in uterus any part: ND74.3\\nForeign body in other specified part of genitourinary tract: ND74.Y\\nForeign body in genitourinary tract unspecified: ND74.Z\\nEffects of foreign body entering through natural orifice unspecified: ND7Z\\nBurn of head or neck except face: ND90\\nBurn of head or neck except face epidermal burn: ND90.0\\nBurn of head or neck except face superficial partial thickness burn: ND90.1\\nBurn of head or neck except face deep partial thickness burn: ND90.2\\nBurn of head or neck except face full thickness burn: ND90.3\\nBurn of head or neck except face deep full thickness or complex burn: ND90.4\\nBurn of head or neck except face depth of burn unspecified: ND90.Z\\nBurn of face except eye or ocular adnexa: ND91\\nBurn of face except eye or ocular adnexa epidermal burn: ND91.0\\nBurn of face except eye or ocular adnexa superficial partial thickness burn: ND91.1\\nBurn of face except eye or ocular adnexa deep partial thickness burn: ND91.2\\nBurn of face except eye or ocular adnexa full thickness burn: ND91.3\\nBurn of face except eye or ocular adnexa deep full thickness or complex burn: ND91.4\\nBurn of face except eye depth of burn unspecified: ND91.Z\\nBurn of trunk except perineum or genitalia: ND92\\nBurn of trunk except perineum or genitalia epidermal burn: ND92.0\\nBurn of breast epidermal burn: ND92.00\\nBurn of chest wall epidermal burn: ND92.01\\nBurn of abdominal wall epidermal burn: ND92.02\\nBurn of back any part epidermal burn: ND92.03\\nOther specified burn of trunk except perineum or genitalia epidermal burn: ND92.0Y\\nBurn of trunk except perineum or genitalia epidermal burn unspecified: ND92.0Z\\nBurn of trunk except perineum or genitalia superficial partial thickness burn: ND92.1\\nBurn of trunk except perineum or genitalia deep partial thickness burn: ND92.2\\nBurn of trunk except perineum or genitalia full thickness burn: ND92.3\\nBurn of trunk except perineum or genitalia deep full thickness or complex burn: ND92.4\\nBurn of trunk except perineum or genitalia depth of burn unspecified: ND92.Z\\nBurn of perineum or genitalia: ND93\\nBurn of perineum or genitalia epidermal burn: ND93.0\\nBurn of perineum or genitalia superficial partial thickness burn: ND93.1\\nBurn of perineum or genitalia deep partial thickness burn: ND93.2\\nBurn of perineum or genitalia full thickness burn: ND93.3\\nBurn of perineum or genitalia deep full thickness or complex burn: ND93.4\\nBurn of perineum or genitalia depth of burn unspecified: ND93.Z\\nBurn of shoulder or arm except wrist or hand: ND94\\nBurn of shoulder or arm except wrist or hand epidermal burn: ND94.0\\nBurn of shoulder or arm except wrist or hand superficial partial thickness burn: ND94.1\\nBurn of forearm or elbow superficial partial thickness burn: ND94.10\\nOther specified burn of shoulder or arm except wrist or hand superficial partial thickness burn: ND94.1Y\\nBurn of shoulder or arm except wrist or hand superficial partial thickness burn unspecified: ND94.1Z\\nBurn of shoulder or arm except wrist or hand deep partial thickness burn: ND94.2\\nBurn of forearm or elbow deep partial thickness burn: ND94.20\\nOther specified burn of shoulder or arm except wrist or hand deep partial thickness burn: ND94.2Y\\nBurn of shoulder or arm except wrist or hand deep partial thickness burn unspecified: ND94.2Z\\nBurn of shoulder or arm except wrist or hand full thickness burn: ND94.3\\nBurn of shoulder or arm except wrist or hand deep full thickness or complex burn: ND94.4\\nBurn of shoulder or arm except wrist or hand depth of burn unspecified: ND94.Z\\nBurn of wrist or hand: ND95\\nBurn of wrist or hand epidermal burn: ND95.0\\nBurn of wrist or hand superficial partial thickness burn: ND95.1\\nBurn of wrist or hand deep partial thickness burn: ND95.2\\nBurn of wrist or hand full thickness burn: ND95.3\\nBurn of wrist or hand deep full thickness or complex burn: ND95.4\\nBurn of wrist or hand depth of burn unspecified: ND95.Z\\nBurn of hip or leg except ankle or foot: ND96\\nBurn of hip or leg except ankle or foot epidermal burn: ND96.0\\nBurn of hip or leg except ankle or foot superficial partial thickness burn: ND96.1\\nBurn of hip or leg except ankle or foot deep partial thickness burn: ND96.2\\nBurn of hip or leg except ankle or foot full thickness burn: ND96.3\\nBurn of hip or leg except ankle or foot deep full thickness or complex burn: ND96.4\\nBurn of hip or leg except ankle or foot depth of burn unspecified: ND96.Z\\nBurn of ankle or foot: ND97\\nBurn of ankle or foot epidermal burn: ND97.0\\nBurn of ankle or foot superficial partial thickness burn: ND97.1\\nBurn of ankle or foot deep partial thickness burn: ND97.2\\nBurn of ankle or foot full thickness burn: ND97.3\\nBurn of ankle or foot deep full thickness or complex burn: ND97.4\\nBurn of ankle or foot depth of burn unspecified: ND97.Z\\nAcute skin injury due to skin contact with corrosive substance: ND99\\nChemical burn due to skin contact with corrosive substance: ND99.1\\nBurns of external body surface other specified site: ND9Y\\nBurns of external body surface unspecified site: ND9Z\\nBurn of eye or ocular adnexa: NE00\\nBurn of respiratory tract: NE01\\nBurn of other internal organs: NE02\\nBurns of unspecified internal organ: NE0Z\\nBurns of multiple body regions: NE10\\nBurn of unspecified body region: NE11\\nBurns unspecified: NE2Z\\nSuperficial frostbite: NE40\\nFrostbite with tissue necrosis: NE41\\nFrostbite involving multiple body regions: NE42\\nFrostbite unspecified: NE4Z\\nHarmful effects of drugs medicaments or biological substances not elsewhere classified: NE60\\nHarmful effects of or exposure to noxious substances chiefly nonmedicinal as to source not elsewhere classified: NE61\\nHarmful effects of unspecified substance: NE6Z\\nInjury or harm arising following infusion transfusion or therapeutic injection not elsewhere classified: NE80\\nAir embolism following infusion transfusion or therapeutic injection: NE80.0\\nABO incompatibility reaction: NE80.1\\nRh incompatibility reaction: NE80.2\\nOther serum reactions: NE80.3\\nOther specified injury or harm arising following infusion transfusion or therapeutic injection not elsewhere classified: NE80.Y\\nInjury or harm arising following infusion transfusion or therapeutic injection not elsewhere classified unspecified: NE80.Z\\nInjury or harm arising from a procedure not elsewhere classified: NE81\\nHaemorrhage or haematoma complicating a procedure not elsewhere classified: NE81.0\\nHaematoma of surgical wound of skin: NE81.00\\nHaemorrhage and haematoma of eye or ocular adnexa complicating a procedure: NE81.01\\nHaemorrhage or haematoma of other or unspecified site complicating a procedure not elsewhere classified: NE81.0Z\\nDisruption of operation wound not elsewhere classified: NE81.1\\nSurgical site infection: NE81.2\\nSuperficial incisional site infection: NE81.20\\nDeep incisional site infection: NE81.21\\nOrgan or organ space surgical site infection: NE81.22\\nOther specified surgical site infection: NE81.2Y\\nSurgical site infection unspecified: NE81.2Z\\nPostsurgical leak: NE81.3\\nOther specified injury or harm arising from a procedure not elsewhere classified: NE81.Y\\nInjury or harm arising from a procedure not elsewhere classified unspecified: NE81.Z\\nDysfunction or complication of pacemaker pacemaker lead or implantable cardioverter defibrillator not elsewhere classified: NE82\\nPacemaker or implantable cardioverter defibrillator complication: NE82.0\\nPacemaker or implantable cardioverter defibrillator pocket erosion: NE82.00\\nPacemaker or implantable cardioverter defibrillator pocket muscle stimulation: NE82.01\\nPacemaker or implantable cardioverter defibrillator phrenic nerve stimulation: NE82.02\\nPacinginduced cardiomyopathy: NE82.03\\nOther specified pacemaker or implantable cardioverter defibrillator complication: NE82.0Y\\nPacemaker or implantable cardioverter defibrillator complication unspecified: NE82.0Z\\nPacemaker or implantable cardioverter defibrillator dysfunction: NE82.1\\nInappropriate implantable cardioverter defibrillator shock: NE82.10\\nPacemaker syndrome: NE82.11\\nPacemaker generator dysfunction: NE82.12\\nOther specified pacemaker or implantable cardioverter defibrillator dysfunction: NE82.1Y\\nPacemaker or implantable cardioverter defibrillator dysfunction unspecified: NE82.1Z\\nPacemaker or implantable cardioverter defibrillator lead complication: NE82.2\\nPacemaker or implantable cardioverter defibrillator lead fracture: NE82.20\\nPacemaker or implantable cardioverter defibrillator lead dislodgement: NE82.21\\nPacemaker or implantable cardioverter defibrillator lead insulation break: NE82.22\\nOther specified pacemaker or implantable cardioverter defibrillator lead complication: NE82.2Y\\nPacemaker or implantable cardioverter defibrillator lead complication unspecified: NE82.2Z\\nPacemaker or implantable cardioverter defibrillator lead dysfunction: NE82.3\\nOther specified dysfunction or complication of pacemaker pacemaker lead or implantable cardioverter defibrillator not elsewhere classified: NE82.Y\\nDysfunction or complication of pacemaker pacemaker lead or implantable cardioverter defibrillator not elsewhere classified unspecified: NE82.Z\\nInjury or harm arising from other device implant or graft not elsewhere classified: NE83\\nDestruction or cartilage wear of joint with hemiarthroplasty: NE83.0\\nInfection arising from device implant or graft not elsewhere classified: NE83.1\\nOther specified injury or harm arising from other device implant or graft not elsewhere classified: NE83.Y\\nFailure or rejection of transplanted organs or tissues: NE84\\nComplications peculiar to reattachment or amputation: NE85\\nComplications of reattached upper extremity: NE85.0\\nComplications of reattached lower extremity: NE85.1\\nComplications of other reattached body part: NE85.2\\nNeuroma of amputation stump: NE85.3\\nInfection of amputation stump: NE85.4\\nNecrosis of amputation stump: NE85.5\\nOther or unspecified complications of amputation stump: NE85.6\\nMalignant hyperthermia due to anaesthesia: NE86\\nFailed or difficult intubation: NE87\\nDrug toxicity associated with harm in surgical or medical care not elsewhere classified: NE88\\nAwareness under general anaesthesia: NE89\\nOther specified injury or harm arising from surgical or medical care not elsewhere classified: NE8Y\\nInjury or harm arising from surgical or medical care not elsewhere classified unspecified: NE8Z\\nEffects of radiation not elsewhere classified: NF00\\nEffects of heat: NF01\\nHeat stroke: NF01.0\\nHeat syncope: NF01.1\\nHeat exhaustion due to fluid depletion: NF01.2\\nHeat fatigue transient: NF01.3\\nOther specified effects of heat: NF01.Y\\nEffects of heat unspecified: NF01.Z\\nHypothermia: NF02\\nOther effects of reduced temperature: NF03\\nChilblains: NF03.0\\nImmersion hand or foot: NF03.1\\nOther specified effects of reduced temperature: NF03.Y\\nUnspecified effects of reduced temperature: NF03.Z\\nEffects of air pressure or water pressure: NF04\\nOtitic barotrauma: NF04.0\\nSinus barotrauma: NF04.1\\nCaisson disease: NF04.2\\nEffects of highpressure fluids: NF04.3\\nOther specified effects of air pressure or water pressure: NF04.Y\\nEffects of air pressure or water pressure unspecified: NF04.Z\\nAsphyxiation: NF05\\nEffects of strenuous physical exercise: NF06\\nExertional heat stroke: NF06.0\\nPost exercise postural hypotension: NF06.1\\nPost exertional dehydration: NF06.2\\nExercise muscle cramp: NF06.3\\nOther specified effects of strenuous physical exercise: NF06.Y\\nEffects of strenuous physical exercise unspecified: NF06.Z\\nEffects of other deprivation: NF07\\nEffects of hunger: NF07.0\\nEffects of thirst: NF07.1\\nExhaustion due to exposure: NF07.2\\nOther specified effects of deprivation: NF07.Y\\nEffects of other deprivation unspecified: NF07.Z\\nEffects of certain specified external causes: NF08\\nEffects of lightning: NF08.0\\nDrowning or nonfatal submersion: NF08.1\\nEffects of vibration: NF08.2\\nHand and arm vibration syndrome: NF08.20\\nOther specified effects of vibration: NF08.2Y\\nEffects of vibration unspecified: NF08.2Z\\nMotion sickness: NF08.3\\nEffects of electric current: NF08.4\\nAdverse effects not elsewhere classified: NF09\\nCertain early complications of trauma not elsewhere classified: NF0A\\nAir embolism traumatic not elsewhere classified: NF0A.0\\nFat embolism traumatic not elsewhere classified: NF0A.1\\nTraumatic secondary or recurrent haemorrhage not elsewhere classified: NF0A.2\\nPost traumatic wound infection not elsewhere classified: NF0A.3\\nTraumatic shock not elsewhere classified: NF0A.4\\nTraumatic anuria not elsewhere classified: NF0A.5\\nTraumatic ischaemia of muscle not elsewhere classified: NF0A.6\\nTraumatic subcutaneous emphysema not elsewhere classified: NF0A.7\\nOther early complication of trauma not elsewhere classified: NF0A.Y\\nEarly complications of trauma not elsewhere classified: NF0A.Z\\nOther specified effects of external causes: NF0Y\\nUnspecified effects of external causes: NF0Z\\nOther specified injury poisoning or certain other consequences of external causes: NF2Y\\nUnspecified injury poisoning or certain other consequences of external causes: NF2Z\\nUnintentional land transport traffic event injuring a pedestrian: PA00\\nUnintentional land transport traffic event injuring the user of a pedestrian conveyance: PA01\\nUnintentional land transport traffic event injuring a pedal cyclist: PA02\\nUnintentional land transport traffic event injuring a motor cyclist: PA03\\nUnintentional land transport traffic event injuring a car occupant: PA04\\nUnintentional land transport traffic event injuring an occupant of a bus or coach: PA05\\nUnintentional land transport traffic event injuring an occupant of a light goods vehicle: PA06\\nUnintentional land transport traffic event injuring an occupant of a heavy goods vehicle: PA07\\nUnintentional land transport traffic event injuring an occupant of a streetcar or tram: PA08\\nUnintentional land transport traffic event injuring an occupant of a low powered passenger vehicle: PA09\\nUnintentional land transport traffic event injuring a user of a special vehicle mainly used in agriculture: PA0A\\nUnintentional land transport traffic event injuring a user of a special vehicle mainly used on industrial premises: PA0B\\nUnintentional land transport traffic event injuring a user of a special construction vehicle: PA0C\\nUnintentional land transport traffic event injuring a user of an allterrain vehicle: PA0D\\nUnintentional land transport traffic event injuring a rider of an animal: PA0E\\nUnintentional land transport traffic event injuring an occupant of an animaldrawn vehicle: PA0F\\nUnintentional land transport traffic event injuring a user of other specified land transport: PA0Y\\nUnintentional land transport traffic event injuring a user of unspecified land transport: PA0Z\\nUnintentional land transport nontraffic event injuring a pedestrian: PA10\\nUnintentional land transport nontraffic event injuring the user of a pedestrian conveyance: PA11\\nUnintentional land transport nontraffic event injuring a pedal cyclist: PA12\\nUnintentional land transport nontraffic event injuring a motor cyclist: PA13\\nUnintentional land transport nontraffic event injuring a car occupant: PA14\\nUnintentional land transport nontraffic event injuring an occupant of a bus or coach: PA15\\nUnintentional land transport nontraffic event injuring an occupant of a light goods vehicle: PA16\\nUnintentional land transport nontraffic event injuring an occupant of a heavy goods vehicle: PA17\\nUnintentional land transport nontraffic event injuring an occupant of a streetcar or tram: PA18\\nUnintentional land transport nontraffic event injuring an occupant of a low powered passenger vehicle: PA19\\nUnintentional land transport nontraffic event injuring a user of a special vehicle mainly used in agriculture: PA1A\\nUnintentional land transport nontraffic event injuring a user of a special vehicle mainly used on industrial premises: PA1B\\nUnintentional land transport nontraffic event injuring a user of a special construction vehicle: PA1C\\nUnintentional land transport nontraffic event injuring a user of an allterrain vehicle: PA1D\\nUnintentional land transport nontraffic event injuring a rider of an animal: PA1E\\nUnintentional land transport nontraffic event injuring an occupant of an animaldrawn vehicle: PA1F\\nUnintentional land transport nontraffic event injuring a user of other specified land transport: PA1Y\\nUnintentional land transport nontraffic event injuring a user of unknown or unspecified land transport: PA1Z\\nUnintentional land transport event unknown whether traffic or nontraffic injuring a pedestrian: PA20\\nUnintentional land transport event unknown whether traffic or nontraffic injuring the user of a pedestrian conveyance: PA21\\nUnintentional land transport event unknown whether traffic or nontraffic injuring a pedal cyclist: PA22\\nUnintentional land transport event unknown whether traffic or nontraffic injuring a motor cyclist: PA23\\nUnintentional land transport event unknown whether traffic or nontraffic injuring a car occupant: PA24\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a bus or coach: PA25\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a light goods vehicle: PA26\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a heavy goods vehicle: PA27\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a streetcar or tram: PA28\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a low powered passenger vehicle: PA29\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a special vehicle mainly used in agriculture: PA2A\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a special vehicle mainly used on industrial premises: PA2B\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of a special construction vehicle: PA2C\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of an allterrain vehicle: PA2D\\nUnintentional land transport event unknown whether traffic or nontraffic injuring a rider of an animal: PA2E\\nUnintentional land transport event unknown whether traffic or nontraffic injuring an occupant of an animaldrawn vehicle: PA2F\\nUnintentional land transport injury event unknown whether traffic or nontraffic injuring a user of other specified transport: PA2Y\\nUnintentional land transport injury event unknown whether traffic or nontraffic injuring a user of unspecified transport: PA2Z\\nUnintentional railway transport injury event with collision or derailment: PA30\\nUnintentional railway transport injury event without collision or derailment: PA31\\nUnintentional railway transport injury event of unspecified type: PA3Z\\nUnintentional water transport injury event with water vessel not damaged disabled or destroyed: PA40\\nUnintentional water transport injury event with water vessel not damaged disabled or destroyed causing submersion or drowning: PA40.0\\nUnintentional water transport injury event with water vessel not damaged disabled or destroyed causing other injury: PA40.1\\nUnintentional water transport injury event with water vessel not damaged disabled or destroyed causing unspecified injury: PA40.Z\\nUnintentional water transport injury event with water vessel damaged disabled or destroyed: PA41\\nUnintentional water transport injury event with water vessel damaged disabled or destroyed causing submersion or drowning: PA41.0\\nUnintentional water transport injury event with water vessel damaged disabled or destroyed causing unspecified injury: PA41.Z\\nUnintentional water transport injury event with damage to water vessel unspecified: PA4Z\\nUnintentional air or space transport injury event: PA50\\nUnintentional air or space transport injury event with aircraft or spacecraft not damaged disabled or destroyed: PA50.0\\nUnintentional air or space transport injury event with aircraft or spacecraft damaged disabled or destroyed: PA50.1\\nUnintentional air or space transport injury event unspecified: PA50.Z\\nOther specified unintentional transport injury event: PA5Y\\nUnintentional transport injury event unspecified: PA5Z\\nUnintentional fall on the same level or from less than  metre: PA60\\nUnintentional fall from a height of  metre or more: PA61\\nUnintentional fall from unspecified height: PA6Z\\nUnintentionally struck kicked or bumped by person: PA70\\nUnintentionally struck kicked or bumped by animal: PA71\\nUnintentionally stepped on or crushed by person: PA72\\nUnintentionally stepped on or crushed by animal: PA73\\nUnintentionally bitten by person: PA74\\nUnintentionally bitten by animal: PA75\\nUnintentionally scratched or clawed by person: PA76\\nUnintentionally scratched or clawed by animal: PA77\\nUnintentionally stung or envenomated by animal: PA78\\nUnintentionally injured by contact with plant: PA79\\nOther specified type of unintentional contact with person animal or plant: PA7Y\\nUnintentional contact with person animal or plant type unspecified: PA7Z\\nUnintentionally struck by projectile from firearm: PA80\\nUnintentionally struck by projectile from handgun: PA80.0\\nUnintentionally struck by projectile from rifle shotgun or larger firearm: PA80.1\\nUnintentionally struck by projectile from other specified firearm: PA80.Y\\nUnintentionally struck by projectile from unspecified firearm: PA80.Z\\nUnintentionally struck by moving object: PA81\\nUnintentional striking against stationary object: PA82\\nUnintentionally cut or pierced by sharp object: PA83\\nUnintentionally cut or pierced by knife sword or dagger: PA83.0\\nUnintentionally cut or pierced by sharp glass: PA83.1\\nUnintentionally cut or pierced by other or unspecified sharp object: PA83.2\\nUnintentionally struck by blunt object: PA84\\nUnintentionally caught crushed jammed or pinched between objects: PA85\\nUnintentional exposure to other specified object not elsewhere classified: PA8Y\\nUnintentional exposure to object unspecified: PA8Z\\nUnintentional drowning or submersion while in body of water: PA90\\nUnintentional drowning or submersion following fall into body of water: PA91\\nUnintentional injury other than drowning following fall into body of water: PA92\\nUnintentional immersion submersion or falling into water unspecified: PA9Z\\nUnintentional threat to breathing by suffocation from object covering mouth or nose: PB00\\nUnintentional threat to breathing by hanging: PB01\\nUnintentional threat to breathing by strangulation: PB02\\nUnintentional threat to breathing by external compression of airways or chest: PB03\\nUnintentional threat to breathing by inhalation or ingestion of gastric contents: PB04\\nUnintentional threat to breathing by inhalation or ingestion of liquids: PB05\\nUnintentional threat to breathing by inhalation or ingestion of food: PB06\\nUnintentional threat to breathing by inhalation or ingestion of other objects or materials: PB07\\nUnintentional threat to breathing from low oxygen environment: PB08\\nUnintentional threat to breathing by other specified means: PB0Y\\nUnintentional threat to breathing by unspecified means: PB0Z\\nUnintentional exposure to uncontrolled fire: PB10\\nUnintentional exposure to controlled fire: PB11\\nUnintentional exposure to ignition or melting of material: PB12\\nUnintentional contact with hot object or liquid: PB13\\nUnintentional exposure to steam hot vapour air or gases: PB14\\nUnintentional exposure to excessive heat: PB15\\nUnintentional exposure to excessive cold: PB16\\nUnintentional exposure to other specified thermal mechanism: PB1Y\\nUnintentional exposure to unspecified thermal mechanism: PB1Z\\nUnintentional exposure to or harmful effects of opioids or related analgesics: PB20\\nUnintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants: PB21\\nUnintentional exposure to or harmful effects of psychostimulants: PB22\\nUnintentional exposure to or harmful effects of cannabinoids or hallucinogens: PB23\\nUnintentional exposure to or harmful effects of analgesics antipyretics or nonsteroidal antiinflammatory drugs: PB24\\nUnintentional exposure to or harmful effects of antidepressants: PB25\\nUnintentional exposure to or harmful effects of antipsychotics: PB26\\nUnintentional exposure to or harmful effects of antiepileptics or antiparkinsonism drugs: PB27\\nUnintentional exposure to or harmful effects of other or unspecified drug medicament or biological substance: PB28\\nUnintentional exposure to or harmful effects of multiple drugs medicaments or biological substances: PB29\\nUnintentional exposure to or harmful effects of alcohols: PB30\\nUnintentional exposure to or harmful effects of organic solvents: PB31\\nUnintentional exposure to or harmful effects of carbon monoxide: PB32\\nUnintentional exposure to or harmful effects of pesticides: PB33\\nUnintentional exposure to or harmful effects of corrosive substances: PB34\\nUnintentional exposure to or harmful effects of halogen derivatives of aliphatic or aromatic hydrocarbons: PB35\\nUnintentional exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source: PB36\\nUnintentional exposure to foreign body in orifice: PB50\\nUnintentional exposure to electric current: PB51\\nUnintentional exposure to sunlight: PB52\\nUnintentional exposure to radiation: PB53\\nUnintentional exposure to high or low air pressure or changes in air pressure: PB54\\nUnintentional exposure to explosion: PB55\\nUnintentional exposure to chemical explosion: PB55.0\\nUnintentional exposure to explosion or rupture of pressurised materials or object: PB55.1\\nOther specified unintentional exposure to explosion: PB55.Y\\nUnintentional exposure to explosion unspecified: PB55.Z\\nUnintentional exposure to physical overexertion: PB56\\nUnintentional lack of food: PB57\\nUnintentional lack of water: PB58\\nUnintentional other specified privation: PB59\\nUnintentional abandonment: PB5A\\nUnintentional neglect: PB5B\\nOther unintentional cause of morbidity or mortality: PB6Y\\nUnspecified unintentional cause of morbidity or mortality: PB6Z\\nIntentional selfharm by land transport road traffic injury event: PB80\\nIntentional selfharm by land transport offroad nontraffic injury event: PB81\\nIntentional selfharm by land transport injury event unknown whether traffic or nontraffic: PB82\\nIntentional selfharm by railway transport injury event: PB83\\nIntentional selfharm by water transport injury event with water vessel damaged disabled or destroyed: PB90\\nIntentional selfharm by water transport injury event with water vessel not damaged disabled or destroyed: PB91\\nIntentional selfharm by water transport injury event with water vessel not damaged disabled or destroyed causing submersion or drowning: PB91.0\\nIntentional selfharm by water transport injury event with water vessel not damaged disabled or destroyed causing other injury: PB91.1\\nIntentional selfharm by water transport injury event with water vessel not damaged disabled or destroyed unspecified: PB91.Z\\nIntentional selfharm by water transport injury event with damage to water vessel unspecified: PB9Z\\nIntentional selfharm by air or space transport injury event with aircraft or spacecraft damaged disabled or destroyed: PC00\\nIntentional selfharm by air or space transport injury event with aircraft or spacecraft not damaged disabled or destroyed: PC01\\nIntentional selfharm by air or space transport injury event with damage to aircraft or spacecraft unspecified: PC0Z\\nIntentional selfharm by other specified transport injury event: PC2Y\\nIntentional selfharm by transport injury event unspecified: PC2Z\\nIntentional selfharm by fall or jump on same level or from less than  metre: PC30\\nIntentional selfharm by fall or jump from a height of  metre or more: PC31\\nOther specified intentional selfharm by fall or jump: PC3Y\\nIntentional selfharm by fall or jump unspecified: PC3Z\\nIntentional selfharm by being struck kicked or bumped by person: PC40\\nIntentional selfharm by being struck kicked or bumped by animal: PC41\\nIntentional selfharm by being stepped on or crushed by person: PC42\\nIntentional selfharm by being stepped on or crushed by animal: PC43\\nIntentional selfharm by being bitten by animal: PC44\\nIntentional selfharm by being scratched or clawed by person: PC45\\nIntentional selfharm by being scratched or clawed by animal: PC46\\nIntentional selfharm by being stung or envenomated by animal: PC47\\nIntentional selfharm by contact with plant: PC48\\nOther specified type of intentional selfharm by contact with person animal or plant: PC4Y\\nIntentional selfharm by contact with person animal or plant type unspecified: PC4Z\\nIntentional selfharm by being struck by projectile from firearm: PC50\\nIntentional selfharm by projectile from handgun: PC50.0\\nIntentional selfharm by projectile from rifle shotgun or larger firearm: PC50.1\\nOther specified intentional selfharm by being struck by projectile from firearm: PC50.Y\\nIntentional selfharm by being struck by projectile from firearm unspecified: PC50.Z\\nIntentional selfharm by being struck by moving object not elsewhere classified: PC51\\nIntentional selfharm by striking against stationary object: PC52\\nIntentional selfharm by being cut or pierced by sharp object: PC53\\nIntentional selfharm by being cut or pierced by knife sword or dagger: PC53.0\\nIntentional selfharm by being cut or pierced by sharp glass: PC53.1\\nOther specified intentional selfharm by being cut or pierced by sharp object: PC53.Y\\nIntentional selfharm by being cut or pierced by sharp object unspecified: PC53.Z\\nIntentional selfharm by being struck by blunt object: PC54\\nIntentional selfharm by being caught crushed jammed or pinched between objects: PC55\\nIntentional self harm by contact with other specified type of weapon: PC5Y\\nIntentional self harm by contact with weapon type unspecified: PC5Z\\nIntentional selfharm by drowning or submersion while in body of water: PC60\\nIntentional selfharm by drowning or submersion following fall into body of water: PC61\\nIntentional selfharm by injury other than drowning while in body of water: PC62\\nIntentional selfharm by injury other than drowning following fall into body of water: PC63\\nIntentional selfharm by immersion submersion or falling into water unspecified: PC6Z\\nIntentional selfharm by threat to breathing by suffocation from object covering mouth or nose: PC70\\nIntentional selfharm by threat to breathing by hanging: PC71\\nIntentional selfharm by threat to breathing by strangulation: PC72\\nIntentional selfharm by threat to breathing by external compression of airways or chest: PC73\\nIntentional selfharm by inhalation or ingestion of gastric contents: PC74\\nIntentional selfharm by threat to breathing by inhalation or ingestion of liquids: PC75\\nIntentional selfharm by threat to breathing by inhalation or ingestion of food: PC76\\nIntentional selfharm by threat to breathing by inhalation or ingestion of other objects or materials: PC77\\nIntentional selfharm by threat to breathing from low oxygen environment: PC78\\nOther specified intentional selfharm by threat to breathing: PC7Y\\nIntentional selfharm by threat to breathing unspecified: PC7Z\\nIntentional selfharm by exposure to controlled fire: PC80\\nIntentional selfharm by exposure to uncontrolled fire: PC81\\nIntentional selfharm by exposure to ignition or melting of material: PC82\\nIntentional selfharm by contact with hot object or liquid: PC83\\nIntentional selfharm by exposure to steam hot vapour air or gases: PC84\\nIntentional selfharm by exposure to excessive heat: PC85\\nIntentional selfharm by exposure to excessive cold: PC86\\nIntentional selfharm by exposure to other specified thermal mechanism: PC8Y\\nIntentional selfharm by exposure to unspecified thermal mechanism: PC8Z\\nIntentional selfharm by exposure to or harmful effects of opioids or related analgesics: PC90\\nIntentional selfharm by exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants: PC91\\nIntentional selfharm by exposure to or harmful effects of psychostimulants: PC92\\nIntentional selfharm by exposure to or harmful effects of cannabinoids or hallucinogens: PC93\\nIntentional selfharm by exposure to or harmful effects of analgesics antipyretics or nonsteroidal antiinflammatory drugs: PC94\\nIntentional selfharm by exposure to or harmful effects of antidepressants: PC95\\nIntentional selfharm by exposure to or harmful effects of antipsychotics: PC96\\nIntentional selfharm by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs: PC97\\nIntentional selfharm by exposure to other or unspecified drug medicament or biological substance: PC98\\nIntentional selfharm by exposure to or harmful effects of multiple drugs medicaments or biological substances: PC99\\nIntentional selfharm by exposure to or harmful effects of alcohols: PD00\\nIntentional selfharm by exposure to or harmful effects of organic solvents: PD01\\nIntentional selfharm by exposure to or harmful effects of carbon monoxide: PD02\\nIntentional selfharm by exposure to or harmful effects of pesticides: PD03\\nIntentional selfharm by exposure to or harmful effects of corrosive substances: PD04\\nIntentional selfharm by exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source: PD05\\nIntentional selfharm by foreign body in orifice: PD20\\nIntentional selfharm by exposure to electric current: PD21\\nIntentional selfharm by exposure to sunlight: PD22\\nIntentional selfharm by exposure to radiation: PD23\\nIntentional selfharm by exposure to high or low air pressure or changes in air pressure: PD24\\nIntentional selfharm by explosion or rupture of pressurised materials or object: PD25\\nIntentional selfharm by physical overexertion: PD26\\nIntentional selfharm by lack of food: PD27\\nIntentional selfharm by lack of water: PD28\\nIntentional selfharm by other specified privation: PD29\\nOther specified intentional selfharm: PD3Y\\nIntentional selfharm unspecified: PD3Z\\nAssault by land transport road traffic injury event: PD50\\nAssault by land transport offroad nontraffic injury event: PD51\\nAssault by land transport injury event unknown whether road traffic or offroad nontraffic: PD52\\nAssault by railway transport injury event: PD53\\nAssault by water transport injury event with water vessel damaged disabled or destroyed: PD60\\nAssault by water transport injury event with water vessel damaged disabled or destroyed causing submersion or drowning: PD60.0\\nAssault by water transport injury event with water vessel damaged disabled or destroyed causing other injury: PD60.1\\nAssault by water transport injury event with water vessel damaged disabled or destroyed causing unspecified injury: PD60.Z\\nAssault by water transport injury event with water vessel not damaged disabled or destroyed: PD61\\nAssault by water transport injury event with water vessel not damaged disabled or destroyed causing submersion or drowning: PD61.0\\nAssault by water transport injury event with water vessel not damaged disabled or destroyed causing other injury: PD61.1\\nAssault by water transport injury event with water vessel not damaged disabled or destroyed causing unspecified injury: PD61.Y\\nAssault by water transport injury event with water vessel not damaged disabled or destroyed unspecified: PD61.Z\\nAssault by water transport injury event with damage to water vessel unspecified: PD6Z\\nAssault by air or space transport injury event with aircraft or spacecraft damaged disabled or destroyed: PD70\\nAssault by air or space transport injury event with aircraft or spacecraft not damaged disabled or destroyed: PD71\\nAssault by air or space transport injury event with damage to aircraft or spacecraft unspecified: PD7Z\\nOther specified assault by transport injury event: PD9Y\\nAssault by transport injury event unspecified: PD9Z\\nAssault by causing a fall or jump on same level or from less than  metre: PE00\\nAssault by causing a fall or jump from a height of  metre or more: PE01\\nAssault by causing a fall or jump from unspecified height: PE0Z\\nAssault by being struck kicked or bumped by person: PE10\\nAssault by being struck kicked or bumped by animal: PE11\\nAssault by being crushed or stepped on by person: PE12\\nAssault by being crushed or stepped on by animal: PE13\\nAssault by being bitten by person: PE14\\nAssault by being bitten by animal: PE15\\nAssault by being scratched or clawed by person: PE16\\nAssault by being scratched or clawed by animal: PE17\\nAssault by being stung or envenomated by animal: PE18\\nAssault by contact with plant: PE19\\nOther specified type of assault by contact with person animal or plant: PE1Y\\nAssault by contact with person animal or plant type unspecified: PE1Z\\nAssault by projectile from firearm: PE20\\nAssault by projectile from handgun: PE20.0\\nAssault by projectile from rifle shotgun or larger firearm: PE20.1\\nAssault by being struck by projectile from other specified firearm: PE20.Y\\nAssault by being struck by projectile from unspecified firearm: PE20.Z\\nAssault by being struck by moving object not elsewhere classified: PE21\\nAssault by striking against stationary object: PE22\\nAssault by being cut or pierced by knife sword or dagger: PE30\\nAssault by being cut or pierced by sharp glass: PE31\\nAssault by being cut or pierced by other or unspecified sharp object: PE3Z\\nAssault by being struck by blunt object: PE40\\nAssault by being caught crushed jammed or pinched between objects: PE41\\nAssault by contact with other specified object not elsewhere classified: PE4Y\\nAssault by exposure to unspecified object not elsewhere classified: PE4Z\\nAssault by drowning or submersion while in body of water: PE50\\nAssault by drowning or submersion following fall into body of water: PE51\\nAssault by injury other than drowning while in body of water: PE52\\nAssault by injury other than drowning following fall into body of water: PE53\\nOther specified assault by immersion submersion or falling into water: PE5Y\\nAssault by immersion submersion or falling into water unspecified: PE5Z\\nAssault by threat to breathing suffocation from object covering mouth or nose: PE60\\nAssault by threat to breathing by hanging: PE61\\nAssault by threat to breathing by strangulation: PE62\\nAssault by threat to breathing by external compression of airways or chest: PE63\\nAssault by threat to breathing by inhalation or ingestion of liquids: PE64\\nAssault by threat to breathing by inhalation or ingestion of food: PE65\\nAssault by threat to breathing by inhalation or ingestion of other objects or materials: PE66\\nAssault by threat to breathing by low oxygen environment: PE67\\nOther specified assault by threat to breathing: PE6Y\\nAssault by threat to breathing unspecified: PE6Z\\nAssault by exposure to uncontrolled fire: PE70\\nAssault by exposure to controlled fire: PE71\\nAssault by exposure to ignition or melting of materials: PE72\\nAssault by contact with hot object or liquid: PE73\\nAssault by contact with steam hot vapour air or gases: PE74\\nAssault by exposure to excessive heat: PE75\\nAssault by exposure to excessive cold: PE76\\nAssault by exposure to other specified thermal mechanism: PE7Y\\nAssault by exposure to unspecified thermal mechanism: PE7Z\\nAssault by exposure to or harmful effects of opioids or related analgesics: PE80\\nAssault by exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants: PE81\\nAssault by exposure to or harmful effects of psychostimulants: PE82\\nAssault by exposure to or harmful effects of cannabinoids or hallucinogens: PE83\\nAssault by exposure to or harmful effects of analgesics antipyretics or nonsteroidal antiinflammatory drugs: PE84\\nAssault by exposure to or harmful effects of antidepressants: PE85\\nAssault by exposure to or harmful effects of antipsychotics: PE86\\nAssault by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs: PE87\\nAssault by exposure to or harmful effects of other or unspecified drug medicament or biological substance: PE88\\nAssault by exposure to or harmful effects of multiple drugs medicaments or biological substances: PE89\\nOther specified assault by exposure to or harmful effects of drugs medicaments or biological substances: PE8Y\\nAssault by exposure to or harmful effects of drugs medicaments or biological substances unspecified: PE8Z\\nAssault by exposure to or harmful effects of alcohols: PE90\\nAssault by exposure to or harmful effects of organic solvents: PE91\\nAssault by exposure to or harmful effects of carbon monoxide: PE92\\nAssault by exposure to or harmful effects of pesticides: PE93\\nAssault by exposure to or harmful effects of corrosive substances: PE94\\nAssault by exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source: PE95\\nAssault by foreign body in orifice or eye: PF10\\nAssault by exposure to electric current: PF11\\nAssault by exposure to sunlight: PF12\\nAssault by exposure to radiation: PF13\\nAssault by exposure to high or low air pressure or changes in air pressure: PF14\\nAssault by exposure to explosion: PF15\\nAssault by exposure to chemical explosion: PF15.0\\nAssault by explosion or rupture of materials or object: PF15.1\\nOther specified assault by exposure to explosion: PF15.Y\\nAssault by exposure to explosion unspecified: PF15.Z\\nAssault by physical overexertion: PF16\\nAssault by lack of food: PF17\\nAssault by lack of water: PF18\\nAssault by other specified privation: PF19\\nAssault by abandonment: PF1A\\nAssault by neglect: PF1B\\nOther specified assault: PF2Y\\nAssault unspecified: PF2Z\\nLand transport traffic injury event of undetermined intent injuring a pedestrian: PF40\\nLand transport traffic injury event of undetermined intent injuring the user of a pedestrian conveyance: PF41\\nLand transport traffic injury event of undetermined intent injuring a pedal cyclist: PF42\\nLand transport traffic injury event of undetermined intent injuring a motor cyclist: PF43\\nLand transport traffic injury event of undetermined intent injuring a car occupant: PF44\\nLand transport traffic injury event of undetermined intent injuring a bus or coach occupant: PF45\\nLand transport traffic injury event of undetermined intent injuring an occupant of light goods vehicle: PF46\\nLand transport traffic injury event of undetermined intent injuring an occupant of heavy goods vehicle: PF47\\nLand transport traffic injury event of undetermined intent injuring an occupant of a streetcar or tram: PF48\\nLand transport traffic injury event of undetermined intent injuring an occupant of a low powered passenger vehicle: PF49\\nLand transport traffic injury event of undetermined intent injuring a user of a special vehicle mainly used in agriculture: PF4A\\nLand transport traffic injury event of undetermined intent injuring a user of a special vehicle mainly used on industrial premises: PF4B\\nLand transport traffic injury event of undetermined intent injuring a user of a special construction vehicle: PF4C\\nLand transport traffic injury event of undetermined intent injuring a user of an allterrain vehicle: PF4D\\nLand transport traffic injury event of undetermined intent injuring a rider of an animal: PF4E\\nLand transport traffic injury event of undetermined intent injuring an occupant of an animaldrawn vehicle: PF4F\\nLand transport traffic injury event of undetermined intent injuring a user of other specified land transport: PF4Y\\nLand transport traffic injury event of undetermined intent injuring a user of unknown or unspecified land transport: PF4Z\\nLand transport nontraffic injury event of undetermined intent injuring a pedestrian: PF50\\nLand transport nontraffic injury event of undetermined intent injuring the user of a pedestrian conveyance: PF51\\nLand transport nontraffic injury event of undetermined intent injuring a pedal cyclist: PF52\\nLand transport nontraffic injury event of undetermined intent injuring a motor cyclist: PF53\\nLand transport nontraffic injury event of undetermined intent injuring a car occupant: PF54\\nLand transport nontraffic injury event of undetermined intent injuring a bus or coach occupant: PF55\\nLand transport nontraffic injury event of undetermined intent injuring an occupant of light goods vehicle: PF56\\nLand transport nontraffic injury event of undetermined intent injuring an occupant of heavy goods vehicle: PF57\\nLand transport nontraffic injury event of undetermined intent injuring an occupant of a streetcar or tram: PF58\\nLand transport nontraffic injury event of undetermined intent injuring an occupant of a low powered passenger vehicle: PF59\\nLand transport nontraffic injury event of undetermined intent injuring a user of a special vehicle mainly used in agriculture: PF5A\\nLand transport nontraffic injury event of undetermined intent injuring a user of a special vehicle mainly used on industrial premises: PF5B\\nLand transport nontraffic injury event of undetermined intent injuring a user of a special construction vehicle: PF5C\\nLand transport nontraffic injury event of undetermined intent injuring a user of an allterrain vehicle: PF5D\\nLand transport nontraffic injury event of undetermined intent injuring a rider of an animal: PF5E\\nLand transport nontraffic injury event of undetermined intent injuring an occupant of an animaldrawn vehicle: PF5F\\nLand transport nontraffic injury event of undetermined intent injuring a user of other specified land transport: PF5Y\\nLand transport nontraffic injury event of undetermined intent injuring a user of unknown or unspecified land transport: PF5Z\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a pedestrian: PF60\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring the user of a pedestrian conveyance: PF61\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a pedal cyclist: PF62\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a motor cyclist: PF63\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a car occupant: PF64\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a bus or coach occupant: PF65\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring an occupant of light goods vehicle: PF66\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring an occupant of heavy goods vehicle: PF67\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring an occupant of a streetcar or tram: PF68\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring an occupant of a low powered passenger vehicle: PF69\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a user of a special vehicle mainly used in agriculture: PF6A\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a user of a special vehicle mainly used on industrial premises: PF6B\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a user of a special construction vehicle: PF6C\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a user of an allterrain vehicle: PF6D\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a rider of an animal: PF6E\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring an occupant of an animaldrawn vehicle: PF6F\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a user of an other specified vehicle: PF6Y\\nLand transport injury event of undetermined intent unknown whether road traffic or offroad nontraffic injuring a user of an unknown or unspecified vehicle: PF6Z\\nRailway transport injury event of undetermined intent with collision or derailment: PF70\\nRailway transport injury event of undetermined intent without collision or derailment: PF71\\nRailway transport injury event of undetermined intent of unspecified type: PF7Z\\nWater transport injury event of undetermined intent with water vessel damaged disabled or destroyed causing submersion or drowning: PF80\\nWater transport injury event of undetermined intent with water vessel damaged disabled or destroyed causing other injury: PF8Y\\nWater transport injury event of undetermined intent with water vessel damaged disabled or destroyed causing unspecified injury: PF8Z\\nWater transport injury event of undetermined intent with water vessel not damaged disabled or destroyed causing submersion or drowning: PF90\\nWater transport injury event of undetermined intent with water vessel not damaged disabled or destroyed causing other injury: PF9Y\\nWater transport injury event of undetermined intent with water vessel not damaged disabled or destroyed causing unspecified injury: PF9Z\\nWater transport injury event of undetermined intent damage to water vessel unspecified: PG1Z\\nAir or space transport injury event of undetermined intent with aircraft or spacecraft damaged disabled or destroyed: PG20\\nAir or space transport injury event of undetermined intent with aircraft or spacecraft not damaged disabled or destroyed: PG21\\nAir or space transport event injury of undetermined intent damage to aircraft or spacecraft unspecified: PG2Z\\nOther specified transport injury event of undetermined intent: PG4Y\\nUnspecified transport injury event of undetermined intent: PG4Z\\nFall or jump of undetermined intent on the same level or from less than  metre: PG50\\nFall or jump of undetermined intent from a height of  metre or more: PG51\\nFall or jump of undetermined intent height unspecified: PG5Z\\nStruck kicked or bumped with undetermined intent by person: PG60\\nStruck kicked or bumped with undetermined intent by animal: PG61\\nStepped on or crushed with undetermined intent by person: PG62\\nStepped on or crushed with undetermined intent by animal: PG63\\nBitten with undetermined intent by person: PG64\\nBitten with undetermined intent by animal: PG65\\nScratched or clawed with undetermined intent by person: PG66\\nScratched or clawed with undetermined intent by animal: PG67\\nStung or envenomated with undetermined intent by animal: PG68\\nContact with plant of undetermined intent: PG69\\nOther specified type of contact with person animal or plant of undetermined intent: PG6Y\\nUnspecified type of contact with person animal or plant of undetermined intent: PG6Z\\nStruck by projectile from handgun of undetermined intent: PG70\\nStruck by projectile from rifle shotgun or larger firearm of undetermined intent: PG71\\nStruck by projectile from other specified firearm with undetermined intent: PG7Y\\nStruck by projectile from unspecified firearm with undetermined intent: PG7Z\\nStruck by moving object not elsewhere classified of undetermined intent: PG80\\nStriking against stationary object of undetermined intent: PG81\\nCut or pierced by knife sword or dagger of undetermined intent: PG90\\nCut or pierced by sharp glass of undetermined intent: PG91\\nCut or pierced by other or unspecified sharp object undetermined intent: PG9Z\\nStruck by blunt object with undetermined intent: PH00\\nCaught crushed jammed or pinched between objects with undetermined intent: PH01\\nContact with other specified object not elsewhere classified with undetermined intent: PH0Y\\nExposure to unspecified object not elsewhere classified undetermined intent: PH0Z\\nDrowning or submersion while in body of water with undetermined intent: PH10\\nDrowning or submersion following fall into body of water with undetermined intent: PH11\\nInjury other than drowning while in body of water with undetermined intent: PH12\\nInjury other than drowning following fall into body of water with undetermined intent: PH13\\nImmersion submersion or falling into water with undetermined intent unspecified: PH1Z\\nThreat to breathing by suffocation from object covering mouth or nose with undetermined intent: PH20\\nThreat to breathing by hanging with undetermined intent: PH21\\nThreat to breathing by strangulation with undetermined intent: PH22\\nThreat to breathing by external compression of airways or chest with undetermined intent: PH23\\nThreat to breathing by inhalation or ingestion of liquids with undetermined intent: PH24\\nThreat to breathing by inhalation or ingestion of food with undetermined intent: PH25\\nThreat to breathing by inhalation or ingestion of other objects or materials with undetermined intent: PH26\\nThreat to breathing by low oxygen environment with undetermined intent: PH27\\nOther specified threat to breathing with undetermined intent: PH2Y\\nThreat to breathing with undetermined intent unspecified: PH2Z\\nExposure to uncontrolled fire with undetermined intent: PH30\\nExposure to controlled fire with undetermined intent: PH31\\nExposure to ignition or melting of materials with undetermined intent: PH32\\nContact with hot object or liquid with undetermined intent: PH33\\nContact with steam hot vapour air or gases with undetermined intent: PH34\\nExposure to excessive heat with undetermined intent: PH35\\nExposure to excessive cold with undetermined intent: PH36\\nExposure to other specified thermal mechanism with undetermined intent: PH3Y\\nExposure to unspecified thermal mechanism with undetermined intent: PH3Z\\nExposure to or harmful effects of undetermined intent of opioids or related analgesics: PH40\\nExposure to or harmful effects of undetermined intent of sedative hypnotic drugs or other CNS depressants: PH41\\nExposure to or harmful effects of undetermined intent of psychostimulants: PH42\\nExposure to or harmful effects of undetermined intent of cannabinoids or hallucinogens: PH43\\nExposure to or harmful effects of undetermined intent of analgesics antipyretics or nonsteroidal antiinflammatory drugs: PH44\\nExposure to or harmful effects of undetermined intent of antidepressants: PH45\\nExposure to or harmful effects of undetermined intent of antipsychotics: PH46\\nExposure to or harmful effects of undetermined intent of antiepileptics or antiparkinsonism drugs: PH47\\nHarmful effects of or exposure to mixed antiepileptics not elsewhere classified undetermined intent: PH47.0\\nUndetermined intent Harmful effects of and exposure to noxious substances Drugs medicaments or biological substances Unspecified antiepileptics or antiparkinsonism drugs: PH47.Z\\nExposure to or harmful effects of undetermined intent of other or unspecified drugs medicaments or biological substances: PH48\\nExposure to or harmful effects of undetermined intent of multiple drugs medicaments or biological substances: PH49\\nExposure to or harmful effects of undetermined intent of alcohols: PH50\\nExposure to or harmful effects of undetermined intent of organic solvents: PH51\\nExposure to or harmful effects of undetermined intent of carbon monoxide: PH52\\nExposure to or harmful effects of undetermined intent of pesticides: PH53\\nExposure to or harmful effects of undetermined intent of corrosive substances: PH54\\nExposure to or harmful effects of undetermined intent of halogen derivatives of aliphatic or aromatic hydrocarbons: PH55\\nExposure to or harmful effects of undetermined intent of other or unspecified substances chiefly nonmedicinal as to source: PH56\\nExposure to foreign body in orifice or eye with undetermined intent: PH70\\nExposure to electric current with undetermined intent: PH71\\nExposure to sunlight with undetermined intent: PH72\\nExposure to radiation with undetermined intent: PH73\\nExposure to high or low air pressure or changes in air pressure with undetermined intent: PH74\\nExposure to explosion with undetermined intent: PH75\\nExposure to chemical explosion with undetermined intent: PH75.0\\nExposure to explosion or rupture of pressurised materials or object with undetermined intent: PH75.1\\nOther specified exposure to explosion with undetermined intent: PH75.Y\\nExposure to explosion with undetermined intent unspecified: PH75.Z\\nPhysical overexertion with undetermined intent: PH76\\nLack of food with undetermined intent: PH77\\nLack of water with undetermined intent: PH78\\nOther specified privation with undetermined intent: PH79\\nAbandonment with undetermined intent: PH7A\\nNeglect with undetermined intent: PH7B\\nOther specified injury event of undetermined intent: PH8Y\\nUnspecified injury event of undetermined intent: PH8Z\\nVictim of lightning: PJ00\\nVictim of earthquake: PJ01\\nVictim of cataclysmic earth movements caused by earthquake: PJ02\\nVictim of tsunami: PJ03\\nVictim of volcanic eruption: PJ04\\nVictim of avalanche landslide or other earth movements: PJ05\\nVictim of cataclysmic storm: PJ06\\nVictim of flood: PJ07\\nExposure to other specified forces of nature: PJ0Y\\nExposure to unspecified forces of nature: PJ0Z\\nPhysical maltreatment: PJ20\\nSexual maltreatment: PJ21\\nPsychological maltreatment: PJ22\\nOther specified maltreatment: PJ2Y\\nMaltreatment unspecified: PJ2Z\\nLegal intervention involving projectile from firearm: PJ40\\nLegal intervention involving other projectile: PJ41\\nLegal intervention involving blunt object: PJ42\\nLegal intervention involving sharp object: PJ43\\nLegal intervention involving electric weapon: PJ44\\nLegal intervention involving explosive: PJ45\\nLegal intervention involving gas: PJ46\\nLegal intervention involving application of physical force: PJ47\\nLegal intervention involving other means: PJ4Y\\nLegal intervention involving unspecified means: PJ4Z\\nExplosion of depthcharge or marine mine during armed conflict: PJ60\\nExplosion of torpedo during armed conflict: PJ61\\nExplosion of seabased artillery shell during armed conflict: PJ62\\nExplosion of other marine weapons during armed conflict: PJ6Y\\nExplosion of unspecified marine weapon: PJ6Z\\nAttack on or destruction of aircraft during armed conflict due to enemy fire or explosives: PJ70\\nAttack on or destruction of aircraft during armed conflict due to collision with other aircraft: PJ71\\nOther destruction of aircraft during armed conflict: PJ7Y\\nUnspecified destruction of aircraft during armed conflict: PJ7Z\\nExplosion of missile during armed conflict: PJ80\\nExplosion of aerial bomb during armed conflict: PJ81\\nExplosion of munitions or weapons during armed conflict: PJ82\\nExplosion of improvised explosive device during armed conflict: PJ83\\nOther explosion or fragments during armed conflict: PJ8Y\\nUnspecified explosion or fragments during armed conflict: PJ8Z\\nUse of gasoline bomb during armed conflict: PJ90\\nUse of flamethrower during armed conflict: PJ91\\nUse of incendiary bullets during armed conflict: PJ92\\nOther specified fires conflagrations or hot substances during armed conflict: PJ9Y\\nUnspecified fire conflagration or hot substance during armed conflict: PJ9Z\\nUse of rubber bullets during armed conflict: PK00\\nUse of firearm pellets during armed conflict: PK01\\nOther firearms discharge during armed conflict: PK02\\nOther weapons use during armed conflict: PK03\\nUnarmed combat during armed conflict: PK04\\nOther specified forms of conventional weapons use during armed conflict: PK0Y\\nUnspecified forms of conventional weapons use during armed conflict: PK0Z\\nThermal or blast effects of nuclear weapon during armed conflict: PK10\\nNuclear radiation effects of nuclear weapon during armed conflict: PK11\\nOther specified effect of nuclear weapon during armed conflict: PK1Y\\nUnspecified effect of nuclear weapon during armed conflict: PK1Z\\nUse of weaponised microorganisms during armed conflict: PK20\\nUse of other specified biological weapons during armed conflict: PK2Y\\nUse of unspecified biological weapons during armed conflict: PK2Z\\nUse of chemical weapons during armed conflict: PK30\\nUse of lasers or other energetic beams or fields during armed conflict: PK31\\nUse of electric weapons during armed conflict: PK32\\nUse of autonomous or semiautonomous machines as weapons during armed conflict: PK33\\nOther specified forms of unconventional warfare during armed conflict: PK3Y\\nUnspecified forms of unconventional warfare during armed conflict: PK3Z\\nExplosion of mine after cessation of armed conflict: PK40\\nExplosion of bomb after cessation of armed conflict: PK41\\nUnspecified harmful event occurring after cessation of armed conflict: PK4Z\\nOther specified armed conflict: PK6Y\\nUnspecified armed conflict: PK6Z\\nMedical or surgical procedure associated with injury or harm in therapeutic use: PK80\\nNeurological procedure associated with injury or harm in therapeutic use: PK80.0\\nNeurological procedure associated with injury or harm open approach: PK80.00\\nNeurological procedure associated with injury or harm percutaneous approach: PK80.01\\nNeurological procedure associated with injury or harm endoscopic approach: PK80.02\\nNeurological procedure associated with injury or harm other specified approach: PK80.0Y\\nNeurological procedure associated with injury or harm unspecified approach: PK80.0Z\\nCardiac procedure associated with injury or harm in therapeutic use: PK80.1\\nCardiac procedure for repair of congenital anomaly associated with injury or harm open approach: PK80.10\\nCardiac procedure for repair of congenital anomaly associated with injury or harm percutaneous approach: PK80.11\\nCardiac procedure for repair of congenital anomaly associated with injury or harm endoscopic approach: PK80.12\\nCardiac procedure for repair of congenital anomaly associated with injury or harm unspecified approach: PK80.13\\nOther cardiac procedure associated with injury or harm open approach: PK80.14\\nOther cardiac procedure associated with injury or harm percutaneous approach: PK80.15\\nOther cardiac procedure associated with injury or harm endoscopic approach: PK80.16\\nOther cardiac procedure associated with injury or harm unspecified approach: PK80.17\\nUnspecified type of cardiac procedure associated with injury or harm in therapeutic use other specified approach: PK80.1Y\\nUnspecified type of cardiac procedure associated with injury or harm in therapeutic use unspecified approach: PK80.1Z\\nThoracic procedure associated with injury or harm in therapeutic use: PK80.2\\nThoracic procedure associated with injury or harm open approach: PK80.20\\nThoracic procedure associated with injury or harm percutaneous approach: PK80.21\\nThoracic procedure associated with injury or harm endoscopic approach: PK80.22\\nThoracic procedure associated with injury or harm other specified approach: PK80.2Y\\nThoracic procedure associated with injury or harm unspecified approach: PK80.2Z\\nGastrointestinal abdominal or abdominal wall procedure associated with injury or harm in therapeutic use: PK80.3\\nGastrointestinal abdominal or abdominal wall procedure associated with injury or harm open approach: PK80.30\\nGastrointestinal abdominal or abdominal wall procedure associated with injury or harm percutaneous approach: PK80.31\\nGastrointestinal abdominal or abdominal wall procedure associated with injury or harm endoscopic approach: PK80.32\\nGastrointestinal abdominal or abdominal wall procedure associated with injury or harm in therapeutic use other specified approach: PK80.3Y\\nGastrointestinal abdominal or abdominal wall procedure associated with injury or harm in therapeutic use unspecified approach: PK80.3Z\\nEndocrine procedure associated with injury or harm in therapeutic use: PK80.4\\nEndocrine procedure associated with injury or harm open approach: PK80.40\\nEndocrine procedure associated with injury or harm percutaneous approach: PK80.41\\nEndocrine procedure associated with injury or harm endoscopic approach: PK80.42\\nEndocrine procedure associated with injury or harm in therapeutic use other specified approach: PK80.4Y\\nEndocrine procedure associated with injury or harm in therapeutic use unspecified approach: PK80.4Z\\nGynaecological or breast procedure associated with injury or harm in therapeutic use: PK80.5\\nGynaecological or breast procedure associated with injury or harm open approach: PK80.50\\nGynaecological or breast procedure associated with injury or harm percutaneous approach: PK80.51\\nGynaecological or breast procedure associated with injury or harm endoscopic approach: PK80.52\\nGynaecological or breast procedure associated with injury or harm in therapeutic use per orifice approach: PK80.53\\nGynaecological or breast procedure associated with injury or harm in therapeutic use other specified approach: PK80.5Y\\nGynaecological or breast procedure associated with injury or harm in therapeutic use unspecified approach: PK80.5Z\\nUrological procedure associated with injury or harm in therapeutic use: PK80.6\\nUrological procedure associated with injury or harm open approach: PK80.60\\nUrological procedure associated with injury or harm percutaneous approach: PK80.61\\nUrological procedure associated with injury or harm endoscopic approach: PK80.62\\nUrological procedure associated with injury or harm other specified approach: PK80.6Y\\nUrological procedure associated with injury or harm unspecified approach: PK80.6Z\\nObstetric procedure associated with injury or harm in therapeutic use: PK80.7\\nCaesarean section or other obstetric procedure associated with injury or harm open approach: PK80.70\\nObstetric procedure associated with injury or harm percutaneous approach: PK80.71\\nObstetric procedure associated with injury or harm endoscopic approach: PK80.72\\nObstetric procedure associated with injury or harm in therapeutic use per orifice approach: PK80.73\\nCaesarean section or other obstetric procedure associated with injury or harm other specified approach: PK80.7Y\\nCaesarean section or other obstetric procedure associated with injury or harm unspecified approach: PK80.7Z\\nMusculoskeletal procedure associated with injury or harm in therapeutic use: PK80.8\\nMusculoskeletal procedure associated with injury or harm open approach: PK80.80\\nMusculoskeletal procedure associated with injury or harm percutaneous approach: PK80.81\\nMusculoskeletal procedure associated with injury or harm endoscopic approach: PK80.82\\nMusculoskeletal procedure associated with injury or harm in therapeutic use other specified approach: PK80.8Y\\nMusculoskeletal procedure associated with injury or harm in therapeutic use unspecified approach: PK80.8Z\\nVascular procedure associated with injury or harm in therapeutic use: PK80.9\\nVascular procedure associated with injury or harm open approach: PK80.90\\nVascular procedure associated with injury or harm percutaneous approach: PK80.91\\nVascular procedure associated with injury or harm endoscopic approach: PK80.92\\nVascular procedure associated with injury or harm other specified approach: PK80.9Y\\nVascular procedure associated with injury or harm unspecified approach: PK80.9Z\\nEar nose oral or throat procedure associated with injury or harm in therapeutic use: PK80.A\\nEar nose oral or throat procedure associated with injury or harm open approach: PK80.A0\\nEar nose oral or throat procedure associated with injury or harm percutaneous approach: PK80.A1\\nEar nose oral or throat procedure associated with injury or harm endoscopic approach: PK80.A2\\nEar nose oral or throat procedure associated with injury or harm in therapeutic use other specified approach: PK80.AY\\nEar nose oral or throat procedure associated with injury or harm in therapeutic use unspecified approach: PK80.AZ\\nDental procedure associated with injury or harm in therapeutic use: PK80.B\\nDental procedure associated with injury or harm open approach: PK80.B0\\nDental procedure associated with injury or harm percutaneous approach: PK80.B1\\nDental procedure associated with injury or harm endoscopic approach: PK80.B2\\nDental procedure associated with injury or harm other specified approach: PK80.BY\\nDental procedure associated with injury or harm unspecified approach: PK80.BZ\\nSkin or integument procedure associated with injury or harm in therapeutic use: PK80.C\\nSkin or integument procedure associated with injury or harm open approach: PK80.C0\\nSkin or integument procedure associated with injury or harm percutaneous approach: PK80.C1\\nSkin or integument procedure associated with injury or harm endoscopic approach: PK80.C2\\nSkin or integument procedure associated with injury or harm in therapeutic use other specified approach: PK80.CY\\nSkin or integument procedure associated with injury or harm in therapeutic use unspecified approach: PK80.CZ\\nOphthalmic procedure associated with injury or harm in therapeutic use: PK80.D\\nCertain medical procedures associated with injury or harm in therapeutic use: PK81\\nVentilation associated with injury or harm in therapeutic use: PK81.0\\nExtracorporeal life support procedure associated with injury or harm in therapeutic use: PK81.1\\nAspiration or drainage of body cavity or fluid collection associated with injury or harm in therapeutic use: PK81.2\\nAcupuncture or related therapies associated with injury or harm in therapeutic use: PK81.3\\nAcupuncture cupping associated with injury or harm in therapeutic use: PK81.30\\nOther specified acupuncture or related therapies associated with injury or harm in therapeutic use: PK81.3Y\\nAcupuncture or related therapies associated with injury or harm in therapeutic use unspecified: PK81.3Z\\nBone marrow aspiration or biopsy associated with injury or harm in therapeutic use: PK81.4\\nBiopsy procedure not elsewhere classified associated with injury or harm in therapeutic use: PK81.5\\nDialysis associated with injury or harm in therapeutic use: PK81.6\\nInjection or infusion for therapeutic or diagnostic purposes associated with injury or harm in therapeutic use: PK81.7\\nInsertion of tube associated with injury or harm in therapeutic use: PK81.8\\nJoint aspiration associated with injury or harm in therapeutic use: PK81.9\\nLumbar puncture associated with injury or harm in therapeutic use: PK81.A\\nManipulative therapies associated with injury or harm in therapeutic use: PK81.B\\nRadiation therapy associated with injury or harm in therapeutic use: PK81.C\\nOther specified medical procedure associated with injury or harm in therapeutic use: PK81.D\\nCardiopulmonary resuscitation associated with injury or harm in therapeutic use: PK81.E\\nNeedle stick associated with injury or harm in therapeutic use: PK81.F\\nOther specified surgical or other medical procedures associated with injury or harm in diagnostic or therapeutic use: PK8Y\\nSurgical or other medical procedures associated with injury or harm in diagnostic or therapeutic use unspecified: PK8Z\\nAnaesthesiology devices associated with injury or harm: PK90\\nAnaesthesiology devices associated with injury or harm diagnostic or monitoring devices: PK90.0\\nAnaesthesiology devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK90.1\\nAnaesthesiology devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK90.2\\nAnaesthesiology devices associated with injury or harm surgical instruments materials or devices: PK90.3\\nAnaesthesiology devices associated with injury or harm miscellaneous devices not elsewhere classified: PK90.4\\nOther specified anaesthesiology devices associated with injury or harm: PK90.Y\\nAnaesthesiology devices associated with injury or harm unspecified: PK90.Z\\nCardiovascular devices implants or grafts associated with injury or harm: PK91\\nCardiovascular devices associated with injury or harm diagnostic or monitoring devices: PK91.0\\nCardiovascular devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK91.1\\nCardiovascular devices associated with injury or harm pacemaker: PK91.10\\nCardiovascular devices associated with injury or harm implantable defibrillator: PK91.11\\nCardiovascular devices associated with injury or harm left ventricular assist devices: PK91.12\\nCardiovascular devices associated with injury or harm intraaortic balloon pump: PK91.13\\nCardiovascular devices associated with injury or harm IVC filter: PK91.14\\nCardiovascular devices associated with injury or harm central venous catheter: PK91.15\\nCardiovascular devices associated with injury or harm peripheral venous catheter: PK91.16\\nOther specified cardiovascular devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK91.1Y\\nCardiovascular devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices unspecified: PK91.1Z\\nCardiovascular devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK91.2\\nCardiovascular devices associated with injury or harm grafts: PK91.20\\nCardiovascular devices associated with injury or harm stents: PK91.21\\nCardiovascular devices associated with injury or harm mechanical or bioprosthetic valves: PK91.22\\nOther specified cardiovascular devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK91.2Y\\nCardiovascular devices associated with injury or harm prosthetic or other implants materials or accessory devices unspecified: PK91.2Z\\nCardiovascular devices associated with injury or harm surgical instruments materials or devices: PK91.3\\nCardiovascular devices associated with injury or harm miscellaneous devices not elsewhere classified: PK91.4\\nOther specified cardiovascular devices implants or grafts associated with injury or harm: PK91.Y\\nCardiovascular devices implants or grafts associated with injury or harm unspecified: PK91.Z\\nOtorhinolaryngological devices implants or grafts associated with injury or harm: PK92\\nOtorhinolaryngological devices associated with injury or harm diagnostic or monitoring devices: PK92.0\\nOtorhinolaryngological devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK92.1\\nOtorhinolaryngological devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK92.2\\nOtorhinolaryngological devices associated with injury or harm surgical instruments materials or devices: PK92.3\\nOtorhinolaryngological devices associated with injury or harm miscellaneous devices not elsewhere classified: PK92.4\\nOther specified otorhinolaryngological devices implants or grafts associated with injury or harm: PK92.Y\\nOtorhinolaryngological devices implants or grafts associated with injury or harm unspecified: PK92.Z\\nGastroenterology or urology devices implants or grafts associated with injury or harm: PK93\\nGastroenterology or urology devices associated with injury or harm diagnostic or monitoring devices: PK93.0\\nGastroenterology or urology devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK93.1\\nGastroenterology or urology devices associated with injury or harm urinary catheter: PK93.10\\nOther specified gastroenterology or urology devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK93.1Y\\nGastroenterology or urology devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices unspecified: PK93.1Z\\nGastroenterology or urology devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK93.2\\nGastroenterology or urology devices associated with injury or harm surgical instruments materials or devices: PK93.3\\nGastroenterology or urology devices associated with injury or harm miscellaneous devices not elsewhere classified: PK93.4\\nOther specified gastroenterology or urology devices implants or grafts associated with injury or harm: PK93.Y\\nGastroenterology or urology devices implants or grafts associated with injury or harm unspecified: PK93.Z\\nGeneral hospital or personal use devices associated with injury or harm: PK94\\nGeneral hospital or personal use devices associated with injury or harm diagnostic or monitoring devices: PK94.0\\nGeneral hospital or personal use devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK94.1\\nGeneral hospital or personal use devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK94.2\\nGeneral hospital or personal use devices associated with injury or harm surgical instruments materials or devices: PK94.3\\nGeneral hospital or personal use devices associated with injury or harm miscellaneous devices not elsewhere classified: PK94.4\\nOther specified general hospital or personal use devices associated with injury or harm: PK94.Y\\nGeneral hospital or personal use devices associated with injury or harm unspecified: PK94.Z\\nNeurological devices implants or grafts associated with injury or harm: PK95\\nNeurological devices associated with injury or harm diagnostic or monitoring devices: PK95.0\\nNeurological devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK95.1\\nNeurological devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK95.2\\nNeurological devices associated with injury or harm ventricular shunt: PK95.20\\nOther specified neurological devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK95.2Y\\nNeurological devices associated with injury or harm prosthetic or other implants materials or accessory devices unspecified: PK95.2Z\\nNeurological devices associated with injury or harm surgical instruments materials or devices: PK95.3\\nNeurological devices associated with injury or harm miscellaneous devices not elsewhere classified: PK95.4\\nOther specified neurological devices implants or grafts associated with injury or harm: PK95.Y\\nNeurological devices implants or grafts associated with injury or harm unspecified: PK95.Z\\nObstetric or gynaecological devices implants or grafts associated with injury or harm: PK96\\nObstetric or gynaecological devices associated with injury or harm diagnostic or monitoring devices: PK96.0\\nObstetric or gynaecological devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK96.1\\nObstetric or gynaecological devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK96.2\\nObstetric or gynaecological devices associated with injury or harm surgical instruments materials or devices: PK96.3\\nObstetric or gynaecological devices associated with injury or harm miscellaneous devices not elsewhere classified: PK96.4\\nOther specified obstetric or gynaecological devices implants or grafts associated with injury or harm: PK96.Y\\nObstetric or gynaecological devices implants or grafts associated with injury or harm unspecified: PK96.Z\\nOphthalmic devices implants or grafts associated with injury or harm: PK97\\nOphthalmic devices associated with injury or harm diagnostic or monitoring devices: PK97.0\\nOphthalmic devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK97.1\\nOphthalmic devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK97.2\\nOphthalmic devices associated with injury or harm surgical instruments materials or devices: PK97.3\\nOphthalmic devices associated with injury or harm miscellaneous devices not elsewhere classified: PK97.4\\nOther specified ophthalmic devices implants or grafts associated with injury or harm: PK97.Y\\nOphthalmic devices implants or grafts associated with injury or harm unspecified: PK97.Z\\nRadiological devices associated with injury or harm: PK98\\nRadiological devices associated with injury or harm diagnostic or monitoring devices: PK98.0\\nRadiological devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK98.1\\nRadiological devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK98.2\\nRadiological devices associated with injury or harm surgical instruments materials or devices: PK98.3\\nRadiological devices associated with injury or harm miscellaneous devices not elsewhere classified: PK98.4\\nOther specified radiological devices associated with injury or harm: PK98.Y\\nRadiological devices associated with injury or harm unspecified: PK98.Z\\nOrthopaedic devices implants or grafts associated with injury or harm: PK99\\nOrthopaedic devices associated with injury or harm diagnostic or monitoring devices: PK99.0\\nOrthopaedic devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK99.1\\nOrthopaedic devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK99.2\\nOrthopaedic devices associated with injury or harm surgical instruments materials or devices: PK99.3\\nOrthopaedic devices associated with injury or harm miscellaneous devices not elsewhere classified: PK99.4\\nOther specified orthopaedic devices implants or grafts associated with injury or harm: PK99.Y\\nOrthopaedic devices implants or grafts associated with injury or harm unspecified: PK99.Z\\nPhysical medicine devices associated with injury or harm: PK9A\\nPhysical medicine devices associated with injury or harm diagnostic or monitoring devices: PK9A.0\\nPhysical medicine devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK9A.1\\nPhysical medicine devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK9A.2\\nCommunication system devices associated with adverse incidents: PK9A.20\\nCommunication system devices associated with adverse incidents in a physical medicine care environment: PK9A.21\\nEnvironmental control system devices associated with adverse incidents: PK9A.22\\nMobility aids associated with adverse incidents: PK9A.23\\nOrthotic devices associated with adverse incidents: PK9A.24\\nOther specified physical medicine devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK9A.2Y\\nPhysical medicine devices associated with injury or harm prosthetic or other implants materials or accessory devices unspecified: PK9A.2Z\\nPhysical medicine devices associated with injury or harm surgical instruments materials or devices: PK9A.3\\nPhysical medicine devices associated with injury or harm miscellaneous devices not elsewhere classified: PK9A.4\\nOther specified physical medicine devices associated with injury or harm: PK9A.Y\\nPhysical medicine devices associated with injury or harm unspecified: PK9A.Z\\nGeneral or plastic surgery devices implants or grafts associated with injury or harm: PK9B\\nGeneral or plastic surgery devices associated with injury or harm diagnostic or monitoring devices: PK9B.0\\nGeneral or plastic surgery devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK9B.1\\nGeneral or plastic surgery devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK9B.2\\nGeneral or plastic surgery devices associated with injury or harm surgical instruments materials or devices: PK9B.3\\nGeneral or plastic surgery devices associated with injury or harm miscellaneous devices not elsewhere classified: PK9B.4\\nOther specified general or plastic surgery devices implants or grafts associated with injury or harm: PK9B.Y\\nGeneral or plastic surgery devices implants or grafts associated with injury or harm unspecified: PK9B.Z\\nOther or unspecified medical devices implants or grafts associated with injury or harm: PK9C\\nOther or unspecified medical devices associated with injury or harm diagnostic or monitoring devices: PK9C.0\\nOther or unspecified medical devices associated with injury or harm therapeutic nonsurgical or rehabilitative devices: PK9C.1\\nOther or unspecified medical devices associated with injury or harm prosthetic or other implants materials or accessory devices: PK9C.2\\nOther or unspecified medical devices associated with injury or harm surgical instruments materials or devices: PK9C.3\\nMechanical complication of nonabsorbable surgical material not otherwise specified: PK9C.30\\nMechanical complication of permanent sutures: PK9C.31\\nOther specified other or unspecified medical devices associated with injury or harm surgical instruments materials or devices: PK9C.3Y\\nOther or unspecified medical devices associated with injury or harm surgical instruments materials or devices unspecified: PK9C.3Z\\nOther or unspecified medical devices associated with injury or harm miscellaneous devices not elsewhere classified: PK9C.4\\nDrugs medicaments or biological substances associated with injury or harm in therapeutic use: PL00\\nComplementary or traditional medicines associated with injury or harm in therapeutic use: PL01\\nComplementary or traditional medicines associated with injury or harm in therapeutic use Herbal Preparations or Formulas: PL01.0\\nComplementary or traditional medicines associated with injury or harm in therapeutic use Dietary Supplements Vitamins or Minerals: PL01.1\\nComplementary or traditional medicines associated with injury or harm in therapeutic use Complementary or Traditional Medicines not elsewhere classified: PL01.2\\nOther specified complementary or traditional medicines associated with injury or harm in therapeutic use: PL01.Y\\nComplementary or traditional medicines associated with injury or harm in therapeutic use unspecified: PL01.Z\\nSubstances associated with injury or harm in therapeutic use unspecified: PL0Z\\nOther health care related causes of injury or harm: PL10\\nMode of injury or harm associated with a surgical or other medical procedure: PL11\\nCut puncture or tear as mode of injury or harm: PL11.0\\nBurn arising during procedure as mode of injury or harm: PL11.1\\nEmbolisation as mode of injury or harm: PL11.2\\nAir embolism as mode of injury: PL11.20\\nOther specified embolisation as mode of injury or harm: PL11.2Y\\nEmbolisation as mode of injury or harm unspecified: PL11.2Z\\nForeign body accidentally left in body as mode of injury or harm: PL11.3\\nFailure of sterile precautions as mode of injury or harm: PL11.4\\nProcedure undertaken at wrong site or wrong side as mode of injury or harm: PL11.5\\nPressure as mode of injury or harm: PL11.6\\nOther specified mode of injury or harm associated with a surgical or other medical procedure: PL11.Y\\nUnspecified mode of injury or harm associated with a surgical or other medical procedure: PL11.Z\\nMode of injury or harm associated with a surgical or other medical device implant or graft: PL12\\nStructural device failure as mode of injury or harm: PL12.0\\nFunctional device failure as mode of injury or harm: PL12.1\\nPerforation or protrusion by device as mode of injury or harm: PL12.2\\nObstruction of device as mode of injury or harm: PL12.3\\nDislodgement misconnection or deattachment as mode of injury or harm: PL12.4\\nOperator error as mode of injury or harm: PL12.5\\nCombination or interaction of operator error and device failure as mode of injury or harm: PL12.6\\nOther specified mode of injury or harm associated with a surgical or other medical device implant or graft: PL12.Y\\nMode of injury or harm associated with a surgical or other medical device implant or graft unspecified: PL12.Z\\nMode of injury or harm associated with exposure to a drug medicament or biological substance: PL13\\nOverdose of substance as mode of injury or harm: PL13.0\\nUnderdosing as mode of injury or harm: PL13.1\\nDrugrelated injury or harm in the context of correct administration or dosage as mode of injury or harm: PL13.2\\nIncorrect substance as mode of injury or harm: PL13.3\\nIncorrect administration of drug or medicament as mode of injury: PL13.5\\nIncorrect route of drug or medicament as mode of injury: PL13.50\\nIncorrect rate of drug or medicament as mode of injury: PL13.51\\nIncorrect timing of drug or medicament as mode of injury: PL13.52\\nIncorrect duration of drug or medicament as mode of injury: PL13.53\\nOther specified incorrect administration of drug or medicament as mode of injury: PL13.5Y\\nIncorrect administration of drug or medicament as mode of injury unspecified: PL13.5Z\\nMedication or substance that is known to be an allergen as mode of injury or harm: PL13.6\\nMedication or substance that is known to be contraindicated for the patient as mode of injury or harm: PL13.7\\nExpired or deteriorated medication or substance as mode of injury or harm: PL13.8\\nDrug or substance interactions as mode of injury or harm: PL13.9\\nInappropriate stoppage or discontinuation of drug as mode of injury or harm: PL13.A\\nOther specified mode of injury or harm associated with exposure to a drug medicament or biological substance: PL13.Y\\nMode of injury or harm associated with exposure to a drug medicament or biological substance unspecified: PL13.Z\\nMode of injury or harm associated with other health care related causes: PL14\\nNonadministration of necessary drug: PL14.0\\nNon provision of necessary procedure: PL14.1\\nProblem associated with physical transfer of patient: PL14.2\\nMismatched blood used in transfusion: PL14.3\\nOther problem associated with transfusion: PL14.4\\nProblem associated with physical restraints: PL14.5\\nProblem associated with isolation protocol: PL14.6\\nProblem associated with clinical documentation: PL14.7\\nProblem associated with clinical software: PL14.8\\nIncorrect diagnosis: PL14.9\\nDelayed diagnosis: PL14.A\\nDelayed treatment: PL14.B\\nPatient received diagnostic test or treatment intended for another patient: PL14.C\\nProblem associated with transitions of care hand offs or handovers: PL14.D\\nFall in health care: PL14.E\\nOther specified aspects of care associated with injury or harm: PL14.Y\\nMode of injury or harm associated with other health care related causes unspecified: PL14.Z\\nOther specified external causes of morbidity or mortality: PL2Y\\nExternal causes of morbidity or mortality unspecified: PL2Z\\nGeneral examination or investigation of persons without complaint or reported diagnosis: QA00\\nGeneral adult medical examination: QA00.0\\nRoutine child health examination: QA00.1\\nRoutine newborn health examination: QA00.2\\nGeneral mental examination: QA00.3\\nExamination of potential donor of organ or tissue: QA00.4\\nExamination for normal comparison or control in clinical research programme: QA00.5\\nExamination of eyes or vision: QA00.6\\nNormal Visual Field: QA00.61\\nNo vision impairment: QA00.62\\nOther specified examination of eyes or vision: QA00.6Y\\nExamination of eyes or vision unspecified: QA00.6Z\\nExamination of ears and hearing: QA00.7\\nDental examination: QA00.8\\nGynaecological examination: QA00.9\\nSkin or other sensitisation tests: QA00.A\\nRadiological examination: QA00.B\\nLaboratory examination: QA00.C\\nEncounter for blood typing: QA00.D\\nEncounter for antibody response examination: QA00.E\\nOther specified general examination or investigation of persons without complaint or reported diagnosis: QA00.Y\\nGeneral examination or investigation of persons without complaint or reported diagnosis unspecified: QA00.Z\\nExamination or encounter for administrative purposes: QA01\\nExamination for admission to educational institution: QA01.0\\nPreemployment examination: QA01.1\\nExamination for admission to residential institutions: QA01.2\\nExamination for recruitment to armed forces: QA01.3\\nExamination for driving license: QA01.4\\nExamination for participation in sport: QA01.5\\nExamination for insurance purposes: QA01.6\\nIssue of medical certificate: QA01.7\\nEncounter for adoption services: QA01.8\\nOther specified examination or encounter for administrative purposes: QA01.Y\\nExamination or encounter for administrative purposes unspecified: QA01.Z\\nMedical observation or evaluation for suspected diseases or conditions ruled out: QA02\\nObservation for suspected tuberculosis ruled out: QA02.0\\nObservation for suspected Dengue ruled out: QA02.1\\nObservation for suspected malignant neoplasm ruled out: QA02.2\\nObservation for suspected mental or behavioural disorders ruled out: QA02.3\\nObservation for suspected nervous system disorder ruled out: QA02.4\\nObservation for suspected toxic effect from ingested substance ruled out: QA02.5\\nObservation and evaluation of newborn for suspected condition ruled out: QA02.6\\nObservation for suspected suicide ideation or attempt ruled out: QA02.7\\nObservation for suspected allergy or hypersensitivity ruled out: QA02.8\\nMedical observation or evaluation for other suspected diseases or conditions ruled out: QA02.Y\\nRoutine general health checkup of defined subpopulation: QA03\\nOccupational health examination: QA03.0\\nRoutine general health checkup of inhabitants of institutions: QA03.1\\nRoutine general health checkup of armed forces: QA03.2\\nRoutine general health checkup of sports teams: QA03.3\\nOther specified routine general health checkup of defined subpopulation: QA03.Y\\nRoutine general health checkup of defined subpopulation unspecified: QA03.Z\\nExamination or observation for reasons other than suspected diseases or conditions or administrative purposes: QA04\\nBloodalcohol or blooddrug test: QA04.0\\nAlcohol and drug testing other than by blood: QA04.1\\nExamination or observation following transport accident: QA04.2\\nExamination or observation following work accident: QA04.3\\nExamination or observation following accident other than work or transport: QA04.4\\nExamination or observation for suspected maltreatment: QA04.5\\nExamination or observation for suspected physical maltreatment: QA04.50\\nExamination or observation for suspected sexual maltreatment: QA04.51\\nExamination or observation for suspected psychological maltreatment: QA04.52\\nExamination or observation for suspected neglect or abandonment: QA04.53\\nOther specified examination or observation for suspected maltreatment: QA04.5Y\\nExamination or observation for suspected maltreatment unspecified: QA04.5Z\\nGeneral mental examination requested by authority: QA04.6\\nExamination for medicolegal reasons: QA04.7\\nOther specified examination or observation for reasons other than suspected diseases or conditions or administrative purposes: QA04.Y\\nExamination or observation for reasons other than suspected diseases or conditions or administrative purposes unspecified: QA04.Z\\nPerson consulting for explanation of investigation findings: QA05\\nFollowup examination after treatment for malignant neoplasms: QA06\\nFollowup examination after treatment for conditions other than malignant neoplasms: QA07\\nFollowup examination after organ transplant: QA07.0\\nOther specified followup examination after treatment for conditions other than malignant neoplasms: QA07.Y\\nFollowup examination after treatment for conditions other than malignant neoplasms unspecified: QA07.Z\\nSpecial screening examination for infectious diseases: QA08\\nSpecial screening examination for intestinal infectious diseases: QA08.0\\nSpecial screening examination for respiratory tuberculosis: QA08.1\\nSpecial screening examination for other bacterial diseases: QA08.2\\nSpecial screening examination for infections with a predominantly sexual mode of transmission: QA08.3\\nSpecial screening examination for human immunodeficiency virus: QA08.4\\nSpecial screening examination for other viral diseases: QA08.5\\nSpecial screening examination for other protozoal diseases or helminthiases: QA08.6\\nSpecial screening examination for other specified infectious diseases: QA08.Y\\nSpecial screening examination for unspecified infectious diseases: QA08.Z\\nSpecial screening examination for neoplasms: QA09\\nSpecial screening examination for neoplasm of stomach: QA09.0\\nSpecial screening examination for neoplasm of intestinal tract: QA09.1\\nSpecial screening examination for neoplasm of respiratory organs: QA09.2\\nSpecial screening examination for neoplasm of breast: QA09.3\\nSpecial screening examination for neoplasm of cervix: QA09.4\\nSpecial screening examination for neoplasm of prostate: QA09.5\\nSpecial screening examination for neoplasm of bladder: QA09.6\\nSpecial screening examination for neoplasm of skin: QA09.7\\nOther specified special screening examination for neoplasms: QA09.Y\\nSpecial screening for neoplasm of unspecified site: QA09.Z\\nSpecial screening examination for other diseases or disorders: QA0A\\nSpecial screening examination for diseases of the blood or bloodforming organs or certain disorders involving the immune mechanism: QA0A.0\\nSpecial screening examination for endocrine and metabolic disorder: QA0A.1\\nSpecial screening examination for diabetes mellitus: QA0A.10\\nOther specified special screening examination for endocrine and metabolic disorder: QA0A.1Y\\nSpecial screening examination for endocrine and metabolic disorder unspecified: QA0A.1Z\\nSpecial screening examination for nutritional disorders: QA0A.2\\nSpecial screening examination for mental or behavioural disorders: QA0A.3\\nSpecial screening examination for certain developmental disorders in childhood: QA0A.4\\nSpecial screening examination for eye or ear disorders: QA0A.5\\nSpecial screening examination for cardiovascular disorders: QA0A.6\\nSpecial screening examination for allergic and hypersensitivity conditions: QA0A.7\\nSpecial screening for diseases or disorders not elsewhere classified: QA0A.Y\\nSpecial screening examination for other diseases or disorders unspecified: QA0A.Z\\nPreprocedural examination: QA0B\\nOther examination or investigation: QA0Y\\nExamination or investigation unspecified: QA0Z\\nContact with health services for dietary counselling or surveillance: QA10\\nContact with health services for alcohol use counselling or surveillance: QA11\\nContact with health services for drug use counselling or surveillance: QA12\\nContact with health services for tobacco use counselling: QA13\\nContact with health services for human immunodeficiency virus counselling: QA14\\nCounselling related to sexuality: QA15\\nCounselling related to sexual attitudes: QA15.0\\nCounselling related to sexual behaviour and orientation or sexual relationships of the person: QA15.1\\nCounselling related to sexual behaviour and orientation or sexual relationships of third party: QA15.2\\nCounselling related to combined sexual attitudes sexual behaviour and sexual relationships: QA15.3\\nOther specified counselling related to sexuality: QA15.Y\\nCounselling related to sexuality unspecified: QA15.Z\\nIndividual psychological or behavioural counselling: QA16\\nMarital or couples counselling: QA17\\nFamily counselling: QA18\\nGroup counselling: QA19\\nDiscussion of issues surrounding impending death: QA1A\\nConcern about or fear of medical treatment: QA1B\\nPerson with feared complaint in whom no diagnosis is made: QA1C\\nContact with health services for other specified counselling: QA1Y\\nContact with health services for unspecified counselling: QA1Z\\nContact with health services for concerns about pregnancy: QA20\\nContact with health services for contraceptive management: QA21\\nContact with health services for postcoital contraception: QA21.0\\nContact with health services for general counselling or advice on contraception: QA21.1\\nContact with health services for insertion of contraceptive device: QA21.2\\nContact with health services for sterilisation: QA21.3\\nContact with health services for menstrual extraction: QA21.4\\nSurveillance of contraceptive drugs: QA21.5\\nSurveillance of contraceptive device: QA21.6\\nRetained intrauterine device without injury or harm in nonpregnant uterus: QA21.60\\nOther specified surveillance of contraceptive device: QA21.6Y\\nSurveillance of contraceptive device unspecified: QA21.6Z\\nOther specified contact with health services for contraceptive management: QA21.Y\\nContact with health services for contraceptive management unspecified: QA21.Z\\nContact with health services for medically assisted reproduction: QA30\\nContact with health services for assisted insemination: QA30.0\\nContact with health services for gamete intrafallopian transfer: QA30.00\\nContact with health services for procreative management by artificial insemination: QA30.01\\nContact with health services for medically assisted sperm insemination: QA30.02\\nContact with health services for other specified assisted insemination: QA30.0Y\\nContact with health services for unspecified assisted insemination: QA30.0Z\\nContact with health services for assisted reproductive technology: QA30.1\\nContact with health services for in vitro fertilisation: QA30.10\\nContact with health services for egg retrieval: QA30.11\\nContact with health services for embryo transfer: QA30.12\\nContact with health services for ovum implantation: QA30.13\\nContact with health services for harvesting ovum for in vitro fertilisation: QA30.14\\nContact with health services for harvesting or implantation of ova: QA30.15\\nContact with health services for other specified assisted reproductive technology: QA30.1Y\\nContact with health services for unspecified assisted reproductive technology: QA30.1Z\\nContact with health services for other assisted fertilisation methods: QA30.2\\nContact with health services for controlled ovarian stimulation for assisted reproductive technology: QA30.20\\nContact with health services for controlled ovarian stimulation for nonassisted reproductive technology cycles: QA30.21\\nContact with health services for ovulation induction: QA30.22\\nContact with health services for other specified assisted fertilisation methods: QA30.2Y\\nContact with health services for unspecified assisted fertilisation methods: QA30.2Z\\nOther specified contact with health services for medically assisted reproduction: QA30.Y\\nContact with health services for medically assisted reproduction unspecified: QA30.Z\\nContact with health services for genetic counselling: QA31\\nContact with health services for tuboplasty or vasoplasty after previous sterilisation: QA32\\nContact with health services for preconception counselling: QA33\\nContact with health services for fertility preservation counselling: QA34\\nContact with health services by gestational carrier: QA35\\nContact with health services for other specified procreative management: QA3Y\\nContact with health services for procreative management unspecified: QA3Z\\nPregnancy examination or test: QA40\\nPregnant state: QA41\\nSupervision of normal pregnancy: QA42\\nSupervision of normal first pregnancy: QA42.0\\nSupervision of other specified normal pregnancy: QA42.Y\\nSupervision of normal pregnancy unspecified: QA42.Z\\nSupervision of highrisk pregnancy: QA43\\nSupervision of pregnancy with history of infertility: QA43.0\\nSupervision of pregnancy with history of abortive outcome: QA43.1\\nSupervision of pregnancy with other poor reproductive or obstetric history: QA43.2\\nSupervision of pregnancy with history of insufficient antenatal care: QA43.3\\nConcealed pregnancy: QA43.30\\nOther specified supervision of pregnancy with history of insufficient antenatal care: QA43.3Y\\nSupervision of pregnancy with history of insufficient antenatal care unspecified: QA43.3Z\\nSupervision of elderly primigravida: QA43.4\\nSupervision of very young primigravida: QA43.5\\nSupervision of highrisk pregnancy due to social problems: QA43.6\\nOther specified supervision of highrisk pregnancy: QA43.Y\\nSupervision of highrisk pregnancy unspecified: QA43.Z\\nExpectant parent prebirth visit: QA44\\nAntenatal screening: QA45\\nAntenatal screening for chromosomal anomalies: QA45.0\\nAntenatal screening due to raised alphafetoprotein level: QA45.1\\nOther specified antenatal screening: QA45.Y\\nAntenatal screening unspecified: QA45.Z\\nOutcome of delivery: QA46\\nSingle live birth: QA46.0\\nSingle stillbirth: QA46.1\\nTwins both liveborn: QA46.2\\nTwins one liveborn and one stillborn: QA46.3\\nTwins both stillborn: QA46.4\\nTriplets all liveborn: QA46.5\\nTriplets some liveborn: QA46.6\\nTriplets all stillborn: QA46.7\\nQuadruplets all liveborn: QA46.8\\nQuadruplets some liveborn: QA46.9\\nQuadruplets all stillborn: QA46.A\\nQuintuplets all liveborn: QA46.B\\nQuintuplets some liveborn: QA46.C\\nQuintuplets all stillborn: QA46.D\\nSextuplets all liveborn: QA46.E\\nSextuplets some liveborn: QA46.F\\nSextuplets all stillborn: QA46.G\\nOther multiple births all liveborn: QA46.H\\nOther multiple births some liveborn: QA46.J\\nOther multiple births all stillborn: QA46.K\\nOutcome of delivery unspecified: QA46.Z\\nLiveborn infants according to place of birth: QA47\\nSingleton born in hospital: QA47.0\\nSingle liveborn infant delivered vaginally: QA47.00\\nSingle liveborn infant delivered by caesarean: QA47.01\\nOther specified singleton born in hospital: QA47.0Y\\nSingleton born in hospital unspecified: QA47.0Z\\nSingleton born outside hospital: QA47.1\\nSingleton unspecified as to place of birth: QA47.2\\nTwin born in hospital: QA47.3\\nTwin liveborn infant delivered vaginally: QA47.30\\nTwin liveborn infant delivered by caesarean: QA47.31\\nOther specified twin born in hospital: QA47.3Y\\nTwin born in hospital unspecified: QA47.3Z\\nTwin born outside hospital: QA47.4\\nTwin unspecified as to place of birth: QA47.5\\nMultiple other than twins born in hospital: QA47.6\\nMultiple other than twins delivered vaginally: QA47.60\\nMultiple other than twins delivered by caesarean section: QA47.61\\nOther specified multiple other than twins born in hospital: QA47.6Y\\nMultiple other than twins born in hospital unspecified: QA47.6Z\\nMultiple other than twins born outside hospital: QA47.7\\nOther multiple unspecified as to place of birth: QA47.8\\nLiveborn infants according to place of birth unspecified: QA47.Z\\nPostpartum care or examination: QA48\\nCare or examination immediately after delivery: QA48.0\\nCare or examination of lactating mother: QA48.1\\nRoutine postpartum followup: QA48.2\\nOther specified postpartum care or examination: QA48.Y\\nPostpartum care or examination unspecified: QA48.Z\\nProblems related to unwanted pregnancy: QA49\\nProblems related to multiparity: QA4A\\nContact with health services for menopausal counselling: QA4B\\nOther specified contact with health services for reasons associated with reproduction: QA4Y\\nContact with health services for reasons associated with reproduction unspecified: QA4Z\\nEmbolisation without injury or harm: QA50\\nForeign body accidentally left in body without injury or harm: QA51\\nFailure of sterile precautions without injury or harm: QA52\\nPressure as potential mode of injury without injury or harm: QA53\\nOther specified circumstances associated with a surgical or other medical procedure influencing the episode of care without injury or harm: QA5Y\\nCircumstances associated with a surgical or other medical procedure influencing the episode of care without injury or harm unspecified: QA5Z\\nStructural device failure without injury or harm: QA60\\nFunctional device failure without injury or harm: QA61\\nDislodgement misconnection or deattachment of a surgical or medical device without injury or harm: QA62\\nObstruction of device without injury or harm: QA63\\nOperator error without injury or harm: QA64\\nCombination or interaction of operator error and device failure without injury or harm: QA65\\nOther specified circumstances associated with a surgical or other medical device influencing the episode of care without injury or harm: QA6Y\\nCircumstances associated with a surgical or other medical device influencing the episode of care without injury or harm unspecified: QA6Z\\nOverdose of substance without injury or harm: QA70\\nUnderdosing without injury or harm: QA71\\nIncorrect substance without injury or harm: QA72\\nIncorrect route of administration without injury or harm: QA73\\nUnspecified appropriateness of dosing or administration without injury or harm: QA74\\nIncorrect duration of administration or course of therapy without injury or harm: QA75\\nMedication or substance that is known to be an allergen without injury or harm: QA76\\nMedication or substance that is known to be contraindicated for the patient without injury or harm: QA77\\nExpired or deteriorated medication or substance without injury or harm: QA78\\nDrug or substance interactions without injury or harm: QA79\\nInappropriate stoppage or discontinuation of drug without injury or harm: QA7A\\nOther specified circumstances associated with exposure to a drug medicament or biological substance influencing the episode of care without injury or harm: QA7Y\\nCircumstances associated with exposure to a drug medicament or biological substance influencing the episode of care without injury or harm unspecified: QA7Z\\nNonadministration of necessary drug without injury or harm: QA80\\nNonprovision of necessary procedure without injury or harm: QA81\\nProblem associated with physical transfer of patient without injury or harm: QA82\\nMismatched blood used in transfusion without injury or harm: QA83\\nOther problem with transfusion without injury or harm: QA84\\nProblem with physical restraints without injury or harm: QA85\\nProblem with isolation protocol without injury or harm: QA86\\nProblem with clinical documentation without injury or harm: QA87\\nProblem with clinical software without injury or harm: QA88\\nIncorrect diagnosis without injury or harm: QA89\\nDelayed diagnosis without injury or harm: QA8A\\nDelayed treatment without injury or harm: QA8B\\nProblem with transitions of care hand offs or handovers without injury or harm: QA8C\\nPatient received diagnostic test or treatment intended for another patient without injury or harm: QA8D\\nFall in health care without injury or harm: QA8E\\nNeedle stick without injury or harm: QA8F\\nOther specified circumstances associated with other aspects of care influencing the episode of care without injury or harm: QA8Y\\nCircumstances associated with other aspects of care influencing the episode of care without injury or harm unspecified: QA8Z\\nOther specified health care related circumstances influencing the episode of care without injury or harm: QB0Y\\nHealth care related circumstances influencing the episode of care without injury or harm unspecified: QB0Z\\nMedical services not available in home: QB10\\nPerson awaiting admission to adequate facility elsewhere: QB11\\nWaiting period for investigation or treatment other than awaiting admission to adequate facility elsewhere: QB12\\nOrgan transplant candidate: QB12.0\\nOther specified waiting period for investigation or treatment other than awaiting admission to adequate facility elsewhere: QB12.Y\\nWaiting period for investigation or treatment other than awaiting admission to adequate facility elsewhere unspecified: QB12.Z\\nUnavailability or inaccessibility of helping agencies other than health care facilities: QB13\\nUnavailability or inaccessibility of health care facilities: QB14\\nMedical services not available in current medical facility: QB15\\nRespite care: QB16\\nOther specified factors related to medical facilities or other health care: QB1Y\\nFactors related to medical facilities or other health care unspecified: QB1Z\\nBlood donor: QB20\\nBone marrow donor: QB21\\nKidney donor: QB22\\nCornea donor: QB23\\nLiver donor: QB24\\nHeart donor: QB25\\nDonors of other specified organs or tissues: QB2Y\\nDonors of organs or tissues unspecified: QB2Z\\nAdjustment or management of implanted devices: QB30\\nAdjustment or management of implanted hearing device: QB30.0\\nAdjustment or management of bone conduction device: QB30.00\\nAdjustment or management of cochlear device: QB30.01\\nAdjustment or management of other implanted hearing device: QB30.0Y\\nAdjustment or management of implanted hearing device unspecified: QB30.0Z\\nAdjustment or management of infusion pump: QB30.1\\nAdjustment or management of cardiac devices: QB30.2\\nAdjustment or management of cardiac pacemaker: QB30.20\\nAdjustment or management of cardiac resynchronization therapy defibrillator: QB30.21\\nAdjustment or management of cardiac resynchronization therapy pacemaker: QB30.22\\nAdjustment or management of cardioverterdefibrillator: QB30.23\\nOther specified adjustment or management of cardiac devices: QB30.2Y\\nAdjustment or management of cardiac devices unspecified: QB30.2Z\\nAdjustment or management of vascular access device: QB30.3\\nAdjustment or management of implanted gastric device: QB30.4\\nFitting or adjustment of urinary device: QB30.5\\nAdjustment or management of breast implant: QB30.6\\nAdjustment or removal of myringotomy stent or tube: QB30.7\\nAdjustment and management of a neurostimulator: QB30.8\\nFitting or adjustment of cerebrospinal fluid drainage device: QB30.9\\nFitting or adjustment of neuropacemaker: QB30.A\\nFitting adjustment or management of other specified implanted devices: QB30.Y\\nAdjustment or management of implanted devices unspecified: QB30.Z\\nFitting adjustment or management of external devices: QB31\\nFitting or adjustment of external prosthetic device: QB31.0\\nFitting or adjustment of artificial arm: QB31.00\\nFitting or adjustment of artificial leg: QB31.01\\nFitting or adjustment of artificial eye: QB31.02\\nFitting or adjustment of external breast prosthesis: QB31.03\\nOther specified fitting or adjustment of external prosthetic device: QB31.0Y\\nFitting or adjustment of external prosthetic device unspecified: QB31.0Z\\nFitting or adjustment of orthopaedic device: QB31.1\\nFitting or adjustment of orthodontic device: QB31.2\\nFitting or adjustment of dental prosthetic device: QB31.3\\nFitting or adjustment of hearing aid: QB31.4\\nFitting or adjustment of spectacles or contact lenses: QB31.5\\nFitting adjustment or management of other specified external devices: QB31.Y\\nFitting adjustment or management of external devices unspecified: QB31.Z\\nFitting adjustment or management of devices unspecified: QB3Z\\nDependence on aspirator: QB40\\nDependence on respirator: QB41\\nDependence on renal dialysis: QB42\\nDependence on artificial heart: QB43\\nDependence on wheelchair: QB44\\nDependence on other specified machine or device: QB4Y\\nDependence on unspecified machine or device: QB4Z\\nPresence of cardiac or vascular implants or grafts: QB50\\nPresence of electronic cardiac devices: QB50.0\\nPresence of cardiac pacemaker: QB50.00\\nPresence of cardiac resynchronization therapy defibrillator: QB50.01\\nPresence of cardiac resynchronization therapy pacemaker: QB50.02\\nPresence of cardioverterdefibrillator: QB50.03\\nOther specified presence of electronic cardiac devices: QB50.0Y\\nPresence of electronic cardiac devices unspecified: QB50.0Z\\nPresence of aortocoronary bypass graft: QB50.1\\nPresence of prosthetic heart valve: QB50.2\\nPresence of mechanical heart valve: QB50.21\\nPresence of bioprosthetic heart valve: QB50.24\\nPresence of prosthetic heart valve other specified type: QB50.2Y\\nPresence of prosthetic heart valve unspecified: QB50.2Z\\nPresence of coronary angioplasty implant or graft: QB50.4\\nPresence of other specified cardiac or vascular implants or grafts: QB50.Y\\nPresence of unspecified cardiac or vascular implants or grafts: QB50.Z\\nPresence of devices other than cardiac or vascular implants: QB51\\nPresence of a neurostimulator: QB51.0\\nPresence of urogenital implants: QB51.1\\nPresence of intraocular lens: QB51.2\\nPresence of otological or audiological implants: QB51.3\\nPresence of artificial larynx: QB51.4\\nPresence of endocrine implants: QB51.5\\nPresence of toothroot or mandibular implants: QB51.6\\nPresence of orthopaedic joint implants: QB51.7\\nPresence of artificial eye: QB51.8\\nPresence of artificial limb: QB51.9\\nPresence of dental prosthetic device: QB51.A\\nPresence of external hearingaid: QB51.B\\nPresence of contraceptive device: QB51.C\\nPresence of cerebrospinal fluid drainage device: QB51.D\\nPresence of other specified devices other than cardiac or vascular implants: QB51.Y\\nPresence of unspecified device: QB5Z\\nPresence of arthrodesis: QB60\\nPresence of artificial opening: QB61\\nPresence of tracheostomy: QB61.0\\nPresence of thoracostomy: QB61.1\\nPresence of gastrostomy: QB61.2\\nPresence of enterostomy: QB61.3\\nPresence of ileostomy: QB61.30\\nOther specified presence of enterostomy: QB61.3Y\\nPresence of enterostomy unspecified: QB61.3Z\\nPresence of colostomy: QB61.4\\nPresence of cystostomy: QB61.5\\nPresence of nephrostomy: QB61.6\\nPresence of ureterostomy: QB61.7\\nPresence of urethrostomy: QB61.8\\nPresence of other artificial opening: QB61.Y\\nPresence of artificial opening unspecified: QB61.Z\\nAttention to artificial openings: QB62\\nAttention to tracheostomy: QB62.0\\nAttention to gastrostomy: QB62.1\\nAttention to ileostomy: QB62.2\\nAttention to colostomy: QB62.3\\nAttention to cystostomy: QB62.4\\nAttention to artificial vagina: QB62.5\\nAttention to nephrostomy: QB62.6\\nAttention to ureterostomy: QB62.7\\nAttention to urethrostomy: QB62.8\\nAttention to other artificial openings: QB62.Y\\nAttention to artificial openings unspecified: QB62.Z\\nPresence of transplanted organ or tissue: QB63\\nPresence of transplanted kidney: QB63.0\\nPresence of transplanted heart: QB63.1\\nPresence of transplanted lung: QB63.2\\nPresence of transplanted liver: QB63.3\\nPresence of transplanted skin: QB63.4\\nPresence of transplanted bone: QB63.5\\nPresence of transplanted bone marrow: QB63.6\\nPresence of transfused blood: QB63.7\\nPresence of transplanted stem cell: QB63.8\\nPresence of transplanted cornea: QB63.9\\nPresence of other transplanted organ or tissue: QB63.Y\\nPresence of transplanted organ or tissue unspecified: QB63.Z\\nOther specified surgical or postsurgical states: QB6Y\\nSurgical or postsurgical states unspecified: QB6Z\\nConvalescence following chemotherapy: QB70\\nConvalescence following psychotherapy: QB71\\nConvalescence following treatment of fracture: QB72\\nConvalescence following combined treatment: QB73\\nOther specified convalescence: QB7Y\\nConvalescence unspecified: QB7Z\\nContact with health services for prophylactic surgery: QB80\\nContact with health services for prophylactic surgery for riskfactors related to malignant neoplasms: QB80.0\\nOther specified contact with health services for prophylactic surgery: QB80.Y\\nContact with health services for prophylactic surgery unspecified: QB80.Z\\nContact with health services for plastic surgery for unacceptable cosmetic appearance other than hair transplant: QB81\\nContact with health services for routine or ritual circumcision: QB82\\nFollowup care involving plastic surgery: QB83\\nFollowup care involving removal of fracture plate or other internal fixation device: QB84\\nAttention to surgical dressings drains or sutures: QB85\\nContact with health services for hair transplant: QB86\\nContact with health services for other specified surgical interventions: QB8Y\\nContact with health services for specific surgical interventions unspecified: QB8Z\\nContact with health services for ear piercing: QB90\\nContact with health services for piercing of body site other than ear: QB91\\nContact with health services for issue of repeat prescription: QB92\\nContact with health services for orthodontic care: QB93\\nCare involving dialysis: QB94\\nPreparatory care for dialysis: QB94.0\\nCare involving extracorporeal dialysis: QB94.1\\nCare involving peritoneal dialysis: QB94.2\\nCare involving other specified dialysis: QB94.Y\\nCare involving dialysis unspecified: QB94.Z\\nCare involving use of rehabilitation procedures: QB95\\nCardiac rehabilitation: QB95.0\\nPhysical rehabilitation: QB95.1\\nAlcohol rehabilitation: QB95.2\\nDrug rehabilitation: QB95.3\\nPsychotherapy: QB95.4\\nSpeech therapy: QB95.5\\nOrthoptic training: QB95.6\\nOccupational therapy or vocational rehabilitation: QB95.7\\nTobacco rehabilitation: QB95.8\\nCare involving use of other specified rehabilitation procedures: QB95.Y\\nCare involving use of rehabilitation procedures unspecified: QB95.Z\\nContact with health services for radiotherapy session: QB96\\nContact with health services for chemotherapy session for neoplasm: QB97\\nBlood transfusion without reported diagnosis: QB98\\nApheresis: QB99\\nPreparatory care for subsequent treatment: QB9A\\nPalliative care: QB9B\\nAllergen immunotherapy: QB9C\\nOther specified contact with health services for nonsurgical interventions not involving devices: QB9Y\\nContact with health services for nonsurgical interventions not involving devices unspecified: QB9Z\\nNeed for immunization against single bacterial diseases: QC00\\nNeed for immunization against cholera alone: QC00.0\\nNeed for immunization against typhoidparatyphoid alone: QC00.1\\nNeed for immunization against tuberculosis: QC00.2\\nNeed for immunization against plague: QC00.3\\nNeed for immunization against tularaemia: QC00.4\\nNeed for immunization against tetanus alone: QC00.5\\nNeed for immunization against diphtheria alone: QC00.6\\nNeed for immunization against pertussis alone: QC00.7\\nOther specified need for immunization against single bacterial diseases: QC00.Y\\nNeed for immunization against single bacterial diseases unspecified: QC00.Z\\nNeed for immunization against certain single viral diseases: QC01\\nNeed for immunization against poliomyelitis: QC01.0\\nNeed for immunization against arthropodborne viral encephalitis: QC01.1\\nNeed for immunization against rabies: QC01.2\\nNeed for immunization against yellow fever: QC01.3\\nNeed for immunization against measles alone: QC01.4\\nNeed for immunization against rubella alone: QC01.5\\nNeed for immunization against viral hepatitis: QC01.6\\nNeed for immunization against mumps alone: QC01.7\\nNeed for immunization against influenza: QC01.8\\nNeed for immunization against COVID: QC01.9\\nOther specified need for immunization against certain single viral diseases: QC01.Y\\nNeed for immunization against certain single viral diseases unspecified: QC01.Z\\nNeed for immunization against certain specified single infectious diseases: QC02\\nNeed for immunization against leishmaniasis: QC02.0\\nOther specified need for immunization against certain specified single infectious diseases: QC02.Y\\nNeed for immunization against certain specified single infectious diseases unspecified: QC02.Z\\nNeed for immunization against combinations of infectious diseases: QC03\\nNeed for immunization against cholera with typhoidparatyphoid: QC03.0\\nNeed for immunization against diphtheriatetanuspertussis combined: QC03.1\\nNeed for immunization against diphtheriatetanuspertussis with typhoidparatyphoid: QC03.2\\nNeed for immunization against diphtheriatetanuspertussis with poliomyelitis: QC03.3\\nNeed for immunization against measlesmumpsrubella: QC03.4\\nOther specified need for immunization against combinations of infectious diseases: QC03.Y\\nNeed for immunization against combinations of infectious diseases unspecified: QC03.Z\\nImmunization not carried out: QC04\\nImmunization not carried out due to patient having had the disease: QC04.0\\nImmunization not carried out because of acute illness: QC04.1\\nImmunization not carried out because of chronic illness or condition of patient: QC04.2\\nImmunization not carried out because of immunecompromised state of patient: QC04.3\\nImmunization not carried out because of patient allergy to vaccine or component: QC04.4\\nImmunization not carried out because of patient refusal: QC04.5\\nImmunization not carried out because of caregiver refusal: QC04.6\\nImmunization not carried out due to lack of availability: QC04.7\\nImmunization not carried out for other reasons: QC04.Y\\nImmunization not carried out for unspecified reason: QC04.Z\\nNeed for certain specified other prophylactic measures: QC05\\nIsolation: QC05.0\\nProphylactic immunotherapy: QC05.1\\nOther specified prophylactic measures: QC05.Y\\nProphylactic measures unspecified: QC05.Z\\nUnderimmunization status: QC06\\nOther specified contact with health services related to immunizations or certain other prophylactic measures: QC0Y\\nContact with health services related to immunizations or certain other prophylactic measures unspecified: QC0Z\\nProcedure not carried out because of contraindication: QC10\\nProcedure not carried out because of patients decision for reasons of belief or group pressure: QC11\\nProcedure not carried out because of patients decision for reasons other than belief or group pressure: QC12\\nIntervention not carried out for other reasons: QC1Y\\nIntervention not carried out unspecified reason: QC1Z\\nPerson consulting on behalf of another person: QC20\\nPartner illness problem: QC20.0\\nIllness problem with child: QC20.1\\nOther specified person consulting on behalf of another person: QC20.Y\\nPerson consulting on behalf of another person unspecified: QC20.Z\\nHealthy person accompanying sick person: QC21\\nHealth supervision or care of abandoned infant: QC22\\nOther specified contact with health services associated with the health of others: QC2Y\\nContact with health services associated with the health of others unspecified: QC2Z\\nMalingering: QC30\\nPersonal history of malignant neoplasm: QC40\\nPersonal history of malignant neoplasm of digestive organs: QC40.0\\nPersonal history of malignant neoplasm of trachea bronchus or lung: QC40.1\\nPersonal history of malignant neoplasm of respiratory or intrathoracic organs other than the digestive organs trachea bronchus or lung: QC40.2\\nPersonal history of malignant neoplasm of breast: QC40.3\\nPersonal history of malignant neoplasm of genital organs: QC40.4\\nPersonal history of malignant neoplasm of urinary tract: QC40.5\\nPersonal history of leukaemia: QC40.6\\nPersonal history of other malignant neoplasms of lymphoid haematopoietic or related tissues: QC40.7\\nPersonal history of malignant neoplasm of other specified site: QC40.Y\\nPersonal history of malignant neoplasm of unspecified site: QC40.Z\\nPersonal history of nonmalignant neoplasms: QC41\\nPersonal history of infectious or parasitic diseases: QC42\\nPersonal history of COVID: QC42.0\\nOther specified personal history of infectious or parasitic diseases: QC42.Y\\nPersonal history of infectious or parasitic diseases unspecified: QC42.Z\\nPersonal history of diseases of the blood or bloodforming organs: QC43\\nPersonal history of diseases of the immune system: QC44\\nPersonal history of anaphylaxis: QC44.0\\nPersonal history of foodinduced allergy or hypersensitivity: QC44.1\\nPersonal history of allergy to drugs medicaments or biological substances: QC44.2\\nPersonal history of allergy other than to drugs or biological substances: QC44.3\\nOther specified personal history of diseases of the immune system: QC44.Y\\nPersonal history of diseases of the immune system unspecified: QC44.Z\\nPersonal history of endocrine nutritional or metabolic diseases: QC45\\nPersonal history of mental or behavioural disorder: QC46\\nPersonal history of diseases of the nervous system or sense organs: QC47\\nPersonal history of medical treatment: QC48\\nPersonal history of longterm use of anticoagulants: QC48.0\\nOther specified personal history of medical treatment: QC48.Y\\nPersonal history of medical treatment unspecified: QC48.Z\\nPersonal history of noncompliance with medical treatment or regimen: QC49\\nPersonal history of poor personal hygiene: QC4A\\nPersonal history of selfharm: QC4B\\nPersonal history of other specified health problems: QC4Y\\nPersonal history of health problems unspecified: QC4Z\\nLate effect of prior health problem not elsewhere classified: QC50\\nFamily history of infectious diseases: QC60\\nFamily history of malignant neoplasm: QC61\\nFamily history of malignant neoplasm of digestive organs: QC61.0\\nFamily history of malignant neoplasm of trachea bronchus or lung: QC61.1\\nFamily history of malignant neoplasm of respiratory or intrathoracic organs other than digestive organs trachea bronchus or lung: QC61.2\\nFamily history of malignant neoplasm of breast: QC61.3\\nFamily history of malignant neoplasm of genital organs: QC61.4\\nFamily history of malignant neoplasm of urinary tract: QC61.5\\nFamily history of leukaemia: QC61.6\\nFamily history of malignant neoplasms of lymphoid haematopoietic or related tissues: QC61.7\\nOther specified family history of malignant neoplasm: QC61.Y\\nFamily history of malignant neoplasm unspecified: QC61.Z\\nFamily history of diseases of the blood or bloodforming organs: QC62\\nFamily history of disorders involving the immune mechanism: QC63\\nFamily history of endocrine nutritional or metabolic diseases: QC64\\nFamily history of diabetes mellitus: QC64.0\\nOther specified family history of endocrine nutritional or metabolic diseases: QC64.Y\\nFamily history of endocrine nutritional or metabolic diseases unspecified: QC64.Z\\nFamily history of mental or behavioural disorder: QC65\\nFamily history of eye or ear disorders: QC66\\nFamily history of ischaemic heart disease or other diseases of the circulatory system: QC67\\nFamily history of consanguinity: QC68\\nFamily history of stroke: QC69\\nFamily history of other specified health problems: QC6Y\\nFamily history of health problems unspecified: QC6Z\\nOther specified personal or family history or late effect of prior health problems: QC8Y\\nPersonal or family history or late effect of prior health problems unspecified: QC8Z\\nContact with or exposure to communicable diseases: QC90\\nContact with or exposure to intestinal infectious diseases: QC90.0\\nExposure to cholera: QC90.00\\nOther specified contact with or exposure to intestinal infectious diseases: QC90.0Y\\nContact with or exposure to intestinal infectious diseases unspecified: QC90.0Z\\nContact with or exposure to tuberculosis: QC90.1\\nContact with or exposure to infections with a predominantly sexual mode of transmission: QC90.2\\nContact with or exposure to rabies: QC90.3\\nContact with or exposure to rubella: QC90.4\\nContact with or exposure to viral hepatitis: QC90.5\\nContact with or exposure to human immunodeficiency virus: QC90.6\\nContact with or exposure to pediculosis acariasis or other infestations: QC90.7\\nContact with or exposure to other specified communicable diseases: QC90.Y\\nContact with or exposure to communicable diseases unspecified: QC90.Z\\nCarrier of salmonella typhi: QD00\\nCarrier of intestinal infectious agents: QD01\\nAsymptomatic enteric carriage of Entamoeba: QD01.0\\nOther specified carrier of intestinal infectious agents: QD01.Y\\nCarrier of intestinal infectious agents unspecified: QD01.Z\\nCarrier of corynebacterium diphtheriae: QD02\\nCarrier of infectious agents with a predominantly sexual mode of transmission: QD03\\nAsymptomatic colonization of the skin by virulent or therapy resistant bacteria: QD04\\nCarrier of other specified infectious disease agent: QD0Y\\nCarrier of infectious disease agent unspecified: QD0Z\\nOther specified health status associated with infectious or certain specified conditions: QD2Y\\nUnspecified health status associated with infectious or certain specified conditions: QD2Z\\nConcern about breast appearance: QD30\\nContact with health services for concerns about body image related to pregnancy: QD31\\nOther specified concern about body appearance: QD3Y\\nConcern about body appearance unspecified: QD3Z\\nPoverty: QD50\\nLow income: QD51\\nOther specified problems associated with finances: QD5Y\\nProblems associated with finances unspecified: QD5Z\\nProblems associated with inadequate drinkingwater: QD60\\nInadequate food: QD61\\nProblems associated with drinking water or nutrition unspecified: QD6Z\\nProblems associated with the natural environment or humanmade changes to the environment: QD70\\nProblems associated with exposure to noise: QD70.0\\nProblems associated with exposure to air pollution: QD70.1\\nProblems associated with exposure to water pollution: QD70.2\\nProblems associated with exposure to soil pollution: QD70.3\\nProblems associated with exposure to radiation: QD70.4\\nProblems associated with exposure to tobacco smoke: QD70.5\\nProblems associated with inadequate access to electricity: QD70.6\\nProblems associated with the natural environment or humanmade changes to the environment unspecified: QD70.Z\\nProblems associated with housing: QD71\\nHomelessness: QD71.0\\nInadequate housing: QD71.1\\nProblems related to living in residential institution: QD71.2\\nProblems associated with housing unspecified: QD71.Z\\nOther specified problems associated with the environment: QD7Y\\nProblems associated with the environment unspecified: QD7Z\\nProblem associated with unemployment: QD80\\nProblem associated with change of job: QD81\\nProblem associated with threat of job loss: QD82\\nProblem with employment conditions: QD83\\nProblem associated with uncongenial work: QD83.0\\nProblem associated with stressful work schedule: QD83.1\\nOther specified problem with employment conditions: QD83.Y\\nProblem with employment conditions unspecified: QD83.Z\\nOccupational exposure to riskfactors: QD84\\nOccupational exposure to dust: QD84.0\\nOccupational exposure to toxic agents in agriculture: QD84.1\\nOccupational exposure to toxic agents in industries other than agriculture: QD84.2\\nOccupational exposure to vibration: QD84.3\\nOccupational exposure to ergonomic risk: QD84.4\\nOther specified occupational exposure to riskfactors: QD84.Y\\nOccupational exposure to riskfactors unspecified: QD84.Z\\nBurnout: QD85\\nOther specified problems associated with employment or unemployment: QD8Y\\nProblems associated with employment or unemployment unspecified: QD8Z\\nProblem associated with illiteracy or lowlevel literacy: QD90\\nProblem associated with education unavailable or unattainable: QD91\\nProblem with educational progress: QD92\\nOther specified problems associated with education: QD9Y\\nProblems associated with education unspecified: QD9Z\\nAcculturation difficulty: QE00\\nStress not elsewhere classified: QE01\\nSocial role conflict: QE02\\nSocial exclusion or rejection: QE03\\nTarget of perceived adverse discrimination or persecution: QE04\\nOther specified problems associated with social or cultural environment: QE0Y\\nProblems associated with social or cultural environment unspecified: QE0Z\\nHazardous alcohol use: QE10\\nHazardous drug use: QE11\\nHazardous use of opioids: QE11.0\\nHazardous use of cannabis: QE11.1\\nHazardous use of sedatives hypnotics or anxiolytics: QE11.2\\nHazardous use of cocaine: QE11.3\\nHazardous use of stimulants including amphetamines or methamphetamine: QE11.4\\nHazardous use of caffeine: QE11.5\\nHazardous use of MDMA or related drugs: QE11.6\\nHazardous use of dissociative drugs including ketamine or PCP: QE11.7\\nHazardous use of other specified psychoactive substances: QE11.8\\nHazardous use of unknown or unspecified psychoactive substances: QE11.9\\nOther specified hazardous drug use: QE11.Y\\nHazardous drug use unspecified: QE11.Z\\nHazardous nicotine use: QE12\\nTobacco use: QE13\\nOther specified hazardous substance use: QE1Y\\nHazardous substance use unspecified: QE1Z\\nLack of physical exercise: QE20\\nHazardous gambling or betting: QE21\\nHazardous gaming: QE22\\nProblems with inappropriate diet or eating habits: QE23\\nProblems with hygiene behaviours: QE24\\nProblems with oral health behaviours: QE25\\nProblem with sun exposure behaviour: QE26\\nProblem with behaviours related to psychological health or wellbeing: QE27\\nProblem with health literacy: QE28\\nProblems with other specified healthrelated behaviours: QE2Y\\nProblem with healthrelated behaviours unspecified: QE2Z\\nInsufficient social insurance support: QE30\\nInsufficient social insurance support aged: QE30.0\\nInsufficient social insurance support disability: QE30.1\\nInsufficient social insurance support unemployment: QE30.2\\nInsufficient social insurance support family support: QE30.3\\nInsufficient social insurance support unspecified: QE30.Z\\nInsufficient social welfare support: QE31\\nInsufficient social welfare support child protection: QE31.0\\nInsufficient social welfare support protection against domestic violence: QE31.1\\nInsufficient social welfare support protection against homelessness: QE31.2\\nInsufficient social welfare support post prison services: QE31.3\\nInsufficient social welfare support unspecified: QE31.Z\\nOther specified problems associated with social insurance or welfare: QE3Y\\nProblems associated with social insurance or welfare unspecified: QE3Z\\nProblem associated with conviction in civil or criminal proceedings without imprisonment: QE40\\nProblem associated with imprisonment and other incarceration: QE41\\nProblem associated with release from prison: QE42\\nOther specified problems associated with the justice system: QE4Y\\nProblems associated with the justice system unspecified: QE4Z\\nProblem associated with interpersonal interactions: QE50\\nProblem associated with relationship with friend: QE50.0\\nRelationships with teachers or classmates: QE50.1\\nDissatisfaction with school environment: QE50.10\\nOther specified relationships with teachers or classmates: QE50.1Y\\nRelationships with teachers or classmates unspecified: QE50.1Z\\nProblem associated with relationships with people at work: QE50.2\\nRelationships with neighbours tenant or landlord: QE50.3\\nRelationship with parents inlaws or other family members: QE50.4\\nDiscord with counsellors: QE50.5\\nInadequate social skills: QE50.6\\nPersonality difficulty: QE50.7\\nOther specified problem associated with interpersonal interactions: QE50.Y\\nProblem associated with interactions with spouse or partner: QE51\\nRelationship distress with spouse or partner: QE51.0\\nHistory of spouse or partner violence: QE51.1\\nOther specified problem associated with interactions with spouse or partner: QE51.Y\\nProblem associated with interactions with spouse or partner unspecified: QE51.Z\\nProblem associated with interpersonal interactions in childhood: QE52\\nCaregiverchild relationship problem: QE52.0\\nLoss of love relationship in childhood: QE52.1\\nOther specified problem associated with interpersonal interactions in childhood: QE52.Y\\nProblem associated with interpersonal interactions in childhood unspecified: QE52.Z\\nOther specified problems associated with relationships: QE5Y\\nProblems associated with relationships unspecified: QE5Z\\nAbsence of family member: QE60\\nDisappearance or death of family member: QE61\\nLoss or death of child: QE61.0\\nDisappearance or death of other family member: QE61.Y\\nUncomplicated bereavement: QE62\\nOther specified problems associated with absence loss or death of others: QE6Y\\nProblems associated with absence loss or death of others unspecified: QE6Z\\nProblems related to primary support group including family circumstances: QE70\\nInadequate family support: QE70.0\\nDisruption of family by separation or divorce: QE70.1\\nDependent relative needing care at home: QE70.2\\nProblems related to primary support group including family circumstances unspecified: QE70.Z\\nVictim of crime or terrorism: QE80\\nExposure to disaster war or other hostilities: QE81\\nPersonal history of maltreatment: QE82\\nPersonal history of physical abuse: QE82.0\\nPersonal history of sexual abuse: QE82.1\\nPersonal history of psychological abuse: QE82.2\\nPersonal history of neglect: QE82.3\\nOther specified personal history of maltreatment: QE82.Y\\nPersonal history of maltreatment unspecified: QE82.Z\\nPersonal frightening experience in childhood: QE83\\nAcute stress reaction: QE84\\nOther specified problems associated with harmful or traumatic events: QE8Y\\nProblems associated with harmful or traumatic events unspecified: QE8Z\\nInadequate parental supervision or control: QE90\\nParental overprotection: QE91\\nAltered pattern of family relationships in childhood: QE92\\nRemoval from home in childhood: QE93\\nInstitutional upbringing: QE94\\nInappropriate parental pressure or other abnormal qualities of upbringing: QE95\\nEvents resulting in loss of selfesteem in childhood: QE96\\nOther specified problems associated with upbringing: QE9Y\\nProblems associated with upbringing unspecified: QE9Z\\nAcquired absence of limb: QF00\\nAcquired absence of organs: QF01\\nAcquired absence of breast: QF01.0\\nAcquired absence of genital organs: QF01.1\\nAcquired absence of female genital organs: QF01.10\\nAcquired absence of male genital organs: QF01.11\\nOther specified acquired absence of organs: QF01.Y\\nAcquired absence of organs unspecified: QF01.Z\\nOther specified acquired absence of body structure: QF0Y\\nAcquired absence of body structure unspecified: QF0Z\\nLimited function or disability of body organ or system: QF10\\nDifficulty or need for assistance with learning: QF20\\nDifficulty or need for assistance with general life tasks or life management: QF21\\nDifficulty or need for assistance with communication: QF22\\nDifficulty or need for assistance with mobility: QF23\\nDifficulty or need for assistance with selfcare: QF24\\nDifficulty or need for assistance with relationships: QF25\\nDifficulty or need for assistance with household tasks: QF26\\nDifficulty or need for assistance at home and no other household member able to render care: QF27\\nDifficulty or need for assistance with work activities: QF28\\nDifficulty or need for assistance with major areas of life: QF29\\nDifficulty or need for assistance with community participation: QF2A\\nNeed for continuous supervision: QF2B\\nDifficulty or need for assistance with other specified activity: QF2Y\\nDifficulty or need for assistance with unspecified activity: QF2Z\\nOther specified factors influencing health status or contact with health services: QF4Y\\nFactors influencing health status or contact with health services unspecified: QF4Z\\nConditions of uncertain aetiology and emergency use: RA00\\nVaping related disorder: RA00.0\\nCOVID: RA01\\nCOVID virus identified: RA01.0\\nCOVID virus not identified: RA01.1\\nPost COVID condition: RA02\\nMultisystem inflammatory syndrome associated with COVID: RA03\\nInternational emergency code: RA09\\nNational emergency code: RA26\\nHypochondrium pain disorder TM: SA00\\nJaundice disorder TM: SM41\\nLiver distension disorder TM: SA02\\nTympanites disorder TM: SA03\\nLiver abscess disorder TM: SM40\\nGallbladder distension disorder TM: SA05\\nOther specified liver system disorders TM: SA0Y\\nLiver system disorders TM unspecified: SA0Z\\nInducible palpitation disorder TM: SA10\\nSpontaneous palpitation disorder TM: SA11\\nOther specified palpitation disorders TM: SA1Y\\nPalpitation disorders TM unspecified: SA1Z\\nTrue heart pain disorder TM: SA20\\nOther specified chest impediment disorders TM: SA2Y\\nChest impediment disorders TM unspecified: SA2Z\\nOther specified heart system disorders TM: SA4Y\\nHeart system disorders TM unspecified: SA4Z\\nDysphagia disorder TM: SA50\\nStomach ache disorder TM: SA51\\nEpigastric distension disorder TM: SA52\\nEpigastric upset disorder TM: SA53\\nFood retention disorder TM: SA54\\nDiarrhea disorder TM: SA55\\nDysentery disorder TM: SM38\\nConstipation disorder TM: SM34\\nAbdominal pain disorder TM: SM33\\nIntestinal abscess disorder TM: SA59\\nOther specified spleen system disorders TM: SA5Y\\nSpleen system disorders TM unspecified: SA5Z\\nCommon cold disorder TM: SA60\\nCough with dyspnea disorder TM: SA70\\nOther specified cough disorders TM: SA7Y\\nCough disorders TM unspecified: SA7Z\\nDyspnea disorder TM: SA80\\nWheezing disorder TM: SA81\\nLung distension disorder TM: SA82\\nPleural fluid retention disorder TM: SA83\\nLung heat disorder TM: SA84\\nLung withering disorder TM: SA85\\nChest bind disorder TM: SA86\\nOther specified lung system disorders TM: SA8Y\\nLung system disorders TM unspecified: SA8Z\\nStony stranguria disorder TM: SA90\\nHeat stranguria disorder TM: SA91\\nOther specified strangury disorders TM: SA9Y\\nStrangury disorders TM unspecified: SA9Z\\nKidney stagnation disorder TM: SB00\\nFlooding urine disorder TM: SB01\\nEnuresis disorder TM: SB02\\nTurbid urine disorder TM: SB03\\nDribbling urinary block disorder TM: SB04\\nBlock and repulsion disorder TM: SB05\\nEdema disorders TM: SB06\\nKidney edema disorder TM: SB06.0\\nWind edema disorder TM: SB06.1\\nOther specified edema disorders TM: SB06.Y\\nEdema disorders TM unspecified: SB06.Z\\nLower abdominal colic disorder TM: SB07\\nPremature ejaculation disorder TM: SB08\\nInvoluntary ejaculation disorder TM: SB09\\nPersistent erection disorder TM: SB0A\\nImpotence disorder TM: SB0B\\nMale infertility disorder TM: SB0C\\nOther specified kidney system disorders TM: SB0Y\\nKidney system disorders TM unspecified: SB0Z\\nOther specified organ system disorders TM: SB2Y\\nOrgan system disorders TM unspecified: SB2Z\\nDampness sore disorder TM: SB30\\nImpetigo disorder TM: SB31\\nSepticemic furunculosis disorder TM: SB40\\nOther specified furuncle disorders TM: SB4Y\\nFuruncle disorders TM unspecified: SB4Z\\nBed sore disorder TM: SB50\\nDeep multiple abscess disorder TM: SB60\\nAnal abscess disorder TM: SM56\\nOther specified abscess disorders TM: SB6Y\\nAbscess disorders TM unspecified: SB6Z\\nHeaded carbuncle disorder TM: SB70\\nFoot dampness itch disorder TM: SB71\\nTinea circinate disorder TM: SB72\\nDry skin disorder TM: SB73\\nGangrene disorder TM: SB74\\nWart disorder TM: SB75\\nHand dampness itch disorder TM: SB76\\nErysipelas disorder TM: SB77\\nCellulitis disorder TM: SB78\\nThrush disorder TM: SB79\\nHerpes zoster disorder TM: SB7A\\nInterior haemorrhoid disorder TM: SB7B\\nFissured anus disorder TM: SB7C\\nOther specified skin and mucosa system disorders TM: SB7Y\\nSkin and mucosa system disorders TM unspecified: SB7Z\\nAdvanced menstruation disorder TM: SB80\\nDelayed menstruation disorder TM: SB81\\nIrregular menstruation disorders TM: SB82\\nOther specified menstruation cycle disorders TM: SB8Y\\nMenstruation cycle disorders TM unspecified: SB8Z\\nMenorrhagia disorder TM: SB90\\nDecreased menstruation disorder TM: SB91\\nProlonged menstruation disorder TM: SB92\\nMetrorrhagia disorder TM: SB93\\nAmenorrhea disorder TM: SB94\\nMenopausal disorder TM: SB95\\nDysmenorrhea disorder TM: SB96\\nOther specified menstruation associated disorders TM: SB9Y\\nMenstruation associated disorders TM unspecified: SB9Z\\nMorning sickness disorder TM: SC00\\nUnstable fetus disorder TM: SC01\\nBladder pressure disorder TM: SC02\\nEclampsia disorder TM: SC03\\nFloating sensation pregnancy disorder TM: SC04\\nOther specified pregnancy associated disorders TM: SC0Y\\nPregnancy associated disorders TM unspecified: SC0Z\\nPuerperal abdominal pain disorder TM: SC10\\nPuerperal wind disorder TM: SC11\\nHypogalactia disorder TM: SC12\\nPostpartum lochiorrhea disorder TM: SC13\\nOther specified puerperium associated disorders TM: SC1Y\\nPuerperium associated disorders TM unspecified: SC1Z\\nLeukorrhea disorder TM: SC20\\nVaginal flatus disorder TM: SC21\\nInfertility disorder TM: SC22\\nUterine mass disorder TM: SC23\\nBreast lump disorder TM: SC24\\nOther specified other female reproductive system associated disorders TM: SC2Y\\nOther female reproductive system associated disorders TM unspecified: SC2Z\\nOther specified female reproductive system disorders TM including childbirth: SC4Y\\nFemale reproductive system disorders TM including childbirth unspecified: SC4Z\\nCold impediment disorder TM: SC50\\nWind impediment disorder TM: SC51\\nDampness impediment disorder TM: SC52\\nOther specified joint impediment disorders TM: SC5Y\\nJoint impediment disorders TM unspecified: SC5Z\\nMuscle spasm disorder TM: SC60\\nLumbago disorder TM: SC61\\nNumbness disorder TM: SK54\\nWilting disorder TM: SC63\\nOther specified bone joint and muscle system disorders TM: SC6Y\\nBone joint and muscle system disorders TM unspecified: SC6Z\\nNight blindness disorder TM: SK64\\nWind glaucoma disorder TM: SC71\\nInflammatory eyelid disorder TM: SC72\\nNoninflammatory eyelid disorder TM: SC73\\nCorneal opacity disorder TM: SK6V\\nTinnitus disorder TM: SK86\\nSudden deafness disorder TM: SC80\\nGradual deafness disorder TM: SC81\\nOther specified deafness disorders TM: SC8Y\\nDeafness disorders TM unspecified: SC8Z\\nAllergic rhinitis disorder TM: SC90\\nNasal sinusitis disorder TM: SC91\\nHoarseness disorder TM: SC92\\nTonsillitis disorder TM: SL06\\nOther specified eye ear nose and throat system disorders TM: SC9Y\\nEye ear nose and throat system disorders TM unspecified: SC9Z\\nFacial paralysis disorder TM: SD00\\nMigraine disorder TM: SK01\\nHead wind disorder TM: SD11\\nOther specified headache disorders TM: SK0Y\\nHeadache disorders TM unspecified: SK0Z\\nConvulsion disorder TM: SD20\\nCerebral tinnitus disorder TM: SD21\\nVertigo disorder TM: SD22\\nForgetfulness disorder TM: SD23\\nFrequent protrusion of tongue disorder TM: SD24\\nProdrome of wind stroke disorder TM: SD30\\nSequela of wind stroke disorder TM: SD31\\nOther specified wind stroke disorders TM: SD3Y\\nWind stroke disorders TM unspecified: SD3Z\\nSyncope disorder TM: SP98\\nOther specified brain system disorders TM: SD4Y\\nBrain system disorders TM unspecified: SD4Z\\nOther specified other body system disorders TM: SD6Y\\nOther body system disorders TM unspecified: SD6Z\\nQi goiter disorder TM: SD70\\nWasting thirst disorder TM: SD71\\nConsumptive disorder TM: SP5B\\nOther specified qi blood and fluid disorders TM: SD7Y\\nQi blood and fluid disorders TM unspecified: SD7Z\\nLily disorder TM: SD80\\nManic disorder TM: SD81\\nDepression disorder TM: SD82\\nUneasiness disorder TM: SD83\\nInsomnia disorder TM: SQ24\\nSomnolence disorder TM: SD85\\nDementia disorder TM: SD86\\nRepressed fire disorder TM: SD87\\nOther specified mental and emotional disorders TM: SD8Y\\nMental and emotional disorders TM unspecified: SD8Z\\nSeasonal cold disorder TM: SD90\\nFatigue consumption disorder TM: SD91\\nSevere vomiting and diarrhoea disorder TM: SM76\\nAlternating fever and chills disorder TM: SD93\\nParasitic disorder TM: SD94\\nFlowing phlegm disorder TM: SD95\\nSummerheat disorder TM: SE00\\nSpring warmth disorder TM: SE01\\nDampness and warmth disorder TM: SE02\\nOther specified warmth disorders TM: SE0Y\\nWarmth disorders TM unspecified: SE0Z\\nOther specified external contraction disorders TM: SE2Y\\nExternal contraction disorders TM unspecified: SE2Z\\nDevelopmental delay disorder TM: SE30\\nGrowth fever disorder TM: SE31\\nGrowth pain disorder TM: SE32\\nAcute convulsion disorder TM: SE33\\nRecurrent convulsion disorder TM: SE34\\nFright seizure disorder TM: SE35\\nNight crying disorder TM: SE36\\nInfantile malnutrition disorder TM: SE37\\nDribbling disorder TM: SE38\\nDiaper dermatitis disorder TM: SE39\\nInfant stiffness disorder TM: SE3A\\nInfant limpness disorder TM: SE3B\\nOther specified childhood and adolescence associated disorders TM: SE3Y\\nChildhood and adolescence associated disorders TM unspecified: SE3Z\\nOther specified traditional medicine disorders TM: SE5Y\\nTraditional medicine disorders TM unspecified: SE5Z\\nYang pattern TM: SE70\\nYin pattern TM: SE71\\nHeat pattern TM: SE72\\nCold pattern TM: SE73\\nExcess pattern TM: SE74\\nDeficiency pattern TM: SE75\\nExterior pattern TM: SE76\\nInterior pattern TM: SE77\\nModerate HeatCold pattern TM: SE78\\nMedium ExcessDeficiency pattern TM: SE79\\nTangled cold and heat pattern TM: SE7A\\nOther specified principlebased patterns TM: SE7Y\\nPrinciplebased patterns TM unspecified: SE7Z\\nWind factor pattern TM: SE80\\nCold factor pattern TM: SE81\\nDampness factor pattern TM: SE82\\nDryness factor pattern TM: SE83\\nFireheat factor pattern TM: SE84\\nSummerheat factor pattern TM: SE85\\nPestilent factor pattern TM: SE86\\nOther specified environmental factor patterns TM: SE8Y\\nEnvironmental factor patterns TM unspecified: SE8Z\\nQi deficiency pattern TM: SE90\\nQi stagnation pattern TM: SE91\\nQi uprising pattern TM: SE92\\nQi sinking pattern TM: SE93\\nQi collapse pattern TM: SE94\\nOther specified qi patterns TM: SE9Y\\nQi patterns TM unspecified: SE9Z\\nBlood deficiency pattern TM: SR1T\\nBlood stasis pattern TM: SF01\\nBlood heat pattern TM: SF02\\nBlood cold pattern TM: SF03\\nBlood dryness pattern TM: SF04\\nOther specified blood patterns TM: SF0Y\\nBlood patterns TM unspecified: SF0Z\\nFluid deficiency pattern TM: SF10\\nFluid disturbance pattern TM: SF11\\nDryphlegm pattern TM: SF12\\nDamp phlegm pattern TM: SF13\\nPhlegmfire harassing the heart system pattern TM: SF14\\nWindphlegm pattern TM: SF15\\nOther specified fluid patterns TM: SF1Y\\nFluid patterns TM unspecified: SF1Z\\nEssence deficiency pattern TM: SF20\\nOther specified essence patterns TM: SF2Y\\nEssence patterns TM unspecified: SF2Z\\nOther specified body constituents patterns TM: SF4Y\\nBody constituents patterns TM unspecified: SF4Z\\nLiver yin deficiency pattern TM: SF50\\nLiver yang deficiency pattern TM: SF51\\nLiver yang ascendant hyperactivity pattern TM: SF52\\nLiver qi deficiency pattern TM: SF53\\nLiver blood deficiency pattern TM: SF54\\nLiver depression and blood stasis pattern TM: SF55\\nLiver wind stirring the interior pattern TM: SF56\\nLiver qi stagnation pattern TM: SF57\\nLiver fire flaming upward pattern TM: SF58\\nLiver heat stirring wind pattern TM: SF59\\nLivergallbladder dampnessheat pattern TM: SF5A\\nLiver meridian dampnessheat pattern TM: SF5B\\nLiver meridian cold stagnation pattern TM: SF5C\\nGallbladder qi deficiency pattern TM: SF5D\\nGallbladder depression with phlegm harassment pattern TM: SF5E\\nGallbladder heat pattern TM: SF5F\\nGallbladder cold pattern TM: SF5G\\nLiver and kidney yin deficiency pattern TM: SF5H\\nDisharmony of liver and spleen systems pattern TM: SF5J\\nDisharmony of liver and stomach systems pattern TM: SF5K\\nLiver fire invading the stomach system pattern TM: SF5L\\nLiver fire invading the lung system pattern TM: SF5M\\nOther specified liver system patterns TM: SF5Y\\nLiver system patterns TM unspecified: SF5Z\\nHeart qi deficiency pattern TM: SF60\\nHeart blood deficiency pattern TM: SF61\\nDual deficiency of heart qi and blood pattern TM: SF62\\nHeart meridian obstruction pattern TM: SF63\\nHeart yin deficiency pattern TM: SF64\\nDeficiency of heart qi and yin pattern TM: SF65\\nHeart yang deficiency pattern TM: SF66\\nHeart yang collapse pattern TM: SF67\\nHeart fire flaming upward pattern TM: SF68\\nFire harassing heart spirit pattern TM: SF69\\nWater qi intimidating the heart system pattern TM: SF6A\\nHeart spirit restlessness pattern TM: SF6B\\nAnxiety damaging the spirit pattern TM: SF6C\\nSmall intestine qi stagnation pattern TM: SF6D\\nSmall intestine excess heat pattern TM: SF6E\\nSmall intestine deficiency cold pattern TM: SF6F\\nHeart and liver blood deficiency pattern TM: SF6G\\nHeart and gallbladder qi deficiency pattern TM: SF6H\\nHeart and spleen systems deficiency pattern TM: SF6J\\nHeart and lung qi deficiency pattern TM: SF6K\\nHeart and kidney systems disharmony pattern TM: SF6L\\nHeart and kidney yang deficiency pattern TM: SF6M\\nOther specified heart system patterns TM: SF6Y\\nHeart system patterns TM unspecified: SF6Z\\nSpleen qi deficiency pattern TM: SF70\\nSpleen qi sinking pattern TM: SF71\\nSpleen deficiency with qi stagnation pattern TM: SF72\\nSpleen deficiency with food retention pattern TM: SF73\\nSpleen failing to control the blood pattern TM: SF74\\nSpleen deficiency and blood depletion pattern TM: SF75\\nSpleen yin deficiency pattern TM: SF76\\nSpleen yang deficiency pattern TM: SF77\\nDampnessheat encumbering the spleen system pattern TM: SF78\\nSpleen deficiency with dampness accumulation pattern TM: SF79\\nSpleen deficiency with water flooding pattern TM: SF7A\\nColddampness encumbering the spleen system pattern TM: SF7B\\nStomach qi deficiency pattern TM: SF7C\\nStomach qi uprising pattern TM: SF7D\\nStomach yin deficiency pattern TM: SF7E\\nStomach heat pattern TM: SF7F\\nDampness in the intestines pattern TM: SF7G\\nCold invading the stomach system pattern TM: SF7H\\nIntestine cold stagnation pattern TM: SF7J\\nAnxiety damaging the spleen system pattern TM: SF7K\\nLung and spleen deficiency pattern TM: SF7L\\nSpleen and kidney yang deficiency pattern TM: SF7M\\nOther specified spleen system patterns TM: SF7Y\\nSpleen system patterns TM unspecified: SF7Z\\nLung qi deficiency pattern TM: SF80\\nLung yin deficiency pattern TM: SF81\\nLung and kidney yin deficiency pattern TM: SF82\\nLung qi and yin deficiency pattern TM: SF83\\nLung yang deficiency pattern TM: SF84\\nCold phlegm obstructing the lung pattern TM: SF85\\nTurbid phlegm accumulation in the lung pattern TM: SF86\\nExterior cold with lung heat pattern TM: SF87\\nIntense congestion of lung heat pattern TM: SF88\\nPhlegm heat obstructing the lung pattern TM: SF89\\nWindheat invading the lung pattern TM: SF8A\\nLung heat transmitting into the intestine pattern TM: SF8B\\nWindcold fettering the lung pattern TM: SF8C\\nDryness invading the lung pattern TM: SF8D\\nLung dryness with intestinal obstruction pattern TM: SF8E\\nLarge intestine excess heat pattern TM: SF8F\\nLarge intestine dampness heat pattern TM: SF8G\\nLarge intestine fluid deficiency pattern TM: SF8H\\nLarge intestine deficiency cold pattern TM: SF8J\\nOther specified lung system patterns TM: SF8Y\\nLung system patterns TM unspecified: SF8Z\\nKidney qi deficiency pattern TM: SF90\\nKidney failing to receive qi pattern TM: SF91\\nKidney qi deficiency with water retention pattern TM: SF92\\nKidney yin deficiency pattern TM: SF93\\nKidney yin and yang deficiency pattern TM: SF94\\nKidney deficiency with marrow depletion pattern TM: SF95\\nKidney essence deficiency pattern TM: SF96\\nKidney yang deficiency pattern TM: SF97\\nFear damaging the kidney system pattern TM: SF98\\nBlood and heat accumulation in the uterus pattern TM: SF99\\nPhlegm obstructing the uterus pattern TM: SF9A\\nDampnessheat in the uterus pattern TM: SF9B\\nCold stagnation in the uterus pattern TM: SF9C\\nUterine deficiency cold pattern TM: SF9D\\nBlood accumulation in the bladder pattern TM: SF9E\\nBladder heat accumulation pattern TM: SF9F\\nBladder dampnessheat pattern TM: SF9G\\nBladder water accumulation pattern TM: SF9H\\nBladder deficiency cold pattern TM: SF9J\\nOther specified kidney system patterns TM: SF9Y\\nKidney system patterns TM unspecified: SF9Z\\nOther specified organ system patterns TM: SG1Y\\nOrgan system patterns TM unspecified: SG1Z\\nLung meridian pattern TM: SG20\\nLarge intestine meridian pattern TM: SG21\\nStomach meridian pattern TM: SG22\\nSpleen meridian pattern TM: SG23\\nHeart meridian pattern TM: SG24\\nSmall intestine meridian pattern TM: SG25\\nBladder meridian pattern TM: SG26\\nKidney meridian pattern TM: SG27\\nPericardium meridian pattern TM: SG28\\nTriple energizer meridian pattern TM: SG29\\nGallbladder meridian pattern TM: SG2A\\nLiver meridian pattern TM: SG2B\\nOther specified main Meridian Patterns TM: SG2Y\\nMain Meridian Patterns TM unspecified: SG2Z\\nGovernor vessel pattern TM: SG30\\nConception vessel pattern TM: SG31\\nYin heel vessel pattern TM: SG32\\nYang heel vessel pattern TM: SG33\\nYin link vessel pattern TM: SG34\\nYang link vessel pattern TM: SG35\\nThoroughfare vessel pattern TM: SG36\\nBelt vessel pattern TM: SG37\\nOther specified extra Meridian Patterns TM: SG3Y\\nExtra Meridian Patterns TM unspecified: SG3Z\\nOther specified meridian and collateral patterns TM: SG5Y\\nMeridian and collateral patterns TM unspecified: SG5Z\\nEarly yang stage pattern TM: SG60\\nMiddle yang stage pattern TM: SG61\\nLate yang stage pattern TM: SG62\\nEarly yin stage pattern TM: SG63\\nMiddle yin stage pattern TM: SG64\\nLate yin stage pattern TM: SG65\\nOther specified six stage patterns TM: SG6Y\\nSix stage patterns TM unspecified: SG6Z\\nUpper energizer stage patterns TM: SG70\\nMiddle energizer stage patterns TM: SG71\\nLower energizer stage patterns TM: SG72\\nOther specified triple energizer stage patterns TM: SG7Y\\nTriple energizer stage patterns TM unspecified: SG7Z\\nDampness obstructing the defense yang pattern TM: SG80\\nHeat attacking the lung defense pattern TM: SG81\\nOther specified defense phase patterns TM: SG8Y\\nDefense phase patterns TM unspecified: SG8Z\\nHeat entering the qi phase pattern TM: SG90\\nQi phase dampness and heat pattern TM: SG91\\nDampness obstructing the qi phase pattern TM: SG92\\nOther specified qi phase patterns TM: SG9Y\\nQi phase patterns TM unspecified: SG9Z\\nNutrient qi and defense qi disharmony pattern TM: SH00\\nHeat in the nutrient phase patternTM: SH01\\nHeat entering the nutrient and blood phase pattern TM: SH02\\nOther specified nutrient phase patterns TM: SH0Y\\nNutrient phase patterns TM unspecified: SH0Z\\nBlood phase pattern TM: SH10\\nHeat entering the blood phase patternTM: SH11\\nOther specified blood phase patterns TM: SH1Y\\nBlood phase patterns TM unspecified: SH1Z\\nOther specified four phase patterns TM: SH3Y\\nFour phase patterns TM unspecified: SH3Z\\nLarge yang type exterior origin lower back pattern TM: SH40\\nLarge yang type interior origin small intestine pattern TM: SH41\\nLarge yang type exterior interior combined pattern TM: SH42\\nOther specified large yang type patterns TM: SH4Y\\nLarge yang type patterns TM unspecified: SH4Z\\nSmall yang type lesser yang wind damage pattern TM: SH50\\nSmall yang type yin depletion pattern TM: SH51\\nSmall yang type chest heat congested pattern TM: SH52\\nSmall yang type yin deficit pattern TM: SH53\\nSmall yang type exterior interior combined pattern TM: SH54\\nOther specified small yang type patterns TM: SH5Y\\nSmall yang type patterns TM unspecified: SH5Z\\nLarge yin type supraspinal exterior pattern TM: SH60\\nLarge yin type esophagus cold pattern TM: SH61\\nLarge yin type liver heat pattern TM: SH62\\nLarge yin type dryness heat pattern TM: SH63\\nLarge yin type exterior Interior combined pattern TM: SH64\\nOther specified large yin type patterns TM: SH6Y\\nLarge yin type patterns TM unspecified: SH6Z\\nSmall yin type congestive hyperpsychotic pattern TM: SH70\\nSmall yin type yang depletion pattern TM: SH71\\nSmall yin type greater yin pattern TM: SH72\\nSmall yin type lesser yin pattern TM: SH73\\nSmall yin type exterior interior combined pattern TM: SH74\\nOther specified small yin type patternsTM: SH7Y\\nSmall yin type patternsTM unspecified: SH7Z\\nOther specified four constitution medicine patterns TM: SH9Y\\nFour constitution medicine patterns TM unspecified: SH9Z\\nOther specified traditional medicine patterns TM: SJ1Y\\nTraditional medicine patterns TM unspecified: SJ1Z\\nCephalalgia disorder TM: SK00\\nVertigo and giddiness disorder TM: SK10\\nOther specified nervous system disorders TM: SK1Y\\nNervous system disorders TM unspecified: SK1Z\\nFacial palsy disorder TM: SK20\\nParaplegia disorder TM: SK21\\nHemiplegia disorder TM: SK22\\nOther specified paralysis disorders TM: SK2Y\\nParalysis disorders TM unspecified: SK2Z\\nSeizure disorder TM: SK30\\nEpilepsy disorder TM: SK31\\nOther specified paroxysmal disorders TM: SK3Y\\nParoxysmal disorders TM unspecified: SK3Z\\nScalp affliction disorder TM: SK50\\nCervicobrachial pain disorder TM: SK51\\nTremor disorder TM: SK52\\nStammering disorder TM: SK53\\nWeakness of thighs due to vata disorder TM: SK55\\nOther specified head brain nerve and movement disorders TM: SK5Y\\nHead brain nerve and movement disorders TM unspecified: SK5Z\\nOcular hyperemia disorder TM: SK60\\nProlapse iris disorder TM: SK61\\nBlepharitis disorder TM: SK62\\nDay blindness disorder TM: SK63\\nCataract disorder TM: SK65\\nConjunctivitis disorder TM: SK66\\nCorneal disorder TM: SK67\\nTear sac swelling disorder TM: SK68\\nEyelid cyst disorder TM: SK69\\nDry eye disorder TM: SK6A\\nEctropion disorder TM: SK6B\\nPterygium disorder TM: SK6C\\nLacrimation disorder TM: SK6D\\nTrichiasis disorder TM: SK6E\\nEyelid tumour disorder TM: SK6F\\nHard swelling of eyelid disorder TM: SK6G\\nEyelid wart disorder TM: SK6H\\nExcessive blinking disorder TM: SK6J\\nEyelid haematoma disorder TM: SK6K\\nPtosis disorder TM: SK6L\\nSticky eyelids disorder TM: SK6M\\nChalazion disorder TM: SK6N\\nStye disorder TM: SK6P\\nPtilosis disorder TM: SK6Q\\nNoninflammatory swelling of eye disorder TM: SK6R\\nPeriorbital polyp disorder TM: SK6S\\nPhlyctenular nodule disorder TM: SK6T\\nTrachoma disorder TM: SK6U\\nPanopthalmitis disorder TM: SK6W\\nPhthisis bulbi disorder TM: SK6X\\nOther specified eye disorders TM: SK7Y\\nEye disorders TM unspecified: SK7Z\\nEar abscess disorder TM: SK80\\nDeafness disorder TM: SK81\\nOtorrhoea disorder TM: SK82\\nPruritus of ear disorder TM: SK83\\nDysacousia disorder TM: SK84\\nImpacted cerumen disorder TM: SK85\\nOtalgia disorder TM: SK87\\nOtitis disorder TM: SK88\\nPustules of pinna disorder TM: SK89\\nOther specified ear disorders TM: SK8Y\\nEar disorders TM unspecified: SK8Z\\nEpistaxis disorder TM: SK90\\nAnosmia disorder TM: SK91\\nDry nose disorder TM: SK92\\nAtrophic rhinitis disorder TM: SK93\\nNasal polyp disorder TM: SK94\\nRhinitis disorder TM: SK95\\nCoryza and catarrh disorder TM: SK96\\nNasal obstruction disorder TM: SK97\\nOzaena disorder TM: SK98\\nSinusitis disorder TM: SK99\\nAdenoiditis disorder TM: SK9A\\nOther specified nose disorders TM: SK9Y\\nNose disorders TM unspecified: SK9Z\\nThroat tumour disorder TM: SL00\\nRetropharyngeal abscess disorder TM: SL01\\nHoarseness of voice disorder TM: SL02\\nIndistinctabnormal voice disorder TM: SL03\\nSevere throat inflammation disorder TM: SL04\\nPharyngitis disorder TM: SL05\\nSpeech disorder TM: SL07\\nLymphadenopathy in throat region disorder TM: SL08\\nLaryngitis disorder TM: SL09\\nOther specified neck and throat disorders TM: SL0Y\\nNeck and throat disorders TM unspecified: SL0Z\\nExcessive sneezing disorder TM: SL20\\nHypernasal speech disorder TM: SL21\\nOther specified eye ear nose throat and neck disorders TM: SL2Y\\nEye ear nose throat and neck disorders TM unspecified: SL2Z\\nBronchial asthma disorder TM: SL40\\nCough disorder TM: SL41\\nDyspnoea disorder TM: SL42\\nOther specified respiratory system disorders TM: SL4Y\\nRespiratory system disorders TM unspecified: SL4Z\\nSlow heart disorder TM: SL60\\nHeart pain disorder TM: SL61\\nPalpitation disorder TM: SL62\\nOther specified heart disorders TM: SL6Y\\nHeart disorders TM unspecified: SL6Z\\nVaricose veins disorder TM: SL70\\nVaricose ulcer disorder TM: SL71\\nThickened arteries disorder TM: SL72\\nOther specified circulatory disorders TM: SL7Y\\nCirculatory disorders TM unspecified: SL7Z\\nAnaemia disorder TM: SL80\\nBleeding disorder disorder TM: SL81\\nOther specified blood related disorders TM: SL8Y\\nBlood related disorders TM unspecified: SL8Z\\nLymphadenopathy disorder TM: SM00\\nElephantiasis disorder TM: SM01\\nOther specified heart blood and circulatory disorders TM: SM0Y\\nHeart blood and circulatory disorders TM unspecified: SM0Z\\nStomatitis disorder TM: SM10\\nDental abscess disorder TM: SM11\\nBruxism disorder TM: SM12\\nPyorrhoea disorder TM: SM13\\nGingivitis disorder TM: SM14\\nHalitosis disorder TM: SM15\\nSialorrhoea disorder TM: SM16\\nPalatitis disorder TM: SM17\\nUvulitis disorder TM: SM18\\nLudwigs angina disorder TM: SM19\\nOdontalgia disorder TM: SM1A\\nBleeding gum disorder TM: SM1B\\nRanula disorder TM: SM1C\\nParotitis disorder TM: SM1D\\nDental caries disorder TM: SM1E\\nDental plaque disorder TM: SM1F\\nDiscolouration of teeth disorder TM: SM1G\\nOdontoseisis disorder TM: SM1H\\nSensitive teeth disorder TM: SM1J\\nLip chapping and bleeding disorder TM: SM1K\\nItchy swollen lip diorder TM: SM1L\\nDry chapped lip disorder TM: SM1M\\nXerostomia disorder TM: SM1N\\nAgeusia disorder TM: SM1P\\nOther specified oral cavity disorders TM: SM1Y\\nOral cavity disorders TM unspecified: SM1Z\\nHaematemesis disorder TM: SM30\\nAbdominal distension disorder TM: SM31\\nAscites disorder TM: SM32\\nVolvulus disorder TM: SM35\\nMalabsorption disorder TM: SM36\\nDiarrhoea disorder TM: SM37\\nDyspepsia disorder TM: SM39\\nHyperacidity disorder TM: SM3A\\nIndigestion disorder TM: SM3B\\nFood stasis indigestion disorder TM: SM3C\\nDuodenal ulcer disorder TM: SM3D\\nGastric ulcer disorder TM: SM3E\\nGastritis disorder TM: SM3F\\nHernia disorder TM: SM3G\\nNausea disorder TM: SM3H\\nRetching disorder TM: SM3J\\nAbdominal lumps disorder TM: SM3K\\nVomiting disorder TM: SM3L\\nOther specified abdominal cavity disorders TM: SM3Y\\nAbdominal cavity disorders TM unspecified: SM3Z\\nHepatomegaly disorder TM: SM42\\nHepatitis disorder TM: SM43\\nSplenomegaly disorder TM: SM44\\nOther specified liver and Spleen disorders TM: SM4Y\\nLiver and Spleen disorders TM unspecified: SM4Z\\nProctalgia disorder TM: SM50\\nAnal fissure disorder TM: SM51\\nFistula in ano disorder TM: SM52\\nHaemorrhoids disorder TM: SM53\\nProctitis disorder TM: SM54\\nRectal prolapse disorder TM: SM55\\nOther specified anorectal disorders TM: SM5Y\\nAnorectal disorders TM unspecified: SM5Z\\nFlank pain disorder TM: SM70\\nAnorexia disorder TM: SM71\\nBowel inflammation disorder TM: SM72\\nInfantile tenesmus disorder TM: SM73\\nHiccough disorder TM: SM74\\nDynamic intestinal obstruction disorder TM: SM75\\nOther specified gastrointestinal disorders TM: SM7Y\\nGastrointestinal disorders TM unspecified: SM7Z\\nRenal abscess disorder TM: SM80\\nRetention of urine disorder TM: SM81\\nInsufficiency of the urinary bladder disorder TM: SM82\\nRenal colic disorder TM: SM83\\nNephritis disorder TM: SM84\\nCystitis disorder TM: SM85\\nWound of the urinary bladder disorder TM: SM86\\nDysuria disorder TM: SM87\\nDribbling of urine disorder TM: SM88\\nThick urine disorder TM: SM89\\nHaematuria disorder TM: SM8A\\nUrinary incontinence disorder TM: SM8B\\nUrinary stone disorder TM: SM8C\\nPolyuria disorder TM: SM8D\\nOliguria disorder TM: SM8E\\nOther specified urinary system disorders TM: SM8Y\\nUrinary system disorders TM unspecified: SM8Z\\nAmenorrhoea disorder TM: SM90\\nEndocervicitis disorder TM: SM91\\nBartholins cyst disorder TM: SM92\\nLeucorrhoea disorder TM: SM93\\nFemale infertility disorder TM: SM94\\nVaginitis disorder TM: SM95\\nDysmenorrhoea disorder TM: SM96\\nHypomenorrhoea disorder TM: SM97\\nDysfunctional uterine bleeding disorder TM: SM98\\nUterine polyps disorder TM: SM99\\nUterine prolapse disorder TM: SM9A\\nVaginismus disorder TM: SM9B\\nMetritis disorder TM: SM9C\\nOther specified female Reproductive System disorders TM: SM9Y\\nFemale Reproductive System disorders TM unspecified: SM9Z\\nBalanitis disorder TM: SN00\\nHydrocele disorder TM: SN01\\nErectile dysfunction disorder TM: SN02\\nOligospermia disorder TM: SN03\\nMustardsize boils on penis disorder TM: SN04\\nOrchitis disorder TM: SN05\\nPenile growth disorder TM: SN06\\nPriapism disorder TM: SN07\\nProstatic enlargement disorder TM: SN08\\nSpermatorrhoea disorder TM: SN09\\nPhimosis disorder TM: SN0A\\nOther specified male Reproductive System disorders TM: SN0Y\\nMale Reproductive System disorders TM unspecified: SN0Z\\nDecreased breastmilk disorder TM: SN10\\nVitiated breast milk disorder TM: SN11\\nRecurrent pregnancy loss disorder TM: SN12\\nOther specified pregnancy and childbirth related disorders TM: SN1Y\\nPregnancy and childbirth related disorders TM unspecified: SN1Z\\nGonorrhoea disorder TM: SN30\\nSyphillis disorder TM: SN31\\nOther specified urinary and reproductive system disorders TM: SN3Y\\nUrinary and reproductive system disorders TM unspecified: SN3Z\\nDermatitis disorder TM: SN40\\nDiscoloration of body disorder TM: SN41\\nDryness of skin disorder TM: SN42\\nEczema disorder TM: SN43\\nFoul body smelling disorder TM: SN44\\nExcess of sweat disorder TM: SN45\\nScabies disorder TM: SN46\\nDracunculosis disorder TM: SN47\\nIntertrigo disorder TM: SN48\\nIntegumentary disorder TM: SN49\\nPsoriasis disorder TM: SN4A\\nIchthyosis disorder TM: SN4B\\nScaling of scalp and forehead skin disorder TM: SN4C\\nVitiligo disorder TM: SN4D\\nLentigo disorder TM: SN4E\\nBirth mark blackish red disorder TM: SN4F\\nMelasma disorder TM: SN4G\\nMole disorder TM: SN4H\\nBlack red skin lesion disorder TM: SN4J\\nUrticaria disorder TM: SN4K\\nWheal disorder TM: SN4L\\nBoil disorder TM: SN4M\\nPrickly heat disorder TM: SN4N\\nPemphigus vulgaris disorder TM: SN4P\\nScar marks disorder TM: SN4Q\\nRoughness of skin disorder TM: SN4R\\nVerruca disorder TM: SN4S\\nHerpes disorder TM: SN4T\\nRing worm infection disorder TM: SN4U\\nAcne disorder TM: SN4V\\nUlcer disorder TM: SN4W\\nOther specified skin disorders TM: SN5Y\\nSkin disorders TM unspecified: SN5Z\\nBrittle nails disorder TM: SN60\\nOther specified nail disorders TM: SN6Y\\nNail disorders TM unspecified: SN6Z\\nFurunculosis of scalp disorder TM: SN70\\nBaldness disorder TM: SN71\\nFolliculitis disorder TM: SN72\\nPremature greying of hair disorder TM: SN73\\nOther specified hair disorders TM: SN7Y\\nHair disorders TM unspecified: SN7Z\\nPatchy alopecia disorder TM: SN90\\nDandruff disorder TM: SN91\\nCarbuncle disorder TM: SN92\\nOther specified skin nail and hair disorders TM: SN9Y\\nSkin nail and hair disorders TM unspecified: SN9Z\\nOsteoporosis disorder TM: SP00\\nOther specified bone disorders TM: SP0Y\\nBone disorders TM unspecified: SP0Z\\nPolyarthritis disorder TM: SP10\\nRheumatism disorder TM: SP11\\nOsteoarthritis disorder TM: SP12\\nHip joint pain disorder TM: SP13\\nGout disorder TM: SP14\\nFrozen shoulder disorder TM: SP15\\nOther specified joint disorders TM: SP1Y\\nJoint disorders TM unspecified: SP1Z\\nMuscle pain twisting disorder TM: SP20\\nAtony disorder TM: SP21\\nOther specified muscle disorders TM: SP2Y\\nMuscle disorders TM unspecified: SP2Z\\nAchillodynia disorder TM: SP40\\nSciatica disorder TM: SP41\\nLumbar spondylosis disorder TM: SP42\\nLumbosacroiliac disorder TM: SP43\\nTorticollis disorder TM: SP44\\nCervical spondylosis disorder TM: SP45\\nOther specified bone joint and muscle disorders TM: SP4Y\\nBone joint and muscle disorders TM unspecified: SP4Z\\nEnteric fever disorder TM: SP50\\nFever disorder TM: SP51\\nFever disorder with excessive salivation TM: SP52\\nHigh fever disorder with yellow discouloration TM: SP53\\nFever with body pain disorder TM: SP54\\nFever with chills disorder TM: SP55\\nHigh grade fever disorder TM: SP56\\nIntermittent fever disorder TM: SP57\\nContinuous fever disorder TM: SP58\\nFever disorder due to external factor TM: SP59\\nInflammation with morbid matter disorder TM: SP5A\\nOther specified febricity disorders TM: SP5Y\\nFebricity disorders TM unspecified: SP5Z\\nDiabetes mellitus disorder TM: SP60\\nEmaciation disorder TM: SP61\\nHigh fat disorder TM: SP62\\nPolydipsia disorder TM: SP63\\nObesity disorder TM: SP64\\nOther specified metabolic disorders TM: SP6Y\\nMetabolic disorders TM unspecified: SP6Z\\nLipoma disorder TM: SP70\\nBenign tumour disorder TM: SP71\\nDeep rooted spreading tumour disorder TM: SP72\\nOther specified tumours disorders TM: SP7Y\\nTumours disorders TM unspecified: SP7Z\\nAbscess disorder TM: SP90\\nGeneralised oedema disorder TM: SP91\\nOedema disorder TM: SP92\\nImpaired immunity disorder TM: SP93\\nInflammation disorder TM: SP94\\nExcessive yawning disorder TM: SP95\\nLaziness disorder TM: SP96\\nSevere fatigue disorder TM: SP97\\nPruritus disorder TM: SP99\\nGeneral debility disorder TM: SP9A\\nOther specified disorders affecting the whole body TM: SP9Y\\nDisorders affecting the whole body TM unspecified: SP9Z\\nDelirium disorder TM: SQ00\\nHallucination disorder TM: SQ01\\nHysteria disorder TM: SQ02\\nInsanity disorder TM: SQ03\\nDepressive disorder TM: SQ04\\nLack of concentration confusion disorder TM: SQ05\\nOther specified mental disorders TM: SQ0Y\\nMental disorders TM unspecified: SQ0Z\\nAnxiety ephemeral fever disorder TM: SQ10\\nOther specified emotional disorders TM: SQ1Y\\nEmotional disorders TM unspecified: SQ1Z\\nAlcoholism disorder TM: SQ20\\nEgomania disorder TM: SQ21\\nNon alcoholic intoxication disorder TM: SQ22\\nPanic attack disorder TM: SQ23\\nOther specified behavioural disorders TM: SQ2Y\\nBehavioural disorders TM unspecified: SQ2Z\\nHypersomnia disorder TM: SQ40\\nLycanthropy disorder TM: SQ41\\nOther specified mental emotional and behavioural disorders TM: SQ4Y\\nMental emotional and behavioural disorders TM unspecified: SQ4Z\\nWorm infestation disorder TM: SQ50\\nOther specified infestation disorders TM: SQ5Y\\nInfestation disorders TM unspecified: SQ5Z\\nPseudo poisoning disorder TM: SQ60\\nArtificial poison disorder TM: SQ61\\nOther specified poisoning disorders TM: SQ6Y\\nPoisoning disorders TM unspecified: SQ6Z\\nInadequate diet disorders TM: SQ80\\nOther specified external factors disorders TM: SQ8Y\\nExternal factors disorders TM unspecified: SQ8Z\\nMarasmus disorder TM: SR00\\nBed wetting disorder TM: SR01\\nInfantile dysentry disorder TM: SR02\\nInfantile epilepsy disorder TM: SR03\\nOphthalmia neonatarum disorder TM: SR04\\nChildhood malnutrition disorder TM: SR05\\nOral thrush in babies disorder TM: SR06\\nOther specified childhood disorders TM: SR0Y\\nChildhood disorders TM unspecified: SR0Z\\nVitiation of vta pattern TM: SR10\\nAccumulation of Vata pattern TM: SR11\\nAggravation of vata pattern TM: SR12\\nSpreading of vata pattern TM: SR13\\nDepletion of vata pattern TM: SR14\\nVitiation of pitta pattern TM: SR15\\nAccumulation of pitta pattern TM: SR16\\nAggravation of pitta pattern TM: SR17\\nSpreading of pitta pattern TM: SR18\\nDepletion of pitta pattern TM: SR19\\nVitiation of kapha pattern TM: SR1A\\nAccumulation of kapha pattern TM: SR1B\\nAggravation of kapha pattern TM: SR1C\\nSpreading of kapha pattern TM: SR1D\\nDepletion of kapha pattern TM: SR1E\\nIncrease of Vai pattern TM: SR1F\\nIncrease of Aal pattern TM: SR1G\\nIncrease of Aiyam pattern TM: SR1H\\nDecrease of Vai pattern TM: SR1J\\nDecrease of Aal pattern TM: SR1K\\nDecrease of Aiyam pattern TM: SR1L\\nPredominance of Dam pattern TM: SR1M\\nPredominance of afr pattern TM: SR1N\\nPredominance of Balgham pattern TM: SR1P\\nPredominance of Sawd pattern TM: SR1Q\\nBlood thickening pattern TM: SR1R\\nBlood thinning pattern TM: SR1S\\nBlood hyperviscosity pattern TM: SR1U\\nSpoilage of humors pattern TM: SR1V\\nBurning of humors pattern TM: SR1W\\nThickening of humors pattern TM: SR1X\\nPattern of occlusion TM: SR20\\nOther specified functional elements and humoral derangement patterns TM: SR2Y\\nFunctional elements and humoral derangement patterns TM unspecified: SR2Z\\nVitiation of primary structural components of the body pattern TM: SR40\\nAggravation of primary circulating nutrient fluid pattern TM: SR41\\nDepletion of primary circulating nutrient fluid pattern TM: SR42\\nMorbid increase of blood pattern TM: SR43\\nDepletion of blood pattern TM: SR44\\nExcessive increase of muscular tissues pattern TM: SR45\\nDepletion of muscular tissues pattern TM: SR46\\nIncrease of adipose tissues pattern TM: SR47\\nDepletion of adipose tissues pattern TM: SR48\\nIncrease of bone tissues pattern TM: SR49\\nDepletion of bone tissues pattern TM: SR4A\\nIncrease of bone marrow pattern TM: SR4B\\nDepletion of bone marrow pattern TM: SR4C\\nIncrease of reproductive tissues and semen pattern TM: SR4D\\nDepletion of reproductive tissues and semen pattern TM: SR4E\\nDiminution of Ojas pattern TM: SR4F\\nDerangement of Ojas pattern TM: SR4G\\nDislodgement of Ojas pattern TM: SR4H\\nIncreased menstrual flow pattern TM: SR4J\\nDiminution of menstrual flow pattern TM: SR4K\\nIncreased secretion of breast milk pattern TM: SR4L\\nDecreased secretion of breast milk pattern TM: SR4M\\nDerangement of channels carrying essense of digested food pattern TM: SR50\\nDerangement of channels enriching blood pattern TM: SR51\\nDerangement of channels enriching muscle tissue pattern TM: SR52\\nDerangement of channels carrying fat pattern TM: SR53\\nDerangement of channels enriching bone pattern TM: SR54\\nDerangement of channels enriching bone marrow pattern TM: SR55\\nDerangement of channels enriching seminal fluid pattern TM: SR56\\nDerangement of channels enriching vital life force pattern TM: SR57\\nDerangement of channels for fluid circulation pattern TM: SR58\\nDerangement of digestive tract pattern TM: SR59\\nDerangement of channels of faeces pattern TM: SR5A\\nDerangement of urinary tract pattern TM: SR5B\\nDerangement of channels producing sweat pattern TM: SR5C\\nDerangement of channels enriching breast milk pattern TM: SR5D\\nDerangement of mind related channels pattern TM: SR5E\\nOther specified derangement of channels pattern TM: SR5Y\\nDerangement of channels pattern TM unspecified: SR5Z\\nIncrease of female reproductive tissue pattern TM: SR60\\nDecrease of female reproductive tissue pattern TM: SR61\\nPattern resulting in abnormal number of organs and appendages TM: SR62\\nPattern of abnormal positioning of organs and appendages TM: SR63\\nPattern of abnormal relative position of organs TM: SR64\\nLoss of continuity pattern TM: SR65\\nR pattern TM: SR66\\nBukhrt pattern TM: SR67\\nCompound pattern TM: SR68\\nPattern of quantity TM: SR69\\nOther specified physical constituent derangement patterns TM: SR6Y\\nPhysical constituent derangement patterns TM unspecified: SR6Z\\nMorbid increase of feces pattern TM: SR80\\nDepletion of faeces pattern TM: SR81\\nExcessive urine pattern TM: SR82\\nReduced urine pattern TM: SR83\\nHyperhidrosis pattern TM: SR84\\nAnhidrosis pattern TM: SR85\\nFaeces with undigested food residues pattern TM: SR86\\nUrine of over heat pattern TM: SR87\\nUrine colour of excessive cold pattern TM: SR88\\nUrine colour of excessive depravement of Vai Aal and Aiyam pattern TM: SR89\\nUrine like colour of rawmeat washings pattern TM: SR8A\\nDelayed passing of stool pattern TM: SR8B\\nDry stool pattern TM: SR8C\\nLarger quantity of stool pattern TM: SR8D\\nSharp smelling sweat pattern TM: SR8E\\nSour smelling sweat pattern TM: SR8F\\nSweat of thick consistency pattern TM: SR8G\\nSweat of thin consistency pattern TM: SR8H\\nLack of sweat pattern TM: SR8J\\nExcess of sputum pattern TM: SR8K\\nLack of sputum pattern TM: SR8L\\nModerate quantity of sputum during convalescence pattern TM: SR8M\\nExcess of sweat pattern due to decreased vitality TM: SR8N\\nOther specified excretory products derangement patterns TM: SR8Y\\nExcretory products derangement patterns TM unspecified: SR8Z\\nDerangement of digestive power pattern TM: SS10\\nIrregular digestive power pattern TM: SS11\\nElevated digestive power pattern TM: SS12\\nSubdued digestive power pattern TM: SS13\\nHighly elevated digestive power pattern TM: SS14\\nState of incomplete digestion transformation or metabolism pattern TM: SS15\\nNatural digestive fire pattern TM: SS16\\nStrong digestive fire pattern TM: SS17\\nToxic digestive fire pattern TM: SS18\\nWeak digestive fire pattern TM: SS19\\nOther specified digestive fire based patterns TM: SS1Y\\nDigestive fire based patterns TM unspecified: SS1Z\\nSuppression of breath pattern TM: SS20\\nSuppression of yawning pattern TM: SS21\\nSuppression of hunger and thirst together pattern TM: SS22\\nSuppression of semen pattern TM: SS23\\nSuppression of cough pattern TM: SS24\\nSuppression of micturition pattern TM: SS25\\nSuppression of sleep pattern TM: SS26\\nSuppression of sneeze pattern TM: SS27\\nSuppression of tears pattern TM: SS28\\nSuppression of vomiting pattern TM: SS29\\nSuppression of stool pattern TM: SS2A\\nSupression of exertional hyperpnea pattern TM: SS2B\\nSuppression of hunger pattern TM: SS2C\\nSuppression of thirst pattern TM: SS2D\\nSuppression of flatus pattern TM: SS2E\\nPattern of humour accumulated with air TM: SS2F\\nPattern of humour accumulated with excess cold TM: SS2G\\nPattern of humour accumulated with excess heat TM: SS2H\\nOther specified chronic accumulation patterns TM: SS2Y\\nChronic accumulation patterns TM unspecified: SS2Z\\nPhysical faculties derangement pattern TM: SS30\\nNutritive faculty derangement pattern TM: SS31\\nCollecting faculty derangement pattern TM: SS32\\nAdhesive faculty derangement pattern TM: SS33\\nAssimilation faculty derangement pattern TM: SS34\\nAbsorptive faculty derangement pattern TM: SS35\\nRetentive faculty derangement pattern TM: SS36\\nDigestive faculty derangement pattern TM: SS37\\nExpulsive faculty derangement pattern TM: SS38\\nGrowth faculty derangement pattern TM: SS39\\nReproductive faculties derangement pattern TM: SS3A\\nVital faculty derangement pattern TM: SS3B\\nPsychic faculties derangement pattern TM: SS3C\\nDebility of organs pattern TM: SS3D\\nInnate heat weakness pattern TM: SS3E\\nDisruption of innate heat pattern TM: SS3F\\nWeakness of psychic spirit pattern TM: SS3G\\nWeakness of natural spirit pattern TM: SS3H\\nWeakness of vital spirit pattern TM: SS3J\\nOther specified power derangement patterns TM: SS3Y\\nPower derangement patterns TM unspecified: SS3Z\\nOther specified power derangement and chronic accumulation patterns TM: SS4Y\\nPower derangement and chronic accumulation patterns TM unspecified: SS4Z\\nVata constitution pattern TM: SS50\\nPitta constitution pattern TM: SS51\\nKapha constitution pattern TM: SS52\\nVataPitta constitution pattern TM: SS53\\nPittaKapha constitution pattern TM: SS54\\nKaphaVata constitution pattern TM: SS55\\nBody constitution with a predominance of all three dosha pattern TM: SS56\\nVai body constitution pattern TM: SS57\\nAal body constitution pattern TM: SS58\\nAiyam body constitution pattern TM: SS59\\nVaipredominant Aal body constitution pattern TM: SS5A\\nVaipredominant Aiyam body constitution pattern TM: SS5B\\nAalpredominant Vai body constitution pattern TM: SS5C\\nAalpredominant Aiyam body constitution pattern TM: SS5D\\nAiyapredominant Aal body constitution pattern TM: SS5E\\nAiyapredominant Vai body constitution pattern TM: SS5F\\nOther specified constitution patterns TM: SS5Y\\nConstitution patterns TM unspecified: SS5Z\\nPersonality with a calm composed mindset TM: SS60\\nPersonality with an agitated reactive mindset TM: SS61\\nPersonality with a confused negative mindset TM: SS62\\nOther specified personality patterns TM: SS6Y\\nPersonality patterns TM unspecified: SS6Z\\nHuman temperament pattern TM: SS70\\nTemperament according to age pattern TM: SS71\\nDam predominant temperament pattern TM: SS72\\nafr predominant temperament pattern TM: SS73\\nBalgham predominant temperament pattern TM: SS74\\nSawd predominant temperament pattern TM: SS75\\nOther specified temperament based patterns TM: SS7Y\\nTemperament based patterns TM unspecified: SS7Z\\nKapha predominant age pattern TM: SS80\\nPitta predominant age pattern TM: SS81\\nVata predominant age pattern TM: SS82\\nChildhood age pattern TM: SS83\\nAdult age pattern TM: SS84\\nOld age pattern TM: SS85\\nHot and moist predominant temperament age pattern TM: SS86\\nHot predominant temperament with lesser degree of moistness age pattern TM: SS87\\nCold and dry predominant temperament age pattern TM: SS88\\nCold predominant temperament with greater degree of dryness age pattern TM: SS89\\nOther specified age dependent patterns TM: SS8Y\\nAge dependent patterns TM unspecified: SS8Z\\nAbnormal temperament pattern TM: ST00\\nSimple morbid temperament pattern TM: ST01\\nSimple abnormal temperament without substance pattern TM: ST02\\nAbnormal hot temperament pattern TM: ST03\\nAbnormal cold temperament pattern TM: ST04\\nAbnormal moist temperament pattern TM: ST05\\nAbnormal dry temperament pattern TM: ST06\\nAbnormal temperament associated with substance pattern TM: ST07\\nAbnormal hot temperament with substance pattern TM: ST08\\nAbnormal cold temperament with substance pattern TM: ST09\\nAbnormal moist temperament with substance pattern TM: ST0A\\nAbnormal dry temperament with substance pattern TM: ST0B\\nCompound morbid temperament pattern TM: ST0C\\nSimple compound abnormal temperament pattern TM: ST0D\\nSimple hot and moist abnormal temperament pattern TM: ST0E\\nSimple hot and dry abnormal temperament pattern TM: ST0F\\nSimple cold and moist abnormal temperament pattern TM: ST0G\\nSimple cold and dry abnormal temperament pattern TM: ST0H\\nCompound abnormal temperament associated with substance pattern TM: ST0J\\nAbnormal hot and moist temperament associated with substance pattern TM: ST0K\\nAbnormal hot and dry temperament associated with substance pattern TM: ST0L\\nAbnormal cold and moist temperament associated with substance pattern TM: ST0M\\nAbnormal cold and dry temperament associated with substance pattern TM: ST0N\\nStable abnormal temperament pattern TM: ST0P\\nUnstable abnormal temperament pattern TM: ST0Q\\nThickening of moisture pattern TM: ST0R\\nPresence of foreign moisture pattern TM: ST0S\\nThinning of moistures pattern TM: ST0T\\nInfection of moistures pattern TM: ST0U\\nChange of temperament of psychic R pattern TM: ST0V\\nPredominance of hotness pattern TM: ST0W\\nPredominance of coldness pattern TM: ST0X\\nPredominance of moistness pattern TM: ST10\\nPredominance of dryness pattern TM: ST11\\nOther specified body constitution and temperament patterns TM: ST1Y\\nBody constitution and temperament patterns TM unspecified: ST1Z\\nInjury pattern in the varmam or marmam TM: ST20\\nOther specified varmam and Marmam patterns TM: ST2Y\\nVarmam and Marmam patterns TM unspecified: ST2Z\\nAttention functions WHODAS: VD00\\nMemory functions WHODAS: VD01\\nSolving problems WHODAS: VD02\\nBasic learning WHODAS: VD03\\nCommunicating with receiving spoken messages WHODAS: VD04\\nConversation WHODAS: VD05\\nMaintaining a standing position WHODAS: VD10\\nChanging body position standing WHODAS: VD11\\nMoving around within the home WHODAS: VD12\\nMoving around outside the home and other buildings WHODAS: VD13\\nWalking WHODAS: VD14\\nWashing oneself WHODAS: VD20\\nDressing WHODAS: VD21\\nEating WHODAS: VD22\\nCarrying out daily routine WHODAS: VD23\\nRelating with strangers WHODAS: VD30\\nInformal relationship with friends maintaining WHODAS: VD31\\nFamily relationships WHODAS: VD32\\nInformal relationship with friends making new friends WHODAS: VD33\\nIntimate relationships WHODAS: VD34\\nTaking care of household responsibilities WHODAS: VD40\\nDoing most important household tasks WHODAS: VD41\\nDoing housework WHODAS: VD42\\nGetting all needed housework done WHODAS: VD42.0\\nGetting household work done quickly WHODAS: VD42.1\\nOther specified doing housework WHODAS: VD42.Y\\nDoing housework WHODAS unspecified: VD42.Z\\nRemunerative employment WHODAS: VD43\\nDifficulties in daily work or school WHODAS: VD43.0\\nDoing most important work or school task WHODAS: VD43.1\\nGetting all needed work or school work done WHODAS: VD43.2\\nGetting remunerative work or school work done quickly WHODAS: VD43.3\\nOther specified remunerative employment WHODAS: VD43.Y\\nRemunerative employment WHODAS unspecified: VD43.Z\\nRecreation and leisure WHODAS: VD50\\nProblems by barriers WHODAS: VD51\\nHuman rights WHODAS: VD52\\nTime spent on health condition WHODAS: VD53\\nEmotional effect of health condition WHODAS: VD54\\nHealth drain on financial resources WHODAS: VD55\\nHealth problems causing family problems WHODAS: VD56\\nProblems in relaxation or pleasure WHODAS: VD57\\nSeeing and related functions BMDS: VE00\\nHearing and vestibular functions BMDS: VE01\\nEnergy and drive functions BMDS: VE10\\nSleep functions BMDS: VE11\\nEmotional functions BMDS: VE12\\nAttention functions BMDS: VE13\\nMemory functions BMDS: VE14\\nSensation of pain BMDS: VE20\\nEnergy and drive functions: VV00\\nSleep functions: VV01\\nAttention functions: VV02\\nMemory functions: VV03\\nEmotional functions: VV04\\nOther specified mental functions: VV0Y\\nMental functions unspecified: VV0Z\\nSeeing and related functions: VV10\\nHearing and vestibular functions: VV11\\nSensation of pain: VV12\\nOther specified sensory functions and pain: VV1Y\\nSensory functions and pain unspecified: VV1Z\\nVoice functions: VV20\\nOther specified voice and speech functions: VV2Y\\nVoice and speech functions unspecified: VV2Z\\nExercise tolerance functions: VV30\\nOther specified functions of the cardiovascular haematological immunological and respiratory systems: VV3Y\\nFunctions of the cardiovascular haematological immunological and respiratory systems unspecified: VV3Z\\nFunctions related to the digestive system: VV40\\nOther specified functions of the digestive metabolic and endocrine systems: VV4Y\\nFunctions of the digestive metabolic and endocrine systems unspecified: VV4Z\\nUrination functions: VV50\\nSexual functions: VV51\\nOther specified genitourinary and reproductive functions: VV5Y\\nGenitourinary and reproductive functions unspecified: VV5Z\\nMobility of joint functions: VV60\\nMuscle power functions: VV61\\nOther specified neuromusculoskeletal and movementrelated functions: VV6Y\\nNeuromusculoskeletal and movementrelated functions unspecified: VV6Z\\nFunctions of the skin: VV70\\nOther specified functions of the skin and related structures: VV7Y\\nFunctions of the skin and related structures unspecified: VV7Z\\nBasic learning: VV80\\nSolving problems: VV81\\nOther specified learning and applying knowledge: VV8Y\\nLearning and applying knowledge unspecified: VV8Z\\nCarrying out daily routine: VV90\\nHandling stress and other psychological demands: VV91\\nOther specified general tasks and demands: VV9Y\\nGeneral tasks and demands unspecified: VV9Z\\nCommunicating with receiving spoken messages: VW00\\nConversation: VW01\\nOther specified communication: VW0Y\\nCommunication unspecified: VW0Z\\nMaintaining a standing position: VW10\\nTransferring oneself: VW11\\nCarrying moving and handling objects: VW12\\nWalking: VW13\\nMoving around within the home: VW14\\nMoving around using equipment: VW15\\nUsing transportation: VW16\\nOther specified mobility: VW1Y\\nMobility unspecified: VW1Z\\nWashing oneself: VW20\\nCaring for body parts: VW21\\nToileting: VW22\\nDressing: VW23\\nEating: VW24\\nLooking after ones health: VW25\\nOther specified selfcare: VW2Y\\nSelfcare unspecified: VW2Z\\nPreparing meals: VW30\\nDoing housework: VW31\\nAssisting others: VW32\\nOther specified domestic life: VW3Y\\nDomestic life unspecified: VW3Z\\nBasic interpersonal interactions: VW40\\nRelating with strangers: VW41\\nIntimate relationships: VW42\\nOther specified interpersonal interactions and relationships: VW4Y\\nInterpersonal interactions and relationships unspecified: VW4Z\\nRemunerative employment: VW50\\nOther specified major life areas: VW5Y\\nMajor life areas unspecified: VW5Z\\nRecreation and leisure: VW60\\nHuman rights: VW61\\nOther specified community social and civic life: VW6Y\\nCommunity social and civic life unspecified: VW6Z\\nOther specified generic functioning domains: VW8Y\\nGeneric functioning domains unspecified: VW8Z\\nnan: XS8H\\nMild: XS5W\\nModerate: XS0T\\nSevere: XS25\\nProfound: XS2R\\nStage: XS76\\nStage a: XS3T\\nStage b: XS90\\nGrade: XS57\\nPhase: XS47\\nNo problem: XS5C\\nMild problem: XS6Y\\nModerate problem: XS8T\\nSevere problem: XS9D\\nComplete problem: XS91\\nNot applicable: XS5P\\nA Remission  Free of disease: XS0J\\nB Local Disease: XS05\\nLocal limited: XS0E\\nLocally advanced: XS67\\nC Regional disease: XS9S\\nD Distant disease: XS4Z\\nStage I: XS1G\\nStage II: XS4P\\nStage III: XS6H\\nStage IV: XS9R\\nGrade I: XS56\\nGrade II: XS58\\nGrade III: XS7Z\\nGrade IV: XS7M\\nUndetermined grade: XS7H\\nNYHA Class I No limitation of physical activity: XS3A\\nNYHA Class II Slight limitation of physical activity: XS6B\\nNYHA Class III Marked limitation of physical activity: XS9T\\nNYHA Class IV Unable to carry on any physical activity without discomfort: XS9F\\nGOLD  mild FEV  predicted: XS80\\nGOLD  moderate  FEV  predicted: XS7U\\nGOLD  severe  FEV  predicted: XS8K\\nGOLD  very severe FEV  predicted: XS50\\nStage I Asymptomatic incomplete blood vessel obstruction: XS1Y\\nStage II Mild claudication pain in limb: XS5L\\nStage IIA Claudication at a distance   metres: XS5V\\nStage IIB Claudication at a distance   metres: XS6C\\nStage III Rest pain mostly in the feet: XS9L\\nStage IV Necrosis andor gangrene of the limb: XS2J\\nNo endometriosis: XS3V\\nFilmy endometriosis: XS5N\\nDense endometriosis: XS55\\nIncomplete vocal cord paralysis: XS1H\\nPartial vocal cord paralysis: XS66\\nComplete vocal cord paralysis: XS7K\\nMild sepsis: XS5E\\nSevere sepsis: XS65\\nSeptic shock: XS26\\nGrade  Category  Asymptomatic no hemodynamically significant occlusive disease: XS1T\\nGrade  Category  Mild claudication: XS0Q\\nGrade I Category  Moderate claudication: XS2W\\nGrade I Category  Severe claudication: XS51\\nGrade II Category  Ischaemic rest pain: XS8M\\nGrade III Category  Minor tissue loss nonhealing ulcer focal gangrene with diffuse pedal ischaemia: XS6U\\nGrade III Category  Major tissue loss extending above transmetatarsal TM level functional foot no longer salvageable: XS0U\\nNo pain: XS5B\\nMild pain: XS5D\\nModerate pain: XS9Q\\nSevere pain: XS2E\\nNo distress: XS1J\\nMild distress: XS3R\\nModerate distress: XS7C\\nSevere distress: XS7N\\nNo painrelated interference: XS71\\nMild painrelated interference: XS5R\\nModerate painrelated interference: XS2L\\nSevere painrelated interference: XS2U\\nPsychosocial factors present: XS7G\\nNo psychosocial factors present: XS8B\\nUnderweight BMI Below  kgm: XS11\\nNormal weight BMI  kgm: XS43\\nPreobesity BMI  kgm: XS7R\\nObesity class I BMI  kgm: XS3Y\\nObesity class II BMI  kgm: XS6N\\nObesity class III BMI greater than or equal to  kgm: XS2B\\nSingle vessel disease: XS2V\\nMultiple vessel disease: XS8U\\nAnaphylaxis grade: XS85\\nIntermittent: XT5G\\nPersistent: XT6Z\\nPersistent with overlaid attacks: XT5T\\nAsymptomatic: XT3B\\nSubclinical: XT1T\\nActive: XT98\\nEpisodic: XT7X\\nProdromal: XT4M\\nRecurrent: XT44\\nRelapse: XT4D\\nCause of late effect: XT9C\\nAcute: XT5R\\nSubacute: XT1L\\nChronic: XT8W\\nEarly onset: XT2Q\\nImmediate onset: XT46\\nLate onset: XT3R\\nDelayed onset: XT64\\nRapid onset: XT3Z\\nGradual onset: XT42\\nPregnancy: XT0S\\nPostpartum: XT4Z\\nPuerperium: XT1G\\nAntenatal WHO Standard: XT77\\nAntenatal Aus Standard: XT5L\\nAntenatal Can Standard: XT5P\\nAntenatal Ger Standard: XT04\\nAntenatal US Standard: XT9S\\nNeonatal: XT16\\nEarly Neonatal: XT6P\\nLate Neonatal: XT30\\nPerinatal: XT3N\\nInfancy: XT2C\\nChild under: XT4X\\nChild over: XT50\\nMiddle Childhood: XT9V\\nEarly Adolescence: XT7Q\\nAdolescent: XT7M\\nMiddle Adolescence: XT4T\\nLate Adolescence: XT9X\\nYoung Adult: XT15\\nAdult: XT6S\\nEarly Geriatric: XT19\\nLate Geriatric: XT13\\nDuration of pregnancy less than  completed weeks: XT3X\\nDuration of pregnancy  completed weeks: XT84\\nDuration of pregnancy more than  completed weeks: XT6G\\nUnspecified duration of pregnancy: XT6K\\nCongenital: XB8M\\nIatrogenic: XB8D\\nIdiopathic: XB5F\\nFamilial: XB1Y\\nNosocomial: XB25\\nEnvironmental: XB4Q\\nOccupation as primary factor: XB17\\nOccupation as cofactor: XB5G\\nNot occupationrelated: XB80\\nLifestyle: XB5W\\nCommunity acquired: XB22\\nAgeingrelated: XT9T\\nPost traumatic: XB2G\\nGenetic: XB4S\\nHereditary: XB7K\\nNonhereditary: XB7S\\nBacteria: XN74M\\nGram Negative Bacteria: XN5PZ\\nAcinetobacter: XN25B\\nAcinetobacter baumannii: XN8LS\\nAcinetobacter junii: XN5YN\\nAcinetobacter nosocomialis: XN0DS\\nAcinetobacter pittii: XN2QH\\nAnaplasma: XN048\\nAnaplasma phagocytophilum: XN1MH\\nBartonella: XN3NJ\\nBartonella bacilliformis: XN0W4\\nBartonella clarridgeiae: XN3F6\\nBartonella elizabethae: XN5J5\\nBartonella grahamii: XN5SH\\nBartonella henselae: XN862\\nBartonella koehlerae: XN302\\nBartonella quintana: XN14D\\nBartonella rochalimae: XN43H\\nBartonella vinsonii: XN6KD\\nBartonella washoensis: XN94Y\\nBordetella: XN9W3\\nBordetella bronchiseptica: XN173\\nBordetella pertussis: XN23B\\nBordetella parapertussis: XN7LQ\\nBrucella: XN22N\\nBrucella abortus: XN7A8\\nBrucella canis: XN84J\\nBrucella melitensis: XN7ZW\\nBrucella suis: XN3UP\\nBurkholderia: XN01M\\nBurkholderia gladioli: XN351\\nBurkholderia mallei: XN6Y3\\nBurkholderia pseudomallei: XN3LD\\nBurkholderia cepacia complex: XN335\\nBurkholderia stabilis: XN06D\\nBurkholderia anthina: XN0ZW\\nBurkholderia contaminans: XN15B\\nCampylobacter: XN7US\\nCampylobacter coli: XN0BA\\nCampylobacter fetus: XN3EN\\nCampylobacter jejuni: XN4Q5\\nChlamydia: XN27H\\nChlamydia pneumoniae: XN9EE\\nChlamydia psittaci: XN4S7\\nChlamydia trachomatis: XN4Q4\\nCitrobacter: XN0FZ\\nCitrobacter freundii: XN0M3\\nCoxiella: XN5H6\\nCoxiella burnetii: XN0QS\\nEhrlichia: XN9M7\\nEhrlichia canis: XN293\\nEhrlichia chaffeensis: XN4GW\\nEhrlichia ewingii: XN2YH\\nEikenella: XN1VF\\nEnterobacter: XN9W5\\nEnterobacter cloacae: XN3YM\\nEscherichia: XN4WC\\nEscherichia coli: XN6P4\\nEnteroinvasive Escherichia coli: XN88S\\nEnteropathogenic Escherichia coli: XN2U0\\nEnterotoxigenic Escherichia coli: XN81Z\\nShiga toxinproducing Escherichia coli: XN108\\nEnterohaemorrhagic Escherichia coli: XN5NF\\nEnteroaggregative Escherichia coli: XN55V\\nEscherichia hermannii: XN6MP\\nPseudescherichia vulneris: XN2S7\\nFrancisella: XN94G\\nFrancisella philomiragia: XN6HJ\\nFrancisella tularensis: XN0BX\\nFrancisella novicida: XN4ZY\\nFusobacterium: XN4LF\\nFusobacterium necrophorum: XN7B1\\nFusobacterium novum: XN5MA\\nFusobacterium nucleatum: XN4P8\\nFusobacterium polymorphum: XN911\\nHaemophilus: XN2HK\\nHaemophilus ducreyi: XN6MB\\nHaemophilus influenzae: XN1P6\\nHaemophilus influenzae aegyptius: XN1BX\\nHaemophilus influenzae type B: XN0FG\\nHelicobacter: XN6XR\\nHelicobacter bilis: XN0YS\\nHelicobacter bizzozeronii: XN0TD\\nHelicobacter canis: XN42L\\nHelicobacter cinaedi: XN354\\nHelicobacter felis: XN6JN\\nHelicobacter ganmani: XN9X3\\nHelicobacter hepaticus: XN8PN\\nHelicobacter pylori: XN3DY\\nHelicobacter salomonis: XN9D7\\nHelicobacter suis: XN079\\nKlebsiella: XN620\\nKlebsiella granulomatis: XN027\\nKlebsiella oxytoca: XN7WL\\nKlebsiella pneumoniae: XN741\\nKingella kingae: XN7EJ\\nLegionella: XN3SZ\\nLegionella longbeachae: XN14Z\\nLegionella pneumophila: XN9YS\\nLeptospira: XN9RA\\nLeptospira alexanderi: XN1R8\\nLeptospira borgpetersenii: XN7D2\\nLeptospira broomii: XN9K9\\nLeptospira fainei: XN5HC\\nLeptospira inadai: XN20F\\nLeptospira interrogans: XN78P\\nLeptospira kirschneri: XN110\\nLeptospira kmetyi: XN481\\nLeptospira licerasiae: XN6NU\\nLeptospira noguchii: XN4KP\\nLeptospira santarosai: XN01X\\nLeptospira species: XN4FL\\nLeptospira weilii: XN4E7\\nLeptospira wolffii: XN77E\\nLeptospira\\xa0genomospecies  alstonii: XN5UB\\nLeptotrichia: XN2JD\\nLeptotrichia buccalis: XN734\\nLeptotrichia goodfellowii: XN4GY\\nLeptotrichia hofstadii: XN0SF\\nLeptotrichia hongkongensis: XN4SA\\nLeptotrichia shahii: XN7NF\\nLeptotrichia trevisanii: XN6QY\\nLeptotrichia wadei: XN5SN\\nMoraxella: XN90V\\nMorganella: XN8G6\\nMycoplasma: XN1W2\\nMycoplasma fermentans: XN3NR\\nMycoplasma genitalium: XN9UG\\nMycoplasma hyorhinis: XN674\\nMycoplasma penetrans: XN3AD\\nMycoplasma pneumoniae: XN4NV\\nNeisseria: XN69X\\nNeisseria gonorrhoeae: XN59Y\\nNeisseria meningitidis: XN1DV\\nNeisseria meningitidis serogroup A: XN3CR\\nNeisseria meningitidis serogroup B: XN8FU\\nNeisseria meningitidis serogroup C: XN7EM\\nNeisseria meningitidis serogroup W: XN03X\\nNeisseria meningitidis serogroup X: XN0C2\\nNeisseria meningitidis serogroup Y: XN5H0\\nNeorickettsia: XN8ST\\nNeorickettsia sennetsu: XN7C8\\nPasteurella: XN3U2\\nPasteurella multocida: XN30D\\nPleisiomonas: XN1ZM\\nProteus: XN3BS\\nProteus mirabilis: XN9ZF\\nProteus morganii: XN9DS\\nProteus penneri: XN7PE\\nProteus vulgaris: XN118\\nProvidencia: XN7R2\\nProvidencia rettgeri: XN2PG\\nPseudomonas: XN022\\nPseudomonas aeruginosa: XN5L6\\nPseudomonas oryzihabitans: XN3JP\\nPseudomonas mallei: XN52E\\nPseudomonas plecoglossicida: XN8J7\\nPseudomonas pseudomallei: XN8AA\\nRickettsia: XN4YH\\nRickettsia africae: XN9YP\\nRickettsia akari: XN7WV\\nRickettsia australis: XN23V\\nRickettsia conorii: XN8U4\\nRickettsia felis: XN6W8\\nRickettsia helvetica: XN9NE\\nRickettsia hoogstraalii: XN5NY\\nRickettsia japonica: XN3XV\\nRickettsia prowazekii: XN8SY\\nRickettsia rickettsii: XN33Q\\nRickettsia sibirica: XN1N6\\nRickettsia typhi: XN2AR\\nSalmonellae: XN0QE\\nSalmonella enterica spp: XN5VC\\nSalmonella Paratyphi: XN0UV\\nSalmonella paratyphi A: XN1K5\\nSalmonella paratyphi B: XN322\\nSalmonella paratyphi C: XN5TR\\nSalmonella Typhi: XN4AM\\nSalmonella Panama: XN7U5\\nSalmonella Weltevreden: XN97K\\nSalmonella Wandsworth: XN13V\\nSalmonella Virchow: XN3DF\\nSalmonella Give: XN4QY\\nSalmonella Gaminara: XN3AE\\nSalmonella Agona: XN0N5\\nSalmonella Kiambu: XN5SM\\nSalmonella Thompson: XN3TU\\nSalmonella Typhimurium: XN15L\\nSalmonella Saintpaul: XN8SF\\nSalmonella Stanley: XN2MU\\nSalmonella Strathcona: XN0LX\\nSalmonella Senftenberg: XN5WE\\nSalmonella Tennessee: XN291\\nSalmonella Newport: XN87G\\nSalmonella Hartford: XN5TM\\nSalmonella Oranienburg: XN1QX\\nSalmonella Poona: XN2SZ\\nSalmonella Kedougou: XN36N\\nSalmonella Litchfield: XN5LV\\nSalmonella Mbandaka: XN4LH\\nSalmonella Montevideo: XN1FK\\nSalmonella Mikawasima: XN3UH\\nSalmonella Concord: XN7QM\\nSalmonella Cubana: XN8RF\\nSalmonella Infantis: XN39C\\nSalmonella Havana: XN6JL\\nSalmonella Enteritidis: XN1W7\\nSalmonella Bareilly: XN0Q7\\nSalmonella Braenderup: XN4MS\\nSalmonella Brandenburg: XN3KA\\nSalmonella Choleraesuis: XN0NU\\nSalmonella Bredeney: XN910\\nSalmonella Nchanga: XN52S\\nSalmonella Lille: XN8F6\\nSalmonella Sandiego: XN7EC\\nSalmonella enterica subspecies enterica serovar i: XN7PN\\nSalmonella bongori spp: XN2DW\\nSerratia spp: XN71D\\nSerratia marcescens: XN2V6\\nShigella spp: XN7HG\\nShigella flexneri: XN7Y2\\nShigella boydii: XN8RN\\nShigella dysenteriae: XN285\\nShigella sonnei: XN9M9\\nSpirillum: XN23Z\\nSpirillum minus: XN0J7\\nSpirillum pulli: XN78V\\nSpirillum volutans: XN17K\\nSpirillum winogradskyi: XN96A\\nStreptobacillus: XN708\\nStreptobacillus moniliformis: XN91U\\nStenotrophomonas: XN1L0\\nStenotrophomonas maltophilia: XN0AD\\nTreponema: XN36C\\nTreponema carateum: XN76V\\nTreponema pallidum: XN711\\nTreponema pallidum carateum: XN6AL\\nTreponema pallidum endemicum: XN35Z\\nTreponema pallidum pallidum: XN030\\nTreponema pallidum pertenue: XN46P\\nUreaplasma: XN1R2\\nVibrio: XN8RL\\nVibrio cholerae: XN7N1\\nVibrio cholerae O biovar cholerae: XN8P1\\nVibrio cholerae O biovar eltor: XN62R\\nVibrio cholerae O: XN8KD\\nVibrio parahaemolyticus: XN1AA\\nVibrio vulnificus: XN44G\\nYersinia: XN4QG\\nYersinia enterocolitica: XN91V\\nYersinia pestis: XN6QS\\nYersinia pseudotuberculosis: XN6K8\\nBacteroides: XN65H\\nBacteroides fragilis: XN2R7\\nCronobacter: XN9EB\\nCronobacter sakazakii: XN2YF\\nBrevundimonas: XN9AS\\nBrevundimonas diminuta: XN8W4\\nBrevundimonas vesicularis: XN2F0\\nAeromonas: XN1J7\\nAeromonas hydrophila: XN40Z\\nAeromonas caviae: XN0XY\\nHerbaspirillum: XN4X0\\nHerbaspirillum huttiense: XN7QA\\nElizabethkingia: XN706\\nElizabethkingia anophelis: XN6BA\\nElizabethkingia meningoseptica: XN6C4\\nRalstonia: XN15X\\nRalstonia picketti: XN6AH\\nRalstonia mannitolilytica: XN694\\nRalstonia insidiosa: XN9VM\\nRaoultella: XN3NY\\nRaoultella ornithinolytica: XN0MD\\nOrientia: XN6PA\\nOrientia tsutsugamushi: XN675\\nGram Positive Bacteria: XN2QM\\nActinomyces: XN3G0\\nActinomyces gerencseriae: XN0GV\\nActinomyces israelii: XN15T\\nActinomyces species: XN8HN\\nActinomycetales: XN8EK\\nActinomadura: XN8P7\\nBacillus: XN9ZE\\nBacillus anthracis: XN94F\\nBacillus cereus: XN8PY\\nBifidobacterium: XN33F\\nBifidobacterium dentium: XN0PT\\nClostridium: XN198\\nClostridium botulinum: XN2JN\\nClostridium perfringens: XN7J5\\nClostridium sordellii: XN4LP\\nClostridium tetani: XN5NQ\\nCorynebacterium: XN3NT\\nCorynebacterium diphtheriae: XN9N1\\nCorynebacterium minutissimum: XN78S\\nCorynebacterium striatum: XN752\\nCorynebacterium tenuis: XN3MP\\nEnterococcus: XN1F7\\nEnterococcus faecalis: XN2H4\\nEnterococcus faecium: XN51E\\nEnterococcus avium: XN0DT\\nEnterococcus casseliflavus: XN3XY\\nEnterococcus durans: XN724\\nEnterococcus gallinarum: XN8BQ\\nEnterococcus mundtii: XN4ZZ\\nEnterococcus raffinosus: XN3QK\\nErysipelothrix: XN494\\nErysipelothrix rhusiopathiae: XN4FJ\\nListeria: XN4D1\\nListeria ivanovii: XN39H\\nListeria monocytogenes: XN602\\nNocardia: XN20K\\nNocardia asteroides: XN2BK\\nNocardia brasiliensis: XN1LG\\nPropionibacterium: XN5M7\\nPropionibacterium propionicus: XN27L\\nStaphylococcus: XN9ZG\\nStaphylococcus aureus: XN6BM\\nPantonValentine Leukocidinproducing Staphylococcus aureus: XN4B5\\nCoagulasenegative Staphylococci: XN9LM\\nStaphylococcus auricularis: XN0PR\\nStaphylococcus capitis: XN0H1\\nStaphylococcus caprae: XN99G\\nStaphylococcus cohnii: XN95B\\nStaphylococcus epidermidis: XN8KJ\\nStaphylococcus haemolyticus: XN2GD\\nStaphylococcus leei: XN09P\\nStaphylococcus lugdunensis: XN4N7\\nStaphylococcus pasteuri: XN8WC\\nStaphylococcus pettenkoferi: XN6FH\\nStaphylococcus schleiferi: XN9X8\\nStaphylococcus sciuri: XN2HN\\nStaphylococcus simulans: XN7RE\\nStaphylococcus warneri: XN4C9\\nStaphylococcus xylosus: XN7TQ\\nStaphylococcus hominis: XN567\\nStreptococcus: XN3NM\\nAlphahemolytic Streptococcus: XN1V3\\nStreptococcus pneumoniae: XN3PW\\nStreptococcus viridans: XN9LA\\nBetahaemolytic Streptococcus: XN1AF\\nGammahaemolytic Streptococcus: XN2NS\\nStreptococcus group A: XN6LP\\nStreptococcus pyogenes: XN7YG\\nStreptococcus group B: XN2M1\\nStreptococcus agalactiae: XN0KC\\nGroup C Streptococcus: XN518\\nStreptococcus zooepidemicus: XN0TY\\nStreptococcus group D: XN5KC\\nStreptococcus bovis: XN6KJ\\nStreptococcus equinus: XN625\\nGroup E Streptococcus: XN8BJ\\nGroup F Streptococcus: XN6BB\\nGroup G Streptococcus: XN84N\\nStreptococcus dysgalactiae: XN8UN\\nGroup H Streptococcus: XN40Y\\nStreptococcus anginosus: XN39R\\nStreptococcus canis: XN3L7\\nStreptococcus constellatus: XN0FR\\nStreptococcus iniae: XN4PA\\nStreptococcus intermedius: XN67P\\nStreptococcus mitis: XN5BP\\nStreptococcus mutans: XN2RH\\nStreptococcus oralis: XN4B2\\nStreptococcus parasanguinis: XN18T\\nStreptococcus peroris: XN58W\\nStreptococcus pseudopneumoniae: XN6KE\\nStreptococcus ratti: XN5DB\\nStreptococcus salivarius: XN3BQ\\nStreptococcus sanguinis: XN9FP\\nStreptococcus sobrinus: XN0XM\\nStreptococcus suis: XN5SE\\nStreptococcus thermophilus: XN4LM\\nStreptococcus uberis: XN1TV\\nStreptococcus vestibularis: XN0Z2\\nTropheryma: XN7PP\\nTropheryma whipplei: XN5P4\\nClostridioides difficile: XN0SE\\nBacteria neither Gram Negative nor Gram Positive: XN87X\\nBorrelia: XN2DX\\nBorrelia afzelii: XN7GL\\nBorrelia burgdorferi: XN13C\\nBorrelia garinii: XN4VZ\\nBorrelia hermsii: XN3PD\\nBorrelia miyamotoi: XN2P3\\nBorrelia parkeri: XN6VH\\nBorrelia recurrentis: XN5R4\\nBorrelia vincentii: XN140\\nMycobacterium: XN2NR\\nMycobacterium africanum: XN6YB\\nMycobacterium bovis: XN8AB\\nMycobacterium canettii: XN8N3\\nMycobacterium caprae: XN4MR\\nMycobacterium colombiense: XN9H9\\nMycobacterium indicus pranii: XN8FC\\nMycobacterium leprae: XN5TS\\nMycobacterium microti: XN3T2\\nMycobacterium pinnipedii: XN7H2\\nMycobacterium tuberculosis: XN1N2\\nNontuberculous mycobacterium: XN96Q\\nMycobacterium kansasii: XN3L9\\nMycobacterium malmoense: XN5C1\\nMycobacterium xenopi: XN53D\\nMycobacterium asiaticum: XN6PL\\nMycobacterium simiae: XN4MW\\nMycobacterium szulgai: XN975\\nMycobacterium scrofulaceum: XN74T\\nMycobacterium haemophilum: XN7YR\\nMycobacterium fortuitum: XN8ZX\\nMycobacterium marinum: XN8RB\\nMycobacterium ulcerans: XN9M0\\nMycobacterium chelonei: XN3D3\\nMycobacterium avium complex: XN97H\\nMycobacterium avium: XN5LZ\\nMycobacterium avium hominissuis: XN8FF\\nMycobacterium avium paratuberculosis: XN5NW\\nMycobacterium avium silvaticum: XN145\\nMycobacterium intracellulare: XN3ZQ\\nMycobacterium chimaera: XN077\\nMycobacterium abscessus complex: XN4TQ\\nMycobacterium abscessus subsp abscessus: XN7V4\\nMycobacterium abscessus subsp massiliense: XN5SW\\nMycobacterium abscessus subsp bolletii: XN017\\nMycobacterium chelonae: XN44M\\nVirus: XN3BH\\nAdenovirus: XN000\\nAtadenovirus: XN0R0\\nAviadenovirus: XN05K\\nIchtadenovirus: XN728\\nMastadenovirus: XN93P\\nSiadenovirus: XN13L\\nAlphavirus: XN6ME\\nAura virus: XN0SK\\nBabanki virus: XN434\\nBarmah Forest virus: XN5KQ\\nBebaru virus: XN6XS\\nCabassou virus: XN0UF\\nChikungunya virus: XN4ZB\\nEastern equine encephalitis virus: XN78T\\nEverglades virus: XN26A\\nKyzylagach virus: XN87D\\nMayaro virus: XN5ZC\\nMiddelburg virus: XN1VS\\nMosso das Pedras virus: XN34P\\nMucambo virus: XN7PD\\nNdumu virus: XN0H9\\nOckelbo virus: XN9WS\\nonyong nyong virus: XN6AD\\nParamana virus: XN240\\nPixuna virus: XN3YZ\\nRo Negro virus: XN79Q\\nRoss River virus: XN49A\\nSalmon pancreatic disease virus: XN4D3\\nSemliki Forest virus: XN3D4\\nSindbis virus: XN0D6\\nSleeping Disease virus: XN132\\nSouthern elephant seal virus: XN5MK\\nTonate virus: XN4ER\\nTrocara virus: XN2B3\\nVenezuelan equine encephalitis virus: XN445\\nWhataroa virus: XN8PC\\nWestern equine encephalitis virus: XN2CK\\nArbovirus: XN1BE\\nLa Crosse virus: XN5VQ\\nArenavirus: XN8AC\\nChapare virus: XN2WG\\nGuanarito virus: XN56K\\nJunn virus: XN2ZL\\nLassa virus: XN0CU\\nLujo virus: XN77P\\nLymphocytic choriomeningitis virus: XN4ZL\\nMachupo virus: XN45B\\nSabi virus: XN55S\\nBornavirus: XN5VM\\nBorna disease virus: XN395\\nvariegated squirrel bornavirus: XN125\\nBunyavirus: XN7S5\\nAmur virus: XN9UC\\nCrimeanCongo haemorrhagic fever virus: XN17V\\nDobrava virus: XN16H\\ngu virus: XN2QZ\\nHantaan virus: XN3GW\\nKurkino virus: XN8UR\\nMuju virus: XN8AF\\nOrthobunyavirus: XN4S8\\nCristoli virus: XN09U\\nOropouche orthobunyavirus: XN4U2\\nPuumala virus: XN28L\\nSaaremaa virus: XN9PD\\nSeoul virus: XN3PV\\nSochi virus: XN95V\\nSoochong virus: XN0E0\\nTula virus: XN9G5\\nAnajatuba virus: XN2VY\\nAndes virus: XN4AP\\nAraucria virus: XN2C8\\nbayou virus: XN2WJ\\nBermejo virus: XN0A0\\nBlack Creek Canal virus: XN66E\\nBlue River virus: XN8LW\\nCastelo dos Sonhos virus: XN18Y\\nEl Moro Canyon virus: XN6XF\\nJuquitiba virus: XN8G9\\nLaguna Negra virus: XN6P0\\nLechiguanas virus: XN2CJ\\nMaciel virus: XN2BW\\nMonongahela virus: XN3WK\\nMuleshoe virus: XN5SF\\nNew York virus: XN9VX\\nOrn virus: XN9BY\\nParano virus: XN5JV\\nPergamino virus: XN65X\\nRo Mamor virus: XN2VC\\nsin nombre virus: XN7R1\\nTunari virus: XN057\\nAraraquara virus: XN8AQ\\nPhlebovirus: XN5VU\\nPunta Toro virus: XN2YW\\nRift Valley fever phlebovirus: XN7AS\\nSicilian phlebovirus: XN72W\\nNaples phlebovirus: XN7FG\\nToscana phlebovirus: XN3V9\\nDabie bandavirus: XN3BT\\nCalicivirus: XN9RK\\nLagovirus: XN4EB\\nNebovirus: XN8L1\\nNorovirus: XN3Y2\\nSapovirus: XN9EH\\nVesivirus: XN0R6\\nCoronavirus: XN83D\\nHuman coronavirus E: XN0UA\\nHuman coronavirus HKU: XN9KN\\nHuman coronavirus OC: XN7CX\\nMiddle East respiratory syndrome coronavirus: XN3BD\\nPipistrellus bat coronavirus HKU: XN5V7\\nRousettus bat coronavirus HKU: XN1N9\\nSevere Acute Respiratory Syndrome coronavirus: XN1V8\\nTylonycteris bat coronavirus HKU: XN1GJ\\nSARSCoV: XN109\\nSARSCoV Alpha: XN0HL\\nSARSCoV Beta: XN4Q7\\nSARSCoV Gamma: XN5BQ\\nSARSCoV Delta: XN8V6\\nSARSCoV Epsilon: XN1GK\\nSARSCoV Zeta: XN3ZE\\nSARSCoV Eta: XN2V4\\nSARSCoV Theta: XN4Q1\\nSARSCoV Iota: XN3UD\\nSARSCoV Kappa: XN9LB\\nSARSCoV Lambda: XN6AM\\nSARSCoV Mu: XN39J\\nSARSCoV Omicron: XN161\\nBA: XN53K\\nBQ: XN4UD\\nXBB: XN201\\nEG: XN8RW\\nEnterovirus: XN2P0\\nCoxsackievirus: XN3MC\\nEchovirus: XN2TU\\nPoliovirus: XN3M0\\nWild poliovirus type: XN97R\\nCirculating vaccinederived poliovirus type: XN7UU\\nRhinovirus: XN19Z\\nFilovirus: XN6R5\\nGenus Orthoebolavirus: XN2LW\\nEbola virus: XN1EN\\nBundibugyo virus: XN8JT\\nReston virus: XN9QG\\nSudan virus: XN13U\\nTa Forest virus: XN8TT\\nBombali virus: XN12Y\\nGenus Orthomarburgvirus: XN4XZ\\nMarburg virus: XN3F2\\nRavn virus: XN5M2\\nFlavivirus: XN0AC\\nDengue virus: XN2EQ\\nJapanese encephalitis virus: XN9ZK\\nSaint Louis encephalitis virus: XN5QW\\nTickborne encephalitis virus: XN0L1\\nTickborne encephalitis virusEuropean subtype: XN1MT\\nTickborne encephalitis virusFar Eastern subtype: XN8WB\\nTickborne encephalitis virusSiberian subtype: XN4LG\\nWest Nile virus: XN4E1\\nYellow fever virus: XN9S3\\nZika virus: XN1H2\\nRocio virus: XN7C2\\nAlkhurma hemorrhagic fever virus: XN7W2\\nKyasanur Forest disease virus: XN2JR\\nHepatitis virus: XN41M\\nGB virus C: XN5XD\\nHepatitis A virus: XN40D\\nHepatitis B virus: XN0GA\\nHepatitis C virus: XN1EZ\\nHepatitis D virus: XN99N\\nHepatitis E virus: XN7TG\\nHepatitis F virus: XN6BW\\nHuman herpesvirus: XN7V1\\nIctalurvirus: XN6DH\\nPityriasis Rosea virus: XN9QL\\nAlphaherpesvirinae: XN465\\nMardivirus: XN42C\\nHerpes simplex virus: XN5V1\\nVaricella zoster virus: XN0TA\\nIltovirus: XN4P4\\nBetaherpesvirinae: XN8TA\\nCytomegalovirus: XN3SQ\\nMuromegalovirus: XN5FN\\nRoseolavirus: XN1GF\\nRoseolavirus A: XN9NM\\nRoseolavirus B: XN8AM\\nGammaherpesvirinae: XN2VN\\nEpsteinBarr virus: XN0R2\\nRhadinovirus: XN7NE\\nHuman immunodeficiency virus: XN487\\nHuman immunodeficiency virus type: XN71W\\nHuman papillomavirus: XN3HA\\nHuman Tcell lymphotropic virus: XN1WJ\\nInfluenza virus: XN5SG\\nInfluenza A virus: XN8WJ\\nInfluenza A HN virus: XN0MW\\nInfluenza A H virus: XN71C\\nInfluenza A HNv virus: XN9FE\\nInfluenza A HN pdm virus: XN9SG\\nInfluenza A HpdmN  reassortant influenza virus: XN3UJ\\nSwine influenza A HN virus: XN476\\nInfluenza A HN variant: XN2SA\\nInfluenza A HN Panama virus: XN3UU\\nInfluenza A HN Moscow virus: XN9HE\\nEquine influenza A HN virus: XN81W\\nInfluenza B virus: XN8SG\\nInfluenza C virus: XN8U3\\nInfluenza D virus: XN67Q\\nLyssavirus: XN33B\\nRabies virus: XN796\\nOrthopolyomavirus: XN8R7\\nJohn Cunningham virus: XN7UP\\nParamyxovirus: XN82V\\nHenipavirus: XN98T\\nCedar Virus: XN5PM\\nHendra virus: XN53N\\nNipah virus: XN931\\nHuman metapneumovirus: XN513\\nMeasles virus: XN186\\nMumps virus: XN22H\\nParainfluenza virus: XN6CR\\nRubulavirus: XN4QJ\\nParvovirus: XN7X8\\nErythrovirus: XN8PS\\nBocaparvovirus: XN447\\nPneumovirus: XN8W9\\nHuman respiratory syncytial virus: XN275\\nPolyomavirus: XN9WH\\nBK polyoma virus: XN0TQ\\nPoxvirus: XN7UC\\nOrthopoxvirus: XN32K\\nBuffalopox virus: XN3Y3\\nCowpox virus: XN0AU\\nMonkeypox virus: XN2GM\\nMonkeypox virus Clade I: XN4L3\\nMonkeypox virus Clade Ia: XN9XX\\nMonkeypox virus Clade Ib: XN8ZK\\nMonkeypox virus Clade II: XN1BH\\nMonkeypox virus Clade IIa: XN00B\\nMonkeypox virus Clade IIb: XN7VR\\nVariola virus: XN4Q0\\nVaccinia virus: XN06N\\nParapox virus: XN1M0\\nbovine papular stomatitis virus: XN7JF\\nOrf virus: XN8E5\\npseudocowpox virus: XN8JR\\nYatapox virus: XN0CV\\ntanapox virus: XN0K5\\nyaba monkey tumour virus: XN81C\\nMolluscipoxvirus: XN5G8\\nMolluscum contagiosum virus: XN7YE\\nReovirus: XN22T\\nRetrovirus: XN6FR\\nAlpharetrovirus: XN2R0\\nBetaretrovirus: XN0TH\\nDeltaretrovirus: XN787\\nEpsilonretrovirus: XN6HX\\nGammaretrovirus: XN4K8\\nLentivirus: XN5R7\\nOncovirus: XN6JB\\nRotavirus: XN6N7\\nRotavirus A: XN6TN\\nRotavirus B: XN55H\\nRotavirus C: XN0F5\\nRotavirus D: XN29P\\nRotavirus E: XN71N\\nRubivirus: XN2F7\\nRubella virus: XN2WE\\nAstrovirus: XN7R4\\nVesiculovirus: XN6T9\\nChandipura virus: XN2BR\\nVesicular stomatitis virus: XN9XS\\nFungi: XN8AY\\nAspergillus: XN0WC\\nAspergillus clavatus: XN6Q9\\nAspergillus flavus: XN6B8\\nAspergillus fumigatus: XN5Z7\\nAspergillus terreus: XN25K\\nAspergillus niger: XN7Q2\\nBasidiobolus: XN4XX\\nBasidiobolus ranarum: XN4RM\\nBlastomyces: XN08A\\nBlastomyces dermatitidis: XN14F\\nCandida: XN3CL\\nCandida albicans: XN31P\\nCandida auris: XN72N\\nCandida haemulonii: XN0RY\\nChromomycosis: XN066\\nChrysosporium: XN106\\nChrysosporium parvum: XN8W1\\nCoccidioides: XN7Q9\\nCoccidioides immitis: XN53F\\nCoccidioides posadasii: XN5TT\\nConidiobolus: XN62A\\nConidiobolus coronatus: XN3KM\\nConidiobolus incongruus: XN4AQ\\nCryptococcus: XN69C\\nCryptococcus gattii: XN0LE\\nCryptococcus neoformans: XN3EH\\nDermatophyte fungi: XN7WW\\nAnthropophilic dermatophytes: XN655\\nEpidermophyton floccosum: XN2T0\\nMicrosporum audouinii: XN3YF\\nMicrosporum ferrugineum: XN2R2\\nTrichophyton concentricum: XN8M6\\nTrichophyton gourvilii: XN628\\nTrichophyton interdigitale: XN8BW\\nTrichophyton megninii: XN96H\\nTrichophyton rubrum: XN2JF\\nTrichophyton schoenleinii: XN53A\\nTrichophyton soudanense: XN135\\nTrichophyton tonsurans: XN1K6\\nTrichophyton violaceum: XN31R\\nTrichophyton yaoundei: XN8BF\\nZoophilic dermatophytes: XN2SY\\nMicrosporum canis: XN5ER\\nMicrosporum equinum: XN6NM\\nMicrosporum gallinae: XN5GR\\nMicrosporum nanum: XN3WX\\nMicrosporum persicolor: XN7JK\\nTrichophyton equinum: XN3YG\\nTrichophyton mentagrophytes: XN4DQ\\nTrichophyton simii: XN4H4\\nTrichophyton verrucosum: XN69S\\nGeophilic dermatophytes: XN1Z2\\nMicrosporum gypseum: XN2VZ\\nMicrosporum praecox: XN7TP\\nGeotrichum: XN3AG\\nGeotrichum candidum: XN0ES\\nHistoplasma: XN9LU\\nHistoplasma capsulatum: XN8VH\\nHistoplasma duboisii: XN7YN\\nHortaea: XN119\\nHortaea werneckii: XN0EF\\nLacazia: XN3CM\\nLacazia loboi: XN3NU\\nLoboa: XN9ZX\\nMalassezia: XN43L\\nMalassezia furfur: XN25C\\nMalassezia globosa fungus: XN0TE\\nMicrosporidia: XN9ZV\\nMucor: XN1NU\\nRhizopus: XN6QM\\nRhizopus arrhizus: XN9KP\\nParacoccidioides: XN7RH\\nParacoccidioides brasiliensis: XN5UX\\nTalaromyces: XN79A\\nPenicillium: XN1ZF\\nPenicillium notatum: XN7JJ\\nTalaromyces marneffei: XN0LD\\nPiedraia: XN4YW\\nPiedraia hortae: XN6H7\\nPneumocystidomycetes: XN5XK\\nPseudallescheria: XN3NS\\nPseudallescheria boydii: XN6BV\\nRhinosporidium: XN720\\nRhinosporidium seeberi: XN18W\\nSporothrix: XN200\\nSporothrix schenckii: XN6GM\\nTrichosporon: XN766\\nFusarium: XN0X5\\nFusarium sporotrichioides: XN55Z\\nFusarium incaratumequiseti: XN7KH\\nFusarium chlamydosporum: XN1FQ\\nFusarium dimerum: XN5KR\\nFusarium fujikuroi: XN6XG\\nFusarium oxysporum: XN3HT\\nFusarium solani: XN0E6\\nAlternaria alternata: XN16V\\nCladosporium herbarum: XN8XY\\nEpicoccum purpurascens: XN7TH\\nMucor racemosus: XN79P\\nPhoma: XN6EG\\nStemphylium botryosum: XN4FM\\nCurvularia lunata: XN93N\\nExserohilum: XN0W9\\nExserohilum rostratum: XN26M\\nExserohilum longirostratum: XN9SM\\nExserohilum mcginnisii: XN9LC\\nSarocladium: XN4XH\\nSarocladium kiliense: XN8VN\\nSarocladium strictum: XN7ZD\\nParasites: XN9S1\\nAncylostoma: XN9CG\\nAncylostoma duodenal: XN5V8\\nAngiostrongylus: XN7A5\\nAngiostrongylus cantonensis: XN2UG\\nAngiostrongylus costaricensis: XN23C\\nAnisakis: XN574\\nAnisakis marina: XN9HA\\nAscaris: XN9PQ\\nAscaris lumbricoides: XN97M\\nBrugia: XN0JL\\nBrugia malayi: XN5RM\\nBrugia timori: XN80F\\nCapillaria: XN8T0\\nCapillaria philippinensis: XN9DT\\nClonorchis: XN9GC\\nClonorchis sinensis: XN5SV\\nDicrocoelium: XN3QD\\nDiphyllobothrium: XN6EF\\nDiphyllobothrium latum: XN67S\\nDiphyllobothrium species: XN7UT\\nDipylidium: XN570\\nDipylidium caninum: XN20Y\\nDirofilaria: XN15W\\nDirofilaria immitis: XN3BX\\nDirofilaria repens: XN7JS\\nDracunculus: XN7A6\\nDracunculus medinensis: XN9Q5\\nEchinococcus: XN84K\\nEchinococcus granulosus: XN1H0\\nEchinococcus multilocularis: XN0K1\\nEchinococcus oligarthrus: XN6TQ\\nEchinococcus vogeli: XN9LQ\\nEchinostoma: XN801\\nEnterobius: XN1DG\\nEnterobius vermicularis: XN4AR\\nFasciola: XN1H3\\nFasciola gigantica: XN90A\\nFasciola hepatica: XN7X9\\nFasciolopsis: XN35Y\\nFasciolopsis buski: XN024\\nGnathostoma: XN0H2\\nGnathostoma hispidum: XN8DD\\nGnathostoma spinigerum: XN8GS\\nHeterophyes: XN23M\\nHookworm: XN69Y\\nHymenolepis: XN629\\nHymenolepis nana: XN9S5\\nLoa: XN8ZQ\\nLoa loa: XN1QQ\\nMansonella: XN5Z0\\nMansonella ozzardi: XN6PZ\\nMansonella perstans: XN8AX\\nMansonella streptocerca: XN0JQ\\nMetagonimus: XN123\\nNanophyetus: XN3E8\\nNecator: XN9T3\\nNecator americanus: XN8K8\\nOesophagostomum: XN7L5\\nOesophagostomum bifurcum: XN0NZ\\nOnchocerca: XN9R1\\nOnchocerca volvulus: XN8T4\\nOpisthorchis: XN91W\\nParagonimus: XN27A\\nParagonimus westermani: XN0A6\\nPhylum Nemata: XN9NR\\nSchistosoma: XN78L\\nSchistosoma haematobium: XN86N\\nSchistosoma matthei: XN90N\\nSchistosoma intercalatum: XN9FK\\nSchistosoma japonicum: XN1ZJ\\nSchistosoma mansoni: XN8HD\\nSchistosoma mekongi: XN9T7\\nSparganum: XN5B9\\nSpirometra: XN89M\\nStrongyloides: XN07X\\nStrongyloides stercoralis: XN1KQ\\nSyngamus: XN5RB\\nSyngamus trachea: XN04L\\nTaenia: XN0D8\\nTaenia saginata: XN871\\nTaenia solium: XN8XE\\nTernidens: XN8DL\\nToxocara: XN2L3\\nToxocara canis: XN7MR\\nToxocara cati: XN54C\\nTrichinella: XN597\\nTrichinella spiralis: XN34A\\nTrichostrongylus: XN025\\nTrichostrongylus colubriformis: XN4K7\\nTrichuris: XN4MM\\nTrichuris trichiura: XN6UA\\nWuchereria: XN0H3\\nWuchereria bancrofti: XN3V2\\nHalicephalobus: XN2DD\\nHalicephalobus gingivalis: XN10L\\nAcanthamoeba: XN0HM\\nAmoeba: XN7S2\\nBabesia: XN9YX\\nBalantidium: XN7ZS\\nBalantidium coli: XN3H4\\nBlastocystis: XN6UY\\nBlastocystis hominis: XN1M7\\nCoccidia: XN1XA\\nCryptosporidium: XN8LE\\nCryptosporidium canis: XN0NC\\nCryptosporidium felis: XN5SZ\\nCryptosporidium hominis: XN4ZT\\nCryptosporidium meleagridis: XN4VU\\nCryptosporidium muris: XN4MN\\nCryptosporidium parvum: XN9BP\\nCyclospora: XN7VL\\nCyclospora cayetanensis: XN4BR\\nEntamoeba: XN3S1\\nEntamoeba histolytica: XN82F\\nGiardia: XN6H5\\nGiardia lamblia: XN94Z\\nIsospora: XN4Y2\\nIsospora belli: XN9ZT\\nLeishmania: XN8JE\\nLeishmania aethiopica: XN87Z\\nLeishmania brasiliensis: XN6DJ\\nLeishmania donovani infantum: XN1M5\\nLeishmania chagasii: XN3HN\\nLeishmania major: XN7EU\\nLeishmania mexicana: XN1EE\\nLeishmania tropica: XN95N\\nNaegleria: XN1M1\\nNaegleria fowleri: XN6EV\\nPlasmodium: XN5FW\\nPlasmodium falciparum: XN69B\\nPlasmodium malariae: XN7K1\\nPlasmodium ovale: XN5WD\\nPlasmodium vivax: XN217\\nPlasmodium knowlesi: XN93K\\nPlasmodium cynomolgi: XN12A\\nSarcocystis: XN92F\\nToxoplasma: XN7HC\\nToxoplasma gondii: XN896\\nTrichomonas: XN316\\nTrichomonas vaginalis: XN7YM\\nTrypanosoma: XN9H4\\nTrypanosoma brucei: XN0C1\\nTrypanosoma brucei gambiense: XN7TC\\nTrypanosoma brucei rhodesiense: XN5C7\\nTrypanosoma cruzi: XN56V\\nDientamoeba: XN7XH\\nDientamoeba fragilis: XN86U\\nRetortamonas: XN30L\\nRetortamonas intestinalis: XN9K3\\nChilomastix: XN4BE\\nChilomastix mesnili: XN0UD\\nDemodex: XN4RB\\nDermanyssus: XN9EL\\nVandellia cirrhosa: XN59U\\nInfestation by beetle: XN857\\nInsect larva: XN00Z\\nLeech: XN2K0\\nLinguatula serrata: XN9MA\\nLiponyssoides: XN0ZB\\nPediculus: XN0D5\\nPhthirus: XN84U\\nSarcoptes: XN3E3\\nSarcoptes scabiei var hominis: XN5YU\\nTrombicula: XN7Z8\\nTunga: XN6VS\\nPorocephalidae: XN2GY\\nScrewworm: XN8CT\\nNew World screwworm: XN4JW\\nOld World screwworm: XN8TR\\nPrion: XN7AM\\nPrototheca: XN42T\\nPythium: XN47C\\nAnterior: XK7V\\nPosterior: XK8L\\nMedial: XK9H\\nLateral: XK09\\nSuperior: XK5N\\nInferior: XK4H\\nVentral: XK4M\\nDorsal: XK87\\nProximal: XK6J\\nDistal: XK6C\\nIpsilateral: XK3Z\\nContralateral: XK3Y\\nExternal: XK2H\\nInternal: XK49\\nSuperficial: XK7F\\nDeep: XK16\\nComplete distribution: XK2J\\nConsolidated distribution: XK6P\\nDiffuse distribution: XK31\\nDisseminated distribution: XK5A\\nFocal distribution: XK37\\nGeneralised distribution: XK63\\nIncomplete distribution: XK06\\nIntertriginous distribution: XK0V\\nLinear distribution: XK5F\\nLocalised distribution: XK9A\\nSegmental distribution: XK36\\nSystematised distribution: XK7Z\\nBilateral: XK9J\\nLeft: XK8G\\nRight: XK9K\\nUnilateral unspecified: XK70\\nBrachial: XK62\\nCaudal: XK07\\nCranial: XK2K\\nInfratentorial: XK0P\\nSupratentorial: XK18\\nBlood: XA8EC5\\nBlood cells: XA8UK8\\nErythrocytes: XM8QV9\\nLeucocytes: XA32R4\\nGranulocytes: XA2WC0\\nNeutrophils: XA8C44\\nBasophils: XA5G96\\nEosinophils: XA0V82\\nMonocytes: XA46Q2\\nMacrophages: XA9DP6\\nLymphocytes: XA8YQ2\\nPlatelets: XA10B5\\nPlasma: XA7UR0\\nPlateletrich plasma: XA3JX0\\nBone marrow: XA9XK1\\nHaematopoietic stem cells: XA5869\\nCommon myeloid progenitor: XA3K78\\nErythroblast: XA8LY0\\nMyeloblast: XA6385\\nMegakaryoblast: XA3EA5\\nLymphoblast: XA0TJ1\\nThymus: XA8373\\nConnective and other soft tissues of thymus: XA2PK9\\nSpleen: XA7FU9\\nLingual tonsil: XA1EM4\\nWaldeyer ring: XA8US7\\nPalatine tonsil: XA3V90\\nLymph nodes: XA33X2\\nLymph nodes of head face and neck: XA9U65\\nOccipital lymph node: XA6H69\\nAuricular lymph node: XA7YF1\\nPosterior auricular lymph node: XA91C5\\nPreauricular lymph node: XA56J5\\nParotid lymph node: XA0W17\\nSubparotid lymph node: XA1Q47\\nSuperficial parotid lymph node: XA85E1\\nDeep parotid lymph node: XA07P4\\nFacial lymph node: XA2U89\\nBuccinator lymph node: XA1SG7\\nMandibular lymph node: XA8DW7\\nDeep facial lymph node: XA2S79\\nLingual lymph node: XA1DV2\\nSublingual lymph node: XA8027\\nSubmental lymph node: XA42P9\\nSubmandibular lymph node: XA9E80\\nAnterior cervical lymph node: XA4759\\nDeep cervical lymph node: XA9PW0\\nPrelaryngeal lymph node: XA2RE9\\nPretracheal lymph node: XA4LC1\\nParatracheal lymph node: XA7W32\\nRetropharyngeal lymph node: XA08L8\\nJugular lymph node: XA60D1\\nAnterior jugular node: XA6YX2\\nJugulodigastric lymph node: XA6HG6\\nJuguloomohyoid lymph node: XA5A75\\nCervical lymph node: XA5XT7\\nInferior cervical lymph node: XA4R20\\nLateral cervical lymph node: XA1W79\\nSuperior deep cervical lymph node: XA6AC0\\nInferior deep cervical lymph node: XA3S48\\nSuperficial cervical lymph node: XA7N00\\nSupraclavicular lymph node: XA00M7\\nIntrathoracic lymph nodes: XA9WH0\\nTracheobronchial lymph node: XA41B8\\nBronchopulmonary lymph node: XA96Z0\\nHilar lymph node: XA5MW1\\nPulmonary lymph node: XA9QW9\\nTracheal lymph node: XA3194\\nSuperior tracheobronchial lymph node: XA2JX0\\nInferior tracheobronchial lymph node: XA1PA1\\nMediastinal lymph node: XA61B8\\nAnterior mediastinal visceral lymph node: XA5HA3\\nPosterior mediastinal visceral lymph node: XA7571\\nOesophageal lymph node: XA8VY5\\nIntercostal lymph node: XA8E34\\nParasternal lymph node: XA2CH0\\nSuperior diaphragmatic lymph node: XA1478\\nInnominate lymph node: XA4P97\\nIntraabdominal lymph nodes: XA05C1\\nLumbar lymph node: XA59Q1\\nAortic lymph node: XA25W0\\nPreaortic lymph node: XA4WV3\\nCoeliac lymph node: XA38T7\\nGastric lymph node: XA1HL1\\nInferior gastric lymph node: XA1FW5\\nUpper superior gastric lymph node: XA1T01\\nSuperior gastric lymph node: XA3F65\\nLower superior gastric lymph node: XA3ET7\\nParacardial superior gastric lymph node: XA4WL5\\nPyloric lymph node: XA2AX1\\nSubpyloric lymph node: XA1RP0\\nHepatic lymph node: XA11U1\\nCommon duct lymph node: XA35G1\\nCystic lymph node: XA71D7\\nPancreaticosplenic lymph node: XA7ZP7\\nPancreaticoduodenal lymph node: XA6W89\\nSplenic lymph node: XA9PJ7\\nSplenic hilar lymph node: XA8X72\\nPancreatic lymph node: XA7T42\\nPeripancreatic lymph node: XA2P83\\nInferior mesenteric lymph node: XA8Y29\\nPararectal inferior mesenteric lymph node: XA6ZA5\\nSuperior mesenteric lymph node: XA37Y9\\nMesenteric lymph node: XA26J2\\nIleocolic lymph node: XA69J6\\nIleal ileocolic lymph node: XA66B8\\nAnterior ileocolic lymph node: XA8W06\\nPosterior ileocolic lymph node: XA7JE2\\nRight colic ileocolic lymph node: XA73R0\\nColic lymph node: XA09W7\\nMidcolic lymph node: XA4F32\\nEpicolic lymph node: XA8JH9\\nParacolic lymph node: XA9JM2\\nIntermediate colic lymph node: XA7PM1\\nPreterminal colic lymph node: XA3TX6\\nLateral aortic lymph node: XA6KK3\\nEpigastric lymph node: XA9T50\\nIliac circumflex lymph node: XA53K4\\nRetroaortic lymph node: XA0TK3\\nIntestinal lymph node: XA3TG4\\nRetroperitoneal lymph node: XA0KH9\\nSuprarenal lymph node: XA7DX9\\nPorta hepatis lymph node: XA2YR9\\nPelvic lymph nodes: XA5HU6\\nIliac lymph node: XA50T5\\nCommon iliac lymph node: XA1MS6\\nInternal iliac lymph node: XA0TJ6\\nExternal iliac lymph node: XA8M66\\nObturator lymph node: XA9Z71\\nSuprainguinal lymph node: XA4J45\\nSacral lymph node: XA24Q3\\nLateral sacral lymph node: XA1EN9\\nMedian sacral lymph node: XA86R4\\nPresymphysial lymph node: XA32C4\\nInferior epigastric lymph node: XA5VA3\\nFemale genital lymph node: XA9TN5\\nParametrial lymph node: XA3QA5\\nUterine paracervical lymph node: XA5M72\\nLymph nodes of upper extremity: XA7TQ3\\nAxillary lymph node: XA90B2\\nPectoral lymph node: XA63L4\\nLateral axillary lymph node: XA6NK2\\nSubscapular lymph node: XA9R12\\nCentral axillary lymph node: XA8HY4\\nSubclavicular axillary lymph node: XA1N88\\nSubclavian lymphatic trunk: XA9CD6\\nIntermediate lymph node: XA2UJ4\\nCubital lymph node: XA3H20\\nEpitrochlear lymph node: XA5183\\nInfraclavicular lymph node: XA0MR2\\nLymph nodes of lower extremity: XA86X1\\nInguinal lymph node: XA7N26\\nSuperficial inguinal lymph node: XA1114\\nSubinguinal lymph node: XA4RT0\\nSuperficial subinguinal lymph node: XA30V5\\nDeep subinguinal lymph nodes: XA6EE2\\nFemoral lymph node: XA5130\\nLymph node of Cloquet: XA4AU1\\nPopliteal lymph node: XA4W98\\nTibial lymph node: XA2PP2\\nAnterior tibial lymph node: XA3X71\\nLymph nodes of multiple regions: XA4T07\\nMononuclear phagocyte system: XA0GJ0\\nHypothalamus: XA1CN1\\nPineal\\xa0gland: XA1EU3\\nPituitary\\xa0gland: XA8J35\\nRathke pouch: XA9787\\nCraniopharyngeal duct: XA5309\\nThyroid\\xa0gland: XA8RK3\\nLeft lobe of thyroid gland: XA8LV3\\nRight lobe of thyroid gland: XA9L72\\nIsthmus of thyroid gland: XA4NE5\\nPyramidal lobe of thyroid gland: XA5109\\nParathyroid\\xa0gland: XA1342\\nPancreatic islets: XA45E6\\nAdrenal gland: XA0NE9\\nAdrenal\\xa0cortex: XA8956\\nAdrenal\\xa0medulla: XA6SS0\\nCentral nervous system: XA3JU6\\nMeninges: XA0AK4\\nCerebral meninges: XA6HA2\\nCranial dura mater: XA9M51\\nCranial arachnoid: XA6WL2\\nCranial pia mater: XA2T81\\nTentorium cerebelli: XA7N98\\nFalx without further specification: XA09H1\\nFalx cerebri: XA1FV7\\nFalx cerebelli: XA33G9\\nSpinal meninges: XA5AH0\\nSpinal dura mater: XA8R98\\nSpinal arachnoid: XA0382\\nSpinal pia mater: XA8SH5\\nDura mater: XA04B5\\nArachnoid mater: XA3D30\\nPia mater: XA6AF5\\nBrain: XA9738\\nCerebrum: XA1M33\\nCerebral hemisphere: XA8GR3\\nFrontal Lobe: XA2NT0\\nFrontal pole: XA3RD9\\nTemporal lobe: XA97T4\\nHippocampus: XA7BD1\\nUncus: XA7J78\\nAmygdala: XA1XY9\\nParietal Lobe: XA92Y6\\nOccipital lobe: XA89Y2\\nBrodmann area: XA5TY2\\nOccipital pole: XA0B59\\nCerebral cortex: XA64R0\\nThalamus: XA7L93\\nBasal ganglia: XA4T82\\nCorpus striatum: XA64F9\\nLentiform nucleus: XA8W72\\nGlobus pallidus: XA80J3\\nPutamen: XA8KA5\\nCaudate nucleus: XA7TX5\\nClaustrum: XA00D6\\nOptic chiasm: XA5TX3\\nOptic tract: XA63Y1\\nVisual cortex: XA5CF8\\nCerebral white matter: XA1ZN9\\nInsula: XA0XP7\\nInternal capsule: XA5JN6\\nOperculum: XA84G1\\nPallium: XA4F88\\nRhinencephalon: XA0Z39\\nCerebral lobe: XA5N14\\nSupratentorial region of brain: XA73A8\\nCerebellum: XA1CW2\\nCerebellar hemisphere: XA4SL2\\nCerebellar tonsil: XA7E38\\nCerebellar vermis: XA8E64\\nSuperior vermis: XA5694\\nInferior vermis: XA70Y8\\nLimbic system: XA8733\\nCerebral ventricle: XA26E8\\nLateral ventricle of the brain: XA45Y8\\nChoroid plexus of lateral ventricle: XA1XM1\\nThird ventricle of the brain: XA1H64\\nChoroid plexus of third ventricle: XA53A3\\nCerebral aqueduct: XA83T2\\nFourth ventricle of the brain: XA1804\\nChoroid plexus of fourth ventricle: XA1B86\\nChoroid plexus: XA9KX2\\nEpendyma: XA6J38\\nBrainstem: XA8AT9\\nMedulla oblongata: XA17J6\\nMidbrain: XA5KS6\\nCerebral peduncle: XA1AA8\\nPons: XA9CM4\\nReticular formation: XA34M4\\nOlives: XA5KN2\\nPyramid: XA5097\\nInfratentorial region of brain: XA1GA1\\nIntracranial site not elsewhere classified: XA08F7\\nSpinal cord: XA0V83\\nCervical spinal cord: XA1SP1\\nC level: XA8965\\nThoracic spinal cord: XA6Z51\\nT level: XA6FB9\\nLumbar spinal cord: XA8PP5\\nL level: XA86M5\\nSacral spinal cord: XA85J0\\nS level: XA4L09\\nMedullary cavity: XA5QM0\\nConus medullaris: XA2FQ1\\nCranial Nerve: XA8EK9\\nOlfactory nerve: XA5QD6\\nOptic nerve: XA1E00\\nOculomotor nerve: XA7488\\nTrochlear nerve: XA0GK2\\nTrigeminal nerve: XA72G0\\nTrigeminal nerve ophthalmic branch: XA95Y8\\nEthmoidal nerve: XA5BP8\\nExternal nasal nerve: XA8482\\nFrontal nerve: XA7F46\\nSupraorbital nerve: XA31J6\\nSupratrochlear nerve: XA95V8\\nLacrimal nerve: XA16M4\\nNasociliary nerve: XA5WM9\\nTrigeminal nerve maxillary branch: XA8KJ5\\nInferior palpebral nerve: XA4E11\\nInfraorbital nerve: XA3G43\\nMiddle meningeal nerve: XA9G70\\nNasopalatine nerve: XA0S35\\nNerve of pterygoid canal: XA9LR9\\nPalatine nerve: XA7P00\\nPharyngeal nerve: XA5Q86\\nSphenopalatine nerves: XA3W58\\nSuperior labial nerve: XA6AE9\\nZygomatic nerve: XA4DJ9\\nZygomaticofacial nerve: XA62X3\\nZygomaticotemporal nerve: XA9MM8\\nTrigeminal nerve mandibular branch: XA1F17\\nAuriculotemporal nerve: XA5DA8\\nBuccal nerve: XA7UK9\\nDeep temporal nerve: XA52H1\\nInferior alveolar nerve: XA3VT0\\nMylohyoid nerve: XA9FV5\\nLateral pterygoid nerve: XA3114\\nLingual nerve: XA5CT7\\nMasseteric nerve: XA5NQ5\\nMedial pterygoid nerve: XA1RH8\\nMental nerve: XA6ZD8\\nAbducens nerve: XA4GX3\\nFacial nerve: XA64Y7\\nPosterior auricular nerve: XA7F87\\nTemporal branch of the facial nerve: XA1VA9\\nZygomatic branch of the facial nerve: XA7JD7\\nBuccal branch of the facial nerve: XA3A57\\nMarginal mandibular branch of the facial nerve: XA1TY5\\nCervical branch of the facial nerve: XA5241\\nDigastric branch of the facial nerve: XA1ZH3\\nStylohyoid branch of the facial nerve: XA36Y9\\nChorda tympani: XA2BL2\\nNerve to the stapedius: XA69Y7\\nVestibulocochlear nerve: XA6LY7\\nCochlear nerve: XA1QU6\\nVestibular nerve: XA1AL7\\nGlossopharyngeal nerve: XA8RW1\\nPharyngeal branches of glossopharyngeal nerve: XA5QA5\\nVagus nerve: XA6VN1\\nAuricular branch of vagus nerve: XA0P44\\nPharyngeal plexus: XA9LV7\\nPharyngeal branch of vagus nerve: XA8F53\\nSuperior laryngeal nerve: XA2HA5\\nExternal laryngeal nerve: XA9LP4\\nInternal laryngeal nerve: XA6UK8\\nLeft recurrent laryngeal nerve: XA3524\\nPulmonary branches of vagus nerve: XA2KY5\\nAccessory nerve: XA2M45\\nHypoglossal nerve: XA3YX3\\nPetrous ganglion: XA48Z8\\nTympanic nerve: XA4Q30\\nDeep petrosal nerve: XA9CT5\\nGreater petrosal nerve: XA4W18\\nCiliary ganglion: XA1SG6\\nLong ciliary nerves: XA3VY1\\nOtic ganglion: XA2260\\nPterygopalatine ganglion: XA0ER1\\nSubmandibular ganglion: XA74N6\\nPeripheral nervous system: XA1630\\nSpinal nerve: XA65L3\\nCervical spinal nerve: XA1YC9\\nFirst cervical spinal nerve: XA9DY6\\nSecond cervical spinal nerve: XA1LR0\\nThird cervical spinal nerve: XA7LF0\\nFourth cervical spinal nerve: XA1QX0\\nFifth cervical spinal nerve: XA06Q1\\nSixth cervical spinal nerve: XA26W5\\nSeventh cervical spinal nerve: XA4WT3\\nEighth cervical spinal nerve: XA3XK7\\nThoracic spinal nerve: XA6KS1\\nFirst thoracic spinal nerve: XA2QF3\\nSecond thoracic spinal nerve: XA1K85\\nThird thoracic spinal nerve: XA0DY5\\nFourth thoracic spinal nerve: XA7BM1\\nFifth thoracic spinal nerve: XA48M5\\nSixth thoracic spinal nerve: XA4GT3\\nSeventh thoracic spinal nerve: XA0RA9\\nEighth thoracic spinal nerve: XA2VJ9\\nNinth thoracic spinal nerve: XA64N5\\nTenth thoracic spinal nerve: XA5AZ7\\nEleventh thoracic spinal nerve: XA6369\\nTwelfth thoracic spinal nerve: XA7QX3\\nLumbar spinal nerve: XA44R0\\nFirst lumbar spinal nerve: XA1471\\nSecond lumbar spinal nerve: XA0VF5\\nThird lumbar spinal nerve: XA9178\\nFourth lumbar spinal nerve: XA6N66\\nFifth lumbar spinal nerve: XA7VL6\\nSacral spinal nerve: XA17Y2\\nFirst sacral spinal nerve: XA2E82\\nSecond sacral spinal nerve: XA9V46\\nThird sacral spinal nerve: XA74E6\\nFourth sacral spinal nerve: XA25F0\\nFifth sacral spinal nerve: XA73B4\\nDorsal spinal nerve: XA4CU7\\nVentral spinal nerve: XA7TS7\\nSpinal nerve root: XA6EC2\\nCervical nerve root: XA3UZ3\\nFirst cervical nerve root: XA53S6\\nSecond cervical nerve root: XA15A2\\nThird cervical nerve root: XA2MT0\\nFourth cervical nerve root: XA36V3\\nFifth cervical nerve root: XA87U1\\nSixth cervical nerve root: XA8YT7\\nSeventh cervical nerve root: XA5BL9\\nEighth cervical nerve root: XA0245\\nThoracic nerve root: XA5SU4\\nFirst thoracic nerve root: XA22C5\\nSecond thoracic nerve root: XA8933\\nThird thoracic nerve root: XA2EK5\\nFourth thoracic nerve root: XA6NV1\\nFifth thoracic nerve root: XA8DN4\\nSixth thoracic nerve root: XA1AB6\\nSeventh thoracic nerve root: XA1VM6\\nEighth thoracic nerve root: XA2UY4\\nNinth thoracic nerve root: XA8QS1\\nTenth thoracic nerve root: XA2VK2\\nEleventh thoracic nerve root: XA61G0\\nTwelfth thoracic nerve root: XA76V2\\nLumbar nerve root: XA4T95\\nFirst lumbar nerve root: XA8VX2\\nSecond lumbar nerve root: XA9BK9\\nThird lumbar nerve root: XA4N03\\nFourth lumbar nerve root: XA2ZQ7\\nFifth lumbar nerve root: XA5W91\\nSacral nerve root: XA9F62\\nFirst sacral nerve root: XA4HY7\\nSecond sacral nerve root: XA4PP9\\nThird sacral nerve root: XA32J7\\nFourth sacral nerve root: XA0WH3\\nFifth sacral nerve root: XA7BN5\\nDorsal nerve root ganglion: XA9J98\\nDorsal nerve root: XA1TP8\\nVentral nerve root ganglion: XA8G34\\nVentral nerve root: XA1V70\\nSpinal nerve plexus: XA64F0\\nCervical plexus: XA6LU7\\nBrachial plexus: XA22K9\\nPosterior cord of brachial plexus: XA1UT5\\nLateral cord of brachial plexus: XA9PG2\\nMedial cord of brachial plexus: XA7UA9\\nLumbosacral plexus: XA8YS2\\nLumbar plexus: XA1E79\\nPresacral plexus: XA1JE5\\nSacral plexus: XA0929\\nPatellar plexus: XA5186\\nSplanchnic plexus: XA3SK8\\nUterovaginal plexus: XA2G95\\nVesical nervous plexus: XA1KP5\\nPeripheral nerve: XA06U6\\nInferior cervical ganglion: XA20S2\\nSuboccipital nerve: XA0Z50\\nGreater auricular nerve: XA4WK4\\nGreater occipital nerve: XA6BB0\\nLesser occipital nerve: XA3ND8\\nThird occipital nerve: XA18D0\\nIliohypogastric nerve: XA8T30\\nIlioinguinal nerve: XA5Q50\\nInferior anal nerves: XA8CZ0\\nLumbar splanchnic nerve: XA8U35\\nMiddle cardiac nerve: XA8ML2\\nPosterior branch of spinal nerve: XA11K1\\nPosterior superior alveolar nerve: XA9AN9\\nProper palmar digital nerves of median nerve: XA7ZD7\\nSacral splanchnic nerves: XA0SA1\\nSemilunar ganglion: XA1SM8\\nShort ciliary nerves: XA07F8\\nSuperior cardiac nerve: XA1AC5\\nSuperior cervical ganglion: XA6BG1\\nSuperior ganglion: XA6YL5\\nTransverse cervical nerve: XA25F4\\nPhrenic nerve: XA9ZM0\\nSympathetic trunk: XA6W14\\nCommon fibular nerve: XA7HH4\\nDeep fibular nerve: XA3QB5\\nFemoral nerve: XA11D4\\nGenitofemoral nerve: XA9JZ4\\nGluteal nerve: XA60R4\\nInferior gluteal nerve: XA1GU3\\nLateral femoral cutaneous nerve: XA4834\\nLateral plantar nerve: XA9958\\nLumbar nerve: XA5UE9\\nLumboinguinal nerve: XA8307\\nLumbosacral trunk: XA76D3\\nMedial plantar nerve: XA9AF5\\nNerve to quadratus femoris: XA7S27\\nPlantar nerve: XA3906\\nPosterior cutaneous nerve of thigh: XA83P9\\nSaphenous nerve: XA9EW1\\nSciatic nerve: XA9KK8\\nSuperficial fibular nerve: XA2125\\nSuperior gluteal nerve: XA9AC5\\nSural nerve: XA4HR8\\nTibial nerve: XA7534\\nAnococcygeal nerve: XA9JU0\\nCauda equina: XA84W1\\nCoccygeal nerve: XA5C62\\nDorsal nerve of clitoris: XA76C3\\nDorsal nerve of the penis: XA8CC3\\nGenital branch of genitofemoral nerve: XA99Q6\\nPerineal nerve: XA0W10\\nPosterior scrotal nerve: XA7NU3\\nPudendal nerve: XA6WU3\\nAccessory obturator nerve: XA55J8\\nDorsal scapular nerve: XA9RP3\\nInferior cardiac nerve: XA9TB4\\nIntercostal nerve: XA5HJ3\\nIntercostobrachial nerve: XA2F71\\nLateral pectoral nerve: XA5A06\\nLong thoracic nerve: XA0A05\\nLower subscapular nerve: XA9XA5\\nMedial pectoral nerve: XA49V5\\nRight recurrent laryngeal nerve: XA1BR5\\nSubcostal nerve: XA3RU6\\nSupraclavicular nerves: XA5318\\nSuprascapular nerve: XA8QY6\\nThoracic splanchnic nerve: XA2R06\\nThoracoabdominal nerve: XA0462\\nThoracodorsal nerve: XA2542\\nUpper subscapular nerve: XA5KR0\\nAxillary nerve: XA1ZC4\\nCommon palmar digital nerves of median nerve: XA1LW6\\nDeep branch of the radial nerve: XA5179\\nDigital nerve: XA37M8\\nDorsal branch of ulnar nerve: XA1TY7\\nLateral cutaneous nerve of forearm: XA6166\\nMedial cutaneous nerve: XA9HJ5\\nMedial cutaneous nerve of arm: XA7K97\\nMedial cutaneous nerve of forearm: XA26F7\\nMuscular branches of the radial nerve: XA3P46\\nPalmar branch of the median nerve: XA89K2\\nPalmar branch of ulnar nerve: XA7FU0\\nPosterior cutaneous nerve of forearm: XA0KL7\\nPosterior cutaneous nerve of arm: XA2XU7\\nSuperficial branch of the radial nerve: XA2E94\\nSuperior lateral cutaneous nerve of arm: XA6B07\\nAnsa cervicalis: XA2M04\\nAnterior interosseous nerve: XA6RQ4\\nAnterior superior alveolar nerve: XA6PJ8\\nBulbar nuclei: XA54B9\\nCeliac ganglion: XA89R1\\nDiagonal band of Broca: XA8QL3\\nGeniculate ganglion: XA66H0\\nIntermediate cutaneous nerve: XA6B81\\nJugular ganglion: XA8AU6\\nLong root of the ciliary ganglion: XA1Z01\\nMiddle cervical ganglion: XA9RD0\\nMusculocutaneous nerve: XA5QF4\\nNerve of the cervical region: XA96Q6\\nNerve to obturator internus: XA1HC7\\nNerve to the piriformis: XA8PE3\\nNerve to the subclavius: XA4XD7\\nNervus intermedius: XA0869\\nNervus spinosus: XA2KG8\\nNodose ganglion: XA5NY4\\nObturator nerve: XA4548\\nParaganglion: XA9519\\nAortic body: XA0VA6\\nCoccygeal glomus: XA6Y08\\nGlomus jugulare: XA17K2\\nParaaortic body: XA8S02\\nPelvic splanchnic nerve: XA1GM8\\nPerforating cutaneous nerve: XA6GZ8\\nPerineal branches of posterior femoral cutaneous nerve: XA4A74\\nAutonomic nervous system: XA7718\\nNerves of the autonomic nervous system: XA2BH4\\nAortic plexus: XA3XN8\\nAuerbach plexus: XA2G56\\nCardiac plexus: XA9QM5\\nCavernous plexus: XA3FS7\\nCoeliac plexus: XA4U92\\nGastric plexus: XA2Y82\\nHepatic plexus: XA4YZ0\\nInferior hypogastric plexus: XA05T1\\nInferior mesenteric plexus: XA8QG3\\nInternal carotid plexus: XA5JN1\\nMeissner plexus: XA8Z10\\nOesophageal plexus: XA7K49\\nOvarian plexus: XA9PB2\\nPancreatic plexus: XA0C44\\nPhrenic plexus: XA9ME3\\nProstatic plexus: XA16Y3\\nPudendal plexus: XA9411\\nRenal plexus: XA82M9\\nSplenic plexus: XA4V38\\nSuperior hypogastric plexus: XA33C1\\nSuperior mesenteric plexus: XA3DJ3\\nSuperior rectal plexus: XA4G22\\nSuprarenal plexus: XA6MY2\\nParasympathetic nervous system: XA7EA2\\nSympathetic nervous system: XA93B4\\nNerve ganglia: XA3PR2\\nInfraorbital plexus: XA2B55\\nMedian nerve: XA0GB0\\nNerve of the Thorax: XA3M58\\nMultiple Nerves: XA2330\\nSingle Nerve: XA7MX8\\nRadial nerve: XA8BJ3\\nUlnar nerve: XA2AS2\\nVentral ramus: XA4M27\\nEye: XA7D89\\nEyelid and ocular surface: XA17K1\\nEyelids: XA3RB1\\nUpper eyelid: XA9K79\\nUpper eyelid margin: XA53T1\\nSuperior palpebral sulcus: XA4649\\nLower eyelid: XA0JV9\\nLower eyelid margin: XA4AX5\\nLateral canthus: XA0403\\nMedial canthus: XA2GQ3\\nConjunctiva: XA8PS3\\nPalpebral conjunctiva: XA3X70\\nConjunctival fornices: XA6EZ4\\nSuperior conjunctival fornix: XA4H06\\nInferior conjunctival fornix: XA3KE6\\nBulbar conjunctiva: XA6V06\\nEyeball: XA0M40\\nSclera: XA2AF4\\nCornea: XA4C02\\nLimbus of cornea: XA1DA5\\nUvea: XA4MT3\\nCiliary body: XA03X9\\nCiliary muscle: XA9SH1\\nCiliary processes: XA1S43\\nChoroid: XA96A7\\nIris: XA3GW7\\nPupil: XA0B15\\nPupillary membrane: XA0571\\nCrystalline lens: XA13U9\\nSuspensory ligament of lens: XA6U53\\nRetina: XA8WV8\\nMacula lutea: XA9V06\\nFovea: XA2U02\\nOptic disc: XA4A75\\nPeripheral retina: XA4YS8\\nChamber of eye: XA0BB2\\nPosterior chamber of the eye: XA0N58\\nVitreous humor: XA4HU2\\nAnterior chamber of the eye: XA4MZ4\\nAqueous humour: XA3518\\nEye fluid: XA1TF9\\nLacrimal apparatus: XA0096\\nLacrimal gland: XA75Y9\\nLacrimal gland ducts: XA2PA4\\nMeibomian gland: XA9D80\\nLacrimal puncta: XA8EM9\\nSuperior lacrimal punctum: XA2VR4\\nInferior lacrimal punctum: XA99D0\\nLacrimal canaliculi: XA6C35\\nNasolacrimal duct: XA5SW9\\nOrbit: XA2WJ9\\nConnective and other soft tissue of orbit: XA9WT4\\nNasofrontal vein: XA8GT2\\nSupraorbital vein: XA7LQ0\\nEar: XA01U5\\nInner Ear: XA57R3\\nSemicircular canals: XA3MS6\\nCochlea: XA0JV0\\nInternal Acoustic Meatus: XA6ZY7\\nLabyrinth: XA0L54\\nAuditory vestibule: XA44P4\\nMiddle Ear: XA0G74\\nEustachian tube: XA7XY6\\nOval window: XA16S6\\nMastoid antrum: XA9RH9\\nTympanic cavity: XA3KB2\\nConnective and other soft tissues of middle ear: XA3UT7\\nTympanic membrane: XA08X4\\nExternal Ear: XA6ZY6\\nPinna: XA4E71\\nHelix of pinna: XA6B58\\nCrus of helix: XA9A86\\nApex of helix: XA9M10\\nSpine of helix: XA7AB8\\nTail of helix: XA1BZ8\\nAntihelix: XA7V14\\nCrura of antihelix: XA96Q7\\nScaphoid fossa of pinna: XA5LW2\\nConcha of pinna: XA8W55\\nCymba conchae: XA5KM5\\nConchal bowl of pinna: XA8D58\\nTriangular fossa of pinna: XA3RC6\\nTragus of pinna: XA2N71\\nIntertragic notch of pinna: XA5VK5\\nEarlobe: XA0TW7\\nAntitragus of pinna: XA7RR9\\nPosterior surface of pinna: XA3S47\\nAntihelical fossa: XA6NU1\\nEminence of concha: XA6KW8\\nEminence of scapha: XA0H47\\nEminence of triangular fossa: XA8VK6\\nRetroauricular sulcus: XA4DV9\\nExternal auditory canal: XA3UC1\\nExternal auditory meatus: XA5GS5\\nCeruminal gland: XA5K66\\nSkin of auricle: XA9E26\\nCardiovascular system: XA4PM9\\nArteries: XA5999\\nArtery of head face and neck: XA4TS7\\nAnterior communicating artery: XA2B10\\nAnterior ethmoidal artery: XA2QF4\\nNasal branches of the anterior ethmoidal artery: XA53D3\\nAnterior meningeal artery: XA00K1\\nAnterior superior alveolar artery: XA1GU9\\nArtery of pterygoid canal: XA2505\\nCarotid artery: XA9AD7\\nCarotid body: XA0F61\\nCommon carotid artery: XA1V84\\nInternal carotid artery: XA78C0\\nOphthalmic artery: XA1CW5\\nExternal carotid artery: XA9EK2\\nCerebellar artery: XA5SN3\\nCerebral artery: XA13S2\\nAnterior cerebral artery: XA1VB0\\nBasilar artery: XA2K99\\nPontine branches of the basilar artery: XA3185\\nMiddle cerebral artery: XA2JH8\\nAnterolateral central artery: XA4WT4\\nPosterior cerebral artery: XA7C50\\nCostocervical trunk: XA2UK9\\nDeep auricular artery: XA7SK1\\nDeep cervical artery: XA1NY7\\nDorsal nasal artery: XA18D8\\nDorsal nasal artery to the root of nose: XA56R8\\nDorsal nasal artery to the dorsum of the nose: XA0PF0\\nExternal striate of the anterolateral central artery: XA4QF0\\nFacial artery: XA3FL3\\nAscending palatine artery: XA7YP8\\nSuperior labial artery: XA4UT8\\nInferior labial artery: XA2ZM0\\nAngular artery: XA36S6\\nCervical artery: XA9QG7\\nDeep branch of the submental artery: XA85T4\\nGlandular branches of the cervical artery: XA83M8\\nGreater palatine artery: XA2626\\nHyoid artery: XA4H29\\nInferior palpebral arch artery: XA4VH9\\nInternal striate of the anterolateral central artery: XA5VX8\\nIntracranial artery: XA85W7\\nLateral branch of the posterior inferior cerebellar artery: XA16L7\\nLateral nasal branch of the facial artery: XA3N26\\nLesser palatine artery: XA5Z38\\nLingual branch of the inferior alveolar artery: XA5TR9\\nMaxillary artery: XA18M5\\nFirst portion of the maxillary artery: XA49F5\\nDeep temporal artery\\xa0anterior and posterior: XA0BD0\\nInferior alveolar artery: XA7SV5\\nIncisor branch of the Inferior alveolar artery: XA3W87\\nMental branch of the Inferior alveolar artery: XA7AG7\\nMasseteric artery: XA49F4\\nDescending palatine artery: XA55G2\\nPharyngeal artery: XA9XM3\\nPosterior superior alveolar artery: XA3WA5\\nBuccal artery: XA0LK0\\nAnterior tympanic artery: XA9MM1\\nAccessory meningeal artery: XA8YX3\\nMiddle meningeal artery: XA5RM1\\nLingual artery: XA2WS5\\nOccipital artery: XA9EU7\\nPosterior auricular artery: XA13U3\\nSuperficial temporal artery: XA0SB1\\nFrontal branch of the superficial temporal artery: XA7WG0\\nSuperior thyroid artery: XA7K29\\nCricothyroid artery: XA0FT7\\nInferior thyroid artery: XA2V10\\nSternocleidomastoid artery: XA77C5\\nAscending pharyngeal artery: XA00E5\\nRight common carotid artery: XA53A8\\nMiddle temporal artery: XA6X36\\nMylohyoid branch of the inferior alveolar artery: XA3TE9\\nParietal branch of the superficial temporal artery: XA6XV2\\nPosterior communicating artery: XA7U73\\nPosterior ethmoidal artery: XA5881\\nNasal branches of the posterior ethmoidal artery: XA7561\\nMeningeal branch of the posterior ethmoidal artery: XA7945\\nPosterior inferior cerebellar artery: XA8RM9\\nPosterior lateral nasal branches of the sphenopalatine artery: XA9VV0\\nPosterior meningeal artery: XA8FA1\\nPosterior septal branches of the sphenopalatine artery: XA4Q78\\nPterygoid branches: XA1K74\\nSphenopalatine artery terminal branch: XA1BZ0\\nSubmental artery of the cervical artery: XA90T0\\nSuperficial branch of the submental artery: XA6FR0\\nSuperficial branch of the transverse cervical artery: XA0898\\nSuperficial petrosal branch of the anterior and posterior meningeal artery: XA82P9\\nSuperior cerebellar artery: XA7423\\nSuperior laryngeal artery: XA9GU1\\nSuperior tympanic artery: XA50Q9\\nSupratrochlear artery: XA6W31\\nTemporal branches of the anterior and posterior meningeal artery: XA65G3\\nThyrocervical trunk: XA9XH0\\nTonsillar branch of the cervical artery: XA2E78\\nTransverse cervical artery: XA6142\\nTransverse facial artery: XA9M59\\nTwig to the upper part of\\xa0lacrimal sac of the dorsal nasal artery: XA5D86\\nVertebral artery: XA1XP6\\nMeningeal branches of vertebral artery: XA3NW4\\nAscending branch of the vertebral artery: XA6TE8\\nDescending branch of the vertebral artery: XA3R20\\nSupraorbital artery: XA1C15\\nSuperficial branch of the supraorbital artery: XA6503\\nDeep branch of the supraorbital artery: XA8BL5\\nOrbital branches of the anterior and posterior meningeal artery: XA34H5\\nInfraorbital artery: XA5C33\\nOrbital branches of the infraorbital artery: XA05E9\\nLong posterior ciliary artery: XA9RA2\\nShort posterior ciliary artery: XA04E2\\nAnterior ciliary artery: XA94Y6\\nCentral retinal artery: XA5RB0\\nCirculus arteriosus major artery: XA22D8\\nCirculus arteriosus minor artery: XA8T70\\nLacrimal artery: XA5P69\\nLateral palpebral artery: XA00Q9\\nMedial palpebral artery: XA8VA1\\nSuperior palpebral arch artery: XA35L5\\nZygomatic branches of the lacrimal artery: XA1Q49\\nBranches to\\xa0gingiva: XA4KE1\\nArtery of thorax: XA9UT1\\nBranches to\\xa0diaphragm of the musculophrenic artery: XA4TH8\\nBranches to lower part of the\\xa0pericardium of the musculophrenic artery: XA1PX4\\nBrachiocephalic trunk: XA2KA0\\nDeep branch of dorsal scapular artery: XA3M86\\nIntercostal artery: XA7KK5\\nIntercostal branches of the musculophrenic artery: XA0T62\\nInternal thoracic artery: XA9S49\\nMediastinal artery: XA4XE2\\nLateral thoracic artery: XA3DE1\\nPulmonary artery: XA09J9\\nLower rd to th\\xa0posterior intercostal artery: XA1EE3\\nLower branches of the space anastomoses of the six\\xa0anterior intercostal branches of the internal thoracic artery: XA0QG6\\nMusculophrenic artery: XA7EC2\\nPerforating branches of the internal thoracic artery: XA1190\\nPosterior intercostal artery: XA0WT1\\nSix\\xa0anterior intercostal branches of the internal thoracic artery: XA14K0\\nSternal\\xa0branches of the internal thoracic artery: XA6UQ6\\nSubcostal artery: XA3311\\nSuperior phrenic artery: XA9J15\\nSuperior thoracic artery: XA8M67\\nSupreme intercostal artery: XA7TT5\\nThoracoacromial artery: XA79X5\\nUpper branches of the six\\xa0anterior intercostal branches of the internal thoracic artery: XA99C2\\nOesophageal artery: XA8ES3\\nAorta of thorax: XA8K52\\nArch of the aorta: XA75Z8\\nAscending aorta: XA01A6\\nDescending aorta: XA5H34\\nBronchial artery: XA6E07\\nSubclavian artery: XA5D68\\nArtery of abdomen: XA9JK8\\nAnterior suprarenal artery: XA7TZ1\\nAscending branch of the left colic artery: XA82R7\\nBranches to\\xa0abdominal muscles of the musculophrenic artery: XA8BY2\\nCoeliac artery: XA8577\\nCommon hepatic artery: XA26R6\\nCystic artery: XA0JE4\\nDescending branch of the left colic artery: XA6NY6\\nDescending\\xa0vasa recta: XA1VJ7\\nDorsal pancreatic artery: XA1QB0\\nGastroduodenal artery: XA0NN4\\nHepatic artery: XA5AP2\\nHepatic branch of the left gastric artery: XA2LQ8\\nIleocolic artery: XA2Z43\\nInferior epigastric artery: XA3F13\\nInferior mesenteric artery: XA2N15\\nInferior pancreaticoduodenal artery: XA6358\\nInferior phrenic artery: XA2LL9\\nIntestinal artery: XA68L7\\nLeft colic artery: XA6WR7\\nLeft gastric artery: XA0LL0\\nLeft gastroomental artery: XA9AQ6\\nLumbar artery: XA4UK9\\nMesenteric artery: XA6CA5\\nMiddle colic artery: XA1Z62\\nMiddle suprarenal artery: XA1GQ7\\nPosterior suprarenal artery: XA00T1\\nProper hepatic artery: XA8C72\\nRenal artery: XA69V9\\nRight colic artery: XA6GC2\\nRight gastric artery: XA9HE0\\nRight gastroomental artery: XA8V02\\nSigmoid artery: XA02A2\\nSplenic artery: XA0R02\\nSuperior pancreaticoduodenal artery: XA2870\\nTerminal branches of the proper hepatic artery: XA51U4\\nUmbilical artery: XA0VZ0\\nSuperior mesenteric artery: XA3VR0\\nArtery of pelvis: XA4GP1\\nArtery of bulb of penis: XA5PV1\\nArtery of bulb of vestibule: XA30X9\\nDeep artery of clitoris: XA4XP0\\nDeep artery of penis: XA7AM0\\nDeep branch of the superior gluteal artery: XA14N2\\nDeep external pudendal artery: XA4AP3\\nDeferential artery: XA27B8\\nDorsal artery of clitoris: XA4FK8\\nDorsal artery of penis: XA4X54\\nIliac branch of the iliolumbar artery: XA5GV0\\nIliolumbar artery: XA7D46\\nInferior branch of the lateral sacral artery: XA3XS2\\nInferior gluteal artery: XA0G82\\nInferior vesical artery: XA2QX3\\nInternal pudendal artery: XA7FK7\\nLateral sacral artery: XA5Y50\\nMedian sacral artery: XA82V4\\nMiddle rectal artery: XA8X93\\nObturator artery: XA69V8\\nOvarian artery\\xa0in females: XA1MF5\\nPerineal artery: XA5MN1\\nPosterior labial branches\\xa0\\xa0of the internal pudendal artery: XA34Z7\\nPosterior scrotal branches\\xa0of the internal pudendal artery: XA2025\\nSuperficial branch of the superior gluteal artery: XA2TT0\\nSuperior branch of the lateral sacral artery: XA0AZ8\\nSuperior gluteal artery: XA26E6\\nSuperior vesical artery: XA1426\\nTesticular artery\\xa0in males: XA0UK9\\nUrethral artery: XA85K8\\nUterine artery: XA0610\\nVaginal artery: XA47A2\\nIliac artery: XA83D6\\nCommon iliac artery: XA6PZ8\\nDeep circumflex iliac artery: XA9MJ1\\nInternal iliac artery: XA4HL2\\nExternal iliac artery: XA53T4\\nInferior adrenal artery: XA9QC3\\nArtery of upper extremity: XA81N7\\nAnterior humeral circumflex artery: XA0H14\\nAnterior ulnar recurrent artery: XA7U09\\nAnterior interosseous artery: XA2PP8\\nAscending branches of the Inferior ulnar collateral artery: XA8ZA6\\nAxillary artery: XA38W3\\nBrachial artery: XA1138\\nBranch to\\xa0volar carpal network of the anterior interosseous artery: XA5RC6\\nBranches to the\\xa0deltoid muscle of the Profunda brachii artery: XA91T8\\nCommon interosseous artery: XA4RU3\\nDeep palmar arch: XA3M37\\nDescending branches of the Inferior ulnar collateral artery: XA1ES5\\nFirst dorsal metacarpal artery: XA2UT9\\nInferior ulnar collateral artery: XA9F90\\nInterosseous recurrent artery: XA9179\\nMedial collateral artery: XA2722\\nMuscular branches of the anterior interosseous artery: XA8LL2\\nPalmar carpal arch: XA0GZ0\\nPalmar carpal branch of radial artery: XA2F13\\nPosterior interosseous artery: XA51P8\\nPosterior ulnar recurrent artery: XA8JY7\\nPrinceps pollicis artery: XA05L5\\nProfunda brachii artery: XA2PP0\\nRadial artery: XA8RG5\\nRadial branches at the\\xa0wrist of the radial artery: XA9W25\\nRadial branches in the hand of the radial artery: XA91J7\\nRadial branches in the\\xa0forearm of the radial artery: XA3SL1\\nRadial collateral artery: XA3PZ4\\nRadial recurrent artery: XA3H61\\nRadialis indicis of the radial artery: XA62C1\\nSuperficial palmar arch: XA5AG1\\nSuperficial palmar branch of the radial artery: XA5BG5\\nSuperior ulnar collateral artery: XA0JA6\\nUlnar artery: XA23B7\\nVolar carpal network: XA90B4\\nDeep volar branch of ulnar artery: XA1VB5\\nDorsal carpal arch: XA9ZJ6\\nDorsal carpal branch of radial artery: XA44C1\\nDorsal carpal network: XA7M90\\nSubscapular artery: XA2YJ5\\nPosterior humeral circumflex artery: XA0882\\nArtery of lower extremity: XA8DW5\\nAcetabular branch: XA61E8\\nAnterior lateral malleolar artery: XA91J1\\nAnterior medial malleolar artery: XA4K68\\nAnterior tibial artery: XA6CN3\\nAnterior tibial recurrent artery: XA7BL5\\nAscending branch of the lateral femoral circumflex artery: XA5BU3\\nAscending branch of the medial femoral circumflex artery: XA0DB6\\nBranch of the medial inferior genicular artery to\\xa0popliteus: XA42R8\\nBranch of the medial superior genicular artery to\\xa0vastus medialis: XA7WF1\\nBranch of the medial superior genicular artery to surface of the femur and the kneejoint: XA2DD1\\nCommunicating branch of the fibular artery to the\\xa0anterior tibial artery: XA4VS8\\nDeep branch of the descending branch of the Medial femoral circumflex artery: XA7DF6\\nDeep branch of the lateral superior genicular artery: XA19F5\\nDeep femoral artery: XA3KL5\\nDescending branch of the lateral femoral circumflex artery: XA3SV6\\nDescending branch of the Medial femoral circumflex artery: XA15J8\\nDescending genicular artery: XA3CV5\\nDorsalis pedis artery: XA41L4\\nFemoral artery: XA2JF3\\nFibular artery: XA9GM6\\nFirst perforating artery: XA2GU0\\nLateral femoral circumflex artery: XA9EP9\\nLateral inferior genicular artery: XA4B67\\nMedial femoral circumflex artery: XA6920\\nMedial inferior genicular artery: XA1QB3\\nMedial plantar artery: XA7PN1\\nMiddle genicular artery: XA5LB1\\nMuscular branches of the anterior tibial artery: XA0PT7\\nMusculoarticular branch of the Descending genicular artery: XA9TP5\\nPerforating artery: XA0GA4\\nPerforating branch of the fibular artery to the\\xa0posterior tibial artery: XA1YF2\\nPopliteal artery: XA44K1\\nPosterior tibial artery: XA6LK2\\nPosterior tibial recurrent artery: XA33D9\\nSaphenous branch of the Descending genicular artery: XA09P5\\nSecond perforating artery: XA2Z59\\nSuperficial branch of the descending branch of the Medial femoral circumflex artery: XA7W56\\nSuperficial branch of the lateral superior genicular artery: XA5687\\nSural artery: XA08Q7\\nThird or fourth perforating artery: XA8J55\\nTransverse branch of the lateral femoral circumflex artery: XA4XR2\\nLateral plantar artery: XA6QR6\\nCommon femoral artery: XA8YC8\\nSuperficial femoral artery: XA5PP5\\nAfferent arteriole of the interlobular artery: XA9PU5\\nAorta: XA6Y34\\nThoracoabdominal aorta: XA9NQ2\\nAbdominal aorta: XA5Z66\\nSuprarenal abdominal aorta: XA5EX6\\nInfrarenal abdominal aorta: XA2LN9\\nVeins: XA5J49\\nVein of head face and neck: XA59M2\\nCortical vein: XA9TJ8\\nBasal vein: XA8ZU5\\nAlveolar vein: XA37J7\\nAngular vein: XA8ZS9\\nTemporal vein: XA6HG4\\nDeep anterior temporal vein: XA1GE4\\nMiddle temporal vein: XA8SD6\\nDeep posterior temporal vein: XA30B2\\nSuperficial temporal vein: XA2NX9\\nBasilar plexus: XA6SL1\\nBuccinator vein: XA5SG1\\nCerebellar vein: XA91N0\\nInferior cerebellar vein: XA93W0\\nSuperior cerebellar vein: XA2Z35\\nCerebral vein: XA2LX2\\nInternal cerebral vein: XA6DC3\\nDeep middle cerebral vein: XA1MX7\\nInferior cerebral vein: XA0U80\\nMiddle cerebral vein: XA43H1\\nSuperficial middle cerebral vein: XA4WV6\\nSuperior cerebral vein: XA0E47\\nSmall anterior cerebral vein: XA7VW1\\nGreat cerebral vein: XA18W3\\nChoroid vein: XA49Y4\\nCricothyroid vein: XA7C08\\nDeep cervical vein: XA9U81\\nDiploic vein: XA2QB0\\nFrontal diploic vein: XA6VQ5\\nAnterior temporal diploic vein: XA6694\\nPosterior temporal diploic vein: XA5AY0\\nOccipital diploic vein: XA2HM1\\nEmissary vein of the foramen of Vesalius: XA12G2\\nEmissary vein: XA14M4\\nCondyloid emissary vein: XA6BA1\\nOccipital emissary vein: XA4K04\\nMastoid emissary vein: XA8C81\\nParietal emissary vein: XA0T02\\nFrontal vein: XA74U9\\nFrontal venous lacunae: XA0CA3\\nGreat anastomotic vein of Trolard: XA3DS7\\nInferior striate vein: XA9GT2\\nMaxillary vein: XA4ZZ3\\nLaryngeal vein: XA23C4\\nInferior laryngeal vein: XA2JH6\\nSuperior laryngeal vein: XA3XZ1\\nMasseteric vein: XA8Z61\\nLingual vein: XA8NY9\\nMeningeal vein: XA4105\\nAnterior meningeal vein: XA8D07\\nMiddle meningeal vein: XA5600\\nPosterior meningeal vein: XA73V2\\nOccipital vein: XA01E7\\nOccipital venous lacunae: XA7AS3\\nOphthalmic vein: XA0X91\\nSuperior ophthalmic vein: XA6C95\\nInferior ophthalmic vein: XA8M04\\nPalatine vein: XA1SM5\\nParietal venous lacunae: XA4HX4\\nParotid vein: XA91G2\\nPharyngeal vein: XA98C1\\nPosterior anastomotic vein of Labb: XA2NF3\\nPterygoid venous plexus: XA0QP2\\nSphenopalatine vein: XA0M51\\nStylomastoid vein: XA4XY4\\nSublingual vein: XA7K99\\nSubmaxillary vein: XA7ZY4\\nSubmental vein: XA1LD6\\nTerminal vein: XA8680\\nTracheal vein: XA7F45\\nTransverse cervical vein: XA6945\\nVein from the tympanic cavity: XA22T9\\nVein of the ala nasi: XA21F0\\nVein of the pterygoid canal: XA9914\\nVena comitans of the hypoglossal nerve: XA1RH4\\nVenous jugular arch: XA1K34\\nVenous Sinuses: XA1VJ8\\nCavernous sinus: XA5WN3\\nConfluence of the sinuses: XA4NJ4\\nInferior petrosal sinus: XA6ZV2\\nInferior sagittal sinus: XA9ED6\\nOccipital sinus: XA2SC7\\nSigmoid sinus: XA4041\\nStraight sinus: XA03D2\\nSuperior sagittal sinus: XA81R3\\nSuperior petrosal sinus: XA1YP1\\nTransverse sinus: XA4289\\nSphenoparietal sinus: XA5255\\nIntercavernous sinus: XA3U52\\nAnterior intercavernous sinus: XA8P44\\nPosterior intercavernous sinus: XA7QE4\\nCircular sinus: XA9JS4\\nPetrosquamous sinus: XA6UW5\\nSinus of the dura mater: XA6HK7\\nCranial venous sinus: XA5UX2\\nThyroid vein: XA9VA8\\nInferior thyroid vein: XA2KJ8\\nMiddle thyroid vein: XA2DN0\\nSuperior thyroid vein: XA9BZ3\\nPalpebral vein: XA9SD5\\nInferior palpebral vein: XA9K84\\nSuperior palpebral vein: XA9T11\\nLateral palpebral vein: XA0Z20\\nLabial vein: XA52V8\\nInferior labial vein: XA5DP6\\nSuperior labial vein: XA4AG1\\nAuricular vein: XA97T8\\nAnterior auricular vein: XA46F3\\nPosterior auricular vein: XA67N9\\nFacial vein: XA0BP3\\nAnterior facial vein: XA7WC0\\nDeep facial vein: XA2681\\nCommon facial vein: XA3LQ0\\nPosterior facial vein: XA4NP1\\nTransverse facial vein: XA5GY9\\nJugular vein: XA4582\\nAnterior jugular vein: XA9U48\\nInternal jugular vein: XA46B9\\nExternal jugular vein: XA99S7\\nPosterior external jugular vein: XA31W7\\nOrbital vein: XA9XW7\\nVein of the pericranium: XA73J2\\nAnterior vertebral vein: XA0ET2\\nDeep temporal vein: XA1LU7\\nExtraspinal vein: XA2L55\\nInternal auditory vein: XA5YM5\\nPterygoid plexus: XA5TG4\\nPterygoid vein: XA1VP6\\nSuperior sagittal vein: XA1RV1\\nVertebral vein: XA7QR6\\nAnterior vertebral venous plexus: XA0BP6\\nVein of thorax: XA8CT1\\nAccessory hemiazygos vein: XA6DM9\\nAzygos vein: XA7AN5\\nBrachiocephalic vein: XA57F8\\nBronchial vein: XA1GY9\\nDiaphragmatic vein: XA9NE2\\nOesophageal vein: XA3VU3\\nHemiazygos vein: XA4GF1\\nInnominate vein: XA27D1\\nIntercostal vein: XA9HG3\\nMediastinal vein: XA6JE5\\nSubclavian vein: XA6YT2\\nSubcostal vein: XA3568\\nSuperior epigastric vein: XA4VD1\\nSuperior vena cava: XA5WA4\\nSuperior intercostal vein: XA4DR2\\nInternal mammary vein: XA3V69\\nTransverse scapular vein: XA2DL5\\nSubscapular vein: XA8WJ4\\nThymic vein: XA2YF2\\nVein of abdomen: XA0RA8\\nAscending lumbar vein: XA4DQ4\\nCaput medusae vein: XA9PF5\\nCystic Vein: XA1MQ4\\nIleocolic vein: XA95M2\\nInferior vena cava: XA7UV5\\nHepatic Vein: XA2UD7\\nLumbar vein: XA52L9\\nPancreatic vein: XA3X37\\nPancreaticoduodenal vein: XA4XM0\\nParaumbilical Vein: XA0N54\\nPortal Vein: XA1E17\\nRectal venous plexus: XA5JV6\\nSplenic vein: XA0J33\\nThoracoepigastric vein: XA46Q0\\nColic vein: XA2DK6\\nRight colic vein: XA2UN4\\nMiddle colic vein: XA49E0\\nLeft colic vein: XA2WF1\\nRectal vein: XA5T10\\nMiddle rectal vein: XA6NJ4\\nInferior rectal vein: XA80L8\\nSuperior hemorrhoidal vein: XA30C9\\nPerineal hemorrhoidal vein: XA34F0\\nPhrenic vein: XA1EK8\\nSuperior phrenic vein: XA27Y3\\nInferior phrenic vein: XA0EZ6\\nMesenteric vein: XA5KA1\\nSuperior mesenteric vein: XA4DA7\\nInferior mesenteric vein: XA4EK2\\nEpigastric vein: XA04Q7\\nSuperficial epigastric vein: XA8WC0\\nInferior epigastric vein: XA30F2\\nVeins of stomach: XA1C53\\nGastric vein: XA7CB3\\nLeft gastric vein: XA73S8\\nRight gastric vein: XA23Q4\\nShort gastric vein: XA5QC9\\nGastroepiploic vein: XA2R35\\nIntestinal vein: XA55H2\\nVein of pelvis: XA26H2\\nRenal vein: XA3200\\nCorpus cavernosum penis: XA6YL8\\nDeep dorsal vein of the penis: XA03F7\\nIliolumbar vein: XA9X28\\nDeep vein of the penis: XA7U63\\nObturator vein: XA5AH6\\nOvarian Vein: XA4PC3\\nPampiniform plexus: XA05M3\\nPerineal vein: XA1W18\\nProstatic vein: XA8WY0\\nPubic vein: XA0GG0\\nSigmoid vein: XA8HY5\\nSuperficial dorsal vein of the penis: XA4TQ4\\nSuprarenal vein: XA2WW4\\nUterine plexus: XA7AB3\\nUterine vein: XA8M77\\nVaginal vein: XA1MK5\\nVesical plexus: XA0DB7\\nVesical vein: XA7GN4\\nVulval vein: XA9GG9\\nGluteal vein: XA8GA3\\nInferior gluteal vein: XA3HW8\\nSuperior gluteal vein: XA47S7\\nIliac vein: XA03Q4\\nInternal iliac vein: XA3EG0\\nExternal iliac vein: XA49T5\\nCommon iliac vein: XA7W40\\nDeep iliac circumflex vein: XA3H93\\nSacral vein: XA71Q4\\nLateral sacral vein: XA4PJ8\\nMiddle sacral vein: XA9Z04\\nSpermatic Vein: XA5KK7\\nPudendal vein: XA3F81\\nInternal pudendal vein: XA7XD2\\nSuperficial external pudendal vein: XA6NF9\\nDeep external pudendal vein: XA1ET7\\nAdrenal vein: XA6TQ3\\nVein of upper extremity: XA9WN7\\nAccessory cephalic vein: XA0QT1\\nAxillary vein: XA3EY8\\nBasilic vein: XA6JD7\\nBrachial vein: XA43Q5\\nCephalic vein: XA4YQ8\\nCommon volar digital vein: XA7FD2\\nDeep volar venous arch: XA7902\\nDorsal interosseous vein: XA6NS3\\nDorsal metacarpal vein: XA9886\\nLateral thoracic vein: XA4A41\\nMedian antebrachial vein: XA3TW9\\nMedian basilic vein: XA1YZ7\\nProper volar digital vein: XA3GZ6\\nRadial vein: XA32L8\\nSuperficial volar venous arch: XA7HM9\\nUlnar vein: XA8CK3\\nVolar digital vein: XA2Y72\\nVolar interosseous vein: XA2C08\\nVolar metacarpal vein: XA13N1\\nVein of lower extremity: XA76A3\\nAccessory saphenous vein: XA8WJ3\\nAnterior tibial vein: XA4CQ8\\nCommon digital vein: XA23R2\\nDeep Femoral Vein: XA3E41\\nDeep plantar venous arch: XA8RN9\\nFemoral vein: XA3QX9\\nGreat saphenous vein: XA59H1\\nLateral femoral circumflex vein: XA74K2\\nLateral marginal vein: XA4L08\\nLateral plantar vein: XA0L88\\nMedial femoral circumflex vein: XA8PZ9\\nMedial marginal vein: XA1XM3\\nMedial plantar vein: XA85B7\\nMetatarsal vein: XA7ND7\\nPlantar cutaneous venous arch: XA4EV7\\nPlantar digital vein: XA8657\\nPopliteal vein: XA08Q1\\nPosterior tibial vein: XA5D60\\nSmall saphenous vein: XA2073\\nSuperficial iliac circumflex vein: XA8HR9\\nPeroneal vein: XA4930\\nAnterior femoral cutaneous vein: XA8LE8\\nVena cava: XA60H0\\nBlood Vessels: XA21T7\\nBlood vessel of the finger: XA6943\\nBlood vessel of the thumb: XA7SM4\\nBlood vessels at wrist or hand level: XA6Y60\\nBlood vessel of the kidney: XA08R7\\nBlood vessel of the lung: XA5K61\\nBlood vessel of the neck: XA9AN5\\nBlood vessel of the thorax: XA8N71\\nBlood vessel of hip: XA7P54\\nBlood vessels at lower leg level: XA9M17\\nCapillary not elsewhere classified: XA2769\\nCerebral vasculature: XA5TF7\\nIntracranial blood vessels not elsewhere classified: XA4H19\\nExtracranial blood vessels not elsewhere classified: XA1SX5\\nHeart: XA6H07\\nLeft atrium: XA6548\\nMitral valve: XA7V72\\nCusps of mitral valve: XA3GE9\\nChordae tendineae of mitral valve: XA69W6\\nInteratrial septum: XA78X5\\nRight atrium: XA6T92\\nTricuspid valve: XA6FF2\\nCusps of tricuspid valve: XA19H9\\nChordae tendineae of tricuspid valve: XA4LY3\\nLeft ventricle: XA8FJ7\\nAortic valve: XA19J4\\nCusps of aortic valve: XA2QK7\\nLeft ventricular papillary muscles: XA7S34\\nInterventricular septum: XA5651\\nRight ventricle: XA9HH8\\nRight ventricular papillary muscles: XA5Y16\\nPulmonary valve: XA6WC4\\nCusps of pulmonary valve: XA1403\\nCoronary arteries: XA3B03\\nLeft main coronary artery: XA0F62\\nLeft circumflex artery: XA9FX9\\nLeft anterior descending coronary artery: XA7NQ7\\nDiagonal branches of left anterior descending coronary artery: XA2N78\\nD first diagonal branch: XA20E5\\nD second diagonal branch: XA86J1\\nD third diagonal branch: XA5SR3\\nLeft obtuse marginal artery: XA1SH6\\nRamus intermedius artery: XA3QP2\\nSeptal artery: XA5LW8\\nRight coronary artery: XA2QX7\\nRight acute marginal artery: XA1LL7\\nPosterior interventricular artery: XA81T7\\nPosterolateral artery: XA8PS0\\nSinoatrial nodal artery: XA7TB5\\nCardiac veins: XA9FK9\\nOblique vein of the left atrium: XA6YW4\\nLeft marginal vein of heart: XA0HP7\\nGreat cardiac vein: XA38Z5\\nPosterior vein of the left ventricle: XA8HT6\\nMiddle cardiac vein: XA3UN3\\nSmall cardiac vein: XA6QD7\\nCoronary sinus: XA16E4\\nAnterior cardiac veins: XA4TZ2\\nSmallest cardiac vein: XA9498\\nRight marginal vein of heart: XA2KE8\\nPericardial vein: XA4366\\nChamber of the heart: XA10E0\\nCardiac atrium: XA91S4\\nCardiac ventricle: XA7XU8\\nConnective and other soft tissue of heart: XA3113\\nArteries of heart: XA42G7\\nPericardiophrenic artery: XA9X98\\nPericardium: XA2XU0\\nParietal pericardium: XA8RK9\\nPericardial cavity: XA48H9\\nEpicardium: XA37Q8\\nEndocardium: XA3227\\nCardiac septum: XA81Z5\\nPapillary muscle: XA2DC8\\nHeart wall: XA6CK2\\nAnterior wall of heart: XA7RE3\\nAnterolateral wall of heart: XA5W05\\nAnteroseptal wall of heart: XA2RT9\\nAnteroapical wall of heart: XA4U99\\nInferior wall of heart: XA3RM8\\nInferolateral wall of heart: XA61Y9\\nInferoposterior wall of heart: XA2H88\\nApicallateral wall of heart: XA8ZQ8\\nBasallateral wall of heart: XA6GR4\\nHigh lateral wall of heart: XA1HH6\\nLateral wall of heart: XA3XS7\\nTrue posterior wall of heart: XA01U7\\nPosterobasal wall of heart: XA7D76\\nPosterolateral wall of heart: XA4RC1\\nPosteroseptal wall of heart: XA60V2\\nSeptal wall of heart: XA83Q5\\nCardiac electrical conducting system: XA79Z5\\nSinoatrial node: XA1UE3\\nAtrioventricular node: XA4359\\nBundle of His: XA7J11\\nHeart valve: XA0QB6\\nMyocardium: XA8SK6\\nLymphatic system of the head and neck: XA10P2\\nJugular lymphatic trunk: XA0LH6\\nLymphatic vessel of the pinna: XA6TY4\\nLymphatic vessel of the external acoustic meatus: XA02Y8\\nLymphatic vessel of the face: XA1EC8\\nLymphatic vessel of the palatine tonsil: XA0167\\nLymphatic vessel of the scalp: XA4QZ6\\nLymphatic vessel of the tongue: XA9FT5\\nLymphatic vessels of the skin and muscles of the neck: XA1G40\\nLymphatic system of the upper extremity: XA23Z9\\nDeep lymphatic vessel: XA05S0\\nDorsal interosseous lymphatic vessel: XA6D43\\nMedian lymphatic vessel: XA7FS7\\nRadial lymphatic vessel: XA3HQ3\\nSuperficial lymphatic vessel: XA12G8\\nUlnar lymphatic vessel: XA4UB1\\nVolar lymphatic vessel: XA5SZ5\\nLymphatic system of the thorax: XA52C3\\nBronchomediastinal trunk: XA94Z9\\nCisterna chyli lymph sac: XA7474\\nDeep lymphatic vessel of the thoracic wall: XA1VK9\\nIntestinal lymphatic trunk: XA9D98\\nJugular lymph sac: XA8JF4\\nLymph Sac: XA1SQ2\\nLymphatic vessel of the diaphragm: XA8YM1\\nLymphatic vessel of the breast: XA4RC7\\nLymphatic vessel of the thoracic viscera: XA3SY2\\nLymphatic vessel of the heart: XA55B8\\nLymphatic vessel of the lungs: XA3EB8\\nLymphatic vessel of the oesophagus: XA8QZ0\\nLymphatic vessel of the pericardium: XA6J62\\nLymphatic vessel of the pleura: XA4QL2\\nLymphatic vessel of the thymus: XA3JF4\\nPosterior lymph sac: XA4J10\\nRetroperitoneal lymph sac: XA8MX8\\nRight lymphatic duct: XA3ER1\\nSuperficial lymphatic vessel of the thoracic wall: XA3TX9\\nThoracic duct: XA8A74\\nLymphatic system of the abdomen: XA81G2\\nIntestinal lumbar trunk: XA07V7\\nLumbar lymphatic trunk: XA6R71\\nLymphatic vessel of the caecum: XA9XL5\\nLymphatic vessel of the colon: XA1BU5\\nLymphatic vessel of the duodenum: XA92E5\\nLymphatic vessel of the gallbladder: XA6VD0\\nLymphatic vessel of the ileum: XA55Y5\\nLymphatic vessel of the jejunum: XA4CQ1\\nLymphatic vessel of the kidney: XA3610\\nLymphatic vessel of the liver: XA0WY9\\nLymphatic vessel of the pancreas: XA9YZ4\\nLymphatic vessel of the spleen: XA5LE6\\nLymphatic vessel of the stomach: XA1599\\nLymphatic vessel of the subdiaphragmatic portion of the digestive tube: XA3RD0\\nLymphatic vessel of the suprarenal lymph node: XA21T8\\nLymphatic vessel of the vermiform process: XA29U5\\nLymphatic system of the pelvis and perineum: XA6709\\nAnterior vesical lymphatic vessel of the bladder: XA9H16\\nLateral vesical lymphatic vessel of the bladder: XA28F6\\nLymphatic vessel of the anal canal: XA4LM3\\nLymphatic vessel of the anus: XA5C29\\nLymphatic vessel of the bladder: XA1UK6\\nLymphatic vessel of the ductus deferens: XA16J8\\nLymphatic vessel of the ovary: XA4229\\nLymphatic vessel of the prostate: XA1SS8\\nLymphatic vessel of the rectum: XA6DH7\\nLymphatic vessel of the reproductive organs: XA2XZ6\\nLymphatic vessel of the testes: XA1UA0\\nLymphatic vessel of the ureter: XA6324\\nLymphatic vessel of the urethra: XA6HM6\\nLymphatic vessel of the urinary organ: XA7JY4\\nLymphatic vessel of the uterine tube: XA5755\\nLymphatic vessel of the uterus: XA9PA3\\nLymphatic vessel of the vagina: XA1ZK1\\nLymphatic vessel of the seminal vesicles: XA0GB7\\nLymphatic system of the lower extremity: XA0Z86\\nAnterior tibial lymphatic trunk: XA6UC7\\nUpper respiratory tract: XA8Z63\\nNasal cavity: XA43C9\\nNasal vestibule: XA53X2\\nNasal septum: XA8D47\\nNasal turbinate: XA8817\\nNasal cartilage: XA7WQ4\\nNasal mucosa: XA4CN5\\nConnective subcutaneous and other soft tissues of nasal cavity: XA6YH7\\nnasal arch vein: XA3HQ4\\nAccessory sinuses: XA3523\\nMaxillary sinus: XA1R64\\nEthmoid sinus: XA58F6\\nFrontal sinus: XA91G8\\nSphenoid sinus: XA4U67\\nNasopharynx: XA9AZ1\\nSuperior wall of nasopharynx: XA0659\\nAnterior wall of nasopharynx: XA21P9\\nPosterior wall of nasopharynx: XA4BR4\\nAdenoid: XA5AS8\\nLateral wall of nasopharynx: XA7PX5\\nPharyngeal recess: XA7W35\\nRetropharyngeal recess: XA9P89\\nParapharyngeal recess: XA6QY3\\nLarynx: XA2RH5\\nSupraglottic larynx: XA1PB3\\nEpiglottis: XA9ZY9\\nAnterior surface of epiglottis: XA4DV7\\nPosterior surface of epiglottis: XA8U54\\nAryepiglottic fold: XA9907\\nLaryngeal aspect of aryepiglottic fold: XA8N50\\nGlottis: XA7AE7\\nVocal cord: XA3299\\nSubglottic larynx: XA25B1\\nLaryngeal cartilage: XA0NK8\\nArytenoid cartilage: XA0AF3\\nCricoid cartilage: XA7S05\\nCricoarytenoid articulation: XA2383\\nCricothyroid articulation: XA73G2\\nCuneiform cartilage: XA7SZ3\\nThyroid cartilage: XA2716\\nLower respiratory tract: XA07R2\\nTrachea: XA26H1\\nCervical trachea: XA7SG3\\nThoracic trachea: XA4RN3\\nLung: XA57M6\\nMain bronchus: XA9TC5\\nRight main bronchus: XA3L52\\nLeft main bronchus: XA5FV2\\nCarina: XA4JA0\\nRight lung: XA7EZ3\\nHilum of right lung: XA29Y4\\nRight upper lobe bronchus: XA8Z30\\nRight lower lobe bronchus: XA41Z3\\nRight middle lobe bronchus: XA1QM3\\nLeft lung: XA2UD3\\nHilum of left lung: XA6VA2\\nLeft upper lobe bronchus: XA6F58\\nLingula of lung: XA4565\\nLeft lower lobe bronchus: XA2XH5\\nLobe of lung: XA90M2\\nUpper lobe of lung: XA9HN5\\nMiddle lobe of lung: XA1N36\\nLower lobe of lung: XA7L34\\nUpper lobe bronchus: XA37W0\\nMiddle lobe bronchus: XA1K94\\nLower lobe bronchus: XA8JM5\\nConnective and other soft tissues of lung: XA2PV7\\nBronchus: XA61M6\\nLung parenchyma: XA8Z62\\nAlveoli: XA5772\\nPulmonary vasculature: XA4646\\nPulmonary vein: XA8FY4\\nLeft pulmonary vein: XA1WN5\\nLeft superior pulmonary vein: XA9941\\nLeft inferior pulmonary vein: XA8TW3\\nRight pulmonary vein: XA86L0\\nRight superior pulmonary vein: XA05T2\\nRight inferior pulmonary vein: XA41F3\\nAccesory right pulmonary vein: XA4530\\nCommon left sided trunk of pulmonary veins: XA1SF4\\nPulmonary capillaries: XA0F36\\nPleura: XA5TT2\\nVisceral pleura: XA1B59\\nParietal pleura: XA7RC6\\nArtery of lung: XA4U64\\nEfferent arteriole of the interlobular artery: XA2AT1\\nInterlobar artery: XA6WT9\\nInterlobular artery: XA2S57\\nPulmonary trunk: XA3713\\nBronchioles: XA5437\\nMouth: XA8182\\nVestibule of mouth: XA5TW5\\nLabial mucosa of upper lip: XA9072\\nLabial mucosa of lower lip: XA72W2\\nBuccal mucosa: XA8WB3\\nRetromolar region: XA0S17\\nLabial sulcus: XA44M8\\nSuperior labial sulcus: XA2151\\nInferior labial sulcus: XA52Q7\\nBuccal sulcus: XA6A73\\nSuperolateral buccal sulcus: XA6WJ3\\nInferolateral buccal sulcus: XA5MG3\\nGingivae: XA54T3\\nUpper gingiva: XA6743\\nUpper alveolar mucosa: XA2C94\\nUpper alveolar ridge mucosa: XA7DA0\\nLower gingiva: XA9303\\nLower alveolar mucosa: XA96F2\\nLower alveolar ridge mucosa: XA8C21\\nAlveolar mucosa: XA3SP9\\nTeeth: XA6CZ2\\nPermanent dentition: XA4GG3\\nUpper right rd molar: XA5306\\nUpper right nd molar: XA0BR9\\nUpper right st molar: XA0TL3\\nUpper right nd bicuspid: XA45K9\\nUpper right st bicuspid: XA64J5\\nUpper right canine: XA0LE1\\nUpper right \\xa0lateral incisor: XA3QH3\\nUpper right central incisor: XA43X2\\nUpper left rd molar: XA8328\\nUpper left nd molar: XA1YK1\\nUpper left st molar: XA2GW7\\nUpper left nd bicuspid: XA5Z15\\nUpper left st bicuspid: XA3EF6\\nUpper left canine: XA2LF2\\nUpper left \\xa0lateral incisor: XA0MG2\\nUpper left central incisor: XA9P69\\nLower right rd molar: XA8YF6\\nLower right nd molar: XA5CA4\\nLower right st molar: XA5M57\\nLower right nd bicuspid: XA26X2\\nLower right st bicuspid: XA47C4\\nLower right canine: XA95A1\\nLower right \\xa0lateral incisor: XA8660\\nLower right central incisor: XA5NT8\\nLower left rd molar: XA0XB1\\nLower left nd molar: XA8YV5\\nLower left st molar: XA6R23\\nLower left nd bicuspid: XA80S2\\nLower left st bicuspid: XA1SQ7\\nLower left canine: XA8P88\\nLower left \\xa0lateral incisor: XA4B13\\nLower left central incisor: XA7B54\\nDeciduous dentition: XA7675\\nUpper right nd molar deciduous: XA2GE5\\nUpper right st molar deciduous: XA7ZT9\\nUpper right canine deciduous: XA06P0\\nUpper right \\xa0lateral incisor deciduous: XA2XZ5\\nUpper right central incisor deciduous: XA3BG3\\nUpper left nd molar deciduous: XA2BD4\\nUpper left st molar deciduous: XA85K7\\nUpper left canine deciduous: XA98V8\\nUpper left lateral incisor deciduous: XA9QP7\\nUpper left central incisor deciduous: XA4ZQ5\\nLower right nd molar deciduous: XA6F50\\nLower right st molar deciduous: XA36B2\\nLower right canine deciduous: XA8KQ7\\nLower right \\xa0lateral incisor deciduous: XA1W31\\nLower right central incisor deciduous: XA6TB6\\nLower left nd molar deciduous: XA8NE2\\nLower left st molar deciduous: XA55D8\\nLower left canine deciduous: XA8QV7\\nLower left \\xa0lateral incisor deciduous: XA8MH6\\nLower left central incisor deciduous: XA2RW5\\nParts of tooth: XA1PT3\\nPulp: XA5B71\\nDentin: XA6FX3\\nEnamel: XA5R09\\nCementum: XA4KC7\\nPeriapical tissue: XA2CA1\\nSurfaces of the teeth: XA2US1\\nDistal surface of tooth: XA5ML5\\nLabial surface of tooth: XA4UP2\\nBuccal surface of tooth: XA6DE2\\nIncisal surface of tooth: XA3W20\\nLingual surface of tooth: XA8M68\\nMesial surface of tooth: XA5Z48\\nOcclusal surface of tooth: XA5DM8\\nProximal surface of tooth: XA3HD5\\nOral cavity: XA1WN1\\nPalate: XA7ZA6\\nHard palate: XA4527\\nSoft palate: XA8HL5\\nUvula: XA2993\\nPalatal mucosa: XA00H5\\nTongue: XA1T19\\nBody of tongue: XA8Q87\\nMidline of tongue: XA65E9\\nJunctional zone of tongue: XA8SX3\\nBase of tongue: XA25G3\\nPosterior of tongue: XA2B11\\nDorsal surface of tongue: XA1V27\\nDorsal surface of body of tongue: XA8YB9\\nDorsal surface of base of tongue: XA0HQ3\\nOther and unspecified parts of tongue: XA9RP1\\nVentral surface of tongue: XA8FK4\\nLingual frenulum: XA9YA2\\nBorder of tongue: XA4DB6\\nLateral margin of tongue: XA49C6\\nTip of tongue: XA1WZ8\\nFloor of mouth: XA8EY7\\nAlveololingual sulcus: XA69M6\\nMucosa of floor of mouth: XA8CF9\\nTonsillar region: XA29D3\\nGlossopalatine arch: XA9A13\\nAnterior tonsillar pillar: XA2JB0\\nTonsillar fossa: XA46Z4\\nPharyngopalatine arch: XA3021\\nPosterior tonsillar pillar: XA0X58\\nPalatine arch: XA15G1\\nOral mucosa: XA6NQ7\\nOther and unspecified parts of mouth: XA2KN0\\nSalivary gland apparatus: XA5T23\\nParotid gland: XA07S5\\nSubmandibular gland: XA9Q61\\nLeft submandibular gland: XA0CS1\\nRight submandibular gland: XA8GQ5\\nSubmandibular gland duct: XA7GY0\\nSublingual gland: XA51Q9\\nMinor salivary gland: XA30Q1\\nSalivary duct: XA5CM1\\nParotid gland duct: XA44X8\\nSublingual gland duct: XA1J93\\nPharynx: XA93V5\\nOropharynx: XA4J67\\nLateral wall of oropharynx: XA8RX5\\nPosterior wall of oropharynx: XA8659\\nVallecula: XA88V4\\nBranchial cleft: XA60Q5\\nHypopharynx: XA2J67\\nPiriform recess: XA3MZ0\\nPostcricoid region: XA4NZ9\\nHypopharyngeal wall: XA0XK1\\nGastrointestinal tract: XA9607\\nOesophagus: XA0828\\nUpper third of oesophagus: XA1180\\nMiddle third of oesophagus: XA2BY3\\nLower third of oesophagus: XA9CB6\\nCervical oesophagus: XA0N03\\nThoracic oesophagus: XA8JT3\\nAbdominal oesophagus: XA0TN5\\nOverlapping sites of oesophagus: XA4YW8\\nCardioesophageal junction: XA7SR6\\nStomach: XA7MC7\\nGastric cardia: XA2828\\nGastric corpus: XA7UE1\\nGastric fundus: XA56K7\\nGastric pylorus: XA6P89\\nPyloric antrum: XA4EC5\\nGreater curvature of stomach: XA7WQ5\\nLesser curvature of stomach: XA4ML9\\nSmall intestine: XA6452\\nDuodenum: XA9780\\nJejunum: XA8UM1\\nIleum: XA0QT6\\nLarge intestine: XA1B13\\nCaecum: XA6J68\\nColon: XA03U9\\nAscending colon: XA3AL5\\nHepatic flexure of colon: XA95L3\\nTransverse colon: XA49U1\\nSplenic flexure of colon: XA1PY9\\nDescending colon: XA2G13\\nSigmoid colon: XA8YJ9\\nRectosigmoid junction: XA33J5\\nDescending colon and splenic flexure of colon: XA7177\\nAscending colon and right flexure of colon: XA25P9\\nRectum: XA4KU2\\nAnus: XA0D34\\nAnal Canal: XA39S6\\nCloacogenic zone: XA8QB7\\nUpper gastrointestinal tract not elsewhere classified: XA28R6\\nAppendix: XA8PW4\\nHepatobiliary system: XA0W19\\nLiver: XA5DY0\\nLeft lobe of liver: XA5766\\nRight lobe of liver: XA2KG6\\nCaudate lobe of liver: XA3278\\nQuadrate lobe of liver: XA13D3\\nBiliary tract: XA0KT3\\nHepatic bile ducts: XA4415\\nLeft hepatic duct: XA89K4\\nRight hepatic duct: XA6M95\\nCommon hepatic duct: XA96K1\\nCystic duct: XA0077\\nGallbladder: XA8KL9\\nCommon bile duct: XA6R80\\nSphincter of Oddi: XA6WA8\\nAmpulla of Vater: XA7QA8\\nExtrahepatic bile duct: XA9HM5\\nPancreas: XA3QC5\\nHead of pancreas: XA1412\\nNeck of pancreas: XA8LA4\\nBody of pancreas: XA6ZE4\\nTail of pancreas: XA0CX6\\nPancreatic duct: XA1XL7\\nDuct of Santorini: XA8WC8\\nDuct of Wirsung: XA3789\\nPeritoneum: XA0KZ0\\nRetroperitoneum: XA6S21\\nMesentery: XA43V8\\nOmentum: XA6DF7\\nMesoappendix: XA46W1\\nMesocolon: XA4QM7\\nPelvic peritoneum: XA5PF4\\nSkin: XA0364\\nEpidermis: XA3JN1\\nStratum corneum: XA5P21\\nStratum lucidum: XA3G02\\nStratum granulosum: XA4W90\\nStratum spinosum: XA8AM6\\nStratum basale: XA9QS1\\nEpidermal basement membrane: XA8JE9\\nEpidermal appendages: XA8113\\nHair follicle: XA0XC8\\nHair bulb: XA2MW3\\nSebaceous gland: XA6666\\nApocrine sweat gland: XA7487\\nHair shaft: XA6DT2\\nHair: XA8T72\\nScalp hair: XA5Y68\\nEyebrow hairs: XA78D2\\nEyelashes: XA1RK2\\nBeard hair: XA9N28\\nBody hair: XA1WH2\\nPubic hair: XA12U4\\nNail apparatus: XA4S72\\nNail matrix: XA4KT3\\nGerminal matrix: XA5LM0\\nSterile matrix: XA0060\\nNail: XA6Q52\\nPerionychium: XA5US0\\nEponychium: XA1ES4\\nHyponychium: XA0NS1\\nEccrine gland: XA63U7\\nAcrosyringium: XA6PJ1\\nEccrine sweat duct: XA7P52\\nEccrine sweat coil: XA5VA9\\nDermis: XA1QT7\\nPapillary dermis: XA4LG9\\nReticular dermis: XA2Q30\\nHypodermis: XA2013\\nSubcutaneous fat: XA5CS6\\nAxial skeleton: XA4S38\\nBones of the head: XA4RY5\\nCranial Bones: XA1RZ4\\nBase of the skull: XA0E94\\nCalvarium: XA2BH0\\nCranial fossa: XA0KU6\\nAnterior fossa: XA7B66\\nMiddle fossa: XA8Y22\\nPosterior fossa: XA5U78\\nEthmoid bone: XA2SR4\\nFrontal bone: XA6ZM9\\nOccipital bone: XA5JA2\\nOccipital condyle: XA4RS9\\nOcciput: XA33W1\\nParietal bone: XA2J87\\nSphenoid bone: XA63R0\\nPituitary fossa: XA9N34\\nTemporal bone: XA2P19\\nPetrous bone: XA1E15\\nMastoid: XA68N3\\nOrbital bone: XA8E69\\nOrbital roof: XA9XW3\\nOrbital floor: XA7MW9\\nFacial bones: XA3Y16\\nHyoid bone: XA5CQ0\\nInferior nasal conchae: XA6UV6\\nLacrimal bone: XA9GZ6\\nPalatine bone: XA4319\\nVomer bone: XA14T2\\nZygomatic bone: XA8N32\\nMandible: XA51B7\\nAlveolar border of body of mandible: XA3B77\\nAngle of mandible: XA0M61\\nCondylar process of the mandible: XA98M7\\nSubcondylar process of mandible: XA7919\\nCoronoid process of the mandible: XA24B3\\nRamus of mandible: XA5969\\nSymphysis of mandible: XA8JR9\\nInferior maxilla: XA0NC8\\nMaxilla: XA7VK5\\nNasal bone: XA8E16\\nJaw unspecified: XA88P5\\nBones of middle ear: XA6EQ1\\nIncus: XA4D04\\nMalleus: XA5DS8\\nStapes: XA3WA4\\nVertebral column: XA5J55\\nVertebra: XA7MS2\\nCervical vertebra: XA9ZW8\\nAtlas: XA2XE8\\nPosterior arch of first cervical vertebra: XA0KQ4\\nLateral mass of first cervical vertebra: XA1304\\nAxis: XA17N0\\nOdontoid process: XA5W02\\nThird cervical vertebra: XA2W05\\nArch of third cervical vertebra: XA51V4\\nBody of third cervical vertebra: XA4UV1\\nProcesses of third cervical vertebra: XA8CG0\\nFourth cervical vertebra: XA3RE9\\nArch of fourth cervical vertebra: XA24X7\\nBody of fourth cervical vertebra: XA3GT0\\nProcesses of fourth cervical vertebra: XA75V3\\nFifth cervical vertebra: XA9C12\\nArch of fifth cervical vertebra: XA1PJ5\\nBody of fifth cervical vertebra: XA1BS2\\nProcesses of fifth cervical vertebra: XA2FY7\\nSixth cervical vertebra: XA5S79\\nArch of sixth cervical vertebra: XA8W16\\nBody of sixth cervical vertebra: XA9Q12\\nProcesses of sixth cervical vertebra: XA60Z0\\nSeventh cervical vertebra: XA34U8\\nArch of seventh cervical vertebra: XA05M5\\nBody of seventh cervical vertebra: XA1JS3\\nProcesses of seventh cervical vertebra: XA91D7\\nThoracic vertebra: XA6E88\\nFirst thoracic vertebra: XA3F93\\nArch of first thoracic vertebra: XA7UP5\\nBody of first thoracic vertebra: XA8PH0\\nProcesses of first thoracic vertebra: XA1AX4\\nSecond thoracic vertebra: XA8QS0\\nArch of second thoracic vertebra: XA2VV9\\nBody of second thoracic vertebra: XA3Z42\\nProcesses of second thoracic vertebra: XA6T61\\nThird thoracic vertebra: XA1Z15\\nArch of third thoracic vertebra: XA2SM3\\nBody of third thoracic vertebra: XA35A0\\nProcesses of third thoracic vertebra: XA41U9\\nFourth thoracic vertebra: XA0C31\\nArch of fourth thoracic vertebra: XA22W3\\nBody of fourth thoracic vertebra: XA3J42\\nProcesses of fourth thoracic vertebra: XA1WL4\\nFifth thoracic vertebra: XA3PH5\\nArch of fifth thoracic vertebra: XA28A7\\nBody of fifth thoracic vertebra: XA8W59\\nProcesses of fifth thoracic vertebra: XA0449\\nSixth thoracic vertebra: XA45S2\\nArch of sixth thoracic vertebra: XA29X2\\nBody of sixth thoracic vertebra: XA0YY2\\nProcesses of sixth thoracic vertebra: XA1R53\\nSeventh thoracic vertebra: XA59Y3\\nArch of seventh thoracic vertebra: XA54G1\\nBody of seventh thoracic vertebra: XA62Y3\\nProcesses of seventh thoracic vertebra: XA1CQ7\\nEighth thoracic vertebra: XA8NQ5\\nArch of eighth thoracic vertebra: XA3PL7\\nBody of eighth thoracic vertebra: XA5JX9\\nProcesses of eighth thoracic vertebra: XA1SD8\\nNinth thoracic vertebra: XA3E70\\nArch of ninth thoracic vertebra: XA9N69\\nBody of ninth thoracic vertebra: XA2X21\\nProcesses of ninth thoracic vertebra: XA5SW1\\nTenth thoracic vertebra: XA0AV7\\nArch of tenth thoracic vertebra: XA7LF7\\nBody of tenth thoracic vertebra: XA6VP6\\nProcesses of tenth thoracic vertebra: XA7122\\nEleventh thoracic vertebra: XA7T69\\nArch of eleventh thoracic vertebra: XA98R9\\nBody of eleventh thoracic vertebra: XA91J0\\nProcesses of eleventh thoracic vertebra: XA92Q6\\nTwelfth thoracic vertebra: XA69W5\\nArch of twelfth thoracic vertebra: XA15N3\\nBody of twelfth thoracic vertebra: XA1401\\nProcesses of twelfth thoracic vertebra: XA2D62\\nLumbar vertebra: XA0D60\\nFirst lumbar vertebra: XA3291\\nArch of first lumbar vertebra: XA8AX7\\nBody of first lumbar vertebra: XA9E61\\nProcesses of first lumbar vertebra: XA4U01\\nSecond lumbar vertebra: XA2GH9\\nArch of second lumbar vertebra: XA24M1\\nBody of second lumbar vertebra: XA5079\\nProcesses of second lumbar vertebra: XA52T1\\nThird lumbar vertebra: XA3N97\\nArch of third lumbar vertebra: XA3G24\\nBody of third lumbar vertebra: XA0TL0\\nProcesses of third lumbar vertebra: XA80X7\\nFourth lumbar vertebra: XA9A53\\nArch of fourth lumbar vertebra: XA7CH7\\nBody of fourth lumbar vertebra: XA4145\\nProcesses of fourth lumbar vertebra: XA38A4\\nFifth lumbar vertebra: XA9641\\nArch of fifth lumbar vertebra: XA2JV2\\nBody of fifth lumbar vertebra: XA5886\\nProcesses of fifth lumbar vertebra: XA4PS3\\nSacrum: XA14W3\\nCoccyx: XA4V28\\nIntervertebral disc or space: XA02R1\\nCervical discs or space: XA8D30\\nCervical intervertebral disc or space CC: XA16L1\\nCervicothoracic disc or space CT: XA2SG0\\nThoracic discs or space: XA1N54\\nThoracic intervertebral disc or space TT: XA5LG2\\nThoracolumbar intervertebral disc or space TL: XA97A4\\nLumbar discs or space: XA54S5\\nLumbar intervertebral disc or space LL: XA2N96\\nLumbosacral intervertebral disc or space LS: XA54R2\\nIntervertebral disc: XA2Y58\\nNucleus pulposus: XA8WM9\\nAnnulus fibrosus: XA10M1\\nBones of the thorax: XA5VB6\\nRib: XA5TK7\\nFirst rib: XA98Q1\\nSecond rib: XA7XY2\\nThird rib: XA2U21\\nFourth rib: XA4SQ6\\nFifth rib: XA31L8\\nSixth rib: XA63Z2\\nSeventh rib: XA2WC3\\nEighth rib: XA9WQ3\\nNinth rib: XA31V8\\nTenth rib: XA54R4\\nEleventh rib: XA3VH4\\nTwelfth rib: XA6W52\\nSternum: XA6NB3\\nBody of sternum: XA3M45\\nManubrium: XA0K13\\nXiphoid: XA2RB7\\nBones of the pelvis: XA4N47\\nPelvis: XA8Y23\\nIlium: XA5FT5\\nIliac crest: XA4743\\nIschium: XA5L47\\nPubis: XA82W3\\nSuperior pubic ramus: XA1XZ3\\nInferior pubic ramus: XA4VB9\\nAcetabulum: XA6Z32\\nPeripheral skeleton: XA4TM1\\nBones of the upper extremity: XA7R53\\nBones of the shoulder girdle: XA2AL0\\nClavicle: XA6384\\nSternal end of clavicle: XA76N8\\nShaft of the clavicle: XA4PT6\\nAcromial end of clavicle: XA09P2\\nScapula: XA53X6\\nNeck of the scapula: XA2HS8\\nGlenoid cavity of the scapula: XA1216\\nCoracoid process of the scapula: XA2Y48\\nAcromion: XA3664\\nHumerus: XA2XL4\\nHead of the humerus: XA4VY5\\nAnatomical neck of the humerus: XA0XN0\\nSurgical neck of the humerus: XA6FR2\\nGreater tuberosity of the humerus: XA7144\\nLesser tuberosity of the humerus: XA72X2\\nShaft of the humerus: XA4RN8\\nCondyle of the humerus: XA3RE0\\nCapitulum of humerus: XA11M8\\nTrochlea of humerus: XA9LK4\\nLateral epicondyle of the humerus: XA6EF8\\nMedial epicondyle of the humerus: XA4097\\nRadius: XA3WG1\\nRadial head: XA2N25\\nRadial neck: XA0ZF7\\nShaft of radius: XA35U4\\nRadial groove: XA6YE5\\nStyloid process of radius: XA3MH2\\nLower end of radius not otherwise specified: XA4X32\\nUpper end of radius not otherwise specified: XA76U7\\nUlna: XA5007\\nCoronoid process of the ulna: XA0NS5\\nLower end of ulna not otherwise specified: XA0725\\nOlecranon process of the ulna: XA5VA1\\nShaft of the ulna: XA8U33\\nStyloid process of the ulna: XA05C5\\nUpper end of ulna not otherwise specified: XA6SV9\\nCarpal\\xa0bones: XA09H2\\nScaphoid bone: XA7480\\nDistal pole of scaphoid: XA8E71\\nDistal third of the scaphoid bone: XA1GV4\\nMiddle third of the scaphoid bone: XA3ZG5\\nProximal third of the scaphoid bone: XA5ZE5\\nLunate bone: XA30C8\\nTriquetrum bone: XA4A64\\nPisiform bone: XA8SZ6\\nTrapezium bone: XA7XM2\\nTrapezoid bone: XA9DH2\\nCapitate bone: XA06T2\\nHamate bone: XA8488\\nHook of hamate: XA97A0\\nCarpal tunnel: XA0GJ4\\nBase of other carpal bone: XA22M5\\nNeck of other carpal bone: XA9640\\nShaft of other carpal bone: XA5TX9\\nMetacarpal bone: XA3YX4\\nFirst metacarpal: XA58X4\\nHead of the first metacarpal bone: XA12D2\\nNeck of the first metacarpal bone: XA8J87\\nShaft of the first metacarpal bone: XA5N95\\nBase of the first metacarpal bone: XA2P67\\nSecond metacarpal: XA5HE0\\nHead of the second metacarpal bone: XA93C5\\nNeck of the second metacarpal bone: XA8KU0\\nShaft of the second metacarpal bone: XA4RC8\\nBase of the second metacarpal bone: XA37V2\\nThird metacarpal: XA7J93\\nHead of the third metacarpal bone: XA6442\\nNeck of the third metacarpal bone: XA50H4\\nShaft of the third metacarpal bone: XA8BP2\\nBase of the third metacarpal bone: XA8NK6\\nFourth metacarpal: XA9KB7\\nHead of the fourth metacarpal bone: XA8X42\\nNeck of the fourth metacarpal bone: XA9NT7\\nShaft of the fourth metacarpal bone: XA4CP7\\nBase of the fourth metacarpal bone: XA3ZF8\\nFifth metacarpal: XA88S1\\nHead of the fifth metacarpal bone: XA3Z46\\nNeck of the fifth metacarpal bone: XA16Y6\\nShaft of the fifth metacarpal bone: XA92G8\\nBase of the fifth metacarpal bone: XA65Y7\\nPhalanx of the hand: XA3PA7\\nProximal phalanx of the hand: XA0HH1\\nProximal phalanx of index finger: XA25U2\\nProximal phalanx of middle finger: XA6ET0\\nProximal phalanx of ring finger: XA9MR0\\nProximal phalanx of little finger: XA73Q6\\nProximal phalanx of thumb: XA0903\\nMiddle phalanx of hand: XA89G7\\nMiddle phalanx of index finger: XA3JL6\\nMiddle phalanx of middle finger: XA5910\\nMiddle phalanx of ring finger: XA8N14\\nMiddle phalanx of little finger: XA6HX0\\nDistal phalanx of the hand: XA7LS3\\nDistal phalanx of index finger: XA54X0\\nDistal phalanx of middle finger: XA8NR0\\nDistal phalanx of ring finger: XA51S6\\nDistal phalanx of little finger: XA32G6\\nDistal phalanx of thumb: XA70H5\\nBone of finger not elsewhere classified: XA5D87\\nBone of thumb not elsewhere classified: XA95Q5\\nBones of the lower extremity: XA2T04\\nFemur: XA6BA0\\nFemoral head: XA96S5\\nFemoral neck: XA1673\\nTrochanter: XA32G0\\nGreater trochanter of femur: XA1VJ3\\nLesser trochanter of femur: XA9TD9\\nIntertrochanteric crest of femur: XA9JB2\\nFemoral shaft: XA4AF2\\nFemoral condyle: XA6UG0\\nFemoral epiphysis: XA2BJ0\\nPertrochanter: XA00N4\\nSubtrochanteric line of femur: XA5EL8\\nPatella: XA4T36\\nTibia: XA44U1\\nTibial condyle: XA5RE8\\nLateral condyle of tibia: XA87A0\\nMedial condyle of tibia: XA7Y69\\nTibial tuberosity: XA3DL5\\nTibial shaft: XA66B3\\nTibial spine: XA2EN5\\nMedial malleolus: XA1HS9\\nPosterior malleolus: XA3450\\nFibula: XA3KT5\\nFibular head: XA0K77\\nFibular shaft: XA5G97\\nLateral malleolus: XA4UL1\\nTarsal\\xa0bone: XA7NN4\\nCalcaneus: XA5LU2\\nAnterior process of calcaneus: XA57V1\\nTuberosity of calcaneus: XA62P4\\nTalus: XA1LF4\\nDome of the talus: XA1N98\\nNeck of the talus: XA6L02\\nPosterior process of the talus: XA3MT9\\nNavicular bone: XA84E6\\nMedial cuneiform bone: XA4J74\\nIntermediate cuneiform bone: XA4046\\nLateral cuneiform bone: XA8462\\nCuboid bone: XA0LW4\\nBone of ankle: XA43L9\\nTarsal canal: XA6UL8\\nMetatarsal\\xa0bone: XA6VH2\\nPhalanx of the foot: XA39M2\\nProximal phalanx\\xa0of the toe: XA6U96\\nProximal phalanx of great toe: XA8KC3\\nProximal phalanx of second toe: XA0AQ0\\nProximal phalanx of third toe: XA11P1\\nProximal phalanx of fourth toe: XA8CX6\\nProximal phalanx of fifth toe: XA8PK1\\nMiddle phalanx of toe: XA8539\\nMiddle phalanx of second toe: XA1UN2\\nMiddle phalanx of third toe: XA9YP5\\nMiddle phalanx of fourth toe: XA2SX4\\nMiddle phalanx of fifth toe: XA90F0\\nDistal phalanx\\xa0of the toe: XA4352\\nDistal phalanx of great toe: XA2AC2\\nDistal phalanx of second toe: XA3QM7\\nDistal phalanx of third toe: XA38Q1\\nDistal phalanx of fourth toe: XA8XV0\\nDistal phalanx of fifth toe: XA6ED4\\nJoints and ligaments of the head and neck: XA7948\\nJoints of the head: XA6UT2\\nAtlantooccipital joint: XA65F2\\nAtlantoaxial joint: XA7EM1\\nTemporomandibular joint: XA2SM2\\nLigaments of the head and neck: XA1LE7\\nAnterior atlantoaxial ligament: XA68Z9\\nAnterior atlantooccipital ligament: XA4XK9\\nAnterior longitudinal ligament: XA9F16\\nApical odontoid ligament: XA3K95\\nArticular capsules: XA3XV5\\nInterarticular ligament: XA3ZW3\\nInterspinal ligament: XA9M15\\nIntertransverse ligament: XA9NZ1\\nIntervertebral fibrocartilage ligament: XA5180\\nLateral atlantooccipital ligament: XA97L7\\nLigamenta flava: XA72L3\\nLigamentum nuchae: XA6RG7\\nOccipitoaxial ligament: XA3J99\\nPosterior atlantoaxial ligament: XA1CC5\\nPosterior atlantooccipital ligament: XA80K5\\nPosterior longitudinal ligament: XA8E20\\nSphenomandibular ligament: XA4FR7\\nStylomandibular ligament: XA4WM3\\nSupraspinal ligament: XA7WU3\\nTemporomandibular ligament: XA4WJ7\\nTransverse ligament of the atlas: XA8389\\nThyrohyoid ligament: XA33F9\\nCricoarytenoid ligament: XA9XG3\\nCricopharyngeal ligament: XA6B16\\nCricotracheal ligament: XA3BV9\\nHyoepiglottic ligament: XA3JR5\\nCricothyroid ligament: XA4051\\nThyroepiglottic ligament: XA56S4\\nVestibular ligament: XA4KB2\\nVocal ligament: XA6928\\nJoints and ligaments of the thorax: XA2EL4\\nJoints of the thorax: XA2NG8\\nSternocostal joint: XA83N6\\nCostochondral joint: XA30Q4\\nCostovertebral joint: XA0892\\nCostotransverse joint: XA7AR2\\nFacet joint: XA0ZE4\\nLigaments of the thorax: XA2UN9\\nAnterior costotransverse ligament: XA70E9\\nAnterior intersternal ligament: XA0QM2\\nAnterior ligament of the spine: XA8V32\\nCostotransverse ligament: XA5G44\\nCostoxiphoid ligament: XA2S05\\nIliolumbar ligament: XA4356\\nInterarticular sternocostal ligament: XA70A1\\nInterchondral ligament: XA8D15\\nLigament of the neck of the rib: XA6ZD7\\nLigament of the tubercle of the rib: XA81P3\\nPosterior costotransverse ligament: XA4A37\\nLumbocostal ligament: XA8B33\\nPosterior intersternal ligament: XA26A7\\nRadiate ligament: XA8RC0\\nRadiate sternocostal ligament: XA43Z7\\nJoints and ligaments of the pelvis and perineum: XA6KC7\\nJoints of the pelvis: XA1TL5\\nLumbosacral joint: XA5A04\\nSacrococcygeal joint: XA70B6\\nSacroiliac joint: XA3T32\\nLigaments of the pelvis and perineum: XA9TF3\\nAnterior pubic ligament: XA5S21\\nAnterior sacroiliac ligament: XA10C4\\nArcuate pubic ligament: XA9621\\nBroad ligament of the uterus: XA0EJ9\\nMesovarium: XA6VF6\\nParovarian region: XA9TX2\\nMesosalpinx: XA6CV1\\nMesometrium: XA3AN2\\nInterarticular ligament of the pelvis: XA46Z2\\nInterosseous sacroiliac ligament: XA02T6\\nLigamentum teres of the Liver: XA1NT7\\nPosterior pubic ligament: XA92G5\\nPosterior sacroiliac ligament: XA6RS4\\nLong posterior sacroiliac ligament: XA69U0\\nShort posterior sacroiliac ligament: XA9HV6\\nPubic symphysis: XA1UP6\\nRound ligament of uterus: XA23X3\\nSacrococcygeal ligament: XA8GZ2\\nAnterior sacrococcygeal ligament: XA2MA4\\nLateral sacrococcygeal ligament: XA4B16\\nPosterior sacrococcygeal ligament: XA2U92\\nSacrospinous ligament: XA8J68\\nSacrotuberous ligament: XA6396\\nSuperior pubic ligament: XA68K7\\nUterine ligament: XA4T57\\nUterosacral ligament: XA2NB2\\nJoints and ligaments of the upper extremity: XA4XC0\\nJoints of the upper extremity: XA4U90\\nShoulder joint: XA05J7\\nGlenohumeral joint: XA49P8\\nAcromioclavicular joint: XA69U6\\nSternoclavicular joint: XA0CH1\\nElbow joint: XA69H4\\nProximal radioulnar joint: XA3G42\\nHumeroulnar joint: XA46J3\\nHumeroradial joint: XA53P1\\nWrist joint: XA64C3\\nDistal radioulnar joint: XA78S6\\nRadiocarpal joint: XA0P38\\nJoints of the hand: XA62V5\\nCarpal joint: XA3MB4\\nIntercarpal joint: XA0E90\\nMidcarpal joint: XA4AS7\\nCarpometacarpal joint: XA0JX0\\nIntermetacarpal joint: XA9DN6\\nMetacarpophalangeal joint: XA86T5\\nFirst metacarpophalangeal joint: XA3M83\\nSecond metacarpophalangeal joint: XA9YH1\\nThird metacarpophalangeal joint: XA6HB0\\nFourth metacarpophalangeal joint: XA7XA8\\nFifth metacarpophalangeal joint: XA7KA0\\nInterphalangeal joint of the hand: XA9291\\nInterphalangeal joint of the thumb: XA6L43\\nProximal interphalangeal joint of finger: XA1307\\nProximal interphalangeal joint of index finger: XA1DN6\\nProximal interphalangeal joint of middle finger: XA3NW6\\nProximal interphalangeal joint of ring finger: XA0BF5\\nProximal interphalangeal joint of little finger: XA4175\\nDistal interphalangeal joint of finger: XA4U75\\nDistal interphalangeal joint of index finger: XA6KB0\\nDistal interphalangeal joint of middle finger: XA15C8\\nDistal interphalangeal joint of ring finger: XA0LT5\\nDistal interphalangeal joint of little finger: XA1928\\nLigaments of the upper extremity: XA4BC2\\nLigament of the shoulder: XA93X9\\nAcromioclavicular ligament: XA2H23\\nInferior acromioclavicular ligament: XA49Z7\\nSuperior acromioclavicular ligament: XA8RC9\\nAnterior ligament of the shoulder: XA01C8\\nAnterior sternoclavicular ligament: XA2JQ3\\nCoracoacromial ligament: XA8MA3\\nCoracoclavicular ligament: XA9WP5\\nConoid ligament: XA4PU7\\nTrapezoid ligament: XA5SJ7\\nCoracohumeral ligament: XA5EW9\\nCostoclavicular ligament: XA1PK9\\nGlenohumeral ligament: XA8H81\\nGlenoidal labrum ligament: XA5Z24\\nInterclavicular ligament: XA84L3\\nPosterior sternoclavicular ligament: XA3PT9\\nRotator cuff capsule: XA6EG3\\nSpinoglenoid ligament: XA6EE7\\nSuprascapular ligament: XA5MU7\\nTransverse humeral ligament: XA9C92\\nLigament of the elbow: XA5Y12\\nAnnular ligament: XA0JJ8\\nLigament of Struthers: XA4S76\\nPosterior ligament of elbow: XA16Y4\\nQuadrate ligament: XA8B40\\nRadial collateral ligament: XA9WJ8\\nUlnar collateral ligament: XA9220\\nInterosseous membrane of forearm: XA6SA0\\nLigament of the wrist and hand: XA9Y28\\nCollateral carpal ligament: XA9MY7\\nCollateral metacarpophalangeal ligament: XA0K88\\nDorsal carpometacarpal ligament: XA20K5\\nDorsal intercarpal ligament: XA0PE4\\nDorsal intermetacarpal ligament: XA0WZ1\\nDorsal metacarpophalangeal ligament: XA2PN5\\nDorsal radiocarpal ligament: XA7Q52\\nInterosseous ligament: XA52E8\\nPalmar aponeurosis: XA10U4\\nPisohamate ligament: XA1Z72\\nPisometacarpal ligament: XA3VJ3\\nRadioulnar ligament: XA0PY0\\nDorsal radioulnar ligament: XA4396\\nVolar radioulnar ligament: XA2940\\nTransverse metacarpal ligament: XA3SZ9\\nUlnocarpal ligament: XA3K32\\nVolar carpometacarpal ligament: XA1PU7\\nVolar intercarpal ligaments: XA47N4\\nVolar intermetacarpal ligament: XA1LF5\\nVolar metacarpophalangeal ligament: XA3VN5\\nVolar radiocarpal ligament: XA0492\\nJoints and ligaments of the lower extremity: XA5ST4\\nJoints of lower extremity: XA7L41\\nHip joint: XA4XS4\\nKnee joint: XA8RL1\\nTibiofemoral joint: XA0LC4\\nPatellofemoral joint: XA0VJ4\\nProximal tibiofibular joint: XA0LG3\\nSemilunar cartilage: XA8VV2\\nAnkle joint: XA27P3\\nTalocrural joint: XA8MM7\\nDistal tibiofibular joint: XA2K81\\nSubtalar joint: XA7SZ8\\nJoint of the foot: XA22T0\\nIntertarsal joint: XA2YS1\\nCalcaneocuboid joint: XA4JJ1\\nTalocalcaneonavicular joint: XA0WY5\\nCuneonavicular joint: XA6NT7\\nCuboideonavicular joint: XA1N77\\nIntercuneiform joint: XA9SD1\\nCuneocuboid joint: XA2FA3\\nTarsometatarsal joint: XA2MY1\\nIntermetatarsal joint: XA6FF3\\nMetatarsophalangeal joint: XA8XU1\\nFirst metatarsophalangeal joint: XA7NJ7\\nSecond metatarsophalangeal joint: XA58K5\\nThird metatarsophalangeal joint: XA2792\\nFourth metatarsophalangeal joint: XA7QC6\\nFifth metatarsophalangeal joint: XA5A23\\nInterphalangeal joint of the foot: XA04T7\\nInterphalangeal joint of great toe: XA87P9\\nProximal interphalangeal joint of the foot: XA5573\\nProximal interphalangeal joint of second toe: XA56K9\\nProximal interphalangeal joint of third toe: XA2QY2\\nProximal interphalangeal joint of fourth toe: XA2R87\\nProximal interphalangeal joint of fifth toe: XA1LM0\\nDistal interphalangeal joint of the foot: XA0RK3\\nDistal interphalangeal joint of second toe: XA8UM5\\nDistal interphalangeal joint of third toe: XA43F0\\nDistal interphalangeal joint of fourth toe: XA8NU9\\nDistal interphalangeal joint of fifth toe: XA39U1\\nTransverse tarsal joint: XA9Z55\\nLigaments of the lower extremity: XA7U26\\nLigament of the hip: XA1A66\\nIliofemoral ligament: XA1F23\\nIliotibial ligament: XA6KC6\\nIliotrochanteric ligament: XA6TZ6\\nIschiocapsular ligament: XA5HX9\\nLigamentum teres femoris: XA13S4\\nPubofemoral ligament: XA3GE8\\nTransverse acetabular ligament: XA9J44\\nLigament of the knee: XA8P38\\nAnterior cruciate ligament: XA0ZC8\\nCoronary ligament: XA04S7\\nFibular collateral ligament: XA4YJ0\\nLateral meniscus of knee joint: XA6HQ4\\nOblique popliteal ligament: XA87R6\\nPatellar ligament: XA3772\\nPosterior cruciate ligament: XA4635\\nTibial collateral ligament: XA7LD2\\nTransverse ligament of the knee: XA71L7\\nMedial meniscus of knee joint: XA7LB6\\nLigament of the ankle or foot: XA2F70\\nAnterior inferior ligament: XA93X1\\nAnterior talofibular ligament: XA84J2\\nAnterior tibiofibular ligament: XA1259\\nBifurcated ligament: XA5EY2\\nCalcaneofibular ligament: XA3154\\nCollateral ligament of the foot: XA59Z4\\nCuneometatarsal ligament: XA2314\\nDeltoid ligament: XA9YS6\\nDorsal calcaneocuboid ligament: XA42X4\\nDorsal cuboideonavicular ligament: XA6Q67\\nDorsal intermetatarsal ligament: XA3TS2\\nDorsal naviculocuneiform ligament: XA8NU3\\nDorsal talonavicular ligament: XA86X4\\nDorsal tarsometatarsal ligament: XA9E13\\nInferior transverse ligament of ankle: XA2FV7\\nIntercuneiform ligament: XA16V1\\nDorsal intercuneiform ligament: XA7075\\nPlantar intercuneiform ligament: XA5HQ7\\nInterosseous talocalcaneal ligament: XA4XJ2\\nLong plantar ligament: XA6NS2\\nPlantar accessory ligament: XA59U6\\nPlantar aponeurosis: XA87B0\\nPlantar calcaneocuboid ligament: XA4N86\\nPlantar calcaneonavicular ligament: XA5KN3\\nPlantar cuboideonavicular ligament: XA2NX5\\nPlantar intermetatarsal ligament: XA18T4\\nPlantar naviculocuneiform ligament: XA1747\\nPlantar tarsometatarsal ligament: XA71L9\\nPosterior inferior ligament: XA2D55\\nPosterior talofibular ligament: XA93E6\\nPosterior tibiofibular ligament: XA6RA3\\nTalocalcaneal ligament: XA6546\\nAnterior talocalcaneal ligament: XA93N5\\nLateral talocalcaneal ligament: XA4VX8\\nMedial talocalcaneal ligament: XA09E2\\nPosterior talocalcaneal ligament: XA60T4\\nTransverse metatarsal ligament: XA5BX0\\nLigaments and joints of multiple sites: XA2P74\\nMultiple Joints: XA4EJ6\\nOligoarticular: XA1CK9\\nPolyarticular: XA3FU7\\nMultiple large joints only: XA02P3\\nMultiple small joints only: XA2SK7\\nBoth large and small joints: XA3BZ3\\nLarge joints only with cervical spine or temporomandibular involvement: XA5X22\\nMonoarticular: XA4BF0\\nMultiple ligaments: XA5XD5\\nSingle ligament: XA5NN2\\nElastic cartilage: XA8YS7\\nFibrous cartilage: XA8VH7\\nHyaline cartilage: XA2686\\nArticular cartilage: XA3NV3\\nCostal cartilage: XA6958\\nMuscles of the head and neck: XA2JQ8\\nAlaeque nasi muscle: XA2SJ6\\nAnterior auricularis muscle: XA2QF2\\nAryepiglotticus muscle: XA3SS4\\nBuccinator muscle: XA8GG0\\nConstrictor of pharynx inferior muscle: XA0UH6\\nConstrictor of pharynx middle muscle: XA3S80\\nConstrictor of pharynx superior muscle: XA9568\\nCorrugator supercilii muscle: XA01U4\\nCricothyroid muscle: XA7W64\\nDepressor anguli oris muscle: XA04G0\\nDepressor labii inferioris muscle: XA60C8\\nDigastric muscle: XA2967\\nFrontalis muscle: XA09D1\\nGenioglossus muscle: XA50R5\\nGeniohyoid muscle: XA5YU7\\nHyoglossus muscle: XA5DX5\\nHyoid muscle: XA3PY5\\nInferior oblique muscle: XA4N79\\nInferior rectus muscle: XA1X67\\nIntrinsic muscles of tongue: XA31C3\\nLateral cricoarytenoid muscle: XA5WQ9\\nLateral pterygoid muscle: XA8ZB7\\nLateral rectus muscle: XA3282\\nLevator anguli oris muscle: XA75X0\\nLevator labii superioris muscle: XA1490\\nLevator palpebrae superioris muscle: XA2R46\\nLevator veli palatini muscle: XA5LP4\\nLongus capitis muscle: XA6YE6\\nLongus colli muscle: XA8EM8\\nMasseter muscle: XA2VD8\\nMedial pterygoid muscle: XA2DX4\\nMedial rectus muscle: XA95N1\\nMentalis muscle: XA0U25\\nMusculus uvulae muscle: XA8AR7\\nMylohyoid muscle: XA83A9\\nNasalis muscle: XA0Y41\\nOblique arytenoid muscle: XA59J0\\nOblique auricularis muscle: XA8L72\\nObliquus capitis inferior muscle: XA6LS5\\nObliquus capitis superior muscle: XA0X13\\nOmohyoid muscle: XA4RN7\\nOrbicularis oculi muscle: XA0ZM1\\nOrbicularis oris muscle: XA55R2\\nPalatoglossus muscle: XA2U72\\nPalatopharyngeus muscle: XA1PG4\\nPlatysma muscle: XA17T6\\nPosterior auricularis muscle: XA8C48\\nPosterior cricoarytenoid muscle: XA9RS8\\nProcerus muscle: XA6648\\nRectus capitis anterior muscle: XA16A4\\nRectus capitis lateralis muscle: XA0JK2\\nRectus capitis posterior major muscle: XA20Q8\\nRectus capitis posterior minor muscle: XA80F2\\nRisorius muscle: XA49A7\\nSalpingopharyngeus muscle: XA81P5\\nScalenus anterior muscle: XA0JF1\\nScalenus medius muscle: XA6S71\\nScalenus minimus muscle: XA3TF5\\nScalenus posterior muscle: XA35K5\\nSplenius capitis muscle: XA58T9\\nSplenius cervicis muscle: XA6095\\nStapedius muscle: XA8D61\\nSternocleidomastoid muscle: XA2H61\\nSternohyoid muscle: XA5QR5\\nSternothyroid muscle: XA9H91\\nStyloglossus muscle: XA5L15\\nStylohyoid muscle: XA1TY3\\nStylopharyngeus muscle: XA9AM5\\nSuperior auricularis muscle: XA8SW4\\nSuperior oblique muscle: XA2X27\\nSuperior rectus muscle: XA51R1\\nTemporalis muscle: XA01H9\\nTemporoparietalis muscle: XA1CQ1\\nTensor tympani muscle: XA42R7\\nTensor veli palatini muscle: XA7LF2\\nThyroarytenoid muscle: XA8352\\nThyroepiglotticus muscle: XA2ZL4\\nThyrohyoid muscle: XA87S0\\nTransverse arytenoid muscle: XA3856\\nTransverse auricularis muscle: XA9AU8\\nVocalis muscle: XA0M12\\nZygomaticus major muscle: XA37U4\\nZygomaticus minor muscle: XA2AP2\\nMuscle of the thorax: XA19W0\\nDiaphragm: XA2JL0\\nExternal intercostal muscle: XA6RW0\\nInnermost intercostal muscle: XA3P12\\nInternal intercostal muscle: XA1256\\nLevator costarum muscle: XA7NL0\\nPectoralis major muscle: XA1QH6\\nPectoralis minor muscle: XA0SB2\\nSerratus anterior muscle: XA7QL8\\nSubcostalis muscle: XA44Y8\\nTransversus thoracis muscle: XA3G64\\nMuscle of the abdomen: XA8PG5\\nExternal oblique abdominis muscle: XA3TW8\\nInternal oblique abdominis muscle: XA9B36\\nPsoas major muscle: XA43E9\\nPsoas minor muscle: XA7DA1\\nPyramidalis muscle: XA6AY9\\nQuadratus lumborum muscle: XA1GP3\\nRectus abdominis muscle: XA1N65\\nTransversus abdominis muscle: XA9FR3\\nMuscle of the back: XA8Z76\\nIliocostalis muscle: XA19S9\\nInterspinales muscle: XA8YU1\\nIntertransversarii muscle: XA02Z7\\nLatissimus dorsi muscle: XA9AG9\\nLevator scapulae muscle: XA00C1\\nLongissimus muscle: XA6MB7\\nMultifidus muscle: XA8512\\nRhomboid major muscle: XA25S1\\nRhomboid minor muscle: XA5GH5\\nRotatores muscle: XA76Q0\\nSemispinalis muscle: XA60Q0\\nSerratus posterior inferior muscle: XA4A47\\nSerratus posterior superior muscle: XA15B6\\nSpinalis muscle: XA0U57\\nTeres major muscle: XA7RM2\\nTrapezius muscle: XA86Q8\\nMuscles of the pelvis and perineum: XA2J71\\nBulbospongiosus muscle: XA2E07\\nCremaster muscle: XA5FZ1\\nDartos muscle: XA8HG2\\nDeep transverse perinei muscle: XA2LG6\\nIliococcygeus muscle: XA3YC6\\nIschiocavernosus muscle: XA73H8\\nLevator anicoccygeus muscle: XA9T66\\nPubococcygeus muscle: XA3HP4\\nPuborectalis muscle: XA7MM8\\nPubovaginalis muscle: XA4RK4\\nSphincter ani muscle: XA3ML6\\nSphincter urethrae muscle: XA8FT0\\nSuperficial transverse perinei muscle: XA56U7\\nMuscles of the upper extremity: XA4Z20\\nAbductor digiti minimi muscle hand: XA90T3\\nAbductor pollicis brevis muscle: XA0Z05\\nAbductor pollicis longus muscle: XA7PS1\\nAdductor pollicis muscle: XA54Z7\\nAnconeus muscle: XA2583\\nArticularis cubiti muscle: XA0GV5\\nBiceps brachii muscle: XA1KL5\\nLong head of the biceps brachii muscle: XA0481\\nShort head of the biceps brachii muscle: XA3J17\\nBrachialis muscle: XA6CR7\\nBrachioradialis muscle: XA2ZN1\\nCoracobrachialis muscle: XA0TQ5\\nDeltoid muscle: XA3VN0\\nExtensor carpi radialis brevis: XA4U40\\nExtensor carpi radialis longus muscle: XA8824\\nExtensor carpi ulnaris muscle: XA9304\\nExtensor digiti minimi muscle hand: XA0T60\\nExtensor digitorum muscle hand: XA7QU8\\nExtensor indicis muscle: XA1AV6\\nExtensor pollicis brevis muscle: XA4V20\\nExtensor pollicis longus muscle: XA0CS4\\nFlexor carpi radialis muscle: XA0S07\\nFlexor carpi ulnaris muscle: XA4HV9\\nFlexor digiti minimi brevis muscle hand: XA3UK3\\nFlexor digitorum profundus muscle: XA4Z43\\nFlexor digitorum superficialis muscle: XA1NW3\\nFlexor pollicis brevis muscle: XA5QD0\\nFlexor pollicis longus muscle: XA3GQ7\\nInterossei of the hand muscle: XA6463\\nDorsal interossei of the hand muscle: XA2QW3\\nPalmar interossei of the hand muscle: XA5055\\nLumbricals of hand muscle: XA9B77\\nOpponens digiti minimi muscle hand: XA4RW9\\nOpponens pollicis muscle: XA0Q73\\nPalmaris brevis muscle: XA9KL5\\nPalmaris longus muscle: XA6P76\\nPronator quadratus muscle: XA91W0\\nPronator teres muscle: XA58Z6\\nRotator cuff muscle: XA3DL4\\nInfraspinatus muscle: XA7E49\\nSubscapularis muscle: XA1QF1\\nSupraspinatus muscle: XA74P3\\nTeres minor muscle: XA3CP1\\nSupinator muscle: XA90Z6\\nTriceps brachii muscle: XA2EB2\\nMuscles of the lower extremity: XA47J0\\nAbductor digiti minimi muscle foot: XA0W07\\nAbductor hallucis muscle: XA7119\\nAdductor brevis muscle: XA8GU7\\nAdductor hallucis muscle: XA0FW7\\nAdductor longus muscle: XA01U3\\nAdductor magnus muscle: XA8HR3\\nArticularis genu muscle: XA0DE1\\nBiceps femoris muscle: XA3CB9\\nExtensor digitorum brevis muscle foot: XA7FZ1\\nExtensor digitorum longus muscle foot: XA24U7\\nExtensor hallucis brevis muscle: XA3T27\\nExtensor hallucis longus muscle: XA7R67\\nFlexor digiti minimi brevis muscle foot: XA20W3\\nFlexor digitorum brevis muscle: XA97C3\\nFlexor digitorum longus muscle foot: XA23Q3\\nFlexor hallucis brevis muscle: XA3MB7\\nFlexor hallucis longus muscle: XA7E33\\nGastrocnemius muscle: XA1PK6\\nGemellus inferior muscle: XA7PN8\\nGemellus superior muscle: XA0472\\nGracilis muscle: XA1HH2\\nIliacus muscle: XA0200\\nInterossei dorsal of foot muscle: XA15P6\\nInterossei plantar of foot muscle: XA8TS8\\nLumbricals of foot muscle: XA7PN0\\nObturator externus muscle: XA7Y24\\nObturator internus muscle: XA11E8\\nPectineus muscle: XA9E00\\nPeroneus brevis muscle: XA26M7\\nPeroneus longus muscle: XA3P60\\nPeroneus tertius muscle: XA9D52\\nPiriformis muscle: XA7XS8\\nPlantaris muscle: XA7W96\\nPopliteus muscle: XA8CL8\\nQuadratus plantae muscle: XA41G3\\nQuadriceps femoris muscle: XA1BT5\\nRectus femoris muscle: XA5447\\nSartorius muscle: XA5CE3\\nSemimembranosus muscle: XA5AM5\\nSemitendinosus muscle: XA2EK1\\nSoleus muscle: XA5B83\\nTibialis anterior muscle: XA02U9\\nTibialis posterior muscle: XA3VR3\\nVastus intermedius muscle: XA33F6\\nVastus lateralis muscle: XA00Z6\\nVastus medialis muscle: XA9RD2\\nGluteus maximus muscle: XA48F2\\nGluteus medius muscle: XA5VJ8\\nGluteus minimus muscle: XA7BY4\\nTensor fasciae lata muscle: XA11U3\\nTendons of the head and neck: XA3PP9\\nAlaeque nasi tendon: XA46A9\\nAryepiglotticus tendon: XA6J99\\nAuricularis tendon: XA8XC7\\nBuccinator tendon: XA3163\\nCorrugator supercilii tendon: XA6L11\\nCricothyroid tendon: XA01X1\\nDepressor anguli oris tendon: XA28X5\\nDepressor labii inferioris tendon: XA6WZ3\\nDigastric tendon: XA5S69\\nFrontalis tendon: XA5CP4\\nGenioglossus tendon: XA6BT8\\nGeniohyoid tendon: XA9L90\\nHyoglossus tendon: XA8N10\\nHyoid tendon: XA7EE6\\nInferior oblique tendon: XA3ZA2\\nInferior rectus tendon: XA7HT8\\nLateral cricoarytenoid tendon: XA1394\\nLateral pterygoid tendon: XA6PK4\\nLateral rectus tendon: XA3LT8\\nLevator anguli oris tendon: XA7653\\nLevator labii superioris tendon: XA0YK7\\nLevator palpebrae superioris tendon: XA61C9\\nLevator veli palatini tendon: XA7VD7\\nLongus capitis tendon: XA1FR7\\nLongus colli tendon: XA0UD3\\nMasseter tendon: XA1FB3\\nMedial pterygoid tendon: XA8F95\\nMedial rectus tendon: XA6SG3\\nMentalis tendon: XA7JW2\\nMylohyoid tendon: XA7ZZ8\\nNasalis tendon: XA7NU6\\nOblique arytenoid tendon: XA5Q22\\nObliquus capitis inferior tendon: XA8AT8\\nObliquus capitis superior tendon: XA39M0\\nOmohyoid tendon: XA2JY6\\nOrbicularis oculi tendon: XA65X4\\nOrbicularis oris tendon: XA0W74\\nPalatoglossus tendon: XA6SX4\\nPalatopharyngeus tendon: XA6LA2\\nPlatysma tendon: XA4758\\nPosterior cricoarytenoid ligament: XA0AE2\\nProcerus tendon: XA5HD8\\nRectus capitis anterior tendon: XA8CQ6\\nRectus capitis lateralis tendon: XA4RG2\\nRectus capitis posterior major tendon: XA6WL6\\nRectus capitis posterior minor tendon: XA1XH8\\nRisorius tendon: XA9450\\nSalpingopharyngeus tendon: XA0SH8\\nScalene tendon: XA3XC1\\nscalenus anterior tendon: XA45L1\\nscalenus medius tendon: XA7XV7\\nscalenus minimus tendon: XA7NL5\\nscalenus posterior tendon: XA9HH7\\nSplenius capitis tendon: XA39C9\\nSplenius cervicis tendon: XA2HL1\\nStapedius tendon: XA8W69\\nSternocleidomastoid tendon: XA70V9\\nSternohyoid tendon: XA6S11\\nSternothyroid tendon: XA4VX2\\nStyloglossus tendon: XA90J0\\nStylohyoid tendon: XA20E0\\nStylopharyngeus tendon: XA7GV2\\nSuperior oblique tendon: XA5ES8\\nSuperior rectus tendon: XA3ZN4\\nTemporalis tendon: XA7D16\\nTemporoparietalis tendon: XA8BT2\\nTensor tympani tendon: XA5956\\nTensor veli palatini tendon: XA2W44\\nThyroarytenoid tendon: XA4ME3\\nThyroepiglotticus tendon: XA0CT5\\nTransverse arytenoid tendon: XA9YC3\\nVocalis tendon: XA4CN7\\nZygomaticus major tendon: XA0XQ7\\nZygomaticus minor tendon: XA0SZ1\\nTendons of the thorax: XA3SA1\\nChordae tendineae: XA01T0\\nDiaphragm tendon: XA9N29\\nIntercostals external tendon: XA5WL5\\nIntercostals innermost tendon: XA8FV0\\nIntercostals internal tendon: XA92E2\\nLevatores costarum tendon: XA5R18\\nPectoralis major tendon: XA3C70\\nPectoralis minor tendon: XA40K0\\nSerratus anterior tendon: XA91D0\\nSerratus posterior inferior tendon: XA7J14\\nSerratus posterior superior tendon: XA0MH0\\nSubcostalis tendon: XA8WS6\\nTendon of Todaro: XA3XC9\\nTransversus thoracis tendon: XA1HX3\\nTendons of the abdomen: XA4797\\nExternal oblique abdominis tendon: XA0101\\nInternal oblique abdominis tendon: XA45G1\\nPsoas major tendon: XA3045\\nPsoas minor tendon: XA7V41\\nPyramidalis tendon: XA49W5\\nQuadratus lumborum tendon: XA34K5\\nRectus abdominis tendon: XA1HT1\\nTransversus abdominis tendon: XA0V25\\nTendons of the back: XA9Z26\\nIliocostalis tendon: XA48X7\\nInfraspinatus tendon: XA2MX3\\nInterspinales tendon: XA2E69\\nIntertransversarii tendon: XA8UU5\\nLatissimus dorsi tendon: XA8467\\nLongissimus tendon: XA3TD7\\nMultifidus tendon: XA33T4\\nRhomboid major tendon: XA3P63\\nRhomboid minor tendon: XA8918\\nRotatores tendon: XA16J2\\nSemispinalis tendon: XA3D42\\nSpinalis tendon: XA28J9\\nTeres major tendon: XA09K4\\nTeres minor tendon: XA42P8\\nTrapezius tendon: XA9PV0\\nTendons of the pelvis and perineum: XA1SN1\\nBulbospongiosus tendon: XA15H4\\nCoccygeus tendon: XA45X9\\nCremaster tendon: XA4755\\nDartos tendon: XA2BV5\\nDeep transverse perinei tendon: XA2TD5\\nIliococcygeus tendon: XA6QW7\\nIschiocavernosus tendon: XA7YP5\\nPubococcygeus tendon: XA5JV1\\nPuborectalis tendon: XA66F5\\nPubovaginalis tendon: XA32R3\\nTendons of the upper extremity: XA0WU6\\nAbductor digiti minimi tendon: XA5AY5\\nAbductor pollicis brevis tendon: XA7YE1\\nAbductor pollicis longus tendon: XA0UY5\\nAdductor pollicis tendon: XA9749\\nAnconeus tendon: XA4HK3\\nBiceps brachii tendon: XA8AM4\\nLong head of biceps brachii tendon: XA2UD9\\nShort head of biceps brachii tendon: XA0FB1\\nBrachialis tendon: XA9G06\\nBrachioradialis tendon: XA3YY6\\nCoracobrachialis tendon: XA83R8\\nDeltoid tendon: XA0942\\nDorsal Interosseous tendon: XA24P4\\nExtensor carpi radialis brevis tendon: XA18F0\\nExtensor carpi radialis longus tendon: XA1T90\\nExtensor carpi ulnaris tendon: XA4PY2\\nExtensor digiti minimi tendon: XA4WU2\\nExtensor digitorum tendon: XA5H06\\nExtensor indicis tendon: XA4EE2\\nExtensor pollicis brevis tendon: XA5KN6\\nExtensor pollicis longus tendon: XA4CG6\\nExtensor tendon: XA8U10\\nFlexor carpi radialis tendon: XA8H50\\nFlexor carpi ulnaris tendon: XA5CE2\\nFlexor digiti minimi tendon: XA23D8\\nFlexor digitorum profundus tendon: XA0GQ6\\nFlexor digitorum superficialis tendon: XA9526\\nFlexor digitorum tendon: XA9Q34\\nFlexor pollicis brevis tendon: XA1Q82\\nFlexor pollicis longus tendon: XA92F7\\nFlexor tendon: XA5YQ2\\nInterossei tendon: XA4M25\\nLevator scapulae tendon: XA1X89\\nLumbrical tendon: XA8TQ1\\nOpponens digiti minimi tendon: XA9KM7\\nOpponens pollicis tendon: XA3W45\\nPalmar interosseous tendon: XA82E6\\nPalmaris brevis tendon: XA7B73\\nPalmaris longus tendon: XA41L1\\nPronator quadratus tendon: XA41Z5\\nPronator teres tendon: XA7EK5\\nSubclavius tendon: XA7V30\\nSubscapularis tendon: XA54N6\\nSupinator tendon: XA5EJ6\\nSupraspinatus tendon: XA5VZ4\\nTriceps brachii tendon: XA5RS6\\nTendons of the lower extremity: XA5L93\\nAbductor digiti minimi foot tendon: XA5ZK0\\nAbductor hallucis tendon: XA14Z8\\nAchilles tendon: XA8BK1\\nAdductor brevis tendon: XA4HF0\\nAdductor hallucis tendon: XA8B14\\nAdductor longus tendon: XA1TK8\\nAdductor magnus tendon: XA8746\\nAnterior ligament of the lower extremity: XA9381\\nArticularis genu tendon: XA7MT0\\nBiceps femoris tendon: XA1MF8\\nDorsal interossei of foot tendon: XA86H9\\nExtensor digitorum brevis foot tendon: XA6230\\nExtensor digitorum longus foot tendon: XA1ZF4\\nExtensor hallucis brevis tendon: XA4NZ0\\nExtensor hallucis longus tendon: XA5L26\\nFlexor digiti minimi brevis foot tendon: XA8X38\\nFlexor digitorum brevis tendon: XA8GD0\\nFlexor digitorum longus foot tendon: XA3MK8\\nFlexor hallucis brevis tendon: XA00Z8\\nFlexor hallucis longus tendon: XA1MF0\\nGastrocnemius tendon: XA5LZ0\\nGemellus inferior tendon: XA2HX4\\nGemellus superior tendon: XA5M18\\nGluteus maximus tendon: XA1JL3\\nGluteus medius tendon: XA1387\\nGluteus minimus tendon: XA4HK9\\nGracilis tendon: XA12U3\\nIliacus tendon: XA8FT1\\nLumbrical of foot tendon: XA5DE3\\nObturator externus tendon: XA3EE9\\nObturator internus tendon: XA2469\\nPectineus tendon: XA07E4\\nPeroneus brevis tendon: XA3AN0\\nPeroneus longus tendon: XA7VY0\\nPeroneus tertius tendon: XA3D16\\nPiriformis tendon: XA3EU4\\nPlantar interossei of foot tendon: XA7L19\\nPlantaris tendon: XA6BZ6\\nPopliteus tendon: XA4V24\\nQuadratus plantae tendon: XA1L44\\nQuadriceps femoris tendon: XA9420\\nRectus femoris tendon: XA4ZG0\\nSartorius tendon: XA0981\\nSemimembranosus tendon: XA4AL5\\nSemitendinosus tendon: XA7DY9\\nSoleus tendon: XA7E05\\nTensor fasciae lata tendon: XA33Q1\\nTibialis anterior tendon: XA8SN1\\nTibialis posterior tendon: XA7FR7\\nVastus intermedius tendon: XA8ST5\\nVastus lateralis tendon: XA8CQ5\\nVastus medialis tendon: XA6RK3\\nEnthesis: XA2C51\\nBursa: XA16K5\\nBursa olecrani: XA12U7\\nBursa praepatellaris: XA7P88\\nKidney: XA6KU8\\nRenal capsule: XA5EP6\\nRenal cortex: XA35W4\\nRenal medulla: XA91E4\\nRenal pyramid: XA9Q52\\nRenal pelvis: XA21J4\\nRenal calyces: XA0AC1\\nMajor calyx: XA6N83\\nMinor calyx: XA8XL0\\nUreteropelvic junction: XA7NQ9\\nRenal hilum: XA4UD2\\nGlomerulus: XA40R2\\nNephron: XA8AN8\\nRenal tubule: XA2364\\nUreter: XA7156\\nUreterovesical orifice: XA9L57\\nUrinary bladder: XA77K2\\nDome of bladder: XA2PT2\\nBladder wall: XA0R03\\nLateral wall of bladder: XA3JA5\\nAnterior wall of bladder: XA4UM5\\nPosterior wall of bladder: XA2562\\nSuperior wall of bladder: XA6SR9\\nTrigone of bladder: XA6KF2\\nUreteric orifice: XA4P63\\nInternal urethral orifice: XA8KN5\\nBladder neck: XA0VZ5\\nUrethra: XA5TA5\\nInternal urethral sphincter: XA33M0\\nMembranous urethra: XA75T3\\nProstatic urethra: XA7869\\nExternal urethral sphincter: XA4DF2\\nPenile urethra: XA8EW9\\nExternal urethral meatus: XA4NU9\\nUrinary tract not elsewhere classified: XA4V93\\nLower urinary tract: XA34X0\\nUpper urinary tract: XA6RS6\\nMale genital organs: XA75A2\\nPenis: XA7QV2\\nRoot of penis: XA0970\\nBody of penis: XA9A26\\nDorsal surface of penis: XA03Y8\\nVentral surface of penis: XA3D56\\nGlans penis: XA0MH6\\nPenile urethral meatus: XA3Q76\\nParaurethral gland: XA3KB3\\nPrepuce: XA71S4\\nOuter surface of prepuce: XA2BL8\\nMucosal surface of prepuce: XA1CP6\\nCoronal sulcus of penis: XA54U4\\nFrenulum of penis: XA7V24\\nTestis: XA4947\\nTunica vaginalis: XA1FS5\\nTunica albuginea: XA07W9\\nSeminiferous tubules: XA9636\\nDescended testis: XA13Z7\\nTesticular appendage: XA14M8\\nEpididymis: XA4D25\\nSpermatic cord: XA9235\\nVas deferens: XA8PQ1\\nSeminal vesicle: XA0MJ1\\nProstate gland: XA63E5\\nFemale genital organs: XA2GU7\\nVulva: XA78U5\\nLabia of vulva: XA11L9\\nLabium majus: XA59G9\\nLabium minus: XA0MU9\\nClitoris: XA4851\\nClitoral hood: XA3C45\\nVulval vestibule: XA1A52\\nBartholin gland: XA27K9\\nPosterior fourchette of vulva: XA0565\\nVagina: XA1LK7\\nVaginal introitus: XA4AH3\\nHymen: XA3A69\\nGartner duct: XA9BM1\\nVaginal vault: XA46V2\\nUterus: XA99N3\\nFundus of uterus: XA3V49\\nCorpus uteri: XA5229\\nEndometrium: XA8QA8\\nEndometrial gland: XA9DM0\\nEndometrial stroma: XA3FR4\\nMyometrium: XA2LU5\\nParametrium: XA9HG1\\nUterine cavity: XA3QZ2\\nIsthmus uteri: XA7F09\\nCervix uteri: XA5WW1\\nInternal os: XA3Z33\\nCervical canal: XA7Z73\\nConnective and other soft tissues of uterus: XA0KR7\\nOvary: XA1QK0\\nCortex of ovary: XA6FA5\\nMedulla of ovary: XA44X6\\nUterine adnexa: XA7E69\\nFallopian tube: XA3EF0\\nEmbryological structures: XA1MQ5\\nDevelopmental tissue: XA7A99\\nEctoderm: XA7TJ5\\nEndoderm: XA3HM5\\nMesoderm: XA3D33\\nEmbryo: XA3NA0\\nFetus: XA23B0\\nFetal membranes: XA85H6\\nAmniotic sac: XA7MU1\\nAmnion: XA8XR0\\nChorion: XA66R5\\nAmniotic fluid: XA33K4\\nAllantois: XA9YJ5\\nThyroglossal duct: XA0SH3\\nUrachus: XA1NC2\\nUmbilical cord: XA3L42\\nPlacenta: XA90F8\\nHead and neck: XA1RS6\\nHead: XA20Q1\\nScalp: XA6CW5\\nFrontal scalp: XA0WK0\\nFrontal scalp margin: XA0WG9\\nTemporal scalp: XA9DZ0\\nTemporal scalp margin: XA26C1\\nParietal scalp: XA4W34\\nOccipital scalp: XA7JE5\\nOccipital scalp margin: XA3EK3\\nVertex of scalp: XA5BY6\\nScalp margin: XA6AL1\\nParietal scalp margin: XA93S9\\nFace: XA86S4\\nForehead: XA6TR8\\nCentral forehead: XA9SG2\\nParamedian forehead: XA1UW4\\nLateral forehead: XA1Z38\\nGlabella: XA90D8\\nTemple: XA9T94\\nOrbital region: XA29E7\\nPeriorbital region: XA0SB3\\nSupraorbital region: XA5WP1\\nEyebrow: XA1LZ5\\nInfraorbital region: XA6TV2\\nCheek: XA7MK8\\nUpper cheek: XA5KE9\\nMalar region: XA0M67\\nMalar eminence: XA57N0\\nCentral cheek: XA6C41\\nParanasal region: XA3ZL3\\nLower cheek: XA7207\\nPreauricular region: XA0SU2\\nMandibular region: XA8KA2\\nNose: XA3H13\\nRoot of nose: XA0LR7\\nDorsum of nose: XA5YP3\\nSupratip of nose: XA3057\\nLateral side wall of nose: XA9JN5\\nTip of nose: XA56T3\\nInfratip lobule of nose: XA3ZG3\\nAla nasi: XA32Q9\\nAlar groove: XA5ED7\\nAlar rim: XA7LG9\\nSide wall of ala nasi: XA2TK5\\nNostril: XA1B05\\nColumella: XA4S17\\nSill of nostril: XA9YZ7\\nOral region: XA5A87\\nPerioral region: XA1A48\\nLip: XA8JD4\\nUpper lip: XA7VQ4\\nExternal upper lip: XA0K68\\nPhiltrum: XA5LY8\\nNasolabial fold: XA5163\\nVermilion border of upper lip: XA8RK1\\nVermilion of upper lip: XA75S0\\nLabial commissure: XA1EF8\\nLower lip: XA15W6\\nExternal lower lip: XA5VD0\\nVermilion border of lower lip: XA9TK2\\nVermilion of lower lip: XA7H02\\nInner aspect of lip: XA1BP2\\nFrenulum of lip: XA3141\\nExternal lip: XA3K27\\nChin: XA2C62\\nSkin of nose: XA04T9\\nNeck: XA7AA6\\nFront of neck: XA4QS6\\nAnterior triangle of neck: XA1NS6\\nSubmental region: XA5TZ1\\nSubmandibular region: XA0MP5\\nSuprasternal notch: XA8RA2\\nSupraclavicular region: XA9DQ5\\nSide of neck: XA2ZF0\\nPosterior triangle of neck: XA45K8\\nNape of neck: XA1M78\\nTrunk: XA3FR3\\nUpper trunk: XA4QH7\\nThorax: XA5D93\\nChest wall: XA55T2\\nAnterior thoracic region: XA00R3\\nUpper anterior thoracic region: XA8ML7\\nClavicular region: XA4MN6\\nInfraclavicular region: XA6M63\\nPresternal region: XA5MS8\\nLower anterior thoracic region: XA7GU3\\nLateral thoracic region: XA7884\\nUpper lateral thoracic region: XA9RL9\\nAnterolateral upper thoracic region: XA0XL3\\nPosterolateral upper thoracic region: XA5C28\\nLower lateral thoracic region: XA9MN4\\nAnterolateral lower thoracic region: XA3266\\nPosterolateral lower thoracic region: XA7MS4\\nUpper back: XA10L7\\nSuprascapular region: XA3PG8\\nScapular region: XA3WD7\\nInterscapular region: XA9LN5\\nInfrascapular region: XA8NK1\\nLower thoracic paraspinal region: XA6RF2\\nSkin of thorax: XA8EK1\\nBreast: XA12C1\\nUpper half of breast: XA1NS5\\nUpper inner quadrant of breast: XA3LS6\\nUpper outer quadrant of breast: XA2Q54\\nAxillary tail of breast: XA3PG5\\nCentral portion of breast: XA0US1\\nAreola: XA2JK3\\nLactiferous ducts: XA85A1\\nNipple: XA5MC5\\nLower half of breast: XA3UY3\\nLower inner quadrant of breast: XA0VX8\\nLower outer quadrant of breast: XA94U2\\nLateral half of breast: XA9CM2\\nMedial half of breast: XA3JH6\\nInframammary flexure: XA0T50\\nLower trunk: XA6CY1\\nAbdomen: XA6GV0\\nUpper abdomen: XA0U66\\nEpigastrium: XA8ZL8\\nHypochondrium: XA3TD4\\nPeriumbilical region: XA1LM1\\nUmbilicus: XA3MT8\\nLateral lumbar region: XA1DN2\\nLower abdomen: XA4TC0\\nHypogastrium: XA6N20\\nIliac region: XA0NH8\\nAbdominal wall: XA3KX0\\nAnterior abdominal wall: XA4SN6\\nLumbosacral region: XA25R8\\nMid back: XA6ZR2\\nLumbar paraspinal region: XA7ZW8\\nPosterior lumbar region: XA8FK6\\nLower back: XA9ET2\\nCoccygeal area: XA6DS1\\nSacral region: XA2UC8\\nSacrococcygeal region: XA4L23\\nBack: XA2P90\\nAnogenital region: XA8HA7\\nGenital region: XA5FG3\\nFemale external genitalia: XA9PG6\\nMale external genitalia: XA1AK8\\nScrotum: XA8MT4\\nPerigenital region: XA9PX3\\nSuprapubic area: XA0LF4\\nMons pubis: XA10Z0\\nInguinocrural fold: XA2XG2\\nInguinal canal: XA00B4\\nPerianal region: XA4B34\\nPerineum: XA53N9\\nIntergluteal cleft: XA2F27\\nExtremities: XA6AS2\\nUpper extremity: XA4BA8\\nShoulder: XA2ND5\\nAnterior surface of shoulder: XA3PZ3\\nApex of shoulder: XA5BU5\\nPosterior surface of shoulder: XA34G7\\nAxilla: XA17J1\\nAnterior axillary fold: XA41A1\\nApex of axilla: XA86E8\\nPosterior axillary fold: XA2RY5\\nUpper arm: XA6809\\nAnterior surface of upper arm: XA22Q1\\nLateral surface of upper arm: XA2W33\\nPosterior surface of upper arm: XA5TK8\\nMedial surface of upper arm: XA3J41\\nElbow: XA9FF8\\nAntecubital fossa: XA9NE6\\nLateral condylar surface of elbow: XA6599\\nElbow tip: XA3RT8\\nMedial condylar surface of elbow: XA4983\\nForearm: XA7WB0\\nVolar surface of forearm: XA8ZL6\\nLateral surface of forearm: XA1VA2\\nDorsal surface of forearm: XA8WH0\\nMedial surface of forearm: XA2Q46\\nWrist: XA2J63\\nVolar surface of wrist: XA6AR5\\nRadial border of wrist: XA3LK1\\nDorsal surface of wrist: XA0SH5\\nUlnar border of wrist: XA0J47\\nHand: XA5R12\\nDorsum of hand: XA30Z6\\nKnuckles: XA3T43\\nInterdigital web space of hand: XA65Z3\\nFirst interdigital web space of hand: XA1BR6\\nSecond interdigital web space of hand: XA5PY9\\nThird interdigital web space of hand: XA4012\\nFourth interdigital web space of hand: XA3WG2\\nPalm of hand: XA3NY8\\nProximal palm: XA3FJ0\\nThenar eminence: XA2JN4\\nHypothenar eminence: XA5TQ4\\nCentral palm: XA50E4\\nDistal palm: XA00D7\\nFingers and thumb: XA2593\\nThumb: XA8DJ6\\nPerionychium of thumb: XA0RL8\\nProximal nailfold of thumb: XA13E9\\nEponychium of thumb: XA20L7\\nLateral nailfold of thumb: XA4GD7\\nHyponychium of thumb: XA63L0\\nThumbnail: XA5PD5\\nLunula of thumb: XA6DM1\\nNail bed of thumb: XA9N39\\nNail plate of thumb: XA5V24\\nPad of thumb: XA5ZV0\\nDorsum of thumb: XA76N2\\nIndex finger: XA6NZ0\\nPerionychium of index finger: XA6YH1\\nEponychium of index finger: XA90K8\\nHyponychium of index finger: XA2UG0\\nIndex fingernail: XA40D9\\nLunula of index finger: XA1GS3\\nNail bed of index finger: XA1SB3\\nNail plate of index finger: XA2XE0\\nPad of index finger: XA6TA9\\nMiddle finger: XA0Y38\\nPerionychium of middle finger: XA1FY2\\nProximal nail fold of middle finger: XA8YE5\\nEponychium of middle finger: XA13L6\\nLateral nail fold of middle finger: XA2N38\\nHyponychium of middle finger: XA8KX8\\nMiddle fingernail: XA9YZ9\\nLunula of middle finger: XA8VS0\\nNail bed of middle finger: XA2A53\\nNail plate of middle finger: XA10T8\\nPad of middle finger: XA79X0\\nRing finger: XA06X8\\nPerionychium of ring finger: XA7K11\\nProximal nail fold of ring finger: XA1F61\\nEponychium of ring finger: XA8L06\\nLateral nail fold of ring finger: XA3HG9\\nHyponychium of ring finger: XA1W89\\nRing fingernail: XA6Y59\\nLunula of ring finger: XA4P58\\nNail bed of ring finger: XA3MW5\\nNail plate of ring finger: XA3PS0\\nPad of ring finger: XA6C72\\nLittle finger: XA5EN3\\nPerionychium of little finger: XA89P0\\nProximal nail fold of little finger: XA4KU5\\nEponychium of little finger: XA2AV8\\nLateral nail fold of little finger: XA3LC5\\nHyponychium of little finger: XA1C10\\nPad of little finger: XA4WN3\\nLittle fingernail: XA29K9\\nLunula of little finger: XA3R66\\nNail bed of little finger: XA6HB9\\nNail plate of little finger: XA4A79\\nSide of finger: XA4HZ3\\nTips of fingers: XA7GT9\\nTip of index finger: XA41X5\\nTip of middle finger: XA9Y99\\nTip of ring finger: XA91S7\\nTip of little finger: XA8QW7\\nFingernails: XA0EH9\\nSkin of elbow: XA66R9\\nLower extremity: XA45A6\\nButtock: XA3VA7\\nGluteal fold: XA5UE3\\nThigh: XA5S78\\nAnterior surface of thigh: XA98B3\\nLateral surface of thigh: XA8RH9\\nTrochanteric region: XA4TQ2\\nPosterior surface of thigh: XA0183\\nMedial surface of thigh: XA1YQ6\\nUpper medial surface of thigh: XA9ZB4\\nKnee: XA8KL5\\nPatellar region: XA9L17\\nLateral surface of knee: XA77E9\\nMedial surface of knee: XA9S09\\nPopliteal fossa: XA4DM3\\nLower leg: XA3YG1\\nAnterior surface of lower leg: XA33X4\\nCalf: XA4K86\\nLateral surface of lower leg: XA4RR4\\nPosterior surface of lower leg: XA0LQ2\\nMedial surface of lower leg: XA15P0\\nDistal lower leg: XA5U49\\nProximal lower leg: XA90X0\\nAnkle: XA67V4\\nAnterior surface of ankle: XA2V14\\nLateral surface of ankle: XA7AM4\\nLateral supramalleolar region: XA1D83\\nLateral retromalleolar region: XA41K4\\nMedial surface of ankle: XA7P78\\nMedial supramalleolar region: XA87M9\\nMedial retromalleolar region: XA1SM7\\nPosterior surface of ankle: XA6AP4\\nFoot: XA47V8\\nHindfoot: XA99M7\\nHeel: XA5HK0\\nPosterior surface of heel: XA5ZE2\\nMedial surface of heel: XA1QH8\\nLateral surface of heel: XA3R99\\nPlantar surface of heel: XA2N02\\nMidfoot: XA5151\\nDorsal surface of midfoot: XA02P2\\nForefoot: XA5YL1\\nDorsal surface of forefoot: XA81Z3\\nInterdigital web space of foot: XA1FL5\\nFirst interdigital web space of foot: XA81N1\\nSecond interdigital web space of foot: XA8HC5\\nThird interdigital web space of foot: XA9LB9\\nFourth interdigital web space of foot: XA2A07\\nPlantar surface of forefoot: XA6KE9\\nFirst metatarsal head region: XA6V29\\nSecond metatarsal head region: XA2P22\\nThird metatarsal head region: XA0HX4\\nFourth metatarsal head region: XA86J0\\nFifth metatarsal head region: XA05N7\\nDorsum of foot: XA8BE2\\nSole of foot: XA1XM4\\nLateral border of foot: XA9Y82\\nMedial border of foot: XA3WM8\\nArch of foot: XA3T29\\nToes: XA4LC9\\nGreat toe: XA2RP7\\nPerionychium of great toe: XA4774\\nProximal nail fold of great toe: XA8L19\\nEponychium of great toe: XA7WP9\\nLateral nail fold of great toe: XA7GD8\\nHyponychium of great toe: XA2F64\\nGreat toenail: XA1RE3\\nLunula of great toe: XA64R9\\nNail bed of great toe: XA0HX8\\nNail plate of great toe: XA47T1\\nPad of great toe: XA6VJ2\\nSecond toe: XA8ZZ3\\nPerionychium of second toe: XA5446\\nProximal nail fold of second toe: XA1ED1\\nEponychium of second toe: XA0SL7\\nLateral nail fold of second toe: XA7003\\nHyponychium of second toe: XA2ZJ7\\nSecond toenail: XA7GG3\\nLunula of second toe: XA9439\\nNail bed of second toe: XA7B22\\nNail plate of second toe: XA1WQ6\\nPad of second toe: XA3626\\nThird toe: XA0SP3\\nPerionychium of third toe: XA3UC8\\nProximal nail fold of third toe: XA2484\\nEponychium of third toe: XA8DQ2\\nLateral nail fold of third toe: XA1MM3\\nHyponychium of third toe: XA2H72\\nPad of third toe: XA5JP9\\nThird toenail: XA3D73\\nLunula of third toe: XA9UL1\\nNail bed of third toe: XA6189\\nNail plate of third toe: XA3LW9\\nFourth toe: XA4KK7\\nPerionychium of fourth toe: XA40R3\\nProximal nail fold of fourth toe: XA2Y79\\nEponychium of fourth toe: XA0XZ8\\nLateral nail fold of fourth toe: XA0PV4\\nHyponychium of fourth toe: XA4ZB3\\nPad of fourth toe: XA9316\\nFourth toenail: XA6TS5\\nLunula of fourth toe: XA2PD3\\nNail bed of fourth toe: XA65U3\\nNail plate of fourth toe: XA8F87\\nFifth toe: XA42W4\\nPerionychium of fifth toe: XA1AV3\\nProximal nail fold of fifth toe: XA43K6\\nEponychium of fifth toe: XA2W24\\nLateral nail fold of fifth toe: XA38J0\\nHyponychium of fifth toe: XA0DD8\\nPad of fifth toe: XA3C43\\nFifth toenail: XA3VM6\\nLunula of fifth toe: XA1PK7\\nNail bed of fifth toe: XA9L52\\nNail plate of fifth toe: XA4U10\\nPlantar surface of toe: XA9LJ5\\nDorsal surface of toe: XA7J49\\nSide of toe: XA14Y9\\nToenail: XA9E36\\nAlveolar wall: XA4UM2\\nCell wall: XA5UL3\\nIntestinal Wall: XA3JR1\\nOral floor: XA37C7\\nParietal wall: XA9KX3\\nPelvic floor: XA5CW9\\nPelvic wall: XA29C1\\nRectovaginal septum: XA60B5\\nRectovesical septum: XA37K5\\nUterine wall: XA1DP8\\nVaginal wall: XA57Q2\\nBody fluid: XA06R8\\nCerebrospinal fluid: XA1N55\\nInterstitial fluid: XA08M4\\nSerous fluid: XA2L90\\nSynovial fluid: XA0518\\nBone tissue: XA0UK0\\nCollagen fibres: XA7YJ2\\nConnective tissue: XA5A05\\nAdipose tissue: XA6R65\\nFascia: XA0FR0\\nLoose connective tissue: XA51U1\\nPerichondrium: XA53R0\\nPeriodontium: XA7YP0\\nPeriosteum: XA6FQ2\\nSynovium: XA3G85\\nLymphatic tissue: XA8SZ4\\nSoft tissue not elsewhere classified: XA97C4\\nSoft tissue of limb not elsewhere classified: XA5P05\\nEpithelium: XA56S9\\nMucosa: XA0PT3\\nMesothelium: XA0182\\nGamete: XA1922\\nFemale gamete: XA95A3\\nMale gamete: XA2470\\nMuscle tissue: XA39T1\\nCardiac muscle: XA6283\\nSkeletal muscle: XA0DD5\\nSmooth muscle: XA0JY3\\nNervous Tissue: XA5B23\\nNeuroglia: XA1J91\\nNeuron: XA1413\\nInterneuron: XA5BW5\\nMotor Neuron: XA5DJ5\\nSensory Neuron: XA2LT7\\nCranial cavity: XA1ZV6\\nSubarachnoid space: XA1XM6\\nSubdural space: XA1FQ8\\nDorsal body cavity: XA9QA7\\nPerineural space: XA1GB6\\nVentral body cavity: XA2N82\\nAbdominopelvic cavity: XA34B0\\nAbdominal cavity: XA9M74\\nPelvic cavity: XA25Q2\\nIschiorectal fossa: XA9CK0\\nPresacral region: XA53A7\\nPerirectal region: XA2EG4\\nInguinal region: XA0GN7\\nMediastinum: XA7WA2\\nAnterior mediastinum: XA5UF8\\nMiddle mediastinum: XA99Z0\\nPosterior mediastinum: XA1FD0\\nConnective and other soft tissues of mediastinum: XA8607\\nVertebral cavity: XA8YW7\\nEpidural space: XA8SS8\\nIntramedullary space: XA4LQ4\\nThoracic cavity: XA1XJ5\\nPleural cavity: XA3LX5\\nPrecordium: XA2RT1\\nAcinar cell adenoma: XH96Q1\\nAcinar cell carcinoma: XH3PG9\\nAcinar cell cystadenocarcinoma: XH99S4\\nMixed acinarductal carcinoma: XH9B93\\nAcinar adenocarcinoma of the lung: XH0F68\\nAcinar cell tumour: XH2SK9\\nAcidophil adenoma: XH9574\\nAdenoma NOS: XH3DV3\\nAdenomatous polyposis coli: XH1CV4\\nAdrenal cortical adenoma clear cell: XH1YP0\\nAdrenal cortical adenoma compact cell: XH2CT2\\nAdrenal cortical adenoma glomerulosa cell: XH60N5\\nAdrenal cortical adenoma mixed cell: XH2VZ8\\nAdrenal cortical adenoma pigmented: XH2FJ6\\nAlveolar adenoma: XH9356\\nBasal cell adenoma: XH60D1\\nBasophil adenoma: XH3AH8\\nBile duct adenoma: XH6KR6\\nBile duct cystadenoma: XH0778\\nBiliary intraepithelial neoplasia low grade: XH7BS0\\nBiliary papillomatosis: XH5YG5\\nCanalicular adenoma: XH1TD7\\nChief cell adenoma: XH6WK1\\nChromophobe adenoma: XH7475\\nClear cell adenofibroma: XH9JJ4\\nClear cell adenoma: XH8R87\\nCylindroma of skin: XH6J91\\nEccrine dermal cylindroma: XH5GN1\\nEmbryonal adenoma: XH6685\\nOesophageal glandular dysplasia intraepithelial neoplasia low grade: XH3K13\\nFlat adenoma: XH83X4\\nFollicular adenoma: XH0LM0\\nFollicular adenoma oxyphilic cell: XH5SM2\\nGlandular intraepithelial neoplasia low grade: XH6AF9\\nGlandular papilloma: XH3BK2\\nHurthle cell adenoma: XH6PG8\\nHurthle cell tumour: XH5X53\\nJuxtaglomerular tumour: XH6M13\\nLactating adenoma: XH0W31\\nLipoadenoma: XH8P28\\nLiver cell adenoma: XH68V1\\nMacrofollicular adenoma: XH19E3\\nMetanephric adenoma: XH0JC7\\nMicrocystic adenoma: XH3DH3\\nMixed acidophilbasophil adenoma: XH5LD9\\nMixed adenomatous and hyperplastic polyp: XH0WV8\\nMixed cell adenoma: XH1XU4\\nMonomorphic adenoma: XH2CQ8\\nMultiple adenomatous polyps: XH6CZ4\\nOxyphilic adenoma: XH9Z86\\nPancreatobiliary neoplasm noninvasive: XH0BF2\\nPancreatic microadenoma: XH6GG6\\nPapillomatosis glandular: XH1BH4\\nPapillotubular adenoma: XH6EJ4\\nLactotroph adenoma: XH1QS0\\nSerrated adenoma: XH5903\\nTrabecular adenoma: XH9G87\\nTurban tumour: XH8T50\\nVillous papilloma: XH0731\\nWaterclear cell adenoma: XH8UC1\\nCylindroma of breast: XH28X1\\nAdenomatous polyp NOS: XH8MU5\\nTubular adenoma NOS: XH7SY6\\nSessile serrated adenoma: XH2F06\\nSessile serrated polyp: XH63V9\\nTraditional sessile serrated adenoma: XH9PD9\\nAtypical adenomatous hyperplasia: XH5QL3\\nPapillary adenoma NOS: XH09B0\\nVillous adenoma NOS: XH90D6\\nTubulovillous adenoma NOS: XH10B0\\nPituitary adenoma NOS: XH94U0\\nSpindle cell oncocytoma: XH26P7\\nAdrenal cortical adenoma NOS: XH52F6\\nEndometrioid adenoma NOS: XH6ZD0\\nEndometrioid adenofibroma NOS: XH1CX5\\nMicrofollicular adenoma NOS: XH2H83\\nAdenoma intestinal type: XH7DU3\\nPancreatic neuroendocrine microadenoma: XH1Q16\\nOncocytic papillary cystadenoma: XH8NK5\\nNull cell adenoma: XH8Y40\\nPlurihormonal adenoma: XH1JL3\\nGonadotroph adenoma: XH50K4\\nSomatotroph adenoma: XH4HE3\\nThyrotroph adenoma: XH0MY4\\nPituitary adenoma ectopic: XH5RH2\\nCorticotroph adenoma: XH1C58\\nBronchiolar adenoma  Ciliated muconodular papillary tumour: XH7743\\nAdenocarcinoma in situ NOS: XH2L30\\nAdenocarcinoma in situ in adenomatous polyp: XH4J07\\nAdenocarcinoma in situ in tubulovillous adenoma: XH3770\\nAdenocarcinoma in situ in villous adenoma: XH8TV2\\nBiliary intraepithelial neoplasia high grade: XH5U91\\nCribriform carcinoma in situ: XH7Y32\\nDuctal carcinoma in situ solid type: XH0557\\nOesophageal glandular dysplasia intraepithelial neoplasia high grade: XH36M5\\nFlat intraepithelial glandular neoplasia high grade: XH5161\\nGlandular intraepithelial neoplasia high grade: XH28N7\\nPapillary neoplasm pancreatobiliarytype with high grade intraepithelial neoplasia: XH26M2\\nProstatic intraepithelial neoplasia grade III: XH5C49\\nAdenocarcinoma in situ of lung nonmucinous: XH1FR9\\nAdenocarcinoma in situ of lung mucinous: XH6BU6\\nEndometrioid intraepithelial neoplasia: XH4Z68\\nAcidophil carcinoma: XH2QZ6\\nAdenocarcinoid tumour: XH5LA4\\nAdenocarcinoma NOS: XH74S1\\nAdenocarcinoma in adenomatous polyp: XH7QZ0\\nAdenocarcinoma in adenomatous polyposis coli: XH2ZH8\\nAdenocarcinoma in multiple adenomatous polyps: XH9YR3\\nAdenocarcinoma in tubulovillous adenoma: XH7QB1\\nAdenocarcinoma in villous adenoma: XH6DA5\\nAdenocarcinoma of anal glands: XH5RE1\\nAdenocarcinoma with mixed subtypes: XH2ZQ0\\nAdenocarcinoma intestinal type: XH0349\\nSolid carcinoma NOS: XH8B45\\nNeuroendocrine tumour NOS: XH8DS0\\nNeuroendocrine carcinoma low grade: XH8LX8\\nNeuroendocrine carcinoma welldifferentiated: XH55D7\\nNeuroendocrine tumor grade: XH9LV8\\nEnterochromaffin cell carcinoid: XH7NM1\\nNeuroendocrine carcinoma NOS: XH0U20\\nNeuroendocrine carcinoma moderately differentiated: XH7F73\\nLepidic adenocarcinoma: XH24W2\\nMinimally invasive adenocarcinoma Nonmucinous: XH3QM0\\nAdenoid cystic carcinoma: XH4302\\nMinimally invasive adenocarcinoma Mucinous: XH2098\\nPapillary adenocarcinoma NOS: XH6LV9\\nVilloglandular carcinoma: XH95U1\\nMicropapillary carcinoma NOS: XH6QG3\\nMicropapillary adenocarcinoma: XH4MW7\\nPituitary carcinoma NOS: XH7KL6\\nClear cell adenocarcinoma NOS: XH6L02\\nHereditary leiomyomatosis and renal cell carcinoma HLRCC syndromeassociated renal cell carcinoma: XH5085\\nMiT Family translocation carcinomas: XH1442\\nSuccinate dehydrogenase deficient renal cell carcinoma: XH8EN1\\nAlveolar adenocarcinoma: XH07X3\\nRenal cell carcinoma NOS: XH05V6\\nRenal cell carcinoma unclassified: XH3Z08\\nAcquired cystic disease associated renal cell carcinoma: XH0RU3\\nTubulocystic renal cell carcinoma: XH7K79\\nHybrid oncocytic chromophobe tumour: XH1VB1\\nFollicular carcinoma NOS: XH3Z50\\nEndometrioid adenocarcinoma ciliated cell variant: XH9508\\nEndometrioid adenocarcinoma secretory variant: XH0718\\nAdrenal cortical carcinoma: XH4KH2\\nEndometrioid adenocarcinoma NOS: XH0SD2\\nNeuroendocrine tumour grade: XH5QW8\\nEndometrioid cystadenocarcinoma: XH09B7\\nEndometrioid adenofibroma malignant: XH6KR7\\nAdenocarcinoma endocervical type: XH0GS9\\nIslet cell adenomatosis: XH8SF8\\nPerihilar cholangiocarcinoma: XH43E4\\nIslet cell adenoma: XH4BY1\\nVilloglandular variant of endometrioid adenocarcinoma: XH3CU4\\nPituitary blastoma: XH5QV8\\nFollicular carcinoma encapsulated angioinvasive: XH0Y80\\nClear cell renal cell carcinoma NOS: XH46F1\\nBasal cell adenocarcinoma: XH9SA7\\nEndolymphatic sac tumor: XH85C2\\nAcinar adenocarcinoma of prostate: XH4PB1\\nMixed neuroendocrine nonneuroendocrine neoplasm MiNEN: XH8E54\\nNesidioblastoma: XH1NL5\\nIslet cell carcinoma: XH5XB7\\nIslet cell tumor NOS: XH2ST7\\nInsulinoma NOS: XH4SH8\\nGastrinoma: XH93H8\\nParathyroid carcinoma: XH7JQ0\\nBasophil carcinoma: XH9LV7\\nGlucagonlike peptideproducing tumour: XH7152\\nLcell tumour: XH7LW9\\nPancreatic peptide and pancreatic peptidelike peptide within terminal tyrosine amide producing tumour: XH9ZS8\\nGlucagonoma: XH4NQ8\\nEnteroglucagonoma: XH2PF0\\nVipoma: XH72E5\\nSomatostatinoma: XH5VH0\\nEndocrine tumour functioning NOS: XH41P2\\nACTHproducing tumour: XH7AG8\\nMedullary thyroid carcinoma: XH60V1\\nBile duct cystadenocarcinoma: XH3BU6\\nMedullary carcinoma with amyloid stroma: XH2MW1\\nPoorly differentiated thyroid carcinoma: XH8VU6\\nPituitary neuroendocrine tumour: XH4NH4\\nBronchial adenoma carcinoid: XH2ZA2\\nAdenocarcinoma of lung mixed mucinous and nonmucinous: XH5TR7\\nAdenocarcinoma of lung mucinous: XH7GY6\\nBronchioloalveolar carcinoma nonmucinous: XH2035\\nCarcinoma simplex: XH6LF9\\nCarcinoma diffuse type: XH0XL5\\nCholangiocarcinoma: XH7M15\\nChromophobe carcinoma: XH7SS7\\nClear cell adenocarcinofibroma: XH2Q13\\nClear cell adenocarcinoma mesonephroid: XH6YS0\\nCollecting duct carcinoma: XH4SQ4\\nCombined hepatocellular carcinoma and cholangiocarcinoma: XH7QJ6\\nCystassociated renal cell carcinoma: XH4KK0\\nEnterochromaffinlike cell tumour: XH0LH8\\nFetal adenocarcinoma: XH5P16\\nFollicular adenocarcinoma moderately differentiated: XH7TE3\\nFollicular adenocarcinoma trabecular: XH0VD1\\nFollicular adenocarcinoma well differentiated: XH8FK7\\nFollicular carcinoma minimally invasive: XH3DN7\\nFollicular carcinoma oxyphilic cell: XH90N9\\nGlycogenrich carcinoma: XH3XT5\\nGoblet cell carcinoid: XH4262\\nGranular cell carcinoma: XH2EH4\\nHepatocellular carcinoma clear cell type: XH4T58\\nHepatocellular carcinoma fibrolamellar: XH9Q35\\nHepatocellular carcinoma pleomorphic type: XH0G90\\nHepatocellular carcinoma scirrhous: XH5761\\nHepatocellular carcinoma spindle cell variant: XH3T17\\nHurthle cell adenocarcinoma: XH6YH5\\nHurthle cell carcinoma: XH8MQ3\\nLinitis plastica: XH8WM4\\nLipidrich carcinoma: XH6TK0\\nMerkel cell carcinoma: XH81N8\\nMixed acidophilbasophil carcinoma: XH7019\\nMixed acinarendocrine carcinoma: XH8EZ3\\nMixed acinarendocrineductal carcinoma: XH74Y9\\nMixed adenoneuroendocrine carcinoma: XH6H10\\nMixed cell adenocarcinoma: XH2AM6\\nMixed ductalendocrine carcinoma: XH7CY5\\nMixed endocrine and exocrine adenocarcinoma: XH6UP4\\nMixed medullaryfollicular carcinoma: XH7DG7\\nMixed medullarypapillary carcinoma: XH3340\\nMixed pancreatic endocrine and exocrine tumour malignant: XH9LZ7\\nNonencapsulated sclerosing carcinoma: XH1108\\nOxyphilic adenocarcinoma: XH09D6\\nIslet cell adenocarcinoma: XH3614\\nPancreatic neuroendocrine tumor nonfunctioning: XH3709\\nPancreatobiliarytype carcinoma: XH6XY9\\nPapillary carcinoma of thyroid: XH1ND9\\nPapillary carcinoma columnar cell: XH85E5\\nPapillary carcinoma diffuse sclerosing: XH0426\\nPapillary carcinoma encapsulated of thyroid: XH0Q59\\nPapillary carcinoma follicular variant: XH29M4\\nPapillary carcinoma oncocytic variant: XH5YT2\\nPapillary microcarcinoma: XH2AW7\\nPapillary renal cell carcinoma: XH1D07\\nPapillotubular adenocarcinoma: XH4Q20\\nParietal cell carcinoma: XH1JZ0\\nRenal cell carcinoma chromophobe type: XH6153\\nRenal cell carcinoma sarcomatoid: XH9DH7\\nScirrhous adenocarcinoma: XH4FS4\\nSolid carcinoma with mucin formation: XH34G3\\nSuperficial spreading adenocarcinoma: XH0JE3\\nTrabecular adenocarcinoma: XH7EX3\\nTubular adenocarcinoma: XH4TA4\\nTypical carcinoid: XH1Z69\\nCarcinoma of Skene Cowper and Littre Glands: XH22Z8\\nVillous adenocarcinoma: XH0X20\\nWaterclear cell adenocarcinoma: XH0A57\\nAdenocarcinoma metastatic NOS: XH8UE4\\nBasal cell carcinoma of the prostate: XH4ZC3\\nHepatocellular carcinoma NOS: XH4W48\\nBronchial adenoma cylindroid: XH81Q9\\nThymic carcinoma with adenoid cystic carcinomalike features: XH92Y9\\nCribriform carcinoma NOS: XH1YZ3\\nCribriform comedotype carcinoma: XH4YG1\\nSerrated adenocarcinoma: XH74B2\\nApudoma: XH6770\\nAtypical adenoma: XH6VL9\\nAtypical follicular adenoma: XH3T38\\nClear cell adenofibroma of borderline malignancy: XH0S86\\nEndometrioid adenoma borderline malignancy: XH5DQ2\\nMultiple endocrine adenomas: XH76W6\\nPulmonary adenomatosis: XH8468\\nHypernephroid tumour: XH54H3\\nMultilocular cystic renal neoplasm of low malignant potential: XH7PR9\\nEndometrioid adenofibroma borderline malignancy: XH9DS4\\nTubular carcinoid: XH4JG0\\nAggressive papillary tumour: XH4XL2\\nWell differentiated tumor of uncertain malignant potential: XH9PN4\\nNoninvasive follicular thyroid neoplasm with papillarylike nuclear features NIFTP: XH6SY0\\nHyalinizing trabecular tumour: XH1Y66\\nFollicular tumor of uncertain malignant potential: XH27W5\\nClear cell papillary renal cell carcinoma: XH9T60\\nClear cell borderline tumour: XH6CZ3\\nApocrine adenoma: XH6YZ9\\nClear cell hidradenoma: XH0AQ8\\nEccrine acrospiroma: XH46Z2\\nEccrine papillary adenoma: XH42Z3\\nEccrine poroma: XH25Z9\\nSpiradenoma NOS: XH3AM1\\nFollicular fibroma: XH4YU8\\nHidradenoma NOS: XH4MV7\\nPapillary hidradenoma: XH4DX4\\nSyringocystadenoma papilliferum: XH1PY0\\nSkin appendage adenoma: XH96Q5\\nSweat gland adenoma: XH3U61\\nSyringofibroadenoma: XH06Y5\\nSyringoma NOS: XH6325\\nSyringomatous tumour of nipple: XH9GB7\\nSebaceous adenoma: XH1NC5\\nSebaceous epithelioma: XH0SH5\\nCeruminous adenoma: XH7AL8\\nSpindle cell predominant trichodiscoma: XH8R55\\nApocrine poroma: XH1A80\\nPoroma NOS: XH8N28\\nSebaceoma: XH0QL4\\nPorocarcinoma in situ: XH7WE6\\nApocrine adenocarcinoma: XH9L77\\nDigital papillary adenocarcinoma: XH6FB5\\nPorocarcinoma NOS: XH7VK4\\nMalignant eccrine spiradenoma: XH58E1\\nHidradenocarcinoma: XH7NK9\\nMicrocystic adnexal carcinoma: XH17P2\\nAdnexal adenocarcinoma NOS: XH89V4\\nSweat gland adenocarcinoma: XH5LY3\\nSebaceous carcinoma: XH4VR2\\nEccrine adenocarcinoma: XH8NE4\\nCeruminous adenocarcinoma: XH6Z69\\nMalignant neoplasm arising from preexisting spiradenoma: XH9C82\\nMalignant neoplasm arising from preexisting cylindroma: XH2ZK9\\nMalignant neoplasm arising from preexisting spiradenocylindroma: XH9NW9\\nSialadenoma papilliferum: XH65F9\\nSyringocystadenocarcinoma papilliferum: XH0BE5\\nSweat gland tumour NOS: XH8BW1\\nIntraepidermal epithelioma of Jadassohn: XH1PG0\\nTrichilemmoma: XH5AU2\\nTrichoepithelioma: XH6QT9\\nTrichofolliculoma: XH0U05\\nPilar tumour: XH5L76\\nPilomatricoma NOS: XH9E37\\nTrichogerminoma: XH05Z3\\nMelanocytic matricoma: XH7CM2\\nPilar sheath acanthoma: XH3EY8\\nTumor of follicular infundibulum: XH0489\\nTrichoblastoma: XH2K97\\nAdenoid basal carcinoma: XH70J2\\nBasal cell carcinoma fibroepithelial: XH45F3\\nBasal cell carcinoma micronodular: XH4GJ2\\nBasal cell carcinoma nodular: XH2CR0\\nBasal cell carcinoma NOS: XH2615\\nBasosquamous carcinoma: XH4C18\\nInfiltrating basal cell carcinoma NOS: XH5VK4\\nInfiltrating basal cell carcinoma nonsclerosing: XH0T12\\nInfiltrating basal cell carcinoma sclerosing: XH67Y4\\nMetatypical carcinoma: XH9E93\\nSuperficial basal cell carcinoma: XH5NL6\\nPigmented basal cell carcinoma: XH2HE7\\nTrichilemmocarcinoma: XH9K96\\nPilomatrical carcinoma: XH9G49\\nBasal cell carcinoma with adnexal differentiation: XH6S67\\nTrichoblastic carcinoma: XH3DL9\\nTrichoblastic carcinosarcoma: XH8324\\nBasal cell carcinoma sarcomatoid: XH1JH6\\nBasal cell tumour: XH8189\\nProliferating trichilemmal cyst: XH7WJ7\\nCapillary haemangioma: XH3U29\\nCavernous haemangioma: XH1GU2\\nEpithelioid haemangioma: XH10T4\\nHaemangioendothelioma benign: XH0LN3\\nIntramuscular haemangioma: XH0553\\nRacemose haemangioma: XH2HR3\\nVenous haemangioma: XH4NS3\\nHaemangioma NOS: XH5AW4\\nMyointimoma: XH37N4\\nAngiofibroma NOS: XH1JJ2\\nVerrucous keratotic haemangioma: XH23S6\\nCellular angiofibroma: XH4E06\\nGiant cell angiofibroma: XH73S9\\nAcquired tufted haemangioma: XH2EX4\\nCutaneous epithelioid angiomatoid nodule: XH8SM9\\nAtypical vascular lesion: XH8KN7\\nCherry hemangioma: XH9Q71\\nSinusoidal hemangioma: XH88L5\\nMicrovenular hemangioma: XH9UU3\\nGlomeruloid hemangioma: XH9NB0\\nSpindle cell hemangioma: XH6RP8\\nCongenital hemangioma NOS: XH27G6\\nCongenital hemangioma rapidly involuting: XH6RC4\\nCongenital hemangioma noninvoluting: XH5427\\nHobnail hemangioma: XH8PD3\\nLobular capillary hemangioma: XH4LY5\\nHaemangioendothelioma malignant: XH4E71\\nHemangiosarcoma: XH6264\\nKaposi sarcoma: XH36A5\\nKupffer cell sarcoma: XH6FJ5\\nIntravascular bronchial alveolar tumour: XH3C78\\nIntimal sarcoma: XH36H7\\nEpithelioid haemangioendothelioma NOS: XH9GF8\\nPapillary intralymphatic angioendothelioma: XH4SY7\\nKaposiform haemangioendothelioma: XH6PA4\\nSpindle cell haemangioendothelioma: XH2PS0\\nPseudomyogenic epithelioid sarcomalike haemangioendothelioma: XH26F6\\nRetiform haemangioendothelioma: XH64U8\\nComposite haemangioendothelioma: XH8D24\\nHaemangioendothelioma NOS: XH2L98\\nHaemangioblastoma: XH6810\\nAdenolymphoma: XH9ZB2\\nMixed squamous cell and glandular papilloma: XH1TX5\\nLymphadenoma: XH7J33\\nAdenocarcinoma with squamous metaplasia: XH2PY4\\nAdenosquamous carcinoma: XH7873\\nEpithelialmyoepithelial carcinoma: XH9JP2\\nAdenocarcinoma with cartilaginous and osseous metaplasia: XH7247\\nAdenocarcinoma with spindle cell metaplasia: XH2QL8\\nFibromatosislike metaplastic carcinoma: XH6G98\\nAdenocarcinoma with apocrine metaplasia: XH4GA3\\nAdenocarcinoma with neuroendocrine differentiation: XH4T39\\nMetaplastic carcinoma NOS: XH0RD4\\nHepatoid adenocarcinoma: XH7MV6\\nSquamoid eccrine ductal carcinoma: XH95Y6\\nEndometrioid carcinoma with squamous differentiation: XH8XD1\\nAdenomyoma: XH4ZH4\\nAtypical polypoid adenomyoma: XH7ZB1\\nBenign cystic nephroma: XH6YS4\\nChondroid syringoma: XH70N8\\nEndometrial stromal nodule: XH8C13\\nOssifying renal tumour: XH3SR2\\nPleomorphic adenoma: XH2KC1\\nRenomedullary interstitial cell tumour: XH3470\\nStromal tumour benign: XH2E97\\nMixed epithelial and stromal tumour: XH0533\\nPaediatric cystic nephroma: XH7TJ0\\nAdenomyoepithelioma NOS: XH5QU1\\nAdenomyoepithelioma benign: XH2V57\\nPhosphaturic mesenchymal tumour benign: XH9T96\\nPulmonary hamartoma: XH3UD9\\nMyoepithelioma: XH3CQ8\\nMesenchymoma benign: XH7AA3\\nAdult cystic nephroma: XH1SP3\\nMesenchymal hamartoma: XH2P15\\nEctomesenchymal chondromyxoid tumour: XH1WZ6\\nAdenosarcoma: XH5544\\nCarcinofibroma: XH1YV7\\nCarcinoma ex pleomorphic adenoma: XH42V2\\nCarcinosarcoma embryonal: XH2RK1\\nEndometrial stromal sarcoma high grade: XH2CV3\\nEndometrial stromal sarcoma low grade: XH1S94\\nGastrointestinal stromal tumour: XH9HQ1\\nClear cell sarcoma of kidney: XH0765\\nMalignant chondroid syringoma: XH64D5\\nMalignant cystic nephroma: XH9M31\\nRhabdoid tumor NOS: XH3RF3\\nMesodermal mixed tumour: XH0Y65\\nMullerian mixed tumour: XH7ZJ9\\nPancreatoblastoma: XH27L5\\nPleuropulmonary blastoma: XH2FY9\\nPulmonary blastoma: XH5VH1\\nEndometrial stromal sarcoma NOS: XH1TK5\\nStromal sarcoma NOS: XH49Y5\\nMixed tumour malignant NOS: XH0V86\\nNephroblastoma NOS: XH5QN3\\nHepatoblastoma epithelioid: XH0H07\\nHepatoblastoma mixed epithelialmesenchymal: XH33R5\\nCarcinosarcoma NOS: XH2W45\\nAdenomyoepithelioma with carcinoma: XH7TL5\\nPhosphaturic mesenchymal tumour malignant: XH3B27\\nMyoepithelial carcinoma: XH43E6\\nMesenchymoma malignant: XH9N95\\nEmbryonal sarcoma: XH42Q2\\nGastroblastoma: XH4VQ1\\nGastrointestinal autonomic nerve tumour: XH5CT2\\nGastrointestinal pacemaker cell tumour: XH0712\\nCystic partially differentiated nephroblastoma: XH1JB4\\nMesoblastic nephroma: XH10F1\\nSialoblastoma: XH0G00\\nStromal tumour NOS: XH6R49\\nMetanephric stromal tumour: XH4N88\\nStromal tumour of uncertain malignant potential: XH8747\\nCalcifying nested stromalepithelial tumor: XH8X78\\nMesenchymoma NOS: XH2AD1\\nPrimitive nonneural granular cell tumor: XH5LL8\\nClear cell cystadenoma: XH6ZU1\\nCystic tumour of atrioventricular node: XH55F1\\nIntraductal papillarymucinous adenoma: XH5232\\nIntraductal papillarymucinous tumour with intermediate dysplasia: XH4070\\nIntraductal papillarymucinous tumour with low grade dysplasia: XH8MD2\\nIntraductal papillarymucinous tumour with moderate dysplasia: XH8ML6\\nSerous microcystic adenoma: XH0556\\nSerous surface papilloma: XH38C4\\nCystadenoma NOS: XH5RJ2\\nSerous cystadenoma NOS: XH8TJ0\\nPapillary cystadenoma NOS: XH0FM6\\nMucinous cystadenoma NOS: XH6H73\\nMucinous cystic neoplasm with intermediategrade dysplasia: XH8XL1\\nMucinous cystic neoplasm with lowgrade intraepithelial neoplasia: XH6NK7\\nMucinous cystic tumour with intermediate dysplasia: XH7K36\\nMucinous cystic tumour with moderate dysplasia: XH7834\\nMucinous cystic neoplasm with lowgrade dysplasia: XH0EK3\\nMucinous cystic neoplasm with intermediategrade intraepithelial neoplasia: XH8EW6\\nSeromucinous cystadenoma: XH9BE7\\nMucinous adenoma: XH2M29\\nMucous gland adenoma: XH5RX2\\nPapillary cystadenofibroma: XH9MS1\\nIntraductal papillarymucinous carcinoma noninvasive: XH5E08\\nIntraductal papillary mucinous neoplasm with high grade dysplasia: XH3MB3\\nMucinous cystadenocarcinoma noninvasive: XH06M2\\nMucinous cystic neoplasm with highgrade dysplasia: XH81P3\\nSerous intraepithelial carcinoma: XH8PZ6\\nSerous borderline tumour micropapillary variant: XH9DM1\\nSerous tubal intraepithelial carcinoma STIC: XH8NV8\\nSerous endometrial intraepithelial carcinoma: XH1YW4\\nIntraductal papillarymucinous carcinoma invasive: XH5WU3\\nIntraductal papillary mucinous neoplasm with an associated invasive carcinoma: XH2SE1\\nMicropapillary serous carcinoma: XH0572\\nSolid pseudopapillary carcinoma: XH5P21\\nCystadenocarcinoma NOS: XH0219\\nSerous carcinoma NOS: XH7A08\\nPapillary cystadenocarcinoma NOS: XH6JU6\\nLow grade serous carcinoma: XH12V5\\nHigh grade serous carcinoma: XH24N6\\nMucinous cystadenocarcinoma NOS: XH1390\\nMucinous cystic tumour with an associated invasive carcinoma: XH1K19\\nSeromucinous carcinoma: XH4186\\nMucinous adenocarcinoma: XH1S75\\nPseudomyxoma peritonei with unknown primary site: XH4U83\\nMucinous tubular and spindle cell carcinoma: XH5EQ2\\nPseudomyxoma peritonei: XH83J5\\nMucinous carcinoma gastric type: XH4KC5\\nMetastatic signet ring cell carcinoma: XH56K0\\nMucinproducing adenocarcinoma: XH5AF5\\nSignet ring cell carcinoma: XH4546\\nPoorly cohesive carcinoma: XH2KK0\\nKrukenberg tumour: XH3RD4\\nSignet ring cellhistiocytoid carcinoma: XH0XE5\\nSolid pseudopapillary neoplasm of pancreas: XH3AE9\\nMucinous cystic tumour of borderline malignancy: XH2FF0\\nPapillary cystadenoma borderline malignancy: XH1P30\\nSeromucinous borderline tumour: XH0RB9\\nSerous borderline tumour NOS: XH3ZK9\\nSolid pseudopapillary tumor of ovary: XH3FD4\\nLow grade appendiceal mucinous neoplasm: XH7BB4\\nIntracystic papillary neoplasm with low grade intraepithelial neoplasia: XH6RX1\\nIntraductal papillary neoplasm with low grade intraepithelial neoplasia: XH5ZH7\\nIntraductal papilloma: XH4LZ4\\nIntraductal tubularpapillary neoplasm low grade: XH7QS7\\nIntraductal papillary neoplasm NOS: XH6HK2\\nIntraductal papilloma with atypical ductal hyperplasia: XH60S7\\nAdenoma of nipple: XH7GN3\\nIntracystic papillary adenoma: XH9F80\\nIntraductal papillomatosis NOS: XH4JD3\\nComedocarcinoma noninfiltrating: XH8P86\\nIntraductal papillary neoplasm with high grade intraepithelial neoplasia: XH6AH7\\nNoninfiltrating intraductal papillary adenocarcinoma: XH9VG0\\nIntraductal carcinoma noninfiltrating NOS: XH1H31\\nDuctal carcinoma in situ NOS: XH4V32\\nIntraductal papilloma with DCIS: XH11S9\\nIntraductal tubularpapillary neoplasm high grade: XH64S7\\nNoninfiltrating intracystic carcinoma: XH9XV2\\nSolid papillary carcinoma in situ: XH0134\\nIntraductal carcinoma clinging high grade: XH39X8\\nCystic hypersecretory carcinoma intraductal: XH9SL6\\nIntraductal micropapillary carcinoma: XH0GQ3\\nLobular carcinoma in situ pleomorphic: XH2HB2\\nLobular carcinoma in situ NOS: XH6EH0\\nIntraductal carcinoma and lobular carcinoma in situ: XH7XE0\\nIntraductal tubulopapillary neoplasm: XH3PE9\\nEndocrine mucinproducing sweat gland carcinoma in situ: XH8010\\nIntraductal papilloma with lobular carcinoma in situ: XH4US4\\nSecretory carcinoma: XH44J4\\nInfiltrating duct carcinoma NOS: XH7KH3\\nAdenocarcinoma of mammary gland type: XH9FX2\\nComedocarcinoma NOS: XH1N58\\nIntraductal papillary adenocarcinoma with invasion: XH8MA7\\nPapillary carcinoma of the breast: XH8KR8\\nIntraductal papillary neoplasm with associated invasive carcinoma: XH90W1\\nEncapsulated papillary carcinoma with invasion: XH0GT6\\nInvasive micropapillary carcinoma of breast: XH9C56\\nSolid papillary carcinoma with invasion: XH1XB5\\nMedullary carcinoma NOS: XH2YP5\\nMedullarylike carcinoma: XH9B99\\nLobular carcinoma NOS: XH2XR3\\nMedullary adenocarcinoma: XH9620\\nAtypical medullary carcinoma: XH6KZ1\\nDuct carcinoma desmoplastic type: XH6PY4\\nMedullary carcinoma with lymphoid stroma: XH55H7\\nTubulolobular carcinoma: XH3RK9\\nInfiltrating ductular carcinoma: XH0408\\nInfiltrating duct and lobular carcinoma: XH8RN5\\nIntraductal and lobular carcinoma: XH9Z29\\nInfiltrating duct and lobular carcinoma in situ: XH6MH3\\nInfiltrating lobular carcinoma and ductal carcinoma in situ: XH9551\\nInfiltrating duct mixed with other types of carcinoma: XH8CS0\\nInfiltrating duct and colloid carcinoma: XH9GX4\\nInfiltrating duct and cribriform carcinoma: XH2ST9\\nInfiltrating duct and mucinous carcinoma: XH3969\\nInfiltrating duct and tubular carcinoma: XH1ND7\\nInfiltrating lobular mixed with other types of carcinoma: XH3CB4\\nPolymorphous adenocarcinoma: XH5SD5\\nInflammatory carcinoma: XH9G73\\nPaget disease mammary: XH3E21\\nPaget disease and infiltrating duct carcinoma of breast: XH47A6\\nPaget disease extramammary: XH70F8\\nPaget disease and intraductal carcinoma of breast: XH0C76\\nBasallike carcinoma of breast: XH32K6\\nAdenocarcinoma of anogenital mammarylike glands: XH4ZU9\\nCarcinoma of male breast: XH5KW8\\nEndocrine mucinproducing sweat gland carcinoma: XH4EK4\\nLobular carcinoma pleomorphic: XH9HB7\\nJuvenile carcinoma of breast: XH1146\\nCystic hypersecretory carcinoma: XH8TH6\\nEpithelial tumour benign: XH9HV0\\nTumourlet benign: XH1TD2\\nEpithelioma benign: XH65S3\\nFocal nodular hyperplasia: XH0M86\\nCarcinoma in situ NOS: XH5NV6\\nCarcinoma with osteoclastlike giant cells: XH56X7\\nCarcinoma NOS: XH63D2\\nGiant cell and spindle cell carcinoma: XH3XZ6\\nGiant cell carcinoma: XH1JZ2\\nGlassy cell carcinoma: XH00N7\\nLarge cell carcinoma with rhabdoid phenotype: XH4QU2\\nLarge cell neuroendocrine carcinoma: XH0NL5\\nPleomorphic carcinoma: XH35G0\\nPolygonal cell carcinoma: XH92T7\\nPseudosarcomatous carcinoma: XH35M3\\nCarcinoma metastatic NOS: XH1YN3\\nCarcinomatosis: XH8D74\\nEpithelioma malignant: XH4P61\\nLarge cell carcinoma NOS: XH45J4\\nCarcinoma undifferentiated NOS: XH1YY4\\nCarcinoma anaplastic NOS: XH57U9\\nNuclear protein in testis NUT associated carcinoma: XH2855\\nSpindle cell carcinoma NOS: XH3RZ4\\nSmall cell carcinoma NOS: XH0YB0\\nSmall cell neuroendocrine carcinoma: XH9SY0\\nOat cell carcinoma: XH28J9\\nSmall cell carcinoma fusiform cell: XH3T00\\nSmall cell carcinoma intermediate cell: XH6GK0\\nSmall cell carcinoma hypercalcaemic type: XH8ZR8\\nCombined small cell carcinoma: XH7YE3\\nCombined small celladenocarcinoma: XH0793\\nCombined small celllarge cell carcinoma: XH6FK9\\nCombined small cellsquamous cell carcinoma: XH9ZD2\\nNonsmall cell carcinoma: XH1DU4\\nHeterotopiaassociated carcinoma: XH26N1\\nCombined large cell neuroendocrine carcinoma: XH90B3\\nAnaplastic undifferentiated carcinoma: XH98Z7\\nDedifferentiated carcinoma: XH5R16\\nSquamous carcinoma with osteoclastlike giant cells: XH2BS4\\nUndifferentiated carcinoma with osteoclastlike giant cells: XH2224\\nTumourlet NOS: XH1N44\\nBrenner tumour NOS: XH5DX3\\nIntracanalicular fibroadenoma: XH4MA6\\nPapillary adenofibroma: XH7JU0\\nPericanalicular fibroadenoma: XH0N11\\nFibroadenoma NOS: XH9HE2\\nAdenofibroma NOS: XH91Y8\\nCystadenofibroma NOS: XH5S99\\nSerous adenofibroma NOS: XH5ZB5\\nSerous cystadenofibroma NOS: XH6RL8\\nSeromucinous adenofibroma: XH1VJ0\\nMucinous adenofibroma NOS: XH59X8\\nMucinous cystadenofibroma NOS: XH9SM7\\nPhyllodes tumour benign: XH50P7\\nGiant fibroadenoma: XH4RU1\\nJuvenile fibroadenoma: XH70H4\\nLipofibroadenoma: XH5853\\nMetanephric adenofibroma: XH7ZU2\\nBrenner tumour malignant: XH6NJ7\\nMucinous adenocarcinofibroma: XH7284\\nPeriductal stromal tumour low grade: XH75P5\\nSerous adenocarcinofibroma: XH9JC2\\nSerous cystadenocarcinofibroma: XH6PQ0\\nMucinous cystadenocarcinofibroma: XH0WW5\\nPhyllodes tumour malignant: XH8HJ7\\nBrenner tumour borderline malignancy: XH2CH8\\nMucinous adenofibroma of borderline malignancy: XH7AR7\\nMucinous cystadenofibroma of borderline malignancy: XH2YZ1\\nPhyllodes tumour borderline: XH5NK4\\nSerous adenofibroma of borderline malignancy: XH07C7\\nSerous cystadenofibroma of borderline malignancy: XH2M30\\nAngiomyofibroblastoma: XH8A47\\nBenign fibrous histiocytoma: XH06N0\\nElastofibroma: XH3BQ8\\nFascial fibroma: XH2MW3\\nFibromyxoma: XH5XQ3\\nMyofibroblastoma: XH3NQ0\\nMyofibroma: XH0953\\nPeriosteal fibroma: XH7FV0\\nFibroma NOS: XH8E66\\nDesmoplastic fibroblastoma: XH2ZF3\\nGardner fibroma: XH7GT0\\nNuchal fibroma: XH0XH6\\nPlexiform fibromyxoma: XH2WT6\\nFibroma of tendon sheath: XH0WB3\\nSolitary fibrous tumourHaemangiopericytoma grade: XH1EH1\\nCalcifying fibrous tumour: XH7TH6\\nNodular fasciitis: XH5LM1\\nHistiocytoma NOS: XH1UJ5\\nDermatofibroma NOS: XH8B90\\nSclerosing pneumocytoma: XH7436\\nDeep histiocytoma: XH5DP4\\nJuvenile histiocytoma: XH9VG1\\nReticulohistiocytoma: XH33Q1\\nCalcifying aponeurotic fibroma: XH8ZE3\\nCollagenous fibroma: XH2874\\nPlaquelike CD positive dermal fibroma: XH3665\\nAcral fibromyxoma: XH8173\\nSclerotic fibroma: XH5JG7\\nProliferative fasciitis: XH6JX7\\nProliferative myositis: XH87F9\\nEpithelioid fibrous histiocytoma: XH15M9\\nPleomorphic fibroma: XH1BV2\\nDermatomyofibroma: XH18K3\\nMyopericytoma: XH2HE9\\nFibrous dysplasia: XH5FY2\\nFascial fibrosarcoma: XH8EV4\\nFibromyxosarcoma: XH6LT0\\nInfantile fibrosarcoma: XH7BC6\\nPeriosteal fibrosarcoma: XH3406\\nPeriosteal sarcoma NOS: XH56W2\\nSolitary fibrous tumour malignant: XH1HP3\\nFibrosarcoma NOS: XH4EP1\\nMyofibroblastic sarcoma: XH2668\\nMalignant fibrous histiocytoma: XH0947\\nMyxofibrosarcoma: XH8WH0\\nDermatofibrosarcoma protuberans fibrosarcomatous: XH9V92\\nAbdominal fibromatosis: XH6116\\nAggressive fibromatosis: XH13Z3\\nAtypical fibrous histiocytoma: XH1RM7\\nCellular fibroma: XH9HH5\\nCongenital generalised fibromatosis: XH5MH2\\nMyofibroblastic tumour peribronchial: XH85R1\\nMyofibromatosis: XH1N00\\nMyxoinflammatory fibroblastic sarcoma: XH2D15\\nAtypical myxoinflammatory fibroblastic tumour: XH0TA8\\nHaemosiderotic fibrolipomatous tumour: XH9526\\nPalmarplantar type fibromatosis: XH75J5\\nSolitary fibrous tumour NOS: XH7E62\\nMyofibroblastic tumour NOS: XH66Z0\\nDesmoplastic fibroma: XH6YK5\\nDermatofibrosarcoma protuberans NOS: XH4QZ8\\nPigmented dermatofibrosarcoma protuberans: XH5CT4\\nGiant cell fibroblastoma: XH9AV8\\nPlexiform fibrohistiocytic tumour: XH4GL1\\nAngiomatoid fibrous histiocytoma: XH9362\\nHaemangiopericytic meningioma: XH7050\\nTeratoma benign: XH3GV5\\nDermoid cyst NOS: XH9F67\\nTeratoma prepubertal type: XH52Q4\\nStruma ovarii NOS: XH22M4\\nIntratubular malignant germ cells: XH8AD3\\nDysgerminoma: XH24E0\\nGerm cell tumour nonseminomatous: XH0A34\\nGerminoma: XH1E13\\nHepatoid yolk sac tumour: XH7SG5\\nImmature teratoma malignant: XH0N49\\nMalignant teratoma undifferentiated: XH2PP9\\nPolyembryoma: XH9Z28\\nSeminoma anaplastic: XH6YQ4\\nSpermatocytic seminoma: XH80D1\\nTeratocarcinoma: XH56W1\\nYolk sac tumour: XH09W7\\nSeminoma NOS: XH9FM4\\nEmbryonal carcinoma NOS: XH8MB9\\nYolk sac tumour post pubertal type: XH15X1\\nTeratoma malignant NOS: XH7YZ9\\nMalignant teratoma intermediate: XH43T4\\nTeratoma with malignant transformation: XH33E8\\nMixed germ cell tumour: XH2PS1\\nGerm cell tumour with associated haematological malignancy: XH9QP9\\nMixed teratoma and seminoma: XH5U02\\nStruma ovarii malignant: XH5PU7\\nTeratocarcinosarcoma: XH1P78\\nGonadoblastoma: XH0K61\\nTeratoma NOS: XH83G5\\nGerm cell tumour regressed: XH4NU1\\nImmature teratoma of the lung: XH5MG2\\nImmature teratoma of the thymus: XH2KP9\\nStrumal carcinoid: XH2XW3\\nImmature teratoma of thyroid: XH5PC3\\nTenosynovial giant cell tumour localised: XH6911\\nTenosynovial giant cell tumour NOS: XH0HZ1\\nGiant cell tumour of bone malignant: XH0492\\nMalignant giant cell tumour of soft parts: XH84X1\\nGiant cell tumour of bone NOS: XH4TC2\\nGiant cell tumour of soft parts NOS: XH81M1\\nTenosynovial giant cell tumour diffuse: XH52J9\\nMalignant tenosynovial giant cell tumour: XH5AQ9\\nChoroid plexus papilloma NOS: XH0RF9\\nDysembryoplastic neuroepithelial tumour: XH0H76\\nSellar ependymoma: XH1Q28\\nAstroblastoma: XH1DC5\\nAstrocytoma anaplastic: XH96C7\\nAstrocytoma low grade: XH1S63\\nCellular ependymoma: XH54D9\\nChoroid plexus carcinoma: XH3M77\\nClear cell ependymoma: XH6E51\\nDiffuse astrocytoma: XH8W32\\nDiffuse astrocytoma low grade: XH6UY7\\nEpendymoma anaplastic: XH6922\\nFibrillary astrocytoma: XH6C35\\nGemistocytic astrocytoma: XH5Y81\\nGlioma malignant: XH4RQ3\\nGliomatosis cerebri: XH6ZH4\\nGliosarcoma: XH9RC8\\nOligoastrocytoma NOS: XH6F49\\nPapillary ependymoma: XH9J28\\nPleomorphic xanthoastrocytoma: XH99U2\\nProtoplasmic astrocytoma: XH6UV4\\nTanycytic ependymoma: XH4BJ4\\nDiffuse midline glioma H KMmutant: XH7692\\nDiffuse intrinsic pontine glioma H KMmutant: XH9YU2\\nEpendymoma NOS: XH1511\\nEpendymoma RELA fusionpositive: XH2AY7\\nAstrocytoma NOS: XH6PH6\\nCystic astrocytoma: XH36Y8\\nDiffuse astrocytoma IDHmutant: XH2HK4\\nAstrocytoma anaplastic IDHmutant: XH7HQ6\\nPolar spongioblastoma: XH83Y5\\nAnaplastic pleomorphic xanthoastrocytoma: XH8BK8\\nGlioblastoma NOS: XH7F82\\nGlioblastoma IDHwild type: XH5571\\nGlioblastoma primary NOS: XH0MB1\\nDiffuse midline glioma NOS: XH3N49\\nDiffuse intrinsic pontine glioma: XH61Y5\\nGlioblastoma IDH mutant: XH4FN3\\nGlioblastoma secondary NOS: XH17J4\\nOligodendroglioma NOS: XH7W59\\nOligodendroglioma IDHmutant and pq co deleted: XH7K31\\nOligodendroglioma anaplastic IDH mutant and pq co deleted: XH9QF3\\nOligodendroblastoma: XH7CX7\\nMedulloblastoma NOS: XH8P29\\nMedulloblastoma SHHactivated and TPwild type: XH9M38\\nOligodendroglioma anaplastic: XH8844\\nMelanotic medulloblastoma: XH4B47\\nMedulloblastoma with extensive nodularity: XH6JN6\\nMedulloblastoma SHH activated NOS: XH85M7\\nCNS embryonal tumour NOS: XH8SH6\\nMedulloblastoma WNTactivated classic: XH3EX1\\nMedulloblastoma WNTactivated Large cell type: XH5163\\nMedulloblastoma WNTactivated Anaplastic type: XH2FW8\\nMedulloblastoma SHHactivated and TPmutant: XH1SH4\\nMedulloblastoma nonWNTnonSHH: XH87Q5\\nEmbryonal tumours with multilayered rosettes with CMC alteration: XH51C5\\nEmbryonal tumour with multilayered rosettes NOS: XH0KZ2\\nCerebellar sarcoma NOS: XH5538\\nMedullomyoblastoma: XH8R14\\nSupratentorial PNET: XH7Y86\\nLarge cell medulloblastoma: XH5PR7\\nAnaplastic medulloblastoma: XH0H95\\nGiant cell glioblastoma: XH8UC5\\nClassic medulloblastoma: XH0RY1\\nDesmoplastic nodular medulloblastoma: XH7PN5\\nPapillary tumour of the pineal region: XH3904\\nDiffuse astrocytoma IDHwildtype: XH2C49\\nEpithelioid glioblastoma: XH2BA5\\nMedulloblastoma WNTactivated NOS: XH0ZP6\\nMedulloblastoma group: XH25R4\\nAstrocytoma anaplastic IDHwildtype: XH39Z7\\nDiffuse lowgrade glioma MAPK pathwayaltered: XH17F8\\nDiffuse hemispheric glioma H Gmutant: XH2SS9\\nDiffuse paediatrictype highgrade glioma Hwildtype and IDHwildtype: XH4Q01\\nInfanttype hemispheric glioma: XH4ZM8\\nPilocytic astrocytoma: XH12D2\\nPilomyxoid astrocytoma: XH29Q5\\nAngiocentric glioma: XH41C5\\nAtypical choroid plexus papilloma: XH3Y57\\nDesmoplastic infantile astrocytoma: XH7M44\\nDesmoplastic infantile ganglioglioma: XH6TQ7\\nGliofibroma: XH0B58\\nMixed subependymomaependymoma: XH6738\\nMyxopapillary ependymoma: XH15U1\\nSubependymal giant cell astrocytoma: XH1L48\\nSubependymoma: XH8FZ9\\nPituicytoma: XH59V4\\nChordoid glioma: XH9HV1\\nChordoid glioma of third ventricle: XH4101\\nGranular cell tumour NOS: XH09A9\\nGranular cell tumour of the sellar region: XH2XW8\\nAlveolar soft part sarcoma: XH8V95\\nGranular cell tumour malignant: XH90D3\\nFibrolipoma: XH2SJ1\\nFibromyxolipoma: XH0PH8\\nInfiltrating angiolipoma: XH7TB0\\nInfiltrating lipoma: XH5GN5\\nIntramuscular lipoma: XH3TE0\\nPleomorphic lipoma: XH30M7\\nSpindle cell lipoma: XH4E98\\nLipoma NOS: XH1PL8\\nThymolipoma: XH4G31\\nAngiolipoma NOS: XH3C77\\nAngiomyolipoma: XH4VB4\\nChondroid lipoma: XH7WX8\\nMyelolipoma: XH17C5\\nHibernoma: XH1054\\nLipoblastomatosis: XH8L55\\nDedifferentiated liposarcoma: XH1C03\\nFibroblastic liposarcoma: XH6R46\\nInflammatory liposarcoma: XH7PE7\\nLiposarcoma well differentiated: XH7Y61\\nMixed liposarcoma: XH8VG3\\nMyxoid liposarcoma: XH3EL0\\nPleomorphic liposarcoma: XH25R1\\nSclerosing liposarcoma: XH8D43\\nLiposarcoma NOS: XH2J05\\nAtypical lipomatous tumour: XH0RW4\\nLipofibromatosis: XH4QB6\\nAngiomyolipoma Epithelioid: XH0QR3\\nLymphangioma NOS: XH9MR8\\nCapillary lymphangioma: XH6LF7\\nCavernous lymphangioma: XH2EU7\\nCystic lymphangioma: XH8G00\\nLymphangiomyoma: XH2DS9\\nHaemolymphangioma: XH62A3\\nLymphangiosarcoma: XH10U6\\nLymphangiomyomatosis: XH10K6\\nFibrous meningioma: XH5ZC7\\nLymphoplasmacyterich meningioma: XH0R11\\nMeningioma NOS: XH11P5\\nMeningothelial meningioma: XH40T5\\nMetaplastic meningioma: XH7N06\\nMicrocystic meningioma: XH1F70\\nSecretory meningioma: XH6Z51\\nHaemangioblastic meningioma: XH3L73\\nPsammomatous meningioma: XH4ZM7\\nAngiomatous meningioma: XH6L68\\nTransitional meningioma: XH4EX5\\nMeningioma malignant: XH0324\\nPapillary meningioma: XH2NY9\\nRhabdoid meningioma: XH6QS9\\nMeningeal sarcomatosis: XH5976\\nClear cell meningioma: XH71V9\\nChordoid meningioma: XH2LS4\\nAtypical meningioma: XH1PF6\\nAdenoma of rete ovarii: XH3SX7\\nMesonephroma benign: XH5AH3\\nAdenocarcinoma of rete ovarii: XH71B5\\nMesonephroma malignant: XH5WG5\\nWolffian tumour: XH2WJ5\\nFibrous mesothelioma benign: XH2VV6\\nMesothelioma benign: XH1SS1\\nEpithelioid mesothelioma benign: XH0KC4\\nWell differentiated papillary mesothelioma: XH67N8\\nPeritoneal inclusion cysts: XH8U12\\nAdenomatoid tumour NOS: XH6BY3\\nFibrous mesothelioma malignant: XH54S8\\nMesothelioma malignant: XH0XV0\\nMesothelioma biphasic malignant: XH1DX8\\nEpithelioid mesothelioma malignant: XH0VP5\\nWell differentiated papillary mesothelioma of the pleura: XH85T6\\nOssifying fibroma: XH6M86\\nAdamantinoma of long bones: XH8F52\\nMelanotic neuroectodermal tumour: XH6C72\\nBenign notochordal cell tumour: XH7MT7\\nParachordoma: XH0S20\\nMixed pineal tumour: XH2S71\\nPineal parenchymal tumour of intermediate differentiation: XH1S48\\nPineoblastoma: XH1ZH1\\nTransitional pineal tumour: XH3D20\\nNeuroectodermal tumour NOS: XH7K24\\nPeripheral primitive neuroectodermal tumour: XH6P76\\nChordoma NOS: XH9GH0\\nEwing sarcoma: XH8KJ8\\nAskin tumour: XH0FH0\\nChondroid chordoma: XH17D8\\nDedifferentiated chordoma: XH7303\\nCraniopharyngioma: XH1AZ2\\nCraniopharyngioma adamantinomatous: XH15X9\\nCraniopharyngioma papillary: XH2BF0\\nPinealoma: XH8QA9\\nPineocytoma: XH1K94\\nMucoepidermoid carcinoma: XH1J36\\nMucoepidermoid tumour: XH80V3\\nAngiomyoma: XH7CL0\\nBizarre leiomyoma: XH9824\\nCellular leiomyoma: XH9662\\nEpithelioid leiomyoma: XH8S79\\nFetal rhabdomyoma: XH4729\\nLipoleiomyoma: XH4FS5\\nMyoma: XH1CZ1\\nPlexiform leiomyoma: XH4EP9\\nLeiomyoma NOS: XH4CY6\\nMyxoid leiomyoma: XH9CC7\\nRhabdomyoma NOS: XH8WG9\\nAdult cellular rhabdomyoma: XH4BG5\\nGlycogenic rhabdomyoma: XH2736\\nGenital rhabdomyoma: XH5AF2\\nLeiomyoma apoplectic: XH8B88\\nLeiomyoma hydropic: XH5Z76\\nCotyledonoid leiomyoma: XH5G84\\nMyolipoma: XH6GV7\\nAngiomyosarcoma: XH27W3\\nEpithelioid leiomyosarcoma: XH13Z5\\nLeiomyosarcoma NOS: XH7ED4\\nMixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma: XH08B3\\nMixed type rhabdomyosarcoma: XH6YL0\\nMyosarcoma: XH8H07\\nMyxoid leiomyosarcoma: XH3122\\nPleomorphic rhabdomyosarcoma NOS: XH5SX9\\nPleomorphic rhabdomyosarcoma adult type: XH4VB5\\nRhabdomyosarcoma NOS: XH0GA1\\nEmbryonal rhabdomyosarcoma NOS: XH83G1\\nEmbryonal rhabdomyosarcoma pleomorphic: XH4749\\nSarcoma botryoides: XH7V57\\nSpindle cell rhabdomyosarcoma: XH7NM2\\nAlveolar rhabdomyosarcoma: XH7099\\nEctomesenchymoma: XH0S12\\nIntravascular leiomyomatosis: XH60C2\\nLeiomyomatosis NOS: XH2L80\\nMetastasizing leiomyoma: XH1EX8\\nSmooth muscle tumour of uncertain malignant potential: XH1EN1\\nSmooth muscle tumour NOS: XH00B4\\nLeiomyomatosis peritonealis disseminata: XH8MR2\\nLeiomyosarcoma cutaneous: XH22N2\\nMyxoma NOS: XH6Q84\\nAngiomyxoma: XH9HK9\\nOssifying fibromyxoid tumour: XH1DA7\\nDeep angiomyxoma: XH4V74\\nSuperficial angiomyxoma: XH58A9\\nLow grade fibromyxoid sarcoma: XH4V76\\nSclerosing epithelioid fibrosarcoma: XH4BT2\\nOssifying fibromyxoid tumour malignant: XH3TB0\\nPulmonary myxoid sarcoma with EWSRCREB translocation: XH51Y9\\nMyxosarcoma: XH5WF6\\nAcoustic neuroma: XH5T39\\nAncient schwannoma: XH0U07\\nCellular schwannoma: XH8WW8\\nDegenerated schwannoma: XH75P8\\nMelanotic neurofibroma: XH2GD5\\nNeurofibroma NOS: XH87J5\\nPlexiform neurofibroma: XH2MJ4\\nPlexiform schwannoma: XH9XT2\\nPsammomatous schwannoma: XH9MN2\\nSchwannoma NOS: XH98Z3\\nNerve sheath tumour NOS: XH27Y1\\nHybrid nerve sheath tumour: XH01G0\\nNeuroma NOS: XH4UE6\\nSolitary circumscribed neuroma: XH90Y8\\nPerineurioma NOS: XH0XF7\\nNerve sheath myxoma: XH3L35\\nSoft tissue perineurioma: XH9QH2\\nIntraneural perineurioma: XH4BQ8\\nCellular neurothekeoma: XH1UZ6\\nBenign Triton tumour: XH9J01\\nMalignant peripheral nerve sheath tumour: XH2XP8\\nMelanotic MPNST: XH5C30\\nMelanotic psammomatous MPNST: XH3NT0\\nMPNST with glandular differentiation: XH8HF5\\nMPNST with mesenchymal differentiation: XH7HR8\\nMPNST with perineurial differentiation: XH3W53\\nMalignant peripheral nerve sheath tumour epithelioid: XH4V81\\nNeurilemoma malignant: XH88C2\\nMalignant peripheral nerve sheath tumour with rhabdomyoblastic differentiation: XH2VV8\\nPerineurioma malignant: XH31C8\\nMelanotic schwannoma: XH2637\\nDysplastic gangliocytoma of cerebellum LhermitteDuclos: XH6K00\\nGangliocytoma: XH6KA6\\nGanglioneuroma: XH03L9\\nGanglioneuromatosis: XH6LR5\\nMedulloepithelioma benign: XH28W9\\nPacinian tumour: XH8NQ6\\nRetinocytoma: XH5AV1\\nTeratoid medulloepithelioma benign: XH5NR7\\nAtypical teratoidrhabdoid tumour: XH7ZQ4\\nGanglioglioma anaplastic: XH2GG3\\nGanglioneuroblastoma: XH77W7\\nGanglioneuroblastoma intermixed: XH0RB7\\nRetinoblastoma differentiated: XH6JM6\\nSpongioneuroblastoma: XH49K9\\nTeratoid medulloepithelioma: XH0AM8\\nCNS ganglioneuroblastoma: XH70S0\\nNeuroblastoma NOS: XH85Z0\\nMedulloepithelioma NOS: XH2WK5\\nNeuroepithelioma NOS: XH9FP2\\nRetinoblastoma NOS: XH8WC7\\nRetinoblastoma undifferentiated: XH7KP6\\nRetinoblastoma diffuse: XH1YZ7\\nOlfactory neurogenic tumour: XH09A4\\nOlfactory neurocytoma: XH7QE0\\nOlfactory neuroepithelioma: XH2Y49\\nCNS embryonal tumor with rhabdoid features: XH3AV2\\nCentral neurocytoma: XH0C11\\nCerebellar liponeurocytoma: XH2GB0\\nGanglioglioma NOS: XH5FJ3\\nExtraventricular neurocytoma: XH2HS1\\nPapillary glioneuronal tumour: XH3XU4\\nRosetteforming glioneuronal tumour: XH2JU8\\nRetinoblastoma spontaneously regressed: XH2F27\\nBalloon cell naevus: XH8RN4\\nCompound naevus: XH27A6\\nInflamed juvenile conjunctival naevus: XH8WP0\\nDiffuse melanocytosis: XH6DN3\\nDysplastic naevus: XH9035\\nEpithelioid and spindle cell naevus: XH2HG8\\nHairy naevus: XH8ZB4\\nHalo naevus: XH5971\\nDermal naevus: XH2MQ5\\nMagnocellular naevus: XH1BE4\\nNeuronevus: XH8CU4\\nNonpigmented naevus: XH0XH2\\nPigmented naevus NOS: XH4L78\\nMelanocytoma NOS: XH02Z5\\nMeningeal melanocytosis: XH8974\\nJunctional naevus NOS: XH1M79\\nSpindle cell naevus NOS: XH9QV1\\nBlue nevus NOS: XH7QJ7\\nPigmented spindle cell naevus of Reed: XH2P88\\nEpithelioid cell naevus: XH79G6\\nCellular blue naevus: XH3X84\\nNaevus spilus: XH40S8\\nDeep penetrating naevus: XH81Y1\\nCombined naevus: XH0DU8\\nGenital naevus: XH5EL4\\nConjunctival naevus: XH8FS8\\nLentiginous melanocytic naevus: XH9QC8\\nSimple lentigo: XH88L0\\nAcral naevus: XH9DB2\\nMeyerson naevus: XH8NP4\\nCongenital melanocytic naevus NOS: XH5YN0\\nSpitz naevus atypical: XH9WF4\\nMelanoma in situ: XH3XX3\\nPrecancerous melanosis NOS: XH41F9\\nAcral melanoma: XH9L11\\nAmelanotic melanoma: XH3TK1\\nBalloon cell melanoma: XH8TE3\\nDesmoplastic melanoma amelanotic: XH1P36\\nDesmoplastic melanoma NOS: XH1Z15\\nLentigo maligna melanoma: XH9NL4\\nMalignant melanoma arising in giant congenital naevus: XH5L25\\nMalignant melanoma in junctional naevus: XH23B1\\nMalignant melanoma in precancerous melanosis: XH7L76\\nMalignant melanoma regressing: XH6XP3\\nMeningeal melanomatosis: XH1BP7\\nMucosal lentiginous melanoma: XH5QP3\\nNeurotropic melanoma malignant: XH5F94\\nNodular melanoma: XH4QG5\\nSuperficial spreading melanoma: XH08X7\\nMalignant melanoma NOS: XH4846\\nSpindle cell melanoma NOS: XH25M1\\nMixed epithelioid and spindle cell melanoma: XH8HA2\\nEpithelioid cell melanoma: XH0QL5\\nSpindle cell melanoma type A: XH5KW3\\nSpindle cell melanoma type B: XH5YE7\\nBlue naevus malignant: XH1G74\\nLow cumulative sun damage melanoma: XH7JW1\\nMalignant Spitz tumour: XH8DS3\\nMelanoma meningeal: XH3DN1\\nNevoid melanoma: XH8681\\nGiant pigmented naevus NOS: XH2C28\\nIntermediate and giant congenital naevus: XH1XJ3\\nMeningeal melanocytoma: XH2RY7\\nProliferative dermal lesion in congenital naevus: XH6AH3\\nPigmented epithelioid melanocytoma: XH4VD0\\nAdenomatoid odontogenic tumour: XH2SD0\\nAmeloblastic fibroodontoma: XH44W7\\nAmeloblastic fibrodentinoma: XH0964\\nCalcifying odontogenic cyst: XH3R33\\nCementifying fibroma: XH5Y46\\nCementoossifying fibroma: XH52T0\\nCementoblastoma benign: XH4VL1\\nOdontogenic fibroma NOS: XH1MT3\\nComplex odontoma: XH7H47\\nCompound odontoma: XH57B1\\nGigantiform cementoma: XH6W94\\nOdontoameloblastoma: XH06N8\\nDentinogenic ghost cell tumour: XH12N4\\nOdontogenic myxoma: XH48L4\\nOdontogenic tumour benign: XH43L1\\nSquamous odontogenic tumour: XH4PV9\\nCementoma NOS: XH8FX0\\nOdontoma NOS: XH4QJ8\\nAmeloblastoma NOS: XH1SV4\\nPeripheral odontogenic fibroma: XH2M31\\nAmeloblastic fibroma: XH06Y3\\nCalcifying epithelial odontogenic tumour: XH4PT4\\nSinonasal ameloblastoma: XH39C5\\nAmeloblastoma unicystic type: XH5ZZ6\\nAmeloblastoma extraosseousperipheral type: XH4KQ4\\nAmeloblastic odontosarcoma: XH1MW0\\nAmeloblastoma metastasizing: XH96J9\\nOdontogenic tumour malignant: XH4M89\\nAmeloblastic fibrosarcoma: XH0XD5\\nOdontogenic carcinosarcoma: XH4LP1\\nGhost cell odontogenic carcinoma: XH2BX2\\nClear cell odontogenic carcinoma: XH5DZ4\\nOdontogenic tumour NOS: XH1P03\\nEnchondroma: XH9SY5\\nOsteochondroma: XH5Y87\\nOsteoma NOS: XH4818\\nOsteoid osteoma NOS: XH61J9\\nOsteoblastoma NOS: XH4316\\nOsteochondromyxoma: XH6KR3\\nBizarre parosteal osteochondromatous proliferation: XH23J5\\nChondroma NOS: XH0NS4\\nJuxtacortical chondroma: XH49G1\\nPeriosteal chondroma: XH3BC3\\nChondromyxoid fibroma: XH89S0\\nSubungual exostosis: XH1XL9\\nCentral osteosarcoma: XH1Y90\\nChondroblastic osteosarcoma: XH3T03\\nFibroblastic osteosarcoma: XH23T4\\nFibrochondrosarcoma: XH29N8\\nHigh grade surface osteosarcoma: XH6TL0\\nIntracortical osteosarcoma: XH9LS2\\nIntraosseous well differentiated osteosarcoma: XH9119\\nOsteosarcoma in Paget disease of bone: XH06W9\\nParosteal osteosarcoma: XH8HG5\\nPeriosteal osteosarcoma: XH48A9\\nSmall cell osteosarcoma: XH4EZ4\\nTelangiectatic osteosarcoma: XH5CL5\\nOsteosarcoma NOS: XH1XF3\\nOsteosarcoma extraskeletal: XH2CD6\\nLow grade central osteosarcoma: XH7N84\\nChondrosarcoma NOS: XH8J23\\nChondrosarcoma grade: XH0Y34\\nJuxtacortical chondrosarcoma: XH5FH4\\nPeriosteal chondrosarcoma: XH1S32\\nChondroblastoma malignant: XH6W00\\nMyxoid chondrosarcoma: XH9344\\nMesenchymal chondrosarcoma: XH8X47\\nClear cell chondrosarcoma: XH7XB9\\nDedifferentiated chondrosarcoma: XH6E77\\nAggressive osteoblastoma: XH2RD1\\nOsteochondromatosis NOS: XH70W8\\nChondromatosis NOS: XH5BT0\\nAtypical cartilaginous tumour: XH0FY0\\nChondroblastoma NOS: XH4NK2\\nGangliocytic paraganglioma: XH2012\\nGlomus tumour NOS: XH47J2\\nPerivascular epithelioid tumour benign: XH4CC6\\nGlomangioma: XH3RX1\\nGlomangiomyoma: XH2702\\nPerivascular epithelioid tumour malignant: XH9WD1\\nExtraadrenal paraganglioma: XH1UN6\\nNonchromaffin paraganglioma: XH8GG7\\nGlomangiosarcoma: XH05Y1\\nGlomus tumour malignant: XH21E6\\nMiddle ear paraganglioma: XH9YX6\\nLaryngeal paraganglioma: XH5521\\nVagal paraganglioma: XH1493\\nComposite paraganglioma: XH3JF3\\nComposite pheochromocytoma: XH9K97\\nParaganglioma NOS: XH0EW6\\nSympathetic paraganglioma: XH4G21\\nParasympathetic paraganglioma: XH5LK3\\nAortic body tumour: XH7YU4\\nCarotid body paraganglioma: XH3FS7\\nChemodectoma: XH20B4\\nPheochromocytoma NOS: XH3854\\nGlomangiomatosis: XH7CP7\\nGlomus tumor of uncertain malignant potential: XH5D10\\nSoft tissue tumour benign: XH67T7\\nSarcoma NOS: XH4UM7\\nSarcomatosis NOS: XH7Y17\\nSpindle cell sarcoma: XH7AN8\\nGiant cell sarcoma: XH73J4\\nSmall cell sarcoma: XH85G7\\nEpithelioid sarcoma: XH4F96\\nUndifferentiated sarcoma: XH6HY6\\nDesmoplastic small round cell tumour: XH5SN6\\nPleomorphic dermal sarcoma: XH7XH3\\nEpithelioid sarcoma undifferentiated: XH92Y0\\nPleomorphic hyalinizing angiectatic tumour: XH2193\\nGLIaltered epithelioid soft tissue tumor: XH52J1\\nAndroblastoma benign: XH7H87\\nSclerosing stromal tumour: XH6NZ8\\nSertoli cell tumour with lipid storage: XH0BG7\\nSertoliLeydig cell tumour well differentiated: XH7E53\\nThecoma luteinized: XH0Z30\\nSex cordstromal tumour benign: XH3C14\\nSignetring stromal tumour: XH69N5\\nMicrocystic stromal tumour: XH35B3\\nThecoma NOS: XH34A0\\nLuteoma NOS: XH40J2\\nGranulosa cell tumour of the testis juvenile: XH2U25\\nLeydig cell tumour of the ovary NOS: XH5XQ2\\nHilus cell tumour: XH9LH4\\nLipid cell tumour of ovary: XH9XY1\\nMasculinovoblastoma: XH1PE9\\nAdrenal rest tumour: XH9RV1\\nAndroblastoma malignant: XH44E8\\nGranulosa cell carcinoma: XH1QG7\\nGranulosa cell tumour sarcomatoid: XH97Z8\\nSertoliLeydig cell tumour poorly differentiated: XH29E0\\nSertoliLeydig cell tumour poorly differentiated with heterologous elements: XH3BT2\\nSertoliLeydig cell tumour sarcomatoid: XH4KB9\\nThecoma malignant: XH1JS6\\nAdult granulosa cell tumor of ovary: XH0GA5\\nGranulosa cell tumour adult type: XH7DV5\\nLeydig cell tumour malignant: XH9G68\\nSteroid cell tumour malignant: XH4L39\\nSertoli cell carcinoma: XH7051\\nGranulosa cell tumour juvenile: XH2KH2\\nGranulosa celltheca cell tumour: XH37K7\\nGynandroblastoma: XH0Q64\\nLarge cell calcifying Sertoli cell tumour: XH9E02\\nSertoliLeydig cell tumour of intermediate differentiation: XH0UP7\\nSertoliLeydig cell tumour NOS: XH6FQ9\\nSertoliLeydig cell tumour intermediate differentiation with heterologous elements: XH8U56\\nSertoliLeydig cell tumour retiform: XH6XB6\\nSertoliLeydig cell tumour retiform with heterologous elements: XH3PN1\\nSex cord tumour with annular tubules: XH5BV8\\nSex cordgonadal stromal tumour incompletely differentiated: XH5PC7\\nSex cordgonadal stromal tumour mixed forms: XH19F9\\nSex cordgonadal stromal tumour NOS: XH9G57\\nStromal tumour with minor sex cord elements: XH8033\\nUterine tumour resembling ovarian sex cord tumour: XH8CW8\\nSex cordstromal tumour unclassified: XH0667\\nMixed germ cellsex cordstromal tumour NOS: XH0U48\\nMixed germ cellsex cordstromal tumour unclassified: XH27A8\\nAdult granulosa cell tumour of testis: XH5BN5\\nAndroblastoma NOS: XH0GT2\\nSertoli cell tumour NOS: XH4H24\\nIntratubular large cell hyalinizing Sertoli cell neoplasia: XH7RD2\\nLeydig cell tumour of the testis NOS: XH51L7\\nPapilloma NOS: XH17Q9\\nSquamous cell papilloma inverted: XH7YQ5\\nSquamous cell papilloma NOS: XH50T2\\nSquamous intraepithelial neoplasia low grade: XH4611\\nSquamous papillomatosis: XH50N3\\nVerrucous papilloma: XH2Y10\\nAnal intraepithelial neoplasia low grade: XH9S34\\nCervical intraepithelial neoplasia low grade: XH1W63\\nOesophageal squamous intraepithelial neoplasia dysplasia low grade: XH3Y37\\nBenign keratosis NOS: XH0S03\\nLichen planuslike keratosis: XH63L8\\nLarge cell acanthoma: XH7AQ2\\nPUVA keratosis: XH8MN8\\nArsenical keratosis: XH5NG4\\nClear cell acanthoma: XH13L5\\nWarty dyskeratoma: XH65S7\\nSolar lentigo: XH7B58\\nBowen disease: XH2NM8\\nDifferentiated VIN: XH9CL8\\nDifferentiated PeIN: XH6824\\nPapillary carcinoma in situ: XH4JA4\\nPapillary squamous cell carcinoma noninvasive: XH8YK9\\nSquamous cell carcinoma in situ with questionable stromal invasion: XH1U36\\nSquamous cell carcinoma in situ NOS: XH7WM7\\nSquamous intraepithelial neoplasia high grade: XH3EA2\\nAnal intraepithelial neoplasia grade III: XH7SX5\\nCervical intraepithelial neoplasia grade III: XH62N8\\nOesophageal squamous intraepithelial neoplasia dysplasia high grade: XH9ND8\\nVaginal intraepithelial neoplasia grade III: XH6F63\\nVulvar intraepithelial neoplasia grade III: XH5FT2\\nQueyrat erythroplasia: XH2H04\\nDifferentiated intraepithelial neoplasia: XH6RW7\\nBasaloid squamous cell carcinoma: XH3GS1\\nPapillary carcinoma NOS: XH0UU4\\nPapillary squamous cell carcinoma: XH6S97\\nSquamous cell carcinoma adenoid: XH7LH0\\nSquamous cell carcinoma clear cell type: XH9DC1\\nSquamous cell carcinoma keratinizing NOS: XH4CR9\\nSquamous cell carcinoma metastatic NOS: XH84Q4\\nSquamous cell carcinoma microinvasive: XH90Y3\\nSquamous cell carcinoma NOS: XH0945\\nSquamous cell carcinoma small cell nonkeratinizing: XH2435\\nSquamous cell carcinoma spindle cell: XH6D80\\nVerrucous carcinoma NOS: XH5PM0\\nWarty carcinoma: XH7UR7\\nSquamous cell carcinoma large cell nonkeratinizing NOS: XH6705\\nSquamous cell carcinoma with horn formation: XH2JN3\\nLymphoepithelial carcinoma: XH1E40\\nSchmincke tumour: XH4GV2\\nPseudovascular squamous cell carcinoma: XH0Z16\\nPapillarybasaloid carcinoma: XH24M0\\nSquamous cell carcinoma HPV positive: XH0EJ7\\nSquamous cell carcinoma HPV negative: XH2137\\nWartybasaloid carcinoma: XH6FU0\\nSynovioma benign: XH2AW8\\nSynovial sarcoma NOS: XH9B22\\nClear cell sarcoma NOS: XH77N6\\nSynovial sarcoma spindle cell: XH9346\\nSynovial sarcoma epithelioid cell: XH06L8\\nSynovial sarcoma biphasic: XH1J28\\nBiphenotypic sinonasal sarcoma: XH3797\\nMalignant melanoma of soft parts: XH5854\\nMicroscopic thymoma: XH9QW0\\nThymoma benign: XH4341\\nEctopic hamartomatous thymoma: XH0707\\nThymoma type A: XH6WN9\\nThymoma type AB: XH0JH0\\nThymoma type B: XH4EW9\\nThymoma NOS: XH3734\\nIntrapulmonary thymoma: XH1GA4\\nSclerosing thymoma: XH6QN6\\nMetaplastic thymoma: XH3DX0\\nThymic carcinoma NOS: XH6AK2\\nSpindle epithelial tumour with thymuslike element: XH6ZG8\\nIntrathyroid thymic carcinoma: XH33N4\\nMicronodular thymoma with lymphoid stroma: XH56K5\\nSinonasal papilloma exophytic: XH0TP8\\nTransitional papilloma inverted NOS: XH3HQ8\\nUrothelial papilloma inverted: XH5A08\\nUrothelial papilloma NOS: XH5M82\\nPapillary urothelial carcinoma noninvasive: XH12F0\\nUrothelial carcinoma in situ: XH5GH8\\nCylindrical cell carcinoma: XH4UA2\\nSchneiderian carcinoma: XH35M0\\nTransitional cell carcinoma NOS: XH8EH1\\nTransitional carcinoma: XH7TL4\\nUrothelial carcinoma sarcomatoid: XH5P27\\nPapillary urothelial carcinoma: XH0NZ4\\nTransitional cell carcinoma micropapillary: XH08S6\\nCloacogenic carcinoma: XH3UJ1\\nBasaloid carcinoma: XH2V80\\nUrothelial carcinoma micropapillary: XH4W76\\nCylindrical cell papilloma: XH7R01\\nSchneiderian papilloma inverted: XH4PB5\\nPapillary urothelial neoplasm of low malignant potential: XH5UU5\\nSinonasal papilloma inverted: XH8FH7\\nSinonasal papilloma oncocytic: XH8CD4\\nHydatidiform mole NOS: XH8CX2\\nPartial hydatidiform mole: XH5325\\nChoriocarcinoma combined with other germ cell elements: XH3WM1\\nMalignant teratoma trophoblastic: XH0774\\nChoriocarcinoma NOS: XH8PK7\\nTrophoblastic tumour epithelioid: XH8FW3\\nInvasive hydatidiform mole: XH46G2\\nPlacental site trophoblastic tumour: XH1RM5\\nMyelodysplastic syndrome with single lineage dysplasia: XH2N45\\nMyelodysplastic syndrome with ring sideroblasts and single lineage dysplasia: XH5B21\\nMyelodysplastic syndrome with excess blasts: XH79X8\\nRefractory anaemia with excess blasts in transformation: XH1D20\\nMyelodysplastic syndrome with multilineage dysplasia: XH5DA2\\nMyelodysplastic syndrome with isolated del q: XH3T02\\nTherapyrelated myelodysplastic syndrome NOS: XH0L58\\nMyelodysplastic syndrome NOS: XH7PK9\\nMyelodysplastic syndrome with ring sideroblasts and multilineage dysplasia: XH8BA8\\nMyeloproliferative neoplasm unclassifiable: XH3EJ1\\nMyelodysplasticmyeloproliferative neoplasm unclassifiable: XH28M3\\nLymphoproliferative disorder NOS: XH2LK2\\nPost transplant lymphoproliferative disorder NOS: XH2R75\\nPolymorphic post transplant lymphoproliferative disorder: XH74K1\\nMyeloproliferative neoplasm NOS: XH5HH7\\nEssential thrombocythemia: XH4ZM5\\nChronic eosinophilic leukaemia: XH51D2\\nMyeloid and lymphoid neoplasms with PDGFRA rearrangement: XH07H5\\nMyeloid neoplasms with PDGFRB rearrangement: XH6QD4\\nMyeloid and lymphoid neoplasms with FGFR abnormalities: XH1WR8\\nMyeloid or lymphoid neoplasm with PCMJAK: XH2WB4\\nLeukaemia NOS: XH4S92\\nAleukemic leukaemia NOS: XH29P0\\nChronic leukaemia NOS: XH80C3\\nSubacute leukaemia NOS: XH6QV5\\nAcute leukaemia NOS: XH1B20\\nAcute biphenotypic leukaemia: XH37U0\\nAcute bilineal leukaemia: XH2H98\\nAcute mixed lineage leukaemia: XH3VV7\\nMixed phenotype acute leukaemia with tqq BCRABL: XH97B7\\nMixed phenotype acute leukaemia with tvq MLL rearranged: XH2S51\\nMixed phenotype acute leukaemia Bmyeloid NOS: XH1928\\nMixed phenotype acute leukaemia Tmyeloid NOS: XH4YB5\\nB lymphoblastic leukaemialymphoma NOS: XH81V3\\nB lymphoblastic leukaemialymphoma with tqq BCRABL: XH73L9\\nB lymphoblastic leukaemialymphoma with tvq MLL rearranged: XH8GG0\\nB lymphoblastic leukaemialymphoma with tpq TELAML ETVRUNX: XH4KA2\\nB lymphoblastic leukaemialymphoma with hyperdiploidy: XH24C7\\nB lymphoblastic leukaemialymphoma with hypodiploidy Hypodiploid ALL: XH2MD9\\nB lymphoblastic leukaemialymphoma with tqq ILIGH: XH4ZL2\\nB lymphoblastic leukaemialymphoma with tqp EAPBX TCFPBX: XH3GU8\\nLymphoid leukaemia NOS: XH7Q12\\nLymphatic leukaemia NOS: XH1GQ1\\nLymphocytic leukaemia NOS: XH7PW5\\nAleukemic lymphoid leukaemia: XH4KS4\\nLymphosarcoma cell leukaemia: XH5BA6\\nSubacute lymphoid leukaemia: XH8GQ0\\nBcell chronic lymphocytic leukaemiasmall lymphocytic lymphoma: XH15T2\\nAdult Tcell leukaemialymphoma HTLV positive: XH6TE2\\nChronic lymphoproliferative disorder of NK cells: XH5EN4\\nProlymphocytic leukaemia NOS: XH8TD6\\nProlymphocytic leukaemia Bcell type: XH95H2\\nProlymphocytic leukaemia Tcell type: XH0DU4\\nPrecursor cell lymphoblastic leukaemia NOS: XH5J37\\nPrecursor Tcell lymphoblastic leukaemia: XH7T28\\nT lymphoblastic leukaemialymphoma: XH50W7\\nB lymphoblastic leukemialymphoma BCRABLlike: XH1D04\\nB lymphoblastic leukemialymphoma with iAMP: XH0KD4\\nEarly Tcell precursor acute lymphoblastic leukemia: XH8F29\\nAcute erythroid leukemia: XH43N4\\nMyeloid leukaemia NOS: XH7S21\\nAleukemic myeloid leukaemia: XH7LG8\\nAleukemic monocytic leukaemia: XH5DV4\\nChronic monocytic leukaemia: XH0E35\\nEosinophilic leukaemia: XH6JX2\\nMonocytic leukaemia NOS: XH5JT8\\nSubacute monocytic leukaemia: XH1S60\\nSubacute myeloid leukaemia: XH7DF6\\nAcute myeloid leukaemia NOS: XH8AA5\\nAcute myeloid leukemia with biallelic mutation of CEBPA: XH4M02\\nAcute myeloid leukaemia with mutated NPM: XH74W8\\nChronic myeloid leukaemia NOS: XH4XG8\\nAcute myeloid leukaemia with tpq DEKNUP: XH9Y46\\nAcute promyelocytic leukaemia tqq: XH1A50\\nAcute myeloid leukaemia with invqq or tqq RPNEVI: XH2KE3\\nAcute myeloid leukaemia with abnormal marrow eosinophils: XH3PA4\\nAcute myeloid leukaemia minimal differentiation: XH90G0\\nChronic myelogenous leukaemia BCRABL positive: XH2AB7\\nAtypical chronic myeloid leukaemia BCRABL negative: XH21X5\\nAtypical chronic myeloid leukaemia Philadelphia chromosome Ph negative: XH26U9\\nAcute monocytic leukaemia: XH9NE2\\nAcute monoblastic and monocytic leukaemia: XH1K97\\nAcute myeloid leukaemia tqq: XH3CX5\\nAcute myeloid leukaemia q abnormalities: XH1E41\\nMyeloid leukaemia associated with Down Syndrome: XH6AQ7\\nAcute myeloid leukaemia megakaryoblastic with tpq RBMMKL: XH16K4\\nTherapy related myeloid neoplasm: XH7045\\nTherapyrelated acute myeloid leukaemia alkylating agent related: XH6Z50\\nTherapyrelated acute myeloid leukaemia epipodophyllotoxinrelated: XH4EJ0\\nAcute myeloid leukemia with BCRABL: XH6FZ7\\nAcute myeloid leukemia with mutated RUNX: XH1EK4\\nChronic myelomonocytic leukaemia NOS: XH86N4\\nChronic myelomonocytic leukaemia Type I: XH0FC4\\nChronic myelomonocytic leukaemia Type II: XH7HJ7\\nAggressive NKcell leukaemia: XH9MA0\\nHairy cell leukaemia: XH5J10\\nMalignant lymphoma NOS: XH5FJ5\\nMalignant lymphoma nonHodgkin NOS: XH50P3\\nB cell lymphoma NOS: XH5RG7\\nLymphosarcoma NOS: XH9MU1\\nMalignant lymphoma diffuse NOS: XH8226\\nMalignant lymphoma noncleaved cell NOS: XH5WX8\\nReticulum cell sarcoma NOS: XH51A9\\nHairy cell leukaemia variant: XH9E18\\nMalignant lymphoma lymphocytic intermediate differentiation nodular: XH1SK1\\nMalignant lymphoma lymphocytic poorly differentiated diffuse: XH06Q4\\nMalignant lymphoma small cell noncleaved diffuse: XH9PT6\\nMalignant lymphoma small cleaved cell diffuse: XH2TN1\\nSplenic Bcell lymphomaleukaemia unclassifiable: XH75T5\\nSplenic diffuse red pulp small Bcell lymphoma: XH99V9\\nComposite Hodgkin and nonHodgkin lymphoma: XH3BP6\\nBcell lymphoma unclassifiable with features intermediate between diffuse large Bcell lymphoma and classical Hodgkin lymphoma: XH04Y1\\nMonoclonal Bcell lymphocytosis NOS: XH73D5\\nMonoclonal Bcell lymphocytosis nonCLL type: XH5M35\\nHodgkin lymphoma NOS: XH94F7\\nClassical Hodgkin lymphoma posttransplant lymphoproliferative disease: XH22K3\\nHodgkin lymphoma lymphocyterich: XH8CB2\\nHodgkin disease lymphocyte predominance NOS: XH7KX4\\nHodgkin lymphoma mixed cellularity NOS: XH9NJ5\\nHodgkin lymphoma lymphocyte depletion NOS: XH7RN9\\nHodgkin lymphoma lymphocyte depletion diffuse fibrosis: XH7299\\nHodgkin lymphoma lymphocyte depletion reticular: XH4E19\\nHodgkin lymphoma nodular lymphocyte predominant: XH2FG7\\nHodgkin granuloma: XH13B0\\nHodgkin sarcoma: XH11Y2\\nHodgkin lymphoma nodular sclerosis NOS: XH6SC5\\nHodgkin lymphoma nodular sclerosis cellular phase: XH51K7\\nHodgkin lymphoma nodular sclerosis grade: XH8K28\\nMature Bcell lymphomas: XH3FE9\\nImmunocytoma: XH43K4\\nMalignant lymphoma plasmacytoid: XH9TT4\\nPlasmacytic lymphoma: XH3KQ3\\nMalignant lymphoma mixed small and large cell diffuse: XH1J80\\nMediastinal large Bcell lymphoma: XH8U09\\nDiffuse large Bcell lymphoma NOS: XH9B17\\nFibrinassociated EBV diffuse large Bcell lymphoma: XH0RM6\\nMalignant lymphoma centroblastic NOS: XH1VQ1\\nMalignant lymphoma centroblastic diffuse: XH9JY8\\nAnaplastic large Bcell lymphoma: XH78W3\\nBcell lymphoma unclassifiable with features intermediate between diffuse large Bcell lymphoma and Burkitt lymphoma: XH9L43\\nEBV positive diffuse large Bcell lymphoma: XH1QK0\\nPrimary cutaneous DLBCL leg type: XH8657\\nPrimary diffuse large Bcell lymphoma of CNS: XH2MP0\\nHigh grade Bcell lymphoma NOS: XH2WM7\\nHigh grade Bcell lymphoma with MYC and BCL andor BCL rearrangements: XH23Z3\\nVitreoretinal lymphoma: XH86B5\\nMalignant lymphoma large Bcell diffuse immunoblastic NOS: XH7Z25\\nBurkitt lymphoma NOS: XH4KA9\\nBurkittlike lymphoma: XH0H23\\nBurkittlike lymphoma with q aberration: XH8NN2\\nBurkitt cell leukaemia: XH6B12\\nSplenic marginal zone Bcell lymphoma: XH0MV1\\nFollicular lymphoma NOS: XH0LK1\\nFollicular lymphoma pediatric type: XH9RH9\\nFollicular lymphoma duodenal type: XH9L76\\nLarge Bcell lymphoma with IRF rearrangement: XH6SU8\\nMarginal zone Bcell lymphoma NOS: XH1X21\\nExtranodal marginal zone lymphoma of mucosaassociated lymphoid tissue: XH1V99\\nPrimary choroidal lymphoma: XH6JB5\\nIn situ mantle cell neoplasia: XH8EM2\\nEBV positive mucocutaneous ulcer: XH3SG2\\nIn situ follicular neoplasia: XH4L38\\nMature Tand NKcell lymphomas: XH3400\\nGranulomatous slack skin: XH0EH1\\nSezary syndrome: XH8HN3\\nMature Tcell lymphoma NOS: XH3HJ2\\nLymphoepithelioid lymphoma: XH92G2\\nFollicular Tcell lymphoma: XH14S3\\nNodal peripheral Tcell lymphoma with T follicular helper phenotype: XH6SR1\\nCutaneous Tcell lymphoma NOS: XH1951\\nPrimary cutaneous CDpositive aggressive epidermotropic cytotoxic Tcell lymphoma: XH2513\\nPrimary cutaneous acral CD positive Tcell lymphoma: XH7S84\\nAnaplastic large cell lymphoma T cell and Null cell type: XH7EZ9\\nAnaplastic large cell lymphoma NOS: XH1LC0\\nAnaplastic large cell lymphoma ALK positive: XH9484\\nIntestinal Tcell lymphoma: XH9FT0\\nMonomorphic epitheliotropic intestinal Tcell lymphoma: XH1AG7\\nPrimary cutaneous anaplastic large cell lymphoma: XH5SC3\\nPrimary mucosal CD Tcell lymphoproliferative disorder: XH0353\\nNKTcell lymphoma nasal and nasaltype: XH5LU6\\nIndolent Tcell lymphoproliferative disorder of gastrointestinal tract: XH0B02\\nPrimary cutaneous CD positive smallmedium Tcell lymphoproliferative disorder: XH3QE7\\nPrimary cutaneous CDpositive smallmedium Tcell lymphoma: XH7EL2\\nAnaplastic large cell lymphoma ALK negative: XH9T74\\nBreast implantassociated anaplastic large cell lymphoma: XH05D8\\nPrimary cutaneous CD Tcell lymphoproliferative disorder: XH40C0\\nPrecursor cell lymphoblastic lymphoma: XH2216\\nSystemic EBV positive Tcell lymphoproliferative disease of childhood: XH6TZ4\\nPrimary cutaneous gammadelta Tcell lymphoma: XH84A5\\nPrecursor cell lymphoblastic lymphoma NOS: XH14N1\\nBlastic NKcell lymphoma: XH42X4\\nHydroa vacciniformelike lymphoproliferative disorder: XH0AK5\\nImmunoproliferative disease NOS: XH4KF3\\nWaldenstrom macroglobulinemia: XH8GW4\\nHeavy chain disease NOS: XH7RJ1\\nImmunoproliferative small intestinal disease: XH3SS7\\nLymphomatoid granulomatosis grade: XH7BG6\\nAngiocentric immunoproliferative lesion: XH3U73\\nAngioimmunoblastic lymphadenopathy AIL: XH2A53\\nTgamma lymphoproliferative disease: XH0HS7\\nImmunoglobulin deposition disease: XH2WA6\\nIgM monoclonal gammopathy of undetermined significance: XH16T1\\nPlasmacytoma NOS: XH4BL1\\nPlasmacytoma extramedullary: XH0N40\\nALK positive large Bcell lymphoma: XH1EB9\\nLarge Bcell lymphoma arising in HHVassociated multicentric Castleman disease: XH5HJ5\\nMalignant mastocytosis: XH2992\\nAggressive systemic mastocytosis: XH10N1\\nSystemic mastocytosis with AHNMD: XH1H01\\nSystemic mastocytosis with associated haematological clonal nonmast cell disorder: XH5191\\nErdheimChester disease: XH1VJ3\\nMastocytoma NOS: XH1J17\\nDiffuse cutaneous mastocytosis: XH2RG8\\nIndolent systemic mastocytosis: XH2Y59\\nSolitary mastocytoma of skin: XH2RL8\\nMalignant histiocytosis: XH2WJ3\\nHistiocytic medullary reticulosis: XH7PV7\\nAcute progressive histiocytosis X: XH4XT4\\nHistiocytosis X NOS: XH8VV4\\nHandSchullerChristian disease: XH86U0\\nLettererSiwe disease: XH60Q1\\nNonlipid reticuloendotheliosis: XH0YE1\\nLangerhans cell histiocytosis disseminated: XH40U7\\nTrue histiocytic lymphoma: XH46Q0\\nDendritic cell sarcoma NOS: XH8Q19\\nIndeterminate dendritic cell tumour: XH3ZM0\\nFollicular dendritic cell tumour: XH6ZR5\\nEosinophilic granuloma: XH75E6\\nLangerhans cell histiocytosis monostotic: XH0RF4\\nLangerhans cell histiocytosis polyostotic: XH2PY9\\nBurns involving less than  of body surface: XJ4NH\\nBurns involving  of body surface: XJ1HD\\nBurns involving  or more of body surface: XJ9JX\\nFull thickness or deep full thickness burn involving less than  of body surface: XJ243\\nFull thickness or deep full thickness burn involving  of body surface: XJ9UE\\nFull thickness or deep full thickness burn involving  or more of body surface: XJ3MB\\nDeep full thickness or complex burn with no loss of limb: XJ71T\\nDeep full thickness or complex burn with loss of digit: XJ6NX\\nDeep full thickness or complex burn with loss of limb: XJ36Y\\nFracture extends into joint: XJ5GS\\nFracture extends into joint and a portion of the articular part remains attached to the main part of the bone: XJ5L7\\nFracture extends into joint and the entire articular part is detached from the main part of the bone: XJ92H\\nFracture does not extend into joint: XJ5VJ\\nClosed fracture: XJ44E\\nOpen fracture: XJ7YM\\nAvulsion fracture: XJ36W\\nBucket handle or corner fracture: XJ2EL\\nBuckle fracture: XJ76E\\nBurst fracture: XJ7ZH\\nComminuted fracture: XJ1Z6\\nCompound fracture: XJ1PP\\nCompression fracture: XJ778\\nDepressed fracture: XJ9UB\\nDislocated fracture: XJ69V\\nDisplaced fracture: XJ8PQ\\nElevated fracture: XJ0QE\\nFissured fracture: XJ5N9\\nGreenstick fracture: XJ45W\\nImpacted fracture: XJ7AT\\nInfected fracture: XJ4PE\\nLinear fracture: XJ392\\nLongitudinal fracture: XJ6RL\\nMissile fracture: XJ4CX\\nOsteochondral fracture: XJ4FU\\nPhyseal fracture: XJ3HH\\nPuncture fracture: XJ64N\\nSimple fracture: XJ909\\nSlipped epiphysis fracture: XJ9XQ\\nSpiral fracture: XJ967\\nTransverse fracture: XJ5V7\\nWedge fracture: XJ6NA\\nFracture with foreign body: XJ8QL\\nAbrasion: XJ652\\nBlister nonthermal: XJ8JK\\nContusion: XJ9NV\\nExternal constriction: XJ4D1\\nInsect bite nonvenomous: XJ69A\\nSuperficial foreign body: XJ06K\\nSuperficial splinter: XJ3U1\\nSuperficial haematoma: XJ1C6\\nExposure to injurious transport event: XE72E\\nExposure to land transport injury event: XE9S7\\nExposure to land transport onroad injury event: XE9EE\\nExposure to land transport offroad injury event: XE8TM\\nExposure to railway transport injury event: XE3S3\\nExposure to water transport injury event: XE85L\\nExposure to air or space transport injury event: XE5XH\\nExposure to fall: XE3Y8\\nExposure to fall on the same level or from less than  metre: XE8J4\\nExposure to fall from a height of  metre or more: XE3QG\\nExposure to person animal or plant: XE4U1\\nExposure to being struck kicked or bumped: XE1TU\\nExposure to being stepped on or crushed: XE0VW\\nExposure to being bitten: XE359\\nExposure to being scratched or clawed: XE9PG\\nExposure to being stung or envenomated: XE972\\nExposure to object not elsewhere classified: XE214\\nExposure to being struck by projectile from firearm: XE2YW\\nExposure to being struck by moving object: XE4UV\\nExposure to being struck against stationary object: XE6LQ\\nExposure to being cut or pierced by sharp object: XE20S\\nExposure to being struck by blunt object: XE59C\\nExposure to being caught crushed jammed or pinched between objects: XE4FE\\nExposure to immersion submersion or falling into water: XE64Q\\nExposure to drowning or submersion while in body of water: XE72F\\nExposure to drowning or submersion following fall into body of water: XE1AF\\nExposure to threat to breathing: XE8NX\\nExposure to threat to breathing by suffocation from object covering mouth or nose: XE9N2\\nExposure to threat to breathing by hanging: XE9LA\\nExposure to threat to breathing by strangulation: XE17S\\nExposure to threat to breathing by external compression of airways or chest: XE2NR\\nExposure to threat to breathing by inhalation or ingestion of gastric contents: XE33X\\nExposure to threat to breathing by inhalation or ingestion of liquids: XE2PV\\nExposure to threat to breathing by inhalation or ingestion of food: XE5QH\\nExposure to threat to breathing by inhalation or ingestion of other objects or materials: XE9RJ\\nExposure to threat to breathing from low oxygen environment: XE2DJ\\nExposure to thermal mechanism: XE6JM\\nExposure to uncontrolled fire: XE0S0\\nExposure to controlled fire: XE5WP\\nExposure to ignition or melting of material: XE9T8\\nExposure to hot object or liquid: XE494\\nExposure to steam hot vapour air or gases: XE515\\nExposure to excessive heat: XE00Z\\nExposure to excessive cold: XE4AY\\nExposure to or harmful effects of substances: XE3SH\\nPoisoning or toxic effect of exposure to substance: XE13E\\nCorrosion due to exposure to substance: XE1SS\\nForeign body in orifice: XE202\\nExposure to electric current: XE8A0\\nExposure to sunlight: XE8DS\\nExposure to radiation: XE60C\\nExposure to welding light: XE82Y\\nExposure to other visible and ultraviolet light of manmade sources: XE436\\nExposure to ultraviolet radiation: XE500\\nExposure to other nonionizing radiation: XE6JQ\\nExposure to microwave radiation: XE6VK\\nExposure to infrared radiation: XE9G0\\nExposure to ionizing radiation: XE5PJ\\nExposure to high or low air pressure or changes in air pressure: XE5DF\\nExposure to changes in air pressure: XE4ZB\\nExposure to high air pressure: XE07M\\nExposure to low air pressure: XE67J\\nExposure to explosion: XE9Y8\\nExposure to chemical explosion: XE22U\\nExposure to explosion or rupture of pressurised materials or object: XE27P\\nExposure to noise: XE7Y1\\nExposure to vibration: XE3RX\\nExposure to suction: XE7BT\\nLack of food: XE7SS\\nLack of water: XE3WS\\nExposure to physical overexertion: XE4TW\\nExposure to other specified privation: XE67Q\\nAbandonment: XE42R\\nNeglect: XE00G\\nPaid work: XE545\\nTravelling to or from paid work: XE7NW\\nTravelling in the course of paid work: XE9Q2\\nRepetitive forceful work: XE2QJ\\nExtended periods of work in a kneeling position: XE88E\\nExtended periods of work in a squatting position: XE714\\nUnpaid work: XE8VF\\nTravelling to or from unpaid work: XE1C6\\nTravelling in the course of unpaid work: XE3RL\\nUnpaid cleaning cooking or maintenance at own place of residence: XE9ME\\nEducational activity: XE729\\nPhysical education class school sports: XE3HD\\nTravelling to or from educational activity: XE4SM\\nOrganised sports and exercise during leisure time: XE5UF\\nLeisure or play: XE617\\nOther specified sports and exercise during leisure time: XE5C9\\nBeing taken care of by health care professional: XE245\\nBeing taken care of by non health care person: XE2EZ\\nBeing taken care of by a person not specified as a health care professional or non health care person: XE643\\nHome: XE266\\nDetached house: XE9XY\\nTerrace house or row house: XE9P0\\nApartment or flat: XE7DU\\nFarmhouse: XE7F8\\nResidential caravan mobile home houseboat or motor home: XE1LE\\nHut: XE3ZC\\nBoarding house or hotel: XE6X4\\nResidential institution: XE9DC\\nHome for the elderly: XE8PL\\nNursing home: XE498\\nPrison: XE30E\\nShelter for battered women and their children: XE8BC\\nMilitary institution: XE138\\nMedical service area: XE9VC\\nHospital: XE28K\\nOutpatient clinic or health centre: XE8DZ\\nHealth professionals office: XE86F\\nHospice: XE9ZD\\nSchool or educational area: XE6TU\\nChild centre or day care centre: XE3JM\\nPreschool or kindergarten: XE9LH\\nPrimary school: XE1ZF\\nSecondary school: XE3CZ\\nCollege or university: XE9BK\\nAdult education institution: XE1JM\\nSports and athletics area: XE7K0\\nOutdoor sporting grounds: XE9WC\\nIndoor sporting hall: XE1CY\\nPublic swimming centre: XE3YG\\nRacetrack or racecourse: XE8BN\\nEquestrian facility: XE2LU\\nSkating rink or ice palace: XE7QG\\nSkiing or snowboarding area: XE7WU\\nPublic highway street or road: XE5NE\\nRoadway: XE6NQ\\nSidewalk: XE53A\\nCycleway: XE4U4\\nTransport area other than highway street or road: XE5KY\\nParking area: XE3NV\\nPublic transport area or facility: XE4N9\\nIndustrial or construction area: XE7T4\\nBuilding under construction: XE11T\\nDemolition site: XE0Z7\\nFactory or plant: XE3U5\\nMine or quarry: XE0Y1\\nOil or gas extraction facility: XE7GD\\nShipyard: XE7MT\\nPower station: XE8Q1\\nFarm or other place of primary production: XE9CS\\nArea for growing crops market gardening horticulture: XE1ES\\nArea for raising or care of animals: XE54N\\nAnimal stables: XE9WB\\nArea for growing crops combined with raising and care of animals: XE9C6\\nPlace for socialising and consumption of alcoholic drinks: XE1WL\\nBar pub saloon or other commercial place primarily for provision of alcoholic drinks: XE03P\\nNightclub restaurant or other commercial place for socialising and recreation: XE7Y2\\nRecreational area cultural area or public building: XE7GY\\nPublic playground: XE0AJ\\nAmusement park or theme park: XE35Q\\nPublic park: XE5C2\\nNoncultural public building: XE774\\nHoliday park or campground: XE4TG\\nPublic religious place: XE0ES\\nCommercial area nonrecreational: XE48U\\nShop or store: XE319\\nCaf or fast food outlet: XE058\\nCommercial garage: XE543\\nOffice building: XE58T\\nCountryside: XE5JL\\nArea of still water: XE0ZP\\nStream of water: XE17F\\nLarge area of water: XE93X\\nMarsh or swamp: XE5TX\\nBeach shore or bank of a body of water: XE010\\nForest: XE6AV\\nDesert: XE601\\nOutofhospital: XE2BE\\nInhospital: XE36S\\nPart of building or grounds bathroom toilet: XE2XM\\nPart of building or grounds kitchen: XE4XM\\nPart of building or grounds living room: XE1M5\\nPart of building or grounds bedroom: XE8RZ\\nPart of building or grounds playroom or family room: XE45Z\\nPart of building or grounds office or home office: XE051\\nPart of building or grounds classroom: XE115\\nPart of building or grounds canteen or cafeteria: XE70Z\\nPart of building or grounds balcony: XE4U5\\nPart of building or grounds stairs: XE2NQ\\nPart of building or grounds elevator: XE9L8\\nPart of building or grounds corridor: XE6ZJ\\nPart of building or grounds lobby: XE3R6\\nPart of building or grounds garden or yard: XE3DE\\nPart of building or grounds garage: XE2Q4\\nPart of building or grounds driveway: XE65J\\nPart of building or grounds swimming pool: XE4PW\\nPart of building or grounds tennis court: XE7DE\\nPart of building or grounds other specified sporting facility: XE9DN\\nPart of building or grounds playground: XE8SG\\nPart of building or grounds private road: XE5RE\\nPart of building or grounds private parking area: XE5MW\\nPart of building or grounds other specified indoor part of building or grounds: XE6ZY\\nPart of building or grounds other specified outdoor part of building or grounds: XE06N\\nPersonpowered means of transport: XE81T\\nTransport vehicle drawn or pushed by person: XE38Y\\nPedal cycle: XE94Q\\nAnimalpowered means of transport: XE1MP\\nAnimal being ridden: XE0ZZ\\nAnimaldrawn vehicle: XE1CF\\nMotorised twoor threewheeled vehicle: XE3ZP\\nMotorcycle: XE0TY\\nMoped scooter: XE9N6\\nThreewheeled motor vehicle or scooter: XE9AX\\nLight transport vehicle with four or more wheels: XE3GH\\nPassenger car: XE50Z\\nLight truck Sports Utility Vehicle SUV utility van x vehicle jeep pickup truck: XE4BF\\nMinibus: XE6DC\\nHeavy transport vehicle with four or more wheels: XE4NR\\nBus coach: XE60G\\nTractortrailer articulated lorry wheeler rig: XE8XB\\nHeavy truck not elsewhere classified: XE5A8\\nTrailer or horsefloat: XE5KW\\nRail vehicle: XE0ZK\\nStreetcar tram electric car car trolley: XE40X\\nTrain: XE9Q3\\nFunicular monorail or other similar rail vehicle: XE3P6\\nParts or components of land vehicle or means of land transport: XE0YD\\nVehicle doors not elsewhere classified: XE954\\nVehicle seat belts deploying air bags: XE226\\nTyre tire or battery attached or unattached: XE8UK\\nVehicle window or windshield: XE8CT\\nInterior of vehicle: XE1LF\\nEngine of vehicle: XE5D5\\nCertain specified land vehicle or means of land transport: XE3C0\\nCable car ski chair lift ski lift with gondola: XE8KJ\\nMotorized wheelchair: XE8C8\\nSmallsized motorized vehicles for children: XE4D7\\nMotor home: XE3FP\\nMobile machinery or special purpose vehicle mainly used in agriculture: XE7X0\\nRideon lawn mower: XE9HQ\\nTractor: XE0S2\\nHarvesting machine: XE0YP\\nAuger post hole digger: XE7SF\\nEquipment towed or powered by tractors not elsewhere classified: XE0LF\\nMobile machinery or special purpose vehicle mainly used in industry: XE0M8\\nForklift or lift truck: XE21P\\nMobile crane: XE8TB\\nBatterypowered airport passenger vehicle: XE6VY\\nLogging car: XE13Q\\nCoalcar in mine: XE6B4\\nTram truck or tub in mine or quarry: XE1BG\\nMobile machinery or special purpose vehicle mainly used in construction: XE1GE\\nGrader: XE4MS\\nFrontend loader bulldozer: XE69J\\nExcavator digger mechanical shovel: XE6XP\\nRoad roller: XE3GR\\nCertain specified mobile machinery or special purpose vehicle: XE381\\nAmbulance: XE80A\\nFire truck fire engine: XE5BQ\\nRace car: XE387\\nSnowmobile skiscooter: XE2LT\\nSpecial allterrain vehicle or offroad vehicle: XE6R9\\nPowered watercraft or means of water transport: XE70T\\nMerchant ship cargo ship oil tanker: XE7NQ\\nPassenger ship passenger liner ocean liner: XE3HS\\nFishing boat trawler: XE801\\nFerry used for short trips across closed waters: XE69F\\nMotorised yacht motorboat powered boat personal powered watercraft: XE3WZ\\nHouseboat: XE304\\nHovercraft: XE5ZR\\nAirboat: XE3PW\\nSubmarine or related craft: XE4UQ\\nUnpowered watercraft or means of water transport: XE29V\\nSailboat unpowered yacht: XE9SF\\nCanoe kayak row boat pirogue piragua: XE8BZ\\nWave board surfboard paddle ski: XE3CC\\nWindsurfer: XE3LU\\nPart or component of powered or unpowered watercraft: XE5G3\\nPowered aircraft or means of air transport: XE9LQ\\nHelicopter: XE4LN\\nAirship blimp: XE8RL\\nUltralight powered aircraft: XE0WR\\nPrivate fixedwing powered aircraft: XE7MP\\nCommercial fixedwing powered aircraft: XE7FK\\nMilitary fixedwing powered aircraft: XE6FD\\nSpacecraft: XE346\\nUnpowered aircraft or means of air transport: XE4QU\\nPassenger balloon unpowered: XE96T\\nParachute: XE627\\nHangglider: XE3VU\\nGlider: XE2KU\\nPart or component of powered or unpowered aircraft: XE79E\\nFurniture or furnishing: XE5HA\\nBed bedding or bedding accessories: XE8PK\\nBunk bed: XE86G\\nSpecial bed orthopaedic bed or stretcher: XE7QQ\\nHammock: XE27V\\nMattress sleeping mat: XE0TM\\nOther specified bed: XE2DR\\nPillow cushion: XE6R1\\nBed rails: XE38G\\nChair or sofa: XE769\\nUpholstered chair or sofa: XE33K\\nHard chair or bench: XE853\\nRocking or gliding chair: XE5NL\\nFolding chair: XE1NC\\nRevolving chair: XE7FS\\nStool: XE484\\nCommode chair: XE61B\\nTable stand cupboard shelf or partition: XE2F3\\nRack bookshelf: XE002\\nCabinet cupboard side board chest of drawers tall boy dresser: XE3BY\\nDining room or kitchen table: XE1DK\\nCoffee table: XE6E5\\nNight table end table: XE2C9\\nDesk workbench: XE2AM\\nTelevision table stand cupboard: XE3TY\\nFolding table: XE6EN\\nRoom divider or partition: XE4B1\\nDecoration decorating item: XE7MK\\nRug mat loose carpet: XE3WK\\nDraperies curtains: XE003\\nRoller or venetian blind or indoor shutter: XE92A\\nWindow covering hardware: XE3EA\\nMirror or mirror glass: XE962\\nPortrait picture picture frame or other wall hanging or similar decoration: XE05Q\\nChristmas tree: XE1FR\\nHoliday decorations: XE4CE\\nInfant or child product: XE8RW\\nBaby or child article: XE1AW\\nBaby pram buggy pusher stroller carriage: XE0CS\\nBaby walker: XE4JE\\nBaby exerciser jumper or portable swing for home use: XE8U9\\nHigh chair booster seat: XE39K\\nBaby or child car seat: XE52H\\nPotty chair training seat: XE9MB\\nCot crib baby bed: XE8RG\\nPlaypen travel yard: XE5QK\\nBaby gate or barrier: XE12N\\nBaby carrier back pack type: XE34A\\nPedal cycle baby carrier: XE8HU\\nBaby baths or bathinettes: XE8VC\\nBaby or child changing table: XE49V\\nBaby or child pacifier dummy: XE9R1\\nBaby bottle or nipple: XE1JQ\\nDiaper nappy: XE7HA\\nDiaper fastener: XE5E9\\nToy: XE3Y2\\nChilds tricycle or other rideon toy: XE0GX\\nToy vehicle: XE959\\nToy gun or related accessory: XE93L\\nOther toy weapon or projectile toy: XE8ZY\\nToy art craft or kit: XE1DG\\nBoard game or accessory or piece: XE9DY\\nToy sports equipment: XE887\\nBall general other than sport specific: XE1HM\\nInfant or child product flying toy: XE5FF\\nInfant or child product doll doll accessory or part stuffed toy: XE30M\\nInfant or child product toy balloon: XE5E1\\nInfant or child product inflatable toy: XE4HX\\nInfant or child product marble bead: XE2KV\\nInfant or child product play tent tunnel or other enclosure: XE1X0\\nInfant or child product toy box or chest: XE7UT\\nPlayground equipment: XE6JS\\nTree house play house: XE7YQ\\nPlayground equipment flying fox: XE8H2\\nPlayground equipment monkey bar: XE27W\\nOther playground climbing apparatus: XE8K7\\nPlayground equipment slide sliding board: XE0R1\\nPlayground equipment swing swing set: XE5W3\\nPlayground equipment seesaw teeter totter: XE9AU\\nPowered amusement rides: XE59P\\nAppliance mainly used in household: XE14C\\nCooking or kitchen appliance: XE68B\\nElectric kettle: XE3WY\\nElectric frying pan deep fryer: XE3FW\\nElectric bread making machine: XE03R\\nFood processor blender juicer: XE6DV\\nPowered knife: XE02T\\nElectric toaster toaster oven: XE5LB\\nMicrowave oven: XE7D9\\nStove oven cooktop: XE6PT\\nPressurised kerosene or paraffin cooking stove: XE464\\nCoal pot: XE0U0\\nChulo stove: XE5YC\\nBarbeque outdoor cookers or griller outdoor clay oven: XE6A4\\nDishwasher: XE0U1\\nRefrigerator freezer appliance: XE3JZ\\nCleaning or laundering appliance or tool: XE87D\\nWashing machine: XE4FB\\nClothes dryer: XE0Y0\\nClothes iron press: XE2VW\\nClothesline clothes drying rack clotheshorse: XE06L\\nUnpowered cleaning tool: XE9H2\\nVacuum cleaner: XE5PE\\nPowered cleaning tool not elsewhere classified: XE7Z3\\nLighting appliance: XE4KD\\nFreestanding gas oil or kerosene lamp: XE3QJ\\nElectric lamp: XE926\\nOther specified lamp or lamp component: XE5GA\\nBatteryoperated torch: XE1D7\\nCandle candlestick: XE01B\\nHeating or cooling appliance: XE84K\\nFan: XE5VR\\nElectric or gas radiator heater: XE1ZZ\\nKerosene heater: XE0KQ\\nSewing appliance or equipment: XE9WK\\nSewing machine: XE0PW\\nScissors: XE204\\nPin needle: XE8D1\\nEntertainment appliance: XE80T\\nTelevision: XE6SR\\nVideo recorder decoder player: XE1PK\\nVideo camera camera digital camera or accessory: XE5Y8\\nSound equipment: XE59W\\nCord of household appliance extension cord: XE2MS\\nCooking or food processing utensil: XE4G0\\nNonelectric kettle: XE7VX\\nKnife not elsewhere classified: XE8WH\\nCooking pot pan: XE9LY\\nPressure cooker: XE50Y\\nCutlery food preparation utensil: XE5CG\\nCrockery kitchen container: XE9W8\\nDrinking glass cup made from glass or china: XE532\\nPlate bowl dish made from glass or china: XE9Q8\\nGlass bottle or jar: XE6LK\\nContainer made from plastic wood or clay: XE5G7\\nCleaning utensil or container: XE8EL\\nBucket pail: XE383\\nFood storage or related utensil or container: XE4WL\\nTinned container tin can: XE1GJ\\nBox or carton containing food or drink: XE5N6\\nGrocery or shopping trolley or cart: XE8JZ\\nCertain specified utensil or container: XE31H\\nRubbish bin trash can dumpster: XE3SR\\nHeavy container box package not elsewhere classified: XE0GP\\nBag sack not elsewhere classified: XE80G\\nClothes foot wear or related products: XE12D\\nBelt braces suspenders sash: XE42F\\nButton: XE06P\\nOther specified clothes fastener: XE8H8\\nShoe sandal slipper boot: XE1KG\\nShoelace shoe buckle: XE0MQ\\nShirt blouse tshirt trousers slacks jacket coat outerwear: XE6A6\\nNightclothes pyjamas nightwear underwear undergarment lingerie: XE4AP\\nClothing accessory or personal decoration item: XE91F\\nWristwatch jewellery: XE79Y\\nPersonal grooming utensil: XE9WV\\nHair dryer curling iron curler: XE7FF\\nComb hairbrush: XE2CA\\nRazor razor blade: XE22C\\nElectric shaver: XE39S\\nElectric toothbrush: XE1RS\\nOther toothbrush: XE88G\\nToiletries cosmetics or related product: XE45T\\nCleaning agent for contact lenses: XE5U0\\nDental care products: XE5CY\\nCotton swab cotton bud Qtip: XE94F\\nSoap: XE1H5\\nDeodorants: XE1B1\\nPerfume cologne: XE5DV\\nHair colouring preparation: XE8PE\\nHair removal preparation depilatory: XE1T3\\nOther hair care product: XE8EH\\nNail polish: XE3EV\\nBody or facial cream or lotion: XE7DF\\nBody powder talc: XE8W8\\nCosmetics not elsewhere classified: XE79N\\nSuntan or sunscreen products selftan products: XE8NY\\nEssential oils oils used in aromatherapy: XE4KX\\nCommunication or related utensil or accessory: XE3AM\\nTelephone mobile phone cellular phone: XE2A3\\nPersonal computer or related accessory: XE9K5\\nFax machine and other related equipment: XE38S\\nTypewriter correction fluid: XE5V8\\nPen pencil: XE38A\\nOther stationery item: XE1RG\\nArts and crafts supplies: XE58R\\nArtist paint: XE0NW\\nChalk crayon: XE2EN\\nGlazes: XE6E6\\nCanvas: XE8ZP\\nPersonal aid: XE0X7\\nEyewear: XE5EM\\nWheelchair: XE293\\nCane walker walking stick walking frame: XE90Y\\nProsthesis: XE5W4\\nRubber bathtub mat: XE6ZS\\nTobacco or related product: XE7P9\\nCigarette cigar pipe: XE01N\\nLighter match: XE4U8\\nAids to quit smoking: XE0Q7\\nCertain specified personal use item: XE2H2\\nVaporizer humidifier: XE1NP\\nOil burner: XE1PV\\nCondom or other contraceptive device: XE7S6\\nSex aids: XE9GS\\nAlarm clock clock: XE030\\nUmbrella: XE9R0\\nCoins: XE3T5\\nHandheld fan: XE6N6\\nBall used in sport: XE5BJ\\nSoft ball: XE9X9\\nPuck hard ball: XE7M5\\nHandheld sports equipment: XE68L\\nSpear javelin not elsewhere classified: XE3H8\\nBow arrow crossbow bolt crossbow not elsewhere classified: XE9CT\\nOther specified sports projectile: XE557\\nBat hockey stick: XE23P\\nRacquet: XE9MP\\nIce pick: XE1HX\\nEquipment or structure for playing sports or exercise: XE0AQ\\nNet for sports or exercise: XE2EM\\nRugby pole net pole goal post: XE9R3\\nTrampoline for playing sports or exercise: XE6HE\\nGymnastic equipment: XE8C0\\nSports mat for playing sports or exercise: XE76Q\\nDiving board platform: XE9TW\\nExercise fitness equipment movable: XE1EH\\nExercise fitness equipment fixed: XE6G9\\nEquipment with wheels or designed for movement mainly for use in sports or recreational activity: XE70Q\\nRoller skates rollerski inline skates roller blades: XE38Q\\nSkateboard: XE7TJ\\nFolding scooter: XE06X\\nWaterski: XE9XZ\\nSnow ski: XE5W5\\nSnow board: XE6DZ\\nIce skate: XE2AY\\nSled toboggan sleigh snow disk snow tube: XE0AR\\nUnderwater diving equipment: XE9TA\\nAqualung: XE1WX\\nDiving belt weight: XE85D\\nWetsuit: XE8X8\\nGoggle or mask flipper or fin snorkel: XE3NW\\nCertain specified equipment for sports or recreational activity: XE8FX\\nPersonal protective equipment PPE designed for use in sports: XE92X\\nTool machine apparatus mainly used for workrelated activity: XE0P3\\nMachinery or fixed plant: XE6TZ\\nCutting or slicing machinery or fixed plant: XE43P\\nCrushing or pressing machinery or fixed plant: XE0VT\\nHeating or cooking machinery or fixed plant: XE1WC\\nRefrigeration machinery or fixed plant: XE76C\\nLifting machinery: XE14G\\nHoist machinery: XE77A\\nCrane machinery or fixed plant: XE3BT\\nElevated work platform: XE9U1\\nConveyors: XE6T6\\nMains gas water sewerage steam hot water electricity: XE99N\\nShearing plant: XE8FD\\nDairy or milking plant: XE6VH\\nPress: XE6AF\\nGarbage compactor: XE0JX\\nThreshing machine: XE02Q\\nChaffcutter foddercutter: XE8KN\\nPowered hand tool or equipment: XE5WX\\nDrill: XE88U\\nChainsaw: XE8MJ\\nOther power saw: XE66P\\nWelder welding equipment: XE0TD\\nNail gun stud driver: XE3E3\\nGrinder buffer polisher sander: XE3UP\\nPowered garden tool: XE8T6\\nPowered push lawn mower: XE89A\\nIndustrial vacuum cleaner: XE0N1\\nUnpowered hand tool or equipment: XE16F\\nUnpowered push lawnmower: XE8P1\\nHammer mallet: XE0VV\\nChopping tool: XE56E\\nCutting tool: XE9CU\\nDigging or tilling tool: XE9GT\\nLifting tool: XE3KL\\nNail screw tack: XE7VR\\nFishhook used for workrelated activity: XE3W7\\nRat or mouse trap used for workrelated activity: XE8KL\\nPressurebased equipment: XE9N7\\nGas cylinder: XE5VQ\\nPressurised hose pipe: XE974\\nCertain unpowered equipment: XE3RZ\\nLadder movable step: XE9P7\\nScaffolding: XE7RK\\nHelmet: XE5F6\\nEarplugs: XE67K\\nWelding mask: XE2PS\\nPersonal protective equipment not elsewhere classified: XE7RJ\\nFire extinguisher: XE7HB\\nMechanical power transmission device: XE505\\nSharp object: XE4BU\\nSpear javelin designed as weapon: XE3KV\\nArrow or bolt designed as weapon: XE9PM\\nKnife designed as weapon: XE174\\nSword dagger bayonet machete panga cutlass: XE598\\nFirearm or related item: XE04A\\nBullet pellet: XE4KC\\nHand gun: XE72J\\nRifle: XE0Q9\\nShotgun: XE32H\\nAir gun: XE6YZ\\nCertain specified weapon: XE1XM\\nClub cudgel rod knobkierie: XE61H\\nElectrical prod stun gun: XE9F9\\nCapsicum spray mace pepper spray: XE203\\nPlant: XE3C1\\nTree plant: XE9CV\\nLeaves flowers: XE2ZX\\nMushroom toadstool fungus: XE4DN\\nPlant seed: XE8XA\\nFruit from plant: XE4KB\\nPlant thorn: XE8SV\\nBranch or stick separate from branch or tree: XE50M\\nVenomous or toxic plant not elsewhere classified: XE2PR\\nBird: XE6L5\\nOstrich emu: XE99A\\nParrot parakeet cockatoo: XE69N\\nRaven crow magpie: XE1Q3\\nInsect invertebrate: XE6UV\\nBee: XE4D9\\nWasp: XE6LT\\nHornet: XE322\\nYellow hornet: XE7WQ\\nWhitefaced hornet: XE7TV\\nAnt: XE4YS\\nSpider: XE75L\\nScorpion: XE2EP\\nTick: XE779\\nCentipede millipede: XE11M\\nCochineal: XM6QA5\\nLand mammal: XE813\\nDog: XE33Q\\nDog dander: XE0W5\\nDog epithelium: XE3GM\\nCat: XE4V0\\nCat dander: XE896\\nRat guinea pig mouse: XE8X3\\nPig wild boar: XE3UD\\nSheep goat: XE25P\\nCow bull bovine animals: XE257\\nBeef: XE1LR\\nCow dander: XE5NG\\nHorse pony donkey mule ass: XE5VC\\nBaboon monkey chimpanzee gorilla: XE7NS\\nMarsupials: XE4TZ\\nDeer moose antelope zebra wildebeest: XE1MH\\nHippopotamus: XE37L\\nLion puma panther cougar mountain lion tiger: XE82S\\nBear grizzly bear polar bear: XE7UA\\nElephant: XE2Q6\\nBuffalo bison African buffalo: XE96F\\nHamster epithelium: XE08V\\nHorse dander: XE09T\\nMouse epithelium: XE7CQ\\nMouse urine proteins: XE43Q\\nRabbit epithelium: XE7TQ\\nPork: XE9BL\\nBlue mussel: XE6T4\\nScallop: XE6WA\\nGuinea pig epithelium: XE5ZB\\nMarine animal: XE2AH\\nShark: XE765\\nOther fishes: XE71F\\nSea snake: XE48L\\nMarine mammal: XE3UQ\\nJellyfish: XE8BW\\nNematocysts: XE40R\\nCoral: XE75E\\nSea urchin: XE6ZA\\nSea anemone: XE45C\\nSea cucumber: XE43L\\nReptile or amphibian: XE1PT\\nNonvenomous snake: XE44L\\nVenomous snake: XE9H6\\nCobra: XE9X2\\nFer de lance: XE5N3\\nRattlesnake: XE2RM\\nViper: XE8LD\\nKrait: XE2UZ\\nSnake unspecified whether venomous or not: XE11V\\nLizard gecko goanna: XE6A7\\nGila monster: XE65X\\nFrog toad: XE4YK\\nCrocodile alligator: XE4FD\\nPerson: XE653\\nPerson self: XE70B\\nCrowd of people: XE0TZ\\nBuilding fitting: XE1P6\\nFlush toilet: XE766\\nPit latrine: XE429\\nBathtub spabath shower cubicle: XE2C6\\nBathtub: XE78X\\nspabath: XE5T1\\nshower cubicle: XE5RW\\nShower: XE31Q\\nFitted counter countertop kitchen top: XE8P0\\nDoor window or related fitting or feature: XE2AC\\nDoor door sill: XE68A\\nGlass door: XE4YT\\nSecurity door or gate fly gate: XE4NX\\nBars on windows: XE6FE\\nWindow: XE4BD\\nExterior window shutters: XE5B1\\nFloor or related fitting or feature: XE7SG\\nFloor carpeted: XE0SK\\nFloor tile brick concrete: XE19Z\\nFloor wood: XE6M6\\nFloor mud clay animal dung: XE6ZE\\nWall or related fitting or feature: XE4ZE\\nFireplace: XE19W\\nBuiltin barbecue: XE1B2\\nWall brick concrete tile: XE0WS\\nWall wood: XE7CH\\nWall mud clay animal dung: XE3GJ\\nCertain specified building building component or fitting: XE3PF\\nInground swimming pool: XE39L\\nAboveground swimming pool external spa or hot tub: XE4PB\\nAboveground swimming pool: XE5PL\\nexternal spa: XE3PX\\nexternal hot tub: XE8AX\\nFence gate: XE7FP\\nFence: XE3BP\\nGate: XE3GT\\nMoving ramp escalator: XE9QW\\nMoving ramp: XE0KF\\nEscalator: XE73T\\nLift elevator: XE8PC\\nStairs steps: XE3HC\\nHandrail railing banister: XE2VG\\nElectrical transmission line in or around building: XE6T1\\nFittings or pipes for gas steam or hot water: XE7UU\\nFittings or pipes for gas: XE171\\nFittings or pipes for steam: XE2BH\\nFittings or pipes for hot water: XE48P\\nElectrical fixture: XE871\\nDucted airconditioning unit or related fitting: XE9HH\\nGround surface: XE58F\\nCliff: XE1AK\\nSlope ramp: XE94G\\nTrench ditch pit: XE3EC\\nSewer grate: XE5Y0\\nOpen drain channel: XE2G4\\nBody of water: XE7K9\\nBody of water manmade well dug well for underground water: XE9TJ\\nBody of water water reservoir: XE40U\\nBody of water puddle: XE64D\\nBody of water dam lake: XE285\\nBody of water river stream: XE1CZ\\nBody of water swamp marsh estuary: XE57J\\nBody of water beach seashore: XE636\\nBody of water open sea: XE5N4\\nBody of water flood water: XE0CX\\nBody of water canal or irrigation channel: XE2QX\\nCertain specified surface conformation: XE7CY\\nSloping surface not elsewhere classified: XE45P\\nEven surface not elsewhere classified: XE9CC\\nUneven surface not elsewhere classified: XE1DA\\nNatural material: XE4BY\\nSnow ice: XE3LV\\nNatural grass: XE233\\nRock stone not elsewhere classified: XE83R\\nWood timber board splinter not elsewhere classified: XE2JN\\nGravel soil sand not elsewhere classified: XE9D4\\nHay straw: XE36E\\nGrain in bulk: XE410\\nManufactured or industrial material: XE4Y6\\nArtificial grass: XE59G\\nBrick concrete concrete block: XE6MG\\nMolten metal: XE983\\nMetal sheet part piece etc: XE1FP\\nChina ceramics sheet part piece: XE1LM\\nMolten glass: XE57U\\nGlass sheet piece shard: XE4KU\\nPlastic: XE7K4\\nPaper cardboard: XE63Q\\nBitumen: XE7CA\\nMaterial not mentioned elsewhere: XE16B\\nTextiles: XE5XN\\nFire flame or smoke causing injury: XE3NR\\nFire flame causing injury: XE9DT\\nBurning oil: XE7PM\\nOther burning liquid: XE73M\\nBurning gas not elsewhere classified: XE3K6\\nControlled fire flame in building or structure: XE27S\\nControlled fire flame not in building or structure: XE7W8\\nUncontrolled fire flame in building or structure: XE87S\\nUncontrolled fire flame not in building or structure: XE7V9\\nSmoke causing injury: XE4F3\\nHot object or substance not elsewhere classified: XE63H\\nHot liquid: XE4VA\\nHot tap water: XE396\\nBoiling water other than tap water: XE4WG\\nHot air or gas: XE3BS\\nSteam hot vapour: XE77R\\nFood drink or related product: XE3FD\\nHot cooking oil or fat: XE5VU\\nHot solid food: XE3KH\\nHot drink: XE36T\\nCold solid food: XE3VM\\nCold drink nonalcoholic: XE6SF\\nLaw enforcement equipment: XE4QT\\nHandcuffs: XE8YS\\nPublic use item: XE5TH\\nFire hydrant: XE6KX\\nTelephone pole Stobie pole: XE0MT\\nHightension overhead power line: XE35R\\nCamping equipment: XE63M\\nTent: XE14D\\nFastening binding or securing item not elsewhere classified: XE11D\\nRope string or twine: XE4H9\\nBarbed wire: XE3U7\\nOther wire: XE1PL\\nChain: XE18Y\\nExplosive material or flammable object not elsewhere classified: XE3WL\\nFireworks: XE6KQ\\nExplosive: XE59Q\\nCertain other specified object or living thing involved in causing injury: XE908\\nHighpressure jet: XE2JA\\nLaser light and equipment: XE5DQ\\nLaser pointer: XE9AP\\nSharp object not elsewhere classified: XE6UH\\nBlunt object not elsewhere classified: XE9GE\\nMotor engine not elsewhere classified: XE98K\\nDry cell battery: XE8AE\\nDisc battery: XE8H0\\nBattery not elsewhere classified: XE72W\\nAnimal cage: XE146\\nGastric content: XE12Z\\nExcrement human or animal: XE8FT\\nBlood carcass body bone not elsewhere classified human or animal: XE08P\\nPlastic bag: XE2DW\\nGarbage litter trash: XE2AU\\nEnvironmental pollution not elsewhere classified: XE2VX\\nMedical or surgical device not in therapeutic use: XE6QS\\nAlcohol use no information available: XE47R\\nAlcohol use no suspicion or evidence of alcohol use by any person involved in the injury event: XE08X\\nAlcohol use suspicion or evidence of alcohol use by the injured person: XE1G3\\nAlcohol use suspicion or evidence of alcohol use by other persons involved in the injury event: XE15H\\nAlcohol use suspicion or evidence of alcohol use by both the injured person and other persons involved in the injury event: XE3JF\\nPsychoactive drug use no information available: XE43G\\nPsychoactive drug use no suspicion or evidence of psychoactive drug use by any person involved in the injury event: XE5TU\\nPsychoactive drug use suspicion or evidence of psychoactive drug use by the injured person: XE5VY\\nPsychoactive drug use suspicion or evidence of psychoactive drug use by other persons involved in the injury event: XE8GW\\nPsychoactive drug use suspicion or evidence of psychoactive drug use by both the injured person and other persons involved in the injury event: XE28E\\nPedestrian as mode of transport of person injured in transport event: XE88K\\nPerson on foot injured in transport related event: XE645\\nPerson on foot standing walking or running at the time of the crash: XE0HE\\nPedestrian conveyance as mode of transport of person injured in transport event: XE7ZY\\nMobility scooter as mode of transport of person injured in transport related event: XE0TE\\nMotorised wheelchair as mode of transport of person injured in transport related event: XE80N\\nIce skates as mode of transport of person injured in transport related event: XE08H\\nSkis as mode of transport of person injured in transport related event: XE0FX\\nSnowboard as mode of transport of person injured in transport related event: XE3JS\\nSled as mode of transport of person injured in transport related event: XE036\\nSkateboard as mode of transport of person injured in transport related event: XE96G\\nRoller skates as mode of transport of person injured in transport related event: XE2PW\\nScooter as mode of transport of person injured in transport related event: XE4HS\\nBaby carriage as mode of transport of person injured in transport related event: XE7RL\\nPerambulator as mode of transport of person injured in transport related event: XE1BH\\nPush chair as mode of transport of person injured in transport related event: XE9SV\\nStroller as mode of transport of person injured in transport related event: XE7KT\\nPedal cycle as mode of transport of person injured in transport related event: XE71D\\nTrailer or sidecar attached to a pedal cycle as mode of transport of person injured in transport related event: XE2BW\\nCycle rickshaw or trishaw as mode of transport of person injured in transport related event: XE6R4\\nMotorcycle as mode of transport of person injured in transport related event: XE7NK\\nMoped as mode of transport of person injured in transport related event: XE2J1\\nUnderbone motorcycle as mode of transport of person injured in transport related event: XE39A\\nMotor scooter as mode of transport of person injured in transport related event: XE9BU\\nMotorised bicycle as mode of transport of injured person in transport related event: XE9RC\\nAg bike as mode of transport of person injured in transport related event: XE1ZG\\nCar as mode of transport of person injured in transport related event: XE2W4\\nx vehicle as mode of transport of person injured in transport related event: XE0V3\\nLight transport vehicle with four or more wheels used in sport and leisure activities as mode of transport of person injured in transport related event: XE2TP\\nMicrocar as mode of transport of person injured in transport related event: XE9K7\\nMotor car as mode of transport of person injured in transport related event: XE62M\\nStation wagon as mode of transport of person injured in transport related event: XE85J\\nMinivan as mode of transport of person injured in transport related event: XE7LL\\nJeep as mode of transport of person injured in transport related event: XE1CK\\nSport utility vehicle as mode of transport of person injured in transport related event: XE5X0\\nBus or coach as mode of transport of person injured in transport related event: XE2RA\\nLight goods vehicle as mode of transport of person injured in transport related event: XE9JB\\nMinibus or passenger van as mode of transport of person injured in transport related event: XE6PF\\nPickup truck goods or work van ambulance motor home as mode of transport of person injured in transport related event: XE165\\nHeavy goods vehicle as mode of transport of person injured in transport related event: XE1PH\\nTrucks lorries and other heavy goods vehicle as mode of transport of person injured in transport related event: XE10A\\nFire brigade pump vehicle as mode of transport of person injured in transport related event: XE1VN\\nRoad tractor with or without semitrailer as mode of transport of person injured in transport related event: XE7XM\\nTruck with trailer as mode of transport of person injured in transport related event: XE5ET\\nStreetcar or tram as mode of transport of person injured in transport related event: XE41E\\nLowpowered passenger vehicle as mode of transport of person injured in transport event: XE5WB\\nTuktuk as mode of transport of person injured in transport related event: XE8DK\\nMototaxi as mode of transport of person injured in transport related event: XE1DF\\nAuto rickshaw threewheeler as mode of transport of person injured in transport related event: XE4SA\\nSpecial vehicle mainly used in agriculture as mode of transport of person injured in transport related event: XE35C\\nSelfpropelled agricultural machine as mode of transport of person injured in transport related event: XE3WV\\nHarvester as mode of transport of person injured in transport related event: XE3QK\\nAgricultural tractor as mode of transport of person injured in transport related event: XE872\\nSpecial vehicle mainly used on industrial premises as mode of transport of person injured in transport related event: XE885\\nFork lift truck as mode of transport of person injured in transport related event: XE31K\\nSpecial construction vehicle as mode of transport of person injured in transport related event: XE312\\nSpecial allterrain vehicle as mode of transport of person injured in transport related event: XE5RK\\nSnowmobile as mode of transport of person injured in transport related event: XE63N\\nHovercraft operating on land or swamp as mode of transport of person injured in transport related event: XE5U7\\nAmphibious vehicle on land as mode of transport of person injured in transport related event: XE4MT\\nQuad bike as mode of transport of person injured in transport related event: XE3SA\\nAnimal being ridden as mode of transport of person injured in transport related event: XE940\\nHorse as mode of transport of person injured in transport related event: XE1ZJ\\nAnimal drawn vehicle as mode of transport of person injured in transport related event: XE4ZZ\\nRailway vehicle as mode of transport of person injured in transport related event: XE8YD\\nRailway train as mode of transport of person injured in transport related event: XE1KN\\nFunicular or monorail as mode of transport of person injured in transport related event: XE3NY\\nWatercraft as mode of transport of person injured in transport related event: XE27K\\nSubmarine as mode of transport of person injured in transport related event: XE4FF\\nMerchant ship as mode of transport of person injured in transport related event: XE3QY\\nPassenger ship as mode of transport of person injured in transport related event: XE9YQ\\nFishing boat or trawler as mode of transport of person injured in transport related event: XE9PA\\nSailboat or unpowered yacht as mode of transport of person injured in transport related event: XE0L4\\nHovercraft and amphibious vehicles when in or above a body of water as mode of transport of person injured in transport related event: XE4AK\\nOther specified powered or motorised watercraft as mode of transport of person injured in transport related event: XE5WL\\nOther specified unpowered watercraft as mode of transport of person injured in transport related event: XE36L\\nAircraft as mode of transport of person injured in transport related event: XE1JR\\nBalloons and other lighter than air devices as mode of transport of person injured in transport related event: XE3J3\\nPowered aircraft as mode of transport of person injured in transport related event: XE2UU\\nUnpowered aircraft as mode of transport of person injured in transport related event: XE6SQ\\nParachute used in descent from damaged aircraft as mode of transport of person injured in transport related event: XE4VS\\nParachute used in descent from undamaged aircraft as mode of transport of person injured in transport related event: XE08L\\nGlider as mode of transport of person injured in transport related event: XE33H\\nHelicopter as mode of transport of person injured in transport related event: XE48X\\nSpacecraft as mode of transport of person injured in transport related event: XE0VS\\nDevices or parts of devices designed for ascent from and landing on earth or the surface of other bodies as mode of transport of person injured in transport related event: XE82G\\nVehicle driver injured in transport related event: XE42A\\nPerson driving a motor vehicle injured in transport related event: XE8ZW\\nPerson riding operating or controlling a motorcycle or pedal cycle injured in transport related event: XE65U\\nPerson responsible to resume manual control of a vehicle under autonomous or partly autonomous control injured in transport related event: XE3WH\\nPerson with control of steering and braking in the case of a tandem bicycle or similar vehicle injured in transport related event: XE8SZ\\nPerson directing or attempting to direct an animal injured in transport related event: XE302\\nVehicle passenger injured in transport related event: XE1LZ\\nVehicle occupant not otherwise specified: XE5X3\\nOccupant of position provided for patient in an ambulance: XE3FA\\nOccupants of wheelchair or mobility scooter located in a position in a motor vehicle provided for carrying such devices: XE9FE\\nOccupants of area in a bus provided for standing: XE9CP\\nPerson boarding or alighting a vehicle injured in transport related event: XE9Y1\\nPerson getting into or out of a vehicle injured in transport related event: XE76V\\nPerson boarding or alighting from a bus tram streetcar or railway vehicle injured in transport related event: XE6LC\\nPerson on outside of vehicle or in load space injured in transport related event: XE166\\nPerson being transported by a vehicle and occupying space intended for the transport of goods or cargo injured in transport related event: XE7FA\\nPerson being transported by a vehicle and occupying space on the roof injured in transport related event: XE4CZ\\nPerson being transported by a vehicle and occupying space on a running board injured in transport related event: XE9X1\\nPerson being transported by a vehicle and occupying space outside the cabin holding onto the vehicle injured in transport related event: XE7PL\\nRider of an animal injured in transport event: XE6R5\\nPedestrian as counterpart in land transport crash: XE6K0\\nPerson on foot as counterpart in land transport crash: XE57K\\nPerson using a pedestrian conveyance as counterpart in land transport crash: XE2ZK\\nPedestrian conveyance as counterpart in land transport crash: XE3NU\\nMobility scooter as counterpart in land transport crash: XE93R\\nWheelchair as counterpart in land transport crash: XE3XF\\nIce skates as counterpart in land transport crash: XE1TJ\\nSkis as counterpart in land transport crash: XE5XW\\nSnowboard as counterpart in land transport crash: XE4NZ\\nSled as counterpart in land transport crash: XE5D9\\nSkateboard as counterpart in land transport crash: XE5H4\\nRoller skates as counterpart in land transport crash: XE9J0\\nScooter as counterpart in land transport crash: XE28X\\nBaby carriage as counterpart in land transport crash: XE5SX\\nPerambulator as counterpart in land transport crash: XE1ZX\\nPush chair as counterpart in land transport crash: XE168\\nStroller as counterpart in land transport crash: XE2JL\\nPedal cycle as counterpart in land transport crash: XE7ZZ\\nTrailer or sidecar attached to a pedal cycle as counterpart in land transport crash: XE5GG\\nCycle rickshaw or trishaw as counterpart in land transport crash: XE2PY\\nMotorcycle as counterpart in land transport crash: XE8XQ\\nMotorised bicycle as counterpart in land transport crash: XE1SA\\nMoped as counterpart in land transport crash: XE0V4\\nUnderbone motorcycle as counterpart in land transport crash: XE4C1\\nMotor scooter as counterpart in land transport crash: XE9FR\\nAgbike as counterpart in land transport crash: XE59J\\nCar as counterpart in land transport crash: XE0JH\\nMotorcar as counterpart in land transport crash: XE0LP\\nStation wagon as counterpart in land transport crash: XE0HH\\nMinivan as counterpart in land transport crash: XE0T7\\nx as counterpart in land transport crash: XE38X\\nSport utility vehicle as counterpart in land transport crash: XE6G7\\nJeep as counterpart in land transport crash: XE3BW\\nMicrocar as counterpart in land transport crash: XE0ZR\\nBus or coach as counterpart in land transport crash: XE5LJ\\nLight goods vehicle as counterpart in land transport crash: XE6UN\\nMinibus or passenger van as counterpart in land transport crash: XE0ZL\\nPickup truck goods or work van ambulance or motor home as counterpart in land transport crash: XE4DB\\nLight transport vehicle with four or more wheels used in sport and leisure activities as counterpart in land transport crash: XE0MB\\nHeavy goods vehicle as counterpart in land transport crash: XE854\\nTrucks lorries and other heavy goods vehicles as counterpart in land transport crash: XE590\\nTruck with trailer as counterpart in land transport crash: XE4Q6\\nRoad tractor with or without semitrailer as counterpart in land transport crash: XE45E\\nFire brigade pump vehicle as counterpart in land transport crash: XE3M3\\nStreetcar or tram as counterpart in land transport crash: XE8UX\\nLow powered passenger vehicle as counterpart in land transport crash: XE90S\\nTuktuk as counterpart in land transport crash: XE9VV\\nMototaxi as counterpart in land transport crash: XE9ML\\nAuto rickshaw threewheeler as counterpart in land transport crash: XE73V\\nSpecial vehicle mainly used in agriculture as counterpart in land transport crash: XE9HB\\nSelfpropelled agricultural machine as counterpart in land transport crash: XE9HZ\\nHarvester as counterpart in land transport crash: XE6W7\\nAgricultural tractor as counterpart in land transport crash: XE9GD\\nSpecial vehicle mainly used on industrial premises as counterpart in land transport crash: XE9DQ\\nFork lift truck as counterpart in land transport crash: XE1U3\\nSpecial construction vehicle as counterpart in land transport crash: XE1YW\\nSpecial allterrain vehicle as counterpart in land transport crash: XE23Q\\nSnowmobile as counterpart in land transport crash: XE60L\\nHovercraft operating on land or swamp as counterpart in land transport crash: XE28S\\nAmphibious vehicle on land as counterpart in land transport crash: XE8AH\\nQuad bike as counterpart in land transport crash: XE9KN\\nAnimal as counterpart in land transport crash: XE6QK\\nUnattended animal as counterpart in land transport crash: XE7A0\\nAnimal being herded as counterpart in land transport crash: XE22V\\nAnimal being ridden as counterpart in land transport crash: XE756\\nAnimal drawn vehicle as counterpart in land transport crash: XE6X8\\nRailway vehicle as counterpart in land transport crash: XE6DQ\\nRailway train as counterpart in land transport crash: XE320\\nFunicular or monorail as counterpart in land transport crash: XE1W8\\nFixed or stationary object as counterpart in land transport crash: XE98X\\nVehicle parked at the side of a road or in a parking lot as counterpart in land transport crash: XE3KY\\nSmall loose object as counterpart in land transport crash: XE1RC\\nSmall or light fixed object as counterpart in land transport crash: XE9KG\\nLarge or heavy fixed object as counterpart in land transport crash: XE43C\\nFall in mode of transport without counterpart: XE0JJ\\nFall from mode of transport without counterpart: XE3M5\\nFall from horse without counterpart: XE64P\\nFall from motor vehicle without counterpart: XE20L\\nFall from motorcycle without counterpart: XE7JA\\nFall from pedal cycle without counterpart: XE2K7\\nFall from pedestrian conveyance without counterpart: XE929\\nOther specified mechanism with no counterpart: XE5XB\\nSudden movement of vehicle without collision resulting in injury: XE5FP\\nVehicle overturned without counterpart: XE9K8\\nVehicle out of control without mention of collision with another vehicle or fixed object: XE5YL\\nTeam ball sports: XE3GK\\nType of sport or exercise activity basketball: XE9UG\\nType of sport or exercise activity football American tackle: XE3T2\\nType of sport or exercise activity football American touch or flag: XE31W\\nType of sport or exercise activity football Australian rules: XE72L\\nType of sport or exercise activity football not otherwise specified: XE3BA\\nType of sport or exercise activity handball team: XE7D6\\nType of sport or exercise activity netball: XE510\\nType of sport or exercise activity rugby union: XE9RW\\nType of sport or exercise activity rugby league: XE5XZ\\nType of sport or exercise activity rugby not otherwise specified: XE1XR\\nType of sport or exercise activity soccer outdoor: XE5EU\\nType of sport or exercise activity soccer indoor: XE0TN\\nType of sport or exercise activity soccer not otherwise specified: XE8WP\\nType of sport or exercise activity volleyball: XE79M\\nType of sport or exercise activity wallyball: XE0JP\\nTeam bat or stick sports: XE2BF\\nType of sport or exercise activity baseball: XE84M\\nType of sport or exercise activity cricket: XE5M7\\nType of sport or exercise activity ice hockey: XE2UD\\nType of sport or exercise activity hockey street or ball: XE6B7\\nType of sport or exercise activity field hockey: XE8HB\\nType of sport or exercise activity floor hockey: XE9N5\\nType of sport or exercise activity hockey not otherwise specified: XE02P\\nType of sport or exercise activity ringette: XE8M1\\nType of sport or exercise activity softball: XE63E\\nType of sport or exercise activity tball: XE5WM\\nTeam water sports: XE2BG\\nType of sport or exercise activity rescue and resuscitation: XE8KM\\nType of sport or exercise activity synchronized swimming: XE6Y2\\nType of sport or exercise activity underwater hockey: XE323\\nType of sport or exercise activity water polo: XE2YS\\nBoating sports: XE85T\\nType of sport or exercise activity canoeing: XE1LG\\nType of sport or exercise activity jet skiing: XE7BZ\\nType of sport or exercise activity kayaking or whitewater rafting: XE99V\\nType of sport or exercise activity power boat racing: XE4LT\\nType of sport or exercise activity rowing or sculling: XE4XV\\nType of sport or exercise activity surf boating: XE0XD\\nType of sport or exercise activity yachting or sailing: XE0G3\\nIndividual water sports: XE6W9\\nType of sport or exercise activity platform diving: XE3R2\\nType of sport or exercise activity springboard diving: XE7S0\\ntype of sportexercise activity diving unspecified: XE5UC\\nType of sport or exercise activity fishing: XE5FN\\nType of sport or exercise activity scuba diving: XE1TE\\nType of sport or exercise activity snorkelling: XE1ZK\\nType of sport or exercise activity surfing or boogie boarding: XE48G\\nType of sport or exercise activity surf life saving: XE84Q\\nType of sport or exercise activity competitive swimming: XE1FN\\nType of sport or exercise activity water skiing: XE167\\nType of sport or exercise activity water tubing: XE92F\\nType of sport or exercise activity wind surfing: XE7PV\\nType of sport or exercise activity cliff diving: XE5RZ\\nType of sport or exercise activity recreational swimming: XE6P1\\nIce or snow sports: XE9DF\\nType of sport or exercise activity bobsledding: XE225\\nType of sport or exercise activity curling: XE7J1\\nType of sport or exercise activity ice skating or ice dancing: XE1SZ\\nType of sport or exercise activity luge: XE9KF\\nType of sport or exercise activity ski patrolling: XE7E1\\nType of sport or exercise activity skiing alpine or downhill: XE9X7\\nType of sport or exercise activity skiing Nordic cross country: XE8CR\\nType of sport or exercise activity freestyle skiing: XE8UF\\nType of sport or exercise activity snow ski jumping: XE471\\nType of sport or exercise activity snowmobiling: XE240\\nType of sport or exercise activity snow boarding: XE7J0\\nType of sport or exercise activity speed skating: XE6RE\\nType of sport or exercise activity tobogganing: XE8G0\\nIndividual athletic activities: XE3L1\\nType of sport or exercise activity aerobic or callisthenics: XE286\\nType of sport or exercise activity jogging or running: XE5KC\\nType of sport or exercise activity tai chi: XE05C\\nType of sport or exercise activity track and field racing over obstacles or hurdles: XE1SW\\nType of sport or exercise activity track and field sprinting  metres: XE02A\\nType of sport or exercise activity track and field running middle distances  metres: XE2RC\\nType of sport or exercise activity track and field running long distances greater than  metres: XE4Y7\\nType of sport or exercise activity track and field high jump: XE1X1\\nType of sport or exercise activity track and field long jump: XE10W\\nType of sport or exercise activity track and field pole vault: XE8YM\\nType of sport or exercise activity track and field triple jump: XE5X4\\nType of sport or exercise activity track and field discus: XE4C5\\nType of sport or exercise activity track and field javelin: XE037\\nType of sport or exercise activity track and field hammer throw: XE1FT\\nType of sport or exercise activity track and field shot putt: XE3M7\\nType of sport or exercise activity walking: XE2TV\\nType of sport or exercise activity yoga or Pilates: XE7F9\\nType of sport or exercise activity stationary aerobic exercise with equipment: XE9V7\\nAcrobatic sports: XE4HZ\\nType of sport or exercise activity cheerleading: XE2T9\\nType of sport or exercise activity gymnastics balance beam: XE65D\\nType of sport or exercise activity gymnastics floor exercise or tumbling: XE5WY\\nType of sport or exercise activity gymnastics high bar: XE69D\\nType of sport or exercise activity gymnastics parallel bars: XE6R6\\nType of sport or exercise activity gymnastics rhythmic with or without props: XE4YF\\nType of sport or exercise activity gymnastics rings: XE8WK\\nType of sport or exercise activity gymnastics side horse or pommel horse: XE802\\nType of sport or exercise activity gymnastics trampoline or minitrampoline: XE8V7\\nType of sport or exercise activity gymnastics uneven parallel bars: XE5KU\\nType of sport or exercise activity gymnastics vault: XE7PU\\nAesthetic activities: XE9SK\\nType of sport or exercise activity dancing: XE6H2\\nType of sport or exercise activity marching: XE0R2\\nRacquet sports: XE0KE\\nType of sport or exercise activity badminton: XE3SV\\nType of sport or exercise activity racquetball: XE5Z7\\nType of sport or exercise activity squash: XE629\\nType of sport or exercise activity table tennis or pingpong: XE5JM\\nType of sport or exercise activity tennis: XE97B\\nTarget or precision sports: XE2NY\\nType of sport or exercise activity archery: XE0KA\\nType of sport or exercise activity bocce boules or petanque: XE760\\nType of sport or exercise activity billiards pool or snooker: XE5XX\\nType of sport or exercise activity lawn bowling: XE5VJ\\nType of sport or exercise activity croquet: XE8AU\\nType of sport or exercise activity darts: XE7NG\\nType of sport or exercise activity golf: XE416\\nType of sport or exercise activity tenpin bowling: XE6YY\\nType of sport or exercise activity firearm shooting: XE08Q\\nType of sport or exercise activity bb or pellet gun shooting: XE0HX\\nType of sport or exercise activity paintball gun shooting: XE1N9\\nCombative sports: XE3E4\\nType of sport or exercise activity aikido: XE7K5\\nType of sport or exercise activity boxing: XE8AB\\nType of sport or exercise activity fencing: XE4E3\\nType of sport or exercise activity judo: XE6B1\\nType of sport or exercise activity jujitsu: XE0U2\\nType of sport or exercise activity karate: XE567\\nType of sport or exercise activity kendo: XE8WT\\nType of sport or exercise activity kickboxing: XE0Y9\\nType of sport or exercise activity kung fu: XE5QV\\nType of sport or exercise activity tae kwon do: XE7RA\\nType of sport or exercise activity freestyle wrestling: XE0CG\\nType of sport or exercise activity GrecoRoman wrestling: XE8M6\\nType of sport or exercise activity professional wrestling entertainment style: XE4QQ\\nType of sport or exercise activity self defence training: XE75J\\nPower sports: XE1EU\\nType of sport or exercise activity power lifting: XE7QE\\nType of sport or exercise activity Olympic weightlifting: XE6RQ\\nType of sport or exercise activity strength training or body building: XE0N6\\nType of sport or exercise activity timberrelated sports: XE3PG\\nEquestrian activities: XE42Q\\nType of sport or exercise activity equestrian dressage: XE6DF\\nType of sport or exercise activity endurance riding: XE75K\\nType of sport or exercise activity equestrian eventing: XE8JM\\nType of sport or exercise activity mustering or stock work: XE0BK\\nType of sport or exercise activity equestrian polo or polocrosse: XE6PK\\nType of sport or exercise activity pony club: XE4GZ\\nType of sport or exercise activity horse racing: XE0P4\\nType of sport or exercise activity rodeo: XE56X\\nType of sport or exercise activity show jumping: XE7X5\\nType of sport or exercise activity equestrian steeplechase: XE7MC\\nType of sport or exercise activity trail or general horseback riding: XE1LH\\nType of sport or exercise activity equestrian trotting or harness: XE2LJ\\nAdventure sports: XE3T3\\nType of sport or exercise activity abseiling or rappelling: XE08U\\nType of sport or exercise activity hiking: XE5BS\\nType of sport or exercise activity mountaineering: XE79W\\nType of sport or exercise activity orienteering or rogaining: XE8WG\\nType of sport or exercise activity river rafting: XE2J8\\nType of sport or exercise activity rock climbing: XE6Z2\\nType of sport or exercise activity bungee jumping: XE74G\\nWheeled motor sports: XE85A\\nType of sport or exercise activity riding an allterrain vehicle ATV: XE7HV\\nType of sport or exercise activity motorcycling: XE1R5\\nType of sport or exercise activity motor car racing: XE26F\\nType of sport or exercise activity gocarting or carting: XE46F\\nType of sport or exercise activity motorised scootering: XE1MM\\nWheeled nonmotored sports: XE4DA\\nType of sport or exercise activity BMX cycling: XE5UJ\\nType of sport or exercise activity mountain cycling: XE4SS\\nType of sport or exercise activity road cycling: XE87G\\nType of sport or exercise activity track or velodrome cycling: XE8U6\\nType of sport or exercise activity cycling not otherwise specified: XE7MG\\ntype of sportexercise activity inline skatingrollerblading: XE5V9\\nType of sport or exercise activity roller skating: XE2DY\\nType of sport or exercise activity skate boarding: XE1AS\\nType of sport or exercise activity scootering: XE6X9\\nType of sport or exercise activity spinning or stationary bike riding: XE72X\\nType of sport or exercise activity street luge: XE78K\\nMultidiscipline sports: XE7BS\\nType of sport or exercise activity biathlon crosscountry skiing event: XE3BK\\nType of sport or exercise activity biathlon shooting event: XE05T\\nType of sport or exercise activity biathlon unspecified event: XE7ZX\\nType of sport or exercise activity decathlon  metre event: XE9AM\\nType of sport or exercise activity decathlon  metre hurdles event: XE5C1\\nType of sport or exercise activity decathlon long jump event: XE6CK\\nType of sport or exercise activity decathlon high jump event: XE331\\nType of sport or exercise activity decathlon shot put event: XE6GN\\nType of sport or exercise activity decathlon discus event: XE11Q\\nType of sport or exercise activity decathlon javelin event: XE37C\\nType of sport or exercise activity decathlon pole vault event: XE7LJ\\nType of sport or exercise activity decathlon unspecified event: XE48E\\nType of sport or exercise activity heptathlon  metre event: XE4CW\\nType of sport or exercise activity heptathlon  metre hurdles event: XE9EF\\nType of sport or exercise activity heptathlon high jump event: XE90J\\nType of sport or exercise activity heptathlon long jump event: XE8WE\\nType of sport or exercise activity heptathlon javelin event: XE7TG\\nType of sport or exercise activity heptathlon shot putt event: XE294\\nType of sport or exercise activity heptathlon unspecified event: XE1JE\\nType of sport or exercise activity modern pentathlon shooting event: XE3GA\\nType of sport or exercise activity modern pentathlon fencing event: XE758\\nType of sport or exercise activity modern pentathlon swimming event: XE7GA\\nType of sport or exercise activity modern pentathlon equestrian event: XE8KQ\\nType of sport or exercise activity modern pentathlon running event: XE84E\\nType of sport or exercise activity modern pentathlon unspecified event: XE2B4\\nType of sport or exercise activity triathlon cycling event: XE2XU\\nType of sport or exercise activity triathlon running event: XE0J9\\nType of sport or exercise activity triathlon swimming event: XE8ZK\\nType of sport or exercise activity triathlon unspecified event: XE01T\\nAero nonmotored sports: XE03W\\nType of sport or exercise activity aerobatics: XE34L\\nType of sport or exercise activity gliding: XE88Y\\nType of sport or exercise activity hang gliding: XE3VS\\ntype of sportexercise activity parachutingsky diving: XE0JU\\nType of sport or exercise activity paragliding or parasailing: XE06C\\nType of sport or exercise activity hot air ballooning: XE99S\\nOther schoolrelated recreational activities: XE68C\\nType of sport or exercise activity school physical education class: XE49T\\nType of sport or exercise activity school free play: XE67P\\nPhase of sport or exercise activity Training or practice: XE9ET\\nPhase of activity sportspecific or skillspecific practice: XE1U5\\nPhase of activity scrimmaging: XE07B\\nPhase of activity strength and conditioning or weight training: XE0BT\\nPhase of activity cardiovascular training: XE945\\nPhase of activity not otherwise specified training or practice: XE583\\nPhase of activity preevent: XE8MZ\\nPhase of activity warmup: XE2D1\\nPhase of sport or exercise activity Competition or participation: XE5TJ\\nPhase of activity competition or participation first  of expected event duration: XE66C\\nPhase of activity competition or participation middle  of expected event duration: XE0QY\\nPhase of activity competition or participation last  of expected event duration: XE2CG\\nPhase of activity competition or participation events whose time course can not be anticipated: XE20Y\\nPhase of activity competition or participation unspecified stage of the event: XE4ZN\\nPhase of activity cool down: XE1P9\\nPhase of activity postevent: XE2BD\\nPhase of activity recreational participation: XE49R\\nPhase of activity other specified phase of activity: XE0QV\\nUnspecified phase of activity: XE8ZT\\nPersonal countermeasures no protective devices used: XE4K4\\nPersonal countermeasures braces guards or orthoses: XE8Z8\\nPersonal countermeasures rigid taping of joint: XE75U\\nPersonal countermeasures padding of joint bony prominence or muscle: XE9TY\\nPersonal countermeasures thermal devices: XE10N\\nPersonal countermeasures splints: XE0LS\\nPersonal countermeasures jock strap or protective cup: XE16J\\nPersonal countermeasures gloves: XE4RU\\nPersonal countermeasures mouth guard: XE49L\\nPersonal countermeasures eye goggles or protective glasses: XE338\\nPersonal countermeasures helmet: XE2ZG\\nPersonal countermeasures face mask or shield: XE3RM\\nPersonal countermeasures foot wear: XE7K8\\nPersonal countermeasures personal flotation device: XE26E\\nEnvironmental countermeasures no protective devices used: XE3U8\\nEnvironmental countermeasures protective padding on competition surface: XE0DA\\nEnvironmental countermeasures padded goal posts or corner markers: XE0W0\\nEnvironmental countermeasures barrier between area of activity and spectators or surrounds: XE8UC\\nEnvironmental countermeasures safety restraints or vehicle restraints: XE0LL\\nEconomic activity agriculture hunting or forestry: XE7J2\\nEconomic activity fishing: XE227\\nEconomic activity mining quarrying or extraction: XE45Q\\nEconomic activity manufacturing: XE13G\\nEconomic activity electricity gas or water supply: XE6WE\\nEconomic activity construction: XE0SE\\nEconomic activity wholesale or retail trade: XE139\\nEconomic activity repair of motor vehicles motorcycles or personal and household goods: XE6J4\\nEconomic activity hotels or restaurants: XE4JS\\nEconomic activity transport storage or communications: XE5JN\\nEconomic activity financial intermediation: XE8A7\\nEconomic activity real estate renting or business activities: XE3YF\\nEconomic activity public administration defence or compulsory social security: XE3K1\\nEconomic activity providing education: XE54F\\nEconomic activity health or social work: XE0G4\\nEconomic activity other community social or personal service activities: XE7X1\\nEconomic activity private households with employed persons: XE2PM\\nEconomic activity extraterritorial organisations or bodies: XE6N7\\nOccupation legislators senior officials managers: XE3TU\\nOccupation professionals: XE59Y\\nOccupation technicians or associate professionals: XE558\\nOccupation clerks secretaries: XE17U\\nOccupation service workers shop and market sales workers: XE1CA\\nOccupation skilled agriculture or fishery workers: XE6TG\\nOccupation craft or related trades workers: XE0VC\\nOccupation plantmachine operators or assemblers: XE37Y\\nOccupation elementary occupations: XE4EE\\nOccupation armed forces: XE5G8\\nSpouse or partner: XE454\\nPerpetratorvictim relationship legal spouse: XE041\\nPerpetratorvictim relationship cohabiting partner: XE8JN\\nPerpetratorvictim relationship noncohabiting partner: XE8GZ\\nPerpetratorvictim relationship Exspouse: XE6Q9\\nPerpetratorvictim relationship Expartner: XE8TC\\nParent: XE8AA\\nPerpetratorvictim relationship father or mother: XE8QX\\nPerpetratorvictim relationship stepparent: XE9FD\\nOther relative: XE5WN\\nPerpetratorvictim relationship full sibling: XE9JY\\nperpetratorvictim relationship partial or half sibling: XE9RK\\nPerpetratorvictim relationship stepsibling: XE4KJ\\nPerpetratorvictim relationship grandparent: XE9S0\\nPerpetratorvictim relationship offspring: XE10C\\nPerpetratorvictim relationship other blood relative: XE8EU\\nPerpetratorvictim relationship inlaws: XE8FS\\nUnrelated care giver: XE4BG\\nPerpetratorvictim relationship foster parent: XE4BZ\\nPerpetratorvictim relationship care giver in institution: XE670\\nPerpetratorvictim relationship health care provider: XE02B\\nAcquaintance or friend: XE270\\nPerpetratorvictim relationship parents partner: XE1X5\\nPerpetratorvictim relationship date: XE7GT\\nPerpetratorvictim relationship roommate: XE6WK\\nPerpetratorvictim relationship business relation: XE6P9\\nPerpetratorvictim relationship neighbour: XE32X\\nPerpetratorvictim relationship institutional comember: XE80F\\nPerpetratorvictim relationship friend not otherwise specified: XE5MH\\nPerpetratorvictim relationship acquaintance not otherwise specified: XE39B\\nOfficial or legal authority: XE2HC\\nPerpetratorvictim relationship official or legal authority military: XE6AM\\nPerpetratorvictim relationship official or legal authority police: XE2Z7\\nPerpetratorvictim relationship national or official authority not otherwise specified: XE5ZT\\nPerpetratorvictim relationship security group not otherwise specified: XE8PB\\nPerpetratorvictim relationship official or legal authority civilian authority: XE59K\\nStranger: XE4WS\\nPerpetratorvictim relationship stranger in vigilante group: XE0CA\\nPerpetratorvictim relationship stranger in mob: XE7XG\\nPerpetratorvictim relationship stranger not otherwise specified: XE2XY\\nPerpetratorvictim relationship prisoner or detainee: XE0H2\\nPerpetratorvictim relationship person executing a felony or crime: XE3FJ\\nPerpetratorvictim relationship person interceding in a crime: XE388\\nGender of perpetrator male: XE5YG\\nGender of perpetrator female: XE56C\\nGender of perpetrator unknown: XE9SL\\nGender of perpetrator other: XE6W8\\nAltercation: XE0UM\\nAbout family issues: XE591\\nContext of assault altercation about family issues children: XE2RR\\nContext of assault altercation about family issues inlaws: XE37R\\nContext of assault altercation about family issues dowry issues: XE1B3\\nContext of assault altercation about family issues family honour: XE1F9\\nAbout personal issues: XE9SP\\nContext of assault altercation about current love relationship: XE1XB\\nContext of assault altercation about terminating a love relationship: XE3YH\\nContext of assault altercation about sex: XE6DB\\nAbout personallyheld views: XE4H5\\nContext of assault altercation about personallyheld views regarding politics: XE03X\\nContext of assault altercation about personallyheld views regarding religious or spiritual matters: XE860\\nContext of assault altercation about personallyheld views regarding cultural issues: XE1RW\\nContext of assault altercation about personallyheld views regarding racial or ethnic issues: XE6YL\\nContext of assault altercation about personallyheld views regarding issues of gender or sexual orientation: XE1Q8\\nAbout business or financial issues: XE0Z5\\nContext of assault altercation about loss of employment: XE4ML\\nContext of assault altercation about other financial losses related to employment or business: XE00W\\nContext of assault other employment disputes: XE05L\\nContext of assault altercation about money or property: XE62S\\nAbout sports and other leisure: XE6VD\\nContext of assault altercation about gambling: XE81U\\nContext of assault altercation about sports: XE47F\\nContext of assault altercation about traffic: XE8NL\\nContext of assault malicious misconduct: XE4XA\\nContext of assault bullying intimidation: XE4P2\\nContext of assault altercation about past altercation: XE3KE\\nIllegal acquisition or attempted illegal acquisition of money or property: XE91G\\nContext of assault burglary: XE0LR\\nRobbery: XE6PL\\nContext of assault unarmed robbery: XE6YM\\nContext of assault armed robbery: XE989\\nDrugrelated incident: XE933\\nContext of assault selling drugs or drug business: XE5AY\\nContext of assault argument over possession use or cost of drugs: XE0Z6\\nContext of assault failure to pay a drug debt: XE1GC\\nContext of assault probable drug involvement but no positive evidence: XE1LL\\nContext of assault sexual assault: XE213\\nContext of assault rape or attempted rape: XE6U2\\nContext of assault sodomy or attempted sodomy: XE85Q\\nContext of assault touching or fondling of genitals: XE29Q\\nContext of assault oral sex: XE18N\\nGangrelated incident: XE8DB\\nContext of assault gang initiation: XE3QM\\nContext of assault gang rivalry: XE2A5\\nOther criminal activity: XE3V7\\nContext of assault blackmail: XE2QF\\nContext of assault kidnapping: XE1N7\\nContext of assault contract injuring or killing: XE0NB\\nContext of assault driveby shooting: XE5A7\\nOther specified context of assault: XE5QX\\nContext of assault retaliation or revenge: XE6FN\\nContext of assault mercy killing or euthanasia: XE3G0\\nContext of assault neglect: XE90G\\nContext of assault torture: XE580\\nContext of assault additional context mistaken identity: XE92U\\nConflict in relationship with family member partner or friend: XE17Z\\nProximal risk factors for intentional selfharm Conflict in relationship with spouse partner boygirlfriend: XE9SZ\\nProximal risk factors for intentional selfharm Conflict in relationship with parent: XE6QA\\nProximal risk factors for intentional selfharm Conflict in relationship with offspring: XE1A1\\nDeath of a relative partner or friend: XE3GP\\nProximal risk factors for intentional selfharm Suicide of a relative partner or friend: XE19R\\nProximal risk factors for intentional selfharm Other manner of death of a relative partner or friend: XE8T3\\nProximal risk factors for intentional selfharm Unspecified manner of death of a relative partner or friend: XE2FT\\nPhysical problem: XE97R\\nProximal risk factors for intentional selfharm HIV or AIDS: XE5CU\\nProximal risk factors for intentional selfharm Unwanted pregnancy: XE3AG\\nMental condition: XE6XD\\nProximal risk factors for intentional selfharm Substance abuse: XE2Q7\\nProximal risk factors for intentional selfharm Postpartum depression: XE79G\\nIncomerelated or financial problem: XE3U9\\nProximal risk factors for intentional selfharm Workrelated: XE70C\\nProximal risk factors for intentional selfharm Dowry: XE4UX\\nAbuse: XE5J3\\nProximal risk factors for intentional selfharm Sexual abuse: XE8HX\\nProximal risk factors for intentional selfharm Physical abuse: XE8ND\\nProximal risk factors for intentional selfharm Neglect: XE2RX\\nProximal risk factors for intentional selfharm Legal system encounters: XE31V\\nProximal risk factors for intentional selfharm Schoolrelated problem: XE8MK\\nProximal risk factors for intentional selfharm Religious belief or affiliation: XE98Q\\nProximal risk factors for intentional selfharm Cultural issue: XE6TW\\nPrevious suicide attempt No: XE76W\\nPrevious suicide attempt Yes: XE3YR\\nIntentional selfharm person intended to die: XE97V\\nIntentional selfharm person did not intend to die: XE5D6\\nIntentional selfharm not known or not determined if person intended to die: XE2SF\\nType of conflict civil war or guerrilla operation: XE2RB\\nType of conflict war: XE324\\nType of conflict declared terrorism: XE4RJ\\nType of conflict civil insurrection: XE0EG\\nType of conflict postconflict incident: XE7HW\\nMilitary personnel: XE42H\\nCivilian: XE2WZ\\nRole of injured person in armed conflict unknown: XE3P0\\nPotential arrest situation: XE52B\\nType of legal intervention potential arrest related traffic pursuit: XE9JF\\nType of legal intervention potential arrest related investigation of a suspicious person or incident: XE25D\\nType of legal intervention potential arrest related execution of an arrest: XE3XD\\nResponse to a disturbance call: XE8Z9\\nType of legal intervention response to a disturbance call because of a family dispute: XE84H\\nType of legal intervention response to a disturbance call because of a person behaving aberrantly: XE8WD\\nType of legal intervention response to other specified disturbance call: XE3FV\\nType of legal intervention response to unspecified disturbance call: XE439\\nType of legal intervention ambush situation: XE8M2\\nType of legal intervention civil disorder: XE1DD\\nType of legal intervention handling transporting or custody of prisoner: XE0RZ\\nType of legal intervention execution of a legal sentence: XE7AT\\nPatient device interaction problem: XE4HK\\nPatientdevice incompatibility: XE6GS\\nBiocompatibility: XE7ZE\\nDevice appears to trigger rejection: XE2CL\\nInadequacy of device shape or size: XE584\\nOsseointegration problem: XE7JV\\nFailure to osseointegrate: XE94Z\\nLoss of osseointegration: XE0Z9\\nLoosening of implant not related to boneingrowth: XE2K9\\nMigration or expulsion of device: XE0VD\\nMigration of device: XE763\\nExpulsion of device: XE1FH\\nManufacturing packaging or shipping problem: XE7Q8\\nProduct quality problem: XE5Y1\\nDull or blunt: XE4UR\\nNonstandard device: XE46G\\nDefective component: XE1K1\\nDefective device: XE9CD\\nDevice damaged prior to use: XE12L\\nPackaging problem: XE8RY\\nDifficult to open or remove packaging material: XE01Z\\nIncomplete or missing packaging: XE5YH\\nUnsealed device packaging: XE4VM\\nTear rip or hole in device packaging: XE2AN\\nDevice misassembled during manufacturing or shipping: XE151\\nComponent misassembled: XE9R8\\nComponent missing: XE89V\\nShipping damage or problem: XE8ZA\\nDelivered as unsterile product: XE78P\\nChemical problem: XE52X\\nDevice emits odour: XE9AC\\nDevice ingredient or reagent problem: XE3E0\\nClumping in device or device ingredient: XE4BC\\nCoagulation in device or device ingredient: XE49W\\nPrecipitate in device or device ingredient: XE4VP\\nCross reactivity: XE8Z6\\nParticulates: XE0VB\\nHigh pH: XE0K7\\nLow pH: XE657\\nImproper chemical reaction: XE6E7\\nMaterial integrity problem: XE4LP\\nBreak: XE8D2\\nFracture of device: XE1M6\\nLoss of or failure to bond: XE9DU\\nMaterial fragmentation: XE2ET\\nSolder joint fracture: XE82N\\nBurst container or vessel: XE638\\nExplosion: XE5EZ\\nCrack: XE38M\\nDegraded: XE0HB\\nCalcified: XE8J3\\nCorroded: XE228\\nMaterial erosion: XE1WE\\nPitted: XE9F6\\nFlaked: XE0YK\\nPeeled or delaminated: XE3VG\\nNaturally worn: XE975\\nUnraveled material: XE9JW\\nMaterial deformation: XE1LJ\\nDeformation due to compressive stress: XE0JB\\nDent in material: XE5NT\\nFailure to fold: XE0ZV\\nFailure to unfold or unwrap: XE06Q\\nMaterial frayed: XE37M\\nMaterial invagination: XE8PS\\nMaterial too rigid or stiff: XE4Z7\\nMaterial too soft or flexible: XE9WH\\nMaterial twisted or bent: XE47S\\nMelted: XE8ZQ\\nStretched: XE5D0\\nMaterial discoloured: XE2G9\\nMaterial disintegration: XE0RF\\nMaterial opacification: XE585\\nMaterial perforation: XE9AR\\nMaterial puncture or hole: XE0X4\\nMaterial protrusion or extrusion: XE72S\\nMaterial rupture: XE6G0\\nMaterial separation: XE6K7\\nMaterial split cut or torn: XE4FP\\nScratched material: XE609\\nMechanical problem: XE2GF\\nDetachment of device or device component: XE2CM\\nDevice damaged by another device: XE634\\nEjection problem: XE7NX\\nFailure to eject: XE0VZ\\nUnintended ejection: XE1PM\\nLeak or splash: XE944\\nFluid leak: XE2ZY\\nGas leak: XE0RV\\nGel leak: XE53W\\nRadiation leak: XE0B1\\nPerivalvular leak: XE2JE\\nFiring problem: XE1RJ\\nFailure to fire: XE666\\nMisfire: XE5P4\\nMechanical jam: XE88N\\nMechanics altered: XE279\\nFailure to align: XE7KY\\nFailure to cut: XE0XR\\nFailure to cycle: XE23L\\nFailure to form staple: XE289\\nNoise audible: XE4F9\\nPhysical resistance or sticking: XE635\\nRetraction problem: XE306\\nStructural problem: XE79Q\\nStructural collapse: XE8H1\\nSharp edges: XE3VF\\nDifficult to fold or unfold: XE8ZX\\nDifficult to open or close: XE2EV\\nIncomplete coaptation: XE3UJ\\nUnintended movement: XE8ZZ\\nDevice dislodged or dislocated: XE6KT\\nDevice tipped over: XE78C\\nDevice fell: XE5JJ\\nDevice slipped: XE1Q1\\nUnintended collision of device: XE0QZ\\nUnintended system motion: XE1Y1\\nUnstable device: XE5CH\\nVibration of device: XE76A\\nOptical problem: XE941\\nMisfocusing: XE5CX\\nOptical decentration: XE4W1\\nOptical discolouration: XE1VT\\nOptical distortion: XE4BE\\nOptical obstruction: XE93N\\nOutput problem: XE28Y\\nAudible prompt or feedback: XE8NW\\nInappropriate audible prompt or feedback: XE0WU\\nInaudible or unclear audible prompt or feedback: XE487\\nNo audible prompt or feedback: XE8MP\\nDisplay or visual feedback problem: XE2S2\\nDevice displays incorrect message: XE4TX\\nDisplay difficult to read: XE2NW\\nErratic or intermittent display: XE2ES\\nImage display error or artifact: XE7T8\\nImage orientation incorrect: XE2V3\\nNo display or image: XE5Q5\\nNo visual prompts or feedback: XE4FQ\\nPoor quality image: XE5XP\\nVisual prompts will not clear: XE1C5\\nTactile prompts or feedback: XE7Z4\\nInappropriate tactile prompt or feedback: XE6CE\\nNo tactile prompts or feedback: XE963\\nEnergy output problem: XE0KH\\nEnergy spectrum incorrect: XE7ST\\nFailure to deliver energy: XE5PU\\nIntermittent energy output: XE538\\nOutput above specifications: XE81P\\nOutput below specifications: XE8XC\\nTherapeutic or diagnostic output failure: XE2MC\\nTherapy delivered to incorrect body area: XE1US\\nRadiation output problem: XE1ED\\nRadiation output failure: XE5F0\\nRadiation overexposure: XE0JA\\nRadiation underexposure: XE74E\\nUnexpected or unintended radiation output: XE6UD\\nGas output problem: XE68Z\\nNo device output: XE7E5\\nIncorrect inadequate or imprecise result or readings: XE4BB\\nSignal artifact: XE7TS\\nFailure to obtain sample: XE3MS\\nFalse negative result: XE2E8\\nFalse positive result: XE9K2\\nIncorrect measurement: XE3XG\\nNonreproducible results: XE5E8\\nHigh readings: XE9D6\\nLow readings: XE5KE\\nHigh test results: XE485\\nLow test results: XE8EM\\nUnable to obtain readings: XE8YH\\nMissing test results: XE56S\\nUnexpected therapeutic results: XE3YZ\\nElectrical or electronic property problem: XE16C\\nCapturing problem: XE57L\\nFailure to capture: XE0UH\\nHigh capture threshold: XE18Z\\nIntermittent capture: XE1T0\\nUnstable capture threshold: XE350\\nContinuous firing: XE4QC\\nArcing: XE4HP\\nArcing at paddles: XE4X8\\nArcing of electrodes: XE7KZ\\nSparking: XE2SR\\nBattery problem: XE16Z\\nBattery problem with high impedance: XE2MD\\nBattery problem with low impedance: XE41Q\\nFailure to run on battery: XE548\\nPremature discharge of battery: XE5U8\\nCharging problem: XE5ER\\nAborted charge: XE6QY\\nDelayed charge time: XE67U\\nFailure to charge: XE5PM\\nFailure to discharge: XE8DT\\nPower problem: XE2B3\\nComplete loss of power: XE1DB\\nIntermittent loss of power: XE2A6\\nFailure to power up: XE38R\\nUnintended power up: XE7Z7\\nDevice sensing problem: XE0Q2\\nDecreased sensitivity: XE6SM\\nIncreased sensitivity: XE7QR\\nFailure to analyze signal: XE8H3\\nFailure to select signal: XE0K3\\nHigh sensing threshold: XE6H7\\nLow sensing threshold: XE2P7\\nLoss of threshold: XE9TK\\nFailure to sense: XE210\\nOversensing: XE02C\\nUndersensing: XE73Q\\nSensing intermittently: XE69X\\nIncorrect interpretation of signal: XE28F\\nFailure to conduct: XE22D\\nInterrogation problem: XE8S0\\nDifficult to interrogate: XE9HR\\nFailure to interrogate: XE3PE\\nPacing problem: XE8HJ\\nFailure to convert rhythm: XE19S\\nInaccurate synchronization: XE47M\\nInappropriate waveform: XE2LL\\nNo pacing: XE9A9\\nPacemaker found in backup mode: XE281\\nPacing asynchronously: XE13R\\nPacing inadequately: XE10M\\nPacing intermittently: XE1SU\\nPocket stimulation: XE99K\\nDefibrillation problem: XE440\\nFailure to deliver shock: XE12S\\nInappropriate shock: XE6T0\\nIntermittent shock: XE8BU\\nUnintended electrical shock: XE739\\nGrounding malfunction: XE9QT\\nElectrical overstress: XE3S7\\nElectrostatic discharge: XE268\\nFailure to shut off: XE20P\\nUnexpected shutdown: XE7JN\\nElectromagnetic compatibility problem: XE4PR\\nCircuit failure: XE5FA\\nImpedance problem: XE6ZB\\nCalibration problem: XE55U\\nFailure to calibrate: XE6GR\\nFailure to recalibrate: XE8MT\\nImprecision: XE7H5\\nOvercorrection: XE1WU\\nTemperature problem: XE586\\nExcessive cooling: XE9C7\\nExcessive heating: XE77H\\nInsufficient cooling: XE200\\nInsufficient heating: XE2A4\\nOverheating of device: XE14Q\\nThermal decomposition of device: XE6DP\\nFire: XE5T3\\nFlare or flash: XE03F\\nSmoke: XE5H5\\nComputer software problem: XE85E\\nApplication network problem: XE6PS\\nApplication program problem: XE8HP\\nApplication program freezes or becomes nonfunctional: XE5YA\\nApplication program problem dose calculation error: XE46R\\nApplication program problem medication error: XE09U\\nApplication program problem parameter calculation error: XE2BJ\\nApplication program problem power calculation error: XE6SW\\nApplication program version or upgrade problem: XE2CW\\nProblem with software installation: XE5CT\\nUnintended application program shutdown: XE842\\nProgram or algorithm execution problem: XE1HG\\nDelayed program or algorithm execution: XE87N\\nIntermittent program or algorithm execution: XE1WW\\nProgram or algorithm execution failure: XE0UN\\nComputer operating system problem: XE4Z0\\nOperating system becomes nonfunctional: XE5F1\\nOperating system version or upgrade problem: XE6VL\\nComputer system security problem: XE5EP\\nApplication security problem: XE9XK\\nUnauthorized access to computer system: XE15X\\nData backup problem: XE2ZM\\nFailure to back up: XE72G\\nFailure to convert to backup: XE8PZ\\nData problem: XE99Y\\nLoss of data: XE992\\nPatient data problem: XE7BE\\nDate or time related software problem: XE048\\nConnection problem: XE3UR\\nBlocked connection: XE9D0\\nDecoupling: XE74X\\nDisconnection: XE5WZ\\nFailure to disconnect: XE9HJ\\nLoose or intermittent connection: XE3G6\\nMisconnection: XE0WB\\nIncomplete or inadequate connection: XE4C0\\nFitting problem: XE0P9\\nCommunication or transmission problem: XE0JD\\nFailure to read input signal: XE3EG\\nFailure to transmit record: XE0V5\\nIntermittent communication failure: XE4JX\\nTelemetry discrepancy: XE5H8\\nWireless communication problem: XE4YY\\nInfusion or flow problem: XE7NV\\nDeflation problem: XE4VT\\nExcess flow or overinfusion: XE6YH\\nFilling problem: XE49K\\nInability to autofill: XE3T4\\nOverfill: XE97E\\nShort fill: XE8RE\\nVolume accuracy problem: XE1QQ\\nFiltration problem: XE2YK\\nInadequate filtration process: XE3VH\\nInadequate ultra filtration: XE4UN\\nImproper flow or infusion: XE1H4\\nBackflow: XE9RA\\nFree or unrestricted flow: XE447\\nGradient increase: XE628\\nInaccurate delivery: XE667\\nInaccurate flow rate: XE44F\\nIntermittent infusion: XE2DM\\nReflux with device: XE09Q\\nRestricted flow rate: XE8AY\\nTidal volume fluctuations: XE1V7\\nInflation problem: XE5GY\\nInsufficient flow or under infusion: XE1S7\\nNo flow: XE1Y3\\nFailure to deliver flow: XE94H\\nFailure to infuse: XE1JK\\nInability to irrigate: XE8L2\\nObstruction of flow: XE3GX\\nComplete blockage: XE3QL\\nPartial blockage: XE2JF\\nDifficult to flush: XE6BM\\nPressure problem: XE8Z5\\nDecrease in pressure: XE3XR\\nIncrease in pressure of device: XE6S6\\nNo pressure: XE94J\\nPumping problem: XE6Z5\\nDecreased pump speed: XE64X\\nIncreased pump speed: XE7BN\\nFailure to pump: XE5R0\\nPumping stopped: XE0TF\\nSuction problem: XE69E\\nDecrease in suction: XE3Y3\\nIncrease in suction: XE35T\\nSuction failure: XE5FE\\nPriming problem: XE0B4\\nFailure to prime: XE3KR\\nIncomplete or inadequate priming: XE63F\\nActivation positioning or separation problem: XE4GH\\nActivation problem: XE76U\\nActivation failure or expansion failures: XE48N\\nDifficult or delayed activation: XE9Y0\\nPremature activation: XE6E9\\nSelfactivation or keying: XE5VT\\nPositioning problem: XE2J9\\nPositioning failure: XE41N\\nMalposition of device: XE8P2\\nDifficult or delayed positioning: XE74U\\nFailure to advance: XE4CG\\nDifficult to advance: XE9NU\\nDifficult to insert: XE2JZ\\nDifficult to remove: XE0HC\\nEntrapment of device: XE9MQ\\nSeparation problem: XE1KB\\nSeparation failure: XE9BM\\nDifficult or delayed separation: XE6U9\\nPremature separation of device: XE1TT\\nProtective measures problem: XE1XC\\nDevice alarm system: XE98H\\nAlarm not visible: XE5JP\\nNo audible alarm: XE6DH\\nLow audible alarm: XE2RK\\nDelayed alarm: XE3QU\\nFalse alarm: XE2K0\\nDefective alarm: XE3UE\\nFailsafe problem: XE78D\\nFailsafe did not activate: XE659\\nNo failsafe mechanism: XE6VE\\nFailure of device to selftest: XE3V3\\nFailure to auto stop: XE16Y\\nReset problem: XE4KE\\nFailure to reset: XE59S\\nFailure to zero: XE0HZ\\nInappropriate or unexpected reset: XE2T4\\nPremature indicator activation: XE1H0\\nPremature elective replacement indicator: XE6KH\\nPremature endoflife indicator: XE6ND\\nShielding failure: XE4PS\\nCompatibility problem: XE452\\nComponent or accessory incompatibility: XE02E\\nAccessory incompatible: XE7N5\\nComponent incompatible: XE1UE\\nDevicedevice incompatibility: XE8KS\\nMeasurement system incompatibility: XE0HJ\\nUnintended compatibility: XE4UP\\nContamination or decontamination problem: XE4XW\\nContamination during use: XE9L2\\nBiofilm coating in device: XE9H4\\nContamination of device ingredient or reagent: XE2AR\\nDevice contamination with body fluid: XE4VF\\nDevice contamination with chemical or other material: XE9AH\\nMicrobial contamination of device: XE97G\\nDevice contaminated during manufacture or shipping: XE450\\nDevice reprocessing problem: XE5LK\\nFailure to clean adequately: XE3MN\\nFailure to disinfect: XE4A4\\nFlushing problem: XE0VE\\nProblem with sterilisation: XE2LR\\nResidue after decontamination: XE0HG\\nEnvironmental compatibility problem: XE6K5\\nAmbient noise problem: XE027\\nAmbient temperature problem: XE5R1\\nFumes or vapours as environmental compatibility problem: XE50X\\nFungus in device environment: XE011\\nMoisture or humidity problem: XE8HD\\nVentilation problem in device environment: XE7KA\\nDevice unsafe to use in environment: XE5NF\\nEnvironmental particulates: XE55E\\nMedical gas supply problem: XE6V9\\nElectrical power problem: XE5ZE\\nInstallation related problem: XE2H3\\nMisassembled during installation: XE36N\\nLabelling instructions for use or training problem: XE3J4\\nDevice markings or labelling problem: XE23E\\nLack of maintenance documentation or guidelines: XE25T\\nInadequate instructions for healthcare professional: XE13S\\nInadequate instructions for nonhealthcare professional: XE17P\\nInadequate or insufficient training: XE22G\\nHumandevice interface problem: XE5DG\\nDevice difficult to set up or prepare: XE1C2\\nDevice difficult to program or calibrate: XE3B8\\nDevice difficult to maintain: XE2N3\\nInadequate user interface: XE35S\\nUse of device problem: XE0AG\\nDevice handling problem: XE6PE\\nUse of incorrect control settings: XE7S3\\nImproper or incorrect procedure or method: XE2XZ\\nOfflabel use: XE7VD\\nMisassembled: XE61V\\nAdverse event without identified device or use problem: XE3GL\\nNo apparent adverse event: XE3DN\\nAppropriate term or code not available for aspects of incidents related to devices: XE1W0\\nCause traced to device design: XE1UR\\nCause traced to component failure: XE7NC\\nCause traced to manufacturing: XE2TX\\nCause traced to transport or storage: XE18E\\nCause traced to infrastructure: XE7NN\\nCause traced to environment: XE1WV\\nCause traced to maintenance: XE5AS\\nCause traced to training: XE5UX\\nCause traced to labeling: XE674\\nCause cannot be traced to device: XE5BM\\nCause traced to user: XE6LX\\nKnown inherent risk of device: XE0QB\\nFalsified device: XE8UG\\nNo problem with device detected: XE51D\\nCause of problem with device not established: XE2SY\\nConclusion not yet available regarding problem with device: XE0T3\\nBiological problem with device identified: XE0WX\\nBiocompatibility problem with device identified: XE5T0\\nBiological contamination of device: XE4YZ\\nMaterial or material leachate pyrogenic problem with device identified: XE7B7\\nCytotoxicity problem with device identified: XE2RY\\nGenotoxicity problem with device identified: XE2PA\\nHematological problem with device identified: XE7AM\\nUnintended presence of allergens in device identified: XE1Y9\\nReproductive toxicity problem with device identified: XE2XW\\nElectrical problem with device identified: XE4CB\\nElectrical or electronic component problem with device identified: XE1YA\\nHardware timing problem with device identified: XE53K\\nImpedance problem with device identified: XE546\\nInsulation problem with device identified: XE1TX\\nOpen circuit in device: XE4PP\\nCurrent leakage problem of device identified: XE2V6\\nPower source problem identified in device: XE0KB\\nEnergy storage system problem in device: XE4ZM\\nLoss of power to device: XE2WJ\\nPower fluctuation in device: XE7RB\\nShort circuit of device: XE7AB\\nSignal loss of device: XE8KR\\nElectromagnetic compatibility problem with device identified: XE6AQ\\nConducted interference with device: XE6BD\\nElectrostatic discharge of device: XE8P9\\nInadequate immunity of device: XE2ME\\nUnintended emission of device: XE8TZ\\nRadiofrequency interference with device identified: XE1LT\\nInteroperability problem with device identified: XE02N\\nCommunications problem with device identified: XE6C8\\nWired communication problem with device identified: XE22K\\nWireless communication problem with device identified: XE1PD\\nNetwork communication problem with device identified: XE5NA\\nIncompatible component or accessory of device identified: XE1SP\\nLabeling and instructions for use or maintenance of device problem identified: XE1YT\\nInadequate labelling or instructions for use of device identified: XE3PV\\nIncorrect labelling or instructions for use of device identified: XE4MR\\nInadequate or incorrect instructions for maintenance of device identified: XE7Y7\\nMaterial or chemical problem with device identified: XE3RW\\nDegradation problem identified with device: XE2H0\\nInappropriate material identified in device: XE2WT\\nInadequate physicochemical properties identified in device: XE60T\\nIncompatible material identified in device: XE4EB\\nReactivity problem identified with device: XE25Z\\nTolerance stackup identified in device: XE6U0\\nMechanical problem with device identified: XE640\\nDevice migration identified: XE8RU\\nFriction problem identified with device: XE3HZ\\nLeakage or seal problem identified with device: XE1P8\\nLubrication problem identified with device: XE6UT\\nStiffness problem identified with device: XE69Q\\nStress problem with device identified: XE8V5\\nDeformation problem with device identified: XE0WG\\nFatigue problem with device identified: XE3Y4\\nFracture problem with device identified: XE1ZP\\nMechanical shock problem with device identified: XE1UJ\\nVibration problem with device identified: XE1H3\\nWear problem with device identified: XE1ZQ\\nIncorrect dimension of device identified: XE1EJ\\nOptical problem with device identified: XE4KN\\nOptical transmission problem identified with device: XE42B\\nLight source problem identified with device: XE8XT\\nClinical imaging problem with device identified: XE05W\\nGradient induced field problem with device identified: XE15N\\nImage artifact identified in device: XE1HK\\nMagneticallyinduced movement of device identified: XE6YW\\nRadiofrequency induced overheating of device identified: XE9Y9\\nSoftware problem with device identified: XE6TE\\nConfiguration issue of device identified: XE77W\\nDesign error of device identified: XE6DT\\nData compression error in device identified: XE006\\nIncorrect algorithm in device identified: XE62E\\nIncorrect data definition in device identified: XE1X4\\nInterface design error of device identified: XE2FL\\nNonfunctional defect in device identified: XE85U\\nSoftware timing problem in device identified: XE3RD\\nSoftware maintenance problem identified with device: XE9JR\\nSoftware installation problem identified with device: XE688\\nSoftware requirement error with device identified: XE4SV\\nSoftware runtime error in device identified: XE51Q\\nSoftware security vulnerability of device identified: XE9W2\\nErroneous data transfer in device identified: XE1KR\\nData storage or loss of data problem in device identified: XE2A7\\nThermal problem with device identified: XE8XM\\nOverheating of device problem identified: XE62G\\nExcessive heating of device problem identified: XE9HT\\nInadequate cooling of device problem identified: XE7A1\\nProtective system problem with device identified: XE5HU\\nFailsafe problem with device identified: XE0WJ\\nAlarm system problem with device identified: XE4JQ\\nProblem of device to selftest identified: XE7ZT\\nProblem of device to auto stop identified: XE1JG\\nReset problem with device identified: XE9AV\\nPremature indicator activation problem identified: XE2FY\\nShielding problem with device identified: XE3BG\\nMissing or inadequate safety measures of device identified: XE0M6\\nOperational problem with device identified: XE82X\\nDevice incorrectly reprocessed: XE5RS\\nDevice incorrectly cleaned during reprocessing identified: XE2RQ\\nDevice incorrectly disinfected or sterilised during reprocessing identified: XE63T\\nDevice incorrectly assembled during reprocessing identified: XE0TU\\nFailure to calibrate problem identified: XE15Q\\nDevice difficult to operate problem identified: XE3W1\\nIncorrect interpretation of results or data problem identified: XE2QD\\nPatient sample problem with device identified: XE2YD\\nNew or unknown interferent problem with device identified: XE8DL\\nKnown interferent problem with device identified: XE9C0\\nPreanalytical handling problem with device identified: XE83B\\nEnvironment problem with device identified: XE3AL\\nEnvironmental temperature problem with device identified: XE5K2\\nDust or dirt problem with device identified: XE9HK\\nContamination of environment by device identified: XE2VF\\nEnvironmental pressure problem with device identified: XE6QW\\nAmbient light problem with device identified: XE5SF\\nEnvironmental humidity problem with device identified: XE4V1\\nManufacturing process problem with device identified: XE205\\nAssembly problem with device identified: XE3NF\\nSterilization problem with device identified: XE00F\\nInstallation problem with device identified: XE1PG\\nMaintenance of manufacturing machinery problem with device identified: XE843\\nPackaging problem with device identified: XE278\\nPackaging of device compromised problem identified: XE9F7\\nPackaging materials of device problem identified: XE0KG\\nPackaging of device contains unintended material problem identified: XE8S1\\nPackaging contains incorrect device problem identified: XE8TA\\nMaintenance problem with device identified: XE6LZ\\nTransport or storage problem with device identified: XE9VK\\nStorage of device problem identified: XE32G\\nNo device problem found: XE41R\\nNo findings available: XE587\\nResults pending completion of investigation: XE3PA\\nAppropriate term or code for investigation of device not available: XE3WR\\nTesting of actual or suspected device: XE9HD\\nTesting of device from same lot or batch retained by manufacturer: XE7XH\\nTesting of device from same lot batch returned from user: XE4S0\\nTesting of device from other lot batch retained by manufacturer: XE2ZR\\nTesting of device from other lot or batch returned from user: XE4X1\\nTesting of model variant: XE1XT\\nTesting of raw or starting materials: XE8XV\\nTesting of patient sample or reference material using manufacturers device: XE6FS\\nTesting of patient sample or reference material using reference method: XE9MY\\nTesting of patient sample or reference material using competitors device: XE89L\\nHistorical data analysis: XE8UH\\nTrend analysis: XE8BM\\nCommunication or interviews: XE7GK\\nAnalysis of production records: XE4KV\\nAnalysis of data provided by user or third party: XE59M\\nDevice not manufactured by reporting manufacturer: XE8FB\\nDevice not returned: XE970\\nDevice discarded: XE18W\\nIncomplete device returned: XE5AN\\nDevice not accessible for testing: XE53L\\nType of investigation not yet determined: XE6Q2\\nInsufficient information available: XE3TW\\nAbsorber component of medical device: XE8XD\\nCautery tip component of medical device: XE6Z7\\nDevice ingredient or reagent component of medical device: XE7JR\\nGas scavenging component of medical device: XE8HT\\nMonomer liquid component of medical device: XE4VK\\nTest strip component of medical device: XE68H\\nPolymer powder component of medical device: XE7WP\\nAntenna component of medical device: XE321\\nBattery component of medical device: XE3WM\\nBattery charger component of medical device: XE80Z\\nCable electrical component of medical device: XE7JQ\\nCable grip component of medical device: XE77B\\nCable sleeve component of medical device: XE2BS\\nCircuit board component of medical device: XE2WY\\nCircuit breaker component of medical device: XE5BT\\nComputer hardware component of medical device: XE2ZE\\nComputer processor component of medical device: XE3Q8\\nMemory or storage component of medical device: XE1JS\\nNetwork interface component of medical device: XE2YC\\nComputer software component of medical device: XE8UU\\nComputer software driver component of medical device: XE59Z\\nSoftware interface component of medical device: XE2JQ\\nUser interface component of medical device: XE8V6\\nCooling module component of medical device: XE7P0\\nDevice programmer component of medical device: XE8UV\\nDevice reader component of medical device: XE033\\nDiscrete electrical component of medical device: XE6UE\\nElectrical capacitor component of medical device: XE845\\nElectrical fuse component of medical device: XE38E\\nElectrical inductor component of medical device: XE1UQ\\nElectrical resistor component of medical device: XE2AJ\\nElectrical solenoid component of medical device: XE4VJ\\nElectrical transducer component of medical device: XE018\\nElectrical semiconductor component of medical device: XE27R\\nIntegrated circuit chip component of medical device: XE9ZW\\nDisplay component of medical device: XE8GY\\nDisplay indicator component of medical device: XE4YD\\nDisplay screen component of medical device: XE2JV\\nElectrical lead or wire component of medical device: XE59E\\nElectrode component of medical device: XE5U9\\nGround strap or wire component of medical device: XE561\\nWiring harness component of medical device: XE753\\nElectrical mixer component of medical device: XE6S4\\nElectrical port component of medical device: XE0Y5\\nEmitter component of medical device: XE2PX\\nHeadphone or headset component of medical device: XE5GC\\nHeater component of medical device: XE9TB\\nHub component of medical device: XE713\\nInverter component of medical device: XE8JV\\nMagnet component of medical device: XE4BN\\nOscillator component of medical device: XE7YS\\nPatient lead component of medical device: XE525\\nLead conductor component of medical device: XE7F1\\nPatient electrode component of medical device: XE25C\\nPower cord component of medical device: XE4XJ\\nPower supply component of medical device: XE4Q4\\nPressure transducer probe component of medical device: XE7EJ\\nPrinter component of medical device: XE062\\nReceiver component of medical device: XE2KA\\nReceiver stimulator unit component of medical device: XE6SG\\nScanner component of medical device: XE4TH\\nSpeaker or sounder component of medical device: XE0ST\\nSwitch or relay component of medical device: XE5R5\\nPower switch component of medical device: XE1EF\\nRelay component of medical device: XE4QR\\nTelemetry component of medical device: XE884\\nTemperature compensator component of medical device: XE30P\\nThermostat component of medical device: XE56F\\nTransformer component of medical device: XE256\\nTransmitter component of medical device: XE579\\nUser input device component of medical device: XE5A0\\nJoystick component of medical device: XE9TZ\\nKeyboard or keypad component of medical device: XE6CN\\nMicrophone component of medical device: XE9FY\\nTouchscreen component of medical device: XE9ZJ\\nAnalyzer component of medical device: XE37A\\nOxygen analyzer component of medical device: XE0A7\\nAperture component of medical device: XE6E8\\nCalibrator component of medical device: XE34X\\nClock component of medical device: XE06B\\nCounter component of medical device: XE9NB\\nCurvette component of medical device: XE20X\\nGauges or meters component of medical device: XE00B\\nFlowmeter component of medical device: XE1WJ\\nManometer component of medical device: XE6V2\\nThermometer component of medical device: XE019\\nMarker component of medical device: XE8RD\\nPipette component of medical device: XE7MS\\nPointer component of medical device: XE5UB\\nScale component of medical device: XE2MH\\nSensor component of medical device: XE8GP\\nBubble sensor component of medical device: XE5Q2\\nOxygen sensor component of medical device: XE5ZD\\nPhotodetector component of medical device: XE9G5\\nPressure sensor component of medical device: XE5WR\\nSensor probe component of medical device: XE7Q4\\nTemperature sensor component of medical device: XE3W9\\nTimer component of medical device: XE3R3\\nAccess port component of medical device: XE3UX\\nActuator component of medical device: XE0WZ\\nAdaptor component of medical device: XE0SV\\nAir eliminator component of medical device: XE6D6\\nAnchor component of medical device: XE4F2\\nApplicator component of medical device: XE94Y\\nAutomatic injection system component of medical device: XE968\\nBag component of medical device: XE7E4\\nBall component of medical device: XE0HN\\nBalloon component of medical device: XE5AV\\nBearings component of medical device: XE1G8\\nPotting component of medical device: XE0Y2\\nProbe component of medical device: XE46S\\nProcessor component of medical device: XE23M\\nPulley component of medical device: XE9DJ\\nPump component of medical device: XE0K1\\nPusher component of medical device: XE8RF\\nRachet component of medical device: XE76K\\nRail component of medical device: XE4JZ\\nSide rail component of medical device: XE0KN\\nRegulator component of medical device: XE6YN\\nReservoir component of medical device: XE65T\\nBellows component of medical device: XE1XK\\nRing component of medical device: XE7DG\\nRod or shaft component of medical device: XE017\\nSeal component of medical device: XE4BJ\\nShock absorber component of medical device: XE7N2\\nSleeve component of medical device: XE7ZG\\nSlide component of medical device: XE6VJ\\nSocket component of medical device: XE740\\nSpacer component of medical device: XE4DU\\nSpring component of medical device: XE7QZ\\nStand component of medical device: XE4K0\\nBelt component of medical device: XE9CF\\nSteering wire component of medical device: XE82E\\nStent component of medical device: XE7UE\\nStopcock component of medical device: XE8M4\\nStopper component of medical device: XE00C\\nStrain relief component of medical device: XE4E4\\nStylet component of medical device: XE3GN\\nSyringe component of medical device: XE05P\\nTable component of medical device: XE3ED\\nTip component of medical device: XE06W\\nTool component of medical device: XE6GE\\nBottle component of medical device: XE7G4\\nTranslational motion component of medical device: XE0UG\\nTrap component of medical device: XE2FM\\nTrocar component of medical device: XE4M3\\nTube component of medical device: XE8TY\\nCapillary tube component of medical device: XE2PZ\\nValve component of medical device: XE01P\\nControl valve component of medical device: XE3YJ\\nLuer valve component of medical device: XE229\\nOneway valve component of medical device: XE2LS\\nVaporiser component of medical device: XE6MT\\nVibrator component of medical device: XE0FP\\nWasher component of medical device: XE83A\\nWeld component of medical device: XE1PW\\nWheel component of medical device: XE6HA\\nBreathing circuit component of medical device: XE0C3\\nWindow component of medical device: XE99Z\\nShutter component of medical device: XE2Q3\\nBrush component of medical device: XE5YT\\nBrushing component of medical device: XE0AX\\nCable mechanical structural component of medical device: XE4NU\\nCannula component of medical device: XE2UB\\nCannula hub component of medical device: XE9FK\\nCap component of medical device: XE44H\\nCarrier component of medical device: XE00E\\nCaster component of medical device: XE3K0\\nCatheter component of medical device: XE088\\nCatheter hub component of medical device: XE8NS\\nCell component of medical device: XE1TF\\nChain component of medical device: XE65A\\nChamber component of medical device: XE6N0\\nChassis or frame component of medical device: XE4BK\\nClutch component of medical device: XE5CL\\nCoating material component of medical device: XE3C8\\nCoil component of medical device: XE1S0\\nHelifix coil component of medical device: XE8AQ\\nCollimator component of medical device: XE0YX\\nConcentrator component of medical device: XE7YF\\nCone component of medical device: XE5TK\\nConnector or coupler component of medical device: XE7EE\\nConnector pin component of medical device: XE4T6\\nController component of medical device: XE83L\\nCompressor component of medical device: XE46J\\nCover component of medical device: XE1S2\\nCuff component of medical device: XE8LZ\\nCup component of medical device: XE8YR\\nCusp and leaflet component of medical device: XE8T8\\nCutter or blade component of medical device: XE3LB\\nCylinder component of medical device: XE9WL\\nDevice collapser component of medical device: XE3CX\\nDevice deployer component of medical device: XE8J5\\nDiaphragm component of medical device: XE1KD\\nDome component of medical device: XE85G\\nEjector component of medical device: XE5K4\\nEquipment pole component of medical device: XE1VC\\nExtender component of medical device: XE8ZU\\nFabric component of medical device: XE026\\nFan or blower component of medical device: XE8VD\\nFastner component of medical device: XE5DL\\nAdhesive fastner component of medical device: XE1A5\\nBolt fastner component of medical device: XE4V8\\nClamp fastner component of medical device: XE4PG\\nClip fastner component of medical device: XE3VN\\nFixation wire fastner component of medical device: XE9KR\\nLatch fastner component of medical device: XE6R2\\nNail fastner component of medical device: XE7GP\\nNut fastner component of medical device: XE0F0\\nPin fastner component of medical device: XE6A2\\nProng fastner component of medical device: XE059\\nRetainer fastner component of medical device: XE33C\\nRivet fastner component of medical device: XE9MM\\nScrew fastner component of medical device: XE3NX\\nStaple fastner component of medical device: XE2HY\\nSuture thread fastner component of medical device: XE0NL\\nTape for fixation component of medical device: XE8MX\\nFiber component of medical device: XE15J\\nFilter component of medical device: XE65M\\nFlange component of medical device: XE10F\\nFoil component of medical device: XE4PC\\nGas exchanger component of medical device: XE3HQ\\nGasket component of medical device: XE3QZ\\nGears component of medical device: XE5M6\\nGenerator component of medical device: XE0RK\\nGuide component of medical device: XE1ND\\nGuidewire component of medical device: XE64H\\nHandpiece component of medical device: XE11W\\nHeader component of medical device: XE37B\\nSewing ring component of medical device: XE2AL\\nHeat exchanger component of medical device: XE12Q\\nHinge component of medical device: XE5ZS\\nHolder component of medical device: XE4FZ\\nHose component of medical device: XE3A4\\nHousing component of medical device: XE5S9\\nHumidifier component of medical device: XE0YE\\nHydraulic system component of medical device: XE1TK\\nImpeller component of medical device: XE4NN\\nInserter component of medical device: XE3WA\\nInsulation component of medical device: XE1Y2\\nIsolator component of medical device: XE7JF\\nJaw component of medical device: XE7N3\\nJoint component of medical device: XE7GQ\\nKnob component of medical device: XE3AW\\nLabel component of medical device: XE6R7\\nLeaflet component of medical device: XE1VQ\\nLever component of medical device: XE5XR\\nFoot pedal component of medical device: XE08E\\nLiner component of medical device: XE80W\\nMagazine or cassette component of medical device: XE17E\\nManifold component of medical device: XE87E\\nMask component of medical device: XE26U\\nMechanical mixer component of medical device: XE74K\\nMembrane component of medical device: XE9VQ\\nMesh component of medical device: XE8R6\\nMotor component of medical device: XE0R5\\nMount component of medical device: XE8X1\\nNeedle component of medical device: XE4BH\\nNozzle component of medical device: XE78G\\nPackaging component of medical device: XE7C4\\nPad component of medical device: XE5AR\\nPanel component of medical device: XE080\\nPlate component of medical device: XE965\\nPlug component of medical device: XE09R\\nPlunger component of medical device: XE9R2\\nPost component of medical device: XE25A\\nCamera component of medical device: XE120\\nFilm component of medical device: XE5CR\\nImager component of medical device: XE7NH\\nLaser component of medical device: XE6GJ\\nLight emitting diode component of medical device: XE6QH\\nLenses component of medical device: XE616\\nLight source component of medical device: XE5LN\\nBulb component of medical device: XE5G9\\nMirror component of medical device: XE9EM\\nOptical fiber component of medical device: XE7A6\\nAlarm component of medical device: XE28G\\nAlarm component of medical device audible: XE5DW\\nAlarm component of medical device visual: XE3WT\\nEmergency button or switch component of medical device: XE2N6\\nFailsafe system component of medical device: XE37H\\nLocking mechanism component of medical device: XE51V\\nProtector or shield component of medical device: XE8RN\\nSafety interlock component of medical device: XE0ZU\\nNeedle stick prevention mechanism: XE4HV\\nSafety valve component of medical device: XE58K\\nPart component or subassembly term not applicable: XE27U\\nAppropriate term or code not available for medical device component: XE8NG\\nOne or both eyes are opening spontaneously: XC3W\\nOne or both eyes opening to verbal stimulation: XC5L\\nOne or both eyes opening to pressure stimulation: XC3H\\nNo eye opening even with pressure stimulation: XC87\\nEyes opening non testable: XC2N\\nObeys commands: XC4L\\nLocalising response to pressure stimulation: XC6J\\nNormal flexion response to pressure stimulation: XC8Q\\nAbnormal flexion response to pressure stimulation: XC8W\\nExtension response to pressure stimulation: XC8H\\nNo motion even with pressure stimulation: XC34\\nMotor score non testable: XC3S\\nOriented normal speech: XC2X\\nConfused disoriented speech: XC4Y\\nIntelligible single words: XC4A\\nIncomprehensible sounds to pressure stimulation: XC7U\\nNo verbal output even with pressure stimulation: XC8U\\nVerbal score non testable: XC03\\nNeither pupil reacts: XC5Y\\nOne pupil reacts: XC16\\nBoth pupils react: XC5K\\nData not available: XC85\\nAntacids: XM1349\\nMagnesium compounds: XM7GM7\\nMagnesium hydroxide: XM39M3\\nAluminium aluminium magnesium silicate: XM35X7\\nAluminium compounds: XM3JP8\\nAlgeldrate: XM9N47\\nAluminium aluminium phosphate: XM2VU8\\nAloglutamol: XM4NY5\\nAluminium aluminium glycinate: XM7DC3\\nDihydroxyaluminum sodium carbonate: XM9PG0\\nAluminum hydroxide gel: XM38T8\\nCalcium compounds: XM0SA0\\nCalcium carbonate: XM9003\\nCalcium silicate: XM8EF6\\nCombinations and complexes of aluminium calcium and magnesium compounds: XM0D52\\nMagaldrate: XM5R16\\nAlmagate: XM8J56\\nHydrotalcite: XM3EB6\\nAlmasilate: XM9Y49\\nCimetidine: XM9YL4\\nFamotidine: XM6441\\nNizatidine: XM9ZP3\\nRanitidine: XM6WY8\\nRoxatidine: XM0SH0\\nNiperotidine: XM08A8\\nRanitidine bismuth citrate: XM1ZT1\\nLafutidine: XM0Q37\\nProton pump inhibitors: XM2WX5\\nOmeprazole: XM8X45\\nPantoprazole: XM86M3\\nLansoprazole: XM39X4\\nRabeprazole: XM3M01\\nEsomeprazole: XM8YE1\\nDexlansoprazole: XM5RA0\\nDexrabeprazole: XM1J18\\nTegoprazan: XM3MK2\\nProstaglandins: XM4ML1\\nMisoprostol: XM28N9\\nEnprostil: XM4GD1\\nAlprostadil: XM1CF2\\nDinoprost: XM3Q43\\nDinoprostone: XM5VF9\\nGemeprost: XM2L11\\nCarboprost: XM8XM0\\nSulprostone: XM9BJ7\\nCarbenoxolone: XM2H82\\nSucralfate: XM0044\\nPirenzepine: XM6690\\nProglumide: XM6WX3\\nGefarnate: XM0HB8\\nSulglicotide: XM2689\\nAlginic acid: XM4H50\\nRebamipide: XM2891\\nMethiosulfonium chloride: XM1F15\\nBismuth subcitrate: XM1BG6\\nAcetoxolone: XM1LT9\\nZolimidine: XM9SW3\\nTroxipide: XM1Y11\\nBismuthyl subnitrate: XM84X1\\nFixed Combinations for Helicobacter pylori eradication: XM1364\\nSerotonin receptor antagonists: XM4S40\\nOndansetron: XM7423\\nGranisetron: XM8123\\nCilansetron: XM3X37\\nDiisopromine: XM2493\\nChlorbenzoxamine: XM30Q8\\nPinaverium: XM2GC8\\nFenoverine: XM3CZ9\\nAlverine: XM5RS2\\nIsometheptene: XM27M9\\nMigalstat: XM6UH6\\nFenpiprane: XM49K4\\nIdanpramine: XM7F16\\nProxazole: XM8N97\\nTrepibutone: XM2SK3\\nCaroverine: XM3R36\\nPhloroglucinol: XM66E5\\nTrimethyldiphenylpropylamine: XM7ZC5\\nValethamate bromide: XM9K48\\nAluminium aluminium tannate: XM6Q06\\nAmylopectin: XM62S7\\nAntidiarrhoeal drug absorbent: XM8A95\\nAttapulgite: XM6V74\\nBacillus subtilis: XM4SG9\\nBismuth salts subcarbonate: XM98L3\\nBismuth salts: XM5U61\\nCarbo medicinalis: XM3962\\nCharcoal: XM0S42\\nCharcoal activated: XM46T5\\nCharcoal medicinal activated: XM2269\\nCharcoal medicinal antidiarrhoeal: XM8D61\\nDifenoxin: XM8ET0\\nFetoxilate: XM15K3\\nIntestinal motility control drug: XM3ZU0\\nKaolin: XM7CN8\\nKaolin light: XM2GB1\\nLactobacillus acidophilus compound: XM1N12\\nLactobacillus acidophilus: XM0EB5\\nLactobacillus bifidus lyophilized: XM0QG1\\nLactobacillus bulgaricus: XM1TF2\\nLactobacillus sporogenes: XM4KH7\\nLignin hemicellulose: XM48X2\\nLomotil: XM8683\\nMiyari bacteria: XM2UP7\\nPectin: XM2HR7\\nSaccharomyces boulardii: XM4X08\\nAnise oil: XM2663\\nAntiflatulent: XM8A26\\nBetaine: XM0090\\nBile salts: XM0TD5\\nCarminative: XM5TC9\\nCholagogues: XM5QD3\\nCholeretic: XM6RN6\\nCytochrome C: XM5CH0\\nDehydrocholic acid: XM00U8\\nDill: XM0365\\nElastase: XM4RK4\\nEnzyme intestinal: XM5H83\\nFlorantyrone: XM2Q01\\nGastric enzymes: XM5BH7\\nGentian: XM63F8\\nGinger: XM1TN8\\nGlutamic acid: XM0994\\nHydrochloric acid medicinal digestant: XM15D5\\nOx bile extract: XM2702\\nPancreatin: XM6HM1\\nPancrelipase: XM9Z07\\nPapain: XM6DW4\\nPapain digestant: XM72V4\\nPeppermint oil: XM1XP0\\nPepsin digestant: XM17U7\\nPhenylpropanol: XM7L34\\nTilactase: XM4U70\\nCerium oxalate: XM4H25\\nCopper emetic: XM3ME7\\nCopper sulfate medicinal emetic: XM9FG8\\nMustard black: XM2WE8\\nChlorobutanol: XM5SW7\\nTrimethobenzamide: XM8SN3\\nMetopimazine: XM46N1\\nAprepitant: XM1DC1\\nCasopitant: XM2633\\nRolapitant: XM41Y6\\nPipamazine: XM2170\\nPyrathiazine: XM9FU8\\nAmmonium sulfonate resin: XM3KJ5\\nBacillus lactobacillus: XM4KK2\\nCarrageenan: XM4663\\nCharcoal medicinal poison control: XM8NM7\\nCharcoal medicinal specified use other than for diarrhoea: XM4GA5\\nDimethyl polysiloxane: XM7ER1\\nGastrointestinal drug biological: XM30A7\\nGastrointestinal drug specified: XM0KJ8\\nGlucurolactone: XM7L13\\nHepatic secretion stimulant: XM9Q94\\nIntestinal motility control drug biological: XM7EV4\\nIon exchange resin anion: XM9S11\\nIon exchange resin intestinal: XM1AX0\\nLiquorice extract: XM0UP4\\nMesalazine: XM8UW6\\nOlsalazine: XM0TN5\\nPancreatic digestive secretion stimulant: XM73P5\\nPolysilane: XM0EK0\\nSodium alginate: XM2K96\\nSodium amylosulfate: XM7M46\\nSulfated amylopectin: XM7AL9\\nAlexitol sodium: XM6347\\nAluminium aluminium carbonate gel basic: XM8YP0\\nAluminium aluminium chlorhydroxidecomplex: XM3Q55\\nAluminium aluminium hydroxidemagnesium carb gel: XM9DS4\\nAluminium aluminium silicate: XM8FL6\\nAluminium aluminium sodium silicate: XM0BM4\\nAntacid: XM37S3\\nAntigastricsecretion drug: XM5XT4\\nBenexate: XM9KD3\\nBismuth salts aluminate: XM1F19\\nBurimamide: XM5R07\\nCetraxate: XM7Y04\\nChalk precipitated: XM1WQ5\\nDihydroxyaluminum aminoacetate: XM1622\\nDimethicone: XM9BS9\\nMagnesia magma: XM6YR9\\nMagnesium carbonate: XM7V20\\nMagnesium trisilicate: XM8L43\\nMethylpolysiloxane: XM1EN3\\nMetiamide: XM9414\\nMilk of magnesia: XM7SH2\\nOrnoprostil: XM01K0\\nPepstatin: XM7K87\\nPotassium glucaldrate: XM7W08\\nRolaids: XM7Z18\\nRosaprostol: XM87Z0\\nSimaldrate: XM64X9\\nSimethicone: XM38C5\\nSoda bicarb: XM0QL9\\nSodium glucaldrate: XM43U8\\nSodium polyhydroxyaluminium monocarbonate: XM7M59\\nTriple carbonate: XM38H3\\nVitamin ulceroprotectant: XM5QM5\\nAgar: XM8K92\\nArachis oil cathartic: XM5FL6\\nAtonia drug intestinal: XM5993\\nBran wheat: XM9281\\nBulk filler cathartic: XM21B3\\nCalcium dioctyl sulfosuccinate: XM0ML8\\nCarboxymethylcellulose: XM0HS3\\nCarmellose: XM3EV1\\nCathartic bulk: XM99E9\\nCathartic emollient: XM4DA2\\nCathartic mucilage: XM2Y48\\nCellulose cathartic: XM3000\\nCellulose hydroxyethyl: XM22V5\\nDioctyl sulfosuccinate calcium sodium: XM6ZN5\\nEthylhydroxycellulose: XM2UB3\\nFecal softener: XM6CL0\\nFiber dietary: XM1RJ7\\nIspagula husk: XM4A22\\nKaraya gum: XM1J98\\nKonsyl: XM5CR2\\nMetamucil: XM2J55\\nMethylcellulose laxative: XM0X73\\nMucilage plant: XM5VW0\\nOlive oil medicinal: XM1VV2\\nPeach kernel oil emulsion: XM3CM0\\nPeanut oil emulsion: XM85Z3\\nPhosphate laxative: XM4PD5\\nPoloxamer: XM95P7\\nPolycarbophil: XM9PF1\\nPsyllium hydrophilic mucilloid: XM4YU2\\nSoap enema: XM0ZU4\\nSodium dioctyl sulfosuccinate: XM6J59\\nTartrate laxative: XM3DH4\\nCathartic saline: XM69K0\\nEpsom salt: XM40M7\\nLaxative osmotic: XM4WX6\\nLaxative saline: XM5NK8\\nPotassium bisulfate: XM06D3\\nAloes: XM9P20\\nAloin: XM6UQ2\\nBryonia: XM9N98\\nCarters Little Pills: XM9YN3\\nCathartic anthacene derivative: XM2632\\nCathartic contact: XM3W96\\nCathartic irritant: XM53Q7\\nCathartic vegetable: XM6LH5\\nColocynth: XM0JN3\\nCroton oil: XM4217\\nDianthone: XM4C29\\nDihydroxyanthraquinone: XM8PF5\\nDulcolax: XM77A6\\nElaterium: XM9KZ8\\nExLax phenolphthalein: XM6CR4\\nFrangula: XM7XD6\\nFrangula extract: XM6L10\\nGamboge: XM1L58\\nHinkles pills: XM1RP5\\nJalap: XM6XG3\\nMineral oil emulsion: XM9DZ3\\nPhenisatin: XM4CS7\\nPotassium sulfate: XM5042\\nRhubarb dry extract: XM14Q1\\nRhubarb tincture compound: XM40D1\\nScammony: XM38T6\\nSennoside AB: XM91P4\\nSodium phosphate dibasic: XM9ML9\\nSodium phosphate monobasic: XM38A9\\nSquirting cucumber cathartic: XM7XV5\\nSulisatin: XM8WQ0\\nYellow phenolphthalein: XM69R3\\nSofteners or emollients: XM1NY1\\nLiquid paraffin: XM8UE2\\nDocusate sodium: XM59Z2\\nContact laxatives: XM5CM0\\nOxyphenisatine: XM5E72\\nBisacodyl: XM14G1\\nDantron: XM86Q2\\nPhenolphthalein: XM30Q0\\nCastor oil: XM7G77\\nSenna glycosides: XM9LC4\\nSodium picosulfate: XM8YN7\\nBisoxatin: XM00W5\\nCascara: XM8N88\\nBulkforming laxatives: XM42M0\\nSterculia: XM9JR8\\nLinseed: XM3VP9\\nMethylcellulose: XM5DN2\\nIspaghula: XM3JB5\\nEthulose: XM0LV6\\nTriticum wheat fibre: XM4SJ2\\nPolycarbophil calcium: XM5BR4\\nOsmotically acting laxatives: XM2806\\nMagnesium oxide: XM7G33\\nMagnesium sulfate: XM6EC7\\nMagnesium peroxide: XM3CD3\\nLactulose: XM7W31\\nSodium sulfate: XM6AX9\\nMacrogol: XM6FQ8\\nSorbitol: XM9YJ1\\nLactitol: XM4RE1\\nPentaerithrityl: XM7RN6\\nGlycerol: XM5348\\nCarbon dioxide producing drugs: XM7DT2\\nLubiprostone: XM4U05\\nLinaclotide: XM3086\\nPrucalopride: XM2396\\nTegaserod: XM2SC1\\nPlecanatide: XM78V7\\nOil: XM6DL1\\nMetoclopramide: XM3XX3\\nCisapride: XM3346\\nDomperidone: XM3GF5\\nBromopride: XM2Q19\\nAlizapride: XM6AH6\\nClebopride: XM4GL7\\nItopride: XM2KJ6\\nCinitapride: XM1W04\\nMosapride: XM6ZM7\\nEluxadoline: XM8136\\nAlkylating agents: XM09D9\\nNitrogen mustard analogues: XM06G0\\nCyclophosphamide: XM7SY9\\nChlorambucil: XM5TX7\\nMelphalan: XM2VC7\\nChlormethine: XM9W18\\nIfosfamide: XM7FY4\\nTrofosfamide: XM4EP0\\nPrednimustine: XM4NR8\\nBendamustine: XM45K9\\nMelphalan flufenamide: XM0DA1\\nAlkyl sulfonates: XM3WS2\\nBusulfan: XM7WX6\\nTreosulfan: XM9CR4\\nMannosulfan: XM4TU0\\nEthylene imines: XM66A3\\nThiotepa: XM8QS9\\nTriaziquone: XM2RU1\\nCarboquone: XM8A50\\nNitrosoureas: XM9708\\nCarmustine: XM82H4\\nLomustine: XM2G49\\nSemustine: XM0VS7\\nStreptozocin: XM5GB0\\nNimustine: XM1KF0\\nUramustine: XM9KU3\\nFotemustine: XM5RH5\\nRanimustine: XM64P5\\nEtoglucid: XM4KL3\\nMitobronitol: XM31W0\\nPipobroman: XM0MB5\\nTemozolomide: XM3VF4\\nDacarbazine: XM32Y8\\nBischloromethyl ether: XM7Y28\\nFolic acid analogues: XM4DQ8\\nMethotrexate: XM7KT0\\nMercaptopurine: XM1SK9\\nTioguanine: XM3FP5\\nRaltitrexed: XM5NF9\\nPemetrexed: XM16W8\\nPralatrexate: XM06R0\\nPurine analogues: XM71S1\\nCytarabine: XM3ZN1\\nFluorouracil: XM55V5\\nTegafur: XM10L4\\nCarmofur: XM6CQ5\\nAzacitidine: XM92X1\\nCladribine: XM1055\\nFludarabine: XM9RH9\\nClofarabine: XM2YA3\\nNelarabine: XM6079\\nPyrimidine analogues: XM9584\\nTrifluridine combinations: XM0YN9\\nGemcitabine: XM8GX9\\nCapecitabine: XM40Y4\\nDecitabine: XM1458\\nAminopterin sodium: XM7GE5\\nAntibiotic anticancer: XM3264\\nAntimetabolite: XM8T13\\nAntineoplastic antibiotics: XM9D05\\nAzaribine: XM4TR6\\nBroxuridine: XM3HR8\\nChloropurine: XM3A97\\nDoxifluridine: XM1BL2\\nEnocitabine: XM5ZK1\\nFolic acid antagonist: XM2SL0\\nMopidamol: XM0KZ3\\nPyrimidine antagonist: XM2FK2\\nVinca alkaloids and analogues: XM6137\\nVinblastine: XM0BG8\\nVincristine: XM82R6\\nVindesine: XM59U2\\nVinorelbine: XM1Y07\\nVinflunine: XM9QY3\\nVintafolide: XM9DS3\\nPodophyllotoxin derivatives: XM3SH7\\nEtoposide: XM9VL7\\nTeniposide: XM4565\\nTaxanes: XM05L1\\nPaclitaxel: XM5TC8\\nDocetaxel: XM5U86\\nPaclitaxel poliglumex: XM9NR6\\nCabazitaxel: XM50E3\\nActinomycin C: XM6F82\\nDemecolcine: XM7K70\\nTrabectedin: XM3F90\\nCytotoxic antibiotics and related substances: XM4DQ7\\nAnthracyclines and related substances: XM5GC9\\nDoxorubicin: XM7JU8\\nDaunorubicin: XM0031\\nEpirubicin: XM6LT8\\nAclarubicin: XM1VB7\\nZorubicin: XM9R95\\nIdarubicin: XM3PF9\\nMitoxantrone: XM26H0\\nPirarubicin: XM4AY9\\nValrubicin: XM9CA4\\nAmrubicin: XM3J03\\nPixantrone: XM8ZP9\\nBleomycin: XM0VU1\\nPlicamycin: XM3JL4\\nMitomycin: XM21Z8\\nIxabepilone: XM65P2\\nFibroblast growth factor receptor tyrosine kinase inhibitors: XM4RQ4\\nEdrecolomab: XM52L2\\nRituximab: XM3AY3\\nTrastuzumab: XM2FU8\\nGemtuzumab ozogamicin: XM1WL2\\nCetuximab: XM3VL3\\nBevacizumab: XM5ST9\\nPanitumumab: XM1GA2\\nCatumaxomab: XM9P40\\nOfatumumab: XM2KB4\\nIpilimumab: XM5JH7\\nBrentuximab vedotin: XM5VT7\\nPertuzumab: XM6618\\nTrastuzumab emtansine: XM6H29\\nObinutuzumab: XM6ES5\\nDinutuximab: XM74W8\\nNivolumab: XM6M26\\nPembrolizumab: XM8UG5\\nBlinatumomab: XM9BU9\\nRamucirumab: XM6Y05\\nNecitumumab: XM5WX4\\nElotuzumab: XM10Z6\\nDaratumumab: XM4ES5\\nMogamulizumab: XM3JP4\\nInotuzumab ozogamicin: XM8648\\nOlaratumab: XM3DU2\\nDurvalumab: XM7NY5\\nErmekumab: XM6PT2\\nAvelumab: XM2065\\nAtezolizumab: XM8SU2\\nCemiplimab: XM9Z80\\nAlemtuzumab: XM5WX2\\nErenumab: XM8LF5\\nGalcanezumab: XM4XM4\\nFremanezumab: XM47L7\\nUbrogepant: XM46X2\\nEptinezumab: XM1D23\\nRimegepant: XM8C95\\nAtogepant: XM4W34\\nSensitizers used in photodynamic or radiation therapy: XM3T47\\nPorfimer sodium: XM8EW4\\nMethyl aminolevulinate: XM5GF8\\nAminolevulinic acid: XM40J3\\nTemoporfin: XM04X3\\nEfaproxiral: XM2BE2\\nPadeliporfin: XM1ER6\\nPlatinum compounds: XM40B7\\nCisplatin: XM05M0\\nCarboplatin: XM6Z30\\nOxaliplatin: XM2LX1\\nSatraplatin: XM86Z5\\nPolyplatillen: XM0FB2\\nProcarbazine: XM1MP7\\nAmsacrine: XM8307\\nAsparaginase: XM4LJ7\\nAltretamine: XM9YD3\\nHydroxycarbamide: XM7SD2\\nLonidamine: XM3R45\\nEstramustine: XM9JX7\\nTretinoin: XM9DB5\\nPentostatin: XM9T72\\nMitoguazone: XM2Q11\\nVenetoclax: XM7PT2\\nVosaroxin: XM1NF7\\nNiraparib: XM1DL2\\nRucaparib: XM2G84\\nEtirinotecan pegol: XM0569\\nPlitidepsin: XM8UF4\\nEpacadostat: XM8QL8\\nEnasidenib: XM8NP2\\nTalazoparib: XM5QR0\\nCopanlisib: XM44N1\\nMitotane: XM10P3\\nIvosidenib: XM56L5\\nGlasdegib: XM6038\\nEntinostat: XM7FX3\\nAlpelisib: XM3BC1\\nSelinexor: XM1840\\nTagraxofusp: XM4MB0\\nBelotecan: XM7RN1\\nHolmium: XM5A01\\nArsenic trioxide: XM2HS5\\nAlkylating drug antimyeloproliferative: XM3ST0\\nAlkylating drug lymphatic: XM9DP5\\nAlkylating drug: XM6AB6\\nHexalen: XM0JA8\\nAntramycin: XM07W3\\nAnticancer agents: XM9F82\\nAntimitotic agent: XM3MH4\\nAntineoplastic without further specification: XM6Q44\\nAntineoplastic alkaloidal: XM0V25\\nAntineoplastic combination: XM4DV2\\nAzaserine: XM1Q78\\nAzatepa: XM0TE5\\nBenzcarbimine: XM7WD3\\nCactinomycin: XM3WB5\\nCancer chemotherapy drug regimen: XM7RS5\\nChlorhexamide: XM6Z55\\nChromic phosphate P: XM3ZJ5\\nChromomycin A: XM5VY1\\nCorynebacterium parvum: XM6ZM0\\nCycloleucin: XM8C02\\nDactinomycin: XM7L47\\nElliptinium acetate: XM0HK3\\nFAC fluorouracil  doxorubicin  cyclophosphamide: XM32L4\\nFloxuridine: XM8NR1\\nHormone cancer therapy: XM9FT7\\nImidazolecarboxamide: XM5UH8\\nInproquone: XM2D46\\nIproplatin: XM5DL7\\nMvac: XM8C52\\nMannomustine: XM8XQ7\\nMatulane: XM33V8\\nMetoprine: XM1NW0\\nMitolactol: XM6VK8\\nMitopodozide: XM3A89\\nMOPP mechlorethamine  vincristine  prednisone  procarbazine: XM3L39\\nMustard emetic: XM4582\\nMyelobromal: XM6MP1\\nMyleran: XM5C25\\nOlivomycin: XM5MX5\\nOncovin: XM9TL3\\nParoxypropione: XM7TK6\\nPeplomycin: XM7040\\nPhenyl hydrazine antineoplastic: XM7NL0\\nPhenylalanine mustard: XM03S1\\nPorfiromycin: XM7S82\\nPteroyltriglutamate: XM6QJ7\\nRazoxane: XM2CG3\\nRufocromomycin: XM9TR7\\nSarcolysin: XM4ZA6\\nSarkomycin: XM1TG4\\nTauromustine: XM5FB8\\nTEPA: XM0L32\\nTrichlormethine: XM3SV7\\nTrichlorotriethylamine: XM5FH3\\nTriethanomelamine: XM7TR9\\nTriethylenemelamine: XM9T22\\nTriethylenephosphoramide: XM6NM1\\nTriethylenethiophosphoramide: XM5GV6\\nTrimustine: XM4J62\\nUracil mustard: XM6A19\\nUrethane: XM9AV3\\nZinostatin: XM1DU5\\nMasoprocol: XM4KU8\\nTopotecan: XM7ST9\\nTiazofurine: XM3ZR1\\nIrinotecan: XM0992\\nAlitretinoin: XM8200\\nPegaspargase: XM6AL6\\nBexarotene: XM3NJ7\\nDenileukin diftitox: XM6027\\nBortezomib: XM5Z86\\nAnagrelide: XM2PZ5\\nOblimersen: XM1NQ8\\nSitimagene ceradenovec: XM3VC2\\nVorinostat: XM7R04\\nRomidepsin: XM91S2\\nOmacetaxine mepesuccinate: XM3RX2\\nEribulin: XM3BC3\\nPanobinostat: XM96L9\\nVismodegib: XM0N96\\nAflibercept: XM4XD1\\nCarfilzomib: XM0A07\\nOlaparib: XM7202\\nIdelalisib: XM8F40\\nSonidegib: XM9E27\\nBelinostat: XM0Y26\\nIxazomib: XM3753\\nTalimogene laherparepvec: XM1BM0\\nProtein kinase inhibitors: XM1CT6\\nImatinib: XM5W30\\nGefitinib: XM3A37\\nErlotinib: XM3420\\nSunitinib: XM1982\\nSorafenib: XM4A57\\nDasatinib: XM50U1\\nLapatinib: XM1FM4\\nNilotinib: XM6BP0\\nTemsirolimus: XM93U4\\nEverolimus: XM69S5\\nPazopanib: XM4FT3\\nVandetanib: XM3W52\\nAfatinib: XM7917\\nBosutinib: XM60L5\\nVemurafenib: XM55B8\\nCrizotinib: XM2U80\\nAxitinib: XM6JL9\\nRuxolitinib: XM0853\\nRidaforolimus: XM0SL6\\nRegorafenib: XM0601\\nMasitinib: XM0JZ7\\nDabrafenib: XM1HB8\\nPonatinib: XM70G2\\nTrametinib: XM7VJ9\\nCabozantinib: XM4TL0\\nIbrutinib: XM0C70\\nCeritinib: XM14D3\\nLenvatinib: XM7ZH9\\nNintedanib: XM4EA3\\nCediranib: XM2QS0\\nPalbociclib: XM4K70\\nTivozanib: XM8B31\\nOsimertinib: XM8YD2\\nAlectinib: XM4JL2\\nRociletinib: XM21J7\\nCobimetinib: XM6K99\\nMidostaurin: XM5Y46\\nOlmutinib: XM0J75\\nBinimetinib: XM3YP5\\nRibociclib: XM2RL4\\nBrigatinib: XM2DD8\\nLorlatinib: XM59V9\\nNeratinib: XM5MT6\\nEncorafenib: XM5RQ2\\nDacomitinib: XM15D6\\nIcotinib: XM9L11\\nAbemaciclib: XM8E34\\nAcalabrutinib: XM09W7\\nQuizartinib: XM1L31\\nLarotrectinib: XM2LF4\\nGilteritinib: XM4BT2\\nEntrectinib: XM16Z9\\nFedratinib: XM28Z0\\nAsciminib: XM7168\\nPacritinib: XM7380\\nInfigratinib: XM9U75\\nFutibatinib: XM9XE8\\nSelpercatinib: XM74A3\\nPralsetinib: XM1UG8\\nMonoclonal antibodies and antibody drug conjugates: XM1JG6\\nClusters of differentiation  inhibitors: XM4F67\\nHuman epidermal growth factor receptor  inhibitors: XM6DT1\\nEpidermal growth factor receptor inhibitors: XM3ZP2\\nTrastuzumab duocarmazine: XM9KZ5\\nProgrammed cell death protein death ligand  inhibitors: XM9ND9\\nTislelizumab: XM3Q80\\nRetifanlimab: XM2KA7\\nOportuzumab monatox: XM0AN7\\nSacituzumab govitecan: XM5Q93\\nAmivantamab: XM0550\\nVascular endothelial growth factor inhibitors: XM1GS6\\nOther monoclonal antibodies and antibody drug conjugates: XM4ZA4\\nPamiparib: XM0PX7\\nTazemetostat: XM4WB3\\nSotorasib: XM78S9\\nBelzutifan: XM7SW9\\nColony stimulating factors: XM9VN3\\nFilgrastim: XM93Q2\\nMolgramostim: XM2M96\\nSargramostim: XM38N5\\nLenograstim: XM7UB4\\nAncestim: XM17W1\\nPegfilgrastim: XM4TX7\\nLipegfilgrastim: XM1G49\\nBalugrastim: XM7670\\nEmpegfilgrastim: XM9RV6\\nPegteograstim: XM8VY9\\nInterferon alfaa: XM1KX1\\nInterferons: XM58E0\\nInterferon alfa: XM1GZ3\\nInterferon beta: XM3CU5\\nInterferon gamma: XM3KQ4\\nInterferon alfab: XM6QT3\\nInterferon betaa: XM6D22\\nInterferon betab: XM0CS1\\nInterferon alfacon: XM0C05\\nPeginterferon alfacon: XM5L32\\nPeginterferon alfab: XM70P0\\nPeginterferon alfaa: XM1RW9\\nAlbinterferon alfab: XM1HG5\\nPeginterferon betaa: XM3XV8\\nCepeginterferon alfab: XM41L0\\nRopeginterferon alfab: XM24N9\\nInterleukins: XM2Q27\\nInterferon alfan: XM4MJ0\\nAldesleukin: XM0RF4\\nOprelvekin: XM4PY0\\nNetakimab: XM3SM5\\nBimekizumab: XM8615\\nSpesolimab: XM4YW3\\nThymopentin: XM7N26\\nLentinan: XM6GW5\\nRoquinimex: XM48E5\\nPegademase: XM9D28\\nPidotimod: XM30D0\\nPoly IC: XM1R32\\nPoly ICLC: XM4J95\\nImmunocyanin: XM9D43\\nTasonermin: XM94J4\\nMelanoma vaccine: XM99P5\\nGlatiramer acetate: XM4PM9\\nHistamine dihydrochloride: XM5KS2\\nMifamurtide: XM97M6\\nPlerixafor: XM19S3\\nSipuleucelT: XM2ZJ6\\nCridanimod: XM4ZS8\\nDasiprotimutT: XM9BT1\\nElapegademase: XM3R87\\nSelective immunosuppressants: XM5140\\nMuromonabCD: XM9RY3\\nAntilymphocyte immunoglobulin horse: XM3TG8\\nAntithymocyte immunoglobulin rabbit: XM2Q51\\nMycophenolic acid: XM57B1\\nSirolimus: XM76R4\\nLeflunomide: XM5M04\\nAlefacept: XM1PY3\\nGusperimus: XM75G0\\nEfalizumab: XM8CX4\\nAbetimus: XM4RN7\\nNatalizumab: XM9YN4\\nAbatacept: XM45M8\\nEculizumab: XM3KK5\\nBelimumab: XM9M75\\nFingolimod: XM9K56\\nBelatacept: XM4FP8\\nTofacitinib: XM7U27\\nTeriflunomide: XM1835\\nApremilast: XM9UD1\\nVedolizumab: XM5MC2\\nBegelomab: XM7BS8\\nOcrelizumab: XM2B74\\nBaricitinib: XM1SM6\\nOzanimod: XM0700\\nEmapalumab: XM3F23\\nImlifidase: XM09N4\\nSiponimod: XM6N55\\nRavulizumab: XM31G3\\nUpadacitinib: XM0V48\\nBelumosudil: XM6QJ6\\nPeficitinib: XM3RJ6\\nPonesimod: XM69Y4\\nAnifrolumab: XM1PC0\\nTeprotumumab: XM8AR9\\nPegcetacoplan: XM8913\\nSutimlimab: XM6PD2\\nDeucravacitinib: XM93Q8\\nTumour necrosis factor alpha inhibitors: XM9PG4\\nEtanercept: XM0FU1\\nInfliximab: XM3MX3\\nAfelimomab: XM31F7\\nAdalimumab: XM9DS9\\nCertolizumab pegol: XM9QW1\\nGolimumab: XM97H7\\nOpinercept: XM0PE5\\nInterleukin inhibitors: XM5ZL1\\nDaclizumab: XM3CD8\\nBasiliximab: XM6FT1\\nAnakinra: XM3CP6\\nRilonacept: XM4YD0\\nUstekinumab: XM1BA7\\nTocilizumab: XM2FV1\\nCanakinumab: XM67R0\\nBriakinumab: XM5JM2\\nSecukinumab: XM0NF8\\nSiltuximab: XM9D29\\nBrodalumab: XM6601\\nIxekizumab: XM7AB4\\nSarilumab: XM45G5\\nSirukumab: XM7N41\\nGuselkumab: XM2L20\\nTildrakizumab: XM9VJ6\\nRisankizumab: XM70N9\\nCalcineurin inhibitors: XM3CM4\\nCiclosporin: XM28J8\\nTacrolimus: XM1661\\nVoclosporin: XM0Z09\\nImmunosuppressive drug: XM1079\\nAzathioprine: XM99R8\\nThalidomide: XM6B78\\nLenalidomide: XM5Q10\\nPirfenidone: XM7952\\nPomalidomide: XM6S50\\nDimethyl fumarate: XM2EM8\\nDarvadstrocel: XM0LG0\\nMepolizumab: XM8X05\\nDiroximel fumarate: XM9UK4\\nVitamin K antagonists: XM7S34\\nDicoumarol: XM8RN0\\nPhenindione: XM79U8\\nWarfarin: XM86W0\\nPhenprocoumon: XM4E47\\nAcenocoumarol: XM6QR1\\nEthyl biscoumacetate: XM5XY7\\nDiphenadione: XM2567\\nTioclomarol: XM6550\\nFluindione: XM4GN9\\nClorindione: XM3508\\nHeparin and heparin derivatives: XM2YP8\\nHeparin: XM1MN3\\nAntithrombin III: XM12N6\\nDalteparin: XM3DU0\\nEnoxaparin: XM8ZP5\\nNadroparin: XM5727\\nParnaparin: XM9V60\\nReviparin: XM9JC4\\nDanaparoid: XM2YJ7\\nTinzaparin: XM3SS4\\nSulodexide: XM3E38\\nBemiparin: XM7QG7\\nDipyridamole: XM9J84\\nEpoprostenol: XM51R2\\nIndobufen: XM5G01\\nTiclopidine: XM5A15\\nIloprost: XM00R9\\nTriflusal: XM5PR9\\nDitazole: XM5K56\\nCloricromen: XM8NM5\\nPicotamide: XM09W2\\nClopidogrel: XM7CM7\\nAbciximab: XM39C9\\nEptifibatide: XM2924\\nTirofiban: XM0DS1\\nBeraprost: XM8Y64\\nTreprostinil: XM5057\\nPrasugrel: XM8LN2\\nCilostazol: XM92L1\\nTicagrelor: XM1HH4\\nCangrelor: XM3126\\nVorapaxar: XM3835\\nSelexipag: XM5MZ5\\nAnticoagulant and antithrombotic enzymes: XM17B1\\nStreptokinase: XM1AV3\\nAlteplase: XM9A41\\nAnistreplase: XM1P81\\nUrokinase: XM1QH1\\nBrinase: XM77L2\\nAncrod: XM3YU3\\nDirect thrombin inhibitors: XM5PV9\\nDesirudin: XM84G2\\nLepirudin: XM2HU1\\nArgatroban: XM7Y21\\nMelagatran: XM1D58\\nXimelagatran: XM2QF7\\nBivalirudin: XM1WF7\\nDabigatran etexilate: XM16E4\\nDirect factor Xa inhibitors: XM4SD9\\nRivaroxaban: XM48G2\\nApixaban: XM3Y33\\nEdoxaban: XM2SN5\\nOther antithrombotic agents: XM1AM0\\nDefibrotide: XM2JQ1\\nDermatan sulfate: XM2XP4\\nFondaparinux: XM31P2\\nAnticoagulants: XM3W80\\nAnisindione: XM02P8\\nBromindione: XM54A7\\nCoumarin: XM9E78\\nCoumetarol: XM0SY0\\nDrotrecogin alfa: XM0PM7\\nEnoxaparin sodium: XM9313\\nEthylidene dicoumarol: XM7AL6\\nHeparin sodium: XM4S57\\nHeparinfraction: XM5YT5\\nHeparinoid systemic: XM5LC3\\nIndandione derivatives: XM38V8\\nIndendione derivatives: XM4Z97\\nPanwarfin: XM5796\\nProthrombin synthesis inhibitor: XM04M3\\nXigris: XM8J87\\nZovant: XM7EQ6\\nAmino acids: XM4Z15\\nArginine hydrochloride: XM0ES3\\nAlanyl glutamine: XM2NR2\\nLysine: XM44Y2\\nTyrosine: XM8KJ7\\nPhenylalanine: XM4PP7\\nLeucine: XM4H38\\nCysteine: XM2K61\\nAlanine: XM6VX4\\nAminocaproic acid: XM4BG8\\nTranexamic acid: XM8GE2\\nAminomethylbenzoic acid: XM41G3\\nFibrinolysis inhibitor: XM3QV9\\nAprotinin: XM6Y53\\nAntifibrinolytic drug: XM0UH4\\nEpsilon aminocaproic acid: XM7XD3\\nHemostatic drug systemic: XM8X82\\nAlfa antitrypsin: XM9PF3\\nCamostat: XM9QH4\\nVitamin K: XM1YD0\\nMenadione: XM1KN2\\nEtamsylate: XM1VC9\\nAcetomenaphthone: XM0M37\\nAnticoagulant Antagonist: XM5LG4\\nAntihemophilic globulin concentrate: XM0D26\\nAntihemophilic plasma dried: XM2KH0\\nAntiheparin drug: XM0RA5\\nCoagulant: XM4Z99\\nCotarnine: XM3RB9\\nCytozyme: XM8MM4\\nGelfoam: XM5WF6\\nHeparin action reverser: XM35E4\\nHexadimethrine bromide: XM9CA7\\nMenadiol: XM3AJ3\\nMenadiol sodium sulfate: XM2JG9\\nMenadione sodium bisulfite: XM7MA9\\nMenaquinone: XM8912\\nMenatetrenone: XM55W0\\nProtamine sulfate: XM4U16\\nProthrombin activator: XM0SY7\\nRussels viper venin: XM8RT8\\nSnake venom or bite hemocoagulase: XM6QQ2\\nThromboplastin: XM0HF1\\nCarbazochrome: XM5UU0\\nCarbazochrome sodium sulfonate: XM6RT1\\nBatroxobin: XM7KW2\\nRomiplostim: XM96S9\\nEltrombopag: XM95R8\\nCoagulation factor VIII: XM9766\\nThrombin: XM3GR1\\nBlood plasma: XM04N3\\nAlbumin bovine: XM5WD4\\nAlbumin human serum saltpoor: XM1YW8\\nAlbumin human serum: XM7150\\nBlood derivatives natural plasma whole: XM2NV9\\nBlood dried: XM1GJ9\\nBlood fraction: XM5GG5\\nEPO: XM9TT2\\nEpoetin alpha: XM6BM2\\nErythropoietin human: XM79U3\\nFactor I fibrinogen: XM3TM8\\nFactor III thromboplastin: XM3ZZ2\\nCoagulation factor IX: XM44Z6\\nFibrin: XM9JK6\\nHuman albumin: XM6HF0\\nNatural blood product: XM0XT3\\nNormal serum albumin saltpoor human: XM3YQ9\\nWhole blood human: XM8TU6\\nBlood substitutes and plasma protein fractions: XM1596\\nOther plasma protein fractions: XM84Y1\\nGelatin agents: XM0CQ3\\nGelatin intravenous: XM4NU0\\nPolygeline: XM99H6\\nHemoglobin crosfumaril: XM8BW6\\nHemoglobin raffimer: XM4MK5\\nHemoglobin glutamer: XM6W72\\nDextran: XM3CZ0\\nPlasma protein fraction human: XM1H99\\nAlbumin: XM6KC5\\nHydroxyethylstarch: XM8H48\\nOxypolygelatin: XM6YJ2\\nPolyvinylpyrrolidone: XM8UH8\\nHematin: XM8K98\\nFactor VIII inhibitor bypassing activity: XM3P96\\nCoagulation factor VII: XM58W5\\nCoagulation factor XIII: XM1UV6\\nCoagulation factor VIIa: XM0A85\\nVon Willebrand factor: XM25U1\\nCatridecacog: XM4S88\\nCoagulation factor X: XM2RZ4\\nSusoctocog alfa: XM6B13\\nThrombocytes: XM7KC2\\nStem cells from umbilical cord blood: XM6GB5\\nSerum complement inhibitor: XM7JU3\\nSerum hemolytic complement: XM08V1\\nEpoetin beta: XM8VX7\\nRed blood cells packed: XM26D5\\nCalcium ferrous citrate: XM8ZX9\\nDextriferron: XM6S51\\nFerric chloride: XM5DJ4\\nFerric hydroxide colloidal: XM60G9\\nFerric hydroxide polymaltose: XM9W49\\nFerric pyrophosphate: XM2C90\\nFerritin: XM55G4\\nFerrocholinate: XM8GJ1\\nFerrodextrane: XM3SU9\\nFerropolimaler: XM1018\\nFerrous fumerate gluconate lactate salt sulfate medicinal: XM7EW8\\nFerrous phosphate: XM2LA7\\nFerrous salt: XM8L47\\nIron compounds medicinal: XM8Z42\\nIron ammonium: XM6FS8\\nIron dextran injection: XM7PP8\\nIron salts: XM54R9\\nIron sorbitol citric acid complex: XM3EH2\\nIsomaltose ferric complex: XM8KK0\\nJectofer: XM77C5\\nPolyferose: XM1Y67\\nSodium iron edetate: XM5SE8\\nSaccharated iron oxide: XM85E8\\nSodium feredetate: XM5HE0\\nFerrous glycine sulfate: XM7E86\\nFerrous fumarate: XM04C6\\nFerrous gluconate: XM3N76\\nFerrous carbonate: XM2865\\nFerrous chloride: XM6UB4\\nFerrous succinate: XM8SK2\\nFerrous sulfate: XM3SQ1\\nFerrous tartrate: XM0FD3\\nFerrous aspartate: XM8638\\nFerrous ascorbate: XM0S20\\nFerrous iodine: XM1BG1\\nFerric sodium citrate: XM7FV2\\nFerric hydroxide: XM4HF0\\nFerric oxide polymaltose complexes: XM5AW9\\nChondroitin sulfateiron complex: XM6CK7\\nFerric acetyl transferrin: XM5L86\\nFerric proteinsuccinylate: XM8NX7\\nFerric maltol: XM4J31\\nFerrous amino acid complex: XM0216\\nSodium dipantoyl ferrate: XM6435\\nHydroxocobalamin: XM7CP9\\nFolic acid: XM7R82\\nMecobalamin: XM2AT9\\nCobalamine: XM2RU3\\nCyanocobalamin: XM9KD4\\nHematinic preparation: XM20E6\\nLeucovorin factor: XM16W1\\nErythropoietin: XM9130\\nCyanocobalamin tannin complex: XM09N3\\nCobamamide: XM2NR4\\nDarbepoetin alfa: XM7M42\\nMethoxy polyethylene glycolepoetin beta: XM66M0\\nPeginesatide: XM9D96\\nDaprodustat: XM27M4\\nVadadustat: XM59J5\\nAlidase: XM6Y81\\nAlpha amylase: XM0KX8\\nChymotrypsin: XM7NZ6\\nCocarboxylase: XM8P48\\nDeoxyribonuclease: XM1819\\nDiffusin: XM3HF5\\nEnzyme fibrolytic: XM3TF2\\nEnzyme thrombolytic: XM5GS9\\nHyaluronidase: XM0543\\nPancreatic dornase: XM2P48\\nPenicillinase: XM9J86\\nPronase: XM52N4\\nSerrapeptase: XM94J1\\nStreptodornase: XM93U7\\nSutilains: XM8183\\nTrypsin: XM40V6\\nReteplase: XM6RN7\\nSaruplase: XM04S7\\nDrotrecogin alfa activated: XM8K47\\nTenecteplase: XM5ZA2\\nProtein C: XM35D2\\nFibrinolysin and desoxyribonuclease: XM32Y3\\nFibrinolysin: XM4XM2\\nTissue plasminogen activator: XM9PZ9\\nCinhibitor plasma derived: XM9AX4\\nIcatibant: XM7TQ2\\nEcallantide: XM9192\\nConestat alfa: XM7M63\\nBerotralstat: XM2UN9\\nAbsorbable gelatin sponge: XM3RF2\\nOxidized cellulose: XM6EK6\\nTetragalacturonic acid hydroxymethylester: XM1MS7\\nAdrenalone: XM6BS8\\nCalcium alginate: XM1JS6\\nVoxelotor: XM8F45\\nAtosiban: XM8R05\\nFlibanserin: XM5EY9\\nAgni casti fructus: XM19G4\\nCimicifugae rhizoma: XM6DH4\\nPlastic intrauterine contraceptive device: XM92Y5\\nPlastic intrauterine contraceptive device with copper: XM0B44\\nPlastic intrauterine contraceptive device with progestogen: XM7P32\\nVaginal ring with progestogen and estrogen: XM2AH3\\nProgestogens and estrogens fixed combinations: XM9N33\\nLevonorgestrel with ethinylestradiol: XM65V3\\nGestodene and ethinylestradiol: XM4BC7\\nNorgestimate and ethinylestradiol: XM5PH2\\nNorelgestromin and ethinylestradiol: XM01B4\\nNomegestrol and estradiol: XM0QV1\\nChlormadinone and ethinylestradiol: XM3727\\nQuingestanol and ethinylestradiol: XM4AD5\\nLynestrenol and ethinylestradiol: XM9ZQ5\\nMegestrol and ethinylestradiol: XM3344\\nNorethisterone with ethinylestradiol: XM7D82\\nMedroxyprogesterone and ethinyloestradiol: XM6EU8\\nDesogestrel and ethinylestradiol: XM6Y16\\nDrospirenone and ethinylestradiol: XM3L86\\nDienogest and ethinylestradiol: XM5KE9\\nEthinylestradiol ethinyloestradiol with levonorgestrel: XM3WW4\\nEthinylestradiol ethinyloestradiol with norethisterone: XM7M76\\nEthynodiol with mestranol diacetate: XM8HJ8\\nProgestogens and estrogens sequential preparations: XM0ZZ0\\nEstrogens: XM70N0\\nDiethylstilbestrol: XM51S9\\nEpimestrol: XM7YR1\\nEstriol: XM4EH0\\nChlorotrianisene: XM1058\\nEstrone: XM8YK8\\nEstrogen conjugated: XM56M0\\nDienoestrol: XM6UC0\\nMethallenestril: XM4T41\\nPolyestradiol phosphate: XM3YX8\\nFosfestrol: XM03K8\\nPromestriene: XM7FC3\\nMoxestrol: XM7ST1\\nTibolone: XM70N6\\nEthinyloestradiol: XM1SV5\\nEstrogen: XM7CP4\\nProgestogens: XM9HA7\\nMedroxyprogesterone acetate depot: XM2HB5\\nGestonorone caproate: XM1KX5\\nLevonorgestrel: XM6U53\\nQuingestanol: XM1DX1\\nLynestrenol: XM8Y77\\nMegestrol: XM7KS3\\nNorethisterone: XM7LY6\\nDesogestrel: XM7ZG5\\nDrospirenone: XM7XY6\\nHydroxyprogesterone: XM0R79\\nProgesterone: XM3799\\nDydrogesterone: XM71X5\\nMedrogestone: XM4HQ9\\nNomegestrol: XM2LR3\\nDemegestone: XM6SD5\\nChlormadinone: XM5FK8\\nPromegestone: XM71B5\\nDienogest: XM0U58\\nAllylestrenol: XM77R9\\nEthisterone: XM0TH1\\nEthynodiol: XM6TX3\\nMethylestrenolone: XM37T7\\nEtonogestrel: XM94C4\\nNorgestrienone: XM31C0\\nAnhydrohydroxyprogesterone: XM6CL2\\nAntineoplastic combination estrogen: XM0W29\\nConjugated estrogenic substances: XM76F9\\nDelalutin: XM4DR7\\nDimestrol: XM49U4\\nDimethisterone: XM5RK3\\nEpiestriol: XM1P34\\nEstradiol benzoate: XM39W0\\nEstrogen with progesterone: XM2GR3\\nEstropipate: XM6133\\nGonadal tissue extract female: XM7JV9\\nHexestrol: XM8WE5\\nHydroxyestrone: XM4NZ9\\nHydroxyprogesterone caproate: XM5A00\\nMestranol: XM3AK8\\nNoretynodrel: XM1SH1\\nNormethandrone: XM1B43\\nOvarian hormone: XM3MJ7\\nOvarian stimulant: XM26R0\\nOxendolone: XM8AV0\\nPregnandiol: XM1K26\\nProgestogen: XM8FT3\\nQuinestradol: XM9HS1\\nQuinestrol: XM3HH8\\nSteroid antineoplastic hormone estrogen: XM0SU9\\nClomiphene: XM74M2\\nOrmeloxifene: XM1ZT8\\nCyclofenil: XM7P20\\nRaloxifene: XM2CF9\\nBazedoxifene: XM8818\\nLasofoxifene: XM4JW0\\nOspemifene: XM8HF1\\nMifepristone: XM4RW1\\nUlipristal: XM04R5\\nStanozolol: XM8VE0\\nMethandrostenolone: XM24D1\\nMestanolone: XM0E55\\nOxymesterone: XM1E21\\nOxymetholone: XM7WQ1\\nQuinbolone: XM8788\\nPrasterone: XM5Q72\\nOxandrolone: XM6327\\nNorethandrolone: XM5115\\nFluoxymesterone: XM29P0\\nMethyltestosterone: XM4TC8\\nTestosterone: XM3HM6\\nMesterolone: XM3QK3\\nAndrostalone: XM3478\\nAnabolic steroid: XM3BT9\\nAndrogen: XM65R6\\nAndrogenestrogen mixture: XM5CT6\\nAndrosterone: XM89R1\\nAntineoplastic steroid: XM7LM1\\nCalusterone: XM0T50\\nCongener anabolic: XM1SV6\\nDromostanolone: XM1RM3\\nDurabolin: XM81H5\\nEpitiostanol: XM76Q0\\nEstradiol with testosterone: XM3UJ6\\nGonadal tissue extract male: XM7X01\\nMacrolide anabolic drug: XM6R95\\nMepitiostane: XM21D8\\nMetenolone: XM2GQ1\\nMethandriol: XM6966\\nMethyl androstanolone: XM8HC6\\nNandrolone: XM8NZ0\\nSteroid androgenic: XM3KV3\\nSteroid antineoplastic hormone: XM1KA5\\nTestolactone: XM5T49\\nZeranol: XM50S2\\nEthylestrenol: XM54A1\\nOxabolone cipionate: XM6RN8\\nDrugs for urinary frequency and incontinence: XM11B1\\nPhenyl salicylate: XM1TG5\\nAcetohydroxamic acid: XM5549\\nPhenazopyridine: XM2VJ5\\nDimethyl sulfoxide: XM1JS5\\nPentosan polysulfate sodium: XM8GM2\\nTiopronin: XM2D76\\nSuccinimide: XM6VX1\\nDapoxetine: XM8BX6\\nPrunus africanae cortex: XM3WK8\\nSabalis serrulatae fructus: XM5B91\\nFexapotide: XM2Y08\\nAdrenocorticotrophic hormone: XM5Y80\\nCorticotropin: XM7XJ1\\nTetracosactide: XM4B77\\nAnterior pituitary hormone: XM7309\\nCosyntropin: XM1EM4\\nFolliclestimulating hormone human: XM4MB2\\nFSH: XM1027\\nHuman growth hormone HGH: XM1NX7\\nLuteinizing hormone: XM86N5\\nMenotropins: XM92R5\\nPergonal: XM4QA7\\nPituitary extracts anterior: XM0Y82\\nProlactin: XM77Q1\\nSeractide: XM9NW5\\nSomatotropin: XM3LZ6\\nTetracosactrin: XM52T6\\nThyrotrophin: XM4WS0\\nThyrotropic hormone: XM7J71\\nUrofollitropin: XM8HC4\\nSomatropin and somatropin agonists: XM03E8\\nSomatrem: XM96L8\\nSermorelin: XM30J6\\nMecasermin: XM3038\\nPegvisomant: XM5CS4\\nMecasermin rinfabate: XM9BW0\\nTesamorelin: XM9109\\nSomatrogon: XM9WW0\\nChorionic gonadotrophin: XM49L1\\nHuman menopausal gonadotrophin: XM2J59\\nSerum gonadotrophin: XM5ZL8\\nFollitropin alfa: XM4K30\\nFollitropin beta: XM6EZ5\\nLutropin alfa: XM8TP5\\nChoriogonadotropin alfa: XM6HX4\\nCorifollitropin alfa: XM5M71\\nFollitropin delta: XM0RZ5\\nThyrotropin alfa: XM26R5\\nEnterogastrone: XM9EQ9\\nFelypressin: XM3MT8\\nGonadal tissue extract: XM6X07\\nGonadotropin: XM10K7\\nLeuprolide: XM3GP5\\nMelanocytestimulating hormone: XM7399\\nPituitary extracts posterior: XM00P3\\nPlacental hormone: XM0J12\\nPosterior pituitary hormone: XM5714\\nThymus extract: XM7LM2\\nVasopressor drugs: XM1Y33\\nVasopressin and analogues: XM25M7\\nVasopressin: XM6A76\\nDesmopressin: XM77T2\\nLypressin: XM3GU1\\nTerlipressin: XM4E12\\nOrnipressin: XM3LP5\\nOxytocin and analogues: XM1DB3\\nOxytocin: XM9SN0\\nDemoxytocin: XM41G8\\nCarbetocin: XM4ZX0\\nBuserelin: XM32E8\\nGoserelin: XM8CG4\\nGonadorelin: XM2TU9\\nNafarelin: XM4VT6\\nHistrelin: XM78X7\\nLeuprorelin: XM3S25\\nSomatostatin and analogues: XM9XC3\\nSomatostatin: XM5L29\\nOctreotide: XM01Z4\\nLanreotide: XM7GZ3\\nVapreotide: XM28Z2\\nPasireotide: XM3AN9\\nCabergoline: XM4S44\\nMetergoline: XM7828\\nQuinagolide: XM96P1\\nTerguride: XM3MG0\\nAdrenal extract cortex or medulla glucocorticoids hormones mineralocorticoids: XM51K6\\nBetamethasone: XM6SU0\\nClocortolone: XM0XB5\\nCloprednol: XM4AF4\\nCompound E cortisone: XM3R56\\nCompound F hydrocortisone: XM4HH6\\nCortate: XM6FJ6\\nCorticosteroid: XM6TY3\\nCortisone: XM5AE3\\nCortivazol: XM17S1\\nCortone: XM25L1\\nDeflazacort: XM5CF7\\nDexamethasone: XM72R5\\nFluorinated corticosteroids: XM48E4\\nFluprednisolone: XM2GK4\\nGlucocorticoids: XM4Z52\\nHormone adrenal cortical steroids: XM0XY8\\nKenacort: XM2UL5\\nMeprednisone: XM5V41\\nParamethasone: XM4RH1\\nPercorten: XM5AM2\\nPrednisolone: XM6JJ4\\nPrednisone: XM39W4\\nPrednylidene: XM3YJ1\\nSteroid: XM8JY6\\nFluocortolone: XM5FR6\\nTriamcinolone: XM4J30\\nHydrocortisone: XM21H0\\nBudesonide: XM3UP9\\nFlunisolide: XM9VX0\\nMometasone: XM8PN0\\nFluticasone: XM5PW9\\nMethylprednisolone: XM3FX7\\nRimexolone: XM3SM4\\nBeclometasone: XM3293\\nCiclesonide: XM4TY1\\nFluticasone furoate: XM1XF3\\nTrilostane: XM7DQ5\\nOsilodrostat: XM8676\\nGonadotrophinreleasing hormone antagonists: XM6W81\\nGanirelix: XM5JS1\\nCetrorelix: XM8Z22\\nElagolix: XM5064\\nAbarelix: XM5ZS9\\nDegarelix: XM8292\\nLinzagolix: XM3NR0\\nAntiestrogen: XM10A6\\nTamoxifen: XM2UX2\\nToremifene: XM1312\\nFulvestrant: XM2ZV3\\nAntiandrogen: XM7JF4\\nFlutamide: XM3G31\\nNilutamide: XM9AL0\\nBicalutamide: XM5FE9\\nEnzalutamide: XM7BF6\\nApalutamide: XM6Q81\\nDarolutamide: XM3FZ0\\nAromatase inhibitors: XM9X91\\nAminoglutethimide: XM7D25\\nFormestane: XM14P8\\nAnastrozole: XM4Z64\\nLetrozole: XM2J37\\nVorozole: XM6976\\nExemestane: XM2VT0\\nAntigonadotrophin: XM8MB2\\nCyproterone: XM3C58\\nDanazol: XM0FW7\\nNafoxidine: XM9QT3\\nTaleranol: XM0P47\\nMepartricin: XM40Q3\\nTestosteronealpha reductase inhibitors: XM3028\\nFinasteride: XM8P68\\nDutasteride: XM01Y3\\nGestrinone: XM7E94\\nAbiraterone: XM1517\\nRelugolix: XM5XB7\\nDetrothyronine: XM68B8\\nDextrothyroxine: XM2YU4\\nDextrothyroxine sodium: XM27J7\\nEuthroid: XM5M40\\nHormone thyroid: XM93X7\\nLevoid: XM10Z7\\nLevothyroxine: XM5G81\\nLevothyroxine sodium: XM2WC1\\nLiothyronine: XM2XB6\\nLiotrix: XM0P56\\nProloid: XM9RU3\\nSodium Ltriiodothyronine: XM65J7\\nThyroglobulin: XM66B8\\nThyroxine: XM5685\\nTiratricol: XM4H64\\nTitroid: XM5590\\nLiothyronine sodium: XM47Z3\\nThyroid gland preparations: XM8CX3\\nBenzylthiouracil: XM1H03\\nCarbimazole: XM35K1\\nDiiodotyrosine: XM6Y24\\nIodine  therapeutic: XM8492\\nIodine for thyroid conditions antithyroid: XM6VL9\\nIothiouracil: XM7TM9\\nMethimazole: XM38T7\\nMethylthiouracil: XM54P6\\nPotassium perchlorate antithyroid: XM6V39\\nPotassium perchlorate medicinal: XM9LL4\\nPropylthiouracil: XM5DE7\\nThiouracil benzyl methyl propyl: XM8X98\\nThiourea: XM3G29\\nDibromotyrosine: XM2MJ8\\nSodium iodide: XM8AS5\\nGlucagon: XM9N95\\nParathyroid gland extract: XM7GD6\\nTeriparatide: XM59Z3\\nParathyroid hormone: XM4RN4\\nCalcitonin preparations: XM0S16\\nCalcitonin salmon synthetic: XM74V3\\nCalcitonin pork natural: XM28Z6\\nCalcitonin human synthetic: XM32U7\\nElcatonin: XM6US3\\nCinacalcet: XM40P9\\nParicalcitol: XM9LS5\\nDoxercalciferol: XM48A9\\nEtelcalcetide: XM0NY4\\nInsulin human: XM21C9\\nAntidiabetic: XM8S35\\nAntidiabetic biguanide and sulfonyl combined: XM9AX5\\nBiguanides: XM5DC4\\nPhenformin: XM4K79\\nMetformin: XM0JN5\\nBuformin: XM6EJ2\\nProguanil: XM0S91\\nCycloguanil embonate: XM0EG5\\nAntidiabetic combined: XM5SK7\\nSulfonylureas: XM11C9\\nChlorpropamide: XM8S18\\nTolbutamide: XM1RV6\\nGlibornuride: XM8E97\\nTolazamide: XM8YD0\\nCarbutamide: XM8ZU0\\nGlipizide: XM3TQ4\\nGliquidone: XM8597\\nGliclazide: XM2G21\\nGlisoxepide: XM65J8\\nAcetohexamide: XM60R0\\nMetahexamide: XM5N48\\nGlimepiride: XM5N74\\nBiguanide derivatives oral: XM6932\\nGlimidine: XM06A4\\nGlisolamide: XM2584\\nGlobin zinc insulin: XM4SE3\\nGlyburide: XM6JN8\\nGlyclopyramide: XM0K09\\nGlycyclamide: XM6861\\nGlymidine sodium: XM88E8\\nHormone antidiabetic agents: XM4M26\\nIletin: XM5MV9\\nInsular tissue extract: XM4C63\\nInsulin amorphous globin isophane Lente NPH Semilente Ultralente: XM2JC7\\nInsulin defalan: XM3RW5\\nBiphasic insulin injection: XM16M5\\nInsulin injection soluble: XM1DZ9\\nInsulin intermediate acting: XM9728\\nInsulin protamine zinc: XM54Q2\\nInsulin slow acting: XM0KT2\\nProtamine zinc insulin injection: XM7VD3\\nInsulin zinc suspension amorphous crystalline: XM0US2\\nIsophane insulin: XM73L8\\nLente iletin insulin: XM9AZ3\\nNeutral insulin injection: XM8502\\nNPH iletin insulin: XM8VX4\\nProtamine sulfate zinc insulin: XM3J06\\nPZI: XM8QQ1\\nSulfonylurea derivatives oral: XM73P6\\nInsulins and analogues: XM99F8\\nAlpha glucosidase inhibitors: XM2WY1\\nAcarbose: XM9JV9\\nMiglitol: XM9EX0\\nVoglibose: XM4QD6\\nAcedapsone: XM19U1\\nAcesulfamethoxypyridazine: XM91Z9\\nAcetylsulfamethoxypyridazine: XM1RU4\\nDiaphenylsulfone: XM7WC8\\nDisulfanilamide: XM96M6\\nNeoprontosil: XM3GA0\\nPhthalylsulfathiazole: XM1RY1\\nProntosil: XM55D8\\nSuccinylsulfathiazole: XM85A7\\nSulfachlorpyridazine: XM69G3\\nSulfacitine: XM5C46\\nSulfadoxine: XM57L7\\nSulfaethidole: XM03X3\\nSulfaguanidine: XM0F36\\nSulfaloxate: XM6N26\\nSulfaloxic acid: XM57M8\\nSulfameter: XM8UP5\\nSulfamethylthiazole: XM5X85\\nSulfamonomethoxine: XM6D90\\nSulfaphenylthiazole: XM2187\\nSulfaproxyline: XM8QW8\\nSulfasalazine: XM2XQ2\\nSulfasuxidine: XM9MJ3\\nSulfasymazine: XM2Y59\\nSulfisomidine: XM6BM7\\nTrisulfapyrimidines: XM7Z85\\nGlymidine: XM5EH1\\nThiazolidinediones: XM4UA3\\nTroglitazone: XM0NQ7\\nRosiglitazone: XM27D8\\nPioglitazone: XM0TX6\\nDipeptidyl peptidase  inhibitors: XM9SM6\\nSitagliptin: XM4M71\\nVildagliptin: XM9867\\nSaxagliptin: XM5QH2\\nAlogliptin: XM1044\\nLinagliptin: XM9X94\\nGemigliptin: XM5T11\\nEvogliptin: XM5SF9\\nGlucagonlike peptide analogues: XM4MK4\\nExenatide: XM06C6\\nLiraglutide: XM0EQ7\\nLixisenatide: XM3U71\\nAlbiglutide: XM2516\\nDulaglutide: XM1FT0\\nSemaglutide: XM9KJ3\\nMeglitinide: XM0FD1\\nRepaglinide: XM9V31\\nNateglinide: XM5Z74\\nMitiglinide: XM7967\\nOther blood glucose lowering drugs: XM9EK1\\nPramlintide: XM62R6\\nTeduglutide: XM7VJ0\\nSodiumglucose cotransporter  inhibitors: XM0615\\nDapagliflozin: XM97T4\\nCanagliflozin: XM1NP2\\nEmpagliflozin: XM9RW3\\nErtugliflozin: XM66V1\\nIpragliflozin: XM8Y84\\nSotagliflozin: XM7947\\nInsulin beef: XM29C4\\nInsulin pork: XM8YE2\\nInsulin lispro: XM6NY5\\nInsulin aspart: XM0HQ0\\nInsulin glulisine: XM7WH3\\nInsulin detemir: XM96W1\\nInsulin degludec: XM6R62\\nTolrestat: XM65E7\\nImeglimin: XM93G5\\nCholecystokinin: XM5374\\nClodronic acid: XM7171\\nEtidronic acid: XM6UW3\\nPamidronic acid: XM55G3\\nAlendronic acid: XM94M8\\nTiludronic acid: XM2M01\\nIbandronic acid: XM93D5\\nRisedronic acid: XM5CM8\\nZoledronic acid: XM5908\\nDibotermin alfa: XM5GF1\\nEptotermin alfa: XM8NB9\\nCollagen: XM94X8\\nChymopapain: XM2UE2\\nBromelains: XM6F64\\nCollagenase clostridium histolyticum: XM0NQ8\\nIpriflavone: XM4GT8\\nAluminium chlorohydrate: XM5AP2\\nStrontium ranelate: XM6U91\\nDenosumab: XM2P79\\nBurosumab: XM4MQ4\\nRomosozumab: XM7AJ2\\nHyaluronic acid: XM6EQ0\\nChondrocytes autologous: XM2SL6\\nVosoritide: XM99J5\\nPreparations inhibiting uric acid production: XM2ZB4\\nAllopurinol: XM9589\\nTisopurine: XM47Z2\\nFebuxostat: XM0K04\\nPreparations increasing uric acid excretion: XM7F05\\nProbenecid: XM0WT0\\nSulfinpyrazone: XM7K05\\nBenzbromarone: XM9DK8\\nIsobromindione: XM3WF1\\nLesinurad: XM95H8\\nAtophan: XM2D08\\nCinchophen: XM3WA0\\nEthebenecid: XM0M93\\nNeocinchophen: XM5VG7\\nOxipurinol: XM6FA5\\nPhenoquin: XM3JP7\\nSpindle inactivator: XM9DH5\\nUrate oxidase: XM56G7\\nUric acid metabolism drug: XM95S3\\nUricosuric agent: XM6953\\nPegloticase: XM9TL4\\nCalcium: XM8KC2\\nCalcium phosphate: XM1AY1\\nCalcium glubionate: XM7ND2\\nCalcium gluconate: XM3EU2\\nCalcium lactate: XM46G3\\nCalcium acetate: XM0VY0\\nCalcium lactate gluconate: XM4N33\\nCalcium glycerylphosphate: XM9WA2\\nCalcium citrate lysine complex: XM4X88\\nCalcium glucoheptonate: XM08S9\\nCalcium pangamate: XM7G46\\nCalcium acetate anhydrous: XM5TW4\\nCalcium citrate: XM4S97\\nCalcium laevulate: XM6AK3\\nCalcium bromolactobionate: XM8AM9\\nCalcium salts: XM9566\\nPotassium: XM8278\\nPotassium citrate: XM7D96\\nPotassium bitartrate: XM46S4\\nPotassium bicarbonate: XM56J9\\nPotassium gluconate: XM2P49\\nPotassium salts: XM0H50\\nSodium: XM1ZS4\\nSodium acid phosphate: XM0VG1\\nSodium biphosphate: XM6R29\\nSodium cyclamate: XM8ZD6\\nSodium hydrogen carbonate: XM9KZ3\\nSodium magnesium citrate: XM7L15\\nSodium salt: XM3H90\\nZinc: XM1U95\\nZinc chloride nonmedicinal: XM3E63\\nZinc chromate: XM52P2\\nZinc oxide nonmedicinal: XM93K2\\nZinc phosphide: XM6D77\\nZinc sulfate nonmedicinal: XM82L3\\nZinc pesticide not elsewhere classified: XM27E8\\nZinc sulfate: XM68Z2\\nZinc gluconate: XM5WL8\\nZinc protein complex: XM0418\\nZinc acetate: XM3R55\\nMagnesium: XM5TD2\\nMagnesium citrate: XM7KF0\\nMagnesium gluconate: XM1AU1\\nMagnesium aspartate: XM2U66\\nMagnesium lactate: XM3U21\\nMagnesium levulinate: XM8W21\\nMagnesium pidolate: XM9GU6\\nMagnesium orotate: XM8P82\\nMagnesium silicofluoride: XM5VT1\\nFluoride: XM1VS5\\nSodium fluoride: XM1F39\\nSodium monofluorophosphate: XM82S0\\nSelenium: XM47M7\\nSelenium fumes: XM4HH9\\nSodium selenate: XM5RR4\\nSodium selenite: XM7809\\nAcetic acid irrigating solution: XM6777\\nAminoacetic acid derivatives: XM7KG7\\nCarbacrylamine resin: XM6DF0\\nDialysis solution intraperitoneal: XM1619\\nElectrolytic agent: XM6YF0\\nGlucose with sodium chloride: XM6598\\nGlycerol intravenous: XM02Y3\\nGlycine: XM7NQ3\\nLactated potassic saline: XM8UU5\\nMineral salt: XM5FN3\\nPolyaminostyrene resins: XM6P40\\nPotassic saline injection lactated: XM3UT8\\nRinger solution lactate: XM11X8\\nSodium free salt: XM6XG7\\nTravert: XM7JQ2\\nWater balance drug: XM1DP8\\nWater distilled: XM5N49\\nWater purified: XM9V59\\nCobalt medicinal trace chloride: XM8323\\nCopper medicinal trace: XM5DN1\\nDietary supplements rich in vitamins and antioxidants: XM3046\\nLiver extract: XM7113\\nLiver fraction: XM9GC7\\nLiver hydrolysate: XM25P4\\nCodliver oil: XM09R3\\nYeast: XM9FC4\\nYeast dried: XM2W18\\nReadytouse therapeutic food: XM40J4\\nSolutions producing osmotic diuresis: XM0N15\\nMannitol: XM5BJ8\\nCarbamide: XM4HL5\\nAntikaluretic: XM62S0\\nCaloric agent: XM51Y8\\nDextrose: XM7BR0\\nElectrolyte balance drug: XM7UQ5\\nElectrolyte solutions: XM9SL7\\nPotassium chloride: XM0U09\\nSodium bicarbonate: XM4XZ4\\nSodium chloride: XM0X22\\nCalcium chloride: XM9VN8\\nAmmonium chloride: XM1W37\\nSodium phosphate: XM76C9\\nSodium acetate: XM7F36\\nMagnesium phosphate: XM6NV5\\nMagnesium chloride: XM03Q8\\nZinc chloride: XM40H8\\nSodium glycerophosphate: XM83Z9\\nPotassium lactate: XM3T43\\nCardioplegia solutions: XM99L3\\nPotassium acetate: XM45S7\\nCompound solution of sodium lactate: XM3US9\\nGluconic acid: XM7E16\\nGlycerophosphate: XM2S34\\nSodium citrate: XM61E9\\nHartmanns solution: XM5Y58\\nInvert sugar: XM0KH7\\nLevulose: XM9XU2\\nOral rehydration salts: XM39B5\\nPeritoneal dialysis solution: XM39C1\\nPotassiumremoving resin: XM03B7\\nPotassiumretaining drug: XM5KE7\\nReplacement solution: XM3UA2\\nSodium removing resins: XM4EK0\\nSucrose: XM9Y86\\nCarnitine: XM6JX1\\nElectrolytes: XM5S14\\nTrometamol: XM9QW3\\nAdemethionine: XM7345\\nGlutamine: XM1P36\\nMercaptamine: XM85F8\\nCarglumic acid: XM0977\\nFat emulsions: XM9GM1\\nCarbohydrates: XM4YU3\\nProtein hydrolysates: XM55C2\\nAminometradine: XM5W29\\nAmisometradine: XM2E81\\nAnhydron: XM8U06\\nBenzothiadiazides: XM8TM1\\nBenzylhydrochlorothiazide: XM0JW3\\nCarbonic acid gas anhydrase inhibitor: XM3ER5\\nChlorazanil: XM80T6\\nChlormerodrin: XM6946\\nDiupres: XM4JM8\\nDiuretic: XM4D06\\nDiuretic benzothiadiazine: XM68T7\\nDiuretic carbonic acid anhydrase inhibitors: XM8B36\\nDiuretic furfuryl: XM1N83\\nDiuretic mercurial: XM6VW0\\nDiuretic saluretic: XM43Q2\\nDiuretic sulfonamide: XM3558\\nDiuretic thiazide: XM58W3\\nDiurgin: XM04R3\\nFlumethiazide: XM5L31\\nHydromox: XM8T28\\nMeralluride: XM8HM6\\nMerbaphen: XM5R34\\nMercaptomerin: XM1SB8\\nMercumatilin: XM3PF7\\nMercurophylline: XM3L13\\nOsmotic diuretics: XM4B84\\nPurine diuretics: XM6BR0\\nRegroton: XM7660\\nSalicylate theobromine calcium: XM01E9\\nSaluretic: XM9409\\nSodium mersalate: XM7J43\\nThiomercaptomerin: XM9VJ2\\nThiomerin: XM1177\\nTiamizide: XM0YS2\\nTripamide: XM3YV1\\nXanthine diuretics: XM93H5\\nLowceiling diuretics: XM3K70\\nAltizide: XM5FV5\\nBendroflumethiazide: XM64R7\\nBenzthiazide: XM7Q17\\nButizide: XM83Q3\\nChlorothiazide: XM3PJ4\\nCyclopenthiazide: XM4SP9\\nCyclothiazide: XM1PM4\\nDisulfamide: XM71N6\\nEpitizide: XM8532\\nHydrochlorothiazide: XM6910\\nHydroflumethiazide: XM2671\\nMebutizide: XM3EW9\\nMethyclothiazide: XM9T97\\nPenflutizide: XM1DC4\\nPolythiazide: XM7NZ7\\nTeclothiazide: XM26G2\\nTrichlormethiazide: XM1L59\\nMersalyl: XM4AF6\\nCicletanine: XM0G11\\nLowceiling diuretic sulfonamides: XM6U69\\nQuinethazone: XM3WN8\\nClopamide: XM7A66\\nChlortalidone: XM51L8\\nMefruside: XM1DG9\\nClofenamide: XM0EZ6\\nMetolazone: XM7G39\\nMeticrane: XM3GK5\\nXipamide: XM4U11\\nIndapamide: XM49L3\\nClorexolone: XM8GT1\\nFenquizone: XM6CD1\\nAldosterone antagonists and other potassiumsparing agents: XM3L93\\nAldosterone: XM94A6\\nCanrenoic acid: XM6QK1\\nCanrenone: XM1ML2\\nEplerenone: XM0TH6\\nPotassium canrenoate: XM0ET8\\nSpironolactone: XM1JS8\\nFinerenone: XM8ZW7\\nAmiloride: XM1SM2\\nTriamterene: XM5SJ5\\nDiuretic loop highceiling: XM8CG7\\nEthacrynate sodium: XM79L6\\nEtacrynic acid: XM2LW1\\nEtozolin: XM1H00\\nLasix: XM06E2\\nLyovac Sodium Edecrin: XM2C78\\nTienilic acid: XM9KF7\\nMuzolimine: XM6M47\\nLoop highceiling diuretic sulfonamides: XM2W24\\nFurosemide: XM8UE3\\nBumetanide: XM6MV2\\nPiretanide: XM9ML2\\nTorasemide: XM4DR4\\nVasopressin antagonists: XM7VU2\\nTolvaptan: XM9LF5\\nConivaptan: XM25L2\\nAntagonist Aldosterone: XM44R0\\nCorticosteroid mineral: XM8CC8\\nSaltretaining mineralocorticoid: XM4HZ4\\nDeoxycortone: XM9SX2\\nDesoxycorticosteroid: XM6PJ9\\nDesoxycortone: XM9HZ6\\nFludrocortisone: XM6JQ6\\nMineralocorticosteroid: XM9X54\\nVitamin D: XM5G71\\nErgocalciferol: XM75Z5\\nDihydrotachysterol: XM37C2\\nAlfacalcidol: XM3NT7\\nCalcitriol: XM85V3\\nCholecalciferol: XM11C6\\nCalcifediol: XM8SM6\\nB complex vitamins and derivates: XM4H09\\nBenfotiamine: XM5HF5\\nNicotinamide: XM4PS9\\nRiboflavin: XM8V93\\nBiotin: XM9RX3\\nPyridoxal phosphate: XM4GD2\\nDexpanthenol: XM41P5\\nCalcium pantothenate: XM7398\\nThiamine: XM50T4\\nsulbutiamine: XM42G9\\nVitamin Bcomplex plain: XM2SV4\\nPotassium aminobenzoate: XM0Y25\\nAcetiamine: XM3UQ2\\nBisbentiamine: XM3HE8\\nBisbutiamine: XM5LG0\\nCetotiamine: XM8SY7\\nFursultiamine: XM20C9\\nOctotiamine: XM9609\\nPanthenol: XM72U8\\nProsultiamine: XM7D01\\nPyridoxine: XM5MM0\\nAscorbic acid: XM7XY8\\nTocopherol: XM1PU6\\nVitamin E: XM5TU4\\nThioctic acid: XM9CG5\\nOctyl gallate: XM1SD9\\nSodium metabisulfite: XM88X6\\nChlorophyll: XM4BD4\\nThioctamide: XM31S0\\nPangamic acid: XM2EM5\\nBetacarotene: XM7E89\\nRetinol: XM4BT6\\nChenodeoxycholic acid: XM7KX6\\nUrsodeoxycholic acid: XM8MG9\\nCholic acid: XM37T5\\nDiastase: XM1F53\\nMultienzymes: XM5888\\nProtease: XM2VN0\\nPepsin: XM3UE5\\nHydrochloric acid: XM6F61\\nHydrochloric acid vapor: XM6QZ3\\nCitric acid: XM3RH9\\nAlglucerase: XM96V4\\nObeticholic acid: XM51F9\\nGlutamic acid hydrochloride: XM3UT3\\nBetaine hydrochloride: XM7Y97\\nImiglucerase: XM7EN2\\nAgalsidase alfa: XM3EW0\\nAgalsidase beta: XM1CJ9\\nLaronidase: XM4PC4\\nSacrosidase: XM69V4\\nAlglucosidase alfa: XM3EE9\\nGalsulfase: XM11U1\\nIdursulfase: XM3Z98\\nVelaglucerase alfa: XM8J61\\nTaliglucerase alfa: XM8HN5\\nElosulfase alfa: XM7QH6\\nAsfotase alfa: XM5U98\\nSebelipase alfa: XM6UN5\\nVelmanase alfa: XM5U91\\nIdursulfase beta: XM98F5\\nCerliponase alfa: XM9L40\\nVestronidase alfa: XM3FP4\\nPegvaliase: XM8F43\\nPegunigalsidase alfa: XM30U5\\nAtidarsagene autotemcel: XM56M4\\nAvalglucosidase alfa: XM9F01\\nArginine glutamate: XM4HD8\\nSilymarin: XM5RS5\\nEpomediol: XM6T01\\nOrnithine: XM1GT0\\nNicotinyl methylamide: XM1R31\\nPiprozolin: XM03F0\\nHymecromone: XM0HT0\\nCyclobutyrol: XM2EM9\\nCitiolone: XM0413\\nTidiacic arginine: XM0F81\\nAnethole trithione: XM7600\\nSodium dehydrocholate: XM8B34\\nMonooctanoin: XM56J1\\nOrazamide: XM44G8\\nTidiacic: XM3E24\\nMaralixibat chloride: XM3VV1\\nOdevixibat: XM30B2\\nBenfluorex: XM9UB7\\nCentrally acting antiobesity products: XM2AF4\\nPhentermine: XM5VK3\\nFenfluramine: XM5TZ8\\nAmfepramone: XM84W9\\nDexfenfluramine: XM5WS4\\nMazindol: XM25W6\\nCathine: XM8K95\\nClobenzorex: XM2NX7\\nMefenorex: XM3DL8\\nEtilamfetamine: XM7830\\nSibutramine: XM13P5\\nLorcaserin: XM4NN9\\nAminorex: XM54E8\\nBenzphetamine: XM4DD3\\nChlorphentermine: XM16Q1\\nCloforex: XM3AJ4\\nClortermine: XM8H60\\nDiethylpropion: XM5FP0\\nFenproporex: XM1145\\nPhenbutrazate: XM4PR1\\nPhendimetrazine: XM6AJ3\\nPhenmetrazine: XM73T8\\nSetmelanotide: XM5DN4\\nOrlistat: XM0NL0\\nRimonabant: XM7GX4\\nAmfetamine and amfetamine derivatives: XM2520\\nAmfetamine: XM48Z9\\nFencamfamin: XM2154\\nFenetylline: XM8N26\\nLisdexamfetamine: XM4SD7\\nSolriamfetol: XM0462\\nSodium phenylbutyrate: XM5SC6\\nNitisinone: XM1843\\nMiglustat: XM19C6\\nSapropterin: XM6ZV0\\nGlycerol phenylbutyrate: XM4F44\\nEliglustat: XM0K95\\nSodium benzoate: XM2QP5\\nMigalastat: XM6QN8\\nCholine chloride: XM53N4\\nCholine dihydrogen citrate: XM3KK0\\nInositol: XM7291\\nAdenine: XM9J35\\nFlavine adenine dinucleotide: XM3CJ7\\nFosdenopterin: XM7ZH6\\nLonafarnib: XM4L78\\nImidapril: XM4MG6\\nAngiotensinconvertingenzyme inhibitors: XM72L5\\nRenininhibitors: XM3FH7\\nZofenopril: XM9N15\\nSpirapril: XM8091\\nRamipril: XM2A48\\nQuinapril: XM3DU1\\nPerindopril: XM58G7\\nLisinopril: XM7TF8\\nFosinopril: XM4Z53\\nEnalaprilat: XM5609\\nEnalapril: XM6X56\\nCilazapril: XM1AZ4\\nCaptopril: XM6P97\\nBenazepril: XM0HG1\\nAngiotensin II antagonists: XM7169\\nLosartan: XM7DY0\\nEprosartan: XM2F90\\nValsartan: XM29M2\\nIrbesartan: XM1935\\nTasosartan: XM0T42\\nCandesartan: XM4168\\nTelmisartan: XM2P63\\nOlmesartan medoxomil: XM1B39\\nAzilsartan: XM5GC5\\nFimasartan: XM2T51\\nAlacepril: XM3YY8\\nTrandolapril: XM3F15\\nDelapril: XM3DT0\\nMoexipril: XM6DX1\\nTemocapril: XM25N5\\nHMG CoA reductase inhibitors: XM5SK2\\nSimvastatin: XM7AU9\\nPravastatin: XM7SM7\\nLovastatin: XM72M6\\nFluvastatin: XM5UF1\\nAtorvastatin: XM2WF6\\nCerivastatin: XM0M94\\nRosuvastatin: XM6NK5\\nPitavastatin: XM8420\\nFibrates: XM1KP1\\nClofibrate: XM19J9\\nBezafibrate: XM3F75\\nAluminium clofibrate: XM7929\\nGemfibrozil: XM01S9\\nFenofibrate: XM73E0\\nSimfibrate: XM6MW5\\nRonifibrate: XM39Z8\\nCiprofibrate: XM9HU7\\nEtofibrate: XM4390\\nClofibride: XM93U8\\nCholine fenofibrate: XM9554\\nBile acid sequestrants: XM1W44\\nColestyramine: XM0HQ4\\nColestipol: XM0KK8\\nColextran: XM5RQ3\\nColesevelam: XM6MC3\\nNicotinic acid and derivatives: XM0563\\nInositol nicotinate: XM5QD1\\nCiclonicate: XM48Y3\\nAcipimox: XM6QT0\\nOxiniacic acid: XM2KX4\\nAntiarteriosclerotic drug: XM3N68\\nAnticholesterolemic drug: XM2EA3\\nAntihyperlipidemic drug: XM3108\\nAntilipemic drug: XM4FN5\\nbbenzalbutyramide: XM2GM2\\nbsitosterol s: XM4KW6\\nBenzalbutyramide: XM6BA8\\nBenzyl nicotinate: XM4WS4\\nBinifibrate: XM43X4\\nCholesterollowering agents: XM35X4\\nCholestyramine resin: XM8FB5\\nClinofibrate: XM2LR7\\nClofibric acid: XM6DX0\\nCyamopsis tetragonoloba: XM2R17\\nDetaxtran: XM8K49\\nEthylparachlorophenoxyisobutyrate: XM8FC2\\nEtiroxate: XM0TN1\\nEtofylline clofibrate: XM6B07\\nGuar gum medicinal: XM6DW9\\nHalofenate: XM4E46\\nIon exchange resin cholestyramine: XM2WA3\\nLinoleic acid: XM0H99\\nLinolenic acid: XM5VN6\\nMesoglycan: XM0KD7\\nOleic acid: XM45F6\\nPirozadil: XM68L2\\nPolidexide sulfate: XM1Q10\\nProbucol: XM4UK3\\nSafflower oil: XM2YX6\\nSitosterols: XM5F26\\nSoysterol: XM2LX5\\nSunflower seed oil: XM3C43\\nTriparanol: XM95B1\\nUnsaturated fatty acid: XM3PL9\\nOmegatriglycerides: XM2KC4\\nTiadenol: XM2AL6\\nMeglutol: XM44B6\\nMagnesium pyridoxal phosphate glutamate: XM10P8\\nPolicosanol: XM9HP8\\nEzetimibe: XM5BK7\\nAlipogene tiparvovec: XM52K4\\nMipomersen: XM7049\\nLomitapide: XM3RL5\\nEvolocumab: XM9F64\\nAlirocumab: XM1LB0\\nEvinacumab: XM2KT4\\nVolanesorsen: XM4RG7\\nSelective calciumchannel blockers: XM8BT9\\nDihydropyridine derivatives: XM3D74\\nFelodipine: XM1BZ0\\nIsradipine: XM1SC0\\nNicardipine: XM3L32\\nNifedipine: XM3N90\\nNimodipine: XM5TX8\\nNisoldipine: XM5W45\\nNitrendipine: XM17Z8\\nLacidipine: XM2QH8\\nAmlodipine: XM68M5\\nNilvadipine: XM6PC3\\nManidipine: XM3GA2\\nBarnidipine: XM84M5\\nLercanidipine: XM3MV9\\nCilnidipine: XM3TF3\\nBenidipine: XM8EW6\\nClevidipine: XM5GS7\\nLevamlodipine: XM91L4\\nPhenylalkylamine derivatives selective: XM2XU6\\nVerapamil: XM5GX3\\nGallopamil: XM2WH6\\nMibefradil: XM6GX5\\nDiltiazem: XM5K59\\nTiapamil: XM1EL1\\nOxodipine: XM3BC0\\nNonselective calciumchannel blockers: XM2JS2\\nPhenylalkylamine derivatives nonselective: XM6T88\\nBepridil: XM1LR8\\nFendiline: XM5BR3\\nLidoflazine: XM3NU8\\nMoxonidine hydrochloride: XM0T83\\nCardiac glycosides: XM5JS3\\nDigitalis glycosides: XM2EL5\\nAcetyldigitoxin: XM0QK0\\nAcetyldigoxin: XM1640\\nDigitalis leaves: XM2GT4\\nDigoxin: XM8VJ6\\nDigitoxin: XM13W9\\nLanatoside C: XM8036\\nDeslanoside: XM8XH2\\nMetildigoxin: XM37V6\\nGitoformate: XM2505\\nScilla glycosides: XM71V6\\nProscillaridin: XM1EG1\\nStrophanthus glycosides: XM6GX1\\nCymarin: XM30Z9\\ngStrophanthin: XM9YU9\\nPeruvoside: XM3WU3\\nPhosphodiesterase inhibitors: XM2PQ4\\nAmrinone: XM0QD0\\nMilrinone: XM6JT4\\nEnoximone: XM2H68\\nBucladesine: XM4BC1\\nPredominantly alphaadrenoreceptor and dopamine receptor agonists: XM1K71\\nDopamine: XM9NM4\\nNorfenefrine: XM2A75\\nOxedrine: XM5HS9\\nMetaraminol: XM6L38\\nMethoxamine: XM2CG2\\nGepefrine: XM4B54\\nIbopamine: XM1641\\nDimetofrine: XM6LP2\\nDopexamine: XM4ZY2\\nMidodrine: XM79K5\\nFenoldopam: XM91X4\\nCafedrine: XM2BX9\\nTheodrenaline: XM1CS6\\nDexmedetomidine: XM9QY5\\nAmidefrine mesilate: XM38P3\\nFenoxazoline: XM7AV8\\nIndanazoline: XM0H59\\nMetizoline: XM5J98\\nNaphazoline: XM3Q12\\nOxymetazoline: XM4KH5\\nPropylhexedrine: XM4435\\nTramazoline: XM1RJ9\\nTuaminoheptane: XM8706\\nTymazoline: XM0240\\nXylometazoline: XM8US0\\nAgonist predominantly betaadrenoreceptor: XM96M5\\nAngiotensin: XM10L5\\nBeclomethasone: XM3D85\\nDobutamine: XM4E14\\nPrenalterol: XM18Q9\\nRacepinephrine: XM5HL3\\nRitodrine: XM1CS3\\nSelective betaadrenoceptor agonists: XM1X48\\nSalbutamol: XM8MA0\\nTerbutaline: XM6NE3\\nFenoterol: XM2HS2\\nClenbuterol: XM3NS3\\nReproterol: XM7MM4\\nProcaterol: XM2YD0\\nBitolterol: XM15R7\\nBambuterol: XM2U16\\nIndacaterol: XM51C1\\nOlodaterol: XM1QR3\\nBroxaterol: XM05Y4\\nCarbuterol: XM4ZB3\\nRimiterol: XM22C3\\nHexoprenaline: XM1GA5\\nIsoetarine: XM8ZC3\\nPirbuterol: XM1QR7\\nTretoquinol: XM3GQ2\\nTulobuterol: XM2YE0\\nSalmeterol: XM6B34\\nClorprenaline: XM27W7\\nEtafedrine: XM4YX5\\nIbuterol: XM55D7\\nLevalbuterol: XM6EU7\\nFormoterol: XM0QJ7\\nIsoprenaline: XM6KG3\\nOrciprenaline: XM6AG0\\nMethoxyphenamine: XM78W6\\nOctopamine: XM9TS0\\nArbutamine: XM17S3\\nProtokylol: XM0FE9\\nAlpha acetyldigoxin: XM7YK1\\nbacetyldigoxin: XM0SY1\\nCardiotonic glycoside: XM91S1\\nCerberin: XM1W74\\nChan su: XM5NG4\\nConvallaria glycosides: XM11U7\\nCrataegus extract: XM4Q19\\nDigitalin e: XM7RY5\\nDigitalis lanata: XM2SP4\\nDigitalis purpurea: XM3Y64\\nDigitoxose: XM0V98\\nGitalin: XM0DG3\\nGitaloxin: XM8K74\\nLanatosides: XM7KP5\\nMeproscillarin: XM2X57\\nOleandrin: XM6AA6\\nOuabain e: XM0N63\\nPengitoxin: XM02F5\\nSquill: XM77L9\\nStrophanthin: XM2AW9\\nAngiotensinamide: XM0EP6\\nXamoterol: XM45U9\\nLevosimendan: XM88B5\\nAngiotensin II: XM11H1\\nAntiarrhythmics class Ia: XM2FU1\\nQuinidine: XM8AL5\\nProcainamide: XM4MK3\\nDisopyramide: XM8B35\\nSparteine: XM9ZC0\\nAjmaline: XM5CS7\\nLorajmine: XM18V8\\nHydroquinidine: XM0D87\\nPrajmaline: XM6FW1\\nAntiarrhythmics class Ib: XM7844\\nLidocaine: XM2BR1\\nLidocaine regional: XM93V0\\nLidocaine spinal: XM4RU4\\nMexiletine: XM3XK1\\nTocainide: XM1V81\\nAprindine: XM37J0\\nAntiarrhythmics class Ic: XM0NC9\\nPropafenone: XM9R82\\nFlecainide: XM1E38\\nLorcainide: XM04P2\\nEncainide: XM6TZ8\\nEthacizine: XM23Q8\\nAntiarrhythmics class III: XM1AP6\\nAmiodarone: XM3ZJ7\\nBretylium tosilate: XM3ZG2\\nBunaftine: XM56N7\\nDofetilide: XM1143\\nIbutilide: XM8AA1\\nTedisamil: XM8QN8\\nDronedarone: XM8K75\\nOther antiarrhythmics class I and III: XM5JW0\\nCibenzoline: XM1SV2\\nMoracizine: XM6KX7\\nVernakalant: XM6602\\nAntidysrhythmic: XM0KK7\\nCardiac depressants: XM9ZL3\\nCardiac rhythm regulator specified: XM2W76\\nCardiac rhythm regulator: XM88L7\\nPilsicainide: XM0Y13\\nPrajmalium bitartrate: XM64X0\\nQuinaglute: XM1NG6\\nTiracizine: XM7MH8\\nCentrally acting antiadrenergic agents: XM4X84\\nRauwolfia alkaloids: XM67X4\\nRescinnamine: XM9SB3\\nDeserpidine: XM7424\\nMethoserpidine: XM0ND0\\nReserpine: XM2764\\nRauwolfia alkaloids whole root: XM39Z4\\nBietaserpine: XM64M5\\nMethyldopa: XM9G49\\nMethyldopa levorotatory: XM54Y3\\nMethyldopa racemic: XM9ZV9\\nImidazoline receptor agonists: XM2298\\nClonidine: XM6GV8\\nGuanfacine: XM5KP4\\nTolonidine: XM9SU8\\nMoxonidine: XM4NH5\\nRilmenidine: XM6AB8\\nGanglionblocking antiadrenergic agents: XM7NT3\\nPeripherally acting antiadrenergic agents: XM8SX7\\nGuanidine derivatives: XM3EN5\\nBetanidine: XM8LD0\\nGuanethidine: XM3QD6\\nGuanoxan: XM3952\\nDebrisoquine: XM4L51\\nGuanoclor: XM4189\\nGuanoxabenz: XM4L63\\nGuanazodine: XM6N54\\nRipasudil: XM9M92\\nAgents affecting arteriolar smooth muscle: XM1AF9\\nThiazide derivatives: XM7XR3\\nDiazoxide: XM8YG1\\nHydrazinophthalazine derivatives: XM9021\\nDihydralazine: XM2FP9\\nHydralazine: XM8D89\\nEndralazine: XM1KN9\\nCadralazine: XM33U1\\nAntihypertensives for pulmonary arterial hypertension: XM8V56\\nBosentan: XM4KA3\\nAmbrisentan: XM8HR5\\nSitaxentan: XM7WR2\\nMacitentan: XM21T1\\nRiociguat: XM8BU0\\nAlkavervir: XM4NN7\\nAlseroxylon: XM28Y3\\nAmiquinsin: XM6T97\\nAntagonist serotonin: XM3WP0\\nAntihypertensive drug: XM2PT6\\nApresoline: XM0CY8\\nBenazepril hydrochloride: XM4FW8\\nBudralazine: XM5E71\\nCryptenamine tannates: XM9W04\\nDHE: XM8DJ7\\nDihydrazine: XM24X9\\nGuanabenz: XM7NV2\\nGuanacline: XM5ET8\\nGuanadrel: XM5JL6\\nGuanoctine: XM7TE8\\nHarmonyl: XM1LN2\\nHypotensive drug: XM4EP4\\nMethyldopate: XM7W35\\nMetirosine: XM1F18\\nModeril: XM7HA8\\nPargyline: XM1U35\\nProtoveratrine s A B: XM1GS9\\nRaudixin: XM01D4\\nRautina: XM74W2\\nRautotal: XM5FH0\\nRauwoldin: XM5PW7\\nSaralasin: XM00F2\\nSerpasil: XM6E07\\nSodium nitroprusside: XM2W66\\nSyrosingopine: XM8AK5\\nTeprotide: XM3HS0\\nTodralazine: XM5T36\\nVeratrine: XM48R9\\nVeratrum: XM8BQ9\\nKetanserin: XM0YY0\\nOrganic nitrates: XM2856\\nGlyceryl trinitrate: XM8LK8\\nPentaerythrityl tetranitrate: XM7KD0\\nPropatylnitrate: XM0DY4\\nIsosorbide dinitrate: XM3077\\nTrolnitrate: XM55H8\\nEritrityl tetranitrate: XM8SP5\\nTenitramine: XM5KH9\\nMethylpropylpropanediol dinitrate: XM9UE1\\nIsosorbide: XM01Q8\\nAmikhelline: XM6801\\nBendazol: XM5QW3\\nBenziodarone: XM3K91\\nCarbocromen: XM38C7\\nCoronary vasodilator: XM38U6\\nCromonar: XM0SG8\\nDiisopropylamine: XM0MW9\\nDilazep: XM1E15\\nDimoxyline: XM8Q26\\nEfloxate: XM5M47\\nEtafenone: XM3ZB0\\nFenalcomine: XM3E93\\nFluorosol: XM6QE9\\nHeptaminol: XM8Y13\\nHexadiline: XM4A49\\nHexobendine: XM5MP5\\nIsoamyl nitrite: XM5B68\\nItramin tosilate: XM5BS6\\nKhellin: XM9PV4\\nKhelloside: XM39T6\\nMannitol hexanitrate: XM30P9\\nMolsidomine: XM5720\\nNicorandil: XM7HW6\\nNitrite amyl medicinal vapor: XM5YX5\\nNitrous ether spirit: XM4J35\\nOctyl nitrite: XM1VC4\\nOrganonitrate: XM0A82\\nOxyfedrine: XM5YA6\\nPentaerythritol: XM2N57\\nPentrinat: XM3VX9\\nPerhexiline: XM7F31\\nPiridoxilate: XM7FE6\\nPrenylamine: XM4K89\\nSweet niter spirit: XM2BJ0\\nTrapidil: XM24R2\\nTriethanolamine trinitrate biphosphate: XM5770\\nTrinitrine: XM8YZ8\\nFlosequinan: XM23M8\\nImolamine: XM6V17\\nCinepazet: XM0UA6\\nCloridarol: XM30L8\\nLinsidomine: XM5AY1\\nNesiritide: XM2460\\nSerelaxin: XM1M18\\nRegadenoson: XM2VG8\\nMeldonium: XM1HP8\\nTadalafil: XM6G82\\nVardenafil: XM9AZ1\\nSildenafil: XM65A3\\nAluminium nicotinate: XM7DC4\\nAzapetine: XM1269\\nBencyclane: XM3GB4\\nBrovincamine: XM3FH5\\nBuflomedil: XM3B71\\nButalamine: XM6XW8\\nCetiedil: XM1UQ0\\nCinepazide: XM7LH3\\nCyclandelate: XM16K3\\nDihydroergocornine: XM9Q04\\nDihydroergokryptine: XM7K86\\nDihydroergotoxine: XM3WW1\\nEtofylline: XM9CH9\\nHepronicate: XM8317\\nHydromethylpyridine: XM2LT4\\nIfenprodil: XM86J1\\nKallidinogenase: XM8MZ0\\nKallikrein: XM5TC7\\nLipoalprostadil: XM6F75\\nMinoxidil: XM46T4\\nMoxisylyte: XM8YE5\\nNaftidrofuryl: XM3J93\\nNiacin: XM3PK2\\nNicametate: XM2GA2\\nNicofuranose: XM5TA2\\nNicotinyl alcohol: XM0274\\nNylidrin: XM6B85\\nPhenoxybenzamine: XM12T2\\nProstaglandin E: XM67M9\\nRaubasine: XM1B47\\nSuloctidil: XM9761\\nTetranicotinoyl fructose: XM07V4\\nThurfyl nicotinate: XM4074\\nThymoxamine: XM79S2\\nVasodilan: XM1UM9\\nVinburnine: XM3LG1\\nViquidil: XM51E4\\nXanthinol nicotinate: XM0122\\naminophenylethanol derivatives: XM0BT5\\nIsoxsuprine: XM5RH0\\nBamethan: XM0HU4\\nImidazoline derivatives: XM0B82\\nPhentolamine: XM5NP2\\nTolazoline: XM3BY1\\nPurine derivatives: XM5NF4\\nPentifylline: XM5RL7\\nXantinol nicotinate: XM91G7\\nPentoxifylline: XM8BD1\\nEtofylline nicotinate: XM0JV4\\nPinacidil: XM9PA9\\nVincamine: XM3VH9\\nVisnadine: XM68C7\\nErgot alkaloids: XM0XY6\\nErgoloid mesylates: XM0U65\\nNicergoline: XM5TD8\\nDihydroergocristine mesilate: XM0TP6\\nMethylergometrine: XM93Q7\\nErgometrine: XM3LX6\\nErgotamine: XM5P25\\nMethysergide: XM4G36\\nLisuride: XM4E49\\nfasudil: XM4CT2\\nYohimbine: XM5021\\nAvanafil: XM1WB2\\nUdenafil: XM4914\\nAdrenochrome semicarbazone mono: XM20Z9\\nAdrenochrome derivative: XM7NH6\\nAurantiin: XM8ZY5\\nBenzopyrone: XM6YS0\\nCalcium dobesilate: XM3LU4\\nChlorisondamine chloride: XM53V8\\nEscin: XM1H36\\nEthoxazorutoside: XM8AB2\\nFlavodic acid: XM6BM1\\nHesperidin: XM0WZ5\\nLeucocianidol: XM63M1\\nMetescufylline: XM4U20\\nPhenopyrazone: XM6102\\nPholedrine: XM6EY7\\nAdenosine: XM62Q1\\nTrimetazidine: XM3PB7\\nCamphora: XM5FW1\\nCrataegus glycosides: XM7F77\\nCreatinolfosfate: XM6619\\nFosfocreatine: XM8R77\\nFructose diphosphate: XM2PV3\\nUbidecarenone: XM4MP2\\nAcadesine: XM2UJ1\\nIvabradine: XM09Q3\\nRanolazine: XM9DF5\\nTiazotic acid: XM2DH5\\nCapillary stabilising agents: XM50P4\\nBioflavonoids: XM41G5\\nRutoside: XM5734\\nDiosmin: XM6UE1\\nTroxerutin: XM71U2\\nmonoxerutin: XM7EF1\\nhidrosmin: XM2SA0\\nTribenoside: XM6N03\\nNaftazone: XM1PT0\\nHippocastani semen: XM0MJ2\\nEsculin: XM93T6\\nAntivaricose drug: XM0NL5\\nDextrose concentrated solution intravenous: XM57B0\\nEthanolamine oleate: XM1ME2\\nPhenol in oil injection: XM6C05\\nSclerosing agent: XM9854\\nSodium morrhuate: XM3846\\nSodium psylliate: XM52L8\\nSodium tetradecyl sulfate: XM2N32\\nVaricose reduction drug: XM1LV9\\nVenous sclerosing drug: XM3FL1\\nZinc antivaricose: XM4J29\\nMonoethanolamine: XM3WS8\\nPolidocanol: XM4DD8\\nSotradecol: XM81W1\\nAlphaand betaadrenoreceptor agonists: XM36U7\\nEtilefrine: XM9187\\nMephentermine: XM6RQ3\\nEpinephrine: XM3273\\nAmezinium metilsulfate: XM10F0\\nEphedrine: XM5H72\\nDroxidopa: XM7B75\\nEthylnorepinephrine: XM9K94\\nCinnamedrine: XM1H52\\nPredominantly alphaadrenoreceptor agonists: XM3LR7\\nThenyldiamine: XM39Y4\\nPhenyltoloxamine: XM2V55\\nParedrine: XM7D21\\nNorepinephrine: XM81D8\\nMoxastine: XM7RF2\\nMethaphenilene: XM8TK4\\nLevocabastine hydrochloride: XM4TB9\\nHomochlorcyclizine: XM2305\\nEmbramine: XM59T1\\nDimenhydrinate: XM8ZH9\\nDifenidol: XM29D4\\nDibenzheptropine: XM62B0\\nCyclopentamine: XM8Y26\\nClemizole: XM0Y33\\nChlorothen: XM4PH8\\nChlorTrimeton: XM66X7\\nCetoxime: XM0AN5\\nBisulepin hydrochloride: XM88Z7\\nBenzquinamide: XM35M7\\nApraclonidine hydrochloride: XM25T0\\nAntistine: XM0W81\\nPhenylpropanolamine: XM6XN3\\nPhenylephrine: XM6ZQ3\\nPseudoephedrine: XM0CL2\\nPrazosin: XM45W7\\nIndoramin: XM3L37\\nDoxazosin: XM58X5\\nUrapidil: XM30L7\\nAlpha adrenergic blocking drug: XM2L44\\nBunazosin: XM6MJ9\\nDibenamine: XM4UW6\\nDibenzyline: XM70W7\\nHydergine: XM3Y81\\nPriscol Priscoline: XM81R1\\nTamsulosin: XM3F82\\nTerazosin: XM9LH2\\nAlfuzosin: XM1C94\\nTrimazosin: XM7D19\\nSilodosin: XM1FQ5\\nBetaadrenoreceptor antagonists non selective: XM7R98\\nAlprenolol: XM2YK6\\nOxprenolol: XM0M15\\nPindolol: XM2SH3\\nPropranolol: XM3HA9\\nTimolol: XM1KQ9\\nSotalol: XM5BT4\\nNadolol: XM69F3\\nMepindolol: XM89L8\\nCarteolol: XM1AJ9\\nTertatolol: XM6489\\nBopindolol: XM79L8\\nBupranolol: XM9RX1\\nPenbutolol: XM17Y6\\nCloranolol: XM2M62\\nBetaadrenoreceptor antagonists selective: XM9MF0\\nPractolol: XM9VG1\\nMetoprolol: XM8L21\\nAtenolol: XM0M62\\nAcebutolol: XM0V36\\nBetaxolol: XM7U87\\nBevantolol: XM0HY3\\nBisoprolol: XM8QC9\\nCeliprolol: XM54E1\\nEsmolol: XM4AB1\\nEpanolol: XM1T80\\nSatenolol: XM7115\\nNebivolol: XM0995\\nTalinolol: XM3156\\nLandiolol: XM44F9\\nBeta adrenergic blocking agent heart: XM5S93\\nBunitrolol: XM8026\\nCarazolol: XM3N87\\nIndenolol: XM7V19\\nPronetalol: XM91L7\\nTolamolol: XM77W2\\nAlpha and beta blocking agents antagonists: XM77E7\\nLabetalol: XM8ER3\\nCarvedilol: XM80G6\\nMedroxalol: XM0TY3\\nAgents predominantly used for gastrointestinal disorders: XM9FY5\\nSynthetic anticholinergics esters with tertiary amino group: XM8921\\nOxyphencyclimine: XM5D56\\nCamylofin: XM5RM7\\nMebeverine: XM90R8\\nTrimebutine: XM0EL4\\nRociverine: XM7GS6\\nDicycloverine: XM0CE0\\nPiperidolate: XM24K8\\nOxyphenonium: XM1LM4\\nPropantheline: XM05C6\\nOtilonium bromide: XM8YF7\\nMethantheline: XM5WL4\\nIsopropamide: XM6XN4\\nHexocyclium: XM1WN2\\nPoldine: XM7EV5\\nMepenzolate: XM7W33\\nPipenzolate: XM6FV2\\nBevonium: XM63B0\\nDihexyverine: XM4SN3\\nDifemerine: XM2043\\nSynthetic anticholinergics quaternary ammonium compounds: XM26J4\\nbenzhydryloxyethyldiethylmethylammonium iodide: XM2WF7\\nTiemonium iodide: XM2LU4\\nPrifinium bromide: XM6X69\\nTimepidium bromide: XM51J2\\nBenzilone: XM7XV6\\nTridihexethyl: XM4LY7\\nFenpiverinium: XM0D83\\nSynthetic antispasmodics amides with tertiary amines: XM7W64\\nDimethylaminopropionylphenothiazine: XM4VE1\\nNicofetamide: XM5LN3\\nTiropramide: XM36J3\\nPapaverine and derivatives: XM7FH3\\nPapaverine: XM8X70\\nDrotaverine: XM13K8\\nMoxaverine: XM1V30\\nBelladonna alkaloids and derivatives: XM6089\\nAtropine: XM7Y01\\nHyoscyamine: XM11J9\\nMethylatropine: XM4P67\\nCimetropium bromide: XM0PN2\\nHomatropine methylbromide: XM1642\\nScopolamine: XM1MW1\\nButylscopolamine: XM0QS6\\nMethylscopolamine: XM3068\\nFentonium: XM08K5\\nAgents predominantly used for urinary frequency and incontinence: XM1JA8\\nAnticholinergics predominantly used for Parkinson disease: XM6WD2\\nTertiary amines: XM8U00\\nMetixene: XM4RV4\\nTrihexyphenidyl: XM9W98\\nBiperiden: XM65C9\\nProcyclidine: XM9AG2\\nProfenamine: XM8VR6\\nDexetimide: XM1H88\\nPhenglutarimide: XM64K1\\nBornaprine: XM8T72\\nTropatepine: XM4YL9\\nMazaticol: XM3FW6\\nDiethazine: XM0HT8\\nEthers chemically close to antihistamines: XM3B14\\nOrphenadrine: XM7U62\\nEtanautine: XM8UB6\\nEthers of tropine or tropine derivatives: XM72C6\\nBenzatropine: XM8ZR2\\nEtybenzatropine: XM2789\\nEmepronium bromide: XM0CR7\\nAdiphenine: XM1Q67\\nAmbutonium bromide: XM0DF0\\nAminopentamide: XM0TL7\\nAmprotropine: XM1Q22\\nAniscoropine: XM3HR2\\nAnticholinergic: XM0B31\\nAntimuscarinic: XM5BE4\\nArtane: XM66R0\\nAtropine derivative: XM7LZ6\\nBelladonna alkaloids: XM5098\\nBelladonna extract: XM6RQ9\\nBelladonna herb: XM2YW9\\nBenactyzine: XM29D7\\nBenaprizine: XM3NJ0\\nBenzilonium bromide: XM54W7\\nBenztropine anticholinergic: XM8NZ1\\nButropium bromide: XM5ML2\\nButyl scopolamine bromide: XM1T59\\nCaramiphen: XM9633\\nCarpronium chloride: XM8JS6\\nClidinium bromide: XM2619\\nClorotepine: XM8KY2\\nCogentin: XM2HD0\\nCyclodrine: XM0VC2\\nCyclopentolate: XM7VB2\\nCycrimine: XM93T2\\nDibutoline sulfate: XM4CZ8\\nDiphemanil: XM89R5\\nDuboisine: XM1M52\\nDyphylline: XM3A08\\nEthaverine: XM17M9\\nEtomidoline: XM62B7\\nEuphthalmine: XM1VS4\\nExtrapyramidal antagonist: XM6L51\\nFlopropione: XM3L41\\nHexasonium iodide: XM8WX2\\nHomatropine: XM7832\\nHyoscyamus: XM1EF8\\nHyoscyamus dry extract: XM4FB2\\nIsopropamide iodide: XM4QH8\\nLevsin: XM5ED5\\nMepenzolate bromide: XM0WK8\\nMepiperphenidol: XM1FH6\\nMethanthelinium bromide: XM39X0\\nMethscopolamine bromide: XM0E13\\nMethylatropine nitrate: XM3KR9\\nMethylbenactyzium bromide: XM14X3\\nMilverine: XM5F96\\nMuscle affecting agents relaxants smooth: XM3YV6\\nOctatropine methylbromide: XM4U03\\nOxapium iodide: XM5YT3\\nParasympatholytic: XM3A77\\nPenthienate: XM8U27\\nPipethanate: XM6MG0\\nPramiverine: XM7711\\nProfenil: XM3CK8\\nPropantheline bromide: XM7VK4\\nQuaternary ammonium parasympatholytic: XM1JN1\\nScopolia extract: XM3UE6\\nSmooth muscle relaxant: XM31L2\\nSpacoline: XM7PY1\\nSpasmolytic anticholinergics: XM14Z1\\nSpasmolytic autonomic: XM6RA6\\nSpasmolytic quaternary ammonium: XM9NH9\\nThiphenamil: XM0GS2\\nTiemonium: XM9WW9\\nTigloidine: XM8346\\nTiquizium bromide: XM2595\\nToquizine: XM8YD7\\nTriampyzine: XM64P0\\nTricyclamol chloride: XM2TJ3\\nTridihexethyl iodide: XM17K9\\nTrimeprazine tartrate: XM5S52\\nTriperiden: XM2M46\\nTritiozine: XM4YB7\\nTropacine: XM2973\\nTropicamide: XM4466\\nTrospium chloride: XM8F25\\nAnticholinergics predominantly used for obstructive airway diseases: XM1CE8\\nIpratropium bromide: XM54K2\\nOxitropium bromide: XM55K5\\nGlycopyrronium bromide: XM42V2\\nStramonium: XM6LS6\\nTiotropium bromide: XM9HA8\\nAclidinium bromide: XM2PE9\\nUmeclidinium bromide: XM3MF8\\nRevefenacin: XM8BL4\\nFlutropium bromide: XM4DL3\\nPropiverine: XM9FU4\\nTolterodine: XM82U8\\nSolifenacin: XM2Z66\\nTrospium: XM7V08\\nDarifenacin: XM1N89\\nFesoterodine: XM4265\\nMirabegron: XM5L72\\nDesfesoterodine: XM5QR7\\nEmepronium: XM6190\\nFlavoxate: XM0CH2\\nMeladrazine: XM0M49\\nOxybutynin: XM0LB8\\nTerodiline: XM4DW3\\nAceclidine: XM4AJ3\\nAcetylcholine chloride: XM1EC3\\nAcetylcholine derivative: XM3GM3\\nAmbenonium: XM4PZ3\\nAnticholinesterase: XM8KF3\\nAnticholinesterase organophosphorus: XM87V2\\nAnticholinesterase reversible: XM9D92\\nCholinergic organophosphorus: XM4VC4\\nDFP: XM1L81\\nDiflos: XM1389\\nDifluorophate: XM86K6\\nDiisopropylfluorophosphonate: XM0UQ3\\nDistigmine bromide: XM5YK5\\nEdrophonium chloride: XM6565\\nGalantamine: XM99M6\\nIsoflurophate: XM1NE7\\nNeomycin with neostigmine: XM40R6\\nNeostigmine bromide: XM3671\\nProstigmin: XM3YR0\\nPyridostigmine bromide: XM41N9\\nTacrine: XM4LN1\\nDonepezil: XM62U1\\nRivastigmine: XM0NP3\\nIpidacrine: XM3B88\\nNeostigmine: XM8C30\\nPyridostigmine: XM4NE1\\nArecoline: XM7494\\nBenzpyrinium bromide: XM0000\\nBethanechol chloride: XM0MZ4\\nCholinergic drug: XM4LE7\\nCholinergic muscle tone enhancer: XM4ZZ7\\nCholinergic trimethyl ammonium propanediol: XM6VJ2\\nParasympathomimetic drug: XM8JX6\\nPilocarpine: XM0RX5\\nPilocarpus extract jaborandi: XM5EY0\\nCholine esters: XM9223\\nCarbachol: XM4AT9\\nBethanechol: XM9XA2\\nCholine alfoscerate: XM63Q0\\nCevimeline: XM31K4\\nVarenicline: XM6PN9\\nCytisinicline: XM7HS1\\nAmifampridine: XM4C58\\nHexamethonium bromide: XM90S5\\nMecamylamine: XM13Z0\\nPempidine: XM8JB8\\nPentamethonium bromide: XM68K9\\nPentolonium tartrate: XM2A33\\nQuaternary ammonium ganglion blocking: XM3YS6\\nTetraethylammonium chloride: XM6JW6\\nTetrylammonium chloride: XM9MS2\\nTrimetaphan camsilate: XM3YZ9\\nTrimethaphan: XM4BZ9\\nTrimethidinium: XM9BT3\\nDisulfiram: XM51D2\\nCalcium carbimide: XM2FC3\\nNicotine: XM6BN2\\nAcamprosate: XM9T01\\nBetahistine: XM14C0\\nCinnarizine: XM7CE7\\nFlunarizine: XM52G4\\nAcetylleucine: XM2U21\\nErgot derivative: XM0Q45\\nErgot prepared: XM77J5\\nErgotocine: XM5NB5\\nHormone oxytocic: XM4534\\nMuscle affecting agents oxytocic: XM8BU6\\nProstaglandin F alpha: XM5606\\nTocosamine: XM7F20\\nVetrabutine: XM6MR2\\nMuscle relaxants peripherally acting: XM8SY4\\nAlcuronium: XM23H5\\nTubocurarine: XM7139\\nDimethyltubocurarine: XM2RT6\\nHexafluronium: XM0L61\\nFazadinium bromide: XM87E3\\nMivacurium chloride: XM2SB5\\nAtracurium: XM0FZ0\\nPipecuronium bromide: XM0Q59\\nDoxacurium chloride: XM2811\\nRocuronium bromide: XM4R62\\nCisatracurium: XM0SQ7\\nBotulinum toxin: XM9M51\\nMuscle relaxants centrally acting: XM9YY8\\nCarbamic acid esters: XM5AB5\\nPhenprobamate: XM8DV7\\nCarisoprodol: XM2DC7\\nMethocarbamol: XM7AC3\\nStyramate: XM3KM3\\nFebarbamate: XM2339\\nOxazol thiazine and triazine derivatives: XM09D8\\nChlormezanone: XM8MD5\\nChlorzoxazone: XM7Q44\\nZoxazolamine: XM7ZQ9\\nMetaxalone: XM5PZ1\\nSuxamethonium: XM09Y8\\nPancuronium: XM5CB4\\nGallamine: XM9416\\nVecuronium: XM7S28\\nOrphenadrine citrate: XM6X03\\nBaclofen: XM5US2\\nTizanidine: XM1BK1\\nPridinol: XM26R3\\nTolperisone: XM4MA5\\nMephenesin: XM1HD7\\nTetrazepam: XM2RH8\\nCyclobenzaprine: XM7LP5\\nThiocolchicoside: XM52Y2\\nEperisone: XM9UU4\\nFenyramidol: XM7995\\nAfloqualone: XM0W80\\nAclatonium napadisilate: XM3V06\\nAnesthesia muscle relaxation: XM9RW1\\nAtracurium besilate: XM5GC4\\nCarbolonium bromide: XM8PU1\\nDecamethonium bromide: XM7DG2\\nDimethyltubocurarinium chloride: XM6XS1\\nFlaxedil: XM8A87\\nHexafluorenium bromide: XM9QC2\\nHexanuorenium: XM9WH2\\nHexcarbacholine bromide: XM82Z5\\nLaudexium: XM3676\\nMethocarbamol skeletal muscle relaxant: XM3RJ7\\nMuscle affecting agents relaxants skeletal: XM4W78\\nMyoneural blocking agents: XM3SC6\\nNeuromuscular blocking drug: XM2UG5\\nSkeletal muscle relaxants: XM8QC2\\nSpasmolytic skeletal muscle: XM91M0\\nSuxethonium chloride: XM7142\\nWoorali: XM9502\\nDantrolene: XM5ZN8\\nBruceine: XM0WW2\\nHydrastine: XM7E87\\nLututrin: XM7C89\\nStrychnine medicinal: XM20G5\\nDuchenne muscular dystrophy therapy: XM8NV1\\nAtaluren: XM1CL7\\nDrisapersen: XM7H79\\nEteplirsen: XM0BM1\\nHydroquinine: XM6TG6\\nAceneuramic acid: XM0TQ8\\nNusinersen: XM90G7\\nViltolarsen: XM0U21\\nCasimersen: XM4VE2\\nRimabotulinumtoxinB: XM2501\\nAbobotulinumtoxinA: XM0BF0\\nIncobotulinumtoxinA: XM21V3\\nDaxibotulinumtoxinA: XM5JZ1\\nLetibotulinumtoxinA: XM2L71\\nDrugs for obstructive airway diseases: XM9P78\\nCromoglicic acid: XM3R34\\nNedocromil: XM4TP3\\nAntileukotrienes: XM0B09\\nZafirlukast: XM9BZ0\\nPranlukast: XM1C43\\nMontelukast: XM10P5\\nIbudilast: XM12R0\\nMonoclonal antibodies used in airway diseases: XM4U85\\nOmalizumab: XM4LH9\\nReslizumab: XM6VB5\\nBenralizumab: XM0KT0\\nAmlexanox: XM82N7\\nAcefylline piperazine: XM5SD1\\nAcepifylline: XM1719\\nAmbuphylline: XM6493\\nAminophylline: XM5XJ1\\nBamifylline: XM5Y44\\nBufylline: XM1QL3\\nEnprofylline: XM31P6\\nEtamiphylline: XM1W21\\nLevoproxyphylline: XM3ZP6\\nOxtriphylline: XM81W0\\nProxyphylline: XM5YJ3\\nTheobromine: XM4L37\\nTheophylline: XM1FP4\\nTheophylline aminobenzoic acid: XM07L0\\nTheophylline piperazine paminobenzoate: XM07F4\\nDoxofylline: XM9608\\nMepyramine theophyllinacetate: XM7X44\\nFenspiride: XM42T9\\nEprozinol: XM40T5\\nSeratrodast: XM8DS8\\nRoflumilast: XM53U2\\nTranilast: XM5Y33\\nBufrolin: XM2351\\nTezepelumab: XM9Y50\\nAmbroxol: XM6JV7\\nAmmonium chloride expectorant: XM4A47\\nBromhexine: XM8CT0\\nCalcium iodide: XM9FP2\\nCarbocisteine: XM3XU8\\nCough mixture syrup: XM2NU9\\nCough mixture expectorants: XM1MJ1\\nCreosote: XM81Q9\\nCreosote syrup: XM4C87\\nDeglycyrrhizinized extract of liquorice: XM68U4\\nDomiodol: XM1KM0\\nDornase: XM28N4\\nEprazinone: XM71N5\\nGlyceryl guaiacolate: XM7QX2\\nGlycyrrhiza extract: XM86G0\\nGlycyrrhizic acid: XM3CL2\\nGlycyrrhizinate potassium: XM8EW0\\nGuaiacol derivatives: XM0G60\\nGuaimesal: XM48K1\\nGuaiphenesin: XM8GY5\\nHydriodic acid: XM31Y1\\nIodide potassium expectorant: XM3E62\\nIodinated glycerol: XM60L0\\nIpecacuanha: XM8BL3\\nLetosteine: XM2K57\\nLiquorice: XM9Q09\\nMecysteine: XM6MB5\\nMucolytic drug: XM4DQ1\\nOrganidin: XM4KG8\\nQuillaja extract: XM8A78\\nRespiratory drug expectorant: XM44A1\\nSCarboxymethylcysteine: XM4Y94\\nSenega: XM1Y62\\nSobrerol: XM92P8\\nSodium dibunate: XM06E7\\nSputum viscositylowering drug: XM2BM5\\nStepronin: XM7BF1\\nSulfogaiacol: XM1PU5\\nSuperinone: XM6JE5\\nTenoglicin: XM1CP3\\nTerpin hydrate cis: XM0ES0\\nTyloxapol: XM1F74\\nAntimony pentasulfide: XM1KG9\\nDornase alfa: XM61F4\\nAlthaeae radix: XM48C4\\nGuaiacolsulfonate: XM8983\\nLevoverbenone: XM5QU8\\nHederae helicis folium: XM48W4\\nCineole: XM7Q79\\nNeltenexine: XM66E3\\nErdosteine: XM7Y66\\nBenproperine: XM6NJ7\\nBenzonatate: XM8G23\\nBibenzonium bromide: XM1U36\\nButamirate: XM8WM3\\nClobutinol: XM4D27\\nChlophedianol: XM9DL9\\nCloperastine: XM80M9\\nDimethoxanate: XM9KL2\\nDropropizine: XM6995\\nEthyl dibunate: XM61F3\\nFedrilate: XM0SA9\\nFominoben: XM5BB1\\nIsoaminile: XM8300\\nLevodropropizine: XM97D0\\nMethorate: XM3WX2\\nOxeladin: XM2ET3\\nOxolamine: XM9FU3\\nPentoxyverine: XM4331\\nPicoperine: XM7G25\\nPipazetate: XM84C4\\nPiperidione: XM0HR9\\nPrenoxdiazine: XM8JR1\\nZipeprol: XM9KN8\\nDibunate: XM6SJ0\\nMeprotixol: XM1G75\\nMorclofone: XM2W89\\nNepinalone: XM7UA5\\nButetamate: XM06F9\\nGefapixant: XM4SL3\\nAntihistamines: XM4J58\\nFirstgeneration antihistamine: XM2JE5\\nAminoalkyl ethers: XM8MV2\\nBromazine: XM1TL5\\nDiphenhydramine: XM6KY0\\nClemastine: XM3DL4\\nChlorphenoxamine: XM4QD7\\nDiphenylpyraline: XM7GV4\\nCarbinoxamine: XM9KZ9\\nDoxylamine: XM77K6\\nPiprinhydrinate: XM7180\\nRotoxamine: XM3FN3\\nSubstituted alkylamines: XM5YE8\\nBrompheniramine: XM5PK9\\nDexchlorpheniramine: XM6CF9\\nDimetindene: XM74S1\\nChlorpheniramine: XM9VG3\\nPheniramine: XM4UU4\\nDexbrompheniramine: XM1107\\nTalastine: XM4AA0\\nSubstituted ethylene diamines: XM9MB0\\nPyrilamine: XM54R1\\nChloropyramine: XM9CM1\\nTripelennamine: XM0N55\\nMethapyrilene: XM7TD1\\nThonzylamine: XM6NM2\\nHistapyrrodine: XM4NS9\\nPhenothiazine derivatives: XM52P9\\nAlimemazine: XM1N75\\nPromethazine: XM0605\\nThiethylperazine: XM9QY1\\nMethdilazine: XM5E89\\nMequitazine: XM5EB9\\nOxomemazine: XM5DB5\\nIsothipendyl: XM4Z91\\nHydroxyethylpromethazine: XM5QG6\\nThiazinam: XM29Q8\\nPiperazine derivatives of firstgeneration antihistaminic agents: XM9NA0\\nBuclizine: XM8GH2\\nCyclizine: XM0S26\\nChlorcyclizine: XM9SK3\\nMeclozine: XM1A78\\nOxatomide: XM6AV1\\nCetirizine: XM0QD9\\nPiperazine: XM07V7\\nDiethylcarbamazine: XM1VF1\\nLevocetirizine: XM5AC9\\nBamipine: XM4GX4\\nCyproheptadine: XM11C5\\nPhenindamine: XM9BD4\\nAntazolin: XM5Q41\\nTriprolidine: XM8RT2\\nAzatadine: XM6Z93\\nMebhydrolin: XM4280\\nThenalidine: XM7ZS2\\nPipoxizine: XM0404\\nSetastine: XM5463\\nSecondgeneration antihistamine: XM3B95\\nPiperazine derivatives of secondgeneration antihistaminic agents: XM6G21\\nAstemizole: XM7S59\\nTerfenadine: XM2S36\\nLoratadine: XM4PE5\\nKetotifen: XM4F63\\nAcrivastine: XM4GA2\\nAzelastine: XM9VB8\\nEbastine: XM9EU0\\nMizolastine: XM7J45\\nFexofenadine: XM1586\\nDesloratadine: XM2656\\nRupatadine: XM3E25\\nBilastine: XM1WZ8\\nQuifenadine: XM3YG8\\nPyrrobutamine: XM57C9\\nDeptropine: XM8ZS4\\nTritoqualine: XM0J21\\nPimethixene: XM70F3\\nEpinastine: XM5BJ5\\nSequifenadine: XM40P7\\nDoxantrazole: XM9L77\\nAlmitrine: XM0AP5\\nAmiphenazole: XM9QA2\\nBemegride: XM0WB3\\nBicuculline: XM5T65\\nCentral nervous system stimulants analeptics: XM7BN2\\nCentral nervous system stimulants opiate antagonists: XM6938\\nCrotethamide with cropropamide: XM3465\\nDimefline: XM0A24\\nDimorpholamine: XM2ZT4\\nDoxapram: XM3FP9\\nEtamivan: XM6D72\\nLeptazol: XM6YR1\\nLobeline: XM4CU0\\nNikethamide: XM0001\\nPentetrazol: XM0Q86\\nPimeclone: XM5VY2\\nPrethcamide: XM4901\\nMepixanox: XM1D17\\nOther respiratory system products: XM04S2\\nNitric oxide: XM4HQ2\\nIvacaftor: XM3CW0\\nIvacaftor and lumacaftor: XM15G5\\nIvacaftor and tezacaftor: XM2QZ5\\nAmphenicols: XM0MG9\\nChloramphenicol: XM2TE7\\nThiamphenicol: XM40F4\\nAdicillin: XM1JY8\\nAncillin: XM1LV7\\nApalcillin: XM0JT4\\nBacampicillin: XM46K9\\nBenethamine penicillin: XM94E1\\nCarfecillin: XM2SP1\\nCephalosporins N adicillin: XM9MK4\\nClemizole penicillin: XM4YY1\\nCiclacillin: XM2361\\nHydrabamine penicillin: XM9VG2\\nImipenem: XM7LA4\\nIsoxazolyl penicillin: XM0V84\\nMethoxybenzyl penicillin: XM00H2\\nPenethamate: XM9XB6\\nPenicillin any: XM7Q57\\nPhenbenicillin: XM71L1\\nXantocillin: XM3UP8\\nPenicillins with extended spectrum: XM3173\\nAmpicillin: XM5MY7\\nPivampicillin: XM7CR7\\nCarbenicillin: XM3D58\\nAmoxicillin: XM7CM1\\nCarindacillin: XM7J83\\nEpicillin: XM31J4\\nPivmecillinam: XM9LR3\\nAzlocillin: XM8820\\nMezlocillin: XM1Z93\\nMecillinam: XM5562\\nPiperacillin: XM3MP9\\nTicarcillin: XM4D90\\nMetampicillin: XM1HX8\\nTalampicillin: XM3Z13\\nSulbenicillin: XM3S35\\nTemocillin: XM1QC3\\nHetacillin: XM9HP3\\nAspoxicillin: XM70P4\\nBetalactamase sensitive penicillins: XM9FQ5\\nBenzylpenicillin: XM83S8\\nPhenoxymethylpenicillin: XM9B11\\nPropicillin: XM5MN2\\nAzidocillin: XM4EZ4\\nPheneticillin: XM9NF6\\nPenamecillin: XM16L6\\nClometocillin: XM5N44\\nBenzathine benzylpenicillin: XM4E82\\nProcaine benzylpenicillin: XM4HD6\\nBenzathine phenoxymethylpenicillin: XM6MK0\\nBetalactamase resistant penicillins: XM9QY0\\nDicloxacillin: XM5SF7\\nCloxacillin: XM6L30\\nMethicillin: XM0PP7\\nOxacillin: XM2UY3\\nFlucloxacillin: XM6AV2\\nNafcillin: XM8HL9\\nCombinations of penicillins: XM6QQ6\\nSultamicillin: XM0RU1\\nAmpicillin and betalactamase inhibitor: XM3DN8\\nAmoxicillin and betalactamase inhibitor: XM7UP4\\nTicarcillin and betalactamase inhibitor: XM1FZ0\\nPiperacillin and betalactamase inhibitor: XM0LH3\\nBetalactamase inhibitors: XM9XT2\\nSulbactam: XM3Y87\\nTazobactam: XM2D37\\nAntibiotic blactam: XM3WK4\\nAntibiotic cephalosporin group: XM7TD6\\nCefaloglycin: XM5J74\\nCefamycin antibiotic: XM8J52\\nCefpimizole: XM01V2\\nCefteram: XM45T3\\nCefuzonam: XM0C25\\nCephalosporins: XM4HC8\\nCephalothin: XM67G9\\nClavulanic acid: XM2K88\\nFirstgeneration cephalosporins: XM9BE0\\nCefalexin: XM9Z22\\nCefaloridine: XM7GR3\\nCefazolin: XM0BY6\\nCefadroxil: XM11S1\\nCefazedone: XM1EQ8\\nCefatrizine: XM8UF3\\nCefapirin: XM6DE1\\nCefradine: XM8X72\\nCefacetrile: XM7DR9\\nCefroxadine: XM75P2\\nCeftezole: XM2L78\\nSecondgeneration cephalosporins: XM4DG8\\nCefoxitin: XM26N9\\nCefuroxime: XM7VY3\\nCefamandole: XM8839\\nCefaclor: XM1ZJ9\\nCefotetan: XM5QJ0\\nCefonicid: XM3M14\\nCefotiam: XM3V37\\nCefmetazole: XM8S59\\nCeforanide: XM3QK7\\nCefminox: XM27Z3\\nCefbuperazone: XM14Q0\\nFlomoxef: XM83K2\\nLoracarbef: XM6KH0\\nCefprozil: XM4CP3\\nThirdgeneration cephalosporins: XM3FN8\\nCefotaxime: XM7CZ4\\nCeftazidime: XM94G4\\nCefsulodin: XM9732\\nCeftriaxone: XM3P83\\nCefmenoxime: XM6FL0\\nLatamoxef: XM0B94\\nCeftizoxime: XM1064\\nCefixime: XM4Q77\\nCefetamet: XM8YC6\\nCefpiramide: XM9YD6\\nCefoperazone: XM5425\\nCefodizime: XM12J5\\nCefpodoxime: XM85Q0\\nCeftibuten: XM2D98\\nCefdinir: XM2141\\nCefditoren: XM2SP6\\nCefcapene: XM0H82\\nCefotaxime and betalactamase inhibitor: XM9RH3\\nCeftazidime and betalactamase inhibitor: XM8EN5\\nCefoperazone and betalactamase inhibitor: XM4UZ8\\nCeftriaxone and betalactamase inhibitor: XM19K3\\nFourthgeneration cephalosporins: XM60V7\\nCefepime: XM1HW5\\nCefpirome: XM0MR4\\nCefozopran: XM1BL5\\nMonobactams: XM3XC6\\nAztreonam: XM3DB8\\nCarumonam: XM9FE9\\nCarbapenems: XM1JU9\\nMeropenem: XM82S6\\nErtapenem: XM50J4\\nDoripenem: XM27D0\\nBiapenem: XM1Q21\\nImipenem and cilastatin: XM12K6\\nPanipenem: XM02N8\\nFaropenem: XM1N97\\nBetamipron: XM5261\\nCeftobiprole medocaril: XM3QS2\\nCeftaroline fosamil: XM2LW5\\nCeftolozane and betalactamase inhibitor: XM7RT0\\nSulfonamides and trimethoprim derivatives: XM8SY8\\nTrimethoprim derivatives: XM3MG7\\nTrimethoprim: XM7NY9\\nShortacting sulfonamides: XM8162\\nSulfamethizole: XM0XY9\\nSulfapyridine: XM72R1\\nSulfathiazole: XM3G53\\nSulfanilamide: XM72K1\\nSulfisoxazole: XM9TQ5\\nIntermediateacting sulfonamides: XM06K1\\nSulphamethoxazole: XM1AM5\\nSulfadiazine: XM12D1\\nSulfamoxole: XM43U3\\nLongacting sulfonamides: XM4J39\\nSulfadimethoxine: XM3ER6\\nSulfalene: XM8LL9\\nSulfamethoxypyridazine: XM7XJ2\\nSulfaperin: XM92E0\\nSulfamerazine: XM7R74\\nSulfaphenazole: XM1G41\\nSulfamazone: XM0ZN8\\nSulfametomidine: XM95D0\\nSulfonamides and trimethoprim derivatives fixed combinations: XM3EU7\\nTrimethoprim with sulfamethoxazole: XM22Y8\\nSulfadiazine and trimethoprim: XM18A9\\nSulfametrole and trimethoprim: XM87N2\\nSulfamoxole and trimethoprim: XM4008\\nSulfadimidine and trimethoprim: XM4WW1\\nSulfadiazine and tetroxoprim: XM1UR3\\nSulfamerazine and trimethoprim: XM3Y04\\nBrodimoprim: XM4YB5\\nIclaprim: XM98X3\\nSulfathiourea: XM4L44\\nAzithromycin: XM1329\\nErythromycin: XM36F7\\nJosamycin: XM2YT6\\nKitasamycin: XM06K0\\nMidecamycin: XM80A1\\nMiocamycin: XM3CC3\\nOleandomycin: XM8HR9\\nRokitamycin: XM8UC1\\nRoxithromycin: XM98M0\\nSpiramycin: XM1K16\\nTroleandomycin: XM2WF8\\nClarithromycin: XM1VG4\\nDirithromycin: XM0EH3\\nFlurithromycin: XM2J45\\nTelithromycin: XM5TV4\\nSolithromycin: XM2LU0\\nAnsamycin: XM4094\\nLincosamides: XM7E36\\nClindamycin: XM8158\\nLincomycin: XM53Q9\\nStreptogramins: XM69N7\\nPristinamycin: XM48W5\\nQuinupristin: XM4NJ6\\nDalfopristin: XM2YS9\\nAmikacin: XM3X89\\nAntibiotic aminoglycoside: XM4LV0\\nAntitubercular antibiotics: XM7WC2\\nAstromicin: XM4BG6\\nBekanamycin: XM4PT0\\nDibekacin: XM45U4\\nDihydrostreptomycin: XM8KT1\\nFramycetin: XM0PH0\\nGentamicin: XM3YS5\\nIsepamicin: XM6YS3\\nKanamycin: XM0C03\\nMicronomicin: XM9VS3\\nNeomycin derivatives: XM2YC8\\nNetilmicin: XM1W69\\nNovobiocin: XM1QQ2\\nParomomycin: XM1696\\nRibostamycin: XM58T2\\nSisomicin: XM4GS3\\nStreptomycin: XM6T34\\nStreptomycin derivative: XM32G0\\nStreptoduocin: XM7N64\\nStreptonivicin: XM4YK6\\nStreptovarycin: XM40X6\\nTobramycin: XM6G20\\nArbekacin: XM79T7\\nPlazomicin: XM1KN3\\nQuinolones and derivatives: XM7YK9\\nFluoroquinolones: XM3HL2\\nOfloxacin: XM8072\\nCiprofloxacin: XM77G2\\nPefloxacin: XM1Z91\\nEnoxacin: XM7SH9\\nNorfloxacin: XM85E7\\nFleroxacin: XM2GR2\\nTemafloxacin: XM98Z1\\nLomefloxacin: XM3JX8\\nSparfloxacin: XM6MR3\\nRufloxacin: XM7BN7\\nGrepafloxacin: XM6RS6\\nLevofloxacin: XM7KX7\\nTrovafloxacin: XM6YH9\\nMoxifloxacin: XM8147\\nGemifloxacin: XM5HN4\\nGatifloxacin: XM17A4\\nPrulifloxacin: XM3NU2\\nPazufloxacin: XM3Z59\\nGarenoxacin: XM1QZ5\\nSitafloxacin: XM5MK4\\nTosufloxacin: XM3S71\\nDelafloxacin: XM9CC7\\nRosoxacin: XM8SV4\\nNalidixic acid: XM82P4\\nPiromidic acid: XM1298\\nPipemidic acid: XM61M8\\nCombinations of antibacterials: XM3GX9\\nSulfonamides combinations with other antibacterials: XM5CX9\\nPenicillins combinations with other antibacterials: XM39C8\\nCefuroxime and metronidazole: XM9162\\nSpiramycin and metronidazole: XM3E19\\nLevofloxacin and ornidazole: XM8TH8\\nCefepime and amikacin: XM3DB6\\nAzithromycin fluconazole and secnidazole: XM5QC3\\nTetracycline and oleandomycin: XM1CM9\\nOfloxacin and ornidazole: XM2CJ8\\nCiprofloxacin and metronidazole: XM9T47\\nCiprofloxacin and tinidazole: XM36B5\\nCiprofloxacin and ornidazole: XM51W6\\nNorfloxacin and tinidazole: XM31E8\\nGlycopeptides: XM8S33\\nVancomycin: XM9YD1\\nTeicoplanin: XM2004\\nTelavancin: XM8WT1\\nDalbavancin: XM4F99\\nOritavancin: XM9LJ3\\nNitrofuran derivatives: XM2CE2\\nNitrofurantoin: XM09K7\\nNifurtoinol: XM1QV5\\nNifurtimox: XM9F49\\nFurazidin: XM8FX2\\nFurazolidone: XM08Z2\\nPolymyxins: XM3DZ3\\nColistin: XM6510\\nPolymyxin B: XM0NQ2\\nPolymyxin: XM8MH4\\nAerosporin: XM5183\\nAlbamycin: XM5PV6\\nAmphomycin: XM4E54\\nAntiinfective antibiotics specified: XM2H40\\nAntibiotic intestinal: XM41T2\\nAntibiotic polypeptide: XM0MJ1\\nAntibiotic specified: XM7SQ4\\nBetamicin: XM2EH2\\nCarbomycin: XM0D75\\nEnviomycin: XM74K5\\nFosfomycin: XM0HU8\\nFusafungine: XM5UL0\\nFusidic acid: XM6AH3\\nNeosporin: XM14K4\\nRistocetin: XM19A7\\nSodium fusidate: XM0BX1\\nSulfomyxin: XM4F54\\nViomycin: XM6HE3\\nVirginiamycin: XM2A60\\nXibornol: XM71G5\\nSpectinomycin: XM2TG1\\nMethenamine mandelate: XM02L5\\nMandelic acid: XM3HJ6\\nNitroxoline: XM33S9\\nClofoctol: XM11V4\\nLinezolid: XM9WV9\\nDaptomycin: XM2NL4\\nBacitracin: XM20R8\\nTedizolid: XM9GT9\\nLefamulin: XM9QK9\\nAntibiotic tetracycline group: XM8124\\nChlormethylenecycline: XM7FD5\\nChlortetracycline: XM1JT2\\nClomocycline: XM0WY0\\nDemeclocycline: XM9219\\nDemethylchlortetracycline: XM17F8\\nDemethyltetracycline: XM7KG3\\nDoxycycline: XM7J58\\nGuamecycline: XM4492\\nLymecycline: XM47D7\\nMeclocycline: XM9KD5\\nMetacycline: XM4CA1\\nMinocycline: XM5TY0\\nOxytetracycline: XM8DQ8\\nPenimepicycline: XM3D34\\nRolitetracycline: XM45X2\\nTetracycline: XM0BP1\\nTigecycline: XM74B7\\nAminosalicylic acid and derivatives: XM8781\\nAminosalicylic acid: XM1X82\\nSodium aminosalicylate: XM6TY4\\nCalcium aminosalicylate: XM7FE7\\nThiocarbamide derivatives: XM3BE3\\nProtionamide: XM1GT1\\nEthionamide: XM86N7\\nDrugs for treatment of lepra: XM8Q31\\nClofazimine: XM3122\\nDapsone: XM73W4\\nClascoterone: XM34C6\\nAminosalylum: XM6QT5\\nAntiinfective antimycobacterial: XM4TV0\\nAntimycobacterial drug combination: XM5K63\\nAntituberculars: XM6DX3\\nBenzoylpas calcium: XM18Y4\\nBromosalicylhydroxamic acid: XM3307\\nCalcium benzamidosalicylate: XM2754\\nChaulmosulfone: XM7TM4\\nCyanacetyl hydrazide: XM95S8\\nEthambutol: XM4N96\\nEthyl chaulmoograte: XM64N2\\nFenamisal: XM23G7\\nGlucosulfone sodium: XM4RF4\\nGlyconiazide: XM7945\\nIsoniazid: XM5FH2\\nIsonicotinic acid hydrazide: XM2ZK2\\nMethaniazide: XM3XE5\\nMorinamide: XM8UX1\\nMorphazinamide: XM6LM1\\nPasiniazid: XM2QH1\\nPentylsalicylamide: XM4Q32\\nPotassium aminosalicylate: XM3UQ6\\nPromacetin: XM8DJ8\\nPromin: XM8CP2\\nPyrazinamide: XM4611\\nRimifon: XM4GU0\\nSalinazid: XM7SC9\\nAcetosulfone sodium: XM3070\\nSolasulfone: XM06Z9\\nSulfonazide: XM3SD9\\nSulfones: XM3SN8\\nAldesulfone sodium: XM72Q4\\nTerizidone: XM9TD0\\nThiambutosine: XM99P0\\nThioacetazone: XM0AR8\\nThioacetazone with isoniazid: XM5MQ5\\nTiocarlide: XM62H2\\nBedaquiline: XM60U0\\nDelamanid: XM1FD5\\nAntimycobacterial antibiotic: XM7AQ6\\nCycloserine: XM63V4\\nRifampicin: XM0R30\\nRifamycin: XM7HL1\\nRifabutin: XM5QH8\\nRifapentine: XM8MQ4\\nCapreomycin: XM0892\\nRifaximin: XM2LE1\\nRifamide: XM38J6\\nImidazole derivatives: XM2SD6\\nMiconazole: XM9UH0\\nKetoconazole: XM9795\\nTriazole and tetrazole derivatives: XM4GT1\\nFluconazole: XM97S6\\nItraconazole: XM5XD2\\nVoriconazole: XM70R4\\nPosaconazole: XM1VE3\\nOteseconazole: XM69J7\\nGriseofulvin: XM8YE6\\nNystatin: XM32L5\\nFlucytosine: XM3BU7\\nTerbinafine: XM7HQ1\\nCaspofungin: XM0K47\\nMicafungin: XM1F82\\nAnidulafungin: XM0HG4\\nAntifungal antibiotics: XM7S10\\nAmphotericin B: XM5TR4\\nHachimycin: XM9CM4\\nNucleosides and nucleotides: XM56B8\\nAciclovir: XM3MC4\\nVidarabine: XM30N1\\nGanciclovir: XM1M61\\nIdoxuridine: XM2GP5\\nFamciclovir: XM3RL1\\nValaciclovir: XM4GK4\\nCidofovir: XM6HE0\\nPenciclovir: XM3AF7\\nValganciclovir: XM2RU2\\nBrivudine: XM5L76\\nRemdesivir: XM1ES0\\nBrincidofovir: XM4CD1\\nCyclic amines: XM7QR0\\nRimantadine: XM2TS5\\nTromantadine: XM7GR8\\nPhosphonic acid derivatives: XM90G3\\nFoscarnet: XM5XQ9\\nFosfonet: XM8Z26\\nProtease inhibitors: XM8GK2\\nSaquinavir: XM7YP4\\nIndinavir: XM1VT6\\nRitonavir: XM56L1\\nNelfinavir: XM6175\\nAmprenavir: XM6WJ3\\nFosamprenavir: XM2AR2\\nAtazanavir: XM2U50\\nTipranavir: XM8QH1\\nDarunavir: XM63Q8\\nNucleoside and nucleotide reverse transcriptase inhibitors: XM3EZ0\\nZidovudine: XM9C07\\nZalcitabine: XM7XQ2\\nDidanosine: XM8Z78\\nStavudine: XM7RM1\\nLamivudine: XM5471\\nAbacavir: XM35P4\\nTenofovir disoproxil: XM67N3\\nAdefovir: XM96H1\\nEmtricitabine: XM2L06\\nEntecavir: XM0Z52\\nTelbivudine: XM2P85\\nClevudine: XM9K66\\nTenofovir alafenamide: XM06Z6\\nNonnucleoside reverse transcriptase inhibitors: XM5PT4\\nNevirapine: XM10T5\\nDelavirdine: XM0LC3\\nEfavirenz: XM1DX2\\nEtravirine: XM7N44\\nRilpivirine: XM1KD4\\nNeuraminidase inhibitors: XM6DT0\\nZanamivir: XM0JN4\\nOseltamivir: XM6823\\nPeramivir: XM0AQ6\\nLaninamivir: XM6M67\\nAntivirals for treatment of hepatitis C infections: XM9DH8\\nRibavirin: XM8YT1\\nTelaprevir: XM2WF9\\nBoceprevir: XM07W4\\nFaldaprevir: XM1QK4\\nSimeprevir: XM9FF9\\nAsunaprevir: XM6LF8\\nDaclatasvir: XM41F6\\nSofosbuvir: XM0ZZ5\\nDasabuvir: XM34X5\\nElbasvir: XM5HK2\\nGrazoprevir: XM9WK5\\nCoblopasvir: XM6ZX2\\nAntivirals for treatment of hepatitis C infections combinations: XM3SJ3\\nSofosbuvir and Ledipasvir: XM5CA7\\nDasabuvir Ombitasvir Paritaprevir and Ritonavir: XM4R75\\nOmbitasvir Paritaprevir and Ritonavir: XM70P2\\nElbasvir and Grazoprevir: XM7VS7\\nSofosbuvir and Velpatasvir: XM3K33\\nSofosbuvir Velpatasvir and Voxilaprevir: XM14S9\\nGlecaprevir and Pibrentasvir: XM1NF4\\nDaclatasvir Asunaprevir and Beclabuvir: XM10G0\\nAntivirals for treatment of human immunodeficiency virus infections combinations: XM3U67\\nZidovudine and Lamivudine: XM5UM7\\nLamivudine and Abacavir: XM41D4\\nTenofovir disoproxil and Emtricitabine: XM75H2\\nZidovudine Lamivudine and Abacavir: XM2F89\\nZidovudine Lamivudine and Nevirapine: XM0SL5\\nEmtricitabine Tenofovir disoproxil and Efavirenz: XM7RZ6\\nStavudine Lamivudine and Nevirapine: XM99U8\\nEmtricitabine Tenofovir disoproxil and Rilpivirine: XM1KH0\\nEmtricitabine Tenofovir disoproxil Elvitegravir and Cobicistat: XM99Q5\\nLopinavir: XM3EH7\\nLamivudine Tenofovir disoproxil and Efavirenz: XM9NL2\\nLamivudine and Tenofovir disoproxil: XM50Z0\\nLamivudine Abacavir and Dolutegravir: XM2UU9\\nDarunavir and Cobicistat: XM1FA4\\nAtazanavir and Cobicistat: XM4KM0\\nLamivudine and Raltegravir: XM0229\\nEmtricitabine and Tenofovir alafenamide: XM8RF0\\nEmtricitabine Tenofovir alafenamide Elvitegravir and Cobicistat: XM4JT2\\nEmtricitabine Tenofovir alafenamide and Rilpivirine: XM08B7\\nEmtricitabine Tenofovir alafenamide and Bictegravir: XM0UN9\\nDolutegravir and Rilpivirine: XM4C60\\nEmtricitabine Tenofovir alafenamide Darunavir and Cobicistat: XM7T33\\nAtazanavir and Ritonavir: XM4TF3\\nLamivudine Tenofovir disoproxil and Doravirine: XM5FB9\\nLamivudine and Dolutegravir: XM9CE4\\nDarunavir and Ritonavir: XM8ZN1\\nLamivudine Tenofovir disoproxil and Dolutegravir: XM8QY9\\nAntiinfective antiviral: XM63K0\\nDideoxyinosine: XM7SG2\\nFoscarnet sodium: XM9VL0\\nFosfonet sodium: XM6CJ2\\nIbacitabine: XM1R42\\nMetisazone: XM6SP8\\nMoroxydine: XM5GV1\\nTrifluridine: XM6WB2\\nLysozyme: XM60K5\\nInosine pranobex: XM8AQ1\\nPleconaril: XM23V6\\nEnfuvirtide: XM1EQ6\\nRaltegravir: XM82D3\\nMaraviroc: XM3FG0\\nMaribavir: XM7HJ6\\nElvitegravir: XM7WY9\\nDolutegravir: XM6K45\\nUmifenovir: XM3S98\\nEnisamium iodide: XM8CN1\\nLetermovir: XM01X3\\nTilorone: XM1UC2\\nPentanedioic acid imidazolyl ethanamide: XM90X2\\nIbalizumab: XM2KW1\\nTecovirimat: XM7FP8\\nBaloxavir marboxil: XM9A16\\nAmenamevir: XM1QY5\\nFavipiravir: XM2L29\\nCobicistat: XM1KL9\\nLenacapavir: XM85A9\\nAHLG: XM6MB2\\nAntihuman lymphocytic globulin: XM9CH0\\nAntidiphtheria serum: XM9L34\\nAntiscorpion sera: XM9D37\\nAntitoxin: XM5CP2\\nAntitoxin gas gangrene: XM81Z0\\nAntivenin antivenom sera: XM5TW5\\nAntivenin antivenom crotaline: XM2T48\\nAntivenin antivenom spider bite: XM6D91\\nBlack widow spider antivenin: XM4XP6\\nGamimune: XM7VG2\\nGamma globulin: XM6Z81\\nGamulin: XM7MC6\\nGlandular extract medicinal: XM1AG2\\nGlobulin antilymphocytic: XM8MQ7\\nGlobulin antirhesus: XM6UW5\\nGlobulin antivenin: XM3LT2\\nGlobulin antiviral: XM9XP6\\nHomotet: XM5443\\nHorse antihuman lymphocytic serum: XM3KZ0\\nHuman immune serum: XM7BR5\\nHypertussis: XM42S1\\nPegademase bovine: XM5DZ4\\nRhoGAM: XM67L1\\nSerum antiRh: XM77D4\\nSerum antibotulinus: XM3HE6\\nSerum anticytotoxic: XM9V23\\nSerum antimeningococcus: XM7HP0\\nSerum antitetanic: XM5F14\\nSerum antitoxic: XM8MX1\\nSerum convalescent: XM9QJ7\\nSerum protective: XM0SJ2\\nSpider antivenin: XM5CC6\\nTetanus toxoid or vaccine antitoxin: XM2042\\nTetanus toxoid or vaccine immune globulin human: XM2GK5\\nVaccine antineoplastic: XM8Y67\\nImmune sera: XM6VF9\\nDiphtheria antitoxin: XM2MN8\\nTetanus antitoxin: XM18X1\\nAntirabies hyperimmune serum: XM5083\\nSnake venom antiserum: XM18Y9\\nBotulinum antitoxin: XM0AD6\\nGasgangrene sera: XM1FR6\\nImmunoglobulins: XM1RS8\\nImmunoglobulins normal human: XM0AQ7\\nImmunoglobulins normal human intravenous: XM26U5\\nImmunoglobulins normal human extravascular: XM3H32\\nSpecific immunoglobulins: XM5YM7\\nAntiD rh immunoglobulin: XM4361\\nTetanus immunoglobulin: XM8824\\nHepatitis B immunoglobulin: XM6JK2\\nRabies immunoglobulin: XM5R25\\nVaccinia immunoglobulin: XM8Q08\\nPertussis immunoglobulin: XM3FU2\\nMumps immunoglobulin: XM8Z30\\nVaricella zoster immunoglobulin: XM7X82\\nRubella immunoglobulin: XM3ZS8\\nStaphylococcus immunoglobulin: XM1V63\\nCytomegalovirus immunoglobulin: XM7NM9\\nDiphtheria immunoglobulin: XM4YT6\\nHepatitis A immunoglobulin: XM7LD1\\nEncephalitis tick borne immunoglobulin: XM5NX5\\nMeasles immunoglobulin: XM1GU6\\nPalivizumab: XM45N8\\nMotavizumab: XM0QB1\\nRaxibacumab: XM0U74\\nAnthrax immunoglobulin: XM8Y60\\nBezlotoxumab: XM6GD5\\nObiltoxaximab: XM54X9\\nImmunoglobulin not elsewhere classified: XM1BS2\\nAntiviral monoclonal antibodies: XM3NK9\\nTixagevimab: XM78P5\\nCilgavimab: XM1CT9\\nBacterial vaccines: XM3KV2\\nCholera vaccines: XM29K4\\nCholera inactivated whole cell vaccines: XM3Z26\\nCholera live attenuated vaccines: XM72A0\\nCholera combinations with typhoid vaccine inactivated whole cell vaccines: XM1FT6\\nHaemophilus influenzae B vaccines: XM11V3\\nHib purified antigen conjugated vaccines: XM6RG9\\nHib combinations with toxoids vaccines: XM7F70\\nHib combinations with pertussis and toxoids vaccines: XM81F7\\nHib combinations with meningococcus C conjugated vaccines: XM0X86\\nMeningococcal vaccines: XM2WV4\\nMeningococcal monovalent purified polysaccharides antigen vaccines: XM92B2\\nMeningococcal polyvalent purified polysaccharides antigen vaccines: XM5LC2\\nMeningococcus A C bivalent purified polysaccharides antigen vaccines: XM3T39\\nMeningococcus A C Y W tetravalent purified polysaccharides antigen vaccines: XM2AR0\\nMeningococcus A C Y W tetravalent purified polysaccharides antigen conjugated vaccines: XM2EH7\\nMeningococcus C purified polysaccharides antigen conjugated vaccines: XM18Y8\\nMeningococcus A purified polysaccharides antigen conjugated vaccines: XM2280\\nMeningococcus B outer membrane vesicle vaccines: XM9GJ1\\nMeningococcus B multicomponent vaccines: XM1X81\\nMeningococcus A purified polysaccharides antigen vaccines: XM37L5\\nPertussis vaccines: XM43M9\\nPertussis inactivated whole cell vaccines: XM45L8\\nPertussis purified antigen vaccines: XM62J1\\nPertussis inactivated whole cell combinations with toxoids vaccines: XM2TK2\\nPertussis purified antigen combinations with toxoids vaccines: XM4082\\nVaccines pertussis with diphtheria: XM2CV8\\nPneumococcal vaccines: XM9EM7\\nPneumococcal conjugate valent vaccines: XM9G97\\nPneumococcal polysaccharide valent vaccines: XM2249\\nPneumococcus purified polysaccharides antigen vaccines: XM91D7\\nPneumococcus purified polysaccharides antigen conjugated vaccines: XM96S7\\nPneumococcus purified polysaccharides antigen and Haemophilus influenzae conjugated vaccines: XM4R39\\nTetanus vaccines: XM5L44\\nTetanus toxoid vaccines: XM29H5\\nTetanus toxoid combinations with diphtheria toxoid vaccines: XM1G86\\nTetanus toxoid combinations with tetanus immunoglobulin vaccines: XM9AK2\\nTetanus diphtheria acellular pertussis vaccines: XM31Q8\\nTriple vaccines DPT: XM1PB8\\nPertussis vaccines with diphtheria toxoid with tetanus toxoid: XM9ZL9\\nDiphtheria toxoid with tetanus toxoid with pertussis component vaccines: XM9YH9\\nTetanus and diphtheria vaccines: XM32Q5\\nVaccines diphtheria with tetanus: XM4039\\nTetanus toxoid or vaccines toxoid with diphtheria toxoid: XM8XH5\\nTyphoid vaccines: XM8BU8\\nTyphoid oral live attenuated vaccines: XM33K4\\nTyphoid inactivated whole cell vaccines: XM89G3\\nTyphoid purified polysaccharide antigen vaccines: XM3SF6\\nTyphoidparatyphoid vaccines: XM9UB1\\nVaccines TAB: XM3VD2\\nParatyphoid vaccines: XM95H3\\nPlague vaccines: XM8ZX8\\nPlague inactivated whole cell vaccines: XM3796\\nVaccines bacterial with other bacterial component: XM9SW5\\nVaccines rickettsial: XM91J8\\nTyphus exanthematicus vaccines: XM3JJ2\\nTyphus exanthematicus inactivated whole cell vaccines: XM2NU8\\nVaccines rickettsial with bacterial component: XM4F19\\nRocky Mountain spotted fever vaccines: XM0E84\\nVaccines bacterial mixed not elsewhere classified: XM5926\\nAnthrax vaccines: XM8NU9\\nAnthrax antigen vaccines: XM2C05\\nBrucellosis vaccines: XM7PB3\\nBrucella antigen vaccines: XM7RX8\\nDiphtheria vaccines: XM8AW3\\nDiphtheria toxoid vaccines: XM86V7\\nDiphtheria vaccines combination including pertussis: XM46V1\\nDiphtheria vaccines combination without pertussis: XM39K8\\nDiphtheria vaccines combination: XM8YP9\\nTuberculosis vaccines: XM4639\\nTuberculosis live attenuated vaccines: XM8142\\nViral vaccines: XM61M7\\nCOVID vaccines: XM68M6\\nCOVID vaccines inactivated virus: XM1NL1\\nCoronaVac: XM7HT3\\nCovilo: XM8866\\nKCONVAC: XM9TQ1\\nCovaxin: XM1G90\\nCoviVac: XM85P5\\nHayatVax: XM9FQ7\\nQazVac: XM97N6\\nCOVIran Barekat: XM2YG8\\nCovidful: XM0K39\\nFAKHRAVAC MIVAC: XM0J98\\nInactivated SARSCoV vaccine: XM1FB4\\nTurkovac: XM86F7\\nVLA: XM42N8\\nInavac: XM7KM9\\nCOVID vaccines live attenuated virus: XM5DF6\\nCOVID vaccines nonreplicating viral vector: XM9QW8\\nCOVID Vaccine AstraZeneca Vaxzevria: XM4YL8\\nCovishield: XM97T2\\nCOVID Vaccine Janssen: XM6QV1\\nConvidecia: XM1AG7\\nSputnikLight: XM5QM6\\nConvidecia Air: XM4T09\\nConvidecia Air XBB: XM2LP0\\nGamCOVIDVac intranasal: XM6Z24\\nGamCOVIDVacM: XM4PM4\\niNCOVACC: XM5309\\nSputnikV: XM37C0\\nCOVID vaccines replicating viral vector: XM0CX4\\nDelNSnCoVRBDOPT: XM5BL0\\nPatria: XM3UC0\\nCOVID vaccines virus protein subunit: XM5JC5\\nZifivax: XM3CT4\\nAbdala: XM8T18\\nSoberana: XM3PG0\\nMVC COVID: XM4EC8\\nEpiVacCorona: XM6SZ8\\nSoberana Plus: XM0RV9\\nAuroraCoV: XM3SK8\\nSpikoGen: XM9P21\\nNUVAXOVID: XM9T65\\nRazi COV PARS: XM9N08\\nBimervax: XM6790\\nBivalent Omicron: XM8R60\\nCorbevax: XM63N7\\nCoviccine: XM2NP9\\nCoviccine Trivalent XBBBADelta: XM0E93\\nCovovax: XM85Q5\\nEuCorVac: XM85Q8\\nIndovac: XM7E37\\nNoora: XM7P85\\nNUVAXOVID XBB: XM2FM2\\nPastoCovac: XM97Q5\\nPastoCovac Plus: XM8BU1\\nRecombinant SARSCoV Vaccine CHO Cell: XM9P29\\nSARSCOV Bivalent: XM5YS2\\nSCB: XM8ME2\\nSCTVC: XM71X6\\nSKYCovione: XM62V8\\nTetravalent SCTVE: XM8267\\nV: XM6WB0\\nVidprevtyn Beta: XM9ZB6\\nNUVAXOVID JN: XM6YA9\\nConvacell: XM5TF6\\nARVACCG Gamma  Omicron: XM4AC5\\nCOVID RECOMBINANT: XM7Y13\\nCOVID vaccines virus like particle: XM1J92\\nCovifenz: XM0BS6\\nCOVID vaccines DNA based: XM6AT1\\nZyCovD: XM52P3\\nCOVID vaccines RNA based: XM0GQ8\\nComirnaty: XM8NQ0\\nCOVID Vaccine Moderna Spikevax: XM3DT5\\nAWcorna: XM5E97\\nComirnaty Bivalent OriginalOmicron BA: XM1CQ8\\nComirnaty Bivalent OriginalOmicron BABA: XM5U85\\nComirnaty XBB: XM7U45\\nDaichirona: XM6HM3\\nDuentai: XM15E9\\nDuentai Bivalent XBBBQ: XM2708\\nGemcovac: XM3X29\\nGemcovacOM: XM8FH6\\nKOSTAIVE: XM6FF0\\nCOVID Vaccine Moderna Spikevax Bivalent OriginalOmicron BA: XM0QH5\\nCOVID Vaccine Moderna Spikevax Bivalent OriginalOmicron BABA: XM3984\\nCOVID Vaccine Moderna Spikevax XBB: XM21B8\\nComirnaty KP: XM52Y9\\nSpikevax KP: XM15B2\\nDengue vaccines: XM38G7\\nEbola vaccines: XM7P50\\nrVSVGZEBOVGP vaccine: XM4P37\\nAdZEBOV and MVABNFilo vaccine: XM4TZ2\\nEncephalitis vaccines: XM0RC1\\nEncephalitis tick borne inactivated whole virus: XM8MP6\\nEncephalitis Japanese inactivated whole virus: XM0LB5\\nEncephalitis Japanese live attenuated: XM47S0\\nInfluenza vaccines: XM1LR5\\nInfluenza vaccines inactivated whole virus: XM8857\\nInfluenza vaccines live attenuated: XM5V64\\nInfluenza vaccines inactivated split virus or surface antigen: XM8MP2\\nInfluenza vaccines virus like particle: XM9E16\\nInfluenza purified antigen: XM33X8\\nHepatitis vaccines: XM6LL6\\nHepatitis B purified antigen: XM9V38\\nHepatitis A inactivated whole virus: XM2A12\\nCombinations hepatitis vaccines: XM03Y7\\nMeasles vaccines: XM28X5\\nMeasles live attenuated: XM8L15\\nMeasles combinations with mumps live attenuated: XM9439\\nMeasles combinations with mumps and rubella live attenuated: XM8TF3\\nMeasles combinations with rubella live attenuated: XM21H2\\nMeasles combinations with mumps rubella and varicella live attenuated: XM4AJ8\\nMumps vaccines: XM1131\\nMumps live attenuated: XM2340\\nPoliomyelitis vaccines: XM0N50\\nOrimune: XM4KG4\\nVaccine sabin oral: XM1Y59\\nDiplovax: XM2KH7\\nPoliomyelitis oral monovalent live attenuated: XM0VX8\\nPoliomyelitis oral trivalent live attenuated: XM0KZ1\\nPoliomyelitis oral bivalent live attenuated: XM79H3\\nPoliomyelitis trivalent inactivated whole virus: XM5V19\\nRotavirus diarrhoea vaccines: XM1CE0\\nRota virus live attenuated: XM4GV0\\nRota virus pentavalent live reassorted: XM4VG1\\nRubella vaccines: XM7PP1\\nRubella live attenuated: XM9PS9\\nRubella combinations with mumps live attenuated: XM3B09\\nVaricella zoster vaccines: XM8DG3\\nVaricella live attenuated: XM0NS8\\nZoster live attenuated: XM1SS1\\nPapillomavirus vaccines: XM9QP0\\nPapillomavirus human types: XM5CE9\\nSmallpox vaccine: XM95R0\\nRabies vaccines: XM6T09\\nRabies inactivated whole virus: XM7BE8\\nRespiratory syncytial virus vaccines: XM02Y0\\nSynagis: XM69P6\\nYellow fever vaccines: XM0N24\\nYellow fever live attenuated: XM3418\\nMpox vaccines: XM7ZF1\\nLCm vaccine: XM3ZY6\\nBacterial and viral vaccines combined: XM7C66\\nDiphtheria poliomyelitis tetanus vaccines: XM8AW1\\nDiphtheria pertussis poliomyelitis tetanus vaccines: XM09Q7\\nDiphtheria rubella tetanus vaccines: XM9744\\nDiphtheria hepatitis B pertussis tetanus vaccines: XM41N3\\nDiphtheria hemophilus influenzae B pertussis poliomyelitis tetanus vaccines: XM1LX9\\nDiphtheria hepatitis B tetanus vaccines: XM3G68\\nHemophilus influenzae B and hepatitis B vaccines: XM32L7\\nTyphoid hepatitis A vaccines: XM3JA6\\nDiphtheria hemophilus influenzae B pertussis tetanus hepatitis B vaccines: XM7JP3\\nDiphtheria pertussis poliomyelitis tetanus hepatitis B vaccines: XM0LT9\\nDiphtheria hemophilus influenzae B pertussis tetanushepatitis B meningococcus A  C vaccines: XM5XP9\\nDiphtheria tetanus acellular pertussis inactivated polio virus haemophilus Influenzae type B vaccines: XM21E6\\nDiphtheria hepatitis B tetanus acellular pertussis inactivated polio virus haemophilus Influenzae type B vaccines: XM84S1\\nDiphtheria tetanus acellular pertussis inactivated polio virus vaccines: XM9JP8\\nHemophilus influenzae B and poliomyelitis vaccines: XM01H1\\nMetronidazole: XM5YM6\\nTinidazole: XM7Z72\\nTrimetrexate: XM6BF7\\nAcetarsol: XM3Y85\\nPentamidine: XM0067\\nSuramin sodium: XM11F5\\nAtovaquone: XM9CB1\\nMiltefosine: XM71Y7\\nHydroxyquinoline derivatives: XM21E9\\nBroxyquinoline: XM5MW6\\nClioquinol: XM1V59\\nChlorquinaldol: XM56H5\\nTilbroquinol: XM1KS8\\nTiliquinol: XM0V89\\nAminoquinoline drugs: XM6M61\\nAmopyroquin: XM0NC8\\nAntiinfective antimalarial: XM37R2\\nAntiinfective antiprotozoal blood: XM0VE8\\nAntimalarial: XM1914\\nAntimalarial prophylactic: XM5WN6\\nAntimalarial pyrimidine derivative: XM5Q32\\nAntiprotozoal drug blood: XM7LP3\\nChlorproguanil: XM0KE4\\nCinchona: XM38E0\\nCinchonine alkaloids: XM9V39\\nDaraprim: XM9511\\nGuanatol: XM23A5\\nHalofantrine: XM3T26\\nIsopentaquine: XM17W0\\nMefloquine: XM50J2\\nPamaquine naphthoate: XM08Q1\\nPentaquine: XM0346\\nPyrimethamine: XM0XQ2\\nPyrimethamine with sulfadoxine: XM90Z4\\nQuinacrine: XM10R3\\nQuinine: XM8RC3\\nQuinocide: XM0RU7\\nSchizontocide blood tissue: XM9Z81\\nAminoquinolines: XM50C8\\nChloroquine: XM6ZE6\\nHydroxychloroquine: XM9YB2\\nPrimaquine: XM9F55\\nAmodiaquine: XM3GB3\\nTafenoquine: XM5EL4\\nArtemisinin and derivatives plain: XM5SP0\\nArtemisinin: XM1ED1\\nArtemether: XM7D52\\nArtesunate: XM7Q22\\nArtemotil: XM37K1\\nArtenimol: XM9ND1\\nArterolane and Piperaquine: XM3B54\\nNaphthoquine: XM8H63\\nArtemether and Lumefantrine: XM6TH1\\nActerol: XM8MB3\\nAminitrozole: XM0FS7\\nAntiinfective antiprotozoal: XM4GE4\\nAntimony dimercaptosuccinate: XM4W96\\nAntimony sodium dimercaptosuccinate: XM9GG8\\nAntiprotozoal drug: XM4393\\nAntitrichomonal drug: XM2HL1\\nBialamicol: XM83L5\\nCarbarsone: XM8E05\\nGlaucarubin: XM1RE2\\nHydroxystilbamidine: XM1LB9\\nMelarsonyl potassium: XM5NQ7\\nMelarsoprol: XM4UC9\\nMisonidazole: XM1HA1\\nOrnidazole: XM3WL0\\nOxophenarsine: XM3E43\\nStibogluconate: XM45H6\\nStilbamidine isetionate: XM0CL7\\nTeclozan: XM05U5\\nTrichomonacides: XM6XS3\\nTryparsamide: XM5R30\\nNitroimidazole derivatives: XM7BM9\\nAzanidazole: XM4HZ1\\nNimorazole: XM5LH9\\nSecnidazole: XM98K0\\nBenznidazole: XM0JG6\\nPropenidazole: XM61Z9\\nFexinidazole: XM5VX1\\nDichloroacetamide derivatives: XM4RW6\\nDiloxanide: XM7AM3\\nClefamide: XM9H76\\nEtofamide: XM3PL8\\nArsenic compounds: XM4787\\nArsthinol: XM09B5\\nDifetarsone: XM0A09\\nGlycobiarsol: XM6V40\\nAntimony compounds: XM64G7\\nMeglumine antimonate: XM2TP0\\nSodium stibogluconate: XM2284\\nAkritoin: XM3E78\\nAntiinfective arsenical: XM8LB8\\nAntiinfective heavy metals: XM44A9\\nAntimony antiinfectives: XM8CX5\\nAntimony potassium tartrate sodium: XM69W3\\nAntimony tartrated: XM2AH2\\nAntiparasitic drug specified: XM1Z32\\nArsphenamine silver: XM0L93\\nBismuth salts antiinfectives: XM12U8\\nBismuth salts subsalicylate: XM7A39\\nBithionol: XM8SJ3\\nChiniofon: XM7PV2\\nCinoxacin: XM6DH1\\nCroconazole: XM0402\\nDichlorhydroxyquinoline: XM1YN6\\nDisinfectant intestinal: XM59A1\\nFlumequine: XM4923\\nFlunidazole: XM7BY8\\nFluorocytosine: XM4XE9\\nHexetidine: XM6UT2\\nIodobismitol: XM74Y8\\nIodoquinol: XM80M5\\nLead antiinfectives: XM7T64\\nMapharsen: XM0FS9\\nMercury mercurial mercuric mercurous antiinfective systemic: XM0RW4\\nNeoarsphenamine: XM08P3\\nNeosilversalvarsan: XM0M05\\nNifuratel: XM39N3\\nOxolinic acid: XM70Q8\\nPotassium antimony tartrate: XM10R8\\nQuiniobine: XM8WV6\\nQuinoline derivatives: XM8U22\\nSalvarsan  neosilver silver: XM3VB9\\nSilver salvarsan: XM6260\\nSodium cacodylate antiinfective: XM3DB2\\nStovarsal: XM9L57\\nSulfarsphenamine: XM80F6\\nTartar emetic: XM96Q1\\nTartrated antimony antiinfective: XM6A32\\nThiobismol: XM9KU4\\nThiocarbarsone: XM9UP9\\nTin antiinfectives: XM5VM3\\nUrinary antiinfective: XM2SB0\\nEmetine: XM2HD6\\nPhanquinone: XM5GF4\\nMepacrine: XM9VB9\\nTenonitrozole: XM5RX3\\nDehydroemetine: XM28N6\\nFumagillin: XM5WJ8\\nNitazoxanide: XM84S6\\nEflornithine: XM9JL2\\nAlantolactone: XM2NT3\\nAmphotalide: XM1PP4\\nAnthiolimine: XM8LU8\\nAntiinfective anthelmintic: XM95R7\\nAntifilarial drug: XM43K9\\nAntihelmintics: XM4EC0\\nAntihookworm drug: XM9637\\nAntinematode drug: XM16G5\\nAntiplatyhelmintic drug: XM2078\\nAntischistosomal drug: XM60W7\\nAntitapeworm drug: XM6500\\nAntiwhipworm drug: XM5273\\nAscaridole: XM7QL4\\nAspidium oleoresin: XM9GK4\\nBenzimidazole derivatives: XM3JR4\\nMebendazole: XM3GX0\\nTiabendazole: XM0CU8\\nAlbendazole: XM79J1\\nFlubendazole: XM8RG6\\nFenbendazole: XM5XC2\\nCiclobendazole: XM7982\\nBephenium: XM3667\\nBithionol anthelminthic: XM6FY4\\nBitoscanate: XM5L27\\nChenopodium: XM4WY5\\nDichlorophen: XM0ZD3\\nDithiazanine iodide: XM8C12\\nFilix mas: XM2RX7\\nIvermectin: XM05F2\\nLevamisole: XM5W42\\nLucanthone: XM9Z70\\nMale fern extract: XM4SZ4\\nNiclosamide: XM2034\\nNiridazole: XM2WY0\\nNitrothiazol: XM7NR1\\nOxamniquine: XM5JZ6\\nPelletierine tannate: XM9FH0\\nPerchloroethylene medicinal: XM5ZH0\\nPinkroot: XM3T27\\nPraziquantel: XM8205\\nPumpkin seed extract: XM7SZ5\\nPyrvinium: XM5PX0\\nSantonin: XM9KL1\\nSpigelia root: XM3FE9\\nStibophen: XM5VV1\\nTeroxalene: XM4GA8\\nTetrachloroethylene medicinal: XM7PN4\\nTetramisole: XM93X2\\nUrea stibamine: XM2621\\nVeroxil: XM5C18\\nViprynium: XM3AT4\\nWormseed American: XM4555\\nTetrahydropyrimidine derivatives: XM6U56\\nPyrantel: XM90N4\\nOxantel: XM05V2\\nMetrifonate: XM9H59\\nTriclabendazole: XM7VW8\\nMoxidectin: XM7F99\\nDesaspidin: XM0399\\nTetrabenazine: XM9DZ4\\nMemantine: XM3BR4\\nGinkgo folium: XM1CG4\\nTirilazad: XM9VG8\\nRiluzole: XM9Z74\\nXaliproden: XM4ER7\\nFampridine: XM5PS1\\nTafamidis: XM2AL2\\nLaquinimod: XM1LU9\\nPitolisant: XM3QR7\\nPatisiran: XM3FT2\\nEdaravone: XM1KZ8\\nInotersen: XM7DT3\\nValbenazine: XM8MX8\\nAducanumab: XM87M0\\nDeutetrabenazine: XM5UK9\\nArimoclomol: XM4F26\\nNonsteroidal antiinflammatory and antirheumatic agents: XM4KS4\\nButylpyrazolidines: XM7W23\\nPhenylbutazone: XM8HN0\\nMofebutazone: XM8P27\\nOxyphenbutazone: XM12M5\\nClofezone: XM8X86\\nKebuzone: XM4H41\\nAcetic acid derivatives and related substances: XM74U4\\nIndometacin: XM7497\\nSulindac: XM24W2\\nTolmetin: XM97N5\\nZomepirac: XM92G8\\nDiclofenac: XM2AU1\\nEtodolac: XM2186\\nKetorolac: XM8M52\\nBumadizone: XM6KJ8\\nLonazolac: XM12Q6\\nFentiazac: XM2AX1\\nAcemetacin: XM3458\\nDifenpiramide: XM7K80\\nOxametacin: XM7CA3\\nProglumetacin: XM2P51\\nAceclofenac: XM5W40\\nBufexamac: XM7AB1\\nAlclofenac: XM9S89\\nIbufenac: XM8G95\\nOxicams: XM0UL8\\nPiroxicam: XM9MD6\\nDroxicam: XM7WP9\\nLornoxicam: XM3X14\\nMeloxicam: XM1XY0\\nIsoxicam: XM83U4\\nTenoxicam: XM1867\\nPropionic acid derivatives: XM2S54\\nIbuprofen: XM2RR6\\nNaproxen: XM1KL8\\nKetoprofen: XM63J5\\nFenoprofen: XM7BS7\\nSuprofen: XM2N63\\nFlurbiprofen: XM8VP8\\nTiaprofenic acid: XM0WQ1\\nOxaprozin: XM9694\\nIbuproxam: XM1918\\nFenbufen: XM4W51\\nBenoxaprofen: XM7F06\\nPirprofen: XM4KX7\\nIndoprofen: XM3G14\\nDexibuprofen: XM32V2\\nFlunoxaprofen: XM4FK3\\nAlminoprofen: XM1W06\\nDexketoprofen: XM1ZF2\\nNaproxcinod: XM9ES5\\nCarprofen: XM8GM3\\nFenamates: XM9DC7\\nMefenamic acid: XM6Q83\\nFlufenamic acid: XM31G8\\nMeclofenamic acid: XM3W40\\nTolfenamic acid: XM9WQ9\\nCoxibs: XM16D6\\nCelecoxib: XM63D2\\nRofecoxib: XM70K9\\nValdecoxib: XM4SK9\\nParecoxib: XM96Q4\\nEtoricoxib: XM2W58\\nLumiracoxib: XM0BC7\\nPolmacoxib: XM1N20\\nGlafenine: XM7AM9\\nFloctafenine: XM3WB0\\nNabumetone: XM8WS4\\nAzapropazone: XM6SW5\\nGlucosamine: XM6SR1\\nBenzydamine: XM73Q0\\nProquazone: XM8GX7\\nNimesulide: XM5C49\\nFeprazone: XM37T1\\nNiflumic acid: XM4KV5\\nGlucosaminoglycan polysulfate: XM5Z51\\nOrgotein: XM9Z19\\nDiacerein: XM51H0\\nMorniflumate: XM1019\\nTenidap: XM7Z95\\nOxaceprol: XM4L54\\nChondroitin sulfate: XM9352\\nAvocado and soyabean oil unsaponifiables: XM0H27\\nEthoxazene: XM9C36\\nFenflumizol: XM85Z4\\nAnalgesic antirheumatic: XM46B3\\nAntiphlogistic: XM8DE1\\nAntirheumatic: XM95N2\\nAurothioglycanide: XM8526\\nFarnesil: XM4XH9\\nSodium aurothiosulfate: XM4DJ6\\nGold preparations: XM3LE3\\nSodium aurothiomalate: XM9ZC2\\nAuranofin: XM5HT1\\nAurothioglucose: XM1MX1\\nAurotioprol: XM28Y9\\nSodium aurotiosulfate: XM8CF5\\nBucillamine: XM0VQ7\\nOxycinchophen: XM5L52\\nPenicillamine: XM1QA0\\nAcetylsalicylic acid: XM4G06\\nCarbaspirin: XM0XT0\\nCholine salicylate: XM0GX7\\nFiorinal: XM72N6\\nSodium salicylate: XM6PW4\\nSalicylamide: XM4WV7\\nSalsalate: XM68K3\\nDiflunisal: XM5UX6\\nAloxiprin: XM2JA1\\nEthenzamide: XM3ZP5\\nMorpholine salicylate: XM49Y6\\nDipyrocetyl: XM9TC0\\nBenorilate: XM1UA7\\nPotassium salicylate: XM2CV1\\nGuacetisal: XM1DD2\\nCarbasalate calcium: XM4TV1\\nImidazole salicylate: XM5UF9\\nCalcium salicylate: XM8F16\\nCarbethyl salicylate: XM5X48\\nMagnesium salicylate: XM6M40\\nSodium thiosalicylate: XM8FA6\\nAminophenazone: XM7045\\nAnalgesic pyrazole: XM7840\\nAntipyrine: XM22E9\\nCoal tar medicinal analgesics: XM60M2\\nDipyrone: XM4T98\\nIsopropylaminophenazone: XM2FJ5\\nMyochrysin e: XM8762\\nNifenazone: XM4YB4\\nNoramidopyrine: XM53Q3\\nPropyphenazone: XM6GV7\\nPyrazole derivatives: XM5H28\\nPyrazolone analgesic: XM5L33\\nRamifenazone: XM0K68\\nSulfamidopyrine: XM1SG0\\nSuxibuzone: XM9CV5\\nAcetaminophen: XM5DJ7\\nParaaminophenol derivatives: XM75Y5\\nPhenacetin: XM43A6\\nBucetin: XM7HP8\\nPropacetamol: XM8QF6\\nAcetaminosalol: XM24R8\\nAcetanilide: XM45S5\\nBromoseltzer: XM4T97\\nAcetylphenylhydrazine: XM2XD8\\nClonixin: XM3J63\\nCropropamide: XM1LX8\\nCrotethamide: XM0LT4\\nCyclopyrabital: XM0M53\\nDarvon: XM3YJ4\\nDiclonixin: XM7K04\\nDoloxene: XM2PY3\\nEmorfazone: XM7SA1\\nEtomide: XM9455\\nFluradoline: XM5YR6\\nJamaica dogwood bark: XM7983\\nLefetamine: XM6233\\nMethopholine: XM03M0\\nNefopam: XM4WT5\\nPerisoxal: XM8QV3\\nPhenicarbazide: XM0D38\\nPhenyramidol: XM2DH4\\nPiroxicam betacyclodextrin complex: XM0X95\\nPiscidia bark erythrina: XM63V3\\nPyrabital: XM49C9\\nPyridium: XM3WM4\\nRimazolium metilsulfate: XM4PW4\\nTiaramide: XM3375\\nTinoridine: XM9YA8\\nZactane: XM0794\\nMethoxyflurane: XM3P63\\nRimazolium: XM6Z00\\nFlupirtine: XM5WQ7\\nZiconotide: XM5XN0\\nTanezumab: XM70Q6\\nAntimigraine drugs: XM6HK1\\nTriptans: XM6FB9\\nSumatriptan: XM9AV2\\nNaratriptan: XM8BC6\\nZolmitriptan: XM06P8\\nRizatriptan: XM6W13\\nAlmotriptan: XM92S7\\nEletriptan: XM7YU2\\nFrovatriptan: XM4WN0\\nLasmiditan: XM7P17\\nDimetotiazine: XM81Q8\\nOxetorone: XM7N03\\nPizotifen: XM4WH4\\nIprazochrome: XM2G27\\nAntiepileptics: XM63D6\\nAlbutoin: XM52B4\\nAminodiphenylhydantoin valeric acid: XM9QF8\\nAnticonvulsant hydantoin: XM55H4\\nDilantin: XM08H9\\nEpanutin: XM45R0\\nEthotoin: XM8MV0\\nMephenytoin: XM4A36\\nMetetoin: XM02E9\\nPhenytoin: XM0RY4\\nOxazolidine derivatives: XM4DR6\\nParamethadione: XM7N89\\nTrimethadione: XM31H5\\nEthadione: XM9993\\nAloxidone: XM1535\\nFatty acid derivatives: XM4521\\nValproic acid: XM29Q3\\nValpromide: XM71X1\\nVigabatrin: XM5G31\\nProgabide: XM2HC7\\nAminobutyric acid: XM2XY6\\nTiagabine: XM8HQ0\\nSuccinimide derivatives: XM3C23\\nEthosuximide: XM1K85\\nPhensuximide: XM9E68\\nMesuximide: XM2KZ3\\nMorsuximide: XM6421\\nOther antiepileptics: XM9GA9\\nSultiame: XM1RS9\\nPhenacemide: XM7BQ9\\nPheneturide: XM4RJ7\\nBeclamide: XM6KR2\\nLamotrigine: XM6FN4\\nFelbamate: XM15W2\\nTopiramate: XM2103\\nGabapentin: XM0J96\\nLevetiracetam: XM9326\\nZonisamide: XM0SP9\\nPregabalin: XM0AK1\\nStiripentol: XM34S0\\nLacosamide: XM30R8\\nCarisbamate: XM7PP9\\nRetigabine: XM1P90\\nPerampanel: XM46J5\\nBrivaracetam: XM78C3\\nGanaxolone: XM7QW2\\nCarboxamide derivatives: XM70W8\\nCarbamazepine: XM3D95\\nOxcarbazepine: XM69D6\\nRufinamide: XM6BU4\\nEslicarbazepine: XM5HL7\\nClonazepam: XM2909\\nAntiparkinson drugs: XM9G63\\nDopaminergic agents: XM5Y20\\nCarbidopa: XM1Z60\\nDopa and dopa derivatives: XM7SN1\\nLevodopa: XM2WU7\\nDifluoromethyldopa: XM7RF5\\nLevodopa with carbidopa: XM3MW1\\nLevodopa and decarboxylase inhibitor: XM7ZB9\\nLevodopa Decarboxylase inhibitor and COMT inhibitor: XM3PK3\\nMelevodopa: XM1JZ7\\nMelevodopa and Decarboxylase inhibitor: XM0D22\\nEtilevodopa and Decarboxylase inhibitor: XM6R13\\nBromocriptine: XM5QR9\\nPergolide: XM1GL7\\nApomorphine: XM5PE4\\nPiribedil: XM2QX7\\nDihydroergocryptine mesylate: XM5DT8\\nRopinirole: XM9D35\\nPramipexole: XM5YJ4\\nRotigotine: XM7B98\\nMesulergine: XM50V4\\nMonoamine oxidase B inhibitors: XM9GG4\\nSelegiline: XM8FH5\\nRasagiline: XM6XW7\\nSafinamide: XM8H59\\nAmantadine: XM2H09\\nTolcapone: XM0BA4\\nEntacapone: XM07G6\\nBudipine: XM0K96\\nOpicapone: XM6TZ5\\nCarphenazine: XM7KE0\\nCompazine: XM83L8\\nDioxopromethazine: XM7WF8\\nEthyl aminophenothiazine: XM5EP8\\nIsopromethazine: XM9C32\\nMellaril: XM2WD3\\nMepazine: XM2VU6\\nMethoxypromazine: XM8ZW1\\nMetofenazate: XM4TX5\\nPhenothiazine psychotropic: XM52V9\\nPiperacetazine: XM0F82\\nPropylaminophenothiazine: XM6GY2\\nSparine: XM2XX6\\nStelazine: XM5JH1\\nStemetil: XM9Q32\\nSulforidazine: XM5Z28\\nThiazinamium metilsulfate: XM6YW4\\nTindal: XM87F3\\nTranquilizer dimethylamine: XM0EE9\\nTranquilizer ethylamine: XM9B27\\nTranquilizer phenothiazine: XM1QV8\\nTranquilizer piperazine: XM7057\\nTranquilizer piperidine: XM5KD3\\nTranquilizer propylamine: XM3Z20\\nPhenothiazines with aliphatic sidechain: XM4SG0\\nChlorpromazine: XM4U75\\nLevomepromazine: XM61Z1\\nPromazine: XM3CL7\\nAcepromazine: XM8LW2\\nTriflupromazine: XM1TZ3\\nCyamemazine: XM3AU5\\nChlorproethazine: XM6WY7\\nPhenothiazines with piperazine structure: XM1YC7\\nDixyrazine: XM75P4\\nFluphenazine: XM6Z10\\nPerphenazine: XM5Z27\\nProchlorperazine: XM84U4\\nThiopropazate: XM0PU2\\nTrifluoperazine: XM18F5\\nAcetophenazine: XM3EY1\\nThioproperazine: XM1V98\\nButaperazine: XM5JD6\\nPerazine: XM0TU3\\nPhenothiazines with piperidine structure: XM9HH5\\nPericiazine: XM5664\\nThioridazine: XM4DG6\\nMesoridazine: XM6447\\nPipotiazine: XM0168\\nBenperidol: XM12B1\\nBromperidol: XM4QG3\\nButyrophenonebased tranquilizers: XM2HT3\\nDroperidol: XM6FV0\\nFluanisone: XM0FM0\\nHaloperidol: XM9580\\nLenperone: XM6E81\\nMelperone: XM26W9\\nMoperone: XM7DW6\\nPipamperone: XM5AB4\\nSpiperone: XM1UG0\\nTimiperone: XM7RP6\\nTranquilizer butyrophenone: XM5NL7\\nTrifluperidol: XM4U52\\nLumateperone: XM9NX2\\nIndole derivatives: XM1QY7\\nOxypertine: XM84W2\\nMolindone: XM61G1\\nSertindole: XM69Z2\\nZiprasidone: XM8YM0\\nLurasidone: XM9EW5\\nThioxanthene derivatives: XM8X87\\nFlupentixol: XM4EY8\\nClopenthixol: XM87S1\\nChlorprothixene: XM2H35\\nTiotixene: XM6B79\\nZuclopenthixol: XM3MW6\\nDiphenylbutylpiperidine derivatives: XM2NF9\\nFluspirilene: XM0Q81\\nPimozide: XM1FB1\\nPenfluridol: XM5SZ6\\nDiazepines oxazepines thiazepines and oxepines: XM12F2\\nLoxapine: XM8FG8\\nClozapine: XM8UG6\\nOlanzapine: XM6GK7\\nQuetiapine: XM4G70\\nAsenapine: XM90C7\\nClotiapine: XM9DC4\\nVeralipride: XM9Q20\\nLevosulpiride: XM0624\\nBenzamides: XM1W79\\nSulpiride: XM7Z05\\nSultopride: XM9G21\\nTiapride: XM8KD4\\nRemoxipride: XM3WA3\\nAmisulpride: XM1DG3\\nLithium gluconate: XM0W09\\nLithium salts carbonate: XM5C35\\nAmperozide: XM4GQ2\\nAmphenidone: XM3JM5\\nAntipsychotic drug specified: XM7AA5\\nAzacyclonol: XM23M7\\nBenzperidine: XM56Y5\\nBenzperidol: XM9VY2\\nEnpiprazole: XM3KB9\\nHydroxyphenamate: XM9097\\nMebutamate: XM7EB1\\nMosapramine: XM88L2\\nNemonapride: XM7B44\\nOxanamide: XM5F36\\nPhenaglycodol: XM9799\\nProthipendyl: XM3BH3\\nRaclopride: XM7L04\\nSetoperone: XM7KX5\\nSpirilene: XM6YS4\\nTranquilizer carbamate: XM0ES8\\nTranquilizer hydroxyzine: XM7Z64\\nTranquilizer specified: XM3ES1\\nTranquilizer thioxanthene: XM0GN3\\nTybamate: XM06W2\\nZotepine: XM4EU4\\nRisperidone: XM1Z15\\nAripiprazole: XM67P4\\nPaliperidone: XM7H28\\nIloperidone: XM0FR9\\nCariprazine: XM1SS2\\nBrexpiprazole: XM8504\\nPimavanserin: XM0715\\nAmiflamine: XM3533\\nAntidepressant monoamine oxidase inhibitor: XM8CW9\\nClorgiline: XM9VZ7\\nIproclozide: XM2WY9\\nIproniazid: XM6DW5\\nIsocarboxazid: XM4T23\\nMebanazine: XM2K50\\nMonoamine oxidase inhibitor hydrazine: XM2GX9\\nMonoamine oxidase inhibitor: XM6944\\nNialamide: XM0158\\nParnate: XM3KZ3\\nPhenelzine: XM4S21\\nPheniprazine: XM4A50\\nSafrazine: XM96M0\\nTranylcypromine: XM1023\\nAntidepressant selective serotonin reuptake inhibitor: XM2NP3\\nCitalopram: XM6WT9\\nFemoxetine: XM24M0\\nFluoxetine: XM7LE6\\nFluvoxamine: XM64L1\\nIndalpine: XM5R26\\nParoxetine: XM3PJ6\\nZimeldine: XM6WB9\\nSertraline: XM5TZ9\\nAlaproclate: XM7ZN2\\nEtoperidone: XM4MF4\\nEscitalopram: XM7PX8\\nCianopramine: XM0HR7\\nAntidepressant selective serotonin norepinephrine reuptake inhibitor: XM0PE4\\nAntidepressant triazolopyridine: XM8D31\\nDuloxetine: XM10Q5\\nDesvenlafaxine: XM3KS5\\nMilnacipran: XM6J21\\nLevomilnacipran: XM17Z4\\nVenlafaxine: XM36V6\\nBifemelane: XM03J9\\nBupropion: XM03E6\\nDiclofensine: XM7U12\\nOther specified antidepressant: XM78C1\\nMianserin: XM0T46\\nMinaprine: XM5QV7\\nNomifensine: XM6X89\\nOxitriptan: XM6AP8\\nPrazitone: XM4WM9\\nThiazesim: XM0ST5\\nTianeptine: XM5DV5\\nViloxazine: XM5L45\\nTrazodone: XM62E7\\nMirtazapine: XM0B23\\nTryptophan: XM54Q7\\nNefazodone: XM85H1\\nOxaflozane: XM4ML8\\nMedifoxamine: XM80H8\\nPivagabine: XM4ZF1\\nReboxetine: XM70H2\\nGepirone: XM5KP8\\nAgomelatine: XM5F11\\nVilazodone: XM7T91\\nHyperici herba: XM4230\\nVortioxetine: XM0EP0\\nSerotonin: XM8FB6\\nMetapramine: XM0227\\nNonselective monoamine reuptake inhibitors: XM9KG1\\nDesipramine: XM6FC9\\nImipramine: XM6PZ9\\nClomipramine: XM76Z6\\nOpipramol: XM37K4\\nTrimipramine: XM9WZ5\\nLofepramine: XM7T42\\nDibenzepin: XM6H22\\nAmitriptyline: XM7BL0\\nNortriptyline: XM79G5\\nProtriptyline: XM2WA4\\nDoxepin: XM1LC7\\nIprindole: XM24M7\\nMelitracen: XM1575\\nButriptyline: XM8QA6\\nDosulepin: XM2T20\\nAmoxapine: XM8TQ9\\nAmineptine: XM1190\\nMaprotiline: XM41L8\\nQuinupramine: XM34S5\\nImipramine oxide: XM4SZ9\\nDimetacrine: XM3MV6\\nOxaprotiline: XM5RG3\\nNoxiptiline: XM7GY1\\nMonoamine oxidase A inhibitors: XM1UL5\\nMoclobemide: XM14X9\\nToloxatone: XM1TG1\\nCannabinoids: XM2PL7\\nNabilone: XM3UF9\\nTetrahydrocannabinol: XM4HM2\\nCannabidiol: XM5B55\\nDronabinol: XM1W83\\nHallucinogens: XM4SV9\\nPsilocin: XM5JH5\\nPsilocybin: XM7642\\nMescaline: XM0T53\\nAeruginascin: XM78V1\\nBufotenine: XM9WX3\\nNNDimethyltryptamine: XM9T61\\nLysergic acid amide: XM9CL3\\nPhencyclidine: XM5M84\\nMuscimol: XM50E4\\nIbotenic acid: XM1PJ8\\nSalvinorin A: XM5SB5\\nAmfetaminil: XM3C53\\nBenzedrine amphetamine: XM3E65\\nCentral nervous system stimulants amphetamines: XM1NA8\\nDexedrine: XM1WW4\\nDextroamphetamine: XM6LD5\\nEcstasy: XM07Y4\\nMethamphetamine: XM5B49\\nMethedrine: XM3WD9\\nMethylamphetamine: XM3Q37\\nPsychostimulant caffeine: XM9932\\nPsychostimulant amphetamine: XM6RB6\\nTenamfetamine: XM6V10\\nPsychostimulants ADHD and nootropic agents: XM12M9\\nCentrally acting sympathomimetics: XM7LR7\\nMethylphenidate: XM1NX2\\nPemoline: XM52S5\\nModafinil: XM75Z6\\nFenozolone: XM5921\\nAtomoxetine: XM9DQ5\\nDexmethylphenidate: XM5288\\nArmodafinil: XM3ZW9\\nEtryptamine: XM9FY1\\nLevopropylhexedrine: XM3K58\\nXanthine derivatives: XM2XU4\\nCaffeine: XM0NG8\\nPropentofylline: XM3Y68\\nMeclofenoxate: XM1SE2\\nNizofenone: XM8QG2\\nProlintane: XM84X9\\nPipradrol: XM8EX0\\nVinpocetine: XM8029\\nTipepidine: XM37E2\\nPyritinol: XM1LB1\\nPiracetam: XM5207\\nDeanol: XM3HZ4\\nFipexide: XM2AB6\\nCiticoline: XM5TT1\\nOxiracetam: XM5N75\\nPirisudanol: XM6EM2\\nLinopirdine: XM1MZ1\\nAniracetam: XM0Z60\\nAcetylcarnitine: XM77H2\\nIdebenone: XM5CY6\\nPramiracetam: XM59Z4\\nAdrafinil: XM3WZ9\\nMebicar: XM94C0\\nPhenibut: XM3J14\\nDeanol aceglumate: XM45U3\\nDiethyltryptamine DET: XM9DQ3\\nDimethyl tryptamine: XM6LV4\\nHawaiian Woodrose seeds: XM9438\\nHeavenly Blue morning glory: XM52J2\\nMagic mushroom: XM79N5\\nMescal buttons: XM0169\\nMorning glory seeds: XM32H5\\nPearly Gates morning glory seeds: XM4B51\\nPeyote: XM0QA2\\nYohimbic acid: XM0075\\nCannabinol: XM8E16\\nCentral nervous system depressants hallucinogenics: XM0XQ5\\nPsychodysleptic drug: XM31A7\\nPsychotomimetic agents: XM3Z58\\nHallucinogen: XM8X97\\nMegahallucinogen: XM7DW4\\nDiamorphine: XM05B3\\nMorphine morphine derivatives and metabolites: XM69R4\\nhydroxydihydromorphinone: XM39E2\\nAcemorphan: XM5CY8\\nBenzomorphan: XM0E25\\nBenzyl morphine: XM8YM7\\nBlue velvet: XM0BB1\\nDesomorphine: XM45R8\\nDihydromorphine: XM4T95\\nHydromorphinol: XM3473\\nHydromorphone: XM8SD7\\nMetopon: XM78E0\\nMorpholinylethylmorphine: XM7VL7\\nNicomorphine: XM7W06\\nNormorphine: XM9BE3\\nOxymorphone: XM64M0\\nMorphine: XM1KZ5\\nBenzylmorphine: XM0P98\\nMyrophine: XM7ZJ1\\nOpium: XM4ES0\\nOpium alkaloids total: XM2T93\\nOpium alkaloids standardized powdered: XM69X3\\nOpium alkaloids tincture camphorated: XM91H1\\nLaudanum: XM1EE2\\nPapaveretum: XM1YK2\\nParegoric: XM1LB8\\nOxycodone: XM4SL9\\nAcetyldihydrocodeinone: XM79K2\\nEucodal: XM7HX3\\nNalfurafine: XM9UH3\\nCodeine codeine derivatives and other opioids used in cough suppression: XM4587\\nAcetyldihydrocodeine: XM3DS6\\nAntitussive codeine mixture: XM05R0\\nCliradon: XM3YP8\\nDesocodeine: XM4046\\nDihydrocodeine: XM06K5\\nDihydroisocodeine: XM77C9\\nHycodan: XM9UN6\\nHydroxydihydrocodeinone: XM0YG5\\nPercodan: XM07U7\\nPiminodine: XM5NP7\\nEthylmorphine: XM3WN9\\nHydrocodone: XM8E09\\nNoscapine: XM6RX7\\nPholcodine: XM4QV7\\nDextromethorphan: XM9UV0\\nThebacon: XM2358\\nDimemorfan: XM7V96\\nNormethadone: XM5PZ4\\nMethadone methadone derivatives and other drugs used to treat opioid addictive disorders: XM1ZY9\\nMethadone: XM7XP1\\nLevoisomethadone: XM9RG7\\nOpioid anaesthetics: XM4MV8\\nAlfentanil: XM4G88\\nSufentanil: XM1EF3\\nAnileridine: XM7YQ6\\nRemifentanil: XM0YQ0\\nAntagonist narcotic analgesic: XM7TT0\\nCyclazocine: XM0850\\nLevallorphan: XM65J2\\nMorphine antagonist: XM4HP3\\nNaloxone: XM14T9\\nNaltrexone: XM2M16\\nNarcotic antagonist: XM9BM4\\nOpiate antagonists: XM5DJ2\\nMethylnaltrexone bromide: XM3TK0\\nAlvimopan: XM4GP3\\nNaloxegol: XM93Z3\\nOpioid antagonist: XM6KY8\\nOther opioid analgesics natural synthetic and semisynthetic: XM4S22\\nProdine: XM30T6\\nAntitussive opiate: XM9907\\nCough mixture containing opiates: XM6C31\\nDextrorphan: XM8ZF5\\nDifencloxazine: XM1K75\\nDipipanone: XM9SW6\\nDromoran: XM81P5\\nEptazocine: XM4EW3\\nEthoheptazine: XM6CK0\\nHeptalgin: XM35C1\\nLevodromoran: XM5F21\\nLevopropoxyphene: XM4P40\\nLevorphanol: XM1R71\\nMeperidine: XM0GS3\\nNarcotic synthetic: XM8PP7\\nNisentil: XM8MP5\\nOpioid: XM7S23\\nPhenadoxone: XM04Z5\\nPhenazocine: XM2542\\nPhenomorphan: XM9B34\\nPipadone: XM72D5\\nProfadol: XM39L3\\nPromedol: XM9AZ5\\nPropoxyphene: XM3E08\\nRacemoramide: XM6625\\nThebaine: XM8804\\nTilidine: XM09H6\\nTramadol: XM7KC0\\nViminol: XM5UK3\\nDiphenoxylate: XM9Y28\\nLoperamide: XM86N4\\nPhenylpiperidine derivatives: XM9NL3\\nKetobemidone: XM9HP7\\nFentanyl: XM76M8\\nDiphenylpropylamine derivatives: XM8286\\nDextromoramide: XM3246\\nPiritramide: XM55Z5\\nDextropropoxyphene: XM8GB8\\nBezitramide: XM5GN5\\nBenzomorphan derivatives: XM1QE0\\nPentazocine: XM9K14\\nMorphinan derivatives: XM09R6\\nButorphanol: XM1682\\nNalbuphine: XM4P05\\nBuprenorphine: XM9Z94\\nEtorphine: XM02X7\\nAcetorphine: XM3PK7\\nPhenoperidine: XM0K66\\nMeptazinol: XM40T9\\nDrotebanol: XM0GU8\\nLoperamide oxide: XM7VK6\\nDezocine: XM13Q9\\nTapentadol: XM25Z3\\nOliceridine: XM1G85\\nNalmefene: XM4PD9\\nDifelikefalin: XM4M74\\nCatha edulis tea: XM0VG7\\nKhat: XM0238\\nCentral nervous system stimulants not elsewhere classified: XM3GQ0\\nCerebral stimulants psychotherapeutic: XM0854\\nCerebral stimulants: XM93X4\\nStimulant central nervous system psychotherapeutic: XM7125\\nInhaled anaesthetics: XM8T75\\nEthers: XM4VX3\\nDiethyl ether: XM3J00\\nVinyl ether: XM7UB3\\nHalogenated hydrocarbons: XM0TE1\\nHalothane: XM2FH0\\nChloroform: XM7MX5\\nChloroform vapor: XM1GP5\\nEnflurane: XM35M6\\nTrichloroethylene anaesthetic gas: XM1E91\\nIsoflurane: XM9HY9\\nAnaesthesia endotracheal: XM0ZA2\\nAnaesthetic gaseous: XM05Z8\\nAnaesthetic halogenated hydrocarbon derivatives: XM8V73\\nCentral nervous system depressants anaesthetic gases: XM5UK1\\nChloroform anaesthetic: XM42D4\\nChloroform water concentrated: XM2DK4\\nDivinyl ether: XM9TE3\\nEthyl bromide anaesthetic: XM3EA4\\nEthyl chloride anaesthetic: XM2D90\\nEthylene anaesthetic: XM6WF0\\nFluroxene: XM9K99\\nNitrous oxide: XM73B5\\nTrifluoroethyl vinyl ether: XM9NP2\\nVinesthene: XM7Q24\\nDesflurane: XM1C44\\nSevoflurane: XM07G7\\nXenon: XM8X62\\nIntravenous anaesthetics: XM7D47\\nAlphadolone: XM14F2\\nAlfaxalone: XM4PF7\\nBarbiturate anaesthetic intravenous: XM59B1\\nBrevital sodium: XM9CB4\\nButhalitone sodium: XM6LE6\\nButyl thiobarbital sodium: XM5K69\\nCentral nervous system depressants anaesthetic intravenous: XM9SR9\\nEtomidate: XM5MB2\\nEvipal sodium: XM93E9\\nSernyl: XM5ZF4\\nThialbarbital: XM4XN0\\nThiamylal: XM66H8\\nThiamylal sodium: XM8UK0\\nThiobarbital sodium: XM4NL3\\nThiobarbiturate anaesthetic: XM1QW9\\nThiobutabarbital sodium: XM72F2\\nMethohexital: XM7JR4\\nHexobarbital: XM08U4\\nThiopental sodium: XM0EL8\\nKetamine: XM7C11\\nPropanidid: XM4BS0\\nPropofol: XM1903\\nEsketamine: XM2W08\\nCyclopropane: XM7T11\\nGammahydroxybutyrate: XM9MS5\\nHexobarbital rectal: XM5C03\\nMinaxolone: XM20X3\\nTiletamine: XM2MR8\\nTribromoethanol rectal: XM8DR0\\nLocal anaesthetics: XM7Y85\\nAmylocaine regional: XM1FJ6\\nAmylocaine regional infiltration: XM1H49\\nAmylocaine regional nerve block: XM7CH6\\nAmylocaine regional spinal: XM37J6\\nAmylocaine regional topical: XM5JY6\\nAnaesthesia caudal: XM5R82\\nAnaesthesia epidural: XM8MY3\\nAnaesthesia mucosal: XM25C7\\nAnesthesia rectal local: XM0D14\\nAnesthesia regional: XM0FJ3\\nAnaesthetic infiltration: XM0LM0\\nAnaesthetic spinal: XM7EC3\\nAnesthetic topical: XM8E23\\nAnaesthetic with local muscle relaxant: XM3S41\\nAptocaine: XM5ZK7\\nArticaine: XM52S4\\nBenzamine: XM4YN0\\nBenzocaine: XM8KD9\\nBetoxycaine: XM1604\\nBupivacaine: XM5YL1\\nBupivacaine infiltration: XM7WQ7\\nBupivacaine nerve block: XM4216\\nBupivacaine spinal: XM46M2\\nButacaine: XM3781\\nButamben: XM7MD5\\nButanilicaine: XM9VA7\\nButyl aminobenzoate: XM0HA0\\nButyn: XM5NW5\\nCarbocaine infiltration: XM2YU2\\nCarbocaine nerve block: XM8C65\\nCarbocaine topical: XM2DT1\\nChloroprocaine: XM6HZ0\\nChloroprocaine infiltration: XM8XD3\\nChloroprocaine nerve block: XM0GC2\\nChloroprocaine spinal: XM94U2\\nCinchocaine: XM0L28\\nCinchocaine topical: XM5Y10\\nCyclaine: XM7FD6\\nCyclomethycaine: XM41W7\\nDimethocaine: XM3BB4\\nDiperodon: XM8UZ3\\nDorsacaine: XM23R3\\nDyclone: XM5601\\nDyclonine: XM3QB4\\nEndocaine: XM20M0\\nEPAB: XM0P92\\nEthocaine infiltration: XM2H77\\nEthocaine nerve block: XM6585\\nEthocaine spinal: XM7217\\nEthyl aminobenzoate: XM1WJ3\\nEthyl chloride local anaesthetic: XM87H9\\nEtidocaine: XM8X57\\nEtidocaine infiltration: XM8013\\nEtidocaine nerve block: XM8RU6\\nEucaine: XM2F20\\nHexylcaine: XM76M6\\nLeucinocaine: XM5863\\nMepivacaine: XM1MK4\\nMepivacaine epidural: XM0EH7\\nMeprylcaine: XM9DE9\\nMetabutethamine: XM7CG8\\nNesacaine: XM68T6\\nNesacaine infiltration: XM6AA0\\nNesacaine nerve block: XM4148\\nNovocain infiltration: XM38C9\\nNovocain topical: XM6R58\\nNupercaine spinal: XM6NN7\\nNupercaine topical: XM8739\\nOrthocaine: XM0QU2\\nOxetacaine: XM5HP0\\nOxethazine: XM6V01\\nOxybuprocaine: XM6RN9\\nPercaine spinal: XM7H65\\nPercaine topical: XM7EK6\\nPhenacaine: XM6Z26\\nPiperocaine: XM2ZH3\\nPiperocaine infiltration: XM7UW6\\nPiperocaine nerve block: XM8J09\\nPiperocaine topical: XM40M8\\nPitkins solution: XM8AE6\\nPrilocaine: XM2X66\\nPrilocaine infiltration: XM9NH0\\nPrilocaine nerve block: XM85Q7\\nPrilocaine regional: XM4EE1\\nProcaine: XM5L66\\nProcaine nerve block: XM05Z5\\nProcaine regional: XM1CG3\\nProcaine spinal: XM8KS3\\nProparacaine: XM97J9\\nPropoxycaine: XM72A2\\nPropoxycaine infiltration: XM9BY7\\nPropoxycaine nerve block: XM2DT4\\nPropoxycaine topical: XM0BG4\\nQuotane: XM87E0\\nStovaine: XM2MX6\\nStovaine infiltration: XM79W4\\nStovaine nerve block: XM08B5\\nStovaine spinal: XM9657\\nStovaine topical: XM3MW8\\nSurfacaine: XM6392\\nTetracaine: XM1HW1\\nTetracaine nerve block: XM32E4\\nTetracaine regional: XM9H96\\nTetracaine spinal: XM9CQ9\\nTrimecaine: XM3QD1\\nTronothane: XM2FR2\\nXylocaine infiltration: XM7771\\nXylocaine nerve block: XM18M2\\nXylocaine spinal: XM5K48\\nXylocaine topical: XM5G11\\nAlprazolam: XM1030\\nBentazepam: XM4R58\\nBenzodiapin: XM2GL0\\nBromazepam: XM9JC7\\nBrotizolam: XM2S43\\nCamazepam: XM5133\\nCarpipramine: XM9S41\\nCentral nervous system depressants benzodiazepines: XM1J81\\nChlordiazepoxide: XM5JC4\\nClobazam: XM43U0\\nDipotassium clorazepate: XM3C29\\nClotiazepam: XM0A75\\nCloxazolam: XM5M11\\nDelorazepam: XM0GD3\\nDiazepam: XM8P99\\nEstazolam: XM9YX9\\nEthyl loflazepate: XM54N1\\nEtizolam: XM9DN9\\nFludiazepam: XM8NC2\\nFlunitrazepam: XM9W71\\nFlurazepam: XM73H1\\nFlutazolam: XM68Z6\\nFlutoprazepam: XM81V7\\nHalazepam: XM3FR2\\nHaloxazolam: XM86G3\\nKetazolam: XM5WE7\\nLoprazolam: XM6KW2\\nLorazepam: XM85H7\\nLormetazepam: XM1EE3\\nMedazepam: XM9KN4\\nMexazolam: XM7QC1\\nMidazolam: XM9PG6\\nNimetazepam: XM8TH1\\nNitrazepam: XM4TR7\\nNordazepam: XM4FQ9\\nOxazepam: XM1A29\\nOxazolam: XM62U2\\nPerlapine: XM3LR9\\nPinazepam: XM0GW7\\nPrazepam: XM4M86\\nQuazepam: XM42F4\\nTemazepam: XM3215\\nTofisopam: XM79N8\\nTranquilizer benzodiazepine: XM9X46\\nTriazolam: XM1VC3\\nPotassium clorazepate: XM36R8\\nAdinazolam: XM94Z2\\nDoxefazepam: XM66N4\\nCinolazepam: XM4BU2\\nDiphenylmethane derivatives: XM8CM3\\nHydroxyzine: XM8CV8\\nCaptodiame: XM70L1\\nCarbamates: XM96H3\\nMeprobamate: XM3MX1\\nEmylcamate: XM8G67\\nAldehydes and derivatives: XM3XU7\\nChloral hydrate: XM8AH5\\nChloralodol: XM8D85\\nParacetaldehyde: XM0ZC2\\nAcetylglycinamide chloral hydrate: XM46J8\\nDichloralphenazone: XM9V32\\nCinnamaldehyde: XM0V58\\nHexyl cinnamal: XM37U9\\nAmyl cinnamal: XM5TZ2\\nButylchloral hydrate: XM9J50\\nPiperidinedione derivatives: XM6R00\\nGlutethimide: XM5S80\\nMethyprylon: XM2MN1\\nPyrithyldione: XM2MC9\\nBarbiturates and derivatives: XM4YG0\\nNarcobarbital: XM3Z73\\nPentobarbital: XM01Z3\\nAmobarbital: XM01F5\\nButobarbital: XM8TB8\\nBarbital: XM2B90\\nSecobarbital: XM6QG0\\nTalbutal: XM28V1\\nVinylbital: XM6NX3\\nVinbarbital: XM9VX7\\nCyclobarbital: XM89L9\\nHeptabarbital: XM7ZK9\\nAllobarbital: XM8FN0\\nProxibarbal: XM8C15\\nMethylphenobarbital: XM60H4\\nPhenobarbital: XM2605\\nPrimidone: XM5J41\\nBarbexaclone: XM45T7\\nMetharbital: XM64T5\\nReposal: XM1ZM1\\nEtallobarbital: XM1WN6\\nAprobarbital: XM8YV1\\nBrallobarbital: XM50Q3\\nButalbital: XM3UQ5\\nButallylonal: XM6XH1\\nDifebarbamate: XM4C65\\nMethobarbital methobarbitone: XM8DQ9\\nNealbarbital: XM3YG4\\nProbarbital: XM6F85\\nPropallylonal: XM37N4\\nSecbutabarbital: XM81J9\\nZdrugs: XM4843\\nZopiclone: XM8LM1\\nZolpidem: XM8188\\nzaleplon: XM0UU3\\nEszopiclone: XM4DP1\\nMelatonin receptor agonists: XM0GA0\\nMelatonin: XM7R38\\nRamelteon: XM4Y11\\nTasimelteon: XM0DX1\\nBromide salts: XM93J2\\nAcecarbromal: XM5V35\\nBromisoval: XM3260\\nBromoform: XM7XH5\\nCarbromal: XM68H5\\nAcetylpheneturide: XM4JD8\\nAllylisopropylacetylurea: XM0Y74\\nAllyltribromide: XM2MT0\\nAmmonium bromide: XM0FX2\\nAnticonvulsant hypnotic: XM2P06\\nAnticonvulsant pyrimidinedione: XM4LR0\\nAnticonvulsant specified: XM80V1\\nApronal: XM2851\\nAvomine: XM8WF0\\nBetaChlor: XM34M8\\nBromal hydrate: XM2S35\\nBromine compounds medicinal: XM16D8\\nBromine sedative: XM0JD2\\nBromisovalum: XM14P7\\nBromural: XM0L99\\nCalcium bromide: XM7Q19\\nBromides: XM44G1\\nCentral nervous system depressants chloral hydrate: XM6Z70\\nCentral nervous system depressants hypnotics specified: XM4A26\\nCentral nervous system depressants paraldehyde: XM0MP0\\nChloral derivative: XM2PX1\\nChloralamide: XM5HQ1\\nChloretone: XM1XU2\\nChlorhexadol: XM7N56\\nClomethiazole: XM7GE6\\nCroton chloral: XM58S5\\nDiethylsulfonediethylmethane: XM1L51\\nDivalproex: XM5P16\\nDoriden: XM2ML0\\nDormison: XM0YS0\\nEctylurea: XM76A5\\nEthchlorvynol: XM4SW2\\nEthinamate: XM8HM5\\nEtifoxine: XM0959\\nHexapropymate: XM5084\\nHypnotic drug specified: XM3GR8\\nLactuca virosa extract: XM1H40\\nLactucarium: XM7EA2\\nLettuce opium: XM2447\\nLevanil: XM1SJ9\\nLevoprome: XM9S20\\nMethaqualone: XM3C52\\nMethyl sulfonal: XM8UW8\\nMethylpentynol: XM79Y3\\nNiaprazine: XM9L86\\nNoludar: XM67F2\\nPericlor: XM41Z4\\nPetrichloral: XM7865\\nPhenergan: XM8U36\\nPotassium bromide: XM3YQ0\\nPropionaldehyde medicinal: XM23J2\\nQuaalude: XM5KU5\\nSedative mixed: XM5YQ4\\nSedormid: XM53R6\\nSerenesil: XM5BF2\\nSodium bromide: XM8SU3\\nSodium valproate: XM9F88\\nSomnos: XM4ZG6\\nSopor: XM1BT3\\nSoporific drug specified type: XM2N03\\nSulfonal: XM81Z5\\nSulfonethylmethane: XM9QV2\\nSulfonmethane: XM4YF8\\nTetronal: XM8296\\nTranquilizer with hypnotic or sedative: XM6WP4\\nTribromacetaldehyde: XM9XF5\\nTrichloroethanol: XM1DU6\\nTrichloroethyl phosphate: XM4236\\nTriclofos: XM68E8\\nTrional: XM2334\\nTriple bromides: XM16S3\\nValerian root: XM3PP3\\nValerian tincture: XM0MV0\\nValmid: XM1WZ4\\nValnoctamide: XM2TP4\\nWelldorm: XM2AQ9\\nBuspirone: XM1ZF1\\nMephenoxalone: XM01J5\\nPropiomazine: XM9TL2\\nSodium oxybate: XM15N4\\nBenzoctamine: XM3EH5\\nGedocarnil: XM9727\\nFabomotizole: XM5928\\nLavandulae aetheroleum: XM4DF5\\nValerianae radix: XM8488\\nSuvorexant: XM2HN6\\nDipiperonylaminoethanol: XM2AY7\\nLemborexant: XM9235\\nHexethal sodium: XM1VL2\\nMephebarbital: XM7MG1\\nMethitural: XM0217\\nAlcohol deterrent: XM3XY4\\nAntabuse: XM2XV6\\nAntidote: XM1S43\\nChelating agent: XM65Y8\\nCholinesterase reactivator: XM68U2\\nCysteamine: XM81B1\\nDetoxifying agent: XM9M46\\nDisodium edetate: XM0ZM0\\nEDTA: XM1V56\\nPhytic acid nonasodium: XM0FL5\\nGlutathione: XM7SW5\\nMethylthioninium chloride: XM1YY3\\nNitrefazole: XM7Z31\\nObidoxime chloride: XM7HV6\\nPralidoxime: XM2ZD4\\nPotassium ferric hexacyanoferrate medicinal: XM6TE9\\nPralidoxime iodide: XM7K47\\nPralidoxime chloride: XM6BZ5\\nPrussian blue therapeutic: XM8P25\\nPyridine aldoxime methiodide: XM6DU2\\nPyridine aldoxime methyl chloride: XM6043\\nSodium nitrite: XM3810\\nSodium phytate: XM7LV6\\nThiosulfate: XM6NW5\\nSodium versenate: XM2KC9\\nTetraethylthiuram disulfide: XM99S5\\nTrientine: XM6GP9\\nTrisodium hydrogen edetate: XM2U68\\nVersenate: XM7KV3\\nNalorphine: XM4UW9\\nDimercaprol: XM89R9\\nPotassium iodide: XM1260\\nAcetylcysteine: XM7372\\nMethionine: XM5MC0\\nUridine triacetate: XM28B1\\nEdetates: XM0588\\nPrednisolone and Promethazine: XM5VJ5\\nObidoxime: XM8ET8\\nProtamine: XM2GR4\\nCopper sulfate: XM4JM7\\nDigitalis antitoxin: XM9AD6\\nFlumazenil: XM2UQ5\\ndimethylaminophenol: XM2H17\\nCholinesterase: XM8ZA0\\nPrussian blue: XM62Q3\\nFomepizole: XM7LQ9\\nSugammadex: XM9NQ8\\nIdarucizumab: XM0666\\nAndexanet alfa: XM01C9\\nDeferoxamine: XM5A41\\nDeferiprone: XM03A5\\nDeferasirox: XM12X8\\nPolystyrene sulfonate: XM3B07\\nFerric citrate: XM8NS1\\nSodium phosphate cellulose: XM1AY3\\nSevelamer: XM6Q80\\nLanthanum carbonate: XM22K8\\nCalcium acetate and Magnesium carbonate: XM4MP9\\nSucroferric oxyhydroxide: XM9188\\nColestilan: XM4C26\\nMesna: XM1JB5\\nCalcium folinate: XM7BJ9\\nDexrazoxane: XM45R5\\nCalcium levofolinate: XM2852\\nAmifostine: XM5GF2\\nSodium folinate: XM61A6\\nRasburicase: XM4NB1\\nPalifermin: XM8J47\\nGlucarpidase: XM8L87\\nSodium levofolinate: XM1EU2\\nArginine and Lysine: XM0MC0\\nTrilaciclib: XM7PK0\\nAfamelanotide: XM0LA6\\nCanthaxanthin: XM8337\\nRetinoids: XM3GF4\\nEtretinate: XM0Z07\\nAcitretin: XM2M63\\nTrioxysalen: XM4RP3\\nMethoxsalen: XM47G3\\nBergapten: XM1G69\\nFumaric acid: XM7WA3\\nIsotretinoin: XM98J9\\nIchtasol: XM9FP6\\nCoccidioidin: XM4CF3\\nCongo red: XM1V31\\nEvans blue: XM34X2\\nFluorescein: XM5618\\nHistoplasmin: XM3Y60\\nIndocyanine green: XM2818\\nLymphogranuloma venereum antigen: XM3WZ1\\nMumps skin test antigen: XM1VN8\\nPenicilloyl polylysine: XM3Q40\\nSodium metrizoate: XM36R6\\nSulfonphthalein sulfonphthol: XM1QL6\\nSulkowitchs reagent: XM8478\\nToxin diphtheria Schick Test: XM4DA3\\nTuberculin purified protein derivative PPD: XM0EK6\\nGlucose: XM6XX8\\nSincalide: XM53M3\\nCeruletide: XM0D92\\nMetyrapone: XM5GR6\\nSomatorelin: XM7E13\\nCorticorelin: XM1UJ0\\nMacimorelin: XM5AM6\\nTests for liver functional capacity: XM60V4\\nGalactose: XM9ZW8\\nSulfobromophthalein: XM1XE0\\nMethacetin C: XM0N95\\nIprofenin: XM90L9\\nLidofenin: XM3114\\nRose bengal sodium i: XM2PX0\\nTests for gastric secretion: XM9H30\\nCation exchange resin: XM44K8\\nBetazole: XM1MP2\\nHistamine phosphate: XM1286\\nPentagastrin: XM9AU1\\nCaffeine and Sodium benzoate: XM1Q27\\nAzuresin: XM1F97\\nTests for renal function and ureteral injuries: XM4E68\\nIndigo carmine: XM9RK1\\nAlsactide: XM3G67\\nAminohippuric acid: XM27H8\\nSodium paraaminohippurate: XM87Y9\\nInulin and other polyfructosans: XM2JZ2\\nPhenolsulfonphthalein: XM7M20\\nTests for thyroid function: XM0N07\\nProtirelin: XM7R30\\nTests for pancreatic function: XM76Z9\\nSecretin: XM3L99\\nBentiromide: XM7A79\\nPancreozymincholecystokinin: XM6014\\nSelenomethionine Se: XM24K5\\nEdrophonium: XM8B05\\nMethacholine: XM3YJ9\\nFructose: XM5K20\\nVitamin A concentrates: XM9258\\nTuberculin: XM7PF6\\nCurea: XM9QZ5\\nHexaminolevulinate: XM0UW4\\nPatent blue: XM02S2\\nBromophenol blue reagent: XM9Y95\\nDiacetyl monoxime: XM5PT0\\nGuaiac reagent: XM8M78\\nOxalic acid ammonium salt: XM3385\\nPhenaphthazine reagent: XM74W0\\nOxygen: XM4SZ3\\nCarbon dioxide medicinal: XM6NZ1\\nNitrogen: XM3K31\\nMedical air: XM7EZ9\\nXray contrast media iodinated: XM2S71\\nWatersoluble nephrotropic high osmolar Xray contrast media: XM7YS2\\nMetrizoic acid: XM7PH4\\nIodamide: XM6583\\nIotalamic acid: XM8XV8\\nIoxitalamic acid: XM34M9\\nAcetrizoic acid: XM50Y6\\nIocarmic acid: XM7ZV2\\nDiodone: XM2DC4\\nDiatrizoic acid: XM8KK9\\nIoglicic acid: XM50U3\\nMethiodal: XM9C52\\nWatersoluble nephrotropic low osmolar Xray contrast media: XM4AG5\\nMetrizamide: XM3WB6\\nIohexol: XM3R65\\nIoxaglic acid: XM5EP5\\nIopamidol: XM8C50\\nIopromide: XM4UK7\\nIotrolan: XM8VT7\\nIotroxic acid: XM5LW4\\nIopentol: XM6227\\nIodixanol: XM8NA7\\nIomeprol: XM75B4\\nIobitridol: XM79B6\\nIoxilan: XM6VV1\\nWatersoluble hepatotropic Xray contrast media: XM0KA6\\nIodoxamic acid: XM2VE6\\nIoglycamic acid: XM8411\\nAdipiodone: XM7QU5\\nIobenzamic acid: XM1QH8\\nIopanoic acid: XM2NU7\\nIocetamic acid: XM8PW2\\nSodium iopodate: XM4ZU7\\nTyropanoic acid: XM8WD0\\nCalcium iopodate: XM6TF5\\nNonwatersoluble Xray contrast media: XM0LK3\\nIopydol: XM1AX3\\nPropyliodone: XM1YV8\\nIofendylate: XM1R87\\nEthyl esters of iodised fatty acids: XM6SE3\\nDiatrizoate: XM6XU2\\nIodophthalein sodium: XM8QZ2\\nAmidotrizoate: XM0L44\\nBunamiodyl: XM80W7\\nIodipamide: XM5NA9\\nIodohippuric acid: XM4E01\\nIophenoic acid: XM9402\\nIopodic acid: XM7S30\\nIotroxate: XM4R74\\nIoxaglate: XM44B9\\nMethiodal sodium: XM5N73\\nPhenobutiodil: XM96Q8\\nThorium dioxide suspension: XM3E15\\nTyropanoate: XM90A9\\nBarium sulfate with suspending agents: XM2MR0\\nBarium sulfate without suspending agents: XM1FW7\\nMagnetic resonance imaging contrast media: XM05Z9\\nParamagnetic contrast media: XM2LS2\\nGadopentetic acid: XM7CY5\\nGadoteric acid: XM4UX1\\nGadodiamide: XM1564\\nGadoteridol: XM0FN2\\nMangafodipir: XM73Z5\\nGadoversetamide: XM3BF7\\nFerric ammonium citrate: XM29E1\\nGadobenic acid: XM0XE4\\nGadobutrol: XM3VG2\\nGadoxetic acid: XM7W85\\nGadofosveset: XM6GF6\\nSuperparamagnetic contrast media: XM8966\\nferumoxsil: XM33C2\\nferristene: XM84N5\\niron oxide nanoparticles: XM2945\\nPerflubron: XM2666\\nUltrasound contrast media: XM5TN4\\nMicrospheres of human albumin: XM40N1\\nMicroparticles of galactose: XM3PF3\\nPerflenapent: XM7S16\\nMicrospheres of phospholipids: XM4VR4\\nSulfur hexafluoride: XM8169\\nPerflubutane polymer microspheres: XM8G80\\nDiagnostic radiopharmaceuticals: XM9320\\nTechnetium mTc compounds: XM8ZM1\\nSodium pertechnetate Tcm: XM5VK7\\nIodine I compounds: XM9YB1\\nsodium iodide i: XM2R88\\nRubidium chloride Rb: XM6941\\nGallium citrate: XM3GL6\\nGallium Ga citrate: XM8SB4\\nFludeoxyglucose F: XM3WK3\\nIodocholesterol I: XM4ML0\\nXenon Xe gas: XM6Z69\\nXenon xe: XM6EQ3\\nSodium iodide I: XM1899\\nMaternal antibodies: XM9F18\\nferric Fe citrate: XM3HU5\\nSodium iodohippurate I: XM0RB0\\nIobenguane I: XM1QL4\\nFluoroethylLtyrosine F: XM6UT0\\nFluoroestradiol F: XM80F7\\nFluciclovine F: XM5G08\\nFluorodopa F: XM3LK2\\nFluoromethylcholine F: XM1N90\\nFluoroethylcholine F: XM5XR7\\nGallium Ga edotreotide: XM5EC5\\nCobalt Co cyanocobalamine: XM8YZ3\\nTauroselcholic acid: XM5FA9\\nSelenium Se norcholesterol: XM42A5\\nIodinated i human serum albumin: XM2MJ2\\nIodine: XM8YZ7\\nSodium iothalamate I: XM15W7\\nAmmonia N: XM5674\\nGallium Ga gozetotide: XM05N6\\nTherapeutic radiopharmaceuticals: XM45C8\\nSodium iodide I therapeutic: XM6RC9\\nIsoaminile citrate: XM01S1\\nAntimonic sulfide: XM9XW5\\nYttrium Y ferrihydroxide colloid: XM8Z31\\nSamarium Sm hydroxyapatite colloid: XM0JJ4\\nDysprosium Dy colloid: XM56F9\\nYttrium Y citrate colloid: XM10B1\\nErbium Er citrate colloid: XM3MD6\\nAmylene dichloride: XM5ZE8\\nEthiodized oil  i: XM1WG6\\nIodine I omburtamab: XM7MV3\\nbeucaine: XM32B6\\nBenzamine lactate: XM79Q0\\nCoal tar: XM8MM9\\nEthersoluble tar distillate: XM96H7\\nJuniper tar: XM6PP6\\nPhenol medicinal: XM8YS8\\nPhenolic preparation: XM96T6\\nPramoxine: XM8485\\nQuinisocaine: XM6A20\\nTar distillate: XM8W74\\nTar ointment: XM8WM2\\nTolpropamine: XM4543\\nMepyramine topical: XM2833\\nDiphenhydramine methylbromide: XM29P8\\nThonzylamine topical: XM9UN5\\nThenalidine topical: XM7JY5\\nPromethazine topical: XM6WM2\\nAcetic acid with sodium acetate ointment: XM4B01\\nAcrylic resin: XM7MV6\\nAllylthiourea: XM8U60\\nAluminium aluminum ointment surgical topical: XM06X6\\nAminobenzoic acid p: XM1S82\\nArachis oil: XM3VB3\\nBarrier cream: XM8SU9\\nBentonite: XM5L08\\nBenzophenones: XM7D95\\nBenzophenone: XM4DT5\\nBetula oil: XM08U7\\nCalamine lotion: XM7K00\\nCellulose nitrates topical: XM2EP3\\nChlordiethyl benzamide: XM9ZA9\\nCold cream: XM88R8\\nCorn starch: XM7033\\nCornhuskers lotion: XM38M3\\nCottonseed oil: XM8P34\\nDemulcent external: XM5PK1\\nDiethyl toluamide medicinal: XM0XB3\\nDimethyl phthalate: XM9U76\\nFlaxseed medicinal: XM8KY4\\nHomosalate: XM6694\\nHydrophilic lotion: XM8M74\\nLanolin: XM8WH4\\nLanolin alcohol: XM4HE0\\nMecrilate: XM7TK2\\nMelanizing agents: XM7VP7\\nMexenone: XM8EY7\\nMineral oil topical: XM9TZ7\\nOctafonium chloride: XM3214\\nOil wintergreen bitter: XM66S8\\nMethoxsalen topical: XM9CQ4\\nPadimate: XM0VT0\\nParaaminobenzoic acid: XM9AG3\\nPeanut oil topical: XM1U48\\nPetrolatum: XM8PB6\\nPlaster dressing: XM8J96\\nPlastic dressing: XM9V04\\nPolyethylene adhesive: XM2BL7\\nProtectant skin: XM6J14\\nPyroxylin: XM9VE3\\nRose water ointment: XM8293\\nSilicone medicinal: XM06Y2\\nTopical sunscreen: XM9410\\nSulisobenzone: XM4YA6\\nSweet oil birch: XM7YQ8\\nTalcum: XM3599\\nThiosinamine: XM3MF9\\nTitanium dioxide: XM7Q94\\nTitanium oxide: XM6WX7\\nUltraviolet light protectants: XM5E39\\nDiethylaminohydroxybenzoylbenzoic acid hexylester: XM4D35\\nMethylenebisbenzotriazolyltetramethylbutylphenol: XM8A13\\nPhenylbenzimidazolsulfonic acid: XM6UT3\\nTrianilinopcarboethylhexyloxitriazine: XM65Q8\\nUnnas boot: XM5PP3\\nZinc gelatin: XM8H46\\nZinc oxide: XM7RG9\\nZinc stearate: XM4NT3\\nColophonium: XM8YJ6\\nSorbitan sesquioleate: XM1LY7\\nOctinoxate: XM2M34\\nHyaluronic acid topical: XM2F87\\nCetomacrogol: XM90Q0\\nEtofenamate: XM8N69\\nFluoride medicinal dental use: XM85Z1\\nStannous fluoride: XM9RB7\\nBismuth salts formic iodide: XM60N7\\nCadexomer: XM0DJ3\\nDiiodohydroxypropane: XM12P7\\nDiiodohydroxyquin topical: XM8UZ7\\nIodide: XM0809\\nIodide mercury ointment: XM8C24\\nIodide methylate: XM3Q63\\nIodochlorhydroxyquin topical: XM6TG8\\nIodoform: XM3X72\\nPotassium iodate: XM58X1\\nPovidone iodine: XM24J7\\nAllantoin: XM9ZS1\\nAlum medicinal: XM7H25\\nAmmonium ichthyosulfonate: XM2GV6\\nAmmonium persulfate: XM8RR9\\nAnthralin: XM8HL4\\nAntiseborrheics: XM8SX1\\nButantrone: XM8GU1\\nCade oil: XM4FV2\\nCadmium sulfide medicinal: XM2ST0\\nCapsicum: XM9TT3\\nCarbon dioxide snow: XM4AW0\\nChlorothymol: XM01Q7\\nChloroxine: XM92H5\\nChrysarobin: XM7HY4\\nCoal tar medicinal ointment: XM3P37\\nCollagenase topical: XM3LD7\\nCorn cures: XM7PM1\\nDepilatory: XM5W78\\nDiachylon plaster: XM95C8\\nDimethyl sulfoxide medicinal: XM64V2\\nDimethylamine sulfate: XM26P0\\nDithranol: XM8RS8\\nEnzyme proteolytic: XM17Y7\\nEthyl chloride local: XM3JC8\\nEthyl fumarate: XM4P92\\nEuresol: XM7WC9\\nHair dye: XM7VL9\\nHemostyptic: XM8GV4\\nIsopropyl alcohol medicinal: XM7KM8\\nKeratolytic drug anthracene: XM6ES1\\nKeratolytic drug: XM23V5\\nKeratoplastic: XM4KL1\\nLassars paste: XM76E0\\nMethyl nicotinate: XM1VX5\\nMonobenzone: XM8N27\\nPyrithione zinc: XM6YQ8\\nResorcin resorcinol medicinal: XM4549\\nRubefacient: XM5DQ2\\nSalicylic acid: XM68B5\\nSavin oil: XM02N6\\nSelenium sulfide: XM43T8\\nSelsun: XM1UK4\\nSilver nitrate toughened keratolytic: XM3E07\\nSulfur compounds not elsewhere classified medicinal: XM1FW6\\nSulfur keratolytic ointment: XM6ZA6\\nThioglycolate: XM1W96\\nTioxolone: XM7GY2\\nTriacetoxyanthracene: XM4ZP4\\nTrichloroacetic acid medicinal: XM6U21\\nVleminckxs solution: XM2V83\\nWhite lotion keratolytic: XM6T99\\nXenysalate: XM25J6\\nGlyceryl monothioglycolate: XM7AM5\\npToluenediamine: XM5L79\\nAdrenal ophthalmic preparation: XM75W8\\nAmmonium acid tartrate: XM6H73\\nAntiinfective ophthalmic preparation: XM6G79\\nAnticholinesterase reversible ophthalmological: XM5568\\nBefunolol: XM5T83\\nBibrocathol: XM6NB7\\nChymotrypsin ophthalmic preparation: XM32H1\\nColistin sulfate eye preparation: XM6E41\\nContact lens solution: XM1WZ1\\nCopper sulfate cupric medicinal eye: XM3X79\\nCycloplegic drug: XM3918\\nDemecarium bromide: XM8S71\\nDendrid: XM1X30\\nDipivefrine: XM0L12\\nEchothiophate: XM17P1\\nEcothiopate iodide: XM7K14\\nEdoxudine: XM09W6\\nEucatropine: XM8PJ6\\nFluorphenylalanine: XM45L3\\nHerplex: XM1783\\nHydroxyamphetamine: XM9EN3\\nHypromellose: XM9E72\\nLachesine: XM0PE3\\nLevobunolol: XM8098\\nMethylparaben ophthalmic: XM4QZ9\\nMetipranolol: XM0YH4\\nMiotic drug: XM2JE0\\nMycitracin ophthalmic preparation: XM4DY8\\nMydriatic drug: XM5PU9\\nNeosporin ophthalmic preparation: XM28C3\\nPhospholine: XM4PY4\\nPhysostigmine: XM4605\\nPolymyxin E sulfate eye preparation: XM9N59\\nPropylparaben ophthalmic: XM2WK3\\nSilver protein: XM56H1\\nSodium borate cleanser eye: XM7AV0\\nStoxil: XM6Q18\\nSulfisoxazole ophthalmic preparation: XM8A14\\nSulfonamide eye: XM9PG5\\nTear solution: XM61C9\\nTetrahydrozoline: XM5RC2\\nVisine: XM31C8\\nAcetazolamide: XM9X81\\nDichlorphenamide: XM4LU1\\nEthoxzolamide: XM4DH5\\nMethazolamide: XM8P33\\nPemirolast: XM3ZJ4\\nPicloxydine: XM2JR8\\nFluostigmine: XM6JB1\\nDorzolamide: XM3BT0\\nBrinzolamide: XM9GB8\\nLatanoprost: XM5130\\nUnoprostone: XM5ZG4\\nBimatoprost: XM6E95\\nTravoprost: XM9BS0\\nTafluprost: XM3UC8\\nDapiprazole: XM6PD6\\nNetarsudil: XM8469\\nPegaptanib: XM0GK6\\nRanibizumab: XM95Y7\\nIodoheparinate: XM42E0\\nLifitegrast: XM67C4\\nCenegermin: XM57P1\\nOcriplasmin: XM2RM5\\nAutologous limbal stem cells: XM0YQ8\\nArtificial tears and other indifferent preparations: XM2GK8\\nAnecortave: XM3PF8\\nGuaiazulen: XM7CE4\\nOlopatadine: XM0ST2\\nAzidamfenicol: XM49V8\\nSulfadicramide: XM3G39\\nSulfafenazol: XM13T1\\nInterferon ophthalmic preparation: XM4F24\\nFomivirsen: XM0C71\\nBesifloxacin: XM1A96\\nMercury compounds: XM7415\\nLoteprednol: XM9KL6\\nFormocortal: XM6GF5\\nPranoprofen: XM9166\\nNepafenac: XM4GZ0\\nBromfenac: XM0QS2\\nBrimonidine ophthalmic preparation: XM14H0\\nAcetylcholine ophthalmic preparation: XM9KS5\\nLevocabastine: XM32J7\\nLodoxamide: XM9L65\\nEmedastine: XM1CM1\\nAlcaftadine: XM4JE3\\nSodium chloride hypertonic ophthalmic: XM7SY2\\nSodium edetate ophthalmic preparation: XM2LQ4\\nCiclosporin ophthalmic preparation: XM3ZG3\\nNandrolone ophthalmic preparation: XM7UH0\\nApraclonidine: XM3XE4\\nVerteporfin: XM2Y24\\nSpaglumic acid: XM63C9\\nDentifrice: XM3YZ7\\nDressing live pulp: XM1JW3\\nEucalyptus oil: XM0PR1\\nOil cloves: XM3XP7\\nPulp devitalizing paste: XM8PE1\\nAcetylsalicylic acid topical: XM9023\\nOlaflur: XM7K59\\nSodium monofluorophosphate topical: XM5GY2\\nTetracycline topical: XM53X2\\nAcriflavinium chloride: XM2FL0\\nAcrinol: XM8K50\\nAcrisorcin: XM5PD0\\nAdrenal topical: XM7696\\nAerosporin topical: XM9B70\\nAlclometasone: XM2ET5\\nAlkonium bromide: XM3NX2\\nAllethrin: XM7TF6\\nAluminium acetate solution: XM0CC9\\nAluminium sulfate: XM6JG7\\nGlutaraldehyde medicinal: XM18N0\\nGlyceryl triacetate topical: XM7XA4\\nGramicidin: XM7Y78\\nHalcinolone: XM5UQ0\\nHalethazole: XM9Q64\\nHaloprogin: XM0C80\\nHalquinols: XM3KW0\\nHCH medicinal: XM6XH7\\nHedaquinium: XM8UW4\\nHexachlorophene: XM95K6\\nAminoacridine: XM6RK6\\nHexamidine: XM7RK5\\nHydrargaphen: XM19W1\\nHydrargyri aminochloridum: XM0JC1\\nHydrogen peroxide: XM4AG2\\nHydroxytoluene medicinal: XM6E35\\nHypochlorite: XM02H1\\nIchthammol: XM3PT9\\nIsoconazole: XM6BF8\\nKwell antiinfective topical: XM07S0\\nLaurolinium: XM3U48\\nAmphotericin B topical: XM7CU1\\nLidex: XM8C45\\nLindane medicinal: XM8E58\\nLocorten: XM7CM3\\nMafenide: XM5MZ8\\nMalathion medicinal: XM6QD7\\nMedrysone: XM6L15\\nMelaleuca alternifolia oil: XM53R5\\nMerbromin: XM35K3\\nMercaptobenzothiazole salts: XM7FY5\\nMercurochrome: XM1B13\\nAntiinfective bismuth local: XM8GN4\\nMercury ammoniated: XM2J64\\nMercury antiinfective topical: XM9Z76\\nMercury chloride ammoniated: XM10V3\\nMercury oxide yellow: XM6Q50\\nMerthiolate: XM9613\\nMesulfen: XM2JH4\\nMetactesylacetate: XM2M00\\nMethyl paraben: XM0XV0\\nMethyl prednisolone topical: XM1910\\nMethylbenzethonium chloride: XM5HR1\\nAntifungal disinfectant local: XM1JC6\\nMethylrosaniline: XM7C91\\nMethylrosanilinium chloride: XM2793\\nMicatin: XM0ZY9\\nMonistat: XM9A06\\nMupirocin: XM23B6\\nMycifradin topical: XM43U9\\nMyralact: XM14D6\\nNaftifine: XM1HX1\\nNatamycin: XM2BK7\\nNeomycin topical: XM7D13\\nArgyrol: XM44R8\\nNeomycin with bacitracin: XM51P6\\nNeosporin topical: XM6YS1\\nNilstat topical: XM5BH2\\nNitrofurazone: XM71W2\\nNitromersol: XM4T72\\nNitrozone: XM2HP9\\nNoxytiolin: XM1102\\nOrthoboric acid: XM70Z6\\nOxiconazole: XM63S9\\nOxychlorosene: XM8610\\nAsiaticoside: XM7VP9\\nOxylone: XM7N08\\nParachlorophenol camphorated: XM9LG4\\nParamethasone acetate: XM12F4\\nPeruvian balsam: XM0MS1\\nPhenoctide: XM70C4\\nPhenol: XM6L76\\nPhenothrin: XM4H85\\nPhenoxyethanol: XM9D74\\nPhenylmercuric acetate: XM3R68\\nPhenylmercuric borate: XM89P9\\nChlortetracycline topical: XM0295\\nPhenylmercuric nitrate: XM0K18\\nPiketoprofen: XM3DV8\\nPolymyxin B topical: XM7B69\\nPolynoxylin: XM0J95\\nPolyoxymethyleneurea: XM2G74\\nPotassium Permanganate medicinal: XM0XP0\\nProflavine: XM6YA5\\nPropamidine: XM35Q1\\nPropiolactone: XM4TA7\\nPropion gel: XM3DH9\\nAzelaic acid: XM6SG3\\nPropionate calcium sodium: XM77H8\\nPyrethrum extract: XM03K3\\nPyrogallic acid: XM2A13\\nPyrogallol: XM8BE0\\nQuaternary ammonium antiinfective: XM97F8\\nRetinoic acid: XM2SR9\\nSalicylhydroxamic acid: XM9773\\nSodium hypochlorite medicinal antiinfective external: XM5GX7\\nSodium hyposulfite: XM5372\\nSodium perborate medicinal: XM7Z80\\nBacimycin: XM4PL5\\nSodium propionate: XM7EV2\\nSporostacin: XM1VV3\\nStaphisagria or stavesacre pediculicide: XM38S1\\nSteroid topical: XM8HC5\\nSulbentine: XM2237\\nSulfacetamide: XM2CH0\\nSulfiram: XM06Y3\\nSulfur ointment: XM4XY4\\nSynalar: XM9ST9\\nTerconazole: XM33Y9\\nBacitracin zinc: XM00V5\\nTetramethylthiuram medicinal: XM2GG6\\nThimerosal: XM9ZY9\\nThymol: XM7W47\\nTiclatone: XM3C36\\nTioconazole: XM9HG1\\nTolciclate: XM9SF6\\nTolnaftate: XM23C3\\nTriacetin: XM6848\\nTriamcinolone hexacetonide: XM4873\\nTriclobisonium chloride: XM5KU0\\nBacitracin zinc with neomycin: XM6Y48\\nTriclocarban: XM74T6\\nTriclosan: XM5WW5\\nTridesilon: XM93J3\\nUndecenoic acid: XM84C7\\nUndecoylium: XM5GQ1\\nUndecylenic acid derivatives: XM1TP6\\nUrea peroxide: XM81Z1\\nValisone: XM2VU7\\nVioform topical: XM0GR5\\nZinc antiinfectives: XM2B18\\nBasic fuchsin: XM7E88\\nZinc peroxide: XM6KL1\\nZinc sulfate topical: XM8SM1\\nZinc undecylenate: XM5L28\\nCloponone: XM71H0\\nAcriflavine: XM0BF3\\nNifuraldezone: XM1KZ4\\nTibezonium iodide: XM4DT4\\nEosin: XM5U34\\nPropanol: XM24W5\\nIsopropanol: XM5DR7\\nBenisone: XM2ZR2\\nPecilocin: XM2Q40\\nPyrrolnitrin: XM6UW2\\nPolihexanide: XM8S89\\nPolicresulen: XM0SV3\\nBiphenylol: XM80T0\\nDidecyldimethylammonium chloride: XM68P2\\nMercury metallic: XM5LX3\\nDecamethoxine: XM53J8\\nEuflavine: XM2UH3\\nSodium chlorite: XM7KH0\\nBenzalkonium chloride: XM2VS1\\nNadifloxacin: XM7022\\nClindamycin topical: XM8BY6\\nChlormidazole: XM6AC5\\nSulconazole: XM2NB3\\nBifonazole: XM8B91\\nFenticonazole: XM4J78\\nOmoconazole: XM0072\\nSertaconazole: XM9U15\\nFlutrimazole: XM49Z6\\nEberconazole: XM5XM5\\nBenzethonium chloride: XM1QH3\\nLuliconazole: XM6H72\\nBromochlorosalicylanilide: XM7CT0\\nTribromometacresol: XM89W5\\nchlorphenoxyethanol: XM8JJ2\\nEthyl hydroxybenzoate: XM67B0\\nAmorolfine: XM6474\\nButenafine: XM2L70\\nTavaborole: XM3PR6\\nEfinaconazole: XM20T9\\nImiquimod: XM0CH6\\nBenzoic acid with salicylic acid: XM7SQ2\\nInosine: XM8BH0\\nDocosanol: XM4BA3\\nSinecatechins: XM2CA6\\nMercuric iodide: XM0N01\\nBenzododecinium: XM4796\\nAluminium acetotartrate: XM2PS8\\nBendazac: XM0P54\\nBioallethrin: XM3J77\\nCopper oleinate: XM7MQ0\\nDecamethrin: XM73B3\\nBenzoic acid: XM9JZ6\\nDibutylsuccinate: XM4KG9\\nDibutylphthalate: XM84S5\\nDimethylcarbate: XM1BB3\\nDimethylphthalate: XM74X3\\nEthacridine lactate: XM4UE1\\nEtohexadiol: XM2Y03\\nFelbinac: XM8XZ0\\nOxyquinoline: XM6XJ9\\nPotassium polysulfide: XM4PX0\\nQuassia: XM9R96\\nBenzoxonium chloride: XM63Y9\\nTyrothricin: XM0GR6\\nFidaxomicin: XM0FD5\\nNifuroxazide: XM1071\\nNifurzide: XM5BH0\\nBalsalazide: XM7MF9\\nDimeticone topical: XM0JJ7\\nStreptomycin topical: XM6XD8\\nAcetic acid medicinal: XM4KV4\\nTerbinafine topical: XM7014\\nIdoxuridine topical: XM0K16\\nBenzoyl peroxide: XM43M3\\nPenciclovir topical: XM9X60\\nFamciclovir topical: XM3SK7\\nGanciclovir topical: XM7A63\\nLomefloxacin topical: XM1P27\\nLevofloxacin topical: XM3CL3\\nGatifloxacin topical: XM92Q3\\nMoxifloxacin topical: XM6VX8\\nLoxoprofen: XM1HU5\\nAbametapir: XM8TB9\\nBenzyl benzoate: XM7QG0\\nBenzyl Benzoic acid: XM0GX2\\nBHC medicinal: XM9208\\nBismuth salts glycolylarsenate: XM7S48\\nBoric acid: XM5RT8\\nBromosalicylchloranitide: XM84D8\\nBuclosamide: XM0YT9\\nButoconazole nitrate: XM6862\\nCalomel: XM7VA5\\nCandicidin: XM2AV1\\nCarbamide peroxide: XM2V43\\nCarbol fuchsin: XM2ZX1\\nCarfusin: XM6C04\\nCastellanis paint: XM9H69\\nCeepryn: XM5ZY9\\nCetalkonium chloride: XM9432\\nCethexonium chloride: XM1BP8\\nCetrimide: XM62D0\\nCetrimonium bromide: XM6ZW9\\nCetylpyridinium chloride: XM94W4\\nChamomile: XM7CX5\\nChloramine T: XM8HU1\\nChloramphenicol topical: XM72P5\\nChlorhexidine: XM7DZ3\\nChlorhydroxyquinolin: XM2ZT2\\nChlorinated lime and boric acid solution: XM5D99\\nChlorinated soda solution: XM0HL8\\nChlorocresol: XM8FE7\\nChloroxylenol: XM3XC5\\nChlorphenesin topical antifungal: XM93C6\\nChlorquinol: XM2CN0\\nCiclopirox olamine: XM0852\\nClobetasone: XM6MJ1\\nClodantoin: XM2WP5\\nClofenotane: XM8TG2\\nClotrimazole: XM8W85\\nCloxiquine: XM6BT6\\nCopper gluconate: XM4M83\\nCreosol compound: XM42L5\\nCreosote coal tar beechwood: XM35M5\\nCresol s: XM7ZK1\\nCresol and soap solution: XM0WM0\\nCresyl acetate: XM4YB3\\nCresylic acid: XM0348\\nCrotamiton: XM3726\\nDakins solution: XM7YY8\\nDequalinium chloride: XM8CF0\\nDesonide: XM6LZ1\\nDettol: XM0PQ7\\nDibromopropamidine isethionate: XM1RR7\\nDibrompropamidine: XM0UE0\\nDicophane: XM06U7\\nDiethyltoluamide: XM2355\\nDimazole: XM4A13\\nDixanthogen: XM42D3\\nDodicin: XM3JL3\\nDofamium chloride: XM7YF5\\nDomiphen bromide: XM3TY6\\nEconazole: XM5XH3\\nErythromycin topical: XM8E88\\nEthacridine: XM5QE6\\nEthylene oxide medicinal: XM09B1\\nEurax: XM91H3\\nExalamide: XM2258\\nFenticlor: XM9K22\\nFluocinonide: XM2E99\\nFlurobate: XM67C1\\nFurazolium chloride: XM6AZ9\\nGammabenzene hexachloride medicinal: XM5JA4\\nGentamicin topical: XM0XR4\\nAluminium acetate: XM3P38\\nAluminium chloride: XM7FE1\\nAluminium diacetate: XM2D21\\nAluminium subacetate: XM2399\\nAntihemorrhoidal preparation: XM38V9\\nDetergent external medication: XM1KT1\\nDial soap: XM16X4\\nDuponol C EP: XM2KD7\\nGreen soap: XM3Y82\\nLauryl sulfoacetate: XM2273\\nLead acetate: XM8P35\\nPolyethanolamine alkyl sulfate: XM3E94\\nSoap medicinal soft: XM2P20\\nSoap superfatted: XM6EW6\\nSodium lauryl sulfate: XM1X23\\nTannic acid medicinal astringent: XM1484\\nThiram medicinal: XM7KD1\\nVegetable extract astringent: XM19Y0\\nWitch hazel: XM4S15\\nAntiperspirant: XM4KJ0\\nHamamelis: XM20Y8\\nIproheptine: XM1DT0\\nLowila: XM9RY1\\nSeptisol: XM1AY0\\nSulfatostearate: XM3DK8\\nBenoquin: XM9R98\\nCantharides: XM4597\\nCell stimulants and proliferants: XM8JB2\\nCharcoal medicinal topical: XM4JD6\\nChloresium: XM6GG8\\nDextromoramide topical: XM9YX8\\nElase: XM1KB4\\nEnzyme depolymerizing: XM0M69\\nGelfilm: XM5VL6\\nHeet: XM1FF8\\nLactic acid: XM6P44\\nLytta vittatta: XM2D09\\nNonoxinol: XM54L7\\nNonylphenoxy polyethoxyethanol: XM4M68\\nOctoxinol: XM2TV0\\nPanthenol topical: XM7DL5\\nPodophyllotoxin: XM8865\\nPreparation H: XM3403\\nSantyl: XM0VK2\\nScarlet red: XM4AZ3\\nSodium borate therapeutic: XM6Z04\\nSpermicide: XM8EC8\\nTosylchloramide sodium: XM0M54\\nUrea topical: XM8WU4\\nBecaplermin: XM0M02\\nGamolenic acid: XM4QZ6\\nCapsaicin: XM14C4\\nZucapsaicin: XM5DL8\\nOrganoheparinoid: XM7ZQ6\\nSodium apolate: XM1485\\nTacalcitol: XM3711\\nTazarotene: XM6BQ3\\nDextranomer: XM3GL1\\nCrilanomer: XM7618\\nEnoxolone: XM1JG0\\nTrolamine: XM0W31\\nBetulae cortex: XM1W34\\nIngenol mebutate: XM1NP5\\nSelenium compounds: XM60N1\\nMetandienone topical: XM4HG0\\nPimecrolimus: XM5DF2\\nDupilumab: XM1015\\nBrimonidine: XM1A95\\nDeoxycholic acid: XM8HP9\\nCalcipotriol: XM2TT0\\nAluminium oxide: XM41S0\\nCadmium compounds medicinal: XM8ZR0\\nLithium succinate: XM9MC0\\nMequinol: XM0RJ6\\nAlbumin tannate: XM7XL9\\nDiosmectite: XM87L7\\nCeratonia: XM0XA0\\nCrospovidone: XM3AJ8\\nRacecadotril: XM86M9\\nTrafermin: XM33M4\\nAbrocitinib: XM0A16\\nAlkaline antiseptic solution aromatic: XM7BG3\\nAmbazone: XM7CJ4\\nAmylmetacresol: XM9SX0\\nBiclotymol: XM59F4\\nBisdequalinium salts diacetate: XM51P8\\nChloromycetin otic solution: XM0LW6\\nCopper sulfate cupric medicinal ear: XM2954\\nCorbadrine: XM6270\\nDichlorobenzyl alcohol: XM96Z5\\nGlycerol borax: XM37H6\\nLevonordefrin: XM4UQ0\\nNeosporin ENT agent: XM9EQ5\\nNose preparations: XM4RA5\\nThenoic acid: XM8YH0\\nZinc chloride mouthwash: XM9VY0\\nAcetic acid ENT agent: XM83Z7\\nRitiometan: XM0G17\\nMyristylbenzalkonium: XM3RP3\\nAntazoline topical: XM8XE9\\nCalcium hexamine thiocyanate: XM9FX7\\nOctenidine: XM3NR8\\nPhenazone topical: XM0M82\\nPodophyllin: XM5HX7\\nPodophyllum resin: XM4L14\\nAmcinonide: XM35S7\\nTriamcinolone topical: XM8WS1\\nBetamethasone topical: XM46G7\\nClobetasol: XM4FN3\\nCorticosteroid topical: XM57Z7\\nDesoximetasone: XM5PM3\\nDexamethasone topical: XM6TE1\\nDiflorasone: XM8V58\\nDiflucortolone: XM4XD6\\nFluclorolone acetonide: XM4TV8\\nFludrocortisone topical: XM0WP2\\nFludroxycortide: XM84F4\\nFlumethasone: XM6LQ2\\nFluocortin butyl: XM3EM1\\nFluorometholone: XM7MM0\\nFluprednidene: XM52K8\\nFlurandrenolide: XM5086\\nHalcinonide: XM0ZX1\\nHalometasone: XM8TL4\\nHydrocortisone aceponate: XM8KB5\\nHydrocortisone topical: XM6JE7\\nPrednicarbate: XM0ME0\\nPrednisolone steaglate: XM1B59\\nPrednisolone topical: XM09Z4\\nHydrocortisone butyrate: XM4Y24\\nFlumetasone: XM55S3\\nFluperolone: XM41T8\\nButeprate: XM5ZS6\\nUlobetasol: XM64R0\\nDifluprednate: XM6DT9\\nMethylprednisolone aceponate: XM5EY3\\nFluocinolone acetonide: XM4HA4\\nFluclorolone: XM1068\\nCiclesonide topical: XM9DE4\\nTixocortol pivalate: XM8963\\nUfenamate: XM5PA8\\nChlorphenesin: XM3VA9\\nIdrocilamide: XM2NU3\\nMethyl salicylate: XM6H69\\nAdapalene: XM10R5\\nMotretinide: XM6KD7\\nTretinoin topical: XM7C94\\nRetinol topical: XM6PV8\\nIsotretinoin topical: XM2PQ2\\nSilver: XM01G3\\nSilver antiinfectives: XM0CN1\\nSilver colloidal: XM3QX7\\nSilver nitrate ophthalmic preparation: XM2U36\\nSilver sulfadiazine: XM9R64\\nSilver nitrate: XM6RF0\\nAcrylamide: XM5LS4\\nAgrochemical: XM1SE1\\nFertilizer: XM10X3\\nAmmonium nitrate: XM4NU1\\nGuano: XM0AR7\\nMagnesium thiosulfate: XM7046\\nPesticide: XM7D46\\nDibromochloropropane: XM6PM8\\nDichloropropene: XM61U9\\nEthylene oxide: XM4G15\\nFungicide: XM83G4\\nAuramine: XM0MT5\\nBenzimidazole: XM44B4\\nCarbendazim: XM9F10\\nBenomyl: XM2WG5\\nFuberidazole: XM0ZM1\\nThiabendazole nonmedicinal: XM7ZN0\\nThiophanatemethyl: XM7E92\\nBlasticidinS: XM9051\\nBordeaux mixture: XM6TA8\\nCaptafol: XM3F05\\nCaptan: XM9BL0\\nChlorothalonil: XM75T2\\nCycloheximide: XM21E5\\nDichlone: XM8E94\\nDifenoconazole: XM3365\\nDithiocarbamate: XM5KQ8\\nEdifenphos: XM3TR4\\nFolpet: XM04K8\\nGlutaral nonmedicinal: XM40T8\\nHexachlorobenzene: XM4AW6\\nTetramethylthiuram disulfide: XM0HQ1\\nZineb: XM3JA8\\nOctylisothiazolinone: XM0P16\\nHerbicide: XM6J29\\nAmmonium sulfamate: XM3FE7\\nBromoxynil: XM2RT5\\nChloroacetic acid: XM62D4\\nDalapon: XM3KU8\\nDicamba: XM3MM5\\nDichlobenil: XM5DH1\\nDichlorophenoxyacetic acid: XM9CD8\\nDinoseb: XM23C2\\nDinoseb acetate: XM60K0\\nDinoterb: XM62Q7\\nDiquat: XM1M07\\nDiuron: XM5TV1\\nEndothall: XM6KX6\\nGlyphosate: XM50V7\\nMCPA: XM88B4\\nMCPAthioethyl: XM6T93\\nMecoprop: XM0CJ6\\nMecopropP: XM0QY2\\nMonuron: XM0TQ1\\nParaquat: XM4SL8\\nPropachlor: XM8J05\\nPropanil: XM66Q3\\nSimazine: XM48M2\\nSodium cacodylate herbicide: XM7KH8\\nTriazine derivative herbicide not elsewhere classified: XM0MH9\\nTriazole: XM7ML8\\nTrichlorophenoxyacetic acid: XM9MT5\\nCarbamate herbicide not elsewhere classified: XM4PA4\\nInsecticide: XM3K66\\nCarbamate insecticide: XM0231\\nAldicarb: XM0HS9\\nButocarboxim: XM0ZT6\\nButoxycarboxim: XM4DS5\\nCarbaryl: XM9G20\\nNaphthol: XM1KX0\\nCarbofuran: XM7A68\\nEthiofencarb: XM8FU1\\nFurathiocarb: XM9HR4\\nMethiocarb: XM9Y05\\nMethomyl: XM2CU6\\nOxamyl: XM0DL6\\nPropoxur: XM79F9\\nThiofanox: XM3358\\nCryolite: XM7LT1\\nDEET: XM12C2\\nDiflubenzuron: XM4NG6\\nNaphthalene: XM5S01\\nNicotine insecticide: XM3AD4\\nOrganochlorine insecticide: XM41B3\\nAldrin: XM5Y08\\nChlordane: XM12L2\\nChlorobenzilate: XM7JD5\\nDDT: XM9EL1\\nDDE dichlorodiphenyldichloroethylene: XM1UT2\\nParadichlorobenzene: XM3XK2\\nDicofol: XM2CK5\\nDieldrin: XM5U23\\nEndosulfan: XM5C19\\nEndrin: XM6ZU9\\nHeptachlor: XM2JS5\\nIsobenzan: XM5642\\nKelevan: XM4H89\\nLindane: XM16G7\\nLindane vapor: XM07J5\\nMirex: XM5NU4\\nPentachlorophenol: XM32P2\\nStrobane: XM4FV5\\nToxaphene: XM91D0\\nOrganophosphate insecticide: XM7154\\nAzinphosethyl: XM7RX0\\nAzinphosmethyl: XM7H46\\nCadusafos: XM2JZ1\\nCarbophenothion: XM8AZ4\\nChlorethoxyfos: XM3DK0\\nChlorfenvinphos: XM20D7\\nChlormephos: XM4RG9\\nChlorpyrifos: XM3QX6\\nChlorthion: XM5566\\nChlorthiophos: XM2MP2\\nCoumaphos: XM8WL8\\nDemephion: XM6L87\\nDemephionO: XM4WK8\\nDemephionS: XM8KA9\\nDemeton: XM5F29\\nDemetonO: XM4724\\nDemetonOmethyl: XM8LS8\\nDemetonS: XM6UD3\\nDemetonSmethyl: XM8ZM3\\nDiazinon: XM6AY4\\nDicapthon: XM26D3\\nDichlorvos: XM03V8\\nDicrotophos: XM5UL4\\nDimefox: XM5Q52\\nDimethoate: XM58G9\\nDimetilan: XM56E1\\nDioxathion: XM3494\\nDisulfoton: XM9SP5\\nEPN: XM5BC5\\nEthion: XM7X81\\nEthoprophos: XM9F71\\nFamphur: XM7818\\nFenthion: XM7SU5\\nFluorophosphate insecticide: XM5KA2\\nHeptenophos: XM7TZ6\\nHexaethyl tetraphosphate: XM5G36\\nIsoxathion: XM5JS5\\nLeptophos: XM6A89\\nMalathion insecticide: XM0G23\\nMecarbam: XM5406\\nMephosfolan: XM9R34\\nMethamidophos: XM56W1\\nMethidathion: XM83J2\\nMevinphos: XM8ZT2\\nMipafox: XM4197\\nMonocrotophos: XM27J3\\nNaled: XM0US9\\nOmethoate: XM2D86\\nOxydemetonmethyl: XM48D2\\nParaoxon: XM7LW0\\nParathion: XM14N6\\nParathionmethyl: XM1YY0\\nPhorate: XM20V2\\nPhosfolan: XM2324\\nPhosphamidon: XM3QY4\\nPropetamphos: XM6YG2\\nProthoate: XM7GK7\\nQuinalphos: XM7UW2\\nSchradan: XM0TB4\\nSulfotep: XM1E56\\nTebupirimfos: XM7LH6\\nTEPP: XM6P90\\nTerbufos: XM2QB5\\nThiometon: XM72Q5\\nThionazin: XM4T49\\nTriazophos: XM2AH6\\nTrichloronate: XM13H5\\nVamidothion: XM9FN4\\nPhenothiazine insecticide: XM5EB8\\nPyrethroid insecticide: XM4AP8\\nAllethrin insecticide: XM27C9\\nBifenthrin: XM79U4\\nCyfluthrin: XM7YT2\\nCyhalothrin: XM8HR7\\nCypermethrin: XM1MQ5\\nCyphenothrin: XM3Y88\\nDeltamethrin: XM3BQ7\\nEsfenvalerate: XM76R8\\nFenpropathrin: XM1Z58\\nFenvalerate: XM9JZ0\\nFlucythrinate: XM6H26\\nPermethrin: XM7461\\nPrallethrin: XM4AC0\\nTefluthrin: XM5QE0\\nTetramethrin: XM1MW0\\nTralomethrin: XM2H33\\nRotenone: XM1S21\\nMetaldehyde: XM95F1\\nMethyl bromide: XM0NK1\\nPiperonyl butoxide: XM6FE7\\nRodenticide: XM2KK3\\nAlpha chlorhydrin: XM8UV3\\nAlpha naphthylthiourea: XM4X40\\nBrodifacoum: XM7138\\nBromadiolone: XM7RU0\\nBromethalin: XM3QV7\\nChloralose: XM1GN8\\nChlorophacinone: XM1FD8\\nCoumatetralyl: XM0DK0\\nCrimidine: XM3KE1\\nDifenacoum: XM9VL9\\nDifethialone: XM6DL4\\nDiphacinone: XM4J38\\nFlocoumafen: XM7HA0\\nFluoroacetamide: XM7P90\\nNorbormide: XM2WD6\\nPindone: XM4116\\nPyriminil: XM8QH8\\nSodium fluoroacetate: XM9LE1\\nWarfarin rodenticide: XM8LJ0\\nTetradifon: XM6BS1\\nAcaricide not elsewhere classified: XM6372\\nFumigant not elsewhere classified: XM8V89\\nMolluscicide not elsewhere classified: XM0ZQ8\\nOrganochlorine pesticide not elsewhere classified: XM5E09\\nSeed disinfectant not elsewhere classified: XM8HA3\\nSulfur pesticide not elsewhere classified: XM86Y5\\nThiocarbamate pesticides not elsewhere classified: XM0J68\\nWood preservative not elsewhere classified: XM86L9\\nCopper oleate: XM55D5\\nAlcohol: XM6U34\\nAlcohol vapor: XM9BA5\\nAllyl Alcohol: XM51N7\\nBay rum: XM6K71\\nBenzyl alcohol nonmedicinal: XM0AD5\\nCinnamyl alcohol: XM7VB3\\nCyclohexanol: XM3XS0\\nEthanol: XM8ZW3\\nAlcohol beverage: XM1A61\\nAbsolute alcohol: XM8HG4\\nDenatured alcohol: XM3094\\nEthanol disinfectant: XM6DN6\\nEthanol motor fuel: XM8RP6\\nEthyl methylcarbinol: XM2VC0\\nFusel alcohol: XM48D0\\nAmyl alcohol: XM88C8\\nAmylene hydrate: XM5JW4\\nButyl alcohol: XM49S0\\nDiethyl carbinol: XM6HQ5\\nIsoamyl alcohol: XM5SH0\\nPropyl alcohol: XM5RS7\\nTrimethylcarbinol: XM5M32\\nHexahydrocresol: XM6C11\\nHydroabietyl alcohol: XM4BN8\\nIsopropyl alcohol: XM5531\\nIsopropyl rubbing alcohol: XM8YA1\\nJamaica ginger: XM80Q0\\nMethanol: XM7KD9\\nMethanol motor fuel: XM0ZA4\\nAntifreeze not elsewhere classified: XM6VD7\\nCanned heat not elsewhere classified: XM7XX5\\nGeraniol: XM4S45\\nHydroxycitronellal: XM7UN9\\nAlgal toxin: XM9TZ4\\nCyanotoxin: XM6F50\\nMicrocystin: XM38M2\\nAmyl propionate: XM9RM0\\nAmphibian toxin: XM26J2\\nFrog toxin: XM0KH6\\nBrunos casque headed frog venom: XM0CW7\\nGreenings frog venom: XM8QW3\\nPoison dart frog poison: XM7JP5\\nGolden poison frog poison: XM4BD8\\nAnthonys poison arrow frog poison: XM6K27\\nStrawberry poison dart frog poison: XM7JV0\\nKokoe poison frog poison: XM9TX1\\nBlack legged poison frog poison: XM2698\\nSalamander toxin: XM7P83\\nNewt toxin: XM93N2\\nToad toxin: XM7YQ1\\nColorado River toad toxin: XM8YT6\\nMarine toad toxin: XM54D9\\nArthropod venom: XM7930\\nArachnid venom: XM12G1\\nScorpion venom: XM9DM8\\nAsian black scorpion venom: XM0HC0\\nBlack emperor scorpion venom: XM8F59\\nGiant forest scorpion venom: XM52D7\\nAustralian forest scorpion venom: XM72V7\\nAustralian urodacus scorpion venom: XM10T2\\nAustralian black rock scorpion venom: XM48S4\\nAustralian desert scorpion venom: XM10R0\\nAustralian marbled scorpion venom: XM0YV3\\nBark scorpion venom: XM3HL0\\nBrazilian yellow scorpion venom: XM2HW7\\nChinese scorpion venom: XM12P5\\nCommon yellow scorpion venom: XM5QE7\\nDeath stalker scorpion venom: XM0E23\\nFattail scorpion venom: XM95A6\\nFlat rock scorpion venom: XM91Z5\\nIndian red scorpion venom: XM67X5\\nLesser Asian scorpion venom: XM11L8\\nTransvaal thick tailed scorpion venom: XM1WF9\\nYellow creeping leg scorpion venom: XM8XC7\\nSpider venom: XM6NN5\\nBrown recluse spider venom: XM2RM6\\nFalse widow spider venom: XM6SD4\\nFunnel web spider venom: XM3KD6\\nHobo spider venom: XM57S7\\nJumping spider venom: XM0C68\\nMouse spider venom: XM1LF5\\nSix eyed sand spider venom: XM6QH2\\nTarantula spider venom: XM8095\\nWandering spider venom: XM8FT7\\nWidow spider venom: XM7JS2\\nBlack widow spider venom: XM7M21\\nBrown widow spider venom: XM9Z42\\nRedback spider venom: XM1TF6\\nRed widow spider venom: XM2JA0\\nWolf spider venom: XM2WM2\\nYellow sac spider venom: XM3UW9\\nTick venom: XM94S4\\nAmerican dog tick venom: XM7WR0\\nAustralian paralysis tick venom: XM51Y1\\nBrown dog tick venom: XM3J29\\nDeer tick venom: XM77E1\\nLone star tick venom: XM5RS1\\nSpinose ear tick venom: XM8YN1\\nCentipede venom: XM6TD6\\nAmazonian giant centipede venom: XM5LB1\\nAustralian giant centipede venom: XM52L4\\nTexas redheaded centipede venom: XM9FP1\\nVietnamese centipede venom: XM2WU4\\nInsect venom: XM50Y9\\nAnt venom: XM3Y95\\nBull ant venom: XM4CP1\\nBullet ant venom: XM02L8\\nFire ant venom: XM3UK8\\nHarvester ant venom: XM1547\\nJack jumper ant venom: XM5ZS2\\nBee venom: XM13H7\\nAfricanized honey bee venom: XM1GA3\\nBumblebee venom: XM0NK4\\nHoney bee venom: XM42T0\\nCaterpillar venom: XM1142\\nCup moth caterpillar venom: XM2T44\\nPuss caterpillar venom: XM57P9\\nHorsefly venom: XM7D92\\nWasp venom: XM2YA4\\nYellow jacket venom: XM6D92\\nPaper wasp venom: XM1PF5\\nHornet venom: XM31U2\\nAsian giant hornet venom: XM7CC3\\nMillipede toxin: XM4C00\\nBird toxin: XM0HS8\\nIfrita bird toxin: XM5V29\\nPitohui bird toxin: XM5Y38\\nMammal toxin: XM35H6\\nPlatypus venom: XM27R8\\nShrew venom: XM8EC2\\nSlow loris venom: XM9R52\\nSolenodon venom: XM67Y0\\nVampire bat venom: XM6NB8\\nMarine and freshwater animal toxins: XM2P96\\nMarine and freshwater animal venom: XM99J1\\nBlue ringed octopus venom: XM2GR5\\nBrittle star venom: XM56D3\\nCoral venom: XM0CW4\\nFire coral venom: XM65N5\\nSoft coral venom: XM0R26\\nFish venom: XM05Z4\\nCobbler fish venom: XM0UJ4\\nDogfish shark venom: XM6643\\nGhost shark venom: XM3DB5\\nGoblinfish venom: XM5FP5\\nLionfish venom: XM4CL4\\nRabbitfish venom: XM17D1\\nScorpionfish venom: XM5V26\\nStargazer fish venom: XM73V9\\nStingray venom: XM7P10\\nStonefish venom: XM8P00\\nStriped blenny fish venom: XM83T2\\nStriped eel catfish venom: XM0784\\nToadfish venom: XM33N5\\nWaspfish venom: XM0U57\\nWeeverfish venom: XM1VW1\\nJellyfish venom: XM9YA3\\nBox jellyfish venom: XM4057\\nIrukandji jellyfish venom: XM0ZB2\\nSea wasp venom: XM87R6\\nLions mane jellyfish venom: XM6PY9\\nSea nettle venom: XM8EA9\\nPortuguese man o war venom: XM6S92\\nSea anemone venom: XM41L4\\nSea cucumber venom: XM2HU5\\nSea urchin venom: XM2M75\\nSnail venom: XM48L3\\nStarfish venom: XM7A02\\nCrown of thorns starfish venom: XM3X53\\nSeafood poison: XM3BZ7\\nCrab seafood poison: XM1KF5\\nFish seafood poison: XM7V29\\nCiguatera fish seafood poison: XM1DD9\\nGreenland shark seafood poison: XM7N43\\nPuffer fish seafood poison: XM33K2\\nScombroid fish seafood poison: XM74Y6\\nToadfish seafood poison: XM40D3\\nSea cucumber seafood poison: XM5QW5\\nSea snail seafood poison: XM51R6\\nShellfish seafood poison: XM7VB5\\nOyster seafood poison: XM3XQ0\\nClam seafood poison: XM3S96\\nScallop seafood poison: XM3KC2\\nMussel seafood poison: XM41B9\\nTurtle seafood poison: XM7DB8\\nBox turtle seafood poison: XM2YA1\\nGreen sea turtle seafood poison: XM1C12\\nHawksbill sea turtle seafood poison: XM0RH0\\nReptile venom: XM2X61\\nLizard venom: XM4RP9\\nBeaded lizard venom: XM5HY6\\nGila monster lizard venom: XM7HD4\\nSnake venom: XM4KN1\\nSea snake venom: XM6UB3\\nTerrestrial snake venom: XM8DS9\\nAdder snake venom: XM9034\\nPuff adder snake venom: XM4R63\\nDeath adder snake venom: XM8DE0\\nEuropean adder snake venom: XM2J41\\nAmerican copperhead snake venom: XM6CL7\\nAsp viper snake venom: XM5UK6\\nAustralasian black snake venom: XM3DZ2\\nMulga snake venom: XM9E44\\nAustralian brown snake venom: XM5MD7\\nCommon brown snake venom: XM2UN5\\nAustralian copperhead snake venom: XM1FY9\\nBoomslang snake venom: XM0RN4\\nBush viper snake venom: XM26Z0\\nBushmaster snake venom: XM2650\\nCarpet viper snake venom: XM6HP1\\nCobra snake venom: XM1R49\\nChinese cobra snake venom: XM45D4\\nEgyptian cobra snake venom: XM4760\\nIndian cobra snake venom: XM6052\\nKing cobra snake venom: XM0W24\\nNorthern Philippine cobra snake venom: XM1UH2\\nSpitting cobra snake venom: XM5F28\\nBlack necked spitting cobra snake venom: XM7LZ0\\nJavan spitting cobra snake venom: XM69M0\\nMozambique spitting cobra venom: XM6U92\\nRed spitting cobra snake venom: XM2B16\\nWest African brown spitting cobra venom: XM7BF9\\nTree cobra snake venom: XM7P11\\nCoral snake venom: XM4WV8\\nHarlequin coralsnake venom: XM2PM7\\nTexas coralsnake venom: XM0EN5\\nDesert viper snake venom: XM5A72\\nGaboon viper snake venom: XM2RJ2\\nHorned viper snake venom: XM6LU5\\nHump nosed pit viper snake venom: XM7WL0\\nKrait snake venom: XM7TD0\\nBanded krait snake venom: XM2RD0\\nIndian krait snake venom: XM5J22\\nMalayan krait snake venom: XM78S0\\nLancehead snake venom: XM7JF1\\nCommon lancehead snake venom: XM2267\\nFer de lance snake venom: XM9Y58\\nLevant viper snake venom: XM40A2\\nMamba snake venom: XM9JL4\\nBlack mamba snake venom: XM2SH0\\nEastern green mamba snake venom: XM1RM0\\nJamesons mamba snake venom: XM8E53\\nWestern green mamba snake venom: XM1GY6\\nMole viper snake venom: XM81Z8\\nMoorish viper snake venom: XM3G20\\nOttoman viper snake venom: XM2A66\\nPalestine viper snake venom: XM88F6\\nRattlesnake venom: XM1504\\nEastern diamondback rattlesnake venom: XM3RE1\\nMojave rattlesnake venom: XM1RY2\\nPrairie rattlesnake venom: XM8MU5\\nTimber rattlesnake venom: XM2P01\\nWestern diamondback rattlesnake venom: XM5JD1\\nRussell viper snake venom: XM8JD0\\nTaipan snake venom: XM4SM0\\nCoastal taipan snake venom: XM5T51\\nInland taipan snake venom: XM7NG4\\nWestern ranges taipan snake venom: XM7XU4\\nTiger snake venom: XM23U8\\nWater mocassin snake venom: XM59V3\\nTetrodotoxin: XM7FH1\\nCarbon disulfide: XM7S46\\nAcetic anhydride: XM34D2\\nAcrolein: XM4HP5\\nAcrolein gas: XM2MJ1\\nAziridine: XM3GN3\\nBenzidine: XM9WX0\\nCorrosive acid: XM6PB5\\nFormic acid: XM6HP3\\nFormic acid vapor: XM6SY2\\nHydrazoic acid: XM3C02\\nHydrogen fluoride: XM0VA0\\nHydrogen fluoride vapor: XM34T7\\nNitric acid: XM5NZ1\\nNitric acid vapor: XM5CC8\\nNitrohydrochloric acid: XM5WU5\\nNitrous acid: XM2WH3\\nNitrous acid fumes: XM6QY4\\nOrthotolidine: XM5JW8\\nOsmic acid: XM22A0\\nOsmic acid fumes: XM07R4\\nOxalic acid: XM4AK6\\nPotassium oxalate: XM03N8\\nSodium oxalate: XM6CB1\\nPhosphoric acid: XM0270\\nPicric acid: XM0KV1\\nSulfuric acid: XM8724\\nTrichloroacetic acid: XM9SC9\\nCorrosive alkali: XM2R89\\nAmmonia: XM4TP4\\nAmmonia liquid: XM2KS4\\nAmmonium carbonate: XM51W3\\nBorate nonmedicinal: XM8X28\\nSodium borate cleanser: XM4Q76\\nSodium perborate nonmedicinal: XM25T4\\nCalcium hydroxide: XM4AF1\\nCalcium hypochlorite: XM50U9\\nCalcium oxide: XM87X9\\nCaustic hydroxide: XM8586\\nPotassium hydroxide: XM5N47\\nSodium hydroxide: XM4SW1\\nPotassium carbonate: XM8WC7\\nSodium carbonate: XM9370\\nSodium hypochlorite: XM0KW1\\nSodium hypochlorite vapor: XM6KZ0\\nTriethanolamine: XM8F93\\nAlkaline disinfectant not elsewhere classified: XM9JC6\\nDimethyl sulfate: XM71L2\\nDimethyl sulfate fumes: XM8TX4\\nFluoride nonmedicinal: XM10Z2\\nSulfuryl fluoride: XM48A5\\nHydrazine: XM8LE5\\nMethyl hydrazine: XM0WH6\\nMethyl iodide: XM7BT1\\nPhenol nonmedicinal: XM92T1\\nAminophenol: XM3FK8\\nMethyl aminophenol: XM9JR4\\nButylated hydroxytoluene: XM2PP7\\nNitrophenol: XM7645\\nPhenol disinfectant not elsewhere classified: XM0HB7\\nPhenol pesticide not elsewhere classified: XM5YF7\\nLiquor cresolis compositus: XM9814\\nPhthalic anhydride: XM5380\\nSilver nitrate nonmedicinal: XM49E4\\nSodium bisulfate: XM9GW2\\nSodium chlorate: XM0345\\nSodium oxide: XM5M78\\nSodium peroxide: XM4XF6\\nSodium silicate: XM8FM5\\nThioglycolic acid: XM6826\\nCorrosive aromatics not elsewhere classified: XM85F7\\nCorrosive cleaning product not elsewhere classified: XM1ZR1\\nBleach not elsewhere classified: XM2A78\\nDrain cleaner not elsewhere classified: XM6AU8\\nCorrosive cleaning product fumes not elsewhere classified: XM57L3\\nOxidizing agent not elsewhere classified: XM05Q8\\nCyanide: XM3HX8\\nAcrylonitrile: XM23N0\\nAliphatic thiocyanates: XM9R22\\nCalcium cyanide: XM42L1\\nCyanogen: XM1ZE4\\nCyanogen chloride: XM1293\\nHydrogen cyanide: XM8WA4\\nIsocyanate: XM0YF6\\nMethyl isothiocyanate: XM4QN2\\nPotassium cyanide: XM1VD7\\nPotassium ferric hexacyanoferrate nonmedicinal: XM2Q39\\nSodium cyanide: XM1AZ9\\nToluene diisocyanate: XM36N4\\nCyanide pesticide not elsewhere classified: XM77X3\\nDichloroformoxine: XM4VA2\\nEthylidene diacetate: XM14Q4\\nCordite: XM5NJ3\\nCordite vapor: XM1926\\nNitrocellulose: XM4PQ8\\nNitroglycerin nonmedicinal: XM8T02\\nNitroglycerin nonmedicinal fumes: XM5VU2\\nDynamite: XM9YX2\\nDynamite fumes: XM7Q61\\nNitronaphthalene: XM7GP0\\nPotassium chlorate: XM7EN6\\nFiberglass: XM8SN2\\nBromine vapor: XM3GS6\\nCarbon dioxide: XM8XZ6\\nCarbon monoxide: XM1X11\\nBlast furnace gas: XM8MR4\\nCarbon monoxide from engine exhaust gas: XM7SP6\\nCarbon monoxide from engine driven electrical generator: XM7R97\\nCarbon monoxide from motor vehicle exhaust: XM2LM9\\nCarbon monoxide from incomplete combustion of\\xa0charcoal: XM4QD5\\nCarbon monoxide from incomplete combustion of\\xa0coal: XM2EK4\\nCarbon monoxide from incomplete combustion of\\xa0coke: XM7NG7\\nCarbon monoxide from incomplete combustion of fuel gas: XM9675\\nCarbon monoxide from incomplete combustion of\\xa0acetylene: XM1MB6\\nCarbon monoxide from incomplete combustion of\\xa0coal gas: XM5TT8\\nCarbon monoxide from incomplete combustion of producer gas: XM1JF3\\nCarbon monoxide from incomplete combustion of\\xa0utility gas: XM3ES0\\nCarbon monoxide from incomplete combustion of\\xa0liquefied petroleum gas: XM5XY1\\nCarbon monoxide from incomplete combustion of\\xa0butane: XM45F2\\nCarbon monoxide from incomplete combustion of propane: XM3UB7\\nCarbon monoxide from incomplete combustion of utility natural gas: XM6708\\nCarbon monoxide from incomplete combustion of\\xa0water gas: XM9ZV7\\nCarbon monoxide from incomplete combustion of\\xa0wood: XM8WR8\\nChlorine: XM0GT6\\nCyanic acid: XM3KE4\\nDiazomethane: XM8Z33\\nDiborane: XM70H1\\nDichloroethyl sulfide: XM6UG7\\nEthidium chloride: XM0YQ4\\nEthylene: XM1947\\nFerrovanadium: XM5EU1\\nFluorine: XM9SB2\\nFormaldehyde: XM0TV9\\nHelium: XM0JJ6\\nHydrocarbon gas: XM5LN6\\nAcetylene: XM3FZ1\\nCoal gas: XM8GS7\\nLiquefied petroleum gas: XM53K7\\nPropane: XM76Q9\\nButane: XM4653\\nNatural gas: XM6BD0\\nMethane: XM56Q2\\nProducer gas: XM6993\\nWater gas: XM4X82\\nHydrogen: XM8ZY7\\nHydrogen sulfide: XM7FL0\\nIodine vapor: XM74J0\\nLacrimogenic gas: XM2JX3\\nBromobenzylcyanide: XM9FN5\\nChloroacetone: XM2N89\\nChloroacetophenone: XM7J14\\nEthyl iodoacetate: XM41V6\\nMace lacrimogenic gas: XM3RL0\\nMethyl chloroformate: XM6RK9\\nMethyl chloride: XM29D2\\nMethyl mercaptan: XM4FU5\\nMustard gas: XM16X6\\nNitrogen oxide: XM69M3\\nNitrogen dioxide: XM05F4\\nNonchlorofluorocarbon refrigerant gas: XM1418\\nOzone: XM54H2\\nPhosgene: XM91W5\\nPolyester fumes: XM3D40\\nPolytetrafluoroethylene: XM1663\\nPropylene: XM8242\\nSulfur oxides: XM2598\\nSulfur dioxide: XM0Z74\\nAerosol spray not elsewhere classified: XM3NH9\\nFiredamp not elsewhere classified: XM1D37\\nNerve gas not elsewhere classified: XM61G0\\nOil fumes not elsewhere classified: XM60X6\\nSewer gas not elsewhere classified: XM1EM9\\nSmog not elsewhere classified: XM6QK6\\nSmoke not elsewhere classified: XM9N00\\nSternutator gas not elsewhere classified: XM0G86\\nAcetyl bromide: XM2X70\\nAcetyl chloride: XM7594\\nAcetylene tetrachloride: XM2W36\\nAcetylene tetrachloride vapor: XM4YD3\\nAmyl chloride: XM45Q9\\nCarbon tetrachloride: XM3CP7\\nCarbon tetrachloride vapor: XM0386\\nChlorex: XM77V1\\nChlorinated camphene: XM1363\\nChlorinated hydrocarbons not elsewhere classified: XM4XU4\\nChlorinated naphthalene: XM1YR6\\nChlorinated naphthalene vapor: XM9P39\\nChloroaniline: XM0WL1\\nChlorobenzene: XM6LC4\\nChlorobromomethane: XM0KE3\\nChlorodinitrobenzene: XM6QB9\\nChlorodinitrobenzene vapor: XM5VH9\\nChlorodiphenyl: XM8D04\\nChloroethylene: XM6YR0\\nChlorofluorocarbons: XM2HX1\\nFreon: XM9813\\nDichlorodifluoromethane: XM3QE2\\nTrichlorofluoromethane: XM7FF5\\nChloronitrobenzene: XM8G05\\nChloronitrobenzene vapor: XM5S30\\nChlorophenol: XM84K8\\nChloropicrin: XM3U53\\nDibromoethane: XM9GK3\\nDichlorobenzene: XM55X0\\nDichloroethane: XM1AF0\\nDichloroethylene: XM8G49\\nAcetylene dichloride: XM7JZ1\\nVinylidene chloride: XM3DX7\\nDichloromethane: XM73T7\\nDichloromethane vapor: XM7EF6\\nDioxin: XM9Y80\\nEthyl chloride: XM45K4\\nEthylene chlorohydrin: XM9B31\\nEthylene chlorohydrin vapor: XM5HK4\\nEthylene dichloride: XM4Z80\\nEthylene dichloride vapor: XM8QX0\\nHexachlorocyclohexane: XM8PE4\\nMethoxychlor: XM0MD1\\nOrthodichlorobenzene: XM42E8\\nPentachloroethane: XM5JU8\\nPolybrominated biphenyl: XM59S9\\nPolychlorinated biphenyl: XM77J7\\nTetrachloroethane: XM4D89\\nTetrachloroethane vapor: XM4N54\\nTetrachloroethylene: XM3DA8\\nTetrachloroethylene vapor: XM86D7\\nTrichloroethane: XM9R55\\ntrichloroethane: XM1992\\nTrichloroethylene: XM3NB3\\nTrichloroethylene vapor: XM7YS9\\nTrichloropropane: XM58Q9\\nArsenic: XM2KQ2\\nArsine: XM00Z1\\nCacodyl: XM0DR1\\nCacodylic acid: XM6C50\\nChlorovinyldichloroarsine: XM1BL4\\nCopper\\xa0arsenic complex: XM8SC0\\nDiphenylchlorarsine: XM9YA9\\nEthyl dichloroarsine: XM1AE2\\nLead arsenate: XM8LC6\\nLead arsenite: XM3M96\\nPotassium arsenite: XM4TW8\\nRealgar: XM32L9\\nSodium arsenate: XM7H00\\nSodium arsenite: XM7Y18\\nArsenic pesticide not elsewhere classified: XM4GU5\\nAsbestos: XM53B3\\nBarium nonmedicinal: XM8SU1\\nBarium carbonate: XM3709\\nBarium chloride: XM5DL6\\nBarium sulfite: XM38G1\\nBorane complex: XM8QL6\\nBoron: XM2BF4\\nBoron hydride: XM3FZ9\\nBoron trifluoride: XM5AP1\\nCalcium dichromate: XM0XT5\\nChloramine: XM4QG2\\nDecaborane: XM5JW5\\nDecaborane fumes: XM74T0\\nHydrogen chloride: XM97M0\\nManganese: XM3FY4\\nManganese dioxide: XM9ZR0\\nPermanganate: XM1FQ3\\nPotassium permanganate nonmedicinal: XM3VC7\\nPhosphorus: XM2AZ6\\nPhosphine: XM3G46\\nYellow phosphorus: XM0LP4\\nPotassium perchlorate nonmedicinal: XM95X4\\nPotassium Fluoride: XM2SG3\\nPotassium nitrate: XM2G85\\nSodium bichromate: XM5XL5\\nSodium chromate: XM9EQ8\\nSodium nitrate: XM7FZ2\\nErionite: XM3M65\\nAlum nonmedicinal: XM68C9\\nAlum ammonium: XM9CV4\\nAlum potassium: XM5GN1\\nAluminium nonmedicinal: XM7JJ2\\nAluminium phosphide: XM3TB8\\nAntimony: XM5HW4\\nAntimony hydride: XM2AE9\\nAntimony pesticide not elsewhere classified: XM81B2\\nBeryllium: XM4QG7\\nBismuth nonmedicinal: XM0TX8\\nBrass: XM4DZ8\\nCadmium: XM0V73\\nCadmium carbonate: XM3S39\\nCadmium chloride: XM3YF2\\nCadmium selenide: XM4YU7\\nCadmium succinate: XM9217\\nCadmium sulfate: XM0TH7\\nCadmium sulfide nonmedicinal: XM5YV2\\nCadmium pesticide not elsewhere classified: XM1TW0\\nChromium: XM9YJ8\\nChromic acid: XM95L9\\nChromyl chloride: XM79V9\\nPotassium dichromate: XM0QY9\\nChromium VI compounds: XM34P0\\nCobalt: XM1NV2\\nCopper: XM5KH2\\nCopper acetate: XM5U84\\nCopper hydroxide: XM0EX6\\nCopper oxide: XM0Y98\\nCopper oxychloride: XM48K0\\nCopper sulfate nonmedicinal: XM6859\\nOxinecopper: XM98Z3\\nVerdigris: XM30V1\\nCopper pesticide not elsewhere classified: XM3757\\nIron nonmedicinal: XM8U54\\nLead: XM0ZH6\\nLead acetate nonmedicinal: XM5071\\nLead alkyl: XM17Q5\\nLead antimonate: XM2PV9\\nLead azide: XM9WK6\\nLead carbonate: XM3Y96\\nLead chromate: XM91V9\\nLead dioxide: XM59W8\\nLead iodide: XM4EW1\\nLead monoxide: XM7LD9\\nLead oxide: XM2R16\\nLead sulfide: XM3ZU1\\nLead paint not elsewhere classified: XM0891\\nLithium nonmedicinal: XM4AM4\\nMercury: XM1FG4\\nEthyl mercuric chloride: XM8JX9\\nMethoxyethyl mercuric chloride: XM90P2\\nMercuric chloride nonmedicinal: XM9524\\nMercuric cyanide nonmedicinal: XM39J4\\nMercuric\\xa0oxide nonmedicinal: XM5X38\\nMercuric sulfate nonmedicinal: XM8HV3\\nMercury fulminate: XM4WJ1\\nMercury thiocyanate: XM3W50\\nMethyl mercury: XM5DJ5\\nPhenylmercury acetate: XM2Z22\\nMercury pesticide not elsewhere classified: XM7UW8\\nNickel: XM4E11\\nNickel carbonyl: XM9P91\\nNickel sulphate: XM7K88\\nNickelocene: XM5F09\\nSilver nonmedicinal: XM9359\\nTellurium: XM0XQ4\\nThallium: XM63C5\\nThallium sulfate: XM9YD2\\nTin: XM1NS5\\nTin chloride: XM9KC4\\nTin oxide: XM0K92\\nTitanium: XM7B62\\nTitanium tetrachloride: XM4WJ2\\nTitanocene: XM89Q2\\nVanadium: XM0907\\nAmalgam: XM7UJ7\\nPalladium chloride: XM0FY1\\nMetal not elsewhere classified: XM6NP0\\nHard metal dust: XM3AW0\\nOsmium: XM1UC6\\nTungsten: XM0JD9\\nMethyl acrylate: XM5H13\\nMonosodium glutamate: XM34R5\\nMycotoxin: XM5490\\nAflatoxin: XM7U84\\nCitreoviridin: XM0232\\nCitrinin: XM4UE5\\nCyclopiazonic acid: XM3NK1\\nFusarium toxin: XM3G74\\nErgot alkaloid mycotoxin: XM2BE5\\nFumonisin: XM9C09\\nMoniliformin: XM9GV7\\nTrichothecenes: XM6X33\\nZearalenone: XM4E53\\nNitropropionic acid: XM9F85\\nOchratoxin: XM5WG7\\nPatulin: XM9C47\\nPenitrem: XM28H1\\nSatratoxin: XM77Q2\\nSterigmatocystin: XM6VH6\\nTenuazonic acid: XM1PM8\\nNaphthylamine: XM6PE4\\nAcetal: XM50A4\\nAcetaldehyde: XM4LM8\\nAcetaldehyde vapor: XM5Q94\\nAcetic acid ester: XM6QH4\\nAmyl acetate: XM2KF5\\nAmyl acetate vapor: XM1JM2\\nBenzyl acetate: XM5AK0\\nButyl acetate: XM3RG6\\nCyclohexyl acetate: XM3AP0\\nEthyl acetate: XM00H9\\nIsobutyl acetate: XM3MD8\\nIsopropyl acetate: XM1EQ5\\nMethyl cyclohexyl acetate: XM27U4\\nAcetonitrile: XM6XW9\\nAmyl formate: XM5HX1\\nBenzene: XM0QY7\\nBenzene homologue: XM2738\\nButyltoluene: XM4214\\nHexylresorcinol: XM01R0\\nHydroquinone: XM50B6\\nHydroquinone vapor: XM1N69\\nToluene: XM00E9\\nXylene: XM0D44\\nBenzene\\xa0vapor: XM3TU9\\nDiphenylmethane: XM9UH2\\nNitroderivative or aminoderivative of benzene or benzene homologue: XM83H3\\nAniline: XM76E2\\nAniline vapor: XM0061\\nAnisidine: XM3R71\\nAzobenzene: XM1UP9\\nDinitroorthocresol: XM1ZR2\\nDichlorobenzidine: XM76A0\\nDinitrobenzene: XM11G0\\nDinitrobenzene vapor: XM54Q3\\nDinitrocyclohexylphenol: XM95M5\\nDinitrophenol: XM73Y7\\nDiphenylamine: XM2732\\nNitroaniline: XM0179\\nNitroaniline vapor: XM8M07\\nNitrobenzene: XM2W93\\nNitrobenzene vapor: XM2VA4\\nNitrobiphenyl: XM6GM2\\nNitrosodimethylamine: XM1MY0\\nNitrotoluene: XM6EB1\\nNitrotoluene vapor: XM5F24\\nPhenylenediamine: XM1E24\\nNisopropylNphenylpparaphenylenediamine: XM54V0\\npPhenylenediamine: XM0AK0\\nPhenylhydrazine: XM9BN0\\nTetryl: XM9ZV3\\nTNT: XM1X35\\nToluylenediamine: XM67F1\\nTrinitrobenzol: XM4B36\\nResorcin nonmedicinal: XM6ZJ9\\nStyrene: XM5V50\\nButyl butyrate: XM0M80\\nButyl formate: XM3XT7\\nButyl lactate: XM59Y7\\nButyl propionate: XM3NC8\\nDecahydronaphthalene: XM4DT3\\nDialkyl carbonate: XM8R64\\nEthyl carbonate: XM77E6\\nMethyl carbonate: XM7CR8\\nDichlorhydrin: XM38Z7\\nDimethylformamide: XM7MB5\\nDioxane: XM2XU7\\nDipentene: XM1LN6\\nEpichlorhydrin: XM5L21\\nEthyl benzoate: XM29X5\\nEthyl ether\\xa0nonmedicinal: XM0N40\\nPhenylglycidylether: XM5YV7\\nEthyl formate: XM6FX9\\nEthyl hydroxyisobutyrate: XM7TN8\\nEthyl lactate: XM3NZ9\\nEthyl oxybutyrate: XM6FQ2\\nFurfural: XM7QX9\\nHexahydrobenzene: XM4QR6\\nIsophorone: XM2D79\\nIsophoronediisocyanate: XM4XC6\\nIsophoronediamine: XM58V1\\nIsopropyl ether: XM38W0\\nKetones: XM9UX0\\nAcetone: XM7U59\\nNail polish remover: XM0ES5\\nAcetophenone: XM0AM0\\nCyclohexanone: XM1L02\\nDiacetone alcohol: XM9F73\\nHexanone: XM7KB7\\nHydroxymethylpentanone: XM5E65\\nMethyl acetate: XM12H2\\nMethyl acetone: XM9LD3\\nMethyl isobutyl ketone: XM5H65\\nNHexane and Methyl nbutyl ketone solvent: XM5LH2\\nBenzoquinone: XM4GN3\\nMethyl benzoate: XM6UK4\\nMethyl cyclohexane: XM4513\\nMethyl cyclohexanone: XM91A0\\nMethyl sulfate: XM5BM9\\nMethyl sulfate fumes: XM5Y11\\nNitropropane: XM5CA9\\nPetroleum: XM0TB3\\nPetroleum product: XM7MJ9\\nAutomobile fuel: XM27Z5\\nAutomobile fuel vapor: XM7CM2\\nGas oil: XM4RN1\\nDiesel fuel: XM9A95\\nGasoline: XM8WE9\\nGasohol: XM52C5\\nGasoline vapor: XM0FK9\\nCoal tar fumes: XM81T5\\nCoal tar naphtha: XM6U93\\nCoal tar nonmedicinal: XM2CE3\\nPitch: XM16M2\\nAnthracene: XM7WM1\\nKerosene: XM2Q78\\nKerosine vapor: XM3QU8\\nMineral oil nonmedicinal: XM3SU8\\nLubricating oil: XM4NT9\\nMineral spirits: XM7CX7\\nMineral spirits fumes: XM2E62\\nParaffin wax: XM8PX9\\nPetrolatum nonmedicinal: XM3ZG5\\nSolid petroleum: XM9WJ0\\nTar: XM4C94\\nTar fumes: XM5LE8\\nPetroleum pesticide not elsewhere classified: XM8AA6\\nPetroleum vapor: XM0B41\\nPhosphate solvent: XM02T2\\nTricresyl phosphate: XM5FS3\\nPyridine: XM2NF0\\nPyridine vapor: XM7TE7\\nTetrahydrofuran: XM5XP8\\nTetralin: XM2GY2\\nOrganic solvents not elsewhere classified: XM0W28\\nGlue: XM3U55\\nLighter fluid: XM0R56\\nPaint stripper: XM9B14\\nPolishing compound: XM0KG9\\nCar polish: XM39J1\\nFloor polish: XM1545\\nFurniture polish: XM2BC0\\nMetal polish: XM1J33\\nSilver polish: XM5J78\\nPorcelain\\xa0polish: XM1P52\\nPolyester resin hardener: XM3JF2\\nPolyester resin hardener fumes: XM3EF0\\nEthylene glycol: XM1762\\nEthylene glycol dinitrate: XM0WA9\\nEthylene glycol monobutyl ether: XM8BF5\\nEthylene\\xa0glycol\\xa0monoethyl\\xa0ether: XM4E62\\nEthylene\\xa0glycol\\xa0monomethyl\\xa0ether: XM0C04\\nDiethylene glycol: XM55M8\\nDiethylene glycol monoacetate: XM3834\\nDiethylene glycol monobutyl ether: XM1A56\\nDiethylene glycol monoethyl ether: XM8XU3\\nBrake fluid not elsewhere classified: XM99B7\\nBrake fluid vapor: XM8TE5\\nAcridine: XM9UE9\\nAcridine vapor: XM2QW2\\nDisperse dye: XM4UG8\\nLacquer: XM5C83\\nNitrocellulose lacquer: XM8B47\\nPrussian blue nonmedicinal: XM2FV2\\nWhitewash: XM9WW6\\nInk not elsewhere classified: XM6HZ8\\nPaint fumes not elsewhere classified: XM1XL9\\nDye not elsewhere classified: XM8H37\\nCochineal extract: XM3K54\\nParatertiary butylphenol formaldehyde resin: XM7U05\\nPhthalate: XM5B21\\nDiethylhexyl phthalate: XM75C9\\nDimethyl phthalate nonmedicinal: XM34N7\\nDinbutyl phthalate: XM9HC2\\nPoisonous mushroom: XM74S8\\nAgaricus xanthodermus mushroom: XM0366\\nAmanita mushroom: XM7P94\\nAmanita bisporigera mushroom: XM82H0\\nAmanita hygroscopica mushroom: XM5911\\nAmanita muscaria mushroom: XM91N3\\nAmanita ocreata mushroom: XM8MF4\\nAmanita phalloides mushroom: XM6HP7\\nAmanita pantherina mushroom: XM4NS6\\nAmanita pseudoporphyria hongo mushroom: XM23X2\\nAmanita suballiacea mushroom: XM2HH5\\nAmanita smithiana mushroom: XM3VN8\\nAmanita tenuifolia mushroom: XM5039\\nAmanita verna mushroom: XM0G40\\nAmanita virosa mushroom: XM1DV5\\nClitocybe mushroom: XM2FU2\\nClitocybe rivulosa mushroom: XM2BD5\\nConocybe filaris mushroom: XM9BX0\\nCortinarius mushroom: XM4CB0\\nCortinarius rubellus mushroom: XM85A8\\nCortinarius orellanus mushroom: XM9TZ1\\nCortinarius speciosissimus mushroom: XM2BB9\\nGalerina mushroom: XM1LD8\\nGalerina fasciculata mushroom: XM6W91\\nGalerina marginata mushroom: XM7NR0\\nGalerina sulcipes mushroom: XM24L3\\nGalerina venenata mushroom: XM78T5\\nGyromitra mushroom: XM0M17\\nGyromitra ambigua mushroom: XM0BM0\\nGyromitra esculenta mushroom: XM76X5\\nGyromitra infula mushroom: XM3LC5\\nHapalopilus rutilans\\xa0mushroom: XM1PK2\\nHebeloma crustuliniforme mushroom: XM87D0\\nInocybe mushroom: XM9B73\\nLepiota mushroom: XM2BC2\\nLepiota brunneoincarnata mushroom: XM7K06\\nLepiota brunneolilacea mushroom: XM4L76\\nLepiota chlorophyllum mushroom: XM0FJ0\\nLepiota fulvella mushroom: XM6882\\nLepiota helveola mushroom: XM1UJ5\\nLepiota josserandii mushroom: XM8R10\\nOmphalotus mushroom: XM95E9\\nOmphalotus nidiformis mushroom: XM8VV0\\nOmphalotus illudens mushroom: XM7RG5\\nPanaeolus mushroom: XM1M89\\nPanaeolus papilionaceus mushroom: XM3NJ2\\nPanaeolus sphinctrinus mushroom: XM0B62\\nPanaeolus subbalteatus mushroom: XM27Y3\\nPleurocybella porrigens mushroom: XM44P3\\nPodostroma cornudamae mushroom: XM3CK7\\nPsilocybe semilanceata mushroom: XM4321\\nRussula subnigricans mushroom: XM36C7\\nTricholoma equestre mushroom: XM0QR2\\nSilicone: XM9KE6\\nSilicon dioxide: XM3DP9\\nAbrus precatorius plant: XM98Y1\\nAconitum plant: XM99Y1\\nAconitine: XM2WR7\\nAconitum ferox plant: XM3VB6\\nActaea plant: XM7BA0\\nActaea spicata: XM3QE1\\nAethusa cynapium plant: XM55K4\\nAnamirta cocculus plant: XM3AF3\\nPicrotoxin: XM6KR6\\nAntiaris toxicaria plant: XM8SE2\\nArum maculatum plant: XM2X16\\nAtropa belladonna plant: XM1EY0\\nAzadirachta plant: XM17F2\\nBergamot oil: XM5W16\\nBitter almond: XM1GJ1\\nDiallyl disulfide: XM4XS8\\nSesquiterpene lactones: XM6A31\\nCitronellol: XM4W45\\nCitral: XM9CQ1\\nEugenol: XM6CP3\\nEvernia prunastri extract: XM9CZ8\\nIsoeugenol: XM5AM5\\nAbietic acid: XM88U7\\nTurpentine oil: XM9L39\\nAtranorin: XM3B42\\nBlighia sapida plant: XM4BW2\\nEvernic acid: XM6635\\nUsnic acid: XM26G6\\nGrains and flours: XM3XH8\\nPlant or herbal extracted compounds: XM21W4\\nFolium stramoniae: XM7CA8\\nEphedra: XM1D48\\nBenzoin tincture: XM82G2\\nMenthol: XM9GX9\\nCianidanol: XM8UA9\\nGelsemine: XM4Y73\\nPalm kernel oil: XM2YX0\\nTragacanth: XM1PQ5\\nDatura stramonium plant: XM8VJ2\\nRubber: XM8MB5\\nCotton plant: XM0XN7\\nSisal: XM1KF1\\nBrucea javanica plant: XM2BX6\\nCaladium plant: XM9B82\\nCaladium bicolor: XM1021\\nCaladium seguinum: XM0BS2\\nCannabis natural phytocannabinoids: XM9S25\\nAfghanistan black: XM08L6\\nIndian hemp: XM5WR8\\nLebanese red: XM3R78\\nMarijuana: XM8PV1\\nCelastrus scandens plant: XM0WA6\\nCerbera plant: XM5L03\\nCerbera odollam plant: XM2KR7\\nCerbera manghas plant: XM1FN8\\nCerbera venenifera plant: XM8AZ9\\nChelidonium majus plant: XM9DJ3\\nChrysanthemum cinerariifolium plant: XM49V0\\nPyrethrin nonmedicinal: XM5HR7\\nCicuta maculata plant: XM6709\\nCicutoxin: XM1S86\\nCinnamomum camphora plant: XM6YA3\\nClematis plant: XM5804\\nClematis vitalba plant: XM5D25\\nCoffee: XM9KW2\\nColchicum plant: XM7TP8\\nColchicine: XM3Q99\\nConium maculatum plant: XM9Z51\\nConiine: XM3FY5\\nConvallaria majalis plant: XM9T69\\nCyclamen plant: XM72P9\\nCyclamen europaeum plant: XM56R9\\nCyclamen persicum plant: XM5174\\nCytisus laburnum plant: XM5ZF9\\nCytisus scoparius plant: XM2YN7\\nDaphne plant: XM4TF9\\nDelphinium plant: XM8YH8\\nDerris elliptica plant: XM3KT4\\nDigitalis purpurea plant: XM46Y1\\nErythroxylum coca lam plant: XM1LE7\\nCocaine: XM7UN8\\nCocaine topical anesthetic: XM0BC6\\nEquisetum plant: XM0XS0\\nEquisetum diuretic: XM0EC2\\nEuphorbia plant: XM4TJ7\\nGaultheria procumbens plant: XM91T0\\nGaultheria procumbens plant oil: XM5P41\\nGelsemium sempervirens plant: XM1VX3\\nGloriosa superba plant: XM66Z7\\nGratiola officinalis plant: XM5EL7\\nHelleborus niger plant: XM3QP5\\nHelleborus viridis plant: XM0SF4\\nHyoscyamus niger plant: XM4UC8\\nIlex plant: XM3EA9\\nJatropha plant: XM7ED8\\nJatropha curcas plant: XM8QC3\\nJatropha gossypiifolia plant: XM7CZ8\\nJatropha hastata plant: XM2C70\\nJatropha macrorhiza plant: XM4R06\\nJatropha multifida plant: XM84E3\\nJatropha podagrica plant: XM04B0\\nLatex: XM7762\\nLathyrus sativus plant: XM5EH9\\nLigustrum plant: XM5F38\\nLigustrum lucidum plant: XM1WT1\\nLigustrum sinense plant: XM4CK0\\nLigustrum vulgare plant: XM23X8\\nLobelia plant: XM2BQ5\\nLolium temulentum plant: XM76G6\\nManihot esculenta plant: XM6LL4\\nMelia azedarach plant: XM1TB2\\nMyristica fragrans plant: XM3M91\\nNutmeg oil: XM6FE5\\nMyristicin: XM31J1\\nMyrsine africana plant: XM14Y1\\nNerium oleander plant: XM3XT1\\nNicotiana plant: XM2VY1\\nTobacco: XM88J8\\nNux vomica plant: XM33X3\\nBrucine: XM7134\\nStrychnine: XM5421\\nStrychnine rodenticide: XM9JS2\\nPhysostigma venenosum plant: XM7JG0\\nPhytolacca decandra plant: XM61M4\\nPine oil: XM19G9\\nPiper cubeba plant: XM1XZ4\\nPoison oak plant: XM21J6\\nPoison sumak plant: XM4882\\nPrimula plant: XM95D5\\nPrimula obconica plant: XM9HN7\\nPrimin: XM07P7\\nPrimula officinalis plant: XM4TX6\\nPrimula veris plant: XM19S7\\nPrunus plant: XM3QL7\\nAmygdalin: XM01R5\\nApricot kernel: XM0PX4\\nCherry kernel: XM5MK6\\nPeach kernel: XM7B39\\nPlum kernel: XM52C3\\nPsoralea corylifolia plant: XM6Z57\\nPsoralen nonmedicinal: XM1MV4\\nPulsatilla plant: XM03C0\\nPyrrolizidine alkaloids: XM3PV6\\nRanunculus plant: XM0NB5\\nRicinus communis plant: XM0PR3\\nRicin: XM2VG9\\nRuta graveolens plant: XM4AC2\\nSambucus plant: XM7BE0\\nSanguinaria canadensis plant: XM9W70\\nSchoenocaulon officinale plant: XM0EH6\\nSabadilla insecticide: XM4BY7\\nSenecio vulgaris plant: XM8YX9\\nSolanum plant: XM4TE3\\nSolanum dulcamara plant: XM56G1\\nSolanum nigrum plant: XM1AE1\\nSolanum pseudocapsicum plant: XM0QV6\\nSolanine: XM9588\\nSpartium junceum plant: XM4UE4\\nStrophanthus gratus plant: XM9834\\nStrophanthink: XM9QZ9\\nTanacetum plant: XM58G8\\nTartaric acid: XM7EL5\\nTaxus plant: XM5YT6\\nThevetia peruviana plant: XM6WF4\\nToxicodendron radicans plant: XM40N4\\nUrginea maritima plant: XM46N0\\nScilliroside: XM0SG7\\nUrtica plant: XM84R4\\nVeratrum plant: XM5KR7\\nVeratrum album plant: XM86L8\\nVeratrum viride plant: XM9Z08\\nWisteria plant: XM43H5\\nWisteria floribunda plant: XM29R2\\nWisteria sinensis plant: XM8ZH3\\nZygadenus plant: XM6076\\nPlant derived pesticide not elsewhere classified: XM8PU3\\nPoisonous plant berries not elsewhere classified: XM98M9\\nPoisonous plant flowers not elsewhere classified: XM7MT6\\nPoisonous plant fruits not elsewhere classified: XM6LL5\\nPoisonous plant leaves not elsewhere classified: XM2BH3\\nPoisonous plant roots not elsewhere classified: XM0GB3\\nPoisonous plant sap not elsewhere classified: XM2CE0\\nPoisonous plant seeds not elsewhere classified: XM7JK8\\nPoisonous plant stem not elsewhere classified: XM7KY1\\nPoisonous plant thorns not elsewhere classified: XM56V2\\nSubstance of marine plant origin not elsewhere classified: XM5NH2\\nPlant protein: XM8A62\\nAmerican beech wood dust: XM7A46\\nOak wood dust: XM4M03\\nEuropean ash wood dust: XM6VG6\\nApple: XM1K52\\nBanana: XM07U6\\nGrape: XM77D3\\nKiwifruit: XM4TY6\\nMango: XM6AW1\\nMelon: XM0DF7\\nOlive: XM2Q13\\nOrange: XM2XN1\\nPaprika: XM9UT8\\nCabbage: XM7S13\\nGrapefruit: XM5J64\\nBlack pepper: XM5733\\nGreen bean: XM9BG0\\nSpinach: XM25M2\\nMexican firebush: XM3EW6\\nRice: XM3XQ1\\nPecan or hickory nut: XM9135\\nPeach: XM5S85\\nPear: XM4GG6\\nStrawberry: XM5ZK9\\nPineapple: XM6E89\\nBarley: XM9MB5\\nBahia grass: XM47Z9\\nBermuda grass: XM5ZN2\\nBuckwheat: XM13D1\\nCorn: XM3GC8\\nGluten: XM56U7\\nJapanese hop: XM9898\\nJohnson grass: XM39Y3\\nKentucky blue grass: XM0D79\\nOat: XM8X04\\nRye: XM6JA2\\nPerennial rye grass: XM01D6\\nCultivated rye: XM8M82\\nSalt grass: XM4BW3\\nSweet vernal grass: XM13U2\\nTimothy: XM94M9\\nAvocado: XM63G5\\nBaker yeast: XM1E00\\nCarrot: XM9S46\\nCelery: XM1PN2\\nCocksfoot: XM5TW0\\nCocoa: XM9SJ1\\nCommon pigweed: XM9DZ5\\nCommon ragweed: XM5V61\\nEnglish plantain: XM3KE2\\nGarlic: XM40Y5\\nGoosefoot: XM4GX7\\nGiant ragweed: XM1X29\\nLentils: XM45L6\\nLettuce: XM6798\\nMugwort: XM0L96\\nMustard: XM7GY3\\nNettle: XM8F26\\nOnion: XM9KB5\\nPea: XM56E2\\nPotato: XM9J59\\nRough pigweed: XM3VS0\\nSheep sorrel: XM72E8\\nSoybean: XM3TW1\\nTomato: XM72C5\\nWall pellitory: XM3LL8\\nWestern ragweed: XM42C5\\nWhite bean: XM0GA2\\nWormwood: XM9S45\\nAlmond: XM60Q8\\nAmerican beech: XM1304\\nArizona cypress: XM5TH6\\nBrazil nut: XM3ES3\\nCedar elm: XM9GG3\\nCoastal maple: XM36B2\\nCoconut: XM6MF9\\nCottonwood: XM9JG2\\nEnglish walnut pollen: XM2044\\nCashew nut: XM2EQ3\\nGrey alder: XM7QD6\\nHazelnut: XM7L19\\nItalian cypress: XM4WW3\\nJapanese cedar: XM3940\\nJapanese cypress: XM8QG1\\nMacadamia: XM9AZ7\\nMesquite: XM0QL5\\nMountain juniper: XM7G21\\nPaper mulberry: XM8K37\\nPeanut: XM6Q82\\nPecan or hickory tree: XM1QN3\\nPine nut: XM7833\\nPistachio: XM2B46\\nRed maple: XM34T8\\nRed mulberry: XM03B3\\nSesame seed: XM1L09\\nSilver birch: XM30J5\\nWalnut: XM3DB3\\nWattle: XM5VB3\\nWestern white pine: XM3ZG1\\nWhite ash: XM3DL1\\nWhite birch: XM3VX2\\nWhite hickory: XM6V15\\nWhite mulberry: XM5AD4\\nWillow: XM4YR5\\nRed top grass: XM8SV5\\nPacific squid: XM6SX5\\nLemon: XM7AS2\\nSunflower seed: XM2YD2\\nChick pea: XM2XV2\\nSweet gum: XM1FG7\\nGumtree: XM1A07\\nCherry: XM0885\\nHuman seminal plasma: XM0RZ0\\nToluidine: XM7FG4\\nToluidine vapor: XM7S87\\nTriorthocresyl phosphate: XM5NA2\\nTriphenyl phosphate: XM90U0\\nVinyl acetate: XM3FJ3\\nVinyl bromide: XM6A87\\nEpoxy resin not elsewhere classified: XM23X0\\nButylglycidylether: XM9MV5\\nChromium sesquioxide: XM87D3\\nBorate buffer: XM83G3\\nCyclamate: XM1FY5\\nSaccharin: XM7CN5\\nSodium propyl hydroxybenzoate: XM5567\\nSodium barbiturate: XM16M4\\nIminostilbene: XM6DJ2\\nNCyclohexylbenzothiazyl sulphenamide: XM45E1\\nDibenzothiazyl disulphide: XM90X8\\nDipentamethylenethiuram disulphide: XM2RH1\\nTetramethylthiuram monosulphide: XM3BY9\\nMorpholinylmercaptobenzothiazole: XM1A88\\nDetergent nonmedicinal not elsewhere classified: XM0XA8\\nDisinfectant not elsewhere classified: XM7DD6\\nScouring powder not elsewhere classified: XM5151\\nShampoo not elsewhere classified: XM8VR0\\nSoap not elsewhere classified: XM8B44\\nWindow cleaning fluid not elsewhere classified: XM5FV8\\nParatertiary butylphenol: XM6PY1\\nMethylcoumarin: XM6000\\nDiaminodiphenyl methane: XM2EK8\\nHydroxyisohexyl cyclohexene carboxaldehyde: XM7N15\\nFarnesol: XM2TV3\\nBisphenol Aglycidyl methacrylate: XM3MM6\\nHydroxyethylmethacrylate: XM0BY4\\nDiurethane dimethacrylate: XM90H5\\nMethyl methacrylate: XM49C3\\nDiethanolamine: XM58E5\\nDiethylenetriamine: XM0L39\\nHexamethylenetetramine: XM2TA7\\nTriethylenetetramine: XM7QN7\\nBisphenol A: XM1GH9\\nCresylglycidylether: XM7AX9\\nBromonitropropanediol: XM1AH4\\nMercaptobenzothiazole: XM3TN8\\nEthylhexyl methoxycinnamate: XM2ZT3\\nOctocrylene: XM63U8\\nOctyltriazone: XM3YZ8\\nAminoethylisothiourium: XM8VV3\\nSodium cacodylate nonmedicinal: XM7W63\\nButylated hydroxyanisole: XM6GU7\\nCoenzyme A: XM2YA2\\nCogalactoisomerase: XM4S70\\nLactose as excipient: XM1X04\\nMethylethyl cellulose: XM82Y6\\nPentane: XM39E8\\nBenzisothiazolinone: XM2RB2\\nMethylenebismethyloxazolidine: XM6XV7\\nDMDM hydantoin: XM88M1\\nMethylchloroisothiazolinone and methylisothiazolinone: XM8DV5\\nMethylisothiazolinone: XM87J0\\nMethyldibromo glutaronitrile and phenoxyethanol: XM9NB7\\nMethyl parahydroxybenzoate: XM04A1\\nEthyl parahydroxybenzoate: XM1CG8\\nPropyl parahydroxybenzoate: XM0XV1\\nButyl parahydroxybenzoate: XM38K5\\nDiazolidinyl urea: XM51H6\\nImidazolidinyl urea: XM5TQ9\\nFentichlor: XM0562\\nSoldering fluid not elsewhere classified: XM6F66\\nBone meal: XM44A4\\nFungus eaten in food not elsewhere classified: XM77G6\\nClaviceps purpurea: XM00E5\\nNoxious meat non bacterial not elsewhere classified: XM4L77\\nAnimal protein: XM3825\\nChicken: XM9Y41\\nChicken feather: XM4500\\nCockatiel droppings: XM66A9\\nCockatiel feather: XM9LW5\\nCockatiel serum: XM9JZ2\\nEgg white: XM6AD6\\nWhole egg: XM2E06\\nEgg yolk: XM9CD1\\nGoose feather: XM2PB2\\nDuck feather: XM3LH5\\nFish: XM95M8\\nCodfish: XM6BL6\\nSalmon: XM8Q65\\nTuna: XM3QU9\\nHalibut: XM31E6\\nSardine: XM8Y82\\nTrout: XM64N8\\nCrab: XM5MB3\\nLobster: XM9JT3\\nShrimp: XM7E84\\nOyster: XM55Z4\\nOctopus: XM66P3\\nBlomia tropicalis: XM6ZC1\\nAmerican house dust mite: XM5AK3\\nDermatophagoides pteronyssinus: XM8BV4\\nMite dust: XM99T8\\nMosquito: XM0B91\\nAedes: XM95T4\\nAnopheles: XM7VF0\\nCulex: XM0ZZ8\\nMoth: XM3WD1\\nCockroach: XM0K01\\nAmerican cockroach: XM27E1\\nMilk: XM8RU4\\nCow milk: XM6RB2\\nGoat milk: XM4Y68\\nCheese: XM4JV9\\nCheese cheddar type: XM5GA5\\nCheese mold type: XM3FK1\\nEthylenediamine dihydrochloride: XM5T39\\nVarnish not elsewhere classified: XM15W5\\nSoot not elsewhere classified: XM6MC4\\nAromatic amine: XM4VX8\\nAntiseptic not elsewhere classified: XM6ZV1\\nBetanaphthylamine: XM60L2\\nHouse dust: XM76S9\\nWheat dust: XM7XM0\\nMain condition: XY0Y\\nMain resource condition: XY7B\\nInitial reason for encounter or admission: XY6E\\nPresent on admission: XY6M\\nDeveloped after admission: XY69\\nUncertain timing of onset relative to admission: XY85\\nPreoperative: XY9U\\nIntraoperative: XY9N\\nPostoperative: XY7V\\nDiagnosis confirmed by laboratory examination: XY3B\\nDiagnosis confirmed by serology: XY0E\\nDiagnosis confirmed by histology: XY9Q\\nDiagnosis confirmed by genetics: XY8K\\nDiagnosis confirmed by imaging: XY9R\\nDiagnosis confirmed by microscopy: XY19\\nDiagnosis confirmed by culture: XY0K\\nProvisional diagnosis: XY7Z\\nDifferential diagnosis: XY75\\nDelivered with or without mention of antepartum condition: XY3K\\nDelivered with mention of postpartum condition: XY8Q\\nAntepartum condition or complication: XY8U\\nPostpartum condition or complication: XY9P\\nUnspecified as to episode of care or not applicable: XY9S\\nInitial encounter: XY18\\nSubsequent encounter: XY8S\\nCondition of the fetus and newborn reported in the context of the mother: XX2QG9\\nFemale: XX2V25\\nMale: XX2UQ8\\nIntersex: XX45B7\\nBiological sex not specified: XX2PX3\\nCentral venous catheters: XD7FF9\\nStethoscopes: XD4ZY0\\nStethoscopes Binaural: XD8DB0\\nStethoscopes MRI: XD04L8\\nDialysis filters: XD8V84\\nHaemodialysis hemofiltration haemodiafiltration filters: XD8DD4\\nDialyzers UHF   mlhmmHg: XD1904\\nDialyzers UHF   mlhmmHg cellulose membranes: XD2T66\\nDialyzers UHF   mlhmmHg substituted cellulose membranes: XD4S95\\nDialyzers UHF   mlhmmHg synthetic membranes: XD4379\\nDialyzers UHF   mlhmmHg others: XD8UZ1\\nDialyzers UHF    mlhmmHg: XD4WX5\\nDialyzers UHF    mlhmmHg cellulose membranes: XD9RP1\\nDialyzers UHF    mlhmmHg substituted cellulose membranes: XD0XB0\\nDialyzers UHF    mlhmmHg synthetic membranes: XD2KD5\\nDialyzers UHF    mlhmmHg others: XD7ZP1\\nDialyzers for special hemodiafiltration and other therapies: XD8VS0\\nHemoperfusion filters: XD1V74\\nHemoperfusion carbon filters: XD27T5\\nHemoperfusion resin filters: XD2RV2\\nHemoperfusion filters others: XD9GN2\\nAbsorption filters and columns: XD5TA3\\nImmunoabsorption filters and columns: XD8NE7\\nImmunoabsorption filters: XD0TG6\\nImmunoabsorption columns: XD6RX5\\nEndotoxin removal filters and columns: XD3RD1\\nEndotoxin removal filters: XD5SV0\\nEndotoxin removal columns: XD6KC0\\nHaemodialysis filters others: XD5DX9\\nDialysis lines: XD6F86\\nDialysis lines haemodialysishaemofiltrationhaemodiafiltration: XD12J0\\nArterovenous dialysis lines one needle: XD5BR1\\nArterovenous dialysis lines two needles: XD0B51\\nReinfusion dialysis lines: XD5ED6\\nArterovenous dialysis lines accessories: XD8QE4\\nArterovenous dialysis lines others: XD0270\\nPeritoneal dialysis lines: XD65W3\\nPermanent peritoneal dialysis lines: XD51F1\\nPermanent peritoneal dialysis lines one bag CAPD: XD65K8\\nPermanent peritoneal dialysis lines two bags CAPD: XD6QD1\\nPermanent peritoneal dialysis lines others: XD0DE3\\nTemporary peritoneal dialysis lines: XD8H28\\nTemporary peritoneal dialysis lines gravimetric APD: XD6606\\nTemporary peritoneal dialysis lines with pump APD: XD89M1\\nTemporary peritoneal dialysis lines others: XD2M70\\nPeritoneal dialysis lines accessories: XD4SJ0\\nPeritoneal dialysis lines others: XD2WX9\\nDialysis lines others: XD0ZQ3\\nDialysis sets: XD83M2\\nHaemofiltrationhaemodiafiltration sets: XD0KV9\\nBiofiltration sets: XD0R67\\nHaemodialysis sets: XD6TC6\\nDialysis washingfilling sets: XD80S8\\nHemoperfusion sets: XD2QE7\\nContinuous dialysis sets: XD7QD7\\nUltrafiltration sets: XD5KR3\\nDialysis sets others: XD9Z50\\nDialysates: XD5C20\\nDialysates acid solutions: XD62N1\\nDialysates acid solutions nonsterile: XD3V66\\nDialysates acid solutions sterile: XD1KF2\\nDialysates basic solutions: XD0UL9\\nDialysates basic solutions powder: XD2JY9\\nDialysates basic solutions liquid: XD5240\\nDialysates without acetate buffer: XD6LX2\\nDialysates without acetate buffer AFB: XD9594\\nDialysates without acetate buffer other treatments: XD6W13\\nDialysis procedures salts: XD7157\\nDialysates others: XD67E6\\nDialysis devices various: XD8VC9\\nPeritoneal dialysis devices not in other groups: XD18U5\\nPeritoneal dialysis catheters: XD7RE0\\nPeritoneal dialysis others: XD47T0\\nVascular access devices only for haemodialysis: XD8689\\nTemporary haemodialysis catheters: XD9YY6\\nPermanent haemodialysis catheters: XD3AU4\\nVascular access devices only for haemodialysis others: XD3297\\nDialysis adaptors: XD2EM7\\nHaemodialysis adaptors: XD8Q72\\nPeritoneal dialysis adaptors: XD39M3\\nDialysate tanks collection and reinfusion: XD25C5\\nDialysate tanks collection: XD6LH4\\nHaemodialysate tanks collection: XD6MC0\\nPeritoneal dialysate tanks collection: XD22A9\\nDialysate tanks reinfusion: XD1ZR7\\nExtracorporeal dialysis devices: XD8A37\\nDialysis devices other accessories: XD9KW0\\nDialysis devices others: XD46Z0\\nNasogastric tube: XD53A5\\nNasopharyngeal tubes: XD9246\\nAirway guedel tubes: XD2M69\\nLaryngeal masks: XD78N3\\nEndotracheal tubes without cuff: XD0T92\\nEndotracheal tubes with cuff: XD37X2\\nEndotracheal tubes accessories: XD3UM6\\nTracheolaryngostomy cannulas and kits with cuff: XD2MG6\\nBipapCPAP circuits: XD7EB1\\nRespiratory masks and balloons singleuse and reusable: XD5GF6\\nAiroxygen masks and nasal cannulas: XD3W67\\nAiroxygen masks: XD0VQ3\\nVenturi masks: XD5RM4\\nAiroxygen nasal cannulas: XD61Z5\\nOxygen administration tubings: XD5AL4\\nHandoperated ventilation balloons: XD51T0\\nVentilation filters antibacterial and antiviral moisturizer: XD9AF0\\nRespiratory suction probes and systems: XD35D5\\nHumidifying systems oxygen administration: XD76M0\\nExamination  treatment gloves nitrile: XD3ZH8\\nSurgical drapes: XD3LV8\\nSurgical gowns standard: XD4E80\\nStandard surgical face masks: XD9LJ2\\nUrological catheters selfretained: XD1ZP3\\nElectronic thermometers and end caps: XD2AJ4\\nClinical trays and bowls: XD97L1\\nCREACTIVE PROTEIN: XD5GV0\\nTransport media: XD9YL7\\nCoronavirusNA Reagents: XD9S44\\nCoronavirus diagnostic: XD9N16\\nOther Virology RT  POC: XD7M68\\nReagents for DNA andor RNA extraction and preparation  bacteria andor virus: XD1C76\\nBlood gas portable analysers: XD6EG0\\nSamples transport containers other: XD80L4\\nUltrasound Scanners: XD6EX8\\nUltrasound Scanners Mobile: XD89G9\\nUltrasound Scanners Portable: XD7FU9\\nUltrasound Scanners Handheld: XD4T57\\nBulk steam sterilizing units: XD8DR8\\nLaryngoscopes: XD0U91\\nVideolaryngoscopes: XD3JX1\\nContinuous positive airway pressure units CPAP: XD7EC8\\nTransportable ventilators: XD60Z6\\nIntensive care ventilators: XD3SM4\\nPortable multiparameter patient monitors: XD4KU3\\nPulse Oximeters: XD66D8\\nPulse Oximeters Tabletop: XD8QN4\\nPulse Oximeters Handheld: XD4U89\\nPulse Oximeters Spotcheck: XD5QV8\\nInfusion Pumps: XD8QY1\\nInfusion Pumps Volumetric: XD4CT3\\nInfusion Pumps Volumetric Nuclear Magnetic Resonance: XD52M6\\nInfusion Pumps Enteral nutrition: XD8DH3\\nInfusion Pumps Syringe: XD36Q1\\nInfusion Pumps Syringe Nuclear Magnetic Resonance: XD1N14\\nMedicalmedicinal gas systems and relative accessories: XD80Z7\\nGeneral purpose electrocardiographs: XD4U38\\nOxygen Concentrators: XD6UU3\\n\\nNow, given the following extracted lab test names from a report:\\n- Cholesterol Total\\nTriglycerides\\nHDL Cholesterol\\nLDL Cholesterol\\nVLDL Cholesterol\\nNon-HDL Cholesterol\\n\\nPlease map each extracted test to the closest matching ICD code from the given mapping. If no exact match exists, find the most semantically appropriate match.\\n\\nProvide the output in the format:\\n- Extracted Test: [Name]\\n- Mapped ICD Test: [Closest Lab Test Name]\\n- ICD Code: [Code]\\n'"
            ]
          },
          "execution_count": 21,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "prompt"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 23,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 36
        },
        "id": "fYQmUtAR9U8v",
        "outputId": "e64a612b-a7e9-4d25-fb68-6d7d43bfa8a1"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "'- Cholesterol Total\\n- Triglycerides\\n- HDL Cholesterol\\n- LDL Cholesterol\\n- VLDL Cholesterol\\n- Non-HDL Cholesterol'"
            ]
          },
          "execution_count": 23,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "lab_tests_response"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 24,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Q1SR_UxU9U8w",
        "outputId": "e69997f6-411f-404d-d75f-c793a2952592"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Extracted Lab Tests: - Cholesterol Total\n",
            "- Triglycerides\n",
            "- HDL Cholesterol\n",
            "- LDL Cholesterol\n",
            "- VLDL Cholesterol\n",
            "- Non-HDL Cholesterol\n"
          ]
        }
      ],
      "source": [
        "# # Convert response into a structured list\n",
        "extracted_lab_tests = [test.strip() for test in lab_tests_response.split(\"\\n-\") if test.strip()]\n",
        "print(\"Extracted Lab Tests:\", lab_tests_response)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 33,
      "metadata": {
        "id": "aktIDxrD9U8w"
      },
      "outputs": [],
      "source": [
        "# # Run with Claude Sonnet on Bedrock\n",
        "# response = chat_model(prompt)\n",
        "\n",
        "# # Print response\n",
        "# print(response)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 26,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "9AE2zY0F9U8x",
        "outputId": "102d32c4-83f3-47e7-a948-a96d0353df88"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting rapidfuzz\n",
            "  Downloading rapidfuzz-3.12.2-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (12 kB)\n",
            "Downloading rapidfuzz-3.12.2-cp311-cp311-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (3.1 MB)\n",
            "\u001b[?25l   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m0.0/3.1 MB\u001b[0m \u001b[31m?\u001b[0m eta \u001b[36m-:--:--\u001b[0m\r\u001b[2K   \u001b[91m━━━━━━━━━━━━━━━━━━━━━\u001b[0m\u001b[90m╺\u001b[0m\u001b[90m━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.7/3.1 MB\u001b[0m \u001b[31m43.5 MB/s\u001b[0m eta \u001b[36m0:00:01\u001b[0m\r\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m3.1/3.1 MB\u001b[0m \u001b[31m48.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: rapidfuzz\n",
            "Successfully installed rapidfuzz-3.12.2\n"
          ]
        }
      ],
      "source": [
        "!pip install rapidfuzz"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 27,
      "metadata": {
        "id": "N0gWkaNf9U8x"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "from rapidfuzz import process, fuzz\n",
        "\n",
        "# Load the ICD codes CSV file\n",
        "icd_df = pd.read_csv(\"/content/ICD_11_Codes.csv\")  # Replace with actual path"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 28,
      "metadata": {
        "id": "oNQPril69U8x"
      },
      "outputs": [],
      "source": [
        "# Assuming the CSV has columns: \"Lab Test Name\" and \"ICD Code\"\n",
        "icd_test_names = icd_df[\"Title\"].tolist()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 29,
      "metadata": {
        "id": "ZqsSeAK49U8x"
      },
      "outputs": [],
      "source": [
        "# Function to find the best match using fuzzy matching\n",
        "def find_best_icd_match(test_name, icd_test_names, icd_df):\n",
        "    match, score, index = process.extractOne(test_name, icd_test_names, scorer=fuzz.WRatio)\n",
        "    if score > 80:  # Set threshold for good match (adjust if needed)\n",
        "        return match, icd_df.iloc[index][\"Code\"], score\n",
        "    else:\n",
        "        return None, None, score\n",
        "\n",
        "# Map extracted lab tests to ICD codes\n",
        "mapped_tests = []\n",
        "for test in extracted_lab_tests:\n",
        "    best_match, icd_code, match_score = find_best_icd_match(test, icd_test_names, icd_df)\n",
        "    mapped_tests.append({\n",
        "        \"Extracted Test Name\": test,\n",
        "        \"Matched ICD Test Name\": best_match,\n",
        "        \"ICD Code\": icd_code,\n",
        "        \"Match Score\": match_score\n",
        "    })"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 30,
      "metadata": {
        "id": "kTY0aw2c9U8x"
      },
      "outputs": [],
      "source": [
        "# Convert to DataFrame and display results\n",
        "mapped_df = pd.DataFrame(mapped_tests)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 31,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 237
        },
        "id": "B9E7kU339U8y",
        "outputId": "cf7cacee-e39c-42e7-8727-309473e0ecc6"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"mapped_df\",\n  \"rows\": 6,\n  \"fields\": [\n    {\n      \"column\": \"Extracted Test Name\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \"- Cholesterol Total\",\n          \"Triglycerides\",\n          \"Non-HDL Cholesterol\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Matched ICD Test Name\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"Total external ophthalmoplegia\",\n          \"Cholesterol atheroembolism\",\n          \"Cholesterol atheroembolism to kidneys\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"ICD Code\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"9C81.3\",\n          \"BD53.4\",\n          \"BD53.40\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Match Score\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 3.2989095729418594,\n        \"min\": 77.41935483870968,\n        \"max\": 85.5,\n        \"num_unique_values\": 2,\n        \"samples\": [\n          77.41935483870968,\n          85.5\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "mapped_df"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-85f23bd4-a55b-4b3a-8de7-d6dc2a3c4d42\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Extracted Test Name</th>\n",
              "      <th>Matched ICD Test Name</th>\n",
              "      <th>ICD Code</th>\n",
              "      <th>Match Score</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>- Cholesterol Total</td>\n",
              "      <td>Total external ophthalmoplegia</td>\n",
              "      <td>9C81.3</td>\n",
              "      <td>85.500000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Triglycerides</td>\n",
              "      <td>None</td>\n",
              "      <td>None</td>\n",
              "      <td>77.419355</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>HDL Cholesterol</td>\n",
              "      <td>Cholesterol atheroembolism</td>\n",
              "      <td>BD53.4</td>\n",
              "      <td>85.500000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>LDL Cholesterol</td>\n",
              "      <td>Cholesterol atheroembolism</td>\n",
              "      <td>BD53.4</td>\n",
              "      <td>85.500000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>VLDL Cholesterol</td>\n",
              "      <td>Cholesterol atheroembolism</td>\n",
              "      <td>BD53.4</td>\n",
              "      <td>85.500000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>Non-HDL Cholesterol</td>\n",
              "      <td>Cholesterol atheroembolism to kidneys</td>\n",
              "      <td>BD53.40</td>\n",
              "      <td>85.500000</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-85f23bd4-a55b-4b3a-8de7-d6dc2a3c4d42')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-85f23bd4-a55b-4b3a-8de7-d6dc2a3c4d42 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-85f23bd4-a55b-4b3a-8de7-d6dc2a3c4d42');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-aed91269-00c0-46dd-b26f-4b4e9d7abe84\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-aed91269-00c0-46dd-b26f-4b4e9d7abe84')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-aed91269-00c0-46dd-b26f-4b4e9d7abe84 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_a60945b1-d135-42f1-94be-54a1efb5c745\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('mapped_df')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_a60945b1-d135-42f1-94be-54a1efb5c745 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('mapped_df');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Extracted Test Name                  Matched ICD Test Name ICD Code  \\\n",
              "0  - Cholesterol Total         Total external ophthalmoplegia   9C81.3   \n",
              "1        Triglycerides                                   None     None   \n",
              "2      HDL Cholesterol             Cholesterol atheroembolism   BD53.4   \n",
              "3      LDL Cholesterol             Cholesterol atheroembolism   BD53.4   \n",
              "4     VLDL Cholesterol             Cholesterol atheroembolism   BD53.4   \n",
              "5  Non-HDL Cholesterol  Cholesterol atheroembolism to kidneys  BD53.40   \n",
              "\n",
              "   Match Score  \n",
              "0    85.500000  \n",
              "1    77.419355  \n",
              "2    85.500000  \n",
              "3    85.500000  \n",
              "4    85.500000  \n",
              "5    85.500000  "
            ]
          },
          "execution_count": 31,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "mapped_df"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "HPyOBZdA9U8y"
      },
      "outputs": [],
      "source": []
    }
  ],
  "metadata": {
    "accelerator": "GPU",
    "colab": {
      "gpuType": "T4",
      "provenance": []
    },
    "kernelspec": {
      "display_name": "Python 3 (ipykernel)",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.11.10"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}
